PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	SC	GA	UT	PM	OA	HC	HP	DA
J	Bajaj, S; Vanuk, JR; Smith, R; Dailey, NS; Killgore, WDS				Bajaj, Sahil; Vanuk, John R.; Smith, Ryan; Dailey, Natalie S.; Killgore, William D. S.			Blue-light Therapy following Mild Traumatic Brain injury: effects on White Matter Water Diffusion in the Brain	FRONTIERS IN NEUROLOGY			English	Article						concussion; diffusion tensor imaging; fractional isotropy; isotropic diffusion; neuropsychological function; quantitative anisotropy; sleep; structural recovery	SLEEP LATENCY TEST; AXONAL INJURY; PREFRONTAL CORTEX; MEMORY; PERFORMANCE; INTEGRITY; DISTURBANCE; ACTIVATION; RESPONSES; COGNITION	Mild traumatic brain injury (mTBI) is a common and often inconspicuous wound that is frequently associated with chronic low-grade symptoms and cognitive dysfunction. Previous evidence suggests that daily blue wavelength light therapy may be effective at reducing fatigue and improving sleep in patients recovering from mTBI. However, the effects of light therapy on recovering brain structure remain unexplored. In this study, we analyzed white matter diffusion properties, including generalized fractional anisotropy, and the quantity of water diffusion in isotropic (i.e., isotropic diffusion) and anisotropic fashion (i.e., quantitative anisotropy, QA) for fibers crossing 11 brain areas known to be significantly affected following mTBI. Specifically, we investigated how 6 weeks of daily morning blue light exposure therapy (compared to an amber-light placebo condition) impacted changes in white matter diffusion in individuals with mTBI. We observed a significant impact of the blue light treatment (relative to the placebo) on the amount of water diffusion (QA) for multiple brain areas, including the corpus callosum, anterior corona radiata, and thalamus. Moreover, many of these changes were associated with improvements in sleep latency and delayed memory. These findings suggest that blue wavelength light exposure may serve as one of the potential non-pharmacological treatments for facilitating structural and functional recovery following mTBI; they also support the use of QA as a reliable neuro-biomarker for mTBI therapies.	[Bajaj, Sahil; Vanuk, John R.; Smith, Ryan; Dailey, Natalie S.; Killgore, William D. S.] Univ Arizona, Dept Psychiat, Coll Med, SCAN Lab, Tucson, AZ 85721 USA	Killgore, WDS (corresponding author), Univ Arizona, Dept Psychiat, Coll Med, SCAN Lab, Tucson, AZ 85721 USA.	killgore@psychiatry.arizona.edu	; Bajaj, Sahil/C-6580-2016	Smith, Ryan/0000-0002-4448-185X; Bajaj, Sahil/0000-0003-0629-6036; Dailey, Natalie S./0000-0003-4800-4118	U.S. Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-11-1-0056]	This research was supported by a U.S. Army Medical Research and Materiel Command Grant (W81XWH-11-1-0056) to WK. Opinions, interpretations, conclusions, and recommendations in this study are those of the author and are not necessarily endorsed by the Department of Defense. We would also like to thank Dr. Fang-Cheng Yeh for answering our enquires on numerous occasions during data analysis.	Aggleton JP, 2010, EUR J NEUROSCI, V31, P2292, DOI 10.1111/j.1460-9568.2010.07251.x; Alkozei A, 2016, SLEEP, V39, P1671, DOI 10.5665/sleep.6090; Armstrong RC, 2016, EXP NEUROL, V275, P328, DOI 10.1016/j.expneurol.2015.02.011; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Bekiesinska-Figatowska M, 2017, BRAIN DEV-JPN, V39, P203, DOI 10.1016/j.braindev.2016.10.003; Bellesi M, 2013, J NEUROSCI, V33, P14288, DOI 10.1523/JNEUROSCI.5102-12.2013; Benedetti F, 2017, J AFFECT DISORDERS, V218, P380, DOI 10.1016/j.jad.2017.05.008; Berger RP, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e31; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Browne KD, 2011, J NEUROTRAUM, V28, P1747, DOI 10.1089/neu.2011.1913; Carpenter JS, 2017, BRAIN IMAGING BEHAV, V11, P1741, DOI 10.1007/s11682-016-9650-2; CARSKADON MA, 1986, SLEEP, V9, P519, DOI 10.1093/sleep/9.4.519; Chellappa SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016429; Cicerone KD, 1996, BRAIN INJURY, V10, P277, DOI 10.1080/026990596124458; Cieslik EC, 2013, CEREB CORTEX, V23, P2677, DOI 10.1093/cercor/bhs256; Clarner T, 2012, GLIA, V60, P1468, DOI 10.1002/glia.22367; Correa A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164945; Dijk DJ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000145; Duffy JF, 2009, SLEEP MED CLIN, V4, P165, DOI 10.1016/j.jsmc.2009.01.004; Elvsashagen T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127351; Feldman HM, 2010, J DEV BEHAV PEDIATR, V31, P346, DOI 10.1097/DBP.0b013e3181dcaa8b; FlorinLechner SM, 1996, BRAIN RES, V742, P89, DOI 10.1016/S0006-8993(96)00967-5; Fong SYY, 2005, J PSYCHOSOM RES, V58, P55, DOI 10.1016/j.jpsychores.2004.05.004; FOOTE SL, 1991, PROG BRAIN RES, V88, P521; Fritzsche KH, 2010, NEUROIMAGE, V51, P242, DOI 10.1016/j.neuroimage.2010.02.007; Geary EK, 2010, J INT NEUROPSYCH SOC, V16, P506, DOI 10.1017/S135561771000010X; Huang XQ, 2015, INT J CLIN EXP MED, V8, P21991; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jiang CB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109984; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kumar R, 2012, J NEUROSCI RES, V90, P2043, DOI 10.1002/jnr.23083; Kurowski BG, 2016, J HEAD TRAUMA REHAB, V31, P369, DOI 10.1097/HTR.0000000000000180; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Ling JM, 2012, BRAIN, V135, P1281, DOI 10.1093/brain/aws073; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Little DM, 2010, NEUROLOGY, V74, P558, DOI 10.1212/WNL.0b013e3181cff5d5; Littner MR, 2005, SLEEP, V28, P113, DOI 10.1093/sleep/28.1.113; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Matsushita M, 2011, J NEUROSURG, V115, P130, DOI 10.3171/2011.2.JNS101547; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; McKay C, 2007, ARCH CLIN NEUROPSYCH, V22, P91, DOI 10.1016/j.acn.2006.11.003; Menzler K, 2012, SLEEP MED, V13, P736, DOI 10.1016/j.sleep.2012.02.013; Mierzwa AJ, 2015, J NEUROPATH EXP NEUR, V74, P218, DOI 10.1097/NEN.0000000000000165; Miller KE, 2008, EXP CELL RES, V314, P1981, DOI 10.1016/j.yexcr.2008.03.004; Mori S., 2005, MRI ATLAS HUMAN WHIT; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Paniak C, 2000, BRAIN INJURY, V14, P219; Parcell DL, 2006, ARCH PHYS MED REHAB, V87, P278, DOI 10.1016/j.apmr.2005.10.024; Petraglia AL, 2012, NEUROSURGERY, V70, P1520, DOI 10.1227/NEU.0b013e31824cebe8; Phipps-Nelson J, 2009, CHRONOBIOL INT, V26, P891, DOI 10.1080/07420520903044364; Randolph C, 1998, J CLIN EXP NEUROPSYC, V20, P310, DOI 10.1076/jcen.20.3.310.823; Rorden C, 2007, J COGNITIVE NEUROSCI, V19, P1081, DOI 10.1162/jocn.2007.19.7.1081; Rosenblum WI, 2007, J NEUROPATH EXP NEUR, V66, P771, DOI 10.1097/nen.0b013e3181461965; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Sinclair KL, 2014, NEUROREHAB NEURAL RE, V28, P303, DOI 10.1177/1545968313508472; Stokum JA, 2015, BRAIN INJURY, V29, P47, DOI 10.3109/02699052.2014.947628; Sullivan KA, 2015, J NEUROTRAUM, V32, P474, DOI 10.1089/neu.2013.3284; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Viola AU, 2008, SCAND J WORK ENV HEA, V34, P297, DOI 10.5271/sjweh.1268; WINOCUR G, 1985, BEHAV BRAIN RES, V16, P135, DOI 10.1016/0166-4328(85)90088-9; Wright HR, 2004, J PINEAL RES, V36, P140, DOI 10.1046/j.1600-079X.2003.00108.x; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Xiong KL, 2014, BRAIN RES, V1591, P86, DOI 10.1016/j.brainres.2014.10.030; Yeh FC, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005203; Yeh FC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080713; Yeh FC, 2011, NEUROIMAGE, V58, P91, DOI 10.1016/j.neuroimage.2011.06.021	70	11	11	0	8	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	NOV 22	2017	8								616	10.3389/fneur.2017.00616			12	Clinical Neurology; Neurosciences	Neurosciences & Neurology	FN3SH	WOS:000415918700001	29213254	DOAJ Gold, Green Published			2021-06-18	
J	Friedman, SD; Poliakov, AV; Budech, C; Shaw, DWW; Breiger, D; Jinguji, T; Krabak, B; Coppel, D; Lewis, TM; Browd, S; Ojemann, JG				Friedman, Seth D.; Poliakov, Andrew V.; Budech, Christopher; Shaw, Dennis W. W.; Breiger, David; Jinguji, Thomas; Krabak, Brian; Coppel, David; Lewis, Tressa Mattioli; Browd, Samuel; Ojemann, Jeffrey G.			GABA alterations in pediatric sport concussion	NEUROLOGY			English	Article							TRAUMATIC BRAIN-INJURY; HEAD IMPACT EXPOSURE; YOUTH FOOTBALL; INHIBITION; DIFFUSION; STATEMENT; SPECTRA; MEMORY	Objective: To evaluate whether frontal-lobe magnetic resonance spectroscopy measures of g-aminobutyric acid (GABA) would be altered in a sample of adolescents scanned after sport concussion because mild traumatic brain injury is often associated with working memory problems. Methods: Eleven adolescents (age 14-17 years) who had sustained a first-time sport concussion were studied with MRI/magnetic resonance spectroscopy within 23 to 44 days after injury (mean 30.4 +/- 6.1 days). Age-and sex-matched healthy controls, being seen for sports-related injuries not involving the head and with no history of concussion, were also examined. GABA/creatine 1 phosphocreatine (Cre) was measured in left-sided frontal lobe and central posterior cingulate regions. The frontal voxel was positioned to overlap with patient-specific activation on a 1-back working memory task. Results: Increased GABA/Cre was shown in the frontal lobe for the concussed group. A decreased relationship was observed in the parietal region. High correlations between GABA/Cre and task activation were observed for the control group in the frontal lobe, a relationship not shown in the concussed participants. Conclusions: GABA/Cre appears increased in a region colocalized with working memory task activation after sport concussion. Further work extending these results in larger samples and at time points across the injury episode will aid in refining the clinical significance of these observations.	[Friedman, Seth D.; Poliakov, Andrew V.; Budech, Christopher; Shaw, Dennis W. W.; Breiger, David; Jinguji, Thomas; Krabak, Brian; Coppel, David; Lewis, Tressa Mattioli; Browd, Samuel; Ojemann, Jeffrey G.] Seattle Childrens Hosp, Seattle, WA 98105 USA; [Friedman, Seth D.; Poliakov, Andrew V.; Budech, Christopher; Shaw, Dennis W. W.; Breiger, David; Jinguji, Thomas; Krabak, Brian; Coppel, David; Lewis, Tressa Mattioli; Browd, Samuel; Ojemann, Jeffrey G.] Seattle Res Inst, Seattle, WA 98105 USA; [Shaw, Dennis W. W.; Breiger, David; Jinguji, Thomas; Krabak, Brian; Coppel, David; Browd, Samuel; Ojemann, Jeffrey G.] Univ Washington, Seattle, WA 98195 USA	Ojemann, JG (corresponding author), Seattle Childrens Hosp, Seattle, WA 98105 USA.; Ojemann, JG (corresponding author), Seattle Res Inst, Seattle, WA 98105 USA.; Ojemann, JG (corresponding author), Univ Washington, Seattle, WA 98195 USA.	jeff.ojemann@seattlechildrens.org			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5R03NS08650-02]	This work was conducted with a grant from the NIH (5R03NS08650-02) and work-in-progress MEGA-PRESS software package from Siemens Medical Systems.	Aguila MER, 2015, NMR BIOMED, V28, P890, DOI 10.1002/nbm.3321; Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; Balz J, 2016, NEUROIMAGE, V125, P724, DOI 10.1016/j.neuroimage.2015.10.087; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Boy F, 2010, CURR BIOL, V20, P1779, DOI 10.1016/j.cub.2010.09.003; Brooks WM, 2000, J NEUROTRAUM, V17, P629, DOI 10.1089/089771500415382; Chrisman SPD, 2016, J CHILD NEUROL, V31, P971, DOI 10.1177/0883073816634857; Clarkson AN, 2010, NATURE, V468, P305, DOI 10.1038/nature09511; Croall Iain, 2015, Top Magn Reson Imaging, V24, P267, DOI 10.1097/RMR.0000000000000063; Daniel RW, 2012, ANN BIOMED ENG, V40, P976, DOI 10.1007/s10439-012-0530-7; De Beaumont L, 2012, CEREB CORTEX, V22, P112, DOI 10.1093/cercor/bhr096; Dunning DL, 2016, NEUROPSYCHOLOGY, V30, P811, DOI 10.1037/neu0000285; Dzhala V, 2012, J NEUROSCI, V32, P4017, DOI 10.1523/JNEUROSCI.5139-11.2012; Edden RAE, 2014, J MAGN RESON IMAGING, V40, P1445, DOI 10.1002/jmri.24478; Edden RAE, 2009, J NEUROSCI, V29, P15721, DOI 10.1523/JNEUROSCI.4426-09.2009; Friedman SD, 1998, AM J NEURORADIOL, V19, P1879; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; Hannawi Y, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0642-9; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Harris AD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117531; Imbrosci B, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/614329; Ishak GE, 2012, AM J NEURORADIOL, V33, P1726, DOI 10.3174/ajnr.A3045; Maccotta L, 2007, CEREB CORTEX, V17, P443, DOI 10.1093/cercor/bhj161; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; Muthukumaraswamy SD, 2012, HUM BRAIN MAPP, V33, P455, DOI 10.1002/hbm.21223; Pangilinan PH, 2010, PM&R, V2, P1127, DOI 10.1016/j.pmrj.2010.07.007; Poliachik SL, 2016, PEDIATR NEUROL, V54, P43, DOI 10.1016/j.pediatrneurol.2015.09.012; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Puts NAJ, 2011, J NEUROSCI, V31, P16556, DOI 10.1523/JNEUROSCI.4489-11.2011; Raible DJ, 2012, J NEUROTRAUM, V29, P2548, DOI 10.1089/neu.2012.2483; Siegmund GP, 2016, ANN BIOMED ENG, V44, P1257, DOI 10.1007/s10439-015-1420-6; Sumner P, 2010, NAT NEUROSCI, V13, P825, DOI 10.1038/nn.2559; Wang GY, 2017, NEUROIMAGE, V147, P164, DOI 10.1016/j.neuroimage.2016.12.013	33	11	11	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	NOV 21	2017	89	21					2151	2156		10.1212/WNL.0000000000004666			6	Clinical Neurology	Neurosciences & Neurology	FP5RF	WOS:000417677500008	29030453	Green Published			2021-06-18	
J	Espana, LY; Lee, RM; Ling, JM; Jeromin, A; Mayer, AR; Meier, TB				Espana, Lezlie Y.; Lee, Ryan M.; Ling, Josef M.; Jeromin, Andreas; Mayer, Andrew R.; Meier, Timothy B.			Serial Assessment of Gray Matter Abnormalities after Sport-Related Concussion	JOURNAL OF NEUROTRAUMA			English	Article						concussion; diffusion; GFAP; fractional anisotropy; mTBI	TRAUMATIC BRAIN-INJURY; FIBRILLARY ACIDIC PROTEIN; TENSOR IMAGING FINDINGS; COLLEGIATE FOOTBALL PLAYERS; C-TERMINAL HYDROLASE-L1; LONGITUDINAL ASSESSMENT; COORDINATE SYSTEM; SERUM BIOMARKERS; CORTICAL SURFACE; PLASMA-LEVELS	There is an urgent need to characterize the acute physiological effects of sport-related concussion (SRC). We investigated the effects of SRC on gray matter structure and diffusion metrics in collegiate athletes at 1.64 (T1; n = 33), 8.33 (T2; n = 30), and 32.15 days (T3; n = 36) post-concussion, with healthy collegiate contact-sport athletes serving as controls (HA; n = 46). Plasma levels of glial fibrillary acidic protein (GFAP) were assessed in a subset of athletes. We hypothesized that acute SRC would be associated with increased fractional anisotropy (FA), decreased mean diffusivity (MD), and increased GFAP relative to noninjured HA, without acute differences in gray matter volume or cortical thickness. Further, we hypothesized that neither diffusion nor structure would show longitudinal changes across the first month post-SRC. Finally, we hypothesized that gray matter diffusion metrics would correlate with plasma GFAP levels, as indicated by preclinical literature. Consistent with our hypothesis, acute SRC was associated with decreased MD in the left pallidum, increased FA in the right amygdala, and a significantly greater number and volume of subject-specific clusters with increased FA compared to HA. No differences in gray matter volume, cortical thickness, or GFAP were observed between groups. There were no longitudinal changes in any measure across the first month post-SRC. Finally, FA in the right amygdala was inversely correlated with GFAP at T2. These results suggest that gray matter diffusion metrics may be useful in determining the physiological effects of SRC.	[Espana, Lezlie Y.; Lee, Ryan M.; Meier, Timothy B.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Ling, Josef M.; Mayer, Andrew R.] Lovelace Biomed & Environm Res Inst, Mind Res Network, Albuquerque, NM USA; [Jeromin, Andreas] Quanterix Corp, Lexington, MA USA; [Mayer, Andrew R.] Univ New Mexico, Sch Med, Dept Neurol, Albuquerque, NM 87131 USA; [Mayer, Andrew R.] Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA; [Meier, Timothy B.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA; [Meier, Timothy B.] Laureate Inst Brain Res, Tulsa, OK USA	Meier, TB (corresponding author), Med Coll Wisconsin, Neurosci Res Ctr, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	tmeier@mcw.edu			Laureate Institute for Brain Research - William K. Warren Foundation; Research and Education Program, a component of the Advancing a Healthier Wisconsin endowment at the Medical College of Wisconsin	This research was conducted using internal funds from the Laureate Institute for Brain Research, which is supported by The William K. Warren Foundation. Dr. Meier received support for this work through a project funded through the Research and Education Program, a component of the Advancing a Healthier Wisconsin endowment at the Medical College of Wisconsin. The authors thank the psychiatric assessment team and MRI technicians at the Laureate Institute for Brain Research, Dr. Rashmi Singh and Dr. Patrick Bellgowan for their assistance with data collection, Christopher Nerio, David Polanski, Dr. Thomas Allen, and Dr. Lamont Cavanagh for athlete referral and injury oversight, and Dr. Kent Teague and Ashlee Taylor at the University of Oklahoma Integrative Immunology Center for assistance with blood processing and storage.	Albaugh MD, 2015, J PEDIATR-US, V166, P394, DOI 10.1016/j.jpeds.2014.10.016; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Bogoslovsky T, 2017, J NEUROTRAUM, V34, P66, DOI 10.1089/neu.2015.4333; Bouix S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066205; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Chen G, 2014, NEUROIMAGE, V99, P571, DOI 10.1016/j.neuroimage.2014.06.027; Chen G, 2013, NEUROIMAGE, V73, P176, DOI 10.1016/j.neuroimage.2013.01.047; Chu Z, 2010, AM J NEURORADIOL, V31, P340, DOI 10.3174/ajnr.A1806; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Dimou S, 2014, J NEUROTRAUM, V31, P413, DOI 10.1089/neu.2013.3050; Dodd AB, 2014, J NEUROTRAUM, V31, P1235, DOI 10.1089/neu.2014.3337; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; ENG LF, 1971, BRAIN RES, V28, P351, DOI 10.1016/0006-8993(71)90668-8; Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Gardner A, 2012, J NEUROTRAUM, V29, P2521, DOI 10.1089/neu.2012.2628; Grossman EJ, 2013, AM J NEURORADIOL, V34, P951, DOI 10.3174/ajnr.A3358; Hasan KM, 2014, J NEUROTRAUM, V31, P466, DOI [10.1089/NEU.2013.3085, 10.1089/neu.2013.3085]; Helmer KG, 2014, J NEUROSURG, V120, P864, DOI [10.3171/2013.12.JNS132093, 10.3171/2013.12.JNS132090]; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; Keightley ML, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00139; Kou ZF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080296; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leh SE, 2017, J NEUROTRAUM, V34, P1402, DOI 10.1089/neu.2016.4591; Lewis LM, 2017, ACAD EMERG MED, V24, P710, DOI 10.1111/acem.13174; Ling J, 2012, HUM BRAIN MAPP, V33, P50, DOI 10.1002/hbm.21192; Ling JM, 2013, NEUROLOGY, V81, P2121, DOI 10.1212/01.wnl.0000437302.36064.b1; Mannix R, 2014, J NEUROTRAUM, V31, P1072, DOI 10.1089/neu.2013.3265; Mayer AR, 2015, J NEUROTRAUM, V32, P1759, DOI 10.1089/neu.2014.3833; Mayer AR, 2015, J NEUROTRAUM, V32, P723, DOI 10.1089/neu.2014.3534; Mayer AR, 2014, HUM BRAIN MAPP, V35, P5457, DOI 10.1002/hbm.22563; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; McAllister TW, 2010, ANN NY ACAD SCI, V1208, P46, DOI 10.1111/j.1749-6632.2010.05720.x; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097447; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meier TB, 2016, J NEUROTRAUM, V33, P1349, DOI 10.1089/neu.2015.4118; Meier TB, 2016, J NEUROTRAUM, V33, P330, DOI 10.1089/neu.2015.3919; Meier TB, 2016, HUM BRAIN MAPP, V37, P833, DOI 10.1002/hbm.23072; Mondello S, 2016, SCI REP-UK, V6, DOI 10.1038/srep28203; Olsson B, 2011, PROG NEUROBIOL, V95, P520, DOI 10.1016/j.pneurobio.2011.04.006; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Papa L, 2014, J NEUROTRAUM, V31, P1815, DOI 10.1089/neu.2013.3245; Posti JP, 2017, J NEUROTRAUM, V34, P1427, DOI 10.1089/neu.2016.4442; Raz E, 2011, AM J NEURORADIOL, V32, P1851, DOI 10.3174/ajnr.A2637; Reuter M, 2012, NEUROIMAGE, V61, P1402, DOI 10.1016/j.neuroimage.2012.02.084; Rhine T, 2016, BRAIN INJURY, V30, P1231, DOI 10.1080/02699052.2016.1178396; Rissin DM, 2010, NAT BIOTECHNOL, V28, P595, DOI 10.1038/nbt.1641; Ross DE, 2012, BRAIN INJURY, V26, P1500, DOI 10.3109/02699052.2012.694570; Saad ZS, 2012, NEUROIMAGE, V62, P768, DOI 10.1016/j.neuroimage.2011.09.016; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Singh K, 2016, EXP NEUROL, V275, P427, DOI 10.1016/j.expneurol.2015.07.016; Singh R, 2014, JAMA-J AM MED ASSOC, V311, P1883, DOI 10.1001/jama.2014.3313; Turken And U, 2009, BMC Med Imaging, V9, P20, DOI 10.1186/1471-2342-9-20; Vallez Garcia D, 2016, J NEUROTRAUM, V33, P1855, DOI 10.1089/neu.2015.4230; Wilson DH, 2016, JALA-J LAB AUTOM, V21, P533, DOI 10.1177/2211068215589580; Xu S, 2011, J NEUROTRAUM, V28, P2091, DOI 10.1089/neu.2010.1739; Zagorchev L, 2016, J NEUROTRAUM, V33, P29, DOI 10.1089/neu.2014.3831; Zhang K, 2010, EXP BRAIN RES, V204, P57, DOI 10.1007/s00221-010-2294-3; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542; Zhu Y., 2014, BIOMED RES INT, V2014, DOI DOI 10.1155/2014/548392; Zhuo JC, 2012, NEUROIMAGE, V59, P467, DOI 10.1016/j.neuroimage.2011.07.050	67	11	11	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV 15	2017	34	22					3143	3152		10.1089/neu.2017.5002			10	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	FL9GC	WOS:000414560000010	28665173				2021-06-18	
J	Sen, AK; Gurdziel, K; Liu, J; Qu, W; Nuga, OO; Burl, RB; Huttemann, M; Pique-Regi, R; Ruden, DM				Sen, Arko; Gurdziel, Katherine; Liu, Jenney; Qu, Wen; Nuga, Oluwademi O.; Burl, Rayanne B.; Huttemann, Maik; Pique-Regi, Roger; Ruden, Douglas. M.			Smooth, an hnRNP-L Homolog, Might Decrease Mitochondrial Metabolism by Post-Transcriptional Regulation of Isocitrate Dehydrogenase (Idh) and Other Metabolic Genes in the Sub-Acute Phase of Traumatic Brain Injury	FRONTIERS IN GENETICS			English	Article						traumatic brain injury; alternative splicing; intron retention; histone modification; smooth; hnRNP-L	CYTOCHROME-C-OXIDASE; MESSENGER-RNA; TYROSINE PHOSPHORYLATION; SUBUNIT-I; DROSOPHILA; DEMETHYLASE; NEURODEGENERATION; PLURIPOTENCY; PROTEIN; ROLES	Traumatic brain injury (TBI) can cause persistent pathological alteration of neurons. This may lead to cognitive dysfunction, depression and increased susceptibility to life threatening diseases, such as epilepsy and Alzheimer's disease. To investigate the underlying genetic and molecular basis of TBI, we subjected W-1118 Drosophila melanogaster to mild closed head trauma and found that mitochondrial activity is reduced in the brains of these flies 24h after inflicting trauma. To determine the transcriptomic changes after mild TBI, we collected fly heads 24 h after inflicting trauma, and performed RNA-seq analyses. Classification of alternative splicing changes showed selective retention (RI) of long introns (>81 bps), with a mean size of similar to 3,000 nucleotides. Some of the genes containing RI showed a significant reduction in transcript abundance and are involved in mitochondrial metabolism such as Isocitrate dehydrogenase (Idh), which makes alpha-KG, a co-factor needed for both DNA and histone demethylase enzymes. The long introns are enriched in CA-rich motifs known to bind to Smooth (Sm), a heterogeneous nuclear ribonucleoprotein L (hnRNP-L) class of splicing factor, which has been shown to interact with the H3K36 histone methyltransferase, SFT2, and to be involved in intron retention in human cells. H3K36me3 is a histone mark that demarcates exons in genes by interacting with the mRNA splicing machinery. Mutating sm (sm(4)/Df) resulted in loss of both basal and induced levels of RI in many of the same long-intron containing genes. Reducing the levels of Kdm4A, the H3K36me3 histone demethylase, also resulted in loss of basal levels of RI in many of the same long-intron containing genes. Chromatin immunoprecipitation followed by deep sequencing (ChIP-seq) for H3K36me3 revealed increased levels of this histone modification in retained introns post-trauma at CA-rich motifs. Based on these results, we propose a model in which TBI temporarily decreases mitochondrial activity in the brain 24 h after inflicting trauma, which decreases alpha-KG levels, and increases H3K36me3 levels and intron retention of long introns by decreasing Kdm4A activity. The consequent reduction in mature mRNA levels in metabolism genes, such as Idh, further reduces alpha-KG levels in a negative feedback loop. We further propose that decreasing metabolism after TBI in such a manner is a protective mechanism that gives the brain time to repair cellular damage induced by TBI.	[Sen, Arko; Ruden, Douglas. M.] Wayne State Univ, Inst Environm Hlth Sci, Detroit, MI 48202 USA; [Sen, Arko; Qu, Wen; Nuga, Oluwademi O.] Wayne State Univ, Dept Pharmacol, Detroit, MI 48201 USA; [Gurdziel, Katherine; Burl, Rayanne B.; Ruden, Douglas. M.] Wayne State Univ, Dept Obstet & Gynecol, CS Mott Ctr Human Growth & Dev, Detroit, MI 48202 USA; [Liu, Jenney; Burl, Rayanne B.; Huttemann, Maik; Pique-Regi, Roger] Wayne State Univ, Ctr Mol Med & Genet, Detroit, MI USA; [Pique-Regi, Roger; Ruden, Douglas. M.] Wayne State Univ, Dept Obstet & Gynecol, Detroit, MI 48202 USA	Ruden, DM (corresponding author), Wayne State Univ, Inst Environm Hlth Sci, Detroit, MI 48202 USA.; Ruden, DM (corresponding author), Wayne State Univ, Dept Obstet & Gynecol, CS Mott Ctr Human Growth & Dev, Detroit, MI 48202 USA.; Ruden, DM (corresponding author), Wayne State Univ, Dept Obstet & Gynecol, Detroit, MI 48202 USA.	douglasr@wayne.edu		Huttemann, Maik/0000-0001-6310-7081; Sen, Arko/0000-0001-9876-281X	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5R01ES012933, 5P30ES020957, 1UG3OD023285, 5R01GM109215]; pilot finds from the Wayne State University Office of the Vice President for Research; NIH Center grantUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P30 CA022453]; Perinatology Research Branch of the National Institutes of Child Health and Development at Wayne State University; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA022453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [P30ES020957, R01ES012933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R25GM058905, R01GM109215] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [UH3OD023285, UG3OD023285] Funding Source: NIH RePORTER	This work was supported by National Institutes of Health (NIH) [grant number 5R01ES012933 (DR), 5P30ES020957 (DR), 1UG3OD023285 (DR), 5R01GM109215 (RP-R)] and pilot finds from the Wayne State University Office of the Vice President for Research (DR). Funding was also provided by the NIH Center grant P30 CA022453 to the Karmanos Cancer Institute at Wayne State University and the Perinatology Research Branch of the National Institutes of Child Health and Development at Wayne State University.	Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111; Andrews S, 2010, FASTQC QUALITY CONTR; Arnold S, 1999, FEBS LETT, V443, P105, DOI 10.1016/S0014-5793(98)01694-9; Arnold S, 1997, EUR J BIOCHEM, V249, P350, DOI 10.1111/j.1432-1033.1997.t01-1-00350.x; Arnold S, 2012, ADV EXP MED BIOL, V748, P305, DOI 10.1007/978-1-4614-3573-0_13; Bailey TL, 2011, BIOINFORMATICS, V27, P1653, DOI 10.1093/bioinformatics/btr261; Barekat A, 2016, SCI REP-UK, V6, DOI 10.1038/srep25252; Barrand S, 2010, BIOCHEM BIOPH RES CO, V401, P611, DOI 10.1016/j.bbrc.2010.09.116; Bischof J, 2014, NAT PROTOC, V9, P1607, DOI 10.1038/nprot.2014.105; Broglio SP, 2012, EXERC SPORT SCI REV, V40, P138, DOI 10.1097/JES.0b013e3182524273; Carey BW, 2015, NATURE, V518, P413, DOI 10.1038/nature13981; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Chapin A, 2014, G3-GENES GENOM GENET, V4, P485, DOI 10.1534/g3.113.009357; Chia N, 2011, EPIGENETICS-US, V6, P853, DOI 10.4161/epi.6.7.16461; Copur O, 2013, DEVELOPMENT, V140, P3478, DOI 10.1242/dev.097204; Crona F, 2013, DEV BIOL, V373, P453, DOI 10.1016/j.ydbio.2012.11.011; Daneshvar DH, 2015, MOL CELL NEUROSCI, V66, P81, DOI 10.1016/j.mcn.2015.03.007; Draper I, 2009, FLY, V3, P235, DOI 10.4161/fly.9517; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Herz HM, 2014, SCIENCE, V345, P1065, DOI 10.1126/science.1255104; Huang XD, 2011, MOL CELL BIOL, V31, P3682, DOI 10.1128/MCB.06001-11; Hung LH, 2008, RNA, V14, P284, DOI 10.1261/rna.725208; Isken O, 2007, GENE DEV, V21, P1833, DOI 10.1101/gad.1566807; Kadenbach B, 2004, BBA-BIOENERGETICS, V1655, P400, DOI 10.1016/j.bbabio.2003.06.005; KARPEN GH, 1992, GENETICS, V132, P737; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Katzenberger RJ, 2013, P NATL ACAD SCI USA, V110, pE4152, DOI 10.1073/pnas.1316895110; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim S, 2011, P NATL ACAD SCI USA, V108, P13564, DOI 10.1073/pnas.1109475108; Layalle S, 2005, GENES CELLS, V10, P119, DOI 10.1111/j.1365-2443.2005.00822.x; Lee I, 2005, J BIOL CHEM, V280, P6094, DOI 10.1074/jbc.M411335200; Lee I, 2009, METHOD ENZYMOL, V457, P193, DOI 10.1016/S0076-6879(09)05011-3; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039758; Ling H, 2015, MOL CELL NEUROSCI, V66, P114, DOI 10.1016/j.mcn.2015.03.012; Lorbeck MT, 2010, GENE, V450, P8, DOI 10.1016/j.gene.2009.09.007; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luco RF, 2010, SCIENCE, V327, P996, DOI 10.1126/science.1184208; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; Pelosi M, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0689-7; Pradeepa MM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002717; Ray D, 2013, NATURE, V499, P172, DOI 10.1038/nature12311; Samavati L, 2008, J BIOL CHEM, V283, P21134, DOI 10.1074/jbc.M801954200; Smith ER, 2008, MOL CELL BIOL, V28, P1041, DOI 10.1128/MCB.01504-07; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsurumi A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02894; Unterharnscheidt F, 1995, Rev Neurol, V23, P661; Yuan W, 2009, J BIOL CHEM, V284, P15701, DOI 10.1074/jbc.M808431200; Zhang DZ, 2005, MOL CELL BIOL, V25, P6404, DOI 10.1128/MCB.25.15.6404-6414.2005; Zhao JX, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317697546; Zhou HL, 2014, NUCLEIC ACIDS RES, V42, P701, DOI 10.1093/nar/gkt875	51	11	11	1	9	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1664-8021		FRONT GENET	Front. Genet.	NOV 15	2017	8								175	10.3389/fgene.2017.00175			14	Genetics & Heredity	Genetics & Heredity	FM6OP	WOS:000415173800001	29187863	DOAJ Gold, Green Published			2021-06-18	
J	Tsao, JW; Stentz, LA; Rouhanian, M; Howard, RS; Perry, BN; Haran, FJ; Pasquina, PF; Wolde, M; Taylor, CE; Lizardo, R; Liu, S; Flores, E; Creason, AH; Sher, K				Tsao, Jack W.; Stentz, Lauren A.; Rouhanian, Minoo; Howard, Robin S.; Perry, Briana N.; Haran, F. Jay; Pasquina, Paul F.; Wolde, Mikias; Taylor, Carolyn E.; Lizardo, Radhames; Liu, Scott; Flores, Eusebio, III; Creason, Alia H.; Sher, Katalina			Effect of concussion and blast exposure on symptoms after military deployment	NEUROLOGY			English	Article							TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; LOW-LEVEL BLAST; PERSONNEL; SLEEP; IRAQ	Objective: To examine whether blast exposure alone and blast-associated concussion result in similar neurologic and mental health symptoms. Methods: A 14-item questionnaire was administered to male US Marines on their return from deployment in Iraq and/or Afghanistan. Results: A total of 2,612 Marines (median age 22 years) completed the survey. Of those, 2,320 (88.9%) reported exposure to >= 1 blast during their current and/or prior deployments. In addition, 1,022 (39.1%) reported >= 1 concussion during the current deployment, and 731 (28.0%) had experienced at least 1 prior lifetime concussion. Marines were more likely to have sustained a concussion during the current deployment if they had a history of 1 (odds ratio [OR] 1.5, 95% confidence interval [CI] 1.2-2.0) or >= 1 (OR 2.3, 95% CI 1.7-3.0) prior concussion. The most common symptoms were trouble sleeping (38.4%), irritability (37.9%), tinnitus (33.8%), and headaches (33.3%). Compared to those experiencing blast exposure without injury, Marines either experiencing a concussion during the current deployment or being moved or injured by a blast had an increased risk of postinjury symptoms. Conclusions: There appears to be a continuum of increasing total symptoms from no exposure to blast exposure plus both current deployment concussion and past concussion. Concussion had a greater influence than blast exposure alone on the presence of postdeployment symptoms. A high blast injury score can be used to triage those exposed to explosive blasts for evaluation.	[Tsao, Jack W.] Univ Tennessee, Ctr Hlth Sci, Memphis, TN 38163 USA; [Tsao, Jack W.] Le Bonheur Childrens Hosp, Childrens Fdn Res Ctr, Memphis, TN 38103 USA; [Tsao, Jack W.; Haran, F. Jay; Pasquina, Paul F.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Stentz, Lauren A.; Rouhanian, Minoo; Howard, Robin S.; Perry, Briana N.; Pasquina, Paul F.; Wolde, Mikias; Taylor, Carolyn E.; Sher, Katalina] Walter Reed Natl Mil Med Ctr, Bethesda, MD USA; [Lizardo, Radhames] Naval Med Ctr San Diego, San Diego, CA USA; [Flores, Eusebio, III] Neurosci Consultants PLC, Naval Med Ctr Portsmouth, Reston, VA USA; [Creason, Alia H.] Informat Innovators Inc, Springfield, VA USA	Tsao, JW (corresponding author), Univ Tennessee, Ctr Hlth Sci, Memphis, TN 38163 USA.; Tsao, JW (corresponding author), Le Bonheur Childrens Hosp, Childrens Fdn Res Ctr, Memphis, TN 38103 USA.; Tsao, JW (corresponding author), Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA.	jtsao@uthsc.edu		Taylor, Carolyn/0000-0002-1862-4773	US Navy Bureau of Medicine and Surgery	This study was supported by the US Navy Bureau of Medicine and Surgery.	Bryan CJ, 2013, JAMA PSYCHIAT, V70, P686, DOI 10.1001/jamapsychiatry.2013.1093; Bryan CJ, 2013, SLEEP, V36, P941, DOI 10.5665/sleep.2730; Carr W, 2016, MIL MED, V181, P28, DOI 10.7205/MILMED-D-15-00137; Defense and Veterans Brain Injury Center, 2017, DOD WORLDW NUMB TBL; Dionne JP, 2011, INCREASED BLAST INJU; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; JONES EDGAR, 2005, SHELL SHOCK PTSD MIL; Mac Donald CL, 2014, JAMA NEUROL, V71, P994, DOI 10.1001/jamaneurol.2014.1114; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Shively SB, 2012, J HEAD TRAUMA REHAB, V27, P234, DOI 10.1097/HTR.0b013e318250e9dd; Shively SB, 2016, LANCET NEUROL, V15, P944, DOI 10.1016/S1474-4422(16)30057-6; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Spira JL, 2014, J NEUROTRAUM, V31, P1823, DOI 10.1089/neu.2014.3363; Tate CM, 2013, J NEUROTRAUM, V30, P1620, DOI 10.1089/neu.2012.2683; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Vandrey R, 2014, INT REV PSYCHIATR, V26, P237, DOI 10.3109/09540261.2014.901300; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wolf SJ, 2009, LANCET, V374, P405, DOI 10.1016/S0140-6736(09)60257-9; Yankaskas K, 2013, HEARING RES, V295, P3, DOI 10.1016/j.heares.2012.04.016	21	11	11	1	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	NOV 7	2017	89	19					2010	2016		10.1212/WNL.0000000000004616			7	Clinical Neurology	Neurosciences & Neurology	FP5QW	WOS:000417675300017	29030450				2021-06-18	
J	Alotaibi, NM; Wang, JZ; Pasarikovski, CR; Guha, D; Al-Mufti, F; Mamdani, M; Saposnik, G; Schweizer, TA; Macdonald, RL				Alotaibi, Naif M.; Wang, Justin Z.; Pasarikovski, Christopher R.; Guha, Daipayan; Al-Mufti, Fawaz; Mamdani, Muhammad; Saposnik, Gustavo; Schweizer, Tom A.; Macdonald, R. Loch			Management of raised intracranial pressure in aneurysmal subarachnoid hemorrhage: time for a consensus?	NEUROSURGICAL FOCUS			English	Article						aneurysm; subarachnoid hemorrhage; aSAH; intracranial pressure; ICP; management	CEREBRAL PERFUSION-PRESSURE; CRITICAL-CARE MANAGEMENT; TRAUMATIC BRAIN-INJURY; DECOMPRESSIVE CRANIECTOMY; THERAPEUTIC HYPOTHERMIA; HYPERTONIC SALINE; BARBITURATE COMA; CLINICAL CHARACTERISTICS; GRADE; VASOSPASM	Elevated intracranial pressure (ICP) is a well-recognized phenomenon in aneurysmal subarachnoid hemorrhage (aSAH) that has been demonstrated to lead to poor outcomes. Despite significant advances in clinical research into aSAH, there are no consensus guidelines devoted specifically to the management of elevated ICP in the setting of aSAH. To treat high ICP in aSAH, most centers extrapolate their treatment algorithms from studies and published guidelines for traumatic brain injury. Herein, the authors review the current management strategies for treating raised ICP within the aSAH population, emphasize key differences from the traumatic brain injury population, and highlight potential directions for future research in this controversial topic.	[Alotaibi, Naif M.; Guha, Daipayan; Schweizer, Tom A.; Macdonald, R. Loch] Univ Toronto, Fac Med, Inst Med Sci, Toronto, ON, Canada; [Alotaibi, Naif M.; Wang, Justin Z.; Pasarikovski, Christopher R.; Guha, Daipayan; Schweizer, Tom A.; Macdonald, R. Loch] Univ Toronto, St Michaels Hosp, Dept Surg, Div Neurosurg, Toronto, ON, Canada; [Alotaibi, Naif M.] King Fahad Med City, Natl Neurosci Inst, Dept Neurosurg, Riyadh, Saudi Arabia; [Al-Mufti, Fawaz] Robert Wood Johnson Univ Hosp, Dept Neurol & Crit Care, New Brunswick, NJ USA; [Mamdani, Muhammad] Univ Toronto, Inst Clin Evaluat Sci, Li Ka Shing Ctr Healthcare Analyt Res & Training, Toronto, ON, Canada; [Saposnik, Gustavo; Schweizer, Tom A.; Macdonald, R. Loch] Univ Toronto, Neurosci Res Program, Keenan Res Ctr, Li Ka Shing Knowledge Inst,St Michaels Hosp, Toronto, ON, Canada; [Saposnik, Gustavo] Univ Toronto, St Michaels Hosp, Stroke Outcomes & Decis Neurosci Res Unit, Toronto, ON, Canada	Alotaibi, NM (corresponding author), Univ Toronto, Div Neurosurg, 399 Bathurst St,WW 4-427, Toronto, ON M5T 2S8, Canada.	naif.alotaibi@mail.utoronto.ca	Saposnik, Gustavo/M-3937-2017; Al-Mufti, Fawaz/AAZ-3360-2020	Saposnik, Gustavo/0000-0002-5950-9886; Al-Mufti, Fawaz/0000-0003-4461-7005; Alotaibi, Naif/0000-0002-8227-347X	Brain Aneurysm Foundation; Canadian Institutes for Health ResearchCanadian Institutes of Health Research (CIHR); Heart and Stroke Foundation of CanadaHeart & Stroke Foundation of Canada	Dr. Macdonald receives grant support from the Brain Aneurysm Foundation, Canadian Institutes for Health Research, and the Heart and Stroke Foundation of Canada. Dr. Saposnik is supported by the 2017-2021 Heart and Stroke Foundation of Canada Mid-Career Scientist Award.	Alotaibi NM, 2017, J NEUROSURG, V127, P1315, DOI 10.3171/2016.9.JNS161383; Alotaibi NM, 2016, WORLD NEUROSURG, V89, P587, DOI 10.1016/j.wneu.2015.11.072; Anei R, 2010, NEUROL MED-CHIR, V50, P879, DOI 10.2176/nmc.50.879; BAILES JE, 1990, J NEUROSURG, V72, P559, DOI 10.3171/jns.1990.72.4.0559; Bentsen G, 2006, CRIT CARE MED, V34, P2912, DOI 10.1097/01.CCM.0000245665.46789.7C; Bor-Seng-Shu E, 2012, J NEUROSURG, V117, P589, DOI 10.3171/2012.6.JNS101400; Bracard S, 2002, AM J NEURORADIOL, V23, P953; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chen H, 2012, CAN J NEUROL SCI, V39, P483, DOI 10.1017/S0317167100013998; Chouhan RS, 2006, J ANAESTH CLIN PHARM, V22, P21; Claassen J, 2002, STROKE, V33, P1225, DOI 10.1161/01.STR.0000015624.29071.1F; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Cossu G, 2016, MINERVA ANESTESIOL, V82, P684; Cross DT, 1998, AM J NEURORADIOL, V19, P1319; Czorlich P, 2017, EUR J NEUROL, V24, P645, DOI 10.1111/ene.13265; D'Souza S, 2015, J NEUROSURG ANESTH, V27, P222, DOI 10.1097/ANA.0000000000000130; Dereeper E, 2002, J CRIT CARE, V17, P58, DOI 10.1053/jcrc.2002.33032; Diringer MN, 2011, NEUROCRIT CARE, V15, P211, DOI 10.1007/s12028-011-9605-9; Etminan N, 2017, HAND CLINIC, V140, P195, DOI 10.1016/B978-0-444-63600-3.00012-X; Fei L, 2007, CLIN DRUG INVEST, V27, P827, DOI 10.2165/00044011-200727120-00004; Finfer SR, 1999, INTENS CARE MED, V25, P406, DOI 10.1007/s001340050866; FINK A, 1984, AM J PUBLIC HEALTH, V74, P979, DOI 10.2105/AJPH.74.9.979; Frontera JA, 2013, STROKE RES TREAT, V2013, DOI 10.1155/2013/263974; Gigante P, 2010, BRIT J NEUROSURG, V24, P625, DOI 10.3109/02688697.2010.505989; Gomis P, 2010, J NEUROSURG, V112, P681, DOI 10.3171/2009.4.JNS081377; Guresir E, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0954; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Hays AN, 2011, NEUROCRIT CARE, V14, P222, DOI 10.1007/s12028-010-9477-4; Helbok R, 2014, NEUROCRIT CARE, V21, P85, DOI 10.1007/s12028-014-0040-6; Heuer GG, 2004, J NEUROSURG, V101, P408, DOI 10.3171/jns.2004.101.3.0408; Hindman BJ, 1999, NEUROSURGERY, V44, P23, DOI 10.1097/00006123-199901000-00009; Hollig A, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0954-1; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Holzer M, 2002, NEW ENGL J MED, V346, P549; Huang Xue-cai, 2015, Zhejiang Da Xue Xue Bao Yi Xue Ban, V44, P389; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; JONES J, 1995, BRIT MED J, V311, P376, DOI 10.1136/bmj.311.7001.376; Keller E, 2005, ACT NEUR S, V94, P65; Kim YI, 2008, J KOREAN NEUROSURG S, V44, P141, DOI 10.3340/jkns.2008.44.3.141; Kimme P, 2004, BRIT J ANAESTH, V93, P343, DOI 10.1093/bja/aeh206; Kolias AG, 2013, NAT REV NEUROL, V9, P405, DOI 10.1038/nrneurol.2013.106; Lane PL, 2000, CAN J SURG, V43, P442; Lantigua H, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1036-0; Li LYR, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008445.pub2; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Macdonald RL, 2017, LANCET, V389, P655, DOI 10.1016/S0140-6736(16)30668-7; Mak CHK, 2013, VASC HEALTH RISK MAN, V9, P353, DOI 10.2147/VHRM.S34046; Manoel ALD, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1193-9; Marko NF, 2012, CRIT CARE, V16, DOI 10.1186/cc11182; Mocco J, 2007, Neurosurg Focus, V22, pE7; Mrozek S, 2012, ANESTHESIOL RES PRAC, V2012, DOI 10.1155/2012/989487; NELSON E, 1982, J CLIN PHARMACOL, V22, P141, DOI 10.1002/j.1552-4604.1982.tb02662.x; NORNES H, 1973, J NEUROSURG, V39, P226, DOI 10.3171/jns.1973.39.2.0226; Olson DM, 2013, J NEUROSURG, V119, P974, DOI 10.3171/2013.6.JNS122403; Otani N, 2011, WORLD NEUROSURG, V75, P73, DOI 10.1016/j.wneu.2010.10.021; Pasarikovski CR, 2017, WORLD NEUROSURG, V105, P1, DOI 10.1016/j.wneu.2017.05.085; 허동화, 2003, [Journal of Korean Neurosurgical Society, 대한신경외과학회지], V33, P142; Ransom ER, 2007, NEUROCRIT CARE, V6, P174, DOI 10.1007/s12028-007-0019-7; Rogers M, 2017, J NEUROSCI NURS, V49, P85, DOI 10.1097/JNN.0000000000000257; Rosengart AJ, 2007, STROKE, V38, P2315, DOI 10.1161/STROKEAHA.107.484360; Sauvigny T, 2018, J NEUROSURG, V128, P819, DOI 10.3171/2016.11.JNS162263; Scirica BM, 2013, CIRCULATION, V127, P244, DOI 10.1161/CIRCULATIONAHA.111.076851; Seule MA, 2009, NEUROSURGERY, V64, P86, DOI 10.1227/01.NEU.0000336312.32773.A0; Springborg JB, 2005, BRIT J ANAESTH, V94, P259, DOI 10.1093/bja/aei004; Strandvik GF, 2009, ANAESTHESIA, V64, P990, DOI 10.1111/j.1365-2044.2009.05986.x; Thongrong C, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2013.02.027; Todd MM, 2005, NEW ENGL J MED, V352, P135, DOI 10.1056/NEJMoa040975; Tuzgen S, 2012, J NEUROSCI RURAL PRA, V3, P251, DOI 10.4103/0976-3147.102598; Wan A, 2016, J NEUROSURG, V125, P1344, DOI 10.3171/2015.10.JNS151036; Wartenberg KE, 2006, CRIT CARE MED, V34, P617, DOI 10.1097/01.CCM.0000201903.46435.35; Weerakkody RA, 2010, ACTA NEUROCHIR, V152, P1763, DOI 10.1007/s00701-010-0748-9; Zhao B, 2017, J NEUROSURG SCI, V61, P403, DOI 10.23736/S0390-5616.16.03457-3; Zoerle T, 2015, CRIT CARE MED, V43, P168, DOI 10.1097/CCM.0000000000000670	74	11	12	0	5	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	NOV	2017	43	5							E13	10.3171/2017.7.FOCUS17426			8	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	FL5JE	WOS:000414270800005	29088956	Bronze			2021-06-18	
J	Beauchamp, MH				Beauchamp, Miriam H.			Neuropsychology's Social Landscape: Common Ground With Social Neuroscience	NEUROPSYCHOLOGY			English	Article						neuropsychology; social neuroscience; social cognition; behavior; assessment	TRAUMATIC BRAIN-INJURY; AUTISM SPECTRUM DISORDERS; CEREBRAL BLOOD-FLOW; VIRTUAL-REALITY; COGNITIVE NEUROSCIENCE; CLINICAL-NEUROPSYCHOLOGY; NEURAL BASIS; COMMUNICATION DIFFICULTIES; BEHAVIORAL-VARIANT; EXECUTIVE FUNCTION	Looking back 25 years into neuropsychology's past coincides almost perfectly with the birth of social neuroscience as a discipline. Social neuroscience aims to identify the biological bases of social behavior through multilevel analyses of neural, cognitive, and social processes. Neuropsychology, on the other hand, aspires to understand brain-behavior relationships more generally. Given that much of human behavior comprises social interactions, the goals, theories, methods, and findings derived from social neuroscience are likely to have bearing on the issues and interests of neuropsychologists. This review summarizes some of the main developments that have emerged from social neuroscience and their relevance to neuropsychology. Applications of social neuroscience principles are presented in the context of brain insult, assessment, and intervention. Recommendations are made for improving neuropsychological approaches to the evaluation of social cognition and competence. In closing, a discussion of the challenges and possible future directions for the 2 disciplines is offered. General Scientific Summary Neuropsychology and social neuroscience share some common goals and methods. In this review, the contributions of social neuroscience to neuropsychological research and practice are considered and applications of social neuroscience findings to the study of brain disorders, assessment, and intervention are discussed, alongside recommendations for the joint evolution of the 2 disciplines.	[Beauchamp, Miriam H.] Univ Montreal, Montreal, PQ, Canada; [Beauchamp, Miriam H.] Ste Justine Hosp Res Ctr, CP 6128 Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada	Beauchamp, MH (corresponding author), Ste Justine Hosp Res Ctr, CP 6128 Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.; Beauchamp, MH (corresponding author), Univ Montreal, Dept Psychol, CP 6128 Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	miriam.beauchamp@umontreal.ca			Fonds de la recherche en sante du Quebec career fellowship	This work was supported by a Fonds de la recherche en sante du Quebec career fellowship to Miriam II. Beauchamp. The author is grateful for the constructive comments provided by Keith Yeates and Lyn Turkstra on a preliminary version of the manuscript. Thank you to Cindy Beaudoin, Anne Seni and Catherine Landry-Roy for their assistance with the content and preparation of the boxes and figures.	Adolphs R, 2003, NAT REV NEUROSCI, V4, P165, DOI 10.1038/nrn1056; Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Adolphs R, 2003, ANN NY ACAD SCI, V985, P326; Adolphs R, 2013, CURR OPIN NEUROBIOL, V23, P291, DOI 10.1016/j.conb.2013.04.011; Adolphs R, 2010, NEURON, V65, P752, DOI 10.1016/j.neuron.2010.03.006; Adolphs R, 2009, ANNU REV PSYCHOL, V60, P693, DOI 10.1146/annurev.psych.60.110707.163514; Ahmed SP, 2015, DEV COGN NEUROS-NETH, V15, P11, DOI 10.1016/j.dcn.2015.07.006; American Psychiatric Association (APA), 2013, DIAGN STAT MAN MENT, V5th; Anderson SW, 1999, NAT NEUROSCI, V2, P1032; Annaz D, 2012, J AUTISM DEV DISORD, V42, P401, DOI 10.1007/s10803-011-1256-3; Apperly IA, 2005, TRENDS COGN SCI, V9, P572, DOI 10.1016/j.tics.2005.10.004; Arsenio WF, 2004, CHILD DEV, V75, P987, DOI 10.1111/j.1467-8624.2004.00720.x; Avram M, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-39; Baez S., 2016, CURRENT TOPICS BEHAV, V30, P379; Barlow J, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003680.pub3; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; Barrett LF, 2013, CURR OPIN NEUROBIOL, V23, P361, DOI 10.1016/j.conb.2012.12.012; Bauer RM, 2012, ARCH CLIN NEUROPSYCH, V27, P362, DOI 10.1093/arclin/acs027; Beauchamp C, 2013, EDUC PSYCHOL REV, V25, P47, DOI 10.1007/s10648-012-9207-x; Beauchamp MH, 2013, BRAIN INJURY, V27, P896, DOI 10.3109/02699052.2013.775486; Beauchamp MH, 2010, PSYCHOL BULL, V136, P39, DOI 10.1037/a0017768; Beaumont J., 2008, INTRO NEUROPSYCHOLOG; Beblo T, 2011, NEUROPSYCHOL REV, V21, P337, DOI 10.1007/s11065-011-9171-0; Bedford R, 2012, J AUTISM DEV DISORD, V42, P2208, DOI 10.1007/s10803-012-1450-y; Bellerose J.S., 2011, BRAIN MAPPING NEURAL, P181; Bierman K. L., 2004, PEER REJECTION DEV P; Bilder RM, 2011, J INT NEUROPSYCH SOC, V17, P7, DOI 10.1017/S1355617710001396; Blakemore SJ, 2008, NAT REV NEUROSCI, V9, P267, DOI 10.1038/nrn2353; Blakemore SJ, 2012, J ROY SOC MED, V105, P111, DOI 10.1258/jrsm.2011.110221; Blakemore SJ, 2010, HUM BRAIN MAPP, V31, P926, DOI 10.1002/hbm.21052; Blakemore SJ, 2006, J CHILD PSYCHOL PSYC, V47, P296, DOI 10.1111/j.1469-7610.2006.01611.x; Blakemore SJ, 2004, TRENDS COGN SCI, V8, P216, DOI 10.1016/j.tics.2004.03.012; Blumstein DT, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00034; Bohil CJ, 2011, NAT REV NEUROSCI, V12, P752, DOI 10.1038/nrn3122; Bonfils KA, 2017, PSYCHIAT RES, V249, P293, DOI 10.1016/j.psychres.2016.12.033; Bonfils KA, 2016, SCHIZOPHR RES, V175, P109, DOI 10.1016/j.schres.2016.03.037; Bonini L., 2016, NEUROSCIENTIST, V23; Bonini L, 2011, ANN NY ACAD SCI, V1225, P166, DOI 10.1111/j.1749-6632.2011.06002.x; Bora E, 2016, PSYCHOL MED, V46, P699, DOI 10.1017/S0033291715002573; Bora E, 2016, EPILEPSY BEHAV, V60, P50, DOI 10.1016/j.yebeh.2016.04.024; Bora E, 2013, SCHIZOPHR RES, V144, P31, DOI 10.1016/j.schres.2012.12.013; Borod J. C, 2000, NEUROPSYCHOLOGY EMOT; Bouchard S, 2011, EXPERT REV NEUROTHER, V11, P207, DOI 10.1586/ERN.10.196; BROTHERS L, 1990, BEHAV BRAIN RES, V41, P199, DOI 10.1016/0166-4328(90)90108-Q; Bufalari I, 2007, CEREB CORTEX, V17, P2553, DOI 10.1093/cercor/bhl161; Byrne Richard W., 1996, Evolutionary Anthropology, V5, P172, DOI 10.1002/(SICI)1520-6505(1996)5:5<172::AID-EVAN6>3.0.CO;2-H; Cacioppo JT, 2014, WORLD PSYCHIATRY, V13, P131, DOI 10.1002/wps.20118; Cacioppo JT, 2013, PERSPECT PSYCHOL SCI, V8, P667, DOI 10.1177/1745691613507456; Cacioppo JT, 2010, SOC COGNITION, V28, P675, DOI 10.1521/soco.2010.28.6.675; Cacioppo JT, 2002, AM PSYCHOL, V57, P819, DOI 10.1037/0003-066X.57.11.819; CACIOPPO JT, 1992, AM PSYCHOL, V47, P1019, DOI 10.1037/0003-066X.47.8.1019; Cacioppo S, 2013, SCI REP-UK, V3, DOI 10.1038/srep02027; Cage E, 2013, AUTISM RES, V6, P433, DOI 10.1002/aur.1313; Carrigan B, 2016, BRAIN COGNITION, V108, P88, DOI 10.1016/j.bandc.2016.07.007; Casebeer WD, 2003, NAT REV NEUROSCI, V4, P840, DOI 10.1038/nrn1223; Casey BJ, 2005, CURR OPIN NEUROBIOL, V15, P239, DOI 10.1016/j.conb.2005.03.012; Cassel A., 2016, NEUROPSYCHOLOGICAL R; Chang YC, 2016, RES AUTISM SPECT DIS, V27, P1, DOI 10.1016/j.rasd.2016.03.010; Cheng Y, 2008, NEUROIMAGE, V40, P1833, DOI 10.1016/j.neuroimage.2008.01.064; Chiasson V, 2017, BRAIN IMPAIR, V18, P102, DOI 10.1017/BrImp.2016.33; Chiasson V, 2017, CLIN NEUROPSYCHOL, V31, P515, DOI 10.1080/13854046.2016.1268650; Chisholm JD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092696; Chita-Tegmark M, 2016, RES DEV DISABIL, V48, P79, DOI 10.1016/j.ridd.2015.10.011; Cooper RP, 2010, TOP COGN SCI, V2, P398, DOI 10.1111/j.1756-8765.2010.01090.x; Corrigan PW, 1997, PSYCHIATRY, V60, P309, DOI 10.1080/00332747.1997.11024809; COSTA L, 1983, J CLIN NEUROPSYCHOL, V5, P1, DOI 10.1080/01688638308401147; Cotter J, 2016, NEUROLOGY, V87, P1727, DOI 10.1212/WNL.0000000000003236; Couper E, 2002, BRAIN IMPAIR, V3, P105, DOI DOI 10.1375/BRIM.3.2.105; Cowell JM, 2015, P NATL ACAD SCI USA, V112, P12657, DOI 10.1073/pnas.1508832112; CRICK NR, 1994, PSYCHOL BULL, V115, P74, DOI 10.1037/0033-2909.115.1.74; Crone EA, 2015, WIRES COGN SCI, V6, P53, DOI 10.1002/wcs.1327; Crowe LM, 2011, CLIN PSYCHOL REV, V31, P767, DOI 10.1016/j.cpr.2011.03.008; Das P, 2012, SCHIZOPHR RES, V134, P158, DOI 10.1016/j.schres.2011.08.019; DAVIDSON RJ, 1995, CURR OPIN NEUROBIOL, V5, P217, DOI 10.1016/0959-4388(95)80029-8; de Borst AW, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00576; de Castro BO, 2002, CHILD DEV, V73, P916, DOI 10.1111/1467-8624.00447; de Sousa A, 2012, J CLIN EXP NEUROPSYC, V34, P606, DOI 10.1080/13803395.2012.667067; Decety J, 2006, THESCIENTIFICWORLDJO, V6, P1146, DOI 10.1100/tsw.2006.221; Decety Jean, 2004, Behav Cogn Neurosci Rev, V3, P71, DOI 10.1177/1534582304267187; Decety J, 2010, PERSPECT PSYCHOL SCI, V5, P767, DOI 10.1177/1745691610388780; Dickerson Bradford C, 2015, Continuum (Minneap Minn), V21, P660, DOI 10.1212/01.CON.0000466659.05156.1d; Dinstein I, 2008, CURR BIOL, V18, pR956, DOI 10.1016/j.cub.2008.09.007; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; Dunbar RIM, 2009, ANN HUM BIOL, V36, P562, DOI 10.1080/03014460902960289; Dunbar RIM, 1998, EVOL ANTHROPOL, V6, P178, DOI 10.1002/(SICI)1520-6505(1998)6:5<178::AID-EVAN5>3.0.CO;2-8; Eddy CM, 2016, LANCET PSYCHIAT, V3, P1079, DOI 10.1016/S2215-0366(16)30144-4; Eddy CM, 2013, BEHAV NEUROL, V27, P15, DOI [10.1155/2013/417516, 10.3233/BEN-120298]; Elsabbagh M, 2016, BIOL PSYCHIAT, V80, P94, DOI 10.1016/j.biopsych.2016.02.019; Erdley CA, 2010, ABCT CLIN ASSESS SER, P21, DOI 10.1007/978-1-4419-0609-0_2; Eslinger PJ, 2004, BRAIN COGNITION, V55, P84, DOI 10.1016/s0278-2626(03)00281-1; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608; Fehr T, 2014, BRAIN RES, V1583, P141, DOI 10.1016/j.brainres.2014.04.041; Fett AKJ, 2011, NEUROSCI BIOBEHAV R, V35, P573, DOI 10.1016/j.neubiorev.2010.07.001; Fiske S.T., 2013, SOCIAL COGNITION BRA; Fletcher-Watson S, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008785.pub2; FOX PT, 1984, J NEUROPHYSIOL, V51, P1109; Frith CD, 2008, NEURON, V60, P503, DOI 10.1016/j.neuron.2008.10.032; Frith CD, 2007, PHILOS T R SOC B, V362, P671, DOI 10.1098/rstb.2006.2003; Frith CD, 2006, NEURON, V50, P531, DOI 10.1016/j.neuron.2006.05.001; Funamoto A, 2015, INFANT MENT HEALTH J, V36, P3, DOI 10.1002/imhj.21481; Furlong Mairead, 2013, Evid Based Child Health, V8, P318, DOI 10.1002/ebch.1905; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gangitano M, 2004, EUR J NEUROSCI, V20, P2193, DOI 10.1111/j.1460-9568.2004.03655.x; Gibson J, 2011, RES DEV DISABIL, V32, P2458, DOI 10.1016/j.ridd.2011.07.014; Giedd JN, 2008, J ADOLESCENT HEALTH, V42, P335, DOI 10.1016/j.jadohealth.2008.01.007; Gill KE, 2016, EARLY INTERV PSYCHIA, V10, P77, DOI 10.1111/eip.12182; Gomes A, 2014, DEV NEUROPSYCHOL, V39, P9, DOI 10.1080/87565641.2013.827197; Gonzalez-Liencres C, 2013, NEUROSCI BIOBEHAV R, V37, P1537, DOI 10.1016/j.neubiorev.2013.05.001; Green MF, 2016, J CLIN PSYCHIAT, V77, P8, DOI 10.4088/JCP.14074su1c.02; Green MF, 2015, NAT REV NEUROSCI, V16, P620, DOI 10.1038/nrn4005; Green MF, 2013, SCHIZOPHRENIA BULL, V39, P1192, DOI 10.1093/schbul/sbt131; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Gur RC, 2016, AM J MED GENET B, V171, P132, DOI 10.1002/ajmg.b.32394; Guyer AE, 2016, NEUROSCI BIOBEHAV R, V70, P74, DOI 10.1016/j.neubiorev.2016.07.037; Hamilton AFD, 2006, J NEUROSCI, V26, P1133, DOI 10.1523/JNEUROSCI.4551-05.2006; Happe F, 2017, ANNU REV PSYCHOL, V68, P243, DOI 10.1146/annurev-psych-010416-044046; Happe F, 2014, J CHILD PSYCHOL PSYC, V55, P553, DOI 10.1111/jcpp.12162; Healey KM, 2016, CLIN PSYCHOL REV, V50, P108, DOI 10.1016/j.cpr.2016.10.001; Heilbronner RL, 2007, CLIN NEUROPSYCHOL, V21, P209, DOI 10.1080/13825580601025932; Hein G, 2008, CURR OPIN NEUROBIOL, V18, P153, DOI 10.1016/j.conb.2008.07.012; Henry JD, 2016, NAT REV NEUROL, V12, DOI 10.1038/nrneurol.2015.229; Henry JD, 2014, NEUROPSYCHOLOGIA, V56, P53, DOI 10.1016/j.neuropsychologia.2013.12.024; Heyes C, 2010, NEUROIMAGE, V51, P789, DOI 10.1016/j.neuroimage.2010.02.034; Hickok G, 2009, J COGNITIVE NEUROSCI, V21, P1229, DOI 10.1162/jocn.2009.21189; Hillis AE, 2014, BRAIN, V137, P981, DOI 10.1093/brain/awt317; Camargo SPH, 2014, J AUTISM DEV DISORD, V44, P2096, DOI 10.1007/s10803-014-2060-7; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Iacoboni M, 2009, ANNU REV PSYCHOL, V60, P653, DOI 10.1146/annurev.psych.60.110707.163604; Ibanez A, 2012, NEUROLOGY, V78, P1354, DOI 10.1212/WNL.0b013e3182518375; Jackson PL, 2006, NEUROIMAGE, V31, P429, DOI 10.1016/j.neuroimage.2005.11.026; Jeste SS, 2015, CURR OPIN NEUROL, V28, P110, DOI 10.1097/WCO.0000000000000181; Jordan K, 2013, INT J REHABIL RES, V36, P221, DOI 10.1097/MRR.0b013e32835d0b43; Kahane G, 2015, SOC NEUROSCI-UK, V10, P551, DOI 10.1080/17470919.2015.1023400; Kaplan JT, 2006, SOC NEUROSCI-UK, V1, P175, DOI 10.1080/17470910600985605; Keane J, 2002, NEUROPSYCHOLOGIA, V40, P655, DOI 10.1016/S0028-3932(01)00156-7; Kennedy DP, 2012, TRENDS COGN SCI, V16, P559, DOI 10.1016/j.tics.2012.09.006; Kensinger EA, 2017, J GERONTOL B-PSYCHOL, V72, P61, DOI 10.1093/geronb/gbw056; Keysers C, 2009, CURR OPIN NEUROBIOL, V19, P666, DOI 10.1016/j.conb.2009.10.006; Kilford EJ, 2016, NEUROSCI BIOBEHAV R, V70, P106, DOI 10.1016/j.neubiorev.2016.08.016; Kim ES, 2013, J AUTISM DEV DISORD, V43, P1038, DOI 10.1007/s10803-012-1645-2; Kim K, 2007, CYBERPSYCHOL BEHAV, V10, P215, DOI 10.1089/cpb.2006.9966; KLING A S, 1992, P353; Koscik TR, 2012, J INT NEUROPSYCH SOC, V18, P394, DOI 10.1017/S1355617712000264; Ku J, 2007, CYBERPSYCHOL BEHAV, V10, P567, DOI 10.1089/cpb.2007.9989; Kumfor F, 2012, NEUROPSYCHOL REV, V22, P280, DOI 10.1007/s11065-012-9201-6; Kurtz MM, 2016, CLIN PSYCHOL REV, V43, P80, DOI 10.1016/j.cpr.2015.09.003; Lalonde G, 2013, J NEUROSCI METH, V219, P76, DOI 10.1016/j.jneumeth.2013.07.005; Lamm C, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0083; Leekam S, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0082; Lemerise EA, 2000, CHILD DEV, V71, P107, DOI 10.1111/1467-8624.00124; Levallois C, 2012, NAT REV NEUROSCI, V13, P789, DOI 10.1038/nrn3354; Levenson RW, 2014, ANNU REV CLIN PSYCHO, V10, P581, DOI 10.1146/annurev-clinpsy-032813-153653; Lieberman MD, 2012, NEUROIMAGE, V61, P432, DOI 10.1016/j.neuroimage.2011.12.089; Lindinger NM, 2016, ALCOHOL CLIN EXP RES, V40, P367, DOI 10.1111/acer.12961; Lozier LM, 2014, DEV PSYCHOPATHOL, V26, P933, DOI 10.1017/S0954579414000479; Marsh LE, 2011, NEUROIMAGE, V56, P1511, DOI 10.1016/j.neuroimage.2011.02.003; Marshall PJ, 2011, DEV COGN NEUROS-NETH, V1, P110, DOI 10.1016/j.dcn.2010.09.001; Martin AK, 2016, NEUROPSYCHOLOGIA, V93, P158, DOI 10.1016/j.neuropsychologia.2016.10.013; Matto HC, 2010, SOC WORK, V55, P147, DOI 10.1093/sw/55.2.147; Matusall S., 2011, OXFORD HDB SOCIAL NE, P9; Mazza M, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00791; McConachie H, 2015, HEALTH TECHNOL ASSES, V19, P1, DOI 10.3310/hta19410; McDonald S, 2013, J INT NEUROPSYCH SOC, V19, P231, DOI 10.1017/S1355617712001506; Miller BL, 2003, ANN NEUROL, V54, pS7, DOI 10.1002/ana.10568; Mills KL, 2014, SOC COGN AFFECT NEUR, V9, P123, DOI 10.1093/scan/nss113; Mitchell P, 2007, J AUTISM DEV DISORD, V37, P589, DOI 10.1007/s10803-006-0189-8; Moll J, 2003, NEUROREPORT, V14, P299, DOI 10.1097/01.wnr.0000057866.05120.28; Moll J, 2005, NAT REV NEUROSCI, V6, P799, DOI 10.1038/nrn1768; Mortensen JA, 2014, INFANT MENT HEALTH J, V35, P336, DOI 10.1002/imhj.21451; Mueser KT, 2013, ANNU REV CLIN PSYCHO, V9, P465, DOI 10.1146/annurev-clinpsy-050212-185620; Murphy SM, 2014, RES DEV DISABIL, V35, P2821, DOI 10.1016/j.ridd.2014.07.026; Murza KA, 2016, INT J LANG COMM DIS, V51, P236, DOI 10.1111/1460-6984.12212; National Collaborating Centre for Mental Health, 2013, ANT BEH COND DIS CHI; Nikolaides A, 2016, EUR ARCH PSY CLIN N, V266, P649, DOI 10.1007/s00406-016-0705-6; Northoff G, 2010, NEURON, V65, P748, DOI 10.1016/j.neuron.2010.02.024; Ochsner KN, 2008, BIOL PSYCHIAT, V64, P48, DOI 10.1016/j.biopsych.2008.04.024; Ochsner KN, 2004, CURR OPIN NEUROBIOL, V14, P254, DOI 10.1016/j.conb.2004.03.011; Ochsner KN, 2001, AM PSYCHOL, V56, P717, DOI 10.1037//0003-066X.56.9.717; Okruszek L, 2017, SCHIZOPHR RES, V190, P3, DOI 10.1016/j.schres.2017.03.013; Otero TL, 2015, CHILD ADOL PSYCH CL, V24, P99, DOI 10.1016/j.chc.2014.09.002; Park KM, 2009, HUM PSYCHOPHARM CLIN, V24, P619, DOI 10.1002/hup.1071; Parsons S, 2005, AUTISM, V9, P95, DOI 10.1177/1362361305049032; Parsons S, 2004, J AUTISM DEV DISORD, V34, P449, DOI 10.1023/B:JADD.0000037421.98517.8d; Parsons TD, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7040042; Parsons TD, 2009, DEV NEUROREHABIL, V12, P224, DOI 10.1080/17518420902991719; Pavone EF, 2016, J NEUROSCI, V36, P268, DOI 10.1523/JNEUROSCI.0494-15.2016; Payne JM, 2016, NEUROPSYCHOLOGY, V30, P439, DOI 10.1037/neu0000262; Pelphrey K, 2004, MENT RETARD DEV D R, V10, P259, DOI 10.1002/mrdd.20040; Penn DL, 2007, PSYCHIAT SERV, V58, P449; Penn PR, 2009, DEV NEUROREHABIL, V12, P32, DOI 10.1080/17518420902739365; Pfeifer JH, 2012, SOC COGN AFFECT NEUR, V7, P1, DOI 10.1093/scan/nsr099; Pinkham AE, 2008, SCHIZOPHR RES, V99, P164, DOI 10.1016/j.schres.2007.10.024; Pinkham AE, 2014, SCHIZOPHRENIA BULL, V40, P813, DOI 10.1093/schbul/sbt081; Port RG, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00414; Puente A. E., 1989, HDB CLIN CHILD NEURO, P3; RALEIGH MJ, 1981, EXP NEUROL, V73, P378, DOI 10.1016/0014-4886(81)90273-9; Ramsey R, 2013, J COGNITIVE NEUROSCI, V25, P670, DOI 10.1162/jocn_a_00345; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rizzolatti G, 2008, CURR OPIN NEUROBIOL, V18, P179, DOI 10.1016/j.conb.2008.08.001; Rizzolatti G, 2010, NAT REV NEUROSCI, V11, P264, DOI 10.1038/nrn2805; Robillard G, 2010, STUD HEALTH TECHNOL, V154, P57, DOI 10.3233/978-1-60750-561-7-57; ROLAND PE, 1982, J NEUROPHYSIOL, V48, P467; Romine CB, 2005, APPL NEUROPSYCHOL, V12, P190, DOI 10.1207/s15324826an1204_2; Rose FD, 2005, CYBERPSYCHOL BEHAV, V8, P241, DOI 10.1089/cpb.2005.8.241; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; Rosen HJ, 2004, DEMENT GERIATR COGN, V17, P277, DOI 10.1159/000077154; Ruff RM, 2003, ARCH CLIN NEUROPSYCH, V18, P847, DOI 10.1016/j.acn.2003.07.002; Samuels BM, 2009, MIND BRAIN EDUC, V3, P45, DOI 10.1111/j.1751-228X.2008.01052.x; Saxe R, 2006, CURR OPIN NEUROBIOL, V16, P235, DOI 10.1016/j.conb.2006.03.001; Schaafsma SM, 2015, TRENDS COGN SCI, V19, P65, DOI 10.1016/j.tics.2014.11.007; Scourfield J, 1999, BRIT J PSYCHIAT, V175, P559, DOI 10.1192/bjp.175.6.559; Sevinc G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087427; Shany-Ur T, 2011, CURR OPIN NEUROL, V24, P550, DOI 10.1097/WCO.0b013e32834cd42a; Shaw DJ, 2013, DEV NEUROPSYCHOL, V38, P256, DOI 10.1080/87565641.2013.783832; Singer T, 2012, NEUROIMAGE, V61, P437, DOI 10.1016/j.neuroimage.2012.01.109; Singer T, 2009, ANN NY ACAD SCI, V1156, P81, DOI 10.1111/j.1749-6632.2009.04418.x; Spooner DM, 2006, ARCH CLIN NEUROPSYCH, V21, P327, DOI 10.1016/j.acn.2006.04.004; Steinberg L, 2008, DEV REV, V28, P78, DOI 10.1016/j.dr.2007.08.002; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; Suchy Y., 2011, CLIN NEUROPSYCHOLOGY; Tan B-L, 2016, ASIAN J PSYCHIAT; Tarr MJ, 2002, NAT NEUROSCI, V5, P1089, DOI 10.1038/nn948; Telford EJ, 2016, J CHILD PSYCHOL PSYC, V57, P861, DOI 10.1111/jcpp.12546; Todorov A, 2006, BRAIN RES, V1079, P76, DOI 10.1016/j.brainres.2005.12.114; Tousignant B, 2017, INFANT BEHAV DEV, V48, P5, DOI 10.1016/j.infbeh.2015.11.006; Turkstra LS, 2014, AJIDD-AM J INTELLECT, V119, P319, DOI 10.1352/1944-7558-119.4.319; Vakil E, 2012, J CLIN EXP NEUROPSYC, V34, P135, DOI 10.1080/13803395.2011.623121; Verweij M, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00332; Vivanti G, 2014, J ABNORM CHILD PSYCH, V42, P1395, DOI 10.1007/s10802-014-9874-9; Vogeley K, 2004, J COGNITIVE NEUROSCI, V16, P817, DOI 10.1162/089892904970799; Vrijhof CI, 2016, J ADOLESCENCE, V52, P27, DOI 10.1016/j.adolescence.2016.07.005; Wellman HM, 2001, CHILD DEV, V72, P655, DOI 10.1111/1467-8624.00304; Will GJ, 2016, DEV COGN NEUROS-NETH, V19, P288, DOI 10.1016/j.dcn.2016.05.004; Wittenberg D, 2008, NEUROPSYCHOL REV, V18, P91, DOI 10.1007/s11065-008-9056-z; Woodward AL, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0181; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Zaki J, 2009, ANN NY ACAD SCI, V1167, P16, DOI 10.1111/j.1749-6632.2009.04601.x; Zelazo PD, 2010, SOC NEUROSCI-UK, V5, P417, DOI 10.1080/17470919.2010.510002; Zwaigenbaum L, 2013, BEHAV BRAIN RES, V251, P133, DOI 10.1016/j.bbr.2013.04.004	240	11	11	0	17	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	NOV	2017	31	8			SI		981	1002		10.1037/neu0000395			22	Psychology, Clinical; Neurosciences; Psychology	Psychology; Neurosciences & Neurology	FT6JH	WOS:000423259900010	29376673				2021-06-18	
J	Kvint, S; Schuster, J; Kumar, MA				Kvint, Svetlana; Schuster, James; Kumar, Monisha A.			Neurosurgical applications of viscoelastic hemostatic assays	NEUROSURGICAL FOCUS			English	Article						viscoelastic; hemostatic; assays; coagulation; hemostasis; thromboelastography; rotational thromboelastometry	TRAUMATIC BRAIN-INJURY; INTRACEREBRAL HEMORRHAGE; VENOUS THROMBOEMBOLISM; COAGULATION MANAGEMENT; THROMBOELASTOGRAPHY TEG; ANTIPLATELET THERAPY; BLOOD-TRANSFUSION; CARDIAC-SURGERY; THROMBELASTOGRAPHY; COAGULOPATHY	Patients taking antithrombotic agents are very common in neurosurgical practice. The perioperative management of these patients can be extremely challenging especially as newer agents, with poorly defined laboratory monitoring and reversal strategies, become more prevalent. This is especially true with emergent cases in which rapid reversal of anticoagulation is required and the patient's exact medical history is not available. With an aging patient population and the associated increase in diseases such as atrial fibrillation, it is expected that the use of these agents will continue to rise in coming years. Furthermore, thromboembolic complications such as deep venous thrombosis, pulmonary embolism, and myocardial infarction are common complications of major surgery. These trends, in conjunction with a growing understanding of the hemostatic process and its contribution to the pathophysiology of disease, stress the importance of the complete evaluation of a patient's hemostatic profile in guiding management decisions. Viscoelastic hemostatic assays (VHAs), such as thromboelastography and rotational thromboelastometry, are global assessments of coagulation that account for the cellular and plasma components of coagulation. This FDA-approved technology has been available for decades and has been widely used in cardiac surgery and liver transplantation. Although VHAs were cumbersome in the past, advances in software and design have made them more accurate, reliable, and accessible to the neurosurgeon. VHAs have demonstrated utility in guiding intraoperative blood product transfusion, identifying coagulopathy in trauma, and managing postoperative thromboprophylaxis. The first half of this review aims to evaluate and assess VHAs, while the latter half seeks to appraise the evidence supporting their use in neurosurgical populations.	[Kvint, Svetlana; Schuster, James; Kumar, Monisha A.] Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA; [Kumar, Monisha A.] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA	Kumar, MA (corresponding author), Hosp Univ Penn, Dept Neurol, 3 West Gates Bldg,3400 Spruce St, Philadelphia, PA 19104 USA.	monisha.kumar@uphs.upenn.edu					Afshari A, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007871.pub2; Alexander DC, 2010, THROMB RES, V125, P387, DOI 10.1016/j.thromres.2009.07.001; Baharoglu MI, 2016, LANCET, V387, P2605, DOI 10.1016/S0140-6736(16)30392-0; Bolliger D, 2012, TRANSFUS MED REV, V26, P1, DOI 10.1016/j.tmrv.2011.07.005; Cotton BA, 2012, J TRAUMA ACUTE CARE, V73, P365, DOI 10.1097/TA.0b013e31825c1234; Davis PK, 2013, NEUROCRIT CARE, V18, P201, DOI 10.1007/s12028-012-9745-6; Dias JD, 2015, ARCH PATHOL LAB MED, V139, P665, DOI 10.5858/arpa.2014-0170-OA; Dzik Walter H, 2004, Curr Hematol Rep, V3, P324; Fahrendorff M, 2017, SCAND J TRAUMA RESUS, V25, DOI 10.1186/s13049-017-0378-9; Flibotte JJ, 2004, NEUROLOGY, V63, P1059, DOI 10.1212/01.WNL.0000138428.40673.83; Folkerson LE, 2015, SURGERY, V158, P655, DOI 10.1016/j.surg.2015.02.029; Frontera JA, 2017, NEUROCRIT CARE, V26, P48, DOI 10.1007/s12028-016-0292-4; Garcia D, 2013, J THROMB HAEMOST, V11, P245, DOI 10.1111/jth.12096; Gonzalez E, 2010, SEMIN THROMB HEMOST, V36, P723, DOI 10.1055/s-0030-1265289; Gozal Yair M, 2017, Surg Neurol Int, V8, P48, DOI 10.4103/sni.sni_265_16; Haas T, 2012, BRIT J ANAESTH, V108, P36, DOI 10.1093/bja/aer342; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Herrmann R, 2014, THROMB HAEMOSTASIS, V111, P989, DOI 10.1160/TH13-07-0607; Hoffman M, 2001, THROMB HAEMOSTASIS, V85, P958; Holcomb JB, 2012, ANN SURG, V256, P476, DOI 10.1097/SLA.0b013e3182658180; Hunt H, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010438.pub2; Jansohn E, 2017, SCAND J CLIN LAB INV, V77, P289, DOI 10.1080/00365513.2017.1306877; Johansson PI, 2014, BLOOD, V124, P3052, DOI 10.1182/blood-2014-05-575340; Kawano-Castillo J, 2014, STROKE, V45, P683, DOI 10.1161/STROKEAHA.113.003826; Kreitzer NP, 2015, NEUROCRIT CARE, V23, P427, DOI 10.1007/s12028-015-0187-9; Kunio NR, 2012, AM J SURG, V203, P584, DOI 10.1016/j.amjsurg.2011.12.011; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; Larsen CC, 2010, ACTA NEUROCHIR, V152, P1577, DOI 10.1007/s00701-010-0699-1; Levine J, 2010, NEUROSURGERY, V66, P312, DOI 10.1227/01.NEU.0000363747.47587.6C; Li ZJ, 2013, EUR SPINE J, V22, P1950, DOI 10.1007/s00586-013-2774-9; Lindroos AC, 2014, J ANESTH, V28, P189, DOI 10.1007/s00540-013-1711-8; Liotta EM, 2012, STROKE, V43, P2503, DOI 10.1161/STROKEAHA.112.664540; Luostarinen T, 2012, J ANESTH, V26, P770, DOI 10.1007/s00540-012-1400-z; Massaro AM, 2015, NEUROCRIT CARE, V22, P45, DOI 10.1007/s12028-014-0051-3; May AK, 1997, AM SURGEON, V63, P233; McTaggart RA, 2015, J NEUROINTERV SURG, V7, P425, DOI 10.1136/neurintsurg-2013-011089; Mittermayr M, 2007, ANESTH ANALG, V105, P905, DOI 10.1213/01.ane.0000280481.18570.27; Moore HB, 2016, J AM COLL SURGEONS, V222, P347, DOI 10.1016/j.jamcollsurg.2016.01.006; Naik BI, 2015, J NEUROSURG-SPINE, V23, P239, DOI 10.3171/2014.12.SPINE14620; Narayan RK, 2008, J NEUROTRAUM, V25, P629, DOI 10.1089/neu.2007.0385; Norton Robert P, 2013, Evid Based Spine Care J, V4, P157, DOI 10.1055/s-0033-1357364; Ogawa S, 2012, TRANSFUSION, V52, P14, DOI 10.1111/j.1537-2995.2011.03241.x; Phelan HA, 2012, J NEUROTRAUM, V29, P1821, DOI 10.1089/neu.2012.2459; Qian CF, 2016, THROMB RES, V137, P58, DOI 10.1016/j.thromres.2015.11.018; Qureshi AI, 2000, NEUROSURGERY, V46, P1360, DOI 10.1097/00006123-200006000-00014; Raghavan M, 2005, CHEST, V127, P295, DOI 10.1378/chest.127.1.295; Ramchand P, 2016, WORLD NEUROSURG, V96, P215, DOI 10.1016/j.wneu.2016.04.002; REED RL, 1992, J TRAUMA, V33, P465, DOI 10.1097/00005373-199209000-00022; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Rossaint R, 2010, CRIT CARE, V14, DOI 10.1186/cc8943; Rotondo MFC, 2014, RESOURCES OPTIMAL CA; Salinas D, 2017, AORN J, V105, P370, DOI 10.1016/j.aorn.2017.01.013; Salooja N, 2001, BLOOD COAGUL FIBRIN, V12, P327, DOI 10.1097/00001721-200107000-00001; SAWAYA R, 1992, J NEURO-ONCOL, V14, P119; Serraino GF, 2017, BRIT J ANAESTH, V118, P823, DOI 10.1093/bja/aex100; Shander A, 2007, BEST PRACT RES-CLIN, V21, P271, DOI 10.1016/j.bpa.2007.01.002; Shen L, 2017, J THORAC DIS, V9, pS299, DOI 10.21037/jtd.2017.03.85; Solbeck S, 2016, INT J CARDIOL, V208, P14, DOI 10.1016/j.ijcard.2016.01.148; Solomon C, 2016, SCAND J CLIN LAB INV, V76, P503, DOI 10.1080/00365513.2016.1200136; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; Stricker PA, 2010, PEDIATR ANESTH, V20, P150, DOI 10.1111/j.1460-9592.2009.03227.x; Tanaka KA, 2012, J CARDIOTHOR VASC AN, V26, P1083, DOI 10.1053/j.jvca.2012.06.015; Velez AM, 2011, NEUROSURGERY, V68, pE1165, DOI 10.1227/NEU.0b013e31820a181a; White N, 2015, J CRANIOFAC SURG, V26, P30, DOI 10.1097/SCS.0000000000001108; Whiting D, 2014, AM J HEMATOL, V89, P228, DOI 10.1002/ajh.23599; Whiting P, 2015, HEALTH TECHNOL ASSES, V19, pv; Whiting P, 2015, HEALTH TECHNOL ASSES, V19, P1, DOI 10.3310/hta19580; Wikkelso A, 2017, ANAESTHESIA, V72, P519, DOI 10.1111/anae.13765; Wikkelso A, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007871.pub3; Windelov NA, 2011, BLOOD COAGUL FIBRIN, V22, P416, DOI 10.1097/MBC.0b013e3283464f53; Xiao W, 2016, J CLIN ANESTH, V33, P149, DOI 10.1016/j.jclinane.2016.02.040; Yang HC, 2015, INTERV NEURORADIOL, V21, P61, DOI 10.15274/INR-2014-10094; Yoshihara H, 2014, SPINE, V39, P304, DOI 10.1097/BRS.0000000000000123; Yust-Katz S, 2015, J NEURO-ONCOL, V124, P87, DOI 10.1007/s11060-015-1805-2	74	11	12	0	3	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	NOV	2017	43	5							E9	10.3171/2017.8.FOCUS17447			9	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	FL5JE	WOS:000414270800014	29088950	Bronze			2021-06-18	
J	Prabhakaran, K; Petrone, P; Lombardo, G; Stoller, C; Policastro, A; Marini, CP				Prabhakaran, Kartik; Petrone, Patrizio; Lombardo, Gary; Stoller, Christy; Policastro, Anthony; Marini, Corrado P.			Mortality rates of severe traumatic brain injury patients: impact of direct versus nondirect transfers	JOURNAL OF SURGICAL RESEARCH			English	Article						Traumatic brain injury; Transfer; Mortality	HEAD-INJURY; MANAGEMENT	Background: Direct transport of patients with severe traumatic brain injury (sTBI) to trauma centers (TCs) that can provide definitive care results in lower mortality rates. This study investigated the impact of direct versus nondirect transfers on the mortality rates of patients with sTBI. Methods: Data on patients with TBI admitted between January 1, 2012, and December 31, 2013, to our Level I TC were obtained from the trauma registry. Data included patient age, sex, mechanism, and type of injury, comorbidities, Glasgow Coma Scale, Injury Severity scores, prehospital time, time to request and to transfer, time to initiation of multimodality monitoring and goal-directed therapy protocol, dwell time in the emergency department (EDT), and mortality. Data, reported in means +/- standard deviation, were analyzed with the Student t-test and chi-square. Statistical significance was accepted at a P value < 0.05. Results: sTBI direct transfer to TC versus transfer from non-TCs (NTC): Of the 1187 patients with TBI admitted to our TC, 768 (64.7%) were admitted directly from the scene, whereas 419 (35.3%) were admitted after secondary transfer. One hundred seventy-one (22.2%) of the direct transfers had Glasgow Coma Scale < 8 (sTBI) and 92 (21.9%) of the secondary transfers had sTBI. The transfer time: Time from scene to arrival to the EDT was significantly shorter for TC versus NTCs 43 +/- 14 versus 77 +/- 26 min, respectively (P < 0.05). EDT dwell time before transfer and time from injury to arrival to TC were 4.2 +/- 2.1 and 6.2 +/- 8.3 h, respectively. Mortality: There was a statistically significant lower mortality for patients with sTBI transferred directly from the scene to TCs as opposed to patients secondarily transferred, 33/171 (19.3%) versus 33/92 (35.8%), respectively (P < 0.05). Conclusions: To decrease TBI-related mortality, patients with suspected sTBI should be taken directly to a Level I or II TC unless they require life-saving stabilization at NTCs. (C) 2017 Elsevier Inc. All rights reserved.	[Prabhakaran, Kartik; Lombardo, Gary; Stoller, Christy; Policastro, Anthony] New York Med Coll, Div Trauma Surg Surg Crit Care & Emergency Gen Su, Dept Surg, Westchester Med Ctr,Univ Hosp, E150 Taylor Pavil,100 Woods Rd, Valhalla, NY 10595 USA; [Petrone, Patrizio; Marini, Corrado P.] Winthrop Univ Hosp, Div Trauma Surg Surg Crit Care & Emergency Gen Su, Mineola, NY 11501 USA	Prabhakaran, K (corresponding author), New York Med Coll, Div Trauma Surg Surg Crit Care & Emergency Gen Su, Dept Surg, Westchester Med Ctr,Univ Hosp, E150 Taylor Pavil,100 Woods Rd, Valhalla, NY 10595 USA.	Kartik.Prabhakaran@wmchealth.org	Petrone, Patrizio/AAQ-7986-2020	Petrone, Patrizio/0000-0002-7629-1663			Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS65; Brenner M, 2012, J TRAUMA ACUTE CARE, V72, P1135, DOI 10.1097/TA.0b013e31824af90b; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Clark RSB, 1997, NEUROSURGERY, V41, P1284, DOI 10.1097/00006123-199712000-00010; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P202, DOI 10.1097/01.WCB.0000103022.98348.24; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P191, DOI 10.1097/01.WCB.0000100045.07481.DE; Cunningham AS, 2005, BRAIN, V128, P1931, DOI 10.1093/brain/awh536; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Faul M, 2016, PREHOSP EMERG CARE, V20, P594, DOI 10.3109/10903127.2016.1149651; Hartl R, 2006, J TRAUMA, V60, P1250, DOI 10.1097/01.ta.0000203717.57821.8d; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/s0140-6736(04)17188-2; Nangunoori R, 2012, NEUROCRIT CARE, V17, P131, DOI 10.1007/s12028-011-9621-9; Sharma S, 2014, J AM COLL SURGEONS, V218, P510, DOI 10.1016/j.jamcollsurg.2014.01.002; Sharma S, 2014, J AM COLL SURGEONS, V218, P51, DOI 10.1016/j.jamcollsurg.2013.10.005; Stein NR, 2012, NEUROCRIT CARE, V17, P49, DOI 10.1007/s12028-012-9708-y; Stein SC, 2010, J NEUROSURG, V112, P1105, DOI 10.3171/2009.8.JNS09738; Sugerman DE, 2012, J TRAUMA ACUTE CARE, V73, P1491, DOI 10.1097/TA.0b013e3182782675	21	11	12	0	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	NOV	2017	219						66	71		10.1016/j.jss.2017.05.103			6	Surgery	Surgery	FK8RF	WOS:000413775200011	29078912				2021-06-18	
J	Shibahashi, K; Sugiyama, K; Okura, Y; Hoda, H; Hamabe, Y				Shibahashi, Keita; Sugiyama, Kazuhiro; Okura, Yoshihiro; Hoda, Hidenori; Hamabe, Yuichi			Multicenter Retrospective Cohort Study of " Talk and Die" After Traumatic Brain Injury	WORLD NEUROSURGERY			English	Article						Mortality; Risk factor; Skull fracture; Subdural hematoma; Talk and die; Traumatic brain injury	HEAD-INJURY; PROGESTERONE; DETERIORATE; PERIOD; DEATH; COMA	BACKGROUND: Patients who "talk and die" after traumatic brain injury (TBI) are potentially salvageable. The reported incidences and risk factors for the "talk and die" phenomenon are conflicting and do not take into account recent improvements in trauma care. The aim of this study was to determine the incidences of "talk and die" after TBI in a modern trauma care system, as well as associated risk factors. METHODS: We identified patients who experienced TBI (abbreviated injury scale 3-5) between 2004 and 2015 who talked on admission (i.e., their verbal component on the Glasgow Coma Scale was >= 3 on admission) using a nationwide trauma registry (the Japan Trauma Data Bank). The end point was in-hospital mortality. We compared patients who talked and died with those who talked and survived. RESULTS: During the study period, 236,698 patients were registered in the database. Of the 24,833 patients who were eligible for analysis, 956 (4.0%) patients subsequently died in the hospital. The in-hospital mortality rate significantly decreased over the past 12 years. Older age; male sex; a higher injury severity score; a lower Glasgow Coma Scale score; comorbidities (congestive heart failure, chronic kidney disease, liver cirrhosis, and hematologic disorders); hypotension on arrival; subdural hemorrhage; contusion; and vault fracture were independently associated with higher in-hospital mortality. CONCLUSION: Even in modern trauma care systems, some patients still talk and die after TBI. We identified certain risk factors in patients with TBI that elicit the requirement for close observation, even if these patients talk after TBI.	[Shibahashi, Keita] Tokyo Metropolitan Bokutoh Hosp, Dept Emergency, Tokyo, Japan; Tokyo Metropolitan Bokutoh Hosp, Intens Care Ctr, Tokyo, Japan	Shibahashi, K (corresponding author), Tokyo Metropolitan Bokutoh Hosp, Dept Emergency, Tokyo, Japan.	kshibahashi@yahoo.co.jp		Sugiyama, Kazuhiro/0000-0003-4543-3064; Hoda, Hidenori/0000-0002-4283-4412			BAKER SP, 1976, J TRAUMA, V16, P882, DOI 10.1097/00005373-197611000-00006; Brasel KJ, 2013, J TRAUMA ACUTE CARE, V74, P1363, DOI 10.1097/TA.0b013e31828b82f5; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; Davis DP, 2007, J TRAUMA, V62, P277, DOI 10.1097/TA.0b013e31802ef4a3; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Dunn LT, 2003, J TRAUMA, V54, P497, DOI 10.1097/01.TA.0000030627.71453.CD; GALBRAITH S, 1976, BMJ-BRIT MED J, V1, P1438, DOI 10.1136/bmj.1.6023.1438; Goldschlager T, 2007, J CLIN NEUROSCI, V14, P618, DOI 10.1016/j.jocn.2006.02.018; Hlatky R, 2004, NEUROSURGERY, V55, P1318, DOI 10.1227/01.NEU.0000143029.42638.2C; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; LOBATO RD, 1991, J NEUROSURG, V75, P256, DOI 10.3171/jns.1991.75.2.0256; Marion DW, 2006, NEUROSURGERY, V58, P655; MARSHALL LF, 1983, J NEUROSURG, V59, P285, DOI 10.3171/jns.1983.59.2.0285; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; RATANALERT S, 1990, SURG NEUROL, V34, P27, DOI 10.1016/0090-3019(90)90168-O; REILLY PL, 1975, LANCET, V2, P375; ROOF RL, 1994, EXP NEUROL, V129, P64, DOI 10.1006/exnr.1994.1147; ROSE J, 1977, BRIT MED J, V2, P615, DOI 10.1136/bmj.2.6087.615; Stein Donald G, 2003, Pediatr Rehabil, V6, P13, DOI 10.1080/1363849031000095279; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165	21	11	11	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	NOV	2017	107						82	86		10.1016/J.WNEU.2017.07.117			5	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	FN2XV	WOS:000415860500013	28765023				2021-06-18	
J	Sinha, S; Raheja, A; Samson, N; Goyal, K; Bhoi, S; Selvi, A; Sharma, P; Sharma, BS				Sinha, Sumit; Raheja, Amol; Samson, Neha; Goyal, Keshav; Bhoi, Sanjeev; Selvi, Arul; Sharma, Pushpa; Sharma, Bhawani Shankar			A randomized placebo-controlled trial of progesterone with or without hypothermia in patients with acute severe traumatic brain injury	NEUROLOGY INDIA			English	Article						Factorial design; hypothermia; progesterone; randomized clinical trial; severe head injury	SEVERE HEAD-INJURY; CLINICAL-TRIAL	Objective: Among newer neuroprotectant modalities, hypothermia and progesterone have shown a beneficial role in preliminary studies enrolling patients with severe traumatic brain injury (sTBI). The primary objective of this study was to evaluate the efficacy of progesterone with or without prophylactic hypothermia in acute sTBI patients. Materials and Methods: This is a prospective, outcome assessor, statistician blinded, randomized, and placebo-controlled phase II trial of progesterone with or without hypothermia (factorial design). All adult patients (18-65 years) with acute sTBI (Glasgow coma score of 4-8) and presenting to trauma center within 8 h after injury were included in the trial. Computer-generated randomization was done after exclusion; sequentially numbered, opaque, sealed envelope technique was used for allocation concealment. The enrollment duration was from January 2012 to October 2014. The primary endpoint was dichotomized Glasgow outcome score (GOS) [poor recovery = GOS 1-3; good recovery = GOS 4-5], and secondary endpoints were functional independence measure (FIM) score and mortality rate at 6 and 12 months follow-up after recruitment. Results: A total of 107 patients were randomized into four groups (placebo [n = 27], progesterone [n = 26], hypothermia alone [n = 27], and progesterone + hypothermia [n = 27]). The study groups were comparable in baseline parameters except for a higher incidence of decompressive craniectomy in the placebo group (P = 0.001). The analysis of GOS at 6 months revealed statistically significant better outcome in the hypothermia group (82%; P = 0.01) and a weaker evidence for progesterone group (74%; P = 0.07) as compared with the placebo group (44%). However, the outcome benefit was marginal at 1-year follow-up for the hypothermia group (82% vs. 58%, P = 0.17). The adjusted odds ratio of poor recovery at 6 months in the hypothermia group was 0.21 (confidence interval = 0.05-0.84, P = 0.03), as compared with the placebo group. Although mean FIM scores at 6 and 12 months respectively were marginally higher in the hypothermia and progesterone groups compared with the placebo group (P = 0.06 and 0.27), the proportion of functionally independent individuals were similar in all the groups (P = 0.79 and 0.51). The mortality rates were similar in all the groups at 6 and 12 months (P = 0.78 and 0.52 respectively). Conclusions: A strong evidence for prophylactic hypothermia and a weak evidence for progesterone therapy was observed for a better primary outcome at 6 months as compared to the placebo. A similar trend was observed at a 1-year follow-up. Contrary to our hypothesis, prophylactic hypothermia therapy suppressed the beneficial effects of progesterone therapy in sTBI patients. The complex cascades of factors responsible for such interactions are still unknown and need to be further determined.	[Sinha, Sumit; Raheja, Amol; Samson, Neha; Sharma, Bhawani Shankar] All India Inst Med Sci, Dept Neurosurg, New Delhi 110029, India; [Goyal, Keshav] All India Inst Med Sci, Dept Neuroanaesthesia, New Delhi, India; [Bhoi, Sanjeev] All India Inst Med Sci, Dept Emergency Med, New Delhi, India; [Selvi, Arul] All India Inst Med Sci, Lab Med, New Delhi, India; [Sharma, Pushpa] Uniformed Serv Univ Hlth Sci, Dept Anesthesiol, Bethesda, MD 20814 USA	Sinha, S (corresponding author), All India Inst Med Sci, Dept Neurosurg, New Delhi 110029, India.	sumitneuro@gmail.com	Sharma, Pushpa/AAY-8756-2020		Department of Biotechnology, Ministry of Science and Technology, India	The National Trial Registry Number CTRI/2009/091/000893; Funded by Department of Biotechnology, Ministry of Science and Technology, India.	Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2011, THER HYPOTHERMIA TEM, V1, DOI 10.1089/ther.2011.0009; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Jiang JY, 2000, J NEUROSURG, V93, P546, DOI 10.3171/jns.2000.93.4.0546; Ma JP, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008409.pub3; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Roberts I, 1998, J NEUROL NEUROSUR PS, V65, P729, DOI 10.1136/jnnp.65.5.729; Shiozaki T, 2003, J NEUROSURG, V99, P47, DOI 10.3171/jns.2003.99.1.0047; Sinha S, 2014, INDIAN J NEUROSURG, V3, P138, DOI 10.4103/2277-9167.146827; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887	14	11	12	0	0	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	0028-3886	1998-4022		NEUROL INDIA	Neurol. India	NOV-DEC	2017	65	6					1304	1311		10.4103/0028-3886.217973			8	Neurosciences	Neurosciences & Neurology	FM7IL	WOS:000415249200028	29133706				2021-06-18	
J	Tariq, A; Aguilar-Salinas, P; Hanel, RA; Naval, N; Chmayssani, M				Tariq, Areej; Aguilar-Salinas, Pedro; Hanel, Ricardo A.; Naval, Neeraj; Chmayssani, Mohamad			The role of ICP monitoring in meningitis	NEUROSURGICAL FOCUS			English	Article						meningitis; intracranial pressure; cerebrospinal fluid; critical care	CEREBRAL-BLOOD-FLOW; INCREASED INTRACRANIAL-PRESSURE; SEVERE BACTERIAL-MENINGITIS; PNEUMOCOCCAL MENINGITIS; DECOMPRESSIVE CRANIECTOMY; BRAIN-BARRIER; HYPERTENSION; ADULTS; MANAGEMENT; MENINGOENCEPHALITIS	Intracranial pressure (ICP) monitoring has been widely accepted in the management of traumatic brain injury. However, its use in other pathologies that affect ICP has not been advocated as strongly, especially in CNS infections. Despite the most aggressive and novel antimicrobial therapies for meningitis, the mortality rate associated with this disease is far from satisfactory. Although intracranial hypertension and subsequent death have long been known to complicate meningitis, no specific guidelines targeting ICP monitoring are available. A review of the literature was performed to understand the pathophysiology of elevated ICP in meningitis, diagnostic challenges, and clinical outcomes in the use of ICP monitoring.	[Tariq, Areej] Ohio State Univ, Dept Neurol, Div Cerebrovasc Dis & Neurocrit Care, Columbus, OH 43210 USA; [Aguilar-Salinas, Pedro; Hanel, Ricardo A.; Naval, Neeraj; Chmayssani, Mohamad] Baptist Neurol Inst, Lyerly Neurosurg, 800 Prudential Dr,Ste 1100, Jacksonville, FL 32207 USA	Chmayssani, M (corresponding author), Baptist Neurol Inst, Lyerly Neurosurg, 800 Prudential Dr,Ste 1100, Jacksonville, FL 32207 USA.	mohamad.chmayssani@bmcjax.com	Aguilar-Salinas, Pedro/AAJ-4444-2020	Aguilar-Salinas, Pedro/0000-0002-5268-6548			Abulhasan YB, 2013, NEUROCRIT CARE, V19, P199, DOI 10.1007/s12028-013-9853-y; Baussart B, 2006, ACTA ANAESTH SCAND, V50, P762, DOI 10.1111/j.1399-6576.2006.01038.x; Bordes J, 2011, ACTA ANAESTH SCAND, V55, P130, DOI 10.1111/j.1399-6576.2010.02355.x; Bromilow J, 2007, BRIT J ANAESTH, V99, P528, DOI 10.1093/bja/aem208; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cuthbertson BH, 2004, ANAESTHESIA, V59, P908, DOI 10.1111/j.1365-2044.2004.03748.x; Dagdemir A, 2006, PEDIATR NEUROL, V35, P352, DOI 10.1016/j.pediatrneurol.2006.05.014; de Vedia L, 2013, INFECTION, V41, P1073, DOI 10.1007/s15010-013-0538-4; Depreitere B, 2016, ACTA NEUROCHIR SUPPL, V122, P101, DOI 10.1007/978-3-319-22533-3_20; Di Rienzo A, 2008, ACTA NEUROCHIR, V150, P1057, DOI 10.1007/s00701-008-0019-1; DURAND ML, 1993, NEW ENGL J MED, V328, P21, DOI 10.1056/NEJM199301073280104; Gliemroth J, 2002, CLIN NEUROL NEUROSUR, V105, P27, DOI 10.1016/S0303-8467(02)00088-4; Glimaker M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091976; Goh KJ, 2000, NEW ENGL J MED, V342, P1229, DOI 10.1056/NEJM200004273421701; Grande PO, 2002, ACTA ANAESTH SCAND, V46, P264, DOI 10.1034/j.1399-6576.2002.460307.x; JOHNSON RT, 1975, DEV MED CHILD NEUROL, V17, P807; Koedel U, 2002, LANCET INFECT DIS, V2, P721, DOI 10.1016/S1473-3099(02)00450-4; Kumar G, 2009, CLIN NEUROL NEUROSUR, V111, P399, DOI 10.1016/j.clineuro.2009.03.004; Kumar R, 2014, CRIT CARE MED, V42, P1775, DOI 10.1097/CCM.0000000000000298; Larsen L, 2017, INFECT DIS-NOR, V49, P356, DOI 10.1080/23744235.2016.1269265; Lindvall P, 2004, CLIN INFECT DIS, V38, P384, DOI 10.1086/380970; LYONS MK, 1990, MAYO CLIN PROC, V65, P684, DOI 10.1016/S0025-6196(12)65131-3; Macsween KF, 2005, J INFECTION, V51, pE221, DOI 10.1016/j.jinf.2005.02.010; Mactier H, 1998, BMJ-BRIT MED J, V316, P1887, DOI 10.1136/bmj.316.7148.1887; Merkelbach S, 1999, INFECTION, V27, P239, DOI 10.1007/s150100050019; Mertineit C, 2000, CAN J PHYSIOL PHARM, V78, P217, DOI 10.1139/cjpp-78-3-217; Moller K, 2004, STROKE, V35, P1333, DOI 10.1161/01.STR.0000128418.17312.0e; Odetola FO, 2006, PEDIATRICS, V117, P1893, DOI 10.1542/peds.2005-2179; Ozisik HI, 2004, MICROBES INFECT, V6, P861, DOI 10.1016/j.micinf.2004.04.012; Pedersen M, 2008, J CEREBR BLOOD F MET, V28, P126, DOI 10.1038/sj.jcbfm.9600514; Pedersen M, 2007, J APPL PHYSIOL, V102, P72, DOI 10.1152/japplphysiol.00697.2006; Perin A, 2008, ACTA NEUROCHIR, V150, P837, DOI 10.1007/s00701-008-1596-8; PFISTER HW, 1993, ARCH NEUROL-CHICAGO, V50, P575, DOI 10.1001/archneur.1993.00540060015010; PFISTER HW, 1990, J CEREBR BLOOD F MET, V10, P914, DOI 10.1038/jcbfm.1990.148; Pili-Floury S, 2009, ANN FR ANESTH, V28, P709, DOI 10.1016/j.annfar.2009.05.012; QUAGLIARELLO V, 1992, NEW ENGL J MED, V327, P864, DOI 10.1056/NEJM199209173271208; QUAGLIARELLO VJ, 1986, J CLIN INVEST, V77, P1084, DOI 10.1172/JCI112407; Radetsky M, 2014, PEDIATR INFECT DIS J, V33, P204, DOI 10.1097/01.inf.0000435508.67490.f0; REBAUD P, 1988, INTENS CARE MED, V14, P522, DOI 10.1007/BF00263524; REESE TS, 1967, J CELL BIOL, V34, P207, DOI 10.1083/jcb.34.1.207; RENNICK G, 1993, BRIT MED J, V306, P953, DOI 10.1136/bmj.306.6883.953; SCHELD WM, 1980, J CLIN INVEST, V66, P243, DOI 10.1172/JCI109850; Scheld WM, 2002, J INFECT DIS, V186, pS225, DOI 10.1086/344939; Schutte CM, 1998, J INFECTION, V37, P112, DOI 10.1016/S0163-4453(98)80163-1; Sparing R, 2004, NERVENARZT, V75, P1016, DOI 10.1007/s00115-004-1718-3; Spence M, 1979, Int Anesthesiol Clin, V17, P285, DOI 10.1097/00004311-197917020-00011; TAUBER MG, 1989, PEDIATR INFECT DIS J, V8, P842; Thigpen MC, 2007, N ENGL J MED, V364, P2016, DOI DOI 10.1056/NEJMoa1005384; Tunkel A R, 1996, Curr Clin Top Infect Dis, V16, P215; Wall ECB, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008806.pub2; Weisfelt M, 2006, LANCET NEUROL, V5, P332, DOI 10.1016/S1474-4422(06)70409-4; Weisfelt M, 2008, ANN NEUROL, V63, P90, DOI 10.1002/ana.21216; Winkler F, 2002, J NEUROL, V249, P1292, DOI 10.1007/s00415-002-0844-8	53	11	12	0	2	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	NOV	2017	43	5							E7	10.3171/2017.8.FOCUS17419			7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	FL5JE	WOS:000414270800007	29088943	Bronze			2021-06-18	
J	Zuraik, C; Sampalis, J				Zuraik, Christopher; Sampalis, John			Epidemiology of Traumatic Injuries at an Urban Hospital in Port-au-Prince, Haiti	WORLD JOURNAL OF SURGERY			English	Article							CAPACITY; PATTERNS; CARE	Traumatic injuries represent a major burden of disease worldwide. Haiti lacks statistics on the epidemiology of traumatic injuries, as there is no formal injury surveillance program. This study will assess the burden of traumatic injuries in an urban trauma center in the capital city of Port-au-Prince, Haiti. A retrospective, cross-sectional chart review study at an urban trauma hospital was carried out for the period December 1, 2015, to January 31, 2016. Data were obtained through the hospital's main patient logbook, medical charts, and trauma registry forms. Data on medical documentation, demographics, and injury characteristics were collected and analyzed using descriptive statistics. A total of 410 patients were evaluated for treatment of traumatic injuries during the 2-month study. The mean age in years was 30, with 66.3% male and 78.4% less than 41 years of age. There were 6.6 injuries per day and no correlation between frequency of injury and day of the week. Road traffic accidents accounted for 43.0% of trauma modes. The mean and median length of stay were 6.6 and 3.0 days. 9.0% of patients suffered severe trauma (ISS ae<yen> 16). 21.0% of patients with traumatic brain injury suffered severe head injuries. Extremity trauma was the most frequently injured anatomical region (50.0%). 22.7% of patients were admitted, and 15.1% patients underwent at least one surgical procedure. Road traffic accidents are the primary reason for injury; thus, prevention initiatives and improved trauma care may provide substantial public health benefits.	[Zuraik, Christopher; Sampalis, John] McGill Univ, Dept Expt Surg, Fac Med, Montreal, PQ, Canada; [Zuraik, Christopher; Sampalis, John] JSS Med Res Inc, Sci Affairs, 9400 Henri Bourassa Blvd West, St Laurent, PQ H4S 1N8, Canada	Sampalis, J (corresponding author), McGill Univ, Dept Expt Surg, Fac Med, Montreal, PQ, Canada.; Sampalis, J (corresponding author), JSS Med Res Inc, Sci Affairs, 9400 Henri Bourassa Blvd West, St Laurent, PQ H4S 1N8, Canada.	jsampalis@jssresearch.com					Adeyekun AA, 2013, NIGER J CLIN PRACT, V16, P19, DOI 10.4103/1119-3077.106717; Aluisio AR, 2015, PREHOSP DISASTER MED, V30, P599, DOI 10.1017/S1049023X15005361; Aluisio AR, 2014, PREHOSP DISASTER MED, V29, P230, DOI 10.1017/S1049023X14000430; Association for the Advancement of Automotive Medicine, 2016, ABBR INJ SCAL AIS; Brasure M., 2012, AGENCY HEALTHCARE RE, V72, pES1; DeGennaro V, 2015, J CRANIOFAC SURG, V26, P1042, DOI 10.1097/SCS.0000000000001678; Dewberry L, 2014, J SURG RES, V192, P34, DOI 10.1016/j.jss.2014.06.009; Emejulu J. K. C., 2008, East and Central African Journal of Surgery, V13, P86; Furey Andrew, 2015, J Orthop Trauma, V29 Suppl 10, pS14, DOI 10.1097/BOT.0000000000000407; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Kobusingye OC, 2002, INJ PREV, V8, P133, DOI 10.1136/ip.8.2.133; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Marsh RH, 2015, LANCET GLOBAL HLTH S, V2, pV3; McCullough C, 2016, J SURG RES, V201, P126, DOI 10.1016/j.jss.2015.10.018; Mock C, 2004, LANCET, V363, P2172, DOI 10.1016/S0140-6736(04)16510-0; Mock CN, 1998, J TRAUMA, V44, P804, DOI 10.1097/00005373-199805000-00011; MOCK CN, 1993, J TRAUMA, V35, P518, DOI 10.1097/00005373-199310000-00004; Mock CN, 2003, ACCIDENT ANAL PREV, V35, P81, DOI 10.1016/S0001-4575(01)00092-6; Mutasingwa D R, 2001, Cent Afr J Med, V47, P203; Peden M, 2003, INJURY LEADING CAUSE; Siddiqui Arshad A, 2004, J Coll Physicians Surg Pak, V14, P173; The Haiti Case Study, 2012, WORK PAP COLL NATO H; WAMAI RG, 2011, JAPAN MED ASS J, V54, P56; World Health Organization, 2010, INJ VIOL FACTS; World Health Organization (WHO), 2008, GLOB BURD DIS 2004 U; Zafarghandi MR, 2003, J TRAUMA, V55, P459, DOI 10.1097/01.TA.0000027132.39340.FE; Zagaran E, 2013, AM COLL SURG, V218, P41; Zavalaa Diego E, 2008, Med Confl Surviv, V24, P260, DOI 10.1080/13623690802373884	29	11	11	0	3	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0364-2313	1432-2323		WORLD J SURG	World J.Surg.	NOV	2017	41	11					2674	2680		10.1007/s00268-017-4088-2			7	Surgery	Surgery	FJ9QN	WOS:000413114900004	28681141				2021-06-18	
J	Chapman, SB; Spence, JS; Aslan, S; Keebler, MW				Chapman, Sandra B.; Spence, Jeffrey S.; Aslan, Sina; Keebler, Molly W.			Enhancing Innovation and Underlying Neural Mechanisms Via Cognitive Training in Healthy Older Adults	FRONTIERS IN AGING NEUROSCIENCE			English	Article						innovation; cognitive training; aging; creativity; CBF; functional connectivity; reasoning training; randomized trial	DEFAULT MODE NETWORK; TRAUMATIC BRAIN-INJURY; AGE-RELATED-CHANGES; FUNCTIONAL CONNECTIVITY; DIVERGENT THINKING; LIFE-SPAN; CREATIVE-THINKING; MEMORY; PLASTICITY; VARIABLES	Non-invasive interventions, such as cognitive training (CT) and physical exercise, are gaining momentum as ways to augment both cognitive and brain function throughout life. One of the most fundamental yet little studied aspects of human cognition is innovative thinking, especially in older adults. In this study, we utilize a measure of innovative cognition that examines both the quantity and quality of abstracted interpretations. This randomized pilot trial in cognitively normal adults (56-75 years) compared the effect of cognitive reasoning training (SMART) on innovative cognition as measured by Multiple Interpretations Measure (MIM). We also examined brain changes in relation to MIM using two MRI-based measurement of arterial spin labeling (ASL) to measure cerebral blood flow (CBF) and functional connectivity MRI (fcMRI) to measure default mode and central executive network (CEN) synchrony at rest. Participants (N = 58) were randomized to the CT, physical exercise (physical training, PT) or control (CN) group where CT and PT groups received training for 3 h/week over 12 weeks. They were assessed at baseline-, mid-and post-training using innovative cognition and MRI measures. First, the CT group showed significant gains pre- to post-training on the innovation measure whereas the physical exercise and control groups failed to show significant gains. Next, the CT group showed increased CBF in medial orbitofrontal cortex (mOFC) and bilateral posterior cingulate cortex (PCC), two nodes within the Default Mode Network (DMN) compared to physical exercise and control groups. Last, significant correlations were found between innovation performance and connectivity of two major networks: CEN (positive correlation) and DMN (negative correlation). These results support the view that both the CEN and DMN are important for enhancement of innovative cognition. We propose that neural mechanisms in healthy older adults can be modified through reasoning training to better subserve enhanced innovative cognition.	[Chapman, Sandra B.; Spence, Jeffrey S.; Aslan, Sina; Keebler, Molly W.] Univ Texas Dallas, Dept Behav & Brain Sci, Ctr BrainHlth, Dallas, TX 75275 USA; [Aslan, Sina] Adv MRI LLC, Frisco, TX USA	Chapman, SB (corresponding author), Univ Texas Dallas, Dept Behav & Brain Sci, Ctr BrainHlth, Dallas, TX 75275 USA.	schapman@utdallas.edu			National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RC1-AG035954, R01-NS067015, R01-AG033106]; T. Boone Pickens Foundation; Lyda Hill Foundation; Dee Wyly Distinguished University Endowment; Dee Wyly Distinguished University Endowed Chair; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS067015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [RC1AG035954, R01AG033106] Funding Source: NIH RePORTER	This work was supported by a grant from the National Institute of Health (RC1-AG035954, R01-NS067015, R01-AG033106) and by grants from the T. Boone Pickens Foundation, the Lyda Hill Foundation and Dee Wyly Distinguished University Endowment. Funding to pay the Open Access publication charges for this article was provided by funds from the Dee Wyly Distinguished University Endowed Chair held by SBC.	ALPAUGH PK, 1977, HUM DEV, V20, P240, DOI 10.1159/000271559; Anguera JA, 2013, NATURE, V501, P97, DOI 10.1038/nature12486; Aslan S, 2010, MAGN RESON MED, V63, P765, DOI 10.1002/mrm.22245; Baer J, 2006, INTERNATIONAL HANDBOOK OF CREATIVITY, P10; Ball K, 2010, J AM GERIATR SOC, V58, P2107, DOI 10.1111/j.1532-5415.2010.03138.x; Baltes PB, 1999, ANNU REV PSYCHOL, V50, P471, DOI 10.1146/annurev.psych.50.1.471; Beaty RE, 2016, TRENDS COGN SCI, V20, P87, DOI 10.1016/j.tics.2015.10.004; Benedek M, 2014, NEUROIMAGE, V88, P125, DOI 10.1016/j.neuroimage.2013.11.021; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; BORG G, 1990, SCAND J WORK ENV HEA, V16, P55, DOI 10.5271/sjweh.1815; Chapman SB, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00338; Chapman SB, 2015, CEREB CORTEX, V25, P396, DOI 10.1093/cercor/bht234; Chapman SB, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00069; Chapman SB, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00075; Elgamal SA, 2011, CAN GERIATR J, V14, P66, DOI 10.5770/cgj.v14i3.17; Fink A, 2015, HUM BRAIN MAPP, V36, P4104, DOI 10.1002/hbm.22901; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Geerligs L, 2015, CEREB CORTEX, V25, P1987, DOI 10.1093/cercor/bhu012; Green AE, 2015, HUM BRAIN MAPP, V36, P923, DOI 10.1002/hbm.22676; Greenwood PM, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00150; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Guilford J. P., 1967, NATURE HUMAN INTELLI; Hafkemeijer A, 2012, BBA-MOL BASIS DIS, V1822, P431, DOI 10.1016/j.bbadis.2011.07.008; Heilman KM, 2016, ARCH CLIN NEUROPSYCH, V31, P285, DOI 10.1093/arclin/acw009; Hohenfeld C, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00384; Jung RE, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00330; Kennedy KM, 2009, NEUROPSYCHOLOGIA, V47, P916, DOI 10.1016/j.neuropsychologia.2009.01.001; Kim KH, 2011, CREATIVITY RES J, V23, P285, DOI 10.1080/10400419.2011.627805; Kramer AF, 1999, NATURE, V400, P418, DOI 10.1038/22682; Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; Li WF, 2015, SOC COGN AFFECT NEUR, V10, P191, DOI 10.1093/scan/nsu041; Lu HZ, 2011, CEREB CORTEX, V21, P1426, DOI 10.1093/cercor/bhq224; Mahncke HW, 2006, PROG BRAIN RES, V157, P81, DOI 10.1016/S0079-6123(06)57006-2; Mahncke HW, 2006, P NATL ACAD SCI USA, V103, P12523, DOI 10.1073/pnas.0605194103; Massimiliano P, 2015, HIGH ABIL STUD, V26, P93, DOI 10.1080/13598139.2015.1029117; Mayseless N, 2015, NEUROIMAGE, V116, P232, DOI 10.1016/j.neuroimage.2015.05.030; MCCRAE RR, 1987, PSYCHOL AGING, V2, P130, DOI 10.1037/0882-7974.2.2.130; McFadden SH, 2010, CLIN GERIATR MED, V26, P149, DOI 10.1016/j.cger.2009.11.004; Palmiero M, 2017, EXP BRAIN RES, V235, P1021, DOI 10.1007/s00221-016-4857-4; Raz N, 1997, CEREB CORTEX, V7, P268, DOI 10.1093/cercor/7.3.268; Rebok GW, 2014, J AM GERIATR SOC, V62, P16, DOI 10.1111/jgs.12607; Reese HW, 2001, INT J BEHAV DEV, V25, P491, DOI 10.1080/01650250042000483; Roskos-Ewoldsen B, 2008, J CREATIVE BEHAV, V42, P33, DOI 10.1002/j.2162-6057.2008.tb01079.x; Runco MA, 2012, CREATIVITY RES J, V24, P92, DOI 10.1080/10400419.2012.650092; Saggar M, 2017, CEREB CORTEX, V27, P3542, DOI 10.1093/cercor/bhw171; Sambataro F, 2010, NEUROBIOL AGING, V31, P839, DOI 10.1016/j.neurobiolaging.2008.05.022; Takeuchi H, 2012, CEREB CORTEX, V22, P2921, DOI 10.1093/cercor/bhr371; WALLACH MA, 1968, AM EDUC RES J, V5, P272, DOI 10.2307/1161826	49	11	12	0	18	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1663-4365			FRONT AGING NEUROSCI	Front. Aging Neurosci.	OCT 9	2017	9								314	10.3389/fnagi.2017.00314			11	Geriatrics & Gerontology; Neurosciences	Geriatrics & Gerontology; Neurosciences & Neurology	FJ1HS	WOS:000412466400001	29062276	DOAJ Gold, Green Published			2021-06-18	
J	Chen, H; Yuan, F; Chen, SW; Guo, Y; Wang, G; Deng, ZF; Tian, HL				Chen, Hao; Yuan, Fang; Chen, Shi-Wen; Guo, Yan; Wang, Gan; Deng, Zhi-Feng; Tian, Heng-Li			Predicting posttraumatic hydrocephalus: derivation and validation of a risk scoring system based on clinical characteristics	METABOLIC BRAIN DISEASE			English	Article						Posttraumatic hydrocephalus; Traumatic brain injury; Prognostic model; Risk score; Validation	TRAUMATIC BRAIN-INJURY; DECOMPRESSIVE CRANIECTOMY; INTERHEMISPHERIC HYGROMA	Posttraumatic hydrocephalus (PTH) is a disorder of disturbed cerebrospinal fluid (CSF) dynamics after traumatic brain injury (TBI). It can lead to brain metabolic impairment and dysfunction and has a high risk of clinical deterioration and worse outcomes. The incidence and risk factors for the development of PTH after decompressive craniectomy (DC) has been assessed in previous studies, but rare studies identify patients with higher risk for PTH among all TBI patients. This study aimed to develop and validate a risk scoring system to predict PTH after TBI. Demographics, injury severity, duration of coma, radiologic findings, and DC were evaluated to determine the independent predictors of PTH during hospitalization until 6 months following TBI through logistic regression analysis. A risk stratification system was created by assigning a number of points for each predictor and validated in an independent cohort. The model accuracy was assessed by the area under the receiver operating characteristic curve (AUC). Of 526 patients in the derivation cohort, 57 (10.84%) developed PTH during 6 months follow up. Age > 50 yrs (Odd ratio [OR] = 1.91, 95% confidence interval [CI] 1.09-3.75, 4 points), duration of coma ae<yen>1 w (OR = 5.68, 95% CI 2.57-13.47, 9 points), Fisher grade III (OR = 2.19, 95% CI 1.24-4.36, 5 points) or IV (OR = 3.87, 95% CI 1.93-8.43, 7 points), bilateral DC (OR = 6.13, 95% CI 2.82-18.14, 9 points), and extra herniation after DC (OR = 2.36, 95% CI 1.46-4.92, 5 points) were independently associated with PTH. Rates of PTH for the low- (0-12 points), intermediate- (13-22 points) and high-risk (23-34 points) groups were 1.16%, 35.19% and 78.57% (p < 0.0001). The corresponding rates in the validation cohort, where 17/175 (9.71%) developed PTH, were 1.35%, 37.50% and 81.82% (p < 0.0001). The risk score model exhibited good-excellent discrimination in both cohorts, with AUC of 0.839 versus 0.894 (derivation versus validation) and good calibration (Hosmer-Lemshow p = 0.56 versus 0.68). This model will be useful to identify patients at high risk for PTH who may be candidates for preventive interventions, and to improve their outcomes.	[Chen, Hao; Yuan, Fang; Chen, Shi-Wen; Guo, Yan; Wang, Gan; Deng, Zhi-Feng; Tian, Heng-Li] Shanghai Jiao Tong Univ, Sch Med, Affiliated Peoples Hosp 6, Dept Neurosurg, 600 Yishan Rd, Shanghai 200233, Peoples R China	Tian, HL (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Affiliated Peoples Hosp 6, Dept Neurosurg, 600 Yishan Rd, Shanghai 200233, Peoples R China.	tianhlsh@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81471245, 81501657]	This study was supported by the National Natural Science Foundation of China (grant 81471245 and 81501657).	Beauchamp KM, 2010, J TRAUMA, V69, P270, DOI 10.1097/TA.0b013e3181e491c2; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Chen H, 2012, EMERG MED INT, V2012, DOI 10.1155/2012/134905; Choi I, 2008, J KOREAN NEUROSURG S, V43, P227, DOI 10.3340/jkns.2008.43.5.227; Czosnyka M, 2000, J NEUROL NEUROSUR PS, V68, P246; Czosnyka M, 2001, J NEUROSURG, V94, P482, DOI 10.3171/jns.2001.94.3.0482; De Bonis P, 2013, CLIN NEUROL NEUROSUR, V115, P1308, DOI 10.1016/j.clineuro.2012.12.011; De Bonis P, 2010, J NEUROTRAUM, V27, P1965, DOI 10.1089/neu.2010.1425; Denes Z, 2011, INT J REHABIL RES, V34, P222, DOI 10.1097/MRR.0b013e328346e87d; Ding J, 2014, ARQ NEURO-PSIQUIAT, V72, P715, DOI 10.1590/0004-282X20140106; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Fotakopoulos G, 2016, J NEUROL SURG PART A, V77, P88, DOI 10.1055/s-0035-1558411; GUDEMAN SK, 1981, RADIOLOGY, V141, P397, DOI 10.1148/radiology.141.2.6974874; Guyot LL, 2000, NEUROL RES, V22, P25; Honeybul S, 2010, J CLIN NEUROSCI, V17, P430, DOI 10.1016/j.jocn.2009.09.007; Honeybul S, 2012, J NEUROTRAUM, V29, P1872, DOI 10.1089/neu.2012.2356; Jiao Qing-fang, 2007, Chin J Traumatol, V10, P159; Kaen A, 2010, J NEUROSURG, V113, P1287, DOI 10.3171/2010.4.JNS10132; Kammersgaard LP, 2013, NEUROREHABILITATION, V33, P473, DOI 10.3233/NRE-130980; Ki HJ, 2015, J KOREAN NEUROSURG S, V58, P254, DOI 10.3340/jkns.2015.58.3.254; Kondziella D, 2008, J NEUROCHEM, V106, P1515, DOI 10.1111/j.1471-4159.2008.05422.x; Licata C, 2001, J Neurosurg Sci, V45, P141; Mazzini L, 2003, ARCH PHYS MED REHAB, V84, P1637, DOI 10.1053/S0003-9993(03)00314-9; Nor MAM, 2013, MALAYS J MED SCI, V20, P95; Relkin N, 2005, NEUROSURGERY, V57, P4, DOI 10.1227/01.NEU.0000168185.29659.C5; Shi SS, 2011, CHIN J TRAUMATOL, V14, P343, DOI 10.3760/cma.j.issn.1008-1275.2011.06.004; Symss NP, 2013, J NEUROSURG-PEDIATR, V11, P170, DOI 10.3171/2012.3.PEDS0934; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Tian HL, 2008, NEUROSURG REV, V31, P431, DOI 10.1007/s10143-008-0153-5; Tian HL, 2008, SURG NEUROL, V69, P241, DOI 10.1016/j.surneu.2007.02.032; Yoshioka H, 2000, SURG NEUROL, V53, P119, DOI 10.1016/S0090-3019(99)00185-8; Yuan F, 2012, J NEUROTRAUM, V29, P2137, DOI 10.1089/neu.2011.2233	32	11	15	0	8	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0885-7490	1573-7365		METAB BRAIN DIS	Metab. Brain Dis.	OCT	2017	32	5					1427	1435		10.1007/s11011-017-0008-2			9	Endocrinology & Metabolism; Neurosciences	Endocrinology & Metabolism; Neurosciences & Neurology	FG9BD	WOS:000410732300009	28391551				2021-06-18	
J	Davies, DJ; Clancy, M; Lighter, D; Balanos, GM; Lucas, SJE; Dehghani, H; Su, ZJ; Forcione, M; Belli, A				Davies, David James; Clancy, Michael; Lighter, Daniel; Balanos, George M.; Lucas, Samuel John Edwin; Dehghani, Hamid; Su, Zhangjie; Forcione, Mario; Belli, Antonio			Frequency-domain vs continuous-wave near-infrared spectroscopy devices: a comparison of clinically viable monitors in controlled hypoxia	JOURNAL OF CLINICAL MONITORING AND COMPUTING			English	Article						Head injury; Cerebral blood flow; Frequency-domain near-infrared spectroscopy; Continuous-wave near-infrared spectroscopy	TRAUMATIC BRAIN-INJURY; DIFFUSE OPTICAL TOMOGRAPHY; CEREBRAL OXYGENATION; SURGERY; ACTIVATION; SATURATION; FMRI	The Near-infrared spectroscopy (NIRS) has not been adopted as a mainstream monitoring modality in acute neurosurgical care due to concerns about its reliability and consistency. However, improvements in NIRS parameter recovery techniques are now available that may improve the quantitative accuracy of NIRS for this clinical context. Therefore, the aim of this study was to compare the abilities of a continuous-wave (CW) NIRS device with a similarly clinically viable NIRS device utilising a frequency-domain (FD) parameter recovery technique in detecting changes in cerebral tissue saturation during stepwise increases of experimentally induced hypoxia. Nine healthy individuals (6M/3F) underwent a dynamic end-tidal forced manipulation of their expiratory gases to induce a stepwise induced hypoxia. The minimum end-tidal oxygen partial pressure (EtO2) achieved was 40 mm Hg. Simultaneous neurological and extra-cranial tissue NIRS reading were obtained during this protocol by both tested devices. Both devices detected significant changes in cerebral tissue saturation during the induction of hypoxia (CW 9.8 +/- 2.3 %; FD 7.0 +/- 3.4 %; Wilcoxon signed rank test P < 0.01 for both devices). No significant difference was observed between the saturation changes observed by either device (P = 0.625). An observably greater degree of noise was noticed in parameters recovered by the FD device, and both demonstrated equally variable baseline readings (Coefficient of variance 8.4 and 9.7 % for the CW and FD devices, respectively) between individuals tested. No advantageous difference was observed in parameters recovered from the FD device compared with those detected by CW.	[Davies, David James; Su, Zhangjie; Belli, Antonio] Univ Hosp Birmingham NHS Fdn Trust, NIHR SRMRC, Heritage Bldg Old Queen Elizabeth Hosp, Birmingham B15 2TH, W Midlands, England; [Davies, David James; Forcione, Mario; Belli, Antonio] Univ Hosp Birmingham NHS Fdn Trust, Dept Neurosurg, Birmingham, W Midlands, England; [Clancy, Michael; Dehghani, Hamid] Univ Birmingham, PSIBS Doctoral Training Ctr, Birmingham, W Midlands, England; [Lighter, Daniel] Univ Birmingham, Sch Chem, Birmingham, W Midlands, England; [Balanos, George M.; Lucas, Samuel John Edwin] Univ Birmingham, Sch Sport Exercise & Rehabil Sci, Birmingham, W Midlands, England; [Su, Zhangjie; Belli, Antonio] Univ Birmingham, Sch Clin & Expt Med, Birmingham, W Midlands, England	Davies, DJ (corresponding author), Univ Hosp Birmingham NHS Fdn Trust, NIHR SRMRC, Heritage Bldg Old Queen Elizabeth Hosp, Birmingham B15 2TH, W Midlands, England.; Davies, DJ (corresponding author), Univ Hosp Birmingham NHS Fdn Trust, Dept Neurosurg, Birmingham, W Midlands, England.	David.Davies@uhb.nhs.uk	Belli, Antonio/I-3799-2015; Lucas, Samuel/J-4124-2014; Forcione, Mario/K-2852-2018	Belli, Antonio/0000-0002-3211-9933; Lucas, Samuel/0000-0002-8713-2457; Forcione, Mario/0000-0002-4045-8011; Dehghani, Hamid/0000-0003-4117-0412			Calderon-Arnulphi M, 2007, J NEUROSURG, V106, P283, DOI 10.3171/jns.2007.106.2.283; Clancy M, 2015, EUR C BIOM OPT INT S; Contini D, 2007, PROC SPIE, V6629, DOI 10.1117/12.728104; Cooper RJ, 2012, NEUROIMAGE, V62, P1999, DOI 10.1016/j.neuroimage.2012.05.031; Davie SN, 2012, ANESTHESIOLOGY, V116, P834, DOI 10.1097/ALN.0b013e31824c00d7; Davies DJ, 2015, J NEUROTRAUM, V32, P933, DOI 10.1089/neu.2014.3748; Eggebrecht AT, 2012, NEUROIMAGE, V61, P1120, DOI 10.1016/j.neuroimage.2012.01.124; Fantini S, 1999, PHYS MED BIOL, V44, P1543, DOI 10.1088/0031-9155/44/6/308; Franceschini MA, 2007, PEDIATR RES, V61, P546, DOI 10.1203/pdr.0b013e318045be99; Ghosh A, 2012, ANESTH ANALG, V115, P1373, DOI 10.1213/ANE.0b013e31826dd6a6; Leal-Noval SR, 2010, INTENS CARE MED, V36, P1309, DOI 10.1007/s00134-010-1920-7; Lucas SJE, 2011, J PHYSIOL-LONDON, V589, P741, DOI 10.1113/jphysiol.2010.192534; Maas AIR, 2010, INTENS CARE MED, V36, P1283, DOI 10.1007/s00134-010-1921-6; MATCHER SJ, 1995, ANAL BIOCHEM, V227, P54, DOI 10.1006/abio.1995.1252; Murkin JM, 2007, ANESTH ANALG, V104, P51, DOI 10.1213/01.ane.0000246814.29362.f4; Pogue BW, 2001, RADIOLOGY, V218, P261, DOI 10.1148/radiology.218.1.r01ja51261; Rothschild Ryan Mark, 2010, Front Neuroeng, V3, P112, DOI 10.3389/fneng.2010.00112; Sato H, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1960907; Strangman G, 2002, NEUROIMAGE, V17, P719, DOI 10.1006/nimg.2002.1227; Suzuki S, 1999, P SOC PHOTO-OPT INS, V3597, P582, DOI 10.1117/12.356862; Toronov V, 2001, OPT EXPRESS, V9, P417, DOI 10.1364/OE.9.000417; Tyburski JG, 2003, J TRAUMA, V55, P892, DOI 10.1097/01.TA.0000097827.51916.7E; Vohra Hunaid A, 2009, Interact Cardiovasc Thorac Surg, V9, P318, DOI 10.1510/icvts.2009.206367; Wise RG, 2007, J CEREBR BLOOD F MET, V27, P1521, DOI 10.1038/sj.jcbfm.9600465; Wolf M, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2804899	25	11	11	0	4	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1387-1307	1573-2614		J CLIN MONIT COMPUT	J. Clin. Monitor. Comp.	OCT	2017	31	5					967	974		10.1007/s10877-016-9942-5			8	Anesthesiology	Anesthesiology	FG9PL	WOS:000410771300012	27778208	Green Published, Other Gold			2021-06-18	
J	Ewing-Cobbs, L; Prasad, MR; Cox, CS; Granger, DA; Duque, G; Swank, PR				Ewing-Cobbs, Linda; Prasad, Mary R.; Cox, Charles S., Jr.; Granger, Douglas A.; Duque, Gerardo; Swank, Paul R.			Altered stress system reactivity after pediatric injury: Relation with post traumatic stress symptoms	PSYCHONEUROENDOCRINOLOGY			English	Article						Hypothalamic pituitary adrenal; Autonomic nervous system; Cortisol; Salivary alpha amylase; Injury; Post-traumatic stress	SALIVARY ALPHA-AMYLASE; PTSD SYMPTOMS; CORTISOL CONCENTRATIONS; PSYCHOSOCIAL STRESS; DISORDER; CHILDREN; BRAIN; HISTORY; HEALTH; YOUTH	Injury is the leading cause of death and disability in childhood. Injured children are at high risk for developing alterations in stress response systems and post-traumatic stress symptoms (PTSS) that may compromise longterm physical and psychological health. In a prospective, observational cohort study, we examined individual differences in, and correlates of, stress-reactivity of the hypothalamic-pituitary-adrenal axis (HPA; salivary cortisol) and autonomic nervous system (ANS; salivary alpha amylase, sAA) following pediatric injury. Participants were 8-15 years of age and hospitalized for traumatic brain injury (TBI; n = 55; M age = 13.9 yrs; 40 males) or extracranial injury (EI; n = 29; M age 12.3 yrs, 20 males) following vehicular accidents. Six months post-injury, saliva was collected before and after the Trier Social Stress Test and later assayed for cortisol and sAA. Relative to a healthy non-injured comparison group (n = 33; M age = 12.5 yrs, 16 males), injured children (ages 8-12 years), but not adolescents (ages 13-15 yrs), had higher cortisol levels; regardless of age, injured participants showed dampened cortisol reactivity to social evaluative threat. Compared to participants with EI, children with TBI had elevated cortisol and adolescents had elevated sAA. With respect to PTSS, individual differences in sAA were negatively correlated with avoidance in the TBI group and positively correlated with emotional numbing within the EI group. Importantly, psychological and neurobiological sequelae were weakly related to injury severity. Given the high prevalence of pediatric injury, these sequelae affect many children and represent a significant public health concern. Consequently, surveillance of post-traumatic sequelae should in dude the full spectrum of injury severity. Monitoring the activity, reactivity, and regulation of biological systems sensitive to environmental insults may advance our understanding of individual differences in sequelae and adaptation following traumatic pediatric injury.	[Ewing-Cobbs, Linda; Prasad, Mary R.; Duque, Gerardo] Univ Texas Hlth Sci Ctr Houston, Dept Pediat, Houston, TX 77030 USA; [Ewing-Cobbs, Linda; Prasad, Mary R.; Duque, Gerardo] Univ Texas Hlth Sci Ctr Houston, Childrens Learning Inst, Houston, TX 77030 USA; [Cox, Charles S., Jr.] Univ Texas Hlth Sci Ctr Houston, Dept Pediat Surg, Houston, TX 77030 USA; [Swank, Paul R.] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Houston, TX 77030 USA; [Granger, Douglas A.] Univ Calif Irvine, Dept Psychol & Social Behav Pediat & Publ Hlth, Irvine, CA USA; [Granger, Douglas A.] Univ Calif Irvine, Inst Interdisciplinary Salivary Biosci, Irvine, CA USA; [Granger, Douglas A.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Sch Nursing, Baltimore, MD 21218 USA; [Granger, Douglas A.] Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA	Ewing-Cobbs, L (corresponding author), Dept Pediat, 7000 Fannin St,Suite 2401, Houston, TX 77030 USA.	Linda.ewing-cobbs@uth.tmc.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS046308]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS046308] Funding Source: NIH RePORTER	This work was funded in part by National Institutes of HealthR01 NS046308. The content is solely the responsibility of the authors and does not necessarily represent the official views of the granting institute.	Abelson JL, 2014, PSYCHONEUROENDOCRINO, V44, P60, DOI 10.1016/j.psyneuen.2014.02.016; Achenbach T. M., 1991, MANUAL CHILD BEHAV C; Allwood MA, 2011, J CLIN CHILD ADOLESC, V40, P659, DOI 10.1080/15374416.2011.597081; Allwood MA, 2011, BIOL PSYCHOL, V88, P57, DOI 10.1016/j.biopsycho.2011.06.008; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5, DOI [10.1176/appi.books.9780890425596., DOI 10.1176/APPI.BOOKS.9780890425596, 10.1176/appi.books.9780890425596]; Bae YJ, 2015, J PSYCHIATR RES, V71, P78, DOI 10.1016/j.jpsychires.2015.09.013; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Biederman J, 2002, AM J PSYCHIAT, V159, P1556, DOI 10.1176/appi.ajp.159.9.1556; BuskeKirschbaum A, 1997, PSYCHOSOM MED, V59, P419, DOI 10.1097/00006842-199707000-00012; Carrion VG, 2002, BIOL PSYCHIAT, V51, P575, DOI 10.1016/S0006-3223(01)01310-5; Centers for Disease Control and Prevention, 2016, NCFIPAC; De Bellis MD, 2014, CHILD ADOL PSYCH CL, V23, P185, DOI 10.1016/j.chc.2014.01.002; Delahanty DL, 2005, PSYCHONEUROENDOCRINO, V30, P121, DOI 10.1016/j.psyneuen.2004.06.004; Delahanty DL, 2006, ANN NY ACAD SCI, V1071, P27, DOI 10.1196/annals.1364.003; Doom JR, 2015, PSYCHONEUROENDOCRINO, V59, P102, DOI 10.1016/j.psyneuen.2015.04.024; Ewing-Cobbs L, 2014, J PEDIATR PSYCHOL, V39, P653, DOI 10.1093/jpepsy/jsu018; Foa EB, 2001, J CLIN CHILD PSYCHOL, V30, P376, DOI 10.1207/S15374424JCCP3003_9; Frewen PA, 2012, J CLIN PSYCHIAT, V73, P431, DOI 10.4088/JCP.10m06477; Gandubert C, 2016, NEUROBIOL STRESS, V3, P61, DOI 10.1016/j.ynstr.2016.02.002; Gordis EB, 2008, HORM BEHAV, V53, P96, DOI 10.1016/j.yhbeh.2007.09.002; Granger DA, 2007, ANN NY ACAD SCI, V1098, P122, DOI 10.1196/annals.1384.008; Granger DA, 2009, PSYCHONEUROENDOCRINO, V34, P1437, DOI 10.1016/j.psyneuen.2009.06.017; Gunnar MR, 2001, DEV PSYCHOPATHOL, V13, P515, DOI 10.1017/S0954579401003066; Hendrickson RC, 2016, EXP NEUROL, V284, P181, DOI 10.1016/j.expneurol.2016.05.014; Hopper JW, 2007, J TRAUMA STRESS, V20, P713, DOI 10.1002/jts.20284; Juranek J, 2012, BRAIN IMAGING BEHAV, V6, P36, DOI 10.1007/s11682-011-9140-5; Kassam-Adams N, 2010, J AM ACAD CHILD PSY, V49, P616, DOI 10.1016/j.jaac.2010.02.011; Kaulfers AMD, 2010, J PEDIATR-US, V157, P894, DOI 10.1016/j.jpeds.2010.07.004; Keeshin BR, 2015, J CHILD ADOL PSYCHOP, V25, P344, DOI 10.1089/cap.2014.0034; Khoury JE, 2015, NEUROBIOL STRESS, V2, P34, DOI 10.1016/j.ynstr.2015.04.002; Koss KJ, 2016, PSYCHONEUROENDOCRINO, V66, P31, DOI 10.1016/j.psyneuen.2015.12.018; Kuras YI, 2017, DEV PSYCHOBIOL, V59, P91, DOI 10.1002/dev.21470; Laflamme L, 2010, INT J PEDIAT, V2010, DOI 10.1155/2010/819687; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Max JE, 2015, J PEDIATR REHAB MED, V8, P345, DOI 10.3233/PRM-150352; MAYER T, 1980, J PEDIATR SURG, V15, P719, DOI 10.1016/S0022-3468(80)80271-5; McEwen BS, 2015, NEUROBIOL STRESS, V1, P1, DOI 10.1016/j.ynstr.2014.09.001; McEwen BS, 1998, ANN NY ACAD SCI, V840, P33, DOI 10.1111/j.1749-6632.1998.tb09546.x; McFarlane AC, 2011, PSYCHONEUROENDOCRINO, V36, P720, DOI 10.1016/j.psyneuen.2010.10.007; Pacella ML, 2017, SOC SCI MED, V175, P228, DOI 10.1016/j.socscimed.2016.12.046; Pacella ML, 2013, J ANXIETY DISORD, V27, P33, DOI 10.1016/j.janxdis.2012.08.004; Payne L. A., 2014, J CHILD ADOLESC BEHA, V2; Peckins MK, 2015, DEV PSYCHOPATHOL, V27, P1461, DOI 10.1017/S0954579415000875; Pervanidou P, 2007, BIOL PSYCHIAT, V62, P1095, DOI 10.1016/j.biopsych.2007.02.008; Price J, 2016, J PEDIATR PSYCHOL, V41, P86, DOI 10.1093/jpepsy/jsv074; Reifschneider K, 2015, J CLIN MED, V4, P1536, DOI 10.3390/jcm4081536; Schreier H, 2005, J TRAUMA, V58, P353, DOI 10.1097/01.TA.0000152537.15672.B7; Shirtcliff EA, 2008, DEV PSYCHOBIOL, V50, P690, DOI 10.1002/dev.20336; TEASDALE G, 1974, LANCET, V2, P81; Trickett PK, 2014, CHILD MALTREATMENT, V19, P27, DOI 10.1177/1077559513520466; Trickett PK, 2010, DEV PSYCHOPATHOL, V22, P165, DOI 10.1017/S0954579409990332; Weems CF, 2007, J TRAUMA STRESS, V20, P903, DOI 10.1002/jts.20251; Weems CF, 2003, J CLIN CHILD ADOLESC, V32, P166, DOI 10.1207/15374420360533158; Wilde EA, 2007, DEV MED CHILD NEUROL, V49, P294, DOI 10.1111/j.1469-8749.2007.00294.x; Williamson John B, 2013, Front Neuroeng, V6, P13, DOI 10.3389/fneng.2013.00013; Yehuda R, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.57; Yehuda R, 2010, PSYCHOPHARMACOLOGY, V212, P405, DOI 10.1007/s00213-010-1969-6; Yim IS, 2015, PSYCHONEUROENDOCRINO, V57, P61, DOI 10.1016/j.psyneuen.2015.03.021; Zatzick DF, 2010, ARCH GEN PSYCHIAT, V67, P1291, DOI 10.1001/archgenpsychiatry.2010.158	59	11	11	0	17	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4530			PSYCHONEUROENDOCRINO	Psychoneuroendocrinology	OCT	2017	84						66	75		10.1016/j.psyneuen.2017.06.003			10	Endocrinology & Metabolism; Neurosciences; Psychiatry	Endocrinology & Metabolism; Neurosciences & Neurology; Psychiatry	FF3IQ	WOS:000408789100008	28667938	Green Accepted			2021-06-18	
J	Human, T; Cook, AM; Anger, B; Bledsoe, K; Castle, A; Deen, D; Gibbs, H; Lesch, C; Liang, N; McAllen, K; Morrison, C; Parker, D; Rowe, AS; Rhoney, D; Sangha, K; Santayana, E; Taylor, S; Tesoro, E; Brophy, G				Human, Theresa; Cook, Aaron M.; Anger, Brian; Bledsoe, Kathleen; Castle, Amber; Deen, David; Gibbs, Haley; Lesch, Christine; Liang, Norah; McAllen, Karen; Morrison, Christopher; Parker, Dennis, Jr.; Rowe, A. Shaun; Rhoney, Denise; Sangha, Kiranpal; Santayana, Elena; Taylor, Scott; Tesoro, Eljim; Brophy, Gretchen			Treatment of Hyponatremia in Patients with Acute Neurological Injury	NEUROCRITICAL CARE			English	Article						Hyponatremia; Neurocritical care; Intensive care unit; Subarachnoid hemorrhage; Intracerebral hemorrhage; Traumatic brain injury; Intracranial tumor	ANEURYSMAL SUBARACHNOID HEMORRHAGE; SEVERE HEAD-INJURY; TRANSSPHENOIDAL SURGERY; ANTIDIURETIC-HORMONE; WATER	Little data exist regarding the practice of sodium management in acute neurologically injured patients. This study describes the practice variations, thresholds for treatment, and effectiveness of treatment in this population. This retrospective, multicenter, observational study identified 400 ICU patients, from 17 centers, admitted for >= 48 h with subarachnoid hemorrhage (SAH), traumatic brain injury (TBI), intraparenchymal hemorrhage, or intracranial tumors between January 1, 2011 and July 31, 2012. Data collection included demographics, APACHE II, Glascow Coma Score (GCS), serum sodium (Na+), fluid rate and tonicity, use of sodium-altering therapies, intensive care unit (ICU) and hospital length of stay, and modified Rankin score upon discharge. Data were collected for the first 21 days of ICU admission or ICU discharge, whichever came first. Sodium trigger for treatment defined as the Na+ value prior to treatment with response defined as an increase of >= 4 mEq/L at 24 h. Sodium-altering therapy was initiated in 34 % (137/400) of patients with 23 % (32/137) having Na+ > 135 mEq/L at time of treatment initiation. The most common indications for treatment were declining serum Na+ (68/116, 59 %) and cerebral edema with mental status changes (21/116, 18 %). Median Na+ treatment trigger was 133 mEq/L (IQR 129-139) with no difference between diagnoses. Incidence and treatment of hyponatremia was more common in SAH and TBI [SAH (49/106, 46 %), TBI (39/97, 40 %), ICH (27/102, 26 %), tumor (22/95, 23 %); p = 0.001]. The most common initial treatment was hypertonic saline (85/137, 62 %), followed by oral sodium chloride tablets (42/137, 31 %) and fluid restriction (15/137, 11 %). Among treated patients, 60 % had a response at 24 h. Treated patients had lower admission GCS (12 vs. 14, p = 0.02) and higher APACHE II scores (12 vs. 10, p = 0.001). There was no statistically significant difference in outcome when comparing treated and untreated patients. Sodium-altering therapy is commonly employed among neurologically injured patients. Hypertonic saline infusions were used first line in more than half of treated patients with the majority having a positive response at 24 h. Further studies are needed to evaluate the impact of various treatments on patient outcomes.	[Human, Theresa] Washington Univ, Barnes Jewish Hosp, St Louis, MO USA; [Cook, Aaron M.] Univ Kentucky, Lexington, KY USA; [Anger, Brian] St Louis Univ Hosp, St Louis, MO USA; [Bledsoe, Kathleen] Univ Virginia Hlth Syst, Charlottesville, VA USA; [Castle, Amber] Yale New Haven Med Ctr, 20 York St, New Haven, CT 06504 USA; [Deen, David] Mem Univ Ctr, Savannah, GA USA; [Gibbs, Haley] Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA; [Lesch, Christine] New York Presbyterian Hosp, New York, NY USA; [Liang, Norah] Hartford Hosp, Hartford, CT 06115 USA; [McAllen, Karen] Spectrum Hlth, Grand Rapids, MI USA; [Morrison, Christopher] Jackson Mem Hosp, Miami, FL 33136 USA; [Parker, Dennis, Jr.] Detroit Receiving Hosp & Univ Hlth Ctr, Detroit, MI USA; [Rowe, A. Shaun] Univ Tennessee, Knoxville, TN USA; [Rhoney, Denise] Univ N Carolina, Chapel Hill, NC USA; [Sangha, Kiranpal] Univ Cincinnati, Univ Hosp, Cincinnati, OH USA; [Santayana, Elena] Univ Chicago, Med Ctr, Chicago, IL 60637 USA; [Taylor, Scott] Via Cristi, Wichita, KS USA; [Tesoro, Eljim] Univ Illinois, Chicago, IL USA; [Brophy, Gretchen] Virginia Commonwealth, Med Coll Virginia, Richmond, VA 23284 USA	Brophy, G (corresponding author), Virginia Commonwealth, Med Coll Virginia, Richmond, VA 23284 USA.	gbrophy@vcu.edu		Cook, Aaron/0000-0001-8539-902X; Brophy, Gretchen/0000-0002-4749-2693			ARIEFF AI, 1976, MEDICINE, V55, P121, DOI 10.1097/00005792-197603000-00002; BORN JD, 1985, SURG NEUROL, V23, P383, DOI 10.1016/0090-3019(85)90212-5; Cole Chad D, 2004, Neurosurg Focus, V16, pE9; Ellison DH, 2007, NEW ENGL J MED, V356, P2064, DOI 10.1056/NEJMcp066837; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; HASAN D, 1990, ANN NEUROL, V27, P106, DOI 10.1002/ana.410270118; Hensen J, 1999, CLIN ENDOCRINOL, V50, P431, DOI 10.1046/j.1365-2265.1999.00666.x; Qureshi AI, 2002, NEUROSURGERY, V50, P749, DOI 10.1097/00006123-200204000-00012; Rabinstein AA, 2003, NEUROLOGIST, V9, P290, DOI 10.1097/01.nrl.0000095258.07720.89; SANE T, 1994, J CLIN ENDOCR METAB, V79, P1395, DOI 10.1210/jc.79.5.1395; UNTERBERG A, 1993, NEUROSURGERY, V32, P17, DOI 10.1227/00006123-199301000-00003; Verbalis JG, 2003, BEST PRACT RES CL EN, V17, P471, DOI 10.1016/S1521-690X(03)00049-6; Vermeij FH, 1998, STROKE, V29, P924, DOI 10.1161/01.STR.29.5.924; Waikar SS, 2009, AM J MED, V122, P857, DOI 10.1016/j.amjmed.2009.01.027; Wei Tao, 2003, Chin Med Sci J, V18, P120; WEINAND ME, 1989, NEUROSURGERY, V25, P781, DOI 10.1227/00006123-198911000-00014	16	11	11	1	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	OCT	2017	27	2					242	248		10.1007/s12028-016-0343-x			7	Critical Care Medicine; Clinical Neurology	General & Internal Medicine; Neurosciences & Neurology	FJ4VC	WOS:000412739900013	28054290				2021-06-18	
J	Neidecker, JM; Gealt, DB; Luksch, JR; Weaver, MD				Neidecker, John M.; Gealt, David B.; Luksch, John R.; Weaver, Martin D.			First-Time Sports-Related Concussion Recovery: The Role of Sex, Age, and Sport	JOURNAL OF THE AMERICAN OSTEOPATHIC ASSOCIATION			English	Article						athlete; concussion; head injury; sports	HIGH-SCHOOL; GENDER-DIFFERENCES; UNITED-STATES; TRAJECTORIES; MODIFIERS; SYMPTOMS; ANXIETY	Background: Concussion is one of the most common injuries in athletes. Current concussion consensus statements propose that female sex may be a modifying factor in concussion management and recovery. Objective: To determine whether female athletes in middle school and high school with a first-time, sports-related concussion remained symptomatic longer than their male counterparts. Methods: A retrospective medical record analysis was performed among athletes who sustained a concussion between 2011 and 2013. Inclusion criteria consisted of age between 11 and 18 years and diagnosis of first-time concussion sustained while playing organized sports. Using the documented notes in the medical record, length of time that each athlete was symptomatic from his or her concussion was calculated. Results: A total of 110 male and 102 female athletes (N=212) met the eligibility criteria for the study. A significant difference was found in the median number of days female athletes remained symptomatic (28 days) when compared with male athletes (11 days) (P<.001). No statistically significant difference was found in symptom duration between age groups. When matched for sex, no statistically significant differences were found in symptom duration between the type of sports played. Conclusion: Female athletes aged 11 to 18 years with first-time, sports-related concussions remained symptomatic for a longer period when compared with male athletes of similar age, regardless of sport played. The mechanism behind this difference needs to be further elucidated.	[Neidecker, John M.] Orthopaed Specialists North Carolina, 11200 Governor Manly Way,Ste 309, Raleigh, NC 27614 USA; [Gealt, David B.; Weaver, Martin D.] Cooper Univ Hosp, Cooper Bone & Joint Inst, Camden, NJ USA; [Luksch, John R.] Rothman Inst, Philadelphia, PA USA	Neidecker, JM (corresponding author), Orthopaed Specialists North Carolina, 11200 Governor Manly Way,Ste 309, Raleigh, NC 27614 USA.	neidy13@yahoo.com	Weaver, Martin/AAK-7062-2020	Weaver, Martin/0000-0001-8969-2186			Altemus M, 2014, FRONT NEUROENDOCRIN, V35, P320, DOI 10.1016/j.yfrne.2014.05.004; ANDREASON PJ, 1994, PSYCHIAT RES, V51, P175, DOI 10.1016/0165-1781(94)90037-X; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bernstein A, 2006, BEHAV RES THER, V44, P679, DOI 10.1016/j.brat.2005.03.011; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Cantu RC, 2010, PM&R, V2, P1088, DOI 10.1016/j.pmrj.2010.07.483; Covassin T, 2003, J ATHL TRAINING, V38, P238; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Dvorak J, 2007, BRIT J SPORT MED, V41, pI44, DOI 10.1136/bjsm.2007.037960; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Finocchi C, 2014, NEUROL SCI, V35, pS207, DOI 10.1007/s10072-014-1772-y; GE XJ, 1994, DEV PSYCHOL, V30, P467, DOI 10.1037/0012-1649.30.4.467; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gilchrist J., 2011, MMWR-MORBID MORTAL W, V60, P1337; Hankin BL, 2009, J CLIN CHILD ADOLESC, V38, P460, DOI 10.1080/15374410902976288; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Kadyan V, 2004, AM J PHYS MED REHAB, V83, P747, DOI 10.1097/01.PHM.0000140790.30468.F4; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Kostyun RO, 2015, SPORTS HEALTH, V7, P52, DOI 10.1177/1941738114555075; Lee YM, 2013, J NEUROSURG-PEDIATR, V12, P537, DOI 10.3171/2013.7.PEDS12572; Makdissi M, 2013, BRIT J SPORT MED, V47, P314, DOI 10.1136/bjsports-2013-092256; McCory P, 2017, BRIT J SPORT MED, V51, P838, DOI [DOI 10.1136/BJSPORTS-2017-097699, 10.1136/bjsports-2017-097699]; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Noble JM, 2013, NEUROPSYCHOL REV, V23, P273, DOI 10.1007/s11065-013-9239-0; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Scopaz KA, 2013, SPORTS HEALTH, V5, P537, DOI 10.1177/1941738112473059; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Zuckerman Scott L, 2012, Surg Neurol Int, V3, P130, DOI 10.4103/2152-7806.102945	31	11	11	0	4	AMER OSTEOPATHIC ASSN	CHICAGO	142 EAST ONTARIO STREET, CHICAGO, IL 60611-2864 USA	0098-6151	1945-1997		J AM OSTEOPATH ASSOC	J. Am. Osteopath. Assoc.	OCT	2017	117	10					635	642		10.7556/jaoa.2017.120			8	Medicine, General & Internal	General & Internal Medicine	FO3UX	WOS:000416761800005	28973180				2021-06-18	
J	Low, E; Crewther, SG; Ong, B; Perre, D; Wijeratne, T				Low, Essie; Crewther, Sheila Gillard; Ong, Ben; Perre, Diana; Wijeratne, Tissa			Compromised Motor Dexterity Confounds Processing Speed Task Outcomes in Stroke Patients	FRONTIERS IN NEUROLOGY			English	Article						processing speed; motor speed; cognitive speed; stroke; transient ischemic attack; motor impairment	DIGIT SYMBOL SUBSTITUTION; TRAUMATIC BRAIN-INJURY; ADULT AGE-DIFFERENCES; INSPECTION-TIME; COGNITIVE IMPAIRMENT; INDIVIDUAL-DIFFERENCES; MULTIPLE-SCLEROSIS; WORKING-MEMORY; WAIS-III; INTELLIGENCE	Most conventional measures of information processing speed require motor responses to facilitate performance. However, although not often addressed clinically, motor impairment, whether due to age or acquired brain injury, would be expected to confound the outcome measure of such tasks. The current study recruited 29 patients (20 stroke and 9 transient ischemic attack) with documented reduction in dexterity of the dominant hand, and 29 controls, to investigate the extent to which 3 commonly used processing speed measures with varying motor demands (a Visuo-Motor Reaction Time task, and the Wechsler Adult Intelligence Scale-IV Symbol Search and Coding subtests) may be measuring motor-related speed more so than cognitive speed. Analyses include correlations between indices of cognitive and motor speed obtained from two other tasks (Inspection Time and Pegboard task, respectively) with the three speed measures, followed by hierarchical regressions to determine the relative contribution of cognitive and motor speed indices toward task performance. Results revealed that speed outcomes on tasks with relatively high motor demands, such as Coding, were largely reflecting motor speed in individuals with reduced dominant hand dexterity. Thus, findings indicate the importance of employing measures with minimal motor requirements, especially when the assessment of speed is aimed at understanding cognitive rather than physical function.	[Low, Essie; Crewther, Sheila Gillard; Wijeratne, Tissa] Western Hlth, Sunshine Hosp, Dept Neurol, Melbourne, Vic, Australia; [Low, Essie; Crewther, Sheila Gillard; Ong, Ben; Wijeratne, Tissa] La Trobe Univ, Sch Psychol & Publ Hlth, Dept Psychol & Counselling, Bundoora, Vic, Australia; [Perre, Diana] Western Hlth, Sunshine Hosp, Dept Psychol, Melbourne, Vic, Australia; [Wijeratne, Tissa] Univ Melbourne, Western Hlth Sunshine Hosp, Melbourne Med Sch, Dept Med, St Albans, Vic, Australia; [Wijeratne, Tissa] Univ Rajarata, Dept Med, Anuradhapura, Sri Lanka	Low, E; Wijeratne, T (corresponding author), Western Hlth, Sunshine Hosp, Dept Neurol, Melbourne, Vic, Australia.; Low, E; Wijeratne, T (corresponding author), La Trobe Univ, Sch Psychol & Publ Hlth, Dept Psychol & Counselling, Bundoora, Vic, Australia.; Wijeratne, T (corresponding author), Univ Melbourne, Western Hlth Sunshine Hosp, Melbourne Med Sch, Dept Med, St Albans, Vic, Australia.; Wijeratne, T (corresponding author), Univ Rajarata, Dept Med, Anuradhapura, Sri Lanka.	essie.low@wh.org.au; tissa.wijeratne@wh.org.au	Crewther, Sheila G/A-2165-2008; Wijeratne, Tissa/I-2086-2019; Kinsella, Glynda/O-6347-2017	Wijeratne, Tissa/0000-0002-1701-7111; Kinsella, Glynda/0000-0002-5859-0934			Ackerman PL, 2000, J EXP PSYCHOL-APPL, V6, P259, DOI 10.1037//1076-898X.6.4.259; Alexander LD, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-6; Arauz A, 2013, J NEUROL NEUROSUR PS, V84, P240, DOI 10.1136/jnnp-2012-303328; Awh E, 1996, PSYCHOL SCI, V7, P25, DOI 10.1111/j.1467-9280.1996.tb00662.x; Ballard C, 2003, DEMENT GERIATR COGN, V16, P52, DOI 10.1159/000069994; BERES CA, 1981, J GERONTOL, V36, P591, DOI 10.1093/geronj/36.5.591; Buetefisch CM, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00214; Burns NR, 1998, PERS INDIV DIFFER, V24, P25, DOI 10.1016/S0191-8869(97)00142-6; Calautti C, 2007, NEUROIMAGE, V34, P322, DOI 10.1016/j.neuroimage.2006.08.026; Carroll J. B., 1993, HUMAN COGNITIVE ABIL; Carvalho JO, 2016, J CLIN EXP NEUROPSYC, V38, P217, DOI 10.1080/13803395.2015.1101054; Chiaravalloti ND, 2003, J CLIN EXP NEUROPSYC, V25, P489, DOI 10.1076/jcen.25.4.489.13878; Crowe SF, 1999, AUST PSYCHOL, V34, P204, DOI 10.1080/00050069908257455; Cunningham DA, 2015, ARCH PHYS MED REHAB, V96, pS94, DOI 10.1016/j.apmr.2014.07.419; DEARY IJ, 1993, PERCEPTION, V22, P1245, DOI 10.1068/p221245; Deary IJ, 1996, AM PSYCHOL, V51, P599; Dik MG, 2000, STROKE, V31, P2431, DOI 10.1161/01.STR.31.10.2431; Ebaid D, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00062; Fong KNK, 2009, NEUROREHABILITATION, V24, P165, DOI 10.3233/NRE-2009-0465; Garaas TW, 2008, VISION RES, V48, P523, DOI 10.1016/j.visres.2007.11.011; Moreno MJG, 2013, PSICOTHEMA, V25, P452, DOI 10.7334/psicothema2012.308; Gillebert CR, 2013, NEUROSCIENTIST, V19, P509, DOI 10.1177/1073858412463168; Gregory T, 2008, INTELLIGENCE, V36, P664, DOI 10.1016/j.intell.2008.03.005; Grudnik JL, 2001, INTELLIGENCE, V29, P523, DOI 10.1016/S0160-2896(01)00078-2; HARVEY LO, 1986, BEHAV RES METH INSTR, V18, P623, DOI 10.3758/BF03201438; Hurford R, 2013, J NEUROL, V260, P237, DOI 10.1007/s00415-012-6625-0; Kenworthy L, 2013, NEUROPSYCHOLOGY, V27, P529, DOI 10.1037/a0033599; Knowles EEM, 2012, SCHIZOPHR RES, V142, P129, DOI 10.1016/j.schres.2012.08.020; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Kreiner DS, 2001, CLIN NEUROPSYCHOL, V15, P109, DOI 10.1076/clin.15.1.109.1906; Lesniak M, 2008, DEMENT GERIATR COGN, V26, P356, DOI 10.1159/000162262; Lezak M.D., 2004, NEUROPSYCHOLOGICAL A, Vfourth; Lichtenberger EO., 2009, ESSENTIALS WAIS 4 AS; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; Low E, 2016, SCI REP-UK, V6, DOI 10.1038/srep22598; Luxton J, 2014, J CLIN EXP NEUROPSYC, V36, P944, DOI 10.1080/13803395.2014.957168; Mehrabian S, 2015, NEUROPSYCH DIS TREAT, V11, P2711, DOI 10.2147/NDT.S86366; Middleton LE, 2014, NEUROREHABILITATION, V34, P305, DOI 10.3233/NRE-131030; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Parmenter BA, 2007, J INT NEUROPSYCH SOC, V13, P417, DOI 10.1017/S1355617707070580; Petrill SA, 2001, INTELLIGENCE, V29, P487, DOI 10.1016/S0160-2896(01)00074-5; Ponsford J, 2014, J HEAD TRAUMA REHAB, V29, P321, DOI 10.1097/HTR.0000000000000072; Ragland JD, 2002, NEUROPSYCHOLOGY, V16, P370, DOI 10.1037//0894-4105.16.3.370; Roberts RD, 1999, LEARN INDIVID DIFFER, V11, P1, DOI 10.1016/S1041-6080(00)80007-2; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; SALTHOUSE TA, 1992, J GERONTOL, V47, pP121, DOI 10.1093/geronj/47.3.P121; Sankarasubramanian V, 2017, CLIN NEUROPHYSIOL, V128, P892, DOI 10.1016/j.clinph.2017.03.030; Schear J M, 1989, Arch Clin Neuropsychol, V4, P25, DOI 10.1016/0887-6177(89)90004-8; Schneider LA, 2017, CHILD NEUROPSYCHOL, V23, P300, DOI 10.1080/09297049.2015.1102215; Sims JR, 2009, NEUROLOGY, V72, P2104, DOI 10.1212/WNL.0b013e3181aa5329; Strober LB, 2014, MULT SCLER RELAT DIS, V3, P473, DOI 10.1016/j.msard.2014.03.004; Su CY, 2015, ARCH CLIN NEUROPSYCH, V30, P148, DOI 10.1093/arclin/acu057; Takeuchi H, 2011, J NEUROSCI, V31, P12139, DOI 10.1523/JNEUROSCI.2948-11.2011; Tiffin J, 1948, J APPL PSYCHOL, V32, P234, DOI 10.1037/h0061266; Turunen KEA, 2013, EUR J NEUROL, V20, P286, DOI 10.1111/j.1468-1331.2012.03844.x; Vickers D, 1972, Perception, V1, P263, DOI 10.1068/p010263; Wagle J, 2011, DEMENT GERIATR COGN, V31, P379, DOI 10.1159/000328970; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th ed; Wisdom NM, 2012, ARCH CLIN NEUROPSYCH, V27, P389, DOI 10.1093/arclin/acs041; Zbinden L, 2006, BRIT J NEUROSURG, V20, P203, DOI 10.1080/02688690600852258	60	11	11	0	0	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	SEP 21	2017	8								484	10.3389/fneur.2017.00484			11	Clinical Neurology; Neurosciences	Neurosciences & Neurology	FH6BL	WOS:000411257100002	28983276	DOAJ Gold, Green Published			2021-06-18	
J	Ziebell, JM; Ray-Jones, H; Lifshitz, J				Ziebell, Jenna M.; Ray-Jones, Helen; Lifshitz, Jonathan			NOGO PRESENCE IS INVERSELY ASSOCIATED WITH SHIFTS IN CORTICAL MICROGLIAL MORPHOLOGY FOLLOWING EXPERIMENTAL DIFFUSE BRAIN INJURY	NEUROSCIENCE			English	Article						microglia; Nogo; traumatic brain injury; myelin; oligodendrocytes	AXONAL REGENERATION; IN-VITRO; RECEPTOR; CNS; DEGENERATION; MACROPHAGES; ACTIVATION; MICE; INFLAMMATION; INHIBITION	Diffuse traumatic brain injury (TBI) initiates secondary pathology, including inflammation and reduced myelination. Considering these injury-related pathologies, the many states of activated microglia as demonstrated by differing morphologies would form, migrate, and function in and through fields of growth-inhibitory myelin byproduct, specifically Nogo. Here we evaluate the relationship between inflammation and reduced myelin antigenicity in the wake of diffuse TBI and present the hypothesis that the Nogo-66 receptor antagonist peptide NEP(1-40) would reverse the injury-induced shift in distribution of microglia morphologies by limiting myelin-based inhibition. Adult male rats were subjected to midline fluid percussion sham or brain injury. At 2 h, 6 h, 1 d, 2 d, 7 d, and 21 d post injury, immunohistochemical staining was analyzed in sensory cortex (S1BF) for myelin antigens (myelin basic protein; MBP and CNPase), microglia morphology (ionized calcium-binding adapter protein; lba1), Nogo receptor and Nogo. Pronounced reduction in myelin antigenicity was evident transiently at 1 d post-injury, as evidenced by decreased MBP and CNPase staining, as well as loss of white matter organization, compared to sham and later injury time points. Concomitant with reduced myelin antigenicity, injury shifted microglia morphology from the predominantly ramified morphology observed in sham-injured cortex to hyper-ramified, activated, fully activated, or rod. Changes in microglial morphology were evident as early as 2 h post-injury, and remained at least until day 21. Additional cohorts of uninjured and brain-injured animals received vehicle or drug (NEP(1-40), i.p., 15 min and 19 h post-injury) and brains were collected at 2 h, 6 h, 1 d, 2 d, or 7 d post-injury. NEP(1-40) administration further shifted distributions of microglia away from an injury-induced activated morphology toward greater proportions of rod and macrophage-like morphologies compared to vehicle-treated. By 7 d post-injury, no differences in the distributions of microglia were noted between vehicle and NEP(1-40). This study begins to link secondary pathologies of white matter damage and inflammation after diffuse TBI. In the injured brain, secondary pathologies co-occur and likely interact, with consequences for neuronal circuit disruption leading to neurological symptoms. (C) 2017 IBRO. Published by Elsevier Ltd. All rights reserved.	[Ziebell, Jenna M.; Ray-Jones, Helen; Lifshitz, Jonathan] Phoenix Childrens Hosp, Barrow Neurol Inst, Phoenix, AZ USA; [Ziebell, Jenna M.; Ray-Jones, Helen; Lifshitz, Jonathan] Univ Arizona, Coll Med Phoenix, Dept Child Hlth, Phoenix, AZ USA; [Lifshitz, Jonathan] VA Healthcare Syst, Phoenix, AZ USA; [Lifshitz, Jonathan] Arizona State Univ, Psychol, Tempe, AZ USA; [Ray-Jones, Helen] Univ Bath, Dept Biol & Biochem, Bath, Avon, England	Ziebell, JM (corresponding author), Univ Tasmania, Wicking Dementia Res & Educ Ctr, Private Bag 143, Hobart, Tas 7001, Australia.	Jenna.ziebell@gmail.com	Ziebell, Jenna/Y-4496-2019	Ziebell, Jenna/0000-0003-2497-4347	National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS065052]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS065052] Funding Source: NIH RePORTER	The authors would like to thank Megan Evilsizor and Daniel Griffiths for surgical preparation of animals and tissue collection for this study, Anika Perdok for assistance with cell counts, Rachel K. Rowe, Ph.D. and Dr. M. Cristina Morganti-Kossmann for critical analysis of the manuscript. Research for this report was supported, in part, by National Institute of Neurological Disorders and Stroke of the National Institutes of Health under award number R01NS065052 and Mission Support from Phoenix Children's Hospital.	Batchelor PE, 2002, MOL CELL NEUROSCI, V21, P436, DOI 10.1006/mcne.2002.1185; Batchelor PE, 1999, J NEUROSCI, V19, P1708; BROADWELL RD, 1982, SCIENCE, V217, P164, DOI 10.1126/science.7089551; Bye N, 2007, EXP NEUROL, V204, P220, DOI 10.1016/j.expneurol.2006.10.013; Cao T, 2012, NEUROSCIENCE, V225, P65, DOI 10.1016/j.neuroscience.2012.08.058; Chong SYC, 2012, P NATL ACAD SCI USA, V109, P1299, DOI 10.1073/pnas.1113540109; David S, 2008, TRENDS NEUROSCI, V31, P221, DOI 10.1016/j.tins.2008.02.002; Filbin MT, 2003, NAT REV NEUROSCI, V4, P703, DOI 10.1038/nrn1195; Flygt J, 2013, EUR J NEUROSCI, V38, P2153, DOI 10.1111/ejn.12179; Fry EJ, 2007, NEURON, V53, P649, DOI 10.1016/j.neuron.2007.02.009; Gennarelli T. A., 1998, SEM CLIN NEUR, V3, P160; Glezer I, 2007, NEUROSCIENCE, V147, P867, DOI 10.1016/j.neuroscience.2007.02.055; Graeber MB, 2010, SCIENCE, V330, P783, DOI 10.1126/science.1190929; GrandPre T, 2002, NATURE, V417, P547, DOI 10.1038/417547a; Hanell A, 2010, J NEUROTRAUM, V27, P1297, DOI 10.1089/neu.2009.1255; Hanisch UK, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00065; Hosseini AH, 2009, MED SCI SPORT EXER, V41, P1687, DOI 10.1249/MSS.0b013e31819fcd1b; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Lifshitz J, 2007, J NEUROPATH EXP NEUR, V66, P218, DOI 10.1097/01.jnen.0000248558.75950.4d; Lifshitz J, 2012, BRAIN STRUCT FUNCT, V217, P49, DOI 10.1007/s00429-011-0323-z; Liu MC, 2006, J NEUROCHEM, V98, P700, DOI 10.1111/j.1471-4159.2006.03882.x; Lotocki G, 2011, NEUROSCI LETT, V499, P143, DOI 10.1016/j.neulet.2011.05.056; Marklund N, 2009, NEUROSCIENCE, V163, P540, DOI 10.1016/j.neuroscience.2009.06.042; Marklund N, 2007, J NEUROSURG, V107, P844, DOI 10.3171/JNS-07/10/0844; Miron VE, 2013, NAT NEUROSCI, V16, P1211, DOI 10.1038/nn.3469; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Nissl F., 1899, ARCH PSYCHIAT NERVEN, V32, P656; Pernet V, 2008, J NEUROSCI, V28, P7435, DOI 10.1523/JNEUROSCI.0727-08.2008; Perry VH, 2010, ASN NEURO, V2, P281, DOI 10.1042/AN20100024; Satoh JI, 2005, J NEUROPATH EXP NEUR, V64, P129, DOI 10.1093/jnen/64.2.129; Schwab ME, 2010, NAT REV NEUROSCI, V11, P799, DOI 10.1038/nrn2936; Tanaka T, 2009, J BIOL CHEM, V284, P21626, DOI 10.1074/jbc.M109.005603; Taylor SE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097096; Tong J, 2013, J NEUROTRAUM, V30, P247, DOI 10.1089/neu.2012.2493; Tremblay ME, 2011, NEURON GLIA BIOL, V7, P67, DOI 10.1017/S1740925X12000038; Tremblay ME, 2011, J NEUROSCI, V31, P16064, DOI 10.1523/JNEUROSCI.4158-11.2011; Tremblay Marie-Eve, 2011, Commun Integr Biol, V4, P220, DOI 10.4161/cib.4.2.14506; Wake H, 2013, TRENDS NEUROSCI, V36, P209, DOI 10.1016/j.tins.2012.11.007; Wang F, 2012, BRAIN RES, V1469, P153, DOI 10.1016/j.brainres.2012.06.040; Wierzba-Bobrowicz T, 2002, FOLIA NEUROPATHOL, V40, P125; WILLIAMS K, 1994, J NEUROSCI RES, V38, P433, DOI 10.1002/jnr.490380409; Yan J, 2012, J NEUROCHEM, V120, P721, DOI 10.1111/j.1471-4159.2011.07619.x; Ziebell JM, 2015, METAB BRAIN DIS, V30, P393, DOI 10.1007/s11011-014-9539-y; Ziebell JM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-247; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	47	11	11	0	5	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	SEP 17	2017	359						209	223		10.1016/j.neuroscience.2017.07.027			15	Neurosciences	Neurosciences & Neurology	FE7QD	WOS:000408401100019	28736137	Green Accepted			2021-06-18	
J	Lee, BE; Choi, BY; Hong, DK; Kim, JH; Lee, SH; Kho, AR; Kim, H; Choi, HC; Suh, SW				Lee, Bo Eun; Choi, Bo Young; Hong, Dae Kee; Kim, Jin Hee; Lee, Song Hee; Kho, A. Ra; Kim, Haesung; Choi, Hui Chul; Suh, Sang Won			The cancer chemotherapeutic agent paclitaxel (Taxol) reduces hippocampal neurogenesis via down-regulation of vesicular zinc	SCIENTIFIC REPORTS			English	Article							LONG-TERM POTENTIATION; RECEIVING ADJUVANT TREATMENT; TRAUMATIC BRAIN-INJURY; BREAST-CANCER; COGNITIVE DYSFUNCTION; ADULT NEUROGENESIS; DENTATE GYRUS; CELLS; WOMEN; MICE	Chemotherapy-induced cognitive impairment (CICI) is increasingly recognized as a major unwanted side effect of an otherwise highly valuable life-saving technology. In part, this awareness is a result of increased cancer survival rates following chemotherapy. Altered hippocampal neurogenesis may play a role in mediating CICI. In particular, zinc could act as a key regulator of this process. To test this hypothesis, we administered paclitaxel (Px) to male C57BL/6 mice for set time periods and then evaluated the effects of Px treatment on hippocampal neurogenesis and vesicular zinc. We found that vesicular zinc levels and expression of zinc transporter 3 (ZnT3) were reduced in Px-treated mice, compared to vehicle-treated mice. Moreover, Px-treated mice demonstrated a significant decrease in the number of neuroblasts present. However, no difference in the number of progenitor cells were observed. In addition, zinc supplementation by treatment with ZnCl2 ameliorated the Px-induced decrease in hippocampal neurogenesis and cognitive impairment. These results suggest that via disruption of vesicular zinc stores in hippocampal mossy fiber terminals, chemotherapy may impinge upon one or more of the sequential stages involved in the maturation of new neurons derived via adult neurogenesis and thereby leads to the progressive cognitive decline associated with CICI.	[Lee, Bo Eun; Choi, Bo Young; Hong, Dae Kee; Kim, Jin Hee; Lee, Song Hee; Kho, A. Ra; Suh, Sang Won] Hallym Univ, Coll Med, Dept Phys, Chunchon, South Korea; [Choi, Hui Chul] Chuncheon Sacred Heart Hosp, Coll Med, Dept Neurol, Chunchon, South Korea; [Kim, Haesung] Chuncheon Sacred Heart Hosp, Coll Med, Dept Surg, Chunchon, South Korea	Suh, SW (corresponding author), Hallym Univ, Coll Med, Dept Phys, Chunchon, South Korea.	swsuh@hallym.ac.kr		Choi, Bo Young/0000-0002-9579-3503; Suh, Sang Won/0000-0002-7492-579X; Hong, Dae-Ki/0000-0003-3769-3456	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [NRF-2016M3C7A1913844]	This work was support by Brain Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (NRF-2016M3C7A1913844) to S.W.S.	Avraham HK, 2014, J PATHOL, V232, P369, DOI 10.1002/path.4304; Baron MK, 2006, SCIENCE, V311, P531, DOI 10.1126/science.1118995; Barton DL, 2013, SUPPORT CARE CANCER, V21, P1185, DOI 10.1007/s00520-012-1647-9; Besser L, 2009, J NEUROSCI, V29, P2890, DOI 10.1523/JNEUROSCI.5093-08.2009; Bower JE, 2008, J CLIN ONCOL, V26, P768, DOI 10.1200/JCO.2007.14.3248; Brayer SW, 2015, NEUROREHAB NEURAL RE, V29, P483, DOI 10.1177/1545968314550367; CAMERON HA, 1994, NEUROSCIENCE, V61, P203, DOI 10.1016/0306-4522(94)90224-0; Choi BY, 2016, NEUROSCIENCE, V339, P634, DOI 10.1016/j.neuroscience.2016.10.035; Choi BY, 2014, J TRACE ELEM MED BIO, V28, P474, DOI 10.1016/j.jtemb.2014.07.007; Choi BY, 2014, METALLOMICS, V6, P1513, DOI 10.1039/c4mt00067f; Davis J, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-153; Dietrich J, 2008, ONCOLOGIST, V13, P1285, DOI 10.1634/theoncologist.2008-0130; Fan HGM, 2008, SUPPORT CARE CANCER, V16, P577, DOI 10.1007/s00520-007-0341-9; FREDERICKSON CJ, 1989, INT REV NEUROBIOL, V31, P145; FREDERICKSON CJ, 1987, J NEUROSCI METH, V20, P91, DOI 10.1016/0165-0270(87)90042-2; Gangloff A, 2005, J NUCL MED, V46, P1866; Ganguly A, 2010, MOL CANCER THER, V9, P2914, DOI 10.1158/1535-7163.MCT-10-0552; GOLUB MS, 1994, AM J CLIN NUTR, V60, P238; Grabrucker AM, 2011, EMBO J, V30, P569, DOI 10.1038/emboj.2010.336; Hirzel K, 2006, NEURON, V52, P679, DOI 10.1016/j.neuron.2006.09.035; Huang YZ, 2008, NEURON, V57, P546, DOI 10.1016/j.neuron.2007.11.026; Huang YS, 2015, BIOCHEM J, V466, P499, DOI 10.1042/BJ20141143; Janelsins MC, 2010, CANCER INVEST, V28, P544, DOI 10.3109/07357900903405942; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Kampan NC, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/413076; Kim JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048543; Kodirov SA, 2006, P NATL ACAD SCI USA, V103, P15218, DOI 10.1073/pnas.0607131103; LaPointe NE, 2013, NEUROTOXICOLOGY, V37, P231, DOI 10.1016/j.neuro.2013.05.008; Lemaire V, 2000, P NATL ACAD SCI USA, V97, P11032, DOI 10.1073/pnas.97.20.11032; Linkous DH, 2008, J HISTOCHEM CYTOCHEM, V56, P3, DOI 10.1369/jhc.6A7035.2007; Madsen TM, 2003, NEUROSCIENCE, V119, P635, DOI 10.1016/S0306-4522(03)00199-4; Mennenga SE, 2015, PHYSIOL BEHAV, V138, P260, DOI 10.1016/j.physbeh.2014.09.001; Monje M, 2012, BEHAV BRAIN RES, V227, P376, DOI 10.1016/j.bbr.2011.05.012; Moore HCF, 2014, ONCOLOGY-NY, V28, P797; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Nabholtz J M, 2000, Expert Opin Pharmacother, V1, P187, DOI 10.1517/14656566.1.2.187; Nokia MS, 2012, EUR J NEUROSCI, V36, P3521, DOI 10.1111/ejn.12007; PerezClausell J, 1996, J CHEM NEUROANAT, V11, P99, DOI 10.1016/0891-0618(96)00131-7; Qian AQ, 2006, J NEUROSCI, V26, P10899, DOI 10.1523/JNEUROSCI.3453-06.2006; Qian J, 2005, J PHYSIOL-LONDON, V566, P747, DOI 10.1113/jphysiol.2005.089276; Raber J, 2004, RADIAT RES, V162, P39, DOI 10.1667/RR3206; Rodriguez PL, 2014, INT J CANCER, V134, P1034, DOI 10.1002/ijc.28433; Shemesh OA, 2010, ACTA NEUROPATHOL, V119, P235, DOI 10.1007/s00401-009-0586-0; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Sindreu C, 2011, P NATL ACAD SCI USA, V108, P3366, DOI 10.1073/pnas.1019166108; Slotnick BM, 1975, STEREOTAXIC ATLAS AL; Suh SW, 2009, J CEREBR BLOOD F MET, V29, P1579, DOI 10.1038/jcbfm.2009.80; Suzuki M, 2015, NEUROCHEM INT, V87, P60, DOI 10.1016/j.neuint.2015.05.006; Takeda A, 2008, NEUROCHEM INT, V52, P241, DOI 10.1016/j.neuint.2007.06.021; Tanimukai H, 2013, BIOCHEM BIOPH RES CO, V437, P151, DOI 10.1016/j.bbrc.2013.06.057; van Dam FSAM, 1998, J NATL CANCER I, V90, P210, DOI 10.1093/jnci/90.3.210; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; Vardy JL, 2007, J CLIN ONCOL, V25, DOI 10.1200/JCO.2006.08.1604; Vardy J, 2007, CRIT REV ONCOL HEMAT, V63, P183, DOI 10.1016/j.critrevonc.2007.06.001; Wefel JS, 2004, CANCER-AM CANCER SOC, V100, P2292, DOI 10.1002/cncr.20272; WEISS JH, 1989, NATURE, V338, P212, DOI 10.1038/338212b0; You L, 2015, BIOCHEM BIOPH RES CO, V456, P598, DOI 10.1016/j.bbrc.2014.11.120	57	11	11	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	SEP 15	2017	7								11667	10.1038/s41598-017-12054-7			10	Multidisciplinary Sciences	Science & Technology - Other Topics	FH0VQ	WOS:000410859100005	28916767	DOAJ Gold, Green Published			2021-06-18	
J	Liang, DY; Shi, XY; Liu, P; Sun, Y; Sahbaie, P; Li, WW; Yeomans, DC; Clark, JD				Liang, De-Yong; Shi, Xiaoyou; Liu, Peng; Sun, Yuan; Sahbaie, Peyman; Li, Wen-Wu; Yeomans, David C.; Clark, J. David			The Chemokine Receptor CXCR2 Supports Nociceptive Sensitization after Traumatic Brain Injury	MOLECULAR PAIN			English	Article						Traumatic Brain Injury; CXCR2; Histone acetyltransferase; Anarcardic acid; Chronic pain	SPINAL-CORD ASTROCYTES; BONE CANCER PAIN; NEUROPATHIC PAIN; UP-REGULATION; EPIGENETIC REGULATION; INFLAMMATORY PAIN; NERVE INJURY; RAT MODEL; CXCL1; MICE	Chronic pain after traumatic brain injury (TBI) is very common, but the mechanisms linking TBI to pain and the pain-related interactions of TBI with peripheral injuries are poorly understood. Chemokine receptors play an important role in both pain and brain injury. In the current work we pursued the hypothesis that the epigenetically-regulated CXC chemokine receptor 2 (CXCR2) is a crucial modulator of nociceptive sensitization induced by TBI. For these studies we used the rat lateral fluid percussion model of TBI. Histone actyltransferase activity was blocked using anacardic acid beginning immediately following injury, or delayed for 7 days prior to administration. The selective CXCR2 antagonist SCH527123 administered systemically or intrathecally was used to probe the role of chemokine signaling on mechanical hindpaw sensitization after TBI. The expression of the CXCR2 receptor was accomplished using real-time PCR, immunohistochemistry and Western blotting, while epigenetic regulation was assessed using chromatin immunoprecipitation assay. The spinal levels of several pain-related mediators including CXCL1, an endogenous ligand for CXCR2, as well as BDNF and PDYN were measured by ELISA. We observed that anacardic acid potently blocked and reversed mechanical hindpaw sensitization after TBI. The same drug was able to prevent the up-regulation of CXCR2 after TBI, but did not affect the spinal expression of other pain mediators. On the other hand, both systemically and intrathecally administered SCH527123 reversed hindpaw allodynia after TBI. Most of the spinal CXCR2 appeared to be expressed by spinal cord neurons. Chromatin immunoprecipitation experiments demonstrated TBI-enhanced association of the CXCR2 promoter with acetylated-H3K9 histone protein that was also reversible using anacardic acid. Taken together, our findings suggested that TBI causes the up-regulation of spinal CXCR2 through an epigenetic mechanism ultimately supporting nociceptive sensitization. The use of CXCR2 antagonists may, therefore, be useful in pain resulting from TBI.	[Liang, De-Yong; Sun, Yuan; Sahbaie, Peyman; Clark, J. David] Vet Affairs Palo Alto Hlth Care Syst, Dept Anesthesiol, Palo Alto, CA USA; [Liang, De-Yong; Shi, Xiaoyou; Liu, Peng; Sun, Yuan; Sahbaie, Peyman; Li, Wen-Wu; Yeomans, David C.; Clark, J. David] Stanford Univ, Dept Anesthesiol Pain & Perioperat Med, Sch Med, Stanford, CA 94305 USA; [Liang, De-Yong; Clark, J. David] Stanford Univ, Sch Med, Stanford, CA 94305 USA	Liang, DY (corresponding author), Stanford Univ, Sch Med, Stanford, CA 94305 USA.				DOD CDMRP award [MR130295]; VA Merit Review GrantUS Department of Veterans Affairs [1I01RX001776]; Veterans AffairsUS Department of Veterans Affairs [I01RX001776] Funding Source: NIH RePORTER	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the DOD CDMRP award MR130295 and VA Merit Review Grant 1I01RX001776 to JDC.	Bose P, 2013, J NEUROTRAUM, V30, P1177, DOI 10.1089/neu.2012.2740; Boyer N, 2014, PAIN, V155, P1196, DOI 10.1016/j.pain.2014.03.001; Cao DL, 2016, BRAIN RES BULL, V127, P219, DOI 10.1016/j.brainresbull.2016.09.016; Cao DL, 2014, EXP NEUROL, V261, P328, DOI 10.1016/j.expneurol.2014.05.014; Chen G, 2014, BRAIN, V137, P2193, DOI 10.1093/brain/awu140; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Coronado VG, 2011, MMWR SURVEILL SUMM, V60, P1; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; De Felice M, 2016, PAIN MANAG, V6, P111, DOI 10.2217/pmt.15.63; Defrin R, 2015, J NEUROTRAUM, V32, P28, DOI 10.1089/neu.2014.3359; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Feliciano DP, 2014, NEUROSCI LETT, V583, P55, DOI 10.1016/j.neulet.2014.09.030; Guo TZ, 2004, PAIN, V108, P95, DOI 10.1016/j.pain.2003.12.010; Higgins DM, 2014, PAIN MED, V15, P782, DOI 10.1111/pme.12388; Holz O, 2010, EUR RESPIR J, V35, P564, DOI 10.1183/09031936.00048509; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jang SH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004017; Kiguchi N, 2013, CYTOKINE, V64, P666, DOI 10.1016/j.cyto.2013.09.019; Kiguchi N, 2012, J PHARMACOL EXP THER, V340, P577, DOI 10.1124/jpet.111.187724; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Liang DY, 2017, IBRO REP, V2, P14, DOI 10.1016/j.ibror.2016.12.001; Liang DY, 2013, J PAIN, V14, P36, DOI 10.1016/j.jpain.2012.10.005; Ling G.S, 2004, CURR PROTOC NEUROSCI, V2; Luo Y, 2000, J IMMUNOL, V165, P4015, DOI 10.4049/jimmunol.165.7.4015; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Murphy MP, 2012, NEUROREHABILITATION, V31, P85, DOI 10.3233/NRE-2012-0777; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Ning Y, 2012, MOL CANCER THER, V11, P1353, DOI 10.1158/1535-7163.MCT-11-0915; OSSIPOV MH, 1985, BRAIN RES, V341, P320, DOI 10.1016/0006-8993(85)91071-6; Otto VI, 2001, NEUROREPORT, V12, P2059, DOI 10.1097/00001756-200107030-00053; Poree LR, 1998, ANESTH ANALG, V87, P941, DOI 10.1097/00000539-199810000-00037; Rao V, 2015, SEMIN NEUROL, V35, P64, DOI 10.1055/s-0035-1544241; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Sayer NA, 2009, PM&R, V1, P23, DOI 10.1016/j.pmrj.2008.10.003; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P459, DOI 10.1038/jcbfm.2009.240; Strigo IA, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2013.116; Sun Y, 2014, J PAIN, V15, P856, DOI 10.1016/j.jpain.2014.05.003; Sun Y, 2013, ANESTHESIOLOGY, V119, P1198, DOI 10.1097/ALN.0b013e31829ce340; Ucal M, 2017, J NEUROTRAUM, V34, P475, DOI 10.1089/neu.2016.4411; Valles A, 2006, NEUROBIOL DIS, V22, P312, DOI 10.1016/j.nbd.2005.11.015; Wang YG, 2011, J NEUROTRAUM, V28, P259, DOI 10.1089/neu.2010.1648; Xu J, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-38; Yang LH, 2016, NEUROSCI LETT, V626, P135, DOI 10.1016/j.neulet.2015.12.044; Zhang ZJ, 2013, PAIN, V154, P2185, DOI 10.1016/j.pain.2013.07.002; Zhou XR, 2007, IMMUNOLOGY, V122, P476, DOI 10.1111/j.1365-2567.2007.02674.x; Zhou YQ, 2015, CURR PHARM DESIGN, V21, P5029, DOI 10.2174/1381612821666150831141931	46	11	11	0	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1744-8069			MOL PAIN	Mol. Pain	SEP 8	2017	13								1744806917730212	10.1177/1744806917730212			37	Neurosciences	Neurosciences & Neurology	FF0RO	WOS:000408609000001	28845733	DOAJ Gold, Green Published			2021-06-18	
J	Brizuela, M; Blizzard, CA; Chuckowree, JA; Pitman, KA; Young, KM; Dickson, T				Brizuela, Mariana; Blizzard, Catherine A.; Chuckowree, Jyoti A.; Pitman, Kimberley A.; Young, Kaylene M.; Dickson, Tracey			Mild Traumatic Brain Injury Leads to Decreased Inhibition and a Differential Response of Calretinin Positive Interneurons in the Injured Cortex	JOURNAL OF NEUROTRAUMA			English	Article						calretinin; cortex; GAD67; interneuron; mild traumatic brain injury; mouse	POSTTRAUMATIC-STRESS-DISORDER; SYNAPTIC-TRANSMISSION; GRANULE CELLS; PLASTICITY; NEURONS; REORGANIZATION; MODEL; PROLIFERATION; EPIDEMIOLOGY; NEUROGENESIS	It is clear that even mild forms of traumatic brain injury (TBI) can have lasting cognitive effects; however, the specific cellular changes responsible for the functional deficits remain poorly understood. Previous studies suggest that not all neurons respond in the same way and that changes to neuronal architecture may be subtype specific. The current study aimed to characterize the response of interneurons to TBI. To model TBI in vitro, the neurites of primary cortical neurons were transected at 15 days in vitro. In response, calretinin(+) interneurons underwent significant neurite remodeling around the injury site. By examining the response of pyramidal neurons, GAD67-GFP(+) interneurons, and calretinin(+) interneurons to the injury, we found that this response was specific to the calretinin(+) cells. To determine whether calretinin(+) interneurons respond in this way to a clinically relevant in vivo model of mild diffuse and focal injury, we subjected mice to the lateral fluid percussion injury model. We found that calretinin(+) interneuron density was unaltered by this mild injury, but consistent with our in vitro data, these neurons underwent morphological alterations in their dendrites. These alterations evolved over a 28-day period, and calretinin(+) interneurons in the injured mice had a reduction in mean dendrite length and reduced number of secondary dendrites than those in the sham-injured controls by 7 days post-injury. Further, these structural alterations were accompanied by a reduction in the frequency of miniature inhibitory post-synaptic currents in layer V pyramidal neurons. These data suggest that even a mild TBI can lead to an overall change in the excitatory/inhibitory balance of the cortex that may play an important role in the longer-term behavioral pathology associated with mild TBI.	[Brizuela, Mariana; Blizzard, Catherine A.; Chuckowree, Jyoti A.; Pitman, Kimberley A.; Young, Kaylene M.; Dickson, Tracey] Univ Tasmania, Menzies Inst Med Res, Private Bag 23, Hobart, Tas 7000, Australia	Dickson, T (corresponding author), Univ Tasmania, Menzies Inst Med Res, Private Bag 23, Hobart, Tas 7000, Australia.	Tracey.Dickson@utas.edu.au	; Pitman, Kimberley/O-4843-2017	Dickson, Tracey/0000-0002-9196-1661; Young, Kaylene/0000-0002-1686-3463; Pitman, Kimberley/0000-0003-3198-9336; Blizzard, Catherine/0000-0002-8683-2937	National Health and Medical Research Foundation; Tasmanian Masonic Medical Research Foundation; Rebecca L. Cooper Medical Research Foundation; Clive and Vera Ramaciotti Foundation	GAD67-GFP mice were developed by Prof. Nobuaki Tamamaki (Kyoto University) and were provided by Prof. John Bekkers (Australian National University). This work was support by the National Health and Medical Research Foundation, the Tasmanian Masonic Medical Research Foundation, the Rebecca L. Cooper Medical Research Foundation and the Clive and Vera Ramaciotti Foundation.	Albrecht MA, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00105; Alder J, 2011, JOVE-J VIS EXP, DOI 10.3791/3063; Almeida-Suhett CP, 2015, EXP NEUROL, V273, P11, DOI 10.1016/j.expneurol.2015.07.028; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Banerjee A, 2013, INT J NEUROPSYCHOPH, V16, P1309, DOI 10.1017/S1461145712001216; Barinka F, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00108; Baroncelli L, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/286073; Blaiss CA, 2011, J NEUROSCI, V31, P4906, DOI 10.1523/JNEUROSCI.5265-10.2011; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Blizzard CA, 2013, J NEUROTRAUM, V30, P1908, DOI 10.1089/neu.2013.2850; Blizzard CA, 2011, CEREB CORTEX, V21, P281, DOI 10.1093/cercor/bhq091; Cafferty WBJ, 2008, TRENDS NEUROSCI, V31, P215, DOI 10.1016/j.tins.2008.02.004; Cantu D, 2015, CEREB CORTEX, V25, P2306, DOI 10.1093/cercor/bhu041; Canty AJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3038; Caputi A, 2009, CEREB CORTEX, V19, P1345, DOI 10.1093/cercor/bhn175; Carbonnel WS, 1999, ACTA NEUROPATHOL, V98, P396, DOI 10.1007/s004010051100; Carmichael ST, 2006, ANN NEUROL, V59, P735, DOI 10.1002/ana.20845; Chen JL, 2013, NEUROSCIENTIST, V19, P384, DOI 10.1177/1073858413479824; Chen JL, 2011, J NEUROSCI, V31, P12437, DOI 10.1523/JNEUROSCI.0420-11.2011; Chen R, 2002, NEUROSCIENCE, V111, P761, DOI 10.1016/S0306-4522(02)00025-8; Chuckowree JA, 2004, NEUROSCIENTIST, V10, P280, DOI 10.1177/1073858404263511; Clarke LE, 2012, J NEUROSCI, V32, P8173, DOI 10.1523/JNEUROSCI.0928-12.2012; Cohen AS, 2007, PROG BRAIN RES, V161, P143, DOI 10.1016/S0079-6123(06)61010-8; Combs HL, 2015, J NEUROTRAUM, V32, P956, DOI 10.1089/neu.2014.3585; Cope EC, 2016, EXP NEUROL, V279, P96, DOI 10.1016/j.expneurol.2016.02.017; Dancause N, 2011, PROG BRAIN RES, V192, P273, DOI 10.1016/B978-0-444-53355-5.00015-4; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Di Cristo G, 2007, NAT NEUROSCI, V10, P1569, DOI 10.1038/nn2008; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Dzaja D, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00103; Girgis F, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00008; Hayes R L, 1987, Brain Inj, V1, P93, DOI 10.3109/02699058709034449; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hollrigel GS, 1997, J NEUROSCI, V17, P5119; Horner PJ, 2000, NATURE, V407, P963, DOI 10.1038/35039559; Hunt RF, 2011, J NEUROSCI, V31, P6880, DOI 10.1523/JNEUROSCI.0032-11.2011; Keck T, 2011, NEURON, V71, P869, DOI 10.1016/j.neuron.2011.06.034; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Keyvani K, 2002, J NEUROPATH EXP NEUR, V61, P831, DOI 10.1093/jnen/61.10.831; King AE, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-59; Lee WCA, 2006, PLOS BIOL, V4, P271, DOI 10.1371/journal.pbio.0040029; Lee WCA, 2008, P NATL ACAD SCI USA, V105, P19968, DOI 10.1073/pnas.0810149105; Li W, 2016, J NEUROL, V263, P1280, DOI 10.1007/s00415-016-8093-4; Macias M, 2008, ACTA NEUROBIOL EXP, V68, P334; Marik SA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000395; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; Mizrahi A, 2003, NAT NEUROSCI, V6, P1201, DOI 10.1038/nn1133; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Mtchedlishvili Z, 2010, NEUROBIOL DIS, V38, P464, DOI 10.1016/j.nbd.2010.03.012; Ostergard T, 2016, J NEUROSCI METH, V272, P50, DOI 10.1016/j.jneumeth.2016.03.023; Pavlov I, 2011, NEUROSCIENCE, V194, P208, DOI 10.1016/j.neuroscience.2011.07.074; Peredeny JV, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00017; Peterson TC, 2015, BEHAV BRAIN RES, V294, P254, DOI 10.1016/j.bbr.2015.08.007; Pitkanen A, 2014, NEUROTHERAPEUTICS, V11, P286, DOI 10.1007/s13311-014-0260-7; Rice AC, 2003, EXP NEUROL, V183, P406, DOI 10.1016/S0014-4886(03)00241-3; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Salman H, 2004, J NEUROTRAUM, V21, P283, DOI 10.1089/089771504322972077; Smith CJ, 2015, FRONT NEUROL, V6, DOI [10.3389/fneur.2015.00240, 10.3389/fneur.2015.00073]; Sullivan K. A., 2016, NEUROPSYCHOL REV; Suzuki N, 2010, CEREB CORTEX, V20, P2971, DOI 10.1093/cercor/bhq046; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Toth K, 2014, FRONT NEUROANAT, V8, DOI [10.3389/thana.2014.00100, 10.3389/fnana.2014.00100]; Toth K, 2010, BRAIN, V133, P2763, DOI 10.1093/brain/awq149; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Wang XT, 2016, J NEUROTRAUM, V33, P721, DOI 10.1089/neu.2015.4097; Weber JT, 2001, J BIOL CHEM, V276, P1800, DOI 10.1074/jbc.M009209200; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Yazaki-Sugiyama Y, 2009, NATURE, V462, P218, DOI 10.1038/nature08485; Young NA, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00027	74	11	12	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP	2017	34	17					2504	2517		10.1089/neu.2017.4977			14	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	FE6HI	WOS:000408310200003	28463587	Green Accepted			2021-06-18	
J	El-Dessouki, AM; Galal, MA; Awad, AS; Zaki, HF				El-Dessouki, Ahmed M.; Galal, Mai A.; Awad, Azza S.; Zaki, Hala F.			Neuroprotective Effects of Simvastatin and Cilostazol in L-Methionine-Induced Vascular Dementia in Rats	MOLECULAR NEUROBIOLOGY			English	Article						Vascular dementia; L-methionine; Simvastatin; Cilostazol; Oxidative stress; Acetylcholinesterase	FOCAL CEREBRAL-ISCHEMIA; NF-KAPPA-B; TRAUMATIC BRAIN-INJURY; SMOOTH-MUSCLE-CELLS; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; BLOOD-FLOW; CEREBROVASCULAR-DISEASE; ENDOTHELIAL FUNCTION; CEREBROSPINAL-FLUID	Vascular dementia (VaD) is a degenerative cerebrovascular disorder that leads to progressive decline in cognitive abilities and memory. Several reports demonstrated that oxidative stress and endothelial dysfunction are principal pathogenic factors in VaD. The present study was constructed to determine the possible neuroprotective effects of simvastatin in comparison with cilostazol in VaD induced by l-methionine in rats. Male Wistar rats were divided into four groups. Group I (control group), group II received l-methionine (1.7 g/kg, p.o.) for 32 days. The remaining two groups received simvastatin (50 mg/kg, p.o.) and cilostazol (100 mg/kg, p.o.), respectively, for 32 days after induction of VaD by l-methionine. Subsequently, rats were tested for cognitive performance using Morris water maze test then sacrificed for biochemical and histopathological assays. l-methionine induced VaD reflected by alterations in rats' behavior as well as the estimated neurotransmitters, acetylcholinesterase activity as well as increased brain oxidative stress and inflammation parallel to histopathological changes in brain tissue. Treatment of rats with simvastatin ameliorated l-methionine-induced behavioral, neurochemical, and histological changes in a manner comparable to cilostazol. Simvastatin may be regarded as a potential therapeutic strategy for the treatment of VaD. To the best of our knowledge, this is the first study to reveal the neuroprotective effects of simvastatin or cilostazol in l-methionine-induced VaD.	[Galal, Mai A.; Zaki, Hala F.] Cairo Univ, Dept Pharmacol & Toxicol, Fac Pharm, Cairo 11562, Egypt; [El-Dessouki, Ahmed M.; Awad, Azza S.] Ahram Canadian Univ, Dept Pharmacol & Toxicol, Fac Pharm, 6 October,4th Ind Area, Giza 12566, Egypt	El-Dessouki, AM; Awad, AS (corresponding author), Ahram Canadian Univ, Dept Pharmacol & Toxicol, Fac Pharm, 6 October,4th Ind Area, Giza 12566, Egypt.	a_desoky88@yahoo.com; azza_mohie@hotmail.com; halafzaki@gmail.com		Zaki, Hala/0000-0001-9026-4015			Abbas AM, 2013, J PHYSIOL BIOCHEM, V69, P737, DOI 10.1007/s13105-013-0250-y; Akyol S, 2014, REDOX REP, V19, P180, DOI 10.1179/1351000214Y.0000000094; ALLAIN CC, 1974, CLIN CHEM, V20, P470; Allard P, 1999, DEMENT GERIATR COGN, V10, P77, DOI 10.1159/000017105; Arai H, 2009, AM J GERIAT PSYCHIAT, V17, P353, DOI 10.1097/JGP.0b013e31819431ea; ARMSTRONG D, 1994, ADV EXP MED BIOL, V366, P43; Association AD, 2014, PER ART DIS PEOPL DI; Aviles H, 2005, NEUROIMMUNOMODULAT, V12, P173, DOI 10.1159/000084850; BEUTLER E, 1963, J LAB CLIN MED, V61, P882; Burn DJ, 2014, NONMOTOR SYMPTOMS PA, V158; Cervellati C, 2014, J NEUROL SCI, V337, P156, DOI 10.1016/j.jns.2013.11.041; Chen CT, 2014, J CEREBR BLOOD F MET, V34, P376, DOI 10.1038/jcbfm.2013.221; Chen F, 1999, CLIN CHEM, V45, P7; Choi JM, 2002, J PHARMACOL EXP THER, V300, P787, DOI 10.1124/jpet.300.3.787; Cimino A, 2005, NEUROTOXICOLOGY, V26, P929, DOI 10.1016/j.neuro.2005.03.009; Cui X, 2009, NEUROSCIENCE, V159, P744, DOI 10.1016/j.neuroscience.2008.12.055; Dai XM, 2010, CIRC RES, V106, P1870, DOI 10.1161/CIRCRESAHA.109.212746; DENBLAAUWEN DH, 1983, J CLIN CHEM CLIN BIO, V21, P381; Di Paolo G, 2011, NAT REV NEUROSCI, V12, P284, DOI 10.1038/nrn3012; Duron E, 2008, VASC HEALTH RISK MAN, V4, P363; Elliott MS, 2009, BRAIN; Elrod R, 1997, AM J PSYCHIAT, V154, P25; Eskdale J, 1997, IMMUNOGENETICS, V46, P120, DOI 10.1007/s002510050250; Fassbender K, 2001, P NATL ACAD SCI USA, V98, P5856, DOI 10.1073/pnas.081620098; Frick M, 2003, ATHEROSCLEROSIS, V170, P229, DOI 10.1016/S0021-9150(03)00299-5; Frisardi V, 2010, AGEING RES REV, V9, P399, DOI 10.1016/j.arr.2010.04.007; Gloire G, 2006, BIOCHEM PHARMACOL, V72, P1493, DOI 10.1016/j.bcp.2006.04.011; Gupta S, 2014, EUR J PHARMACOL, V723, P80, DOI 10.1016/j.ejphar.2013.12.003; Hase Y, 2012, EXP NEUROL, V233, P523, DOI 10.1016/j.expneurol.2011.11.038; Hiramatsu M, 2010, BRIT J PHARMACOL, V161, P1899, DOI 10.1111/j.1476-5381.2010.01014.x; Ho PI, 2001, J NEUROCHEM, V78, P249, DOI 10.1046/j.1471-4159.2001.00384.x; Honda F, 2006, STROKE, V37, P223, DOI 10.1161/01.STR.0000196977.76702.6d; Jasinska M, 2007, PHARMACOL REP, V59, P483; Jefferies H, 2003, ANZ J SURG, V73, P517, DOI 10.1046/j.1445-1433.2003.02682.x; Jeynes B, 2009, NEUROSCI LETT, V463, P244, DOI 10.1016/j.neulet.2009.07.091; Keil U, 2004, POL J PHARMACOL, V56, P631; Kepe V, 2006, P NATL ACAD SCI USA, V103, P702, DOI 10.1073/pnas.0510237103; Kim KY, 2002, J PHARMACOL EXP THER, V300, P709, DOI 10.1124/jpet.300.2.709; Kobori N, 2006, J NEUROTRAUM, V23, P1094, DOI 10.1089/neu.2006.23.1094; Kou JH, 2010, BRAIN RES, V1356, P102, DOI 10.1016/j.brainres.2010.07.102; Lee JH, 2006, BRAIN RES, V1082, P182, DOI 10.1016/j.brainres.2006.01.088; Lee JH, 2003, BRAIN RES, V994, P91, DOI 10.1016/j.brainres.2003.09.021; Leeson CPM, 2002, CIRC RES, V90, P1153, DOI 10.1161/01.RES.0000020562.07492.D4; Margaritis M, 2014, ANTIOXID REDOX SIGN, V20, P1198, DOI 10.1089/ars.2013.5430; Mathew JS, 2001, J VET DIAGN INVEST, V13, P17, DOI 10.1177/104063870101300104; McKay A, 2004, J IMMUNOL, V172, P2903, DOI 10.4049/jimmunol.172.5.2903; Mendoza-Oliva A, 2013, CNS NEUROL DISORD-DR, V12, P842, DOI 10.2174/18715273113129990083; Moreira ELG, 2015, DIET NUTR DEMENTIA C, P743; Obeid R, 2006, FEBS LETT, V580, P2994, DOI 10.1016/j.febslet.2006.04.088; Parle M., 2004, Asia Pacific Journal of Pharmacology, V16, P101; Perna AF, 2003, AMINO ACIDS, V25, P409, DOI 10.1007/s00726-003-0026-8; Qi XF, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.44; Rauch BJ, 2014, MOL MICROBIOL, V94, P1330, DOI 10.1111/mmi.12832; Reischl S, 2014, INHIBITION HIF PROLY; Saito S, 2014, HEPATOL RES, V44, P460, DOI 10.1111/hepr.12140; Sakurai H, 2013, GERIATR GERONTOL INT, V13, P90, DOI 10.1111/j.1447-0594.2012.00866.x; Sato A, 2004, NEUROSCI LETT, V361, P90, DOI 10.1016/j.neulet.2004.01.004; Sato A, 2001, INT J DEV NEUROSCI, V19, P327, DOI 10.1016/S0736-5748(01)00017-X; Shabanzadeh AP, 2005, BRAIN RES, V1042, P1, DOI 10.1016/j.brainres.2005.01.105; Sharma B, 2012, PROG NEURO-PSYCHOPH, V38, P207, DOI 10.1016/j.pnpbp.2012.03.013; Simard M, 2015, J NEUROPSYCHIATRY CL; Song GH, 2005, NEUROGASTROENT MOTIL, V17, P744, DOI 10.1111/j.1365-2982.2005.00653.x; Surh YJ, 2001, MUTAT RES-FUND MOL M, V480, P243, DOI 10.1016/S0027-5107(01)00183-X; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Tan XL, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0020-0; Toda Y, 2014, NEUROL RES, V36, P1011, DOI 10.1179/1743132814Y.0000000389; TOHGI H, 1992, J NEURAL TRANSM-PARK, V4, P69, DOI 10.1007/BF02257623; Tong XK, 2015, J CEREBR BLOOD F MET, V35, P512, DOI 10.1038/jcbfm.2014.226; Tramontina AC, 2011, J NEURAL TRANSM, V118, P1641, DOI 10.1007/s00702-011-0680-z; Ullrich C, 2010, MOL CELL NEUROSCI, V45, P408, DOI 10.1016/j.mcn.2010.08.001; Ungureanu Didona, 2003, Rev Med Chir Soc Med Nat Iasi, V107, P66; Venihaki M, 2001, J CLIN INVEST, V108, P1159, DOI 10.1172/JCI200112869; Wang KW, 2014, ANN CLIN LAB SCI, V44, P145; Wang R, 1996, J BIOL CHEM, V271, P31894, DOI 10.1074/jbc.271.50.31894; Wang X, 2012, J MOL CELL CARDIOL, V52, P753, DOI 10.1016/j.yjmcc.2011.12.009; Yuzawa Izumi, 2008, J Stroke Cerebrovasc Dis, V17, P281, DOI 10.1016/j.jstrokecerebrovasdis.2008.03.007; Zhang L, 2006, CELL BIOL INT, V30, P592, DOI 10.1016/j.cellbi.2006.03.007	77	11	11	0	12	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	SEP	2017	54	7					5074	5084		10.1007/s12035-016-0051-8			11	Neurosciences	Neurosciences & Neurology	FC0BO	WOS:000406503500019	27544235				2021-06-18	
J	Elliott, TR; Hsiao, YY; Kimbrel, NA; Meyer, E; DeBeer, BB; Gulliver, SB; Kwok, OM; Morissette, SB				Elliott, Timothy R.; Hsiao, Yu-Yu; Kimbrel, Nathan A.; Meyer, Eric; DeBeer, Bryann B.; Gulliver, Suzy Bird; Kwok, Oi-Man; Morissette, Sandra B.			Resilience and Traumatic Brain Injury Among Iraq/Afghanistan War Veterans: Differential Patterns of Adjustment and Quality of Life	JOURNAL OF CLINICAL PSYCHOLOGY			English	Article						Resilience; PTSD; depression; combat exposure; traumatic brain injury	POSTTRAUMATIC-STRESS-DISORDER; ACTION QUESTIONNAIRE-II; PSYCHOLOGICAL RESILIENCE; PSYCHOMETRIC PROPERTIES; PERSONALITY PROTOTYPES; LONGITUDINAL EVIDENCE; MENTAL-HEALTH; SYMPTOMS; PTSD; DEPLOYMENT	Objective: We examined the degree to which a resilient personality prototype predicted adjustment among war Veterans with and without a traumatic brain injury (TBI) while covarying the level of combat exposure. Method: A total of 127 war Veterans (107 men, 20 women; average age = 37 years) participated. Personality prototypes were derived from the Multidimensional Personality Questionnaire (Patrick, Curtain, & Tellegen, 2002). Measures were administered at baseline, and a subset was administered at 4-and 8-month follow-ups. Results: Veterans with resilient personalities reported less sleep disturbance, more health-promoting behaviors, psychological flexibility, and emotional distress tolerance than Veterans with undercontrolled or overcontrolled prototypes. Path models revealed that resilience significantly predicted posttraumatic stress disorder (PTSD), depression, quality of life, and social support over time. TBI had unique and consistent effects only on PTSD. Conclusion: Personality characteristics influence distress and quality of life among war Veterans with and without TBI. Implications for assessment, interventions, and research are discussed. (C) 2016 Wiley Periodicals, Inc.	[Elliott, Timothy R.; Hsiao, Yu-Yu; Kwok, Oi-Man] Texas A&M Univ, College Stn, TX 77843 USA; [Kimbrel, Nathan A.] Durham Vet Affairs Med Ctr, Durham, NC USA; [Kimbrel, Nathan A.] VA Midatlantic Mental Illness Res, Educ Clin Ctr, Washington, DC USA; [Kimbrel, Nathan A.] Duke Univ, Med Ctr, Durham, NC 27706 USA; [Meyer, Eric; DeBeer, Bryann B.] Cent Texas Vet Healthcare Syst, VA VISN Ctr Excellence Res Returning War Vet 17, Temple, TX USA; [Meyer, Eric; DeBeer, Bryann B.; Gulliver, Suzy Bird] Texas A&M Univ, Hlth Sci Ctr, College Stn, TX 77843 USA; [Gulliver, Suzy Bird] Baylor Scott & White Hlth, Warrior Res Inst, Dallas, TX USA; [Morissette, Sandra B.] Univ Texas San Antonio, San Antonio, TX USA	Elliott, TR (corresponding author), Dept Educ Psychol, College Stn, TX 77843 USA.	telliott@tamu.edu	Elliott, Timothy R./I-5301-2012; Gulliver, Suzy/X-9776-2019	Elliott, Timothy R./0000-0002-6608-7714; Kwok, Oiman/0000-0002-4617-4562; Gulliver, Suzy Bird/0000-0002-6476-9447	Rehabilitation Research and Development (RD) Service [I01RX000304-01, I01RX000304-04]; Clinical Science R&D Service of the VA Office of RD [1IK2 CX000525]; Veterans AffairsUS Department of Veterans Affairs [I01RX000304, IK2CX000525] Funding Source: NIH RePORTER	This research was supported by Merit Award #I01RX000304-01 to Dr. Morissette and #I01RX000304-04 to Dr. Meyer and Morissette from the Rehabilitation Research and Development (R&D) Service. Dr. Kimbrel was supported by a Career Development Award (#1IK2 CX000525) from the Clinical Science R&D Service of the VA Office of R&D. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the United States government.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Armed Forces Health Surveillance Center, 2011, DOD NUMB TRAUM BRAIN; Asendorpf JB, 2001, EUR J PERSONALITY, V15, P169, DOI 10.1002/per.408; Bahraini NH, 2014, PSYCHIAT CLIN N AM, V37, P55, DOI 10.1016/j.psc.2013.11.002; Bailie JM, 2016, J HEAD TRAUMA REHAB, V31, P2, DOI 10.1097/HTR.0000000000000142; Beck A. T., 1996, BECK DEPRESSION INVE, VII; Berry JW, 2007, J PERS ASSESS, V89, P292, DOI 10.1080/00223890701629813; Berry JW, 2009, J PERS, V77, P1381, DOI 10.1111/j.1467-6494.2009.00586.x; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Block J, 1996, J PERS SOC PSYCHOL, V70, P349, DOI 10.1037/0022-3514.70.2.349; Block J., 1993, STUDYING LIVES TIME, P9, DOI DOI 10.1037/10127-018; Block J. H., 1980, MINNESOTA S CHILD PS, V13, P39; Bonanno GA, 2012, BRIT J PSYCHIAT, V200, P317, DOI 10.1192/bjp.bp.111.096552; Bond FW, 2011, BEHAV THER, V42, P676, DOI 10.1016/j.beth.2011.03.007; Brickell TA, 2014, MIL MED, V179, P827, DOI 10.7205/MILMED-D-13-00506; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; BROWNE MW, 1992, SOCIOL METHOD RES, V21, P230, DOI 10.1177/0049124192021002005; BURCKHARDT CS, 1989, RES NURS HEALTH, V12, P347, DOI 10.1002/nur.4770120604; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Carlson K, 2009, ASSESSMENT TREATMENT; Caruso D, 2014, J REHABIL RES DEV, V51, P1103, DOI 10.1682/JRRD.2013.05.0119; Carver CS, 1997, INT J BEHAV MED, V4, P92, DOI 10.1207/s15327558ijbm0401_6; CASPI A, 1995, CHILD DEV, V66, P486, DOI 10.1111/j.1467-8624.1995.tb00885.x; Chapman BP, 2011, J PERS SOC PSYCHOL, V101, P593, DOI 10.1037/a0024289; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Davydov DM, 2010, CLIN PSYCHOL REV, V30, P479, DOI 10.1016/j.cpr.2010.03.003; Denissen JJA, 2008, J PERS, V76, P67, DOI 10.1111/j.1467-6494.2007.00480.x; Denning Laura, 2014, PREVENTING PSYCHOL D; Dretsch MN, 2015, J NEUROTRAUM, V32, P1301, DOI 10.1089/neu.2014.3810; EFRON B, 1988, PSYCHOL BULL, V104, P293; Elliott T., 2016, ASSESSMENT HLTH PSYC, P201; Elliott TR, 2015, REHABIL PSYCHOL, V60, P263, DOI 10.1037/rep0000050; Fletcher D, 2013, EUR PSYCHOL, V18, P12, DOI 10.1027/1016-9040/a000124; Forbes D, 2001, BEHAV RES THER, V39, P977, DOI 10.1016/S0005-7967(00)00084-X; Fulton JJ, 2015, J ANXIETY DISORD, V31, P98, DOI 10.1016/j.janxdis.2015.02.003; Garden N, 2010, NEUROPSYCHOLOGY, V24, P168, DOI 10.1037/a0017431; Green KT, 2014, ASSESSMENT, V21, P443, DOI 10.1177/1073191114524014; Grosso JA, 2014, J TRAUMA STRESS, V27, P478, DOI 10.1002/jts.21943; Hayes SC, 2004, PSYCHOL REC, V54, P553, DOI 10.1007/BF03395492; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Kazis LE, 2006, J AMBUL CARE MANAG, V29, P310, DOI 10.1097/00004479-200610000-00007; Kennedy JE, 2015, ARCH CLIN NEUROPSYCH, V30, P236, DOI 10.1093/arclin/acv014; King LA, 2006, MIL PSYCHOL, V18, P89, DOI 10.1207/s15327876mp1802_1; Kinnunen ML, 2012, SCAND J PSYCHOL, V53, P512, DOI 10.1111/j.1467-9450.2012.00969.x; Kline R.B., 2005, PRINCIPLES PRACTICE, V2nd; Kruse M. I., 2008, THESIS; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lange RT, 2014, ARCH CLIN NEUROPSYCH, V29, P329, DOI 10.1093/arclin/acu013; Lee JEC, 2015, PSYCHOSOM MED, V77, P1006, DOI 10.1097/PSY.0000000000000250; Losoi H, 2015, J NEUROTRAUM, V32, P942, DOI 10.1089/neu.2014.3799; McCauley SR, 2013, J NEUROTRAUM, V30, P642, DOI 10.1089/neu.2012.2393; Merritt VC, 2015, BRAIN INJURY, V29, P1325, DOI 10.3109/02699052.2015.1043948; Meyer EC, 2013, PSYCHOL TRAUMA-US, V5, P521, DOI 10.1037/a0030178; Miskey HM, 2015, BRAIN IMAGING BEHAV, V9, P461, DOI 10.1007/s11682-015-9391-7; Morissette SB, 2011, REHABIL PSYCHOL, V56, P340, DOI 10.1037/a0025462; Muthen L.K., 2013, MPLUS USERS GUIDE, V7th ed.; Ong AD, 2010, PSYCHOL AGING, V25, P516, DOI 10.1037/a0019384; Ong AD, 2009, J PERS, V77, P1777, DOI 10.1111/j.1467-6494.2009.00600.x; Panayiotou A, 2010, J CLIN EXP NEUROPSYC, V32, P463, DOI 10.1080/13803390903164371; Patrick CJ, 2002, PSYCHOL ASSESSMENT, V14, P150, DOI 10.1037//1040-3590.14.2.150; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Robins RW, 1996, J PERS SOC PSYCHOL, V70, P157, DOI 10.1037/0022-3514.70.1.157; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Steca P, 2010, PERS INDIV DIFFER, V48, P442, DOI 10.1016/j.paid.2009.11.016; Steenkamp MM, 2013, AM J PREV MED, V44, P507, DOI 10.1016/j.amepre.2013.01.013; Sullivan KA, 2015, REHABIL PSYCHOL, V60, P147, DOI 10.1037/rep0000037; Sumpter RE, 2006, BRAIN INJURY, V20, P93, DOI 10.1080/02699050500394090; Telch M. J., 2016, DISTRESS TOLERANCE I; Tibshirani, 1994, INTRO BOOTSTRAP, DOI 10.1201/9780429246593; Tsai J, 2012, PSYCHIATRY, V75, P135, DOI 10.1521/psyc.2012.75.2.135; Vanderploeg RD, 2012, ARCH PHYS MED REHAB, V93, P1887, DOI 10.1016/j.apmr.2012.05.024; Vogt DS, 2008, ASSESSMENT, V15, P381, DOI 10.1177/1073191108316030; Walker S, 1995, HLTH PROMOTING LIFES; Walsh MV, 2016, ARCH PHYS MED REHAB, V97, P781, DOI 10.1016/j.apmr.2016.01.016; Weathers F. W., 1993, ANN M INT SOC TRAUMA; Weston R, 2008, REHABIL PSYCHOL, V53, P340, DOI 10.1037/a0013039; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604; Windle G, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-8; Yu C. Y, 2002, Evaluating Cutoff Criteria of Model Fit Indices For Latent Variable Models With Binary and Continuous Outcomes	84	11	12	2	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-9762	1097-4679		J CLIN PSYCHOL	J. Clin. Psychol.	SEP	2017	73	9					1160	1178		10.1002/jclp.22414			19	Psychology, Clinical	Psychology	FG2ER	WOS:000409896400011	27922725	Green Accepted			2021-06-18	
J	Hernandez, MC; Thiels, CA; Aho, JM; Habermann, EB; Zielinski, MD; Stubbs, JA; Jenkins, DH; Zietlow, SP				Hernandez, Matthew C.; Thiels, Cornelius A.; Aho, Johnathon M.; Habermann, Elizabeth B.; Zielinski, Martin D.; Stubbs, James A.; Jenkins, Donald H.; Zietlow, Scott P.			Prehospital plasma resuscitation associated with improved neurologic outcomes after traumatic brain injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Traumatic brain injury; GOSE; prehospital; resuscitation; blood product	FRESH-FROZEN PLASMA; LARGE ANIMAL-MODEL; UNITED-STATES; BLOOD-TRANSFUSIONS; COAGULOPATHY; EXPERIENCE; RATIONALE; PLATELETS; FIELD; SHOCK	BACKGROUND: Trauma-related hypotension and coagulopathy worsen secondary brain injury in patients with traumatic brain injuries (TBIs). Early damage control resuscitation with blood products may mitigate hypotension and coagulopathy. Preliminary data suggest resuscitation with plasma in large animals improves neurologic function after TBI; however, data in humans are lacking. METHODS: We retrospectively identified all patients with multiple injuries age > 15 years with head injuries undergoing prehospital resuscitation with blood products at a single Level I trauma center from January 2002 to December 2013. Inclusion criteria were prehospital resuscitation with either packed red blood cells (pRBCs) or thawed plasma as sole colloid resuscitation. Patients who died in hospital and those using anticoagulants were excluded. Primary outcomes were Glasgow Outcomes Score Extended (GOSE) and Disability Rating Score (DRS) at dismissal and during follow-up. RESULTS: Of 76 patients meeting inclusion criteria, 53% (n = 40) received prehospital pRBCs and 47%(n = 36) received thawed plasma. Age, gender, injury severity or TBI severity, arrival laboratory values, and number of prehospital units were similar (all p > 0.05). Patients who received thawed plasma had an improved neurologic outcome compared to those receiving pRBCs (median GOSE 7 [7-8] vs. 5.5 [3-7], p < 0.001). Additionally, patients who received thawed plasma had improved functionality compared to pRBCs (median DRS 2 [1-3.5] vs. 9 [3-13], p < 0.001). Calculated GOSE and DRS scores during follow-up, median 6 [5-7] months, demonstrated increased function in those resuscitated with thawed plasma compared to pRBCs by both median GOSE (8 [7-8] vs. 6 [6-7], p < 0.001) and DRS (0 [0-1] vs. 4 [2-8], p < 0.001). CONCLUSION: In critically injured trauma patients with TBI, early resuscitation with thawed plasma is associated with improved neurologic and functional outcomes at discharge and during follow-up compared to pRBCs alone. These preliminary data support the further investigation and use of plasma in the resuscitation of critically injured TBI patients. (Copyright (C) 2017 Wolters Kluwer Health, Inc. All rights reserved.)	[Hernandez, Matthew C.; Aho, Johnathon M.; Zielinski, Martin D.; Jenkins, Donald H.; Zietlow, Scott P.] Mayo Clin, Dept Surg, Rochester, MN 55905 USA; [Thiels, Cornelius A.; Habermann, Elizabeth B.] Mayo Clin, Div Trauma Crit Care & Gen Surg, Robert D & Patricia E Kern Ctr Sci Hlth Care Deli, Rochester, MN 55905 USA; [Stubbs, James A.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN 55905 USA	Hernandez, MC (corresponding author), Mayo Clin, Div Trauma Crit Care & Gen Surg, Dept Surg, 200 First St SW, Rochester, MN 55905 USA.	hernandez.matthew@mayo.edu		Habermann, Elizabeth/0000-0002-1140-003X	Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery; CTSAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2 TR000136]; National Heart, Lung, and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [T32 HL105355]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR000136] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [T32HL105355] Funding Source: NIH RePORTER	Support provided by the Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery (C.A.T. and E.B.H.), CTSA grant KL2 TR000136 (M.D.Z.), and by the National Heart, Lung, and Blood Institute T32 HL105355 (J.M.A.).	Bhangu A, 2013, INJURY, V44, P1693, DOI 10.1016/j.injury.2012.07.193; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS7; Brohi K, 2008, J TRAUMA, V64, P1211, DOI 10.1097/TA.0b013e318169cd3c; Brown JB, 2015, PREHOSP EMERG CARE, V19, P343, DOI 10.3109/10903127.2014.995851; Chapman MP, 2015, SHOCK, V44, P63, DOI 10.1097/SHK.0000000000000376; Cohan MJ, 2007, J TRAUMA, V63, P1254, DOI 10.1097/TA.0b013e318156ee4c; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Cuthbert JP, 2015, J HEAD TRAUMA REHAB, V30, P160, DOI 10.1097/HTR.0000000000000090; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2001, DOI 10.1089/neu.2013.3047; del Junco DJ, 2013, J TRAUMA ACUTE CARE, V75, pS24, DOI 10.1097/TA.0b013e31828fa3b9; DITUNNO JF, 1992, J NEUROTRAUM, V9, pS301; Epstein DS, 2015, BRIT J NEUROSURG, V29, P118, DOI 10.3109/02688697.2014.950632; Epstein DS, 2016, J CLIN NEUROSCI, V29, P64, DOI 10.1016/j.jocn.2015.11.024; Epstein DS, 2014, INJURY, V45, P819, DOI 10.1016/j.injury.2014.01.011; Halaweish I, 2015, J AM COLL SURGEONS, V220, P809, DOI 10.1016/j.jamcollsurg.2015.01.057; Higgins GL, 2012, PREHOSP DISASTER MED, V27, P231, DOI 10.1017/S1049023X12000659; Imam AM, 2013, J TRAUMA ACUTE CARE, V75, P976, DOI 10.1097/TA.0b013e31829e2186; Jenkins D, 2014, SHOCK, V41, P84, DOI 10.1097/SHK.0000000000000133; King JT, 2005, J NEUROTRAUM, V22, P947, DOI 10.1089/neu.2005.22.947; Maegele M, 2010, WORLD J EMERG MED, V1, P12; Mitra B, 2010, INJURY, V41, P35, DOI 10.1016/j.injury.2009.09.029; Moore HB, 2015, J AM COLL SURGEONS, V220, P872, DOI 10.1016/j.jamcollsurg.2015.01.026; Novak DJ, 2015, TRANSFUSION, V55, P1331, DOI 10.1111/trf.13098; Peiniger S, 2011, CRIT CARE, V15, DOI 10.1186/cc10048; Riskin DJ, 2009, J AM COLL SURGEONS, V209, P198, DOI 10.1016/j.jamcollsurg.2009.04.016; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Savage SA, 2015, J TRAUMA ACUTE CARE, V78, P224, DOI 10.1097/TA.0000000000000502; Schrieber M, 2007, J TRAUMA, V63, P1261; Sillesen M, 2017, J AM COLL SURGEONS, V224, P49, DOI 10.1016/j.jamcollsurg.2016.09.015; Sillesen M, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/s13049-014-0046-2; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Thiels CA, 2016, WORLD J SURG, V40, P2297, DOI 10.1007/s00268-016-3572-4; Wilson JTL, 2000, J NEUROL NEUROSUR PS, V69, P204, DOI 10.1136/jnnp.69.2.204	35	11	11	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	SEP	2017	83	3					398	405		10.1097/TA.0000000000001581			8	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	FF0ET	WOS:000408575700008	28538641	Green Accepted			2021-06-18	
J	Hinson, HE; Schreiber, MA; Laurie, AL; Baguley, IJ; Bourdette, D; Ling, GSF				Hinson, Holly E.; Schreiber, Martin A.; Laurie, Amber L.; Baguley, Ian J.; Bourdette, Dennis; Ling, Geoffrey S. F.			Early Fever As a Predictor of Paroxysmal Sympathetic Hyperactivity in Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						autonomic instability; fever; paroxysmal sympathetic hyperactivity; sympathetic storms; traumatic brain injury	DIAGNOSTIC-CRITERIA; DYSAUTONOMIA; STROKE; IMPACT	Objective: Paroxysmal sympathetic hyperactivity (PSH) is characterized by episodic, hyperadrenergic alterations in vital signs after traumatic brain injury (TBI). We sought to apply an objective scale to the vital sign alterations of PSH in order to determine whether 1 element might be predictive of developing PSH. Setting/Participants/Design: We conducted an observational study of consecutive TBI patients (Glasgow Coma Scale score <= 12) and monitored the cohort for clinical evidence of PSH. PSH was defined as a paroxysm of 3 or more of the following characteristics: (1) tachycardia, (2) tachypnea, (3) hypertension, (4) fever, (5) dystonia (rigidity or decerebrate posturing), and (6) diaphoresis, with no other obvious causation (ie, alcohol withdrawal, sepsis). Main Measures: TheModified Clinical Feature Severity Scale (mCFSS) was applied to each participant once daily for the first 5 days of hospitalization. Results: Nineteen (11%) of the 167 patients met criteria for PSH. Patients with PSH had a higher 5-day cumulative mCFSS score than those without PSH (median [interquartile range] = 36 [29-42] vs 29 [22-35], P = .01). Of the 4 components of the mCFSS, elevated temperature appeared to be most predictive of the development of PSH, especially during the first 24 hours (odds ratio = 1.95; 95% confidence interval, 1.12-3.40). Conclusion: Early fever after TBI may signal impending autonomic dysfunction.	[Hinson, Holly E.; Bourdette, Dennis] Oregon Hlth & Sci Univ, Dept Neurol, 3181 SW Sam Jackson Pk Rd,CR-127, Portland, OR 97239 USA; [Hinson, Holly E.; Laurie, Amber L.] Oregon Hlth & Sci Univ, Dept Emergency Med, 3181 SW Sam Jackson Pk Rd,CR-127, Portland, OR 97239 USA; [Schreiber, Martin A.] Oregon Hlth & Sci Univ, Dept Trauma Crit Care & Acute Surg, Portland, OR 97201 USA; [Baguley, Ian J.] Westmead Hosp, Brain Injury Rehabil Serv, Sydney, NSW, Australia; [Ling, Geoffrey S. F.] Def Adv Res Projects Agcy, Biol Technol Off, Bethesda, MD USA	Hinson, HE (corresponding author), Oregon Hlth & Sci Univ, Dept Neurol, 3181 SW Sam Jackson Pk Rd,CR-127, Portland, OR 97239 USA.; Hinson, HE (corresponding author), Oregon Hlth & Sci Univ, Dept Emergency Med, 3181 SW Sam Jackson Pk Rd,CR-127, Portland, OR 97239 USA.	hinson@ohsu.edu	Baguley, Ian/AAM-5828-2021; Hinson, Holly/Q-2268-2019	Hinson, Holly/0000-0003-1598-9782	National Heart, Lung, and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [5K12HL108974-03]; Oregon Clinical and Translational Research Institute from the National Center for Advancing Translational Sciences at the National Institutes of Health (NIH) [UL1TR000128]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000128] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [K12HL108974] Funding Source: NIH RePORTER	The project described was supported in part by award no. 5K12HL108974-03 from the National Heart, Lung, and Blood Institute. This publication was supported by Oregon Clinical and Translational Research Institute, grant no. UL1TR000128, from the National Center for Advancing Translational Sciences at the National Institutes of Health (NIH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Heart, Lung, and Blood Institute or the NIH.	Baguley IJ, 2007, BRAIN INJURY, V21, P1175, DOI 10.1080/02699050701687375; Baguley IJ, 2014, J NEUROTRAUM, V31, P1515, DOI 10.1089/neu.2013.3301; Baguley IJ, 2008, SEMIN NEUROL, V28, P716, DOI 10.1055/s-0028-1105971; Greer DM, 2008, STROKE, V39, P3029, DOI 10.1161/STROKEAHA.108.521583; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Li J, 2012, J NEUROTRAUM, V29, P96, DOI 10.1089/neu.2011.1753; Lv LQ, 2011, J TRAUMA, V71, P538, DOI 10.1097/TA.0b013e31820ebee1; Lv LQ, 2010, J NEUROTRAUM, V27, P1945, DOI 10.1089/neu.2010.1391; MILHOLLAND AV, 1973, NEW ENGL J MED, V288, P1272, DOI 10.1056/NEJM197306142882405; Perkes IE, 2011, BRAIN INJURY, V25, P925, DOI 10.3109/02699052.2011.589797; Saxena M, 2015, INTENS CARE MED, V41, P823, DOI 10.1007/s00134-015-3676-6	11	11	12	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2017	32	5					E50	E54		10.1097/HTR.0000000000000271			5	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	FG2DW	WOS:000409893800006	28060200	Green Accepted			2021-06-18	
J	Pluta, A; Gawron, N; Sobanska, M; Wojcik, AD; Lojek, E				Pluta, Agnieszka; Gawron, Natalia; Sobanska, Marta; Wojcik, Adrian Dominik; Lojek, Emilia			The Nature of the Relationship Between Neurocognition and Theory of Mind Impairments in Stroke Patients	NEUROPSYCHOLOGY			English	Article						theory of mind; stroke; cognitive and affective components of theory of mind; cognitive function	CARD SORTING TEST; VENTROMEDIAL PREFRONTAL CORTEX; TRAUMATIC BRAIN-INJURY; EXECUTIVE FUNCTION; FRONTAL-LOBE; COGNITIVE THEORY; WORKING-MEMORY; ADULTS; TRAIL; SCHIZOPHRENIA	Objective: Theory of mind (ToM) is a complex, high-level cognitive function that allows people to infer the cognitive and affective mental states of others. Previous studies have produced limited and frequently contradictory findings on the neuropsychological underpinnings of ToM performance in patients with stroke. The aim of the present study is to investigate neuropsychological mechanisms of cognitive and affective theory of mind dysfunctions in patients with stroke. Method: Fifty-eight patients with stroke and 22 healthy controls matched in age, gender, and education level underwent robust neuropsychological examination of their pragmatic abilities, executive functions, attention, memory, psychomotor speed, and visuospatial abilities as well as a cognitive and affective ToM assessment. Results: Patients with stroke demonstrated impaired performance in all ToM tasks. While pragmatic competence and, to a lesser degree, executive functions had the strongest contribution to ToM impairments, attention and general cognitive functioning did not directly affect mentalizing abilities, as demonstrated by a path analysis. Our study reveals the different roles of cognitive functions in cognitive and affective components of ToM. Executive functions contributed only to the cognitive components of ToM. Conclusion: Deficits in cognitive aspects of ToM are best explained by impairment of pragmatic competence and executive functions. In contrast, executive dysfunction does not affect the ability to understand the affective mental states of others.	[Pluta, Agnieszka; Gawron, Natalia; Sobanska, Marta; Lojek, Emilia] Univ Warsaw, Fac Psychol, Warsaw, Poland; [Wojcik, Adrian Dominik] Nicolaus Copernicus Univ, Fac Humanities, Torun, Poland	Pluta, A (corresponding author), Stawki 5-7, Warsaw, Poland.	apluta@psych.uw.edu.pl	Gawron, Natalia/AAW-9718-2020; Sobanska, Marta/ABE-1807-2020; Wojcik, Adrian Dominik/I-5593-2019; Gawron, Natalia/H-4831-2013	Sobanska, Marta/0000-0003-4242-308X; Wojcik, Adrian Dominik/0000-0002-7073-6019; Gawron, Natalia/0000-0002-6052-1946	START Scholarship - Foundation for the Polish Science; Faculty of Psychology, University of Warsaw [BST 171203/2014, 174403/2015]; National Science Centre, PolandNational Science Centre, Poland [DEC-2014/15/B/HS6/03738]	Agnieszka Pluta was supported by the START Scholarship awarded by the Foundation for the Polish Science. Emilia Lojek was supported by Faculty of Psychology, University of Warsaw (BST 171203/2014 and 174403/2015). Adrian Dominik Wojcik was supported by the National Science Centre, Poland (Grant DEC-2014/15/B/HS6/03738).	Aboulafia-Brakha T, 2011, J NEUROPSYCHOL, V5, P39, DOI 10.1348/174866410X533660; Angeleri R, 2014, CAN J EXP PSYCHOL, V68, P133, DOI 10.1037/cep0000011; Apperly IA, 2006, SOC NEUROSCI-UK, V1, P334, DOI 10.1080/17470910601038693; Apperly IA, 2009, DEV PSYCHOL, V45, P190, DOI 10.1037/a0014098; Baez S, 2015, J NEUROPSYCHOL, V9, P203, DOI 10.1111/jnp.12046; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; Bejanin A, 2017, SOC NEUROSCI-UK, V12, P287, DOI 10.1080/17470919.2016.1168314; Bentler PM, 1999, MULTIVAR BEHAV RES, V34, P181, DOI 10.1207/S15327906Mb340203; BERMAN KF, 1995, NEUROPSYCHOLOGIA, V33, P1027, DOI 10.1016/0028-3932(95)00035-2; Bibby H, 2005, NEUROPSYCHOLOGIA, V43, P99, DOI 10.1016/j.neuropsychologia.2004.04.027; Bird CM, 2004, BRAIN, V127, P914, DOI 10.1093/brain/awh108; Brzezinski J, 2004, WECHSLER ADULT INTEL; Carlson SM, 2002, INFANT CHILD DEV, V11, P73, DOI 10.1002/icd.298; Champagne-Lavau M, 2009, J NEUROLINGUIST, V22, P413, DOI 10.1016/j.jneuroling.2009.02.002; Charlton RA, 2009, PSYCHOL AGING, V24, P338, DOI 10.1037/a0015225; Colle L, 2008, J AUTISM DEV DISORD, V38, P28, DOI 10.1007/s10803-007-0357-5; Corradi-Dell'Acqua C, 2014, SOC COGN AFFECT NEUR, V9, P1175, DOI 10.1093/scan/nst097; Couture SM, 2011, SCHIZOPHR RES, V125, P152, DOI 10.1016/j.schres.2010.09.020; Cummings L, 2011, PRAGMAT SOC, V2, P17, DOI 10.1075/ps.2.1.02cum; De Mulder H., 2015, J CHILD LANG, V42, P1; de Villiers JG, 2002, COGNITIVE DEV, V17, P1037, DOI 10.1016/S0885-2014(02)00073-4; de Villiers J, 2007, LINGUA, V117, P1858, DOI 10.1016/j.lingua.2006.11.006; Edwards JR, 2007, PSYCHOL METHODS, V12, P1, DOI 10.1037/1082-989X.12.1.1; Fernandez C, 2013, FIRST LANG, V33, P20, DOI 10.1177/0142723711422633; Fine C, 2001, BRAIN, V124, P287, DOI 10.1093/brain/124.2.287; Martin-Rodriguez JF, 2010, NEUROPSYCHOLOGIA, V48, P1181, DOI 10.1016/j.neuropsychologia.2010.02.009; Frank C Kobayashi, 2010, Open Neuroimag J, V4, P37, DOI 10.2174/1874440001004020037; Goodglass H., 1983, ASSESSMENT APHASIA R; Gordon ACL, 1998, J EXP CHILD PSYCHOL, V68, P70, DOI 10.1006/jecp.1997.2423; Greve KW, 1998, ARCH CLIN NEUROPSYCH, V13, P597; Guariglia P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099700; Hale CM, 2003, DEVELOPMENTAL SCI, V6, P346, DOI 10.1111/1467-7687.00289; Hynes CA, 2006, NEUROPSYCHOLOGIA, V44, P374, DOI 10.1016/j.neuropsychologia.2005.06.011; Jaworowska A., 2002, WISCONSIN CARD SORTI; Kalbe E, 2010, CORTEX, V46, P769, DOI 10.1016/j.cortex.2009.07.010; Karpinski J, 1990, CAUSALITY SOCIOLOGIC; KAWASAKI Y, 1993, SCHIZOPHR RES, V10, P109, DOI 10.1016/0920-9964(93)90045-K; Leopold A, 2012, SOC COGN AFFECT NEUR, V7, P871, DOI 10.1093/scan/nsr071; Lezak M.D., 2004, NEUROPSYCHOLOGICAL A, Vfourth; Li XM, 2013, INT J PSYCHOL, V48, P715, DOI 10.1080/00207594.2012.673724; Lojek E, 2009, INTERDISCIPLINARY CO, V1, P1; Lojek E., 2007, RIGHT HEMISPHERE LAN; Lojek E., 2012, COLOUR TRAIL MAKING; Lough S, 2006, NEUROPSYCHOLOGIA, V44, P950, DOI 10.1016/j.neuropsychologia.2005.08.009; Marcovitch S, 2015, COGNITIVE DEV, V33, P40, DOI 10.1016/j.cogdev.2014.07.001; McDonald S, 2014, NEUROPSYCHOLOGY, V28, P801, DOI 10.1037/neu0000089; Milligan K, 2007, CHILD DEV, V78, P622, DOI 10.1111/j.1467-8624.2007.01018.x; Mohammadzadeh A, 2016, ADHD-ATTEND DEFICIT, V8, P73, DOI 10.1007/s12402-015-0187-9; Muller F, 2010, CORTEX, V46, P1088, DOI 10.1016/j.cortex.2009.08.014; Newton AM, 2007, PSYCHOL SCI, V18, P574, DOI 10.1111/j.1467-9280.2007.01942.x; Oosterman JM, 2010, CLIN NEUROPSYCHOL, V24, P203, DOI 10.1080/13854040903482848; Orellana Gricel, 2013, Front Psychiatry, V4, P35, DOI 10.3389/fpsyt.2013.00035; Perner J, 1999, TRENDS COGN SCI, V3, P337, DOI 10.1016/S1364-6613(99)01362-5; Poletti M, 2012, NEUROSCI BIOBEHAV R, V36, P2147, DOI 10.1016/j.neubiorev.2012.07.004; Poletti M, 2011, BEHAV BRAIN RES, V219, P342, DOI 10.1016/j.bbr.2011.01.010; Polgar P, 2010, SCHIZOPHR RES, V122, P85, DOI 10.1016/j.schres.2010.06.007; Rouder JN, 2016, PSYCHOL METHODS; Rowe AD, 2001, BRAIN, V124, P600, DOI 10.1093/brain/124.3.600; Sabbagh MA, 2006, PSYCHOL SCI, V17, P74, DOI 10.1111/j.1467-9280.2005.01667.x; Salthouse TA, 2011, INTELLIGENCE, V39, P222, DOI 10.1016/j.intell.2011.03.001; Samson D, 2009, J NEUROPSYCHOL, V3, P3, DOI 10.1348/174866408X377883; Sanchez-Cubillo I, 2009, J INT NEUROPSYCH SOC, V15, P438, DOI 10.1017/S1355617709090626; Saxe R, 2006, BRAIN RES, V1079, P57, DOI 10.1016/j.brainres.2006.01.001; Saxe R., 2009, ENCY CONSCIOUSNESS, P401; Schlaffke L, 2015, HUM BRAIN MAPP, V36, P29, DOI 10.1002/hbm.22610; Sebastian CL, 2012, SOC COGN AFFECT NEUR, V7, P53, DOI 10.1093/scan/nsr023; Shamay-Tsoory SG, 2006, SOC NEUROSCI-UK, V1, P149, DOI 10.1080/17470910600985589; Shamay-Tsoory SG, 2007, NEUROPSYCHOLOGIA, V45, P3054, DOI 10.1016/j.neuropsychologia.2007.05.021; Siegal M, 2002, NAT REV NEUROSCI, V3, P463, DOI 10.1038/nrn844; Singer T, 2006, NEUROSCI BIOBEHAV R, V30, P855, DOI 10.1016/j.neubiorev.2006.06.011; Thoemmes F, 2015, BASIC APPL SOC PSYCH, V37, P226, DOI 10.1080/01973533.2015.1049351; Varley R, 2000, CURR BIOL, V10, P723, DOI 10.1016/S0960-9822(00)00538-8; Volz HP, 1997, PSYCHIAT RES-NEUROIM, V75, P145, DOI 10.1016/S0925-4927(97)00053-X; Wang ZW, 2013, PSYCHOL AGING, V28, P284, DOI 10.1037/a0030876; Wetzels R, 2012, AM STAT, V66, P104, DOI 10.1080/00031305.2012.695956; Xi CH, 2011, BEHAV BRAIN RES, V221, P587, DOI 10.1016/j.bbr.2010.09.031; Yeh ZT, 2014, PSYCHIAT CLIN NEUROS, V68, P612, DOI 10.1111/pcn.12173; Zakzanis KK, 2005, NEUROPSYCHOLOGIA, V43, P1878, DOI 10.1016/j.neuropsychologia.2005.03.013	78	11	11	0	12	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	SEP	2017	31	6					666	681		10.1037/neu0000379			16	Psychology, Clinical; Neurosciences; Psychology	Psychology; Neurosciences & Neurology	FT3IZ	WOS:000423042100008	28459255				2021-06-18	
J	Rajajee, V; Riggs, B; Seder, DB				Rajajee, Venkatakrishna; Riggs, Becky; Seder, David B.			Emergency Neurological Life Support: Airway, Ventilation, and Sedation	NEUROCRITICAL CARE			English	Article						Airway; Ventilation; Sedation; Neurocritical care; Emergency	INTENSIVE-CARE-UNIT; RAPID-SEQUENCE INTUBATION; CEREBRAL-BLOOD-FLOW; CRITICALLY-ILL PATIENTS; TRAUMATIC BRAIN-INJURY; DIFFICULT TRACHEAL INTUBATION; CERVICAL-SPINE MOTION; NASAL CANNULA OXYGEN; HEART-ASSOCIATION GUIDELINES; AWAKE FIBEROPTIC INTUBATION	Airway management and ventilation are central to the resuscitation of the neurologically ill. These patients often have evolving processes that threaten the airway and adequate ventilation. Furthermore, intubation, ventilation, and sedative choices directly affect brain perfusion. Therefore, Airway, Ventilation, and Sedation was chosen as an Emergency Neurological Life Support protocol. Topics include airway management, when and how to intubate with special attention to hemodynamics and preservation of cerebral blood flow, mechanical ventilation settings and the use of sedative agents based on the patient's neurological status.	[Rajajee, Venkatakrishna] Univ Michigan, Dept Neurosurg, Ann Arbor, MI 48109 USA; [Rajajee, Venkatakrishna] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA; [Riggs, Becky] Johns Hopkins Univ, Dept Pediat, Baltimore, MD 21218 USA; [Seder, David B.] Tufts Univ, Sch Med, Maine Med Ctr, Dept Crit Care Serv, Boston, MA 02111 USA	Rajajee, V (corresponding author), Univ Michigan, Dept Neurosurg, Ann Arbor, MI 48109 USA.; Rajajee, V (corresponding author), Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA.	vrajajee@yahoo.com; sederd@mmc.org	Seder, David B./M-4829-2019	Seder, David/0000-0002-9717-1038			Abel M, 2002, MT SINAI J MED, V69, P31; Abou-Chebl A, 2010, STROKE, V41, P1175, DOI 10.1161/STROKEAHA.109.574129; Al MJ, 2010, CRIT CARE, V14, DOI 10.1186/cc9313; Albanese J, 1997, ANESTHESIOLOGY, V87, P1328, DOI 10.1097/00000542-199712000-00011; Amer Soc Anesthesiologists, 2013, ANESTHESIOLOGY, V118, P251, DOI 10.1097/ALN.0b013e31827773b2; [Anonymous], 2009, P ANN M AM SOC AN NE; Austin Naola, 2014, Int J Crit Illn Inj Sci, V4, P50, DOI 10.4103/2229-5151.128013; Avitsian R, 2005, J NEUROSURG ANESTH, V17, P97, DOI 10.1097/01.ana.0000161268.01279.ba; Baillard C, 2006, AM J RESP CRIT CARE, V174, P171, DOI 10.1164/rccm.200509-1507OC; Balan IS, 2006, STROKE, V37, P3008, DOI 10.1161/01.STR.0000248455.73785.b1; Bar-Joseph G, 2009, J NEUROSURG-PEDIATR, V4, P40, DOI 10.3171/2009.1.PEDS08319; Barr J, 2013, CRIT CARE MED, V41, P263, DOI 10.1097/CCM.0b013e3182783b72; BEDFORD RF, 1980, ANESTH ANALG, V59, P435; Bellomo R, 2011, CRIT CARE, V15, DOI 10.1186/cc10090; Bennett SS, 2007, NEUROCRIT CARE, V7, P221, DOI 10.1007/s12028-007-0084-y; Bergen Joseph M., 1997, Journal of Emergency Medicine, V15, P221, DOI 10.1016/S0736-4679(96)00350-2; Bergeron N, 2001, INTENS CARE MED, V27, P859, DOI 10.1007/s001340100909; Bittigau P, 2002, P NATL ACAD SCI USA, V99, P15089, DOI 10.1073/pnas.222550499; Bosch J, 2014, EMERG MED J, V31, P750, DOI 10.1136/emermed-2012-202283; Bourgoin A, 2003, CRIT CARE MED, V31, P711, DOI 10.1097/01.CCM.0000044505.24727.16; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; Bray RJ, 1998, PAEDIATR ANAESTH, V8, P491; Brinjikji W, 2015, AM J NEURORADIOL, V36, P525, DOI 10.3174/ajnr.A4159; Brock-Utne JG, 2002, PAEDIATR ANAESTH, V12, P1, DOI 10.1046/j.1460-9592.2002.00824.x; Brook AD, 1999, CRIT CARE MED, V27, P2609, DOI 10.1097/00003246-199912000-00001; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Brown CA, 2010, ANN EMERG MED, V56, P83, DOI 10.1016/j.annemergmed.2010.01.033; Brown RL, 2001, J PEDIATR SURG, V36, P1107, DOI 10.1053/jpsu.2001.25665; Brucken A, 2010, RESUSCITATION, V81, P1698, DOI 10.1016/j.resuscitation.2010.06.027; Caricato A, 2005, J TRAUMA, V58, P571, DOI 10.1097/01.TA.0000152806.19198.DB; Carrera E, 2010, J NEUROL NEUROSUR PS, V81, P793, DOI 10.1136/jnnp.2009.174425; Chen HI, 2008, NEUROSURGERY, V63, P880, DOI 10.1227/01.NEU.0000327882.10629.06; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; Citerio Giuseppe, 2003, Curr Opin Crit Care, V9, P120, DOI 10.1097/00075198-200304000-00007; Coles JP, 2007, CRIT CARE MED, V35, P568, DOI 10.1097/01.CCM.0000254066.37187.88; Coles JP, 2002, CRIT CARE MED, V30, P1950, DOI 10.1097/00003246-200209000-00002; Collins JS, 2004, OBES SURG, V14, P1171, DOI 10.1381/0960892042386869; Collins SR, 2014, RESP CARE, V59, P865, DOI 10.4187/respcare.03012; Cook TM, 2015, BRIT J ANAESTH, V115, P497, DOI 10.1093/bja/aev156; Cook TM, 2011, BRIT J ANAESTH, V106, P632, DOI 10.1093/bja/aer059; Cook TM, 2011, BRIT J ANAESTH, V106, P617, DOI 10.1093/bja/aer058; Cooper RM, 2013, ANAESTHESIA, V68, P217, DOI 10.1111/anae.12139; Coplin WM, 2000, AM J RESP CRIT CARE, V161, P1530, DOI 10.1164/ajrccm.161.5.9905102; CORMACK RS, 1984, ANAESTHESIA, V39, P1105, DOI 10.1111/j.1365-2044.1984.tb08932.x; Cote C, 2009, PRACTICE ANESTHESIA, P237; Davis DP, 2005, J TRAUMA, V59, P484, DOI 10.1097/00005373-200508000-00037; Davis DP, 2006, CRIT CARE MED, V34, P1202, DOI 10.1097/01.CCM.0000208359.74623.1C; Davis DP, 2004, J TRAUMA, V56, P808, DOI 10.1097/01.TA.0000100217.05066.87; De Jong A, 2014, INTENS CARE MED, V40, P629, DOI 10.1007/s00134-014-3236-5; Deogaonkar A, 2004, CRIT CARE MED, V32, P2403, DOI 10.1097/01.CCM.0000147442.14921.A5; Devabhakthuni S, 2012, ANN PHARMACOTHER, V46, P530, DOI 10.1345/aph.1Q525; Dhakal LP, 2015, STROKE, V46, P1748, DOI 10.1161/STROKEAHA.115.008223; Diringer MN, 2002, J NEUROSURG, V96, P103, DOI 10.3171/jns.2002.96.1.0103; DONEGAN MF, 1980, ANESTHESIOLOGY, V52, P516, DOI 10.1097/00000542-198006000-00014; Downard C, 2000, J TRAUMA, V49, P654, DOI 10.1097/00005373-200010000-00012; Dumont TM, 2010, J NEUROTRAUM, V27, P1233, DOI 10.1089/neu.2009.1216; Dyer BA, 2013, CRIT CARE NURS Q, V36, P310, DOI 10.1097/CNQ.0b013e318294ea8f; ELIASJONES AC, 1992, ARCH DIS CHILD, V67, P1430, DOI 10.1136/adc.67.12.1430; Ellis DY, 2007, ANN EMERG MED, V50, P653, DOI 10.1016/j.annemergmed.2007.05.006; Elmer J, 2015, INTENS CARE MED, V41, P49, DOI 10.1007/s00134-014-3555-6; Ely EW, 2003, JAMA-J AM MED ASSOC, V289, P2983, DOI 10.1001/jama.289.22.2983; Erdman MJ, 2014, CRIT CARE MED, V42, P1696, DOI 10.1097/CCM.0000000000000328; Filanovsky Y, 2010, CAN J EMERG MED, V12, P154; Flandreau G, 2011, RESP CARE, V56, P953, DOI 10.4187/respcare.00862; Fraser GL, 2001, PHARMACOTHERAPY, V21, P1, DOI 10.1592/phco.21.1.1.34444; Freeman SS, 2008, ANESTHESIOLOGY, V108, P588, DOI 10.1097/ALN.0b013e31816725d7; Frerk C, 2015, BRIT J ANAESTH, V115, P827, DOI 10.1093/bja/aev371; Gabriel Edward J., 2002, Journal of Neurotrauma, V19, P111; Galinski M, 2006, ANN EMERG MED, V47, P545, DOI 10.1016/j.annemergmed.2005.08.012; Griesdale DEG, 2012, CAN J ANESTH, V59, P1032, DOI 10.1007/s12630-012-9775-8; Griesdale DEG, 2012, CAN J ANESTH, V59, P41, DOI 10.1007/s12630-011-9620-5; Grof TM, 2010, NEUROCRIT CARE, V12, P356, DOI 10.1007/s12028-008-9156-x; Gronert GA, 2001, ANESTHESIOLOGY, V94, P523, DOI 10.1097/00000542-200103000-00026; Hardman JG, 2003, ANESTH ANALG, V97, P1846, DOI 10.1213/01.ANE.0000090316.46604.89; HAUSWALD M, 1991, AM J EMERG MED, V9, P535, DOI 10.1016/0735-6757(91)90106-T; Helm M, 2003, BRIT J ANAESTH, V90, P327, DOI 10.1093/bja/aeg069; Henzler D, 2007, CRIT CARE MED, V35, P1027, DOI 10.1097/01.CCM.0000259526.45894.08; Himmelseher S, 2005, ANESTH ANALG, V101, P524, DOI 10.1213/01.ANE.0000160585.43587.5B; Hopkins RO, 2006, CHEST, V130, P869, DOI 10.1378/chest.130.3.869; Horinek EL, 2009, ANN PHARMACOTHER, V43, P1964, DOI 10.1345/aph.1M313; Iyer VN, 2009, CRIT CARE MED, V37, P3024, DOI 10.1097/CCM.0b013e3181b08ac7; Jaber S, 2006, CRIT CARE MED, V34, P2355, DOI 10.1097/01.CCM.0000233879.58720.87; Jaber S, 2016, INTENS CARE MED, V42, P1877, DOI 10.1007/s00134-016-4588-9; Jaber S, 2010, INTENS CARE MED, V36, P248, DOI 10.1007/s00134-009-1717-8; Jacobi J, 2002, CRIT CARE MED, V30, P119, DOI 10.1097/00003246-200201000-00020; Jakob SM, 2012, JAMA-J AM MED ASSOC, V307, P1151, DOI 10.1001/jama.2012.304; Janz DR, 2016, CRIT CARE MED, V44, P1980, DOI 10.1097/CCM.0000000000001841; Jevtovic-Todorovic V, 2003, J NEUROSCI, V23, P876, DOI 10.1523/jneurosci.23-03-00876.2003; Jones AE, 2008, RESUSCITATION, V77, P26, DOI 10.1016/j.resuscitation.2007.10.021; Jones C, 2007, INTENS CARE MED, V33, P978, DOI 10.1007/s00134-007-0600-8; Karabinis A, 2004, CRIT CARE, V8, pR268, DOI 10.1186/cc2896; Khine HH, 1997, ANESTHESIOLOGY, V86, P627, DOI 10.1097/00000542-199703000-00015; Kilgannon JH, 2011, CIRCULATION, V123, P2717, DOI 10.1161/CIRCULATIONAHA.110.001016; Kilgannon JH, 2010, JAMA-J AM MED ASSOC, V303, P2165, DOI 10.1001/jama.2010.707; Kilgannon JH, 2008, RESUSCITATION, V79, P410, DOI 10.1016/j.resuscitation.2008.07.019; Kill C, 2013, J EMERG MED, V44, P750, DOI 10.1016/j.jemermed.2012.07.080; KING BR, 1993, ANN EMERG MED, V22, P530, DOI 10.1016/S0196-0644(05)81937-7; Kleinman ME, 2010, CIRCULATION, V122, pS876, DOI 10.1161/CIRCULATIONAHA.110.971101; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Koenig MA, 2008, NEUROLOGY, V70, P1023, DOI 10.1212/01.wnl.0000304042.05557.60; Koutsoukou A, 2006, INTENS CARE MED, V32, P1947, DOI 10.1007/s00134-006-0406-0; KOVARIK WD, 1994, ANESTH ANALG, V78, P469; Kox WJ, 2006, ANESTH ANALG, V102, P825, DOI 10.1213/01.ane.0000197776.26307.fa; Kress JP, 2000, NEW ENGL J MED, V342, P1471, DOI 10.1056/NEJM200005183422002; Landsman I, 2004, PAEDIATR ANAESTH, V14, P43, DOI 10.1046/j.1460-9592.2003.01202.x; Langsjo JW, 2005, ANESTHESIOLOGY, V103, P258; Larach MG, 1997, CLIN PEDIATR, V36, P9; Lascarrou JB, 2017, JAMA-J AM MED ASSOC, V317, P483, DOI 10.1001/jama.2016.20603; Law JA, 2013, CAN J ANESTH, V60, P1089, DOI 10.1007/s12630-013-0019-3; LAWES EG, 1987, BRIT J ANAESTH, V59, P315, DOI 10.1093/bja/59.3.315; Lee C, 2009, ANESTHESIOLOGY, V110, P1020, DOI 10.1097/ALN.0b013e31819dabb0; Lev Roneet, 1994, Journal of Emergency Medicine, V12, P499, DOI 10.1016/0736-4679(94)90347-6; Levitan RM, 2006, ACAD EMERG MED, V13, P1255, DOI 10.1197/j.aem.2006.06.058; Lewis SR, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011136.pub2; Li J, 1999, AM J EMERG MED, V17, P141, DOI 10.1016/S0735-6757(99)90046-3; Loepke AW, 2008, ANESTH ANALG, V106, P1681, DOI 10.1213/ane.0b013e318167ad77; Lucking SMF, 2012, PEDIAT CRITICAL CARE, P690; Malcharek MJ, 2012, J NEUROSURG ANESTH, V24, P217, DOI 10.1097/ANA.0b013e31824da7e5; MALLAMPATI SR, 1985, CAN ANAESTH SOC J, V32, P429, DOI 10.1007/BF03011357; Marik PE, 2012, NEUROCRIT CARE, V17, P219, DOI 10.1007/s12028-012-9739-4; Marshall GT, 2010, J TRAUMA, V69, P275, DOI 10.1097/TA.0b013e3181de74c7; Martyn JAJ, 2006, ANESTHESIOLOGY, V104, P158, DOI 10.1097/00000542-200601000-00022; McConnell RA, 2016, RESP CARE, V61, P902, DOI 10.4187/respcare.04191; Mehta S, 2008, CRIT CARE MED, V36, P2092, DOI 10.1097/CCM.0b013e31817bff85; Miguel-Montanes R, 2015, CRIT CARE MED, V43, P574, DOI 10.1097/CCM.0000000000000743; Mosier JM, 2017, INTENS CARE MED, V43, P226, DOI 10.1007/s00134-016-4426-0; MOSS E, 1979, BRIT J ANAESTH, V51, P347, DOI 10.1093/bja/51.4.347; MOYNIHAN RJ, 1993, ANESTHESIOLOGY, V78, P652, DOI 10.1097/00000542-199304000-00007; Muench E, 2005, CRIT CARE MED, V33, P2367, DOI 10.1097/01.CCM.0000181732.37319.DF; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Murray Michael J, 2002, CJEM, V4, P338; Myatra SN, 2016, INDIAN J ANAESTH, V60, P922, DOI 10.4103/0019-5049.195485; Nemergut ME, 2014, PEDIATR ANESTH, V24, P120, DOI 10.1111/pan.12325; NOLAN JP, 1993, ANAESTHESIA, V48, P630, DOI 10.1111/j.1365-2044.1993.tb07133.x; Noppens RR, 2010, ANAESTHESIA, V65, P716, DOI 10.1111/j.1365-2044.2010.06388.x; Oddo M, 2014, NEUROCRIT CARE, V21, P103, DOI 10.1007/s12028-014-0024-6; Oertel M, 2002, J NEUROSURG, V97, P1045, DOI 10.3171/jns.2002.97.5.1045; Olson DM, 2009, NEUROCRIT CARE, V11, P20, DOI 10.1007/s12028-008-9184-6; Orebaugh SL, 2002, J EMERG MED, V22, P31, DOI 10.1016/S0736-4679(01)00435-8; PARKE TJ, 1992, BRIT MED J, V305, P613, DOI 10.1136/bmj.305.6854.613; Patanwala AE, 2016, PHARMACOTHERAPY, V36, P57, DOI 10.1002/phar.1683; PATEL R, 1994, CAN J ANAESTH, V41, P771, DOI 10.1007/BF03011582; Paule MG, 2011, NEUROTOXICOL TERATOL, V33, P220, DOI 10.1016/j.ntt.2011.01.001; Peberdy MA, 2010, CIRCULATION, V122, pS768, DOI 10.1161/CIRCULATIONAHA.110.971002; Petridis AK, 2010, ACTA NEUROCHIR, V152, P2143, DOI 10.1007/s00701-010-0761-z; Phipps Lorri M, 2005, Pediatr Crit Care Med, V6, P519, DOI 10.1097/01.PCC.0000165802.32383.9E; Piastra M, 2006, RESPIRATION, V73, P791, DOI 10.1159/000090777; Piepho T, 2011, ANAESTHESIA, V66, P1101, DOI 10.1111/j.1365-2044.2011.06872.x; Pohl D, 1999, P NATL ACAD SCI USA, V96, P2508, DOI 10.1073/pnas.96.5.2508; POKELA ML, 1993, DEV PHARMACOL THERAP, V20, P26, DOI 10.1159/000457538; Prough DS, 1997, J TRAUMA, V42, pS10, DOI 10.1097/00005373-199705001-00003; Qureshi AI, 2000, CRIT CARE MED, V28, P1556, DOI 10.1097/00003246-200005000-00049; Rangel-Castilla L, 2010, J NEUROTRAUM, V27, P1853, DOI 10.1089/neu.2010.1339; REDDY RV, 1993, ANESTH ANALG, V77, P1008; Reed MJ, 2005, EMERG MED J, V22, P99, DOI 10.1136/emj.2003.008771; Reinprecht A, 2003, CRIT CARE MED, V31, P1831, DOI 10.1097/01.CCM.0000063453.93855.0A; Reynolds SF, 2005, CHEST, V127, P1397, DOI 10.1378/chest.127.4.1397; Rice MJ, 2009, ANESTH ANALG, V109, P1546, DOI 10.1213/ane.0b013e3181b05404; Riker RR, 2014, NEUROCRIT CARE, V21, P27, DOI 10.1007/s12028-014-0025-5; Riker Richard R, 2011, Anesthesiol Clin, V29, P663, DOI 10.1016/j.anclin.2011.09.006; Riker RR, 1999, CRIT CARE MED, V27, P1325, DOI 10.1097/00003246-199907000-00022; Robitaille A, 2008, ANESTH ANALG, V106, P935, DOI 10.1213/ane.0b013e318161769e; Rosenblatt WH, 1998, ANESTH ANALG, V87, P153, DOI 10.1097/00000539-199807000-00032; Roth C, 2014, NEUROCRIT CARE, V21, P186, DOI 10.1007/s12028-014-0004-x; Sagarin MJ, 2002, PEDIATR EMERG CARE, V18, P417, DOI 10.1097/00006565-200212000-00004; Sagarin MJ, 2005, ANN EMERG MED, V46, P328, DOI 10.1016/j.annemergmed.2005.01.009; Sakles JC, 1998, ANN EMERG MED, V31, P325, DOI 10.1016/S0196-0644(98)70342-7; Sakles JC, 2016, ACAD EMERG MED, V23, P703, DOI 10.1111/acem.12931; Sakles JC, 2012, ACAD EMERG MED, V19, P235, DOI 10.1111/j.1553-2712.2011.01271.x; Salhi B, 2007, ANN EMERG MED, V49, P84, DOI 10.1016/j.annemergmed.2006.09.003; Samaniego EA, 2011, NEUROCRIT CARE, V15, P113, DOI 10.1007/s12028-010-9412-8; Sample GMP, 2010, CRIT CARE S1, V14, P231; SAMSOON GLT, 1987, ANAESTHESIA, V42, P487, DOI 10.1111/j.1365-2044.1987.tb04039.x; Sawin PD, 1996, ANESTHESIOLOGY, V85, P26, DOI 10.1097/00000542-199607000-00005; Schmidt UH, 2008, ANESTHESIOLOGY, V109, P973, DOI 10.1097/ALN.0b013e31818ddb90; Schonenberger S, 2016, JAMA-J AM MED ASSOC, V316, P1986, DOI 10.1001/jama.2016.16623; Schramm P, 2013, J NEUROSURG ANESTH, V25, P162, DOI 10.1097/ANA.0b013e31827c2f46; Seder DB, 2009, CLIN CHEST MED, V30, P103, DOI 10.1016/j.ccm.2008.11.004; Sehdev Rajesh S, 2006, Emerg Med Australas, V18, P37; Semler MW, 2016, AM J RESP CRIT CARE, V193, P273, DOI 10.1164/rccm.201507-1294OC; Seneviratne J, 2008, ARCH NEUROL-CHICAGO, V65, P54, DOI 10.1001/archneurol.2007.1; Sessler CN, 2002, AM J RESP CRIT CARE, V166, P1338, DOI 10.1164/rccm.2107138; Silverberg MJ, 2015, CRIT CARE MED, V43, P636, DOI 10.1097/CCM.0000000000000751; Simpson GD, 2012, BRIT J ANAESTH, V108, P792, DOI 10.1093/bja/aer504; Skippen P, 1997, CRIT CARE MED, V25, P1402, DOI 10.1097/00003246-199708000-00031; Skoglund K, 2009, NEUROCRIT CARE, V11, P135, DOI 10.1007/s12028-009-9255-3; Sorensen MK, 2012, BRIT J ANAESTH, V108, P682, DOI 10.1093/bja/aer503; Spies C, 2011, INTENS CARE MED, V37, P469, DOI 10.1007/s00134-010-2100-5; Stocchetti N, 2005, CHEST, V127, P1812, DOI 10.1378/chest.127.5.1812; Stocchetti N, 1996, J TRAUMA, V40, P764, DOI 10.1097/00005373-199605000-00014; Strom T, 2010, LANCET, V375, P475, DOI 10.1016/S0140-6736(09)62072-9; Su YC, 2011, EUR J ANAESTH, V28, P788, DOI 10.1097/EJA.0b013e32834a34f3; Teitelbaum JS, 2011, CAN J NEUROL SCI, V38, P815, DOI 10.1017/S0317167100012385; Treggiari MM, 2009, CRIT CARE MED, V37, P2527, DOI 10.1097/CCM.0b013e3181a5689f; Trzeciak S, 2009, CRIT CARE MED, V37, P2895, DOI 10.1097/CCM.0b013e3181b01d8c; Turkstra TP, 2005, ANESTH ANALG, V101, P910, DOI 10.1213/01.ane.0000166975.38649.27; van Rompaey B, 2009, CRIT CARE, V13, DOI 10.1186/cc7892; Vourc'h M, 2015, INTENS CARE MED, V41, P1538, DOI 10.1007/s00134-015-3796-z; Walls R, 2008, MANUAL EMERGENCY AIR; WALLS RM, 1993, ANN EMERG MED, V22, P1008, DOI 10.1016/S0196-0644(05)82743-X; Walsh BK, 2011, RESP CARE, V56, P503, DOI 10.4187/respcare.01175; Wang CH, 2014, RESUSCITATION, V85, P1142, DOI 10.1016/j.resuscitation.2014.05.021; Weiler N, 1995, Prehosp Disaster Med, V10, P101; Weingart S, 2007, ANN EMERG MED, V50, P353, DOI 10.1016/j.annemergmed.2007.02.032; Weiss M, 2009, BRIT J ANAESTH, V103, P867, DOI 10.1093/bja/aep290; Weiss M, 2008, PEDIATR ANESTH, V18, P97, DOI 10.1111/j.1460-9592.2007.02324.x; Yahwak JA, 2008, PHARMACOTHERAPY, V28, P984, DOI 10.1592/phco.28.8.984; Yeganeh N, 2010, J TRAUMA, V69, P1185, DOI 10.1097/TA.0b013e3181cb4434; Yentis SM, 1998, ANAESTHESIA, V53, P1041, DOI 10.1046/j.1365-2044.1998.00605.x; Zelicof-Paul A, 2005, CURR OPIN PEDIATR, V17, P355, DOI 10.1097/01.mop.0000162365.64140.b7	211	11	11	0	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	SEP	2017	27			1			S4	S28		10.1007/s12028-017-0451-2			25	Critical Care Medicine; Clinical Neurology	General & Internal Medicine; Neurosciences & Neurology	FU8HO	WOS:000424094100002	28913751				2021-06-18	
J	Risen, SR; Reesman, J; Yenokyan, G; Slomine, BS; Suskauer, SJ				Risen, Sarah R.; Reesman, Jennifer; Yenokyan, Gayane; Slomine, Beth S.; Suskauer, Stacy J.			The Course of Concussion Recovery in Children 6-12 Years of Age: Experience From an Interdisciplinary Rehabilitation Clinic	PM&R			English	Article							TRAUMATIC BRAIN-INJURY; SYMPTOM DURATION; HEAD-INJURY; HIGH-SCHOOL; EMERGENCY-DEPARTMENT; PROLONGED RECOVERY; PREDICTORS; SPORT; ADOLESCENTS	Background: Current concussion evidence is derived largely from teenagers and adults. Concussion in younger children occurs within the context of neuromaturation, with differing age-based pathophysiological responses to injury. Therefore, our current understanding of concussion in older children and adults is unlikely to directly apply to younger children. Objective: To describe patient variables, clinical course, and factors associated with time to discharge from concussion care in children 6-12 years of age with concussion treated in an interdisciplinary rehabilitation-based concussion clinic. Design: Retrospective chart review. Setting: Interdisciplinary concussion clinic at an academically affiliated rehabilitation center. Patients: Children aged 6-12 years (n = 105; mean 10.8 years of age, 70% male) seen within 60 days of concussive injury. Main Outcome Measurements: Descriptive statistics explored demographic, injury, and clinical features. The primary outcome measure, time to discharge from concussion care, was estimated with survival-analysis methods based on the date of discharge from the clinic. Multivariate models were used to examine factors associated with longer time to discharge. Results: Median time to discharge was 34 days postinjury (range 5-192 days); 75% of children were discharged within 60 days of injury. A minority reported persisting symptoms at discharge. Younger age and increased symptom burden at initial evaluation predicted longer time to discharge. Conclusions: Although children 6-12 years old treated in a specialty concussion clinic show variability in time to discharge from concussion care, most were discharged within 2 months after injury. Risk factors for prolonged recovery, such as younger age and greater symptom burden at initial visit, can be used when counseling families and planning interventions. There may be varying contributions, including psychosocial stressors, to ongoing symptoms in children who experience persisting symptoms after other concussion-related concerns have resolved. Future work focused on the subset of children who report persisting symptoms will be useful for developing an evidence base related to their care.	[Risen, Sarah R.; Reesman, Jennifer] Johns Hopkins Univ, Kennedy Krieger Inst, Sch Med, Baltimore, MD 21205 USA; [Risen, Sarah R.] Johns Hopkins Univ, Dept Neurol, Sch Med, Baltimore, MD 21205 USA; [Risen, Sarah R.] Baylor Coll Med, Pediat Neurol & Dev Med, Houston, TX 77030 USA; [Risen, Sarah R.] Texas Childrens Hosp, Houston, TX 77030 USA; [Reesman, Jennifer; Slomine, Beth S.] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; [Yenokyan, Gayane] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; [Suskauer, Stacy J.] Kennedy Krieger Inst, 707 N Broadway, Baltimore, MD 21230 USA; [Suskauer, Stacy J.] Johns Hopkins Univ, Sch Med, Dept Phys Med & Rehabil, Baltimore, MD 21218 USA; [Suskauer, Stacy J.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21218 USA	Suskauer, SJ (corresponding author), Kennedy Krieger Inst, 707 N Broadway, Baltimore, MD 21230 USA.; Suskauer, SJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Phys Med & Rehabil, Baltimore, MD 21218 USA.; Suskauer, SJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21218 USA.	Suskauer@kennedykrieger.org		Reesman, Jennifer/0000-0002-0884-3323	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32HD007414-20]; Johns Hopkins School of Public Health; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32HD007414-20]; National Center for Advancing Translational Sciences (NCATS) of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [1UL1TR001079]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD007414] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001079] Funding Source: NIH RePORTER	Disclosures related to this publication: grant, NIH Grant T32HD007414-20 (money to institution); Disclosures related to this publication: grant, Johns Hopkins School of Public Health (money to institution); All phases of this study were supported by a grant from the National Institutes of Health, #T32HD007414-20. Support for statistical analysis came from the National Center for Research Resources and the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health through grant number 1UL1TR001079.	Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; [Anonymous], 2013, STAT STAT SOFTW REL; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Bernard CO, 2016, J INT NEUROPSYCH SOC, V22, P793, DOI 10.1017/S1355617716000709; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Castile L, 2012, BRIT J SPORT MED, V46, P603, DOI 10.1136/bjsports-2011-090115; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; Dillard C, 2017, DISABIL REHABIL, V39, P544, DOI 10.3109/09638288.2016.1152602; Donders J, 2007, J HEAD TRAUMA REHAB, V22, P296, DOI 10.1097/01.HTR.0000290974.01872.82; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Giza CC, 2007, CURR OPIN CRIT CARE, V13, P143, DOI 10.1097/MCC.0b013e32808255dc; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Grubenhoff JA, 2016, J PEDIATR-US, V174, P27, DOI 10.1016/j.jpeds.2016.03.027; Heyer GL, 2016, J PEDIATR-US, V174, P33, DOI 10.1016/j.jpeds.2016.03.014; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; KRIEL RL, 1989, PEDIATR NEUROL, V5, P296, DOI 10.1016/0887-8994(89)90021-0; Kriz PK, 2016, J PEDIATR-US, V171, P234, DOI 10.1016/j.jpeds.2015.12.006; Maxwell WL, 2012, INT J DEV NEUROSCI, V30, P167, DOI 10.1016/j.ijdevneu.2011.12.008; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McNally KA, 2013, NEUROPSYCHOLOGY, V27, P1, DOI 10.1037/a0031370; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Meehan WP, 2011, AM J SPORT MED, V39, P2304, DOI 10.1177/0363546511423503; Meehan WP, 2010, J PEDIATR-US, V157, P889, DOI 10.1016/j.jpeds.2010.06.040; Olsson KA, 2013, BRAIN INJURY, V27, P145, DOI 10.3109/02699052.2012.729286; Phillips MM, 2016, PHYS MED REH CLIN N, V27, P455, DOI 10.1016/j.pmr.2015.12.005; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Prasad MR, 2017, J HEAD TRAUMA REHAB, V32, pE24, DOI 10.1097/HTR.0000000000000218; Rane S, 2014, J INT NEUROPSYCH SOC, V20, P19; Risen SR, 2015, J PEDIATR REHAB MED, V8, P309, DOI 10.3233/PRM-150349; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Seiger A, 2015, J HEAD TRAUMA REHAB, V30, pE52, DOI 10.1097/HTR.0000000000000051; Taylor AM, 2015, J PEDIATR-US, V167, P738, DOI 10.1016/j.jpeds.2015.05.036; Yeates KO, 2001, J PEDIATR PSYCHOL, V26, P79, DOI 10.1093/jpepsy/26.2.79; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	38	11	11	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1934-1482	1934-1563		PM&R	PM&R	SEP	2017	9	9					874	883		10.1016/j.pmrj.2016.12.005			10	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	FL7PN	WOS:000414440500005	28082178	Green Accepted			2021-06-18	
J	Robinson, ME; Clark, DC; Milberg, WP; McGlinchey, RE; Salat, DH				Robinson, Meghan E.; Clark, Dustin C.; Milberg, William P.; McGlinchey, Regina E.; Salat, David H.			Characterization of Differences in Functional Connectivity Associated with Close-Range Blast Exposure	JOURNAL OF NEUROTRAUMA			English	Article						adult brain injury; military injury; MRI	TRAUMATIC BRAIN-INJURY; SURFACE-BASED ANALYSIS; CONCUSSIVE BLAST; SIGNAL; MODEL; SEGMENTATION; FLUCTUATIONS; POPULATIONS; EXPRESSION; VARIANCE	Despite the prevalence of blast injuries in recent overseas conflicts, knowledge of their impact on neural health is lacking. We have recently published work demonstrating differences in functional magnetic resonance imaging (fMRI) connectivity that were specific to close-range blast exposure (CBE), as opposed to other prevalent military-related factors. Here, we replicate this finding in an independent sample of 135 veterans, again finding that CBE, regardless of concussion, is predictive of persistent changes in brain physiology. Although there was weak overlap anatomically, in both samples, the group differences could be described as spreading of anticorrelation. Using the combined sample, we now seek to identify likely mechanisms that could bring about this effect. We compared participants with (n=116) and without (n=153) CBE by analyzing two networks through group difference maps and correlation distributions to assess spatially homogenous and heterogeneous effects. As boundaries between positive and negative correlations in fcMRI are determined by noise covariates, we compared analyses with and without global signal regression. We found evidence of widespread altered connectivity that was spatially heterogeneous across participants, and that the role of global signal regression was network dependent. These findings are not consistent with expected results from damaged white matter or impaired neural function. Rather, potential biological interpretations include disrupted cerebral blood flow or impaired neurovascular coupling, which have each been observed in animal models of blast exposure. Further targeted work will be necessary to distinguish the contribution of each of these mechanisms to producing changes in brain function associated with CBE.	[Robinson, Meghan E.; Clark, Dustin C.; Salat, David H.] VA Boston Healthcare Syst, Neuroimaging Res Vet NeRVe Ctr, 150 South Huntington Ave, Boston, MA 02132 USA; [Robinson, Meghan E.; Milberg, William P.; McGlinchey, Regina E.; Salat, David H.] VA Boston Healthcare Syst, Translat Res Ctr TBI & Stress Disorders TRACTS, Natl Res Ctr, Boston, MA 02132 USA; [Milberg, William P.; McGlinchey, Regina E.] VA Boston Healthcare Syst, GRECC, Boston, MA 02132 USA; [Robinson, Meghan E.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Milberg, William P.; McGlinchey, Regina E.] Harvard Med Sch, Dept Psychiat, Boston, MA USA	Robinson, ME (corresponding author), VA Boston Healthcare Syst, Neuroimaging Res Vet NeRVe Ctr, 150 South Huntington Ave, Boston, MA 02132 USA.	dr.meghan.robinson@gmail.com			Translational Research Center for TBI and Stress Disorders (TRACTS), a VA Rehabilitation Research and Development Traumatic Brain Injury National Research Center [B9254-C]	This research was supported by the Translational Research Center for TBI and Stress Disorders (TRACTS), a VA Rehabilitation Research and Development Traumatic Brain Injury National Research Center (B9254-C).	Abbas K, 2015, BRAIN CONNECT, V5, P91, DOI 10.1089/brain.2014.0279; Bandettini PA, 2014, BRAIN CONNECT, V4, P487, DOI 10.1089/brain.2014.0288; Bazarian JJ, 2013, J HEAD TRAUMA REHAB, V28, P1, DOI 10.1097/HTR.0b013e318256d3d3; Behrens TEJ, 2012, CURR OPIN NEUROBIOL, V22, P144, DOI 10.1016/j.conb.2011.08.005; Bir C, 2012, MAGN RESON IMAGING, V30, P527, DOI 10.1016/j.mri.2011.12.003; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Blake D, 2006, J TRAUMA STRESS, V8, P75; Bright MG, 2015, NEUROIMAGE, V114, P158, DOI 10.1016/j.neuroimage.2015.03.070; Cernak I, 2001, BRAIN INJURY, V15, P593, DOI 10.1080/02699050010009559; Cernak Ibolja, 2010, Front Neurol, V1, P151, DOI 10.3389/fneur.2010.00151; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; D'Esposito M, 2003, NAT REV NEUROSCI, V4, P863, DOI 10.1038/nrn1246; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Davenport ND, 2012, NEUROIMAGE, V59, P2017, DOI 10.1016/j.neuroimage.2011.10.050; Elder GA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00269; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fortier CB, 2014, J HEAD TRAUMA REHAB, V29, P89, DOI 10.1097/HTR.0b013e3182865859; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Gonzalez-Castillo J, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00138; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Hahamy A, 2014, BRAIN CONNECT, V4, P395, DOI 10.1089/brain.2014.0244; Han K, 2014, NEUROIMAGE, V84, P76, DOI 10.1016/j.neuroimage.2013.08.017; Handwerker DA, 2007, HUM BRAIN MAPP, V28, P846, DOI 10.1002/hbm.20307; Hayes JP, 2015, NEUROIMAGE-CLIN, V8, P148, DOI 10.1016/j.nicl.2015.04.001; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Huber BR, 2013, J ALZHEIMERS DIS, V37, P309, DOI 10.3233/JAD-130182; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Kamnaksh A., 2014, TRANSL PROTEOM, V3, P22, DOI [10.1016/j.trprot.2013.11.001, DOI 10.1016/J.TRPROT.2013.11.001]; Kamnaksh A, 2012, ELECTROPHORESIS, V33, P3680, DOI 10.1002/elps.201200319; Lu J, 2012, J NEUROTRAUM, V29, P1434, DOI 10.1089/neu.2010.1591; Mac Donald CL, 2017, NEUROIMAGE-CLIN, V14, P371, DOI 10.1016/j.nicl.2017.02.005; Mac Donald CL, 2014, JAMA NEUROL, V71, P994, DOI 10.1001/jamaneurol.2014.1114; Magnuson J, 2012, CURR NEUROL NEUROSCI, V12, P570, DOI 10.1007/s11910-012-0303-6; McGlinchey R., 2017, INT J METHO IN PRESS; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; Murphy K., 2016, NEUROIMAGE IN PRESS; Murphy K, 2011, NEUROIMAGE, V54, P369, DOI 10.1016/j.neuroimage.2010.07.059; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Robinson ME, 2015, HUM BRAIN MAPP, V36, P911, DOI 10.1002/hbm.22675; Saad ZS, 2012, BRAIN CONNECT, V2, P25, DOI 10.1089/brain.2012.0080; Saljo A, 2002, J NEUROTRAUM, V19, P985, DOI 10.1089/089771502320317131; Scholvinck ML, 2010, P NATL ACAD SCI USA, V107, P10238, DOI 10.1073/pnas.0913110107; Shively SB, 2016, LANCET NEUROL, V15, P944, DOI 10.1016/S1474-4422(16)30057-6; Shmuel A, 2008, HUM BRAIN MAPP, V29, P751, DOI 10.1002/hbm.20580; Shmueli K, 2007, NEUROIMAGE, V38, P306, DOI 10.1016/j.neuroimage.2007.07.037; Taber KH, 2015, J HEAD TRAUMA REHAB, V30, pE15, DOI 10.1097/HTR.0000000000000030; Tompkins P, 2013, J NEUROTRAUM, V30, P1888, DOI 10.1089/neu.2012.2674; Trotter BB, 2015, BRAIN, V138, P2278, DOI 10.1093/brain/awv139; Van Dijk KRA, 2010, J NEUROPHYSIOL, V103, P297, DOI 10.1152/jn.00783.2009	55	11	11	1	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP	2017	34			1			S53	S61		10.1089/neu.2016.4709			9	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	FI2DA	WOS:000411746000007	28486051	Bronze			2021-06-18	
J	Tepe, V; Smalt, C; Nelson, J; Quatieri, T; Pitts, K				Tepe, Victoria; Smalt, Christopher; Nelson, Jeremy; Quatieri, Thomas; Pitts, Kenneth			Hidden Hearing Injury: The Emerging Science and Military Relevance of Cochlear Synaptopathy	MILITARY MEDICINE			English	Article							MEDIAL-OLIVOCOCHLEAR REFLEX; TRAUMATIC BRAIN-INJURY; NOISE EXPOSURE; SPEECH; NEUROPATHY; DAMAGE; DYSFUNCTION; ACCELERATION; DEGENERATION; PERCEPTION	Introduction: The phenomenon recently described as "hidden hearing loss" was the subject of a meeting co-hosted by the Department of Defense Hearing Center of Excellence and MIT Lincoln Laboratory to consider the potential relevance of noise-related synaptopathic injury to military settings and performance, service-related injury scenarios, and military medical priorities. Participants included approximately 50 researchers and subject matter experts from academic, federal, and military laboratories. Here we present a synthesis of discussion topics and concerns, as well as specific research objectives identified to develop militarily relevant knowledge. Materials and Methods: We consider findings from studies to date that have demonstrated cochlear synaptopathy and neurodegenerative processes apparently linked to noise exposure in animal models. We explore the potential relevance of these findings to the prediction and prevention of military hearing injuries, and to comorbid injuries in the neurological domain. Results: Noise-induced cochlear synaptopathic injury is not detected by conventional audiometric assessment of threshold sensitivity. Animal studies suggest there may be a generous window of opportunity for intervention to mitigate or prevent cochlear neurodegenerative processes, e.g., by administration of neurotrophins or antioxidants. However, it is not yet known if the mechanisms that underlie "hidden hearing loss" also occur in human beings or, if so, how to identify them early, and how and when to intervene. Conclusion: Neurological injuries resulting from noise exposures via the auditory system have potentially significant implications for military Service Member performance, long-term Veteran health, and noise exposure standards. Mediated via auditory pathways, such injuries have possible relationship to clinical impairments including speech perception, and may be a largely overlooked contributor to cognitive symptoms associated with other military service-related injuries such as blast exposure and brain trauma. The potential health and performance consequences of noise-induced cochlear synaptopathic injury are easily overlooked, especially if it is assumed that hearing threshold sensitivity loss is the major concern. There should be a renewed impetus to further characterize and model synaptopathic mechanisms of auditory injury; study its potential impact on human auditory function, cognition, and performance metrics of military relevance; and develop solutions for auditory protection (including noise dosimetry) and treatment if appropriate following noise or blast exposure in military scenarios. We identify specific problems, solution objectives, and research objectives. Recommended research calls for a multidisciplinary approach to address cochlear nerve synaptopathy, central (brain) dysfunction, noise exposure measurement and metrics, and clinical assessment.	[Tepe, Victoria; Nelson, Jeremy] JBSA Lackland, Hearing Ctr Excellence, Dept Def, 2200 Bergquist Dr, Lackland AFB, TX 78236 USA; [Smalt, Christopher; Quatieri, Thomas] MIT, Lincoln Lab, 244 Wood St, Lexington, MA 02420 USA; [Pitts, Kenneth] US Army, Inst Environm Med, 15 Kansas St, Natick, MA 01760 USA	Tepe, V (corresponding author), JBSA Lackland, Hearing Ctr Excellence, Dept Def, 2200 Bergquist Dr, Lackland AFB, TX 78236 USA.			Nelson, Jeremy/0000-0003-4428-8694	US Army Research Institute of Environmental Medicine (USARIEM) [FA8721-05-C-0002, FA8702-15-D-0001]	We extend our thanks to COL (retired) Karl Friedl (University of California San Francisco) for his thoughts in the development of this report, and to Dr. Sharon Kujawa (Massachusetts Eye and Ear) for her very helpful comments and corrections. The DoD Hearing Center of Excellence also wishes to thank researchers and staff at MIT Lincoln Laboratory for their collaboration, and for the use of their meeting facilities. Contributions to this paper from Dr. Smalt and Dr. Quatieri were sponsored by the US Army Research Institute of Environmental Medicine (USARIEM) under Air Force Contract No. FA8721-05-C0002 and/or FA8702-15-D-0001.	Alivisatos AP, 2012, NEURON, V74, P970, DOI 10.1016/j.neuron.2012.06.006; Anderson S, 2011, EAR HEARING, V32, P750, DOI 10.1097/AUD.0b013e31822229d3; Arciniegas D, 1999, BRAIN INJURY, V13, P1, DOI 10.1080/026990599121827; Aydelott J, 2010, TRENDS AMPLIF, V14, P218, DOI 10.1177/1084713810393751; Bernstein LR, 2016, J ACOUST SOC AM, V140, P3540, DOI 10.1121/1.4966113; Bharadwaj HM, 2015, J NEUROSCI, V35, P2161, DOI 10.1523/JNEUROSCI.3915-14.2015; Bharadwaj HM, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00026; Bramhall NF, 2017, EAR HEARING, V38, pE1, DOI 10.1097/AUD.0000000000000370; Bressler S, 2014, J ACOUST SOC AM, V135, P2415; Brungart DS, 2014, J ACOUST SOC AM, V136, P777, DOI 10.1121/1.4887440; Buckey JC, 2015, NOISE HEALTH, V17, P263, DOI 10.4103/1463-1741.165037; Campbell K, 2015, ADA616584 TR US ARM; Casali JG, 2009, NOISE HEALTH, V11, P69, DOI 10.4103/1463-1741.48564; Cho SI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067618; Clasing JE, 2014, INT J AUDIOL, V53, pS43, DOI 10.3109/14992027.2013.860489; Dalton DS, 2003, GERONTOLOGIST, V43, P661, DOI 10.1093/geront/43.5.661; Department of Health and Human Services National Institutes of Health, 2016, NOIS IND SYN HUM AUD; Earl B. R., 2015, AUDIOL TODAY, V27, P16; Ewert DL, 2012, HEARING RES, V285, P29, DOI 10.1016/j.heares.2012.01.013; Fausti SA, 2009, J REHABIL RES DEV, V46, P797, DOI 10.1682/JRRD.2008.09.0118; Fernandez KA, 2015, J NEUROSCI, V35, P7509, DOI 10.1523/JNEUROSCI.5138-14.2015; Fulton Susan E., 2015, Seminars in Hearing, V36, P140, DOI 10.1055/s-0035-1555117; Furman AC, 2013, J NEUROPHYSIOL, V110, P577, DOI 10.1152/jn.00164.2013; Gallun FJ, 2012, J REHABIL RES DEV, V49, P1059, DOI 10.1682/JRRD.2010.09.0166; Gannouni N, 2015, J NEUROSCI RES, V93, P848, DOI 10.1002/jnr.23567; Hamernik RP, 2007, J ACOUST SOC AM, V122, P2245, DOI 10.1121/1.2775160; Hebert S, 2009, INT J HYG ENVIR HEAL, V212, P37, DOI 10.1016/j.ijheh.2007.11.005; Hickok G, 2000, TRENDS COGN SCI, V4, P131, DOI 10.1016/S1364-6613(00)01463-7; Hickox AE, 2014, J NEUROPHYSIOL, V111, P552, DOI 10.1152/jn.00184.2013; Jensen JB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125160; Kopke R, 2015, HEARING RES, V323, P40, DOI 10.1016/j.heares.2015.01.002; Kraus KS, 2010, NEUROSCIENCE, V167, P1216, DOI 10.1016/j.neuroscience.2010.02.071; Kraus N., 2016, HEAR J, V69, P38, DOI [10.1097/01.HJ.0000483269.59643.1a, DOI 10.1097/01.HJ.0000483269.59643.1A]; Kryter K, 1950, J SPEECH HEAR DISORD; Kujawa SG, 2006, J NEUROSCI, V26, P2115, DOI 10.1523/JNEUROSCI.4985-05.2006; Kujawa SG, 2015, HEARING RES, V330, P191, DOI 10.1016/j.heares.2015.02.009; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; Le Prell C, 2015, FREE RADICALS ENT PA; Le Prell CG, 2007, FREE RADICAL BIO MED, V42, P1454, DOI 10.1016/j.freeradbiomed.2007.02.008; Le Prell CG, 2016, OTOL NEUROTOL, V37, pE295, DOI 10.1097/MAO.0000000000001069; Le Prell CG, 2012, EAR HEARING, V33, pE44, DOI 10.1097/AUD.0b013e31825f9d89; Le Prell CG, 2012, ADV EXP MED BIOL, V730, P191, DOI 10.1007/978-1-4419-7311-5_43; Le Prell CG, 2011, TRANSL RES, V158, P38, DOI 10.1016/j.trsl.2011.02.006; LEI SF, 1994, J ACOUST SOC AM, V96, P1435, DOI 10.1121/1.410287; Lemke U, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00998; Lew HL, 2007, J REHABIL RES DEV, V44, P921, DOI 10.1682/JRRD.2007.09.0140; Lew HL, 2004, AM J PHYS MED REHAB, V83, P428, DOI 10.1097/00002060-200406000-00004; Li CM, 2014, JAMA OTOLARYNGOL, V140, P293, DOI 10.1001/jamaoto.2014.42; Liberman MC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162726; Liberman MC, 2014, J ACOUST SOC AM, V135, P2311, DOI DOI 10.1523/JNEUROSCI.2845-09.2009; Lin FR, 2013, JAMA INTERN MED, V173, P293, DOI 10.1001/jamainternmed.2013.1868; Lin FR, 2011, NEUROPSYCHOLOGY, V25, P763, DOI 10.1037/a0024238; Lin HW, 2011, JARO-J ASSOC RES OTO, V12, P605, DOI 10.1007/s10162-011-0277-0; Lobarinas E., 2016, ABS ASS RES OTOLARYN, P68; Makary CA, 2011, JARO-J ASSOC RES OTO, V12, P711, DOI 10.1007/s10162-011-0283-2; Marshall L, 2014, J ACOUST SOC AM, V136, P2697, DOI 10.1121/1.4896745; Mehraei G, 2016, J NEUROSCI, V36, P3755, DOI 10.1523/JNEUROSCI.4460-15.2016; Mentel K, 2013, P HUM FACTORS ERGON, V57, P1204; Moser T, 2016, NAT REV NEUROL, V12, P135, DOI 10.1038/nrneurol.2016.10; Moser T, 2013, OTOL NEUROTOL, V34, P995, DOI 10.1097/MAO.0b013e3182814d4a; Munjal SK, 2010, BRAIN INJURY, V24, P525, DOI 10.3109/02699050903516872; National Institute on Deafness and Other Communication Disorders (NIDCD), 2015, SYN NOIS IND HEAR LO; National Institutes of Health, 2016, NOIS IND COCHL SYN B; Nelson J, 2016, HEAR RES; Niwa K, 2016, SCI REP-UK, V6, DOI 10.1038/srep31754; Oleksiak M, 2012, J REHABIL RES DEV, V49, P995, DOI 10.1682/JRRD.2011.01.0001; Parthasarathy A, 2014, JARO-J ASSOC RES OTO, V15, P649, DOI 10.1007/s10162-014-0460-1; Paul BT, 2017, HEARING RES, V344, P170, DOI 10.1016/j.heares.2016.11.010; Pengfei S, 2016, IEEE EMBS INT C BIOM; Peters L., 1990, 1190 US ARM HUM ENG; Plack CJ, 2014, TRENDS HEAR, V18, DOI 10.1177/2331216514550621; Prendergast G., 2016, ABS ASS RES OTOLARYN, V39, P202; PRICE GR, 1991, J ACOUST SOC AM, V90, P219, DOI 10.1121/1.401291; Qiu W, 2013, J ACOUST SOC AM, V133, P2856, DOI 10.1121/1.4799813; Salvi RJ, 2000, HEARING RES, V147, P261, DOI 10.1016/S0378-5955(00)00136-2; Saunders GH, 2015, J REHABIL RES DEV, V52, P343, DOI 10.1682/JRRD.2014.11.0275; Schaette R, 2011, J NEUROSCI, V31, P13452, DOI 10.1523/JNEUROSCI.2156-11.2011; Schmiedt RA, 1996, J NEUROPHYSIOL, V76, P2799; SCHUKNECHT H F, 1955, J Laryngol Otol, V69, P75, DOI 10.1017/S0022215100050465; Sergeyenko Y, 2013, J NEUROSCI, V33, P13686, DOI 10.1523/JNEUROSCI.1783-13.2013; Seung HS, 2011, NATURE, V471, P170, DOI 10.1038/471170a; Shaheen LA, 2015, JARO-J ASSOC RES OTO, V16, P727, DOI 10.1007/s10162-015-0539-3; Sheffield B., 2015, P HUM FACT ERG SOC A, V59, P1346; Shirwany N, 2015, FREE RADICALS ENT PA; Smalt C, 2016, J ACOUST SOC AM, V140, P3151, DOI DOI 10.1121/1.4969883; Smalt CJ, 2017, HEARING RES, V349, P42, DOI 10.1016/j.heares.2016.11.008; Smalt CJ, 2014, JARO-J ASSOC RES OTO, V15, P159, DOI 10.1007/s10162-013-0430-z; Smith SM, 2013, TRENDS COGN SCI, V17, P666, DOI 10.1016/j.tics.2013.09.016; Suzuki J, 2016, SCI REP-UK, V6, DOI 10.1038/srep24907; Tepe V, 2013, PSYCHIAT ANN, V43; Tun PA, 2009, PSYCHOL AGING, V24, P761, DOI 10.1037/a0014802; Valero MD, 2016, HEARING RES, V332, P29, DOI 10.1016/j.heares.2015.11.005; Veterans Benefits Administration, 2015, VBA ANN BEN REP FISC; Viana LM, 2015, HEARING RES, V327, P78, DOI 10.1016/j.heares.2015.04.014; Wan GQ, 2014, ELIFE, V3, DOI 10.7554/eLife.03564; Wang Y, 2012, JARO-J ASSOC RES OTO, V13, P505, DOI 10.1007/s10162-012-0329-0; WARD WD, 1991, J ACOUST SOC AM, V90, P164, DOI 10.1121/1.401310; Wells TS, 2015, NOISE HEALTH, V17, P34, DOI 10.4103/1463-1741.149574; Wild CJ, 2012, J NEUROSCI, V32, P14010, DOI 10.1523/JNEUROSCI.1528-12.2012; Wilson RH, 2005, J REHABIL RES DEV, V42, P79, DOI 10.1682/JRRD.2005.06.0096; Wilson RH, 2002, J REHABIL RES DEV, V39, P105; Wilson RH, 2007, J SPEECH LANG HEAR R, V50, P844, DOI 10.1044/1092-4388(2007/059); Wilson RH, 2008, J AM ACAD AUDIOL, V19, P548, DOI 10.3766/jaaa.19.7.4; ZILANY MSA, 2007, P 3 INT IEEE EMBS C; Zundorf IC, 2014, BRAIN, V137, P1410, DOI 10.1093/brain/awu044	105	11	11	1	5	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	SEP-OCT	2017	182	9-10					E1785	E1795		10.7205/MILMED-D-17-00025			11	Medicine, General & Internal	General & Internal Medicine	FT7AW	WOS:000423306300010	28885938	Bronze			2021-06-18	
J	de Castro, MRT; Ferreira, APD; Busanello, GL; da Silva, LRH; da Silveira, MEP; Fiorin, FD; Arrifano, G; Crespo-Lopez, ME; Barcelos, RP; Cuevas, MJ; Bresciani, G; Gonzalez-Gallego, J; Fighera, MR; Royes, LFF				Torres de Castro, Mauro Robson; de Oliveira Ferreira, Ana Paula; Busanello, Guilherme Lago; Hart da Silva, Luis Roberto; Porto da Silveira Junior, Mauro Eduardo; Fiorin, Fernando da Silva; Arrifano, Gabriela; Crespo-Lopez, Maria Elena; Barcelos, Romulo Pillon; Cuevas, Maria J.; Bresciani, Guilherme; Gonzalez-Gallego, Javier; Fighera, Michele Rechia; Freire Royes, Luiz Fernando			Previous physical exercise alters the hepatic profile of oxidative-inflammatory status and limits the secondary brain damage induced by severe traumatic brain injury in rats	JOURNAL OF PHYSIOLOGY-LONDON			English	Article							CONTROLLED CORTICAL IMPACT; INSULIN-RESISTANCE; LIPID-PEROXIDATION; POSTTRAUMATIC EPILEPSY; NA+,K+-ATPASE ACTIVITY; SYSTEMIC RESPONSE; FLUID PERCUSSION; INDUCED SEIZURES; SKELETAL-MUSCLE; HEAD TRAUMA	Although systemic responses have been described after traumatic brain injury (TBI), little is known regarding potential interactions between brain and peripheral organs after neuronal injury. Accordingly, we aimed to investigate whether a peripheral oxidative/inflammatory response contributes to neuronal dysfunction after TBI, as well as the prophylactic role of exercise training. Animals were submitted to fluid percussion injury after 6 weeks of swimming training. Previous exercise training increased mRNA expression of X receptor alpha and ATP-binding cassette transporter, and decreased inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), tumor necrosis factor (TNF)-alpha and interleukin (IL)-6 expression per se in liver. Interestingly, exercise training protected against hepatic inflammation (COX-2, iNOS, TNF-alpha and IL-6), oxidative stress (decreases in non-protein sulfhydryl and glutathione, as well as increases in 2',7'-dichlorofluorescein diacetate oxidation and protein carbonyl), which altered hepatic redox status (increases in myeloperoxidase and superoxide dismutase activity, as well as inhibition of catalase activity) mitochondrial function (decreases in methyl-tetrazolium and Delta psi, as well as inhibition of citrate synthase activity) and ion gradient homeostasis (inhibition of Na+, K+-ATPase activity inhibition) when analysed 24 h after TBI. Previous exercise training also protected against dysglycaemia, impaired hepatic signalling (increase in phosphorylated c-Jun NH2-terminal kinase, phosphorylated decreases in insulin receptor substrate and phosphorylated AKTexpression), high levels of circulating and neuronal cytokines, the opening of the blood-brain barrier, neutrophil infiltration and Na+, K+-ATPase activity inhibition in the ipsilateral cortex after TBI. Moreover, the impairment of protein function, neurobehavioural (neuromotor dysfunction and spatial learning) disability and hippocampal cell damage in sedentary rats suggests that exercise training also modulates peripheral oxidative/inflammatory pathways in TBI, which corroborates the ever increasing evidence regarding health-related outcomes with respect to a physically active lifestyle.	[Torres de Castro, Mauro Robson; Busanello, Guilherme Lago; Hart da Silva, Luis Roberto; Fighera, Michele Rechia; Freire Royes, Luiz Fernando] Univ Fed Santa Maria, Programa Posgrad Educ Fis, Santa Maria, RS, Brazil; [Torres de Castro, Mauro Robson; Busanello, Guilherme Lago; Fighera, Michele Rechia; Freire Royes, Luiz Fernando] Univ Fed Santa Maria, Ctr Educ Fis & Desportos, Lab Bioquim Exercicio, Santa Maria, RS, Brazil; [de Oliveira Ferreira, Ana Paula] Univ Fed Santa Maria, Programa Posgrad Farmacol, Santa Maria, RS, Brazil; [Porto da Silveira Junior, Mauro Eduardo; Fiorin, Fernando da Silva; Barcelos, Romulo Pillon; Fighera, Michele Rechia; Freire Royes, Luiz Fernando] Univ Fed Santa Maria, Programa Posgrad Ciencias Biol Bioquim Toxicol, Santa Maria, RS, Brazil; [Arrifano, Gabriela; Crespo-Lopez, Maria Elena] UFPA, Lab Farmacol Mol, ICB, Belem, Para, Brazil; [Cuevas, Maria J.; Gonzalez-Gallego, Javier] Univ Leon, Inst Biomed IBIOMED, Leon, Spain; [Cuevas, Maria J.; Gonzalez-Gallego, Javier] Univ Leon, CIBERehd, Leon, Spain; [Bresciani, Guilherme] PUCV, Escuela Educ Fis, Valparaiso, Chile	Royes, LFF (corresponding author), Univ Fed Santa Maria, Dept Metodos & Tecnicas Desportivas, Ctr Educ Fis & Desportos, BR-97105900 Santa Maria, RS, Brazil.	nandoroyes@yahoo.com.br	da Silva Fiorin, Fernando/AAQ-9472-2021; Crespo-Lopez, Maria Elena/X-7912-2018; DE PAULA FONSECA ARRIFANO, GABRIELA/E-3451-2014; Fighera, Michele R/J-9576-2014; Gonzalez-Gallego, Javier/D-8219-2012; Barcelos, Romulo/J-8231-2015	Crespo-Lopez, Maria Elena/0000-0002-1335-6853; DE PAULA FONSECA ARRIFANO, GABRIELA/0000-0003-2817-3539; Gonzalez-Gallego, Javier/0000-0002-4386-9342; da Silva Fiorin, Fernando/0000-0002-6517-7160; Bresciani, Guilherme/0000-0003-1526-5573; Barcelos, Romulo/0000-0002-6366-6366	CNPq/FAPERGSConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS) [Pronem 11/2082-4]; CNPqConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) [CNPq: 306309/2013-0]; Instituto de Salud Carlos III, SpainInstituto de Salud Carlos III	The present study was supported by CNPq/FAPERGS (grants: Pronem 11/2082-4). M. R. Fighera and L. F. F. Royes are recipients of CNPq fellowships (CNPq: 306309/2013-0). CIBERehd is funded by Instituto de Salud Carlos III, Spain.	El-Kader SMA, 2014, AFR HEALTH SCI, V14, P551, DOI 10.4314/ahs.v14i3.8; AEBI H, 1984, METHOD ENZYMOL, V105, P121; AKERMAN KEO, 1976, FEBS LETT, V68, P191, DOI 10.1016/0014-5793(76)80434-6; Silva LFA, 2013, J NEUROTRAUM, V30, P1278, DOI 10.1089/neu.2012.2577; Ang ET, 2007, CURR MED CHEM, V14, P2564, DOI 10.2174/092986707782023280; Anthony DC, 2014, EXP NEUROL, V258, P105, DOI 10.1016/j.expneurol.2014.03.013; Anthony DC, 2012, BRAIN BEHAV IMMUN, V26, P534, DOI 10.1016/j.bbi.2011.10.011; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Bao F, 2011, EXP NEUROL, V231, P272, DOI 10.1016/j.expneurol.2011.07.001; Barcelos RP, 2017, FREE RADICAL RES, P1; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Bayir H, 2007, J NEUROCHEM, V101, P168, DOI 10.1111/j.1471-4159.2006.04353.x; Bergamini CM, 2004, CURR PHARM DESIGN, V10, P1611, DOI 10.2174/1381612043384664; BERRIDGE MV, 1993, ARCH BIOCHEM BIOPHYS, V303, P474, DOI 10.1006/abbi.1993.1311; Bigford GE, 2009, J NEUROTRAUM, V26, P703, DOI 10.1089/neu.2008.0783; Botezelli JD, 2016, SCI REP-UK, V6, DOI 10.1038/srep31106; Boveris A, 2008, FREE RADICAL BIO MED, V44, P224, DOI 10.1016/j.freeradbiomed.2007.08.015; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRADLEY PP, 1982, BLOOD, V60, P618; Bugianesi E, 2005, HEPATOLOGY, V42, P987, DOI 10.1002/hep.20920; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Cohen G, 1997, P NATL ACAD SCI USA, V94, P4890, DOI 10.1073/pnas.94.10.4890; D'Ambrosio R, 2004, BRAIN, V127, P304, DOI 10.1093/brain/awh038; Dong GZ, 2014, EUR J PHARMACOL, V740, P634, DOI 10.1016/j.ejphar.2014.06.017; ELLMAN GL, 1967, J LAB CLIN MED, V70, P518; Filippin LI, 2011, INFLAMM RES, V60, P347, DOI 10.1007/s00011-010-0277-2; Fiorin FD, 2016, J NEUROTRAUM, V33, P1317, DOI 10.1089/neu.2015.4068; Fiske CH, 1927, SCIENCE, V65, P401, DOI 10.1126/science.65.1686.401; Fu YH, 2014, INT IMMUNOPHARMACOL, V22, P379, DOI 10.1016/j.intimp.2014.07.015; Garcia-Mediavilla MV, 2005, J HEPATOL, V43, P606, DOI 10.1016/j.jhep.2005.04.019; Ghanbari-Niaki A, 2007, BIOCHEM BIOPH RES CO, V361, P841, DOI 10.1016/j.bbrc.2007.07.100; Gobatto CA, 2001, COMP BIOCHEM PHYS A, V130, P21, DOI 10.1016/S1095-6433(01)00362-2; Gomez-Pinilla F, 2008, SURG NEUROL, V70, P333, DOI 10.1016/j.surneu.2008.05.023; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Gupta A, 2012, J NEUROSCI, V32, P2523, DOI 10.1523/JNEUROSCI.4141-11.2012; Hall ED, 2004, J NEUROTRAUM, V21, P9, DOI 10.1089/089771504772695904; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Handelman GJ, 1998, ANAL BIOCHEM, V258, P339, DOI 10.1006/abio.1998.2592; HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2; Hoene M, 2010, EXERC IMMUNOL REV, V16, P163; Huang GJ, 2012, EUR J MED CHEM, V48, P371, DOI 10.1016/j.ejmech.2011.12.008; Hunt RF, 2011, J NEUROSCI, V31, P6880, DOI 10.1523/JNEUROSCI.0032-11.2011; INIGUEZ C, 1985, J NEUROSCI METH, V13, P77, DOI 10.1016/0165-0270(85)90045-7; Jamme I, 1995, NEUROREPORT, V7, P333; Kamm K, 2006, J TRAUMA, V60, P152, DOI 10.1097/01.ta.0000196345.81169.a1; Kazeminasab F, 2013, EUR J APPL PHYSIOL, V113, P2285, DOI 10.1007/s00421-013-2658-z; Kazeminasab S, 2012, PSYCHIAT RES, V200, P1086, DOI 10.1016/j.psychres.2012.04.006; Kim DH, 2010, PHYSIOL BEHAV, V101, P660, DOI 10.1016/j.physbeh.2010.09.021; Klein E, 2003, CAN J PSYCHIAT, V48, P28; Kostyuk VA, 2010, ANTIOXID REDOX SIGN, V13, P607, DOI 10.1089/ars.2009.2976; LEBEL CP, 1992, CHEM RES TOXICOL, V5, P227, DOI 10.1021/tx00026a012; Leeuwenburgh C, 2001, CURR MED CHEM, V8, P829, DOI 10.2174/0929867013372896; Lenzlinger PM, 2004, RESTOR NEUROL NEUROS, V22, P73; LEVINE RL, 1990, METHOD ENZYMOL, V186, P464; Lima FD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055668; Lima FD, 2008, BEHAV BRAIN RES, V193, P306, DOI 10.1016/j.bbr.2008.05.013; Lima FD, 2009, BRAIN RES, V1279, P147, DOI 10.1016/j.brainres.2009.04.052; Ljungqvist O, 2000, SURGERY, V128, P757, DOI 10.1067/msy.2000.107166; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Lubrano C, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/490613; Mansoor O, 1996, P NATL ACAD SCI USA, V93, P2714, DOI 10.1073/pnas.93.7.2714; Mansoor O, 1997, AM J PHYSIOL-ENDOC M, V273, pE898; Marquezi ML, 2003, INT J SPORT NUTR EXE, V13, P65, DOI 10.1123/ijsnem.13.1.65; Mirzayan MJ, 2008, NEUROL RES, V30, P457, DOI 10.1179/174313208X276907; MISRA HP, 1972, J BIOL CHEM, V247, P3170; Mitro N, 2007, NATURE, V445, P219, DOI 10.1038/nature05449; Moinard C, 2005, INTENS CARE MED, V31, P281, DOI 10.1007/s00134-004-2489-9; Moinard C, 2008, J NEUROTRAUM, V25, P124, DOI 10.1089/neu.2007.0391; Morel P, 1998, NEUROCHEM INT, V33, P531, DOI 10.1016/S0197-0186(98)00062-X; Moschen AR, 2008, CURR OPIN CLIN NUTR, V11, P620, DOI 10.1097/MCO.0b013e32830b5d09; Mota BC, 2012, NEUROTOX RES, V21, P175, DOI 10.1007/s12640-011-9257-8; Motta L, 2013, J SMALL ANIM PRACT, V54, P213, DOI 10.1111/jsap.12028; Motta VF, 2016, J SPORT MED PHYS FIT, V56, P655; Myhre O, 2003, BIOCHEM PHARMACOL, V65, P1575, DOI 10.1016/S0006-2952(03)00083-2; O'Connell KM, 2012, MIL MED, V177, P546, DOI 10.7205/MILMED-D-11-00422; Olsen AL, 2007, ANTIVIR RES, V75, P104, DOI 10.1016/j.antiviral.2006.11.013; Packer L, 2008, FREE RADICAL BIO MED, V44, P123, DOI 10.1016/j.freeradbiomed.2007.05.031; Pavlov I, 2011, NEUROSCIENCE, V194, P208, DOI 10.1016/j.neuroscience.2011.07.074; Petersen AMW, 2005, J APPL PHYSIOL, V98, P1154, DOI 10.1152/japplphysiol.00164.2004; Radak Z, 2008, AGEING RES REV, V7, P34, DOI 10.1016/j.arr.2007.04.004; Raghupathi R, 1998, J CEREBR BLOOD F MET, V18, P1259, DOI 10.1097/00004647-199811000-00013; Rambo LM, 2009, NEUROCHEM INT, V55, P333, DOI 10.1016/j.neuint.2009.04.007; Rao V, 2008, J NEUROPSYCH CLIN N, V20, P118, DOI 10.1176/jnp.2008.20.1.118; Ray Katrina, 2012, Nat Rev Gastroenterol Hepatol, V9, P244, DOI 10.1038/nrgastro.2012.61; Rizza RA, 2010, DIABETES, V59, P2697, DOI 10.2337/db10-1032; SALO DC, 1991, FREE RADICAL BIO MED, V11, P239, DOI 10.1016/0891-5849(91)90119-N; Salvemini Daniela, 1995, Am J Ther, V2, P616; Santhakumar V, 2000, J PHYSIOL-LONDON, V524, P117, DOI 10.1111/j.1469-7793.2000.00117.x; Shi J, 2016, ONCOTARGET; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Siems WG, 1996, FREE RADICAL BIO MED, V20, P215, DOI 10.1016/0891-5849(95)02041-1; Sigala F, 2004, TOXICOLOGY, V196, P155, DOI 10.1016/j.tox.2003.12.005; Silva VS, 2013, J INORG BIOCHEM, V128, P208, DOI 10.1016/j.jinorgbio.2013.06.011; Souza MA, 2009, EPILEPSIA, V50, P811, DOI 10.1111/j.1528-1167.2008.01908.x; Spillmann F, 2014, ATHEROSCLEROSIS, V232, P1, DOI 10.1016/j.atherosclerosis.2013.10.001; SRERE PA, 1969, ARCH BIOCHEM BIOPHYS, V129, P708, DOI 10.1016/0003-9861(69)90231-8; Sun LJ, 2010, LIFE SCI, V86, P39, DOI 10.1016/j.lfs.2009.11.003; SUZUKI K, 1983, ANAL BIOCHEM, V132, P345, DOI 10.1016/0003-2697(83)90019-2; Toldy A, 2005, BRAIN RES BULL, V65, P487, DOI 10.1016/j.brainresbull.2005.02.028; Tsatsoulis A, 2013, METABOLISM, V62, P622, DOI 10.1016/j.metabol.2012.11.004; Tsuzuki T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132029; Tunon MJ, 2011, J PINEAL RES, V50, P38, DOI 10.1111/j.1600-079X.2010.00807.x; Unterberg AW, 1997, ACT NEUR S, V70, P106; Vaynman S, 2005, NEUROREHAB NEURAL RE, V19, P283, DOI 10.1177/1545968305280753; VIGUIE CA, 1993, J APPL PHYSIOL, V75, P566; Villapol S, 2015, AM J PATHOL, V185, P2641, DOI 10.1016/j.ajpath.2015.06.016; Villapol S, 2015, BRAIN, V138, DOI 10.1093/brain/awv172; Wang GX, 2001, LIFE SCI, V69, P2801, DOI 10.1016/S0024-3205(01)01354-6; Wang XC, 2014, WORLD J GASTROENTERO, V20, P17914, DOI 10.3748/wjg.v20.i47.17914; Wang Yan-bin, 2010, Zhonghua Yi Xue Za Zhi, V90, P1716; Wang YD, 2011, HEPATOLOGY, V54, P1421, DOI 10.1002/hep.24525; WANNAMETHEE G, 1992, BRIT MED J, V304, P597, DOI 10.1136/bmj.304.6827.597; Xu J, 2008, ENDOCRINOLOGY, V149, P2369, DOI 10.1210/en.2007-0922; Yan LJ, 1996, ARCH BIOCHEM BIOPHYS, V327, P330, DOI 10.1006/abbi.1996.0130; YAN LJ, 1995, ANAL BIOCHEM, V228, P349, DOI 10.1006/abio.1995.1362; Yang SG, 2013, J NEUROSCI RES, V91, P230, DOI 10.1002/jnr.23159; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	120	11	11	0	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3751	1469-7793		J PHYSIOL-LONDON	J. Physiol.-London	SEP 1	2017	595	17					6023	6044		10.1113/JP273933			22	Neurosciences; Physiology	Neurosciences & Neurology; Physiology	FF2HY	WOS:000408719700026	28726269	Green Published, Bronze			2021-06-18	
J	Yamakawa, GR; Salberg, S; Barlow, KM; Brooks, BL; Esser, MJ; Yeates, KO; Mychasiuk, R				Yamakawa, Glenn R.; Salberg, Sabrina; Barlow, Karen M.; Brooks, Brian L.; Esser, Michael J.; Yeates, Keith Owen; Mychasiuk, Richelle			Manipulating cognitive reserve: Pre-injury environmental conditions influence the severity of concussion symptomology, gene expression, and response to melatonin treatment in rats	EXPERIMENTAL NEUROLOGY			English	Article						Mild traumatic brain injury; Epigenetic; Animal model; Telomere length; qRT-PCR	TRAUMATIC BRAIN-INJURY; OXIDATIVE STRESS; TELOMERE LENGTH; PROFESSIONAL FOOTBALL; SOCIOECONOMIC-STATUS; POSSIBLE INVOLVEMENT; NEUROTROPHIC FACTOR; DNA METHYLATION; PLASTICITY; RECEPTOR	In an effort to understand the factors that contribute to heterogeneity in outcomes often associated with mTBI in youth, this study examined the role of premorbid differences in cognitive reserve on post-concussive symptoms (PCS), molecular markers, and treatment response. Male and female rats matured in one of three environmental conditions (Stress, Enrichment, Control), received a mTBI in adolescence, and were randomized to melatonin or placebo treatment. All animals underwent a behavioural test battery designed to examine PCS. Using prefrontal cortex and hippocampus tissue, expression of 9 genes was assessed in an effort to determine how the brain's epi-genome was influenced by cognitive reserve, mTBI, and melatonin. Enrichment increased cognitive reserve (CR) and prevented lingering symptoms. Conversely, stress was associated with progressive worsening and manifestation of PCS in the longer-term. Melatonin was able to restore baseline function for control and enriched animals, but was ineffective for the stress condition. Epigenetic change in the prefrontal cortex was largely driven by the injury, while gene expression changes in the hippocampus were dependent upon cognitive reserve. The occurrence and severity of PCS is dependent upon a complex and multifaceted array of factors that modify behavioural and epigenetic responses to mTBI and its treatment. (C) 2017 Elsevier Inc. All rights reserved.	[Yamakawa, Glenn R.; Salberg, Sabrina; Barlow, Karen M.; Brooks, Brian L.; Esser, Michael J.; Yeates, Keith Owen; Mychasiuk, Richelle] Alberta Childrens Prov Gen Hosp, Res Inst, Calgary, AB, Canada; [Yeates, Keith Owen; Mychasiuk, Richelle] Cumming Sch Med, Hotchkiss Brain Inst, Calgary, AB, Canada; [Yeates, Keith Owen; Mychasiuk, Richelle] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [Barlow, Karen M.; Brooks, Brian L.; Esser, Michael J.; Yeates, Keith Owen] Univ Calgary, Dept Pediat, Calgary, AB, Canada; [Barlow, Karen M.; Brooks, Brian L.; Esser, Michael J.; Yeates, Keith Owen] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada	Mychasiuk, R (corresponding author), Univ Calgary, Alberta Childrens Hosp, Res Inst, Dept Psychol,Hotchkiss Brain Inst, 3330 Hosp Dr NW, Calgary, AB, Canada.	rmmychas@ucalgary.ca	Yeates, Keith/AAJ-4223-2020; Barlow, Karen/I-6492-2019; Barlow, Karen/C-1323-2014	Yeates, Keith/0000-0001-7680-2892; Barlow, Karen/0000-0003-2612-8507; Yamakawa, Glenn/0000-0003-3079-6532; Mychasiuk, Richelle/0000-0001-5291-5083	Alberta Children's Hospital Research Foundation; O'Brien Continuing Scholarship Research Fund; Integrated Concussion Research Program	The authors would like to thank the Alberta Children's Hospital Research Foundation, the O'Brien Continuing Scholarship Research Fund, and the Integrated Concussion Research Program for their financial assistance.	Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; Alluri H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154427; Andersen SL, 2003, NEUROSCI BIOBEHAV R, V27, P3, DOI 10.1016/S0149-7634(03)00005-8; Ates O, 2006, INT J DEV NEUROSCI, V24, P357, DOI 10.1016/j.ijdevneu.2006.08.003; Barlow KM, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-271; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Beni SM, 2004, FASEB J, V18, P149, DOI 10.1096/fj.03-0323fje; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Casey BJ, 2000, BIOL PSYCHOL, V54, P241, DOI 10.1016/S0301-0511(00)00058-2; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Ceanga M, 2010, NEUROSCI LETT, V477, P15, DOI 10.1016/j.neulet.2010.04.024; Chuang DM, 2009, TRENDS NEUROSCI, V32, P591, DOI 10.1016/j.tins.2009.06.002; Ding K, 2014, NEUROCHEM INT, V76, P23, DOI 10.1016/j.neuint.2014.06.015; Dubocovich ML, 2007, SLEEP MED, V8, pS34, DOI 10.1016/j.sleep.2007.10.007; Eitan E, 2014, TRENDS NEUROSCI, V37, P256, DOI 10.1016/j.tins.2014.02.010; Entringer S, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003580; Entringer S, 2011, P NATL ACAD SCI USA, V108, pE513, DOI 10.1073/pnas.1107759108; Epstein HT, 1999, BRAIN DEV-JPN, V21, P535, DOI 10.1016/S0387-7604(99)00066-2; Esposito E, 2010, CURR NEUROPHARMACOL, V8, P228, DOI 10.2174/157015910792246155; Fagiolini M, 2009, CURR OPIN NEUROBIOL, V19, P207, DOI 10.1016/j.conb.2009.05.009; Farmer JE, 2002, DEV NEUROPSYCHOL, V22, P455, DOI 10.1207/S15326942DN2202_2; Fay TB, 2010, J INT NEUROPSYCH SOC, V16, P94, DOI 10.1017/S1355617709991007; Feng J, 2010, NAT NEUROSCI, V13, P423, DOI 10.1038/nn.2514; Galan A., 2012, J PINEAL RES, V24; Garcia R, 2008, NEUROBIOL LEARN MEM, V89, P560, DOI 10.1016/j.nlm.2007.10.005; Griesbach GS, 2009, BRAIN RES, V1288, P105, DOI 10.1016/j.brainres.2009.06.045; Hackman DA, 2010, NAT REV NEUROSCI, V11, P651, DOI 10.1038/nrn2897; Hamberger A, 2009, NEUROSURGERY, V64, P1174, DOI 10.1227/01.NEU.0000316855.40986.2A; Hehar H, 2016, NEUROBIOL DIS, V87, P11, DOI 10.1016/j.nbd.2015.12.007; Hehar H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139842; Horch HW, 2002, NAT NEUROSCI, V5, P1177, DOI 10.1038/nn927; Joels M, 2008, TRENDS NEUROSCI, V31, P1, DOI 10.1016/j.tins.2007.10.005; Johnson NF, 2013, AGE, V35, P2045, DOI 10.1007/s11357-012-9493-8; Kamphuis W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042823; Kang HJ, 2004, J NEUROSCI, V24, P1280, DOI 10.1523/JNEUROSCI.4082-03.2004; Karver CL, 2014, CHILD NEUROPSYCHOL, V20, P343, DOI 10.1080/09297049.2013.796918; Kitraki E, 1999, NEUROENDOCRINOLOGY, V69, P331, DOI 10.1159/000054435; Knudsen EI, 2004, J COGNITIVE NEUROSCI, V16, P1412, DOI 10.1162/0898929042304796; Kurowski BG, 2011, PM&R, V3, P836, DOI 10.1016/j.pmrj.2011.05.016; Levi Y, 2013, J INT NEUROPSYCH SOC, V19, P664, DOI 10.1017/S1355617713000192; Lewen A, 2001, J CEREBR BLOOD F MET, V21, P914, DOI 10.1097/00004647-200108000-00003; Liu L, 2004, GENE, V340, P1, DOI 10.1016/j.gene.2004.06.011; Markham JA, 2004, NEURON GLIA BIOL, V1, P351, DOI 10.1017/S1740925X05000219; Mathias JL, 2015, NEUROSCI BIOBEHAV R, V55, P573, DOI 10.1016/j.neubiorev.2015.06.001; Mattson MP, 2000, EXP GERONTOL, V35, P489, DOI 10.1016/S0531-5565(00)00115-7; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; Molteni R, 2002, NEUROSCIENCE, V112, P803, DOI 10.1016/S0306-4522(02)00123-9; Moore LD, 2013, NEUROPSYCHOPHARMACOL, V38, P23, DOI 10.1038/npp.2012.112; Moretti L, 2012, LANCET NEUROL, V11, P1103, DOI 10.1016/S1474-4422(12)70226-0; Mychasiuk R, 2015, NEUROSCIENCE, V288, P145, DOI 10.1016/j.neuroscience.2014.12.034; Mychasiuk R, 2016, NEUROSCI BIOBEHAV R, V70, P189, DOI 10.1016/j.neubiorev.2016.07.013; Mychasiuk R, 2016, J NEUROSCI METH, V257, P168, DOI 10.1016/j.jneumeth.2015.10.002; Mychasiuk R, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00017; Mychasiuk R, 2015, NEUROBIOL DIS, V73, P1, DOI 10.1016/j.nbd.2014.09.003; Mychasiuk R, 2014, J NEUROTRAUM, V31, P749, DOI 10.1089/neu.2013.3132; Noguchi T, 2010, ENDOCRINOLOGY, V151, P4344, DOI 10.1210/en.2010-0266; Oldenburg C, 2016, BRAIN INJURY, V30, P146, DOI 10.3109/02699052.2015.1089598; Ostrowski NL, 1998, PSYCHONEUROENDOCRINO, V23, P989, DOI 10.1016/S0306-4530(98)00070-5; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Puterman E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010837; Radley JJ, 2005, AGEING RES REV, V4, P271, DOI 10.1016/j.arr.2005.03.004; REPPERT SM, 1995, P NATL ACAD SCI USA, V92, P8734, DOI 10.1073/pnas.92.19.8734; Richter-Levin G, 2010, CEREB CORTEX, V20, P2433, DOI 10.1093/cercor/bhp311; Ropacki MT, 2003, ARCH CLIN NEUROPSYCH, V18, P643, DOI 10.1016/S0887-6177(02)00153-1; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Ryan NP, 2016, INT J DEV NEUROSCI, V49, P23, DOI 10.1016/j.ijdevneu.2015.12.004; Schallert T., 2002, PHARM CEREBRAL ISCHE, P201; Schneider EB, 2014, NEUROLOGY, V82, P1636, DOI 10.1212/WNL.0000000000000379; Smith JA, 2013, NEUROCHEM INT, V62, P764, DOI 10.1016/j.neuint.2013.02.013; Spanswick SC, 2010, LEARN MEMORY, V17, P241, DOI 10.1101/lm.1746710; Stern Y, 1999, NEUROLOGY, V53, P1942, DOI 10.1212/WNL.53.9.1942; Sumowski JF, 2013, ARCH PHYS MED REHAB, V94, P2562, DOI 10.1016/j.apmr.2013.07.023; Tarry-Adkins JL, 2009, FASEB J, V23, P1521, DOI 10.1096/fj.08-122796; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Volmar C.-H., 2015, NEUROEPIGENETICS, V1, P20, DOI [10.1016/j.nepig.2014.10.002, DOI 10.1016/J.NEPIG.2014.10.002]; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Whalley LJ, 2004, AGEING RES REV, V3, P369, DOI 10.1016/j.arr.2004.05.001; Whishaw I. Q., 2005, BEHAV LAB RAT HDB TE; Wu AG, 2004, EUR J NEUROSCI, V19, P1699, DOI 10.1111/j.1460-9568.2004.03246.x; Xu J, 2008, BRIT J CLIN PHARMACO, V66, P901, DOI 10.1111/j.1365-2125.2008.03300.x; Yadid G, 2001, BRAIN RES, V896, P43, DOI 10.1016/S0006-8993(00)03248-0; Yuruker V, 2015, METAB BRAIN DIS, V30, P223, DOI 10.1007/s11011-014-9623-3; Zhu HY, 2000, J NEUROCHEM, V75, P117, DOI 10.1046/j.1471-4159.2000.0750117.x	85	11	11	1	6	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	SEP	2017	295						55	65		10.1016/j.expneurol.2017.06.001			11	Neurosciences	Neurosciences & Neurology	FC4OS	WOS:000406820900006	28579327				2021-06-18	
J	Hu, YN; Lu, JH; Xu, XJ; Lyu, JY; Zhang, HX				Hu, Ya'nan; Lu, Junhou; Xu, Xiaojing; Lyu, Jingya; Zhang, Huanxiang			Regulation of focal adhesion turnover in SDF-1 alpha-stimulated migration of mesenchymal stem cells in neural differentiation	SCIENTIFIC REPORTS			English	Article							HEMATOPOIETIC PROGENITOR CELLS; ENDOTHELIAL GROWTH-FACTOR; TRAUMATIC BRAIN-INJURY; TYROSINE PHOSPHORYLATION; CHEMOTACTIC RESPONSES; KINASE; ACTIVATION; ACTIN; PAXILLIN; DYNAMICS	Directed migration of the transplanted mesenchymal stem cells ( MSCs) to the lesion sites plays a pivotal role in the efficacy of cell-based therapy. Our previous study demonstrates that MSCs under varying neural differentiation states possess different migratory capacities in response to chemoattractants. However, the underlying mechanism has not been fully addressed. Herein, we show that the assembly and turnover of focal adhesions, the phosphorylation of FAK and paxillin, and the reorganisation of F-actin in MSCs are closely related to their differentiation states in response to SDF-1 alpha. Upon SDF-1 alpha stimulation, FAs turnover more rapidly with the most obvious reduction in the existing time of FAs in MSCs of 24-h preinduction that exhibit the most effective migration towards SDF-1 alpha. Further, we confirm that PI3K/Akt and MAPK pathways participate in the regulation of SDF-1 alpha-induced cell migration and FA assembly, and moreover, that the regulatory effects vary greatly depending on the differentiation states. Collectively, these results demonstrate that FA assembly and turnover, which is accompanied with F-actin reorganisation in response to SDF-1 alpha, correlates closely with the differentiation states of MSCs, which might contribute to the different chemotactic responses of these cells, and thus help develop new strategy to improve the efficacy of MSCs-based therapy.	[Hu, Ya'nan; Lu, Junhou; Xu, Xiaojing; Lyu, Jingya; Zhang, Huanxiang] Soochow Univ, Coll Med, Dept Cell Biol, Jiangsu Key Lab Stem Cell Res, Suzhou 215123, Peoples R China	Zhang, HX (corresponding author), Soochow Univ, Coll Med, Dept Cell Biol, Jiangsu Key Lab Stem Cell Res, Suzhou 215123, Peoples R China.	hzhang@suda.edu.cn		Lyu, Jingya/0000-0002-1270-625X	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31371407, 31071220]; Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by National Natural Science Foundation of China (No. 31371407 and 31071220) and the Priority Academic Program Development of Jiangsu Higher Education Institutions.	Alexanian AR, 2008, STEM CELLS DEV, V17, P1123, DOI 10.1089/scd.2007.0212; Alon R, 2011, EXP CELL RES, V317, P632, DOI 10.1016/j.yexcr.2010.12.007; Ballestrem C, 2000, MOL BIOL CELL, V11, P2999, DOI 10.1091/mbc.11.9.2999; Bellis SL, 1997, BIOCHEM J, V325, P375, DOI 10.1042/bj3250375; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Foxman EF, 1999, J CELL BIOL, V147, P577, DOI 10.1083/jcb.147.3.577; Gao H, 2009, STEM CELLS, V27, P857, DOI 10.1002/stem.23; Geiger B, 2001, CURR OPIN CELL BIOL, V13, P584, DOI 10.1016/S0955-0674(00)00255-6; Hamadi A, 2005, J CELL SCI, V118, P4415, DOI 10.1242/jcs.02565; Harting MT, 2009, J NEUROSURG, V110, P1189, DOI 10.3171/2008.9.JNS08158; Hu CJ, 2013, J SURG RES, V183, P427, DOI 10.1016/j.jss.2013.01.019; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Huang Z, 2008, CELL SIGNAL, V20, P2002, DOI 10.1016/j.cellsig.2008.07.014; Iwasaki T, 2002, INT J CANCER, V97, P330, DOI 10.1002/ijc.1609; Ji JF, 2004, STEM CELLS, V22, P415, DOI 10.1634/stemcells.22-3-415; Jimenez C, 2000, J CELL BIOL, V151, P249, DOI 10.1083/jcb.151.2.249; Karp JM, 2009, CELL STEM CELL, V4, P206, DOI 10.1016/j.stem.2009.02.001; Karussis D, 2008, J NEUROL SCI, V265, P131, DOI 10.1016/j.jns.2007.05.005; Katz BZ, 2003, J BIOL CHEM, V278, P29115, DOI 10.1074/jbc.M212396200; Kaverina I, 2002, INT J BIOCHEM CELL B, V34, P746, DOI 10.1016/S1357-2725(01)00171-6; Kim DH, 2013, FASEB J, V27, P1351, DOI 10.1096/fj.12-220160; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Leiker M, 2008, CELL TRANSPLANT, V17, P911, DOI 10.3727/096368908786576444; Liu J, 2011, J NEUROSCI RES, V89, P1173, DOI 10.1002/jnr.22623; Ma JH, 2015, NEUROL RES, V37, P50, DOI 10.1179/1743132814Y.0000000399; Marquez-Curtis LA, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/561098; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Petit V, 2000, J CELL BIOL, V148, P957, DOI 10.1083/jcb.148.5.957; Rousseau S, 2000, J BIOL CHEM, V275, P10661, DOI 10.1074/jbc.275.14.10661; Segarra J, 2006, J BIOL CHEM, V281, P4771, DOI 10.1074/jbc.M508298200; Shaw LM, 1997, CELL, V91, P949, DOI 10.1016/S0092-8674(00)80486-9; Shen Y, 1999, MOL BIOL CELL, V10, P2507, DOI 10.1091/mbc.10.8.2507; Sieg DJ, 2000, NAT CELL BIOL, V2, P249; Spaeth E, 2008, GENE THER, V15, P730, DOI 10.1038/gt.2008.39; Stehbens SJ, 2014, METHOD CELL BIOL, V123, P335, DOI 10.1016/B978-0-12-420138-5.00018-5; Togel FE, 2011, KIDNEY INT SUPPL, V1, P87, DOI 10.1038/kisup.2011.20; Tomar A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044041; Torrente Y, 2008, CELL TRANSPLANT, V17, P1103, DOI 10.3727/096368908787236576; Totsukawa G, 2004, J CELL BIOL, V164, P427, DOI 10.1083/jcb.200306172; Tureckova J, 2009, TRANSL ONCOL, V2, P281, DOI 10.1593/tlo.09160; Veit C, 2004, CANCER RES, V64, P5291, DOI 10.1158/0008-5472.CAN-04-1112; Wang JF, 2000, BLOOD, V95, P2505, DOI 10.1182/blood.V95.8.2505.008k24_2505_2513; Wang SJ, 2012, J CELL BIOL, V199, P331, DOI 10.1083/jcb.201202041; Wehrle-Haller B, 2003, INT J BIOCHEM CELL B, V35, P39, DOI 10.1016/S1357-2725(02)00071-7; Won YW, 2014, BIOMATERIALS, V35, P5627, DOI 10.1016/j.biomaterials.2014.03.070; Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007; Wu WS, 2008, CANCER METAST REV, V27, P303, DOI 10.1007/s10555-008-9112-4; Xu XJ, 2014, CELL MOL NEUROBIOL, V34, P1047, DOI 10.1007/s10571-014-0082-5; Yu JXA, 2010, CELL ADHES MIGR, V4, P342, DOI 10.4161/cam.4.3.11406; Yu YC, 2007, EUR J CANCER PREV, V16, P430, DOI 10.1097/01.cej.0000236259.88146.a4; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858; Zhang XF, 2001, BLOOD, V97, P3342, DOI 10.1182/blood.V97.11.3342; Zhao XK, 2016, SCI REP-UK, V6, DOI 10.1038/srep19276; Zheng B, 2013, J CELL PHYSIOL, V228, P149, DOI 10.1002/jcp.24114; ZICHA D, 1991, J CELL SCI, V99, P769	56	11	11	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	AUG 30	2017	7								10013	10.1038/s41598-017-09736-7			14	Multidisciplinary Sciences	Science & Technology - Other Topics	FF0WS	WOS:000408622400107	28855566	DOAJ Gold, Green Published			2021-06-18	
J	Sanchez, MIGL; Waugh, HS; Tsatsanis, A; Wong, BX; Crowston, JG; Duce, JA; Trounce, IA				Sanchez, M. Isabel G. Lopez; Waugh, Hayley S.; Tsatsanis, Andrew; Wong, Bruce X.; Crowston, Jonathan G.; Duce, James A.; Trounce, Ian A.			Amyloid precursor protein drives down-regulation of mitochondrial oxidative phosphorylation independent of amyloid beta	SCIENTIFIC REPORTS			English	Article							TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; CYTOCHROME-OXIDASE; GENE-EXPRESSION; NMDA-RECEPTOR; NEUROPROTECTION; DYSFUNCTION; PEPTIDE; ACCUMULATION; MUTATION	Amyloid precursor protein (APP) and its extracellular domain, soluble APP alpha (sAPP alpha) play important physiological and neuroprotective roles. However, rare forms of familial Alzheimer's disease are associated with mutations in APP that increase toxic amyloidogenic cleavage of APP and produce amyloid beta (A beta) at the expense of sAPPa and other non-amyloidogenic fragments. Although mitochondrial dysfunction has become an established hallmark of neurotoxicity, the link between A beta and mitochondrial function is unclear. In this study we investigated the effects of increased levels of neuronal APP or A beta on mitochondrial metabolism and gene expression, in human SH-SY5Y neuroblastoma cells. Increased non-amyloidogenic processing of APP, but not A beta, profoundly decreased respiration and enhanced glycolysis, while mitochondrial DNA (mtDNA) transcripts were decreased, without detrimental effects to cell growth. These effects cannot be ascribed to A beta toxicity, since higher levels of endogenous A beta in our models do not cause oxidative phosphorylation (OXPHOS) perturbations. Similarly, chemical inhibition of beta-secretase decreased mitochondrial respiration, suggesting that non-amyloidogenic processing of APP may be responsible for mitochondrial changes. Our results have two important implications, the need for caution in the interpretation of mitochondrial perturbations in models where APP is overexpressed, and a potential role of sAPPa or other non-amyloid APP fragments as acute modulators of mitochondrial metabolism.	[Sanchez, M. Isabel G. Lopez; Waugh, Hayley S.; Crowston, Jonathan G.; Trounce, Ian A.] Ctr Eye Res Australia, 75 Commercial Rd, Melbourne, Vic 3004, Australia; [Sanchez, M. Isabel G. Lopez; Waugh, Hayley S.; Crowston, Jonathan G.; Trounce, Ian A.] Univ Melbourne, Dept Surg, Ophthalmol, Melbourne, Vic, Australia; [Tsatsanis, Andrew; Wong, Bruce X.; Duce, James A.] Univ Leeds, Fac Biol Sci, Sch Biomed Sci, Leeds LS2 9JT, W Yorkshire, England; [Wong, Bruce X.; Duce, James A.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Oxidat Biol Unit, 30 Royal Parade, Parkville, Vic 3052, Australia	Trounce, IA (corresponding author), Ctr Eye Res Australia, 75 Commercial Rd, Melbourne, Vic 3004, Australia.; Trounce, IA (corresponding author), Univ Melbourne, Dept Surg, Ophthalmol, Melbourne, Vic, Australia.	i.trounce@unimelb.edu.au	Sanchez, Isabel G Lopez/A-5472-2019; Wong, Bruce/AAY-5884-2020; Trounce, Ian A/F-8338-2010	Sanchez, Isabel G Lopez/0000-0002-1528-5964; Wong, Bruce/0000-0002-1687-4138; Trounce, Ian A/0000-0002-1070-8892	BrightFocus FoundationBrightFocus Foundation [G2009020]; DHB Foundation	This research was supported by the BrightFocus Foundation Thomas R. Lee award (G2009020) and DHB Foundation. CERA receives Operational Infrastructure Support from the Victorian Government, Australia.	Anandatheerthavarada HK, 2003, J CELL BIOL, V161, P41, DOI 10.1083/jcb.200207030; Ayton S, 2014, FREE RADICAL BIO MED, V69, P331, DOI 10.1016/j.freeradbiomed.2014.01.041; Belyaev ND, 2010, J BIOL CHEM, V285, P41443, DOI 10.1074/jbc.M110.141390; Bour A, 2004, NEUROBIOL LEARN MEM, V81, P27, DOI 10.1016/S1074-7427(03)00071-6; Cardoso SM, 2004, J NEUROCHEM, V89, P1417, DOI 10.1111/j.1471-4159.2004.02438.x; Ciallella JR, 2002, J NEUROTRAUM, V19, P1555, DOI 10.1089/089771502762300229; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Clarke J, 2007, EUR J NEUROSCI, V26, P1845, DOI 10.1111/j.1460-9568.2007.05807.x; Corrigan F, 2014, J NEUROCHEM, V128, P196, DOI 10.1111/jnc.12391; Corrigan F, 2012, J NEUROCHEM, V122, P208, DOI 10.1111/j.1471-4159.2012.07761.x; Crouch PJ, 2005, J NEUROSCI, V25, P672, DOI 10.1523/JNEUROSCI.4276-04.2005; Devi L, 2006, J NEUROSCI, V26, P9057, DOI 10.1523/JNEUROSCI.1469-06.2006; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; Forman MS, 1997, J BIOL CHEM, V272, P32247, DOI 10.1074/jbc.272.51.32247; GOODMAN Y, 1994, EXP NEUROL, V128, P1, DOI 10.1006/exnr.1994.1107; Gralle M, 2009, J BIOL CHEM, V284, P15016, DOI 10.1074/jbc.M808755200; HAASS C, 1993, J BIOL CHEM, V268, P3021; Haass C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006270; Harkany T, 2000, NEUROSCIENCE, V101, P101, DOI 10.1016/S0306-4522(00)00296-7; Hauptmann S, 2009, NEUROBIOL AGING, V30, P1574, DOI 10.1016/j.neurobiolaging.2007.12.005; HOLLOSZY JO, 1970, BIOCHEM BIOPH RES CO, V40, P1368, DOI 10.1016/0006-291X(70)90017-3; Itoh T, 2009, NEUROL RES, V31, P103, DOI 10.1179/016164108X323771; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Keil U, 2004, J BIOL CHEM, V279, P50310, DOI 10.1074/jbc.M405600200; Kish SJ, 1999, J NEUROCHEM, V72, P700, DOI 10.1046/j.1471-4159.1999.0720700.x; KISH SJ, 1992, J NEUROCHEM, V59, P776, DOI 10.1111/j.1471-4159.1992.tb09439.x; Kogel D, 2012, EXP BRAIN RES, V217, P471, DOI 10.1007/s00221-011-2932-4; Kojro E, 2005, SUB CELL BIOCHEM, V38, P105; Kozera B, 2013, J APPL GENET, V54, P391, DOI 10.1007/s13353-013-0173-x; Krako N, 2013, J ALZHEIMERS DIS, V37, P747, DOI 10.3233/JAD-130728; Lim SC, 2016, FASEB J, V30, P2236, DOI 10.1096/fj.201500137R; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manczak M, 2006, HUM MOL GENET, V15, P1437, DOI 10.1093/hmg/ddl066; Mann DMA, 1996, AM J PATHOL, V148, P1257; Milosch N, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.352; Morais VA, 2010, J ALZHEIMERS DIS, V20, pS255, DOI 10.3233/JAD-2010-100345; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; MUTISYA EM, 1994, J NEUROCHEM, V63, P2179; PARKER WD, 1990, NEUROLOGY, V40, P1302, DOI 10.1212/WNL.40.8.1302; Parks JK, 2001, J NEUROCHEM, V76, P1050, DOI 10.1046/j.1471-4159.2001.00112.x; Pierce JES, 1996, J NEUROSCI, V16, P1083; Plummer S, 2016, AGING DIS, V7, P163, DOI 10.14336/AD.2015.0907; Rackham O, 2012, WIRES RNA, V3, P675, DOI 10.1002/wrna.1128; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Reddy PH, 2008, TRENDS MOL MED, V14, P45, DOI 10.1016/j.molmed.2007.12.002; Rhein V, 2009, CELL MOL NEUROBIOL, V29, P1063, DOI 10.1007/s10571-009-9398-y; Rhein V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012359; Sanchez MIGL, 2016, PHARMACOL THERAPEUT, V165, P132, DOI 10.1016/j.pharmthera.2016.06.004; Sanchez MIGL, 2015, MOL ENDOCRINOL, V29, P14, DOI 10.1210/me.2014-1077; Sanchez MIGL, 2011, CELL CYCLE, V10, P2904, DOI 10.4161/cc.10.17.17060; Schaefer PM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168157; SCHUBERT D, 1993, BRAIN RES, V629, P275, DOI 10.1016/0006-8993(93)91331-L; Shukla V, 2011, ADV PHARMACOL SCI, V2011, DOI 10.1155/2011/572634; Taylor CJ, 2008, NEUROBIOL DIS, V31, P250, DOI 10.1016/j.nbd.2008.04.011; Thornton E, 2006, BRAIN RES, V1094, P38, DOI 10.1016/j.brainres.2006.03.107; TROUNCE I, 1994, P NATL ACAD SCI USA, V91, P8334, DOI 10.1073/pnas.91.18.8334; Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0; Van Bergen NJ, 2014, MITOCHONDRION, V15, P24, DOI 10.1016/j.mito.2014.03.003; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Wang XL, 2008, P NATL ACAD SCI USA, V105, P19318, DOI 10.1073/pnas.0804871105; WILLIAMS RS, 1986, J BIOL CHEM, V261, P376; Yang TT, 2009, MECH AGEING DEV, V130, P592, DOI 10.1016/j.mad.2009.07.002	63	11	11	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	AUG 29	2017	7								9835	10.1038/s41598-017-10233-0			10	Multidisciplinary Sciences	Science & Technology - Other Topics	FE9QL	WOS:000408538100077	28852095	DOAJ Gold, Green Published			2021-06-18	
J	Xin, YC; Liu, HY; Zhang, P; Chang, LH; Xie, KL				Xin, Yuchang; Liu, Huiying; Zhang, Peng; Chang, Liuhui; Xie, Keliang			Molecular hydrogen inhalation attenuates postoperative cognitive impairment in rats	NEUROREPORT			English	Article						caspase-3 activity; molecular hydrogen; postoperative cognitive impairment; proinflammatory cytokines	REDUCING OXIDATIVE STRESS; ISCHEMIA-REPERFUSION INJURY; FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; RICH SALINE; CARDIAC-SURGERY; INFLAMMATION; DYSFUNCTION; NEUROINFLAMMATION; MODEL	Postoperative cognitive decline is a major clinical problem with high morbidity and mortality after surgery. Many studies have found that molecular hydrogen ( H-2) has significant neuroprotection against acute and chronic neurological injury by regulating inflammation and apoptosis. In this study, we hypothesized that H-2 treatment could ameliorate the development of cognitive impairment following surgery. Adult male rats were subjected to stabilized tibial fracture operation under anesthesia. Two percent of H-2 was inhaled for 3 h beginning at 1 h after surgery. Separate cohorts of rats were tested for cognitive function with fear conditioning and the Y-maze test, or euthanized to assess blood-brain barrier integrity, and systemic and hippocampal proinflammatory cytokine and caspase-3 activity. Surgery-challenged animals showed significant cognitive impairment evidenced by a decreased percentage of freezing time and an increased number of learning trials on days 1, 3, and 7 after operation, which were significantly improved by H-2 treatment. Furthermore, H2 treatment significantly ameliorated the increase in serum and hippocampal proinflammatory cytokines tumor necrosis factor-a, interleukin-1 beta, interleukin-6, and highmobility group protein 1 in surgery-challenged animals. Moreover, H-2 treatment markedly improved blood-brain barrier integrity and reduced caspase-3 activity in the hippocampus of surgery-challenged animals. These findings suggest that H-2 treatment could significantly mitigate surgery-induced cognitive impairment by regulating inflammation and apoptosis. Copyright (C) 2017 Wolters Kluwer Health, Inc. All rights reserved.	[Xin, Yuchang; Chang, Liuhui] Soochow Univ, Affiliated Hosp 2, Dept Anesthesiol, Suzhou, Peoples R China; [Zhang, Peng] Soochow Univ, Affiliated Hosp 2, Dept Orthopaed, Suzhou 215004, Peoples R China; [Liu, Huiying] PLA, Hosp 307, Dept Resp & Crit Care Dis, Beijing, Peoples R China; [Xie, Keliang] Tianjin Med Univ, Gen Hosp, Dept Anesthesiol, Tianjin Inst Anesthesiol, Tianjin 300052, Peoples R China	Zhang, P (corresponding author), Soochow Univ, Affiliated Hosp 2, Dept Orthopaed, Suzhou 215004, Peoples R China.; Xie, KL (corresponding author), Tianjin Med Univ, Gen Hosp, Dept Anesthesiol, Tianjin Inst Anesthesiol, Tianjin 300052, Peoples R China.	tougaozy2011@126.com; xiekeliang2009@hotmail.com					Barber PA, 2009, ANN THORAC SURG, V87, P672, DOI 10.1016/j.athoracsur.2008.05.021; Cibelli M, 2010, ANN NEUROL, V68, P360, DOI 10.1002/ana.22082; Cui J, 2016, NEUROSCIENCE, V335, P232, DOI 10.1016/j.neuroscience.2016.08.021; Cui YM, 2014, J SURG RES, V192, P564, DOI 10.1016/j.jss.2014.05.060; Dohi K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108034; Fidalgo AR, 2011, NEUROSCI LETT, V498, P63, DOI 10.1016/j.neulet.2011.04.063; Green D, 2015, BRIT J ANAESTH, V114, P343, DOI 10.1093/bja/aeu471; He HJ, 2012, CNS NEUROSCI THER, V18, P994, DOI 10.1111/cns.12018; Hovens IB, 2016, BRAIN BEHAV IMMUN, V54, P178, DOI 10.1016/j.bbi.2016.02.003; Ji Q, 2011, SURG RES, V168, P95; Ji XT, 2012, J SURG RES, V178, pE9, DOI 10.1016/j.jss.2011.12.038; Ji XT, 2010, BRAIN RES, V1354, P196, DOI 10.1016/j.brainres.2010.07.038; Jin WJ, 2014, NEUROREPORT, V25, P1, DOI 10.1097/WNR.0000000000000082; Kim J, 2016, ANESTH ANALG, V123, P436, DOI 10.1213/ANE.0000000000001352; Le Freche H, 2012, ANESTHESIOLOGY, V116, P779, DOI 10.1097/ALN.0b013e31824be8c7; Li J, 2010, BRAIN RES, V1328, P152, DOI 10.1016/j.brainres.2010.02.046; Li JJ, 2012, BRAIN RES, V1486, P103, DOI 10.1016/j.brainres.2012.09.031; Liu LL, 2014, BRAIN RES, V1589, P78, DOI 10.1016/j.brainres.2014.09.030; Liu Y, 2011, MED GAS RES, V1, DOI 10.1186/2045-9912-1-15; Sun L, 2014, NEUROREPORT, V25, P718, DOI 10.1097/WNR.0000000000000181; Terrando N, 2011, ANN NEUROL, V70, P986, DOI 10.1002/ana.22664; Terrando N, 2010, P NATL ACAD SCI USA, V107, P20518, DOI 10.1073/pnas.1014557107; Tian RF, 2016, BRAIN RES, V1637, P1, DOI 10.1016/j.brainres.2016.01.029; Tian Y, 2017, MOL NEUROBIOL, V54, P2579, DOI 10.1007/s12035-016-9825-2; Wan YJ, 2007, ANESTHESIOLOGY, V106, P436, DOI 10.1097/00000542-200703000-00007; Wang C, 2011, NEUROSCI LETT, V491, P127, DOI 10.1016/j.neulet.2011.01.022; Xie KL, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/807635; Xie KL, 2012, SHOCK, V37, P548, DOI 10.1097/SHK.0b013e31824ddc81; Xie KL, 2010, SHOCK, V34, P90, DOI 10.1097/SHK.0b013e3181cdc4ae; Xie ZC, 2013, ANN SURG, V258, P364, DOI 10.1097/SLA.0b013e318298b077; Yonamine R, 2013, ANESTHESIOLOGY, V118, P105, DOI 10.1097/ALN.0b013e318275146d	31	11	13	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0959-4965	1473-558X		NEUROREPORT	Neuroreport	AUG 2	2017	28	11					694	700		10.1097/WNR.0000000000000824			7	Neurosciences	Neurosciences & Neurology	EZ4BN	WOS:000404656000013	28614179				2021-06-18	
J	Fares, J; Gebeily, S; Saad, M; Harati, H; Nabha, S; Said, N; Kanso, M; Rassou, RA; Fares, Y				Fares, Jawad; Gebeily, Souheil; Saad, Mohamad; Harati, Hayat; Nabha, Sanaa; Said, Najwane; Kanso, Mohamad; Rassou, Ronza Abdel; Fares, Youssef			Post-traumatic stress disorder in adult victims of cluster munitions in Lebanon: a 10-year longitudinal study	BMJ OPEN			English	Article							TRAUMATIC BRAIN-INJURY; PRECLINICAL MEDICAL-STUDENTS; SOUTH LEBANON; WAR VETERANS; PRIMARY-CARE; PSYCHOLOGICAL IMPACT; VIETNAM VETERANS; MENTAL-HEALTH; MAJOR TRAUMA; RISK-FACTORS	Objective This study aims to explore the short-term and long-term prevalence and effects of post-traumatic stress disorder (PTSD) among victims of cluster munitions. Design and setting A prospective 10-year longitudinal study that took place in Lebanon. Participants Two-hundred-and-forty-four Lebanese civilian victims of submunition blasts, who were injured in 2006 and were over 18 years old, were interviewed. Included were participants who had been diagnosed with PTSD according to the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) and the PTSD Checklist-Civilian Version in 2006. Interviewees were present for the 10-year follow-up. Main outcome measures PTSD prevalence rates of participants in 2006 and 2016 were compared. Analysis of the demographical data pertaining to the association of long-term PTSD with other variables was performed. p Values <0.05 were considered statistically significant for all analyses (95% CI). Results All the 244 civilians injured by cluster munitions in 2006 responded, and were present for long-term follow-up in 2016. The prevalence of PTSD decreased significantly from 98% to 43% after 10 years (p<0.001). A lower long-term prevalence was significantly associated with male sex (p<0.001), family support (p<0.001) and religion (p<0.001). Hospitalisation (p=0.005) and severe functional impairment (p<0.001) post-trauma were significantly associated with increased prevalence of long-term PTSD. Symptoms of negative cognition and mood were more common in the long run. In addition, job instability was the most frequent socioeconomic repercussion among the participants (88%). Conclusions Psychological symptoms, especially PTSD, remain high in war-affected populations many years after the war; this is particularly evident for Lebanese civilians who were victimised by cluster munitions. Screening programmes and psychological interventions need to be implemented in vulnerable populations exposed to war traumas. Officials and public health advocates should consider the socioeconomic implications, and help raise awareness against the harm induced by cluster munitions and similar weaponry.	[Fares, Jawad; Gebeily, Souheil; Saad, Mohamad; Harati, Hayat; Nabha, Sanaa; Said, Najwane; Kanso, Mohamad; Rassou, Ronza Abdel; Fares, Youssef] Lebanese Univ, Neurosci Res Ctr, Fac Med Sci, Beirut, Lebanon; [Fares, Jawad] Amer Univ Beirut, Fac Med, Beirut, Lebanon; [Gebeily, Souheil] Lebanese Univ, Fac Med Sci, Dept Neurol, Beirut, Lebanon; [Saad, Mohamad] Univ Washington, Dept Biostat, Div Stat Genet, Seattle, WA 98195 USA; [Kanso, Mohamad] Amer Univ, Beirut Med Ctr, Dept Emergency Med, Beirut, Lebanon; [Rassou, Ronza Abdel] Hop Robert Debre, Inst Natl Sante & Rech Med, UMR 1141, Paris, France; [Fares, Youssef] Lebanese Univ, Dept Neurosurg, Fac Med Sci, Beirut, Lebanon	Fares, J; Fares, Y (corresponding author), Lebanese Univ, Neurosci Res Ctr, Fac Med Sci, Beirut, Lebanon.; Fares, J (corresponding author), Amer Univ Beirut, Fac Med, Beirut, Lebanon.; Fares, Y (corresponding author), Lebanese Univ, Dept Neurosurg, Fac Med Sci, Beirut, Lebanon.	jyf04@mail.aub.edu; yfares@ul.edu.lb	Fares, Jawad/X-4341-2018	Fares, Jawad/0000-0002-5368-8764	Central Administration of the Lebanese University, Beirut, Lebanon	This research was funded by a grant from the Central Administration of the Lebanese University, Beirut, Lebanon.	Abou-Abbass H, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005342; Basoglu M, 2005, JAMA-J AM MED ASSOC, V294, P580, DOI 10.1001/jama.294.5.580; Bedrossian N, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00016; Beehner L., 2006, BACKGROUNDER; Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; Boscarino JA, 2004, ANN NY ACAD SCI, V1032, P141, DOI 10.1196/annals.1314.011; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; Copeland-Linder N, 2006, J COMMUNITY PSYCHOL, V34, P577, DOI 10.1002/jcop.20116; de Jong JTVM, 2001, JAMA-J AM MED ASSOC, V286, P555, DOI 10.1001/jama.286.5.555; DiGrande L, 2011, AM J EPIDEMIOL, V173, P271, DOI 10.1093/aje/kwq372; Fares J, 2016, J EPIDEMIOL GLOB HEA, V6, P177, DOI 10.1016/j.jegh.2015.10.003; Fares J, 2016, N AM J MED SCI, V8, P75, DOI 10.4103/1947-2714.177299; Fares Y, 2017, WORLD NEUROSURG, V99, P524, DOI 10.1016/j.wneu.2016.12.014; Fares Y, 2014, NEUROL SCI, V35, P905, DOI 10.1007/s10072-013-1623-2; Fares Y, 2013, NEUROL SCI, V34, P2095, DOI 10.1007/s10072-013-1343-7; Fares Y, 2013, J INFECT PUBLIC HEAL, V6, P482, DOI 10.1016/j.jiph.2013.05.006; Fares Y, 2013, NEUROL SCI, V34, P1971, DOI 10.1007/s10072-013-1427-4; Farhood L., 2014, OPEN PSYCHIAT J, V8, P1, DOI DOI 10.2174/1874354401408010001; Farhood L, 2006, J TRANSCULT NURS, V17, P333, DOI 10.1177/1043659606291549; Farhood LF, 2016, EUR J PSYCHOTRAUMATO, V7, DOI 10.3402/ejpt.v7.31509; Farhood LF, 2012, SOC PSYCH PSYCH EPID, V47, P639, DOI 10.1007/s00127-011-0368-6; Feder A, 2013, J AFFECT DISORDERS, V147, P156, DOI 10.1016/j.jad.2012.10.027; Freedman SA, 1999, BRIT J PSYCHIAT, V174, P353, DOI 10.1192/bjp.174.4.353; Freedy JR, 2010, FAM PRACT, V27, P615, DOI 10.1093/fampra/cmq049; Gates MA, 2012, PSYCHOL SERV, V9, P361, DOI 10.1037/a0027649; Greist J., 2014, POSTTRAUMATIC STRESS; Hall BJ, 2008, J TRAUMA STRESS, V21, P22, DOI 10.1002/jts.20301; Hasanovic M, 2010, PSYCHIAT DANUB, V22, P203; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Holbrook TL, 2002, J TRAUMA, V53, P882, DOI 10.1097/00005373-200211000-00012; Holbrook TL, 2005, J TRAUMA, V58, P764, DOI 10.1097/01.TA.0000159247.48547.7D; Hoteit A., 2016, CANADIAN SOCIAL SCI, V12, P1; Hoteit A, 2015, CANADIAN SOCIAL SCI, V11, P42; Hoteit A, 2014, SCI AFRIC J SCI ISSU, V2, P469; Hoteit A., 2015, INT J DEV RES, V5; Javidi H, 2011, INT J OCCUP ENV MED, V3; Johnson H, 2008, CLIN PSYCHOL REV, V28, P36, DOI 10.1016/j.cpr.2007.01.017; JORDAN BK, 1992, J CONSULT CLIN PSYCH, V60, P916, DOI 10.1037/0022-006X.60.6.916; Karam EG, 2014, J TRAUMA STRESS, V27, P192, DOI 10.1002/jts.21895; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Khamis V, 2012, SOC SCI MED, V74, P2005, DOI 10.1016/j.socscimed.2012.02.025; Koren D, 2005, AM J PSYCHIAT, V162, P276, DOI 10.1176/appi.ajp.162.2.276; Kulka R. A., 1990, TRAUMA VIETNAM WAR G; Long N, 1996, AUST NZ J PSYCHIAT, V30, P253, DOI 10.3109/00048679609076102; McAllister TW, 2010, ANN NY ACAD SCI, V1208, P46, DOI 10.1111/j.1749-6632.2010.05720.x; Mollica RF, 2002, BRIT J PSYCHIAT, V181, P339, DOI 10.1192/bjp.181.4.339; Mora AG, 2009, J TRAUMA, V66, pS178, DOI 10.1097/TA.0b013e31819ce2d6; O'Toole BI, 2009, AM J EPIDEMIOL, V170, P318, DOI 10.1093/aje/kwp146; Ohry A, 1996, BRAIN INJURY, V10, P687, DOI 10.1080/026990596124106; OZER EJ, 2008, ANN M INT SOC TRAUM; Priebe S, 2010, ARCH GEN PSYCHIAT, V67, P518, DOI 10.1001/archgenpsychiatry.2010.37; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Shalev AY, 1996, AM J PSYCHIAT, V153, P219; Shalev AY, 1998, AM J PSYCHIAT, V155, P630, DOI 10.1176/ajp.155.5.630; Smith Mark W, 2005, Ment Health Serv Res, V7, P89, DOI 10.1007/s11020-005-3780-2; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Verger P, 2004, AM J PSYCHIAT, V161, P1384, DOI 10.1176/appi.ajp.161.8.1384; Yeager DE, 2007, GEN HOSP PSYCHIAT, V29, P294, DOI 10.1016/j.genhosppsych.2007.03.004	59	11	12	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open	AUG	2017	7	8							e017214	10.1136/bmjopen-2017-017214			8	Medicine, General & Internal	General & Internal Medicine	FI2UT	WOS:000411802700245	28821528	DOAJ Gold, Green Published			2021-06-18	
J	Ottomanelli, L; Goetz, LL; Barnett, SD; Njoh, E; Dixon, TM; Holmes, SA; LePage, JP; Ota, D; Sabharwal, S; White, KT				Ottomanelli, Lisa; Goetz, Lance L.; Barnett, Scott D.; Njoh, Eni; Dixon, Thomas M.; Holmes, Sally Ann; LePage, James P.; Ota, Doug; Sabharwal, Sunil; White, Kevin T.			Individual Placement and Support in Spinal Cord Injury: A Longitudinal Observational Study of Employment Outcomes	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Employment, supported; Rehabilitation; Rehabilitation, vocational; Spinal cord injuries; Veterans	QUALITY-OF-LIFE; VOCATIONAL INTERESTS; VETERANS; WORK; INTERVENTIONS; FIDELITY; PROGRAM; PEOPLE; RETURN; REHABILITATION	Objective: To determine the effects of a 24-month program of Individual Placement and Support (IPS) supported employment (SE) on employment outcomes for veterans with spinal cord injury (SCI). Design: Longitudinal, observational multisite study of a single-arm, nonrandomized cohort. Setting: SCI centers in the Veterans Health Administration (n=7). Participants: Veterans with SCI (N=213) enrolled during an episode of either inpatient hospital care (24.4%) or outpatient care (75.6%). More than half the sample (59.2%) had a history of traumatic brain injury (TBI). Intervention: IPS SE for 24 months. Main Outcome Measure: Competitive employment. Results: Over the 24-month period, 92 of 213 IPS participants obtained competitive jobs for an overall employment rate of 43.2%. For the subsample of participants without TBI enrolled as outpatients (n=69), 36 obtained competitive jobs for an overall employment rate of 52.2%. Overall, employed participants averaged 38.2 +/- 29.7 weeks of employment, with an average time to first employment of 348.3 +/- 220.0 days. Nearly 25% of first jobs occurred within 4 to 6 months of beginning the program. Similar employment characteristics were observed in the subsample without TBI history enrolled as outpatients. Conclusions: Almost half of the veterans with SCI participating in the 24-month IPS program as part of their ongoing SCI care achieved competitive employment, consistent with their expressed preferences at the start of the study. Among a subsample of veterans without TBI history enrolled as outpatients, employment rates were >50%. Time to first employment was highly variable, but quite long in many instances. These findings support offering continued IPS services as part of ongoing SCI care to achieve positive employment outcomes. (C) 2017 by the American Congress of Rehabilitation Medicine	[Ottomanelli, Lisa; Barnett, Scott D.; Njoh, Eni; White, Kevin T.] James A Haley Vet Hosp, Vet Affairs Hlth Serv Res & Dev, Ctr Innovat Disabil & Rehabil Res, Tampa, FL 33612 USA; [Ottomanelli, Lisa] Univ S Florida, Dept Rehabil & Mental Hlth Counseling, Tampa, FL USA; [Goetz, Lance L.] Hunter Holmes McGuire Vet Affairs Med Ctr, Richmond, VA USA; [Goetz, Lance L.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA; [Dixon, Thomas M.] Louis Stokes Cleveland Dept Vet Affairs Med Ctr, Cleveland, OH USA; [Holmes, Sally Ann] Michael E DeBakey VA Med Ctr, Houston, TX USA; [LePage, James P.] Vet Affairs North Texas Healthcare Syst, Dallas, TX USA; [LePage, James P.] Univ Texas Southwestern Med Sch, Dept Psychiat, Dallas, TX USA; [Ota, Doug] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Ota, Doug] Stanford Univ, Div Phys Med & Rehabil, Stanford, CA 94305 USA; [Sabharwal, Sunil] Vet Affairs Boston Hlth Care Syst, Boston, MA USA; [Sabharwal, Sunil] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA USA	Ottomanelli, L (corresponding author), James A Haley Vet Hosp, 8900 Grand Oak Circle, Tampa, FL 33637 USA.	lisa.ottomanelli-slone@va.gov			Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Rehabilitation Research and Development ServiceUS Department of Veterans Affairs [O7824R]	Supported by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Rehabilitation Research and Development Service (project no. O7824R).	Anderson D, 2007, J VOCAT REHABIL, V27, P57; Becker DR, 2011, AM J PSYCHIATR REHAB, V14, P230, DOI 10.1080/15487768.2011.598083; Becker DR, 2006, EVID-BASED MENT HEAL, V9, P22, DOI 10.1136/ebmh.9.1.22; Bond GR, 2008, PSYCHIATR REHABIL J, V31, P300, DOI 10.2975/31.4.2008.300.305; Bond GR, 1997, REHABIL COUNS BULL, V40, P265; Bond GR, 2001, PSYCHIATR SERV, V52, P313, DOI 10.1176/appi.ps.52.3.313; Bond GR, 2004, PSYCHIATR REHABIL J, V27, P345, DOI 10.2975/27.2004.345.359; BOND GR, 2001, J MENTAL HLTH, V10, P383, DOI DOI 10.1080/09638230124258; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Drake R. E., 2012, INDIVIDUAL PLACEMENT; Ferdiana A, 2014, J REHABIL MED, V46, P984, DOI 10.2340/16501977-1873; Franceschini M, 2012, SPINAL CORD, V50, P238, DOI 10.1038/sc.2011.131; GUTTMANN L, 1954, P ROY SOC MED, V47, P1099, DOI 10.1177/003591575404701226; Kennedy P, 2006, SPINAL CORD, V44, P95, DOI 10.1038/sj.sc.3101787; Kennedy P, 2016, SPINAL CORD, V54, P141, DOI 10.1038/sc.2015.122; Krause JS, 2010, J VOCAT REHABIL, V33, P89, DOI 10.3233/JVR-2010-0518; Krause James S, 2015, Top Spinal Cord Inj Rehabil, V21, P189, DOI 10.1309/sci2103-189; Krause JS, 2014, REHABIL PSYCHOL, V59, P321, DOI 10.1037/a0037265; Krause JS, 2012, ARCH PHYS MED REHAB, V93, P373, DOI 10.1016/j.apmr.2011.09.006; Krause JS, 2011, ARCH PHYS MED REHAB, V92, P626, DOI 10.1016/j.apmr.2010.11.026; KRAUSE JS, 1992, REHABIL COUNS BULL, V35, P218; Krause JS, 1999, ARCH PHYS MED REHAB, V80, P1492; Latimer EA, 2004, PSYCHIAT SERV, V55, P401, DOI 10.1176/appi.ps.55.4.401; Leduc BE, 2002, DISABIL REHABIL, V24, P196, DOI 10.1080/09638280110067603; Marini I, 2008, J VOCAT REHABIL, V28, P1; Marshall T, 2014, PSYCHIAT SERV, V65, P16, DOI 10.1176/appi.ps.201300262; Meade Michelle A, 2015, Top Spinal Cord Inj Rehabil, V21, P1, DOI 10.1310/sci2101-1; Ottomanelli L, 2016, HDB RETURN WORK RES, P519; Ottomanelli Lisa, 2015, Top Spinal Cord Inj Rehabil, V21, P31, DOI 10.1310/sci2101-31; Ottomanelli L, 2014, ARCH PHYS MED REHAB, V95, P784, DOI 10.1016/j.apmr.2013.11.012; Ottomanelli L, 2013, QUAL LIFE RES, V22, P2133, DOI 10.1007/s11136-013-0353-5; Ottomanelli L, 2012, ARCH PHYS MED REHAB, V93, P740, DOI 10.1016/j.apmr.2012.01.002; Ottomanelli L, 2009, J REHABIL RES DEV, V46, P919, DOI 10.1682/JRRD.2008.10.0145; Ottomanelli L, 2009, J SPINAL CORD MED, V32, P503, DOI 10.1080/10790268.2009.11754553; Roels EH, 2016, SPINAL CORD, V54, P2, DOI 10.1038/sc.2015.133; Rohe DE, 1999, REHABIL PSYCHOL, V44, P160, DOI 10.1037/0090-5550.44.2.160; Sinnott PL, 2014, ARCH PHYS MED REHAB, V95, P1254, DOI 10.1016/j.apmr.2014.01.010; Trenaman LM, 2014, SPINAL CORD, V52, P788, DOI 10.1038/sc.2014.149; Trenaman L, 2015, J SPINAL CORD MED, V38, P422, DOI 10.1179/2045772315Y.0000000031; Wehman P, 2003, ARCH PHYS MED REHAB, V84, P192, DOI 10.1053/apmr.2003.50027; WEST M, 1991, ARCH PHYS MED REHAB, V72, P127; World Health Organization & ISCOS, 2014, INT PERSP SPIN CORD	42	11	11	0	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	AUG	2017	98	8					1567	1575		10.1016/j.apmr.2016.12.010			9	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	FD1OF	WOS:000407305900009	28115071				2021-06-18	
J	Antonakakis, M; Dimitriadis, SI; Zervakis, M; Papanicolaou, AC; Zouridakis, G				Antonakakis, Marios; Dimitriadis, Stavros I.; Zervakis, Michalis; Papanicolaou, Andrew C.; Zouridakis, George			RECONFIGURATION OF DOMINANT COUPLING MODES IN MILD TRAUMATIC BRAIN INJURY MEDIATED BY delta-BAND ACTIVITY: A RESTING STATE MEG STUDY	NEUROSCIENCE			English	Article						magnetoencephalography (MEG); mild traumatic brain injury (mTBI); cross-frequency coupling; intrinsic networks; brain network models	RICH-CLUB ORGANIZATION; SMALL-WORLD NETWORKS; FUNCTIONAL CONNECTIVITY; IMAGING APPROACH; FREQUENCY; MAGNETOENCEPHALOGRAPHY; SCHIZOPHRENIA; DYNAMICS; EEG; THETA	During the last few years, rich-club (RC) organization has been studied as a possible brain-connectivity organization model for large-scale brain networks. At the same time, empirical and simulated data of neurophysiological models have demonstrated the significant role of intra-frequency and inter-frequency coupling among distinct brain areas. The current study investigates further the importance of these couplings using recordings of resting state magnetoencephalographic activity obtained from 30 mild traumatic brain injury (mTBI) subjects and 50 healthy controls. Intra-frequency and inter-frequency coupling modes are incorporated in a single graph to detect group differences within individual rich-club subnetworks (type I networks) and networks connecting RC nodes with the rest of the nodes (type II networks). Our results show a higher probability of inter-frequency coupling for (delta-gamma(1)), (delta-gamma(2)), (theta-beta), (theta-gamma(2)), (alpha-gamma(2)), (gamma(1)-gamma(2)) and intra-frequency coupling for (gamma(1)-gamma(1)) and (delta-delta) for both type I and type II networks in the mTBI group. Additionally, mTBI and control subjects can be correctly classified with high accuracy (98.6%), whereas a general linear regression model can effectively predict the subject group using the ratio of type I and type II coupling in the (delta, theta), (delta, beta), (delta, gamma(1)), and (delta, gamma(2)) frequency pairs. These findings support the presence of an RC organization simultaneously with dominant frequency interactions within a single functional graph. Our results demonstrate a hyperactivation of intrinsic RC networks in mTBI subjects compared to controls, which can be seen as a plausible compensatory mechanism for alternative frequency-dependent routes of information flow in mTBI subjects. (C) 2017 IBRO. Published by Elsevier Ltd. All rights reserved.	[Antonakakis, Marios] Westfalian Wilhelms Univ Muenster, Inst Biomagnetism & Biosignal Anal, D-48149 Munster, Germany; [Antonakakis, Marios; Zervakis, Michalis] Tech Univ Crete, Sch Elect & Comp Engn, Digital Image & Signal Proc Lab, Khania 73100, Greece; [Dimitriadis, Stavros I.] Cardiff Univ, Sch Med, Inst Psychol Med & Clin Neurosci, Cardiff, S Glam, Wales; [Dimitriadis, Stavros I.] Cardiff Univ, Sch Psychol, CUBRIC, Cardiff, S Glam, Wales; [Papanicolaou, Andrew C.] Univ Tennessee, Ctr Hlth Sci, Dept Pediat, Memphis, TN 38163 USA; [Papanicolaou, Andrew C.] Univ Tennessee, Dept Anat & Neurobiol, Memphis, TN 38163 USA; [Papanicolaou, Andrew C.] Le Bonheur Childrens Hosp, Neurosci Inst, Memphis, TN USA; [Zouridakis, George] Univ Houston, Biomed Imaging Lab, Dept Engn Technol, 4730 Calhoun Rd Room 300, Houston, TX USA; [Zouridakis, George] Univ Houston, Biomed Imaging Lab, Dept Engn Technol, 4730 Calhoun Rd Room 300, Houston, TX USA	Antonakakis, M (corresponding author), Westfalian Wilhelms Univ Muenster, Inst Biomagnetism & Biosignal Anal, D-48149 Munster, Germany.	marios.antonakakis@uni-muenster.de; stidimitriadis@gmail.com; michalis@display.tuc.gr; apapanic@uthsc.edu; zouridakis@uh.edu	Antonakakis, Marios/ABD-8218-2020; DIMITRIADIS, STAVROS I/AAN-8992-2020; Zouridakis, George/R-8876-2019	DIMITRIADIS, STAVROS I/0000-0002-0000-5392; Zouridakis, George/0000-0002-7770-9857	Department of Defense Congressionally Directed Medical Research ProgramUnited States Department of Defense [W81XWH-08-2-0135]; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MR/K004360/1]; EU-UK	The current study is part of a larger project, the Integrated Clinical Protocol, conducted by the Investigators and staff of The Mission Connect Mild Traumatic Brain Injury Translational Research Consortium and supported by the Department of Defense Congressionally Directed Medical Research Program W81XWH-08-2-0135. SID was supported by MRC grant MR/K004360/1 (Behavioural and Neurophysiological Effects of Schizophrenia Risk Genes: A Multi-locus, Pathway Based Approach) and by EU-UK COFUND FELLOWSHIP.	Alawieh A, 2015, SCI REP-UK, V5, DOI 10.1038/srep13513; Antonakakis M, 2016, C P IEEE SYS TECH; Antonakakis M, 2016, C P IEEE ENG MED BIO; Antonakakis M, 2016, INT J PSYCHOPHYSIOL, V102, P1, DOI 10.1016/j.ijpsycho.2016.02.002; Antonakakis M, 2015, IEEE ENG MED BIO, P7426, DOI 10.1109/EMBC.2015.7320108; Arakaki X, 2017, 12 WORLD C BRAIN INJ; Aru J, 2015, CURR OPIN NEUROBIOL, V31, P51, DOI 10.1016/j.conb.2014.08.002; Assistant Secretary D. O. D, 2007, TRAUM BRAIN INJ DEF; Bassett DS, 2009, P NATL ACAD SCI USA, V106, P11747, DOI 10.1073/pnas.0903641106; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bharath RD, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00513; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Castellanos NP, 2010, BRAIN, V133, P2365, DOI 10.1093/brain/awq174; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Crossley NA, 2016, SCHIZOPHRENIA BULL, V42, P434, DOI 10.1093/schbul/sbv146; da Costa L, 2015, J NEUROL NEUROSUR PS, V86, P1008, DOI 10.1136/jnnp-2014-308571; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dimitriadis SI, 2015, COGN NEURODYNAMICS, V9, P371, DOI 10.1007/s11571-015-9330-8; Dimitriadis SI, 2013, NEUROIMAGE, V83, P307, DOI 10.1016/j.neuroimage.2013.06.036; Dimitriadis SI, 2013, IEEE ENG MED BIO, P2940, DOI 10.1109/EMBC.2013.6610156; Dimitriadis SI, 2013, BRAIN TOPOGR, V26, P397, DOI 10.1007/s10548-013-0276-z; Dimitriadis S, 2016, IEEE T NEUR SYS REH, V24, P1017, DOI 10.1109/TNSRE.2016.2516107; Dimitriadis SI, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00163; Dimitriadis SI, 2015, NEUROIMAGE-CLIN, V9, P519, DOI 10.1016/j.nicl.2015.09.011; Dimitriadis SI, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00350; Dimitriadis SI, 2015, ANN BIOMED ENG, V43, P977, DOI 10.1007/s10439-014-1143-0; Dimitriadis SI, 2009, BRAIN TOPOGR, V22, P119, DOI 10.1007/s10548-008-0071-4; Dunkley BT, 2015, NEUROIMAGE-CLIN, V7, P611, DOI 10.1016/j.nicl.2015.02.020; Engel AK, 2013, NEURON, V80, P867, DOI 10.1016/j.neuron.2013.09.038; Escudero J, 2011, ANN BIOMED ENG, V39, P2274, DOI 10.1007/s10439-011-0312-7; Fornito A, 2012, NEUROIMAGE, V62, P2296, DOI 10.1016/j.neuroimage.2011.12.090; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; He X, 2005, ADV NEURAL INFORM P; HORN RA, 1990, SIAM J MATRIX ANAL A, V11, P481, DOI 10.1137/0611034; Huang MX, 2014, NEUROIMAGE-CLIN, V5, P109, DOI 10.1016/j.nicl.2014.06.004; Huang MX, 2009, J NEUROTRAUM, V26, P1213, DOI 10.1089/neu.2008.0672; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Len TK, 2011, CLIN PHYSIOL FUNCT I, V31, P85, DOI 10.1111/j.1475-097X.2010.00990.x; Levin H. S., 2009, MISSION CONNECT MILD; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Li L, 2017, 12 WORLD C BRAIN INJ; Li LY, 2015, IEEE ENG MED BIO, P6963, DOI 10.1109/EMBC.2015.7319994; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Martin-Buro MC, 2016, HUM BRAIN MAPP, V37, P179, DOI 10.1002/hbm.23027; Micheloyannis S, 2006, SCHIZOPHR RES, V87, P60, DOI 10.1016/j.schres.2006.06.028; Misic B, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003427; Mvula E, 2017, 12 WORLD C BRAIN INJ; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Palva JM, 2011, PROG BRAIN RES, V193, P335, DOI 10.1016/B978-0-444-53839-0.00022-3; Pang EW, 2016, ANN CLIN TRANSL NEUR, V3, P124, DOI 10.1002/acn3.280; Rapp PE, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00011; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Senden M, 2014, NEUROIMAGE, V96, P174, DOI 10.1016/j.neuroimage.2014.03.066; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Talavage TM, 2016, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00273; Tarapore PE, 2013, J NEUROSURG, V118, P1306, DOI 10.3171/2013.3.JNS12398; THEILER J, 1992, PHYSICA D, V58, P77, DOI 10.1016/0167-2789(92)90102-S; Tort ABL, 2008, P NATL ACAD SCI USA, V105, P20517, DOI 10.1073/pnas.0810524105; Tsiaras V, 2011, COMPUT BIOL MED, V41, P1166, DOI 10.1016/j.compbiomed.2011.04.004; van den Heuvel MP, 2013, JAMA PSYCHIAT, V70, P783, DOI 10.1001/jamapsychiatry.2013.1328; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Vertes PE, 2015, J CHILD PSYCHOL PSYC, V56, P299, DOI 10.1111/jcpp.12365; Voytek B, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00191; Watanabe T, 2015, SCI REP-UK, V5, DOI 10.1038/srep16152; Xu XX, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00027; Zouridakis G, 2016, 20 INT C BIOM BIOMAG; Zouridakis G, 2012, J MECH MED BIOL, V12, DOI 10.1142/S0219519412400064	69	11	11	0	11	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	JUL 25	2017	356						275	286		10.1016/j.neuroscience.2017.05.032			12	Neurosciences	Neurosciences & Neurology	EZ9MZ	WOS:000405055800025	28576727	Green Accepted			2021-06-18	
J	Mahmood, A; Roberts, I; Shakur, H				Mahmood, Abda; Roberts, Ian; Shakur, Haleema			A nested mechanistic sub-study into the effect of tranexamic acid versus placebo on intracranial haemorrhage and cerebral ischaemia in isolated traumatic brain injury: study protocol for a randomised controlled trial (CRASH-3 Trial Intracranial Bleeding Mechanistic Sub-Study [CRASH-3 IBMS])	TRIALS			English	Article						Tranexamic acid; Intracranial haemorrhage; Cerebral ischaemia; Traumatic brain injury	SPONTANEOUS INTRACEREBRAL HEMORRHAGE; ASSISTED VOLUMETRIC-ANALYSIS; ABC/2 ESTIMATION TECHNIQUE; SUBARACHNOID HEMORRHAGE; EXPLORATORY ANALYSIS; HEMATOMA VOLUME; PROGRESSION; COAGULATION; STROKE; VASOSPASM	Background: Tranexamic acid prevents blood clots from breaking down and reduces bleeding. However, it is uncertain whether tranexamic acid is effective in traumatic brain injury. The CRASH-3 trial is a randomised controlled trial that will examine the effect of tranexamic acid (versus placebo) on death and disability in 13,000 patients with traumatic brain injury. The CRASH-3 trial hypothesizes that tranexamic acid will reduce intracranial haemorrhage, which will reduce the risk of death. Although it is possible that tranexamic acid will reduce intracranial bleeding, there is also a potential for harm. In particular, tranexamic acid may increase the risk of cerebral thrombosis and ischaemia. The protocol detailed here is for a mechanistic sub-study nested within the CRASH-3 trial. This mechanistic sub-study aims to examine the effect of tranexamic acid (versus placebo) on intracranial bleeding and cerebral ischaemia. Methods: The CRASH-3 Intracranial Bleeding Mechanistic Sub-Study (CRASH-3 IBMS) is nested within a prospective, double-blind, multi-centre, parallel-arm randomised trial called the CRASH-3 trial. The CRASH-3 IBMS will be conducted in a cohort of approximately 1000 isolated traumatic brain injury patients enrolled in the CRASH-3 trial. In the CRASH-3 IBMS, brain scans acquired before and after randomisation are examined, using validated methods, for evidence of intracranial bleeding and cerebral ischaemia. The primary outcome is the total volume of intracranial bleeding measured on computed tomography after randomisation, adjusting for baseline bleeding volume. Secondary outcomes include progression of intracranial haemorrhage (from pre-to post-randomisation scans), new intracranial haemorrhage (seen on post-but not pre-randomisation scans), intracranial haemorrhage following neurosurgery, and new focal ischaemic lesions (seen on post-but not pre-randomisation scans). A linear regression model will examine whether receipt of the trial treatment can predict haemorrhage volume. Bleeding volumes and new ischaemic lesions will be compared across treatment groups using relative risks and 95% confidence intervals. Discussion: The CRASH-3 IBMS will provide an insight into the mechanism of action of tranexamic acid in traumatic brain injury, as well as information about the risks and benefits. Evidence from this trial could inform the management of patients with traumatic brain injury.	[Mahmood, Abda; Roberts, Ian; Shakur, Haleema] Univ London, London Sch Hyg & Trop Med, Clin Trials Unit, Keppel St, London WC1E 7HT, England	Mahmood, A (corresponding author), Univ London, London Sch Hyg & Trop Med, Clin Trials Unit, Keppel St, London WC1E 7HT, England.	abda.mahmood@lshtm.ac.uk		Shakur-Still, Haleema/0000-0002-6511-109X; Mahmood, Abda/0000-0002-3267-4590	JP Moulton Charitable Trust (United Kingdom); United Kingdom Department for International Development/Medical Research Council/Wellcome Trust through the Joint Global Health Trials Scheme in low-middle income countries [MR/M009211/1]; National Institute for Health Research, Health Technology Assessment programme for the United Kingdom [14/190/01]; London School of Hygiene and Tropical Medicine [EPNPBH61, EPAA6020]	The JP Moulton Charitable Trust (United Kingdom) is funding the run-in costs for the CRASH- 3 trial and the recruitment of up to 500 patients (Additional file 4). Full funding for the main trial is provided through joint funding by the United Kingdom Department for International Development/Medical Research Council/Wellcome Trust through the Joint Global Health Trials Scheme in low- middle income countries (Grant number MR/M009211/1; Additional file 5) and by the National Institute for Health Research, Health Technology Assessment programme for the United Kingdom (Grant number 14/190/01; Additional file 6).; Funding for recruitment in the European Union and North America is provided by the London School of Hygiene and Tropical Medicine (Grant reference EPNPBH61; Additional file 7). The CRASH-3 IBMS is fully funded by the London School of Hygiene and Tropical Medicine (Grant reference EPAA6020; Additional file 7). The design, management and interpretation of the CRASH-3 trial and CRASH-3 IBMS are entirely independent of the manufacturers of tranexamic acid or the funders.	Baharoglu MI, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001245.pub2; Barber PA, 2000, LANCET, V355, P1670, DOI 10.1016/S0140-6736(00)02237-6; Bayir A, 2006, NEUROL INDIA, V54, P363, DOI 10.4103/0028-3886.28106; Berkner J, 2016, METHODS MOL BIOL, V1462, P11, DOI 10.1007/978-1-4939-3816-2_2; Bingham EC., 1940, RHEOLOGICAL MEMOIRS, V1; Boudokhane S, 2016, ANN PHYS REHABIL M S, V59S, pe134, DOI DOI 10.1016/j.rehab.2016.07.301; Brohi K, 2008, J TRAUMA, V64, P1211, DOI 10.1097/TA.0b013e318169cd3c; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Bryan-Hancock C, 2010, INJURY PREV, V16, pA17, DOI 10.1136/ip.2010.029215.61; Bullock MR, 2006, NEUROSURGERY S, V58, pSi; Bunch J, 2000, INFORM RESOURCES COL, V4; Burke JF, 2013, NEUROLOGY, V81, P33, DOI 10.1212/WNL.0b013e318297eecf; Chang EF, 2006, NEUROSURGERY, V58, P647, DOI 10.1227/01.NEU.0000197101.68538.E6; Chieregato A, 2005, NEUROSURGERY, V56, P671, DOI 10.1227/01.NEU.0000156200.76331.7A; Dewan Y, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-87; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Edwards P, 2005, LANCET, V365, P1957; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Freeman WD, 2008, NEUROCRIT CARE, V9, P307, DOI 10.1007/s12028-008-9089-4; Frontera JA, 2006, NEUROSURGERY, V59, P21, DOI 10.1227/01.NEU.0000218821.34014.1B; Gando S, 2011, ANN SURG, V254, P10, DOI 10.1097/SLA.0b013e31821221b1; Gebel JM, 1998, STROKE, V29, P1799, DOI 10.1161/01.STR.29.9.1799; Ghroubi S, 2016, ANN PHYS REHABIL M S, V59S, pe135; Great Britain, 1998, DATA PROTECTION ACT; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Homnick A, 2012, INJURY, V43, P2122, DOI 10.1016/j.injury.2012.04.013; Hu TT, 2016, BIOL RES NURS, V18, P5, DOI 10.1177/1099800415577634; Hulka F, 1996, ARCH SURG-CHICAGO, V131, P923; Hulka F, 1996, ARCH SURG-CHICAGO, V131, P7; Huttner HB, 2006, STROKE, V37, P404, DOI 10.1161/01.STR.0000198806.67472.5c; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH), 2016, ICH HARM GUID INT AD; KAUFMAN HH, 1984, NEUROSURGERY, V15, P34, DOI 10.1227/00006123-198407000-00008; Ker K, 2013, BRIT J SURG, V100, P1271, DOI 10.1002/bjs.9193; Ker K, 2015, COCHRANE DB SYST REV, V5, DOI DOI 10.1002/14651858.CD004896.PUB4; Khan M, 2017, J NEUROIMAGING, V27, P144, DOI 10.1111/jon.12370; Kirsch T, 2004, EMERGENCY MED COMPRE; Kleinman JT, 2011, DEV MED CHILD NEUROL, V53, P281, DOI 10.1111/j.1469-8749.2010.03798.x; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Krishnan K, 2015, J NEUROL NEUROSUR PS, V86, P1258, DOI 10.1136/jnnp-2014-309845; Lingsma HF, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-201; Maeda AK, 2013, ARQ NEURO-PSIQUIAT, V71, P540, DOI 10.1590/0004-282X20130084; Marion DW, 2006, NEUROSURGERY, V58, P655; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mazzeo AT, 2006, J NEUROSURG ANESTH, V18, P170, DOI 10.1097/01.ana.0000210999.18033.f6; Mirsky DM SN, 2013, ANN NEUROL S17, V74; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; Narayan RK, 2008, J NEUROTRAUM, V25, P629, DOI 10.1089/neu.2007.0385; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Pedraza S, 2012, J NEUROIMAGING, V22, P155, DOI 10.1111/j.1552-6569.2011.00588.x; Perel P, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16130; Perel P, 2009, BMC EMERG MED, V9, DOI 10.1186/1471-227X-9-15; Roberts I, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0685-8; Roberts I, 2014, J INTENSIVE CARE, V2, DOI 10.1186/s40560-014-0056-1; Roberts I, 2011, LANCET, V377, P1096, DOI 10.1016/S0140-6736(11)60278-X; ROOS YB, 2003, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD001245, 10.1002/14651858.CD001245]; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rosen DS, 2005, NEUROCRIT CARE, V2, P110, DOI 10.1385/NCC:2:2:110; Rothman KJ, 2013, INT J EPIDEMIOL, V42, P1012, DOI 10.1093/ije/dys223; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.2307/2335739; Sa de Camargo Erica C, 2005, NeuroRx, V2, P265; Schwinn DA, 2012, J CLIN INVEST, V122, P4339, DOI 10.1172/JCI66724; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Smajlovic Dzevdet, 2004, Med Arh, V58, P282; Su Z, 2006, PRELIMINARY RESULT 2; Tao HY, 2012, J NEUROINTERV SURG, V4, P256, DOI 10.1136/neurintsurg-2011-010062; Tsair TJ, 2010, RADIOGRAPHY, V16, P209, DOI 10.1016/j.radi.2010.04.004; Wang CW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102326; Wang CW, 2009, ACTA RADIOL, V50, P306, DOI 10.1080/02841850802647039; Webb AJS, 2015, STROKE, V46, P2470, DOI 10.1161/STROKEAHA.114.007343; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; World Health Organization, 2013, GLOB STAT REP ROAD S; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; Xu XH, 2014, STROKE, V45, P3433, DOI 10.1161/STROKEAHA.114.007095; Yan J, 2013, NEUROL RES, V35, P382, DOI 10.1179/1743132812Y.0000000141; Yan PF, 2016, PEERJ, V4, DOI 10.7717/peerj.1921; Yang W., 2013, NAT MATER, V2, P1; Yutthakasemsunt S, 2013, BMC EMERG MED, V13, DOI 10.1186/1471-227X-13-20	79	11	12	0	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1745-6215			TRIALS	Trials	JUL 17	2017	18								330	10.1186/s13063-017-2073-6			13	Medicine, Research & Experimental	Research & Experimental Medicine	FA8ZV	WOS:000405736400004	28716153	DOAJ Gold, Green Published, Green Accepted			2021-06-18	
J	Truss, K; Godfrey, C; Takagi, M; Babl, FE; Bressan, S; Hearps, S; Clarke, C; Dunne, K; Anderson, V				Truss, Katherine; Godfrey, Celia; Takagi, Michael; Babl, Franz E.; Bressan, Silvia; Hearps, Stephen; Clarke, Cathriona; Dunne, Kevin; Anderson, Vicki			Trajectories and Risk Factors for Post-Traumatic Stress Symptoms following Pediatric Concussion	JOURNAL OF NEUROTRAUMA			English	Article						concussion; group-based trajectory modeling; mild traumatic brain injury; pediatrics; post-traumatic stress	TRAUMATIC BRAIN-INJURY; CHILD PTSD; POSTCONCUSSIVE SYMPTOMS; PSYCHOMETRIC PROPERTIES; HEAD-INJURY; DISORDER; EPIDEMIOLOGY; ADOLESCENTS; PREDICTORS; SCALE	A substantial minority of children experience post-traumatic stress symptoms (PTSS) following injury. Research indicates variation in the trajectory of PTSS following pediatric injury, but investigation of PTSS following concussion has assumed homogeneity. This study aimed to identify differential trajectories of PTSS following pediatric concussion and to investigate risk factors, including acute post-concussive symptoms (PCS), associated with these trajectories. A total of 120 children ages 8-18 years reported PTSS for 3 months following concussion diagnosis using the Child PTSD Symptom Scale, with a score of 16 or above indicating probable post-traumatic stress disorder diagnosis. Age, gender, injury mechanism, loss of consciousness, previous concussions, prior hospitalization, prior diagnosis of depression or anxiety, and acute PCS were assessed as risk factors. Data were analyzed using group-based trajectory modeling. Results revealed 16% of children had clinically significant PTSS 2 weeks post-concussion, declining to 10% at 1 month and 6% at 3 months post-injury. Group-based trajectory modeling identified three trajectories of PTSS post-concussion: resilient (70%); recovering (25%), in which children experienced elevated acute symptoms that declined over time; and chronic symptomatology (5%). Due to small size, the chronic group should be interpreted with caution. Higher acute PCS and prior diagnosis of depression or anxiety both significantly increased predicted probability of recovering trajectory group membership. These findings establish that most children are resilient to PTSS following concussion, but that PTSS do occur acutely in a substantial minority of children. The study indicates mental health factors, particularly PTSS, depression, and anxiety, should be considered integral to models of concussion management and treatment.	[Truss, Katherine; Godfrey, Celia; Takagi, Michael; Babl, Franz E.; Bressan, Silvia; Hearps, Stephen; Clarke, Cathriona; Dunne, Kevin; Anderson, Vicki] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Truss, Katherine; Anderson, Vicki] Univ Melbourne, Sch Psychol Sci, Melbourne, Vic, Australia; [Godfrey, Celia; Babl, Franz E.; Dunne, Kevin] Univ Melbourne, Dept Pediat, Melbourne, Vic, Australia; [Babl, Franz E.] Royal Childrens Hosp, Emergency Dept, Melbourne, Vic, Australia; [Bressan, Silvia] Univ Padua, Dept Womens & Childrens Hlth, Padua, Italy; [Dunne, Kevin] Royal Childrens Hosp, Dept Rehabil Med, Melbourne, Vic, Australia; [Anderson, Vicki] Royal Childrens Hosp, Psychol Serv, Melbourne, Vic, Australia	Anderson, V (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Flemington Rd, Parkville, Vic 3052, Australia.	vicki.anderson@rch.org.au	Hearps, Stephen/L-6853-2016		Royal Children's Hospital Research Foundation; Victorian Government Operational Infrastructure Scheme; Australian National Health and Medical Research Council (NHMRC) Development grantNational Health and Medical Research Council of Australia; NHMRC Senior Practitioner FellowshipNational Health and Medical Research Council of Australia	This study was funded by the Royal Children's Hospital Research Foundation and the Victorian Government Operational Infrastructure Scheme. SH was funded by an Australian National Health and Medical Research Council (NHMRC) Development grant, FEB was funded by the Royal Children's Hospital Research Foundation, and VA by an NHMRC Senior Practitioner Fellowship. The funding organizations did not have a role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or the decision to submit the manuscript for publication.	Albicini M., 2015, FRESH LOOK ANXIETY D; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5, DOI [10.1176/appi.books.9780890425596., DOI 10.1176/APPI.BOOKS.9780890425596, 10.1176/appi.books.9780890425596]; American Psychiatric Association, 1994, DIAGNOSTIC STAT MANU; Anderson V, 2009, BRAIN, V132, P45, DOI 10.1093/brain/awn293; Barlow KM, 2016, J CHILD NEUROL, V31, P57, DOI 10.1177/0883073814543305; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Blume HK, 2011, PHYS MED REH CLIN N, V22, P665, DOI 10.1016/j.pmr.2011.08.007; Bonanno GA, 2005, CURR DIR PSYCHOL SCI, V14, P135, DOI 10.1111/j.0963-7214.2005.00347.x; Bressan S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009427; Brosbe MS, 2011, J PEDIATR PSYCHOL, V36, P718, DOI 10.1093/jpepsy/jsq115; Bryant RA, 1999, J NERV MENT DIS, V187, P302, DOI 10.1097/00005053-199905000-00006; Bryant RA, 2001, CLIN PSYCHOL REV, V21, P931; Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Clayton GH, 2013, CURR PHYS MED REHABI, V1, P88; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Copeland WE, 2007, ARCH GEN PSYCHIAT, V64, P577, DOI 10.1001/archpsyc.64.5.577; Crowe L, 2009, J PAEDIATR CHILD H, V45, P346, DOI 10.1111/j.1440-1754.2009.01499.x; Donlon K, 2015, CHILD NEUROPSYCHOL, V21, P803, DOI 10.1080/09297049.2014.944491; Foa EB, 2001, J CLIN CHILD PSYCHOL, V30, P376, DOI 10.1207/S15374424JCCP3003_9; Gerring JP, 2002, J AM ACAD CHILD PSY, V41, P157, DOI 10.1097/00004583-200202000-00009; Gillies ML, 2003, J TRAUMA STRESS, V16, P523, DOI 10.1023/A:1025774915005; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Guo XY, 2017, NEUROPSYCHOLOGY, V31, P84, DOI 10.1037/neu0000305; Hajek CA, 2010, BRAIN INJURY, V24, P100, DOI 10.3109/02699050903508226; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hong SB, 2014, J CHILD PSYCHOL PSYC, V55, P1226, DOI 10.1111/jcpp.12241; Hung Ryan, 2014, Arch Phys Med Rehabil, V95, pS174, DOI 10.1016/j.apmr.2013.08.301; Iselin G, 2010, J ANXIETY DISORD, V24, P774, DOI 10.1016/j.janxdis.2010.05.011; Jones BL, 2012, STATA PLUGIN ESTIMAT; Kahana SY, 2006, TRAUMATOLOGY, V12, P148, DOI [10.77/1534765606294562, DOI 10.1177/1534765606294562]; Kassam-Adams N, 2004, J AM ACAD CHILD PSY, V43, P403, DOI 10.1097/00004583-200404000-00006; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Layne C. M., 2009, TREATING TRAUMATIZED, P13; Le Brocque RM, 2010, J PEDIATR PSYCHOL, V35, P637, DOI 10.1093/jpepsy/jsp050; Levi RB, 1999, J CLIN CHILD PSYCHOL, V28, P232, DOI 10.1207/s15374424jccp2802_10; Marshall RD, 2001, AM J PSYCHIAT, V158, P1467, DOI 10.1176/appi.ajp.158.9.1467; Mather FJ, 2003, BRAIN INJURY, V17, P1077, DOI 10.1080/0269905031000114045; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Nagin D., 2005, GROUP BASED MODELING; Nagin DS, 2010, ANNU REV CLIN PSYCHO, V6, P109, DOI 10.1146/annurev.clinpsy.121208.131413; Nagin DS, 1999, PSYCHOL METHODS, V4, P139, DOI 10.1037/1082-989X.4.2.139; Nixon RDV, 2013, PSYCHOL ASSESSMENT, V25, P1025, DOI 10.1037/a0033324; Olsson KA, 2008, J ANXIETY DISORD, V22, P1447, DOI 10.1016/j.janxdis.2008.02.007; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Trickey D, 2012, CLIN PSYCHOL REV, V32, P122, DOI 10.1016/j.cpr.2011.12.001; WONG JL, 1994, ARCH CLIN NEUROPSYCH, V9, P411, DOI 10.1016/0887-6177(94)90004-3; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216; Ziegler MF, 2005, PEDIATRICS, V115, P1261, DOI 10.1542/peds.2004-1217	52	11	11	0	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 15	2017	34	14					2272	2279		10.1089/neu.2016.4842			8	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	EZ8RQ	WOS:000404995000010	28293983				2021-06-18	
J	Hill, LJ; Di Pietro, V; Hazeldine, J; Davies, D; Tomman, E; Logan, A; Belli, A				Hill, Lisa J.; Di Pietro, Valentina; Hazeldine, Jon; Davies, David; Tomman, Emma; Logan, Ann; Belli, Antonio			Cystatin D (CST5): An ultra-early inflammatory biomarker of traumatic brain injury	SCIENTIFIC REPORTS			English	Article							FIBRILLARY ACIDIC PROTEIN; NF-KAPPA-B; OXIDATIVE STRESS; HEAD-INJURY; DIAGNOSIS; SEVERITY; TRANSCRIPTION; MARKERS; SERUM; GENE	Traumatic brain injury (TBI) is set to become the leading cause of neurological disability across all age groups. Currently, no reliable biomarkers exist to help diagnose the severity of TBI to identify patients who are at risk of developing secondary injuries. Thus, the discovery of reliable biomarkers for the management of TBI would improve clinical interventions. Inflammatory markers are particularly suited for biomarker discovery as TBI leads to very early alterations in inflammatory proteins. Using the Proseek Multiplex Inflammation assay, we measured in patients that had suffered mild TBI (n = 10) or severe TBI (n = 10) with extra-cranial injury or extracranial injury only (EC) (n = 10), 92 inflammation-associated proteins in serum obtained: <1 hr (within 1-hour), 4-12 hr and 48-72 hr post injury. Changes were compared to healthy volunteers (HV). Our results identified CST5, AXIN1 and TRAIL as novel early biomarkers of TBI. CST5 identified patients with severe TBI from all other cohorts and importantly was able to do so within the first hour of injury. AXIN1 and TRAIL were able to discriminate between TBI and HV at <1 hr. We conclude that CST5, AXIN1 and TRAIL are worthy of further study in the context of a pre-hospital or pitch-side test to detect brain injury.	[Hill, Lisa J.; Di Pietro, Valentina; Logan, Ann; Belli, Antonio] Univ Birmingham, Inst Inflammat & Ageing, Coll Med & Dent Sci, Neurosci & Ophthalmol Res Grp, Birmingham B15 2TT, W Midlands, England; [Hill, Lisa J.; Di Pietro, Valentina; Hazeldine, Jon; Davies, David; Tomman, Emma; Logan, Ann; Belli, Antonio] Queen Elizabeth Hosp, Natl Inst Hlth Res, Surg Reconstruct & Microbiol Res Ctr, Birmingham B15 2TH, W Midlands, England	Hill, LJ (corresponding author), Univ Birmingham, Inst Inflammat & Ageing, Coll Med & Dent Sci, Neurosci & Ophthalmol Res Grp, Birmingham B15 2TT, W Midlands, England.; Hill, LJ (corresponding author), Queen Elizabeth Hosp, Natl Inst Hlth Res, Surg Reconstruct & Microbiol Res Ctr, Birmingham B15 2TH, W Midlands, England.	l.j.hill@bham.ac.uk	Hazeldine, Jon/T-5725-2019; Belli, Antonio/I-3799-2015; Hill, Lisa J/AAO-1560-2021	Belli, Antonio/0000-0002-3211-9933; Hill, Lisa J/0000-0001-8431-7029; Toman, Emma/0000-0003-2142-1923	Biotechnology and Biological Sciences Research CouncilUK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC) [G18986] Funding Source: Medline; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MR/J011584/1, MR/N019016/1] Funding Source: Medline		Arand M, 2001, LANGENBECK ARCH SURG, V386, P241, DOI 10.1007/s004230100204; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Bohmer AE, 2011, NEUROSURGERY, V68, P1624, DOI 10.1227/NEU.0b013e318214a81f; Bogoslovsky T, 2017, J NEUROTRAUM, V34, P66, DOI 10.1089/neu.2015.4333; Carr ME, 2009, MIL MED, V174, P622, DOI 10.7205/MILMED-D-02-4708; Chiaretti A, 2005, CHILD NERV SYST, V21, P185, DOI 10.1007/s00381-004-1032-1; Collins AR, 1998, ORAL MICROBIOL IMMUN, V13, P59, DOI 10.1111/j.1399-302X.1998.tb00753.x; Dash PK, 2010, NEUROTHERAPEUTICS, V7, P100, DOI 10.1016/j.nurt.2009.10.019; Di Pietro V, 2015, NEUROCHEM RES, V40, P991, DOI 10.1007/s11064-015-1554-9; Di Pietro V, 2010, J NEUROTRAUM, V27, P349, DOI 10.1089/neu.2009.1095; Dikmen S, 2001, J CLIN EXP NEUROPSYC, V23, P729, DOI 10.1076/jcen.23.6.729.1019; Ferrer-Mayorga G, 2015, J BIOL CHEM, V290, P26533, DOI 10.1074/jbc.M115.660175; GOLDSTEIN M, 1990, ANN NEUROL, V27, P327, DOI 10.1002/ana.410270315; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Gutierrez H, 2011, TRENDS NEUROSCI, V34, P316, DOI 10.1016/j.tins.2011.03.001; Hergenroeder GW, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-19; Hergenroeder GW, 2008, MOL DIAGN THER, V12, P345, DOI 10.2165/1250444-200812060-00002; Homsi S, 2009, BRAIN RES, V1291, P122, DOI 10.1016/j.brainres.2009.07.031; Kikuchi A, 1999, CELL SIGNAL, V11, P777, DOI 10.1016/S0898-6568(99)00054-6; Kovesdi Erzsebet, 2012, Front Neurol, V3, P111, DOI 10.3389/fneur.2012.00111; Lei J, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1081-8; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; ONeill LAJ, 1997, TRENDS NEUROSCI, V20, P252, DOI 10.1016/S0166-2236(96)01035-1; PALFREYMAN JW, 1978, CLIN CHIM ACTA, V82, P259, DOI 10.1016/0009-8981(78)90008-6; Reiser J, 2010, J CLIN INVEST, V120, P3421, DOI 10.1172/JCI42918; Seol DW, 2001, CANCER RES, V61, P1138; Shahim P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36791; Siesjo BK, 1996, EUR J ANAESTH, V13, P247, DOI 10.1046/j.1365-2346.1996.00976.x; Strathmann FG, 2014, CLIN BIOCHEM, V47, P876, DOI 10.1016/j.clinbiochem.2014.01.028; STUSS DT, 1995, NEUROLOGY, V45, P1251, DOI 10.1212/WNL.45.7.1251; Tavazzi B, 2005, NEUROSURGERY, V56, P582, DOI 10.1227/01.NEU.0000156715.04900.E6; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Yokobori S, 2013, CNS NEUROSCI THER, V19, P556, DOI 10.1111/cns.12127	34	11	11	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUL 10	2017	7								5002	10.1038/s41598-017-04722-5			10	Multidisciplinary Sciences	Science & Technology - Other Topics	FA1EA	WOS:000405180900075	28694499	DOAJ Gold, Green Published, Green Accepted			2021-06-18	
J	Nakase-Richardson, R; Stevens, LF; Tang, X; Lamberty, GJ; Sherer, M; Walker, WC; Pugh, MJ; Eapen, BC; Finn, JA; Saylors, M; Dillahunt-Aspillaga, C; Adams, RS; Garofano, JS				Nakase-Richardson, Risa; Stevens, Lillian Flores; Tang, Xinyu; Lamberty, Greg J.; Sherer, Mark; Walker, William C.; Pugh, Mary Jo; Eapen, Blessen C.; Finn, Jacob A.; Saylors, Mimi; Dillahunt-Aspillaga, Christina; Adams, Rachel Sayko; Garofano, Jeffrey S.			Comparison of the VA and NIDILRR TBI Model System Cohorts	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						civilians; outcomes; traumatic brain injury; Veterans	TRAUMATIC BRAIN-INJURY; FUNCTIONAL INDEPENDENCE MEASURE; POSTTRAUMATIC AMNESIA; GALVESTON ORIENTATION; OUTCOME MEASURES; PRACTICAL SCALE; REHABILITATION; SEVERITY; COMA; INDIVIDUALS	Objective: Within the same time frame, compare the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR) and VA Traumatic Brain Injury Model System (TBIMS) data sets to inform future research and generalizability of findings across cohorts. Setting: Inpatient comprehensive interdisciplinary rehabilitation facilities. Participants: Civilians, Veterans, and active duty service members in the VA (n = 550) and NIDILRR civilian settings (n = 5270) who were enrolled in TBIMS between August 2009 and July 2015. Design: Prospective, longitudinal, multisite study. Main Measures: Demographics, Injury Characteristics, Functional Independence Measures, Disability Rating Scale. Results: VA and NIDILRR TBIMS participants differed on 76% of comparisons (18 Important, 8 Minor), with unique differences shown across traumatic brain injury etiology subgroups. The VA cohort was more educated, more likely to be employed at the time of injury, utilized mental health services premorbidly, and experienced greater traumatic brain injury severity. As expected, acute and rehabilitation lengths of stay were longer in the VA with no differences in death rate found between cohorts. Conclusions: Substantial baseline differences between the NIDILRR and VA TBIMS participants warrant caution when comparing rehabilitation outcomes. A substantive number of NIDILRR enrollees had a history of military service (>13%) warranting further focused study. The TBIMS participant data collected across cohorts can be used to help evidence-informed policy for the civilian and military-related healthcare systems.	[Nakase-Richardson, Risa] James A Haley Vet Hosp, MHBS, Polytrauma Mail Code 117,13000 Bruce B Downs Blvd, Tampa, FL 33612 USA; [Nakase-Richardson, Risa] Def & Vet Brain Injury Ctr, Tampa, FL USA; [Nakase-Richardson, Risa] Univ S Florida, Dept Internal Med, Tampa, FL USA; [Nakase-Richardson, Risa] VA HSRD Ctr Innovat Disabil & Rehabil Res, Tampa, FL USA; [Stevens, Lillian Flores; Walker, William C.] Hunter Holmes McGuire Vet AffairsMed Ctr, Richmond, VA USA; [Stevens, Lillian Flores] Virginia Commonwealth Univ, Dept Psychol, Box 2018, Richmond, VA 23284 USA; [Stevens, Lillian Flores; Walker, William C.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA; [Stevens, Lillian Flores; Walker, William C.] Def & Vet Brain Injury Ctr, Richmond, VA USA; [Tang, Xinyu; Saylors, Mimi] Univ Arkansas Med Sci, Dept Pediat, Biostat Program, Little Rock, AR 72205 USA; [Lamberty, Greg J.; Finn, Jacob A.] Minneapolis VA Hlth Care Syst, Mental Hlth Serv, Minneapolis, MN USA; [Lamberty, Greg J.; Finn, Jacob A.] Univ Minnesota, Sch Med, Dept Psychiat, Minneapolis, MN 55455 USA; [Lamberty, Greg J.; Finn, Jacob A.] DVBIC, Minneapolis, MN USA; [Sherer, Mark] TIRR Mem Hermann, Brain Injury Res Ctr, Houston, TX USA; [Pugh, Mary Jo; Eapen, Blessen C.] South Texas Vet Hlth Care Syst, Polytrauma Rehabil Ctr, San Antonio, TX USA; [Pugh, Mary Jo] Univ Texas Hlth Sci Ctr San Antonio, Dept Epidemiol & Biostat, San Antonio, TX 78229 USA; [Dillahunt-Aspillaga, Christina] Univ S Florida, Coll Behav & Community Sci, Tampa, FL USA; [Adams, Rachel Sayko] Brandeis Univ, Boston, MA USA; [Garofano, Jeffrey S.] Univ S Florida, Coll Educ, Tampa, FL USA	Nakase-Richardson, R (corresponding author), James A Haley Vet Hosp, MHBS, Polytrauma Mail Code 117,13000 Bruce B Downs Blvd, Tampa, FL 33612 USA.	Risa.Richardson@va.gov	Garofano, Jeffrey/AAK-9469-2021; Pugh, Mary Jo/K-5336-2019; Adams, Rachel/AAH-4653-2020	Pugh, Mary Jo/0000-0003-4196-7763; 	US Department of Veterans Affairs Health Services Research and Development COIN grant (CINDRR) [1 I50 HX00123301]; Department of Veterans AffairsUS Department of Veterans Affairs; Department of Health & Human Services (National Institute on Disability, Independent Living, and Rehabilitation Research); VHA Central Office VA TBI Model System Program of Research; General Dynamics Health Solutions from the Defense and Veterans Brain Injury Center within the Defense Health Agency [W91YTZ-13-C-0015]; National Institute on Disability, Independent Living, and Rehabilitation ResearchUnited States Department of Health & Human Services [90DP0028, 90DP00303]	The authors acknowledge the support of US Department of Veterans Affairs Health Services Research and Development COIN grant (1 I50 HX00123301; CINDRR) for assistance in manuscript preparation.; The Polytrauma Rehabilitation Center Traumatic Brain Injury (TBI) Model System collaboration is funded through an Interagency Agreement between the Department of Veterans Affairs and the Department of Health & Human Services (National Institute on Disability, Independent Living, and Rehabilitation Research). This research is sponsored by VHA Central Office VA TBI Model System Program of Research, and Subcontract from General Dynamics Health Solutions (W91YTZ-13-C-0015) from the Defense and Veterans Brain Injury Center within the Defense Health Agency.; The contents of this publication were developed under grants from the National Institute on Disability, Independent Living, and Rehabilitation Research (grant numbers 90DP0028 [PI: Sherer] and 90DP00303 [PI: Kreutzer]). NIDILRR is a Center within the Administration for Community Living (ACL), Department of Health and Human Services (HHS). The contents of this publication do not necessarily represent the policy of NIDILRR, ACL, HHS, and Veterans Affairs, and endorsement by the Federal Government should not be assumed.	Adams RS, 2016, J HEAD TRAUMA REHAB, V31, P13, DOI 10.1097/HTR.0000000000000082; Bailey EK, 2017, J HEAD TRAUMA REHAB, V32, P245, DOI 10.1097/HTR.0000000000000317; Bode RK, 2000, J HEAD TRAUMA REHAB, V15, P637, DOI 10.1097/00001199-200002000-00004; Corrigan JD, 2013, AM J PSYCHIAT, V170, P351, DOI 10.1176/appi.ajp.2012.12121602; Corrigan JD, 2012, J HEAD TRAUMA REHAB, V27, P391, DOI 10.1097/HTR.0b013e3182238cdd; Corrigan JD, 2010, J TRAUMA, V69, P722, DOI 10.1097/TA.0b013e3181e904cc; Dijkers MP, 2010, J HEAD TRAUMA REHAB, V25, P81, DOI 10.1097/HTR.0b013e3181cd3528; Dillahunt-Aspillaga C, 2017, J HEAD TRAUMA REHAB, V32, P271, DOI 10.1097/HTR.0000000000000275; DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U; Donaghy S, 1998, ARCH PHYS MED REHAB, V79, P1231, DOI 10.1016/S0003-9993(98)90267-2; Farrell-Carnahan L, 2015, BRAIN INJURY, V29, P1400, DOI 10.3109/02699052.2015.1063161; Fuhrer MJ, 1987, REHABILITATION OUTCO, P137; Gause LR, 2017, J HEAD TRAUMA REHAB, V32, P255, DOI 10.1097/HTR.0000000000000309; Hall KM, 2001, ARCH PHYS MED REHAB, V82, P367, DOI 10.1053/apmr.2001.21525; Hammond FM, 2004, J HEAD TRAUMA REHAB, V19, P314, DOI 10.1097/00001199-200407000-00006; HarrisonFelix C, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199610000-00002; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; Institute of Medicine, 2008, GULF WAR HLTH, V7; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; Lamberty GJ, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e31829a64d1; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McGarity S, 2017, J HEAD TRAUMA REHAB, V32, P34, DOI 10.1097/HTR.0000000000000242; Nakase-Richardson R, 2011, J NEUROL NEUROSUR PS, V82, P494, DOI 10.1136/jnnp.2010.222489; Nakase-Richardson R, 2007, J NEUROL NEUROSUR PS, V78, P872, DOI 10.1136/jnnp.2006.104190; Nakase-Richardson R, 2009, ARCH PHYS MED REHAB, V90, P17, DOI 10.1016/j.apmr.2008.06.030; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Sherer M, 2008, J NEUROL NEUROSUR PS, V79, P678, DOI 10.1136/jnnp.2006.111187; Stevens LF, 2017, J HEAD TRAUMA REHAB, V32, P234, DOI 10.1097/HTR.0000000000000324; TEASDALE G, 1974, LANCET, V2, P81; Tran J, 2017, J HEAD TRAUMA REHAB, V32, P264, DOI 10.1097/HTR.0000000000000296; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033	34	11	11	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2017	32	4					221	233		10.1097/HTR.0000000000000334			13	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	FA2KB	WOS:000405269200010	28678118				2021-06-18	
J	Oldham, JR; DiFabio, MS; Kaminski, TW; DeWolf, RM; Buckley, TA				Oldham, Jessie R.; DiFabio, Melissa S.; Kaminski, Thomas W.; DeWolf, Ryan M.; Buckley, Thomas A.			Normative Tandem Gait in Collegiate Student-Athletes: Implications for Clinical Concussion Assessment	SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH			English	Article						brain; mild traumatic brain injury; balance; postural control	ERROR SCORING SYSTEM; TRAUMATIC BRAIN-INJURY; POSTURAL-CONTROL; BALANCE CONTROL; PERFORMANCE; DEFICITS; SPORT; STABILITY; RECOVERY; EXERCISE	Background: Impaired balance is common after concussion. The third edition of the Sport Concussion Assessment Tool (SCAT-3) recommends the Balance Error Scoring System (BESS) and/or tandem gait for postconcussion balance assessment. The limitations of the BESS are well documented; however, tandem gait has received little attention throughout concussion literature. The purpose of this study was to provide normative data for tandem gait in collegiate student-athletes based on sport type, concussion history, and gender. Hypothesis: Tandem gait will be influenced by concussion history, sport, and gender. Study Design: Cohort study. Level of Evidence: Level 3. Methods: Four hundred collegiate student-athletes from both collision/contact (n = 200) and limited contact/noncontact (n = 200) sports performed 4 tandem gait trials, consistent with SCAT-3 guidelines. The dependent variables included the best of the 4 trials (BEST), the mean of the 4 trials (MEAN), and the mean of each of the trials individually (ORDER). Separate multivariate analyses of variance were performed for each of the independent variables to determine effect on BEST and MEAN trial times. Significant main effects were followed up with a 1-way analysis of variance (ANOVA). A separate 1-way ANOVA was used to assess ORDER differences. Results: The mean BEST was 10.37 +/- 1.76 seconds, and the MEAN was 11.32 +/- 0.70 seconds. There were no significant differences in BEST or MEAN tandem gait times, respectively, between those with and without concussion history (P = 0.41 and P = 0.69, respectively), sport type (P = 0.57 and P = 0.42, respectively), or gender (P = 0.73 and P = 0.49, respectively). There were significant differences (P < 0.05) between ORDER of the 4 tandem gait trials across the population, with improved times at each trial. Conclusion: The results of this study provide a normative data set for tandem gait in healthy collegiate student-athletes and suggest that common determinants of balance, including concussion history, collision sport participation, and gender do not appear to influence performance, but ORDER could have significant clinical implications.	[Oldham, Jessie R.; DiFabio, Melissa S.; Kaminski, Thomas W.; DeWolf, Ryan M.; Buckley, Thomas A.] Univ Delaware, Dept Kinesiol & Appl Physiol, Newark, DE USA; [DiFabio, Melissa S.; Buckley, Thomas A.] Univ Delaware, Biomech & Movement Sci, Newark, DE USA	Buckley, TA (corresponding author), Univ Delaware, Human Performance Lab, 541 South Coll Ave, Newark, DE 19716 USA.	tbuckley@udel.edu	Buckley, Thomas A/B-7525-2016	Buckley, Thomas A/0000-0002-0515-0150; Oldham, Jessie/0000-0003-2801-2110	National Athletic Trainers' Association Research and Education Foundation; CARE [NCAA/DoD CARE W81XWH-14-2-0151]	The following author declared potential conflicts of interest: Thomas A. Buckley, EdD, ATC, has grants/grants pending from National Athletic Trainers' Association Research and Education Foundation. This study was funded by CARE, grant number NCAA/DoD CARE W81XWH-14-2-0151.	[Anonymous], 2013, Br J Sports Med, V47, P259; Buckley TA, 2016, J SPORT HEALTH SCI, V5, P417, DOI 10.1016/j.jshs.2015.03.010; Buckley TA, 2013, GAIT POSTURE, V38, P549, DOI 10.1016/j.gaitpost.2013.02.008; Burk JM, 2013, CLIN J SPORT MED, V23, P312, DOI 10.1097/JSM.0b013e318285633f; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Corwin DJ, 2015, J PEDIATR-US, V166, P1221, DOI 10.1016/j.jpeds.2015.01.039; Docherty CL, 2006, CLIN J SPORT MED, V16, P203, DOI 10.1097/00042752-200605000-00003; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Fox ZG, 2008, J ATHL TRAINING, V43, P456, DOI 10.4085/1062-6050-43.5.456; Giorgetti M M, 1998, Physiother Res Int, V3, P274, DOI 10.1002/pri.150; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Guyton A., 1986, TXB MED PHYSL; Hanninen T, 2016, J SCI MED SPORT, V19, P636, DOI 10.1016/j.jsams.2015.08.005; HORSTMANN GA, 1988, NEUROSCI LETT, V95, P179, DOI 10.1016/0304-3940(88)90653-2; Howell D, 2015, J BIOMECH, V48, P3364, DOI 10.1016/j.jbiomech.2015.06.014; Howell DR, 2013, ARCH PHYS MED REHAB, V94, P1513, DOI 10.1016/j.apmr.2013.04.015; Hubble JP, 1997, MOVEMENT DISORD, V12, P969, DOI 10.1002/mds.870120620; Kammerlind AS, 2005, EUR J PHYSIOTHER, V7, P96, DOI 10.1080/14038190510010403; Kelly KC, 2014, J ATHL TRAINING, V49, P665, DOI 10.4085/1062-6050-49.3.25; Kerr ZY, 2012, MED SCI SPORT EXER, V44, P377, DOI 10.1249/MSS.0b013e31823240f2; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Martini DN, 2011, ARCH PHYS MED REHAB, V92, P585, DOI 10.1016/j.apmr.2010.11.029; Mayhew JL, 2010, J STRENGTH COND RES, V24, P447, DOI 10.1519/JSC.0b013e3181c08860; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Oldham JR, 2016, GAIT POSTURE, V49, P437, DOI 10.1016/j.gaitpost.2016.07.327; Parker TM, 2008, MED ENG PHYS, V30, P959, DOI 10.1016/j.medengphy.2007.12.006; Parker TM, 2006, MED SCI SPORT EXER, V38, P1032, DOI 10.1249/01.mss.0000222828.56982.a4; Perry J, 1992, GAIT ANAL NORMAL PAT; Rahn C, 2015, CLIN J SPORT MED, V25, P248, DOI 10.1097/JSM.0000000000000141; Rice SG, 2008, PEDIATRICS, V121, P841, DOI 10.1542/peds.2008-0080; Schneiders AG, 2008, BRIT J SPORT MED, V42, P1011, DOI 10.1136/bjsm.2007.041665; Schneiders AG, 2010, J SCI MED SPORT, V13, P196, DOI 10.1016/j.jsams.2009.05.004; Sosnoff JJ, 2011, J ATHL TRAINING, V46, P85, DOI 10.4085/1062-6050-46.1.85; Stolze H, 2002, J NEUROL NEUROSUR PS, V73, P310, DOI 10.1136/jnnp.73.3.310; Valovich TC, 2003, J ATHL TRAINING, V38, P51; Vander A., 1990, HUMAN PHYSL MECH BOD; Woollacott, 2001, MOTOR CONTROL THEORY; Zimmer A, 2015, APPL NEUROPSYCH-ADUL, V22, P132, DOI 10.1080/23279095.2013.867265; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	40	11	11	0	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1941-7381	1941-0921		SPORTS HEALTH	Sports Health	JUL-AUG	2017	9	4					305	311		10.1177/1941738116680999			7	Sport Sciences	Sport Sciences	FH9XL	WOS:000411570600002	27899680	Green Published			2021-06-18	
J	Stevens, LF; Lapis, Y; Tang, X; Sander, AM; Dreer, LE; Hammond, FM; Kreutzer, JS; O'Neil-Pirozzi, TM; Nakase-Richardson, R				Stevens, Lillian Flores; Lapis, Yanna; Tang, Xinyu; Sander, Angelle M.; Dreer, Laura E.; Hammond, Flora M.; Kreutzer, Jeffrey S.; O'Neil-Pirozzi, Therese M.; Nakase-Richardson, Risa			Relationship Stability After Traumatic Brain Injury Among Veterans and Service Members: A VA TBI Model Systems Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injuries; couples; marital status; polytrauma; relationship stability; Veterans	HEAD-INJURY; MARITAL STABILITY; MILITARY SERVICE; CAREGIVERS; MARRIAGE; REHABILITATION; PERSPECTIVES; INDIVIDUALS; POLYTRAUMA; FAMILIES	Objective: To explore stability of relationships and predictors of change in relationship status 2 years following TBI/polytrauma. Setting: Five Department of Veterans Affairs Polytrauma Rehabilitation Centers (VA PRCs). Participants: A total of 357 active duty service members and Veterans enrolled in the Veterans Affairs Polytrauma Rehabilitation Centers Traumatic Brain Injury Model Systems database with complete marital status information at 2 years postinjury. Design: Prospective, longitudinal, multisite. Main Measures: Relationship status change was defined as change in marital status (single/never married; married; divorced/separated) at 2-year follow-up, compared with status at enrollment. Results: At the time of enrollment, 134 participants (38%) were single/never married; 151 (42%) were married, and 72 (20%) were divorced/separated. Of those married at enrollment, 78% remained married at year 2 while 22% underwent negative change. Multivariable analyses revealed that age and education at the time of injury and mental health utilization prior to injury were significant predictors of relationship change. Among those who were single/ divorced/ separated at the time of enrollment, 87% remained so at year 2 while 13% underwent positive change. Injury during deployment significantly predicted positive relationship change. Conclusions: The unmalleable, preinjury characteristics identified may be used as potential triggers for education, prevention, surveillance, and couples therapy, if needed.	[Stevens, Lillian Flores; Lapis, Yanna] Hunter Holmes McGuire Vet Affairs Med Ctr, Richmond, VA USA; [Stevens, Lillian Flores] Virginia Commonwealth Univ, Dept Psychol, Box 2018, Richmond, VA 23284 USA; [Stevens, Lillian Flores; Lapis, Yanna; Kreutzer, Jeffrey S.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA; [Stevens, Lillian Flores] Hunter Holmes McGuire Vet Affairs Med Ctr, DVBIC, Richmond, VA USA; [Tang, Xinyu] Univ Arkansas Med Sci, Biostat Program, Dept Pediat, Little Rock, AR 72205 USA; [Sander, Angelle M.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Sander, Angelle M.] Baylor Coll Med, Beth K & Stuart C Yudofsky Div Neuropsychiat, Houston, TX 77030 USA; [Sander, Angelle M.] Baylor Coll Med, Dept Psychiat, Houston, TX 77030 USA; [Sander, Angelle M.] Harris Hlth Syst, Houston, TX USA; [Sander, Angelle M.] TIRR Mem Hermann, Brain Injury Res Ctr, Houston, TX USA; [Dreer, Laura E.] Univ Alabama Birmingham, Dept Phys Med & Rehabil, Birmingham, AL USA; [Dreer, Laura E.] Univ Alabama Birmingham, Dept Ophthalmol, Birmingham, AL 35294 USA; [Hammond, Flora M.] Indiana Univ Sch Med, Dept Phys Med & Rehabil, Indianapolis, IN 46202 USA; [O'Neil-Pirozzi, Therese M.] Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA USA; [O'Neil-Pirozzi, Therese M.] Northeastern Univ, Dept Commun Sci & Disorders, Boston, MA 02115 USA; [Nakase-Richardson, Risa] James A Haley Vet Hosp, MHBS, Tampa, FL USA; [Nakase-Richardson, Risa] James A Haley Vet Hosp, VA HSR&D Ctr Innovat Disabil Rehabil & Res CINDRR, Tampa, FL USA; [Nakase-Richardson, Risa] James A Haley Vet Hosp, DVBIC, Tampa, FL USA; [Nakase-Richardson, Risa] Univ S Florida, Dept Internal Med, Tampa, FL USA	Stevens, LF (corresponding author), Hunter Holmes McGuire Vet Affairs Med Ctr, Mental Hlth Serv, 1201 Broad Rock Blvd 116B, Richmond, VA 23249 USA.	lillian.stevens@va.gov			U.S. Department of Veterans Affairs Health Services Research and Development COIN grant (CINDRR) [1 I50 HX001233-01]; Department of Veterans AffairsUS Department of Veterans Affairs; Department of Health & Human Services (National Institute on Disability, Independent Living, and Rehabilitation Research); VHA Central Office VA TBI Model System Program of Research; General Dynamics Health Solutions from the Defense and Veterans Brain Injury Center within the Defense Health Agency [W91YTZ-13-C-0015]; National Institute on Disability, Independent Living, and Rehabilitation ResearchUnited States Department of Health & Human Services [90RT5007, 90DP0028, 90DP0060, 90DP0044-01-00, 90DP0036, 90DP00303, 90DP0039-02-01]; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMOUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [U48DP000036, U48DP000060, U48DP000028, U48DP000039] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I50HX001233] Funding Source: NIH RePORTER	The authors acknowledge the support of U.S. Department of Veterans Affairs Health Services Research and Development COIN grant (1 I50 HX001233-01; CINDRR) for assistance in manuscript preparation.; The Polytrauma Rehabilitation Center Traumatic Brain Injury (TBI) Model System collaboration is funded through an Interagency Agreement between the Department of Veterans Affairs and the Department of Health & Human Services (National Institute on Disability, Independent Living, and Rehabilitation Research). This research is sponsored by VHA Central Office VA TBI Model System Program of Research, and Subcontract from General Dynamics Health Solutions (W91YTZ-13-C-0015) from the Defense and Veterans Brain Injury Center within the Defense Health Agency.; The contents of this publication were developed under grants from the National Institute on Disability, Independent Living, and Rehabilitation Research (grant numbers 90RT5007 [PI: Sander], 90DP0028 [PI: Sherer], and 90DP0060 [PI: Arciniegas]; 90DP0044-01-00 [PI: Novak], 90DP0036 [PI: Hammond], 90DP00303 [PI: Kreutzer], and # 90DP0039-02-01 [PI: Giacino]). NIDILRR is a Center within the Administration for Community Living (ACL), Department of Health & Human Services (HHS). The contents of this publication do not necessarily represent the policy of NIDILRR, ACL, and HHS, and endorsement by the Federal Government should not be assumed.	ALLEN K, 1994, REHABIL PSYCHOL, V39, P29, DOI 10.1037/h0080313; Arango-Lasprilla JC, 2008, BRAIN INJURY, V22, P565, DOI 10.1080/02699050802172004; Arango-Lasprilla JC, 2011, J REHABIL MED, V43, P983, DOI 10.2340/16501977-0883; Baptist JA, 2011, CONTEMP FAM THER, V33, P199, DOI 10.1007/s10591-011-9162-6; Bin Zubair U, 2015, J ROY ARMY MED CORPS, V161, P127, DOI 10.1136/jramc-2014-000253; Burridge AC, 2007, NEUROPSYCHOL REHABIL, V17, P95, DOI 10.1080/09602010500505070; Call VRA, 1996, J MARRIAGE FAM, V58, P219, DOI 10.2307/353390; Centers for Disease Control and Prevention, 1998, BEH RISK FACT SURV S; Cohen J, 2009, ARMED FORCES SOC, V36, P19, DOI 10.1177/0095327X09332146; Collins RC, 2008, J CLIN PSYCHOL, V64, P993, DOI 10.1002/jclp.20515; Cown, 2007, FAMILIES STRESS ASSE; Cutrona CE, 2011, J CONSULT CLIN PSYCH, V79, P814, DOI 10.1037/a0025874; Davies RC, 2012, J HEAD TRAUMA REHAB, V27, pE21, DOI 10.1097/HTR.0b013e31825360da; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; Friedemann-Sanchez G, 2008, ARCH PHYS MED REHAB, V89, P171, DOI 10.1016/j.apmr.2007.10.017; Fuhrer MJ, 1987, REHABILITATION OUTCO, P137; Gill CJ, 2011, J HEAD TRAUMA REHAB, V26, P56, DOI 10.1097/HTR.0b013e3182048ee9; GIMBEL C, 1994, J MARRIAGE FAM, V56, P691, DOI 10.2307/352879; Gordon W, 1993, J HEAD TRAUMA REHAB, V8, P26; Gosling J, 1999, BRAIN INJURY, V13, P785; Hammond FM, 2011, J HEAD TRAUMA REHAB, V26, P69, DOI 10.1097/HTR.0b013e318205174d; Harris JKJ, 2001, BRAIN INJURY, V15, P223; Hogan PF, 2010, ARMED FORCES SOC, V36, P420, DOI 10.1177/0095327X09351228; Karney BR, 2012, J FAM ISSUES, V33, P1572, DOI 10.1177/0192513X12439690; Knight RG, 1998, BRAIN INJURY, V12, P467, DOI 10.1080/026990598122430; Kreutzer JS, 2007, NEUROREHABILITATION, V22, P53; Kreutzer JS, 2016, NEUROREHABILITATION, V38, P271, DOI 10.3233/NRE-161318; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; KREUTZER JS, 1992, ARCH PHYS MED REHAB, V73, P771; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; Lamberty GJ, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e31829a64d1; McLeland K. C., 2005, INDIVIDUAL DIFFERENC, V3, P177; Melvin KC, 2015, RES NURS HEALTH, V38, P7, DOI 10.1002/nur.21630; Naimi TS, 2003, JAMA-J AM MED ASSOC, V289, P70, DOI 10.1001/jama.289.1.70; Paley B, 2013, CLIN CHILD FAM PSYCH, V16, P245, DOI 10.1007/s10567-013-0138-y; Panting A., 1972, REHABILITATION, V38, P33; Perlesz A, 2000, J HEAD TRAUMA REHAB, V15, P909, DOI 10.1097/00001199-200006000-00005; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Ponsford J, 2003, NEUROPSYCHOL REHABIL, V13, P275, DOI 10.1080/09602010244000363; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; Raley RK, 2015, FUTURE CHILD, V25, P89, DOI 10.1353/foc.2015.0014; Rivera PA, 2008, ARCH PHYS MED REHAB, V89, P931, DOI 10.1016/j.apmr.2007.12.032; Rosand GMB, 2014, SOC PSYCH PSYCH EPID, V49, P109, DOI 10.1007/s00127-013-0681-3; Ruger W, 2002, ARMED FORCES SOC, V29, P85, DOI 10.1177/0095327X0202900105; Sander AM, 2016, ARCH PHYS MED REHAB, V97, P753, DOI 10.1016/j.apmr.2016.01.009; Sander AM, 2012, ARCH PHYS MED REHAB, V93, P1331, DOI 10.1016/j.apmr.2012.03.037; Segal Mady W., 1989, ORG FAMILY WORK FAMI, P3; Substance Abuse and Mental Health Services Administration, 1998, NAT HOUS SURV DRUG A; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Vanderploeg RD, 2003, J HEAD TRAUMA REHAB, V18, P148, DOI 10.1097/00001199-200303000-00006; Wade TJ, 2004, J HEALTH SOC BEHAV, V45, P155, DOI 10.1177/002214650404500203; Wang L, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0517-7; Wood RL, 2005, BRAIN INJURY, V19, P845, DOI 10.1080/02699050500058778; Wood RL, 1997, BRAIN INJURY, V11, P491, DOI 10.1080/713802183	55	11	11	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2017	32	4					234	244		10.1097/HTR.0000000000000324			11	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	FA2KB	WOS:000405269200011	28520674	Green Accepted			2021-06-18	
J	Xia, Z; Peng, WJ; Cheng, SH; Zhong, BW; Sheng, CX; Zhang, CH; Gong, W; Cheng, S; Li, J; Wang, Z				Xia, Zian; Peng, Weijun; Cheng, Shunhua; Zhong, Bingwu; Sheng, Chenxia; Zhang, Chunhu; Gong, Wei; Cheng, Shuai; Li, Jun; Wang, Zhe			Naoling decoction restores cognitive function by inhibiting the neuroinflammatory network in a rat model of Alzheimer's disease	ONCOTARGET			English	Article						Alzheimer's disease; Naoling decoction; amyloid-beta (A beta) deposits; neuroinflammatory network; Chromogranin A	TRAUMATIC BRAIN-INJURY; MOUSE MODEL; KAPPA-B; INTERLEUKIN-1-BETA PRODUCTION; MICROGLIAL ACTIVATION; NLRP3 INFLAMMASOME; TRANSGENIC MICE; CHROMOGRANIN-A; AMYLOID-BETA; IMPAIRMENT	Neuroinflammation is central to the pathogenesis of Alzheimer's disease (AD). We previously showed that Naoling decoction (NLD), a traditional Chinese medicine, was effective against AD, acting by inhibiting expression of IL-1 beta and IL-6. In the present study, we generated the rat model of AD by injecting A beta(1-42) peptide intracerebroventricularly and evaluated the dose- dependent effects of NLD treatment. The NLD-treated rats exhibited significant improvements in cognitive function as evaluated by the Morris water maze test. Golgi-Cox staining revealed that NLD treatment dose- dependently increased dendritic spines in the CA1 region, which were diminished in vehicle-treated rats. Further, NLD treatment normalized hippocampal Chromogranin A levels, which were elevated by A beta(1-42) induction. NLD also attenuated activation of microglia and astrocytes induced by A beta(1-2.) Subsequently, NLD dose-dependently reduced levels TNF-alpha, IL-1 beta and IL-6 by inhibiting the NF-B-K signaling pathway and the ASC-dependent inflammasome in the hippocampus. These findings reveal that NLD is a promising therapeutic agent that exerts inhibitory effects at multiple sites within the neuroinflammatory network induced in AD.	[Xia, Zian; Peng, Weijun; Cheng, Shunhua; Zhong, Bingwu; Sheng, Chenxia; Gong, Wei; Cheng, Shuai; Wang, Zhe] Cent S Univ, Dept Integrated Tradit Chinese & Western Med, Xiangya Hosp 2, Changsha 410011, Hunan, Peoples R China; [Xia, Zian; Zhang, Chunhu] Cent S Univ, Dept Integrated Tradit Chinese & Western Med, Xiangya Hosp, Changsha 410008, Hunan, Peoples R China; [Cheng, Shunhua] Cent S Univ, Dept Urol, Xiangya Hosp 2, Changsha 410011, Hunan, Peoples R China; [Gong, Wei] Liuyang Hosp Tradit Chinese Med, Dept Neurol, Liuyang 4103002, Hunan, Peoples R China; [Li, Jun] Cent S Univ, Xiangya Sch Med, Canc Hosp, Thyroid Tumour Internal Med Dept, Changsha 410013, Hunan, Peoples R China	Wang, Z (corresponding author), Cent S Univ, Dept Integrated Tradit Chinese & Western Med, Xiangya Hosp 2, Changsha 410011, Hunan, Peoples R China.	ericwangzhe@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81373705, 81603670]; Hunan Provincial Natural Science Foundation of ChinaNatural Science Foundation of Hunan Province	This work was financially supported by the National Natural Science Foundation of China (No. 81373705, 81603670), and Hunan Provincial Natural Science Foundation of China.	Baek H, 2016, ONCOTARGET, V7, P69347, DOI 10.18632/oncotarget.12469; Bordt EA, 2014, FREE RADICAL BIO MED, V76, P34, DOI 10.1016/j.freeradbiomed.2014.07.033; Braidy N, 2016, ONCOTARGET, V7, P64589, DOI 10.18632/oncotarget.10905; Calsolaro V, 2016, ALZHEIMERS DEMENT, V12, P719, DOI 10.1016/j.jalz.2016.02.010; Couturier J, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0477-y; Delcambre GH, 2016, PEERJ, V4, DOI 10.7717/peerj.1601; Edison P, 2008, NEUROBIOL DIS, V32, P412, DOI 10.1016/j.nbd.2008.08.001; Eimer WA, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-2; El Khoury J, 2007, NAT MED, V13, P432, DOI 10.1038/nm1555; Guo JT, 2002, J NEUROSCI, V22, P5900; Hoarau JJ, 2011, CNS NEUROL DISORD-DR, V10, P25, DOI 10.2174/187152711794488601; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Kaushal V, 2015, CELL DEATH DIFFER, V22, P1676, DOI 10.1038/cdd.2015.16; Kong LW, 2015, INT IMMUNOPHARMACOL, V29, P401, DOI 10.1016/j.intimp.2015.10.023; Lai J, 2014, NEUROCHEM INT, V75, P26, DOI 10.1016/j.neuint.2014.05.006; Lechner T, 2004, EXP GERONTOL, V39, P101, DOI 10.1016/j.exger.2003.09.018; Li X, 2010, PRACTICAL PREVENTIVE, V17, P959, DOI [10.3969/j.issn.1006-3110.2010.05.051, DOI 10.3969/J.ISSN.1006-3110.2010.05.051]; Lin LF, 2015, J ETHNOPHARMACOL, V159, P158, DOI 10.1016/j.jep.2014.11.009; Liu B, 2015, NEUROSCIENCE, V294, P193, DOI 10.1016/j.neuroscience.2015.02.053; Liu L, 2014, NEUROBIOL AGING, V35, P309, DOI 10.1016/j.neurobiolaging.2013.08.016; Loh YP, 2012, J MOL NEUROSCI, V48, P347, DOI 10.1007/s12031-012-9728-2; Lull ME, 2010, NEUROTHERAPEUTICS, V7, P354, DOI 10.1016/j.nurt.2010.05.014; Lyman M, 2014, NEUROSCI RES, V79, P1, DOI 10.1016/j.neures.2013.10.004; Mattsson N, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.69; Medeiros R, 2013, EXP NEUROL, V239, P133, DOI 10.1016/j.expneurol.2012.10.007; Morales I, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00112; Perez-Gonzalez R, 2013, NEUROBIOL AGING, V34, P2133, DOI 10.1016/j.neurobiolaging.2013.03.011; Ritchie CW, 2016, LANCET PSYCHIAT, V3, P179, DOI 10.1016/S2215-0366(15)00454-X; Ryu J, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.30; Sastre M, 2003, J NEUROSCI, V23, P9796; Scheltens P, 2016, LANCET, V388, P505, DOI 10.1016/S0140-6736(15)01124-1; Shao AW, 2016, MOL NEUROBIOL, V53, P18, DOI 10.1007/s12035-014-8986-0; Sheedy FJ, 2013, NAT IMMUNOL, V14, P812, DOI 10.1038/ni.2639; Shi JQ, 2013, CNS NEUROSCI THER, V19, P262, DOI 10.1111/cns.12066; Shi S, 2016, EUR J IMMUNOL, V46, P665, DOI 10.1002/eji.201545855; Spangenberg EE, 2017, BRAIN BEHAV IMMUN, V61, P1, DOI 10.1016/j.bbi.2016.07.003; Verkhratsky A, 2010, NEUROTHERAPEUTICS, V7, P399, DOI 10.1016/j.nurt.2010.05.017; Wang WZ, 2016, MOL NEUROBIOL, V53, P4809, DOI 10.1007/s12035-015-9385-x; Wang Zhe, 2013, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V38, P113, DOI 10.3969/j.issn.1672-7347.2013.02.001; Wildsmith KR, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-22; Wu Z, 2013, NEUROBIOL AGING, V34, P2715, DOI 10.1016/j.neurobiolaging.2013.05.018; Xing ZH, 2016, SCI REP-UK, V6, DOI 10.1038/srep20040; Xuan AG, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-202; Yang B, 2017, MOL NEUROBIOL, V54, P4833, DOI 10.1007/s12035-016-0038-5; Yasuno F, 2012, PSYCHIAT RES-NEUROIM, V203, P67, DOI 10.1016/j.pscychresns.2011.08.013; Zendedel A, 2016, MOL NEUROBIOL, V53, P3063, DOI 10.1007/s12035-015-9203-5; Zeng KW, 2010, INT IMMUNOPHARMACOL, V10, P668, DOI 10.1016/j.intimp.2010.03.010; Zhong Bingwu, 2010, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V35, P910, DOI 10.3969/j.issn.1672-7347.2010.09.002; Zhong Bingwu, 2010, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V35, P431, DOI 10.3969/j.issn.1672-7347.2010.05.005; Zhu D, 2016, J ALZHEIMERS DIS, V52, P483, DOI 10.3233/JAD-151090	50	11	14	0	11	IMPACT JOURNALS LLC	ORCHARD PARK	6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA		1949-2553		ONCOTARGET	Oncotarget	JUN 27	2017	8	26					42648	42663		10.18632/oncotarget.17337			16	Oncology; Cell Biology	Oncology; Cell Biology	FA5OQ	WOS:000405493400074	28487495	Green Published, Other Gold			2021-06-18	
J	Guo, XB; Deng, X; Wei, Y				Guo, Xin-bin; Deng, Xin; Wei, Ying			Homing of Cultured Endothelial Progenitor Cells and Their Effect on Traumatic Brain Injury in Rat Model	SCIENTIFIC REPORTS			English	Article							ENHANCES NEUROGENESIS; CEREBRAL-ISCHEMIA; CD34(+) CELLS; ANGIOGENESIS; TRANSPLANTATION; STROKE; DISEASE	Transplanted endothelial progenitor cells (EPCs) may play an important role in reestablishing the endothelial integrity of the vessels after brain injury, and contribute to neurogenesis. We, therefore, tested the homing of ex vivo cultured peripheral blood-derived EPCs and their effect on injured brain tissue after intravenous administration. To track the homing of implanted EPCs in injured brain tissues, EPCs were labeled with DAPI and BrdU in vitro before transplantation. EPCs were transplanted into the host animal through peripheral administration through the femoral vein, and homing of EPCs was evaluated. The integration of intravenously injected EPCs into the injured brain tissue was demonstrated. Immunohistochemical staining showed that microvessel density in the perifocal region of EPCs-transplanted rats was significantly increased, and the numbers of BrdU+ cells in the DG of subventricular zone were increased in EPCs-transplanted rats as compared to the control group. Transplanted EPCs may play an important role in reestablishing the endothelial integrity in the vessels after brain injury and further contribute to neurogenesis. EPCs enhanced recovery following brain injury in a rat model of TBI.	[Guo, Xin-bin; Deng, Xin; Wei, Ying] Zhengzhou Univ, Dept Neurointervent Radiol, Affiliated Hosp 1, 1 Jianshe Rd, Zhengzhou 450052, Peoples R China	Guo, XB (corresponding author), Zhengzhou Univ, Dept Neurointervent Radiol, Affiliated Hosp 1, 1 Jianshe Rd, Zhengzhou 450052, Peoples R China.	gxb3906080@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81100928]; Henan Medical Science Research Project [2011020010]	The work is supported by National Natural Science Foundation of China 81100928, and Henan Medical Science Research Project 2011020010.	Adamczak J, 2015, STROKE, V46, pE103, DOI 10.1161/STROKEAHA.114.007642; Alphonse RS, 2015, NAT PROTOC, V10, P1697, DOI 10.1038/nprot.2015.107; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Bennis Y, 2012, J THROMB HAEMOST, V10, P1914, DOI 10.1111/j.1538-7836.2012.04835.x; Chong MSK, 2016, STEM CELL TRANSL MED, V5, P530, DOI 10.5966/sctm.2015-0227; Guo XB, 2009, J NEUROTRAUM, V26, P1337, DOI [10.1089/neu.2008.0733, 10.1089/neu.2008-0733]; Hecht N, 2014, J CEREBR BLOOD F MET, V34, P1297, DOI 10.1038/jcbfm.2014.78; Hou LQ, 2016, AM J PHYSIOL-HEART C, V310, pH455, DOI 10.1152/ajpheart.00726.2015; Ishida Y, 2012, J CLIN INVEST, V122, P711, DOI 10.1172/JCI43027; Leistner DM, 2011, CLIN RES CARDIOL, V100, P925, DOI 10.1007/s00392-011-0327-y; Long JT, 2013, J VASC SURG, V58, P756, DOI 10.1016/j.jvs.2012.11.096; Ma FF, 2015, BRAIN RES, V1623, P150, DOI 10.1016/j.brainres.2015.02.010; Nguyen MP, 2015, ONCOTARGET, V6, P16588, DOI 10.18632/oncotarget.3752; Morancho A, 2015, J CEREBR BLOOD F MET, V35, P1547, DOI 10.1038/jcbfm.2015.180; Okamoto R, 2002, NAT MED, V8, P1011, DOI 10.1038/nm755; Rafii S, 2016, NATURE, V529, P316, DOI 10.1038/nature17040; Rodrigues HG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165115; Seki T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12152; Subramaniyam V, 2009, AM HEART J, V158, P53, DOI 10.1016/j.ahj.2009.04.014; Sun K, 2016, CURR STEM CELL RES T, V11, P265, DOI 10.2174/1574888X1103160303181155; Taguchi A, 2004, J CLIN INVEST, V114, P330, DOI 10.1172/jci200420622; Tan Y, 2016, ONCOTARGET, V7, P87100, DOI 10.18632/oncotarget.13527; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xiong Y, 2011, TRANSL STROKE RES, V2, P619, DOI 10.1007/s12975-011-0120-2; Xu XF, 2015, SCI REP-UK, V5, DOI 10.1038/srep11456; Yang J, 2015, BRAIN RES, V1625, P189, DOI 10.1016/j.brainres.2015.09.001	26	11	12	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUN 23	2017	7								4164	10.1038/s41598-017-04153-2			10	Multidisciplinary Sciences	Science & Technology - Other Topics	EY6UL	WOS:000404118700055	28646184	DOAJ Gold, Green Published			2021-06-18	
J	Kawoos, U; McCarron, RM; Chavko, M				Kawoos, Usmah; McCarron, Richard M.; Chavko, Mikulas			Protective Effect of N-Acetylcysteine Amide on Blast-Induced Increase in Intracranial Pressure in Rats	FRONTIERS IN NEUROLOGY			English	Article						blast overpressure; traumatic brain injury; intracranial pressure; oxidative stress; N-acetylcysteine amide	TRAUMATIC BRAIN-INJURY; ATTENUATES EDEMA FORMATION; ANTIOXIDANT THERAPY; CORTICAL CONTUSION; OXIDATIVE STRESS; MITOCHONDRIAL BIOENERGETICS; FUNCTIONAL RECOVERY; NEUROPROTECTION; OPC-14117; PATHOPHYSIOLOGY	Blast-induced traumatic brain injury is associated with acute and possibly chronic elevation of intracranial pressure (ICP). The outcome after TBI is dependent on the progression of complex processes which are mediated by oxidative stress. So far, no effective pharmacological protection against TBI exists. In this study, rats were exposed to a single or repetitive blast overpressure (BOP) at moderate intensities of 72 or 110 kPa in a compressed air-driven shock tube. The degree and duration of the increase in ICP were proportional to the intensity and frequency of the blast exposure(s). In most cases, a single dose of antioxidant N-acetylcysteine amide (NACA) (500 mg/kg) administered intravenously 2 h after exposure to BOP significantly attenuated blast-induced increase in ICP. A single dose of NACA was not effective in improving the outcome in the group of animals that were subjected to repetitive blast exposures at 110 kPa on the same day. In this group, two treatments with NACA at 2 and 4 h post-BOP exposure resulted in significant attenuation of elevated ICP. Treatment with NACA prior to BOP exposure completely prevented the elevation of ICP. The findings indicate that oxidative stress plays an important role in blast-induced elevated ICP as treatment with NACA-ameliorated ICP increase, which is frequently related to poor functional recovery after TBI.	[Kawoos, Usmah; McCarron, Richard M.; Chavko, Mikulas] Naval Med Res Ctr, Dept Neurotrauma, Silver Spring, MD 20910 USA; [McCarron, Richard M.] Uniformed Serv Univ Hlth Sci, Dept Surg, Walter Reed Natl Mil Med Ctr, Bethesda, MD 20814 USA	Kawoos, U (corresponding author), Naval Med Res Ctr, Dept Neurotrauma, Silver Spring, MD 20910 USA.	usmah.kawoos.ctr@mail.mil			Office of Naval Research (ONR) Work UnitOffice of Naval Research [601152N.0000.001.A1308]	This work was supported by Office of Naval Research (ONR) Work Unit 601152N.0000.001.A1308.	Aoyama N, 2002, BRAIN RES, V934, P117, DOI 10.1016/S0006-8993(02)02366-1; Arent AM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/723060; Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Beaumont A, 2000, ACTA NEUROCHIR SUPPL, V76, P125; Cernak I, 2000, J NEUROTRAUM, V17, P53, DOI 10.1089/neu.2000.17.53; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; Chavko M, 2009, SHOCK, V32, P325, DOI 10.1097/SHK.0b013e31819c38f1; Clark RSB, 2008, AUTOPHAGY, V4, P88, DOI 10.4161/auto.5173; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Dalle Lucca Jurandir J, 2012, J Neurol Sci, V318, P146, DOI 10.1016/j.jns.2012.02.002; Deepmala, 2015, NEUROSCI BIOBEHAV R, V55, P294, DOI 10.1016/j.neubiorev.2015.04.015; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; DeWitt DS, 2009, J NEUROTRAUM, V26, P877, DOI 10.1089/neu.2007.0439; Dodd S, 2008, EXPERT OPIN BIOL TH, V8, P1955, DOI 10.1517/14728220802517901 ; Du XP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080138; Eakin K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090617; Elsayed NM, 1997, TOXICOLOGY, V121, P1, DOI 10.1016/S0300-483X(97)03651-2; Gilgun-Sherki Y, 2002, PHARMACOL REV, V54, P271, DOI 10.1124/pr.54.2.271; Grinberg L, 2005, FREE RADICAL BIO MED, V38, P136, DOI 10.1016/j.freeradbiomed.2004.09.025; Gruenbaum SE, 2016, CNS DRUGS, V30, P791, DOI 10.1007/s40263-016-0355-2; Guild SJ, 2015, J APPL PHYSIOL, V119, P576, DOI 10.1152/japplphysiol.00165.2015; Gullotti DM, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4027873; Gunther M, 2015, J CLIN NEUROSCI, V22, P1477, DOI 10.1016/j.jocn.2015.03.025; Hawthorne C, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00121; Hiebert JB, 2015, AM J MED SCI, V350, P132, DOI 10.1097/MAJ.0000000000000506; Hoffer ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054163; Kawamata T, 1997, ACT NEUR S, V70, P191; Kawoos U, 2008, IEEE T MICROW THEORY, V56, P2356, DOI 10.1109/TMTT.2008.2004253; Kawoos U, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167510; Kawoos U, 2015, INT J MOL SCI, V16, P28979, DOI 10.3390/ijms161226146; Kawoos U, 2014, IEEE T BIO-MED ENG, V61, P841, DOI 10.1109/TBME.2013.2291239; Kaynar MY, 1998, NEUROSURG REV, V21, P260, DOI 10.1007/BF01105782; Kinoshita K, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0138-3; Kobeissy F, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00186; Kucherov Y, 2012, J APPL PHYS, V112, DOI 10.1063/1.4765727; Magnuson J, 2012, CURR NEUROL NEUROSCI, V12, P570, DOI 10.1007/s11910-012-0303-6; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; Marmarou Anthony, 2007, Neurosurg Focus, V22, pE1; Moochhala SM, 2004, J TRAUMA, V56, P393, DOI 10.1097/01.TA.0000066181.50879.7A; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Mori T, 1998, ACT NEUR S, V71, P120; National Academies Press, 2014, GULF WAR AND HLTH; OLSSON B, 1988, EUR J CLIN PHARMACOL, V34, P77, DOI 10.1007/BF01061422; Pandya JD, 2014, EXP NEUROL, V257, P106, DOI 10.1016/j.expneurol.2014.04.020; Patel SP, 2014, EXP NEUROL, V257, P95, DOI 10.1016/j.expneurol.2014.04.026; Penugonda S, 2011, TOXICOL LETT, V201, P1, DOI 10.1016/j.toxlet.2010.11.013; PHILLIPS YY, 1991, TXB MILITARY MED 1, V5, P295; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Reed TT, 2009, J NEUROSCI RES, V87, P408, DOI 10.1002/jnr.21872; Romner B, 2013, NAT REV NEUROL, V9, P185, DOI 10.1038/nrneurol.2013.37; Saljo A, 2009, J NEUROTRAUM, V26, P1345, DOI [10.1089/neu.2008.0856, 10.1089/neu.2008-0856]; Samuni Y, 2013, BBA-GEN SUBJECTS, V1830, P4117, DOI 10.1016/j.bbagen.2013.04.016; Sarker KP, 1999, THROMB HAEMOSTASIS, V82, P1071; Semple BD, 2014, EXP NEUROL, V261, P291, DOI 10.1016/j.expneurol.2014.07.013; Shahripour RB, 2014, BRAIN BEHAV, V4, P108, DOI 10.1002/brb3.208; Shen QH, 2016, WORLDV EVID-BASED NU, V13, P380, DOI 10.1111/wvn.12167; Smith M, 2008, ANESTH ANALG, V106, P240, DOI 10.1213/01.ane.0000297296.52006.8e; Song HL, 2018, BEHAV BRAIN RES, V340, P147, DOI 10.1016/j.bbr.2016.08.037; Stein M, 1999, SURG CLIN N AM, V79, P1537, DOI 10.1016/S0039-6109(05)70091-8; Stiefel MF, 2005, J NEUROSURG, V103, P707, DOI 10.3171/jns.2005.103.4.0707; Sunitha K, 2013, FREE RADICAL RES, V47, P357, DOI 10.3109/10715762.2013.781595; Thomale UW, 2006, INTENS CARE MED, V32, P149, DOI 10.1007/s00134-005-2845-4; Tobwala S, 2013, FREE RADICAL RES, V47, P740, DOI 10.3109/10715762.2013.819974; Toklu H. Z., 2015, BRAIN NEUROTRAUMA MO, P43, DOI 10.1201/b18126-7; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Xiong Y, 1999, J NEUROTRAUM, V16, P1067, DOI 10.1089/neu.1999.16.1067; Yi JH, 2005, BRAIN RES, V1033, P13, DOI 10.1016/j.brainres.2004.10.055; YONUTAS HM, 2016, BRAIN RES, V1640, DOI DOI 10.1016/BRAINRES.2016.02.007; Zhang XS, 2009, BRAIN RES, V1275, P87, DOI 10.1016/j.brainres.2009.04.008	71	11	11	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUN 6	2017	8								219	10.3389/fneur.2017.00219			8	Clinical Neurology; Neurosciences	Neurosciences & Neurology	EX6YH	WOS:000403387700001	28634463	DOAJ Gold, Green Published			2021-06-18	
J	Albanese, BJ; Boffa, JW; Macatee, RJ; Schmidt, NB				Albanese, Brian J.; Boffa, Joseph W.; Macatee, Richard J.; Schmidt, Norman B.			Anxiety sensitivity mediates gender differences in post-concussive symptoms in a clinical sample	PSYCHIATRY RESEARCH			English	Article						Cognitive risk factors; Traumatic brain injury; Post-concussive symptoms; Gender	TRAUMATIC BRAIN-INJURY; POSTCONCUSSIVE SYMPTOMS; DISTRESS TOLERANCE; METAANALYSIS; VALIDATION; DIMENSIONS; DISORDERS; COMBAT; INDEX; US	Traumatic brain injury (TBI) is both prevalent and potentially disabling. Extant literature has demonstrated women to report greater post-concussive symptoms (PCS) compared to men, highlighting the necessity of investigations into malleable, gender-linked risk factors for PCS that hold promise for reducing this gender disparity. Anxiety Sensitivity (AS) and Distress Tolerance (DT) are gender-linked risk factors that may be related to PCS. Despite a breadth of research supporting elevated AS and reduced DT in women, no study to date has investigated whether AS and DT mediate gender differences in PCS. The current sample was composed of 59 participants selected from a larger study based on their report of a past TBI. Findings indicated that AS, but not DT, significantly mediated gender differences in PCS. The present results suggest that AS is a cognitive risk factor that can partially account for the gender disparity in the expression of PCS. AS may influence an individual's interpretation of PCS as dangerous, thereby amplifying the perception of PCS severity. This suggests that efforts to reduce the burden of TBI may benefit from targeting AS in prevention and treatment paradigms, especially among women.	[Albanese, Brian J.; Boffa, Joseph W.; Macatee, Richard J.; Schmidt, Norman B.] Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA	Schmidt, NB (corresponding author), Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA.	schmidt@psy.fsu.edu	Schmidt, Norman B/C-6426-2015	Schmidt, Norman B/0000-0003-4125-9601	NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [T32MH093311] Funding Source: NIH RePORTER; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [T32 MH093311] Funding Source: Medline		Allan N.P., 2015, J ANXIETY DISORD; Armstrong KA, 2002, BEHAV COGN PSYCHOTH, V30, P227, DOI 10.1017/S1352465802002114; Bryant RA, 1999, J NERV MENT DIS, V187, P302, DOI 10.1097/00005053-199905000-00006; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Deacon BJ, 2003, BEHAV RES THER, V41, P1427, DOI 10.1016/S0005-7967(03)00065-2; Diamond PM, 2007, J HEAD TRAUMA REHAB, V22, P330, DOI 10.1097/01.HTR.0000300228.05867.5c; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Farris SG, 2015, PSYCHOL ASSESSMENT, V27, P1123, DOI 10.1037/pas0000112; First M., 1994, STRUCTURED CLIN INTE; Garden N, 2010, APPL NEUROPSYCHOL, V17, P1, DOI 10.1080/09084280903297495; Gratz KL, 2011, COMPR PSYCHIAT, V52, P63, DOI 10.1016/j.comppsych.2010.04.009; Hayes AF., 2012, PROCESS VERSATILE CO; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Iverson GL, 2006, BRAIN INJURY, V20, P1335, DOI 10.1080/02699050601082156; KARZMARK P, 1995, BRAIN INJURY, V9, P21, DOI 10.3109/02699059509004567; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Leyro TM, 2010, PSYCHOL BULL, V136, P576, DOI 10.1037/a0019712; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Matthews S, 2011, PSYCHIAT RES-NEUROIM, V191, P76, DOI 10.1016/j.pscychresns.2010.09.013; Matthews SC, 2012, PSYCHIAT RES-NEUROIM, V204, P149, DOI 10.1016/j.pscychresns.2012.04.018; Naragon-Gainey K, 2010, PSYCHOL BULL, V136, P128, DOI 10.1037/a0018055; Olatunji BO, 2009, PSYCHOL BULL, V135, P974, DOI 10.1037/a0017428; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Reiss S., 1985, THEORETICAL ISSUES B, P107; Richardson JD, 2014, PSYCHIAT RES, V218, P118, DOI 10.1016/j.psychres.2014.04.008; Roe C, 2009, DISABIL REHABIL, V31, P1235, DOI 10.1080/09638280802532720; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Schmidt NB, 2000, COGNITIVE THER RES, V24, P533, DOI 10.1023/A:1005562011960; Schmidt NB, 2014, J CONSULT CLIN PSYCH, V82, P1023, DOI 10.1037/a0036651; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schwab KA, 2006, NEUROLOGY, V66, pA235; Setnik L, 2007, BRAIN INJURY, V21, P1, DOI 10.1080/02699050601111419; Shu IW, 2014, PSYCHIAT RES-NEUROIM, V224, P58, DOI 10.1016/j.pscychresns.2014.07.010; Simons JS, 2005, MOTIV EMOTION, V29, P83, DOI 10.1007/s11031-005-7955-3; Stewart SH, 1997, J ANXIETY DISORD, V11, P179, DOI 10.1016/S0887-6185(97)00005-4; Taylor S., 2003, J COGN PSYCHOTHER, V17, P361, DOI [10.1891/jcop.17.2.179.57431, DOI 10.1891/JC0P.17.2.179.57431]; Taylor S, 2007, PSYCHOL ASSESSMENT, V19, P176, DOI 10.1037/1040-3590.19.2.176; Walsh TM, 2004, J ANXIETY DISORD, V18, P695, DOI 10.1016/S0887-6185(03)00043-4; Wood RL, 2014, J HEAD TRAUMA REHAB, V29, pE9, DOI 10.1097/HTR.0b013e31827eabba; Wood RL, 2011, BRAIN INJURY, V25, P1296, DOI 10.3109/02699052.2011.624569; Zhao XS, 2010, J CONSUM RES, V37, P197, DOI 10.1086/651257; Zvolensky MJ, 2001, BEHAV RES THER, V39, P477, DOI 10.1016/S0005-7967(00)00010-3	46	11	12	0	7	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-1781			PSYCHIAT RES	Psychiatry Res.	JUN	2017	252						242	246		10.1016/j.psychres.2017.01.099			5	Psychiatry	Psychiatry	EX3FX	WOS:000403119100039	28285252	Green Accepted			2021-06-18	
J	Combs, B; Kanaan, NM				Combs, Benjamin; Kanaan, Nicholas M.			Exposure of the Amino Terminus of Tau Is a Pathological Event in Multiple Tauopathies	AMERICAN JOURNAL OF PATHOLOGY			English	Article							PROGRESSIVE SUPRANUCLEAR PALSY; CHRONIC TRAUMATIC ENCEPHALOPATHY; DEPENDENT AXONAL-TRANSPORT; REPETITIVE HEAD-INJURY; CORTICOBASAL DEGENERATION; ALZHEIMERS-DISEASE; PICKS-DISEASE; NEUROFIBRILLARY DEGENERATION; MESSENGER-RNA; KINESIN	Pathological changes to the tau protein, including conformational changes and aggregation, are major hallmarks of a group of neurodegenerative disorders known as tauopathies. Among the conformational changes are alterations involving the extreme amino terminus of the protein, known as the phosphatase-activating domain (PAD). Aberrant PAD exposure induces a signaling cascade that leads to disruption of axonal transport, a critical function for neuronal survival. Conformational display of PAD is an early marker of pathological tau in Alzheimer disease (AD), but its role in other tauopathies has yet to be firmly established. We used a relatively novel N-terminal, conformation-sensitive antibody, TNT2, to determine whether misfolding in the amino terminus (ie, PAD exposure) occurs in non-AD tauopathies. We found that TNT2 specifically labeled pathological tau in post-mortem human brain tissue from Pick disease, progressive supranuclear palsy, corticobasal degeneration, and chronic traumatic encephalopathy, but did not Label nonpathological, parenchymal tau. Tau13, another N-terminal antibody, was not sensitive to pathological N-terminal conformations. Tau13 did not readily distinguish between normal (ie, parenchymal tau) and pathological tau species and showed a range of effectiveness at identifying tau pathologies in the non-AD tauopathies. These findings demonstrate that the conformational display of the PAD in tau represents a common pathological event in many tauopathies.	[Combs, Benjamin; Kanaan, Nicholas M.] Michigan State Univ, Dept Translat Sci & Mol Med, Coll Human Med, Grand Rapids, MI USA; [Kanaan, Nicholas M.] Michigan State Univ, Neurosci Program, Grand Rapids, MI USA; [Kanaan, Nicholas M.] Mercy Hlth St Marys, Hauenstein Neurosci Ctr, Grand Rapids, MI USA	Combs, B (corresponding author), 333 Bostwick Ave NE, Grand Rapids, MI 49503 USA.	benjamin.combs@hc.msu.edu	Kanaan, Nicholas/J-3428-2016	Kanaan, Nicholas/0000-0002-4362-2593; Combs, Benjamin/0000-0003-3136-7545	NlH/National Institute on Aging [R01 AG044372]; NIH/National Institute of Neurological Diseases and Stroke grant [R01 NS082730]; Jean P. Schultz Biomedical Research Endowment; Secchia Family Foundation Research Fund; BrightFocus Foundation grantBrightFocus Foundation [A2013364S]; Department of Veterans Affairs, NH/National Institute of Neurological Diseases and Stroke grant [1U01NS086659-01]; National Institute of Aging Boston University Alzheimer's Disease Center grant [P30AG13846, 0572063345-5]; Northwestern Alzheimer's Disease Center grant [AG13854]; NADC Neuropathology Core Tissue Bank; Michigan Alzheimer's Disease Center grant [P30AG053760]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS082730, U01NS086659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG013846, P30AG053760, P30AG013854, R01AG044372] Funding Source: NIH RePORTER	Supported by NlH/National Institute on Aging grant R01 AG044372 (N.M.K.), NIH/National Institute of Neurological Diseases and Stroke grant R01 NS082730 (N.M.K.), the Jean P. Schultz Biomedical Research Endowment (N.M.K.), the Secchia Family Foundation Research Fund (N.M.K.), BrightFocus Foundation grant A2013364S (N.M.K.), the Department of Veterans Affairs, NH/National Institute of Neurological Diseases and Stroke grant 1U01NS086659-01, National Institute of Aging Boston University Alzheimer's Disease Center grant P30AG13846 (supplement 0572063345-5), Northwestern Alzheimer's Disease Center grant AG13854, NADC Neuropathology Core Tissue Bank, and the Michigan Alzheimer's Disease Center grant P30AG053760.	Arai T, 2004, ANN NEUROL, V55, P72, DOI 10.1002/ana.10793; Arai T, 2001, NEUROREPORT, V12, P935, DOI 10.1097/00001756-200104170-00014; Berry RW, 2004, J NEUROCYTOL, V33, P287, DOI 10.1023/B:NEUR.0000044190.96426.b9; BONDAREFF W, 1994, J NEUROPATH EXP NEUR, V53, P158, DOI 10.1097/00005072-199403000-00007; BRAAK E, 1994, ACTA NEUROPATHOL, V87, P554, DOI 10.1007/s004010050124; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Buee L, 1999, BRAIN PATHOL, V9, P681; Carmel G, 1996, J BIOL CHEM, V271, P32789, DOI 10.1074/jbc.271.51.32789; Carson JH, 1997, CELL MOTIL CYTOSKEL, V38, P318, DOI 10.1002/(SICI)1097-0169(1997)38:4<318::AID-CM2>3.0.CO;2-#; Coleman BM, 2015, SEMIN CELL DEV BIOL, V40, P89, DOI 10.1016/j.semcdb.2015.02.007; Combs B, 2016, NEUROBIOL DIS, V94, P18, DOI 10.1016/j.nbd.2016.05.016; Cox K, 2016, NEUROBIOL AGING, V47, P113, DOI 10.1016/j.neurobiolaging.2016.07.015; DICKSON DW, 1992, ACTA NEUROPATHOL, V84, P596; FEANY MB, 1995, ACTA NEUROPATHOL, V90, P37; Feany MB, 1996, J NEUROPATH EXP NEUR, V55, P53, DOI 10.1097/00005072-199601000-00006; FEANY MB, 1995, AM J PATHOL, V146, P1388; Ferrer I, 2014, J NEUROPATH EXP NEUR, V73, P81, DOI 10.1097/NEN.0000000000000030; Fruhbeis C, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00182; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; Ghoshal N, 2002, EXP NEUROL, V177, P475, DOI 10.1006/exnr.2002.8014; Guillozet-Bongaarts AL, 2007, ACTA NEUROPATHOL, V113, P513, DOI 10.1007/s00401-007-0209-6; HAUW JJ, 1990, NEUROSCI LETT, V119, P182, DOI 10.1016/0304-3940(90)90829-X; HYMAN BT, 1988, ANN NEUROL, V23, P371, DOI 10.1002/ana.410230410; IWATSUBO T, 1994, ACTA NEUROPATHOL, V88, P129; Jicha GA, 1997, J NEUROSCI RES, V48, P128, DOI 10.1002/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO;2-E; Jicha GA, 1999, J NEUROSCI RES, V55, P713, DOI 10.1002/(SICI)1097-4547(19990315)55:6<713::AID-JNR6>3.0.CO;2-G; Kanaan NM, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.06.006; Kanaan NM, 2011, J NEUROSCI, V31, P9858, DOI 10.1523/JNEUROSCI.0560-11.2011; Kanaan NM, 2015, J NEUROPATHOLOGY EXP, V75, P19; Komori T, 1999, BRAIN PATHOL, V9, P663; Kovacs GG, 2015, NEUROPATH APPL NEURO, V41, P3, DOI 10.1111/nan.12208; LaPointe NE, 2009, J NEUROSCI RES, V87, P440, DOI 10.1002/jnr.21850; Lyons DA, 2009, NAT GENET, V41, P854, DOI 10.1038/ng.376; Marszalek JR, 1999, J CELL BIOL, V145, P469, DOI 10.1083/jcb.145.3.469; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Patterson KR, 2011, BIOCHEMISTRY-US, V50, P10300, DOI 10.1021/bi2009147; POLLOCK NJ, 1986, LANCET, V2, P1211; Potokar M, 2007, TRAFFIC, V8, P12, DOI 10.1111/j.1600-0854.2006.00509.x; Probst A, 1996, ACTA NEUROPATHOL, V92, P588, DOI 10.1007/s004010050565; Reyes JF, 2008, NEUROBIOL DIS, V31, P198, DOI 10.1016/j.nbd.2008.04.005; Schmidt I, 2012, J NEUROSCI, V32, P7466, DOI 10.1523/JNEUROSCI.0349-12.2012; Sergeant N, 1999, J NEUROCHEM, V72, P1243, DOI 10.1046/j.1471-4159.1999.0721243.x; Stein TD, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt234; Tiernan CT, 2016, EXP NEUROL, V283, P318, DOI 10.1016/j.expneurol.2016.06.030; YAMADA T, 1992, NEUROSCI LETT, V135, P99, DOI 10.1016/0304-3940(92)90145-W; Yoshida M, 2006, NEUROPATHOLOGY, V26, P457, DOI 10.1111/j.1440-1789.2006.00743.x	47	11	12	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9440	1525-2191		AM J PATHOL	Am. J. Pathol.	JUN	2017	187	6					1222	1229		10.1016/j.ajpath.2017.01.019			8	Pathology	Pathology	EW1AE	WOS:000402221500003	28413156	Green Published, Bronze			2021-06-18	
J	Heron-Delaney, M; Warren, J; Kenardy, JA				Heron-Delaney, Michelle; Warren, Jacelle; Kenardy, Justin A.			Predictors of non-return to work 2 years post-injury in road traffic crash survivors: Results from the UQ SuPPORT study	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Motor vehicles; Traffic accidents; Return to work; Mental health; Health	RETURN-TO-WORK; POSTTRAUMATIC-STRESS-DISORDER; LOW-BACK-PAIN; TRAUMATIC BRAIN-INJURY; RECOVERY EXPECTATIONS; CLINICAL-IMPLICATIONS; MULTIPLE INJURIES; DEPRESSION SCALE; HOSPITAL ANXIETY; SEVERITY SCORE	Purpose: Individuals who have sustained an injury from a road traffic crash (RTC) are at increased risk for long lasting health problems and non-return to work (NRTW). Determining the predictors of NRTW is necessary to develop screening tools to identify at-risk individuals and to provide early targeted intervention for successful return to work (RTW). The aim of this study was to identify factors that can predict which individuals will not RTW following minor or moderate injuries sustained from a RTC. Method: Participants were 194 claimants (63.4% female) within a common-law "fault-based" system from the UQ SuPPORT cohort who were working prior to their RTC. Participants were assessed at 6 months on a variety of physical and mental health measures and RTW status was determined at 2 years post-RTC. RTW rate was 78.4%. Results: Univariate predictors of NRTW included being the driver or passenger, having a prior psychiatric diagnosis, high disability level, low mental or physical quality of life, predicted non-recovery, high pain, low function, high expectations of pain persistency, low expectations about RTW, having a psychiatric diagnosis, elevated depression or anxiety. The final multivariable logistic regression model included only two variables: disability level and expectations about RTW. Seventy-five percent of individuals who will not RTW by 2 years can be identified accurately at an early stage, using only these two predictors. Conclusion: The results are promising, because they suggest that having information about two factors, which are easily obtainable, can predict with accuracy those who will require additional support to facilitate RTW. (C) 2017 Elsevier Ltd. All rights reserved.	[Heron-Delaney, Michelle] Australian Catholic Univ, Sch Psychol, 1100 Nudgee Rd, Brisbane, Qld 4014, Australia; [Warren, Jacelle; Kenardy, Justin A.] Univ Queensland, Recover Injury Res Ctr, Brisbane, Qld, Australia; [Kenardy, Justin A.] Univ Queensland, Sch Psychol, Brisbane, Qld, Australia	Heron-Delaney, M (corresponding author), Australian Catholic Univ, Sch Psychol, 1100 Nudgee Rd, Brisbane, Qld 4014, Australia.	michelle.delaney@acu.edu.au	Kenardy, Justin A/H-6603-2014; Warren, Jacelle/G-2125-2010; Kenardy, Justin/F-2085-2010; Heron-Delaney, Michelle/M-7540-2014	Kenardy, Justin A/0000-0001-9475-8450; Warren, Jacelle/0000-0002-2273-1846; Heron-Delaney, Michelle/0000-0003-1332-9385	Motor Accident Insurance Commission (MAIC)	We acknowledge the Policy and Research Team at the Motor Accident Insurance Commission (MAIC) for its input at various stages of the project and four anonymous reviewers. This research was funded by the Motor Accident Insurance Commission (MAIC), however, the views in this paper do not necessarily reflect those of the funder.	ALTMAN DG, 1994, BRIT MED J, V309, P102, DOI 10.1136/bmj.309.6947.102; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Association for the Advancement of Automotive Medicine, 2005, ABBR INJ SCAL AIS; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Barnes Jo, 2006, Annu Proc Assoc Adv Automot Med, V50, P253; Berecki-Gisolf J, 2012, J OCCUP REHABIL, V22, P283, DOI 10.1007/s10926-011-9344-y; BITRE, 2009, 118 BITRE; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Blackwell TL, 2003, REHABIL COUNS BULL, V46, P108, DOI 10.1177/00343552030460020501; Brewin CR, 2005, J TRAUMA STRESS, V18, P53, DOI 10.1002/jts.20007; Bureau of Transport Economics, 2000, ROAD CRASH COSTS AUS; Carriere JS, 2015, J OCCUP REHABIL, V25, P348, DOI 10.1007/s10926-014-9543-4; Clay FJ, 2012, J OCCUP REHABIL, V22, P363, DOI 10.1007/s10926-012-9354-4; Clay FJ, 2010, INJURY, V41, P787, DOI 10.1016/j.injury.2010.04.005; Cole DC, 2002, CAN MED ASSOC J, V166, P749; COPES WS, 1988, J TRAUMA, V28, P69, DOI 10.1097/00005373-198801000-00010; Du Bois M, 2008, EUR SPINE J, V17, P380, DOI 10.1007/s00586-007-0567-8; Ebrahim S, 2015, J OCCUP REHABIL, V25, P240, DOI 10.1007/s10926-014-9535-4; Fadyl J, 2008, J OCCUP REHABIL, V18, P362, DOI 10.1007/s10926-008-9153-0; Fitzharris M, 2010, AUST NZ J PUBL HEAL, V34, P153, DOI 10.1111/j.1753-6405.2010.00500.x; Fort E, 2011, J REHABIL MED, V43, P283, DOI 10.2340/16501977-0670; Friedland JF, 2001, J NERV MENT DIS, V189, P426, DOI 10.1097/00005053-200107000-00003; Gabbe BJ, 2007, MED J AUSTRALIA, V187, P14, DOI 10.5694/j.1326-5377.2007.tb01108.x; Garrelfs SF, 2015, BRAIN INJURY, V29, P550, DOI 10.3109/02699052.2014.995227; Gopinath B, 2015, EUR J PAIN, V19, P1111, DOI 10.1002/ejp.634; Grafarend E.W., 2006, LINEAR NONLINEAR MOD; Harrison Kate, 2003, Work, V21, P141; Hayden JA, 2006, ANN INTERN MED, V144, P427, DOI 10.7326/0003-4819-144-6-200603210-00010; He YH, 2010, J OCCUP REHABIL, V20, P378, DOI 10.1007/s10926-010-9232-x; Heijbel B, 2006, J OCCUP REHABIL, V16, P173, DOI 10.1007/s10926-006-9016-5; Hours M, 2013, ACCIDENT ANAL PREV, V50, P92, DOI 10.1016/j.aap.2012.03.037; Huijs JJJM, 2012, J OCCUP REHABIL, V22, P301, DOI 10.1007/s10926-011-9351-z; Iakova M, 2012, J OCCUP REHABIL, V22, P532, DOI 10.1007/s10926-012-9369-x; Iles RA, 2009, J OCCUP REHABIL, V19, P25, DOI 10.1007/s10926-008-9161-0; Kenardy J, EUR J PSYCHOTRAUMATO; Kenardy J, 2015, INJURY, V46, P883, DOI 10.1016/j.injury.2014.11.006; Kenardy J, 2015, ARCH PHYS MED REHAB, V96, P410, DOI 10.1016/j.apmr.2014.10.007; Kessler R. C., 1998, INT J METH PSYCH RES, V7, P171, DOI 10.1002/mpr.47.; Kuijer W, 2006, J OCCUP REHABIL, V16, P439, DOI 10.1007/s10926-006-9021-8; Kuijpers PMJC, 2003, PSYCHOSOMATICS, V44, P329, DOI 10.1176/appi.psy.44.4.329; Kvam L, 2015, J OCCUP REHABIL, V25, P368, DOI 10.1007/s10926-014-9545-2; Lackner JM, 1996, J CONSULT CLIN PSYCH, V64, P212, DOI 10.1037/0022-006X.64.1.212; Lange C, 2007, J OCCUP REHABIL, V17, P1, DOI 10.1007/s10926-006-9039-y; Lilley R, 2012, BMJ, V2; Lin KH, 2013, J OCCUP REHABIL, V23, P55, DOI 10.1007/s10926-012-9381-1; Linton SJ, 2003, CLIN J PAIN, V19, P80, DOI 10.1097/00002508-200303000-00002; Littleton SM, 2012, INJURY, V43, P1586, DOI 10.1016/j.injury.2011.03.002; Lloyd C, 2008, AUST OCCUP THER J, V55, P23, DOI 10.1111/j.1440-1630.2006.00624.x; Matthews LR, 2005, BEHAV RES THER, V43, P475, DOI 10.1016/j.brat.2004.03.008; Mayou R, 2001, BRIT J PSYCHIAT, V179, P528, DOI 10.1192/bjp.179.6.528; Motor Accident Insurance Commission, 2015, STAT INF 1 JUL 31 DE; Nightingale EJ, 2007, BRAIN IMPAIR, V8, P101, DOI [10.1375/brim.8.2.101, DOI 10.1375/BRIM.8.2.101]; O'Donnell ML, 2009, MED J AUSTRALIA, V190, pS71; Ottomanelli L, 2009, J SPINAL CORD MED, V32, P503, DOI 10.1080/10790268.2009.11754553; Peters L, 1996, INT J METHOD PSYCH, V6, P167, DOI 10.1002/(SICI)1234-988X(199610)6:3<167::AID-MPR159>3.3.CO;2-Z; Read KM, 2004, J TRAUMA, V57, P815, DOI 10.1097/01.TA.0000136289.15303.44; Schnyder U, 2003, AM J PSYCHIAT, V160, P2025, DOI 10.1176/appi.ajp.160.11.2025; Smith B, 2007, COUNS PSYCHOL Q, V20, P149, DOI 10.1080/09515070701403679; Soberg HL, 2007, J TRAUMA, V62, P461, DOI 10.1097/01.ta.0000222916.30253.ea; Stiers W, 2012, OXFORD HDB REHABILIT, P417; Street TD, 2015, WORK, V51, P373, DOI 10.3233/WOR-141980; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Turner JA, 2006, SPINE, V31, P682, DOI 10.1097/01.brs.0000202762.88787.af; Ustin TB, 2010, MEASURING HLTH DISAB; van Velzen JM, 2009, BRAIN INJURY, V23, P385, DOI 10.1080/02699050902838165; Waljas M, 2014, J HEAD TRAUMA REHAB, V29, P443, DOI 10.1097/HTR.0000000000000002; Ware JE., 2000, SCORE VERSION 2 SF 3; Weiss DS., 1997, ASSESSING PSYCHOL TR, P399, DOI DOI 10.1037/T12199-000; World Health Organization, 2009, GLOB STAT REP ROAD S; Zampolini M, 2007, DISABIL REHABIL, V29, P1377, DOI 10.1080/09638280701314980; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; ZIMET GD, 1988, J PERS ASSESS, V52, P30, DOI 10.1207/s15327752jpa5201_2	72	11	11	0	10	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	JUN	2017	48	6					1120	1128		10.1016/j.injury.2017.03.012			9	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	EW4QO	WOS:000402486200005	28343652	Green Accepted			2021-06-18	
J	King, D; Hecimovich, M; Clark, T; Gissane, C				King, D.; Hecimovich, M.; Clark, T.; Gissane, C.			Measurement of the head impacts in a sub-elite Australian Rules football team with an instrumented patch: An exploratory analysis	INTERNATIONAL JOURNAL OF SPORTS SCIENCE & COACHING			English	Article						Biomechanics; concussion; linear acceleration; rotational acceleration	HIGH-SCHOOL FOOTBALL; CHRONIC TRAUMATIC ENCEPHALOPATHY; RUGBY UNION PLAYERS; RISK-FACTORS; PROFESSIONAL FOOTBALL; BRAIN-INJURY; CONCUSSION; ACCELERATION; BIOMECHANICS; SPORT	An investigation was made of the frequency, magnitude, and distribution of head impacts in Australian Football League players over a season of matches. In a prospective cohort analysis of impact magnitude, frequency, and distribution on data collected with a wireless head impact sensor worn behind the ear of 23 players, a total of 4903 impacts were recorded. Players experienced on average 407 +/- 143 impacts over the duration of the study resulting in 30 +/- 38 impacts per-player per-match. Linear accelerations ranged from 10 g to 153 g with a mean, median, and 95th percentile value of 17 g, 13 g, and 40 g, respectively. Rotational accelerations ranged from 130 rad/s(2) to 21,890 rad/s(2) with a mean, median, and 95th percentile value of 2426 rad/s(2), 1556 rad/s(2), and 7571 rad/s(2), respectively. This study obtained initial measurements on the frequency, magnitude, distribution, and risk weighted exposure of head impacts in Australia Rules Football in order to better inform medical personnel in the identification and evaluation of at-risk players for concussion. The location of impacts varied considerably with the back of the head recording more total impacts than the front, side, and top. Midfielders sustained more impacts per-player, per-match, and had higher median resultant linear accelerations than forwards and defenders. The results of this study, in which most impacts were within the low severity limit for linear, rotational, HITSP, and RWECP, indicate that Australian Rules football needs to include more encompassing methods of examination of player exposure.	[King, D.] Auckland Univ Technol, Fac Hlth & Environm Sci, Auckland, New Zealand; [Hecimovich, M.] Univ Northern Iowa, Div Athlet Training, Cedar Falls, IA USA; [Clark, T.] Australian Coll Phys Educ, Fac Sport Performance, Sydney, NSW, Australia; [Gissane, C.] St Marys Univ, Sch Sport Hlth & Appl Sci, Twickenham, England	King, D (corresponding author), Hutt Valley Dist Hlth Board, Emergency Dept, Private Bag 31-907, Lower Hutt, New Zealand.	dking@aut.ac.nz		Clark, Dr Trevor/0000-0002-2853-0068	West Australian Football Commission	We would like to thank the West Australian Football Commission and, in particular, Troy Kirkham for their support of this research project. We also recognize the work of Myles Murphy, Head Physiotherapist, and student Mason Gittins. According to the definition given by the International Committee of Medical Journal Editors (ICMJE), the authors listed above qualify for authorship on the basis of making one or more of the substantial contributions to the intellectual content of the manuscript.	Bartsch Adam, 2014, Stapp Car Crash J, V58, P1; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Brainard LL, 2012, MED SCI SPORT EXER, V44, P297, DOI 10.1249/MSS.0b013e31822b0ab4; Broglio SP, 2012, CURR OPIN PEDIATR, V24, P702, DOI 10.1097/MOP.0b013e3283595616; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Broglio SP, 2011, J NEUROTRAUM, V28, P2061, DOI 10.1089/neu.2011.1905; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Covassin T, 2012, J SCHOOL HEALTH, V82, P233, DOI 10.1111/j.1746-1561.2012.00692.x; Crisco J, 2010, J ATHL TRAINING, V45, P459; Crisco JJ, 2004, J BIOMECH ENG-T ASME, V126, P849, DOI 10.1115/1.1824135; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; De Beaumont L, 2007, BRAIN INJURY, V21, P631, DOI 10.1080/02699050701426931; Deutsch MU, 2007, J SPORT SCI, V25, P461, DOI 10.1080/02640410600631298; Finch CF, 2013, MED J AUSTRALIA, V198, P427, DOI 10.5694/mja12.11217; Fortington Lauren V, 2015, Inj Epidemiol, V2, P20; Fortington LV, 2016, J SCI MED SPORT, V19, P18, DOI 10.1016/j.jsams.2014.12.008; Gastin PB, 2013, J SCI MED SPORT, V16, P589, DOI 10.1016/j.jsams.2013.01.007; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Gray AJ, 2010, SPORTS MED, V40, P347, DOI 10.2165/11531400-000000000-00000; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Greenwald RM, 2012, CLIN J SPORT MED, V22, P83, DOI 10.1097/JSM.0b013e31824cc5d3; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; Gysland SM, 2012, ANN BIOMED ENG, V40, P14, DOI 10.1007/s10439-011-0421-3; Hanlon EM, 2012, MED SCI SPORT EXER, V44, P1102, DOI 10.1249/MSS.0b013e3182444d7d; Harpham JA, 2014, ANN BIOMED ENG, V42, P1, DOI 10.1007/s10439-013-0881-8; Hendricks S, 2012, J SPORT SCI, V30, P1215, DOI 10.1080/02640414.2012.707328; Hernandez F, 2015, ANN BIOMED ENG, V43, P1918, DOI 10.1007/s10439-014-1212-4; Hopkins WG, 2007, CLIN J SPORT MED, V17, P208, DOI 10.1097/JSM.0b013e3180592a68; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Hrysomallis C., 2006, WEIGHT TRAINING AUST; Hrysomallis C, 2013, SPORTS MED, V43, P339, DOI 10.1007/s40279-013-0034-0; King D, 2016, SPORTS MED, V46, P151, DOI 10.1007/s40279-015-0423-7; King D, 2015, AM J SPORT MED, V43, P614, DOI 10.1177/0363546514560876; King D, 2010, INT J PERF ANAL SPOR, V10, P241; King D, 2012, RES SPORTS MED, V20, P86, DOI 10.1080/15438627.2012.660824; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory P, 2011, CLIN J SPORT MED, V21, P6, DOI 10.1097/JSM.0b013e318204db50; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McManus A, 2004, J SCI MED SPORT, V7, P384, DOI 10.1016/S1440-2440(04)80033-1; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Mihalik JP, 2010, PEDIATRICS, V125, pE1394, DOI 10.1542/peds.2009-2849; Nevins D, 2015, PROCEDIA ENGINEER, V112, P175, DOI 10.1016/j.proeng.2015.07.195; Ocwieja KE, 2012, ANN BIOMED ENG, V40, P90, DOI 10.1007/s10439-011-0401-7; Orchard J, 1998, J Sci Med Sport, V1, P83, DOI 10.1016/S1440-2440(98)80016-9; Orchard J, 2002, BRIT J SPORT MED, V36, P39, DOI 10.1136/bjsm.36.1.39; Orchard J, 2014, AFL INJURY REPORT; Orchard JW, 2013, AM J SPORT MED, V41, P734, DOI 10.1177/0363546513476270; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Quarrie KL, 2008, AM J SPORT MED, V36, P1705, DOI 10.1177/0363546508316768; Robertson S, 2016, J SPORT SCI, V34, P637, DOI 10.1080/02640414.2015.1066026; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; Schnebel B, 2007, NEUROSURGERY, V60, P490, DOI 10.1227/01.NEU.0000249286.92255.7F; Stevenson MR, 2000, BRIT J SPORT MED, V34, P188, DOI 10.1136/bjsm.34.3.188; Urban JE, 2013, ANN BIOMED ENG, V41, P2474, DOI 10.1007/s10439-013-0861-z; Wilcox BJ, 2015, J BIOMECH, V48, P2201, DOI 10.1016/j.jbiomech.2015.04.005; Wu LC, 2016, ANN BIOMED ENG, V44, P1234, DOI 10.1007/s10439-015-1423-3; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	59	11	11	0	8	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1747-9541	2048-397X		INT J SPORTS SCI COA	Int. J. Sports Sci. Sci. Coach.	JUN	2017	12	3					359	370		10.1177/1747954117710512			12	Hospitality, Leisure, Sport & Tourism; Psychology, Applied	Social Sciences - Other Topics; Psychology	EX3SF	WOS:000403152000009		Green Accepted			2021-06-18	
J	McDonald, S; Fisher, A; Flanagan, S; Honan, CA				McDonald, Skye; Fisher, Alana; Flanagan, Sharon; Honan, Cynthia A.			Impaired perception of sincerity after severe traumatic brain injury	JOURNAL OF NEUROPSYCHOLOGY			English	Article							ASSESSING SOCIAL-PERCEPTION; CLOSED HEAD-INJURY; EMOTION RECOGNITION; AFFECTIVE RESPONSIVITY; INFERENCE TEST; MIND DEFICITS; COGNITION; EMPATHY; AWARENESS; MIMICRY	Background. People with a severe traumatic brain injury (TBI) often experience problems understanding non-literal utterances such as sarcasm and lies in dyadic exchanges. This study aimed to investigate whether these problems extend to settings where speakers vary in their degree of sincerity and whether such problems are associated with deficits in social cognitive abilities (emotion perception, theory of mind, and self-reported empathy) or cognitive abilities (abstract reasoning, working memory, processing speed, attentional switching). Methods. Thirty-one adults with severe TBI (24 males) and 25 demographically matched controls (20 males) participated. They watched video vignettes depicting four actors volunteering for additional duties. Each speaker made a limited verbal response which literally suggested a willingness to be involved, but the sincerity with which the response was made was tempered by the actor's emotional demeanour. Participants rated each speaker in the vignettes for degree of sincerity (0-100%). Standardized measures of cognitive and social cognitive function were also taken. Results. Control participants had excellent agreement (a =.90) in their rankings of actors according to sincerity. TBI participants were less consistent (a =.65). Overall, they were sensitive to decreasing sincerity but generally less accurate than control participants. They were poorer at differentiating between levels of sincerity and rated insincere expressions as more sincere, although they rated sincere expressions similarly. Poorer working memory and poorer social cognition were associated with poorer sincerity/sarcasm detection in the participants with TBI, but only social cognition was uniquely associated. Conclusions. Some adults with TBI have difficulty assessing the level of sincerity of speakers. Moreover, poorer social cognition abilities are associated with this difficulty.	[McDonald, Skye; Fisher, Alana; Flanagan, Sharon; Honan, Cynthia A.] UNSW Australia, Sch Psychol, Sydney, NSW 2052, Australia	McDonald, S (corresponding author), UNSW Australia, Sch Psychol, Sydney, NSW 2052, Australia.	s.mcdonald@unsw.edu.au	Fisher, Alana/T-1869-2019; McDonald, Skye/G-4118-2014; Honan, Cynthia/O-6332-2017	McDonald, Skye/0000-0003-0723-6094; Honan, Cynthia/0000-0001-5735-4270; Fisher, Alana/0000-0002-6027-659X	Australian Research CouncilAustralian Research Council	This study was funded by a grant from the Australian Research Council. We are indebted to our volunteers with brain injuries and their families. They have given their time so generously to help us learn more about the consequences of their injuries and possible paths forward for remediation and improving quality of life. We are also indebted to our community control participants.	Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Angeleri R, 2008, BRAIN LANG, V107, P229, DOI 10.1016/j.bandl.2008.01.002; Austin John L, 1962, DO THINGS WORDS, Vsecond; Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; Bach LJ, 2000, COGN NEUROPSYCHIATRY, V5, P175, DOI DOI 10.1080/13546800050083520; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; Channon S, 2005, BRAIN LANG, V93, P123, DOI 10.1016/j.bandl.2004.09.002; Channon Shelley, 2003, Cogn Neuropsychiatry, V8, P243, DOI 10.1080/135468000344000002; Channon S, 2010, NEUROPSYCHOL REHABIL, V20, P739, DOI 10.1080/09602011003794583; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; de Sousa A, 2012, J CLIN EXP NEUROPSYC, V34, P606, DOI 10.1080/13803395.2012.667067; de Sousa A, 2011, CORTEX, V47, P526, DOI 10.1016/j.cortex.2010.02.004; Dennis M, 2001, BRAIN LANG, V78, P1, DOI 10.1006/brln.2000.2431; Dennis M, 2001, J HEAD TRAUMA REHAB, V16, P456, DOI 10.1097/00001199-200110000-00005; ELSASS L, 1987, PSYCHOL MED, V17, P67, DOI 10.1017/S003329170001299X; Martin-Rodriguez JF, 2010, NEUROPSYCHOLOGIA, V48, P1181, DOI 10.1016/j.neuropsychologia.2010.02.009; Goldman AI, 2005, COGNITION, V94, P193, DOI 10.1016/j.cognition.2004.01.005; Grice H.P, 1989, STUDIES WAY WORDS; GRICE HP, 1957, PHILOS REV, V66, P377, DOI 10.2307/2182440; HARTLEY L L, 1992, Brain Injury, V6, P271, DOI 10.3109/02699059209029669; Hess U, 2001, INT J PSYCHOPHYSIOL, V40, P129, DOI 10.1016/S0167-8760(00)00161-6; KINSELLA G, 1991, J NEUROL NEUROSUR PS, V54, P422, DOI 10.1136/jnnp.54.5.422; LEZAK MD, 1978, J CLIN PSYCHIAT, V39, P592; Lieberman MD, 2007, ANNU REV PSYCHOL, V58, P259, DOI 10.1146/annurev.psych.58.110405.085654; McDonald S, 2005, J INT NEUROPSYCH SOC, V11, P392, DOI 10.1017/S1355617705050447; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; McDonald S, 2006, DISABIL REHABIL, V28, P1529, DOI 10.1080/09638280600646185; McDonald S, 2012, AUST PSYCHOL, V47, P39, DOI 10.1111/j.1742-9544.2011.00054.x; McDonald S, 2011, INT J PSYCHOPHYSIOL, V82, P124, DOI 10.1016/j.ijpsycho.2011.01.014; McDonald S, 2011, J CLIN EXP NEUROPSYC, V33, P17, DOI 10.1080/13803391003761967; Mehrabian A., 2000, MANUAL BALANCED EMOT; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; Niedenthal PM, 2001, COGNITION EMOTION, V15, P853, DOI 10.1080/02699930143000194; Perry J, 2012, STANFORD ENCY PHILOS; Reitan R. M, 1992, TRAIL MAKING TEST; Rogers K, 2007, J AUTISM DEV DISORD, V37, P709, DOI 10.1007/s10803-006-0197-8; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; SARNO MT, 1980, J NERV MENT DIS, V168, P685, DOI 10.1097/00005053-198011000-00008; SEARLE JR, 1976, LANG SOC, V5, P1, DOI 10.1017/S0047404500006837; Stone VE, 1998, J COGNITIVE NEUROSCI, V10, P640, DOI 10.1162/089892998562942; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Wechsler D, 1997, WAIS 3 ADM SCORING M; Williams C, 2010, J CLIN EXP NEUROPSYC, V32, P259, DOI 10.1080/13803390902976940; Winner E, 1998, BRAIN LANG, V62, P89, DOI 10.1006/brln.1997.1889; Wood RL, 2008, J INT NEUROPSYCH SOC, V14, P289, DOI 10.1017/S1355617708080326	49	11	11	2	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1748-6645	1748-6653		J NEUROPSYCHOL	J. Neuropsychol.	JUN	2017	11	2					291	304		10.1111/jnp.12086			14	Psychology; Psychology, Experimental	Psychology	FF4BY	WOS:000408874400008	26482440				2021-06-18	
J	McDonough, TL; Paolicchi, JM; Heier, LA; Das, N; Engel, M; Perlman, JM; Grinspan, ZM				McDonough, Tiffani L.; Paolicchi, Juliann M.; Heier, Linda A.; Das, Nikkan; Engel, Murray; Perlman, Jeffrey M.; Grinspan, Zachary M.			Prediction of Future Epilepsy in Neonates With Hypoxic-Ischemic Encephalopathy Who Received Selective Head Cooling	JOURNAL OF CHILD NEUROLOGY			English	Article						epilepsy; cohort studies; all epilepsy / seizures; cohort studies; risk factors in epidemiology; childhood stroke	HYPOTHERMIA TREATMENT; MODERATE HYPOTHERMIA; ASPHYXIATED INFANTS; TERM INFANTS; FOLLOW-UP; SEIZURES; ELECTROENCEPHALOGRAPHY; TRIAL; OUTCOMES; NEWBORNS	Epilepsy outcomes after therapeutic hypothermia for neonates with hypoxic-ischemic encephalopathy are understudied. The authors used multivariable logistic regression to predict epilepsy in neonates after selective head cooling. Sensitivity analyses used magnetic resonance imaging (MRI) and electroencephalogram (EEG) interpretations by different clinicians. Fifty neonates had 2-year follow-up. Nine developed epilepsy. Predictors included pH <= 6.8 on day of birth (adjusted odds ratio [OR] 19 [95% confidence interval (CI) 1-371]), burst suppression on EEG on day 4 (8.2 [1.3-59]), and MRI deep gray matter injury (OR 33 [2.4-460]). These factors stratify neonates into low (0-1 factors; 3% [0%-14%] risk), medium (2 factors; 56% [21%-86%] risk), and high-risk groups (3 factors; 100% [29%-100%] risk) for epilepsy. The stratification was robust to varying clinical interpretations of the MRI and EEG. Neonates with hypoxic-ischemic encephalopathy who undergo selective head cooling appear at risk of epilepsy if they have 2 to 3 identified factors. If validated, this rule may help counsel families and identify children for close clinical follow-up.	[McDonough, Tiffani L.] Columbia Univ, Med Ctr, Div Child Neurol, New York, NY USA; [Paolicchi, Juliann M.] Hackensack Med Ctr, Hackensack, NJ 07604 USA; [Heier, Linda A.] New York Presbyterian Hosp, Weill Cornell Med Ctr, Dept Radiol, New York, NY USA; [Das, Nikkan] Weill Cornell Med Coll, New York, NY USA; [Engel, Murray; Grinspan, Zachary M.] Weill Cornell Med Ctr, Div Child Neurol, New York, NY USA; [Perlman, Jeffrey M.] New York Presbyterian Hosp, Div Neonatol, Weill Cornell Med Ctr, New York, NY USA; [Grinspan, Zachary M.] Weill Cornell Med Coll, Div Hlth Policy & Econ, Dept Healthcare Policy & Res, 402 East 67th St Room LA 220, New York, NY 10065 USA	Grinspan, ZM (corresponding author), Weill Cornell Med Coll, Div Hlth Policy & Econ, Dept Healthcare Policy & Res, 402 East 67th St Room LA 220, New York, NY 10065 USA.	zag9005@med.cornell.edu		Grinspan, Zachary/0000-0001-6705-0932	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K12NS066274] Funding Source: NIH RePORTER		Ambalavanan N, 2006, PEDIATRICS, V118, P2084, DOI 10.1542/peds.2006-1591; [Anonymous], 2011, R LANG ENV STAT COMP; Azzopardi D, 1999, EARLY HUM DEV, V55, P113, DOI 10.1016/S0378-3782(99)00010-9; Azzopardi DV, 2009, NEW ENGL J MED, V361, P1349, DOI 10.1056/NEJMoa0900854; Barkovich AJ, 1998, AM J NEURORADIOL, V19, P143; Cheong JLY, 2012, ARCH PEDIAT ADOL MED, V166, P634, DOI 10.1001/archpediatrics.2012.284; Cseko AJ, 2013, ACTA PAEDIATR, V102, P707, DOI 10.1111/apa.12226; Eicher DJ, 2005, PEDIATR NEUROL, V32, P11, DOI 10.1016/j.pediatrneurol.2004.06.014; Glass HC, 2011, PEDIATR RES, V70, P535, DOI 10.1203/PDR.0b013e31822f24c7; Glass HC, 2009, J PEDIATR-US, V155, P318, DOI 10.1016/j.jpeds.2009.03.040; Guillet R, 2012, PEDIATR RES, V71, P205, DOI 10.1038/pr.2011.30; Hallberg B, 2010, ACTA PAEDIATR, V99, P531, DOI 10.1111/j.1651-2227.2009.01653.x; Jacobs S, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003311.pub2; Jacobs SE, 2011, ARCH PEDIAT ADOL MED, V165, P692, DOI 10.1001/archpediatrics.2011.43; Jung DE, 2015, PEDIATR NEUROL, V53, P135, DOI 10.1016/j.pediatrneurol.2015.04.009; Kwon JM, 2011, J CHILD NEUROL, V26, P322, DOI 10.1177/0883073810380915; Low E, 2012, ARCH DIS CHILD-FETAL, V97, pF267, DOI 10.1136/archdischild-2011-300716; Lumley T., 2009, LEAPS REGRESSION SUB; Martinez-Biarge M, 2011, NEUROLOGY, V76, P2055, DOI 10.1212/WNL.0b013e31821f442d; McCarthy AL, 2015, PEDIATR RES, V78, P304, DOI 10.1038/pr.2015.99; Merchant N, 2015, DEV MED CHILD NEUROL, V57, P8, DOI 10.1111/dmcn.12726; Newell R, 2013, EJ NEONATOL RES, V3, P38; Pisani F, 2015, EUR J PAEDIATR NEURO, V19, P6, DOI 10.1016/j.ejpn.2014.10.001; Pisani F, 2012, PEDIATR RES, V72, P186, DOI 10.1038/pr.2012.66; Pisani F, 2009, BRAIN DEV-JPN, V31, P64, DOI 10.1016/j.braindev.2008.04.001; Rakhade SN, 2009, NAT REV NEUROL, V5, P380, DOI 10.1038/nrneurol.2009.80; ROBERTSON C, 1985, DEV MED CHILD NEUROL, V27, P473; Shankaran S, 2012, NEW ENGL J MED, V366, P2085, DOI 10.1056/NEJMoa1112066; Shellhaas RA, 2008, J PEDIATR-US, V153, P369, DOI 10.1016/j.jpeds.2008.03.004; Stevenson D, 2009, FETAL NEONATAL BRAIN; Steyerberg EW, 2000, STAT MED, V19, P1059, DOI 10.1002/(SICI)1097-0258(20000430)19:8<1059::AID-SIM412>3.0.CO;2-0; Takenouchi T, 2010, RESUSCITATION, V81, P1637, DOI 10.1016/j.resuscitation.2010.08.001; Twomey E, 2010, PEDIATR RADIOL, V40, P1526, DOI 10.1007/s00247-010-1692-9; Volpe J., 2008, NEUROLOGY NEWBORN; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wusthoff CJ, 2017, EPILEPSIA, V58, P429, DOI 10.1111/epi.13661; Wusthoff CJ, 2011, J CHILD NEUROL, V26, P724, DOI 10.1177/0883073810390036; Yap V, 2009, PEDIATR NEUROL, V41, P327, DOI 10.1016/j.pediatrneurol.2009.05.004	38	11	11	0	3	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0883-0738	1708-8283		J CHILD NEUROL	J. Child Neurol.	JUN	2017	32	7					630	637		10.1177/0883073817698628			8	Clinical Neurology; Pediatrics	Neurosciences & Neurology; Pediatrics	EV1XV	WOS:000401545900004	28359187				2021-06-18	
J	Ryu, JA; Yang, JH; Chung, CR; Suh, GY; Hong, SC				Ryu, Jeong-Am; Yang, Jeong Hoon; Chung, Chi Ryang; Suh, Gee Young; Hong, Seung-Chyul			Impact of Neurointensivist Co-management on the Clinical Outcomes of Patients Admitted to a Neurosurgical Intensive Care Unit	JOURNAL OF KOREAN MEDICAL SCIENCE			English	Article						Neurosurgery; Intensive Care Unit; Critical Care Outcomes	TRAUMATIC BRAIN-INJURY; NEUROCRITICAL CARE; STROKE PATIENTS; ILL PATIENTS; TEAM; MANAGEMENT; MORTALITY; KOREA	Limited data are available on improved outcomes after initiation of neurointensivist co-management in neurosurgical intensive care units (NSICUs) in Korea. We evaluated the impact of a newly appointed neurointensivist on the outcomes of neurosurgical patients admitted to an intensive care unit (ICU). This retrospective observational study involved neurosurgical patients admitted to the NSICU at Samsung Medical Center between March 2013 and May 2016. Neurointensivist co-management was initiated in October 1 2014. We compared the outcomes of neurosurgical patients before and after neurointensivist co-management. The primary outcome was ICU mortality. A total of 571 patients were admitted to the NSICU during the study period, 291 prior to the initiation of neurointensivist co-management and 280 thereafter. Intracranial hemorrhage (29.6%) and traumatic brain injury (TBI) (26.6%) were the most frequent reasons for ICU admission. TBI was the most common cause of death (39.0%). There were no significant differences in mortality rates and length of ICU stay before and after co-management. However, the rates of ICU and 30-day mortality among the TBI patients were significantly lower after compared to before initiation of neurointensivist co-management (8.5% vs. 22.9%; P = 0.014 and 11.0% vs. 27.1%; P = 0.010, respectively). Although overall outcomes were not different after neurointensivist co-management, initiation of a strategy of routine involvement of a neurointensivist significantly reduced the ICU and 30-day mortality rates of TBI patients.	[Ryu, Jeong-Am; Yang, Jeong Hoon; Chung, Chi Ryang; Suh, Gee Young] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Crit Care Med, Seoul, South Korea; [Yang, Jeong Hoon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol,Dept Med, Seoul, South Korea; [Suh, Gee Young] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Pulm & Crit Care Med,Dept Med, Seoul, South Korea; [Hong, Seung-Chyul] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurosurg, 81 Irwon Ro, Seoul 06351, South Korea	Hong, SC (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurosurg, 81 Irwon Ro, Seoul 06351, South Korea.	nsschong@skku.edu	Suh, Gee Young/O-3676-2019	Suh, Gee Young/0000-0001-5473-1712; Yang, Jeong Hoon/0000-0001-8138-1367; Chung, Chi Ryang/0000-0003-1830-307X			Bershad EM, 2008, NEUROCRIT CARE, V9, P287, DOI 10.1007/s12028-008-9051-5; Bithal PK, 2016, J NEUROANAESTHESIOL, V3, P1, DOI DOI 10.4103/2348-0548.173249; Deepika A, 2015, ACTA NEUROCHIR, V157, P2033, DOI 10.1007/s00701-015-2575-5; Haddad SH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-12; Helmy A, 2007, BRIT J ANAESTH, V99, P32, DOI 10.1093/bja/aem139; Jarquin-Valdivia AA, 2003, SEMIN NEUROSURG, V14, P131; Josephson SA, 2010, J NEUROSURG, V112, P626, DOI 10.3171/2009.8.JNS09441; Knopf L, 2012, NEUROCRIT CARE, V16, P63, DOI 10.1007/s12028-011-9620-x; Kumpers P, 2010, CRIT CARE, V14, DOI 10.1186/cc8861; Kwak SH, 2014, J KOREAN MED SCI, V29, P431, DOI 10.3346/jkms.2014.29.3.431; Lim CM, 2015, J KOREAN MED SCI, V30, P1540, DOI 10.3346/jkms.2015.30.11.1540; Mirski MA, 2001, J NEUROSURG ANESTH, V13, P83, DOI 10.1097/00008506-200104000-00004; Morrow DA, 2012, CIRCULATION, V126, P1408, DOI 10.1161/CIR.0b013e31826890b0; Park CM, 2014, ANN SURG TREAT RES, V86, P319, DOI 10.4174/astr.2014.86.6.319; Raj R, 2014, J NEUROTRAUM, V31, P1721, DOI 10.1089/neu.2014.3361; Song HK, 2013, J NEUROCRIT CARE, V6, P82; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Suarez JI, 2004, CRIT CARE MED, V32, P2311, DOI 10.1097/01.CCM.0000146132.29042.4c; Suarez JI, 2006, CRIT CARE MED, V34, pS232, DOI 10.1097/01.CCM.0000231881.29040.25; Varelas PN, 2006, J NEUROSURG, V104, P713, DOI 10.3171/jns.2006.104.5.713; Varelas PN, 2004, CRIT CARE MED, V32, P2191, DOI 10.1097/01.CCM.0000146131.03578.21; Wijayatilake DS, 2012, CURR OPIN ANESTHESIO, V25, P540, DOI 10.1097/ACO.0b013e328357960a	22	11	12	0	1	KOREAN ACAD MEDICAL SCIENCES	SEOUL	302 75 DONG DU ICHON, DONG YONGSAN KU, SEOUL 140 031, SOUTH KOREA	1011-8934	1598-6357		J KOREAN MED SCI	J. Korean Med. Sci.	JUN	2017	32	6					1024	1030		10.3346/jkms.2017.32.6.1024			7	Medicine, General & Internal	General & Internal Medicine	EX3VP	WOS:000403162400020	28480662	DOAJ Gold, Green Published			2021-06-18	
J	Dreer, LE; Crowley, MT; Cash, A; O'Neill, JA; Cox, MK				Dreer, Laura E.; Crowley, Maria T.; Cash, Augusta; O'Neill, Jilian A.; Cox, Molly K.			Examination of Teacher Knowledge, Dissemination Preferences, and Classroom Management of Student Concussions: Implications for Return-to-Learn Protocols	HEALTH PROMOTION PRACTICE			English	Article						concussions; teachers; return-to-learn	SCHOOL; RECOMMENDATIONS; RECOVERY	Objectives. To determine teacher knowledge of (1) concussion symptomatology, (2) dissemination preferences, and (3) classroom management practices of student concussions. Study Design. A cross-sectional survey assessing concussion-related information was completed by teachers/instructors in the state of Alabama. Results. One-hundred and thirty participants completed the survey. Only a quarter perceived they were "very" or "extremely" confident enough to recognize signs related to a concussion (22.3%), and only 12.4% reported they were "very knowledgeable" about concussions. The majority were able to recognize more common concussion symptoms/challenges: headaches (95.4%), trouble concentrating (86.2%), memory (82.3%), balance problems/dizziness (82.3%), changes vision/hearing (76.2%), difficulty completing tasks (70.8%), difficulty making decisions (66.2%), changes in sleep (61.5%), and fatigue (60.8%); only half recognized emotional symptoms (e.g., mood) or symptoms associated with more prolonged recovery. Concussion informants were school nurses (74.4%), followed by parents (46.2%), students (46.2%), and coaches/athletic trainers (45.4%). A little under half of participants received concussion information as part of their job (41.9%). About 14.1% of teachers reported that someone had come to their school to talk with them as a group about concussions, and 82% felt they needed more information. Of the 37% who taught a concussed student, 83% reported they altered the classroom management strategies. Conclusions. In general, teachers were able to recognize the more commonly experienced concussion symptoms as well as management strategies. However, they appear to want greater concussion information and training. Given the daily influence of teachers on student tasks involving cognitive exertion, incorporation of formal concussion education for teachers is warranted.	[Dreer, Laura E.; O'Neill, Jilian A.; Cox, Molly K.] Univ Alabama Birmingham, 1720 Univ Blvd, Birmingham, AL USA; [Crowley, Maria T.; Cash, Augusta] Alabama Dept Rehabil Serv, Birmingham, AL USA	Dreer, LE (corresponding author), Univ Alabama Birmingham, 1720 Univ Blvd, Birmingham, AL USA.; Dreer, LE (corresponding author), Psychol & Neuropsychol Clin Res Serv, Suite H-405, Birmingham, AL 35243 USA.	lauradreer@uabmc.edu			Health Resources and Services Administration of the U.S. Department of Health and Human Services [H21MC26930]; Wise Up! Initiative of the Al and Sharyne Wallace Foundation	Funding from the Health Resources and Services Administration of the U.S. Department of Health and Human Services (H21MC26930) and the Wise Up! Initiative of the Al and Sharyne Wallace Foundation.	Arbogast KB, 2013, CLIN PEDIATR, V52, P397, DOI 10.1177/0009922813478160; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Carson JD, 2014, CAN FAM PHYSICIAN, V60, pE310; Centers for Disease Control and Prevention, 2015, HEADS SCH KNOW YOUR; Centers for Disease Control and Prevention, 2015, HEADS SCH CONC FACT; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; DeMatteo C, 2015, CLIN PEDIATR, V54, P783, DOI 10.1177/0009922814567305; Dettmer J, 2014, J HEAD TRAUMA REHAB, V29, P224, DOI 10.1097/HTR.0b013e3182a1cd68; Dreer L. E, 2006, REHABIL PSYCHOL, V53, P486; Dreer Laura E, 2014, J Health Dispar Res Pract, V7, P14; Dreer LE, 2016, CURR EYE RES, V41, P50, DOI 10.3109/02713683.2014.1002045; Dreer LE, 2013, OPTOMETRY VISION SCI, V90, P883, DOI 10.1097/OPX.0000000000000009; Dreer LE, 2008, REHABIL PSYCHOL, V53, P486, DOI 10.1037/a0013798; Gioia GA, 2016, J CHILD NEUROL, V31, P93, DOI 10.1177/0883073814555604; Glang AE, 2015, J ADOLESCENT HEALTH, V56, P91, DOI 10.1016/j.jadohealth.2014.08.011; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Heyer GL, 2015, J PEDIATR-US, V166, P594, DOI 10.1016/j.jpeds.2014.09.038; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Master CL, 2012, PEDIATR ANN, V41, pE180, DOI 10.3928/00904481-20120827-09; McAvoy K, 2014, REAP BENEFITS GOOD C; McGrath N, 2010, J ATHL TRAINING, V45, P492, DOI 10.4085/1062-6050-45.5.492; McLeod Tamara C Valovich, 2014, NASN Sch Nurse, V29, P232; Piebes SK, 2009, J SCH NURS, V25, P270, DOI 10.1177/1059840509339782; Popoli DM, 2014, CLIN PEDIATR, V53, P217, DOI 10.1177/0009922813499070; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; Sawyer RJ, 2010, HEALTH PROMOT PRACT, V11, P34, DOI 10.1177/1524839907309377; Sim A, 2008, J NEUROSURG, V108, P511, DOI 10.3171/JNS/2008/108/3/0511; Weber ML, 2015, J SCH NURS, V31, P146, DOI 10.1177/1059840514540939; Werther K., 2014, COLORADO DEP ED CONC	29	11	11	0	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1524-8399	1552-6372		HEALTH PROMOT PRACT	Health Promot. Pract.	MAY	2017	18	3					428	436		10.1177/1524839916650865			9	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	ES7SN	WOS:000399751100014	27234985				2021-06-18	
J	Richter, A; Barman, A; Wustenberg, T; Soch, J; Schanze, D; Deibele, A; Behnisch, G; Assmann, A; Klein, M; Zenker, M; Seidenbecher, C; Schott, BH				Richter, Anni; Barman, Adriana; Wuestenberg, Torsten; Soch, Joram; Schanze, Denny; Deibele, Anna; Behnisch, Gusalija; Assmann, Anne; Klein, Marieke; Zenker, Martin; Seidenbecher, Constanze; Schott, Bjoern H.			Behavioral and Neural Manifestations of Reward Memory in Carriers of Low-Expressing versus High-Expressing Genetic Variants of the Dopamine D2 Receptor	FRONTIERS IN PSYCHOLOGY			English	Article						dopamine D2 receptor; TaqIA; C957T; episodic memory; reward; fMRI; intermediate phenotype	LONG-TERM-MEMORY; TRAUMATIC BRAIN-INJURY; AVAILABILITY IN-VIVO; C957T POLYMORPHISM; A1 ALLELE; BINDING CHARACTERISTICS; NICOTINE DEPENDENCE; ALCOHOL DEPENDENCE; HEALTHY-VOLUNTEERS; INHIBITORY CONTROL	Dopamine is critically important in the neural manifestation of motivated behavior, and alterations in the human dopaminergic system have been implicated in the etiology of motivation-related psychiatric disorders, most prominently addiction. Patients with chronic addiction exhibit reduced dopamine D2 receptor (DRD2) availability in the striatum, and the DRD2 TaqIA (rs1800497) and C957T (rs6277) genetic polymorphisms have previously been linked to individual differences in striatal dopamine metabolism and clinical risk for alcohol and nicotine dependence. Here, we investigated the hypothesis that the variants of these polymorphisms would show increased reward-related memory formation, which has previously been shown to jointly engage the mesolimbic dopaminergic system and the hippocampus, as a potential intermediate phenotype for addiction memory. To this end, we performed functional magnetic resonance imaging (fMRI) in 62 young, healthy individuals genotyped for DRD2 TaqIA and C957T variants. Participants performed an incentive delay task, followed by a recognition memory task 24 h later. We observed effects of both genotypes on the overall recognition performance with carriers of low-expressing variants, namely TaqIA A1 carriers and C957T C homozygotes, showing better performance than the other genotype groups. In addition to the better memory performance, C957T C homozygotes also exhibited a response bias for cues predicting monetary reward. At the neural level, the C957T polymorphism was associated with a genotype-related modulation of right hippocampal and striatal fMRI responses predictive of subsequent recognition confidence for reward-predicting items. Our results indicate that genetic variations associated with DRD2 expression affect explicit memory, specifically for rewarded stimuli. We suggest that the relatively better memory for rewarded stimuli in carriers of low-expressing DRD2 variants may reflect an intermediate phenotype of addiction memory.	[Richter, Anni; Barman, Adriana; Soch, Joram; Deibele, Anna; Behnisch, Gusalija; Assmann, Anne; Klein, Marieke; Seidenbecher, Constanze; Schott, Bjoern H.] Leibniz Inst Neurobiol, Magdeburg, Germany; [Wuestenberg, Torsten; Schott, Bjoern H.] Charite, Dept Psychiat & Psychotherapy, Berlin, Germany; [Schanze, Denny; Zenker, Martin] Otto von Guericke Univ, Inst Human Genet, Magdeburg, Germany; [Assmann, Anne; Schott, Bjoern H.] Univ Magdeburg, Dept Neurol, Magdeburg, Germany; [Seidenbecher, Constanze; Schott, Bjoern H.] Ctr Behav Brain Sci, Magdeburg, Germany	Richter, A (corresponding author), Leibniz Inst Neurobiol, Magdeburg, Germany.	anni.richter@lin-magdeburg.de	Klein, Marieke/G-9870-2015; Schott, Bjorn H/U-5626-2017	Klein, Marieke/0000-0001-8784-5679; Schott, Bjorn H/0000-0002-8237-4481; Soch, Joram/0000-0002-8879-5666; Wustenberg, Torsten/0000-0001-8408-2864	Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [SFB 779, TP A8]; Leibniz Graduate School Synaptogenetics	This project was supported by the Deutsche Forschungsgemeinschaft (SFB 779, TP A8) and the Leibniz Graduate School Synaptogenetics (Ph.D. stipend to AB, Master stipend to MK).	Aarts E, 2014, PSYCHOL SCI, V25, P1003, DOI 10.1177/0956797613517240; Adcock RA, 2006, NEURON, V50, P507, DOI 10.1016/j.neuron.2006.03.036; Apitz T, 2013, NEUROPSYCHOPHARMACOL, V38, P2409, DOI 10.1038/npp.2013.141; Barman A, 2015, SOC COGN AFFECT NEUR, V10, P1537, DOI 10.1093/scan/nsv044; Barman A, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00260; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Bartres-Faz D, 2002, NEUROREPORT, V13, P1121, DOI 10.1097/00001756-200207020-00010; Bello EP, 2011, NAT NEUROSCI, V14, P1033, DOI 10.1038/nn.2862; Bertolino A, 2006, BIOL PSYCHIAT, V60, P1250, DOI 10.1016/j.biopsych.2006.03.078; Buckholtz JW, 2010, SCIENCE, V329, P532, DOI 10.1126/science.1185778; Colzato LS, 2013, NEUROPSYCHOLOGIA, V51, P1377, DOI 10.1016/j.neuropsychologia.2013.01.014; Costa A, 2011, SYNAPSE, V65, P998, DOI 10.1002/syn.20927; CUBEDDU LX, 1990, ANN NY ACAD SCI, V604, P452, DOI 10.1111/j.1749-6632.1990.tb32011.x; de Jong JW, 2015, NEUROPSYCHOPHARMACOL, V40, P2085, DOI 10.1038/npp.2015.60; Doehring A, 2009, PHARMACOGENET GENOM, V19, P407, DOI 10.1097/FPC.0b013e328320a3fd; Duan JB, 2003, HUM MOL GENET, V12, P205, DOI 10.1093/hmg/ddg055; Duzel E, 2011, HIPPOCAMPUS, V21, P803, DOI 10.1002/hipo.20834; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Elfman KW, 2008, J EXP PSYCHOL LEARN, V34, P752, DOI 10.1037/0278-7393.34.4.752; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Everitt BJ, 2014, EUR J NEUROSCI, V40, P2163, DOI 10.1111/ejn.12644; Gelernter J, 2006, HUM MOL GENET, V15, P3498, DOI [10.1093/hmg/ddl426, 10.1093/hmg/ddl144]; GRANDY DK, 1989, AM J HUM GENET, V45, P778; Heinz A, 2010, SCHIZOPHRENIA BULL, V36, P472, DOI 10.1093/schbul/sbq031; Hirvonen M, 2004, MOL PSYCHIATR, V9, P1060, DOI 10.1038/sj.mp.4001561; Hirvonen MM, 2009, SYNAPSE, V63, P907, DOI 10.1002/syn.20672; Hirvonen MM, 2009, PROG NEURO-PSYCHOPH, V33, P630, DOI 10.1016/j.pnpbp.2009.02.021; Jocham G, 2009, J NEUROSCI, V29, P3695, DOI 10.1523/JNEUROSCI.5195-08.2009; Jonsson EG, 1999, MOL PSYCHIATR, V4, P290, DOI 10.1038/sj.mp.4000532; Jou J, 2013, PSYCHOL RES-PSYCH FO, V77, P671, DOI 10.1007/s00426-012-0472-6; Kienast T., 2006, CNS & Neurological Disorders-Drug Targets, V5, P109, DOI 10.2174/187152706784111560; Klein TA, 2007, SCIENCE, V318, P1642, DOI 10.1126/science.1145044; Krebs RM, 2009, NEUROPSYCHOLOGIA, V47, P2272, DOI 10.1016/j.neuropsychologia.2009.01.015; Laakso A, 2005, PHARMACOGENET GENOM, V15, P387, DOI 10.1097/01213011-200506000-00003; Laruelle M, 1998, MOL PSYCHIATR, V3, P261, DOI 10.1038/sj.mp.4000343; Li SC, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2012.08.001; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; Lisman J, 2011, TRENDS NEUROSCI, V34, P536, DOI 10.1016/j.tins.2011.07.006; Machulska A, 2016, J PSYCHIATR RES, V76, P44, DOI 10.1016/j.jpsychires.2015.11.015; Markett S, 2013, NEUROIMAGE, V64, P167, DOI 10.1016/j.neuroimage.2012.08.059; Markett S, 2011, COGN AFFECT BEHAV NE, V11, P644, DOI 10.3758/s13415-011-0058-6; McAllister TW, 2008, BRAIN INJURY, V22, P705, DOI 10.1080/02699050802263019; McAllister TW, 2005, AM J PSYCHIAT, V162, P1749, DOI 10.1176/appi.ajp.162.9.1749; Meyer-Lindenberg A, 2006, NAT REV NEUROSCI, V7, P818, DOI 10.1038/nrn1993; Mier D, 2010, MOL PSYCHIATR, V15, P918, DOI 10.1038/mp.2009.36; Miller MB, 1999, PSYCHOL REV, V106, P398, DOI 10.1037/0033-295X.106.2.398; Morton LM, 2006, PHARMACOGENET GENOM, V16, P901, DOI 10.1097/01.fpc.0000230417.20468.d0; NOBLE EP, 1991, ARCH GEN PSYCHIAT, V48, P648; Papenberg G, 2013, J COGNITIVE NEUROSCI, V25, P571, DOI 10.1162/jocn_a_00359; Persson J, 2015, HUM BRAIN MAPP, V36, P1325, DOI 10.1002/hbm.22704; Pohjalainen T, 1998, MOL PSYCHIATR, V3, P256, DOI 10.1038/sj.mp.4000350; Richter A, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00140; Richter A, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00250; Ritchie T, 2003, NEUROCHEM RES, V28, P73, DOI 10.1023/A:1021648128758; Robbins TW, 2008, ANN NY ACAD SCI, V1141, P1, DOI 10.1196/annals.1441.020; Robbins TW, 2002, NEUROBIOL LEARN MEM, V78, P625, DOI 10.1006/nlme.2002.4103; ROEDIGER HL, 1995, J EXP PSYCHOL LEARN, V21, P803, DOI 10.1037/0278-7393.21.4.803; Samochowiec J, 2014, NEUROPSYCHOBIOLOGY, V70, P77, DOI 10.1159/000364826; Schmitz Y, 2003, J NEUROCHEM, V87, P273, DOI 10.1046/j.1471-4159.2003.02050.x; Schott BH, 2006, J NEUROSCI, V26, P1407, DOI 10.1523/JNEUROSCI.3463-05.2006; Schott BH, 2007, BRAIN, V130, P2412, DOI 10.1093/brain/awm147; Schott BH, 2008, J NEUROSCI, V28, P14311, DOI 10.1523/JNEUROSCI.2058-08.2008; Shumay E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022754; Spencer TJ, 2013, BIOL PSYCHIAT, V74, P84, DOI 10.1016/j.biopsych.2012.11.010; Swagell CD, 2012, ALCOHOL ALCOHOLISM, V47, P397, DOI 10.1093/alcalc/ags047; Thompson J, 1997, PHARMACOGENETICS, V7, P479, DOI 10.1097/00008571-199712000-00006; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vijayraghavan S, 2007, NAT NEUROSCI, V10, P376, DOI 10.1038/nn1846; Voisey J, 2012, PSYCHIAT RES, V196, P285, DOI 10.1016/j.psychres.2011.09.024; Wittmann BC, 2005, NEURON, V45, P459, DOI 10.1016/j.neuron.2005.01.010; Wittmann BC, 2013, NEUROPSYCHOLOGIA, V51, P2469, DOI 10.1016/j.neuropsychologia.2013.09.031; WOLF ME, 1990, ANN NY ACAD SCI, V604, P323, DOI 10.1111/j.1749-6632.1990.tb32003.x; Yacubian J, 2007, NEUROIMAGE, V38, P557, DOI 10.1016/j.neuroimage.2007.08.007; Yonelinas AP, 2002, NAT NEUROSCI, V5, P1236, DOI 10.1038/nn961; Zimmermann P, 1993, TESTBATTERIE AUFMERK	75	11	12	0	11	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-1078			FRONT PSYCHOL	Front. Psychol.	MAY 1	2017	8								654	10.3389/fpsyg.2017.00654			13	Psychology, Multidisciplinary	Psychology	EU6XD	WOS:000401178300001	28507526	DOAJ Gold, Green Published			2021-06-18	
J	Soble, JR; Critchfield, EA; O'Rourke, JJF				Soble, Jason R.; Critchfield, Edan A.; O'Rourke, Justin J. F.			Neuropsychological Evaluation in Traumatic Brain Injury	PHYSICAL MEDICINE AND REHABILITATION CLINICS OF NORTH AMERICA			English	Article						Neuropsychology; Assessment; Cognition; Brain-behavior relationships; Psychometrics; Outcome; Rehabilitation	NORMAL-PRESSURE HYDROCEPHALUS; HEAD-INJURY; COGNITIVE PERFORMANCE; LIKELIHOOD RATIOS; DIAGNOSIS; VALIDITY; AMNESIA	Clinical neuropsychology is a subspecialty of professional psychology that is concerned with the scientific study and clinical application of brain-behavior relationships. Broadly defined, a neuropsychological evaluation is a flexible clinical tool that involves integration of objective, psychometric test data along with various other sources of clinical information to comprehensively elucidate the cognitive, behavioral, and emotional sequelae after traumatic brain injury (TBI). In addition to characterizing TBI sequelae, evidenced based neuropsychological assessment can contribute to TBI patient care by aiding with prognostic assessment, measuring interval change/recovery overtime (eg, resolution of posttraumatic amnesia), informing and implementing rehabilitation strategies, and evaluating the effectiveness of interventions.	[Soble, Jason R.; Critchfield, Edan A.; O'Rourke, Justin J. F.] South Texas Vet Healthcare Syst, Psychol Serv 116B, 7400 Merton Minter, San Antonio, TX 78229 USA	Soble, JR (corresponding author), South Texas Vet Healthcare Syst, Psychol Serv 116B, 7400 Merton Minter, San Antonio, TX 78229 USA.	jason.soble@va.gov					American Psychological Association, CLIN NEUROPSYCHOLOGY; Barr WB, 2008, TXB CLIN NEUROPSYCHO, P3; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Boone KB, 2003, CLIN NEUROPSYCHOL, V17, P244, DOI 10.1076/clin.17.2.244.16497; Bush SS, 2011, ENCY CLIN NEUROPSYCH, P1589; Chelune GJ, 2010, CLIN NEUROPSYCHOL, V24, P454, DOI 10.1080/13854040802360574; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Eapen Blessen C, 2015, Semin Neurol, V35, pe1, DOI 10.1055/s-0035-1549094; Frey KL, 2007, BRAIN INJURY, V21, P513, DOI 10.1080/02699050701311026; Grimes DA, 2005, LANCET, V365, P1500, DOI 10.1016/S0140-6736(05)66422-7; Hanks RA, 2008, ARCH PHYS MED REHAB, V89, P950, DOI 10.1016/j.apmr.2008.01.011; Hannay HJ, 1998, ARCH CLIN NEUROPSYCH, V13, P157, DOI 10.1016/S0887-6177(98)00003-1; Heaton RK, 2004, REVISED COMPREHENSIV; Heilman K.M., 2003, CLIN NEUROPSYCHOLOGY; Hellstrom P, 2007, NEUROSURGERY, V61, P1219, DOI 10.1227/01.NEU.0000280167.18344.85; Iverson GL, 2012, NEUROPSYCHOLOGICAL A, P360; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P923, DOI 10.1007/978-0-387-76978-3_32; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Larrabee GJ, 2015, AM PSYCHOL, V70, P779, DOI 10.1037/a0039835; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lezak M., 2012, NEUROPSYCHOLOGICAL A, V5th; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; Maassen GH, 2009, J CLIN EXP NEUROPSYC, V31, P339, DOI 10.1080/13803390802169059; Mateer CA, 2008, TXB CLIN NEUROPSYCHO, P996; McCrea M, 2008, MILD TRAUMATIC BRAIN; Mitrushina M., 2005, HDB NORMATIVE DATA N; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; Prigatano GP., 1999, PRINCIPLES NEUROPSYC; Sandhaug M, 2011, J NEUROLOGICAL RES, V1, P48; Schoenberg MR, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P1, DOI 10.1007/978-0-387-76978-3; Sherer M, 2002, CLIN NEUROPSYCHOL, V16, P157, DOI 10.1076/clin.16.2.157.13238; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Smith G. E., 2008, TXB CLIN NEUROPSYCHO, P38; Sohlberg MM., 2011, OPTIMIZING COGNITIVE; Spitz G, 2012, NEUROPSYCHOLOGY, V26, P604, DOI 10.1037/a0029239; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; The Center for Outcome Measurement in Brain Injury, COMBI FEAT SCAL; Tranel D, 2008, TXB CLIN NEUROPSYCHO, P25; van der Horn HJ, 2013, ARCH PHYS MED REHAB, V94, P867, DOI 10.1016/j.apmr.2012.11.039; Vanneste JAL, 2000, J NEUROL, V247, P5, DOI 10.1007/s004150050003	44	11	11	0	21	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1047-9651	1558-1381		PHYS MED REH CLIN N	Phys. Med. Rehabil. Clin. N. Am.	MAY	2017	28	2					339	+		10.1016/j.pmr.2016.12.009			13	Rehabilitation	Rehabilitation	EU5AJ	WOS:000401043700011	28390517				2021-06-18	
J	Yang, Y; Mackey, DC; Liu-Ambrose, T; Leung, PM; Feldman, F; Robinovitch, SN				Yang, Yijian; Mackey, Dawn C.; Liu-Ambrose, Teresa; Leung, Pet-Ming; Feldman, Fabio; Robinovitch, Stephen N.			Clinical Risk Factors for Head Impact During Falls in Older Adults: A Prospective Cohort Study in Long-Term Care	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						falls; head impact; long-term care; older adults; traumatic brain injury	TRAUMATIC BRAIN-INJURIES; UPPER EXTREMITY; SERIOUS INJURY; HIP FRACTURE; CIRCUMSTANCES; PERFORMANCE; MEDICATION; MORTALITY; PATIENT; GENDER	Objective: To examine risk factors associated with head impact during falls in older adults in long-term care (LTC). Setting: Two LTC facilities in British Columbia, Canada. Participants: 160 LTC residents. Design: Prospective cohort study. Main Measures: Between 2007 and 2014, we video captured 520 falls experienced by participants. Each fall video was analyzed to determine whether impact occurred to the head. Using generalized estimating equation models, we examined how head impact was associated with other fall characteristics and health status prior to the fall. Results: Head impact occurred in 33% of falls. Individuals with mild cognitive impairment were at higher risk for head impact (odds ratio = 2.8; 95% confidence interval, 1.5-5.0) than those with more severe cognitive impairment. Impaired vision was associated with 2.0-fold (1.3-3.0) higher odds of head impact. Women were 2.2 times (1.4-3.3) more likely than men to impact their head during a fall. Conclusion: Head impact is common during falls in LTC, with less cognitively impaired, female residents who suffered from visual impairment, being most likely to impact their head. Future research should focus on improving our ability to detect neural consequences of head impact and evaluating the effect of interventions for reducing the risk for fall-related head injuries in LTC.	[Yang, Yijian; Leung, Pet-Ming; Feldman, Fabio; Robinovitch, Stephen N.] Simon Fraser Univ, Technol Injury Prevent Seniors Program, Burnaby, BC, Canada; [Yang, Yijian; Mackey, Dawn C.; Feldman, Fabio; Robinovitch, Stephen N.] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC, Canada; [Robinovitch, Stephen N.] Simon Fraser Univ, Sch Engn Sci, Burnaby, BC, Canada; [Yang, Yijian; Mackey, Dawn C.; Liu-Ambrose, Teresa; Robinovitch, Stephen N.] Univ British Columbia, Ctr Hip Hlth & Mobil, Robert HN Ho Res Ctr, 7-F 2635 Laurel St, Vancouver, BC V5Z 1M9, Canada; [Liu-Ambrose, Teresa] Univ British Columbia, Dept Phys Therapy, Vancouver, BC, Canada; [Liu-Ambrose, Teresa] Djavad Mowafaghian Ctr Brain Hlth, Vancouver, BC, Canada; [Leung, Pet-Ming; Feldman, Fabio] Fraser Hlth Author, Surrey, BC, Canada	Yang, Y (corresponding author), Univ British Columbia, Ctr Hip Hlth & Mobil, Robert HN Ho Res Ctr, 7-F 2635 Laurel St, Vancouver, BC V5Z 1M9, Canada.	yijiany@sfu.ca	Yang, Yijian/G-1580-2016; Liu-Ambrose, Teresa/W-2332-2019	Yang, Yijian/0000-0002-5831-186X; Liu-Ambrose, Teresa/0000-0002-8297-5308; Robinovitch, Stephen/0000-0003-3881-6227	Canadian Institutes for Health ResearchCanadian Institutes of Health Research (CIHR) [AMG-100487, TIR-103945, TEI-138295]; AGE-WELL Core Research Program [AW CRP 2015-WP5.2]; Canada Research Chair programCanada Research Chairs	This study was funded by grants from the Canadian Institutes for Health Research (funding reference nos. AMG-100487, TIR-103945, and TEI-138295), and the AGE-WELL Core Research Program (AW CRP 2015-WP5.2). The Canada Research Chair program supported Stephen N. Robinovitch and Teresa Liu-Ambrose. The authors thank the staff and residents of New Vista Society Care Home and Delta View Life Enrichment Centre and Habilitation Centre for their partnership in this study.	Amyot F, 2015, J NEUROTRAUM, V32, P1693, DOI 10.1089/neu.2013.3306; Aziz O, 2014, GAIT POSTURE, V39, P506, DOI 10.1016/j.gaitpost.2013.08.034; Bouras T, 2007, J NEUROTRAUM, V24, P1355, DOI 10.1089/neu.2005.370; Bowers B, 2008, REHABIL NURS, V33, P253, DOI 10.1002/j.2048-7940.2008.tb00237.x; Boye NDA, 2014, INJURY, V45, P1224, DOI 10.1016/j.injury.2014.03.021; Cameron ID, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005465.pub2; Conte V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034473; DargentMolina P, 1996, LANCET, V348, P145, DOI 10.1016/S0140-6736(96)01440-7; DeGoede KM, 2003, J BIOMECH, V36, P413, DOI 10.1016/S0021-9290(02)00396-2; Drahota AK, 2013, AGE AGEING, V42, P633, DOI 10.1093/ageing/aft067; Greenspan SL, 1998, AM J MED, V104, P539, DOI 10.1016/S0002-9343(98)00115-6; Groen BE, 2010, MARTIAL ARTS TECHNIQ; Hamden K, 2014, AM J EMERG MED, V32, P890, DOI 10.1016/j.ajem.2014.04.051; Harvey LA, 2012, INJURY, V43, P1821, DOI 10.1016/j.injury.2012.07.188; Hauer K, 2006, AGE AGEING, V35, P5, DOI 10.1093/ageing/afi218; Hawes C, 1997, AGE AGEING, V26, P19, DOI 10.1093/ageing/26.suppl_2.19; Hsiao ET, 1998, J BIOMECH, V31, P1; Hwang HF, 2015, J HEAD TRAUMA REHAB, V30, pE9, DOI 10.1097/HTR.0000000000000093; Inui TS, 2014, J TRAUMA ACUTE CARE, V76, P642, DOI 10.1097/TA.0000000000000138; Karon SL, 2007, J HEAD TRAUMA REHAB, V22, P350, DOI 10.1097/01.HTR.0000300230.13490.11; Knoefel F, 2013, J AM MED DIR ASSOC, V14, P303, DOI 10.1016/j.jamda.2012.12.077; Korhonen N, 2013, JAMA-J AM MED ASSOC, V309, P1891, DOI 10.1001/jama.2013.3356; Kulmala J, 2008, AGING CLIN EXP RES, V20, P25; Laing AC, 2009, ACCIDENT ANAL PREV, V41, P642, DOI 10.1016/j.aap.2009.03.001; Lavoie A, 2004, J TRAUMA, V56, P802, DOI 10.1097/01.TA.0000066183.02177.AF; Morris JN, 1999, J GERONTOL A-BIOL, V54, pM546, DOI 10.1093/gerona/54.11.M546; MORRIS JN, 1994, J GERONTOL, V49, pM174, DOI 10.1093/geronj/49.4.M174; Mustard CA, 1997, AM J EPIDEMIOL, V145, P738, DOI 10.1093/aje/145.8.738; Neutel CI, 2002, PHARMACOEPIDEM DR S, V11, P97, DOI 10.1002/pds.686; OLOUGHLIN JL, 1993, AM J EPIDEMIOL, V137, P342, DOI 10.1093/oxfordjournals.aje.a116681; Riccardi A, 2013, AM J EMERG MED, V31, P37, DOI 10.1016/j.ajem.2012.05.023; Robinovitch SN, 2004, J BIOMECH, V37, P1329, DOI 10.1016/j.jbiomech.2003.12.015; Schlicht EJ, 2007, EXP BRAIN RES, V182, P47, DOI 10.1007/s00221-007-0970-8; Schonnop R, 2013, CAN MED ASSOC J, V185, pE803, DOI 10.1503/cmaj.130498; Shan RZ, 2016, J NEUROTRAUM, V33, P49, DOI 10.1089/neu.2014.3811; Shankar S., 2006, PROTECTIVE RESPONSES; Sran MA, 2010, J GERONTOL A-BIOL, V65, P312, DOI 10.1093/gerona/glp153; Stevens JA, 2005, INJURY PREV, V11, P115, DOI 10.1136/ip.2004.005835; Tabbarah M, 2002, J GERONTOL A-BIOL, V57, pM228, DOI 10.1093/gerona/57.4.M228; TINETTI ME, 1987, J AM GERIATR SOC, V35, P644, DOI 10.1111/j.1532-5415.1987.tb04341.x; TINETTI ME, 1995, J AM GERIATR SOC, V43, P1214, DOI 10.1111/j.1532-5415.1995.tb07396.x; Watson WL, 2011, OSTEOPOROSIS INT, V22, P2623, DOI 10.1007/s00198-010-1511-z; Watt SJ, 2000, EXP BRAIN RES, V135, P411, DOI 10.1007/s002210000545; Weerdesteyn V, 2008, J ELECTROMYOGR KINES, V18, P235, DOI 10.1016/j.jelekin.2007.06.010; Willinger R, 2003, INT J CRASHWORTHINES, V8, P605, DOI 10.1533/cras.8.6.605.19261; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4; Wright AD, 2012, MED ENG PHYS, V34, P1071, DOI 10.1016/j.medengphy.2011.11.012; Yang YJ, 2015, J AM MED DIR ASSOC, V16, P388, DOI 10.1016/j.jamda.2014.12.003; Yang YJ, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-40	49	11	11	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2017	32	3					168	177		10.1097/HTR.0000000000000257			10	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	EV4GM	WOS:000401716900003	27603766				2021-06-18	
J	Das, SK; Shetty, SP; Sen, KK				Das, Sudha Kiran; Shetty, Sachin P.; Sen, Kamal Kumar			Novel Triage Tool: Optic Nerve Sheath Diameter in Traumatic Brain Injury and its Correlation to Rotterdam Computed Tomography (CT) Scoring	POLISH JOURNAL OF RADIOLOGY			English	Article						Brain Injuries; Optic Nerve; Tomography, Spiral Computed	INTRACRANIAL-PRESSURE; HEAD-INJURY; DECOMPRESSIVE CRANIECTOMY; SCAN CHARACTERISTICS; IMPACT	Background: Optic nerve sheath diameter (ONSD) evaluated in CT imaging as well as Rotterdam CT Score (RCTS) are proven independent predictors of outcome in patients with traumatic brain injury (TBI). To date, no study has correlated ONSD on admission CT scan with RCTS. Material/Methods: Retrospective cohort study comprised of consecutive patients undergoing CT imaging for traumatic brain injury recruited between January and October 2015. Bilateral ONSD was measured 3 mm behind the eyeball in axial and sagittal planes and mean value was calculated. RCTS was assessed on the same CT images, bias was eliminated by blinding RCTS to ONSD measurement. Results: 150 patients were included; mean age in the group was 42.94 +/- 16.7 years. ONSD in mild TBI, RCTS 2 and 3 were 3.3 mm (SD 0.39 mm) and 4.1 mm (0.047 mm), respectively. Mean ONSD in moderate and severe TBI (RCTS score 4 and above) was 4.83 mm and above, SD 0.4 mm. Mean ONSD correlated with occurrence of diffuse cerebral oedema, presence of subdural and extradural hematoma; however in isolation there was no statistical significance. Conclusions: Higher ONSD was observed in patients with moderate and severe TBI, correlating with admission RCTS of 4 and above. Subsequent increase in ONSD was also found with increase in RCTS. ONSD could serve as an initial triage tool in the emergency department as well as a method of determining the need for sequential CT in patients	[Das, Sudha Kiran; Shetty, Sachin P.; Sen, Kamal Kumar] JSS Univ, JSS Med Coll & Hosp, Dept Radiodiag & Imaging, MG Rd, Mysore 570004, Karnataka, India	Das, SK (corresponding author), JSS Univ, JSS Med Coll & Hosp, Dept Radiodiag & Imaging, MG Rd, Mysore 570004, Karnataka, India.	sudha7492@gmail.com	Das, Sudha/ABB-1662-2020	Das, Sudha/0000-0002-1289-2953			BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; Dubourg J, 2011, INTENS CARE MED, V37, P1059, DOI 10.1007/s00134-011-2224-2; Goel RS, 2008, INJURY, V39, P519, DOI 10.1016/j.injury.2007.09.029; Gururaj G, 2002, NEUROL RES, V24, P24, DOI 10.1179/016164102101199503; HANSEN HC, 1994, NEURO-OPHTHALMOLOGY, V14, P345, DOI 10.3109/01658109409024061; Hansen HC, 1996, SURG RADIOL ANAT, V18, P323, DOI 10.1007/BF01627611; Huang YH, 2012, NEUROSURGERY, V71, P80, DOI 10.1227/NEU.0b013e3182517aa1; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Karakitsos D, 2006, TRANSPL P, V38, P3700, DOI 10.1016/j.transproceed.2006.10.185; Legrand A, 2013, CRIT CARE, V17, DOI 10.1186/cc12589; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Miller MT, 2004, J TRAUMA, V56, P967, DOI 10.1097/01.TA.0000123699.16465.8B; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Rajajee V, 2011, NEUROCRIT CARE, V15, P506, DOI 10.1007/s12028-011-9606-8; Samabasivan, 1991, NEUROL INDIA S, V43, P9; Sekhon MS, 2014, INTENS CARE MED, V40, P1267, DOI 10.1007/s00134-014-3392-7; Tayal VS, 2007, ANN EMERG MED, V49, P508, DOI 10.1016/j.annemergmed.2006.06.040; Waqas M, 2016, J NEURORADIOLOGY, V43, P25, DOI 10.1016/j.neurad.2015.07.003; World Health Organization, 2002, PROJ MORT BURD DIS 2	21	11	11	0	2	INT SCIENTIFIC INFORMATION INC	SMITHTOWN	361 FOREST LN, SMITHTOWN, NY 11787 USA	0137-7183	1899-0967		POL J RADIOL	Pol. J. Radiol.	APR 28	2017	82						240	243		10.12659/PJR.900196			4	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	EU7FF	WOS:000401200000001	28533826	Green Published			2021-06-18	
J	Darabi, S; Tiraihi, T; Delshad, A; Sadeghizadeh, M; Khalil, W; Taheri, T				Darabi, Shahram; Tiraihi, Taki; Delshad, AliReza; Sadeghizadeh, Majid; Khalil, Wisam; Taheri, Taher			In vitro non-viral murine pro-neurotrophin 3 gene transfer into rat bone marrow stromal cells	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						NT-3; Transfection; BMSCs; Secretory vector; Non-viral transfection	SPINAL-CORD-INJURY; MESENCHYMAL STEM-CELLS; DEVELOPING NERVOUS-SYSTEM; NEURAL PRECURSOR CELLS; ISCHEMIC BRAIN-INJURY; TRANSIENT TRANSFECTION; NEURONAL DIFFERENTIATION; OXIDATIVE STRESS; MOTOR-NEURONS; EXPRESSION	Neurotrophin 3 (NT-3) is an important factor for promoting prenatal neural development, as well as regeneration, axogenesis and plasticity in postnatal life. Therapy with NT-3 was reported to improve the condition of patients suffering from degenerative diseases and traumatic injuries, however, the disadvantage of NT-3 protein delivery is its short half-life, thus our alternative approach is the use of NT-3 gene therapy. In this study, the bone marrow stromal cells (BMSCs) were isolated from adult rats, cultured for 4 passages and transfected with either pEGFP-N1 or a constructed vector containing murine proNT-3 (pSecTag2/HygroB-murine proNT-3) using Lipofectamine 2000 followed by Hygromycin B (200 mg/kg). The transfection efficiency of the transiently transfected BMSCs was evaluated using the green fluorescence protein containing vector (pEGFP-N1). A quantitative evaluation of the NT-3 expression of mRNA using real time qRT-PCR shows that there was double fold increase in NT-3 gene expression compared with non-transfected BMSCs, also, the culture supernatant yielded double fold increase in NT-3 using ELISA technique, the data were supported by immunoblotting technique. This suggests that the use of this transfection technique can be useful for gene therapy in different neurological disorders with neurodegenerative or traumatic origins. (C) 2017 Elsevier B.V. All rights reserved.	[Darabi, Shahram] Qazvin Univ Med Sci, Cellular & Mol Res Ctr, Qazvin, Iran; [Tiraihi, Taki] Tarbiat Modares Univ, Sch Med Sci, Dept Anat Sci, Tehran, Iran; [Delshad, AliReza] Shahed Univ, Dept Anat, Tehran, Iran; [Sadeghizadeh, Majid] Tarbiat Modares Univ, Fac Basic Sci, Dept Genet, Tehran, Iran; [Khalil, Wisam] Tarbiat Modares Univ, Sch Med Sci, Dept Anat Sci, POB 14155-4838, Tehran, Iran; [Taheri, Taher] Khatam Al Anbia Hosp, Shefa Neurosci Res Ctr, Tehran, Iran	Tiraihi, T (corresponding author), Tarbiat Modares Univ, Sch Med Sci, Dept Anat Sci, POB 14155-4838, Tehran, Iran.	takialtr@modares.ac.ir		darabi, shahram/0000-0002-9405-6640	Shefa Neuroscience Research Center at Khatam Al-Anbia Hospital, Tehran, Iran [86-N-105]; Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran	The project was funded by Shefa Neuroscience Research Center at Khatam Al-Anbia Hospital, Tehran, Iran (Grant # 86-N-105). We are also grateful for the support of the Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.	Abbaszadeh HA, 2015, CYTOTHERAPY, V17, P912, DOI 10.1016/j.jcyt.2015.03.689; Abe K, 2000, J CEREBR BLOOD F MET, V20, P1393, DOI 10.1097/00004647-200010000-00001; Anwar MA, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00098; Arnhold S, 2006, EUR J CELL BIOL, V85, P551, DOI 10.1016/j.ejcb.2006.01.015; Bernd P, 2008, GENE EXPRESSION, V14, P241, DOI 10.3727/105221608786883799; Bialas M, 2011, J PHYSIOL PHARMACOL, V62, P219; Birmingham E, 2012, EUR CELLS MATER, V23, P13, DOI 10.22203/eCM.v023a02; Bothwell M, 2014, Handb Exp Pharmacol, V220, P3, DOI 10.1007/978-3-642-45106-5_1; Bradbury EJ, 2006, NAT REV NEUROSCI, V7, P644, DOI 10.1038/nrn1964; Castellanos DA, 2002, CELL TRANSPLANT, V11, P297; Chalazonitis A, 1996, MOL NEUROBIOL, V12, P39, DOI 10.1007/BF02740746; Chalazonitis A, 2004, PROG BRAIN RES, V146, P243, DOI 10.1016/S0079-6123(03)46016-0; Chao MV, 2006, CLIN SCI, V110, P167, DOI 10.1042/CS20050163; Chen HH, 1999, CURR OPIN NEUROBIOL, V9, P405, DOI 10.1016/S0959-4388(99)80061-0; Chen JH, 2004, P NATL ACAD SCI USA, V101, P16357, DOI 10.1073/pnas.0406795101; CHENG B, 1994, BRAIN RES, V640, P56, DOI 10.1016/0006-8993(94)91857-0; Curtis KM, 2012, MOL CELL NEUROSCI, V49, P138, DOI 10.1016/j.mcn.2011.10.008; Curtis KM, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-61; de Munter Johannes P J M, 2014, Parkinsonism Relat Disord, V20 Suppl 1, pS150, DOI 10.1016/S1353-8020(13)70036-1; Delcroix GJR, 2010, DIFFERENTIATION, V80, P213, DOI 10.1016/j.diff.2010.07.001; Derouazi M, 2004, BIOTECHNOL BIOENG, V87, P537, DOI 10.1002/bit.20161; FARINAS I, 1994, NATURE, V369, P658, DOI 10.1038/369658a0; Fatima G, 2015, SPINAL CORD, V53, P3, DOI 10.1038/sc.2014.178; Filipowicz W, 2005, CURR OPIN STRUC BIOL, V15, P331, DOI 10.1016/j.sbi.2005.05.006; Fowler SC, 2002, INT J DEV NEUROSCI, V20, P303, DOI 10.1016/S0736-5748(02)00010-2; Garcia-Alias G, 2011, J NEUROSCI, V31, P17788, DOI 10.1523/JNEUROSCI.4308-11.2011; GHOSH A, 1995, NEURON, V15, P89, DOI 10.1016/0896-6273(95)90067-5; Green SH, 2012, ANAT REC, V295, P1877, DOI 10.1002/ar.22587; Hall ED, 2011, NEUROTHERAPEUTICS, V8, P152, DOI 10.1007/s13311-011-0026-4; Hastings NB, 1999, J COMP NEUROL, V415, P144; Hawryluk GWJ, 2012, STEM CELLS DEV, V21, P432, DOI 10.1089/scd.2011.0242; Hossain WA, 2008, J NEUROSCI RES, V86, P2376, DOI 10.1002/jnr.21685; Hossain WA, 2006, J NEUROBIOL, V66, P897, DOI 10.1002/neu.20264; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Hu XH, 2004, J NEUROCHEM, V90, P1339, DOI 10.1111/j.1471-4159.2004.02594.x; Kearns MD, 2008, MOL PHARMACEUT, V5, P128, DOI 10.1021/mp700131c; Kumar S, 2007, NEUROCHEM RES, V32, P783, DOI 10.1007/s11064-006-9208-6; Lachyankar MB, 1997, EXP NEUROL, V144, P350, DOI 10.1006/exnr.1997.6434; Lee H, 2001, ANAL CHEM, V73, P837, DOI 10.1021/ac000831n; Lessmann V, 2003, PROG NEUROBIOL, V69, P341, DOI 10.1016/S0301-0082(03)00019-4; Li XJ, 2005, NAT BIOTECHNOL, V23, P215, DOI 10.1038/nbt1063; Liu CT, 2008, MOL BIOTECHNOL, V39, P141, DOI 10.1007/s12033-008-9051-x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martyn JC, 2007, ARCH VIROL, V152, P329, DOI 10.1007/s00705-006-0845-5; Moradi F, 2012, CELL J, V13, P243; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Noori-Zadeh A, 2014, J NEUROL SCI, V339, P81, DOI 10.1016/j.jns.2014.01.025; OAKLEY BR, 1980, ANAL BIOCHEM, V105, P361, DOI 10.1016/0003-2697(80)90470-4; Ohtsuka M, 2009, J NEUROSCI RES, V87, P301, DOI 10.1002/jnr.21855; Ringstedt T, 1997, DEVELOPMENT, V124, P2603; Risbud RM, 2011, BRAIN RES, V1424, P53, DOI 10.1016/j.brainres.2011.09.039; Rowland JW, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E2; Sajdel-Sulkowska EM, 2009, CEREBELLUM, V8, P366, DOI 10.1007/s12311-009-0105-9; SCHNELL L, 1994, NATURE, V367, P170, DOI 10.1038/367170a0; Scuri Mario, 2010, Inflammation & Allergy Drug Targets, V9, P173; Sieber-Blum M, 1998, BIOCHEM CELL BIOL, V76, P1039, DOI 10.1139/bcb-76-6-1039; Taylor L, 2006, J NEUROSCI, V26, P9713, DOI 10.1523/JNEUROSCI.0734-06.2006; Tender GC, 2011, NEUROSURGERY, V68, P1048, DOI 10.1227/NEU.0b013e318208f9c4; Tinsley R, 2004, ACTA NEUROL SCAND, V109, P1, DOI 10.1046/j.1600-0404.2003.00240.x; Tseng HC, 2006, NEUROBIOL DIS, V22, P88, DOI 10.1016/j.nbd.2005.10.007; Wang LJ, 2014, ACTA NEUROCHIR, V156, P1409, DOI 10.1007/s00701-014-2089-6; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Yaghoobi MM, 2006, NEUROSCI LETT, V397, P149, DOI 10.1016/j.neulet.2005.12.009; Yin WX, 2005, ANAL BIOCHEM, V346, P289, DOI 10.1016/j.ab.2005.08.029; Yoo MJ, 2007, J MICROBIOL BIOTECHN, V17, P2033; Zhang J, 2012, NEUROSCIENCE, V222, P1, DOI 10.1016/j.neuroscience.2012.07.023; Zhou XF, 1996, MOL NEUROBIOL, V13, P185, DOI 10.1007/BF02740622; Zhu TQ, 2015, CELL MOL NEUROBIOL, V35, P255, DOI 10.1007/s10571-014-0120-3	68	11	12	0	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-510X	1878-5883		J NEUROL SCI	J. Neurol. Sci.	APR 15	2017	375						137	145		10.1016/j.jns.2017.01.058			9	Clinical Neurology; Neurosciences	Neurosciences & Neurology	ER4EN	WOS:000398752000025	28320116				2021-06-18	
J	Adams, RS; Corrigan, JD; Mohr, BA; Williams, TV; Larson, MJ				Adams, Rachel Sayko; Corrigan, John D.; Mohr, Beth A.; Williams, Thomas V.; Larson, Mary Jo			Traumatic Brain Injury and Post-Deployment Binge Drinking among Male and Female Army Active Duty Service Members Returning from Operation Enduring Freedom/Operation Iraqi Freedom	JOURNAL OF NEUROTRAUMA			English	Article						binge drinking; gender; post-deployment; traumatic brain injury	POSTTRAUMATIC-STRESS-DISORDER; SUBSTANCE USE; MILITARY PERSONNEL; GENDER-DIFFERENCES; ALCOHOL MISUSE; MENTAL-HEALTH; PRIMARY-CARE; COMBAT; AFGHANISTAN; SYMPTOMS	This study examines whether the relationship between traumatic brain injury (TBI) and post-deployment binge drinking is independent of screening positive for mental health problems among male and female service members. Data are from the Substance Use and Psychological Injury Combat Study of Army members returning from deployment to Afghanistan or Iraq in fiscal years 2008-2011. The sample consists of 240,694 male and 26,406 female active duty members who completed initial and follow-up questionnaires. The initial questionnaire, completed at the end of deployment, included screens for TBI and mental health problems (post-traumatic stress disorder, depression, harmful thoughts). The dependent variable, frequent binge drinking (six or more drinks on one occasion, at least monthly), was assessed on the follow-up questionnaire on average 3-9 months post-deployment. More than 21% of males and 7% of females reported frequent binge drinking. Male members were more likely to screen positive for TBI, compared with females (7.5% vs. 4.4%). Females with both TBI and mental health positive screens had more than double the risk of frequent binge drinking, compared with those without either problem (15.8% vs. 6.6%), and males with both problems had almost double the risk, compared with males with neither problem (33.6% vs. 19.7%). In multivariable logistic regression models, having a TBI and a comorbid positive mental health screen was associated with increased odds of frequent binge drinking among both males and females (adjusted odds ratio [AOR] = 1.59, CI: 1.50-1.69, and AOR= 2.11, CI: 1.57-2.83, respectively), compared with those with neither condition. More research is needed on the interaction of gender and binge drinking, especially when TBI and mental health problems co-exist.	[Adams, Rachel Sayko; Mohr, Beth A.; Larson, Mary Jo] Brandeis Univ, Heller Sch Social Policy & Management, Waltham, MA USA; [Corrigan, John D.] Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA; [Williams, Thomas V.] US Dept Def, Falls Church, VA USA	Adams, RS (corresponding author), Brandeis Univ, Heller Sch Social Policy & Management, Inst Behav Hlth, 415 South St, Waltham, MA 02453 USA.	radams@brandeis.edu	Corrigan, John D./E-2921-2011; Adams, Rachel/AAH-4653-2020		National Institute of Drug Abuse (NIDA)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [R01DA030150]; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R01DA030150] Funding Source: NIH RePORTER	This study was funded by National Institute of Drug Abuse (NIDA) grant R01DA030150. We acknowledge Kennell and Associates, Inc. for compiling the data files used in these analyses, as well as Dr. Thomas V. Williams, the Defense Health Agency's (DHA) DoD data sponsor. The DHA's Privacy and Civil Liberties Office, and the U.S. Army Medical Department's Patient Administration Systems and Biostatistics Activity of the U.S. DoD provided access to these data.	Adams RS, 2016, J HEAD TRAUMA REHAB, V31, P13, DOI 10.1097/HTR.0000000000000082; Adams RS, 2013, SUBST USE MISUSE, V48, P821, DOI 10.3109/10826084.2013.797995; Adams RS, 2012, J HEAD TRAUMA REHAB, V27, P349, DOI 10.1097/HTR.0b013e318268db94; Barlas FM, 2013, 2011 DEP DEFENSE HLT; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Bliese P. D., 2005, POSTDEPLOYMENT PSYCH; Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; Bliese PD, 2011, DEPLOYMENT PSYCHOL E, P175; Bray RM, 2009, DEP DEFENSE SURVEY H; Bray RM, 2013, SUBST USE MISUSE, V48, P799, DOI 10.3109/10826084.2013.796990; Bray RM, 2010, MIL MED, V175, P390, DOI 10.7205/MILMED-D-09-00132; Brown JM, 2010, MIL MED, V175, P101, DOI 10.7205/MILMED-D-09-00080; Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; Calhoun PS, 2010, PSYCHIAT RES, V178, P330, DOI 10.1016/j.psychres.2009.11.009; Casement MD, 2015, SOC COGN AFFECT NEUR, V10, P416, DOI 10.1093/scan/nsu061; Chase S, 2012, HEALTH CARE WOMEN IN, V33, P631, DOI 10.1080/07399332.2012.673652; Conard PL, 2014, NURS FORUM, V49, P1, DOI 10.1111/nuf.12049; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1940, DOI 10.1016/j.apmr.2013.05.018; Corrigan JD, 2012, BRAIN INJURY, V26, P139, DOI 10.3109/02699052.2011.648705; Forbes EE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094640; Golub A, 2014, ADDICT BEHAV, V39, P449, DOI 10.1016/j.addbeh.2013.06.020; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Institute of Medicine, 2012, TREATM POSTTR STRESS; Jakupcak M, 2010, ADDICT BEHAV, V35, P840, DOI 10.1016/j.addbeh.2010.03.023; Kay T., 1993, J HEAD TRAUMA REHABI, V8, P86, DOI [10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kennedy CH, 2012, ARCH CLIN NEUROPSYCH, V27, P817, DOI 10.1093/arclin/acs092; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Kroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3C; Larson MJ, 2012, J SOC WORK PRACT ADD, V12, P6, DOI 10.1080/1533256X.2012.647586; Larson MJ, 2014, AM J PUBLIC HEALTH, V104, P1402, DOI 10.2105/AJPH.2014.301901; Larson MJ, 2013, SUBST USE MISUSE, V48, P863, DOI 10.3109/10826084.2013.794840; Maguen S, 2012, J PSYCHIATR RES, V46, P311, DOI 10.1016/j.jpsychires.2011.11.007; Mattiko MJ, 2011, ADDICT BEHAV, V36, P608, DOI 10.1016/j.addbeh.2011.01.023; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P22, DOI 10.1111/j.1365-2214.2009.00947.x; National Institute of Alcohol Abuse and Alcoholism, 2005, HELP PAT WHO DRINK T; Niemeier JP, 2007, NEUROPSYCHOL REHABIL, V17, P293, DOI 10.1080/09602010600814729; OBrien CP, 2013, SUBSTANCE USE DISORD; Pietrzak RH, 2011, J PSYCHIATR RES, V45, P1579, DOI 10.1016/j.jpsychires.2011.07.010; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Preiss-Farzanegan SJ, 2009, PM&R, V1, P245, DOI 10.1016/j.pmrj.2009.01.011; Prins A, 2003, PRIMARY CARE PSYCHIA, V9, P9; Ramchand R, 2011, MIL PSYCHOL, V23, P6, DOI 10.1080/08995605.2011.534407; Rona RJ, 2012, J HEAD TRAUMA REHAB, V27, P33, DOI 10.1097/HTR.0b013e318212f814; Santiago PN, 2010, PSYCHIAT SERV, V61, P575, DOI 10.1176/ps.2010.61.6.575; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Sellitto M, 2010, J NEUROSCI, V30, P16429, DOI 10.1523/JNEUROSCI.2516-10.2010; Slewa-Younan S, 2008, J NEUROL NEUROSUR PS, V79, P1197, DOI 10.1136/jnnp.2008.147983; Spera C, 2011, J STUD ALCOHOL DRUGS, V72, P5, DOI 10.15288/jsad.2011.72.5; Stahre MA, 2009, AM J PREV MED, V36, P208, DOI 10.1016/j.amepre.2008.10.017; Stein M. B., 2016, J NEUROTRAUMA; Tanielian T, 2008, INVISIBLE WOUNDS WAR; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; US Department of Defense, 2013, EL 1994 DIR GROUND C; Weil ZM, 2016, NEUROSCI BIOBEHAV R, V62, P89, DOI 10.1016/j.neubiorev.2016.01.005; Wilk JE, 2010, J HEAD TRAUMA REHAB, V25, P9, DOI 10.1097/HTR.0b013e3181bd090f; Wunderle K, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000006	56	11	11	0	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2017	34	7					1457	1465		10.1089/neu.2016.4693			9	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	ER0FB	WOS:000398461600015	27762655	Green Published			2021-06-18	
J	Andrade, P; Nissinen, J; Pitkanen, A				Andrade, Pedro; Nissinen, Jari; Pitkanen, Asla			Generalized Seizures after Experimental Traumatic Brain Injury Occur at the Transition from Slow-Wave to Rapid Eye Movement Sleep	JOURNAL OF NEUROTRAUMA			English	Article						epilepsy; lateral fluid percussion; paradoxical sleep; post-traumatic epilepsy; rat	EPILEPSY; DISORDERS; DISTURBANCES; NEUROGENESIS; DEPRIVATION; SPINDLES; INSOMNIA	Sleep disturbances commonly occur after traumatic brain injury (TBI) and may predispose patients to epileptic seizures. We hypothesized that unprovoked seizure occurrence post-TBI depends on the sleep-wake cycle, and that the electrographic characteristics of a given sleep stage provide biomarkers for post-traumatic epilepsy (PTE). We show, in a rat lateral fluid percussion model, that 92% of spontaneous generalized seizures occur during the transition from stage III to rapid eye movement sleep. Moreover, a reduction in spindle duration and dominant frequency during the transition stage present as specific and sensitive noninvasive biomarkers for experimentally induced PTE with generalized electrographic seizures.	[Andrade, Pedro; Nissinen, Jari; Pitkanen, Asla] Univ Eastern Finland, AI Virtanen Inst Mol Sci, Dept Neurobiol, POB 1627, FI-70211 Kuopio, Finland	Pitkanen, A (corresponding author), Univ Eastern Finland, AI Virtanen Inst Mol Sci, Dept Neurobiol, POB 1627, FI-70211 Kuopio, Finland.	asla.pitkanen@uef.fi	Andrade, Pedro/N-8410-2018	Andrade, Pedro/0000-0001-9118-8341	Academy of Finland, CURE (Citizens United for Research in Epilepsy), FP7-HEALTH project [602102]	This study was supported by the Academy of Finland, CURE (Citizens United for Research in Epilepsy), FP7-HEALTH project 602102 (EPITARGET). The authors thank Mr. Jarmo Hartikainen and Mrs. Merja Lukkari for their excellent technical assistance.	Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Baumann CR, 2016, SLEEP MED CLIN, V11, P19, DOI 10.1016/j.jsmc.2015.10.004; Beetar JT, 1996, ARCH PHYS MED REHAB, V77, P1298, DOI 10.1016/S0003-9993(96)90196-3; Brites D, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00476; Castriotta RJ, 2011, CNS DRUGS, V25, P175, DOI 10.2165/11584870-000000000-00000; Castriotta RJ, 2001, ARCH PHYS MED REHAB, V82, P1403, DOI 10.1053/apmr.2001.26081; De Gennaro L, 2003, SLEEP MED REV, V7, P423, DOI 10.1053/smrv.2002.0252; Duclos C, 2014, PATHOL BIOL, V62, P252, DOI 10.1016/j.patbio.2014.05.014; Feige B, 2013, INT J PSYCHOPHYSIOL, V89, P171, DOI 10.1016/j.ijpsycho.2013.04.002; Gelinas JN, 2016, NAT MED, V22, P641, DOI 10.1038/nm.4084; Gottesmann C, 1996, NEUROSCI BIOBEHAV R, V20, P367, DOI 10.1016/0149-7634(95)00055-0; Halasz P, 2013, EPILEPSY RES, V107, P9, DOI 10.1016/j.eplepsyres.2013.06.021; Halasz Peter, 2012, Handb Clin Neurol, V107, P305, DOI 10.1016/B978-0-444-52898-8.00019-7; Huusko N, 2014, NEUROSCIENCE, V267, P30, DOI 10.1016/j.neuroscience.2014.02.026; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Iber C, 2007, AASM MANUAL SCORING; Imbach LL, 2016, NEUROLOGY, V86, P1945, DOI 10.1212/WNL.0000000000002697; Kalia M, 2006, METABOLISM, V55, pS2, DOI 10.1016/j.metabol.2006.07.005; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kreutzmann JC, 2015, NEUROSCIENCE, V309, P173, DOI 10.1016/j.neuroscience.2015.04.053; Luthi A, 2014, NEUROSCIENTIST, V20, P243, DOI 10.1177/1073858413500854; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Maxwell WL, 2004, BRAIN, V127, P2470, DOI 10.1093/brain/awh294; Ng M., 2013, EPILEPSY RES TREAT; Niedermeyer E, 2005, ELECTROENCEPHALOGRAP; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; PACESCHOTT EF, 2002, NEUROPSYCHOPHARMACOL, P1859; Pitkanen A, 2002, LANCET NEUROL, V1, P173, DOI 10.1016/S1474-4422(02)00073-X; Pitkanen A, 2014, NEUROTHERAPEUTICS, V11, P286, DOI 10.1007/s13311-014-0260-7; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Raymont V, 2010, NEUROLOGY, V75, P224, DOI 10.1212/WNL.0b013e3181e8e6d0; Schmitt B, 2015, NEUROPEDIATRICS, V46, P171, DOI 10.1055/s-0035-1551574; Valko PO, 2016, SLEEP, V39, P1249, DOI 10.5665/sleep.5844	34	11	11	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2017	34	7					1482	1487		10.1089/neu.2016.4675			6	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	ER0FB	WOS:000398461600018	27707084				2021-06-18	
J	de la Tremblaye, PB; Bondi, CO; Lajud, N; Cheng, JP; Radabaugh, HL; Kline, AE				de la Tremblaye, Patricia B.; Bondi, Corina O.; Lajud, Naima; Cheng, Jeffrey P.; Radabaugh, Hannah L.; Kline, Anthony E.			Galantamine and Environmental Enrichment Enhance Cognitive Recovery after Experimental Traumatic Brain Injury But Do Not Confer Additional Benefits When Combined	JOURNAL OF NEUROTRAUMA			English	Article						acetylcholinesterase inhibitors (AChEIs); beam-walking; behavior; controlled cortical impact (CCI); functional recovery; galantamine; hippocampus; learning and memory; Morris water maze; traumatic brain injury	CORTICAL IMPACT INJURY; SPATIAL-LEARNING DEFICITS; NEUROPROTECTION AND/OR ENHANCEMENT; MUSCARINIC ACETYLCHOLINE-RECEPTORS; ALPHA-7 NICOTINIC ACETYLCHOLINE; MEDIATED FUNCTIONAL IMPROVEMENT; MODERATE ALZHEIMERS-DISEASE; REDUCED EVOKED RELEASE; CHOLINESTERASE-INHIBITORS; CHOLINERGIC SYSTEM	Environmental enrichment (EE) enhances cognition after traumatic brain injury (TBI). Galantamine (GAL) is an acetylcholinesterase inhibitor that also may promote benefits. Hence, the aims of this study were to assess the efficacy of GAL alone (standard [STD] housing) and in combination with EE in adult male rats after TBI. The hypothesis was that both therapies would confer motor, cognitive, and histological benefits when provided singly, but that their combination would be more efficacious. Anesthetized rats received a controlled cortical impact or sham injury, then were randomly assigned to receive GAL (1, 2, or 3 mg/kg; intraperitoneally [i.p.]) or saline vehicle (VEH; 1 mL/kg; i.p.) beginning 24 h after surgery and once daily for 21 days (experiment 1). Motor (beam-balance/walk) and cognitive (Morris water maze [MWM]) assessments were conducted on post-operative Days 1-5 and 14-19, respectively. Cortical lesion volumes were quantified on Day 21. Sham controls were better versus all TBI groups. No differences in motor function or lesion volumes were observed among the TBI groups (p > 0.05). In contrast, GAL (2 mg/kg) enhanced MWM performance versus VEH and GAL (1 and 3 mg/kg; p < 0.05). In experiment 2, GAL (2 mg/kg) or VEH was combined with EE and the data were compared with the STD-housed groups from experiment 1. EE alone enhanced motor performance over the VEH-treated and GAL-treated (2 mg/kg) STD-housed groups (p < 0.05). Moreover, both EE groups (VEH or GAL) facilitated spatial learning and reduced lesion size versus STD + VEH controls (p < 0.05). No additional benefits were observed with the combination paradigm, which does not support the hypothesis. Overall, the data demonstrate that EE and once daily GAL (2 mg/kg) promote cognitive recovery after TBI. Importantly, the combined therapies did not negatively affect outcome and thus this therapeutic protocol may have clinical utility.	[de la Tremblaye, Patricia B.; Bondi, Corina O.; Lajud, Naima; Cheng, Jeffrey P.; Radabaugh, Hannah L.; Kline, Anthony E.] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA USA; [de la Tremblaye, Patricia B.; Bondi, Corina O.; Lajud, Naima; Cheng, Jeffrey P.; Radabaugh, Hannah L.; Kline, Anthony E.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA USA; [Bondi, Corina O.] Univ Pittsburgh, Dept Neurobiol, Pittsburgh, PA USA; [Bondi, Corina O.; Kline, Anthony E.] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15260 USA; [Bondi, Corina O.; Kline, Anthony E.] Univ Pittsburgh, Ctr Neural Basis Cognit, Pittsburgh, PA USA; [Kline, Anthony E.] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA USA; [Kline, Anthony E.] Univ Pittsburgh, Dept Psychol, Pittsburgh, PA 15260 USA; [Lajud, Naima] Mexican Social Secur Inst, Biomed Res Ctr Michoacan, Div Neurosci, Morelia, Michoacan, Mexico	Kline, AE (corresponding author), Univ Pittsburgh, Safar Ctr Resuscitat Res, Phys Med & Rehabil, 3471 Fifth Ave,Suite 201, Pittsburgh, PA 15213 USA.	klineae@upmc.edu	Lajud, Naima/B-4605-2018	Lajud, Naima/0000-0003-3905-798X; Bondi, Corina/0000-0002-5733-4912	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS060005, HD069620, HD069620-S1, NS084967, NS094950]; University of Pittsburgh Physicians /UPMC Academic Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD069620] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [T32NS086749, R01NS084967, R03NS094950, R01NS060005] Funding Source: NIH RePORTER	This work was supported, in part, by the National Institutes of Health grants NS060005, HD069620, HD069620-S1, NS084967 (AEK), and NS094950 (COB), and the University of Pittsburgh Physicians /UPMC Academic Foundation (COB).	Ago Y, 2010, INT J NEUROPSYCHOPH, V13, P58; Anthonymuthu TS, 2016, BRAIN RES, V1640, P57, DOI 10.1016/j.brainres.2016.02.006; Arciniegas D, 1999, BRAIN INJURY, V13, P1, DOI 10.1080/026990599121827; Arciniegas David B, 2003, Curr Psychiatry Rep, V5, P391, DOI 10.1007/s11920-003-0074-5; Ballesteros J, 2008, J HEAD TRAUMA REHAB, V23, P171, DOI 10.1097/01.HTR.0000319935.99837.96; Barnes CA, 2000, NEUROSCIENCE, V99, P17, DOI 10.1016/S0306-4522(00)00180-9; Benetti F, 2009, INT J DEV NEUROSCI, V27, P59, DOI 10.1016/j.ijdevneu.2008.09.200; Bentley P, 2011, PROG NEUROBIOL, V94, P360, DOI 10.1016/j.pneurobio.2011.06.002; BICKEL U, 1991, NEUROPHARMACOLOGY, V30, P447, DOI 10.1016/0028-3908(91)90005-V; Blesa R, 2003, DEMENT GERIATR COGN, V15, P79, DOI 10.1159/000067974; Bondi CO, 2015, NEUROSCI BIOBEHAV R, V58, P123, DOI 10.1016/j.neubiorev.2014.12.004; Bondi CO, 2014, J NEUROTRAUM, V31, P926, DOI 10.1089/neu.2013.3295; Bondi CO, 2014, J NEUROTRAUM, V31, P873, DOI 10.1089/neu.2014.3328; Briones TL, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-57; Bruel-Jungerman E, 2011, BEHAV BRAIN RES, V221, P379, DOI 10.1016/j.bbr.2011.01.021; Buendia I, 2016, MOL NEUROBIOL, V53, P3338, DOI 10.1007/s12035-015-9272-5; Cheng JP, 2012, J NEUROTRAUM, V29, P2684, DOI 10.1089/neu.2012.2560; Colovic MB, 2013, CURR NEUROPHARMACOL, V11, P315, DOI 10.2174/1570159X11311030006; Coyle J, 2001, BIOL PSYCHIAT, V49, P289, DOI 10.1016/S0006-3223(00)01101-X; Dash PK, 2016, J NEUROSCI, V36, P2809, DOI 10.1523/JNEUROSCI.3197-15.2016; de Bruin N, 2006, PHARMACOL BIOCHEM BE, V85, P253, DOI 10.1016/j.pbb.2006.08.007; de Witt BW, 2011, NEUROREHAB NEURAL RE, V25, P343, DOI 10.1177/1545968310390520; DEANGELIS MM, 1994, BRAIN RES, V653, P39, DOI 10.1016/0006-8993(94)90369-7; Dewar D, 1996, J NEUROTRAUM, V13, P181, DOI 10.1089/neu.1996.13.181; Dimitrova DS, 2006, J PHARMACOL SCI, V101, P199, DOI 10.1254/jphs.FPE05006X; Dixon CE, 1997, BRAIN RES, V749, P127, DOI 10.1016/S0006-8993(96)01310-8; Dixon CE, 1996, PHARMACOL BIOCHEM BE, V53, P679, DOI 10.1016/0091-3057(95)02069-1; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Emre M, 2002, INT J CLIN PRACT, P64; Erkinjuntti T, 2002, LANCET, V359, P1283, DOI 10.1016/S0140-6736(02)08267-3; Farlow MR, 2001, CLIN THER, V23, pA13, DOI 10.1016/S0149-2918(01)80164-8; Fayuk D, 2004, MOL PHARMACOL, V66, P658, DOI 10.1124/mol.104.000042; Garcia AN, 2011, PM&R, V3, pS18, DOI 10.1016/j.pmrj.2011.03.017; Geerts H, 2005, BRAIN RES, V1033, P186, DOI 10.1016/j.brainres.2004.11.042; Gorman LK, 1996, J NEUROTRAUM, V13, P457, DOI 10.1089/neu.1996.13.457; Gould TJ, 2005, BEHAV BRAIN RES, V165, P160, DOI 10.1016/j.bbr.2005.06.040; Griffin SL, 2003, J NEUROPSYCH CLIN N, V15, P17, DOI 10.1176/appi.neuropsych.15.1.17; Hamm RJ, 1996, J NEUROTRAUM, V13, P41, DOI 10.1089/neu.1996.13.41; Hasselmo ME, 2006, CURR OPIN NEUROBIOL, V16, P710, DOI 10.1016/j.conb.2006.09.002; Hicks RR, 2002, NEUROSCIENCE, V112, P631, DOI 10.1016/S0306-4522(02)00104-5; Hoffman AN, 2008, NEUROSCI LETT, V431, P226, DOI 10.1016/j.neulet.2007.11.042; Holschneider DP, 2011, J NEUROTRAUM, V28, P1909, DOI 10.1089/neu.2011.1978; Huber KBG, 2016, CURR PHARM DESIGN, V22, P2072, DOI 10.2174/1381612822666160127113631; Hwang TY, 2016, PSYCHIAT INVEST, V13, P341, DOI 10.4306/pi.2016.13.3.341; Iliev AI, 2000, J PHARM PHARMACOL, V52, P1151, DOI 10.1211/0022357001774921; Ji XH, 2007, NEUROSCI LETT, V416, P92, DOI 10.1016/j.neulet.2007.01.053; Kelso ML, 2012, CURR DRUG TARGETS, V13, P631, DOI 10.2174/138945012800398964; Kelso ML, 2011, PROG MOL BIOL TRANSL, V98, P85, DOI 10.1016/B978-0-12-385506-0.00003-X; Khateb A, 2005, EUR NEUROL, V54, P39, DOI 10.1159/000087718; Kline AE, 2001, NEUROSCIENCE, V106, P547, DOI 10.1016/S0306-4522(01)00300-1; Kline AE, 2007, BEHAV BRAIN RES, V177, P186, DOI 10.1016/j.bbr.2006.11.036; Kline AE, 2016, PROG NEUROBIOL, V142, P45, DOI 10.1016/j.pneurobio.2016.05.002; Kline AE, 2012, J NEUROTRAUM, V29, P1960, DOI 10.1089/neu.2012.2385; Kline AE, 2010, J NEUROTRAUM, V27, P2021, DOI 10.1089/neu.2010.1535; Kumar A, 2011, BRAIN RES BULL, V85, P158, DOI 10.1016/j.brainresbull.2011.03.010; Leary J., 2016, J NEUROTRAUMA; Lorrio S, 2007, J PHARMACOL EXP THER, V322, P591, DOI 10.1124/jpet.107.122747; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Maelicke A, 2001, CLIN THER, V23, pA8, DOI 10.1016/S0149-2918(01)80163-6; Maelicke A, 2000, BEHAV BRAIN RES, V113, P199, DOI 10.1016/S0166-4328(00)00214-X; Matter AM, 2011, NEUROREHAB NEURAL RE, V25, P558, DOI 10.1177/1545968310397206; McAllister TW, 2016, NEUROPSYCHOPHARMACOL, V41, P1191, DOI 10.1038/npp.2015.282; Mintzer JE, 2003, INT J GERIATR PSYCH, V18, P292, DOI 10.1002/gps.826; Monaco CM, 2014, J NEUROTRAUM, V31, P1934, DOI 10.1089/neu.2014.3541; Monaco CM, 2013, EXP NEUROL, V247, P410, DOI 10.1016/j.expneurol.2013.01.007; Morey CE, 2003, BRAIN INJURY, V17, P809, DOI 10.1080/0269905031000088586; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Murdoch I, 1998, J NEUROTRAUM, V15, P295, DOI 10.1089/neu.1998.15.295; Muthuraju S, 2011, EUR J PHARMACOL, V672, P96, DOI 10.1016/j.ejphar.2011.08.023; Muthuraju S, 2011, INT J NEUROSCI, V121, P279, DOI 10.3109/00207454.2011.556279; Muthuraju S, 2010, EXP BRAIN RES, V203, P583, DOI 10.1007/s00221-010-2266-7; Muthuraju S, 2009, BEHAV BRAIN RES, V203, P1, DOI 10.1016/j.bbr.2009.03.026; Narimatsu N, 2009, J PHARMACOL EXP THER, V330, P2, DOI 10.1124/jpet.108.147280; Nikiforuk A, 2016, BEHAV BRAIN RES, V313, P214, DOI 10.1016/j.bbr.2016.07.023; Olsen AS, 2012, J NEUROTRAUM, V29, P1898, DOI 10.1089/neu.2012.2358; Passineau MJ, 2001, EXP NEUROL, V168, P373, DOI 10.1006/exnr.2000.7623; Peruzzaro ST, 2013, RESTOR NEUROL NEUROS, V31, P431, DOI 10.3233/RNN-120299; Phelps TI, 2015, J NEUROTRAUM, V32, P590, DOI 10.1089/neu.2014.3711; Pike BR, 1997, J NEUROTRAUM, V14, P897, DOI 10.1089/neu.1997.14.897; Pike BR, 1997, EXP NEUROL, V147, P55, DOI 10.1006/exnr.1997.6582; Raskind MA, 2004, ARCH NEUROL-CHICAGO, V61, P252, DOI 10.1001/archneur.61.2.252; Raskind MA, 2003, NEUROLOGIST, V9, P235, DOI 10.1097/01.nrl.0000087722.46430.c4; Reid RT, 2008, J NEURAL TRANSM, V115, P1437, DOI 10.1007/s00702-008-0107-7; SAIJA A, 1988, BRAIN RES, V452, P303, DOI 10.1016/0006-8993(88)90034-0; Samochocki M, 2003, J PHARMACOL EXP THER, V305, P1024, DOI 10.1124/jpet.102.045773; Sarter M, 2005, BRAIN RES REV, V48, P98, DOI 10.1016/j.brainresrev.2004.08.006; Scremin OU, 2006, BRAIN RES, V1124, P155, DOI 10.1016/j.brainres.2006.09.062; Scremin OU, 2012, J NEUROTRAUM, V29, P2457, DOI 10.1089/neu.2012.2465; Seltzer Ben, 2005, Expert Opin Drug Metab Toxicol, V1, P527, DOI 10.1517/17425255.1.3.527; Shaw KE, 2013, J NEUROTRAUM, V30, P557, DOI 10.1089/neu.2012.2782; Shin SS, 2015, NEURAL REGEN RES, V10, P1552, DOI 10.4103/1673-5374.165309; Shin SS, 2015, J NEUROTRAUM, V32, P1429, DOI 10.1089/neu.2014.3445; Silver JM, 2006, NEUROLOGY, V67, P748, DOI 10.1212/01.wnl.0000234062.98062.e9; Sozda CN, 2010, J NEUROTRAUM, V27, P1047, DOI 10.1089/neu.2010.1313; Svoboda Z, 2006, NEUROENDOCRINOL LETT, V27, P183; Taverni JP, 1998, BRAIN INJURY, V12, P77; Tenovuo O, 2005, PROG NEURO-PSYCHOPH, V29, P61, DOI 10.1016/j.pnpbp.2004.10.006; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Tomassoni D, 2012, CURR ALZHEIMER RES, V9, P120, DOI 10.2174/156720512799015118; Verbois SL, 2002, J NEUROTRAUM, V19, P1569, DOI 10.1089/089771502762300238; Wilcock GK, 2000, BRIT MED J, V321, P1445, DOI 10.1136/bmj.321.7274.1445; Wilkinson DG, 2004, DRUG AGING, V21, P453, DOI 10.2165/00002512-200421070-00004; Winblad B, 2001, NEUROLOGY, V57, P489, DOI 10.1212/WNL.57.3.489; Woodruff-Pak DS, 2002, CNS DRUG REV, V8, P405; Yu TS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118793; Zhang L, 2004, ARCH PHYS MED REHAB, V85, P1050, DOI 10.1016/j.apmr.2003.10.014	106	11	11	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2017	34	8					1610	1622		10.1089/neu.2016.4790			13	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	ES1ZM	WOS:000399325500013	27806662	Green Published			2021-06-18	
J	Gates, M; Mallory, G; Planchard, R; Nothdurft, G; Graffeo, C; Atkinson, J				Gates, Marcus; Mallory, Grant; Planchard, Ryan; Nothdurft, Georgia; Graffeo, Christopher; Atkinson, John			Triage Patterns of Traumatic Subarachnoid Hemorrhage: Is Referral to a Tertiary Care Center Necessary?	WORLD NEUROSURGERY			English	Article						Cost effective care; Isolated traumatic subarachnoid hemorrhage; Mild head injury	BRAIN-INJURY; CLINICAL-SIGNIFICANCE; DETERIORATION; MANAGEMENT; ADMISSION; SCORES; RISK	OBJECTIVE: Isolated traumatic subarachnoid hemorrhage (iTSAH) in mild head injuries has more evidence that triage to a tertiary care facility, intensive care unit admission, and repeat imaging is not warranted. Certain factors were identified that predict radiographic and clinical progression in hopes of preventing avoidable cost, which occur with transfer and subsequent management. METHODS: A retrospective analysis identified 67 patients transferred between January 2010 and December 2014 who met inclusion criteria. Primary outcomes assessing neurosurgical intervention, radiographic, and clinical progression were documented. Secondary outcomes included any operative intervention, length of stay, standardized hospital costs, disposition at discharge, and 30-day mortality. RESULTS: The mean age of the cohort was 67.7 +/- 16.4 years, with most patients (82.1%) having a Glasgow coma score of 15. Warfarin was used in 10 patients (14.9%), although 55.2% were on an antiplatelet or anticoagulation agent. No patient required neurosurgical intervention. One patient, on clopidogrel (Plavix) and warfarin, neurologically declined with radiographic progression. Older age seem to correlate with radiographic progression (P = 0.05). Dementia (P = 0.05) as well as warfarin use (P = 0.06) correlated with clinical progression. Cost in patients without other injuries was associated with warfarin use (P = 0.0002), injury severity scores (P = 0.01), and initial Glasgow coma score (P = 0.0003) on multivariate analysis. CONCLUSIONS: In this series of patients with mild traumatic brain injury, the rate of neurological deterioration due to expansion of iTSAH in patients is low, regardless of the use of antiplatelets/anticoagulants. Triage to a tertiary care facility generally is not warranted and can prove costly to patients with iTSAH without other injures.	[Gates, Marcus; Mallory, Grant; Planchard, Ryan; Nothdurft, Georgia; Graffeo, Christopher; Atkinson, John] Mayo Clin, Dept Neurol Surg, Rochester, MN 55905 USA	Gates, M (corresponding author), Mayo Clin, Dept Neurol Surg, Rochester, MN 55905 USA.	Gates.marcus@mayo.edu	Graffeo, Christopher S/ABE-5578-2020	Graffeo, Christopher S/0000-0001-5314-1067; Planchard, Ryan/0000-0002-7550-9843			AbdelFattah KR, 2012, J TRAUMA ACUTE CARE, V73, P685, DOI 10.1097/TA.0b013e318265ccd9; Albertine P, 2016, EMERG RADIOL, V23, P207, DOI 10.1007/s10140-016-1377-2; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Bardes JM, 2016, AM SURGEON, V82, P36; Borczuk P, 2013, J TRAUMA ACUTE CARE, V74, P1504, DOI 10.1097/TA.0b013e31829215cf; Brazinova A, 2010, J NEUROTRAUM, V27, P1549, DOI 10.1089/neu.2010.1315; Carlson AP, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.8.FOCUS10182; Chieregato A, 2005, NEUROSURGERY, V56, P671, DOI 10.1227/01.NEU.0000156200.76331.7A; Corral L, 2009, BRAIN INJURY, V23, P403, DOI 10.1080/02699050902788477; Deepika A, 2013, J HEAD TRAUMA REHAB, V28, P442, DOI 10.1097/HTR.0b013e31825e19e5; Ditty BJ, 2015, J NEUROSURG, V123, P649, DOI 10.3171/2014.10.JNS132713; Klein Y, 2010, J TRAUMA, V69, P544, DOI 10.1097/TA.0b013e3181c99936; Levy AS, 2011, J TRAUMA, V71, P1199, DOI 10.1097/TA.0b013e31822067fc; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Phelan HA, 2014, J NEUROTRAUM, V31, P1733, DOI 10.1089/neu.2014.3377; Quigley MR, 2013, J TRAUMA ACUTE CARE, V74, P581, DOI 10.1097/TA.0b013e31827d6088; Stippler M, 2012, EMERG MED J, V29, P528, DOI 10.1136/emermed-2011-200162; von der Brelie C, 2015, J TRAUMA ACUTE CARE, V79, P295, DOI 10.1097/TA.0000000000000722; Washington CW, 2012, J NEUROSURG, V116, P549, DOI 10.3171/2011.11.JNS111092	19	11	11	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	APR	2017	100						417	423		10.1016/j.wneu.2017.01.046			7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	EV7BT	WOS:000401930000054	28130166				2021-06-18	
J	Jamnia, N; Urban, JH; Stutzmann, GE; Chiren, SG; Reisenbigler, E; Marr, R; Peterson, DA; Kozlowski, DA				Jamnia, Naseem; Urban, Janice H.; Stutzmann, Grace E.; Chiren, Sarah G.; Reisenbigler, Emily; Marr, Robert; Peterson, Daniel A.; Kozlowski, Dorothy A.			A Clinically Relevant Closed-Head Model of Single and Repeat Concussive Injury in the Adult Rat Using a Controlled Cortical Impact Device	JOURNAL OF NEUROTRAUMA			English	Article						controlled cortical impact; learning and memory; locomotor function; models of brain injury; rat	TRAUMATIC BRAIN-INJURY; MOUSE MODEL; SHORT-TERM; COGNITIVE IMPAIRMENT; ANIMAL-MODEL; HIGH-SCHOOL; PITUITARY; MOTOR; MEMORY; ENCEPHALOPATHY	Repeat concussions (RC) can result in significant long-term neurological consequences and increased risk for neurodegenerative disease compared with single concussion (SC). Mechanisms underlying this difference are poorly understood and best elucidated using an animal model. To the best of our knowledge, there is no closed-head model in the adult rat using a commercially available device. We developed a novel and clinically relevant closed-head injury (CHI) model of both SC and RC in the adult rat using a controlled cortical impact (CCI) device. Adult rats received either a single or repeat CHI (three injuries, 48 h apart), and acute deficits in sensorimotor and locomotor function (foot fault; open field), memory (novel object), and anxiety (open field; corticosterone [CORT]) were measured. Assessment of cellular pathology was also conducted. Within the first week post-CHI, rats with SC or RC showed similar deficits in motor coordination, decreased locomotion, and higher resting CORT levels. Rats with an SC had memory deficits post-injury day (PID) 3 that recovered to sham levels by PID 7; however, rats with RC continued to show memory deficits. No obvious gross pathology was observed on the cortical surface or in coronal sections. Further examination showed thinning of the cortex and corpus callosum in RC animals compared with shams and increased axonal pathology in the corpus callosum of both SC and RC animals. Our data present a model of CHI that results in clinically relevant markers of concussion and an early differentiation between SC and RC.	[Jamnia, Naseem; Kozlowski, Dorothy A.] Depaul Univ, Dept Biol Sci, 2325 N Clifton Ave, Chicago, IL 60614 USA; [Urban, Janice H.] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Physiol & Biophys, N Chicago, IL USA; [Stutzmann, Grace E.; Chiren, Sarah G.; Reisenbigler, Emily; Marr, Robert; Peterson, Daniel A.] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Ctr Stem Cell & Regenerat Med, N Chicago, IL USA; [Stutzmann, Grace E.; Chiren, Sarah G.; Reisenbigler, Emily; Marr, Robert; Peterson, Daniel A.] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Neurosci, N Chicago, IL USA	Kozlowski, DA (corresponding author), Depaul Univ, Dept Biol Sci, 2325 N Clifton Ave, Chicago, IL 60614 USA.	dkozlows@depaul.edu		Jamnia, Naseem/0000-0003-4825-7764	DePaul-RFUMS Research Pilot Grant; DePaul University Research Council	The authors wish to acknowledge Sarah Scheinman, Gina DeJoseph, and Nic Kapecki for their technical support. Funding was provided by the DePaul-RFUMS Research Pilot Grant (JHU, GES, RM, DAP, DAK) and the DePaul University Research Council (NJ, DAK).	Adkins DL, 2015, NEUROREHAB NEURAL RE, V29, P989, DOI 10.1177/1545968315576577; Allen GV, 2000, NEUROSCIENCE, V99, P93, DOI 10.1016/S0306-4522(00)00185-8; Bazarian JJ, 2006, ACAD EMERG MED, V13, P199, DOI 10.1197/j.aem.2005.07.031; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; Cantu RC, 2003, CLIN SPORT MED, V22, P593, DOI 10.1016/S0278-5919(02)00095-9; CARROLL BJ, 1976, ARCH GEN PSYCHIAT, V33, P1039; Champion HR, 2009, J TRAUMA, V66, P1468, DOI 10.1097/TA.0b013e3181a27e7f; Charmandari E, 2005, ANNU REV PHYSIOL, V67, P259, DOI 10.1146/annurev.physiol.67.040403.120816; Chen YC, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00100; DeFord SM, 2002, J NEUROTRAUM, V19, P427, DOI 10.1089/08977150252932389; Dimitrov EL, 2007, ENDOCRINOLOGY, V148, P3666, DOI 10.1210/en.2006-1730; Doulames VM, 2015, FRONT BEHAV NEUROSCI, V9, DOI [10.3389/fnbeh.2015.00369, 10.3389/fnbeh.2015.00275]; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Ennaceur A, 2006, BEHAV BRAIN RES, V171, P26, DOI 10.1016/j.bbr.2006.03.016; Fujita M, 2012, J NEUROTRAUM, V29, P2172, DOI 10.1089/neu.2012.2357; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Greco T, 2013, J NEUROTRAUM, V30, P1983, DOI 10.1089/neu.2013.2990; Griesbach GS, 2011, NEUROSCIENCE, V178, P147, DOI 10.1016/j.neuroscience.2011.01.028; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Hazrati LN, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00222; HERNANDEZ TD, 1988, EXP NEUROL, V102, P318, DOI 10.1016/0014-4886(88)90226-9; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Huang L, 2013, BRAIN RES, V1499, P109, DOI 10.1016/j.brainres.2012.12.038; Hylin MJ, 2013, J NEUROTRAUM, V30, P716, DOI 10.1089/neu.2012.2717; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Karaca Z, 2016, PROG MOL BIOL TRANSL, V138, P167, DOI 10.1016/bs.pmbts.2015.10.010; KATZ RJ, 1981, NEUROSCI BIOBEHAV R, V5, P247, DOI 10.1016/0149-7634(81)90005-1; Klemenhagen KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074510; Krahulik D, 2010, J NEUROSURG, V113, P581, DOI 10.3171/2009.10.JNS09930; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Luo J, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00012; Ma HP, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004205; Maldonado MA, 2008, NEUROREHAB NEURAL RE, V22, P250, DOI 10.1177/1545968307308551; Mallya S, 2015, J NEUROTRAUM, V32, P411, DOI 10.1089/neu.2014.3504; Markel A L, 1989, Neurosci Behav Physiol, V19, P279, DOI 10.1007/BF01236015; Masel BE, 2015, J NEUROTRAUM, V32, P1902, DOI 10.1089/neu.2014.3526; Mathiasen JR., 2010, CURR PROTOC PHARM, V5, P59, DOI [10.1002/0471141755.ph0559s49, DOI 10.1002/0471141755.PH0559S49]; McCrory PR, 2000, NEUROLOGY, V54, P1488, DOI 10.1212/WNL.54.7.1488; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meziane H, 2007, GENES BRAIN BEHAV, V6, P192, DOI 10.1111/j.1601-183X.2006.00249.x; Miyauchi T, 2013, J NEUROTRAUM, V30, P1664, DOI 10.1089/neu.2013.2995; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Namjoshi DR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053529; Ojo JO, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00213; Ojo JO, 2013, J NEUROPATH EXP NEUR, V72, P137, DOI 10.1097/NEN.0b013e3182814cdf; Omalu Bennet I, 2010, J Forensic Nurs, V6, P40, DOI 10.1111/j.1939-3938.2009.01064.x; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pearce N, 2014, LANCET NEUROL, V13, P969, DOI 10.1016/S1474-4422(14)70146-2; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Petraglia Anthony L, 2014, Surg Neurol Int, V5, P184, DOI 10.4103/2152-7806.147566; Petraglia Anthony L, 2014, Neurosurgery, V75 Suppl 4, pS34, DOI 10.1227/NEU.0000000000000472; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Rowe RK, 2016, ENDOCR CONNECT, V5, P152, DOI 10.1530/EC-16-0031; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Shultz SR, 2011, BEHAV BRAIN RES, V224, P326, DOI 10.1016/j.bbr.2011.06.012; Sousa JC, 2004, J NEUROCHEM, V88, P1052, DOI 10.1046/j.1471-4159.2003.02309.x; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; Tanriverdi F, 2010, PITUITARY, V13, P146, DOI 10.1007/s11102-009-0215-x; Taylor AN, 2008, J NEUROTRAUM, V25, P311, DOI 10.1089/neu.2007.0486; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; Wall SE, 2006, J NEUROL NEUROSUR PS, V77, P518, DOI 10.1136/jnnp.2004.061044; WALSH RN, 1976, PSYCHOL BULL, V83, P482, DOI 10.1037/0033-2909.83.3.482; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xu LY, 2016, EXP NEUROL, V275, P436, DOI 10.1016/j.expneurol.2014.11.004; Yu HR, 2014, BRAIN INJURY, V28, P244, DOI 10.3109/02699052.2013.859735	67	11	12	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2017	34	7					1351	1363		10.1089/neu.2016.4517			13	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	ER0FB	WOS:000398461600006	27762651				2021-06-18	
J	Liras, IN; Caplan, HW; Stensballe, J; Wade, CE; Cox, CS; Cotton, BA				Liras, Ioannis N.; Caplan, Henry W.; Stensballe, Jakob; Wade, Charles E.; Cox, Charles S.; Cotton, Bryan A.			Prevalence and Impact of Admission Acute Traumatic Coagulopathy on Treatment Intensity, Resource Use, and Mortality: An Evaluation of 956 Severely Injured Children and Adolescents	JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS			English	Article; Proceedings Paper	128th Annual Meeting of the Southern-Surgical-Association	DEC, 2016	Palm Beach, FL	So Surg Assoc			PEDIATRIC TRAUMA; BRAIN-INJURY; RAPID THROMBELASTOGRAPHY; HEAD TRAUMA; OUTCOMES; SHOCK	BACKGROUND: Acute coagulopathy of trauma in children is of potential importance to clinical outcomes, but knowledge is limited and has only been investigated using conventional coagulation testing. The purpose of this study was to assess the prevalence and impact of arrival coagulopathy, determined by viscoelastic hemostatic testing, in severely injured children. STUDY DESIGN: Pediatric patients (younger than 17 years of age) who were admitted January 2010 to May 2016 and met highest-level trauma activation were included. Patients were divided into 2 groups (coagulopathy and controls) based on arrival rapid thrombelastography values. Coagulopathy was defined as the presence of any of the following on rapid thrombelastography: activated clotting time >= 128 seconds, alpha-angle <= 65 degrees, maximum amplitude <= 55 mm, and lysis at 30 minutes from 20-mm amplitude >= 3%. Logistic regression was used to adjust for age, sex, blood pressure, mechanism, and injury severity. RESULTS: Nine hundred and fifty-six patients met inclusion; 507 (57%) were coagulopathic and 449 (43%) were not (noncoagulopathic and control cohort). Coagulopathic patients were younger (median 14 vs 15 years) and more likely to be male (68% vs 60%) and Hispanic (38% vs 31%) (all p < 0.05). Coagulopathic patients received more RBC and plasma transfusions and had fewer ICU and ventilator-free days and higher mortality (12% vs 3%; all p < 0.05). Of these 956, 197 (21%) sustained severe brain injury-123 (62%) were coagulopathic and 74 (38%) were noncoagulopathic. The mortality difference was even greater for coagulopathic head injuries (31% vs 10%; p = 0.002). Adjusting for confounders, admission coagulopathy was an independent predictor of death, with an odds ratio of 3.67 (95% CI 1.768 to 7.632; p < 0.001). CONCLUSIONS: Almost 60% of severely injured children and adolescents arrive with evidence of acute traumatic coagulopathy. The presence of admission coagulopathy is associated with high mortality in children, especially among those with head injuries. (C) 2017 by the American College of Surgeons. Published by Elsevier Inc. All rights reserved.)	[Liras, Ioannis N.; Caplan, Henry W.; Wade, Charles E.; Cotton, Bryan A.] McGovern Med Sch, Dept Surg, Houston, TX USA; [Wade, Charles E.; Cotton, Bryan A.] Ctr Translat Injury Res, 6410 Fannin St,1100-20 UPB, Houston, TX 77030 USA; [Cox, Charles S.] McGovern Med Sch, Dept Pediat Surg, Houston, TX USA; [Cox, Charles S.] McGovern Med Sch, Ctr Surg Trials & Evidence Based Practice, Houston, TX USA; [Stensballe, Jakob] Capital Reg Blood Bank, Transfus Med Sect, Copenhagen, Denmark; [Stensballe, Jakob] Rigshosp, Copenhagen Univ Hosp, Dept Anesthesia, Ctr Head & Orthoped, Copenhagen, Denmark	Cotton, BA (corresponding author), Ctr Translat Injury Res, 6410 Fannin St,1100-20 UPB, Houston, TX 77030 USA.	bryan.a.cotton@uth.tmc.edu		Caplan, Henry/0000-0003-0012-1606			Affonseca CA, 2007, J PEDIAT-BRAZIL, V83, P274, DOI [10.1590/S0021-75572007000400014, 10.2223/JPED.1639]; Calkins CM, 2002, J TRAUMA, V53, P1058, DOI 10.1097/00005373-200212000-00005; Centers for Disease Control and Prevention, 2014, REP C TRAUM BRAIN IN; Centers for Disease Control and Prevention, 2013, 10 LEAD CAUS DEATH A; Chiaretti A, 2001, PEDIATR NEUROSURG, V34, P131, DOI 10.1159/000056008; Christiaans SC, 2014, SHOCK, V41, P476, DOI 10.1097/SHK.0000000000000151; Cohen MJ, 2013, J TRAUMA ACUTE CARE, V75, pS40, DOI 10.1097/TA.0b013e31828fa43d; Hendrickson JE, 2012, J PEDIATR-US, V160, P204, DOI 10.1016/j.jpeds.2011.08.019; Holcomb JB, 2012, ANN SURG, V256, P476, DOI 10.1097/SLA.0b013e3182658180; Hollingworth W, 2007, PEDIATR CRIT CARE ME, V8, P348, DOI 10.1097/01.PCC.0000270837.66217.3B; Imam AM, 2013, J TRAUMA ACUTE CARE, V75, P976, DOI 10.1097/TA.0b013e31829e2186; Kunitake RC, 2017, J TRAUMA ACUTE CARE, V82, P302, DOI 10.1097/TA.0000000000001313; Lao ZQ, 2012, INT J PREVENTIVE MED, V3, P303; Lee TH, 2014, J TRAUMA ACUTE CARE, V77, P67, DOI 10.1097/TA.0000000000000255; Leeper CM, 2016, J TRAUMA ACUTE CARE, V81, P34, DOI 10.1097/TA.0000000000001002; Leeper CM, 2016, J TRAUMA ACUTE CARE, V80, P711, DOI 10.1097/TA.0000000000000954; Liras IN, 2016, J TRAUMA ACUTE CARE, V80, P778, DOI 10.1097/TA.0000000000000985; Liras IN, 2015, SURGERY, V158, P812, DOI 10.1016/j.surg.2015.05.004; Maegele M, 2013, TRANSFUSION, V53, p28S, DOI 10.1111/trf.12033; Marton E, 2007, CHILD NERV SYST, V23, P873, DOI 10.1007/s00381-007-0314-9; Moore HB, 2016, J AM COLL SURGEONS, V222, P347, DOI 10.1016/j.jamcollsurg.2016.01.006; Nystrup KB, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0097-z; Patregnani JT, 2012, PEDIATR CRIT CARE ME, V13, P273, DOI 10.1097/PCC.0b013e31822f1727; Shore PM, 2006, CRIT CARE MED, V34, P1981, DOI 10.1097/01.CCM.0000220765.22184.ED; Sixta SL, 2015, J NEUROL NEUROPHYSIO, V06; Spinella PC, 2009, BLOOD REV, V23, P231, DOI 10.1016/j.blre.2009.07.003; Stensballe J, 2016, CURR OPIN CRIT CARE, V22, P591, DOI 10.1097/MCC.0000000000000359; Strumwasser A, 2016, J TRAUMA ACUTE CARE, V81, P312, DOI 10.1097/TA.0000000000001060; Suominen P, 1998, INJURY, V29, P425; White NJ, 2015, J THROMB HAEMOST, V13, P978, DOI 10.1111/jth.12919; Whittaker B, 2013, SHOCK, V39, P421, DOI 10.1097/SHK.0b013e31828e08cb	31	11	11	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1072-7515	1879-1190		J AM COLL SURGEONS	J. Am. Coll. Surg.	APR	2017	224	4					625	632		10.1016/j.jamcollsurg.2016.12.046			8	Surgery	Surgery	EW4SR	WOS:000402491700044	28131925				2021-06-18	
J	Patet, C; Quintard, H; Zerlauth, JB; Maibach, T; Carteron, L; Suys, T; Bouzat, P; Bervini, D; Levivier, M; Daniel, RT; Eckert, P; Meuli, R; Oddo, M				Patet, Camille; Quintard, Herve; Zerlauth, Jean-Baptiste; Maibach, Thomas; Carteron, Laurent; Suys, Tamarah; Bouzat, Pierre; Bervini, David; Levivier, Marc; Daniel, Roy T.; Eckert, Philippe; Meuli, Reto; Oddo, Mauro			Bedside cerebral microdialysis monitoring of delayed cerebral hypoperfusion in comatose patients with poor grade aneurysmal subarachnoid haemorrhage	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article							POSITRON-EMISSION-TOMOGRAPHY; TRAUMATIC BRAIN-INJURY; PERFUSION COMPUTED-TOMOGRAPHY; CT PERFUSION; BLOOD-FLOW; ISCHEMIA; METABOLISM	Background Delayed cerebral ischaemia (DCI) is frequent after poor grade aneurysmal subarachnoid haemorrhage (SAH). Owing to the limited accuracy of clinical examination, DCI diagnosis is often based on multimodal monitoring. We examined the value of cerebral microdialysis (CMD) in this setting. Methods 20 comatose SAH participants underwent CMD monitoring-for hourly sampling of cerebral extracellular lactate/pyruvate ratio (LPR) and glucose-and brain perfusion CT (PCT). Patients were categorised as DCI when PCT (8 +/- 3 days after SAH) showed cerebral hypoperfusion, defined as cerebral blood flow <32.5 mL/100 g/min with a mean transit time >5.7 s. Clinicians were blinded to CMD data; for the purpose of the study, only patients who developed cerebral hypoperfusion in anterior and/or middle cerebral arteries were analysed. Results DCI (n=9/20 patients) was associated with higher CMD LPR (51 +/- 36 vs 31 +/- 10 in patients without DCI, p=0.0007) and lower CMD glucose (0.64 +/- 0.34 vs 1.22 +/- 1.05, p=0.0005). In patients with DCI, CMD changes over the 18 hours preceding PCT diagnosis revealed a pattern of CMD LPR increase (coefficient +2.96 (95% CI 0.13 to 5.79), p=0.04) with simultaneous CMD glucose decrease (coefficient -0.06 (95% CI -0.08 to -0.01), p=0.03, mixed-effects multilevel regression model). No significant CMD changes were noted in patients without DCI. Conclusions In comatose patients with SAH, delayed cerebral hypoperfusion correlates with a CMD pattern of lactate increase and simultaneous glucose decrease. CMD abnormalities became apparent in the hours preceding PCT, thereby suggesting that CMD monitoring may anticipate targeted therapeutic interventions.	[Patet, Camille; Quintard, Herve; Carteron, Laurent; Suys, Tamarah; Eckert, Philippe; Oddo, Mauro] Univ Lausanne Hosp, CHUV, Dept Intens Care Med, Neurosci Crit Care Res Grp, Lausanne, Switzerland; [Quintard, Herve] Univ Hosp, Dept Anesthesia & Crit Care, Nice, France; [Zerlauth, Jean-Baptiste; Meuli, Reto] Univ Lausanne Hosp, CHUV, Dept Radiol, Lausanne, Switzerland; [Maibach, Thomas] Univ Lausanne, Lausanne, Switzerland; [Bouzat, Pierre] Univ Hosp, Dept Anesthesia & Crit Care, Grenoble, France; [Bouzat, Pierre] Neurosci Inst, Grenoble, France; [Bervini, David; Levivier, Marc; Daniel, Roy T.] Univ Lausanne Hosp, CHUV, Div Neurosurg, Clin Neurosci, Lausanne, Switzerland	Oddo, M (corresponding author), Univ Lausanne Hosp, CHUV, Dept Intens Care Med, Rue Bugnon 46, CH-1011 Lausanne, Switzerland.	mauro.oddo@chuv.ch	Bouzat, Pierre/AAC-4105-2019; Bouzat, Pierre/L-6881-2014	Bouzat, Pierre/0000-0003-4667-6738; Bervini, David/0000-0003-4873-4452	Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission [32003B_155957]; Novartis Foundation for Biomedical Research	Supported by research grants from the Swiss National Science Foundation (grant number 32003B_155957) and the Novartis Foundation for Biomedical Research (both to MO).	Binaghi S, 2007, AM J NEURORADIOL, V28, P750; Bouzat P, 2015, CRIT CARE MED, V43, P445, DOI 10.1097/CCM.0000000000000720; Budohoski KP, 2014, J NEUROL NEUROSUR PS, V85, P1343, DOI 10.1136/jnnp-2014-307711; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Cremers CHP, 2014, J CEREBR BLOOD F MET, V34, P200, DOI 10.1038/jcbfm.2013.208; Dankbaar JW, 2010, STROKE, V41, P1927, DOI 10.1161/STROKEAHA.109.574392; Dankbaar JW, 2009, STROKE, V40, P3493, DOI 10.1161/STROKEAHA.109.559013; Diringer MN, 2011, NEUROCRIT CARE, V15, P211, DOI 10.1007/s12028-011-9605-9; Enblad P, 1996, J CEREBR BLOOD F MET, V16, P637, DOI 10.1097/00004647-199607000-00014; Enblad P, 2001, STROKE, V32, P1574, DOI 10.1161/01.STR.32.7.1574; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Huang APH, 2014, J NEUROSURG, V120, P473, DOI 10.3171/2013.10.JNS13103; Hutchinson PJ, 2015, INTENS CARE MED, V41, P1517, DOI 10.1007/s00134-015-3930-y; Hutchinson PJ, 2002, J CEREBR BLOOD F MET, V22, P735, DOI 10.1097/00004647-200206000-00012; Le Roux P, 2014, NEUROCRIT CARE, V21, P297, DOI 10.1007/s12028-014-0081-x; Macdonald RL, 2014, NAT REV NEUROL, V10, P44, DOI 10.1038/nrneurol.2013.246; Oddo M, 2012, CURR OPIN CRIT CARE, V18, P111, DOI 10.1097/MCC.0b013e32835132a5; Rostami E, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00089; Sala N, 2013, J CEREBR BLOOD F MET, V33, P1815, DOI 10.1038/jcbfm.2013.142; Sanelli PC, 2011, AM J NEURORADIOL, V32, P2047, DOI 10.3174/ajnr.A2693; Sarrafzadeh AS, 2004, STROKE, V35, P638, DOI 10.1161/01.STR.0000116101.66624.F1; Sarrafzadeh AS, 2002, CRIT CARE MED, V30, P1062, DOI 10.1097/00003246-200205000-00018; Sarrafzadeh AS, 2010, J CEREBR BLOOD F MET, V30, P36, DOI 10.1038/jcbfm.2009.199; Skjoth-Rasmussen J, 2004, J NEUROSURG, V100, P8, DOI 10.3171/jns.2004.100.1.0008; Stocchetti N, 2011, NEUROCRIT CARE, V15, P324, DOI 10.1007/s12028-011-9597-5; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; Wintermark M, 2004, CRIT CARE MED, V32, P1579, DOI 10.1097/01.CCM.0000130171.08842.72	27	11	12	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	APR	2017	88	4					332	338		10.1136/jnnp-2016-313766			7	Clinical Neurology; Psychiatry; Surgery	Neurosciences & Neurology; Psychiatry; Surgery	EP8JO	WOS:000397621900011	27927702				2021-06-18	
J	Picetti, E; Caspani, ML; Iaccarino, C; Pastorello, G; Salsi, P; Viaroli, E; Servadei, F				Picetti, Edoardo; Caspani, Maria Luisa; Iaccarino, Corrado; Pastorello, Giulia; Salsi, Pierpaolo; Viaroli, Edoardo; Servadei, Franco			Intracranial pressure monitoring after primary decompressive craniectomy in traumatic brain injury: a clinical study	ACTA NEUROCHIRURGICA			English	Article						Intracranial pressure; Cerebral perfusion pressure; Monitoring; Primary decompressive craniectomy; Traumatic brain injury; Outcome	HYPERTENSION; HEMICRANIECTOMY; IMPACT; SCORE; TIME	Background Intracranial pressure (ICP) monitoring represents an important tool in the management of traumatic brain injury (TBI). Although current information exists regarding ICP monitoring in secondary decompressive craniectomy (DC), little is known after primary DC following emergency hematoma evacuation. Methods Retrospective analysis of prospectively collected data. Inclusion criteria were age >= 18 years and admission to the intensive care unit (ICU) for TBI and ICP monitoring after primary DC. Exclusion criteria were ICU length of stay (LOS) < 1 day and pregnancy. Major objectives were: (1) to analyze changes in ICP/cerebral perfusion pressure (CPP) after primary DC, (2) to evaluate the relationship between ICP/CPP and neurological outcome and (3) to characterize and evaluate ICP-driven therapies after DC. Results A total of 34 patients were enrolled. Over 308 days of ICP/CPP monitoring, 130 days with at least one episode of intracranial hypertension (26 patients, 76.5%) and 57 days with at least one episode of CPP < 60 mmHg (22 patients, 64.7%) were recorded. A statistically significant relationship was discovered between the Glasgow Outcome Scale (GOS) scores and mean post-decompression ICP (p < 0.04) and between GOS and CPP minimum (CPPmin) (p < 0.04). After DC, persisting intracranial hypertension was treated with: barbiturate coma (n = 7, 20.6%), external ventricular drain (EVD) (n = 4, 11.8%), DC diameter widening (n = 1, 2.9%) and removal of newly formed hematomas (n = 3, 8.8%). Conclusion Intracranial hypertension and/or low CPP occurs frequently after primary DC; their occurence is associated with an unfavorable neurological outcome. ICP monitoring appears useful in guiding therapy after primary DC.	[Picetti, Edoardo; Caspani, Maria Luisa] Azienda Osped Univ Parma, Serv Anestesia Rianimaz 1, Via Gramsci 14, I-43100 Parma, Italy; [Iaccarino, Corrado; Pastorello, Giulia; Viaroli, Edoardo; Servadei, Franco] Azienda Osped Univ Parma, Neurochirugia & Neurotraumatol, Parma, Italy; [Iaccarino, Corrado; Pastorello, Giulia; Viaroli, Edoardo; Servadei, Franco] Arcispedale Santa Maria Nuova Reggio Emilia, Parma, Italy; [Iaccarino, Corrado; Pastorello, Giulia; Viaroli, Edoardo; Servadei, Franco] Azienda Osped Univ Parma, Neurochirugia & Neurotraumatol, Reggio Emilia, Italy; [Iaccarino, Corrado; Pastorello, Giulia; Viaroli, Edoardo; Servadei, Franco] Arcispedale Santa Maria Nuova Reggio Emilia, Reggio Emilia, Italy; [Salsi, Pierpaolo] Arcispedale Santa Maria Nuova Reggio Emilia, Serv Anestesia & Rianimaz, Reggio Emilia, Italy	Picetti, E (corresponding author), Azienda Osped Univ Parma, Serv Anestesia Rianimaz 1, Via Gramsci 14, I-43100 Parma, Italy.	edoardopicetti@hotmail.com	Viaroli, Edoardo/AAB-1988-2021; Iaccarino, Corrado/ABE-2361-2020	Iaccarino, Corrado/0000-0002-5133-6327; Servadei, Franco/0000-0002-3595-3464			Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chesnut R, 2014, NEUROCRIT CARE, V21, P64, DOI 10.1007/s12028-014-0048-y; Chesnut RM, 2015, J NEUROTRAUM, V32, P1722, DOI 10.1089/neu.2015.3976; Chesnut RM, 2015, ANN NY ACAD SCI, V1345, P74, DOI 10.1111/nyas.12482; Chesnut RM, 2015, ANN NY ACAD SCI, V1345, P99, DOI 10.1111/nyas.12483; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; Flint AC, 2008, J NEUROTRAUM, V25, P503, DOI 10.1089/neu.2007.0442; Guiza F, 2015, INTENS CARE MED, V41, P1067, DOI 10.1007/s00134-015-3806-1; Hamilton R, 2009, IEEE ENG MED BIO, P4331, DOI 10.1109/IEMBS.2009.5332749; Huang YH, 2016, WORLD NEUROSURG, V88, P59, DOI 10.1016/j.wneu.2015.12.041; Huang YH, 2013, J NEUROTRAUM, V30, P96, DOI 10.1089/neu.2012.2563; JENNETT B, 1975, LANCET, V1, P480; Kolias AG, 2013, NAT REV NEUROL, V9, P405, DOI 10.1038/nrneurol.2013.106; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; RangeL-Castilla L, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E7; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Servadei F, 2007, CURR OPIN CRIT CARE, V13, P163, DOI 10.1097/MCC.0b013e32807f2a94; Shafi S, 2008, J TRAUMA, V64, P335, DOI 10.1097/TA.0b013e31815dd017; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Stocchetti N, 2008, INTENS CARE MED, V34, P461, DOI 10.1007/s00134-007-0948-9; Stocchetti N, 2014, ACTA NEUROCHIR, V156, P1615, DOI 10.1007/s00701-014-2127-4; Stocchetti N, 2014, NEW ENGL J MED, V370, P2121, DOI 10.1056/NEJMra1208708; TEASDALE G, 1974, LANCET, V2, P81; Vik A, 2008, J NEUROSURG, V109, P678, DOI 10.3171/JNS/2008/109/10/0678; Zeng JS, 2013, J NEUROSURG, V119, P1228, DOI 10.3171/2013.7.JNS122131	34	11	12	0	3	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	APR	2017	159	4					615	622		10.1007/s00701-017-3118-z			8	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	EQ6AP	WOS:000398164500004	28236181				2021-06-18	
J	Tasker, RC; Vonberg, FW; Ulano, ED; Akhondi-Asl, A				Tasker, Robert C.; Vonberg, Frederick W.; Ulano, Elizabeth D.; Akhondi-Asl, Alireza			Updating Evidence for Using Hypothermia in Pediatric Severe Traumatic Brain Injury: Conventional and Bayesian Meta-Analytic Perspectives	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						Bayesian analysis; meta-analysis; therapeutic hypothermia; traumatic brain injury	RANDOMIZED CONTROLLED-TRIAL; MODERATE HYPOTHERMIA; CLINICAL-TRIAL; THERAPEUTIC HYPOTHERMIA; PRIOR ELICITATION; CARDIAC-ARREST; PRIOR BELIEFS; CHILDREN; CARE; ASSOCIATION	Objective: To evaluate clinical trials of hypothermia management on outcome in pediatric patients with severe traumatic brain injury using conventional and Bayesian meta-analyses. Data Sources: Screening of PubMed and other databases to identify randomized controlled trials of hypothermia for pediatric severe traumatic brain injury published before September 2016. Study Selection: Four investigators assessed and reviewed randomized controlled trial data. Data Extraction: Details of trial design, patient number, Glasgow Coma Scale score, hypothermia and control normothermia therapy, and outcome of mortality were collated. Data Synthesis: In conventional meta-analysis, random-effects models were expressed as odds ratio (odds ratio with 95% credible-interval). Bayesian outcome probabilities were calculated as probability of odds ratio greater than or equal to 1. In seven randomized controlled trials (n = 472, patients 0-17 yr old), there was no difference in mortality (hypothermia vs normothermia) with pooled estimate 1.42 (credible-interval, 0.77-2.61; p = 0.26). Duration of hypothermia (24, 48, or 72 hr) did not show difference in mortality. (Similar results were found using poor outcome.) Bayesian analyses of randomized controlled trials ordered by time of study completed recruitment showed, after the seventh trial, chance of relative risk reduction of death by greater than 20% is 1-in-3. An optimistic belief (0.90 probability that relative risk reduction of death > 20% hypothermia vs normothermia) gives a chance of relative risk reduction of death by greater than 20% of 1-in-2. Conclusions: Conventional meta-analysis shows the null hypothesis-no difference between hypothermia versus normothermia on mortality and poor outcome-cannot be rejected. However, Bayesian meta-analysis shows chance of relative risk reduction of death greater than 20% with hypothermia versus normothermia is 1-in-3, which may be further altered by one's optimistic or skeptical belief about a patient.	[Tasker, Robert C.; Vonberg, Frederick W.; Ulano, Elizabeth D.; Akhondi-Asl, Alireza] Boston Childrens Hosp, Dept Anesthesiol Perioperat & Pain Med, Div Crit Care Med, Boston, MA 02115 USA; [Tasker, Robert C.; Vonberg, Frederick W.; Ulano, Elizabeth D.; Akhondi-Asl, Alireza] Harvard Med Sch, Boston, MA 02115 USA; [Tasker, Robert C.] Boston Childrens Hosp, Dept Neurol, Boston, MA 02115 USA	Tasker, RC (corresponding author), Boston Childrens Hosp, Dept Anesthesiol Perioperat & Pain Med, Div Crit Care Med, Boston, MA 02115 USA.; Tasker, RC (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Tasker, RC (corresponding author), Boston Childrens Hosp, Dept Neurol, Boston, MA 02115 USA.	Robert.tasker@childrens.harvard.edu	Tasker, Robert C/R-5837-2019; Akhondi-Asl, Alireza/I-3664-2018	Tasker, Robert/0000-0003-3647-8113			Adelson PD, 2013, LANCET NEUROL, V12, P546, DOI 10.1016/S1474-4422(13)70077-2; Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; Beca J, 2015, CRIT CARE MED, V43, P1458, DOI 10.1097/CCM.0000000000000947; Biswas AK, 2002, CRIT CARE MED, V30, P2742, DOI 10.1097/00003246-200212000-00020; Bourdages M, 2010, PEDIATR CRIT CARE ME, V11, P408, DOI 10.1097/PCC.0b013e3181c51dea; Boylan JF, 2011, J ROY COLL PHYS EDIN, V41, P126, DOI 10.4997/JRCPE.2011.216; CHALONER K, 1993, J ROY STAT SOC D-STA, V42, P341; Cumming G., 2013, UNDERSTANDING NEW ST; Diamond GA, 2004, J AM COLL CARDIOL, V43, P1929, DOI 10.1016/j.jacc.2004.01.035; FISER DH, 1992, J PEDIATR-US, V121, P68, DOI 10.1016/S0022-3476(05)82544-2; Fulkerson DH, 2015, J NEUROSURG-PEDIATR, V16, P410, DOI 10.3171/2015.3.PEDS14679; Georgiou AP, 2013, BRIT J ANAESTH, V110, P357, DOI 10.1093/bja/aes500; Goodman S, 2008, SEMIN HEMATOL, V45, P135, DOI 10.1053/j.seminhematol.2008.04.003; Harrell FE, 2001, INT J TECHNOL ASSESS, V17, P17, DOI 10.1017/S0266462301104034; Hedges LV, 1998, PSYCHOL METHODS, V3, P486, DOI 10.1037/1082-989X.3.4.486; Hiance A, 2009, J CLIN EPIDEMIOL, V62, P431, DOI 10.1016/j.jclinepi.2008.04.009; Higgins JPT, 2002, INT J EPIDEMIOL, V31, P96, DOI 10.1093/ije/31.1.96; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Hutchison JS, 2013, LANCET NEUROL, V12, P527, DOI 10.1016/S1474-4422(13)70058-9; JENNETT B, 1975, LANCET, V1, P480; Johnson SR, 2010, J CLIN EPIDEMIOL, V63, P355, DOI 10.1016/j.jclinepi.2009.06.003; Kalil AC, 2014, CRIT CARE MED, V42, P2267, DOI 10.1097/CCM.0000000000000576; Kalil AC, 2011, INTENS CARE MED, V37, P420, DOI 10.1007/s00134-010-2121-0; Kalil AC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002291; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Korner-Nievergelt F., 2015, BAYESIAN DATA ANAL E; Lazaridis C, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0681-2; Li H, 2009, J NEUROTRAUM, V26, P1905, DOI 10.1089/neu.2008-0828; Ma CK, 2013, CHILD NERV SYST, V29, P979, DOI 10.1007/s00381-013-2076-x; Meert KL, 2016, PEDIATR CRIT CARE ME, V17, pE543, DOI 10.1097/PCC.0000000000000969; Moatti M, 2013, CLIN TRIALS, V10, P505, DOI 10.1177/1740774513493528; Morrison LJ, 2015, CIRCULATION, V132, pS368, DOI 10.1161/CIR.0000000000000253; Pedroza C, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1480-4; Salonia R, 2010, J NEUROTRAUM, V27, P1819, DOI 10.1089/neu.2010.1402; Salpeter SR, 2009, AM J MED, V122, P1016, DOI 10.1016/j.amjmed.2009.05.021; Schoenfeld DA, 2009, CLIN TRIALS, V6, P297, DOI 10.1177/1740774509339238; See CW, 2012, OPHTHAL EPIDEMIOL, V19, P407, DOI 10.3109/09286586.2012.735332; Smith TC, 1995, STAT MED, V14, P2685, DOI 10.1002/sim.4780142408; Spiegelhalter DJ, 2004, BAYESIAN APPROACHES; Stangl D., 2000, METAANALYSIS MED HLT; Sun CQ, 2013, INVEST OPHTH VIS SCI, V54, P4167, DOI 10.1167/iovs.13-11716; Sutton AJ., 2000, METHODS METAANALYSIS; Tasker RC, 2016, PEDIATR CRIT CARE ME, V17, P789, DOI 10.1097/PCC.0000000000000799; Wasserstein RL, 2016, AM STAT, V70, P129, DOI 10.1080/00031305.2016.1154108; Zhang BF, 2015, WORLD NEUROSURG, V83, P567, DOI 10.1016/j.wneu.2014.12.010	45	11	12	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	APR	2017	18	4					355	362		10.1097/PCC.0000000000001098			8	Critical Care Medicine; Pediatrics	General & Internal Medicine; Pediatrics	ES2EJ	WOS:000399339000006	28230712				2021-06-18	
J	Rochefort, C; Walters-Stewart, C; Aglipay, M; Barrowman, N; Zemek, R; Sveistrup, H				Rochefort, Coralie; Walters-Stewart, Coren; Aglipay, Mary; Barrowman, Nick; Zemek, Roger; Sveistrup, Heidi			Balance Markers in Adolescents at 1 Month Postconcussion	ORTHOPAEDIC JOURNAL OF SPORTS MEDICINE			English	Article						concussion; balance; adolescents; center of pressure; dual task	TRAUMATIC BRAIN-INJURY; ERROR SCORING SYSTEM; POSTURAL STABILITY; PEDIATRIC CONCUSSION; FORCE PLATFORM; HEAD-INJURY; BOARD; INTERFERENCE; FREQUENCY; SYMPTOMS	Background: The Balance Error Scoring System (BESS) shows that balance tends to recover within days after a concussion, whereas measures of the movement of the center of pressure (COP) show that balance deficits can persist up to 1 month after concussion. While approximately 30% of adolescents suffering concussion have functional consequences including balance deficits, evidence of the use of different balance assessments for concussion is limited within this population. Purpose: To compare performance on a series of balance assessments between adolescents with a diagnosed concussion at 1 month postinjury and noninjured control participants within the same age distribution. Study Design: Cross-sectional study; Level of evidence, 3. Methods: Thirty-three adolescents 1 month postconcussion and 33 control participants completed the BESS followed by two, 2-minute trials standing on a Nintendo Wii Balance Board (WBB), during which the COP under their feet was recorded using 2 testing protocols: (1) double-leg stance, eyes open (EO) and (2) double-leg stance, eyes closed (EC). Participants then completed a dual-task condition (DT) with eyes open combining a double-leg stance and a Stroop color and word test while standing on the WBB. Three commonly used COP variables, anterior-posterior (A/P) and mediolateral (M/L) velocity and 95% ellipse, were computed for each condition performed on the WBB. Results: Participants postconcussion swayed over a significantly larger ellipse area compared with the control group in the EO (P = .008), EC (P = .002), and DT (P = .003) conditions and also performed the DT condition with faster COP velocity in the M/L direction (P = .007). No significant group difference was identified for BESS total score. Conclusion: At 1 month postconcussion, participants continued to demonstrate balance deficits in COP control despite scoring similar to controls on the BESS. Simple COP measures of balance may identify subtle impairments not captured by the BESS.	[Sveistrup, Heidi] Univ Ottawa, Sch Rehabil Sci, Fac Hlth Sci, 200 Lees Ave A-121, Ottawa, ON K1N 6N5, Canada; [Rochefort, Coralie; Walters-Stewart, Coren; Sveistrup, Heidi] Univ Ottawa, Sch Human Kinet, Fac Hlth Sci, 200 Lees Ave A-121, Ottawa, ON, Canada; [Aglipay, Mary; Barrowman, Nick; Zemek, Roger] Eastern Ontario Res Inst, Childrens Hosp, Ottawa, ON, Canada; [Zemek, Roger] Univ Ottawa, Dept Pediat, Fac Med, Ottawa, ON, Canada; [Zemek, Roger] Univ Ottawa, Dept Emergency Med, Fac Med, Ottawa, ON, Canada	Sveistrup, H (corresponding author), Univ Ottawa, Sch Rehabil Sci, Fac Hlth Sci, 200 Lees Ave A-121, Ottawa, ON K1N 6N5, Canada.	heidi.sveistrup@uottawa.ca	Barrowman, Nick/AAL-3166-2020; Zemek, Roger/H-1039-2018	Barrowman, Nick/0000-0002-4704-9595; 			Bartlett HL, 2014, GAIT POSTURE, V39, P224, DOI 10.1016/j.gaitpost.2013.07.010; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Broglio SP, 2005, MED SCI SPORT EXER, V37, P689, DOI 10.1249/01.MSS.0000159019.14919.09; Chang JO, 2014, CLIN J SPORT MED, V24, P256, DOI 10.1097/JSM.0000000000000016; Cifu DX, 2015, J HEAD TRAUMA REHAB, V30, P21, DOI 10.1097/HTR.0000000000000036; Clark RA, 2010, GAIT POSTURE, V31, P307, DOI 10.1016/j.gaitpost.2009.11.012; Dorman JC, 2015, J SCI MED SPORT, V18, P2, DOI 10.1016/j.jsams.2013.11.010; Duarte M, 2010, REV BRAS FISIOTER, V14, P183, DOI 10.1590/S1413-35552010000300003; Furman GR, 2013, AM J SPORT MED, V41, P1404, DOI 10.1177/0363546513484446; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Heitger MH, 2002, PROG BRAIN RES, V140, P433; Huurnink A, 2013, J BIOMECH, V46, P1392, DOI 10.1016/j.jbiomech.2013.02.018; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Lynall RC, 2015, MED SCI SPORT EXER, V47, P2487, DOI 10.1249/MSS.0000000000000716; McCrory Paul, 2013, Phys Ther Sport, V14, pe1, DOI 10.1016/j.ptsp.2013.03.002; McGuine TA, 2000, CLIN J SPORT MED, V10, P239, DOI 10.1097/00042752-200010000-00003; Pavan P, 2015, EUR J SPORT SCI, V15, P600, DOI 10.1080/17461391.2014.956801; Pietrosimone B, 2015, MED SCI SPORT EXER, V47, P2366, DOI 10.1249/MSS.0000000000000684; Piirtola M, 2006, GERONTOLOGY, V52, P1, DOI 10.1159/000089820; Powers KC, 2014, GAIT POSTURE, V39, P611, DOI 10.1016/j.gaitpost.2013.05.026; Quatman-Yates CC, 2015, PEDIATR PHYS THER, V27, P316, DOI 10.1097/PEP.0000000000000193; Rhine T, 2017, J HEAD TRAUMA REHAB, V32, pE18, DOI 10.1097/HTR.0000000000000192; Rhine TD, 2016, CLIN J SPORT MED, V26, P221, DOI 10.1097/JSM.0000000000000234; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Scoppa F, 2013, GAIT POSTURE, V37, P290, DOI 10.1016/j.gaitpost.2012.07.009; Slobounov S, 2012, CLIN NEUROPHYSIOL, V123, P1755, DOI 10.1016/j.clinph.2011.12.022; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Thiagarajan P, 2014, BRAIN INJURY, V28, P930, DOI 10.3109/02699052.2014.888761; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216	31	11	11	0	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2325-9671			ORTHOP J SPORTS MED	Orthop. J. Sports Med.	MAR 17	2017	5	3							2325967117695507	10.1177/2325967117695507			7	Orthopedics; Sport Sciences	Orthopedics; Sport Sciences	ET4XB	WOS:000400287300001	28451603	DOAJ Gold, Green Published			2021-06-18	
J	Dardiotis, E; Siokas, V; Zafeiridis, T; Paterakis, K; Tsivgoulis, G; Dardioti, M; Grigoriadis, S; Simeonidou, C; Deretzi, G; Zintzaras, E; Jagiella, J; Hadjigeorgiou, GM				Dardiotis, Efthimios; Siokas, Vasileios; Zafeiridis, Tilemachos; Paterakis, Konstantinos; Tsivgoulis, Georgios; Dardioti, Maria; Grigoriadis, Savas; Simeonidou, Constantina; Deretzi, Georgia; Zintzaras, Elias; Jagiella, Jeremiasz; Hadjigeorgiou, Georgios M.			Integrins AV and B8 Gene Polymorphisms and Risk for Intracerebral Hemorrhage in Greek and Polish Populations	NEUROMOLECULAR MEDICINE			English	Article						Integrins; ITGAV; ITGB8; Intracerebral hemorrhage; Polymorphism; Tag SNPs	SINGLE NUCLEOTIDE POLYMORPHISMS; TRAUMATIC BRAIN-INJURY; ALPHA-V INTEGRINS; ASSOCIATION; STROKE; EXPRESSION	I limited number of genetic variants have been linked to the development of intracerebral hemorrhage (ICH). I (TM) ntegrin AV and/or B8-deficient mice were found to develop ICH. The present candidate gene association study was designed to investigate possible influence of integrin AV (ITGAV) and integrin B8 (ITGB8) gene region polymorphisms on the risk of ICH. 1015 participants (250 Greek and 193 Polish patients with primary ICH and 250 Greek and 322 Polish controls) were included in the study. Using logistic regression analyses, 11 tag single nucleotide polymorphisms (SNPs) for ITGAV and 11 for ITGB8 gene were tested for associations with ICH risk, lobar ICH risk and non-lobar ICH after adjustment for age, gender, history of hypertension and country of origin. Linear regression models were used to test the effect of tag SNPs on the ICH age of onset. Correction for multiple comparisons was carried out. The rs7565633 tag SNP of the ITGAV gene was independently associated with the risk of lobar ICH in the codominant model of inheritance [odds ratio (95 % confidence interval (CI)) 0.56 (0.36-0.86), p = 0.0013]. Furthermore, heterozygous individuals of the rs10251386 and the rs10239099 of the ITGB8 gene had significantly lower age of ICH onset compared to the wild-type genotypes [regression coefficient (b) -3.884 (95 % CI -6.519, -1.249), p = 0.0039 and b = -4.502 (95 % CI -7.159, -1.845), p = 0.0009, respectively]. The present study provides preliminary indication for an influence of ITGAV gene tag SNP in the development of lobar ICH and of ITGB8 gene variants in the age of ICH onset.	[Dardiotis, Efthimios; Siokas, Vasileios; Dardioti, Maria; Hadjigeorgiou, Georgios M.] Univ Thessaly, Univ Hosp Larissa, Dept Neurol, Lab Neurogenet,Fac Med,Biopolis, Mezourlo Hill, Larisa 41100, Greece; [Zafeiridis, Tilemachos] Gen Hosp Larissa, Intens Care Unit, Larisa, Greece; [Paterakis, Konstantinos] Univ Thessaly, Univ Hosp Larissa, Dept Neurosurg, Larisa, Greece; [Tsivgoulis, Georgios] Univ Athens, Attikon Univ Hosp, Sch Med, Dept Neurol 2, Athens, Greece; [Tsivgoulis, Georgios] St Annes Univ Hosp Brno, Int Clin Res Ctr, Brno, Czech Republic; [Grigoriadis, Savas] Aristotle Univ Thessaloniki, Hippokrat Univ Hosp, Dept Neurosurg 2, Thessaloniki, Greece; [Simeonidou, Constantina] Aristotle Univ Thessaloniki, Dept Physiol, Thessaloniki, Greece; [Deretzi, Georgia] Papageorgiou Gen Hosp, Dept Neurol, Thessaloniki, Greece; [Zintzaras, Elias] Univ Thessaly, Dept Biomath, Sch Med, Larisa, Greece; [Jagiella, Jeremiasz] Jagiellonian Univ, Coll Med, Dept Neurol, Krakow, Poland	Hadjigeorgiou, GM (corresponding author), Univ Thessaly, Univ Hosp Larissa, Dept Neurol, Lab Neurogenet,Fac Med,Biopolis, Mezourlo Hill, Larisa 41100, Greece.	gmhadji@med.uth.gr	Tsivgoulis, Georgios/AAD-5360-2020; Paterakis, Konstantinos/AAH-4554-2019; Tsivgoulis, Georgios/AAD-7467-2019	Tsivgoulis, Georgios/0000-0002-0640-3797; Zafeiridis, Tilemachos/0000-0001-5020-312X; Dardiotis, Efthimios/0000-0003-2957-641X	Research Committee of the University of Thessaly, Greece [2845]	The study was supported in part by a research grant of the Research Committee of the University of Thessaly, Greece (Code: 2845).	Bader BL, 1998, CELL, V95, P507, DOI 10.1016/S0092-8674(00)81618-9; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Cox D, 2010, NAT REV DRUG DISCOV, V9, P804, DOI 10.1038/nrd3266; Dardiotis E, 2008, EUR NEUROL, V59, P307, DOI 10.1159/000121420; Dardiotis E, 2015, PHARMACOGENET GENOM, V25, P485, DOI 10.1097/FPC.0000000000000161; Dardiotis E, 2014, J NEUROTRAUM, V31, P1920, DOI 10.1089/neu.2014.3347; Dardiotis E, 2011, PHARMACOGENET GENOM, V21, P136, DOI 10.1097/FPC.0b013e328343ab15; del Zoppo GJ, 2006, ARTERIOSCL THROM VAS, V26, P1966, DOI 10.1161/01.ATV.0000232525.65682.a2; Falcone GJ, 2014, LANCET NEUROL, V13, P405, DOI 10.1016/S1474-4422(14)70029-8; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gauderman WJ, 2002, AM J EPIDEMIOL, V155, P478, DOI 10.1093/aje/155.5.478; Greenberg SM, 2002, CEREBROVASC DIS, V13, P42, DOI 10.1159/000049149; Han HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064839; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ikram MA, 2012, CURR ATHEROSCLER REP, V14, P300, DOI 10.1007/s11883-012-0252-1; Jagiella J, 2014, NEUROL NEUROCHIR POL, V48, P105, DOI 10.1016/j.pjnns.2013.12.004; Lammie GA, 2002, BRAIN PATHOL, V12, P358; Lettre G, 2007, GENET EPIDEMIOL, V31, P358, DOI 10.1002/gepi.20217; McCarty JH, 2005, DEVELOPMENT, V132, P165, DOI 10.1242/dev.01551; Mobley AK, 2009, J CELL SCI, V122, P1842, DOI 10.1242/jcs.043257; Pe'er I, 2008, GENET EPIDEMIOL, V32, P381, DOI 10.1002/gepi.20303; Proctor JM, 2005, J NEUROSCI, V25, P9940, DOI 10.1523/JNEUROSCI.3467-05.2005; Qureshi AI, 2001, NEW ENGL J MED, V344, P1450, DOI 10.1056/NEJM200105103441907; Rost NS, 2008, STROKE, V39, P2166, DOI 10.1161/STROKEAHA.107.501650; Sacco RL, 2000, NEW ENGL J MED, V342, P276, DOI 10.1056/NEJM200001273420410; Saharinen P, 2015, EMBO J, V34, P1293, DOI 10.15252/embj.201591504; Sawcer S, 2014, LANCET NEUROL, V13, P700, DOI 10.1016/S1474-4422(14)70041-9; Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268; Su H, 2010, AM J PATHOL, V176, P1018, DOI 10.2353/ajpath.2010.090453; Wang QW, 2008, NEUROBIOL AGING, V29, P1485, DOI 10.1016/j.neurobiolaging.2007.03.018; Woo D, 2002, STROKE, V33, P1190, DOI 10.1161/01.STR.0000014774.88027.22; Yamada Y, 2006, ARTERIOSCL THROM VAS, V26, P1920, DOI 10.1161/01.ATV.0000229694.97827.38; Zhu JW, 2002, DEVELOPMENT, V129, P2891; Ziegler A, 2011, BREAST CANCER RES TR, V128, P197, DOI 10.1007/s10549-010-1295-z	35	11	11	0	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1535-1084	1559-1174		NEUROMOL MED	Neuromol. Med.	MAR	2017	19	1					69	80		10.1007/s12017-016-8429-3			12	Neurosciences	Neurosciences & Neurology	EN5EX	WOS:000396029500007	27476161				2021-06-18	
J	Lamanna, JJ; Urquia, LN; Hurtig, CV; Gutierrez, J; Anderson, C; Piferi, P; Federici, T; Oshinski, JN; Boulis, NM				Lamanna, Jason J.; Urquia, Lindsey N.; Hurtig, Carl V.; Gutierrez, Juanmarco; Anderson, Cody; Piferi, Pete; Federici, Thais; Oshinski, John N.; Boulis, Nicholas M.			Magnetic Resonance Imaging-Guided Transplantation of Neural Stem Cells into the Porcine Spinal Cord	STEREOTACTIC AND FUNCTIONAL NEUROSURGERY			English	Article						Image-guided neurosurgery; Interventional magnetic resonance imaging; Magnetic resonance imaging; Percutaneous transplantation; Spinal cord; Stereotactic techniques; Targeting; Cell therapy; Molecular imaging; Swine	AMYOTROPHIC-LATERAL-SCLEROSIS; PERCUTANEOUS SELECTIVE CORDOTOMY; PHASE-I; THERAPEUTICS DELIVERY; PROGENITOR CELLS; SAFETY OUTCOMES; RAT MODEL; TRIAL; INJURY; BRAIN	Background: Cell-based therapies are a promising treatment option for traumatic, tumorigenic and degenerative diseases of the spinal cord. Transplantation into the spinal cord is achieved with intravascular, intrathecal, or direct intraparenchymal injection. The current standard for direct injection is limited by surgical invasiveness, difficulty in reinjection, and the inability to directly target anatomical or pathological landmarks. The objective of this study was to present the proof of principle for minimally invasive, percutaneous transplantation of stem cells into the spinal cord parenchyma of live minipigs under MR guidance. Methods: An MR-compatible spine injection platform was developed to work with the ClearPoint SmartFrame system (MRI Interventions Inc.). The system was attached to the spine of 2 live minipigs, a percutaneous injection cannula was advanced into the spinal cord under MR guidance, and cells were delivered to the cord. Results: A graft of 2.5 x 10(6) human (n = 1) or porcine (n = 1) neural stem cells labeled with ferumoxytol nanoparticles was transplanted into the ventral horn of the spinal cord with MR guidance in 2 animals. Graft delivery was visualized with postprocedure MRI, and characteristic iron precipitates were identified in the spinal cord by Prussian blue histochemistry. Grafted stem cells were observed in the spinal cord of the pig injected with porcine neural stem cells. No postoperative morbidity was observed in either animal. Conclusion: This report supports the proof of principle for transplantation and visualization of pharmacological or biological agents into the spinal cord of a large animal under the guidance of MRI. (C) 2017 S. Karger AG, Basel	[Lamanna, Jason J.; Urquia, Lindsey N.; Hurtig, Carl V.; Gutierrez, Juanmarco; Federici, Thais; Boulis, Nicholas M.] Georgia Inst Technol, Sch Med, Dept Neurosurg, Atlanta, GA 30332 USA; [Oshinski, John N.] Georgia Inst Technol, Sch Med, Dept Radiol & Imaging Sci, Atlanta, GA 30332 USA; [Lamanna, Jason J.; Oshinski, John N.; Boulis, Nicholas M.] Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA; [Lamanna, Jason J.; Oshinski, John N.; Boulis, Nicholas M.] Emory Univ, Atlanta, GA 30322 USA; [Anderson, Cody] Emory Univ, Dept Phys, Atlanta, GA 30322 USA; [Piferi, Pete] MRI Intervent Inc, Irvine, CA USA	Boulis, NM (corresponding author), 101 Woodruff Circle,Room 6339, Atlanta, GA 30322 USA.	nboulis@emory.edu			National Center for Advancing Translational Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000454]; John and Mary Brock Discovery Fund; Atlanta Clinical and Translational Science Institute; Amyotrophic Lateral Sclerosis Association; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM008169] Funding Source: NIH RePORTER	The Atlanta Clinical and Translational Science Institute, the John and Mary Brock Discovery Fund, and the Amyotrophic Lateral Sclerosis Association supported this work. It was also supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award No. UL1TR000454. We thank the Emory University Division of Animal Resources for veterinary care.	Barczewska M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074658; Blanquer M, 2012, STEM CELLS, V30, P1277, DOI 10.1002/stem.1080; Castaneda RT, 2011, JOVE-J VIS EXP, DOI 10.3791/3482; Chhabra V, 2010, J NEUROSURG, V112, P497, DOI 10.3171/2009.7.JNS09572; Chung WH, 2013, J VET SCI, V14, P495, DOI 10.4142/jvs.2013.14.4.495; Duprez TP, 2008, AM J NEURORADIOL, V29, P1991, DOI 10.3174/ajnr.A1134; Ebert Allison D, 2008, Curr Protoc Stem Cell Biol, VChapter 2, DOI 10.1002/9780470151808.sc02d02s6; Federici T, 2012, JOVE-J VIS EXP, DOI 10.3791/4371; Fritz J, 2012, AM J ROENTGENOL, V198, pW266, DOI 10.2214/AJR.11.6918; Fritz J, 2009, AM J ROENTGENOL, V192, pW161, DOI 10.2214/AJR.08.1569; Gowing G, 2014, NEUROREPORT, V25, P367, DOI 10.1097/WNR.0000000000000092; Guest J, 2011, BRAIN RES BULL, V84, P267, DOI 10.1016/j.brainresbull.2010.11.007; Jones LAT, 2010, SPINAL CORD, V48, P798, DOI 10.1038/sc.2010.29; Kanpolat Y, 2002, ACTA NEUROCHIR, V144, P595, DOI 10.1007/s00701-002-0945-2; KANPOLAT Y, 1993, ACTA NEUROCHIR, V123, P92, DOI 10.1007/BF01476292; Klein SM, 2005, HUM GENE THER, V16, P509, DOI 10.1089/hum.2005.16.509; Knoller N, 2005, J NEUROSURG-SPINE, V3, P173, DOI 10.3171/spi.2005.3.3.0173; Lamanna JJ, 2013, THER DELIV, V4, P1397, DOI [10.4155/TDE.13.111, 10.4155/tde.13.111]; Lammertse DP, 2012, SPINAL CORD, V50, P661, DOI 10.1038/sc.2012.39; Larson PS, 2012, NEUROSURGERY, V70, DOI 10.1227/NEU.0b013e31822f4a91; Lee JH, 2009, J NEUROSURG-SPINE, V11, P749, DOI 10.3171/2009.6.SPINE08710; Liu M, 2015, J MAGN RESON IMAGING, V42, P1740, DOI 10.1002/jmri.24924; Martin AJ, 2005, MAGN RESON MED, V54, P1107, DOI 10.1002/mrm.20675; Mazzini L, 2003, AMYOTROPH LATERAL SC, V4, P158, DOI 10.1080/14660820310014653; Mazzini L, 2010, EXP NEUROL, V223, P229, DOI 10.1016/j.expneurol.2009.08.007; Mazzini L, 2012, CYTOTHERAPY, V14, P56, DOI 10.3109/14653249.2011.613929; McGirt MJ, 2002, STEREOT FUNCT NEUROS, V78, P53, DOI 10.1159/000068012; Netuka D, 2011, J NEUROSURG-SPINE, V14, P754, DOI 10.3171/2011.2.SPINE10715; Raore B, 2011, SPINE, V36, pE164, DOI 10.1097/BRS.0b013e3181d77a47; Richardson RM, 2011, STEREOT FUNCT NEUROS, V89, P141, DOI 10.1159/000323544; Riley J, 2008, STEREOT FUNCT NEUROS, V86, P67, DOI 10.1159/000112426; Riley J, 2014, NEUROSURGERY, V74, P77, DOI 10.1227/NEU.0000000000000156; Riley J, 2012, NEUROSURGERY, V71, P405, DOI 10.1227/NEU.0b013e31825ca05f; Riley J, 2009, NEUROSURGERY, V65, P754, DOI 10.1227/01.NEU.0000343524.45387.9E; Starr PA, 2010, J NEUROSURG, V112, P479, DOI 10.3171/2009.6.JNS081161; Suzuki M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000689; TARLOV IM, 1954, AMA ARCH NEUROL PSY, V71, P271, DOI 10.1001/archneurpsyc.1954.02320390001001; Thu MS, 2012, NAT MED, V18, P463, DOI 10.1038/nm.2666	38	11	11	0	5	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1011-6125	1423-0372		STEREOT FUNCT NEUROS	Stereotact. Funct. Neurosurg.	MAR	2017	95	1					60	68		10.1159/000448765			9	Neurosciences; Neuroimaging; Surgery	Neurosciences & Neurology; Surgery	EN2EK	WOS:000395822200010	28132063	Green Accepted, Bronze			2021-06-18	
J	Markos, SM; Failla, MD; Ritter, AC; Dixon, CE; Conley, YP; Ricker, JH; Arenth, PM; Juengst, SB; Wagner, AK				Markos, Steven M.; Failla, Michelle D.; Ritter, Anne C.; Dixon, C. Edward; Conley, Yvette P.; Ricker, Joseph H.; Arenth, Patricia M.; Juengst, Shannon B.; Wagner, Amy K.			Genetic Variation in the Vesicular Monoamine Transporter: Preliminary Associations With Cognitive Outcomes After Severe Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						cognition; depression; genetic polymorphism; traumatic brain injury; vesicular monoamine transporter type 2 (VMAT2); Rehabilomics	SEVERE TBI; GENDER-DIFFERENCES; DOPAMINE LEVELS; OLDER-ADULTS; DEPRESSION; VALIDITY; VMAT2; RECOVERY; MODERATE; VARIANTS	Introduction: Traumatic brain injury (TBI) frequently results in impaired cognition, a function that can be modulated by monoaminergic signaling. Genetic variation among monoaminergic genes may affect post-TBI cognitive performance. The vesicular monoamine transporter-2 (VMAT2) gene may be a novel source of genetic variation important for cognitive outcomes post-TBI given VMAT2's role in monoaminergic neurotransmission. Objective: To evaluate associations between VMAT2 variability and cognitive outcomes post-TBI. Methods: We evaluated 136 white adults with severe TBI for variation in VMAT2 using a tagging single nucleotide polymorphism (tSNP) approach (rs363223, rs363226, rs363251, and rs363341). We show genetic variation interacts with assessed cognitive impairment (cognitive composite [ Comp-Cog] T-scores) to influence functional cognition (functional independence measure cognitive [FIM-Cog] subscale] 6 and 12 months postinjury. Results: Multivariate analyses at 6 months postinjury showed rs363226 genotype was associated with Comp-Cog (P = .040) and interacted with Comp-Cog to influence functional cognition (P < .001). G-homozygotes had the largest cognitive impairment, and their cognitive impairment had the greatest adverse effect on functional cognition. Discussion: We provide the first evidence that genetic variation within VMAT2 is associated with cognitive outcomes after TBI. Further work is needed to validate this finding and elucidate mechanisms by which genetic variation affects monoaminergic signaling, mediating differences in cognitive outcomes.	[Markos, Steven M.; Failla, Michelle D.; Ritter, Anne C.; Dixon, C. Edward; Arenth, Patricia M.; Juengst, Shannon B.; Wagner, Amy K.] Univ Pittsburgh, Sch Med, Dept Phys Med & Rehabil, Pittsburgh, PA USA; [Wagner, Amy K.] Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA USA; [Dixon, C. Edward; Wagner, Amy K.] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15260 USA; [Dixon, C. Edward; Wagner, Amy K.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA USA; [Dixon, C. Edward] Pittsburgh VA Healthcare Syst, Pittsburgh, PA USA; [Dixon, C. Edward] Univ Pittsburgh, Sch Med, Dept Neurol Surg, Pittsburgh, PA 15261 USA; [Ricker, Joseph H.] NYU, Sch Med, Dept Rehabil Med, New York, NY USA; [Conley, Yvette P.] Univ Pittsburgh, Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15260 USA; [Conley, Yvette P.] Univ Pittsburgh, Sch Nursing, Hlth Promot & Dev, Pittsburgh, PA 15261 USA	Wagner, AK (corresponding author), Univ Pittsburgh, Phys Med & Rehabil, 3471 Fifth Ave,Ste 202, Pittsburgh, PA 15213 USA.	wagnerak@upmc.edu	Juengst, Shannon B/AAC-5891-2019; Failla, Michelle/AAI-3788-2021	Failla, Michelle/0000-0001-9734-3373; Conley, Yvette/0000-0002-1784-6067; Juengst, Shannon/0000-0003-4709-545X; Ricker, Joseph/0000-0003-3415-991X	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5T35AT005933-02, R01 HD048162-02, R01NR008424, 5P01NS030318-16]; NIDILRRUnited States Department of Health & Human Services [90DP0041]; DODUnited States Department of Defense [W81XWH-071-0701]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD048162] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine [T35AT005933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS030318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01NR008424] Funding Source: NIH RePORTER	The project described was supported by NIH 5T35AT005933-02, NIH R01 HD048162-02, NIH R01NR008424, NIH 5P01NS030318-16, NIDILRR 90DP0041, and DOD W81XWH-071-0701. The authors thank the UPMC Trauma Registry for their support with some elements of data collection.	Alderman N, 2003, J INT NEUROPSYCH SOC, V9, P31, DOI 10.1017/S1355617703910046; Andersson S, 2002, NEUROPSY NEUROPSY BE, V15, P184, DOI 10.1097/01.WNN.0000026596.88167.8E; Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; BARON JC, 1985, NEUROLOGY, V35, P16, DOI 10.1212/WNL.35.1.16; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bell KR, 2005, ARCH PHYS MED REHAB, V86, P851, DOI 10.1016/j.apmr.2004.09.015; Blasi G, 2005, J NEUROSCI, V25, P5038, DOI 10.1523/JNEUROSCI.0476-05.2005; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; BORKOWSKI JG, 1967, NEUROPSYCHOLOGIA, V5, P135, DOI 10.1016/0028-3932(67)90015-2; BORNSTEIN RA, 1989, J NEUROSURG, V70, P509, DOI 10.3171/jns.1989.70.4.0509; Brighina L, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2012.12.020; Brown SB, 2012, HEALTH CARE WOMEN IN, V33, P896, DOI 10.1080/07399332.2012.673654; Bushnik T, 2008, J HEAD TRAUMA REHAB, V23, P25, DOI 10.1097/01.HTR.0000308718.88214.bb; Cartier EA, 2010, J BIOL CHEM, V285, P1957, DOI 10.1074/jbc.M109.054510; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; Comings DE, 2000, MOL GENET METAB, V71, P19, DOI 10.1006/mgme.2000.3015; Cristofori Irene, 2015, Handb Clin Neurol, V128, P579, DOI 10.1016/B978-0-444-63521-1.00037-6; Crownover J, 2012, CURR GERIATR REP, V1, P149, DOI 10.1007/s13670-012-0021-6; Cruz-Muros I, 2008, NEUROBIOL AGING, V29, P1702, DOI 10.1016/j.neurobiolaging.2007.04.003; Darrah SD, 2013, EPILEPSY RES, V103, P180, DOI 10.1016/j.eplepsyres.2012.07.006; Davidson J, 2015, NEUROSCIENTIST, V21, P424, DOI 10.1177/1073858414543150; Dawson JD, 2010, J AM GERIATR SOC, V58, P1090, DOI 10.1111/j.1532-5415.2010.02872.x; Delis DC, 2000, CALIFORNIA VERBAL LE; Donnemiller E, 2000, EUR J NUCL MED, V27, P1410, DOI 10.1007/s002590000308; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Eiden LE, 2011, ANN NY ACAD SCI, V1216, P86, DOI 10.1111/j.1749-6632.2010.05906.x; Erickson JD, 1996, P NATL ACAD SCI USA, V93, P5166, DOI 10.1073/pnas.93.10.5166; Failla MD, J HEAD TRAU IN PRESS; Failla MD, 2013, BRAIN INJURY, V27, P696, DOI 10.3109/02699052.2013.775481; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Farace E, 2000, Neurosurg Focus, V8, pe6; Fehr C, 2013, J NEURAL TRANSM, V120, P1161, DOI 10.1007/s00702-013-0996-y; Gao WM, 2006, BRAIN RES, V1070, P31, DOI 10.1016/j.brainres.2005.11.038; GFELLER JD, 1994, HEADACHE, V34, P503, DOI 10.1111/j.1526-4610.1994.hed3409503.x; Glatt CE, 2006, HUM MOL GENET, V15, P299, DOI 10.1093/hmg/ddi445; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS16, DOI 10.1016/j.apmr.2008.09.551; Hanson GR, 2004, ANN NY ACAD SCI, V1025, P146, DOI 10.1196/annals.1316.019; Hart T, 2012, ARCH PHYS MED REHAB, V93, P1343, DOI 10.1016/j.apmr.2012.03.036; Henry JM, 1997, J INVEST SURG, V10, P281, DOI 10.3109/08941939709032167; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Kim ST, 2005, J NEUROCHEM, V95, P89, DOI 10.1111/j.1471-4159.2005.03342.x; Kramer UM, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-150; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LARRABEE GJ, 1995, J CLIN EXP NEUROPSYC, V17, P536, DOI 10.1080/01688639508405144; Larson EB, 2010, J HEAD TRAUMA REHAB, V25, P61, DOI 10.1097/HTR.0b013e3181c1d1e1; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Lin ZC, 2005, HUM MOL GENET, V14, P1393, DOI 10.1093/hmg/ddi148; Lin ZC, 2010, FASEB J, V24, P2191, DOI 10.1096/fj.09-140368; Marshall S, 2012, CAN FAM PHYSICIAN, V58, P257; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Myrga JM, 2016, J HEAD TRAUMA REHAB, V31, pE15, DOI 10.1097/HTR.0000000000000199; Narendran R, 2012, AM J PSYCHIAT, V169, P55, DOI 10.1176/appi.ajp.2011.11010126; NCBI, RS3632260 NCBI; Nelson DW, 2012, J NEUROTRAUM, V29, P2613, DOI 10.1089/neu.2012.2468; Nomura M, 2006, PSYCHOPHARMACOLOGY, V187, P30, DOI 10.1007/s00213-006-0398-z; Olsen AS, 2012, J NEUROTRAUM, V29, P1898, DOI 10.1089/neu.2012.2358; Pedroli E, 2013, STUD HEALTH TECHNOL, V191, P38, DOI 10.3233/978-1-61499-282-0-38; Ponsford J, 2013, NEUROREHABILITATION, V32, P803, DOI 10.3233/NRE-130904; Ponsford JL, 2008, INJURY, V39, P67, DOI 10.1016/j.injury.2007.08.028; Rapoport MJ, 2005, J NEUROPSYCH CLIN N, V17, P61, DOI 10.1176/appi.neuropsych.17.1.61; Reitan RM., 1985, HALSTEAD REITAN NEUR; Renner C, 2012, BRAIN INJURY, V26, P1360, DOI 10.3109/02699052.2012.667592; Ruhe HG, 2007, MOL PSYCHIATR, V12, P331, DOI 10.1038/sj.mp.4001949; Sager JJ, 2011, BIOCHEMISTRY-US, V50, P7295, DOI 10.1021/bi200405c; Satz P, 1998, BRAIN INJURY, V12, P537, DOI 10.1080/026990598122313; SEEMAN P, 1978, FED PROC, V37, P130; Stefanis NC, 2005, AM J PSYCHIAT, V162, P1752, DOI 10.1176/appi.ajp.162.9.1752; Stelzel C, 2010, J NEUROSCI, V30, P14205, DOI 10.1523/JNEUROSCI.1062-10.2010; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Trenerry M.R., 1989, STROOP NEUROPSYCHOLO; Udekwu P, 2004, J TRAUMA, V56, P1084, DOI 10.1097/01.TA.0000124283.02605.A5; Utomo WK, 2009, INJURY, V40, P973, DOI 10.1016/j.injury.2009.05.034; van Veelen NMJ, 2010, SCHIZOPHR RES, V120, P191, DOI 10.1016/j.schres.2010.04.011; Vergo S, 2007, BRAIN RES, V1185, P18, DOI 10.1016/j.brainres.2007.09.028; Wagner AK, 2010, EUR J PHYS REHAB MED, V46, P549; Wagner AK, 2000, AM J PHYS MED REHAB, V79, P235, DOI 10.1097/00002060-200005000-00004; Wagner AK, 2000, J TRAUMA, V49, P411, DOI 10.1097/00005373-200009000-00005; Wagner AK, 2007, J NEUROSURG, V106, P538, DOI 10.3171/jns.2007.106.4.538; Wagner AK, 2014, J CEREBR BLOOD F MET, V34, P1328, DOI 10.1038/jcbfm.2014.87; Wagner AK, 2012, BRAIN INJURY, V26, P1226, DOI 10.3109/02699052.2012.667594; Wagner AK, 2011, J CEREBR BLOOD F MET, V31, P1886, DOI 10.1038/jcbfm.2011.31; Wagner AK, 2011, J NEUROTRAUM, V28, P871, DOI 10.1089/neu.2010.1586; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Wimalasena K, 2011, MED RES REV, V31, P483, DOI 10.1002/med.20187; Yan HQ, 2001, NEUROREPORT, V12, P2323, DOI 10.1097/00001756-200108080-00009; Yang XL, 2015, PARKINSONS DIS-US, V2015, DOI 10.1155/2015/903164; Zai CC, 2013, J PSYCHIATR RES, V47, P1760, DOI 10.1016/j.jpsychires.2013.07.025	92	11	11	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2017	32	2					E24	E34		10.1097/HTR.0000000000000224			11	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	EN3YU	WOS:000395944700004	26828714	Green Accepted			2021-06-18	
J	Min, J; Moon, WJ; Jeon, JY; Choi, JW; Moon, YS; Han, SH				Min, Jeeyoung; Moon, Won-Jin; Jeon, Ji Young; Choi, Jin Woo; Moon, Yeon-Sil; Han, Seol-Heui			Diagnostic Efficacy of Structural MRI in Patients With Mild-toModerate Alzheimer Disease: Automated Volumetric Assessment Versus Visual Assessment	AMERICAN JOURNAL OF ROENTGENOLOGY			English	Article						Alzheimer disease; medial temporal lobe; MRI; quantitative; Scheltens scale; volumetry	TRAUMATIC BRAIN-INJURY; MEDIAL TEMPORAL ATROPHY; HIPPOCAMPAL ATROPHY; RADIOLOGISTS INTERPRETATIONS; COGNITIVE IMPAIRMENT; LOBE; NEUROQUANT(R); ASSOCIATION; FREESURFER; DEMENTIA	OBJECTIVE. The purpose of this study was to compare the diagnostic efficacies of an automated volumetric assessment tool and visual assessment in the evaluation of medial temporal lobar atrophy in mild-to-moderate Alzheimer disease (AD). MATERIALS AND METHODS. This retrospective study included 30 patients with mild-to-moderate AD and 25 age-matched healthy control subjects undergoing MRI with a 3D fast spoiled gradient recalled-echo sequence at 3 T. The images were processed with fully automated volumetric analysis software. To assess medial temporal lobe (MTL) atrophy, two MTL indexes, which took into account the volumes of the hippocampus and the inferior lateral ventricle, were calculated with the automated volumetric assessment software. In addition, two neuroradiologists assessed MTL atrophy visually using the Scheltens scale. ROC curve analysis was used to compare the diagnostic performances of the two methods. The weighted kappa statistic was used to assess the intrarater and interrater reliability of visual inspection. RESULTS. The automated volumetric assessment tool had moderate sensitivity (63.3%) and high specificity (100%) in differentiating patients with mild-to-moderate AD from control subjects. Visual inspection showed sensitivity of 63.3% and specificity of 92.0%. The diagnostic performance was not significantly different between the two methods (p = 0.536-0.906). Intraobserver reliability for visual inspection was 0.858 and 0.902 for the two reviewers, and interobserver reliability was 0.692-0.780. CONCLUSION. Both the automated volumetric assessment tool and visual inspection can be used to evaluate MTL atrophy and differentiate patients with AD from healthy individuals with good diagnostic accuracy. Thus, the automated tool can be a useful and efficient adjunct in clinical practice for evaluating MTL atrophy in the diagnosis of AD.	[Min, Jeeyoung; Moon, Won-Jin; Jeon, Ji Young; Choi, Jin Woo] Konkuk Univ, Med Ctr, Dept Radiol, Sch Med, 120-1 Neungdong Ro, Seoul 05030, South Korea; [Jeon, Ji Young] Gachon Univ, Gil Med Ctr, Dept Radiol, Incheon, South Korea; [Moon, Yeon-Sil; Han, Seol-Heui] Konkuk Univ, Dept Neurol, Sch Med, Seoul, South Korea	Moon, WJ (corresponding author), Konkuk Univ, Med Ctr, Dept Radiol, Sch Med, 120-1 Neungdong Ro, Seoul 05030, South Korea.	mdmoonwj@kuh.ac.kr		Choi, Jin Woo/0000-0002-0716-5137; Moon, Won-Jin/0000-0002-8925-7376	Korean Health Technology RD; Ministry of Health & Welfare, Republic of KoreaMinistry of Health & Welfare, Republic of Korea [HI12C0713]; Samsung Electronics, Suwon, Republic of Korea	Supported by a Korean Health Technology R& D Project Grant from the Ministry of Health & Welfare, Republic of Korea ( HI12C0713) and by Samsung Electronics, Suwon, Republic of Korea.	Azab M, 2015, AM J NEURORADIOL, V36, P1400, DOI 10.3174/ajnr.A4313; Bastos-Leite AJ, 2006, AM J NEURORADIOL, V27, P2141; Boutet C, 2012, NEURORADIOLOGY, V54, P1321, DOI 10.1007/s00234-012-1058-0; Brewer JB, 2009, AM J NEURORADIOL, V30, P578, DOI 10.3174/ajnr.A1402; Cavallin L, 2012, ACTA RADIOL, V53, P318, DOI 10.1258/ar.2012.110552; Chee MWL, 2011, J COGNITIVE NEUROSCI, V23, P1065, DOI 10.1162/jocn.2010.21513; DeCarli C, 2007, ARCH NEUROL-CHICAGO, V64, P108, DOI 10.1001/archneur.64.1.108; Desikan RS, 2013, AM J NEURORADIOL, V34, P2075, DOI 10.3174/ajnr.A3644; Farid N, 2012, RADIOLOGY, V264, P542, DOI 10.1148/radiol.12112638; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frisoni GB, 2013, NEUROLOGY, V81, P487, DOI 10.1212/WNL.0b013e31829d86e8; Galluzzi S, 2008, DEMENT GERIATR COGN, V26, P314, DOI 10.1159/000161056; Giorgio A, 2013, J MAGN RESON IMAGING, V37, P1, DOI 10.1002/jmri.23671; Jack CR, 2012, RADIOLOGY, V263, P343, DOI 10.1148/radiol.12110433; Kundel HL, 2003, RADIOLOGY, V228, P303, DOI 10.1148/radiol.2282011860; Lee JS, 2005, J KOREAN MED SCI, V20, P483, DOI 10.3346/jkms.2005.20.3.483; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Moon WJ, 2012, KOREAN J RADIOL, V13, P674, DOI 10.3348/kjr.2012.13.6.674; Ochs AL, 2015, J NEUROIMAGING, V25, P721, DOI 10.1111/jon.12229; Ross DE, 2015, J NEUROPSYCH CLIN N, V27, P147, DOI 10.1176/appi.neuropsych.13040088; Ross DE, 2013, BRAIN INJURY, V27, P634, DOI 10.3109/02699052.2013.767939; Ross DE, 2013, J NEUROPSYCH CLIN N, V25, P32, DOI 10.1176/appi.neuropsych.11120377; SCHELTENS P, 1992, J NEUROL NEUROSUR PS, V55, P967, DOI 10.1136/jnnp.55.10.967; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Tae WS, 2008, NEURORADIOLOGY, V50, P569, DOI 10.1007/s00234-008-0383-9; Urs R, 2009, J COMPUT ASSIST TOMO, V33, P73, DOI 10.1097/RCT.0b013e31816373d8; VERMERSCH P, 1994, J NEUROL NEUROSUR PS, V57, P1015, DOI 10.1136/jnnp.57.8.1015; Wahlund LO, 2000, J NEUROL NEUROSUR PS, V69, P630, DOI 10.1136/jnnp.69.5.630; Wattjes MP, 2009, RADIOLOGY, V253, P174, DOI 10.1148/radiol.2531082262	29	11	12	0	8	AMER ROENTGEN RAY SOC	RESTON	1891 PRESTON WHITE DR, SUBSCRIPTION FULFILLMENT, RESTON, VA 22091 USA	0361-803X	1546-3141		AM J ROENTGENOL	Am. J. Roentgenol.	MAR	2017	208	3					617	623		10.2214/AJR.16.16894			7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	EL4MT	WOS:000394596000033	28075620				2021-06-18	
J	Rhea, CK; Kuznetsov, NA; Ross, SE; Long, B; Jakiela, JT; Bailie, JM; Yanagi, MA; Haran, J; Wright, WG; Robins, RK; Sargent, PD; Duckworth, JL				Rhea, Christopher K.; Kuznetsov, Nikita A.; Ross, Scott E.; Long, Benjamin; Jakiela, Jason T.; Bailie, Jason M.; Yanagi, Matthew A.; Haran, Jay; Wright, W. Geoffrey; Robins, Rebecca K.; Sargent, Paul D.; Duckworth, Joshua L.			Development of a Portable Tool for Screening Neuromotor Sequelae From Repetitive Low-Level Blast Exposure	MILITARY MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; NEUROCOGNITIVE ASSESSMENT-TOOL; SUBCONCUSSIVE HEAD TRAUMA; INTERPRETING CHANGE; FOOTBALL PLAYERS; CONCUSSION; GAIT; DYNAMICS; DEFICITS; DEFENSE	Blast exposure is a prevalent cause of mild traumatic brain injury (mTBI) in military personnel in combat. However, it is more common for a service member to be exposed to a low-level blast (LLB) that does not result in a clinically diagnosable mTBI. Recent research suggests that repetitive LLB exposure can result in symptomology similar to symptoms observed after mTBI. This manuscript reports on the use of an Android-based smartphone application (AccWalker app) to capture changes in neuromotor functioning after blast exposure. Active duty U.S. Navy personnel (N = 59) performed a stepping-in-place task before repetitive LLB exposure (heavy weapons training), and again immediately after, 24 hours after, and 72 to 96 hours after the completion of the training. The AccWalker app revealed that there are changes in neuromotor functioning after LLB exposure (slower self-selected movement pace and increased stride time variability) in participants who experienced neurocognitive decline. These data suggest that neurocognitive and neuromotor decline can occur after repeated LLB exposure.	[Rhea, Christopher K.; Kuznetsov, Nikita A.; Ross, Scott E.; Long, Benjamin; Jakiela, Jason T.] Univ North Carolina Greensboro, 1400 Spring Garden St, Greensboro, NC 27412 USA; [Bailie, Jason M.] Def & Vet Brain Injury Ctr, 1335 East West Highway 600, Silver Spring, MD 20910 USA; [Bailie, Jason M.] Naval Hosp Camp Pendleton, 200 Mercy Circle, Oceanside, CA 92058 USA; [Yanagi, Matthew A.] SPAWAR Syst Ctr Pacific, 53560 Hull St, San Diego, CA 92152 USA; [Haran, Jay] Naval Submarine Base New London, Naval Submarine Med Res Lab, Box 900, Groton, CT 06349 USA; [Wright, W. Geoffrey; Robins, Rebecca K.] Temple Univ, 1801 North Broad St, Philadelphia, PA 19122 USA; [Sargent, Paul D.] Naval Special Warfare Grp ONE, 2000 Trident Way, San Diego, CA 92155 USA; [Duckworth, Joshua L.] Uniformed Serv Univ Hlth Sci, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA	Rhea, CK (corresponding author), Univ North Carolina Greensboro, 1400 Spring Garden St, Greensboro, NC 27412 USA.				Office of the Assistant Secretary of Defense for Health Affairs [W81XWH-15-1-0094, HU0001-14-1-0022]	The U.S. Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick MD 21702-5014 is the awarding and administering acquisition office. This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs under award no. W81XWH-15-1-0094 to Christopher K. Rhea and HU0001-14-1-0022 to Joshua L. Duckworth.	Abbas K, 2015, BRAIN CONNECT, V5, P91, DOI 10.1089/brain.2014.0279; Bandak F A, 2015, Handb Clin Neurol, V127, P89, DOI 10.1016/B978-0-444-52892-6.00006-4; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Brandt J, 2001, HOPKINS VERBAL LEARN, P17; Carr W, 2015, J HEAD TRAUMA REHAB, V30, P47, DOI 10.1097/HTR.0000000000000064; Catena RD, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-25; Chagdes JR, 2009, EXP BRAIN RES, V197, P297, DOI 10.1007/s00221-009-1915-1; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Delignieres D, 2004, HUM MOVEMENT SCI, V23, P87, DOI 10.1016/j.humov.2004.07.001; Denis A. M., 2007, INTENS CARE MED, P1011; Department of Defence, 2012, DOD POL GUID MAN MIL; Fausti SA, 2009, J REHABIL RES DEV, V46, P797, DOI 10.1682/JRRD.2008.09.0118; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Gysland SM, 2012, ANN BIOMED ENG, V40, P14, DOI 10.1007/s10439-011-0421-3; Haran FJ, 1511 NEDU TR; Hausdorff JM, 2007, HUM MOVEMENT SCI, V26, P555, DOI 10.1016/j.humov.2007.05.003; Hubel KA, 2013, J CLIN EXP NEUROPSYC, V35, P745, DOI 10.1080/13803395.2013.824070; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Iverson GL, 2001, ARCH CLIN NEUROPSYCH, V16, P183, DOI 10.1016/S0887-6177(00)00060-3; Johnson B, 2014, J NEUROTRAUM, V31, P1907, DOI 10.1089/neu.2014.3415; Kennedy CH, 2012, ARCH CLIN NEUROPSYCH, V27, P817, DOI 10.1093/arclin/acs092; Lathan C, 2013, MIL MED, V178, P365, DOI 10.7205/MILMED-D-12-00438; Laubscher J, 2006, AFR J PHYS HLTH ED R, V12, P468; Lee H, 2013, J SCI MED SPORT, V16, P2, DOI 10.1016/j.jsams.2012.03.013; Levinson DM, 1997, ARCH CLIN NEUROPSYCH, V12, P155, DOI 10.1016/S0887-6177(96)00026-1; Martini DN, 2011, ARCH PHYS MED REHAB, V92, P585, DOI 10.1016/j.apmr.2010.11.029; McCrea M, 2008, CLIN NEUROPSYCHOL, V22, P10, DOI 10.1080/13854040701760981; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Niechwiej-Szwedo E, 2007, GAIT POSTURE, V25, P70, DOI 10.1016/j.gaitpost.2006.01.002; O'Neil RL, 2013, NEUROREHABILITATION, V33, P667, DOI 10.3233/NRE-130985; Onge PS, 2011, US ARMY MED DEP J, P97; Parker TM, 2006, MED SCI SPORT EXER, V38, P1032, DOI 10.1249/01.mss.0000222828.56982.a4; Puvenna V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096296; Repp BH, 2005, PSYCHON B REV, V12, P969, DOI 10.3758/BF03206433; Repp BH, 2010, J MOTOR BEHAV, V42, P111, DOI 10.1080/00222890903566418; Rhea CK, 2014, J APPL BIOMECH, V30, P534, DOI 10.1123/jab.2013-0314; Rhea CK, 2014, GAIT BIOMETRICS BASI; Russo CR, 2015, APPL PSYCH MEAS, V39, P566, DOI 10.1177/0146621615577361; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Shively SB, 2016, LANCET NEUROL, V15, P944, DOI 10.1016/S1474-4422(16)30057-6; Spira JL, 2014, J NEUROTRAUM, V31, P1823, DOI 10.1089/neu.2014.3363; Stergiou N, 2011, HUM MOVEMENT SCI, V30, P869, DOI 10.1016/j.humov.2011.06.002; Stone JR, 2013, J NEUROTRAUM, V30, pA120; Tate CM, 2013, J NEUROTRAUM, V30, P1620, DOI 10.1089/neu.2012.2683; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Tung WW, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.046210; van Orden G. C., 2007, PSYCHOL SCI AGENDA, V22; Warden DL, 2005, J NEUROTRAUM, V22, P1178; Williams G, 2010, J HEAD TRAUMA REHAB, V25, P366, DOI 10.1097/HTR.0b013e3181cd3600; Young L, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00089; Zelaznik HN, 2002, J EXP PSYCHOL HUMAN, V28, P575, DOI 10.1037//0096-1523.28.3.575	55	11	11	0	3	ASSOC MILITARY SURG US	BETHESDA	9320 OLD GEORGETOWN RD, BETHESDA, MD 20814 USA	0026-4075	1930-613X		MIL MED	Milit. Med.	MAR	2017	182			1			147	154		10.7205/MILMED-D-16-00140			8	Medicine, General & Internal	General & Internal Medicine	ER6VN	WOS:000398947100024	28291466	Bronze			2021-06-18	
J	Sinha, SP; Avcu, P; Spiegler, KM; Komaravolu, S; Kim, K; Cominski, T; Servatius, RJ; Pang, KCH				Sinha, Swamini P.; Avcu, Pelin; Spiegler, Kevin M.; Komaravolu, Sreeya; Kim, Kevin; Cominski, Tara; Servatius, Richard J.; Pang, Kevin C. H.			Startle suppression after mild traumatic brain injury is associated with an increase in pro-inflammatory cytokines, reactive gliosis and neuronal loss in the caudal pontine reticular nucleus	BRAIN BEHAVIOR AND IMMUNITY			English	Article						Concussion; Post-concussion symptoms; Lateral fluid percussion; Glial activation; Interleukin-1; TNE-alpha; GFAP; IBA-1; Pons; ASR	TUMOR-NECROSIS-FACTOR; FACTOR-KAPPA-B; FACTOR-ALPHA; INTERLEUKIN-1; ACTIVATION; EXPRESSION; STRESS; NEUROPATHOLOGY; VETERANS; MODERATE	Mild traumatic brain injury (mTBI) can produce somatic symptoms such as headache, dizziness, fatigue, sleep disturbances and sensorimotor dysfunction. Sensorimotor function can be measured by tests such as the acoustic startle reflex (ASR), an evolutionarily conserved defensive response to a brief yet sharp acoustic stimulus. mTBI produces a long-lasting suppression of ASR in rodents and humans; however, the mechanism of this suppression is unknown. The present study examined whether inflammatory processes in the brainstem (particularly the caudal pontine reticular nucleus, PnC) could account for the suppression of ASR after mTBI, because the PnC is an essential nucleus of the ASR circuit. Furthermore, while inflammation after mTBI is commonly observed in brain regions proximal to the site of impact (cortex and hippocampus), the effects of mTBI in brainstem structures remains largely understudied. The present study demonstrated a suppression of ASR one day after injury and lasting at least three weeks after an mTBI, replicating previous findings. Within the PnC, transient elevations of IL-1 beta and TNF-alpha mRNA were observed at one day after injury, while IL-1 alpha mRNA exhibited a delayed increase at three weeks after injury. Reactive gliosis (via IBA-1-ir for microglia and GFAP-ir for astrocytes) were also observed in the PnC, at one day and seven days after injury, respectively. Finally, the number of giant neurons (the major functional cell population in the PnC) was decreased three weeks after injury. The results indicate that glial activation precedes neuronal loss in the PnC, and correlates with the behavioral suppression of the ASR. The results also raise implications for brainstem involvement in the development of post traumatic symptoms. (C) 2017 Elsevier Inc. All rights reserved.	[Cominski, Tara; Pang, Kevin C. H.] Dept Veteran Affairs Med Ctr New Jersey Hlth Care, Neurobehav Res Lab, E Orange, NJ USA; [Servatius, Richard J.; Pang, Kevin C. H.] Univ Med & Dent New Jersey, Dept Pharmacol Physiol & Neurosci, Rutgers Biomed & Hlth Sci, Newark, NJ USA; [Sinha, Swamini P.; Avcu, Pelin; Spiegler, Kevin M.; Servatius, Richard J.; Pang, Kevin C. H.] Univ Med & Dent New Jersey, Grad Sch Biomed Sci, Rutgers Biomed & Hlth Sci, Newark, NJ USA; [Servatius, Richard J.] Syracuse Vet Affairs Med Ctr, Syracuse, NY USA; [Komaravolu, Sreeya; Kim, Kevin] Coll New Jersey, Program, Ewing, NJ USA	Pang, KCH (corresponding author), VA New Jersey Hlth Care Syst, 385 Tremont Ave Mailstop 15, E Orange, NJ 07018 USA.	kevin.pang@va.gov		Spiegler, Kevin/0000-0002-9271-5825; Servatius, Richard/0000-0002-7023-4895	Biomedical Laboratory Research & Development Service of the Department of Veterans Affairs Office of Research Development [101BX000132]; New Jersey Commission on Brain Injury Research [CBIR11 PJT003]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RO1-NS44373]; Stress and Motivated Behavior Institute; Veterans AffairsUS Department of Veterans Affairs [I01BX000132] Funding Source: NIH RePORTER	The research presented in the current study was funded by the Biomedical Laboratory Research & Development Service of the Department of Veterans Affairs Office of Research & Development (grant 101BX000132), New Jersey Commission on Brain Injury Research (grant CBIR11 PJT003), National Institutes of Health (grant RO1-NS44373), and the Stress and Motivated Behavior Institute.	Abdul-Wahab R., 2011, IEEE 37 ANN NE, V1, P22011; Anwar MA, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00098; Barker-Collo S, 2015, BRAIN INJURY, V29, P1604, DOI 10.3109/02699052.2015.1075143; Bartfai T, 2007, ANN NY ACAD SCI, V1113, P173, DOI 10.1196/annals.1391.022; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; BILLINGHAM MEJ, 1987, BRIT MED BULL, V43, P350, DOI 10.1093/oxfordjournals.bmb.a072187; Brough D, 2015, IUBMB LIFE, V67, P323, DOI 10.1002/iub.1377; Browne KD, 2011, J NEUROTRAUM, V28, P1747, DOI 10.1089/neu.2011.1913; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Correale J, 2014, MULT SCLER J, V20, P1288, DOI 10.1177/1352458514533230; DAVIS M, 1982, J NEUROSCI, V2, P791; Delano-Wood L, 2015, BRAIN IMAGING BEHAV, V9, P500, DOI 10.1007/s11682-015-9432-2; Dunn SL, 2002, GLIA, V37, P31, DOI 10.1002/glia.10010; FAN L, 1995, MOL BRAIN RES, V30, P125; Fan L, 1996, MOL BRAIN RES, V36, P287, DOI 10.1016/0169-328X(95)00274-V; Frakes AE, 2014, NEURON, V81, P1009, DOI 10.1016/j.neuron.2014.01.013; Gosselin D, 2007, BRAIN BEHAV IMMUN, V21, P281, DOI 10.1016/j.bbi.2006.12.004; Grillon C, 1996, PSYCHIAT RES, V64, P169, DOI 10.1016/S0165-1781(96)02942-3; Holmin S, 1997, J NEUROSURG, V86, P493, DOI 10.3171/jns.1997.86.3.0493; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Janke KL, 2015, FRONT PSYCHIATRY, V6, DOI 10.3389/fpsyt.2015.00106; Johnson Victoria E, 2015, Handb Clin Neurol, V127, P115, DOI 10.1016/B978-0-444-52892-6.00008-8; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Knoblach SM, 1999, J NEUROIMMUNOL, V95, P115, DOI 10.1016/S0165-5728(98)00273-2; Koch M, 1999, PROG NEUROBIOL, V59, P107, DOI 10.1016/S0301-0082(98)00098-7; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; LINGENHOHL K, 1994, J NEUROSCI, V14, P1176; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Longhi L, 2013, J CEREBR BLOOD F MET, V33, P1182, DOI 10.1038/jcbfm.2013.65; Lu J, 2003, NEUROPHARMACOLOGY, V44, P253, DOI 10.1016/S0028-3908(02)00380-5; Luheshi NM, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-186; Luheshi NM, 2009, EUR J IMMUNOL, V39, P2973, DOI 10.1002/eji.200939712; Lv QS, 2014, J NEUROL SCI, V345, P48, DOI 10.1016/j.jns.2014.06.037; Miremami JD, 2014, SOMATOSENS MOT RES, V31, P127, DOI 10.3109/08990220.2014.897602; Neuberger EJ, 2014, J NEUROSCI RES, V92, P1350, DOI 10.1002/jnr.23401; Nurmi A, 2004, J NEUROCHEM, V91, P755, DOI 10.1111/j.1471-4159.2004.02756.x; Pang K, 1998, J COMP NEUROL, V394, P186, DOI 10.1002/(SICI)1096-9861(19980504)394:2<186::AID-CNE4>3.0.CO;2-Z; Pang KCH, 2015, J NEUROTRAUM, V32, P801, DOI 10.1089/neu.2014.3451; Perez-Polo JR, 2013, J NEUROTRAUM, V30, P727, DOI 10.1089/neu.2012.2650; Petraglia Anthony L, 2014, Neurosurgery, V75 Suppl 4, pS34, DOI 10.1227/NEU.0000000000000472; Pissiota A, 2002, EUR J NEUROSCI, V15, P395, DOI 10.1046/j.0953-816x.2001.01870.x; RAGHUPATHI R, 1995, BRAIN PATHOL, V5, P437, DOI 10.1111/j.1750-3639.1995.tb00622.x; Sajja VSSS, 2016, FRONT INTEGR NEUROSC, V10, DOI [10.3389/fnint.2016.00007, 10.3389/fnint.7016.00007]; Saunders JC, 2006, NEUROPSYCHOLOGY, V20, P224, DOI 10.1037/0894-4105.20.2.224; SCHRECK R, 1992, J EXP MED, V175, P1181, DOI 10.1084/jem.175.5.1181; Servatius RJ, 2005, BIOL PSYCHIAT, V57, P865, DOI 10.1016/j.biopsych.2005.01.015; Shaftel SS, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-7; Shohami E, 1999, CYTOKINE GROWTH F R, V10, P119, DOI 10.1016/S1359-6101(99)00008-8; Stein TD, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt234; Sun D, 2012, NEUROSCIENTIST, V18, P567, DOI 10.1177/1073858411423441; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; WEST MJ, 1993, NEUROBIOL AGING, V14, P275, DOI 10.1016/0197-4580(93)90112-O; Wiley JL, 1996, BRAIN RES, V716, P47, DOI 10.1016/0006-8993(96)00045-5; Xing GQ, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00196; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	57	11	12	1	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0889-1591	1090-2139		BRAIN BEHAV IMMUN	Brain Behav. Immun.	MAR	2017	61						353	364		10.1016/j.bbi.2017.01.006			12	Immunology; Neurosciences; Psychiatry	Immunology; Neurosciences & Neurology; Psychiatry	EM5PZ	WOS:000395365900037	28089558				2021-06-18	
J	Tate, DF; Gusman, M; Kini, J; Reid, M; Velez, CS; Drennon, AM; Cooper, DB; Kennedy, JE; Bowles, AO; Bigler, ED; Lewis, JD; Ritter, J; York, GE				Tate, David F.; Gusman, Maria; Kini, Jonathan; Reid, Matthew; Velez, Carmen S.; Drennon, Ann Marie; Cooper, Douglas B.; Kennedy, Jan E.; Bowles, Amy O.; Bigler, Erin D.; Lewis, Jeffrey D.; Ritter, John; York, Gerald E.			Susceptibility Weighted Imaging and White Matter Abnormality Findings in Service Members With Persistent Cognitive Symptoms Following Mild Traumatic Brain Injury	MILITARY MEDICINE			English	Article							LESIONS; HYPERINTENSITIES; OUTCOMES; EDITION; RELATE	Mild traumatic brain injury (mTBI) is a major health concern among active duty service members and Veterans returning from combat operations, and it can result in variable clinical and cognitive outcomes. Identifying biomarkers that can improve diagnosis and prognostication has been at the forefront of recent research efforts. The purpose of this study was to compare the sensitivity and specificity of abnormalities identified using more traditional magnetic resonance imaging (MRI) sequences such as fluid attenuation inversion recovery (FLAIR) to more advanced MRI sequences such as susceptibility weighted imaging (SWI) among a cohort of active duty service members experiencing persistent cognitive symptoms after mTBI. One-hundred and fifty-two active duty service members (77 mTBI, 58 orthopedically injured [OI] only, 17 post-traumatic stress disorder [PTSD] only) underwent MRI and neuropsychological evaluation at a large military treatment facility. Results demonstrated that FLAIR white matter hyperintensities (WMHs) were present in all three groups at statistically similar rates (41% mTBI, 49% OI, and 29% PTSD). With the exception of a single OI participant showing a small discrete SWI lesion, SWI abnormalities were overwhelmingly present in mTBI patients (22% mTBI, 1% OI, and 0% PTSD). Functionally, mTBI participants with and without SWI abnormalities did not differ in demographics, symptom reporting, or cognitive performance. However, mTBI participants with and without WMH did differ for on measures of working memory with the mTBI participants with WMH having worse cognitive performance. No other significant differences were noted for those participants with and without imaging abnormalities for either the OI or PTSD only cohorts. These results appear to illustrate the sensitivity and specificity of SWI findings though these results did not have any significant functional impact in this cohort. In contrast, WMHs noted on FLAIR imaging were not sensitive or specific findings, but functionally relevant among mTBI participants. These findings emphasize the complexity of injury and functional outcome in mTBI patients that requires additional examination.	[Tate, David F.; Velez, Carmen S.] Univ Missouri St Louis, Missouri Inst Mental Hlth, 4633 World Pkwy Circle, Berkeley, MO 63134 USA; [Gusman, Maria] Brooke Army Med Ctr, Dept Radiol, 3551 Roger Brooke Dr, Ft Sam Houston, TX 78234 USA; [Kini, Jonathan; Ritter, John] Austin Radiol Associates, 12554 Riata Vista Circle, Austin, TX 78727 USA; [Reid, Matthew; Drennon, Ann Marie; Cooper, Douglas B.; Kennedy, Jan E.] Brooke Army Med Ctr, Gen Dynam Technol, Def & Vet Brain Injury Ctr, 3551 Roger Brooke Dr, Ft Sam Houston, TX 78234 USA; [Bowles, Amy O.] Brooke Army Med Ctr, Dept Rehabil, Brain Injury Rehabil Serv, 3551 Roger Brooke Dr, Ft Sam Houston, TX 78234 USA; [Bigler, Erin D.] Brigham Young Univ, Dept Psychol, 1001 SWKT, Provo, UT 84604 USA; [Bigler, Erin D.] Brigham Young Univ, Ctr Neurosci, 1001 SWKT, Provo, UT 84604 USA; [Lewis, Jeffrey D.] Uniformed Serv Univ Hlth Sci, Dept Neurol, Sch Med, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [York, Gerald E.] Alaska Radiol Associates, TBI Imaging & Res, 3650 Piper St,Suite A, Anchorage, AK 99508 USA	Tate, DF (corresponding author), Univ Missouri St Louis, Missouri Inst Mental Hlth, 4633 World Pkwy Circle, Berkeley, MO 63134 USA.		Tate, David F/I-3963-2013; Ritter, John/AAG-8899-2020	Tate, David F/0000-0003-0213-1920; 	Defense and Veterans Brain Injury Centers; U.S. Army Medical Research and Material Command (USAMRMC)U.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-13-2-0025]; Chronic Effects of Neurotrauma Consortium (CENC) [PT108802-SC104835]	This work is supported in part by the Defense and Veterans Brain Injury Centers, the U.S. Army Medical Research and Material Command (USAMRMC; W81XWH-13-2-0025), and the Chronic Effects of Neurotrauma Consortium (CENC; PT108802-SC104835).	Ashwal S, 2006, ARCH PHYS MED REHAB, V87, pS50, DOI 10.1016/j.apmr.2006.07.275; Beauchamp MH, 2013, CORTEX, V49, P591, DOI 10.1016/j.cortex.2012.08.015; Benedictus MR, 2015, STROKE, V46, P2661, DOI 10.1161/STROKEAHA.115.009475; Bigler ED, 2003, NEUROPSYCHOLOGY, V17, P339, DOI 10.1037/0894-4105.17.3.339; Bigler ED, 2002, ALZ DIS ASSOC DIS, V16, P161, DOI 10.1097/00002093-200207000-00006; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; BORCZUK P, 1995, ANN EMERG MED, V25, P731, DOI 10.1016/S0196-0644(95)70199-0; Brickman AM, 2006, BIOL PSYCHIAT, V60, P444, DOI 10.1016/j.biopsych.2006.01.011; Carlozzi NE, 2015, CLIN NEUROPSYCHOL, V29, P21, DOI 10.1080/13854046.2015.1005677; Chastain CA, 2009, J NEUROTRAUM, V26, P1183, DOI 10.1089/neu.2008.0650; Dahm J, 2015, INJURY, V46, P142, DOI 10.1016/j.injury.2014.07.012; Donders J, 2015, ASSESSMENT, V22, P17, DOI 10.1177/1073191114530776; Fink AZ, 2016, BRIT J RADIOL, V89, DOI 10.1259/bjr.20150753; Guidelines VDCP, 2016, MAN CONC MILD TRAUM; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P516, DOI 10.1002/jmri.22259; Haley AP, 2009, AM J GERIAT PSYCHIAT, V17, P976, DOI 10.1097/JGP.0b013e3181b208ef; Hoofien D, 2005, APPL NEUROPSYCHOL, V12, P30, DOI 10.1207/s15324826an1201_6; Hoth KF, 2007, STROKE, V38, P308, DOI 10.1161/01.STR.0000254517.04275.3f; Jacobs ML, 2008, ARCH CLIN NEUROPSYCH, V23, P113, DOI 10.1016/j.acn.2007.09.003; Kou ZF, 2010, J HEAD TRAUMA REHAB, V25, P267, DOI 10.1097/HTR.0b013e3181e54793; Lezak M., 2012, NEUROPSYCHOLOGICAL A, V5th; Liu J, 2015, J NEUROTRAUM, V33, P10; Liu W, 2016, RADIOLOGY, V278, P536, DOI 10.1148/radiol.2015150160; Lloyd AJ, 2009, ACTA PSYCHIAT SCAND, V120, P481, DOI 10.1111/j.1600-0447.2009.01416.x; McGuire SA, 2014, NEUROLOGY, V83, P638, DOI 10.1212/WNL.0000000000000694; McGuire SA, 2012, AVIAT SPACE ENVIR MD, V83, P1117, DOI 10.3357/ASEM.3395.2012; Mittal S, 2009, AM J NEURORADIOL, V30, P232, DOI 10.3174/ajnr.A1461; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Riedy G, 2016, RADIOLOGY, V279, P207, DOI 10.1148/radiol.2015150438; Shen YM, 2007, MAGN RESON IMAGING, V25, P219, DOI 10.1016/j.mri.2006.09.018; Spitz G, 2013, J NEUROTRAUM, V30, P2038, DOI 10.1089/neu.2013.3021; Tate DF, 2008, BRAIN IMAGING BEHAV, V2, P200, DOI 10.1007/s11682-008-9032-5; Tong KA, 2003, RADIOLOGY, V227, P332, DOI 10.1148/radiol.2272020176; Wilde EA, 2015, BRAIN IMAGING BEHAV, V9, P367, DOI 10.1007/s11682-015-9444-y; Wisse LEM, 2015, NEUROBIOL AGING, V36, P3152, DOI 10.1016/j.neurobiolaging.2015.08.029; Wu Z, 2010, AM J NEURORADIOL, V31, P1302, DOI 10.3174/ajnr.A2022	36	11	11	0	5	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	MAR-APR	2017	182	3-4					E1651	E1658		10.7205/MILMED-D-16-00132			8	Medicine, General & Internal	General & Internal Medicine	ER6WA	WOS:000398948700015	28290939	Bronze			2021-06-18	
J	Zupan, B; Babbage, D; Neumann, D; Willer, B				Zupan, Barbra; Babbage, Duncan; Neumann, Dawn; Willer, Barry			Sex Differences in Emotion Recognition and Emotional Inferencing Following Severe Traumatic Brain Injury	BRAIN IMPAIRMENT			English	Article						Emotion recognition; emotional inferencing; sex; traumatic brain injury	FACIAL AFFECT RECOGNITION; GENDER-DIFFERENCES; PERCEPTION DEFICITS; FEMALE ADVANTAGE; VOCAL AFFECT; EXPRESSIONS; MIND; IMPAIRMENTS; INTENSITY; RESPONSES	The primary objective of the current study was to determine if men and women with traumatic brain injury (TBI) differ in their emotion recognition and emotional inferencing abilities. In addition to overall accuracy, we explored whether differences were contingent upon the target emotion for each task, or upon high-and low-intensity facial and vocal emotion expressions. A total of 160 participants (116 men) with severe TBI completed three tasks - a task measuring facial emotion recognition (DANVA-Faces), vocal emotion recognition (DANVA-Voices) and one measuring emotional inferencing (emotional inference from stories test (EIST)). Results showed that women with TBI were significantly more accurate in their recognition of vocal emotion expressions and also for emotional inferencing. Further analyses of task performance showed that women were significantly better than men at recognising fearful facial expressions and also facial emotion expressions high in intensity. Women also displayed increased response accuracy for sad vocal expressions and low-intensity vocal emotion expressions. Analysis of the EIST task showed that women were more accurate than men at emotional inferencing in sad and fearful stories. A similar proportion of women and men with TBI were impaired (>= 2 SDs when compared to normative means) at facial emotion perception,x(2) = 1.45, p = 0.228, but a larger proportion of men was impaired at vocal emotion recognition, x(2) = 7.13, p = 0.008, and emotional inferencing, x(2) = 7.51, p = 0.006.	[Zupan, Barbra] Brock Univ, Dept Appl Linguist, St Catharines, ON L2S 3A1, Canada; [Babbage, Duncan] Auckland Univ Technol, Ctr Person Ctr Res, Auckland, New Zealand; [Babbage, Duncan] Auckland Univ Technol, Ctr EHealth, Auckland, New Zealand; [Neumann, Dawn] Indiana Univ, Rehabil Hosp Indiana, Sch Med, Dept Phys Med & Rehabil, Bloomington, IN 47405 USA; [Willer, Barry] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Dept Psychiat, Buffalo, NY USA	Zupan, B (corresponding author), Brock Univ, Dept Appl Linguist, St Catharines, ON L2S 3A1, Canada.	bzupan@brocku.ca		Babbage, Duncan/0000-0002-9259-9246; Barbra, Zupan/0000-0002-4603-333X	National Institute on Disability and Rehabilitation Research [H133G080043]	This work was supported by the National Institute on Disability and Rehabilitation Research (grant no. H133G080043).	Adolphs R, 2003, BRAIN COGNITION, V52, P61, DOI 10.1016/S0278-2626(03)00009-5; Adolphs Ralph, 2002, Behav Cogn Neurosci Rev, V1, P21, DOI 10.1177/1534582302001001003; Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; Baron-Cohen S, 2003, PHILOS T ROY SOC B, V358, P361, DOI 10.1098/rstb.2002.1206; Barrett LF, 2011, CURR DIR PSYCHOL SCI, V20, P286, DOI 10.1177/0963721411422522; Bibby H, 2005, NEUROPSYCHOLOGIA, V43, P99, DOI 10.1016/j.neuropsychologia.2004.04.027; Bonebright TL, 1996, SEX ROLES, V34, P429, DOI 10.1007/BF01547811; Bornhofen C, 2008, J INT NEUROPSYCH SOC, V14, P511, DOI 10.1017/S1355617708080703; Camarata S, 2006, INTELLIGENCE, V34, P231, DOI 10.1016/j.intell.2005.12.001; Campanella S, 2004, NEUROSCI LETT, V367, P14, DOI 10.1016/j.neulet.2004.05.097; Colantonio A, 2010, J WOMENS HEALTH, V19, P1109, DOI 10.1089/jwh.2009.1740; Collignon O, 2010, NEUROPSYCHOLOGIA, V48, P220, DOI 10.1016/j.neuropsychologia.2009.09.007; Collignon O, 2008, BRAIN RES, V1242, P126, DOI 10.1016/j.brainres.2008.04.023; Cunningham DW, 2009, J VISION, V9, DOI 10.1167/9.13.7; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Ferstl EC, 2005, J COGNITIVE NEUROSCI, V17, P724, DOI 10.1162/0898929053747658; Frank MG, 2001, J PERS SOC PSYCHOL, V80, P75, DOI 10.1037/0022-3514.80.1.75; Hall JA, 2004, EMOTION, V4, P201, DOI 10.1037/1528-3542.4.2.201; Hampson E, 2006, EVOL HUM BEHAV, V27, P401, DOI 10.1016/j.evolhumbehav.2006.05.002; Hoffmann H, 2010, ACTA PSYCHOL, V135, P278, DOI 10.1016/j.actpsy.2010.07.012; Ietswaart M, 2008, NEUROPSYCHOLOGIA, V46, P148, DOI 10.1016/j.neuropsychologia.2007.08.002; Johnstone T., 2000, HDB EMOTION, P220, DOI DOI 10.1016/J.JML.2007.11.007; Keltner D., 2000, HDB EMOTIONS; Kessels RPC, 2014, J NEUROPSYCHOL, V8, P75, DOI 10.1111/jnp.12009; Killgore WDS, 2001, NEUROREPORT, V12, P427, DOI 10.1097/00001756-200102120-00047; Krach S, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-9; LaBar KS, 2003, CEREB CORTEX, V13, P1023, DOI 10.1093/cercor/13.10.1023; Lee TMC, 2002, NEUROSCI LETT, V333, P13, DOI 10.1016/S0304-3940(02)00965-5; Li H, 2008, NEUROIMAGE, V40, P1921, DOI 10.1016/j.neuroimage.2008.01.033; Martin I, 2003, BRAIN LANG, V85, P451, DOI 10.1016/S0093-934X(03)00070-1; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Milders M, 2006, NEUROPSYCHOLOGY, V20, P400, DOI 10.1037/0894-4105.20.4.400; Montagne Barbara, 2005, Cogn Process, V6, P136, DOI 10.1007/s10339-005-0050-6; Nalder E., 2016, ARCH PHYS MED REHA S, V2, P546; Neumann D, 2015, J HEAD TRAUMA REHAB, V30, pE12, DOI 10.1097/HTR.0000000000000054; Neumann D, 2014, J HEAD TRAUMA REHAB, V29, pE18, DOI 10.1097/HTR.0b013e31827fb0b5; Neumann D, 2012, ARCH PHYS MED REHAB, V93, P1414, DOI 10.1016/j.apmr.2012.03.009; Nowicki S, 1998, GENET SOC GEN PSYCH, V124, P39; NOWICKI S, 1993, J SOC PSYCHOL, V133, P749, DOI 10.1080/00224545.1993.9713934; Nowicki S., 2008, MANUAL RECEPTIVE TES; NOWICKI S, 1994, THE JOURNAL OF GENET, V153, P385; Phillips ML, 2003, BRIT J PSYCHIAT, V182, P190, DOI 10.1192/bjp.182.3.190; Radice-Neumann D, 2007, BRAIN INJURY, V21, P807, DOI 10.1080/02699050701504281; Ratcliff JJ, 2007, BRAIN INJURY, V21, P1023, DOI 10.1080/02699050701633072; Rigon A, 2016, COGN AFFECT BEHAV NE, V16, P866, DOI 10.3758/s13415-016-0437-0; Rosenberg H, 2014, J INT NEUROPSYCH SOC, V20, P994, DOI 10.1017/S1355617714000940; Rosip JC, 2004, J NONVERBAL BEHAV, V28, P267, DOI 10.1007/s10919-004-4159-6; Russell JA, 2003, ANNU REV PSYCHOL, V54, P329, DOI 10.1146/annurev.psych.54.101601.145102; Schirmer A, 2005, NEUROREPORT, V16, P635, DOI 10.1097/00001756-200504250-00024; Schirmer A, 2002, COGNITIVE BRAIN RES, V14, P228, DOI 10.1016/S0926-6410(02)00108-8; Schirmer A, 2003, J COGNITIVE NEUROSCI, V15, P1135, DOI 10.1162/089892903322598102; Schultz J, 2009, EXP BRAIN RES, V194, P465, DOI 10.1007/s00221-009-1721-9; Spell LA, 2000, J NONVERBAL BEHAV, V24, P285, DOI 10.1023/A:1006675230193; Thayer JF, 2000, SCAND J PSYCHOL, V41, P243, DOI 10.1111/1467-9450.00193; Thompson AE, 2014, COGNITION EMOTION, V28, P1164, DOI 10.1080/02699931.2013.875889; Turkstra LS, 2008, BRAIN INJURY, V22, P397, DOI 10.1080/02699050802027059; WALLBOTT HG, 1986, J PERS SOC PSYCHOL, V51, P690, DOI 10.1037/0022-3514.51.4.690; Wildgruber D, 2002, NEUROIMAGE, V15, P856, DOI 10.1006/nimg.2001.0998; Yim J, 2013, BRAIN INJURY, V27, P1155, DOI 10.3109/02699052.2013.804203; Zupan B, 2015, BRAIN INJURY, V29, P877, DOI 10.3109/02699052.2015.1011233; Zupan B, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e31829dded6; Zupan B, 2014, BRAIN INJURY, V28, P1087, DOI 10.3109/02699052.2014.901560; Zupan B, 2009, J COMMUN DISORD, V42, P1, DOI 10.1016/j.jcomdis.2008.06.001	64	11	11	2	10	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	MAR	2017	18	1					36	48		10.1017/BrImp.2016.22			13	Clinical Neurology; Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	EQ3SZ	WOS:000397994400004		Bronze			2021-06-18	
J	Limbrick, DD; Baksh, B; Morgan, CD; Habiyaremye, G; McAllister, JP; Inder, TE; Mercer, D; Holtzman, DM; Strahle, J; Wallendorf, MJ; Morales, DM				Limbrick, David D., Jr.; Baksh, Brandon; Morgan, Clinton D.; Habiyaremye, Gakwaya; McAllister, James P., II; Inder, Terrie E.; Mercer, Deanna; Holtzman, David M.; Strahle, Jennifer; Wallendorf, Michael J.; Morales, Diego M.			Cerebrospinal fluid biomarkers of infantile congenital hydrocephalus	PLOS ONE			English	Article							NORMAL-PRESSURE HYDROCEPHALUS; AMYLOID PRECURSOR PROTEIN; KAOLIN-INDUCED HYDROCEPHALUS; WHITE-MATTER DAMAGE; CELL JUNCTION PATHOLOGY; TRAUMATIC BRAIN-INJURY; NEURAL STEM-CELLS; ALZHEIMERS-DISEASE; POSTHEMORRHAGIC HYDROCEPHALUS; NEUROLOGICAL DISEASES	Introduction Hydrocephalus is a complex neurological disorder with a pervasive impact on the central nervous system. Previous work has demonstrated derangements in the biochemical profile of cerebrospinal fluid ( CSF) in hydrocephalus, particularly in infants and children, in whom neurodevelopment is progressing in parallel with concomitant neurological injury. The objective of this study was to examine the CSF of children with congenital hydrocephalus ( CHC) to gain insight into the pathophysiology of hydrocephalus and identify candidate biomarkers of CHC with potential diagnostic and therapeutic value. Methods CSF levels of amyloid precursor protein ( APP) and derivative isoforms ( sAPP alpha, sAPP beta, A beta(42)), tau, phosphorylated tau ( pTau), L1CAM, NCAM-1, aquaporin 4 ( AQP4), and total protein ( TP) were measured by ELISA in 20 children with CHC. Two comparative groups were included: age-matched controls and children with other neurological diseases. Demographic parameters, ventricular frontal-occipital horn ratio, associated brain malformations, genetic alterations, and surgical treatments were recorded. Logistic regression analysis and receiver operating characteristic curves were used to examine the association of each CSF protein with CHC. Results CSF levels of APP, sAPP alpha, sAPP beta, A beta(42), tau, pTau, L1CAM, and NCAM-1 but not AQP4 or TP were increased in untreated CHC. CSF TP and normalized L1CAM levels were associated with FOR in CHC subjects, while normalized CSF tau levels were associated with FOR in control subjects. Predictive ability for CHC was strongest for sAPPa, especially in subjects <= 12 months of age ( p<0.0001 and AUC = 0.99), followed by normalized sAPP beta ( p = 0.0001, AUC = 0.95), tau, APP, and L1CAM. Among subjects <= 12 months, a normalized CSF sAPP alpha cut-point of 0.41 provided the best prediction of CHC ( odds ratio = 528, sensitivity = 0.94, specificity = 0.97); these infants were 32 times more likely to have CHC. Conclusions CSF proteins such as sAPPa and related proteins hold promise as biomarkers of CHC in infants and young children, and provide insight into the pathophysiology of CHC during this critical period in neurodevelopment.	[Limbrick, David D., Jr.; Baksh, Brandon; Habiyaremye, Gakwaya; McAllister, James P., II; Mercer, Deanna; Strahle, Jennifer; Morales, Diego M.] Washington Univ, Sch Med, Dept Neurol Surg, St Louis, MO USA; [Limbrick, David D., Jr.; Strahle, Jennifer] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Morgan, Clinton D.] Barrow Neurol Inst, Phoenix, AZ 85013 USA; [Inder, Terrie E.] Harvard Med Sch, Brigham & Womens Hosp, Dept Pediat, Boston, MA USA; [Holtzman, David M.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Wallendorf, Michael J.] Washington Univ, Sch Med, Dept Biostat, St Louis, MO USA	Morales, DM (corresponding author), Washington Univ, Sch Med, Dept Neurol Surg, St Louis, MO USA.	moralesd@wudosis.wustl.edu	McAllister, James P./N-9657-2019	Morales, Diego/0000-0001-6672-9046; Morgan, Clinton/0000-0002-7511-0488	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T34GM083914] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS075151] Funding Source: NIH RePORTER; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T34 GM083914] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23 NS075151] Funding Source: Medline		Agren-Wilsson A, 2007, ACTA NEUROL SCAND, V116, P333, DOI 10.1111/j.1600-0404.2007.00890.x; Aojula A, 2016, FLUIDS BARRIERS CNS, V13, DOI 10.1186/s12987-016-0033-2; Blennow K, 2016, MOVEMENT DISORD, V31, P836, DOI 10.1002/mds.26656; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Dawkins E, 2014, J NEUROCHEM, V129, P756, DOI 10.1111/jnc.12675; Del Bigio MR, 2012, J NEUROPATH EXP NEUR, V71, P274, DOI 10.1097/NEN.0b013e31824c1b44; Del Bigio MR, 2010, DEV DISABIL RES REV, V16, P16, DOI 10.1002/ddrr.94; DELBIGIO MR, 1989, NEUROSURGERY, V25, P416, DOI 10.1227/00006123-198909000-00016; Di Curzio DL, 2013, EXP NEUROL, V248, P112, DOI 10.1016/j.expneurol.2013.06.004; Douglas MR, 2009, J NEUROL NEUROSUR PS, V80, P545, DOI 10.1136/jnnp.2008.155671; Eskandari R, 2004, J NEUROSURG, V101, P196, DOI 10.3171/ped.2004.101.2.0196; Eskandari R, 2011, CHILD NERV SYST, V27, P2067, DOI 10.1007/s00381-011-1552-4; GONZALEZDARDER J, 1984, J NEUROSURG, V61, P918, DOI 10.3171/jns.1984.61.5.0918; Gopal SC, 2008, CHILD NERV SYST, V24, P713, DOI 10.1007/s00381-007-0546-8; Gopal SC, 2007, PEDIATR SURG INT, V23, P571, DOI 10.1007/s00383-006-1689-5; Heep A, 2006, CHILD NERV SYST, V22, P1249, DOI 10.1007/s00381-006-0102-y; Herukka SK, 2015, J ALZHEIMERS DIS, V46, P261, DOI 10.3233/JAD-142862; Huang H, 2016, NEUROCHEM RES, V41, P1713, DOI 10.1007/s11064-016-1887-z; Iliff JJ, 2015, LANCET NEUROL, V14, P977, DOI 10.1016/S1474-4422(15)00221-5; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Iliff JJ, 2013, STROKE, V44, pS93, DOI 10.1161/STROKEAHA.112.678698; Iliff JJ, 2013, J CLIN INVEST, V123, P1299, DOI 10.1172/JCI67677; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Jeppsson A, 2013, NEUROLOGY, V80, P1385, DOI 10.1212/WNL.0b013e31828c2fda; Jimenez AJ, 2014, TISSUE BARRIERS, V2, DOI 10.4161/tisb.28426; Jingami N, 2015, J ALZHEIMERS DIS, V45, P109, DOI 10.3233/JAD-142622; Kahle KT, 2016, LANCET, V387, P788, DOI 10.1016/S0140-6736(15)60694-8; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kang K, 2014, J CLIN NEUROSCI, V21, P1398, DOI 10.1016/j.jocn.2013.11.039; Klarica M, 2013, NEUROSCIENCE, V248, P278, DOI 10.1016/j.neuroscience.2013.06.022; Kondziella D, 2002, BRAIN RES, V927, P35, DOI 10.1016/S0006-8993(01)03320-0; KOO EH, 1990, P NATL ACAD SCI USA, V87, P1561, DOI 10.1073/pnas.87.4.1561; Kress BT, 2014, ANN NEUROL, V76, P845, DOI 10.1002/ana.24271; Krishnamurthy S, 2012, FLUIDS BARRIERS CNS, V9, DOI 10.1186/2045-8118-9-13; Krishnamurthy S, 2009, FLUIDS BARRIERS CNS, V6, DOI 10.1186/1743-8454-6-16; Kudo T, 2000, PSYCHIAT CLIN NEUROS, V54, P199, DOI 10.1046/j.1440-1819.2000.00658.x; Lee L, 2013, J NEUROSCI RES, V91, P1117, DOI 10.1002/jnr.23238; Leinonen Ville, 2011, Int J Alzheimers Dis, V2011, P312526, DOI 10.4061/2011/312526; Lewczuk P, 2004, J MOL NEUROSCI, V23, P115, DOI 10.1385/JMN:23:1-2:115; Li XF, 2007, NEUROSCI LETT, V413, P141, DOI 10.1016/j.neulet.2006.11.039; Lim TS, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-66; McAllister JP, 2015, J NEUROSURG, V123, P1427, DOI 10.3171/2014.12.JNS132352; McAllister JP, 2012, SEMIN FETAL NEONAT M, V17, P285, DOI 10.1016/j.siny.2012.06.004; Merhar S, 2012, NEONATOLOGY, V101, P1, DOI 10.1159/000323498; Miyajima M, 2013, EUR J NEUROL, V20, P236, DOI 10.1111/j.1468-1331.2012.03781.x; Guerra MM, 2015, J NEUROPATH EXP NEUR, V74, P653, DOI 10.1097/NEN.0000000000000203; Morales DM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115045; Morales DM, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.011973; Morales DM SS, NEUROSURGER IN PRESS; Murlidharan G, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88034; Nakajima M, 2015, J NEUROL SCI, V357, P88, DOI 10.1016/j.jns.2015.07.001; Nakajima Madoka, 2010, Rinsho Shinkeigaku, V50, P973; Narita K, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00039; Naureen I, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-34; O'Hayon BB, 1998, PEDIATR NEUROSURG, V29, P245, DOI 10.1159/000028730; Ohata S, 2016, TRENDS NEUROSCI; Ohata S, 2014, NEURON, V83, P558, DOI 10.1016/j.neuron.2014.06.022; Petraglia Anthony L, 2014, Surg Neurol Int, V5, P184, DOI 10.4103/2152-7806.147566; Priller C, 2006, J NEUROSCI, V26, P7212, DOI 10.1523/JNEUROSCI.1450-06.2006; Pyykko OT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091974; Ray B, 2011, J PSYCHIATR RES, V45, P539, DOI 10.1016/j.jpsychires.2010.07.011; Reiber H, 1998, MULT SCLER, V4, P99, DOI 10.1177/135245859800400302; Reiber H, 2003, RESTOR NEUROL NEUROS, V21, P79; REIBER H, 1994, J NEUROL SCI, V122, P189, DOI 10.1016/0022-510X(94)90298-4; Reiber H, 2001, CLIN CHIM ACTA, V310, P173, DOI 10.1016/S0009-8981(01)00573-3; Rodriguez EM, 2012, BIOL RES, V45, P231, DOI 10.4067/S0716-97602012000300005; Savman K, 2002, ACTA PAEDIATR, V91, P1357; Schirinzi T, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00086; Schmitz T, 2007, PEDIATR RES, V61, P722, DOI 10.1203/pdr.0b013e31805341f1; Schmitz T, 2011, J PERINAT MED, V39, P83, DOI 10.1515/jpm.2010.125; Schob S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160680; Sendrowski K, 2004, Rocz Akad Med Bialymst, V49 Suppl 1, P236; Sival Deborah A, 2008, Cerebrospinal Fluid Res, V5, P21, DOI 10.1186/1743-8454-5-21; Sussmuth SD, 2001, NEUROSCI LETT, V300, P95, DOI 10.1016/S0304-3940(01)01556-7; Tarnaris A, 2011, J NEUROSURG, V115, P145, DOI 10.3171/2011.2.JNS101316; Tarnaris A, 2009, BIOMARK MED, V3, P787, DOI 10.2217/BMM.09.37; Tullberg M, 2007, EUR J NEUROL, V14, P248, DOI 10.1111/j.1468-1331.2006.01553.x; Tullberg M, 2008, CEREBROSPINAL FLUID, V5, P9, DOI DOI 10.1186/1743-8454-5-9; van der Kant R, 2015, DEV CELL, V32, P502, DOI 10.1016/j.devcel.2015.01.022; Waybright T, 2010, J PROTEOMICS, V73, P1156, DOI 10.1016/j.jprot.2010.02.004; Zhang SL, 2013, INT J NEUROSCI, V123, P392, DOI 10.3109/00207454.2012.762363	81	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172353	10.1371/journal.pone.0172353			20	Multidisciplinary Sciences	Science & Technology - Other Topics	EL2BI	WOS:000394424700037	28212403	DOAJ Gold, Green Published			2021-06-18	
J	Haefeli, J; Ferguson, AR; Bingham, D; Orr, A; Won, SJ; Lam, TI; Shi, J; Hawley, S; Liu, JL; Swanson, RA; Massa, SM				Haefeli, Jenny; Ferguson, Adam R.; Bingham, Deborah; Orr, Adrienne; Won, Seok Joon; Lam, Tina I.; Shi, Jian; Hawley, Sarah; Liu, Jialing; Swanson, Raymond A.; Massa, Stephen M.			A data-driven approach for evaluating multi-modal therapy in traumatic brain injury	SCIENTIFIC REPORTS			English	Article							PRINCIPAL-COMPONENTS-ANALYSIS; EXERCISE; MINOCYCLINE; PLASTICITY; NEUROGENESIS; IMPROVEMENT; MICROGLIA; STABILITY; LIGAND; CANCER	Combination therapies targeting multiple recovery mechanisms have the potential for additive or synergistic effects, but experimental design and analyses of multimodal therapeutic trials are challenging. To address this problem, we developed a data-driven approach to integrate and analyze raw source data from separate pre-clinical studies and evaluated interactions between four treatments following traumatic brain injury. Histologic and behavioral outcomes were measured in 202 rats treated with combinations of an anti-inflammatory agent (minocycline), a neurotrophic agent (LM11A-31), and physical therapy consisting of assisted exercise with or without botulinum toxin-induced limb constraint. Data was curated and analyzed in a linked workflow involving non-linear principal component analysis followed by hypothesis testing with a linear mixed model. Results revealed significant benefits of the neurotrophic agent LM11A-31 on learning and memory outcomes after traumatic brain injury. In addition, modulations of LM11A-31 effects by co-administration of minocycline and by the type of physical therapy applied reached statistical significance. These results suggest a combinatorial effect of drug and physical therapy interventions that was not evident by univariate analysis. The study designs and analytic techniques applied here form a structured, unbiased, internally validated workflow that may be applied to other combinatorial studies, both in animals and humans.	[Haefeli, Jenny; Ferguson, Adam R.; Liu, Jialing] Univ Calif San Francisco, Dept Neurol Surg, BASIC, San Francisco, CA USA; [Ferguson, Adam R.; Bingham, Deborah; Orr, Adrienne; Won, Seok Joon; Lam, Tina I.; Shi, Jian; Hawley, Sarah; Liu, Jialing; Swanson, Raymond A.; Massa, Stephen M.] San Francisco VA Med Ctr, San Francisco, CA 94121 USA; [Won, Seok Joon; Lam, Tina I.; Shi, Jian; Swanson, Raymond A.; Massa, Stephen M.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA	Massa, SM (corresponding author), San Francisco VA Med Ctr, San Francisco, CA 94121 USA.; Massa, SM (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.	Stephen.Massa@ucsf.edu		Ferguson, Adam/0000-0001-7102-1608	Department of Veterans Affairs Research Enhancement Award Program GrantUS Department of Veterans Affairs; Craig H. Neilsen Foundation; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS067092, R01NS088475]; VA Merit ReviewsUS Department of Veterans Affairs [I01BX000267, I01RX000655]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS088475, R01NS067092] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01RX000655, I01BX000267] Funding Source: NIH RePORTER	The authors thank Dr. Frank Longo, Stanford University, for the generous provision of part of the LM11A-31 used in these studies. This work was funded by a Department of Veterans Affairs Research Enhancement Award Program Grant (RAS), the Craig H. Neilsen Foundation (http://chnfoundation.org/) (JH and ARF), NIH R01NS067092 (ARF), R01NS088475 (ARF) (https://grants.nih.gov/grants/oer.htm), and VA Merit Reviews (http://www.research.va.gov/) I01BX000267 (SMM) and I01RX000655 (JL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Lazikani B, 2012, NAT BIOTECHNOL, V30, P679, DOI 10.1038/nbt.2284; Alano CC, 2006, P NATL ACAD SCI USA, V103, P9685, DOI 10.1073/pnas.0600554103; Allred RP, 2008, J NEUROSCI METH, V170, P229, DOI 10.1016/j.jneumeth.2008.01.015; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; CATTELL RB, 1969, EDUC PSYCHOL MEAS, V29, P781, DOI 10.1177/001316446902900405; Chan AW, 2014, LANCET, V383, P257, DOI 10.1016/S0140-6736(13)62296-5; Creer DJ, 2010, P NATL ACAD SCI USA, V107, P2367, DOI 10.1073/pnas.0911725107; d'Avila JC, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-31; Duricki DA, 2016, NAT PROTOC, V11, P1112, DOI 10.1038/nprot.2016.048; Ferguson AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059712; Ferguson AR, 2011, TRANSL STROKE RES, V2, P438, DOI 10.1007/s12975-011-0121-1; Friedli L, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5811; Goodman SN, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf5027; Griesbach GS, 2007, J NEUROTRAUM, V24, P1161, DOI 10.1089/neu.2006.0255; Griesbach GS, 2004, BRAIN RES, V1016, P154, DOI 10.1016/j.brainres.2004.04.079; GUADAGNOLI E, 1988, PSYCHOL BULL, V103, P265, DOI 10.1037/0033-2909.103.2.265; GUADAGNOLI E, 1991, MULTIVAR BEHAV RES, V26, P323, DOI 10.1207/s15327906mbr2602_7; Holman C, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002331; Humm JL, 1998, BRAIN RES, V783, P286, DOI 10.1016/S0006-8993(97)01356-5; Ioannidis JPA, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001747; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Iqbal SA, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002333; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; Kovesdi E, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00042; Kozlowski DA, 1996, J NEUROSCI, V16, P4776; Krzywinski M, 2014, NAT METHODS, V11, P355, DOI 10.1038/nmeth.2900; Lam TI, 2013, NEUROREHAB NEURAL RE, V27, P889, DOI 10.1177/1545968313491003; Landis SC, 2012, NATURE, V490, P187, DOI 10.1038/nature11556; Linting M, 2007, PSYCHOL METHODS, V12, P336, DOI 10.1037/1082-989X.12.3.336; Linting M, 2007, PSYCHOL METHODS, V12, P359, DOI 10.1037/1082-989X.12.3.359; Linting M, 2012, J PERS ASSESS, V94, P12, DOI 10.1080/00223891.2011.627965; Longo FM, 2013, NAT REV DRUG DISCOV, V12, P507, DOI 10.1038/nrd4024; Manley GT, 2013, JAMA-J AM MED ASSOC, V310, P473, DOI 10.1001/jama.2013.169158; Massa SM, 2006, J NEUROSCI, V26, P5288, DOI 10.1523/JNEUROSCI.3547-05.2006; Matter AM, 2011, NEUROREHAB NEURAL RE, V25, P558, DOI 10.1177/1545968310397206; Meeker RB, 2012, J NEUROIMMUNE PHARM, V7, P388, DOI 10.1007/s11481-011-9325-0; Mejia ROS, 2001, NEUROSURGERY, V48, P1393; Morganti JM, 2015, J NEUROSCI, V35, P748, DOI 10.1523/JNEUROSCI.2405-14.2015; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Nielson JL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9581; Paillard T, 2015, J CLIN NEUROL, V11, P212, DOI 10.3988/jcn.2015.11.3.212; Rubin MA, 2015, NATURE, V520, P290, DOI 10.1038/520290a; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Shi J, 2013, STEM CELLS, V31, P2561, DOI 10.1002/stem.1516; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Taylor J, 2015, P NATL ACAD SCI USA, V112, P7629, DOI 10.1073/pnas.1507583112; Tep C, 2013, J NEUROSCI, V33, P397, DOI 10.1523/JNEUROSCI.0399-12.2013; Tsilidis KK, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001609; van Praag H, 2008, NEUROMOL MED, V10, P128, DOI 10.1007/s12017-008-8028-z; Vaynman S, 2004, EUR J NEUROSCI, V20, P2580, DOI 10.1111/j.1460-9568.2004.03720.x; Vukovic J, 2012, J NEUROSCI, V32, P6435, DOI 10.1523/JNEUROSCI.5925-11.2012; Wahl AS, 2014, SCIENCE, V344, P1250, DOI 10.1126/science.1253050; Yang T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003604; Yune TY, 2007, J NEUROSCI, V27, P7751, DOI 10.1523/JNEUROSCI.1661-07.2007	54	11	11	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	FEB 16	2017	7								42474	10.1038/srep42474			10	Multidisciplinary Sciences	Science & Technology - Other Topics	EK9CB	WOS:000394220400001	28205533	DOAJ Gold, Green Published			2021-06-18	
J	Meier, TB; Lancaster, MA; Mayer, AR; Teague, TK; Savitz, J				Meier, Timothy B.; Lancaster, Melissa A.; Mayer, Andrew R.; Teague, T. Kent; Savitz, Jonathan			Abnormalities in Functional Connectivity in Collegiate Football Athletes with and without a Concussion History: Implications and Role of Neuroactive Kynurenine Pathway Metabolites	JOURNAL OF NEUROTRAUMA			English	Article						kynurenine; mild traumatic brain injury; quinolinic acid; resting state; sport concussion	TRAUMATIC BRAIN-INJURY; RESTING-STATE-FMRI; QUINOLINIC ACID; RECURRENT CONCUSSION; CEREBROSPINAL-FLUID; CEREBRAL-CORTEX; NETWORK; HIPPOCAMPAL; ACTIVATION; DEPRESSION	There is a great need to identify potential long-term consequences of contact sport exposure and to identify molecular pathways that may be associated with these changes. We tested the hypothesis that football players with (Ath-mTBI) (n = 25) and without a concussion history (Ath) (n = 24) have altered resting state functional connectivity in regions with previously documented structural changes relative to healthy controls without football or concussion history (HC) (n = 27). As a secondary aim, we tested the hypothesis that group differences in functional connectivity are moderated by the relative ratio of neuroprotective to neurotoxic metabolites of the kynurenine pathway. Ath-mTBI had significantly increased connectivity of motor cortex to the supplementary motor area relative to Ath and HC. In contrast, both Ath-mTBI and Ath had increased connectivity between the left orbital frontal cortex and the right lateral frontal cortex, and between the left cornu ammonis areas 2 and 3/dentate gyrus (CA2-3/DG) of the hippocampus and the middle and posterior cingulate cortices, relative to HC. The relationship between the ratio of plasma concentrations of kynurenic acid to quinolinic acid (KYNA/QUIN) and left pregenual anterior cingulate cortex connectivity to multiple regions as well as KYNA/QUIN and right CA2-3/DG connectivity to multiple regions differed significantly according to football and concussion history. The results suggest that football exposure with and without concussion history can have a significant effect on intrinsic brain connectivity and implicate the kynurenine metabolic pathway as one potential moderator of functional connectivity dependent on football exposure and concussion history.	[Meier, Timothy B.; Lancaster, Melissa A.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Meier, Timothy B.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA; [Lancaster, Melissa A.] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA; [Meier, Timothy B.; Savitz, Jonathan] Laureate Inst Brain Res, Tulsa, OK USA; [Mayer, Andrew R.] Lovelace Biomed & Environm Res Inst, Mind Res Network, Albuquerque, NM USA; [Mayer, Andrew R.] Univ New Mexico, Sch Med, Dept Neurol, Albuquerque, NM 87131 USA; [Mayer, Andrew R.] Univ New Mexico, Sch Med, Dept Psychiat, Albuquerque, NM 87131 USA; [Mayer, Andrew R.] Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA; [Teague, T. Kent] Univ Oklahoma, Coll Med, Dept Surg, Tulsa, OK USA; [Teague, T. Kent] Univ Oklahoma, Coll Med, Dept Psychiat, Tulsa, OK USA; [Teague, T. Kent] Univ Oklahoma, Coll Pharm, Dept Pharmaceut Sci, Tulsa, OK USA; [Teague, T. Kent] Oklahoma State Univ, Ctr Hlth Sci, Dept Biochem & Microbiol, Tulsa, OK USA; [Savitz, Jonathan] Univ Tulsa, Fac Community Med, Tulsa, OK 74104 USA	Meier, TB (corresponding author), Med Coll Wisconsin, Neurosci Res Ctr, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	tmeier@mcw.edu	Teague, T. Kent/A-2527-2008; Savitz, Jonathan/C-3088-2009	Teague, T. Kent/0000-0002-4680-5440; Savitz, Jonathan/0000-0001-8143-182X	Laureate Institute for Brain Research; William K. Warren Foundation; Research and Education Program of the Advancing a Healthier Wisconsin endowment at the Medical College of Wisconsin	This research was conducted using internal funds from the Laureate Institute for Brain Research, which is supported by The William K. Warren Foundation. Dr. Meier received support for this work through a project funded through the Research and Education Program, a component of the Advancing a Healthier Wisconsin endowment at the Medical College of Wisconsin. The authors thank the psychiatric assessment team and MRI technicians at the Laureate Institute for Brain Research; Dr. Rashmi Singh and Dr. Patrick Bellgowan for their assistance with data collection; and Christopher Nerio, David Polanski, Dr. Thomas Allen, and Dr. Lamont Cavanagh for athlete referral and injury oversight.	Amaral M, 2013, J MOL MED, V91, P705, DOI 10.1007/s00109-013-1046-9; Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Bay-Richter C, 2015, BRAIN BEHAV IMMUN, V43, P110, DOI 10.1016/j.bbi.2014.07.012; Bell MJ, 1999, CRIT CARE MED, V27, P493, DOI 10.1097/00003246-199903000-00023; Berger RP, 2004, J NEUROTRAUM, V21, P1123; Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Chen G, 2014, NEUROIMAGE, V99, P571, DOI 10.1016/j.neuroimage.2014.06.027; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Czerniak SM, 2015, BRAIN IMAGING BEHAV, V9, P323, DOI 10.1007/s11682-014-9312-1; Dantzer R, 2011, PSYCHONEUROENDOCRINO, V36, P426, DOI 10.1016/j.psyneuen.2010.09.012; De Beaumont L, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-109; De Beaumont L, 2012, CEREB CORTEX, V22, P112, DOI 10.1093/cercor/bhr096; De Beaumont L, 2011, J ATHL TRAINING, V46, P234; Didehbani N, 2013, ARCH CLIN NEUROPSYCH, V28, P418, DOI 10.1093/arclin/act028; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Doucet GE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154660; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; FOSTER AC, 1984, NEUROSCI LETT, V48, P273, DOI 10.1016/0304-3940(84)90050-8; FUKUI S, 1991, J NEUROCHEM, V56, P2007, DOI 10.1111/j.1471-4159.1991.tb03460.x; Goh JOS, 2011, AGING DIS, V2, P30; Goswami R, 2016, BRAIN STRUCT FUNCT, V221, P1911, DOI 10.1007/s00429-015-1012-0; Guillemin GJ, 2012, FEBS J, V279, P1356, DOI 10.1111/j.1742-4658.2012.08485.x; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Henry LC, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-105; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; Iraji A, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/4072402; Iraji A, 2015, J NEUROTRAUM, V32, P1031, DOI 10.1089/neu.2014.3610; Jo HJ, 2010, NEUROIMAGE, V52, P571, DOI 10.1016/j.neuroimage.2010.04.246; Jones TB, 2010, NEUROIMAGE, V49, P401, DOI 10.1016/j.neuroimage.2009.07.051; Kasahara M, 2010, NEUROLOGY, V75, P168, DOI 10.1212/WNL.0b013e3181e7ca58; Kerr ZY, 2015, AM J SPORT MED, V43, P606, DOI 10.1177/0363546514562180; Koerte IK, 2016, BRAIN IMAGING BEHAV, V10, P792, DOI 10.1007/s11682-015-9442-0; Kraemer WJ, 2005, J STRENGTH COND RES, V19, P485; List J, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00228; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Marchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056805; Maxwell WL, 2010, BRAIN, V133, P139, DOI 10.1093/brain/awp264; Mayer AR, 2015, NEUROSCI BIOBEHAV R, V49, P8, DOI 10.1016/j.neubiorev.2014.11.016; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McDonald BC, 2012, BRAIN IMAGING BEHAV, V6, P193, DOI 10.1007/s11682-012-9173-4; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meier T. B., 2016, BRAIN IMAGING BEHAV; Meier TB, 2016, J NEUROTRAUM, V33, P1349, DOI 10.1089/neu.2015.4118; Meier TB, 2016, BRAIN BEHAV IMMUN, V53, P39, DOI 10.1016/j.bbi.2015.11.003; Meier TB, 2016, J NEUROTRAUM, V33, P330, DOI 10.1089/neu.2015.3919; Ode JJ, 2007, MED SCI SPORT EXER, V39, P403, DOI 10.1249/01.mss.0000247008.19127.3e; Okuda S, 1998, J NEUROCHEM, V70, P299; Orr CA, 2016, J NEUROTRAUM, V33, P803, DOI 10.1089/neu.2014.3721; Perez-Polo JR, 2013, J NEUROTRAUM, V30, P727, DOI 10.1089/neu.2012.2650; Quiroz YT, 2010, ANN NEUROL, V68, P865, DOI 10.1002/ana.22105; SAITO K, 1992, NEUROSCIENCE, V51, P25, DOI 10.1016/0306-4522(92)90467-G; Sasaki Takeshi, 2014, J Neurosurg, V120, P882, DOI 10.3171/2013.12.JNS132092; Savitz J, 2015, PSYCHONEUROENDOCRINO, V52, P200, DOI 10.1016/j.psyneuen.2014.11.015; Savitz J, 2015, NEUROPSYCHOPHARMACOL, V40, P463, DOI 10.1038/npp.2014.194; SCHWARCZ R, 1983, SCIENCE, V219, P316, DOI 10.1126/science.6849138; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Seichepine DR, 2013, J NEUROTRAUM, V30, P1299, DOI 10.1089/neu.2012.2690; Seidenberg M, 2009, NEUROLOGY, V73, P612, DOI 10.1212/WNL.0b013e3181b389ad; Shulman RG, 2004, TRENDS NEUROSCI, V27, P489, DOI 10.1016/j.tins.2004.06.005; Shultz SR, 2012, BEHAV BRAIN RES, V229, P145, DOI 10.1016/j.bbr.2011.12.015; Singh R, 2016, J NEUROL NEUROSUR PS, V87, P670, DOI 10.1136/jnnp-2015-311369; Singh R, 2014, JAMA-J AM MED ASSOC, V311, P1883, DOI 10.1001/jama.2014.3313; Sinz EH, 1998, J CEREBR BLOOD F MET, V18, P610, DOI 10.1097/00004647-199806000-00002; Slobounov SM, 2011, NEUROIMAGE, V55, P1716, DOI 10.1016/j.neuroimage.2011.01.024; Sours C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134019; Sours C, 2013, BRAIN RES, V1537, P201, DOI 10.1016/j.brainres.2013.08.034; St'astny F, 2000, BRAIN RES BULL, V53, P415, DOI 10.1016/S0361-9230(00)00368-3; Stamm JM, 2015, J NEUROTRAUM, V32, P1768, DOI 10.1089/neu.2014.3822; Stevens MC, 2012, BRAIN IMAGING BEHAV, V6, P293, DOI 10.1007/s11682-012-9157-4; Stockmeier CA, 2004, BIOL PSYCHIAT, V56, P640, DOI 10.1016/j.biopsych.2004.08.022; Strain JF, 2015, JAMA NEUROL, V72, P773, DOI 10.1001/jamaneurol.2015.0206; Urban KJ, 2015, J NEUROTRAUM, V32, P833, DOI 10.1089/neu.2014.3577; Van Leemput K, 2009, HIPPOCAMPUS, V19, P549, DOI 10.1002/hipo.20615; Weissberg I, 2014, JAMA NEUROL, V71, P1453, DOI 10.1001/jamaneurol.2014.2682; Yan EB, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0328-2; Yarkoni T, 2011, NAT METHODS, V8, P665, DOI [10.1038/NMETH.1635, 10.1038/nmeth.1635]; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; Zhan J, 2015, J NERV MENT DIS, V203, P786, DOI 10.1097/NMD.0000000000000368; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748; Zhu DC, 2015, J NEUROTRAUM, V32, P327, DOI 10.1089/neu.2014.3413	86	11	11	0	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB 15	2017	34	4					824	837		10.1089/neu.2016.4599			14	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	EL0XD	WOS:000394344200009	27618518				2021-06-18	
J	Qin, XH; You, H; Cao, F; Wu, Y; Peng, JH; Pang, JW; Xu, H; Chen, Y; Chen, LG; Vitek, MP; Li, FQ; Sun, XC; Jiang, Y				Qin, Xinghu; You, Hong; Cao, Fang; Wu, Yue; Peng, Jianhua; Pang, Jinwei; Xu, Hong; Chen, Yue; Chen, Ligang; Vitek, Michael P.; Li, Fengqiao; Sun, Xiaochuan; Jiang, Yong			Apolipoprotein E Mimetic Peptide Increases Cerebral Glucose Uptake by Reducing Blood-Brain Barrier Disruption after Controlled Cortical Impact in Mice: An F-18-Fluorodeoxyglucose PET/CT Study	JOURNAL OF NEUROTRAUMA			English	Article						brain edema; COG1410; metabolism; TBI; VEGF	ENDOTHELIAL GROWTH-FACTOR; MICROGLIAL ACTIVATION; RAT MODEL; INJURY; COG1410; INSULIN; CORTEX; INFLAMMATION; ANGIOGENESIS; METABOLISM	Traumatic brain injury (TBI) disrupts the blood-brain barrier (BBB) and reduces cerebral glucose uptake. Vascular endothelial growth factor (VEGF) is believed to play a key role in TBI, and COG1410 has demonstrated neuroprotective activity in several models of TBI. However, the effects of COG1410 on VEGF and glucose metabolism following TBI are unknown. The current study aimed to investigate the expression of VEGF and glucose metabolism effects in C57BL/6J male mice subjected to experimental TBI. The results showed that controlled cortical impact (CCI)-induced vestibulo-motor deficits were accompanied by increases in brain edema and the expression of VEGF, with a decrease in cerebral glucose uptake. COG1410 treatment significantly improved vestibulomotor deficits and glucose uptake and produced decreases in VEGF in the pericontusion and ipsilateral hemisphere of injury, as well as in brain edema and neuronal degeneration compared with the control group. These data support that COG1410 may have potential as an effective drug therapy for TBI.	[Qin, Xinghu; Peng, Jianhua; Pang, Jinwei; Chen, Yue; Chen, Ligang; Jiang, Yong] Southwest Med Univ, Affiliated Hosp, Dept Neurosurg, Luzhou 646000, Peoples R China; [Qin, Xinghu; Xu, Hong] Peoples Hosp Deyang City, Dept Neurosurg, Deyang, Peoples R China; [You, Hong] Peoples Hosp Deyang City, Dept Oncol, Deyang, Peoples R China; [Cao, Fang] Zunyi Med Coll, Affiliated Hosp, Dept Cerebrovasc Dis, Zunyi, Peoples R China; [Wu, Yue; Sun, Xiaochuan] Chongqing Med Univ, Affiliated Hosp 1, Dept Surg, Chongqing, Peoples R China; [Vitek, Michael P.] Duke Univ, Med Ctr, Dept Med Neurol, Med, Durham, NC 27710 USA; [Li, Fengqiao] Cognosci Inc, Res Triangle Pk, NC USA	Jiang, Y (corresponding author), Southwest Med Univ, Affiliated Hosp, Dept Neurosurg, Luzhou 646000, Peoples R China.	jiangy0122@gmail.com		Vitek, Michael/0000-0001-8140-8048; Peng, Jianhua/0000-0003-3348-9538	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81371319, 81000528]; Program for New Century Excellent Talents in UniversityProgram for New Century Excellent Talents in University (NCET) [NCET-12-1057]; Foundation for Outstanding Youth Academic Technology Leaders of Sichuan Province [2041JQ0022]; Cognosci Inc. [COG1410]	This work was supported by the National Natural Science Foundation of China (81371319, 81000528), the Program for New Century Excellent Talents in University (NCET-12-1057), and the Foundation for Outstanding Youth Academic Technology Leaders of Sichuan Province (2041JQ0022). We thank Cognosci Inc. for providing COG1410.	Agudo J, 2012, DIABETES, V61, P2851, DOI 10.2337/db12-0134; Allaman I, 2011, PSYCHOPHARMACOLOGY, V216, P75, DOI 10.1007/s00213-011-2190-y; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Bauer AT, 2010, J CEREBR BLOOD F MET, V30, P837, DOI 10.1038/jcbfm.2009.248; Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; Bosomtwi A, 2008, J CEREBR BLOOD F MET, V28, P1978, DOI 10.1038/jcbfm.2008.85; Byrnes Kimberly R, 2014, Front Neuroenergetics, V5, P13, DOI 10.3389/fnene.2013.00013; Cao F, 2016, J NEUROTRAUM, V33, P175, DOI 10.1089/neu.2015.3887; Damianovich M, 2013, CLIN LUNG CANCER, V14, P688, DOI 10.1016/j.cllc.2013.06.007; Dimopoulos S, 2015, CLIN OPHTHALMOL, V9, P1537, DOI 10.2147/OPTH.S87919; Fernandez-Robredo P, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/213505; Foley N, 2008, J NEUROTRAUM, V25, P1415, DOI 10.1089/neu.2008.0628; Foster LJ, 2000, AM J PHYSIOL-CELL PH, V279, pC877; Gao WW, 2015, BRAIN RES, V1622, P230, DOI 10.1016/j.brainres.2015.04.035; Hagberg CE, 2012, NATURE, V490, P426, DOI 10.1038/nature11464; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Huang YD, 2001, P NATL ACAD SCI USA, V98, P8838, DOI 10.1073/pnas.151254698; Iliadis F, 2011, DIABETES RES CLIN PR, V93, pS86, DOI 10.1016/S0168-8227(11)70019-5; Jiang Y, 2007, J NEUROTRAUM, V24, P1802, DOI 10.1089/neu.2007.0299; Jiang Y, 2012, J NEUROTRAUM, V29, P2332, DOI 10.1089/neu.2012.2362; Johanson C, 2011, J NEURAL TRANSM, V118, P115, DOI 10.1007/s00702-010-0498-0; Johnstone VPA, 2015, J NEUROTRAUM, V32, P1333, DOI 10.1089/neu.2014.3785; Kato T, 2007, J NEUROTRAUM, V24, P919, DOI 10.1089/neu.2006.0203; Kaufman NA, 2010, BEHAV BRAIN RES, V214, P395, DOI 10.1016/j.bbr.2010.06.017; Kaya M, 2011, METHODS MOL BIOL, V763, P369, DOI 10.1007/978-1-61779-191-8_25; Keeney JTR, 2015, J ALZHEIMERS DIS, V48, P411, DOI 10.3233/JAD-150348; Laskowitz DT, 2006, ACTA NEUROL SCAND, V114, P15, DOI 10.1111/j.1600-0404.2006.00680.x; Laskowitz DT, 2001, EXP NEUROL, V167, P74, DOI 10.1006/exnr.2001.7541; Li J, 2012, J NEUROTRAUM, V29, P2635, DOI 10.1089/neu.2012.2411; Li L, 2012, J CEREBR BLOOD F MET, V32, P2023, DOI 10.1038/jcbfm.2012.106; Li M, 2016, CLIN NEUROL NEUROSUR, V144, P7, DOI 10.1016/j.clineuro.2016.02.032; Liew HK, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-13; Mountney A, 2016, J NEUROTRAUM, V33, P567, DOI 10.1089/neu.2015.4130; Namjoshi DR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053529; Phillips MC, 2014, IUBMB LIFE, V66, P616, DOI 10.1002/iub.1314; Pocivavsek A, 2009, J NEUROIMMUNOL, V214, P25, DOI 10.1016/j.jneuroim.2009.06.010; Pocivavsek A, 2009, GLIA, V57, P444, DOI 10.1002/glia.20772; Russell KL, 2014, PROSTAG LEUKOTR ESS, V90, P5, DOI 10.1016/j.plefa.2013.11.003; Schumacher M, 2016, J STEROID BIOCHEM, V160, P53, DOI 10.1016/j.jsbmb.2015.11.010; Selwyn R, 2013, J NEUROTRAUM, V30, P1943, DOI 10.1089/neu.2013.2928; Shin JY, 2016, OPTOMETRY VISION SCI, V93, P173, DOI 10.1097/OPX.0000000000000777; Terpolilli NA, 2013, J CEREBR BLOOD F MET, V33, P311, DOI 10.1038/jcbfm.2012.176; Thau-Zuchman O, 2012, NEUROSCIENCE, V202, P334, DOI 10.1016/j.neuroscience.2011.11.071; Ulbrich C, 2012, J STEROID BIOCHEM, V131, P10, DOI 10.1016/j.jsbmb.2012.01.007; van Berkel A, 2014, J NUCL MED, V55, P1253, DOI 10.2967/jnumed.114.137034; Vavilala MS, 2014, CRIT CARE MED, V42, P2258, DOI 10.1097/CCM.0000000000000507; Wang H, 2007, NEUROSCIENCE, V144, P1324, DOI 10.1016/j.neuroscience.2006.11.017; Wang K, 2014, CHINESE MED J-PEKING, V127, P1964, DOI 10.3760/cma.j.issn.0366-6999.20120638; Wei K, 2013, NAT MED, V19, P1331, DOI 10.1038/nm.3295	50	11	12	0	10	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB 15	2017	34	4					943	951		10.1089/neu.2016.4485			9	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	EL0XD	WOS:000394344200022	27411737	Green Published			2021-06-18	
J	Tang, QL; Wu, X; Weng, WJ; Li, HP; Feng, JF; Mao, QN; Gao, GY; Jiang, JY				Tang, Qilin; Wu, Xiang; Weng, Weiji; Li, Hongpeng; Feng, Junfeng; Mao, Qing; Gao, Guoyi; Jiang, Jiyao			The preventive effect of dexmedetomidine on paroxysmal sympathetic hyperactivity in severe traumatic brain injury patients who have undergone surgery: a retrospective study	PEERJ			English	Article						Paroxysmal sympathetic hyperactivity; Dexmedetomidine; Traumatic brain injury; Preventive effect; Prognosis	INTENSIVE-CARE-UNIT; AUTONOMIC INSTABILITY; DIENCEPHALIC SEIZURES; DIAGNOSTIC-CRITERIA; AFFERENT STIMULI; HEAD-INJURY; DYSAUTONOMIA; DYSTONIA; OVERRESPONSIVENESS; BROMOCRIPTINE	Background. Paroxysmal sympathetic hyperactivity (PSH) results and aggravates in secondary brain injury, which seriously affects the prognosis of severe traumatic brain injury patients. Although several studies have focused on the treatment of PSH, few have concentrated on its prevention. Methods. Ninety post-operation (post-op) severe traumatic brain injury (sTBI) patients admitted from October 2014 to April 2016 were chosen to participate in this study. Fifty of the post-op sTBI patients were sedated with dexmedetomidine and were referred as the "dexmedetomidine group" (admitted from May 2015 to April 2016). The other 40 patients (admitted from October 2014 to May 2015) received other sedations and were referred as the "control group." The two groups were then compared based on their PSH scores and the scores and ratios of those patients who met the criteria of "probable," "possible" and "unlikely" using the PSH assessment measure (PSH-AM) designed by Baguley et al. (2014). The durations of the neurosurgery intensive care unit (NICU) and hospital stays and the Glasgow outcome scale (GOS) values for the two groups were also compared to evaluate the therapeutic effects and the patients' prognosis. Results. The overall PSH score for the dexmedetomidine group was 5.26 +/- 4.66, compared with 8.58 +/- 8.09 for the control group. The difference between the two groups' PSH scores was significant (P = 0.017). The score of the patients who met the criterion of "probable" was 18.33 +/- 1.53 in the dexmedetomidine group and 22.63 +/- 2.97 in the control group, and the difference was statistically significant (P = 0.045). The ratio of patients who were classified as "unlikely" between the two groups was statistically significant (P = 0.028); that is, 42 (84%) in the dexmedetomidine group and 25 (62.5%) in the control group. The differences in NICU, hospital stays and GOS values between the two groups were not significant. Conclusion. Dexmedetomidine has a preventive effect on PSH in sTBI patients who have undergone surgery.	[Tang, Qilin; Wu, Xiang; Weng, Weiji; Feng, Junfeng; Mao, Qing; Gao, Guoyi; Jiang, Jiyao] Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med, Dept Neurosurg, Shanghai, Peoples R China; [Tang, Qilin; Wu, Xiang; Weng, Weiji; Feng, Junfeng; Mao, Qing; Gao, Guoyi; Jiang, Jiyao] Shanghai Inst Head Trauma, Shanghai, Peoples R China; [Li, Hongpeng] Rizhao City Hosp Traditional Chinese Med, Dept Neurosurg, Rizhao, Peoples R China	Gao, GY (corresponding author), Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med, Dept Neurosurg, Shanghai, Peoples R China.; Gao, GY (corresponding author), Shanghai Inst Head Trauma, Shanghai, Peoples R China.	gao3@sina.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81671198]; Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support [20152212]	This work was supported by the National Natural Science Foundation of China (No. 81671198) and grants from the Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support (No. 20152212). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baguley IJ, 2008, MED HYPOTHESES, V70, P26, DOI 10.1016/j.mehy.2007.04.037; Baguley IJ, 2007, BRAIN INJURY, V21, P1175, DOI 10.1080/02699050701687375; Baguley IJ, 2007, J NEUROL NEUROSUR PS, V78, P539, DOI 10.1136/jnnp.2006.096388; Baguley IJ, 2006, BRAIN INJURY, V20, P437, DOI 10.1080/02699050600664715; Baguley IJ, 2014, J NEUROTRAUM, V31, P1515, DOI 10.1089/neu.2013.3301; Baguley IJ, 2009, AM J PHYS MED REHAB, V88, P615, DOI 10.1097/PHM.0b013e3181aeab96; Baguley IJ, 2009, ARCH PHYS MED REHAB, V90, P580, DOI 10.1016/j.apmr.2008.10.020; Baguley IJ, 2008, SEMIN NEUROL, V28, P716, DOI 10.1055/s-0028-1105971; Becker R, 2000, J CLIN NEUROSCI, V7, P316, DOI 10.1054/jocn.1999.0227; BHIGJEE AI, 1985, J NEUROL SCI, V71, P77, DOI 10.1016/0022-510X(85)90038-3; Blackman JA, 2004, ARCH NEUROL-CHICAGO, V61, P321, DOI 10.1001/archneur.61.3.321; Boeve BF, 1998, MAYO CLIN PROC, V73, P148; BULLARD DE, 1987, ANN NEUROL, V21, P609, DOI 10.1002/ana.410210617; Cai Y, 2014, MOL MED REP, V9, P1542, DOI 10.3892/mmr.2014.2034; Choi HA, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0370-3; Cosar M, 2009, SURG NEUROL, V71, P54, DOI 10.1016/j.surneu.2007.08.020; Cuny E, 2001, BRAIN INJURY, V15, P917, DOI 10.1080/02699050110065277; Dahmani S, 2005, ANESTHESIOLOGY, V103, P969, DOI 10.1097/00000542-200511000-00011; Do D, 2000, J NEUROL NEUROSUR PS, V69, P832, DOI 10.1136/jnnp.69.6.832; Dolce G, 2021, J NEUROTRAUM, V38, P1441, DOI 10.1089/neu.2008.0536; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; Fernandez-Ortega JF, 2006, J TRAUMA, V61, P1129, DOI 10.1097/01.ta.0000197634.83217.80; Fernandez-Ortega JF, 2012, J NEUROTRAUM, V29, P1364, DOI 10.1089/neu.2011.2033; Goddeau RP, 2007, NEUROCRIT CARE, V7, P217, DOI 10.1007/s12028-007-0066-0; Greer DM, 2008, STROKE, V39, P3029, DOI 10.1161/STROKEAHA.108.521583; Hendricks HT, 2007, CLIN REHABIL, V21, P545, DOI 10.1177/0269215507075260; Hinson HE, 2012, CURR OPIN CRIT CARE, V18, P139, DOI 10.1097/MCC.0b013e3283513290; JENNETT B, 1975, LANCET, V1, P480; Kern J, 2016, CHEST, V149, pE39, DOI 10.1016/j.chest.2015.08.003; Ko SB, 2010, NEUROLOGIST, V16, P384, DOI 10.1097/NRL.0b013e3181b1cdff; Lv LQ, 2011, J TRAUMA, V71, P538, DOI 10.1097/TA.0b013e31820ebee1; Lv LQ, 2010, J NEUROTRAUM, V27, P1945, DOI 10.1089/neu.2010.1391; Martin Eike, 2003, J Intensive Care Med, V18, P29, DOI 10.1177/0885066602239122; Mehta NM, 2008, JPEN-PARENTER ENTER, V32, P281, DOI 10.1177/0148607108316196; Nelson LE, 2003, ANESTHESIOLOGY, V98, P428, DOI 10.1097/00000542-200302000-00024; Panzer Oliver, 2011, Anesthesiol Clin, V29, P587, DOI 10.1016/j.anclin.2011.09.002; Penfield W, 1929, ARCH NEURO PSYCHIATR, V22, P358, DOI 10.1001/archneurpsyc.1929.02220020174010; Perkes I, 2010, ANN NEUROL, V68, P126, DOI 10.1002/ana.22066; Perkes IE, 2011, BRAIN INJURY, V25, P925, DOI 10.3109/02699052.2011.589797; PRANZATELLI MR, 1991, J CHILD NEUROL, V6, P115, DOI 10.1177/088307389100600204; Rabinstein AA, 2008, CURR TREAT OPTION N, V10, P151, DOI 10.1007/s11940-008-0016-y; Rabinstein AA, 2007, NEUROL RES, V29, P680, DOI 10.1179/016164107X240071; Russo RN, 2000, J PAEDIATR CHILD H, V36, P283, DOI 10.1046/j.1440-1754.2000.00485.x; SNEED RC, 1995, ARCH PHYS MED REHAB, V76, P101, DOI 10.1016/S0003-9993(95)80051-4; Thorley RR, 2001, ARCH PHYS MED REHAB, V82, P246, DOI 10.1053/apmr.2001.18698; Tracey KJ, 2007, J CLIN INVEST, V117, P289, DOI 10.1172/JCI30555; Venn RM, 2000, CRIT CARE, V4, P302, DOI 10.1186/cc712	48	11	12	1	7	PEERJ INC	LONDON	341-345 OLD ST, THIRD FLR, LONDON, EC1V 9LL, ENGLAND	2167-8359			PEERJ	PeerJ	FEB 15	2017	5								e2986	10.7717/peerj.2986			15	Multidisciplinary Sciences	Science & Technology - Other Topics	EO7VZ	WOS:000396899500002	28229021	DOAJ Gold, Green Published			2021-06-18	
J	Russell, DW; Janz, DR; Emerson, WL; May, AK; Bernard, GR; Zhao, ZG; Koyama, T; Ware, LB				Russell, Derek W.; Janz, David R.; Emerson, William L.; May, Addison K.; Bernard, Gordon R.; Zhao, Zhiguo; Koyama, Tatsuki; Ware, Lorraine B.			Early exposure to hyperoxia and mortality in critically ill patients with severe traumatic injuries	BMC PULMONARY MEDICINE			English	Article							INTENSIVE-CARE-UNIT; ARTERIAL HYPEROXIA; BRAIN-INJURY; CEREBRAL METABOLISM; CARDIAC-ARREST; INTRACRANIAL-PRESSURE; NORMOBARIC HYPEROXIA; HOSPITAL MORTALITY; SEVERE SEPSIS; OXYGEN	Background: Hyperoxia is common early in the course of resuscitation of critically ill patients. It has been associated with mortality in some, but not all, studies of cardiac arrest patients and other critically ill cohorts. Reasons for the inconsistency are unclear and may depend on unmeasured patient confounders, the timing and duration of hyperoxia, population characteristics, or the way that hyperoxia is defined and measured. We sought to determine whether, in a prospectively collected cohort of mechanically ventilated patients with traumatic injuries with and without head trauma, higher maximum partial pressure of arterial oxygen (PaO2) within 24 hours of admission would be associated with increased risk of in-hospital mortality. Methods: Critically ill patients with traumatic injuries undergoing invasive mechanical ventilation enrolled in the Validating Acute Lung Injury biomarkers for Diagnosis (VALID) study were included in this study. All arterial blood gases (ABGs) from the first 24 hours of admission were recorded. Primary analysis was comparison of the highest PaO2 between hospital survivors and non-survivors. Results: A total of 653 patients were evaluated for inclusion. Of these, 182 were not mechanically ventilated or did not have an ABG measured in the first 24 hours, leaving 471 patients in the primary analysis. In survivors, the maximum PaO2 was 141 mmHg (median, interquartile range 103 - 212) compared to 148 mmHg (IQR 105 - 209) in non-survivors (p = 0.82). In the subgroup with head trauma (n = 266), the maximum PaO2 was 133 mmHg (IQR 97 - 187) among survivors and 152 mmHg (108 - 229) among non-survivors (p = 0.19). After controlling for age, injury severity score, number of arterial blood gases, and fraction of inspired oxygen, maximum PaO2 was not associated with increased mortality (OR 1.27 for every fold increase of PaO2 (95% CI 0.72 - 2.25). Conclusions: In mechanically ventilated patients with severe traumatic injuries, hyperoxia in the first 24 hours of admission was not associated with increased risk of death or worsened neurological outcomes in a setting without brain tissue oxygenation monitoring.	[Russell, Derek W.] Univ Alabama Birmingham, Lung Hlth Ctr, Div Pulm & Crit Care Med, 1900 Univ Blvd,THT 423, Birmingham, AL 35233 USA; [Janz, David R.] Louisiana State Univ, Sch Med, Sect Pulm & Crit Care Med, New Orleans, LA 70112 USA; [Emerson, William L.; May, Addison K.; Bernard, Gordon R.; Zhao, Zhiguo; Koyama, Tatsuki; Ware, Lorraine B.] Vanderbilt Univ, Dept Med, Nashville, TN USA; [Emerson, William L.; May, Addison K.; Bernard, Gordon R.; Zhao, Zhiguo; Koyama, Tatsuki; Ware, Lorraine B.] Vanderbilt Univ, Dept Pathol, Dept Microbiol & Immunol, Nashville, TN USA	Russell, DW (corresponding author), Univ Alabama Birmingham, Lung Hlth Ctr, Div Pulm & Crit Care Med, 1900 Univ Blvd,THT 423, Birmingham, AL 35233 USA.	dwrussell@uabmc.edu	Ware, Lorraine/AAJ-9307-2021; Russell, Derek/X-7040-2019	Ware, Lorraine/0000-0002-9429-4702; Russell, Derek/0000-0002-2716-1344	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HL103836, 132 HL087738]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [K24HL103836, T32HL087738] Funding Source: NIH RePORTER	This study was funded by the NIH through the following grants: HL103836 and 132 HL087738.	Ainslie PN, 2014, CLIN SCI, V126, P661, DOI 10.1042/CS20130343; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bellomo R, 2011, CRIT CARE, V15, DOI 10.1186/cc10090; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS65; Branson RD, 2013, RESP CARE, V58, P86, DOI 10.4187/respcare.02251; Brenner M, 2012, ARCH SURG-CHICAGO, V147, P1042, DOI 10.1001/archsurg.2012.1560; Callcut RA, 2016, J TRAUMA ACUTE CARE, V80, P210, DOI 10.1097/TA.0000000000000930; de Jonge E, 2008, CRIT CARE, V12, DOI 10.1186/cc7150; Diringer MN, 2007, J NEUROSURG, V106, P526, DOI 10.3171/jns.2007.106.4.526; Eastwood G, 2012, INTENS CARE MED, V38, P91, DOI 10.1007/s00134-011-2419-6; Floyd TF, 2003, J APPL PHYSIOL, V95, P2453, DOI 10.1152/japplphysiol.00303.2003; Harrell Frank E., 2001, REGRESSION MODELING; Helmerhorst HJF, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1067-6; Helmerhorst HJF, 2015, CRIT CARE MED, V43, P1508, DOI 10.1097/CCM.0000000000000998; Ihle JF, 2013, CRIT CARE RESUSC, V15, P186; Janz DR, 2012, CRIT CARE MED, V40, P3135, DOI 10.1097/CCM.0b013e3182656976; JENNETT B, 1976, LANCET, V1, P1031; Kilgannon JH, 2010, JAMA-J AM MED ASSOC, V303, P2165, DOI 10.1001/jama.2010.707; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Leitgeb J, 2013, EUR J TRAUMA EMERG S, V39, P285, DOI 10.1007/s00068-013-0269-3; Miyamoto O, 2000, NEUROLOGY, V54, P362, DOI 10.1212/WNL.54.2.362; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Narotam PK, 2009, J NEUROSURG, V111, P672, DOI 10.3171/2009.4.JNS081150; Nelskyla A, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-35; Nyquist PA, 2014, CRIT CARE MED, V42, P469, DOI 10.1097/CCM.0b013e3182a525a4; O'Neal HR, 2011, CRIT CARE MED, V39, P1343, DOI 10.1097/CCM.0b013e3182120992; Raj R, 2013, CRIT CARE, V17, DOI 10.1186/cc12856; RCT, 2014, R LANG ENV STAT COMP; Rincon F, 2014, J NEUROL NEUROSUR PS, V85, P799, DOI 10.1136/jnnp-2013-305505; Rincon F, 2014, CRIT CARE MED, V42, P387, DOI 10.1097/CCM.0b013e3182a27732; Rockswold SB, 2013, J NEUROSURG, V118, P1317, DOI 10.3171/2013.2.JNS121468; Siew ED, 2010, CLIN J AM SOC NEPHRO, V5, P1497, DOI 10.2215/CJN.09061209; Siew ED, 2009, J AM SOC NEPHROL, V20, P1823, DOI 10.1681/ASN.2008070673; Singhal AB, 2005, STROKE, V36, P797, DOI 10.1161/01.STR.0000158914.66827.2e; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; Tolias CM, 2004, J NEUROSURG, V101, P435, DOI 10.3171/jns.2004.101.3.0435; University of Texas Southwestern Medical Center, 2000, BRAIN TISS OXYG MON; Vaahersalo J, 2014, CRIT CARE MED, V42, P1463, DOI 10.1097/CCM.0000000000000228; Ware LB, 2013, CRIT CARE, V17, DOI 10.1186/cc13080	39	11	11	0	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2466			BMC PULM MED	BMC Pulm. Med.	FEB 3	2017	17								29	10.1186/s12890-017-0370-1			7	Respiratory System	Respiratory System	EJ6QQ	WOS:000393344300001	28158980	DOAJ Gold, Green Published			2021-06-18	
J	Allison, RZ; Nakagawa, K; Hayashi, M; Donovan, DJ; Koenig, MA				Allison, Randall Z.; Nakagawa, Kazuma; Hayashi, Michael; Donovan, Daniel J.; Koenig, Matthew A.			Derivation of a Predictive Score for Hemorrhagic Progression of Cerebral Contusions in Moderate and Severe Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						Cerebral contusion; Traumatic brain injury; Triage; Critical care; Resource allocation	HEAD TRAUMA; LESIONS	After traumatic brain injury (TBI), hemorrhagic progression of contusions (HPCs) occurs frequently. However, there is no established predictive score to identify high-risk patients for HPC. Consecutive patients who were hospitalized (2008-2013) with non-penetrating moderate or severe TBI were studied. The primary outcome was HPC, defined by both a relative increase in contusion volume by >= 30 % and an absolute increase by >= 10 mL on serial imaging. Logistic regression models were created to identify independent risk factors for HPC. The HPC Score was then derived based on the final model. Among a total of 286 eligible patients, 61 (21 %) patients developed HPC. On univariate analyses, HPC was associated with older age, higher initial blood pressure, antiplatelet medications, anticoagulants, subarachnoid hemorrhage (SAH) subdural hematoma (SDH), skull fracture, frontal contusion, larger contusion volume, and shorter interval from injury to initial CT. In the final model, SAH (OR 6.33, 95 % CI, 1.80-22.23), SDH (OR 3.46, 95 % CI, 1.39-8.63), and skull fracture (OR 2.67, 95 % CI, 1.28-5.58) were associated with HPC. Based on these factors, the HPC Score was derived (SAH = 2 points, SDH = 1 point, and skull fracture = 1 point). This score had an area under the receiver operating curve of 0.77. Patients with a score of 0-2 had a 4.0 % incidence of HPC, while patients with a score of 3-4 had a 34.6 % incidence of HPC. A simple HPC Score was developed for early risk stratification of HPC in patients with moderate or severe TBI.	[Allison, Randall Z.] Univ Texas Med Branch, Dept Surg, Div Neurosurg, Galveston, TX 77555 USA; [Nakagawa, Kazuma; Donovan, Daniel J.; Koenig, Matthew A.] Queens Med Ctr, Inst Neurosci, Dept Surg, Honolulu, HI 96813 USA; [Nakagawa, Kazuma; Koenig, Matthew A.] Univ Hawaii, John A Burns Sch Med, Dept Med, Honolulu, HI 96822 USA; [Hayashi, Michael; Donovan, Daniel J.] Univ Hawaii, John A Burns Sch Med, Dept Surg, Honolulu, HI 96822 USA; [Hayashi, Michael] Queens Med Ctr, Dept Surg, Honolulu, HI USA	Koenig, MA (corresponding author), Queens Med Ctr, Inst Neurosci, Dept Surg, 1301 Punchbowl St QET5, Honolulu, HI 96813 USA.	zainallison@gmail.com; knakagawa@queens.org; mhayashi@queens.org; donovand001@hawaii.rr.com; mkoenig@queens.org		Hayashi, Michael/0000-0001-9743-4945	National Institute on Minority Health and Health Disparities of the National Institutes of Health [P20MD000173]; National Institute on Minority Health and Health DisparitiesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD) [P20MD000173] Funding Source: NIH RePORTER	Dr. Nakagawa was partially supported by the National Institute on Minority Health and Health Disparities of the National Institutes of Health (P20MD000173).	Alahmadi H, 2010, J NEUROSURG, V112, P1139, DOI 10.3171/2009.5.JNS081369; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Chang EF, 2006, NEUROSURGERY, V58, P647, DOI 10.1227/01.NEU.0000197101.68538.E6; Chieregato A, 2005, NEUROSURGERY, V56, P671, DOI 10.1227/01.NEU.0000156200.76331.7A; Engstrom M, 2005, J NEUROTRAUM, V22, P291, DOI 10.1089/neu.2005.22.291; Fabbri A, 2010, J NEUROL NEUROSUR PS, V81, P1275, DOI 10.1136/jnnp.2009.197467; Givner A, 2002, J PEDIATR SURG, V37, P381, DOI 10.1053/jpsu.2002.30825; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Iaccarino C, 2014, J NEUROSURG, V120, P908, DOI 10.3171/2013.12.JNS131090; Kaups KL, 2004, J TRAUMA, V56, P475, DOI 10.1097/01.TA.0000114304.56006.D4; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Narayan RK, 2008, J NEUROTRAUM, V25, P629, DOI 10.1089/neu.2007.0385; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Peterson EC, 2011, J TRAUMA, V71, P1588, DOI 10.1097/TA.0b013e31822b791d; Reed SD, 2001, NEUROLOGY, V57, P305, DOI 10.1212/WNL.57.2.305; Sanus GZ, 2004, NEUROSURG QUART, V14, P97, DOI 10.1097/01.wnq.0000127718.06183.12; Schnuriger B, 2010, J TRAUMA, V68, P881, DOI 10.1097/TA.0b013e3181d3cc58; Stein SC, 2004, NEUROCRIT CARE, V1, P479, DOI 10.1385/NCC:1:4:479; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; Tong WS, 2011, NEURORADIOLOGY, V53, P305, DOI 10.1007/s00234-010-0659-8; White CL, 2009, J TRAUMA, V67, P508, DOI 10.1097/TA.0b013e3181b2519f; Yuan F, 2012, J NEUROTRAUM, V29, P2137, DOI 10.1089/neu.2011.2233	25	11	12	1	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	FEB	2017	26	1					80	86		10.1007/s12028-016-0303-5			7	Critical Care Medicine; Clinical Neurology	General & Internal Medicine; Neurosciences & Neurology	EI2AI	WOS:000392287900012	27473209	Green Accepted			2021-06-18	
J	D'Hondt, F; Lassonde, M; Thebault-Dagher, F; Bernier, A; Gravel, J; Vannasing, P; Beauchamp, MH				D'Hondt, Fabien; Lassonde, Maryse; Thebault-Dagher, Fanny; Bernier, Annie; Gravel, Jocelyn; Vannasing, Phetsamone; Beauchamp, Miriam H.			Electrophysiological correlates of emotional face processing after mild traumatic brain injury in preschool children	COGNITIVE AFFECTIVE & BEHAVIORAL NEUROSCIENCE			English	Article						Mild traumatic brain injury; Emotional facial expression; Social skills; Childhood; Event-related potential	EVENT-RELATED POTENTIALS; FEARFUL FACIAL EXPRESSIONS; WEIGHTED IMAGING SWI; MINOR HEAD TRAUMA; YOUNG-CHILDREN; TIME-COURSE; EXPERIENCED MALTREATMENT; 3-YEAR-OLD CHILDREN; EARLY-CHILDHOOD; 1ST YEAR	Evidence suggests that social skills are affected by childhood mild traumatic brain injury (mTBI), but the neural and affective substrates of these difficulties are still underexplored. In particular, nothing is known about consequences on the perception of emotional facial expressions, despite its critical role in social interactions and the importance of the preschool period in the development of this ability. This study thus aimed to investigate the electrophysiological correlates of emotional facial expressions processing after early mTBI. To this end, 18 preschool children (mean age 53 +/- 8 months) who sustained mTBI and 15 matched healthy controls (mean age 55 +/- 11 months) were presented with pictures of faces expressing anger, happiness, or no emotion (neutral) while event-related potentials (ERP) were recorded. The main results revealed that P1 amplitude was higher for happy faces than for angry faces, and that N170 latency was shorter for emotional faces than for neutral faces in the control group only. These findings suggest that preschool children who sustain mTBI do not present the early emotional effects that are observed in healthy preschool children at visuospatial and visual expertise stages. This study provides new evidence regarding the consequences of childhood mTBI on socioemotional processing, by showing alterations of emotional facial expressions processing, an ability known to underlie social competence and appropriate social interactions.	[D'Hondt, Fabien; Lassonde, Maryse; Thebault-Dagher, Fanny; Bernier, Annie; Beauchamp, Miriam H.] Univ Montreal, Dept Psychol, CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada; [D'Hondt, Fabien; Lassonde, Maryse; Thebault-Dagher, Fanny] Univ Montreal, Ctr Rech Neuropsychol & Cognit CERNEC, Montreal, PQ, Canada; [D'Hondt, Fabien; Lassonde, Maryse; Thebault-Dagher, Fanny; Gravel, Jocelyn; Vannasing, Phetsamone; Beauchamp, Miriam H.] Univ Montreal, Ctr Rech, Ctr Hosp Univ St Justine, Montreal, PQ, Canada; [D'Hondt, Fabien] Univ Lille, CNRS, SCALab, UMR 9193,Sci Cognit & Sci Affect, F-59000 Lille, France; [D'Hondt, Fabien] CHU Lille, Clin Psychiat, CURE, F-59000 Lille, France	Beauchamp, MH (corresponding author), Univ Montreal, Dept Psychol, CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.; Beauchamp, MH (corresponding author), Univ Montreal, Ctr Rech, Ctr Hosp Univ St Justine, Montreal, PQ, Canada.	miriam.beauchamp@umontreal.ca		Thebault-Dagher, Fanny/0000-0001-7601-2292; Gravel, Jocelyn/0000-0001-5901-4990; D'Hondt, Fabien/0000-0001-5683-0490	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); CHU Sainte-Justine Foundation	This study was funded by the Canadian Institutes of Health Research, but this fund did not exert any editorial direction or censorship on any part of this article. Fabien D'Hondt was funded by a postdoctoral fellowship from the CHU Sainte-Justine Foundation. The Cartool software (brainmapping.unige.ch/cartool) was programmed by Denis Brunet, from the Functional Brain Mapping Laboratory, Geneva, Switzerland, and is supported by the Center for Biomedical Imaging (CIBM) of Geneva and Lausanne.	Adolphs R, 2003, BRAIN COGNITION, V52, P61, DOI 10.1016/S0278-2626(03)00009-5; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; Anderson V, 2009, J HEAD TRAUMA REHAB, V24, P303, DOI 10.1097/HTR.0b013e3181ada830; Anderson V, 2009, BRAIN, V132, P45, DOI 10.1093/brain/awn293; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Ashwal S, 2014, J CHILD NEUROL, V29, P1704, DOI 10.1177/0883073814538504; Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; Batty M, 2006, DEVELOPMENTAL SCI, V9, P207, DOI 10.1111/j.1467-7687.2006.00480.x; Batty M, 2003, COGNITIVE BRAIN RES, V17, P613, DOI 10.1016/S0926-6410(03)00174-5; Bayley N., 2005, BAYLEY SCALES INFANT, VThird; Beauchamp M., 2010, PRINCIPLES PRACTICE, P315, DOI 10.1017/CBO9780511674815.024; Beauchamp MH, 2013, BRAIN INJURY, V27, P896, DOI 10.3109/02699052.2013.775486; Beauchamp MH, 2011, J NEUROTRAUM, V28, P915, DOI 10.1089/neu.2010.1712; Bellerose J, 2015, J INT NEUROPSYCHOL S, P1, DOI DOI 10.1902/JOP.2015.150455; BENTIN S, 1994, J EXP PSYCHOL LEARN, V20, P130, DOI 10.1037/0278-7393.20.1.130; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; BLISHEN BR, 1987, CAN REV SOC ANTHROP, V24, P465; BONADIO WA, 1989, AM J DIS CHILD, V143, P1061, DOI 10.1001/archpedi.1989.02150210095025; Bornstein MH, 2003, DEVELOPMENTAL SCI, V6, P585, DOI 10.1111/1467-7687.00314; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Calvo MG, 2014, J NONVERBAL BEHAV, V38, P549, DOI 10.1007/s10919-014-0191-3; Calvo MG, 2005, J EXP PSYCHOL HUMAN, V31, P502, DOI 10.1037/0096-1523.31.3.502; Carver LJ, 2003, DEV PSYCHOBIOL, V42, P148, DOI 10.1002/dev.10078; Cicchetti D, 2005, DEV PSYCHOPATHOL, V17, P641, DOI 10.1017/S09545794050315; Crowe Louise M, 2015, Handb Clin Neurol, V128, P661, DOI 10.1016/B978-0-444-63521-1.00041-8; Cunningham MG, 2002, J COMP NEUROL, V453, P116, DOI 10.1002/cne.10376; Curtis WJ, 2011, DEV PSYCHOPATHOL, V23, P373, DOI 10.1017/S0954579411000125; Dadds MR, 2008, CHILD PSYCHIAT HUM D, V39, P111, DOI 10.1007/s10578-007-0075-4; Dawson G, 2002, CHILD DEV, V73, P700, DOI 10.1111/1467-8624.00433; Dawson G, 2004, DEVELOPMENTAL SCI, V7, P340, DOI 10.1111/j.1467-7687.2004.00352.x; de Haan M, 2004, J CHILD PSYCHOL PSYC, V45, P1209, DOI 10.1111/j.1469-7610.2004.00320.x; de Haan M, 2003, INT J PSYCHOPHYSIOL, V51, P45, DOI 10.1016/S0167-8760(03)00152-1; Dekowska M, 2008, ACTA NEUROBIOL EXP, V68, P229; DIETRICH AM, 1993, ANN EMERG MED, V22, P1535, DOI 10.1016/S0196-0644(05)81254-5; Dimberg U, 2011, J PSYCHOPHYSIOL, V25, P26, DOI 10.1027/0269-8803/a000029; DUHAIME AC, 1987, J NEUROSURG, V66, P409, DOI 10.3171/jns.1987.66.3.0409; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Eimer M, 2002, NEUROREPORT, V13, P427, DOI 10.1097/00001756-200203250-00013; Eimer M., 2011, OXFORD HDB FACE PERC, P329, DOI [10.1093/oxfordhb/9780199559053.013.0017, DOI 10.1093/OXFORDHB/9780199559053.013.0017]; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Frith C, 2009, PHILOS T R SOC B, V364, P3453, DOI 10.1098/rstb.2009.0142; Gao XQ, 2010, J EXP CHILD PSYCHOL, V107, P67, DOI 10.1016/j.jecp.2010.05.003; George N, 1996, COGNITIVE BRAIN RES, V4, P65, DOI 10.1016/0926-6410(95)00045-3; Greenes DS, 2003, ANN EMERG MED, V42, P515, DOI 10.1067/S0196-0644(03)00631-0; Greenes DS, 1999, PEDIATRICS, V104, P861, DOI 10.1542/peds.104.4.861; Hayden MG, 2007, CHILD NERV SYST, V23, P431, DOI 10.1007/s00381-006-0277-2; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; Herba C, 2004, J CHILD PSYCHOL PSYC, V45, P1185, DOI 10.1111/j.1469-7610.2004.00316.x; Hinojosa JA, 2015, NEUROSCI BIOBEHAV R, V55, P498, DOI 10.1016/j.neubiorev.2015.06.002; Hoehl S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002389; Hopf JM, 2000, CLIN NEUROPHYSIOL, V111, P1241, DOI 10.1016/S1388-2457(00)00313-8; Izard C, 2001, PSYCHOL SCI, V12, P18, DOI 10.1111/1467-9280.00304; Izard CE, 2002, DEV PSYCHOPATHOL, V14, P761, DOI 10.1017/S0954579402004066; Johnson MH, 2005, NAT REV NEUROSCI, V6, P766, DOI 10.1038/nrn1766; Joyce C, 2005, CLIN NEUROPHYSIOL, V116, P2613, DOI 10.1016/j.clinph.2005.07.005; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; Keenan HT, 2008, AM J PREV MED, V34, pS120, DOI 10.1016/j.amepre.2007.11.001; Keenan HT, 2007, PEDIATRICS, V119, pE616, DOI 10.1542/peds.2006-2313; Keenan HT, 2004, PEDIATRICS, V114, P633, DOI 10.1542/peds.2003-1020-L; Kennard MA, 1936, AM J PHYSIOL, V115, P138; Kobiella A, 2008, COGNITION EMOTION, V22, P134, DOI 10.1080/02699930701394256; Kuefner D, 2010, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.067.2009; Kuppermann N, 2008, PEDIATR RADIOL, V38, pS670, DOI 10.1007/s00247-008-0996-5; Lalonde G, 2018, J NEUROPSYCHOL, V12, P1, DOI 10.1111/jnp.12104; Leon-Carrion J, 2003, BRAIN INJURY, V17, P207, DOI 10.1080/0269905021000010249; Leppanen JM, 2007, CHILD DEV, V78, P232, DOI 10.1111/j.1467-8624.2007.00994.x; Luu P., 2005, DETERMINATION HYDROC; MALATESTAMAGAI C, 1994, INT J BEHAV DEV, V17, P239, DOI 10.1177/016502549401700202; Massagli TL, 2004, ARCH PHYS MED REHAB, V85, P1428, DOI 10.1016/j.apmr.2003.12.036; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Miller G, 2010, SCIENCE, V328, P297, DOI 10.1126/science.328.5976.297; Muscara F, 2009, NEUROPSYCHOL REHABIL, V19, P541, DOI 10.1080/09602010802365223; NELSON CA, 1990, DEV PSYCHOL, V26, P171, DOI 10.1037/0012-1649.26.2.171; Olivares EI, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/514361; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Parker SW, 2005, CHILD DEV, V76, P54, DOI 10.1111/j.1467-8624.2005.00829.x; Peykarjou S, 2013, DEVELOPMENTAL SCI, V16, P905, DOI 10.1111/desc.12063; PHILIPPOT P, 1990, BRIT J SOC PSYCHOL, V29, P43, DOI 10.1111/j.2044-8309.1990.tb00885.x; Pinal D, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00075; Pollak SD, 2002, P NATL ACAD SCI USA, V99, P9072, DOI 10.1073/pnas.142165999; Pollak SD, 2008, CURR DIR PSYCHOL SCI, V17, P370, DOI 10.1111/j.1467-8721.2008.00608.x; Pourtois G, 2008, BRAIN TOPOGR, V20, P265, DOI 10.1007/s10548-008-0053-6; Pourtois G, 2013, BIOL PSYCHOL, V92, P492, DOI 10.1016/j.biopsycho.2012.02.007; Quayle KS, 1997, PEDIATRICS, V99, part. no., DOI 10.1542/peds.99.5.e11; Rellecke J, 2013, BRAIN TOPOGR, V26, P62, DOI 10.1007/s10548-012-0261-y; Rossion B, 2008, NEUROIMAGE, V39, P1959, DOI 10.1016/j.neuroimage.2007.10.011; Rossion B, 2014, TRENDS COGN SCI, V18, P310, DOI 10.1016/j.tics.2014.02.013; Rotshtein P, 2010, HUM BRAIN MAPP, V31, P1089, DOI 10.1002/hbm.20921; Rousselet GA, 2008, J VISION, V8, DOI 10.1167/8.12.3; Rugg M.D., 1995, ELECTROPHYSIOLOGY MI; RUSSELL JA, 1985, J PERS SOC PSYCHOL, V48, P1290, DOI 10.1037/0022-3514.48.5.1290; Ryan NP, 2015, HUM BRAIN MAPP, V36, P1677, DOI 10.1002/hbm.22729; Ryan NP, 2015, NEUROPSYCHOLOGIA, V66, P32, DOI 10.1016/j.neuropsychologia.2014.10.040; Sagiv N, 2001, J COGNITIVE NEUROSCI, V13, P937, DOI 10.1162/089892901753165854; Schutzman SA, 2001, PEDIATRICS, V107, P983, DOI 10.1542/peds.107.5.983; Schweinberger SR, 2002, NEUROPSYCHOLOGIA, V40, P2057, DOI 10.1016/S0028-3932(02)00050-7; Serra-Grabulosa JM, 2005, J NEUROL NEUROSUR PS, V76, P129, DOI 10.1136/jnnp.2004.027631; SERRANO JM, 1992, DEV PSYCHOBIOL, V25, P411, DOI 10.1002/dev.420250603; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Somerville LH, 2011, DEV NEUROPSYCHOL, V36, P408, DOI 10.1080/87565641.2010.549865; Sprengelmeyer R, 2006, NEUROPSYCHOLOGIA, V44, P2899, DOI 10.1016/j.neuropsychologia.2006.06.020; Stancin T, 2008, J DEV BEHAV PEDIATR, V29, P253, DOI 10.1097/DBP.0b013e31816b6b0f; Taylor MJ, 1999, CLIN NEUROPHYSIOL, V110, P910, DOI 10.1016/S1388-2457(99)00006-1; Taylor MJ, 2004, J COGNITIVE NEUROSCI, V16, P1426, DOI 10.1162/0898929042304732; Taylor-Colls S, 2015, CHILD DEV, V86, P877, DOI 10.1111/cdev.12348; Todd RM, 2008, NEUROPSYCHOLOGIA, V46, P595, DOI 10.1016/j.neuropsychologia.2007.10.011; Toledo E, 2012, NEUROSCI BIOBEHAV R, V36, P1510, DOI 10.1016/j.neubiorev.2012.03.007; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; TUCKER DM, 1993, ELECTROEN CLIN NEURO, V87, P154, DOI 10.1016/0013-4694(93)90121-B; Vlamings PHJM, 2010, CHILD DEV, V81, P1304, DOI 10.1111/j.1467-8624.2010.01470.x; Vuilleumier P, 2007, NEUROPSYCHOLOGIA, V45, P174, DOI 10.1016/j.neuropsychologia.2006.06.003; Vuilleumier P, 2015, CURR OPIN NEUROL, V28, P29, DOI 10.1097/WCO.0000000000000159; Wade SL, 2008, REHABIL PSYCHOL, V53, P180, DOI 10.1037/0090-5550.53.2.180; WALDEN TA, 1990, BRIT J DEV PSYCHOL, V8, P65; Wechsler, 2002, WECHSLER PRESCHOOL P; Widen SC, 2013, EMOT REV, V5, P72, DOI 10.1177/1754073912451492; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542	119	11	11	0	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1530-7026	1531-135X		COGN AFFECT BEHAV NE	Cogn. Affect. Behav. Neurosci.	FEB	2017	17	1					124	142		10.3758/s13415-016-0467-7			19	Behavioral Sciences; Neurosciences	Behavioral Sciences; Neurosciences & Neurology	EK2QW	WOS:000393772800007	27699681	Bronze			2021-06-18	
J	Dickson, TJ; Trathen, S; Terwiel, FA; Waddington, G; Adams, R				Dickson, T. J.; Trathen, S.; Terwiel, F. A.; Waddington, G.; Adams, R.			Head injury trends and helmet use in skiers and snowboarders in Western Canada, 2008-2009 to 2012-2013: an ecological study	SCANDINAVIAN JOURNAL OF MEDICINE & SCIENCE IN SPORTS			English	Article						Skiing; snowboarding; concussion; helmets; injury prevention	SAFETY HELMETS; RISK; NECK	This research explored associations between helmet use and head injuries in snowsports by investigating reported snowsport injuries in Western Canada from 2008-2009 to 2012-2013. The key finding was that increased helmet use (from 69% to 80%) was not associated with a reduction in reported head injuries. Over the study period, the average rate of reported head injuries was 0.2/1000 skier visits, with a statistically significant variation (P < 0.001). The line of best fit showed an non-significant upward trend (P = 0.13). Lacerations were the only subcategory of head injuries that decreased significantly with helmet use. A higher proportion of people who reported a head injury were wearing a helmet than for injuries other than to the head. Skiers were more likely to report a head injury when wearing a helmet than snowboarders (P < 0.001 cf. P = 0.22). There were significant differences in characteristics of helmet and non-helmet wearers. Helmet wearers were more likely to be: young adults (P < 0.001); beginner/novices (P = 0.004); and snowboarders (P < 0.001), but helmet wearing was not associated with gender (P = 0.191). Further research is needed to explore the possible reasons for the failure of helmets to reduce head injuries, for example, increased reporting of head injuries and increased risk-taking combined with overrating of the helmets' protection.	[Dickson, T. J.; Trathen, S.; Waddington, G.; Adams, R.] Univ Canberra, Res Inst Sport & Exercise, Univ Ave, Canberra, ACT 2601, Australia; [Terwiel, F. A.] Thompson Rivers Univ, Fac Adventure Culinary Arts & Tourism, Kamloops, BC, Canada	Dickson, TJ (corresponding author), Univ Canberra, Res Inst Sport & Exercise, Univ Ave, Canberra, ACT 2601, Australia.	tracey.dickson@canberra.edu.au	Dickson, Tracey/Z-5352-2019	Dickson, Tracey/0000-0002-9889-1512; Terwiel, Anne/0000-0003-4621-201X; Waddington, Gordon/0000-0002-4306-9193			Ackery A, 2007, INJURY PREV, V13, P368, DOI 10.1136/ip.2007.017285; ASTM International, 2000, F2040 ASTM INT; Bianchi G., 2011, SKIING TRAUMA SAFETY, V18, P32; Bussewitz C., 2010, US TODAY; Canadian Ski Council, 2014, 2008 9 2012 13 AD HO; Canadian Ski Council, 2010, CAN SKIER SNOWB FACT; CDC, 2014, PAR ATHL CONC INF SH; Cusimano MD, 2010, BRIT J SPORT MED, V44, P781, DOI 10.1136/bjsm.2009.070573; CWSAA, 2014, CAN W SKI AR ASS; CWSAA, 2013, CAN W SKI AR ASS NAT; Dickson TJ, 2012, RISK MANAGEMENT OUTD, P204; Dickson TJ, 2012, AM SOC TEST MATER, V1553, P184, DOI 10.1520/STP104490; Dickson TJ, 2016, APPL ERGON, V53, P79, DOI 10.1016/j.apergo.2015.08.006; European Committee for Standardization, 1996, 1077 EN EUR COMM STA; Finch C, 2006, J SCI MED SPORT, V9, P3, DOI 10.1016/j.jsams.2006.02.009; Finch CF, 2011, SPORTS MED, V41, P59, DOI 10.2165/11537260-000000000-00000; Graves JM, 2013, INJURY PREV, V19, P399, DOI 10.1136/injuryprev-2012-040727; Hagel B, 2005, ACCIDENT ANAL PREV, V37, P103, DOI 10.1016/j.aap.2004.04.003; Hagel BE, 2005, BRIT MED J, V330, P281, DOI 10.1136/bmj.38314.480035.7C; Hagel BE, 2010, AM J EPIDEMIOL, V171, P1134, DOI 10.1093/aje/kwq039; Haider AH, 2012, J TRAUMA ACUTE CARE, V73, P1340, DOI 10.1097/TA.0b013e318270bbca; Jung CS, 2011, ACTA NEUROCHIR, V153, P101, DOI 10.1007/s00701-010-0704-8; Khan U., 2009, TELEGRAPH IN PRESS; Marshall SW, 2008, EPIDEMIOLOGY, V19, P277, DOI 10.1097/EDE.0b013e3181632700; McCrory P, 2002, BRIT J SPORT MED, V36, P314, DOI 10.1136/bjsm.36.5.314; McMillan K., 2013, SKI HELMET USE ISNT; Morris H., 2014, TELEGRAPH; Mueller BA, 2008, EPIDEMIOLOGY, V19, P270, DOI 10.1097/EDE.0b013e318163567c; National Ski Areas Association, 2014, LIDS KIDS HELM ITS S; Parry T., 2013, DAILY MIRROR; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Ruedl G, 2015, SCAND J MED SCI SPOR, V25, P125, DOI 10.1111/sms.12139; Ruedl G, 2012, SCAND J MED SCI SPOR, V22, P448, DOI 10.1111/j.1600-0838.2011.01429.x; Russell K, 2013, CLIN J SPORT MED, V23, P172, DOI 10.1097/JSM.0b013e31827bd918; SafeKids Canada, 2010, EFF STAND SKI SNOWB; Scher I., 2006, Journal of ASTM International (JAI), V3, pJAI14203, DOI 10.1520/JAI14203; Scott MD, 2007, INJURY PREV, V13, P173, DOI 10.1136/ip.2006.014142; Shealy JE, 2015, W CONSHOHOCKEN, P22, DOI DOI 10.1520/STP158220140079; Slobounov S, 2014, BRIT J SPORT MED, V48, P75, DOI 10.1136/bjsports-2013-092362; Snell Memorial Foundation, 1998, STAND PROT HEADG RS; Stevenson M, 2005, INJURY PREV, V11, P2, DOI 10.1136/ip.2003.003384; Sulheim S, 2006, JAMA-J AM MED ASSOC, V295, P919, DOI 10.1001/jama.295.8.919; Sulheim S, 2011, BRIT J SPORT MED, V45, P1303, DOI 10.1136/bjsports-2011-090407; Worksafe BC, SKI HELM AR IN PRESS	44	11	11	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0905-7188	1600-0838		SCAND J MED SCI SPOR	Scand. J. Med. Sci. Sports	FEB	2017	27	2					236	244		10.1111/sms.12642			9	Sport Sciences	Sport Sciences	EL4UQ	WOS:000394616800013	26688174				2021-06-18	
J	Hogeveen, J; Hauner, KK; Chau, A; Krueger, F; Grafman, J				Hogeveen, Jeremy; Hauner, Katherina K.; Chau, Aileen; Krueger, Frank; Grafman, Jordan			Impaired Valuation Leads to Increased Apathy Following Ventromedial Prefrontal Cortex Damage	CEREBRAL CORTEX			English	Article						apathy; stimulus valuation; traumatic brain injury; ventromedial prefrontal cortex; voxel-based lesion-symptom mapping	TRAUMATIC BRAIN-INJURY; FRONTAL-LOBE DAMAGE; ORBITOFRONTAL CORTEX; DECISION-MAKING; CHOICE; HUMANS; INTELLIGENCE; MODULATION; CONFIDENCE; JUDGMENT	Apathy is defined by reduced goal-directed behavior, and is common in patients with damage to the ventromedial prefrontal cortex (vmPFC). Separately, in neuroeconomics research, the vmPFC has been shown to play a role in reward processingnamely, in "stimulus valuation," or the computation of the subjective reward value of a stimulus. Here, we used a sample of patients with focal brain lesions (N = 93) and matched healthy controls (N = 21) to determine whether the association between vmPFC damage and increased apathy is driven by impaired valuation. An auction task was used to measure valuation, and apathy was assessed via caregiver ratings of patients' day-to-day behavior. Lesion-symptom mapping identified the locus of impaired valuation in the vmPFC, and patients with damage to this region demonstrated increased apathy relative to patients with damage to dorsomedial prefrontal cortex (dmPFC), patients with damage to other brain regions, and healthy controls. Critically, the association between vmPFC damage and apathywas mediated by impaired valuation, with no effect as a function of dmPFC damage. Our results implicate a valuation-based mechanism underlying the relationship between vmPFC integrity and apathy, bridging findings from both the clinical literature and neuroeconomics research.	[Hogeveen, Jeremy; Hauner, Katherina K.; Chau, Aileen; Grafman, Jordan] Rehabil Inst Chicago, Cognit Neurosci Lab, 345 East Super St, Chicago, IL 60611 USA; [Hogeveen, Jeremy; Hauner, Katherina K.; Grafman, Jordan] George Mason Univ, Dept Phys Med & Rehabil, Fairfax, VA 22030 USA; [Hauner, Katherina K.; Grafman, Jordan] Northwestern Univ, Feinberg Sch Med, Dept Neurol, Chicago, IL 60611 USA; [Krueger, Frank] George Mason Univ, Mol Neurosci Dept, Fairfax, VA 22030 USA; [Krueger, Frank] George Mason Univ, Dept Psychol, Fairfax, VA 22030 USA	Hogeveen, J (corresponding author), Rehabil Inst Chicago, Cognit Neurosci Lab, 345 East Super St, Chicago, IL 60611 USA.	jeremy.hogeveen@northwestern.edu		Hogeveen, Jeremy/0000-0001-9612-2085	Agency for Healthcare Research and QualityUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K12 HS023011]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITYUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K12HS023011] Funding Source: NIH RePORTER	K.K.H. is supported by the Agency for Healthcare Research and Quality (K12 HS023011).	Andersson S, 1999, PSYCHOL MED, V29, P447, DOI 10.1017/S0033291798008046; Arnould A, 2013, NEUROPSYCHOL REV, V23, P210, DOI 10.1007/s11065-013-9236-3; Barrash J, 2000, DEV NEUROPSYCHOL, V18, P355, DOI 10.1207/S1532694205Barrash; Bartra O, 2013, NEUROIMAGE, V76, P412, DOI 10.1016/j.neuroimage.2013.02.063; BECKER GM, 1964, BEHAV SCI, V9, P226, DOI 10.1002/bs.3830090304; Camille N, 2011, J NEUROSCI, V31, P15048, DOI 10.1523/JNEUROSCI.3164-11.2011; Camille N, 2011, J NEUROSCI, V31, P7527, DOI 10.1523/JNEUROSCI.6527-10.2011; Camus M, 2009, EUR J NEUROSCI, V30, P1980, DOI 10.1111/j.1460-9568.2009.06991.x; Chib VS, 2009, J NEUROSCI, V29, P12315, DOI 10.1523/JNEUROSCI.2575-09.2009; Clithero JA, 2014, SOC COGN AFFECT NEUR, V9, P1289, DOI 10.1093/scan/nst106; Coussons-Read ME, 2012, BRAIN BEHAV IMMUN, V26, P650, DOI 10.1016/j.bbi.2012.02.009; De Coster L, 2013, COGN AFFECT BEHAV NE, V13, P519, DOI 10.3758/s13415-013-0168-4; De Martino B, 2013, NAT NEUROSCI, V16, P105, DOI 10.1038/nn.3279; Deci EL, 2000, PSYCHOL INQ, V11, P227, DOI 10.1207/S15327965PLI1104_01; Fellows LK, 2007, CEREB CORTEX, V17, P2669, DOI 10.1093/cercor/bhl176; Fellows LK, 2011, ANN NY ACAD SCI, V1239, P51, DOI 10.1111/j.1749-6632.2011.06229.x; Fellows LK, 2005, NEUROPSYCHOLOGIA, V43, P1214, DOI 10.1016/j.neuropsychologia.2004.07.018; Glascher J, 2009, NEURON, V61, P681, DOI 10.1016/j.neuron.2009.01.026; Glimcher PW, 2005, GAME ECON BEHAV, V52, P213, DOI 10.1016/j.geb.2004.06.011; Grace J., 2001, FRSBE FRONTAL SYSTEM; GRAY JM, 1994, CLIN REHABIL, V8, P188, DOI DOI 10.1080/09602010902949207; Hare TA, 2009, SCIENCE, V324, P646, DOI 10.1126/science.1168450; Hayes A. F., 2008, INTRO MEDIATION MODE; Hayes AF, 2014, BRIT J MATH STAT PSY, V67, P451, DOI 10.1111/bmsp.12028; Hayes AF, 2013, PSYCHOL SCI, V24, P1918, DOI 10.1177/0956797613480187; Kepecs A, 2008, NATURE, V455, P227, DOI 10.1038/nature07200; Kirk U, 2011, P NATL ACAD SCI USA, V108, P10332, DOI 10.1073/pnas.1019332108; Koenigs M, 2008, NAT NEUROSCI, V11, P232, DOI 10.1038/nn2032; Koenigs M, 2008, J NEUROSCI, V28, P12341, DOI 10.1523/JNEUROSCI.2324-08.2008; Krueger F, 2011, J NEUROSCI, V31, P598, DOI 10.1523/JNEUROSCI.1399-10.2011; Krueger F, 2009, P NATL ACAD SCI USA, V106, P22486, DOI 10.1073/pnas.0912568106; Lane-Brown AT, 2009, BRAIN INJURY, V23, P999, DOI 10.3109/02699050903379347; Lawrence AD, 2011, SOC NEUROSCI-UK, V6, P653, DOI 10.1080/17470919.2011.556821; Leopold A, 2012, SOC COGN AFFECT NEUR, V7, P871, DOI 10.1093/scan/nsr071; Levy R, 2006, CEREB CORTEX, V16, P916, DOI 10.1093/cercor/bhj043; Markus HR, 2010, J CONSUM RES, V37, P344, DOI 10.1086/651242; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Padoa-Schioppa C, 2011, ANNU REV NEUROSCI, V34, P333, DOI 10.1146/annurev-neuro-061010-113648; Pardini M, 2010, NEUROLOGY, V74, P749, DOI 10.1212/WNL.0b013e3181d25b6b; Peters F, 2006, DEMENT GERIATR COGN, V21, P373, DOI 10.1159/000091898; Plassmann H, 2007, J NEUROSCI, V27, P9984, DOI 10.1523/JNEUROSCI.2131-07.2007; Rangel A., 2014, NEUROECONOMICS DECIS, P125, DOI [10.1016/B978-0-12-416008-8.00008-5, DOI 10.1016/B978-0-12-416008-8.00008-5, 10 .1016/B978-0-12-416008-8.00008-5]; Raymont Vanessa, 2011, Front Neurol, V2, P15, DOI 10.3389/fneur.2011.00015; Regenwetter M, 2011, PSYCHOL REV, V118, P42, DOI 10.1037/a0021150; Schoenbaum G, 2005, NEURON, V47, P633, DOI 10.1016/j.neuron.2005.07.018; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; Solomon J, 2007, COMPUT METH PROG BIO, V86, P245, DOI 10.1016/j.cmpb.2007.02.006; Stuss DT., 2000, DIFFERENTIATION STAT, P340; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vorauer JD, 2009, PSYCHOL SCI, V20, P838, DOI 10.1111/j.1467-9280.2009.02369.x; Wunderlich K, 2010, P NATL ACAD SCI USA, V107, P15005, DOI 10.1073/pnas.1002258107	53	11	11	0	5	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1047-3211	1460-2199		CEREB CORTEX	Cereb. Cortex	FEB	2017	27	2					1401	1408		10.1093/cercor/bhv317			8	Neurosciences	Neurosciences & Neurology	EP3BN	WOS:000397257600040	26740488	Bronze			2021-06-18	
J	Huang, SW; Wang, WT; Chou, LC; Liou, TH; Lin, HW				Huang, Shih-Wei; Wang, Wei-Te; Chou, Lin-Chuan; Liou, Tsan-Hon; Lin, Hui-Wen			Risk of Dementia in Patients with Spinal Cord Injury: A Nationwide Population-Based Cohort Study	JOURNAL OF NEUROTRAUMA			English	Article						dementia; population-based study; risk; SCI	TRAUMATIC BRAIN-INJURY; PHYSICAL-ACTIVITY; DISABILITY ASSESSMENT; FALLS; DEPRESSION; DISEASE; PEOPLE; NEUROINFLAMMATION; METAANALYSIS; DEFICITS	Spinal cord injury (SCI) can cause physical disability and psychological distress; however, whether SCI is a risk factor for dementia is unclear. This study evaluated the incidence of dementia in patients with SCI. Study participants were recruited from a nationwide cohort during 2004-2007 and categorized into SCI (patients diagnosed with SCI; n = 941) and non-SCI (age- and sex-matched controls; n = 5060) cohorts. Each participant was followed for 7 years until diagnosis of dementia or December 31, 2010, whichever occurred first. Data were subjected to Kaplan-Meier and Cox regression analyses. The incidence of dementia was significantly higher in the SCI cohort (1106 per 100,000 person-years) than in the non-SCI cohort (p <0.001). Patients with SCI had a significantly higher risk of dementia than did those without SCI (crude hazard ratio [HR] = 2.14, 95% confidence interval [CI], 1.57-2.92, p <0.001 vs. adjusted HR = 1.95, 95% CI, 1.43-2.67, p <0.001). Further analysis found that there is no statistical significance of higher risk for developing Alzheimer's disease among SCI patients, but that SCI patients were at higher risk of developing other types of dementia than the control cohort (crude HR= 1.88, 95% CI, 1.33-2.63, p <0.001 vs. adjusted HR= 1.90, 95% CI, 1.35-2.68, p <0.001). In conclusion, patients with SCI are at high risk of dementia, and effective dementia prevention strategies are recommended for comprehensive SCI care.	[Huang, Shih-Wei; Chou, Lin-Chuan; Liou, Tsan-Hon] Taipei Med Univ, Shuang Ho Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Huang, Shih-Wei; Liou, Tsan-Hon] Taipei Med Univ, Dept Phys Med & Rehabil, Sch Med, Coll Med, Taipei, Taiwan; [Liou, Tsan-Hon] Taipei Med Univ, Grad Inst Injury Prevent & Control, Taipei, Taiwan; [Lin, Hui-Wen] Taipei Med Univ, Evidence Based Med Ctr, Wan Fang Hosp, Taipei, Taiwan; [Wang, Wei-Te] Changhua Christian Hosp, Dept Phys Med & Rehabil, Changhua, Taiwan; [Lin, Hui-Wen] Soochow Univ, Dept Math, 70 Linhsi Rd, Taipei, Taiwan; [Huang, Shih-Wei] Natl Taiwan Sport Univ, Grad Inst Sports Sci, Taoyuan, Taiwan	Lin, HW (corresponding author), Soochow Univ, Dept Math, 70 Linhsi Rd, Taipei, Taiwan.	linhw@tmu.edu.tw	Liou, Tsan-Hon/I-8808-2019; Huang, ShihWei/S-9278-2019	Liou, Tsan-Hon/0000-0002-0959-4023	National Science Council of TaiwanMinistry of Science and Technology, Taiwan [MOST 104-2118-M-031-001]	This study was based partly on data from the NHIRD, provided by the BNHI (Department of Health), managed by the Taiwan National Health Research Institutes, and supported by the National Science Council of Taiwan under grant MOST 104-2118-M-031-001. S.W.H. and H.W.L. conceptualized and designed the study, and S.W.H. drafted the manuscript; S.W.H. and H.W.L. analyzed and interpreted the data; S.W.H. critically revised the article for valuable intellectual content; T.H.L. and H.W.L. approved the article; L.C.C. provided study materials and patients; H.W.L. offered statistical expertise; and W.T.W. provided administrative, technical, and logistical support.	Adriaansen JJE, 2013, DISABIL REHABIL, V35, P1104, DOI 10.3109/09638288.2012.712196; Allan LM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005521; BRESLOW NE, 1993, J AM STAT ASSOC, V88, P9, DOI 10.1080/01621459.1993.10594284; BUCHNER DM, 1987, JAMA-J AM MED ASSOC, V257, P1492, DOI 10.1001/jama.257.11.1492; Craig A, 2009, SPINAL CORD, V47, P108, DOI 10.1038/sc.2008.115; DAVIDOFF GN, 1992, ARCH PHYS MED REHAB, V73, P275; Dowler R N, 1995, Appl Neuropsychol, V2, P124, DOI 10.1207/s15324826an0203&4_4; Dowler RN, 1997, J INT NEUROPSYCH SOC, V3, P464, DOI 10.1017/S1355617797004645; Eikelenboom P, 2010, NEURODEGENER DIS, V7, P38, DOI 10.1159/000283480; Feldman H, 2001, ALZ DIS ASSOC DIS, V15, P89, DOI 10.1097/00002093-200104000-00008; FLEMING KC, 1995, MAYO CLIN PROC, V70, P1093, DOI 10.4065/70.11.1093; Freund P, 2013, LANCET NEUROL, V12, P873, DOI 10.1016/S1474-4422(13)70146-7; FUHRER MJ, 1993, ARCH PHYS MED REHAB, V74, P255; Ginis KAM, 2011, SPINAL CORD, V49, P1088, DOI 10.1038/sc.2011.63; Ginis KAM, 2010, ARCH PHYS MED REHAB, V91, P722, DOI 10.1016/j.apmr.2009.12.027; Graafmans WC, 1996, AM J EPIDEMIOL, V143, P1129; Hamer M, 2009, PSYCHOL MED, V39, P3, DOI 10.1017/S0033291708003681; HANCOCK KM, 1993, PARAPLEGIA, V31, P349, DOI 10.1038/sc.1993.59; Hoffman JM, 2011, ARCH PHYS MED REHAB, V92, P411, DOI 10.1016/j.apmr.2010.10.036; Jensen MP, 2007, ARCH PHYS MED REHAB, V88, P638, DOI 10.1016/j.apmr.2007.02.002; Kuo CY, 2015, INT J ENV RES PUB HE, V12, P4116, DOI 10.3390/ijerph120404116; Lazzaro I, 2013, J CLIN NEUROPHYSIOL, V30, P59, DOI 10.1097/WNP.0b013e31827edb0c; Mead GE, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004366.pub3; Muller R, 2012, SPINAL CORD, V50, P94, DOI 10.1038/sc.2011.116; Murray RF, 2007, SPINAL CORD, V45, P429, DOI 10.1038/sj.sc.3102022; Ownby RL, 2006, ARCH GEN PSYCHIAT, V63, P530, DOI 10.1001/archpsyc.63.5.530; Perry GML, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-56; Post MWM, 2012, SPINAL CORD, V50, P382, DOI 10.1038/sc.2011.182; Prince M, 2009, WORLD ALZHEIMER REPO; RICHARDS JS, 1988, AM J PHYS MED REHAB, V67, P211, DOI 10.1097/00002060-198810000-00005; Ripatti S, 2000, BIOMETRICS, V56, P1016, DOI 10.1111/j.0006-341X.2000.01016.x; Rolland Y, 2008, J AM MED DIR ASSOC, V9, P390, DOI 10.1016/j.jamda.2008.02.007; ROTH E, 1989, PARAPLEGIA, V27, P480, DOI 10.1038/sc.1989.75; Scarmeas N, 2009, JAMA-J AM MED ASSOC, V302, P627, DOI 10.1001/jama.2009.1144; Schaller S, 2015, INT J GERIATR PSYCH, V30, P111, DOI 10.1002/gps.4198; Sofi F, 2011, J INTERN MED, V269, P107, DOI 10.1111/j.1365-2796.2010.02281.x; Strubreither W, 1997, SPINAL CORD, V35, P487, DOI 10.1038/sj.sc.3100495; Therneau TM, 2000, STAT BIOL HEALTH, DOI 10.1007/978-1-4757-3294-8; Tinetti ME, 1997, NEW ENGL J MED, V337, P1279, DOI 10.1056/NEJM199710303371806; van Doorn C, 2003, J AM GERIATR SOC, V51, P1213, DOI 10.1046/j.1532-5415.2003.51404.x; van Leeuwen CMC, 2012, SPINAL CORD, V50, P174, DOI 10.1038/sc.2011.120; Widerstrom-Noga EG, 1999, ARCH PHYS MED REHAB, V80, P580, DOI 10.1016/S0003-9993(99)90203-4; Wu JF, 2014, CELL CYCLE, V13, P2446, DOI 10.4161/cc.29420; Wu JF, 2014, J NEUROSCI, V34, P10989, DOI 10.1523/JNEUROSCI.5110-13.2014	44	11	11	1	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB	2017	34	3					615	622		10.1089/neu.2016.4525			8	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	EI9GJ	WOS:000392815600009	27539630				2021-06-18	
J	Ilie, G; Mann, RE; Boak, A; Hamilton, HA; Rehm, J; Cusimano, MD				Ilie, Gabriela; Mann, Robert E.; Boak, Angela; Hamilton, Hayley A.; Rehm, Juergen; Cusimano, Michael D.			Possession of weapon and school violence among adolescents and their association with history of traumatic brain injury, substance use and mental health issues	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article							CLASSIFICATION; SYSTEM	Purpose: Assessment of the association between illegal possession of weapon and assault on school property among adolescents with and without a history of traumatic brain injury (TBI) while assessing risk factors for these outcomes. Methods: Data were derived from the Centre for Addiction and Mental Health's 2013 Ontario Student Drug Use and Health Survey completed by students in grades 7-12 (ages 11-20). Results: In this sample of 5478 adolescents, 6.1% (95% CI: 5.0, 7.4) reported carrying a weapon (e. g., gun or knife) on school property, 10.8% (95% CI: 9.5, 12.3) were engaged in a physical fight and 6.4% (95% CI: 5.4, 7.6) reported having beat up or hurt someone on purpose at school, during last year. Youth who reported carrying a weapon, who were engaged in a physical fight and those who assaulted peers on school property during last year had statistically significantly higher odds of reporting a history of TBIs, being male, in first years of high-school, scored positive for elevated psychological distress, and were current regular alcohol (weapon possession only) and cannabis users. Conclusion: Previously it was thought that alcohol and drugs were the main contributors to school violence. Here we show that history of TBIs is yet another significant predictor of violence at school among adolescents. The results suggest that school vigilance and combined violence and TBI prevention, treatment and rehabilitation programs in this population are warranted. (C) 2016 Elsevier Ltd. All rights reserved.	[Ilie, Gabriela] Dalhousie Univ, Fac Med, 5790 Univ Ave, Halifax, NS, Canada; [Ilie, Gabriela; Mann, Robert E.; Boak, Angela; Hamilton, Hayley A.; Rehm, Juergen] Social & Epidemiol Res Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Mann, Robert E.; Hamilton, Hayley A.; Rehm, Juergen] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Cusimano, Michael D.] St Michaels Hosp, Dept Neurosurg, Toronto, ON, Canada	Ilie, G (corresponding author), Dalhousie Univ, Fac Med, 5790 Univ Ave, Halifax, NS, Canada.	Gabriela.Ilie@dal.ca	Cusimano, Michael/X-4059-2019; Ilie, Gabriela/AAM-9122-2021		STAIR Team Grant from the Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [TIR-103946]; Ontario Neurotrauma Foundation; Natural Sciences and Engineering Research CouncilNatural Sciences and Engineering Research Council of Canada (NSERC); Social Sciences and Humanities Research CouncilSocial Sciences and Humanities Research Council of Canada (SSHRC); Ontario Ministry of Health and Long-Term CareMinistry of Health and Long-Term Care, Ontario; Industry Canada;  [AUTO21]	This work was financially supported by a STAIR Team Grant from the Canadian Institutes of Health Research (#TIR-103946) and by the Ontario Neurotrauma Foundation. Additional funding was obtained from a grant from AUTO21, a member of the Networks of Centres of Excellence program that is administered and funded by the Natural Sciences and Engineering Research Council, the Social Sciences and Humanities Research Council, in partnership with Industry Canada, and ongoing funding support from the Ontario Ministry of Health and Long-Term Care.	[Anonymous], 2001, MMWR-MORBID MORTAL W, V60, P1337; Anstey KJ, 2004, J CLIN EPIDEMIOL, V57, P1202, DOI 10.1016/j.jclinepi.2003.11.011; Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; Benedict A., 2013, COMMUNICATION; Boak A, 2013, CAMH RES DOCUMENT SE, V38; Butterworth P, 2004, J CLIN EPIDEMIOL, V57, P742, DOI 10.1016/j.jclinepi.2003.10.015; Cantu RC, 2001, J ATHL TRAINING, V36, P244; CDC, 2014, 1991 2013 HIGH SCH Y; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Courser MW, 2009, EVALUATION REV, V33, P370, DOI 10.1177/0193841X09337228; Dicker BG, 1989, HEAD TRAUMA REHABIL, V4, P73; Dooley JJ, 2008, BRAIN INJURY, V22, P836, DOI 10.1080/02699050802425444; ESSELMAN PC, 1995, BRAIN INJURY, V9, P417, DOI 10.3109/02699059509005782; Frances A, DSM 4 CLASSIFICATION; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Hux D, 1998, BRAIN INJURY, V12, P667; Ilie G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094936; Ilie G, 2013, JAMA-J AM MED ASSOC, V309, P2550, DOI 10.1001/jama.2013.6750; Kay T., 1993, J HEAD TRAUMA REHABI, V8, P86, DOI [10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Korn EL, 1999, ANAL HLTH SURVEYS, V1st; Kuipers P, 2000, J HEAD TRAUMA REHAB, V15, P1275, DOI 10.1097/00001199-200012000-00007; Lowry R, 1999, J SCHOOL HEALTH, V69, P347, DOI 10.1111/j.1746-1561.1999.tb06427.x; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Mitka M, 2012, JAMA-J AM MED ASSOC, V308, P2327, DOI 10.1001/jama.2012.111345; Office of National Drug Control Policy, 2007, TEENS DRUGS VIOL SPE; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Paglia-Boak A, 2013, CAMH RES DOCUMENT SE, V36; Reid Robert J, 2006, J Prim Prev, V27, P281, DOI 10.1007/s10935-006-0035-y; Ruff RM, 2011, NEUROREHABILITATION, V28, P167, DOI 10.3233/NRE-2011-0646; Simpson G, 2002, PSYCHOL MED, V32, P687, DOI 10.1017/S0033291702005561; Tait RJ, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-171; Timonen M, 2002, PSYCHIAT RES, V113, P217, DOI 10.1016/S0165-1781(02)00269-X; West BT, 2008, STATA J, V8, P520, DOI 10.1177/1536867X0800800404	35	11	11	5	17	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	FEB	2017	48	2					285	292		10.1016/j.injury.2016.09.030			8	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	EO8BO	WOS:000396914100012	27955825				2021-06-18	
J	Jayakumar, AR; Tong, XY; Shamaladevi, N; Barcelona, S; Gaidosh, G; Agarwal, A; Norenberg, MD				Jayakumar, Arumugam Radhakrishnan; Tong, Xiao Y.; Shamaladevi, Nagarajarao; Barcelona, Stephanie; Gaidosh, Gabriel; Agarwal, Apeksha; Norenberg, Michael D.			Defective synthesis and release of astrocytic thrombospondin-1 mediates the neuronal TDP-43 proteinopathy, resulting in defects in neuronal integrity associated with chronic traumatic encephalopathy: in vitro studies	JOURNAL OF NEUROCHEMISTRY			English	Article						astrocytes; chronic traumatic encephalopathy; neurons; p-tau; TDP-43 proteinopathy; thrombospondin-1	NF-KAPPA-B; POSTTRAUMATIC-STRESS-DISORDER; K-CL COTRANSPORTER-1; BRAIN-INJURY; ABNORMAL PHOSPHORYLATION; SYNAPTIC PLASTICITY; OXIDATIVE STRESS; AMMONIA; IDENTIFICATION; MECHANISM	Transactivating DNA-binding protein-43 (TDP-43) inclusions and the accumulation of phosphorylated and ubiquitinated tau proteins (p-tau) have been identified in postmortem brain specimens from patients with chronic traumatic encephalopathy (CTE). To examine whether these proteins contribute to the development of CTE, we utilized an in vitro trauma system known to reproduce many of the findings observed in humans and experimental animals with traumatic brain injury. Accordingly, we examined the role of TDP-43 and Tau in an in vitro model of trauma, and determined whether these proteins contribute to the defective neuronal integrity associated with CNS trauma. Single or multiple episodes of trauma to cultured neurons resulted in a time-dependent increase in cytosolic levels of phosphorylated TDP-43 (p-TDP-43). Trauma to cultured neurons also caused an increase in levels of casein kinase 1 epsilon (CK1 epsilon), and ubiquitinated p-TDP-43, along with a decrease in importin-beta (all factors known to mediate the TDP-43 proteinopathy"). Defective neuronal integrity, as evidenced by a reduction in levels of the NR1 subunit of the NMDA receptor, and in PSD95, along with increased levels of phosphorylated tau were also observed. Additionally, increased levels of intra-and extracellular thrombospondin-1 (TSP-1) (a factor known to regulate neuronal integrity) were observed in cultured astrocytes at early stages of trauma, while at later stages decreased levels were identified. The addition of recombinant TSP-1, conditioned media from cultured astrocytes at early stages of trauma, or the CK1 epsilon. inhibitor PF4800567 hydrochloride to traumatized cultured neurons reduced levels of p-TDP-43, and reversed the trauma induced decline in NR1 subunit of the NMDA receptor and PSD95 levels. These findings suggest that a trauma-induced increase in TDP-43 phosphorylation contributes to defective neuronal integrity, and that increasing TSP-1 levels may represent a useful therapeutic approach for the prevention of the neuronal TDP-43 proteinopathy associated with CTE.	[Jayakumar, Arumugam Radhakrishnan; Norenberg, Michael D.] Vet Affairs Med Ctr, Neuropathol Lab, Miami, FL 33125 USA; [Tong, Xiao Y.; Barcelona, Stephanie; Agarwal, Apeksha; Norenberg, Michael D.] Univ Miami, Sch Med, Dept Pathol, Miami, FL USA; [Shamaladevi, Nagarajarao] Univ Miami, Sch Med, Urol, Miami, FL USA; [Gaidosh, Gabriel] Univ Miami, Sch Med, Ophthalmol, Miami, FL USA; [Norenberg, Michael D.] Univ Miami, Sch Med, Biochem & Mol Biol, Miami, FL USA; [Norenberg, Michael D.] Univ Miami, Sch Med, Neuro, Miami, FL USA	Norenberg, MD (corresponding author), Univ Miami, Sch Med, Dept Pathol D 33, POB 016960, Miami, FL 33101 USA.	mnorenbe@med.miami.edu	Agarwal, Apeksha/AAO-2787-2021		Department of Veterans AffairsUS Department of Veterans Affairs; Veterans AffairsUS Department of Veterans Affairs [I01BX000416] Funding Source: NIH RePORTER	This work was supported by a Merit Review from the Department of Veterans Affairs. The authors thank Alina Fernandez-Revuelta for the preparation of cell cultures. The authors declare no competing financial interests.	Ampuero J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049279; Arai T, 2010, NEUROPATHOLOGY, V30, P170, DOI 10.1111/j.1440-1789.2009.01089.x; Ayala V, 2011, ACTA NEUROPATHOL, V122, P259, DOI 10.1007/s00401-011-0850-y; Ban VS, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.2.FOCUS15609; Barmada SJ, 2010, J NEUROSCI, V30, P639, DOI 10.1523/JNEUROSCI.4988-09.2010; BRANDENBURG W, 1954, Virchows Arch Pathol Anat Physiol Klin Med, V325, P680, DOI 10.1007/BF00955101; BUEE L, 1992, AM J PATHOL, V141, P783; Buratti E, 2010, FEBS J, V277, P2268, DOI 10.1111/j.1742-4658.2010.07643.x; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Choksi DK, 2014, HUM MOL GENET, V23, P1025, DOI 10.1093/hmg/ddt498; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Clippinger AK, 2013, ACTA NEUROPATHOL, V126, P39, DOI 10.1007/s00401-013-1123-8; Colombrita C, 2009, J NEUROCHEM, V111, P1051, DOI 10.1111/j.1471-4159.2009.06383.x; Curtis KM, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-61; DE MICHELIS F, 1953, Nova Acta Stomatol, V5, P21; DUCIS I, 1990, BRAIN RES, V514, P349, DOI 10.1016/0006-8993(90)91431-F; Ehlers MD, 2005, CURR BIOL, V15, pR134, DOI 10.1016/j.cub.2005.02.013; Eroglu C, 2009, CELL, V139, P380, DOI 10.1016/j.cell.2009.09.025; Garcia O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014200; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Guo A, 2010, BRAIN RES, V1366, P1, DOI 10.1016/j.brainres.2010.09.099; Huang Y, 2013, NEURAL REGEN RES, V8, P869, DOI 10.3969/j.issn.1673-5374.2013.10.001; Iguchi Y, 2012, NEUROBIOL DIS, V45, P862, DOI 10.1016/j.nbd.2011.12.002; Inukai Y, 2008, FEBS LETT, V582, P2899, DOI 10.1016/j.febslet.2008.07.027; JAFFE E, 1990, GENOMICS, V7, P123, DOI 10.1016/0888-7543(90)90528-3; Jayakumar AR, 2016, NEUROCHEM RES, V41, P307, DOI 10.1007/s11064-015-1801-0; Jayakumar AR, 2006, J NEUROSCI, V26, P4774, DOI 10.1523/JNEUROSCI.0120-06.2006; Jayakumar AR, 2004, NEUROCHEM RES, V29, P2051, DOI 10.1007/s11064-004-6878-9; Jayakumar AR, 2008, J NEUROPATH EXP NEUR, V67, P417, DOI 10.1097/NEN.0b013e31816fc9d4; Jayakumar AR, 2014, J NEUROCHEM, V131, P333, DOI 10.1111/jnc.12810; Jayakumar AR, 2014, J NEUROTRAUM, V31, P1249, DOI 10.1089/neu.2013.3169; Jayakumar AR, 2011, J NEUROCHEM, V117, P437, DOI 10.1111/j.1471-4159.2011.07211.x; Jayakumar AR, 2008, J BIOL CHEM, V283, P33874, DOI 10.1074/jbc.M804016200; Johnson VE, 2011, ACTA NEUROPATHOL, V122, P715, DOI 10.1007/s00401-011-0909-9; JUURLINK BHJ, 1985, DEV NEUROSCI-BASEL, V7, P263, DOI 10.1159/000112295; Kametani F, 2009, BIOCHEM BIOPH RES CO, V382, P405, DOI 10.1016/j.bbrc.2009.03.038; Lakis N, 2013, NEUROL RES, V35, P290, DOI 10.1179/1743132813Y.0000000177; Lew HL, 2005, J REHABIL RES DEV, V42, pXIII, DOI 10.1682/JRRD.2005.07.0124; Li JL, 2003, NEUROPSYCHOPHARMACOL, V28, P1017, DOI 10.1038/sj.npp.1300112; Li ZQ, 2002, J CELL BIOL, V157, P509, DOI 10.1083/jcb.200109098; Liauw J, 2008, J CEREBR BLOOD F MET, V28, P1722, DOI 10.1038/jcbfm.2008.65; Lin TN, 2003, STROKE, V34, P177, DOI 10.1161/01.STR.0000047100.84604.BA; Lo FS, 2011, J NEUROPHYSIOL, V106, P2876, DOI 10.1152/jn.00312.2011; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Michael DB, 2005, J CLIN NEUROSCI, V12, P284, DOI 10.1016/j.jocn.2004.11.003; MILLER H, 1966, P ROY SOC MED, V59, P257, DOI 10.1177/003591576605900327; Newman EA, 2003, TRENDS NEUROSCI, V26, P536, DOI 10.1016/S0166-2236(03)00237-6; Nishimura AL, 2010, BRAIN, V133, P1763, DOI 10.1093/brain/awq111; Nonaka T, 2009, FEBS LETT, V583, P394, DOI 10.1016/j.febslet.2008.12.031; Norenberg M. D., 1998, NEUROSCI INTELL UNIT, P41; Ojo JO, 2016, EXP NEUROL, V275, P389, DOI 10.1016/j.expneurol.2015.06.003; Omalu B, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.9.FOCUS11178; Panickar KS, 2002, NEUROCHEM RES, V27, P161, DOI 10.1023/A:1014875210852; Rick FG, 2013, P NATL ACAD SCI USA, V110, P2617, DOI 10.1073/pnas.1222355110; Rosenfeld JV, 2013, LANCET NEUROL, V12, P882, DOI 10.1016/S1474-4422(13)70161-3; Sato T, 2009, NEUROSCIENCE, V164, P1565, DOI 10.1016/j.neuroscience.2009.09.050; Saulle M, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/816069; Sayed M, 2000, J BIOL CHEM, V275, P16569, DOI 10.1074/jbc.M000312200; Schousboe A., 1989, DISSECTION TISSUE CU, P203; Sephton CF, 2011, J BIOL CHEM, V286, P1204, DOI 10.1074/jbc.M110.190884; SHEPARD SR, 1991, J SURG RES, V51, P417, DOI 10.1016/0022-4804(91)90144-B; Shindo A, 2013, BRAIN RES, V1533, P131, DOI 10.1016/j.brainres.2013.08.007; Shively SB, 2012, J HEAD TRAUMA REHAB, V27, P234, DOI 10.1097/HTR.0b013e318250e9dd; Sinke AP, 2008, J NEUROCHEM, V106, P2302, DOI 10.1111/j.1471-4159.2008.05549.x; Slezak M, 2006, J PHYSIOLOGY-PARIS, V99, P84, DOI 10.1016/j.jphysparis.2005.12.082; Stein TD, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt234; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; SULLIVAN HG, 1976, J NEUROSURG, V45, P520, DOI 10.3171/jns.1976.45.5.0520; Suzuki H, 2013, MOL CELL BIOCHEM, V372, P241, DOI 10.1007/s11010-012-1465-x; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Tan BK, 2009, CARDIOVASC RES, V83, P566, DOI 10.1093/cvr/cvp131; Tran MD, 2006, P NATL ACAD SCI USA, V103, P9321, DOI 10.1073/pnas.0603146103; Ullian EM, 2004, GLIA, V47, P209, DOI 10.1002/glia.20082; van Eersel J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022850; WOLF FW, 1990, GENOMICS, V6, P685, DOI 10.1016/0888-7543(90)90505-O; WROBLEWSKI F, 1955, P SOC EXP BIOL MED, V90, P210; Yu KM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002470; Zhang YJ, 2007, J NEUROSCI, V27, P10530, DOI 10.1523/JNEUROSCI.3421-07.2007; Zhang YJ, 2009, P NATL ACAD SCI USA, V106, P7607, DOI 10.1073/pnas.0900688106	81	11	11	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	FEB	2017	140	4					645	661		10.1111/jnc.13867			17	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	EM8QV	WOS:000395577000010	27735996	Bronze			2021-06-18	
J	Zaninotto, AL; Vicentini, JE; Solla, DJF; Silva, TT; Guirado, VMD; Feltrin, F; de Lucia, MCS; Teixeira, MJ; Paiva, WS				Zaninotto, Ana Luiza; Vicentini, Jessica Elias; Fontoura Solla, Davi Jorge; Silva, Tatiana Tateishi; de Paula Guirado, Vinicius Monteiro; Feltrin, Fabricio; Souza de Lucia, Mara Cristina; Teixeira, Manoel Jacobsen; Paiva, Wellingson Silva			Visuospatial memory improvement in patients with diffuse axonal injury (DAI): a 1-year follow-up study	ACTA NEUROPSYCHIATRICA			English	Article						cognition; improvement; progmostic; traumatic brain injury; visuospatial memory	TRAUMATIC BRAIN-INJURY; RANDOMIZED CONTROLLED-TRIAL; CLOSED-HEAD INJURY; REHABILITATION; MODERATE; DISABILITY; TBI; CONSEQUENCES; PERFORMANCE; DEPRESSION	Objective Diffuse axonal injury (DAI) is prevalent in traumatic brain injury (TBI), and is often associated with poor outcomes and cognitive impairment, including memory deficits. Few studies have explored visual memory after TBI and its relationship to executive functioning. Executive functioning is crucial for remembering an object's location, operating devices, driving, and route finding. We compared visual memory performance via the Rey-Osterrieth Complex Figure (ROCF) test 6 and 12 months after DAI. Method In total, 40 patients (mean age 28.7 years; 87.5% male) with moderate-to-severe DAI following a road traffic accident completed the 1-year follow-up. There was a three-phase prospective assessment. In phase 1 (1-3 months after trauma), patients completed the Beck Depression Inventory (BDI) and State-Trait Anxiety Inventory (STAI). In phases 2 (6 months) and 3 (12 months), they completed the BDI, STAI, and a neuropsychological battery [ROCF copy and recall, digit span forward/backward, Grooved Pegboard test, intelligence quotient (IQ) by Wechsler Adult Intelligence Scale-III (WAIS-III)]. Results There was an improvement in ROCF recall over time (p=0.013), but not ROCF copy (p=0.657).There was no change in executive function (Savage scores) copy (p=0.230) or recall (p=0.155). Age, years of education, severity of the trauma, and IQ did not influence ROCF recall improvement. Conclusion There are time-dependent improvements in visual memory in patients with DAI. Neuroplasticity in the 1st months after trauma provides an opportunity for visuospatial memory learning. The present findings may be useful to formulate management plans for long-term TBI rehabilitation.	[Zaninotto, Ana Luiza; Vicentini, Jessica Elias; Silva, Tatiana Tateishi; Souza de Lucia, Mara Cristina] Univ Sao Paulo, Div Psychol, Clin Hosp, Sch Med, Sao Paulo, Brazil; [Zaninotto, Ana Luiza; Fontoura Solla, Davi Jorge; de Paula Guirado, Vinicius Monteiro; Teixeira, Manoel Jacobsen; Paiva, Wellingson Silva] Univ Sao Paulo, Div Neurosurg, Clin Hosp, Sch Med, Sao Paulo, Brazil; [Feltrin, Fabricio] Univ Sao Paulo, Inst Radiol, Clin Hosp, Sch Med, Sao Paulo, Brazil	Paiva, WS (corresponding author), 255 Eneas de Carvalho Aguiar St,Off 4079, BR-05403010 Sao Paulo, SP, Brazil.	wellingsonpaiva@yahoo.com.br	Paiva, Wellingson S/G-5517-2013; Zaninotto, Ana Luiza C./I-4095-2016; de Paula Guirado, Vinicius Monteiro/AAG-7299-2019; Vicentini, Jessica/E-5692-2014; Solla, Davi/E-6988-2013	Paiva, Wellingson S/0000-0002-5165-7040; Zaninotto, Ana Luiza C./0000-0003-0639-0612; de Paula Guirado, Vinicius Monteiro/0000-0002-7782-3609; Solla, Davi/0000-0002-5092-6595			Andelic N, 2012, J NEUROTRAUM, V29, P66, DOI 10.1089/neu.2011.1811; Ariza M, 2006, BRAIN INJURY, V20, P1053, DOI 10.1080/02699050600909862; Ashton VL, 2005, J CLIN EXP NEUROPSYC, V27, P55, DOI 10.1080/138033990513636; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bell KR, 2005, ARCH PHYS MED REHAB, V86, P851, DOI 10.1016/j.apmr.2004.09.015; BROOKS DN, 1974, J NEUROL NEUROSUR PS, V37, P794, DOI 10.1136/jnnp.37.7.794; Christensen BK, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2008.10.002; Cicerone KD, 2008, ARCH PHYS MED REHAB, V89, P2239, DOI 10.1016/j.apmr.2008.06.017; Costa TL, 2015, NEUROPSYCHOLOGIA, V78, P142, DOI 10.1016/j.neuropsychologia.2015.10.008; COUTINHO ACADM, 2010, AVALIACAO PSICOLOGIC, V9, P25; DIKMEN S, 1987, J NEUROL NEUROSUR PS, V50, P1613, DOI 10.1136/jnnp.50.12.1613; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; Goetz CG., 1999, TXB CLIN NEUROLOGY; Goodrich GL, 2013, OPTOMETRY VISION SCI, V90, P105, DOI 10.1097/OPX.0b013e31827f15a1; Gorenstein C, 1996, BRAZ J MED BIOL RES, V29, P453; Gorestein C, 1998, REV PSIQ CLIN, V25, P245; Greenwald BD, 2015, J NEUROTRAUM, V32, P1883, DOI 10.1089/neu.2014.3454; Herrera-Melero MC, 2015, BRAIN INJURY, V29, P1439, DOI 10.3109/02699052.2015.1071428; Imai M F, 1996, Rev Esc Enferm USP, V30, P116; Kersel DA, 2001, BRAIN INJURY, V15, P283, DOI 10.1080/02699050010005887; Kraus J F, 1993, EPIDEMIOLOGY HEAD IN; Lannoo E, 2001, BRAIN INJURY, V15, P1, DOI 10.1080/02699050150209084; Lee JH, 2003, J CLIN EXP NEUROPSYC, V25, P594, DOI 10.1076/jcen.25.5.594.14582; LEVIN HS, 1990, J CLIN EXP NEUROPSYC, V12, P129, DOI 10.1080/01688639008400960; Levine AJ, 2004, CLIN NEUROPSYCHOL, V18, P373, DOI 10.1080/1385404049052420; MAPOU R, 2013, HDB HEAD TRAUMA EARL; Matthews C, 1964, INSTRUCTION MANUAL A; McArthur DL, 2004, BRAIN PATHOL, V14, P185, DOI 10.1111/j.1750-3639.2004.tb00052.x; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; OSTERRIETH P, 1944, ARCH PSYCHOL, V1, P1021; Palacios EM, 2013, CORTEX, V49, P646, DOI 10.1016/j.cortex.2012.02.011; REY A, 2010, FIGURASCOMPLEXAS REY; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Ringe WK, 2002, ASSESSMENT, V9, P254, DOI 10.1177/1073191102009003004; Savage CR, 1999, BIOL PSYCHIAT, V45, P905, DOI 10.1016/S0006-3223(98)00278-9; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; Shum DHK, 2000, J CLIN EXP NEUROPSYC, V22, P25, DOI 10.1076/1380-3395(200002)22:1;1-8;FT025; Sozda CN, 2014, NEUROPSYCHOLOGY, V28, P347, DOI 10.1037/neu0000043; SPIELBERG CD, 1970, TESTMANUAL STATE TRA; Spreen O., 1998, COMPENDIUM NEUROPSYC; Tomaiuolo F, 2004, J NEUROL NEUROSUR PS, V75, P1314, DOI 10.1136/jnnp.2003.017046; TOMBAUGH TN, 1992, J CLIN EXP NEUROPSYC, V14, P647, DOI 10.1080/01688639208402853; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Vanderploeg RD, 2008, ARCH PHYS MED REHAB, V89, P2227, DOI 10.1016/j.apmr.2008.06.015; Ventura RE, 2014, LANCET NEUROL, V13, P1006, DOI 10.1016/S1474-4422(14)70111-5; Villamar MF, 2012, NEUROMODULATION, V15, P326, DOI 10.1111/j.1525-1403.2012.00474.x; Wade SL, 2008, J HEAD TRAUMA REHAB, V23, P369, DOI 10.1097/01.HTR.0000341432.67251.48; Weschler D., 1997, WESCHLER ADULT INTEL; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; ZANINOTTO AL, CLIN TRIAL TRAUMATIC; Zec RF, 2001, J CLIN EXP NEUROPSYC, V23, P671, DOI 10.1076/jcen.23.5.671.1247	51	11	12	0	6	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1601-5215			ACTA NEUROPSYCHIATR	Acta Neuropsychiatr.	FEB	2017	29	1					35	42		10.1017/neu.2016.29			8	Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	EK1AC	WOS:000393657200004	27725006				2021-06-18	
J	de Souza, JS; Carromeu, C; Torres, LB; Araujo, BHS; Cugola, FR; Maciel, RMB; Muotri, AR; Giannocco, G				de Souza, Janaina S.; Carromeu, Cassiano; Torres, Laila B.; Araujo, Bruno H. S.; Cugola, Fernanda R.; Maciel, Rui M. B.; Muotri, Alysson R.; Giannocco, Gisele			IGF1 neuronal response in the absence of MECP2 is dependent on TRalpha 3	HUMAN MOLECULAR GENETICS			English	Article							THYROID-HORMONE RECEPTOR; GROWTH-FACTOR-I; PLURIPOTENT STEM-CELLS; TRAUMATIC BRAIN-INJURY; RETT-SYNDROME; GENE-EXPRESSION; BINDING; PROLIFERATION; HIPPOCAMPUS; ASTROCYTES	Rett syndrome (RTT) is an X-linked neurodevelopmental disorder in which the MECP2 (methyl CpG-binding protein 2) gene is mutated. Recent studies showed that RTT-derived neurons have many cellular deficits when compared to control, such as: less synapses, lower dendritic arborization and reduced spine density. Interestingly, treatment of RTT-derived neurons with Insulin-like Growth Factor 1 (IGF1) could rescue some of these cellular phenotypes. Given the critical role of IGF1 during neurodevelopment, the present study used human induced pluripotent stem cells (iPSCs) from RTT and control individuals to investigate the gene expression profile of IGF1 and IGF1R on different developmental stages of differentiation. We found that the thyroid hormone receptor (TRalpha 3) has a differential expression profile. Thyroid hormone is critical for normal brain development. Our results showed that there is a possible link between IGF1/IGF1R and the TRalpha 3 and that over expression of IGF1R in RTT cells may be the cause of neurites improvement in neural RTT-derived neurons.	[de Souza, Janaina S.; Maciel, Rui M. B.; Giannocco, Gisele] Univ Fed Sao Paulo, UNIFESP EPM, Dept Med, Lab Endocrinol & Translat Med, Sao Paulo, SP, Brazil; [de Souza, Janaina S.; Carromeu, Cassiano; Torres, Laila B.; Cugola, Fernanda R.; Muotri, Alysson R.] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, Rady Childrens Hosp San Diego,Dept Pediat,Stem Ce, La Jolla, CA 92093 USA; [Araujo, Bruno H. S.] Univ Fed Sao Paulo, UNIFESP EPM, Neurosci Lab, Dept Neurol & Neurosurg, Sao Paulo, SP, Brazil; [Giannocco, Gisele] Univ Fed Sao Paulo, Dept Biol Sci, Diadema, SP, Brazil	Giannocco, G (corresponding author), Rua Pedro de Toledo 669,11 Andar, BR-04039032 Sao Paulo, SP, Brazil.	ggiannocco@unifesp.br	Giannocco, Gisele/I-2197-2015; Cugola, Fernanda/I-9556-2016; Torres, Laila Brito/O-2599-2013; Araujo, Bruno/P-9975-2019; Maciel, Rui M. B./A-9826-2013	Giannocco, Gisele/0000-0002-0126-7677; Cugola, Fernanda/0000-0002-6677-2404; Araujo, Bruno/0000-0003-0012-4217; Maciel, Rui M. B./0000-0002-6123-6098; Carromeu, Cassiano/0000-0002-7570-2213	California Institute for Regenerative Medicine (CIRM)California Institute for Regenerative Medicine [TR2-01814, TR4-06747]; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01MH094753, R01MH103134, U19MH107367]; NARSAD Independent Investigator GrantNARSAD; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brasilia, Brazil)Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [18952-12-7]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, Sao Paulo, Brazil)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2014/08049-1]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH094753, U19MH107367, R01MH103134] Funding Source: NIH RePORTER	This work was supported by a grant from the California Institute for Regenerative Medicine (CIRM) TR2-01814, TR4-06747, the National Institutes of Health (NIH) R01MH094753, R01MH103134, U19MH107367, a NARSAD Independent Investigator Grant to A.R.M., and the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brasilia, Brazil) 18952-12-7 to J.S.S., and from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, Sao Paulo, Brazil) 2014/08049-1 to B.H.S.A.	Ahmed OM, 2008, INT J DEV NEUROSCI, V26, P147, DOI 10.1016/j.ijdevneu.2007.09.011; Ahmed RG, 2016, TOXICOL LETT, V258, P46, DOI 10.1016/j.toxlet.2016.05.020; Ahmed RG, 2016, FOOD CHEM TOXICOL, V95, P168, DOI 10.1016/j.fct.2016.06.017; Aleman A, 2009, PROG NEUROBIOL, V89, P256, DOI 10.1016/j.pneurobio.2009.07.008; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Anderson MF, 2002, DEV BRAIN RES, V134, P115; Bauer M, 2008, J NEUROENDOCRINOL, V20, P1101, DOI 10.1111/j.1365-2826.2008.01774.x; Bernal J, 2007, NAT CLIN PRACT ENDOC, V3, P249, DOI 10.1038/ncpendmet0424; Bernal J, 2013, BBA-GEN SUBJECTS, V1830, P3893, DOI 10.1016/j.bbagen.2012.04.014; BINOUX M, 1991, ADV EXP MED BIOL, V293, P161; BONDY CA, 1993, ANN NY ACAD SCI, V692, P33; Bondy CA, 2004, EUR J PHARMACOL, V490, P25, DOI 10.1016/j.ejphar.2004.02.042; BRENT GA, 1991, ANNU REV PHYSIOL, V53, P17, DOI 10.1146/annurev.physiol.53.1.17; Butler AA, 1998, COMP BIOCHEM PHYS B, V121, P19, DOI 10.1016/S0305-0491(98)10106-2; Castro J, 2014, P NATL ACAD SCI USA, V111, P9941, DOI 10.1073/pnas.1311685111; Chatonnet F., 2013, PNAS, V110, P766; Desouza LA, 2005, MOL CELL NEUROSCI, V29, P414, DOI 10.1016/j.mcn.2005.03.010; Dupraz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054462; Dussault AA, 2006, BIOL PROCED ONLINE, V8, P1, DOI 10.1251/bpo114; Fernandez AM, 2012, NAT REV NEUROSCI, V13, P225, DOI 10.1038/nrn3209; Flamant F, 2003, TRENDS ENDOCRIN MET, V14, P85, DOI 10.1016/S1043-2760(02)00043-7; Gilbert ME, 2016, ENDOCRINOLOGY, V157, P774, DOI 10.1210/en.2015-1643; Guan J, 2003, PROG NEUROBIOL, V70, P443, DOI 10.1016/j.pneurobio.2003.08.002; Harvey CB, 2002, THYROID, V12, P441, DOI 10.1089/105072502760143791; Hewitt SC, 2010, J BIOL CHEM, V285, P2676, DOI 10.1074/jbc.M109.043471; HODIN RA, 1989, SCIENCE, V244, P76, DOI 10.1126/science.2539642; Holzenberger M, 2011, NESTLE NUTR WORKS SE, V68, P237, DOI 10.1159/000325914; Incerpi S, 2014, AM J PHYSIOL-CELL PH, V307, pC150, DOI 10.1152/ajpcell.00308.2013; Iskaros J, 2000, J CLIN ENDOCR METAB, V85, P2620, DOI 10.1210/jc.85.7.2620; Jimenez-Cervantes C, 1998, BBA-MOL CELL RES, V1403, P232, DOI 10.1016/S0167-4889(98)00063-9; Johnston M., 2015, F1000RES; LAZAR MA, 1993, ENDOCR REV, V14, P184, DOI 10.1210/er.14.2.184; Madathil SK, 2010, J NEUROTRAUM, V27, P95, DOI 10.1089/neu.2009.1002; Manzano J, 2007, INT J DEV NEUROSCI, V25, P171, DOI 10.1016/j.ijdevneu.2007.01.003; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Martin S, 2015, HORM-INT J ENDOCRINO, V14, P651, DOI 10.14310/horm.2002.1577; Nageshappa S, 2016, MOL PSYCHIATR, V21, P178, DOI 10.1038/mp.2015.128; Mendes-de-Aguiar CBN, 2008, J NEUROSCI RES, V86, P3117, DOI 10.1002/jnr.21755; Netchine I, 2009, J CLIN ENDOCR METAB, V94, P3913, DOI 10.1210/jc.2009-0452; Niblock MM, 2000, J NEUROSCI, V20, P4165; OCRANT I, 1990, ENDOCRINOLOGY, V127, P1260, DOI 10.1210/endo-127-3-1260; Pini G, 2014, FRONT PEDIATR, V2, DOI 10.3389/fped.2014.00052; Pini Giorgio, 2012, Autism Res Treat, V2012, P679801, DOI 10.1155/2012/679801; Ribeiro RCJ, 1998, RECENT PROG HORM RES, V53, P351; Roskoden T, 1999, EXP BRAIN RES, V127, P307, DOI 10.1007/s002210050800; Ross P. D., 2016, HUM MOL GENET; Royo NC, 2006, EUR J NEUROSCI, V23, P1089, DOI 10.1111/j.1460-9568.2006.04642.x; Rozario KS, 2000, ENDOTEXT; Sabatino L, 2007, BIOMED PHARMACOTHER, V61, P457, DOI 10.1016/j.biopha.2007.04.002; Schroeder AC, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00040; SCHWARTZ HL, 1994, J BIOL CHEM, V269, P24777; Shigyo M, 2015, SCI REP-UK, V5, DOI 10.1038/srep12055; Sinha RA, 2009, MOL CELL NEUROSCI, V40, P354, DOI 10.1016/j.mcn.2008.12.001; Stagi S, 2015, HORM RES PAEDIAT, V83, P118, DOI 10.1159/000370066; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Veeragavan S., 2016, HUM MOL GENT; Wang YF, 2011, COMP BIOCHEM PHYS A, V160, P474, DOI [10.1016/j.cbpa.2011.08.002, 10.1016/j.cbpa.2011.08.005]; White MF, 2014, DIABETES OBES METAB, V16, P4, DOI 10.1111/dom.12347; Yan H, 2011, J ENDOCRINOL, V211, P27, DOI 10.1530/JOE-11-0200; Zhang QP, 2015, BMC MED GENET, V16, DOI 10.1186/s12881-015-0264-0	60	11	11	0	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0964-6906	1460-2083		HUM MOL GENET	Hum. Mol. Genet.	JAN 15	2017	26	2					270	281		10.1093/hmg/ddw384			12	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	EP0GX	WOS:000397066400003	28007906	Green Published, Bronze			2021-06-18	
J	Maki-Marttunen, V; Kuusinen, V; Perakyla, J; Ogawa, KH; Brause, M; Brander, A; Hartikainen, KM				Maki-Marttunen, Veronica; Kuusinen, Venla; Perakyla, Jari; Ogawa, Keith H.; Brause, Maarja; Brander, Antti; Hartikainen, Kaisa M.			Greater Attention to Task-Relevant Threat Due to Orbitofrontal Lesion	JOURNAL OF NEUROTRAUMA			English	Article						behavioral assessments; cognitive function; EEG; human studies; traumatic brain injury	TRAUMATIC BRAIN-INJURY; PREFRONTAL CORTEX LESIONS; ANTERIOR THALAMIC NUCLEI; RESPONSE-INHIBITION; EXECUTIVE FUNCTIONS; EMOTIONAL STIMULI; VISUAL-ATTENTION; NEURAL MECHANISMS; FRONTAL LOBES; HEAD-INJURY	Injury to the orbitofrontal cortex (OFC) is a frequent consequence of head injury and may lead to dysfunctional regulation of emotional and social behavior. Dysfunctional emotional behavior may partly be related to the role of the OFC in emotion-attention interaction, as reported previously. In order to better understand its role in emotion-attention and emotion-cognitive control interactions, we investigated attention allocation to task-relevant and task-irrelevant threat-related emotional stimuli during a task requiring cognitive control in patients with lesion to the OFC. We measured the behavioral performance and event-related potentials (ERP) of 13 patients with OFC lesion and 11 control subjects during a Go/NoGo visual discrimination task. In the task, line drawings of threatening (spider) and neutral (flower) figures served as either task-relevant Go or NoGo signals, or as task-irrelevant distractors. Overall performance did not differ between the groups. In contrast to the control group performance, the orbitofrontal group performance was improved by relevant threat signal in comparison with neutral signal. Further, task-relevant threat signals evoked larger frontocentral N2-P3 amplitude in the orbitofrontal group. Taken together, behavioral and electrophysiological results suggest that patients with OFC injury allocated more attentional and cognitive control resources in the context of task-relevant emotional stimuli. This study provides new evidence for the role of the OFC in emotion-attention and emotion-cognitive control interactions. Further, the OFC seems to contribute to the balance between voluntary and involuntary attention networks in context of emotional stimuli. Better understanding of alterations in emotion-attention interaction offers insight into affective dysfunction due to OFC lesion.	[Maki-Marttunen, Veronica; Kuusinen, Venla; Perakyla, Jari; Brause, Maarja; Hartikainen, Kaisa M.] Tampere Univ Hosp, Dept Neurosci & Rehabil, Behav Neurol Res Unit, Finnmedi 6,5th Floor,Biokatu 14, Tampere 33520, Finland; [Maki-Marttunen, Veronica] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina; [Ogawa, Keith H.] St Marys Coll, John Magaddino Neurosci Lab, Moraga, CA 94575 USA; [Brander, Antti] Tampere Univ Hosp, Dept Radiol, Tampere, Finland; [Hartikainen, Kaisa M.] Tampere Univ Hosp, Dept Neurol & Rehabil, Tampere, Finland; [Kuusinen, Venla; Perakyla, Jari; Hartikainen, Kaisa M.] Univ Tampere, Sch Med, Tampere, Finland	Hartikainen, KM (corresponding author), Tampere Univ Hosp, Dept Neurosci & Rehabil, Behav Neurol Res Unit, Finnmedi 6,5th Floor,Biokatu 14, Tampere 33520, Finland.	kaisa.hartikainen@uta.fi		Hartikainen, Kaisa/0000-0001-7278-9635	Academy of FinlandAcademy of FinlandEuropean Commission; Competitive Research Fund of Pirkanmaa Hospital District	This research was supported by the Academy of Finland and the Competitive Research Fund of Pirkanmaa Hospital District.	Anderson AK, 2001, NATURE, V411, P305, DOI 10.1038/35077083; Angrilli A, 1999, NEUROREPORT, V10, P1741, DOI 10.1097/00001756-199906030-00021; [Anonymous], 2008, CURR CAR GUID; Bates DM, 2010, LME4 MIXED EFFECTS M; Bechara A, 2004, BRAIN COGNITION, V55, P30, DOI 10.1016/j.bandc.2003.04.001; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Beer JS, 2006, J COGNITIVE NEUROSCI, V18, P871, DOI 10.1162/jocn.2006.18.6.871; Beer JS, 2003, J PERS SOC PSYCHOL, V85, P594, DOI 10.1037/0022-3514.85.4.594; Berlin HA, 2004, BRAIN, V127, P1108, DOI 10.1093/brain/awh135; Bokura H, 2001, CLIN NEUROPHYSIOL, V112, P2224, DOI 10.1016/S1388-2457(01)00691-5; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bonelli Raphael M, 2007, Dialogues Clin Neurosci, V9, P141; Bramham J, 2009, J NEUROPSYCHOL, V3, P125, DOI 10.1348/174866408X293994; Braver TS, 2010, CURR OPIN NEUROBIOL, V20, P242, DOI 10.1016/j.conb.2010.03.002; Carretie L, 2014, COGN AFFECT BEHAV NE, V14, P1228, DOI 10.3758/s13415-014-0270-2; Chen AJW, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00187; Chudasama Y, 2003, BEHAV BRAIN RES, V146, P105, DOI 10.1016/j.bbr.2003.09.020; Cicerone KD, 1997, ARCH CLIN NEUROPSYCH, V12, P173, DOI 10.1016/S0887-6177(96)00022-4; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Daffner KR, 2000, J COGNITIVE NEUROSCI, V12, P393, DOI 10.1162/089892900562219; Daffner KR, 1998, NEUROREPORT, V9, P787, DOI 10.1097/00001756-199803300-00004; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.neuro.18.1.193; Desimone R, 1998, PHILOS T R SOC B, V353, P1245, DOI 10.1098/rstb.1998.0280; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Dixon P, 2008, J MEM LANG, V59, P447, DOI 10.1016/j.jml.2007.11.004; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Hardman JM, 2002, NEUROIMAG CLIN N AM, V12, P175, DOI 10.1016/S1052-5149(02)00009-6; Hartikainen K. M., 2003, DETECTION CHANGE EVE, P99, DOI DOI 10.1007/978-1-4615-0294-4; Hartikainen KM, 2007, NEUROREPORT, V18, P1929, DOI 10.1097/WNR.0b013e3282f1ca18; Hartikainen KM, 2014, J CLIN EXP NEUROPSYC, V36, P540, DOI 10.1080/13803395.2014.913554; Hartikainen KM, 2012, J CLIN EXP NEUROPSYC, V34, P588, DOI 10.1080/13803395.2012.666231; Hartikainen KM, 2012, NEUROREPORT, V23, P447, DOI 10.1097/WNR.0b013e3283531e74; Hartikainen KM, 2010, J CLIN EXP NEUROPSYC, V32, P767, DOI 10.1080/13803390903521000; Hartikainen KM, 2010, NEUROREPORT, V21, P344, DOI 10.1097/WNR.0b013e328336eeb3; Hartikainen KM, 2000, NEUROPSYCHOLOGIA, V38, P1576, DOI 10.1016/S0028-3932(00)00072-5; Horn NR, 2003, NEUROPSYCHOLOGIA, V41, P1959, DOI 10.1016/S0028-3932(03)00077-0; Hornak J, 2003, BRAIN, V126, P1691, DOI 10.1093/brain/awg168; Jaeger TF, 2008, J MEM LANG, V59, P434, DOI 10.1016/j.jml.2007.11.007; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Lavie N, 2005, TRENDS COGN SCI, V9, P75, DOI 10.1016/j.tics.2004.12.004; Liimatainen J., 2016, INTERACT J CARDIOVAS; Lobue V, 2008, PSYCHOL SCI, V19, P284, DOI 10.1111/j.1467-9280.2008.02081.x; Lovstad M, 2012, BRAIN INJURY, V26, P1586, DOI 10.3109/02699052.2012.698787; Lovstad M, 2012, J COGNITIVE NEUROSCI, V24, P378, DOI 10.1162/jocn_a_00099; Maki-Marttunen V, 2015, J NEUROTRAUM, V32, P272, DOI 10.1089/neu.2014.3557; Maki-Marttunen V, 2014, NEUROREPORT, V25, P1038, DOI 10.1097/WNR.0000000000000223; Ohman A, 2001, J EXP PSYCHOL GEN, V130, P466, DOI 10.1037/0096-3445.130.3.466; Ohman A, 2005, PSYCHONEUROENDOCRINO, V30, P953, DOI 10.1016/j.psyneuen.2005.03.019; Oliveira L, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00364; Padmala S, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00192; Papazacharias A, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00097; Pessoa L, 2009, TRENDS COGN SCI, V13, P160, DOI 10.1016/j.tics.2009.01.006; R Core Team, 2018, R LANG ENV STAT COMP; Rorden C, 2007, J COGNITIVE NEUROSCI, V19, P1081, DOI 10.1162/jocn.2007.19.7.1081; Roth R.M., 2005, BEHAV RATING INVENTO; Rule RR, 2002, COGN AFFECT BEHAV NE, V2, P264, DOI 10.3758/CABN.2.3.264; Sakaki M, 2012, COGN AFFECT BEHAV NE, V12, P115, DOI 10.3758/s13415-011-0062-x; Seidenberg M, 2009, FUTUR NEUROL, V4, P663, DOI 10.2217/FNL.09.32; Shimamura AP, 2000, PSYCHOBIOLOGY, V28, P207; Solbakk AK, 2005, J CLIN EXP NEUROPSYC, V27, P205, DOI 10.1080/13803390490515739; Solbakk AK, 2014, SCAND J PSYCHOL, V55, P233, DOI 10.1111/sjop.12106; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Sun LH, 2015, NEUROPSYCHOLOGIA, V78, P88, DOI 10.1016/j.neuropsychologia.2015.10.001; Szczepanski SM, 2014, NEURON, V83, P1002, DOI 10.1016/j.neuron.2014.08.011; Vossel S, 2014, NEUROSCIENTIST, V20, P150, DOI 10.1177/1073858413494269; Vuilleumier P, 2001, NEUROREPORT, V12, P1119, DOI 10.1097/00001756-200105080-00014; Waid-Ebbs JK, 2012, BRAIN INJURY, V26, P1646, DOI 10.3109/02699052.2012.700087; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; Zald DH, 2010, NEUROPSYCHOLOGIA, V48, P3377, DOI 10.1016/j.neuropsychologia.2010.08.012	70	11	12	0	19	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2017	34	2					400	413		10.1089/neu.2015.4390			14	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	EH4QD	WOS:000391754800016	27502875				2021-06-18	
J	Bricker-Anthony, C; D'Surney, L; Lunn, B; Hines-Beard, J; Jo, M; Bernardo-Colon, A; Rex, TS				Bricker-Anthony, Courtney; D'Surney, Lauren; Lunn, Brendan; Hines-Beard, Jessica; Jo, Minhee; Bernardo-Colon, Alexandra; Rex, Tonia S.			Erythropoietin either Prevents or Exacerbates Retinal Damage from Eye Trauma Depending on Treatment Timing	OPTOMETRY AND VISION SCIENCE			English	Article						erythropoietin; eye trauma; blast; neuroprotection	BRAIN-INJURY; GANGLION-CELLS; MOUSE MODEL; VISUAL FUNCTION; OCULAR TRAUMA; GENE-TRANSFER; DEGENERATION; PROTECTS; GLAUCOMA; DERIVATIVES	Purpose. Erythropoietin (EPO) is a promising neuroprotective agent and is currently in Phase III clinical trials for the treatment of traumatic brain injury. The goal of this study was to determine if EPO is also protective in traumatic eye injury. Methods. The left eyes of anesthetized DBA/2J or Balb/c mice were exposed to a single 26 psi overpressure air-wave while the rest of the body was shielded. DBA/2J mice were given intraperitoneal injections of EPO or buffer and analyses were performed at 3 or 7 days post-blast. Balb/c mice were given intramuscular injections of rAAV.EpoR76E or rAAV.eGFP either pre- or post-blast and analyses were performed at 1 month post-blast. Results. EPO had a bimodal effect on cell death, glial reactivity, and oxidative stress. All measures were increased at 3 days post-blast and decreased at 7-days post-blast. Increased retinal ferritin and NADPH oxygenases were detected in retinas from EPO-treated mice. The gene therapy approach protected against axon degeneration, cell death, and oxidative stress when given after blast, but not before. Conclusions. Systemic, exogenous EPO and EPO-R76E protects the retina after trauma even when initiation of treatment is delayed by up to 3 weeks. Systemic treatment with EPO or EPO-R76E beginning before or soon after trauma may exacerbate protective effects of EPO within the retina as a result of increased iron levels from erythropoiesis and, thus, increased oxidative stress within the retina. This is likely overcome with time as a result of an increase in levels of antioxidant enzymes. Either intraocular delivery of EPO or treatment with non-erythropoietic forms of EPO may be more efficacious.	[Bricker-Anthony, Courtney; Hines-Beard, Jessica; Jo, Minhee; Bernardo-Colon, Alexandra; Rex, Tonia S.] Vanderbilt Univ, Med Ctr, Vanderbilt Eye Inst, Nashville, TN USA; [Bricker-Anthony, Courtney; Hines-Beard, Jessica; Rex, Tonia S.] Vanderbilt Univ, Med Ctr, Vanderbilt Brain Inst, Nashville, TN USA; [D'Surney, Lauren; Lunn, Brendan] Univ Tennessee, Hlth Sci Ctr, Dept Ophthalmol, Memphis, TN USA	Rex, TS (corresponding author), Vanderbilt Univ, Med Ctr, Dept Ophthalmol & Visual Sci, 11425 Langford MRB-4,2213 Garland Ave, Nashville, TN 37232 USA.	tonia.rex@vanderbilt.edu		Bricker-Anthony, Courtney/0000-0001-5000-3523	Department of DefenseUnited States Department of Defense [W81XW-10-1-0528, W81XWH-13-1-0048, W81XWH-15-1-0096]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 EY022349, P30 EY008126]; Fight for Sight Summer Undergraduate Fellowship; Research to Prevent Blindness Unrestricted Funds; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01EY022349, P30EY008126] Funding Source: NIH RePORTER	This research was funded by Department of Defense grants W81XW-10-1-0528 (TSR), W81XWH-13-1-0048 (TSR), W81XWH-15-1-0096 (TSR), NIH grants R01 EY022349 (TSR) and P30 EY008126 (David Calkins), Fight for Sight Summer Undergraduate Fellowship (LDS), and Research to Prevent Blindness Unrestricted Funds (Paul Sternberg, Jr.).	Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bond WS, 2016, MOL THER, V24, P230, DOI 10.1038/mt.2015.198; Bond WS, 2012, FRONT IMMUNOL, V8, P24; Bosco A, 2011, J COMP NEUROL, V519, P599, DOI 10.1002/cne.22516; Bricker-Anthony C, 2016, J OCUL PHARMACOL TH, V32, P286, DOI 10.1089/jop.2015.0104; Bricker-Anthony C, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0192-5; Bricker-Anthony C, 2014, INVEST OPHTH VIS SCI, V55, P4853, DOI 10.1167/iovs.14-14353; Cockerham GC, 2011, NEW ENGL J MED, V364, P2172, DOI 10.1056/NEJMc1010683; Cockerham GC, 2009, J REHABIL RES DEV, V46, P811, DOI 10.1682/JRRD.2008.08.0109; Dumont F, 2010, EXPERT OPIN THER PAT, V20, P715, DOI 10.1517/13543771003627464; Dvoriantchikova G, 2012, INVEST OPHTH VIS SCI, V53, P2823, DOI 10.1167/iovs.12-9526; Fisher JW, 2003, EXP BIOL MED, V228, P1; Gammella E, 2015, AM J PHYSIOL-REG I, V308, pR330, DOI 10.1152/ajpregu.00410.2014; Gawad AE, 2009, EYE, V23, P2245, DOI 10.1038/eye.2008.398; Grimm C, 2002, NAT MED, V8, P718, DOI 10.1038/nm723; Grimm C, 2004, J NEUROSCI, V24, P5651, DOI 10.1523/JNEUROSCI.1288-04.2004; He XN, 2007, PROG RETIN EYE RES, V26, P649, DOI 10.1016/j.preteyeres.2007.07.004; Hilber David J, 2011, MSMR, V18, P2; Hines-Beard J, 2012, EXP EYE RES, V99, P63, DOI 10.1016/j.exer.2012.03.013; Inman DM, 2006, INVEST OPHTH VIS SCI, V47, P986, DOI 10.1167/iovs.05-0925; John SWM, 1998, INVEST OPHTH VIS SCI, V39, P951; Junk AK, 2002, P NATL ACAD SCI USA, V99, P10659, DOI 10.1073/pnas.152321399; Kilic E, 2005, FASEB J, V19, P2026, DOI 10.1096/fj.05-3941fje; Kim A, 2015, CURR OPIN HEMATOL, V22, P199, DOI 10.1097/MOH.0000000000000132; King CE, 2007, EXP NEUROL, V205, P48, DOI 10.1016/j.expneurol.2007.01.017; Lee DE, 2006, BIOCHEM BIOPH RES CO, V339, P380, DOI 10.1016/j.bbrc.2005.11.034; Leist M, 2004, SCIENCE, V305, P239, DOI 10.1126/science.1098313; Louboutin JP, 2005, J GENE MED, V7, P442, DOI 10.1002/jgm.686; Nichol A, 2015, TRIALS, V16, DOI 10.1186/s13063-014-0528-6; Peng WJ, 2014, J NEUROSURG, V121, P653, DOI 10.3171/2014.6.JNS132577; Presneill Jeffrey, 2014, Trials, V15, P501, DOI 10.1186/1745-6215-15-501; Rex TS, 2009, EXP EYE RES, V89, P735, DOI 10.1016/j.exer.2009.06.017; Rex TS, 2004, MOL THER, V10, P855, DOI 10.1016/j.ymthe.2004.07.027; Scott R, 2011, PHILOS T R SOC B, V366, P251, DOI 10.1098/rstb.2010.0234; Sullivan T, 2011, NEUROCHEM RES, V36, P613, DOI 10.1007/s11064-010-0272-6; Sullivan TA, 2012, EXP EYE RES, V96, P36, DOI 10.1016/j.exer.2012.01.006; Sullivan TA, 2011, HUM GENE THER, V22, P1191, DOI 10.1089/hum.2011.052; Tsai JC, 2005, CURR EYE RES, V30, P1025, DOI 10.1080/02713680500320729; U.S. Centers for Disease Control and Prevention (CDC), 2013, MMWR-MORBID MORTAL W, V62, P374; Weichel EA, 2009, J HEAD TRAUMA REHAB, V24, P41, DOI 10.1097/HTR.0b013e3181956ffd; Weishaupt JH, 2004, INVEST OPHTH VIS SCI, V45, P1514, DOI 10.1167/iovs.03-1039; Weitlauf C, 2014, J NEUROSCI, V34, P15369, DOI 10.1523/JNEUROSCI.3424-14.2014; World Health Organization (WHO), WORLD HLTH ORG PRIOR; Xiong Y, 2010, J NEUROSURG, V113, P598, DOI 10.3171/2009.9.JNS09844	44	11	11	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1040-5488	1538-9235		OPTOMETRY VISION SCI	Optom. Vis. Sci.	JAN	2017	94	1					20	32		10.1097/OPX.0000000000000898			13	Ophthalmology	Ophthalmology	EM5ZZ	WOS:000395393900005	27281679	Green Accepted			2021-06-18	
J	Clacy, A; Goode, N; Sharman, R; Lovell, GP; Salmon, PM				Clacy, Amanda; Goode, Natassia; Sharman, Rachael; Lovell, Geoff P.; Salmon, Paul M.			A knock to the system: A new sociotechnical systems approach to sport-related concussion	JOURNAL OF SPORTS SCIENCES			English	Article						Injury & prevention; decision making; dynamic systems; qualitative analysis; team sports	MANAGEMENT; PREVENTION; STRATEGIES; CAUSATION; INJURIES; MODELS	Broader contextual factors that influence concussion management have tended to be overlooked. To address this, the present study used a sociotechnical systems approach to identify perceived responsibilities and applied strategies for three domains of concussion management (i.e., prevention, identification and treatment). Participants were 118 members of the community rugby union system in Australia (69.2% male). Participants from throughout the rugby system (e.g., players, parents, coaches, club management) were asked open-ended questions about their perceived responsibilities and the strategies they use for concussion management. It was found that (a) proper training, technique correction and education were recurrent prevention themes; (b) the majority of key stakeholders felt that they could consistently identify concussion; however, medical aids (medics) were the only system actors who stated a responsibility to use standardised concussion assessment measures and (c) less than one third of the respondents indicated their involvement in treating concussion. This study identifies specific junctures in the system that prevents effective concussion management strategies. A sociotechnical systems approach improves the understanding of concussion prevention, and management beliefs and behaviours.	[Clacy, Amanda; Goode, Natassia; Salmon, Paul M.] Univ Sunshine Coast, Fac Arts Business & Law, Ctr Human Factors & Sociotech Syst, Maroochydore, Qld, Australia; [Sharman, Rachael; Lovell, Geoff P.] Univ Sunshine Coast, Fac Arts Business & Law, Sch Social Sci Fac, Maroochydore, Qld, Australia	Clacy, A (corresponding author), Univ Sunshine Coast, Fac Arts Business & Law, Ctr Human Factors & Sociotech Syst, Maroochydore, Qld, Australia.	aclacy@usc.edu.au		Goode, Natassia/0000-0003-0736-7043; Salmon, Paul/0000-0001-7403-0286			Ajzen I., 1985, INTENTIONS ACTIONS T; Borich MR, 2013, J NEUROL PHYS THER, V37, P133, DOI 10.1097/NPT.0b013e31829f7460; Braun V., 2006, QUALITATIVE RES PSYC, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706qp063oa]; Clacy A, 2015, PROCEDIA MANUF, V3, P1173, DOI 10.1016/j.promfg.2015.07.195; Clacy A, 2013, J BIOETHIC INQ, V10, P127, DOI 10.1007/s11673-012-9421-8; Cohen JS, 2009, CURR OPIN PEDIATR, V21, P288, DOI 10.1097/MOP.0b013e32832b1195; Collins CL, 2008, INJURY PREV, V14, P34, DOI 10.1136/ip.2007.017277; Dallat C, 2015, PROCEDIA MANUF, V3, P1157, DOI 10.1016/j.promfg.2015.07.193; Dekker S, 2011, DRIFT INTO FAILURE: FROM HUNTING BROKEN COMPONENTS TO UNDERSTANDING COMPLEX SYSTEMS, P1; Donaldson A, 2016, AM J LIFESTYLE MED, V10, P120, DOI 10.1177/1559827614538751; Finch CF, 2013, BRIT J SPORT MED, V47, P12, DOI 10.1136/bjsports-2012-091796; Godin G, 1996, AM J HEALTH PROMOT, V11, P87, DOI 10.4278/0890-1171-11.2.87; Goode N, 2015, PROCEDIA MANUF, V3, P1125, DOI 10.1016/j.promfg.2015.07.188; Hollis SJ, 2012, BRIT J SPORT MED, V46, P735, DOI 10.1136/bjsm.2011.085332; Kerr HA, 2014, PEDIATR ANN, V43, pE309, DOI 10.3928/00904481-20141124-10; King D, 2014, J SCI MED SPORT, V17, P250, DOI 10.1016/j.jsams.2013.05.007; Makdissi M, 2013, BRIT J SPORT MED, V47, P314, DOI 10.1136/bjsports-2013-092256; McAllister-Deitrick J, 2014, ATHL TRAIN SPORTS HL, V6, P280, DOI DOI 10.3928/01484834-20141112-03; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McGlashan AJ, 2010, SPORTS MED, V40, P841, DOI 10.2165/11534960-000000000-00000; McKeever CK, 2003, APPL NEUROPSYCHOL, V10, P4, DOI 10.1207/S15324826AN1001_2; Rasmussen J, 1997, SAFETY SCI, V27, P183, DOI 10.1016/S0925-7535(97)00052-0; Reason J, 2000, BMJ-BRIT MED J, V320, P768, DOI 10.1136/bmj.320.7237.768; Salmon PM, 2017, APPL ERGON, V59, P637, DOI 10.1016/j.apergo.2015.07.017; Salmon PM, 2014, ACCIDENT ANAL PREV, V63, P111, DOI 10.1016/j.aap.2013.10.019	25	11	11	0	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0264-0414	1466-447X		J SPORT SCI	J. Sports Sci.		2017	35	22					2232	2239		10.1080/02640414.2016.1265140			8	Sport Sciences	Sport Sciences	FF1NY	WOS:000408667400011	27935422				2021-06-18	
J	Coats, B; Binenbaum, G; Smith, C; Peiffer, RL; Christian, CW; Duhaime, AC; Margulies, SS				Coats, Brittany; Binenbaum, Gil; Smith, Colin; Peiffer, Robert L.; Christian, Cindy W.; Duhaime, Ann-Christine; Margulies, Susan S.			Cyclic Head Rotations Produce Modest Brain Injury in Infant Piglets	JOURNAL OF NEUROTRAUMA			English	Article						abusive head trauma; biomechanics; pediatric traumatic brain injury; shaken baby syndrome	SHAKEN BABY SYNDROME; TRAUMATIC AXONAL INJURY; YOUNG-CHILDREN; NEONATAL PIG; RETINAL HEMORRHAGES; OVINE MODEL; AGE; FALLS; DIRECTION; RESPONSES	Repetitive back-and-forth head rotation from vigorous shaking is purported to be a central mechanism responsible for diffuse white matter injury, subdural hemorrhage, and retinal hemorrhage in some cases of abusive head trauma (AHT) in young children. Although animal studies have identified mechanisms of traumatic brain injury (TBI) associated with single rapid head acceleration-decelerations at levels experienced in a motor vehicle crash, few experimental studies have investigated TBI from repetitive head rotations. The objective of this study was to systematically investigate the post-injury pathological time-course after cyclic, low-velocity head rotations in the piglet and compare them with single head rotations. Injury metrics were the occurrence and extent of axonal injury (AI), extra-axial hemorrhage (EAH), red cell neuronal/axonal change (RCNAC), and ocular injury (OI). Hyperflexion/extension of the neck were purposefully avoided in the study, resulting in unscaled angular accelerations at the lower end of reported infant surrogate shaking kinematics. All findings were at the mild end of the injury spectrum, with no significant findings at 6 h post-injury. Cyclic head rotations, however, produced modest AI that significantly increased with time post-injury (p < 0.035) and had significantly greater amounts of RCNAC and EAH than noncyclic head rotations after 24 h post-injury (p < 0.05). No OI was observed. Future studies should investigate the contributions of additional physiological and mechanical features associated with AHT (e.g., hyperflexion/extension, increased intracranial pressure from crying or thoracic compression, and more than two cyclic episodes) to enhance our understanding of the causality between proposed mechanistic factors and AHT in infants.	[Coats, Brittany] Univ Utah, Dept Mech Engn, 1495 E 100 St,2157 MEK, Salt Lake City, UT 84112 USA; [Binenbaum, Gil] Childrens Hosp Philadelphia, Dept Ophthalmol, Philadelphia, PA 19104 USA; [Binenbaum, Gil; Peiffer, Robert L.] Univ Penn, Dept Ophthalmol, Philadelphia, PA 19104 USA; [Smith, Colin] Univ Edinburgh, Dept Pathol, Edinburgh, Midlothian, Scotland; [Christian, Cindy W.] Univ Penn, Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA; [Duhaime, Ann-Christine] Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA; [Duhaime, Ann-Christine] Harvard Univ, Boston, MA 02115 USA; [Margulies, Susan S.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA	Coats, B (corresponding author), Univ Utah, Dept Mech Engn, 1495 E 100 St,2157 MEK, Salt Lake City, UT 84112 USA.	brittany.coats@utah.edu		Smith, Colin/0000-0002-4507-5132	NIH NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [T32 NS043126, K12 EY015398, R01 NS39679]; ARRA administrative supplemental award; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [K12EY015398] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [T32NS043126, U01NS069545] Funding Source: NIH RePORTER	Research funding was provided by NIH NINDS T32 NS043126, K12 EY015398, R01 NS39679 and its associated ARRA administrative supplemental award. The authors are grateful to Jill Ralston for assistance with animal handling, tissue processing, and scoring of axonal injury and red cell neuronal/axonal change; Sarah Sullivan for assistance with extra-axial hemorrhage scoring and statistical analysis; Justin Jones for assistance with data analysis; and Dr. Andrew Merryweather for using data motion capture to evaluate head motion during surrogate shaking.	Adamsbaum C, 2010, PEDIATRICS, V126, P546, DOI 10.1542/peds.2009-3647; Anderson RWG, 2014, J BIOMECH, V47, P2578, DOI 10.1016/j.jbiomech.2014.06.002; [Anonymous], 1956, NEWSWEEK, P90; Bechtel K, 2004, PEDIATRICS, V114, P165, DOI 10.1542/peds.114.1.165; Bell E, 2011, CHILD ABUSE NEGLECT, V35, P74, DOI 10.1016/j.chiabu.2010.11.001; Bhardwaj G, 2010, OPHTHALMOLOGY, V117, P983, DOI 10.1016/j.ophtha.2009.09.040; Binenbaum G, 2009, J AAPOS, V13, P268, DOI 10.1016/j.jaapos.2009.03.005; Bonnier C, 2002, BRAIN PATHOL, V12, P320; BRAZY JE, 1988, J PEDIATR-US, V112, P457, DOI 10.1016/S0022-3476(88)80336-6; BUCKLEY NM, 1986, COMP BIOCHEM PHYS A, V83, P1, DOI 10.1016/0300-9629(86)90080-0; CDC, 2015, PERC DISTR TBI REL D; Choudhary AK, 2014, PEDIATR RADIOL, V44, P1130, DOI 10.1007/s00247-014-2959-3; Christian CW, 2015, PEDIATRICS, V135, pE1337, DOI 10.1542/peds.2015-0356; Christian CW, 2009, PEDIATRICS, V123, P1409, DOI 10.1542/peds.2009-0408; Coats B, 2008, J NEUROSURG-PEDIATR, V2, P321, DOI 10.3171/PED.2008.2.11.321; Coats B, 2010, INVEST OPHTH VIS SCI, V51, P4792, DOI 10.1167/iovs.10-5211; Cory CZ, 2003, MED SCI LAW, V43, P317, DOI 10.1258/rsmmsl.43.4.317; Dickerson J. W. T., 1966, Proceedings of the Royal Society, V166B, P384; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; DOBBING J, 1973, ARCH DIS CHILD, V48, P757, DOI 10.1136/adc.48.10.757; DUHAIME AC, 1992, PEDIATRICS, V90, P179; DUHAIME AC, 1987, J NEUROSURG, V66, P409, DOI 10.3171/jns.1987.66.3.0409; Duhaime AC, 2006, DEV NEUROSCI-BASEL, V28, P380, DOI 10.1159/000094164; Eucker S., 2009, EFFECT HEAD ROTATION; Eucker S., 2008, REGIONAL CEREBRAL BL, P854; Eucker SA, 2011, EXP NEUROL, V227, P79, DOI 10.1016/j.expneurol.2010.09.015; Eucker SA, 2010, BRAIN RES, V1326, P128, DOI 10.1016/j.brainres.2010.02.059; Finnie JW, 2012, J CLIN NEUROSCI, V19, P1159, DOI 10.1016/j.jocn.2011.12.019; Finnie JW, 2010, J CLIN NEUROSCI, V17, P237, DOI 10.1016/j.jocn.2009.07.001; FLYNN TJ, 1984, NEUROCHEM RES, V9, P935, DOI 10.1007/BF00964525; Friess SH, 2007, EXP NEUROL, V204, P234, DOI 10.1016/j.expneurol.2006.10.010; Friess SH, 2009, J NEUROTRAUM, V26, P1111, DOI [10.1089/neu.2008.0845, 10.1089/neu.2008-0845]; Hettler J, 2003, PEDIATRICS, V111, P602, DOI 10.1542/peds.111.3.602; Ibrahim NG, 2010, J NEUROTRAUM, V27, P1021, DOI 10.1089/neu.2009.1212; Ichord RN, 2007, J NEUROTRAUM, V24, P106, DOI 10.1089/neu.2006.0087; Jayawant S, 1998, BMJ-BRIT MED J, V317, P1558, DOI 10.1136/bmj.317.7172.1558; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Lee C, 2007, J DEV BEHAV PEDIATR, V28, P288, DOI 10.1097/DBP.0b013e3180327b55; Lind NM, 2007, NEUROSCI BIOBEHAV R, V31, P728, DOI 10.1016/j.neubiorev.2007.02.003; Maguire S, 2009, ARCH DIS CHILD, V94, P860, DOI 10.1136/adc.2008.150110; Margulies S. S., 1999, COMPARISON DIFFUSE B; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; Matschke J, 2009, PEDIATRICS, V124, P1587, DOI 10.1542/peds.2008-3734; Naim MY, 2010, DEV NEUROSCI-BASEL, V32, P466, DOI 10.1159/000322448; Ohman Anna Maria, 2008, Pediatr Phys Ther, V20, P53, DOI 10.1097/PEP.0b013e31815ebb27; OMMAYA AK, 1971, J BIOMECH, V4, P13, DOI 10.1016/0021-9290(71)90011-X; PAMPIGLIONE G, 1971, P ROY SOC MED, V64, P429, DOI 10.1177/003591577106400441; PATTERSON DS, 1971, J NEUROCHEM, V18, P2027, DOI 10.1111/j.1471-4159.1971.tb05062.x; Prange M., 2001, ASME 2001 BIOENG C S, P833; Prange MT, 2003, J NEUROSURG, V99, P143, DOI 10.3171/jns.2003.99.1.0143; Raghupathi R, 2004, J NEUROTRAUM, V21, P307, DOI 10.1089/089771504322972095; Raghupathi R, 2002, J NEUROTRAUM, V19, P843, DOI 10.1089/08977150260190438; Reece RM, 2000, ARCH PEDIAT ADOL MED, V154, P11; Smith SL, 1998, J NEUROTRAUM, V15, P693, DOI 10.1089/neu.1998.15.693; Starling SP, 2004, ARCH PEDIAT ADOL MED, V158, P454, DOI 10.1001/archpedi.158.5.454; STOW PJ, 1988, BRIT J ANAESTH, V60, P167, DOI 10.1093/bja/60.2.167; Sullivan S, 2015, ACCIDENT ANAL PREV, V82, P143, DOI 10.1016/j.aap.2015.05.020; Sullivan S, 2015, BIOMECH MODEL MECHAN, V14, P877, DOI 10.1007/s10237-014-0643-z; Sullivan S, 2013, J NEUROTRAUM, V30, P1770, DOI 10.1089/neu.2013.2913; Sullivan S, 2013, J NEUROTRAUM, V30, P538, DOI 10.1089/neu.2012.2594; Tommasi DG, 2009, SPINE, V34, P1910, DOI 10.1097/BRS.0b013e3181afe826; Trenchs V, 2008, CHILD NERV SYST, V24, P815, DOI 10.1007/s00381-008-0583-y; Vinchon M, 2005, J NEUROSURG, V102, P380, DOI 10.3171/ped.2005.102.4.0380; Vinchon M, 2010, CHILD NERV SYST, V26, P637, DOI 10.1007/s00381-009-1048-7; Weeks D, 2014, J NEUROTRAUM, V31, P206, DOI 10.1089/neu.2013.3113; Yu B, 1999, J APPL BIOMECH, V15, P318, DOI 10.1123/jab.15.3.318	66	11	11	0	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2017	34	1					235	247		10.1089/neu.2015.4352			13	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	EF6DE	WOS:000390420100025	26953505	Green Published			2021-06-18	
J	Coutinho, V; Camara-Costa, H; Kemlin, I; de Villemeur, TB; Rodriguez, D; Dellatolas, G				Coutinho, V.; Camara-Costa, H.; Kemlin, I.; de Villemeur, T. Billette; Rodriguez, D.; Dellatolas, G.			The Discrepancy between Performance-Based Measures and Questionnaires when Assessing Clinical Outcomes and Quality of Life in Pediatric Patients with Neurological Disorders	APPLIED NEUROPSYCHOLOGY-CHILD			English	Article						Assessment; neurofibromatosis type 1; neuropsychological tests; outcome; parental reports	TRAUMATIC BRAIN-INJURY; NEUROFIBROMATOSIS TYPE-1; COGNITIVE DYSFUNCTION; EXECUTIVE FUNCTION; CHILDREN; COMPLAINTS; ATTENTION; SYMPTOMS; BEHAVIOR; RATINGS	In clinical outcome assessment, the relation between performance-based measures and questionnaire ratings of the same domain is weak, but correlations between questionnaires proposed for the evaluation of different domains are strong. The present study aims to illustrate these phenomena in a group of patients with neurofibromatosis type 1 (NF1) and to propose an explanatory hypothesis. A single neuropsychologist interviewed the parents about the child's situation and current difficulties and then assessed this parental view as overall positive or overall negative. The same assessor then administered the Wechsler Intelligence Scales and neuropsychological tests to 78 children and adolescents with NF1 (5-18 years). Parents then completed the Child Behavioral Checklist (CBCL), the Conners' Parent Rating Scale, the Behavior Rating Inventory of Executive Function (BRIEF), as well as questionnaires assessing quality of life, impact of the medical disorder, and their own difficulties. All questionnaires were inter-correlated (r=0.29 - 0.84) and associated with the overall positive or negative parental view of the child's progress (effect size=0.41-1.46). Conversely, questionnaires were weakly or not significantly related to intelligence, cognitive measures, or clinical severity. In conclusion, the parental view of the child's progress was related to the answers to questionnaires assessing quality of life or strengths and difficulties of patients with a neurological disorder. This factor should be assessed independently and taken into account when assessing clinical outcome.	[Coutinho, V.; Kemlin, I.; de Villemeur, T. Billette; Rodriguez, D.] Trousseau Hosp, AP HP, Pediat Neurol Unit, GHUEP, Paris, France; [Coutinho, V.; Kemlin, I.; Rodriguez, D.] Neurofibromatosis Referral Ctr, Paris, France; [Coutinho, V.; Camara-Costa, H.; Dellatolas, G.] Natl Inst Hlth & Med Res, INSERM CESP1018, Villejuif, France; [Coutinho, V.] Paris Descartes Univ, Paris, France; [de Villemeur, T. Billette; Rodriguez, D.] Sorbonne Univ, UPMC, Paris, France; [de Villemeur, T. Billette; Rodriguez, D.] Natl Inst Hlth & Med Res, INSERM U1141, Paris, France	Coutinho, V (corresponding author), Hop Trousseau, Serv Neuropediat, 26 Ave Docteur Arnold Netter, F-75012 Paris, France.	virginie.coutinho@trs.aphp.fr		Camara-Costa, Hugo/0000-0002-3739-7190			Achenbach TM, 2001, MANUAL ASEBA SCH AGE; Biglia N, 2012, EUR J CANCER CARE, V21, P485, DOI 10.1111/j.1365-2354.2011.01320.x; Chevignard MP, 2012, BRAIN INJURY, V26, P1033, DOI 10.3109/02699052.2012.666366; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Cortese S, 2007, J PSYCHOSOM RES, V63, P587, DOI 10.1016/j.jpsychores.2007.08.005; Coutinho V, 2016, RES DEV DISABIL, V48, P220, DOI 10.1016/j.ridd.2015.11.010; Cutting LE, 2010, CHILD NEUROPSYCHOL, V16, P417, DOI 10.1080/09297041003761985; Descheemaeker MJ, 2005, J INTELL DISABIL RES, V49, P33, DOI 10.1111/j.1365-2788.2005.00660.x; Dirven L, 2015, NEURO-ONCOL PRACT, V2, P2, DOI 10.1093/nop/npv002; Ferner Rosalie E, 2010, Pract Neurol, V10, P82, DOI 10.1136/jnnp.2010.206532; Frol AB, 2013, ALLERGY ASTHMA PROC, V34, P170, DOI 10.2500/aap.2013.34.3642; Gehring K, 2015, NEURO-ONCOL PRACT, V2, P20, DOI 10.1093/nop/npu035; Gioa G. A., 2000, INVENTAIRE EVALUATIO; GOYETTE CH, 1978, J ABNORM CHILD PSYCH, V6, P221, DOI 10.1007/BF00919127; Hermelink K, 2010, PSYCHO-ONCOLOGY, V19, P1321, DOI 10.1002/pon.1695; Hooper L, 2007, NEUROPSYCHOL REHABIL, V17, P621, DOI 10.1080/09602010601137054; Isenberg JC, 2013, J CHILD NEUROL, V28, P45, DOI 10.1177/0883073812439435; Kennedy C, 2014, INT J RADIAT ONCOL, V88, P292, DOI 10.1016/j.ijrobp.2013.09.046; Lehtonen A, 2013, DEV MED CHILD NEUROL, V55, P111, DOI 10.1111/j.1469-8749.2012.04399.x; Liemburg GB, 2015, MOL GENET METAB, V114, P425, DOI 10.1016/j.ymgme.2014.12.302; Mahone EM, 2007, CLIN NEUROPSYCHOL, V21, P569, DOI 10.1080/13854040600762724; McCarthy ML, 2005, ARCH PHYS MED REHAB, V86, P1901, DOI 10.1016/j.apmr.2005.03.026; Moore LH, 1997, J NEUROPSYCH CLIN N, V9, P37; Mora PA, 2007, ANN BEHAV MED, V34, P77, DOI 10.1007/BF02879923; National Institutes of Health (NIH), 1988, CONS DEV C STAT NEUR, V6, P1; Payne JM, 2011, CHILD NEUROPSYCHOL, V17, P313, DOI 10.1080/09297049.2010.542746; Pullens MJJ, 2010, PSYCHO-ONCOLOGY, V19, P1127, DOI 10.1002/pon.1673; Soria Carmen, 2007, Dev Neurorehabil, V10, P213, DOI 10.1080/13638490601111129; Stulemeijer M, 2007, J PSYCHOSOM RES, V63, P637, DOI 10.1016/j.jpsychores.2007.06.023; Toplak ME, 2013, J CHILD PSYCHOL PSYC, V54, P131, DOI 10.1111/jcpp.12001; Wechsler D., 2004, ECHELLE INTELLIGENCE; Wechsler D., 2005, ECHELLE INTELLIGENCE, V4th	33	11	11	0	4	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2162-2965	2162-2973		APPL NEUROPSYCH-CHIL	Appl. Neuropsychol.-Child		2017	6	4					255	261		10.1080/21622965.2016.1146141			7	Clinical Neurology; Psychology	Neurosciences & Neurology; Psychology	FK7SD	WOS:000413706600002	27182681				2021-06-18	
J	Cusimano, MD; Zhang, S; Topolovec-Vranic, J; Hutchison, MG; Jing, R				Cusimano, Michael D.; Zhang, Stanley; Topolovec-Vranic, Jane; Hutchison, Michael G.; Jing, Rowan			Factors affecting the concussion knowledge of athletes, parents, coaches, and medical professionals	SAGE OPEN MEDICINE			English	Article						Concussion; traumatic brain injury; sports; knowledge; public health; prevention	TRAUMATIC BRAIN-INJURY; COLLEGIATE FOOTBALL PLAYERS; FOR-DISEASE-CONTROL; HIGH-SCHOOL SPORTS; RACIAL DISPARITIES; UNITED-STATES; PREVENTION; EDUCATION; HEADS; ADOLESCENTS	Objectives: To determine the predictors of knowledge and awareness of concussion symptoms and outcomes through a survey of athletes, parents of players and coaches in sports settings in Canada. Methods: A cross-sectional survey of athletic communities in Canada was conducted. Respondents' concussion knowledge score consists of responses to questions about the symptoms, diagnosis, and treatment of a concussion and the timing of return-to-sport post-concussion. The percentage of correct responses was defined as the "identification rate." The extent to which participant factors affected the scores was examined by univariate and multivariate analyses. Results: Respondents were able to identify a mean of 80.6% of symptoms. Cognitive symptoms were most commonly known, and mental health symptoms associated with concussion were least known, and health professionals, coaches, and those with a personal history of concussion had the highest levels of overall knowledge. Language, age, educational level, annual household income, and traumatic brain injury history were good predictors of better concussion knowledge. Conclusion: Those designing and implementing interventions aimed at concussion management and prevention should ensure that younger, lower income, lower educational, non-English-speaking persons, and those without experience of traumatic brain injury or concussion be specifically accounted for in the design and implementation of interventions to prevent and treat concussion and mild traumatic brain injury.	[Cusimano, Michael D.; Zhang, Stanley; Topolovec-Vranic, Jane; Jing, Rowan] St Michaels Hosp, Injury Prevent Res Off, Div Neurosurg, Li Ka Shing Knowledge Inst, 30 Bond St, Toronto, ON M5B 1W8, Canada; [Cusimano, Michael D.; Zhang, Stanley; Topolovec-Vranic, Jane; Jing, Rowan] St Michaels Hosp, Trauma & Neurosurg Program, 30 Bond St, Toronto, ON M5B 1W8, Canada; [Cusimano, Michael D.] Univ Toronto, Fac Med, Toronto, ON, Canada; [Cusimano, Michael D.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Cusimano, Michael D.] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Hutchison, Michael G.] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada	Cusimano, MD (corresponding author), St Michaels Hosp, Injury Prevent Res Off, Div Neurosurg, Li Ka Shing Knowledge Inst, 30 Bond St, Toronto, ON M5B 1W8, Canada.; Cusimano, MD (corresponding author), St Michaels Hosp, Trauma & Neurosurg Program, 30 Bond St, Toronto, ON M5B 1W8, Canada.	injuryprevention@smh.ca	Cusimano, Michael/X-4059-2019; Topolovec-Vranic, Jane/A-5293-2013	Topolovec-Vranic, Jane/0000-0001-7695-4212	Public Health Agency of Canada; Canadian Institutes of Health Research Strategic Team Grant in Applied Injury ResearchCanadian Institutes of Health Research (CIHR) [TIR-103946]; Ontario Neurotrauma Foundation	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The research was partially supported by the Public Health Agency of Canada (M.D.C), the Canadian Institutes of Health Research Strategic Team Grant in Applied Injury Research #TIR-103946 (M.D.C), and the Ontario Neurotrauma Foundation (M.D.C).	Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Asoogo C, 2015, CURATIONIS, V38, DOI [10.4102/curationisv38i1.1287, DOI 10.4102/CURATIONISV38I1.1287]; Bagley AF, 2012, CLIN J SPORT MED, V22, P385, DOI 10.1097/JSM.0b013e3182639bb4; Bazarian JJ, 2006, ACAD EMERG MED, V13, P31, DOI 10.1197/j.aem.2005.07.038; Cao ZJ, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-26; Chrisman SP, 2014, AM J SPORT MED, V42, P1190, DOI 10.1177/0363546513519073; Covassin T, 2012, J SCHOOL HEALTH, V82, P233, DOI 10.1111/j.1746-1561.2012.00692.x; Cusimano MD, 2009, CAN J NEUROL SCI, V36, P315, DOI 10.1017/S0317167100007046; Delaney JS, 2001, CLIN J SPORT MED, V11, P234, DOI 10.1097/00042752-200110000-00005; Demakis GJ, 2010, ARCH CLIN NEUROPSYCH, V25, P191, DOI 10.1093/arclin/acq004; Echlin PS, 2014, J NEUROSURG, V121, P1331, DOI 10.3171/2014.8.JNS132804; Gelaw Sifrash Meseret, 2016, Tuberc Res Treat, V2016, P6207457, DOI 10.1155/2016/6207457; Gonçalves Helen, 2013, Rev. bras. epidemiol., V16, P420, DOI 10.1590/S1415-790X2013000200017; Guerrero JL, 2000, BRAIN INJURY, V14, P181, DOI 10.1080/026990500120827; Guilmette TJ, 2007, BRAIN INJURY, V21, P1039, DOI 10.1080/02699050701633080; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Hutton A, 2015, PREHOSP DISASTER MED, V30, P175, DOI 10.1017/S1049023X15000187; Ilie G, 2013, JAMA-J AM MED ASSOC, V309, P2550, DOI 10.1001/jama.2013.6750; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Kurowski B, 2014, J TRAUMA ACUTE CARE, V77, pS12, DOI 10.1097/TA.0000000000000316; Lantz PM, 1998, JAMA-J AM MED ASSOC, V279, P1703, DOI 10.1001/jama.279.21.1703; Macciocchi SN, 2001, J ATHL TRAINING, V36, P303; Mannings C, 2014, J TRAUMA ACUTE CARE, V77, pS18, DOI 10.1097/TA.0000000000000371; Matuszak JM, 2016, SPORTS HEALTH, V8, P260, DOI 10.1177/1941738116641394; McLaughlin KA, 2013, J HEAD TRAUMA REHAB, V28, P341, DOI 10.1097/HTR.0b013e31824e1d43; Menger R, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15615; Montgomery M, 2014, QUEBEC IGNORES CONCU; Mrazik M, 2015, BRIT J SPORT MED, V49, DOI 10.1136/bjsports-2015-094848; National Coaching Certification Program, NAT COACH CERT PROGR; Nonzee NJ, 2015, J WOMENS HEALTH, V24, P506, DOI 10.1089/jwh.2014.4998; Norrie J, 2010, BRAIN INJURY, V24, P1528, DOI 10.3109/02699052.2010.531687; North Vancouver Minor Hockey Association, CONC AW TRAIN TOOL C; Pang EW, 2016, ANN CLIN TRANSL NEUR, V3, P124, DOI 10.1002/acn3.280; Papa L, 2013, CURR TRANSL GERIATR, V1, P135; Paz-Soldan VA, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00281; Ponsford JL, 2013, J NEUROTRAUM, V30, P1498, DOI 10.1089/neu.2012.2843; Runyan CW, 2000, AM J PREV MED, V18, P116, DOI 10.1016/S0749-3797(00)00147-1; Sarmiento K, 2010, J SCHOOL HEALTH, V80, P112, DOI 10.1111/j.1746-1561.2010.00491.x; Sawyer RJ, 2010, HEALTH PROMOT PRACT, V11, P34, DOI 10.1177/1524839907309377; Shafi S, 2007, J TRAUMA, V63, P1263, DOI 10.1097/TA.0b013e31815b8f00; Shermer CR, 2007, J TRAUMA, V63, P1268; Statistics Canada, 2009, TYP MOST SER INJ PEO; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Styrke J, 2013, J REHABIL MED, V45, P749, DOI 10.2340/16501977-1215; Theye Fred, 2004, Clin Med Res, V2, P165; Topolovec-Vranic J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141699; Tucker-Drob EM, 2012, PERS INDIV DIFFER, V53, P9, DOI 10.1016/j.paid.2012.02.004; Wang Y, 2007, EPIDEMIOL REV, V29, P6, DOI 10.1093/epirev/mxm007; Weber M, 2012, ARCH CLIN NEUROPSYCH, V27, P355, DOI 10.1093/arclin/acs029; Williamson Richard W, 2014, Neurosurgery, V75 Suppl 4, pS131, DOI 10.1227/NEU.0000000000000482; Zhang LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070563; Zonfrillo MR, 2012, PEDIATRICS, V130, P1120, DOI 10.1542/peds.2012-1431	54	11	11	0	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2050-3121			SAGE OPEN MED	SAGE Open Med.	JAN-DEC	2017	5									10.1177/2050312117699799			9	Medicine, General & Internal	General & Internal Medicine	GS3AT	WOS:000443441700011	28540042	DOAJ Gold			2021-06-18	
J	Das, J; Singh, R; Sharma, D				Das, Jharana; Singh, Rameshwar; Sharma, Deepak			Antiepileptic effect of fisetin in iron-induced experimental model of traumatic epilepsy in rats in the light of electrophysiological, biochemical, and behavioral observations	NUTRITIONAL NEUROSCIENCE			English	Article						Fisetin; Epilepsy; Oxidative stress; Na+; K+-ATPase; Lipid peroxidation; Morris water maze; Open-field test	OXIDATIVE STRESS; ANTIOXIDANT; FLAVONOIDS; SEIZURES; MICE; INVOLVEMENT; ACTIVATION; MECHANISMS; DISEASE; PROTEIN	Background: Traumatic epilepsy is defined by episodes of recurring seizures secondary to severe brain injury. Though drugs are found effective to control seizures, their long-term use have been observed to increase reactive oxygen species in animals. Flavonoid fisetin, a natural bioactive phytonutrient reported to exert anticonvulsive effect in experimental seizure models. But, trauma-induced seizures could not be prevented by anticonvulsants was reported in some clinical studies. Objective: To study the effect of fisetin on epileptiform electrographic activity in iron-induced traumatic epilepsy and also the probable reason behind the effect in rats. Methods: Fisetin pretreatment (20mg/kg body wt., p.o.) of rats for 12 weeks were chosen followed by injecting iron (5 mu l, 100mM) stereotaxically to generate iron-induced epilepsy. Experimental design include electrophysiological study (electroencephalograph in correlation with multiple unit activity (MUA) in the cortex and CA1 subfield of the hippocampus; spectral analysis of seizure and seizure-associated behavioral study (Morris water maze for spatial learning, open-field test for anxiety) and biochemical study (lipid peroxidation, Na+,K+-ATPase activity) in both the cortex and the hippocampus. Results: Fisetin pretreatment was found to prevent the development of iron-induced electrical seizure and decrease the corresponding MUA in the cortex (*P < 0.05) as well as in the hippocampus (***P < 0.001). Fisetin pretreatment decreased the lipid peroxides (*P < 0.05) and retained the Na+,K+-ATPase activity (*P < 0.05) which was found altered in the epileptic animals and also found to attenuate the seizure-associated cognitive dysfunctions. Conclusion: This study demonstrated the antiepileptic action of fisetin in iron-induced model of epileptic rats by inhibiting oxidative stress.	[Das, Jharana; Singh, Rameshwar; Sharma, Deepak] Jawaharlal Nehru Univ, Sch Life Sci, Lab Neurobiol, New Delhi 110067, India	Sharma, D (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India.	deepak57in@yahoo.co.in		Das, Jharana/0000-0001-7212-9215	Department of Biotechnology, Ministry of Science and Technology, Government of India, New Delhi, IndiaDepartment of Biotechnology (DBT) India [BT/PR4993/MED/30/914/2012]	Department of Biotechnology, Ministry of Science and Technology, Government of India, New Delhi, India (BT/PR4993/MED/30/914/2012).	Silva LFA, 2011, J NEUROL SCI, V308, P35, DOI 10.1016/j.jns.2011.06.030; Arakawa H, 2003, DEV PSYCHOBIOL, V43, P11, DOI 10.1002/dev.10120; Beltowski J, 2003, ACTA BIOCHIM POL, V50, P103; Cao GH, 1997, FREE RADICAL BIO MED, V22, P749, DOI 10.1016/S0891-5849(96)00351-6; Cesnik E, 2013, NEUROL NEUROPHYSIO S, VS2, P1; Constantin RP, 2011, J BIOCHEM MOL TOXIC, V25, P117, DOI 10.1002/jbt.20367; Currais A, 2014, AGING CELL, V13, P379, DOI 10.1111/acel.12185; Diniz TC, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/171756; Fiske CH, 1925, J BIOL CHEM, V66, P375; HOLMES GL, 1990, ANN NEUROL, V27, P24, DOI 10.1002/ana.410270106; Ishige K, 2001, FREE RADICAL BIO MED, V30, P433, DOI 10.1016/S0891-5849(00)00498-6; Javed H, 2015, J NEUROL SCI, V348, P51, DOI 10.1016/j.jns.2014.10.044; Junker H, 2005, EPILEPSIA, V46, P339, DOI 10.1111/j.0013-9580.2005.46904.x; Kang KA, 2014, IN VITRO CELL DEV-AN, V50, P66, DOI 10.1007/s11626-013-9681-6; Khan N, 2013, ANTIOXID REDOX SIGN, V19, P151, DOI 10.1089/ars.2012.4901; Kovacs Z, 2011, J NEUROSCI METH, V197, P133, DOI 10.1016/j.jneumeth.2011.02.005; Maher P, 2007, BRAIN RES, V1173, P117, DOI 10.1016/j.brainres.2007.07.061; Maher P, 2011, HUM MOL GENET, V20, P261, DOI 10.1093/hmg/ddq460; Maher P, 2009, GENES NUTR, V4, P297, DOI 10.1007/s12263-009-0142-5; Markovic JMD, 2014, RSC ADV, V4, P32228, DOI 10.1039/c4ra02577f; Markovic JMD, 2011, DALTON T, V40, P4560, DOI 10.1039/c0dt01834a; Mishra M, 2010, EPILEPSY BEHAV, V19, P264, DOI 10.1016/j.yebeh.2010.06.048; Miteva MA, 2006, NUCLEIC ACIDS RES, V34, pW738, DOI 10.1093/nar/gkl065; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Moseley AE, 2007, J NEUROSCI, V27, P616, DOI 10.1523/JNEUROSCI.4464-06.2007; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Ozdemir D, 2005, NEUROSCI LETT, V385, P234, DOI 10.1016/j.neulet.2005.05.055; Piao MJ, 2013, BIOMOL THER, V21, P210, DOI 10.4062/biomolther.2013.017; Raygude KS, 2012, BIOMED PREV NUTR, V2, P215, DOI DOI 10.1016/J.BIONUT.2012.04.005; Rezin GT, 2014, REV BRAS PSIQUIATR, V36, P138, DOI 10.1590/1516-4446-2012-0956; Saenz JCB, 2006, BEHAV BRAIN RES, V169, P57, DOI 10.1016/j.bbr.2005.12.001; Sagara Y, 2004, J NEUROCHEM, V90, P1144, DOI 10.1111/j.1471-4159.2004.02563.x; Shin EJ, 2011, NEUROCHEM INT, V59, P122, DOI 10.1016/j.neuint.2011.03.025; WILLMORE LJ, 1981, NEUROLOGY, V31, P63, DOI 10.1212/WNL.31.1.63; Zhao X, 2015, SCI REP-UK, V5, DOI 10.1038/srep09043; Zhen LL, 2012, BEHAV BRAIN RES, V228, P359, DOI 10.1016/j.bbr.2011.12.017	36	11	11	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1028-415X	1476-8305		NUTR NEUROSCI	Nutr. Neurosci.		2017	20	4					255	264		10.1080/1028415X.2016.1183342			10	Neurosciences; Nutrition & Dietetics	Neurosciences & Neurology; Nutrition & Dietetics	ES6QF	WOS:000399673200006	27198489				2021-06-18	
J	Drapeau, J; Gosselin, N; Peretz, I; McKerral, M				Drapeau, Joanie; Gosselin, Nathalie; Peretz, Isabelle; McKerral, Michelle			Emotional recognition from dynamic facial, vocal and musical expressions following traumatic brain injury	BRAIN INJURY			English	Article						Traumatic brain injury; mild; complicated mild; moderate; severe; emotions; faces; non-linguistic vocalizations; music	IMPAIRED RECOGNITION; MILD; DEFICITS; PERCEPTION; DAMAGE; CONCUSSION; RECOVERY; MODERATE; PEOPLE; SCARY	Objectives: To assess emotion recognition from dynamic facial, vocal and musical expressions in sub-groups of adults with traumatic brain injuries (TBI) of different severities and identify possible common underlying mechanisms across domains.Methods: Forty-one adults participated in this study: 10 with moderate-severe TBI, nine with complicated mild TBI, 11 with uncomplicated mild TBI and 11 healthy controls, who were administered experimental (emotional recognition, valence-arousal) and control tasks (emotional and structural discrimination) for each domain.Results: Recognition of fearful faces was significantly impaired in moderate-severe and in complicated mild TBI sub-groups, as compared to those with uncomplicated mild TBI and controls. Effect sizes were medium-large. Participants with lower GCS scores performed more poorly when recognizing fearful dynamic facial expressions. Emotion recognition from auditory domains was preserved following TBI, irrespective of severity. All groups performed equally on control tasks, indicating no perceptual disorders. Although emotional recognition from vocal and musical expressions was preserved, no correlation was found across auditory domains.Conclusions: This preliminary study may contribute to improving comprehension of emotional recognition following TBI. Future studies of larger samples could usefully include measures of functional impacts of recognition deficits for fearful facial expressions. These could help refine interventions for emotional recognition following a brain injury.	[Drapeau, Joanie; McKerral, Michelle] CRLB, CRIR, 2275 Ave Laurier Est, Montreal, PQ H2N 2N8, Canada; [Drapeau, Joanie; Gosselin, Nathalie; McKerral, Michelle] Ctr Rech Neuropsychol & Cognit CERNEC, Montreal, PQ, Canada; [Drapeau, Joanie; Gosselin, Nathalie; Peretz, Isabelle] CRBLM, Montreal, PQ, Canada; [Drapeau, Joanie; Gosselin, Nathalie; Peretz, Isabelle] Int Lab Brain Mus & Sound Res BRAMS, Montreal, PQ, Canada; [Drapeau, Joanie; Gosselin, Nathalie; Peretz, Isabelle; McKerral, Michelle] Univ Montreal, Dept Psychol, Montreal, PQ, Canada	McKerral, M (corresponding author), CRLB, CRIR, 2275 Ave Laurier Est, Montreal, PQ H2N 2N8, Canada.	michelle.mckerral@umontreal.ca			National Science and Engineering Research Council of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC); Centre de readaptation Lucie-Bruneau; Canada Research ChairNatural Resources CanadaCanadian Forest ServiceCanada Research Chairs; Fonds de recherche du Quebec-SanteFonds de la Recherche en Sante du Quebec; Faculte des etudes superieures et postdoctorales de l'Universite de Montreal	This study was supported by the National Science and Engineering Research Council of Canada and the Centre de readaptation Lucie-Bruneau (grants to M.M.), a Canada Research Chair (to I.P.), the Fonds de recherche du Quebec-Sante and the Faculte des etudes superieures et postdoctorales de l'Universite de Montreal (scholarships to J.D.). The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.	Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; ADOLPHS R, 1994, NATURE, V372, P669, DOI 10.1038/372669a0; Adolphs R., 2000, NEUROPSYCHOLOGY EMOT, P194; Ambadar Z, 2005, PSYCHOL SCI, V16, P403, DOI 10.1111/j.0956-7976.2005.01548.x; Arlinghaus KA, 2011, TXB TRAUMATIC BRAIN, P55; Arnal LH, 2015, CURR BIOL, V25, P2051, DOI 10.1016/j.cub.2015.06.043; Aube W, 2015, SOC COGN AFFECT NEUR, V10, P399, DOI 10.1093/scan/nsu067; Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; Beauchamp MH, 2011, INT J DEV NEUROSCI, V29, P137, DOI 10.1016/j.ijdevneu.2010.12.003; Beck AT, 2013, MANUAL BECK DEPRESSI; Belin P, 2004, TRENDS COGN SCI, V8, P129, DOI 10.1016/j.tics.2004.01.008; Belin P, 2008, BEHAV RES METHODS, V40, P531, DOI 10.3758/BRM.40.2.531; Bigler ED, 2011, TXB TRAUMATIC BRAIN, P73, DOI DOI 10.1177/1753193410381840; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Borgaro SR, 2003, BRAIN INJURY, V17, P189, DOI 10.1080/0269905021000013183; Broglio SP, 2011, INT J PSYCHOPHYSIOL, V82, P16, DOI 10.1016/j.ijpsycho.2011.02.010; Callahan BL, 2011, BRAIN COGNITION, V77, P412, DOI 10.1016/j.bandc.2011.08.017; Carlozzi NE, 2015, CLIN NEUROPSYCHOL, V29, P21, DOI 10.1080/13854046.2015.1005677; Croker V, 2005, BRAIN INJURY, V19, P787, DOI 10.1080/02699050500110033; Deguise E, 2008, J HEAD TRAUMA REHAB, V23, P294, DOI 10.1097/01.HTR.0000336842.53338.f4; Dellacherie D, 2011, NEUROPSYCHOLOGIA, V49, P618, DOI 10.1016/j.neuropsychologia.2010.11.008; Dimoska A, 2010, J INT NEUROPSYCH SOC, V16, P1; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Ellemberg D, 2009, J NEUROTRAUM, V26, P2365, DOI 10.1089/neu.2009.0906; Genova HM, 2015, SOC NEUROSCI-UK, V10, P27, DOI 10.1080/17470919.2014.959618; Gosselin N, 2005, BRAIN, V128, P628, DOI 10.1093/brain/awh420; Gosselin N, 2012, NEUROSURG FOCUS, V33, P1, DOI DOI 10.3171/2012.10.F0CUS12253; Gosselin N, 2007, NEUROPSYCHOLOGIA, V45, P236, DOI 10.1016/j.neuropsychologia.2006.07.012; Gosselin N, 2011, CORTEX, V47, P1116, DOI 10.1016/j.cortex.2011.05.012; Green REA, 2004, NEUROPSYCHOLOGIA, V42, P133, DOI 10.1016/j.neuropsychologia.2003.07.005; Hawk ST, 2009, EMOTION, V9, P293, DOI 10.1037/a0015178; Hopkins MJ, 2002, BRAIN INJURY, V16, P245, DOI 10.1080/02699050110103346; Ietswaart M, 2008, NEUROPSYCHOLOGIA, V46, P148, DOI 10.1016/j.neuropsychologia.2007.08.002; Iverson GL, 2006, BRAIN INJURY, V20, P1335, DOI 10.1080/02699050601082156; Iverson GL, 2011, MANUAL OF TRAUMATIC BRAIN INJURY MANAGEMENT, P43; Juslin Patrik N, 2011, HDB MUSIC EMOTION TH; Knox L, 2009, BRAIN COGNITION, V69, P442, DOI 10.1016/j.bandc.2008.09.009; Koelsch S, 2014, NAT REV NEUROSCI, V15, P170, DOI 10.1038/nrn3666; Lachapelle J, 2008, BRAIN INJURY, V22, P265, DOI 10.1080/02699050801938983; Lange RT, 2009, BRAIN INJURY, V23, P83, DOI 10.1080/02699050802635281; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McDonald S, 2005, J INT NEUROPSYCH SOC, V11, P392, DOI 10.1017/S1355617705050447; McDonald S, 2011, BRAIN IMPAIR, V12, P165; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; Neumann D, 2016, BRAIN IMAGING BEHAV, V10, P569, DOI 10.1007/s11682-015-9415-3; Peretz I., 2010, HDB MUSIC EMOTION TH; Peretz I, 2013, EVOLUTION EMOTIONAL, P277; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Rosenberg H, 2014, J INT NEUROPSYCH SOC, V20, P994, DOI 10.1017/S1355617714000940; Roy S, STOIC DATABASE DYNAM; Rymarczyk K, 2011, INT J PSYCHOPHYSIOL, V79, P330, DOI 10.1016/j.ijpsycho.2010.11.001; Sarkamo T, 2008, BRAIN, V131, P866, DOI 10.1093/brain/awn013; Sarkamo T, 2012, ANN NY ACAD SCI, V1252, P266, DOI 10.1111/j.1749-6632.2011.06405.x; Sarkamo T, 2010, J COGNITIVE NEUROSCI, V22, P2716, DOI 10.1162/jocn.2009.21376; Scott SK, 1997, NATURE, V385, P254, DOI 10.1038/385254a0; Spell LA, 2000, J NONVERBAL BEHAV, V24, P285, DOI 10.1023/A:1006675230193; Spikman JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065581; Temkin NR, 2009, J HEAD TRAUMA REHAB, V24, P460, DOI 10.1097/HTR.0b013e3181c13413; Trautmann SA, 2009, BRAIN RES, V1284, P100, DOI 10.1016/j.brainres.2009.05.075; Vandekerckhove M, 2014, NEUROPSYCHOLOGY, V28, P605, DOI 10.1037/neu0000057; VieIllard S, 2008, COGNITION EMOTION, V22, P720, DOI 10.1080/02699930701503567; Wechsler D, 1997, WAIS 3 ADM SCORING M; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Yeo RA, 2011, J NEUROTRAUM, V28, P1, DOI 10.1089/neu.2010.1578; Zupan B, 2014, BRAIN INJURY, V28, P1087, DOI 10.3109/02699052.2014.901560	66	11	11	1	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	2					221	229		10.1080/02699052.2016.1208846			9	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	EM2RO	WOS:000395163500010	28067551				2021-06-18	
J	Frias, FJL; McNamee, M				Frias, Francisco Javier Lopez; McNamee, Mike			Ethics, Brain Injuries, and Sports: Prohibition, Reform, and Prudence	SPORT ETHICS AND PHILOSOPHY			English	Article						Brain injuries; autonomy; paternalism; football; consensual domination	DANGEROUS SPORT; CONCUSSION; PATERNALISM; MEDICINE; MANAGEMENT; CONFLICTS; LIBERTY	In this paper, we explore the issue of the elimination of sports, or elements of sports, that present a high risk of brain injury. In particular, we critically examine two elements of Angelo Corlett's and Pam Sailors' arguments for the prohibition of football and Nicholas Dixon's claim for the reformation of boxing to eliminate blows to the head based on (a) the empirical assumption of an essential or causal connection between brain injuries incurred in football and the development of a degenerative brain disease known as chronic traumatic encephalopathy (CTE); and (b) John Stuart Mill's rejection of consensual domination (ie voluntary enslavement). We present four arguments to contest the validity of Corlett, Dixon's and Sailor's positions. Specifically, we argue that (i) certain autonomy-based arguments undermine paternalist arguments for reform; (ii) the nature of the goods people pursue in their lives might justify their foregoing (degrees of) future autonomy; (iii) Mill's argument against consensual domination draws on ambiguous and arbitrary distinctions; (iv) the lack of consensus and empirical evidence regarding CTE arising from brain injuries in sport underdetermines calls for reform. We conclude that these proposals for reforming or eliminating sports with high risks of brain injuries are not well founded.	[Frias, Francisco Javier Lopez] Penn State Univ, Kinesiol, University Pk, PA 16802 USA; [Frias, Francisco Javier Lopez] Penn State Univ, Rock Eth Inst, University Pk, PA 16802 USA; [McNamee, Mike] Swansea Univ, Coll Engn, Sch Sport & Exercise Sci, Swansea, W Glam, Wales	Frias, FJL (corresponding author), Penn State Univ, Kinesiol, University Pk, PA 16802 USA.; Frias, FJL (corresponding author), Penn State Univ, Rock Eth Inst, University Pk, PA 16802 USA.	fjl13@psu.edu	McNamee, Michael/AAI-8780-2020; Frias, Francisco Javier Lopez/AAQ-5337-2020	Frias, Francisco Javier Lopez/0000-0001-7278-7656; McNamee, MIchael/0000-0002-5857-909X			Anderson, 2015, KINESIOL REV, V4, P190, DOI DOI 10.1123/KR.2015-0011; Andre Judith, 1991, RETHINKING COLL ATHL; [Anonymous], 2014, BBC; ARCHARD D, 1990, PHILOS QUART, V40, P453, DOI 10.2307/2220110; Beauchamp TL, 2003, J MED ETHICS, V29, P269, DOI 10.1136/jme.29.5.269; Bloodworth A, 2014, SPORT ETHICS PHILOS, V8, P191, DOI 10.1080/17511321.2014.935741; Breivik G., 2007, PHILOS RISK ADVENTUR, P10; Brink D., 2010, OXFORD HDB TIME, P353; Brink DO, 2003, PHILOS REV, V112, P215, DOI 10.1215/00318108-112-2-215; Corlett JA, 2014, SPORT ETHICS PHILOS, V8, P116, DOI 10.1080/17511321.2014.918167; Devlin P, 2009, ENFORCEMENT MORALS; Dixon N., 2001, SOCIAL THEORY PRACTI, V27, P323, DOI DOI 10.5840/SOCTHEORPRACT200127215; Dixon N, 2007, J PHILOS SPORT, V34, P147, DOI 10.1080/00948705.2007.9714718; Duber D, 2015, LIBR ETHICS APPL PHI, V35, P31, DOI 10.1007/978-3-319-17960-5_3; DWORKIN G, 1972, MONIST, V56, P64, DOI 10.5840/monist197256119; Dworkin G., 1983, PATERNALISM, P105; Dworkin Gerald., 2013, PATERNALISM THEORY P, P25; Fainaru-Wada M, 2014, LEAGUE DENIAL NFL CO; Farrar D., 2012, SHUTDOWN CORNER 0710; Fateh-Moghadam B, 2014, ETHICAL THEORY MORAL, V17, P383, DOI 10.1007/s10677-013-9450-3; Feinberg J., 1984, HARM OTHERS; Fox RC., 2000, HDB SOCIAL STUDIES H, P409, DOI DOI 10.4135/9781848608412.N26; HUME D., 2014, ENQUIRY PRINCIPLES M; Johnson LSM, 2015, NEUROETHICS-NETH, V8, P1, DOI 10.1007/s12152-015-9233-8; KANT I., 2006, OLD SAW MAY BE RIGHT; Loosemore Mike, 2008, Br J Sports Med, V42, P564; Lovett F, 2008, CAMB CRIT GUIDE, P123, DOI 10.1017/CBO9780511575181.007; LUNDBERG GD, 1986, JAMA-J AM MED ASSOC, V255, P2483, DOI 10.1001/jama.255.18.2483; Malcolm D, 2009, SOCIOL SPORT J, V26, P191, DOI 10.1123/ssj.26.2.191; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mcnamee M., 2007, PHILOS RISK ADVENTUR, P1; McNamee MJ, 2016, CLIN SPORT MED, V35, P257, DOI 10.1016/j.csm.2015.10.008; McNamee M, 2013, AM J BIOETHICS, V13, P15, DOI 10.1080/15265161.2013.828123; Meeuwisse WH, 2017, BRIT J SPORT MED, V51, P873, DOI 10.1136/bjsports-2017-097569; Mill JohnS., 1989, LIBERTY SUBJECTION W; PARFIT D, 2007, REASONS PERSONS; Parfit D, 2001, WHAT MATTERS; Parry Jim, 1998, ETHICS SPORT, P205; Partridge B, 2014, J BIOETHIC INQ, V11, P65, DOI 10.1007/s11673-013-9491-2; Pettit Philip, 2010, REPUBLICANISM THEORY; RADFORD C, 1988, PHILOSOPHY, V63, P63, DOI 10.1017/S0031819100043138; ROSENBERG D, 2014, BLOOMSBURY COMPANION, P262; Russell JS, 2007, J PHILOS SPORT, V34, P176, DOI 10.1080/00948705.2007.9714720; Russell JS, 2005, J PHILOS SPORT, V32, P1; Sailors PR, 2015, J PHILOS SPORT, V42, P269, DOI 10.1080/00948705.2014.1000338; Schonsheck Jonathan, 1994, CRIMINALIZATION ESSA; SIDGWICK H., 2012, METHODS ETHICS; Signoretti S, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10183; Simon R.L., 2015, FAIR PLAY ETHICS SPO, V4th ed.; Slobounov SM, 2013, NEUROSCI LETT, V547, P6, DOI 10.1016/j.neulet.2013.05.001; Slote M., 1983, GOODS VIRTUES; STRASSER M, 1984, PHILOS QUART, V34, P63, DOI 10.2307/2218890; Vagnozzi R, 2005, NEUROSURGERY, V57, P164, DOI 10.1227/01.NEU.0000163413.90259.85; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; VAN DER VEER D., 1986, PATERNALISTIC INTERV; VanDeVeer D., 2014, PATERNALISTIC INTERV	58	11	11	0	2	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1751-1321	1751-133X		SPORT ETHICS PHILOS	Sport Ethics Philos.		2017	11	3			SI		264	280		10.1080/17511321.2017.1342688			17	Ethics	Social Sciences - Other Topics	FQ6PF	WOS:000418485800002		Green Accepted			2021-06-18	
J	Gardner, AJ; Wojtowicz, M; Terry, DP; Levi, CR; Zafonte, R; Iverson, GL				Gardner, Andrew J.; Wojtowicz, Magdalena; Terry, Douglas P.; Levi, Christopher R.; Zafonte, Ross; Iverson, Grant L.			Video and clinical screening of national rugby league players suspected of sustaining concussion	BRAIN INJURY			English	Article						Concussion; sideline assessment; SCAT3; video analysis	SPORT-RELATED CONCUSSION; ERROR SCORING SYSTEM; ICE HOCKEY PLAYERS; ASSESSMENT-TOOL; BRAIN-INJURY; SCAT2; CHILDREN; SAC	Primary Objective: This study reviewed the available sideline Sport Concussion Assessment Tool-Third Edition (SCAT3) performance of players who were removed from play using the 'concussion interchange rule' (CIR), the available video footage of these incidences, and associated return to play and concussion diagnosis decisions. Research Design: Descriptive, observational case series. Methods and Procedures: Data were collected from all NRL players who used the CIR during the 2014 season. Main Outcomes and Results: Complete SCAT3 and video analysis data were available for 38 (23%) of 167 uses of the concussion interchange rule, of which 20 (52.6%) players were medically diagnosed with concussion. Those with video evidence of unresponsiveness performed more poorly on the modified Balance Error Scoring System (M-BESS; p = .04; Cohen's d = .69) and reported greater symptoms (p = .03; d = .51). Similarly, players with a vacant stare reported greater symptoms (p - .05; d = .78). Those who demonstrated three signs (unresponsiveness, vacant stare and gait ataxia) performed more poorly on the M-BESS (p = .03; d = 1.4) and reported greater symptoms than those with no observable signs (p = .03; d = 1.4). Conclusions: The SCAT3 is sensitive to the acute effects of concussion in professional athletes; however, a minority of injured athletes might go undetected by this test.	[Gardner, Andrew J.; Levi, Christopher R.] John Hunter Hosp, Hunter New England Sports Concuss Program, New Lambton Hts, NSW, Australia; [Gardner, Andrew J.; Levi, Christopher R.] Univ Newcastle, Sch Med & Publ Hlth, Ctr Stroke & Brain Injury, Callaghan, NSW, Australia; [Wojtowicz, Magdalena; Iverson, Grant L.] Harvard Med Sch, Dept Phys Med & Rehabil, Spaulding Rehabil Hosp, MassGen Hosp Children,Sport Concuss Program, Boston, MA USA; [Wojtowicz, Magdalena; Zafonte, Ross; Iverson, Grant L.] Home Base, Boston, MA USA; [Terry, Douglas P.] MassGen Hosp Children, Sports Concuss Program, Spaulding Rehabil Network, Ctr Hlth & Rehabil Res, Boston, MA USA; [Terry, Douglas P.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA USA; [Zafonte, Ross] Harvard Med Sch, Brigham & Womens Hosp, Massachusetts Gen Hosp, Dept Phys Med & Rehabil,Spaulding Rehabil Hosp, Boston, MA USA	Gardner, AJ (corresponding author), Calvary Mater Hosp, Ctr Stroke & Brain Injury, Level 5,McCauley Bldg, Waratah, NSW, Australia.	andrew.gardner@neurogard.com.au		Levi, Christopher/0000-0002-9474-796X; Iverson, Grant/0000-0001-7348-9570	Hunter Medical Research Institute (HMRI); University of Newcastle's Priority Research Centre for Stroke and Brain Injury; Hunter New England Local Health District; Australian Football League (AFL); The Trust, a National Football League Players Association program; National Health and Medical Research Council (NHMRC)National Health and Medical Research Council of Australia; School of Medicine and Public Health, University of Newcastle	Andrew Gardner has a clinical practice in neuropsychology involving individuals who have sustained sports-related concussion (including current and former athletes). He has operated as a contracted concussion consultant to the Australian Rugby Union (ARU) from July 2016. He has received travel funding from the Australian Football League (AFL) to present at the Concussion in Football Conference in 2013 and 2017. He acknowledges funding through the National Health and Medical Research Council (NHMRC), the School of Medicine and Public Health, University of Newcastle, the University of Newcastle's Priority Research Centre for Stroke and Brain Injury, the Hunter New England Local Health District and the Hunter Medical Research Institute (HMRI), support by Jennie Thomas and support by Anne Greaves.& para;& para;Ross Zafonte serves on the scientific advisory boards of Oxeia Biopharmaceuticals, Inc., ElMindA Ltd., and Myomo Inc. He provides health care services to former professional athletes through the Massachusetts General Hospital Brain and Body Program which is funded by The Trust, a National Football League Players Association program.	[Anonymous], 2013, Br J Sports Med, V47, P259; Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Brown HJ, 2014, MED SCI SPORT EXER, V46, P1610, DOI 10.1249/MSS.0000000000000263; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10210; Galetta MS, 2013, J NEUROL SCI, V328, P28, DOI 10.1016/j.jns.2013.02.008; Gardner AJ, 2016, INT J SPORTS MED, V37, P267, DOI 10.1055/s-0035-1565203; Gardner A, 2015, BRIT J SPORT MED, V49, P495, DOI 10.1136/bjsports-2013-093102; Gardner AJ, 2017, INT J SPORTS MED, V38, P71, DOI 10.1055/s-0042-116072; Gardner AJ, 2015, BRAIN INJURY, V29, P1182, DOI 10.3109/02699052.2015.1034179; Glaviano NR, 2015, CLIN J SPORT MED, V25, P373, DOI 10.1097/JSM.0000000000000154; Hanninen T, 2016, J SCI MED SPORT, V19, P636, DOI 10.1016/j.jsams.2015.08.005; Hoskins W, 2006, J SCI MED SPORT, V9, P46, DOI 10.1016/j.jsams.2006.03.013; Iverson GL, 2008, BRAIN INJURY, V22, P147, DOI 10.1080/02699050701867407; King D, 2014, SPORTS MED, V44, P449, DOI 10.1007/s40279-013-0134-x; King LA, 2014, ARCH PHYS MED REHAB, V95, P353, DOI 10.1016/j.apmr.2013.10.015; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrea M, 2001, CLIN J SPORT MED, V11, P176, DOI 10.1097/00042752-200107000-00008; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; National Rugby League, 2014, MAN CONC RUGB LEAG; Putukian M, 2015, CLIN J SPORT MED, V25, P36, DOI 10.1097/JSM.0000000000000102; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Snyder AR, 2014, CLIN NEUROPSYCHOL, V28, P1091, DOI 10.1080/13854046.2014.952667; Wang Y, 2016, J NEUROTRAUM, V33, P1227, DOI 10.1089/neu.2015.4072; Yengo-Kahn AM, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15611; Zimmer A, 2014, APPL NEUROPSYCH-ADUL, P1	30	11	11	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	13-14					1918	1924		10.1080/02699052.2017.1358399			7	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	FO2MD	WOS:000416612500026	28872354				2021-06-18	
J	Green, J; Zuckerman, SL; Dalton, SL; Djoko, A; Folger, D; Kerr, ZY				Green, James; Zuckerman, Scott L.; Dalton, Sara L.; Djoko, Aristarque; Folger, Dustin; Kerr, Zachary Y.			A 6-year surveillance study of "Stingers" in NCAA American Football	RESEARCH IN SPORTS MEDICINE			English	Article						Epidemiology; injury surveillance; stingers; burners; neurologic injury	CERVICAL-SPINAL STENOSIS; STATES HIGH-SCHOOL; BURNER SYNDROME; NECK INJURIES; NERVE INJURY; PLAYERS; SPORTS; EPIDEMIOLOGY; ATHLETE; CONCUSSIONS	This study describes the epidemiology of stinger injuries in National Collegiate Athletic Association (NCAA) Men's Football. About 57 NCAA Men's Football programmes provided 153 team-seasons of injury data to the NCAA Injury Surveillance Programme (NCAA-ISP) during the 2009/2010-2014/2015 academic years. In the study period, 229 stingers were reported for an injury rate of 2.04/10,000 athlete-exposures (AE). Most stingers were reported during competitions (55.5%) and the preseason (80.3%) and resulted in time loss less than 24hours (63.8%). One in five (18.8%) were recurrent. Most stingers were due to player contact (93.0%), particularly while tackling (36.7%) and blocking (25.8%) and occurred to defensive ends/linebackers (25.8%) and offensive linemen (23.6%). Although previous research reports a large prevalence of stingers among football players, the NCAA-ISP reported a relatively low injury rate. The transient nature of pain associated with stingers may have contributed to under-reporting, highlighting the need to deduce manners to increase reporting.	[Green, James; Kerr, Zachary Y.] Univ North Carolina Chapel Hill, Chapel Hill, NC 27514 USA; [Zuckerman, Scott L.] Vanderbilt Univ, 221 Kirkland Hall, Nashville, TN 37235 USA; [Dalton, Sara L.] Springfield Coll, Springfield, IL USA; [Djoko, Aristarque; Folger, Dustin; Kerr, Zachary Y.] Datalys Ctr Sports Injury Res & Prevent, Indianapolis, IN USA	Kerr, ZY (corresponding author), Univ North Carolina Chapel Hill, Chapel Hill, NC 27514 USA.; Kerr, ZY (corresponding author), Univ North Carolina Chapel Hill, Dept Exercise & Sport Sci, 313 Woollen Gym,CB 8700, Chapel Hill, NC 27599 USA.	zkerr@email.unc.edu			NCAA	This work was supported by the NCAA.	ALBRIGHT JP, 1985, AM J SPORT MED, V13, P147, DOI 10.1177/036354658501300301; Charbonneau RME, 2012, CLIN J SPORT MED, V22, P472, DOI 10.1097/JSM.0b013e3182699ed5; Clarsen B, 2014, BRIT J SPORT MED, V48, P510, DOI 10.1136/bjsports-2013-093297; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Cunnane M, 2011, BRIT J SPORT MED, V45, pA19; Dick R, 2007, J ATHL TRAINING, V42, P221; Drakos MC, 2011, NEUROSURGERY, V68, pE1743, DOI 10.1227/NEU.0b013e31821815af; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Greenberg J, 2011, SPORTS HEALTH, V3, P264, DOI 10.1177/1941738111403866; Hibberd EE, 2013, CLIN J SPORT MED, V23, P450, DOI 10.1097/JSM.0b013e31829aa8ff; Kartal A, 2004, EUR SPINE J, V13, P76, DOI 10.1007/s00586-003-0623-y; Kawasaki T, 2015, AM J SPORT MED, V43, P2809, DOI 10.1177/0363546515597678; Kepler CK, 2012, CLIN SPORT MED, V31, P499, DOI 10.1016/j.csm.2012.03.005; Kerr ZY, 2014, J ATHL TRAINING, V49, P552, DOI 10.4085/1062-6050-49.3.58; Kuhlman GS, 1999, AM FAM PHYSICIAN, V60, P2035; Levitz CL, 1997, AM J SPORT MED, V25, P73, DOI 10.1177/036354659702500114; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; MEYER SA, 1994, AM J SPORT MED, V22, P158, DOI 10.1177/036354659402200202; PAVLOV H, 1987, RADIOLOGY, V164, P771, DOI 10.1148/radiology.164.3.3615879; Presciutti SM, 2009, J NEUROSURG-SPINE, V11, P264, DOI 10.3171/2009.3.SPINE08642; Rihn JA, 2009, SPORTS MED, V39, P697, DOI 10.2165/11315190-000000000-00000; ROBERTSON WC, 1979, JAMA-J AM MED ASSOC, V241, P1480, DOI 10.1001/jama.241.14.1480; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Safran MR, 2004, AM J SPORT MED, V32, P1063, DOI 10.1177/0363546504265193; SALLIS RE, 1992, PHYSICIAN SPORTSMED, V20, P47, DOI 10.1080/00913847.1992.11947521; Shannon B, 2002, CLIN SPORT MED, V21, P29, DOI 10.1016/S0278-5919(03)00055-3; SPEER KP, 1990, AM J SPORT MED, V18, P591, DOI 10.1177/036354659001800606; Standaert CJ, 2009, ARCH PHYS MED REHAB, V90, P402, DOI 10.1016/j.apmr.2008.09.569; Torg JS, 1996, J BONE JOINT SURG AM, V78A, P1308, DOI 10.2106/00004623-199609000-00003; Vaccaro Alexander R, 2002, Spine J, V2, P351; WATKINS RG, 1986, CLIN SPORT MED, V5, P215; Weinstein SM, 1998, CLIN SPORT MED, V17, P127, DOI 10.1016/S0278-5919(05)70067-3; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	33	11	11	0	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1543-8627	1543-8635		RES SPORTS MED	Res. Sports Med.		2017	25	1					26	36		10.1080/15438627.2016.1258642			11	Sport Sciences	Sport Sciences	EG4ZX	WOS:000391053800003	27873542				2021-06-18	
J	Gurer, B; Kertmen, H; Yilmaz, ER; Dolgun, H; Hasturk, AE; Sekerci, Z				Gurer, Bora; Kertmen, Hayri; Yilmaz, Erdal Resit; Dolgun, Habibullah; Hasturk, Askin Esen; Sekerci, Zeki			The Surgical Outcome of Traumatic Extraaxial Hematomas Causing Brain Herniation	TURKISH NEUROSURGERY			English	Article						Epidural hematoma; Herniation; Intracranial pressure; Outcome; Subdural hematoma	ACUTE SUBDURAL-HEMATOMA; SEVERE HEAD-INJURY; EXTRADURAL HEMATOMA; PROGNOSTIC-FACTORS; EPIDURAL HEMATOMA; ADULT PATIENTS; MORTALITY; CRANIOTOMY; VOLUME; PREDICTION	AIM: The aim of this study was to assess the surgical outcome and the prognostic importance of clinical and radiological data of patients operated emergently for an extraaxial hematoma causing brain herniation. MATERIAL and METHODS: This retrospective study comprised 108 adult patients who were operated due to herniated traumatic extraaxial hematomas from January 2000 to January 2013. RESULTS: Of 108 patients, 63 patients (58.3%) were diagnosed as subdural hematoma (SDH), and 45 patients (41.7%) as epidural hematoma (EDH). An unfavorable outcome was significantly increased for patients who were diagnosed as SDH (90.4%) compared with EDH patients (33.3%). Mortality rate for herniated SDH patients was 65.1%, and 26.6% for herniated EDH patients. High mortality and unfavorable outcome ratios were associated with Glasgow Coma Scale scores at admission, mean postoperative intracranial pressure (ICP) values, type of the brain herniation, interval from the time of trauma to the time of hematoma decompression, the duration of the brain herniation, intraoperative acute brain swelling, hematoma volume and thickness, degree of the midline shift and the obliteration of the basal cisterns. CONCLUSION: Our data showed that, postoperative ICP values were one most important predictor of the mortality. We recommended postoperative ICP monitoring for all patients presenting with the brain herniation due to traumatic extraaxial hematoma.	[Gurer, Bora] Fatih Sultan Mehmet Educ & Res Hosp, Neurosurg Clin, Istanbul, Turkey; [Kertmen, Hayri; Yilmaz, Erdal Resit; Dolgun, Habibullah; Sekerci, Zeki] Diskapi Yildirim Beyazit Educ & Res Hosp, Neurosurg Clin, Ankara, Turkey; [Hasturk, Askin Esen] Oncol Educ & Res Hosp, Neurosurg Clin, Ankara, Turkey	Gurer, B (corresponding author), Fatih Sultan Mehmet Educ & Res Hosp, Neurosurg Clin, Istanbul, Turkey.	boragurer@gmail.com	Dolgun, Habibullah/AAL-6610-2021; dolgun, habibullah/AAF-6745-2021; HASTURK, ASKIN ESEN/AAE-5065-2019; Gurer, Bora/K-1177-2012	Dolgun, Habibullah/0000-0002-1513-2044; Gurer, Bora/0000-0003-1500-6184			American Association for the Surgery of Trauma, 2003, J Trauma, V54, pS235; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; BRICOLO AP, 1984, NEUROSURGERY, V14, P8, DOI 10.1227/00006123-198401000-00003; Bullock M Ross, 2006, Neurosurgery, V58, pS7; Chen SH, 2011, J TRAUMA, V71, P1632, DOI 10.1097/TA.0b013e3182367b3c; Cohen JE, 1996, J TRAUMA, V41, P120, DOI 10.1097/00005373-199607000-00019; CORDOBES F, 1981, J NEUROSURG, V54, P179, DOI 10.3171/jns.1981.54.2.0179; D'Amato L, 2007, J Neurosurg Sci, V51, P107; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; HASELSBERGER K, 1988, ACTA NEUROCHIR, V90, P111, DOI 10.1007/BF01560563; Hatashita Shizuo, 1993, Neurologia Medico-Chirurgica, V33, P13, DOI 10.2176/nmc.33.13; HOWARD MA, 1989, J NEUROSURG, V71, P858, DOI 10.3171/jns.1989.71.6.0858; JENNETT B, 1975, LANCET, V1, P480; Karasu A, 2010, ULUS TRAVMA ACIL CER, V16, P233; Kernohan JW, 1929, ARCH NEURO PSYCHIATR, V21, P274, DOI 10.1001/archneurpsyc.1929.02210200030004; Kim KH, 2009, J KOREAN NEUROSURG S, V45, P143, DOI 10.3340/jkns.2009.45.3.143; KOTWICA Z, 1993, ACTA NEUROCHIR, V121, P95, DOI 10.1007/BF01809257; KUDAY C, 1994, ACTA NEUROCHIR, V131, P203, DOI 10.1007/BF01808613; Leach P, 2007, BRIT J NEUROSURG, V21, P11, DOI 10.1080/02688690701210562; Lee EJ, 1998, J TRAUMA, V45, P946, DOI 10.1097/00005373-199811000-00017; LOBATO RD, 1988, J NEUROSURG, V68, P48, DOI 10.3171/jns.1988.68.1.0048; Marion DW, 2006, NEUROSURGERY, V58, P655; Marmarou A, 2000, J NEUROSURG, V93, P183, DOI 10.3171/jns.2000.93.2.0183; MARSHALL LF, 1983, J NEUROSURG, V59, P285, DOI 10.3171/jns.1983.59.2.0285; Nelson JA, 2011, ACAD EMERG MED, V18, P78, DOI 10.1111/j.1553-2712.2010.00949.x; Ono J, 2001, J CLIN NEUROSCI, V8, P120, DOI 10.1054/jocn.2000.0732; PETERSEN OF, 1984, NEURORADIOLOGY, V26, P363, DOI 10.1007/BF00327488; PHUENPATHOM N, 1993, SURG NEUROL, V40, P22, DOI 10.1016/0090-3019(93)90164-V; RIVAS JJ, 1988, NEUROSURGERY, V23, P44, DOI 10.1227/00006123-198807000-00010; SAKAS DE, 1995, J NEUROSURG, V82, P961, DOI 10.3171/jns.1995.82.6.0961; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Servadei E, 2000, BRIT J NEUROSURG, V14, P110; Servadei F, 1997, ACTA NEUROCHIR, V139, P279, DOI 10.1007/BF01808822; Servadei F, 1997, ACTA NEUROCHIR, V139, P273, DOI 10.1007/BF01808821; SHENKIN HA, 1982, J NEUROSURG, V57, P254, DOI 10.3171/jns.1982.57.2.0254; Skoglund TS, 2005, ACTA ANAESTH SCAND, V49, P337, DOI 10.1111/j.1399-6576.2005.00624.x; STENING WA, 1986, AUST NZ J SURG, V56, P549, DOI 10.1111/j.1445-2197.1986.tb07098.x; STONE JL, 1986, J TRAUMA, V26, P445, DOI 10.1097/00005373-198605000-00006; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Tian HL, 2008, CHINESE MED J-PEKING, V121, P1080, DOI 10.1097/00029330-200806020-00007; Tien HCN, 2011, ANN SURG, V253, P1178, DOI 10.1097/SLA.0b013e318217e339; Uzan M, 1998, J Neurosurg Sci, V42, P89; Valadka AB, 2000, J TRAUMA, V49, P1, DOI 10.1097/00005373-200007000-00001; van den Brink WA, 1999, ACTA NEUROCHIR, V141, P509, DOI 10.1007/s007010050332; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212; Wu JJ, 1999, J TRAUMA, V47, P39, DOI 10.1097/00005373-199907000-00009; Yanaka Kiyoyuki, 1993, Neurologia Medico-Chirurgica, V33, P552, DOI 10.2176/nmc.33.552	48	11	12	0	0	TURKISH NEUROSURGICAL SOC	BAHCELIEVLER	TASKENT CADDESI 13-4, BAHCELIEVLER, ANKARA 06500, TURKEY	1019-5149			TURK NEUROSURG	Turk. Neurosurg.	JAN	2017	27	1					37	52		10.5137/1019-5149.JTN.14809-15.0			16	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	EH8SG	WOS:000392042000006	27593740	Bronze			2021-06-18	
J	Harrison, AL; Hunter, EG; Thomas, H; Bordy, P; Stokes, E; Kitzman, P				Harrison, Anne L.; Hunter, Elizabeth G.; Thomas, Heather; Bordy, Paige; Stokes, Erin; Kitzman, Patrick			Living with traumatic brain injury in a rural setting: supports and barriers across the continuum of care	DISABILITY AND REHABILITATION			English	Article						Rehabilitation; neurological injury; rural health care; caregiving	QUALITATIVE RESEARCH; CASE-MANAGEMENT; SERVICES; NEEDS; FAMILIES; PEOPLE; INDIVIDUALS; EXPERIENCE; MODEL; TBI	Purpose: Traumatic brain injury (TBI) is prevalent in Kentucky and comes with a high cost in care and quality of life for individuals and caregivers affected. Many people living with the condition of TBI have unmet needs. Research among people living with TBI in rural areas is limited. The purposes of this study were to (1) increase understanding of the lived experience of people with TBI and caregivers in rural regions of Kentucky across the continuum of their care and (2) provide their perspectives on barriers and facilitators of optimal function and well-being. Methods: A qualitative descriptive interview study was conducted by a multidisciplinary team. Content analysis was completed with data-derived coding and iterative modifications to analysis, coalescing codes into categories and themes. Results: Thirteen people with TBI and six caregivers participated in the interview. Categories that emerged in analysis included the experiences under each locus of care; themes included relationships, functional competence, and participation in meaningful activity. Conclusion: Relationships represented both barriers and facilitators of well-being. Major unmet needs persisted in terms of medical problems, support for caregivers, community linkages, and participation in meaningful activities. Recommendations are made regarding avenues for addressing unmet needs.	[Harrison, Anne L.; Kitzman, Patrick] Univ Kentucky, Dept Rehabil Sci, KARRN, Coll Hlth Sci, Lexington, KY USA; [Hunter, Elizabeth G.] Univ Kentucky, Grad Ctr Gerontol, Coll Publ Hlth, Lexington, KY USA; [Thomas, Heather] Kentucky Outpatient Rehabil Therapy, Lebanon, KY USA; [Bordy, Paige] Advocate Childrens Hosp, Pediat Rehabil & Dev Outpatient Pavil, Oak Lawn, IL USA; [Stokes, Erin] Select Med, Nicholasville, KY USA	Harrison, AL (corresponding author), Room 204J Wethington Bldg,900 S Limestone, Lexington, KY 40536 USA.	alharr01@uky.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NIH-NCMHD-1RC4MD005760]; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD) [RC4MD005760] Funding Source: NIH RePORTER	National Institutes of Health, 10.13039/100000002 [NIH-NCMHD-1RC4MD005760 (Principal Investigators Anne Harrison and Patrick Kitzman)]	Baptiste B, 2015, NEUROREHABILITATION, V36, P301, DOI 10.3233/NRE-151218; Beaven S., 2013, CENTRAL NERVOUS SYST; Bellon M, 2015, BRAIN IMPAIR, V16, P131, DOI 10.1017/BrImp.2015.17; Campbell JL, 2013, SOCIOL METHOD RES, V42, P294, DOI 10.1177/0049124113500475; CDC, CONC SIGNS SYMPT CHE; Cheek J, 2008, QUAL HEALTH RES, V18, P1599, DOI 10.1177/1049732308324865; Clark-Wilson J, 2015, NEUROREHABILITATION, V36, P289, DOI 10.3233/NRE-151217; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P1, DOI 10.1097/00001199-200102000-00004; Danzl MM, 2013, J RURAL HEALTH, V29, P368, DOI 10.1111/jrh.12023; Degeneffe CE, 2001, HEALTH SOC WORK, V26, P257, DOI 10.1093/hsw/26.4.257; DiCicco-Bloom B, 2006, MED EDUC, V40, P314, DOI 10.1111/j.1365-2929.2006.02418.x; Donaldson EA, 2012, CANCER-AM CANCER SOC, V118, P4851, DOI 10.1002/cncr.27487; Duncan PW, 2005, STROKE, V36, pE100, DOI 10.1161/01.STR.0000180861.54180.FF; Espinosa C., 2015, HOME VS I LIVING REL; Gaboda D, 2009, TRAUMATIC BRAIN INJU; Halverson Joel, 2004, ANAL DISPARITIES HLT; Heinemann AW, 2002, ARCH PHYS MED REHAB, V83, P1052, DOI 10.1053/apmr.2002.34283; Johnstone B, 2002, J RURAL HEALTH, V18, P109, DOI 10.1111/j.1748-0361.2002.tb00882.x; Kitzman PH, 2011, J RURAL COMMUNITY D, V6, P95; Lannin NA, 2014, NEUROREHABILITATION, V35, P635, DOI 10.3233/NRE-141161; Lefebvre H, 2005, BRAIN INJURY, V19, P585, DOI 10.1080/02699050400025026; Lefebvre H, 2008, BRAIN INJURY, V22, P535, DOI 10.1080/02699050802158243; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; Lewis FD, 2015, NEUROREHABILITATION, V36, P243, DOI 10.3233/NRE-151213; Malec JF, 2013, J HEAD TRAUMA REHAB, V28, P476, DOI 10.1097/HTR.0000000000000003; Martin EM, 2010, NEUROREHABILITATION, V26, P279, DOI 10.3233/NRE-2010-0563; Marwitz JH, 2001, J HEAD TRAUMA REHAB, V16, P307, DOI 10.1097/00001199-200108000-00002; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Pistarini C, 2011, DISABIL REHABIL, V33, P2333, DOI 10.3109/09638288.2011.570414; Poston KM, 2014, J NURS CARE QUAL, V29, P237, DOI 10.1097/NCQ.0000000000000040; Rivera P, 2007, NEUROREHABILITATION, V22, P3; Rotondi AJ, 2005, J HEAD TRAUMA REHAB, V20, P173, DOI 10.1097/00001199-200503000-00005; Rotondi AJ, 2007, J HEAD TRAUMA REHAB, V22, P14, DOI 10.1097/00001199-200701000-00002; Salter K, 2011, BRAIN INJURY, V25, P1147, DOI 10.3109/02699052.2011.613088; Saman DM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-108; Sample PL, 1998, BRAIN INJURY, V12, P855, DOI 10.1080/026990598122089; Sample PL, 2005, J HEAD TRAUMA REHAB, V20, P270, DOI 10.1097/00001199-200505000-00009; Sandelowski M, 2000, RES NURS HEALTH, V23, P334, DOI 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G; Saverino C, 2016, ARCH PHYS MED REHAB, V97, pS19, DOI 10.1016/j.apmr.2015.04.016; Schoenberg NE, 2015, SOUTH MED J, V108, P170, DOI 10.14423/SMJ.0000000000000245; Schootman M, 1999, BRAIN INJURY, V13, P995; Solovieva TI, 2014, J REHABIL, V80, P10; Trudel TM, 2011, EXCEPTIONAL PARENT, V41, P33; Turner-Stokes L, 2005, COCHRANE DB SYST REV, V3, P535; US Department of Agriculture, RUR URB CONT COD; Walker R, 2004, STUDY PREPARED KENTU; Winkler D, 2006, J HEAD TRAUMA REHAB, V21, P8, DOI 10.1097/00001199-200601000-00002; World Health Organization, 2002, INN CAR CHRON COND; Zitnay GA, 2008, J NEUROTRAUM, V25, P1135, DOI 10.1089/neu.2008.0599	49	11	11	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.		2017	39	20					2071	2080		10.1080/09638288.2016.1217081			10	Rehabilitation	Rehabilitation	FC3BI	WOS:000406712900008	27549899	Green Published, Green Accepted			2021-06-18	
J	Jamal, A; Sankhyan, N; Jayashree, M; Singhi, S; Singhi, P				Jamal, Atahar; Sankhyan, Naveen; Jayashree, Murlidharan; Singhi, Sunit; Singhi, Pratibha			Full Outline of Unresponsiveness score and the Glasgow Coma Scale in prediction of pediatric coma	WORLD JOURNAL OF EMERGENCY MEDICINE			English	Article						Altered sensorium; Neuro-intensive care; Neuro-monitoring; Neuroinfection; Tropical neurology	INTERRATER RELIABILITY; HEAD TRAUMA; CHILDREN; VALIDATION; MORTALITY; VALIDITY	BACKGROUND: This study was done to compare the admission Ful l Out l ine of Unresponsiveness (FOUR) score and Glasgow Coma Scale (GCS) as predictors of outcome in children with impaired consciousness. METHODS: In this observational study, children (5-12 years) with impaired consciousness of <7 days were included. Children with traumatic brain injury, on sedatives or neuromuscular blockade; with pre-existing cerebral palsy, mental retardation, degenerative brain disease, vision/ hearing impairment; and seizure within last 1 hour were excluded. Primary outcomes: comparison of area under curve (AUC) of receiver operating characteristic (ROC) curve for in-hospital mortality. Secondary outcomes: comparison of AUC of ROC curve for mortality and poor outcome on Pediatric Overall Performance Category Scale at 3 months. RESULTS: Of the 63 children, 20 died during hospital stay. AUC for in-hospital mortality for GCS was 0.83 (CI 0.7 to 0.9) and FOUR score was 0.8 (CI 0.7 to 0.9) [difference between areas -0.0250 (95% CI 0.0192 to 0.0692), Z statistic 1.109, P = 0.2674]. AUC for mortality at 3 months for GCS was 0.78 (CI 0.67 to 0.90) and FOUR score was 0.74 (CI 0.62 to 0.87) (P = 0.1102) and AUC for poor functional outcome for GCS was 0.82 (CI 0.72 to 0.93) and FOUR score was 0.79 (CI 0.68 to 0.9) (P = 0.2377), which were also comparable. Inter-rater reliability for GCS was 0.96 and for FOUR score 0.98. CONCLUSION: FOUR score was as good as GCS in prediction of in-hospital and 3-month mortality and functional outcome at 3 months. FOUR score had a good inter-rater reliability.	[Jamal, Atahar; Sankhyan, Naveen; Jayashree, Murlidharan; Singhi, Sunit; Singhi, Pratibha] Postgrad Inst Med Educ & Res, Adv Pediat Ctr, Dept Pediat, Chandigarh, India	Sankhyan, N (corresponding author), Postgrad Inst Med Educ & Res, Adv Pediat Ctr, Dept Pediat, Chandigarh, India.	drnsankhyan@yahoo.co.in	SANKHYAN, NAVEEN/AAP-6531-2021				Buyukcam F, 2012, ULUS TRAVMA ACIL CER, V18, P469, DOI 10.5505/tjtes.2012.23169; Cohen J, 2009, J NEUROSCI NURS, V41, P261, DOI 10.1097/JNN.0b013e3181b2c766; Czaikowski BL, 2014, J NEUROSCI NURS, V46, P79, DOI 10.1097/JNN.0000000000000041; Fischer M, 2010, CRIT CARE, V14, DOI 10.1186/cc8963; Fugate JE, 2010, NEUROCRIT CARE, V13, P205, DOI 10.1007/s12028-010-9407-5; Holmes JF, 2005, ACAD EMERG MED, V12, P814, DOI 10.1197/j.aem.2005.04.019; Idrovo L, 2010, EUR NEUROL, V63, P364, DOI 10.1159/000292498; Khajeh A, 2014, IRAN J PEDIATR, V24, P603; Kochar GS, 2014, J CHILD NEUROL, V29, P1299, DOI 10.1177/0883073813514293; Wijdicks EFM, 2015, CRIT CARE MED, V43, P439, DOI 10.1097/CCM.0000000000000707; Wijdicks EFM, 2011, NEUROLOGY, V77, P84, DOI 10.1212/WNL.0b013e318220ac06; Wijdicks EFM, 2005, ANN NEUROL, V58, P585, DOI 10.1002/ana.20611; Wijdicks EFM, 2014, THE COMATOSE PATIENT, P89	13	11	16	0	5	ZHEJIANG UNIV SCH MEDICINE	HANGZHOU	SECOND AFFILIATED HOSPITAL, 88 JIEFANG RD, HANGZHOU, 310009, PEOPLES R CHINA	1920-8642			WORLD J EMERG MED	World J. Emerg. Med.		2017	8	1					55	60		10.5847/wjem.j.1920-8642.2017.01.010			6	Emergency Medicine	Emergency Medicine	ER7AQ	WOS:000398962600010	28123622	Green Published			2021-06-18	
J	Kisser, J; Waldstein, SR; Evans, MK; Zonderman, AB				Kisser, Jason; Waldstein, Shari R.; Evans, Michele K.; Zonderman, Alan B.			Lifetime prevalence of traumatic brain injury in a demographically diverse community sample	BRAIN INJURY			English	Article						Traumatic brain injury; prevalence; demographics; sex; race: poverty; age	FUNCTIONAL DECLINE; POPULATION; RISK; DEMENTIA; MIDLIFE; HEALTH; RACE	Background: Although incidence rates are well documented for traumatic brain injury, lifetime prevalence in a demographically diverse sample is unknown. We examined the prevalence of self-reported traumatic brain injury (TBI) in a demographically diverse sample.Methods: History of TBI was examined in 2881 African-Americans and Whites in the Healthy Aging in Neighborhoods of Diversity across the Life Span (HANDLS) studya community-based, epidemiological investigation of urban-dwelling adults. Logistic regression analyses examined the odds of TBI as a function of sex, race, poverty status, age quintile and their interactions.Results: A significant 3-way interaction was noted amongst race, poverty status and age (odds ratio (OR) = 1.57, 95% confidence interval (CI) 1.07-2.31, p = 0.021). Amongst Whites living in poverty, younger (30-36 years of age) individuals had greater odds of TBI than older (58-64 years of age) individuals, whereas older African-Americans living in poverty had greater odds of TBI. Additionally, a main effect of sex (OR = 2.36, 95% CI 1.85-3.03, p < 0.001) indicated that men had greater odds of TBI.Conclusions: History of TBI is most prevalent in men, older African-Americans in poverty, and younger Whites in poverty. Preventive measures targeting relevant TBI risk factors in these populations are warranted.	[Kisser, Jason; Waldstein, Shari R.] Univ Maryland Baltimore Cty, Dept Psychol, Baltimore, MD 21228 USA; [Evans, Michele K.] NIA, Hlth Dispar Res Sect, Lab Epidemiol & Populat Sci, Baltimore, MD 21224 USA; [Zonderman, Alan B.] NIA, Behav Epidemiol Sect, Lab Epidemiol & Populat Sci, Baltimore, MD 21224 USA	Kisser, J (corresponding author), Univ Maryland Baltimore Cty, Dept Psychol, Math Psychol 312, 1000 Hilltop Circle, Baltimore, MD 21250 USA.	Jason.kisser@gmail.com	Kisser, Jason/AAA-8217-2021; Evans, Michele Kim/AAE-4776-2019	Evans, Michele/0000-0002-8546-2831	National Institute on Aging's Intramural Research Program; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1RO1AG034161]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG034161, P30AG028747, Z01AG000194, ZIAAG000199, ZIAAG000513] Funding Source: NIH RePORTER	The authors report no conflicts of interests. The National Institute on Aging's Intramural Research Program and National Institutes of Health Grant 1RO1AG034161 supported this research.	Anttila T, 2002, NEUROLOGY, V59, P887, DOI 10.1212/WNL.59.6.887; Case A, 2015, P NATL ACAD SCI USA, V112, P15078, DOI 10.1073/pnas.1518393112; Centers for Disease Control and Prevent, 2013, TRAUM BRAIN INJ CONC; Coronado VG, 2010, TRAUMATIC BRAIN INJU, P891, DOI [10.1016/B978-0-444-52910-7.00011-8, DOI 10.1016/B978-0-444-52910-7.00011-8]; Evans MK, 2010, ETHNIC DIS, V20, P267; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Guland B, 1997, DIFFERENCE RATES DEM, P233; Harrison DA, 2012, INTENS CARE MED, V38, pS240; Ilie G, 2015, J NEUROTRAUM, V32, P1130, DOI 10.1089/neu.2014.3619; Kraus J, 2006, NEUROLOGY AND TRAUMA, P3; Lunney JR, 2003, JAMA-J AM MED ASSOC, V289, P2387, DOI 10.1001/jama.289.18.2387; National Highway Traffic Safety Administration, 2009, TRAFF SAF FACTS 2006; Nguyen HT, 2007, ANN EPIDEMIOL, V17, P736; Sloan FA, 2009, AM J PUBLIC HEALTH, V99, P2261, DOI 10.2105/AJPH.2007.127621; Smith JP, 2004, POPUL DEV REV, V30, P108; Sosin DM, 1996, BRAIN INJURY, V10, P47; US Department of Health and Human Services, 2004, FED REGISTER, V69, P7336; Wang HK, 2012, J NEUROL NEUROSUR PS, V83, P1080, DOI 10.1136/jnnp-2012-302633; Wee CC, 2011, ANN INTERN MED, V154, P645, DOI 10.7326/0003-4819-154-10-201105170-00003	20	11	11	0	7	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	5					620	623		10.1080/02699052.2017.1283057			4	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	EV8OA	WOS:000402039900006	28326858	Green Accepted			2021-06-18	
S	Korbakis, G; Vespa, PM		Wijdicks, EFM; Kramer, AH		Korbakis, G.; Vespa, P. M.			Multimodal neurologic monitoring	CRITICAL CARE NEUROLOGY, PT I	Handbook of Clinical Neurology		English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; ANEURYSMAL SUBARACHNOID HEMORRHAGE; CEREBRAL PERFUSION-PRESSURE; SEVERE HEAD-INJURY; POSITRON-EMISSION-TOMOGRAPHY; NEAR-INFRARED SPECTROSCOPY; VENOUS OXYGEN-SATURATION; LASER-DOPPLER FLOWMETRY; INTENSIVE-CARE-UNIT; INTRACRANIAL-PRESSURE	Neurocritical care has two main objectives. Initially, the emphasis is on treatment of patients with acute damage to the central nervous system whether through infection, trauma, or hemorrhagic or ischemic stroke. Thereafter, attention shifts to the identification of secondary processes that may lead to further brain injury, including fever, seizures, and ischemia, among others. Multimodal monitoring is the concept of using various tools and data integration to understand brain physiology and guide therapeutic interventions to prevent secondary brain injury. This chapter will review the use of electroencephalography, intracranial pressure monitoring, brain tissue oxygenation, cerebral microdialysis and neurochemistry, near-infrared spectroscopy, and transcranial Doppler sonography as they relate to neuromonitoring in the critically ill. The concepts and design of each monitor, in addition to the patient population that may most benefit from each modality, will be discussed, along with the various tools that can be used together to guide individualized patient treatment options. Major clinical trials, observational studies, and their effect on clinical outcomes will be reviewed. The future of multimodal monitoring in the field of bioinformatics, clinical research, and device development will conclude the chapter.	[Korbakis, G.; Vespa, P. M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA; [Vespa, P. M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA	Vespa, PM (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, 757 Westwood Blvd,RR UCLA 6236A, Los Angeles, CA 90095 USA.	Pvespa@mednet.ucla.edu					AASLID R, 1984, J NEUROSURG, V60, P37, DOI 10.3171/jns.1984.60.1.0037; Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Belli A, 2008, ACTA NEUROCHIR, V150, P461, DOI 10.1007/s00701-008-1580-3; Bellner J, 2004, SURG NEUROL, V62, P45, DOI 10.1016/j.surneu.2003.12.007; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Bhatia R, 2007, J NEUROSURG ANESTH, V19, P97, DOI 10.1097/ANA.0b013e318031376d; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; Bratton SL, 2007, J NEUROTRAUMA S1, V24, P555, DOI DOI 10.1089/NEU.2007.9988; Bullock R, 1995, ANN NY ACAD SCI, V765, P290, DOI 10.1111/j.1749-6632.1995.tb16586.x; Cammarata G, 2011, J TRAUMA, V71, P779, DOI 10.1097/TA.0b013e3182220673; Carrera E, 2009, NEUROSURGERY, V65, P316, DOI 10.1227/01.NEU.0000349209.69973.88; Chamoun R, 2010, J NEUROSURG, V113, P564, DOI 10.3171/2009.12.JNS09689; Chen Jeff W, 2011, Surg Neurol Int, V2, P82, DOI 10.4103/2152-7806.82248; Chesnut RM, 2015, J NEUROTRAUM, V32, P1722, DOI 10.1089/neu.2015.3976; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Claassen J, 2007, NEUROLOGY, V69, P1356, DOI 10.1212/01.wnl.0000281664.02615.6c; Claassen J, 2006, NEUROCRIT CARE, V4, P103, DOI 10.1385/NCC:4:2:103; Claassen Jan, 2002, Curr Neurol Neurosci Rep, V2, P534, DOI 10.1007/s11910-002-0042-1; Claassen J, 2014, NEUROCRIT CARE, V21, P129, DOI 10.1007/s12028-014-0022-8; Claassen J, 2013, ANN NEUROL, V74, P53, DOI 10.1002/ana.23859; Coles JP, 2007, CRIT CARE MED, V35, P568, DOI 10.1097/01.CCM.0000254066.37187.88; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P202, DOI 10.1097/01.WCB.0000103022.98348.24; Coles JP, 2002, CRIT CARE MED, V30, P1950, DOI 10.1097/00003246-200209000-00002; Coplin WM, 1997, NEUROSURGERY, V41, P101, DOI 10.1097/00006123-199707000-00022; Cormio M, 1999, J NEUROSURG, V90, P9, DOI 10.3171/jns.1999.90.1.0009; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Dawes AJ, 2015, J TRAUMA ACUTE CARE, V78, P492, DOI 10.1097/TA.0000000000000559; De Turck F, 2007, COMPUT BIOL MED, V37, P97, DOI 10.1016/j.compbiomed.2005.10.004; Deans KJ, 2010, ANESTH ANALG, V111, P444, DOI 10.1213/ane.0b013e3181aa8903; Dhar Rajat, 2015, Acta Neurochir Suppl, V120, P161, DOI 10.1007/978-3-319-04981-6_27; Diaz-Arrastia R, 2014, 12 ANN NEUR CAR SOC; Dings J, 1998, NEUROSURGERY, V43, P1082, DOI 10.1097/00006123-199811000-00045; Dizdarevic K, 2012, CLIN NEUROL NEUROSUR, V114, P142, DOI 10.1016/j.clineuro.2011.10.005; Ekelund A, 1996, BRIT J NEUROSURG, V10, P19, DOI 10.1080/bjn.10.1.19; Enblad P, 1996, J CEREBR BLOOD F MET, V16, P637, DOI 10.1097/00004647-199607000-00014; Engstrom M, 2005, J NEUROSURG, V102, P460, DOI 10.3171/jns.2005.102.3.0460; Eriksson EA, 2012, J TRAUMA ACUTE CARE, V72, P1345, DOI 10.1097/TA.0b013e318249a0f4; Fortune JB, 1995, J TRAUMA, V39, P1091, DOI 10.1097/00005373-199512000-00014; FORTUNE JB, 1994, J NEUROSURG, V80, P461, DOI 10.3171/jns.1994.80.3.0461; Gallagher CN, 2009, BRAIN, V132, P2839, DOI 10.1093/brain/awp202; Gaspard N, 2014, EPILEPSIA, V55, P1366, DOI 10.1111/epi.12653; Gavvala J, 2014, EPILEPSIA, V55, P1864, DOI 10.1111/epi.12809; Ghosh A, 2012, ANESTH ANALG, V115, P1373, DOI 10.1213/ANE.0b013e31826dd6a6; Gollwitzer S, 2015, CLIN NEUROPHYSIOL, V126, P1514, DOI 10.1016/j.clinph.2014.10.215; Gonzalez NR, 2007, J NEUROSURG, V107, P1101, DOI 10.3171/JNS-07/12/1101; Goodman JC, 1999, CRIT CARE MED, V27, P1965, DOI 10.1097/00003246-199909000-00041; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; Hametner C, 2015, J CEREBR BLOOD F MET, V35, P1722, DOI 10.1038/jcbfm.2015.181; Hebb MO, 2007, J NEUROTRAUM, V24, P579, DOI 10.1089/neu.2006.0146; Heran NS, 2004, CAN J NEUROL SCI, V31, P80, DOI 10.1017/S0317167100002870; Highton D, 2010, CURR OPIN ANESTHESIO, V23, P576, DOI 10.1097/ACO.0b013e32833e1536; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Hillered L, 1998, J NEUROL NEUROSUR PS, V64, P486, DOI 10.1136/jnnp.64.4.486; Hutchinson PJ, 2015, INTENS CARE MED, V41, P1517, DOI 10.1007/s00134-015-3930-y; Jaeger M, 2007, STROKE, V38, P981, DOI 10.1161/01.STR.0000257964.65743.99; Jaeger M, 2006, CRIT CARE MED, V34, P1783, DOI 10.1097/01.CCM.0000218413.51546.9E; Kett-White R, 2002, NEUROSURGERY, V50, P1213, DOI 10.1097/00006123-200206000-00008; Kinoshita K, 2010, J SURG RES, V162, P221, DOI 10.1016/j.jss.2009.06.009; KIRKPATRICK PJ, 1994, J NEUROL NEUROSUR PS, V57, P1382, DOI 10.1136/jnnp.57.11.1382; Knight WA, 2013, EPILEPSY RES, V106, P396, DOI 10.1016/j.eplepsyres.2013.06.018; Kruyt ND, 2009, STROKE, V40, pE424, DOI 10.1161/STROKEAHA.108.529974; Kurtz P, 2014, CRIT CARE, V18, DOI 10.1186/cc13857; Lam JMK, 1997, J NEUROSURG, V86, P438, DOI 10.3171/jns.1997.86.3.0438; Le Roux P, 2014, NEUROCRIT CARE, V21, P1, DOI 10.1007/s12028-014-0041-5; Li CY, 2012, BIOMED MICRODEVICES, V14, P759, DOI 10.1007/s10544-012-9646-7; Lin C-M, 2015, BIOMED RES INT, V2015; Lindegaard K F, 1988, Acta Neurochir Suppl (Wien), V42, P81; Logi F, 2011, BRAIN INJURY, V25, P972, DOI 10.3109/02699052.2011.589795; Loov C, 2015, J NEUROTRAUM, V32, P244, DOI 10.1089/neu.2014.3517; LUNDBERG N, 1965, J NEUROSURG, V22, P581, DOI 10.3171/jns.1965.22.6.0581; Maas AIR, 2012, J NEUROTRAUM, V29, P32, DOI 10.1089/neu.2010.1599; MacLaughlin BW, 2015, AM J SURG, V210, P1082, DOI 10.1016/j.amjsurg.2015.08.007; Marcoux J, 2008, CRIT CARE MED, V36, P2871, DOI 10.1097/CCM.0b013e318186a4a0; Marin-Caballos A, 2005, CRIT CARE, V9, pR670, DOI 10.1186/cc3822; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Mazzeo AT, 2015, J NEUROTRAUMA; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; Naidech AM, 2008, NEUROCRIT CARE, V9, P326, DOI 10.1007/s12028-008-9077-8; Narotam PK, 2014, J NEUROTRAUM, V31, P630, DOI 10.1089/neu.2013.3104; Narotam PK, 2009, J NEUROSURG, V111, P672, DOI 10.3171/2009.4.JNS081150; Nikaina I, 2012, J CRIT CARE, V27, P83, DOI 10.1016/j.jcrc.2011.04.004; Nilsson OG, 1999, NEUROSURGERY, V45, P1176, DOI 10.1097/00006123-199911000-00032; Obrenovitch TP, 1999, ANN NY ACAD SCI, V890, P273, DOI 10.1111/j.1749-6632.1999.tb08004.x; Oddo M, 2014, NEUROCRIT CARE, V21, P103, DOI 10.1007/s12028-014-0024-6; Oddo M, 2012, STROKE, V43, P1418, DOI 10.1161/STROKEAHA.111.648568; Oddo M, 2011, NEUROSURGERY, V69, P1037, DOI 10.1227/NEU.0b013e3182287ca7; Oddo M, 2008, CRIT CARE MED, V36, P3233, DOI 10.1097/CCM.0b013e31818f4026; Oertel M, 2005, J NEUROSURG, V103, P812, DOI 10.3171/jns.2005.103.5.0812; Paraforou Theoniki, 2011, BMC Res Notes, V4, P540, DOI 10.1186/1756-0500-4-540; PERSSON L, 1992, J NEUROSURG, V76, P72, DOI 10.3171/jns.1992.76.1.0072; Ponce LL, 2012, NEUROSURGERY, V70, P1492, DOI 10.1227/NEU.0b013e31824ce933; Ramakrishna R, 2008, J NEUROSURG, V109, P1075, DOI 10.3171/JNS.2008.109.12.1075; Robertson CS, 2010, J NEUROTRAUM, V27, P1597, DOI 10.1089/neu.2010.1340; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Rosenthal G, 2011, J NEUROSURG, V114, P62, DOI 10.3171/2010.6.JNS091360; Rossetti AO, 2010, CRIT CARE, V14, DOI 10.1186/cc9276; Rots ML, 2016, NEUROCRIT CARE, V24, P207, DOI 10.1007/s12028-015-0205-y; Sarrafzadeh A, 2004, J NEUROSURG, V100, P400, DOI 10.3171/jns.2004.100.3.0400; Sarrafzadeh AS, 2002, CRIT CARE MED, V30, P1062, DOI 10.1097/00003246-200205000-00018; Schlenk F, 2008, INTENS CARE MED, V34, P1200, DOI 10.1007/s00134-008-1044-5; Schlenk F, 2008, CRIT CARE, V12, DOI 10.1186/cc6776; Schulz MK, 2000, J NEUROSURG, V93, P808, DOI 10.3171/jns.2000.93.5.0808; Shannon RJ, 2013, J PHARMACOKINET PHAR, V40, P343, DOI 10.1007/s10928-013-9306-4; Sharbrough FW, 1973, STROKE, V4, P674, DOI 10.1161/01.STR.4.4.674; Skjoth-Rasmussen J, 2004, J NEUROSURG, V100, P8, DOI 10.3171/jns.2004.100.1.0008; Sorani MD, 2007, NEUROCRIT CARE, V7, P45, DOI 10.1007/s12028-007-0043-7; Spiotta AM, 2010, J NEUROSURG, V113, P571, DOI 10.3171/2010.1.JNS09506; Springborg JB, 2005, BRIT J ANAESTH, V94, P259, DOI 10.1093/bja/aei004; Stein NR, 2012, NEUROCRIT CARE, V17, P49, DOI 10.1007/s12028-012-9708-y; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Szaflarski JP, 2008, EPILEPSIA, V49, P974, DOI 10.1111/j.1528-1167.2007.01513.x; Talving P, 2013, J NEUROSURG, V119, P1248, DOI 10.3171/2013.7.JNS122255; Tang A, 2015, J SURG RES, V194, P565, DOI 10.1016/j.jss.2014.11.017; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; Tisdall MM, 2006, BRIT J ANAESTH, V97, P18, DOI 10.1093/bja/ael109; Treggiari MM, 2007, NEUROCRIT CARE, V6, P104, DOI 10.1007/s12028-007-0012-1; Unterberg AW, 2001, J NEUROSURG, V94, P740, DOI 10.3171/jns.2001.94.5.0740; Vajkoczy P, 2000, J NEUROSURG, V93, P265, DOI 10.3171/jns.2000.93.2.0265; Vespa P, 2006, CRIT CARE MED, V34, P850, DOI 10.1097/01.CCM.0000201875.12245.6F; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vespa P, 1998, J NEUROSURG, V89, P971, DOI 10.3171/jns.1998.89.6.0971; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Vespa PM, 1997, ELECTROEN CLIN NEURO, V103, P607, DOI 10.1016/S0013-4694(97)00071-0; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF; Vigue B, 1999, INTENS CARE MED, V25, P445, DOI 10.1007/s001340050878; Waziri A, 2009, ANN NEUROL, V66, P366, DOI 10.1002/ana.21721; WILLMORE LJ, 1978, SCIENCE, V200, P1501, DOI 10.1126/science.96527; Woitzik J, 2014, STROKE, V45, P1183, DOI 10.1161/STROKEAHA.113.004475; Zauner A, 1997, NEUROL RES, V19, P265, DOI 10.1080/01616412.1997.11740812; Zauner A, 1996, ACT NEUR S, V67, P40; Zweifel C, 2010, J NEUROTRAUM, V27, P1951, DOI 10.1089/neu.2010.1388; Zweifel C, 2010, STROKE, V41, P1963, DOI 10.1161/STROKEAHA.109.577320; Zweifel C, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E2	135	11	11	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0072-9752		978-0-12-803563-4; 978-0-44-463600-3	HAND CLINIC			2017	140						91	105		10.1016/B978-0-444-63600-3.00006-4			15	Critical Care Medicine; Clinical Neurology	General & Internal Medicine; Neurosciences & Neurology	BJ3DL	WOS:000422931500008	28187816				2021-06-18	
J	Li, ZZ; Wang, Y; Zeng, G; Zheng, XW; Wang, WB; Ling, Y; Tang, HM; Zhang, JF				Li, Zhengzhao; Wang, Yong; Zeng, Guang; Zheng, Xiaowen; Wang, Wenbo; Ling, Yun; Tang, Huamin; Zhang, Jianfeng			Increased miR-155 and heme oxygenase-1 expression is involved in the protective effects of formononetin in traumatic brain injury in rats	AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH			English	Article						Formononetin; phytoestrogen; traumatic brain injury (TBI); miR-155; heme oxygenase-1 (HO-1); BACH1	NRF2-ARE SIGNALING PATHWAY; OXIDATIVE STRESS; CANCER CELLS; DOWN-REGULATION; ACTIVATION; APOPTOSIS; NEUROPROTECTION; MECHANISM; MODELS; BACH1	Oxidative stress has been considered a major contributing factor to traumatic brain injury (TBI). Formononetin, a phytoestrogen that belongs to the flavonoid family, is extracted from plants and herbs such as the red clover. Growing evidence demonstrates that formononetin has antioxidant properties. Therefore, formononetin has potential use in treating oxidative stress injuries in TBI. In this study, the neuroprotective and antioxidant effects of formononetin against TBI, as well as the related probable mechanisms, were investigated. The TBI model was produced in male Wistar rats through Feeney's weight-drop model. At 1 day after TBI, the neurological function score and brain water content were assessed. TUNEL assay was used to determine neuronal apoptosis. The expression levels of miR-155, HO-1, and BACH1 were measured by RT-PCR and western blotting. Consequently, our findings showed that formononetin pretreatment for 5 days significantly improved the neurological scores, reduced brain edema and inhibited neuronal apoptosis in rats after TBI. MiR-155 was substantially decreased and BACH1 expression was significantly increased in the TBI model, while pretreatment with formononetin dramatically up-regulated the expression levels of miR-155 and HO-1 and down-regulated the protein expression of BACH1 in rats after TBI. In summary, formononetin has been shown to have neuroprotective effects, and the mechanisms of this effect may be associated with its inhibition of oxidative stress and activation of Nrf2-dependent antioxidant pathways in TBI.	[Li, Zhengzhao; Zeng, Guang; Zheng, Xiaowen; Ling, Yun; Tang, Huamin; Zhang, Jianfeng] Guangxi Med Univ, Dept Emergency, Affiliated Hosp 2, Nanning 530007, Peoples R China; [Wang, Yong] Guilin Med Univ, Dept Physiol, Guilin 541004, Peoples R China; [Wang, Wenbo] Guilin Med Univ, Dept Neurosurg, Affiliated Hosp, Guilin 541001, Peoples R China	Zhang, JF (corresponding author), Guangxi Med Univ, Dept Emergency, Affiliated Hosp 2, Nanning 530007, Peoples R China.	jianfeng_zhang888@126.com		Zhang, Jianfeng/0000-0003-4213-9310	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [8146-0211, 81560378]; Guangxi Emergency and Medical Rescue Talent Highland [GXJZ-201506]	This work was supported by the National Natural Science Foundation of China (8146-0211, 81560378) and the Guangxi Emergency and Medical Rescue Talent Highland (GXJZ-201506).	Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Berry C, 2009, J TRAUMA, V67, P950, DOI 10.1097/TA.0b013e3181ba3354; Chen J, 2012, HORM METAB RES, V44, P943, DOI 10.1055/s-0032-1321818; Chen J, 2015, FOOD FUNCT, V6, P3091, DOI [10.1039/c5fo00374a, 10.1039/C5FO00374A]; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chen RL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050957; Cheng T, 2016, FREE RADICAL BIO MED, V92, P15, DOI 10.1016/j.freeradbiomed.2015.12.027; Cheng XH, 2013, FREE RADICAL BIO MED, V64, P4, DOI 10.1016/j.freeradbiomed.2013.07.025; Ding K, 2014, FREE RADICAL BIO MED, V73, P1, DOI 10.1016/j.freeradbiomed.2014.04.031; Engler-Chiurazzi EB, 2017, PROG NEUROBIOL, V157, P188, DOI 10.1016/j.pneurobio.2015.12.008; Li ZZ, 2014, J NEUROL SCI, V338, P112, DOI 10.1016/j.jns.2013.12.027; Liu L., 2014, ADV DIFFER EQU, V217, P9, DOI DOI 10.1371/J0URNAL.P0NE.0103948; Liu ZW, 2017, NEUROCHEM RES, V42, P1375, DOI 10.1007/s11064-017-2186-z; Lou J, 2016, NEUROCHEM RES, V41, P1291, DOI 10.1007/s11064-016-1826-z; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Pulkkinen KH, 2011, FREE RADICAL BIO MED, V51, P2124, DOI 10.1016/j.freeradbiomed.2011.09.014; Reichard JF, 2007, NUCLEIC ACIDS RES, V35, P7074, DOI 10.1093/nar/gkm638; Sabirzhanov B, 2014, J NEUROSCI, V34, P10055, DOI 10.1523/JNEUROSCI.1260-14.2014; Shu LF, 2016, NEUROSCI LETT, V611, P74, DOI 10.1016/j.neulet.2015.11.012; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Soltani Z, 2015, PHYSIOL BEHAV, V152, P26, DOI 10.1016/j.physbeh.2015.08.037; Wan C, 2016, TOXICOL APPL PHARM, V295, P85, DOI 10.1016/j.taap.2016.01.023; Wang P, 2016, NEUROCHEM RES, V41, P2627, DOI 10.1007/s11064-016-1975-0; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yang T, 2016, J NEUROCHEM, V137, P122, DOI 10.1111/jnc.13534; Yang YQ, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00580; Zhang L, 2017, MOL NEUROBIOL; Zhang X, 2014, NUTR CANCER, V66, P656, DOI 10.1080/01635581.2014.894098; Zhou Y, 2016, CLIN REV ALLERG IMMU, V50, P345, DOI 10.1007/s12016-016-8538-7	29	11	12	0	3	E-CENTURY PUBLISHING CORP	MADISON	40 WHITE OAKS LN, MADISON, WI 53711 USA	1943-8141			AM J TRANSL RES	Am. J. Transl. Res.		2017	9	12					5653	5661					9	Oncology; Medicine, Research & Experimental	Oncology; Research & Experimental Medicine	FR6YN	WOS:000419213500042	29312517				2021-06-18	
J	McGarity, S; Barnett, SD; Lamberty, G; Kretzmer, T; Powell-Cope, G; Patel, N; Nakase-Richardson, R				McGarity, Suzanne; Barnett, Scott D.; Lamberty, Greg; Kretzmer, Tracy; Powell-Cope, Gail; Patel, Nitin; Nakase-Richardson, Risa			Community Reintegration Problems Among Veterans and Active Duty Service Members With Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						community reintegration; driving; employment; Model Systems; mTBI; NIDRR; OEF/OIF; polytrauma; TBIMS; traumatic brain injury; VA; veterans	GENERALIZED ANXIETY DISORDER; PARTICIPATION ASSESSMENT; MAJOR DEPRESSION; RATING-SCALE; INTEGRATION; HEALTH; SOLDIERS; RETURN; PEOPLE; VALIDATION	Objectives: To examine community reintegration problems among Veterans and military service members with mild or moderate/severe traumatic brain injury (TBI) at 1 year postinjury and to identify unique predictors that may contribute to these difficulties. Setting: VA Polytrauma Rehabilitation Centers. Participants: Participants were 154 inpatients enrolled in the VA TBI Model Systems Program with available injury severity data (mild = 28.6%; moderate/severe = 71.4%) and 1-year postinjury outcome data. Design: Prospective, longitudinal cohort. Main Measures: Community reintegration outcomes included independent driving, employability, and general community participation. Additional measures assessed depression, posttraumatic stress, and cognitive and motor functioning. Results: In the mild TBI (mTBI) group, posttraumatic stress disorder and depressive symptoms were associated with lower levels of various community reintegration outcomes. In the moderate/severe TBI group, cognition and motor skills were significantly associated with lower levels of community participation, independent driving, and employability. Conclusion: Community reintegration is problematic for Veterans and active duty service members with a history of TBI. Unique comorbidities across injury severity groups inhibit full reintegration into the community. These findings highlight the ongoing rehabilitation needs of persons with TBI, specifically evidence-based mental healthcare, in comprehensive rehabilitation programs consistent with a chronic disease management model.	[McGarity, Suzanne; Barnett, Scott D.; Lamberty, Greg; Kretzmer, Tracy; Powell-Cope, Gail; Patel, Nitin; Nakase-Richardson, Risa] Univ S Florida, James A Haley Vet Hosp, Dept Med, Tampa, FL USA	McGarity, S (corresponding author), James A Haley Vet Hosp, 13000 Bruce B Downs Blvd,MC 116 B, Tampa, FL 33612 USA.	Suzanne.McGarity@va.gov			VHA Central Office Division of Rehabilitation Medicine Health Services Research and Development [HSRD SDR 13-228]; VA TBI Model System Program of Research; General Dynamics Information Technology from the Defense and Veterans Brain Injury Center, US Army Medical Research and Material Command (USAMRMC) [W91YTZ-13-C-0015]; Department of Veterans Affairs, National Institute on Disability, Independent Living, and Rehabilitation Research; Department of Education, National Institute on Disability, Independent Living, and Rehabilitation Research	This research is sponsored by VHA Central Office Division of Rehabilitation Medicine Health Services Research and Development (HSRD SDR 13-228), VA TBI Model System Program of Research, and Subcontract from General Dynamics Information Technology (W91YTZ-13-C-0015) from the Defense and Veterans Brain Injury Center, US Army Medical Research and Material Command (USAMRMC). The Polytrauma Rehabilitation Center Traumatic Brain Injury (TBI) Model System collaboration is funded through an Interagency Agreement between the Department of Veterans Affairs and the Department of Education, National Institute on Disability, Independent Living, and Rehabilitation Research. The authors acknowledge DVBIC personnel for their contribution to this study including collection of follow-up data and ongoing collaborative efforts at improving data collection efficiency in TBIMS. These individuals include Katherine Levie; Jennifer Boyce, RN; Adam Haskin; Joyce Chung, MPH; and Tiffany Amos. The views, opinions, and/or findings contained in this article are those of the authors and should not be construed as an official Department of Defense position or any other federal agency, policy, or decision unless so designated by other official documentation.	Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0; Bier N, 2009, J HEAD TRAUMA REHAB, V24, P187, DOI 10.1097/HTR.0b013e3181a0b15a; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Bogner JA, 2011, ARCH PHYS MED REHAB, V92, P552, DOI 10.1016/j.apmr.2010.11.014; Bombardier CH, 2004, ARCH PHYS MED REHAB, V85, P1749, DOI 10.1016/j.apmr.2004.07.348; Braden CA, 2012, BRAIN INJURY, V26, P1315, DOI 10.3109/02699052.2012.706351; Brenner LA, 2015, REHABIL PSYCHOL, V60, P277, DOI 10.1037/rep0000048; Brouwer WH, 1997, NEUROPSYCHOL REHABIL, V7, P177, DOI 10.1080/713755536; Brown AW, 2011, J NEUROTRAUM, V28, P167, DOI 10.1089/neu.2010.1400; Bushnik T, 2008, ARCH PHYS MED REHAB, V89, P894, DOI 10.1016/j.apmr.2008.03.001; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; Classen S, 2011, AM J OCCUP THER, V65, P419, DOI 10.5014/ajot.2011.000893; Coleman BR., 2005, DRIVER REHABILITATIO, P165; Coleman RD, 2002, ARCH PHYS MED REHAB, V83, P1415, DOI 10.1053/apmr.2002.35111; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Dobie DJ, 2002, GEN HOSP PSYCHIAT, V24, P367, DOI 10.1016/S0163-8343(02)00207-4; Doig E, 2001, BRAIN INJURY, V15, P747, DOI 10.1080/02699050110034343; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Frayne SM, 2011, J GEN INTERN MED, V26, P33, DOI 10.1007/s11606-010-1497-4; Frazier PA, 2004, J COUNS PSYCHOL, V51, P115, DOI 10.1037/0022-0167.51.1.115; Fuhrer MJ, 1987, REHABILITATION OUTCO, P137; Graves DE, 2008, J SPINAL CORD MED, V31, P177, DOI 10.1080/10790268.2008.11760709; Hanks RA, 2008, ARCH PHYS MED REHAB, V89, P950, DOI 10.1016/j.apmr.2008.01.011; Hannold EM, 2013, J REHABIL RES DEV, V50, P1315, DOI 10.1682/JRRD.2013.04.0084; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hundt Natalie E, 2015, Psychol Trauma, V7, P539, DOI 10.1037/tra0000035; Institute of Medicine (IOM), 2008, GULF WAR HLTH, V7; Jacobsson LJ, 2009, ACTA NEUROL SCAND, V120, P389, DOI 10.1111/j.1600-0404.2009.01238.x; Kalmar K, 2008, ARCH PHYS MED REHAB, V89, P942, DOI 10.1016/j.apmr.2008.01.008; Kang HK, 1996, NEW ENGL J MED, V335, P1498, DOI 10.1056/NEJM199611143352006; Kelley AM, 2012, J PSYCHIATR RES, V46, P582, DOI 10.1016/j.jpsychires.2012.01.017; Koren D, 2005, AM J PSYCHIAT, V162, P276, DOI 10.1176/appi.ajp.162.2.276; Kreutzer JS, 2007, NEUROREHABILITATION, V22, P53; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lamberty GJ, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e31829a64d1; Lang AJ, 2003, J TRAUMA STRESS, V16, P257, DOI 10.1023/A:1023796007788; Lew HL, 2011, J REHABIL RES DEV, V48, P913, DOI 10.1682/JRRD.2010.08.0140; Lew HL, 2010, NEUROREHABILITATION, V26, P271, DOI 10.3233/NRE-2010-0562; Lowe B, 2008, MED CARE, V46, P266, DOI 10.1097/MLR.0b013e318160d093; Luis CA, 2003, J INT NEUROPSYCH SOC, V9, P1001, DOI 10.1017/S1355617703970044; McColl MA, 1998, BRAIN INJURY, V12, P15, DOI 10.1080/026990598122827; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Nakase-Richardson R, 2011, J NEUROL NEUROSUR PS, V82, P494, DOI 10.1136/jnnp.2010.222489; Nakase-Richardson R, 2007, J NEUROL NEUROSUR PS, V78, P872, DOI 10.1136/jnnp.2006.104190; Nakase-Richardson R, 2009, ARCH PHYS MED REHAB, V90, P17, DOI 10.1016/j.apmr.2008.06.030; O'Neill J, 1998, J HEAD TRAUMA REHAB, V13, P68, DOI 10.1097/00001199-199808000-00007; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Rapport L, 2006, J HEAD TRAUMA REHAB, V21, P34, DOI 10.1097/00001199-200601000-00004; Rapport LJ, 2008, ARCH PHYS MED REHAB, V89, P922, DOI 10.1016/j.apmr.2008.01.009; Rauch SAM, 2009, DEPRESS ANXIETY, V26, P732, DOI 10.1002/da.20518; Resnik L, 2011, J REHABIL RES DEV, V48, P89, DOI 10.1682/JRRD.2010.04.0070; Resnik LJ, 2007, J REHABIL RES DEV, V44, P991, DOI 10.1682/JRRD.2007.05.0071; Rona RJ, 2012, J HEAD TRAUMA REHAB, V27, P33, DOI 10.1097/HTR.0b013e318212f814; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P16, DOI DOI 10.1001/ARCHNEUR.1961.00450130006002; Salter K, 2008, BRAIN INJURY, V22, P820, DOI 10.1080/02699050802425428; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Smith TC, 2007, ANN EPIDEMIOL, V17, P525, DOI 10.1016/j.annepidem.2006.12.002; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Trzepacz PT, 2001, J NEUROPSYCH CLIN N, V13, P229, DOI 10.1176/appi.neuropsych.13.2.229; U.S. Department of Veterans Affairs & Department of Defense, 2010, VA DOD CLIN PRACT GU; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; van Velzen JM, 2009, BRAIN INJURY, V23, P473, DOI 10.1080/02699050902970737; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Vasterling JJ, 2006, JAMA-J AM MED ASSOC, V296, P519, DOI 10.1001/jama.296.5.519; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Weathers F. W., 1993, ANN M INT SOC TRAUM; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P542, DOI 10.1016/j.apmr.2010.08.002	70	11	11	0	13	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2017	32	1					34	45		10.1097/HTR.0000000000000242			12	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	EI2GH	WOS:000392304400004	27323217				2021-06-18	
J	McKinlay, A; Horwood, LJ				McKinlay, Audrey; Horwood, L. John			The accuracy of adult recall for early mild traumatic brain injury	DISABILITY AND REHABILITATION			English	Article						Adult recall; childhood; traumatic brain injury	EARLY-CHILDHOOD; HEAD-INJURY; BIRTH COHORT; OUTCOMES; CHILDREN; ADOLESCENTS; AMNESIA; MEMORY; SKILLS	Background: Childhood mild traumatic brain injury (mTBI) has been associated with negative adult outcomes. Effective interventions require identification of the injury event. There is currently little information regarding the accuracy of adult recall of childhood mTBI. Method: Prospectively collected information from a large birth cohort was used to examine adult recall accuracy at age 25 for 161 childhood mTBI events occurring before age 10. Results: At age 25 cohort members recalled 11 outpatient injuries and 16 inpatient injuries. Recall accuracy increased with age. Logistic regression analysis distinguished between respondents who reported and did not report a childhood mTBI event correctly classifying 84.5% of cases. Age at injury, injury severity and loss of consciousness (LoC) made a unique statistically significant contribution to the model. Conclusions: Most childhood mTBI events are not recalled in adulthood. Age at injury, injury severity and LoC significantly increase likelihood of recall and should be used in measures that evaluate whether injury has occurred.	[McKinlay, Audrey] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic 3010, Australia; [Horwood, L. John] Univ Otago, Christchurch Hlth & Dev Study, Christchurch, New Zealand	McKinlay, A (corresponding author), Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic 3010, Australia.	audrey.mckinlay@unimelb.edu.au		Horwood, L./0000-0003-4881-1956; McKinlay, Audrey/0000-0001-9846-8514			Anderson SW, 2000, DEV NEUROPSYCHOL, V18, P281, DOI 10.1207/S1532694202Anderson; Anderson V, 2005, BRAIN INJURY, V19, P699, DOI 10.1080/02699050400025281; Anderson V, 2006, J INT NEUROPSYCH SOC, V12, P519, DOI 10.1017/S135561770606067X; Anderson V, 2010, NEUROPSYCHOLOGIA, V48, P2041, DOI 10.1016/j.neuropsychologia.2010.03.025; Anderson V, 2009, PEDIATRICS, V124, pE1064, DOI 10.1542/peds.2009-0365; Bauer PJ, 2015, PSYCHOL REV, V122, P204, DOI 10.1037/a0038939; Catroppa C, 2012, J NEUROTRAUM, V29, P2539, DOI 10.1089/neu.2012.2403; Cordon IM, 2004, DEV REV, V24, P101, DOI 10.1016/j.dr.2003.09.003; Hessen E, 2007, BRAIN INJURY, V21, P963, DOI 10.1080/02699050701528454; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P3, DOI 10.1111/j.1365-2214.2009.01006.x; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P22, DOI 10.1111/j.1365-2214.2009.00947.x; McKinlay A, 2012, MILD TRAUMATIC BRAIN, V18, P361; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P498, DOI 10.1097/HTR.0000000000000001; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Peterson C, 2012, DEV REV, V32, P287, DOI 10.1016/j.dr.2012.06.002; Satz P, 1997, PSYCHOL BULL, V122, P107, DOI 10.1037/0033-2909.122.2.107; Satz P, 2001, CURR DIR PSYCHOL SCI, V10, P106, DOI 10.1111/1467-8721.00127	20	11	11	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.		2017	39	13					1296	1299		10.1080/09638288.2016.1193905			4	Rehabilitation	Rehabilitation	EQ9WM	WOS:000398437000006	27346060				2021-06-18	
J	Milakara, D; Grozea, C; Dahlem, M; Major, S; Winkler, MKL; Luckl, J; Scheel, M; Kola, V; Schoknecht, K; Lublinsky, S; Friedman, A; Martus, P; Hartings, JA; Woitzik, J; Dreier, JP				Milakara, Denny; Grozea, Cristian; Dahlem, Markus; Major, Sebastian; Winkler, Maren K. L.; Lueckl, Janos; Scheel, Michael; Kola, Vasilis; Schoknecht, Karl; Lublinsky, Svetlana; Friedman, Alon; Martus, Peter; Hartings, Jed A.; Woitzik, Johannes; Dreier, Jens P.			Simulation of spreading depolarization trajectories in cerebral cortex: Correlation of velocity and susceptibility in patients with aneurysmal subarachnoid hemorrhage	NEUROIMAGE-CLINICAL			English	Article						Cytotoxic edema; Ischemia; Spreading depression; Stroke; Subarachnoid hemorrhage; Traumatic brain injury	ISCHEMIC RAT-BRAIN; MIGRAINE AURA; BLOOD-FLOW; IN-VIVO; ANOXIC DEPOLARIZATION; HEMODYNAMIC-RESPONSES; CORTICAL DEPRESSION; CLASSIC MIGRAINE; CYTOTOXIC EDEMA; IMAGING REVEALS	In many cerebral grey matter structures including the neocortex, spreading depolarization (SD) is the principal mechanism of the near-complete breakdown of the transcellular ion gradients with abrupt water influx into neurons. Accordingly, SDs are abundantly recorded in patients with traumatic brain injury, spontaneous intracerebral hemorrhage, aneurysmal subarachnoid hemorrhage (aSAH) and malignant hemispheric stroke using subdural electrode strips. SD is observed as a large slow potential change, spreading in the cortex at velocities between 2 and 9 mm/min. Velocity and SD susceptibility typically correlate positively in various animal models. In patients monitored in neurocritical care, the Co-Operative Studies on Brain Injury Depolarizations (COSBID) recommends several variables to quantify SD occurrence and susceptibility, although accurate measures of SD velocity have not been possible. Therefore, we developed an algorithm to estimate SD velocities based on reconstructing SD trajectories of the wave-front's curvature center from magnetic resonance imaging scans and time-of-SD-arrival-differences between subdural electrode pairs. We then correlated variables indicating SD susceptibility with algorithm-estimated SD velocities in twelve aSAH patients. Highly significant correlations supported the algorithm's validity. The trajectory search failed significantly more often for SDs recorded directly over emerging focal brain lesions suggesting in humans similar to animals that the complexity of SD propagation paths increase in tissue undergoing injury.	[Milakara, Denny; Major, Sebastian; Winkler, Maren K. L.; Lueckl, Janos; Kola, Vasilis; Schoknecht, Karl; Dreier, Jens P.] Humboldt Univ, Charite Univ Med Berlin, Ctr Stroke Res, Freie Univ Berlin, Charite Campus Mitte,Charitepl 1, D-10117 Berlin, Germany; [Milakara, Denny; Major, Sebastian; Winkler, Maren K. L.; Lueckl, Janos; Scheel, Michael; Kola, Vasilis; Schoknecht, Karl; Woitzik, Johannes; Dreier, Jens P.] Berlin Inst Hlth, Charitepl 1, D-10117 Berlin, Germany; [Grozea, Cristian] VISCOM Visual Comp Fraunhofer Inst Open Commun Sy, Berlin, Germany; [Dahlem, Markus] Humboldt Univ, Dept Phys, Berlin, Germany; [Major, Sebastian; Dreier, Jens P.] Humboldt Univ, Charite Univ Med Berlin, Dept Neurol, Freie Univ Berlin, Berlin, Germany; [Major, Sebastian; Schoknecht, Karl; Dreier, Jens P.] Humboldt Univ, Charite Univ Med Berlin, Dept Expt Neurol, Freie Univ Berlin, Berlin, Germany; [Scheel, Michael] Humboldt Univ, Charite Univ Med Berlin, Dept Neuroradiol, Freie Univ Berlin, Berlin, Germany; [Lublinsky, Svetlana; Friedman, Alon] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Physiol & Neurobiol, Beer Sheva, Israel; [Lublinsky, Svetlana; Friedman, Alon] Ben Gurion Univ Negev, Zlotowski Ctr Neurosci, Beer Sheva, Israel; [Friedman, Alon] Dalhousie Univ, Fac Med, Dept Med Neurosci, Halifax, NS, Canada; [Martus, Peter] Univ Tubingen, Inst Clin Epidemiol & Appl Biometry, Tubingen, Germany; [Hartings, Jed A.] Univ Cincinnati, Coll Med, Dept Neurosurg, Cincinnati, OH 45267 USA; [Woitzik, Johannes] Humboldt Univ, Freie Univ Berlin, Charite Univ Med Berlin, Dept Neurosurg, Berlin, Germany	Dreier, JP (corresponding author), Humboldt Univ, Charite Univ Med Berlin, Ctr Stroke Res, Freie Univ Berlin, Charite Campus Mitte,Charitepl 1, D-10117 Berlin, Germany.; Dreier, JP (corresponding author), Berlin Inst Hlth, Charitepl 1, D-10117 Berlin, Germany.	jens.dreier@charite.de	Milakara, Denny/AAL-8129-2021; Major, Sebastian/I-1838-2019; Scheel, Michael/M-2350-2019	Milakara, Denny/0000-0003-3148-6122; Major, Sebastian/0000-0003-0970-1308; Hartings, Jed/0000-0001-8583-3471; , Alon/0000-0003-4780-8456; Scheel, Michael/0000-0002-3505-2914	Bundesministerium fur Bildung und Forschung (Center for Stroke Research Berlin)Federal Ministry of Education & Research (BMBF) [01 EO 0801, BCCN 01GQ1001C B2]; NeuroCure SESAH [EXC 257/2]; Deutsche Forschungsgemeinschaft (DFG)German Research Foundation (DFG) [DR 323/5-1]; Mayfield Education and Research Foundation	This work was supported by the Bundesministerium fur Bildung und Forschung (Center for Stroke Research Berlin, 01 EO 0801; BCCN 01GQ1001C B2) and NeuroCure SESAH (EXC 257/2) to Dr. Dreier JP and Deutsche Forschungsgemeinschaft (DFG DR 323/5-1) to Drs. Dreier JP, Martus P, and Woitzik J and Mayfield Education and Research Foundation to Dr. Hartings JA.	Aitken PG, 1998, J NEUROPHYSIOL, V80, P1514; ASTRUP J, 1981, STROKE, V12, P723, DOI 10.1161/01.STR.12.6.723; BACK T, 1994, J CEREBR BLOOD F MET, V14, P12, DOI 10.1038/jcbfm.1994.3; Basarsky TA, 1998, J NEUROSCI, V18, P7189; Bere Z, 2014, NEUROSCIENCE, V260, P217, DOI 10.1016/j.neuroscience.2013.12.032; Bere Z, 2014, J CEREBR BLOOD F MET, V34, P1695, DOI 10.1038/jcbfm.2014.136; Bogdanov VB, 2011, NEUROBIOL DIS, V41, P430, DOI 10.1016/j.nbd.2010.10.014; Bosche B, 2010, ANN NEUROL, V67, P607, DOI 10.1002/ana.21943; Bowyer SM, 2001, ANN NEUROL, V50, P582, DOI 10.1002/ana.1293; Bruce DA, 2000, CHILD NERV SYST, V16, P724, DOI 10.1007/s003810000336; Budde MD, 2010, P NATL ACAD SCI USA, V107, P14472, DOI 10.1073/pnas.1004841107; Cain SM, 2017, P NATL ACAD SCI USA, V114, P2401, DOI 10.1073/pnas.1614447114; Chen SB, 2006, NEUROSCI LETT, V396, P132, DOI 10.1016/j.neulet.2005.11.025; Dahlem MA, 2004, ANN PHYS-BERLIN, V13, P442, DOI 10.1002/andp.200410087; Dahlem MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005007; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; de Crespigny A, 1998, J CEREBR BLOOD F MET, V18, P1008; de Crespigny AJ, 1999, STROKE, V30, P2212, DOI 10.1161/01.STR.30.10.2212; Desbrun M, 1999, COMP GRAPH, P317; Dhir A, 2012, NEUROSCI LETT, V514, P67, DOI 10.1016/j.neulet.2012.02.058; Dijkhuizen RM, 1999, BRAIN RES, V840, P194, DOI 10.1016/S0006-8993(99)01769-2; Dohmen C, 2008, ANN NEUROL, V63, P720, DOI 10.1002/ana.21390; Dreier JP, 2006, BRAIN, V129, P3224, DOI 10.1093/brain/awl297; Dreier JP, 2017, J CEREBR BLOOD F MET, V37, P1595, DOI 10.1177/0271678X16654496; Dreier JP, 2017, P NATL ACAD SCI USA, V114, P2112, DOI 10.1073/pnas.1700760114; Dreier JP, 2015, NEURON, V86, P902, DOI 10.1016/j.neuron.2015.04.004; Dreier JP, 2013, NEUROSCIENTIST, V19, P25, DOI 10.1177/1073858412453340; Dreier JP, 2012, BRAIN, V135, P259, DOI 10.1093/brain/awr303; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Dreier JP, 2009, BRAIN, V132, P1866, DOI 10.1093/brain/awp102; Drenckhahn C, 2016, J CLIN NEUROPHYSIOL, V33, P250, DOI 10.1097/WNP.0000000000000274; Eikermann-Haerter K, 2009, J CLIN INVEST, V119, P99, DOI 10.1172/JCI36059; Eiselt M, 2004, BRAIN RES, V1028, P83, DOI 10.1016/j.brainres.2004.09.002; Eross L, 2009, J NEUROSURG, V110, P327, DOI 10.3171/2008.6.JNS17611; Fabricius M, 2006, BRAIN, V129, P778, DOI 10.1093/brain/awh716; Farkas E, 2010, NEUROIMAGE, V51, P734, DOI 10.1016/j.neuroimage.2010.02.055; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Fujita S, 2016, CEREB CORTEX, V26, P1580, DOI 10.1093/cercor/bhu336; GRAFSTEIN B, 1956, J NEUROPHYSIOL, V19, P308; HABLITZ JJ, 1989, DEV BRAIN RES, V46, P243, DOI 10.1016/0165-3806(89)90288-5; Hadjikhani N, 2001, P NATL ACAD SCI USA, V98, P4687, DOI 10.1073/pnas.071582498; HAGLUND MM, 1985, BRAIN RES, V343, P198, DOI 10.1016/0006-8993(85)91180-1; HAGLUND MM, 1990, J NEUROPHYSIOL, V63, P225; Hartings JA, 2003, J NEUROSCI, V23, P11602; Hartings JA, 2017, J CEREBR BLOOD F MET, V37, P1857, DOI 10.1177/0271678X16653135; Hartings JA, 2017, J CEREBR BLOOD F MET, V37, P1571, DOI 10.1177/0271678X16654495; Hartings JA, 2011, LANCET NEUROL, V10, P1058, DOI 10.1016/S1474-4422(11)70243-5; Hartings JA, 2011, BRAIN, V134, P1529, DOI 10.1093/brain/awr048; Helbok R, 2017, J CEREBR BLOOD F MET, V37, P1871, DOI 10.1177/0271678X16651269; HERRERAS O, 1993, BRAIN RES, V610, P276, DOI 10.1016/0006-8993(93)91411-K; Hinzman JM, 2015, EXP NEUROL, V267, P243, DOI 10.1016/j.expneurol.2015.03.014; Hinzman JM, 2014, BRAIN, V137, P2960, DOI 10.1093/brain/awu241; HOSSMANN KA, 1994, ANN NEUROL, V36, P557, DOI 10.1002/ana.410360404; James MF, 1999, J PHYSIOL-LONDON, V519, P415, DOI 10.1111/j.1469-7793.1999.0415m.x; Jarvis CR, 2001, CEREB CORTEX, V11, P249, DOI 10.1093/cercor/11.3.249; Kager H, 2002, J NEUROPHYSIOL, V88, P2700, DOI 10.1152/jn.00237.2002; Kaufmann D, 2017, J CEREBR BLOOD F MET, V37, P1748, DOI 10.1177/0271678X16659496; Kneer F, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/5/053010; KOROLEVA VI, 1979, BRAIN RES, V173, P209, DOI 10.1016/0006-8993(79)90622-X; Koroleva VI, 1996, P NATL ACAD SCI USA, V93, P3710, DOI 10.1073/pnas.93.8.3710; Kudo C, 2008, EXP NEUROL, V212, P201, DOI 10.1016/j.expneurol.2008.03.026; LAURITZEN M, 1983, ANN NEUROL, V13, P633, DOI 10.1002/ana.410130609; LAURITZEN M, 1994, BRAIN, V117, P199, DOI 10.1093/brain/117.1.199; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359; LEAO AAP, 1947, J NEUROPHYSIOL, V10, P409, DOI 10.1152/jn.1947.10.6.409; LEAO AAP, 1945, J NEUROPHYSIOL, V8, P33; Lindquist BE, 2017, J CEREBR BLOOD F MET, V37, P1656, DOI 10.1177/0271678X16650696; Major S, 2017, J CEREBR BLOOD F MET, V37, P1687, DOI 10.1177/0271678X16639059; Makarova J, 2010, J NEUROPHYSIOL, V103, P2446, DOI 10.1152/jn.01045.2009; MARRANNES R, 1988, BRAIN RES, V457, P226, DOI 10.1016/0006-8993(88)90690-7; MARSHALL WH, 1959, PHYSIOL REV, V39, P239; MARTINSFERREIRA H, 1974, J NEUROPHYSIOL, V37, P773; Maslarova A, 2011, STROKE, V42, P2917, DOI 10.1161/STROKEAHA.111.621581; Mazel T, 2002, PHYSIOL RES, V51, pS85; Menyhart A, 2015, NEUROBIOL AGING, V36, P3269, DOI 10.1016/j.neurobiolaging.2015.08.014; Merkler D, 2009, ANN NEUROL, V66, P355, DOI 10.1002/ana.21746; Murphy TH, 2008, J NEUROSCI, V28, P1756, DOI 10.1523/JNEUROSCI.5128-07.2008; Nakamura H, 2010, BRAIN, V133, P1994, DOI 10.1093/brain/awq117; Nallet H, 1999, BRAIN RES, V842, P148, DOI 10.1016/S0006-8993(99)01859-4; Obeidat AS, 2000, J CEREBR BLOOD F MET, V20, P412, DOI 10.1097/00004647-200002000-00024; OLESEN J, 1981, ANN NEUROL, V9, P344, DOI 10.1002/ana.410090406; Oliveira-Ferreira AI, 2010, J CEREBR BLOOD F MET, V30, P1504, DOI 10.1038/jcbfm.2010.40; PEREZPINON MA, 1995, J NEUROPHYSIOL, V74, P565; Petzold GC, 2008, STROKE, V39, P1292, DOI 10.1161/STROKEAHA.107.500710; Petzold GC, 2005, STROKE, V36, P1270, DOI 10.1161/01.STR.0000166023.51307.e0; Pluta RM, 2009, NEUROL RES, V31, P151, DOI 10.1179/174313209X393564; RICHTER F, 1993, NEUROSCI LETT, V152, P65, DOI 10.1016/0304-3940(93)90484-3; Rungta RL, 2015, CELL, V161, P610, DOI 10.1016/j.cell.2015.03.029; Santos E, 2017, J CEREB BLOOD FLOW M; Santos E, 2014, NEUROIMAGE, V99, P244, DOI 10.1016/j.neuroimage.2014.05.021; Sawant-Pokam PM, 2017, CEREB CORTEX, V27, P1311, DOI 10.1093/cercor/bhv328; Scholl MJ, 2017, J CEREBR BLOOD F MET, V37, P1706, DOI 10.1177/0271678X16668988; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; SHIBATA M, 1972, J NEUROPHYSIOL, V35, P381; Shirman L. A., 1990, CONSTRUCTION SMOOTH; Steffensen AB, 2015, J NEUROSCI, V35, P12172, DOI 10.1523/JNEUROSCI.0400-15.2015; Strong AJ, 2002, STROKE, V33, P2738, DOI 10.1161/01.STR.0000043073.69602.09; Sukhotinsky I, 2011, CEPHALALGIA, V31, P1601, DOI 10.1177/0333102411425865; Takano T, 2007, NAT NEUROSCI, V10, P754, DOI 10.1038/nn1902; Theis M, 2003, J NEUROSCI, V23, P766; ULMER HJ, 1995, BRAIN RES, V691, P239, DOI 10.1016/0006-8993(95)00737-B; van den Maagdenberg AMJM, 2004, NEURON, V41, P701, DOI 10.1016/S0896-6273(04)00085-6; Van Harreveld A., 1967, Journal of Neurophysiology, V30, P911; Windmuller O, 2005, BRAIN, V128, P2042, DOI 10.1093/brain/awh545; Winkler MKL, 2017, J CEREBR BLOOD F MET, V37, P1841, DOI 10.1177/0271678X16641424; Woitzik J, 2013, NEUROLOGY, V80, P1095, DOI 10.1212/WNL.0b013e3182886932; WOODS RP, 1994, NEW ENGL J MED, V331, P1689, DOI 10.1056/NEJM199412223312505; Zandt BJ, 2013, J NEUROSCI, V33, P5915, DOI 10.1523/JNEUROSCI.5115-12.2013	110	11	11	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2017	16						524	538		10.1016/j.nicl.2017.09.005			15	Neuroimaging	Neurosciences & Neurology	FK1IU	WOS:000413235100056	28948141	DOAJ Gold, Green Published			2021-06-18	
J	Phelps, TI; Bondi, CO; Mattiola, VV; Kline, AE				Phelps, Thomas I.; Bondi, Corina O.; Mattiola, Vincent V.; Kline, Anthony E.			Relative to Typical Antipsychotic Drugs, Aripiprazole Is a Safer Alternative for Alleviating Behavioral Disturbances After Experimental Brain Trauma	NEUROREHABILITATION AND NEURAL REPAIR			English	Article						agitation; cognition; environmental enrichment; neurological rehabilitation; spatial learning; receptor; serotonin; 5-HT1A; receptor; dopamine; D-2	ENVIRONMENTAL ENRICHMENT; PREFRONTAL CORTEX; TREATMENT REGIMEN; MOTOR RECOVERY; UNITED-STATES; DOPAMINE D2; INJURY; HALOPERIDOL; AGITATION; RISPERIDONE	Background. Antipsychotic drugs (APDs) are used to manage traumatic brain injury (TBI)-induced behavioral disturbances, such as agitation and aggression. However, APDs exhibiting D-2 receptor antagonism impede cognitive recovery after experimental TBI. Hence, empirical evaluation of APDs with different mechanistic actions is warranted. Aripiprazole (ARIP) is a D-2 and 5-hydroxytryptamine(1A) (5-HT1A) receptor agonist; pharmacotherapies with these properties enhance cognition after TBI. Objective. To test the hypothesis that ARIP would increase behavioral performance and decrease histopathology after TBI. Methods. Adult male rats were subjected to either a controlled cortical impact (CCI) or sham injury and then randomly assigned to ARIP (0.1 or 1.0 mg/kg) or VEH (1.0 mL/kg, saline vehicle) groups. Treatments began 24 hours after surgery and were administered once daily for 19 days. Motor (beam-balance/beam-walk) and cognitive (Morris water maze) performance was assessed on postoperative days 1 to 5 and 14 to 19, respectively, followed by quantification of hippocampal CA(1,3) neuron survival and cortical lesion volume. Results. Beam-balance was significantly improved in the CCI + ARIP (1.0 mg/kg) group versus CCI + ARIP (0.1 mg/kg) and CCI + VEH (P < .05). Spatial learning and memory retention were significantly improved in the CCI + ARIP (0.1 mg/kg) group versus the CCI + ARIP (1.0 mg/kg) and CCI + VEH groups (P < .05). Both doses of ARIP reduced lesion size and CA(3) cell loss versus VEH (P < .05). Importantly, neither dose of ARIP impeded functional recovery as previously reported with other APDs. Conclusion. These findings support the hypothesis and endorse ARIP as a safer APD for alleviating behavioral disturbances after TBI.	[Phelps, Thomas I.; Bondi, Corina O.; Mattiola, Vincent V.; Kline, Anthony E.] Univ Pittsburgh, Pittsburgh, PA USA; [Phelps, Thomas I.] Case Western MetroHlth Med Ctr, Cleveland, OH USA	Kline, AE (corresponding author), Univ Pittsburgh, Safar Ctr Resuscitat Res, Dept Phys Med & Rehabil, 3471 Fifth Ave,Suite 201, Pittsburgh, PA 15213 USA.; Kline, AE (corresponding author), Univ Pittsburgh, Safar Ctr Resuscitat Res, Dept Crit Care Med, 3471 Fifth Ave,Suite 201, Pittsburgh, PA 15213 USA.; Kline, AE (corresponding author), Univ Pittsburgh, Safar Ctr Resuscitat Res, Dept Psychol, 3471 Fifth Ave,Suite 201, Pittsburgh, PA 15213 USA.	klineae@upmc.edu		Bondi, Corina/0000-0002-5733-4912	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS084967, NS060005, HD069620, HD069620-S1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD069620] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS060005, R01NS084967] Funding Source: NIH RePORTER	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported, in part, by National Institutes of Health grants NS084967, NS060005, HD069620, and HD069620-S1 (AEK).	Bondi CO, 2015, NEUROSCI BIOBEHAV R, V58, P123, DOI 10.1016/j.neubiorev.2014.12.004; Bondi CO, 2014, J NEUROTRAUM, V31, P873, DOI 10.1089/neu.2014.3328; BROOKE MM, 1992, ARCH PHYS MED REHAB, V73, P917; Burris KD, 2002, J PHARMACOL EXP THER, V302, P381, DOI 10.1124/jpet.102.033175; Cheng JP, 2008, BEHAV BRAIN RES, V194, P79, DOI 10.1016/j.bbr.2008.06.025; Cheng JP, 2016, BRAIN RES, V1640, P5, DOI 10.1016/j.brainres.2015.11.026; Ciurli P, 2011, J HEAD TRAUMA REHAB, V26, P116, DOI 10.1097/HTR.0b013e3181dedd0e; COHENMANSFIELD J, 1989, J GERONTOL, V44, pM77, DOI 10.1093/geronj/44.3.M77; de Witt BW, 2011, NEUROREHAB NEURAL RE, V25, P343, DOI 10.1177/1545968310390520; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Elovic EP, 2008, J HEAD TRAUMA REHAB, V23, P132, DOI 10.1097/01.HTR.0000314532.07530.e5; Faul M.D., 2010, TRAUMATIC BRAIN INJU; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; Fugate LP, 1997, ARCH PHYS MED REHAB, V78, P924, DOI 10.1016/S0003-9993(97)90051-4; Gold PE, 2003, NEUROBIOL LEARN MEM, V80, P194, DOI 10.1016/j.nlm.2003.07.003; Goldstein LB, 2002, NEUROREHAB NEURAL RE, V16, P321, DOI 10.1177/154596830201600402; GOLDSTEIN M, 1990, ANN NEUROL, V27, P327, DOI 10.1002/ana.410270315; Goozee R, 2016, SCHIZOPHR RES, V173, P174, DOI 10.1016/j.schres.2015.02.023; Halbauer JD, 2009, J REHABIL RES DEV, V46, P757, DOI 10.1682/JRRD.2008.08.0119; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; Harmsen M, 2004, BRAIN INJURY, V18, P787, DOI 10.1080/02699050410001671757; Hasselmo ME, 2006, CURR OPIN NEUROBIOL, V16, P710, DOI 10.1016/j.conb.2006.09.002; Hoffman AN, 2008, LIFE SCI, V83, P602, DOI 10.1016/j.lfs.2008.08.007; Huang GB, 2012, NEUROSCI LETT, V528, P131, DOI 10.1016/j.neulet.2012.09.024; Kline AE, 2002, J NEUROTRAUM, V19, P415, DOI 10.1089/08977150252932370; Kline AE, 2004, J NEUROTRAUM, V21, P1712, DOI 10.1089/0897715042664849; Kline AE, 2007, CRIT CARE MED, V35, P919, DOI 10.1097/01.CCM.0000256722.88854.C0; Kline AE, 2010, J NEUROTRAUM, V27, P2021, DOI 10.1089/neu.2010.1535; Kline AE, 2008, NEUROSCI LETT, V448, P263, DOI 10.1016/j.neulet.2008.10.076; Leary JB, 2017, J NEUROTRAUM, V34, P444, DOI 10.1089/neu.2016.4438; LEVIN HS, 1978, ARCH NEUROL-CHICAGO, V35, P720, DOI 10.1001/archneur.1978.00500350024005; Levy M, 2005, NEUROREHABILITATION, V20, P279; Li Z, 2004, EUR J PHARMACOL, V493, P75, DOI 10.1016/j.ejphar.2004.04.028; Lombard LA, 2005, AM J PHYS MED REHAB, V84, P797, DOI 10.1097/01.phm.0000179438.22235.08; Maat A, 2014, EUR NEUROPSYCHOPHARM, V24, P575, DOI 10.1016/j.euroneuro.2013.12.009; Matsuda Y, 2014, PSYCHIAT CLIN NEUROS, V68, P425, DOI 10.1111/pcn.12147; Matter AM, 2011, NEUROREHAB NEURAL RE, V25, P558, DOI 10.1177/1545968310397206; Monaco CM, 2014, J NEUROTRAUM, V31, P1934, DOI 10.1089/neu.2014.3541; Monaco CM, 2013, EXP NEUROL, V247, P410, DOI 10.1016/j.expneurol.2013.01.007; Mysiw WJ, 2006, BRAIN INJURY, V20, P905, DOI 10.1080/02699050600743972; Mysiw WJ, 1997, ARCH PHYS MED REHAB, V78, P213, DOI 10.1016/S0003-9993(97)90266-5; Nott MT, 2006, BRAIN INJURY, V20, P1175, DOI 10.1080/02699050601049114; Nott MT, 2010, BRAIN INJURY, V24, P1214, DOI 10.3109/02699052.2010.506858; Olsen AS, J NEUROTRAUMA; Phelps TI, 2015, J NEUROTRAUM, V32, P590, DOI 10.1089/neu.2014.3711; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; Sozda CN, 2010, J NEUROTRAUM, V27, P1047, DOI 10.1089/neu.2010.1313; Summers CR, 2009, MT SINAI J MED, V76, P105, DOI 10.1002/msj.20100; Tanahashi S, 2012, NEUROPHARMACOLOGY, V62, P765, DOI 10.1016/j.neuropharm.2011.08.031; Ukai W, 2004, J NEURAL TRANSM, V111, P667, DOI 10.1007/s00702-004-0109-z; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Wilson MS, 2003, AM J PHYS MED REHAB, V82, P871, DOI 10.1097/01.PHM.0000091982.33232.CB; Wolf AP, 1996, BRAIN INJURY, V10, P241, DOI 10.1080/026990596124412; Wood M, EXPERT OPIN INVESTIG, P2; Yeh CB, 2014, NORD J PSYCHIAT, V68, P219, DOI 10.3109/08039488.2013.799228	56	11	11	0	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1545-9683	1552-6844		NEUROREHAB NEURAL RE	Neurorehabil. Neural Repair	JAN	2017	31	1					25	33		10.1177/1545968316650281			9	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	EG2BG	WOS:000390846800002	27225976	Green Accepted, Bronze			2021-06-18	
J	Poppen, M; Lindstrom, L; Unruh, D; Khurana, A; Bullis, M				Poppen, Marcus; Lindstrom, Lauren; Unruh, Deanne; Khurana, Atika; Bullis, Michael			Preparing youth with disabilities for employment: An analysis of vocational rehabilitation case services data	JOURNAL OF VOCATIONAL REHABILITATION			English	Article						Transition; youth with disabilities; vocational rehabilitation; employment outcomes	POSTSCHOOL OUTCOMES; YOUNG-ADULTS; PREDICTORS; SCHOOL; STUDENTS	BACKGROUND: Despite national efforts to improve post-school outcomes, many students with disabilities are unprepared to enter the workforce. Coordination with Vocational Rehabilitation (VR) can offer opportunities for improved employment outcomes. OBJECTIVE: This study examined Oregon VR data to identify predictors of positive closure status for youth with disabilities. METHODS: Researchers used logistic regression to explore the effects of individual, in-school, post-school and contextual factors on VR case closure status among 4,443 young adults with disabilities who received and completed services from Oregon VR between 2003 and 2013. RESULTS: Being female, having a mental illness, traumatic brain injury, multiple disabilities, interpersonal or self-care impediments to employment, receiving SSI, and closing with VR in periods of high unemployment reduce the likelihood of a positive VR closure. Participating in a collaborative transition program, earning a high school completion certificate, receiving a greater number of VR services, closing below the median number of days to closure, and closing in low unemployment periods increase the likelihood of a positive VR case closure status. CONCLUSION: These findings highlight specific barriers to employment for vulnerable groups of young adults with disabilities, and identify service and contextual factors that can support positive employment outcomes.	[Poppen, Marcus] Washington State Univ, Dept Teaching & Learning, POB 642132, Pullman, WA 99164 USA; [Lindstrom, Lauren; Khurana, Atika] Univ Oregon, Counseling Pyschol & Human Serv, Eugene, OR 97403 USA; [Unruh, Deanne] Univ Oregon, Special Educ & Clin Sci, Eugene, OR 97403 USA; [Bullis, Michael] Univ Oregon, Educ Methodol Policy & Leadership, Eugene, OR 97403 USA	Poppen, M (corresponding author), Washington State Univ, Dept Teaching & Learning, POB 642132, Pullman, WA 99164 USA.	marcus.poppen@wsu.edu					Allison P, 2002, SAGE U PAPERS SERIES; Alverson C., 2014, OREGON YOUTH TRANSIT; [Anonymous], 2013, OREGON ANN PERFORMAN; Benz MR, 2000, EXCEPT CHILDREN, V66, P509, DOI 10.1177/001440290006600405; BENZ MR, 1999, J VOCATIONAL REHABIL, V13, P55; Boeltzig H, 2008, INT J REHABIL RES, V31, P217, DOI 10.1097/MRR.0b013e3282fb7ce5; Butterworth John, 2014, TRENDS EMPLOYMENT OU; Carter EW, 2012, J DISABIL POLICY STU, V23, P50, DOI 10.1177/1044207311414680; Chan JY, 2014, REHABIL COUNS BULL, V57, P209, DOI 10.1177/0034355213509855; Cimera RE, 2009, J VOCAT REHABIL, V30, P1, DOI 10.3233/JVR-2009-0448; Doren B, 2013, J ADOLESCENCE, V36, P1083, DOI 10.1016/j.adolescence.2013.08.014; Doren B, 2012, EXCEPT CHILDREN, V79, P7; Flannery KB, 2011, REHABIL COUNS BULL, V54, P106, DOI 10.1177/0034355210368432; Giesen JM, 2012, J VISUAL IMPAIR BLIN, V106, P475, DOI 10.1177/0145482X1210600804; Gilmore D., 2001, VOCATIONAL REHABILIT; Gonzalez R, 2011, J VOCAT REHABIL, V34, P163, DOI 10.3233/JVR-2011-0544; Honeycutt T., 2013, MATH POLICY RES; Honeycutt T, 2015, J VOCAT REHABIL, V43, P229, DOI 10.3233/JVR-150772; Hosmer DW., 2013, APPL LOGISTIC REGRES, V3rd ed.; Jun S, 2015, J REHABIL, V81, P47; Kortering L, 2012, HANDBOOK OF ADOLESCENT TRANSITION EDUCATION FOR YOUTH WITH DISABILITIES, P208; Madaus JW, 2013, CAREER DEV TRANSIT E, V36, P4, DOI 10.1177/2165143413485225; Mazzotti VL, 2016, CAREER DEV TRANSIT E, V39, P196, DOI 10.1177/2165143415588047; MCDANIEL M, 2013, REV BLACK POLITICAL, V40, P371, DOI DOI 10.1007/S12114-012-9147-1; McDonnall M. C., 2009, J VISUAL IMPAIRMENT, V103, P329; McDonough JT, 2010, J VOCAT REHABIL, V32, P89, DOI 10.3233/JVR-2010-0498; Metzel DS, 2007, INTELLECT DEV DISAB, V45, P149, DOI 10.1352/1934-9556(2007)45[149:ACMTCR]2.0.CO;2; Migliore A, 2012, REHABIL COUNS BULL, V55, P176, DOI 10.1177/0034355212438943; Newman L., 2011, 20113005 NLTS2 NCSER; Newman L, 2009, POSTHIGH SCH OUTCOME; Poppen M, 2014, THESIS; Rabren K., 2003, J VOCATIONAL REHABIL, V18, P145; Repetto J. B., 2002, CAREER DEV EXCEPTION, V25, P123, DOI [10.1177/088572880202500203, DOI 10.1177/088572880202500203]; Roux M., 2013, J AM ACAD CHILD ADOL, V52, P897; Samuels C., 2015, ED WEEK DIPLOMAS COU, V34, P2; Sanford C., 2011, POSTHIGH SCH OUTCOME; Schaller J., 2006, J APPL REHABILITATIO, V37, P3; Sima AP, 2015, CAREER DEV TRANSIT E, V38, P89, DOI 10.1177/2165143414534887; Sung C, 2015, J AUTISM DEV DISORD, V45, P3204, DOI 10.1007/s10803-015-2480-z; Test DW, 2009, CAREER DEV TRANSIT E, V32, P160, DOI 10.1177/0885728809346960; U.S. Bureau of Labor Statistics, 2012, BLS SPOTL STAT REC 2; U.S. Bureau of Labor Statistics, DAT RETR CURR POP SU; U.S. Census Bureau, 2014, URB RUR CLASS; U.S. Department of Labor, 2013, PERS DIS LAB FORC CH; U.S. Social Security Administration, 2014, DIS BEN; Wagner MM, 2014, CAREER DEV TRANSIT E, V37, P5, DOI 10.1177/2165143414523980	46	11	11	1	11	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1052-2263	1878-6316		J VOCAT REHABIL	J. Vocat. Rehabil.		2017	46	2					209	224		10.3233/JVR-160857			16	Rehabilitation	Rehabilitation	EM4SP	WOS:000395303400010					2021-06-18	
J	Reches, A; Kutcher, J; Elbin, RJ; Or-Ly, H; Sadeh, B; Greer, J; McAllister, DJ; Geva, A; Kontos, AP				Reches, A.; Kutcher, J.; Elbin, R. J.; Or-Ly, H.; Sadeh, B.; Greer, J.; McAllister, D. J.; Geva, A.; Kontos, A. P.			Preliminary investigation of Brain Network Activation (BNA) and its clinical utility in sport-related concussion	BRAIN INJURY			English	Article						Concussion management; sports-related concussion (SRC); mild traumatic brain injury (mTBI); event related potential (ERP); functional brain imaging; Brain Network Activation (BNA); electroencephalogram (EEG)	STATES HIGH-SCHOOL; INJURY; EPIDEMIOLOGY; CONNECTIVITY; ATTENTION; RECOVERY; ERPS	Background: The clinical diagnosis and management of patients with sport-related concussion is largely dependent on subjectively reported symptoms, clinical examinations, cognitive, balance, vestibular and oculomotor testing. Consequently, there is an unmet need for objective assessment tools that can identify the injury from a physiological perspective and add an important layer of information to the clinician's decision-making process.Objective: The goal of the study was to evaluate the clinical utility of the EEG-based tool named Brain Network Activation (BNA) as a longitudinal assessment method of brain function in the management of young athletes with concussion.Methods: Athletes with concussion (n = 86) and age-matched controls (n = 81) were evaluated at four time points with symptom questionnaires and BNA. BNA scores were calculated by comparing functional networks to a previously defined normative reference brain network model to the same cognitive task.Results: Subjects above 16 years of age exhibited a significant decrease in BNA scores immediately following injury, as well as notable changes in functional network activity, relative to the controls. Three representative case studies of the tested population are discussed in detail, to demonstrate the clinical utility of BNA.Conclusion: The data support the utility of BNA to augment clinical examinations, symptoms and additional tests by providing an effective method for evaluating objective electrophysiological changes associated with sport-related concussions.	[Reches, A.; Or-Ly, H.; Sadeh, B.; Geva, A.] ElMindA Ltd, 16 Haminhara St, Herzliyya, Israel; [Kutcher, J.; Greer, J.] Univ Michigan, Sports Neurol Clin, Ann Arbor, MI 48109 USA; [Elbin, R. J.] Univ Arkansas, Dept Hlth Human Performance & Recreat, Fayetteville, AR 72701 USA; [McAllister, D. J.; Kontos, A. P.] Univ Pittsburgh, Dept Orthopaed Surg, UPMC Sports Med Concuss Program, Pittsburgh, PA USA	Reches, A (corresponding author), ElMindA Ltd, 16 Haminhara St, Herzliyya, Israel.	amit@elminda.com		Geva, Amir/0000-0003-3159-3673; Kontos, Anthony/0000-0002-3749-4310	National Institute on Deafness and Other Communication DisordersUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [1K01DC012332-01A1]; ElMindA Ltd; University of MichiganUniversity of Michigan System; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [K01DC012332] Funding Source: NIH RePORTER	This research was supported in part by grants to the University of Pittsburgh from the National Institute on Deafness and Other Communication Disorders (1K01DC012332-01A1) and through a research contract between ElMindA Ltd on the one hand and both the University of Pittsburgh and the University of Michigan on the other. A. Reches, H. Ol-Ly, B. Sadeh and A. Geva are employees of ElmindA Ltd.	Rojas-Benjumea MA, 2015, BEHAV BRAIN FUNCT, V11, DOI 10.1186/s12993-015-0067-7; Bonala BK, 2012, J INTEGR NEUROSCI, V11, P277, DOI 10.1142/S0219635212500215; Broglio SP, 2011, INT J PSYCHOPHYSIOL, V82, P16, DOI 10.1016/j.ijpsycho.2011.02.010; Cao C, 2010, IEEE T NEUR SYS REH, V18, P11, DOI 10.1109/TNSRE.2009.2027704; Castellanos NP, 2010, BRAIN, V133, P2365, DOI 10.1093/brain/awq174; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Daniel JC, 1999, NEUROPSY NEUROPSY BE, V12, P167; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Gaetz M, 2000, BRAIN INJURY, V14, P815; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gosselin N, 2006, NEUROSURGERY, V58, P1151, DOI 10.1227/01.NEU.0000215953.44097.FA; HILLYARD SA, 1994, COGNITIVE ELECTROPHY, P1, DOI DOI 10.1007/978-1-4612-0283-7_1; Hogan AM, 2005, DEVELOPMENTAL SCI, V8, P525, DOI 10.1111/j.1467-7687.2005.00444.x; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Kiefer AW, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00243; Kontos AP, 2016, BRAIN IMAGING BEHAV, V10, P594, DOI 10.1007/s11682-015-9412-6; Kumar S, 2009, J NEUROTRAUM, V26, P665, DOI [10.1089/neu.2008.0644, 10.1089/neu.2008-0644]; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lavoie ME, 2004, J CLIN EXP NEUROPSYC, V26, P55, DOI 10.1076/jcen.26.1.55.23936; Lee TW, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-121; Lovell MR, 2000, NEUROLOGICAL ATHLETI; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; Moore RD, 2014, J ATHL TRAINING, V49, P36, DOI 10.4085/1062-6050-49.1.02; Moser RS, 2002, ARCH CLIN NEUROPSYCH, V17, P91, DOI 10.1016/S0887-6177(01)00108-1; Mueller V, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-18; Polich J., 1999, ELECTROENCEPHALOGRAP, P1073; Prichep LS, 2013, J HEAD TRAUMA REHAB, V28, P266, DOI 10.1097/HTR.0b013e318247b54e; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Rapp PE, 2012, J TRAUMA ACUTE CARE, V73, pS13, DOI 10.1097/TA.0b013e318260604b; Reches A, 2014, NEUROIMAGE, V88, P228, DOI 10.1016/j.neuroimage.2013.11.020; Reches A., 2013, FUNCT NEUROL REHABIL, V3, P295; Reches A, 2015, EUROPEAN J PAIN, V11, P22; Reches A, 2014, J MOL NEUROSCI, V54, P59, DOI 10.1007/s12031-014-0250-6; Shahaf G, 2012, CLIN NEUROPHYSIOL, V123, P1568, DOI 10.1016/j.clinph.2011.12.010; Slobounov SM, 2011, NEUROIMAGE, V55, P1716, DOI 10.1016/j.neuroimage.2011.01.024; Slobounov S, 2012, BRAIN IMAGING BEHAV, V6, P224, DOI 10.1007/s11682-012-9167-2; Wang HM, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00064	40	11	11	1	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	2					237	246		10.1080/02699052.2016.1231343			10	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	EM2RO	WOS:000395163500012	28055228	Other Gold, Green Published			2021-06-18	
J	Rose, SC; Schaffer, CE; Young, JA; McNally, KA; Fischer, AN; Heyer, GL				Rose, Sean C.; Schaffer, Caroline E.; Young, Julie A.; McNally, Kelly A.; Fischer, Anastasia N.; Heyer, Geoffrey L.			Utilization of conventional neuroimaging following youth concussion	BRAIN INJURY			English	Article						Mild traumatic brain injury; post-concussion syndrome; CT; MRI; paediatric	TRAUMATIC BRAIN-INJURY; MANAGEMENT; SPORT; STATEMENT; SYMPTOMS; MRI; DIAGNOSIS; CHILDREN	Background/objective: Conventional neuroimaging is not recommended for the routine diagnosis of concussion, but some patients with concussion undergo computed tomography (CT) or magnetic resonance imaging (MRI). The objective of this study was to explore the clinical factors that predict neuroimaging utilization in concussion.Methods: Concussion-related CT and MRI data were analysed from 1953 patients, aged 10-19 years, who presented to a sports concussion clinic within 30 days of injury.Results: The majority of CT scans (n = 193) were obtained during the acute concussion period (mean = 2.7 days post-concussion), whereas MRI scans (n = 134) were ordered later during recovery (mean = 39.4 days post-concussion). Predictors of CT utilization included loss of consciousness, amnesia and vomiting (all p < 0.001). Prior concussion (p = 0.002) and continued participation in activity after injury (p = 0.03) predicted greater MRI utilization. Neuroimaging with either CT (p = 0.024, hazard ratio = 1.2) or MRI (p < 0.001, hazard ratio = 2.75) was associated with prolonged symptoms. Only 3.1% of CTs and 1.5% of MRIs demonstrated signs of traumatic brain injury.Conclusion: Several clinical factors predict neuroimaging utilization in patients with concussion. CT is generally used acutely, while MRI is used in the sub-acute and chronic post-concussion periods. In a sports concussion clinic, delayed neuroimaging has limited clinical yield.	[Rose, Sean C.; Heyer, Geoffrey L.] Nationwide Childrens Hosp, Div Pediat Neurol, 700 Childrens Dr,ED 5, Columbus, OH 43205 USA; [Rose, Sean C.; Heyer, Geoffrey L.] Ohio State Univ, Dept Neurol, 700 Childrens Dr,ED 5, Columbus, OH 43210 USA; [Schaffer, Caroline E.] Clemson Univ, Dept Hlth Sci, Clemson, SC USA; [Young, Julie A.; Fischer, Anastasia N.] Nationwide Childrens Hosp, Div Sports Med, Columbus, OH USA; [McNally, Kelly A.] Nationwide Childrens Hosp, Div Pediat Psychol & Neuropsychol, Columbus, OH USA; [McNally, Kelly A.] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA	Heyer, GL (corresponding author), Nationwide Childrens Hosp, Div Pediat Neurol, 700 Childrens Dr,ED 5, Columbus, OH 43205 USA.; Heyer, GL (corresponding author), Ohio State Univ, Dept Neurol, 700 Childrens Dr,ED 5, Columbus, OH 43210 USA.	geoffrey.heyer@nationwidechildrens.org		Heyer, Geoffrey/0000-0001-9334-3739; Rose, Sean/0000-0001-5177-7715; McNally, Kelly/0000-0001-9278-9413			Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Beauchamp MH, 2011, J NEUROTRAUM, V28, P915, DOI 10.1089/neu.2010.1712; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Chastain CA, 2009, J NEUROTRAUM, V26, P1183, DOI 10.1089/neu.2008.0650; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Gur RE, 2013, AM J NEURORADIOL, V34, P2021, DOI 10.3174/ajnr.A3525; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Heyer GL, 2016, CEPHALALGIA, V36, P309, DOI 10.1177/0333102415590240; Huang YL, 2015, NEUROLOGY, V84, P580, DOI 10.1212/WNL.0000000000001237; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Manolakaki D, 2009, J TRAUMA, V66, P1008, DOI 10.1097/TA.0b013e31819adba2; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Melnick ER, 2012, JT COMM J QUAL PATIE, V38, P483, DOI 10.1016/S1553-7250(12)38064-1; Perez FA, 2012, NEUROIMAG CLIN N AM, V22, P467, DOI 10.1016/j.nic.2012.05.002; Rose SC, 2016, SPORTS HEALTH, V8, P37, DOI 10.1177/1941738115591948; Sullivan KA, 2014, J HEAD TRAUMA REHAB, V29, P54, DOI 10.1097/HTR.0b013e31828c708a; Tavender EJ, 2011, ACAD EMERG MED, V18, P880, DOI 10.1111/j.1553-2712.2011.01134.x; Toth A, 2013, J NEUROTRAUM, V30, P2, DOI 10.1089/neu.2012.2486; Weber M, 2010, BRAIN INJURY, V24, P1364, DOI 10.3109/02699052.2010.507110; Wilkins SA, 2014, J NEUROSURG-PEDIATR, V13, P82, DOI 10.3171/2013.10.PEDS13241; Wintermark Max, 2015, J Am Coll Radiol, V12, pe1, DOI 10.1016/j.jacr.2014.10.014; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783	26	11	12	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	2					260	266		10.1080/02699052.2016.1235285			7	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	EM2RO	WOS:000395163500014	28095029				2021-06-18	
J	Snow, PC; Woodward, MN				Snow, Pamela C.; Woodward, Mary N.			Intervening to address communication difficulties in incarcerated youth: A Phase 1 clinical trial	INTERNATIONAL JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article						Youth justice; language; intervention	ORAL LANGUAGE COMPETENCE; TRAUMATIC BRAIN-INJURY; JUVENILE-OFFENDERS; YOUNG OFFENDERS; CHILD MALTREATMENT; SPEECH; QUESTIONNAIRE; BEHAVIORS; PATHOLOGY; ABILITY	Purpose: Although a number of studies have described high rates of wide-ranging language difficulties in youth offender samples, minimal intervention research has been conducted with this population. The aim of this study was to implement a small-scale speech-language pathology (SLP) intervention study in a secure youth justice facility and to identify key practical challenges associated with conducting SLP interventions in youth custodial settings. Method: Six young males were recruited and underwent assessment via a range of standardised and self-report communication measures. Measures of nonverbal IQ and of therapeutic engagement were also employed, and participants' own goals concerning communication competence were incorporated into treatment. Participants completed seven to 16 weeks' of 1:1 SLP intervention, once or twice per week. Result: Therapeutic engagement was generally strong. All participants made gains and responded favourably regarding the usefulness of the intervention. Many practical issues conspired to make this a challenging SLP intervention setting. Conclusion: Youth custodial sentences represent an important opportunity for high-risk youths with compromised communication skills to receive specialist SLP therapeutic services to reduce the impact of their communication difficulties post-release into the community.	[Snow, Pamela C.] La Trobe Univ, Coll Sci Hlth & Engn, La Trobe Rural Hlth Sch, POB 199, Bendigo, Vic 3552, Australia; [Woodward, Mary N.] Speak Your Mind Serv, Sydney, NSW, Australia	Snow, PC (corresponding author), La Trobe Univ, Coll Sci Hlth & Engn, La Trobe Rural Hlth Sch, POB 199, Bendigo, Vic 3552, Australia.	p.snow@latrobe.edu.au		Snow, Pamela/0000-0002-2426-8349	New South Wales Department of the Attorney General (Juvenile Justice)	We are grateful to the New South Wales Department of the Attorney General (Juvenile Justice) for funding this project and to NSW JJ staff for assisting with its implementation.	Australian Bureau of Statistics, 2012, CULT DIV AUSTR; Australian Institute of Health and Welfare, 2014, JUV JUST SER, V16; Bell N, 1986, VISUALIZING VERBALIZ; Blanton DJ, 2007, LANG SPEECH HEAR SER, V38, P309, DOI 10.1044/0161-1461(2007/033); Bryan K, 2004, INT J LANG COMM DIS, V39, P391, DOI 10.1080/13682820410001666376; Bryan K, 2007, INT J LANG COMM DIS, V42, P505, DOI 10.1080/13682820601053977; Bryan K, 2013, CHILD LANG TEACH THE, V29, P359, DOI 10.1177/0265659013482930; Caire L., 2013, SPEECH PATHOLOGY YOU; Cohen N. J., 2001, LANGUAGE IMPAIRMENT; Douglas JM, 2007, APHASIOLOGY, V21, P1181, DOI 10.1080/02687030600980950; Douglas JM, 2007, J HEAD TRAUMA REHAB, V22, P31, DOI 10.1097/00001199-200701000-00004; Douglas JM, 2000, APHASIOLOGY, V14, P251, DOI 10.1080/026870300401469; Enderby P., 1983, FRENCHAY DYSARTHIA A; Gray C., 1994, COMIC STRIP CONVERSA; Gregory J, 2011, INT J LANG COMM DIS, V46, P202, DOI 10.3109/13682822.2010.490573; Grice P, 1975, SYNTAX SEMANTICS, VIII, P41; Hall M, 2001, J MENTAL HLTH, V10, P457, DOI DOI 10.1080/09638230120041227; Jeffries J. H., 2001, AUDITORY PROCESSING; Joffe V., 2012, VOCABULARY ENRICHMEN; Kaufman A. S., 2004, KAUFMAN BRIEF INTELL; Kelly A., 2009, TALKABOUT TEENAGERS; LaVigne M, 2013, CUNY LAW REV U WISCO; Law J, 2004, J SPEECH LANG HEAR R, V47, P924, DOI 10.1044/1092-4388(2004/069); National Health and Medical Research Council (NHMRC), 2009, NHMRC LEV EV GRAD RE; Royal College of Speech Language Therapists, YOUNG OFF CRIM JUST; Ryan EP, 2004, PSYCHIAT SERV, V55, P1397, DOI 10.1176/appi.ps.55.12.1397; Sanger D, 2003, J COMMUN DISORD, V36, P465, DOI 10.1016/S0021-9924(03)00034-0; Sanger D., 2001, COMMUN DISORD Q, V23, P17, DOI [10.1177/152574010102300104, DOI 10.1177/152574010102300104, 10.1177/152574010102300104.]; Sanger DD, 2000, J COMMUN DISORD, V33, P31, DOI 10.1016/S0021-9924(99)00024-6; Secord, 1989, TEST LANGUAGE COMPET; Semel E., 2003, CLIN EVALUATION LANG; Sloan S., 2006, COMMUNICATE CONFIDEN; SNOW P. C., 2011, TRENDS ISSUES CRIME, V435, P1; Snow PC, 2008, CHILD SOC, V22, P16, DOI 10.1111/j.1099-0860.2006.00076.x; Snow PC, 2016, INT J SPEECH-LANG PA, V18, P216, DOI 10.3109/17549507.2015.1112837; Snow PC, 2016, INT J SPEECH-LANG PA, V18, P20, DOI 10.3109/17549507.2015.1081291; Snow PC, 2015, INT J LANG COMM DIS, V50, P1, DOI 10.1111/1460-6984.12117; Snow PC, 2011, INT J SPEECH-LANG PA, V13, P480, DOI 10.3109/17549507.2011.578661; Snow PC, 2009, INT J SPEECH-LANG PA, V11, P95, DOI 10.1080/17549500802415712; Snow PC, 2005, PSYCHOL CRIME LAW, V11, P239, DOI 10.1080/1068316042000209323; Speechmark, 2002, SKILLS DIAL LIV SOC; Stewart A, 2008, CHILD ABUSE NEGLECT, V32, P51, DOI 10.1016/j.chiabu.2007.04.011; Tomlin K., 1994, SOURCE APRAXIA THERA	43	11	11	2	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1754-9507	1754-9515		INT J SPEECH-LANG PA	Int. J. Speech-Lang. Pathol.		2017	19	4					392	406		10.1080/17549507.2016.1216600			15	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	FB6FF	WOS:000406236100005	27712123				2021-06-18	
J	Tu, TW; Lescher, JD; Williams, RA; Jikaria, N; Turtzo, LC; Frank, JA				Tu, Tsang-Wei; Lescher, Jacob D.; Williams, Rashida A.; Jikaria, Neekita; Turtzo, L. Christine; Frank, Joseph A.			Abnormal Injury Response in Spontaneous Mild Ventriculomegaly Wistar Rat Brains: A Pathological Correlation Study of Diffusion Tensor and Magnetization Transfer Imaging in Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						animal studies; DTI; model of injury; rats; TBI	NEONATAL HYDROCEPHALUS; CORPUS-CALLOSUM; REACTIVE ASTROCYTOSIS; INFLAMMATION; EDEMA; MODEL; PATHOPHYSIOLOGY; AQUAPORIN-4; DYSGENESIS; AGENESIS	Spontaneous mild ventriculomegaly (MVM) was previously reported in similar to 43% of Wistar rats in association with vascular anomalies without phenotypic manifestation. This mild traumatic brain injury (TBI) weight drop model study investigates whether MVM rats (n = 15) have different injury responses that could inadvertently complicate the interpretation of imaging studies compared with normal rats (n = 15). Quantitative MRI, including diffusion tensor imaging (DTI) and magnetization transfer imaging (MTI), and immunohistochemistry (IHC) analysis were used to examine the injury pattern up to 8 days post-injury in MVM and normal rats. Prior to injury, the MVM brain showed significant higher mean diffusivity, axial diffusivity, and radial diffusivity, and lower fractional anisotropy (FA) and magnetization transfer ratio (MTR) in the corpus callosum than normal brain (p < 0.05). Following TBI, normal brains exhibited significant decreases of FA in the corpus callosum, whereas MVM brains demonstrated insignificant changes in FA, suggesting less axonal injury. At day 8 after mild TBI, MTR of the normal brains significantly decreased whereas the MTR of the MVM brains significantly increased. IHC staining substantiated the MRI findings, demonstrating limited axonal injury with significant increase of microgliosis and astrogliosis in MVM brain compared with normal animals. The radiological-pathological correlation data showed that both DTI and MTI were sensitive in detecting mild diffuse brain injury, although DTI metrics were more specific in correlating with histologically identified pathologies. Compared with the higher correlation levels reflecting axonal injury pathology in the normal rat mild TBI, the DTI and MTR metrics were more affected by the increased inflammation in the MVM rat mild TBI. Because MVM Wistar rats appear normal, there was a need to screen rats prior to TBI research to rule out the presence of ventriculomegaly, which may complicate the interpretation of imaging and IHC observations.	[Tu, Tsang-Wei; Lescher, Jacob D.; Williams, Rashida A.; Jikaria, Neekita; Frank, Joseph A.] NIH, Ctr Clin, Frank Lab Radiol & Imaging Sci, Bethesda, MD 20892 USA; [Turtzo, L. Christine] NIH, Acute Studies Core, Natl Inst Neurol Disorders & Stroke, Bldg 10, Bethesda, MD 20892 USA; [Frank, Joseph A.] NIH, Natl Inst Biomed Imaging & Bioengn, Bldg 10, Bethesda, MD 20892 USA	Tu, TW (corresponding author), NIH, Radiol & Imaging Sci, Ctr Clin, USA Bldg 10,RM B1N256,10 Ctr Dr,MSC 1074, Bethesda, MD 20892 USA.	tut@cc.nih.gov	frank, joseph/AAJ-6680-2020; Frank, Joseph/W-2021-2019		Department of Defense through the Center for Neuroscience and Regenerative Medicine (Henry M. Jackson Foundation) [300604-8.01-60855, 305500-8.01-60855]; Intramural Research Programs of the Clinical Center at the National Institutes of Health; National Institute of Biomedical Imaging and Bioengineering at the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB); CLINICAL CENTER [ZIACL090020] Funding Source: NIH RePORTER	This work was supported by funding from the Department of Defense through the Center for Neuroscience and Regenerative Medicine (Henry M. Jackson Foundation Awards #300604-8.01-60855 and #305500-8.01-60855) and from the Intramural Research Programs of the Clinical Center and of the National Institute of Biomedical Imaging and Bioengineering at the National Institutes of Health.	Boulet T, 2013, J NEUROTRAUM, V30, P1512, DOI 10.1089/neu.2012.2788; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Couzin-Frankel J, 2013, SCIENCE, V342, P922, DOI 10.1126/science.342.6161.922; Del Bigio MR, 2001, NEUROSURG CLIN N AM, V12, P639, DOI 10.1016/S1042-3680(18)30022-6; Deren KE, 2010, EXP NEUROL, V226, P110, DOI 10.1016/j.expneurol.2010.08.010; Eskandari R, 2011, CHILD NERV SYST, V27, P2067, DOI 10.1007/s00381-011-1552-4; Gadani SP, 2015, NEURON, V87, P47, DOI 10.1016/j.neuron.2015.05.019; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Irfanoglu MO, 2008, LECT NOTES COMPUT SC, V5242, P1014, DOI 10.1007/978-3-540-85990-1_122; Jain-Ghai S, 2014, PEDIATRICS, V133, pE1092, DOI 10.1542/peds.2013-1230; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kacew S, 1996, J TOXICOL ENV HEALTH, V47, P1; Khan OH, 2006, EXP NEUROL, V200, P311, DOI 10.1016/j.expneurol.2006.02.113; Kuroiwa T, 2006, ACTA NEUROCHIR SUPPL, V96, P254; Laitinen T, 2015, FRONT NEUROSCI-SWITZ, V9, DOI [10.3389/fnins.7015.00128, 10.3389/fnins.2015.00128]; Li J, 2011, EUR J NEUROSCI, V33, P933, DOI 10.1111/j.1460-9568.2010.07573.x; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; McAllister JP, 2012, SEMIN FETAL NEONAT M, V17, P285, DOI 10.1016/j.siny.2012.06.004; Miller Janet M, 2007, Cerebrospinal Fluid Res, V4, P5, DOI 10.1186/1743-8454-4-5; Noguchi R, 2014, ARCH GYNECOL OBSTET, V290, P237, DOI 10.1007/s00404-014-3196-6; Oh KY, 2012, J ULTRAS MED, V31, P1811, DOI 10.7863/jum.2012.31.11.1811; Papadopoulos MC, 2004, FASEB J, V18, P1291, DOI 10.1096/fj.04-1723fje; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Saadoun S, 2005, J CELL SCI, V118, P5691, DOI 10.1242/jcs.02680; Schell-Apacik CC, 2008, AM J MED GENET A, V146A, P2501, DOI 10.1002/ajmg.a.32476; Selinummi J, 2005, BIOTECHNIQUES, V39, P859, DOI 10.2144/000112018; Smith SM, 2007, NAT PROTOC, V2, P499, DOI 10.1038/nprot.2007.45; Streitberger KJ, 2011, NMR BIOMED, V24, P385, DOI 10.1002/nbm.1602; Tourdias T, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-143; Tourdias T, 2009, NEUROIMAGE, V47, P659, DOI 10.1016/j.neuroimage.2009.04.070; Tu T., 2013, J NEUROSCI NEUROENG, V2, P415; Tu TW, 2014, J NEUROPATH EXP NEUR, V73, P1152, DOI 10.1097/NEN.0000000000000140; Turtzo LC, 2013, NMR BIOMED, V26, P468, DOI 10.1002/nbm.2886; Vavasour IM, 2011, J MAGN RESON IMAGING, V33, P713, DOI 10.1002/jmri.22441; Veeramuthu V, 2015, J NEUROTRAUM, V32, P1497, DOI 10.1089/neu.2014.3750; Wang Y, 2011, BRAIN, V134, P3587, DOI 10.1093/brain/awr307; YOSHIDA Y, 1990, Neurologia Medico-Chirurgica, V30, P445, DOI 10.2176/nmc.30.445	37	11	11	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2017	34	1					248	256		10.1089/neu.2015.4355			9	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	EF6DE	WOS:000390420100026	26905805	Green Published			2021-06-18	
J	Yue, JK; Winkler, EA; Sharma, S; Vassar, MJ; Ratcliff, JJ; Korley, FK; Seabury, SA; Ferguson, AR; Lingsma, HF; Deng, HS; Meeuws, S; Adeoye, OM; Rick, JW; Robinson, CK; Duarte, SM; Yuh, EL; Mukherjee, P; Dikmen, SS; McAllister, TW; Diaz-Arrastia, R; Valadka, AB; Gordon, WA; Okonkwo, DO; Manley, GT				Yue, John K.; Winkler, Ethan A.; Sharma, Sourabh; Vassar, Mary J.; Ratcliff, Jonathan J.; Korley, Frederick K.; Seabury, Seth A.; Ferguson, Adam R.; Lingsma, Hester F.; Deng, Hansen; Meeuws, Sacha; Adeoye, Opeolu M.; Rick, Jonathan W.; Robinson, Caitlin K.; Duarte, Siena M.; Yuh, Esther L.; Mukherjee, Pratik; Dikmen, Sureyya S.; McAllister, Thomas W.; Diaz-Arrastia, Ramon; Valadka, Alex B.; Gordon, Wayne A.; Okonkwo, David O.; Manley, Geoffrey T.		TRACK-TBI Investigators	Temporal profile of care following mild traumatic brain injury: predictors of hospital admission, follow-up referral and six-month outcome	BRAIN INJURY			English	Article						Clinical evaluation; follow-up care; outcome assessment; rehabilitation; traumatic brain injury	COMMON DATA ELEMENTS; GLASGOW COMA SCALE; COMPLICATED MILD; DECISION-MAKING; 1ST YEAR; TRANSFORMING RESEARCH; CLINICAL KNOWLEDGE; UNCOMPLICATED MILD; SEVERITY SCORE; UNITED-STATES	Objective: To Investigate the clinical management and medical follow-up of patients with mild traumatic brain injury (mTBI) presenting to emergency departments (EDs). Methods: Overall, 168 aduit patients with mTBI from the prospective, multicentre Transforming Research and Clinical Knowledge in TBI (TRACK-TBI) Pilot study with Glasgow Coma Scale (GCS) 13-15, no polytrauma and alive at six months were included. Predictors for hospital admission, three-month follow-up referral and six-month functional disability (Glasgow Outcome Scale-Extended (GOSE) <= 6) were analysed using multivariable regression. Results: Overall, 48% were admitted to hospital, 22% received three-month referral and 27% reported six-month functional disability. Intracranial pathology on ED head computed tomography (multivariable odds ratio (OR) = 81.08,95% confidence interval (Cl) [10.28-639.36]) and amnesia (>30-minutes: OR = 5.27 [1.75-15.87]; unknown duration: OR = 4.43 [1.26-15.62]) predicted hospital admission. Older age (per-year OR = 1.03 [1.01-1.05]) predicted three-month referral, while part-time/unemployment predicted lack of referral (OR = 0.17 [0.06-0.50]). GCS < 15 (OR = 2.46 [1.05-5.78]) and prior history of seizures (OR = 3.62 [1.21-10.89]) predicted six-month functional disability, while increased education (per-year OR = 0.86 [0.76-0.97]) was protective. Conclusions: Clinical factors modulate triage to admission, while demographic/socioeconomic elements modulate follow-up care acquisition; six-month functional disability associates with both clinical and demographic/socioeconomic variables. Improving triage to acute and outpatient care requires further investigation to optimize resource allocation and outcome after mTBI.	[Yue, John K.; Winkler, Ethan A.; Sharma, Sourabh; Vassar, Mary J.; Ferguson, Adam R.; Deng, Hansen; Rick, Jonathan W.; Robinson, Caitlin K.; Duarte, Siena M.; Manley, Geoffrey T.] Univ Calif San Francisco, Dept Neurol Surg, 1001 Potrero Ave,Bldg 1,Room 101, San Francisco, CA 94110 USA; [Yue, John K.; Winkler, Ethan A.; Sharma, Sourabh; Vassar, Mary J.; Ferguson, Adam R.; Deng, Hansen; Rick, Jonathan W.; Robinson, Caitlin K.; Duarte, Siena M.; Yuh, Esther L.; Mukherjee, Pratik; Manley, Geoffrey T.] San Francisco Gen Hosp, Brain & Spinal Injury Ctr, San Francisco, CA 94110 USA; [Ratcliff, Jonathan J.] Emory Univ, Dept Emergency Med, Atlanta, GA 30322 USA; [Ratcliff, Jonathan J.] Emory Univ, Dept Neurol, Atlanta, GA 30322 USA; [Korley, Frederick K.] Univ Michigan, Dept Emergency Med, Ann Arbor, MI 48109 USA; [Seabury, Seth A.] Univ Southern Calif, Leonard D Schaeffer Ctr Hlth Policy & Econ, Los Angeles, CA USA; [Lingsma, Hester F.] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Meeuws, Sacha] Univ Hosp Antwerp, Dept Neurol Surg, Edegem, Belgium; [Adeoye, Opeolu M.] Univ Cincinnati, Dept Emergency Med, Cincinnati, OH USA; [Yuh, Esther L.; Mukherjee, Pratik] Univ Calif San Francisco, Dept Radiol, San Francisco, CA 94110 USA; [Dikmen, Sureyya S.] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [McAllister, Thomas W.] Indiana Univ, Dept Psychiat, Indianapolis, IN 46204 USA; [Diaz-Arrastia, Ramon] Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD 20814 USA; [Diaz-Arrastia, Ramon] Ctr Neurosci & Regenerat Med, Bethesda, MD USA; [Valadka, Alex B.] Seton Brain & Spine Inst, Austin, TX USA; [Gordon, Wayne A.] Icahn Sch Med Mt Sinai, Dept Rehabil Med, New York, NY 10029 USA; [Okonkwo, David O.] Univ Pittsburgh, Dept Neurol Surg, Med Ctr, Pittsburgh, PA 15260 USA	Manley, GT (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, 1001 Potrero Ave,Bldg 1,Room 101, San Francisco, CA 94110 USA.	manleyg@neurosurg.ucsf.edu	Yue, John K/P-1348-2015	Yue, John K/0000-0001-9694-7722; Ferguson, Adam/0000-0001-7102-1608	 [NINDS 1RC2NS069409-01];  [3RC2NS069409-02S1];  [5RC2NS069409-02];  [1U01NS086090-01];  [3U0 IN S086090-02S1];  [3U01NS086090-02S2];  [3U01NS086090-03S1];  [5U0INS086090-02];  [5U01NS086090-03];  [US DOD W81XWH-13-1-0441];  [US DOD W81XWH-14-2-0176]	This work was supported by the following grants: NINDS 1RC2NS069409-01, 3RC2NS069409-02S1, 5RC2NS069409-02, 1U01NS086090-01,3U0 IN S086090-02S1, 3U01NS086090-02S2, 3U01NS086090-03S1,5U0INS086090-02, 5U01NS086090-03; US DOD W81XWH-13-1-0441, US DOD W81XWH-14-2-0176.	American College of Surgeons, 2014, RES OPT CAR INJ PAT; Barker-Collo S, 2015, BRAIN INJURY, V29, P1604, DOI 10.3109/02699052.2015.1075143; Bazarian JJ, 2005, EMERG MED J, V22, P473, DOI 10.1136/emj.2004.019273; Borgaro SR, 2003, BRAIN INJURY, V17, P189, DOI 10.1080/0269905021000013183; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Cudnik MT, 2009, J TRAUMA, V66, P1321, DOI 10.1097/TA.0b013e3181929e2b; Dagher JH, 2013, BRAIN INJURY, V27, P189, DOI 10.3109/02699052.2012.729288; Koning ME, 2017, J NEUROTRAUM, V34, P257, DOI 10.1089/neu.2015.4377; Demetriades D, 2006, J AM COLL SURGEONS, V202, P212, DOI 10.1016/j.jamcollsurg.2005.09.027; Dikmen S, 2017, J NEUROTRAUM, V34, P1524, DOI 10.1089/neu.2016.4618; Duhaime AC, 2010, ARCH PHYS MED REHAB, V91, P1661, DOI 10.1016/j.apmr.2010.07.238; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Farmer JE, 2003, J HEAD TRAUMA REHAB, V18, P116, DOI 10.1097/00001199-200303000-00003; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Finkelstein EA., 2006, INCIDENCE EC BURDEN; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Glasgow RE, 2012, AM J PUBLIC HEALTH, V102, P1274, DOI 10.2105/AJPH.2012.300755; Haider AH, 2013, J TRAUMA ACUTE CARE, V74, P1195, DOI 10.1097/TA.0b013e31828c331d; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Heitger MH, 2006, BRAIN INJURY, V20, P807, DOI 10.1080/02699050600676354; Hicks R, 2013, J NEUROTRAUM, V30, P1852, DOI 10.1089/neu.2013.2938; Howell DC., 2012, STAT METHODS PSYCHOL; IVERSON GL, 2012, REHABIL RES PRACT, V2012, DOI DOI 10.1155/2012/415740; Jacobs B, 2010, J NEUROTRAUM, V27, P655, DOI 10.1089/neu.2009.1059; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Jagoda AS, 2002, ANN EMERG MED, V40, P231, DOI 10.1016/j.jen.2008.12.010; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P74, DOI DOI 10.1097/00001199-199309000-00009; KREUTZER J S, 1991, Brain Injury, V5, P177, DOI 10.3109/02699059109008088; Lange RT, 2012, ARCH CLIN NEUROPSYCH, V27, P480, DOI 10.1093/arclin/acs059; LEE ST, 1992, J NEUROSURG, V76, P435, DOI 10.3171/jns.1992.76.3.0435; Lingsma HF, 2015, J NEUROTRAUM, V32, P83, DOI 10.1089/neu.2014.3384; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AI, 2010, ARCH PHYS MED REHAB, V91, P1641, DOI 10.1016/j.apmr.2010.07.232; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Manley GT, 2010, ARCH PHYS MED REHAB, V91, P1667, DOI 10.1016/j.apmr.2010.05.018; MARSHALL LF, 1995, J NEUROTRAUM, V12, P929, DOI 10.1089/neu.1995.12.929; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; McMillan T, 2016, NAT REV NEUROL, V12, P477, DOI 10.1038/nrneurol.2016.89; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Nathens AB, 2000, J TRAUMA, V48, P25, DOI 10.1097/00005373-200001000-00005; O'Neil M.E, 2014, J INT NEUROPSYCH SOC, P1; Ratcliff JJ, 2014, AM J EMERG MED, V32, P844, DOI 10.1016/j.ajem.2014.04.003; Russo J, 2013, GEN HOSP PSYCHIAT, V35, P485, DOI 10.1016/j.genhosppsych.2013.04.016; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Scholten AC, 2015, INJURY, V46, P616, DOI 10.1016/j.injury.2014.10.064; Schwab W, 2000, J TRAUMA, V48, P30; Shafi S, 2007, J TRAUMA, V63, P1138, DOI 10.1097/TA.0b013e3181568cd4; Shah SM, 2003, PRINCIPLES PRACTICE; Sweeney TE, 2015, WORLD J EMERG SURG, V10, DOI 10.1186/s13017-015-0017-6; TEASDALE G, 1974, LANCET, V2, P81; Theadom A, 2016, BRIT J GEN PRACT, V66, pE16, DOI 10.3399/bjgp16X683161; Tunis SR, 2003, JAMA-J AM MED ASSOC, V290, P1624, DOI 10.1001/jama.290.12.1624; US Department of Health & Human Services; Centers for Disease Control (CDC), REP C MILD TRAUM BRA; Vos PE, 2012, EUR J NEUROL, V19, P191, DOI 10.1111/j.1468-1331.2011.03581.x; Wade DT, 1998, J NEUROL NEUROSUR PS, V65, P177, DOI 10.1136/jnnp.65.2.177; Wenden FJ, 1998, CLIN REHABIL, V12, P53, DOI 10.1191/026921598675567949; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970	66	11	11	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	13-14					1820	1829		10.1080/02699052.2017.1351000			10	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	FO2MD	WOS:000416612500014	29166203				2021-06-18	
J	Zimmermann, N; Mograbi, DC; Hermes-Pereira, A; Fonseca, R; Prigatano, GP				Zimmermann, Nicolle; Mograbi, Daniel C.; Hermes-Pereira, Andressa; Fonseca, RocheleP.; Prigatano, George P.			Memory and executive functions correlates of self-awareness in traumatic brain injury	COGNITIVE NEUROPSYCHIATRY			English	Article						Traumatic brain injury; memory; metacognition; awareness	ALZHEIMERS-DISEASE; WORKING-MEMORY; RATING-SCALE; CONSCIOUSNESS; IMPAIRMENT; ANOSOGNOSIA; UNAWARENESS; COMPETENCE; ATTENTION; DISTRESS	Objective: The purpose of this study was to investigate the contribution of executive functions (EF) components and episodic and working memory variables, as well as clinical and demographic factors, to awareness of cognitive ability in traumatic brain injury (TBI).Methods: Sixty-five TBI patients (mild: n=26; moderate/severe: n=39) took part in the study. Independent stepwise regression models were calculated for EF and memory predictors, with awareness being measured by patient/informant discrepancy in the Patient Competency Rating Scale.Results: Models with EF variables indicated that semantic verbal fluency and age are the best predictors of awareness, whereas models including mnemonic functions suggested verbal delayed episodic recall and TBI severity as predictors.Conclusions: These results are discussed in relation to clinical implications, such as the need to focus efforts of rehabilitation in the cognitive abilities related to awareness, and theoretical models.	[Zimmermann, Nicolle] Univ Fed Rio de Janeiro, Dept Radiol, Rio De Janeiro, Brazil; [Mograbi, Daniel C.] Pontificia Univ Catolica Rio de Janeiro, Dept Psychol, Rio de Janeiro, Brazil; [Mograbi, Daniel C.] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Psychol, London, England; [Zimmermann, Nicolle; Hermes-Pereira, Andressa; Fonseca, RocheleP.] Pontificia Univ Catolica Rio Grande do Sul, Dept Psychol Human Cognit, Porto Alegre, RS, Brazil; [Prigatano, George P.] St Josephs Hosp, Barrow Neurol Inst, Dept Clin Neuropsychol, Phoenix, AZ USA; [Zimmermann, Nicolle] Paulo Niemeyer State Brain Inst, Neuropsychol Serv, Rio De Janeiro, Brazil	Mograbi, DC (corresponding author), Pontificia Univ Catolica Rio de Janeiro, Dept Psychol, Rio de Janeiro, Brazil.; Mograbi, DC (corresponding author), Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Psychol, London, England.	daniel.mograbi@kcl.ac.uk	Mograbi, Daniel C/O-9352-2014	ZIMMERMANN, NICOLLE/0000-0003-4771-4070; Mograbi, Daniel/0000-0002-4271-2984	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Brazil)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (Brazil)	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Brazil) and Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (Brazil).	Aalten P, 2005, AGING MENT HEALTH, V9, P414, DOI 10.1080/13607860500143075; Agnew SK, 1998, AGING MENT HEALTH, V2, P7, DOI 10.1080/13607869856876; AITB, 1944, ARM IND TEST BATT; Baars BJ, 2003, TRENDS COGN SCI, V7, P166, DOI 10.1016/S1364-6613(03)00056-1; BADDELEY A, 1992, CONSCIOUS COGN, V1, P3, DOI 10.1016/1053-8100(92)90037-B; Baird B, 2013, J NEUROSCI, V33, P16657, DOI 10.1523/JNEUROSCI.0786-13.2013; Barkley R, 2012, EXECUTIVE FUNCTIONS; Birn RM, 2010, NEUROIMAGE, V49, P1099, DOI 10.1016/j.neuroimage.2009.07.036; Bivona U, 2008, J INT NEUROPSYCH SOC, V14, P862, DOI 10.1017/S1355617708081125; Bogod NM, 2003, J INT NEUROPSYCH SOC, V9, P450, DOI 10.1017/S1355617703930104; Busch RM, 2005, J CLIN EXP NEUROPSYC, V27, P1022, DOI 10.1080/13803390490919263; Ciurli P, 2010, J INT NEUROPSYCH SOC, V16, P360, DOI 10.1017/S135561770999141X; DANEMAN M, 1983, J EXP PSYCHOL LEARN, V9, P561, DOI 10.1037/0278-7393.9.4.561; DEATON AV, 1986, REHABIL PSYCHOL, V31, P231, DOI 10.1037//0090-5550.31.4.231; Demery JA, 2002, J CLIN EXP NEUROPSYC, V24, P818, DOI 10.1076/jcen.24.6.818.8400; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Dobbins IG, 2002, NEURON, V35, P989, DOI 10.1016/S0896-6273(02)00858-9; Fernandez-Duque D, 2000, CONSCIOUS COGN, V9, P288, DOI 10.1006/ccog.2000.0447; Field A., 2013, DISCOVERING STAT USI, V4; FLAVELL JH, 1979, AM PSYCHOL, V34, P906, DOI 10.1037/0003-066X.34.10.906; Fleming SM, 2012, PHILOS T R SOC B, V367, P1338, DOI 10.1098/rstb.2011.0417; Fonseca R. P., 2008, BATERIA MONTREAL AVA; Fonseca R. P., 2010, AVALIACAO PSICOLOGIC, P337; Fonseca RP, 2008, SPAN J PSYCHOL, V11, P678, DOI 10.1017/S1138741600004686; Fonseca RP., 2009, INSTRUMENTO AVALIACA; Garcia-Molina A, 2012, BRAIN INJURY, V26, P864, DOI 10.3109/02699052.2012.655362; Hertzog C, 2011, CURR DIR PSYCHOL SCI, V20, P167, DOI 10.1177/0963721411409026; Hill PF, 2013, CONSCIOUS COGN, V22, P677, DOI 10.1016/j.concog.2013.04.002; Hurks PPM, 2010, CHILD NEUROPSYCHOL, V16, P366, DOI 10.1080/09297041003671184; Hurks PPM, 2006, J CLIN EXP NEUROPSYC, V28, P684, DOI 10.1080/13803390590954191; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P923, DOI 10.1007/978-0-387-76978-3_32; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kave G, 2011, J CLIN EXP NEUROPSYC, V33, P358, DOI 10.1080/13803395.2010.518703; Malec JF, 2000, REHABIL PSYCHOL, V45, P227, DOI 10.1037/0090-5550.45.3.227; Mograbi DC, 2009, CONSCIOUS COGN, V18, P989, DOI 10.1016/j.concog.2009.07.005; Morin A, 2006, CONSCIOUS COGN, V15, P358, DOI 10.1016/j.concog.2005.09.006; Morris RG, 2013, CORTEX, V49, P1553, DOI 10.1016/j.cortex.2012.09.006; Naccache L, 2005, NEUROPSYCHOLOGIA, V43, P1318, DOI 10.1016/j.neuropsychologia.2004.11.024; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; Noe E, 2005, J NEUROL, V252, P168, DOI 10.1007/s00415-005-0625-2; Ownsworth T, 2006, NEUROPSYCHOL REHABIL, V16, P415, DOI 10.1080/09602010500505641; Pergola G, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00162; Prigatano G. P., 1986, NEUROPSYCHOLOGICAL R; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; Prigatano GP, 1998, CLIN NEUROPSYCHOL, V12, P56, DOI 10.1076/clin.12.1.56.1721; Prigatano GP, 1997, NEUROPSY NEUROPSY BE, V10, P135; Quinette P, 2006, NEUROPSYCHOLOGIA, V44, P2508, DOI 10.1016/j.neuropsychologia.2006.03.031; Salgado JV, 2011, REV BRAS PSIQUIATR, V33, P234, DOI 10.1590/S1516-44462011000300005; Sbordone RJ, 1998, BRAIN INJURY, V12, P505, DOI 10.1080/026990598122467; Schmitter-Edgecombe M, 2008, J CLIN EXP NEUROPSYC, V30, P212, DOI 10.1080/13803390701363803; Schmitz TW, 2006, NEUROPSYCHOLOGIA, V44, P762, DOI 10.1016/j.neuropsychologia.2005.07.012; Shallice, 1997, HAYLING BRIXTON TEST; Sherer M, 2003, ARCH PHYS MED REHAB, V84, P168, DOI 10.1053/apmr.2003.50045; Sherer M, 2003, BRAIN INJURY, V17, P25, DOI 10.1080/0269905021000010113; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Stuss DT, 2011, J INT NEUROPSYCH SOC, V17, P759, DOI 10.1017/S1355617711000695; Sveen U, 2008, CLIN REHABIL, V22, P45, DOI 10.1177/0269215507080768; TEASDALE G, 1974, LANCET, V2, P81; Vanderploeg RD, 2010, J CLIN EXP NEUROPSYC, V23, P37; WEINSTEIN EA, 1994, NEUROPSY NEUROPSY BE, V7, P176; Ylikoski R, 2003, INT PSYCHOGERIATR, V15, P219, DOI 10.1017/S1041610203009232; Zimmermann Nicolle, 2015, Dement. neuropsychol., V9, P120, DOI 10.1590/1980-57642015DN92000006; Zimmermann Nicolle, 2014, Trends Psychiatry Psychother., V36, P40, DOI 10.1590/2237-6089-2013-0021	63	11	11	0	9	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1354-6805	1464-0619		COGN NEUROPSYCHIATRY	Cogn. Neuropsychiatry		2017	22	4					346	360		10.1080/13546805.2017.1330191			15	Psychiatry	Psychiatry	EY1HS	WOS:000403717500006	28566003				2021-06-18	
J	Szmydynger-Chodobska, J; Shan, RZ; Thomasian, N; Chodobski, A				Szmydynger-Chodobska, Joanna; Shan, Rongzi; Thomasian, Nicole; Chodobski, Adam			The Involvement of Pial Microvessels in Leukocyte Invasion after Mild Traumatic Brain Injury	PLOS ONE			English	Article							NEUTROPHIL INFILTRATION; MONOCLONAL-ANTIBODY; ENDOTHELIAL-CELLS; HEAD-INJURY; P-SELECTIN; EXPRESSION; BARRIER; MODEL; INFLAMMATION; RECRUITMENT	The pathophysiological mechanisms underlying mild traumatic brain injury (mTBI) are not well understood, but likely involve neuroinflammation. Here the controlled cortical impact model of mTBI in rats was used to test this hypothesis. Mild TBI caused a rapid (within 6 h post-mTBI) upregulation of synthesis of TNF-alpha and IL-1 beta in the cerebral cortex and hippocampus, followed by an increase in production of neutrophil (CXCL1 - 3) and monocyte (CCL2) chemoattractants. While astrocytes were not a significant source of CXC chemokines, they highly expressed CCL2. An increase in production of CXC chemokines coincided with the influx of neutrophils into the injured brain. At 6 h post-mTBI, we observed a robust influx of CCL2-expressing neutrophils across pial microvessels into the subarachnoid space (SAS) near the injury site. Mild TBI was not accompanied by any significant influx of neutrophils into the brain parenchyma until 24 h after injury. This was associated with an early induction of expression of intercellular adhesion molecule 1 on the endothelium of the ipsilateral pial, but not intraparenchymal, microvessels. At 6 h post-mTBI, we also observed a robust influx of neutrophils into the ipsilateral cistern of velum interpositum (CVI), a slit-shaped cerebrospinal fluid space located above the 3rd ventricle with highly vascularized pia mater. From SAS and CVI, neutrophils appeared to move along the perivascular spaces to enter the brain parenchyma. The monocyte influx was not observed until 24 h post-mTBI, and these inflammatory cells predominantly entered the ipsilateral SAS and CVI, with a limited invasion of brain parenchyma. These observations indicate that the endothelium of pial microvessels responds to injury differently than that of intraparenchymal microvessels, which may be associated with the lack of astrocytic ensheathment of cerebrovascular endothelium in pial microvessels. These findings also suggest that neuroinflammation represents the potential therapeutic target in mTBI.	[Szmydynger-Chodobska, Joanna; Shan, Rongzi; Thomasian, Nicole; Chodobski, Adam] Brown Univ, Alpert Med Sch, Dept Emergency Med, Neurotrauma & Brain Barriers Res Lab, Providence, RI 02912 USA	Szmydynger-Chodobska, J (corresponding author), Brown Univ, Alpert Med Sch, Dept Emergency Med, Neurotrauma & Brain Barriers Res Lab, Providence, RI 02912 USA.	Joanna_Szmydynger-Chodobska@brown.edu		Thomasian, Nicole/0000-0001-9563-4580	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS94440, NS99605]; Department of Emergency Medicine at the Alpert Medical School of Brown University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS099605, R01NS094440] Funding Source: NIH RePORTER	This work was supported by grants NS94440 and NS99605 from NIH (to AC), and by funds from Diane N. Weiss and from the Department of Emergency Medicine at the Alpert Medical School of Brown University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allt G, 1997, BRAIN RES REV, V24, P67, DOI 10.1016/S0165-0173(97)00011-8; Alvarez JI, 2006, J NEUROIMMUNOL, V173, P45, DOI 10.1016/j.jneuroim.2005.11.020; ANDERSSON PB, 1992, J EXP MED, V176, P255, DOI 10.1084/jem.176.1.255; Bao F, 2012, J NEUROTRAUM, V29, P2375, DOI 10.1089/neu.2012.2408; Bartholomaus I, 2009, NATURE, V462, P94, DOI 10.1038/nature08478; Bonneh-Barkay D, 2010, J NEUROTRAUM, V27, P1215, DOI 10.1089/neu.2010.1310; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cera MR, 2009, J CELL SCI, V122, P268, DOI 10.1242/jcs.037127; DeWitt DS, 2013, J NEUROTRAUM, V30, P688, DOI 10.1089/neu.2012.2349; Didier N, 2003, J NEUROCHEM, V86, P246, DOI 10.1046/j.1471-4159.2003.01829.x; Faul M.D., 2010, TRAUMATIC BRAIN INJU; GOTSCH U, 1994, CELL ADHES COMMUN, V2, P7, DOI 10.3109/15419069409014198; Hadass O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076904; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Kawada M, 2012, ONCOGENE, V31, P3111, DOI 10.1038/onc.2011.498; Kenne E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-17; Lee CG, 2011, ANNU REV PHYSIOL, V73, P479, DOI 10.1146/annurev-physiol-012110-142250; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; MCEVER RP, 1989, J CLIN INVEST, V84, P92, DOI 10.1172/JCI114175; Mishra PK, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002099; Perez-Polo JR, 2013, J NEUROTRAUM, V30, P727, DOI 10.1089/neu.2012.2650; Rabinowitz AR, 2015, J NEUROTRAUM, V32, P1488, DOI 10.1089/neu.2014.3555; Redell JB, 2013, J NEUROTRAUM, V30, P752, DOI 10.1089/neu.2012.2437; Rot A, 2009, METHOD ENZYMOL, V461, P191, DOI 10.1016/S0076-6879(09)05409-3; Royo NC, 1999, NEUROREPORT, V10, P1363, DOI 10.1097/00001756-199904260-00038; Scapini P, 2000, IMMUNOL REV, V177, P195, DOI 10.1034/j.1600-065X.2000.17706.x; Semple BD, 2010, NEUROBIOL DIS, V40, P394, DOI 10.1016/j.nbd.2010.06.015; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Shan RZ, 2016, J NEUROTRAUM, V33, P49, DOI 10.1089/neu.2014.3811; Szmydynger-Chodobska J, 2010, J NEUROTRAUM, V27, P1449, DOI 10.1089/neu.2010.1331; Szmydynger-Chodobska J, 2009, J CEREBR BLOOD F MET, V29, P1503, DOI 10.1038/jcbfm.2009.71; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tran ND, 1999, STROKE, V30, P1671, DOI 10.1161/01.STR.30.8.1671; Utagawa A, 2008, BRAIN RES, V1207, P155, DOI 10.1016/j.brainres.2008.02.057; Vestweber D, 2015, NAT REV IMMUNOL, V15, P692, DOI 10.1038/nri3908; Villapol S, 2015, AM J PATHOL, V185, P2641, DOI 10.1016/j.ajpath.2015.06.016; Walker-Caulfield ME, 2015, J NEUROIMMUNOL, V278, P112, DOI 10.1016/j.jneuroim.2014.12.009; Walter UM, 1997, HYBRIDOMA, V16, P249, DOI 10.1089/hyb.1997.16.249; Wang XY, 2000, J NEUROSCI, V20, P7037, DOI 10.1523/JNEUROSCI.20-18-07037.2000; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056; ZHANG ET, 1990, J ANAT, V170, P111	41	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0167677	10.1371/journal.pone.0167677			17	Multidisciplinary Sciences	Science & Technology - Other Topics	EG7JB	WOS:000391222000017	28030563	DOAJ Gold, Green Published			2021-06-18	
J	Woods, DL; Wyma, JM; Herron, TJ; Yund, EW				Woods, David L.; Wyma, John M.; Herron, Timothy J.; Yund, E. William			Computerized Analysis of Verbal Fluency: Normative Data and the Effects of Repeated Testing, Simulated Malingering, and Traumatic Brain Injury	PLOS ONE			English	Article							LATENT SEMANTIC ANALYSIS; WORD-ASSOCIATION TEST; COMPONENT ANALYSIS; NEUROPSYCHOLOGICAL OUTCOMES; ALZHEIMERS-DISEASE; EXECUTIVE FUNCTION; CATEGORY FLUENCY; DESIGN FLUENCY; LOBE LESIONS; FREE-RECALL	In verbal fluency (VF) tests, subjects articulate words in a specified category during a short test period (typically 60 s). Verbal fluency tests are widely used to study language development and to evaluate memory retrieval in neuropsychiatric disorders. Performance is usually measured as the total number of correct words retrieved. Here, we describe the properties of a computerized VF (C-VF) test that tallies correct words and repetitions while providing additional lexical measures of word frequency, syllable count, and typicality. In addition, the C-VF permits (1) the analysis of the rate of responding over time, and (2) the analysis of the semantic relationships between words using a new method, Explicit Semantic Analysis (ESA), as well as the established semantic clustering and switching measures developed by Troyer et al. (1997). In Experiment 1, we gathered normative data from 180 subjects ranging in age from 18 to 82 years in semantic ("animals) and phonemic (letter "F") conditions. The number of words retrieved in 90 s correlated with education and daily hours of computeruse. The rate of word production declined sharply over time during both tests. In semantic conditions, correct-word scores correlated strongly with the number of ESA and Troyer-defined semantic switches as well as with an ESA-defined semantic organization index (SOI). In phonemic conditions, ESA revealed significant semantic influences in the sequence of words retrieved. In Experiment 2, we examined the test-retest reliability of different measures across three weekly tests in 40 young subjects. Different categories were used for each semantic ("animals", "parts of the body", and "foods") and phonemic (letters "F", "A", and "S") condition. After regressing out the influences of education and computeruse, we found that correct-word z-scores in the first session did not differ from those of the subjects in Experiment 1. Word production was uniformly greater in semantic than phonemic conditions. Intraclass correlation coefficients (ICCs) of correct-word z-scores were higher for phonemic (0.91) than semantic (0.77) tests. In semantic conditions, good reliability was also seen for the SOI (ICC = 0.68) and ESA-defined switches in semantic categories (ICC = 0.62). In Experiment 3, we examined the performance of subjects from Experiment 2 when instructed to malinger: 38% showed abnormal (p<0.05) performance in semantic conditions. Simulated malingerers with abnormal scores could be distinguished with 80% sensitivity and 89% specificity from subjects with abnormal scores in Experiment 1 using lexical, temporal, and semantic measures. In Experiment 4, we tested patients with mild and severe traumatic brain injury (mTBI and sTBI). Patients with mTBI performed within the normal range, while patients with sTBI showed significant impairments in correct-word z-scores and category shifts. The lexical, temporal, and semantic measures of the C-VF provide an automated and comprehensive description of verbal fluency performance.	[Woods, David L.; Wyma, John M.; Herron, Timothy J.; Yund, E. William] VANCHCS, Human Cognit Neurophysiol Lab, Martinez, CA 94553 USA; [Woods, David L.] UC Davis Dept Neurol, Sacramento, CA 95820 USA; [Woods, David L.] Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; [Woods, David L.] UC Davis Ctr Mind & Brain, Davis, CA 95616 USA; [Woods, David L.; Wyma, John M.] NeuroBehav Syst Inc, Berkeley, CA 94706 USA	Woods, DL (corresponding author), VANCHCS, Human Cognit Neurophysiol Lab, Martinez, CA 94553 USA.; Woods, DL (corresponding author), UC Davis Dept Neurol, Sacramento, CA 95820 USA.; Woods, DL (corresponding author), Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA.; Woods, DL (corresponding author), UC Davis Ctr Mind & Brain, Davis, CA 95616 USA.; Woods, DL (corresponding author), NeuroBehav Syst Inc, Berkeley, CA 94706 USA.	dlwoods@ucdavis.edu		Woods, David/0000-0002-8804-3587; Yund, E./0000-0002-6833-0052; Herron, Timothy/0000-0002-4297-014X	"VA Rehabilitation Research and Development Grants'' [CX000583, CX001000]; "VA Research and Development Grants'' [CX000583, CX001000]; Veterans AffairsUS Department of Veterans Affairs [I01CX001000] Funding Source: NIH RePORTER	The funding source should be changed from "VA Rehabilitation Research and Development Grants grant CX000583 and CX001000 to DLW" to "VA Research and Development Grants grant CX000583 and CX001000 to DLW".	Andreou G, 2013, ADHD-ATTEND DEFICIT, V5, P343, DOI 10.1007/s12402-013-0112-z; Baldo JV, 2001, J INT NEUROPSYCH SOC, V7, P586, DOI 10.1017/S1355617701755063; Basso MR, 1999, CLIN NEUROPSYCHOL, V13, P283, DOI 10.1076/clin.13.3.283.1743; Benito-Cuadrado MM, 2002, J CLIN EXP NEUROPSYC, V24, P1117, DOI 10.1076/jcen.24.8.1117.8376; Benton A.L., 1983, MULTILINGUAL APLASIA, V2nd; Bittner RM, 2006, BRAIN INJURY, V20, P971, DOI 10.1080/02699050600909763; BORKOWSKI JG, 1967, NEUROPSYCHOLOGIA, V5, P135, DOI 10.1016/0028-3932(67)90015-2; Bousfield WA, 1944, J GEN PSYCHOL, V30, P149, DOI 10.1080/00221309.1944.10544467; BUTTERS N, 1978, ARCH NEUROL-CHICAGO, V35, P585, DOI 10.1001/archneur.1978.00500330033006; Capitani E, 1999, CORTEX, V35, P273, DOI 10.1016/S0010-9452(08)70800-1; Cavaco S, 2013, ARCH CLIN NEUROPSYCH, V28, P262, DOI 10.1093/arclin/act001; Cohen MJ, 1999, ARCH CLIN NEUROPSYCH, V14, P433, DOI 10.1016/S0887-6177(98)00038-9; Connelly V., 2005, EDUC PSYCHOL-UK, V25, P99, DOI [10.1080/0144341042000294912, DOI 10.1080/0144341042000294912]; Cralidis A, 2014, BRAIN INJURY, V28, P456, DOI 10.3109/02699052.2014.896945; Crowe SF, 1998, J CLIN EXP NEUROPSYC, V20, P391, DOI 10.1076/jcen.20.3.391.810; Curtis KL, 2008, CLIN NEUROPSYCHOL, V22, P930, DOI 10.1080/13854040701563591; Passos VMD, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0454-6; Delis D.C., 2001, DELIS KAPLAN EXECUTI; Demakis GJ, 1999, ARCH CLIN NEUROPSYCH, V14, P401, DOI 10.1016/S0887-6177(98)00039-0; Drake AI, 2000, J HEAD TRAUMA REHAB, V15, P1103, DOI 10.1097/00001199-200010000-00004; Dykiert D, 2013, PSYCHOL ASSESSMENT, V25, P1361, DOI 10.1037/a0033623; EGOZI O., 2011, ACM T INFORM SYSTEMS, V29, P8, DOI DOI 10.1145/1961209.1961211; Ehlen F, 2015, PSYCHON B REV; Federmeier KD, 2010, BRAIN LANG, V115, P149, DOI 10.1016/j.bandl.2010.07.006; Fernaeus SE, 1998, J CLIN EXP NEUROPSYC, V20, P137, DOI 10.1076/jcen.20.2.137.1170; Fernaeus SE, 2001, DEMENT GERIATR COGN, V12, P52, DOI 10.1159/000051235; Fernaeus SE, 2008, CORTEX, V44, P161, DOI 10.1016/j.cortex.2006.04.002; Fitzpatrick S, 2013, NEUROPSYCHOL REV, V23, P138, DOI 10.1007/s11065-013-9224-7; Gabrilovich E, 2009, J ARTIF INTELL RES, V34, P443, DOI 10.1613/jair.2669; Gladsjo JA, 1999, ASSESSMENT, V6, P147, DOI 10.1177/107319119900600204; Green REA, 2008, J CLIN EXP NEUROPSYC, V30, P163, DOI 10.1080/13803390701300524; GRUENEWALD PJ, 1980, J EXP PSYCHOL-HUM L, V6, P225, DOI 10.1037/0278-7393.6.3.225; Hall JR, 2011, AGING NEUROPSYCHOL C, V18, P353, DOI [10.1080/13825585.2011.557495, 10.3109/17482941.2010.538698]; Hankee LD, 2013, EXP AGING RES, V39, P515, DOI 10.1080/0361073X.2013.839029; Haugrud N, 2011, J INT NEUROPSYCH SOC, V17, P1153, DOI 10.1017/S1355617711001196; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P621, DOI 10.1037/0894-4105.18.4.621; Henry JD, 2004, NEUROPSYCHOLOGIA, V42, P1212, DOI 10.1016/j.neuropsychologia.2004.02.001; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P284, DOI 10.1037/0894-4105.18.2.284; Henry JD, 2004, J INT NEUROPSYCH SOC, V10, P608, DOI 10.1017/S1355617704104141; Henry Julie D, 2005, Cogn Neuropsychiatry, V10, P1, DOI 10.1080/13546800344000309; Hills TT, 2012, PSYCHOL REV, V119, P431, DOI 10.1037/a0027373; Hoogendam YY, 2014, EUR J EPIDEMIOL, V29, P133, DOI 10.1007/s10654-014-9885-4; Hubel KA, 2013, PERCEPT MOTOR SKILL, V116, P929, DOI 10.2466/25.29.PMS.116.3.929-952; Hubel KA, 2013, J CLIN EXP NEUROPSYC, V35, P745, DOI 10.1080/13803395.2013.824070; Ide N, 2001, PROCEEDINGS OF CORPU; John D, 2009, J PHYS ACT HEALTH, V6, P617, DOI 10.1123/jpah.6.5.617; Jones MN, 2007, PSYCHOL REV, V114, P1, DOI 10.1037/0033-295X.114.1.1; Juhasz BJ, 2012, PSYCHIAT RES, V200, P177, DOI 10.1016/j.psychres.2012.06.035; Kaplan E, 1983, THE ASSESSMENT OF AP; Kave G, 2011, J CLIN EXP NEUROPSYC, V33, P358, DOI 10.1080/13803395.2010.518703; KERTESZ A, 1982, WESTERN APHASIA BATT; Khalil MS, 2010, J CLIN EXP NEUROPSYC, V32, P1028, DOI 10.1080/13803391003672305; Koren R, 2005, ARCH CLIN NEUROPSYCH, V20, P1087, DOI 10.1016/j.acn.2005.06.012; Landauer TK, 1998, DISCOURSE PROCESS, V25, P259, DOI 10.1080/01638539809545028; Lanting S, 2009, J INT NEUROPSYCH SOC, V15, P196, DOI 10.1017/S1355617709090237; Ledoux K, 2014, J CLIN EXP NEUROPSYC, V36, P205, DOI 10.1080/13803395.2013.878689; Llewellyn DJ, 2009, AGING NEUROPSYCHOL C, V16, P433, DOI 10.1080/13825580902773867; Loonstra A S, 2001, Appl Neuropsychol, V8, P161, DOI 10.1207/S15324826AN0803_5; Mac Donald CL, 2015, BRAIN, V138, P1314, DOI 10.1093/brain/awv038; Mathias JL, 2004, J INT NEUROPSYCH SOC, V10, P286, DOI 10.1017/S1355617704102117; McCauley SR, 2014, J NEUROTRAUM, V31, P914, DOI 10.1089/neu.2012.2826; Nicodemus KK, 2014, CORTEX, V55, P182, DOI 10.1016/j.cortex.2013.12.004; OBER BA, 1986, J CLIN EXP NEUROPSYC, V8, P75, DOI 10.1080/01688638608401298; Ostrosky-Solis F, 2007, ARCH CLIN NEUROPSYCH, V22, P367, DOI 10.1016/j.acn.2007.01.011; Pakhomov SVS, 2016, NEUROPSYCHOLOGIA, V89, P42, DOI 10.1016/j.neuropsychologia.2016.05.031; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Raskin SA, 1996, NEUROPSYCHOLOGY, V10, P416, DOI 10.1037/0894-4105.10.3.416; Robert PH, 1997, EUR PSYCHIAT, V12, P124, DOI 10.1016/S0924-9338(97)80200-3; Roberts PM, 1997, BRAIN LANG, V59, P412, DOI 10.1006/brln.1997.1753; Rodriguez-Aranda C, 2006, DEV NEUROPSYCHOL, V30, P697, DOI 10.1207/s15326942dn3002_3; ROHRER D, 1995, J EXP PSYCHOL LEARN, V21, P1127, DOI 10.1037/0278-7393.21.5.1127; Roldan-Tapia L, 2012, APPL NEUROPSYCH-ADUL, V19, P2, DOI 10.1080/09084282.2011.595458; Ross TP, 2007, ARCH CLIN NEUROPSYCH, V22, P475, DOI 10.1016/j.acn.2007.01.026; Ross TP, 2003, ARCH CLIN NEUROPSYCH, V18, P153, DOI 10.1016/S0887-6177(01)00192-5; Rosselli M, 2009, AGING NEUROPSYCHOL C, V16, P721, DOI 10.1080/13825580902912739; Shandera-Ochsner AL, 2013, CLIN NEUROPSYCHOL, V27, P881, DOI 10.1080/13854046.2013.802017; Shao Z, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00772; Stolwyk R, 2015, J CLIN EXP NEUROPSYC, P1; Sugarman MA, 2015, APPL NEUROPSYCH-ADUL, V22, P141, DOI 10.1080/23279095.2013.873439; Takacs A, 2014, CHILD NEUROPSYCHOL, V20, P415, DOI 10.1080/09297049.2013.799645; Tallberg IM, 2008, SCAND J PSYCHOL, V49, P479, DOI 10.1111/j.1467-9450.2008.00653.x; Then FS, 2014, J OCCUP MED TOXICOL, V9, DOI 10.1186/1745-6673-9-23; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; Troyer AK, 1997, NEUROPSYCHOLOGY, V11, P138, DOI 10.1037/0894-4105.11.1.138; Troyer AK, 1998, NEUROPSYCHOLOGIA, V36, P499, DOI 10.1016/S0028-3932(97)00152-8; Troyer AK, 2000, J CLIN EXP NEUROPSYC, V22, P370, DOI 10.1076/1380-3395(200006)22:3;1-V;FT370; Tsirka V, 2010, INT J NEUROSCI, V120, P184, DOI 10.3109/00207450903585308; Turken And U, 2009, BMC Med Imaging, V9, P20, DOI 10.1186/1471-2342-9-20; Van der Elst W, 2006, J INT NEUROPSYCH SOC, V12, P80, DOI 10.1017/S1355617706060115; van Hooren SAH, 2007, AGING NEUROPSYCHOL C, V14, P40, DOI 10.1080/138255890969483; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Verfaellie M, 2014, NEUROPSYCHOLOGY, V28, P337, DOI 10.1037/neu0000027; Vita MG, 2014, J ALZHEIMERS DIS, V42, P1171, DOI 10.3233/JAD-140570; Vonberg I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115846; Wecker NS, 2005, NEUROPSYCHOLOGY, V19, P345, DOI 10.1037/0894-4105.19.3.345; WIXTED JT, 1994, PSYCHON B REV, V1, P89, DOI 10.3758/BF03200763; Woods DL, 2016, MEMORY, V24, P1142, DOI 10.1080/09658211.2015.1076849; Woods DL, 2016, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00690; Woods DL, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00595; Woods DL, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00540; Woods DL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124345; Woods DL, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00288; Woods DL, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00193; Woods DL, 2011, J CLIN EXP NEUROPSYC, V33, P721, DOI 10.1080/13803395.2010.550602; Woods DL, 2011, J CLIN EXP NEUROPSYC, V33, P101, DOI 10.1080/13803395.2010.493149; Woods DL, 2015, FRONT HUM NEUROSCI; Woods DL, 2016, PLOS ONE; Woods DL, 2016, FRONTIERS IN HUMAN N; Woods SP, 2005, J INT NEUROPSYCH SOC, V11, P408, DOI 10.1017/S1355617705050460; Zahodne LB, 2011, J INT NEUROPSYCH SOC, V17, P1039, DOI 10.1017/S1355617711001044; Zakzanis KK, 2013, BRAIN INJURY, V27, P903, DOI 10.3109/02699052.2013.775505; Zakzanis KK, 2011, J CLIN EXP NEUROPSYC, V33, P785, DOI 10.1080/13803395.2011.558496; Zarino B, 2014, NEUROL SCI, V35, P1405, DOI 10.1007/s10072-014-1729-1	113	11	11	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0166439	10.1371/journal.pone.0166439			37	Multidisciplinary Sciences	Science & Technology - Other Topics	EE4PU	WOS:000389587100026	27936001	DOAJ Gold, Green Published			2021-06-18	
J	Renfro, M; Bainbridge, DB; Smith, ML				Renfro, Mindy; Bainbridge, Donna B.; Smith, Matthew Lee			Validation of Evidence-Based Fall Prevention Programs for Adults with Intellectual and/or Developmental Disorders: A Modified Otago Exercise Program	FRONTIERS IN PUBLIC HEALTH			English	Article						falls; fall prevention; intellectual and/or developmental disorders; older adults; evidence-based program; Otago Exercise Program; functional performance	2-MINUTE WALK TEST; OLDER-ADULTS; PHYSICAL-ACTIVITY; YOUNG-ADULTS; PRIMARY-CARE; HEALTH; DISABILITY; RISK; ASSOCIATION; RELIABILITY	Introduction: Evidence-based fall prevention (EBFP) programs significantly decrease fall risk, falls, and fall-related injuries in community-dwelling older adults. To date, EBFP programs are only validated for use among people with normal cognition and, therefore, are not evidence-based for adults with intellectual and/or developmental disorders (IDD) such as Alzheimers disease and related dementias, cerebral vascular accident, or traumatic brain injury. Background: Adults with IDD experience not only a higher rate of falls than their community-dwelling, cognitively intact peers but also higher rates and earlier onset of chronic diseases, also known to increase fall risk. Adults with IDD experience many barriers to health care and health promotion programs. As the lifespan for people with IDD continues to increase, issues of aging (including falls with associated injury) are on the rise and require effective and efficient prevention. Methods: A modified group-based version of the Otago Exercise Program (OEP) was developed and implemented at a worksite employing adults with IDD in Montana. Participants were tested pre- and post-intervention using the Center for Disease Control and Preventions (CDC) Stopping Elderly Accidents Deaths and Injuries (STEADI) tool kit. Participants participated in progressive once weekly, 1-h group exercise classes and home programs over a 7-week period. Discharge planning with consumers and caregivers included home exercise, walking, and an optional home assessment. Results: Despite the limited number of participants (n = 15) and short length of participation, improvements were observed in the 30-s Chair Stand Test, 4-Stage Balance Test, and 2-Minute Walk Test. Additionally, three individuals experienced an improvement in ambulation independence. Participants reported no falls during the study period. Discussion: Promising results of this preliminary project underline the need for further study of this modified OEP among adults with IDD. Future multicenter study should include more participants in diverse geographic regions with longer lengths of participation and follow-up.	[Renfro, Mindy; Bainbridge, Donna B.] Univ Montana, MonTECH Rural Inst, Missoula, MT 59812 USA; [Smith, Matthew Lee] Univ Georgia, Inst Gerontol, Coll Publ Hlth, Athens, GA 30602 USA; [Smith, Matthew Lee] Texas A&M Sch Publ Hlth, College Stn, TX USA	Renfro, M (corresponding author), Univ Montana, MonTECH Rural Inst, Missoula, MT 59812 USA.	mindy.renfro@mso.umt.edu	Renfro, Mindy/X-7984-2019				ALEXANDER BH, 1992, AM J PUBLIC HEALTH, V82, P1020, DOI 10.2105/AJPH.82.7.1020; American Association of Intellectual and Developmental Disabilities, 2013, DEF INT DIS; Anderson L, 2013, AM PUBLIC HLTH ASS A; Anderson LL, 2013, INTELLECT DEV DISAB, V51, P385, DOI 10.1352/1934-9556-51.5.385; Bishop KM, 2013, J PSYCHOSOC NURS MEN, V51, P15, DOI 10.3928/02793695-20121218-02; Bohannon Richard W, 2014, BMC Res Notes, V7, P269, DOI 10.1186/1756-0500-7-269; Campbell AJ, 1999, AGE AGEING, V28, P513, DOI 10.1093/ageing/28.6.513; Campbell AJ., 2003, OTAGO EXERCISE PROGR; Carande-Kulis V, 2015, J SAFETY RES, V52, P65, DOI 10.1016/j.jsr.2014.12.007; Carmeli E, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00031; Carter K, 2014, ACSMS HEALTH FIT J, V18, P37; Connelly DM, 2009, PHYSIOTH CAN, V61, P78, DOI 10.3138/physio.61.2.78; Copeland S.R., 2002, TEACH EXCEPT CHILD, V35, DOI [10.1177/004005990203500103, DOI 10.1177/004005990203500103]; Esbensen AJ, 2010, INT REV RES MENT RET, V39, P107, DOI 10.1016/S0074-7750(10)39004-5; Farrell RJ, 2004, ADAPT PHYS ACT Q, V21, P153, DOI 10.1123/apaq.21.2.153; Focht-New G, 2012, INTELLECT DEV DISAB, V50, P129, DOI 10.1352/1934-9556-50.02.129; Ford JA, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010652; Gardner MM, 2001, AGE AGEING, V30, P77, DOI 10.1093/ageing/30.1.77; Gillespie LD., 2003, Cochrane Database Syst Rev, V4, DOI DOI 10.1002/14651858.CD007146.PUB2; Grenier S, 2014, INT PSYCHOGERIATR, V26, P1511, DOI 10.1017/S104161021400074X; Hale LA, 2016, DISABIL REHABIL, V38, P36, DOI 10.3109/09638288.2015.1017613; Hallum A, 1995, Curr Probl Pediatr, V25, P12, DOI 10.1016/S0045-9380(06)80013-7; Hosking FJ, 2016, AM J PUBLIC HEALTH, V106, P1483, DOI 10.2105/AJPH.2016.303240; Hutzler Y, 2010, J INTELL DISABIL RES, V54, P767, DOI 10.1111/j.1365-2788.2010.01313.x; Irvin DJ, 2004, GERIATR NURS, V25, P99, DOI 10.1016/j.gerinurse.2003.10.022; Iwarsson S, 2009, CLIN REHABIL, V23, P558, DOI 10.1177/0269215508101740; Jones CJ, 1999, RES Q EXERCISE SPORT, V70, P113, DOI 10.1080/02701367.1999.10608028; Jones David, 2011, Nurs Stand, V25, P50; Kamer Angela R, 2016, Alzheimers Dement (Amst), V2, P49, DOI 10.1016/j.dadm.2016.01.001; Kojima G, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0039-7; Kojima T, 2011, GERIATR GERONTOL INT, V11, P438, DOI 10.1111/j.1447-0594.2011.00703.x; Kraemer BR, 2003, MENT RETARD, V41, P250, DOI 10.1352/0047-6765(2003)41<250:QOLFYA>2.0.CO;2; McCarron M, 2013, RES DEV DISABIL, V34, P521, DOI 10.1016/j.ridd.2012.07.029; McCarthy EK, 2004, J GERONTOL A-BIOL, V59, P1207, DOI 10.1093/gerona/59.11.1207; Mertz KJ, 2010, AM J PREV MED, V39, P15, DOI 10.1016/j.amepre.2010.03.013; Moran JA, 2013, MAYO CLIN PROC, V88, P831, DOI 10.1016/j.mayocp.2013.04.024; National Council on Aging, 2012, HIGH TIER EV BAS HLT; Neece CL, 2009, INTELLECT DEV DISAB, V47, P31, DOI 10.1352/2009.47:31-43; Noonan RK, 2011, J SAFETY RES, V42, P427, DOI 10.1016/j.jsr.2010.12.002; Phelan EA, 2015, MED CLIN N AM, V99, P281, DOI 10.1016/j.mcna.2014.11.004; Raad J, 2013, REHAB MEASURES; Renfro M, 2015, FALLPAIDD SURVEY; Rimmer JH, 2014, INTRO ACHIEVING BENE; Robertson MC, 2001, BRIT MED J, V322, P697, DOI 10.1136/bmj.322.7288.697; ROSSITERFORNOFF JE, 1995, J GERONTOL A-BIOL, V50, pM291, DOI 10.1093/gerona/50A.6.M291; Salb J, 2015, J INTELL DISABIL RES, V59, P1121, DOI 10.1111/jir.12216; Selman JPR, 2014, RESP CARE, V59, P525, DOI 10.4187/respcare.02649; Shaw BH, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0168-z; Sherrington Catherine, 2011, N S W Public Health Bull, V22, P78, DOI 10.1071/NB10056; Shubert TE, 2016, J APPL GERO IN PRESS; Shubert TE, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00152; Smith E, 2016, GAIT POSTURE, V43, P239, DOI 10.1016/j.gaitpost.2015.10.004; Smith WN, 2010, CLIN INTERV AGING, V5, P173; Smulders E, 2013, J INTELL DISABIL RES, V57, P1173, DOI 10.1111/j.1365-2788.2012.01643.x; Stevens JA, 2013, HEALTH PROMOT PRACT, V14, P706, DOI 10.1177/1524839912463576; Stevens Judy A., 2000, Morbidity and Mortality Weekly Report, V49, P3; Timar B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154654; UNC School of Medicine, 2016, REF; van Schijndel-Speet M, 2014, INTELLECT DEV DISAB, V52, P175, DOI 10.1352/1934-9556-52.3.175; Waters DL, 2011, ARCH PHYS MED REHAB, V92, P1581, DOI 10.1016/j.apmr.2011.05.014; Wilkinson JE, 2008, J AM BOARD FAM MED, V21, P215, DOI 10.3122/jabfm.2008.03.070197; Zia A, 2015, POSTGRAD MED, V127, P186, DOI 10.1080/00325481.2015.996505	62	11	11	0	30	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		2296-2565		FRONT PUBLIC HEALTH	Front. Public Health	DEC 6	2016	4								261	10.3389/fpubh.2016.00261			9	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	FE9CS	WOS:000408502400001	27999771	DOAJ Gold, Green Published			2021-06-18	
J	Demorest, RA; Koutures, C				Demorest, Rebecca A.; Koutures, Chris		Council Sports Med & Fitness	Youth Participation and Injury Risk in Martial Arts	PEDIATRICS			English	Article							VERTEBRAL-ARTERY DISSECTION; COMPETITION TAEKWONDO; SHOTOKAN KARATE; HEAD BLOWS; CONCUSSION; PREVENTION; RATES; SUGGESTIONS; TRAUMA; JUDO	The martial arts can provide children and adolescents with vigorous levels of physical exercise that can improve overall physical fitness. The various types of martial arts encompass noncontact basic forms and techniques that may have a lower relative risk of injury. Contact-based sparring with competitive training and bouts have a higher risk of injury. This clinical report describes important techniques and movement patterns in several types of martial arts and reviews frequently reported injuries encountered in each discipline, with focused discussions of higher risk activities. Some of these higher risk activities include blows to the head and choking or submission movements that may cause concussions or significant head injuries. The roles of rule changes, documented benefits of protective equipment, and changes in training recommendations in attempts to reduce injury are critically assessed. This information is intended to help pediatric health care providers counsel patients and families in encouraging safe participation in martial arts.					Moffatt, Kody/0000-0001-5539-9969; Peterson, Andrew/0000-0003-4555-7366			Alesi Marianha, 2014, Muscles Ligaments Tendons J, V4, P114; Birrer R B, 1983, Br J Sports Med, V17, P131; BIRRER RB, 1988, AM J SPORT MED, V16, P408, DOI 10.1177/036354658801600418; Birrer RB, 1996, AM J SPORT MED, V24, pS72, DOI 10.1177/036354659602406S21; Burke DT, 2003, BRIT J SPORT MED, V37, P401, DOI 10.1136/bjsm.37.5.401; Buse GJ, 2006, BRIT J SPORT MED, V40, P169, DOI 10.1136/bjsm.2005.021295; Clements John, 2006, MEIBUKAN MAGAZINE HO, V1, P2; Conant KD, 2008, EPILEPSY BEHAV, V12, P61, DOI 10.1016/j.yebeh.2007.08.011; Council on Communications and Media, 2016, PEDIATRICS, V138; Critchley GR, 1999, BRIT J SPORT MED, V33, P174, DOI 10.1136/bjsm.33.3.174; Deshmukh NV, BR J SPORTS MED; Doiz E, BR J SPORTS MED; Feehan M, 1995, BRIT J SPORT MED, V29, P258, DOI 10.1136/bjsm.29.4.258; Fife GP, 2013, BRIT J SPORT MED, V47, P1161, DOI 10.1136/bjsports-2012-090979; Gartland S, 2001, BRIT J SPORT MED, V35, P308, DOI 10.1136/bjsm.35.5.308; Gartland S, CLIN J SPORT MED; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Hutchison MG, 2014, AM J SPORT MED, V42, P1352, DOI 10.1177/0363546514526151; Knapik JJ, 2007, SPORTS MED, V37, P117, DOI 10.2165/00007256-200737020-00003; Kochhar T, BR J SPORTS MED; Koh JO, 2004, CLIN J SPORT MED, V14, P72, DOI 10.1097/00042752-200403000-00004; Koh JO, 2004, BRAIN INJURY, V18, P1287, DOI 10.1080/02699050410001719907; LANNUZEL A, 1994, NEUROPEDIATRICS, V25, P106, DOI 10.1055/s-2008-1071595; Lee AD, SPORTS HLTH; Lystad RP, 2013, BRIT J SPORT MED, V47, P441, DOI 10.1136/bjsports-2012-091666; Lystad RP, ORTHOP J SPORTS MED; Macan J, 2006, BRIT J SPORT MED, V40, P330; Malek AM, 2000, J TRAUMA, V48, P143, DOI 10.1097/00005373-200001000-00027; Mars JS, 1995, BRIT J SPORT MED, V29, P273, DOI 10.1136/bjsm.29.4.273; Mbubaegbu CE, BR J SPORTS MED; McCarron MA, 1997, BRIT J SPORT MED, V31, P346, DOI 10.1136/bjsm.31.4.346; McClain R, 2014, CLIN J SPORT MED, V24, P497, DOI 10.1097/JSM.0000000000000078; National Collegiate Athletic Association, FOOTB INJ; Ngai KM, BR J SPORTS MED; Ortu M, 2006, BRIT J SPORT MED, V40, P730, DOI 10.1136/bjsm.2006.026500; Padulo J, 2014, J SPORT MED PHYS FIT, V54, P715; Pieter W, 2005, MED SPORT SCI, V48, P59, DOI 10.1159/000084283; Pieter W, 2012, BRIT J SPORT MED, V46, P485, DOI 10.1136/bjsports-2012-091011; Pocecco E, 2013, BRIT J SPORT MED, V47, P1139, DOI 10.1136/bjsports-2013-092886; Reider B, 2014, AM J SPORT MED, V42, P1287, DOI 10.1177/0363546514535717; Slowey M, 2012, EMERG MED AUSTRALAS, V24, P203, DOI 10.1111/j.1742-6723.2011.01496.x; United States Fight League, 2016, PANKR GRAPPL MIX MAR; Vando S, 2013, J HUM KINET, V38, P45, DOI 10.2478/hukin-2013-0044; Wall Robert B, 2005, J Pediatr Health Care, V19, P230, DOI 10.1016/j.pedhc.2005.02.006; Wong V, PEDIAT SPORTS MED ES; Woodward Thomas W, 2009, WMJ, V108, P40; Yard EE, 2007, J SCI MED SPORT, V10, P219, DOI 10.1016/j.jsams.2006.06.016; Zetaruk MN, 2005, BRIT J SPORT MED, V39, P29, DOI 10.1136/bjsm.2003.010322; Zetaruk MN, 2000, CLIN J SPORT MED, V10, P117, DOI 10.1097/00042752-200004000-00006; Zigun JR, AM J SPORTS MED	51	11	11	0	25	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	DEC	2016	138	6							e20163022	10.1542/peds.2016-3022			9	Pediatrics	Pediatrics	ED5WX	WOS:000388924800071		Bronze			2021-06-18	
J	Gu, YQ; Chen, J; Wang, TH; Zhou, CN; Liu, ZD; Ma, LH				Gu, Youquan; Chen, Jun; Wang, Tianhong; Zhou, Chaoning; Liu, Zhaodong; Ma, Lanhua			Hsp70 inducer, 17-allylamino-demethoxygeldanamycin, provides neuroprotection via anti-inflammatory effects in a rat model of traumatic brain injury	EXPERIMENTAL AND THERAPEUTIC MEDICINE			English	Article						17-allylamino-demethoxygeldanamycin; neuroprotection; traumatic brain injury; inflammatory cytokines; neuronal death; rats	HEAT-SHOCK-PROTEIN; FOCAL CEREBRAL-ISCHEMIA; TRANSGENIC MOUSE MODEL; NF-KAPPA-B; OVEREXPRESSION; EXPRESSION; MICE; EXCITOTOXICITY; INFLAMMATION; MECHANISM	Traumatic brain injury (TBI) is the predominant cause of mortality in young adults and children living in China. TBI induces inflammatory responses; in addition, tumor necrosis factor-alpha (TNF-alpha), interleukin-1 beta (IL-1 beta), and IL-6 are important pro-inflammatory cytokines. Considering the observation that Hsp-70 overexpression can exert neuroprotection, identifying a drug that is able to induce the upregulation of Hsp70 has the potential to be a promising therapy for the treatment of neurological diseases. Thus, the present study assessed the clinical effectiveness of an anticancer drug and Hsp70 activator, 17-allylamino-demethoxygeldanamycin (17-AAG), to evaluate its potential as a treatment for patients with TBI. The aim of present study was to determine the neuroprotective effects of 17-AAG following trauma and to investigate the underlying mechanisms of action. To establish rat models, rats were subjected to a controlled cortical impact injury and randomly divided into vehicle or 17-AAG groups. In the 17-AAG group, rats were administered with an intraperitoneal injection of 17-AAG (80 mg/kg) immediately following the establishment of TBI. The motor function was measured using Neurologic Severity Score, and neuronal death was evaluated using immunofluorescence. The expression levels of GLT-1, Bcl-2 and Hsp-70 were detected by western blot analysis and the expression levels of inflammatory cytokines were quantified using ELISA. The present study determined that 17-AAG significantly reduced brain edema and motor neurological deficits (P<0.05), in addition to increasing neuronal survival. The aforementioned findings are associated with a downregulation of the expression levels of pro-inflammatory cytokines TNF-alpha, IL-1 beta and IL-6. Conversely, no significant changes of glutamate transporter-1 expression were observed. The present results suggest that 17-AAG treatment may provide a neuroprotective effect by reducing inflammation following TBI.	[Gu, Youquan; Zhou, Chaoning; Liu, Zhaodong; Ma, Lanhua] Lanzhou Univ, Hosp 1, Donggang Branch, Dept Neurol, Lanzhou 730000, Gansu, Peoples R China; [Chen, Jun; Wang, Tianhong] Lanzhou Univ, Hosp 1, Dept Neurol, 1 Donggangxi Rd, Lanzhou 730000, Gansu, Peoples R China	Chen, J (corresponding author), Lanzhou Univ, Hosp 1, Dept Neurol, 1 Donggangxi Rd, Lanzhou 730000, Gansu, Peoples R China.	guyq@lzu.edu.cn					Adachi H, 2003, J NEUROSCI, V23, P2203; Aibiki M, 1999, J NEUROTRAUM, V16, P225, DOI 10.1089/neu.1999.16.225; Chen G, 2007, NEUROSCI LETT, V425, P177, DOI 10.1016/j.neulet.2007.08.022; Chen SF, 2008, BRIT J PHARMACOL, V155, P1279, DOI 10.1038/bjp.2008.345; Cui CM, 2015, MOL MED REP, V12, P2323, DOI 10.3892/mmr.2015.3611; Ding XZ, 2001, CYTOKINE, V16, P210, DOI 10.1006/cyto.2001.0959; Fumo G, 2004, BLOOD, V103, P1078, DOI 10.1182/blood-2003-07-2477; Hang CH, 2005, J SURG RES, V123, P188, DOI 10.1016/j.jss.2004.08.002; Harrison EM, 2008, AM J PHYSIOL-RENAL, V295, pF397, DOI 10.1152/ajprenal.00361.2007; Heneka MT, 2000, J CEREBR BLOOD F MET, V20, P800, DOI 10.1097/00004647-200005000-00006; Hollander JM, 2004, CIRCULATION, V110, P3544, DOI 10.1161/01.CIR.0000148825.99184.50; Hutter JJ, 1996, CIRCULATION, V94, P1408, DOI 10.1161/01.CIR.94.6.1408; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; IKEDA Y, 1990, NEUROSURGERY, V27, P1; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Kamm K, 2006, J TRAUMA, V60, P152, DOI 10.1097/01.ta.0000196345.81169.a1; Kelly Stephen, 2002, Curr Med Res Opin, V18 Suppl 2, ps55, DOI 10.1185/030079902125000732; Kim Nuri, 2012, Inflammopharmacology, V20, P177, DOI 10.1007/s10787-011-0115-3; Lee SH, 2001, STROKE, V32, P2905, DOI 10.1161/hs1201.099604; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; NOWAK TS, 1994, BRAIN PATHOL, V4, P67; O'Connor WT, 2011, PHARMACOL THERAPEUT, V130, P106, DOI 10.1016/j.pharmthera.2011.01.001; Outeiro TF, 2006, BIOCHEM BIOPH RES CO, V351, P631, DOI 10.1016/j.bbrc.2006.10.085; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Wei J, 2012, J TRAUMA ACUTE CARE, V73, P654, DOI 10.1097/TA.0b013e31825133c0; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Zheng Z, 2008, J CEREBR BLOOD F MET, V28, P53, DOI 10.1038/sj.jcbfm.9600502	31	11	12	0	9	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-0981	1792-1015		EXP THER MED	Exp. Ther. Med.	DEC	2016	12	6	A				3767	3772		10.3892/etm.2016.3821			6	Medicine, Research & Experimental	Research & Experimental Medicine	EG5IB	WOS:000391076400046	28101166	Green Published, Bronze			2021-06-18	
J	Moore, M; Whiteside, LK; Dotolo, D; Wang, J; Ho, LN; Conley, B; Forrester, M; Fouts, SO; Vavilala, MS; Zatzick, DF				Moore, Megan; Whiteside, Lauren K.; Dotolo, Danae; Wang, Jin; Ho, Leyna; Conley, Bonnie; Forrester, Mollie; Fouts, Susan O.; Vavilala, Monica S.; Zatzick, Douglas F.			The Role of Social Work in Providing Mental Health Services and Care Coordination in an Urban Trauma Center Emergency Department	PSYCHIATRIC SERVICES			English	Article							BRAIN-INJURY; UNITED-STATES; DISORDERS; IMPLEMENTATION; INTERVENTION; COMORBIDITY; DEPRESSION; SETTINGS; TRENDS; PTSD	Objective: This study examined the role of emergency department (ED) social workers and identified predictors of receipt of social work services and length of ED stay. Methods: Comprehensive reviews were conducted of medical records of all patients (N= 49,354) treated in a level 1 trauma center ED from January 1, 2012, to March 31, 2013. Content analysis of chart notes was used to categorize the types of social work services provided. Poisson regression was used to assess associations between demographic and clinical characteristics, receipt of social work services, and length of ED stay. Results: Social work services were provided to 18,532 (38%) patients. Most were mental health services (54%), followed by care coordination (31%) and material support or other referrals (15%). Patients seen by social workers had complex presentations, involving mental disorder diagnoses (18%), substance use disorder diagnoses (29%), comorbid diagnoses (32%), and injuries (51%); a quarter of patients had multiple ED visits (26%). In adjusted regression analysis, females (relative risk [RR]= 1.15), patients not discharged home (RR= 1.44), and those with two or more comorbid diagnoses (RR= 1.80), injuries due to assault (RR= 1.37), and traumatic brain injury (RR= 1.20) were more likely to receive social work services. Such services were associated with an increased length of ED stay (RR= 1.34). Conclusions: Social workers provided services to patients with multifaceted needs resulting from complex presentations. Provision of social work services modestly increased length of ED stay. Triage algorithms are needed to target efficiencies, systematize provision of ED social work services, and improve access to services for all patients.	[Moore, Megan; Dotolo, Danae; Ho, Leyna] Univ Washington, Sch Social Work, Seattle, WA 98195 USA; [Moore, Megan] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA; [Whiteside, Lauren K.; Wang, Jin; Vavilala, Monica S.; Zatzick, Douglas F.] Univ Washington, Dept Emergency Med, Seattle, WA 98195 USA; [Conley, Bonnie; Forrester, Mollie; Fouts, Susan O.] Univ Washington, Harborview Dept Social Work, Seattle, WA 98195 USA; [Vavilala, Monica S.] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA; [Zatzick, Douglas F.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA	Moore, M (corresponding author), Univ Washington, Sch Social Work, Seattle, WA 98195 USA.; Moore, M (corresponding author), Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA.	mm99@uw.edu		Whiteside, Lauren/0000-0002-0284-5336	National Center for Advancing Translational Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR000421]	This work was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health (grant KL2TR000421 to Dr. Moore).	Almgren G, 2012, SAFETY-NET HEALTH CARE SYSTEM: HEALTH CARE AT THE MARGINS, P1; American College of Surgeons Committee on Trauma, 2014, RESOURCES OPTIMAL CA, V6th; Andrews CM, 2013, HEALTH SOC WORK, V38, P67, DOI 10.1093/hsw/hlt002; [Anonymous], 2010, MATR E COD GROUP; [Anonymous], 2010, GREATER SEATTLE DATA; Auerbach C, 2000, SOC WORK HEALTH CARE, V32, P9; Auerbach C, 2007, SOC WORK HEALTH CARE, V44, P17, DOI 10.1300/J010v44n04_02; Auerbach C, 2010, SOC WORK HEALTH CARE, V49, P314, DOI 10.1080/00981380903426772; Baillargeon J, 2008, PSYCHIAT SERV, V59, P808, DOI 10.1176/appi.ps.59.7.808; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Cavanagh S, 1997, Nurse Res, V4, P5, DOI 10.7748/nr.4.3.5.s2; Council on Social Work Education, 2008, ED POL ACCR STAND; Dikmen SS, 2004, ARCH PHYS MED REHAB, V85, P1457, DOI 10.1016/j.apmr.2003.12.041; Faul M XL, 2010, TRAUMATIC BRAIN INJU; Gordon JA, 2001, ACAD EMERG MED, V8, P54, DOI 10.1111/j.1553-2712.2001.tb00552.x; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Hackman AL, 2006, PSYCHIAT SERV, V57, P563, DOI 10.1176/appi.ps.57.4.563; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617; Kushel MB, 2006, J GEN INTERN MED, V21, P71, DOI 10.1111/j.1525-1497.2005.00278.x; Love J, 2014, PSYCHIAT SERV, V65, P918, DOI 10.1176/appi.ps.201300399; Mahajan P, 2005, ANN EMERG MED, V45, P245, DOI 10.1016/j.annemergmed.2004.06.008; Moore M, 2014, BRAIN INJURY, V28, P448, DOI 10.3109/02699052.2014.890746; Moore M, 2012, SOC WORK HEALTH CARE, V51, P140, DOI 10.1080/00981389.2011.610872; [NAT'L CTR. FOR HEALTH STATISTICS CTRS. FOR DISEASE CONTROL & PREVENTION], 2008, NAT HOSP AMB MED CAR; National Center for Health Statistics, 2010, NAT HOSP AMB MED CAR; Pines JM, 2009, ACAD EMERG MED, V16, P403, DOI 10.1111/j.1553-2712.2009.00381.x; Pletcher MJ, 2008, JAMA-J AM MED ASSOC, V299, P70, DOI 10.1001/jama.2007.64; Rasooly IR, 2014, J PEDIATR-US, V165, P618, DOI 10.1016/j.jpeds.2014.04.059; Rockett IRH, 2003, ANN EMERG MED, V41, P802, DOI 10.1067/mem.2003.189; Russo J, 2013, GEN HOSP PSYCHIAT, V35, P485, DOI 10.1016/j.genhosppsych.2013.04.016; Shumway M, 2008, AM J EMERG MED, V26, P155, DOI 10.1016/j.ajem.2007.04.021; Smulowitz PB, 2011, ANN EMERG MED, V58, P225, DOI 10.1016/j.annemergmed.2011.02.020; Tang N, 2010, JAMA-J AM MED ASSOC, V304, P664, DOI 10.1001/jama.2010.1112; Taubman SL, 2014, SCIENCE, V343, P263, DOI 10.1126/science.1246183; Thomas DR, 2006, AM J EVAL, V27, P237, DOI 10.1177/1098214005283748; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; Van Eaton EG, 2014, J AM COLL SURGEONS, V219, P505, DOI 10.1016/j.jamcollsurg.2014.02.032; Wu LT, 2012, ANN EMERG MED, V60, P172, DOI 10.1016/j.annemergmed.2012.02.003; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	39	11	11	0	11	AMER PSYCHIATRIC PUBLISHING, INC	ARLINGTON	1000 WILSON BOULEVARD, STE 1825, ARLINGTON, VA 22209-3901 USA	1075-2730	1557-9700		PSYCHIAT SERV	Psychiatr. Serv.	DEC 1	2016	67	12					1348	1354		10.1176/appi.ps.201500469			7	Health Policy & Services; Public, Environmental & Occupational Health; Psychiatry	Health Care Sciences & Services; Public, Environmental & Occupational Health; Psychiatry	EF1ZE	WOS:000390122900016	27417898	Bronze			2021-06-18	
J	Naito, H; Isotani, E; Callaway, CW; Hagioka, S; Morimoto, N				Naito, Hiromichi; Isotani, Eiji; Callaway, Clifton W.; Hagioka, Shingo; Morimoto, Naoki			Intracranial Pressure Increases During Rewarming Period After Mild Therapeutic Hypothermia in Postcardiac Arrest Patients	THERAPEUTIC HYPOTHERMIA AND TEMPERATURE MANAGEMENT			English	Article						intracranial pressure; cerebral edema; heart arrest	INTRA-CRANICAL PRESSURE; TRAUMATIC BRAIN-INJURY; CARDIOPULMONARY-RESUSCITATION; CARDIAC-ARREST; HYPERTENSION; ICP; MODEL	Elevation of intracranial pressure (ICP) may worsen brain injury and neurological outcome. Studies on the use of therapeutic hypothermia (TH) for traumatic brain injury suggests that rapid rewarming from TH is associated with elevated ICP and poorer outcomes. However, few studies describe the time course of ICP changes during TH/rewarming after cardiac arrest (CA). In this study, we observed the changes in ICP during mild TH and rewarming after CA. Secondarily, we examined whether ICP is related to outcome. We studied comatose patients resuscitated from CA, who were treated with TH and who had ICP monitored. Target core temperature was 34 degrees C for 24h and target rewarming rate was 0.25 degrees C/h. ICP and cerebral perfusion pressure (CPP) were monitored during the period. Outcome was rated as cerebral performance category. In nine patients, ICP increased during TH and rewarming (6.0 [4.0-9.0] mmHg to 16.0 [12.0-26.0] mmHg, p=0.008). CPP did not change during the period (83.3 [80.1-91.0] mmHg to 74.3 [52.0-87.3] mmHg). Higher ICP was associated with worse outcomes (p=0.009). All the cases with ICP >25mmHg or CPP <40mmHg died. Major ICP increment was observed during the rewarming period, although, some increase of ICP occurred even during the mild TH. ICP increment was higher in patients with worse outcomes.	[Naito, Hiromichi; Callaway, Clifton W.] Univ Pittsburgh, Sch Med, Dept Emergency Med, 400A Iroquois Bldg,3600 Forbes Ave, Pittsburgh, PA 15261 USA; [Isotani, Eiji] Tokyo Womens Med Univ, Med Ctr East, Dept Emergency & Crit Care Med, Tokyo, Japan; [Hagioka, Shingo; Morimoto, Naoki] Tsuyama Chuo Byoin, Emergency Ctr, Tsuyama, Japan; [Hagioka, Shingo; Morimoto, Naoki] Tsuyama Chuo Byoin, Crit Care Unit, Tsuyama, Japan	Naito, H (corresponding author), Univ Pittsburgh, Sch Med, Dept Emergency Med, 400A Iroquois Bldg,3600 Forbes Ave, Pittsburgh, PA 15261 USA.	naito.hiromichi@gmail.com		Naito, Hiromichi/0000-0002-7308-1716			Callaway CW, 2015, CIRCULATION, V132, pS465, DOI 10.1161/CIR.0000000000000262; DEAN JM, 1981, NEUROSURGERY, V9, P627; Flynn LMC, 2015, THER HYPOTHERMIA TEM, V5, P143, DOI 10.1089/ther.2015.0002; GUEUGNIAUD PY, 1991, INTENS CARE MED, V17, P392, DOI 10.1007/BF01720676; Iida K, 1997, CRIT CARE MED, V25, P971, DOI 10.1097/00003246-199706000-00013; Kim YH, 2014, ACAD EMERG MED, V21, P1121, DOI 10.1111/acem.12477; Kurtz P, 2013, NEUROCRIT CARE, V19, P311, DOI 10.1007/s12028-013-9919-x; Lee KJ, 2015, BIOMED ENG ONLINE, V14, DOI 10.1186/s12938-015-0051-3; Maitinez-Manas RM, 2000, J NEUROL NEUROSUR PS, V69, P82, DOI 10.1136/jnnp.69.1.82; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; MILLER JD, 1987, ACTA NEUROCHIR, V85, P80, DOI 10.1007/BF01456102; Moretti R, 2009, J NEUROSURG ANESTH, V21, P16, DOI 10.1097/ANA.0b013e318185996a; Nordmark J, 2009, ACTA ANAESTH SCAND, V53, P289, DOI 10.1111/j.1399-6576.2008.01885.x; Robba C, 2015, NEUROCRIT CARE, V23, P419, DOI 10.1007/s12028-015-0163-4; SAKABE T, 1987, INTENS CARE MED, V13, P256, DOI 10.1007/BF00265114; SENTER HJ, 1981, J NEUROSURG, V54, P489, DOI 10.3171/jns.1981.54.4.0489	17	11	11	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	2153-7658	2153-7933		THER HYPOTHERMIA TEM	Ther. Hypothermia Temp. Manag.	DEC	2016	6	4					189	193		10.1089/ther.2016.0009			5	Critical Care Medicine	General & Internal Medicine	EL1DR	WOS:000394361200006	27213805				2021-06-18	
J	Roumeliotis, N; Dong, C; Pettersen, G; Crevier, L; Emeriaud, G				Roumeliotis, Nadia; Dong, Christian; Pettersen, Graldine; Crevier, Louis; Emeriaud, Guillaume			Hyperosmolar therapy in pediatric traumatic brain injury: a retrospective study	CHILDS NERVOUS SYSTEM			English	Article						Traumatic brain injury; Pediatric; Hyperosmolar therapy; Mannitol; 3% hypertonic saline; Intracranial hypertension	INCREASED INTRACRANIAL-PRESSURE; HYPERTONIC SALINE; 20-PERCENT MANNITOL; CHILDREN; HYPERTENSION; 7.2-PERCENT; TRIAL	The objectives of the study are to describe the use of hyperosmolar therapy in pediatric traumatic brain injury (TBI) and examine its effect on intracranial pressure (ICP) and cerebral perfusion pressure (CPP). A retrospective review of patients with severe TBI admitted to the pediatric intensive care unit (PICU) was conducted. Inclusion criteria were ICP monitoring and administration of a hyperosmolar agent (20 % mannitol or 3 % hypertonic saline) within 48 h of PICU admission; for which dose and timing were recorded. For the first two boluses received for increased ICP (> 20 mmHg), the impact on ICP and CPP was assessed during the following 4 h, using repeated measures ANOVA. Co-interventions to control ICP (additional hyperosmolar agent, propofol, or barbiturate bolus) and serum sodium were also documented. A tertiary care pediatric hospital center. Children aged 1 month to 18 years, with severe traumatic brain injury (Glasgow Coma Score 8) and intracranial pressure (ICP) monitor. Sixty-four patients were eligible, of which 16 met inclusion criteria. Average age was 11 years (SD +/- 4) and median Glasgow Coma Score was 6 (range 4-7). Seventy percent of boluses were 3 % hypertonic saline, with no identified baseline difference associated with this initial choice. Both mannitol and hypertonic saline were followed by a non-significant decrease in ICP (mannitol, p = 0.055 and hypertonic saline, p = 0.096). There was no significant change in CPP post bolus. A co-intervention occurred in 69 % of patients within the 4 h post hyperosmolar agent, and eight patients received continuous 3 % saline. In pediatric TBI with intracranial hypertension, mannitol and 3 % hypertonic saline are commonly used, but dose and therapeutic threshold for use vary without clear indications for one versus another. Controlled trials are warranted, but several barriers were identified, including high exclusion rate, multiple co-interventions, and care variability.	[Roumeliotis, Nadia; Pettersen, Graldine; Emeriaud, Guillaume] Univ Montreal, CHU St Justine, Dept Critial Care, 3175 Cote St Catherine, Montreal, PQ H3T 1C5, Canada; [Dong, Christian] Univ Montreal, CHU St Justine, Res Ctr, Montreal, PQ, Canada; [Crevier, Louis] Univ Montreal, CHU St Justine, Dept Neurosurg, Montreal, PQ, Canada	Roumeliotis, N (corresponding author), Univ Montreal, CHU St Justine, Dept Critial Care, 3175 Cote St Catherine, Montreal, PQ H3T 1C5, Canada.	nadia.roumeliotis@gmail.com		Roumeliotis, Nadia/0000-0001-7463-1233	Centre D'excellence en Traumatologie du CHU Sainte-Justine; Fonds de Recherche Quebec Sant (FRQS)	Centre D'excellence en Traumatologie du CHU Sainte-Justine 2) GE's research program is supported by the Fonds de Recherche Quebec Sant (FRQS).	Adelson P David, 2003, Pediatr Crit Care Med, V4, pS40; Battison C, 2005, CRIT CARE MED, V33, P196, DOI 10.1097/01.CCM.0000150269.65485.A6; Bell MJ, 2013, PEDIATR CRIT CARE ME, V14, P811, DOI 10.1097/PCC.0b013e3182975e2f; Bennett TD, 2012, ARCH PEDIAT ADOL MED, V166, P641, DOI 10.1001/archpediatrics.2012.322; Bennett TD, 2012, CRIT CARE MED, V40, P208, DOI 10.1097/CCM.0b013e31822e9d31; Bentsen G, 2006, CRIT CARE MED, V34, P2912, DOI 10.1097/01.CCM.0000245665.46789.7C; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS91; Cottenceau V, 2011, J NEUROTRAUM, V28, P2003, DOI 10.1089/neu.2011.1929; Favre JB, 1996, SCHWEIZ MED WSCHR, V126, P1635; FISHER B, 1992, J NEUROSURG ANESTH, V4, P4, DOI 10.1097/00008506-199201000-00002; Francony G, 2008, CRIT CARE MED, V36, P795, DOI 10.1097/CCM.0B013E3181643B41; Harutjunyan L, 2005, CRIT CARE, V9, pR530, DOI 10.1186/cc3767; Heron Melonie, 2015, Natl Vital Stat Rep, V64, P1; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Li M, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000736; MUIZELAAR JP, 1983, J NEUROSURG, V59, P822, DOI 10.3171/jns.1983.59.5.0822; Rickard AC, 2014, EMERG MED J, V31, P679, DOI 10.1136/emermed-2013-202679; Roumeliotis N, 2015, CHILD NERV SYST, V31, P2011, DOI 10.1007/s00381-015-2837-9; Sakellaridis N, 2011, J NEUROSURG, V114, P545, DOI 10.3171/2010.5.JNS091685; Shein SL, 2015, PEDIAT CRIT CARE MED; Simma B, 1998, CRIT CARE MED, V26, P1265, DOI 10.1097/00003246-199807000-00032; Stein DM, 2011, J TRAUMA, V71, P364, DOI 10.1097/TA.0b013e31822820da; Vialet R, 2003, CRIT CARE MED, V31, P1683, DOI 10.1097/01.CCM.0000063268.91710.DF	23	11	13	0	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	DEC	2016	32	12					2363	2368		10.1007/s00381-016-3231-y			6	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	EE5GL	WOS:000389633500017	27568371				2021-06-18	
J	Visser-Keizer, AC; Westerhof-Evers, HJ; Gerritsen, MJJ; van der Naalt, J; Spikman, JM				Visser-Keizer, Annemarie C.; Westerhof-Evers, Herma J.; Gerritsen, Marleen J. J.; van der Naalt, Joukje; Spikman, Jacoba M.			To Fear Is to Gain? The Role of Fear Recognition in Risky Decision Making in TBI Patients and Healthy Controls	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; IOWA GAMBLING TASK; FACIAL EMOTION RECOGNITION; PREFRONTAL CORTEX; SEX-DIFFERENCES; SOCIAL COGNITION; DEFICITS; DAMAGE; LESIONS; METAANALYSIS	Fear is an important emotional reaction that guides decision making in situations of ambiguity or uncertainty. Both recognition of facial expressions of fear and decision making ability can be impaired after traumatic brain injury (TBI), in particular when the frontal lobe is damaged. So far, it has not been investigated how recognition of fear influences risk behavior in healthy subjects and TBI patients. The ability to recognize fear is thought to be related to the ability to experience fear and to use it as a warning signal to guide decision making. We hypothesized that a better ability to recognize fear would be related to a better regulation of risk behavior, with healthy controls outperforming TBI patients. To investigate this, 59 healthy subjects and 49 TBI patients were assessed with a test for emotion recognition (Facial Expression of Emotion: Stimuli and Tests) and a gambling task (Iowa Gambling Task (IGT)). The results showed that, regardless of post traumatic amnesia duration or the presence of frontal lesions, patients were more impaired than healthy controls on both fear recognition and decision making. In both groups, a significant relationship was found between better fear recognition, the development of an advantageous strategy across the IGT and less risk behavior in the last blocks of the IGT. Educational level moderated this relationship in the final block of the IGT. This study has important clinical implications, indicating that impaired decision making and risk behavior after TBI can be preceded by deficits in the processing of fear.	[Visser-Keizer, Annemarie C.; Gerritsen, Marleen J. J.; van der Naalt, Joukje; Spikman, Jacoba M.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands; [Westerhof-Evers, Herma J.] Univ Groningen, Univ Med Ctr Groningen, Ctr Rehabil, Groningen, Netherlands; [Westerhof-Evers, Herma J.; Spikman, Jacoba M.] Univ Groningen, Dept Clin & Dev Neuropsychol, Groningen, Netherlands	Visser-Keizer, AC (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands.	a.c.visser@umcg.nl		Spikman, Jacoba/0000-0002-6477-0763	Dutch Brain Foundation [F2008-1-18]	This study was funded by the Dutch Brain Foundation, grant number F2008-1-18 ww.hersenstichting.nl. JMS HJWE JN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Adolphs R, 2000, J NEUROSCI, V20, P2683; Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; Aite A, 2013, EMOTION, V13, P177, DOI 10.1037/a0031345; Arrais KC, 2010, J PSYCHIATR RES, V44, P535, DOI 10.1016/j.jpsychires.2009.11.003; Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; Balconi M, 2011, NEUROSCI RES, V71, P251, DOI 10.1016/j.neures.2011.07.1833; Bastiaansen JACJ, 2009, PHILOS T R SOC B, V364, P2391, DOI 10.1098/rstb.2009.0058; Bechara A, 2000, BRAIN, V123, P2189, DOI 10.1093/brain/123.11.2189; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; Beitz KM, 2014, J EXP PSYCHOL GEN, V143, P1677, DOI 10.1037/a0035823; Bonatti E, 2008, COGN BEHAV NEUROL, V21, P164, DOI 10.1097/WNN.0b013e318184e688; Bornhofen C, 2008, NEUROPSYCHOL REHABIL, V18, P22, DOI 10.1080/09602010601061213; Brand M, 2007, J CLIN EXP NEUROPSYC, V29, P86, DOI 10.1080/13803390500507196; Buchanan TW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010640; Bull PN, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00391; Cotrena C, 2014, BRAIN INJURY, V28, P1070, DOI 10.3109/02699052.2014.896943; Croker V, 2005, BRAIN INJURY, V19, P787, DOI 10.1080/02699050500110033; de Sousa A, 2010, NEUROPSYCHOLOGIA, V48, P3585, DOI 10.1016/j.neuropsychologia.2010.08.008; Dimberg U, 2000, PSYCHOL SCI, V11, P86, DOI 10.1111/1467-9280.00221; DIMBERG U, 1990, BIOL PSYCHOL, V30, P151, DOI 10.1016/0301-0511(90)90024-Q; Doty TJ, 2014, COGN AFFECT BEHAV NE, V14, P1438, DOI 10.3758/s13415-014-0290-y; Duffau H, 2012, CORTEX, V48, P120, DOI 10.1016/j.cortex.2011.04.029; Dunn BD, 2010, PSYCHOL SCI, V21, P1835, DOI 10.1177/0956797610389191; EKMAN P, 1992, COGNITION EMOTION, V6, P169, DOI 10.1080/02699939208411068; Evans JSBT, 2011, DEV REV, V31, P86, DOI 10.1016/j.dr.2011.07.007; Evans KL, 2015, BRAIN COGNITION, V93, P42, DOI 10.1016/j.bandc.2014.11.006; Fellows LK, 2005, CEREB CORTEX, V15, P58, DOI 10.1093/cercor/bhh108; Figner B, 2009, J EXP PSYCHOL LEARN, V35, P709, DOI 10.1037/a0014983; Fujiwara E, 2008, NEUROPSYCHOLOGIA, V46, P461, DOI 10.1016/j.neuropsychologia.2007.08.027; Genova HM, 2015, SOC NEUROSCI-UK, V10, P27, DOI 10.1080/17470919.2014.959618; Green REA, 2004, NEUROPSYCHOLOGIA, V42, P133, DOI 10.1016/j.neuropsychologia.2003.07.005; Heilman RM, 2010, EMOTION, V10, P257, DOI 10.1037/a0018489; Ibarretxe-Bilbao N, 2009, EUR J NEUROSCI, V30, P1162, DOI 10.1111/j.1460-9568.2009.06892.x; Jenkins LM, 2014, PSYCHIAT RES-NEUROIM, V224, P192, DOI 10.1016/j.pscychresns.2014.08.007; Keltner D, 1999, COGNITION EMOTION, V13, P505, DOI 10.1080/026999399379168; Knox L, 2009, BRAIN COGNITION, V69, P442, DOI 10.1016/j.bandc.2008.09.009; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Letswaart M, 2008, NEUROPSYCHOLOGIA, V46, P148; Levenson RW, 1999, COGNITION EMOTION, V13, P481, DOI 10.1080/026999399379159; Levine B, 2005, COGN BEHAV NEUROL, V18, P45, DOI 10.1097/01.wnn.0000152227.13001.c3; Loewenstein GF, 2001, PSYCHOL BULL, V127, P267, DOI 10.1037//0033-2909.127.2.267; LUNDQVIST LO, 1995, SCAND J PSYCHOL, V36, P130, DOI 10.1111/j.1467-9450.1995.tb00974.x; MacPherson SE, 2009, CLIN NEUROPSYCHOL, V23, P510, DOI 10.1080/13854040802396586; Maia TV, 2004, P NATL ACAD SCI USA, V101, P16075, DOI 10.1073/pnas.0406666101; Manes F, 2002, BRAIN, V125, P624, DOI 10.1093/brain/awf049; Marsh AA, 2008, NEUROSCI BIOBEHAV R, V32, P454, DOI 10.1016/j.neubiorev.2007.08.003; Marsh AA, 2011, J CHILD PSYCHOL PSYC, V52, P834, DOI 10.1111/j.1469-7610.2010.02353.x; McDonald S, 2011, J CLIN EXP NEUROPSYC, V33, P17, DOI 10.1080/13803391003761967; Moody EJ, 2007, EMOTION, V7, P447, DOI 10.1037/1528-3542.7.2.447; Neumann D, 2014, J HEAD TRAUMA REHABI; Neumann D, 2014, J HEAD TRAUMA REHAB, V29, pE18, DOI 10.1097/HTR.0b013e31827fb0b5; Niedenthal PM, 2007, SCIENCE, V316, P1002, DOI 10.1126/science.1136930; Oberman LM, 2007, SOC NEUROSCI-UK, V2, P167, DOI 10.1080/17470910701391943; Ohman A, 2005, PSYCHONEUROENDOCRINO, V30, P953, DOI 10.1016/j.psyneuen.2005.03.019; Overman WH, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00935; Radice-Neumann D, 2009, J HEAD TRAUMA REHAB, V24, P313, DOI 10.1097/HTR.0b013e3181b09160; Rosenberg H, 2015, NEUROPSYCHOLOGY, V29, P509, DOI 10.1037/neu0000171; Ruffman T, 2008, NEUROSCI BIOBEHAV R, V32, P863, DOI 10.1016/j.neubiorev.2008.01.001; Schwarz N., 1990, HDB MOTIVATION COGNI, V2, P527, DOI DOI 10.2307/2072281; Seo MG, 2007, ACAD MANAGE J, V50, P923, DOI 10.2307/20159897; Sigurdardottir S, 2010, NEUROPSYCHOLOGY, V24, P504, DOI 10.1037/a0018934; Spikman JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065581; Spikman JM, 2012, J NEUROTRAUM, V29, P101, DOI 10.1089/neu.2011.2084; Surcinelli P, 2006, J ANXIETY DISORD, V20, P110, DOI 10.1016/j.janxdis.2004.11.010; Terasawa Y, 2014, COGNITION EMOTION, V28, P1435, DOI 10.1080/02699931.2014.888988; Thompson AE, 2014, COGNITION EMOTION, V28, P1164, DOI 10.1080/02699931.2013.875889; van den Bos R, 2013, BEHAV BRAIN RES, V238, P95, DOI 10.1016/j.bbr.2012.10.002; Van Kleef GA, 2010, SOC PERSONAL PSYCHOL, V4, P331, DOI 10.1111/j.1751-9004.2010.00262.x; Vandekerckhove M, 2014, NEUROPSYCHOLOGY, V28, P605, DOI 10.1037/neu0000057; Verdejo-Garcia A, 2007, DRUG ALCOHOL DEPEN, V86, P139, DOI 10.1016/j.drugalcdep.2006.05.024; Wallesch CW, 2001, BRAIN INJURY, V15, P401, DOI 10.1080/02699050010005959; Werner NS, 2009, PSYCHOPHYSIOLOGY, V46, P1123, DOI 10.1111/j.1469-8986.2009.00855.x; Yasuno F, 2014, BRAIN COGNITION, V84, P63, DOI 10.1016/j.bandc.2013.11.005; Yechiam E, 2005, PSYCHOL SCI, V16, P973, DOI 10.1111/j.1467-9280.2005.01646.x; Young A.W., 2002, FACIAL EXPRESSIONS E, P3595, DOI [10.1016/j.neuropsychologia.2010.08.008, DOI 10.1016/J.NEUROPSYCHOLOGIA.2010.08.008]; Zeelenberg M, 2008, JUDGM DECIS MAK, V3, P18	77	11	11	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2016	11	11							e0166995	10.1371/journal.pone.0166995			16	Multidisciplinary Sciences	Science & Technology - Other Topics	ED4UE	WOS:000388846400053	27870900	DOAJ Gold, Green Published			2021-06-18	
J	Tang, WC; Hsu, YC; Wang, CC; Hu, CY; Chio, CC; Kuo, JR				Tang, Wei-Chen; Hsu, Yao-Chin; Wang, Che-Chuan; Hu, Chiao-Ya; Chio, Chung-Ching; Kuo, Jinn-Rung			Early electroacupuncture treatment ameliorates neuroinflammation in rats with traumatic brain injury	BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE			English	Article						Astrocyte; Electroacupuncture; Microglia; Neuronal apoptosis; Traumatic brain injury; Tumor Necrosis factor-alpha a	TUMOR-NECROSIS-FACTOR; LATERAL FLUID-PERCUSSION; ACUPUNCTURE; ETANERCEPT; ACTIVATION; EXPRESSION; APOPTOSIS; ALPHA; ST36	Background: Neuroinflammation is the leading cause of neurological sequelae after traumatic brain injury (TBI). The aim of the present study was to investigate whether the neuroprotective effects of electroacupuncture (EA) are mediated by anti-neuroinflammatory effects in a rat model of TBI. Methods: Male Sprague-Dawley rats were randomly divided into three groups: sham-operated, TBI control, and EA-treated. The animals in the sham-operated group underwent a sham operation, those in the TBI control group were subjected to TBI, but not EA, and those in the EA group were treated with EA for 60 min immediately after TBI, daily for 3 consecutive days. EA was applied at the acupuncture points GV20, GV26, LI4, and KI1, using a densedispersed wave, at frequencies of 0.2 and 1 Hz, and an amplitude of 1 mA. Cell infarction volume (TTC stain), neuronal apoptosis (markers: TUNEL and Caspase-3), activation of microglia (marker: Iba1) and astrocytes (marker: GFAP), and tumor necrosis factor (TNF)-alpha expression in the microglia and astrocytes were evaluated by immunofluorescence. Functional outcomes were assessed using the inclined plane test. All tests were performed 72 h after TBI. Results: We found that TBI-induced loss of grasp strength, infarction volume, neuronal apoptosis, microglial and astrocyte activation, and TNF-alpha expression in activated microglia and astrocytes were significantly attenuated by EA treatment. Conclusions: Treatment of TBI in the acute stage with EA for 60 min daily for 3 days could ameliorate neuroinflammation. This may thus represent a mechanism by which functional recovery can occur after TBI.	[Tang, Wei-Chen] Tainan Municipal An Nan Hosp, Dept Chinese Med, Tainan, Taiwan; [Hsu, Yao-Chin] Chi Mei Med Ctr, Dept Chinese Med, Tainan, Taiwan; [Wang, Che-Chuan] Chi Mei Med Ctr, Dept Neurosurg, Tainan, Taiwan; [Wang, Che-Chuan; Hu, Chiao-Ya; Chio, Chung-Ching; Kuo, Jinn-Rung] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Wang, Che-Chuan] Southern Taiwan Univ Sci & Technol, Dept Child Care, Tainan, Taiwan; [Kuo, Jinn-Rung] Southern Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan, Taiwan; [Kuo, Jinn-Rung] Chi Mei Hosp, Traumat Brain Injury Ctr, 901 Zhonghua Rd, Tainan 710, Taiwan	Kuo, JR (corresponding author), Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan.; Kuo, JR (corresponding author), Southern Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan, Taiwan.	kuojinnrung@gmail.com			Chi-Mei Medical Center [CMFHR10315]	This work was supported by Chi-Mei Medical Center, grant number CMFHR10315.	Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; Chan HHL, 2005, J ALTERN COMPLEM MED, V11, P315, DOI 10.1089/acm.2005.11.315; Cheng CY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091426; Cheong CU, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/620837; Chio CC, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-33; Chio CC, 2010, J NEUROCHEM, V115, P921, DOI 10.1111/j.1471-4159.2010.06969.x; Chuang CH, 2013, ACUPUNCT MED, V31, P395, DOI 10.1136/acupmed-2013-010406; Du MH, 2015, J SURG RES, V195, P89, DOI 10.1016/j.jss.2014.12.043; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Eshkevari L, 2013, J ENDOCRINOL, V217, P95, DOI 10.1530/JOE-12-0404; Gu Chen-Yi, 2011, Zhongguo Zhen Jiu, V31, P236; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; Holmin S, 1999, NEUROREPORT, V10, P1889, DOI 10.1097/00001756-199906230-00017; Jiang SH, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/431580; Kim MW, 2012, ACUPUNCT MED, V30, P222, DOI 10.1136/acupmed-2011-010126; Koshinaga M, 2000, J NEUROTRAUM, V17, P185, DOI 10.1089/neu.2000.17.185; Kuai Le, 2005, Zhongguo Zhen Jiu, V25, P68; Kuo JR, 2011, J TRAUMA, V71, pE87, DOI 10.1097/TA.0b013e31820932e2; Li B, 2009, NEUROSURGERY, V65, P179, DOI 10.1227/01.NEU.0000346272.76537.DC; Lim SW, 2013, J SURG RES, V184, P1076, DOI 10.1016/j.jss.2013.04.070; Liu Xuan, 2009, Zhongguo Zhen Jiu, V29, P1026; Mayer DJ, 2000, ANNU REV MED, V51, P49, DOI 10.1146/annurev.med.51.1.49; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; ROSS SA, 1994, BRIT J NEUROSURG, V8, P419, DOI 10.3109/02688699408995109; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Wang Q, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-24; Wang Y, 1997, J NEUROSCI, V17, P4341; Xu H, 2014, CHIN J INTEGR MED, V20, P369, DOI 10.1007/s11655-014-1800-z; Yu JB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104924; Zhang D, 2010, MOL NEUROBIOL, V41, P232, DOI 10.1007/s12035-010-8098-4; Zhang J.Y., 2014, SCI WORLD J, V2014, P1, DOI DOI 10.1111/NPH.13030; Zhang L., 2014, EVID-BASED COMPL ALT, V2014	34	11	13	2	10	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1472-6882		BMC COMPLEM ALTERN M	BMC Complement. Altern. Med.	NOV 16	2016	16								470	10.1186/s12906-016-1457-6			12	Integrative & Complementary Medicine	Integrative & Complementary Medicine	EC7RZ	WOS:000388339300001	27852302	DOAJ Gold, Green Published			2021-06-18	
J	Bilotta, F; Robba, C; Santoro, A; Delfini, R; Rosa, G; Agati, L				Bilotta, Federico; Robba, Chiara; Santoro, Antonio; Delfini, Roberto; Rosa, Giovanni; Agati, Luciano			CONTRAST-ENHANCED ULTRASOUND IMAGING IN DETECTION OF CHANGES IN CEREBRAL PERFUSION	ULTRASOUND IN MEDICINE AND BIOLOGY			English	Article						Contrast ultrasound imaging; Decompressive craniectomy; Brain perfusion; Intra-cranial pressure	TRAUMATIC BRAIN-INJURY; BLOOD-VOLUME; INTRACRANIAL HYPERTENSION; DECOMPRESSIVE CRANIECTOMY; MECHANICAL VENTILATION; PULMONARY TRANSIT; ARTERIAL FRACTION; ECHOCARDIOGRAPHY; HEMICRANIECTOMY; ASSOCIATION	Contrast-enhanced ultrasonography (CEU) is a non-invasive imaging technique that provides real-time, bedside information on changes in global and segmental organ perfusion. Currently, there is a lack of data concerning changes in the distribution of segmental brain perfusion in acute ischemic stroke treated by decompressive craniectomy. The aim of our case series was to assess the role of CEU after decompressive craniectomy in patients with acute ischemic stroke. CEU was performed in 12 patients at baseline and after any one of the following interventions was performed as dictated by the patient's clinical condition: vasoactive drug administration (in order to achieve cerebral perfusion pressure >= 70 mm Hg and mean arterial pressure,100 mm Hg for management of arterial blood pressure) and mild hyperventilation (carbon dioxide arterial pressure 5 3035 mm Hg). CEU was able to detect a significant variation in cerebral contrast distribution in both normal and pathologic hemispheres after induced hyperventilation (difference in time to peak [dTTP] = -38.4%), vasodilation (dTTP = -6.6%) and vasoconstriction (dTTP = +31.2%) (p < 0.05). CEU can be useful in assessing real-time cerebral perfusion changes in neurocritical care patients. (C) 2016 World Federation for Ultrasound in Medicine & Biology.	[Bilotta, Federico; Rosa, Giovanni] Univ Rome Sapienza, Dept Anesthesiol, Rome, Italy; [Robba, Chiara] Addenbrookes Hosp, Neurocrit Care Unit, Cambridge, England; [Santoro, Antonio; Delfini, Roberto] Univ Rome Sapienza, Dept Neurosurg, Rome, Italy; [Agati, Luciano] Univ Rome Sapienza, Dept Cardiol, Rome, Italy	Robba, C (corresponding author), Cambridge Univ Hosp Trust, Addenbrookes Hosp, Neurocrit Care Unit, Hills Rd, Cambridge CB2 0QQ, England.	kiarobba@gmail.com	Robba, Chiara/AAS-7421-2020	agati, luciano/0000-0003-3186-1797			Adams HP, 2007, CIRCULATION, V115, pE478, DOI 10.1161/CIRCULATIONAHA.107.181486; Albanese J, 2003, CRIT CARE MED, V31, P2535, DOI 10.1097/01.CCM.0000089927.67396.F3; [Anonymous], 2007, J NEUROTRAUM, V24, pS1, DOI 10.1089/neu.2007.9997; [Anonymous], 2004, T AM CLIN CLIMAT ASS, V115, P137; Bilotta F, 2005, ECHOCARDIOGR-J CARD, V22, P395, DOI 10.1111/j.1540-8175.2005.04084.x; Bilotta F, 1999, ANESTH ANALG, V89, P273; Bilotta F, 2013, NEUROL RES, V35, P149, DOI 10.1179/1743132812Y.0000000155; Bor-Seng-Shu E, 2006, J NEUROSURG, V104, P93, DOI 10.3171/jns.2006.104.1.93; Brain Trauma Foundation, 2003, PEDIATR CRIT CARE ME, V4, P45; Ciccone MM, 2012, CURR NEUROVASC RES, V9, P120; Curry R, 2008, PEDIATR CRIT CARE ME, V9, P141, DOI 10.1097/PCC.0B013e318166870e; Daboussi A, 2009, J NEUROSURG ANESTH, V21, P339, DOI 10.1097/ANA.0b013e3181b1dbba; FORTUNE JB, 1995, J TRAUMA, V39, P463; Galiuto L, 2008, J AM COLL CARDIOL, V51, P552, DOI 10.1016/j.jacc.2007.09.051; Gover A, 2011, ISR MED ASSOC J, V13, P9; HARRINGTON T, 1973, NEUROLOGY, V23, P294, DOI 10.1212/WNL.23.3.294; He W, 2008, CLIN IMAG, V32, P419, DOI 10.1016/j.clinimag.2008.05.006; Heppner P, 2006, J NEUROSURG, V104, P738, DOI 10.3171/jns.2006.104.5.738; Hofmeijer J, 2006, TRIALS, V7, DOI 10.1186/1745-6215-7-29; Ito H, 2005, J CEREBR BLOOD F MET, V25, P852, DOI 10.1038/sj.jcbfm.9600076; Ito H, 2001, ANN NUCL MED, V15, P111, DOI 10.1007/BF02988600; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Kern R, 2004, STROKE, V35, P1665, DOI 10.1161/01.STR.0000129332.10721.7e; Li X, 2016, CLIN CARDIOL, V39, P453, DOI 10.1002/clc.22548; LUNDBERG N, 1965, J NEUROSURG, V22, P581, DOI 10.3171/jns.1965.22.6.0581; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; Neumann JO, 2008, INTENS CARE MED, V34, P1676, DOI 10.1007/s00134-008-1123-7; Orlacchio A, 2011, ULTRASOUND MED BIOL, V37, P1, DOI 10.1016/j.ultrasmedbio.2010.10.012; Rim SJ, 2001, CIRCULATION, V104, P2582, DOI 10.1161/hc4601.099400; Schirmer CM, 2008, NEUROCRIT CARE, V8, P456, DOI 10.1007/s12028-008-9082-y; Schirmer CM, 2007, STROKE, V38, P987, DOI 10.1161/01.STR.0000257962.58269.e2; Senior R, 2009, EUR J ECHOCARDIOGR, V10, P194, DOI 10.1093/ejechocard/jep005; Strebel SP, 1998, ANESTHESIOLOGY, V89, P67, DOI 10.1097/00000542-199807000-00012; Timofeev I, 2006, INJURY, V37, P1125, DOI 10.1016/j.injury.2006.07.031; Unsgaard G, 2002, NEUROSURGERY, V51, P402, DOI 10.1097/00006123-200208000-00019; VOCI P, 1995, CIRCULATION, V91, P1714, DOI 10.1161/01.CIR.91.6.1714; Voci P, 1994, J Am Soc Echocardiogr, V7, P337; Wintermark M, 2005, STROKE, V36, pE83, DOI 10.1161/01.STR.0000177884.72657.8b; Yang C, 2015, MED PHYS, V42, P4762, DOI 10.1118/1.4926550	39	11	11	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0301-5629	1879-291X		ULTRASOUND MED BIOL	Ultrasound Med. Biol.	NOV	2016	42	11					2708	2716		10.1016/j.ultrasmedbio.2016.06.007			9	Acoustics; Radiology, Nuclear Medicine & Medical Imaging	Acoustics; Radiology, Nuclear Medicine & Medical Imaging	EE3QR	WOS:000389511000020	27475927				2021-06-18	
J	Failla, MD; Juengst, SB; Graham, KM; Arenth, PM; Wagner, AK				Failla, Michelle D.; Juengst, Shannon B.; Graham, Kristin M.; Arenth, Patricia M.; Wagner, Amy K.			Effects of Depression and Antidepressant Use on Cognitive Deficits and Functional Cognition Following Severe Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						antidepressants; cognition; depression; international classification of functioning; Rehabilomics; traumatic brain injury	MULTIPLE ERRANDS TEST; MAJOR DEPRESSION; SIMPLIFIED VERSION; OLDER-ADULTS; SEVERE TBI; MILD; MEMORY; MODERATE; REHABILITATION; RECOVERY	Objective: To use a Rehabilomics framework to evaluate relations hips between post-traumatic brain injury (TBI) depression (PTD) and potential associated factors, including antidepressant use, on cognitive recovery following severe TBI. Participants: Severe TBI survivors (n = 154), recruited from a level 1 trauma center. Design: Prospective cohort study with assessments at 6 and 12 months postinjury. Main Measures: Patient Health Questionnaire-9 (PTD symptoms); cognitive composite score from a neuropsychological assessment battery (cognitive impairment); and Functional Independence Measure-Cognition (FIM-Cog, self-reported functional cognition). Results: Individuals with and without PTD did not differ with respect to cognitive impairment. However, antidepressant use, regardless of PTD status, was associated with cognitive impairment. Individuals with PTD reported lower FIM-Cog scores at both time points compared with those without PTD. In a post hoc longitudinal analysis, individuals with late-onset PTD had worse cognitive impairment. Conclusion: These results suggest that antidepressant use impairs cognition among individuals without PTD. Also, PTD did not directly affect cognitive impairment but may affect functional cognitive limitations through self-evaluation and apathy/motivation factors.	[Failla, Michelle D.; Wagner, Amy K.] Univ Pittsburgh, Ctr Neurosci, 4200 Fifth Ave, Pittsburgh, PA 15260 USA; [Failla, Michelle D.; Juengst, Shannon B.; Arenth, Patricia M.; Wagner, Amy K.] Univ Pittsburgh, Dept Phys Med & Rehabil, Sch Med, Pittsburgh, PA USA; [Graham, Kristin M.] Univ Pittsburgh, Dept Rehabil Sci & Technol, Pittsburgh, PA USA; [Wagner, Amy K.] Univ Pittsburgh, Dept Neurosci, Coll Arts & Sci, Pittsburgh, PA USA; [Wagner, Amy K.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA USA	Wagner, AK (corresponding author), Univ Pittsburgh, Phys Med & Rehabil, 3471 Fifth Ave Ste 202, Pittsburgh, PA 15213 USA.; Arenth, PM (corresponding author), Univ Pittsburgh, Dept Phys Med & Rehabil, 4200 Fifth Ave, Pittsburgh, PA 15260 USA.	arenthpm@upmc.edu; wagnerak@upmc.edu	Failla, Michelle/AAI-3788-2021; Juengst, Shannon B/AAC-5891-2019	Failla, Michelle/0000-0001-9734-3373; Juengst, Shannon/0000-0003-4709-545X	Department of DefenseUnited States Department of Defense [DoD W81XWH-07-1-0701]; National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR) GrantUnited States Department of Health & Human Services [90DP0041]; National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01HD048162]; UPMC Rehabilitation Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD048162] Funding Source: NIH RePORTER	This research was supported by Department of Defense (DoD W81XWH-07-1-0701), National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR) Grant 90DP0041, National Institute of Health (R01HD048162), and the UPMC Rehabilitation Institute. NIDILRR is a Center within the Administration for Community Living (ACL), Department of Health and Human Services (HHS). The contents of this manuscript do not necessarily represent the policy of the DoD, NIDILRR, ACL, NIH, or HHS, and endorsement of this content by the Federal Government should not be assumed.	Alderman N, 2003, J INT NEUROPSYCH SOC, V9, P31, DOI 10.1017/S1355617703910046; Andersson S, 2002, NEUROPSY NEUROPSY BE, V15, P184, DOI 10.1097/01.WNN.0000026596.88167.8E; Ashman TA, 2009, ARCH PHYS MED REHAB, V90, P733, DOI 10.1016/j.apmr.2008.11.005; Banos JH, 2010, J HEAD TRAUMA REHAB, V25, P357, DOI 10.1097/HTR.0b013e3181d6c715; Bilbao A, 2003, NEUROREHABILITATION, V18, P239; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; BORKOWSKI JG, 1967, NEUROPSYCHOLOGIA, V5, P135, DOI 10.1016/0028-3932(67)90015-2; BORNSTEIN RA, 1989, J NEUROSURG, V70, P509, DOI 10.3171/jns.1989.70.4.0509; Brooks J, 1999, J TRAUMA, V46, P159, DOI 10.1097/00005373-199901000-00027; BURT DB, 1995, PSYCHOL BULL, V117, P285, DOI 10.1037/0033-2909.117.2.285; Bushnik T, 2008, J HEAD TRAUMA REHAB, V23, P25, DOI 10.1097/01.HTR.0000308718.88214.bb; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Castiel M, 2012, NEUROPSYCHOL REHABIL, V22, P734, DOI 10.1080/09602011.2012.686884; Chamelian L, 2006, J NEUROPSYCH CLIN N, V18, P33, DOI 10.1176/appi.neuropsych.18.1.33; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; Cook KF, 2011, ARCH PHYS MED REHAB, V92, P818, DOI 10.1016/j.apmr.2010.12.008; Dawson JD, 2010, J AM GERIATR SOC, V58, P1090, DOI 10.1111/j.1532-5415.2010.02872.x; Delis D.C., 2001, DELIS KAPLAN EXECUTI; Delis DC, 2000, CALIFORNIA VERBAL LE; Dikmen SS, 2004, ARCH PHYS MED REHAB, V85, P1457, DOI 10.1016/j.apmr.2003.12.041; DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U; Elovic EP, 2003, J HEAD TRAUMA REHAB, V18, P177, DOI 10.1097/00001199-200303000-00008; Failla MD, 2016, NEUROREHAB NEURAL RE, V30, P419, DOI 10.1177/1545968315600525; Failla MD, 2015, J HEAD TRAUMA REHAB, V30, pE54, DOI 10.1097/HTR.0000000000000118; Failla MD, 2013, BRAIN INJURY, V27, P696, DOI 10.3109/02699052.2013.775481; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Fann JR, 2001, PSYCHOSOMATICS, V42, P48, DOI 10.1176/appi.psy.42.1.48; Fiske A, 2009, ANNU REV CLIN PSYCHO, V5, P363, DOI 10.1146/annurev.clinpsy.032408.153621; Fleming J, 1999, BRAIN INJURY, V13, P417; Gavett BE, 2013, NEUROREHABILITATION, V32, P253, DOI 10.3233/NRE-130842; GFELLER JD, 1994, HEADACHE, V34, P503, DOI 10.1111/j.1526-4610.1994.hed3409503.x; Gotlib IH, 2010, ANNU REV CLIN PSYCHO, V6, P285, DOI 10.1146/annurev.clinpsy.121208.131305; Graham DP, 2013, J PSYCHIATR RES, V47, P835, DOI 10.1016/j.jpsychires.2013.02.006; Heaton R. K, 1981, WISCONSIN CARD SORTI; HERTEL PT, 1991, J EXP PSYCHOL GEN, V120, P301, DOI 10.1037/0096-3445.120.3.301; Hertel PT, 1998, J ABNORM PSYCHOL, V107, P166, DOI 10.1037/0021-843X.107.1.166; Horsfield SA, 2002, INT J PSYCHIAT MED, V32, P337, DOI 10.2190/KQ48-XT0L-2H14-5UMV; Hudak AM, 2012, J HEAD TRAUMA REHAB, V27, P87, DOI 10.1097/HTR.0b013e3182114efd; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Juengst SB, 2012, THESIS; Juengst S, 2013, ARCH PHYS MED REHAB, V94, P74, DOI 10.1016/j.apmr.2012.07.025; Juengst SB, 2015, J HEAD TRAUMA REHAB, V30, P207, DOI 10.1097/HTR.0000000000000031; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Kouneiher F, 2009, NAT NEUROSCI, V12, P939, DOI 10.1038/nn.2321; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lanctot KL, 2010, BRAIN INJURY, V24, P959, DOI 10.3109/02699051003789229; LARRABEE GJ, 1995, J CLIN EXP NEUROPSYC, V17, P536, DOI 10.1080/01688639508405144; Larson EB, 2010, J HEAD TRAUMA REHAB, V25, P61, DOI 10.1097/HTR.0b013e3181c1d1e1; Lee H, 2005, HUM PSYCHOPHARM CLIN, V20, P97, DOI 10.1002/hup.668; Levin RL, 2007, COGNITIVE THER RES, V31, P211, DOI 10.1007/s10608-007-9128-z; Maki-Marttunen V, 2015, J NEUROTRAUM, V32, P272, DOI 10.1089/neu.2014.3557; Malec JF, 2010, ARCH PHYS MED REHAB, V91, P1087, DOI 10.1016/j.apmr.2010.04.002; Murphy E, 2013, NEUROPSYCHOPHARMACOL, V38, P2598, DOI 10.1038/npp.2013.166; NINDS Common Data Elements, TRAUMATIC BRAIN INJU; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Osterrieth PA, 1944, ARCH PSYCHOLOGIE, V30, P205; Peckham AD, 2010, DEPRESS ANXIETY, V27, P1135, DOI 10.1002/da.20755; Pedroli E, 2013, STUD HEALTH TECHNOL, V191, P38, DOI 10.3233/978-1-61499-282-0-38; Perlstein WM, 2006, NEUROPSYCHOLOGIA, V44, P260, DOI 10.1016/j.neuropsychologia.2005.05.009; Phelps TI, 2015, J NEUROTRAUM, V32, P590, DOI 10.1089/neu.2014.3711; Pittenger C, 2008, NEUROPSYCHOPHARMACOL, V33, P88, DOI 10.1038/sj.npp.1301574; Rapoport M, 2002, NEUROPSY NEUROPSY BE, V15, P123, DOI 10.1097/01.WNN.0000016801.80266.36; Rapoport MJ, 2005, J NEUROPSYCH CLIN N, V17, P61, DOI 10.1176/appi.neuropsych.17.1.61; Reitan RM., 1985, HALSTEAD REITAN NEUR; Satz P, 1998, BRAIN INJURY, V12, P537, DOI 10.1080/026990598122313; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Udekwu P, 2004, J TRAUMA, V56, P1084, DOI 10.1097/01.TA.0000124283.02605.A5; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Wagner AK, 2010, EUR J PHYS REHAB MED, V46, P549; Wagner AK, 2011, PM&R, V3, pS28, DOI 10.1016/j.pmrj.2011.04.013; Wang YG, 2011, J NEUROTRAUM, V28, P259, DOI 10.1089/neu.2010.1648; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; Wilson MS, 2002, AM J PHYS MED REHAB, V81, P364, DOI 10.1097/00002060-200205000-00009; Yasuda S, 2001, AM J PHYS MED REHAB, V80, P852, DOI 10.1097/00002060-200111000-00011	77	11	11	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2016	31	6					E62	E73		10.1097/HTR.0000000000000214			12	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	EC0IW	WOS:000387784800007	26828711	Green Accepted			2021-06-18	
J	Harada, K; Matsuo, K; Nakashima, M; Hobara, T; Higuchi, N; Higuchi, F; Nakano, M; Otsuki, K; Shibata, T; Watanuki, T; Matsubara, T; Fujita, Y; Shimoji, K; Yamagata, H; Watanabe, Y				Harada, Kenichiro; Matsuo, Koji; Nakashima, Mami; Hobara, Teruyuki; Higuchi, Naoko; Higuchi, Fumihiro; Nakano, Masayuki; Otsuki, Koji; Shibata, Tomohiko; Watanuki, Toshio; Matsubara, Toshio; Fujita, Yusuke; Shimoji, Keigo; Yamagata, Hirotaka; Watanabe, Yoshifumi			Disrupted orbitomedial prefrontal limbic network in individuals with later-life depression	JOURNAL OF AFFECTIVE DISORDERS			English	Article						Medial frontal; MRI; Diffusion tensor; Uncinate fasciculus; Voxel-based morphometry	WHITE-MATTER ABNORMALITIES; TRAUMATIC BRAIN-INJURY; UNCINATE FASCICULUS; GREY-MATTER; CORTEX; HYPERINTENSITIES; TRACTOGRAPHY; METAANALYSIS; ASSOCIATION; INTEGRITY	Background: Depression in old age is an increasing contributor to poor health and accompanying health care costs. Although there is an abundance of literature on later-life depression (LLD), the neural correlates have not been clarified. The aim of this study was to determine whether patients with LLD show abnormal gray matter volume (GMV) and white matter integrity by using multiple image analysis methods. Methods: The study included 45 patients with LLD and 61 healthy participants who were matched for age, sex, years of education, and vascular risk factors. GMV was examined using voxel-based morphometry, while the white matter integrity was determined by tract-based spatial statistics and tract-specific analysis, which were obtained from high-resolution magnetic resonance images. Results: Patients with LLD showed significantly less GMV in the orbitofrontal cortex, anterior cingulate, insula, amygdala, and temporal regions, as well as higher fractional anisotropy in the uncinate fasciculus, compared with healthy participants. Patients with LLD who had reduced orbitofrontal and insular GMV had more severe clinical variables. The reduced orbitofrontal GMV was associated with higher fractional anisotropy in the uncinate fasciculus. Limitation: The effects of medication should also be considered when interpreting the results of this study. Conclusion: Our results suggest that regional GMV is linked to white matter integrity of the uncinate fasciculus in the orbitomedial prefrontal limbic network, and the disruption of this network may be involved in the pathophysiology of LLD. (C) 2016 Elsevier B.V. All rights reserved.	[Harada, Kenichiro; Matsuo, Koji; Nakashima, Mami; Hobara, Teruyuki; Higuchi, Naoko; Higuchi, Fumihiro; Nakano, Masayuki; Otsuki, Koji; Shibata, Tomohiko; Watanuki, Toshio; Matsubara, Toshio; Yamagata, Hirotaka; Watanabe, Yoshifumi] Yamaguchi Univ, Grad Sch Med, Dept Neurosci, Div Neuropsychiat, 1-1-1 Minamiko Gushi, Ube, Yamaguchi 7558505, Japan; [Nakashima, Mami] Nagato Ichinomiya Hosp, Shimonoseki, Yamaguchi, Japan; [Hobara, Teruyuki] Yamaguchi Grand Med Ctr, Dept Psychiat, Hofu, Yamaguchi, Japan; [Nakano, Masayuki] Katakura Hosp, Ube, Yamaguchi, Japan; [Otsuki, Koji] Konan Hosp, Matsue, Shimane, Japan; [Shibata, Tomohiko] Shinwaen Hosp, Onoda, Yamaguchi, Japan; [Matsubara, Toshio] Yamaguchi Univ, Org Univ Educ, Hlth Adm Ctr, Yamaguchi, Yamaguchi, Japan; [Fujita, Yusuke] Yamaguchi Univ, Grad Sch Med, Dept Biomol Engn Appl Mol Biosci, Ube, Yamaguchi, Japan; [Shimoji, Keigo] Tokyo Metropolitan Geriatr Hosp, Dept Radiol, Tokyo, Japan	Matsuo, K (corresponding author), Yamaguchi Univ, Grad Sch Med, Dept Neurosci, Div Neuropsychiat, 1-1-1 Minamiko Gushi, Ube, Yamaguchi 7558505, Japan.	kmatsuo@yamaguchi-u.ac.jp			Strategic Research Program for Brain Sciences by the Ministry of Education, Culture, Sports, Science, and Technology of Japan; Ministry of Education, Science, Sports, and Culture of JapanMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT); JSPS KAKENHIMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [24591716, 15K09832]; Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [15K09832] Funding Source: KAKEN	This work was supported by Grants-in-Aid for "Integrated research on neuropsychiatric disorders" from the Strategic Research Program for Brain Sciences by the Ministry of Education, Culture, Sports, Science, and Technology of Japan and for Scientific Research on Innovative Areas (Comprehensive Brain Science Network) from the Ministry of Education, Science, Sports, and Culture of Japan and JSPS KAKENHI Grant numbers 24591716 and 15K09832.	Aghajani M, 2014, PSYCHOL MED, V44, P2287, DOI 10.1017/S0033291713003000; Alexapoulos GS, 2005, LANCET, V365, P1961, DOI 10.1016/S0140-6736(05)66665-2; Alexopoulos GS, 2008, AM J PSYCHIAT, V165, P238, DOI 10.1176/appi.ajp.2007.07050744; Alves GS, 2012, PSYCHIAT RES-NEUROIM, V203, P194, DOI 10.1016/j.pscychresns.2011.12.006; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Andreescu C, 2008, NEUROPSYCHOPHARMACOL, V33, P2566, DOI 10.1038/sj.npp.1301655; Arnone D, 2013, MOL PSYCHIATR, V18, P1265, DOI 10.1038/mp.2012.150; Bae JN, 2006, BIOL PSYCHIAT, V60, P1356, DOI 10.1016/j.biopsych.2006.03.052; BALDWIN RC, 1995, BRIT J PSYCHIAT, V167, P649, DOI 10.1192/bjp.167.5.649; Bechara A, 2004, BRAIN COGNITION, V55, P30, DOI 10.1016/j.bandc.2003.04.001; Bezerra DM, 2012, J PSYCHIATR RES, V46, P1643, DOI 10.1016/j.jpsychires.2012.09.001; Bora E, 2012, J AFFECT DISORDERS, V138, P9, DOI 10.1016/j.jad.2011.03.049; Bracht T, 2015, J AFFECT DISORDERS, V170, P143, DOI 10.1016/j.jad.2014.08.031; Catani M, 2006, CURR OPIN NEUROL, V19, P599, DOI 10.1097/01.wco.0000247610.44106.3f; Charlton RA, 2015, AM J GERIAT PSYCHIAT, V23, P642, DOI 10.1016/j.jagp.2014.07.008; Choi KS, 2014, NEUROPSYCHOPHARMACOL, V39, P1332, DOI 10.1038/npp.2013.345; Colloby SJ, 2011, J AFFECT DISORDERS, V133, P158, DOI 10.1016/j.jad.2011.04.010; Dalby RB, 2010, PSYCHIAT RES-NEUROIM, V184, P38, DOI 10.1016/j.pscychresns.2010.06.008; Della Nave R, 2010, AM J NEURORADIOL, V31, P1675, DOI 10.3174/ajnr.A2128; Du MY, 2014, J PSYCHIATR NEUROSCI, V39, P397, DOI 10.1503/jpn.130275; Egger K, 2008, PSYCHIAT RES-NEUROIM, V164, P237, DOI 10.1016/j.pscychresns.2007.12.018; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Greenwald BS, 1996, AM J PSYCHIAT, V153, P1212; Guo WB, 2014, J AFFECT DISORDERS, V163, P70, DOI 10.1016/j.jad.2014.03.044; Hasan KM, 2009, BRAIN RES, V1276, P67, DOI 10.1016/j.brainres.2009.04.025; Johnson CP, 2011, J INT NEUROPSYCH SOC, V17, P663, DOI 10.1017/S1355617711000464; Kier EL, 2004, AM J NEURORADIOL, V25, P677; Klauser P, 2015, J AFFECT DISORDERS, V173, P45, DOI 10.1016/j.jad.2014.10.041; Kunimatsu Akira, 2004, Magn Reson Med Sci, V3, P11, DOI 10.2463/mrms.3.11; Lai CH, 2013, PSYCHIAT RES-NEUROIM, V211, P37, DOI 10.1016/j.pscychresns.2012.06.006; Lavretsky H, 2007, AM J GERIAT PSYCHIAT, V15, P386, DOI 10.1097/JGP.0b013e3180325a16; Lesser IM, 1996, AM J PSYCHIAT, V153, P1280; Mai JK, 2008, ATLAS HUMAN BRAIN; Maldjian JA, 2004, NEUROIMAGE, V21, P450, DOI 10.1016/j.neuroimage.2003.09.032; Martino J, 2014, CLIN ANAT, V27, P563, DOI 10.1002/ca.22321; Masutani Y, 2003, EUR J RADIOL, V46, P53, DOI 10.1016/S0720-048X(02)00328-5; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Otsubo T, 2005, PSYCHIAT CLIN NEUROS, V59, P517, DOI 10.1111/j.1440-1819.2005.01408.x; Price JL, 2012, TRENDS COGN SCI, V16, P61, DOI 10.1016/j.tics.2011.12.011; Rajkowska G, 2005, BIOL PSYCHIAT, V58, P297, DOI 10.1016/j.biopsych.2005.04.013; Sexton CE, 2012, ARCH GEN PSYCHIAT, V69, P680, DOI 10.1001/archgenpsychiatry.2011.1862; Shimony JS, 2009, BIOL PSYCHIAT, V66, P245, DOI 10.1016/j.biopsych.2009.02.032; Taylor Warren D, 2007, Neuropsychiatr Dis Treat, V3, P669; Taylor WD, 2003, BIOL PSYCHIAT, V53, P144, DOI 10.1016/S0006-3223(02)01490-7; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Von Der Heide RJ, 2013, BRAIN, V136, P1692, DOI 10.1093/brain/awt094; Vu NQ, 2013, CURR OPIN NEUROL, V26, P656, DOI 10.1097/WCO.0000000000000028; Weber K, 2010, J AFFECT DISORDERS, V124, P275, DOI 10.1016/j.jad.2009.11.016; Wen MC, 2014, INT J GERIATR PSYCH, V29, P1173, DOI 10.1002/gps.4129; WILLIAMS JBW, 1988, ARCH GEN PSYCHIAT, V45, P742; Yasmin H, 2009, NEURORADIOLOGY, V51, P831, DOI 10.1007/s00234-009-0580-1; Yuan YG, 2008, BIOL PSYCHIAT, V64, P541, DOI 10.1016/j.biopsych.2008.04.032; Yuen GS, 2014, J AFFECT DISORDERS, V166, P179, DOI 10.1016/j.jad.2014.05.008; Zappala G, 2012, CORTEX, V48, P156, DOI 10.1016/j.cortex.2011.06.020; Zhang AF, 2012, NEUROPSYCHOPHARMACOL, V37, P959, DOI 10.1038/npp.2011.279; Zhuo JC, 2012, NEUROIMAGE, V59, P467, DOI 10.1016/j.neuroimage.2011.07.050	56	11	11	0	8	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0327	1573-2517		J AFFECT DISORDERS	J. Affect. Disord.	NOV 1	2016	204						112	119		10.1016/j.jad.2016.06.031			8	Clinical Neurology; Psychiatry	Neurosciences & Neurology; Psychiatry	DW7FT	WOS:000383817300016	27344619				2021-06-18	
J	Kristman, VL; Brison, RJ; Bedard, M; Reguly, P; Chisholm, S				Kristman, Vicki L.; Brison, Robert J.; Bedard, Michel; Reguly, Paula; Chisholm, Shelley			Prognostic Markers for Poor Recovery After Mild Traumatic Brain Injury in Older Adults: A Pilot Cohort Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						adult; aged; brain injuries; depression; emergency service; fatigue; follow-up studies; hospital; prognosis; prospective studies	SYMPTOMS FOLLOWING MILD; GLASGOW OUTCOME SCALE; SEVERE HEAD-INJURY; GENERAL-PRACTITIONER; COPING STRATEGIES; PHYSICAL-THERAPY; EARLY PREDICTION; CONTINUED CARE; MANUAL THERAPY; HEALTH SURVEY	Objective: To identify prognostic markers associated with poor recovery from mild traumatic brain injury (MTBI) in older adults. Setting: Three Ontario emergency departments. Participants: Forty-nine participants aged 65 years and older that visited an emergency department for MTBI. Design: Pilot prospective cohort study. Main Measures: Recovery from MTBI determined using the Rivermead Postconcussion symptom Questionnaire, the Glasgow Outcomes Scale-Extended, physical and mental health functioning (SF-12), and a single question on selfrated recovery assessed by telephone shortly after emergency department visit (baseline) and again 6 months later. Predictors were measured at baseline. Results: Markers potentially associated with poor recovery included reporting worse health 1 year before the injury, poor expectations for recovery, depression, and fatigue. Conclusion: Recovery after MTBI in older adults may be associated more with psychosocial than with biomedical or injury-related factors.	[Kristman, Vicki L.; Bedard, Michel; Reguly, Paula] Lakehead Univ, Dept Hlth Sci, 955 Oliver Rd, Thunder Bay, ON P7B 5E1, Canada; [Kristman, Vicki L.; Bedard, Michel] Lakehead Univ, Div Human Sci, Northern Ontario Sch Med, Thunder Bay, ON, Canada; [Kristman, Vicki L.; Bedard, Michel] Lakehead Univ, Ctr Educ & Res Aging & Hlth, Thunder Bay, ON, Canada; [Kristman, Vicki L.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Brison, Robert J.] Queens Univ, Kingston Gen Hosp, Dept Emergency Med, Kingston, ON, Canada; [Bedard, Michel] St Josephs Care Grp, Thunder Bay, ON, Canada; [Chisholm, Shelley] Thunder Bay Reg Hlth Sci Ctr, Thunder Bay, ON, Canada	Kristman, VL (corresponding author), Lakehead Univ, Dept Hlth Sci, 955 Oliver Rd, Thunder Bay, ON P7B 5E1, Canada.	vkristman@lakeheadu.ca			Ontario Neurotrauma Foundation [2012-ABI-MTBI-EP-950]; CIHR New Investigator Award in Community-Based Primary Health CareCanadian Institutes of Health Research (CIHR)	This project was funded by the Ontario Neurotrauma Foundation, grant reference number 2012-ABI-MTBI-EP-950. Dr Kristman is supported by a CIHR New Investigator Award in Community-Based Primary Health Care.	AMACHER AL, 1987, NEUROSURGERY, V20, P954; ANDERSON AJ, 2002, INT J PSYCHOSOC REHA, V6, P69; Beaton DE, 2001, ARTHRIT RHEUM-ARTHR, V45, P270, DOI 10.1002/1529-0131(200106)45:3<270::AID-ART260>3.3.CO;2-K; BOYD JH, 1982, ARCH GEN PSYCHIAT, V39, P1195; Boyle Eleanor, 2014, Arch Phys Med Rehabil, V95, pS230, DOI 10.1016/j.apmr.2013.08.297; BROOKS DN, 1986, J NEUROL NEUROSUR PS, V49, P549, DOI 10.1136/jnnp.49.5.549; BROWN GK, 1989, J CONSULT CLIN PSYCH, V57, P652, DOI 10.1037/0022-006X.57.5.652; BROWN GK, 1987, PAIN, V31, P53, DOI 10.1016/0304-3959(87)90006-6; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS201, DOI 10.1016/j.apmr.2013.10.010; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS210, DOI 10.1016/j.apmr.2013.06.035; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS101, DOI 10.1016/j.apmr.2013.12.001; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2007, SPINE, V32, P126, DOI 10.1097/01.brs.0000249526.76788.e8; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS278, DOI 10.1016/j.apmr.2013.08.295; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; de Leon MB, 2009, ARCH PHYS MED REHAB, V90, P956, DOI 10.1016/j.apmr.2008.12.016; Devins GM., 1988, PSYCHOL HLTH, V2, P139, DOI [10.1080/08870448808400349, DOI 10.1080/08870448808400349]; Donovan J, 2014, CHIROPR MAN THER, V22, DOI 10.1186/s12998-014-0038-3; Fischer D, 1999, JAMA-J AM MED ASSOC, V282, P1157, DOI 10.1001/jama.282.12.1157; Gandek B, 1998, J CLIN EPIDEMIOL, V51, P1171, DOI 10.1016/S0895-4356(98)00109-7; Gil S, 2005, AM J PSYCHIAT, V162, P963, DOI 10.1176/appi.ajp.162.5.963; Godbolt Alison K, 2014, Arch Phys Med Rehabil, V95, pS245, DOI 10.1016/j.apmr.2013.06.036; Goldstein FC, 2001, J INT NEUROPSYCH SOC, V7, P373, DOI 10.1017/S1355617701733115; Hartford Institute for Geriatric Nursing New York university College of Nursing, 2008, BEST PRACT INF CAR O; Hoving JL, 2006, CLIN J PAIN, V22, P370, DOI 10.1097/01.ajp.0000180185.79382.3f; Hoving JL, 2002, ANN INTERN MED, V136, P713, DOI 10.7326/0003-4819-136-10-200205210-00006; Hung Ryan, 2014, Arch Phys Med Rehabil, V95, pS174, DOI 10.1016/j.apmr.2013.08.301; Jacelon CS, 2007, NURSE RES, V14, P65; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; JENSEN MP, 1986, PAIN, V27, P117, DOI 10.1016/0304-3959(86)90228-9; Karasik D, 2005, J GERONTOL A-BIOL, V60, P574, DOI 10.1093/gerona/60.5.574; Keightley Michelle L, 2014, Arch Phys Med Rehabil, V95, pS192, DOI 10.1016/j.apmr.2013.12.018; King NS, 1999, BRIT J CLIN PSYCHOL, V38, P15, DOI 10.1348/014466599162638; Kristman V, 2004, EUR J EPIDEMIOL, V19, P751, DOI 10.1023/B:EJEP.0000036568.02655.f8; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Lannsjo M, 2013, EUR J NEUROL, V20, P124, DOI 10.1111/j.1468-1331.2012.03813.x; Lannsjo M, 2011, J REHABIL MED, V43, P997, DOI 10.2340/16501977-0875; Levin HS, 2001, J NEUROTRAUM, V18, P575, DOI 10.1089/089771501750291819; MAAS AIR, 1983, J NEUROSURG, V58, P321, DOI 10.3171/jns.1983.58.3.0321; MacDonald SWS, 2011, J GERONTOL B-PSYCHOL, V66, P59, DOI 10.1093/geronb/gbr039; Marras Connie, 2014, Arch Phys Med Rehabil, V95, pS238, DOI 10.1016/j.apmr.2013.08.298; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Norrie J, 2010, BRAIN INJURY, V24, P1528, DOI 10.3109/02699052.2010.531687; Nygren-de Boussard Catharina, 2014, Arch Phys Med Rehabil, V95, pS257, DOI 10.1016/j.apmr.2013.10.009; ORME JG, 1986, J CLIN PSYCHOL, V42, P28, DOI 10.1002/1097-4679(198601)42:1<28::AID-JCLP2270420104>3.0.CO;2-T; PENTLAND B, 1986, AGE AGEING, V15, P193, DOI 10.1093/ageing/15.4.193; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Riedel-Heller SG, 2006, ACTA PSYCHIAT SCAND, V113, P388, DOI 10.1111/j.1600-0447.2005.00632.x; Ritchie PD, 2000, J CLIN NEUROSCI, V7, P301, DOI 10.1054/jocn.1999.0198; Salmi L Rachid, 2014, Arch Phys Med Rehabil, V95, pS95, DOI 10.1016/j.apmr.2013.10.026; SMITH CA, 1995, HEALTH PSYCHOL, V14, P64, DOI 10.1037/0278-6133.14.1.64; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Taylor RR, 2000, PSYCHOL MED, V30, P849, DOI 10.1017/S0033291799002500; Thompson HJ, 2008, J AM GERIATR SOC, V54, P1590; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Weiss DS., 2007, CROSS CULTURAL ASSES, P219; WEWERS ME, 1990, RES NURS HEALTH, V13, P227, DOI 10.1002/nur.4770130405; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson JTL, 2000, J NEUROL NEUROSUR PS, V69, P204, DOI 10.1136/jnnp.69.2.204; ZICH JM, 1990, INT J PSYCHIAT MED, V20, P259, DOI 10.2190/LYKR-7VHP-YJEM-MKM2	65	11	11	0	13	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2016	31	6					E33	E43		10.1097/HTR.0000000000000226			11	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	EC0IW	WOS:000387784800004	27022959				2021-06-18	
J	McKay, A; Liew, C; Schonberger, M; Ross, P; Ponsford, J				McKay, Adam; Liew, Carine; Schonberger, Michael; Ross, Pamela; Ponsford, Jennie			Predictors of the On-Road Driving Assessment After Traumatic Brain Injury: Comparing Cognitive Tests, Injury Factors, and Demographics	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						cognitive; demographics; driving; neuropsychology; posttraumatic amnesia; severity; time postinjury; traumatic brain injury	DRIVERS; FITNESS; RETURN; PERFORMANCE; ABILITY; STROKE; RISK; SIMULATOR; SAFETY; DAMAGE	Objectives: (1) To examine the relations between performance on cognitive tests and on-road driving assessment in a sample of persons with traumatic brain injury (TBI). (2) To compare cognitive predictors of the on-road assessment with demographic and injury-related predictors. Participants: Ninety-nine people with mild-severe TBI who completed an on-road driving assessment in an Australian rehabilitation setting. Design: Retrospective case series. Main Measures: Wechsler Test of Adult Reading or National Adult Reading Test-Revised; 4 subtests from theWechsler Adult Intelligence Scale-III; Rey Auditory Verbal Leaning Test; Rey Complex Figure Test; TrailMaking Test; demographic factors (age, sex, years licensed); and injury-related factors (duration of posttraumatic amnesia; time postinjury). Results: Participants who failed the driving assessment did worse on measures of attention, visual memory, and executive processing; however, cognitive tests were weak correlates (r values < 0.3) and poor predictors of the driving assessment. Posttraumatic amnesia duration mediated by time postinjury was the strongest predictor of the driving assessment-that is, participants with more severe TBIs had later driving assessments and were more likely to fail. Conclusion: Cognitive tests are not reliable predictors of the on-road driving assessment outcome. Traumatic brain injury severity may be a better predictor of on-road driving; however, further research is needed to identify the best predictors of driving behavior after TBI.	[McKay, Adam; Liew, Carine; Schonberger, Michael; Ponsford, Jennie] Monash Univ, Sch Psychol Sci, Melbourne, Vic, Australia; [McKay, Adam; Schonberger, Michael; Ross, Pamela; Ponsford, Jennie] Epworth HealthCare, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [Schonberger, Michael] Univ Freiburg, Inst Psychol, Dept Rehabil Psychol & Psychotherapy, Freiburg, Germany; [Ponsford, Jennie] Natl Trauma Res Inst, Melbourne, Vic, Australia	McKay, A (corresponding author), Monash Univ, Sch Psychol Sci, Clayton, Vic 3800, Australia.	adam.mckay@monash.edu	McKay, Adam/M-6003-2017	McKay, Adam/0000-0002-0479-7681			[Anonymous], 1998, ROADS CORP VIC COMP; Anstey KJ, 2005, CLIN PSYCHOL REV, V25, P45, DOI 10.1016/j.cpr.2004.07.008; Austroads, 2012, ASS FITN DRIV COMM P; BROOKE MM, 1992, AM J PHYS MED REHAB, V71, P177, DOI 10.1097/00002060-199206000-00009; Christie N, 2001, NEUROPSYCHOL REHABIL, V11, P45, DOI 10.1080/09602010042000169; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Collins LM, 2001, PSYCHOL METHODS, V6, P330, DOI 10.1037//1082-989X.6.4.330; Crizzle AM, 2012, NEUROLOGY, V79, P2067, DOI 10.1212/WNL.0b013e3182749e95; Cullen N, 2014, BRAIN INJURY, V28, P38, DOI 10.3109/02699052.2013.849005; Cyr AA, 2009, J CLIN EXP NEUROPSYC, V31, P472, DOI 10.1080/13803390802255627; Devany Serio C, 1994, NeuroRehabilitation, V4, P53, DOI 10.3233/NRE-1994-4108; Devos H, 2011, NEUROLOGY, V76, P747, DOI 10.1212/WNL.0b013e31820d6300; Di Stefano M, 2006, DRIVER REHABILITATIO, P255, DOI DOI 10.1016/B978-032302937-7.50018-6; Fisk GD, 1998, BRAIN INJURY, V12, P683; Formisano R, 2005, BRAIN INJURY, V19, P159, DOI 10.1080/02699050400017163; Fox GK, 1998, ARCH PHYS MED REHAB, V79, P1288, DOI 10.1016/S0003-9993(98)90277-5; GALSKI T, 1993, AM J OCCUP THER, V47, P391, DOI 10.5014/ajot.47.5.391; Galski T, 1997, AM J OCCUP THER, V51, P352, DOI 10.5014/ajot.51.5.352; Graham J. W., 1999, STAT STRATEGIES SMAL, V50, P1, DOI DOI 10.1177/0013164496056006006; Graham JW, 2009, ANNU REV PSYCHOL, V60, P549, DOI 10.1146/annurev.psych.58.110405.085530; Gregersen NP, 2000, ACCIDENT ANAL PREV, V32, P25, DOI 10.1016/S0001-4575(99)00045-7; Griffen JA, 2011, CLIN NEUROPSYCHOL, V25, P1158, DOI 10.1080/13854046.2011.609841; Hawley CA, 2001, J NEUROL NEUROSUR PS, V70, P761, DOI 10.1136/jnnp.70.6.761; Hinton-Bayre A, 2005, PSYCHOL ASSESSMENT, V17, P237, DOI 10.1037/1040-3590.17.2.237; Innes CRH, 2007, J NEUROL SCI, V260, P188, DOI 10.1016/j.jns.2007.04.052; Iverson DJ, 2010, NEUROLOGY, V74, P1316, DOI 10.1212/WNL.0b013e3181da3b0f; Korteling JE, 1996, ARCH PHYS MED REHAB, V77, P138, DOI 10.1016/S0003-9993(96)90158-6; La Guardia JG, 2007, J PERS, V75, P1205, DOI 10.1111/j.1467-6494.2007.00473.x; Lundqvist A, 2008, BRAIN INJURY, V22, P295, DOI 10.1080/02699050801966133; Lundqvist A, 1997, APPL NEUROPSYCHOL, V4, P220, DOI 10.1207/s15324826an0404_3; Meyers J., 1995, REY COMPLEX FIGURE T; Morgan S.F., 1992, NEUROPSYCHOL REV, V6, P327, DOI [10.1037/0894-4105.6.4.327, DOI 10.1037/0894-4105.6.4.327]; Nelson H., 1991, REVISED NATL ADULT R; Neyens DM, 2012, ACCIDENT ANAL PREV, V49, P266, DOI 10.1016/j.aap.2012.01.008; Novack TA, 2006, BRAIN INJURY, V20, P455, DOI 10.1080/02699050600664541; Novack TA, 2010, BRAIN INJURY, V24, P464, DOI 10.3109/02699051003601713; Ortoleva C, 2012, J HEAD TRAUMA REHAB, V27, P302, DOI 10.1097/HTR.0b013e3182236299; PIDIKITI RD, 1991, ARCH PHYS MED REHAB, V72, P109; Pietrapiana P, 2005, BRAIN INJURY, V19, P197, DOI 10.1080/02699050400017197; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Radford KA, 2004, BRAIN INJURY, V18, P775, DOI 10.1080/02699050310001657394; Rapport LJ, 2008, ARCH PHYS MED REHAB, V89, P922, DOI 10.1016/j.apmr.2008.01.009; Reitan RM., 1985, HALSTEAD REITAN NEUR; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Roads Vic, 1999, PROGRAMMED OBSERVATI; Ross PE, 2015, ARCH PHYS MED REHAB, V96, P440, DOI 10.1016/j.apmr.2014.09.027; Schafer JL., 1997, ANAL INCOMPLETE MULT; Schanke AK, 2000, SCAND J PSYCHOL, V41, P113, DOI 10.1111/1467-9450.00179; Smith A., 1982, SYMBOL DIGIT MODALIT; Soderstrom ST, 2006, SCAND J PSYCHOL, V47, P419, DOI 10.1111/j.1467-9450.2006.00550.x; Sommer M, 2010, ARCH CLIN NEUROPSYCH, V25, P99, DOI 10.1093/arclin/acp109; Steyerberg EW., 2009, CLIN PREDICTION MODE; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Strypstein E, 2001, EURA MEDICOPHYS, V37, P227; VANZOMEREN AH, 1988, ARCH PHYS MED REHAB, V69, P90; VANZOMEREN AH, 1987, ARCH PHYS MED REHAB, V68, P697; Wechsler D., 2001, WECHSLER TEST ADULT; Wechsler D, 1997, WAIS 3 ADM SCORING M	58	11	11	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2016	31	6					E44	E52		10.1097/HTR.0000000000000209			9	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	EC0IW	WOS:000387784800005	26709586				2021-06-18	
J	Treble-Barna, A; Zang, HY; Zhang, NH; Taylor, HG; Stancin, T; Yeates, KO; Wade, SL				Treble-Barna, Amery; Zang, Huaiyu; Zhang, Nanhua; Taylor, H. Gerry; Stancin, Terry; Yeates, Keith Owen; Wade, Shari L.			Observed Parent Behaviors as Time-Varying Moderators of Problem Behaviors Following Traumatic Brain Injury in Young Children	DEVELOPMENTAL PSYCHOLOGY			English	Article						pediatric traumatic brain injury; child behavior problems; parenting; recovery; parent-child interactions	ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; CLOSED-HEAD-INJURY; AT-RISK MOTHERS; EARLY-CHILDHOOD; EXTERNALIZING BEHAVIOR; WARM RESPONSIVENESS; FUNCTIONAL RECOVERY; MATERNAL BEHAVIORS; ADULT SURVIVORS; SHORT-TERM	Parent behaviors moderate the adverse consequences of pediatric traumatic brain injury (TBI); however, it is unknown how these moderating effects change over time. This study examined the moderating effect of observed parent behaviors over time since injury on the relation between TBI and behavioral outcomes. Participants included children, ages 3-7 years, hospitalized for moderate (n = 52) or severe (n = 20) TBI or orthopedic injury (OI; n = 95). Parent-child dyads were videotaped during structured task and free play conditions, and parents completed child behavior ratings. Linear mixed models using a lagged, time-varying moderator analysis examined the relationship of observed parent behaviors at the baseline, 6-month, and 12-month assessments to child behavior problems at 6 months, 12 months, and 18 months postinjury, after controlling for preinjury levels of child behavior problems. The effect of TBI on behavior was exacerbated by less favorable parent behaviors, and buffered by more favorable parent behaviors, in children with severe TBI over the first 12 months postinjury. By 18 months postinjury, however, the moderating effect of parent behaviors diminished, such that children with severe TBI showed more behavior problems relative to children with moderate TBI or OI regardless of parent behaviors or in response to parent behaviors that were initially protective. The results suggest that the moderating effects of the family environment are complex and likely vary in relation to both recovery and developmental factors, with potentially important implications for targets and timing of intervention.	[Treble-Barna, Amery; Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, Div Phys Med & Rehabil, Cincinnati, OH 45229 USA; [Zang, Huaiyu; Zhang, Nanhua] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA; [Taylor, H. Gerry] Rainbow Babies & Childrens Hosp, Div Dev & Behav Pediat & Psychol, 2101 Adelbert Rd, Cleveland, OH 44106 USA; [Stancin, Terry] Case Western Reserve Univ, Sch Med, Dept Psychiat, Cleveland, OH 44106 USA; [Yeates, Keith Owen] Univ Calgary, Dept Psychol, Calgary, AB T2N 1N4, Canada	Treble-Barna, A (corresponding author), Univ Pittsburgh, Sch Med, Div Phys Med & Rehabil, 4401 Penn Ave, Pittsburgh, PA 15224 USA.	amery.treble-barna@pitt.edu	Yeates, Keith/AAJ-4223-2020; Stancin, Terry/L-7993-2019	Yeates, Keith/0000-0001-7680-2892; Zhang, Nanhua/0000-0001-5796-3404	NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD042729] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD042729] Funding Source: NIH RePORTER		Achenbach TM, 2001, MANUAL ASEBA SCH AGE; Akai CE, 2008, J PRIM PREV, V29, P223, DOI 10.1007/s10935-008-0134-z; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Anderson V, 2012, DISABIL REHABIL, V34, P1639, DOI 10.3109/09638288.2012.656789; Antonini TN, 2014, BEHAV THER, V45, P455, DOI 10.1016/j.beth.2014.02.003; Arnett AB, 2013, J INT NEUROPSYCH SOC, V19, P881, DOI 10.1017/S1355617713000635; BAKEMAN R, 1980, CHILD DEV, V51, P437, DOI 10.2307/1129277; Barnes MA, 1999, DEV NEUROPSYCHOL, V15, P1, DOI 10.1080/87565649909540737; Bates JE., 2015, HDB SOCIALIZATION TH, P372; Baumrind D., 1989, CHILD DEV TODAY TOMO, P349; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; Bradley RH, 2001, CHILD DEV, V72, P1868, DOI 10.1111/1467-8624.t01-1-00383; Bradley RH, 2007, DEV PSYCHOL, V43, P1390, DOI 10.1037/0012-1649.43.6.1390; Brock RL, 2015, J ABNORM CHILD PSYCH, V43, P1295, DOI 10.1007/s10802-015-0008-9; Brody GH, 2002, CHILD DEV, V73, P274, DOI 10.1111/1467-8624.00405; Brooks BL, 2014, ARCH CLIN NEUROPSYCH, V29, P186, DOI 10.1093/arclin/act083; BURGE D, 1991, J ABNORM PSYCHOL, V100, P174, DOI 10.1037/0021-843X.100.2.174; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Cattelani R, 1998, BRAIN INJURY, V12, P283, DOI 10.1080/026990598122584; Chang H, 2011, J ABNORM CHILD PSYCH, V39, P71, DOI 10.1007/s10802-010-9437-7; Chapman LA, 2010, REHABIL PSYCHOL, V55, P48, DOI 10.1037/a0018418; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Cook DR, 1982, RESIDUALS INFLUENCE; Crowe LM, 2012, PEDIATRICS, V129, pE262, DOI 10.1542/peds.2011-0438; Davidov M, 2006, CHILD DEV, V77, P44, DOI 10.1111/j.1467-8624.2006.00855.x; DEROGATIS LR, 1982, BRIEF SYMPTOM INVENT, V1; DOWNEY G, 1990, PSYCHOL BULL, V108, P50, DOI 10.1037/0033-2909.108.1.50; Eisenberg N, 1999, CHILD DEV, V70, P513, DOI 10.1111/1467-8624.00037; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V25, P107, DOI 10.1207/s15326942dn2501&2_7; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Ewing-Cobbs Linda, 2002, Semin Pediatr Neurol, V9, P209, DOI 10.1053/spen.2002.35502; EYBERG SM, 1995, PSYCHOPHARMACOL BULL, V31, P83; Fairbanks JM, 2013, REHABIL PSYCHOL, V58, P223, DOI 10.1037/a0033119; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; Fay TB, 2009, NEUROPSYCHOLOGY, V23, P271, DOI 10.1037/a0014936; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Ganesalingam K, 2007, J INT NEUROPSYCH SOC, V13, P298, DOI 10.1017/S1355617707070324; Gauvain M., 2015, HDB SOCIALIZATION TH, V2nd ed., P566; Ge XJ, 1996, DEV PSYCHOL, V32, P717, DOI 10.1037/0012-1649.32.4.717; Goldstrohm SL, 2005, ARCH CLIN NEUROPSYCH, V20, P675, DOI 10.1016/j.acn.2005.02.005; Grusec JE, 2011, ANNU REV PSYCHOL, V62, P243, DOI 10.1146/annurev.psych.121208.131650; Guttentag CL, 2014, DEV PSYCHOL, V50, P1482, DOI 10.1037/a0035682; Hastings, 2015, HDB SOCIALIZATION TH, P590; Hawley CA, 2004, BRAIN INJURY, V18, P645, DOI 10.1080/02699050310001646189; HENDERSON B, 1980, CHILD DEV, V51, P457; Konrad KN, 2000, BRAIN INJURY, V14, P859; Kurowski BG, 2011, PM&R, V3, P836, DOI 10.1016/j.pmrj.2011.05.016; LANDRY SH, 1990, CHILD DEV, V61, P1605, DOI 10.2307/1130768; Landry SH, 1997, DEV PSYCHOL, V33, P1040, DOI 10.1037/0012-1649.33.6.1040; Landry SH, 2006, DEV PSYCHOL, V42, P627, DOI 10.1037/0012-1649.42.4.627; Landry SH, 1996, MERRILL PALMER QUART, V42, P177; Landry SH, 2002, DEV NEUROPSYCHOL, V21, P15, DOI 10.1207/S15326942DN2101_2; Landry SH, 2001, DEV PSYCHOL, V37, P387, DOI 10.1037//0012-1649.37.3.387; Landry SH, 2008, DEV PSYCHOL, V44, P1335, DOI 10.1037/a0013030; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; Luis CA, 2002, J CLIN EXP NEUROPSYC, V24, P270, DOI 10.1076/jcen.24.3.270.982; Luyckx K, 2011, J CLIN CHILD ADOLESC, V40, P468, DOI 10.1080/15374416.2011.563470; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1032, DOI 10.1097/01.chi.0000173293.05817.b1; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1041, DOI 10.1097/01.chi.0000173292.05817.f8; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; Max JE, 1998, J NERV MENT DIS, V186, P325, DOI 10.1097/00005053-199806000-00001; Max JE, 1998, ARCH PHYS MED REHAB, V79, P893, DOI 10.1016/S0003-9993(98)90084-3; Max JE, 2012, INT J DEV NEUROSCI, V30, P239, DOI 10.1016/j.ijdevneu.2011.12.005; MCCLELLAND GH, 1993, PSYCHOL BULL, V114, P376, DOI 10.1037/0033-2909.114.2.376; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P22, DOI 10.1111/j.1365-2214.2009.00947.x; Micklewright JL, 2012, J INT NEUROPSYCH SOC, V18, P343, DOI 10.1017/S1355617711001792; MILLER IW, 1985, J MARITAL FAM THER, V11, P345, DOI 10.1111/j.1752-0606.1985.tb00028.x; Raj SP, 2014, J PEDIATR PSYCHOL, V39, P84, DOI 10.1093/jpepsy/jst075; ROBINSON EA, 1981, J CONSULT CLIN PSYCH, V49, P245, DOI 10.1037/0022-006X.49.2.245; ROTHBAUM F, 1994, PSYCHOL BULL, V116, P55, DOI 10.1037/0033-2909.116.1.55; Rubin KH, 2003, DEV PSYCHOL, V39, P164, DOI 10.1037//0012-1649.39.1.164; RUTTER M, 1980, PSYCHOL MED, V10, P633, DOI 10.1017/S0033291700054933; Ryan NP, 2015, J HEAD TRAUMA REHAB, V30, P75, DOI 10.1097/HTR.0000000000000123; Ryan NP, 2013, INT J DEV NEUROSCI, V31, P811, DOI 10.1016/j.ijdevneu.2013.10.002; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Scott C, 2015, NEUROPSYCHOLOGY, V29, P501, DOI 10.1037/neu0000074; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; Taylor HG, 1999, NEUROPSYCHOLOGY, V13, P76, DOI 10.1037/0894-4105.13.1.76; TEASDALE G, 1974, LANCET, V2, P81; TRONICK EZ, 1989, AM PSYCHOL, V44, P112, DOI 10.1037/0003-066X.44.2.112; Verger K, 2000, BRAIN INJURY, V14, P495; Vygotsky L.S., 1978, MIND SOC; Wade M, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00354; Wade SL, 2008, REHABIL PSYCHOL, V53, P180, DOI 10.1037/0090-5550.53.2.180; Wade SL, 2011, DEV PSYCHOL, V47, P119, DOI 10.1037/a0021028; Wade SL, 2003, J HEAD TRAUMA REHAB, V18, P164, DOI 10.1097/00001199-200303000-00007; Weeks M, 2014, DEPRESS ANXIETY, V31, P608, DOI 10.1002/da.22235; WOOD D, 1976, J CHILD PSYCHOL PSYC, V17, P89, DOI 10.1111/j.1469-7610.1976.tb00381.x; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514	96	11	11	0	16	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0012-1649	1939-0599		DEV PSYCHOL	Dev. Psychol.	NOV	2016	52	11					1777	1792		10.1037/dev0000208			16	Psychology, Developmental	Psychology	EB1WK	WOS:000387146800008	27786528	Green Accepted			2021-06-18	
J	Allitt, BJ; Iva, P; Yan, EB; Rajan, R				Allitt, Benjamin J.; Iva, Pippa; Yan, Edwin B.; Rajan, Ramesh			HYPO-EXCITATION ACROSS ALL CORTICAL LAMINAE DEFINES INTERMEDIATE STAGES OF CORTICAL NEURONAL DYSFUNCTION IN DIFFUSE TRAUMATIC BRAIN INJURY	NEUROSCIENCE			English	Article						electrophysiology; sensory cortex; traumatic brain injury; cortical laminae	AXONAL INJURY; TIME-COURSE; RAT MODEL; INHIBITION; MECHANISMS; ADAPTATION; BARREL; PATHOPHYSIOLOGY; INTERNEURONS; ACTIVATION	Traumatic brain injury (TBI) is a major cause of morbidity and mortality world-wide and can result in persistent cognitive, sensory and behavioral dysfunction. Understanding the time course of TBI-induced pathology is essential to effective treatment outcomes. We induced TBI in rats using an impact acceleration method and tested for sensorimotor skill and sensory sensitivity behaviors for two weeks to find persistently poor outcomes post -injury. At two weeks post -injury we made high resolution extracellular recordings from barrel cortex neurons, to simple and complex whisker deflections. We found that the supragranular suppression of neural firing (compared to normal) previously seen in the immediate post-TBI aftermath had spread to include suppression of input and infragranular layers at two weeks post -injury; thus, there was suppression of whisker -driven firing rates in all cortical layers to both stimulus types. Further, there were abnormalities in temporal response patterns such that in layers 3-5 there was a temporal broadening of response patterns in response to both whisker deflection stimulus types and in L2 a narrowing of temporal patterns in response to the complex stimulus. Thus, at two weeks post-TBI, supragranular hypo -excitation has evolved to include deep cortical layers likely as a function of progressive atrophy and neurodegeneration. These results are consistent with the hypothesis that TBI alters the delicate excitatory/inhibitory balance in cortex and likely contributes to temporal broadening of responses and restricts the ability to code for complex sensory stimuli. (C) 2016 IBRO. Published by Elsevier Ltd. All rights reserved.	[Allitt, Benjamin J.; Iva, Pippa; Yan, Edwin B.; Rajan, Ramesh] Monash Univ, Dept Physiol, Clayton, Vic, Australia	Rajan, R (corresponding author), Monash Univ, Dept Physiol, Clayton, Vic, Australia.	ben.allitt@monash.edu; pliva1@student.monash.edu; Edwin.yan@monash.edu; ramesh.rajan@monash.edu	rajan, ramesh/L-4842-2019	Iva, Pippa/0000-0003-2398-1190; Rajan, Ramesh/0000-0001-9862-0520	Australian National HealthNational Health and Medical Research Council of Australia; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [APP 1029311]	This research was funded by the Australian National Health and Medical Research Council, grant # APP 1029311. The National Health and Medical Research Council did not contribute to study design, data collection, analysis, manuscript preparation or in the decision to submit this research for publication.	Abdi H., 2007, ENCY MEASUREMENT STA; Abelson-Mitchell N, 2008, J CLIN NURS, V17, P46, DOI 10.1111/j.1365-2702.2007.01941.x; Ahissar E, 2000, NATURE, V406, P302, DOI 10.1038/35018568; Ahissar E, 2001, J NEUROPHYSIOL, V86, P354; Allitt BJ, 2016, J NEUROTRAUM, V33, P375, DOI 10.1089/neu.2015.3946; Alwis DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052169; Alwis DS, 2013, P AUST PHYS SOC, V44, P13; Ansari MA, 2008, J NEUROTRAUM, V25, P513, DOI 10.1089/neu.2007.0451; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; ARMSTRONGJAMES M, 1992, J NEUROPHYSIOL, V68, P1345; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Camp AJ, 2009, INT J BIOCHEM CELL B, V41, P2118, DOI 10.1016/j.biocel.2009.05.007; Cantu D, 2015, CEREB CORTEX, V25, P2306, DOI 10.1093/cercor/bhu041; Carandini M, 1997, SCIENCE, V276, P949, DOI 10.1126/science.276.5314.949; Carron SF, 2016, J COMP NEUROL; Cernak I, 2001, CLIN EXP PHARMACOL P, V28, P922, DOI 10.1046/j.1440-1681.2001.03549.x; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Compte A, 2003, J NEUROPHYSIOL, V89, P2707, DOI 10.1152/jn.00845.2002; Cook NL, 2010, J MOL NEUROSCI, V42, P192, DOI 10.1007/s12031-010-9347-8; Corbo J, 2004, ANN EMERG MED, V44, P57, DOI 10.1016/j.annemergmed.2003.11.010; Diamond ME, 2008, NAT REV NEUROSCI, V9, P601, DOI 10.1038/nrn2411; DIAMOND ME, 1992, J COMP NEUROL, V318, P462, DOI 10.1002/cne.903180410; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; Ding MC, 2011, J NEUROSCI, V31, P14085, DOI 10.1523/JNEUROSCI.3572-11.2011; Draper K, 2009, NEUROPSYCHOL REHABIL, V19, P645, DOI 10.1080/17405620802613935; Feldmeyer D, 1999, J PHYSIOL-LONDON, V521, P169, DOI 10.1111/j.1469-7793.1999.00169.x; Feliciano DP, 2014, NEUROSCI LETT, V583, P55, DOI 10.1016/j.neulet.2014.09.030; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Gilmore E, 2010, NEUROLOGY, V74, pE28, DOI 10.1212/WNL.0b013e3181d55f8a; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; Hall KD, 2010, BRAIN RES, V1323, P161, DOI 10.1016/j.brainres.2010.01.067; Hartings JA, 2014, ANN NEUROL, V76, P681, DOI 10.1002/ana.24256; Hartmann MJ, 2003, J NEUROSCI, V23, P6510; Heiss JE, 2008, J NEUROSCI, V28, P13320, DOI 10.1523/JNEUROSCI.2646-08.2008; Hellewell SC, 2010, J NEUROTRAUM, V27, P1997, DOI 10.1089/neu.2009.1245; Higley MJ, 2006, J NEUROSCI, V26, P448, DOI 10.1523/JNEUROSCI.3506-05.2006; Hoover E, 2014, J ACOUST SOC AM, V135, P2166, DOI DOI 10.1121/1.4877039; Hulsebosch CE, 1998, NEUROSCI LETT, V255, P83, DOI 10.1016/S0304-3940(98)00712-5; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Johnson VE, 2016, ACTA NEUROPATHOL, V131, P115, DOI 10.1007/s00401-015-1506-0; Johnstone VPA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063454; Kampa BM, 2006, NAT NEUROSCI, V9, P1472, DOI 10.1038/nn1798; Kapfer C, 2007, NAT NEUROSCI, V10, P743, DOI 10.1038/nn1909; Katayama Y, 1990, J NEUROSURG, V32, P15252; Lamy M, 2013, MED BIOL ENG COMPUT, V51, P353, DOI 10.1007/s11517-012-1004-7; Learoyd AE, 2012, BEHAV BRAIN RES, V226, P197, DOI 10.1016/j.bbr.2011.09.016; Levchakov A, 2006, J NEUROTRAUM, V23, P1570, DOI 10.1089/neu.2006.23.1570; Lifshitz J, 2007, J NEUROPATH EXP NEUR, V66, P218, DOI 10.1097/01.jnen.0000248558.75950.4d; Lifshitz J, 2012, BRAIN STRUCT FUNCT, V217, P49, DOI 10.1007/s00429-011-0323-z; Ma YY, 2006, J NEUROSCI, V26, P5069, DOI 10.1523/JNEUROSCI.0661-06.2006; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; McNamara KCS, 2010, J NEUROTRAUM, V27, P695, DOI 10.1089/neu.2009.1237; Meyer HS, 2011, P NATL ACAD SCI USA, V108, P16807, DOI 10.1073/pnas.1113648108; Pinto DJ, 2003, CEREB CORTEX, V13, P33, DOI 10.1093/cercor/13.1.33; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Radnikow G, 2015, SESNORIMOTOR INTEGRA, P59, DOI 10.1007/978-1-4939-2975-7; Rajan R, 2007, EUR J NEUROSCI, V25, P2383, DOI 10.1111/j.1460-9568.2007.05481.x; Rajan R, 2006, J NEUROSCI METH, V157, P103, DOI 10.1016/j.jneumeth.2006.04.008; Rodriguez-Paez AC, 2005, ACTA NEUROPATHOL, V109, P603, DOI 10.1007/s00401-005-1010-z; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4286; Sawant-Pokam PM, 2016, CEREB CORTEX; Stocchetti N, 2007, J NEUROTRAUM, V24, P1339, DOI 10.1089/neu.2007.0300; Styrke J, 2007, J NEUROTRAUM, V24, P1425, DOI 10.1089/neu.2007.0266; TAFT WC, 1992, J NEUROTRAUM, V9, P281, DOI 10.1089/neu.1992.9.281; Theriot JJ, 2012, J NEUROSCI, V32, P15252, DOI 10.1523/JNEUROSCI.2092-12.2012; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wilson NR, 2012, NATURE, V488, P343, DOI 10.1038/nature11347; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yan EB, 2013, NEUROSCIENCE, V248, P17, DOI 10.1016/j.neuroscience.2013.05.045; Yan EB, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-147	78	11	11	1	10	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	OCT 15	2016	334						290	308		10.1016/j.neuroscience.2016.08.018			19	Neurosciences	Neurosciences & Neurology	DW1OK	WOS:000383412300026	27530700				2021-06-18	
J	van Klaveren, D; Gonen, M; Steyerberg, EW; Vergouwe, Y				van Klaveren, David; Gonen, Mithat; Steyerberg, Ewout W.; Vergouwe, Yvonne			A new concordance measure for risk prediction models in external validation settings	STATISTICS IN MEDICINE			English	Article						concordance; discrimination; logistic regression; proportional hazards regression; case-mix heterogeneity; censoring	PERCUTANEOUS CORONARY INTERVENTION; TRAUMATIC BRAIN-INJURY; SYNTAX SCORE II; LEFT MAIN; PERFORMANCE; REGRESSION; SURGERY; DISEASE; TRIAL; TESTS	Concordance measures are frequently used for assessing the discriminative ability of risk prediction models. The interpretation of estimated concordance at external validation is difficult if the case-mix differs from the model development setting. We aimed to develop a concordance measure that provides insight into the influence of case-mix heterogeneity and is robust to censoring of time-to-event data. We first derived a model-based concordance (mbc) measure that allows for quantification of the influence of case-mix heterogeneity on discriminative ability of proportional hazards and logistic regression models. This mbc can also be calculated including a regression slope that calibrates the predictions at external validation (c-mbc), hence assessing the influence of overall regression coefficient validity on discriminative ability. We derived variance formulas for both mbc and c-mbc. We compared the mbc and the c-mbc with commonly used concordance measures in a simulation study and in two external validation settings. The mbc was asymptotically equivalent to a previously proposed resampling-based case-mix corrected c-index. The c-mbc remained stable at the true value with increasing proportions of censoring, while Harrell's c-index and to a lesser extent Uno's concordance measure increased unfavorably. Variance estimates of mbc and c-mbc were well in agreement with the simulated empirical variances. We conclude that the mbc is an attractive closed-form measure that allows for a straightforward quantification of the expected change in a model's discriminative ability due to case-mix heterogeneity. The c-mbc also reflects regression coefficient validity and is a censoring-robust alternative for the c-index when the proportional hazards assumption holds. Copyright (c) 2016 John Wiley & Sons, Ltd.	[van Klaveren, David; Steyerberg, Ewout W.; Vergouwe, Yvonne] Erasmus Univ, Dept Publ Hlth, Med Ctr, Rotterdam, Netherlands; [Gonen, Mithat] Mem Sloan Kettering Canc Ctr, Epidemiol & Biostat, 1275 York Ave, New York, NY 10021 USA	van Klaveren, D (corresponding author), Erasmus Univ, Dept Publ Hlth, Med Ctr, Rotterdam, Netherlands.	d.vanklaveren.1@erasmusmc.nl	Gonen, Mithat/E-4826-2012; Steyerberg, Ewout W/C-1509-2018	Gonen, Mithat/0000-0001-8683-8477; Steyerberg, Ewout W/0000-0002-7787-0122	Netherlands Organisation for Scientific ResearchNetherlands Organization for Scientific Research (NWO) [917.11.383.]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA008748] Funding Source: NIH RePORTER	This work was supported by the Netherlands Organisation for Scientific Research (grant 917.11.383.). David van Klaveren, Mithat Gonen, Ewout Steyerberg, and Yvonne Vergouwe designed the study. David van Klaveren and Yvonne Vergouwe analyzed the data and wrote the first draft of the paper. All authors contributed to writing the paper and approved the final version.	[Anonymous], 2011, R LANG ENV STAT COMP; Austin PC, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-82; Campos CM, 2014, CIRC J, V78, P1942, DOI 10.1253/circj.CJ-14-0204; Farooq V, 2013, LANCET, V381, P639, DOI 10.1016/S0140-6736(13)60108-7; Gonen M, 2005, BIOMETRIKA, V92, P965, DOI 10.1093/biomet/92.4.965; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; Hukkelhoven CWPM, 2002, J NEUROSURG, V97, P549, DOI 10.3171/jns.2002.97.3.0549; Kimura T, 2011, CARDIOVASC INTERV TH, V26, P234, DOI 10.1007/s12928-011-0065-0; KORN EL, 1990, STAT MED, V9, P487, DOI 10.1002/sim.4780090503; Lambert J, 2016, STAT METHODS MED RES, V25, P2088, DOI 10.1177/0962280213515571; Marshall LF, 1998, J NEUROSURG, V89, P519, DOI 10.3171/jns.1998.89.4.0519; Mohr FW, 2013, LANCET, V381, P629, DOI 10.1016/S0140-6736(13)60141-5; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Quade D, 1967, I STAT MIMEO SERIES, V526; Royston P, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-33; Stare J, 2011, BIOMETRICS, V67, P750, DOI 10.1111/j.1541-0420.2010.01526.x; Steyerberg EW., 2009, CLIN PREDICTION MODE; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Uno H, 2011, STAT MED, V30, P1105, DOI 10.1002/sim.4154; van Klaveren D, 2014, STAT MED, V33, P714, DOI 10.1002/sim.5928; Vergouwe Y, 2010, AM J EPIDEMIOL, V172, P971, DOI 10.1093/aje/kwq223	23	11	11	1	5	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0277-6715	1097-0258		STAT MED	Stat. Med.	OCT 15	2016	35	23					4136	4152		10.1002/sim.6997			17	Mathematical & Computational Biology; Public, Environmental & Occupational Health; Medical Informatics; Medicine, Research & Experimental; Statistics & Probability	Mathematical & Computational Biology; Public, Environmental & Occupational Health; Medical Informatics; Research & Experimental Medicine; Mathematics	DW5YC	WOS:000383722600005	27251001	Green Accepted			2021-06-18	
J	Derakhshanrad, N; Yekaninejad, MS; Vosoughi, F; Fazel, FS; Saberi, H				Derakhshanrad, N.; Yekaninejad, M. S.; Vosoughi, F.; Fazel, F. Sadeghi; Saberi, H.			Epidemiological study of traumatic spinal cord injuries: experience from a specialized spine center in Iran	SPINAL CORD			English	Article							UNITED-STATES; CLINICAL-OUTCOMES; PREVALENCE; ETIOLOGY; REGISTRY; CANADA; MORTALITY; WORLDWIDE; COUNTRIES; PROFILE	Study design: A cross-sectional study. Objectives: This study was performed for epidemiological assessment of Iranian Traumatic Spinal Cord Injuries (TSCI), referred to a specialized spine center. Setting: Patient recruitment and evaluations were conducted at the Brain and Spinal Injury Research Center, Tehran, Iran. Methods: This study was performed from September 2011 to March 2015 on 1137 consecutive TSCIs. History, clinicoradiological findings as well as chronic complications and social integration were recorded. The capture-recapture method was used to calculate a rough estimation of TSCI prevalence in Tehran Province. Results: Our report includes 1137 cases with a mean age of 29.1 years (s.d.=11.2 year)-79.2% of them being male (M/F=3.8/1). Rough estimation of TSCI prevalence in Tehran province was 2.36 per 10 000 population. Regarding etiology, 61.8% were due to motor vehicle accident (MVA), followed by falling 24.5%, heavy drop 5.2%, violence 3.8%, sport 2.8% and others causes 1.9%. Regarding injury level, 31.5% were cervical, 57.9% thoracic and 10.6% lumbar. Complete lesions were 53.5% of patients and 46.5% were incomplete. Most common neurological type was T1-S5 (American Spinal Injury Association Impairment Scale: A, B, C, 61.7%). Most common complications included urinary tract infection followed by pressure sore (grade III and IV, 37.5%), autonomic dysreflexia (37%) and neuropathic pain (31.2%). Substance abuse was observed in 8.8% of cases. Overall, similar to 25% in our cases were employed after TSCI. Secondary divorce was also much more frequent than normal matched controls. Conclusion: MVA was the most common cause for TSCI. The elderly subjects were less frequent among our patients than more developed countries. The high rate of unemployment and divorce in our cases deserves special consideration.	[Derakhshanrad, N.; Vosoughi, F.; Fazel, F. Sadeghi; Saberi, H.] Univ Tehran Med Sci, Neurosci Inst, Brain & Spinal Cord Injuries Res Ctr BASIR, Imam Khomeini Hosp Complex, Tehran, Iran; [Yekaninejad, M. S.] Univ Tehran Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Tehran, Iran; [Saberi, H.] Univ Tehran Med Sci, Imam Khomeini Hosp, Dept Neurosurg, Tehran, Iran	Saberi, H (corresponding author), Univ Tehran Med Sci, Brain & Spinal Cord Injuries Res Ctr, Imam Khomeini Hosp Complex,Keshavarz Blvd, Tehran 1449614535, Iran.	hgsaberi@yahoo.com	Vosoughi, fardis/AAG-9424-2019; Yekaninejad, Mir Saeed/L-6752-2016	Yekaninejad, Mir Saeed/0000-0003-3648-5276; Vosoughi, Fardis/0000-0002-9136-0479			Aito S, 2014, SPINAL CORD, V52, P268, DOI 10.1038/sc.2014.2; Alshahri SS, 2012, SPINAL CORD, V50, P882, DOI 10.1038/sc.2012.65; Bakhtiyari M, 2014, INT J INJ CONTROL SA, V21, P103, DOI 10.1080/17457300.2012.762027; Botterell E H, 1975, Can J Neurol Sci, V2, P361; Burns S, 2012, TOP SPINAL CORD INJ, V18, P85, DOI DOI 10.1310/SCI1801-85; Cardenas DD, 2004, ARCH PHYS MED REHAB, V85, P1757, DOI 10.1016/j.apmr.2004.03.016; Chabok S. Y., 2010, Acta Medica Iranica, V48, P308; Chen Y, 2015, J SPINAL CORD MED; Chiu WT, 2010, ASIA-PAC J PUBLIC HE, V22, P9, DOI 10.1177/1010539509355470; CHIU WT, 1993, J TRAUMA, V35, P206, DOI 10.1097/00005373-199308000-00006; DeVivo MJ, 1997, SPINAL CORD, V35, P809, DOI 10.1038/sj.sc.3100501; Feng HY, 2011, J SPINAL CORD MED, V34, P388, DOI 10.1179/2045772311Y.0000000017; Furlan JC, 2013, CAN J NEUROL SCI, V40, P456, DOI 10.1017/S0317167100014530; Hagen EM, 2010, SPINAL CORD, V48, P313, DOI 10.1038/sc.2009.133; Hoque MF, 1999, SPINAL CORD, V37, P858, DOI 10.1038/sj.sc.3100938; Jain NB, 2015, JAMA-J AM MED ASSOC, V313, P2236, DOI 10.1001/jama.2015.6250; Jetha Arif, 2014, Top Spinal Cord Inj Rehabil, V20, P310, DOI 10.1310/sci2004-310; Johnson RL, 1996, SPINAL CORD, V34, P470, DOI 10.1038/sc.1996.81; Kattail D, 2009, J TRAUMA, V67, P936, DOI 10.1097/TA.0b013e3181a8b431; Knutsdottir S, 2012, SPINAL CORD, V50, P123, DOI 10.1038/sc.2011.105; Krause JS, 2009, ARCH PHYS MED REHAB, V90, P1708, DOI 10.1016/j.apmr.2009.04.020; Lofvenmark I, 2015, SPINAL CORD, V53, P150, DOI 10.1038/sc.2014.203; Mann R, 2013, SPINAL CORD, V51, P564, DOI 10.1038/sc.2013.34; Mathur N, 2015, SPINAL CORD, V53, P349, DOI 10.1038/sc.2014.153; McCammon JR, 2011, J SPINAL CORD MED, V34, P6, DOI 10.1179/107902610X12923394765733; Murphy G, 2009, J REHABIL MED, V41, P1074, DOI 10.2340/16501977-0465; National Spinal Cord Injury Statistical Center, 2013, J Spinal Cord Med, V36, P1, DOI 10.1179/1079026813Z.000000000136; Nijendijk JHB, 2014, SPINAL CORD, V52, P258, DOI 10.1038/sc.2013.180; Noonan VK, 2012, SPINAL CORD, V50, P22, DOI 10.1038/sc.2011.109; Obalum DC, 2009, SPINAL CORD, V47, P134, DOI 10.1038/sc.2008.93; Patel AA, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E8; Perez K, 2012, ACCIDENT ANAL PREV, V46, P37, DOI 10.1016/j.aap.2011.12.004; Pickett GE, 2006, SPINE, V31, P799, DOI 10.1097/01.brs.0000207258.80129.03; Pickett W, 2003, J TRAUMA, V55, P1070, DOI 10.1097/01.TA.0000034228.18541.D1; Post MWM, 2016, SPINAL CORD, V54, P314, DOI 10.1038/sc.2015.99; Powell-Cope G, 2015, REHABIL NURS, V40, P100, DOI 10.1002/rnj.134; QUINONES POM, 2002, MIDDLE E J EMERG MED, V2, P1; Rahimi-Movaghar V, 2009, J SPINAL CORD MED, V32, P428, DOI 10.1080/10790268.2009.11754572; RAIBULET T, 2001, KUWAIT MED J, V33, P211; Rekand Tiina, 2012, Tidsskr Nor Laegeforen, V132, P970, DOI 10.4045/tidsskr.10.0872; Bellucci CHS, 2015, NEUROEPIDEMIOLOGY, V44, P85, DOI 10.1159/000371519; Vaccaro AR, 2005, J SPINAL DISORD TECH, V18, P209; van den Berg MEL, 2010, NEUROEPIDEMIOLOGY, V34, P184, DOI 10.1159/000279335; Wilson JR, 2013, SPINE, V38, P97, DOI 10.1097/BRS.0b013e31826e2b91; Wyndaele JJ, 2012, SPINAL CORD, V50, P483, DOI 10.1038/sc.2012.73; Wyndaele M, 2006, SPINAL CORD, V44, P523, DOI 10.1038/sj.sc.3101893	46	11	12	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1362-4393	1476-5624		SPINAL CORD	Spinal Cord	OCT	2016	54	10					901	907		10.1038/sc.2016.10			7	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	EA1QF	WOS:000386366200023	26882485	Bronze			2021-06-18	
J	Fischer-Baum, S; Miozzo, M; Laiacona, M; Capitani, E				Fischer-Baum, Simon; Miozzo, Michele; Laiacona, Marcella; Capitani, Erminio			Perseveration During Verbal Fluency in Traumatic Brain Injury Reflects Impairments in Working Memory	NEUROPSYCHOLOGY			English	Article						perseveration; traumatic brain injury; verbal fluency	ALZHEIMERS-DISEASE; INHIBITORY CONTROL; CATEGORY FLUENCY; COGNITIVE IMPAIRMENT; HUNTINGTONS-DISEASE; SEMANTIC FLUENCY; DEFICITS; PERFORMANCE; APHASIA; MILD	Objective: Previous studies of verbal fluency have reported higher rates of perseverative responses in both Alzheimer's disease (AD) and traumatic brain injury (TBI) relative to control groups. These perseverations could arise from a number of impairments-for example, failures in working memory, inhibitory control, or word retrieval-and different clinical populations may show an increase in perseveration because of different underlying deficits. The objective of the current report is to investigate the cause of perseveration in verbal fluency in individuals with TBI and compare those results to a recent study of individuals with AD. Method: In a previous study, conducted by Miozzo, Fischer-Baum, and Caccappolo-van Vliet (2013), perseveration errors produced by individuals with AD were shown to have long lags between the 1st occurrence of a word and its repetition in verbal fluency, suggesting that perseverations were caused by a failure of the working memory mechanisms that control response monitoring. In the present investigation, we applied the same analysis to the perseveration errors produced during 197 administrations of the verbal fluency task with 143 individuals with TBI. Results: The perseverations of individuals with TBI showed a lag distribution similar to that of the AD population, with the lag between the 1st occurrence of a word and its repetition systematically longer than would be expected by chance. Conclusions: These results suggest that the perseverations produced during verbal fluency in individuals with TBI stem from the same working memory mechanism proposed in AD, rather than inhibitory control or word retrieval deficits.	[Fischer-Baum, Simon] Rice Univ, Dept Psychol, MS 25,POB 1892, Houston, TX 77251 USA; [Miozzo, Michele] New Sch, Dept Psychol, New York, NY USA; [Laiacona, Marcella] Veruno Sci Inst, IRCCS, S Maugeri Fdn, Veruno, Italy; [Capitani, Erminio] Univ Milan, Dept Hlth Sci, I-20122 Milan, Italy	Fischer-Baum, S (corresponding author), Rice Univ, Dept Psychol, MS 25,POB 1892, Houston, TX 77251 USA.	simon.j.fischer-baum@rice.edu					Ackerman T, 2007, APHASIOLOGY, V21, P1018, DOI 10.1080/02687030701198361; ALBERT ML, 1986, CORTEX, V22, P103, DOI 10.1016/S0010-9452(86)80035-1; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Baldo JV, 1998, NEUROPSYCHOLOGY, V12, P259, DOI 10.1037/0894-4105.12.2.259; BAYLES KA, 1993, J CLIN EXP NEUROPSYC, V15, P547, DOI 10.1080/01688639308402578; Bayles Kathryn A., 2004, Seminars in Speech and Language, V25, P335, DOI 10.1055/s-2004-837246; Belleville S, 2007, NEUROPSYCHOLOGY, V21, P458, DOI 10.1037/0894-4105.21.4.458; Bittner RM, 2006, BRAIN INJURY, V20, P971, DOI 10.1080/02699050600909763; Brooks J, 1999, J TRAUMA, V46, P159, DOI 10.1097/00005373-199901000-00027; BURGESS PW, 1990, NEUROBEHAVIOURAL SEQUELAE OF TRAUMATIC BRAIN INJURY, P110; Caccappolo-van Vliet E, 2003, NEUROCASE, V9, P297; Capitani E, 2009, NEUROPSYCHOLOGIA, V47, P423, DOI 10.1016/j.neuropsychologia.2008.09.016; Cohen L, 1998, BRAIN, V121, P1641, DOI 10.1093/brain/121.9.1641; Collette F, 1997, HUM BRAIN MAPP, V5, P110, DOI 10.1002/(SICI)1097-0193(1997)5:2<110::AID-HBM4>3.0.CO;2-6; Cossa FM, 1999, BRAIN INJURY, V13, P583; Crawford TJ, 2005, BIOL PSYCHIAT, V57, P1052, DOI 10.1016/j.biopsych.2005.01.017; Crawford TJ, 2013, AGE, V35, P1637, DOI 10.1007/s11357-012-9466-y; Croot K, 2000, BRAIN LANG, V75, P277, DOI 10.1006/brln.2000.2357; CUMMINGS JL, 1985, NEUROLOGY, V35, P394, DOI 10.1212/WNL.35.3.394; Dell GS, 1997, PSYCHOL REV, V104, P123, DOI 10.1037/0033-295X.104.1.123; Duncan J, 1997, COGNITIVE NEUROPSYCH, V14, P713, DOI 10.1080/026432997381420; Engle RW, 2002, CURR DIR PSYCHOL SCI, V11, P19, DOI 10.1111/1467-8721.00160; Fischer-Baum S, 2012, NEUROPSYCHOLOGIA, V50, P305, DOI 10.1016/j.neuropsychologia.2011.12.001; Foldi NS, 2003, AGING NEUROPSYCHOL C, V10, P268, DOI 10.1076/anec.10.4.268.28970; Frankel T, 2007, APHASIOLOGY, V21, P1039, DOI 10.1080/02687030701198395; Hauser MD, 1999, CURR OPIN NEUROBIOL, V9, P214, DOI 10.1016/S0959-4388(99)80030-0; HELMICK JW, 1976, J COMMUN DISORD, V9, P143, DOI 10.1016/0021-9924(76)90006-X; Henry JD, 2005, NEUROPSYCHOLOGY, V19, P243, DOI 10.1037/0894-4105.19.2.243; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P621, DOI 10.1037/0894-4105.18.4.621; Henry JD, 2004, NEUROPSYCHOLOGIA, V42, P1212, DOI 10.1016/j.neuropsychologia.2004.02.001; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P284, DOI 10.1037/0894-4105.18.2.284; Henry JD, 2004, J INT NEUROPSYCH SOC, V10, P608, DOI 10.1017/S1355617704104141; Henry JD, 2006, AGING NEUROPSYCHOL C, V13, P529, DOI 10.1080/138255890969537; Henry Julie D, 2005, Cogn Neuropsychiatry, V10, P1, DOI 10.1080/13546800344000309; HOTZ G, 1995, BRAIN INJURY, V9, P151, DOI 10.3109/02699059509008188; Hsiao EY, 2009, BRAIN LANG, V108, P133, DOI 10.1016/j.bandl.2008.11.003; HUFF FJ, 1986, BRAIN LANG, V28, P235, DOI 10.1016/0093-934X(86)90103-3; Huntley JD, 2010, INT J GERIATR PSYCH, V25, P121, DOI 10.1002/gps.2314; Kave G, 2011, J CLIN EXP NEUROPSYC, V33, P358, DOI 10.1080/13803395.2010.518703; KERR C, 1995, BRAIN INJURY, V9, P777, DOI 10.3109/02699059509008234; Konrad KN, 2000, BRAIN INJURY, V14, P859; KOZORA E, 1995, CLIN NEUROPSYCHOL, V9, P313, DOI 10.1080/13854049508400495; Levin HS, 2002, ANN NEUROL, V52, P82, DOI 10.1002/ana.10252; Marczinski CA, 2006, BRAIN LANG, V97, P258, DOI 10.1016/j.bandl.2005.11.001; Martin N, 1998, APHASIOLOGY, V12, P319, DOI 10.1080/02687039808249536; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; MILLER E, 1984, BRIT J CLIN PSYCHOL, V23, P53, DOI 10.1111/j.2044-8260.1984.tb00626.x; Miozzo M, 2013, CORTEX, V49, P2028, DOI 10.1016/j.cortex.2012.10.016; Pekkala S, 2008, DEMENT GERIATR COGN, V25, P109, DOI 10.1159/000112476; Peters F, 2007, J CLIN EXP NEUROPSYC, V29, P405, DOI 10.1080/13803390600733064; Pettit LD, 2013, BRAIN, V136, P3290, DOI 10.1093/brain/awt243; PRICE BH, 1993, ARCH NEUROL-CHICAGO, V50, P931, DOI 10.1001/archneur.1993.00540090038008; Ramage A, 1999, BRAIN LANG, V66, P329, DOI 10.1006/brln.1999.2032; Raskin SA, 1996, NEUROPSYCHOLOGY, V10, P416, DOI 10.1037/0894-4105.10.3.416; Reverberi C, 2006, NEUROPSYCHOLOGIA, V44, P469, DOI 10.1016/j.neuropsychologia.2005.05.011; Roche RAP, 2004, NEUROSCI LETT, V362, P1, DOI 10.1016/j.neulet.2003.11.064; SANDSON J, 1984, NEUROPSYCHOLOGIA, V22, P715, DOI 10.1016/0028-3932(84)90098-8; Schwartz S, 2003, BRAIN LANG, V87, P400, DOI 10.1016/S0093-934X(03)00141-X; Serino A, 2006, BRAIN INJURY, V20, P23, DOI 10.1080/02699050500309627; SHINDLER AG, 1984, BRAIN LANG, V23, P148, DOI 10.1016/0093-934X(84)90013-0; Stopford CL, 2012, CORTEX, V48, P429, DOI 10.1016/j.cortex.2010.12.002; Suhr JA, 1998, ARCH CLIN NEUROPSYCH, V13, P447, DOI 10.1016/S0887-6177(97)00040-1; TROSTER AI, 1989, BRAIN LANG, V37, P500, DOI 10.1016/0093-934X(89)90032-1; Unsworth N, 2011, Q J EXP PSYCHOL, V64, P447, DOI 10.1080/17470218.2010.505292; Vallat-Azouvi C, 2007, J INT NEUROPSYCH SOC, V13, P770, DOI 10.1017/S1355617707070993; Zhao QH, 2013, NEUROSCI BULL, V29, P75, DOI 10.1007/s12264-013-1301-7	67	11	11	3	15	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	OCT	2016	30	7					791	799		10.1037/neu0000286			9	Psychology, Clinical; Neurosciences; Psychology	Psychology; Neurosciences & Neurology	DY9FX	WOS:000385440400002	27054439				2021-06-18	
J	Khalili, H; Sadraei, N; Niakan, A; Ghaffarpasand, F; Sadraei, A				Khalili, Hosseinali; Sadraei, Nazanin; Niakan, Amin; Ghaffarpasand, Fariborz; Sadraei, Amin			Role of Intracranial Pressure Monitoring in Management of Patients with Severe Traumatic Brain Injury: Results of a Large Level I Trauma Center in Southern Iran	WORLD NEUROSURGERY			English	Article						Cerebral perfusion pressure; Intracranial pressure monitoring; Prognosis; Traumatic brain injury; Ventriculostomy	PREDICTION; OUTCOMES	OBJECTIVE: To determine the role of intracranial pressure (ICP) monitoring in management of patients with severe traumatic brain injury (TBI) admitted to a large level I trauma center in Southern Iran. METHODS: This was a cohort study performed during a 2-year period in a level I trauma center in Southern Iran including all adult patients (> 16 years) with severe TBI (Glasgow Coma Scale [GCS] score, 3-8) who underwent ICP monitoring through ventriculostomy. The management was based on the recorded ICP values with threshold of 20 mm Hg. Decompressive craniectomy was performed in patients with intractable intracranial hypertension (persistent ICP >= 25 mm Hg). In unresponsive patients, barbiturate coma was induced. Patients were followed for 6 months and Glasgow Outcome Scale Extended was recorded. The determinants of favorable and unfavorable outcome were also determined. RESULTS: Overall, we included 248 patients with mean age of 34.6 +/- 16.6 years, among whom there were 216 men (87.1%) and 32 women (12.9%). Eighty-five patients (34.2%) had favorable and 163 (65.8%) unfavorable outcomes. Those with favorable outcome had significantly lower age (P = 0.004), higher GCS score on admission (P < 0.001), lower Rotterdam score (P=0.035), fewer episodes of intracranial hypertension (P < 0.001), and lower maximum recorded ICP (P=0.041). These factors remained statistically significant after elimination of confounders by multivariate logistic regression model. CONCLUSIONS: Age, GCS score on admission, Rotterdam score, intracranial hypertension, and maximum recorded ICP are important determinants of outcome in patients with severe TBI. ICP monitoring assisted us in targeted therapy and management of patients with severe TBI.	[Khalili, Hosseinali] Shiraz Univ Med Sci, Dept Neurosurg, Trauma Res Ctr, Shiraz, Iran; [Sadraei, Nazanin; Sadraei, Amin] Shiraz Univ Med Sci, Neurosci Res Ctr, Shiraz, Iran; [Niakan, Amin; Ghaffarpasand, Fariborz; Sadraei, Amin] Shiraz Univ Med Sci, Dept Neurosurg, Student Res Comm, Shiraz, Iran	Ghaffarpasand, F (corresponding author), Shiraz Univ Med Sci, Dept Neurosurg, Student Res Comm, Shiraz, Iran.	fariborz.ghaffarpasand@gmail.com	Khalili, Hosseinali/I-1087-2016; Ghaffarpasand, Fariborz/I-4204-2019; niakan, amin/A-6818-2019	Khalili, Hosseinali/0000-0002-3390-4212; Ghaffarpasand, Fariborz/0000-0002-1721-9987; niakan, amin/0000-0003-2644-8543	 [91-01-55-5320]	The authors wish to thank all the patients and their families who participated in the study. This research project is a result of a thesis project for partial fulfillment of a medical doctorate degree by Nazanin Sadraei (no. 91-01-55-5320), supported by the vice-chancellor of research of Shiraz University of Medical Sciences. We would like to acknowledge Mr. Arya Zamiri and Miss Sedigheh Hoosmandi, who assisted us with data collection.	Abbasi Hamid Reza, 2013, Bull Emerg Trauma, V1, P81; Baum J, 2016, WORLD NEUROSURG, V90, P525, DOI 10.1016/j.wneu.2015.12.012; Bratton SL, 2007, J NEUROTRAUMA S1, V24, P555, DOI DOI 10.1089/NEU.2007.9988; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Dawes AJ, 2015, J TRAUMA ACUTE CARE, V78, P492, DOI 10.1097/TA.0000000000000559; DiRusso S, 2001, J TRAUMA, V51, P294, DOI 10.1097/00005373-200108000-00011; Ferreira Cesar Biselli, 2015, Rev Bras Ter Intensiva, V27, P315, DOI 10.5935/0103-507X.20150055; Forsyth RJ, 2015, COCHRANE DB SYST REV, V11; Georgoff P, 2010, WORLD NEUROSURG, V74, P331, DOI 10.1016/j.wneu.2010.03.025; Grossman EJ, 2013, AM J NEURORADIOL, V34, P951, DOI 10.3174/ajnr.A3358; Han JS, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002827; Heydari ST, 2013, PUBLIC HEALTH, V127, P704, DOI 10.1016/j.puhe.2013.05.003; Kavosi Z, 2015, ARCH TRAUMA RES, V4, DOI 10.5812/atr.22594; Kim JH, 2012, WORLD NEUROSURG, V77, P135, DOI 10.1016/j.wneu.2011.04.017; Kinoshita K, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0138-3; Lozier AP, 2008, NEUROSURGERY, V62, P688, DOI [10.1227/01.NEU.0000017465.78245.6C, 10.1227/01.neu.0000316273.35833.7c]; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas Andrew I R, 2015, Handb Clin Neurol, V128, P455, DOI 10.1016/B978-0-444-63521-1.00029-7; Mani Arash, 2015, Bull Emerg Trauma, V3, P93; Menon DK, 2009, CURR OPIN CRIT CARE, V15, P437, DOI 10.1097/MCC.0b013e3283307a26; Paydar Shahram, 2013, Bull Emerg Trauma, V1, P38; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Rahmanian Abdolkarim, 2014, Bull Emerg Trauma, V2, P151; Reilly P., 2005, HEAD INJURY PATHOPHY, P331; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Smith M, 2008, ANESTH ANALG, V106, P240, DOI 10.1213/01.ane.0000297296.52006.8e; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Taghipour M, 2006, J RES MED SCI, V11, P248; Wright K, 2013, NEUROSURG FOCUS, V34, DOI 10.3171/2013.2.FOCUS12271; Yuan Q, 2016, NEUROSURGERY, V78, P361, DOI 10.1227/NEU.0000000000001050; Yuan Q, 2015, CRIT CARE MED, V43, P1405, DOI 10.1097/CCM.0000000000000965	32	11	11	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	OCT	2016	94						120	125		10.1016/j.wneu.2016.06.122			6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	EF5EJ	WOS:000390353200017	27392896				2021-06-18	
J	Kimura-Ohba, S; Yang, Y; Thompson, J; Kimura, T; Salayandia, VM; Cosse, M; Yang, YR; Sillerud, LO; Rosenberg, GA				Kimura-Ohba, Shihoko; Yang, Yi; Thompson, Jeffrey; Kimura, Tomonori; Salayandia, Victor M.; Cosse, Melissa; Yang, Yirong; Sillerud, Laurel O.; Rosenberg, Gary A.			Transient increase of fractional anisotropy in reversible vasogenic edema	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						Blood-brain barrier; brain vasogenic edema; diffusion tensor imaging; fractional anisotropy; posterior reversible encephalopathy syndrome	TRAUMATIC BRAIN-INJURY; DIFFUSION-TENSOR; ENCEPHALOPATHY SYNDROME; WHITE-MATTER; ACUTE STROKE; MULTIPLE-SCLEROSIS; HYPERTENSIVE-RATS; CYCLOSPORINE; ISCHEMIA; BARRIER	Brain vasogenic edema, involving disruption of the blood-brain barrier, is a common pathological condition in several neurological diseases, with a heterogeneous prognosis. It is sometimes reversible, as in posterior reversible encephalopathy syndrome, but often irreversible and our current clinical tools are insufficient to reveal its reversibility. Here, we show that increased fractional anisotropy in magnetic resonance imaging is associated with the reversibility of vasogenic edema. Spontaneously, hypertensive rats-stroke prone demonstrated posterior reversible encephalopathy syndrome-like acute encephalopathy in response to high-dose cyclosporine A treatment; the deteriorating neurological symptoms and worsening scores in behavioral tests, which were seen in acute phase, dissappered after recovery by cessation of cyclosporine A. In the acute phase of encephalopathy, the fractional anisotropy and apparent diffusion coefficient increased in areas with IgG leakage. This increase of fractional anisotropy occurred in the absence of demyelination: fluid leakage into the myelinated space increased the axial, but not the radial, diffusivity, resulting in the increased fractional anisotropy. This increased fractional anisotropy returned to pre-encephalopathy values in the recovery phase. Our results highlight the importance of the fractional anisotropy increase as a marker for the reversibility of brain edema, which can delineate the brain areas for which recovery is possible.	[Kimura-Ohba, Shihoko; Yang, Yi; Thompson, Jeffrey; Salayandia, Victor M.; Cosse, Melissa; Sillerud, Laurel O.; Rosenberg, Gary A.] Univ New Mexico, Dept Neurol, Albuquerque, NM 87131 USA; [Kimura, Tomonori] Univ New Mexico, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA; [Yang, Yirong; Sillerud, Laurel O.] Univ New Mexico, BRaIN Imaging Ctr, Albuquerque, NM 87131 USA; [Yang, Yirong; Sillerud, Laurel O.] Univ New Mexico, Coll Pharm, Albuquerque, NM 87131 USA; [Rosenberg, Gary A.] Univ New Mexico, Dept Neurosci, Albuquerque, NM 87131 USA; [Rosenberg, Gary A.] Univ New Mexico, Dept Cell Biol & Physiol, Hlth Sci Ctr, Albuquerque, NM 87131 USA	Kimura-Ohba, S (corresponding author), Univ New Mexico, Dept Neurol, Hlth Sci Ctr, MSC11 6035,Domenici Hall NRF,1101 Yale Blvd NE, Albuquerque, NM 87106 USA.	ShKimura@salud.unm.edu		Kimura, Tomonori/0000-0001-8186-094X	NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [RO1 NS045847]; Manpei Suzuki Diabetes Foundation; Uehara Memorial FoundationUehara Memorial Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS045847] Funding Source: NIH RePORTER	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: GAR was supported by the NINDS (RO1 NS045847). TK was supported by Manpei Suzuki Diabetes Foundation and Uehara Memorial Foundation.	Alba-Ferrara LM, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00009; Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Aoki Shigeki, 2005, Radiat Med, V23, P195; Arroyo MVA, 2002, TRANSPLANTATION, V74, P1618, DOI 10.1097/01.TP.0000041449.31360.16; Bailey EL, 2011, NEUROPATH APPL NEURO, V37, P711, DOI 10.1111/j.1365-2990.2011.01170.x; Bartynski WS, 2008, AM J NEURORADIOL, V29, P1036, DOI 10.3174/ajnr.A0928; Bartynski WS, 2008, AM J NEURORADIOL, V29, P1043, DOI 10.3174/ajnr.A0929; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Bouix S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066205; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Chen YJ, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-62; Croall ID, 2014, NEUROLOGY, V83, P494, DOI 10.1212/WNL.0000000000000666; Endo A, 2012, PEDIATR EMERG CARE, V28, P153, DOI 10.1097/PEC.0b013e3182442fe8; GABRIEL KR, 1971, BIOMETRIKA, V58, P453, DOI 10.1093/biomet/58.3.453; Guo AC, 2002, RADIOLOGY, V222, P729, DOI 10.1148/radiol.2223010311; Hugonnet E, 2013, Diagn Interv Imaging, V94, P45, DOI 10.1016/j.diii.2012.02.005; Jalal FY, 2015, J CEREBR BLOOD F MET, V35, P1145, DOI 10.1038/jcbfm.2015.21; Jalal FY, 2012, STROKE, V43, P1115, DOI 10.1161/STROKEAHA.111.643080; Lawrence AJ, 2014, NEUROLOGY, V83, P304, DOI 10.1212/WNL.0000000000000612; Liang Danny, 2007, Neurosurg Focus, V22, pE2, DOI 10.3171/foc.2007.22.5.3; Lin JT, 2003, AM J NEURORADIOL, V24, P102; Ling JM, 2012, BRAIN, V135, P1281, DOI 10.1093/brain/aws073; Liu X, 2013, J MAGN RESON IMAGING, V37, P15, DOI 10.1002/jmri.23647; Liu Y, 2013, BEHAV BRAIN RES, V257, P166, DOI 10.1016/j.bbr.2013.10.007; LUKE DR, 1990, DRUG METAB DISPOS, V18, P158; Mountney A, 2013, J NEUROSCI METH, V212, P1, DOI 10.1016/j.jneumeth.2012.08.025; Newcombe VFJ, 2013, J CEREBR BLOOD F MET, V33, P855, DOI 10.1038/jcbfm.2013.11; Osuka S, 2012, J NEUROSURG, V117, P363, DOI 10.3171/2012.4.JNS112305; Petullo D, 1999, LIFE SCI, V64, P1099, DOI 10.1016/S0024-3205(99)00038-7; Puig J, 2013, STROKE, V44, P1162, DOI 10.1161/STROKEAHA.111.678110; Rosenberg GA, 2005, LANCET, V365, P1291, DOI 10.1016/S0140-6736(05)61008-2; Rosenberg GA, 2012, J CEREBR BLOOD F MET, V32, P1139, DOI 10.1038/jcbfm.2011.197; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; Shbarou RM, 2000, BONE MARROW TRANSPL, V26, P801, DOI 10.1038/sj.bmt.1702603; Singh N, 2000, TRANSPLANTATION, V69, P467, DOI 10.1097/00007890-200002270-00001; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Sotak CH, 2002, NMR BIOMED, V15, P561, DOI 10.1002/nbm.786; Wood JN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006597; Yamagata K, 2012, NEUROCHEM INT, V60, P91, DOI 10.1016/j.neuint.2011.11.002; Yang Q, 1999, STROKE, V30, P2382, DOI 10.1161/01.STR.30.11.2382; Yang Y, 2007, J CEREBR BLOOD F MET, V27, P697, DOI 10.1038/sj.jcbfm.9600375; Yang Y, 2011, STROKE, V42, P3323, DOI 10.1161/STROKEAHA.110.608257; Yang YR, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0245-4; Yasuhara T, 2011, J CLIN NEUROSCI, V18, P406, DOI 10.1016/j.jocn.2010.06.011	45	11	11	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	OCT	2016	36	10					1731	1743		10.1177/0271678X16630556			13	Endocrinology & Metabolism; Hematology; Neurosciences	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	DY8AC	WOS:000385349400007	26865662	Bronze, Green Published			2021-06-18	
J	Magruder, JT; Hibino, N; Collica, S; Zhang, HT; Harness, HL; Heitmiller, ES; Jacobs, ML; Cameron, DE; Vricella, LA; Everett, AD				Magruder, J. Trent; Hibino, Narutoshi; Collica, Sarah; Zhang, Huaitao; Harness, H. Lynn; Heitmiller, Eugenie S.; Jacobs, Marshall L.; Cameron, Duke E.; Vricella, Luca A.; Everett, Allen D.			Association of nadir oxygen delivery on cardiopulmonary bypass with serum glial fibrillary acid protein levels in paediatric heart surgery patients	INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY			English	Article						Congenital heart disease; Paediatric; Brain injury; Cardiopulmonary bypass	TRAUMATIC BRAIN-INJURY; BIOMARKER; HYPOTENSION; CHILDREN; RISK	OBJECTIVES: Protecting the brain during cardiac surgery is a major challenge. We evaluated associations between nadir oxygen delivery (DO2) during paediatric cardiac surgery and a biomarker of brain injury, glial fibrillary acidic protein (GFAP). METHODS: Blood samples were obtained during a prospective, single-centre observational study of children undergoing congenital heart surgery with cardiopulmonary bypass (CPB) (2010-2011). Remnant blood samples, collected serially prior to cannulation for bypass and until incision closure, were analysed for GFAP levels. Perfusion records were reviewed to calculate nadir DO2. Linear regression analysis was used to assess the association between nadir DO2 and GFAP levels. RESULTS: A total of 116 consecutive children were included, with the median age of 0.75 years (interquartile range: 0.42-8.00) and the median weight of 8.3 kg (5.8-20.0). Single-ventricle anatomy was present in 19 patients (16.4%). Deep hypothermic circulatory arrest (DHCA) was used in 14 patients (12.1%). On univariable analysis, nadir DO2 was significantly associated with GFAP values measured during rewarming on CPB (P = 0.005) and after CPB decannulation (P = 0.02). On multivariable analysis controlling for CPB time, DHCA and procedure risk category, a significant negative relationship remained between nadir DO2 and post-CPB GFAP (P = 0.03). CONCLUSIONS: Lower nadir DO2 is associated with increased GFAP levels, suggesting that diminished DO2 during paediatric heart surgery may be contributing to neurological injury. The DO2-GFAP relationship may provide a useful measure for the implementation of neuroprotective strategies in paediatric heart surgery, including goal-directed perfusion.	[Magruder, J. Trent; Hibino, Narutoshi; Collica, Sarah; Zhang, Huaitao; Harness, H. Lynn; Jacobs, Marshall L.; Cameron, Duke E.; Vricella, Luca A.] Johns Hopkins Univ, Sch Med, Div Cardiac Surg, Baltimore, MD USA; [Heitmiller, Eugenie S.] Johns Hopkins Univ, Sch Med, Div Anesthesiol, Baltimore, MD USA; [Everett, Allen D.] Johns Hopkins Univ, Sch Med, Div Pediat Cardiol, Baltimore, MD USA	Everett, AD (corresponding author), 1800 Orleans St, Baltimore, MD 21231 USA.	aeveret3@jhmi.edu			Veracis	Under a licensing agreement between ImmunArray Ltd and the Johns Hopkins University, Allen D. Everett is entitled to royalties on an invention described in this article. Allen D. Everett also is a paid consultant to Veracis, a subsidiary of ImmunArray Ltd. Otherwise, the authors have no competing interests or conflicts of interest to disclose.	Andropoulos DB, 2010, J THORAC CARDIOV SUR, V139, P543, DOI 10.1016/j.jtcvs.2009.08.022; Beca J, 2013, CIRCULATION, V127, P971, DOI 10.1161/CIRCULATIONAHA.112.001089; Bembea MM, 2011, PEDIATR CRIT CARE ME, V12, P572, DOI 10.1097/PCC.0b013e3181fe3ec7; Brunetti MA, 2014, CARDIOL YOUNG, V24, P623, DOI 10.1017/S1047951113000851; Chalak LF, 2014, J PEDIATR-US, V164, P468, DOI 10.1016/j.jpeds.2013.10.067; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; de Somer F, 2011, CRIT CARE, V15, DOI 10.1186/cc10349; Ennen CS, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.06.025; Gaynor JW, 2003, J THORAC CARDIOV SUR, V126, P1736, DOI 10.1016/S0022-5223(03)01188-7; Honda M, 2010, J TRAUMA, V69, P104, DOI 10.1097/TA.0b013e3181bbd485; Hori D, 2015, ANN THORAC SURG, V100, P1353, DOI 10.1016/j.athoracsur.2015.04.006; Hori D, 2015, ANN THORAC SURG, V100, P487, DOI 10.1016/j.athoracsur.2015.03.036; Jenkins KJ, 2002, J THORAC CARDIOV SUR, V123, P110, DOI 10.1067/mtc.2002.119064; Kaneko T, 2009, RESUSCITATION, V80, P790, DOI 10.1016/j.resuscitation.2009.04.003; Magruder JT, 2015, ANN THORAC SURG, V100, P1697, DOI 10.1016/j.athoracsur.2015.05.059; Mahle WT, 2002, CIRCULATION, V106, pI109, DOI 10.1161/01.cir.0000032908.33237.b1; McKenney SL, 2016, CARDIOL YOUNG, P1; Nylen K, 2006, J NEUROL SCI, V240, P85, DOI 10.1016/j.jns.2005.09.007; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Ranucci M, 2005, ANN THORAC SURG, V80, P2213, DOI 10.1016/j.athoracsur.2005.05.069; Rappold T, 2016, BRIT J ANAESTH, V116, P83, DOI 10.1093/bja/aev415; Sarajuuri A, 2012, PEDIATRICS, V130, pE1636, DOI 10.1542/peds.2012-0486; Savage WJ, 2011, AM J HEMATOL, V86, P427, DOI 10.1002/ajh.21995; Seghaye MC, 1996, J THORAC CARDIOV SUR, V112, P687, DOI 10.1016/S0022-5223(96)70053-3; Stewart A, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.02.049	25	11	11	0	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1569-9293	1569-9285		INTERACT CARDIOV TH	Interact Cardiovasc. Thorac. Surg.	OCT	2016	23	4					531	537		10.1093/icvts/ivw194			7	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	DZ8NS	WOS:000386127700005	27316657	Bronze			2021-06-18	
J	Padgett, CR; Summers, MJ; Skilbeck, CE				Padgett, Christine R.; Summers, Mathew J.; Skilbeck, Clive E.			Is APOE epsilon 4 Associated With Poorer Cognitive Outcome Following Traumatic Brain Injury? A Meta-Analysis	NEUROPSYCHOLOGY			English	Article						traumatic brain injury; apolipoprotein E; cognitive function; executive function; memory	APOLIPOPROTEIN-E POLYMORPHISM; ENVIRONMENT INTERACTION RESEARCH; GLASGOW COMA SCALE; ALZHEIMERS-DISEASE; OLDER-ADULTS; HEAD-INJURY; ANTAGONISTIC PLEIOTROPY; POSTTRAUMATIC AMNESIA; GENETIC POLYMORPHISMS; NEURONAL DAMAGE	Objective: Cognitive impairment is a common sequelae of traumatic brain injury (TBI); however, predicting who will experience poorer outcomes remains challenging. A potential risk factor that has gained attention is the APOE gene, with the epsilon 4 allele hypothesized to have a detrimental effect on post-TBI cognitive outcome. The aim of this meta-analysis was to evaluate the effect of APOE epsilon 4 both in terms of general cognitive function and within specific domains known to be prone to impairment following TBI (executive function, working memory, verbal memory and visual memory). Method: A literature search was undertaken in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA), resulting in the inclusion of 10 studies (epsilon 4-carriers n = 143, noncarriers n = 510). Neuropsychological tasks were identified, and Cohen's d was calculated and pooled. Meta-analyses were conducted on general cognitive functioning and for the specific cognitive domains of interest. Results: No significant differences were found between APOE epsilon 4-carriers or noncarriers, either in general cognitive function or in the cognitive domains of executive function, working memory, verbal memory, or visual memory. Conclusions: This meta-analysis indicates that APOE epsilon 4 does not have a detrimental effect on cognitive performance following TBI. We propose that the relationship between APOE and cognitive function following TBI is complex, and a more-nuanced exploration of APOE genotypes is needed.	[Padgett, Christine R.] Univ Tasmania, Fac Hlth Sci, Sch Med Psychol, Launceston, Tas, Australia; [Summers, Mathew J.] Univ Sunshine Coast, Fac Arts & Business, Sch Social Sci, Sunshine Coast, Qld, Australia; [Summers, Mathew J.] Univ Tasmania, Sch Med, Wicking Dementia Res & Educ Ctr, Hobart, Tas, Australia; [Skilbeck, Clive E.] Univ Tasmania, Bag 1342, Launceston, Tas 7250, Australia	Padgett, CR (corresponding author), Univ Tasmania, Bag 1342, Launceston, Tas 7250, Australia.	christine.padgett@utas.edu.au	Summers, Mathew J/G-3168-2011; Padgett, Christine/J-2774-2013	Summers, Mathew J/0000-0002-3869-4920; Padgett, Christine/0000-0003-4398-4268	Eli Lily (Australia) Pty Ltd; Novotech Pty Ltd	Mathew J. Summers reports personal fees from Eli Lily (Australia) Pty Ltd and grants from Novotech Pty Ltd, outside the submitted work. The remaining authors declare that they have no conflicts of interest.	Alexander S, 2007, J NEUROTRAUM, V24, P790, DOI 10.1089/neu.2006.0133; American Psychological Association, 2012, PUBL MAN AM PSYCH AS; Anderson GD, 2009, EPILEPSY BEHAV, V16, P501, DOI 10.1016/j.yebeh.2009.08.025; Ariza M, 2006, J NEUROL NEUROSUR PS, V77, P1191, DOI 10.1136/jnnp.2005.085167; Ashman TA, 2008, J HEAD TRAUMA REHAB, V23, P139, DOI 10.1097/01.HTR.0000319930.69343.64; Azouvi P, 2000, CURR OPIN NEUROL, V13, P665, DOI 10.1097/00019052-200012000-00009; Bagiella E, 2010, J HEAD TRAUMA REHAB, V25, P375, DOI 10.1097/HTR.0b013e3181d27fe3; Becker JT, 2015, J NEUROVIROL, V21, P24, DOI 10.1007/s13365-014-0290-2; Blackman JA, 2005, DEV MED CHILD NEUROL, V47, P64, DOI 10.1017/S0012162205000113; Bour AMJJ, 2010, DEMENT GERIATR COGN, V29, P534, DOI 10.1159/000314678; Bunce D, 2014, J GERONTOL A-BIOL, V69, P379, DOI 10.1093/gerona/glt103; Bunce D, 2011, NEUROPSYCHOLOGIA, V49, P1693, DOI 10.1016/j.neuropsychologia.2011.02.042; Carter AJR, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-160; Chamelian L, 2004, BRAIN, V127, P2621, DOI 10.1093/brain/awh296; Chang L, 2011, NEUROIMAGE, V58, P1017, DOI 10.1016/j.neuroimage.2011.07.010; Chang L, 2014, NEUROLOGY, V82, P2213, DOI 10.1212/WNL.0000000000000526; Corbo RM, 1999, ANN HUM GENET, V63, P301, DOI 10.1046/j.1469-1809.1999.6340301.x; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Crawford FC, 2002, NEUROLOGY, V58, P1115, DOI 10.1212/WNL.58.7.1115; Cudaback E, 2015, GLIA, V63, P51, DOI 10.1002/glia.22732; Cumming G., 2012, UNDERSTANDING NEW ST; Cumming G, 2014, PSYCHOL SCI, V25, P7, DOI 10.1177/0956797613504966; Dardiotis E, 2012, CURR OPIN PSYCHIATR, V25, P231, DOI 10.1097/YCO.0b013e3283523c0e; Dick DM, 2015, PERSPECT PSYCHOL SCI, V10, P37, DOI 10.1177/1745691614556682; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Duncan LE, 2011, AM J PSYCHIAT, V168, P1041, DOI 10.1176/appi.ajp.2011.11020191; Eisenberg DTA, 2010, AM J PHYS ANTHROPOL, V143, P100, DOI 10.1002/ajpa.21298; Engelborghs S, 2006, NEUROBIOL AGING, V27, P285, DOI 10.1016/j.neurobiolaging.2005.02.005; Eramudugolla R, 2014, J INT NEUROPSYCH SOC, V20, P444, DOI 10.1017/S1355617714000174; Fagerholm ED, 2015, BRAIN, V138, P1696, DOI 10.1093/brain/awv075; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.278.16.1349; Federoff M, 2012, NEUROBIOL DIS, V46, P389, DOI 10.1016/j.nbd.2012.02.002; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Han SD, 2008, ALZHEIMERS DEMENT, V4, P251, DOI 10.1016/j.jalz.2008.02.006; Han SD, 2007, J NEUROL NEUROSUR PS, V78, P1103, DOI 10.1136/jnnp.2006.108183; Han SH, 2000, ANN NY ACAD SCI, V903, P357, DOI 10.1111/j.1749-6632.2000.tb06387.x; Hodgkinson A, 2009, BRAIN IMPAIR, V10, P162, DOI 10.1375/brim.10.2.162; Horsburgh K, 1999, J NEUROPATH EXP NEUR, V58, P227, DOI 10.1097/00005072-199903000-00002; Horsburgh K, 2003, INT CONGR SER, V1252, P171, DOI 10.1016/S0531-5131(03)00024-4; Hostage CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054483; Howell DC., 2013, STAT METHODS PSYCHOL, V8th ed; IGNATIUS MJ, 1986, P NATL ACAD SCI USA, V83, P1125, DOI 10.1073/pnas.83.4.1125; Isoniemi H, 2006, J NEUROTRAUM, V23, P1600, DOI 10.1089/neu.2006.23.1600; Jacobs B, 2013, NEUROCRIT CARE, V19, P79, DOI 10.1007/s12028-012-9795-9; Jochemsen HM, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.07.016; Jorm AF, 2007, NEUROPSYCHOLOGY, V21, P1, DOI 10.1037/0894-4105.21.1.1; Kemp S, 2010, J NEUROPSYCHOL, V4, P231, DOI 10.1348/174866409X482614; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Koutseff A, 2014, BRAIN RES, V1542, P32, DOI 10.1016/j.brainres.2013.10.003; Kulminski AM, 2013, AGING CELL, V12, P237, DOI 10.1111/acel.12046; Kulminski AM, 2011, AGING CELL, V10, P533, DOI 10.1111/j.1474-9726.2011.00689.x; Lannsjo M, 2013, EUR J NEUROL, V20, P124, DOI 10.1111/j.1468-1331.2012.03813.x; Laskowitz DT, 1998, J CEREBR BLOOD F MET, V18, P465, DOI 10.1097/00004647-199805000-00001; Lawrence DW, 2015, BRAIN INJURY, V29, P1018, DOI 10.3109/02699052.2015.1005131; Leoni V, 2010, BIOCHEM SOC T, V38, P1021, DOI 10.1042/BST0381021; Leroi AM, 2005, MECH AGEING DEV, V126, P421, DOI 10.1016/j.mad.2004.07.012; Lezak M.D., 2004, NEUROPSYCHOLOGICAL A, Vfourth; Liberman JN, 2002, NEUROLOGY, V58, P1038, DOI 10.1212/WNL.58.7.1038; Lichtman SW, 2000, NEUROLOGY, V55, P1536, DOI 10.1212/WNL.55.10.1536; Lipsey M.W., 2001, PRACTICAL META ANAL; Louko AM, 2006, ACTA NEUROL SCAND, V114, P315, DOI 10.1111/j.1600-0404.2006.00676.x; Lynch JR, 2002, ANN NEUROL, V51, P113, DOI 10.1002/ana.10098; Mahley RW, 2012, NEURON, V76, P871, DOI 10.1016/j.neuron.2012.11.020; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; Mahley RW, 1999, CURR OPIN LIPIDOL, V10, P207, DOI 10.1097/00041433-199906000-00003; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Mannix R, 2013, ANN NEUROL, V74, P65, DOI 10.1002/ana.23858; Mannix RC, 2011, J CEREBR BLOOD F MET, V31, P351, DOI 10.1038/jcbfm.2010.99; Mata IF, 2014, JAMA NEUROL, V71, P1405, DOI 10.1001/jamaneurol.2014.1455; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; Maxwell SS, 2011, NEUROLOGY, V77, P158, DOI 10.1212/WNL.0b013e318224afa3; McAllister TW, 2010, PM&R, V2, pS241, DOI 10.1016/j.pmrj.2010.10.005; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Methia N, 2001, MOL MED, V7, P810, DOI 10.1007/BF03401973; Millar K, 2003, J NEUROL NEUROSUR PS, V74, P1047, DOI 10.1136/jnnp.74.8.1047; Miller MA, 2010, BRAIN INJURY, V24, P1468, DOI 10.3109/02699052.2010.520299; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b2535, 10.1371/journal.pmed.1000097, 10.1016/j.ijsu.2010.02.007]; Moran LM, 2009, J NEUROTRAUM, V26, P1489, DOI 10.1089/neu.2008.0767; Morris PG, 2004, ACTA NEUROL SCAND, V109, P205, DOI 10.1034/j.1600-0404.2003.00206.x; Muller K, 2009, NEUROSURGERY, V64, P698, DOI 10.1227/01.NEU.0000340978.42892.78; Noe E, 2010, BRAIN INJURY, V24, P886, DOI 10.3109/02699051003724952; Orihara Y, 2002, INT J LEGAL MED, V116, P92, DOI 10.1007/s00414-001-0265-8; Perrin PB, 2015, J HEAD TRAUMA REHAB, V30, P136, DOI 10.1097/HTR.0000000000000026; POIRIER J, 1991, MOL BRAIN RES, V11, P97, DOI 10.1016/0169-328X(91)90111-A; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Ponsford J, 2007, NEUROLOGY, V68, P619, DOI 10.1212/01.wnl.0000254609.04330.9d; Ponsford J, 2011, J NEUROTRAUM, V28, P1683, DOI 10.1089/neu.2010.1623; Pruthi N, 2010, NEUROL INDIA, V58, P264, DOI 10.4103/0028-3886.63810; Raber J, 1998, P NATL ACAD SCI USA, V95, P10914, DOI 10.1073/pnas.95.18.10914; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Rapoport M, 2008, J NEUROPSYCH CLIN N, V20, P68, DOI 10.1176/jnp.2008.20.1.68; Thais MERD, 2014, J NEUROPSYCHOL, V8, P125, DOI 10.1111/jnp.12000; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Rusted JM, 2013, NEUROIMAGE, V65, P364, DOI 10.1016/j.neuroimage.2012.10.010; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Schonberger M, 2009, J NEUROTRAUM, V26, P2157, DOI 10.1089/neu.2009.0939; SCOTT J, 1985, HUM GENET, V71, P144; Shadli RM, 2011, BRAIN INJURY, V25, P596, DOI 10.3109/02699052.2011.572947; Sherer M, 2008, J NEUROL NEUROSUR PS, V79, P678, DOI 10.1136/jnnp.2006.111187; Sherer M, 2015, ARCH PHYS MED REHAB, V96, P652, DOI 10.1016/j.apmr.2014.10.024; Small BJ, 2004, PSYCHOL AGING, V19, P592, DOI 10.1037/0882-7974.19.4.592; SNIPS GJ, 1986, P NATL ACAD SCI USA, V83, P1130, DOI 10.1073/pnas.83.4.1130; Spitz G, 2012, NEUROPSYCHOLOGY, V26, P604, DOI 10.1037/a0029239; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Struble RG, 2007, EXP GERONTOL, V42, P54, DOI 10.1016/j.exger.2006.05.013; Sundstrom A, 2004, NEUROLOGY, V62, P1963, DOI 10.1212/01.WNL.0000129268.83927.A8; Suri S, 2013, NEUROSCI BIOBEHAV R, V37, P2878, DOI 10.1016/j.neubiorev.2013.10.010; Tai LM, 2015, J NEUROCHEM, V133, P465, DOI 10.1111/jnc.13072; Tate RL, 2013, NEUROREHABILITATION, V32, P729, DOI 10.3233/NRE-130898; Teasdale TW, 2000, NEUROPSYCHOL REHABIL, V10, P151, DOI 10.1080/096020100389228; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Tuminello Elizabeth R, 2011, Int J Alzheimers Dis, V2011, P726197, DOI 10.4061/2011/726197; UTERMANN G, 1980, AM J HUM GENET, V32, P339; Verghese PB, 2011, LANCET NEUROL, V10, P241, DOI 10.1016/S1474-4422(10)70325-2; Wagle J, 2010, INT J GERIATR PSYCH, V25, P833, DOI 10.1002/gps.2425; Wagner AK, 2012, BRAIN INJURY, V26, P1658, DOI 10.3109/02699052.2012.700089; Weaver SM, 2014, BRAIN IMAGING BEHAV, V8, P420, DOI 10.1007/s11682-012-9197-9; Weaver SM, 2012, NEUROSCIENTIST, V18, P631, DOI 10.1177/1073858411435706; White F, 2001, EXP NEUROL, V169, P307, DOI 10.1006/exnr.2001.7655; Wierenga CE, 2013, J ALZHEIMERS DIS, V34, P921, DOI 10.3233/JAD-121897; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wisdom NM, 2011, NEUROBIOL AGING, V32, P63, DOI 10.1016/j.neurobiolaging.2009.02.003; ZANNIS VI, 1981, AM J HUM GENET, V33, P11; Zeng S, 2014, GENET TEST MOL BIOMA, V18, P202, DOI 10.1089/gtmb.2013.0421; Zhou WD, 2008, J NEUROTRAUM, V25, P279, DOI 10.1089/neu.2007.0489; Zuercher M, 2009, BRAIN INJURY, V23, P371, DOI 10.1080/02699050902926267	127	11	11	1	23	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	OCT	2016	30	7					775	790		10.1037/neu0000270			16	Psychology, Clinical; Neurosciences; Psychology	Psychology; Neurosciences & Neurology	DY9FX	WOS:000385440400001	26986748				2021-06-18	
J	Raji, CA; Merrill, DA; Barrio, JR; Omalu, B; Small, GW				Raji, Cyrus A.; Merrill, David A.; Barrio, Jorge R.; Omalu, Bennet; Small, Gary W.			Progressive Focal Gray Matter Volume Loss in a Former High School Football Player: A Possible Magnetic Resonance Imaging Volumetric Signature for Chronic Traumatic Encephalopathy	AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY			English	Article						CTE; volumetric MRI; Neuroreader; FDDNP; brain PET	BRAIN-INJURY; LEAGUE PLAYER; MRI; PATTERN; ATROPHY	Here a case is presented of a 51-year-old former high school football player with multiple concussions, including one episode with loss of consciousness. The patient experienced 6 years of cognitive and mood decline, and his wife corroborated increasing memory loss, attentional difficulties, and depressed mood without suicidal ideation. He had been unable to maintain full-time employment because of progressive decline. Based on his presentation, he had been previously diagnosed with attention deficit hyperactivity disorder and bipolar disorder, type II. Neuropsychological tests indicated domain-specific cognitive impairment, and longitudinal volumetric magnetic resonance imaging (MRI) of the brain showed progressive brainstem, diencephalic, and frontal lobe atrophy. This regional volume loss correlated with the increased signal seen on tau and amyloid imaging (FDDNP-PET scan) of a separate case of suspected chronic traumatic encephalopathy (CTE). Visual assessment of the MRI also showed evidence of old petechial hemorrhages in the frontal and temporal-parietal lobe white matter. This case raises the possibility of distinct quantitative and visual brain MRI findings in suspected CTE.	[Raji, Cyrus A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Radiol, CLA, Los Angeles, CA 90095 USA; [Merrill, David A.; Small, Gary W.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, CLA, Los Angeles, CA 90095 USA; [Barrio, Jorge R.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, CLA, Los Angeles, CA 90095 USA; [Omalu, Bennet] Univ Calif Davis, Med Ctr, Dept Pathol, Davis, CA 95616 USA	Raji, CA (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Radiol, 10751 Wilshire Blvd,Unit 608, Los Angeles, CA 90024 USA.	cyrusraji@gmail.com	Lang, Steven/AAE-8102-2021	Lang, Steven/0000-0003-1669-9146			Ahdidan J, 2016, J ALZHEIMERS DIS, V49, P723, DOI 10.3233/JAD-150559; Alhilali LM, 2015, RADIOLOGY, V277, P793, DOI 10.1148/radiol.2015142974; Amen DG, 2011, J PSYCHOACTIVE DRUGS, V43, P1, DOI 10.1080/02791072.2011.566489; Barrio JR, 2015, P NATL ACAD SCI USA, V112, pE2039, DOI 10.1073/pnas.1409952112; Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; Boccardi M, 2003, NEUROBIOL AGING, V24, P95, DOI 10.1016/S0197-4580(02)00045-3; Brewer JB, 2009, BEHAV NEUROL, V21, P21, DOI [10.3233/BEN-2009-0226, 10.1155/2009/616581]; Brueggen K, 2015, J ALZHEIMERS DIS, V48, P197, DOI 10.3233/JAD-150063; Costanza A, 2011, NEUROPATH APPL NEURO, V37, P570, DOI 10.1111/j.1365-2990.2011.01186.x; Iverson GL, 2014, APPL NEUROPSYCH-ADUL, V21, P36, DOI 10.1080/09084282.2012.721149; Klein C, 2012, TEDDY ROOSEVELT SAVE; Maas A, 2016, CHIN J TRAUMATOL, V19, P3, DOI 10.1016/j.cjtee.2016.01.001; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; Mez J, 2016, JAMA NEUROL, V73, P353, DOI 10.1001/jamaneurol.2015.3998; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Raji CA, 2014, AM J PREV MED, V47, P444, DOI 10.1016/j.amepre.2014.05.037; Redlich R, 2014, JAMA PSYCHIAT, V71, P1222, DOI 10.1001/jamapsychiatry.2014.1100; Ross DE, 2012, J NEUROPSYCH CLIN N, V24, pE33, DOI 10.1176/appi.neuropsych.11020044; Ross DE, 2011, BRAIN INJURY, V25, P1271, DOI 10.3109/02699052.2011.624568; Small GW, 2013, AM J GERIAT PSYCHIAT, V21, P138, DOI 10.1016/j.jagp.2012.11.019; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; YARNELL PR, 1970, NEUROLOGY, V20, P416	23	11	11	0	24	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1064-7481	1545-7214		AM J GERIAT PSYCHIAT	Am. J. Geriatr. Psychiatr.	OCT	2016	24	10					784	790		10.1016/j.jagp.2016.07.018			7	Geriatrics & Gerontology; Gerontology; Psychiatry	Geriatrics & Gerontology; Psychiatry	EA6WX	WOS:000386770900002	27567184	Green Published			2021-06-18	
J	Woo, PYM; Wong, HT; Pu, JKS; Wong, WK; Wong, LYW; Lee, MW; Yam, KY; Lui, WM; Poon, WS				Woo, Peter Y. M.; Wong, H. T.; Pu, Jenny K. S.; Wong, W. K.; Wong, Larry Y. W.; Lee, Michael W. Y.; Yam, K. Y.; Lui, W. M.; Poon, W. S.		Working Grp Neurosurgical Outcomes	Primary ventriculoperitoneal shunting outcomes: a multicentre clinical audit for shunt infection and its risk factors	HONG KONG MEDICAL JOURNAL			English	Article							CEREBROSPINAL-FLUID SHUNT; SURGICAL SITE INFECTIONS; RED MAN SYNDROME; VENTRICULAR SHUNTS; PEDIATRIC-PATIENTS; UNITED-STATES; HYDROCEPHALUS; VANCOMYCIN; PROPHYLAXIS; CATHETERS	Objectives: To determine the frequency of primary ventriculoperitoneal shunt infection among patients treated at neurosurgical centres of the Hospital Authority and to identify underlying risk factors. Methods: This multicentre historical cohort study included consecutive patients who underwent primary ventriculoperitoneal shunting at a Hospital Authority neurosurgery centre from 1 January 2009 to 31 December 2011. The primary endpoint was shunt infection, defined as: (1) the presence of cerebrospinal fluid or shunt hardware culture that yielded the pathogenic micro-organism with associated compatible symptoms and signs of central nervous system infection or shunt malfunction; or (2) surgical incision site infection requiring shunt reinsertion (even in the absence of positive culture); or (3) intraperitoneal pseudocyst formation (even in the absence of positive culture). Secondary endpoints were shunt malfunction, defined as unsatisfactory cerebrospinal fluid drainage that required shunt reinsertion, and 30-day mortality. Results: A. primary ventriculoperitoneal shunt was inserted in 538 patients during the study period. The mean age of patients was 48 years (range, 13-88 years) with a male-to-female ratio of 1:1. Aneurysmal subarachnoid haemorrhage was the most common aetiology (n=169, 31%) followed by intracranial tumour (n=164, 30%), central nervous system infection (n=42, 8%), and traumatic brain injury (n=27, 5%). The mean operating time was 75 (standard deviation, 29) minutes. Shunt reinsertion and infection rates were 16% (n=87) and 7% (n=36), respectively. The most common cause for shunt reinsertion was malfunction followed by shunt infection. Independent predictors for shunt infection were: traumatic brain injury (adjusted odds ratio=6.2; 95% confidence interval, 2.3-16.8), emergency shunting (2.3; 1.0-5.1), and prophylactic vancomycin as the sole antibiotic (3.4; 1.1-11.0). The 30-day all-cause mortality was 6% and none were directly procedure-related. Conclusions: This is the first Hong Kong territory wide review of infection in primary ventriculoperitoneal shunts. Although the ventriculoperitoneal shunt infection rate met international standards, there are areas of improvement such as vancomycin administration and the avoidance of scheduling the procedure as an emergency.	[Woo, Peter Y. M.; Wong, H. T.] Kwong Wah Hosp, Dept Neurosurg, Yaumatei, Hong Kong, Peoples R China; [Pu, Jenny K. S.; Lui, W. M.] Queen Mary Hosp, Dept Surg, Div Neurosurg, Pokfulam, Hong Kong, Peoples R China; [Wong, W. K.] Princess Margaret Hosp, Dept Neurosurg, Laichikok, Hong Kong, Peoples R China; [Wong, Larry Y. W.] Queen Elizabeth Hosp, Dept Neurosurg, Jordan, Hong Kong, Peoples R China; [Lee, Michael W. Y.] Pamela Youde Nethersole Eastern Hosp, Dept Neurosurg, Chaiwan, Hong Kong, Peoples R China; [Yam, K. Y.] Tuen Mun Hosp, Dept Neurosurg, Tuen Mun, Hong Kong, Peoples R China; [Poon, W. S.] Prince Wales Hosp, Dept Surg, Div Neurosurg, Shatin, Hong Kong, Peoples R China	Woo, PYM (corresponding author), Kwong Wah Hosp, Dept Neurosurg, Yaumatei, Hong Kong, Peoples R China.	wym307@ha.org.hk	Poon, Wai Sang/F-1558-2011		Tung Wah Group of Hospitals Neuroscience Research Fund	We would like to thank members of the Hospital Authority Head Office (HAHO) Co-ordinating Committee (Neurosurgery), the Clinical Effectiveness & Technology Management Department, the Division of Quality and Safety, and the Clinical Data Analysis and Reporting System Team, HAHO IT Service for their administrative advice and data collection. We also wish to thank Drs Chris YW Liu, Alphon HY Ip, and Claudia Law for their contributions in data collection and entry. This study was supported by the Tung Wah Group of Hospitals Neuroscience Research Fund.	Abdullah KG, 2015, J NEUROSURG, V123, P1600, DOI 10.3171/2014.12.JNS142092; Albanese J, 2000, ANTIMICROB AGENTS CH, V44, P1356, DOI 10.1128/AAC.44.5.1356-1358.2000; BAYSTON R, 1974, DEV MED CHILD NEUROL, V16, P16; Birjandi A, 2012, NEUROSURG QUART, V22, P145, DOI 10.1097/WNQ.0b013e318202bb83; BORGBJERG BM, 1995, ACTA NEUROCHIR, V136, P1, DOI 10.1007/BF01411427; Choksey MS, 2004, J NEUROL NEUROSUR PS, V75, P87; CHOUX M, 1992, J NEUROSURG, V77, P875, DOI 10.3171/jns.1992.77.6.0875; Cochrane DD, 2003, PEDIATR NEUROSURG, V38, P295, DOI 10.1159/000070413; Davis SE, 1999, PEDIATR NEUROSURG, V30, P253, DOI 10.1159/000028806; DUHAIME AC, 1991, CHILD NERV SYST, V7, P211; FAILLACE WJ, 1995, SURG NEUROL, V43, P344, DOI 10.1016/0090-3019(95)80060-T; FANHAVARD P, 1990, CHEMOTHERAPY, V36, P103, DOI 10.1159/000238755; HEALY DP, 1990, ANTIMICROB AGENTS CH, V34, P550, DOI 10.1128/AAC.34.4.550; Honeybul S, 2012, J NEUROTRAUM, V29, P1872, DOI 10.1089/neu.2012.2356; HORAN TC, 1992, INFECT CONT HOSP EP, V13, P606; Jeelani NUO, 2009, J NEUROS-PEDIATR, V4, P166, DOI 10.3171/2009.3.PEDS08458; Kausch W, 1908, ARCH KLIN CHIR, V87, P709; Keong NCH, 2012, NEUROSURGERY, V71, P394, DOI 10.1227/NEU.0b013e318257bebb; Kestle JRW, 2011, J NEUROSURG-PEDIATR, V8, P22, DOI 10.3171/2011.4.PEDS10551; Konstantelias AA, 2015, J NEUROSURG, V122, P1096, DOI 10.3171/2014.12.JNS14908; Korinek AM, 2011, NEUROSURGERY, V68, P985, DOI 10.1227/NEU.0b013e318208f360; ODIO C, 1984, AM J DIS CHILD, V138, P1103, DOI 10.1001/archpedi.1984.02140500009004; ODIO C, 1984, AM J DIS CHILD, V138, P17, DOI 10.1001/archpedi.1984.02140390009004; Overturf Gary D, 2005, Pediatr Crit Care Med, V6, pS14, DOI 10.1097/01.PCC.0000161933.42822.86; Parker Scott L, 2011, Clin Neurosurg, V58, P122; Parker SL, 2015, WORLD NEUROSURG, V83, P382, DOI 10.1016/j.wneu.2014.06.010; Patwardhan RV, 2005, NEUROSURGERY, V56, P139, DOI 10.1227/01.NEU.0000146206.40375.41; Pirotte BJM, 2007, CHILD NERV SYST, V23, P1251, DOI 10.1007/s00381-007-0415-5; PONS VG, 1993, NEUROSURGERY, V33, P416; Ragel BT, 2006, J NEUROSURG, V105, P242, DOI 10.3171/jns.2006.105.2.242; Ratilal B, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.Cd005365.pub2; SCHOENBAUM SC, 1975, J INFECT DIS, V131, P543, DOI 10.1093/infdis/131.5.543; Sciubba DM, 2005, J NEUROSURG, V103, P131, DOI 10.3171/ped.2005.103.2.0131; Shannon CN, 2011, J NEUROSURG-PEDIATR, V8, P593, DOI 10.3171/2011.9.PEDS11192; Simon TD, 2008, J NEUROS-PEDIATR, V1, P131, DOI 10.3171/PED/2008/1/2/131; Sivagnanam S, 2003, CRIT CARE, V7, P119, DOI 10.1186/cc1871; Stevens DL, 2006, CLIN INFECT DIS, V42, pS51, DOI 10.1086/491714; Thomas R, 2012, BRIT J NEUROSURG, V26, P175, DOI 10.3109/02688697.2011.603856; Tuli S, 2000, J NEUROSURG, V92, P31, DOI 10.3171/jns.2000.92.1.0031; Tulipan N, 2006, J NEUROSURG, V104, P5, DOI 10.3171/ped.2006.104.1.5; Vanaclocha V, 1996, ACTA NEUROCHIR, V138, P829, DOI 10.1007/BF01411261; Wang KW, 2004, JPN J INFECT DIS, V57, P44; Wong JM, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.7.FOCUS12179; World Health Organization and Department of Health Hong Kong, 2012, HONG KONG CHIN HLTH	44	11	11	0	4	HONG KONG ACAD MEDICINE PRESS	HONG KONG	9/F/, ROOM 901, 99 WONG CHUK HANG RD, ABERDEEN, HONG KONG, 00000, PEOPLES R CHINA	1024-2708			HONG KONG MED J	Hong Kong Med. J.	OCT	2016	22	5					410	419		10.12809/hkmj154735			10	Medicine, General & Internal	General & Internal Medicine	DY2ZJ	WOS:000384960300002	27562986	DOAJ Gold			2021-06-18	
J	Xu, J; Sisniega, A; Zbijewski, W; Dang, H; Stayman, JW; Mow, M; Wang, XH; Foos, DH; Koliatsos, VE; Aygun, N; Siewerdsen, JH				Xu, Jennifer; Sisniega, Alejandro; Zbijewski, Wojciech; Dang, Hao; Stayman, J. Webster; Mow, Michael; Wang, Xiaohui; Foos, David H.; Koliatsos, Vassillis E.; Aygun, Nafi; Siewerdsen, Jeffrey H.			Technical assessment of a prototype cone-beam CT system for imaging of acute intracranial hemorrhage	MEDICAL PHYSICS			English	Article						cone-beam CT; dose; image quality; head imaging; imaging performance	X-RAY CT; COMPUTED-TOMOGRAPHY; ARTIFACT-CORRECTION; AXONAL INJURY; NECK-SURGERY; HEAD; QUALITY; STROKE; MOBILE; ALGORITHM	Purpose: A cone-beam CT scanner has been developed for detection and monitoring of traumatic brain injury and acute intracranial hemorrhage (ICH) at the point of care. This work presents a technical assessment of imaging performance and dose for the scanner in phantom and cadaver studies as a prerequisite to clinical translation. Methods: The scanner incorporates a compact, rotating-anode x-ray source and a flat-panel detector (43x43 cm(2)) on a mobile U-arm gantry with source-axis distance = 550 mm and source-detector distance = 1000 mm. Central and peripheral doses were measured in 16 cm diameter CTDI phantoms using a 0.6 cm(3) Farmer ionization chamber for various scan techniques and as a function of longitudinal position, including out of field. Spatial resolution, contrast, noise, and image uniformity were assessed in quantitative and anthropomorphic head phantoms. Two reconstruction protocols were evaluated, including filtered backprojection (FBP) for high-resolution bone imaging and penalized weighted least squares (PWLS) reconstruction for low-contrast soft tissue (ICH) visualization. A fresh cadaver was imaged with and without simulated ICH using the scanner as well as a diagnostic multidetector CT (MDCT) scanner using a standard head protocol. Images were interpreted by a fellowship-trained neuroradiologist for imaging tasks of ICH detection, gray-white-CSF differentiation, detection of midline shift, and fracture detection. Results: The nominal scan protocol involved 720 projections acquired over a 360 degrees orbit at 100 kV and 216 mAs, giving a dose (weighted CTDI) of 22.8 mGy (similar to 1.2 mSv effective dose). Out-of-field dose decreased to <10% within 6 cm of the field edge (approximate to the thyroid position). Image uniformity demonstrated <1% variation between the edge of the field (near the cranium) and center of the image. The high-resolution FBP reconstruction protocol showed similar to 0.9 mm point spread function (PSF) full-width at half-maximum (FWHM). The smooth PWLS reconstruction protocol yielded similar to 1.2 mm PSF FWHM and contrast-to-noise ratio exceeding 5.7 in similar to 50 HU spherical ICH, resulting in conspicuous depiction of ICH down to similar to 2 mm (the smallest diameter investigated). Cadaver images demonstrated good differentiation of brain and CSF (sufficient, but inferior to MDCT, recognizing that the CBCT dose was one-third that of MDCT), excellent visualization of cranial sutures and fracture (potentially superior to MDCT), clear detection of midline shift, and conspicuous detection of ICH. Conclusions: Technical assessment of the prototype demonstrates dose characteristics and imaging performance consistent with point-of-care detection and monitoring of head injury-most notably, conspicuous detection of ICH-and supports translation of the system to clinical studies. (C) 2016 American Association of Physicists in Medicine.	[Xu, Jennifer; Sisniega, Alejandro; Zbijewski, Wojciech; Dang, Hao; Stayman, J. Webster; Mow, Michael; Siewerdsen, Jeffrey H.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21205 USA; [Wang, Xiaohui; Foos, David H.] Carestream Hlth, Rochester, NY 14608 USA; [Koliatsos, Vassillis E.] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21205 USA; [Aygun, Nafi; Siewerdsen, Jeffrey H.] Johns Hopkins Univ, Russell H Morgan Dept Radiol, Baltimore, MD 21205 USA; [Siewerdsen, Jeffrey H.] Johns Hopkins Univ, Dept Comp Sci, Baltimore, MD 21205 USA; [Siewerdsen, Jeffrey H.] Johns Hopkins Univ, Dept Neurosurg, Baltimore, MD 21205 USA; [Siewerdsen, Jeffrey H.] Johns Hopkins Univ, Armstrong Inst Patient Safety & Qual, Baltimore, MD 21205 USA	Siewerdsen, JH (corresponding author), Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21205 USA.; Siewerdsen, JH (corresponding author), Johns Hopkins Univ, Russell H Morgan Dept Radiol, Baltimore, MD 21205 USA.; Siewerdsen, JH (corresponding author), Johns Hopkins Univ, Dept Comp Sci, Baltimore, MD 21205 USA.; Siewerdsen, JH (corresponding author), Johns Hopkins Univ, Dept Neurosurg, Baltimore, MD 21205 USA.; Siewerdsen, JH (corresponding author), Johns Hopkins Univ, Armstrong Inst Patient Safety & Qual, Baltimore, MD 21205 USA.	jeff.siewerdsen@jhu.edu	Dang, Hao/U-4865-2018	Dang, Hao/0000-0001-5861-6535; Stayman, Joseph/0000-0003-4358-378X; Sisniega, Alejandro/0000-0003-2030-2711	Carestream Health	The research was supported by academic-industry research partnership with Carestream Health. The authors thank Dr. Nathan Packard, Joe Stagnito, Kevin Richard, and William Snyder (Carestream Health, Rochester NY, USA) for engineering related to the scanner prototype and control system and to Dr. Brian Whitaker and colleagues (Varian Imaging Products, Palo Alto CA, USA) for assistance with custom DG readout configurations. Thanks also to Mr. Ron Wade and colleagues at the Maryland Anatomy Board (University of Maryland, Baltimore MD, USA) for assistance with cadaver studies.	AAPM, 2011, SIZ SPEC DOS EST SSD; Badal A, 2009, IEEE T MED IMAGING, V28, P1894, DOI 10.1109/TMI.2009.2021615; BARO J, 1995, NUCL INSTRUM METH B, V100, P31, DOI 10.1016/0168-583X(95)00349-5; Beck M, 2009, EUR SPINE J, V18, P1469, DOI 10.1007/s00586-009-1050-5; Blaickner M, 2013, RADIAT PROT DOSIM, V155, P451, DOI 10.1093/rpd/nct033; Boone JM, 2001, RADIOLOGY, V221, P657, DOI 10.1148/radiol.2213010334; Bruder N., 2016, OXFORD TXB NEUROCRIT, P197; Carlson AP, 2012, J NEUROIMAGING, V22, P408, DOI 10.1111/j.1552-6569.2011.00621.x; Carrino JA, 2014, RADIOLOGY, V270, P816, DOI 10.1148/radiol.13130225; Chen B, 2002, MED PHYS, V29, P755, DOI 10.1118/1.1461843; Chesnut RM, 2004, CRIT CARE CLIN, V20, P25, DOI 10.1016/S0749-0704(03)00090-3; Daly MJ, 2006, MED PHYS, V33, P3767, DOI 10.1118/1.2349687; Dang H, 2016, PROC SPIE, V9783, DOI 10.1117/12.2216937; Dang H, 2015, PHYS MED BIOL, V60, P6153, DOI 10.1088/0031-9155/60/16/6153; Doddamani RS, 2012, INDIAN J NEUROTRAUM, V9, P33, DOI 10.1016/j.ijnt.2012.04.007; DUBLIN AB, 1977, RADIOLOGY, V122, P365, DOI 10.1148/122.2.365; Erdogan H, 1999, PHYS MED BIOL, V44, P2835, DOI 10.1088/0031-9155/44/11/311; FELDKAMP LA, 1984, J OPT SOC AM A, V1, P612, DOI 10.1364/JOSAA.1.000612; Fiebach JB, 2004, NEURORADIOLOGY, V46, P44, DOI 10.1007/s00234-003-1132-8; Gerlach R, 2008, NEUROSURGERY, V63, P272, DOI 10.1227/01.NEU.0000312362.63693.78; Gilberto G. R., 2016, NEUROIMAGING 1; Gross T, 2010, BRIT J SURG, V97, P118, DOI 10.1002/bjs.6842; Helm PA, 2015, IEEE T MED IMAGING, V34, P1738, DOI 10.1109/TMI.2015.2391200; Hernandez AM, 2014, MED PHYS, V41, DOI 10.1118/1.4866216; Huda W, 2001, MED PHYS, V28, P393, DOI 10.1118/1.1350435; Jaffray DA, 2002, INT J RADIAT ONCOL, V53, P1337, DOI 10.1016/S0360-3016(02)02884-5; JOSEPH PM, 1978, J COMPUT ASSIST TOMO, V2, P100, DOI 10.1097/00004728-197801000-00017; King E, 2013, HEAD NECK-J SCI SPEC, V35, P959, DOI 10.1002/hed.23060; Konstantinidis AC, 2012, NUCL INSTRUM METH A, V689, P12, DOI 10.1016/j.nima.2012.06.024; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Lev MH, 2001, STROKE, V32, P2021, DOI 10.1161/hs0901.095680; Li T, 2006, PHYS MED BIOL, V51, P253, DOI 10.1088/0031-9155/51/2/005; Li YS, 2016, PROC SPIE, V9783, DOI 10.1117/12.2216838; Linfante I, 1999, STROKE, V30, P2263, DOI 10.1161/01.STR.30.11.2263; Long Y, 2010, IEEE T MED IMAGING, V29, P1839, DOI 10.1109/TMI.2010.2050898; Manninen PH, 1999, CAN J ANAESTH, V46, P7, DOI 10.1007/BF03012507; Miracle AC, 2009, AM J NEURORADIOL, V30, P1285, DOI 10.3174/ajnr.A1654; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI [10.1161/01.cir.0000441139.02102.80, 10.1161/CIR.0000000000000152, 10.1161/CIR.0b013e31828124ad]; Murayama Y, 2011, NEUROSURGERY, V68, P1427, DOI 10.1227/NEU.0b013e31820b4f1c; Nael K, 2014, STROKE, V45, P1985, DOI 10.1161/STROKEAHA.114.005305; Navab N, 1996, P SOC PHOTO-OPT INS, V2708, P361, DOI 10.1117/12.237798; Ott Lora K, 2011, J Radiol Nurs, V30, P49; Parizel PM, 1998, EUR RADIOL, V8, P960, DOI 10.1007/s003300050496; Poludniowski G, 2009, PHYS MED BIOL, V54, P3847, DOI 10.1088/0031-9155/54/12/016; POVLISHOCK JT, 1993, ANN EMERG MED, V22, P980, DOI 10.1016/S0196-0644(05)82738-6; Punnoose J, 2016, MED PHYS, V43, P4711, DOI 10.1118/1.4955438; Purdie TG, 2007, INT J RADIAT ONCOL, V68, P243, DOI 10.1016/j.ijrobp.2006.12.022; Rumboldt Z, 2009, AM J NEURORADIOL, V30, P1630, DOI 10.3174/ajnr.A1603; SAUER K, 1993, IEEE T SIGNAL PROCES, V41, P534, DOI 10.1109/78.193196; Scarfe William C, 2008, Dent Clin North Am, V52, P707, DOI 10.1016/j.cden.2008.05.005; Schafer S, 2011, MED PHYS, V38, P4563, DOI 10.1118/1.3597566; Seeberger R, 2012, J CRANIO MAXILL SURG, V40, P731, DOI 10.1016/j.jcms.2012.01.008; Siewerdsen JH, 2011, NUCL INSTRUM METH A, V648, pS241, DOI 10.1016/j.nima.2010.11.088; Sisniega A, 2016, PROC SPIE, V9783, DOI 10.1117/12.2217243; Sisniega A, 2015, PHYS MED BIOL, V60, P1415, DOI 10.1088/0031-9155/60/4/1415; Sisniega A, 2013, MED PHYS, V40, DOI 10.1118/1.4801895; SMITH I, 1990, CRIT CARE MED, V18, P278, DOI 10.1097/00003246-199003000-00006; Tyndall Donald A, 2008, Dent Clin North Am, V52, P825, DOI 10.1016/j.cden.2008.05.002; Valentin J., 2007, ANN ICRP PUBLICATION, V103; Wallace MJ, 2009, J VASC INTERV RADIOL, V20, pS523, DOI 10.1016/j.jvir.2009.04.059; Wang AS, 2014, PHYS MED BIOL, V59, P1005, DOI 10.1088/0031-9155/59/4/1005; Wang AS, 2013, PROC SPIE, V8668, DOI 10.1117/12.2008421; Waydhas C, 1999, CRIT CARE, V3, pR83, DOI 10.1186/cc362; Wilson JM, 2013, MED PHYS, V40, DOI 10.1118/1.4791645; Wintermark M, 2013, AM J NEURORADIOL, V34, pE117, DOI 10.3174/ajnr.A3690; Xu J, 2016, PHYS MED BIOL, V61, P3180, DOI 10.1088/0031-9155/61/8/3180; Xu J, 2012, MED PHYS, V39, P4932, DOI 10.1118/1.4736805; Xu J, 2016, PHYS MED BIOL, V61, P5973, DOI 10.1088/0031-9155/61/16/5973; Zbijewski W., 2014, 3 INT C IM FORM XRAY, P401; Zbijewski W., 2014, P SOC PHOTO-OPT INS, V9033; Zbijewski W, 2007, IEEE NUCL SCI CONF R, P2985, DOI 10.1109/NSSMIC.2007.4436761; Zhao Z, 2014, MED PHYS, V41, DOI 10.1118/1.4875688; Zhuang ZQ, 2005, J OCCUP ENVIRON HYG, V2, P567, DOI 10.1080/15459620500324727	73	11	12	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0094-2405	2473-4209		MED PHYS	Med. Phys.	OCT	2016	43	10					5745	5757		10.1118/1.4963220			13	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	DZ1DA	WOS:000385577900049	27782694	Other Gold			2021-06-18	
J	Grin'kina, NM; Li, Y; Haber, M; Sangobowale, M; Nikulina, E; Le'Pre, C; El Sehamy, AM; Dugue, R; Ho, JS; Bergold, PJ				Grin'kina, Natalia M.; Li, Yang; Haber, Margalit; Sangobowale, Michael; Nikulina, Elena; Le'Pre, Charm; El Sehamy, Alexander M.; Dugue, Rachelle; Ho, Johnson S.; Bergold, Peter J.			Righting Reflex Predicts Long-Term Histological and Behavioral Outcomes in a Closed Head Model of Traumatic Brain Injury	PLOS ONE			English	Article								Blunt impact produces a heterogeneous brain injury in people and in animal models of traumatic brain injury. We report that a single closed head impact to adult C57/BL6 mice produced two injury syndromes (CHI-1 and CHI-2). CHI-1 mice spontaneously reinitiated breathing after injury while CHI-2 mice had prolonged apnea and regained breathing only after cardiopulmonary resuscitation and supplementation of 100% O-2. The CHI-1 group significantly regained righting reflex more rapidly than the CHI-2 group. At 7 days postinjury, CHI-1, but not CHI-2 mice, acquired but had no long-term retention of an active place avoidance task. The behavioral deficits of CHI-1 and CHI-2 mice were retained one-month after the injury. CHI-1 mice had loss of hippocampal neurons and localized white matter injury at one month after injury. CHI-2 had a larger loss of hippocampal neurons and more widespread loss of myelin and axons. High-speed videos made during the injury were followed by assessment of breathing and righting reflex. These videos show that CHI-2 mice experienced a larger vertical g-force than CHI-1 mice. Time to regain righting reflex in CHI-2 mice significantly correlated with vertical g-force. Thus, physiological responses occurring immediately after injury can be valuable surrogate markers of subsequent behavioral and histological deficits.	[Haber, Margalit; Sangobowale, Michael; Le'Pre, Charm; Dugue, Rachelle; Bergold, Peter J.] Suny Downstate Med Ctr, Program Neural & Behav Sci, Brooklyn, NY 11203 USA; [Grin'kina, Natalia M.; Li, Yang; Haber, Margalit; Nikulina, Elena; El Sehamy, Alexander M.; Ho, Johnson S.; Bergold, Peter J.] Suny Downstate Med Ctr, Robert F Furchgott Ctr Neural Sci, Brooklyn, NY 11203 USA; [Grin'kina, Natalia M.; Nikulina, Elena; Bergold, Peter J.] Suny Downstate Med Ctr, Dept Physiol & Pharmacol, 450 Clarkson Ave, Brooklyn, NY 11203 USA; [Li, Yang] New York Psychiat Inst, 1051 Riverside Dr,Kolb Annex 669, New York, NY 10032 USA; [Haber, Margalit] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Rm 227,12725 Twinbrook Pkwy, Rockville, MD USA	Bergold, PJ (corresponding author), Suny Downstate Med Ctr, Program Neural & Behav Sci, Brooklyn, NY 11203 USA.; Bergold, PJ (corresponding author), Suny Downstate Med Ctr, Robert F Furchgott Ctr Neural Sci, Brooklyn, NY 11203 USA.; Bergold, PJ (corresponding author), Suny Downstate Med Ctr, Dept Physiol & Pharmacol, 450 Clarkson Ave, Brooklyn, NY 11203 USA.	pbergold@downstate.edu		Bergold, Peter/0000-0002-6335-1380	United States Army Medical Research and Material CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-10-2-0171]	This study was supported by the award number: W81XWH-10-2-0171, http://mrmc.amedd.army.mil/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge the invaluable assistance of Mr. Polaris and Hilarion Banks in assisting with the high-speed video recordings of the head movements and Ms. Kristen Whitney for critically reading the manuscript. This work was funded by an award from the United States Army Medical Research and Material Command (W81XWH-10-2-0171) to P.J.B.	Alder J, 2011, JOVE-J VIS EXP, DOI 10.3791/3063; Baki SGA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012490; Burghardt NS, 2012, HIPPOCAMPUS, V22, P1795, DOI 10.1002/hipo.22013; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Creed JA, 2011, J NEUROTRAUM, V28, P547, DOI 10.1089/neu.2010.1729; Ding GL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061241; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Grin'kina NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053775; Huh JW, 2011, J NEUROTRAUM, V28, P245, DOI 10.1089/neu.2010.1639; Hylin MJ, 2013, J NEUROTRAUM, V30, P716, DOI 10.1089/neu.2012.2717; Ip EY, 2003, J CEREBR BLOOD F MET, V23, P900, DOI 10.1097/01.WCB.0000076702.71231.F2; Johnson Victoria E, 2015, Handb Clin Neurol, V127, P115, DOI 10.1016/B978-0-444-52892-6.00008-8; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kilbourne M, 2009, J NEUROTRAUM, V26, P2233, DOI 10.1089/neu.2009.0968; Kubik S, 2005, J NEUROSCI, V25, P9205, DOI 10.1523/JNEUROSCI.1707-05.2005; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Shinohara Y, 2012, HIPPOCAMPUS, V22, P117, DOI 10.1002/hipo.20886; Skelton RW, 1998, BEHAV BRAIN RES, V96, P13, DOI 10.1016/S0166-4328(97)00199-X; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Young N, 2010, CURR OPIN CRIT CARE, V16, P45, DOI 10.1097/MCC.0b013e32833546fa	24	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0161053	10.1371/journal.pone.0161053			18	Multidisciplinary Sciences	Science & Technology - Other Topics	DW8GO	WOS:000383893200004	27657499	DOAJ Gold, Green Published			2021-06-18	
J	Hehar, H; Yu, K; Ma, I; Mychasiuk, R				Hehar, Harleen; Yu, Katrina; Ma, Irene; Mychasiuk, Richelle			PATERNAL AGE AND DIET: THE CONTRIBUTIONS OF A FATHER'S EXPERIENCE TO SUSCEPTIBILITY FOR POST-CONCUSSION SYMPTOMOLOGY	NEUROSCIENCE			English	Article						traumatic brain injury; development; epigenetics; High-Fat Diet; aging	TRAUMATIC BRAIN-INJURY; SLOW GROWTH PERIOD; POSTCONCUSSION SYNDROME; DOPAMINE TRANSPORTER; PPAR-ALPHA; RAT; EXPRESSION; NUTRITION; OUTCOMES; MODEL	In an attempt to improve current understanding of risk factors that influence individual susceptibility to poor outcomes following mild traumatic brain injury (mTBI) or concussion, this project investigated whether modifications to paternal experiences (Advanced Age (AA) or High-Fat Diet (HFD)) affected offspring susceptibility to behavioral symptomology and changes in gene expression following pediatric concussion in a rodent model. The study demonstrated that paternal treatment prior to conception altered behavioral outcomes and molecular characterization of offspring. Offspring of AA fathers demonstrated abnormal behavioral performance when compared to offspring of control fathers. Similarly, paternal HFD altered pathophysiological outcomes for offspring, contributing to the heterogeneity in post-concussion syndrome. Additionally, this study provided insight into the mechanisms that mediate non-genetic paternal inheritance. Paternal treatment and the mTBI significantly influenced expression of a majority of the genes under examination in the prefrontal cortex, hippocampus, and nucleus accumbens, with changes being dependent upon sex and the brain region examined. These epigenetic changes may have contributed to the differences in offspring susceptibility to concussion. (C) 2016 IBRO. Published by Elsevier Ltd. All rights reserved.	[Hehar, Harleen; Yu, Katrina; Ma, Irene; Mychasiuk, Richelle] Univ Calgary, Dept Psychol, Calgary, AB, Canada	Mychasiuk, R (corresponding author), Univ Calgary, Alberta Childrens Hosp Res Inst, Dept Psychol, 2500 Univ Dr NW,AD030, Calgary, AB T2N 4N1, Canada.	rmmychas@ucalgary.ca			Alberta Children's Hospital Research Institute (ACHRI); Integrated Concussion Research Program (ICRP)	The authors would like to thank the Alberta Children's Hospital Research Institute (ACHRI) and the Integrated Concussion Research Program (ICRP) for their financial support.	Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Bakos HW, 2011, INT J ANDROL, V34, P402, DOI 10.1111/j.1365-2605.2010.01092.x; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Barlow KM, 2015, PEDIATR NEUROL, V53, P491, DOI 10.1016/j.pediatrneurol.2015.04.011; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bateson P, 2004, NATURE, V430, P419, DOI 10.1038/nature02725; Bohacek J, 2013, NEUROPSYCHOPHARMACOL, V38, P220, DOI 10.1038/npp.2012.110; Bonefeld BE, 2008, SYNAPSE, V62, P302, DOI 10.1002/syn.20496; Bygren LO, 2001, ACTA BIOTHEOR, V49, P53, DOI 10.1023/A:1010241825519; Champagne FA, 2003, PHYSIOL BEHAV, V79, P359, DOI 10.1016/S0031-9384(03)00149-5; Chen XR, 2007, J NEUROTRAUM, V24, P1119, DOI 10.1089/neu.2006.0216; Cloots RJH, 2008, ANN BIOMED ENG, V36, P1203, DOI 10.1007/s10439-008-9510-3; De Bellis MD, 2001, CEREB CORTEX, V11, P552, DOI 10.1093/cercor/11.6.552; Elias MF, 2003, INT J OBESITY, V27, P260, DOI 10.1038/sj.ijo.802225; Feng J, 2010, NAT NEUROSCI, V13, P423, DOI 10.1038/nn.2514; Fullston T, 2013, FASEB J, V27, P4226, DOI 10.1096/fj.12-224048; Gregg C, 2010, SCIENCE, V329, P643, DOI 10.1126/science.1190830; Hammoud SS, 2009, NATURE, V460, P473, DOI 10.1038/nature08162; Hehar H., 2015, NONGENET INHERITANCE, V2, P23; Hehar H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139842; Helmeke C, 2009, NEUROSCIENCE, V163, P790, DOI 10.1016/j.neuroscience.2009.07.008; Inoue I, 2001, METABOLISM, V50, P3, DOI 10.1053/meta.2001.19415; Jenkins TG, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004458; Jenkins TG, 2011, ASIAN J ANDROL, V13, P76, DOI 10.1038/aja.2010.61; Kaati G, 2002, EUR J HUM GENET, V10, P682, DOI 10.1038/sj.ejhg.5200859; Kaati G, 2007, EUR J HUM GENET, V15, P784, DOI 10.1038/sj.ejhg.5201832; Kim Nuri, 2012, Inflammopharmacology, V20, P177, DOI 10.1007/s10787-011-0115-3; Kirkwood M, 2008, CLIN NEUROPSYCHOL, V22; Levitan RD, 2004, BIOL PSYCHIAT, V56, P665, DOI 10.1016/j.biopsych.2004.08.013; Liu YS, 2011, AGEING RES REV, V10, P115, DOI 10.1016/j.arr.2010.09.004; Luchsinger JA, 2002, ARCH NEUROL-CHICAGO, V59, P1258, DOI 10.1001/archneur.59.8.1258; Lundstrom S, 2010, J CHILD PSYCHOL PSYC, V51, P850, DOI 10.1111/j.1469-7610.2010.02223.x; Malaspina D, 2001, ARCH GEN PSYCHIAT, V58, P361, DOI 10.1001/archpsyc.58.4.361; Manaenko A, 2010, NEUROCHEM INT, V57, P844, DOI 10.1016/j.neuint.2010.09.001; Milekic M, 2014, MOL PSYCHIATR; Mitchell M, 2011, FERTIL STERIL, V95, P1349, DOI 10.1016/j.fertnstert.2010.09.038; Moron JA, 2002, J NEUROSCI, V22, P389, DOI 10.1523/JNEUROSCI.22-02-00389.2002; Mychasiuk R, 2013, NEUROSCIENCE, V241, P100, DOI 10.1016/j.neuroscience.2013.03.025; Mychasiuk R, 2016, J NEUROSCI METH, V257, P168, DOI 10.1016/j.jneumeth.2015.10.002; Mychasiuk R, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00017; Mychasiuk R, 2015, NEUROBIOL DIS, V73, P1, DOI 10.1016/j.nbd.2014.09.003; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Onyango IG, 2010, BBA-MOL BASIS DIS, V1802, P228, DOI 10.1016/j.bbadis.2009.07.014; Pembrey ME, 2006, EUR J HUM GENET, V14, P159, DOI 10.1038/sj.ejhg.5201538; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Reichenberg A, 2006, ARCH GEN PSYCHIAT, V63, P1026, DOI 10.1001/archpsyc.63.9.1026; Schallert T., 2002, PHARM CEREBRAL ISCHE, P201; Sinclair KD, 2014, REPROD FERT DEVELOP, V26, P99, DOI 10.1071/RD13290; Smith RG, 2013, MOL PSYCHIATR, V18, P635, DOI 10.1038/mp.2012.88; Smith RG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008456; Smits M, 2011, NEURORADIOLOGY, V53, P553, DOI 10.1007/s00234-010-0774-6; Spanswick SC, 2010, LEARN MEMORY, V17, P241, DOI 10.1101/lm.1746710; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Truettner J, 1999, J NEUROTRAUM, V16, P471, DOI 10.1089/neu.1999.16.471; U. S. Census Bureau, 2011, CENS REP DEL BOOM MO; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Whishaw I. Q., 2005, BEHAV LAB RAT HDB TE; Yadid G, 2001, BRAIN RES, V896, P43, DOI 10.1016/S0006-8993(00)03248-0; Yan HQ, 2002, NEUROREPORT, V13, P1899, DOI 10.1097/00001756-200210280-00013	60	11	11	0	18	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	SEP 22	2016	332						61	75		10.1016/j.neuroscience.2016.06.039			15	Neurosciences	Neurosciences & Neurology	DT2SD	WOS:000381329800006	27365176				2021-06-18	
J	Holla, FK; Postma, TJ; Blankenstein, MA; van Mierlo, TJM; Vos, MJ; Sizoo, EM; de Groot, M; Uitdehaag, BMJ; Buter, J; Klein, M; Reijneveld, JC; Heimans, JJ				Holla, F. K.; Postma, T. J.; Blankenstein, M. A.; van Mierlo, T. J. M.; Vos, M. J.; Sizoo, E. M.; de Groot, M.; Uitdehaag, B. M. J.; Buter, J.; Klein, M.; Reijneveld, J. C.; Heimans, J. J.			Prognostic value of the S100B protein in newly diagnosed and recurrent glioma patients: a serial analysis	JOURNAL OF NEURO-ONCOLOGY			English	Article						Glioma; S100B; Survival; Chemotherapy; Prognosis	TRAUMATIC BRAIN-INJURY; NEURON-SPECIFIC ENOLASE; HIGH-GRADE GLIOMAS; SERUM S100B; RADIATION-THERAPY; S-100B PROTEIN; ADJUVANT TEMOZOLOMIDE; ANAPLASTIC GLIOMAS; S-100-BETA PROTEIN; PREDICTIVE-VALUE	The S100B protein is associated with brain damage and a breached blood-brain barrier. A previous pilot study showed that high serum levels of S100B are associated with shorter survival in glioma patients. The aim of our study was to assess the prognostic value in terms of survival and longitudinal dynamics of serum S100B for patients with newly diagnosed and recurrent glioma. We obtained blood samples from patients with newly diagnosed and recurrent glioma before the start (baseline) and at fixed time-points during temozolomide chemotherapy. S100B-data were dichotomized according to the upper limit of the reference value of 0.1 mu g/L. Overall survival (OS) was estimated with Kaplan-Meier curves and groups were compared with the log rank analysis. To correct for potential confounders a Cox regression analysis was used. We included 86 patients with newly-diagnosed and 27 patients with recurrent glioma. Most patients in both groups had baseline serum levels within normal limits. In the newly diagnosed patients we found no significant difference in OS between the group of patients with S100B levels > 0.1 mu g/L at baseline compared to those with < 0.1 mu g/L. In the patients with recurrent glioma we found a significantly shorter OS for patients with raised levels. In both groups, S100B values did not change significantly throughout the course of the disease. Serum S100B levels do not seem to have prognostic value in newly diagnosed glioma patients. In recurrent glioma patients S100B might be of value in terms of prognostication of survival.	[Holla, F. K.; Postma, T. J.; van Mierlo, T. J. M.; Sizoo, E. M.; de Groot, M.; Uitdehaag, B. M. J.; Reijneveld, J. C.; Heimans, J. J.] Vrije Univ Amsterdam, Med Ctr, Dept Neurol, POB 7057, NL-1007 MB Amsterdam, Netherlands; [Blankenstein, M. A.] Vrije Univ Amsterdam, Med Ctr, Clin Chem, Amsterdam, Netherlands; [Vos, M. J.] Med Ctr Haaglanden, Dept Neurol, The Hague, Netherlands; [Uitdehaag, B. M. J.] Vrije Univ Amsterdam, Med Ctr, Epidemiol & Biostat, Amsterdam, Netherlands; [Buter, J.] Vrije Univ Amsterdam, Med Ctr, Med Oncol, Amsterdam, Netherlands; [Klein, M.] Vrije Univ Amsterdam, Med Ctr, Med Psychol, Amsterdam, Netherlands	Postma, TJ (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Neurol, POB 7057, NL-1007 MB Amsterdam, Netherlands.	tj.postma@vumc.nl	Klein, Martin/C-4192-2012	Klein, Martin/0000-0003-4160-5746; Sizoo, Eefje/0000-0001-5994-0652; Klein, Martin/0000-0001-5553-7911			Abraha HD, 1997, ANN CLIN BIOCHEM, V34, P546, DOI 10.1177/000456329703400510; Back MF, 2007, ANN ACAD MED SINGAP, V36, P338; BROCKES JP, 1979, BRAIN RES, V165, P105, DOI 10.1016/0006-8993(79)90048-9; Brommeland T, 2007, ACTA NEUROL SCAND, V116, P380, DOI 10.1111/j.1600-0404.2007.00889.x; Cairncross G, 2006, J CLIN ONCOL, V24, P2707, DOI 10.1200/JCO.2005.04.3414; COCCHIA D, 1981, NATURE, V294, P85, DOI 10.1038/294085a0; Cohen AL, 2015, CANCER TREAT RES, V163, P15, DOI 10.1007/978-3-319-12048-5_2; CURRAN WJ, 1993, J NATL CANCER I, V85, P704, DOI 10.1093/jnci/85.9.704; Dassan P, 2009, CEREBROVASC DIS, V27, P295, DOI 10.1159/000199468; Donato V, 2007, TUMORI, V93, P248; Foerch C, 2005, ARCH NEUROL-CHICAGO, V62, P1130, DOI 10.1001/archneur.62.7.1130; Gerlach R, 2006, NEUROSCIENCE, V141, P1697, DOI 10.1016/j.neuroscience.2006.05.008; Gonzalez-Garcia S, 2012, CLIN BIOCHEM, V45, P1302, DOI 10.1016/j.clinbiochem.2012.07.094; Gradisek P, 2012, BRAIN INJURY, V26, P1472, DOI 10.3109/02699052.2012.694567; Hamberg AP, 2003, MELANOMA RES, V13, P45, DOI 10.1097/00008390-200302000-00008; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Ilhan-Mutlu A, 2013, NEUROSURG REV, V36, P45, DOI 10.1007/s10143-012-0401-6; Kanner AA, 2003, CANCER, V97, P2806, DOI 10.1002/cncr.11409; Kapural M, 2002, BRAIN RES, V940, P102, DOI 10.1016/S0006-8993(02)02586-6; Kluger HM, 2011, CLIN CANCER RES, V17, P2417, DOI 10.1158/1078-0432.CCR-10-2402; Kruijff S, 2012, ANN SURG ONCOL, V19, P620, DOI 10.1245/s10434-011-2027-2; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; LUDWIN SK, 1976, J COMP NEUROL, V165, P197, DOI 10.1002/cne.901650206; Lyubimova NV, 2011, B EXP BIOL MED+, V150, P732, DOI 10.1007/s10517-011-1236-9; Marchi N, 2004, CLIN CHIM ACTA, V342, P1, DOI 10.1016/j.cccn.2003.12.008; Martenson ED, 2001, J CLIN ONCOL, V19, P824, DOI 10.1200/JCO.2001.19.3.824; Mercier E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1757; MICHETTI F, 1983, BRAIN RES, V262, P352, DOI 10.1016/0006-8993(83)91032-6; Moritz S, 2010, J NEUROSURG ANESTH, V22, P21, DOI 10.1097/ANA.0b013e3181bdf50d; Nuno M, 2013, NEUROSURGERY, V73, P458, DOI 10.1227/01.neu.0000431477.02408.5e; Portela LVC, 2002, CLIN CHEM, V48, P950; Rajendra A, 2004, J NEURO-ONCOL, V67, P345, DOI 10.1023/B:NEON.0000024216.15923.77; RICKMANN M, 1995, NEUROSCIENCE, V67, P977, DOI 10.1016/0306-4522(94)00615-C; Sanai N, 2008, NEUROSURGERY, V62, P753, DOI 10.1227/01.neu.0000318159.21731.cf; Sanchez-Pena P, 2008, CRIT CARE MED, V36, P2267, DOI 10.1097/CCM.0b013e3181809750; Sienkiewicz-Jarosz H, 2009, NEUROL NEUROCHIR POL, V43, P126; Speirs CK, 2015, INT J RADIAT ONCOL, V91, P268, DOI 10.1016/j.ijrobp.2014.10.027; STEFANSSON K, 1982, NATURE, V295, P63, DOI 10.1038/295063a0; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Syeda T, 2013, JCPSP-J COLL PHYSICI, V23, P112, DOI 02.2013/JCPSP.112115; Tubaro C, 2010, J CELL PHYSIOL, V223, P270, DOI 10.1002/jcp.22035; van Munster BC, 2010, INT J GERIATR PSYCH, V25, P234, DOI 10.1002/gps.2326; Vogelbaum MA, 2005, CANCER-AM CANCER SOC, V104, P817, DOI 10.1002/cncr.21220; Vos MJ, 2004, ANTICANCER RES, V24, P2511; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541; Wiesmann M, 2010, ACTA NEUROL SCAND, V121, P178, DOI 10.1111/j.1600-0404.2009.01196.x; Wiesmann M, 1998, CLIN CHEM, V44, P1056	47	11	11	0	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0167-594X	1573-7373		J NEURO-ONCOL	J. Neuro-Oncol.	SEP	2016	129	3					525	532		10.1007/s11060-016-2204-z			8	Oncology; Clinical Neurology	Oncology; Neurosciences & Neurology	DX7JU	WOS:000384563800016	27401156	Green Published, Other Gold			2021-06-18	
J	Liu, K; Li, B; Qian, SW; Jiang, QJ; Li, L; Wang, W; Zhang, GY; Sun, YJ; Sun, G				Liu, Kai; Li, Bo; Qian, Shaowen; Jiang, Qingjun; Li, Li; Wang, Wei; Zhang, Gaiyun; Sun, Yajuan; Sun, Gang			Mental fatigue after mild traumatic brain injury: a 3D-ASL perfusion study	BRAIN IMAGING AND BEHAVIOR			English	Article						Mild traumatic brain injury; Mental fatigue; Psychomotor vigilance test; Attention; ASL perfusion fMRI	WORKING-MEMORY; SUSTAINED ATTENTION; RESTING-STATE; ACTIVATION; MODERATE; NETWORK; FMRI; BOLD; ADOLESCENTS; PERFORMANCE	Our purpose was to evaluate mental fatigue associated with mild traumatic brain injury (MTBI) and investigate the underlying neurological mechanisms. We used a 20-min psychomotor vigilance test (PVT) related ASL-fMRI to evaluate mental fatigue in 25 MTBI patients in acute phase, 21 MTBI patients in chronic phase, and 20 healthy subjects. Mental fatigue in patients in acute phase was more severe than in chronic phase patients and healthy controls. The first 5-min-PVT increased CBF of patients in acute phase in "bottom-up" and "top-down" attention areas, and decreased CBF in default mode network (DMN) areas. Twenty-min-PVT results showed that sustained attention of patients was more fragile than in healthy subjects, while sustained attention in the acute phase was less stable than that in the chronic phase. CBF results showed that in patients in the acute phase, the second, third, and last 5-min-PVT decreased CBF in DMN areas, increased CBF of "bottom-up" and "top-down" areas; in the chronic phase, the third and last 5-min-PVT increased CBF of "bottom-up" and "top-down" cortex, while the second 5-min-PVT only increased CBF of the "top-down" cortex. Mental fatigue of MTBI patients persists for more than 12 months, and can be mitigated partly within the first year after injury. The "bottom-up" and "top-down" deficits result in mental fatigue of MTBI patients.	[Liu, Kai; Li, Bo; Qian, Shaowen; Jiang, Qingjun; Li, Li; Wang, Wei; Zhang, Gaiyun; Sun, Yajuan; Sun, Gang] Jinan Mil Gen Hosp, Dept Med Imaging, Jinan, Shandong, Peoples R China	Qian, SW; Sun, G (corresponding author), Jinan Mil Gen Hosp, Dept Med Imaging, Jinan, Shandong, Peoples R China.	qianshaowen1110@163.com; cjr.sungang@vip.163.com			China Postdoctoral Science FoundationChina Postdoctoral Science Foundation [2014M552596]; Jinan Military General Hospital President Foundation [2014MS07]	This work was supported by the China Postdoctoral Science Foundation [2014M552596] and Jinan Military General Hospital President Foundation [no. 2014MS07].	Aguirre GK, 2002, NEUROIMAGE, V15, P488, DOI 10.1006/nimg.2001.0990; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Belmont A, 2009, NEUROREHAB NEURAL RE, V23, P939, DOI 10.1177/1545968309340327; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Bushnik T, 2008, J HEAD TRAUMA REHAB, V23, P17, DOI 10.1097/01.HTR.0000308717.80590.22; Chen CJ, 2012, RADIOLOGY, V264, P844, DOI 10.1148/radiol.12112154; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Cook DB, 2007, NEUROIMAGE, V36, P108, DOI 10.1016/j.neuroimage.2007.02.033; Esbjornsson E, 2013, J REHABIL MED, V45, P771, DOI 10.2340/16501977-1170; Fan J, 2005, NEUROIMAGE, V26, P471, DOI 10.1016/j.neuroimage.2005.02.004; Foucher JR, 2004, NEUROIMAGE, V22, P688, DOI 10.1016/j.neuroimage.2004.01.048; Greenberg AS, 2010, J NEUROSCI, V30, P14330, DOI 10.1523/JNEUROSCI.4248-09.2010; Hocking C, 2001, COMP BIOCHEM PHYS A, V128, P719, DOI 10.1016/S1095-6433(01)00278-1; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Juengst S, 2013, ARCH PHYS MED REHAB, V94, P74, DOI 10.1016/j.apmr.2012.07.025; Kay T., 1993, J HEAD TRAUMA REHABI, V8, P86, DOI [10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kempton MJ, 2011, HUM BRAIN MAPP, V32, P71, DOI 10.1002/hbm.20999; Kohl AD, 2009, BRAIN INJURY, V23, P420, DOI 10.1080/02699050902788519; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kurca E, 2006, NEURORADIOLOGY, V48, P661, DOI 10.1007/s00234-006-0109-9; Lange G, 2005, NEUROIMAGE, V26, P513, DOI 10.1016/j.neuroimage.2005.02.011; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; Lim J, 2010, NEUROIMAGE, V49, P3426, DOI 10.1016/j.neuroimage.2009.11.020; Liu K, 2013, BEHAV BRAIN RES, V243, P220, DOI 10.1016/j.bbr.2013.01.013; Malojcic B, 2008, J NEUROTRAUM, V25, P30, DOI 10.1089/neu.2007.0384; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; Messe A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065470; Monti JM, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00041; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Rao HY, 2007, BIOL PSYCHIAT, V62, P600, DOI 10.1016/j.biopsych.2006.11.028; Sarter M, 2001, BRAIN RES REV, V35, P146, DOI 10.1016/S0165-0173(01)00044-3; Scheibel RS, 2007, NEUROREHAB NEURAL RE, V21, P36, DOI 10.1177/1545968306294730; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Shomstein S, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00038; Sinclair KL, 2013, J CLIN EXP NEUROPSYC, V35, P210, DOI 10.1080/13803395.2012.762340; Smits M, 2009, HUM BRAIN MAPP, V30, P2789, DOI 10.1002/hbm.20709; SOSIN DM, 1991, BRAIN INJURY, V10, P47, DOI DOI 10.1080/026990596124719; Sours C, 2013, BRAIN RES, V1537, P201, DOI 10.1016/j.brainres.2013.08.034; Stuss DT, 2003, BRAIN, V126, P2363, DOI 10.1093/brain/awg237; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; Tjandra T, 2005, NEUROIMAGE, V27, P393, DOI 10.1016/j.neuroimage.2005.04.021; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wu TC, 2010, J NEUROTRAUM, V27, P303, DOI 10.1089/neu.2009.1110; Yount R, 2002, J NEUROPSYCH CLIN N, V14, P416, DOI 10.1176/appi.neuropsych.14.4.416; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748	48	11	11	2	11	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	SEP	2016	10	3					857	868		10.1007/s11682-015-9492-3			12	Neuroimaging	Neurosciences & Neurology	DU7IL	WOS:000382387300024	26781483				2021-06-18	
J	Lopez-Picon, F; Snellman, A; Shatillo, O; Lehtiniemi, P; Gronroos, TJ; Marjamaki, P; Trigg, W; Jones, PA; Solin, O; Pitkanen, A; Haaparanta-Solin, M				Lopez-Picon, Francisco; Snellman, Anniina; Shatillo, Olena; Lehtiniemi, Paula; Gronroos, Tove J.; Marjamaki, Paivi; Trigg, William; Jones, Paul A.; Solin, Olof; Pitkanen, Asia; Haaparanta-Solin, Merja			Ex Vivo Tracing of NMDA and GABA-A Receptors in Rat Brain After Traumatic Brain Injury Using F-18-GE-179 and F-18-GE-194 Autoradiography	JOURNAL OF NUCLEAR MEDICINE			English	Article						N-methyl-aspartic acid receptor; gamma-aminobutyric acid receptor A; GE-179; GE-194; traumatic brain injury	POSTTRAUMATIC EPILEPSY; HIPPOCAMPUS; ANTAGONISTS; SUBUNITS; EXPRESSION; GLUTAMATE; THALAMUS; BINDING; EDEMA; MODEL	In vivo imaging of N-methyl-d-aspartate (NMDA) glutamate receptor and gamma-aminobutyric acid (GABA)-A receptor during progression of brain pathology is challenging because of the lack of imaging tracers with high affinity and specificity. Methods: We monitored changes in NMDA receptor and GABA-A receptor in a clinically relevant model of traumatic brain injury (TBI) induced by lateral fluid percussion in adult rats, using 2 new ligands for PET: (18)F-GE-179 for the open/active state of the NMDA receptor ion channel and F-18-GE-194 for GABA-A receptor. Ex vivo brain autoradiography of radioligands was performed at subacute (5-6 d) and chronic (40-42 d) time points after TBI. Results: At 5-6 d after TBI, F-18-GE-179 binding was higher in the cortical lesion area, in the lesion core, and in the hippocampus than in the corresponding contralateral regions; this increase was probably related to increased permeability of the blood-brain barrier. At 40-42 d after TBI, F-18-GE-179 binding was significantly higher in the medial cortex, in the corpus callosum, and in the thalamus than in the corresponding contralateral regions. Five to 6 days after TBI, F-18-GE-194 binding was significantly higher in the lesion core and significantly lower in the ipsilateral thalamus. By 40-42 d after TBI, the reduction in F-18-GE-194 binding extended to the cortical lesion, including the perilesional cortex around the lesion core. The reduction in thalamic binding was more extensive at 40-42 d than at 5-6 d after TBI, suggesting a progressive decrease in thalamic GABA-A receptor density. Immunohistochemistry against GABA-A alpha 1 subunit revealed a similar decrease to F-18-GE-194 binding, particularly during the chronic phase. Conclusion: Our data support the validity of novel F-18-GE-179 and F-18-GE-194 radioligands for the detection of changes in active NMDA receptor and GABA-A receptor in the injured brain. These tools are useful for follow-up evaluation of secondary postinjury pathologies.	[Lopez-Picon, Francisco; Snellman, Anniina; Gronroos, Tove J.; Marjamaki, Paivi; Haaparanta-Solin, Merja] Univ Turku, Turku PET Ctr, PET Preclin Lab, Turku, Finland; [Lopez-Picon, Francisco; Snellman, Anniina; Gronroos, Tove J.; Marjamaki, Paivi; Haaparanta-Solin, Merja] Univ Turku, Medicity Res Lab, Turku, Finland; [Shatillo, Olena; Pitkanen, Asia] Univ Eastern Finland, AI Virtanen Inst Mol Sci, Kuopio, Finland; [Lehtiniemi, Paula; Solin, Olof] Univ Turku, Turku PET Ctr, Radiopharmaceut Chem Lab, Turku, Finland; [Trigg, William; Jones, Paul A.] GE Healthcare Life Sci, Amersham, Bucks, England; [Solin, Olof] Abo Akad Univ, Accelerator Lab, Turku, Finland; [Solin, Olof] Univ Turku, Dept Chem, Turku, Finland	Haaparanta-Solin, M (corresponding author), Univ Turku, MediCity PET Preclin Lab, Tykistokatu 6A, FI-20520 Turku, Finland.	mehaaso@utu.fi	Jones, Paul/M-1841-2013	Jones, Paul/0000-0002-8385-1702; Haaparanta-Solin, Merja/0000-0002-3602-4587; Trigg, William/0000-0003-4046-0813; Snellman, Anniina/0000-0001-6191-0954; Lopez Picon, Francisco R./0000-0002-3871-1735	Academy of FinlandAcademy of FinlandEuropean Commission [272249, 273909, 271683]; EUROCORES EuroEPINOMICS Program (EpiGENet); Strategic Funding of the University of Eastern Finland (UEF-Brain); GE Healthcare Ltd.;  [266891]	The costs of publication of this article were defrayed in part by the payment of page charges. Therefore, and solely to indicate this fact, this article is hereby marked "advertisement" in accordance with 18 USC section 1734. This study was supported by The Academy of Finland projects 272249, 273909, and 271683; project 266891; the EUROCORES EuroEPINOMICS Program (EpiGENet); Strategic Funding of the University of Eastern Finland (UEF-Brain); and GE Healthcare Ltd., which also provided the chemicals for <SUP>18</SUP>F-GE-179 and <SUP>18</SUP>F-GE-194 synthesis. No other potential conflict of interest relevant to this article was reported.	Armstead WM, 2002, DEV BRAIN RES, V139, P19, DOI 10.1016/S0165-3806(02)00511-4; Bauer R, 1999, EXP TOXICOL PATHOL, V51, P143, DOI 10.1016/S0940-2993(99)80088-8; Byrnes Kimberly R, 2014, Front Neuroenergetics, V5, P13, DOI 10.3389/fnene.2013.00013; Centers for Disease Control and Prevention, 2017, SEV TBI; Drexel M, 2015, NEUROPHARMACOLOGY, V88, P122, DOI 10.1016/j.neuropharm.2014.08.023; Giza CC, 2006, J NEUROTRAUM, V23, P950, DOI 10.1089/neu.2006.23.950; Gustavsson A, 2011, EUR NEUROPSYCHOPHARM, V21, P718, DOI 10.1016/j.euroneuro.2011.08.008; Hicks RR, 1997, MOL BRAIN RES, V48, P401, DOI 10.1016/S0169-328X(97)00158-7; Huusko N, 2014, NEUROSCIENCE, V267, P30, DOI 10.1016/j.neuroscience.2014.02.026; Huusko N, 2015, BRAIN STRUCT FUNCT, V220, P153, DOI 10.1007/s00429-013-0644-1; Injury Prevention and Control, INJ PREV CONTR TRAUM; Kalviainen R, 1998, NEUROLOGY, V50, P1377, DOI 10.1212/WNL.50.5.1377; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kharlamov EA, 2011, EPILEPSY RES, V95, P20, DOI 10.1016/j.eplepsyres.2011.02.008; McGinnity CJ, 2015, J NEUROL NEUROSUR PS, V86, P1150, DOI 10.1136/jnnp-2014-309897; McGinnity CJ, 2014, J NUCL MED, V55, P423, DOI 10.2967/jnumed.113.130641; Obrenovitch TP, 1997, J NEUROTRAUM, V14, P677, DOI 10.1089/neu.1997.14.677; Okiyama K, 1997, J NEUROTRAUM, V14, P211, DOI 10.1089/neu.1997.14.211; Osteen CL, 2004, NEUROSCIENCE, V128, P305, DOI 10.1016/j.neuroscience.2004.06.034; Pavlov I, 2011, NEUROSCIENCE, V194, P208, DOI 10.1016/j.neuroscience.2011.07.074; Pitkanen A, 2014, NEUROTHERAPEUTICS, V11, P286, DOI 10.1007/s13311-014-0260-7; Robins EG, 2010, BIOORG MED CHEM LETT, V20, P1749, DOI 10.1016/j.bmcl.2010.01.052; Rodnick ME, 2013, NUCL MED BIOL, V40, P901, DOI 10.1016/j.nucmedbio.2013.06.004; Sihver S, 2001, J NEUROCHEM, V78, P417, DOI 10.1046/j.1471-4159.2001.00428.x; SMITH DH, 1993, J NEUROSCI, V13, P5383; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111	26	11	11	0	9	SOC NUCLEAR MEDICINE INC	RESTON	1850 SAMUEL MORSE DR, RESTON, VA 20190-5316 USA	0161-5505	1535-5667		J NUCL MED	J. Nucl. Med.	SEP	2016	57	9					1442	1447		10.2967/jnumed.115.167403			6	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	DU7UK	WOS:000382419900034	27199360	Bronze			2021-06-18	
J	Mao, XX; Liu, J; Chen, C; Zhang, WD; Qian, R; Chen, XL; Lu, HJ; Ge, JB; Zhao, CJ; Zhang, DM; Wang, YH				Mao, Xingxing; Liu, Jin; Chen, Chen; Zhang, Weidong; Qian, Rong; Chen, Xinlei; Lu, Hongjian; Ge, Jianbing; Zhao, Chengjin; Zhang, Dongmei; Wang, Youhua			PCBP2 Modulates Neural Apoptosis and Astrocyte Proliferation After Spinal Cord Injury	NEUROCHEMICAL RESEARCH			English	Article						Spinal cord injury; PCBP2; Neuron; Apoptosis; Astrocyte; Proliferation	ASTROGLIAL CELL-PROLIFERATION; TRAUMATIC BRAIN-INJURY; SCAR FORMATION; GROWTH-FACTORS; CYCLIN D1; PROTEIN; ACTIVATION; EXPRESSION; DIFFERENTIATION; MECHANISMS	PCBP2, a member of the poly(C)-binding protein (PCBP) family, plays a pivotal role in posttranscriptional and translational regulation by interacting with single-stranded poly(C) motifs in target mRNAs. It is reported that several PCBP family members are involved in human malignancies. However, the distribution and function of PCBP2 in the central nervous system (CNS) remain unclear. In this study, we performed an acute spinal cord injury (SCI) model in adult rats and investigated the dynamic changes of PCBP2 expression in the spinal cord. Western blot and immunohistochemistry analysis revealed that PCBP2 presented in normal spinal cord. It gradually increased, reached a peak at 3 day, and then declined to basal levels at 14 days after SCI. We observed that the expression of PCBP2 was enhanced in the gray and white matter. Immunofluorescence indicated that PCBP2 was located in the neurons and astrocytes. Moreover, colocalization of PCBP2/active caspase-3 was detected in neurons, and colocalization of PCBP2/proliferating cell nuclear antigen was detected in astrocytes after SCI. These results indicated that PCBP2 might play an important role in neuronal apoptosis and astrocyte proliferation. In vitro, PCBP2-specific siRNA-transfected neuron showed significantly decrease of neuronal apoptosis and expression of cell cycle related proteins following glutamate stimulation. Meanwhile, PCBP2 knockdown also reduced primary astrocytes proliferation. All above indicated that PCBP2 might play a crucial role in cell proliferation and apoptosis. Collectively, our data suggested that PCBP2 might play important roles in CNS pathophysiology after SCI.	[Mao, Xingxing; Liu, Jin; Chen, Chen; Zhang, Weidong; Qian, Rong; Chen, Xinlei; Wang, Youhua] Nantong Univ, Dept Orthoped, Affiliated Hosp, Nantong 226001, Jiangsu, Peoples R China; [Lu, Hongjian; Ge, Jianbing; Zhao, Chengjin] Second Peoples Hosp Nantong, Dept Rehabil, Nantong 226001, Jiangsu, Peoples R China; [Zhang, Dongmei] Jiangsu Prov Key Lab Inflammat & Mol Drug Target, Nantong, Peoples R China	Wang, YH (corresponding author), Nantong Univ, Dept Orthoped, Affiliated Hosp, Nantong 226001, Jiangsu, Peoples R China.	docwangyh@163.com					Becker EBE, 2004, PROG NEUROBIOL, V72, P1, DOI 10.1016/j.pneurobio.2003.12.005; Bramanti V, 2015, J NEUROSCI RES, V93, P521, DOI 10.1002/jnr.23506; Bramanti V, 2012, NEUROCHEM RES, V37, P2795, DOI 10.1007/s11064-012-0873-3; Bramanti V, 2010, NEUROCHEM RES, V35, P2070, DOI 10.1007/s11064-010-0256-6; Bramanti V, 2015, J NEUROSCI RES, V93, P1378, DOI 10.1002/jnr.23606; Byrnes KR, 2007, BRAIN, V130, P2977, DOI 10.1093/brain/awm179; Carnevale D., 2007, CNS & Neurological Disorders-Drug Targets, V6, P388; Cernak I, 2005, CELL CYCLE, V4, P1286, DOI 10.4161/cc.4.9.1996; Chong ZZ, 2006, CURR NEUROVASC RES, V3, P25, DOI 10.2174/156720206775541741; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Di Giovanni S, 2003, ANN NEUROL, V53, P454, DOI 10.1002/ana.10472; Du ZH, 2008, J BIOL CHEM, V283, P28757, DOI 10.1074/jbc.M803046200; Dumont RJ, 2001, CLIN NEUROPHARMACOL, V24, P254, DOI 10.1097/00002826-200109000-00002; Eversole A, 2000, MOL CELL BIOL, V20, P5425, DOI 10.1128/MCB.20.15.5425-5432.2000; Fukushi S, 2001, VIRUS RES, V73, P67, DOI 10.1016/S0168-1702(00)00228-8; Grasso S, 2014, J NEUROSCI RES, V92, P86, DOI 10.1002/jnr.23289; Han W, 2013, J CLIN INVEST, V123, P2103, DOI 10.1172/JCI61820; Harrop J S, 2000, Neurosurg Focus, V8, pe4; Hay DC, 2001, MOL CELL BIOL, V21, P3482, DOI 10.1128/MCB.21.10.3482-3490.2001; Hu CE, 2014, BIOCHEM BIOPH RES CO, V448, P437, DOI 10.1016/j.bbrc.2014.04.124; Iwanaga K, 2005, BIOCHEM BIOPH RES CO, V333, P888, DOI 10.1016/j.bbrc.2005.05.180; Johnson RL, 1997, AM J EPIDEMIOL, V146, P266; Kan EM, 2012, BRAIN RES BULL, V87, P359, DOI 10.1016/j.brainresbull.2012.01.007; McDonald JW, 2002, LANCET, V359, P417, DOI 10.1016/S0140-6736(02)07603-1; MORRIS GF, 1989, J BIOL CHEM, V264, P13856; Pan TT, 2006, BIOCHEM BIOPH RES CO, V347, P683, DOI 10.1016/j.bbrc.2006.06.144; Rieder E, 2003, J GEN VIROL, V84, P2203, DOI 10.1099/vir.0.19013-0; Roychoudhury P, 2007, MOL CARCINOGEN, V46, P198, DOI 10.1002/mc.20265; Sean P, 2008, VIROLOGY, V378, P243, DOI 10.1016/j.virol.2008.05.007; Sean P, 2009, VIROLOGY, V389, P45, DOI 10.1016/j.virol.2009.03.012; Tator C H, 1996, J Spinal Cord Med, V19, P206; Tian DS, 2006, J NEUROSCI RES, V84, P1053, DOI 10.1002/jnr.20999; Tommerup N, 1996, GENOMICS, V32, P297, DOI 10.1006/geno.1996.0121; Wang ZB, 2005, CELL BIOL INT, V29, P489, DOI 10.1016/j.cellbi.2005.04.001; Wu JF, 2011, NEUROTHERAPEUTICS, V8, P221, DOI 10.1007/s13311-011-0028-2; You FP, 2009, NAT IMMUNOL, V10, P1300, DOI 10.1038/ni.1815	36	11	14	1	3	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	SEP	2016	41	9					2401	2414		10.1007/s11064-016-1953-6			14	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	DS3XV	WOS:000380716900022	27209304				2021-06-18	
J	Markus, TE; Zeharia, A; Cohen, YH; Konen, O				Markus, Tal Eidlitz; Zeharia, Avraham; Cohen, Yishai Haimi; Konen, Osnat			Persistent Headache and Cephalic Allodynia Attributed to Head Trauma in Children and Adolescents	JOURNAL OF CHILD NEUROLOGY			English	Article						mild traumatic brain injury; moderate to severe traumatic brain injury; allodynia; tension headache; migraine headache	CHRONIC POSTTRAUMATIC HEADACHE; BRAIN-INJURY; MIGRAINE; SENSITIZATION	The aim of the study was to investigate clinical features of headache associated with minor versus moderate to severe traumatic brain injury and of posttraumatic versus primary headache in children and adolescents. Study group included 74 patients after mild (n = 60) or moderate to severe (n = 14) traumatic brain injury identified by retrospective review of the computerized files of a tertiary pediatric headache clinic. Forty patients (54%) had migraine-like headache, 23 (31.1%) tension-like headache, and 11 (14.9%) nonspecified headache. Fourteen patients (53.8%) had allodynia. In comparison with 174 control patients, the study group had a significantly lower proportion of patients with migraine-like headache and a higher proportion of male patients and patients with allodynia. There was no statistically significant correlation of any of the clinical parameters with the type or severity of the posttraumatic headache or rate of allodynia. The high rate of allodynia in the study group may indicate a central sensitization in posttraumatic headache.	[Markus, Tal Eidlitz; Zeharia, Avraham; Cohen, Yishai Haimi] Schneider Childrens Med Ctr Israel, Day Hospitalizat Dept, Pediat Headache Clin, IL-49202 Petah Tiqwa, Israel; [Markus, Tal Eidlitz; Zeharia, Avraham; Cohen, Yishai Haimi; Konen, Osnat] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel; [Konen, Osnat] Schneider Childrens Med Ctr Israel, Dept Pediat Radiol, Petah Tiqwa, Israel	Markus, TE (corresponding author), Schneider Childrens Med Ctr Israel, Day Hospitalizat Dept, Pediat Headache Clin, IL-49202 Petah Tiqwa, Israel.	eidlitz@post.tau.ac.il					Abu-Arafeh I, 2014, PAIN MANAG, V4, P303, DOI [10.2217/pmt.14.16, 10.2217/PMT.14.16]; Anthony DC, 2014, EXP NEUROL, V258, P105, DOI 10.1016/j.expneurol.2014.03.013; Blume HK, 2012, PEDIATRICS, V129, pE31, DOI 10.1542/peds.2011-1742; Burstein R, 2000, ANN NEUROL, V47, P614, DOI 10.1002/1531-8249(200005)47:5<614::AID-ANA9>3.0.CO;2-N; Callaghan M, 2001, DEV MED CHILD NEUROL, V43, P819, DOI 10.1017/S0012162201001487; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; D'Onofrio F, 2014, NEUROL SCI, V35, pS203, DOI 10.1007/s10072-014-1771-z; De Felice M, 2011, CURR OPIN NEUROL, V24, P193, DOI 10.1097/WCO.0b013e328346af25; De Felice M, 2010, BRAIN, V133, P2475, DOI 10.1093/brain/awq159; De Felice M, 2010, ANN NEUROL, V67, P325, DOI 10.1002/ana.21897; Defrin R, 2010, EUR J PAIN, V14, P924, DOI 10.1016/j.ejpain.2010.03.004; Dixon WJ, 1993, BMPD STAT SOFTWARE M; Eidlitz-Markus T, 2007, HEADACHE, V47, P1219, DOI 10.1111/j.1526-4610.2007.00892.x; Ekizoglu E, 2012, CEPHALALGIA, V32, P1049, DOI 10.1177/0333102412457091; Fanciullacci Marcello, 2005, J Headache Pain, V6, P331, DOI 10.1007/s10194-005-0224-8; Goryunova A V, 2007, Neurosci Behav Physiol, V37, P761, DOI 10.1007/s11055-007-0079-3; Jankowski MP, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-34; Kirk C, 2008, DEV MED CHILD NEUROL, V50, P422, DOI 10.1111/j.1469-8749.2008.02063.x; Kuczynski A, 2013, DEV MED CHILD NEUROL, V55, P636, DOI 10.1111/dmcn.12152; Lewis DW, 2002, NEUROLOGY, V59, P490, DOI 10.1212/WNL.59.4.490; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Lucas S, 2012, CEPHALALGIA, V32, P600, DOI 10.1177/0333102412445224; Macolino CM, 2014, J NEUROSCI METH, V226, P139, DOI 10.1016/j.jneumeth.2014.01.008; McCarthy ML, 2002, ACAD EMERG MED, V9, P684; Moscato Davide, 2005, J Headache Pain, V6, P284, DOI 10.1007/s10194-005-0208-8; Necajauskaite Olga, 2005, Medicina (Kaunas), V41, P100; Ofek H, 2007, PAIN, V131, P330, DOI 10.1016/j.pain.2007.06.015; Packard RC, 1997, HEADACHE, V37, P142, DOI 10.1046/j.1526-4610.1997.3703142.x; Quayle KS, 2014, NEW ENGL J MED, V371, P1945, DOI 10.1056/NEJMc1407902; Torelli P, 2004, CEPHALALGIA, V24, P29, DOI 10.1111/j.1468-2982.2004.00633.x	30	11	11	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0883-0738	1708-8283		J CHILD NEUROL	J. Child Neurol.	SEP	2016	31	10					1213	1219		10.1177/0883073816650036			7	Clinical Neurology; Pediatrics	Neurosciences & Neurology; Pediatrics	DU9OA	WOS:000382546000001	27221373				2021-06-18	
J	Martini, DN; Goulet, GC; Gates, DH; Broglio, SP				Martini, Douglas N.; Goulet, Grant C.; Gates, Deanna H.; Broglio, Steven P.			Long-term effects of adolescent concussion history on gait, across age	GAIT & POSTURE			English	Article						Chronic; Sport concussion; High school; Dual task	TRAUMATIC BRAIN-INJURY; COGNITIVE IMPAIRMENT; OLDER-ADULTS; BIOMECHANICS; STABILITY; OBSTACLES; EPIDEMIOLOGY; SYMPTOMS; PATTERNS; EXERCISE	The aim of this study was to examine the possible long-term effects of high school concussion history on gait performance across the lifespan. Individuals with and without a concussion history were grouped into 20-year-old (yo) (n=40), 40yo (n=19), and 60yo (n= 18) age groups. Participants completed five trials of four walking conditions: a normal walk, a dual task walk, an obstructed walk, and an obstructed, dual task walk. Spatiotemporal gait parameters for gait analyses during single and dual task conditions. Gait velocity, step width, stride length, percent of time in double support, and obstacle toe clearance were the gait variables assessed along with number correct from dual task. Gait was analyzed via optical motion capture. Data were analyzed by two-factor, multivariate ANOVAs and significant interactions were explored using post hoc contrasts. A significant (F= 2.62, p = 0.03) interaction was observed for the obstructed walk condition. Further analyses yielded no significant concussion history and control group differences, within age. The data indicate that an adolescent concussion history has a non-observable effect on gait across the lifespan. (C) 2016 Elsevier B.V. All rights reserved.	[Martini, Douglas N.; Broglio, Steven P.] Univ Michigan, Sch Kinesiol, NeuroTrauma Res Lab, Ann Arbor, MI 48109 USA; [Goulet, Grant C.] Univ Michigan, Sch Kinesiol, Michigan Performance Res Lab, Ann Arbor, MI 48109 USA; [Gates, Deanna H.] Univ Michigan, Sch Kinesiol, Rehabil Biomech Lab, Ann Arbor, MI 48109 USA	Martini, DN (corresponding author), 3181 SW Sam Jackson Pk Rd OP32, Portland, OR 97239 USA.	martidou@ohsu.edu		Gates, Deanna/0000-0002-6086-0913	National Athletic Trainers' Association - Research and Education Foundation (NATA-REF.); Rackham Graduate School - University of MichiganUniversity of Michigan System; University of Michigan Injury Center	This project was funded by the National Athletic Trainers' Association - Research and Education Foundation (NATA-REF.) The Rackham Graduate School - University of Michigan, and The University of Michigan Injury Center.	Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Broglio SP, 2006, BRIT J SPORT MED, V40, P802, DOI 10.1136/bjsm.2006.028019; Broglio SP, 2012, EXERC SPORT SCI REV, V40, P138, DOI 10.1097/JES.0b013e3182524273; Broglio SP, 2009, J NEUROTRAUM, V26, P1463, DOI [10.1089/neu.2008.0766, 10.1089/neu.2008-0766]; BROOKS LR, 1967, Q J EXP PSYCHOL, V19, P289, DOI 10.1080/14640746708400105; Buckley T. A., 2015, J SPORT HLTH SCI; CHEN HC, 1991, J GERONTOL, V46, pM196, DOI 10.1093/geronj/46.6.M196; Chou LS, 2004, GAIT POSTURE, V20, P245, DOI 10.1016/j.gaitpost.2003.09.007; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; De Beaumont L, 2007, BRAIN INJURY, V21, P631, DOI 10.1080/02699050701426931; Dretsch MN, 2015, J NEUROTRAUM, V32, P1301, DOI 10.1089/neu.2014.3810; Fino PC, 2016, J BIOMECH, V49, P1983, DOI 10.1016/j.jbiomech.2016.05.004; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; Gibson T. B., 2014, NEUROLOGY; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Howell DR, 2015, MED SCI SPORT EXER, V47, P673, DOI 10.1249/MSS.0000000000000462; Judge JO, 1996, CLIN GERIATR MED, V12, P659; JUDGE JO, 1993, ARCH PHYS MED REHAB, V74, P400; Kahneman D., 1973, ATTENTION EFFORT; Kerrigan DC, 1998, ARCH PHYS MED REHAB, V79, P317, DOI 10.1016/S0003-9993(98)90013-2; Krebs DE, 1998, ARCH PHYS MED REHAB, V79, P1489, DOI 10.1016/S0003-9993(98)90408-7; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LaRoche AA, 2016, CLIN J SPORT MED, V26, P33, DOI 10.1097/JSM.0000000000000192; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lu TW, 2006, GAIT POSTURE, V23, P471, DOI 10.1016/j.gaitpost.2005.06.005; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Martini DN, 2011, ARCH PHYS MED REHAB, V92, P585, DOI 10.1016/j.apmr.2010.11.029; McAuley E, 2004, BRAIN BEHAV IMMUN, V18, P214, DOI 10.1016/j.bbi.2003.12.007; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McLean SG, 2004, MED SCI SPORT EXER, V36, P1008, DOI 10.1249/01.MSS.0000128180.51443.83; Nandy S, 2004, J PUBLIC HEALTH-UK, V26, P138, DOI 10.1093/pubmed/fdh132; Palmieri-Smith RM, 2015, AM J SPORT MED, V43, P1662, DOI 10.1177/0363546515578252; Parker TM, 2006, MED SCI SPORT EXER, V38, P1032, DOI 10.1249/01.mss.0000222828.56982.a4; Patla AE, 1996, J MOTOR BEHAV, V28, P35, DOI 10.1080/00222895.1996.9941731; Prince F, 1997, GAIT POSTURE, V5, P128, DOI 10.1016/S0966-6362(97)01118-1; Sosnoff JJ, 2011, J ATHL TRAINING, V46, P85, DOI 10.4085/1062-6050-46.1.85; Sparrow WA, 1996, HUM MOVEMENT SCI, V15, P605, DOI 10.1016/0167-9457(96)00022-X; TINETTI ME, 1990, J GERONTOL, V45, pP239, DOI 10.1093/geronj/45.6.P239	41	11	11	1	16	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0966-6362	1879-2219		GAIT POSTURE	Gait Posture	SEP	2016	49						264	270		10.1016/j.gaitpost.2016.06.028			7	Neurosciences; Orthopedics; Sport Sciences	Neurosciences & Neurology; Orthopedics; Sport Sciences	DY1MF	WOS:000384858400046	27472823				2021-06-18	
J	Moattari, M; Shirazi, FA; Sharifi, N; Zareh, N				Moattari, Marzieh; Shirazi, Fatemeh Alizadeh; Sharifi, Nasrin; Zareh, Najaf			Effects of a Sensory Stimulation by Nurses and Families on Level of Cognitive Function, and Basic Cognitive Sensory Recovery of Comatose Patients With Severe Traumatic Brain Injury: A Randomized Control Trial	TRAUMA MONTHLY			English	Article						Coma; Sensory Stimulation; Traumatic Brain Injury; Consciousness Level; Cognitive Function	CONSCIOUSNESS LEVEL; VEGETATIVE STATE; HEAD-INJURY; OF-LIFE; TIME; CARE; RESPONSES; PROGRAM	Background: Several lines of evidence suggest that early sensory stimulation and regular family visiting programs are potential nursing interventions to improve the outcomes of head injured comatose patients. However, little is known about the impacts of family involvement in providing sensory stimulation. Objectives: To determine the effects of a sensory stimulation program conducted by nurses and families on the consciousness, level of cognitive function, and basic cognitive sensory recovery of head injury comatose patients. Patients and Methods: This was a randomized clinical trial performed at the Shiraz level I trauma center including 60 head injured comatose patients with an initial Glasgow coma score (GCS) of less than 8. Patients were randomly assigned to receive sensory stimulation by a qualified nurse (nurse group; n = 20), by the family (family group; n = 20), or usual care (control group; n = 20). The sensory stimulation program involving the nurses and patients' families was conducted, twice daily, in the morning and evening for 7 days. The level of consciousness, level of cognitive function, and basic cognitive sensory recovery of the patients were evaluated and monitored using the GCS, Rancho Los Amigos (RLA), and Western Neuro-Sensory stimulation profile (WNSSP). Data were analyzed by chi square, Kruskal-Wallis, and repeated-measures tests using SPSS. Results: All the patients were comparable regarding their baseline characteristics, level of consciousness, level of cognitive function, and basic cognitive sensory recovery determined by GCS, RLA, and WNSSP. Although the two intervention groups of the study improved, those who received the sensory stimulation program from their families had significantly higher GCS (P = 0.001), RLA (P = 0.001), and WNSSP (P = 0.001) scores after 7 days when compared to the two other groups. Conclusions: The application of sensory stimulation by families led to significant increases in the consciousness, level of cognitive function, and basic cognitive sensory recovery of comatose patients with severe injuries.	[Moattari, Marzieh; Shirazi, Fatemeh Alizadeh; Sharifi, Nasrin] Shiraz Univ Med Sci, Sch Nursing & Midwifery, Dept Med Surg Nursing, Shiraz, Iran; [Zareh, Najaf] Shiraz Univ Med Sci, Infertil Res Ctr, Dept Biostat, Shiraz, Iran	Moattari, M (corresponding author), Shiraz Univ Med Sci, Sch Nursing & Midwifery, Dept Med Surg Nursing, Shiraz, Iran.	moattari@yahoo.com	sharifi, nasrin/C-8925-2017	sharifi, nasrin/0000-0002-6849-7653			Abbasi M, 2009, JPN J NURS SCI, V6, P21, DOI 10.1111/j.1742-7924.2009.00117.x; Aghakhani N, 2013, IRAN RED CRESCENT ME, V15, P173, DOI 10.5812/ircmj.2090; ANSELL BJ, 1989, ARCH PHYS MED REHAB, V70, P104; BARKER E, 2002, NEUROSCIENCE NURSING; Berwick DM, 2004, JAMA-J AM MED ASSOC, V292, P736, DOI 10.1001/jama.292.6.736; Campbell ML, 2003, CHEST, V123, P266, DOI 10.1378/chest.123.1.266; Davis Alice E, 2003, J Neurosci Nurs, V35, P202; Fakharian E, 2015, TRAUMA MON; Gruner ML, 2000, BRAIN INJURY, V14, P585; HALL M E, 1992, Brain Injury, V6, P435, DOI 10.3109/02699059209008139; Henneman Elizabeth A, 2002, Crit Care Nurse, V22, P12; JOHNSON DA, 1993, BRAIN INJURY, V7, P491, DOI 10.3109/02699059309008176; Karma D, 2006, INDIAN PEDIATR, V43, P856; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kater K M, 1989, West J Nurs Res, V11, P20, DOI 10.1177/019394598901100103; Lautrette A, 2007, NEW ENGL J MED, V356, P469, DOI 10.1056/NEJMoa063446; Lilly CM, 2000, AM J MED, V109, P469, DOI 10.1016/S0002-9343(00)00524-6; Lombardi F, 2002, COCHRANE DATABASE SY, V2; Majdzadeh R, 2008, ACCIDENT ANAL PREV, V40, P17, DOI 10.1016/j.aap.2007.03.019; Megha M, 2013, BRAIN INJURY, V27, P570, DOI 10.3109/02699052.2013.767937; MITCHELL S, 1990, Brain Injury, V4, P273, DOI 10.3109/02699059009026177; Moattari M, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-115; Momennasab Marzieh, 2012, Iran J Nurs Midwifery Res, V17, P343; Nelson JE, 2009, J CRIT CARE, V24, DOI 10.1016/j.jcrc.2009.02.007; Noda R, 2004, BRAIN INJURY, V18, P509, DOI 10.1080/02699050310001645810; Oh H, 2003, J CLIN NURS, V12, P394, DOI 10.1046/j.1365-2702.2003.00750.x; Oliveira RG, 2007, REV LAT-AM ENFERM, V15, P431, DOI 10.1590/S0104-11692007000300011; Owen MA, 2007, J NUCL MED TECHNOL, V35, P39; Salmond CH, 2005, BRAIN, V128, P189, DOI 10.1093/brain/awh352; Schneiderman LJ, 2003, JAMA-J AM MED ASSOC, V290, P1166, DOI 10.1001/jama.290.9.1166; SEGATORE M, 1992, HEART LUNG, V21, P548; Sinha S, 2013, NEUROL INDIA, V61, P501, DOI 10.4103/0028-3886.121920; TEASDALE G, 1974, LANCET, V2, P81; Toroyan T, 2009, INJURY PREV, V15, P286, DOI 10.1136/ip.2009.023697; Wijnen VJM, 2006, CLIN NEUROPHYSIOL, V117, P1794, DOI 10.1016/j.clinph.2006.03.006; Wilson SL, 1996, BRAIN INJURY, V10, P807, DOI 10.1080/026990596123927; Wood R L, 1992, Brain Inj, V6, P411, DOI 10.3109/02699059209008137	37	11	12	0	19	NATL CENTER TRAUMA RESEARCH	TEHRAN	NATL CENTER TRAUMA RESEARCH, TEHRAN, IRAN	2251-7464	2251-7472		TRAUMA MON	Trauma Mon.	SEP	2016	21	4							e23531	10.5812/traumamon.23531			10	Emergency Medicine	Emergency Medicine	ED7QK	WOS:000389063900006	28180120	Green Published			2021-06-18	
J	Oyesanya, TO; Thomas, MA; Brown, RL; Turkstra, LS				Oyesanya, Tolu O.; Thomas, Mitchell A.; Brown, Roger L.; Turkstra, Lyn S.			Nurses' Beliefs About Caring for Patients With Traumatic Brain Injury	WESTERN JOURNAL OF NURSING RESEARCH			English	Article						nursing; attitude; brain injuries; education; nursing	KNOWLEDGE; MISCONCEPTIONS; EDUCATION; PROFESSIONALS; EXPERIENCE; FRAMEWORK; SURVIVORS; TBI; PERCEPTIONS; RECOVERY	Patients with traumatic brain injury (TBI) and their families rely on health care providers, particularly nurses, to provide accurate information, yet inaccurate beliefs about TBI have been found among nurses. Although prior studies have assessed nurses' beliefs about TBI recovery and rehabilitation, none have assessed specific beliefs about the nursing role to care for these patients. The purpose of this study was to investigate nurses' beliefs and learning preferences about caring for patients with moderate-to-severe TBI. A cross-sectional survey was administered to 513 nurses at a Midwestern hospital between October and December 2014 (20.3% response rate). Latent class analysis was used. Findings showed that nurses had inaccurate beliefs about TBI relating to recovery and the nursing role, and had significant differences in learning preferences. These findings have implications for development of educational and training interventions specific to nurses to ensure that they have factual information about TBI and to clarify the nursing role.	[Oyesanya, Tolu O.; Thomas, Mitchell A.; Brown, Roger L.; Turkstra, Lyn S.] Univ Wisconsin, Madison, WI USA	Oyesanya, TO (corresponding author), Univ Wisconsin, Sch Nursing, 5130 Signe Skott Cooper Hall,701 Highland Ave, Madison, WI 53705 USA.	toyesanya@wisc.edu		Oyesanya, Tolu/0000-0001-8821-4510	University of Wisconsin-Madison, School of Nursing; National Institutes of Health (NIH)/National Institute of General Medical Sciences (NIGMS) Initiative for Maximizing Student Development [R25GM083252]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R25GM083252] Funding Source: NIH RePORTER	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This research was supported by the University of Wisconsin-Madison, School of Nursing and the National Institutes of Health (NIH)/National Institute of General Medical Sciences (NIGMS) Initiative for Maximizing Student Development (principal investigator, M. Carnes) Grant R25GM083252.	American Association of Neuroscience Nurses, 2008, NURS MAN AD SEV TRAU; American Cancer Society, 2015, WHAT AR KEY STAT BRE; Baker M, 2012, NURS EDUC TODAY, V32, P71, DOI 10.1016/j.nedt.2011.01.011; Bay E, 2011, ADV EMERG NURS J, V33, P71, DOI 10.1097/TME.0b013e318207e851; Blegen MA, 2001, J NURS ADMIN, V31, P33, DOI 10.1097/00005110-200101000-00007; Brain Injury Association of America, 2015, LIV BRAIN INJ; BROOKS DN, 1980, J NEUROL NEUROSUR PS, V43, P529, DOI 10.1136/jnnp.43.6.529; Browndyke JN, 1998, ARCH CLIN NEUROPSYCH, V13, P133; Celeux G, 1996, J CLASSIF, V13, P195, DOI 10.1007/BF01246098; Centers for Disease Control and Prevention, 2014, C TRAUM BRAIN INJ US; Clogg C.C., 1995, HDB STAT MODELING SO, P311, DOI DOI 10.1007/978-1-4899-1292-3; Corrigan JD, 2007, ARCH PHYS MED REHAB, V88, P418, DOI 10.1016/j.apmr.2007.01.010; Costello J, 1989, Nurse Educ Today, V9, P203, DOI 10.1016/0260-6917(89)90045-2; Couper MP, 2008, PUBLIC OPIN QUART, V72, P831, DOI 10.1093/poq/nfn066; Dams-O'Connor K, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000073; Defense and Veterans Brain Injury Center, 2014, WEB TRAUM BRAIN INJ; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Duff MC, 2015, BRAIN INJURY, V29, P64, DOI 10.3109/02699052.2014.965747; Edwards Geraldine, 2006, Br J Nurs, V15, P1180; Ernst WJ, 2009, J HEAD TRAUMA REHAB, V24, P213, DOI 10.1097/HTR.0b013e3181a7ecd8; Estabrooks CA, 2005, QUAL HEALTH RES, V15, P460, DOI 10.1177/1049732304273702; Evans K, 2009, CONT ISSUES COMMUN S, V36, P166; Farmer JE, 1997, REHABIL PSYCHOL, V42, P273; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Forneris S., 2006, INT J NURSING ED SCH, V3, P1; Forsetlund L, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003030.pub2; Fraley C, 1998, COMPUT J, V41, P578, DOI 10.1093/comjnl/41.8.578; Gould D, 2007, NURS EDUC TODAY, V27, P26, DOI 10.1016/j.nedt.2006.02.006; Green REA, 2006, BRAIN COGNITION, V60, P199; Grol R, 1997, BRIT MED J, V315, P418, DOI 10.1136/bmj.315.7105.418; Himanen L, 2006, NEUROLOGY, V66, P187, DOI 10.1212/01.wnl.0000194264.60150.d3; Hintze J.L., 1987, NUMBER CRUNCHER STAT; Hooper S., 2006, EXCEPTIONALITY, V14, P171, DOI DOI 10.1207/s15327035ex1403_5; Hux K, 1996, LANG SPEECH HEAR SER, V27, P171, DOI 10.1044/0161-1461.2702.171; Jeffries PR, 2005, NURS EDUC PERSPECT, V26, P96; Keane M, 1991, Perspect Psychiatr Care, V27, P13, DOI 10.1111/j.1744-6163.1991.tb01557.x; Linden MA, 2012, NURS RES, V61, P58, DOI 10.1097/NNR.0b013e31823ca253; Linden MA, 2011, INT J NURS STUD, V48, P62, DOI 10.1016/j.ijnurstu.2010.05.011; Long AF, 2002, J ADV NURS, V37, P70, DOI 10.1046/j.1365-2648.2002.02059.x; Long AF, 2002, NURS EDUC TODAY, V22, P136, DOI 10.1054/nedt.2001.0671; Lunney M, 2010, REHABIL NURS, V35, P161, DOI 10.1002/j.2048-7940.2010.tb00042.x; Mansour A., 2015, PSYCHOLOGY, V6, P323, DOI DOI 10.4236/PSYCH.2015.64033; MCDONALD RP, 1970, BRIT J MATH STAT PSY, V23, P1, DOI 10.1111/j.2044-8317.1970.tb00432.x; McHugh MD, 2010, RES NURS HEALTH, V33, P276, DOI 10.1002/nur.20388; McQuillan K. A., 2002, TRAUMA NURSING RESUS, P394; Michigan Department of Health and Human Services & Brain Injury Association of Michigan, 2015, MICH TRAUM BRAIN INJ; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Muthen LK., 2010, MPLUS USERS GUIDE ST; NOVICK MR, 1967, PSYCHOMETRIKA, V32, P1, DOI 10.1007/BF02289400; Oyesanya T. O., 2016, CARING US PATI UNPUB; Oyesanya T. O., 2016, NURSES PERCEPT UNPUB; Pryor J, 2002, J ADV NURS, V39, P249; Rao V, 2010, J NEUROPSYCH CLIN N, V22, P100, DOI 10.1176/appi.neuropsych.22.1.100; Redpath SJ, 2010, BRAIN INJURY, V24, P802, DOI 10.3109/02699051003709623; Ruiz JG, 2006, ACAD MED, V81, P207, DOI 10.1097/00001888-200603000-00002; Ryan DL., 2009, AM NURSE TODAY, V4, P18; Saban KL, 2011, J WOMENS HEALTH, V20, P179, DOI 10.1089/jwh.2010.2334; Secomb J, 2008, J CLIN NURS, V17, P703, DOI 10.1111/j.1365-2702.2007.01954.x; Seel RT, 2015, ARCH PHYS MED REHAB, V96, pS197, DOI 10.1016/j.apmr.2015.02.034; Shih TH, 2009, EDUC RES REV-NETH, V4, P26, DOI 10.1016/j.edurev.2008.01.003; Swift TL, 2001, BRAIN INJURY, V15, P149, DOI 10.1080/026990501458380; Verhoeven KJF, 2005, OIKOS, V108, P643, DOI 10.1111/j.0030-1299.2005.13727.x; Watts DD, 2011, J NEUROSCI NURS, V43, P122, DOI 10.1097/JNN.0b013e3182135af6; Xiong Y, 2009, EXPERT OPIN EMERG DR, V14, P67, DOI [10.1517/14728210902769601, 10.1517/14728210902769601 ]; Yuhasz JE, 2013, J CORRECT HEALTH CAR, V19, P135, DOI 10.1177/1078345812474644	65	11	11	0	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0193-9459	1552-8456		WESTERN J NURS RES	West. J. Nurs. Res.	SEP	2016	38	9					1114	1138		10.1177/0193945916636629			25	Nursing	Nursing	DU9TL	WOS:000382560600003	26955844	Green Accepted			2021-06-18	
J	Padaki, AS; Cole, BJ; Ahmad, CS				Padaki, Ajay S.; Cole, Brian J.; Ahmad, Christopher S.			Concussion Incidence and Return-to-Play Time in National Basketball Association Players: Results From 2006 to 2014	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						concussions; basketball; epidemiology	SPORT-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; FOOTBALL PLAYERS; EPIDEMIOLOGY; PATHOPHYSIOLOGY	Background: Various research efforts have studied concussions in the National Football League, Major League Baseball, and the National Hockey League. However, no study has investigated the incidence and return-to-play trends in the National Basketball Association (NBA), which this study aims to do. Hypothesis: Increased media scrutiny and public awareness, in addition to the institution of a league-wide concussion protocol, may have resulted in more conservative return-to-play practices. Study Design: Descriptive epidemiology study. Methods: All concussions to NBA players that were publicly reported in the media from the beginning of the 2006 NBA season to the end of the 2014 season were included. The incidence and return-to-play statistics were generated by synthesizing information from publicly available records. Results: There were 134 publicly reported concussions to NBA players from the beginning of the 2006 season to the conclusion of the 2014 season, resulting in an average of 14.9 concussions per season. The incidence has not changed significantly during this time span. The average games missed after a concussion from 2006 to 2010 was 1.6, significantly less than the 5.0 games missed from 2011 to 2014, following the institution of the NBA concussion protocol (P = .023). Conclusion: Although the incidence of publicly reported concussions in the NBA has not changed appreciably over the past 9 seasons, the time missed after a concussion has. While players often returned in the same game in the 2006 season, the combination of implemented policy, national coverage, medical staff awareness, and player education may have contributed to players now missing an average of 4 to 6 games after a concussion. A multitude of factors has resulted in more conservative return-to-play practices for NBA players after concussions.	[Padaki, Ajay S.; Cole, Brian J.; Ahmad, Christopher S.] Columbia Univ, New York, NY USA; [Padaki, Ajay S.; Ahmad, Christopher S.] Columbia Univ, Med Ctr, 622 West 168th St,PH 1130, New York, NY 10032 USA; [Cole, Brian J.] Rush Univ, Med Ctr, Dept Orthopaed, Chicago, IL 60612 USA	Ahmad, CS (corresponding author), Columbia Univ, Med Ctr, 622 West 168th St,PH 1130, New York, NY 10032 USA.	csa4@columbia.edu	Cole, Brian/K-4268-2019; Padaki, Ajay/AAB-8358-2020	Ahmad, Christopher S./0000-0001-9235-5228; Padaki, Ajay/0000-0002-2124-0340			Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Broglio SP, 2009, SPORTS HEALTH, V1, P361, DOI 10.1177/1941738109343158; Cantu RC, 2007, NEUROSURGERY, V60, P963, DOI 10.1227/01.NEU.0000255430.62291.7B; Casson IR, 2011, SPORTS HEALTH, V3, P11, DOI 10.1177/1941738110391413; Casson IR, 2010, SPORTS HEALTH, V2, P471, DOI 10.1177/1941738110383963; Covassin T, 2009, J ATHL TRAINING, V44, P400, DOI 10.4085/1062-6050-44.4.400; Dick R, 2007, J ATHL TRAINING, V42, P173; Drakos MC, 2010, SPORTS HEALTH, V2, P284, DOI 10.1177/1941738109357303; Green GA, 2015, AM J SPORT MED, V43, P1118, DOI 10.1177/0363546514568089; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Kroshus E, 2015, J ATHL TRAINING, V50, P944, DOI 10.4085/1062-6050-50.6.03; Makhni EC, 2014, PHYSICIAN SPORTSMED, V42, P154, DOI 10.3810/psm.2014.05.2067; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Shrey DW, 2011, PHYS MED REH CLIN N, V22, P577, DOI 10.1016/j.pmr.2011.08.002; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Wasserman EB, 2016, AM J SPORT MED, V44, P226, DOI 10.1177/0363546515610537; Wennberg RA, 2008, CAN J NEUROL SCI, V35, P647, DOI 10.1017/S031716710000946X; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	24	11	11	0	13	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	SEP	2016	44	9					2263	2268		10.1177/0363546516634679			6	Orthopedics; Sport Sciences	Orthopedics; Sport Sciences	DV6CU	WOS:000383019300014	27022062				2021-06-18	
J	Sawyer, Q; Vesci, B; McLeod, TCV				Sawyer, Quinton; Vesci, Brian; McLeod, Tamara C. Valovich			Physical Activity and Intermittent Postconcussion Symptoms After a Period of Symptom-Limited Physical and Cognitive Rest	JOURNAL OF ATHLETIC TRAINING			English	Article							SPORT-RELATED CONCUSSION; MANAGEMENT	Reference: Schneider KJ, Iverson GL, Emery CA, McCrory P, Herring SA, Meeuwisse WH. The effects of rest and treatment following sport-related concussion: a systematic review of the literature. Br J Sports Med. 2013; 47(5):304-307. Clinical Question: After concussion and a period of symptom-limited physical and cognitive rest, do athletes who experience intermittent symptoms return to asymptomatic condition more quickly with physical activity than with prolonged physical rest? Data Sources: One investigator performed an individual search for each research question using the following databases: CINAHL, Cochrane Controlled Trials Registers, EMBASE, HealthSTAR, ProQuest, PsychInfo, PubMed, SPORTDiscus, and Web of Science. Search terms for rest were brain concussion, cognitive rest, mild traumatic brain injury, physical exertion, postconcussive syndrome, rehabilitation, sport-related concussion, therapy, treatment, and treatment outcome. Search terms for treatment were the same terms as for rest, as well as brain training, cervical spine, cognitive therapy, dizziness, exercise, headache, neck, pharmacotherapy, postural balance, and vertigo. The authors included peer-reviewed, published articles and abstracts and performed a citation search. Study Selection: Studies were included based on the following criteria as determined before searching: classified as original research, symptoms resulted after sport-related concussion, and investigation of the effects of either rest or treatment on symptoms. Abstracts that were excluded failed to evaluate rest, omitted sport-related concussion as the cause of symptoms, failed to evaluate a treatment's effect on sport-related concussion, or did not present original research. Data Extraction: The following data were extracted from each study that fit the selection criteria: study design; sample size; participants' demographic information (age and sex); type, duration, and intensity of treatment; key findings including effect sizes and means with 95% confidence intervals (calculated when possible using the data provided in the original study, even if not presented in the original study); and relevant comments. Main Results: The search revealed 749 articles evaluating the effects of rest and 1175 articles evaluating the effects of treatment. Of the 749 articles evaluating the effects of rest, only 2 met all the inclusion criteria. Of the 1175 articles evaluating the effects of treatment, only 10 met all the inclusion criteria. Ultimately, the authors were able to identify additional treatment articles that met the inclusion criteria, for a total of 12. The nature of the treatments and the participants differed enough that meta-analysis was not possible. One of the 2 articles that evaluated rest was a retrospective analysis of athletes that showed those who were prescribed a period of cognitive rest had a longer duration of symptoms. The other study followed athletes postconcussion who were retrospectively assigned to groups based on self-reported activity level after injury. Those who reported moderate levels of cognitive and physical exertion over the first month post-injury appeared to demonstrate improved outcomes compared with those who pursued small or large amounts of activity. Twelve studies evaluated the effects of treatment on symptoms after sport-related concussion. Various interventions were reviewed, including pharmacotherapy, light aerobic activity, graded exercise treadmill test, hyperbaric oxygen therapy, vestibular physiotherapy, and cervical spine manual therapy. Unfortunately, the authors did not report effect sizes for specific interventions, and due to the varied nature of each study and its respective treatment approach, no pooled data could be analyzed. However, a group of adolescents treated with submaximal aerobic and coordination exercises, visualization, and imagery returned to full normal physical activity at a mean duration of 4.4 weeks (95% confidence interval = 3.1, 5.7 weeks). Furthermore, a randomized controlled trial of patients experiencing persistent neck pain, dizziness, and headaches who underwent manual and physical therapy showed they were more likely to return to sport after 8 weeks of treatment. Despite the inability to pool data, the authors concluded that each treatment appeared to positively influence specific aspects of certain patients' symptoms. Conclusions: Little high-quality evidence has addressed the effects of rest and treatment after sport-related concussion. Current evidence suggests that an initial period of rest appears to be beneficial. Further research is needed to evaluate the long-term outcomes of rest (including the quality and quantity of the rest). Low levels of exercise may benefit the athlete post-injury, but additional study is required to determine the optimal timing for initiation of treatment postinjury. Patients with cervical spine or vestibular dysfunction may benefit from rehabilitation techniques targeted at their individual symptom profile to facilitate recovery. Overall, we need high-quality studies evaluating resting period, pharmacologic interventions, rehabilitative techniques, and exercise and their effects on patients slow to recover from concussion symptoms.	[Sawyer, Quinton] Phoenix Suns, 201 East Jefferson St, Phoenix, AZ 85004 USA; [Vesci, Brian] Northwestern Univ, Evanston, IL USA; [Sawyer, Quinton; Vesci, Brian; McLeod, Tamara C. Valovich] AT Still Univ, Arizona Sch Hlth Sci, Dept Interdisciplinary Hlth Sci, Mesa, AZ USA	Sawyer, Q (corresponding author), Phoenix Suns, 201 East Jefferson St, Phoenix, AZ 85004 USA.	qsawyer@atsu.edu	McLeod, Tamara/AAU-9435-2020				Diaz DS, 2014, SEMIN SPEECH LANG, V35, P204, DOI 10.1055/s-0034-1384682; DiFazio M, 2016, CLIN PEDIATR, V55, P443, DOI 10.1177/0009922815589914; Fait P, 2013, J HEAD TRAUMA REHAB, V28, P293, DOI 10.1097/HTR.0b013e3182407ace; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Leddy JJ, 2013, CURR SPORT MED REP, V12, P370, DOI 10.1249/JSR.0000000000000008; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Reddy CC, 2013, J HEAD TRAUMA REHAB, V28, P260, DOI 10.1097/HTR.0b013e318257fbc6; Register-Mihalik JK, 2013, NEUROPSYCHOL REV, V23, P300, DOI 10.1007/s11065-013-9238-1; Schneider KJ, 2013, BRIT J SPORT MED, V47, P304, DOI 10.1136/bjsports-2013-092190; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966	11	11	11	1	25	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	SEP	2016	51	9					739	742		10.4085/1062-6050-51.12.01			4	Sport Sciences	Sport Sciences	EI9WI	WOS:000392859700010	27813685	Green Published, Bronze			2021-06-18	
J	Damiano, DL; Zampieri, C; Ge, J; Acevedo, A; Dsurney, J				Damiano, Diane L.; Zampieri, Cristiane; Ge, Jie; Acevedo, Ana; Dsurney, John			Effects of a rapid-resisted elliptical training program on motor, cognitive and neurobehavioral functioning in adults with chronic traumatic brain injury	EXPERIMENTAL BRAIN RESEARCH			English	Article						Coordination; Motion; Cognition; TBI; Exercise	OLDER-ADULTS; PHYSICAL-THERAPY; EXERCISE; BALANCE; INDIVIDUALS; WALKING; IMPAIRMENT; BENEFITS; MOBILITY; DEFICITS	This small clinical trial utilized a novel rehabilitation strategy, rapid-resisted elliptical training, in an effort to increase motor, and thereby cognitive, processing speed in ambulatory individuals with traumatic brain injury (TBI). As an initial step, multimodal functional abilities were quantified and compared in 12 ambulatory adults with and 12 without TBI. After the baseline assessment, the group with TBI participated in an intensive 8-week daily exercise program using an elliptical trainer and was reassessed after completion and at an 8-week follow-up. The focus of training was on achieving a fast movement speed, and once the target was reached, resistance to motion was increased in small increments to increase intensity of muscle activation. Primary outcomes were: High-Level Mobility Assessment Tool (HiMAT), instrumented balance tests, dual-task (DT) performance and neurobehavioral questionnaires. The group with TBI had poorer movement excursion during balance tests and poorer dual-task (DT) performance. After training, balance reaction times improved and were correlated with gains in the HiMAT and DT. Sleep quality also improved and was correlated with improved depression and learning. This study illustrates how brain injury can affect multiple linked aspects of functioning and provides preliminary evidence that intensive rapid-resisted training has specific positive effects on dynamic balance and more generalized effects on sleep quality in TBI.	[Damiano, Diane L.; Zampieri, Cristiane] Dept Rehabil Med, Funct & Appl Biomech Sect, 10 Ctr Dr,Room 1-1468,MSC 1604, Bethesda, MD 20892 USA; [Ge, Jie] Univ Maryland, Sch Dent, 650 West Baltimore St, Baltimore, MD 21201 USA; [Acevedo, Ana] NIH, Dept Rehabil Med, Ctr Clin, 10 Ctr Dr,Room 1-1469,MSC 1604, Bethesda, MD 20892 USA; [Dsurney, John] NIH, Dept Rehabil Med, CNRM, Ctr Clin, 10 Ctr Dr,Room 1-1468,MSC 1604, Bethesda, MD 20892 USA	Damiano, DL (corresponding author), Dept Rehabil Med, Funct & Appl Biomech Sect, 10 Ctr Dr,Room 1-1468,MSC 1604, Bethesda, MD 20892 USA.	damianod@cc.nih.gov; zampierigallac@cc.nih.gov; jie.ge@umaryland.edu; acevedoat@cc.nih.gov; john.dsurney@nih.gov			Intramural Research Program of the National Institutes of Health, Clinical Center, Rehabilitation Medicine Department [10-CC-0150]; Center for Neuroscience and Regenerative MedicineUnited States Department of Defense; CLINICAL CENTER [ZIACL060077] Funding Source: NIH RePORTER	This research was supported by the Intramural Research Program of the National Institutes of Health, Clinical Center, Rehabilitation Medicine Department (Protocol #10-CC-0150), and by the Center for Neuroscience and Regenerative Medicine.	Baker LD, 2010, ARCH NEUROL-CHICAGO, V67, P71, DOI 10.1001/archneurol.2009.307; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Bisson E, 2007, CYBERPSYCHOL BEHAV, V10, P16, DOI 10.1089/cpb.2006.9997; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1002/jts.2490080106; Bland DC, 2011, BRAIN INJURY, V25, P664, DOI 10.3109/02699052.2011.576306; Broglio SP, 2009, CLIN J SPORT MED, V19, P377, DOI 10.1097/JSM.0b013e3181b625fe; Buster T, 2013, J NEUROL PHYS THER, V37, P176, DOI 10.1097/NPT.0000000000000022; Carruthers K, 2014, TRANSL NEUROSCI, V5, P227, DOI 10.2478/s13380-014-0233-7; Chytrova G, 2008, EUR J NEUROSCI, V27, P1, DOI 10.1111/j.1460-9568.2007.05982.x; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Cooney GM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004366.pub6; Coronado Victor G, 2010, TRAUMATIC BRAIN INJU; Cotman CW, 2002, TRENDS NEUROSCI, V25, P295, DOI 10.1016/S0166-2236(02)02143-4; Dams-O'Connor K, 2014, J HEAD TRAUMA REHAB, V29, P479, DOI 10.1097/HTR.0000000000000099; Drijkoningen D, 2015, NEUROIMAGE-CLIN, V7, P240, DOI 10.1016/j.nicl.2014.12.006; Evans JJ, 2009, J INT NEUROPSYCH SOC, V15, P112, DOI 10.1017/S1355617708090152; Ghajar J, 2008, NEUROREHAB NEURAL RE, V22, P217, DOI 10.1177/1545968308315600; Grealy MA, 1999, ARCH PHYS MED REHAB, V80, P661, DOI 10.1016/S0003-9993(99)90169-7; Griesbach GS, 2011, PM&R, V3, pS64, DOI 10.1016/j.pmrj.2011.02.008; Hellweg S, 2008, BRAIN INJURY, V22, P365, DOI 10.1080/02699050801998250; Ingriselli JM, 2013, J SCI MED SPORT, V28, pS1440; Katz DI, 2004, ARCH PHYS MED REHAB, V85, P865, DOI 10.1016/j.apmr.2003.11.020; Katz-Leurer M, 2009, CLIN REHABIL, V23, P714, DOI 10.1177/0269215509335293; Kaufman KR, 2006, MED ENG PHYS, V28, P234, DOI 10.1016/j.medengphy.2005.05.005; McNamara A, 2007, NEUROIMAGE, V35, P1211, DOI 10.1016/j.neuroimage.2007.01.009; Newman Caren L, 2007, Int J Emerg Ment Health, V9, P133; Peters DM, 2014, ARCH PHYS MED REHAB, V95, P1454, DOI 10.1016/j.apmr.2014.04.006; Silsupadol P, 2009, ARCH PHYS MED REHAB, V90, P381, DOI 10.1016/j.apmr.2008.09.559; Sosnoff JJ, 2008, EXP BRAIN RES, V187, P563, DOI 10.1007/s00221-008-1324-x; Tanaka K, 2009, BRAIN COGNITION, V69, P435, DOI 10.1016/j.bandc.2008.09.008; Ustinova KI, 2015, PHYSIOTHER THEOR PR, V31, P1, DOI 10.3109/09593985.2014.945674; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; Williams GP, 2006, PHYS THER, V86, P395, DOI 10.1093/ptj/86.3.395; Wise EK, 2012, ARCH PHYS MED REHAB, V93, P1319, DOI 10.1016/j.apmr.2012.05.009	34	11	11	0	24	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0014-4819	1432-1106		EXP BRAIN RES	Exp. Brain Res.	AUG	2016	234	8					2245	2252		10.1007/s00221-016-4630-8			8	Neurosciences	Neurosciences & Neurology	DQ5RK	WOS:000379262400013	27025506	Green Accepted			2021-06-18	
J	Devine, JM; Wong, B; Gervino, E; Pascual-Leone, A; Alexander, MP				Devine, Jennifer M.; Wong, Bonnie; Gervino, Ernest; Pascual-Leone, Alvaro; Alexander, Michael P.			Independent, Community-Based Aerobic Exercise Training for People With Moderate-to-Severe Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Exercise; Rehabilitation	COGNITIVE PERFORMANCE; CONTROLLED-TRIAL; OLDER-ADULTS; QUALITY; PROGRAM; DISEASE; STROKE; RISK; LIFE	Objective: To determine whether people with moderate-to-severe traumatic brain injury (TBI) can adhere to a minimally supervised, community based, vigorous aerobic exercise program. Design: Prospective trial. Setting: Young Men's Christian Association (YMCA) facilities. Participants: Community-dwelling volunteers (N=10; 8 men, 2 women; age range, 22-49y) 6 to 15 months after moderate-to-severe TBI. Intervention: Participants received memberships to local YMCAs and brief orientations to exercise. They were then asked to independently complete >= 12 weeks of >= 3 training sessions per week, performed at 65% to 85% of maximum heart rate for >= 30 minutes per session. Participants could selfselect exercise modality, provided they met intensity and duration targets. Programmable heart rate monitors captured session intensity and duration. Main Outcome Measures: Independence with equipment and facility use and compliance with training goals (session frequency, duration, intensity, total weeks of training). Results: All participants achieved independence with equipment and facility use. All met at least 2 of 4 training goals; half met all 4 goals. Participants averaged (+/- SD) 3.3 +/- 0.7 sessions per week for 13 weeks (range, 6-24). Average SD session duration was 62 23 minutes, of which 51 22 minutes occurred at or above individuals' heart rate training targets. Conclusions: People in recovery from moderate-to-severe TBI can, with minimal guidance, perform vigorous, community-based exercise. This suggests that decentralized exercise may be logistically and economically sustainable after TBI, expanding its potential therapeutic utility and rendering longer-duration exercise studies more feasible. (C) 2016 by the American Congress of Rehabilitation Medicine	[Devine, Jennifer M.; Wong, Bonnie; Pascual-Leone, Alvaro; Alexander, Michael P.] Harvard Med Sch, Dept Neurol, Beth Israel Deaconess Med Ctr, Boston, MA USA; [Wong, Bonnie; Pascual-Leone, Alvaro] Beth Israel Deaconess Med Ctr, Div Brain Stimulat & Cognit Training, Brain Fit Club, Berenson Allen Ctr Noninvas Brain Stimulat, Boston, MA 02215 USA; [Gervino, Ernest] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Cardiol, Boston, MA USA	Devine, JM (corresponding author), Integrated Rehab Consultants, 401 North Michigan Ave,Suite 1200, Chicago, IL 60611 USA.	drdevine@irehabconsultants.com	Pascual-Leone, Alvaro/AAC-5101-2019	Pascual-Leone, Alvaro/0000-0001-8975-0382	National Institutes of Health-Harvard Clinical and Translational Science Center/Harvard Catalyst [UL1 RR025758]; Center for Integrative Medicine and Technology; Sidney-Baer Foundation; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR025758] Funding Source: NIH RePORTER	Supported by the National Institutes of Health-Harvard Clinical and Translational Science Center/Harvard Catalyst (grant no. UL1 RR025758), the Center for Integrative Medicine and Technology, and the Sidney-Baer Foundation, and by Joseph Hamilburg through his generous donation to the Berenson-Allen Center for Noninvasive Brain Stimulation at Beth Israel Deaconess Medical Center in support of this work.	Baker LD, 2010, J ALZHEIMERS DIS, V22, P569, DOI 10.3233/JAD-2010-100768; Baker LD, 2010, ARCH NEUROL-CHICAGO, V67, P71, DOI 10.1001/archneurol.2009.307; Chin LM, 2015, ARCH PHYS MED REHAB, V96, P754, DOI 10.1016/j.apmr.2014.11.009; Fiocco AJ, 2013, CAN J DIABETES, V37, P214, DOI 10.1016/j.jcjd.2013.03.369; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Hassett LM, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006123.pub2; Hoffman JM, 2010, PM&R, V2, P911, DOI 10.1016/j.pmrj.2010.06.008; Lautenschlager NT, 2008, JAMA-J AM MED ASSOC, V300, P1027, DOI 10.1001/jama.300.9.1027; Marzolini S, 2013, NEUROREHAB NEURAL RE, V27, P392, DOI 10.1177/1545968312465192; Pang MYC, 2013, CEREBROVASC DIS, V35, P7, DOI 10.1159/000346075	10	11	11	0	10	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	AUG	2016	97	8					1392	1397		10.1016/j.apmr.2016.04.015			6	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	DT1LM	WOS:000381244200022	27216223				2021-06-18	
J	Grieve, R; Sadique, Z; Gomes, M; Smith, M; Lecky, FE; Hutchinson, PJA; Menon, DK; Rowan, KM; Harrison, DA				Grieve, R.; Sadique, Z.; Gomes, M.; Smith, M.; Lecky, F. E.; Hutchinson, P. J. A.; Menon, D. K.; Rowan, K. M.; Harrison, D. A.		Risk Adjustment In Neurocritical C	An evaluation of the clinical and cost-effectiveness of alternative care locations for critically ill adult patients with acute traumatic brain injury	BRITISH JOURNAL OF NEUROSURGERY			English	Article						Cost-effectiveness analysis; neurocritical care; traumatic brain injury	SEVERE HEAD-INJURY; INTENSIVE-CARE; GUIDELINES; MANAGEMENT; VALIDATION	Background: For critically ill adult patients with acute traumatic brain injury (TBI), we assessed the clinical and cost-effectiveness of: (a) Management in dedicated neurocritical care units versus combined neuro/general critical care units within neuroscience centres. (b) Early' transfer to a neuroscience centre versus no or late' transfer for those who present at a non-neuroscience centre.Methods: The Risk Adjustment In Neurocritical care (RAIN) Study included prospective admissions following acute TBI to 67 UK adult critical care units during 2009-11. Data were collected on baseline case-mix, mortality, resource use, and at six months, Glasgow Outcome Scale Extended (GOSE), and quality of life (QOL) (EuroQol 5D-3L). We report incremental effectiveness, costs and cost per Quality-Adjusted Life Year (QALY) of the alternative care locations, adjusting for baseline differences with validated risk prediction models. We tested the robustness of results in sensitivity analyses.Findings: Dedicated neurocritical care unit patients (N=1324) had similar six-month mortality, higher QOL (mean gain 0.048, 95% CI -0.002 to 0.099) and increased average costs compared with those managed in combined neuro/general units (N=1341), with a lifetime cost per QALY gained of 14,000. Early' transfer to a neuroscience centre (N=584) was associated with lower mortality (odds ratio 0.52, 0.34-0.80), higher QOL for survivors (mean gain 0.13, 0.032-0.225), but positive incremental costs (15,001 pound, 11,123 pound to 18,880) pound compared with late or no transfer' (N=263). The lifetime cost per QALY gained for early' transfer was 11,000 pound.Conclusions: For critically ill adult patients with acute TBI, within neuroscience centres management in dedicated neurocritical care units versus combined neuro/general units led to improved QoL and higher costs, on average, but these differences were not statistically significant. This study finds that early' transfer to a neuroscience centre is associated with reduced mortality, improvement in QOL and is cost-effective.	[Grieve, R.; Sadique, Z.; Gomes, M.] London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, 15-17 Tavistock Pl, London WC1H 9SH, England; [Smith, M.] Univ Coll London Hosp NHS Fdn Trust, Natl Hosp Neurol & Neurosurg, London, England; [Lecky, F. E.] Univ Sheffield, Sch Hlth & Related Res, Sheffield, S Yorkshire, England; [Hutchinson, P. J. A.; Menon, D. K.] Univ Cambridge, Sch Clin Med, Cambridge, England; [Rowan, K. M.; Harrison, D. A.] Intens Care Natl Audit & Res Ctr, Clin Trials Unit, London, England	Grieve, R (corresponding author), London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, 15-17 Tavistock Pl, London WC1H 9SH, England.	Richard.Grieve@lshtm.ac.uk	Harrison, David A/O-4355-2018	Harrison, David A/0000-0002-9002-9098; Sadique, Zia/0000-0001-5814-0258; Gomes, Manuel/0000-0002-1428-1232; Grieve, Richard/0000-0001-8899-1301	Department of HealthEuropean Commission [SRF-2013-06-016, NIHR-RP-R3-12-013, 07/37/29, 12/35/57] Funding Source: Medline; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0601025, G106/1173] Funding Source: Medline; Economic and Social Research CouncilUK Research & Innovation (UKRI)Economic & Social Research Council (ESRC) [ES/G00188X/1] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [SRF-2013-06-016, 12/35/57, NIHR-RP-R3-12-013, NF-SI-0512-10090, 07/37/29] Funding Source: researchfish		ANDREWS PJD, 1990, LANCET, V335, P327, DOI 10.1016/0140-6736(90)90614-B; Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Barratt H, 2010, EMERG MED J, V27, P173, DOI 10.1136/emj.2009.075382; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Centers for Disease Control and Prevention, 2010, TRAUMATIC BRAIN INJU; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; Department of Health, 2011, NHS REF COSTS 2010 2; Dolan P, 1999, 138 CHE U YORK; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; Faul M, 2007, J TRAUMA, V63, P1271, DOI 10.1097/TA.0b013e3181493080; Fuller G, 2011, J NEUROSURG ANESTH, V23, P198, DOI 10.1097/ANA.0b013e3182161816; GENTLEMAN D, 1981, LANCET, V2, P853; Harrison DA, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17230; Harrison DA, 2015, J NEUROTRAUM, V32, P1522, DOI 10.1089/neu.2014.3628; Ibrahim MI, 2007, ASIAN J SURG, V30, P261, DOI 10.1016/S1015-9584(08)60036-6; Jacobsson LJ, 2010, BRAIN INJURY, V24, P1075, DOI 10.3109/02699052.2010.494590; Latimer N, 2011, NICE DSU TECHNICAL S; McMillan TM, 2011, J NEUROL NEUROSUR PS, V82, P931, DOI 10.1136/jnnp.2010.222232; National Collaborating Centre for Acute Care (UK), 2007, HEAD INJ TRIAG ASS I; NHS Information Standards Board, 2007, PAED CRIT CAR MIN DA; *OFF NAT STAT, 2011, INT LIF TABL 2008 20; Park CA, 2001, AM SURGEON, V67, P665; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Rubin DB., 1987, MULTIPLE IMPUTATION; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Teig M, 2010, J NEUROSURG ANESTH, V22, P357, DOI 10.1097/ANA.0b013e3181f0dada	30	11	11	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.	AUG	2016	30	4					388	396		10.3109/02688697.2016.1161166			9	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	DT3NG	WOS:000381387400004	27188663	Green Accepted			2021-06-18	
J	Pajoumand, M; Kufera, JA; Bonds, BW; Devabhakthuni, S; Boswell, S; Hesselton, K; Scalea, TM; Stein, DM				Pajoumand, Mehrnaz; Kufera, Joseph A.; Bonds, Brandon W.; Devabhakthuni, Sandeep; Boswell, Sharon; Hesselton, Kathleen; Scalea, Thomas M.; Stein, Deborah M.			Dexmedetomidine as an adjunct for sedation in patients with traumatic brain injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Dexmedetomidine; intensive care unit (ICU); sedation; traumatic brain injury	CRITICALLY-ILL PATIENTS; CEREBRAL-BLOOD-FLOW; SEVERE HEAD-INJURY; INTENSIVE-CARE; PROPOFOL INFUSION; TERM SEDATION; MIDAZOLAM; AGONIST; SURGERY; SAFETY	BACKGROUND: In patients with traumatic brain injury (TBI), optimizing sedation is challenging because maintaining a clinical examination is important in being able to detect neurological deterioration. Propofol (PROP) is frequently used as a sedative in TBI since it has been shown to reduce the cerebral metabolic rate, but it may lead to PROP-related infusion syndrome and hemodynamic compromise. Dexmedetomidine (DEX) is a sedative that produces minimal respiratory depression with opioid-sparing effects. The purpose of this study was to determine whether sedation with DEX would be safe in patients with severe TBI. METHODS: This prospective observational single-center study was conducted from 2011 to 2013. Patients with severe TBI were treated according to standard of care per the Brain Trauma Foundation guidelines. Sedative agents were titrated using the Richmond Agitation Sedation Scale (RASS) while maintaining intracranial pressure of less than 20 mm Hg and cerebral perfusion pressure of greater than 60 mm Hg. The primary outcome measure was the mean time in target RASS (0 = alert and calm to -2 = light sedation). RESULTS: A total of 198 patients were enrolled in the study. Patient-days (1,028 in total) were stratified into four groups: DEX only (n = 222), DEX + PROP (n = 148), PROP only (n = 599), and NEITHER (n = 59). Regression analyses indicated a significant difference in target RASS between sedative agents (p = 0.001). The DEX-only group had the highest adjusted mean daily estimate of 16.0 hours in target RASS. Hypotension was significantly higher in both the DEX only (p = 0.01) and DEX + PROP (p = 0.01) groups than in the PROP-only group. CONCLUSIONS: Dexmedetomidine was found to be associated with significantly more hypotension. Therefore, larger studies are needed to identify the role of DEX in TBI. Copyright (C) 2016 Wolters Kluwer Health, Inc. All rights reserved.	[Pajoumand, Mehrnaz] Univ Maryland, Med Ctr, Baltimore, MD 21201 USA; [Devabhakthuni, Sandeep] Univ Maryland, Sch Pharm, Baltimore, MD 21201 USA; [Kufera, Joseph A.; Bonds, Brandon W.; Boswell, Sharon; Hesselton, Kathleen; Scalea, Thomas M.; Stein, Deborah M.] Univ Maryland, Sch Med, R Adams Cowley Shock Trauma Ctr, Baltimore, MD 21201 USA	Stein, DM (corresponding author), Univ Maryland, Sch Med, R Adams Cowley Shock Trauma Ctr, Dept Surg, 22 S Greene St, Baltimore, MD 21201 USA.	dstein@umm.edu		Stein, Deborah/0000-0003-3683-3963	Hospira, Inc.	M.P. and D.M.S. received an educational grant from Hospira, Inc. The other authors declare no conflicts of interest.	Aryan HE, 2006, BRAIN INJURY, V20, P791, DOI 10.1080/02699050600789447; BLOOR BC, 1992, ANESTHESIOLOGY, V77, P1134, DOI 10.1097/00000542-199212000-00014; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS55; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS71; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Corbett SM, 2008, PHARMACOTHERAPY, V28, P250, DOI 10.1592/phco.28.2.250; Devabhakthuni S, 2011, J TRAUMA, V71, P1164, DOI 10.1097/TA.0b013e3182147670; Ebert TJ, 2000, ANESTHESIOLOGY, V93, P382, DOI 10.1097/00000542-200008000-00016; Erdman MJ, 2014, CRIT CARE MED, V42, P1696, DOI 10.1097/CCM.0000000000000328; FALE A, 1994, ANESTH ANALG, V79, P892; FARLING PA, 1989, ANAESTHESIA, V44, P222, DOI 10.1111/j.1365-2044.1989.tb11228.x; Fong JJ, 2008, CRIT CARE MED, V36, P2281, DOI 10.1097/CCM.0b013e318180c1eb; Grof TM, 2010, NEUROCRIT CARE, V12, P356, DOI 10.1007/s12028-008-9156-x; Herr DL, 2003, J CARDIOTHOR VASC AN, V17, P576, DOI 10.1016/S1053-0770(03)00200-3; Herregods L, 1988, Anaesthesia, V43 Suppl, P107, DOI 10.1111/j.1365-2044.1988.tb09089.x; Ho KM, 2012, ANAESTH INTENS CARE, V40, P927, DOI 10.1177/0310057X1204000603; Ice CJ, 2016, ANESTH ANALG, V122, P462, DOI 10.1213/ANE.0000000000001125; Jakob SM, 2012, JAMA-J AM MED ASSOC, V307, P1151, DOI 10.1001/jama.2012.304; KALLIO A, 1989, CLIN PHARMACOL THER, V46, P33, DOI 10.1038/clpt.1989.103; Keating GM, 2015, DRUGS, V75, P1119, DOI 10.1007/s40265-015-0419-5; Kelly DF, 1999, J NEUROSURG, V90, P1042, DOI 10.3171/jns.1999.90.6.1042; Pandharipande PP, 2007, JAMA-J AM MED ASSOC, V298, P2644, DOI 10.1001/jama.298.22.2644; PINAUD M, 1990, ANESTHESIOLOGY, V73, P404, DOI 10.1097/00000542-199009000-00007; Riker RR, 2009, JAMA-J AM MED ASSOC, V301, P489, DOI 10.1001/jama.2009.56; Roberts DJ, 2011, CRIT CARE MED, V39, P2743, DOI 10.1097/CCM.0b013e318228236f; Ropper AH, 2012, NEW ENGL J MED, V367, P2539, DOI 10.1056/NEJMe1212289; Ruokonen E, 2009, INTENS CARE MED, V35, P282, DOI 10.1007/s00134-008-1296-0; Shehabi Y, 2009, ANESTHESIOLOGY, V111, P1075, DOI 10.1097/ALN.0b013e3181b6a783; Srivastava U, 2014, INDIAN J CRIT CARE M, V18, P431, DOI 10.4103/0972-5229.136071; STEWART L, 1994, ACTA NEUROCHIR, P544; Talke P, 1997, ANESTH ANALG, V85, P1136, DOI 10.1097/00000539-199711000-00033; Tang JF, 2011, NEUROCRIT CARE, V15, P175, DOI 10.1007/s12028-009-9315-8; Urwin SC, 2004, DRUG SAFETY, V27, P107, DOI 10.2165/00002018-200427020-00003; Wang XM, 2013, BRAIN INJURY, V27, P1617, DOI 10.3109/02699052.2013.831130; ZORNOW MH, 1992, ANESTH ANALG, V75, P232	36	11	12	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	AUG	2016	81	2					345	351		10.1097/TA.0000000000001069			7	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	DS5CE	WOS:000380797300020	27116413				2021-06-18	
J	Park, S; Davis, AE				Park, Soohyun; Davis, Alice E.			Effectiveness of direct and non-direct auditory stimulation on coma arousal after traumatic brain injury	INTERNATIONAL JOURNAL OF NURSING PRACTICE			English	Article						auditory stimulation; brain injuries; coma; direct; non-direct	CONSCIOUSNESS; SCALE	The aim of this study was to evaluate the effect of direct and non-direct auditory stimulation on arousal in coma patients with severe traumatic brain injury and to compare the effects of direct vs. non-direct auditory stimulation. A crossover intervention study design was used. Nine participants who were comatose after a severe traumatic brain injury underwent direct and non-direct auditory stimulation. Direct auditory stimulation requires a higher level of interpersonal interaction between the patient and stimuli such as voices of family members, orientation by a nurse or family member and familiar music. In contrast, non-direct auditory stimuli were characterized as more general, less familiar, less interactive, indirect and not lively such as general music and TV sounds. Participants received both direct and non-direct auditory stimulation in randomized order for 15 minutes. Recovery of consciousness was measured with the Glasgow Coma Scale (GCS) and Sensory Stimulation Assessment Measure (SSAM). The Friedman test with post hoc analysis by Wilcoxon's signed-rank test comparisons was used for data analysis. Patients who received both direct and non-direct auditory stimulation exhibited significantly increased GCS (p=0.008) and SSAM scores (p=0.008) over baseline. The improvement in SSAM scores after direct auditory stimulation was significantly greater than that after non-direct auditory stimulation (p=0.021), but there was no statistically significant difference in GCS scores (p=0.139). Auditory stimulation, in particular direct auditory stimulation, might be useful for improving the recovery of consciousness and increasing the arousal of comatose patients. The SSAM is more useful for detecting subtle changes from stimulation intervention than the GCS.	[Park, Soohyun] Eulji Univ, Dept Nursing, 553 Sanseong Daero, Songnam 13135, Gyeonggi Do, South Korea; [Davis, Alice E.] Univ Hawaii, Sch Nursing, Hilo, HI 96720 USA	Park, S (corresponding author), Eulji Univ, Dept Nursing, 553 Sanseong Daero, Songnam 13135, Gyeonggi Do, South Korea.	soohyunp@eulji.ac.kr					Abbasi M, 2009, JPN J NURS SCI, V6, P21, DOI 10.1111/j.1742-7924.2009.00117.x; Abbate Carlo, 2014, Front Hum Neurosci, V8, P616, DOI 10.3389/fnhum.2014.00616; Cheng L, 2013, BMC NEUROLOGY, V18, P13; Davis Alice E, 2003, J Neurosci Nurs, V35, P202; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Gorji MAH, 2014, SAUDI J ANAESTH, V8, P69, DOI 10.4103/1658-354X.125940; HALL M E, 1992, Brain Injury, V6, P435, DOI 10.3109/02699059209008139; Heinz Ute E, 2015, BMC Res Notes, V8, P243, DOI 10.1186/s13104-015-1175-z; Hotz GA, 2006, BRAIN INJURY, V20, P879, DOI 10.1080/02699050600832635; Javouhey E, 2006, ACCIDENT ANAL PREV, V38, P225, DOI 10.1016/j.aap.2005.08.001; JONES R, 1994, ARCH PHYS MED REHAB, V75, P164; Lombardi F, 2002, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD001427; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Majerus S, 2005, PROG BRAIN RES, V150, P397, DOI 10.1016/S0079-6123(05)50028-1; Mandeep Kumar P, 2012, INT J HEAD NECK SURG, V3, P137; McNett Molly, 2007, J Neurosci Nurs, V39, P68; Megha M, 2013, BRAIN INJURY, V27, P570, DOI 10.3109/02699052.2013.767937; Pape TLB, 2015, NEUROREHAB NEURAL RE, V29, P537, DOI 10.1177/1545968314554626; Rader M A, 1989, Brain Inj, V3, P141, DOI 10.3109/02699058909004545; Rader MA, 1994, SENSORY STIMULATION; Ross SE, 1998, J TRAUMA, V45, P42, DOI 10.1097/00005373-199807000-00008; Sadaka F, 2012, NEUROCRIT CARE, V16, P95, DOI 10.1007/s12028-011-9617-5; Sanchez-Sanchez MM, 2014, ENFERM INTENSIV, V25, P15, DOI 10.1016/j.enfi.2013.09.002; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Urbenjaphol P, 2009, J NEUROSCI NURSING, V41, pE10, DOI DOI 10.1097/JNN.0B013E3181A23E94; Wright DW, 2013, MMWR-MORBID MORTAL W, V62, P549	26	11	12	0	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1322-7114	1440-172X		INT J NURS PRACT	Int. J. Nurs. Pract.	AUG	2016	22	4					391	396		10.1111/ijn.12448			6	Nursing	Nursing	DV9NE	WOS:000383266700011	27241789				2021-06-18	
J	Shariatgorji, M; Nilsson, A; Bonta, M; Gan, JR; Marklund, N; Clausen, F; Kallback, P; Loden, H; Limbeck, A; Andren, PE				Shariatgorji, Mohammadreza; Nilsson, Anna; Bonta, Maximilian; Gan, Jinrui; Marklund, Niklas; Clausen, Fredrik; Kallback, Patrik; Loden, Henrik; Limbeck, Andreas; Andren, Per E.			Direct imaging of elemental distributions in tissue sections by laser ablation mass spectrometry	METHODS			English	Article						Brain; Kidney; Elemental imaging; Mass spectrometry; Laser ablation; Inductively coupled plasma	LA-ICP-MS; CALCIUM-ACCUMULATION; BIOLOGICAL TISSUES; CEREBRAL-ISCHEMIA; HIGH-RESOLUTION; TRACE-ELEMENTS; THIN-SECTION; ION; SAMPLES; SODIUM	We present a strategy for imaging of elements in biological tissues using laser ablation (LA) mass spectrometry (MS), which was compared to laser ablation inductively coupled plasma (LA-ICP) MS. Both methods were adopted for quantitative imaging of elements in mouse kidney, as well as traumatic brain injury model tissue sections. MS imaging (MSI) employing LA provides quantitative data by comparing signal abundances of sodium from tissues to those obtained by imaging quantitation calibration standards of the target element applied to adjacent control tissue sections. LA-ICP MSI provided quantitative data for several essential elements in both brain and kidney tissue sections using a dried-droplet approach. Both methods were used to image a rat model of traumatic brain injury, revealing accumulations of sodium and calcium in the impact area and its peripheral regions. LA MSI is shown to be a viable option for quantitative imaging of specific elements in biological tissue sections. (C) 2016 Elsevier Inc. All rights reserved.	[Shariatgorji, Mohammadreza; Nilsson, Anna; Gan, Jinrui; Kallback, Patrik; Loden, Henrik; Andren, Per E.] Uppsala Univ, Dept Pharmaceut Biosci, Biomol Imaging & Prote, Box 591 BMC, SE-75124 Uppsala, Sweden; [Bonta, Maximilian; Limbeck, Andreas] TU Wien, Inst Chem Technol & Analyt, Vienna, Austria; [Gan, Jinrui] Fudan Univ, Dept Chem, Inst Biomed Sci, Shanghai, Peoples R China; [Gan, Jinrui] Fudan Univ, State Key Lab Mol Engn Polymers, Shanghai, Peoples R China; [Marklund, Niklas; Clausen, Fredrik] Uppsala Univ, Univ Uppsala Hosp, Dept Neurosci, Neurosurg, Uppsala, Sweden	Andren, PE (corresponding author), Uppsala Univ, Dept Pharmaceut Biosci, Biomol Imaging & Prote, Box 591 BMC, SE-75124 Uppsala, Sweden.	per.andren@farmbio.uu.se		Shariatgorji, Reza/0000-0001-9484-0921; Clausen, Fredrik/0000-0003-3592-4417; Andren, Per/0000-0002-4062-7743; Kallback, Patrik/0000-0003-2621-136X; Marklund, Niklas/0000-0002-9797-5626; Limbeck, Andreas/0000-0001-5042-2445	Swedish Research Council (Medicine and Health)Swedish Research Council [2013-3105]; Swedish Research Council (Natural and Engineering Science)Swedish Research Council [2014-6215]; Swedish Brain Foundation; Swedish Foundation for Strategic ResearchSwedish Foundation for Strategic Research [RIF14-0078]; China Scholarship CouncilChina Scholarship Council	This work was supported by the Swedish Research Council (Medicine and Health #2013-3105, Natural and Engineering Science #2014-6215), the Swedish Brain Foundation, the Swedish Foundation for Strategic Research (#RIF14-0078) (to P.E.A.) and the China Scholarship Council (to J.G.).	Becker JS, 2013, J MASS SPECTROM, V48, P255, DOI 10.1002/jms.3168; Becker JS, 2007, ANAL CHEM, V79, P6074, DOI 10.1021/ac0700528; Becker JS, 2008, SPECTROCHIM ACTA B, V63, P1248, DOI 10.1016/j.sab.2008.08.001; Becker JS, 2007, J ANAL ATOM SPECTROM, V22, P736, DOI 10.1039/b701558e; Becker JS, 2005, ANAL CHEM, V77, P3208, DOI 10.1021/ac040184q; Becker JS, 2005, J ANAL ATOM SPECTROM, V20, P912, DOI 10.1039/b504978b; BETZ AL, 1994, J CEREBR BLOOD F MET, V14, P29, DOI 10.1038/jcbfm.1994.5; BICKLER PE, 1994, BRAIN RES, V665, P269, DOI 10.1016/0006-8993(94)91347-1; Boada FE, 2012, TRANSL STROKE RES, V3, P236, DOI 10.1007/s12975-012-0168-7; Bonta M, 2016, ANAL CHIM ACTA, V908, P54, DOI 10.1016/j.aca.2015.12.048; Bonta M, 2014, J ANAL ATOM SPECTROM, V29, P2159, DOI 10.1039/c4ja00245h; Caprioli RM, 1997, ANAL CHEM, V69, P4751, DOI 10.1021/ac970888i; Chandra S, 2003, APPL SURF SCI, V203, P679, DOI 10.1016/S0169-4332(02)00790-0; CHANDRA S, 1995, INT J MASS SPECTROM, V143, P161, DOI 10.1016/0168-1176(94)04134-S; Chumbley CW, 2016, ANAL CHEM, V88, P2392, DOI 10.1021/acs.analchem.5b04409; DESHPANDE JK, 1987, J CEREBR BLOOD F MET, V7, P89, DOI 10.1038/jcbfm.1987.13; Edelson-Averbukh M, 2006, ANAL CHEM, V78, P1249, DOI 10.1021/ac051649v; Haraguchi H, 2004, J ANAL ATOM SPECTROM, V19, P5, DOI 10.1039/b308213j; Isaure MP, 2006, SPECTROCHIM ACTA B, V61, P1242, DOI 10.1016/j.sab.2006.10.009; ITO U, 1979, STROKE, V10, P542, DOI 10.1161/01.STR.10.5.542; Jones SC, 2006, STROKE, V37, P883, DOI 10.1161/01.STR.0000198845.79254.0f; Kallback P, 2012, J PROTEOMICS, V75, P4941, DOI 10.1016/j.jprot.2012.07.034; Kindness A, 2003, CLIN CHEM, V49, P1916, DOI 10.1373/clinchem.2003.022046; Leung S, 2011, ADV BIOM ENG, P45; Lobinski R, 2006, BIOCHIMIE, V88, P1591, DOI 10.1016/j.biochi.2006.10.003; Mai FD, 2006, APPL SURF SCI, V252, P6809, DOI 10.1016/j.apsusc.2006.02.227; Margui E, 2009, TRAC-TREND ANAL CHEM, V28, P362, DOI 10.1016/j.trac.2008.11.011; McDonnell LA, 2006, J AM SOC MASS SPECTR, V17, P1195, DOI 10.1016/j.jasms.2006.05.003; Moore KL, 2013, SURF INTERFACE ANAL, V45, P309, DOI 10.1002/sia.4903; NIEHUIS E, 1989, SURF INTERFACE ANAL, V14, P135, DOI 10.1002/sia.740140307; Nilsson A, 2015, ANAL CHEM, V87, P1437, DOI 10.1021/ac504734s; Nilsson A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011411; Norris JL, 2013, CHEM REV, V113, P2309, DOI 10.1021/cr3004295; Shariatgorji M, 2014, NEUROPSYCHOPHARMACOL, V39, P34, DOI 10.1038/npp.2013.215; Spengler B, 2002, J AM SOC MASS SPECTR, V13, P735, DOI 10.1016/S1044-0305(02)00376-8; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Werner M, 1995, CLIN CHIM ACTA, V243, P101; Wu B, 2009, TALANTA, V78, P132, DOI 10.1016/j.talanta.2008.10.061; Yushmanov VE, 2013, BRAIN RES, V1527, P199, DOI 10.1016/j.brainres.2013.06.012	39	11	11	0	51	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1046-2023	1095-9130		METHODS	Methods	JUL 15	2016	104						86	92		10.1016/j.ymeth.2016.05.021			7	Biochemical Research Methods; Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	DS0PN	WOS:000380299300012	27263025				2021-06-18	
J	Widerstrom-Noga, E; Govind, V; Adcock, JP; Levin, BE; Maudsley, AA				Widerstrom-Noga, Eva; Govind, Varan; Adcock, James P.; Levin, Bonnie E.; Maudsley, Andrew A.			Subacute Pain after Traumatic Brain Injury Is Associated with Lower Insular N-Acetylaspartate Concentrations	JOURNAL OF NEUROTRAUMA			English	Article						biomarkers; central pain; MRI spectroscopy; N-acetylaspartate; traumatic brain injury	BECK DEPRESSION INVENTORY; CHRONIC BACK-PAIN; MAGNETIC-RESONANCE-SPECTROSCOPY; NEUROPATHIC PAIN; GRAY-MATTER; PSYCHOMETRIC PROPERTIES; WHITE-MATTER; CORTEX; ANXIETY; ABNORMALITIES	Persistent pain is experienced by more than 50% of persons who sustain a traumatic brain injury (TBI), and more than 30% experience significant pain as early as 6 weeks after injury. Although neuropathic pain is a common consequence after CNS injuries, little attention has been given to neuropathic pain symptoms after TBI. Magnetic resonance spectroscopy (MRS) studies in subjects with TBI show decreased brain concentrations of N-acetylaspartate (NAA), a marker of neuronal density and viability. Although decreased brain NAA has been associated with neuropathic pain associated with spinal cord injury (SCI) and diabetes, this relationship has not been examined after TBI. The primary purpose of this study was to test the hypothesis that lower NAA concentrations in brain areas involved in pain perception and modulation would be associated with greater severity of neuropathic pain symptoms. Participants with TBI underwent volumetric MRS, pain and psychosocial interviews. Cluster analysis of the Neuropathic Pain Symptom Inventory subscores resulted in two TBI subgroups: The Moderate Neuropathic Pain (n = 17; 37.8%), with significantly (p = 0.038) lower insular NAA than the Low or no Neuropathic Pain group (n = 28; 62.2%), or age-and sex-matched controls (n = 45; p < 0.001). A hierarchical linear regression analysis controlling for age, sex, and time post-TBI showed that pain severity was significantly (F = 11.0; p < 0.001) predicted by a combination of lower insular NAA/Creatine (p < 0.001), lower right insular gray matter fractional volume (p < 0.001), female sex (p = 0.005), and older age (p = 0.039). These findings suggest that neuronal dysfunction in brain areas involved in pain processing is associated with pain after TBI.	[Widerstrom-Noga, Eva; Adcock, James P.] Miami Project Cure Paralysis, Miami, FL USA; [Widerstrom-Noga, Eva] Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami, FL 33136 USA; [Widerstrom-Noga, Eva] Univ Miami, Miller Sch Med, Dept Phys Med & Rehabil, Miami, FL 33136 USA; [Govind, Varan; Maudsley, Andrew A.] Univ Miami, Miller Sch Med, Dept Radiol, Miami, FL 33136 USA; [Levin, Bonnie E.] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA	Widerstrom-Noga, E (corresponding author), Miami Project Cure Paralysis R48, 1095 NW 14th Terrace, Miami, FL 33136 USA.	EWiderstrom-Noga@med.miami.edu		Widerstrom-Noga, Eva/0000-0003-0208-3658; Maudsley, Andrew/0000-0001-7653-3063	NIBIB NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R01 EB016064] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS055107] Funding Source: Medline; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R01EB016064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS055107] Funding Source: NIH RePORTER		Apkarian AV, 2009, PROG NEUROBIOL, V87, P81, DOI 10.1016/j.pneurobio.2008.09.018; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Apkarian AV, 2004, J NEUROSCI, V24, P10410, DOI 10.1523/JNEUROSCI.2541-04.2004; As-Sanie S, 2012, PAIN, V153, P1006, DOI 10.1016/j.pain.2012.01.032; Baliki MN, 2009, J NEUROPHYSIOL, V101, P875, DOI 10.1152/jn.91100.2008; Baliki MN, 2006, J NEUROSCI, V26, P12165, DOI 10.1523/JNEUROSCI.3576-06.2006; Baliki MN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026010; BASBAUM AI, 1978, ANN NEUROL, V4, P451, DOI 10.1002/ana.410040511; Beck A.T., 1990, MANUAL BECK ANXIETY; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Bittner DM, 2013, J ALZHEIMERS DIS, V36, P155, DOI 10.3233/JAD-120778; Bouhassira D, 2004, PAIN, V108, P248, DOI 10.1016/j.pain.2003.12.024; Brooks JCW, 2005, NEUROIMAGE, V27, P201, DOI 10.1016/j.neuroimage.2005.03.041; Burkey AR, 1999, J NEUROSCI, V19, P4169; Chang L, 1999, NEUROLOGY, V52, P100, DOI 10.1212/WNL.52.1.100; Chang LD, 2013, J NEUROIMMUNE PHARM, V8, P576, DOI 10.1007/s11481-013-9460-x; Clarke DE, 2007, INT J METH PSYCH RES, V16, P97, DOI 10.1002/mpr.207; Collins DL, 1998, IEEE T MED IMAGING, V17, P463, DOI 10.1109/42.712135; Davis KD, 2008, NEUROLOGY, V70, P153, DOI 10.1212/01.wnl.0000295509.30630.10; Dawson DR, 2007, DISABIL REHABIL, V29, P301, DOI 10.1080/09638280600756687; Derbyshire SWG, 1997, PAIN, V73, P431, DOI 10.1016/S0304-3959(97)00138-3; DESTEFANO N, 1995, MAGN RESON MED, V34, P721; Dick BD, 2007, ANESTH ANALG, V104, P1223, DOI 10.1213/01.ane.0000263280.49786.f5; Folstein MS, 2010, MINIMENTAL STATE EXA; Fukui S, 2006, MAGN RESON IMAGING, V24, P75, DOI 10.1016/j.mri.2005.10.021; FYDRICH T, 1992, J ANXIETY DISORD, V6, P55, DOI 10.1016/0887-6185(92)90026-4; Geha PY, 2008, NEURON, V60, P570, DOI 10.1016/j.neuron.2008.08.022; Glodzik L, 2015, J ALZHEIMERS DIS, V43, P939, DOI 10.3233/JAD-140609; Gore M, 2012, SPINE, V37, pE668, DOI 10.1097/BRS.0b013e318241e5de; Govindaraju V, 2000, NMR BIOMED, V13, P129, DOI 10.1002/1099-1492(200005)13:3<129::AID-NBM619>3.0.CO;2-V; Grachev ID, 2002, J NEURAL TRANSM, V109, P1309, DOI 10.1007/s00702-002-0722-7; Grachev ID, 2000, PAIN, V89, P7, DOI 10.1016/S0304-3959(00)00340-7; Gu T, 2008, NEUROL RES, V30, P229, DOI 10.1179/016164107X235473; Gustin SM, 2014, PAIN, V155, P1027, DOI 10.1016/j.pain.2014.02.008; Gustin SM, 2010, CEREB CORTEX, V20, P1409, DOI 10.1093/cercor/bhp205; Haanpaa M, 2011, PAIN, V152, P14, DOI 10.1016/j.pain.2010.07.031; Harris NG, 2010, J NEUROPATH EXP NEUR, V69, P139, DOI 10.1097/NEN.0b013e3181cb5bee; Hartvigsen Jan, 2014, Arch Phys Med Rehabil, V95, pS286, DOI 10.1016/j.apmr.2013.07.029; Henderson LA, 2008, NEUROIMAGE, V39, P1867, DOI 10.1016/j.neuroimage.2007.10.045; Jensen TS, 2011, PAIN, V152, P2204, DOI 10.1016/j.pain.2011.06.017; Kashani JH, 1999, J AFFECT DISORDERS, V52, P269, DOI 10.1016/S0165-0327(98)00055-X; KERNS RD, 1985, PAIN, V23, P345, DOI 10.1016/0304-3959(85)90004-1; Kim JH, 2015, J HEAD TRAUMA REHAB, V30, pE40, DOI 10.1097/HTR.0000000000000121; Klit H, 2009, LANCET NEUROL, V8, P857, DOI 10.1016/S1474-4422(09)70176-0; Lahz S, 1996, ARCH PHYS MED REHAB, V77, P889, DOI 10.1016/S0003-9993(96)90275-0; Lavigne G, 2015, PAIN, V156, pS75, DOI 10.1097/j.pain.0000000000000111; Levin BE, 2014, J NEUROIMAGING, V24, P39, DOI 10.1111/j.1552-6569.2012.00733.x; Li XY, 2010, SCIENCE, V330, P1400, DOI 10.1126/science.1191792; Lin AP, 2012, BRAIN IMAGING BEHAV, V6, P208, DOI 10.1007/s11682-012-9181-4; Lindsay WR, 2007, J APPL RES INTELLECT, V20, P401, DOI 10.1111/j.1468-3148.2007.00380.x; Lutz J, 2008, ARTHRITIS RHEUM-US, V58, P3960, DOI 10.1002/art.24070; Marin R.S., 1996, SEMIN CLIN NEUROPSYC, V1, P304, DOI [10.1053/SCNP00100304, DOI 10.1053/SCNP00100304]; Maudsley AA, 2006, NMR BIOMED, V19, P492, DOI 10.1002/nbm.1025; Maudsley AA, 2009, MAGN RESON MED, V61, P548, DOI 10.1002/mrm.21875; May A, 2008, PAIN, V137, P7, DOI 10.1016/j.pain.2008.02.034; Mazzola L, 2009, PAIN, V146, P99, DOI 10.1016/j.pain.2009.07.014; Mazzola L, 2012, BRAIN, V135, P631, DOI 10.1093/brain/awr265; Metz AE, 2009, P NATL ACAD SCI USA, V106, P2423, DOI 10.1073/pnas.0809897106; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Mole TB, 2014, NEUROIMAGE-CLIN, V5, P28, DOI 10.1016/j.nicl.2014.05.014; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; [National Hospital Discharge Survey (NHDS) National Hospital Ambulatory Medical Care Survey (NHAMCS) National Vital Statistics System (NVSS)], 2010, ALL DAT SOURC AR MAI; Obermann M, 2009, NEUROLOGY, V73, P978, DOI 10.1212/WNL.0b013e3181b8791a; Ofek H, 2007, PAIN, V131, P330, DOI 10.1016/j.pain.2007.06.015; Ostrowsky K, 2002, CEREB CORTEX, V12, P376, DOI 10.1093/cercor/12.4.376; Park K, 2013, FUTUR NEUROL, V8, P555, DOI 10.2217/FNL.13.35; Pattany PM, 2002, AM J NEURORADIOL, V23, P901; Pleis John R, 2010, Vital Health Stat 10, P1; Qiu S, 2014, J NEUROSCI, V34, P13505, DOI 10.1523/JNEUROSCI.1431-14.2014; Rigotti DJ, 2012, NEUROLOGY, V78, P1383, DOI 10.1212/WNL.0b013e318253d609; ROBERTS MHT, 1991, SYMP PAIN R, P219; Rodriguez-Raecke R, 2009, J NEUROSCI, V29, P13746, DOI 10.1523/JNEUROSCI.3687-09.2009; Scheff SW, 2005, J NEUROTRAUM, V22, P719, DOI 10.1089/neu.2005.22.719; Schmidt-Wilcke T, 2006, PAIN, V125, P89, DOI 10.1016/j.pain.2006.05.004; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Semchenko V V, 2006, Neurosci Behav Physiol, V36, P613, DOI 10.1007/s11055-006-0065-1; Seminowicz DA, 2011, J NEUROSCI, V31, P7540, DOI 10.1523/JNEUROSCI.5280-10.2011; Seminowicz DA, 2010, GASTROENTEROLOGY, V139, P48, DOI 10.1053/j.gastro.2010.03.049; Sherer M, 2014, ARCH PHYS MED REHAB, V95, P1162, DOI [10.1016/j.apmr.2014.02.006, 10.1016/j.apmr.2013.06.004]; Siddall PJ, 2003, PAIN, V103, P249, DOI 10.1016/S0304-3959(02)00452-9; Signoretti S, 2001, J NEUROTRAUM, V18, P977, DOI 10.1089/08977150152693683; Sorensen L, 2008, DIABETES CARE, V31, P980, DOI 10.2337/dc07-2088; Starr CJ, 2009, J NEUROSCI, V29, P2684, DOI 10.1523/JNEUROSCI.5173-08.2009; Steer RA, 2001, PSYCHOL REP, V88, P1075, DOI 10.2466/PR0.88.4.1075-1076; Sullivan-Singh SJ, 2014, ARCH PHYS MED REHAB, V95, P1100, DOI 10.1016/j.apmr.2014.02.001; Tenovuo O, 2007, PAIN, V131, P241, DOI 10.1016/j.pain.2007.07.003; Tham SW, 2013, J PAIN, V14, P1242, DOI 10.1016/j.jpain.2013.05.007; Turk DC, 2003, PAIN, V106, P337, DOI 10.1016/j.pain.2003.08.001; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vagnozzi R, 2013, J HEAD TRAUMA REHAB, V28, P284, DOI 10.1097/HTR.0b013e3182795045; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; von Hehn CA, 2012, NEURON, V73, P638, DOI 10.1016/j.neuron.2012.02.008; Wang Y, 1998, MAGNET RESON MED, V39, P28, DOI 10.1002/mrm.1910390107; Widerstrom-Noga E, 2015, PAIN, V156, P166, DOI 10.1016/j.pain.0000000000000019; Widerstrom-Noga E, 2013, PAIN, V154, P204, DOI 10.1016/j.pain.2012.07.022; Williamson MLC, 2013, BRAIN INJURY, V27, P992, DOI 10.3109/02699052.2013.801512; Younger JW, 2010, PAIN, V149, P222, DOI 10.1016/j.pain.2010.01.006; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	100	11	11	1	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 15	2016	33	14					1380	1389		10.1089/neu.2015.4098			10	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	DQ5CX	WOS:000379223100010	26486760	Green Published			2021-06-18	
J	Feldman, JL; Freitas, AL				Feldman, Julia L.; Freitas, Antonio L.			An Investigation of the Reliability and Self-Regulatory Correlates of Conflict Adaptation	EXPERIMENTAL PSYCHOLOGY			English	Article						cognitive control; conflict adaptation; self-regulation; individual differences	COGNITIVE CONTROL ADJUSTMENTS; TRAUMATIC BRAIN-INJURY; EXECUTIVE CONTROL; FLANKER TASK; EVENT FILES; PERFORMANCE; IMPULSIVITY; MODEL; INDIVIDUALS; INTEGRATION	The study of the conflict-adaptation effect, in which encountering information-processing conflict attenuates the disruptive influence of information-processing conflicts encountered subsequently, is a burgeoning area of research. The present study investigated associations among performance measures on a Stroop-trajectory task (measuring Stroop interference and conflict adaptation), on a Wisconsin Card Sorting Task (WCST; measuring cognitive flexibility), and on self-reported measures of self-regulation (including impulsivity and tenacity). We found significant reliability of the conflict-adaptation effects across a two-week period, for response-time and accuracy. Variability in conflict adaptation was not associated significantly with any indicators of performance on the WCST or with most of the self-reported self-regulation measures. There was substantial covariance between Stroop interference for accuracy and conflict adaptation for accuracy. The lack of evidence of covariance across distinct aspects of cognitive control (conflict adaptation, WCST performance, self-reported self-control) may reflect the operation of relatively independent component processes.	[Feldman, Julia L.; Freitas, Antonio L.] SUNY Stony Brook, Stony Brook, NY 11794 USA	Feldman, JL (corresponding author), SUNY Stony Brook, Dept Psychol, Stony Brook, NY 11790 USA.	Julia.Feldman@stonybrook.edu					Abrahamse E, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00179; ARNETT PA, 1994, NEUROLOGY, V44, P420, DOI 10.1212/WNL.44.3_Part_1.420; Baddeley A, 1996, Q J EXP PSYCHOL-A, V49, P5; Billieux J, 2007, ADDICT BEHAV, V32, P1189, DOI 10.1016/j.addbeh.2006.08.007; Billieux J, 2008, PERS INDIV DIFFER, V44, P1432, DOI 10.1016/j.paid.2007.12.011; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Brown JW, 2007, COGNITIVE PSYCHOL, V55, P37, DOI 10.1016/j.cogpsych.2006.09.005; Bugg JM, 2008, MEM COGNITION, V36, P1217, DOI 10.3758/MC.36.7.1217; Clawson A, 2013, PSYCHOPHYSIOLOGY, V50, P711, DOI 10.1111/psyp.12066; Clayson PE, 2013, PSYCHOPHYSIOLOGY, V50, P1209, DOI 10.1111/psyp.12138; Clayson PE, 2012, PSYCHOPHYSIOLOGY, V49, P627, DOI 10.1111/j.1469-8986.2011.01345.x; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Desender K, 2014, PSYCHOL SCI, V25, P675, DOI 10.1177/0956797613511468; DONCHIN E, 1988, BEHAV BRAIN SCI, V11, P357, DOI 10.1017/S0140525X00058027; Duckworth AL, 2007, J PERS SOC PSYCHOL, V92, P1087, DOI 10.1037/0022-3514.92.6.1087; Duncker K, 1945, PSYCHOL MONOGR, V58, P1; Duthoo W, 2014, PSYCHOL RES-PSYCH FO, V78, P483, DOI 10.1007/s00426-013-0498-4; Duthoo W, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01001; Freitas AL, 2015, PSYCHOL RES-PSYCH FO, V79, P143, DOI 10.1007/s00426-014-0540-1; Freitas AL, 2009, PSYCHOPHYSIOLOGY, V46, P1226, DOI 10.1111/j.1469-8986.2009.00864.x; Funes MJ, 2010, COGN NEUROPSYCHOL, V27, P360, DOI 10.1080/02643294.2010.532618; GRANT DA, 1948, J EXP PSYCHOL, V38, P404, DOI 10.1037/h0059831; Hommel B, 2004, TRENDS COGN SCI, V8, P494, DOI 10.1016/j.tics.2004.08.007; Hommel B, 1998, VIS COGN, V5, P183, DOI 10.1080/713756773; Kan IP, 2013, COGNITION, V129, P637, DOI 10.1016/j.cognition.2013.09.001; Keye D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00947; Keye D, 2009, PSYCHOL RES-PSYCH FO, V73, P762, DOI 10.1007/s00426-008-0188-9; Kim S, 2014, ACTA PSYCHOL, V149, P60, DOI 10.1016/j.actpsy.2014.03.004; Kopp B, 1996, PSYCHOPHYSIOLOGY, V33, P282, DOI 10.1111/j.1469-8986.1996.tb00425.x; KORNBLUM S, 1990, PSYCHOL REV, V97, P253, DOI 10.1037/0033-295X.97.2.253; Larson MJ, 2013, BIOL PSYCHOL, V94, P408, DOI 10.1016/j.biopsycho.2013.08.006; Larson MJ, 2011, INT J PSYCHOPHYSIOL, V82, P69, DOI 10.1016/j.ijpsycho.2011.02.018; Larson MJ, 2009, J INT NEUROPSYCH SOC, V15, P927, DOI 10.1017/S1355617709990701; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Mayr U, 2003, NAT NEUROSCI, V6, P450, DOI 10.1038/nn1051; Mayr U, 2009, PSYCHOL RES-PSYCH FO, V73, P794, DOI 10.1007/s00426-008-0191-1; Miyake A., 1999, MODELS WORKING MEMOR; NEILL WT, 1992, J EXP PSYCHOL LEARN, V18, P993, DOI 10.1037/0278-7393.18.5.993; Nolen-Hoeksema S, 2000, J ABNORM PSYCHOL, V109, P504, DOI 10.1037/0021-843X.109.3.504; Rustamov N, 2013, NEUROPSYCHOLOGIA, V51, P2976, DOI 10.1016/j.neuropsychologia.2013.10.025; Schmidt JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102337; Schmidt JR, 2013, PSYCHON B REV, V20, P615, DOI 10.3758/s13423-012-0373-0; Schmidt JR, 2011, ACTA PSYCHOL, V138, P176, DOI 10.1016/j.actpsy.2011.06.002; Spieler DH, 1996, J EXP PSYCHOL HUMAN, V22, P461, DOI 10.1037/0096-1523.22.2.461; Stratta P, 2000, SCHIZOPHR RES, V44, P57, DOI 10.1016/S0920-9964(99)00142-5; Streeter CC, 2008, NEUROPSYCHOPHARMACOL, V33, P827, DOI 10.1038/sj.npp.1301465; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Tangney JP, 2004, J PERS, V72, P271, DOI 10.1111/j.0022-3506.2004.00263.x; TIPPER SP, 1985, Q J EXP PSYCHOL-A, V37, P571, DOI 10.1080/14640748508400920; Treynor W, 2003, COGNITIVE THER RES, V27, P247, DOI 10.1023/A:1023910315561; Verplanken B, 2003, J APPL SOC PSYCHOL, V33, P1313, DOI 10.1111/j.1559-1816.2003.tb01951.x; Verplanken B, 2007, J PERS SOC PSYCHOL, V92, P526, DOI 10.1037/0022-3514.92.3.526; WAGNER M, 1981, PERCEPT PSYCHOPHYS, V29, P359, DOI 10.3758/BF03207345; Weissman DH, 2014, J EXP PSYCHOL HUMAN, V40, P2022, DOI 10.1037/a0037454; Whiteside SP, 2001, PERS INDIV DIFFER, V30, P669, DOI 10.1016/S0191-8869(00)00064-7; ZAJONC RB, 1968, J PERS SOC PSYCHOL, V9, P1, DOI 10.1037/h0025848	56	11	11	0	10	HOGREFE & HUBER PUBLISHERS	GOTTINGEN	MERKELSTR 3, D-37085 GOTTINGEN, GERMANY	1618-3169	2190-5142		EXP PSYCHOL	Exp. Psychol.	JUL	2016	63	4					237	247		10.1027/1618-3169/a000328			11	Psychology, Experimental	Psychology	EA7DH	WOS:000386788400003	27750519				2021-06-18	
J	Li, W; Long, JA; Watts, L; Shen, Q; Liu, YC; Jiang, Z; Duong, TQ				Li, Wei; Long, Justin Alexander; Watts, Lora; Shen, Qiang; Liu, Yichu; Jiang, Zhao; Duong, Timothy Q.			Spatiotemporal changes in diffusion, T-2 and susceptibility of white matter following mild traumatic brain injury	NMR IN BIOMEDICINE			English	Article						traumatic brain injury; white matter; quantitative susceptibility mapping; diffusion tensor imaging; T-2 mapping	MAGNETIC-FIELD; MRI; PHASE; VIVO; RECOVERY; COSMOS; MYELIN; ORDER	Impaired white matter integrity in traumatic brain injury (TBI) can lead to deficits in various neurological functions. The differentiation of the underlying pathological processes, e.g. edema, demyelination, axonal damage, to name a few, is of key clinical interest for the assessment of white matter injury. In this study, a combination of T-2, diffusion and susceptibility MRI was used to study the spatiotemporal changes in white matter at 1h, 3h, and 1, 2, 7 and 14days following TBI, using a rat controlled cortical impact (CCI) model. Based on radial diffusivity (RD), the rats were divided into two groups: group 1 showed widespread increases in RD along the corpus callosum of the ipsilesional hemisphere at day 2, and group 2 showed normal RD. Based on this group separation, group 1 also showed similar widespread changes in fractional anisotropy (FA) and T-2 at day 2, and group 2 showed normal FA and T-2. The widespread changes in RD and T-2 in group 1 on day 2 were apparently dominated by edema, which obscured possible myelin and axonal damage. In contrast, the susceptibility of group 1 showed more localized increases near the impact site on day 2, and otherwise similar contrast to the contralesional hemisphere. The localized susceptibility increase is probably a result of demyelination and axonal injury. The extent of brain damage between the two groups revealed by MRI was consistent with behavioral results, with the first group showing significantly increased forelimb asymmetry and increased forelimb foot fault deficits. Our results suggest that the combination of T-2, diffusion and susceptibility MRI may provide an opportunity for the differential assessment of edema and axonal damage in TBI. Copyright (c) 2016 John Wiley & Sons, Ltd.	[Li, Wei; Long, Justin Alexander; Watts, Lora; Shen, Qiang; Liu, Yichu; Jiang, Zhao; Duong, Timothy Q.] Univ Texas Hlth Sci Ctr San Antonio, Res Imaging Inst, San Antonio, TX 78229 USA; [Li, Wei; Duong, Timothy Q.] Univ Texas Hlth Sci Ctr San Antonio, Dept Ophthalmol, San Antonio, TX 78229 USA; [Watts, Lora] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Watts, Lora] Univ Texas Hlth Sci Ctr San Antonio, Dept Neurol, San Antonio, TX 78229 USA	Duong, TQ (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Res Imaging Inst, Dept Ophthalmol, San Antonio, TX 78229 USA.	duongt@uthscsa.edu	Shen, Qiang/B-8784-2008; Duong, Tim/AAL-8357-2021	Shen, Qiang/0000-0002-4287-3403; Duong, Tim/0000-0001-6403-2827; jiang, zhao/0000-0002-8192-9908	National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS 45879]; National Center for Advancing Translational Sciences, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2T001118]; Clinical Translational Science Awards (CTSA) [UL1TR001119]; William & Ella Owens Medical Research Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001120, TL1TR001119, KL2TR001118] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS045879] Funding Source: NIH RePORTER	This work was supported in part by the National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS) R01NS 45879 (T.Q.D.). The project described was also supported by the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant KL2T001118 (L.W.). W.L. was also supported in part by UL1TR001119 via the Clinical Translational Science Awards (CTSA), and a research grant from William & Ella Owens Medical Research Foundation.	Argyridis L, 2014, NEUROIMAGE, V88, P134, DOI 10.1016/j.neuroimage.2013.11.026; Ashikaga R, 1997, NEURORADIOLOGY, V39, P239, DOI 10.1007/s002340050401; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; de Rochefort L, 2010, MAGN RESON MED, V63, P194, DOI 10.1002/mrm.22187; Faul M, 2010, TRAUMATIC BRAIN INJU, P2; GO KG, 1975, ARCH NEUROL-CHICAGO, V32, P462, DOI 10.1001/archneur.1975.00490490066006; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kressler B, 2010, IEEE T MED IMAGING, V29, P273, DOI 10.1109/TMI.2009.2023787; Lee J, 2012, NEUROIMAGE, V59, P3967, DOI 10.1016/j.neuroimage.2011.10.076; Li W, 2013, P 1 ACM WORKSH COGN, P21; Li Wei, 2013, J Neurosci Neuroeng, V2, P431; Li W, 2014, HUM BRAIN MAPP, V35, P2698, DOI 10.1002/hbm.22360; Li W, 2014, NMR BIOMED, V27, P219, DOI 10.1002/nbm.3056; Li W, 2012, NEUROIMAGE, V59, P2088, DOI 10.1016/j.neuroimage.2011.10.038; Li W, 2011, NEUROIMAGE, V55, P1645, DOI 10.1016/j.neuroimage.2010.11.088; Liu CL, 2015, J MAGN RESON IMAGING, V42, P23, DOI [10.1002/jmri.24768, 10.3969/j.issn.1001-2400.2015.01.004]; Liu CL, 2012, NEUROIMAGE, V59, P1290, DOI 10.1016/j.neuroimage.2011.07.096; Liu CL, 2011, NEUROIMAGE, V56, P930, DOI 10.1016/j.neuroimage.2011.02.024; Liu CL, 2010, MAGN RESON MED, V63, P1471, DOI 10.1002/mrm.22482; Liu CL, 2010, MAGN RESON MED, V63, P243, DOI 10.1002/mrm.22192; Liu T, 2011, MAGN RESON MED, V66, P777, DOI 10.1002/mrm.22816; Liu T, 2009, MAGN RESON MED, V61, P196, DOI 10.1002/mrm.21828; Lodygensky GA, 2012, NEUROIMAGE, V59, P1979, DOI 10.1016/j.neuroimage.2011.09.057; Long JA, 2015, J NEUROTRAUM, V32, P598, DOI 10.1089/neu.2014.3563; LOUNILA J, 1994, PHYS REV LETT, V72, P4049, DOI 10.1103/PhysRevLett.72.4049; Matsushima GK, 2001, BRAIN PATHOL, V11, P107; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Park KJ, 2014, J CEREBR BLOOD F MET, V34, P357, DOI 10.1038/jcbfm.2013.216; Pu HJ, 2013, J CEREBR BLOOD F MET, V33, P1474, DOI 10.1038/jcbfm.2013.108; Sati P, 2013, NEUROIMAGE, V77, P268, DOI 10.1016/j.neuroimage.2013.03.005; Schmued L, 2008, BRAIN RES, V1229, P210, DOI 10.1016/j.brainres.2008.06.129; Schweser F, 2011, NEUROIMAGE, V54, P2789, DOI 10.1016/j.neuroimage.2010.10.070; Shen Q, 2004, J CEREBR BLOOD F MET, V24, P887, DOI 10.1097/01.WCB.0000124321.60992.87; Shmueli K, 2009, MAGN RESON MED, V62, P1510, DOI 10.1002/mrm.22135; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Stalnacke BM, 2005, J REHABIL MED, V37, P300, DOI 10.1080/16501970510032910; Wang Y, 2015, MAGN RESON MED, V73, P82, DOI 10.1002/mrm.25358; Wang Y, 2011, BRAIN, V134, P3587, DOI 10.1093/brain/awr307; Watts LT, 2014, J NEUROTRAUM, V31, P1063, DOI 10.1089/neu.2013.3193; Wharton S, 2010, MAGN RESON MED, V63, P1292, DOI 10.1002/mrm.22334; Wharton S, 2015, MAGN RESON MED, V73, P1258, DOI 10.1002/mrm.25189; Wharton S, 2012, P NATL ACAD SCI USA, V109, P18559, DOI 10.1073/pnas.1211075109; Wu B, 2012, MAGN RESON MED, V67, P137, DOI 10.1002/mrm.23000	48	11	11	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0952-3480	1099-1492		NMR BIOMED	NMR Biomed.	JUL	2016	29	7					896	903		10.1002/nbm.3536			8	Biophysics; Radiology, Nuclear Medicine & Medical Imaging; Spectroscopy	Biophysics; Radiology, Nuclear Medicine & Medical Imaging; Spectroscopy	DQ2JM	WOS:000379028600005	27149577	Green Accepted			2021-06-18	
J	Yi, MN; Dou, FF; Lu, Q; Yu, ZH; Chen, HZ				Yi, Mengni; Dou, Fangfang; Lu, Qin; Yu, Zhihua; Chen, Hongzhuan			Activation of the KCa3.1 channel contributes to traumatic scratch injury-induced reactive astrogliosis through the JNK/c-Jun signaling pathway	NEUROSCIENCE LETTERS			English	Article						Astrocytes; Migration; Calcium; KCa3.1; Reactivity	SPINAL-CORD-INJURY; K+ CHANNELS; IN-VIVO; MIGRATION; ASTROCYTES; INHIBITION; EXPRESSION; CELLS; MODEL; PROTECTION	Reactive astrogliosis is widely considered to contribute to pathogenic responses to stress and brain injury and to diseases as diverse as ischemia and neurodegeneration. We previously found that expression of the intermediate-conductance calcium-activated potassium channel (KCa3.1) involved in TGF-beta-activated astrogliosis. In the present study, we investigated whether migration of cortical astrocytes following mechanical scratch injury involves the KCa3.1 channel, which contributes to Ca2+ -mediated migration in other cells. We found that scratch injury increased the expression of KCa3.1 protein in reactive astrocytes. Application of the KCa3.1 blocker TRAM-34 decreased glial fibrillary acidic protein (GFAP) expression and slowed migration in a concentration-dependent manner. Application of the Ca2+ chelators, EGTA and BAPTA-AM, also slowed the migration of astrocytes. Blockade or genetic deletion of KCa3.1 both slowed and dramatically reduced the scratch injuries induced the sharp rise in astrocytes Ca2+ concentrations. The scratch injury-induced phosphorylation of JNK and c-Jun proteins was also attenuated both by blockade of KCa3.1 with TRAM-34 and in KCa3.1(-/-) astrocytes. Using KCa3.1 knockout mice, we further confirmed that deletion of KCa3.1 reduced expression of GFAP in an in vivo stab wound model. Taken together, our findings highlight a novel role for KCa3.1 in phenotypic modulation of reactive astrocytes and in astrocyte mobilization in response to mechanical stress, providing a potential target for therapeutic intervention in brain injuries. (C) 2016 Elsevier Ireland Ltd. All rights reserved.	[Yi, Mengni; Lu, Qin; Yu, Zhihua; Chen, Hongzhuan] Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Dept Pharmacol, 280 South Chongqing Rd, Shanghai 200025, Peoples R China; [Dou, Fangfang] Shanghai Univ Tradit Chinese Med, Shanghai Geriatr Inst Chinese Med, Longhua Hosp, Cent Lab, Shanghai 200031, Peoples R China	Yu, ZH; Chen, HZ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Dept Pharmacol, 280 South Chongqing Rd, Shanghai 200025, Peoples R China.	yuzhihua@shsmu.edu.cn; hongzhuan_chen@hotmail.com			Science and Technology Commission of Shanghai MunicipalityScience & Technology Commission of Shanghai Municipality (STCSM) [16ZR1418700]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81102491]	This work was supported by Science and Technology Commission of Shanghai Municipality grant 16ZR1418700 and National Natural Science Foundation of China grant 81102491. The authors declare no competing financial interests.	Bouhy D, 2011, J NEUROSCI, V31, P16298, DOI 10.1523/JNEUROSCI.0047-11.2011; Bradding P, 2009, BRIT J PHARMACOL, V157, P1330, DOI 10.1111/j.1476-5381.2009.00362.x; Buffo A, 2005, P NATL ACAD SCI USA, V102, P18183, DOI 10.1073/pnas.0506535102; Chimote AA, 2013, J IMMUNOL, V191, P6273, DOI 10.4049/jimmunol.1300702; Cruse G, 2011, J ALLERGY CLIN IMMUN, V128, P1303, DOI 10.1016/j.jaci.2011.07.047; Ferreira R, 2014, FRONT CELL NEUROSCI, V8, DOI [10.3389/fncel.2014.00183, 10.3389/fncel.2014.0018]; Gao K, 2013, GLIA, V61, P2063, DOI 10.1002/glia.22577; Joiner WJ, 1997, P NATL ACAD SCI USA, V94, P11013, DOI 10.1073/pnas.94.20.11013; Lanosa XA, 2007, IN VITRO CELL DEV-AN, V43, P186, DOI 10.1007/s11626-007-9038-0; Maezawa I, 2011, J BIOL CHEM, V286, P3693, DOI 10.1074/jbc.M110.135244; Matzner N, 2008, J IMMUNOL, V181, P6803, DOI 10.4049/jimmunol.181.10.6803; Petzold GC, 2011, NEURON, V71, P782, DOI 10.1016/j.neuron.2011.08.009; Renault-Mihara F, 2008, INT J BIOCHEM CELL B, V40, P1649, DOI 10.1016/j.biocel.2008.03.009; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SCHWAB A, 1994, J CLIN INVEST, V93, P1631, DOI 10.1172/JCI117144; Schwab A, 2007, PFLUG ARCH EUR J PHY, V453, P421, DOI 10.1007/s00424-006-0138-6; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Takarada-Iemata M, 2014, J NEUROCHEM, V130, P374, DOI 10.1111/jnc.12729; Turner KL, 2014, CEREB CORTEX, V24, P2388, DOI 10.1093/cercor/bht090; YU ACH, 1993, J NEUROSCI RES, V34, P295, DOI 10.1002/jnr.490340306; Yu ZH, 2014, J NEUROCHEM, V130, P41, DOI 10.1111/jnc.12710; Zhu Z, 2007, GLIA, V55, P546, DOI 10.1002/glia.20476	23	11	13	0	9	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	JUN 15	2016	624						62	71		10.1016/j.neulet.2016.05.004			10	Neurosciences	Neurosciences & Neurology	DP3YV	WOS:000378433200010	27163196				2021-06-18	
J	Cusimano, MD; Ilie, G; Mullen, SJ; Pauley, CR; Stulberg, JR; Topolovec-Vranic, J; Zhang, S				Cusimano, Michael D.; Ilie, Gabriela; Mullen, Sarah J.; Pauley, Christopher R.; Stulberg, Jennifer R.; Topolovec-Vranic, Jane; Zhang, Stanley			Aggression, Violence and Injury in Minor League Ice Hockey: Avenues for Prevention of Injury	PLOS ONE			English	Article							BODY-CHECKING; BRAIN-INJURY; CONCUSSION EDUCATION; BAYESIAN NETWORK; YOUTH HOCKEY; RISK-FACTORS; SPORT; PSYCHOLOGY; BEHAVIOR; PLAYERS	Background In North America, more than 800,000 youth are registered in organized ice hockey leagues. Despite the many benefits of involvement, young players are at significant risk for injury. Body-checking and aggressive play are associated with high frequency of game-related injury including concussion. We conducted a qualitative study to understand why youth ice hockey players engage in aggressive, injury-prone behaviours on the ice. Methods Semi-structured interviews were conducted with 61 minor ice hockey participants, including male and female players, parents, coaches, trainers, managers and a game official. Players were aged 13-15 playing on competitive body checking teams or on non-body checking teams. Interviews were manually transcribed, coded and analyzed for themes relating to aggressive play in minor ice hockey. Results Parents, coaches, teammates and the media exert a large influence on player behavior. Aggressive behavior is often reinforced by the player's social environment and justified by players to demonstrate loyalty to teammates and especially injured teammates by seeking revenge particularly in competitive, body-checking leagues. Among female and male players in non-body checking organizations, aggressive play is not reinforced by the social environment. These findings are discussed within the framework of social identity theory and social learning theory, in order to understand players' need to seek revenge and how the social environment reinforces aggressive behaviors. Conclusion This study provides a better understanding of the players' motivations and environmental influences around aggressive and violent play which may be conducive to injury. The findings can be used to help design interventions aimed at reducing aggression and related injuries sustained during ice hockey and sports with similar cultures and rules.	[Cusimano, Michael D.; Mullen, Sarah J.; Pauley, Christopher R.; Zhang, Stanley] St Michaels Hosp, Injury Prevent Res Off, Dept Surg, Div Neurosurg, 30 Bond St, Toronto, ON M5B 1W8, Canada; [Ilie, Gabriela] Dalhousie Univ, Fac Med, Dept Community Hlth & Epidemiol, Halifax, NS, Canada; [Stulberg, Jennifer R.] Univ Toronto, Family & Community Med, Toronto, ON, Canada; [Topolovec-Vranic, Jane] Univ Toronto, Fac Med, Occupat Sci & Occupat Therapy, Toronto, ON, Canada	Cusimano, MD (corresponding author), St Michaels Hosp, Injury Prevent Res Off, Dept Surg, Div Neurosurg, 30 Bond St, Toronto, ON M5B 1W8, Canada.	cusimanom@smh.ca	Topolovec-Vranic, Jane/A-5293-2013; Ilie, Gabriela/AAM-9122-2021; Cusimano, Michael/X-4059-2019	Topolovec-Vranic, Jane/0000-0001-7695-4212; 	Canadian Institutes of Health Research Strategic Team Grant [TIR-103946]; Ontario Neurotrauma Foundation; St. Michael's Hospital Foundation	This research was supported by the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html) Strategic Team Grant in Applied Injury Research #TIR-103946, the Ontario Neurotrauma Foundation (http://onf.org), as well as the St. Michael's Hospital Foundation (http://www.stmichaelsfoundation.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida PL, 2014, REV PSICOL DEPORTE, V23, P395; Anderson E., 2010, SPORT THEORY AND SOC; [Anonymous], 2012, CULTURE; Arnold E, 2002, WHOSE PUCK IS IT ANY; BANDURA A, 1978, J COMMUN, V28, P12, DOI 10.1111/j.1460-2466.1978.tb01621.x; BAUMEISTER RF, 1995, PSYCHOL BULL, V117, P497, DOI 10.1037/0033-2909.117.3.497; Bawa H BM, 2004, SPORTS RELATED INJUR; Beddoes-Jones F., 2004, TRAINING JOURNAL, V16; Borrego Carla Chicau, 2012, J Hum Kinet, V34, P119, DOI 10.2478/v10078-012-0071-z; Bortoli L, 2012, PSYCHOL SPORT EXERC, V13, P397, DOI 10.1016/j.psychsport.2012.01.001; Bronfenbrenner U., 1988, PERS CONTEXT, V2, P25, DOI DOI 10.1017/CB09780511663949.003; Bruner MW, 2015, J APPL SPORT PSYCHOL, V27, P351, DOI 10.1080/10413200.2015.1010661; Bruner MW, 2013, GROUP DYN-THEOR RES, V17, P30, DOI 10.1037/a0030114; BRUST JD, 1992, AM J DIS CHILD, V146, P741, DOI 10.1001/archpedi.1992.02160180101026; Carron AV, 1982, JOURNAL OF SPORT PSY; Celozzi MJ, 1981, JOURNAL OF SPORT BEH; Chalabaev A, 2013, PSYCHOL SPORT EXERC, V14, P136, DOI 10.1016/j.psychsport.2012.10.005; Chapman J., 2006, MANAGE DECIS, V44, P1391, DOI DOI 10.1108/00251740610715713; Cohen J, 1977, STATISTICAL POWER AN; Cope CJ, 2011, INT J SPORT EXERC PS, V9, P19, DOI 10.1080/1612197X.2011.563124; Cusimano MD, 2012, CANADIAN MEDICAL ASS; Cusimano MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061865; Cusimano Michael D, 2011, Open Med, V5, pe57; DeMatteo CA, 2010, PEDIATRICS, V125, P327, DOI 10.1542/peds.2008-2720; Demorest Rebecca A, 2003, Curr Sports Med Rep, V2, P337; Echlin PS, 2014, J NEUROSURG, V121, P1331, DOI 10.3171/2014.8.JNS132804; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10186; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.10.FOCUS10222; Emery CA, 2006, AM J SPORT MED, V34, P1960, DOI 10.1177/0363546506290061; Emery CA, 2010, JAMA-J AM MED ASSOC, V303, P2265, DOI 10.1001/jama.2010.755; Emery CA, 2010, INJURY PREV, V16, P113, DOI 10.1136/ip.2009.022764; Emery CA, 2009, CLIN J SPORT MED, V19, P207, DOI 10.1097/JSM.0b013e31819d658e; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Ford DW, 2012, JOURNAL OF SPORT ADM, V4; Frederick EL, 2013, CONTRACT NO 1; Freedman J, 1970, AGGRESSION SOCIAL PS, P101; Fu T, 2015, CANADIAN JOURNAL OF, V42; Fuster-Parra P, 2015, HUM MOVEMENT SCI, V40, P98, DOI 10.1016/j.humov.2014.12.005; Fuster-Parra P, 2014, QUAL QUANT, V48, P1473, DOI 10.1007/s11135-013-9848-y; Gillis C., 2014, HOW PARENTS AND THEI; Gould D, 2006, BRIT J SPORT MED, V40, P632, DOI 10.1136/bjsm.2005.024927; Grindel Scott H, 2003, Curr Sports Med Rep, V2, P18, DOI 10.1249/00149619-200302000-00005; Hancock B, 1998, AN INTRODUCTION TO Q; Hardy J, 2005, SMALL GR RES, V36, P166, DOI 10.1177/1046496404266715; Honey CR, 1998, CLIN J SPORT MED, V8, P43, DOI 10.1097/00042752-199801000-00010; Ilie G, 2014, JOURNAL OF NEUROTRAU; Ilie G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094936; Ilie G, 2013, JAMA-J AM MED ASSOC, V309, P2550, DOI 10.1001/jama.2013.6750; Janis IL., 1997, GROUPTHINK; Jeffery-Tosoni S, 2015, J SPORT BEHAV, V38, P3; Juhn MS, 2002, CLIN J SPORT MED, V12, P46, DOI 10.1097/00042752-200201000-00014; Kimmel M., 1987, THE LIFE OF A MANS S, P53; Kirker B, 2000, RES Q EXERCISE SPORT, V71, P373, DOI 10.1080/02701367.2000.10608920; Kleiber DA, 1981, JOURNAL OF SPORT PSY, V3; Lacey A, 2001, TRENT FOCUS FOR RESE; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Loughead TM, 2001, JOURNAL OF SPORT BEH; Macpherson A, 2006, PEDIATRICS, V117, pE143, DOI 10.1542/peds.2005-1163; Mageau GA, 2003, J SPORT SCI, V21, P883, DOI 10.1080/0264041031000140374; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Marchie A, 2003, CAN MED ASSOC J, V169, P124; MARCOTTE G, 1993, ASTM STP, V1212, P103, DOI DOI 10.1520/STP13128S; Mugno D A, 1985, Can J Appl Sport Sci, V10, P26; NASH JE, 1981, YOUTH SOC, V13, P229, DOI 10.1177/0044118X8101300202; Patton MQ., 1990, QUALITATIVE EVALUATI; Pediatrics AAo, 2000, PEDIATRICS PT 1, V105, P657; Perry JL, 2013, ATHLETIC INSIGHT, V5, P197; R M. The Bertuzzi Incident, 2004, GLOBE MAIL; Roberts WO, 1999, PHYSICIAN SPORTSMED, V27, P35, DOI 10.3810/psm.1999.11.1102; Rothe J., 2000, UNDERTAKING QUALITAT; Rutten EA, 2007, J YOUTH ADOLESCENCE, V36, P255, DOI 10.1007/s10964-006-9085-y; Schwandt T. A., 2007, THE SAGE DICTIONARY; Shah C.P., 2003, PUBLIC HEALTH AND PR; Sheldon JP, 2001, RES Q EXERCISE SPORT, V72, P304, DOI 10.1080/02701367.2001.10608965; Shirazi M, 2015, CANADIAN JOURNAL OF, P42; Smith MD, 1979, CANADIAN JOURNAL OF, P105; Sports C., 2015, NHL HOCKEY INJURIES; Steinfeldt JA, PSYCHOLOGY OF MEN MA, V12, P324; STUART MJ, 1995, MAYO CLIN PROC, V70, P350, DOI 10.4065/70.4.350; Surveillance Epidemiology Division CfCDPPHAoC, 2014, CHRONIC DISEASES AND, V34, P272; Tajfel H, 2004, THE SOCIAL IDENTITY; Taylor S J, 1981, Monogr Am Assoc Ment Defic, P71; Toledo E, 2012, NEUROSCI BIOBEHAV R, V36, P1510, DOI 10.1016/j.neubiorev.2012.03.007; Traclet A, 2015, AGGRESSIVE BEHAV, V41, P123, DOI 10.1002/ab.21561; TUCKMAN BW, 1965, PSYCHOL BULL, V63, P384, DOI 10.1037/h0022100; Villani S, 2001, J AM ACAD CHILD PSY, V40, P392, DOI 10.1097/00004583-200104000-00007; Warsh JM, 2009, CLIN J SPORT MED, V19, P134, DOI 10.1097/JSM.0b013e3181987783; Wiese-Bjornstal DM, 2014, REV PSICOL DEPORTE, V23, P411; Wojtys EM, 2015, SPORTS HEALTH, V7, P108, DOI 10.1177/1941738115572986	89	11	12	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156683	10.1371/journal.pone.0156683			14	Multidisciplinary Sciences	Science & Technology - Other Topics	DN8ZV	WOS:000377369700103	27258426	DOAJ Gold, Green Published			2021-06-18	
J	Brandstack, N; Kurki, T; Laalo, J; Kauko, T; Tenovuo, O				Brandstack, N.; Kurki, T.; Laalo, J.; Kauko, T.; Tenovuo, O.			Reproducibility of Tract-based and Region-of-Interest DTI Analysis of Long Association Tracts	CLINICAL NEURORADIOLOGY			English	Article						Reproducibility; DTI tractography; Core ROI method; Tract-based analyses	DIFFUSION-TENSOR TRACTOGRAPHY; TRAUMATIC BRAIN-INJURY; UNCINATE FASCICULUS; RELIABILITY; MR; ABNORMALITIES; DISTORTION; INTEGRITY; 3T	Reproducibility of two different methods for quantifying fiber tracts by using a diffusion tensor imaging (DTI) sequence suitable for clinical magnetic resonance imaging (MRI) protocols was evaluated. DTI of 15 subjects was used to analyze intra-rater and inter-rater reproducibility. Another 10 subjects underwent MRI twice for assessment of between-scan reliability. Ten long association tracts were defined by fiber tracking using inclusion and exclusion regions of interest (ROIs). Whole-tract analysis and tractography-based core analysis were performed, and the effect of fractional anisotropy (FA 0.15/0.30) and turning angle threshold (27A degrees/60A degrees) on reproducibility was evaluated. Additionally, ROI measurements were performed in the core of the tracts. For the tract-based methods, intra-rater and inter-rater reliabilities of FA and mean diffusivity (MD) measurements were excellent. Between-scan reproducibility was good or excellent in 127 of 130 of the measurements. There was no systematic difference in the reproducibility of the FA, MD, and volume measurements depending on the FA or turning angle threshold. For the cross-sectional ROI measurements, reliability showed large variation from poor to excellent depending on the tract. Compared with the commonly used cross-sectional core ROI method, the tract-based analyses seem to be a more robust way to identify and measure white matter tracts of interest, and provide a novel reproducible tool to perform core analysis.	[Brandstack, N.] Helsinki Univ Hosp, Dept Radiol, PL 340, Helsinki 00029, Finland; [Kurki, T.] Terveystalo Turku Pulssi Med Ctr, Dept Radiol, Turku, Finland; [Laalo, J.] Turku Univ Hosp, Dept Radiol, PL 52, Turku 20521, Finland; [Kauko, T.] Univ Turku, Dept Biostat, Turku, Finland; [Tenovuo, O.] Turku Univ Hosp, Dept Neurol, PL 52, Turku 20521, Finland	Brandstack, N (corresponding author), Helsinki Univ Hosp, Dept Radiol, PL 340, Helsinki 00029, Finland.	nina.brandstack@hus.fi		Kurki, Timo/0000-0001-5532-3534			Alexander AL, 2006, NEUROIMAG CLIN N AM, V16, P299, DOI 10.1016/j.nic.2006.02.006; Bisdas S, 2008, AM J NEURORADIOL, V29, P1128, DOI 10.3174/ajnr.A1044; Bonekamp D, 2007, NEUROIMAGE, V34, P733, DOI 10.1016/j.neuroimage.2006.09.020; Borich MR, 2012, NEUROIMAGE, V59, P2393, DOI 10.1016/j.neuroimage.2011.09.009; Brander A, 2010, ACTA RADIOL, V51, P800, DOI 10.3109/02841851.2010.495351; Brandstack N, 2013, RADIOLOGY, V267, P231, DOI 10.1148/radiol.12112570; Chung S, 2010, NEUROIMAGE, V49, P631, DOI 10.1016/j.neuroimage.2009.06.067; Danielian LE, 2010, NEUROIMAGE, V49, P1572, DOI 10.1016/j.neuroimage.2009.08.062; Hasan KM, 2010, BRAIN STRUCT FUNCT, V214, P361, DOI 10.1007/s00429-009-0238-0; Heiervang E, 2006, NEUROIMAGE, V33, P867, DOI 10.1016/j.neuroimage.2006.07.037; Hermoye L, 2006, NEUROIMAGE, V29, P493, DOI 10.1016/j.neuroimage.2005.08.017; Hong YH, 2008, J NEUROIMAGING, V18, P282, DOI 10.1111/j.1552-6569.2007.00153.x; Kanaan RA, 2006, PSYCHIAT RES-NEUROIM, V146, P73, DOI 10.1016/j.pscychresns.2005.11.002; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kurki TJI, 2013, J MAGN RESON IMAGING, V38, P46, DOI 10.1002/jmri.23901; Ling J, 2012, HUM BRAIN MAPP, V33, P50, DOI 10.1002/hbm.21192; Malykhin N, 2008, PSYCHIAT RES-NEUROIM, V164, P132, DOI 10.1016/j.pscychresns.2007.11.007; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Netsch T, 2004, IEEE T MED IMAGING, V23, P789, DOI 10.1109/TMI.2004.827479; Ni H, 2006, AM J NEURORADIOL, V27, P1776; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Partridge SC, 2005, J MAGN RESON IMAGING, V22, P467, DOI 10.1002/jmri.20410; Portney L., 2015, FDN CLIN RES APPL PR, V3rd ed.; Rankin G, 1998, CLIN REHABIL, V12, P187, DOI 10.1191/026921598672178340; Rohde GK, 2004, MAGN RESON MED, V51, P103, DOI 10.1002/mrm.10677; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Salmond CH, 2006, NEUROIMAGE, V29, P117, DOI 10.1016/j.neuroimage.2005.07.012; Schmahmann JD, 2008, ANN NY ACAD SCI, V1142, P266, DOI 10.1196/annals.1444.017; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Snook L, 2007, NEUROIMAGE, V34, P243, DOI 10.1016/j.neuroimage.2006.07.021; Vollmar C, 2010, NEUROIMAGE, V51, P1384, DOI 10.1016/j.neuroimage.2010.03.046; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Wang JY, 2012, NEUROIMAGE, V60, P1127, DOI 10.1016/j.neuroimage.2011.12.062; Wang SM, 2005, ANN NY ACAD SCI, V1064, P61, DOI 10.1196/annals.1340.013; Yasmin H, 2008, NEURORADIOLOGY, V50, P293, DOI 10.1007/s00234-007-0353-7	35	11	12	0	9	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1869-1439	1869-1447		CLIN NEURORADIOL	Clin. Neuroradiol.	JUN	2016	26	2					199	208		10.1007/s00062-014-0349-8			10	Clinical Neurology; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	DQ2CO	WOS:000379009000010	25283182	Green Published			2021-06-18	
J	Butler, CR; Boychuk, JA; Smith, BN				Butler, Corwin R.; Boychuk, Jeffery A.; Smith, Bret N.			Differential effects of rapamycin treatment on tonic and phasic GABAergic inhibition in dentate granule cells after focal brain injury in mice	EXPERIMENTAL NEUROLOGY			English	Article						mTOR; Controlled cortical impact; Hippocampus; Inhibition; Dentate gyrus; Tonic current; Synapse; gamma-Aminobutyric acid receptors	TEMPORAL-LOBE EPILEPSY; CONTROLLED CORTICAL IMPACT; MAMMALIAN TARGET; MOUSE MODEL; POSTTRAUMATIC EPILEPSY; SOMATOSTATIN INTERNEURONS; RECURRENT EXCITATION; MEDIATED INHIBITION; SEIZURE FREQUENCY; MURINE MODEL	The cascade of events leading to post-traumatic epilepsy (PTE) after traumatic brain injury (TBI) remains unclear. Altered inhibition in the hippocampal formation and dentate gyrus is a hallmark of several neurological disorders, including TBI and PTE. Inhibitory synaptic signaling in the hippocampus is predominately driven by gamma-aminobutyric acid (GABA) neurotransmission, and is prominently mediated by postsynaptic type A GABA receptors (GABA(A)R's). Subsets of these receptors involved in tonic inhibition of neuronal membranes serve a fundamental role in maintenance of inhibitory state, and GABA(A)R-mediated tonic inhibition is altered functionally in animal models of both TBI and epilepsy. In this study, we assessed the effect of mTOR inhibition on hippocampal hilar inhibitory interneuron loss and synaptic and tonic GABAergic inhibition of dentate gyrus granule cells (DGCs) after controlled cortical impact (CO) to determine if mTOR activation after TBI modulates GABA(A)R function. Hilar inhibitory interneuron density was significantly reduced 72 h after CCI injury in the dorsal two-thirds of the hemisphere ipsilateral to injury compared with the contralateral hemisphere and sham controls. Rapamycin treatment did not alter this reduction in cell density. Synaptic and tonic current measurements made in DGCs at both 1-2 and 8-13 weeks post-injury indicated reduced synaptic inhibition and THIP-induced tonic current density in DGCs ipsilateral to CCI injury at both time points post-injury, with no change in resting tonic GABA(A)R-mediated currents. Rapamycin treatment did not alter the reduced synaptic inhibition observed in ipsilateral DGCs 1-2 weeks post-CCI injury, but further reduced synaptic inhibition of ipsilateral DGCs at 8-13 weeks post-injury. The reduction in THIP-induced tonic current after injury, however, was prevented by rapamycin treatment at both time points. Rapamycin treatment thus differentially modifies CCI-induced changes in synaptic and tonic GABA(A)R-mediated currents in DGCs. (C) 2016 Elsevier Inc. All rights reserved.	[Butler, Corwin R.; Boychuk, Jeffery A.; Smith, Bret N.] Univ Kentucky, Coll Med, Dept Physiol, MS508 Chandler Med Ctr,800 Rose St, Lexington, KY 40536 USA; [Boychuk, Jeffery A.; Smith, Bret N.] Univ Kentucky, Epilepsy Ctr, Lexington, KY 40536 USA; [Boychuk, Jeffery A.] Univ Kentucky, Ctr Adv Translat Stroke Sci, Lexington, KY 40536 USA; [Smith, Bret N.] Univ Kentucky, Spinal Cord & Brain Injury Res Ctr SCoBIRC, Lexington, KY 40536 USA	Smith, BN (corresponding author), Univ Kentucky, Coll Med, Dept Physiol, MS508 Chandler Med Ctr,800 Rose St, Lexington, KY 40536 USA.	bret.smith@uky.edu		Butler, Corwin/0000-0001-5134-4151; Boychuk, Jeffery A/0000-0002-7003-1553	Department of Defense (USAMRMC) Grant [W81XWH-11-1-0502]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS088608]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS088608] Funding Source: NIH RePORTER	This work was supported by the Department of Defense (USAMRMC) Grant W81XWH-11-1-0502 (B.N.S.) and NIH Grant NS088608 (B.N.S.).	Anderson KJ, 2005, EXP NEUROL, V193, P125, DOI 10.1016/j.expneurol.2004.11.025; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Brown N, 2002, BRIT J PHARMACOL, V136, P965, DOI 10.1038/sj.bjp.0704795; Buckmaster PS, 2011, EPILEPSIA, V52, P2057, DOI 10.1111/j.1528-1167.2011.03253.x; Buckmaster PS, 2011, J NEUROSCI, V31, P2337, DOI 10.1523/JNEUROSCI.4852-10.2011; Buckmaster PS, 2009, J NEUROSCI, V29, P8259, DOI 10.1523/JNEUROSCI.4179-08.2009; BUCKMASTER PS, 1994, EPILEPSY RES, V18, P23, DOI 10.1016/0920-1211(94)90030-2; Butler CR, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00163; CAVENESS WF, 1979, J NEUROSURG, V50, P545, DOI 10.3171/jns.1979.50.5.0545; Coulter DA, 2007, PROG BRAIN RES, V163, P235, DOI 10.1016/S0079-6123(07)63014-3; Diaz-Arrastia R, 2000, ARCH NEUROL-CHICAGO, V57, P1611, DOI 10.1001/archneur.57.11.1611; EBERT B, 1994, MOL PHARMACOL, V46, P957; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Glykys J, 2007, J PHYSIOL-LONDON, V582, P1163, DOI 10.1113/jphysiol.2007.134460; Guo DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064078; Gupta A, 2012, J NEUROSCI, V32, P2523, DOI 10.1523/JNEUROSCI.4141-11.2012; Halabisky B, 2010, J NEUROPHYSIOL, V104, P2214, DOI 10.1152/jn.00147.2010; Hall ED, 2005, J NEUROTRAUM, V22, P669, DOI 10.1089/neu.2005.22.669; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Halmos KC, 2015, NEUROSCIENCE, V306, P115, DOI 10.1016/j.neuroscience.2015.08.023; Heng K, 2013, EPILEPSIA, V54, P1535, DOI 10.1111/epi.12246; Hester MS, 2013, J NEUROSCI, V33, P8926, DOI 10.1523/JNEUROSCI.5161-12.2013; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Hudak AM, 2004, J HEAD TRAUMA REHAB, V19, P290, DOI 10.1097/00001199-200407000-00003; Hunt RF, 2012, EPILEPSY RES, V99, P167, DOI 10.1016/j.eplepsyres.2011.10.011; Hunt RF, 2011, J NEUROSCI, V31, P6880, DOI 10.1523/JNEUROSCI.0032-11.2011; Hunt RF, 2010, J NEUROPHYSIOL, V103, P1490, DOI 10.1152/jn.00957.2009; Hunt RF, 2009, EXP NEUROL, V215, P243, DOI 10.1016/j.expneurol.2008.10.005; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Mody I, 2004, TRENDS NEUROSCI, V27, P569, DOI 10.1016/j.tins.2004.07.002; Mtchedlishvili Z, 2010, NEUROBIOL DIS, V38, P464, DOI 10.1016/j.nbd.2010.03.012; Newcomb JK, 1997, J NEUROTRAUM, V14, P369, DOI 10.1089/neu.1997.14.369; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Oliva AA, 2000, J NEUROSCI, V20, P3354, DOI 10.1523/JNEUROSCI.20-09-03354.2000; Pavlov I, 2011, NEUROSCIENCE, V194, P208, DOI 10.1016/j.neuroscience.2011.07.074; Raible DJ, 2015, EXP NEUROL, V271, P445, DOI 10.1016/j.expneurol.2015.07.001; Raible DJ, 2012, J NEUROTRAUM, V29, P2548, DOI 10.1089/neu.2012.2483; Saatman KE, 2006, J NEUROTRAUM, V23, P1241, DOI 10.1089/neu.2006.23.1241; Santhakumar V, 2000, J PHYSIOL-LONDON, V524, P117, DOI 10.1111/j.1469-7793.2000.00117.x; Tabernero J, 2008, J CLIN ONCOL, V26, P1603, DOI 10.1200/JCO.2007.14.5482; Temkin N R, 1998, Adv Neurol, V76, P179; Temkin NR, 2009, EPILEPSIA, V50, P10, DOI 10.1111/j.1528-1167.2008.02005.x; Temkin NR, 2001, DRUGS, V61, P1045, DOI 10.2165/00003495-200161080-00002; Toth Z, 1997, J NEUROSCI, V17, P8106; Wang QH, 2003, NEURON, V38, P915, DOI 10.1016/S0896-6273(03)00356-8; Weston MC, 2012, J NEUROSCI, V32, P11441, DOI 10.1523/JNEUROSCI.1283-12.2012; Winokur RS, 2004, EPILEPSY RES, V58, P93, DOI 10.1016/j.eplepsyres.2004.01.002; Wuarin JP, 1996, J NEUROSCI, V16, P4438; Zeng LH, 2008, ANN NEUROL, V63, P444, DOI 10.1002/ana.21331; Zeng LH, 2009, J NEUROSCI, V29, P6964, DOI 10.1523/JNEUROSCI.0066-09.2009	50	11	11	0	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	JUN	2016	280						30	40		10.1016/j.expneurol.2016.03.022			11	Neurosciences	Neurosciences & Neurology	DL7LK	WOS:000375822000004	27018320	Green Accepted, Bronze			2021-06-18	
J	Callaway, L; Winkler, D; Tippett, A; Herd, N; Migliorini, C; Willer, B				Callaway, Libby; Winkler, Dianne; Tippett, Alice; Herd, Natalie; Migliorini, Christine; Willer, Barry			The Community Integration Questionnaire - Revised: Australian normative data and measurement of electronic social networking	AUSTRALIAN OCCUPATIONAL THERAPY JOURNAL			English	Article						community integration; social networking; social participation	TRAUMATIC-BRAIN-INJURY; EVERYDAY TECHNOLOGY USE; RESIDENTIAL AGED CARE; SPINAL-CORD-INJURY; PSYCHOMETRIC PROPERTIES; PARTICIPATION OUTCOMES; PEOPLE; INDIVIDUALS; REHABILITATION; CIQ	Background/aim: Consideration of the relationship between meaningful participation, health and wellbeing underpins occupational therapy intervention, and drives measurement of community integration following acquired brain injury (ABI). However, utility of community integration measures has been limited to date by lack of normative data against which to compare outcomes, and none examine the growing use of electronic social networking (ESN) for social participation. This research had four aims: (i) develop and pilot items assessing ESN to add to the Community Integration Questionnaire, producing the Community Integration Questionnaire-Revised (CIQ-R); (ii) examine factor structure of the CIQ-R; (iii) collect Australian CIQ-R normative data; and (iv) assess test-retest reliability of the revised measure. Methods: Setting: Australia. Participants: A convenience sample of adults without ABI (N = 124) was used to develop and pilot ESN items. A representative general population sample of adults without ABI aged 18-64 years (N = 1973) was recruited to gather normative CIQ-R data. Design: Cross-sectional survey. Main measures: Demographic items and the CIQ-R. Results: The CIQ-R demonstrated acceptable psychometric properties, with minor modification to the original scoring based on the factor analyses provided. Large representative general population CIQ-R normative data have been established, detailing contribution of a range of independent demographic variables to community integration. Conclusion: The addition of electronic social networking items to the CIQ-R offers a contemporary method of assessing community integration following ABI. Normative CIQ-R data enhance the understanding of community integration in the general population, allowing occupational therapists and other clinicians to make more meaningful comparisons between groups.	[Callaway, Libby; Migliorini, Christine] Monash Univ, Dept Occupat Therapy, POB 527, Frankston, Vic 3130, Australia; [Winkler, Dianne; Tippett, Alice] Summer Fdn Ltd, Blackburn, Vic, Australia; [Herd, Natalie] Empir Res, Melbourne, Vic, Australia; [Willer, Barry] SUNY Buffalo, Dept Psychiat Med, Buffalo, NY USA	Callaway, L (corresponding author), Monash Univ, Dept Occupat Therapy, POB 527, Frankston, Vic 3130, Australia.	libby.callaway@monash.edu		Migliorini, Christine/0000-0002-2228-9947; Winkler, Di/0000-0003-3899-6248	Transport Accident Commission (TAC) via Institute for Safety, Compensation and Recovery Research (ISCRR)	Funding for this research was provided by the Transport Accident Commission (TAC) via the Institute for Safety, Compensation and Recovery Research (ISCRR).	Arbuckle J., 2012, AMOSS 22 0 USERS GUI; Burleigh SA, 1998, AM J OCCUP THER, V52, P45, DOI 10.5014/ajot.52.1.45; CORRIGAN JD, 1995, J HEAD TRAUMA REHAB, V10, P41, DOI 10.1097/00001199-199508000-00005; Cusick CP, 2000, J HEAD TRAUMA REHAB, V15, P739, DOI 10.1097/00001199-200002000-00012; Dalemans RJ, 2010, ARCH PHYS MED REHAB, V91, P395, DOI 10.1016/j.apmr.2009.10.021; Dijkers M, 1997, J HEAD TRAUMA REHAB, V12, P74, DOI 10.1097/00001199-199712000-00007; Doig E, 2001, BRAIN INJURY, V15, P747, DOI 10.1080/02699050110034343; Esselman PC, 2001, J BURN CARE REHABIL, V22, P221, DOI 10.1097/00004630-200105000-00007; Farnworth L., 2003, AUSTR OCCUPATIONAL T, V50, P116, DOI DOI 10.1046/J.1440-1630.2003.00391.X; Forslund MV, 2013, ACTA NEUROL SCAND, V128, P220, DOI 10.1111/ane.12130; Gontkovsky ST, 2009, NEUROREHABILITATION, V24, P185, DOI 10.3233/NRE-2009-0467; Griffen JA, 2010, REHABIL PSYCHOL, V55, P292, DOI 10.1037/a0020503; Gutman S., 2000, OCCUPATIONAL THERAPY, V15, P71, DOI [10.1300/J004v15n02_05, DOI 10.1300/J004V15N02_05]; Hall KM, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199610000-00004; Hallgren M, 2011, J INTELL DISABIL RES, V55, P610, DOI 10.1111/j.1365-2788.2011.01419.x; Hirsh AT, 2011, ARCH PHYS MED REHAB, V92, P1602, DOI 10.1016/j.apmr.2011.05.004; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Huebner RA, 2003, AM J OCCUP THER, V57, P177, DOI 10.5014/ajot.57.2.177; Hutchison E. D., 2011, DIMENSIONS HUMAN BEH, V4th; Kaplan CP, 2000, AM J PHYS MED REHAB, V79, P243, DOI 10.1097/00002060-200005000-00005; Kaplan CP, 2001, BRAIN INJURY, V15, P725, DOI 10.1080/02699050010005913; Kielhofner G, 2008, MODEL HUMAN OCCUPATI; Kim H, 2010, AM J OCCUP THER, V64, P709, DOI 10.5014/ajot.2010.09188; Kratz AL, 2015, J SPINAL CORD MED, V38, P446, DOI 10.1179/2045772313Y.0000000182; Lequerica AH, 2013, J HEAD TRAUMA REHAB, V28, pE14, DOI 10.1097/HTR.0b013e31826e3ca8; Linden MA, 2005, DISABIL REHABIL, V27, P1353, DOI 10.1080/09638280500164180; McCabe P, 2007, BRAIN INJURY, V21, P231, DOI 10.1080/02699050701201631; McColl MA, 1998, BRAIN INJURY, V12, P15, DOI 10.1080/026990598122827; Negahban H, 2013, DISABIL REHABIL, V35, P1453, DOI 10.3109/09638288.2012.741653; Parvaneh S, 2012, AUST OCCUP THER J, V59, P131, DOI 10.1111/j.1440-1630.2012.01001.x; Ritchie L, 2014, ARCH PHYS MED REHAB, V95, P163, DOI 10.1016/j.apmr.2013.08.237; Rosenberg L, 2009, OTJR-OCCUP PART HEAL, V29, P52, DOI 10.3928/15394492-20090301-05; Sander AM, 1999, ARCH PHYS MED REHAB, V80, P1303, DOI 10.1016/S0003-9993(99)90034-5; Sander AM, 2010, J HEAD TRAUMA REHAB, V25, P121, DOI 10.1097/HTR.0b013e3181cd1635; Seale GS, 2002, BRAIN INJURY, V16, P955, DOI 10.1080/02699050210155258; Sendroy-Terrill M, 2010, ARCH PHYS MED REHAB, V91, P489, DOI 10.1016/j.apmr.2009.11.011; SLOAN S, 2007, BRAIN IMPAIR, V8, P251, DOI DOI 10.1375/BRIM.8.3.251; Sloan S., 2004, BRAIN IMPAIR, V5, P12, DOI DOI 10.1375/BRIM.5.1.12.35399; Sloan S, 2012, BRAIN IMPAIR, V13, P24, DOI 10.1017/BrImp.2012.5; Sloan S, 2009, BRAIN IMPAIR, V10, P282, DOI 10.1375/brim.10.3.282; Sloan S, 2009, BRAIN IMPAIR, V10, P295, DOI 10.1375/brim.10.3.295; Statacorp, 2012, STAT 12 REF MAN; Stiers W, 2012, J REHABIL RES DEV, V49, P139, DOI 10.1682/JRRD.2010.07.0131; Tate R., 2005, BRAIN IMPAIR, V6, P75, DOI DOI 10.1375/BRIM.2005.6.2.75; Tepper S, 1996, BRAIN INJURY, V10, P575, DOI 10.1080/026990596124142; Todis B, 2005, BRAIN INJURY, V19, P389, DOI 10.1080/02699050400003957; Tsaousides T, 2011, BRAIN INJURY, V25, P1155, DOI 10.3109/02699052.2011.613086; Vaccaro M, 2007, DISABIL REHABIL-ASSI, V2, P85, DOI 10.1080/17483100601167586; Wehman P, 2009, J REHABIL RES DEV, V46, P909, DOI 10.1682/JRRD.2008.08.0105; Wheeler S., 2005, HUMAN DEV PERFORMANC, P264; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; Willer B, 1993, J HEAD TRAUMA REHAB, V3, P75, DOI DOI 10.1097/00001199-199308020-00009; Willis B, 1999, QUESTION APPRAISAL S; Winkler D, 2006, J HEAD TRAUMA REHAB, V21, P8, DOI 10.1097/00001199-200601000-00002; Winkler Dianne, 2006, Aust Health Rev, V30, P100; Winkler D, 2010, BRAIN IMPAIR, V11, P313, DOI 10.1375/brim.11.3.313; Winkler D, 2010, BRAIN IMPAIR, V11, P299, DOI 10.1375/brim.11.3.299; Wise EK, 2010, ARCH PHYS MED REHAB, V91, P1357, DOI 10.1016/j.apmr.2010.06.009; Won Yin-Ling Irene, 2002, Ment Health Serv Res, V4, P13, DOI 10.1023/A:1014093008857	59	11	11	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0045-0766	1440-1630		AUST OCCUP THER J	Aust. Occup. Ther. J.	JUN	2016	63	3					143	153		10.1111/1440-1630.12284			11	Rehabilitation	Rehabilitation	DV0BH	WOS:000382582100005	27072343				2021-06-18	
J	Chio, CC; Wei, L; Chen, TG; Lin, CM; Shieh, JP; Yeh, PS; Chen, RM				Chio, Chung-Ching; Wei, Li; Chen, Tyng Guey; Lin, Chien-Min; Shieh, Ja-Ping; Yeh, Poh-Shiow; Chen, Ruei-Ming			Neuron-derived orphan receptor 1 transduces survival signals in neuronal cells in response to hypoxia-induced apoptotic insults	JOURNAL OF NEUROSURGERY			English	Article						NOR-1; neuronal cell; hypoxia; survival signals; CREB/cIAP2; traumatic brain injury	BLOOD-BRAIN-BARRIER; GENE-EXPRESSION; NUCLEAR RECEPTORS; PROTECTS; ACTIVATION; ELEMENT; INJURY; TISSUE; ALPHA	OBJECTIVE Hypoxia can induce cell death or trigger adaptive mechanisms to guarantee cell survival. Neuron-derived orphan receptor 1 (NOR-1) works as an early-response protein in response to a variety of environmental stresses. In this study, the authors evaluated the roles of NOR-1 in hypoxia-induced neuronal insults. METHODS Neuro-2a cells were exposed to oxygen/glucose deprivation (OGD). Cell viability, cell morphology, caspase-3 activity, DNA fragmentation, and cell apoptosis were assayed to determine the mechanisms of OGD-induced neuronal insults. RNA and protein analyses were carried out to evaluate the effects of OGD on expressions of NOR-1, cAMP response element-binding (CREB), and cellular inhibitor of apoptosis protein 2 (cIAP2) genes. Translations of these gene expressions were knocked down using RNA interference. Mice subjected to traumatic brain injury (TBI) and NOR-1 was immunodetected. RESULTS Exposure of neuro-2a cells to OGD decreased cell viability in a time-dependent manner. Additionally, OGD led to cell shrinkage, DNA fragmentation, and cell apoptosis. In parallel, treatment of neuro-2a cells with OGD time dependently increased cellular NOR-1 mRNA and protein expressions. Interestingly, administration of TBI also augmented NOR-1 levels in the impacted regions of mice. As to the mechanism, exposure to OGD increased nuclear levels of the transcription factor CREB protein. Downregulating CREB expression using RNA interference simultaneously inhibited OGD-induced NOR-1 mRNA expression. Also, levels of clAP2 mRNA and protein in neuro-2a cells were augmented by OGD. After reducing clAP2 translation, OGD-induced cell death was reduced. Sequentially, application of NOR-1 small interfering RNA to neuro-2a cells significantly inhibited OGD-induced cIAP2 mRNA expression and concurrently alleviated hypoxia-induced alterations in cell viability, caspase-3 activation, DNA damage, and cell apoptosis. CONCLUSIONS This study shows that NOR-1 can transduce survival signals in neuronal cells responsible for hypoxia-induced apoptotic insults through activation of a CREB/cIAP2-dependent mechanism.	[Chio, Chung-Ching] Chi Mei Med Ctr, Dept Neurosurg, Tainan, Taiwan; [Shieh, Ja-Ping] Chi Mei Med Ctr, Dept Anesthesiol, Tainan, Taiwan; [Yeh, Poh-Shiow] Chi Mei Med Ctr, Dept Neurol, Tainan, Taiwan; [Chio, Chung-Ching; Chen, Ruei-Ming] Taipei Med Univ, Ctr Comprehens Canc, Taipei 110, Taiwan; [Lin, Chien-Min] Taipei Med Univ, Dept Neurosurg, Taipei 110, Taiwan; [Chen, Ruei-Ming] Taipei Med Univ, Grad Inst Med Sci, 250 Wu Xing St, Taipei 110, Taiwan; [Wei, Li] Taipei Med Univ, Wan Fang Hosp, Dept Neurosurg, Taipei 110, Taiwan; [Chen, Tyng Guey] Taipei Med Univ, Wan Fang Hosp, Dept Anesthesiol, Taipei 110, Taiwan; [Chen, Ruei-Ming] Taipei Med Univ, Wan Fang Hosp, Brain Dis Res Ctr, Taipei 110, Taiwan; [Chen, Ruei-Ming] Taipei Med Univ Hosp, Anesthet & Toxicol Res Ctr, Taipei, Taiwan	Chen, RM (corresponding author), Taipei Med Univ, Grad Inst Med Sci, 250 Wu Xing St, Taipei 110, Taiwan.	rmchen@tmu.edu.tw					Axelson H, 2005, SEMIN CELL DEV BIOL, V16, P554, DOI 10.1016/j.semcdb.2005.03.007; Barco A, 2011, MOL NEUROBIOL, V44, P330, DOI 10.1007/s12035-011-8209-x; Chang HC, 2014, J AGR FOOD CHEM, V62, P3466, DOI 10.1021/jf403286w; Chang HC, 2011, J CEREBR BLOOD F MET, V31, P842, DOI 10.1038/jcbfm.2010.180; Chen RM, 2013, SURGERY, V154, P58, DOI 10.1016/j.surg.2013.02.003; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chio CC, 2013, ARCH TOXICOL, V87, P459, DOI 10.1007/s00204-012-0965-5; Chuang CY, 2011, ARCH TOXICOL, V85, P209, DOI 10.1007/s00204-010-0585-x; Chuang CY, 2011, IMMUNOBIOLOGY, V216, P707, DOI 10.1016/j.imbio.2010.10.009; Eftedal I, 2012, PHYSIOL GENOMICS, V44, P1201, DOI 10.1152/physiolgenomics.00073.2012; Fatemi A, 2009, CLIN PERINATOL, V36, P835, DOI 10.1016/j.clp.2009.07.011; Gerstner ER, 2009, NAT REV CLIN ONCOL, V6, P229, DOI 10.1038/nrclinonc.2009.14; Goyal L, 2001, CELL, V104, P805, DOI 10.1016/S0092-8674(01)00276-8; Jana A, 2009, J NEUROL SCI, V278, P5, DOI 10.1016/j.jns.2008.12.010; Jensen RL, 2009, J NEURO-ONCOL, V92, P317, DOI 10.1007/s11060-009-9827-2; Kagaya S, 2005, BIOL PHARM BULL, V28, P1603, DOI 10.1248/bpb.28.1603; Kim Y, 2006, MOL CELLS, V22, P8; Kitagawa K, 2007, FEBS J, V274, P3210, DOI 10.1111/j.1742-4658.2007.05890.x; Liao MH, 2014, BRIT J NUTR, V111, P55, DOI 10.1017/S0007114513002043; Lin JW, 2012, NEURO-ONCOLOGY, V14, P302, DOI 10.1093/neuonc/nor217; Lin YL, 2010, J NUTR, V140, P2187, DOI 10.3945/jn.110.123505; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Martinez-Gonzalez J, 2005, CARDIOVASC RES, V65, P609, DOI 10.1016/j.cardiores.2004.10.002; Martorell L, 2009, MOL CELL BIOL, V29, P5828, DOI 10.1128/MCB.00945-09; Maxwell Megan A, 2006, Nucl Recept Signal, V4, pe002; Mazzeo AT, 2007, J NEUROL SCI, V261, P1, DOI 10.1016/j.jns.2007.04.026; MONTMINY MR, 1987, NATURE, V328, P175, DOI 10.1038/328175a0; Nomiyama T, 2009, CIRCULATION, V119, P577, DOI 10.1161/CIRCULATIONAHA.108.822056; Okouchi M, 2007, ANTIOXID REDOX SIGN, V9, P1059, DOI 10.1089/ars.2007.1511; Ostergaard L, 2013, J CEREBR BLOOD F MET, V33, P1825, DOI 10.1038/jcbfm.2013.173; Park HA, 2015, ANTIOXID REDOX SIGN, V22, P93, DOI 10.1089/ars.2013.5570; Rius J, 2004, ARTERIOSCL THROM VAS, V24, P697, DOI 10.1161/01.ATV.0000121570.00515.dc; Shin HJ, 2003, TOXICOLOGY, V191, P121, DOI 10.1016/S0300-483X(03)00210-5; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wei JD, 2012, J ORTHOP RES, V30, P1058, DOI 10.1002/jor.22046; Weinreb O, 2013, FREE RADICAL BIO MED, V62, P52, DOI 10.1016/j.freeradbiomed.2013.01.017; Wu H, 2007, CELL, V131, P655, DOI 10.1016/j.cell.2007.10.042; Wu TT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072404; Zhao Y, 2010, ARTERIOSCL THROM VAS, V30, P1535, DOI 10.1161/ATVBAHA.109.191163	39	11	11	1	6	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	JUN	2016	124	6					1654	1664		10.3171/2015.6.JNS1535			11	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	DM6PZ	WOS:000376476200016	26613168	Bronze			2021-06-18	
J	Donat, CK; Gaber, K; Meixensberger, J; Brust, P; Pinborg, LH; Hansen, HH; Mikkelsen, JD				Donat, Cornelius K.; Gaber, Khaled; Meixensberger, Juergen; Brust, Peter; Pinborg, Lars H.; Hansen, Henrik H.; Mikkelsen, Jens D.			Changes in Binding of [I-123]CLINDE, a High-Affinity Translocator Protein 18 kDa (TSPO) Selective Radioligand in a Rat Model of Traumatic Brain Injury	NEUROMOLECULAR MEDICINE			English	Article						Traumatic brain injury; Translocator protein 18 kDa; TSPO; Microglia; Neuroinflammation	PERIPHERAL BENZODIAZEPINE-RECEPTORS; POSITRON-EMISSION-TOMOGRAPHY; MICROGLIAL ACTIVATION; NERVOUS-SYSTEM; IN-VIVO; FOCAL ISCHEMIA; INFLAMMATION; PET; NEUROINFLAMMATION; SITES	After traumatic brain injury (TBI), secondary injuries develop, including neuroinflammatory processes that contribute to long-lasting impairments. These secondary injuries represent potential targets for treatment and diagnostics. The translocator protein 18 kDa (TSPO) is expressed in activated microglia cells and upregulated in response to brain injury and therefore a potential biomarker of the neuroinflammatory processes. Second-generation radioligands of TSPO, such as [I-123]CLINDE, have a higher signal-to-noise ratio as the prototype ligand PK11195. [I-123]CLINDE has been employed in human studies using single-photon emission computed tomography to image the neuroinflammatory response after stroke. In this study, we used the same tracer in a rat model of TBI to determine changes in TSPO expression. Adult Sprague-Dawley rats were subjected to moderate controlled cortical impact injury and sacrificed at 6, 24, 72 h and 28 days post surgery. TSPO expression was assessed in brain sections employing [I-123]CLINDE in vitro autoradiography. From 24 h to 28 days post surgery, injured animals exhibited a marked and time-dependent increase in [I-123]CLINDE binding in the ipsilateral motor, somatosensory and parietal cortex, as well as in the hippocampus and thalamus. Interestingly, binding was also significantly elevated in the contralateral M1 motor cortex following TBI. Craniotomy without TBI caused a less marked increase in [I-123]CLINDE binding, restricted to the ipsilateral hemisphere. Radioligand binding was consistent with an increase in TSPO mRNA expression and CD11b immunoreactivity at the contusion site. This study demonstrates the applicability of [I-123]CLINDE for detailed regional and quantitative assessment of glial activity in experimental models of TBI.	[Donat, Cornelius K.; Pinborg, Lars H.; Hansen, Henrik H.; Mikkelsen, Jens D.] Copenhagen Univ Hosp, Rigshosp, Neurobiol Res Unit, Blegdamsvej 9, DK-2100 Copenhagen, Denmark; [Gaber, Khaled; Meixensberger, Juergen] Univ Leipzig, Dept Neurosurg, D-04109 Leipzig, Germany; [Brust, Peter] Helmholtz Zentrum Dresden Rossendorf, Inst Radiopharmaceut Canc Res, Dept Neuroradiopharmaceut, Res Site Leipzig,Permoserstr 15, D-04318 Leipzig, Germany; [Pinborg, Lars H.] Copenhagen Univ Hosp, Rigshosp, Epilepsy Clin, Blegdamsvej 9, DK-2100 Copenhagen, Denmark	Mikkelsen, JD (corresponding author), Copenhagen Univ Hosp, Rigshosp, Neurobiol Res Unit, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.	jens.mikkelsen@nru.dk		Pinborg, Lars Hageman/0000-0001-9024-7936; , Peter/0000-0001-5555-7058	Desiree and Niels Ydes Foundation; Lundbeck FoundationLundbeckfonden; Danish Strategic Research Council (project COGNITO); European UnionEuropean Commission [HEALTH-F2-2011-278850]	We thank Tina Spalholz and the staff of MEZ Leipzig for excellent technical support and assistance in animal experiments and Felix Fischer for assistance in tissue sectioning. CLINDE was kindly supplied by Dr. Nicolas Arlicot, Universite Francois Rabelais de Tours, France. This work was supported by Desiree and Niels Ydes Foundation, the Lundbeck Foundation and the Danish Strategic Research Council (project COGNITO). The research leading to these results was supported by the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement HEALTH-F2-2011-278850 (INMiND).	Arlicot N, 2014, MOL IMAGING, V13, DOI 10.2310/7290.2013.00075; Arlicot N, 2010, EUR J NUCL MED MOL I, V37, P2371, DOI 10.1007/s00259-010-1598-7; Arlicot N, 2008, EUR J NUCL MED MOL I, V35, P2203, DOI 10.1007/s00259-008-0834-x; Baldwin SA, 1996, J NEUROSURG, V85, P476, DOI 10.3171/jns.1996.85.3.0476; Banati RB, 1997, J NEUROCYTOL, V26, P77, DOI 10.1023/A:1018567510105; Banati RB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6452; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Benarroch EE, 2013, NEUROLOGY, V81, P1079, DOI 10.1212/WNL.0b013e3182a4a577; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Cao T, 2012, NEUROSCIENCE, V225, P65, DOI 10.1016/j.neuroscience.2012.08.058; Chen MK, 2008, PHARMACOL THERAPEUT, V118, P1, DOI 10.1016/j.pharmthera.2007.12.004; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Collste K., 2015, EUROPEAN J NUCL MED, V43, P173; Coughlin JM, 2015, NEUROBIOL DIS, V74, P58, DOI 10.1016/j.nbd.2014.10.019; Donat CK, 2008, BRAIN RES, V1246, P167, DOI 10.1016/j.brainres.2008.09.059; Donat CK, 2007, BRAIN INJURY, V21, P1031, DOI 10.1080/02699050701630359; Faden AI, 2016, BRIT J PHARMACOL, V173, P681, DOI 10.1111/bph.13179; Feng L, 2014, J NUCL MED, V55, P1966, DOI 10.2967/jnumed.114.143727; Folkersma H, 2011, J NUCL MED, V52, P1235, DOI 10.2967/jnumed.110.084061; Folkersma H, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-67; Grossman EJ, 2016, J NEUROTRAUM, V33, P163, DOI 10.1089/neu.2015.3965; Grossman R, 2003, NEUROIMAGE, V20, P1971, DOI 10.1016/j.neuroimage.2003.06.003; Guseva MV, 2008, J NEUROTRAUM, V25, P975, DOI 10.1089/neu.2008.0516; Hartig W, 2013, BRAIN RES, V1498, P69, DOI 10.1016/j.brainres.2012.12.022; Herz J, 2012, NEUROBIOL DIS, V45, P1077, DOI 10.1016/j.nbd.2011.12.026; Jaremko L, 2014, SCIENCE, V343, P1363, DOI 10.1126/science.1248725; Jensen P, 2015, J NUCL MED, V56, P1386, DOI 10.2967/jnumed.115.158998; Jensen P, 2015, NEUROLOGY, V84, P859, DOI 10.1212/WNL.0000000000001278; Kelso ML, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-108; Kuhlmann AC, 2000, J NEUROCHEM, V74, P1694, DOI 10.1046/j.1471-4159.2000.0741694.x; Kumar A., 2015, J NEUROTRAUMA; Lagraoui Mouna, 2012, Front Neurol, V3, P155, DOI 10.3389/fneur.2012.00155; Lavisse S, 2015, EUR J NUCL MED MOL I, V42, P478, DOI 10.1007/s00259-014-2962-9; Lavisse S, 2012, J NEUROSCI, V32, P10809, DOI 10.1523/JNEUROSCI.1487-12.2012; Lemstra AW, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-4; Liu GJ, 2014, BRAIN PATHOL, V24, P631, DOI 10.1111/bpa.12196; Liu ZW, 2011, STROKE, V42, P740, DOI 10.1161/STROKEAHA.110.607226; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Madinier A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008101; Maeda J, 2007, BRAIN RES, V1157, P100, DOI 10.1016/j.brainres.2007.04.054; Martin A, 2010, J CEREBR BLOOD F MET, V30, P230, DOI 10.1038/jcbfm.2009.205; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Mattner F, 2005, EUR J NUCL MED MOL I, V32, P557, DOI 10.1007/s00259-004-1690-y; Mattner F, 2008, EUR J NUCL MED MOL I, V35, P779, DOI 10.1007/s00259-007-0645-5; Mattner F, 2011, EUR J NUCL MED MOL I, V38, P1516, DOI 10.1007/s00259-011-1784-2; Miyazawa N, 1995, ACTA NEUROCHIR, V137, P207, DOI 10.1007/BF02187195; MYERS R, 1991, NEUROSCI LETT, V133, P20, DOI 10.1016/0304-3940(91)90047-W; Norden DM, 2015, NEUROPHARMACOLOGY, V96, P29, DOI 10.1016/j.neuropharm.2014.10.028; Owen DR, 2010, J CEREBR BLOOD F MET, V30, P1608, DOI 10.1038/jcbfm.2010.63; Papadopoulos V, 2009, EXP NEUROL, V219, P53, DOI 10.1016/j.expneurol.2009.04.016; Pappata S, 2000, NEUROLOGY, V55, P1052, DOI 10.1212/WNL.55.7.1052; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Rao VLR, 2000, EXP NEUROL, V161, P102, DOI 10.1006/exnr.1999.7269; ROBINSON AP, 1986, IMMUNOLOGY, V57, P239; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schwarzmaier SM, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00358; Scott G, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0445-y; Soustiel JF, 2008, NEUROPATH APPL NEURO, V34, P412, DOI 10.1111/j.1365-2990.2007.00906.x; Stemper BD, 2014, PROG NEUROL SURG, V28, P14, DOI 10.1159/000358748; Toth M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125917; Trapani A, 2013, BIOCONJUGATE CHEM, V24, P1415, DOI 10.1021/bc300666f; Venneti S, 2007, EXP NEUROL, V207, P118, DOI 10.1016/j.expneurol.2007.06.003; Wang Y, 2014, EUR J NUCL MED MOL I, V41, P1440, DOI 10.1007/s00259-014-2727-5; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Yu I, 2010, J NEUROTRAUM, V27, P1463, DOI 10.1089/neu.2009.1196; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067	68	11	12	0	4	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1535-1084	1559-1174		NEUROMOL MED	Neuromol. Med.	JUN	2016	18	2					158	169		10.1007/s12017-016-8385-y			12	Neurosciences	Neurosciences & Neurology	DN9XZ	WOS:000377435300003	26969181				2021-06-18	
J	Ettenhofer, ML; Barry, DM				Ettenhofer, Mark L.; Barry, David M.			Saccadic Impairment Associated With Remote History of Mild Traumatic Brain Injury	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							MINOR HEAD-INJURY; EYE-MOVEMENTS; COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; SPORTS CONCUSSION; PREMOTOR THEORY; ATTENTION; PERFORMANCE; METAANALYSIS; PREDICTORS	Evidence suggests that mild traumatic brain injury (TBI) is associated with long-term changes in brain function, but conventional neurocognitive tools are often insensitive to deficits after 90 days. Eye movements have been proposed as a means to identify more chronic forms of impairment. In this study, saccadic, manual, and conventional neuropsychological measures were compared between participants with remote mild TBI and well-matched control participants. Saccadic impairment was more frequent within the mild TBI group, and a history of multiple injuries or high symptom burden appeared to compound this risk. However, other neurocognitive measures did not differ by group, number of injuries, or symptom severity. These results suggest that saccadic impairment may reflect chronic effects of mild TBI that conventional measures are unable to detect.	[Ettenhofer, Mark L.; Barry, David M.] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Dept Med & Clin Psychol, Bethesda, MD 20814 USA	Ettenhofer, ML (corresponding author), Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Dept Med & Clin Psychol, Bethesda, MD 20814 USA.	mark.ettenhofer@usuhs.edu	Ettenhofer, Mark L./J-7171-2019	Ettenhofer, Mark L./0000-0001-9381-7578	USUHS Research Award [R072LP]; Uniformed Services University of the Health Sciences	This study was supported by USUHS Research Award #R072LP to Dr. Ettenhofer and institutional support from the Uniformed Services University of the Health Sciences. The technology described in this manuscript is included in U.S. Patent Application No. 61/779,801, U.S. Patent Application No. 14/773,987, European Patent Application No. 14780396.9, and International Patent Application No. PCT/US2014/022468 (rights assigned to the Uniformed Services University of the Health Sciences [USUHS]). The views and opinions presented in this manuscript are those of the authors and do not necessarily represent the position of USUHS, the Department of Defense, or the United States government.	Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Bryan C, 2012, J HEAD TRAUMA REHAB, V27, P45, DOI 10.1097/HTR.0b013e318238f146; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cifu DX, 2015, J HEAD TRAUMA REHAB, V30, P21, DOI 10.1097/HTR.0000000000000036; Coldren RL, 2012, MIL MED, V177, P179, DOI 10.7205/MILMED-D-11-00278; Conners C., 2000, CONNERS CONTINUOUS P; Crawford TJ, 2005, BIOL PSYCHIAT, V57, P1052, DOI 10.1016/j.biopsych.2005.01.017; Culotta VP, 1996, NEUROSURGERY, V38, P245, DOI 10.1097/00006123-199602000-00002; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; de Haan B, 2008, BRAIN RES, V1204, P102, DOI 10.1016/j.brainres.2008.01.105; Delis D.C., 2001, DELIS KAPLAN EXECUTI; Delis DC, 2000, CALIFORNIA VERBAL LE; Diwakar M, 2015, NEUROIMAGE-CLIN, V8, P210, DOI 10.1016/j.nicl.2015.04.011; Ettenhofer ML, 2016, J CLIN EXP NEUROPSYC, V38, P96, DOI 10.1080/13803395.2015.1089978; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Gualtieri C Thomas, 2008, Medscape J Med, V10, P90; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Holdnack JA, 2001, WECHSLER TEST ADULT; Ingebrigtsen T, 1998, J NEUROL, V245, P609, DOI 10.1007/s004150050254; Johnson B, 2015, NEUROLOGY, V85, P1163, DOI 10.1212/WNL.0000000000001968; Johnson B, 2015, BRAIN IMAGING BEHAV, V9, P564, DOI 10.1007/s11682-014-9316-x; Jorge RE, 2012, AM J PSYCHIAT, V169, P1284, DOI 10.1176/appi.ajp.2012.12050600; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kraus MF, 2007, COGN BEHAV NEUROL, V20, P170, DOI 10.1097/WNN.0b013e318142badb; Maruta J, 2010, J HEAD TRAUMA REHAB, V25, P293, DOI 10.1097/HTR.0b013e3181e67936; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; RIZZOLATTI G, 1987, NEUROPSYCHOLOGIA, V25, P31, DOI 10.1016/0028-3932(87)90041-8; RIZZOLATTI G, 1994, ATTENTION PERFORM, V15, P231; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Schutte C., 2013, MILD TRAUMATIC BRAIN, P159; SHELIGA BM, 1994, EXP BRAIN RES, V98, P507; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Smith DT, 2012, NEUROPSYCHOLOGIA, V50, P1104, DOI 10.1016/j.neuropsychologia.2012.01.025; Trites RL, 1989, LAFAYETTE GROOVED PE; Tschanz JT, 2000, NEUROLOGY, V54, P1290, DOI 10.1212/WNL.54.6.1290; van Stockum S, 2008, NEUROPSYCHOLOGIA, V46, P3108, DOI 10.1016/j.neuropsychologia.2008.07.002; Ventura RE, 2015, J NEURO-OPHTHALMOL, V35, P73, DOI 10.1097/WNO.0000000000000223; Wechsler D, 2008, WAIS 4 TECHNICAL INT; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th ed; Zhang K, 2010, EXP BRAIN RES, V204, P57, DOI 10.1007/s00221-010-2294-3	46	11	11	0	7	AMER PSYCHIATRIC PUBLISHING, INC	ARLINGTON	1000 WILSON BOULEVARD, STE 1825, ARLINGTON, VA 22209-3901 USA	0895-0172	1545-7222		J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	SUM	2016	28	3					223	231		10.1176/appi.neuropsych.15100243			9	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	DV9MI	WOS:000383264200012	27019067	Bronze			2021-06-18	
J	Leal-Noval, SR; Munoz-Serrano, A; Arellano-Orden, V; Cayuela, A; Munoz-Gomez, M; Recio, A; Alcantara, A; Amaya-Villar, R; Casado-Mendez, M; Murillo-Cabezas, F				Leal-Noval, Santiago R.; Munoz-Serrano, Angela; Arellano-Orden, Victoria; Cayuela, Aurelio; Munoz-Gomez, Manuel; Recio, Antonio; Alcantara, Antonio; Amaya-Villar, Rosario; Casado-Mendez, Manuel; Murillo-Cabezas, Francisco			Effects of Red Blood Cell Transfusion on Long-Term Disability of Patients with Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						Anemia; Disability; Hemoglobin; Neurological; Transfusion; Traumatic brain injury	CEREBRAL OXYGENATION; HEMOGLOBIN CONCENTRATION; SUBARACHNOID HEMORRHAGE; ILL PATIENTS; MORTALITY; SHOCK	This 3-year prospective study examined the association between red blood cell transfusion (RBCT) and 1-year neurocognitive and disability levels in 309 patients with traumatic brain injury (TBI) admitted to the neurological intensive care unit (NICU). Using a telephone interview-based survey, functional outcomes were assessed by the Glasgow Outcome Scale (GOS), Rancho Los Amigos Levels of Cognitive Functioning Scale (RLCFS), and Disability Rating Scale (DRS) and dichotomized as favorable and unfavorable (dependent variable). The adjusted influence of RBCT on unfavorable results was assessed by conventional logistic regression, controlling for illness severity and propensity score (introduced as a continuous variable and by propensity score-matched patients). Overall, 164 (53 %) patients received a parts per thousand yen1 unit of RBCT during their NICU stay. One year postinjury, transfused patients exhibited significantly higher unfavorable GOS (46.0 vs. 22.0 %), RLCFS (37.4 vs. 15.4 %), and DRS (39.6 vs. 18.7 %) scores than nontransfused patients. Although transfused patients were more severely ill upon admission, their adjusted odds ratios (95 % confidence intervals) for unfavorable GOS, RLCFS, and DRS scores were 2.5 (1.2-5.1), 3.0 (1.4-6.3), and 2.3 (1.1-4.8), respectively. These odds ratios remained largely unmodified when the calculated propensity score was incorporated as an independent continuous variable into the multivariate analysis. Furthermore, in 76 pairs of propensity score-matched patients, the rate of an unfavorable RLCFS score at the 1-year (but not 6-month) follow-up was significantly higher in transfused than nontransfused patients [3.0 (1.1-8.2)]. Our results strongly suggest an independent association between RBCT and unfavorable long-term functional outcomes of patients with TBI.	[Leal-Noval, Santiago R.; Arellano-Orden, Victoria; Alcantara, Antonio; Amaya-Villar, Rosario; Casado-Mendez, Manuel; Murillo-Cabezas, Francisco] Hosp Univ Virgen del Rocio, Inst Biomed IBIS, Crit Care Div, Avda Manuel Siurot S-N, Seville 41013, Spain; [Munoz-Serrano, Angela] Hosp Univ Virgen del Rocio, Inst Biomed IBIS, Neuropsychol Div, Seville, Spain; [Cayuela, Aurelio] Hosp Valme, Stat & Design Div, Seville, Spain; [Munoz-Gomez, Manuel] Univ Malaga, Perioperat Transfus Med, E-29071 Malaga, Spain; [Recio, Antonio] Hosp Univ Virgen del Rocio, Transfus Serv, Seville, Spain	Leal-Noval, SR (corresponding author), Hosp Univ Virgen del Rocio, Inst Biomed IBIS, Crit Care Div, Avda Manuel Siurot S-N, Seville 41013, Spain.	srlealnoval@gmail.com	Cayuela, Aurelio/AAZ-1294-2020; Murillo-Cabezas, Francisco/AAO-3348-2021; IBIS, NEUROCRITICOS/C-1805-2016; Noval, Santiago/K-4515-2019; Cayuela, Aurelio/C-6698-2012	Cayuela, Aurelio/0000-0002-4936-9402	MAPFRE foundation (Mutualidad de la Agrupacion de Propietarios de Fincas Rusticas de Espana)	This study was partially supported by MAPFRE foundation (Mutualidad de la Agrupacion de Propietarios de Fincas Rusticas de Espana).	Centre for Disease Control and Prevention Traumatic Brain Injury in the United States, 2010, EM DEP VIS HOSP DEAT; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Desjardins P, 2012, CRIT CARE, V16, DOI 10.1186/cc11293; Elterman J, 2013, J TRAUMA ACUTE CARE, V75, P8, DOI 10.1097/TA.0b013e318298492e; Engoren MC, 2002, ANN THORAC SURG, V74, P1180, DOI 10.1016/S0003-4975(02)03766-9; Leal-Noval SR, 2008, CURR OPIN CRIT CARE, V14, P156, DOI 10.1097/MCC.0b013e3282f57577; Leal-Noval SR, 2013, BLOOD TRANSFUS-ITALY, V11, P585, DOI 10.2450/2013.0029-13; Leal-Noval SR, 2006, INTENS CARE MED, V32, P1733, DOI 10.1007/s00134-006-0376-2; LeRoux P, 2013, CURR OPIN CRIT CARE, V19, P83, DOI 10.1097/MCC.0b013e32835eba43; Menon DK, 2009, CURR OPIN CRIT CARE, V15, P437, DOI 10.1097/MCC.0b013e3283307a26; Park DW, 2012, CRIT CARE MED, V40, P3140, DOI 10.1097/CCM.0b013e3182657b75; Pegoli M, 2015, J NEUROSURG, V122, P414, DOI 10.3171/2014.10.JNS14290; Leal-Noval SR, 2008, CRIT CARE MED, V36, P1290, DOI 10.1097/CCM.0b013e3181692dfc; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Salim A, 2008, J AM COLL SURGEONS, V207, P398, DOI 10.1016/j.jamcollsurg.2008.03.013; Sekhon MS, 2015, NEUROCRIT CARE, P1; Sekhon MS, 2012, CRIT CARE, V16, DOI 10.1186/cc11431; Shukla D, 2011, CLIN NEUROL NEUROSUR, V113, P435, DOI 10.1016/j.clineuro.2011.02.013; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Tan HY, 2015, CRIT CARE MED, V43, pE276, DOI 10.1097/CCM.0000000000001023; Vincent JL, 2008, ANESTHESIOLOGY, V108, P31, DOI 10.1097/01.anes.0000296070.75956.40; Warner MA, 2010, J NEUROSURG, V113, P539, DOI 10.3171/2009.12.JNS091337; Zygun DA, 2009, CRIT CARE MED, V37, P1074, DOI 10.1097/CCM.0b013e318194ad22	24	11	12	0	23	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	JUN	2016	24	3					371	380		10.1007/s12028-015-0220-z			10	Critical Care Medicine; Clinical Neurology	General & Internal Medicine; Neurosciences & Neurology	DN2ZP	WOS:000376932100007	26627227				2021-06-18	
J	Lee, WK; Yeom, J; Lee, WH; Seo, HG; Oh, BM; Han, TR				Lee, Won Kyung; Yeom, Jiwoon; Lee, Woo Hyung; Seo, Han Gil; Oh, Byung-Mo; Han, Tai Ryoon			Characteristics of Dysphagia in Severe Traumatic Brain Injury Patients: A Comparison With Stroke Patients	ANNALS OF REHABILITATION MEDICINE-ARM			English	Article						Deglutition disorders; Fluoroscopy; Deglutition; Brain injuries	FUNCTIONAL ORAL INTAKE; REHABILITATION	Objective To compare the swallowing characteristics of dysphagic patients with traumatic brain injury (TBI) with those of dysphagic stroke patients. Methods Forty-one patients with TBI were selected from medical records (between December 2004 to March 2013) and matched to patients with stroke (n=41) based on age, sex, and disease duration. Patients' swallowing characteristics were analyzed retrospectively using a videofluoroscopic swallowing study (VFSS) and compared between both groups. Following thorough review of medical records, patients who had a history of diseases that could affect swallowing function at the time of the study were excluded. Dysphagia characteristics and severity were evaluated using the American Speech-Language-Hearing Association National Outcome Measurement System swallowing scale, clinical dysphagia scale, and the videofluoroscopic dysphagia scale. Results There was a significant difference in radiological lesion location (p=0.024) between the two groups. The most common VFSS finding was aspiration or penetration, followed by decreased laryngeal elevation and reduced epiglottis inversion. Swallowing function, VFSS findings, or quantified dysphagia severity showed no significant differences between the groups. In a subgroup analysis of TBI patients, the incidence of tube feeding was higher in patients with surgical intervention than in those without (p=0.011). Conclusion The swallowing characteristics of dysphagic patients after TBI were comparable to those of dysphagic stroke patients. Common VFSS findings comprised aspiration or penetration, decreased laryngeal elevation, and reduced epiglottis inversion. Patients who underwent surgical intervention after TBI were at high risk of tube feeding requirement.	[Lee, Won Kyung; Yeom, Jiwoon; Lee, Woo Hyung; Seo, Han Gil; Oh, Byung-Mo] Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Dept Rehabil Med, Seoul, South Korea; [Han, Tai Ryoon] Gangwon Do Rehabil Hosp, Dept Rehabil Med, 24-16,Chungyeol Ro 142Beon Gil, Chunchon 24227, South Korea	Han, TR (corresponding author), Gangwon Do Rehabil Hosp, Dept Rehabil Med, 24-16,Chungyeol Ro 142Beon Gil, Chunchon 24227, South Korea.	tairyoon@snu.ac.kr		Seo, Han Gil/0000-0001-6904-7542			Albanese J, 2003, CRIT CARE MED, V31, P2535, DOI 10.1097/01.CCM.0000089927.67396.F3; Chang YC, 2003, DYSPHAGIA, V18, P135, DOI 10.1007/s00455-002-0096-x; DOTY RW, 1967, EXP NEUROL, V17, P91, DOI 10.1016/0014-4886(67)90125-2; Eng JJ, 2002, ARCH PHYS MED REHAB, V83, P483, DOI 10.1053/apmr.2002.31203; Field L H, 1989, Brain Inj, V3, P19, DOI 10.3109/02699058909008069; Geeganage C, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000323.pub2; Hansen TS, 2008, ARCH PHYS MED REHAB, V89, P2114, DOI 10.1016/j.apmr.2008.04.013; Hansen TS, 2008, ARCH PHYS MED REHAB, V89, P1556, DOI 10.1016/j.apmr.2007.11.063; Jean A, 2001, PHYSIOL REV, V81, P929; Juneja G, 1998, AM J PHYS MED REHAB, V77, P388, DOI 10.1097/00002060-199809000-00005; Jung SH, 2005, ANN REHABIL MED-ARM, V29, P343; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Mackay LE, 1999, ARCH PHYS MED REHAB, V80, P365, DOI 10.1016/S0003-9993(99)90271-X; Mackay LE, 1999, J HEAD TRAUMA REHAB, V14, P435, DOI 10.1097/00001199-199910000-00004; Martino R, 2005, STROKE, V36, P2756, DOI 10.1161/01.STR.0000190056.76543.eb; Paik NJ, 2005, ANN REHABIL MED-ARM, V29, P43; Rogus-Pulia N, 2013, SEMIN SPEECH LANG, V34, P154, DOI 10.1055/s-0033-1358368; Stevens RD, 2013, CRIT CARE MED, V41, P1104, DOI 10.1097/CCM.0b013e318287ee79; TANDON PN, 1964, ACTA NEUROL SCAND, V40, P375; Terre R, 2007, REV ESP ENFERM DIG, V99, P7; Terrte R, 2007, BRAIN INJURY, V21, P1411, DOI 10.1080/02699050701785096; Ward EC, 2007, J HEAD TRAUMA REHAB, V22, P184, DOI 10.1097/01.HTR.0000271119.96780.f5; WINSTEIN CJ, 1983, PHYS THER, V63, P1992, DOI 10.1093/ptj/63.12.1992	23	11	12	1	12	KOREAN ACAD REHABILITATION MEDICINE	SEOUL	5F, YOUNGHAN BLDG, 742-22 BANPO-DONG, SEOCHO-GU, SEOUL, 137-040, SOUTH KOREA	2234-0645	2234-0653		ANN REHABIL MED-ARM	Ann. Rehabil. Med.-ARM	JUN	2016	40	3					432	439		10.5535/arm.2016.40.3.432			8	Rehabilitation	Rehabilitation	FG9WR	WOS:000410791100007	27446779	DOAJ Gold, Green Published			2021-06-18	
J	Rosa, M; da Rocha, AJ; Maia, ACM; Saade, N; Veiga, JCE; Romero, JM				Rosa, Marcos, Jr.; da Rocha, Antonio Jose; Martins Maia, Antonio Carlos, Jr.; Saade, Nelson; Esteves Veiga, Jose Carlos; Romero, Javier M.			Contusion Contrast Extravasation Depicted on Multidetector Computed Tomography Angiography Predicts Growth and Mortality in Traumatic Brain Contusion	JOURNAL OF NEUROTRAUMA			English	Article						contrast extravasation; multidetector CT angiography; spot sign; traumatic brain contusion; traumatic brain injury	LONG-TERM DISABILITY; ACUTE HEAD-INJURY; INTRACEREBRAL HEMORRHAGE; HEMATOMA EXPANSION; SPOT SIGN; INTRACRANIAL HEMORRHAGE; CT ANGIOGRAPHY; UNITED-STATES; ACTIVE EXTRAVASATION; RISK-FACTORS	Traumatic brain injury (TBI) is the main cause of death in trauma victims and causes high rates of disability and neurological sequelae. Approximately 38-65% of traumatic brain contusions (TBC) demonstrate hemorrhagic expansion on serial computed tomography (CT) scans. Thus far, however, no single variable can accurately predict the hemorrhage expansion of a TBC. Our purpose was to evaluate contrast extravasation (CE) as a predictor of expansion, mortality, and poor outcome in TBC in a Brazilian cohort. After Institutional Review Board approval, we used multidetector CT angiography (MDCTA) to study 121 consecutive patients (106 men, 87.6%) with ages varying from 10 to 85 years. Informed consent was obtained from all subjects. The clinical and imaging findings were correlated with the findings on the initial MDCTA using either the Fisher exact test or Student t test and a multivariate logistic regression model. Of the persons who presented CE in TBC, 21.8% died (in-hospital mortality), whereas in the absence of this sign, the mortality rate was 7.6% (p=0.014). In addition, expansion of the hemorrhagic component of the TBC was detected in 61.1% of the CE-positive patients, whereas expansion was only observed in 10% of the CE-negative patients (p<0.001). Poor outcome was observed in 24.2% of the patients in the CE-negative group, but in the presence of CE, 72.7% evolved with poor outcome (p<0.001). The CE was a strong independent predictor of expansion, poor outcome, and increased risk of in-hospital mortality in our series of patients with TBC.	[Rosa, Marcos, Jr.; da Rocha, Antonio Jose; Martins Maia, Antonio Carlos, Jr.] Santa Casa Misericordia Sao Paulo, Neuroradiol Sect, Sao Paulo, SP, Brazil; [Rosa, Marcos, Jr.] Univ Fed Espirito Santo, Sect Radiol, Vitoria, ES, Brazil; [Saade, Nelson; Esteves Veiga, Jose Carlos] Santa Casa Misericordia Sao Paulo, Div Neurosurg, Sao Paulo, SP, Brazil; [Romero, Javier M.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Neuroradiol, Boston, MA USA	Rosa, M (corresponding author), Santa Casa Misericordia Sao Paulo, Serv Diagnost Imagem, Rua Dr Cesario Motta Jr 112, BR-01221020 Sao Paulo, SP, Brazil.	marcosrosajr@hotmail.com	Rosa-Junior, Marcos/S-6617-2017; Veiga, Jose/AAV-1687-2020	Rosa-Junior, Marcos/0000-0001-8668-2804; Romero, Javier/0000-0001-5749-3000			Acosta JA, 1998, J AM COLL SURGEONS, V186, P528, DOI 10.1016/S1072-7515(98)00082-9; Alahmadi H, 2010, J NEUROSURG, V112, P1139, DOI 10.3171/2009.5.JNS081369; Allard CB, 2009, J TRAUMA, V67, P959, DOI 10.1097/TA.0b013e3181ad5d37; Almandoz JED, 2012, J NEUROINTERV SURG, V4, P442, DOI 10.1136/neurintsurg-2011-010061; Almandoz JED, 2011, NEUROIMAG CLIN N AM, V21, P197, DOI 10.1016/j.nic.2011.01.001; Almandoz JED, 2010, STROKE, V41, P54, DOI 10.1161/STROKEAHA.109.565382; Chang EF, 2006, NEUROSURGERY, V58, P647, DOI 10.1227/01.NEU.0000197101.68538.E6; Compagnone C, 2009, NEUROSURGERY, V64, P690, DOI 10.1227/01.NEU.0000340796.18738.F7; Demchuk AM, 2012, LANCET NEUROL, V11, P307, DOI 10.1016/S1474-4422(12)70038-8; Dewan Y, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-87; Divani AA, 2011, STROKE, V42, P1569, DOI 10.1161/STROKEAHA.110.607861; Ederies A, 2009, STROKE, V40, P1672, DOI 10.1161/STROKEAHA.108.541201; Flint AC, 2008, J NEUROTRAUM, V25, P503, DOI 10.1089/neu.2007.0442; Goldstein JN, 2007, NEUROLOGY, V68, P889, DOI 10.1212/01.wnl.0000257087.22852.21; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Huang APH, 2011, J TRAUMA, V71, P1593, DOI 10.1097/TA.0b013e31822c8865; Huttner HB, 2006, STROKE, V37, P404, DOI 10.1161/01.STR.0000198806.67472.5c; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Letourneau-Guillon L, 2013, AM J NEURORADIOL, V34, P773, DOI 10.3174/ajnr.A3309; Li N, 2011, STROKE, V42, P3441, DOI 10.1161/STROKEAHA.111.623405; Lustenberger T, 2010, J TRAUMA, V69, P1410, DOI 10.1097/TA.0b013e3181cdae81; Marion DW, 2006, NEUROSURGERY, V58, P655; MAUSER HW, 1984, NEURORADIOLOGY, V26, P31, DOI 10.1007/BF00328200; Murai Y, 1998, J NEUROSURG, V88, P650, DOI 10.3171/jns.1998.88.4.0650; Narayan RK, 2008, J NEUROTRAUM, V25, P629, DOI 10.1089/neu.2007.0385; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Park SY, 2010, J KOREAN NEUROSURG S, V48, P399, DOI 10.3340/jkns.2010.48.5.399; Patel AD, 2010, J NEUROPATH EXP NEUR, V69, P1177, DOI 10.1097/NEN.0b013e3181fbf6d6; Perel P, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007877.pub2; Rosa M, 2015, J COMPUT ASSIST TOMO, V39, P217, DOI 10.1097/RCT.0000000000000182; Rosa M, 2013, ARQ NEURO-PSIQUIAT, V71, P791, DOI 10.1590/0004-282X20130124; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Simard JM, 2009, J NEUROTRAUM, V26, P2257, DOI 10.1089/neu.2009.1021; Smith JS, 2007, J TRAUMA, V63, P75, DOI 10.1097/01.ta.0000245991.42871.87; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; Takanashi Y, 2001, J CLIN NEUROSCI, V8, P240, DOI 10.1054/jocn.2000.0804; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tomida M, 1998, NEUROSURGERY, V43, P66, DOI 10.1097/00006123-199807000-00040; Wada R, 2007, STROKE, V38, P1257, DOI 10.1161/01.STR.0000259633.59404.f3; White CL, 2009, J TRAUMA, V67, P508, DOI 10.1097/TA.0b013e3181b2519f; Yadav YR, 2006, NEUROL INDIA, V54, P377, DOI 10.4103/0028-3886.28109; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	43	11	11	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 1	2016	33	11					1015	1022		10.1089/neu.2015.4062			8	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	DN3SU	WOS:000376984600005	26214242				2021-06-18	
J	Su, TC; Lin, SH; Lee, PT; Yeh, SH; Hsieh, TH; Chou, SY; Su, TP; Hung, JJ; Chang, WC; Lee, YC; Chuang, JY				Su, Tzu-Chieh; Lin, Shu-Hui; Lee, Pin-Tse; Yeh, Shiu-Hwa; Hsieh, Tsun-Hsun; Chou, Szu-Yi; Su, Tsun-Ping; Hung, Jan-Jong; Chang, Wen-Chang; Lee, Yi-Chao; Chuang, Jian-Ying			The sigma-1 receptor-zinc finger protein 179 pathway protects against hydrogen peroxide-induced cell injury	NEUROPHARMACOLOGY			English	Article						Sig-1R; Znf179; DHEA/DHEAS; Reactive oxygen species; Hydrogen peroxide	TRAUMATIC BRAIN-INJURY; NEURODEGENERATIVE DISEASES; OXIDATIVE STRESS; DEHYDROEPIANDROSTERONE DHEA; ALZHEIMERS-DISEASE; NEUROSTEROIDS; BINDING; ZNF179; DIFFERENTIATION; INVOLVEMENT	The accumulation of reactive oxygen species (ROS) have implicated the pathogenesis of several human diseases including neurodegenerative disorders, stroke, and traumatic brain injury, hence protecting neurons against ROS is very important. In this study, we focused on sigma-1 receptor (Sig-1R), a chaperone at endoplasmic reticulum, and investigated its protective functions. Using hydrogen peroxide (H2O2)-induced ROS accumulation model, we verified that apoptosis-signaling pathways were elicited by H2O2 treatment. However, the Sig-1R agonists, dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS), reduced the activation of apoptotic pathways significantly. By performing protein protein interaction assays and shRNA knockdown of Sig-1R, we identified the brain Zinc finger protein 179 (Znf179) as a downstream target of Sig-1R regulation. The neuroprotective effect of Znf179 over expression was similar to that of DHEAS treatment, and likely mediated by affecting the levels of antioxidant enzymes. We also quantified the levels of peroxiredoxin 3 (Prx3) and superoxide dismutase 2 (SOD2) in the hippocampi of wild-type and Znf179 knockout mice, and found both enzymes to be reduced in the knockout versus the wild-type mice. In summary, these results reveal that Znf179 plays a novel role in neuroprotection, and Sig-1R agonists may be therapeutic candidates to prevent ROS-induced damage in neurodegenerative and neurotraumatic diseases. (C) 2016 Elsevier Ltd. All rights reserved.	[Su, Tzu-Chieh; Lin, Shu-Hui; Chang, Wen-Chang] Taipei Med Univ, Grad Inst Med Sci, Taipei 110, Taiwan; [Lin, Shu-Hui; Hsieh, Tsun-Hsun; Chou, Szu-Yi; Lee, Yi-Chao; Chuang, Jian-Ying] Taipei Med Univ, Grad Inst Neural Regenerat Med, 250 Wuxing St, Taipei 110, Taiwan; [Lee, Pin-Tse; Yeh, Shiu-Hwa] Natl Hlth Res Inst, Inst Biotechnol & Pharmaceut Res, Zhunan Township, Miaoli County, Taiwan; [Lee, Pin-Tse; Su, Tsun-Ping] NIDA, Cellular Pathobiol Sect, Intramural Res Program, Baltimore, MD USA; [Hung, Jan-Jong] Natl Cheng Kung Univ, Inst Bioinformat & Biosignal Transduct, Tainan 701, Taiwan; [Chang, Wen-Chang; Lee, Yi-Chao; Chuang, Jian-Ying] Taipei Med Univ, Ctr Neurotrauma & Neuroregenerat, Taipei 110, Taiwan	Lee, YC; Chuang, JY (corresponding author), Taipei Med Univ, Grad Inst Neural Regenerat Med, 250 Wuxing St, Taipei 110, Taiwan.	yclee@tmu.edu.tw; chuangcy@tmu.edu.tw		Lee, Yi-Chao/0000-0003-3451-183X	Ministry of Science and TechnologyMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [MOST 103-2320-B-038-046-MY3, MOST 103-2321-B-038-001, MOST 104-2923-B-038-002-MY3]; Taipei Medical University [TMU102-AE1-B25]; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [ZIADA000549, ZIADA000206] Funding Source: NIH RePORTER	This work was supported by grants from the Ministry of Science and Technology (MOST 103-2320-B-038-046-MY3, MOST 103-2321-B-038-001, and MOST 104-2923-B-038-002-MY3) and Taipei Medical University (TMU102-AE1-B25).	Aly HF, 2011, ACTA BIOCHIM POL, V58, P513; Arent AM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/723060; Charalampopoulos L, 2004, P NATL ACAD SCI USA, V101, P8209, DOI 10.1073/pnas.0306631101; Di Matteo V, 2003, CNS NEUROL DISORD-DR, V2, P95, DOI 10.2174/1568007033482959; Evangelopoulos ME, 2005, ONCOGENE, V24, P3309, DOI 10.1038/sj.onc.1208494; Camporez JPG, 2011, J PHYSIOL-LONDON, V589, P2585, DOI 10.1113/jphysiol.2011.206078; Gilgun-Sherki Y, 2001, NEUROPHARMACOLOGY, V40, P959, DOI 10.1016/S0028-3908(01)00019-3; Giorgio M, 2007, NAT REV MOL CELL BIO, V8, p722A; Goyagi T, 2001, STROKE, V32, P1613, DOI 10.1161/01.STR.32.7.1613; Grimm A, 2014, BBA-MOL BASIS DIS, V1842, P2427, DOI 10.1016/j.bbadis.2014.09.013; Hanna DMF, 2015, PROG NEURO-PSYCHOPH, V60, P36, DOI 10.1016/j.pnpbp.2015.02.005; Hayashi T., 2005, Current Neuropharmacology, V3, P267, DOI 10.2174/157015905774322516; Hayashi T, 2001, P NATL ACAD SCI USA, V98, P491, DOI 10.1073/pnas.021413698; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; Hetz C, 2014, NAT REV NEUROSCI, V15, P233, DOI 10.1038/nrn3689; Hirata Y, 2011, J NEUROCHEM, V119, P839, DOI 10.1111/j.1471-4159.2011.07464.x; Ishikawa M, 2010, J RECEPT LIGAND CH R, V3, P25; Kimura T, 1997, AM J MED GENET, V69, P320; Kokona D, 2012, NEUROPHARMACOLOGY, V62, P2106, DOI 10.1016/j.neuropharm.2012.01.006; Kourrich S, 2013, CELL, V152, P236, DOI 10.1016/j.cell.2012.12.004; Kourrich S, 2012, TRENDS NEUROSCI, V35, P762, DOI 10.1016/j.tins.2012.09.007; Lin DY, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-98; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Nguyen L, 2015, J PHARMACOL SCI, V127, P17, DOI 10.1016/j.jphs.2014.12.005; Liu L, 2015, CELL, V160, P177, DOI 10.1016/j.cell.2014.12.019; Maurice T, 1996, J NEUROSCI RES, V46, P734; MONNET FP, 1995, P NATL ACAD SCI USA, V92, P3774, DOI 10.1073/pnas.92.9.3774; Pao PC, 2011, CELL DEATH DIFFER, V18, P1791, DOI 10.1038/cdd.2011.52; Peviani M, 2014, NEUROBIOL DIS, V62, P218, DOI 10.1016/j.nbd.2013.10.010; Rodriguez-Rodriguez A, 2014, CURR MED CHEM, V21, P1201, DOI 10.2174/0929867321666131217153310; Ruscher K, 2015, J PHARMACOL SCI, V127, P30, DOI 10.1016/j.jphs.2014.11.011; SU TP, 1988, SCIENCE, V240, P219, DOI 10.1126/science.2832949; Tsai SYA, 2015, P NATL ACAD SCI USA, V112, pE6562, DOI 10.1073/pnas.1518894112; Tuerxun T, 2010, NEUROSCI LETT, V469, P303, DOI 10.1016/j.neulet.2009.12.013; Urani A, 2001, J PHARMACOL EXP THER, V298, P1269; Wang SM, 2015, MOL NEUROBIOL, V51, P370, DOI 10.1007/s12035-014-8714-9; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407	37	11	14	0	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3908	1873-7064		NEUROPHARMACOLOGY	Neuropharmacology	JUN	2016	105						1	9		10.1016/j.neuropharm.2016.01.015			9	Neurosciences; Pharmacology & Pharmacy	Neurosciences & Neurology; Pharmacology & Pharmacy	DN8EF	WOS:000377311300001	26792191	Green Accepted			2021-06-18	
J	Xu, XP; Cao, SW; Chao, HL; Liu, YL; Ji, J				Xu, Xiupeng; Cao, Shengwu; Chao, Honglu; Liu, Yinlong; Ji, Jing			Sex-related differences in striatal dopaminergic system after traumatic brain injury	BRAIN RESEARCH BULLETIN			English	Article						Sex-related differences; DA; Methamphetamine; Potassium; TBI	VESICULAR MONOAMINE-TRANSPORTER; RAT STRIATUM; CD-1 MICE; METHAMPHETAMINE; GENDER; IMPACT; NEUROTOXICITY; ESTROGEN; FEMALE; EXPRESSION	Several studies have demonstrated alterations in the dopamine (DA) system after traumatic brain injury (TBI). Additionally, the existence of significant sex-related differences in the dopaminergic system has long been recognized. Accordingly, the purpose of the present study was to investigate whether TBI would differentially alter, in female and male mice, the expression and the function of the striatal vesicular monoamine transporter-2 (VMAT-2), an important DA transporter. After controlled cortical impact (CCI) injury, female mice showed significantly lower striatal DA concentrations and K+-evoked DA output. By contrast, no significant sex-related differences were observed in the mRNA and protein levels of striatal dopamine transporter (DAT) and VMAT-2 and the methamphetamine (MA)-evoked DA output. These results demonstrated clear sex-related differences in striatal VMAT-2 function in response to TBI and suggested that female mice may be more sensitive to the TBI-induced inhibition of the VMAT-2 function, as indicated by the greater degree of deficits observed when the VMAT-2 DA-storage function was inhibited by TBI. Moreover, the TBI-induced suppression of locomotion was more pronounced than female mice. Such findings highlight the need for sex-specific considerations when examining differences among brain injury conditions. (C) 2016 Elsevier Inc. All rights reserved.	[Xu, Xiupeng; Cao, Shengwu; Chao, Honglu; Liu, Yinlong; Ji, Jing] Nanjing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China; [Ji, Jing] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA USA; [Ji, Jing] Univ Pittsburgh, Dept Environm & Occupat Hlth, Pittsburgh, PA USA	Ji, J (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China.	jijing@njmu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81300998]; National Natural Science Foundation of Jiangsu ProvinceNatural Science Foundation of Jiangsu Province [BK20131022]; Specially-Appointed Professor Foundation of Jiangsu Province [ky216r201307]	This study was funded by the National Natural Science Foundation of China (81300998), National Natural Science Foundation of Jiangsu Province (BK20131022) and the Specially-Appointed Professor Foundation of Jiangsu Province (ky216r201307).	Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Bhatt SD, 2005, BRAIN RES, V1035, P188, DOI 10.1016/j.brainres.2004.12.013; Brown JM, 2006, J NEUROCHEM, V98, P495, DOI 10.1111/j.1471-4159.2006.03902.x; Cadet JL, 2003, FASEB J, V17, P1775, DOI 10.1096/fj.03-0073rev; Carlson S. W., 2015, J NEUROTRAUMA; Chen L, 2013, BRAIN RES, V1521, P59, DOI 10.1016/j.brainres.2013.05.016; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Dluzen DE, 2008, ANN NY ACAD SCI, V1139, P140, DOI 10.1196/annals.1432.010; Dluzen DE, 2003, ENDOCRINE, V21, P67, DOI 10.1385/ENDO:21:1:67; Dluzen DE, 2005, NEUROENDOCRINOLOGY, V82, P78, DOI 10.1159/000090983; Donnemiller E, 2000, EUR J NUCL MED, V27, P1410, DOI 10.1007/s002590000308; Foster JD, 2002, J BIOL CHEM, V277, P25178, DOI 10.1074/jbc.M200294200; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Ji J, 2007, J NEUROENDOCRINOL, V19, P725, DOI 10.1111/j.1365-2826.2007.01581.x; Ji J, 2012, NAT NEUROSCI, V15, P1407, DOI 10.1038/nn.3195; Ji J, 2009, BIOCHEM PHARMACOL, V78, P1401, DOI 10.1016/j.bcp.2009.07.004; Kahlig KM, 2005, P NATL ACAD SCI USA, V102, P3495, DOI 10.1073/pnas.0407737102; Kunnathur V, 2006, NEUROTOXICOL TERATOL, V28, P557, DOI 10.1016/j.ntt.2006.07.001; Lavalaye J, 2000, EUR J NUCL MED, V27, P867, DOI 10.1007/s002590000279; Le Saux M, 2006, J NEUROENDOCRINOL, V18, P25, DOI 10.1111/j.1365-2826.2005.01380.x; Massucci JL, 2004, NEUROSCI LETT, V372, P127, DOI 10.1016/j.neulet.2004.09.026; McEwen B, 2002, RECENT PROG HORM RES, V57, P357, DOI 10.1210/rp.57.1.357; MCINTOSH TK, 1994, J NEUROCHEM, V63, P1426; Miller DB, 1998, ANN NY ACAD SCI, V844, P153, DOI 10.1111/j.1749-6632.1998.tb08230.x; Murray HE, 2003, NEUROSCIENCE, V116, P213, DOI 10.1016/S0306-4522(02)00578-X; Podurgiel SJ, 2013, NEUROSCIENCE, V250, P507, DOI 10.1016/j.neuroscience.2013.07.008; Rehavi M, 1998, MOL BRAIN RES, V57, P31, DOI 10.1016/S0169-328X(98)00058-8; RIVEST R, 1995, BRAIN RES, V692, P269, DOI 10.1016/0006-8993(95)00611-S; Sandoval V, 2001, J NEUROSCI, V21, P1413; Stoica BA, 2014, J NEUROTRAUM, V31, P758, DOI 10.1089/neu.2013.3194; Wagner AK, 2005, J NEUROCHEM, V95, P457, DOI 10.1111/j.1471-4159.2005.03382.x; Wagner AK, 2005, EXP NEUROL, V195, P475, DOI 10.1016/j.expneurol.2005.06.009; Wagner AK, 2007, BEHAV BRAIN RES, V181, P200, DOI 10.1016/j.bbr.2007.04.006; Wagner AK, 2009, J NEUROCHEM, V108, P986, DOI 10.1111/j.1471-4159.2008.05840.x; Walker QD, 2000, NEUROSCIENCE, V95, P1061; Xie T, 2000, J NEUROSCI, V20, P7838; Yu L., 2000, J NEURAL T, V107, P419; Zlotnik A, 2012, INTENS CARE MED, V38, P137, DOI 10.1007/s00134-011-2401-3	38	11	12	0	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0361-9230	1873-2747		BRAIN RES BULL	Brain Res. Bull.	JUN	2016	124						214	221		10.1016/j.brainresbull.2016.05.010			8	Neurosciences	Neurosciences & Neurology	DS2JM	WOS:000380595800025	27210290				2021-06-18	
J	Padgett, CR; Summers, MJ; Vickers, JC; McCormack, GH; Skilbeck, CE				Padgett, Christine R.; Summers, Mathew J.; Vickers, James C.; McCormack, Graeme H.; Skilbeck, Clive E.			Exploring the effect of the apolipoprotein E (APOE) gene on executive function, working memory, and processing speed during the early recovery period following traumatic brain injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						working memory; executive function; processing speed; traumatic brain injury; apolipoprotein E4; apolipoprotein E2; TBI	GLASGOW COMA SCALE; COMPENSATORY MECHANISM; POSTTRAUMATIC AMNESIA; HEAD-INJURY; GENOTYPE; POLYMORPHISM; SEVERITY; ALLELE; AGE; REHABILITATION	Introduction: There is evidence that the e4 allele of the apolipoprotein E (APOE) gene is detrimental to cognitive function, but results from traumatic brain injury (TBI) populations are mixed. A possible explanation is that APOEe2 carriers have routinely been incorporated into APOEe4 and non-e4 groups, despite APOEe2 being proposed to have an ameliorative effect. Our primary aim was to investigate the influence of APOEe4 on cognitive impairment during early recovery following TBI, excluding the potential confound of APOEe2 possession. A secondary objective was to explore whether APOEe4 displays more pronounced effects in moderate to severe TBI and to consider the potential postinjury protective influence of the APOEe2 allele. Method: Participants who recently sustained a TBI (posttraumatic amnesia > 5 minutes) were assessed on measures of information processing speed, executive function, and working memory upon remission of posttraumatic amnesia. APOE genotype was determined by buccal saliva DNA extraction (APOEe4 n = 37, APOEe3 n = 92, APOEe2 n = 13). Results: Stepwise multiple regressions were performed to compare APOEe4 carriers to APOEe3 homozygotes, with injury severity, age, and estimated premorbid IQ included in the first step. This model was found to significantly predict performance on all tasks, accounting for 17.3-24.3% of the variance. When APOEe4 status was added for the second step, there were no significant changes on any tasks (additional variance <1%). The effect of APOEe4 in moderate to severe TBI and the effect of APOEe2 were explored by analysis of covariance (ANCOVA), with no significant effects revealed. Conclusions: It is unlikely that APOE genotype influences cognitive function in the initial recovery period following TBI, regardless of injury severity. However, a more nuanced and long-term exploration of the effect of APOE genotype in the TBI population is warranted.	[Padgett, Christine R.; Skilbeck, Clive E.] Univ Tasmania, Sch Med, Launceston, Tas 7250, Australia; [Padgett, Christine R.; Skilbeck, Clive E.] Royal Hobart Hosp, Tasmanian Neurotrauma Register, Hobart, Tas, Australia; [Summers, Mathew J.] Univ Sunshine Coast, Sch Social Sci, Maroochydore, Qld, Australia; [Summers, Mathew J.; Vickers, James C.; McCormack, Graeme H.] Univ Tasmania, Wicking Dementia Res & Educ Ctr, Hobart, Tas, Australia	Padgett, CR (corresponding author), Univ Tasmania, Private Bag 3502, Burnie, Tas 7320, Australia.	Christine.Padgett@utas.edu.au	Summers, Mathew J/G-3168-2011; Vickers, James/J-7464-2014	Summers, Mathew J/0000-0002-3869-4920; Vickers, James/0000-0001-5671-4879			Adibhatla RM, 2007, FUTURE LIPIDOL, V2, P403, DOI 10.2217/17460875.2.4.403; Anderson GD, 2009, EPILEPSY BEHAV, V16, P501, DOI 10.1016/j.yebeh.2009.08.025; Ariza M, 2006, J NEUROL NEUROSUR PS, V77, P1191, DOI 10.1136/jnnp.2005.085167; BORKOWSKI JG, 1967, NEUROPSYCHOLOGIA, V5, P135, DOI 10.1016/0028-3932(67)90015-2; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; Coughlan AK, 1986, ADULT MEMORY INFORM; Crawford FC, 2002, NEUROLOGY, V58, P1115, DOI 10.1212/WNL.58.7.1115; Donohoe GG, 1999, CLIN CHEM, V45, P143; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Eramudugolla R, 2014, J INT NEUROPSYCH SOC, V20, P444, DOI 10.1017/S1355617714000174; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Han SD, 2008, ALZHEIMERS DEMENT, V4, P251, DOI 10.1016/j.jalz.2008.02.006; Han SD, 2007, J NEUROL NEUROSUR PS, V78, P1103, DOI 10.1136/jnnp.2006.108183; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P621, DOI 10.1037/0894-4105.18.4.621; Horsburgh K, 2003, INT CONGR SER, V1252, P171, DOI 10.1016/S0531-5131(03)00024-4; Horsburgh K, 2002, J CEREBR BLOOD F MET, V22, P1189; Howell D.C., 2010, STAT METHODS PSYCHOL, VInternationa Edition; Jochemsen HM, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.07.016; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Lawrence DW, 2015, BRAIN INJURY, V29, P1018, DOI 10.3109/02699052.2015.1005131; Lezak M.D., 2004, NEUROPSYCHOLOGICAL A, Vfourth; Liberman JN, 2002, NEUROLOGY, V58, P1038, DOI 10.1212/WNL.58.7.1038; Mahley RW, 2006, ACTA NEUROL SCAND, V114, P8, DOI 10.1111/j.1600-0404.2006.00679.x; Mahley RW, 2012, NEURON, V76, P871, DOI 10.1016/j.neuron.2012.11.020; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; Malojcic B, 2008, J NEUROTRAUM, V25, P30, DOI 10.1089/neu.2007.0384; Mannix RC, 2011, J CEREBR BLOOD F MET, V31, P351, DOI 10.1038/jcbfm.2010.99; Methia N, 2001, MOL MED, V7, P810, DOI 10.1007/BF03401973; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Muller K, 2009, NEUROSURGERY, V64, P698, DOI 10.1227/01.NEU.0000340978.42892.78; Noe E, 2010, BRAIN INJURY, V24, P886, DOI 10.3109/02699051003724952; Perrin PB, 2015, J HEAD TRAUMA REHAB, V30, P136, DOI 10.1097/HTR.0000000000000026; Ponsford J, 2007, NEUROLOGY, V68, P619, DOI 10.1212/01.wnl.0000254609.04330.9d; Ponsford J, 2013, NEUROREHABILITATION, V32, P803, DOI 10.3233/NRE-130904; Ponsford J, 2011, J NEUROTRAUM, V28, P1683, DOI 10.1089/neu.2010.1623; Rapoport M, 2008, J NEUROPSYCH CLIN N, V20, P68, DOI 10.1176/jnp.2008.20.1.68; Rusted JM, 2013, NEUROIMAGE, V65, P364, DOI 10.1016/j.neuroimage.2012.10.010; Schonberger M, 2009, J NEUROTRAUM, V26, P2157, DOI 10.1089/neu.2009.0939; Shadli RM, 2011, BRAIN INJURY, V25, P596, DOI 10.3109/02699052.2011.572947; Sherer M, 2008, J NEUROL NEUROSUR PS, V79, P678, DOI 10.1136/jnnp.2006.111187; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Struble RG, 2007, EXP GERONTOL, V42, P54, DOI 10.1016/j.exger.2006.05.013; Suri S, 2013, NEUROSCI BIOBEHAV R, V37, P2878, DOI 10.1016/j.neubiorev.2013.10.010; Teasdale GM, 2005, BRAIN, V128, P2556, DOI 10.1093/brain/awh595; Weaver SM, 2014, BRAIN IMAGING BEHAV, V8, P420, DOI 10.1007/s11682-012-9197-9; WECHSLER D, 1996, WECHSLER ADULT INTEL, V3; ZANNIS VI, 1981, AM J HUM GENET, V33, P11; Zuercher M, 2009, BRAIN INJURY, V23, P371, DOI 10.1080/02699050902926267	50	11	12	0	18	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	MAY 27	2016	38	5					551	560		10.1080/13803395.2015.1137557			10	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	DG4HN	WOS:000372033100006	26898659				2021-06-18	
J	Song, H; Xu, LC; Zhang, RP; Cao, ZZ; Zhang, H; Yang, L; Guo, ZY; Qu, YQ; Yu, JY				Song, Hai; Xu, Lincheng; Zhang, Rongping; Cao, Zhenzhen; Zhang, Huan; Yang, Li; Guo, Zeyun; Qu, Yongqiang; Yu, Jianyun			Rosemary extract improves cognitive deficits in a rats model of repetitive mild traumatic brain injury associated with reduction of astrocytosis and neuronal degeneration in hippocampus	NEUROSCIENCE LETTERS			English	Article						Rosemary extract; Mild traumatic brain injury; Cognitive deficits; Anti-oxidative; Anti-inflammatory	ROSMARINIC ACID PROTECTS; CARNOSIC ACID; CELL-DEATH; IMPAIRMENT; MEMORY; INFLAMMATION; ANTIOXIDANT; POPULATION; CONCUSSION; MECHANISMS	In this study, we investigated whether Rosemary extract (RE) improved cognitive deficits in repetitive mild Traumatic brain injury (rmTBI) rats and its potential mechanisms. The present results showed that rmTBI caused cognitive deficits, such as increased latency to find platform and decreased time spent in target quadrant in Morris water maze (MWM). These behavioral alterations were accompanying with the increased neuronal degeneration and glial fibrillary acidic protein (GFAP)-positive cells, increased Reactive oxygen species (ROS) generation, decreased activity of Superoxide Dismutase (SOD), Glutathione Peroxidase (GPx) and Catalase (CAT), elevated protein level of IL-1 beta, IL-6 and TNF-alpha in hippocampus. Treatment with RE prevented these changes above. Our findings confirmed the effect of rosemary extract on improvement of cognitive deficits and suggested its mechanisms might be mediated by anti-oxidative and anti-inflammatory. Therefore, rosemary extract may be a potential treatment to improve cognitive deficits in rmTBI patients. (C) 2016 Elsevier Ireland Ltd. All rights reserved.	[Song, Hai; Xu, Lincheng; Zhang, Huan; Qu, Yongqiang; Yu, Jianyun] Kunming Med Univ, Dept Forens Med, Kunming 650500, Yunnan, Peoples R China; [Song, Hai] Kunming Med Univ, Affiliated Hosp 1, Dept Neurosurg, Kunming 650032, Yunnan, Peoples R China; [Cao, Zhenzhen] Kunming Med Univ, Basic Med Expt Teaching Ctr, Kunming 650500, Yunnan, Peoples R China; [Yang, Li; Guo, Zeyun] Kunming Med Univ, Dept Histol & Embryol, Kunming 650500, Yunnan, Peoples R China; [Zhang, Rongping] Kunming Med Univ, Pharmaceut Coll, Kunming 650500, Yunnan, Peoples R China	Yu, JY (corresponding author), Kunming Med Univ, Dept Forens Med, Kunming 650500, Yunnan, Peoples R China.	jianyunyu@sina.com			National Nature Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81360467]; Key Project of Application and Basis Research of Yunnan Province, China [2013FB104]	This study was supported by a grant from the National Nature Science Foundation of China (No.81360467) and Key Project of Application and Basis Research of Yunnan Province (No.2013FB104), China.	Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; ARUOMA OI, 1992, XENOBIOTICA, V22, P257, DOI 10.3109/00498259209046624; Bauer J, 2012, J PHARMACOL EXP THER, V342, P169, DOI 10.1124/jpet.112.193847; Birtic S, 2015, PHYTOCHEMISTRY, V115, P9, DOI 10.1016/j.phytochem.2014.12.026; Blostein PA, 1997, J NEUROTRAUM, V14, P171, DOI 10.1089/neu.1997.14.171; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Chkhikvishvili I, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/456253; Clark RE, 2005, HIPPOCAMPUS, V15, P260, DOI 10.1002/hipo.20056; Cooper C, 2013, BRIT J PSYCHIAT, V203, P255, DOI 10.1192/bjp.bp.113.127811; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Drag LL, 2012, J INT NEUROPSYCH SOC, V18, P576, DOI 10.1017/S1355617712000203; Dvorak J, 2007, BRIT J SPORT MED, V41, pI44, DOI 10.1136/bjsm.2007.037960; Gao LP, 2005, PHARMAZIE, V60, P62; Hadad N, 2012, FREE RADICAL BIO MED, V53, P1381, DOI 10.1016/j.freeradbiomed.2012.07.078; Haran FJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079595; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Hinton-Bayre AD, 1999, J CLIN EXP NEUROPSYC, V21, P70, DOI 10.1076/jcen.21.1.70.945; Itoh T, 2010, NEUROCHEM RES, V35, P348, DOI 10.1007/s11064-009-0061-2; Jianyun Y., 2010, CHIN J NEUROSURG DIS, V9, P337; Jimbo D, 2009, PSYCHOGERIATRICS, V9, P173, DOI 10.1111/j.1479-8301.2009.00299.x; Jin X, 2013, NEUROCHEM RES, V38, P1828, DOI 10.1007/s11064-013-1088-y; Khamse S, 2015, PHARM BIOL, V53, P1818, DOI 10.3109/13880209.2015.1010738; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Lee HJ, 2008, TOXICOLOGY, V250, P109, DOI 10.1016/j.tox.2008.06.010; Luan HY, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-28; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; Miller KJ, 2013, J HEAD TRAUMA REHAB, V28, P31, DOI 10.1097/HTR.0b013e318255ceae; Moon DO, 2010, CANCER LETT, V288, P183, DOI 10.1016/j.canlet.2009.06.033; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Moss M, 2003, INT J NEUROSCI, V113, P15, DOI 10.1080/00207450390161903; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Ozarowski M, 2013, FITOTERAPIA, V91, P261, DOI 10.1016/j.fitote.2013.09.012; Ozturk H, 2014, J PAK MED ASSOC, V64, P260; Park DH, 2010, FITOTERAPIA, V81, P644, DOI 10.1016/j.fitote.2010.03.010; Pengelly A, 2012, J MED FOOD, V15, P10, DOI 10.1089/jmf.2011.0005; Petraglia Anthony L, 2014, Surg Neurol Int, V5, P184, DOI 10.4103/2152-7806.147566; Rajasekaran D, 2013, AFR J TRADIT COMPLEM, V10, P102, DOI 10.4314/ajtcam.v10i1.14; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Rossi D, 2015, PROG NEUROBIOL, V130, P86, DOI 10.1016/j.pneurobio.2015.04.003; Swarup V, 2007, ANTIMICROB AGENTS CH, V51, P3367, DOI 10.1128/AAC.00041-07; Wang GH, 2011, J NEUROTRAUM, V28, P2123, DOI 10.1089/neu.2011.1939; Writer BW, 2009, J NEUROPSYCH CLIN N, V21, P362, DOI 10.1176/appi.neuropsych.21.4.362; Yu Jian-Yun, 2008, Fa Yi Xue Za Zhi, V24, P8	45	11	11	0	15	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	MAY 27	2016	622						95	101		10.1016/j.neulet.2016.04.048			7	Neurosciences	Neurosciences & Neurology	DN1OC	WOS:000376834300018	27113205				2021-06-18	
J	Balasundaram, AP; Athens, J; Schneiders, AG; McCrory, P; Sullivan, SJ				Balasundaram, Arun P.; Athens, Josie; Schneiders, Anthony G.; McCrory, Paul; Sullivan, S. John			The Influence of Psychological and Lifestyle Factors on the Reporting of Postconcussion-Like Symptoms	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Total symptom score; Symptom severity score; Psychological factors; Lifestyle factors	POST-CONCUSSIVE SYMPTOMS; TRAUMATIC BRAIN-INJURY; INTERNATIONAL-CONFERENCE; UNIVERSITY-STUDENTS; CONSENSUS STATEMENT; HOSPITAL ANXIETY; SPORT HELD; BASE RATES; DEPRESSION; INDIVIDUALS	Self-reported symptoms are an integral part of the assessment and management of a sports-related concussion. However, postconcussion-like symptoms are reported by non-concussed individuals. Moreover, the current best practice in the reporting of symptoms does not take into account the potential influence of psychological and lifestyle factors. This study aimed to explore the influence of these factors on the reporting of postconcussion-like symptoms. University students (N = 603) completed the Sport Concussion Assessment Tool 2 postconcussion symptom scale along with other predictor variables via a cross-sectionalweb-based survey. Linear regression analyses revealed six modifiers contributing to the total symptom score with the strongest being alcohol consumption (Estimate = 2.75, p<.001). Following these findings, clinicians need to exercise caution when interpreting the symptom scores for making decisions on the return-to-play (RTP). A failure to do so may lead the health professional to either prematurely RTP or not clear the concussed athlete to resume their sport.	[Balasundaram, Arun P.; Sullivan, S. John] Univ Otago, Sch Physiotherapy, Ctr Hlth Act & Rehabil Res, Dunedin 9054, New Zealand; [Athens, Josie] Univ Otago, Dunedin Sch Med, Dept Prevent & Social Med, Dunedin 9054, New Zealand; [Schneiders, Anthony G.] Cent Queensland Univ, Sch Human Hlth & Social Sci, Bundaberg, Qld 4670, Australia; [McCrory, Paul] Univ Melbourne, Melbourne Brain Ctr, Florey Inst Neurosci & Mental Hlth, Melbourne, Vic 3084, Australia	Sullivan, SJ (corresponding author), Univ Otago, Sch Physiotherapy, POB 56, Dunedin 9054, New Zealand.	sjohn.sullivan@otago.ac.nz	McCrory, Paul/Q-8688-2019; Balasundaram, Arun Prasad/D-1270-2017	Balasundaram, Arun Prasad/0000-0001-8256-857X; McCrory, Paul/0000-0003-4850-0568	International Olympic Committee (IOC); Axon Sports (USA); CogState Inc	P.M. is a co-investigator, collaborator, or consultant on grants relating to mild TBI funded by several governmental organisations. He is Co-Chair of the Australian Centre for Research into Sports Injury and its Prevention (ACRISP), which is one of the International Research Centres for Prevention of Injury and Protection of Athlete Health supported by the International Olympic Committee (IOC). He has a clinical and consulting practice in general and sports neurology. He receives book royalties from McGraw-Hill and was employed in an editorial capacity by the British Medical Journal Publishing Group from 2001 to 2008. He has been reimbursed by the government, professional scientific bodies, and sporting bodies for presenting research relating to mild TBI and sports-related concussion at meetings, scientific conferences, and symposiums. He received consultancy fees in 2010 from Axon Sports (USA) for the development of educational material (which was not renewed) and has received support since 2001 from CogState Inc for research costs and the development of educational material. He is a cofounder and shareholder in two biomedical companies (involved in eHealth and Compression garment technologies) but does not hold any individual shares in any company related to concussion or brain injury assessment or technology.	Alla S, 2010, J SCI MED SPORT, V13, P24, DOI 10.1016/j.jsams.2008.12.629; Balasundaram AP, 2013, PHYS THER SPORT, V14, P253, DOI 10.1016/j.ptsp.2013.06.002; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; CHALDER T, 1993, J PSYCHOSOM RES, V37, P147, DOI 10.1016/0022-3999(93)90081-P; COHEN S, 1988, CLAR SYMP, P31; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Dillman D, 2008, INTERNET MAIL MIXED; Edmed S, 2012, PSYCHIAT RES, V200, P41, DOI 10.1016/j.psychres.2012.05.022; Ettenhofer ML, 2012, J INT NEUROPSYCH SOC, V18, P451, DOI 10.1017/S1355617711001895; Eysenbach G, 2004, J MED INTERNET RES, V6, P12, DOI 10.2196/jmir.6.3.e34; Field A. P, 2009, DISCOVERING STAT USI; FOX DD, 1995, CLIN NEUROPSYCHOL, V9, P89, DOI 10.1080/13854049508402064; Gallagher RP, 2012, NATL SURVEY COLL COU; Gasquoine P G, 2000, Appl Neuropsychol, V7, P83, DOI 10.1207/S15324826AN0702_3; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Iverson G.L., 2012, PTSD MILD TRAUMATIC, P37; Iverson G.L., 2007, BRAIN INJURY MED PRI, P373; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Johansson B, 2010, BRAIN INJURY, V24, P2, DOI 10.3109/02699050903452961; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; McClure DJ, 2014, AM J SPORT MED, V42, P472, DOI 10.1177/0363546513510389; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McLeod TCV, 2012, AM J SPORT MED, V40, P927, DOI 10.1177/0363546511431573; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Mihalik JP, 2013, CLIN J SPORT MED, V23, P343, DOI 10.1097/JSM.0b013e318295a834; Moreno E., 2006, SORT-STAT OPER RES T, V30, P3; Mrazik M, 2013, J ATHL TRAINING, V48, P654, DOI 10.4085/1062-6050-48.3.19; Piland SG, 2010, J ATHL TRAINING, V45, P273, DOI 10.4085/1062-6050-45.3.273; Polak MA, 2012, DRUG ALCOHOL REV, V31, P763, DOI 10.1111/j.1465-3362.2012.00429.x; R Core Team, 2013, R LANG ENV STAT COMP; Singleton RA, 2009, J STUD ALCOHOL DRUGS, V70, P355, DOI 10.15288/jsad.2009.70.355; Stallman HM, 2010, AUST PSYCHOL, V45, P249, DOI 10.1080/00050067.2010.482109; Stewart A. L., 1992, MEASURING FUNCTIONIN, P155; Sullivan KA, 2012, J HEAD TRAUMA REHAB, V27, P293, DOI 10.1097/HTR.0b013e31822123ce; Zakzanis KK, 2011, ARCH CLIN NEUROPSYCH, V26, P461, DOI 10.1093/arclin/acr021; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zuckerman SL, 2012, J NEUROSURG-PEDIATR, V10, P504, DOI 10.3171/2012.8.PEDS12139	40	11	11	0	14	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAY	2016	31	3					197	205		10.1093/arclin/acw001			9	Psychology, Clinical; Psychology	Psychology	DL1WX	WOS:000375424900002	26891719	Green Published			2021-06-18	
J	DeCuypere, M; Muhlbauer, MS; Boop, FA; Klimo, P				DeCuypere, Michael; Muhlbauer, Michael S.; Boop, Frederick A.; Klimo, Paul, Jr.			Pediatric intracranial gunshot wounds: the Memphis experience	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						pediatric intracranial gunshot wound; survival; traumatic brain injury; pediatric management; trauma	PENETRATING HEAD-INJURY; TRAUMATIC BRAIN INJURY; PROGNOSTIC-FACTORS; CHILDREN; PREDICTORS; CIVILIANS; MORTALITY; OUTCOMES; UPDATE	OBJECTIVE Penetrating brain injury in civilians is much less common than blunt brain injury but is more severe overall. Gunshot wounds (GSWs) cause high morbidity and mortality related to penetrating brain injury; however, there are few reports on the management and outcome of intracranial GSWs in children. The goals of this study were to identify clinical and radiological factors predictive for death in children and to externally validate a recently proposed pediatric prognostic scale. METHODS The authors conducted a retrospective review of penetrating, isolated GSWs sustained in children whose ages ranged from birth to 18 years and who were treated at 2 major metropolitan Level 1 trauma centers from 1996 through 2013. Several standard clinical, laboratory, and radiological factors were analyzed for their ability to predict death in these patients. The authors then applied the St. Louis Scale for Pediatric Gunshot Wounds to the Head, a scoring algorithm that was designed to provide rapid prognostic information for emergency management decisions. The scale's sensitivity, specificity, and positive and negative predictability were determined, with death as the primary outcome. RESULTS Seventy-one children (57 male, 14 female) had a mean age of 14 years (range 19 months to 18 years). Overall mortality among these children was 47.9%, with 81% of survivors attaining a favorable clinical outcome (Glasgow Outcome Scale score >= 4). A number of predictors of mortality were identified (all p < 0.05): 1) bilateral fixed pupils; 2) deep nuclear injury; 3) transventricular projectile trajectory; 4) bihemispheric injury; 5) injury to >= 3 lobes; 6) systolic blood pressure < 100 mm Hg; 7) anemia (hematocrit < 30%); 8) Glasgow Coma Scale score <= 5; and 9) a blood base deficit < -5 mEq/L. Patient age, when converted to a categorical variable (0-9 or 10-18 years), was not predictive. Based on data from the 71 patients in this study, the positive predictive value of the St. Louis scale in predicting death (score >= 5) was 78%. CONCLUSIONS This series of pediatric cranial GSWs underscores the importance of the initial clinical exam and CT studies along with adequate resuscitation to make the appropriate management decision(s). Based on our population, the St. Louis Scale seems to be more useful as a predictor of who will survive than who will succumb to their injury. http://thejns.org/doi/abs/10.3171/2015.7.PEDS15285	[DeCuypere, Michael; Muhlbauer, Michael S.; Boop, Frederick A.; Klimo, Paul, Jr.] Univ Tennessee, Ctr Hlth Sci, Dept Neurosurg, Memphis, TN 38163 USA; [Muhlbauer, Michael S.; Boop, Frederick A.; Klimo, Paul, Jr.] Semmes Murphey Neurol & Spine Inst, 6325 Humphreys Blvd, Memphis, TN 38120 USA; [Muhlbauer, Michael S.; Boop, Frederick A.; Klimo, Paul, Jr.] Le Bonheur Childrens Hosp, Le Bonheur Neurosci Inst, Memphis, TN USA	Klimo, P (corresponding author), Semmes Murphey Neurol & Spine Inst, 6325 Humphreys Blvd, Memphis, TN 38120 USA.	pklimo@semmes-murphey.com		DeCuypere, Michael/0000-0002-4598-8644			Aarabi B, 2014, J NEUROSURG, V120, P1138, DOI 10.3171/2014.1.JNS131869; [Anonymous], 2001, J TRAUMA, V51, pS16; Bandt SK, 2012, J NEUROSURG-PEDIATR, V10, P511, DOI 10.3171/2012.8.PEDS123; BEAVER BL, 1990, J PEDIATR SURG, V25, P97, DOI 10.1016/S0022-3468(05)80171-X; CAVALIERE R, 1988, ACTA NEUROCHIR, V94, P133, DOI 10.1007/BF01435866; CLARK WC, 1986, J NEUROSURG, V65, P9, DOI 10.3171/jns.1986.65.1.0009; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Coughlan MD, 2003, CHILD NERV SYST, V19, P348, DOI 10.1007/s00381-003-0736-y; GRAHM TW, 1990, NEUROSURGERY, V27, P696, DOI 10.1227/00006123-199011000-00005; Gressot LV, 2014, J NEUROSURG, V121, P645, DOI 10.3171/2014.5.JNS131872; Hofbauer M, 2010, J TRAUMA, V69, P770, DOI 10.1097/TA.0b013e3181c81d7d; Irfan FB, 2010, CHILD NERV SYST, V26, P61, DOI 10.1007/s00381-009-0971-y; Joseph B, 2014, J AM COLL SURGEONS, V218, P58, DOI 10.1016/j.jamcollsurg.2013.08.018; KAUFMAN HH, 1993, NEUROSURGERY, V32, P962, DOI 10.1227/00006123-199306000-00013; KRIEGER MD, 1995, NEUROSURG CLIN N AM, V6, P605; Levy M L, 2000, Neurosurg Focus, V8, pe2, DOI 10.3171/foc.2000.8.1.153; LEVY ML, 1993, NEUROSURGERY, V33, P1018; Martins RS, 2003, SURG NEUROL, V60, P98, DOI 10.1016/S0090-3019(03)00302-1; McNatt SA, 2005, NEUROSURGERY, V57, pE191, DOI [10.1227/01.NEU.0000175727.76530.94, 10.1227/01.NEU.0000164174.07281.F9]; MINER ME, 1990, NEUROSURGERY, V26, P20, DOI 10.1227/00006123-199001000-00002; Murano T, 2005, AM SURGEON, V71, P1009; Nakagawa TA, 2011, PEDIATRICS, V128, pE720, DOI 10.1542/peds.2011-1511; Paret G, 1998, J NEUROTRAUM, V15, P967, DOI 10.1089/neu.1998.15.967; Petridis AK, 2011, CENT EUR NEUROSURG, V72, P5, DOI 10.1055/s-0029-1241850; Prasad MR, 2002, PEDIATR NEUROSURG, V36, P64, DOI 10.1159/000048355; SELDEN BS, 1988, ANN EMERG MED, V17, P247, DOI 10.1016/S0196-0644(88)80117-3; SHAFFREY ME, 1992, J NEUROTRAUM, V9, pS279; SICCARDI D, 1991, SURG NEUROL, V35, P455, DOI 10.1016/0090-3019(91)90179-D; STONE JL, 1995, NEUROSURGERY, V37, P1104, DOI 10.1227/00006123-199512000-00010; Sustic A, 2001, MIL MED, V166, P331; Zafonte RD, 2001, NEUROL RES, V23, P219, DOI 10.1179/016164101101198370	31	11	11	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	MAY	2016	17	5					595	601		10.3171/2015.7.PEDS15285			7	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	DK2CS	WOS:000374722800013	26728100	Bronze			2021-06-18	
J	Honce, JM; Nyberg, E; Jones, I; Nagae, L				Honce, Justin M.; Nyberg, Eric; Jones, Isaac; Nagae, Lidia			Neuroimaging of Concussion	PHYSICAL MEDICINE AND REHABILITATION CLINICS OF NORTH AMERICA			English	Article						Concussion; mTBI; Magnetic resonance imaging; Diffusion tensor imaging; Functional MRI; Spectroscopy	TRAUMATIC BRAIN-INJURY; MILD HEAD-INJURY; WHITE-MATTER INTEGRITY; SPORTS-RELATED CONCUSSION; DIFFUSE AXONAL INJURY; MAGNETIC-RESONANCE; COMPUTED-TOMOGRAPHY; TECHNETIUM-99M-HMPAO SPECT; OUTCOME PREDICTION; CORPUS-CALLOSUM	In this review, we discuss the literature regarding concussion and mild traumatic brain injury. We focus on the role for neuroimaging in patients with suspected concussion and describe the recommended practices related to imaging in mTBI. This discussion first focuses on the exclusion of severe injuries and is followed by a discussion of the potential utility of various advanced imaging techniques in both research and clinical practice.	[Honce, Justin M.; Nyberg, Eric; Jones, Isaac; Nagae, Lidia] Univ Colorado, Sch Med, Dept Radiol, 12700 East 19th Ave,Mailstop C278, Aurora, CO 80045 USA	Honce, JM (corresponding author), Univ Colorado, Sch Med, Dept Radiol, 12700 East 19th Ave,Mailstop C278, Aurora, CO 80045 USA.	justin.honce@ucdenver.edu					[Anonymous], SPEC REP TRAUM BRAIN; Ashwal S, 2014, J CHILD NEUROL, V29, P1704, DOI 10.1177/0883073814538504; Ashwal S, 2006, ARCH PHYS MED REHAB, V87, pS50, DOI 10.1016/j.apmr.2006.07.275; Barrio JR, 2015, P NATL ACAD SCI USA, V112, pE2039, DOI 10.1073/pnas.1409952112; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Bazarian JJ, 2006, ACAD EMERG MED, V13, P199, DOI 10.1197/j.aem.2005.07.031; Beauchamp MH, 2011, J NEUROTRAUM, V28, P915, DOI 10.1089/neu.2010.1712; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Borich M, 2013, J NEUROTRAUM, V30, P1243, DOI 10.1089/neu.2012.2818; Byrnes Kimberly R, 2014, Front Neuroenergetics, V5, P13, DOI 10.3389/fnene.2013.00013; CDC. CDC, TBI DAT STAT TRAUM B; Chen JK, 2008, CLIN J SPORT MED, V18, P241, DOI 10.1097/JSM.0b013e318170b59d; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; Dessy AM., 2015, NEUROSURG QUART, V25, P423, DOI [10.1097/WNQ.0000000000000085, DOI 10.1097/WNQ.0000000000000085]; Dettwiler A, 2014, J NEUROTRAUM, V31, P180, DOI 10.1089/neu.2013.2983; Dimou S, 2014, J NEUROTRAUM, V31, P413, DOI 10.1089/neu.2013.3050; Fodero-Tavoletti MT, 2011, BRAIN, V134, P1089, DOI 10.1093/brain/awr038; Fox MD, 2010, FRONT SYST NEUROSCI, V4, DOI [10.3389/fnsys.2010.00019, 10.3389/fnsys.2010.0001]; Ge YL, 2009, BRAIN INJURY, V23, P666, DOI 10.1080/02699050903014899; Geijerstam JLA, 2003, ACTA NEUROCHIR, V145, P843, DOI 10.1007/s00701-003-0115-1; GENTRY LR, 1988, AM J NEURORADIOL, V9, P91; Ginde AA, 2008, ACAD EMERG MED, V15, P780, DOI 10.1111/j.1553-2712.2008.00192.x; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; GRAHAM DI, 1995, BRAIN PATHOL, V5, P397, DOI 10.1111/j.1750-3639.1995.tb00618.x; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Henry LC, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-105; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; Holbourn AHS, 1943, LANCET, V2, P438; Iverson GL, 2000, BRAIN INJURY, V14, P1057; JACOBS A, 1994, J NUCL MED, V35, P942; Jacobs A, 1996, J NUCL MED, V37, P1605; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; JENKINS A, 1986, LANCET, V2, P445; Johansen-Berg H, 2009, ANNU REV NEUROSCI, V32, P75, DOI 10.1146/annurev.neuro.051508.135735; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Katayama Y, 2009, J NEUROSURG S, V112, P889; Keightley ML, 2014, J NEUROTRAUM, V31, P437, DOI [10.1089/NEU.2013.3052, 10.1089/neu.2013.3052]; KELLY AB, 1988, AM J NEURORADIOL, V9, P699; Koerte IK, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12303; Koerte IK, 2012, JAMA-J AM MED ASSOC, V308, P1859, DOI 10.1001/jama.2012.13735; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kumar R, 2009, BRAIN INJURY, V23, P675, DOI 10.1080/02699050903014915; Kuzma BB, 2000, SURG NEUROL, V53, P400; Lange RT, 2012, J HEAD TRAUMA REHAB, V27, P188, DOI 10.1097/HTR.0b013e318217f0ad; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Lin AP, 2012, BRAIN IMAGING BEHAV, V6, P208, DOI 10.1007/s11682-012-9181-4; Ling JM, 2012, BRAIN, V135, P1281, DOI 10.1093/brain/aws073; Lingsma HF, 2015, J NEUROTRAUM, V32, P83, DOI 10.1089/neu.2014.3384; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Liu W, 2013, NMR BIOMED, V26, P651, DOI 10.1002/nbm.2910; Luther N, 2013, BRIT J SPORT MED, V47, pe1; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McCrory P, 2013, BRIT J SPORT MED, V47, P268, DOI 10.1136/bjsports-2013-092247; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; Metting Z, 2009, ANN NEUROL, V66, P809, DOI 10.1002/ana.21785; Mittal S, 2009, AM J NEURORADIOL, V30, P232, DOI 10.3174/ajnr.A1461; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Moenninghoff C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122329; Morais DF, 2008, ARQ NEURO-PSIQUIAT, V66, P53, DOI 10.1590/S0004-282X2008000100013; Murugavel M, 2014, J NEUROTRAUM, V31, P1860, DOI 10.1089/neu.2014.3368; Nagy KK, 1999, J TRAUMA, V46, P268, DOI 10.1097/00005373-199902000-00012; National Research Council, 2006, HLTH RISKS EXP LOW L, V7; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Okonkwo David O, 2014, Neurosurgery, V75 Suppl 4, pS82, DOI 10.1227/NEU.0000000000000493; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Orman G, 2015, J NEUROSURG-PEDIATR, V16, P426, DOI 10.3171/2015.3.PEDS1553; ORRISON WW, 1994, AM J NEURORADIOL, V15, P351; Poole VN, 2014, DEV NEUROPSYCHOL, V39, P459, DOI 10.1080/87565641.2014.940619; Raji CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091088; Russman A, 2015, NEUROLOGY, V84, pP7; Saluja RS, 2015, J NEUROTRAUM, V32, P712, DOI 10.1089/neu.2014.3470; Schmierer K, 2007, NEUROIMAGE, V35, P467, DOI 10.1016/j.neuroimage.2006.12.010; Sivak S, 2014, BRAIN INJURY, V28, P341, DOI 10.3109/02699052.2013.865270; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Sours C, 2013, BRAIN RES, V1537, P201, DOI 10.1016/j.brainres.2013.08.034; Soustiel JF, 2008, NEURORADIOLOGY, V50, P189, DOI 10.1007/s00234-007-0337-7; Stein TD, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt234; Stevens MC, 2012, BRAIN IMAGING BEHAV, V6, P293, DOI 10.1007/s11682-012-9157-4; Stippich C., 2015, CLIN FUNCTIONAL MRI; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Thiruppathy SP, 2004, ACTA NEUROCHIR, V146, P1075, DOI 10.1007/s00701-004-0335-z; Tong KA, 2003, RADIOLOGY, V227, P332, DOI 10.1148/radiol.2272020176; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vagnozzi R, 2013, J HEAD TRAUMA REHAB, V28, P284, DOI 10.1097/HTR.0b013e3182795045; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Veterans Affairs, DEP DEF CLIN PRACT G; Wang Y, 2015, DEV NEUROPSYCHOL, V40, P40, DOI 10.1080/87565641.2014.979927; Warmuth C, 2003, RADIOLOGY, V228, P523, DOI 10.1148/radiol.2282020409; Wintermark M, 2004, RADIOLOGY, V232, P211, DOI 10.1148/radiol.2321030824; Wintermark Max, 2015, J Am Coll Radiol, V12, pe1, DOI 10.1016/j.jacr.2014.10.014; Wortzel HS, 2011, J AM ACAD PSYCHIATRY, V39, P511; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970; Yuh Esther L, 2014, Neurosurgery, V75 Suppl 4, pS50, DOI 10.1227/NEU.0000000000000491; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Zacharia TT, 2010, EMERG RADIOL, V17, P97, DOI 10.1007/s10140-009-0842-6; Zhang K, 2010, EXP BRAIN RES, V204, P57, DOI 10.1007/s00221-010-2294-3; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748	111	11	11	1	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1047-9651	1558-1381		PHYS MED REH CLIN N	Phys. Med. Rehabil. Clin. N. Am.	MAY	2016	27	2					411	+		10.1016/j.pmr.2016.01.002			19	Rehabilitation	Rehabilitation	DN4RU	WOS:000377055700005	27154853				2021-06-18	
J	Kelleher, MS; Gao, GZ; Rolen, MF; Bokhari, SAJ				Kelleher, Michael S., Jr.; Gao, Guangzu; Rolen, Michael F.; Bokhari, S. A. Jamal			Completion CT of Chest, Abdomen, and Pelvis after Acute Head and Cervical Spine Trauma: Incidence of Acute Traumatic Findings in the Setting of Low-Velocity Trauma	RADIOLOGY			English	Article							COMPUTED-TOMOGRAPHY; RADIATION-EXPOSURE; OBVIOUS SIGNS; BLUNT TRAUMA; INJURY; RADIOLOGY; TRENDS	Purpose: To determine the frequency of acute traumatic findings in computed tomographic (CT) chest abdomen pelvis (CAP) examinations in patients with acute traumatic head and/or cervical spine injury and no evidence suggesting bodily injury. Materials and Methods: After institutional review board approval with a waiver of informed consent was obtained, a HIPAA-compliant retrospective study was performed. A review of the electronic medical records and dictated reports identified patients who met the following criteria: CT-documented acute head and/or cervical spine trauma, CT CAP performed at least 20 minutes after initial brain and/or cervical spine CT, and no evidence of bodily injury at physical examination or on initial plain radiographs. The types of head and/or cervical injury, as well as mechanisms of injury in these patients, were analyzed. The frequency of acute traumatic injury in the CT CAP examinations was also determined, and 95% confidence intervals were calculated. Results: There were 115 patients who met the study criteria (average age, 67.3 years). Sixty-three (54.8%) patients were male. The average injury severity score was 9.3. No patients who met the criteria for this study were found to have an acute traumatic injury to the chest, abdomen, or pelvis. These 115 CT CAP examinations comprised 7.5% (115 of 1530) of all CT CAP examinations performed in the emergency department over the 15-month study period. Conclusion: CT CAP examinations rarely if ever reveal acute traumatic injury in patients who have experienced low-velocity trauma and have acute head and/or cervical spine trauma in the absence of evidence of bodily injury. (C)RSNA, 2015	[Kelleher, Michael S., Jr.; Gao, Guangzu; Rolen, Michael F.; Bokhari, S. A. Jamal] Yale Univ, Sch Med, Dept Radiol, 333 Cedar St, New Haven, CT 06510 USA	Kelleher, MS (corresponding author), Yale Univ, Sch Med, Dept Radiol, 333 Cedar St, New Haven, CT 06510 USA.	m.kelleher@yale.edu					Asha S, 2012, EMERG MED AUSTRALAS, V24, P43, DOI 10.1111/j.1742-6723.2011.01504.x; Broder J, 2006, EMERG RADIOL, V13, P25, DOI 10.1007/s10140-006-0493-9; Caputo ND, 2014, J TRAUMA ACUTE CARE, V77, P534, DOI 10.1097/TA.0000000000000414; FRIED AM, 1992, J COMPUT ASSIST TOMO, V16, P717, DOI 10.1097/00004728-199209000-00009; Gupta M, 2011, ANN EMERG MED, V58, P407, DOI 10.1016/j.annemergmed.2011.06.003; Heller MT, 2014, EMERG RADIOL, V21, P341, DOI 10.1007/s10140-014-1200-x; Horny M, 2014, J AM COLL RADIOL, V11, P692, DOI 10.1016/j.jacr.2014.01.019; Kalra MK, 2004, RADIOLOGY, V230, P619, DOI 10.1148/radiol.2303021726; Kocher KE, 2011, ANN EMERG MED, V58, P452, DOI 10.1016/j.annemergmed.2011.05.020; Korley FK, 2010, JAMA-J AM MED ASSOC, V304, P1465, DOI 10.1001/jama.2010.1408; Mitchell AM, 2010, CLIN J AM SOC NEPHRO, V5, P4, DOI 10.2215/CJN.05200709; Salim A, 2006, ARCH SURG-CHICAGO, V141, P468, DOI 10.1001/archsurg.141.5.468; Tien HC, 2007, J TRAUMA, V62, P151, DOI 10.1097/TA.0b013e31802d9700; Tyburski JG, 2006, ARCH SURG-CHICAGO, V141, P473; Wu SR, 2006, EMERG RADIOL, V13, P61, DOI 10.1007/s10140-006-0514-8	15	11	11	0	2	RADIOLOGICAL SOC NORTH AMERICA	OAK BROOK	820 JORIE BLVD, OAK BROOK, IL 60523 USA	0033-8419			RADIOLOGY	Radiology	MAY	2016	279	2					395	399		10.1148/radiol.2015151509			5	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	DP7YO	WOS:000378715300006	26694053	Bronze			2021-06-18	
J	Kurowski, BG; Backeljauw, B; Zang, HY; Zhang, NH; Martin, LJ; Pilipenko, V; Yeates, K; Taylor, HG; Wade, S				Kurowski, Brad G.; Backeljauw, Barynia; Zang, Huaiyu; Zhang, Nanhua; Martin, Lisa J.; Pilipenko, Valentina; Yeates, Keith; Taylor, H. Gerry; Wade, Shari			Influence of Catechol-O-methyltransferase on Executive Functioning Longitudinally After Early Childhood Traumatic Brain Injury: Preliminary Findings	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injury; child; executive function; genetics; pediatrics; recovery	ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; GENE-ENVIRONMENT INTERACTION; D2 RECEPTOR GENE; SELF-REGULATION; DOPAMINE; OUTCOMES; PREDICTORS; DYSFUNCTION; SYMPTOMS; CHILDREN	Objective: To elucidate the association of a functional catechol-O-methyltransferase (COMT) genotype (rs4680) with recovery of executive functions up to 18 months after early childhood traumatic brain injury (TBI) compared with an orthopedic injury (OI) group. Setting: Outpatient. Participants: A total of 134 children with a moderate to severe TBI (n = 63) or OI (n = 71) between the ages of 3 and 6 years who were followed 18 months postinjury. Design: Case-comparison, longitudinal cohort Main Measures: The Behavior Rating Inventory of Executive Function, developmental NEuroPSYchological Assessment (NEPSY) of Verbal Fluency, and a modified Stroop Test for young children (Shape School). Results: The low-activity COMT enzyme genotype (AA) was associated with better scores on the developmental NEPSY of Verbal Fluency (F = 3.80; P = .02) and the Shape School (F = 2.89; P = .06) in all participants when controlling for injury type (TBI vs OI) over the first 18 months after injury. Injury type (TBI vs OI) did not significantly moderate the effect of the COMT genotypes on executive function recovery. Conclusion: This study provides preliminary evidence for a role of COMT genotypes in long-term recovery of executive function after pediatric TBI and OI. Larger studies are needed to determine the exact link between genetic variation in the COMT gene and TBI recovery in children.	[Kurowski, Brad G.; Backeljauw, Barynia; Wade, Shari] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Phys Med & Rehabil, 3333 Burnet Ave,MLC 4009, Cincinnati, OH 45229 USA; [Zang, Huaiyu; Zhang, Nanhua] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA; [Martin, Lisa J.; Pilipenko, Valentina] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Human Genet, Cincinnati, OH 45229 USA; [Kurowski, Brad G.] Univ Cincinnati, Coll Med, 3333 Burnet Ave,MLC 4009, Cincinnati, OH 45229 USA; [Yeates, Keith] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [Taylor, H. Gerry] Case Western Reserve Univ, Dept Pediat, Div Dev & Behav Pediat, Cleveland, OH 44106 USA; [Taylor, H. Gerry] Case Western Reserve Univ, Dept Pediat, Div Psychol, Cleveland, OH 44106 USA; [Taylor, H. Gerry] Rainbow Babies & Childrens Hosp, Univ Hosp Case Med Ctr, 2101 Adelbert Rd, Cleveland, OH 44106 USA	Kurowski, BG (corresponding author), Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Phys Med & Rehabil, 3333 Burnet Ave,MLC 4009, Cincinnati, OH 45229 USA.; Kurowski, BG (corresponding author), Univ Cincinnati, Coll Med, 3333 Burnet Ave,MLC 4009, Cincinnati, OH 45229 USA.	brad.kurowski@cchmc.org	Martin, Lisa/E-2425-2016; Yeates, Keith/AAJ-4223-2020	Martin, Lisa/0000-0001-8702-9946; Zhang, Nanhua/0000-0001-5796-3404; Yeates, Keith/0000-0001-7680-2892	Rehabilitation Medicine Scientist Training Program [K-12 HD001097-16]; National Institute for Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD074683-01A1, R01 HD42729]; National Center for Advancing Translational Sciences of the National Institutes of Health (NIH) [8 UL1 TR000077]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12HD001097, K23HD074683, R01HD042729] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001425, UL1TR000077] Funding Source: NIH RePORTER	Funding for this study was supported in part by the Rehabilitation Medicine Scientist Training Program (K-12 HD001097-16), National Institute for Child Health and Human Development (K23HD074683-01A1 and R01 HD42729), and grant 8 UL1 TR000077 from the National Center for Advancing Translational Sciences of the National Institutes of Health (NIH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or other supporting agencies.	Anderson V, 2005, BRAIN INJURY, V19, P699, DOI 10.1080/02699050400025281; Anderson V, 2005, BRAIN INJURY, V19, P459, DOI 10.1080/02699050400004823; Anderson V, 2000, PEDIATR NEUROSURG, V32, P282, DOI 10.1159/000028956; Backeljauw B, 2014, PM&R, V6, P814, DOI 10.1016/j.pmrj.2014.04.004; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Beauchamp M, 2011, DEV NEUROPSYCHOL, V36, P578, DOI 10.1080/87565641.2011.555572; Beaver KM, 2012, PSYCHIAT QUART, V83, P29, DOI 10.1007/s11126-011-9180-4; Berry D, 2014, DEV PSYCHOBIOL, V56, P373, DOI 10.1002/dev.21105; Berry D, 2013, DEV PSYCHOPATHOL, V25, P291, DOI 10.1017/S095457941200106X; Best JR, 2010, CHILD DEV, V81, P1641, DOI 10.1111/j.1467-8624.2010.01499.x; Blasi G, 2005, J NEUROSCI, V25, P5038, DOI 10.1523/JNEUROSCI.0476-05.2005; Bussing R, 2010, J AM ACAD CHILD PSY, V49, P595, DOI 10.1016/j.jaac.2010.03.006; Catroppa C, 2004, BRAIN LANG, V88, P68, DOI 10.1016/S0093-934X(03)00159-7; Catroppa C, 2007, J PEDIATR PSYCHOL, V32, P354, DOI 10.1093/jpepsy/jsl019; Chen H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026661; Cicchetti D, 2012, DEV PSYCHOPATHOL, V24, P411, DOI 10.1017/S0954579412000077; Das D, 2011, AM J MED GENET B, V156B, P346, DOI 10.1002/ajmg.b.31169; Davidson J, 2015, NEUROSCIENTIST, V21, P424, DOI 10.1177/1073858414543150; Derogatis L., 1982, BRIEF SYMPTOM INVENT; Espy KA, 1997, DEV NEUROPSYCHOL, V13, P495, DOI 10.1080/87565649709540690; Espy KA, 2006, PSYCHOL ASSESSMENT, V18, P373, DOI 10.1037/1040-3590.18.4.373; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Fossella J, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-14; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Halleland H, 2009, AM J MED GENET B, V150B, P403, DOI 10.1002/ajmg.b.30831; Hayden EP, 2010, PSYCHIAT GENET, V20, P304, DOI 10.1097/YPG.0b013e32833adccb; Kobori N, 2006, J NEUROTRAUM, V23, P1094, DOI 10.1089/neu.2006.23.1094; Korkman M, 1998, NEPSY DEV NEUROPSYCH; Kramer UM, 2007, J NEUROSCI, V27, P14190, DOI 10.1523/JNEUROSCI.4229-07.2007; Kurowski B, 2012, J PEDIATR REHAB MED, V5, P217, DOI 10.3233/PRM-2012-0214; Kurowski BG, 2011, PM&R, V3, P836, DOI 10.1016/j.pmrj.2011.05.016; Lachman HM, 1996, PHARMACOGENETICS, V6, P243, DOI 10.1097/00008571-199606000-00007; Lavigne JV, 2013, DEV PSYCHOPATHOL, V25, P555, DOI 10.1017/S0954579412001241; Lipsky RH, 2005, J NEUROPSYCH CLIN N, V17, P465, DOI 10.1176/appi.neuropsych.17.4.465; LOTTA T, 1995, BIOCHEMISTRY-US, V34, P4202, DOI 10.1021/bi00013a008; Martel MM, 2011, J ABNORM CHILD PSYCH, V39, P1, DOI 10.1007/s10802-010-9439-5; Mattay VS, 2003, P NATL ACAD SCI USA, V100, P6186, DOI 10.1073/pnas.0931309100; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1032, DOI 10.1097/01.chi.0000173293.05817.b1; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1041, DOI 10.1097/01.chi.0000173292.05817.f8; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; McAllister TW, 2008, BRAIN INJURY, V22, P705, DOI 10.1080/02699050802263019; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; McAllister TW, 2010, PM&R, V2, pS241, DOI 10.1016/j.pmrj.2010.10.005; McAllister TW, 2009, J HEAD TRAUMA REHAB, V24, P65, DOI 10.1097/HTR.0b013e3181996e6b; Mcallister TW, 2004, BRAIN INJURY, V18, P331, DOI 10.1080/02699050310001617370; Nackley AG, 2006, SCIENCE, V314, P1930, DOI 10.1126/science.1131262; Nadebaum C, 2007, DEV NEUROPSYCHOL, V32, P703, DOI 10.1080/87565640701376086; Nussbaum R. L., 2007, THOMPSON THOMPSON GE, P151; Schellekens AFA, 2013, ADDICT BIOL, V18, P344, DOI 10.1111/j.1369-1600.2012.00438.x; Sweitzer MM, 2013, SOC COGN AFFECT NEUR, V8, P499, DOI 10.1093/scan/nss020; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; TEASDALE G, 1974, LANCET, V2, P81; van Roekel E, 2011, J CHILD PSYCHOL PSYC, V52, P1044, DOI 10.1111/j.1469-7610.2011.02424.x; Wade SL, 2011, DEV PSYCHOL, V47, P119, DOI 10.1037/a0021028; Wade SL, 2004, J CONSULT CLIN PSYCH, V72, P776, DOI 10.1037/0022-006X.72.5.776; Wade SL, 1998, PEDIATRICS, V102, P110, DOI 10.1542/peds.102.1.110; Wasserman T, 2013, APPL NEUROPSYCH-CHIL, V2, P88, DOI 10.1080/21622965.2013.748394; Williams Leanne M., 2008, Journal of Integrative Neuroscience, V7, P367, DOI 10.1142/S0219635208001939; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387	61	11	11	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2016	31	3					E1	E9		10.1097/HTR.0000000000000162			9	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	DR3FK	WOS:000379787800001	26394291	Green Accepted			2021-06-18	
J	Morland, C; Pettersen, MN; Hassel, B				Morland, Cecilie; Pettersen, Mi Nguyen; Hassel, Bjornar			Hyperosmolar sodium chloride is toxic to cultured neurons and causes reduction of glucose metabolism and ATP levels, an increase in glutamate uptake, and a reduction in cytosolic calcium	NEUROTOXICOLOGY			English	Article						Hyperosmolarity; Dehydration; Delirium; Neurotoxicity; Sodium; Calcium	CEREBELLAR GRANULE CELLS; TRAUMATIC BRAIN-INJURY; REGULATORY VOLUME DECREASE; RAT-BRAIN; AMINO-ACIDS; HYPERNATREMIA; ASTROCYTES; HYPOGLYCEMIA; DEPOLARIZATION; NEUROTOXICITY	Elevation of serum sodium, hypernatremia, which may occur during dehydration or treatment with sodium chloride, may cause brain dysfunction and damage, but toxic mechanisms are poorly understood. We found that exposure to excess NaCl, 10-100 mmol/L, for 20 h caused cell death in cultured cerebellar granule cells (neurons). Toxicity was due to Na+, since substituting excess Na+ with choline reduced cell death to control levels, whereas gluconate instead of excess Cl- did not. Prior to cell death from hyperosmolar NaCl, glucose consumption and lactate formation were reduced, and intracellular aspartate levels were elevated, consistent with reduced glycolysis or glucose uptake. Concomitantly, the level of ATP became reduced. Pyruvate, 10 mmol/L, reduced NaCl-induced cell death. The extracellular levels of glutamate, taurine, and GABA were concentration-dependently reduced by excess NaCl; high affinity glutamate uptake increased. High extracellular [Na+] caused reduction in intracellular free [Ca2+], but a similar effect was seen with mannitol, which was not neurotoxic. We suggest that inhibition of glucose metabolism with ensuing loss of ATP is a neurotoxic mechanism of hyperosmolar sodium, whereas increased uptake of extracellular neuroactive amino acids and reduced intracellular [Ca2+] may, if they occur in vivo, contribute to the cerebral dysfunction and delirium described in hypernatremia. (C) 2016 Elsevier Inc. All rights reserved.	[Morland, Cecilie; Pettersen, Mi Nguyen; Hassel, Bjornar] Norwegian Def Res Estab, N-2007 Kjeller, Norway; [Morland, Cecilie] Oslo & Akershus Univ, Coll Appl Sci, Oslo, Norway; [Hassel, Bjornar] Oslo Univ Hosp, Dept Complex Neurol & Neurohabilitat, N-0450 Oslo, Norway; [Hassel, Bjornar] Univ Oslo, Oslo, Norway	Hassel, B (corresponding author), Norwegian Def Res Estab, N-2007 Kjeller, Norway.	bjornar.hassel@ffl.no	Morland, Cecilie/G-2536-2014	Morland, Cecilie/0000-0002-1776-1821	Norwegian Health Association [1513]; Norwegian Epilepsy Society (NES)	The authors are indebted to Dr. A. Ring for valuable discussion and help. This study was supported by The Norwegian Health Association (grant# 1513) and the Norwegian Epilepsy Society (NES).	Alharfi IM, 2013, J NEUROTRAUM, V30, P361, DOI 10.1089/neu.2012.2410; Beetsch JW, 1996, BBA-GEN SUBJECTS, V1290, P141, DOI 10.1016/0304-4165(96)00011-6; Bhardwaj A, 2000, STROKE, V31, P1694, DOI 10.1161/01.STR.31.7.1694; Bruera E, 2005, J CLIN ONCOL, V23, P2366, DOI 10.1200/JCO.2005.04.069; CHOI DW, 1987, J NEUROSCI, V7, P369; CSERR HF, 1991, J PHYSIOL-LONDON, V442, P277, DOI 10.1113/jphysiol.1991.sp018793; CSERR HF, 1987, AM J PHYSIOL, V253, pF522; Dreiem A, 2005, NEUROTOXICOLOGY, V26, P321, DOI 10.1016/j.neuro.2005.01.006; Elliott MB, 2007, J NEUROTRAUM, V24, P195, DOI 10.1089/neu.2006.0094; ENGELSEN B, 1986, J NEUROCHEM, V47, P1634, DOI 10.1111/j.1471-4159.1986.tb00806.x; ERECINSKA M, 1991, J NEUROSCI, V11, P2410; GALLO V, 1987, J NEUROSCI, V7, P2203; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Gundersen V, 2001, J CEREBR BLOOD F MET, V21, P41, DOI 10.1097/00004647-200101000-00006; Han M.J., 2015, CASE OSMOTIC DEMYELI, V13, P30; HASSEL B, 1995, NEUROCHEM RES, V20, P413, DOI 10.1007/BF00973096; Himmelseher S, 2001, J NEUROSURG ANESTH, V13, P120, DOI 10.1097/00008506-200104000-00009; Himmelseher S, 2007, CURR OPIN ANESTHESIO, V20, P414, DOI 10.1097/ACO.0b013e3282eff9ea; Kanner B.I., 1994, J EXP BIOL, V19, P6237; Kealy J, 2013, J NEUROSCI METH, V215, P110, DOI 10.1016/j.jneumeth.2013.02.016; LAI JCK, 1977, J NEUROCHEM, V28, P625, DOI 10.1111/j.1471-4159.1977.tb10434.x; Li M, 2013, INJURY, V44, P1213, DOI 10.1016/j.injury.2012.05.021; Lieberman HR, 2007, J AM COLL NUTR, V26, p555S, DOI 10.1080/07315724.2007.10719658; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MEADOW R, 1993, ARCH DIS CHILD, V68, P448, DOI 10.1136/adc.68.4.448; Morales-Mulia S, 1998, J NEUROCHEM, V71, P2330; Morland C, 2007, NEUROCHEM INT, V50, P703, DOI 10.1016/j.neuint.2007.01.003; Ofran Y, 2004, J INTERN MED, V256, P525, DOI 10.1111/j.1365-2796.2004.01411.x; Oja SS, 2013, EPILEPSY RES, V104, P187, DOI 10.1016/j.eplepsyres.2013.01.010; Okada Y, 2001, J PHYSIOL-LONDON, V532, P3, DOI 10.1111/j.1469-7793.2001.0003g.x; Olsen C, 1999, BRAIN RES, V850, P144, DOI 10.1016/S0006-8993(99)02115-0; Olsen SN, 2007, COMP BIOCHEM PHYS A, V148, P339, DOI 10.1016/j.cbpa.2007.05.009; PASANTESMORALES H, 1993, NEUROCHEM RES, V18, P445, DOI 10.1007/BF00967248; Passonneau JV., 1972, FLEXIBLE SYSTEM ENZY; Pendlebury ST, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007808; Ring Avi, 2007, Journal of Pharmacological and Toxicological Methods, V56, P300, DOI 10.1016/j.vascn.2007.05.004; Ropper AH, 2012, NEW ENGL J MED, V367, P746, DOI 10.1056/NEJMct1206321; Rose CR, 2013, GLIA, V61, P1191, DOI 10.1002/glia.22492; Schousboe A., 1989, DISSECTION TISSUE CU, P203; SCHRAMM M, 1990, P NATL ACAD SCI USA, V87, P1193, DOI 10.1073/pnas.87.3.1193; Singh P, 2004, J BIOL CHEM, V279, P35176, DOI 10.1074/jbc.M402282200; SOKOLOFF L, 1977, J NEUROCHEM, V28, P897, DOI 10.1111/j.1471-4159.1977.tb10649.x; Sterns RH, 2015, NEW ENGL J MED, V372, P55, DOI 10.1056/NEJMra1404489; Stevens CF, 2000, P NATL ACAD SCI USA, V97, P12828, DOI 10.1073/pnas.230438697; THURSTON JH, 1986, METAB BRAIN DIS, V1, P129, DOI 10.1007/BF00999383; TRIVEDI B, 1966, J BIOL CHEM, V241, P4110; Unal S, 2008, PEDIATR INT, V50, P29, DOI 10.1111/j.1442-200X.2007.02507.x; VANDERVALK JBF, 1991, EUR J PHARMACOL, V201, P247; Vidan MT, 2009, J AM GERIATR SOC, V57, P2029, DOI 10.1111/j.1532-5415.2009.02485.x; WHO, 2000, GLOB WAT SUPPL SAN A; Zhou XJ, 2015, REV NEUROSCIENCE, V26, P39, DOI 10.1515/revneuro-2014-0053	51	11	11	0	10	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0161-813X	1872-9711		NEUROTOXICOLOGY	Neurotoxicology	MAY	2016	54						34	43		10.1016/j.neuro.2016.03.005			10	Neurosciences; Pharmacology & Pharmacy; Toxicology	Neurosciences & Neurology; Pharmacology & Pharmacy; Toxicology	DN4RE	WOS:000377054100004	26994581				2021-06-18	
J	Sohlberg, MM; Ledbetter, AK				Sohlberg, McKay Moore; Ledbetter, Alexander K.			Management of Persistent Cognitive Symptoms After Sport-Related Concussion	AMERICAN JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; CLINICAL-PRACTICE GUIDELINES; RANDOMIZED CONTROLLED-TRIAL; NEUROCOGNITIVE PERFORMANCE; ASSISTIVE TECHNOLOGY; REMEDIATION PROGRAM; REHABILITATION; CHILDHOOD; SCHOOL; RECOMMENDATIONS	Purpose: This case review examines treatments speech-language pathologists at our clinic delivered to middle school, high school, and college students for the management of persistent cognitive symptoms after sport-related concussion. The goal is to examine a range of treatment options, describe clinical rationale for selecting those treatments, and report outcomes in order to identify feasible interventions for systematic evaluation through efficacy research. Method: Review of clinic intake data identified 63 cases referred for cognitive rehabilitation over a 36-month period. Twenty-four cases (14 women and 10 men) met selection criteria, including documented sport-related concussion, postconcussion symptoms persisting at least 2 months with deleterious effect on school performance, and enrollment in secondary or postsecondary education. The authors independently coded demographics, treatment approaches, functional goal domains, and outcomes. Results: Treatment approaches fell into 4 broad categories: direct attention training, metacognitive strategy training, training assistive technology for cognition, and psychoeducational supports. Eighty-three percent of clients achieved self-selected functional goals. Conclusions: Research has focused primarily on return to play and provision of academic accommodations in the initial weeks following concussion. Findings from this case series suggest that speech-language pathologists can deliver individualized interventions that lead to positive clinical outcomes. The authors hope findings encourage efficacy research.	[Sohlberg, McKay Moore; Ledbetter, Alexander K.] Univ Oregon, Eugene, OR 97403 USA	Ledbetter, AK (corresponding author), Univ Oregon, Eugene, OR 97403 USA.	ledbette@uoregon.edu					Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bouwens SFM, 2009, CLIN REHABIL, V23, P310, DOI 10.1177/0269215508101744; Bovend'Eerdt TJH, 2009, CLIN REHABIL, V23, P352, DOI 10.1177/0269215508101741; Burke Janice Posatery, 2012, Am J Occup Ther, V66, pe85, DOI 10.5014/ajot.2012.004432; Butler RW, 2008, J CONSULT CLIN PSYCH, V76, P367, DOI 10.1037/0022-006X.76.3.367; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS210, DOI 10.1016/j.apmr.2013.06.035; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Chachad S, 2006, CLIN PEDIATR, V45, P285, DOI 10.1177/000992280604500314; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Covassin T, 2013, AM J SPORT MED, V41, P2885, DOI 10.1177/0363546513499230; Dams-O'Connor K, 2013, BRAIN IMPAIR, V14, P51, DOI 10.1017/BrImp.2013.9; De Beaumont L, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.9.FOCUS12278; de Joode E, 2010, CLIN REHABIL, V24, P701, DOI 10.1177/0269215510367551; Devineni T, 2005, BEHAV RES THER, V43, P277, DOI 10.1016/j.brat.2004.01.008; Doolan AW, 2012, ANN BIOMED ENG, V40, P106, DOI 10.1007/s10439-011-0413-3; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Federici S., 2012, ASSISTIVE TECHNOLOGY; FitzGerald DB, 2011, INT J PSYCHOPHYSIOL, V82, P79, DOI 10.1016/j.ijpsycho.2011.02.011; Galbiati S, 2009, NEUROPSYCHOLOGY, V23, P40, DOI 10.1037/a0013409; Gillespie A, 2012, J INT NEUROPSYCH SOC, V18, P1, DOI 10.1017/S1355617711001548; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Glang A, 2008, J HEAD TRAUMA REHAB, V23, P243, DOI 10.1097/01.HTR.0000327256.46504.9f; Glang A, 2008, NEUROREHABILITATION, V23, P477; Grant M, 2014, NEUROPSYCHOL REHABIL, V24, P661, DOI 10.1080/09602011.2014.901228; Green Robin, 2010, Neuropsychol Rehabil, V20, P471, DOI 10.1080/09602011003693298; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hux K, 1996, INTERV SCH CLIN, V31, P158, DOI 10.1177/105345129603100305; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; Kennedy Mary R. T, 2005, Seminars in Speech and Language, V26, P242, DOI 10.1055/s-2005-922103; Kennedy MRT, 2008, NEUROREHABILITATION, V23, P511; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Lee J. B., 2012, PERSPECTIVENEUROPH, V22, P90, DOI [10.1044/nnsld22.3.90., DOI 10.1044/NNSLD22.3.90]; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Luton LM, 2011, BRAIN INJURY, V25, P409, DOI 10.3109/02699052.2011.558044; Maher ME, 2014, BRAIN INJURY, V28, P271, DOI 10.3109/02699052.2013.865269; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Makdissi M, 2013, BRIT J SPORT MED, V47, P308, DOI 10.1136/bjsports-2013-092255; Malec JF, 1999, NEUROPSYCHOL REHABIL, V9, P253, DOI 10.1080/096020199389365; Marshall Cameron M, 2012, J Can Chiropr Assoc, V56, P299; Marshall S, 2012, CAN FAM PHYSICIAN, V58, P257; McCrea M, 2008, MILD TRAUMATIC BRAIN; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Medley AR, 2010, NEUROPSYCHOL REHABIL, V20, P481, DOI 10.1080/09602010903529610; Meehan WP, 2009, PEDIATRICS, V123, P114, DOI 10.1542/peds.2008-0309; Mitka M, 2010, JAMA-J AM MED ASSOC, V304, P1775, DOI 10.1001/jama.2010.1487; Nationwide Children's Hospital, ED GUID CONC CLASSR; Porter KK, 2014, AM J SPEECH-LANG PAT, V23, P507, DOI 10.1044/2014_AJSLP-13-0126; Salvatore AP, 2011, J MED SPEECH-LANG PA, V19, P1; Scherer MJ, 2005, CRIT REV PHYS REHABI, V17, P195, DOI [DOI 10.1615/CRITREVPHYSREHABILMED.V17.I3.30, DOI 10.1615/CritRevPhysRehabilMed.v17.i3.30]; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Sohlberg MM, 2007, J MED SPEECH-LANG PA, V15, pXV; Sohlberg MM., 2011, OPTIMIZING COGNITIVE; SOHLBERG MM, 2014, CLIN PRACTICE PEDIAT, V2, P263, DOI DOI 10.1037/CPP0000072; Turner T, 2008, IMPLEMENT SCI, V3, DOI 10.1186/1748-5908-3-45; van 't Hooft I, 2007, NEUROREHABILITATION, V22, P109; Wade DT, 1997, J NEUROL NEUROSUR PS, V62, P478, DOI 10.1136/jnnp.62.5.478; Woodrome SE, 2011, J INT NEUROPSYCH SOC, V17, P317, DOI 10.1017/S1355617710001700; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216	61	11	11	0	25	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1058-0360	1558-9110		AM J SPEECH-LANG PAT	Am. J. Speech-Lang. Pathol.	MAY	2016	25	2								10.1044/2015_AJSLP-14-0128			12	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	DO6AE	WOS:000377863600003	27115516				2021-06-18	
J	Wang, G; Zhang, JN; Guo, JK; Cai, Y; Sun, HS; Dong, K; Wu, CG				Wang, Guan; Zhang, Jian-ning; Guo, Jia-kui; Cai, Ying; Sun, Hong-sheng; Dong, Kun; Wu, Cheng-gang			Neuroprotective effects of cold-inducible RNA-binding protein during mild hypothermia on traumatic brain injury	NEURAL REGENERATION RESEARCH			English	Article						nerve regeneration; traumatic brain injury; mild hypothermia; cold-inducible RNA-binding protein; mitogen-activated extracellular signal-regulated kinase; anti-apoptosis; neural regeneration	SIGNALING PATHWAY; CIRP EXPRESSION; DOWN-REGULATION; APOPTOSIS; CELLS; NEURONS; ACTIVATION; ERK; SUPPRESSION; SENESCENCE	Cold-inducible RNA-binding protein (CIRP), a key regulatory protein, could be facilitated by mild hypothermia in the brain, heart and liver. This study observed the effects of mild hypothermia at 31 +/- 0.5 degrees C on traumatic brain injury in rats. Results demonstrated that mild hypothermia suppressed apoptosis in the cortex, hippocampus and hypothalamus, facilitated CIRP mRNA and protein expression in these regions, especially in the hypothalamus. The anti-apoptotic effect of mild hypothermia disappeared after CIRP silencing. There was no correlation between mitogen-activated extracellular signal-regulated kinase activation and CIRP silencing. CIRP silencing inhibited extracellular signal-regulated kinase-1/2 activation. These indicate that CIRP inhibits apoptosis by affecting extracellular signal-regulated kinase-1/2 activation, and exerts a neuroprotective effect during mild hypothermia for traumatic brain injury.	[Wang, Guan] Tianjin Med Univ Canc Inst & Hosp, Postgrad Inst, Tianjin, Peoples R China; [Wang, Guan; Guo, Jia-kui; Dong, Kun; Wu, Cheng-gang] Tianjin Univ Tradit Chinese Med, Affiliated Hosp 2, Dept Neurosurg, Tianjin, Peoples R China; [Zhang, Jian-ning] Tianjin Med Univ, Gen Hosp, Dept Neurosurg, Tianjin, Peoples R China; [Cai, Ying; Sun, Hong-sheng] Tianjin Huanhu Hosp, Dept Neurosurg, Tianjin, Peoples R China	Wang, G (corresponding author), Tianjin Med Univ Canc Inst & Hosp, Postgrad Inst, Tianjin, Peoples R China.; Wang, G (corresponding author), Tianjin Univ Tradit Chinese Med, Affiliated Hosp 2, Dept Neurosurg, Tianjin, Peoples R China.	neurocrown@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81303091]	This study was supported by the National Natural Science Foundation of China, No. 81303091.	Al-Fageeh MB, 2009, RNA, V15, P1164, DOI 10.1261/rna.1179109; Andresen M, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0121-3; Artero-Castro A, 2009, MOL CELL BIOL, V29, P1855, DOI 10.1128/MCB.01386-08; Atkins CM, 2009, NEUROSCI LETT, V459, P52, DOI 10.1016/j.neulet.2009.04.064; Darwazeh R, 2013, NEURAL REGEN RES, V8, P2677, DOI 10.3969/j.issn.1673-5374.2013.28.010; Goodrich JT, 2014, WORLD NEUROSURG, V81, P300, DOI 10.1016/j.wneu.2013.02.036; Idris Zamzuri, 2014, Asian J Neurosurg, V9, P115, DOI 10.4103/1793-5482.142690; Kaneko T, 2012, BRAIN RES, V1466, P128, DOI 10.1016/j.brainres.2012.05.001; Koh PO, 2015, NEUROSCI LETT, V588, P18, DOI 10.1016/j.neulet.2014.12.047; Kumar P, 2014, INT J BIOCHEM CELL B, V53, P302, DOI 10.1016/j.biocel.2014.05.038; Li Q, 2014, FRONT BIOSCI-LANDMRK, V19, P1411, DOI 10.2741/4291; Li SC, 2012, BRAIN RES, V1441, P47, DOI 10.1016/j.brainres.2011.12.053; Liu AJ, 2010, BRAIN RES, V1347, P104, DOI 10.1016/j.brainres.2010.05.029; Nishiyama H, 1997, J CELL BIOL, V137, P899, DOI 10.1083/jcb.137.4.899; Oishi K, 2013, FEBS OPEN BIO, V3, P192, DOI 10.1016/j.fob.2013.03.005; Saito K, 2010, BRAIN RES, V1358, P20, DOI 10.1016/j.brainres.2010.08.048; Sticozzi C, 2013, NEUROSCIENCE, V252, P367, DOI 10.1016/j.neuroscience.2013.07.061; Sumitomo Y, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-72; Sun Y, 2015, J RECEPT SIG TRANSD, V35, P600, DOI 10.3109/10799893.2015.1030412; Tan HK, 2008, BIOTECHNOL APPL BIOC, V49, P247, DOI 10.1042/BA20070032; Tong G, 2013, BRAIN RES, V1504, P74, DOI 10.1016/j.brainres.2013.01.041; Wang H, 2016, REPROD TOXICOL, V60, P53, DOI 10.1016/j.reprotox.2016.01.006; Xiong M, 2011, NEUROCHEM INT, V58, P625, DOI 10.1016/j.neuint.2011.01.026; Zhang HT, 2015, BRAIN RES, V1622, P474, DOI 10.1016/j.brainres.2015.07.004; Zhang YH, 2015, MOL NEUROBIOL, V52, P522, DOI 10.1007/s12035-014-8840-4; Zhou M, 2014, BBA-GEN SUBJECTS, V1840, P2253, DOI 10.1016/j.bbagen.2014.02.027	26	11	14	0	14	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	MAY	2016	11	5					771	778		10.4103/1673-5374.182704			8	Cell Biology; Neurosciences	Cell Biology; Neurosciences & Neurology	DP5LF	WOS:000378537700025	27335561	DOAJ Gold, Green Published			2021-06-18	
J	Zarzaur, BL; Bell, T				Zarzaur, Ben L.; Bell, Teresa			Trajectory subtypes after injury and patient-centered outcomes	JOURNAL OF SURGICAL RESEARCH			English	Article						Quality of life; Recovery trajectories; Injury; Trauma	QUALITY-OF-LIFE; HEALTH-CARE UTILIZATION; DEMENTIA CARE; MORTALITY; RECOVERY; MODELS; ASSOCIATIONS; DEPRESSION; TRAUMA; SF-36	Background: The recent focus on patient-centered outcomes highlights the need to better describe recovery trajectories after injury. The purpose of this study was to characterize recovery trajectory subtypes that exist after non-neurologic injury. Materials and methods: A prospective, observational cohort of 500 adults with an Injury Severity Score > 10 but without traumatic brain or spinal cord injury from 2009 to 2011 was formed. The Short Form-36 was administered at admission and repeated at 1, 2, 4, and 12 mo after injury. Group-based trajectory modeling was used to determine the number and shape of physical composite score (PCS) and mental composite score (MCS) trajectories. Results: Three PCS trajectories and five MCS trajectories were identified. For PCS, trajectory 1 (10.4%) has low baseline scores, followed by no improvement over time. Trajectory 2 (65.6%) declines 1 mo after injury then improves over time. Trajectory 3 (24.1%) has a sharp decline followed by rapid recovery. For MCS, trajectory 1 (9.4%) is low at baseline and remains low. Trajectory 2 (14.4%) has a large decrease after injury and does not recover over the next 12 mo. Trajectory 3 (22.7%) has an initial decrease in MCS early, followed by continuous recovery. Trajectory 4 (19.1%) has a steady decline over the study period. Trajectory 5 (34.3%) stays consistently high at all time points. Conclusions: Recovery after injury is complex and results in multiple recovery trajectories. This has implications for patient-centered clinical trial design and in development of patient-specific interventions to improve outcomes. (C) 2016 Elsevier Inc. All rights reserved.	[Zarzaur, Ben L.; Bell, Teresa] Indiana Univ Sch Med, Ctr Outcomes Res Surg, Dept Surg, Indianapolis, IN 46202 USA	Zarzaur, BL (corresponding author), Indiana Univ Sch Med, Ctr Outcomes Res Surg, 702 Rotary Circle,Room 022B, Indianapolis, IN 46202 USA.	bzarzaur@iupui.edu	Zarzaur, Ben/S-6572-2019; Bell, Teresa Maria/Q-9271-2019	Bell, Teresa/0000-0002-6519-4358	National Institute of General Medical Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [K23GM084427]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [K23GM084427] Funding Source: NIH RePORTER	The research reported in this publication was supported by National Institute of General Medical Sciences of the National Institutes of Health under award number K23GM084427.	Boustani MA, 2011, AGING MENT HEALTH, V15, P13, DOI 10.1080/13607863.2010.496445; Brown DS, 2015, PREV SCI, V16, P21, DOI 10.1007/s11121-013-0437-z; Callahan CM, 2011, AGING MENT HEALTH, V15, P5, DOI 10.1080/13607861003801052; Callahan CM, 2005, J AM GERIATR SOC, V53, P367, DOI 10.1111/j.1532-5415.2005.53151.x; DeSalvo KB, 2005, HEALTH SERV RES, V40, P1234, DOI 10.1111/j.1475-6773.2005.00404.x; Dominick KL, 2002, AGING CLIN EXP RES, V14, P499, DOI 10.1007/BF03327351; Ferrante LE, 2015, JAMA INTERN MED, V175, P523, DOI 10.1001/jamainternmed.2014.7889; Gill TM, 2013, JAMA INTERN MED, V173, P1780, DOI 10.1001/jamainternmed.2013.9063; Greenspan AI, 2002, J TRAUMA, V53, P709, DOI 10.1097/00005373-200210000-00015; Holbrook TL, 1999, J TRAUMA, V46, P765, DOI 10.1097/00005373-199905000-00003; Iwashyna TJ, 2012, AM J RESP CRIT CARE, V186, P302, DOI 10.1164/rccm.201206-1138ED; Jones BL, 2001, SOCIOL METHOD RES, V29, P374, DOI 10.1177/0049124101029003005; Kaplan RM, 2003, QUAL LIFE RES, V12, P3, DOI 10.1023/A:1023547632545; Kopjar B, 1996, Inj Prev, V2, P135, DOI 10.1136/ip.2.2.135; MacKenzie EJ, 2002, J TRAUMA, V52, P527, DOI 10.1097/00005373-200203000-00018; Michaels AJ, 2000, J TRAUMA, V48, P841, DOI 10.1097/00005373-200005000-00007; Wang B, 2014, SOC SCI MED, V106, P43, DOI 10.1016/j.socscimed.2014.01.023; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Zafar SY, 2015, J ONCOL PRACT, V11, P145, DOI 10.1200/JOP.2014.001542; Zatzick D, 2008, ANN SURG, V248, P429, DOI 10.1097/SLA.0b013e318185a6b8; Zimmer Z, 2014, J GERONTOL B-PSYCHOL, V69, P275, DOI 10.1093/geronb/gbt099	21	11	12	0	7	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	MAY 1	2016	202	1					103	110		10.1016/j.jss.2015.12.038			8	Surgery	Surgery	DK5OR	WOS:000374969800014	27083954	Green Accepted			2021-06-18	
J	Combs, HL; Jones, TA; Kozlowski, DA; Adkins, DL				Combs, Hannah L.; Jones, Theresa A.; Kozlowski, Dorothy A.; Adkins, DeAnna L.			Combinatorial Motor Training Results in Functional Reorganization of Remaining Motor Cortex after Controlled Cortical Impact in Rats	JOURNAL OF NEUROTRAUMA			English	Article						neuroplasticity; exercise; motor rehabilitation; constraint-induced movement therapy; functional recovery	TRAUMATIC BRAIN-INJURY; CORTICOSPINAL SYSTEM INTEGRITY; SENSORIMOTOR CORTEX; PREMOTOR CORTEX; INTRACORTICAL MICROSTIMULATION; VOLUNTARY EXERCISE; SUBCORTICAL STROKE; LESIONS; PLASTICITY; RECOVERY	Cortical reorganization subsequent to post-stroke motor rehabilitative training (RT) has been extensively examined in animal models and humans. However, similar studies focused on the effects of motor training after traumatic brain injury (TBI) are lacking. We previously reported that after a moderate/severe TBI in adult male rats, functional improvements in forelimb use were accomplished only with a combination of skilled forelimb reach training and aerobic exercise, with or without nonimpaired forelimb constraint. Thus, the current study was designed to examine the relationship between functional motor cortical map reorganization after experimental TBI and the behavioral improvements resulting from this combinatorial rehabilitative regime. Adult male rats were trained to proficiency on a skilled reaching task, received a unilateral controlled cortical impact (CCI) over the forelimb area of the caudal motor cortex (CMC). Three days post-CCI, animals began RT (n = 13) or no rehabilitative training (NoRT) control procedures (n = 13). The RT group participated in daily skilled reach training, voluntary aerobic exercise, and nonimpaired forelimb constraint. This RT regimen significantly improved impaired forelimb reaching success and normalized reaching strategies, consistent with previous findings. RT also enlarged the area of motor cortical wrist representation, derived by intracortical microstimulation, compared to NoRT. These findings indicate that sufficient RT can greatly improve motor function and improve the functional integrity of remaining motor cortex after a moderate/severe CCI. When compared with findings from stroke models, these findings also suggest that more intense RT may be needed to improve motor function and remodel the injured cortex after TBI.	[Combs, Hannah L.; Jones, Theresa A.] Univ Texas Austin, Dept Psychol, Austin, TX 78712 USA; [Jones, Theresa A.] Univ Texas Austin, Inst Neurosci, Austin, TX 78712 USA; [Kozlowski, Dorothy A.] Depaul Univ, Dept Biol Sci, Chicago, IL 60604 USA; [Adkins, DeAnna L.] Med Univ S Carolina, Dept Neurosci, Dept Hlth Sci & Res, Charleston, SC 29425 USA; [Adkins, DeAnna L.] Med Univ S Carolina, Ctr Biomed Imaging, Charleston, SC 29425 USA; [Combs, Hannah L.] Univ Kentucky, Dept Psychol, Lexington, KY 40506 USA	Adkins, DL (corresponding author), Med Univ S Carolina, Dept Neurosci, 173 Ashley Ave,CRI404D,MSC 510, Charleston, SC 29425 USA.	adkinsdl@musc.edu	Jones, Theresa A/F-1182-2010	Jones, Theresa A/0000-0003-0906-6439; Adkins, DeAnna L/0000-0002-3063-5731	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM109040] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS065866] Funding Source: NIH RePORTER; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM109040] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS065866] Funding Source: Medline		Adkins DL, 2008, EXP NEUROL, V212, P14, DOI 10.1016/j.expneurol.2008.01.031; Adkins DL, 2006, J APPL PHYSIOL, V101, P1776, DOI 10.1152/japplphysiol.00515.2006; Adkins DL, 2015, NEUROREHAB NEURAL RE, V29, P989, DOI 10.1177/1545968315576577; Adkins DL, 2005, NEUROSCI LETT, V380, P214, DOI 10.1016/j.neulet.2005.01.036; Adkins DL, 2004, NEUROSCIENCE, V128, P473, DOI 10.1016/j.neuroscience.2004.07.019; Allred RP, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00379; Boychuk JA, 2011, NEUROREHAB NEURAL RE, V25, P88, DOI 10.1177/1545968310385126; Carmichael ST, 2012, ARCH NEUROL-CHICAGO, V69, P161, DOI 10.1001/archneurol.2011.1175; Conner JM, 2005, NEURON, V46, P173, DOI 10.1016/j.neuron.2005.03.003; Deffeyes JE, 2015, J NEUROPHYSIOL, V113, P3893, DOI 10.1152/jn.00760.2014; Fridman EA, 2004, BRAIN, V127, P747, DOI 10.1093/brain/awh082; Gharbawie OA, 2005, NEUROSCIENCE, V130, P601, DOI 10.1016/j.neuroscience.2004.10.010; Gharbawie OA, 2005, BEHAV BRAIN RES, V156, P125, DOI 10.1016/j.bbr.2004.05.015; Griesbach GS, 2007, J NEUROTRAUM, V24, P1161, DOI 10.1089/neu.2006.0255; Griesbach GS, 2011, PM&R, V3, pS64, DOI 10.1016/j.pmrj.2011.02.008; Hsu JE, 2005, EUR J NEUROSCI, V22, P2069, DOI 10.1111/j.1460-9568.2005.04370.x; Humm JL, 1998, BRAIN RES, V783, P286, DOI 10.1016/S0006-8993(97)01356-5; Hyland B, 1998, BEHAV BRAIN RES, V94, P255, DOI 10.1016/S0166-4328(97)00157-5; Jain KK, 2008, DRUG DISCOV TODAY, V13, P1082, DOI 10.1016/j.drudis.2008.09.006; Jefferson S. C., 2015, NEUROREHABIL NEURAL; Johansson BB, 2000, STROKE, V31, P223, DOI 10.1161/01.STR.31.1.223; Jones T. A., 2010, BRAIN REPAIR STROKE; JONES TA, 1994, J NEUROSCI, V14, P2140; Jones TA, 2012, J NEUROTRAUM, V29, P1455, DOI 10.1089/neu.2011.2207; Kleim JA, 2003, NEUROL RES, V25, P789, DOI 10.1179/016164103771953862; Kleim JA, 2004, J NEUROSCI, V24, P628, DOI 10.1523/JNEUROSCI.3440-03.2004; Kleim JA, 2003, NEUROCHEM RES, V28, P1757, DOI 10.1023/A:1026025408742; Kleim JA, 1998, J NEUROPHYSIOL, V80, P3321; Kleim JA, 2008, J SPEECH LANG HEAR R, V51, pS225, DOI 10.1044/1092-4388(2008/018); Kozlowski DA, 1996, J NEUROSCI, V16, P4776; Kozlowski DA, 2013, COMPR PHYSIOL, V3, P121, DOI 10.1002/cphy.c110005; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maldonado MA, 2008, NEUROREHAB NEURAL RE, V22, P250, DOI 10.1177/1545968307308551; Metz GAS, 2000, BEHAV BRAIN RES, V116, P111, DOI 10.1016/S0166-4328(00)00245-X; NEAFSEY EJ, 1986, BRAIN RES REV, V11, P77, DOI 10.1016/0165-0173(86)90011-1; Nishibe M, 2010, J NEUROTRAUM, V27, P2221, DOI 10.1089/neu.2010.1456; Nudo RJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00887; Nudo RJ, 1996, J NEUROPHYSIOL, V75, P2144; Nudo RJ, 1996, SCIENCE, V272, P1791, DOI 10.1126/science.272.5269.1791; O'Bryant A. J., 2014, NEUROREHABIL NE 1219, V19; Piecharka DA, 2005, BRAIN RES BULL, V66, P203, DOI 10.1016/j.brainresbull.2005.04.013; Ramanathan D, 2006, P NATL ACAD SCI USA, V103, P11370, DOI 10.1073/pnas.0601065103; ROUILLER EM, 1993, SOMATOSENS MOT RES, V10, P269, DOI 10.3109/08990229309028837; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seitz RJ, 1998, ARCH NEUROL-CHICAGO, V55, P1081, DOI 10.1001/archneur.55.8.1081; Tennant KA, 2015, NEUROREHAB NEURAL RE, V29, P193, DOI 10.1177/1545968314541329; Tennant KA, 2011, CEREB CORTEX, V21, P865, DOI 10.1093/cercor/bhq159; Teskey GC, 2002, CEREB CORTEX, V12, P98, DOI 10.1093/cercor/12.1.98; Wachmann A., 1958, MOVEMENT NOTATION; Ward NS, 2007, EUR J NEUROSCI, V25, P1865, DOI 10.1111/j.1460-9568.2007.05434.x; Ward NS, 2006, BRAIN, V129, P809, DOI 10.1093/brain/awl002; Weightman MM, 2010, J HEAD TRAUMA REHAB, V25, P206, DOI 10.1097/HTR.0b013e3181dc82d3; WHISHAW IQ, 1993, BEHAV BRAIN RES, V56, P59, DOI 10.1016/0166-4328(93)90022-I; WHISHAW IQ, 1993, HIPPOCAMPUS, V3, P373, DOI 10.1002/hipo.450030311; WISE SP, 1979, NEUROSCIENCE, V4, P65, DOI 10.1016/0306-4522(79)90218-5	55	11	11	0	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 15	2016	33	8					741	747		10.1089/neu.2015.4136			7	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	DJ0ZM	WOS:000373932900004	26421759	Green Published			2021-06-18	
J	Bjorkman, A; Wijk, U; Antfolk, C; Bjorkman-Burtscher, I; Rosen, B				Bjorkman, Anders; Wijk, Ulrika; Antfolk, Christian; Bjorkman-Burtscher, Isabella; Rosen, Birgitta			SENSORY QUALITIES OF THE PHANTOM HAND MAP IN THE RESIDUAL FOREARM OF AMPUTEES	JOURNAL OF REHABILITATION MEDICINE			English	Article						sensory feedback; prosthesis; forearm amputees; referred sensations	UPPER-EXTREMITY AMPUTEES; CORTICAL REORGANIZATION; DISCRIMINATION TEST; NERVE INJURY; AMPUTATION; SENSIBILITY; SENSATION	Objective: Most amputees experience referred sensations, known as a phantom hand map, on the residual forearm, where touch on specific areas is perceived as touch on the amputated hand. The aim of this study was to evaluate the sensory qualities of the phantom hand map. Methods: In 10 traumatic forearm-amputees touch thresholds and discriminative touch of the phantom hand map were assessed and compared with corresponding areas on the contralateral forearm. The study assessed the localization of touch on the phantom hand map, and how distinct and similar to normal touch the referred feeling was. Results: Similar touch thresholds were seen in the phantom hand map and the control site. Tactile discrimination, requiring both detection of stimulus and interpretation, was significantly better in the phantom hand map. Conclusion: This explorative study suggests that the phantom hand map and the superior tactile discrimination seen in the phantom hand map are based on adaptations within the brain. Further studies investigating the neural basis for the phantom hand map are needed.	[Bjorkman, Anders; Wijk, Ulrika; Rosen, Birgitta] Skane Univ Hosp, Dept Hand Surg, SE-20502 Malmo, Sweden; [Antfolk, Christian] Lund Univ, Dept Biomed Engn, Lund, Sweden; [Bjorkman-Burtscher, Isabella] Lund Univ, Dept Radiol, Clin Sci, Lund, Sweden; [Bjorkman-Burtscher, Isabella] Lund Univ, BioImaging Ctr, Lund, Sweden	Rosen, B (corresponding author), Skane Univ Hosp, Dept Hand Surg, SE-20502 Malmo, Sweden.	birgitta.rosen@med.lu.se	Bjorkman-Burtscher, Isabella/AAC-8480-2020; Bjorkman, Anders/AAR-5375-2020; Antfolk, Christian/B-2507-2013	Antfolk, Christian/0000-0001-6783-0461; Wijk, Ulrika/0000-0002-4140-7478; Bjorkman-Burtscher, Isabella/0000-0002-9023-3363	Stockholm Brain Institute; Swedish Research CouncilSwedish Research CouncilEuropean Commission; Crawford Foundation; Promobilia Foundation; Skane County Council Research and Development Foundation	This study was supported by the Stockholm Brain Institute, the Swedish Research Council, the Crawford Foundation, the Promobilia Foundation and Skane County Council Research and Development Foundation. The authors thank Associate Professor Mats Geijer for evaluation of MR images.	Antfolk C, 2012, J REHABIL MED, V44, P702, DOI 10.2340/16501977-1001; Bell-Krotoski J, 1993, J Hand Ther, V6, P114; Bell-Krotoski JA, 2011, REHABILITATION HAND, V1, P132, DOI 10.1016/B978-0-323-05602-1.00011-8; Bjorkman A, 2012, EUR J NEUROSCI, V36, P2098, DOI 10.1111/j.1460-9568.2012.08099.x; BRAUNE S, 1993, J NEUROL NEUROSUR PS, V56, P393, DOI 10.1136/jnnp.56.4.393; Ehrsson HH, 2008, BRAIN, V131, P3443, DOI 10.1093/brain/awn297; Flor H, 1998, EXP BRAIN RES, V119, P205, DOI 10.1007/s002210050334; Grusser SM, 2004, EXP BRAIN RES, V154, P97, DOI 10.1007/s00221-003-1649-4; Grusser SM, 2001, NEUROSCI LETT, V302, P13, DOI 10.1016/S0304-3940(01)01606-8; Hunter JP, 2008, NEUROSCIENCE, V156, P939, DOI 10.1016/j.neuroscience.2008.07.053; Jerosch-Herold C, 2005, J HAND SURG-BRIT EUR, V30B, P252, DOI 10.1016/jshb.2004.12.006; JOHNSON KO, 1994, PROG PAIN RES MANAG, V3, P389; Lundborg G, 2004, J HAND SURG-BRIT EUR, V29B, P418, DOI 10.1016/j.jhsb.2004.02.008; Lundborg G., 2004, NERVE INJURY REPAIR; MOBERG E, 1990, SCAND J REHABIL MED, V22, P127; Nikolajsen L, 2001, BRIT J ANAESTH, V87, P107, DOI 10.1093/bja/87.1.107; RAMACHANDRAN VS, 1992, NEUROREPORT, V3, P583, DOI 10.1097/00001756-199207000-00009; Ramachandran VS, 2000, ARCH NEUROL-CHICAGO, V57, P317, DOI 10.1001/archneur.57.3.317; Schmalzl L., 2011, FRONT HUM NEUROSCI, V5, P1, DOI DOI 10.3389/FNHUM.2011.00001; van Gils W, 2013, ARCH PHYS MED REHAB, V94, P2179, DOI 10.1016/j.apmr.2013.05.025; WEINSTEIN SIDNEY, 1968, P195; Wolfe SW., 2011, GREENS OPERATIVE HAN, Ved 6; Wu CWH, 2002, SOMATOSENS MOT RES, V19, P153, DOI 10.1080/08990220220133261	23	11	13	0	8	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	APR	2016	48	4					365	370		10.2340/16501977-2074			6	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	DH0EU	WOS:000372456100007	26999267	DOAJ Gold			2021-06-18	
J	Blackwood, BP; Bean, JF; Sadecki-Lund, C; Helenowski, IB; Kabre, R; Hunter, CJ				Blackwood, Brian P.; Bean, Jonathan F.; Sadecki-Lund, Corinne; Helenowski, Irene B.; Kabre, Rashmi; Hunter, Catherine J.			Observation for isolated traumatic skull fractures in the pediatric population: unnecessary and costly	JOURNAL OF PEDIATRIC SURGERY			English	Article						Pediatric trauma; Skull fracture; Isolated; Management; Costs	BLUNT HEAD TRAUMA; BRAIN-INJURY; NEUROLOGIC EXAMINATION; RESOURCE UTILIZATION; CHILDRENS HOSPITALS; UNITED-STATES; MANAGEMENT; EMERGENCY; ADMISSION; OUTCOMES	Background: Blunt head trauma accounts for a majority of pediatric trauma admissions. There is a growing subset of these patients with isolated skull fractures, but little evidence guiding their management. We hypothesized that inpatient neurological observation for pediatric patients with isolated skull fractures and normal neurological examinations is unnecessary and costly. Methods: We performed a single center 10 year retrospective review of all head traumas with isolated traumatic skull fractures and normal neurological examination. Exclusion criteria included: penetrating head trauma, depressed fractures, intracranial hemorrhage, skull base fracture, pneumocephalus, and poly-trauma. In each patient, we analyzed: age, fracture location, loss of consciousness, injury mechanism, Emergency Department (ED) disposition, need for repeat imaging, hospital costs, intracranial hemorrhage, and surgical intervention. Results: Seventy-one patients presented to our ED with acute isolated skull fractures, 56% were male and 44% were female. Their ages ranged from 1 week to 12.4 years old. The minority (22.5%) of patients were discharged from the ED following evaluation, whereas 77.5% were admitted for neurological observation. None of the patients required neurosurgical intervention. Age was not associated with repeat imaging or inpatient observation (p= 0.7474, p= 0.9670). No patients underwent repeat head imaging during their index admission. Repeat imaging was obtained in three previously admitted patients who returned to the ED. Cost analysis revealed a significant difference in total hospital costs between the groups, with an average increase in charges of $4,291.50 for admitted patients (p < 0.0001). Conclusion: Pediatric isolated skull fractures are low risk conditions with a low likelihood of complications. Further studies are necessary to change clinical practice, but our research indicates that these patients can be discharged safely from the ED without inpatient observation. This change in practice, additionally, would allow for huge health care dollar savings. (c) 2016 Elsevier Inc. All rights reserved.	[Blackwood, Brian P.; Bean, Jonathan F.; Sadecki-Lund, Corinne; Kabre, Rashmi; Hunter, Catherine J.] Ann & Robert H Lurie Childrens Hosp Chicago, Dept Surg, Div Pediat Surg, 225 E Chicago Ave,Box 63, Chicago, IL 60611 USA; [Helenowski, Irene B.; Hunter, Catherine J.] Northwestern Univ, Feinberg Sch Med, Dept Pediat, 310 E Super St,Searle 4-490, Chicago, IL 60611 USA; [Blackwood, Brian P.] Rush Univ, Med Ctr, Dept Gen Surg, 1750 W Harrison St,Suite 785, Chicago, IL 60612 USA	Blackwood, BP (corresponding author), 225 E Chicago Ave,Box 63, Chicago, IL 60611 USA.	brian_p_blackwood@rush.edu; jfbean@uic.edu; CSadeckiLund@luriechildrens.org; i-helenowski@northwestern.edu; rkabre@luriechildrens.org; chunter@luriechildrens.org					Adams J, 2001, J PEDIATR SURG, V36, P119, DOI 10.1053/jpsu.2001.20026; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Bazarian JJ, 2005, EMERG MED J, V22, P473, DOI 10.1136/emj.2004.019273; Dias MS, 2004, J NEUROSURG, V101, P38, DOI 10.3171/ped.2004.101.2.0038; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Fieldston ES, 2013, PEDIATRICS, V131, P1050, DOI 10.1542/peds.2012-2494; Greenes DS, 1997, ANN EMERG MED, V30, P253, DOI 10.1016/S0196-0644(97)70158-6; Gruskin KD, 1999, ARCH PEDIAT ADOL MED, V153, P15; Hassan SF, 2014, J TRAUMA ACUTE CARE, V77, P166, DOI 10.1097/TA.0000000000000256; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; LIVINGSTON DH, 1991, J TRAUMA, V31, P483, DOI 10.1097/00005373-199104000-00006; Macy ML, 2012, J HOSP MED, V7, P530, DOI 10.1002/jhm.1923; Mannix R, 2013, ANN EMERG MED, V62, P327, DOI 10.1016/j.annemergmed.2013.02.027; Metzger RR, 2014, J PEDIATR SURG, V49, P1856, DOI 10.1016/j.jpedsurg.2014.09.038; Nigrovic LE, 2011, PEDIATRICS, V127, P1067, DOI 10.1542/peds.2010-3373; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Plackett TP, 2015, J PEDIATR SURG, V50, P1758, DOI 10.1016/j.jpedsurg.2015.03.067; Powell EC, 2015, PEDIATRICS, V135, pE851, DOI 10.1542/peds.2014-2858; Reid SR, 2012, CLIN PEDIATR, V51, P745, DOI 10.1177/0009922812446009; Rollins MD, 2011, J PEDIATR SURG, V46, P1342, DOI 10.1016/j.jpedsurg.2010.12.019; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Schunk JE, 1996, PEDIATR EMERG CARE, V12, P160, DOI 10.1097/00006565-199606000-00004; SHACKFORD SR, 1992, J TRAUMA, V33, P385, DOI 10.1097/00005373-199209000-00009; Shortell SM, 2009, JAMA-J AM MED ASSOC, V302, P1223, DOI 10.1001/jama.2009.1373; Spencer MT, 2003, AM J EMERG MED, V21, P111, DOI 10.1053/ajem.2003.50031; Stanley RM, 2014, J PEDIATR-US, V165, P1201, DOI 10.1016/j.jpeds.2014.08.008; STEIN SC, 1990, NEUROSURGERY, V26, P638, DOI 10.1227/00006123-199004000-00012; Stimpson JP, 2014, ACAD MED, V89, P853, DOI 10.1097/ACM.0000000000000252; Varano P, 2015, J TRAUMA ACUTE CARE, V78, P1039, DOI 10.1097/TA.0000000000000604	29	11	12	0	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0022-3468	1531-5037		J PEDIATR SURG	J. Pediatr. Surg.	APR	2016	51	4					654	658		10.1016/j.jpedsurg.2015.08.064			5	Pediatrics; Surgery	Pediatrics; Surgery	DJ8SE	WOS:000374482200029	26472656				2021-06-18	
J	Johnstone, B; Bhushan, B; Hanks, R; Yoon, DP; Cohen, D				Johnstone, Brick; Bhushan, Braj; Hanks, Robin; Yoon, Dong Pil; Cohen, Daniel			Factor Structure of the Brief Multidimensional Measure of Religiousness/Spirituality in US and Indian Samples with Traumatic Brain Injury	JOURNAL OF RELIGION & HEALTH			English	Article						Spirituality; Religion; Brief Multidimensional Measure of Religiousness/Spirituality; Factor analysis	RELIGIOUS PRACTICES; CONGREGATIONAL SUPPORT; MENTAL-HEALTH; SPIRITUALITY; INDIVIDUALS; IMPACT	The aim of this paper was to determine the factor structure of the Brief Multidimensional Measure of Religiousness/Spirituality (BMMRS) based on a sample of individuals from diverse cultures (i.e., USA, India), ethnicities (i.e., Caucasian, African-American, South Asian), and religions (i.e., Christian, Muslim, Hindu). A total of 109 individuals with traumatic brain injury (TBI) were included. Participants completed the BMMRS as part of a broader study on spirituality, religion, prosocial behaviors, and neuropsychological function. A principal components factor analysis with varimax rotation and Kaiser normalization identified a six-factor solution accounting for 72 % of the variance in scores. Five of the factors were deemed to be interpretable and were labeled based on face validity as: (1) Positive Spirituality/Religious Practices; (2) Positive Congregational Support; (3) Negative Spirituality/Negative Congregational Support; (4) Organizational Religion; and (5) Forgiveness. The results were generally consistent with previous studies, suggesting the existence of universal religious, spiritual, and congregational support factors across different cultures and faith traditions. For health outcomes research, it is suggested that the BMMRS factors may be best conceptualized as measuring the following general domains: (a) emotional connectedness with a higher power (i.e., spirituality, positive/negative); (b) culturally based behavioral practices (i.e., religion); and (c) social support (i.e., positive/negative). The results indicate that factor relationships may differ among spiritual, religious, and congregational support variables according to culture and/or religious tradition.	[Johnstone, Brick] Univ Missouri, Dept Hlth Psychol, DC 116-88, Columbia, MO 65212 USA; [Bhushan, Braj] Indian Inst Technol, Kanpur 208016, Uttar Pradesh, India; [Hanks, Robin] Wayne State Univ, Dept Phys Med & Rehabil, Detroit, MI USA; [Yoon, Dong Pil] Univ Missouri, Sch Social Work, Columbia, MO USA; [Cohen, Daniel] Univ Missouri, Dept Religious Studies, Columbia, MO USA	Johnstone, B (corresponding author), Univ Missouri, Dept Hlth Psychol, DC 116-88, Columbia, MO 65212 USA.	johnstoneg@health.missouri.edu	Bhushan, Braj/B-1173-2008	Johnstone, Brick/0000-0001-8845-9649			Baskin TW, 2004, J COUNS DEV, V82, P79, DOI 10.1002/j.1556-6678.2004.tb00288.x; Bodling A., 2002, J SPIRITUALITY MENTA, V18, P109; Bodling A, 2013, INT J THER REHABIL, V20, P72, DOI 10.12968/ijtr.2013.20.2.72; Campbell JD, 2010, J RELIG HEALTH, V49, P3, DOI 10.1007/s10943-008-9227-5; Capanna C, 2013, PSYCHOL RELIG SPIRIT, V5, P316, DOI 10.1037/a0033642; Cohen D, 2009, INT J PSYCHOL RELIG, V19, P121, DOI 10.1080/10508610802711335; Ellison CG, 2000, RES AGING, V22, P630, DOI 10.1177/0164027500226003; Fetzer Institute & National Institute on Aging Working Group, 1999, MULT MEAS REL SPIR U; FITZGERALD Timothy, 2000, IDEOLOGY RELIG STUDI; Flood Gavin, 1996, INTRO HINDUISM; Hackney CH, 2003, J SCI STUD RELIG, V42, P43, DOI 10.1111/1468-5906.t01-1-00160; Hart T, 2007, REHABIL PSYCHOL, V52, P152, DOI 10.1037/0090-5550.52.2.152; Idler EL, 2003, RES AGING, V25, P327, DOI 10.1177/0164027503025004001; Johnstone B, 2002, J RURAL HEALTH, V18, P109, DOI 10.1111/j.1748-0361.2002.tb00882.x; Johnstone B, 2012, J RELIG HEALTH, V51, P1017, DOI 10.1007/s10943-012-9615-8; Johnstone B, 2009, J RELIG HEALTH, V48, P146, DOI 10.1007/s10943-008-9179-9; Koeske, 2006, INT J PSYCHOL RELIG, V16, DOI [https://doi.org/10.1207/s15327582ijpr1603_3, DOI 10.1207/S15327582IJPR1603_3, 10.1207/s15327582ijpr1603_3]; MacDonald DA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117701; Mokuau N, 2001, Pac Health Dialog, V8, P407; Neff JA, 2006, J SCI STUD RELIG, V45, P449, DOI 10.1111/j.1468-5906.2006.00318.x; Pargament KI, 1998, LAWS LIF SYMP SER, V1, P59; Piedmont R. L., 2007, RES SOCIAL SCI STUDY, V17, P177; Piedmont RL, 2002, AM BEHAV SCI, V45, P1888; Ray O, 2004, AM PSYCHOL, V59, P29, DOI 10.1037/0003-066X.59.1.29; Thoresen C E, 1999, J Health Psychol, V4, P291, DOI 10.1177/135910539900400314; Waldron-Perrine B, 2011, REHABIL PSYCHOL, V56, P107, DOI 10.1037/a0023552; Yoon DP, 2005, J HUM BEHAV SOC ENVI, V10, P191, DOI 10.1300/J137v10n01_05	27	11	11	0	10	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0022-4197	1573-6571		J RELIG HEALTH	J. Relig. Health	APR	2016	55	2					572	586		10.1007/s10943-015-0170-y			15	Public, Environmental & Occupational Health; Religion	Public, Environmental & Occupational Health; Religion	DG7ST	WOS:000372284700019	26708139				2021-06-18	
J	McNamee, MJ; Partridge, B; Anderson, L				McNamee, Michael J.; Partridge, Bradley; Anderson, Lynley			Concussion Ethics and Sports Medicine	CLINICS IN SPORTS MEDICINE			English	Article						Concussion; Mild traumatic brain injury; Conflicts of interest; Rugby union; Australian football; Rugby league	CONFLICTS-OF-INTEREST; INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; BRAIN; CONFIDENTIALITY; MANAGEMENT; CLINICIAN; PRESSURE; ZURICH	Despite considerable scientific dispute regarding the science of concussion, there has been a proliferation of position statements and professional guidelines published on sports concussion management over the last 15 years. A number of ethical and clinical problems associated with concussion management protocols remain concerning, (i) diagnosis and management; (ii) conflicts of interest and coercion; (iii) same day return to play; and (iv) reporting, auditing and confidentiality. These issues are critically discussed in the light of recent Consensus Statements. It is argued that the use of independent match day doctors may ameliorate some of these concerns.	[McNamee, Michael J.] Swansea Univ, Coll Engn, Singleton Pk, Swansea SA1 8QQ, W Glam, Wales; [Partridge, Bradley] Univ Queensland, Fac Hlth & Behav Sci, St Lucia, Qld 4072, Australia; [Anderson, Lynley] Univ Otago, Div Hlth Sci, Dunedin 9016, New Zealand	McNamee, MJ (corresponding author), Swansea Univ, Coll Engn, Singleton Pk, Swansea SA1 8QQ, W Glam, Wales.	m.j.mcnamee@swansea.ac.uk	McNamee, Michael/AAI-8780-2020	McNamee, MIchael/0000-0002-5857-909X			Anderson, 2015, KINESIOL REV, V4, P190, DOI DOI 10.1123/KR.2015-0011; Anderson L, 2008, J MED ETHICS, V34, DOI 10.1136/jme.2008.024794; Anderson LC, 2005, J MED ETHICS, V31, P88, DOI 10.1136/jme.2002.000836; [Anonymous], 2013, SPORTS RELATED CONCU; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Chammas M, 2015, PARRAMATTA EELS CONC; Crawley P, 2014, WESTS TIGERS HIT 20K; Davis M., 2001, CONFLICT INTEREST PR; Dunn WR, 2007, AM J SPORT MED, V35, P840, DOI 10.1177/0363546506295177; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Holm S, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3898; Khan K, 2013, BJSM BLOG; Kroshus E, 2015, J ATHL TRAINING, V50, P944, DOI 10.4085/1062-6050-50.6.03; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Malcolm D, 2009, SOCIOL SPORT J, V26, P191, DOI 10.1123/ssj.26.2.191; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McLeod TCV, 2007, CLIN J SPORT MED, V17, P140; McNamee M, 2013, AM J BIOETHICS, V13, P15, DOI 10.1080/15265161.2013.828123; Meehan WP, 2009, PEDIATRICS, V123, P114, DOI 10.1542/peds.2008-0309; Miyashita TL, 2014, ORTHOP J SPORTS MED, V2, DOI 10.1177/2325967114554549; Olson DE, 2013, BRIT J SPORT MED, V47, P5, DOI 10.1136/bjsports-2012-091936; Orchard J., 2012, BJSM BLOG; Partridge B, 2011, AJOB NEUROSCI, V2, P62, DOI DOI 10.1080/21507740.2011.620066; Partridge B, 2014, J BIOETHIC INQ, V11, P65, DOI 10.1007/s11673-013-9491-2; Partridge B, 2014, NEUROETHICS-NETH, V7, P63, DOI 10.1007/s12152-013-9182-z; Ribbans B, 2013, BRIT J SPORT MED, V47, P40, DOI 10.1136/bjsports-2011-090439; Thompson C, 2015, KINESIOL REV, V4, P203; Vagnozzi R, 2005, NEUROSURGERY, V57, P164, DOI 10.1227/01.NEU.0000163413.90259.85; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Waddington I, 2002, BRIT J SPORT MED, V36, P118, DOI 10.1136/bjsm.36.2.118; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832	36	11	11	0	29	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-5919	1556-228X		CLIN SPORT MED	Clin. Sports Med.	APR	2016	35	2					257	+		10.1016/j.csm.2015.10.008			12	Sport Sciences	Sport Sciences	DG9AR	WOS:000372375700008	26832975				2021-06-18	
J	Rodriguez, O; Schaefer, ML; Wester, B; Lee, YC; Boggs, N; Conner, HA; Merkle, AC; Fricke, ST; Albanese, C; Koliatsos, VE				Rodriguez, Olga; Schaefer, Michele L.; Wester, Brock; Lee, Yi-Chien; Boggs, Nathan; Conner, Howard A.; Merkle, Andrew C.; Fricke, Stanley T.; Albanese, Chris; Koliatsos, Vassilis E.			Manganese-Enhanced Magnetic Resonance Imaging as a Diagnostic and Dispositional Tool after Mild-Moderate Blast Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						blast-induced neurotrauma; blast injury; manganese-enhanced MRI (MEMRI); traumatic brain injury	CONTRAST AGENTS; RAT-BRAIN; INTRAVENOUS-INJECTION; FREQUENCY-DEPENDENCE; CEREBROSPINAL-FLUID; BARRIER DISRUPTION; CHLORIDE EXPOSURE; BASAL GANGLIA; MOUSE MODEL; MRI	Traumatic brain injury (TBI) caused by explosive munitions, known as blast TBI, is the signature injury in recent military conflicts in Iraq and Afghanistan. Diagnostic evaluation of TBI, including blast TBI, is based on clinical history, symptoms, and neuropsychological testing, all of which can result in misdiagnosis or underdiagnosis of this condition, particularly in the case of TBI of mild-to-moderate severity. Prognosis is currently determined by TBI severity, recurrence, and type of pathology, and also may be influenced by promptness of clinical intervention when more effective treatments become available. An important task is prevention of repetitive TBI, particularly when the patient is still symptomatic. For these reasons, the establishment of quantitative biological markers can serve to improve diagnosis and preventative or therapeutic management. In this study, we used a shock-tube model of blast TBI to determine whether manganese-enhanced magnetic resonance imaging (MEMRI) can serve as a tool to accurately and quantitatively diagnose mild-to-moderate blast TBI. Mice were subjected to a 30 psig blast and administered a single dose of MnCl2 intraperitoneally. Longitudinal T1-magnetic resonance imaging (MRI) performed at 6, 24, 48, and 72 h and at 14 and 28 days revealed a marked signal enhancement in the brain of mice exposed to blast, compared with sham controls, at nearly all time-points. Interestingly, when mice were protected with a polycarbonate body shield during blast exposure, the marked increase in contrast was prevented. We conclude that manganese uptake can serve as a quantitative biomarker for TBI and that MEMRI is a minimally-invasive quantitative approach that can aid in the accurate diagnosis and management of blast TBI. In addition, the prevention of the increased uptake of manganese by body protection strongly suggests that the exposure of an individual to blast risk could benefit from the design of improved body armor.	[Rodriguez, Olga] Georgetown Univ, Dept Oncol, Lombardi Comprehens Canc Ctr, Med Ctr, 3970 Reservoir Rd NW,Res Bldg,Room WB01, Washington, DC 20057 USA; [Schaefer, Michele L.] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Koliatsos, Vassilis E.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Koliatsos, Vassilis E.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Wester, Brock; Boggs, Nathan; Conner, Howard A.; Merkle, Andrew C.] Johns Hopkins Univ, Appl Phys Lab, Res & Exploratory Dev Dept, Laurel, MD USA; [Lee, Yi-Chien; Albanese, Chris] Georgetown Univ, Med Ctr, Dept Oncol, Washington, DC 20007 USA; [Albanese, Chris] Georgetown Univ, Med Ctr, Dept Pathol, Washington, DC 20007 USA; [Fricke, Stanley T.] George Washington Univ, Pediat & Integrat Syst Biol, Washington, DC USA	Rodriguez, O (corresponding author), Georgetown Univ, Dept Oncol, Lombardi Comprehens Canc Ctr, Med Ctr, 3970 Reservoir Rd NW,Res Bldg,Room WB01, Washington, DC 20057 USA.	rodriguo@georgetown.edu			NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA051008] Funding Source: NIH RePORTER; NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30 CA51008-21, P30 CA51008-18] Funding Source: Medline		ANDERSON DW, 1987, INVEST RADIOL, V22, pS9, DOI 10.1097/00004424-198709000-00052; ANDERSON DW, 1987, MED PHYS, V14, P709; Aoki I, 2004, NEUROIMAGE, V22, P1046, DOI 10.1016/j.neuroimage.2004.03.031; ARIAS E, 1979, B ENVIRON CONTAM TOX, V22, P297, DOI 10.1007/BF02026946; Aschner M, 1999, ENVIRON RES, V80, P105, DOI 10.1006/enrs.1998.3918; Au C, 2008, NEUROTOXICOLOGY, V29, P569, DOI 10.1016/j.neuro.2008.04.022; AUTISSIER N, 1982, TOXICOLOGY, V24, P175, DOI 10.1016/0300-483X(82)90055-5; Baldea JD, 2014, CLIN J SPORT MED, V24, P521, DOI 10.1097/JSM.0000000000000157; BARBEAU A, 1984, NEUROTOXICOLOGY, V5, P13; Barzo P, 1996, J NEUROSURG, V85, P1113, DOI 10.3171/jns.1996.85.6.1113; Beauchamp EM, 2011, J CLIN INVEST, V121, P148, DOI 10.1172/JCI42874; Blanchette M, 2014, J CEREBR BLOOD F MET, V34, P820, DOI 10.1038/jcbfm.2014.14; Bock NA, 2008, NMR BIOMED, V21, P473, DOI 10.1002/nbm.1211; Bouilleret V, 2009, J NEUROTRAUM, V26, P1999, DOI 10.1089/neu.2009.0943; Burke C, 2013, SEMIN ULTRASOUND CT, V34, P44, DOI 10.1053/j.sult.2012.11.004; CALNE DB, 1994, NEUROLOGY, V44, P1583, DOI 10.1212/WNL.44.9.1583; CARIDE V J, 1984, Magnetic Resonance Imaging, V2, P107, DOI 10.1016/0730-725X(84)90064-X; Cernak I, 2004, NEUROBIOL DIS, V17, P29, DOI 10.1016/j.nbd.2004.05.011; Cernak Ibolja, 2010, Front Neurol, V1, P151, DOI 10.3389/fneur.2010.00151; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chuang KH, 2009, MAGN RESON MED, V61, P1528, DOI 10.1002/mrm.21962; Conrad ME, 2000, AM J HEMATOL, V64, P287, DOI 10.1002/1096-8652(200008)64:4<287::AID-AJH9>3.0.CO;2-L; Crossgrove J, 2004, NMR BIOMED, V17, P544, DOI 10.1002/nbm.931; Crossgrove JS, 2005, NEUROTOXICOLOGY, V26, P297, DOI 10.1016/j.neuro.2004.09.004; Crossgrove JS, 2003, NEUROTOXICOLOGY, V24, P3, DOI 10.1016/S0161-813X(02)00089-X; Damkier HH, 2013, PHYSIOL REV, V93, P1847, DOI 10.1152/physrev.00004.2013; DESKIN R, 1981, NEUROTOXICOLOGY, V2, P65; Dobson AW, 2004, ANN NY ACAD SCI, V1012, P115, DOI 10.1196/annals.1306.009; Dodd CA, 2005, INT J TOXICOL, V24, P389, DOI 10.1080/10915810500366500; Erikson KM, 2005, ENVIRON TOXICOL PHAR, V20, P390, DOI 10.1016/j.etap.2005.03.009; Essig Marco, 2006, Top Magn Reson Imaging, V17, P89, DOI 10.1097/01.rmr.0000245464.36148.dc; Fa ZQ, 2010, NEUROSCI LETT, V481, P110, DOI 10.1016/j.neulet.2010.06.063; Fricke ST, 2006, PROSTATE, V66, P708, DOI 10.1002/pros.20392; FURCHNER JE, 1966, HEALTH PHYS, V12, P1415, DOI 10.1097/00004032-196610000-00003; Gallez B, 1998, MAGN RESON IMAGING, V16, P1211, DOI 10.1016/S0730-725X(98)00082-4; Gallez B, 1997, CHEM RES TOXICOL, V10, P360, DOI 10.1021/tx960194p; Geddes-Klein DM, 2006, J NEUROCHEM, V97, P462, DOI 10.1111/j.1471-4159.2006.03761.x; Geyer C, 2009, J NEUROS-PEDIATR, V4, P339, DOI 10.3171/2009.5.PEDS08481; Gioia GA, 2015, BRAIN INJURY, V29, P195, DOI 10.3109/02699052.2014.965210; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Grunecker B, 2010, NMR BIOMED, V23, P913, DOI 10.1002/nbm.1508; Gurkoff G, 2013, PHARMACEUTICALS, V6, P788, DOI 10.3390/ph6070788; HUANG CC, 1993, NEUROLOGY, V43, P1479, DOI 10.1212/WNL.43.8.1479; Inoue T, 2011, REV NEUROSCIENCE, V22, P675, DOI 10.1515/RNS.2011.048; KILBURN CJ, 1987, NEUROTOXICOLOGY, V8, P421; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Koretsky AP, 2004, NMR BIOMED, V17, P527, DOI 10.1002/nbm.940; LAUTERBUR PC, 1989, CLIN ORTHOP RELAT R, P3; Lebda MA, 2012, NEUROTOXICOLOGY, V33, P98, DOI 10.1016/j.neuro.2011.12.008; Lee JH, 2005, MAGN RESON MED, V53, P640, DOI 10.1002/mrm.20368; Lin YJ, 1997, MAGN RESON MED, V38, P378, DOI 10.1002/mrm.1910380305; LONDON RE, 1989, BRAIN RES BULL, V23, P229, DOI 10.1016/0361-9230(89)90152-4; LYDEN A, 1983, ACTA PHARMACOL TOX, V52, P205; Maneshi MM, 2015, J NEUROTRAUM, V32, P1020, DOI 10.1089/neu.2014.3677; McCrory P, 2013, J AM COLL SURGEONS, V216, pE55, DOI 10.1016/j.jamcollsurg.2013.02.020; MENDONCADIAS MH, 1983, SEMIN NUCL MED, V13, P364, DOI 10.1016/S0001-2998(83)80048-8; Milatovic D, 2009, TOXICOL APPL PHARM, V240, P219, DOI 10.1016/j.taap.2009.07.004; NEWLAND MC, 1989, EXP NEUROL, V106, P251, DOI 10.1016/0014-4886(89)90157-X; Ni Y, 1997, ACTA RADIOL, V38, P700; NORMAN AB, 1991, BRAIN RES BULL, V26, P593, DOI 10.1016/0361-9230(91)90100-X; Omalu BI, 2005, J FORENSIC SCI, V50, P1453; Pautler RG, 1998, MAGNET RESON MED, V40, P740, DOI 10.1002/mrm.1910400515; Pollock CB, 2010, PPAR RES, V2010, DOI 10.1155/2010/571783; Racette BA, 2005, MOVEMENT DISORD, V20, P492, DOI 10.1002/mds.20381; Rodriguez O, 2006, CELL CYCLE, V5, P113, DOI 10.4161/cc.5.1.2295; Rofsky N M, 1996, Magn Reson Imaging Clin N Am, V4, P73; RUNGE V M, 1985, Magnetic Resonance Imaging, V3, P43, DOI 10.1016/0730-725X(85)90008-6; RUNGE V M, 1985, Magnetic Resonance Imaging, V3, P27, DOI 10.1016/0730-725X(85)90006-2; SCHUHMANNGIAMPIERI G, 1993, INVEST RADIOL, V28, P753, DOI 10.1097/00004424-199308000-00018; SEMELKA RC, 1993, RADIOLOGY, V188, P593, DOI 10.1148/radiology.188.3.8351317; Shahlaie K, 2013, RESTOR NEUROL NEUROS, V31, P141, DOI 10.3233/RNN-120243; SHIRAKUNI T, 1985, NEUROSURGERY, V17, P557, DOI 10.1227/00006123-198510000-00004; Silva AC, 2004, NMR BIOMED, V17, P532, DOI 10.1002/nbm.945; Sirajuddin P, 2012, CELL CYCLE, V11, P3801, DOI 10.4161/cc.21988; Spaethling JM, 2008, J NEUROTRAUM, V25, P1207, DOI 10.1089/neu.2008.0532; STEINER E, 1989, AM J ROENTGENOL, V152, P487, DOI 10.2214/ajr.152.3.487; Tian Y, 2014, IEEE ACM T COMPUT BI, V11, P1009, DOI 10.1109/TCBB.2014.2338304; Tuschl K, 2013, INT REV NEUROBIOL, V110, P277, DOI 10.1016/B978-0-12-410502-7.00013-2; Van der Linden A, 2002, NEUROSCIENCE, V112, P467, DOI 10.1016/S0306-4522(02)00070-2; Vissapragada S, 2010, CELL CYCLE, V9, P1824, DOI 10.4161/cc.9.9.11542; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Watts LT, 2014, J NEUROTRAUMA; Waubant E, 2006, DIS MARKERS, V22, P235, DOI 10.1155/2006/709869; Weber JT, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00060; Young GS, 2007, NEUROL CLIN, V25, P947, DOI 10.1016/j.ncl.2007.07.010; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zhen ZP, 2012, THERANOSTICS, V2, P45, DOI 10.7150/thno.3448	88	11	12	1	13	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 1	2016	33	7					662	671		10.1089/neu.2015.4002			10	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	DI6QK	WOS:000373624700005	26414591	Green Published			2021-06-18	
J	Southerland, LT; Stephens, JA; Robinson, S; Falk, J; Phieffer, L; Rosenthal, JA; Caterino, JM				Southerland, Lauren T.; Stephens, Julie A.; Robinson, Shari; Falk, James; Phieffer, Laura; Rosenthal, Joseph A.; Caterino, Jeffrey M.			Head Trauma from Falling Increases Subsequent Emergency Department Visits More Than Other Fall-Related Injuries in Older Adults	JOURNAL OF THE AMERICAN GERIATRICS SOCIETY			English	Article						older adults; falls; head trauma; emergency department	FUNCTIONAL DECLINE; CARE; INDIVIDUALS	ObjectivesTo determine whether fall-related injuries affect return to the ED after the initial visit. DesignRetrospective chart review. SettingAcademic Level 1 trauma center ED. ParticipantsIndividuals aged 65 and older evaluated for a fall from standing height or less and discharged (N=263, average age 77, 70% female). MeasurementsAfter institutional review board approval, electronic medical record data were queried. Univariate and multivariable logistic regression models were used to determine factors associated with risk of returning to the ED within 90days. ResultsInjuries included fractures (45%, n=117); head trauma (22%, n=58); abrasions, lacerations, or contusions (34%, n=88); and none (22%, n=57). Emergency care was frequently required, with 13 (5%, 95% confidence interval (CI)=2.3-7.6%) returning within 72hours, 35 (13%, 95% CI=9.2-17%] within 30days, and 57 (22%, 95% CI=17-27%) within 90days. Univariately, the odds of returning to the ED within 90days was more than two times as high for those with head trauma as for those without (odds ratio=2.66). This remained significant in the multivariable model, which controlled for Charlson Comorbidity Index, fractures, soft tissue injuries, and ED observation unit use. ConclusionMore than one-third of older adults with minor head trauma from a fall will need to return to the ED in the following 90days. These individuals should receive close attention from primary care providers. The link between minor head trauma and ED recidivism is a new finding.	[Southerland, Lauren T.; Robinson, Shari; Falk, James; Caterino, Jeffrey M.] Ohio State Univ, Dept Emergency Med, Columbus, OH 43210 USA; [Phieffer, Laura] Ohio State Univ, Dept Orthopaed, Columbus, OH 43210 USA; [Rosenthal, Joseph A.] Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA; [Stephens, Julie A.] Ohio State Univ, Ctr Biostat, Dept Biomed Informat, Columbus, OH 43210 USA	Southerland, LT (corresponding author), 750 Prior Hall,376 W 10th Ave, Columbus, OH 43210 USA.	Lauren.Southerland@osumc.edu		Southerland, Lauren/0000-0002-3561-8332	National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K23AG038351]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K23AG038351] Funding Source: NIH RePORTER	Dr. Caterino's work on this project was supported by the National Institute on Aging Grant K23AG038351.	Bell AJ, 2000, MED J AUSTRALIA, V173, P179, DOI 10.5694/j.1326-5377.2000.tb125596.x; Betz ME, 2014, J AM GERIATR SOC, V62, P1317, DOI 10.1111/jgs.12877; Buurman BM, 2011, EUR J EMERG MED, V18, P215, DOI 10.1097/MEJ.0b013e328344597e; Carpenter CR, 2015, ACAD EMERG MED, V22, P1, DOI 10.1111/acem.12569; Carpenter CR, 2014, ACAD EMERG MED, V21, P1069, DOI 10.1111/acem.12488; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; Cheng PL, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/1757-7241-22-7; Close JCT, 2012, EMERG MED J, V29, P742, DOI 10.1136/emermed-2011-200380; Hall EC, 2014, J TRAUMA ACUTE CARE, V76, P859, DOI 10.1097/TA.0000000000000148; Hasegawa K, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-40; Hirshson CI, 2013, NEUROREHABILITATION, V32, P225, DOI 10.3233/NRE-130840; Kaji AH, 2014, ANN EMERG MED, V64, P292, DOI 10.1016/j.annemergmed.2014.03.025; Keegan THM, 2004, AM J EPIDEMIOL, V159, P192, DOI 10.1093/aje/kwh026; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Nance ML, 2013, NATL TRAUMA DATA BAS; Papa L, 2012, CURR GERIATR REP, V1, P135, DOI 10.1007/s13670-012-0019-0; Salter AE, 2006, OSTEOPOROSIS INT, V17, P672, DOI 10.1007/s00198-005-0032-7; Sirois MJ, 2013, J AM GERIATR SOC, V61, P1661, DOI 10.1111/jgs.12482; Southerland Lauren T, 2014, Am J Emerg Med, V32, P1089, DOI 10.1016/j.ajem.2014.05.005; Tirrell G, 2015, ACAD EMERG MED, V22, P461, DOI 10.1111/acem.12634; Wang Han-Yi, 2007, Chang Gung Med J, V30, P437; Wang H, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-37; Wilber ST, 2010, ACAD EMERG MED, V17, P679, DOI 10.1111/j.1553-2712.2010.00799.x	23	11	11	0	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-8614	1532-5415		J AM GERIATR SOC	J. Am. Geriatr. Soc.	APR	2016	64	4					870	874		10.1111/jgs.14041			5	Geriatrics & Gerontology; Gerontology	Geriatrics & Gerontology	DK1WO	WOS:000374705900020	27100582	Green Accepted			2021-06-18	
J	Wang, B; Kang, M; Marchese, M; Rodriguez, E; Lu, W; Li, XT; Maeda, Y; Dowling, P				Wang, Bo; Kang, Mitchell; Marchese, Michelle; Rodriguez, Esther; Lu, Wei; Li, Xintong; Maeda, Yasuhiro; Dowling, Peter			Beneficial Effect of Erythropoietin Short Peptide on Acute Traumatic Brain Injury	NEUROTHERAPEUTICS			English	Article						Traumatic brain injury; Erythropoietin; Small peptide therapy; Neuroprotection	CONTROLLED CORTICAL IMPACT; NECROSIS-FACTOR-ALPHA; CARBAMYLATED ERYTHROPOIETIN; RAT MODEL; IMMUNO/INFLAMMATORY MODULATION; TISSUE PROTECTION; TEMPORAL PROFILE; EXPRESSION; ASIALOERYTHROPOIETIN; NEUROPROTECTION	There is currently no effective medical treatment for traumatic brain injury (TBI). Beyond the immediate physical damage caused by the initial impact, additional damage evolves due to the inflammatory response that follows brain injury. Here we show that therapy with JM4, a low molecular weight 19-amino acid nonhematopoietic erythropoietin (EPO) peptidyl fragment, containing amino acids 28-46 derived from the first loop of EPO, markedly reduces acute brain injury. Mice underwent controlled cortical injury and received either whole molecule EPO, JM4, or sham-treatment with phosphate-buffered saline. Animals treated with JM4 peptide exhibited a large decrease in number of dead neural cells and a marked reduction in lesion size at both 3 and 8 days postinjury. Therapy with JM4 also led to improved functional recovery and we observed a treatment window for JM4 peptide that remained open for at least 9 h postinjury. The full-length EPO molecule was divided into a series of 6 contiguous peptide segments; the JM4-containing segment and the adjoining downstream region contained the bulk of the death attenuating effects seen with intact EPO molecule following TBI. These findings indicate that the JM4 molecule substantially blocks cell death and brain injury following acute brain trauma and, as such, presents an excellent opportunity to explore the therapeutic potential of a small-peptide EPO derivative in the medical treatment of TBI.	[Wang, Bo; Kang, Mitchell; Marchese, Michelle; Rodriguez, Esther; Lu, Wei; Li, Xintong; Maeda, Yasuhiro; Dowling, Peter] VA Med Ctr East Orange, Neurol Serv, E Orange, NJ USA; [Maeda, Yasuhiro; Dowling, Peter] Rutgers New Jersey Med Sch, Dept Neurol & Neurosci, Newark, NJ USA	Dowling, P (corresponding author), VA Med Ctr East Orange, Neurol Serv, E Orange, NJ USA.; Dowling, P (corresponding author), Rutgers New Jersey Med Sch, Dept Neurol & Neurosci, Newark, NJ USA.	dowlinpc@njms.rutgers.edu	Li, Xintong/G-5341-2016; Wang, Bo/ABC-5571-2020	Li, Xintong/0000-0002-7270-3376; 	VA Office of Research and Development [IO1 RX000220-01]; Segal Fund; NJ Brain Injury Commission [08-3208-BIR-E-1]; Veterans AffairsUS Department of Veterans Affairs [I01RX000220, I01RX001305] Funding Source: NIH RePORTER	We thank Kevin Pang, PhD, for his help with animal studies and clinical scoring data analysis. We also thank William Banks, MD (Seattle, WA, USA), for his aid with the blood-brain barrier JM4 studies. This work was funded by the VA Office of Research and Development (IO1 RX000220-01; PD), the Segal Fund, and the NJ Brain Injury Commission (08-3208-BIR-E-1; PD).	Adembri C, 2008, CRIT CARE MED, V36, P975, DOI 10.1097/CCM.0B013E3181644343; Ahmet I, 2011, MOL MED, V17, P194, DOI 10.2119/molmed.2010.00235; Brines M, 2008, J INTERN MED, V264, P405, DOI 10.1111/j.1365-2796.2008.02024.x; Brines M, 2008, P NATL ACAD SCI USA, V105, P10925, DOI 10.1073/pnas.0805594105; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Chen G, 2007, NEUROSCI LETT, V425, P177, DOI 10.1016/j.neulet.2007.08.022; Chen H, 2014, J NEUROIMMUNOL, V268, P64, DOI 10.1016/j.jneuroim.2014.01.006; Cherian L, 2007, J PHARMACOL EXP THER, V322, P789, DOI 10.1124/jpet.107.119628; Corwin HL, 2007, NEW ENGL J MED, V357, P965, DOI 10.1056/NEJMoa071533; Dalgard CL, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00006; Dicato M, 2008, ONCOLOGIST, V13, P11, DOI 10.1634/theoncologist.13-S3-11; Doggrell SA, 2004, EXPERT OPIN INV DRUG, V13, P1517, DOI 10.1517/13543784.13.11.1517; Ehrenreich H, 2009, STROKE, V40, pE647, DOI 10.1161/STROKEAHA.109.564872; Erbayraktar S, 2003, P NATL ACAD SCI USA, V100, P6741, DOI 10.1073/pnas.1031753100; Fan L, 1996, MOL BRAIN RES, V36, P287, DOI 10.1016/0169-328X(95)00274-V; Grasso G, 2001, J Neurosurg Sci, V45, P7; IMAI N, 1990, EUR J BIOCHEM, V194, P457, DOI 10.1111/j.1432-1033.1990.tb15639.x; Leist M, 2004, SCIENCE, V305, P239, DOI 10.1126/science.1098313; Lewen A, 2001, J CEREBR BLOOD F MET, V21, P914, DOI 10.1097/00004647-200108000-00003; Mahmood A, 2007, J NEUROSURG, V107, P392, DOI 10.3171/JNS-07/08/0392; Mammis A, 2009, SURG NEUROL, V71, P527, DOI 10.1016/j.surneu.2008.02.040; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Robertson CS, 2012, J NEUROTRAUM, V29, P1156, DOI 10.1089/neu.2011.1827; Shelton SB, 2008, J NEUROSCI METH, V168, P431, DOI 10.1016/j.jneumeth.2007.11.003; Siren AL, 2009, NEUROTHERAPEUTICS, V6, P108, DOI 10.1016/j.nurt.2008.10.041; Stover JF, 2000, NEUROSCI LETT, V288, P25, DOI 10.1016/S0304-3940(00)01187-3; Ueba H, 2010, P NATL ACAD SCI USA, V107, P14357, DOI 10.1073/pnas.1003019107; Vlodavsky E, 2006, NEUROPATH APPL NEURO, V32, P40, DOI 10.1111/j.1365-2990.2005.00698.x; Wang L, 2004, STROKE, V35, P1732, DOI 10.1161/01.STR.0000132196.49028.a4; Wang Y, 2007, BRIT J PHARMACOL, V151, P1377, DOI 10.1038/sj.bjp.0707285; Wei X, 2014, INFECT IMMUN, V82, P165, DOI 10.1128/IAI.00929-13; Yatsiv I, 2005, FASEB J, V19, P1701, DOI 10.1096/fj.05-3907fje; Yuan RR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001924; Yuan RR, 2015, NEUROTHERAPEUTICS, V12, P850, DOI 10.1007/s13311-015-0379-1	34	11	12	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1933-7213	1878-7479		NEUROTHERAPEUTICS	Neurotherapeutics	APR	2016	13	2					418	427		10.1007/s13311-015-0418-y			10	Clinical Neurology; Neurosciences; Pharmacology & Pharmacy	Neurosciences & Neurology; Pharmacology & Pharmacy	DI6WY	WOS:000373642100014	26715414	Green Published, Bronze			2021-06-18	
J	Murugan, M; Santhakumar, V; Kannurpatti, SS				Murugan, Madhuvika; Santhakumar, Vijayalakshmi; Kannurpatti, Sridhar S.			Facilitating Mitochondria! Calcium Uptake Improves Activation-Induced Cerebral Blood Flow and Behavior after mTBI	FRONTIERS IN SYSTEMS NEUROSCIENCE			English	Article						TBI; mitochondria; CBF; dietary; calcium uniporter; kaempferol; whisker barrel; oxidative metabolism	TRAUMATIC BRAIN-INJURY; FLUID-PERCUSSION MODEL; RAT BARREL CORTEX; NEURONAL-ACTIVITY; PLANT FLAVONOIDS; NEGATIVE BOLD; CBF RESPONSE; KAEMPFEROL; INCREASES; FMRI	Mild to moderate traumatic brain injury (mTBI) leads to secondary neuronal loss via excitotoxic mechanisms, including mitochondria' Ca2+ overload. However, in the surviving cellular population, mitochondrial Ca2+ influx, and oxidative metabolism are diminished leading to suboptimal neuronal circuit activity and poor prognosis. Hence we tested the impact of boosting neuronal electrical activity and oxidative metabolism by facilitating mitochondrial Ca2+ uptake in a rat model of mTBI. In developing rats (P25-P26) sustaining an mTBI, we demonstrate post-traumatic changes in cerebral blood flow (CBF) in the sensorimotor cortex in response to whisker stimulation compared to sham using functional Laser Doppler Imaging (fLDI) at adulthood (P67-P73). Compared to sham, whisker stimulation-evoked positive CBF responses decreased while negative CBF responses increased in the mTBI animals. The spatiotemporal CBF changes representing underlying neuronal activity suggested profound changes to neurovascular activity after mTBI. Behavioral assessment of the same cohort of animals prior to fLDI showed that mTBI resulted in persistent contralateral sensorimotor behavioral deficit along with ipsilateral neuronal loss compared to sham. Treating mTBI rats with Kaempferol, a dietary flavonol compound that enhanced mitochondrial Ca2+ uptake, eliminated the inter-hemispheric asymmetry in the whisker stimulation-induced positive CBF responses and the ipsilateral negative CBF responses otherwise observed in the untreated and vehicle-treated mTBI animals in adulthood. Kaempferol also improved somatosensory behavioral measures compared to untreated and vehicle treated mTBI animals without augmenting post-injury neuronal loss. The results indicate that reduced mitochondria' Ca2+ uptake in the surviving populations affect post-traumatic neural activation leading to persistent behavioral deficits. Improvement in sensorimotor behavior and spatiotemporal neurovascular activity following kaempferol treatment suggests that facilitation of mitochondria' Ca2+ uptake in the early window after injury may sustain optimal neural activity and metabolism and contribute to improved function of the surviving cellular populations after mTBI.	[Murugan, Madhuvika; Kannurpatti, Sridhar S.] Rutgers New Jersey Med Sch, Dept Radiol, Newark, NJ USA; [Santhakumar, Vijayalakshmi] Rutgers New Jersey Med Sch, Dept Pharmacol Physiol & Neurosci, Newark, NJ USA	Kannurpatti, SS (corresponding author), Rutgers New Jersey Med Sch, Dept Radiol, Newark, NJ USA.	kannursr@njms.rutgers.edu	Santhakumar, Viji/K-4856-2019; Murugan, Madhuvika/AAZ-8533-2020	Santhakumar, Viji/0000-0001-6278-4187; Murugan, Madhuvika/0000-0002-0706-0730	New Jersey Commission for Brain Injury Research [CBIR12-PII.028]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS069861] Funding Source: NIH RePORTER	The study was supported by the grant from the New Jersey Commission for Brain Injury Research, CBIR12-PII.028 (SK).	Bartnik-Olson BL, 2014, J NEUROTRAUM, V31, P1497, DOI 10.1089/neu.2013.3213; Barve A, 2009, BIOPHARM DRUG DISPOS, V30, P356, DOI 10.1002/bdd.677; Calderon-Cortes E, 2008, MITOCHONDRION, V8, P262, DOI 10.1016/j.mito.2008.04.005; Devor A, 2007, J NEUROSCI, V27, P4452, DOI 10.1523/JNEUROSCI.0134-07.2007; DIAMOND ME, 1993, P NATL ACAD SCI USA, V90, P2082, DOI 10.1073/pnas.90.5.2082; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Dowling JL, 1996, J NEUROSCI METH, V66, P113, DOI 10.1016/0165-0270(96)00007-6; DuPont MS, 2004, EUR J CLIN NUTR, V58, P947, DOI 10.1038/sj.ejcn.1601916; Fluegge D, 2012, NAT NEUROSCI, V15, P754, DOI 10.1038/nn.3074; Giorgi C, 2012, MITOCHONDRION, V12, P77, DOI 10.1016/j.mito.2011.07.004; Gosselin N, 2011, J NEUROTRAUM, V28, P329, DOI 10.1089/neu.2010.1493; Gupta A, 2012, J NEUROSCI, V32, P2523, DOI 10.1523/JNEUROSCI.4141-11.2012; Hamalainen M, 2007, MEDIAT INFLAMM, V2007, DOI 10.1155/2007/45673; Harel N, 2002, J CEREBR BLOOD F MET, V22, P908, DOI 10.1097/00004647-200208000-00002; Harris KD, 2005, NAT REV NEUROSCI, V6, P399, DOI 10.1038/nrn1669; Hayward NMEA, 2010, J NEUROTRAUM, V27, P2203, DOI 10.1089/neu.2010.1448; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Johnson BN, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00435; Kann O, 2003, NEUROSCIENCE, V119, P87, DOI 10.1016/S0306-4522(03)00026-5; Kannurpatti SS, 2008, J CEREBR BLOOD F MET, V28, P772, DOI 10.1038/sj.jcbfm.9600574; Kannurpatti SS, 2006, BRAIN RES, V1089, P135, DOI 10.1016/j.brainres.2006.02.114; Kannurpatti SS, 2011, BRAIN RES, V1417, P16, DOI 10.1016/j.brainres.2011.08.026; Kannurpatti SS, 2004, NEUROCHEM INT, V44, P361, DOI 10.1016/S0197-0186(03)00164-5; Kannurpatti SS, 2004, J CEREBR BLOOD F MET, V24, P703, DOI 10.1097/01.WCB.0000121232.04853.46; Kim J, 2010, J NEUROTRAUM, V27, P1399, DOI 10.1089/neu.2009.1215; Lagoa R, 2009, J NEUROCHEM, V111, P473, DOI 10.1111/j.1471-4159.2009.06331.x; Li Y, 2015, NEUROBIOL DIS, V74, P240, DOI 10.1016/j.nbd.2014.11.021; Lifshitz J, 2012, BRAIN STRUCT FUNCT, V217, P49, DOI 10.1007/s00429-011-0323-z; LINDGREN STEN, 1965, BIOPHYSIK, V2, P320; Liu RN, 2006, BIOMED CHROMATOGR, V20, P1178, DOI 10.1002/bmc.675; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Masamoto K, 2012, J CEREBR BLOOD F MET, V32, P1233, DOI 10.1038/jcbfm.2012.50; Mathiesen C, 2011, J NEUROSCI, V31, P18327, DOI 10.1523/JNEUROSCI.4526-11.2011; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McNamara KCS, 2010, J NEUROTRAUM, V27, P695, DOI 10.1089/neu.2009.1237; Middleton E, 2000, PHARMACOL REV, V52, P673; Montero M, 2004, BIOCHEM J, V384, P19, DOI 10.1042/BJ20040990; Pandya JD, 2007, J NEUROTRAUM, V24, P798, DOI 10.1089/neu.2006.3673; Pang KCH, 2015, J NEUROTRAUM, V32, P801, DOI 10.1089/neu.2014.3451; Peterson TC, 2015, BEHAV BRAIN RES, V294, P254, DOI 10.1016/j.bbr.2015.08.007; Pitkanen A, 2009, EPILEPSIA, V50, P21, DOI 10.1111/j.1528-1167.2008.02007.x; Ragan DK, 2013, J CEREBR BLOOD F MET, V33, P48, DOI 10.1038/jcbfm.2012.130; Robertson CL, 2004, DEV BRAIN RES, V151, P141, DOI 10.1016/j.devbrainres.2004.04.007; Sanganahalli BG, 2013, J CEREBR BLOOD F MET, V33, P1115, DOI 10.1038/jcbfm.2013.61; Sanganahalli BG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063317; Sauerbeck A, 2012, EXP NEUROL, V234, P85, DOI 10.1016/j.expneurol.2011.12.012; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Schridde U, 2008, CEREB CORTEX, V18, P1814, DOI 10.1093/cercor/bhm208; Sengupta P, 2013, INT J PREVENTIVE MED, V4, P624; Shih TY, 2013, AAPS J, V15, P753, DOI 10.1208/s12248-013-9490-6; Shmuel A, 2002, NEURON, V36, P1195, DOI 10.1016/S0896-6273(02)01061-9; Slobounov SM, 2010, EXP BRAIN RES, V202, P341, DOI 10.1007/s00221-009-2141-6; Smith CJ, 2015, FRONT NEUROL, V6, DOI [10.3389/fneur.2015.00240, 10.3389/fneur.2015.00073]; Truong TK, 2009, NEUROIMAGE, V47, P65, DOI 10.1016/j.neuroimage.2009.04.045; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Vissiennon C, 2012, J NUTR BIOCHEM, V23, P733, DOI 10.1016/j.jnutbio.2011.03.017; WELKER C, 1976, J COMP NEUROL, V166, P173, DOI 10.1002/cne.901660205; Yokobori S, 2014, CNS NEUROL DISORD-DR, V13, P606, DOI 10.2174/187152731304140702112805	59	11	11	0	6	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5137			FRONT SYST NEUROSCI	Front. Syst. Neurosci.	MAR 8	2016	10									10.3389/fnsys.2016.00019			12	Neurosciences	Neurosciences & Neurology	DF7XH	WOS:000371570600002	27013987	DOAJ Gold, Green Published			2021-06-18	
J	Adeleye, AO				Adeleye, Amos O.			Clinical and Radiologic Outcome of a Less Invasive, Low-Cost Surgical Technique of Osteoplastic Decompressive Craniectomy	JOURNAL OF NEUROLOGICAL SURGERY PART A-CENTRAL EUROPEAN NEUROSURGERY			English	Article						decompressive craniectomy; hinge decompressive craniectomy; low-resource practice; surgical technique; outcome study	TRAUMATIC BRAIN-INJURY; HINGE CRANIOTOMY; HEAD-INJURY; BONE FLAP; CLASSIFICATION	Background Decompressive craniectomy (DC) has many technical details with significant constraining logistic/economic considerations in low-resource practice areas. We present a less invasive, cost-saving, and evidence-based technique of DC evolving in our practice. Methods Earlier, we reported a technique of hinge decompressive craniectomy (hDC), in which the frontotemporoparietal skull flap is hinged on the temporal muscle. In this article we describe further refinements of this temporal muscle hDC : The scalp flap is raised in a galeal-skeletonizing plane preserving the subgaleal fascia on the pericranium, ready for use for duraplasty after durotomy. We performed a descriptive analysis of the clinical outcome of this surgical technique in a prospective consecutive cohort of patients with traumatic brain injury (TBI). The primary and secondary clinical outcome measures were in-hospital mortality and survival, respectively, and the immediate as well as long-term surgical wound issues. Results There were 40 cases, 38men (95%) and 2 women over a 40-month period with amild (n = 8), moderate (n = 17), or severe TBI (n = 15). As assessed by the computed tomography Rotterdam score, life-threatening significant brain injury was present in 90%. Poor clinical outcome occurred in about a third of cases (32.5%) mainly in the severe TBI group (77% of poor outcome) and not in the mild TBI group. Surgical site complications occurred in four patients (10%) Conclusions The presented modified temporal muscle hDC technique offers significant economic advantages over the traditional surgical method of DC without added complications. Analysis of the clinical data in a consecutive prospective cohort of patients with potentially fatal TBI who underwent this surgical procedure showed a good outcome in at least two thirds.	[Adeleye, Amos O.] Univ Ibadan, Dept Surg, Div Neurol Surg, Ibadan, Nigeria; [Adeleye, Amos O.] UCH, Ibadan, Nigeria	Adeleye, AO (corresponding author), Univ Coll Hosp, Dept Neurol Surg, PMB 5116, Ibadan 200001, Nigeria.	femdoy@yahoo.com					Adeleye A, 2014, E CENT AFRICA J SURG, V19, P67; Adeleye A Olufemi, 2011, Surg Neurol Int, V2, P150, DOI 10.4103/2152-7806.86227; Adeleye AO, 2013, NEUROSURG QUART, V23, P127, DOI 10.1097/WNQ.0b013e318266c44a; Adeleye AO, 2010, INDIAN J NEUROTRAUM, V7, P41, DOI 10.1016/S0973-0508(10)80010-3; Baldo S, 2010, WORLD NEUROSURG, V73, P552, DOI 10.1016/j.wneu.2010.02.018; Bhaskar IP, 2011, ANZ J SURG, V81, P137, DOI 10.1111/j.1445-2197.2010.05584.x; Burger R, 2008, ACTA NEUROCHIR SUPPL, V102, P93, DOI 10.1007/978-3-211-85578-2_19; Chibbaro S, 2007, SURG NEUROL, V68, P632, DOI 10.1016/j.surneu.2006.12.046; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Goettler CE, 2007, J TRAUMA, V62, P777, DOI 10.1097/TA.0b013e31802ee55e; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Honeybul S, 2009, J CLIN NEUROSCI, V16, P727, DOI 10.1016/j.jocn.2008.06.015; Ito H, 2011, ACTA NEUROCHIR, V153, P2251, DOI 10.1007/s00701-011-1077-3; Kakar V, 2009, BRIT J NEUROSURG, V23, P147, DOI 10.1080/02688690902756702; Kenning TJ, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0960; Kersh AM, 2012, MED J CAIRO U, V80, P143; Ko K, 2007, NEUROSURGERY, V60, P255, DOI 10.1227/01.NEU.0000255380.64969.81; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Missori P, 2008, SURG NEUROL, V70, P437, DOI 10.1016/j.surneu.2007.03.029; Miyake S, 2006, NEUROL MED-CHIR, V46, P104, DOI 10.2176/nmc.46.104; Mracek J, 2011, ACTA NEUROCHIR, V153, P2259, DOI 10.1007/s00701-011-1132-0; Piek Jurgen, 2002, Curr Opin Crit Care, V8, P134, DOI 10.1097/00075198-200204000-00008; Salvatore C, 2008, J NEUROSURG, V108, P74, DOI 10.3171/JNS/2008/108/01/0074; Schirmer CM, 2008, NEUROCRIT CARE, V8, P456, DOI 10.1007/s12028-008-9082-y; Schmidt JH, 2007, J NEUROSURG, V107, P678, DOI 10.3171/JNS-07/09/0678; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965	27	11	11	0	2	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	2193-6315	2193-6323		J NEUROL SURG PART A	J. Neurol. Surg. Part A	MAR	2016	77	2					167	175		10.1055/s-0035-1566115			9	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	DF1CE	WOS:000371075200012	26731715				2021-06-18	
J	Arya, V; Chigurupati, R				Arya, Varun; Chigurupati, Radhika			Treatment Algorithm for Intracranial Intrusion Injuries of the Mandibular Condyle	JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY			English	Article							MIDDLE CRANIAL FOSSA; TRAUMATIC DISLOCATION; GLENOID FOSSA; FRACTURES; EXPERIENCE; MANAGEMENT; DIAGNOSIS; CHILDREN	Purpose: Traumatic injuries of the mandible resulting in intrusion of the condyle into the middle cranial fossa are rare and treatment is often based on anecdotal experience. The objective of this study was to develop an algorithm for the management of condylar intrusion injuries by identifying factors that influenced the treatment decision of closed versus open reduction of the condyle. Materials and Methods: This study was a systematic review of the literature on intracranial intrusion injuries of the mandibular condyle. A thorough search of the PubMed and Cochrane databases and individual maxillofacial and craniofacial journal databases was conducted using the Medical Subject Heading terms condylar impaction, condylar dislocation, condylar intrusion, and middle cranial fossa and condyle without date and language restriction. Quantitative data on the patient's age, gender, etiology of injury, and time from injury to diagnosis were analyzed using descriptive statistics. The authors studied how the predictor variables of age, etiology, time from injury to diagnosis, and associated neurologic injuries influenced the outcome variable of closed versus open reduction of the condyle. Results: Forty-eight of the 62 retrieved case reports, case series, and review articles were published in the English-language literature from 1963 to 2015. Data on 51 patients with these injuries showed that 38 (75%) were female and younger than 30 years. The most common etiology of injury was motor vehicular accidents, occurring in 25 of 51 patients (49%). The mean time from injury to diagnosis was 31.2 days (0 to 106.4 days). Forty of the 51 patients (78%) were diagnosed within the first 2 weeks of injury. A good proportion of patients underwent open reduction (63%) and 18 of the 51 of patients (35%) underwent closed reduction. Conclusions: Predictor variables that influenced the treatment decision of open versus closed reduction were age of the patient, etiology of injury, and time from injury to diagnosis. Based on the present results, younger patients (0 to 15 yr old), patients who sustain condylar intrusion injuries from bicycle accidents, and those diagnosed within the first 2 weeks of injury are more likely to benefit from closed reduction. The treatment algorithm emphasizes the importance of assessment of associated neurologic injuries and an interdisciplinary approach for the management of these injuries. (C) 2016 American Association of Oral and Maxillofacial Surgeons J Oral Maxillofac Surg 74: 569-581, 2016	Boston Univ, Sch Dent Med, Dept Oral & Maxillofacial Surg, Boston, MA 02215 USA; Boston Med Ctr, Boston, MA USA	Arya, V (corresponding author), 100 E Newton St,Suite G-407, Boston, MA 02118 USA.	arya@bu.edu		Arya, Varun/0000-0002-8665-1300			BALDWIN AJ, 1990, J ORAL MAXIL SURG, V48, P623, DOI 10.1016/S0278-2391(10)80479-3; Barron RP, 2002, ORAL SURG ORAL MED O, V93, P640, DOI 10.1067/moe.2002.122824; Cascone P, 2003, J CRANIOFAC SURG, V14, P184, DOI 10.1097/00001665-200303000-00009; Chacon GE, 2003, J ORAL MAXIL SURG, V61, P668, DOI 10.1053/joms.2003.50134; Clauser L, 2006, J CRANIOFAC SURG, V17, P590, DOI 10.1097/00001665-200605000-00036; DAFONSECA GD, 1974, INT J ORAL MAXILLOF, V3, P89, DOI 10.1016/S0300-9785(74)80040-2; DAHLBERG G, 1995, J ORAL MAXIL SURG, V53, P461, DOI 10.1016/0278-2391(95)90725-4; Dijkstra PU, 2005, J TRAUMA, V59, P422, DOI 10.1097/01.ta.0000174942.80363.06; DINGMAN R O, 1963, Plast Reconstr Surg, V31, P563, DOI 10.1097/00006534-196306000-00008; ELLIS E, 1985, ORAL SURG ORAL MED O, V59, P120, DOI 10.1016/0030-4220(85)90002-7; ENGEVALL S, 1992, J ORAL MAXIL SURG, V50, P524, DOI 10.1016/S0278-2391(10)80330-1; Erol BE, 2004, J CRANIO MAXILL SURG, V32, P308, DOI 10.1016/j.jcms.2004.04.006; Harstall R, 2005, J TRAUMA, V59, P1495, DOI 10.1097/01.ta.0000199241.49446.80; KALLAL RH, 1977, ORAL SURG ORAL MED O, V43, P2, DOI 10.1016/0030-4220(77)90342-5; Lloyd TE, 2010, BRIT J ORAL MAX SURG, V48, P176, DOI 10.1016/j.bjoms.2009.08.031; Magge SN, 2007, J NEUROSURG, V107, P75, DOI 10.3171/PED-07/07/075; Man C, 2011, INT J ORAL MAX SURG, V40, P118, DOI 10.1016/j.ijom.2010.02.028; Marker P, 2000, BRIT J ORAL MAX SURG, V38, P417, DOI 10.1054/bjom.2000.0317; Marston AP, 2012, LARYNGOSCOPE, V122, P1401, DOI 10.1002/lary.23260; Matsumoto K, 2006, DENTOMAXILLOFAC RAD, V35, P357, DOI 10.1259/dmfr/30011413; Melugin MB, 1997, J ORAL MAXIL SURG, V55, P1342, DOI 10.1016/S0278-2391(97)90199-3; Meyers JA, 2014, OTOLARYNG HEAD NECK, V150, P133, DOI 10.1177/0194599813512772; Oberman B, 2014, AM J OTOLARYNG, V35, P251, DOI 10.1016/j.amjoto.2013.11.004; Ohura N, 2006, J ORAL MAXIL SURG, V64, P1165, DOI 10.1016/j.joms.2006.03.043; Oikarinen K, 2005, MED PRIN PRACT, V14, P10, DOI 10.1159/000081917; PIROK DJ, 1970, ORAL SURG ORAL MED O, V29, P13, DOI 10.1016/0030-4220(70)90405-6; Rosa Vera L M, 2006, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, V102, pe4, DOI 10.1016/j.tripleo.2006.02.004; Sandler NA, 1996, J ORAL MAXIL SURG, V54, P506, DOI 10.1016/S0278-2391(96)90129-9; Scafati CT, 2008, CHILD NERV SYST, V24, P1067, DOI 10.1007/s00381-008-0659-8; SEYMOUR RL, 1976, J ORAL SURG, V34, P180; Smith RR, 1980, ESSENTIALS NEUROSURG, p[6, 108, 118]; Struewer J, 2012, J CRANIO MAXILL SURG, V40, P396, DOI 10.1016/j.jcms.2011.07.006; Tutela JP, 2013, J CRANIOFAC SURG, V24, P1703, DOI 10.1097/SCS.0b013e31828a76b1; Vaezi T, 2014, ORAL MAXILLOFAC SURG, V18, P69, DOI 10.1007/s10006-013-0395-4; WISH-BARATZ S, 1992, Journal of Craniomandibular Disorders, V6, P171; Zachariades N, 2006, J CRANIO MAXILL SURG, V34, P421, DOI 10.1016/j.jcms.2006.07.854; Zhang SL, 2014, CRANIO, V32, P63, DOI 10.1179/0886963413Z.0000000007	37	11	11	0	6	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-2391	1531-5053		J ORAL MAXIL SURG	J. Oral Maxillofac. Surg.	MAR	2016	74	3					569	581		10.1016/j.joms.2015.09.033			13	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	DE1FX	WOS:000370373300025	26514632				2021-06-18	
J	Bahado-Singh, RO; Graham, SF; Turkoglu, O; Beauchamp, K; Bjorndahl, TC; Han, B; Mandal, R; Pantane, J; Kowalenko, T; Wishart, DS; Stahel, PF				Bahado-Singh, Ray O.; Graham, Stewart F.; Turkoglu, Onur; Beauchamp, Kathryn; Bjorndahl, Trent C.; Han, BeomSoo; Mandal, Rupasri; Pantane, Jenee; Kowalenko, Terry; Wishart, David S.; Stahel, Philip F.			Identification of candidate biomarkers of brain damage in a mouse model of closed head injury: a metabolomic pilot study	METABOLOMICS			English	Article						Metabolomics; Traumatic brain injury; NMR; Biomarkers	MAGNETIC-RESONANCE; OXIDATIVE STRESS; ALZHEIMERS-DISEASE; GLUCOSE-METABOLISM; RAT MODEL; METABOANALYST; MICRODIALYSIS; GLUTAMATE; MICE; HMDB	We aim to identify candidate brain biomarkers for, and to elucidate the pathophysiology of closed traumatic brain injury (TBI). Nuclear magnetic resonance (NMR) based metabolomic analysis was performed on the whole brain of mice undergoing TBI using a validated technique. There were 10 TBI mice compared to 8 sham operated controls. A total of 45 metabolites were evaluated. There was a statistically significant alteration in concentrations of 29 metabolites in TBI brains as compared to controls (FDR <0.05). Profound disturbances of severalmetabolic pathways (FDR <1E-07), including pathways associated with purine, alanine, aspartate and glutamine and glutathione metabolism were observed. Also, a significant elevation in glutamate (the main excitatory neurotransmitter) and depression of GABA (the main inhibitory neurotransmitter) was observed. Four metabolites, ADP, AMP, NAD+, and IMP were the most important indicators of TBI, relative to normal controls. All were elevated in the TBI mice. A combination of these 4 biomarkers produced a perfect predictor of TBI status, AUC (95 % CI) = 1.0 (1.0, 1.0). We also detected significant disturbances in mitochondrial function, energy metabolism, neurotransmitter metabolism and other important biochemical pathways in TBI mouse brains. Further studies to assess the utility of metabolomics to detect and classify the severity of and assess the prognosis of TBI is warranted.	[Bahado-Singh, Ray O.; Graham, Stewart F.; Turkoglu, Onur] Oakland Univ, William Beaumont Sch Med, Dept Obstet & Gynecol, 3601 W 13 Mile Rd, Royal Oak, MI 48073 USA; [Beauchamp, Kathryn; Stahel, Philip F.] Univ Colorado, Sch Med, Dept Neurosurg, Denver Hlth Med Ctr, Denver, CO USA; [Bjorndahl, Trent C.; Han, BeomSoo; Mandal, Rupasri; Wishart, David S.] Univ Alberta, Dept Biol & Comp Sci, Edmonton, AB, Canada; [Kowalenko, Terry] Oakland Univ, Dept Emergency Med, William Beaumont Sch Med, 3601 W 13 Mile Rd, Royal Oak, MI 48073 USA; [Pantane, Jenee; Stahel, Philip F.] Univ Colorado, Sch Med, Dept Orthoped, Denver Hlth Med Ctr, Denver, CO USA	Graham, SF (corresponding author), Oakland Univ, William Beaumont Sch Med, Dept Obstet & Gynecol, 3601 W 13 Mile Rd, Royal Oak, MI 48073 USA.	stewart.graham@beaumont.org	Wishart, David Scott/ABI-3181-2020; Graham, Stewart/AAE-9772-2020	Wishart, David S/0000-0002-3207-2434; Graham, Stewart/0000-0003-1001-0002	Alberta Innovates [201201143] Funding Source: researchfish		Bass CR, 2012, ANN BIOMED ENG, V40, P185, DOI 10.1007/s10439-011-0424-0; Bayir H, 2006, DEV NEUROSCI-BASEL, V28, P420, DOI 10.1159/000094168; Brooks WM, 2001, J HEAD TRAUMA REHAB, V16, P149, DOI 10.1097/00001199-200104000-00005; Casey PA, 2008, J NEUROTRAUM, V25, P603, DOI 10.1089/neu.2007.0481; Chamoun R, 2010, J NEUROSURG, V113, P564, DOI 10.3171/2009.12.JNS09689; Chapman JC, 2014, ALZHEIMERS DEMENT, V10, pS97, DOI 10.1016/j.jalz.2014.04.012; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Di Pietro V, 2014, MOL MED, V20, P147, DOI 10.2119/molmed.2013.00153; Fawcett T., 2003, HPL20034; Fitzpatrick MA, 2013, SWISS MED WKLY, V143, DOI 10.4414/smw.2013.13743; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Folkersma H, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-67; Gallagher CN, 2009, BRAIN, V132, P2839, DOI 10.1093/brain/awp202; Graham SF, 2014, METABOLOMICS, V10, P744, DOI 10.1007/s11306-013-0610-1; Graham SF, 2013, METABOLOMICS, V9, P974, DOI 10.1007/s11306-013-0516-y; Graham SF, 2013, ANAL CHEM, V85, P1803, DOI 10.1021/ac303163f; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jalloh I, 2015, METAB BRAIN DIS, V30, P615, DOI 10.1007/s11011-014-9628-y; Jove M, 2014, J NEUROPATH EXP NEUR, V73, P640, DOI 10.1097/NEN.0000000000000091; Kurowski B, 2012, J PEDIATR REHAB MED, V5, P217, DOI 10.3233/PRM-2012-0214; Lemaire L, 2011, J BIOMED SCI ENG, V4, P110; Lionetto L, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-55; Marcoux J, 2008, CRIT CARE MED, V36, P2871, DOI 10.1097/CCM.0b013e318186a4a0; MorgantiKossman MC, 1997, MOL PSYCHIATR, V2, P133, DOI 10.1038/sj.mp.4000227; Neher MD, 2014, SOUTH MED J, V107, P248, DOI 10.1097/SMJ.0000000000000086; Neher MD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-95; Pascual JM, 2007, J NEUROTRAUM, V24, P944, DOI 10.1089/neu.2006.0190; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Prabakaran S, 2004, MOL PSYCHIATR, V9, P684, DOI 10.1038/sj.mp.4001511; Prasad KN, 2015, BRAIN RES, V1599, P103, DOI 10.1016/j.brainres.2014.12.038; Ravanbakhsh S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124219; Robertson CL, 2013, J NEUROTRAUM, V30, P2066, DOI 10.1089/neu.2013.3007; Rodriguez-Rodriguez A, 2014, CURR MED CHEM, V21, P1201, DOI 10.2174/0929867321666131217153310; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Takao K, 2015, P NATL ACAD SCI USA, V112, P1167, DOI 10.1073/pnas.1401965111; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Viant MR, 2005, NMR BIOMED, V18, P507, DOI 10.1002/nbm.980; Vuille-Dit-Bille RN, 2012, AMINO ACIDS, V43, P1287, DOI 10.1007/s00726-011-1202-x; Walsh BH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050520; Wang Y, 2014, INT J CLIN EXP PATHO, V7, P4067; Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Wishart DS, 2010, METHODS MOL BIOL, V593, P283, DOI 10.1007/978-1-60327-194-3_14; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810; Wright DW, 2013, MMWR-MORBID MORTAL W, V62, P549; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Xia JG, 2013, METABOLOMICS, V9, P280, DOI 10.1007/s11306-012-0482-9; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356; Yatsiv I, 2002, J CEREBR BLOOD F MET, V22, P971, DOI 10.1097/00004647-200208000-00008	54	11	11	2	24	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1573-3882	1573-3890		METABOLOMICS	Metabolomics	MAR	2016	12	3							42	10.1007/s11306-016-0957-1			13	Endocrinology & Metabolism	Endocrinology & Metabolism	DG5XY	WOS:000372156000003					2021-06-18	
J	Wang, JW; Li, J; Han, L; Guo, SB; Wang, L; Xiong, ZJ; Chen, Z; Chen, W; Liang, J				Wang, Junwen; Li, Jun; Han, Lin; Guo, Songbo; Wang, Lei; Xiong, Zuojun; Chen, Zhi; Chen, Wen; Liang, Jian			Serum tau protein as a potential biomarker in the assessment of traumatic brain injury	EXPERIMENTAL AND THERAPEUTIC MEDICINE			English	Article						tau protein; traumatic brain injury; biomarker; outcome	CEREBROSPINAL-FLUID; ALZHEIMERS-DISEASE; CSF; PHOSPHORYLATION; HEMORRHAGE; DISORDERS; PROGNOSIS; SEVERITY; ISOFORMS; SCALE	Traumatic brain injury (TBI) is the leading cause of mortality and disabilities among all trauma cases. Following TBI, damage to axons results in tau protein hyperphosphorylation leading to microtubule instability and tau-mediated neurodegeneration. In addition, tau protein is proteolytically cleaved and is able to access the cerebrospinal fluid (CSF) and serum; thus, this protein may serve as a potential biomarker in the diagnosis of injury severity and outcome prediction. Although a limited number of studies have investigated the CSF tau protein levels after TBI, the data are divergent and conflicting, and investigations into the serum tau protein levels have yet to be conducted. Therefore, the present study aimed to examine the serum tau protein levels in the full spectrum of TBI patients on days 0-14 after TBI, using an enzyme-linked immunosorbent assay. The protein levels were compared to the initial Glasgow Coma Score (GCS) and the Extended Glasgow Outcome Scale (GOS-E), which are used to represent the injury severity and patient outcome, respectively. In total, 56 patients, including 20 patients with mild TBI (GCS, 13-15), 19 patients with moderate TBI (GCS, 9-12) and 17 patients with severe TBI (GCS, 3-8), were included in the current study. The outcome was assessed 1 year after the injury and patients were classified into the good outcome (40 cases; GOS-E, 5-8) and poor outcome groups (16 cases; GOS-E, 1-4). The results indicated that serum tau protein levels increased soon after TBI and reached a peak value at similar to 2 days after the injury. The serum t protein levels were significantly higher in the severe TBI group compared with those in the mild and moderate TBI groups (P<0.0001). Univariate analysis indicated that poor outcome was significantly associated with higher serum tau protein levels on day 2 (P<0.0001). A receiver operating characteristic curve demonstrated that a tau protein level of >116.04 pg/ml on day 2 resulted in a 93.75% sensitivity and 92.50% specificity for predicting a poor outcome. Furthermore, a tau protein level of >372.1 pg/ml on day 2 yielded 100% sensitivity and 83.33% specificity for 1 year mortality in the severe TBI group. In conclusion, the present study suggests that serum tau protein may serve as a potential biomarker for evaluating the injury severity and predicting the outcome of TBI patients.	[Wang, Junwen; Li, Jun; Wang, Lei; Xiong, Zuojun; Chen, Zhi; Chen, Wen; Liang, Jian] Huazhong Univ Sci & Technol, Wuhan Cent Hosp, Tongji Med Coll, Dept Neurosurg, 26 Shengli St, Wuhan 430014, Hubei, Peoples R China; [Han, Lin; Guo, Songbo] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Neurosurg, Wuhan 430014, Hubei, Peoples R China	Li, J (corresponding author), Huazhong Univ Sci & Technol, Wuhan Cent Hosp, Tongji Med Coll, Dept Neurosurg, 26 Shengli St, Wuhan 430014, Hubei, Peoples R China.	wangcelia2013@gmail.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81101620]; Wuhan Health Bureau [WX14B08]	The present study was partially supported by grants from the National Natural Science Foundation of China (grant no. 81101620) and Clinical Project of Wuhan Health Bureau (grant no. WX14B08). Mr. Junwen Wang would like to thank Miss. Shunying Liu (Wuhan Central Hospital) for her great support in this study.	Amadoro G, 2014, J ALZHEIMERS DIS, V42, P211, DOI 10.3233/JAD-140267; BLENNOW K, 1995, ACTA NEUROCHIR, V136, P135, DOI 10.1007/BF01410615; Brain Trauma Foundation, 2000, AM ASS NEUR SURG JOI, P449; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; Chlu WT, 2007, J CLIN NEUROSCI, V14, P930, DOI 10.1016/j.jocn.2006.08.004; Clarke NA, 2011, INT J GERIATR PSYCH, V26, P1283, DOI 10.1002/gps.2678; GOEDERT M, 1992, NEURON, V8, P159, DOI 10.1016/0896-6273(92)90117-V; Guzel A, 2010, AM J EMERG MED, V28, P399, DOI 10.1016/j.ajem.2008.12.025; Huber BR, 2013, J ALZHEIMERS DIS, V37, P309, DOI 10.3233/JAD-130182; Hulstaert F, 1999, NEUROLOGY, V52, P1555, DOI 10.1212/WNL.52.8.1555; Liliang PC, 2010, RESUSCITATION, V81, P1205, DOI 10.1016/j.resuscitation.2010.05.016; Lin JW, 2006, SURG NEUROL, V66, pS20, DOI 10.1016/j.surneu.2006.04.005; Marklund N, 2009, J NEUROSURG, V110, P1227, DOI 10.3171/2008.9.JNS08584; Maxwell WL, 1999, J NEUROTRAUM, V16, P1225, DOI 10.1089/neu.1999.16.1225; Neher MD, 2014, SOUTH MED J, V107, P248, DOI 10.1097/SMJ.0000000000000086; Ost M, 2006, NEUROLOGY, V67, P1600, DOI 10.1212/01.wnl.0000242732.06714.0f; Pedersen AR, 2015, NEUROREHAB NEURAL RE, V29, P299, DOI 10.1177/1545968314545171; Pettus EH, 1996, BRAIN RES, V722, P1, DOI 10.1016/0006-8993(96)00113-8; Posmantur RM, 1996, J NEUROPATH EXP NEUR, V55, P68, DOI 10.1097/00005072-199601000-00007; Rubenstein R, 2015, J NEUROTRAUM, V32, P342, DOI 10.1089/neu.2014.3548; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Shiihara T, 2014, BRAIN DEV-JPN, V36, P489, DOI 10.1016/j.braindev.2013.06.011; TAFT WC, 1992, J NEUROTRAUM, V9, P281, DOI 10.1089/neu.1992.9.281; Takahashi K, 2014, BRAIN DEV-JPN, V36, P670, DOI 10.1016/j.braindev.2013.10.007; TEASDALE G, 1974, LANCET, V2, P81; VANDERMEEREN M, 1993, J NEUROCHEM, V61, P1828, DOI 10.1111/j.1471-4159.1993.tb09823.x; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Zanier ER, 2013, BRIT J ANAESTH, V111, P424, DOI 10.1093/bja/aet149; Zemlan FP, 2002, BRAIN RES, V947, P131, DOI 10.1016/S0006-8993(02)02920-7; Zhang ZY, 2014, PEPTIDES, V60, P13, DOI 10.1016/j.peptides.2014.07.016	31	11	14	0	12	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-0981	1792-1015		EXP THER MED	Exp. Ther. Med.	MAR	2016	11	3					1147	1151		10.3892/etm.2016.3017			5	Medicine, Research & Experimental	Research & Experimental Medicine	DC9PV	WOS:000369554400071	26998051	Green Published, Bronze			2021-06-18	
J	Mata-Mbemba, D; Mugikura, S; Nakagawa, A; Murata, T; Kato, Y; Tatewaki, Y; Takase, K; Kushimoto, S; Tominaga, T; Takahashi, S				Mata-Mbemba, Daddy; Mugikura, Shunji; Nakagawa, Atsuhiro; Murata, Takaki; Kato, Yumiko; Tatewaki, Yasuko; Takase, Kei; Kushimoto, Shigeki; Tominaga, Teiji; Takahashi, Shoki			Canadian CT head rule and New Orleans Criteria in mild traumatic brain injury: comparison at a tertiary referral hospital in Japan	SPRINGERPLUS			English	Article						Canadian computed tomography (CT) head rule; New Orleans Criteria; Computed tomography (CT); Traumatic brain injury; Mild traumatic brain injury	COMPUTED-TOMOGRAPHY; LOGISTIC-REGRESSION; VALIDATION	We compared Canadian computed tomography (CT) head rule (CCHR) and New Orleans Criteria (NOC) in predicting important CT findings in patients with mild traumatic brain injury (TBI). We included 142 consecutive patients with mild TBI [Glasgow coma scale (GCS) 13-15] who showed at least one of the risk factors stated in the CCHR or the NOC. We introduced two scores: a Canadian from the CCHR and a New Orleans from the NOC. A patient's score represented a sum of the number of positive items. We examined the relationship between scores or items and the presence of important CT findings. Only the Canadian was significantly associated with important CT findings in multivariate analyses and showed higher area under the receiver operating characteristic curve (AUC) either in all 142 patients (GCS 13-15: P = 0.0130; AUC = 0.69) or in the 67 with a GCS = 15 (P = 0.0128, AUC = 0.73). Of items, ">60 years" or ">= 65 years" included in either guideline was the strongest predictor of important CT finding, followed by "GCS < 15 after 2 h" included only in the CCHR. In a tertiary referral hospital in Japan, CCHR had higher performance than the NOC in predicting important CT findings.	[Mata-Mbemba, Daddy; Mugikura, Shunji; Murata, Takaki; Kato, Yumiko; Tatewaki, Yasuko; Takase, Kei; Takahashi, Shoki] Tohoku Univ, Grad Sch Med, Dept Diagnost Radiol, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan; [Mata-Mbemba, Daddy; Nakagawa, Atsuhiro; Tominaga, Teiji] Tohoku Univ, Dept Neurosurg, Grad Sch Med, Sendai, Miyagi 9808574, Japan; [Kushimoto, Shigeki] Tohoku Univ, Div Emergency & Crit Care Med, Grad Sch Med, Sendai, Miyagi 9808574, Japan	Mugikura, S (corresponding author), Tohoku Univ, Grad Sch Med, Dept Diagnost Radiol, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.	mugi@rad.med.tohoku.ac.jp	Mata-Mbemba, Daddy/AAP-3184-2020				af Geijerstam JL, 2005, EMERG MED J, V22, P103, DOI 10.1136/emj.2004.015396; Berrington de Gonzalez A, 2004, LANCET, V363, P345, DOI 10.1016/S0140-6736(04)15433-0; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Fabbri A, 2004, J NEUROL NEUROSUR PS, V75, P410, DOI 10.1136/jnnp.2003.016113; Harnan SE, 2011, J TRAUMA, V71, P245, DOI 10.1097/TA.0b013e31820d090f; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Kavalci C, 2014, WORLD J EMERG SURG, V9, DOI 10.1186/1749-7922-9-31; Mata-Mbemba D, 2015, J NEUROTRAUM, V32, P359, DOI 10.1089/neu.2014.3453; Mata-Mbemba D, 2014, ACAD RADIOL, V21, P605, DOI 10.1016/j.acra.2014.01.017; Nakajima Y, 2008, RADIAT MED, V26, P455, DOI 10.1007/s11604-008-0259-2; Novikov I, 2010, STAT MED, V29, P97, DOI 10.1002/sim.3728; Papa L, 2012, ACAD EMERG MED, V19, P2, DOI 10.1111/j.1553-2712.2011.01247.x; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Smits M, 2007, ANN INTERN MED, V146, P397, DOI 10.7326/0003-4819-146-6-200703200-00004; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X	18	11	13	0	3	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND	2193-1801			SPRINGERPLUS	SpringerPlus	FEB 25	2016	5								176	10.1186/s40064-016-1781-9			7	Multidisciplinary Sciences	Science & Technology - Other Topics	DF5TK	WOS:000371415200006	27026873	Other Gold, Green Published			2021-06-18	
J	Shannon, RJ; van der Heide, S; Carter, EL; Jalloh, I; Menon, DK; Hutchinson, PJ; Carpenter, KLH				Shannon, Richard J.; van der Heide, Susan; Carter, Eleanor L.; Jalloh, Ibrahim; Menon, David K.; Hutchinson, Peter J.; Carpenter, Keri L. H.			Extracellular N-Acetylaspartate in Human Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						brain metabolism; microdialysis; N-acetylaspartate; traumatic brain injury (human)	MYELIN LIPID-SYNTHESIS; ACETYL-L-ASPARTATE; CEREBRAL MICRODIALYSIS; VERTEBRATE BRAIN; CANAVAN-DISEASE; NEURONAL DAMAGE; AXONAL INJURY; RAT-BRAIN; SEVERITY; SPECTROSCOPY	N-acetylaspartate (NAA) is an amino acid derivative primarily located in the neurons of the adult brain. The function of NAA is incompletely understood. Decrease in brain tissue NAA is presently considered symptomatic and a potential biomarker of acute and chronic neuropathological conditions. The aim of this study was to use microdialysis to investigate the behavior of extracellular NAA (eNAA) levels after traumatic brain injury (TBI). Sampling for this study was performed using cerebral microdialysis catheters (M Dialysis 71) perfused at 0.3L/min. Extracellular NAA was measured in microdialysates by high-performance liquid chromatography in 30 patients with severe TBI and for comparison, in radiographically normal areas of brain in six non-TBI neurosurgical patients. We established a detailed temporal eNAA profile in eight of the severe TBI patients. Microdialysate concentrations of glucose, lactate, pyruvate, glutamate, and glycerol were measured on an ISCUS clinical microdialysis analyzer. Here, we show that the temporal profile of microdialysate eNAA was characterized by highest levels in the earliest time-points post-injury, followed by a steady decline; beyond 70h post-injury, average levels were 40% lower than those measured in non-TBI patients. There was a significant inverse correlation between concentrations of eNAA and pyruvate; eNAA showed significant positive correlations with glycerol and the lactate/pyruvate (L/P) ratio measured in microdialysates. The results of this on-going study suggest that changes in eNAA after TBI relate to the release of intracellular components, possibly due to neuronal death or injury, as well as to adverse brain energy metabolism.	[Shannon, Richard J.; van der Heide, Susan; Jalloh, Ibrahim; Hutchinson, Peter J.; Carpenter, Keri L. H.] Univ Cambridge, Div Neurosurg, Dept Clin Neurosci, Box 167,Cambridge Biomed Campus, Cambridge CB2 0QQ, England; [Menon, David K.; Hutchinson, Peter J.; Carpenter, Keri L. H.] Univ Cambridge, Wolfson Brain Imaging Ctr, Dept Clin Neurosci, Cambridge CB2 0QQ, England; [Carter, Eleanor L.; Menon, David K.] Univ Cambridge, Dept Med, Div Anaesthesia, Cambridge CB2 0QQ, England	van der Heide, S (corresponding author), Univ Cambridge, Div Neurosurg, Dept Clin Neurosci, Box 167,Cambridge Biomed Campus, Cambridge CB2 0QQ, England.	sv377@cam.ac.uk		Carpenter, Keri/0000-0001-8236-7727; Hutchinson, Peter/0000-0002-2796-1835	Department of HealthEuropean Commission [NIHR-RP-R3-12-013] Funding Source: Medline; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G1002277, G9439390, G0600986] Funding Source: Medline; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NIHR-RP-R3-12-013, NF-SI-0512-10090] Funding Source: researchfish		Al-Samsam RH, 2000, J NEUROTRAUM, V17, P31, DOI 10.1089/neu.2000.17.31; Alessandri B, 2000, NEUROL RES, V22, P705; Amaral A. I., 2013, FRONT ENDOCRINOL, V4, P1, DOI DOI 10.3389/FEND0.2013.00054; ANDERSON RGW, 1978, CELL, V15, P919, DOI 10.1016/0092-8674(78)90276-3; Ariyannur PS, 2008, BRAIN RES, V1227, P34, DOI 10.1016/j.brainres.2008.06.040; Ariyannur PS, 2010, BRAIN RES, V1335, P1, DOI 10.1016/j.brainres.2010.04.008; Baslow MH, 2003, NEUROCHEM RES, V28, P941, DOI 10.1023/A:1023250721185; Baslow MH, 2000, J NEUROCHEM, V75, P453, DOI 10.1046/j.1471-4159.2000.0750453.x; Bates TE, 1996, NEUROREPORT, V7, P1397, DOI 10.1097/00001756-199605310-00014; Belli A, 2006, J NEUROCHEM, V96, P861, DOI 10.1111/j.1471-4159.2005.03602.x; Bonneville F, 2002, AM J NEURORADIOL, V23, P371; Cecil KM, 1998, J NEUROSURG, V88, P795, DOI 10.3171/jns.1998.88.5.0795; Chakraborty G, 2001, J NEUROCHEM, V78, P736, DOI 10.1046/j.1471-4159.2001.00456.x; Clausen T, 2005, J NEUROSURG, V103, P233, DOI 10.3171/jns.2005.103.2.0233; Davies SEC, 1998, NEUROCHEM RES, V23, P1021, DOI 10.1023/A:1020778832745; Demougeot C, 2003, J CEREBR BLOOD F MET, V23, P482, DOI 10.1097/01.WCB.0000050066.57184.60; DESTEFANO N, 1995, MAGN RESON MED, V34, P721; Di Pietro V, 2014, MOL MED, V20, P147, DOI 10.2119/molmed.2013.00153; Goodman JC, 2009, CURR OPIN CRIT CARE, V15, P110, DOI 10.1097/MCC.0b013e328325d142; Gotoh M, 1997, J NEUROCHEM, V69, P655; Hutchinson PJ, 2000, J NEUROSURG, V93, P37, DOI 10.3171/jns.2000.93.1.0037; Hutchinson PJ, 2005, PHYSIOL MEAS, V26, P423, DOI 10.1088/0967-3334/26/4/008; Jalloh I, 2015, J CEREBR BLOOD F MET, V35, P111, DOI 10.1038/jcbfm.2014.177; KAUL R, 1993, NAT GENET, V5, P118, DOI 10.1038/ng1093-118; KAUL R, 1994, AM J HUM GENET, V55, P34; Kumar S, 2006, MENT RETARD DEV D R, V12, P157, DOI 10.1002/mrdd.20108; Madhavarao CN, 2005, P NATL ACAD SCI USA, V102, P5221, DOI 10.1073/pnas.0409184102; Madhavarao CN, 2004, J COMP NEUROL, V472, P318, DOI 10.1002/cne.20080; Madhavarao CN, 2003, J NEUROCHEM, V86, P824, DOI 10.1046/j.1471-4159.2003.01905.x; Marino S, 2007, J NEUROL NEUROSUR PS, V78, P501, DOI 10.1136/jnnp.2006.099796; Miller SL, 1996, NEUROCHEM RES, V21, P615, DOI 10.1007/BF02527761; Moffett JR, 2007, PROG NEUROBIOL, V81, P89, DOI 10.1016/j.pneurobio.2006.12.003; Moffett John R, 2013, Front Neuroenergetics, V5, P11, DOI 10.3389/fnene.2013.00011; Newcombe VFJ, 2013, J CEREBR BLOOD F MET, V33, P855, DOI 10.1038/jcbfm.2013.11; Rigotti DJ, 2007, AM J NEURORADIOL, V28, P1843, DOI 10.3174/ajnr.A0774; Sager TN, 1999, J CEREBR BLOOD F MET, V19, P164; Sager TN, 1997, J NEUROCHEM, V68, P675; Signoretti S, 2001, J NEUROTRAUM, V18, P977, DOI 10.1089/08977150152693683; Signoretti S, 2008, J NEUROSURG, V108, P42, DOI 10.3171/JNS/2008/108/01/0042; TALLAN HH, 1956, J BIOL CHEM, V219, P257; Tavazzi B, 2000, ANAL BIOCHEM, V277, P104, DOI 10.1006/abio.1999.4386; TAYLOR DL, 1994, J NEUROCHEM, V62, P2349; TAYLOR DL, 1995, J NEUROCHEM, V65, P275; TSAI GC, 1995, PROG NEUROBIOL, V46, P531, DOI 10.1016/0301-0082(95)00014-M; Tyson RL, 1998, NEUROSCI LETT, V251, P181, DOI 10.1016/S0304-3940(98)00527-8; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Wiame E, 2010, BIOCHEM J, V425, P127, DOI 10.1042/BJ20091024; Wu WE, 2012, NEUROBIOL AGING, V33, P2440, DOI 10.1016/j.neurobiolaging.2011.12.008	48	11	12	0	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB 15	2016	33	4					319	329		10.1089/neu.2015.3950			11	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	DD2NH	WOS:000369758800001	26159566	Green Published, Other Gold			2021-06-18	
J	Caccamo, D; Pisani, LR; Mazzocchetti, P; Ientile, R; Calabresi, P; Pisani, F; Costa, C				Caccamo, D.; Pisani, L. R.; Mazzocchetti, P.; Ientile, R.; Calabresi, P.; Pisani, F.; Costa, C.			Neuroprotection as a Potential Therapeutic Perspective in Neurodegenerative Diseases: Focus on Antiepileptic Drugs	NEUROCHEMICAL RESEARCH			English	Article						AEDs; Neuroprotection; Experimental animal models	HISTONE DEACETYLASE INHIBITION; FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; IN-VITRO ISCHEMIA; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; PROTECTS DOPAMINERGIC-NEURONS; CELLULAR STRESS RESPONSES; NEURITIC PLAQUE-FORMATION; TEMPORAL-LOBE EPILEPSY; VALPROIC ACID	Neuroprotection is conceived as one of the potential tool to prevent or slow neuronal death and hence a therapeutic hope to treat neurodegenerative diseases, like Parkinson's and Alzheimer's diseases. Increase of oxidative stress, mitochondrial dysfunction, excitotoxicity, inflammatory changes, iron accumulation, and protein aggregation have been identified as main causes of neuronal death and adopted as targets to test experimentally the putative neuroprotective effects of various classes of drugs. Among these agents, antiepileptic drugs (AEDs), both the old and the newer generations, have shown to exert protective effects in different experimental models. Their mechanism of action is mediated mainly by modulating the activity of sodium, calcium and potassium channels as well as the glutamatergic and GABAergic (gamma-aminobutyric acid) synapses. Neurological pathologies in which a neuroprotective action of AEDs has been demonstrated in specific experimental models include: cerebral ischemia, Parkinson's disease, and Alzheimer's disease. Although the whole of experimental data indicating that neuroprotection can be achieved is remarkable and encouraging, no firm data have been produced in humans so far and, at the present time, neuroprotection still remains a challenge for the future.	[Caccamo, D.; Ientile, R.] Univ Messina, Dept Biomed Sci Dent Sci & Morphofunct Imaging, AOU Policlin G Martino, Messina, Italy; [Pisani, L. R.] IRCCS, Ctr Neurolesi Bonino Pulejo, Messina, Italy; [Mazzocchetti, P.; Calabresi, P.; Costa, C.] Univ Perugia, Dept Med, Neurol Clin, S Maria Misericordia Hosp, I-06156 Perugia, Italy; [Calabresi, P.] IRCCS, Fdn Santa Lucia, Rome, Italy; [Pisani, F.] Univ Messina, Dept Clin & Expt Med, Messina, Italy	Costa, C (corresponding author), Univ Perugia, Dept Med, Neurol Clin, S Maria Misericordia Hosp, I-06156 Perugia, Italy.	cinzia.costa@unipg.it	Costa, Cinzia/K-8485-2016; Ientile, Riccardo/AAL-6349-2020	Costa, Cinzia/0000-0002-4862-4221; mazzocchetti, petra/0000-0003-2445-6443; Calabresi, Paolo/0000-0003-0326-5509			Al-Izki S, 2014, BRAIN, V137, P92, DOI 10.1093/brain/awt324; Alberio T, 2012, FEBS J, V279, P1146, DOI 10.1111/j.1742-4658.2012.08516.x; Amin B, 2012, FITOTERAPIA, V83, P888, DOI 10.1016/j.fitote.2012.03.022; Andaluz N, 2002, NEUROSURG CLIN N AM, V13, P385, DOI 10.1016/S1042-3680(02)00006-2; Andersen JK, 2004, NAT MED, V10, pS18, DOI 10.1038/nrn1434; Arawaka S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089076; Asanuma M, 2008, NEUROSCI RES, V60, P106, DOI 10.1016/j.neures.2007.10.002; Barks JD, 2010, PEDIATR RES, V67, P532, DOI 10.1203/PDR.0b013e3181d4ff4d; Belcastro V, 2011, BRAIN DEV-JPN, V33, P289, DOI 10.1016/j.braindev.2010.06.008; Bialer M, 2002, EPILEPSY RES, V51, P31, DOI 10.1016/S0920-1211(02)00106-7; Biton V, 2007, CLIN NEUROPHARMACOL, V30, P230, DOI 10.1097/01.WNF.0B013E3180413D7D; Black JA, 2008, J NEUROL SCI, V274, P57, DOI 10.1016/j.jns.2008.04.001; Black JA, 2007, ANN NEUROL, V62, P21, DOI 10.1002/ana.21172; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Blesa J, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/845618; Boku S, 2011, PROG NEURO-PSYCHOPH, V35, P111, DOI 10.1016/j.pnpbp.2010.09.019; Borlongan CV, 2011, LEUKEMIA, V25, P1674, DOI 10.1038/leu.2011.167; Brown-Croyts LM, 2000, LIFE SCI, V67, P643, DOI 10.1016/S0024-3205(00)00658-5; Calabrese EJ, 2015, BIOGERONTOLOGY, V16, P693, DOI 10.1007/s10522-015-9601-0; Calabrese V, 2012, BBA-MOL BASIS DIS, V1822, P753, DOI 10.1016/j.bbadis.2011.11.002; Calabrese V, 2010, ANTIOXID REDOX SIGN, V13, P1763, DOI 10.1089/ars.2009.3074; Calabrese V, 2010, METHODS MOL BIOL, V610, P285, DOI 10.1007/978-1-60327-029-8_17; Calabresi P, 2003, ANN NEUROL, V53, P693, DOI 10.1002/ana.10603; Calabresi P, 2003, EXP NEUROL, V182, P461, DOI 10.1016/S0014-4886(03)00117-1; Calabresi P, 2003, NEUROBIOL DIS, V12, P82, DOI 10.1016/S0969-9961(02)00016-5; Chang RB, 2015, DRUG DES DEV THER, V9, P2179, DOI 10.2147/DDDT.S58470; Chen PS, 2007, NEUROSCIENCE, V149, P203, DOI 10.1016/j.neuroscience.2007.06.053; Chen PS, 2006, MOL PSYCHIATR, V11, P1116, DOI 10.1038/sj.mp.4001893; Choudhury ME, 2012, EUR J PHARMACOL, V689, P72, DOI 10.1016/j.ejphar.2012.05.012; Choudhury ME, 2010, J PHARMACOL SCI, V114, P298, DOI 10.1254/jphs.10120FP; Condello S, 2013, NEUROCHEM RES, V38, P2631, DOI 10.1007/s11064-013-1181-2; Constantinescu CS, 2011, BRIT J PHARMACOL, V164, P1079, DOI 10.1111/j.1476-5381.2011.01302.x; Costa C, 2006, STROKE, V37, P1319, DOI 10.1161/01.STR.0000217303.22856.38; Costa C, 2004, STROKE, V35, P596, DOI 10.1161/01.STR.0000113691.32026.06; Costa C, 2008, J NEUROSCI, V28, P8040, DOI 10.1523/JNEUROSCI.1947-08.2008; Costa C, 2012, BRAIN, V135, P1884, DOI 10.1093/brain/aws101; Costa C, 2011, NEUROBIOL DIS, V44, P185, DOI [10.1016/j.nbd.2011.06.015, 10.1016/j.nbd.2011.06.011]; Costa C, 2010, EXP NEUROL, V221, P217, DOI 10.1016/j.expneurol.2009.11.002; Cuomo O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080852; Czapinski P, 2005, CURR TOP MED CHEM, V5, P3, DOI 10.2174/1568026053386962; Czuczwar SJ, 2002, EPILEPSY RES, V52, P15, DOI 10.1016/S0920-1211(02)00181-X; Das A, 2010, NEUROCHEM RES, V35, P2175, DOI 10.1007/s11064-010-0321-1; Descalzi G, 2015, TRENDS NEUROSCI, V38, P237, DOI 10.1016/j.tins.2015.02.001; Diaz-Ruiz A, 2013, NEUROCHEM RES, V38, P1819, DOI 10.1007/s11064-013-1087-z; Eikermann-Haerter K, 2015, STROKE, V46, P229, DOI 10.1161/STROKEAHA.114.006982; Fan Y, 2008, EXP NEUROL, V212, P415, DOI 10.1016/j.expneurol.2008.04.032; Follett PL, 2004, J NEUROSCI, V24, P4412, DOI 10.1523/JNEUROSCI.0477-04.2004; Fraser CM, 1999, EPILEPTIC DISORD, V1, P153; Goldberg MS, 2005, NEURON, V45, P489, DOI 10.1016/j.neuron.2005.01.041; Gomez CD, 2014, J NEUROCHEM, V130, P770, DOI 10.1111/jnc.12784; Graham SM, 2004, COMPARATIVE MED, V54, P486; Grover ND, 2013, INDIAN J PHARMACOL, V45, P547, DOI 10.4103/0253-7613.121266; Gubellini P, 2015, REV NEUROL-FRANCE, V171, P750, DOI 10.1016/j.neurol.2015.07.011; Hahm TS, 2009, J KOREAN MED SCI, V24, P146, DOI 10.3346/jkms.2009.24.1.146; Hall AM, 2015, J NEUROSCI, V35, P6221, DOI 10.1523/JNEUROSCI.2552-14.2015; Halonen T, 1996, EUR J PHARMACOL, V299, P69, DOI 10.1016/0014-2999(95)00835-7; Hao YL, 2004, J NEUROSCI, V24, P6590, DOI 10.1523/JNEUROSCI.5747-03.2004; HAYAKAWA T, 1994, EUR J PHARMACOL, V257, P131; Hayden MR, 2005, DRUG DISCOV TODAY, V4, P291; Hsieh J, 2004, P NATL ACAD SCI USA, V101, P16659, DOI 10.1073/pnas.0407643101; Hu JP, 2011, BRAIN RES BULL, V85, P194, DOI 10.1016/j.brainresbull.2011.03.006; Kanai H, 2004, PHARMACOGENOMICS J, V4, P336, DOI 10.1038/sj.tpj.6500269; Kapoor R, 2010, LANCET NEUROL, V9, P681, DOI 10.1016/S1474-4422(10)70131-9; Katsuno M, 2012, J NEUROL NEUROSUR PS, V83, P329, DOI 10.1136/jnnp-2011-301307; Kawajiri S, 2010, NEUROSCI LETT, V481, P88, DOI 10.1016/j.neulet.2010.06.058; Kim HJ, 2007, J PHARMACOL EXP THER, V321, P892, DOI 10.1124/jpet.107.120188; Kim HJ, 2009, J NEUROCHEM, V110, P1226, DOI 10.1111/j.1471-4159.2009.06212.x; Komur M, 2014, CHILD NERV SYST, V30, P1001, DOI 10.1007/s00381-014-2375-x; Kondziella D, 2011, NEUROREPORT, V22, P97, DOI 10.1097/WNR.0b013e328342d2fa; Kovacs G, 2014, EUR MED J NEUROL, V1, P78; Kumar P, 2012, EUR J PHARMACOL, V674, P265, DOI 10.1016/j.ejphar.2011.11.030; Kwon KJ, 2013, NEUROCHEM INT, V62, P240, DOI 10.1016/j.neuint.2012.12.019; Leker RR, 2003, BRAIN RES REV, V42, P187, DOI 10.1016/S0165-0173(03)00170-X; Leng Y, 2013, INT J NEUROPSYCHOPH, V16, P607, DOI 10.1017/S1461145712000429; Leng Y, 2006, J NEUROSCI, V26, P7502, DOI 10.1523/JNEUROSCI.0096-06.2006; Li YL, 2013, INT J NEUROSCI, V123, P823, DOI 10.3109/00207454.2013.804821; Lo AC, 2002, NEUROREPORT, V13, P1909, DOI 10.1097/00001756-200210280-00015; Loscher W, 2010, PHARMACOL REV, V62, P668, DOI 10.1124/pr.110.003046; Long ZM, 2013, CURR ALZHEIMER RES, V10, P261, DOI 10.2174/1567205011310030005; Maragakis NJ, 2003, NEUROSCI LETT, V338, P107, DOI 10.1016/S0304-3940(02)01386-1; Marini H, 2004, LIFE SCI, V74, P1253, DOI 10.1016/j.lfs.2003.08.006; Marinova Z, 2011, NEUROPHARMACOLOGY, V60, P1109, DOI 10.1016/j.neuropharm.2010.09.022; Marinova Z, 2009, J NEUROCHEM, V111, P976, DOI 10.1111/j.1471-4159.2009.06385.x; Markowitz GJ, 2011, EPILEPSY RES, V94, P138, DOI 10.1016/j.eplepsyres.2011.01.002; Meldrum BS, 2007, NEUROTHERAPEUTICS, V4, P18, DOI 10.1016/j.nurt.2006.11.010; Minato H, 1997, EPILEPSIA, V38, P975, DOI 10.1111/j.1528-1157.1997.tb01479.x; Murata M, 2007, NEUROLOGY, V68, P45, DOI 10.1212/01.wnl.0000250236.75053.16; NEY GC, 1994, ARCH NEUROL-CHICAGO, V51, P767, DOI 10.1001/archneur.1994.00540200043014; Noda Y, 1999, RES COMMUN MOL PATH, V105, P23; Noe FM, 2013, NEUROBIOL DIS, V59, P183, DOI 10.1016/j.nbd.2013.07.015; Noh H, 2014, NEUROSCIENCE, V266, P255, DOI 10.1016/j.neuroscience.2014.02.012; Northington FJ, 2006, ILAR J, V47, P32, DOI 10.1093/ilar.47.1.32; Owen AJ, 1997, BRAIN RES, V770, P115, DOI 10.1016/S0006-8993(97)00789-0; Papazisis G, 2008, INT J NEUROPSYCHOPH, V11, P321, DOI 10.1017/S1461145707008012; Pappalardo A, 2004, Clin Ter, V155, P75; Park HJ, 2013, J MOL NEUROSCI, V49, P172, DOI 10.1007/s12031-012-9854-x; Park SW, 2015, BIPOLAR DISORD, V17, P278, DOI 10.1111/bdi.12262; Peng GS, 2005, MOL BRAIN RES, V134, P162, DOI 10.1016/j.molbrainres.2004.10.021; Perluigi M, 2010, J NEUROSCI RES, V88, P3498, DOI 10.1002/jnr.22500; Pisani A, 2004, EPILEPSIA, V45, P719, DOI 10.1111/j.0013-9580.2004.02204.x; PISANI A, 1995, BRIT J PHARMACOL, V116, P2053, DOI 10.1111/j.1476-5381.1995.tb16411.x; Pisani F, 2001, EXP NEUROL, V170, P162, DOI 10.1006/exnr.2001.7681; Pisani F, 2006, EXP BRAIN RES, V171, P511, DOI 10.1007/s00221-005-0298-1; Pitkanen A, 2002, NEUROLOGY, V59, pS27, DOI 10.1212/WNL.59.9_suppl_5.S27; Pitkanen A, 2002, EPILEPSY RES, V50, P141, DOI 10.1016/S0920-1211(02)00076-1; Pitkanen A, 2002, LANCET NEUROL, V1, P173, DOI 10.1016/S1474-4422(02)00073-X; Qian YR, 2010, KOREAN J PHYSIOL PHA, V14, P435, DOI 10.4196/kjpp.2010.14.6.435; Qing H, 2008, J EXP MED, V205, P2781, DOI 10.1084/jem.20081588; Reddy DS, 2013, INT J MOL SCI, V14, P18284, DOI 10.3390/ijms140918284; Reijs R, 2004, EPILEPSY BEHAV, V5, pS66, DOI 10.1016/j.yebeh.2003.11.009; Rekling JC, 2003, NEUROSCI LETT, V335, P167, DOI 10.1016/S0304-3940(02)01193-X; Ren M, 2004, J NEUROCHEM, V89, P1358, DOI 10.1111/j.1471-4159.2004.02406.x; Rigoulot MA, 2004, J PHARMACOL EXP THER, V308, P787, DOI 10.1124/jpet.103.057091; Sano H, 2015, J NEUROCHEM, V134, P371, DOI 10.1111/jnc.13116; Schapira AHV, 2014, LANCET, V384, P545, DOI 10.1016/S0140-6736(14)61010-2; Seckin H, 2008, SURG NEUROL, V70, P344, DOI 10.1016/j.surneu.2007.07.052; Sendrowski K, 2015, PHARMACOL REP, V67, P326, DOI 10.1016/j.pharep.2014.09.013; Shao L, 2005, BIOL PSYCHIAT, V58, P879, DOI 10.1016/j.biopsych.2005.04.052; Shetty AK, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00172; Sinn DI, 2007, NEUROBIOL DIS, V26, P464, DOI 10.1016/j.nbd.2007.02.006; Sonsalla PK, 2010, EXP NEUROL, V221, P329, DOI 10.1016/j.expneurol.2009.11.018; Stepien K, 2005, PHARMACOL REP, V57, P719; Tasca CI, 2015, METHODS MOL BIOL, V1254, P197, DOI 10.1007/978-1-4939-2152-2_15; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Topcu Y, 2014, NEUROL SCI, V35, P1769, DOI 10.1007/s10072-014-1834-1; Tortiglione A, 2007, STROKE, V38, P1614, DOI 10.1161/STROKEAHA.106.478644; Trojnar MK, 2002, POL J PHARMACOL, V54, P557; Tsai LK, 2011, STROKE, V42, P2932, DOI 10.1161/STROKEAHA.110.612788; Tsujii S, 2015, EUR J PHARMACOL, V746, P301, DOI 10.1016/j.ejphar.2014.09.023; Vizuete ML, 1997, J NEUROSCI RES, V49, P301, DOI 10.1002/(SICI)1097-4547(19970801)49:3<301::AID-JNR5>3.0.CO;2-G; Wakita M, 2014, J PHARMACOL EXP THER, V348, P246, DOI 10.1124/jpet.113.208751; Wallis RA, 1995, EUR J PHARMACOL, V294, P475, DOI 10.1016/0014-2999(95)00568-4; Wang HC, 2006, NEUROCRIT CARE, V5, P71, DOI 10.1385/NCC:5:1:71; Wang Z, 2014, CNS NEUROSCI THER, V20, P209, DOI 10.1111/cns.12186; Wang ZF, 2011, J CEREBR BLOOD F MET, V31, P52, DOI 10.1038/jcbfm.2010.195; WIARD RP, 1995, STROKE, V26, P466, DOI 10.1161/01.STR.26.3.466; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xuan AG, 2015, MOL NEUROBIOL, V51, P300, DOI 10.1007/s12035-014-8751-4; Yao ZG, 2014, CELL MOL NEUROBIOL, V34, P805, DOI 10.1007/s10571-013-0012-y; Yasuda S, 2009, MOL PSYCHIATR, V14, P51, DOI 10.1038/sj.mp.4002099; Yokoyama H, 2010, METAB BRAIN DIS, V25, P135, DOI 10.1007/s11011-010-9191-0; Yurekli VA, 2013, CELL MOL NEUROBIOL, V33, P205, DOI 10.1007/s10571-012-9886-3; Zadori D, 2012, J NEUROL SCI, V322, P187, DOI 10.1016/j.jns.2012.06.004; Zadori D, 2009, PHARMACOL BIOCHEM BE, V94, P148, DOI 10.1016/j.pbb.2009.08.001; Zou HC, 2013, NEUROREHAB NEURAL RE, V27, P878, DOI 10.1177/1545968313491007	145	11	11	0	10	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	FEB	2016	41	1-2			SI		340	352		10.1007/s11064-015-1809-5			13	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	DF5SO	WOS:000371412800033	26721507				2021-06-18	
J	Honeybul, S; Janzen, C; Kruger, K; Ho, KM				Honeybul, Stephen; Janzen, Courtney; Kruger, Kate; Ho, Kwok M.			The Incidence of Neurologic Susceptibility to a Skull Defect	WORLD NEUROSURGERY			English	Article						Cranioplasty; Decompressive craniectomy; Syndrome of trephined	TRAUMATIC BRAIN-INJURY; COGNITIVE STATUS EXAMINATION; DECOMPRESSIVE CRANIECTOMY; CRANIOPLASTY; REHABILITATION; COMPLICATIONS; IMPROVEMENT; SERIES; BONE	OBJECTIVE: To determine whether there is a measureable change in neurologic function after cranioplasty. METHODS: This is a prospective single-surgeon, single-center study. Fifty patients who required a cranioplasty procedure were assessed neurologically within 72 hours before and 7 days after surgery. The assessment tools were the Functional Independence Measure (FIM) and the Cognitive assessment report (Cognistat). The scores for both assessments were calculated and then compared before and after surgery. RESULTS: FIM assessment was performed on all fifty patients, and a Cognistat assessment was performed on 47 patients. Most improvements were seen in the Cognistat scores; however, there appeared to be no specific areas in which there was consistent improvement. There were substantial improvements in the Cognistat assessment in 9 patients. One patient had a much-improved FIM assessment (improved from 18 to 34), but a Cognistat assessment was not possible because of poor neurologic function. These results suggested that improvements after cranioplasty were more likely to occur in the domain of cognitive function than motor function, although overall these results did not reach statistically significance. Bifrontal (vs. unilateral) cranioplasty, timing between decompression and cranioplasty, and age of the patients did not appear to affect the postoperative FIM scores, after we adjusted for preoperative FIM scores and surgical complications. CONCLUSIONS: A small but significant number of patients appear to improve clinically after cranioplasty. Neurologic susceptibility to a skull defect may be more common than had been appreciated previously.	[Honeybul, Stephen] Sir Charles Gairdner Hosp, Dept Neurosurg, Nedlands, WA 6009, Australia; [Janzen, Courtney; Kruger, Kate] Sir Charles Gairdner Hosp, Dept Occupat Therapy, Nedlands, WA 6009, Australia; [Ho, Kwok M.] Royal Perth Hosp, Dept Intens Care Med, Perth, WA 6001, Australia; [Ho, Kwok M.] Univ Western Australia, Sch Populat Hlth, Perth, WA 6009, Australia; [Ho, Kwok M.] Murdoch Univ, Sch Vet & Life Sci, Murdoch, WA 6150, Australia	Honeybul, S (corresponding author), Sir Charles Gairdner Hosp, Dept Neurosurg, Nedlands, WA 6009, Australia.	stephen.honeybul@health.wa.gov.au	Ho, Kwok M./E-3546-2010	Ho, Kwok M./0000-0002-6705-6004			Agner C, 2002, ACTA NEUROCHIR, V144, P1033, DOI 10.1007/s00701-002-0996-4; Beauchamp KM, 2010, J TRAUMA, V69, P270, DOI 10.1097/TA.0b013e3181e491c2; Chalouhi N, 2012, NEUROLOGIST, V18, P423, DOI 10.1097/NRL.0b013e318272f7be; Corallo F, 2014, FUNCT NEUROL, V29, P273, DOI 10.11138/FNeur/2014.29.4.273; Di Stefano C, 2012, BRIT J NEUROSURG, V26, P827, DOI 10.3109/02688697.2012.692838; Dickson HG, 1995, SCAND J REHABIL MED, V27, P253; Doninger NA, 2000, J HEAD TRAUMA REHAB, V15, P683, DOI 10.1097/00001199-200002000-00007; Doninger NA, 2006, REHABIL PSYCHOL, V51, P281, DOI 10.1037/0090-5550.51.4.281; Dujovny M, 1999, CRIT REV NEUROSURG, V9, P271, DOI 10.1007/s003290050143; FODSTAD H, 1984, ACTA NEUROCHIR, V70, P21, DOI 10.1007/BF01406039; Grant FC, 1939, ANN SURG, V110, P488, DOI 10.1097/00000658-193910000-00002; Granthan E, 1947, J NEUROSURG, V5, P19; Honeybul S, 2013, BRAIN INJURY, V27, P979, DOI 10.3109/02699052.2013.794974; Honeybul Stephen, 2014, Surg Neurol Int, V5, P83, DOI 10.4103/2152-7806.133886; Honeybul S, 2013, BRAIN INJURY, V27, P1732, DOI 10.3109/02699052.2013.830194; Honeybul S, 2013, BRIT J NEUROSURG, V27, P636, DOI 10.3109/02688697.2013.817532; Honeybul S, 2012, PLAST RECONSTR SURG, V130, P1110, DOI 10.1097/PRS.0b013e318267d4de; Honeybul S, 2011, J NEUROTRAUM, V28, P929, DOI 10.1089/neu.2010.1612; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Krishnan P, 2015, J NEUROSCI RURAL PRA, V6, P225, DOI 10.4103/0976-3147.150281; Matsuno A, 2006, ACTA NEUROCHIR, V148, P535, DOI 10.1007/s00701-006-0740-6; Mazaux JM, 1998, DISABIL REHABIL, V20, P435, DOI 10.3109/09638289809166108; Sakamoto S, 2006, CLIN NEUROL NEUROSUR, V108, P583, DOI 10.1016/j.clineuro.2005.03.012; Schiffer J, 1997, SURG NEUROL, V47, P231, DOI 10.1016/S0090-3019(96)00376-X; Stiver SI, 2008, J NEUROSURG, V109, P245, DOI 10.3171/JNS/2008/109/8/0245; SUZUKI N, 1993, ACTA NEUROCHIR, V122, P49, DOI 10.1007/BF01446986; Voss HU, 2011, CLIN IMAG, V35, P253, DOI 10.1016/j.clinimag.2010.07.008; Winkler PA, 2000, J NEUROSURG, V93, P53, DOI 10.3171/jns.2000.93.1.0053; YAMAURA A, 1977, Neurologia Medico-Chirurgica, V17, P43, DOI 10.2176/nmc.17pt1.43; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9	30	11	12	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	FEB	2016	86						147	152		10.1016/j.wneu.2015.09.081			6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	DD0QU	WOS:000369625300044	26433098	Green Published			2021-06-18	
J	Lesniak, A; Pick, CG; Misicka, A; Lipkowski, AW; Sacharczuk, M				Lesniak, Anna; Pick, Chaim G.; Misicka, Aleksandra; Lipkowski, Andrzej W.; Sacharczuk, Mariusz			Biphalin protects against cognitive deficits in a mouse model of mild traumatic brain injury (mTBI)	NEUROPHARMACOLOGY			English	Article						Neuroprotection; Biphalin; Traumatic brain injury; Mouse model	OPIOID RECEPTOR AGONISTS; MORRIS WATER MAZE; ENDOGENOUS OPIOIDS; HEAD-INJURY; NEOCORTICAL NEURONS; EXCITOTOXIC INJURY; DOPAMINE RELEASE; SPINAL-CORD; MICE; DELTA	Traumatic brain injury (TBI) is often a result of traffic accidents, contact sports or battlefield explosions. A mild form of traumatic brain injury (mTBI) is frequently underestimated, as the immediate physical symptoms decrease rapidly and conventional neuroimaging studies often do not show visible evidence of brain lesions. However, cognitive impairments persist for weeks, months or even years after the incident. Endogenous opioids were documented to play a role in thmodulation of mTBI pathology, whereas exogenous opioids were shown to possess neuroprotective properties. In the present study, biphalin, a dimeric enkephalin analog, improved cognitive performance in the Morris Water Maze and Novel Object Recognition tests in a mouse weight-drop model of mTBI. The effect of a single systemic injection of 10 mg/kg biphalin immediately after trauma was reversed by naltrexone, suggesting an opioid receptor-mediated mechanism. Biphalin also reduced cortical and hippocampal neurodegeneration, as shown by silver staining. Our data indicates that opioid receptor activation by biphalin may provide neuroprotection of post-traumatic neurodegeneration processes and may protect against memory impairments. (C) 2015 Elsevier Ltd. All rights reserved.	[Lesniak, Anna; Misicka, Aleksandra; Lipkowski, Andrzej W.] Polish Acad Sci, Dept Neuropeptides, Mossakowski Med Res Ctr, PL-02106 Warsaw, Poland; [Sacharczuk, Mariusz] Polish Acad Sci, Inst Genet & Anim Breeding, Dept Cytogenet, PL-05552 Magdalenka, Poland; [Pick, Chaim G.] Tel Aviv Univ, Dept Anat, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Lesniak, Anna] Uppsala Univ, Dept Pharmaceut Biosci, SE-75124 Uppsala, Sweden; [Misicka, Aleksandra] Univ Warsaw, Fac Chem, PL-02093 Warsaw, Poland	Sacharczuk, M (corresponding author), Polish Acad Sci, Inst Genet & Anim Breeding, Dept Cytogenet, Postepu 36A, PL-05552 Magdalenka, Poland.	alesniak@imdik.pan.pl; m.sacharczuk@ighz.pl		Lesniak, Anna/0000-0002-6014-9208; Sacharczuk, Mariusz/0000-0002-6309-5292	Polish National Science Centre [2011/03/N/NZ4/02021]	This study was financially supported by the Polish National Science Centre, grant no. 2011/03/N/NZ4/02021.	ARMSTEAD WM, 1994, BRAIN RES, V660, P19, DOI 10.1016/0006-8993(94)90834-6; BAAMONDE A, 1992, EUR J PHARMACOL, V216, P157, DOI 10.1016/0014-2999(92)90356-9; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Chao DM, 2007, J CELL PHYSIOL, V212, P60, DOI 10.1002/jcp.21000; Dean P.J., 2013, FRONT HUM NEUROSCI, V12, P7, DOI DOI 10.3389/FNHUM.2013.00030; Doppenberg EMR, 2004, J NEUROSURG ANESTH, V16, P87, DOI 10.1097/00008506-200401000-00019; DOURMAP N, 1990, BRAIN RES, V524, P153, DOI 10.1016/0006-8993(90)90505-6; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; FADEN AI, 1990, ANN NEUROL, V27, P67, DOI 10.1002/ana.410270111; Falk AC, 2005, CHILD NERV SYST, V21, P430, DOI 10.1007/s00381-005-1142-4; Farace E, 2000, Neurosurg Focus, V8, pe6; Feng Y, 2012, CURR DRUG TARGETS, V13, P230, DOI 10.2174/138945012799201612; Fox GB, 1998, J NEUROTRAUM, V15, P1037, DOI 10.1089/neu.1998.15.1037; Fromm L, 2004, J AM COLL NUTR, V23, p529S, DOI 10.1080/07315724.2004.10719396; HAYES RL, 1990, J NEUROSURG, V72, P252, DOI 10.3171/jns.1990.72.2.0252; He XZ, 2013, CELL MOL LIFE SCI, V70, P2291, DOI 10.1007/s00018-012-1167-2; Heitger MH, 2007, J REHABIL MED, V39, P612, DOI 10.2340/16501977-0100; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; HORAN PJ, 1993, J PHARMACOL EXP THER, V265, P1446; Husain S, 2012, CURR PHARM DESIGN, V18, P6101, DOI 10.2174/138161212803582441; Jones NC, 2008, J NEUROTRAUM, V25, P1367, DOI 10.1089/neu.2008.0641; Jutkiewicz EM, 2012, NEUROPSYCHOPHARMACOL, V37, P303, DOI 10.1038/npp.2011.244; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kawalec M, 2011, NEUROCHEM RES, V36, P2091, DOI 10.1007/s11064-011-0568-1; Kierans AS, 2014, NEUROLOGY, V82, P521, DOI 10.1212/WNL.0000000000000105; Kim JS, 2009, ACTA HISTOCHEM, V111, P150, DOI 10.1016/j.acthis.2008.05.002; Kosson D, 2005, PHARMACOL REP, V57, P545; LIPKOWSKI AW, 1987, LIFE SCI, V40, P2283, DOI 10.1016/0024-3205(87)90065-8; LIPKOWSKI AW, 1982, PEPTIDES, V3, P697, DOI 10.1016/0196-9781(82)90173-5; Luo J, 2006, P NATL ACAD SCI USA, V103, P18326, DOI 10.1073/pnas.0605077103; LYETH BG, 1995, NEUROPEPTIDES, V29, P11, DOI 10.1016/0143-4179(95)90051-9; MCINTOSH TK, 1987, BRAIN RES, V425, P225, DOI 10.1016/0006-8993(87)90505-1; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Mollica A, 2005, BIOORG MED CHEM LETT, V15, P2471, DOI 10.1016/j.bmcl.2005.03.067; Mooney G, 2001, BRAIN INJURY, V15, P865, DOI 10.1080/02699050110065286; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; O'Connor C, 2003, J NEUROTRAUM, V20, P985, DOI 10.1089/089771503770195830; Ostermeier AM, 2000, ANESTHESIOLOGY, V93, P1053, DOI 10.1097/00000542-200010000-00029; Pasaoglu H, 1996, NEUROPEPTIDES, V30, P47; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Sacharczuk M, 2014, ADDICT BIOL, V19, P643, DOI 10.1111/adb.12030; SCHWEGLER H, 1988, BEHAV GENET, V18, P153, DOI 10.1007/BF01067837; Sharma A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112019; SHARMA HS, 1993, NEUROPHARMACOLOGY, V32, P711, DOI 10.1016/0028-3908(93)90085-H; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Siopi E, 2012, NEUROSCI LETT, V511, P110, DOI 10.1016/j.neulet.2012.01.051; Skelton RW, 2006, BRAIN INJURY, V20, P189, DOI 10.1080/02699050500456410; SPANAGEL R, 1990, J NEUROCHEM, V55, P1734, DOI 10.1111/j.1471-4159.1990.tb04963.x; Su TP, 2000, J BIOMED SCI, V7, P195, DOI 10.1159/000025448; Sun D, 2014, NEURAL REGEN RES, V9, P688, DOI 10.4103/1673-5374.131567; Sun K, 2009, BRAIN RES, V1292, P100, DOI 10.1016/j.brainres.2009.06.104; Tashlykov V, 2007, BRAIN RES, V1130, P197, DOI 10.1016/j.brainres.2006.10.032; TEASDALE G, 1974, LANCET, V2, P81; Tsaousides T, 2009, MT SINAI J MED, V76, P173, DOI 10.1002/msj.20099; UPCHURCH M, 1988, BEHAV GENET, V18, P55, DOI 10.1007/BF01067075; von Holst H, 2004, J REHABIL MED, V36, P8, DOI 10.1080/16501960410023633; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; Xiong Y, 2009, EXPERT OPIN EMERG DR, V14, P67, DOI [10.1517/14728210902769601, 10.1517/14728210902769601 ]; Yang L, 2015, BRAIN RES, V1609, P1, DOI 10.1016/j.brainres.2015.03.022; Yang L, 2011, J PHARMACOL EXP THER, V339, P499, DOI 10.1124/jpet.111.184127; Yang L, 2011, BRAIN RES, V1383, P307, DOI 10.1016/j.brainres.2011.01.083; Zhang JH, 2000, BRAIN RES, V885, P143, DOI 10.1016/S0006-8993(00)02906-1; Zheng WM, 2013, J NEUROTRAUM, V30, P1872, DOI 10.1089/neu.2010.1579; Zohar O, 2006, NEUROSCI LETT, V394, P239, DOI 10.1016/j.neulet.2005.10.099; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4	69	11	12	0	17	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3908	1873-7064		NEUROPHARMACOLOGY	Neuropharmacology	FEB	2016	101						506	518		10.1016/j.neuropharm.2015.10.014			13	Neurosciences; Pharmacology & Pharmacy	Neurosciences & Neurology; Pharmacology & Pharmacy	DA0JQ	WOS:000367483800047	26474659				2021-06-18	
J	Sebastiani, A; Granold, M; Ditter, A; Sebastiani, P; Golz, C; Pottker, B; Luh, C; Schaible, EV; Radyushkin, K; Timaru-Kast, R; Werner, C; Schafer, MK; Engelhard, K; Moosmann, B; Thal, SC				Sebastiani, Anne; Granold, Matthias; Ditter, Anja; Sebastiani, Philipp; Goelz, Christina; Poettker, Bruno; Luh, Clara; Schaible, Eva-Verena; Radyushkin, Konstantin; Timaru-Kast, Ralph; Werner, Christian; Schaefer, Michael K.; Engelhard, Kristin; Moosmann, Bernd; Thal, Serge C.			Posttraumatic Propofol Neurotoxicity Is Mediated via the Pro-Brain-Derived Neurotrophic Factor-p75 Neurotrophin Receptor Pathway in Adult Mice	CRITICAL CARE MEDICINE			English	Article						anesthesia; BDNF; brain-derived neurotrophic factor; gamma-aminobutyric acid; GABA(A); nerve growth factor receptor; neurotoxicity; neurotrophin; p75NTR; p75 neurotrophin receptor; proBDNF; proneurotrophin; propofol; TAT-Pep5; traumatic brain injury	NEURONAL CELL-DEATH; SPECTRIN BREAKDOWN PRODUCTS; DEVELOPING RAT-BRAIN; GENERAL-ANESTHESIA; CEREBRAL-ISCHEMIA; INJURED NEURONS; NERVOUS-SYSTEM; P75(NTR); INHIBITION; NEUROPROTECTION	Objectives: The gamma-aminobutyric acid modulator propofol induces neuronal cell death in healthy immature brains by unbalancing neurotrophin homeostasis via p75 neurotrophin receptor signaling. In adulthood, p75 neurotrophin receptor becomes down-regulated and propofol loses its neurotoxic effect. However, acute brain lesions, such as traumatic brain injury, reactivate developmental-like programs and increase p75 neurotrophin receptor expression, probably to foster reparative processes, which in turn could render the brain sensitive to propofol-mediated neurotoxicity. This study investigates the influence of delayed single-bolus propofol applications at the peak of p75 neurotrophin receptor expression after experimental traumatic brain injury in adult mice. Design: Randomized laboratory animal study. Setting: University research laboratory. Subjects: Adult C57BL/6N and nerve growth factor receptor-deficient mice. Interventions: Sedation by IV propofol bolus application delayed after controlled cortical impact injury. Measurements and Main Results: Propofol sedation at 24 hours after traumatic brain injury increased lesion volume, enhanced calpain-induced II-spectrin cleavage, and increased cell death in perilesional tissue. Thirty-day postinjury motor function determined by CatWalk (Noldus Information Technology, Wageningen, The Netherlands) gait analysis was significantly impaired in propofol-sedated animals. Propofol enhanced pro-brain-derived neurotrophic factor/brain-derived neurotrophic factor ratio, which aggravates p75 neurotrophin receptor-mediated cell death. Propofol toxicity was abolished both by pharmacologic inhibition of the cell death domain of the p75 neurotrophin receptor (TAT-Pep5) and in mice lacking the extracellular neurotrophin binding site of p75 neurotrophin receptor. Conclusions: This study provides first evidence that propofol sedation after acute brain lesions can have a deleterious impact and implicates a role for the pro-brain-derived neurotrophic factor-p75 neurotrophin receptor pathway. This observation is important as sedation with propofol and other compounds with GABA receptor activity are frequently used in patients with acute brain pathologies to facilitate sedation or surgical and interventional procedures.	[Sebastiani, Anne; Ditter, Anja; Sebastiani, Philipp; Goelz, Christina; Poettker, Bruno; Luh, Clara; Schaible, Eva-Verena; Timaru-Kast, Ralph; Werner, Christian; Schaefer, Michael K.; Engelhard, Kristin; Thal, Serge C.] Johannes Gutenberg Univ Mainz, Dept Anesthesiol, Univ Med Ctr, D-55122 Mainz, Germany; [Granold, Matthias; Moosmann, Bernd] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Pathobiochem, D-55122 Mainz, Germany; [Radyushkin, Konstantin] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Mouse Behav Outcome Unit, Focus Program Translat Neurosci FTN, D-55122 Mainz, Germany; [Schaefer, Michael K.; Engelhard, Kristin] Johannes Gutenberg Univ Mainz, Focus Program Translat Neurosci FTN, D-55122 Mainz, Germany	Thal, SC (corresponding author), Johannes Gutenberg Univ Mainz, Dept Anesthesiol, Univ Med Ctr, D-55122 Mainz, Germany.	thal@uni-mainz.de	Thal, Serge/D-6593-2011	Thal, Serge/0000-0002-1222-8729	Collaborative Research Center - German Research Foundation (DFG)German Research Foundation (DFG) [1080]; Johannes Gutenberg-University; DFGGerman Research Foundation (DFG)European Commission [TH1430/3-1]; Federal Ministry of Education and Research (BMBF)Federal Ministry of Education & Research (BMBF) [01EO1003]; DFGGerman Research Foundation (DFG)European Commission	Drs. Sebastiani, Schafer, Engelhard, and Thal were supported by the Collaborative Research Center 1080 funded by the German Research Foundation (DFG). Drs. Sebastiani and Thal were supported by Stage 1 funding of the Johannes Gutenberg-University. Dr. Engelhard lectured for AbbVie and Fresenius Kabi and she received support for research from the DFG. Dr. Thal was supported by the Federal Ministry of Education and Research (BMBF 01EO1003) and by the DFG (TH1430/3-1). Dr. Thal's institution received grant support from the DFG. The remaining authors have disclosed that they do not have any potential conflicts of interest.	Banks P, 2010, ANESTHESIOLOGY, V112, P614, DOI 10.1097/ALN.0b013e3181cea398; Beattie MS, 2002, NEURON, V36, P375, DOI 10.1016/S0896-6273(02)01005-X; Brambrink AM, 2012, ANESTHESIOLOGY, V116, P372, DOI 10.1097/ALN.0b013e318242b2cd; Campos-Pires R, 2015, CRIT CARE MED, V43, P149, DOI 10.1097/CCM.0000000000000624; Clewes O, 2008, J NEUROCHEM, V107, P1124, DOI 10.1111/j.1471-4159.2008.05698.x; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Coulson EJ, 2008, J NEUROSCI, V28, P315, DOI 10.1523/JNEUROSCI.2699-07.2008; Cui DR, 2013, NEUROSCIENCE, V246, P117, DOI 10.1016/j.neuroscience.2013.04.054; Dechant G, 2002, NAT NEUROSCI, V5, P1131, DOI 10.1038/nn1102-1131; Ding ZY, 2013, CELL BIOCHEM BIOPHYS, V67, P615, DOI 10.1007/s12013-013-9549-0; Dzhala V, 2012, J NEUROSCI, V32, P4017, DOI 10.1523/JNEUROSCI.5139-11.2012; Engelhard K, 2004, ANESTHESIOLOGY, V101, P912, DOI 10.1097/00000542-200410000-00016; Flower O., 2012, EMERG MED INT, V2012, DOI DOI 10.1155/2012/637171; Head BP, 2009, ANESTHESIOLOGY, V110, P813, DOI 10.1097/ALN.0b013e31819b602b; Hung PL, 2013, STROKE, V44, P2275, DOI 10.1161/STROKEAHA.113.001552; Jevtovic-Todorovic V, 2013, MOL NEUROBIOL, V48, P288, DOI 10.1007/s12035-013-8488-5; Karmarkar SW, 2010, COMPARATIVE MED, V60, P256; KOCHS E, 1992, ANESTHESIOLOGY, V76, P245, DOI 10.1097/00000542-199202000-00014; Lu LX, 2006, APOPTOSIS, V11, P1603, DOI 10.1007/s10495-006-8762-3; Luh C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019948; Luo T, 2013, ANESTHESIOLOGY, V119, P1370, DOI 10.1097/ALN.0000000000000020; Milanovic D, 2010, DEV NEUROSCI-BASEL, V32, P288, DOI 10.1159/000316970; Mintz CD, 2013, ANESTHESIOLOGY, V118, P825, DOI 10.1097/ALN.0b013e318287b850; Mondello S, 2010, J NEUROTRAUM, V27, P1203, DOI 10.1089/neu.2010.1278; Mustafa AG, 2010, J NEUROCHEM, V114, P271, DOI 10.1111/j.1471-4159.2010.06749.x; Neumann M, 2009, J NEUROSCI METH, V176, P34, DOI 10.1016/j.jneumeth.2008.08.026; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; Pariat M, 2000, BIOCHEM J, V345, P129, DOI 10.1042/0264-6021:3450129; Park JA, 2000, J NEUROSCI, V20, P9096; Pearn ML, 2012, ANESTHESIOLOGY, V116, P352, DOI 10.1097/ALN.0b013e318242a48c; Pesic V, 2009, INT J DEV NEUROSCI, V27, P279, DOI 10.1016/j.ijdevneu.2008.12.005; Pineda JA, 2007, J NEUROTRAUM, V24, P354, DOI 10.1089/neu.2006.003789; Popic J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034396; RONAN KP, 1995, CRIT CARE MED, V23, P286, DOI 10.1097/00003246-199502000-00014; Rossaint J, 2009, CRIT CARE, V13, DOI 10.1186/cc7795; Roux PP, 1999, J NEUROSCI, V19, P6887, DOI 10.1523/JNEUROSCI.19-16-06887.1999; Schaible EV, 2014, J NEUROCHEM, V129, P940, DOI 10.1111/jnc.12708; Shulga A, 2013, NEUROSCIENCE, V239, P241, DOI 10.1016/j.neuroscience.2012.12.007; Shulga A, 2012, J NEUROSCI, V32, P1757, DOI 10.1523/JNEUROSCI.3282-11.2012; Sotthibundhu A, 2008, J NEUROSCI, V28, P3941, DOI 10.1523/JNEUROSCI.0350-08.2008; Staib-Lasarzik I, 2014, J NEUROTRAUM, V31, P1664, DOI 10.1089/neu.2013.3243; Teng HK, 2005, J NEUROSCI, V25, P5455, DOI 10.1523/JNEUROSCI.5123-04.2005; Thal SC, 2008, J NEUROTRAUM, V25, P785, DOI 10.1089/neu.2007.0497; Thal SC, 2007, J NEUROSCI METH, V159, P261, DOI 10.1016/j.jneumeth.2006.07.016; Thal SC, 2014, CRIT CARE MED, V42, P129, DOI 10.1097/CCM.0b013e3182a639fd; Thal SC, 2013, CRIT CARE MED, V41, P1305, DOI 10.1097/CCM.0b013e31827ca494; Timaru-Kast R, 2012, CRIT CARE MED, V40, P935, DOI 10.1097/CCM.0b013e31822f08b9; Underwood CK, 2008, INT J BIOCHEM CELL B, V40, P1664, DOI 10.1016/j.biocel.2007.06.010; Underwood CK, 2008, MOL CELL NEUROSCI, V37, P346, DOI 10.1016/j.mcn.2007.10.005; Wang HY, 2011, J NEUROCHEM, V119, P210, DOI 10.1111/j.1471-4159.2011.07400.x; Wei HF, 2011, ANESTH ANALG, V113, P972, DOI 10.1213/ANE.0b013e3182323261; Wise-Faberowski L, 2005, ANESTH ANALG, V101, P651, DOI 10.1213/01.ane.0000167382.79889.7c; Yamada KH, 2012, J BIOL CHEM, V287, P13182, DOI 10.1074/jbc.M111.302612; Yamashita T, 2003, NAT NEUROSCI, V6, P461, DOI 10.1038/nn1045; Yang H, 2008, ANESTHESIOLOGY, V109, P243, DOI 10.1097/ALN.0b013e31817f5c47; Yang JM, 2014, CELL REP, V7, P796, DOI 10.1016/j.celrep.2014.03.040; Yon JH, 2005, NEUROSCIENCE, V135, P815, DOI 10.1016/j.neuroscience.2005.03.064; Zagrebelsky M, 2005, J NEUROSCI, V25, P9989, DOI 10.1523/JNEUROSCI.2492-05.2005; Zheng H, 2013, ANESTHESIOLOGY, V118, P516, DOI 10.1097/ALN.0b013e3182834d5d; Zhu CL, 2010, J CEREBR BLOOD F MET, V30, P1017, DOI 10.1038/jcbfm.2009.274	60	11	13	1	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	FEB	2016	44	2					E70	E82		10.1097/CCM.0000000000001284			13	Critical Care Medicine	General & Internal Medicine	DB4SR	WOS:000368504000002	26317567				2021-06-18	
J	Willyerd, FA; Empey, PE; Philbrick, A; Ikonomovic, MD; Puccio, AM; Kochanek, PM; Okonkwo, DO; Clark, RSB				Willyerd, F. Anthony; Empey, Philip E.; Philbrick, Ashley; Ikonomovic, Milos D.; Puccio, Ava M.; Kochanek, Patrick M.; Okonkwo, David O.; Clark, Robert S. B.			Expression of ATP-Binding Cassette Transporters B1 and C1 after Severe Traumatic Brain Injury in Humans	JOURNAL OF NEUROTRAUMA			English	Article						ABCB1; ABCC1; MDR1; MRP1; multidrug resistance protein; multidrug resistance-associated protein; p-glycoprotein	SEVERE HEAD-INJURY; RESISTANCE-RELATED PROTEINS; MULTIDRUG-RESISTANCE; P-GLYCOPROTEIN; EFFLUX TRANSPORTERS; DRUG-TRANSPORTER; ABC TRANSPORTERS; HIT-I; BARRIER; PROTEOLYSIS	Adenosine triphosphate-binding cassette (ABC) transport proteins ABCC1 and ABCB1 (also known as multidrug resistance-associated protein 1 and p-glycoprotein, respectively), are key membrane efflux transporters of drugs and endogenous substrates, including in the brain. The impact of traumatic brain injury (TBI) on ABCC1 and ABCB1 expression in humans is unknown. We hypothesized that ABCC1 and ABCB1 expression would be altered in brain tissue from patients acutely after severe TBI. Archived TBI samples (n=10) from our Brain Trauma Research Center and control samples (n=7) from our Alzheimer Disease Research Center were obtained under Institutional Review Board approval. Protein was extracted from fresh frozen cortical brain tissue for Western blot analysis and sections were obtained from fixed cortical tissue for immunohistochemistry. Relative abundance of ABCC1 was increased in samples from TBI versus controls (2.8 +/- 2.5 fold; p=0.005). ABCC1 immunohistochemistry was consistent with Western blot data, with increased immunoreactivity in cerebral blood vessel walls, as well as cells with the morphological appearance of neurons and glia in TBI versus controls. Relative abundance of ABCB1 was similar between TBI and controls (p=0.76), and ABCB1 immunoreactivity was primarily associated with cerebral blood vessels in both groups. These human data show that TBI increases ABCC1 expression in the brain, consistent with possible implications for both patients receiving pharmacological inhibitors and/or substrates of ABCC1 after TBI.	[Willyerd, F. Anthony; Kochanek, Patrick M.; Clark, Robert S. B.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA USA; [Ikonomovic, Milos D.] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15261 USA; [Puccio, Ava M.; Okonkwo, David O.] Univ Pittsburgh, Sch Med, Dept Neurol Surg, Pittsburgh, PA 15261 USA; [Kochanek, Patrick M.; Clark, Robert S. B.] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15261 USA; [Empey, Philip E.; Clark, Robert S. B.] Univ Pittsburgh, Sch Med, Clin & Translat Sci Inst, Pittsburgh, PA USA; [Empey, Philip E.; Clark, Robert S. B.] UPMC, Safar Ctr Resuscitat Res, Pittsburgh, PA USA; [Empey, Philip E.; Clark, Robert S. B.] UPMC, Childrens Hosp Pittsburgh, Pittsburgh, PA USA; [Empey, Philip E.; Philbrick, Ashley] Univ Pittsburgh, Sch Pharm, Dept Pharm & Therapeut, Pittsburgh, PA 15261 USA; [Willyerd, F. Anthony] Phoenix Childrens Childrens Hosp, Crit Care, Phoenix, AZ USA; [Willyerd, F. Anthony] Univ Arizona, Phoenix, AZ USA	Clark, RSB (corresponding author), Childrens Hosp Pittsburgh, 4401 Penn Ave, Pittsburgh, PA 15224 USA.	clarkrs@ccm.upmc.edu	Empey, Philip/L-9604-2019	Empey, Philip/0000-0001-7474-2339	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS069247, P50 NS30318, AG05133]; NCATSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2 TR000146]; Children's Hospital of Pittsburgh of UPMC Scientific Program; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR000146] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS069247, P50NS030318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P50AG005133] Funding Source: NIH RePORTER	This work was supported by NIH grants R01 NS069247 (RSBC, PEE), P50 NS30318 (DOO, AMP, PMK, RSBC), and AG05133 (the University of Pittsburgh ADRC), and NCATS KL2 TR000146 (PEE); and the Children's Hospital of Pittsburgh of UPMC Scientific Program. We would like to thank Professor Piet Borst (Netherlands Cancer Institute) for generously providing the overexpressing cell lines.	Arabi YM, 2010, J CRIT CARE, V25, P190, DOI 10.1016/j.jcrc.2009.05.004; Aronica E, 2004, EPILEPSIA, V45, P441, DOI 10.1111/j.0013-9580.2004.57703.x; Bakos E, 2007, PFLUG ARCH EUR J PHY, V453, P621, DOI 10.1007/s00424-006-0160-8; Basic S, 2008, SEIZURE-EUR J EPILEP, V17, P524, DOI 10.1016/j.seizure.2008.01.003; Bayir H, 2002, PEDIATR RES, V51, P571, DOI 10.1203/00006450-200205000-00005; Begley DJ, 2004, CURR PHARM DESIGN, V10, P1295, DOI 10.2174/1381612043384844; Bendayan R, 2002, MICROSC RES TECHNIQ, V57, P365, DOI 10.1002/jemt.10090; Bournissen FG, 2009, EPILEPSIA, V50, P898, DOI 10.1111/j.1528-1167.2008.01858.x; Brown JIM, 1998, J NEUROTRAUM, V15, P253, DOI 10.1089/neu.1998.15.253; Cascorbi I, 2013, PHARMACOGENOMICS, V14, P485, DOI [10.2217/PGS.13.18, 10.2217/pgs.13.18]; Clark RSB, 2008, AUTOPHAGY, V4, P88, DOI 10.4161/auto.5173; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Clark RSB, 1999, FASEB J, V13, P813; Cousar JL, 2013, NEUROCRIT CARE, V19, P192, DOI 10.1007/s12028-013-9881-7; Daood M, 2008, NEUROPEDIATRICS, V39, P211, DOI 10.1055/s-0028-1103272; Decory HH, 2001, DRUG METAB DISPOS, V29, P1256; DeKosky ST, 2007, ARCH NEUROL-CHICAGO, V64, P541, DOI 10.1001/archneur.64.4.541; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; Falcao AS, 2007, NEUROSCIENCE, V144, P878, DOI 10.1016/j.neuroscience.2006.10.026; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Gazzin S, 2008, J COMP NEUROL, V510, P497, DOI 10.1002/cne.21808; Gerberding JL, 2003, REP C MILD TRAUM BRA; Hammond CL, 2007, J BIOL CHEM, V282, P14337, DOI 10.1074/jbc.M611019200; Hartz AMS, 2011, CURR PHARM BIOTECHNO, V12, P656; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Kampfl A, 1997, J NEUROTRAUM, V14, P121, DOI 10.1089/neu.1997.14.121; Lai YC, 2008, J CEREBR BLOOD F MET, V28, P540, DOI 10.1038/sj.jcbfm.9600551; Loscher W, 2002, J PHARMACOL EXP THER, V301, P7, DOI 10.1124/jpet.301.1.7; MARSHALL LF, 1995, J NEUROTRAUM, V12, P929, DOI 10.1089/neu.1995.12.929; Morris GF, 1999, J NEUROSURG, V91, P737, DOI 10.3171/jns.1999.91.5.0737; MUIZELAAR JP, 1995, J NEUROSURG, V83, P942; Murray GD, 1996, ACTA NEUROCHIR, V138, P1163, DOI 10.1007/BF01809745; Nies AT, 2004, NEUROSCIENCE, V129, P349, DOI 10.1016/j.neuroscience.2004.07.051; Nuti SL, 2002, J BIOL CHEM, V277, P29417, DOI 10.1074/jbc.M204054200; Ohkawa K, 1999, INT J ONCOL, V15, P677; Pandya JD, 2014, EXP NEUROL, V257, P106, DOI 10.1016/j.expneurol.2014.04.020; Pop V, 2013, J CEREBR BLOOD F MET, V33, P205, DOI 10.1038/jcbfm.2012.154; Potschka H, 2010, PHARMACOL THERAPEUT, V125, P118, DOI 10.1016/j.pharmthera.2009.10.004; Ren XQ, 2005, J BIOL CHEM, V280, P6231, DOI 10.1074/jbc.M409498200; SCHWARTZ ML, 1984, CAN J NEUROL SCI, V11, P434, DOI 10.1017/S0317167100045960; Siddiqui A, 2003, NEW ENGL J MED, V348, P1442, DOI 10.1056/NEJMoa021986; Silva R, 2015, PHARMACOL THERAPEUT, V149, P1, DOI 10.1016/j.pharmthera.2014.11.013; Sisodiya SM, 2002, BRAIN, V125, P22, DOI 10.1093/brain/awf002; Sun HY, 2003, ADV DRUG DELIVER REV, V55, P83, DOI 10.1016/S0169-409X(02)00172-2; TEASDALE G, 1992, J NEUROTRAUM, V9, pS545; Uchida Y, 2011, J NEUROCHEM, V117, P333, DOI 10.1111/j.1471-4159.2011.07208.x; Wang Y, 2008, CELL MOL LIFE SCI, V65, P237, DOI 10.1007/s00018-007-7288-3; WARD JD, 1985, J NEUROSURG, V62, P383, DOI 10.3171/jns.1985.62.3.0383; Wijesuriya HC, 2010, BRAIN RES, V1358, P228, DOI 10.1016/j.brainres.2010.08.034; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Zhang XP, 2006, J NEUROTRAUM, V23, P1583, DOI 10.1089/neu.2006.23.1583; Zhang XP, 2003, FASEB J, V17, P1367, DOI 10.1096/fj.02-1067fje	53	11	11	0	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2016	33	2					226	231		10.1089/neu.2015.3879			6	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	DA7PH	WOS:000367995800008	25891836	Green Published			2021-06-18	
J	Peach, RK; Coelho, CA				Peach, Richard K.; Coelho, Carl A.			Linking inter- and intra-sentential processes for narrative production following traumatic brain injury: Implications for a model of discourse processing	NEUROPSYCHOLOGIA			English	Article						Traumatic brain injury; Cognition; Language; Executive functions; Discourse; Sentence planning	EXECUTIVE FUNCTIONS; LANGUAGE; IMPAIRMENT; ADULTS; STORY; COHERENCE; COHESION; PATTERNS; MODERATE; CHILDREN	Some suggest that traumatic brain injury (TBI) produces dissociation between the macrolinguistic and microlinguistic levels of discourse production. This assumption is based primarily on studies that have found preserved intersentential cohesion and/or intra-sentential processing in narratives produced by these individuals. However, few studies exist, if any, that have investigated the relationship between these processes in TBI speakers who do demonstrate such microlinguistic impairments. This study investigated the relationship between impairments of intersentential cohesion and intra-sentential processing in the discourse of 15 speakers with severe TBI. The results demonstrated a significant relationship between the production of cohesive ties and instances of intra-sentential impairment that suggests that utilization of resources for adequate cohesion appears to negatively affect intra-sentential processing following TBI. We propose that macrolinguistic and microlinguistic processes are not independent of one another, as has been proposed, but share cognitive resources that support the planning and production of both local (microlinguistic) and long-distance (macrolinguistic) relationships expressed through discourse. (C) 2015 Elsevier Ltd. All rights reserved.	[Peach, Richard K.] Rush Univ, Med Ctr, Dept Commun Disorders & Sci, 1018B Armour Acad Ctr,600 South Paulina St, Chicago, IL 60612 USA; [Peach, Richard K.] Rush Univ, Med Ctr, Dept Neurol Sci, 1018B Armour Acad Ctr,600 South Paulina St, Chicago, IL 60612 USA; [Peach, Richard K.] Rush Univ, Med Ctr, Dept Otolaryngol Head & Neck Surg, 1018B Armour Acad Ctr,600 South Paulina St, Chicago, IL 60612 USA; [Coelho, Carl A.] Univ Connecticut, Dept Speech Language & Hearing Sci, Unit 1085, Storrs, CT 06269 USA	Peach, RK (corresponding author), Rush Univ, Med Ctr, Dept Commun Disorders & Sci, 1018B Armour Acad Ctr,600 South Paulina St, Chicago, IL 60612 USA.; Peach, RK (corresponding author), Rush Univ, Med Ctr, Dept Neurol Sci, 1018B Armour Acad Ctr,600 South Paulina St, Chicago, IL 60612 USA.; Peach, RK (corresponding author), Rush Univ, Med Ctr, Dept Otolaryngol Head & Neck Surg, 1018B Armour Acad Ctr,600 South Paulina St, Chicago, IL 60612 USA.	richard_k_peach@rush.edu; carl.coelho@uconn.edu			Department of Communication Disorders and Sciences, College of Health Sciences, Rush University	The Department of Communication Disorders and Sciences, College of Health Sciences, Rush University provided financial support for the conduct of this research and the preparation of this article. The funding source had no role in the study design, the collection, analysis or interpretation of data, in the writing of the report, or in the decision to submit this article for publication.	ADORNETTI I., 2014, WAYS PROTOLANGUAGE, V3, P9; Armstrong E, 2000, APHASIOLOGY, V14, P875, DOI 10.1080/02687030050127685; Biddle KR, 1996, J COMMUN DISORD, V29, P447, DOI 10.1016/0021-9924(95)00038-0; Boersma P., 2012, PRAAT DOING PHONETIC; Boyle M, 2011, APHASIOLOGY, V25, P1308, DOI 10.1080/02687038.2011.596185; Bubiltz W., 2011, DISCURSIVE PRAGMATIC, P37; Cannizzaro M, 2012, COGNITION ACQUIRED L, P227; CHRISTIANSEN JA, 1995, BRAIN LANG, V51, P291, DOI 10.1006/brln.1995.1062; Coelho C. A., 2007, BRAIN INJURY MED, P895; COELHO CA, 1995, BRAIN INJURY, V9, P471, DOI 10.3109/02699059509008206; Coelho CA, 2005, BRAIN INJURY, V19, P1139, DOI 10.1080/02699050500110678; Coelho CA, 2002, J SPEECH LANG HEAR R, V45, P1232, DOI 10.1044/1092-4388(2002/099); Cosentino E., 2013, 2013 WORKSH COMP MOD, DOI [10.4230/OASIcs.CMN.2013.61, DOI 10.4230/OASICS.CMN.2013.61]; Davis GA, 2004, BRAIN LANG, V89, P508, DOI 10.1016/j.bandl.2004.01.003; EHRLICH JS, 1988, J COMMUN DISORD, V21, P1, DOI 10.1016/0021-9924(88)90006-8; Ellis C, 2009, NEUROREHABILITATION, V24, P255, DOI 10.3233/NRE-2009-0476; Ferreira VS, 2002, J EXP PSYCHOL LEARN, V28, P1187, DOI 10.1037//0278-7393.28.6.1187; Galetto V, 2013, J NEUROLINGUIST, V26, P649, DOI 10.1016/j.jneuroling.2013.05.004; GLOSSER G, 1991, BRAIN LANG, V40, P67, DOI 10.1016/0093-934X(91)90117-J; GLOSSER G, 1993, NARRATIVE DISCOURSE IN NEUROLOGICALLY IMPAIRED AND NORMAL AGING ADULTS, P191; Goldman-Eisler F., 1968, PSYCHOLINGUISTICS EX; GROSJEAN F, 1979, PHONETICA, V36, P98, DOI 10.1159/000259950; Halliday Michael A. K., 1976, COHESION ENGLISH; Harley T. A., 2014, PSYCHOL LANGUAGE DAT; HARTLEY L L, 1991, Brain Injury, V5, P267, DOI 10.3109/02699059109008097; Hough MS, 2003, APHASIOLOGY, V17, P183, DOI 10.1080/02687030244000608; Jennett B, 1981, MANAGEMENT HEAD INJU; Jorgensen M, 2009, BRAIN INJURY, V23, P727, DOI 10.1080/02699050903133954; Kertesz A., 1982, W APHASIA BATTERY; KINTSCH W, 1978, PSYCHOL REV, V85, P363, DOI 10.1037/0033-295X.85.5.363; Levelt W. J. M., 1989, SPEAKING INTENTION A; Lezak M.D., 2004, NEUROPSYCHOLOGICAL A, Vfourth; LILES BZ, 1989, J SPEECH HEAR DISORD, V54, P356, DOI 10.1044/jshd.5403.356; Liles BZ, 1998, ANAL DISCOURSE COMMU, P65; Marini A, 2014, NEUROPSYCHOLOGIA, V64, P282, DOI 10.1016/j.neuropsychologia.2014.09.042; Marini A, 2011, NEUROPSYCHOLOGIA, V49, P2904, DOI 10.1016/j.neuropsychologia.2011.06.017; McDonald S, 2014, NEUROPSYCHOLOGY, V28, P801, DOI 10.1037/neu0000089; MENTIS M, 1987, J SPEECH HEAR RES, V30, P88, DOI 10.1044/jshr.3001.88; Miller J. F., 2008, SYSTEMATIC ANALYSIS; Navarro-Ruiz MI, 2001, CLIN LINGUIST PHONET, V15, P63, DOI 10.3109/02699200109167632; Peach R. K., 1990, ANN CONV AM SPEECH L; Peach R. K., 1986, ANN CONV AM SPEECH L; Peach RK, 2013, AM J SPEECH-LANG PAT, V22, pS285, DOI 10.1044/1058-0360(2013/12-0081); Rispoli M, 2008, J SPEECH LANG HEAR R, V51, P953, DOI 10.1044/1092-4388(2008/070); Stout CE, 2000, J MED SPEECH-LANG PA, V8, P15; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Thordardottir ET, 2002, BRAIN COGNITION, V48, P587, DOI 10.1006/brcg.2001.1422; Zimmermann N, 2015, BRAIN INJURY, V29, P1071, DOI 10.3109/02699052.2015.1015613	48	11	11	0	12	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3932	1873-3514		NEUROPSYCHOLOGIA	Neuropsychologia	JAN 8	2016	80						157	164		10.1016/j.neuropsychologia.2015.11.015			8	Behavioral Sciences; Neurosciences; Psychology, Experimental	Behavioral Sciences; Neurosciences & Neurology; Psychology	DC1CB	WOS:000368953300016	26593882				2021-06-18	
J	Baky, NAA; Fadda, L; Al-Rasheed, NM; Al-Rasheed, NM; Mohamed, A; Yacoub, H				Baky, Nayira Ahmed Abdel; Fadda, Laila; Al-Rasheed, Nouf M.; Al-Rasheed, Nawal M.; Mohamed, Azza; Yacoub, Hazar			Neuroprotective effect of carnosine and cyclosporine-A against inflammation, apoptosis, and oxidative brain damage after closed head injury in immature rats	TOXICOLOGY MECHANISMS AND METHODS			English	Article						lipid peroxidation; oxidative damage; traumatic brain injury; Calcium-adenosine triphosphatase; sFasL	MITOCHONDRIAL PERMEABILITY TRANSITION; CENTRAL-NERVOUS-SYSTEM; DNA-DAMAGE; CELL-DEATH; CALCIUM ACCUMULATION; MOLECULAR-MECHANISMS; COMET ASSAY; FAS LIGAND; IN-VITRO; HISTIDINE	Context: Traumatic brain injury in the pediatric population can have a great economic and emotional impact on both the child's family and society. Objective: The present study aimed to compare the effects of carnosine (CAR) and/or cyclosporine A (CyA) on oxidative brain damage after closed head injury (CHI) in immature rats. Materials and methods: Thirty-day-old rat pups were divided into five groups: non-traumatic control group, trauma group underwent CHI, trauma group injected with CAR (200 mg/kg, i.p.) following CHI for 7 d, trauma group injected with CyA (20 mg/kg, i.p.) given 15 min and 24 h after CHI, and trauma group treated with CAR and CyA. At the end of the treatment, rats were sacrificed; blood and brains were collected for assessing different biochemical parameters. Results: Trauma significantly increased brain level of malondialdehyde, nitric oxide, glucose, calcium, inflammatory mediators. Brain DNA damage was confirmed by comet assay and the significant increase in brain caspase-3 activity. Moreover, the serum level of Fas ligand in traumatized animals was significantly elevated. Concomitant decrease in brain-reduced glutathione (GSH) and calcium-adenosine triphosphatase activity was observed in the traumatized-untreated group. Treatment of traumatized animals with CAR and/or CyA ameliorated all the biochemical changes induced by CHI with marked protective effect in the combination group. Discussion and conclusion: CAR and CyA exerted a synergistic neuroprotective effect against CHI through blocking the induction of lipid peroxidation, reducing inflammatory, and oxidative stress biomarkers, preserving brain GSH content, and reducing the alterations in brain apoptotic biomarkers in traumatized animals.	[Baky, Nayira Ahmed Abdel; Fadda, Laila; Al-Rasheed, Nouf M.; Al-Rasheed, Nawal M.; Yacoub, Hazar] King Saud Univ, Dept Pharmacol, Riyadh, Saudi Arabia; [Mohamed, Azza] King Abdulaziz Univ, Fac Sci Girls, Dept Biochem, Jeddah 21413, Saudi Arabia	Baky, NAA (corresponding author), King Saud Univ, Dept Pharmacol, Riyadh, Saudi Arabia.	nayiraabdelbaky@yahoo.com	Baky, Nayira Abdel/AAF-4768-2021; mohamed, azza Mostafa/I-5066-2012	Mohamed, Azza/0000-0002-8580-2824; Abdel Baky, Nayira/0000-0003-2519-2558	Research Center of the Center for Female Scientific and Medical Colleges, Deanship of Scientific Research, King Saud UniversityKing Saud University	This research was supported by a grant from the Research Center of the Center for Female Scientific and Medical Colleges, Deanship of Scientific Research, King Saud University.	Aldini G, 2002, BIOCHEM BIOPH RES CO, V298, P699, DOI 10.1016/S0006-291X(02)02545-7; Alessandri B, 2002, J NEUROTRAUM, V19, P829, DOI 10.1089/08977150260190429; Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Awasthi D, 1997, SURG NEUROL, V47, P575, DOI 10.1016/S0090-3019(96)00461-2; BABIZHAYEV MA, 1994, BIOCHEM J, V304, P509, DOI 10.1042/bj3040509; Badjatia N, 2012, STROKE, V43, P691, DOI 10.1161/STROKEAHA.111.636035; Barlow KM, 2005, PEDIATRICS, V116, pE174, DOI 10.1542/peds.2004-2739; Bayir H, 2003, CRIT CARE CLIN, V19, P529, DOI 10.1016/S0749-0704(03)00014-9; Boldyrev A, 1999, NEUROSCIENCE, V94, P571, DOI 10.1016/S0306-4522(99)00273-0; Boldyrev A, 2004, COMP BIOCHEM PHYS B, V137, P81, DOI 10.1016/j.cbpc.2003.10.008; BOLDYREV AA, 1988, COMP BIOCHEM PHYS B, V89, P245, DOI 10.1016/0305-0491(88)90218-0; Bullock R, 2002, J NEUROTRAUM, V17, P449; Chen G, 2013, AM J MED SCI, V345, P369, DOI 10.1097/MAJ.0b013e318271c031; CHURCHILL TA, 1995, ARCH BIOCHEM BIOPHYS, V320, P43, DOI 10.1006/abbi.1995.1340; Dagci T, 2009, PHYSIOL RES, V58, P427, DOI 10.33549/physiolres.931388; Dobrota D, 2005, NEUROCHEM RES, V30, P1283, DOI 10.1007/s11064-005-8799-7; El-Ansary A, 2013, GUT PATHOG, V5, DOI 10.1186/1757-4749-5-9; Ellman GL, 1959, ARCH BIOCHEM BIOPHYS, V17, P214; FADEN AI, 1993, CRIT REV NEUROBIOL, V7, P175; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Farooqui AA, 1998, CELL MOL NEUROBIOL, V18, P599, DOI 10.1023/A:1020261600498; Fleisher-Berkovich S, 2009, PEPTIDES, V30, P1306, DOI 10.1016/j.peptides.2009.04.003; Fontana M, 2002, CELL MOL LIFE SCI, V59, P546, DOI 10.1007/s00018-002-8446-2; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Guiotto A, 2005, CURR MED CHEM, V12, P2293, DOI 10.2174/0929867054864796; Hailer NP, 2008, PROG NEUROBIOL, V84, P211, DOI 10.1016/j.pneurobio.2007.12.001; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Hansson MJ, 2004, J NEUROCHEM, V89, P715, DOI 10.1111/j.1471-4159.2004.02400.x; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Hou ZG, 2012, BRAIN RES BULL, V88, P560, DOI 10.1016/j.brainresbull.2012.06.006; Huang WL, 2007, BRAIN, V130, P3004, DOI 10.1093/brain/awm223; Hyland P, 2000, MECH AGEING DEV, V121, P203; Jung JY, 2008, ARCH ORAL BIOL, V53, P1042, DOI 10.1016/j.archoralbio.2008.03.008; Kaminska B, 2004, J CELL MOL MED, V8, P45, DOI 10.1111/j.1582-4934.2004.tb00259.x; Kasparek TR, 2011, SEMIN CELL DEV BIOL, V22, P886, DOI 10.1016/j.semcdb.2011.10.007; Kassubek J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030926; Khama-Murad AK, 2011, REGUL PEPTIDES, V167, P65, DOI 10.1016/j.regpep.2010.11.007; Kochanek PM, 2006, DEV NEUROSCI-BASEL, V28, P244, DOI 10.1159/000094151; Lee YT, 2005, EUR J PHARMACOL, V513, P145, DOI 10.1016/j.ejphar.2005.02.010; Lenzlinger PM, 2002, J NEUROIMMUNOL, V122, P167, DOI 10.1016/S0165-5728(01)00466-0; Li NL, 2004, WORLD J GASTROENTERO, V10, P3151; Luo CL, 2013, BRAIN RES, V1502, P1, DOI 10.1016/j.brainres.2013.01.037; Martin LJ, 2002, J NEUROBIOL, V50, P181, DOI 10.1002/neu.10026; Matsukura T, 2000, BIOCHEMISTRY-MOSCOW+, V65, P817; Mazzeo AT, 2009, J NEUROTRAUM, V26, P2195, DOI 10.1089/neu.2009.1012; McIntosh TK, 1996, LAB INVEST, V74, P315; Millar DJ, 1993, CALCIUM SENSITISING, P117; Mirzayan MJ, 2008, NEUROL RES, V30, P476, DOI 10.1179/174313208X276916; MIWA I, 1972, CLIN CHIM ACTA, V37, P538, DOI 10.1016/0009-8981(72)90483-4; Morita-Fujimura Y, 1999, NEUROSCI LETT, V267, P201, DOI 10.1016/S0304-3940(99)00327-4; Morita-Fujimura Y, 1999, J CEREBR BLOOD F MET, V19, P634, DOI 10.1097/00004647-199906000-00006; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Nakai A, 2004, PEDIATR NEUROL, V30, P247, DOI 10.1016/j.pediatrneurol.2003.09.006; Niu LJ, 2012, NEUROSCIENCE, V213, P19, DOI 10.1016/j.neuroscience.2012.03.057; Ori Y, 2012, BIOMED PHARMACOTHER, V66, P409, DOI 10.1016/j.biopha.2012.06.001; Panickar KS, 2002, NEUROCHEM RES, V27, P161, DOI 10.1023/A:1014875210852; Popa-Wagner A., 2013, OXID MED CELL LONGEV, V2013, P1; PRAJDA N, 1975, FEBS LETT, V59, P245, DOI 10.1016/0014-5793(75)80385-1; Qian NS, 2010, LIFE SCI, V87, P64, DOI 10.1016/j.lfs.2010.05.014; Reiter RJ, 1998, PROG NEUROBIOL, V56, P359, DOI 10.1016/S0301-0082(98)00052-5; Riess P, 2001, RESTOR NEUROL NEUROS, V18, P1; Sandhir R, 2004, NEUROSCI LETT, V369, P28, DOI 10.1016/j.neulet.2004.07.032; Sasaki YF, 1997, MUTAT RES-GEN TOX EN, V391, P215, DOI 10.1016/S1383-5718(97)00073-9; Scheff SW, 1999, J NEUROTRAUM, V16, P783, DOI 10.1089/neu.1999.16.783; Shohami E, 1996, J CEREBR BLOOD F MET, V16, P378, DOI 10.1097/00004647-199605000-00004; Siegel RM, 2000, NAT IMMUNOL, V1, P469, DOI 10.1038/82712; SIESJO BK, 1995, J NEUROTRAUM, V12, P943, DOI 10.1089/neu.1995.12.943; Signoretti S, 2004, J NEUROTRAUM, V21, P1154, DOI 10.1089/neu.2004.21.1154; Simon FR, 1996, J BIOL CHEM, V271, P24967, DOI 10.1074/jbc.271.40.24967; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Soliman K, 2001, COMP BIOCHEM PHYS B, V129, P157, DOI 10.1016/S1096-4959(01)00332-3; Statler KD, 2003, BRAIN RES, V994, P37, DOI 10.1016/j.brainres.2003.09.042; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Stvolinskii SL, 2003, B EXP BIOL MED+, V135, P130, DOI 10.1023/A:1023855428130; Sullivan PG, 2000, NEUROSCIENCE, V101, P289, DOI 10.1016/S0306-4522(00)00380-8; Sullivan PG, 1999, EXP NEUROL, V160, P226, DOI 10.1006/exnr.1999.7197; Sullivan PG, 2005, J NEUROSCI RES, V79, P231, DOI 10.1002/jnr.20292; Sun DA, 2008, EUR J NEUROSCI, V27, P1659, DOI 10.1111/j.1460-9568.2008.06156.x; Tanaka M, 1996, NAT MED, V2, P317, DOI 10.1038/nm0396-317; Tang SC, 2007, J NEUROCHEM, V101, P729, DOI 10.1111/j.1471-4159.2006.04412.x; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1; Vaculova A, 2008, METHOD ENZYMOL, V442, P157, DOI 10.1016/S0076-6879(08)01408-0; Verkhratsky A, 1998, PHYSIOL REV, V78, P99; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Wang JP, 2013, BRAIN RES, V1507, P125, DOI 10.1016/j.brainres.2013.02.032; Wang Q, 2007, J NEUROIMMUNOL, V184, P53, DOI 10.1016/j.jneuroim.2006.11.014; Weber JT, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00060; WILLIS JB, 1961, ANAL CHEM, V33, P556, DOI 10.1021/ac60172a021; YANG MS, 1985, J NEUROSURG, V63, P617, DOI 10.3171/jns.1985.63.4.0617; Yeldandi AV, 2000, MUTAT RES-FUND MOL M, V448, P159, DOI 10.1016/S0027-5107(99)00234-1; Zhang XM, 2011, EUR J PHARMACOL, V667, P202, DOI 10.1016/j.ejphar.2011.06.003; Zhang ZY, 2015, CELL MOL NEUROBIOL, V35, P147, DOI 10.1007/s10571-014-0106-1	93	11	14	0	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1537-6516	1537-6524		TOXICOL MECH METHOD	Toxicol. Mech. Methods	JAN 2	2016	26	1					1	10		10.3109/15376516.2015.1070224			10	Toxicology	Toxicology	DG5EJ	WOS:000372097800001	26275125				2021-06-18	
J	Casaletto, KB; Moore, DJ; Woods, SP; Umlauf, A; Scott, JC; Heaton, RK				Casaletto, Kaitlin B.; Moore, David J.; Woods, Steven Paul; Umlauf, Anya; Scott, J. C.; Heaton, Robert K.			Abbreviated Goal Management Training Shows Preliminary Evidence as a Neurorehabilitation Tool for HIV-associated Neurocognitive Disorders among Substance Users	CLINICAL NEUROPSYCHOLOGIST			English	Article						Activities of daily living; Executive functions; Compensatory strategies.; Awareness	HUMAN-IMMUNODEFICIENCY-VIRUS; TRAUMATIC BRAIN-INJURY; METHAMPHETAMINE DEPENDENCE; NEUROPSYCHOLOGICAL IMPAIRMENT; SELF-AWARENESS; MEDICATION ADHERENCE; PROSPECTIVE MEMORY; DEFICITS; REHABILITATION; RISK	Objective: Substance use disorders are highly comorbid with and contribute to the increased prevalence of neurocognitive dysfunction observed in HIV infection. Despite their adverse impact on everyday functioning, there are currently no compensatory-based neurorehabilitation interventions validated for use among HIV+ substance users (HIV/SUD). This study examined the effectiveness of goal management training (GMT) alone or GMT as part of a metacognitive training among HIV/SUD individuals with executive dysfunction. Methods: Ninety HIV/SUD individuals were randomized to a single 15-min session: (1) GMT (n=30); (2) GMT plus metacognitive training (neurocognitive awareness; GMT+Meta; n=30); or (3) active control (n=30). Following a brief neurocognitive battery and study condition, participants performed a complex laboratory-based function task, Everyday Multitasking Test (Everyday MT), during which metacognition (awareness) was evaluated. Results: There was an increasing, but non-significant tendency for better Everyday MT performances across study conditions (Control <= GMT <= GMT+Meta; ps<.08). Post hoc analyses showed that GMT and GMT+Meta groups demonstrated small benefits (d=.20-.27) compared to the control arm but did not differ from one another (ds<.10). When GMT groups were combined, there were significant medium effect size benefits in Everyday MT performance and metacognitive task appraisals as compared to the control condition. Among participants who underwent GMT, benefits were most prominent in persons with poorer pre-training dual-tasking ability, depression, and methamphetamine use disorders (ds=.35-1.04). Conclusions: A brief compensatory strategy has benefits for everyday multitasking and metacognition among HIV+ substance users with executive dysfunction. Future work exploring more intensive trainings, potentially complimentary to other restorative approaches and/or pharmacological treatments, is warranted.	[Casaletto, Kaitlin B.] SDSU UCSD Joint Doctoral Program Clin Psychol, San Diego, CA USA; [Moore, David J.; Umlauf, Anya; Heaton, Robert K.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Woods, Steven Paul] Univ Houston, Dept Psychol, Houston, TX USA; [Scott, J. C.] Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA; [Scott, J. C.] Philadelphia VA Med Ctr, Mental Illness Res Educ & Clin Ctr VISN4, Philadelphia, PA USA	Casaletto, KB (corresponding author), Univ Calif San Diego, Dept Psychiat, HIV Neurobehav Res Program, 220 Dickinson St,Suite B, San Diego, CA 92103 USA.	kablackstone@ucsd.edu		Scott, J. Cobb/0000-0001-6538-9043	NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [P30MH062512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [F31DA035708, P50DA026306] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [IK2CX000772] Funding Source: NIH RePORTER; NIDA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [F31-DA035708, F31 DA035708, P50 DA026306] Funding Source: Medline; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [P30 MH062512] Funding Source: Medline; CSRD VA [IK2 CX000772] Funding Source: Medline		Alfonso JP, 2011, DRUG ALCOHOL DEPEN, V117, P78, DOI 10.1016/j.drugalcdep.2010.12.025; Altice FL, 2010, LANCET, V376, P367, DOI 10.1016/S0140-6736(10)60829-X; Bandura A., 1997, SELF EFFICACY THE EX; Becker JT, 2012, DISABIL REHABIL, V34, P1848, DOI 10.3109/09638288.2012.667188; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blackstone K, 2013, AIDS BEHAV, V17, P74, DOI 10.1007/s10461-012-0308-9; Blackstone K, 2013, J ADDICT MED, V7, P255, DOI 10.1097/ADM.0b013e318293653d; Boivin MJ, 2010, NEUROPSYCHOLOGY, V24, P667, DOI 10.1037/a0019312; CALLAHAN CD, 2009, REH NEUR DIS PRACT, P75; Carey CL, 2006, AIDS BEHAV, V10, P185, DOI 10.1007/s10461-005-9056-4; Carey CL, 2004, J CLIN EXP NEUROPSYC, V26, P307, DOI 10.1080/13803390490510031; Casaletto KB, 2015, ADDICT BEHAV, V40, P45, DOI 10.1016/j.addbeh.2014.08.007; Casaletto KB, 2014, ARCH CLIN NEUROPSYCH, V29, P818, DOI 10.1093/arclin/acu061; Chana G, 2006, NEUROLOGY, V67, P1486, DOI 10.1212/01.wnl.0000240066.02404.e6; Chiao S, 2013, AIDS RES HUM RETROV, V29, P949, DOI [10.1089/aid.2012.0229, 10.1089/AID.2012.0229]; CLIFF N, 1993, PSYCHOL BULL, V114, P494, DOI 10.1037/0033-2909.114.3.494; DUNCAN J, 1986, COGNITIVE NEUROPSYCH, V3, P271, DOI 10.1080/02643298608253360; Ellis RJ, 2003, J INFECT DIS, V188, P1820, DOI 10.1086/379894; Fernandez-Duque D, 2000, CONSCIOUS COGN, V9, P288, DOI 10.1006/ccog.2000.0447; Fleming J, 1999, OCCUP THER J RES, V19, P3, DOI 10.1177/153944929901900101; Gavrilin MA, 2002, J NEUROVIROL, V8, P240, DOI 10.1080/13550280290049660; Goverover Y, 2007, BRAIN INJURY, V21, P913, DOI 10.1080/02699050701553205; Hacker DJ, 1998, EDUC PSYCHO, P1; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; Heaton RK, 2004, J INT NEUROPSYCH SOC, V10, P317, DOI 10.1017/S1355617704102130; Henry BL, 2010, ADDICT BEHAV, V35, P593, DOI 10.1016/j.addbeh.2010.01.013; Hinkin CH, 2004, AIDS, V18, pS19, DOI 10.1097/00002030-200418001-00004; Hinkin CH, 2007, AIDS BEHAV, V11, P185, DOI 10.1007/s10461-006-9152-0; Iudicello JE, 2014, J NEUROVIROL, V20, P85, DOI 10.1007/s13365-014-0233-y; Jackson JC, 2012, CRIT CARE MED, V40, P1088, DOI 10.1097/CCM.0b013e3182373115; Jernigan TL, 2005, AM J PSYCHIAT, V162, P1461, DOI 10.1176/appi.ajp.162.8.1461; Kelley WM, 2002, J COGNITIVE NEUROSCI, V14, P785, DOI 10.1162/08989290260138672; Kelly AMC, 2005, CEREB CORTEX, V15, P1089, DOI 10.1093/cercor/bhi005; Kliegel M, 2000, MEM COGNITION, V28, P1041, DOI 10.3758/BF03209352; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Langford D, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-8; Le Berre AP, 2010, ALCOHOL CLIN EXP RES, V34, P1888, DOI 10.1111/j.1530-0277.2010.01277.x; Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; Levine B, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00009; Lysaker PH, 2008, J NERV MENT DIS, V196, P384, DOI 10.1097/NMD.0b013e3181710916; Meyer DE, 1997, PSYCHOL REV, V104, P3, DOI 10.1037/0033-295X.104.1.3; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Ownsworth T, 2006, J INT NEUROPSYCH SOC, V12, P54, DOI 10.1017/S135561770606005X; Ownsworth T, 2010, NEUROPSYCHOL REHABIL, V20, P59, DOI 10.1080/09602010902949223; Palepu A, 2004, ADDICTION, V99, P361, DOI 10.1111/j.1360-0443.2003.00670.x; Petersen SE, 1998, P NATL ACAD SCI USA, V95, P853, DOI 10.1073/pnas.95.3.853; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; Prigatano GP, 1999, ARCH PHYS MED REHAB, V80, P77, DOI 10.1016/S0003-9993(99)90311-8; Purcell DW, 2001, J SUBST ABUSE, V13, P185, DOI 10.1016/S0899-3289(01)00072-4; Purohit V, 2011, MOL NEUROBIOL, V44, P102, DOI 10.1007/s12035-011-8195-z; Rippeth JD, 2004, J INT NEUROPSYCH SOC, V10, P1, DOI 10.1017/S1355617704101021; Robertson I. H., 1994, TEST EVERYDAY ATTENT; Robertson IH, 1996, GOAL MANAGEMENT TRAI; Schweizer TA, 2008, NEUROREHAB NEURAL RE, V22, P72, DOI 10.1177/1545968307305303; Scott JC, 2007, NEUROPSYCHOL REV, V17, P275, DOI 10.1007/s11065-007-9031-0; Scott JC, 2011, NEUROPSYCHOLOGY, V25, P511, DOI 10.1037/a0022491; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Siegal S., 1988, NONPARAMETRIC STAT B, V2nd; Stuss DT, 2011, J INT NEUROPSYCH SOC, V17, P759, DOI 10.1017/S1355617711000695; Taylor MJ, 2007, J NEUROVIROL, V13, P150, DOI 10.1080/13550280701194230; Toglia J, 2000, NEUROREHABILITATION, V15, P57; Trudel TM, 1998, REHABIL PSYCHOL, V43, P267, DOI 10.1037/0090-5550.43.4.267; Vance DE, 2012, J ASSOC NURSE AIDS C, V23, P500, DOI 10.1016/j.jana.2012.01.005; Weber E, 2013, NEUROPSYCHOL REV, V23, P81, DOI 10.1007/s11065-013-9225-6; Weber E, 2013, J NEUROVIROL, V19, P65, DOI 10.1007/s13365-012-0141-y; World Health Organization, 1997, COMP INT DIAGN INT V	66	11	12	0	8	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	JAN 2	2016	30	1					107	130		10.1080/13854046.2015.1129437			24	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	DH4CM	WOS:000372733100008	26753986	Green Accepted			2021-06-18	
J	Forbes, CR; Glutting, JJ; Kaminski, TW				Forbes, Cameron R.; Glutting, Joseph J.; Kaminski, Thomas W.			Examining Neurocognitive Function in Previously Concussed Interscholastic Female Soccer Players	APPLIED NEUROPSYCHOLOGY-CHILD			English	Article						ANAM; head injury; neuropsychological; purposeful heading	TRAUMATIC BRAIN-INJURY; NORMATIVE DATA; FOOTBALL; SPORTS; SYMPTOMS; IMPACT; RISK; ENCEPHALOPATHY; EPIDEMIOLOGY; RELIABILITY	Awareness of sport-related concussions in soccer has gained recent attention in the medical community. Interestingly, purposeful headinga unique yet strategic and inherent part of soccerinvolves repeated subconcussive blows to the head. We divided 210 female interscholastic soccer players into control (CON [never concussed]) and experimental (EXP [previously concussed]) groups. We assessed neurocognitive performance using the Automated Neuropsychological Assessment Metrics computer program before and after the players' competitive season. Headers were recorded at all sanctioned matches. Data were analyzed using a series of one-way analyses of covariance and t tests. Both groups essentially played in the same number of games (EXP=16.1 vs. CON=16.1) and had an equal number of total headers (EXP=24.9 vs. CON=24.3). Additionally, headers per game were surprisingly low in both groups (1.4 in EXP vs. 1.3 in CON). Unexpectedly, there were no significant differences between the EXP and CON groups across all dependent variables measured (p > .05). This study suggests that although previously concussed players involve themselves in purposeful heading (i.e., subconcussive insults) throughout a competitive season, there appear to be no negative consequences on neuropsychological test performance or concussion-related symptoms. Additional research is needed to determine what may result during the course of a playing career.	[Forbes, Cameron R.] Univ Delaware, Dept Psychol, Newark, DE USA; [Glutting, Joseph J.] Univ Delaware, Sch Educ, Newark, DE USA; [Kaminski, Thomas W.] Univ Delaware, Human Performance Lab, Dept Kinesiol & Appl Physiol, Room 159,541 South Coll Ave, Newark, DE 19716 USA	Kaminski, TW (corresponding author), Univ Delaware, Human Performance Lab, Dept Kinesiol & Appl Physiol, Room 159,541 South Coll Ave, Newark, DE 19716 USA.	Kaminski@udel.edu					Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Broglio SP, 2012, EXERC SPORT SCI REV, V40, P138, DOI 10.1097/JES.0b013e3182524273; Broglio SP, 2009, SPORTS HEALTH, V1, P361, DOI 10.1177/1941738109343158; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Coldren RL, 2012, MIL MED, V177, P179, DOI 10.7205/MILMED-D-11-00278; Cole WR, 2013, ARCH CLIN NEUROPSYCH, V28, P732, DOI 10.1093/arclin/act040; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Covassin T, 2010, J NEUROL NEUROSUR PS, V81, P597, DOI 10.1136/jnnp.2009.193797; Dashnaw ML, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12284; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; Doolan AW, 2012, ANN BIOMED ENG, V40, P106, DOI 10.1007/s10439-011-0413-3; Giza CC, 2001, J ATHL TRAINING, V36, P228; Graham J. W., 2003, HDB PSYCHOL RES METH, V2, P87, DOI DOI 10.1002/0471264385.WEI0204; Graham J. W., 1999, STAT STRATEGIES SMAL, V50, P1, DOI DOI 10.1177/0013164496056006006; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Gysland SM, 2012, ANN BIOMED ENG, V40, P14, DOI 10.1007/s10439-011-0421-3; Jelicic H, 2009, DEV PSYCHOL, V45, P1195, DOI 10.1037/a0015665; Kaminski TW, 2008, RES Q EXERCISE SPORT, V79, P235; Kaminski TW, 2009, J CLIN EXP NEUROPSYC, V31, P689, DOI 10.1080/13803390802484771; Khurana VG, 2012, J CLIN NEUROSCI, V19, P1, DOI 10.1016/j.jocn.2011.08.002; Kirkendall DT, 2001, J ATHL TRAINING, V36, P328; Koerte IK, 2012, JAMA-J AM MED ASSOC, V308, P1859, DOI 10.1001/jama.2012.13735; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Little R, 2002, STAT ANAL MISSING DA, V2nd; LITTLE RJA, 1988, J AM STAT ASSOC, V83, P1198, DOI 10.2307/2290157; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; Matser JT, 2001, J CLIN EXP NEUROPSYC, V23, P770, DOI 10.1076/jcen.23.6.770.1029; McCrory PR, 2000, CLIN J SPORT MED, V10, P235, DOI 10.1097/00042752-200010000-00002; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Miller JR, 2007, AM J SPORT MED, V35, P1284, DOI 10.1177/0363546507300261; Naunheim RS, 2000, J TRAUMA, V48, P938, DOI 10.1097/00005373-200005000-00020; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Randolph C, 2005, J ATHL TRAINING, V40, P139; REEVES D, 2001, AUTOMATED NEUROPSYCH; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Rubin DB., 1987, MULTIPLE IMPUTATION; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; Schafer J. L., 1997, CHAPMAN HALL SERIES, V72; Schafer JL, 1998, MULTIVAR BEHAV RES, V33, P545, DOI 10.1207/s15327906mbr3304_5; Schafer JL, 2009, MULTIPLE IMPUTATION; Schmidt JD, 2012, MED SCI SPORT EXER, V44, P1621, DOI 10.1249/MSS.0b013e318258a9fb; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Spiotta AM, 2012, NEUROSURGERY, V70, P1, DOI 10.1227/NEU.0b013e31823021b2; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; TYSVAER AT, 1991, AM J SPORT MED, V19, P56, DOI 10.1177/036354659101900109; Zemper ED, 2003, AM J PHYS MED REHAB, V82, P653, DOI 10.1097/01.PHM.0000083666.74494.BA	51	11	11	0	15	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2162-2965	2162-2973		APPL NEUROPSYCH-CHIL	Appl. Neuropsychol.-Child	JAN 2	2016	5	1					14	24		10.1080/21622965.2014.933108			11	Clinical Neurology; Psychology	Neurosciences & Neurology; Psychology	DB7TH	WOS:000368718500003	25495584				2021-06-18	
J	Arndt, DH; Goodkin, HP; Giza, CC				Arndt, Daniel H.; Goodkin, Howard P.; Giza, Christopher C.			Early Posttraumatic Seizures in the Pediatric Population	JOURNAL OF CHILD NEUROLOGY			English	Article						pediatric; posttraumatic seizure; traumatic brain injury; epilepsy; seizure	TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; ANTIEPILEPTIC DRUGS; CONTINUOUS EEG; RISK-FACTORS; UNITED-STATES; SHORT-TERM; EPILEPSY; CHILDREN; PREVENTION	Early posttraumatic seizure is a paramount clinical issue in pediatric traumatic brain injury patients as it is a common occurrence, yet an understudied entity at present. Recent literature recognizes several posttraumatic seizure subtypes based on time of presentation and the underlying pathophysiology: impact, immediate, delayed early, and late/posttraumatic epilepsy. Appropriate classification of pediatric posttraumatic seizure subtypes can be helpful for appropriate management and prognosis. This review will focus on early posttraumatic seizures, and the subtypes of early posttraumatic seizure. Incidence, risk factors, diagnosis, seizure semiology, status epilepticus, management, risk of recurrence, and prognosis were reviewed. The integration of continuous electroencephalographic (EEG) monitoring into pediatric traumatic brain injury management may hold the key to better characterizing and understanding pediatric early posttraumatic seizures. Topics for future research pertaining to pediatric early posttraumatic seizure are identified.	[Arndt, Daniel H.] Oakland Univ, William Beaumont Sch Med, Beaumont Childrens Hosp, Dept Pediat,Div Pediat Neurol, Royal Oak, MI USA; [Arndt, Daniel H.] Oakland Univ, William Beaumont Sch Med, Beaumont Childrens Hosp, Dept Neurol, Royal Oak, MI USA; [Arndt, Daniel H.] Oakland Univ, William Beaumont Sch Med, Beaumont Hlth Syst Neurosci, Royal Oak, MI USA; [Goodkin, Howard P.] Univ Virginia, Sch Med, UVA Hlth Syst, Dept Neurol,Div Pediat Neurol, Charlottesville, VA 22908 USA; [Goodkin, Howard P.] Univ Virginia, Sch Med, UVA Hlth Syst, Dept Pediat, Charlottesville, VA 22908 USA; [Giza, Christopher C.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Div Pediat Neurol, Los Angeles, CA 90095 USA; [Giza, Christopher C.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA; [Giza, Christopher C.] Univ Calif Los Angeles, Mattel Childrens Hosp, Los Angeles, CA USA	Arndt, DH (corresponding author), Beaumont Childrens Hosp & Hlth Syst, Med Off Bldg,Suite 302,3535 W 13 Mile Rd, Royal Oak, MI 48073 USA.	Daniel.Arndt@Beaumont.edu		Goodkin, Howard/0000-0003-0528-4949	Thrasher Research Foundation; Today's and Tomorrow's Children Fund; Winokur Family Foundation/Child Neurology Foundation	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Thrasher Research Foundation (CCG), Today's and Tomorrow's Children Fund (CCG), Winokur Family Foundation/Child Neurology Foundation (CCG).	Adelson P David, 2003, Pediatr Crit Care Med, V4, pS72; ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; Annegers JF, 2000, SEIZURE-EUR J EPILEP, V9, P453, DOI 10.1053/seiz.2000.0458; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Appleton RE, 2002, J NEUROL NEUROSUR PS, V72, P669, DOI 10.1136/jnnp.72.5.669; Arndt DH, 2013, EPILEPSIA, V54, P1780, DOI 10.1111/epi.12369; Arndt DH, 2008, PEDIAT EPILEPSY CASE; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; Barlow KM, 2000, DEV MED CHILD NEUROL, V42, P591, DOI 10.1017/S0012162200001110; Bayir H, 2003, CRIT CARE CLIN, V19, P529, DOI 10.1016/S0749-0704(03)00014-9; Bittigau P, 2002, P NATL ACAD SCI USA, V99, P15089, DOI 10.1073/pnas.222550499; Black P, 1975, Ciba Found Symp, P215; Black P, 1972, T AM NEUROL ASSOC, V97, P247; *BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P549, DOI DOI 10.1089/NEU.2000.17.549; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS83; Bricolo A, 1979, Acta Neurochir Suppl (Wien), V28, P35; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Chang BS, 2003, NEUROLOGY, V60, P10, DOI 10.1212/01.WNL.0000031432.05543.14; Chiaretti A, 2002, CHILD NERV SYST, V18, P129, DOI 10.1007/s00381-002-0558-3; Chiaretti A, 2000, CHILD NERV SYST, V16, P862, DOI 10.1007/s003810000368; DESAI BT, 1983, EPILEPSIA, V24, P289, DOI 10.1111/j.1528-1157.1983.tb04892.x; Dias MS, 1999, PEDIATR NEUROSURG, V30, P232, DOI 10.1159/000028803; DUSSER A, 1989, ELECTROEN CLIN NEURO, V73, P85, DOI 10.1016/0013-4694(89)90187-9; Elvidge A, 1939, T AM NEUROL ASSOC, V65, P125; EVANS BM, 1995, J NEUROL NEUROSUR PS, V59, P17, DOI 10.1136/jnnp.59.1.17; FARWELL JR, 1990, NEW ENGL J MED, V322, P364, DOI 10.1056/NEJM199002083220604; Faul M.D., 2010, TRAUMATIC BRAIN INJU; FOULON M, 1977, ACTA NEUROL BELG, V77, P276; Gallentine WB, 2013, J CLIN NEUROPHYSIOL, V30, P126, DOI 10.1097/WNP.0b013e3182872adf; Giza CC, 2006, DEV NEUROSCI-BASEL, V28, P364, DOI 10.1159/000094163; GLOTZNER FL, 1983, NEUROCHIRURGIA, V26, P66; Goldstein JL, 2011, NEUROCRIT CARE, V15, P63, DOI 10.1007/s12028-010-9468-5; GRAND W, 1974, J NEUROL NEUROSUR PS, V37, P178, DOI 10.1136/jnnp.37.2.178; GUTLING E, 1995, NEUROLOGY, V45, P915, DOI 10.1212/WNL.45.5.915; Hahn CD, 2013, NAT REV NEUROL, V9, P662, DOI 10.1038/nrneurol.2013.231; HAHN YS, 1993, PEDIATR NEUROSURG, V19, P135, DOI 10.1159/000120718; HAHN YS, 1988, NEUROSURGERY, V22, P864, DOI 10.1227/00006123-198805000-00008; HAHN YS, 1988, CHILD NERV SYST, V4, P34; Haltiner AM, 1999, J NEUROSURG, V91, P588, DOI 10.3171/jns.1999.91.4.0588; HAUSER WA, 1991, EPILEPSIA, V32, P429, DOI 10.1111/j.1528-1157.1991.tb04675.x; Hauser WA, 2003, EPILEPSIA, V44, P1, DOI 10.1046/j.1528-1157.44.s10.7.x; HENDRICK EB, 1968, J TRAUM, V8, P547; Holmes JF, 2004, ANN EMERG MED, V43, P706, DOI 10.1016/j.annemergmed.2003.11.008; JAMISON DL, 1974, ARCH DIS CHILD, V49, P376, DOI 10.1136/adc.49.5.376; JENNETT B, 1973, DEV MED CHILD NEUROL, V15, P56; JENNETT B, 1975, J NEUROL NEUROSUR PS, V38, P378, DOI 10.1136/jnnp.38.4.378; JENNETT B, 1975, EPILEPSIA, V16, P251, DOI 10.1111/j.1528-1157.1975.tb06055.x; JENNETT B, 1974, ARCH NEUROL-CHICAGO, V30, P394, DOI 10.1001/archneur.1974.00490350052008; JENNETT B, 1976, LANCET, V1, P1031; JENNETT B, 1973, SCOT MED J, V18, P8, DOI 10.1177/003693307301800103; JENNETT WB, 1969, LANCET, V1, P1023; JENNETT WB, 1960, J NEUROL NEUROSUR PS, V23, P295, DOI 10.1136/jnnp.23.4.295; Jevtovic-Todorovic V, 2003, J NEUROSCI, V23, P876, DOI 10.1523/jneurosci.23-03-00876.2003; Kaindl AM, 2006, CELL MOL LIFE SCI, V63, P399, DOI 10.1007/s00018-005-5348-0; KIESLICH M, 1995, LANCET, V345, P187, DOI 10.1016/S0140-6736(95)90188-4; KLONOFF H, 1977, J NEUROL NEUROSUR PS, V40, P1211, DOI 10.1136/jnnp.40.12.1211; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Kollevold T, 1976, J Oslo City Hosp, V26, P99; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359; LEWIS RJ, 1993, ANN EMERG MED, V22, P1114, DOI 10.1016/S0196-0644(05)80974-6; Liesemer K, 2011, J NEUROTRAUM, V28, P755, DOI 10.1089/neu.2010.1518; Locke GE, 1991, EPILEPSIA S3, V32, pS104; MAHONEY WJ, 1983, PEDIATRICS, V71, P756; MANAKA S, 1992, JPN J PSYCHIAT NEUR, V46, P311; Mandal K, 2001, CHILD NERV SYST, V17, P670, DOI 10.1007/s00381-001-0520-9; Mansfield RT, 1997, CRIT CARE CLIN, V13, P611, DOI 10.1016/S0749-0704(05)70331-6; MCQUEEN JK, 1983, J NEUROL NEUROSUR PS, V46, P899, DOI 10.1136/jnnp.46.10.899; MISES J, 1970, EPILEPSIA, V11, P37, DOI 10.1111/j.1528-1157.1970.tb03864.x; NINDS National Institute of Neurological Disorders and Stroke, 2000, INT HEAD INJ TASK FO; OKA H, 1977, BRAIN, V100, P287, DOI 10.1093/brain/100.2.287; Ong LC, 1996, J PAEDIATR CHILD H, V32, P173, DOI 10.1111/j.1440-1754.1996.tb00917.x; PAGNI CA, 1990, ACT NEUR S, V50, P38; Pearl PL, 2013, EPILEPSIA, V54, pe135, DOI 10.1111/epi.12326; PECHADRE JC, 1991, PRESSE MED, V20, P841; Rakhade SN, 2009, NAT REV NEUROL, V5, P380, DOI 10.1038/nrneurol.2009.80; Ratan SK, 1999, PEDIATR NEUROSURG, V30, P127, DOI 10.1159/000028779; Rogawski MA, 2004, NAT REV NEUROSCI, V5, P553, DOI 10.1038/nrn1430; Ronne-Engstrom E, 2006, ACTA NEUROL SCAND, V114, P47, DOI 10.1111/j.1600-0404.2006.00652.x; ROSE J, 1977, BRIT MED J, V2, P615, DOI 10.1136/bmj.2.6087.615; Sahoo PK, 2007, INDIAN J NEUROTRAUM, V4, P11, DOI 10.1016/S0973-0508(07)80004-9; Schierhout G, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000173; Sills GJ, 2001, EPILEPTIC DISORD, V3, P165; SNOEK JW, 1984, BRAIN, V107, P15, DOI 10.1093/brain/107.1.15; Statler KD, 2006, DEV NEUROSCI-BASEL, V28, P354, DOI 10.1159/000094162; STOWSAND D, 1970, Z NEUROL, V198, P201, DOI 10.1007/BF00316664; Sulzbacher S, 1999, CLIN PEDIATR, V38, P387, DOI 10.1177/000992289903800702; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Temkin NR, 1999, J NEUROSURG, V91, P593, DOI 10.3171/jns.1999.91.4.0593; Temkin NR, 2001, EPILEPSIA, V42, P515, DOI 10.1046/j.1528-1157.2001.28900.x; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tilford JM, 2001, CRIT CARE MED, V29, P1056, DOI 10.1097/00003246-200105000-00037; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; Vespa PM, 2007, CRIT CARE MED, V35, P1153, DOI 10.1097/01.CCM.0000259466.66310.4F; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Vespa PM, 1999, J CLIN NEUROPHYSIOL, V16, P1, DOI 10.1097/00004691-199901000-00001; von Wild KRH, 2008, ACT NEUR S, V101, P55; YOUNG B, 1983, CHILD BRAIN, V10, P185; Young KD, 2004, ANN EMERG MED, V43, P435, DOI 10.1016/j.annemergmed.2003.09.016	100	11	11	0	9	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0883-0738	1708-8283		J CHILD NEUROL	J. Child Neurol.	JAN	2016	31	1			SI		46	56		10.1177/0883073814562249			11	Clinical Neurology; Pediatrics	Neurosciences & Neurology; Pediatrics	CY8HW	WOS:000366650400005	25564481				2021-06-18	
J	Bailie, JM; Kennedy, JE; French, LM; Marshall, K; Prokhorenko, O; Asmussen, S; Reid, MW; Qashu, F; Brickell, TA; Lange, RT				Bailie, Jason M.; Kennedy, Jan E.; French, Louis M.; Marshall, Kathryn; Prokhorenko, Olga; Asmussen, Sarah; Reid, Matthew W.; Qashu, Felicia; Brickell, Tracey A.; Lange, Rael T.			Profile Analysis of the Neurobehavioral and Psychiatric Symptoms Following Combat-Related Mild Traumatic Brain Injury: Identification of Subtypes	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						cluster analysis; mild traumatic brain injury; military; postconcussive symptoms	POSTTRAUMATIC-STRESS-DISORDER; MILITARY SERVICE MEMBERS; COMPLAINTS	Objective: To explore the taxonomy of combat-related mild traumatic brain injury (mTBI) based on symptom patterns. Participants: Up to 1341 military personnel who experienced a combat-related mTBI within 2 years of evaluation. Measures: Neurobehavioral Symptom Inventory and PTSD Checklist-Civilian Version (PCL-C). Results: Cluster analysis revealed the following 4 subtypes: primarily psychiatric (posttraumatic stress disorder) group, a cognitive group, a mixed symptom group, and a good recovery group. The posttraumatic stress disorder cluster (21.9% of the sample) reported symptoms related to hyperarousal and dissociation/depression with few complaints related to cognition or headaches. The cognitive group (21.5% of the sample) had primarily cognitive and headache complaints with few mood symptoms. The mixed profile cluster included 18.6% of the sample and was characterized by a combination of mood complaints (hyperarousal and dissociation/depression), cognitive complaints, and headaches. The largest cluster (37.8% of the sample) had an overall low symptom profile and was labeled the "good recovery" group. Conclusions: The results support a unique taxonomy for combat-related mTBI. The clinical differences among these subtypes indicate a need for unique treatment resources and programs.	[Bailie, Jason M.; Kennedy, Jan E.; French, Louis M.; Marshall, Kathryn; Prokhorenko, Olga; Asmussen, Sarah; Reid, Matthew W.; Qashu, Felicia; Brickell, Tracey A.; Lange, Rael T.] Def & Vet Brain Injury Ctr, Bethesda, MD USA; [French, Louis M.; Brickell, Tracey A.; Lange, Rael T.] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bethesda, MD USA; [French, Louis M.; Brickell, Tracey A.] Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD 20814 USA; [French, Louis M.] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA; [Lange, Rael T.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Kennedy, Jan E.; Reid, Matthew W.] San Antonio Mil Med Ctr, Dept Neurol, San Antonio, TX USA; [Bailie, Jason M.] Naval Med Ctr San Diego, Dept Phys Med & Rehabil, San Diego, CA 92134 USA; [Asmussen, Sarah] Marine Corps Base Camp Pendleton, Oceanside, CA USA; [Kennedy, Jan E.; Marshall, Kathryn; Prokhorenko, Olga; Asmussen, Sarah; Reid, Matthew W.; Brickell, Tracey A.; Lange, Rael T.] Gen Dynam Informat Technol, Frederick, MD USA; [Bailie, Jason M.] Amer Hosp Serv Grp LLC, Exton, PA USA	Bailie, JM (corresponding author), Navy Med Ctr San Diego, Def & Vet Brain Injury Ctr, San Diego, CA 92134 USA.	jason.m.bailie.ctr@mail.mil	french, louis/AAB-2083-2020	french, louis/0000-0002-9451-0604			Aldenderfer FA, 1984, CLUSTER ANAL; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; CAMPBELL DT, 1959, PSYCHOL BULL, V56, P81, DOI 10.1037/h0046016; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Costello AB, 2005, PRACT ASSESS RES EVA, V10, P173, DOI DOI 10.1234/12345678; Everitt B.S., 1993, CLUSTER ANAL; Fabrigar LR, 1999, PSYCHOL METHODS, V4, P272, DOI 10.1037/1082-989X.4.3.272; Force T.B.I.T., 2008, REPORT SURG GEN TRAU; French LM, 2012, J HEAD TRAUMA REHAB, V27, P63, DOI 10.1097/HTR.0b013e3182248344; Halbauer JD, 2009, J REHABIL RES DEV, V46, P757, DOI 10.1682/JRRD.2008.08.0119; Headquarters D.o.t.A., 2012, ARM 2020 GEN HLTH DI; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Iverson G.L., 2012, PTSD MILD TRAUMATIC, P37; Iverson GL, 2007, BRAIN INJURY MED PRI, P333; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Kennedy JE, 2010, NEUROREHABILITATION, V26, P191, DOI 10.3233/NRE-2010-0555; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Lange R.T., 2002, Journal of Cognitive Rehabilitation, V20, P16; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Lange RT, 2011, 12 MONTH OUTCOME MIL; Management of Concussion/mTBI Working Group, 2009, J REHABIL RES DEV, V46, pCP1; Medicine A.f.t.A.o.A., 2007, ABBREVIATED INJURY S; MORRIS R, 1981, Journal of Clinical Neuropsychology, V3, P79, DOI 10.1080/01688638108403115; Rao V, 2002, PSYCHIAT CLIN N AM, V25, P43, DOI 10.1016/S0193-953X(03)00052-2; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Ruff RL, 2008, J REHABIL RES DEV, V45, P941, DOI 10.1682/JRRD.2008.02.0028; Schinka J A, 1997, J Int Neuropsychol Soc, V3, P120; Stevens J.P., 2002, APPL MULTIVARIATE ST, V4th ed; Stevenson M, 2001, Inj Prev, V7, P10, DOI 10.1136/ip.7.1.10; Tanielian T, 2008, INVISIBLE WOUNDS WAR; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Vasterling JJ, 2012, J INT NEUROPSYCH SOC, V18, P390, DOI 10.1017/S1355617712000367; Weathers FW, 1991, PCL C FOR DSM 4	36	11	11	0	24	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2016	31	1					2	12		10.1097/HTR.0000000000000142			11	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	DK9CN	WOS:000375228000008	26716696				2021-06-18	
J	Chiavaroli, F; Derraik, JGB; Zani, G; Lavezzi, S; Chiavaroli, V; Sherwin, E; Basaglia, N				Chiavaroli, Francesca; Derraik, Jose G. B.; Zani, Giulia; Lavezzi, Susanna; Chiavaroli, Valentina; Sherwin, Elisabeth; Basaglia, Nino			Epidemiology and clinical outcomes in a multicentre regional cohort of patients with severe acquired brain injury	DISABILITY AND REHABILITATION			English	Article						Age; assessment; brain injury; outcomes; sex	HEAD-INJURY; REHABILITATION; TRAUMA; MODERATE; CHILDREN; SCALE; COMA	Purpose: To evaluate epidemiological and clinical data on patients with severe acquired brain injury (sABI) admitted to rehabilitation units in the first 6 years since the inception of a regional register (2005-2010) in the Emilia-Romagna region (Italy). Method: Retrospective multicentre study of a regional cohort using data from an online regional register (Gravi Cerebrolesioni Emilia-Romagna - GRACER). The study included 318 patients who suffered sABI (defined by Glasgow Coma Scale score <= 8 recorded in the initial 24 h following injury), who were admitted to and subsequently discharged from rehabilitation units. Physical and cognitive functions were evaluated at admission and discharge. Other data recorded included aetiology, presence of secondary conditions and need for specific medical support. Results: Three-quarters of patients displayed improvements in physical and/or cognitive function at discharge from rehabilitation units, with 71.4% of patients returning home. Better outcomes at discharge were associated in particular with younger age, traumatic brain injury (versus non-traumatic), or absence of tracheostomy at admission. Conclusion: The GRACER register is a useful tool for the assessment of epidemiological and clinical information on sABI patients. In light of the positive impact on patient outcomes, rehabilitation in specialised units is highly encouraged and should occur as soon as possible.	[Chiavaroli, Francesca; Zani, Giulia; Lavezzi, Susanna; Basaglia, Nino] Univ Ferrara, S Giorgio Hosp, Dept Neurosci & Rehabil, Via Fiera, I-44124 Ferrara, Italy; [Derraik, Jose G. B.; Chiavaroli, Valentina] Univ Auckland, Liggins Inst, Auckland, New Zealand; [Sherwin, Elisabeth] Univ Arkansas, Dept Psychol, Little Rock, AR 72204 USA	Basaglia, N (corresponding author), Univ Ferrara, S Giorgio Hosp, Dept Neurosci & Rehabil, Via Fiera, I-44124 Ferrara, Italy.	n.basaglia@ospfe.it	Derraik, Jose Guilherme Behrensdorf/A-1925-2008; Chiavaroli, Valentina/ABB-1911-2020	Derraik, Jose Guilherme Behrensdorf/0000-0003-1226-1956; 			Abdennour L, 2012, Ann Fr Anesth Reanim, V31, pe101, DOI 10.1016/j.annfar.2012.04.013; Andruszkow H, 2013, CLIN ORTHOP RELAT R, V471, P2899, DOI 10.1007/s11999-013-3031-6; Avesani R, 2013, EUR J PHYS REHAB MED, V49, P611; Bayona Nestor A, 2005, Top Stroke Rehabil, V12, P1; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Brenner T, 2003, PEDIATR NEUROL, V28, P104, DOI 10.1016/S0887-8994(02)00491-5; Canadian Institute for Health Information, 2006, HEAD INJ CAN DEC CHA; Chan V, 2013, CAN J AGING, V32, P278, DOI 10.1017/S0714980813000317; Colantonio A, 2011, J REHABIL MED, V43, P311, DOI 10.2340/16501977-0783; Cook AM, 2008, NUTR CLIN PRACT, V23, P608, DOI 10.1177/0884533608326060; Crandon IW, 2007, W INDIAN MED J, V56, P223; Cullen N, 2007, BRAIN INJURY, V21, P113, DOI 10.1080/02699050701201540; Cullen NK, 2011, BRAIN INJURY, V25, P35, DOI 10.3109/02699052.2010.531691; Cullen NK, 2008, BRAIN INJURY, V22, P1013, DOI 10.1080/02699050802530581; Foxx-Orenstein A, 2003, ARCH PHYS MED REHAB, V84, P231, DOI 10.1053/apmr.2003.50095; Goldstein Larry B, 2002, J Stroke Cerebrovasc Dis, V11, P80, DOI 10.1053/jscd.2002.126691; Greenwald BA, 2003, ARCH PHYS MED REHAB, V84, pS3, DOI 10.1053/apmr.2003.50052; Hagen C, 1979, LEVELS COGNITIVE FUN, P87; Heather NL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082245; Johnson AR, 2009, DEV DISABIL RES REV, V15, P124, DOI 10.1002/ddrr.63; Kirkness Catherine J, 2004, Biol Res Nurs, V5, P299, DOI 10.1177/1099800404263050; Kraus J F, 2000, Neurosurg Focus, V8, pe5; MAHONEY F I, 1965, Md State Med J, V14, P61; RAPPAPORT M, 1989, ARCH PHYS MED REHAB, V70, P885; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Saini NS, 2012, INDIAN J NEUROTRAUM, V9, P45, DOI 10.1016/j.ijnt.2012.04.009; TEASDALE G, 1974, LANCET, V2, P81; Teasell R., 2013, EVIDENCE BASED REV M; Teasell R, 2007, BRAIN INJURY, V21, P107, DOI 10.1080/02699050701201524; The Australian Council on Healthcare Standards, 2008, REH MED VERS 4 ACHS; Wade D T, 1988, Int Disabil Stud, V10, P64; Zampolini M, 2013, EUR J PHYS REHAB MED, V49, P365; Zampolini M, 2012, BRAIN INJURY, V26, P27, DOI 10.3109/02699052.2011.635358	35	11	11	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.		2016	38	20-21					2038	2046		10.3109/09638288.2015.1111439			9	Rehabilitation	Rehabilitation	DT5RF	WOS:000381539600007	26729309				2021-06-18	
J	Clark, AL; Sorg, SF; Schiehser, DM; Luc, N; Bondi, MW; Sanderson, M; Werhane, ML; Delano-Wood, L				Clark, Alexandra L.; Sorg, Scott F.; Schiehser, Dawn M.; Luc, Norman; Bondi, Mark W.; Sanderson, Mark; Werhane, Madeleine L.; Delano-Wood, Lisa			Deep white matter hyperintensities affect verbal memory independent of PTSD symptoms in veterans with mild traumatic brain injury	BRAIN INJURY			English	Article						White matter hyperintensities; white matter lesions; WMH; WML; DWMH; PVWMH; periventricular lesions; PVL; deep white matter lesions; DWML; TBI; PCS; cognition; neuropsychology; traumatic brain injury; postconcussive symptoms; head trauma	NEUROPSYCHOLOGICAL TEST-PERFORMANCE; POSTTRAUMATIC-STRESS-DISORDER; APOLIPOPROTEIN-E GENOTYPE; MIDDLE-AGED PARTICIPANTS; DIFFUSE AXONAL INJURY; COGNITIVE IMPAIRMENT; POSTCONCUSSIVE SYMPTOMS; COMMUNITY SAMPLE; RISK-FACTORS; CARDIOVASCULAR HEALTH	Objective: Although white matter hyperintensity (WMH) pathology has been observed in the context of traumatic brain injury (TBI), the contribution of this type of macrostructural damage to cognitive and/or post-concussive symptomatology (PCS) remains unclear. Methods: Sixty-eight Veterans (mTBI = 46, Military Controls [MCs] = 22) with and without history of mild TBI (mTBI) underwent structural MRI and comprehensive cognitive and psychiatric assessment. WMH volume was identified as deep (DWMH) or periventricular (PVWMH) on fluidattenuated inversion recovery (FLAIR) images. Results: Group analyses revealed that mTBI history was not associated with increased WMH pathology (p's > 0.05). However, after controlling for post-traumatic stress disorder (PTSD) and intracranial volume, DWMH was associated with reduced short-and long-delayed memory performance within the mTBI group (p's < 0.05). Additionally, after adjusting for PTSD and time since injury, regression analyses revealed that WMH was not associated with self-reported ratings of PCS (p's > 0.05) in the mTBI group. Conclusions: The results demonstrate that, in relatively young Veterans with mTBI, DWMH differentially and negatively affects memory performance above and beyond the effects of PTSD symptoms. The findings may help to clarify prior mixed results as well as offer focused treatment implications for Veterans with history of neurotrauma and evidence of macrostructural white matter damage.	[Clark, Alexandra L.; Werhane, Madeleine L.] Univ Calif San Diego, San Diego State Univ, San Diego SDSU UCSD Joint Doctoral Program Clin P, San Diego, CA 92103 USA; [Clark, Alexandra L.; Sorg, Scott F.; Schiehser, Dawn M.; Luc, Norman; Bondi, Mark W.; Sanderson, Mark; Werhane, Madeleine L.; Delano-Wood, Lisa] VASDHS, San Diego, CA USA; [Sorg, Scott F.; Schiehser, Dawn M.; Bondi, Mark W.; Delano-Wood, Lisa] UCSD Sch Med, Dept Psychiat, San Diego, CA USA; [Delano-Wood, Lisa] VASDHS, Ctr Excellence Stress & Mental Hlth, San Diego, CA USA	Delano-Wood, L (corresponding author), VA San Diego Healthcare Syst 151B, San Diego, CA 92161 USA.	ldelano@ucsd.edu			Veterans Affairs (Career Development Awards [CDA]); Department of Defense (Investigator-Initiated Research Grant [IIRG])	This work was supported by grants awarded by the Veterans Affairs (Career Development Awards [CDA]: L.D.-W., D.S.; Merit Award; L.D.-W.) as well as the Department of Defense (Investigator-Initiated Research Grant [IIRG]: L.D.-W.). This material is further supported with resources of the Veterans Affairs Center of Excellence for Stress and Mental Health (CESAMH: L.D.-W.; D.S.).	Beck AT., 1996, BECK DEPRESSION INVE, V2; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Benge JF, 2009, REHABIL PSYCHOL, V54, P270, DOI 10.1037/a0016736; Bigler ED, 2013, NEUROPSYCHOL REV, V23, P169, DOI 10.1007/s11065-013-9237-2; Brenner Lisa A, 2011, Dialogues Clin Neurosci, V13, P311; Brenner LA, 2010, NEUROPSYCHOLOGY, V24, P160, DOI 10.1037/a0017966; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Chatelin S, 2011, J MECH BEHAV BIOMED, V4, P1905, DOI 10.1016/j.jmbbm.2011.06.007; Clark AL, 2015, J HEAD TRAUMA REHABI; Cooper DB, 2011, BRAIN INJURY, V25, P1, DOI 10.3109/02699052.2010.531692; de Groot M, 2013, STROKE, V44, P1037, DOI 10.1161/STROKEAHA.112.680223; de la Plata CM, 2007, J NEUROTRAUM, V24, P591, DOI 10.1089/neu.2006.0214; Debette S, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3666; DECARLI C, 1995, NEUROLOGY, V45, P2077, DOI 10.1212/WNL.45.11.2077; Delano-Wood L, 2015, BRAIN IMAGING BEHAV, V9, P500, DOI 10.1007/s11682-015-9432-2; Delano-Wood L, 2008, STROKE, V39, P794, DOI 10.1161/STROKEAHA.107.502534; Delano-Wood L, 2009, J INT NEUROPSYCH SOC, V15, P906, DOI 10.1017/S1355617709990257; Delis D., 2001, D KEFS EXAMINERS TEC; Delis DC, 2001, CALIFORNIA VERBAL LE; Department of Defense, 2009, 2009 VA DOD CLIN PRA; Ding K, 2008, J NEUROTRAUM, V25, P1433, DOI 10.1089/neu.2008.0683; Donnell AJ, 2012, CLIN NEUROPSYCHOL, V26, P1092, DOI 10.1080/13854046.2012.713984; Dufouil C, 2001, NEUROLOGY, V56, P921, DOI 10.1212/WNL.56.7.921; Gebeily S, 2014, INT J NEUROSCI, V124, P799, DOI 10.3109/00207454.2014.884087; Gunning-Dixon FM, 2000, NEUROPSYCHOLOGY, V14, P224, DOI 10.1037//0894-4105.14.2.224; Hopkins RO, 2006, J NEUROIMAGING, V16, P243, DOI 10.1111/j.1552-6569.2006.00047.x; Soriano-Raya JJ, 2014, J CEREBR BLOOD F MET, V34, P861, DOI 10.1038/jcbfm.2014.26; Soriano-Raya JJ, 2012, J INT NEUROPSYCH SOC, V18, P874, DOI 10.1017/S1355617712000677; Kempton MJ, 2011, ARCH GEN PSYCHIAT, V68, P675, DOI 10.1001/archgenpsychiatry.2011.60; Kennedy KM, 2009, NEUROPSYCHOLOGIA, V47, P916, DOI 10.1016/j.neuropsychologia.2009.01.001; Kim SH, 2011, J NEUROIMAGING, V21, P317, DOI 10.1111/j.1552-6569.2010.00527.x; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kuller LH, 1998, STROKE, V29, P388, DOI 10.1161/01.STR.29.2.388; Libon DJ, 2008, STROKE, V39, P806, DOI 10.1161/STROKEAHA.107.489997; Libon DJ, 2008, STROKE, V39, P783, DOI 10.1161/STROKEAHA.108.515569; Lippa SM, 2010, J INT NEUROPSYCH SOC, V16, P856, DOI 10.1017/S1355617710000743; Longstreth WT, 1996, STROKE, V27, P1274, DOI 10.1161/01.STR.27.8.1274; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Maillard P, 2014, STROKE, V45, P1721, DOI 10.1161/STROKEAHA.113.004084; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; Meterko M, 2012, J HEAD TRAUMA REHAB, V27, P55, DOI 10.1097/HTR.0b013e318230fb17; Moore BA, 2004, BRAIN INJURY, V18, P975, DOI 10.1080/02699050410001672350; Murray AD, 2005, RADIOLOGY, V237, P251, DOI 10.1148/radiol.2371041496; Nebes RD, 2001, AM J PSYCHIAT, V158, P878, DOI 10.1176/appi.ajp.158.6.878; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Nyquist PA, 2015, NEUROBIOL AGING, V36, P1653, DOI 10.1016/j.neurobiolaging.2015.01.005; Pierallini A, 2000, NEURORADIOLOGY, V42, P860, DOI 10.1007/s002340000447; Price CC, 2012, NEUROLOGY, V79, P734, DOI 10.1212/WNL.0b013e3182661ef6; Price CC, 2005, NEUROLOGY, V65, P376, DOI 10.1212/01.WNL.0000168877.06011.15; Raz N, 2007, NEUROPSYCHOLOGY, V21, P149, DOI 10.1037/0894-4105.21.2.149; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Silbert LC, 2009, NEUROLOGY, V73, P120, DOI 10.1212/WNL.0b013e3181ad53fd; Silver JM, 2012, J NEUROL NEUROSUR PS, V83, P836, DOI 10.1136/jnnp-2011-302078; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Smith EE, 2008, ARCH NEUROL-CHICAGO, V65, P94, DOI 10.1001/archneurol.2007.23; Sorg SF, 2014, J HEAD TRAUMA REHAB, V29, P21, DOI 10.1097/HTR.0b013e31828a1aa4; Sorg SF, 2015, J HEAD TRAUMA REHABI; Steffens DC, 2007, AM J GERIAT PSYCHIAT, V15, P839, DOI 10.1097/JGP.0b013e318048a1a0; Taber KH, 2015, J HEAD TRAUMA REHAB, V30, pE15, DOI 10.1097/HTR.0000000000000030; Tombaugh TN, 1996, TEST MEMORY MALINGER; United States Army Medical Research and Material Command, REP SURG GEN TRAUM B; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e; Vanderploeg RD, 2012, J REHABIL RES DEV, V49, P545, DOI 10.1682/JRRD.2011.04.0069; Vannorsdall TD, 2009, ARCH CLIN NEUROPSYCH, V24, P209, DOI 10.1093/arclin/acp037; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; WANG R, 2014, LIVER TRANSPLANT, V21, P1076, DOI DOI 10.1111/ENE.12319; Weathers F. W., 1993, ANN M INT SOC TRAUM; Wen W, 2009, HUM BRAIN MAPP, V30, P1155, DOI 10.1002/hbm.20586; Wilde EA, 2015, BRAIN IMAGING BEHAV, V9, P367, DOI 10.1007/s11682-015-9444-y; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME, V4th; Yoshita M, 2006, NEUROLOGY, V67, P2192, DOI 10.1212/01.wnl.0000249119.95747.1f	75	11	11	0	8	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	7					864	871		10.3109/02699052.2016.1144894			8	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	DP2MI	WOS:000378322400005	27058006				2021-06-18	
J	D'Cruz, K; Howie, L; Lentin, P				D'Cruz, Kate; Howie, Linsey; Lentin, Primrose			Client-centred practice: Perspectives of persons with a traumatic brain injury	SCANDINAVIAN JOURNAL OF OCCUPATIONAL THERAPY			English	Article						Acquired brain injury; brain injury; consumer perspectives; person-centred practice; therapeutic alliance; therapeutic relationship	OCCUPATIONAL THERAPISTS; REHABILITATION; PEOPLE; PARTICIPATION; INDIVIDUALS	Background: Client-centred practice is well established as a core foundation of occupational therapy; however, there is little research evidence concerning the client experience. Objectives: To understand client-centred practice from the perspective of adults with a traumatic brain injury (TBI) participating in community-based occupational therapy. Methods: Six adults with a moderate-severe TBI participated in two semi-structured, qualitative interviews each. In total 12 interview transcripts and additional data were coded using constructivist grounded theory methods. Results: Data analysis produced three main themes and sub-themes: (i) Experiencing the client-therapist relationship: Seeing me as the person I was; Getting to know me in the now; Making a positive connection; (ii) Actively participating in therapy: Valuing the therapist; Being partners in therapy; and (iii) Finding my place in life: Adjusting to who I am now and Sharing my journey. Conclusion: The results present a framework for understanding client-centred practice as a person-centred process of engagement between the client and the therapist, as informed from the client perspective. Significance: Occupational therapists are encouraged to value and invest in the development of relationships with clients whilst the importance of seeking and integrating the client perspective into practice and research is affirmed for the profession.	[D'Cruz, Kate; Howie, Linsey] La Trobe Univ, Bundoora, Vic 3083, Australia; [Lentin, Primrose] Monash Univ, Frankston, Australia	D'Cruz, K (corresponding author), La Trobe Univ, Dept Community & Clin Allied Hlth, Bundoora, Vic 3083, Australia.	k.dcruz@latrobe.edu.au	Lentin, Primrose/ABE-5778-2020	D'Cruz, Kate/0000-0002-5155-1350; Howie, Luke/0000-0002-6906-8498			Abreu BC, 2002, BRAIN INJURY, V16, P691, DOI 10.1080/02699050210128942; Biderman D, 2006, INT J PSYCHOL, V41, P355, DOI 10.1080/00207590500345963; Blank A., 2004, BRIT J OCCUP THER, V67, P118; Charmaz K, 2006, CONSTRUCTING GROUNDE; Conneeley AL, 2004, BR J OCCUP THER, V67, P248, DOI DOI 10.1177/030802260406700603; Corring D J, 1999, Can J Occup Ther, V66, P71; Cott CA, 2004, DISABIL REHABIL, V26, P1411, DOI 10.1080/09638280400000237; Curtin M, 2007, AUST OCCUP THER J, V54, P88, DOI 10.1111/j.1440-1630.2007.00661.x; Docherty S, 1999, RES NURS HEALTH, V22, P177, DOI 10.1002/(SICI)1098-240X(199904)22:2<177::AID-NUR9>3.0.CO;2-H; Doig E, 2009, AM J OCCUP THER, V63, P559, DOI 10.5014/ajot.63.5.559; Douglas JM, 2013, BRAIN INJURY, V27, P60, DOI 10.3109/02699052.2012.722254; Duggan Ruth, 2005, Can J Occup Ther, V72, P103; Hammell KRW, 2013, SCAND J OCCUP THER, V20, P174, DOI 10.3109/11038128.2012.752032; Kielhofner G, 2008, MODEL HUMAN OCCUPATI; Kontos PC, 2012, QUAL HEALTH RES, V22, P1612, DOI 10.1177/1049732312458370; Lefebvre H, 2005, BRAIN INJURY, V19, P585, DOI 10.1080/02699050400025026; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; Liamputtong, 2007, RES VULNERABLE GUIDE; Maitra KK, 2006, AM J OCCUP THER, V60, P298, DOI 10.5014/ajot.60.3.298; Padilla R, 2003, AM J OCCUP THER, V57, P413, DOI 10.5014/ajot.57.4.413; Palmadottir G., 2006, BR J OCCUP THER, V69, P394, DOI DOI 10.1177/030802260606900902; Paterson B, 2002, QUAL HEALTH RES, V12, P399, DOI 10.1177/104973202129119973; Petrella L, 2005, BRAIN INJURY, V19, P643, DOI 10.1080/02699050410001671874; Polatajko, 2007, ENABLING OCCUPATION; Rebeiro K L, 2000, Can J Occup Ther, V67, P7; Rosa SA, 2005, AM J OCCUP THER, V59, P198, DOI 10.5014/ajot.59.2.198; Schipper K, 2011, BRAIN INJURY, V25, P832, DOI 10.3109/02699052.2011.589796; Schonberger M, 2006, BRAIN INJURY, V20, P445, DOI 10.1080/02699050600664772; Sloan S, 2009, BRAIN IMPAIR, V10, P282, DOI 10.1375/brim.10.3.282; Sumison T, 2004, BRIT J OCCUPATIONAL, V67, P2; Sumsion T, 2000, Can J Occup Ther, V67, P15; Sumsion Thelma, 2005, Can J Occup Ther, V72, P13; Taylor R.R., 2008, INTENTIONAL RELATION; Turner B, 2009, AM J OCCUP THER, V63, P609, DOI 10.5014/ajot.63.5.609; Wilkins S, 2001, CAN J OCCUP THER, V68, P88; Ylvisaker M, 2000, BRAIN IMPAIR, V1, P12, DOI DOI 10.1375/BRIM.1.1.12	36	11	11	0	12	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1103-8128	1651-2014		SCAND J OCCUP THER	Scand. J. Occup. Ther.		2016	23	1					30	38		10.3109/11038128.2015.1057521			9	Rehabilitation	Rehabilitation	DK4LP	WOS:000374890100004	26094733				2021-06-18	
S	Deng-Bryant, Y; Leung, LY; Caudle, K; Tortella, F; Shear, D		Kobeissy, F; Dixon, CE; Hayes, RL; Mondello, S		Deng-Bryant, Ying; Leung, Lai Yee; Caudle, Krista; Tortella, Frank; Shear, Deborah			Cognitive Evaluation Using Morris Water Maze in Neurotrauma	INJURY MODELS OF THE CENTRAL NERVOUS SYSTEM: METHODS AND PROTOCOLS	Methods in Molecular Biology		English	Article; Book Chapter						Neurotrauma; Traumatic brain injury; Morris water maze; Cognitive function; Spatial learning; Memory; Cognitive deficit	TRAUMATIC BRAIN-INJURY; RAT; MEMORY; PLACE; DEGENERATION; NAVIGATION; LESIONS; IMPACT; MODEL; MOTOR	The Morris water maze (MWM) task is one of the most widely used and versatile tools in behavioral neuroscience for evaluating spatial learning and memory. With regard to detecting cognitive deficits following central nervous system (CNS) injuries, MWM has been commonly utilized in various animal models of neurotrauma, such as fluid percussion injury (FPI), cortical controlled impact (CCI) injury, weight-drop impact injury, and penetrating ballistic-like brain injury (PBBI). More importantly, it serves as a therapeutic index for assessing the efficacy of treatment interventions on cognitive performance following neurotrauma. Thus, it is critical to design an MWM testing paradigm that is sensitive yet discriminating for the purpose of evaluating potential therapeutic interventions. In this chapter, we discuss how multiple test manipulations, including the size of platform, numbers of trials per day, the frequency of retesting intervals, and the texture of platform surface, impact MWM's ability to detect cognitive deficits using a rat model of PBBI.	[Deng-Bryant, Ying; Leung, Lai Yee; Caudle, Krista; Tortella, Frank; Shear, Deborah] Walter Reed Inst Res, Brain Trauma Neuroprotect & Neurorestorat Branch, Ctr Mil Psychiat & Neurosci, Silver Spring, MD 20910 USA	Deng-Bryant, Y (corresponding author), Walter Reed Inst Res, Brain Trauma Neuroprotect & Neurorestorat Branch, Ctr Mil Psychiat & Neurosci, Silver Spring, MD 20910 USA.						Beaumont A, 1999, NEUROL RES, V21, P742, DOI 10.1080/01616412.1999.11741008; Bramlett HM, 1997, BRAIN RES, V762, P195, DOI 10.1016/S0006-8993(97)00387-9; Cain DP, 2006, BEHAV BRAIN RES, V170, P241, DOI 10.1016/j.bbr.2006.02.023; Chen ZY, 2009, J NEUROTRAUM, V26, P1987, DOI 10.1089/neu.2008.0863; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; Devan BD, 1999, BEHAV BRAIN RES, V100, P5, DOI 10.1016/S0166-4328(98)00107-7; DIMATTIA BD, 1988, BEHAV NEUROSCI, V102, P471, DOI 10.1037/0735-7044.102.4.471; Fox GB, 1998, J NEUROSCI RES, V53, P718, DOI 10.1002/(SICI)1097-4547(19980915)53:6<718::AID-JNR9>3.0.CO;2-8; Hamm RJ, 1996, J NEUROTRAUM, V13, P317, DOI 10.1089/neu.1996.13.317; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; Hellawell DJ, 1999, BRAIN INJURY, V13, P489; HOFFMAN SW, 1994, J NEUROTRAUM, V11, P417, DOI 10.1089/neu.1994.11.417; MCNAMARA RK, 1993, BRAIN RES REV, V18, P33, DOI 10.1016/0165-0173(93)90006-L; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Packard MG, 2009, BRAIN RES, V1293, P121, DOI 10.1016/j.brainres.2009.03.029; Shear DA, 2004, BRAIN RES, V1026, P11, DOI 10.1016/j.brainres.2004.07.087; Shear DA, 2002, EXP NEUROL, V178, P59, DOI 10.1006/exnr.2002.8020; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; Williams AJ, 2005, J NEUROTRAUM, V22, P313, DOI 10.1089/neu.2005.22.313; Williams AJ, 2006, NEUROSCI LETT, V408, P183, DOI 10.1016/j.neulet.2006.08.086; Williams AJ, 2006, J NEUROTRAUM, V23, P1828, DOI 10.1089/neu.2006.23.1828	22	11	14	0	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA	1064-3745		978-1-4939-3816-2; 978-1-4939-3814-8	METHODS MOL BIOL	Methods Mol. Biol.		2016	1462						539	551		10.1007/978-1-4939-3816-2_29	10.1007/978-1-4939-3816-2		13	Biochemical Research Methods; Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	BH1UG	WOS:000398551500031	27604737				2021-06-18	
J	Gallun, FJ; Lewis, MS; Folmer, RL; Hutter, M; Papesh, MA; Belding, H; Leek, MR				Gallun, Frederick J.; Lewis, M. Samantha; Folmer, Robert L.; Hutter, Michele; Papesh, Melissa A.; Belding, Heather; Leek, Marjorie R.			Chronic effects of exposure to high-intensity blasts: Results of tests of central auditory processing	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						auditory dysfunction; auditory processing disorder; blast; central auditory processing; dichotic listening; hearing loss; psychoacoustics; rehabilitation; temporal processing; traumatic brain injury; Veterans	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; HEARING HANDICAP; MILD; COMBAT; PERFORMANCE; OUTCOMES; HEALTH	Patients who have recently experienced high-intensity blasts are more likely to perform abnormally on tests developed to be sensitive to deficits of central auditory processing than were age- and hearing-matched individuals without blast exposures. Here, a group of 59 participants was recruited, 30 of whom were exposed to high-intensity blasts between 4 and 11 yr prior to testing and did not participate in the previous study, along with 29 controls similar in age and hearing thresholds to the blast group. All were tested on a set of behavioral tests that were used in the previous study. Abnormal performance was measured with reference both to published normative data and to the average performance of the control group. Members of the blast-exposed group were again found to be significantly more likely to perform in the abnormal range than were the members of the control group. Because the patients in this study were tested a minimum of 4 yr after blast exposure, these results suggest that for some of those exposed, problems processing auditory information may be a chronic effect of blast exposure even in the absence of significant peripheral hearing loss.	[Gallun, Frederick J.; Lewis, M. Samantha; Folmer, Robert L.; Hutter, Michele; Papesh, Melissa A.; Belding, Heather; Leek, Marjorie R.] VA Portland Hlth Care Syst, Natl Ctr Rehabil Auditory Res, Rehabil Res & Dev Serv, Dept Vet Affairs, Portland, OR USA; [Gallun, Frederick J.; Lewis, M. Samantha; Folmer, Robert L.; Leek, Marjorie R.] Oregon Hlth & Sci Univ, Dept Otolaryngol Head & Neck Surg, Portland, OR 97201 USA; [Leek, Marjorie R.] VA Loma Linda Healthcare Syst, Loma Linda, CA USA; [Leek, Marjorie R.] Loma Linda Univ, Dept Otolaryngol Head & Neck Surg, Healthcare, Loma Linda, CA 92350 USA	Gallun, FJ (corresponding author), NCRAR, 3710 SW US Vet Hosp Rd, Portland, OR 97239 USA.	Frederick.Gallun@va.gov	Gallun, Frederick J./G-3792-2012	Gallun, Frederick J./0000-0002-4145-2199	VA Rehabilitation Research & Development (RRD) Service [C7755I]; Senior Research Career Scientist award [C4042L]; Career Development II award [C7067W]; VA RR&D National Center for Rehabilitative Auditory Research [C4844C]	This material was based on work supported by the following awards from the VA Rehabilitation Research & Development (RR&D) Service: Merit Review Award C7755I (principal investigators: Gallun, Leek), Senior Research Career Scientist award to M.R. Leek (C4042L), and a Career Development II award to M. S. Lewis (C7067W). Support was also provided by the VA RR&D National Center for Rehabilitative Auditory Research (C4844C).	Augustine AM, 2013, INDIAN J OTOLARYNGOL, V65, P120, DOI 10.1007/s12070-012-0586-6; Bazarian JJ, 2013, J HEAD TRAUMA REHAB, V28, P1, DOI 10.1097/HTR.0b013e318256d3d3; Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; Broadbent DE, 1958, PERCEPTION COMMUNICA; Eskridge SL, 2013, J NEUROTRAUM, V30, P1391, DOI 10.1089/neu.2012.2537; FIRE KM, 1991, AM J OTOL, V12, P105; Folstein M. F., 2010, PSYCHOL ASSESSMENT R; Gallun FJ, 2012, J REHABIL RES DEV, V49, P1059, DOI 10.1682/JRRD.2010.09.0166; Gallun FJ, 2012, J REHABIL RES DEV, V49, P1005, DOI 10.1682/JRRD.2012.03.0038; Institute of Medicine, 2014, GULF WAR HLTH LONG T, V9; Jerger J, 1990, J Am Acad Audiol, V1, P75; Katz J., 1998, THE SSW TEST MANUAL; Keppel G, 2004, DESIGN ANAL RES HDB; Lingsma HF, 2015, J NEUROTRAUM, V32, P83, DOI 10.1089/neu.2014.3384; Musiek FE, 2005, EAR HEARING, V26, P608, DOI 10.1097/01.aud.0000188069.80699.41; MUSIEK FE, 1983, EAR HEARING, V4, P79, DOI 10.1097/00003446-198303000-00002; MUSIEK FE, 1987, AUDIOLOGY, V26, P79; NEWMAN CW, 1990, EAR HEARING, V11, P430, DOI 10.1097/00003446-199012000-00004; Petrie EC, 2014, J NEUROTRAUM, V31, P425, DOI [10.1089/NEU.2013.2952, 10.1089/neu.2013.2952]; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Vanderploeg RD, 2012, ARCH PHYS MED REHAB, V93, P1887, DOI 10.1016/j.apmr.2012.05.024; Wilson Richard H, 2005, J Am Acad Audiol, V16, P367, DOI 10.3766/jaaa.16.6.5; Wilson Richard H, 2003, J Am Acad Audiol, V14, P1, DOI 10.3766/jaaa.14.1.2	23	11	11	0	1	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2016	53	6					705	720		10.1682/JRRD.2014.12.0313			16	Rehabilitation	Rehabilitation	EK5SC	WOS:000393985100006		Bronze			2021-06-18	
J	Huang, CH; Huang, CC; Sun, CK; Lin, GH; Hou, WH				Huang, Chi-Hsien; Huang, Chia-Chen; Sun, Cheuk-Kwan; Lin, Gong-Hong; Hou, Wen-Hsuan			Methylphenidate on Cognitive Improvement in Patients with Traumatic Brain Injury: A Meta-Analysis	CURRENT NEUROPHARMACOLOGY			English	Article						Attention; cognitive function; methylphenidate; traumatic brain injury	A-META-ANALYSIS; DOUBLE-BLIND; NEUROPSYCHIATRIC SEQUELAE; ATTENTION DEFICITS; CONTROLLED-TRIAL; PLACEBO; REHABILITATION; CROSSOVER; EFFICACY; IMPACT	Although methylphenidate has been used as a neurostimulant to treat patients with attention deficit hyperactivity disorder, its therapeutic role in the psychomotor or cognitive recovery of patients with traumatic brain injuries (TBIs) in both intensive care and rehabilitation settings has not been adequately explored. To address this issue, this meta-analysis searched the available electronic databases using the key words "methylphenidate", "brain injuries", "head injuries", and "traumatic brain injury". Analysis of the ten double-blind RCTs demonstrated significant benefit in using methylphenidate for enhancing vigilance-associated attention (i.e., selective, sustained, and divided attention) in patients with TBIs (standardized mean difference: 0.45, 95% CI: 0.10 to 0.79), especially in sustained attention (standardized mean difference: 0.66, 95% CI: 0.22 to 1.10). However, no significant positive impact was noted on the facilitation of memory or processing speed. More studies on the efficacy and safety of methylphenidate for the cognitive improvement of patients with TBIs are warranted.	[Huang, Chi-Hsien] E DA Hosp, Dept Family Med, Kaohsiung, Taiwan; [Huang, Chi-Hsien] E DA Hosp, Ctr Evidence Based Med, Kaohsiung, Taiwan; [Huang, Chia-Chen] E DA Hosp, Dept Pharm, Kaohsiung, Taiwan; [Sun, Cheuk-Kwan] E DA Hosp, Dept Med Res, Kaohsiung, Taiwan; [Sun, Cheuk-Kwan] E DA Hosp, Dept Emergency Med, Kaohsiung, Taiwan; [Lin, Gong-Hong] Natl Taiwan Univ, Coll Med, Sch Occupat Therapy, Taipei 10764, Taiwan; [Hou, Wen-Hsuan] Taipei Med Univ Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Hou, Wen-Hsuan] Taipei Med Univ, Coll Nursing, Sch Gerontol Healthcare Management, Taipei, Taiwan; [Hou, Wen-Hsuan] Taipei Med Univ, Coll Nursing, Master Program Long Term Care, 250 Wuxing St, Taipei 11031, Taiwan	Hou, WH (corresponding author), Taipei Med Univ, Coll Nursing, Master Program Long Term Care, 250 Wuxing St, Taipei 11031, Taiwan.	houwh@tmu.edu.tw	Sun, Cheuk-Kwan/K-5723-2012				Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Baker B.K., 1990, DISS ABSTR INT; Ben Azouz Olfa, 2009, Tunis Med, V87, P680; BIRMAHER B, 1989, J AM ACAD CHILD PSY, V28, P768, DOI 10.1097/00004583-198909000-00020; BROOKE MM, 1992, ARCH PHYS MED REHAB, V73, P917; Bush G, 2010, NEUROPSYCHOPHARMACOL, V35, P278, DOI 10.1038/npp.2009.120; Frenette A.J., 2011, CRIT CARE, V15, pS111; Frenette AJ, 2012, J NEUROTRAUM, V29, P1, DOI 10.1089/neu.2011.1812; GREENDYKE RM, 1986, J NERV MENT DIS, V174, P290, DOI 10.1097/00005053-198605000-00005; Gualtieri C T, 1988, Brain Inj, V2, P273, DOI 10.3109/02699058809150898; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; JOHNSON ML, 1992, AM J PHYS MED REHAB, V71, P239, DOI 10.1097/00002060-199208000-00008; Kim J, 2012, PSYCHOPHARMACOLOGY, V222, P47, DOI 10.1007/s00213-011-2622-8; Kim YH, 2006, CLIN REHABIL, V20, P24, DOI 10.1191/0269215506cr927oa; Lee H, 2005, HUM PSYCHOPHARM CLIN, V20, P97, DOI 10.1002/hup.668; Leonard BE, 2004, HUM PSYCHOPHARM CLIN, V19, P151, DOI 10.1002/hup.579; Levin H., 2007, AM J PHY MED REHAB, V86, P329; Mahalick DM, 1998, PEDIATR NEUROSURG, V29, P121, DOI 10.1159/000028705; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; Nuechterlein KH, 2004, SCHIZOPHR RES, V72, P29, DOI 10.1016/j.schres.2004.09.007; Oradell N., 1956, NM M RITALIN METHYLP; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; Phillips JP, 2003, J HEAD TRAUMA REHAB, V18, P342, DOI 10.1097/00001199-200307000-00005; Plenger PM, 1996, ARCH PHYS MED REHAB, V77, P536, DOI 10.1016/S0003-9993(96)90291-9; Ponsford J, 2014, J HEAD TRAUMA REHAB, V29, P321, DOI 10.1097/HTR.0000000000000072; Shire US Inc, 2009, PROD INF DAYTR TM TR; Sivan M, 2010, CLIN REHABIL, V24, P110, DOI 10.1177/0269215509343234; Speech Thomas J., 1993, Brain Injury, V7, P333, DOI 10.3109/02699059309034959; Vance DE, 2012, J PSYCHOSOC NURS MEN, V50, P30, DOI 10.3928/02793695-20120508-03; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Weber P, 2002, PEDIATR NEUROL, V26, P261, DOI 10.1016/S0887-8994(01)00408-8; Weintraub S, 2013, NEUROLOGY, V80, pS54, DOI 10.1212/WNL.0b013e3182872ded; Wheaton P, 2011, J CLIN PSYCHOPHARM, V31, P745, DOI 10.1097/JCP.0b013e318235f4ac; Wheaton P, 2009, J CLIN PSYCHOPHARM, V29, P468, DOI 10.1097/JCP.0b013e3181b66f04; Whyte J, 2004, AM J PHYS MED REHAB, V83, P401, DOI 10.1097/01.PHM.0000128789.75375.D3; Whyte J, 1997, AM J PHYS MED REHAB, V76, P440, DOI 10.1097/00002060-199711000-00002; Whyte J, 2002, J HEAD TRAUMA REHAB, V17, P284, DOI 10.1097/00001199-200208000-00003; Williams SE, 1998, J HEAD TRAUMA REHAB, V13, P73, DOI 10.1097/00001199-199806000-00007; Willmott C, 2009, J NEUROL NEUROSUR PS, V80, P552, DOI 10.1136/jnnp.2008.159632; ZAMETKIN AJ, 1987, J AM ACAD CHILD PSY, V26, P676, DOI 10.1097/00004583-198709000-00011	40	11	11	0	3	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1570-159X	1875-6190		CURR NEUROPHARMACOL	Curr. Neuropharmacol.		2016	14	3					272	281		10.2174/1570159X13666150514233033			10	Neurosciences; Pharmacology & Pharmacy	Neurosciences & Neurology; Pharmacology & Pharmacy	DI4EM	WOS:000373453200007	26951094	Green Published			2021-06-18	
J	Lejbman, N; Olivera, A; Heinzelmann, M; Feng, R; Yun, S; Kim, HS; Gill, J				Lejbman, Natasha; Olivera, Anlys; Heinzelmann, Morgan; Feng, Rebekah; Yun, Sijung; Kim, Hyung-Suk; Gill, Jessica			Active duty service members who sustain a traumatic brain injury have chronically elevated peripheral concentrations of A40 and lower ratios of A42/40	BRAIN INJURY			English	Article						Traumatic brain injury; military; amyloid; tauopathies	AMYLOID PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; HEAD-INJURY; NEUROLOGICAL STATUS; MILITARY PERSONNEL; BETA DYNAMICS; ENCEPHALOPATHY; ASSOCIATION; POPULATION; DEPOSITION	Primary objective: Excessive accumulation of amyloid beta (A) and tau have been observed in older individuals with chronic neurological symptoms related to a traumatic brain injury (TBI), yet little is known about the possible role of A in younger active duty service members following a TBI. The purpose of the study was to determine if A 40 or 42 related to sustaining a TBI or to chronic neurological symptoms in a young cohort of military personnel.Research design: This was a cross-sectional study of active duty service members who reported sustaining a TBI and provided self-report of neurological and psychological symptoms and provided blood.Methods and procedures: An ultrasensitive single-molecule enzyme-linked immunosorbent assay was used to compare concentrations of A in active duty service members with (TBI+; n = 53) and without (TBI-; n = 18) a history of TBI. Self-report and medical history were used to measure TBI occurrence and approximate the number of total TBIs and the severity of TBIs sustained during deployment.Main outcomes and results: This study reports that TBI is associated with higher concentrations of A40 (F-1,F-68 = 6.948, p = 0.009) and a lower ratio of A42/A40 (F-1,F-62 = 5.671, p = 0.020). These differences remained significant after controlling for co-morbid symptoms of post-traumatic stress disorder and depression.Conclusions: These findings suggest that alterations in A relate to TBIs and may contribute to chronic neurological symptoms.	[Lejbman, Natasha; Olivera, Anlys; Heinzelmann, Morgan; Feng, Rebekah; Yun, Sijung; Kim, Hyung-Suk; Gill, Jessica] NIH, NINR, Bldg 10, Bethesda, MD 20892 USA; [Yun, Sijung] LLC, Yotta Biomed, Bethesda, MD USA	Gill, J (corresponding author), 1 Cloister Court,Rm 256, Bethesda, MD 20814 USA.	gillj@mail.nih.gov	Feng, Li Rebekah/Y-9204-2019; Gill, Gill M/Q-2020-2017	Feng, Li Rebekah/0000-0003-0445-4088; Heinzelmann, Morgan/0000-0002-4399-6229	Center for Neuroscience and Regenerative MedicineUnited States Department of Defense [60855]; National Institutes of Nursing ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR); NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [ZIANR000015] Funding Source: NIH RePORTER	This study was funded, in part, by the Center for Neuroscience and Regenerative Medicine (Grant 60855). This study was funded by the intramural research program of the National Institutes of Nursing Research. The authors report no conflicts of interest. The opinions and assertions in this manuscript are those of the authors and do not necessarily represent those of the Department of the Army, Department of Defense, US Government, or the Center for Neuroscience and Regenerative Medicine.	Berman DE, 2008, NAT NEUROSCI, V11, P547, DOI 10.1038/nn.2100; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; Brody DL, 2008, SCIENCE, V321, P1221, DOI 10.1126/science.1161591; Claeysen S, 2012, CELL SIGNAL, V24, P1831, DOI 10.1016/j.cellsig.2012.05.008; Dumurgier J, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0114-5; Fryer JD, 2005, J NEUROSCI, V25, P2803, DOI 10.1523/JNEUROSCI.5170-04.2005; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Jan A, 2008, J BIOL CHEM, V283, P28176, DOI 10.1074/jbc.M803159200; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; JORDAN BD, 1995, ANN NEUROL, V38, P698, DOI 10.1002/ana.410380429; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Koffie RM, 2012, BRAIN, V135, P2155, DOI 10.1093/brain/aws127; Kumar A, 2015, PHARMACOL REP, V67, P195, DOI 10.1016/j.pharep.2014.09.004; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Magnoni S, 2010, ARCH NEUROL-CHICAGO, V67, P1068, DOI 10.1001/archneurol.2010.214; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; Mondello S, 2014, SCI REP-UK, V4, DOI 10.1038/srep06446; Nemetz PN, 1999, AM J EPIDEMIOL, V149, P32; Olivera A, 2015, JAMA NEUROL, V72, P1109, DOI 10.1001/jamaneurol.2015.1383; Parihar MS, 2010, J ALZHEIMERS DIS, V22, P741, DOI 10.3233/JAD-2010-101020; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Reid MW, 2014, J NEUROTRAUM, V31, P1899, DOI 10.1089/neu.2014.3455; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; ROBERTS GW, 1991, LANCET, V338, P1422, DOI 10.1016/0140-6736(91)92724-G; Seppala TT, 2010, J NEUROL NEUROSUR PS, V81, P1123, DOI 10.1136/jnnp.2010.205757; Stalder M, 1999, AM J PATHOL, V154, P1673, DOI 10.1016/S0002-9440(10)65423-5; Stein TD, 2015, ACTA NEUROPATHOL, V130, P21, DOI 10.1007/s00401-015-1435-y; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Sun XJ, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00221; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Trivedi MH, 2004, PSYCHOL MED, V34, P73, DOI 10.1017/S0033291703001107; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2002, BIOCHEM SOC T, V30, P552, DOI 10.1042/BST0300552; Wilkins KC, 2011, DEPRESS ANXIETY, V28, P596, DOI 10.1002/da.20837; Yang ST, 2015, J NEUROL SCI, V349, P99, DOI 10.1016/j.jns.2014.12.032; Yurgil KA, 2014, JAMA PSYCHIAT, V71, P149, DOI 10.1001/jamapsychiatry.2013.3080	37	11	12	0	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	12					1436	1441		10.1080/02699052.2016.1219054			6	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	ED1IO	WOS:000388599100005	27834544	Other Gold, Green Published			2021-06-18	
J	McLafferty, FS; Barmparas, G; Ortega, A; Roberts, P; Ko, A; Harada, M; Nuno, M; Black, KL; Ley, EJ				McLafferty, Fred S.; Barmparas, Galinos; Ortega, Alicia; Roberts, Pamela; Ko, Ara; Harada, Megan; Nuno, Miriam; Black, Keith L.; Ley, Eric J.			Predictors of improved functional outcome following inpatient rehabilitation for patients with traumatic brain injury	NEUROREHABILITATION			English	Article						Traumatic brain injury (TBI); inpatient rehabilitation; hypotension; Glasgow Coma Scale (GCS); rehabilitation responder	UNITED-STATES; HEAD-INJURIES; IMPACT; MORTALITY; CONSCIOUSNESS; DISORDERS; SEVERITY; RECOVERY; SURVIVAL; AGE	OBJECTIVE: To determine factors associated with response to inpatient rehabilitation treatment among TBI patients. SETTING: Inpatient rehabilitation service at a Level I trauma center. PARTICIPANTS: Moderate-severe TBI patients ages >= 18 years old admitted between January 1, 2002 and December 31, 2012. MAIN MEASURES: Response to inpatient rehabilitation, measured by the Functional Independence Measure (FIM) score. DESIGN: Retrospective cohort study. RESULTS: Of 1,984 patients treated for TBI, 184 (10.8%) underwent inpatient rehabilitation. The largest proportion of patients improved in mobility (98.9%), followed by self-care (93.7%), communication/social cognition (84.0%), and sphincter control (65.7%). Of these, 99 (53.8%) improved by 2 or more levels of functional independence and were considered rehabilitation responders. Responders were younger (53.1 years vs. 63.8, p < 0.01), had longer average rehabilitation stays (15.4 days vs. 12.2, p < 0.01), and were less likely to have an admission SBP < 100 mm Hg (7.1% vs. 17.1%, p = 0.01). On multivariate analysis, normotension at admission (AOR 0.06, p = 0.01) and longer rehabilitation LOS (AOR 1.11, p < 0.01) were associated with a response to inpatient rehabilitation. CONCLUSION: Of the TBI patients who qualified for same-center inpatient rehabilitation, approximately half responded to treatment. Longer rehabilitation time and normotension at admission predicted response to rehabilitation. Further efforts are necessary to identify and optimize TBI patients for inpatient rehabilitation.	[McLafferty, Fred S.; Ortega, Alicia; Nuno, Miriam; Black, Keith L.] Cedars Sinai Med Ctr, Ctr Neurosurg Outcomes Res, Maxine Dunitz Neurosurg Inst, Dept Neurosurg, Los Angeles, CA 90048 USA; [Barmparas, Galinos; Ko, Ara; Harada, Megan; Ley, Eric J.] Cedars Sinai Med Ctr, Dept Surg, Div Acute Care Surg, Los Angeles, CA 90048 USA; [Roberts, Pamela] Cedars Sinai Med Ctr, Dept Phys Med & Rehabil, Los Angeles, CA 90048 USA	Ley, EJ (corresponding author), Cedars Sinai Med Ctr, Dept Surg, Div Trauma & Crit Care, Los Angeles, CA 90048 USA.	Eric.Ley@cshs.org	Roberts, Pamela S/G-4059-2015; Barmparas, Galinos/L-6530-2019	Black, Keith/0000-0002-0546-4934			Berry C, 2012, INJURY, V43, P1833, DOI 10.1016/j.injury.2011.08.014; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Butcher I, 2007, J NEUROTRAUM, V24, P294, DOI 10.1089/neu.2006.0032; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P883, DOI 10.1016/S0003-9993(96)90274-9; Deguise E, 2008, J HEAD TRAUMA REHAB, V23, P294, DOI 10.1097/01.HTR.0000336842.53338.f4; Dutton RP, 2002, J TRAUMA, V52, P1141, DOI 10.1097/00005373-200206000-00020; Faul M., 2014, TRAUMATIC BRAIN INJU; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Kilaru S, 1996, J TRAUMA, V41, P957, DOI 10.1097/00005373-199612000-00003; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Nakase-Richardson R, 2012, J NEUROTRAUM, V29, P59, DOI 10.1089/neu.2011.1829; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Perel P, 2007, J EVAL CLIN PRACT, V13, P464, DOI 10.1111/j.1365-2753.2006.00713.x; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Roberts PS, 2014, PM&R, V6, P514, DOI 10.1016/j.pmrj.2013.12.007; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; SAYWELL RM, 1989, J AM GERIATR SOC, V37, P625, DOI 10.1111/j.1532-5415.1989.tb01253.x; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; STINEMAN MG, 1994, MED CARE, V32, P366, DOI 10.1097/00005650-199404000-00005; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Testa JA, 2005, ARCH PHYS MED REHAB, V86, P1815, DOI 10.1016/j.apmr.2005.03.010; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009	29	11	11	0	9	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2016	39	3					423	430		10.3233/NRE-161373			8	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	DW7XA	WOS:000383865200009	27589512				2021-06-18	
J	Meng, XF; Shi, BZ				Meng, Xiaofeng; Shi, Baozhong			Traumatic Brain Injury Patients With a Glasgow Coma Scale Score of <= 8, Cerebral Edema, and/or a Basal Skull Fracture are More Susceptible to Developing Hyponatremia	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						epidemiology; traumatic brain injury; serum sodium level; computed tomography	SODIUM; MILD	Background: Traumatic brain injury (TBI) is a common injury treated at the neurosurgery department. The incidence rate is approximately 3% in the general population and the mortality rate is 25%. The incidence of hyponatremia following TBI is 33%. Hyponatremia is one of the main causes of disability and/or death in TBI patients. This study investigated the epidemiology of hyponatremia following TBI. Methods: Patients who were admitted to our hospital with moderate or severe TBI were analyzed retrospectively. The relationship between the occurrence of hyponatremia and age, sex, type of injury, Glasgow coma scale (GCS) score, whether the patient underwent surgery, and the presence of cerebral edema and basal skull fracture was analyzed statistically using a chi(2) test and multivariate logistic regression analysis. Results: Out of the 136 patients recruited for the study (81 males and 55 females; mean +/- SD age of 48 +/- 13 y), 56 suffered from hyponatremia (ie, serum sodium level <135mmol/L). Univariate analysis indicated that hyponatremia following TBI was not related to age (P>0.05), sex (P= 0.347), or surgical history (P= 0.492) but that it was related to the type of injury (P= 0.031), a GCS score <= 8 (P< 0.001), the presence of cerebral edema (P< 0.001), and/or a basal skull fracture (P< 0.001). Multivariate logistic regression analysis confirmed a strong association between the occurrence of hyponatremia and a GCS score <= 8 (P< 0.016), the presence of cerebral edema (P< 0.001), and a basal skull fracture (P< 0.001). Conclusions: TBI patients with a GCS score <= 8, cerebral edema, and/or a basal skull fracture are particularly prone to developing hyponatremia. These patients require additional treatment that should entail the normalization of serum sodium levels to prevent deterioration of their condition.	[Meng, Xiaofeng; Shi, Baozhong] Henan Univ Sci & Technol, Dept Neurosurg, Affiliated Hosp 1, 24 Jinghua Rd, Luoyang 471003, Peoples R China	Shi, BZ (corresponding author), Henan Univ Sci & Technol, Dept Neurosurg, Affiliated Hosp 1, 24 Jinghua Rd, Luoyang 471003, Peoples R China.	sbzmd20569@163.com					American College of Surgeons Committee on Trauma, 1997, ADV TRAUM LIF SUPP M; Andersson EH, 2003, ACTA NEUROL SCAND, V107, P256, DOI 10.1034/j.1600-0404.2003.00112.x; BORN JD, 1985, SURG NEUROL, V23, P383, DOI 10.1016/0090-3019(85)90212-5; Buckley MS, 2013, ANN PHARMACOTHER, V47, P1194, DOI 10.1177/1060028013503126; Cai Jia-ning, 2003, Chin J Traumatol, V6, P179; Dhar R, 2011, NEUROCRIT CARE, V14, P97, DOI 10.1007/s12028-010-9366-x; [董元训 Dong Yuanxun], 2012, [中华神经外科杂志, Chinese Journal of Neurosurgery], V28, P1160; Frey F J, 2004, Ther Umsch, V61, P583, DOI 10.1024/0040-5930.61.9.583; Harrigan MR, 2001, CRIT CARE CLIN, V17, P125, DOI 10.1016/S0749-0704(05)70155-X; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; JENNETT B, 1977, LANCET, V1, P878; John CA, 2012, CRIT CARE NURSE, V32, pE1, DOI 10.4037/ccn2012904; Kirkman MA, 2014, MINERVA ENDOCRINOL, V39, P13; KROLL M, 1992, J INTERN MED, V232, P291; [刘伟 Liu Wei], 2012, [中华骨科杂志, Chinese Journal of Orthopedics], V32, P299; Liu XY, 2012, J BRAIN NERV DIS, V20, P34; Paiva WS, 2011, THER CLIN RISK MANAG, V7, P345, DOI 10.2147/TCRM.S17692; Sajadieh A, 2009, AM J MED, V122, P679, DOI 10.1016/j.amjmed.2008.11.033; TEASDALE G, 1974, LANCET, V2, P81; Tisdall M, 2006, J NEUROSURG ANESTH, V18, P57, DOI 10.1097/01.ana.0000191280.05170.0f; Waikar SS, 2009, AM J MED, V122, P857, DOI 10.1016/j.amjmed.2009.01.027; Wu ZD, 2008, SURGERY; Yao GJ, 1999, CHIN J TRAUMATOL, V15, P269; Yee AH, 2010, NEUROSURG CLIN N AM, V21, P339, DOI 10.1016/j.nec.2009.10.011; 丁之明, 2008, [中国神经精神疾病杂志, Chinese Journal of Nervous and Mental Diseases], V34, P237	25	11	13	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0898-4921	1537-1921		J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	JAN	2016	28	1					21	26		10.1097/ANA.0000000000000192			6	Anesthesiology; Clinical Neurology; Surgery	Anesthesiology; Neurosciences & Neurology; Surgery	DM3FY	WOS:000376233400004	25985316				2021-06-18	
J	Meulenbroek, O; O'Dwyer, S; de Jong, D; van Spijker, G; Kennelly, S; Cregg, F; Rikkert, MO; Abdullah, L; Wallin, A; Walsh, C; Coen, R; Kenny, RA; Daly, L; Segurado, R; Borjesson-Hanson, A; Crawford, F; Mullan, M; Lucca, U; Banzi, R; Pasquier, F; Breuilh, L; Riepe, M; Kalman, J; Molloy, W; Tsolaki, M; Howard, R; Adams, J; Gaynor, S; Lawlor, B				Meulenbroek, Olga; O'Dwyer, Sarah; de Jong, Daan; van Spijker, Gerrita; Kennelly, Sean; Cregg, Fiona; Rikkert, Marcel Olde; Abdullah, Laila; Wallin, Anders; Walsh, Cathal; Coen, Robert; Kenny, Rose Anne; Daly, Leslie; Segurado, Ricardo; Borjesson-Hanson, Anne; Crawford, Fiona; Mullan, Michael; Lucca, Ugo; Banzi, Rita; Pasquier, Florence; Breuilh, Laetitia; Riepe, Matthias; Kalman, Janos; Molloy, William; Tsolaki, Magda; Howard, Robert; Adams, Jessica; Gaynor, Siobhan; Lawlor, Brian			European multicentre double-blind placebo-controlled trial of Nilvadipine in mild-to-moderate Alzheimer's disease-the substudy protocols: NILVAD frailty; NILVAD blood and genetic biomarkers; NILVAD cerebrospinal fluid biomarkers; NILVAD cerebral blood flow	BMJ OPEN			English	Article							TRAUMATIC BRAIN-INJURY; SERUM A-BETA; COGNITIVE IMPAIRMENT; OLDER-ADULTS; DEMENTIA; CSF; PROTEIN; RISK; AUTOREGULATION; HYPERTENSION	Introduction: In conjunction with the NILVAD trial, a European Multicentre Double-Blind Placebo Controlled trial of Nilvadipine in Mild-to-Moderate Alzheimer's disease (AD), there are four NILVAD substudies in which eligible NILVAD patients are also invited to participate. The main NILVAD protocol was previously published in BMJ Open (2014). The objectives of the NILVAD substudies are to determine whether frailty, cerebrospinal fluid (CSF), blood biomarker profile and Apolipoprotein E (APOE) status predict response to Nilvadipine, and to investigate the effect of Nilvadipine on cerebral blood flow and blood biomarkers. Methods and analysis: All participants who fulfil criteria for the main NILVAD study are eligible for participation in the NILVAD substudies. Participation is subject to informed consent and whether the substudy is available at a particular NILVAD study site. Each substudy entails extra measurements during the course of the main NILVAD study. For example, in the blood and genetic biomarkers substudy, extra blood (30 mL) will be collected at week 0, week 13, week 52 and week 78, while in the cerebral blood flow substudy, participants will receive an MRI and transcranial Doppler measurements at week 0, week 26 and week 78. In the CSF substudy, 10 mL CSF is collected at week 0 and week 78. Ethics and dissemination: All NILVAD substudies and all subsequent amendments have received ethical approval within each participating country, according to national regulations. Each participant provides written consent to participate. All participants remain anonymised throughout and the results of each substudy will be published in an international peer reviewed journal.	[Meulenbroek, Olga; de Jong, Daan; van Spijker, Gerrita; Rikkert, Marcel Olde] Radboud Univ Nijmegen, Med Ctr, Radboud Alzheimer Ctr, Nijmegen, Netherlands; [O'Dwyer, Sarah; Coen, Robert; Kenny, Rose Anne; Lawlor, Brian] St James Hosp, Mercers Inst Res Ageing, Dublin, Ireland; [Kennelly, Sean; Cregg, Fiona] TCD, Dublin, Ireland; [Abdullah, Laila] Roskamp Inst, Sarasota, FL USA; [Wallin, Anders; Borjesson-Hanson, Anne] Goeteborgs Univ UGOT, Gothenburg, Sweden; [Walsh, Cathal; Daly, Leslie; Segurado, Ricardo] UCD, Dublin, Ireland; [Crawford, Fiona; Mullan, Michael] Archer Pharmaceut Inc, Sarasota, FL USA; [Lucca, Ugo; Banzi, Rita] IRFMN, IRCCS, Dept Lab Geriatr Neuropsychiat, Milan, Italy; [Pasquier, Florence; Breuilh, Laetitia] Ctr Hosp Reg & Univ Lille CHRU LILLE, Lille, France; [Riepe, Matthias] Univ Ulm, UULM, Ulm, Germany; [Kalman, Janos] Szegedi Tudomanyegyetem SZEGED, Szeged, Hungary; [Molloy, William] Univ Coll Cork, Ctr Gerontol & Rehabil, Cork, Ireland; [Tsolaki, Magda] Aristotle Univ Thessaloniki AUTH, Thessaloniki, Greece; [Howard, Robert; Adams, Jessica] KCL, London, England; [Gaynor, Siobhan] MMI, Dublin, Ireland	Lawlor, B (corresponding author), St James Hosp, Mercers Inst Res Ageing, Dublin, Ireland.	blawlor@stjames.ie	Banzi, Rita/AAA-6381-2020; van Spijker, Gerrita/A-1264-2016; Rikkert, M.G.M. Olde/H-8078-2014; Lucca, Ugo/ABC-1460-2020; Pasquier, Florence/F-1527-2017; Rikkert, Marcel Olde/D-9773-2012; de Jong, Daan LK/P-8260-2015; Segurado, Ricardo/K-6116-2014	Banzi, Rita/0000-0002-2211-3300; Rikkert, M.G.M. Olde/0000-0003-1397-1677; Lucca, Ugo/0000-0003-0452-3215; Pasquier, Florence/0000-0001-9880-9788; de Jong, Daan LK/0000-0002-4263-4402; Tsolaki, Magda/0000-0002-2072-8010; Kennelly, Sean/0000-0002-3721-0197; Kenny, Rose Anne/0000-0002-9336-8124; Howard, Robert/0000-0002-3071-2338; Segurado, Ricardo/0000-0002-3547-6733	European CommissionEuropean CommissionEuropean Commission Joint Research Centre [279093]; Alzheimer's Drug Discovery Foundation (ADDF) [20121210]; Dutch Alzheimer Society [WE.03-2015-01]	The main NILVAD trial and associated substudies are funded by the European Commission Framework 7 Programme health theme collaborative project. Grant Agreement Number: 279093. The CBF substudy is funded by the Alzheimer's Drug Discovery Foundation (ADDF), Grant number: 20121210 and by the Dutch Alzheimer Society, grant number WE.03-2015-01.	Abdullah L, 2014, FASEB J, V28, P5311, DOI 10.1096/fj.14-258228; Abdullah L, 2009, MOL MED, V15, P432, DOI 10.2119/molmed.2009.00083; Abdullah L, 2009, MOL MED, V15, P95, DOI 10.2119/molmed.2008.00118; Bjerke M, 2011, J ALZHEIMERS DIS, V27, P665, DOI 10.3233/JAD-2011-110566; Blennow K, 2003, LANCET NEUROL, V2, P605, DOI 10.1016/S1474-4422(03)00530-1; Blennow K, 1995, MOL CHEM NEUROPATHOL, V26, P231, DOI 10.1007/BF02815140; Chappell MA, 2009, IEEE T SIGNAL PROCES, V57, P223, DOI 10.1109/TSP.2008.2005752; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Claassen JAHR, 2011, J CEREBR BLOOD F MET, V31, P1572, DOI 10.1038/jcbfm.2011.69; Crean S, 2011, DEMENT GERIATR COGN, V31, P20, DOI 10.1159/000321984; de Vries NM, 2011, AGEING RES REV, V10, P104, DOI 10.1016/j.arr.2010.09.001; Emmerich T, 2016, J NEUROTRAUM, V33, P1331, DOI 10.1089/neu.2015.4061; Erickson MA, 2013, J CEREBR BLOOD F MET, V33, P1500, DOI 10.1038/jcbfm.2013.135; Fleisher AS, 2009, NEUROBIOL AGING, V30, P1737, DOI 10.1016/j.neurobiolaging.2008.01.012; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Gelinas I, 1999, AM J OCCUP THER, V53, P471, DOI 10.5014/ajot.53.5.471; Gray SL, 2013, J GERONTOL A-BIOL, V68, P1083, DOI 10.1093/gerona/glt013; Hanyu H, 2007, NUCL MED COMMUN, V28, P281, DOI 10.1097/MNM.0b013e32804c58aa; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; Kagawa H, 1999, CLIN EXP HYPERTENS, V21, P1177, DOI 10.3109/10641969909052196; Katz MH, 2011, MULTIVARIABLE ANAL P; Kennelly S, 2012, INT J GERIATR PSYCH, V27, P415, DOI 10.1002/gps.2735; Kulmala J, 2014, GERONTOLOGY, V60, P16, DOI 10.1159/000353859; Lawlor B, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006364; Lee KS, 2009, DEMENT GERIATR COGN, V28, P281, DOI 10.1159/000245156; Lewczuk P, 2004, NEUROBIOL AGING, V25, P273, DOI 10.1016/S0197-4580(03)00086-1; Lubben J, 2006, GERONTOLOGIST, V46, P503, DOI 10.1093/geront/46.4.503; Marques F, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-38; Mattsson N, 2009, JAMA-J AM MED ASSOC, V302, P385, DOI 10.1001/jama.2009.1064; MOHS RC, 1983, PSYCHOPHARMACOL BULL, V19, P448; Mozolic JL, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/neuro.09.016.2010; Murphy K, 2011, MAGN RESON IMAGING, V29, P1382, DOI 10.1016/j.mri.2011.02.030; Nagga K, 2004, DEMENT GERIATR COGN, V18, P59, DOI 10.1159/000077737; Niwa K, 2002, AM J PHYSIOL-HEART C, V283, pH315, DOI 10.1152/ajpheart.00022.2002; Parati G, 2010, J HUM HYPERTENS, V24, P779, DOI 10.1038/jhh.2010.54; Paris D, 2004, BRAIN RES, V999, P53, DOI 10.1016/j.brainres.2003.11.061; Paris D, 2011, MOL MED, V17, P149, DOI 10.2119/molmed.2010.00180; Raber J, 2004, NEUROBIOL AGING, V25, P641, DOI 10.1016/j.neurobiolaging.2003.12.023; Rockwood K, 2005, CAN MED ASSOC J, V173, P489, DOI 10.1503/cmaj.050051; Rosengren LE, 1999, NEUROLOGY, V52, P1090, DOI 10.1212/WNL.52.5.1090; Salloway S, 2011, NEUROLOGY, V77, P1253, DOI 10.1212/WNL.0b013e3182309fa5; Searle Samuel D, 2008, BMC Geriatr, V8, P24, DOI 10.1186/1471-2318-8-24; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Song XW, 2010, J AM GERIATR SOC, V58, P681, DOI 10.1111/j.1532-5415.2010.02764.x; Thambisetty M, 2010, BIOMARK MED, V4, P65, DOI 10.2217/BMM.09.84; Webb AJS, 2010, LANCET, V375, P906, DOI 10.1016/S0140-6736(10)60235-8; Whiley L, 2014, NEUROBIOL AGING, V35, P271, DOI 10.1016/j.neurobiolaging.2013.08.001; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	48	11	11	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open		2016	6	7							e011584	10.1136/bmjopen-2016-011584			11	Medicine, General & Internal	General & Internal Medicine	DU5LB	WOS:000382252100088	27436668	DOAJ Gold, Green Published			2021-06-18	
J	Migliorini, C; Enticott, J; Callaway, L; Moore, S; Willer, B				Migliorini, Christine; Enticott, Joanne; Callaway, Libby; Moore, Sophie; Willer, Barry			Community integration questionnaire: Outcomes of people with traumatic brain injury and high support needs compared with multiple matched controls	BRAIN INJURY			English	Article						Brain injuries; community assessment; reference values; rehabilitation (community-based); community integration; community living; community participation; social participation; TBI (Traumatic Brain Injury)	LONG-TERM OUTCOMES	Objectives: To determine level of community integration in adults with traumatic brain injury and high support needs (TBI-HSN) compared with multiple matched controls.Setting: Community setting, Victoria, Australia.Participants: Adults with TBI-HSN living in the community (n = 61). Australian normative data (n = 1973) was used for matching purposes (1:4).Design: Matched analysis from people with and without TBI. Matching aimed to reduce variability expected from age, gender, metropolitan/rural residence and co-resident status.Main measures: Community Integration Questionnaire (CIQ): total and sub-scales of Home Integration, Social Integration and Productivity.Results: Matched analysis showed large effects favouring the general population, e.g. CIQ total scores were significantly different, F(1, 304) = 5.8, p < 0.0001. Conditional relative risk showed community-dwelling participants with TBI were 540-times more likely to report a poor CIQ total score compared to the general population.Conclusion: Normative CIQ data has enabled meaningful comparisons of the community integration of adults with chronic TBI to the general population in Australia. Evidence makes clear with numeric precision that individuals with TBI and high support needs are much less integrated than their non-TBI counterparts despite living in the community for many years.	[Migliorini, Christine; Callaway, Libby; Moore, Sophie] Monash Univ, Dept Occupat Therapy, Melbourne, Vic, Australia; [Migliorini, Christine; Callaway, Libby] Summer Fdn, Melbourne, Vic, Australia; [Enticott, Joanne] Southern Synergy, Melbourne, Vic, Australia; [Enticott, Joanne] Southern Clin Sch, Dept Psychiat, Melbourne, Vic, Australia; [Enticott, Joanne] Monash Univ, Sch Primary Hlth Care, Melbourne, Vic, Australia; [Willer, Barry] SUNY Buffalo, Dept Psychiat, Buffalo, NY USA	Migliorini, C (corresponding author), Monash Univ, Dept Occupat Therapy, Peninsula Campus,McMahons Rd, Frankston, Vic 3199, Australia.	christine.migliorini@monash.edu	enticott, joanne C/I-1587-2014	enticott, joanne C/0000-0002-4480-5690	Transport Accident Commission, through the Institute for Safety, Compensation and Recovery Research	The authors report no conflicts of interest. This project was funded by the Transport Accident Commission, through the Institute for Safety, Compensation and Recovery Research.	[Anonymous], 2015, STAND OUTC MEAS; Beane Freeman LE, 2009, JNCI-J NATL CANCER I, V101, P751, DOI 10.1093/jnci/djp096; BRESLOW NE, 1980, ANAL CASE CONTROL ST; Burleigh SA, 1998, AM J OCCUP THER, V52, P45, DOI 10.5014/ajot.52.1.45; Callaway L, AUST OCCUP THER J; Callaway L., 2014, COMMUNITY INTEGRATIO; Colantonio A, 2004, DISABIL REHABIL, V26, P253, DOI 10.1080/09638280310001639722; Cummings P, 2004, STATA J, V4, P274, DOI 10.1177/1536867X0400400305; Cusick CP, 2000, J HEAD TRAUMA REHAB, V15, P739, DOI 10.1097/00001199-200002000-00012; Dijkers M, 1997, J HEAD TRAUMA REHAB, V12, P74, DOI 10.1097/00001199-199712000-00007; Dijkers Marcel., 1998, TOP SPINAL CORD INJ, V4, P1, DOI [10.1310/BJJA-2018-45KL-0VTL, DOI 10.1310/BJJA-2018-45KL-0VTL]; Doig E, 2001, BRAIN INJURY, V15, P747, DOI 10.1080/02699050110034343; Glenn ND., 2007, BLACKWELL ENCY SOCIO; Hoofien D, 2001, BRAIN INJURY, V15, P189; Lezak M.D., 2004, NEUROPSYCHOLOGICAL A, Vfourth; McColl MA, 1998, BRAIN INJURY, V12, P15, DOI 10.1080/026990598122827; Muirhead CR, 2009, BRIT J CANCER, V100, P206, DOI 10.1038/sj.bjc.6604825; Reisenwitz T. H., 2009, MARK MANAG, V19, P91; Rigby AS, 2000, DISABIL REHABIL, V22, P259, DOI 10.1080/096382800296719; Ritchie L, 2014, ARCH PHYS MED REHAB, V95, P163, DOI 10.1016/j.apmr.2013.08.237; Sander AM, 2010, J HEAD TRAUMA REHAB, V25, P121, DOI 10.1097/HTR.0b013e3181cd1635; Schieman S., 2007, BLACKWELL ENCY SOCIO; Settersten RA, 2010, FUTURE CHILD, V20, P19; SLOAN S, 2007, BRAIN IMPAIR, V8, P251, DOI DOI 10.1375/BRIM.8.3.251; Sloan S, 2012, BRAIN IMPAIR, V13, P24, DOI 10.1017/BrImp.2012.5; Sloan S, 2009, BRAIN IMPAIR, V10, P282, DOI 10.1375/brim.10.3.282; [Statewide Rehabilitation Clinical Network South Australia Health], 2012, ACQ BRAIN INJ MOD RE; Tate R., 2011, MANUAL CARE NEEDS SC; Tate RL, 2004, BRAIN INJURY, V18, P445, DOI 10.1080/02699050310001641183; von Lehn D., 2007, BLACKWELL ENCY SOCIO; Waldschmidt A., 2007, BLACKWELL ENCY SOCIO; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; Willer B., 1993, J HEAD TRAUMA REHAB, V8, P75, DOI DOI 10.1097/00001199-199308020-00009; Winkler D, 2006, J HEAD TRAUMA REHAB, V21, P8, DOI 10.1097/00001199-200601000-00002; Winkler D, 2010, BRAIN IMPAIR, V11, P299, DOI 10.1375/brim.11.3.299	35	11	11	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	10					1201	1207		10.1080/02699052.2016.1175666			7	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	DX4BR	WOS:000384324300005	27314287				2021-06-18	
J	Popkin, CA; Schulz, BM; Park, CN; Bottiglieri, TS; Lynch, TS				Popkin, Charles A.; Schulz, Brian M.; Park, Caroline N.; Bottiglieri, Thomas S.; Lynch, T. Sean			Evaluation, management and prevention of lower extremity youth ice hockey injuries	OPEN ACCESS JOURNAL OF SPORTS MEDICINE			English	Article						youth hockey; body checking; injury prevention; femoroacetabular impingement; apophyseal avulsions	MEDIAL COLLATERAL LIGAMENT; SPORTS-RELATED FRACTURES; BODY-CHECKING RULES; GROIN INJURIES; CONCUSSION KNOWLEDGE; SPINAL-INJURIES; HIP INJURIES; SURFACE SIZE; RISK-FACTORS; PLAYERS	Ice hockey is a fast-paced sport played by increasing numbers of children and adolescents in North America and around the world. Requiring a unique blend of skill, finesse, power and teamwork, ice hockey can become a lifelong recreational activity. Despite the rising popularity of the sport, there is ongoing concern about the high frequency of musculoskeletal injury associated with participation in ice hockey. Injury rates in ice hockey are among the highest in all competitive sports. Numerous research studies have been implemented to better understand the risks of injury. As a result, rule changes were adopted by the USA Hockey and Hockey Canada to raise the minimum age at which body checking is permitted to 13-14 years (Bantam level) from 11-12 years (Pee Wee). Continuing the education of coaches, parents and players on rules of safe play, and emphasizing the standards for proper equipment use are other strategies being implemented to make the game safer to play. The objective of this article was to review the evaluation, management and prevention of common lower extremity youth hockey injuries.	[Popkin, Charles A.; Park, Caroline N.; Bottiglieri, Thomas S.; Lynch, T. Sean] Columbia Univ, Dept Orthoped Surg, Ctr Shoulder Elbow & Sports Med, 622 West 168th St, New York, NY 10032 USA; [Schulz, Brian M.] Kerlan Jobe Orthoped Clin, Los Angeles, CA USA	Popkin, CA (corresponding author), Columbia Univ, Dept Orthoped Surg, Ctr Shoulder Elbow & Sports Med, 622 West 168th St, New York, NY 10032 USA.	cp2654@columbia.edu					Ackery AD, 2012, CLIN J SPORT MED, V22, P86, DOI 10.1097/JSM.0b013e3182342b69; Agel J, 2010, CAN J SURG, V53, P319; Anderson K, 2001, AM J SPORT MED, V29, P521, DOI 10.1177/03635465010290042501; Anderson SE, 2012, EUR J RADIOL, V81, P3740, DOI 10.1016/j.ejrad.2011.03.097; Ayeni OR, 2014, OPEN ACCESS J SPORTS, V5, P143, DOI 10.2147/OAJSM.S58985; Benson Brian W, 2005, Med Sport Sci, V49, P86, DOI 10.1159/000085393; Benson BW, 1999, JAMA-J AM MED ASSOC, V282, P2328, DOI 10.1001/jama.282.24.2328; Black AM, 2016, BRIT J SPORT MED, V50, P55, DOI 10.1136/bjsports-2015-095103; Brenner JS, 2014, PEDIATRICS, V133, P1151, DOI 10.1542/peds.2014-0692; Brunelle JP, 2005, J SCI MED SPORT, V8, P294, DOI 10.1016/S1440-2440(05)80040-4; BRUST JD, 1992, AM J DIS CHILD, V146, P741, DOI 10.1001/archpedi.1992.02160180101026; Chang R, 2009, SPORT BIOMECH, V8, P212, DOI 10.1080/14763140903229534; Cook DJ, 2003, INJURY PREV, V9, P361, DOI 10.1136/ip.9.4.361; Cusimano MD, 2014, BRIT J SPORT MED, V48, P141, DOI 10.1136/bjsports-2012-091660; Cusimano MD, 2013, CAN MED ASSOC J, V185, pE57, DOI 10.1503/cmaj.112017; Decloe MD, 2014, BRIT J SPORT MED, V48, P51, DOI 10.1136/bjsports-2012-091653; Deits J, 2010, J ATHL TRAINING, V45, P467, DOI 10.4085/1062-6050-45.5.467; Emery CA, 2006, AM J SPORT MED, V34, P1960, DOI 10.1177/0363546506290061; Emery CA, 2010, JAMA-J AM MED ASSOC, V303, P2265, DOI 10.1001/jama.2010.755; Fabricant PD, 2012, CLIN ORTHOP RELAT R, V470, P261, DOI 10.1007/s11999-011-2015-7; Flik K, 2005, AM J SPORT MED, V33, P183, DOI 10.1177/0363546504267349; Goodman D, 2006, J ADOLESCENCE, V29, P351, DOI 10.1016/j.adolescence.2005.07.004; Grant JA, 2013, SPORTS HEALTH, V5, P270, DOI 10.1177/1941738112473053; Hagel BE, 2006, CAN MED ASSOC J, V175, P155, DOI 10.1503/cmaj.051531; International Ice Hockey Federation (IIHF), 2016, IIHF MEM NAT ASS; Irshad K, 2001, SURGERY, V130, P759, DOI 10.1067/msy.2001.118093; Jakoi A, 2013, AM J SPORT MED, V41, P107, DOI 10.1177/0363546512462679; Kocher MS, 2006, CLIN SPORT MED, V25, P241, DOI 10.1016/j.csm.2006.01.001; Kukaswadia A, 2010, PEDIATRICS, V125, P735, DOI 10.1542/peds.2009-2083; Lacny S, 2014, BRIT J SPORT MED, V48, P1299, DOI 10.1136/bjsports-2014-093493; Laliberte DJ, 2009, SPORT J, V12, P1; LaPrade RF, 2009, BRIT J SPORT MED, V43, P1000, DOI 10.1136/bjsm.2009.067884; LaPrade RF, 2014, BRIT J SPORT MED, V48, P4, DOI 10.1136/bjsports-2013-093020; LeBlanc Kim Edward, 2003, Hernia, V7, P68, DOI 10.1007/s10029-002-0105-x; Lynch SA, 1999, SPORTS MED, V28, P137, DOI 10.2165/00007256-199928020-00006; MacCormick L, 2014, ORTHOP J SPORTS MED, V2, DOI 10.1177/2325967113518181; Macpherson A, 2006, PEDIATRICS, V117, pE143, DOI 10.1542/peds.2005-1163; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Marchie A, 2003, CAN MED ASSOC J, V169, P124; Matic GT, 2015, PHYSICIAN SPORTSMED, V43, P119, DOI 10.1080/00913847.2015.1035210; McFaull S., 2001, CHIRPP NEWS, V19, P1; Mckay CD, 2014, CAN J PUBLIC HEALTH, V105, pE445, DOI 10.17269/cjph.105.4653; Meyers WC, 2008, ANN SURG, V248, P656, DOI 10.1097/SLA.0b013e318187a770; Molsa J, 2003, AM J SPORT MED, V31, P751; Molsa J, 1997, AM J SPORT MED, V25, P495, DOI 10.1177/036354659702500412; Morelli V, 2001, AM FAM PHYSICIAN, V64, P1405; Moslener MD, 2010, CURR SPORT MED REP, V9, P134, DOI 10.1249/JSR.0b013e3181dfccd9; Muschaweck U, 2010, SPORTS HEALTH, V2, P216, DOI 10.1177/1941738110367623; Nauth A, 2014, ORTHOP J SPORTS MED; PASHBY TJ, 1992, CAN J OPHTHALMOL, V27, P226; Philippon MJ, 2013, AM J SPORT MED, V41, P1357, DOI 10.1177/0363546513483448; Pinto M, 1999, CLIN J SPORT MED, V9, P70, DOI 10.1097/00042752-199904000-00005; Polites SF, 2014, PEDIATRICS, V133, pE1601, DOI 10.1542/peds.2013-3628; REYNEN PD, 1994, AM J SPORT MED, V22, P167, DOI 10.1177/036354659402200203; Roberts WO, 1996, ARCH PEDIAT ADOL MED, V150, P140, DOI 10.1001/archpedi.1996.02170270022003; Roberts WO, 1999, MED SCI SPORT EXER, V31, P46, DOI 10.1097/00005768-199901000-00009; Ross JR, 2015, ARTHROSCOPY, V31, P635, DOI 10.1016/j.arthro.2014.10.010; Shindle MK, 2010, CURR OPIN PEDIATR, V22, P54, DOI 10.1097/MOP.0b013e3283350f32; SIMONET WT, 1995, J TRAUMA, V38, P30, DOI 10.1097/00005373-199501000-00009; Small EW, 2007, PEDIATRICS, V119, P1242, DOI 10.1542/peds.2007-0887; Smith A, 2009, J ASTM INT, V6, P1; Smith AM, 2015, CURR SPORT MED REP, V14, P135, DOI 10.1249/JSR.0000000000000132; Smith AM, 2011, CLIN J SPORT MED, V21, P281, DOI 10.1097/JSM.0b013e318225bc15; Smith DV, 2010, CURR SPORT MED REP, V9, P278, DOI 10.1249/JSR.0b013e3181f310e9; STUART MJ, 1995, MAYO CLIN PROC, V70, P350, DOI 10.4065/70.4.350; STUART MJ, 1995, AM J SPORT MED, V23, P458, DOI 10.1177/036354659502300415; Stuart MJ, 2002, AM J SPORT MED, V30, P39, DOI 10.1177/03635465020300012001; Stull JD, 2011, AM J SPORT MED, V39, p29S, DOI 10.1177/0363546511414012; Swenson DM, 2012, AM J SPORT MED, V40, P2078, DOI 10.1177/0363546512453304; Swenson DM, 2010, CLIN J SPORT MED, V20, P293, DOI 10.1097/JSM.0b013e3181e8fae8; TATOR CH, 1991, CAN J SURG, V34, P63; Tator CH, 2016, CLIN J SPORT MED, V26, P232, DOI 10.1097/JSM.0000000000000232; Tlougan BE, 2011, SPORTS MED, V41, P967, DOI 10.2165/11592190-000000000-00000; Tyler TF, 2010, SPORTS HEALTH, V2, P231, DOI 10.1177/1941738110366820; Vartiainen MV, 2015, SCAND J MED SCI SPOR, V25, pe327, DOI 10.1111/sms.12307; Vaughan G., 1996, PUCK STARTS HERE ORI; VAZ EW, 1982, PROFESSIONALIZATION; Veenema KR, 1999, PHYSICIAN SPORTSMED, V27, P62, DOI 10.3810/psm.1999.08.950; Waite BL, 2008, PHYS MED REHABIL CLI, V19, P305, DOI 10.1016/j.pmr.2007.12.005; Warsh JM, 2009, CLIN J SPORT MED, V19, P134, DOI 10.1097/JSM.0b013e3181987783; Watson RC, 1997, CLIN J SPORT MED, V7, P192, DOI 10.1097/00042752-199707000-00007; Wennberg R, 2005, CLIN J SPORT MED, V15, P67, DOI 10.1097/01.jsm.0000152712.27968.fe; Willer B, 2005, MED SCI SPORT EXER, V37, P1658, DOI 10.1249/01.mss.0000181839.86170.06; WOO SLY, 1987, J BONE JOINT SURG AM, V69A, P1200, DOI 10.2106/00004623-198769080-00014; Wright RW, 2004, AM J SPORT MED, V32, P1941, DOI 10.1177/0363546504264581; Zoga AC, 2008, RADIOLOGY, V247, P797, DOI 10.1148/radiol.2473070049	86	11	11	1	11	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1179-1543			OPEN ACCESS J SPORTS	Open Access J. Sports Med.		2016	7						167	176		10.2147/OAJSM.S118595			10	Sport Sciences	Sport Sciences	ET0EJ	WOS:000399934400003	27920584	DOAJ Gold, Green Published			2021-06-18	
J	Rushby, JA; McDonald, S; Fisher, AC; Kornfeld, EJ; De Blasio, FM; Parks, N; Piguet, O				Rushby, Jacqueline A.; McDonald, Skye; Fisher, Alana C.; Kornfeld, Emma J.; De Blasio, Frances M.; Parks, Nicklas; Piguet, Olivier			Brain volume loss contributes to arousal and empathy dysregulation following severe traumatic brain injury	NEUROIMAGE-CLINICAL			English	Article						Brain volume loss; Limbic system; Physiological arousal; Empathy; Severe traumatic brain injury	FALSE DISCOVERY RATE; NEURAL BASIS; MODERATE; VETERANS; BEHAVIOR; DEFICITS; FMRI	Severe traumatic brain injury (TBI) often leads to deficits in physiological arousal and empathy, which are thought to be linked. This study examined whether injury-related brain volume loss in key limbic system structures is associated with these deficits. Twenty-four adults with TBI and 24 matched Controls underwent MRI scans to establish grey matter volumes in the amygdala, thalamus, and hippocampus. EEG and skin conductance levels were recorded to index basal physiological arousal. Self-report emotional empathy levels were also assessed. The TBI group had reduced brain volumes, topographic alpha differences, and lower emotional empathy compared to Controls. Regional brain volumes were differentially correlated to arousal and self-report empathy. Importantly, lower volume in pertinent brain structures correlated with lower empathy, for participants with and without TBI. Overall we provide new insights into empathic processes after TBI and their relationship to brain volume loss. (C) 2016 The Authors. Published by Elsevier Inc.	[Rushby, Jacqueline A.; McDonald, Skye; Fisher, Alana C.; Kornfeld, Emma J.; De Blasio, Frances M.; Parks, Nicklas] Univ New South Wales, Sch Psychol, Sydney, NSW 2052, Australia; [Piguet, Olivier] Neurosci Res Australia, Sydney, NSW 2031, Australia; [Piguet, Olivier] UNSW, Sch Med Sci, Sydney, NSW 2052, Australia; [Piguet, Olivier] Ctr Excellence Cognit & Its Disorders, Sydney, NSW 2052, Australia	Rushby, JA (corresponding author), Univ New South Wales, Sch Psychol, Sydney, NSW 2052, Australia.	j.rushby@unsw.edu.au	De Blasio, Frances M./D-9158-2019; Fisher, Alana/T-1869-2019; Rushby, Jacqueline/D-1820-2010; Piguet, Olivier/C-9658-2011	De Blasio, Frances M./0000-0003-1442-9820; Kornfeld, Emma/0000-0002-8877-3686; Rushby, Jacqueline/0000-0002-5018-638X; Fisher, Alana/0000-0002-6027-659X; Piguet, Olivier/0000-0002-6696-1440			Alway Y, 2016, PSYCHOL MED, V46, P1331, DOI 10.1017/S0033291715002986; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Barry RJ, 2005, CLIN NEUROPHYSIOL, V116, P2693, DOI 10.1016/j.clinph.2005.08.008; Barry RJ, 2008, BIOL PSYCHOL, V77, P304, DOI 10.1016/j.biopsycho.2007.11.002; Barry RJ, 2007, CLIN NEUROPHYSIOL, V118, P2765, DOI 10.1016/j.clinph.2007.07.028; Beadle JN, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00069; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Carr L, 2003, P NATL ACAD SCI USA, V100, P5497, DOI 10.1073/pnas.0935845100; D'Orazio DM, 2004, SEX ABUSE-J RES TR, V16, P173, DOI 10.1177/107906320401600207; Davis M.H, 1980, J PERS SOC PSYCHOL, V10, P85; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; de Sousa A, 2012, J CLIN EXP NEUROPSYC, V34, P606, DOI 10.1080/13803395.2012.667067; de Sousa A, 2011, CORTEX, V47, P526, DOI 10.1016/j.cortex.2010.02.004; de Sousa A, 2010, NEUROPSYCHOLOGIA, V48, P3585, DOI 10.1016/j.neuropsychologia.2010.08.008; Detari L, 2000, BEHAV BRAIN RES, V115, P159, DOI 10.1016/S0166-4328(00)00256-4; Driscoll DM, 2012, COGN BEHAV NEUROL, V25, P160, DOI 10.1097/WNN.0b013e318280cf4e; EISENBERG N, 1990, MOTIV EMOTION, V14, P131, DOI 10.1007/BF00991640; Fearing MA, 2008, J CHILD NEUROL, V23, P729, DOI 10.1177/0883073808314159; Fisher AC, 2015, CLIN NEUROPHYSIOL, V126, P314, DOI 10.1016/j.clinph.2014.05.033; Glickman ME, 2014, J CLIN EPIDEMIOL, V67, P850, DOI 10.1016/j.jclinepi.2014.03.012; KINSELLA G, 1988, PSYCHOL MED, V18, P57, DOI 10.1017/S0033291700001884; Kumaran D, 2005, J NEUROSCI, V25, P7254, DOI 10.1523/JNEUROSCI.1103-05.2005; Larson CL, 1998, PSYCHOPHYSIOLOGY, V35, P162, DOI 10.1017/S0048577298001620; Leigh R, 2013, BRAIN, V136, P2539, DOI 10.1093/brain/awt177; Leunissen I, 2014, CORTEX, V51, P67, DOI 10.1016/j.cortex.2013.10.009; Little DM, 2010, NEUROLOGY, V74, P558, DOI 10.1212/WNL.0b013e3181cff5d5; Mehrabian A., 2000, MANUAL BALANCED EMOT; Muller F, 2010, CORTEX, V46, P1088, DOI 10.1016/j.cortex.2009.08.014; Neumann D, 2012, ARCH PHYS MED REHAB, V93, P1414, DOI 10.1016/j.apmr.2012.03.009; Newsome MR, 2013, J INT NEUROPSYCH SOC, V19, P911, DOI 10.1017/S1355617713000817; Perry RJ, 2001, NEUROCASE, V7, P145, DOI 10.1093/neucas/7.2.145; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Rankin KP, 2006, BRAIN, V129, P2945, DOI 10.1093/brain/awl254; Rubin RD, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00742; Rushby JA, 2013, INT J PSYCHOPHYSIOL, V89, P460, DOI 10.1016/j.ijpsycho.2013.05.009; Rushby JA, 2013, INT J PSYCHOPHYSIOL, V89, P466, DOI 10.1016/j.ijpsycho.2013.06.013; Schnell K, 2011, NEUROIMAGE, V54, P1743, DOI 10.1016/j.neuroimage.2010.08.024; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Steriade M, 2006, NEUROSCIENCE, V137, P1087, DOI 10.1016/j.neuroscience.2005.10.029; Tabachnick B.G., 2012, USING MULTIVARIATE S; Tate DF, 2000, LEARN MEMORY, V7, P442, DOI 10.1101/lm.33000; Wilde EA, 2015, BRAIN IMAGING BEHAV, V9, P367, DOI 10.1007/s11682-015-9444-y; Williams C, 2010, J CLIN EXP NEUROPSYC, V32, P259, DOI 10.1080/13803390902976940; Williams LM, 2001, NEUROIMAGE, V14, P1070, DOI 10.1006/nimg.2001.0904; Wood RL, 2008, J INT NEUROPSYCH SOC, V14, P289, DOI 10.1017/S1355617708080326	47	11	12	0	10	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2016	12						607	614		10.1016/j.nicl.2016.09.017			8	Neuroimaging	Neurosciences & Neurology	EF3AI	WOS:000390196400069	27709066	DOAJ Gold, Green Published			2021-06-18	
J	Sabre, L; Tomberg, T; Korv, J; Kepler, J; Kepler, K; Linnamagi, U; Asser, T				Sabre, L.; Tomberg, T.; Korv, J.; Kepler, J.; Kepler, K.; Linnamaegi, Ue; Asser, T.			Brain activation in the chronic phase of traumatic spinal cord injury	SPINAL CORD			English	Article							SYSTEM; PLASTICITY; REPAIR	Study design: Cross-sectional clinical study. Objectives: Plastic changes within cortical areas occur after traumatic spinal cord injury (TSCI). The aim of the study was to assess cortical activation in the chronic phase of TSCI using functional magnetic resonance imaging (fMRI). Setting: Tartu University Hospital, Tartu, Estonia. Methods: Ten right-handed patients with paraplegia and 18 healthy controls were studied by fMRI. Individuals performed simple flexion/extension of the right hand fingers and the right ankle during fMRI. The activation volumes, maximum t values (T max) and centres of gravity (COG) were calculated. Results: The mean time since trauma was 1848 +/- 1046 days (range 388-4459). During hand movements, the volume of activation (VOA) in the contralateral primary motor cortex was significantly larger among the TSCI patients who did not recover compared with the controls (4112 vs 2777, P=0.02). The VOA did not enlarge during the ankle movements (2420 vs 1114, P=0.08). There was a significant relationship between the VOA in Brodmann area 4 (BA4) and American Spinal Injury Association motor score during hand movements (r=-0.67, P=0.03). A positive correlation was found during hand movements in the VOA of BA4 and time since injury (r=0.62, P=0.05). Conclusions: We found increased cortical activation in the chronic phase of thoraco-lumbar TSCI that may be caused by increased use of upper limbs.	[Sabre, L.; Tomberg, T.; Korv, J.; Linnamaegi, Ue; Asser, T.] Univ Tartu, Dept Neurol & Neurosurg, 8L Puusepa St, EE-51014 Tartu, Estonia; [Tomberg, T.] Tartu Univ Hosp, Radiol Clin, Tartu, Estonia; [Kepler, J.] Parnu Hosp, Med Technol Serv, Parnu, Estonia; [Kepler, K.] Univ Tartu, Inst Phys, EE-51014 Tartu, Estonia	Sabre, L (corresponding author), Univ Tartu, Dept Neurol & Neurosurg, 8L Puusepa St, EE-51014 Tartu, Estonia.	liis.sabre@kliinikum.ee	Korv, Janika/I-4395-2015; Sabre, Liis/D-7931-2014	Korv, Janika/0000-0002-6074-0727; Sabre, Liis/0000-0002-5727-8404	Estonian Science Foundation [7868]; Estonian Institutional Research grant [IUT2-4]	The study was supported by the Estonian Science Foundation research grant No. 7868 and by the Estonian Institutional Research grant IUT2-4.	Brett M, 2002, NEUROIMAGE, V16, P497, DOI DOI 10.1016/S1053-8119(02)90010-8; Bruehlmeier M, 1998, EUR J NEUROSCI, V10, P3918, DOI 10.1046/j.1460-9568.1998.00454.x; Cadotte DW, 2013, NAT REV NEUROL, V9, P546, DOI 10.1038/nrneurol.2013.190; Chen R, 2002, NEUROSCIENCE, V111, P761, DOI 10.1016/S0306-4522(02)00025-8; Cramer SC, 2005, BRAIN, V128, P2941, DOI 10.1093/brain/awh648; Curt A, 2002, BRAIN, V125, P2567, DOI 10.1093/brain/awf250; Dietz V, 2006, LANCET NEUROL, V5, P688, DOI 10.1016/S1474-4422(06)70522-1; Ding YM, 2005, CURR PHARM DESIGN, V11, P1441, DOI 10.2174/1381612053507855; Freund P, 2011, BRAIN, V134, P1610, DOI 10.1093/brain/awr093; Furkiewicz MT, 2007, NEUROREHAB NEURAL RE, V21, P527, DOI 10.1177/1545968307301872; Gustin SM, 2010, CEREB CORTEX, V20, P1409, DOI 10.1093/cercor/bhp205; Halder P, 2006, NEUROIMAGE, V31, P692, DOI 10.1016/j.neuroimage.2005.12.018; Jurkiewicz MT, 2010, NEUROREHAB NEURAL RE, V24, P136, DOI 10.1177/1545968309347680; Kokotilo KJ, 2009, J NEUROTRAUM, V26, P2113, DOI 10.1089/neu.2008.0688; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; Pascual-Leone A, 2005, ANNU REV NEUROSCI, V28, P377, DOI 10.1146/annurev.neuro.27.070203.144216; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; Sabbah P, 2002, J NEUROTRAUM, V19, P53, DOI 10.1089/089771502753460231; Sabre L, 2013, SPINAL CORD, V51, P623, DOI 10.1038/sc.2013.41; Sabre L, 2012, SPINAL CORD, V50, P755, DOI 10.1038/sc.2012.54	20	11	11	1	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1362-4393	1476-5624		SPINAL CORD	Spinal Cord	JAN	2016	54	1					65	68		10.1038/sc.2015.158			4	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	DD1VJ	WOS:000369710400012	26391190	Bronze			2021-06-18	
J	Spilman, PR; Corset, V; Gorostiza, O; Poksay, KS; Galvan, V; Zhang, J; Rao, R; Peters-Libeu, C; Vincelette, J; McGeehan, A; Dvorak-Ewell, M; Beyer, J; Campagna, J; Bankiewicz, K; Mehlen, P; John, V; Bredesen, DE				Spilman, Patricia R.; Corset, Veronique; Gorostiza, Olivia; Poksay, Karen S.; Galvan, Veronica; Zhang, Junli; Rao, Rammohan; Peters-Libeu, Clare; Vincelette, Jon; McGeehan, Andrew; Dvorak-Ewell, Melita; Beyer, Janine; Campagna, Jesus; Bankiewicz, Krystof; Mehlen, Patrick; John, Varghese; Bredesen, Dale E.			Netrin-1 Interrupts Amyloid-beta Amplification, Increases sA beta PP alpha in vitro and in vivo, and Improves Cognition in a Mouse Model of Alzheimer's Disease	JOURNAL OF ALZHEIMERS DISEASE			English	Article						A beta(1-42); A beta PP; amplification; CED; inducible; mimetic; netrin-1; sA beta PP alpha	CONVECTION-ENHANCED DELIVERY; TRAUMATIC BRAIN-INJURY; PRECURSOR PROTEIN; NEURODEGENERATIVE DISEASES; ADENOASSOCIATED VIRUS; MONOCLONAL-ANTIBODY; SECRETASE CLEAVAGE; TRANSGENIC MICE; NEURON DEATH; CELL-DEATH	Recent studies have shown that inoculation of susceptible mice with amyloid-beta (A beta) peptides accelerates A beta deposition in the brain, supporting the idea that A beta may be self-amplifying; however, the exact mechanism is not understood. Here we provide evidence that A beta may self-amplify, in part, by inhibiting alpha-secretase ADAM10 (a disintegrin and metalloprotease) cleavage of full-length A beta precursor protein (FLA beta PP) and therefore allow greater beta-secretase processing, and that A beta itself is a substrate for ADAM10. Exposure of primary neuronal cultures from PD Lambda beta PP mice to exogenous rat A beta(1-40) resulted in increased de novo human A beta(1-42) production and exposure of cells to A beta decreased production of ADAM10 cleavage product soluble A beta PP alpha (sA beta PP alpha). In a cell-free assay, A beta decreased ADAM10 cleavage of the chimeric substrate MBP-A beta PPC125 and A beta itself was apparently cleaved by the enzyme. The axonal guidance and trophic factor netrin-1, however, reduced the A beta(1-4)0-induced A beta(1-42) increase, increased sA beta PP alpha, and reversed the A beta-induced sA beta PP alpha decrease in vitro. In vivo, induction of netrin-1 expression in PDA beta PPSwe/Ind transgenic mice resulted in reductions in both A beta(1-42) and A beta(1-40), and ICV delivery of netrin-1 to PDA beta PPSwe/Ind mice increased sA beta PP alpha, decreased A beta, and improved working memory. Finally, to support further study of netrin-1's potential as a therapeutic for Alzheimer's disease, pilot gene therapy studies were performed and a netrin mimetic peptide synthesized and tested that, like netrin, can increase sA beta PP alpha and decrease A beta(1-42) in vitro. Taken together, these data provide mechanistic insights into A beta self-amplification and the ability of netrin-1 to disrupt it.	[Spilman, Patricia R.; Corset, Veronique; Gorostiza, Olivia; Poksay, Karen S.; Galvan, Veronica; Zhang, Junli; Rao, Rammohan; Peters-Libeu, Clare; Campagna, Jesus; John, Varghese; Bredesen, Dale E.] Buck Inst Res Aging, 8001 Redwood Blvd, Novato, CA 94945 USA; [Corset, Veronique; Mehlen, Patrick] Univ Lyon, Ctr Canc, Apoptosis Canc & Dev Lab, Ctr Leon Berard, Lyon, France; [Gorostiza, Olivia; Vincelette, Jon; McGeehan, Andrew; Dvorak-Ewell, Melita] Biomarin Pharmaceut, Novato, CA USA; [Spilman, Patricia R.; Campagna, Jesus; John, Varghese; Bredesen, Dale E.] Univ Calif Los Angeles, Dept Neurol, Drug Discovery Lab, Los Angeles, CA 90024 USA; [Spilman, Patricia R.; Campagna, Jesus; John, Varghese; Bredesen, Dale E.] Univ Calif Los Angeles, Easton Ctr AD Res, Los Angeles, CA USA; [Beyer, Janine; Bankiewicz, Krystof] Univ Calif San Francisco, Dept Neurol Surg, Lab Translat Neurosci Res, San Francisco, CA USA; [Galvan, Veronica] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, Barshop Inst Longev & Aging Studies, Nathan Shock Aging Ctr, San Antonio, TX 78229 USA; [Zhang, Junli] Gladstone Inst, San Francisco, CA USA; [Dvorak-Ewell, Melita] Ultragenyx, Novato, CA USA	Bredesen, DE (corresponding author), Buck Inst Res Aging, 8001 Redwood Blvd, Novato, CA 94945 USA.	dbredesen@buckinstitute.org			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [AG12282]; Douglas and Ellen Rosenberg Foundation; Joseph Drown Foundation; BioMarin, Inc.; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG012282, P30AG013319] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01BX002211] Funding Source: NIH RePORTER	This work was supported by the NIH (AG12282 to D.E.B.), the Douglas and Ellen Rosenberg Foundation, the Joseph Drown Foundation, and BioMarin, Inc.	Barger SW, 1996, MOL BRAIN RES, V40, P116; Barua NU, 2013, J NEUROSCI METH, V220, P1, DOI 10.1016/j.jneumeth.2013.08.011; Bertrand E, 2001, MOL CELL NEUROSCI, V18, P503, DOI 10.1006/mcne.2001.1030; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; Bredesen DE, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-27; Cheng X, 2014, DRUG DISCOV TODAY, V19, P1822, DOI 10.1016/j.drudis.2014.06.029; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; de la Monte SM, 2014, BIOCHEM PHARMACOL, V88, P548, DOI 10.1016/j.bcp.2013.12.012; Dickson DW, 1997, AM J PATHOL, V151, P7; Domert J, 2014, NEUROBIOL DIS, V65, P82, DOI 10.1016/j.nbd.2013.12.019; Eichler J, 1997, PROTEIN PEPTIDE LETT, V4, P157; Eisele YS, 2009, P NATL ACAD SCI USA, V106, P12926, DOI 10.1073/pnas.0903200106; Fan YF, 2008, J CEREBR BLOOD F MET, V28, P1543, DOI 10.1038/jcbfm.2008.39; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; GOEDERT M, 1993, TRENDS NEUROSCI, V16, P460, DOI 10.1016/0166-2236(93)90078-Z; Goldman JS, 2013, J NEUROSCI, V33, P17278, DOI 10.1523/JNEUROSCI.1085-13.2013; Grad LI, 2014, PRION, V8, P33, DOI 10.4161/pri.27602; Guo JL, 2011, J BIOL CHEM, V286, P15317; Hamaguchi T, 2012, ACTA NEUROPATHOL, V123, P31, DOI 10.1007/s00401-011-0912-1; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; Harris JA, 2010, NEURON, V68, P428, DOI 10.1016/j.neuron.2010.10.020; He XY, 2007, J NEUROSCI, V27, P4052, DOI 10.1523/JNEUROSCI.3993-06.2007; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; IKEDA S, 1987, LAB INVEST, V57, P446; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Kim S, 2015, ELIFE, V4, DOI 10.7554/eLife.04158; Langer F, 2011, J NEUROSCI, V31, P14488, DOI 10.1523/JNEUROSCI.3088-11.2011; Liao SJ, 2013, NEUROSCIENCE, V231, P225, DOI 10.1016/j.neuroscience.2012.11.059; Liberski Pawel P, 2014, Parkinsonism Relat Disord, V20 Suppl 1, pS80, DOI 10.1016/S1353-8020(13)70021-X; Libeu CP, 2011, J ALZHEIMERS DIS, V25, P547, DOI 10.3233/JAD-2011-101938; Lonser RR, 2015, J NEUROSURG, V122, P697, DOI 10.3171/2014.10.JNS14229; Lourenco FC, 2009, CELL DEATH DIFFER, V16, P655, DOI 10.1038/cdd.2008.191; Lu DC, 2000, NAT MED, V6, P397; Lu DC, 2003, ANN NEUROL, V54, P781, DOI 10.1002/ana.10761; Marklund N, 2014, J NEUROTRAUM, V31, P42, DOI 10.1089/neu.2013.2964; Matsushita T, 1998, GENE THER, V5, P938, DOI 10.1038/sj.gt.3300680; Mellott TJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094287; Mougenot AL, 2012, NEUROBIOL AGING, V33, P2225, DOI 10.1016/j.neurobiolaging.2011.06.022; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Munch C, 2011, P NATL ACAD SCI USA, V108, P3548, DOI 10.1073/pnas.1017275108; Nagahara AH, 2009, NAT MED, V15, P331, DOI 10.1038/nm.1912; Narkiewicz J, 2014, PRION, V8, P19, DOI 10.4161/pri.28125; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Obregon D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1781; Park SA, 2009, BIOCHEM BIOPH RES CO, V388, P450, DOI 10.1016/j.bbrc.2009.08.042; Peters-Libeu C, 2015, J ALZHEIMERS DIS, V47, P545, DOI 10.3233/JAD-150282; Popa-Wagner A, 2015, J NEURAL TRANSM, V122, P47, DOI 10.1007/s00702-013-1129-3; Rama N, 2012, J BIOL CHEM, V287, P30014, DOI 10.1074/jbc.M111.324780; Rosenbluth KH, 2011, J NEUROSCI METH, V196, P118, DOI 10.1016/j.jneumeth.2010.12.022; Selkoe DJ, 1996, ANN NY ACAD SCI, V777, P57, DOI 10.1111/j.1749-6632.1996.tb34401.x; Shaked GM, 2006, FASEB J, V20, P1254, DOI 10.1096/fj.05-5032fje; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Sivanandam TM, 2012, NEUROSCI BIOBEHAV R, V36, P1376, DOI 10.1016/j.neubiorev.2012.02.013; Steinacker P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023600; Stohr J, 2012, P NATL ACAD SCI USA, V109, P11025, DOI 10.1073/pnas.1206555109; Tian YA, 2010, J BIOL CHEM, V285, P32549, DOI 10.1074/jbc.M110.128439; Tuszynski MH, 2015, JAMA NEUROL, V72, P1139, DOI 10.1001/jamaneurol.2015.1807; Utomo ARH, 1999, NAT BIOTECHNOL, V17, P1091; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Volpicelli-Daley LA, 2011, NEURON, V72, P57, DOI 10.1016/j.neuron.2011.08.033; Wen JF, 2014, EXP THER MED, V8, P881, DOI 10.3892/etm.2014.1818; Wetzel-Smith MK, 2014, NAT MED, V20, P1452, DOI 10.1038/nm.3736; Wright JF, 2003, CURR OPIN DRUG DI DE, V6, P174; Xia WM, 1998, BIOCHEMISTRY-US, V37, P16465, DOI 10.1021/bi9816195; Yang AJ, 1999, J BIOL CHEM, V274, P20650, DOI 10.1074/jbc.274.29.20650; Yin RH, 2014, CURR ALZHEIMER RES, V11, P755, DOI 10.2174/156720501108140910121425	68	11	13	1	15	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1387-2877	1875-8908		J ALZHEIMERS DIS	J. Alzheimers Dis.		2016	52	1					223	242		10.3233/JAD-151046			20	Neurosciences	Neurosciences & Neurology	DK6CK	WOS:000375008500021	27060954				2021-06-18	
J	Sullivan, KA; Lange, RT; Edmed, SL				Sullivan, Karen A.; Lange, Rael T.; Edmed, Shannon L.			Utility of the Neurobehavioral Symptom Inventory Validity-10 index to detect symptom exaggeration: An analogue simulation study	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						Diagnostic efficiency; Neurobehavioral Symptom Inventory; sensitivity; specificity; symptom exaggeration	TRAUMATIC BRAIN-INJURY; POSTCONCUSSIVE SYMPTOMS; TEST-PERFORMANCE; SCALE; VETERANS	The Neurobehavioral Symptom Inventory (NSI) has been recommended by the interagency Traumatic Brain Injury (TBI) Outcome Workgroup as an outcome measure for TBI research. A new symptom exaggeration indexthe NSI Validity-10can be calculated from its items, but its utility has not been evaluated in a malingering simulation study. Data from a prior analogue study were reanalyzed to examine the NSI Validity-10 test properties. The data were from a sample of 85 Australian undergraduate students. A battery of measures was completed under 1 of 3 experimental conditions: control (i.e., honest responding, n=24), feign postconcussional disorder (PCD; n=29), and feign posttraumatic stress disorder (PTSD; n=32). Participants who feigned PTSD or PCD had significantly higher scores on the NSI Validity-10 compared with controls. There were minimal differences between the 2 feigning groups. Using the combined data from the feigning groups and assuming a 35% symptom exaggeration base rate, the optimal NSI Validity-10 cutoff score was 10. This cutoff score identified probable exaggeration (sensitivity=.75, specificity=1.0, positive predictive power=1.0, negative predictive power=.88). Diagnostic efficiency statistics for 25% and 45% base rates were also generated. The cutoff score identified in this study is lower than previously reported. Its properties are promising, but its usage requires careful consideration.	[Sullivan, Karen A.; Edmed, Shannon L.] Queensland Univ Technol, Sch Psychol & Counselling, Clin Neuropsychol Res Grp, Brisbane, Qld, Australia; [Sullivan, Karen A.; Edmed, Shannon L.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld, Australia; [Lange, Rael T.] Def & Vet Brain Injury Ctr, Bethesda, MD USA; [Lange, Rael T.] Walter Reed Natl Mil Med Ctr, Bethesda, MD USA; [Lange, Rael T.] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada	Sullivan, KA (corresponding author), Queensland Univ Technol, Sch Psychol & Counselling, O Block B Wing,Kelvin Grove Campus,Victoria Pk Rd, Kelvin Grove, Qld 4059, Australia.	karen.sullivan@qut.edu.au			School of Psychology and Counselling, Queensland University of Technology	Funding for this project was provided by the School of Psychology and Counselling, Queensland University of Technology.	Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; Ben-Porath Y. S., 2008, MINNESOTA MULTIPHASI; Caplan LJ, 2010, J HEAD TRAUMA REHAB, V25, P447, DOI 10.1097/HTR.0b013e3181d5bdbd; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Cooper DB, 2011, ARCH CLIN NEUROPSYCH, V26, P718, DOI 10.1093/arclin/acr070; Finn S. E., 2009, OXFORD HDB PERSONALI, P140; Gervais RO, 2010, ARCH CLIN NEUROPSYCH, V25, P274, DOI 10.1093/arclin/acq018; Gizzi M, 2003, J HEAD TRAUMA REHAB, V18, P398, DOI 10.1097/00001199-200309000-00002; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Iverson G.L., 2007, BRAIN INJURY MED PRI, P373; Iverson GL, 2003, HANDBOOK OF FORENSIC NEUROPSYCHOLOGY, P137; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Lange RT, 2015, J CLIN EXP NEUROPSYC, V37, P853, DOI 10.1080/13803395.2015.1064864; Lange RT, 2015, J CLIN EXP NEUROPSYC, V37, P325, DOI 10.1080/13803395.2015.1013021; Lange RT, 2013, J CLIN EXP NEUROPSYC, V35, P192, DOI 10.1080/13803395.2012.761677; Lange RT, 2012, J CLIN EXP NEUROPSYC, V34, P453, DOI 10.1080/13803395.2011.648175; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2009, CLIN NEUROPSYCHOL, V23, P746, DOI 10.1080/13854040802696829; Logan B. W., 2014, BEHAV SCI LAW, V31, P803, DOI [10.1002/bsl/2092, DOI 10.1002/BSL/2092]; Meterko M, 2012, J HEAD TRAUMA REHAB, V27, P55, DOI 10.1097/HTR.0b013e318230fb17; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Morey L. C., 1991, PERSONALITY ASSESSME; Nelson NW, 2010, ARCH CLIN NEUROPSYCH, V25, P713, DOI 10.1093/arclin/acq075; Rogers R., 2008, CLIN ASSESSMENT MALI, P411; Soble JR, 2014, CLIN NEUROPSYCHOL, V28, P614, DOI 10.1080/13854046.2014.894576; Streiner DL, 2003, J PERS ASSESS, V81, P209, DOI 10.1207/S15327752JPA8103_03; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e; Whitney KA, 2010, APPL NEUROPSYCHOL, V17, P196, DOI 10.1080/09084282.2010.499787; Whitney KA, 2009, ARCH CLIN NEUROPSYCH, V24, P145, DOI 10.1093/arclin/acp020; Widows M. R., 2005, STRUCTURED INVENTORY; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033	32	11	11	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult		2016	23	5					353	362		10.1080/23279095.2015.1079714			10	Clinical Neurology; Psychology	Neurosciences & Neurology; Psychology	DR8DX	WOS:000380129700006	26943718				2021-06-18	
J	Wang, YC; Fang, F; Wu, YK; Ai, XL; Lan, T; Liang, RC; Zhang, Y; Trishul, NM; He, M; You, C; Yu, C; Tan, H				Wang, Yan-Chao; Fang, Fang; Wu, Ying-Ke; Ai, Xiao-Lin; Lan, Ting; Liang, Rui-Chao; Zhang, Yu; Trishul, Narasimha Murthy; He, Min; You, Chao; Yu, Chuan; Tan, Hong			Waterborne biodegradable polyurethane 3-dimensional porous scaffold for rat cerebral tissue regeneration	RSC ADVANCES			English	Article							HYALURONIC-ACID HYDROGELS; NERVE REGENERATION; BRAIN; MODEL; FABRICATION; PROTEINS; REPAIR; NANOFIBERS; FIBERS; GROWTH	Rehabilitation from traumatic brain injury (TBI) is a significant challenge for neurosurgeons as no effective strategies for cerebral tissue reconstruction can be adopted in clinical applications. To explore an appropriate method for cerebral tissue regeneration, we developed a type of waterborne biodegradable polyurethane (WBPU) 3-dimentional (3D) porous scaffold. Two types of WBPU (WBPU17 and WBPU25) 3D scaffolds were prepared based on different molar content of poly ethylene glycol (PEG) within the scaffolds. The porosity of WBPU17 and WBPU25 scaffolds was 83.29% +/- 0.53% and 86.72% +/- 0.78%, respectively. The mean pore size of the WBPU17 and WBPU25 scaffolds was 20.10 mm and 22.18 mu m, respectively. No pronounced cytotoxicity was noticed for the rat glial cells when treated with degradation liquid of the WBPU17 and WBPU25 scaffold. Moreover, both the WBPU17 and WBPU25 scaffold treated groups showed stronger expression of neuronal growth associated protein (GAP43) and synaptophysin, indicating better nerve regeneration in the experiment groups compared to none in the scaffold control group in the rat TBI model. In addition, functional recovery also displayed a satisfactory result in the WBPU17 and WBPU25 scaffold treated groups. Overall, the WBPU25 scaffold had better performance than of the WBPU17 scaffold. The results of our experiments proved that the WBPU 3D porous scaffold, especially the WBPU25 scaffold, is a promising therapeutic implant for both cerebral tissue regeneration and neural functional recovery in TBI.	[Wang, Yan-Chao; Fang, Fang; Ai, Xiao-Lin; Liang, Rui-Chao; Trishul, Narasimha Murthy; He, Min; You, Chao] Sichuan Univ, West China Hosp, Dept Neurosurg, Chengdu 610041, Sichuan, Peoples R China; [Wu, Ying-Ke; Tan, Hong] Sichuan Univ, State Key Lab Polymer Mat Engn, Coll Polymer Sci & Engn, Chengdu 610065, Peoples R China; [Lan, Ting] Sichuan Univ, West China Hosp, Dept Pathol, Chengdu 610041, Sichuan, Peoples R China; [Zhang, Yu] Chengdu Univ, Clin Med Coll, Affiliated Hosp, Dept Neurosurg, Chengdu 610081, Sichuan, Peoples R China; [Yu, Chuan] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu 610041, Peoples R China; [Yu, Chuan] Sichuan Univ, West China Hosp, Ctr Canc, Chengdu 610041, Peoples R China	Wang, YC (corresponding author), Sichuan Univ, West China Hosp, Dept Neurosurg, Chengdu 610041, Sichuan, Peoples R China.	merrisn@hotmail.com; hongtan@scu.edu.cn	Yu, Chuan/AAC-1440-2019	Yanchao, Wang/0000-0001-7893-2412	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81100925, 81472361, 51273124, 51273126]; National Science Fund for Distinguished Young Scholars of ChinaNational Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars [51425305]	We would like to thank the financial support by the National Natural Science Foundation of China (contract/grant number: 81100925, 81472361, 51273124, 51273126) and the National Science Fund for Distinguished Young Scholars of China (contract/grant number: 51425305).	Ahmed AI, 2016, J ROY ARMY MED CORPS, V162, P98, DOI 10.1136/jramc-2015-000475; Algarrahi K, 2015, BIOMATERIALS, V53, P149, DOI 10.1016/j.biomaterials.2015.02.092; Aloe L, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-239; Andelic N, 2013, LANCET NEUROL, V12, P28, DOI 10.1016/S1474-4422(12)70294-6; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Carulli D, 2004, PROG NEUROBIOL, V72, P373, DOI 10.1016/j.pneurobio.2004.03.007; Chen G.-E., 2015, KOREAN J CHEM ENG, P1; Chew SY, 2007, ADV FUNCT MATER, V17, P1288, DOI 10.1002/adfm.200600441; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Ellis-Behnke RG, 2006, P NATL ACAD SCI USA, V103, P5054, DOI 10.1073/pnas.0600559103; Frey D, 2000, J CELL BIOL, V149, P1443, DOI 10.1083/jcb.149.7.1443; Gauthier-Kemper A, 2014, MOL BIOL CELL, V25, P3284, DOI 10.1091/mbc.E13-12-0737; George P., 2007, QINGCHUAN ZHUGE TRAN, V32; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Granseth B, 2007, J PHYSIOL-LONDON, V585, P681, DOI 10.1113/jphysiol.2007.139022; Hausner T, 2007, ACTA NEUROCHIR SUPPL, V100, P69; Hou SP, 2005, J NEUROSCI METH, V148, P60, DOI 10.1016/j.jneumeth.2005.04.016; Hou XE, 2000, NEUROCHEM RES, V25, P1275, DOI 10.1023/A:1007600313865; Janik H, 2015, MAT SCI ENG C-MATER, V48, P586, DOI 10.1016/j.msec.2014.12.037; Jiang X, 2010, J BIOMAT SCI-POLYM E, V21, P1637, DOI 10.1163/092050609X12525750021270; Kim JI, 2014, MAT SCI ENG C-MATER, V44, P52, DOI 10.1016/j.msec.2014.07.062; Machado LS, 2009, STROKE, V40, P3028, DOI 10.1161/STROKEAHA.109.556852; Mahat MYA, 2012, J NEUROSCI METH, V211, P272, DOI 10.1016/j.jneumeth.2012.09.013; Maitz M.F., 2015, BIOSURF BIOTRIBOL, V1, DOI [10.1016/j.bsbt.2015.08.002, DOI 10.1016/J.BSBT.2015.08.002]; MEBERG PJ, 1993, P NATL ACAD SCI USA, V90, P12050, DOI 10.1073/pnas.90.24.12050; Niemeier Janet P, 2015, N C Med J, V76, P105; Niu YQ, 2014, BIOMATERIALS, V35, P4266, DOI 10.1016/j.biomaterials.2014.02.013; Pang XM, 2014, J PHARMACOL TOX MET, V69, P217, DOI 10.1016/j.vascn.2014.01.001; Panseri S, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-39; Park KI, 2002, NAT BIOTECHNOL, V20, P1111, DOI 10.1038/nbt751; Piontek J, 2002, J NEUROSCI RES, V67, P471, DOI 10.1002/jnr.10094; Piper LC, 2015, JAMA SURG, V150, P1013, DOI 10.1001/jamasurg.2015.1838; Quigley AF, 2009, ADV MATER, V21, P4393, DOI 10.1002/adma.200901165; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Rosskothen-Kuhl N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092624; Saracino GAA, 2013, CHEM SOC REV, V42, P225, DOI 10.1039/c2cs35065c; Shin OH, 2014, COMPR PHYSIOL, V4, P149, DOI 10.1002/cphy.c130021; Stevenson AT, 2015, BIOMATERIALS, V54, P168, DOI 10.1016/j.biomaterials.2015.03.020; THIEL G, 1993, BRAIN PATHOL, V3, P87, DOI 10.1111/j.1750-3639.1993.tb00729.x; Tian WM, 2005, TISSUE ENG, V11, P513, DOI 10.1089/ten.2005.11.513; Wang W, 2008, J BIOMED MATER RES A, V85A, P919, DOI 10.1002/jbm.a.31522; Wang ZG, 2011, POLYM CHEM-UK, V2, P601, DOI 10.1039/c0py00235f; Wei YT, 2007, BIOMED MATER, V2, pS142, DOI 10.1088/1748-6041/2/3/S11; Xie JW, 2010, NANOSCALE, V2, P35, DOI 10.1039/b9nr00243j; Zhang H, 2007, ADV MATER, V19, P1529, DOI 10.1002/adma.200700154	45	11	13	3	47	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2046-2069			RSC ADV	RSC Adv.		2016	6	5					3840	3849		10.1039/c5ra20181k			10	Chemistry, Multidisciplinary	Chemistry	DC8ZF	WOS:000369508800054					2021-06-18	
J	Li, Y; Zhang, LY; Kallakuri, S; Cohen, A; Cavanaugh, JM				Li, Yan; Zhang, Liying; Kallakuri, Srinivasu; Cohen, Abigail; Cavanaugh, John M.			Correlation of mechanical impact responses and biomarker levels: A new model for biomarker evaluation in TBI	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						Traumatic brain injury; Rodent; Head impact kinematics; Cerebrospinal fluid biomarker; Serum biomarker, head impact acceleration model	TRAUMATIC BRAIN-INJURY; DIFFUSE AXONAL INJURY; NEURON-SPECIFIC ENOLASE; CEREBROSPINAL-FLUID; AMYLOID-BETA; NF-H; SERUM BIOMARKER; HEAD-INJURY; PROTEIN; S100B	A modified Marmarou impact acceleration model was used to help screen biomarkers to assess brain injury severity. Anesthetized male Sprague-Dawley rats were subjected to a closed head injury from 1.25, 1.75 and 2.25 m drop heights. Linear and angular responses of the head were measured in vivo. 24 h after impact, cerebrospinal fluid (CSF) and serum were collected. CSF and serum levels of phosphorylated neurofilament heavy (pNF-H), glial fibrillary acidic protein (GFAP), interleukin 6 (IL-6), and amyloid beta (A beta) 1-42 were assessed by enzyme-linked immunosorbent assay (ELISA). Compared to controls, significantly higher CSF and serum pNFH levels were observed in all impact groups, except between 1.25 m and control in serum. Furthermore, CSF and serum pNF-H levels were significantly different between the impact groups. For GFAP, both CSF and serum levels were significantly higher at 225 m compared to 1.75 m, 125 m and controls. There was no significant difference in CSF and serum GFAP levels between 1.75 m and 125 m, although both groups were significantly higher than control. TBI rats also showed significantly higher levels of IL-6 versus control in both CSF and serum, but no significant difference was observed between each impact group. Levels of A beta were not significantly different between groups. Pearson's correlation analysis showed pNF-H and GFAP levels in CSF and serum had positive correlation with power (rate of impact energy), followed by average linear acceleration and surface righting (p < 0.01), which were good predictors for traumatic axonal injury according to histologic assessment in our previous study, suggesting that they are directly related to the injury mechanism. The model used in this study showed a unique ability in elucidating the relationship between biomarker levels and severity of the mechanical trauma to the brain. (C) 2015 The Authors. Published by Elsevier B.V.	[Li, Yan; Zhang, Liying; Kallakuri, Srinivasu; Cohen, Abigail; Cavanaugh, John M.] Wayne State Univ, Dept Biomed Engn, Detroit, MI 48201 USA	Zhang, LY (corresponding author), Wayne State Univ, Dept Biomed Engn, 818 W Hancock St, Detroit, MI 48201 USA.	lzhang@wayne.edu			 [NIHR01EB006508]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R01EB006508] Funding Source: NIH RePORTER	This research was supported by NIHR01EB006508.	Abrahamson EE, 2006, EXP NEUROL, V197, P437, DOI 10.1016/j.expneurol.2005.10.011; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Ahmed F, 2012, ELECTROPHORESIS, V33, P3705, DOI 10.1002/elps.201200299; Anderson KJ, 2008, J NEUROTRAUM, V25, P1079, DOI 10.1089/neu.2007.0488; Bell MJ, 1997, J NEUROTRAUM, V14, P451, DOI 10.1089/neu.1997.14.451; Berger RP, 2009, PEDIATR RES, V65, P97, DOI 10.1203/PDR.0b013e31818c7e27; Berger RP, 2007, J NEUROTRAUM, V24, P1793, DOI 10.1089/neu.2007.0316; Berger RP, 2006, J HEAD TRAUMA REHAB, V21, P315, DOI 10.1097/00001199-200607000-00004; Berger RP, 2005, J NEUROSURG, V103, P61, DOI 10.3171/ped.2005.103.1.0061; Blennow K, 2011, ACTA NEUROL SCAND, V123, P245, DOI 10.1111/j.1600-0404.2010.01408.x; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Chen XH, 2004, AM J PATHOL, V165, P357, DOI 10.1016/S0002-9440(10)63303-2; Chiaretti A, 2005, CHILD NERV SYST, V21, P185, DOI 10.1007/s00381-004-1032-1; Csuka E, 1999, J NEUROIMMUNOL, V101, P211, DOI 10.1016/S0165-5728(99)00148-4; Dash PK, 2010, NEUROTHERAPEUTICS, V7, P100, DOI 10.1016/j.nurt.2009.10.019; DeKosky ST, 2007, ARCH NEUROL-CHICAGO, V64, P541, DOI 10.1001/archneur.64.4.541; Dilorenzo F.A., 1976, 760014 SAE; Gennarelli TA, 1998, NEUROSCIENTIST, V4, P202, DOI 10.1177/107385849800400316; Honda M, 2010, J TRAUMA, V69, P104, DOI 10.1097/TA.0b013e3181bbd485; Ingebrigtsen T, 2002, J TRAUMA, V52, P798, DOI 10.1097/00005373-200204000-00038; Li Yan, 2011, Stapp Car Crash J, V55, P25; Li Y, 2011, J NEUROTRAUM, V28, P1767, DOI 10.1089/neu.2010.1687; Liu L., 2008, JOVE-J VIS EXP, V10, P21; Lo TYM, 2009, J NEUROTRAUM, V26, P1479, DOI [10.1089/neu.2008.0753, 10.1089/neu.2008-0753]; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Marszalek JR, 1996, J CELL BIOL, V135, P711, DOI 10.1083/jcb.135.3.711; Masters CL, 2006, J NEUROCHEM, V97, P1700, DOI 10.1111/j.1471-4159.2006.03989.x; Metting Z, 2012, NEUROLOGY, V78, P1428, DOI 10.1212/WNL.0b013e318253d5c7; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Mondello S, 2011, EXPERT REV MOL DIAGN, V11, P65, DOI 10.1586/ERM.10.104; Newman J, 2000, P 44 STAPP CAR CRASH; Nylen K, 2006, J NEUROL SCI, V240, P85, DOI 10.1016/j.jns.2005.09.007; Olsson A, 2004, J NEUROL, V251, P870, DOI 10.1007/s00415-004-0451-y; Papa Linda, 2008, Expert Opin Med Diagn, V2, P937, DOI 10.1517/17530059.2.8.937; Pelinka LE, 2005, SHOCK, V24, P119, DOI 10.1097/01.shk.0000168876.68154.43; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Petrova TV, 2000, BRAIN RES, V853, P74, DOI 10.1016/S0006-8993(99)02251-9; Pierce JES, 1996, J NEUROSCI, V16, P1083; Pineda JA, 2004, BRAIN PATHOL, V14, P202, DOI 10.1111/j.1750-3639.2004.tb00054.x; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; PRICE DL, 1995, CURR OPIN NEUROL, V8, P268, DOI 10.1097/00019052-199508000-00004; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Sandler SJI, 2010, CHILD NERV SYST, V26, P205, DOI 10.1007/s00381-009-1009-1; Shaw G, 2005, BIOCHEM BIOPH RES CO, V336, P1268, DOI 10.1016/j.bbrc.2005.08.252; Shaw G, 1998, NEUROFILAMENTS; Siman R, 2004, NEUROBIOL DIS, V16, P311, DOI 10.1016/j.nbd.2004.03.016; Siman R, 2009, J NEUROTRAUM, V26, P1867, DOI 10.1089/neu.2009.0882; Smith DH, 1999, J NEUROPATH EXP NEUR, V58, P982, DOI 10.1097/00005072-199909000-00008; Stemberger LA, 1983, P NATL ACAD SCI USA, V80, P6126; Strong MJ, 2001, J NEUROCHEM, V76, P1315, DOI 10.1046/j.1471-4159.2001.00094.x; Tian LL, 2012, BRAIN RES, V1440, P47, DOI 10.1016/j.brainres.2011.12.059; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; Wang J, 2002, CURR TOP MICROBIOL, V265, P23; Wang KKW, 2005, EXPERT REV PROTEOMIC, V2, P603, DOI 10.1586/14789450.2.4.603; Winter CD, 2004, BRAIN, V127, P315, DOI 10.1093/brain/awh039; Woertgen C, 2002, ACT NEUR S, V81, P205; Ye MM, 2012, J NANOMATER, V2012, DOI 10.1155/2012/583417; Zemlan FP, 1999, J NEUROCHEM, V72, P741, DOI 10.1046/j.1471-4159.1999.0720741.x; Zetterberg H, 2006, ARCH NEUROL-CHICAGO, V63, P1277, DOI 10.1001/archneur.63.9.1277; Zhang L., 2010, 8 WORLD C BRAIN INJ; Zhu Tao, 2004, Chin J Traumatol, V7, P32	63	11	11	0	11	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-510X	1878-5883		J NEUROL SCI	J. Neurol. Sci.	DEC 15	2015	359	1-2					280	286		10.1016/j.jns.2015.08.035			7	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CZ7JR	WOS:000367276200053	26671128				2021-06-18	
J	Arnould, A; Rochat, L; Azouvi, P; Van der Linden, M				Arnould, Annabelle; Rochat, Lucien; Azouvi, Philippe; Van der Linden, Martial			Apathetic symptom presentations in patients with severe traumatic brain injury: Assessment, heterogeneity and relationships with psychosocial functioning and caregivers' burden	BRAIN INJURY			English	Article							MILD COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; EXECUTIVE DYSFUNCTION; DIAGNOSTIC-CRITERIA; EMOTION PERCEPTION; SCHIZOPHRENIA; BEHAVIOR; REHABILITATION; INTERVENTION; EXPRESSION		[Arnould, Annabelle; Rochat, Lucien; Van der Linden, Martial] Univ Geneva, Cognit Psychopathol & Neuropsychol Unit, Geneva, Switzerland; [Arnould, Annabelle; Azouvi, Philippe] Hop Raymond Poincare, AP HP, Serv Med Phys & Readaptat, F-92380 Garches, France; [Arnould, Annabelle; Azouvi, Philippe] Univ Versailles St Quentin, EA 4047, HANDIReSP, Versailles, France; [Rochat, Lucien; Van der Linden, Martial] Univ Geneva, Swiss Ctr Affect Sci, Geneva, Switzerland; [Van der Linden, Martial] Univ Liege, Cognit Psychopathol Unit, B-4000 Liege, Belgium	Arnould, A (corresponding author), Hop Raymond Poincare, AP HP, Serv Med Phys & Readaptat, 104 Blvd Raymond Poincare, F-92380 Garches, France.	annabelle.arnould@rpc.aphp.fr		Rochat, Lucien/0000-0002-9992-2720			Arnould A, 2013, NEUROPSYCHOL REV, V23, P210, DOI 10.1007/s11065-013-9236-3; Bayen E, 2013, J HEAD TRAUMA REHAB, V28, P408, DOI 10.1097/HTR.0b013e31825413cf; Bedard M, 2001, GERONTOLOGIST, V41, P652, DOI 10.1093/geront/41.5.652; Bennett PC, 2005, J INT NEUROPSYCH SOC, V11, P376, DOI 10.1017/S1355617705050423; BURGESS PW, 1996, BEHAV ASSESSMENT DYS, P7; Burkard C, 2014, NEUROPSYCHOL REHABIL, V24, P266, DOI 10.1080/09602011.2014.887023; Clatworthy J, 2005, BRIT J HEALTH PSYCH, V10, P329, DOI 10.1348/135910705X25697; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Damasio A., 1994, DESCARTESERROR EMOTI; Ennis N, 2013, NEUROPSYCHOL REHABIL, V23, P1, DOI 10.1080/09602011.2012.712871; Esposito F, 2014, ARCH GERONTOL GERIAT, V58, P43, DOI 10.1016/j.archger.2013.09.002; Esposito F, 2012, DEMENT GER COGN D EX, V2, P456, DOI 10.1159/000345037; Esposito F, 2010, ALZ DIS ASSOC DIS, V24, P131, DOI 10.1097/WAD.0b013e3181c9c168; Evans JJ, 2003, STUD NEUROPSYCHOL DE, P53; GRAY JM, 1994, CLIN REHABIL, V8, P188, DOI DOI 10.1080/09602010902949207; Henry JD, 2007, SCHIZOPHR RES, V95, P197, DOI 10.1016/j.schres.2007.06.002; Kant R, 1998, BRAIN INJURY, V12, P87, DOI 10.1080/026990598122908; Kelly G, 2008, BRAIN INJURY, V22, P457, DOI 10.1080/02699050802060647; Lee JS, 2014, SCHIZOPHR RES, V152, P268, DOI 10.1016/j.schres.2013.10.043; Levy R, 2006, CEREB CORTEX, V16, P916, DOI 10.1093/cercor/bhj043; MARIN RS, 1991, J NEUROPSYCH CLIN N, V3, P243; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; Mulin E, 2011, INT J GERIATR PSYCH, V26, P158, DOI 10.1002/gps.2508; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Robert P, 2009, EUR PSYCHIAT, V24, P98, DOI 10.1016/j.eurpsy.2008.09.001; Robert PH, 2006, EUR J NEUROL, V13, P729, DOI 10.1111/j.1468-1331.2006.01088.x; Robert PH, 2002, INT J GERIATR PSYCH, V17, P1099, DOI 10.1002/gps.755; Robert PH, 2008, AM J GERIAT PSYCHIAT, V16, P770, DOI 10.1097/JGP.0b013e31817e73db; Saxton ME, 2013, NEUROREHABILITATION, V33, P263, DOI 10.3233/NRE-130954; SERIO CD, 1995, J HEAD TRAUMA REHAB, V10, P32, DOI 10.1097/00001199-199504000-00005; Stanton BR, 2013, J NEUROL, V260, P2481, DOI 10.1007/s00415-013-6989-9; Starkstein SE, 2001, AM J PSYCHIAT, V158, P872, DOI 10.1176/appi.ajp.158.6.872; Strauss GP, 2013, J PSYCHIATR RES, V47, P783, DOI 10.1016/j.jpsychires.2013.01.015; Tate R, 1999, J HEAD TRAUMA REHAB, V14, P543, DOI 10.1097/00001199-199912000-00003; Tate RL, 2004, ARCH PHYS MED REHAB, V85, P538, DOI 10.1016/j.apmr.2003.08.078; Weston R, 2006, COUNS PSYCHOL, V34, P719, DOI 10.1177/0011000006286345; Zarit S., 1985, HIDDEN VICTIMS ALZHE	38	11	11	0	11	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC 6	2015	29	13-14					1597	1603		10.3109/02699052.2015.1075156			7	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	CY8LL	WOS:000366659800010	26452012				2021-06-18	
J	Gilboa, Y; Kerrouche, B; Longaud-Vales, A; Kieffer, V; Tiberghien, A; Aligon, D; Mariller, A; Mintegui, A; Canizares, C; Abada, G; Chevignard, MP				Gilboa, Yafit; Kerrouche, Bernadette; Longaud-Vales, Audrey; Kieffer, Virginie; Tiberghien, Anne; Aligon, Delphine; Mariller, Aude; Mintegui, Amaia; Canizares, Celine; Abada, Genevieve; Chevignard, Mathilde Paule			Describing the attention profile of children and adolescents with acquired brain injury using the Virtual Classroom	BRAIN INJURY			English	Article						Attention deficits; brain tumour; ecological assessment; traumatic brain injury; virtual reality	SUSTAINED ATTENTION; EXECUTIVE FUNCTIONS; EARLY-CHILDHOOD; DEFICITS; PERFORMANCE; REALITY; SURVIVORS; SKILLS; ADHD; MEDULLOBLASTOMA	Objectives: The objectives of the study were: (1) to describe the attention deficits profile of children with significant acquired brain injury (ABI) in comparison to matched controls, using the virtual classroom (VC); (2) to assess the utility of the VC in detecting attention deficits in children with ABI, as compared to classical neuropsychological tests and questionnaire-based assessment of attention; and (3) to determine how performance in the VC is affected by demographic and injury severity variables.Methods: Forty-one children with ABI and 35 age- and gender-matched controls, aged 8-16, were assessed with the VC. The results of the VC were compared to sub-tests of the Test of Everyday Attention for Children (TEA-Ch), the Conners' Parent Rating Scales-Revised: Short (CPRS-R:S) questionnaire and analysed according to demographic and injury severity variables.Results: Significant differences were found between the groups regarding the number of targets correctly identified in the VC. Significant inter-correlations were obtained between the VC variables. Significant correlations were found between the VC variables, the sub-tests of TEA-Ch and the CPRS-R:S and the demographic characteristics of the sample.Conclusion: The VC appears to be a sensitive and ecologically valid assessment tool for use in the diagnosis of attention deficits among children with ABI.	[Gilboa, Yafit] Hebrew Univ Jerusalem, Fac Med, Sch Occupat Therapy, IL-91240 Jerusalem, Israel; [Gilboa, Yafit; Chevignard, Mathilde Paule] Univ Paris 04, UPMC, CNRS, INSERM,Lab Imagerie Biomed, Paris, France; [Kerrouche, Bernadette; Tiberghien, Anne; Aligon, Delphine; Canizares, Celine] St Maurice Hosp, Outreach Team Children & Adolescents Acquired Bra, St Maurice, France; [Longaud-Vales, Audrey; Kieffer, Virginie] Gustave Roussy, Dept Pediat Oncol, Villejuif, France; [Mariller, Aude; Mintegui, Amaia; Abada, Genevieve; Chevignard, Mathilde Paule] St Maurice Hosp, Rehabil Dept Children Acquired Neurol Injury, St Maurice, France	Gilboa, Y (corresponding author), Hebrew Univ Jerusalem, Fac Med, Sch Occupat Therapy, IL-91240 Jerusalem, Israel.	yafitgilboa@yahoo.com	Gilboa, Yafit/AAK-9021-2020; Gilboa, Yafit/AAO-5500-2021	Gilboa, Yafit/0000-0002-0734-3626; Gilboa, Yafit/0000-0002-0734-3626			Adams R, 2009, CHILD NEUROPSYCHOL, V15, P120, DOI 10.1080/09297040802169077; Anderson V, 2005, BRAIN INJURY, V19, P699, DOI 10.1080/02699050400025281; Anderson V, 2011, BRAIN, V134, P2197, DOI 10.1093/brain/awr103; Bart O, 2011, DISABIL REHABIL, V33, P1579, DOI 10.3109/09638288.2010.540291; Betts J, 2006, CHILD NEUROPSYCHOL, V12, P205, DOI 10.1080/09297040500488522; Bioulac S, 2012, EUR J PAEDIATR NEURO, V16, P514, DOI 10.1016/j.ejpn.2012.01.006; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Butler RW, 2006, MENT RETARD DEV D R, V12, P184, DOI 10.1002/mrdd.20110; Catroppa C, 2007, J PEDIATR PSYCHOL, V32, P354, DOI 10.1093/jpepsy/jsl019; Catroppa C, 2014, BRAIN INJURY, V28, P252, DOI 10.3109/02699052.2013.860471; Chevignard MP, 2012, BRAIN INJURY, V26, P1033, DOI 10.3109/02699052.2012.666366; Conklin HM, 2008, J CLIN ONCOL, V26, P3965, DOI 10.1200/JCO.2007.15.9970; Conners CK., 1997, CONNERS RATING SCALE; de Kloet AJ, 2013, BRAIN INJURY, V27, P843, DOI 10.3109/02699052.2013.775496; Everts R, 2008, CHILD NEUROPSYCHOL, V14, P323, DOI 10.1080/09297040701792383; Galbiati S, 2009, NEUROPSYCHOLOGY, V23, P40, DOI 10.1037/a0013409; Garcia-Molina A, 2012, BRAIN INJURY, V26, P864, DOI 10.3109/02699052.2012.655362; Gilboa Y, 2011, INT C VIRT REH ICVR; Gilboa Y, 2011, RES DEV DISABIL, V32, P2608, DOI 10.1016/j.ridd.2011.06.014; Ginstfeldt T, 2010, BRAIN INJURY, V24, P1123, DOI 10.3109/02699052.2010.506853; Kamphaus RW, 1998, BASC MONITOR ADHD MA; Kim Robyn, 2013, Percept Mot Skills, V117, P1361; Levin HS, 2005, PEDIATR NEUROL, V33, P79, DOI 10.1016/j.pediatrneurol.2005.02.002; Loher S, 2014, APPL NEUROPSYCH-CHIL, V3, P103, DOI 10.1080/21622965.2012.716752; Manly T., 1999, TEA CH TEST EVERYDAY; Mulhern RK, 2004, LANCET ONCOL, V5, P399, DOI 10.1016/S1470-2045(04)01507-4; Nadebaum C, 2007, DEV NEUROPSYCHOL, V32, P703, DOI 10.1080/87565640701376086; Nolin P, 2009, STUD HEALTH TECHNOL, V144, P240, DOI 10.3233/978-1-60750-017-9-240; Nygren-de Boussard C, 2014, ARCH PHYS MED REHAB, V95, pS257; Palmer SL, 2007, J PEDIATR PSYCHOL, V32, P1040, DOI 10.1093/jpepsy/jsl056; Palmer SL, 2013, J CLIN ONCOL, V31, P3494, DOI 10.1200/JCO.2012.47.4775; Parsons TD, 2007, CHILD NEUROPSYCHOL, V13, P363, DOI 10.1080/13825580600943473; Parsons TD, 2008, STUD HEALTH TECHNOL, V132, P351; Pollak Y, 2009, J DEV BEHAV PEDIATR, V30, P2, DOI 10.1097/DBP.0b013e3181969b22; Reck SG, 2011, J EXP CHILD PSYCHOL, V108, P504, DOI 10.1016/j.jecp.2010.07.010; Reddick WE, 2014, PEDIATR BLOOD CANCER, V61, P1074, DOI 10.1002/pbc.24947; Rizzo AA, 2006, CNS SPECTRUMS, V11, P35, DOI 10.1017/S1092852900024196; Ross KA, 2011, DEV MED CHILD NEUROL, V53, P692, DOI 10.1111/j.1469-8749.2011.03976.x; Slomine B, 2009, DEV DISABIL RES REV, V15, P133, DOI 10.1002/ddrr.56; Sobeh J, 2012, CHILD NEUROPSYCHOL, V18, P144, DOI 10.1080/09297049.2011.594426; Stevens C, 2009, DEVELOPMENTAL SCI, V12, P634, DOI 10.1111/j.1467-7687.2009.00807.x; Teicher MH, 2008, J CHILD ADOL PSYCHOP, V18, P265, DOI 10.1089/cap.2007.0090; Thurman DJ, 2014, J CHILD NEUROL, P1; van Tol E, 2011, BRAIN INJURY, V25, P1279, DOI 10.3109/02699052.2011.613089; Wechsler D., 2011, WECHLSER ABBREVIATED; Wolfe KR, 2013, CHILD NEUROPSYCHOL, V19, P370, DOI 10.1080/09297049.2012.669470; Woodcock R, 2001, TESTS OF COGNITIVE A	47	11	11	0	17	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC 6	2015	29	13-14					1691	1700		10.3109/02699052.2015.1075148			10	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	CY8LL	WOS:000366659800022	26399584				2021-06-18	
J	Nishijima, DK; Holmes, JF; Dayan, PS; Kuppermann, N				Nishijima, Daniel K.; Holmes, James F.; Dayan, Peter S.; Kuppermann, Nathan			Association of a Guardian's Report of a Child Acting Abnormally With Traumatic Brain Injury After Minor Blunt Head Trauma	JAMA PEDIATRICS			English	Article							COMPUTED-TOMOGRAPHY; RADIATION-EXPOSURE; CANCER; RISK; YOUNGER; SCANS	IMPORTANCE Increased use of computed tomography (CT) in children is concerning owing to the cancer risk from ionizing radiation, particularly in children younger than 2 years. A guardian report that a child is acting abnormally is a risk factor for clinically important traumatic brain injury (ciTBI) and may be a driving factor for CT use in the emergency department. OBJECTIVE To determine the prevalence of ciTBIs and TBIs in children younger than 2 years with minor blunt head trauma and a guardian report of acting abnormally with (1) no other findings or (2) other concerning findings for TBI. DESIGN, SETTING, AND PARTICIPANTS Secondary analysis of a large, prospective, multicenter cohort study that included 43 399 children younger than 18 years with minor blunt head trauma evaluated in 25 emergency departments. The study was conducted on data obtained between June 2004 and September 2006. Data analysis was performed between August 21, 2014, and March 9, 2015. EXPOSURES A guardian report that the child was acting abnormally after minor blunt head trauma. MAIN OUTCOMES AND MEASURES The prevalence of ciTBI (defined as death, neurosurgery, intubation for > 24 hours, or hospitalization for >= 2 nights in association with TBI on CT imaging) and TBI on CT imaging in children with a guardian report of acting abnormally with (1) no other findings and (2) other concerning findings for TBI. RESULTS Of 43 399 children in the cohort study, a total of 1297 children had reports of acting abnormally, of whom 411 (31.7%) had this report as their only finding. Reported as percentage (95% CI), 1 of 411 (0.2%[0-1.3%]) had a ciTBI, and 4 TBIs were noted on the CT scans in 185 children who underwent imaging (2.2%[0.6%-5.4%]). In children with reports of acting abnormally and other concerning findings for TBI, 29 of 886 (3.3%[2.2%-4.7%]) had ciTBIs and 66 of 674 (9.8%[7.7%-12.3%]) had TBIs on CT. CONCLUSIONS AND RELEVANCE Clinically important TBIs are very uncommon, and TBIs noted on CT are uncommon in children younger than 2 years with minor blunt head trauma and guardian reports of the child acting abnormally with no other clinical findings suspicious for TBI. Computed tomographic scans are generally not indicated in these children although observation in the emergency department may be warranted.	[Nishijima, Daniel K.; Holmes, James F.; Kuppermann, Nathan] Univ Calif Davis, Sch Med, Dept Emergency Med, Sacramento, CA 95817 USA; [Dayan, Peter S.] Columbia Univ, Coll Phys & Surg, Div Pediat Emergency Med, New York, NY USA	Nishijima, DK (corresponding author), Univ Calif Davis, Sch Med, Dept Emergency Med, 4150 V St,Patient Serv Support Bldg 2100, Sacramento, CA 95817 USA.	dnishijima@ucdavis.edu		Nishijima, Daniel/0000-0003-4952-8212	Clinical and Translational Science Center at the University of California at Davis; National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000002, KL2TR000134]; NIH Roadmap for Medical ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000002, KL2TR000134] Funding Source: NIH RePORTER	This work was supported by a grant from the Clinical and Translational Science Center at the University of California at Davis. Dr Nishijima was supported by grant UL1TR000002 and linked award KL2TR000134 through the Mentored Clinical Research Training Program Award from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), and the NIH Roadmap for Medical Research.	Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Dayan PS, 2014, ANN EMERG MED, V64, P153, DOI 10.1016/j.annemergmed.2014.02.003; Dayan PS, 2014, ANN EMERG MED, V63, P657, DOI 10.1016/j.annemergmed.2014.01.009; DUHAIME AC, 1992, PEDIATRICS, V90, P179; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Gorelick MH, 2008, ACAD EMERG MED, V15, P812, DOI 10.1111/j.1553-2712.2008.00206.x; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lee LK, 2014, JAMA PEDIATR, V168, P837, DOI 10.1001/jamapediatrics.2014.361; Lyttle MD, 2012, EMERG MED J, V29, P785, DOI 10.1136/emermed-2011-200225; MASTERS SJ, 1987, NEW ENGL J MED, V316, P84, DOI 10.1056/NEJM198701083160205; Mathews JD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2360; Miglioretti DL, 2013, JAMA PEDIATR, V167, P700, DOI 10.1001/jamapediatrics.2013.311; Nigrovic LE, 2012, ARCH PEDIAT ADOL MED, V166, P356, DOI 10.1001/archpediatrics.2011.1156; Nigrovic LE, 2011, PEDIATRICS, V127, P1067, DOI 10.1542/peds.2010-3373; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Overview of the Nationwide Emergency Department Sample (NEDS), 2011, HEALTHC UT PROJ; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0	18	11	11	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-6203	2168-6211		JAMA PEDIATR	JAMA Pediatr.	DEC	2015	169	12					1141	1147		10.1001/jamapediatrics.2015.2743			7	Pediatrics	Pediatrics	CY3UE	WOS:000366334600018	26502172	Green Accepted, Bronze			2021-06-18	
J	Pagan, E; Ownsworth, T; McDonald, S; Fleming, J; Honan, C; Togher, L				Pagan, Elizabeth; Ownsworth, Tamara; McDonald, Skye; Fleming, Jennifer; Honan, Cynthia; Togher, Leanne			A Survey of Multidisciplinary Clinicians Working in Rehabilitation for People with Traumatic Brain Injury	BRAIN IMPAIRMENT			English	Article						multidisciplinary; rehabilitation; traumatic brain injury; clinicians	SPEECH-LANGUAGE PATHOLOGISTS; COGNITIVE REHABILITATION; SELF-EFFICACY; CONFIDENCE; NEUROPSYCHOLOGISTS; COLLABORATION; PERCEPTIONS; TEAM; COMMUNICATION; KNOWLEDGE	Little is known about clinicians' experiences in rehabilitation for people with traumatic brain injury (TBI). This survey study aimed to investigate clinicians' scope of practice, perceived barriers to practice, factors influencing confidence levels and professional development preferences. Participants included 305 clinicians (88% female, 97% aged 20-60 years) from psychology (28%), occupational therapy (27%), speech pathology (15%), physiotherapy (11%), social work (6%), rehabilitation medicine (3%) and nursing (3%) disciplines. Survey results indicated that goal setting, client or family education, and assessment for rehabilitation, were the most common activities across all disciplines (>90%). Client-related barriers, family-related barriers and client-therapist relationship barriers were more frequently selected than workplace context and professional skill barriers (p < .05). Clinicians working with clients with mild TBI reported significantly fewer barriers (p < .05); yet, they were less confident in overcoming barriers than clinicians working with clients with more severe TBI (p < .001). Clinicians with fewer years of experience (<2 years) reported significantly lower confidence in overcoming barriers than clinicians with 2-10 years and >10 years of experience (p < .01). The most commonly selected professional development areas included new interventions and therapies, translating rehabilitation research into everyday practice and client specific topics. These findings provide a unique multidisciplinary perspective on clinicians working in TBI rehabilitation in Australia. Understanding of the perceived barriers to practice and professional development needs may guide training and support initiatives for clinicians which, in turn, may enhance the quality of brain injury rehabilitation.	[Pagan, Elizabeth; Ownsworth, Tamara] Griffith Univ, Sch Appl Psychol, Mt Gravatt, Qld 4122, Australia; [Pagan, Elizabeth; Ownsworth, Tamara] Griffith Univ, Menzies Hlth Inst Queensland, Nathan, Qld 4111, Australia; [Pagan, Elizabeth; Ownsworth, Tamara; McDonald, Skye; Fleming, Jennifer; Honan, Cynthia; Togher, Leanne] Univ New S Wales, Ctr Res Excellence Brain Recovery, Natl Hlth & Med Res Council, Sydney, NSW, Australia; [McDonald, Skye] Univ New S Wales, Sch Psychol, Sydney, NSW, Australia; [Fleming, Jennifer] Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld 4072, Australia; [Fleming, Jennifer] Princess Alexandra Hosp, Occupat Therapy Dept, Brisbane, Qld 4102, Australia; [Honan, Cynthia] Univ Tasmania, Sch Psychol, Launceston, Tas 7250, Australia; [Togher, Leanne] Univ Sydney, Fac Hlth Sci, Discipline Speech Pathol, Sydney, NSW 2006, Australia	Ownsworth, T (corresponding author), Griffith Univ, Sch Appl Psychol, Mt Gravatt, Qld 4122, Australia.	t.ownsworth@griffith.edu.au	Togher, Leanne/AAC-7083-2019; Honan, Cynthia/O-6332-2017	Ownsworth, Tamara/0000-0003-1835-7094; Togher, Leanne/0000-0002-4518-6748; Honan, Cynthia/0000-0001-5735-4270	National Health and Medical Research Council Centre of Research Excellence in Brain Recovery [1083064]	This study was supported by the National Health and Medical Research Council Centre of Research Excellence in Brain Recovery (ID: 1083064).	Access Economics, 2009, EC COST SPINAL CORD; Ammentorp J, 2007, PATIENT EDUC COUNS, V66, P270, DOI 10.1016/j.pec.2006.12.012; [Anonymous], 2010, AR PRACT END REG STA; Australasian Faculty of Rehabilitation Medicine, 2011, STAND PROV INP AD RE; Australian Institute of Health and Welfare, 2007, AIHW B, V55; Barclay DA, 2013, J SOC WORK DISABIL R, V12, P159, DOI 10.1080/1536710X.2013.810093; Bishop M, 2006, AUST J REHABIL COUNS, V12, P73, DOI 10.1375/jrc.12.2.73; Boosman H, 2014, J INT NEUROPSYCH SOC, V20, P1034, DOI 10.1017/S1355617714000897; Booth Julie, 2002, J Interprof Care, V16, P31, DOI 10.1080/13561820220104140; Brooks V, 2014, CREAT NURS, V20, P90, DOI 10.1891/1078-4535.20.2.90; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cook RS, 2013, J NEUROSCI NURS, V45, P108, DOI 10.1097/JNN.0b013e318282906e; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; Di Bernardo G.A., 2013, SOCIAL SCI, V2, P191, DOI [DOI 10.3390/socsci2030191, DOI 10.3390/SOCSCI2030191]; Doig E, 2009, AM J OCCUP THER, V63, P559, DOI 10.5014/ajot.63.5.559; Evans JJ, 2012, CURR OPIN NEUROL, V25, P651, DOI 10.1097/WCO.0b013e3283598f75; Foster AM, 2012, DISABIL REHABIL, V34, P1855, DOI 10.3109/09638288.2012.670028; Government of South Australia, 2012, STAT REH CLIN NETW; Graham F, 2013, AUST OCCUP THER J, V60, P120, DOI 10.1111/1440-1630.12000; Hicks EJ, 2011, INT J SPEECH-LANG PA, V13, P145, DOI 10.3109/17549507.2011.485329; Holland K, 2012, SCAND J OCCUP THER, V19, P214, DOI 10.3109/11038128.2011.583939; Hux K, 1996, LANG SPEECH HEAR SER, V27, P171, DOI 10.1044/0161-1461.2702.171; Jackson H, 2001, NEUROREHABILITATION, V16, P27; Judd D, 2005, BRAIN INJURY, V19, P437, DOI 10.1080/02699050400010994; Korner M, 2010, CLIN REHABIL, V24, P745, DOI 10.1177/0269215510367538; Mazmanian Paul E., 1993, Brain Injury, V7, P319, DOI 10.3109/02699059309034958; McDonald S, 2012, BRAIN IMPAIR, V13, P256, DOI 10.1017/BrImp.2012.21; McLaughlin Anne Marie, 1993, Brain Injury, V7, P45, DOI 10.3109/02699059309008155; Mitsch V., 2011, P 11 NAT RUR HLTH C; NSW Government, 2011, CAR SUPP PATHW PEOPL; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Ryan C, 2013, BRIT J CLIN PHARMACO, V76, P980, DOI 10.1111/bcp.12154; Sander AM, 2009, CLIN NEUROPSYCHOL, V23, P1196, DOI 10.1080/13854040902845706; Sherer M, 2007, BRAIN INJURY, V21, P663, DOI 10.1080/02699050701481589; Stringer AY, 2003, CLIN NEUROPSYCHOL, V17, P34, DOI 10.1076/clin.17.1.34.15625; Suddick KM, 2006, PHYSIOTHER RES INT, V11, P72, DOI 10.1002/pri.325; Tate R.L., 2008, HIGHER BRAIN FUNCTIO, V28, P129; Triola MM, 2012, MED TEACH, V34, pE15, DOI 10.3109/0142159X.2012.638010; Tsaousides T, 2009, MT SINAI J MED, V76, P173, DOI 10.1002/msj.20099; Turner BJ, 2008, AUST OCCUP THER J, V55, P96, DOI 10.1111/j.1440-1630.2007.00660.x; Turner-Stokes L, 2008, J REHABIL MED, V40, P691, DOI 10.2340/16501977-0265; Wertheimer JC, 2008, J HEAD TRAUMA REHAB, V23, P273, DOI 10.1097/01.HTR.0000336840.76209.a1; Wilding C, 2012, AUST OCCUP THER J, V59, P312, DOI 10.1111/j.1440-1630.2012.01031.x; Wittig PG, 2003, DISABIL REHABIL, V25, P97, DOI 10.1080/0963828021000024933; Wong D, 2014, AUST PSYCHOL, V49, P209, DOI 10.1111/ap.12061	47	11	11	0	27	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	DEC	2015	16	3					173	195		10.1017/BrImp.2015.34			23	Clinical Neurology; Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	DD4KV	WOS:000369892700003					2021-06-18	
J	Probst, MA; Dayan, PS; Raja, AS; Slovis, BH; Yadav, K; Lam, SH; Shapiro, JS; Farris, C; Babcock, CI; Griffey, RT; Robey, TE; Fortin, EM; Johnson, JO; Chong, ST; Davenport, M; Grigat, DW; Lang, EL				Probst, Marc A.; Dayan, Peter S.; Raja, Ali S.; Slovis, Benjamin H.; Yadav, Kabir; Lam, Samuel H.; Shapiro, Jason S.; Farris, Coreen; Babcock, Charlene I.; Griffey, Richard T.; Robey, Thomas E.; Fortin, Emily M.; Johnson, Jamlik O.; Chong, Suzanne T.; Davenport, Moira; Grigat, Daniel W.; Lang, Eddy L.			Knowledge Translation and Barriers to Imaging Optimization in the Emergency Department: A Research Agenda	ACADEMIC EMERGENCY MEDICINE			English	Article; Proceedings Paper	Academic-Emergency-Medicine (AEM) Consensus Conference	MAY 12, 2015	San Diego, CA	Acad Emergency Med			CLINICAL DECISION-SUPPORT; HEALTH INFORMATION EXCHANGE; COMPUTED-TOMOGRAPHY USE; TRAUMATIC BRAIN-INJURY; PHYSICIAN ORDER ENTRY; CT HEAD RULE; PRACTICE GUIDELINES; DEFENSIVE MEDICINE; AMERICAN-COLLEGE; CRITICAL-ISSUES	Researchers have attempted to optimize imaging utilization by describing which clinical variables are more predictive of acute disease and, conversely, what combination of variables can obviate the need for imaging. These results are then used to develop evidence-based clinical pathways, clinical decision instruments, and clinical practice guidelines. Despite the validation of these results in subsequent studies, with some demonstrating improved outcomes, their actual use is often limited. This article outlines a research agenda to promote the dissemination and implementation (also known as knowledge translation) of evidence-based interventions for emergency department (ED) imaging, i.e., clinical pathways, clinical decision instruments, and clinical practice guidelines. We convened a multidisciplinary group of stakeholders and held online and telephone discussions over a 6-month period culminating in an in-person meeting at the 2015 Academic Emergency Medicine consensus conference. We identified the following four overarching research questions: 1) what determinants (barriers and facilitators) influence emergency physicians' use of evidence-based interventions when ordering imaging in the ED; 2) what implementation strategies at the institutional level can improve the use of evidence-based interventions for ED imaging; 3) what interventions at the health care policy level can facilitate the adoption of evidence-based interventions for ED imaging; and 4) how can health information technology, including electronic health records, clinical decision support, and health information exchanges, be used to increase awareness, use, and adherence to evidence-based interventions for ED imaging? Advancing research that addresses these questions will provide valuable information as to how we can use evidence-based interventions to optimize imaging utilization and ultimately improve patient care. (C) 2015 by the Society for Academic Emergency Medicine	[Probst, Marc A.; Slovis, Benjamin H.; Shapiro, Jason S.] Icahn Sch Med Mt Sinai, Dept Emergency Med, New York, NY 10029 USA; [Raja, Ali S.] Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA; [Yadav, Kabir] Univ Calif Los Angeles, Los Angeles Sch Med, Dept Emergency Med, Los Angeles, CA USA; [Lam, Samuel H.] Advocate Christ Med Ctr, Dept Emergency Med, Oak Lawn, IL USA; [Babcock, Charlene I.] St John Hosp & Med Ctr, Dept Emergency Med, Detroit, MI USA; [Griffey, Richard T.] Washington Univ, Sch Med, Dept Emergency Med, St Louis, MO USA; [Robey, Thomas E.] Yale Univ, Waterbury Hosp, Dept Emergency Med, New Haven, CT USA; [Davenport, Moira] Allegheny Gen Hosp, Dept Emergency Med, Pittsburgh, PA 15212 USA; [Lang, Eddy L.] Univ Calgary, Dept Emergency Med, Calgary, AB, Canada; [Dayan, Peter S.] Columbia Univ Coll Phys & Surg, Dept Pediat, Div Emergency Med, New York, NY 10032 USA; [Farris, Coreen] RAND Corp, Santa Monica, CA USA; [Farris, Coreen; Fortin, Emily M.] Cent Michigan Univ, Coll Med, Mt Pleasant, MI 48859 USA; [Johnson, Jamlik O.] Emory Healthcare, Dept Radiol, Atlanta, GA USA; [Chong, Suzanne T.] Univ Michigan Hlth Syst, Dept Radiol, Ann Arbor, MI USA; [Grigat, Daniel W.] Emergency Strateg Clin Network, Alberta Hlth Serv, Calgary, AB, Canada	Probst, MA (corresponding author), Icahn Sch Med Mt Sinai, Dept Emergency Med, New York, NY 10029 USA.	mprobst@gmail.com	Lang, Eddy/AAS-2080-2020; Raja, Ali S./AAE-5103-2019	Griffey, Richard/0000-0002-6279-7380; Yadav, Kabir/0000-0002-1092-9935	Agency for Healthcare Research and Quality (AHRQ)United States Department of Health & Human ServicesAgency for Healthcare Research & Quality [1R13HS023498-01]; National Institute of Biomedical Imaging and BioengineeringUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [1 R13 EB 019813-01]; Alberta Innovates [201300468] Funding Source: researchfish; AGENCY FOR HEALTHCARE RESEARCH AND QUALITYUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [R13HS023498] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R13EB019813] Funding Source: NIH RePORTER	Funding for this conference was made possible (in part) by grant number 1R13HS023498-01 from the Agency for Healthcare Research and Quality (AHRQ) and grant number 1 R13 EB 019813-01 from the National Institute of Biomedical Imaging and Bioengineering. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services, nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.	Agrawal P, 2009, EMERG MED CLIN N AM, V27, P555, DOI 10.1016/j.emc.2009.07.001; American Board of Internal Medicine Foundation. Choosing Wisely, AM COLL EM PHYS 5 TH; American Board of Internal Medicine Foundation. Choosing Wisely, 2015, AM COLL RAD 5 THINGS; Anderson NR, 2007, INT J MED INFORM, V76, P821, DOI 10.1016/j.ijmedinf.2006.09.022; Andruchow JE, 2012, ARCH INTERN MED, V172, P660, DOI 10.1001/archinternmed.2011.2243; Arasu VA, 2015, J AM COLL RADIOL, V12, P467, DOI 10.1016/j.jacr.2014.11.018; Ash JS, 2007, J AM MED INFORM ASSN, V14, P415, DOI 10.1197/jamia.M2373; Ash JS, 2012, J AM MED INFORM ASSN, V19, P980, DOI 10.1136/amiajnl-2011-000705; Bailey JE, 2013, J GEN INTERN MED, V28, P176, DOI 10.1007/s11606-012-2092-7; Barac R, 2014, BMC MED INFORM DECIS, V14, DOI 10.1186/s12911-014-0121-7; Bates DW, 2003, J AM MED INFORM ASSN, V10, P523, DOI 10.1197/jamia.M1370; Beitia Anton Oscar, 2013, AMIA Annu Symp Proc, V2013, P94; Blackmore CC, 2011, J AM COLL RADIOL, V8, P19, DOI 10.1016/j.jacr.2010.07.009; Bourgeois FC, 2010, ARCH INTERN MED, V170, P1989, DOI 10.1001/archinternmed.2010.439; Bowen S, 2011, J AM COLL RADIOL, V8, P251, DOI 10.1016/j.jacr.2010.11.020; Bressan S, 2012, ACAD EMERG MED, V19, P801, DOI 10.1111/j.1553-2712.2012.01384.x; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Carayon P, 2006, QUAL SAF HEALTH CARE, V15, pI50, DOI 10.1136/qshc.2005.015842; Carr CM, 2014, J EMERG MED, V46, P250, DOI 10.1016/j.jemermed.2013.05.068; Chaudhry B, 2006, ANN INTERN MED, V144, P742, DOI 10.7326/0003-4819-144-10-200605160-00125; Curran JA, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-25; Curry L, 2011, J AM MED INFORM ASSN, V18, P267, DOI 10.1136/amiajnl-2011-000049; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; Edlow JA, 2008, ANN EMERG MED, V52, P407, DOI 10.1016/j.annemergmed.2008.07.001; Erstad Tricia L, 2003, J Healthc Inf Manag, V17, P51; Finnell John T, 2011, AMIA Annu Symp Proc, V2011, P409; Frisse ME, 2007, J BIOMED INFORM, V40, pS27, DOI 10.1016/j.jbi.2007.08.004; Frisse ME, 2012, J AM MED INFORM ASSN, V19, P328, DOI [10.1136/amiajnl-2011000394, 10.1136/amiajnl-2011-000394]; Gaddis GM, 2007, ACAD EMERG MED, V14, P1015, DOI 10.1197/j.aem.2007.07.010; Garg AX, 2005, JAMA-J AM MED ASSOC, V293, P1223, DOI 10.1001/jama.293.10.1223; Glanz K, 2008, AM J PREV MED, V35, pS3, DOI 10.1016/j.amepre.2008.04.011; Glasgow RE, 1999, AM J PUBLIC HEALTH, V89, P1322, DOI 10.2105/AJPH.89.9.1322; Green RA, 2015, ANN EMERG MED, V65, P679, DOI 10.1016/j.annemergmed.2014.11.017; Griffey RT, 2014, ACAD EMERG MED, V21, P768, DOI 10.1111/acem.12410; Hassan Z, 2005, EMERG MED J, V22, P845, DOI 10.1136/emj.2004.021717; Hawasli AH, 2015, NEUROSURGERY, V76, P1, DOI 10.1227/NEU.0000000000000560; Hillestad R, 2005, HEALTH AFFAIR, V24, P1103, DOI 10.1377/hlthaff.24.5.1103; Hoffman JR, 2000, NEW ENGL J MED, V343, P94, DOI 10.1056/NEJM200007133430203; Huff JS, 2007, ANN EMERG MED, V49, P431, DOI 10.1016/j.annemergmed.2007.02.001; Huff JS, 2014, ANN EMERG MED, V63, P437, DOI 10.1016/j.annemergmed.2014.01.018; Ip IK, 2015, AM J EMERG MED, V33, P320, DOI 10.1016/j.ajem.2014.11.005; Ip IK, 2012, J AM COLL RADIOL, V9, P129, DOI 10.1016/j.jacr.2011.10.010; Ivers N, 2012, COCHRANE DATABASE SY, V6, DOI DOI 10.1002/14651858.CD000259.PUB3; Johnson KB, 2011, J AM MED INFORM ASSN, V18, P690, DOI 10.1136/amiajnl-2011-000308; Judkins A, 2013, ARCH DIS CHILD, V98, P521, DOI 10.1136/archdischild-2012-303032; Kanzaria HK, 2015, ACAD EMERG MED, V22, P390, DOI 10.1111/acem.12625; Kanzaria HK, 2015, ACAD EMERG MED, V22, P399, DOI 10.1111/acem.12627; Kawamoto K, 2005, BMJ-BRIT MED J, V330, P765, DOI 10.1136/bmj.38398.500764.8F; Khorasani R, 2001, RADIOGRAPHICS, V21, P1015, DOI 10.1148/radiographics.21.4.g01jl371015; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; LaBorde DV, 2011, J AM MED INFORM ASSN, V18, P698, DOI 10.1136/amiajnl-2011-000140; Lammers EJ, 2014, MED CARE, V52, P227, DOI 10.1097/MLR.0000000000000067; Lehnert BE, 2010, J AM COLL RADIOL, V7, P192, DOI 10.1016/j.jacr.2009.11.010; Levy G, 2006, AM J ROENTGENOL, V187, P855, DOI 10.2214/AJR.05.1055; Loder E, 2013, HEADACHE, V53, P1651, DOI 10.1111/head.12233; Melnick ER, 2010, ANN EMERG MED, V56, P317, DOI 10.1016/j.annemergmed.2010.03.006; Melnick ER, 2010, INT J EMERG MED, V3, P97, DOI 10.1007/s12245-010-0168-x; Menachemi N, 2006, J MED SYST, V30, P159, DOI 10.1007/s10916-005-7988-x; Menachemi N, 2011, RISK MANAG HEALTHC P, V4, P47, DOI 10.2147/RMHP.S12985; Michie S, 2005, QUAL SAF HEALTH CARE, V14, P26, DOI 10.1136/qshc.2004.011155; Mooney JS, 2011, EMERG MED J, V28, P778, DOI 10.1136/emj.2009.083360; Mower WR, 2005, J TRAUMA, V59, P954, DOI 10.1097/01.ta.0000187813.79047.42; Neta G, 2015, AM J PUBLIC HEALTH, V105, P49, DOI 10.2105/AJPH.2014.302206; Overhage JM, 2005, J AM MED INFORM ASSN, V12, P107, DOI 10.1197/jamia.M1680; Overhage JM, 2002, ANN EMERG MED, V39, P14, DOI 10.1067/mem.2002.120794; Perry JJ, 2006, INJURY, V37, P1157, DOI 10.1016/j.injury.2006.07.028; Perry JJ, 2013, JAMA-J AM MED ASSOC, V310, P1248, DOI 10.1001/jama.2013.278018; Pines JM, 2009, AM J EMERG MED, V27, P552, DOI 10.1016/j.ajem.2008.04.031; Powell BJ, 2012, MED CARE RES REV, V69, P123, DOI 10.1177/1077558711430690; Raja AS, 2014, AM J ROENTGENOL, V203, P355, DOI 10.2214/AJR.13.11892; Raja AS, 2012, RADIOLOGY, V262, P468, DOI 10.1148/radiol.11110951; Raja AS, 2010, ANN EMERG MED, V56, P597, DOI 10.1016/j.annemergmed.2010.09.013; Rosenthal Daniel I, 2006, J Am Coll Radiol, V3, P799, DOI 10.1016/j.jacr.2006.05.006; Roshanov PS, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f657; Sathiyakumar V, 2013, J ORTHOP TRAUMA, V27, P592, DOI 10.1097/BOT.0b013e31828b7ab4; Schuur JD, 2014, JAMA INTERN MED, V174, P509, DOI 10.1001/jamainternmed.2013.12688; Schuur JD, 2011, ANN EMERG MED, V57, P704, DOI 10.1016/j.annemergmed.2011.02.011; Shah LM, 2014, J AM COLL RADIOL, V11, P1002, DOI 10.1016/j.jacr.2013.12.015; Sheehan B, 2013, J BIOMED INFORM, V46, P905, DOI 10.1016/j.jbi.2013.07.005; Stiell IG, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4146; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; STIELL IG, 1993, JAMA-J AM MED ASSOC, V269, P1127, DOI 10.1001/jama.269.9.1127; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; STIELL IG, 1994, JAMA-J AM MED ASSOC, V271, P827, DOI 10.1001/jama.271.11.827; Stiell IG, 2001, JAMA-J AM MED ASSOC, V286, P1841, DOI 10.1001/jama.286.15.1841; Straus SE, 2011, J CLIN EPIDEMIOL, V64, P6, DOI 10.1016/j.jclinepi.2009.08.016; Studdert DM, 2005, JAMA-J AM MED ASSOC, V293, P2609, DOI 10.1001/jama.293.21.2609; Sultan HY, 2004, EMERG MED J, V21, P420, DOI 10.1136/emj.2003.011353; Tavender EJ, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-8; Walker Jan, 2005, Health Aff (Millwood), VSuppl Web Exclusives, pW5; Wang SJ, 2003, AM J MED, V114, P397, DOI 10.1016/S0002-9343(03)00057-3; Waxman DA, 2014, NEW ENGL J MED, V371, P1518, DOI 10.1056/NEJMsa1313308; Winters BD, 2009, CRIT CARE, V13, DOI 10.1186/cc7792; Wong AC, 2011, PEDIATR EMERG CARE, V27, P182, DOI 10.1097/PEC.0b013e31820d64f7; Yamada J, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006808; Zuccotti G, 2014, APPL CLIN INFORM, V5, P746, DOI 10.4338/ACI-2014-02-RA-0018	96	11	11	0	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1069-6563	1553-2712		ACAD EMERG MED	Acad. Emerg. Med.	DEC	2015	22	12			SI		1455	1464		10.1111/acem.12830			10	Emergency Medicine	Emergency Medicine	DA5FP	WOS:000367828900012	26568148	Bronze			2021-06-18	
J	Teramoto, M; Petron, DJ; Cross, CL; Willick, SE				Teramoto, Masaru; Petron, David J.; Cross, Chad L.; Willick, Stuart E.			Style of Play and Rate of Concussions in the National Football League	ORTHOPAEDIC JOURNAL OF SPORTS MEDICINE			English	Article						concussion; style of play; National Football League (NFL); West Coast offense; epidemiology; risk factor; statistics	CHRONIC TRAUMATIC ENCEPHALOPATHY; HIGH-SCHOOL; COLLEGIATE	Background: The majority of studies on concussion in the National Football League (NFL) focus on testing, evaluation, and outcomes. Meanwhile, there is a paucity of research on how a team's style of play influences the risk of concussion. Hypothesis: Style of play, such as offensive and defensive strategies, is associated with the rate of concussions in the NFL. Study Design: Descriptive epidemiology study. Methods: The current study retrospectively analyzed data from the 2012 to 2014 NFL regular seasons. Reported numbers of concussions were stratified by each team and each position and were compared based on style of play, including offensive scheme (West Coast offense, Air Coryell offense, or other offensive schemes) and defensive alignment (3-4 or 4-3), attempts statistics, per-drive statistics, and offensive and defensive productions, along with strength of schedule (SoS) and team quality measured by simple rating system (SRS). Data analyses included descriptive statistics, 1-way analysis of variance, correlation analysis, and regression analysis. Results: There were 437 documented concussions during the 2012 to 2014 NFL regular seasons, with a mean 4.6 concussions per season per team. In general, players most involved in pass plays reported more concussions. The number of concussions sustained by offensive players was significantly higher among the teams adopting the West Coast offense (mean, 3.0) than among those utilizing the Air Coryell offense (mean, 1.6; P =.006) or those with non-West Coast offenses combined (mean, 1.9; P =.004). The multiple regression analysis revealed that the West Coast offense or not, SoS, and SRS explained 25.3% of the variance in the number of concussions by offensive players. After accounting for SRS, the West Coast offense was found to be a significant predictor of the number of concussions (P =.007), while there was a tendency for SoS to be inversely associated with the number of concussions (P =.105). None of the variables for attempts statistics, per-drive statistics, and offensive production were significantly associated with the number of concussions in the regression analysis. Conclusion: In the NFL, players most involved in pass plays appear to be at increased risk for concussions. The West Coast offense may be associated with a greater risk of concussion. Furthermore, teams with easier schedules may have more players sustaining concussions.	[Teramoto, Masaru; Petron, David J.; Cross, Chad L.; Willick, Stuart E.] Univ Utah, Salt Lake City, UT 84108 USA	Teramoto, M (corresponding author), Univ Utah, Sch Med, Div Phys Med & Rehabil, Univ Orthopaed Ctr, 590 Wakara Way, Salt Lake City, UT 84108 USA.	masaru.teramoto@hsc.utah.edu					Carroll B., 1988, HIDDEN GAME FOOTBALL; Carroll Bob, 1997, TOTAL FOOTBALL OFFIC; Casson IR, 2011, SPORTS HEALTH, V3, P130, DOI 10.1177/1941738110397876; Casson IR, 2010, SPORTS HEALTH, V2, P471, DOI 10.1177/1941738110383963; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Jaworski R, 2011, GAMES CHANGED GAME E; Kumar NS, 2014, AM J SPORT MED, V42, P2050, DOI 10.1177/0363546514539449; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; Martini D, 2013, MED SCI SPORT EXER, V45, P755, DOI 10.1249/MSS.0b013e3182798758; Maxcy JG, 2013, J SPORT ECON, V14, P368, DOI 10.1177/1527002513497170; National Football League, NFL EXPL AGR 765M SE; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu Bennet I, 2010, J Forensic Nurs, V6, P40, DOI 10.1111/j.1939-3938.2009.01064.x; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Pellman EJ, 2003, NEUROSURGERY, V53, P797, DOI 10.1093/neurosurgery/53.3.797; Pellman Elliot J, 2006, Neurosurg Focus, V21, pE12; Tagliabue P, 2003, NEUROSURGERY, V53, P796, DOI 10.1227/01.NEU.0000083559.68424.3F; Zemper ED, 2003, RES SPORTS MED, V11, P157	23	11	11	0	15	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA		2325-9671		ORTHOP J SPORTS MED	Orthop. J. Sports Med.	DEC	2015	3	12							2325967115620365	10.1177/2325967115620365			9	Orthopedics; Sport Sciences	Orthopedics; Sport Sciences	DE2AE	WOS:000370427600009	26740957	DOAJ Gold, Green Published			2021-06-18	
J	Warren, AM; Boals, A; Elliott, TR; Reynolds, M; Weddle, RJ; Holtz, P; Trost, Z; Foreman, ML				Warren, Ann Marie; Boals, Adriel; Elliott, Timothy R.; Reynolds, Megan; Weddle, Rebecca Jo; Holtz, Pamela; Trost, Zina; Foreman, Michael L.			Mild traumatic brain injury increases risk for the development of posttraumatic stress disorder	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	45th Annual Meeting of the Western-Trauma-Association	MAR 01-06, 2015	Telluride, CO	Western Trauma Assoc		Posttraumatic stress disorder; mild traumatic brain injury; Level 1 trauma center	SYMPTOMS; PTSD	BACKGROUND Traumatic brain injury (TBI) and posttraumatic stress disorder (PTSD) occur in individuals who sustain physical injury and share a significant overlap in symptoms. PTSD rates in the civilian injury population range from 20% to 40%. The current study examined the presence of PTSD symptoms at multiple time points (3 months and 6 months after injury) among individuals with and without TBI after admission to a Level I trauma center. METHODS This prospective cohort study included patients 18 years and older admitted to a Level I trauma center for 24 hours or greater. Demographic and injury-related data were gathered in addition to assessments of PTSD during initial hospitalization after injury, as well as 3 months and 6 months later. The Primary Care PTSD Screen and PTSD Checklist-Civilian version were used to determine probable PTSD. International Classification of Diseases, 9th Rev. codes were used to determine mild TBI (MTBI). RESULTS A total of 494 patients were enrolled at baseline, 311 (63%) completed 3-month follow-up, and 231 (47%) completed 6-month follow-up at the time of analysis. Preinjury PTSD was reported by 7% of the participants. At 3 months, patients with MTBI evidenced a probable PTSD rate of 18%, compared with a rate of 9% for patients with no MTBI (p = 0.04), although this relationship became a nonsignificant trend (p = 0.06) when demographics were included. At 6 months, patients with MTBI evidenced a probable PTSD rate of 26%, compared with a rate of 15% for patients with no MTBI (p = 0.04), and this relationship remained significant when demographics were included. Preinjury history of TBI did not predict PTSD, but incidence of TBI for the injury in which they were hospitalized did predict PTSD. CONCLUSION TBI at time of injury demonstrated a nonsignificant trend toward higher rates of PTSD at 3 months and significantly predicted PTSD at 6 months after injury. This important finding may help clinicians identify patients at high risk for PTSD after injury and target these patients for screening, intervention, and referral for treatment. LEVEL OF EVIDENCE Prognostic study, level III.	[Warren, Ann Marie; Reynolds, Megan; Weddle, Rebecca Jo; Foreman, Michael L.] Baylor Univ, Med Ctr, Div Trauma Acute Care & Crit Care Surg, Dept Surg, Dallas, TX 75246 USA; [Boals, Adriel; Holtz, Pamela; Trost, Zina] Univ N Texas, Dept Psychol, Denton, TX 76203 USA; [Elliott, Timothy R.] Texas A&M Univ, Dept Educ Psychol, College Stn, TX 77843 USA	Warren, AM (corresponding author), Baylor Univ, Med Ctr, Wadley 1155, Dallas, TX 75246 USA.	AnnMariW@baylorhealth.edu	Elliott, Timothy R./I-5301-2012	Elliott, Timothy R./0000-0002-6608-7714; Warren, Ann Marie/0000-0002-3753-5573	Stanley Seeger Surgical Fund of the Baylor Healthcare System Foundation	Support for this study was graciously provided by the Stanley Seeger Surgical Fund of the Baylor Healthcare System Foundation. No other conflicts of interest exist.	American College of Surgeons, 2006, RESOURCES OPTIMAL CA; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5, DOI [10.1176/appi.books.9780890425596., DOI 10.1176/APPI.BOOKS.9780890425596, 10.1176/appi.books.9780890425596]; Breslau N, 2001, J CLIN PSYCHIAT, V62, P16; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Bryant RA, 2009, J INT NEUROPSYCH SOC, V15, P862, DOI 10.1017/S1355617709990671; Butler DL, 2011, CARING VETERANS DEPL, P87; Center for Disease Control and Prevention (CDC), 2014, INJ PREV CONTR DAT S; Centers for Disease Control and Prevention National Center for Health Statistics, 2015, CLASS DIS FUNCT DIS; Glaesser J, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-5; Greenspan AI, 2006, BRAIN INJURY, V20, P733, DOI 10.1080/02699050600773276; Hanley J, 2013, J TRAUMA ACUTE CARE, V75, P722, DOI 10.1097/TA.0b013e3182a53a5f; Hoffman JM, 2012, ARCH PHYS MED REHAB, V93, P287, DOI 10.1016/j.apmr.2011.08.041; Hoffman SW, 2009, CLIN NEUROPSYCHOL, V23, P1400, DOI 10.1080/13854040903369433; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; KIERNAN RJ, 1987, ANN INTERN MED, V107, P481, DOI 10.7326/0003-4819-107-4-481; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; King NS, 2008, BRAIN INJURY, V22, P1, DOI 10.1080/02699050701829696; Osenbach JE, 2014, PSYCHIATRY, V77, P386, DOI 10.1521/psyc.2014.77.4.386; Prins A, 2003, PRIMARY CARE PSYCHIA, V9, P9; Reese C, 2012, J TRAUMA ACUTE CARE, V73, P462, DOI 10.1097/TA.0b013e31825ff713; Rubin DC, 2013, CLIN PSYCHOL SCI, V1, P375, DOI 10.1177/2167702613483112; Sumpter RE, 2006, BRAIN INJURY, V20, P93, DOI 10.1080/02699050500394090; Tanev KS, 2014, BRAIN INJURY, V28, P261, DOI 10.3109/02699052.2013.873821; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Vasterling JJ, 2011, TREATING PTSD MILITA, P239; Weathers F., 1996, MEASUREMENT STRESS T, P250; WHO, 2014, INT STAT CLASS DIS R; Williams WH, 2002, J TRAUMA STRESS, V15, P397, DOI 10.1023/A:1020185325026	28	11	13	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	DEC	2015	79	6					1062	1066		10.1097/TA.0000000000000875			5	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	CX4TD	WOS:000365692300042	26488326				2021-06-18	
J	Swick, D; Honzel, N; Turken, U				Swick, Diane; Honzel, Nikki; Turken, U.			Intact error monitoring in combat Veterans with post-traumatic stress disorder	PSYCHIATRY RESEARCH-NEUROIMAGING			English	Article						Error-related negativity; Performance monitoring; Self-monitoring; Mild traumatic brain injury; Anterior cingulate cortex; Cognitive control; Anxiety	ANTERIOR CINGULATE CORTEX; MEDIAL PREFRONTAL CORTEX; FUNCTIONAL-SIGNIFICANCE; PSYCHOMETRIC PROPERTIES; RESPONSE-INHIBITION; NEURAL EVIDENCE; ERP COMPONENTS; PERFORMANCE; SCHIZOPHRENIA; DYSFUNCTION	The error-related negativity (ERN) is a neuroelectric signature of performance monitoring during speeded response time tasks. Previous studies indicate that individuals with anxiety disorders show ERN enhancements that correlate with the degree of clinical symptomology. Less is known about the error monitoring system in post-traumatic stress disorder (PTSD). PTSD is characterized by impairments in the regulation of fear and other emotional responses, as well as deficits in maintaining cognitive control. Here, combat Veterans with PTSD were compared to control Veterans in two different versions of the flanker task (n = 13 or 14 per group). Replicating and extending previous findings, PTSD patients showed an intact ERN in both experiments. In addition, task performance and error compensation behavior were intact. Finally, ERN amplitude showed no relationship with self-reported PTSD, depression, or post-concussive symptoms. These results suggest that error monitoring represents a relative strength in PTSD that can dissociate from cognitive control functions that are impaired, such as response inhibition and sustained attention. A healthy awareness of errors in external actions could be leveraged to improve interoceptive awareness of emotional state. The results could have positive implications for PTSD treatments that rely on self-monitoring abilities, such as neurofeedback and mindfulness training. Published by Elsevier Ireland Ltd.	[Swick, Diane; Honzel, Nikki; Turken, U.] VA Northern Calif Hlth Care Syst, Martinez, CA 94553 USA; [Swick, Diane] Univ Calif Davis, Davis, CA 95616 USA; [Honzel, Nikki] Carroll Coll, Helena, MT USA	Swick, D (corresponding author), VA Northern Calif Hlth Care Syst, Res Serv 151, 150 Muir Rd, Martinez, CA 94553 USA.	swicklab@gmail.com			U.S. Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-08-2-0086]; VA Merit Review grant from Clinical Science Research and DevelopmentUS Department of Veterans Affairs [I01CX000566]; VA Career Development Award; Veterans AffairsUS Department of Veterans Affairs [I01CX000566] Funding Source: NIH RePORTER	We are grateful to Dr. Andrew Kayser for patient referrals and to all participants for taking part in the study. We thank Victoria Ashley, Julien Cayton, Dr. Jary Larsen, and Dr. Adrian Willoughby for their assistance in various stages of the project. This work was supported by the U.S. Army Medical Research and Materiel Command under W81XWH-08-2-0086 (D.S.), a VA Merit Review grant (I01CX000566) from Clinical Science Research and Development (D.S.), and a VA Career Development Award (A.T.). The contents reported within do not represent the views of the Department of Veterans Affairs or the United States Government.	Aarts K, 2013, J ABNORM PSYCHOL, V122, P939, DOI 10.1037/a0034616; Alain C, 2002, CEREB CORTEX, V12, P840, DOI 10.1093/cercor/12.8.840; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5, DOI [10.1176/appi.books.9780890425596., DOI 10.1176/APPI.BOOKS.9780890425596, 10.1176/appi.books.9780890425596]; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Araki T, 2005, NEUROIMAGE, V25, P43, DOI 10.1016/j.neuroimage.2004.11.039; Araki T, 2013, SCHIZOPHR RES, V146, P336, DOI 10.1016/j.schres.2013.02.028; Ashley V, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-86; Bailey NW, 2015, BIOL PSYCHOL, V106, P1, DOI 10.1016/j.biopsycho.2015.01.011; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Bilder Robert M, 2009, Cogn Neuropsychiatry, V14, P419, DOI 10.1080/13546800902787180; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Boekel W, 2015, CORTEX, V66, P115, DOI 10.1016/j.cortex.2014.11.019; Bremner JD, 1999, BIOL PSYCHIAT, V45, P806, DOI 10.1016/S0006-3223(98)00297-2; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Carter CS, 2001, AM J PSYCHIAT, V158, P1423, DOI 10.1176/appi.ajp.158.9.1423; Chao L, 2013, PSYCHIAT RES-NEUROIM, V213, P193, DOI 10.1016/j.pscychresns.2013.03.002; Chen YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048298; Chiu PH, 2007, AM J PSYCHIAT, V164, P608, DOI 10.1176/appi.ajp.164.4.608; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Clemans ZA, 2012, NEUROSCI LETT, V525, P105, DOI 10.1016/j.neulet.2012.07.051; Compton RJ, 2008, EMOTION, V8, P58, DOI 10.1037/1528-3542.8.1.58; Danielmeier C, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00233; De Beaumont L, 2013, J CLIN EXP NEUROPSYC, V35, P596, DOI 10.1080/13803395.2013.800023; DEHAENE S, 1994, PSYCHOL SCI, V5, P303, DOI 10.1111/j.1467-9280.1994.tb00630.x; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Endrass T, 2014, NEUROSCI BIOBEHAV R, V46, P124, DOI 10.1016/j.neubiorev.2014.03.024; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; FALKENSTEIN M, 1991, ELECTROEN CLIN NEURO, V78, P447, DOI 10.1016/0013-4694(91)90062-9; Falkenstein M, 2000, BIOL PSYCHOL, V51, P87, DOI 10.1016/S0301-0511(99)00031-9; Fischer BL, 2014, J NEUROTRAUM, V31, P169, DOI 10.1089/neu.2013.2877; Fischer H., 2014, GUID US MIL CAS STAT; Forbes D, 2001, BEHAV RES THER, V39, P977, DOI 10.1016/S0005-7967(00)00084-X; FRITH CD, 1989, PSYCHOL MED, V19, P359, DOI 10.1017/S003329170001240X; Gehring W.J., 2012, OXFORD HDB EVENT REL, P231; Gehring WJ, 2000, PSYCHOL SCI, V11, P1, DOI 10.1111/1467-9280.00206; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Gehring WJ, 2000, NAT NEUROSCI, V3, P516, DOI 10.1038/74899; GOUVIER WD, 1992, ARCH CLIN NEUROPSYCH, V7, P193, DOI 10.1016/0887-6177(92)90162-G; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Hajcak G, 2003, BIOL PSYCHOL, V64, P77, DOI 10.1016/S0301-0511(03)00103-0; Hamner M B, 1999, Depress Anxiety, V9, P1; Hayes JP, 2012, BIOL MOOD ANXIETY DI, V2, DOI 10.1186/2045-5380-2-9; Herringa R, 2012, PSYCHIAT RES-NEUROIM, V203, P139, DOI 10.1016/j.pscychresns.2012.02.005; Holmes AJ, 2008, ARCH GEN PSYCHIAT, V65, P179, DOI 10.1001/archgenpsychiatry.2007.19; Holroyd CB, 1998, NEUROSCI LETT, V242, P65, DOI 10.1016/S0304-3940(98)00035-4; Honzel N, 2014, COGN AFFECT BEHAV NE, V14, P792, DOI 10.3758/s13415-013-0219-x; Insel TR, 2009, BIOL PSYCHIAT, V66, P988, DOI 10.1016/j.biopsych.2009.10.008; Jentzsch I, 2009, Q J EXP PSYCHOL, V62, P209, DOI 10.1080/17470210802240655; Kasai K, 2008, BIOL PSYCHIAT, V63, P550, DOI 10.1016/j.biopsych.2007.06.022; Kim MJ, 2008, J PSYCHIATR RES, V42, P268, DOI 10.1016/j.jpsychires.2007.02.003; Kim MJ, 2005, NEUROREPORT, V16, P1049, DOI 10.1097/00001756-200507130-00004; Kopp B, 1996, PSYCHOPHYSIOLOGY, V33, P282, DOI 10.1111/j.1469-8986.1996.tb00425.x; Kuhn S, 2013, BIOL PSYCHIAT, V73, P70, DOI 10.1016/j.biopsych.2012.06.029; Larson MJ, 2007, J INT NEUROPSYCH SOC, V13, P961, DOI 10.1017/S1355617707071305; Larson MJ, 2012, J INT NEUROPSYCH SOC, V18, P323, DOI 10.1017/S1355617711001779; Larson MJ, 2009, NEUROPSYCHOLOGY, V23, P433, DOI 10.1037/a0015723; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Manoach DS, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00350; Mathalon DH, 2002, J ABNORM PSYCHOL, V111, P22, DOI 10.1037//0021-843X.111.1.22; Matthews S, 2012, PSYCHOSOM MED, V74, P471, DOI 10.1097/PSY.0b013e31824f888f; Miller GA, 2001, J ABNORM PSYCHOL, V110, P40, DOI 10.1037//0021-843X.110.1.40; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Morey RA, 2008, PSYCHIAT RES-NEUROIM, V162, P59, DOI 10.1016/j.pscychresns.2007.07.007; Overbeek TJM, 2005, J PSYCHOPHYSIOL, V19, P319, DOI 10.1027/0269-8803.19.4.319; Pontifex MB, 2009, NEUROPSYCHOLOGIA, V47, P3210, DOI 10.1016/j.neuropsychologia.2009.07.021; Posner MI, 2007, COGN AFFECT BEHAV NE, V7, P391, DOI 10.3758/CABN.7.4.391; Pratt N, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00057; RABBITT PMA, 1966, J EXP PSYCHOL, V71, P264, DOI 10.1037/h0022853; Rabinak CA, 2013, PSYCHIAT RES-NEUROIM, V213, P71, DOI 10.1016/j.pscychresns.2013.01.002; Rauch SL, 1996, ARCH GEN PSYCHIAT, V53, P380; Rauch SL, 2003, NEUROREPORT, V14, P913, DOI 10.1097/01.wnr.0000071767.24455.10; Ridderinkhof KR, 2007, COGN AFFECT BEHAV NE, V7, P261, DOI 10.3758/CABN.7.4.261; Rotteveel M, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00335; Ruchsow M, 2006, J PSYCHIATR RES, V40, P37, DOI 10.1016/j.jpsychires.2005.02.002; Rushworth MFS, 2004, TRENDS COGN SCI, V8, P410, DOI 10.1016/j.tics.2004.07.009; Salkovskis PM, 1999, BEHAV RES THER, V37, pS29, DOI 10.1016/S0005-7967(99)00049-2; Schrijvers D, 2009, INT J PSYCHOPHYSIOL, V71, P218, DOI 10.1016/j.ijpsycho.2008.09.005; Shin LM, 2007, J TRAUMA STRESS, V20, P701, DOI 10.1002/jts.20231; Shin LM, 2006, ANN NY ACAD SCI, V1071, P67, DOI 10.1196/annals.1364.007; Shin LM, 2011, AM J PSYCHIAT, V168, P979, DOI 10.1176/appi.ajp.2011.09121812; Shin LM, 2001, BIOL PSYCHIAT, V50, P932, DOI 10.1016/S0006-3223(01)01215-X; Solbakk AK, 2014, J COGNITIVE NEUROSCI, V26, P1528, DOI 10.1162/jocn_a_00561; Stemmer B, 2004, NEUROPSYCHOLOGIA, V42, P118, DOI 10.1016/S0028-3932(03)00121-0; Stuss DT, 2011, J INT NEUROPSYCH SOC, V17, P759, DOI 10.1017/S1355617711000695; Swick D, 2002, P NATL ACAD SCI USA, V99, P16354, DOI 10.1073/pnas.252521499; Swick D, 2013, NEUROPSYCHOLOGIA, V51, P3033, DOI 10.1016/j.neuropsychologia.2013.10.008; Swick D, 2012, J INT NEUROPSYCH SOC, V18, P917, DOI 10.1017/S1355617712000458; Tanielian T, 2008, INVISIBLE WOUNDS WAR; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Turken U, 2008, NEUROSCI LETT, V441, P7, DOI 10.1016/j.neulet.2008.05.115; Turken U, 2003, AM J PSYCHIAT, V160, P1881, DOI 10.1176/appi.ajp.160.10.1881; Ullsperger M, 2002, NEUROPSYCHOLOGY, V16, P548, DOI 10.1037//0894-4105.16.4.548; Ullsperger M, 2014, TRENDS COGN SCI, V18, P259, DOI 10.1016/j.tics.2014.02.009; Vaidyanathan U, 2012, PSYCHOL MED, V42, P447, DOI 10.1017/S0033291711001528; Wagenmakers EJ, 2011, J PERS SOC PSYCHOL, V100, P426, DOI 10.1037/a0022790; Weathers F.W., 1994, PTSD CHECKLIST MILIT; Weinberg A, 2012, J ABNORM PSYCHOL, V121, P885, DOI 10.1037/a0028270; Woodward SH, 2006, BIOL PSYCHIAT, V59, P582, DOI 10.1016/j.biopsych.2005.07.033; Xiao ZP, 2011, PROG NEURO-PSYCHOPH, V35, P265, DOI 10.1016/j.pnpbp.2010.11.022	100	11	11	1	23	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0925-4927	1872-7506		PSYCHIAT RES-NEUROIM	Psychiatry Res. Neuroimaging	NOV 30	2015	234	2					227	238		10.1016/j.pscychresns.2015.09.016			12	Clinical Neurology; Neuroimaging; Psychiatry	Neurosciences & Neurology; Psychiatry	CW5RF	WOS:000365053600010	26481979	Bronze, Green Accepted			2021-06-18	
J	Bowman, TG; Breedlove, KM; Breedlove, EL; Dodge, TM; Nauman, EA				Bowman, Thomas G.; Breedlove, Katherine M.; Breedlove, Evan L.; Dodge, Thomas M.; Nauman, Eric A.			Impact attenuation properties of new and used lacrosse helmets	JOURNAL OF BIOMECHANICS			English	Article						Gadd Severity Index; Head impact; Protective equipment; Drop test; Helmet evaluation	COLLEGIATE FOOTBALL PLAYERS; INJURY SURVEILLANCE SYSTEM; HIGH-SCHOOL FOOTBALL; DESCRIPTIVE EPIDEMIOLOGY; AMERICAN FOOTBALL; HEAD IMPACTS; CONCUSSIONS; BOYS	The National Operating Committee on Standards for Athletic Equipment (NOCSAE) has developed impact attenuation thresholds that protective helmets worn in sport must meet to be commercially available in an attempt to prevent injury. It remains unknown how normal helmet use in athletic activity alters the force attenuation ability of lacrosse helmets. We tested 3 new and 3 randomly selected used helmets from 2 popular lacrosse models (Cascade Pro7, Cascade CPXR). All used helmets had been worn for 3 collegiate seasons prior to testing and had never been refurbished. Helmets were drop-tested using 3 prescribed impact velocities at 6 locations according to the NOCSAE lacrosse helmet standard, and we compared the Gadd Severity Index (GSI) scores between new and used helmets using a repeated measure ANOVA with location as the repeated variable and data separated by impact velocity. All 12 helmets passed the NOCSAE GSI threshold for all testing conditions; however 1 used helmet shell cracked resulting in a failed test. We found a significant main effect for helmet age at the low (F-5,F-50 = 2.98, P = .02), medium (F-5,F-50 = 3.71, P = .006), and high (F-5,F-50 = 2.70, P = .03) velocities. We suspect that helmet use can degrade materials under some conditions, but improve performance in others due to changes in helmet composition from use. The clinical implications of the differences in GSI scores noted remain unclear. Because one helmet shell cracked resulting in a failed test, used helmets should be regularly inspected for cracks or other signs of mechanical fatigue that may weaken helmet integrity. (C) 2015 Elsevier Ltd. All rights reserved.	[Bowman, Thomas G.] Lynchburg Coll, Dept Athlet Training, Lynchburg, VA 24501 USA; [Breedlove, Katherine M.] Purdue Univ, Dept Hlth & Kinesiol, W Lafayette, IN 47907 USA; [Breedlove, Evan L.; Nauman, Eric A.] Purdue Univ, Sch Mech Engn, W Lafayette, IN 47907 USA; [Dodge, Thomas M.] Springfield Coll, Dept Exercise Sci & Sport Studies, Springfield, MA 01109 USA; [Nauman, Eric A.] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA; [Nauman, Eric A.] Purdue Univ, Dept Basic Med Sci, W Lafayette, IN 47907 USA	Bowman, TG (corresponding author), Lynchburg Coll, Dept Athlet Training, Lynchburg, VA 24501 USA.	Bowman.t@lynchburg.edu	Bowman, Thomas/AAA-3036-2020; Bowman, Tom/AAU-6473-2020	Bowman, Thomas/0000-0002-0034-2946; 	Indiana State Department of Health Spinal Cord and Brain Injury Research Fund; Indiana Clinical and Translational Sciences Institute; Purdue's Office of the Vice President for Research; Lynchburg College	This work was supported in part by grants from the Indiana State Department of Health Spinal Cord and Brain Injury Research Fund, a Core Facility Grant from the Indiana Clinical and Translational Sciences Institute, Purdue's Office of the Vice President for Research, and a faculty development grant from Lynchburg College. We would like to thank the Lynchburg College men's lacrosse program for donating the used helmets tested in the current study. In addition, we thank Jay Hertel, PhD, ATC, FNATA, FACSM for his assistance with the statistical approach to data analysis.	Bachynski KE, 2014, J LAW MED ETHICS, V42, P323, DOI 10.1111/jlme.12149; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Breedlove KM., 2014, ATHLETIC TRAIN SPORT, V6, P119, DOI [10.3928/19425864-20140507-02, DOI 10.3928/19425864-20140507-02]; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Cascade Lacrosse, HELM SAF BOOKL; Caswell SV, 2002, J ATHL TRAINING, V37, P164; Covassin T, 2003, J ATHL TRAINING, V38, P238; Dick R, 2007, J ATHL TRAINING, V42, P255; Dick R, 2007, J ATHL TRAINING, V42, P221; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Gadd CW, 1966, P 10 STAPP CAR CRASH; Goldsmith Werner, 2005, Critical Reviews in Biomedical Engineering, V33, P105, DOI 10.1615/CritRevBiomedEng.v33.i2.20; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; Higgins M.J., 2015, J ATHL TRAINING, V50; Hinton RY, 2005, AM J SPORT MED, V33, P1305, DOI 10.1177/0363546504274148; Ji SB, 2014, ANN BIOMED ENG, V42, P11, DOI 10.1007/s10439-013-0907-2; Koehling E.M., 2015, J ATHL TRAINING, V50; Lincoln AE, 2007, AM J SPORT MED, V35, P207, DOI 10.1177/0363546506293900; Lincoln AE, 2013, AM J SPORT MED, V41, P756, DOI 10.1177/0363546513476265; NCAA, 2015 16 NCAA MENS LA; NOCSAE, 2012, 04111M12 NOCSAE ND; NOCSAE, 2011, 04204M11A NOCSAE ND; NOCSAE, NOCS BOARD APPR 1 HE; NOCSAE, 2013, 00111M13 NOCSAE ND; NOCSAE, 2006, 08104M04 NOCSAE ND; O'Day K.M., 2015, J ATHL TRAINING, V50; Post A, 2013, MATER DESIGN, V45, P653, DOI 10.1016/j.matdes.2012.09.017; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Vollavanh L.R., 2015, J ATHL TRAINING, V50	31	11	12	0	5	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-9290	1873-2380		J BIOMECH	J. Biomech.	NOV 5	2015	48	14					3782	3787		10.1016/j.jbiomech.2015.08.026			6	Biophysics; Engineering, Biomedical	Biophysics; Engineering	CX9YZ	WOS:000366064000007	26429768				2021-06-18	
J	Topolovec-Vranic, J; Zhang, S; Wong, H; Lam, E; Jing, RW; Russell, K; Cusimano, MD				Topolovec-Vranic, Jane; Zhang, Stanley; Wong, Hatty; Lam, Emily; Jing, Rowan; Russell, Kelly; Cusimano, Michael D.		Canadian Brain Injury Violence Res	Recognizing the Symptoms of Mental Illness following Concussions in the Sports Community: A Need for Improvement	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; PUBLIC KNOWLEDGE; FOOTBALL PLAYERS; SEX-DIFFERENCES; HEAD-INJURY; POPULATION; PROFESSIONALS; ADOLESCENTS; ENGLAND; RISK	Objective To evaluate the awareness of concussion-related symptoms amongst members of the sports community in Canada. Methods A cross-sectional national electronic survey was conducted. Youth athletes, parents, coaches and medical professionals across Canada were recruited through mailing lists from sports-related opt-in marketing databases. Participants were asked to identify, from a list of options, the symptoms of a concussion. The proportion of identified symptoms (categorized as physical, cognitive, mental health-related and overall) as well as participant factors associated with symptom recognition were analyzed. Results The survey elicited 6,937 responses. Most of the respondents (92.1%) completed the English language survey, were male (57.7%), 35-54 years of age (61.7%), with post-secondary education (58.2%), or high reported yearly household income (>$80,000; 53.0%). There were respondents from all provinces and territories with the majority of respondents from Ontario (35.2%) or British Columbia (19.1%). While participants identified most of the physical (mean = 84.2% of symptoms) and cognitive (mean = 91.2% of symptoms), they on average only identified 53.5% of the mental health-related symptoms of concussions. Respondents who were older, with higher education and household income, or resided in the Northwest Territories or Alberta identified significantly more of the mental health-related symptoms listed. Interpretation While Canadian youth athletes, parents, coaches and medical professionals are able to identify most of the physical and cognitive symptoms associated with concussion, identification of mental health-related symptoms of concussion is still lagging.	[Topolovec-Vranic, Jane; Cusimano, Michael D.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Topolovec-Vranic, Jane; Cusimano, Michael D.] St Michaels Hosp, Trauma & Neurosurg Program, Toronto, ON M5B 1W8, Canada; [Topolovec-Vranic, Jane] Univ Toronto, Fac Med Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [Zhang, Stanley; Wong, Hatty; Lam, Emily; Jing, Rowan; Cusimano, Michael D.] St Michaels Hosp, Div Neurosurg, Toronto, ON M5B 1W8, Canada; [Russell, Kelly] Univ Manitoba, Dept Pediat, Winnipeg, MB R3T 2N2, Canada; [Cusimano, Michael D.] Univ Toronto, Fac Med, Toronto, ON, Canada; [Cusimano, Michael D.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada	Cusimano, MD (corresponding author), St Michaels Hosp, Li Ka Shing Knowledge Inst, 30 Bond St, Toronto, ON M5B 1W8, Canada.	injuryprevention@smh.ca	Meijer, Anna/K-5118-2016; Topolovec-Vranic, Jane/A-5293-2013; Cusimano, Michael/X-4059-2019	Topolovec-Vranic, Jane/0000-0001-7695-4212; Cusimano, Michael/0000-0002-9989-0650; Russell, Kelly/0000-0002-9159-9201	Canadian Institutes of Health Research Strategic Team Grant in Applied Injury ResearchCanadian Institutes of Health Research (CIHR) [TIR-103946]; Ontario Neurotrauma Foundation; Public Health Agency of Canada	This research was supported by the Canadian Institutes of Health Research Strategic Team Grant in Applied Injury Research #TIR-103946, the Ontario Neurotrauma Foundation, and Public Health Agency of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Author, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058868, DOI 10.1371/J0URNAL.P0NE.0058868]; Babul S, 2014, BRIT J SPORT MED, V48, P563, DOI [10.1136/bjsports-2014-093494.11, DOI 10.1136/BJSP0RTS-2014-093494.11]; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Bazarian JJ, 2006, ACAD EMERG MED, V13, P31, DOI 10.1197/j.aem.2005.07.038; Blake T, 2014, BRIT J SPORT MED, V48, P570, DOI [10.1136/bjsports-2014-093494.28, DOI 10.1136/BJSP0RTS-2014-093494.28]; Burke MJ, 2012, CAN J NEUROL SCI, V39, P763, DOI 10.1017/S0317167100015584; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS210, DOI 10.1016/j.apmr.2013.06.035; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS278, DOI 10.1016/j.apmr.2013.08.295; Chrisman SPD, 2014, J ADOLESCENT HEALTH, V54, P582, DOI 10.1016/j.jadohealth.2013.10.006; Covassin T, 2009, J ATHL TRAINING, V44, P400, DOI 10.4085/1062-6050-44.4.400; Cusimano MD, 2013, CAN MED ASSOC J, V185, pE57, DOI 10.1503/cmaj.112017; Cusimano MD, 2009, CAN J NEUROL SCI, V36, P315, DOI 10.1017/S0317167100007046; Delaney JS, 2000, CLIN J SPORT MED, V10, P9, DOI 10.1097/00042752-200001000-00003; Demakis GJ, 2010, ARCH CLIN NEUROPSYCH, V25, P191, DOI 10.1093/arclin/acq004; Ettenhofer ML, 2009, J CLIN EXP NEUROPSYC, V31, P363, DOI 10.1080/13803390802175270; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; Grubenhoff JA, 2011, BRAIN INJURY, V25, P943, DOI 10.3109/02699052.2011.597043; Guilmette TJ, 2007, BRAIN INJURY, V21, P1039, DOI 10.1080/02699050701633080; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Hogg RV., 2005, INTRO MATH STAT, V6; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Ilie G, 2014, BULLYING OTHER CONDU, V9, P10, DOI DOI 10.1371/J0URNAL.P0NE.0094936; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lebrun C, 2014, BRIT J SPORT MED, V48, P623, DOI [10.1136/bjsports-2014-093494.171, DOI 10.1136/BJSP0RTS-2014-093494.171]; Luis CA, 2002, J CLIN EXP NEUROPSYC, V24, P270, DOI 10.1076/jcen.24.3.270.982; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; Mckinlay A, 2011, BRAIN INJURY, V25, P761, DOI 10.3109/02699052.2011.579935; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; ODDY M, 1978, J NEUROL NEUROSUR PS, V41, P611, DOI 10.1136/jnnp.41.7.611; Papa L, 2012, CURR GERIATR REP, V1, P135, DOI 10.1007/s13670-012-0019-0; Staudenmayer KL, 2007, J TRAUMA, V63, P1364, DOI 10.1097/TA.0b013e31815b897b; Styrke J, 2013, J REHABIL MED, V45, P749, DOI 10.2340/16501977-1215; Swift TL, 2001, BRAIN INJURY, V15, P149, DOI 10.1080/026990501458380; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Whitaker S, 2012, FAM PRACT, V29, P168, DOI 10.1093/fampra/cmr079; Zemper ED, 2003, AM J PHYS MED REHAB, V82, P653, DOI 10.1097/01.PHM.0000083666.74494.BA	40	11	11	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141699	10.1371/journal.pone.0141699			13	Multidisciplinary Sciences	Science & Technology - Other Topics	CV5GZ	WOS:000364298400078	26536016	DOAJ Gold, Green Published			2021-06-18	
J	Acker, SN; Ross, JT; Partrick, DA; Bensard, DD				Acker, Shannon N.; Ross, James T.; Partrick, David A.; Bensard, Denis D.			A pediatric specific shock index in combination with GMS identifies children with life threatening or severe traumatic brain injury	PEDIATRIC SURGERY INTERNATIONAL			English	Article						Children; Traumatic brain injury; Shock index; Hypotension; Age adjusted shock index	GLASGOW COMA SCALE; RISK; TRANSFUSION	We have previously demonstrated that a shock index, pediatric age adjusted (SIPA) accurately identifies severely blunt injured children. We aimed to determine if SIPA could more accurately identify children with severe traumatic brain injury (TBI) than hypotension alone. We performed subset analysis of those children with TBI among a cohort of children age 4-16 years with blunt trauma and injury severity score a parts per thousand yen15 from 1/07 to 6/13. We evaluated the ability of four markers to identify the most severely brain injured children. Markers included hypotension, elevated SIPA, abnormal GCS motor score (GMS), and elevated SIPA or abnormal GMS. We aimed to determine which of these four markers had the highest sensitivity in identifying severely injured children. Three hundred and ninety-two (392) children were included. Hypotension was present in 24 patients (6 %); elevated SIPA in 106 (27 %), abnormal GMS in 172 (44 %), and elevated SIPA or abnormal GMS in 206 (53 %). All markers were able to accurately identify severely injured children with TBI. Elevated SIPA or abnormal GMS identified a greater percentage of patients with each of seven complications with higher sensitivity than each of the three other markers. Among blunt injured children with TBI, elevated SIPA or abnormal GMS identifies severely brain injured children.	[Acker, Shannon N.; Ross, James T.; Partrick, David A.] Univ Colorado, Sch Med, Childrens Hosp Colorado, Dept Pediat Surg, Aurora, CO 80045 USA; [Bensard, Denis D.] Denver Hlth Med Ctr, Dept Surg, Denver, CO USA	Acker, SN (corresponding author), Univ Colorado, Sch Med, Childrens Hosp Colorado, Dept Pediat Surg, 12631 E 17th Ave,C302, Aurora, CO 80045 USA.	shannon.acker@ucdenver.edu; James.ross2@ucsf.edu; david.partrick@childrenscolorado.org; denis.bensard@dhha.org					Acker SN, 2015, J PEDIATR SURG, V50, P331, DOI 10.1016/j.jpedsurg.2014.08.009; Acker SN, 2014, J TRAUMA ACUTE CARE, V77, P304, DOI 10.1097/TA.0000000000000300; Acker SN, 2014, J TRAUMA ACUTE CARE, V76, P1082, DOI 10.1097/TA.0000000000000095; American College of Surgeons. Committe on Trauma, 2008, ADV TRAUM LIF SUPP D; Atabaki SM, 2006, CLIN PEDIATR EMERG M, V7, P94, DOI 10.1016/j.cpem.2006.03.003; Barraco RD, 2010, PRACTICE MANAGEMENT; Brain Trauma Foundation, 2007, GUID PREH MAN TRAUM; Bruijns SR, 2013, J TRAUMA ACUTE CARE, V74, P1432, DOI 10.1097/TA.0b013e31829246c7; Cannon CM, 2009, J TRAUMA, V67, P1426, DOI 10.1097/TA.0b013e3181bbf728; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Kokoska ER, 1998, J PEDIATR SURG, V33, P333, DOI 10.1016/S0022-3468(98)90457-2; Kornbluth J, 2011, NEUROCRIT CARE, V14, P134, DOI 10.1007/s12028-010-9409-3; LIEHLAI MW, 1992, J PEDIATR-US, V120, P195, DOI 10.1016/S0022-3476(05)80426-3; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Vandromme MJ, 2011, J TRAUMA, V70, P384, DOI 10.1097/TA.0b013e3182095a0a; Vavilala MS, 2003, J TRAUMA, V55, P1039, DOI 10.1097/01.TA.0000101759.23607.57	17	11	11	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0179-0358	1437-9813		PEDIATR SURG INT	Pediatr. Surg. Int.	NOV	2015	31	11					1041	1046		10.1007/s00383-015-3789-6			6	Pediatrics; Surgery	Pediatrics; Surgery	CT8BO	WOS:000363040200006	26349487				2021-06-18	
J	Bueso-Izquierdo, N; Hart, SD; Hidalgo-Ruzzante, N; Kropp, PR; Perez-Garcia, M				Bueso-Izquierdo, Natalia; Hart, Stephen D.; Hidalgo-Ruzzante, Natalia; Kropp, P. Randall; Perez-Garcia, Miguel			The mind of the male batterer: A neuroscience perspective	AGGRESSION AND VIOLENT BEHAVIOR			English	Article						Intimate partner violence; Batterers; Neuropsychology; Neuroimaging and psychophysiology	INTIMATE PARTNER VIOLENCE; EXECUTIVE FUNCTION DEFICITS; TRAUMATIC BRAIN-INJURY; HEART-RATE REACTIVITY; DOMESTIC VIOLENCE; COGNITIVE NEUROSCIENCE; AGGRESSIVE-BEHAVIOR; MEN; ALCOHOL; PERPETRATION	This review analyzes neuropsychology, psychophysiology, and neuroimaging studies that examine the neuropsychological functioning and the nervous system (central and peripheral) of male batterers. Previous research has attempted to establish a neuropsychological profile for batterers. Yet factors such as brain injury, drug abuse antecedents, and other methodological concerns (e.g., sample size, control group selection, education level, socio-economic status, ethnicity, variability of the specific neuropsychological measures, and constructs assessed) may have led to inconsistent results. Neuropsychological studies reveal that poor performance on tests of executive functioning, verbal skills, and vocabulary is the most frequently reported characteristic for these men. With regard to research on the central and peripheral nervous system, these results should be considered with caution due to the small number of studies conducted on this topic. Therefore, the neuroscientific approach may be utilized in future studies to provide a better account of batterer typologies, the individualization of therapeutic approaches, and the prediction of recidivism. In summary, advancing our understanding of the mind and brain functioning of male batterers may aid in the prediction and reduction of violence against women in the future. (C) 2015 Elsevier Ltd. All rights reserved.	[Bueso-Izquierdo, Natalia; Perez-Garcia, Miguel] Univ Granada, Sch Psychol, E-18071 Granada, Spain; [Bueso-Izquierdo, Natalia; Hidalgo-Ruzzante, Natalia; Perez-Garcia, Miguel] Univ Granada CIMCYC UGR, Brain Mind & Behav Res Ctr, Granada 18071, Spain; [Hart, Stephen D.] Simon Fraser Univ, Dept Psychol, Burnaby, BC V5A 1S6, Canada; [Hidalgo-Ruzzante, Natalia] Univ Granada, Dept Evolutionary & Educ Psychol, E-18071 Granada, Spain; [Kropp, P. Randall] Forens Psychiat Serv Commiss British Columbia, Vancouver, BC V5A 1P8, Canada; [Perez-Garcia, Miguel] CIBERSAM, Cibersam Ctr Invest Biomed Red Salud Mental, Granada C1BERSAM, Spain	Bueso-Izquierdo, N (corresponding author), Univ Granada CIMCYC UGR, Brain Mind & Behav Res Ctr, Spain Campus Cartuja S-N, Granada 18071, Spain.	nbueso@ugr.es; hart@sfu.ca; nhidalgo@ugr.es; rkropp@sfu.ca; mperezg@ugr.es	Hart, Stephen D./D-3908-2013; Garcia, Miguel Perez/F-9630-2010; Hidalgo-Ruzzante, Natalia/F-1108-2016	Hart, Stephen D./0000-0002-1027-6081; Garcia, Miguel Perez/0000-0003-4775-7556; Hidalgo-Ruzzante, Natalia/0000-0002-9952-9478; Bueso Izquierdo, Natalia/0000-0002-2469-8867	Ministry of Science and Innovation, Spain (MICINN)Spanish Government [PSI 2009-13585]; Ministry of Economy and Competitiveness [PSI2013-42792-R]; Regional Ministry of Economy, Innovation and Science from Andalusian Government [P2012-SEJ1723]	This work has been funded by grants grant by the Ministry of Science and Innovation, Spain (MICINN) (Project: PSI 2009-13585), Ministry of Economy and Competitiveness (Project: PSI2013-42792-R), and Regional Ministry of Economy, Innovation and Science from Andalusian Government (Project: P2012-SEJ1723). The authors declare no conflicts of interest.	Babcock JC, 2005, J ABNORM PSYCHOL, V114, P444, DOI 10.1037/0021-843X.114.3.444; Babcock JC, 2004, J FAM PSYCHOL, V18, P396, DOI 10.1037/0893-3200.18.2.396; Bell KM, 2008, CLIN PSYCHOL REV, V28, P1096, DOI 10.1016/j.cpr.2008.03.003; Blair RJR, 2013, SOC NEUROSCI-UK, V8, P108, DOI 10.1080/17470919.2012.757869; Cacioppo JT, 2000, PSYCHOL BULL, V126, P829, DOI 10.1037//0033-2909.126.6.829; Chan SC, 2010, PSYCHIAT RES, V176, P246, DOI 10.1016/j.psychres.2008.12.013; Chiao JY, 2009, PROG BRAIN RES, V178, P287, DOI 10.1016/S0079-6123(09)17821-4; Choi MH, 2011, PSYCHIAT RES, V186, P441, DOI 10.1016/j.psychres.2010.08.035; Claramunt C., 1999, CASITAS QUEBRADAS PR; Cohen R A, 1999, Violence Vict, V14, P397; Cohen RA, 2003, J INT NEUROPSYCH SOC, V9, P760, DOI 10.1017/S1355617703950090; Cole WR, 2008, BRAIN INJURY, V22, P932, DOI 10.1080/02699050802454808; Corvo K., 2006, J AGGRESS MALTREAT T, V13, P49; Corvo K, 2014, PARTN ABUSE, V5, P342, DOI 10.1891/1946-6560.5.3.342; Corvo K, 2015, PARTN ABUSE, V6, P351, DOI 10.1891/1946-6560.6.3.351; Corvo K, 2013, AGGRESS VIOLENT BEH, V18, P175, DOI 10.1016/j.avb.2012.11.017; Easton CJ, 2008, AM J DRUG ALCOHOL AB, V34, P29, DOI 10.1080/00952990701764326; Echeverri-Vera J. A., 2010, PENSANDO PSICOL, V6, P157; Fabian JM, 2010, AGGRESS VIOLENT BEH, V15, P209, DOI 10.1016/j.avb.2009.12.004; Farrer TJ, 2012, TRAUMA VIOLENCE ABUS, V13, P77, DOI 10.1177/1524838012440338; Fernandez-Serrano MJ, 2011, NEUROSCI BIOBEHAV R, V35, P377, DOI 10.1016/j.neubiorev.2010.04.008; FitzGeraid M. J. T., 2011, CLIN NEUROANATOMY NE; Foran HM, 2008, CLIN PSYCHOL REV, V28, P1222, DOI 10.1016/j.cpr.2008.05.001; George DT, 2004, PSYCHIAT RES-NEUROIM, V130, P11, DOI 10.1016/S0925-4927(03)00105-7; Gondolf E W, 1997, Violence Vict, V12, P373; Gondolf E W, 1988, Violence Vict, V3, P187; GOTTMAN JM, 1995, J FAM PSYCHOL, V9, P227, DOI 10.1037/0893-3200.9.3.227; Green AE, 2008, NAT REV NEUROSCI, V9, P710, DOI 10.1038/nrn2461; Holtzworth-Munroe A, 2000, J CONSULT CLIN PSYCH, V68, P1000, DOI 10.1037/0022-006X.68.6.1000; HOLTZWORTHMUNROE A, 1994, PSYCHOL BULL, V116, P476, DOI 10.1037/0033-2909.116.3.476; JACOBSON NS, 1994, J CONSULT CLIN PSYCH, V62, P982, DOI 10.1037/0022-006X.62.5.982; Kingsnorth R, 2006, VIOLENCE AGAINST WOM, V12, P917, DOI 10.1177/1077801206293081; Lee TMC, 2008, MOL PSYCHIATR, V13, P655, DOI 10.1038/mp.2008.46; Lee TMC, 2009, J CLIN PSYCHIAT, V70, P36, DOI 10.4088/JCP.08m04143; Lezak M.D., 2004, NEUROPSYCHOLOGICAL A, Vfourth; Loinaz I, 2010, PSICOTHEMA, V22, P106; MARGOLIN G, 1988, J CONSULT CLIN PSYCH, V56, P24, DOI 10.1037/0022-006X.56.1.24; Marsh NV, 2006, BRAIN INJURY, V20, P61, DOI 10.1080/02699050500110645; McMurran M, 2008, PSYCHOL CRIME LAW, V14, P107, DOI 10.1080/10683160701483435; Meehan JC, 2001, J FAM PSYCHOL, V15, P394, DOI 10.1037//0893-3200.15.3.394; Merino B., 2009, C IN DENTR CURS HUM, V21, P1; Moll J, 2005, NAT REV NEUROSCI, V6, P799, DOI 10.1038/nrn1768; Murphy CM, 2010, AGGRESS VIOLENT BEH, V15, P325, DOI 10.1016/j.avb.2010.01.006; Noble KG, 2007, DEVELOPMENTAL SCI, V10, P464, DOI 10.1111/j.1467-7687.2007.00600.x; Noble KG, 2012, DEVELOPMENTAL SCI, V15, P516, DOI 10.1111/j.1467-7687.2012.01147.x; Odhuba RA, 2005, BRIT J CLIN PSYCHOL, V44, P269, DOI 10.1348/014466505X29431; Patrick CJ, 2008, PHILOS T R SOC B, V363, P2543, DOI 10.1098/rstb.2008.0028; Pinto LA, 2010, AGGRESS VIOLENT BEH, V15, P387, DOI 10.1016/j.avb.2010.07.001; Puente A. E., 2013, HDB MULTICULTURAL ME, P225; Romero-Martinez A, 2013, INT J PSYCHOPHYSIOL, V90, P329, DOI 10.1016/j.ijpsycho.2013.10.003; Romero-Martinez A, 2014, STRESS, V17, P321, DOI 10.3109/10253890.2014.919448; ROSENBAUM A, 1994, J CONSULT CLIN PSYCH, V62, P1187, DOI 10.1037/0022-006X.62.6.1187; ROSENBAUM A, 1989, AM J PSYCHIAT, V146, P1048; Schafer J, 1997, ADDICT BEHAV, V22, P127, DOI 10.1016/S0306-4603(96)00012-3; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Siegel JP, 2013, TRAUMA VIOLENCE ABUS, V14, P295, DOI 10.1177/1524838013495982; Siever LJ, 2008, AM J PSYCHIAT, V165, P429, DOI 10.1176/appi.ajp.2008.07111774; Stanford MS, 2007, PERS INDIV DIFFER, V43, P365, DOI 10.1016/j.paid.2006.12.011; Teichner G, 2001, INT J NEUROSCI, V111, P241, DOI 10.3109/00207450108994235; Thomas MD, 2013, J FAM VIOLENCE, V28, P121, DOI 10.1007/s10896-012-9479-4; Turkstra L, 2003, BRAIN INJURY, V17, P39, DOI 10.1080/0269905021000010122; Villemaratte-Pittman N. R., 2003, PERSONALITY INDIVIDU, V34, P1533, DOI [10.1016/S0191-8869(02)00136-8., DOI 10.1016/S0191-8869(02)00136-8]; Walling SM, 2012, J MARITAL FAM THER, V38, P471, DOI 10.1111/j.1752-0606.2011.00226.x; Westby MD, 1999, GENET SOC GEN PSYCH, V125, P71; World Health Organization, 2013, GLOB REG EST VIOL WO; Zhang LS, 2013, ADDICT BIOL, V18, P537, DOI 10.1111/j.1369-1600.2011.00381.x	66	11	11	0	21	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1359-1789	1873-6335		AGGRESS VIOLENT BEH	Aggress. Violent Behav.	NOV-DEC	2015	25		B				243	251		10.1016/j.avb.2015.09.009			9	Criminology & Penology; Psychology, Multidisciplinary	Criminology & Penology; Psychology	CY9ZW	WOS:000366765900007					2021-06-18	
J	Kamourieh, S; Braga, RM; Leech, R; Newbould, RD; Malhotra, P; Wise, RJS				Kamourieh, Salwa; Braga, Rodrigo M.; Leech, Robert; Newbould, Rexford D.; Malhotra, Paresh; Wise, Richard J. S.			Neural Systems Involved When Attending to a Speaker	CEREBRAL CORTEX			English	Article						attention; cognitive control; functional mRI; right anterior insula; speech	INDEPENDENT COMPONENT ANALYSIS; POSTERIOR CINGULATE CORTEX; TRAUMATIC BRAIN-INJURY; SELECTIVE ATTENTION; AUDITORY FMRI; NETWORKS; CONNECTIVITY; ARCHITECTURE; SPEECH; ROBUST	Remembering what a speaker said depends on attention. During conversational speech, the emphasis is on working memory, but listening to a lecture encourages episodic memory encoding. With simultaneous interference from background speech, the need for auditory vigilance increases. We recreated these context-dependent demands on auditory attention in 2 ways. The first was to require participants to attend to one speaker in either the absence or presence of a distracting background speaker. The second was to alter the task demand, requiring either an immediate or delayed recall of the content of the attended speech. Across 2 fMRI studies, common activated regions associated with segregating attended from unattended speech were the right anterior insula and adjacent frontal operculum (aI/FOp), the left planum temporale, and the precuneus. In contrast, activity in a ventral right frontoparietal system was dependent on both the task demand and the presence of a competing speaker. Additional multivariate analyses identified other domain-general frontoparietal systems, where activity increased during attentive listening but was modulated little by the need for speech stream segregation in the presence of 2 speakers. These results make predictions about impairments in attentive listening in different communicative contexts following focal or diffuse brain pathology.	[Kamourieh, Salwa; Braga, Rodrigo M.; Leech, Robert; Newbould, Rexford D.; Malhotra, Paresh; Wise, Richard J. S.] Univ London Imperial Coll Sci Technol & Med, Computat Cognit & Clin Neuroimaging Lab, Div Brain Sci, London W12 0NN, England; [Newbould, Rexford D.] Imanova Ctr Imaging Sci, London W12 0NN, England	Kamourieh, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, Computat Cognit & Clin Neuroimaging Lab, Div Brain Sci, Hammersmith Hosp Campus,Du Cane Rd, London W12 0NN, England.	salwa.kamourieh@imperial.ac.uk	Leech, Robert/AAE-8254-2019; Malhotra, Paresh/A-5227-2009	Leech, Robert/0000-0002-5801-6318; Malhotra, Paresh/0000-0002-1897-0780	Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G1100423]; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MR/K014129/1] Funding Source: researchfish	This work was supported by the Medical Research Council (G1100423). Funding to pay the Open Access publication charges for this article was provided by the Medical Research Council.	Algazi VR, 2001, J ACOUST SOC AM, V109, P1110, DOI 10.1121/1.1349185; Aron AR, 2014, TRENDS COGN SCI, V18, P177, DOI 10.1016/j.tics.2013.12.003; Beckmann CF, 2003, NEUROIMAGE, V20, P1052, DOI 10.1016/S1053-8119(03)00435-X; Beckmann CF, 2005, NEUROIMAGE, V25, P294, DOI 10.1016/j.neuroimage.2004.10.043; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Bennett CM, 2010, ANN NY ACAD SCI, V1191, P133, DOI 10.1111/j.1749-6632.2010.05446.x; Boccia M, 2014, NEUROPSYCHOL REV, V24, P236, DOI 10.1007/s11065-014-9247-8; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bregman A.S., 1990, AUDITORY SCENE ANAL; Brungart DS, 2001, J ACOUST SOC AM, V109, P1101, DOI 10.1121/1.1345696; Carlyon RP, 2004, TRENDS COGN SCI, V8, P465, DOI 10.1016/j.tics.2004.08.008; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Corbetta M, 2011, ANNU REV NEUROSCI, V34, P569, DOI 10.1146/annurev-neuro-061010-113731; Darwin CJ, 2008, PHILOS T R SOC B, V363, P1011, DOI 10.1098/rstb.2007.2156; Darwin CJ, 2000, J ACOUST SOC AM, V107, P970, DOI 10.1121/1.428278; Darwin CJ, 2000, J ACOUST SOC AM, V108, P335, DOI 10.1121/1.429468; Dosenbach NUF, 2008, TRENDS COGN SCI, V12, P99, DOI 10.1016/j.tics.2008.01.001; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Duncan J, 2013, NEURON, V80, P35, DOI 10.1016/j.neuron.2013.09.015; Duncan J, 2010, TRENDS COGN SCI, V14, P172, DOI 10.1016/j.tics.2010.01.004; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Fedorenko E, 2013, P NATL ACAD SCI USA, V110, P16616, DOI 10.1073/pnas.1315235110; Feng AS, 2000, ANNU REV PSYCHOL, V51, P699, DOI 10.1146/annurev.psych.51.1.699; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Geranmayeh F, 2014, BRAIN, V137, P2632, DOI 10.1093/brain/awu163; Griffiths TD, 2002, TRENDS NEUROSCI, V25, P348, DOI 10.1016/S0166-2236(02)02191-4; Hall DA, 1999, HUM BRAIN MAPP, V7, P213, DOI 10.1002/(SICI)1097-0193(1999)7:3<213::AID-HBM5>3.0.CO;2-N; Hampshire A, 2012, NEURON, V76, P1225, DOI 10.1016/j.neuron.2012.06.022; Hampshire A, 2010, NEUROIMAGE, V50, P1313, DOI 10.1016/j.neuroimage.2009.12.109; Hyvarinen A, 1999, IEEE T NEURAL NETWOR, V10, P626, DOI 10.1109/72.761722; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; KALIKOW DN, 1977, J ACOUST SOC AM, V61, P1337, DOI 10.1121/1.381436; Kelly AMC, 2008, NEUROIMAGE, V39, P527, DOI 10.1016/j.neuroimage.2007.08.008; Klinkenberg I, 2011, BEHAV BRAIN RES, V221, P430, DOI 10.1016/j.bbr.2010.11.033; Leech R, 2014, BRAIN, V137, P12, DOI 10.1093/brain/awt162; Leech R, 2012, J NEUROSCI, V32, P215, DOI 10.1523/JNEUROSCI.3689-11.2012; Leech R, 2011, J NEUROSCI, V31, P3217, DOI 10.1523/JNEUROSCI.5626-10.2011; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Obleser J, 2007, J NEUROSCI, V27, P2283, DOI 10.1523/JNEUROSCI.4663-06.2007; Robertson IH, 2014, NEUROBIOL AGING, V35, P1375, DOI 10.1016/j.neurobiolaging.2013.11.028; Roca M, 2010, BRAIN, V133, P234, DOI 10.1093/brain/awp269; Schwarzbauer C, 2006, NEUROIMAGE, V29, P774, DOI 10.1016/j.neuroimage.2005.08.025; Shallice T, 2008, FRONT NEUROSCI-SWITZ, V2, P79, DOI 10.3389/neuro.01.013.2008; Singh-Curry V, 2009, NEUROPSYCHOLOGIA, V47, P1434, DOI 10.1016/j.neuropsychologia.2008.11.033; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Snyder JS, 2007, PSYCHOL BULL, V133, P780, DOI 10.1037/0033-2909.133.5.780; Vincent JL, 2008, J NEUROPHYSIOL, V100, P3328, DOI 10.1152/jn.90355.2008; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727; Woolgar A, 2013, J COGNITIVE NEUROSCI, V25, P1542, DOI 10.1162/jocn_a_00432; Woolgar A, 2011, J NEUROSCI, V31, P14592, DOI 10.1523/JNEUROSCI.2616-11.2011; Zundorf IC, 2014, BRAIN, V137, P1410, DOI 10.1093/brain/awu044; Zundorf IC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064259	58	11	11	0	7	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1047-3211	1460-2199		CEREB CORTEX	Cereb. Cortex	NOV	2015	25	11					4284	4298		10.1093/cercor/bhu325			15	Neurosciences	Neurosciences & Neurology	CY5QW	WOS:000366463300023	25596592	Green Published, Bronze			2021-06-18	
J	Krych, AJ; Sousa, PL; King, AH; Morgan, JA; May, JH; Dahm, DL				Krych, Aaron J.; Sousa, Paul L.; King, Alexander H.; Morgan, Joseph A.; May, Jedediah H.; Dahm, Diane L.			The Effect of Cartilage Injury After Arthroscopic Stabilization for Shoulder Instability	ORTHOPEDICS			English	Article							HUMERAL HEAD; OSTEOCHONDRITIS-DISSECANS; INTRAARTICULAR PATHOLOGY; ANTERIOR DISLOCATION; AMERICAN SHOULDER; LESIONS; RESPONSIVENESS; OSTEOARTHRITIS; ARTHROPLASTY; RELIABILITY	This study was undertaken to (1) determine the incidence of articular cartilage injuries in patients with instability of the glenohumeral joint, (2) determine whether recurrent dislocations increased the risk of articular damage, and (3) correlate these injuries with postoperative clinical outcomes. A cohort was identified of consecutive patients who underwent diagnostic magnetic resonance imaging and shoulder arthroscopy for glenohumeral instability with documented dislocation or subluxation between 1997 and 2006 at a single institution. Patients with moderate or severe osteoarthritis were excluded. Arthroscopic findings were recorded, including lesion location and Outerbridge grade. The American Shoulder and Elbow Surgeons Standardized Shoulder Assessment Form (ASES) was used to assess outcome in 61 patients who were available for follow-up. Outcomes were compared between shoulders with and without articular lesions. A total of 87 shoulders (83 patients) met the inclusion criteria, with 69 (83%) men and 14 (17%) women. Mean age was 26.1 years (range, 18-64 years), and mean follow-up was 36 months (range, 33-39 months). Cartilage injuries were found in 56 shoulders (64%). Previously documented shoulder dislocation requiring closed reduction (P=.046) and the number of discrete dislocations (P=.032) were significant for glenoid injury. A greater number of dislocations was associated with higher-grade lesions of the glenohumeral joint (P<.001). Overall, mean ASES score was 89.6 (range, 37-100). In patients with an articular cartilage lesion, mean ASES score was 90.4 (range, 58-100) compared with 88.1 (range, 37-100) in those without this injury (P=.75). Although clinical outcomes were not significantly affected, further investigation is warranted to establish a relationship between these injuries and longer-term outcomes.	[Krych, Aaron J.; Morgan, Joseph A.; May, Jedediah H.; Dahm, Diane L.] Mayo Clin, Dept Orthoped Surg, Rochester, MN 55905 USA; [Sousa, Paul L.; King, Alexander H.] Mayo Clin, Ctr Sports Med, Rochester, MN 55905 USA	Krych, AJ (corresponding author), Mayo Clin, Dept Orthoped Surg, 200 First St SW, Rochester, MN 55905 USA.	Krych.Aaron@Mayo.edu		King, Alexander/0000-0003-3102-4657	Arthrex, Inc.	Mr Sousa, Mr King, Dr Morgan, Dr May, and Dr Dahm have no relevant financial relationships to disclose. Dr Krych's institution receives consulting fees from Arthrex, Inc.	ANDERSON WJ, 1983, CLIN ORTHOP RELAT R, P166; Buscayret F, 2004, AM J SPORT MED, V32, P1165, DOI 10.1177/0363546503262686; CALANDRA J J, 1989, Arthroscopy, V5, P254, DOI 10.1016/0749-8063(89)90138-2; Cameron ML, 2003, AM J SPORT MED, V31, P53, DOI 10.1177/03635465030310012001; Carroll KW, 2001, AM J ROENTGENOL, V176, P393, DOI 10.2214/ajr.176.2.1760393; Crall TS, 2012, ARTHROSCOPY, V28, P1755, DOI 10.1016/j.arthro.2012.05.885; Guntern DV, 2003, RADIOLOGY, V226, P165, DOI 10.1148/radiol.2261012090; HINTERMANN B, 1995, AM J SPORT MED, V23, P545, DOI 10.1177/036354659502300505; Hovelius L, 1996, J BONE JOINT SURG AM, V78A, P1677, DOI 10.2106/00004623-199611000-00006; Hsu HC, 2003, ACTA ORTHOP SCAND, V74, P89, DOI 10.1080/00016470310013725; Jeon IH, 2004, BRIT J SPORT MED, V38, DOI 10.1136/bjsm.2003.007708; Johnson DL, 1997, J SHOULDER ELB SURG, V6, P160, DOI 10.1016/S1058-2746(97)90038-0; Kocher MS, 2005, J BONE JOINT SURG AM, V87A, P2006, DOI 10.2106/JBJS.C.01624; McCarty LP, 2005, ARTHROSCOPY, V21, P1131, DOI 10.1016/j.arthro.2005.06.023; Messner K, 1996, ACTA ORTHOP SCAND, V67, P523, DOI 10.3109/17453679608996682; Michener LA, 2002, J SHOULDER ELB SURG, V11, P587, DOI 10.1067/mse.2002.127096; NEER CS, 1974, J BONE JOINT SURG AM, VA 56, P1; NORLIN R, 1993, ARTHROSCOPY, V9, P546, DOI 10.1016/S0749-8063(05)80402-5; Ogawa K, 2006, J SHOULDER ELB SURG, V15, P23, DOI 10.1016/j.jse.2005.05.011; Robinson CM, 2008, J BONE JOINT SURG AM, V90A, P708, DOI 10.2106/JBJS.G.00679; Ruckstuhl H, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-107; SAMILSON RL, 1983, J BONE JOINT SURG AM, V65, P456, DOI 10.2106/00004623-198365040-00005; Sperling JW, 2002, J BONE JOINT SURG AM, V84A, P1775, DOI 10.2106/00004623-200210000-00006; Werner A, 2003, UNFALLCHIRURG, V106, P110, DOI 10.1007/s00113-002-0480-x	24	11	11	0	3	SLACK INC	THOROFARE	6900 GROVE RD, THOROFARE, NJ 08086 USA	0147-7447	1938-2367		ORTHOPEDICS	Orthopedics	NOV	2015	38	11					E965	E969		10.3928/01477447-20151020-03			5	Orthopedics	Orthopedics	DA5JT	WOS:000367840100003	26558675				2021-06-18	
J	Lorivel, T; Gandin, C; Veyssiere, J; Lazdunski, M; Heurteaux, C				Lorivel, T.; Gandin, C.; Veyssiere, J.; Lazdunski, M.; Heurteaux, C.			Positive Effects of the Traditional Chinese Medicine MLC901 in Cognitive Tasks	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						anxiety disorders; cognitive flexibility; fear extinction; memory; MLC901; NeuroAiD; passive avoidance; posttraumatic stress disorder; stroke	POSTTRAUMATIC-STRESS-DISORDER; CONTEXTUAL FEAR EXTINCTION; TRAUMATIC BRAIN-INJURY; ELEVATED PLUS-MAZE; D2 KNOCKOUT MICE; HIPPOCAMPAL NEUROGENESIS; NEUROAID EFFICACY; ANIMAL-MODELS; DOUBLE-BLIND; OBJECT RECOGNITION	MLC901 (NurAiDII) is used as a treatment for stroke patients. It has been shown that MLC901 improves motor and cognitive recovery in ischemic and traumatic brain-injured rodents. The present study seeks to delineate cognitive effects induced by MLC901 in normal, non-injured mice. To this end, the behaviors of vehicle-and MLC901-treated C57BL/6 mice in hippocampus-dependent (passive avoidance, Morris water maze) and hippocampus-independent (novel object recognition) cognitive tasks are compared. The potential influence of the compound on the anxiety level and nycthemeral rhythm of mice is also assessed. In addition, the long-term effects of MLC901 on hippocampal neurogenesis are measured. The results clearly demonstrate that MLC901 promotes extinction in passive avoidance and reversal learning in the Morris water maze and improves the performance of mice in novel object recognition. In parallel, this study shows the long-term proneurogenesis effects of MLC901 that result in the increase in the number of mature neurons in the hippocampus. If these observations can be extended to humans, then MLC901 could represent a promising therapeutic strategy. (C) 2015 The Authors. Journal of Neuroscience Research Published by Wiley Periodicals, Inc.	[Lorivel, T.; Gandin, C.; Veyssiere, J.; Lazdunski, M.; Heurteaux, C.] Univ Nice Sophia Antipolis, Inst Pharmacol Mol & Cellulaire, CNRS, UMR7275, F-06560 Valbonne, France	Heurteaux, C (corresponding author), Univ Nice Sophia Antipolis, Inst Pharmacol Mol & Cellulaire, CNRS, UMR7275, 660 Route Lucioles Sophia Antipolis, F-06560 Valbonne, France.	heurteau@ipmc.cnrs.fr	HEURTEAUX, Catherine/M-4947-2016	HEURTEAUX, Catherine/0000-0002-9741-9777	Centre National de la Recherche ScientifiqueCentre National de la Recherche Scientifique (CNRS); Moleac	Contract grant sponsor: Centre National de la Recherche Scientifique; Contract grant sponsor: Moleac.	An B, 2012, J NEUROSCI, V32, P16845, DOI 10.1523/JNEUROSCI.3017-12.2012; Andero R, 2012, GENES BRAIN BEHAV, V11, P503, DOI 10.1111/j.1601-183X.2012.00801.x; Barker GRI, 2011, J NEUROSCI, V31, P10721, DOI 10.1523/JNEUROSCI.6413-10.2011; Boschen MJ, 2009, AUST NZ J PSYCHIAT, V43, P89, DOI 10.1080/00048670802607154; Brown MW, 2012, NEUROPSYCHOLOGIA, V50, P3122, DOI 10.1016/j.neuropsychologia.2012.07.034; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Caroni P, 2012, NAT REV NEUROSCI, V13, P478, DOI 10.1038/nrn3258; Chen C, 2009, STROKE, V40, P859, DOI 10.1161/STROKEAHA.108.531616; Chen CLH, 2013, STROKE, V44, P3580, DOI 10.1161/STROKEAHA.113.003226; Chen CLH, 2013, STROKE, V44, P2093, DOI 10.1161/STROKEAHA.113.002055; Chen YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040165; Cimadevilla JM, 2007, J NEUROSCI RES, V85, P1138, DOI 10.1002/jnr.21222; Daskalakis NP, 2013, PSYCHONEUROENDOCRINO, V38, P1895, DOI 10.1016/j.psyneuen.2013.06.006; Davis Michael, 2011, Dialogues Clin Neurosci, V13, P463; de Kleine RA, 2013, EUR J PSYCHOTRAUMATO, V4, DOI 10.3402/ejpt.v4i0.21626; Delgado MR, 2006, BIOL PSYCHOL, V73, P39, DOI 10.1016/j.biopsycho.2006.01.006; Denny CA, 2012, HIPPOCAMPUS, V22, P1188, DOI 10.1002/hipo.20964; Dere E, 2007, NEUROSCI BIOBEHAV R, V31, P673, DOI 10.1016/j.neubiorev.2007.01.005; Difede J, 2014, NEUROPSYCHOPHARMACOL, V39, P1052, DOI 10.1038/npp.2013.317; Dubrovina N I, 2012, Ross Fiziol Zh Im I M Sechenova, V98, P488; Dupret D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001959; Edmondson D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066435; Ehninger D, 2008, CELL TISSUE RES, V331, P243, DOI 10.1007/s00441-007-0478-3; Fitzgerald PJ, 2014, BRAIN RES BULL, V105, P46, DOI 10.1016/j.brainresbull.2013.12.007; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; Gan R, 2008, CEREBROVASC DIS, V25, P450, DOI 10.1159/000126919; Garthe A, 2014, GENES BRAIN BEHAV, V13, P357, DOI 10.1111/gbb.12130; Garthe A, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00063; Garthe A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005464; Gil-Mohapel J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075125; Goldfinger JZ, 2014, J STROKE CEREBROVASC, V23, P1099, DOI 10.1016/j.jstrokecerebrovasdis.2013.09.019; Goodman T, 2010, NEUROSCIENCE, V171, P769, DOI 10.1016/j.neuroscience.2010.09.047; Griebel G, 1997, PHARMACOL BIOCHEM BE, V57, P817, DOI 10.1016/S0091-3057(96)00402-9; Harandi AA, 2011, STROKE RES TREAT, V2011, DOI 10.4061/2011/721613; Herry C, 2010, EUR J NEUROSCI, V31, P599, DOI 10.1111/j.1460-9568.2010.07101.x; Heurteaux C, 2013, CEREBROVASC DIS, V35, P1, DOI 10.1159/000346228; Heurteaux C, 2010, NEUROPHARMACOLOGY, V58, P987, DOI 10.1016/j.neuropharm.2010.01.001; Heurteaux C, 2006, NAT NEUROSCI, V9, P1134, DOI 10.1038/nn1749; Hogg S, 1996, PHARMACOL BIOCHEM BE, V54, P21, DOI 10.1016/0091-3057(95)02126-4; Huang ACW, 2013, BEHAV BRAIN RES, V237, P23, DOI 10.1016/j.bbr.2012.09.024; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Jaholkowski P, 2009, LEARN MEMORY, V16, P439, DOI 10.1101/lm.1459709; Kalm M, 2013, EXP NEUROL, V247, P402, DOI 10.1016/j.expneurol.2013.01.006; Kao TK, 2013, EXP NEUROL, V247, P188, DOI 10.1016/j.expneurol.2013.04.010; Kaplan GB, 2011, PHARMACOL BIOCHEM BE, V99, P217, DOI 10.1016/j.pbb.2011.01.009; Kim SJ, 2007, NEURON, V56, P582, DOI 10.1016/j.neuron.2007.10.030; Kleinman JT, 2013, BEHAV NEUROL, V26, P131, DOI [10.3233/BEN-2012-110235, 10.1155/2013/438965]; Koh PO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054217; Kong KH, 2009, CEREBROVASC DIS, V28, P514, DOI 10.1159/000247001; Liss B, 2001, MOL MEMBR BIOL, V18, P117; Litz BT, 2012, J PSYCHIATR RES, V46, P1184, DOI 10.1016/j.jpsychires.2012.05.006; Maati HMO, 2012, NEUROPHARMACOLOGY, V63, P692, DOI 10.1016/j.neuropharm.2012.05.035; Myers KM, 2007, MOL PSYCHIATR, V12, P120, DOI 10.1038/sj.mp.4001939; Nam KN, 2013, CELL BIOCHEM FUNCT, V31, P707, DOI 10.1002/cbf.2959; Navarro JC, 2014, INT J STROKE, V9, P102, DOI 10.1111/ijs.12324; Navarro JC, 2013, INT J STROKE, V8, P491, DOI 10.1111/ijs.12044; O'Sullivan NC, 2007, J NEUROCHEM, V101, P1085, DOI 10.1111/j.1471-4159.2006.04418.x; Ottoni EB, 2000, BEHAV RES METH INS C, V32, P446, DOI 10.3758/BF03200814; Pan YW, 2013, NEUROBIOL LEARN MEM, V105, P81, DOI 10.1016/j.nlm.2013.07.011; Pan YW, 2012, J NEUROSCI, V32, P6444, DOI 10.1523/JNEUROSCI.6076-11.2012; Pape HC, 2010, PHYSIOL REV, V90, P419, DOI 10.1152/physrev.00037.2009; Parsons RG, 2013, NAT NEUROSCI, V16, P146, DOI 10.1038/nn.3296; Peters J, 2010, SCIENCE, V328, P1288, DOI 10.1126/science.1186909; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Psotta L, 2013, NEUROBIOL LEARN MEM, V103, P34, DOI 10.1016/j.nlm.2013.03.003; Quintard H, 2014, NEUROSCIENCE, V277, P72, DOI 10.1016/j.neuroscience.2014.06.047; Quintard H, 2011, NEUROPHARMACOLOGY, V61, P622, DOI 10.1016/j.neuropharm.2011.05.003; Quirk GJ, 2008, NEUROPSYCHOPHARMACOL, V33, P56, DOI 10.1038/sj.npp.1301555; Rola R, 2004, EXP NEUROL, V188, P316, DOI 10.1016/j.expneurol.2004.05.005; Schulz-Klaus B, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00205; Sehlmeyer C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005865; Shahripour RB, 2011, EUR J INTERN MED, V22, P509, DOI 10.1016/j.ejim.2011.01.002; Siddiqui FJ, 2013, CEREBROVASC DIS, V35, P8, DOI 10.1159/000346231; Sik A, 2003, BEHAV BRAIN RES, V147, P49, DOI 10.1016/S0166-4328(03)00117-7; Siow CHC, 2008, EUR NEUROL, V60, P264, DOI 10.1159/000155220; Suarez-Pereira I, 2015, HIPPOCAMPUS, V25, P51, DOI 10.1002/hipo.22349; Tang QQ, 2012, BRAIN RES, V1488, P81, DOI 10.1016/j.brainres.2012.09.034; Tate RL, 1999, CORTEX, V35, P39, DOI 10.1016/S0010-9452(08)70784-6; Tsai MC, 2015, J NEUROIMMUNE PHARM, V10, P45, DOI 10.1007/s11481-014-9570-0; Venketasubramanian N, 2009, INT J STROKE, V4, P54, DOI 10.1111/j.1747-4949.2009.00237.x; Webster SJ, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00088; Williamson John B, 2013, Front Neuroeng, V6, P13, DOI 10.3389/fneng.2013.00013; Yehuda R, 2007, NEURON, V56, P19, DOI 10.1016/j.neuron.2007.09.006; Young SHY, 2010, CEREBROVASC DIS, V30, P1, DOI 10.1159/000313398; Zatorre RJ, 2012, NAT NEUROSCI, V15, P528, DOI 10.1038/nn.3045; Zhuang PW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035636	86	11	11	0	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	NOV	2015	93	11					1648	1663		10.1002/jnr.23591			16	Neurosciences	Neurosciences & Neurology	CT5ET	WOS:000362831800004	25821139	Green Published, Other Gold			2021-06-18	
J	Sun, ZX; Zu, HC; Yuan, D; Sun, YX; Zhang, K; Cui, ZQ; Wang, J				Sun, Zhenxing; Zu, Huancong; Yuan, Dan; Sun, Yaxing; Zhang, Kai; Cui, Zhiqiang; Wang, Jin			Predictors of prognosis in patients with temporal lobe epilepsy after anterior temporal lobectomy	EXPERIMENTAL AND THERAPEUTIC MEDICINE			English	Article						anterior temporal lobectomy; mesial temporal lobe epilepsy; predictor; prognosis	SURGICAL-TREATMENT; MULTIVARIATE-ANALYSIS; SELECTIVE AMYGDALOHIPPOCAMPECTOMY; HIPPOCAMPAL SCLEROSIS; INTRACTABLE EPILEPSY; SEIZURE RECURRENCE; SURGERY; RESECTION; MRI; EXTENT	The aim of this study was to evaluate the predictive value of prognostic factors for the surgical outcome of patients with mesial temporal lobe epilepsy (MTLE) using Engel seizure classification. The clinical data of 121 patients with MTLE who underwent anterior temporal lobectomy (ATL) and received a 1-year minimum follow-up were collected between January 2005 and December 2008. Patients were divided into seizure and seizure-free groups according to the Engel seizure classification. Univariate analysis and multivariate logistic regression analysis were used to analyze the potential predictive and prognostic factors, including medical history, clinical features of seizures, magnetic resonance imaging (MRI) and video-electroencephalogram (EEG) monitoring results. Univariate analysis indicated no statistically significant differences in gender, age at seizure onset, age at surgery, history of traumatic brain injury, perinatal anoxia, intracranial infection, family history of seizure, auras or site of surgery between the two groups; however, significant differences were detected in pre-surgical seizure duration, history of febrile seizures, seizure types, MRI and video-EEG results. Multivariate logistic regression analysis demonstrated that a pre-surgical seizure duration of <10 years, history of positive febrile seizures, simple complex partial seizure, positive MRI results and unilateral local video-EEG spikes may be considered as predictors of a good prognosis. These results indicate that remission may be achieved in patients with MTLE via the collection of accurate clinical information and adequate pre-surgical evaluation.	[Sun, Zhenxing; Zu, Huancong; Cui, Zhiqiang] Tsinghua Univ, Yuquan Hosp, Dept Neurosurg, Beijing 100084, Peoples R China; [Yuan, Dan] Capital Med Univ, Luhe Teaching Hosp, Dept Neurol, Beijing 101149, Peoples R China; [Sun, Yaxing] Second Municipal Hosp Zaozhuang, Dept Psychiat, Zaozhuang 277100, Shandong, Peoples R China; [Zhang, Kai] Capital Med Univ, Tiantan Hosp, Dept Neurosurg, Beijing 101149, Peoples R China; [Wang, Jin] Tsinghua Univ, Med Ctr, Changgung Hosp, Dept Neurosurg, Beijing 100084, Peoples R China	Wang, J (corresponding author), Tsinghua Univ, Med Ctr, Changgung Hosp, Dept Neurosurg, 168 Litang Rd, Beijing 100084, Peoples R China.	wja01068@btch.edu.cn					Antel SB, 2002, NEUROLOGY, V58, P1505, DOI 10.1212/WNL.58.10.1505; BANCAUD J, 1981, EPILEPSIA, V22, P489, DOI 10.1111/j.1528-1157.1981.tb06159.x; BEHRENS E, 1994, ACTA NEUROCHIR, V128, P84, DOI 10.1007/BF01400656; BERKOVIC SF, 1995, NEUROLOGY, V45, P1358, DOI 10.1212/WNL.45.7.1358; BLUME WT, 1994, J EPILEPSY, V7, P203, DOI 10.1016/0896-6974(94)90031-0; Bote RP, 2008, SEMIN ULTRASOUND CT, V29, P2, DOI 10.1053/j.sult.2007.11.005; Camacho DLA, 2007, SEMIN ULTRASOUND CT, V28, P424, DOI 10.1053/j.sult.2007.09.005; Clusmann H, 2004, J NEUROL NEUROSUR PS, V75, P1589, DOI 10.1136/jnnp.2003.024208; Clusmann H, 2002, J NEUROSURG, V97, P1131, DOI 10.3171/jns.2002.97.5.1131; Clusmann H, 2008, SEMIN ULTRASOUND CT, V29, P60, DOI 10.1053/j.sult.2007.11.004; Engel J, 1999, ARCH NEUROL-CHICAGO, V56, P1338, DOI 10.1001/archneur.56.11.1338; Engel J, 2001, NEUROSCIENTIST, V7, P340, DOI 10.1177/107385840100700410; FALCONER MA, 1968, ARCH NEUROL-CHICAGO, V19, P353, DOI 10.1001/archneur.1968.00480040019001; Foldvary N, 2000, NEUROLOGY, V54, P630, DOI 10.1212/WNL.54.3.630; Gilliam F, 1997, EPILEPSIA, V38, P1315, DOI 10.1111/j.1528-1157.1997.tb00069.x; GULDVOG B, 1994, EPILEPSIA, V35, P566, DOI 10.1111/j.1528-1157.1994.tb02476.x; Hennessy MJ, 2001, ACTA NEUROL SCAND, V103, P344, DOI 10.1034/j.1600-0404.2001.103006344.x; Ho SS, 1996, EPILEPSIA, V37, P788, DOI 10.1111/j.1528-1157.1996.tb00653.x; Holmes MD, 2000, SEIZURE-EUR J EPILEP, V9, P407, DOI 10.1053/seiz.2000.0423; Janszky J, 2003, EPILEPSY RES, V55, P1, DOI 10.1016/S0920-1211(03)00087-1; Jeong SW, 1999, EPILEPSIA, V40, P1735, DOI 10.1111/j.1528-1157.1999.tb01591.x; McIntosh AM, 2001, EPILEPSIA, V42, P1288, DOI 10.1046/j.1528-1157.2001.02001.x; McIntosh AM, 2005, ANN NEUROL, V57, P283, DOI 10.1002/ana.20372; Pavlidou E, 2008, BRAIN DEV-JPN, V30, P7, DOI 10.1016/j.braindev.2007.05.001; Pillai JJ, 2007, SEMIN ULTRASOUND CT, V28, P437, DOI 10.1053/j.sult.2007.09.006; Radhakrishnan K, 1998, NEUROLOGY, V51, P465, DOI 10.1212/WNL.51.2.465; Schramm J, 2008, EPILEPSIA, V49, P1296, DOI 10.1111/j.1528-1167.2008.01604.x; Schulz R, 2000, EPILEPSIA, V41, P564, DOI 10.1111/j.1528-1157.2000.tb00210.x; Semah F, 1998, NEUROLOGY, V51, P1256, DOI 10.1212/WNL.51.5.1256; Specht U, 1997, J NEUROL NEUROSUR PS, V62, P501, DOI 10.1136/jnnp.62.5.501; Spencer SS, 2003, NEUROLOGY, V61, P1680, DOI 10.1212/01.WNL.0000098937.35486.A3; SPERLING MR, 1994, NEUROLOGY, V44, P2325, DOI 10.1212/WNL.44.12.2325; Tanriverdi T, 2008, J NEUROSURG, V108, P517, DOI 10.3171/JNS/2008/108/3/0517; Tezer FI, 2008, SEIZURE-EUR J EPILEP, V17, P549, DOI 10.1016/j.seizure.2008.02.003; Vinton AB, 2007, BRAIN, V130, P548, DOI 10.1093/brain/awl232; Wiebe S, 2001, NEW ENGL J MED, V345, P311, DOI 10.1056/NEJM200108023450501; Wieser HG, 2004, EPILEPSIA, V45, P32; Wieser HG, 2004, SEIZURE-EUR J EPILEP, V13, P534, DOI 10.1016/j.seizure.2003.12.010; ZENTNER J, 1995, J NEUROL NEUROSUR PS, V58, P666, DOI 10.1136/jnnp.58.6.666	39	11	11	0	4	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-0981	1792-1015		EXP THER MED	Exp. Ther. Med.	NOV	2015	10	5					1896	1902		10.3892/etm.2015.2753			7	Medicine, Research & Experimental	Research & Experimental Medicine	CW3JW	WOS:000364889600043	26640569	Green Published, Bronze			2021-06-18	
J	Yamal, JM; Benoit, JS; Doshi, P; Rubin, ML; Tilley, BC; Hannay, HJ; Robertson, CS				Yamal, Jose-Miguel; Benoit, Julia S.; Doshi, Pratik; Rubin, Maria Laura; Tilley, Barbara C.; Hannay, H. Julia; Robertson, Claudia S.			Association of transfusion red blood cell storage age and blood oxygenation, long-term neurologic outcome, and mortality in traumatic brain injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Blood transfusion complications; adult; leukoreduced red blood cells; traumatic brain injury	DURATION; LEUKOREDUCTION; THRESHOLD; ADULTS	BACKGROUND The effect of red blood cell (RBC) storage on oxygenation in critically ill patients is still unknown. The objective of this study was to determine the association of RBC storage with oxygenation, long-term neurologic recovery, and death after traumatic brain injury. METHODS We used data from a 2 x 2 factorial randomized controlled trial of administration of erythropoietin or placebo and of assignment to transfusion threshold of less than 7g/dL or less than 10 g/dL in neurosurgical intensive care units in two US Level 1 trauma centers. Patients had severe traumatic brain injury with closed head injury, were unable to follow commands, and were enrolled within 6 hours of injury. Blood oxygenation 1 hour after the transfusion as measured by jugular venous oxygen saturation (n = 59) was the primary outcome. Secondary outcomes were brain tissue oxygenation (n = 77), 6-month Glasgow Outcome Scale (GOS) score (n = 122) collected using a structured interview and dichotomized into favorable (good recovery or moderate disability) or unfavorable outcome (severe disability, vegetative state, or dead), and mortality (n = 125). RBC age was defined as the maximum age of RBCs over all units in one transfusion per patient. For long-term outcomes, RBC age was defined as the mean age over all units given. RESULTS We failed to detect an association of RBC age with jugular venous oxygen saturation (linear regression = 1.59; 95% confidence interval [CI], -2.99 to 6.18; p = 0.49), brain tissue oxygenation (linear regression = 0.20; 95% CI, -0.23 to 0.63; p = 0.36), GOS score (odds ratio, 1.37; 95% CI, 0.53-3.57; p = 0.52), and mortality (hazard ratio, 1.35; 95% CI, 0.61-2.98; p = 0.46). CONCLUSION Limitations of this study include the fact that the RBC ages were not randomized, although this was a prospective study. We conclude that older blood does not seem to have adverse effects in severe traumatic brain injury. LEVEL OF EVIDENCE Prognostic study, level III.	[Yamal, Jose-Miguel; Rubin, Maria Laura; Tilley, Barbara C.] Univ Texas Houston, Dept Biostat, Sch Publ Hlth, Houston, TX 77030 USA; [Benoit, Julia S.] Univ Houston, Dept Vis Sci, Houston, TX USA; [Hannay, H. Julia] Univ Houston, Dept Psychol, Houston, TX USA; [Doshi, Pratik] Univ Texas Hlth Sci Ctr Houston, Dept Emergency Med & Internal Med, Houston, TX 77030 USA; [Robertson, Claudia S.] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA	Yamal, JM (corresponding author), Univ Texas Hlth Sci Ctr Houston, 1200 Pressler,RAS W928, Houston, TX 77030 USA.	Jose-Miguel.Yamal@uth.tmc.edu			National Institute of Neurological Disorders and Stroke, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS38660]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS038660] Funding Source: NIH RePORTER	This work was supported by the National Institute of Neurological Disorders and Stroke, National Institutes of Health (grant no. P01NS38660).	del Junco DJ, 2013, J TRAUMA ACUTE CARE, V75, pS97, DOI 10.1097/TA.0b013e318298b0a4; Kiraly LN, 2009, J TRAUMA, V67, P29, DOI 10.1097/TA.0b013e3181af6a8c; Lacroix J, 2015, NEW ENGL J MED, V372, P1410, DOI 10.1056/NEJMoa1500704; Lelubre C, 2013, CRIT CARE, V17, DOI 10.1186/cc12600; Phelan HA, 2010, J TRAUMA, V69, P330, DOI 10.1097/TA.0b013e3181e0b253; Leal-Noval SR, 2008, CRIT CARE MED, V36, P1290, DOI 10.1097/CCM.0b013e3181692dfc; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Spinella PC, 2009, CRIT CARE, V13, DOI 10.1186/cc8050; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Utter GH, 2011, J NEUROTRAUM, V28, P155, DOI 10.1089/neu.2010.1451; Weinberg JA, 2008, J TRAUMA, V65, P794, DOI 10.1097/TA.0b013e318184aa11; Weinberg JA, 2008, J TRAUMA, V65, P279, DOI 10.1097/TA.0b013e31817c9687; Weinberg JA, 2010, J TRAUMA, V69, P1427, DOI 10.1097/TA.0b013e3181fa0019; Yamal JM, 2015, J NEUROTRAUM, V32, P1239, DOI 10.1089/neu.2014.3752	14	11	11	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	NOV	2015	79	5					843	849		10.1097/TA.0000000000000834			7	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	CV3XX	WOS:000364201100022	26496111	Green Accepted			2021-06-18	
J	Zhang, XL; Shuttleworth, CW; Moskal, JR; Stanton, PK				Zhang, Xiao-lei; Shuttleworth, C. William; Moskal, Joseph R.; Stanton, Patric K.			Suppression of spreading depolarization and stabilization of dendritic spines by GLYX-13, an NMDA receptor glycine-site functional partial agonist	EXPERIMENTAL NEUROLOGY			English	Article						CA1; Hippocampus; Migraine; Schaffer collateral; Spreading depression	INTRINSIC OPTICAL SIGNALS; PERIINFARCT DEPOLARIZATIONS; ANOXIC DEPOLARIZATION; HIPPOCAMPAL SLICE; LIGHT-SCATTERING; RAT HIPPOCAMPUS; DEPRESSION; MIGRAINE; ISCHEMIA; BLOCKADE	Cortical spreading depolarization (SD) is a slow self-propagating wave of mass cellular depolarization in brain tissue, thought to be the underlying cause of migraine scintillating scotoma and aura, and associated with stroke, traumatic brain injury, and termination of status epilepticus. The N-methyl-D-aspartate subtype of glutamate receptor (NMDAR), which gates influx of calcium and is an important trigger of long-term synaptic plasticity, is also a contributor to the initiation and propagation of SD. The current study tested the potential of pharmacological modulation of NMDAR activity through the obligatory co-agonist binding site, to suppress the initiation of SD, and modulate the effects of SD on dendritic spine morphology, in in vitro hippocampal slices. A novel NMDAR functional glycine site partial agonist, GLYX-13, sometimes completely prevented the induction of SD and consistently slowed its rate of propagation. The passage of SD through the hippocampal CA1 region produced a rapid retraction of dendritic spines which reversed after neuronal depolarization had recovered. GLYX-13 improved the rate and extent of return of dendritic spines to their original sizes and locations following SD, suggesting that NMDAR modulators can protect synaptic connections in the brain from structural alterations elicited by SD. These data indicate that NMDAR modulation to renormalize activity may be an effective new treatment strategy for suppression or amelioration of the contribution of SD to short and long-term symptoms of migraine attacks, as well as the effects of SD on tissue damaged by stroke or traumatic brain injury. (C) 2015 Elsevier Inc. All rights reserved.	[Zhang, Xiao-lei; Stanton, Patric K.] New York Med Coll, Dept Cell Biol & Anat, Valhalla, NY 10595 USA; [Shuttleworth, C. William] Univ New Mexico, Sch Med, Dept Neurosci, Albuquerque, NM 87131 USA; [Moskal, Joseph R.] Northwestern Univ, Robert R McCormick Sch Engn & Appl Sci, Dept Biomed Engn, Falk Ctr Mol Therapeut, Evanston, IL 60208 USA; [Stanton, Patric K.] New York Med Coll, Dept Neurol, Valhalla, NY 10595 USA	Stanton, PK (corresponding author), New York Med Coll, Dept Cell Biol & Anat, Valhalla, NY 10595 USA.	patric_stanton@nymc.edu	Moskal, Joseph/B-7628-2009	Stanton, Patric/0000-0002-2294-0613	Naurex Inc.; Migraine Research Foundation	This study was supported by Naurex Inc. and the Migraine Research Foundation. This work is dedicated to the memories of John M. Sarvey, Lewis N. Stanton, Sr., Eleanor F. Stanton and Gary L Stanton.	Aiba I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075739; Aiba I, 2012, J PHYSIOL-LONDON, V590, P5877, DOI 10.1113/jphysiol.2012.234476; Aitken PG, 1999, METHODS, V18, P91, DOI 10.1006/meth.1999.0762; Aitken PG, 1998, J NEUROPHYSIOL, V80, P1514; AMEMORI T, 1990, BRAIN RES, V519, P351, DOI 10.1016/0006-8993(90)90101-G; Anderson TR, 2002, J NEUROPHYSIOL, V88, P2713, DOI 10.1152/jn.00321.2002; Ashina M, 2013, CEPHALALGIA, V33, P540, DOI 10.1177/0333102412475234; Ayata C, 2010, HEADACHE, V50, P725, DOI 10.1111/j.1526-4610.2010.01647.x; Ba AM, 2002, J NEUROPHYSIOL, V88, P2726, DOI 10.1152/jn.00729.2001; Basarsky TA, 1998, J NEUROSCI, V18, P7189; Burgdorf J., 2009, NEUROBIOL AGING, V32, P698; Burgdorf J, 2013, NEUROPSYCHOPHARMACOL, V38, P729, DOI 10.1038/npp.2012.246; Costa C, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-62; Dietz RM, 2008, J NEUROSCI, V28, P8014, DOI 10.1523/JNEUROSCI.0765-08.2008; Dreier Jens P, 2015, Acta Neurochir Suppl, V120, P137, DOI 10.1007/978-3-319-04981-6_23; Dreier JP, 2012, BRAIN, V135, P259, DOI 10.1093/brain/awr303; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Edvinsson L, 2012, PHARMACOL THERAPEUT, V136, P319, DOI 10.1016/j.pharmthera.2012.08.011; Eikermann-Haerter K, 2010, CURR NEUROL NEUROSCI, V10, P167, DOI 10.1007/s11910-010-0099-1; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fabricius M, 2008, CLIN NEUROPHYSIOL, V119, P1973, DOI 10.1016/j.clinph.2008.05.025; Faria LC, 2004, J NEUROPHYSIOL, V92, P2610, DOI 10.1152/jn.00466.2004; GILL R, 1992, J CEREBR BLOOD F MET, V12, P371, DOI 10.1038/jcbfm.1992.54; HABLITZ JJ, 1989, DEV BRAIN RES, V46, P243, DOI 10.1016/0165-3806(89)90288-5; HANSEN AJ, 1980, ACTA PHYSIOL SCAND, V108, P355, DOI 10.1111/j.1748-1716.1980.tb06544.x; Hartings JA, 2003, J NEUROSCI, V23, P11602; Hartings JA, 2014, ANN NEUROL, V76, P681, DOI 10.1002/ana.24256; Hartings JA, 2011, BRAIN, V134, P1529, DOI 10.1093/brain/awr048; Hartings JA, 2009, J NEUROTRAUM, V26, P1857, DOI [10.1089/neu.2009.0961, 10.1089/neu.2009-0961]; Hasbani MJ, 2001, J NEUROSCI, V21, P2393; HERNANDEZCACERES J, 1987, BRAIN RES, V437, P360, DOI 10.1016/0006-8993(87)91652-0; IIJIMA T, 1992, J CEREBR BLOOD F MET, V12, P727, DOI 10.1038/jcbfm.1992.103; James MF, 1999, J PHYSIOL-LONDON, V519, P415, DOI 10.1111/j.1469-7793.1999.0415m.x; Jourdain P, 2002, J NEUROSCI, V22, P3108, DOI 10.1523/JNEUROSCI.22-08-03108.2002; Lapilover EG, 2012, NEUROBIOL DIS, V48, P495, DOI 10.1016/j.nbd.2012.06.024; LAURITZEN M, 1992, J CEREBR BLOOD F MET, V12, P223, DOI 10.1038/jcbfm.1992.32; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359; MARTINSF.H, 1966, J NEUROPHYSIOL, V29, P715; Moskal JR, 2014, EXPERT OPIN INV DRUG, V23, P243, DOI 10.1517/13543784.2014.852536; Moskal JR, 2005, NEUROPHARMACOLOGY, V49, P1077, DOI 10.1016/j.neuropharm.2005.06.006; Muller M, 1999, J NEUROPHYSIOL, V82, P1818, DOI 10.1152/jn.1999.82.4.1818; Murphy TH, 2008, J NEUROSCI, V28, P1756, DOI 10.1523/JNEUROSCI.5128-07.2008; Nagerl UV, 2004, NEURON, V44, P759, DOI 10.1016/j.neuron.2004.11.016; NELLGARD B, 1992, ACTA PHYSIOL SCAND, V146, P497, DOI 10.1111/j.1748-1716.1992.tb09451.x; O'Farrell AM, 2000, NEUROREPORT, V11, P2121, DOI 10.1097/00001756-200007140-00013; Obeidat AS, 1998, EUR J NEUROSCI, V10, P3451, DOI 10.1046/j.1460-9568.1998.00358.x; Peeters M, 2007, J PHARMACOL EXP THER, V321, P564, DOI 10.1124/jpet.106.117101; Pomper JK, 2006, J NEUROPHYSIOL, V95, P355; Risher WC, 2010, J NEUROSCI, V30, P9859, DOI 10.1523/JNEUROSCI.1917-10.2010; SNOW RW, 1983, J NEUROPHYSIOL, V50, P561; Sword J, 2013, BRAIN, V136, P1446, DOI 10.1093/brain/awt026; Takano T, 2007, NAT NEUROSCI, V10, P754, DOI 10.1038/nn1902; Tao L, 2002, BRAIN RES, V952, P290, DOI 10.1016/S0006-8993(02)03254-7; Tso AR, 2014, CURR TREAT OPTION NE, V16, DOI 10.1007/s11940-014-0318-1; Velisek L, 2007, ANN NEUROL, V61, P109, DOI 10.1002/ana.21082; Vilagi I, 2001, BRAIN RES, V898, P288, DOI 10.1016/S0006-8993(01)02196-5; Zhang XL, 2008, NEUROPHARMACOLOGY, V55, P1238, DOI 10.1016/j.neuropharm.2008.08.018; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011	59	11	12	0	14	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	NOV	2015	273						312	321		10.1016/j.expneurol.2015.07.025			10	Neurosciences	Neurosciences & Neurology	CW7BB	WOS:000365151800029	26244282				2021-06-18	
J	Roy, A; Allain, P; Roulin, JL; Fournet, N; Le Gall, D				Roy, Arnaud; Allain, Philippe; Roulin, Jean-Luc; Fournet, Nathalie; Le Gall, Didier			Ecological approach of executive functions using the Behavioural Assessment of the Dysexecutive Syndrome for Children (BADS-C): Developmental and validity study	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Neuropsychology; Development; Everyday life; Executive functions; Ecological assessment	TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; PERFORMANCE; DYSFUNCTION; DISORDER; TESTS; SCHIZOPHRENIA; INTELLIGENCE; IMPAIRMENTS; PERSPECTIVE	Introduction. Ecological assessment of executive functions (EF) with tasks simulating everyday-life difficulties in children remains poorly developed. The Behavioural Assessment of the Dysexecutive Syndrome for Children (BADS-C) is one of the rare tools proposed in this perspective, for which developmental and convergent validity are, however, rather limited. The objectives of this study were to explore EF development using the BADS-C, while considering the effect of gender and parental education as well as controversial relationships between intelligence and EF. We also aimed to examine to what extent the BADS-C could reflect EF of children in everyday life, as reported by their parents on questionnaires. Method. A group of 120 healthy children aged from 7 to 12 years was recruited. Their executive performance was examined by means of the BADS-C, and their intellectual efficiency was tested with the Wechsler intelligence scales. Rating of EF in everyday life was simultaneously carried out by children's parents, using two questionnaires: the Dysexecutive Questionnaire for Children (DEX-C) of the BADS-C and the Behavior Rating Inventory of Executive Function (BRIEF). Results. Results showed a significant effect of age on BADS-C subtests, with inconsistencies from one subtest to another. Gender effect on EF performance was nonsignificant. Weak correlations were found between EF scores and parental education or intelligence quotient. Lastly, while the two questionnaires of everyday-life EF were strongly correlated with each other, their links with BADS-C subtests scores were weak. Conclusions. This study shows differentiated developmental curves on BADS-C, reflecting a variable implication of executive resources according to subtests. The limited relations between BADS-C performance and sociodemographic variables or IQ could be due to the fact that executive difficulties are moderate in healthy children at this age. Moreover, the capacity of the BADS-C to reflect EF as perceived by the child's relatives in everyday life remains questionable.	[Roy, Arnaud; Allain, Philippe; Le Gall, Didier] Univ Angers, LUNAM, EA4638, Psychol Lab Pays Loire, F-49045 Angers 01, France; [Roy, Arnaud] Nantes Univ Hosp, Neurofibromatosis Clin, Nantes, France; [Roy, Arnaud] Nantes Univ Hosp, Learning Disabil Reference Ctr, Nantes, France; [Roulin, Jean-Luc; Fournet, Nathalie] Savoie Univ, Neurocognit & Psychol Lab, Chambery, France; [Roulin, Jean-Luc; Fournet, Nathalie] CNRS, UMR 5105, Neurocognit & Psychol Lab, Grenoble, France	Roy, A (corresponding author), Univ Angers, Fac Lettres Langues & Sci Humaines, 11 Blvd Lavoisier, F-49045 Angers 01, France.	arnaud.roy@univ-angers.fr		ALLAIN, Philiooe/0000-0003-0668-0986	Direction of Clinical Research of University Hospital of Nantes (France) [BRD/05/1-K]; Recklinghausen and Neurofibromatosis Association (Blagnac, France)	This work was supported by the Direction of Clinical Research of University Hospital of Nantes (France) [grant number BRD/05/1-K]. Recklinghausen and Neurofibromatosis Association (Blagnac, France) is gratefully acknowledged for its generous financial contribution to this project.	Allain P, 2007, REV NEUROL-FRANCE, V163, P222, DOI 10.1016/S0035-3787(07)90393-8; Allain P, 2004, REV NEUROPSYCHOL, V14, P285; Allain P, 2005, BRAIN COGNITION, V57, P4, DOI 10.1016/j.bandc.2004.08.011; Amanzio M, 2013, J INT NEUROPSYCH SOC, V19, P63, DOI 10.1017/S1355617712000896; Anderson P, 2002, CHILD NEUROPSYCHOL, V8, P71, DOI 10.1076/chin.8.2.71.8724; Anderson V, 1998, NEUROPSYCHOL REHABIL, V8, P319, DOI 10.1080/713755568; Ardila A, 2000, ARCH CLIN NEUROPSYCH, V15, P31, DOI 10.1016/S0887-6177(98)00159-0; Ardila A, 2005, DEV NEUROPSYCHOL, V28, P539, DOI 10.1207/s15326942dn2801_5; Ardila A, 2013, APPL NEUROPSYCH-CHIL, V2, P82, DOI 10.1080/21622965.2013.748388; Baddeley A., 1974, PSYCHOL LEARN MOTIV, P47, DOI [10.1016/s0079-7421(08)60452-1, DOI 10.1016/S0079-7421(08)60452-1]; Bennett PC, 2005, J INT NEUROPSYCH SOC, V11, P606, DOI 10.1017/S1355617705050721; Best JR, 2010, CHILD DEV, V81, P1641, DOI 10.1111/j.1467-8624.2010.01499.x; Blair C, 2006, BEHAV BRAIN SCI, V29, P109; Bodimeade HL, 2013, DEV MED CHILD NEUROL, V55, P926, DOI 10.1111/dmcn.12195; Boghi A, 2006, NEUROIMAGE, V33, P999, DOI 10.1016/j.neuroimage.2006.07.022; Brocki KC, 2004, DEV NEUROPSYCHOL, V26, P571, DOI 10.1207/s15326942dn2602_3; Brosnan M, 2002, NEUROPSYCHOLOGIA, V40, P2144, DOI 10.1016/S0028-3932(02)00046-5; Burden V., 2003, BEHAV ASSESSMENT DYS; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Chan RCK, 2008, ARCH CLIN NEUROPSYCH, V23, P201, DOI 10.1016/j.acn.2007.08.010; Chevignard MP, 2012, BRAIN INJURY, V26, P1033, DOI 10.3109/02699052.2012.666366; Chevignard MP, 2010, BRAIN IMPAIR, V11, P125, DOI 10.1375/brim.11.2.125; Chevignard MP, 2009, DEV NEUROREHABIL, V12, P76, DOI 10.1080/17518420902777019; Christ SE, 2010, MOL GENET METAB, V99, pS22, DOI 10.1016/j.ymgme.2009.10.007; CRONBACH LJ, 1955, PSYCHOL BULL, V52, P281, DOI 10.1037/h0040957; Dennis M, 2006, SER INT NEUROPSYCHOL, P128, DOI 10.1017/CBO9780511545917.007; Dennis M, 2009, J INT NEUROPSYCH SOC, V15, P331, DOI 10.1017/S1355617709090481; DIAMOND A, 1985, CHILD DEV, V56, P868, DOI 10.1111/j.1467-8624.1985.tb00160.x; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Emslie H., 2013, PROFESSIONAL MANUA S; Engel-Yeger B, 2009, NEUROPSYCHOL REHABIL, V19, P662, DOI 10.1080/09602010802622730; Eslinger PJ, 2004, BRAIN COGNITION, V55, P84, DOI 10.1016/s0278-2626(03)00281-1; Espinosa A, 2009, J INT NEUROPSYCH SOC, V15, P751, DOI 10.1017/S135561770999035X; Fournet N., 2014, CHILD NEUROPSYCHOL, V22, P1; Gioia G.A., 2000, BEHAV RATING INVENTO; Gioia GA, 2010, J HEAD TRAUMA REHAB, V25, P433, DOI 10.1097/HTR.0b013e3181fbc272; Hooper L, 2007, NEUROPSYCHOL REHABIL, V17, P621, DOI 10.1080/09602010601137054; Kamei S, 2008, MOVEMENT DISORD, V23, P566, DOI 10.1002/mds.21890; Katz N, 2007, NEUROPSYCHOL REHABIL, V17, P192, DOI 10.1080/09602010600685053; Krabbendam L, 1999, CLIN NEUROPSYCHOL, V13, P370, DOI 10.1076/clin.13.3.370.1739; Lan XZ, 2011, J EXP CHILD PSYCHOL, V108, P677, DOI 10.1016/j.jecp.2010.11.001; Leaper C, 2004, DEV PSYCHOL, V40, P993, DOI 10.1037/0012-1649.40.6.993; Lehto JE, 2003, BRIT J DEV PSYCHOL, V21, P59, DOI 10.1348/026151003321164627; Levin HS, 2005, PEDIATR NEUROL, V33, P79, DOI 10.1016/j.pediatrneurol.2005.02.002; LEVIN HS, 1991, DEV NEUROPSYCHOL, V7, P377, DOI 10.1080/87565649109540499; Lezak M.D., 2004, NEUROPSYCHOLOGICAL A, Vfourth; Luria A. R., 1966, HIGHER CORTICAL FUNC; Moriyama Y, 2002, ALCOHOL CLIN EXP RES, V26, P1239, DOI 10.1097/01.ALC.0000026103.08053.86; Norris G, 2000, NEUROPSYCHOL REHABIL, V10, P33, DOI 10.1080/096020100389282; Odhuba RA, 2005, BRIT J CLIN PSYCHOL, V44, P269, DOI 10.1348/014466505X29431; Parrish J, 2007, DEV MED CHILD NEUROL, V49, P412, DOI 10.1111/j.1469-8749.2007.00412.x; Pentland L., 1998, NEUROPSYCHOL REHABIL, V8, P319, DOI 10.1080/713755572; Robinson S, 2009, BRAIN COGNITION, V71, P362, DOI 10.1016/j.bandc.2009.06.007; Roth R., 2005, BRIEF A BEHAV RATING; Roy A, 2013, BRIEF INVENTAIRE EVA; Roy A, 2010, J INT NEUROPSYCH SOC, V16, P1056, DOI 10.1017/S135561771000086X; Saigal S, 2008, LANCET, V371, P261, DOI 10.1016/S0140-6736(08)60136-1; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Shimoni M, 2012, RES DEV DISABIL, V33, P858, DOI 10.1016/j.ridd.2011.12.014; Shinagawa Y, 2007, INT J GERIATR PSYCH, V22, P951, DOI 10.1002/gps.1768; Siu AFY, 2014, J CHILD NEUROL, V29, P608, DOI 10.1177/0883073813516191; Stuss D.T., 1986, FRONTAL LOBES; Toplak ME, 2013, J CHILD PSYCHOL PSYC, V54, P131, DOI 10.1111/jcpp.12001; Vargas ML, 2009, COGN BEHAV NEUROL, V22, P95, DOI 10.1097/WNN.0b013e318192cd08; Ward C, 2009, CHILD NERV SYST, V25, P663, DOI 10.1007/s00381-009-0832-8; Wechsler D, 1996, ECHELLE INTELLIGENCE; WELSH MC, 1991, DEV NEUROPSYCHOL, V7, P131, DOI 10.1080/87565649109540483; White SJ, 2009, AUTISM RES, V2, P138, DOI 10.1002/aur.78; Willcutt EG, 2005, BIOL PSYCHIAT, V57, P1336, DOI 10.1016/j.biopsych.2005.02.006; Willner P, 2010, J INTELL DISABIL RES, V54, P366, DOI 10.1111/j.1365-2788.2010.01249.x; WILSON BA, 1997, METHODOLOGY FRONTAL; Wilson BA, 1996, BEHAV ASSESSMENT DYS	73	11	11	1	51	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	OCT 21	2015	37	9					956	971		10.1080/13803395.2015.1072138			16	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	CQ5LZ	WOS:000360647100005	26332175				2021-06-18	
J	Vaaramo, K; Puljula, J; Tetri, S; Juvela, S; Hillbom, M				Vaaramo, Kalle; Puljula, Jussi; Tetri, Sami; Juvela, Seppo; Hillbom, Matti			Head Trauma with or without Mild Brain Injury Increases the Risk of Future Traumatic Death: A Controlled Prospective 15-Year Follow-Up Study	JOURNAL OF NEUROTRAUMA			English	Article						adult brain injury; epidemiology; head trauma	SUICIDAL IDEATION; POPULATION; MORTALITY; PREDICTORS; SURVIVAL; BEHAVIOR; COHORT; RATES	Patients who have recovered from traumatic brain injury (TBI) show an increased risk of premature death. To investigate long-term mortality rates in a population admitted to the hospital for head injury (HI), we conducted a population-based prospective case-control, record-linkage study, All subjects who were living in Northern Ostrobothnia, and who were admitted to Oulu University Hospital in 1999 because of HI (n=737), and 2196 controls matched by age, gender, and residence randomly drawn from the population of Northern Ostrobothnia were included. Death rate and causes of death in HI subjects during 15 years of follow-up was compared with the general population controls. The crude mortality rates were 56.9, 18.6, and 23.8% for subjects having moderate-to-severe traumatic brain injury (TBI), mild TBI, and head injury without TBI, respectively. The corresponding approximate annual mortality rates were 6.7%, 1.4%, and 1.9%. All types of index HI predicted a significant risk of traumatic death in the future. Subjects who had HI without TBI had an increased risk of both death from all causes (hazard ratio 2.00; 95% confidence interval 1.57-2.55) and intentional or unintentional traumatic death (4.01, 2.20-7.30), compared with controls. The main founding was that even HI without TBI carries an increased risk of future traumatic death. The reason for this remains unknown and further studies are needed. To prevent such premature deaths, post-traumatic therapy should include an interview focusing on lifestyle factors.	[Vaaramo, Kalle; Puljula, Jussi; Hillbom, Matti] Univ Oulu, Dept Neurol, Oulu, Finland; [Tetri, Sami] Univ Oulu, Dept Neurosurg, Oulu, Finland; Oulu Univ Hosp, Oulu 90029, Finland; [Juvela, Seppo] Univ Helsinki, Dept Clin Neurosci, Helsinki, Finland	Tetri, S (corresponding author), Oulu Univ Hosp, Dept Neurosurg, Kajaanintie 52, Oulu 90029, Finland.	sami.tetri@ppshp.fi					Andelic N, 2008, NEUROEPIDEMIOLOGY, V30, P120, DOI 10.1159/000120025; Baguley IJ, 2012, MED J AUSTRALIA, V196, P40, DOI 10.5694/mja11.10090; Brown AW, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e318280d3e6; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cheng PL, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/1757-7241-22-7; Colantonio A, 2008, J TRAUMA, V64, P876, DOI 10.1097/TA.0b013e31804d493e; Fazel S, 2014, JAMA PSYCHIAT, V71, P326, DOI 10.1001/jamapsychiatry.2013.3935; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Giza CC, 2001, J ATHL TRAINING, V36, P228; Harrison-Felix CL, 2009, ARCH PHYS MED REHAB, V90, P1506, DOI 10.1016/j.apmr.2009.03.015; Himanen L, 2011, BRAIN INJURY, V25, P443, DOI 10.3109/02699052.2011.556580; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; Koven R, 2005, PREV MED, V41, P240, DOI 10.1016/j.ypmed.2004.11.009; Lahti RA, 2001, FORENSIC SCI INT, V115, P15, DOI 10.1016/S0379-0738(00)00300-5; Mackelprang JL, 2014, AM J PUBLIC HEALTH, V104, pE100, DOI 10.2105/AJPH.2013.301794; McMillan TM, 2014, J NEUROL NEUROSUR PS, V85, P1214, DOI 10.1136/jnnp-2013-307279; Nordstrom A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f723; Numminen HJ, 2011, EUR J NEUROL, V18, P460, DOI 10.1111/j.1468-1331.2010.03179.x; Oquendo MA, 2004, J NERV MENT DIS, V192, P430, DOI 10.1097/01.nmd.0000126706.53615.7b; Shi HY, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1066; Tsaousides T, 2011, J HEAD TRAUMA REHAB, V26, P265, DOI 10.1097/HTR.0b013e3182225271; Ventura T, 2010, ARCH PHYS MED REHAB, V91, P20, DOI 10.1016/j.apmr.2009.08.151	22	11	11	1	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 15	2015	32	20					1579	1583		10.1089/neu.2014.3757			5	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	CS6VH	WOS:000362220500005	25584928				2021-06-18	
J	Cheng, CY; Ho, CH; Wang, CC; Liang, FW; Wang, JJ; Chio, CC; Chang, CH; Kuo, JR				Cheng, Chieh-Yang; Ho, Chung-Han; Wang, Che-Chuan; Liang, Fu-Wen; Wang, Jhi-Joung; Chio, Chung-Ching; Chang, Chin-Hung; Kuo, Jinn-Rung			One-Year Mortality after Traumatic Brain Injury in Liver Cirrhosis Patients-A Ten-Year Population-Based Study	MEDICINE			English	Article							HEPATITIS-C VIRUS; ALCOHOL-CONSUMPTION; B-VIRUS; ESSENTIAL-HYPERTENSION; CLINICAL-RELEVANCE; NONHEPATIC SURGERY; MEDICAL PROGRESS; RENAL-FAILURE; FOLLOW-UP; DISEASE	This study investigated the 1-year mortality of patients who underwent brain surgery following traumatic brain injury (TBI) who also had alcoholic and/or nonalcoholic liver cirrhosis (LC) using a nationwide database in Taiwan. A longitudinal cohort study matched by propensity score with age, gender, length of ICU stay, HTN, DM, MI, stroke, HF, renal diseases, and year of TBI diagnosis in TBI patients with alcoholic and/or nonalcoholic LC and TBI patients without LC was conducted using the National Health Insurance Research Database in Taiwan between January 1997 and December 2007. The main outcome studied was 1-year mortality. In total, 7296 subjects (2432 TBI patients with LC and 4864 TBI patients without LC) were enrolled in this study. The main findings were (1) TBI patients with LC had a higher 1-year mortality (52.18% vs 30.61%) and a 1.75-fold increased risk of mortality (95% CI 1.61-1.90) compared with non-LC TBI patients, (2) renal diseases and HF are risk factors, but hypertension could be a protective factor in cirrhotic TBI patients, and (3) TBI patients with non-alcoholic LC and the coexistence of alcoholic and nonalcoholic LC had higher 1-year mortality compared with TBI patients with alcoholic cirrhosis. This study showed that patients with LC who have undergone brain surgery might have higher risk of 1-year mortality than those without LC. In addition, nonalcoholic and the coexistence of alcoholic and nonalcoholic LC show higher 1-year mortality risk than alcoholic in TBI patients with LC, especially in those with comorbidities of hypertension, diabetes mellitus, and stroke.	[Cheng, Chieh-Yang; Wang, Che-Chuan; Chio, Chung-Ching; Chang, Chin-Hung; Kuo, Jinn-Rung] Chi Mei Med Ctr, Dept Neurosurg, Tainan, Taiwan; [Ho, Chung-Han; Wang, Jhi-Joung; Kuo, Jinn-Rung] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Kuo, Jinn-Rung] Southern Taiwan Univ Sci & Technol, Dept Biotechnol, ChildCare, Tainan, Taiwan; [Liang, Fu-Wen] Natl Cheng Kung Univ, Dept Publ Hlth, Tainan 701, Taiwan; [Ho, Chung-Han] Chia Nan Univ Pharm & Sci, Dept Hosp, Tainan, Taiwan; [Ho, Chung-Han] Chia Nan Univ Pharm & Sci, Hlth Care Adm, Tainan, Taiwan	Kuo, JR (corresponding author), Chi Mei Med Ctr, Traumat Brain Ctr, Dept Neurosurg, 901 Zhonghua Rd, Tainan 710, Taiwan.	kuojinnrung@gmail.com		Liang, Fu-Wen/0000-0002-3396-037X; Ho, Chung-Han/0000-0001-5925-8477	Chi-Mei Medical Center [CMFHR10337]	This study is based in part on data from the National Health Insurance Research Database provided by the National Health Insurance Administration, Ministry of Health, and Welfare and managed by the National Health Research Institutes. The interpretation and conclusions contained herein do not represent those of the National Health Insurance Administration, the Ministry of Health and Welfare or the National Health Research Institutes. In addition, this work was supported by Chi-Mei Medical Center grant number CMFHR10337.	Alali AS, 2014, NEUROCRIT CARE, V20, P514, DOI 10.1007/s12028-013-9903-5; Andersen UO, 2002, BLOOD PRESSURE, V11, P357, DOI 10.1080/080370502321095320; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1056/NEJMra011775; Chen CC, 2012, J NEUROSURG, V117, P348, DOI 10.3171/2012.4.JNS111338; CHEN DS, 1977, NEW ENGL J MED, V297, P668; CHEN DS, 1990, J INFECT DIS, V162, P817, DOI 10.1093/infdis/162.4.817; Chen YW, 2010, J AM GERIATR SOC, V58, P2230, DOI 10.1111/j.1532-5415.2010.03102.x; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Chien CC, 2012, AM J HYPERTENS, V25, P900, DOI 10.1038/ajh.2012.60; Chiu WT, 1997, NEUROL RES, V19, P261, DOI 10.1080/01616412.1997.11740811; Chou YC, 2013, J HEAD TRAUMA REHAB; Christmas AB, 2005, AM SURGEON, V71, P996; Clark JM, 2003, JAMA-J AM MED ASSOC, V289, P3000, DOI 10.1001/jama.289.22.3000; Corrao G, 1998, HEPATOLOGY, V27, P914, DOI 10.1002/hep.510270404; de Goede B, 2012, BEST PRACT RES CL GA, V26, P47, DOI 10.1016/j.bpg.2012.01.010; Fede G, 2012, J HEPATOL, V56, P810, DOI 10.1016/j.jhep.2011.10.016; Georgiou C, 2009, WORLD J SURG, V33, P1087, DOI 10.1007/s00268-009-9923-7; Gines P, 2009, NEW ENGL J MED, V361, P1279, DOI 10.1056/NEJMra0809139; Hayashi PH, 2005, MED CLIN N AM, V89, P371, DOI 10.1016/j.mcna.2004.08.014; Henriksen JH, 2006, WORLD J GASTROENTERO, V12, P678, DOI 10.3748/wjg.v12.i5.678; Jepsen P, 2008, HEPATOLOGY, V48, P214, DOI 10.1002/hep.22341; Kerr WC, 2000, ADDICTION, V95, P339, DOI 10.1046/j.1360-0443.2000.9533394.x; Krousel-Wood MA, 2004, MED CLIN N AM, V88, P223, DOI 10.1016/S0025-7125(03)00126-3; Lai CH, 2011, STROKE, V42, P2615, DOI 10.1161/STROKEAHA.111.617076; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Liao CC, 2014, MAYO CLIN PROC, V89, P163, DOI 10.1016/j.mayocp.2013.09.019; Liao JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093956; LIAW YF, 1988, HEPATOLOGY, V8, P493, DOI 10.1002/hep.1840080310; Lin CS, 2013, BRIT J SURG, V100, P1784, DOI 10.1002/bjs.9312; Lin Tung-Yi, 2014, Biomed J, V37, P18, DOI 10.4103/2319-4170.113376; LOYKE HF, 1962, ARCH INTERN MED, V110, P45, DOI 10.1001/archinte.1962.03620190047006; Lustenberger T, 2011, AM SURGEON, V77, P311; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MENDENHALL CL, 1991, HEPATOLOGY, V14, P581; Moller S, 2002, HEART, V87, P9, DOI 10.1136/heart.87.1.9; Mueller S, 2009, WORLD J GASTROENTERO, V15, P3462, DOI 10.3748/wjg.15.3462; Neeff HP, 2014, SURGERY, V155, P623, DOI 10.1016/j.surg.2013.11.009; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Riggio Oliviero, 2010, World J Gastrointest Pharmacol Ther, V1, P54, DOI 10.4292/wjgpt.v1.i2.54; Roman E, 2010, AM J GASTROENTEROL; SCHWARTZ DT, 1967, ANN INTERN MED, V66, P862, DOI 10.7326/0003-4819-66-5-862; STEVENS CE, 1975, NEW ENGL J MED, V292, P771, DOI 10.1056/NEJM197504102921503; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tarantino G, 2013, WORLD J GASTROENTERO, V19, P3375, DOI 10.3748/wjg.v19.i22.3375; Thompson HJ, 2010, ANN SURG, V252, P370, DOI 10.1097/SLA.0b013e3181df03d6; TINKOFF G, 1990, ANN SURG, V211, P172, DOI 10.1097/00000658-199002000-00009; VEGLIO F, 1992, CLIN EXP HYPERTENS A, V14, P889, DOI 10.3109/10641969209036225; VINGILIS E, 1983, RES ADV ALCOHOL DRUG, V7, P299; Wahlstrom K, 2000, AM SURGEON, V66, P1071; Wiese S, 2014, NAT REV GASTRO HEPAT, V11, P177, DOI 10.1038/nrgastro.2013.210; Younossi ZM, 2013, ALIMENT PHARM THER, V37, P703, DOI 10.1111/apt.12265	51	11	11	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	OCT	2015	94	40							e1468	10.1097/MD.0000000000001468			9	Medicine, General & Internal	General & Internal Medicine	DC7NC	WOS:000369406100001	26448001	DOAJ Gold, Green Published			2021-06-18	
J	Plackett, TP; Asturias, S; Tadlock, M; Wright, F; Ton-That, H; Demetriades, D; Esposito, T; Inaba, K				Plackett, Timothy P.; Asturias, Sabrina; Tadlock, Matthew; Wright, Franklin; Ton-That, Hieu; Demetriades, Demetrios; Esposito, Thomas; Inaba, Kenji			Re-evaluating the need for hospital admission and observation of pediatric traumatic brain injury after a normal head CT	JOURNAL OF PEDIATRIC SURGERY			English	Article						Traumatic brain injury; Concussion; Closed head injury; Pediatrics; Blunt head trauma; Resource utilization	CHILDREN; MANAGEMENT	There is no consensus on the optimal management of pediatric patients with suspected trauma brain injury and a normal head CT. This study characterizes the clinical outcomes of patients with a normal initial CT scan of the head. A retrospective chart review of pediatric blunt trauma patients who underwent head CT for closed head injury at two trauma centers was performed. Charts were reviewed for demographics, neurologic function, CT findings, and complications. 631 blunt pediatric trauma patients underwent a head CT. 63% had a negative CT, 7% had a non-displaced skull fracture, and 31% had an intracranial hemorrhage and/or displaced skull fracture. For patients without intracranial injury, the mean age was 8 years, mean ISS was 5, and 92% had a GCS of 13-15 on arrival. All patients with an initial GCS of 13-15 and no intracranial injury were eventually discharged to home with a normal neurologic exam and no patient required craniotomy. Not admitting those children with an initial GCS of 13-15, normal CT scan, and no other injuries would have saved 1.8 +/- 1.5 hospital days per patient. Pediatric patients who have sustained head trauma, have a negative CT scan, and present with a GCS 13-15 can safely be discharged home without admission. Published by Elsevier Inc.	[Plackett, Timothy P.; Wright, Franklin; Ton-That, Hieu; Esposito, Thomas] Loyola Univ, Med Ctr, Dept Surg, Div Trauma Surg Crit Care & Burns, Maywood, IL 60153 USA; [Asturias, Sabrina; Tadlock, Matthew; Demetriades, Demetrios; Inaba, Kenji] Los Angeles Cty Univ Southern Calif Med Ctr, Div Acute Care Surg & Surg Crit Care, Dept Surg, Los Angeles, CA USA	Plackett, TP (corresponding author), Loyola Univ, Med Ctr, Dept Surg, 2160 S First Ave, Maywood, IL 60153 USA.	tplacke@lumc.edu; sasturias@hotmail.com; matthewtadlockmd@gmail.com; fwright@gmail.com; hton@lumc.edu; demetria@usc.edu; tesposi@gmail.com; kenji.inaba@med.usc.edu		Wright, Franklin/0000-0002-4433-5385			Barbosa RR, 2012, J TRAUMA ACUTE CARE, V73, pS307, DOI 10.1097/TA.0b013e3182701885; Bergman DA, 1999, PEDIATRICS, V104, P1407; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Haider AH, 2007, J TRAUMA, V62, P1259, DOI 10.1097/TA.0b013e31803c760e; Holmes JF, 2011, ANN EMERG MED, V58, P315, DOI 10.1016/j.annemergmed.2011.03.060; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Martin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Rollins MD, 2011, J PEDIATR SURG, V46, P1342, DOI 10.1016/j.jpedsurg.2010.12.019; Wang MY, 2000, NEUROSURGERY, V46, P1093, DOI 10.1097/00006123-200005000-00014	11	11	11	0	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0022-3468	1531-5037		J PEDIATR SURG	J. Pediatr. Surg.	OCT	2015	50	10					1758	1761		10.1016/j.jpedsurg.2015.03.067			4	Pediatrics; Surgery	Pediatrics; Surgery	CU1HI	WOS:000363271000027	25957025				2021-06-18	
J	Yu, M; Xue, YX; Liang, WD; Zhang, YP; Zhang, ZQ				Yu, Min; Xue, Yixue; Liang, Weidi; Zhang, Yupeng; Zhang, Zhiqiang			Protection mechanism of early hyperbaric oxygen therapy in rats with permanent cerebral ischemia	JOURNAL OF PHYSICAL THERAPY SCIENCE			English	Article						Hyperbaric oxygen therapy; Cerebrovascular protection; Cerebral ischemic rats	TRAUMATIC BRAIN-INJURY; ARTERY OCCLUSION; ALPHA; NEUROPROTECTION; INFARCTION; MICE; PKC	[Purpose] The purpose of this study was to investigate whether early hyperbaric oxygen is useful in rats with permanent cerebral ischemia, and whether its mechanism relates to the inhibition of the tumor necrosis factor-alpha-protein kinase C-alpha pathway. [Subjects] Healthy, male Sprague-Dawley rats (N = 108) were the subjects. [Methods] After middle cerebral artery occlusion models were successfully made, rats were randomly divided into sham-operated, cerebral ischemia, and hyperbaric oxygen groups. At 4 and 12 hours after modeling, the volume of cerebral infarction was determined by triphenyltetrazolium chloride staining, and brain water content was measured using the dry and wet method. The expression of tumor necrosis factor-alpha and protein kinase C-alpha in the ischemic penumbra tissue was measured using Western blot analysis. [Results] The data showed that at 4 and 12 hours after modeling, cerebral infarct volume and brain water content decreased in the hyperbaric oxygen group, and expression of tumor necrosis factor-alpha and phospho-protein kinase C-alpha in the ischemic penumbra tissue also decreased. [Conclusion] Our study demonstrates that early hyperbaric oxygen therapy has protective effects on brain tissue after cerebral ischemia, possibly via inhibition of tumor necrosis factor-alpha and phospho-protein kinase C-alpha.	[Yu, Min; Liang, Weidi; Zhang, Yupeng; Zhang, Zhiqiang] China Med Univ, Shengjing Hosp, Dept Rehabil, Shenyang 110022, Liaoning, Peoples R China; [Xue, Yixue] China Med Univ, Coll Basic Med Sci, Dept Neurobiol, Shenyang 110022, Liaoning, Peoples R China	Zhang, ZQ (corresponding author), China Med Univ, Shengjing Hosp, Dept Rehabil, 39 Huaxiang Rd, Shenyang 110022, Liaoning, Peoples R China.	zhangzq@sj-hospital.org					Badr AE, 2001, AM J PHYSIOL-REG I, V280, pR766; BEDERSON JB, 1986, STROKE, V17, P1304, DOI 10.1161/01.STR.17.6.1304; Chen X, 2014, NEUROSCIENCE, V266, P235, DOI 10.1016/j.neuroscience.2013.11.036; CORKILL G, 1985, SURG NEUROL, V24, P206, DOI 10.1016/0090-3019(85)90186-7; Dong Y, 2015, J PHYS THER SCI, V27, P1295, DOI 10.1589/jpts.27.1295; Gong C, 1998, BRAIN RES, V801, P1, DOI 10.1016/S0006-8993(98)00489-2; Lee JY, 2000, J BIOL CHEM, V275, P29290, DOI 10.1074/jbc.M000170200; Lin KC, 2012, J TRAUMA ACUTE CARE, V72, P650, DOI 10.1097/TA.0b013e31823c575f; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Lou M, 2007, NEUROSCIENCE, V146, P555, DOI 10.1016/j.neuroscience.2007.01.046; Mehta D, 2001, J BIOL CHEM, V276, P22614, DOI 10.1074/jbc.M101927200; Michalski D, 2011, ACTA NEUROL SCAND, V123, P85, DOI 10.1111/j.1600-0404.2010.01363.x; Nishimura Y, 2000, STROKE, V31, P2478, DOI 10.1161/01.STR.31.10.2478; REITAN JA, 1990, STROKE, V21, P119, DOI 10.1161/01.STR.21.1.119; Salamanca DA, 2005, BIOCHEM PHARMACOL, V70, P1537, DOI 10.1016/j.bcp.2005.07.017; Sandoval R, 2001, J PHYSIOL-LONDON, V533, P433, DOI 10.1111/j.1469-7793.2001.0433a.x; Schabitz WR, 2004, STROKE, V35, P1175, DOI 10.1161/01.STR.0000125868.86298.8e; Sunami K, 2000, CRIT CARE MED, V28, P2831, DOI 10.1097/00003246-200008000-00025; TAKAGI K, 1993, J CEREBR BLOOD F MET, V13, P575, DOI 10.1038/jcbfm.1993.75	19	11	15	0	3	SOC PHYSICAL THERAPY SCIENCE	TOKYO	C/O PUBLICATION CENTER, 1-24-12 SUGAMO, TOSHIMA-KU, TOKYO, 170-0002, JAPAN	0915-5287	2187-5626		J PHYS THER SCI	J. Phys. Ther. Sci.	OCT	2015	27	10					3271	3274		10.1589/jpts.27.3271			4	Rehabilitation	Rehabilitation	CW6UH	WOS:000365133000056	26644690	Bronze, Green Published			2021-06-18	
J	Flach, PM; Schroth, S; Schweitzer, W; Ampanozi, G; Slotboom, J; Kiefer, C; Germerott, T; Thali, MJ; El-Koussy, M				Flach, Patricia Mildred; Schroth, Sarah; Schweitzer, Wolf; Ampanozi, Garyfalia; Slotboom, Johannes; Kiefer, Claus; Germerott, Tanja; Thali, Michael J.; El-Koussy, Marwan			Deep Into the Fibers! Postmortem Diffusion Tensor Imaging in Forensic Radiology	AMERICAN JOURNAL OF FORENSIC MEDICINE AND PATHOLOGY			English	Article						diffusion tensor imaging; DTI; forensic radiology; magnetic resonance imaging; postmortem MR; Virtopsy	TRAUMATIC BRAIN-INJURY; WHITE-MATTER; VIRTUAL AUTOPSY; AXONAL INJURY; MRI; ANGIOGRAPHY; DEATH; WHOLE; TRACTOGRAPHY; FEASIBILITY	Purpose In traumatic brain injury, diffusion-weighted and diffusion tensor imaging of the brain are essential techniques for determining the pathology sustained and the outcome. Postmortem cross-sectional imaging is an established adjunct to forensic autopsy in death investigation. The purpose of this prospective study was to evaluate postmortem diffusion tensor imaging in forensics for its feasibility, influencing factors and correlation to the cause of death compared with autopsy. Methods Postmortem computed tomography, magnetic resonance imaging, and diffusion tensor imaging with fiber tracking were performed in 10 deceased subjects. The Likert scale grading of colored fractional anisotropy maps was correlated to the body temperature and intracranial pathology to assess the diagnostic feasibility of postmortem diffusion tensor imaging and fiber tracking. Results Optimal fiber tracking (>15,000 fiber tracts) was achieved with a body temperature at 10 degrees C. Likert scale grading showed no linear correlation (P > 0.7) to fiber tract counts. No statistically significant correlation between total fiber count and postmortem interval could be observed (P = 0.122). Postmortem diffusion tensor imaging and fiber tracking allowed for radiological diagnosis in cases with shearing injuries but was impaired in cases with pneumencephalon and intracerebral mass hemorrhage. Conclusions Postmortem diffusion tensor imaging with fiber tracking provides an exceptional in situ insight deep into the fibers of the brain with diagnostic benefit in traumatic brain injury and axonal injuries in the assessment of the underlying cause of death, considering influencing factors for optimal imaging technique.	[Flach, Patricia Mildred; Schweitzer, Wolf; Ampanozi, Garyfalia; Thali, Michael J.] Univ Zurich, Inst Forens Med, CH-8057 Zurich, Switzerland; [Flach, Patricia Mildred] Univ Zurich Hosp, Dept Diagnost & Intervent Radiol, CH-8091 Zurich, Switzerland; [Flach, Patricia Mildred; Schroth, Sarah; Germerott, Tanja] Univ Bern, Inst Forens Med, Bern, Switzerland; [Schroth, Sarah; Slotboom, Johannes; Kiefer, Claus; El-Koussy, Marwan] Univ Bern, Inselspital, Univ Hosp Bern, Dept Intervent & Diagnost Neuroradiol, CH-3010 Bern, Switzerland; [Schroth, Sarah] Univ Bern, Inselspital, Univ Hosp Bern, Dept Neurol, CH-3010 Bern, Switzerland; [Germerott, Tanja] Hannover Med Sch, Inst Legal Med, Hannover, Germany	Flach, PM (corresponding author), Univ Zurich, Virtopsy, Inst Forens Med, Winterthurerstr 190-52, CH-8057 Zurich, Switzerland.	patricia.flach@irm.uzh.ch	Schweitzer, Wolf/ABE-9689-2020; Germerott, Tanja/AAC-5743-2019	Ampanozi, Garyfalia/0000-0002-9033-3161			Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Auer RN, 2006, FORENSIC NEUROPATHOL, P177; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Christe A, 2010, LEGAL MED, V12, P215, DOI 10.1016/j.legalmed.2010.05.005; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; D'Arceuil H, 2007, NEUROIMAGE, V36, P64, DOI 10.1016/j.neuroimage.2007.02.039; Dellanoy J, 1991, MAGN RESON MED, V19, P333; DiMaio V J, 2001, FORENSIC PATHOLOGY, P147; Englund E, 2004, J NEUROL, V251, P350, DOI 10.1007/s00415-004-0318-2; Ezaki Y, 2006, ACTA RADIOL, V47, P733, DOI 10.1080/02841850600771486; Filograna L, 2010, LEGAL MED, V12, P233, DOI 10.1016/j.legalmed.2010.04.003; Flach P.M., 2010, BROGDONS FORENSIC RA, P409; Flach PM, 2012, J FORENSIC SCI, V57, P1376, DOI 10.1111/j.1556-4029.2012.02144.x; Grabherr S, 2007, AM J ROENTGENOL, V188, P832, DOI 10.2214/AJR.06.0787; Hansen B, 2011, NEUROIMAGE, V57, P1458, DOI 10.1016/j.neuroimage.2011.04.052; Helenius J, 2002, AM J NEURORADIOL, V23, P194; Ith M, 2011, NMR BIOMED, V24, P791, DOI 10.1002/nbm.1623; Jackowski C, 2008, J FORENSIC SCI, V53, P465, DOI 10.1111/j.1556-4029.2008.00673.x; Kim JH, 2007, NMR BIOMED, V20, P352, DOI 10.1002/nbm.1138; Knight B., 2004, KNIGHTS FORENSIC PAT, P174; Kobayashi T, 2010, MAGN RESON MED SCI, V9, P101, DOI 10.2463/mrms.9.101; Kobayashi T, 2010, JPN J RADIOL, V28, P8, DOI 10.1007/s11604-009-0373-9; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Miller KL, 2011, NEUROIMAGE, V57, P167, DOI 10.1016/j.neuroimage.2011.03.070; Moseley M, 2002, NMR BIOMED, V15, P553, DOI 10.1002/nbm.785; Muir KW, 2006, LANCET NEUROL, V5, P755; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Oehmichen M, 2008, ACTA NEUROPATHOL, V116, P317, DOI 10.1007/s00401-008-0356-4; Pfefferbaum A, 2004, NEUROIMAGE, V21, P1585, DOI 10.1016/j.neuroimage.2003.11.024; Roberts ISD, 2012, LANCET, V379, P136, DOI 10.1016/S0140-6736(11)61483-9; Ross S, 2012, AM J ROENTGENOL, V199, P1186, DOI 10.2214/AJR.12.8767; Ross SG, 2012, RADIOLOGY, V264, P250, DOI 10.1148/radiol.12092415; Ruder TD, 2014, BRIT J RADIOL, V87, DOI 10.1259/bjr.20130567; Ruder TD, 2012, EUR J RADIOL, V81, P1366, DOI 10.1016/j.ejrad.2011.02.062; Scheurer E, 2011, AM J NEURORADIOL, V32, P1518, DOI 10.3174/ajnr.A2508; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Thali Michael J., 2007, Legal Medicine, V9, P100, DOI 10.1016/j.legalmed.2006.11.011; Thali MJ, 2003, J FORENSIC SCI, V48, P386; Yen K, 2006, AM J NEURORADIOL, V27, P70; Yen K, 2007, FORENSIC SCI INT, V173, P21, DOI 10.1016/j.forsciint.2007.01.027	41	11	11	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-7910	1533-404X		AM J FOREN MED PATH	Am. J. Forensic Med. Pathol.	SEP	2015	36	3					153	161		10.1097/PAF.0000000000000177			9	Medicine, Legal; Pathology	Legal Medicine; Pathology	CQ3UX	WOS:000360530200008	26132433	Green Published			2021-06-18	
J	Johanssen, T; Suphantarida, N; Donnelly, PS; Liu, XM; Petrou, S; Hill, AF; Barnham, KJ				Johanssen, Timothy; Suphantarida, Nuttawat; Donnelly, Paul S.; Liu, Xiang M.; Petrou, Steven; Hill, Andrew F.; Barnham, Kevin J.			PBT2 inhibits glutamate-induced excitotoxicity in neurons through metal-mediated preconditioning	NEUROBIOLOGY OF DISEASE			English	Article						Excitotoxicity; Zinc; Calcium flux; Huntington's disease (HD); Alzheimer's disease (AD)	A-BETA OLIGOMERS; HUNTINGTONS-DISEASE; ALZHEIMERS-DISEASE; TRANSGENIC MICE; PRION PROTEIN; UP-REGULATION; NMDA; ACTIVATION; MODEL; NEUROPROTECTION	Excitotoxicity is the pathological process by which neuronal death occurs as a result of excessive stimulation of receptors at the excitatory synapse such as the NMDA receptor (NMDAR). Excitotoxicity has been implicated in the acute neurological damage from ischemia and traumatic brain injury and in the chronic neurodegeneration in Alzheimer's disease (AD) and Huntington's disease (HD). As a result NMDAR antagonists have become an attractive therapeutic strategy for the potential treatment of multiple neurodegenerative diseases. However NMDAR signaling is dichotomous in nature, with excessive increases in neuronal intracellular calcium through excessive NMDAR activity being lethal but moderate increases to intracellular calcium levels during normal synaptic function providing neuroprotection. Subsequently indiscriminant inhibition of this receptor is best avoided as was concluded from previous clinical trials of NMDAR antagonists. We show that the metal chaperone, PBT2, currently in clinical trials for HD, is able to protect against glutamate-induced excitotoxicity mediated through NMDARs. This was achieved by PBT2 inducing Zn2+-dependent increases in intracellular Ca2+ levels resulting in preconditioning of neurons and inhibition of Ca2+-induced neurotoxic signaling cascade involving calpain-activated cleavage of calcineurin. Our study demonstrates that modulating intracellular Ca2+ levels by a zinc ionophore is a valid therapeutic strategy to protect against the effects of excitotoxicity thought to underlie both acute and chronic neurodegenerative diseases. (C) 2015 Elsevier Inc. All rights reserved.	[Johanssen, Timothy] Univ Melbourne, Dept Pathol, Parkville, Vic 3010, Australia; [Johanssen, Timothy; Suphantarida, Nuttawat; Liu, Xiang M.; Petrou, Steven; Barnham, Kevin J.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3010, Australia; [Johanssen, Timothy; Donnelly, Paul S.; Liu, Xiang M.; Hill, Andrew F.; Barnham, Kevin J.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia; [Suphantarida, Nuttawat; Petrou, Steven] Univ Melbourne, Ctr Neural Engn, Parkville, Vic 3010, Australia; [Suphantarida, Nuttawat; Petrou, Steven] Univ Melbourne, Dept Elect & Elect Engn, Parkville, Vic 3010, Australia; [Donnelly, Paul S.] Univ Melbourne, Sch Chem, Parkville, Vic 3010, Australia; [Hill, Andrew F.] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia; [Barnham, Kevin J.] Univ Melbourne, Dept Pharmacol & Therapeut, Parkville, Vic 3010, Australia	Johanssen, T (corresponding author), Univ Melbourne, Inst Bio21, 30 Flemington Rd, Parkville, Vic 3010, Australia.	jot@unimelb.edu.au; kbarnham@unimelb.edu.au	Hill, Andrew/AAX-6727-2020; Hill, Andrew F/B-4527-2009; Hill, Andrew F./AAH-2854-2020	Hill, Andrew/0000-0001-5581-2354; Hill, Andrew F/0000-0001-5581-2354; Petrou, Steven/0000-0002-4960-6375	National Health and Medical Research Council of AustraliaNational Health and Medical Research Council of AustraliaUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [628946, APP1002373, APP1031193, 628952, 100505]; Victorian Government through the Operational Infrastructure Scheme; National Health & Medical Research CouncilNational Health and Medical Research Council of Australia; Commonwealth Scientific & Industrial Research Organisation of Australia	This work was supported by the National Health and Medical Research Council of Australia (Program Grant 628946 to AFH, KJB: Senior Research Fellowship APP1002373 to KJB, Project Grant APP1031193 to KJB, PSD Program Grant 628952 and Senior Research Fellowship 100505 to SP) and by the Victorian Government through the Operational Infrastructure Scheme. T.J. received PhD scholarships from the National Health & Medical Research Council and Commonwealth Scientific & Industrial Research Organisation of Australia.	AbdelHamid KM, 1997, NEUROSCIENCE, V81, P673, DOI 10.1016/S0306-4522(97)00162-0; Adlard PA, 2008, NEURON, V59, P43, DOI 10.1016/j.neuron.2008.06.018; Adlard PA, 2014, AGING CELL, V13, P351, DOI 10.1111/acel.12178; Avila J, 2004, PHYSIOL REV, V84, P361, DOI 10.1152/physrev.00024.2003; Bamham K.J., 2003, J BIOL CHEM, V278, P42959; Bickler PE, 2004, NEUROSCIENCE, V127, P673, DOI 10.1016/j.neuroscience.2004.05.035; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOTTOMLEY GA, 1994, AUST J CHEM, V47, P143, DOI 10.1071/CH9940143; Bradley CA, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00013; Carmichael J, 2002, J BIOL CHEM, V277, P33791, DOI 10.1074/jbc.m204861200; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; Chorin E, 2011, J NEUROSCI, V31, P12916, DOI 10.1523/JNEUROSCI.2205-11.2011; CHUANG DM, 1992, MOL PHARMACOL, V42, P210; Corona C, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.57; Crouch PJ, 2011, J NEUROCHEM, V119, P220, DOI 10.1111/j.1471-4159.2011.07402.x; Crouch PJ, 2009, P NATL ACAD SCI USA, V106, P381, DOI 10.1073/pnas.0809057106; Donnelly PS, 2008, J BIOL CHEM, V283, P4568, DOI 10.1074/jbc.M705957200; Dugan L.L., 1999, BASIC NEUROCHEMISTRY, V6th; Endo H, 2006, J CEREBR BLOOD F MET, V26, P1479, DOI 10.1038/sj.jcbfm.9600303; Engel T, 2006, NEUROBIOL AGING, V27, P1258, DOI 10.1016/j.neurobiolaging.2005.06.010; Fan MMY, 2007, PROG NEUROBIOL, V81, P272, DOI 10.1016/j.pneurobio.2006.11.003; FERRANTE RJ, 1993, EXP NEUROL, V119, P46, DOI 10.1006/exnr.1993.1006; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hershfinkel M, 2001, P NATL ACAD SCI USA, V98, P11749, DOI 10.1073/pnas.201193398; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Katsura K, 2001, NEUROL RES, V23, P751, DOI 10.1179/016164101101199126; KIRINO T, 1991, J CEREBR BLOOD F MET, V11, P299, DOI 10.1038/jcbfm.1991.62; Lannfelt L, 2008, LANCET NEUROL, V7, P779, DOI 10.1016/S1474-4422(08)70167-4; Lee JY, 2008, J NEUROSCI, V28, P10919, DOI 10.1523/JNEUROSCI.3421-08.2008; Lees KR, 2000, LANCET, V355, P1949, DOI 10.1016/S0140-6736(00)02326-6; Li MT, 2000, MOL CELL BIOL, V20, P9356, DOI 10.1128/MCB.20.24.9356-9363.2000; Lipton SA, 2006, NAT REV DRUG DISCOV, V5, P160, DOI 10.1038/nrd1958; McKay S, 2013, NEUROPHARMACOLOGY, V74, P119, DOI 10.1016/j.neuropharm.2013.01.024; Muir KW, 2006, CURR OPIN PHARMACOL, V6, P53, DOI 10.1016/j.coph.2005.12.002; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; OLNEY JW, 1969, SCIENCE, V164, P719, DOI 10.1126/science.164.3880.719; Papadia S, 2008, NAT NEUROSCI, V11, P476, DOI 10.1038/nn2071; Pivovarova NB, 2010, FEBS J, V277, P3622, DOI 10.1111/j.1742-4658.2010.07754.x; Pohl D, 1999, P NATL ACAD SCI USA, V96, P2508, DOI 10.1073/pnas.96.5.2508; Qin Y, 2011, P NATL ACAD SCI USA, V108, P7351, DOI 10.1073/pnas.1015686108; Rocha M, 1999, BRAIN RES, V827, P79, DOI 10.1016/S0006-8993(99)01307-4; Soriano FX, 2006, J NEUROSCI, V26, P4509, DOI 10.1523/JNEUROSCI.0455-06.2006; Stout AK, 1998, NAT NEUROSCI, V1, P366; Talantova M, 2013, P NATL ACAD SCI USA, V110, pE2518, DOI 10.1073/pnas.1306832110; Tauskela JS, 2008, J BIOL CHEM, V283, P34667, DOI 10.1074/jbc.M805624200; Um JW, 2012, NAT NEUROSCI, V15, P1227, DOI 10.1038/nn.3178; Vogler EC, 2014, CURR PHARM DESIGN, V20, P2520, DOI 10.2174/13816128113199990510; White AR, 2006, J BIOL CHEM, V281, P17670, DOI 10.1074/jbc.M602487200; Wu HY, 2007, ACTA MED OKAYAMA, V61, P123; You HT, 2012, P NATL ACAD SCI USA, V109, P1737, DOI 10.1073/pnas.1110789109; Zhang H, 2008, NEUROBIOL DIS, V31, P80, DOI 10.1016/j.nbd.2008.03.010	51	11	11	1	13	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0969-9961	1095-953X		NEUROBIOL DIS	Neurobiol. Dis.	SEP	2015	81				SI		176	185		10.1016/j.nbd.2015.02.008			10	Neurosciences	Neurosciences & Neurology	CV9LC	WOS:000364607700018	25697105				2021-06-18	
J	Joseph, B; Haider, AA; Pandit, V; Tang, A; Kulvatunyou, N; O'Keeffe, T; Rhee, P				Joseph, Bellal; Haider, Ansab A.; Pandit, Viraj; Tang, Andrew; Kulvatunyou, Narong; O'Keeffe, Terence; Rhee, Peter			Changing Paradigms in the Management of 2184 Patients With Traumatic Brain Injury	ANNALS OF SURGERY			English	Article; Proceedings Paper	135th Annual Meeting of the American-Surgical-Association (ASA)	APR 23-25, 2015	San Diego, CA	Amer Surg Assoc		acute care surgeons; brain injury guidelines; changing management; changing trends in traumatic brain injury; neurosurgical consultation; no repeat scans; repeat CT scans; traumatic brain injury	CRANIAL COMPUTED-TOMOGRAPHY; UNITED-STATES; HEAD TRAUMA; LOW-RISK; LEVEL I; MILD; CARE; HEMORRHAGE; COVERAGE; MODERATE	Objectives: The aim of this study was to assess the change in trends in the management of traumatic brain injury (TBI) at a level I trauma center and the utilization of resources as a result of this change in management. Background: The management of TBI has been evolving with trends toward management of minimally injured patients with intracranial hemorrhage exclusively by trauma surgeons. Methods: A 5-year (2009-2014) prospective database on all patients with TBI (skull fracture/intracranial hemorrhage on head computed tomography) presenting to a level I trauma center was analyzed for patient demographics, injuries, admission physiology, computed tomographic scan results, and hospital outcomes. These records were matched to the institutional registry and hospital financial database. Results: A total of 2184 patients were included with median (interquartile range) Glasgow Coma Scale score of 15 (12-15), and median (interquartile range) head-abbreviated injury scale score of 3 (2-4). The distribution of types and size of intracranial bleeds remained unchanged throughout the study period. The proportion of TBI managed exclusively by trauma surgeons increased significantly over the years from 6.8% to 40.1% (P < 0.001). Proportion of patients who received neurosurgical consultations (P < 0.001) and repeat head computed tomographic scans (P < 0.001), hospital length of stay (P = 0.028), and costs (P < 0.001) decreased significantly over time. The overall mortality rate (18.5%) and rate of intervention (14.1%) remained unchanged. Conclusions: TBI patients can be selectively managed without initially involving neurosurgeons safely in a cost-effective manner, resulting in more effective use of precious resources.	[Joseph, Bellal; Haider, Ansab A.; Pandit, Viraj; Tang, Andrew; Kulvatunyou, Narong; O'Keeffe, Terence; Rhee, Peter] Univ Arizona, Med Ctr, Dept Surg, Div Trauma & Acute Care Surg, 1501 N Campbell Ave,Rm 5411,POB 245063, Tucson, AZ 85727 USA	Joseph, B (corresponding author), Univ Arizona, Med Ctr, Dept Surg, Div Trauma & Acute Care Surg, 1501 N Campbell Ave,Rm 5411,POB 245063, Tucson, AZ 85727 USA.	bjoseph@surgery.arizona.edu					Almenawer SA, 2013, NEUROSURGERY, V72, P56, DOI 10.1227/NEU.0b013e318276f899; [Anonymous], 2015, REP C MILD TRAUM BRA; Aziz H, 2013, J TRAUMA ACUTE CARE, V75, P550, DOI 10.1097/TA.0b013e3182a53a77; Barker DE, 2006, AM SURGEON, V72, P1166; Blackwell CD, 2007, ANN EMERG MED, V49, P320, DOI 10.1016/j.annemergmed.2006.09.025; Borczuk P, 2013, J TRAUMA ACUTE CARE, V74, P1504, DOI 10.1097/TA.0b013e31829215cf; Brown CVR, 2004, J TRAUMA, V57, P939, DOI 10.1097/01.TA.0000149492.92558.03; Connon FF, 2011, ANN SURG, V254, P1028, DOI 10.1097/SLA.0b013e318219727f; Ditty BJ, 2014, J NEUROSURG, V19, P1; Esposito TJ, 2005, ANN SURG, V242, P364, DOI 10.1097/01.sla.0000179624.50455.db; Homnick A, 2012, INJURY, V43, P2122, DOI 10.1016/j.injury.2012.04.013; Huynh T, 2006, AM SURGEON, V72, P1162; Il'Giovine Z, 2015, DO ALL PATIENTS MILD; JERET JS, 1993, NEUROSURGERY, V32, P9, DOI 10.1227/00006123-199301000-00002; Joseph B, 2014, J TRAUMA ACUTE CARE, V77, P984, DOI 10.1097/TA.0000000000000428; Joseph B, 2014, J AM COLL SURGEONS, V219, P45, DOI 10.1016/j.jamcollsurg.2013.12.062; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P965, DOI 10.1097/TA.0000000000000161; Joseph B, 2013, J TRAUMA ACUTE CARE, V75, P102, DOI 10.1097/TA.0b013e3182946667; Kaups KL, 2004, J TRAUMA, V56, P475, DOI 10.1097/01.TA.0000114304.56006.D4; Klein Y, 2010, J TRAUMA, V69, P544, DOI 10.1097/TA.0b013e3181c99936; Levy AS, 2014, WORLD NEUROSURG, V82, pE319, DOI 10.1016/j.wneu.2013.11.008; da Silva PSL, 2008, J TRAUMA, V65, P1293, DOI 10.1097/TA.0b013e318156866c; O'Keefe GE, 1999, ANN SURG, V229, P409, DOI 10.1097/00000658-199903000-00015; Overton TL, 2014, AM J SURG, V208, P806, DOI 10.1016/j.amjsurg.2014.02.012; Patel NY, 2000, J TRAUMA, V48, P367, DOI 10.1097/00005373-200003000-00001; Rao MB, 2010, ACAD EMERG MED, V17, P1374, DOI 10.1111/j.1553-2712.2010.00927.x; Shackford SR, 2004, J TRAUMA, V56, P480; Sifri ZC, 2006, J TRAUMA, V61, P862, DOI 10.1097/01.ta.0000224225.54982.90; Spain DA, 1998, J TRAUMA, V45, P101, DOI 10.1097/00005373-199807000-00022; STEIN SC, 1990, NEUROSURGERY, V26, P638, DOI 10.1227/00006123-199004000-00012; Stippler M, 2012, EMERG MED J, V29, P528, DOI 10.1136/emermed-2011-200162; Sugerman DE, 2012, J TRAUMA ACUTE CARE, V73, P1491, DOI 10.1097/TA.0b013e3182782675; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; van Essen TA, 2010, CLIN NEUROL NEUROSUR, V112, P775, DOI 10.1016/j.clineuro.2010.06.012	35	11	11	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-4932	1528-1140		ANN SURG	Ann. Surg.	SEP	2015	262	3					440	448		10.1097/SLA.0000000000001418			9	Surgery	Surgery	DD0LZ	WOS:000369612800005	26258312				2021-06-18	
J	Lamprecht, MR; Morrison, B				Lamprecht, Michael R.; Morrison, Barclay, III			A Combination Therapy of 17 beta-Estradiol and Memantine Is More Neuroprotective Than Monotherapies in an Organotypic Brain Slice Culture Model of Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						traumatic brain injury; E2; memantine; electrophysiology; combination therapies	LONG-TERM POTENTIATION; INDUCED CELL-DEATH; IN-VITRO MODELS; HEAD-INJURY; SYNAPTIC-TRANSMISSION; HIPPOCAMPAL CULTURE; ESTRADIOL PROTECTS; CEREBRAL-ISCHEMIA; CLINICAL-TRIALS; ESTROGEN	Combination therapies are a promising therapeutic option for traumatic brain injury (TBI) owing to the clinical failure of monotherapy treatments, such as progesterone. Organotypic hippocampal slice cultures (OHSCs) from Sprague-Dawley rats were subjected to an in vitro TBI, and the neuroprotective effects of 17 beta-estradiol (E2) or memantine (MEM) monotherapies were quantified. Several combination treatments at different concentrations of both drugs were tested, with 100 pM of E2 and 10 mu M of MEM statistically and significantly reducing cell death over either monotherapy when administered immediately after injury. This combination was also significantly neuroprotective when administered 1 h postinjury, possibly supporting future in vivo studies. Further, we hypothesized that this synergy could be the result of MEM blocking a potentially deleterious effect of E2, specifically E2 enhancement of N-methyl-d-aspartate (NMDA) currents. Evoked electrophysiological responses in OHSCs were potentiated by E2 treatment, whereas this potentiation was significantly reduced by MEM. In conclusion, a combination therapy of E2 and memantine was significantly more neuroprotective than both monotherapy treatments, and this synergy may be the result of MEM blocking a deleterious E2-mediated enhancement of NMDA receptors.	[Lamprecht, Michael R.; Morrison, Barclay, III] Columbia Univ, Dept Biomed Engn, New York, NY 10027 USA	Morrison, B (corresponding author), Columbia Univ, Dept Biomed Engn, 351 Engn Terrace,MC 8904, New York, NY 10027 USA.	bm2119@columbia.edu	Morrison, Barclay/B-7132-2008	Morrison, Barclay/0000-0001-7676-0864	National Science Foundation Graduate Research FellowshipNational Science Foundation (NSF); Multi-disciplinary University Research Initiative from the Army Research Office [W911MF-10-1-05026]	This work was supported by a National Science Foundation Graduate Research Fellowship (MRL) and a Multi-disciplinary University Research Initiative from the Army Research Office (W911MF-10-1-05026). The authors thank Benjamin S. Elkin and Gwen B. Effgen for their help with experimental design and insightful comments.	BEHL C, 1995, BIOCHEM BIOPH RES CO, V216, P473, DOI 10.1006/bbrc.1995.2647; Biegon A, 2004, P NATL ACAD SCI USA, V101, P5117, DOI 10.1073/pnas.0305741101; Bjornstrom Linda, 2004, Nucl Recept, V2, P3, DOI 10.1186/1478-1336-2-3; Brown CM, 2009, SEMIN REPROD MED, V27, P240, DOI 10.1055/s-0029-1216277; Cater HL, 2007, J NEUROCHEM, V101, P434, DOI 10.1111/j.1471-4159.2006.04379.x; Cimarosti H, 2005, NEUROCHEM RES, V30, P191, DOI 10.1007/s11064-004-2441-y; Day NL, 2013, J NEUROTRAUM, V30, P1531, DOI 10.1089/neu.2013.2854; Elkin BS, 2007, STAPP CAR CRASH JO, V51, P127; EMERSON CS, 1993, BRAIN RES, V608, P95, DOI 10.1016/0006-8993(93)90778-L; Faden AI, 2002, CURR OPIN NEUROL, V15, P707, DOI 10.1097/00019052-200212000-00008; Foy MR, 1999, J NEUROPHYSIOL, V81, P925; Frankiewicz T, 1996, BRIT J PHARMACOL, V117, P689, DOI 10.1111/j.1476-5381.1996.tb15245.x; Haddad SH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-12; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Heuschkel MO, 2002, J NEUROSCI METH, V114, P135, DOI 10.1016/S0165-0270(01)00514-3; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; KOEK W, 1988, J PHARMACOL EXP THER, V245, P969; Kutzing MK, 2012, ANN BIOMED ENG, V40, P1170, DOI 10.1007/s10439-011-0494-z; Lamprecht MR, 2014, BRAIN RES, V1563, P131, DOI 10.1016/j.brainres.2014.03.037; Lingsma HF, 2011, NEUROSURGERY, V68, P601, DOI 10.1227/NEU.0b013e318209333b; Liu R, 2007, NEUROSCI LETT, V415, P237, DOI 10.1016/j.neulet.2007.01.074; Liu SB, 2013, BRAIN RES BULL, V93, P27, DOI 10.1016/j.brainresbull.2012.10.004; Liu YT, 2007, J NEUROSCI, V27, P2846, DOI 10.1523/JNEUROSCI.0116-07.2007; Maas AIR, 1999, NEUROSURGERY, V44, P1286, DOI 10.1097/00006123-199906000-00076; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI [10.1089/neu.2008.0794, 10.1089/neu.2008-0794]; Mathys ML, 2013, ANN PHARMACOTHER, V47, DOI 10.1345/aph.1R522; Moretti L, 2012, LANCET NEUROL, V11, P1103, DOI 10.1016/S1474-4422(12)70226-0; Morrison B, 2002, BRIT J PHARMACOL, V137, P1255, DOI 10.1038/sj.bjp.0704986; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Nilsson S, 2002, CRIT REV EUKAR GENE, V12, P237, DOI 10.1615/CritRevEukaryotGeneExpr.v12.i4.10; Numakawa Y, 2007, ENDOCRINOLOGY, V148, P627, DOI 10.1210/en.2006-1210; Parsons CG, 1999, NEUROPHARMACOLOGY, V38, P735, DOI 10.1016/S0028-3908(99)00019-2; Parsons CG, 1998, DRUG NEWS PERSPECT, V11, P523, DOI 10.1358/dnp.1998.11.9.863689; Robertson CL, 2004, J BIOENERG BIOMEMBR, V36, P363, DOI 10.1023/B:JOBB.0000041769.06954.e4; Roof RL, 2000, J NEUROTRAUM, V17, P1155, DOI 10.1089/neu.2000.17.1155; Schneider Lon S, 2013, Continuum (Minneap Minn), V19, P339, DOI 10.1212/01.CON.0000429180.60095.d0; Simpkins JW, 2008, ALZHEIMERS DEMENT, V4, pS131, DOI 10.1016/j.jalz.2007.10.009; Simpkins JW, 1997, J NEUROSURG, V87, P724, DOI 10.3171/jns.1997.87.5.0724; Simpson ER, 2005, ENDOCR REV, V26, P322, DOI 10.1210/er.2004-0020; Smith CC, 2006, J NEUROSCI, V26, P8517, DOI 10.1523/JNEUROSCI.5279-05.2006; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Strom JO, 2011, INT J MOL SCI, V12, P1533, DOI 10.3390/ijms12031533; Sundstrom L, 2005, DRUG DISCOV TODAY, V10, P993, DOI 10.1016/S1359-6446(05)03502-6; TASKER RC, 1992, J NEUROSCI, V12, P4298; Vornov J. J., 1994, STROKE, V2, P464; VORNOV JJ, 1994, STROKE, V25, P457, DOI 10.1161/01.STR.25.2.457; Wigginton JG, 2010, CRIT CARE MED, V38, pS620, DOI 10.1097/CCM.0b013e3181f243a9; Xia MN, 2007, APPL OPTICS, V46, P8315, DOI 10.1364/AO.46.008315; Yu Z, 2010, J NEUROPHYSIOL, V103, P499, DOI 10.1152/jn.00775.2009; Zivadinovic D, 2005, BREAST CANCER RES, V7, pR101, DOI 10.1186/bcr958; Zlotnik A, 2012, INTENS CARE MED, V38, P137, DOI 10.1007/s00134-011-2401-3	54	11	11	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP 1	2015	32	17					1361	1368		10.1089/neu.2015.3912			8	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	CP0KP	WOS:000359564500009	25752651				2021-06-18	
J	Peterson, RL; Connery, AK; Baker, DA; Kirkwood, MW				Peterson, Robin L.; Connery, Amy K.; Baker, David A.; Kirkwood, Michael W.			Preinjury Emotional-Behavioral Functioning of Children With Lingering Problems After Mild Traumatic Brain Injury	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							SYMPTOM VALIDITY TEST; POSTCONCUSSIVE SYMPTOMS; HEAD-INJURY; ANXIETY DISORDERS; COGNITIVE RESERVE; ABDOMINAL-PAIN; PREDICTORS; PERFORMANCE; CHILDHOOD; OUTCOMES	This study aimed to characterize preinjury emotional-behavioral functioning in pediatric patients with lingering problems after mild traumatic brain injury (TBI). The clinical case series design included 278 patients 8-17 years old. Parents retrospectively rated children's preinjury emotional-behavioral functioning on a broadband questionnaire. The rate of clinically significant preinjury anxiety was elevated compared with national norms. The number of previous TBIs was associated with clinically significant preinjury externalizing problems, suggesting a link between externalizing disorders and mild TBI exposure. Premorbid emotional-behavioral difficulties may play an important role in the establishment or maintenance of lingering symptoms after pediatric mild TBI.	[Peterson, Robin L.] Univ Colorado, Dept Phys Med & Rehabil, Sch Med, Aurora, CO USA; Childrens Hosp Colorado, Aurora, CO USA	Peterson, RL (corresponding author), Univ Colorado, Dept Phys Med & Rehabil, Sch Med, Aurora, CO USA.	robin.peterson@childrenscolorado.org					Babikian T, 2013, J INT NEUROPSYCH SOC, V19, P145, DOI 10.1017/S135561771200104X; Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; BIJUR PE, 1990, PEDIATRICS, V86, P337; Brehaut JC, 2003, PEDIATRICS, V111, P262, DOI 10.1542/peds.111.2.262; Brooks BL, 2014, ARCH CLIN NEUROPSYCH, V29, P186, DOI 10.1093/arclin/act083; DiScala C, 1998, PEDIATRICS, V102, P1415, DOI 10.1542/peds.102.6.1415; Dorn LD, 2003, J AM ACAD CHILD PSY, V42, P66, DOI 10.1097/00004583-200301000-00012; Ensign J, 2012, ARCH CLIN NEUROPSYCH, V27, P277, DOI 10.1093/arclin/acs030; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Fay TB, 2010, J INT NEUROPSYCH SOC, V16, P94, DOI 10.1017/S1355617709991007; HINSHAW SP, 1992, PSYCHOL BULL, V111, P127, DOI 10.1037/0033-2909.111.1.127; Hung Ryan, 2014, Arch Phys Med Rehabil, V95, pS174, DOI 10.1016/j.apmr.2013.08.301; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Keenan HT, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1984; Kirkwood MW, 2014, CHILD NEUROPSYCHOL, V20, P245, DOI 10.1080/09297049.2012.759553; Kirkwood MW, 2012, PSYCHOL ASSESSMENT, V24, P36, DOI 10.1037/a0024628; Kirkwood MW, 2011, ARCH CLIN NEUROPSYCH, V26, P377, DOI 10.1093/arclin/acr040; Kirkwood MW, 2010, CLIN NEUROPSYCHOL, V24, P860, DOI 10.1080/13854040903527287; Legerstee JS, 2010, EUR CHILD ADOLES PSY, V19, P143, DOI 10.1007/s00787-009-0051-6; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; McCrea M, 2008, MILD TRAUMATIC BRAIN; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P22, DOI 10.1111/j.1365-2214.2009.00947.x; McNally KA, 2013, NEUROPSYCHOLOGY, V27, P1, DOI 10.1037/a0031370; Mild Traumatic Brain Injury Committee American Congress of Rehabilitation Medicine Head Injury Interdisciplinary Special Interest Group, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Mittenberg W, 1997, NEUROPSYCHOLOGY, V11, P447, DOI 10.1037/0894-4105.11.3.447; Pine DS, 1996, J CHILD ADOL PSYCHOP, V6, P153, DOI 10.1089/cap.1996.6.153; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Reynolds C.R., 2004, BEHAV ASSESSMENT SYS; Rowe R, 2004, J PEDIATR PSYCHOL, V29, P119, DOI 10.1093/jpepsy/jsh015; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Vervoort T, 2006, J PEDIATR PSYCHOL, V31, P674, DOI 10.1093/jpepsy/jsj059; Wechsler D., 2011, WECHLSER ABBREVIATED; Whalley LJ, 2004, AGEING RES REV, V3, P369, DOI 10.1016/j.arr.2004.05.001; White KS, 2006, J PEDIATR PSYCHOL, V31, P582, DOI 10.1093/jpepsy/jsj050; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; Willcutt EG, 2012, J ABNORM PSYCHOL, V121, P991, DOI 10.1037/a0027347; Yeates KO, 2012, INT J DEV NEUROSCI, V30, P231, DOI 10.1016/j.ijdevneu.2011.05.008; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056	40	11	11	0	2	AMER PSYCHIATRIC PUBLISHING, INC	ARLINGTON	1000 WILSON BOULEVARD, STE 1825, ARLINGTON, VA 22209-3901 USA	0895-0172	1545-7222		J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	FAL	2015	27	4					280	286		10.1176/appi.neuropsych.14120373			7	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	DM0ON	WOS:000376045400005	26258490	Bronze			2021-06-18	
J	Poersch, AB; Trombetta, F; Souto, NS; Lima, CD; Braga, ACM; Dobrachinski, F; Ribeiro, LR; Soares, FAA; Fighera, MR; Royes, LFF; Oliveira, MS; Furian, AF				Poersch, Alice Bertotto; Trombetta, Francielle; Souto, Naieli Schiefelbein; Lima, Camilla de Oliveira; Monteiro Braga, Ana Claudia; Dobrachinski, Fernando; Ribeiro, Leandro Rodrigo; Antunes Soares, Felix Alexandre; Fighera, Michele Rechia; Freire Royes, Luiz Fernando; Oliveira, Mauro Schneider; Furian, Ana Flavia			Fumonisin B1 facilitates seizures induced by pentylenetetrazol in mice	NEUROTOXICOLOGY AND TERATOLOGY			English	Article						Fumonisin 61; Seizure; Mitochondrial membrane potential; Neurotoxicity	OXYGEN SPECIES GENERATION; TRAUMATIC BRAIN-INJURY; MITOCHONDRIAL DYSFUNCTION; NA+,K+-ATPASE ACTIVITY; OXIDATIVE STRESS; RATS; SUSCEPTIBILITY; TOXICITY; B-1; MYCOTOXIN	Fumonisin B1 (FB1) is a Fusarium spp. mycotoxin which constitutes a major public health issue because of its worldwide distribution and diversity of toxic effects. While the liver and kidney are considered the major target organs of FB1 toxicity in several species, evidence indicates that FB1 may be toxic to the brain. To further investigate the effects of FB1 on the central nervous system the present study aimed to test the hypothesis that acute FB1 exposure causes brain hyperexcitability and the potential underlying mechanisms. For these purposes, adult male C57BL/6 mice were injected with FB1 (8 mg/kg, i.p.) or its vehicle and 30 min thereafter received with a low dose of the classical convulsant pentylenetetrazol (PTZ, 30 mg/kg, i.p.) or its vehicle. After behavioral evaluation the cerebral cortex and the hippocampus were collected for analysis of Na+,K+-ATPase activity, mitochondrial membrane potential (Delta psi m) and mitochondrial complex I and II activities. We found that FB1 reduced the latency for PTZ-induced myoclonic jerks and increased the number of these events. After exposure to FB1 total and alpha 1 Na+,K+-ATPase activities increased in cerebral cortex, whereas the same enzyme activities decreased in the hippocampus. Although no changes in mitochondrial complex I and II activities were found, acute exposure to FB1 increased Delta psi m in the cerebral cortex. Altogether, present results indicate that FB1 causes brain hyperexcitability in vivo, and that mitochondrial dysfunction may represent a potential underlying mechanism. (C) 2015 Elsevier Inc. All rights reserved.	[Poersch, Alice Bertotto; Trombetta, Francielle; Lima, Camilla de Oliveira; Monteiro Braga, Ana Claudia; Ribeiro, Leandro Rodrigo; Fighera, Michele Rechia; Freire Royes, Luiz Fernando; Oliveira, Mauro Schneider; Furian, Ana Flavia] Univ Fed Santa Maria, Programa Posgrad Farmacol, BR-97105900 Santa Maria, RS, Brazil; [Souto, Naieli Schiefelbein; Furian, Ana Flavia] Univ Fed Santa Maria, Programa Posgrad Ciencia & Tecnol Alimentos, BR-97105900 Santa Maria, RS, Brazil; [Dobrachinski, Fernando; Antunes Soares, Felix Alexandre; Freire Royes, Luiz Fernando; Oliveira, Mauro Schneider] Univ Fed Santa Maria, Programa Posgrad Bioquim Toxicol, BR-97105900 Santa Maria, RS, Brazil	Furian, AF (corresponding author), Univ Fed Santa Maria, Dept Tecnol & Ciencia Alimentos, Predio 43,Sala 4217, BR-97105900 Santa Maria, RS, Brazil.	furian.anaflavia@gmail.com	Soares, Felix/AAE-6251-2020; Soares, Felix AA/K-7611-2012; Fighera, Michele R/J-9576-2014; Dobrachinski, Fernando/C-4316-2014; Oliveira, Mauro Schneider/G-3437-2012	Soares, Felix/0000-0002-6453-7902; Soares, Felix AA/0000-0002-6453-7902; Dobrachinski, Fernando/0000-0002-3948-1273; Oliveira, Mauro Schneider/0000-0002-5381-1208; Ribeiro, Leandro/0000-0002-8442-4075; Bertotto Poersch, Alice/0000-0003-2353-0314			AKERMAN KEO, 1976, FEBS LETT, V68, P191, DOI 10.1016/0014-5793(76)80434-6; Silva LFA, 2011, J NEUROL SCI, V308, P35, DOI 10.1016/j.jns.2011.06.030; Banczerowski-Pelyhe I, 2002, MYCOPATHOLOGIA, V153, P149, DOI 10.1023/A:1014584303427; Bhat RV, 1997, J TOXICOL-CLIN TOXIC, V35, P249, DOI 10.3109/15563659709001208; BONDY G, 1995, FOOD CHEM TOXICOL, V33, P653, DOI 10.1016/0278-6915(95)00031-V; Bottje W, 2002, POULTRY SCI, V81, P546, DOI 10.1093/ps/81.4.546; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bulder A.S., 2012, 74 M JOINT FAO WHO E; da-Silva WS, 2004, J BIOL CHEM, V279, P39846, DOI 10.1074/jbc.M403835200; Domijan AM, 2012, NEUROSCIENCE, V202, P10, DOI 10.1016/j.neuroscience.2011.12.005; Domijan AM, 2012, ARH HIG RADA TOKSIKO, V63, P531, DOI 10.2478/10004-1254-63-2012-2239; Domijan AM, 2011, INT J BIOCHEM CELL B, V43, P897, DOI 10.1016/j.biocel.2011.03.003; Ferraro TN, 1999, J NEUROSCI, V19, P6733, DOI 10.1523/JNEUROSCI.19-16-06733.1999; FISCHER JC, 1985, CLIN CHIM ACTA, V153, P23, DOI 10.1016/0009-8981(85)90135-4; Fiske CH, 1925, J BIOL CHEM, V66, P375; Folbergrova J, 2012, MITOCHONDRION, V12, P35, DOI 10.1016/j.mito.2011.04.004; Funck VR, 2015, NEUROSCIENCE, V298, P171, DOI 10.1016/j.neuroscience.2015.04.031; Golarai G, 2001, J NEUROSCI, V21, P8523; Hussein HS, 2001, TOXICOLOGY, V167, P101, DOI 10.1016/S0300-483X(01)00471-1; Kahlert S, 2005, J NEUROSCI RES, V79, P262, DOI 10.1002/jnr.20322; Kwon OS, 1997, NEUROTOXICOL TERATOL, V19, P151, DOI 10.1016/S0892-0362(96)00217-6; Liang LP, 2004, FREE RADICAL BIO MED, V36, P542, DOI 10.1016/j.freeradbiomed.2003.11.029; Malfatti CRM, 2003, EPILEPSIA, V44, P761, DOI 10.1046/j.1528-1157.2003.42902.x; Mary VS, 2012, TOXICOLOGY, V302, P299, DOI 10.1016/j.tox.2012.08.012; Monnet-Tschudi F, 1999, NEUROTOXICOLOGY, V20, P41; Moseley AE, 2007, J NEUROSCI, V27, P616, DOI 10.1523/JNEUROSCI.4464-06.2007; Nishi A, 1999, J NEUROCHEM, V73, P1492, DOI 10.1046/j.1471-4159.1999.0731492.x; Oliveira MS, 2009, J NEUROCHEM, V109, P416, DOI 10.1111/j.1471-4159.2009.05961.x; Patel M, 2004, FREE RADICAL BIO MED, V37, P1951, DOI 10.1016/j.freeradbiomed.2004.08.021; Rambo LM, 2013, AMINO ACIDS, V44, P857, DOI 10.1007/s00726-012-1408-6; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; SHEPHARD GS, 1992, TOXICON, V30, P768, DOI 10.1016/0041-0101(92)90011-S; SHEPHARD GS, 1992, FOOD CHEM TOXICOL, V30, P277, DOI 10.1016/0278-6915(92)90004-5; Tsunoda M, 1998, COMP BIOCHEM PHYS C, V120, P457, DOI 10.1016/S0742-8413(98)10061-0; Veliskova J., 2006, BEHAV CHARACTERIZAIT; Vilagi I, 2002, BRAIN RES BULL, V59, P35, DOI 10.1016/S0361-9230(02)00835-3; Voss KA, 2007, ANIM FEED SCI TECH, V137, P299, DOI 10.1016/j.anifeedsci.2007.06.007; Willis S, 2010, NEUROBIOL DIS, V40, P565, DOI 10.1016/j.nbd.2010.07.017; Yang DD, 1997, NATURE, V389, P865, DOI 10.1038/39899; Yazar S, 2008, INT J MOL SCI, V9, P2062, DOI 10.3390/ijms9112062	40	11	12	0	8	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0892-0362	1872-9738		NEUROTOXICOL TERATOL	Neurotoxicol. Teratol.	SEP-OCT	2015	51						61	67		10.1016/j.ntt.2015.08.007			7	Neurosciences; Toxicology	Neurosciences & Neurology; Toxicology	CT6LQ	WOS:000362924900008	26342287				2021-06-18	
J	Pu, BF; Xue, YH; Wang, QM; Hua, CH; Li, XY				Pu, Benfang; Xue, Yonghua; Wang, Qingming; Hua, Chunhui; Li, Xinyuan			Dextromethorphan provides neuroprotection via anti-inflammatory and anti-excitotoxicity effects in the cortex following traumatic brain injury	MOLECULAR MEDICINE REPORTS			English	Article						dextromethorphan; neuroprotection; traumatic brain injury; inflammatory; excitotoxicity; rats	TUMOR-NECROSIS-FACTOR; GLUTAMATE TRANSPORTER; PARKINSONS-DISEASE; HEAD-INJURY; RAT; CYTOKINES; NEURONS; MICE; IL-6; INFLAMMATION	Traumatic brain injury (TBI) is caused by primary and secondary injury mechanisms. TBI induces a certain amount of inflammatory responses and glutamate excitotoxicity that are believed to participate in the pathogenesis of secondary injury. The non-narcotic anti-tussive drug dextromethorphan (DM) has been reported to have a high safety profile in humans and its neuroprotective against a variety of disorders, including cerebral ischemia, epilepsy and acute brain injury. However, few studies have explored the underlying mechanisms of the neuroprotective effects of DM in animals in the setting of TBI. The aim of the present study was to investigate the neuroprotective effects of DM on TBI and to determine the underlying mechanisms. Rats were subjected to a controlled cortical impact (CCI) injury and randomly divided into three groups: Sham-operated, TBI and DM treatment groups. The DM treatment group was administered DM (30 mg/kg of body weight, intraperitoneally) immediately after injury. It was identified that DM treatment following TBI significantly reduced brain edema and neurological deficits, as well as increased neuronal survival. These effects correlated with a decrease of tumor necrosis factor alpha, interleukin-1 beta (IL-1 beta) and IL-6 protein expression and an increase of glutamate/aspartate transporter and glutamate transporter-1 in the cortex of the brain. These results provided in vivo evidence that DM exerts neuroprotective effects via reducing inflammation and excitotoxicity induced following TBI. The present study has shed light on the potential use of DM as a neuroprotective agent in the treatment of cerebral injuries.	[Pu, Benfang; Xue, Yonghua; Wang, Qingming; Hua, Chunhui; Li, Xinyuan] Shanghai Jiao Tong Univ, Sch Med, Tongren Hosp, Dept Neurosurg, Shanghai 200333, Peoples R China	Li, XY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Tongren Hosp, Dept Neurosurg, 1111 Xianxia Rd, Shanghai 200333, Peoples R China.	leexinyuan24k@163.com					Aibiki M, 1999, J NEUROTRAUM, V16, P225, DOI 10.1089/neu.1999.16.225; Allan SM, 2001, NAT REV NEUROSCI, V2, P734, DOI 10.1038/35094583; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; CARPENTER CL, 1988, BRAIN RES, V439, P372, DOI 10.1016/0006-8993(88)91497-7; Csuka E, 1999, J NEUROIMMUNOL, V101, P211, DOI 10.1016/S0165-5728(99)00148-4; Cui CM, 2014, NEUROL SCI, V35, P695, DOI 10.1007/s10072-013-1585-4; Duhaime AC, 1996, J NEUROTRAUM, V13, P79, DOI 10.1089/neu.1996.13.79; Feng S, 2014, BIOL TRACE ELEM RES, V159, P332, DOI 10.1007/s12011-014-9977-8; FEUERSTEIN GZ, 1994, CEREBROVAS BRAIN MET, V6, P341; Gao HM, 2003, TRENDS PHARMACOL SCI, V24, P395, DOI 10.1016/S0165-6147(03)00176-7; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; GOODMAN JC, 1990, J NEUROIMMUNOL, V30, P213; Hayakata T, 2004, SHOCK, V22, P102, DOI 10.1097/01.shk.0000131193.80038.f1; KANAI Y, 1992, NATURE, V360, P467, DOI 10.1038/360467a0; Klette KL, 1997, BRAIN RES, V756, P231, DOI 10.1016/S0006-8993(97)00142-X; Liu YX, 2003, J PHARMACOL EXP THER, V305, P212, DOI 10.1124/jpet.102.043166; Lu KT, 2005, J NEUROTRAUM, V22, P885, DOI 10.1089/neu.2005.22.885; Luo CL, 2011, NEUROSCIENCE, V184, P54, DOI 10.1016/j.neuroscience.2011.03.021; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Pawlak J, 2005, MOL BRAIN RES, V138, P1, DOI 10.1016/j.molbrainres.2004.10.043; POVLISHOCK JT, 1994, J NEUROTRAUM, V11, P723, DOI 10.1089/neu.1994.11.723; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; Tortella FC, 1999, J PHARMACOL EXP THER, V291, P399; TORTELLA FC, 1989, TRENDS PHARMACOL SCI, V10, P501, DOI 10.1016/0165-6147(89)90050-3; Wang CX, 2002, PROG NEUROBIOL, V67, P161, DOI 10.1016/S0301-0082(02)00010-2; Werling LL, 2007, NEUROLOGIST, V13, P272, DOI 10.1097/NRL.0b013e3180f60bd8; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Zhang W, 2004, FASEB J, V18, P589, DOI 10.1096/fj.03-0983fje	29	11	11	0	6	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	SEP	2015	12	3					3704	3710		10.3892/mmr.2015.3830			7	Oncology; Medicine, Research & Experimental	Oncology; Research & Experimental Medicine	CP5OW	WOS:000359933900068	26004757	Bronze			2021-06-18	
J	Saban, KL; Hogan, NS; Hogan, TP; Pape, TLB				Saban, Karen L.; Hogan, Nancy S.; Hogan, Timothy P.; Pape, Theresa Louise-Bender			He Looks Normal But ... Challenges of Family Caregivers of Veterans Diagnosed with a Traumatic Brain Injury	REHABILITATION NURSING			English	Article						Caregivers; brain injury; research; qualitative	QUALITATIVE CONTENT-ANALYSIS; PSYCHIATRIC DIAGNOSES; FEMALE CAREGIVERS; WAR VETERANS; HEALTH; IMPACT; TBI; AGGRESSION; RELATIVES; SURVIVORS	Purpose: To describe the experience of family caregivers providing care to veterans with traumatic brain injury (TBI). Design/Methods: Using a qualitative design, interviews were conducted with a purposeful sample of women caregivers. Data were analyzed using content analysis procedures. Findings: Findings resulted in the key concept phrased by participants as "He looks normal but." This phrase conceptualizes the participants' description of their experience caring for a brain injured veteran who could appear normal to others but the caregiver's description revealed substantial cognitive, social, and emotional deficits. Concepts include (a) Becoming aware of his disabilities, (b) Observing his troubling symptoms, (c) Dealing with his memory loss, (d) Being fearful of his anger, (e) Sensing his loneliness, (f) Acknowledging the effects on the children, and (g) Managing the best I can. Conclusions/Clinical Relevance: A better understanding of the needs of caregivers of veterans with TBI may allow clinicians to better support caregivers.	[Saban, Karen L.; Pape, Theresa Louise-Bender] Edward Hines Jr VA Hosp, Ctr Innovat Complex Chron Healthcare, Hines, IL USA; [Saban, Karen L.; Hogan, Nancy S.] Loyola Univ Chicago, Marcella Niehoff Sch Nursing, Maywood, IL 60153 USA; [Hogan, Timothy P.] Edith Nourse Rogers Mem Vet Hosp, Ctr Hlth Qual Outcomes & Econ Res, Bedford, MA USA; [Hogan, Timothy P.] Univ Massachusetts, Sch Med, Worcester, MA USA; [Pape, Theresa Louise-Bender] Northwestern Univ, Feinberg Sch Med, Dept Phys Med & Rehabil, Chicago, IL 60611 USA	Saban, KL (corresponding author), Loyola Univ Chicago, Marcella Niehoff Sch Nursing, 2160 S First Ave, Maywood, IL 60153 USA.	ksaban@luc.edu			Center for Complex Chronic Care Management, Edward Hines VA Hospital (LIP) [42-104]; 3-year Veterans Affairs (VA) Health Service Research and Development (HSR&D) Postdoctoral Fellowship [TPN-42-001]	The authors would like to kindly acknowledge the financial support from the Center for Complex Chronic Care Management, Edward Hines VA Hospital (LIP #42-104). In addition, KLS was supported by a 3-year Veterans Affairs (VA) Health Service Research and Development (HSR&D) Postdoctoral Fellowship (TPN-42-001).	Anderson MI, 2013, J HEAD TRAUMA REHAB, V28, P453, DOI 10.1097/HTR.0b013e31825d6087; Anderson MI, 2002, BRAIN INJURY, V16, P743, DOI 10.1080/02699050210128906; Aveyard P, 2009, SOC SCI MED, V68, P397, DOI 10.1016/j.socscimed.2008.10.036; Bakas Tamilyn, 2004, J Neurosci Nurs, V36, P95; Bay E, 2012, BRAIN INJURY, V26, P941, DOI 10.3109/02699052.2012.666365; Ben A. N., 2000, BRAIN INJURY, V14, P725; Brain Injury Association of America, 2012, FAM CAR; Braine ME, 2011, J NEUROSCI NURS, V43, P156, DOI 10.1097/JNN.0b013e3182135bb2; Calvete E, 2012, BRAIN INJURY, V26, P834, DOI 10.3109/02699052.2012.655363; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Crewe-Brown SJ, 2011, S AFR J COMMUN DISOR, V58, P48; Daggett V, 2009, J NEUROSCI NURS, V41, P59, DOI 10.1097/JNN.0b013e31819a7133; de Sousa A, 2011, CORTEX, V47, P526, DOI 10.1016/j.cortex.2010.02.004; Defense and Veterans Brain Injury Center, 2014, DOD WORLDW NUMB TBI; Dyer KFW, 2006, BRAIN INJURY, V20, P1163, DOI 10.1080/02699050601049312; Elo S, 2008, J ADV NURS, V62, P107, DOI 10.1111/j.1365-2648.2007.04569.x; Engstrom A, 2011, J NEUROSCI NURS, V43, P253, DOI 10.1097/JNN.0b013e318227ef9b; Fumiyo I, 2009, J NEUROSCI NURS, V41, P277, DOI 10.1097/JNN.0b013e3181b2c73c; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; Griffin JM, 2009, J REHABIL RES DEV, V46, P879, DOI 10.1682/JRRD.2008.08.0104; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Jumisko E, 2007, J FAM NURS, V13, P353, DOI 10.1177/1074840707303842; Kalb R, 2007, J NEUROL SCI, V256, pS29, DOI 10.1016/j.jns.2007.01.061; King PR, 2012, J CLIN PSYCHOL MED S, V19, P376, DOI 10.1007/s10880-012-9345-9; Lew HL, 2011, J REHABIL RES DEV, V48, P913, DOI 10.1682/JRRD.2010.08.0140; Magnuson J, 2012, CURR NEUROL NEUROSCI, V12, P570, DOI 10.1007/s11910-012-0303-6; Morgan DG, 2002, SOC SCI MED, V55, P1129, DOI 10.1016/S0277-9536(01)00255-6; Olson-Madden JH, 2010, J HEAD TRAUMA REHAB, V25, P470, DOI 10.1097/HTR.0b013e3181d717a7; Phelan SM, 2011, DISABIL HEALTH J, V4, P177, DOI 10.1016/j.dhjo.2011.03.003; Saban KL, 2012, BIOL RES NURS, V14, P396, DOI 10.1177/1099800412439458; Sayer NA, 2012, ANNU REV MED, V63, P405, DOI 10.1146/annurev-med-061610-154046; Testa JA, 2006, J HEAD TRAUMA REHAB, V21, P236, DOI 10.1097/00001199-200605000-00004; Vangel SJ, 2011, J HEAD TRAUMA REHAB, V26, P20, DOI 10.1097/HTR.0b013e318204a70d	33	11	11	0	9	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0278-4807	2048-7940		REHABIL NURS	Rehabil. Nurs.	SEP-OCT	2015	40	5					277	285		10.1002/rnj.182			9	Nursing; Rehabilitation	Nursing; Rehabilitation	CV9FI	WOS:000364592400002	25424609	Bronze			2021-06-18	
J	Whiteside, DM; Gaasedelen, OJ; Hahn-Ketter, AE; Luu, H; Miller, ML; Persinger, V; Rice, L; Basso, MR				Whiteside, Douglas M.; Gaasedelen, Owen J.; Hahn-Ketter, Amanda E.; Luu, Hien; Miller, Michelle L.; Persinger, Virginia; Rice, Linda; Basso, Michael R.			Derivation of a Cross-Domain Embedded Performance Validity Measure in Traumatic Brain Injury	CLINICAL NEUROPSYCHOLOGIST			English	Article						Performance validity test; Traumatic brain injury; California Verbal Learning Test; Boston Naming Test; Brief Test of Attention	VERBAL-LEARNING TEST; BOSTON NAMING TEST; TEST-RETEST RELIABILITY; MALINGERED NEUROCOGNITIVE DYSFUNCTION; ADULT INTELLIGENCE SCALE; WECHSLER-MEMORY-SCALE; CARD SORTING TEST; CLASSIFICATION ACCURACY; SUSPECT EFFORT; TEST-II	Objective: Performance validity assessment is increasingly considered standard practice in neuropsychological evaluations. The current study extended research on logistically derived performance validity tests (PVTs) by utilizing neuropsychological measures from multiple cognitive domains instead of from a single measure or a single cognitive domain.Method: A logistic-derived PVT was calculated using several measures from multiple cognitive domains, including verbal memory (California Verbal Learning Test-II Trial 5, Total Hits, and False Positives), attention (Brief Test of Attention Total score), and language (Boston Naming Test T-score, and Animal Fluency T-score). Due to its cross-domain nature, the cross-domain logistic-derived embedded PVT was hypothesized to have excellent classification accuracy for non-credible performance. Participants included 224 patients who completed all measures and were moderate to severe traumatic brain injury (STBI) patients (N=66), possible mild TBI (MTBI-FAIL) patients who failed at least 2 independent PVTs (N=67), and possible mild TBI patients who passed all PVTs (MTBI-PASS; N=91). Logistic regression and ROC analyses were conducted on the MTBI-FAIL group and the STBI group.Results: Multivariate analysis of variance indicated that the MTBI-FAIL group was significantly lower on all measures than the MTBI-PASS and the STBI groups. Using logistic regression, CVLT Total Hits, BTA, and the CVLT False Positives best differentiated between the MTBI-FAIL and STBI groups. The logistically derived PVT had excellent classification accuracy (area under the curve [AUC]=.84), with sensitivity at .54 when specificity was set at .90, higher than any individual variable.Conclusions: Findings support the use of this logistical-derived variable as an embedded PVT and support further research with this type of methodology.	[Whiteside, Douglas M.; Luu, Hien] Univ Iowa, Dept Psychiat, Iowa City, IA 52242 USA; [Gaasedelen, Owen J.] Univ Iowa, Dept Psychol & Quantitat Fdn, Counseling Psychol, Iowa City, IA 52242 USA; [Hahn-Ketter, Amanda E.] Mt Sinai Hosp, Dept Rehabil Med, New York, NY 10029 USA; [Miller, Michelle L.] Univ Iowa, Dept Psychol, Iowa City, IA 52242 USA; [Persinger, Virginia] Southern Oregon Vet Affairs Rehabil Ctr & Clin, Dept Psychol, Medford, MA USA; [Rice, Linda] Rehabil Inst Chicago, Dept Psychol, Chicago, IL 60611 USA; [Basso, Michael R.] Univ Tulsa, Dept Psychol, Tulsa, OK 74104 USA	Whiteside, DM (corresponding author), Univ Iowa, Dept Psychiat, 200 Hawkins Dr, Iowa City, IA 52242 USA.	douglas-whiteside@uiowa.edu	Basso, Michael/S-9587-2019; Whiteside, Douglas/AAK-6396-2020	Basso, Michael/0000-0002-0217-662X; Miller, Michelle/0000-0001-6150-0242; Whiteside, Douglas/0000-0002-8454-4413; Hahn-Ketter, Amanda/0000-0002-0226-3598			Arnold G, 2005, CLIN NEUROPSYCHOL, V19, P105, DOI 10.1080/13854040490888567; Axelrod BN, 2006, CLIN NEUROPSYCHOL, V20, P513, DOI 10.1080/13854040590967117; Babikian T, 2006, CLIN NEUROPSYCHOL, V20, P145, DOI 10.1080/13854040590947362; Bashem JR, 2014, CLIN NEUROPSYCHOL, V28, P851, DOI 10.1080/13854046.2014.927927; Bauer L, 2005, APPL NEUROPSYCHOL, V12, P202, DOI 10.1207/s15324826an1204_3; Bird CM, 2004, BRIT J CLIN PSYCHOL, V43, P197, DOI 10.1348/014466504323088051; Bodin D, 2012, PEDIATRIC AND ADOLESCENT CONCUSSION: DIAGNOSIS, MANAGEMENT AND OUTCOMES, P9, DOI 10.1007/978-0-387-89545-1_2; Boone, 2007, ASSESSMENT FEIGNED C; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; Busse M, 2012, CLIN NEUROPSYCHOL, V26, P675, DOI 10.1080/13854046.2012.679623; Curtis KL, 2009, ASSESSMENT, V16, P401, DOI 10.1177/1073191109338161; Curtis KL, 2006, ASSESSMENT, V13, P46, DOI 10.1177/1073191105285210; Delis DC, 2000, CALIFORNIA VERBAL LE; Dikmen SS, 1999, J INT NEUROPSYCH SOC, V5, P346, DOI 10.1017/S1355617799544056; Donders J, 2011, CLIN NEUROPSYCHOL, V25, P173, DOI 10.1080/13854046.2010.536781; Flanagan JL, 1997, J COMMUN DISORD, V30, P33, DOI 10.1016/S0021-9924(96)00039-1; FRANZEN MD, 1995, CLIN NEUROPSYCHOL, V9, P225, DOI 10.1080/13854049508400484; Gladsjo JA, 1999, ASSESSMENT, V6, P147, DOI 10.1177/107319119900600204; Green P., 2005, MED SYMPTOM VALIDIDY; Green P., 1996, WORD MEMORY TEST USE; Greiffenstein M.F., 1994, PSYCHOL ASSESSMENT, V6, P218, DOI [https://doi.org/10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; GREIFFENSTEIN MF, 1995, CLIN NEUROPSYCHOL, V9, P230, DOI 10.1080/13854049508400485; Greve KW, 2007, CLIN NEUROPSYCHOL, V21, P318, DOI 10.1080/13854040500488552; Greve K, 2009, CLIN NEUROPSYCHOL, V23, P343, DOI 10.1080/13854040802054169; Hosmer D. W., 2000, APPL LOGISTIC REGRES, DOI [10. 1002/0471722146, DOI 10.1002/0471722146, 10.1002/0471722146]; Iverson GL, 2002, CLIN NEUROPSYCHOL, V16, P398, DOI 10.1076/clin.16.3.398.13861; Jacobs ML, 2007, ARCH CLIN NEUROPSYCH, V22, P143, DOI 10.1016/j.acn.2006.12.002; Kaplan E., 1983, BOSTON NAMING TEST; Laine Matti, 2006, ANOMIA THEORETICAL C; Larrabee G.J., 2007, ASSESSMENT MALINGERE; Larrabee G. L., 2007, ASSESSMENT MALINGERE, P100; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; Mathias CW, 2002, ASSESSMENT, V9, P301, DOI 10.1177/1073191102009003009; Menard S., 1995, APPL LOGISTIC REGRES; Meyers JE, 2003, ARCH CLIN NEUROPSYCH, V18, P261, DOI 10.1016/S0887-6177(02)00136-1; Miller JB, 2011, CLIN NEUROPSYCHOL, V25, P160, DOI 10.1080/13854046.2010.533197; Millis S. R., 2009, NEUROPSYCHOLOGY MALI, P21; NICHOLAS LE, 1989, APHASIOLOGY, V3, P569, DOI 10.1080/02687038908249023; Ord JS, 2008, CLIN NEUROPSYCHOL, V22, P689, DOI 10.1080/13854040701425437; Ord JS, 2010, J CLIN EXP NEUROPSYC, V32, P380, DOI 10.1080/13803390903066881; Pannu JK, 2005, NEUROPSYCHOL REV, V15, P105, DOI 10.1007/s11065-005-7091-6; Pearson Education Inc., 2008, WECHSL MEM SCAL; Root JC, 2006, J INT NEUROPSYCH SOC, V12, P688, DOI 10.1017/S1355617706060838; Ross SR, 2006, CLIN NEUROPSYCHOL, V20, P798, DOI 10.1080/13854040500328477; Schretlen, 1996, BRIEF TEST ATTENTION; Schroeder RW, 2010, CLIN NEUROPSYCHOL, V24, P326, DOI 10.1080/13854040903369441; Schutte C., 2013, MILD TRAUMATIC BRAIN, P159; Schutte C, 2011, CLIN NEUROPSYCHOL, V25, P454, DOI 10.1080/13854046.2010.550635; Slick DJ, 2000, J CLIN EXP NEUROPSYC, V22, P569, DOI 10.1076/1380-3395(200010)22:5;1-9;FT569; Sugarman MA, 2015, APPL NEUROPSYCH-ADUL, V22, P141, DOI 10.1080/23279095.2013.873439; Suhr JA, 1999, J CLIN EXP NEUROPSYC, V21, P701, DOI 10.1076/jcen.21.5.701.868; Sweet JJ, 2000, ARCH CLIN NEUROPSYCH, V15, P105, DOI 10.1016/S0887-6177(98)00153-X; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; Tombaugh TN, 1997, J CLIN EXP NEUROPSYC, V19, P922, DOI 10.1080/01688639708403773; Tombaugh TN, 1996, TEST MEMORY MALINGER; TRUEBLOOD W, 1993, J CLIN EXP NEUROPSYC, V15, P578, DOI 10.1080/01688639308402580; VANGORP WG, 1986, J CLIN EXP NEUROPSYC, V8, P702, DOI 10.1080/01688638608405189; VERWEIJ PJM, 1993, STAT MED, V12, P2305, DOI 10.1002/sim.4780122407; Whiteside D, 2011, CLIN NEUROPSYCHOL, V25, P287, DOI 10.1080/13854046.2010.538436; Whiteside DM, 2015, J CLIN EXP NEUROPSYC, V37, P220, DOI 10.1080/13803395.2014.1002758; Whittle C, 2007, J CLIN EXP NEUROPSYC, V29, P290, DOI 10.1080/13803390600678038; Wolfe PL, 2010, CLIN NEUROPSYCHOL, V24, P153, DOI 10.1080/13854040903107791; Woods SP, 2006, ARCH CLIN NEUROPSYCH, V21, P413, DOI 10.1016/j.acn.2006.06.002	65	11	11	0	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	AUG 18	2015	29	6					788	803		10.1080/13854046.2015.1093660			16	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	CV8SA	WOS:000364556800004	26430920				2021-06-18	
J	Lichte, P; Andruszkow, H; Kappe, M; Horst, K; Pishnamaz, M; Hildebrand, F; Lefering, R; Pape, HC; Kobbe, P				Lichte, Philipp; Andruszkow, Hagen; Kappe, Miriam; Horst, Klemens; Pishnamaz, Miguel; Hildebrand, Frank; Lefering, Rolf; Pape, Hans-Christoph; Kobbe, Philipp		TraumaRegister DGU	Increased in-hospital mortality following severe head injury in young children: results from a nationwide trauma registry	EUROPEAN JOURNAL OF MEDICAL RESEARCH			English	Article							GLASGOW COMA SCALE; RECOVERY 10 YEARS; BRAIN-INJURY; DECOMPRESSIVE CRANIECTOMY; PEDIATRIC-PATIENTS; MULTIPLE INJURIES; AGE; OUTCOMES; SCORE; PREDICTORS	Background: In the current literature, the outcome of paediatric brain injury is controversially discussed. According to the majority of the studies, there seems to be a decreased mortality but worse recovery in paediatric, traumatic brain injury in comparison with adults. However, there is a lack of information concerning the differences in various stages of development in patients younger than 18 years. The aim of our study was to verify the in-hospital outcome of different paediatric age groups in comparison to adults with respect to the treatment strategy. Methods: We performed a retrospective analysis of the TraumaRegister DGU (R) from 2002 to 2012. Inclusion criteria were an Abbreviated Injury Scale (AIS) head >= 3 points and an AIS <= 2 points of the remaining body regions. The collective was divided into different subgroups according to age (1-3, 4-6, 7-10, 11-14, 15-17) and an adult control group aged between 18 and 55 years. We descriptively analysed the endpoint rate of sepsis, multiple organ failure, and mortality. Additionally, the Glasgow Outcome Scale (GOS) at discharge was observed. Results: Overall, 1110 children and 6491 adult control patients were included. Comparing the rate of intubation on-scene, the rate of cranial CT scans, the rate of craniotomies, and the rate and length of intensive care treatment, we could only identify minor differences between the age groups. The treatment after discharge from hospital was markedly different due to a very low rate of in-patient rehabilitation treatment in children. On one hand, the rate of systemic complications, such as sepsis and multiple organ failure increased with increasing age. On the other hand, we found a significantly increased mortality in children younger than 7 years after very (AIS head = 5) severe brain injury. The in-hospital functional outcome in survivors, according to the GOS, was beneficial for younger children in comparison to adolescents and adults. Conclusions: We were unable to identify marked age-related differences in the therapeutic approach. Nevertheless, we were able to demonstrate marked differences of outcome. Children younger than 7 years significantly die more often due to direct impact of severe trauma. But if they survive, they seem to develop less systemic complications and profit from a better functional outcome.	[Lichte, Philipp; Andruszkow, Hagen; Kappe, Miriam; Horst, Klemens; Pishnamaz, Miguel; Hildebrand, Frank; Pape, Hans-Christoph; Kobbe, Philipp] Univ Hosp Aachen, Dept Orthopaed Trauma Surg, D-52074 Aachen, Germany; [Horst, Klemens; Pishnamaz, Miguel] Univ Hosp RWTH Aachen, Dept Orthopaed Trauma Surg, Harald Tscherne Res Lab Orthoped Trauma, Aachen, Germany; [Lefering, Rolf] Univ Witten Herdecke, Inst Res Operat Med IFOM, D-51109 Cologne, Germany; German Trauma Soc Sekt NIS, Comm Emergency Med Intens Care & Trauma Managemen, Cologne, Germany	Lichte, P (corresponding author), Univ Hosp Aachen, Dept Orthopaed Trauma Surg, Pauwelsstr 30, D-52074 Aachen, Germany.	plichte@ukaachen.de	Lichte, Philipp/AAG-2263-2020; Hildebrand, Frank/J-3176-2017	Pape, Hans-Christoph/0000-0002-2059-4980			Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson VA, 2001, PEDIATR NEUROSURG, V34, P138, DOI 10.1159/000056009; Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; Anderson V, 2009, PEDIATRICS, V124, pE1064, DOI 10.1542/peds.2009-0365; Andruszkow H, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-26; Bailey BM, 2012, J TRAUMA ACUTE CARE, V72, P263, DOI 10.1097/TA.0b013e31822a9512; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Beauchamp MH, 2011, J NEUROTRAUM, V28, P915, DOI 10.1089/neu.2010.1712; BONE RC, 1992, CRIT CARE MED, V20, P724, DOI 10.1097/00003246-199206000-00002; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Catroppa C, 2012, J NEUROTRAUM, V29, P2539, DOI 10.1089/neu.2012.2403; Cicero MX, 2013, PEDIATR EMERG CARE, V29, P43, DOI 10.1097/PEC.0b013e31827b52bf; Crowe L, 2009, J PAEDIATR CHILD H, V45, P346, DOI 10.1111/j.1440-1754.2009.01499.x; Crowe LM, 2012, PEDIATRICS, V129, pE262, DOI 10.1542/peds.2011-0438; Demetriades D, 2004, J AM COLL SURGEONS, V199, P216, DOI 10.1016/j.jamcollsurg.2004.02.030; Flaada JT, 2007, J NEUROTRAUM, V24, P435, DOI 10.1089/neu.2006.0119; HAHN YS, 1988, CHILD NERV SYST, V4, P34; Hejazi N, 2002, EUR J PEDIATR, V161, P99, DOI 10.1007/s00431-001-0864-x; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Jagannathan J, 2008, J NEUROSURG-PEDIATR, V2, P240, DOI 10.3171/PED.2008.2.10.240; Jagannathan J, 2007, J NEUROSURG, V106, P268, DOI 10.3171/ped.2007.106.4.268; Jakob H, 2009, UNFALLCHIRURG, V112, P951, DOI 10.1007/s00113-009-1682-2; JENNETT B, 1975, LANCET, V1, P480; KISSOON N, 1990, CAN MED ASSOC J, V142, P27; Kramer ME, 2013, J HEAD TRAUMA REHAB, V28, P361, DOI 10.1097/HTR.0b013e31824da031; Laurer H, 2009, UNFALLCHIRURG, V112, P771, DOI 10.1007/s00113-009-1589-y; Lippert-Gruner M, 2007, BRAIN INJURY, V21, P451, DOI 10.1080/02699050701343961; da Silva PSL, 2008, J TRAUMA, V65, P1293, DOI 10.1097/TA.0b013e318156866c; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; Maegele M, 2008, NOTFALL RETTUNGSMED, V11, P266, DOI 10.1007/s10049-008-1060-6; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Remmers D, 1998, UNFALLCHIRURG, V101, P388, DOI 10.1007/s001130050285; Rickels E, 2009, CHIRURG, V80, P153, DOI 10.1007/s00104-008-1655-y; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Sigmund GA, 2007, PEDIATR NEUROL, V36, P217, DOI 10.1016/j.pediatrneurol.2007.01.003; Stocchetti N, 2010, MINERVA ANESTESIOL, V76, P1052; Suominen P, 2000, Eur J Emerg Med, V7, P3; VENES JL, 1975, J NEUROSURG, V42, P429, DOI 10.3171/jns.1975.42.4.0429; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; von Elm E, 2009, BRIT J ANAESTH, V103, P371, DOI 10.1093/bja/aep202; Woischneck D., 2010, Intensivmedizin und Notfallmedizin, V47, P582, DOI 10.1007/s00390-010-0213-2; Zsoter A, 2011, MONATSSCHR KINDERH, V159, P634, DOI 10.1007/s00112-010-2326-x	43	11	11	0	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0949-2321	2047-783X		EUR J MED RES	Eur. J. Med. Res.	AUG 14	2015	20								65	10.1186/s40001-015-0159-8			8	Medicine, Research & Experimental	Research & Experimental Medicine	CP2FI	WOS:000359692500001	26272597	DOAJ Gold, Green Published			2021-06-18	
J	Gradus, JL; Wisco, BE; Luciano, MT; Iverson, KM; Marx, BP; Street, AE				Gradus, Jaimie L.; Wisco, Blair E.; Luciano, Matthew T.; Iverson, Katherine M.; Marx, Brian P.; Street, Amy E.			Traumatic Brain Injury and Suicidal Ideation Among US Operation Enduring Freedom and Operation Iraqi Freedom Veterans	JOURNAL OF TRAUMATIC STRESS			English	Article							POSTTRAUMATIC-STRESS-DISORDER; SERVICES	Traumatic brain injury (TBI) is associated with suicidal behavior among veterans, and gender differences in the strength of associations may exist. Almost all research has been limited to Veterans Health Administration (VHA) patients, and it is unclear if findings generalize to veterans who do not use VHA services. We examined gender- and VHA-user-specific associations between TBI related to deployment and postdeployment suicidal ideation in a U.S. national sample of 1,041 female and 880 male Operation Enduring Freedom (OEF) and Operation Iraqi Freedom (OIF) veterans. Path analysis was used to estimate TBI and suicidal ideation association, and examine PTSD and depression symptomatology in these associations. TBI was associated with suicidal ideation among male VHA users, OR = 3.64, 95% CI [2.21, 6.01]; and male and female nonusers, OR = 2.24, 95% CI [1.14, 4.44] and OR = 2.65, 95% CI [1.26, 5.58], respectively, in unadjusted analyses. This association was explained by depression symptoms among male and female nonusers. Among male VHA users an association between TBI and suicidal ideation remained when accounting for depression symptoms, OR = 2.50, 95% CI [1.33, 4.71]. Our findings offered evidence of an association between TBI and suicidal ideation among male OEF/OIF VHA users. Resumen LCT e Ideacion Suicida en Veteranos OEF/OIF La Lesion cerebral traumatica (TBI) se asocia con la conducta suicida entre los veteranos, y puede haber diferencias de genero en la fuerza de las asociaciones. Casi toda la investigacion esta limitada a pacientes de la Administracion de Salud de Veteranos (VHA), y no esta claro si los hallazgos se generalizan a los veteranos que no son usuarios de VHA. Evaluamos asociaciones especificas de genero - y usuarios de VHA- en TBI relacionado a ideacion suicida en el despliegue militar y post despliegue militar en una muestra nacional de 1041 mujeres y 880 varones veteranos de OEF y OIF. Se utilizo analisis de pautas para estimar asociacion de TBI e ideacion suicida, y evaluar sintomatologia de TEPT y depresion en estas asociaciones. TBI se asocio con ideacion suicida en varones usuarios VHA (OR: 3.64, 95% CI:[2.21, 6.01]) y en varones y mujeres no usuarios (OR: 2.24, 95% CI:[1.14, 4.44] y OR:2.65, 95% CI:[1.26, 5.58], respectivamente) en analisis no ajustados. Esta asociacion fue explicada por sintomas depresivos entre varones y mujeres no usuarias. Entre los usuarios masculinos VHA una asociacion se mantiene entre TBI e ideacion suicida cuando se incluyen los sintomas depresivos (OR: 2.50, 95% CI:[1.33, 4.71]). Nuestros hallazgos ofrecen evidencia de una asociacion entre TBI e ideacion suicida entre varones OEF/OIF usuarios de VHA. Traditional and Simplified Chinese Abstracts by AsianSTSS ?? : ????????(OEF)??????????(OIF)???????????????? ??: ??????(TBI)????????????,????????????????????????????????????(VHA)???,?????????????????VHA??????????????????????????(OEF)??????????(OIF)???????(1,041????880???),???????TBI???????????,?????VHA??????????????????TBI????????,????????PTSD?????????????????,TBI??????VHA?????? (OR = 3.64, 95% CI = [2.21, 6.01]) ,???VHA???????????? (??? OR = 2.24, 95% CI = [1.14, 4.44] ? OR = 2.65, 95% CI = [1.26, 5.58]) ,?????????VHA???????????????VHA???,????????,TBI????????? (OR = 2.50, 95% CI = [1.33, 4.71])??????OEF/OIF?VHA???TBI????????????? ?? : ????????(OEF)??????????(OIF)???????????????? ??: ??????(TBI)????????????,????????????????????????????????????(VHA)???,?????????????????VHA??????????????????????????(OEF)??????????(OIF)???????(1,041????880???),???????TBI???????????,?????VHA??????????????????TBI????????,????????PTSD????????????????,TBI??????VHA?????? (OR = 3.64, 95% CI = [2.21, 6.01]) ,???VHA???????????? (??? OR = 2.24, 95% CI = [1.14, 4.44] ? OR = 2.65, 95% CI = [1.26, 5.58]) ,?????????VHA???????????????VHA???,????????,TBI????????? (OR = 2.50, 95% CI = [1.33, 4.71])??????OEF/OIF?VHA???TBI?????????????	[Gradus, Jaimie L.; Luciano, Matthew T.; Iverson, Katherine M.; Marx, Brian P.; Street, Amy E.] VA Boston HCS, Natl Ctr PTSD, Womens Hlth Sci Div, Boston, MA 02130 USA; [Gradus, Jaimie L.; Iverson, Katherine M.; Marx, Brian P.; Street, Amy E.] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA; [Gradus, Jaimie L.] Boston Univ, Sch Med, Dept Epidemiol, Boston, MA 02118 USA; [Wisco, Blair E.] Univ N Carolina, Dept Psychol, Greensboro, NC 27412 USA	Gradus, JL (corresponding author), VA Boston HCS, 150 South Huntington Ave, Boston, MA 02130 USA.	Jaimie.gradus@va.gov	Luciano, Matthew/K-1216-2019; Marx, Brian/AAK-5072-2020	Street, Amy/0000-0003-4554-9075; Gradus, Jaimie/0000-0003-1459-5327	Department of Veterans Affairs, Veterans Health Administration, Health Services Research and Development (HSR&D) Services as part of her HSR&D Career Development Award [CDA 10-029]	Dr. Iverson's contribution to this work was supported by the Department of Veterans Affairs, Veterans Health Administration, Health Services Research and Development (HSR&D) Services as part of her HSR&D Career Development Award (CDA 10-029). The views expressed in this article are those of the authors and do not necessarily represent the views of the Department of Veterans Affairs.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Arlinghaus K. A., 2005, TBI QUICK SCR UNPUB; Brenner LA, 2011, SUICIDE LIFE-THREAT, V41, P416, DOI 10.1111/j.1943-278X.2011.00041.x; Brenner LA, 2011, J HEAD TRAUMA REHAB, V26, P257, DOI 10.1097/HTR.0b013e31821fdb6e; Dillman D.A., 2011, MAIL INTERNET SURVEY; Epidemiology Program Post-Deployment Health Group Office of Public Health Veterans Health Administration Department of Veterans Affairs, 2013, AN VA HLTH CAR UT OP; Hayes A.F., 2018, INTRO MEDIATION MODE, V2nd ed.; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Iverson KM, 2011, WOMEN HEALTH ISS, V21, pS210, DOI 10.1016/j.whi.2011.04.019; Linehan MM, 1996, SUICIDAL BEHAV UNPUB; Miller EA, 2012, SOC WORK PUBLIC HLTH, V27, P379, DOI 10.1080/19371910903176197; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Radloff L. S., 1977, APPLIED PSYCHOL MEAS, V1, P358, DOI DOI 10.1177/014662167700100306; Smith B, 2007, AM J EPIDEMIOL, V166, P1345, DOI 10.1093/aje/kwm212; Street AE, 2013, J GEN INTERN MED, V28, pS556, DOI 10.1007/s11606-013-2333-4; United States Department of Veterans Affairs & Department of Defense, 2009, VA DOD CLIN PRACT GU; Weathers F. W., 1993, 9 ANN M INT SOC TRAU; Wisco BE, 2014, J TRAUMA STRESS, V27, P244, DOI 10.1002/jts.21900	18	11	11	1	23	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-9867	1573-6598		J TRAUMA STRESS	J. Trauma Stress	AUG	2015	28	4					361	365		10.1002/jts.22021			5	Psychology, Clinical; Psychiatry	Psychology; Psychiatry	CP5HR	WOS:000359912400013	26179483				2021-06-18	
J	Miao, XT; Yang, L; Gu, H; Ren, YY; Chen, GW; Liu, J; Wei, YX				Miao, Xutao; Yang, Ling; Gu, Hua; Ren, Yuanyuan; Chen, Guowei; Liu, Jia; Wei, Yongxiang			Evaluation of post-traumatic anosmia with MRI and chemosensory ERPs	EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY			English	Article						Olfactory disorder; Head injury, closed; Event-related potentials (ERPs); MRI; Anosmia	OLFACTORY-BULB VOLUME; EMISSION COMPUTED-TOMOGRAPHY; ORBITOFRONTAL CORTEX; DYSFUNCTION; SULCUS; DEPTH; IDENTIFICATION; PERCEPTION; PLASTICITY; CHILDREN	Magnetic resonance imaging (MRI) and chemosensory event-related potentials (ERPs) are important methods to evaluate olfactory function, but there is lack of study to explore the application of MRI and chemosensory ERPs in the patients with traumatic anosmia. The data of 26 post-traumatic anosmic patients and 21 healthy controls were retrospectively surveyed; olfaction and olfactory pathway of all participants were measured clinically using the T&T olfactometer, the Sniffin' Sticks, chemosensory ERPs and MRI. All patients were anosmic based on complaints and clinical examinations. In five patients, the olfactory bulb volume was significantly lower than control group. In 18 patients, the olfactory sulcus (OS) depth was similar to control group, but all the participants had a deeper right OS (right = 7.79 +/- A 1.31, left = 7.06 +/- A 1.44, p < 0.01). Olfactory ERPs (oERPs) could be evoked in 17 patients, but these signals showed longer latencies and lower amplitude than controls in the N1 (latency p < 0.05, amplitude p < 0.01) and P2 (latency p < 0.01, amplitude p < 0.05) waves. Nine traumatic anosmic patients had no identifiable oERPs; most of them had olfactory center injury. Trigeminal ERPs were detected in all anosmic patients and controls; patients had longer latencies for N1 (p < 0.05) and P2 (p < 0.05) waves, while there was no similar change in amplitude. Older subjects had smaller OB volume and OS depth. Closed head injury could induce anosmia; the severity extent, injury site and subsequent consciousness are related to the olfaction. oERP is the gold standard for olfactory subjective examination; MRI could indicate the lesions on the olfactory pathway and reflect the possibility of detectable oERPs.	[Miao, Xutao; Ren, Yuanyuan; Chen, Guowei; Liu, Jia; Wei, Yongxiang] Capital Med Univ, Beijing Chaoyang Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China; [Miao, Xutao] Beijing Jishuitan Hosp, Dept Otolaryngol, Beijing, Peoples R China; [Yang, Ling] Capital Med Univ, Beijing Tongren Hosp, Ctr Lab, Beijing, Peoples R China; [Gu, Hua] Capital Med Univ, Beijing Chaoyang Hosp, Dept Radiol, Beijing, Peoples R China; [Wei, Yongxiang] Capital Med Univ, Beijing Anzhen Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China	Wei, YX (corresponding author), Capital Med Univ, Beijing Chaoyang Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China.	weiyongxiang@vip.sina.com			National Natural Science Foundation of China (NSFC)National Natural Science Foundation of China (NSFC) [81271062]; Capital Application Research of Clinical Specialty [Z121107001012041]	The study was supported by National Natural Science Foundation of China (NSFC) under the project No. 81271062 and Capital Application Research of Clinical Specialty under the project No. Z121107001012041. We thank Dr. Jayant M. Pinto from Section of Otolaryngology-Head and Neck Surgery, the University of Chicago Medicine and Biological Sciences for reviewing the manuscript. The authors have no conflict of interest regarding this study.	Atighechi S, 2009, AM J RHINOL ALLERGY, V23, P409, DOI 10.2500/ajra.2009.23.3345; Buschuter D, 2008, NEUROIMAGE, V42, P498, DOI 10.1016/j.neuroimage.2008.05.004; de Kruijk JR, 2003, BRAIN INJURY, V17, P73, DOI 10.1080/0269905021000010221; Duprez TP, 2010, EUR J RADIOL, V74, P288, DOI 10.1016/j.ejrad.2009.05.065; Eftekhari M, 2006, AM J RHINOL, V20, P577, DOI 10.2500/ajr.2006.20.2906; Fitzek S, 2004, MAGN RESON IMAGING, V22, P205, DOI 10.1016/j.mri.2003.08.031; Goektas O, 2009, EUR J RADIOL, V71, P469, DOI 10.1016/j.ejrad.2008.10.039; Hawkes CH, 1997, J NEUROL NEUROSUR PS, V62, P436, DOI 10.1136/jnnp.62.5.436; Hawkes CH, 1997, J NEUROL NEUROSUR PS, V63, P145, DOI 10.1136/jnnp.63.2.145; Haxel BR, 2008, J HEAD TRAUMA REHAB, V23, P407, DOI 10.1097/01.HTR.0000341437.59627.ec; Huart C, 2011, AM J NEURORADIOL, V32, P1911, DOI 10.3174/ajnr.A2632; Hummel T, 2011, EXP BRAIN RES, V214, P285, DOI 10.1007/s00221-011-2832-7; Hummel T, 2003, BRAIN RES, V975, P85, DOI 10.1016/S0006-8993(03)02589-7; Hummel T, 2007, BEHAV BRAIN RES, V180, P133, DOI 10.1016/j.bbr.2007.02.040; Ishimaru T, 2002, ANN OTO RHINOL LARYN, V111, P518, DOI 10.1177/000348940211100607; Jiang RS, 2009, AM J RHINOL ALLERGY, V23, P582, DOI 10.2500/ajra.2009.23.3370; Kern RC, 2000, LARYNGOSCOPE, V110, P2106, DOI 10.1097/00005537-200012000-00025; Kettenmann B, 1997, CHEM SENSES, V22, P493, DOI 10.1093/chemse/22.5.493; Kobal G, 2000, EUR ARCH OTO-RHINO-L, V257, P205, DOI 10.1007/s004050050223; Li W, 2010, PSYCHOL SCI, V21, P1454, DOI 10.1177/0956797610382121; Lotsch J, 2006, BEHAV BRAIN RES, V170, P78, DOI 10.1016/j.bbr.2006.02.013; Mandairon N, 2009, J NEUROPHYSIOL, V101, P2204, DOI 10.1152/jn.00076.2009; Ren YY, 2012, ACTA OTO-LARYNGOL, V132, P974, DOI 10.3109/00016489.2012.663933; Rombaux P, 2010, EUR ARCH OTO-RHINO-L, V267, P1551, DOI 10.1007/s00405-010-1230-2; Rombaux P, 2007, AM J RHINOL, V21, P548, DOI 10.2500/ajr.2007.21.3067; Rombaux P, 2012, OTOLARYNG HEAD NECK, V147, P1136, DOI 10.1177/0194599812459704; Rombaux P, 2006, ARCH OTOLARYNGOL, V132, P1346, DOI 10.1001/archotol.132.12.1346; Seubert J, 2013, CEREB CORTEX, V23, P2448, DOI 10.1093/cercor/bhs230; Temmel AFP, 2002, ARCH OTOLARYNGOL, V128, P635, DOI 10.1001/archotol.128.6.635; Wilson DA, 2004, NEUROSCIENTIST, V10, P513, DOI 10.1177/1073858404267048; Yang L, 2012, MED SCI MONITOR, V18, pCR154, DOI 10.12659/MSM.882520; Yang L, 2010, OTOLARYNG HEAD NECK, V143, P554, DOI 10.1016/j.otohns.2010.05.010; Yousem DM, 1996, AM J NEURORADIOL, V17, P1171; Yousem DM, 1998, ANN NY ACAD SCI, V855, P546, DOI 10.1111/j.1749-6632.1998.tb10624.x	34	11	12	0	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0937-4477	1434-4726		EUR ARCH OTO-RHINO-L	Eur. Arch. Oto-Rhino-Laryn.	AUG	2015	272	8					1945	1953		10.1007/s00405-014-3278-x			9	Otorhinolaryngology	Otorhinolaryngology	CK8ZR	WOS:000356529500017	25253545				2021-06-18	
J	Peng, FY; Muzik, O; Gatson, J; Kernie, SG; Diaz-Arrastia, R				Peng, Fangyu; Muzik, Otto; Gatson, Joshua; Kernie, Steven G.; Diaz-Arrastia, Ramon			Assessment of Traumatic Brain Injury by Increased Cu-64 Uptake on (CuCl2)-Cu-64 PET/CT	JOURNAL OF NUCLEAR MEDICINE			English	Article						traumatic brain injury; copper metabolism; neuroimaging; positron emission tomography; Cu-64-chloride	POSITRON-EMISSION-TOMOGRAPHY; RADIOACTIVE COPPER; WILSONS-DISEASE; MOUSE MODEL; METABOLISM; ACTIVATION; ZINC; RATS; MICE; EXPRESSION	Copper is a nutritional trace element required for cell proliferation and wound repair. Methods: To explore increased copper uptake as a biomarker for noninvasive assessment of traumatic brain injury (TBI), experimental TBI in C57BL/6 mice was induced by controlled cortical impact, and Cu-64 uptake in the injured cortex was assessed with (CuCl2)-Cu-64 PET/CT. Results: At 24 h after intravenous injection of the tracer, uptake was significantly higher in the injured cortex of TBI mice (1.15 +/- 0.53 percentage injected dose per gram of tissue [%ID/g]) than in the uninjured cortex of mice without TBI (0.53 +/- 0.07 %ID/g, P = 0.027) or the cortex of mice that received an intracortical injection of zymosan A (0.62 +/- 0.22 %ID/g, P = 0.025). Furthermore, uptake in the traumatized cortex of untreated TBI mice (1.15 +/- 0.53 %ID/g) did not significantly differ from that in minocycline-treated TBI mice (0.93 +/- 0.30 %ID/g, P = 0.33). Conclusion: Overall, the data suggest that increased Cu-64 uptake in traumatized brain tissues holds potential as a new biomarker for noninvasive assessment of TBI with (CuCl2)-Cu-64 PET/CT.	[Peng, Fangyu] Univ Texas SW Med Ctr Dallas, Dept Radiol, Dallas, TX 75390 USA; [Peng, Fangyu] Univ Texas SW Med Ctr Dallas, Adv Imaging Res Ctr, Dallas, TX 75390 USA; [Muzik, Otto] Wayne State Univ, Sch Med, Carman & Ann Adams Dept Pediat, Detroit, MI USA; [Muzik, Otto] Wayne State Univ, Sch Med, Dept Radiol, Detroit, MI USA; [Gatson, Joshua] Univ Texas SW Med Ctr Dallas, Dept Surg, Dallas, TX 75390 USA; [Kernie, Steven G.] Columbia Univ, Dept Pediat, Coll Physicians & Surg, New York, NY 10027 USA; [Kernie, Steven G.] Columbia Univ, Dept Pathol & Cell Biol, Coll Physicians & Surg, New York, NY USA; [Diaz-Arrastia, Ramon] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA	Peng, FY (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Radiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	fangyu.peng@utsouthwestern.edu	Kernie, Steven/AAT-9912-2020; Peng, Fangyu/D-1079-2015	Peng, Fangyu/0000-0002-3142-3845; Diaz-Arrastia, Ramon/0000-0001-6051-3594; Kernie, Steven/0000-0003-1371-0549	NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R24CA086307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R21EB005331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS074394] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R21AG047953] Funding Source: NIH RePORTER; NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R24 CA086307, R24 CA86307] Funding Source: Medline; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R21 AG047953] Funding Source: Medline; NIBIB NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R21 EB005331, 7R21EB005331-03] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R21NS074394-01A, R21 NS074394] Funding Source: Medline		BUSH JA, 1955, J CLIN INVEST, V34, P1766, DOI 10.1172/JCI103232; Cai HW, 2014, J NUCL MED, V55, P622, DOI 10.2967/jnumed.113.126979; Choi BS, 2009, BRAIN RES, V1248, P14, DOI 10.1016/j.brainres.2008.10.056; Chuang N, 2011, NEUROIMAGE, V54, P80, DOI 10.1016/j.neuroimage.2010.07.043; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P191, DOI 10.1097/01.WCB.0000100045.07481.DE; Converse AK, 2011, J NUCL MED, V52, P257, DOI 10.2967/jnumed.110.082743; Cowell RM, 2003, J NEUROSCI, V23, P9459; Duckworth Josh L, 2013, Pathophysiology, V20, P23, DOI 10.1016/j.pathophys.2012.03.001; Garcia-Panach J, 2011, J NEUROTRAUM, V28, P1707, DOI 10.1089/neu.2011.1851; Gatson JW, 2012, J NEUROTRAUM, V29, P2209, DOI 10.1089/neu.2011.2274; Hattori N, 2004, J NUCL MED, V45, P775; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Homsi S, 2010, J NEUROTRAUM, V27, P911, DOI 10.1089/neu.2009.1223; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Jones PW, 2000, J INORG BIOCHEM, V81, P1, DOI 10.1016/S0162-0134(00)00119-7; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; Lech T, 2007, BIOL TRACE ELEM RES, V118, P10, DOI 10.1007/s12011-007-0014-z; Lewen A, 2001, NEUROBIOL DIS, V8, P380, DOI 10.1006/nbdi.2001.0396; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Linder M. C., 1991, BIOCH COPPER; Liu AY, 1999, AM J NEURORADIOL, V20, P1636; Loening Andreas Markus, 2003, Mol Imaging, V2, P131, DOI 10.1162/153535003322556877; Lutsenko S, 2010, METALLOMICS, V2, P596, DOI 10.1039/c0mt00006j; Matusch A, 2010, J AM SOC MASS SPECTR, V21, P161, DOI 10.1016/j.jasms.2009.09.022; Mirastschijski U, 2013, BIOL TRACE ELEM RES, V153, P76, DOI 10.1007/s12011-013-9658-z; Noshita N, 2002, J NEUROSCI, V22, P7923; OSBORN SB, 1969, Q J MED, V38, P467; Peng FY, 2012, MOL IMAGING BIOL, V14, P70, DOI 10.1007/s11307-011-0476-4; Sen CK, 2002, AM J PHYSIOL-HEART C, V282, pH1821, DOI 10.1152/ajpheart.01015.2001; Trumbo P, 2001, J AM DIET ASSOC, V101, P294, DOI 10.1016/S0002-8223(01)00078-5; Turnlund JR, 1998, AM J CLIN NUTR, V67, p960S, DOI 10.1093/ajcn/67.5.960S; WALSHE JM, 1977, Q J MED, V46, P445; Wang LM, 2010, METALLOMICS, V2, P348, DOI 10.1039/c003875j; Wang Y, 2014, EUR J NUCL MED MOL I, V41, P1440, DOI 10.1007/s00259-014-2727-5; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Zee CS, 1998, NEUROIMAG CLIN N AM, V8, P525; Zhang HY, 2011, ACAD RADIOL, V18, P1561, DOI 10.1016/j.acra.2011.08.006; Zheng ZQ, 2010, J NEUROCHEM, V114, P1630, DOI 10.1111/j.1471-4159.2010.06888.x	39	11	11	0	16	SOC NUCLEAR MEDICINE INC	RESTON	1850 SAMUEL MORSE DR, RESTON, VA 20190-5316 USA	0161-5505	1535-5667		J NUCL MED	J. Nucl. Med.	AUG	2015	56	8					1252	1257		10.2967/jnumed.115.154575			6	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CO5CX	WOS:000359178300037	26112025	Bronze, Green Accepted			2021-06-18	
J	Powell, MA; Corbo, V; Fonda, JR; Otis, JD; Milberg, WP; McGlinchey, RE				Powell, Margaret A.; Corbo, Vincent; Fonda, Jennifer R.; Otis, John D.; Milberg, William P.; McGlinchey, Regina E.			Sleep Quality and Reexperiencing Symptoms of PTSD Are Associated With Current Pain in US OEF/OIF/OND Veterans With and Without mTBIs	JOURNAL OF TRAUMATIC STRESS			English	Article							POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; OPERATIONS ENDURING FREEDOM; IRAQI FREEDOM; CLINICAL INTERVIEW; GENDER-DIFFERENCES; BOSTON ASSESSMENT; SAMPLE; RISK; QUESTIONNAIRE	Pain, a debilitating condition, is frequently reported by U.S. veterans returning from Afghanistan and Iraq. This study investigated how commonly reported clinical factors were associated with pain and whether these associations differed for individuals with a history of chronic pain. From the Boston metropolitan area, 171 veterans enrolled in the Veterans Affairs Center of Excellence were assessed for current posttraumatic stress disorder (PTSD) symptom severity, current mood and anxiety diagnoses, lifetime traumatic brain injury, combat experiences, sleep quality, and alcohol use. Hierarchical regression models were used to determine the association of these conditions with current pain. Average pain for the previous 30 days, assessed with the McGill Pain Questionnaire, was 30.07 out of 100 (SD = 25.43). Sleep quality, PTSD symptom severity, and alcohol use were significantly associated with pain (R-2 = .24), as were reexperiencing symptoms of PTSD (R-2 = .25). For participants with a history of chronic pain (n = 65), only PTSD symptoms were associated with pain (R-2 = .19). Current pain severity was associated with increased PTSD severity (notably, reexperiencing symptoms), poor sleep quality, and increased alcohol use. These data support the hypothesis that PTSD symptoms influence pain, but suggest that problems with sleep and alcohol use may exacerbate the relationship. Resumen SUENO, TEPT Y DOLOR EN VETERANOS El dolor, una condicion debilitante, es frecuentemente reportado por veteranos norteamericanos que vuelven de Afganistan e Iraq. Este estudio investigo como los factores clinicos comunmente reportados se asociaron con dolor y si estas asociaciones difieren en los individuos con historia de dolor cronico. Desde el area metropolitana de Boston, 171 veteranos enrolados en el Centro de Excelencia de Asuntos Veteranos fueron evaluados en la severidad de los sintomas de TEPT, diagnosticos de estado de animo y ansiedad actuales, LCT (lesion cerebral traumatica) a lo largo de la vida, experiencias de combate, calidad del sueno y consumo de alcohol. Modelos de regresion jerarquica fueron usados para determinar la asociacion de estas condiciones con el dolor actual. El dolor promedio para los 30 dias previos, evaluados con el cuestionario de dolor McGill, fue 30.07 de 100 (DE = 25.43). La calidad del sueno, severidad de los sintomas de TEPT, y uso de alcohol se asociaron significativamente con dolor (R2 = .24), asi como tambien los sintomas de re-experimentacion de TEPT (R2 = .25). Para los participantes con historia de dolor cronico (n = 67), solo los sintomas de TEPT se asociaron con dolor (R2 = .19). La severidad del dolor actual se asocio con mayor severidad de TEPT (mayormente, sintomas de re-experimentacion), mala calidad de sueno, y aumento del consumo de alcohol. Estos datos apoyan la idea que los sintomas de TEPT influyen sobre el dolor, pero sugieren que los problemas del sueno y consumo de alcohol pueden exacerbar esta asociacion. Traditional and Simplified Chinese Abstracts by AsianSTSS ?? : ????????????OEF/OIF/OND????,?????PTSD????????????? ??: ??????,????????????????????????????????????????????,??????????????????????????,171??????????????????????????(PTSD)??????????????????????????(TBIs)???????????????????????????????????????????????????????,??????,??30???????30.07 (SD = 25.43)??????PTSD??????????????????(R2 = .24),PTSD???????????????(R2 = .25)???????????(n = 67)?,??PTSD???????(R2 = .19)?????????PTSD?????(????????)????????????????????????PTSD?????????,?????????????????????? ?? : ????????????OEF/OIF/OND????,?????PTSD????????????? ??: ??????,????????????????????????????????????????????,??????????????????????????,171??????????????????????????(PTSD)??????????????????????????(TBIs)??????????????????????????????????????????????????????,??????,??30???????30.07 (SD = 25.43)??????PTSD??????????????????(R2 = .24),PTSD???????????????(R2 = .25)???????????(n = 67)?,??PTSD???????(R2 = .19)?????????PTSD?????(????????)????????????????????????PTSD?????????,??????????????????????	[Powell, Margaret A.; Corbo, Vincent; Fonda, Jennifer R.; Otis, John D.; Milberg, William P.; McGlinchey, Regina E.] VA Boston Healthcare Syst, Translat Res Ctr TBI & Stress Disorders TRACTS, Boston, MA 02130 USA; [Powell, Margaret A.; Corbo, Vincent; Fonda, Jennifer R.; Otis, John D.; Milberg, William P.; McGlinchey, Regina E.] VA Boston Healthcare Syst, Geriatr Res Educ & Clin Ctr GRECC, Boston, MA 02130 USA; [Corbo, Vincent] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Fonda, Jennifer R.] Boston Univ, Dept Epidemiol, Boston, MA 02215 USA; [Otis, John D.] Boston Univ, Dept Psychiat, Boston, MA 02215 USA; [Otis, John D.] Boston Univ, Dept Psychol, Boston, MA 02215 USA; [Milberg, William P.; McGlinchey, Regina E.] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA	McGlinchey, RE (corresponding author), VA Boston Healthcare Syst, 150 South Huntington Ave, Boston, MA 02130 USA.	Regina_McGlinchey@hms.harvard.edu	McGlinchey, Regina E/R-1971-2016	Otis, John/0000-0002-5441-7421	Translational Research Center for TBI and Stress Disorders (TRACTS); VA Rehabilitation Research and Development Traumatic Brain Injury Center of Excellence [B9254-C]; VA CSR&D Merit Review Award from the United States Department of Veterans Affairs [CX000181]	This research was supported by the Translational Research Center for TBI and Stress Disorders (TRACTS), a VA Rehabilitation Research and Development Traumatic Brain Injury Center of Excellence (B9254-C), and in part by a VA CSR&D Merit Review Award (CX000181) to Regina McGlinchey from the United States Department of Veterans Affairs. The authors would like to thank Wally Musto, CMSgt (Ret) for his recruitment efforts, and Drs. Alexandra Kenna, Catherine Fortier, Brad Brummett, Melissa Amick, and Sara Lippa for the clinical interviews.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Beetar JT, 1996, ARCH PHYS MED REHAB, V77, P1298, DOI 10.1016/S0003-9993(96)90196-3; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1002/jts.2490080106; Bryan CJ, 2013, JAMA PSYCHIAT, V70, P686, DOI 10.1001/jamapsychiatry.2013.1093; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Capaldi VF, 2011, MIL MED, V176, P879, DOI 10.7205/MILMED-D-10-00440; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Fortier CB, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000008; Fortier CB, 2014, J HEAD TRAUMA REHAB, V29, P89, DOI 10.1097/HTR.0b013e3182865859; Galloway SK, 2012, PAIN RES TREAT, V2012, DOI 10.1155/2012/851276; Geisser ME, 1996, PAIN, V66, P207, DOI 10.1016/0304-3959(96)03038-2; Gironda RJ, 2006, PAIN MED, V7, P339, DOI 10.1111/j.1526-4637.2006.00146.x; Goebel JR, 2011, J PAIN SYMPTOM MANAG, V41, P848, DOI 10.1016/j.jpainsymman.2010.07.009; Grafton KV, 2005, CLIN J PAIN, V21, P73, DOI 10.1097/00002508-200501000-00009; Haskell SG, 2010, J WOMENS HEALTH, V19, P267, DOI 10.1089/jwh.2008.1262; Haskell SG, 2009, PAIN MED, V10, P1167, DOI 10.1111/j.1526-4637.2009.00714.x; Helmer DA, 2009, PAIN MED, V10, P1174, DOI 10.1111/j.1526-4637.2009.00723.x; IASP terminology part III: pain terms a current list with definitions and notes on usage, 1994, CLASSIFICATION CHRON, pH; Kerns RD, 2003, J REHABIL RES DEV, V40, P371, DOI 10.1682/JRRD.2003.09.0371; King KA, 2006, APHASIOLOGY, V20, P233, DOI 10.1080/02687030500473155; Lang KP, 2014, J HEAD TRAUMA REHAB, V29, P44, DOI 10.1097/HTR.0b013e31829c85d0; Lew HL, 2010, AM J PHYS MED REHAB, V89, P437, DOI 10.1097/PHM.0b013e3181ddd301; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Lippa SM, 2015, J TRAUMA STRESS, V28, P25, DOI 10.1002/jts.21979; Manchikanti Laxmaiah, 2007, J Opioid Manag, V3, P89; MELZACK R, 1975, PAIN, V1, P277, DOI 10.1016/0304-3959(75)90044-5; Mogil JS, 2010, PROG BRAIN RES, V186, P141, DOI 10.1016/B978-0-444-53630-3.00009-9; Neylan TC, 1998, AM J PSYCHIAT, V155, P929, DOI 10.1176/ajp.155.7.929; Norman SB, 2014, J STUD ALCOHOL DRUGS, V75, P557, DOI 10.15288/jsad.2014.75.557; Otis J. D., 2012, PSTD MILD TRAUMATIC; Otis JD, 2010, PSYCHOL SERV, V7, P126, DOI 10.1037/a0020512; Sharp TJ, 2001, CLIN PSYCHOL REV, V21, P857, DOI 10.1016/S0272-7358(00)00071-4; Shipherd JC, 2007, J REHABIL RES DEV, V44, P153, DOI 10.1682/JRRD.2006.06.0065; SKINNER HA, 1982, J STUD ALCOHOL, V43, P1157, DOI 10.15288/jsa.1982.43.1157; Tan G, 2009, PAIN MED, V10, P1237, DOI 10.1111/j.1526-4637.2009.00712.x; U. S. Department of Defense, 2012, DEM PROF MIL COMM; U. S. Department of Veterans Affairs Office of Public Health Epidemiology Program, 2012, HLTH CAR UT OP END F; Vogt DS, 2008, ASSESSMENT, V15, P381, DOI 10.1177/1073191108316030; Walker RL, 2010, PSYCHOL SERV, V7, P136, DOI 10.1037/a0019684; Weathers FW, 1999, PSYCHOL ASSESSMENT, V11, P124, DOI 10.1037/1040-3590.11.2.124; WILLIAMS JBW, 1992, ARCH GEN PSYCHIAT, V49, P630	42	11	11	0	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-9867	1573-6598		J TRAUMA STRESS	J. Trauma Stress	AUG	2015	28	4					322	329		10.1002/jts.22027			8	Psychology, Clinical; Psychiatry	Psychology; Psychiatry	CP5HR	WOS:000359912400008	26194844				2021-06-18	
J	Wang, Y; Rao, W; Zhang, C; Zhang, C; Liu, MD; Han, F; Yao, LB; Han, H; Luo, P; Su, N; Fei, Z				Wang, Y.; Rao, W.; Zhang, C.; Zhang, C.; Liu, M-D; Han, F.; Yao, L-B; Han, H.; Luo, P.; Su, N.; Fei, Z.			Scaffolding protein Homer1a protects against NMDA-induced neuronal injury	CELL DEATH & DISEASE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; TRAUMATIC BRAIN-INJURY; MITOCHONDRIAL DYSFUNCTION; SYNAPTIC PLASTICITY; IN-VITRO; PSD-95; ACTIVATION; CALCIUM; 1A; BINDS	Excessive N-methyl-D-aspartate receptor (NMDAR) activation and the resulting activation of neuronal nitric oxide synthase (nNOS) cause neuronal injury. Homer1b/c facilitates NMDAR-PSD95-nNOS complex interactions, and Homer1a is a negative competitor of Homer1b/c. We report that Homer1a was both upregulated by and protected against NMDA-induced neuronal injury in vitro and in vivo. The neuroprotective activity of Homer1a was associated with NMDA-induced Ca2+ influx, oxidative stress and the resultant downstream signaling activation. Additionally, we found that Homer1a functionally regulated NMDAR channel properties in neurons, but did not regulate recombinant NR1/NR2B receptors in HEK293 cells. Furthermore, we found that Homer1a detached the physical links among NR2B, PSD95 and nNOS and reduced the membrane distribution of NMDAR. NMDA-induced neuronal injury was more severe in Homer1a homozygous knockout mice (KO, Homer1a(-/-)) when compared with NMDA-induced neuronal injury in wild-type mice (WT, Homer1a(+/+)). Additionally, Homer1a overexpression in the cortex of Homer1a(-/-) mice alleviated NMDA-induced neuronal injury. These findings suggest that Homer1a may be a key neuroprotective endogenous molecule that protects against NMDA-induced neuronal injury by disassembling NR2B-PSD95-nNOS complexes and reducing the membrane distribution of NMDARs.	[Wang, Y.; Rao, W.; Zhang, C.; Liu, M-D; Han, F.; Luo, P.; Su, N.; Fei, Z.] Fourth Mil Med Univ, Xijing Hosp, Dept Neurosurg, Xian 710032, Peoples R China; [Wang, Y.] Wuhan Zhong Xin Hosp, Dept Neurosurg, Wuhan, Peoples R China; [Zhang, C.] Second Artillery Gen Hosp PLA, Dept Neurol, Beijing, Peoples R China; [Yao, L-B] Fourth Mil Med Univ, State Key Lab Canc Biol, Dept Biochem & Mol Biol, Xian, Peoples R China; [Han, H.] Fourth Mil Med Univ, State Key Lab Canc Biol, Dept Med Genet & Dev Biol, Xian 710032, Peoples R China	Fei, Z (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Neurosurg, Changle West Rd 127, Xian 710032, Peoples R China.	feizhou@fmmu.edu.cn		Luo, Peng/0000-0003-0746-939X	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81430043, 30930093]; National Science and Technology Major Project of China [2013ZX 09J13109-02C]; National Science and Technology Pillar Program of China [2012BAI11B02]; Science and Technology Project of Shaanxi [2013KTCQ03-01]	We would like to express our thanks to Prof. Bo Xiao and Paul Worley for providing the Homer1a KO mice, Prof. Jian-hong Luo for the gifts of the NR1A and NR2B plasmids, Prof. Jing-hua Yang, Dr Jie Zhu and Dr Sanzhong Li for helpful discussion and Jun-li Huo, Juan Li, Xiao-yan Chen and Yu-fen Shi for technical assistance. This work was supported by the National Natural Science Foundation of China (81430043 and 30930093), the National Science and Technology Major Project of China (2013ZX 09J13109-02C), the National Science and Technology Pillar Program of China (2012BAI11B02) and the Science and Technology Project of Shaanxi (2013KTCQ03-01).	Aarts M, 2002, SCIENCE, V298, P846, DOI 10.1126/science.1072873; Algattas H, 2014, INT J MOL SCI, V15, P309, DOI 10.3390/ijms15010309; Ango F, 2001, NATURE, V411, P962, DOI 10.1038/35082096; Ayata C, 1997, J NEUROSCI, V17, P6908; Bach A, 2012, P NATL ACAD SCI USA, V109, P3317, DOI 10.1073/pnas.1113761109; Bertaso F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009755; Bettini E, 2010, J PHARMACOL EXP THER, V335, P636, DOI 10.1124/jpet.110.172544; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; Brennan AM, 2009, NAT NEUROSCI, V12, P857, DOI 10.1038/nn.2334; Cheng FR, 2011, J NEUROCHEM, V119, P815, DOI 10.1111/j.1471-4159.2011.07460.x; Ciruela F, 2000, MOL CELL NEUROSCI, V15, P36, DOI 10.1006/mcne.1999.0808; Cook DJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003824; Cook DJ, 2012, NATURE, V483, P213, DOI 10.1038/nature10841; Cui H, 2007, J NEUROSCI, V27, P9901, DOI 10.1523/JNEUROSCI.1464-07.2007; de Tassigny XD, 2007, J NEUROSCI, V27, P6103, DOI 10.1523/JNEUROSCI.5595-06-2007; DeRidder MN, 2006, NEUROBIOL DIS, V22, P165, DOI 10.1016/j.nbd.2005.10.011; Goebel DJ, 2009, BRAIN RES, V1256, P190, DOI 10.1016/j.brainres.2008.12.051; Gu ZL, 2005, J NEUROSCI, V25, P4974, DOI 10.1523/JNEUROSCI.1086-05.2005; Haelewyn B, 2008, J NEUROSCI METH, V168, P479, DOI 10.1016/j.jneumeth.2007.10.015; Hardingham GE, 2009, BIOCHEM SOC T, V37, P1147, DOI 10.1042/BST0371147; Hu JH, 2010, NEURON, V68, P1128, DOI 10.1016/j.neuron.2010.11.008; Kammermeier PJ, 2008, J NEUROSCI, V28, P8560, DOI 10.1523/JNEUROSCI.1830-08.2008; Kammermeier PJ, 2000, J NEUROSCI, V20, P7238; Kato A, 2003, MOL BRAIN RES, V118, P33, DOI 10.1016/j.molbrainres.2003.07.005; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Kim JH, 2006, J BIOL CHEM, V281, P26144, DOI 10.1074/jbc.M603636200; KOH JY, 1988, J NEUROSCI, V8, P2153, DOI 10.1523/jneurosci.08-06-02153.1988; Lan JY, 2001, NAT NEUROSCI, V4, P382, DOI 10.1038/86028; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Lavezzari G, 2004, J NEUROSCI, V24, P6383, DOI 10.1523/JNEUROSCI.1890-04.2004; Li WX, 2008, J NEUROSCI, V28, P12190, DOI 10.1523/JNEUROSCI.3019-08.2008; Lipton SA, 2006, NAT REV DRUG DISCOV, V5, P160, DOI 10.1038/nrd1958; Liu YT, 2007, J NEUROSCI, V27, P2846, DOI 10.1523/JNEUROSCI.0116-07.2007; Lu KT, 2014, PFLUGERS ARCH, V467, P1651; Luo P, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.116; Luo P, 2012, APOPTOSIS, V17, P975, DOI 10.1007/s10495-012-0736-z; Luo P, 2012, FREE RADICAL RES, V46, P766, DOI 10.3109/10715762.2012.678340; Mahan AL, 2012, J NEUROSCI, V32, P4651, DOI 10.1523/JNEUROSCI.3308-11.2012; Maret S, 2007, P NATL ACAD SCI USA, V104, P20090, DOI 10.1073/pnas.0710131104; Martel MA, 2009, CHANNELS, V3, P12, DOI 10.4161/chan.3.1.7864; MURASE K, 1990, BRAIN RES, V525, P84, DOI 10.1016/0006-8993(90)91323-9; Naisbitt S, 1999, NEURON, V23, P569, DOI 10.1016/S0896-6273(00)80809-0; Nikam SS, 2002, CURR PHARM DESIGN, V8, P845, DOI 10.2174/1381612024607072; Paoletti P, 2013, NAT REV NEUROSCI, V14, P383, DOI 10.1038/nrn3504; Park JM, 2013, CELL, V154, P637, DOI 10.1016/j.cell.2013.07.001; Qiu S, 2005, J BIOL CHEM, V280, P24923, DOI 10.1074/jbc.M413915200; Redmond L, 2002, NEURON, V34, P999, DOI 10.1016/S0896-6273(02)00737-7; Roche KW, 1999, J BIOL CHEM, V274, P25953, DOI 10.1074/jbc.274.36.25953; Roloff AM, 2010, J NEUROSCI, V30, P3072, DOI 10.1523/JNEUROSCI.4603-09.2010; Ronesi JA, 2012, NAT NEUROSCI, V15, P431, DOI 10.1038/nn.3033; Sato M, 2001, J NEUROSCI, V21, P3797, DOI 10.1523/JNEUROSCI.21-11-03797.2001; Scott DB, 2003, NEUROPHARMACOLOGY, V45, P755, DOI 10.1016/S0028-3908(03)00250-8; Shiraishi-Yamaguchi Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-206; SHOHAMI E, 1995, BRAIN RES, V674, P55, DOI 10.1016/0006-8993(94)01433-I; Srejic LR, 2013, J CEREBR BLOOD F MET, V33, P1937, DOI 10.1038/jcbfm.2013.153; Stanika RI, 2010, NEUROBIOL DIS, V37, P403, DOI 10.1016/j.nbd.2009.10.020; Stanika RI, 2009, P NATL ACAD SCI USA, V106, P9854, DOI 10.1073/pnas.0903546106; Tadokoro S, 1999, P NATL ACAD SCI USA, V96, P13801, DOI 10.1073/pnas.96.24.13801; Takagi N, 2000, J NEUROCHEM, V74, P169, DOI 10.1046/j.1471-4159.2000.0740169.x; Takeda H, 2007, BRAIN RES, V1184, P306, DOI 10.1016/j.brainres.2007.09.055; Tu JC, 1998, NEURON, V21, P717, DOI 10.1016/S0896-6273(00)80589-9; Tu JC, 1999, NEURON, V23, P583, DOI 10.1016/S0896-6273(00)80810-7; Xia ZG, 1996, J NEUROSCI, V16, P5425; Xiao B, 1998, NEURON, V21, P707, DOI 10.1016/S0896-6273(00)80588-7; Xiong ZQ, 2003, J NEUROSCI, V23, P955; Xu TL, 1999, NEUROPHARMACOLOGY, V38, P659, DOI 10.1016/S0028-3908(98)00227-5; Yuan JP, 2012, ACTA PHYSIOL, V204, P238, DOI 10.1111/j.1748-1716.2011.02319.x; Yuan JP, 2003, CELL, V114, P777, DOI 10.1016/S0092-8674(03)00716-5; Zhou L, 2010, NAT MED, V16, P1439, DOI 10.1038/nm.2245	69	11	14	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-4889			CELL DEATH DIS	Cell Death Dis.	AUG	2015	6								e1843	10.1038/cddis.2015.216			12	Cell Biology	Cell Biology	CQ4NP	WOS:000360581900007	26247728	DOAJ Gold, Green Published			2021-06-18	
J	Johnson, EA; Guignet, MA; Dao, TL; Hamilton, TA; Kan, RK				Johnson, Erik A.; Guignet, Michelle A.; Dao, Thuy L.; Hamilton, Tracey A.; Kan, Robert K.			Interleukin-18 expression increases in response to neurovascular damage following soman-induced status epilepticus in rats	JOURNAL OF INFLAMMATION-LONDON			English	Article						Interleukin 18; Status epilepticus; Soman (GD); Macrophage; T-cell; Neutrophil; Piriform cortex; Hippocampus; Thalamus	SIGNAL-TRANSDUCTION PATHWAYS; INTERFERON-GAMMA PRODUCTION; TRAUMATIC BRAIN-INJURY; RHEUMATOID-ARTHRITIS; T-CELLS; MICROGLIAL ACTIVATION; MOLECULAR-MECHANISMS; INDUCED CONVULSIONS; INDUCED SEIZURES; B-CELLS	Background: Status epilepticus (SE) can cause neuronal cell death and impaired behavioral function. Acute exposure to potent acetylcholinesterase inhibitors such as soman (GD) can cause prolonged SE activity, micro-hemorrhage and cell death in the hippocampus, thalamus and piriform cortex. Neuroinflammation is a prominent feature of brain injury with upregulation of multiple pro-inflammatory cytokines including those of the IL-1 family. The highly pleiotropic pro-inflammatory cytokine interleukin-18 (IL-18) belongs to the IL-1 family of cytokines and can propagate neuroinflammation by promoting immune cell infiltration, leukocyte and lymphocyte activation, and angiogenesis and helps facilitate the transition from the innate to the adaptive immune response. The purpose of this study is to characterize the regional and temporal expression of IL -18 and related factors in the brain following SE in a rat GD seizure model followed by localization of IL-18 to specific cell types. Methods: The protein levels of IL-18, vascular endothelial growth factor and interferon gamma was quantified in the lysates of injured brain regions up to 72 h following GD-induced SE onset using bead multiplex immunoassays. IL-18 was localized to various cell types using immunohistochemistry and transmission electron microscopy. In addition, macrophage appearance scoring and T-cell quantification was determined using immunohistochemistry. Micro-hemorrhages were identified using hematoxylin and eosin staining of brain sections. Results: Significant increases in IL-18 occurred in the piriform cortex, hippocampus and thalamus following SE. IL-18 was primarily expressed by endothelial cells and astrocytes associated with the damaged neurovascular unit. The increase in IL-18 was not related to macrophage accumulation, neutrophil infiltration or T-cell appearance in the injured tissue. Conclusions: These data show that IL-18 is significantly upregulated following GD-induced SE and localized primarily to endothelial cells in damaged brain vasculature. IL-18 upregulation occurred following leukocyte/lymphocyte infiltration and in the absence of other IL-18-related cytokines, suggesting another function, potentially for angiogenesis related to GD-induced micro-hemorrhage formation. Further studies at more chronic time points may help to elucidate this function.	[Johnson, Erik A.; Guignet, Michelle A.; Dao, Thuy L.; Kan, Robert K.] US Army, Med Res Inst Chem Def, Div Res, Pharmacol Branch, Aberdeen Proving Ground, MD 21010 USA; [Hamilton, Tracey A.] US Army, Med Res Inst Chem Def, Res Support Div, Comparat Pathol Branch, Aberdeen Proving Ground, MD 21010 USA	Johnson, EA (corresponding author), US Army, Med Res Inst Chem Def, Div Res, Pharmacol Branch, Aberdeen Proving Ground, MD 21010 USA.	erik.a.johnson1.civ@mail.mil		Guignet, Michelle/0000-0003-4788-0175	Defense Threat Reduction Agency - Joint Science and Technology Office, Medical ST DivisionUnited States Department of DefenseDefense Threat Reduction Agency; U.S. Army's In-House Laboratory Independent Research (ILIR) program	The authors would like to thank Nicole Rosellini, Marissa Babnew, and Dominique Scutella for their technical contributions to the research. This research was supported by the Defense Threat Reduction Agency - Joint Science and Technology Office, Medical S&T Division and by the U.S. Army's In-House Laboratory Independent Research (ILIR) program. The views expressed herein are those of the author(s) and do not reflect the official policy of the Department of Army, Department of Defense, or the U.S. Government.	Alboni S, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-9; Andoh T, 2008, J IMMUNOL, V180, P2322, DOI 10.4049/jimmunol.180.4.2322; Arend WP, 2008, IMMUNOL REV, V223, P20, DOI 10.1111/j.1600-065X.2008.00624.x; Ariel A, 2002, J LEUKOCYTE BIOL, V72, P192; Baille V, 2005, TOXICOLOGY, V215, P1, DOI 10.1016/j.tox.2005.05.028; BATAILLARD A, 1990, PHARMACOL TOXICOL, V67, P27, DOI 10.1111/j.1600-0773.1990.tb00777.x; Bernardini G, 2003, J IMMUNOL METHODS, V273, P83, DOI 10.1016/S0022-1759(02)00420-9; BOUCHAUD C, 1994, BRAIN RES, V660, P249, DOI 10.1016/0006-8993(94)91296-3; Cho ML, 2006, IMMUNOL LETT, V105, P159, DOI [10.1016/j.imlet.2006.02.003, 10.1016/j.imlet.2005.10.020]; Collombet JM, 2007, NEUROTOXICOLOGY, V28, P38, DOI 10.1016/j.neuro.2006.07.011; Conti B, 1999, MOL BRAIN RES, V67, P46, DOI 10.1016/S0169-328X(99)00034-0; Culhane AC, 1998, MOL PSYCHIATR, V3, P362, DOI 10.1038/sj.mp.4000389; Dai SM, 2007, ANN RHEUM DIS, V66, P1411, DOI 10.1136/ard.2006.067793; Dai SM, 2004, ARTHRITIS RHEUM-US, V50, P432, DOI 10.1002/art.20064; Dinarello CA, 1998, J LEUKOCYTE BIOL, V63, P658; Gerdes N, 2002, J EXP MED, V195, P245, DOI 10.1084/jem.20011022; Gracie JA, 2003, J LEUKOCYTE BIOL, V73, P213, DOI 10.1189/jlb.0602313; Hedtjarn M, 2002, J NEUROSCI, V22, P5910; Jander S, 2002, J CEREBR BLOOD F MET, V22, P62, DOI 10.1097/00004647-200201000-00008; Jeon GS, 2008, NEUROCHEM RES, V33, P179, DOI 10.1007/s11064-007-9434-6; Johnson EA, 2005, EXP BRAIN RES, V167, P17, DOI 10.1007/s00221-005-2362-2; Johnson EA, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-41; Johnson EA, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-40; Koplovitz I, 1998, EPILEPSY RES, V30, P159, DOI 10.1016/S0920-1211(97)00100-9; Lallement G, 1999, ARCH TOXICOL, V73, P115, DOI 10.1007/s002040050595; LEMERCIER G, 1983, ACTA NEUROPATHOL, V61, P123, DOI 10.1007/BF00697391; Letienne R, 1999, FUND CLIN PHARMACOL, V13, P468, DOI 10.1111/j.1472-8206.1999.tb00005.x; Leung BP, 2001, J IMMUNOL, V167, P2879, DOI 10.4049/jimmunol.167.5.2879; MCDONOUGH JH, 1995, NEUROTOXICOLOGY, V16, P123; MCLEOD CG, 1984, NEUROTOXICOLOGY, V5, P53; Micallef MJ, 1996, EUR J IMMUNOL, V26, P1647, DOI 10.1002/eji.1830260736; Morel JCM, 2002, J BIOL CHEM, V277, P34679, DOI 10.1074/jbc.M206337200; Morel JCM, 2001, J BIOL CHEM, V276, P37069, DOI 10.1074/jbc.M103574200; Mori I, 2001, VIROLOGY, V287, P163, DOI 10.1006/viro.2001.1029; Nakanishi K, 2001, ANNU REV IMMUNOL, V19, P423, DOI 10.1146/annurev.immunol.19.1.423; Ogura T, 2001, BLOOD, V98, P2101, DOI 10.1182/blood.V98.7.2101; Park CC, 2001, J IMMUNOL, V167, P1644, DOI 10.4049/jimmunol.167.3.1644; Paxinos G, 2005, RAT BRAIN STEREOTAXI, P205; Prinz M, 1999, J NEUROCHEM, V72, P2215, DOI 10.1046/j.1471-4159.1999.0722215.x; Ren XF, 2011, J NEUROSCI, V31, P8556, DOI 10.1523/JNEUROSCI.1623-11.2011; Ryu HJ, 2010, NEUROSCIENCE, V170, P711, DOI 10.1016/j.neuroscience.2010.07.048; Shichita T, 2009, NAT MED, V15, P946, DOI 10.1038/nm.1999; Shih TM, 1997, J APPL TOXICOL, V17, P255, DOI 10.1002/(SICI)1099-1263(199707)17:4<255::AID-JAT441>3.0.CO;2-D; SHIH TM, 1992, BRAIN RES BULL, V28, P735, DOI 10.1016/0361-9230(92)90253-T; Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942; Walker W, 1999, J IMMUNOL, V162, P5894; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; Wheeler RD, 2000, MOL BRAIN RES, V77, P290, DOI 10.1016/S0169-328X(00)00069-3; Yatsiv I, 2002, J CEREBR BLOOD F MET, V22, P971, DOI 10.1097/00004647-200208000-00008; Yoo JK, 2005, J IMMUNOL, V175, P8280, DOI 10.4049/jimmunol.175.12.8280; Yoshimoto T, 1997, P NATL ACAD SCI USA, V94, P3948, DOI 10.1073/pnas.94.8.3948; Zhang XM, 2007, EXP NEUROL, V205, P64, DOI 10.1016/j.expneurol.2007.01.019; Zhang XM, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-26; Zimmer LA, 1997, J COMP NEUROL, V378, P482, DOI 10.1002/(SICI)1096-9861(19970224)378:4<482::AID-CNE4>3.0.CO;2-Z	54	11	12	0	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1476-9255			J INFLAMM-LOND	J. Inflamm.-Lond.	JUL 22	2015	12								43	10.1186/s12950-015-0089-9			11	Immunology	Immunology	CN1QR	WOS:000358195400001	26203299	DOAJ Gold, Green Published			2021-06-18	
J	Evans, TM; Jaramillo, CA; Sataranatarajan, K; Watts, L; Sabia, M; Qi, W; Van Remmen, H				Evans, T. M.; Jaramillo, C. A.; Sataranatarajan, K.; Watts, L.; Sabia, M.; Qi, W.; Van Remmen, H.			THE EFFECT OF MILD TRAUMATIC BRAIN INJURY ON PERIPHERAL NERVOUS SYSTEM PATHOLOGY IN WILD-TYPE MICE AND THE G93A MUTANT MOUSE MODEL OF MOTOR NEURON DISEASE	NEUROSCIENCE			English	Article						TBI; amyotrophic lateral sclerosis; mouse model; oxidative stress; spinal cord	AMYOTROPHIC-LATERAL-SCLEROSIS; SPINAL-CORD-INJURY; OXIDATIVE STRESS; SKELETAL-MUSCLE; HEAD-INJURY; ANTIOXIDANT THERAPIES; SUPEROXIDE-DISMUTASE; LIPID-PEROXIDATION; TRANSGENIC MODEL; HIGH-SCHOOL	Traumatic brain injury (TBI) is associated with a risk of neurodegenerative disease. Some suggest a link between TBI and motor neuron disease (MND), including amyotrophic lateral sclerosis (ALS). To investigate the potential mechanisms linking TBI to MND, we measured motor function and neuropathology following mild-TBI in wild-type and a transgenic model of ALS, G93A mutant mice. Mild-TBI did not alter the lifespan of G93A mice or age of onset; however, rotarod performance was impaired in G93A verses wild-type mice. Grip strength was reduced only in G93A mice after mild-TBI. Increased electromyography (EMG) abnormalities and markers of denervation (AchR, Runx1) indicate that mild-TBI may result in peripheral effects that are exaggerated in G93A mice. Markers of inflammation (cell edema, astrogliosis and microgliosis) were detected at 24 and 72 h in the brain and spinal cord in wild-type and G93A mice. Levels of F2-isoprostanes, a marker of oxidative stress, were increased in the spinal cord 24 h post mild-TBI in wild-type mice but were not affected by TBI in G93A mice. In summary, our data demonstrate that mild-TBI induces inflammation and oxidative stress and negatively impacts muscle denervation and motor performance, suggesting mild-TBI can potentiate motor neuron pathology and influence the development of MND in mice. Published by Elsevier Ltd. on behalf of IBRO.	[Evans, T. M.] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA; [Watts, L.; Van Remmen, H.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Watts, L.] Univ Texas Hlth Sci Ctr San Antonio, Dept Neurol, San Antonio, TX 78229 USA; [Watts, L.] Univ Texas Hlth Sci Ctr San Antonio, Dept Res, Imaging Inst, San Antonio, TX 78229 USA; [Jaramillo, C. A.] Polytrauma Rehabil Ctr, San Antonio, TX USA; [Jaramillo, C. A.; Sabia, M.; Qi, W.] South Texas Vet Hlth Care Syst, San Antonio, TX USA; [Jaramillo, C. A.] Univ Texas Hlth Sci Ctr San Antonio, Dept Rehabil Med, San Antonio, TX 78229 USA; [Sataranatarajan, K.; Van Remmen, H.] Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA; [Sataranatarajan, K.; Van Remmen, H.] Oklahoma City VA Med Ctr, Oklahoma City, OK USA	Van Remmen, H (corresponding author), Oklahoma Med Res Fdn, Free Rad Biol & Aging Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.	EvansTM@uthscsa.edu; jaramilloc3@uthscsa.edu; Kavithalakshmi-Sataranatarajan@omrf.org; wattsl@uthscsa.edu; sabia@uthscsa.edu; Qi@uthscsa.edu; holly-vanremmen@omrf.org	Watts, Lora Talley/A-2724-2012	Watts, Lora Talley/0000-0002-2337-1504; Evans, Teresa/0000-0002-3860-2205	independent National Research Service Award, National Institute for Neurological Diseases and Stroke [1F31NS080508-01]; Hartford Foundation/American Federation for Aging Research Scholars in Geriatric Medicine Program; VA Merit Review grantUS Department of Veterans Affairs; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001120, KL2TR001118] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F31NS080508] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01BX000517] Funding Source: NIH RePORTER	This research was funded in part by an independent National Research Service Award, National Institute for Neurological Diseases and Stroke (1F31NS080508-01; Evans TM) and the Hartford Foundation/American Federation for Aging Research Scholars in Geriatric Medicine Program (Jaramillo CA) and a VA Merit Review grant to Dr. Van Remmen. We also acknowledge the assistance of Vivian Diaz and the Nathan Shock Center in animal care and maintenance and collection of body weight and body composition data. We would also like to acknowledge the help and guidance of Shane Sprague and the Neurosurgery Department Brain Injury Core for their support in establishing our TBI procedures.	Armon C, 2012, AMYOTROPH LATERAL SC, V13, P351, DOI 10.3109/17482968.2012.660954; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Bayir H, 2004, J NEUROTRAUM, V21, P1, DOI 10.1089/089771504772695896; Bayir H, 2002, PEDIATR RES, V51, P571, DOI 10.1203/00006450-200205000-00005; Bongers KS, 2013, AM J PHYSIOL-ENDOC M, V305, pE907, DOI 10.1152/ajpendo.00380.2013; Brahmachari S, 2006, J NEUROSCI, V26, P4930, DOI 10.1523/JNEUROSCI.5480-05.2006; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Chen HL, 2007, AM J EPIDEMIOL, V166, P810, DOI 10.1093/aje/kwm153; CHIO A, 1991, NEUROEPIDEMIOLOGY, V10, P174, DOI 10.1159/000110267; Choi GS, 2012, ARCH NEUROL-CHICAGO, V69, P363, DOI 10.1001/archneurol.2011.1930; Clausen F, 2012, J NEUROTRAUM, V29, P766, DOI 10.1089/neu.2011.1754; Czeiter E, 2008, J NEUROTRAUM, V25, P205, DOI 10.1089/neu.2007.0331; DALCANTO MC, 1994, AM J PATHOL, V145, P1271; Davis A E, 2000, Crit Care Nurs Q, V23, P1; Evans Teresa M, 2014, Transl Proteom, V3, P10; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Funk JR, 2012, ANN BIOMED ENG, V40, P79, DOI 10.1007/s10439-011-0400-8; GALLAGHER JP, 1987, ACTA NEUROL SCAND, V75, P145, DOI 10.1111/j.1600-0404.1987.tb07909.x; Gessel LM, 2007, J ATHL TRAINING, V42, P495; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Gurney ME, 1996, PATHOL BIOL, V44, P51; Guskiewicz Kevin M, 2003, Curr Sports Med Rep, V2, P24; Hall ED, 1998, J NEUROSCI RES, V53, P66, DOI 10.1002/(SICI)1097-4547(19980701)53:1<66::AID-JNR7>3.3.CO;2-K; Hall ED, 2011, NEUROTHERAPEUTICS, V8, P152, DOI 10.1007/s13311-011-0026-4; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Ishido M, 2004, ACTA PHYSIOL SCAND, V180, P281, DOI 10.1046/j.0001-6772.2003.01238.x; Jang YC, 2011, EXP GERONTOL, V46, P193, DOI 10.1016/j.exger.2010.08.029; Kamper JE, 2013, EXP NEUROL, V250, P8, DOI 10.1016/j.expneurol.2013.09.016; Katz DI, 1998, ARCH PHYS MED REHAB, V79, P488, DOI 10.1016/S0003-9993(98)90060-0; Kontos H A, 1986, Cent Nerv Syst Trauma, V3, P257; KURTZKE JF, 1980, NEUROLOGY, V30, P453, DOI 10.1212/WNL.30.5.453; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Martin PT, 2009, AM J PHYSIOL-CELL PH, V296, pC476, DOI 10.1152/ajpcell.00456.2008; McFadyen BJ, 2009, ARCH PHYS MED REHAB, V90, P1596, DOI 10.1016/j.apmr.2009.03.010; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Milatovic D, 2011, METHODS MOL BIOL, V758, P195, DOI 10.1007/978-1-61779-170-3_13; Morrow JD, 1999, METHOD ENZYMOL, V300, P3; Nagamoto-Combs K, 2007, J NEUROTRAUM, V24, P1719, DOI 10.1089/neu.2007.0377; O'Neil M.E., 2013, COMPLICATIONS MILD T; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Schmidt S, 2008, NEUROEPIDEMIOLOGY, V30, P191, DOI 10.1159/000126911; Schmidt S, 2010, J NEUROL SCI, V291, P22, DOI 10.1016/j.jns.2010.01.011; Slobounov S, 2008, CLIN NEUROPHYSIOL, V119, P281, DOI 10.1016/j.clinph.2007.10.006; SPAANS F, 1982, J NEUROL SCI, V57, P291, DOI 10.1016/0022-510X(82)90036-3; Wang XX, 2005, GENE DEV, V19, P1715, DOI 10.1101/gad.1318305; Ward WF, 2005, J GERONTOL A-BIOL, V60, P847, DOI 10.1093/gerona/60.7.847; Watts LT, 2013, J NEUROTRAUM, V30, P55, DOI 10.1089/neu.2012.2488; WILLIAMS DB, 1991, NEUROLOGY, V41, P1554, DOI 10.1212/WNL.41.10.1554; Winkler EA, 2014, P NATL ACAD SCI US; Wu AG, 2011, NEUROREHAB NEURAL RE, V25, P332, DOI 10.1177/1545968310397706; Yang SH, 2013, SHOCK, V40, P471, DOI 10.1097/SHK.0000000000000037; Yang SH, 2013, J SURG RES, V184, P981, DOI 10.1016/j.jss.2013.03.075; Yu FS, 2013, J NEUROSURG, V119, P766, DOI 10.3171/2013.6.JNS13135	54	11	12	1	7	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	JUL 9	2015	298						410	423		10.1016/j.neuroscience.2015.04.041			14	Neurosciences	Neurosciences & Neurology	CI5GT	WOS:000354783300032	25921732	Green Accepted			2021-06-18	
J	Palermo, S; Cauda, F; Costa, T; Duca, S; Gallino, G; Geminiani, G; Keller, R; Amanzio, M				Palermo, S.; Cauda, F.; Costa, T.; Duca, S.; Gallino, G.; Geminiani, G.; Keller, R.; Amanzio, M.			Unawareness of bipolar disorder: the role of the cingulate cortex	NEUROCASE			English	Article						fMRI; awareness deficit; remitted bipolar disorder patients; anterior cingulate cortex; response inhibition	TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; RATING-SCALE; RESPONSE-INHIBITION; EXECUTIVE FUNCTIONS; EUTHYMIC PATIENTS; SOCIAL COGNITION; SELF-AWARENESS; I DISORDER; INSIGHT	Reduced awareness of illness is a well-known phenomenon that has been understudied in remitted patients with bipolar disorder. In particular, the relationship between reduced awareness and executive dysfunction is an intriguing question that has yet to be resolved. The aim of the current study is to analyze the link between reduced awareness, brain dysfunction, and concomitant cognitive-behavioral disturbances from a neurocognitive perspective. In previous studies, we demonstrated the role of the anterior cingulate cortex (ACC) in the unawareness of distinct pathologies that exhibit overlapping symptoms in the context of overlapping circuit-specific dysfunction. Given the clinical importance of the results obtained, the present study considers six aware and four unaware remitted bipolar disorder patients. Cingulate functionality was assessed with functional magnetic resonance imaging while patients performed a go/no-go task. Patients were also studied on an overall cognitive task battery and with behavioral assessment of mood changes in terms of apathy and disinhibited behavior. Unaware patients showed frontoparietal hypo-perfusion, with a significant reduction of task-sensitive activity in the bilateral superior and middle frontal gyrus, putamen, insular, and ACCs.	[Palermo, S.; Cauda, F.; Costa, T.] Univ Turin, Dept Psychol, Turin, Italy; [Cauda, F.; Costa, T.; Duca, S.; Geminiani, G.] Koelliker Hosp, CCS fMRI, Turin, Italy; [Gallino, G.] ASL TO1, Natl Hlth Syst, Dept Mental Hlth, Turin, Italy; [Geminiani, G.; Amanzio, M.] Dept Psychol, Turin, Italy; [Geminiani, G.; Amanzio, M.] NIT, Turin, Italy; [Geminiani, G.; Amanzio, M.] Natl Inst Neurosci, Turin, Italy; [Keller, R.] ASL TO2, Natl Hlth Syst, Dept Mental Hlth, Turin, Italy	Amanzio, M (corresponding author), Dept Psychol, Turin, Italy.	martina.amanzio@unito.it	Cauda, Franco/G-5021-2010; Palermo, Sara/M-7102-2013; Amanzio, Martina/A-9085-2010	Cauda, Franco/0000-0003-1526-8475; Palermo, Sara/0000-0002-1451-3793; Amanzio, Martina/0000-0002-2504-032X; BRISCHETTO COSTA, Tommaso/0000-0002-0822-862X			Adams RB, 2010, J COGNITIVE NEUROSCI, V22, P97, DOI 10.1162/jocn.2009.21187; Amador X.F., 2004, INSIGHT PSYCHOSIS AW; AMADOR XF, 1993, AM J PSYCHIAT, V150, P873; Amador XF, 1990, SCALE ASSESS UNAWARE; Amanzio M, 2008, BRAIN LANG, V107, P1, DOI 10.1016/j.bandl.2007.08.003; Amanzio M, 2013, J INT NEUROPSYCH SOC, V19, P63, DOI 10.1017/S1355617712000896; Amanzio M, 2011, BRAIN, V134, P1061, DOI 10.1093/brain/awr020; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; BEWICK KC, 1995, NEUROREHABILITATION, V5, P367, DOI 10.3233/NRE-1995-5411; Bogod NM, 2003, J INT NEUROPSYCH SOC, V9, P450, DOI 10.1017/S1355617703930104; Braver TS, 2001, CEREB CORTEX, V11, P825, DOI 10.1093/cercor/11.9.825; Brooks JO, 2010, BIPOLAR DISORD, V12, P866, DOI 10.1111/j.1399-5618.2010.00881.x; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Carter CS, 1999, REV NEUROSCIENCE, V10, P49; Casey BJ, 1997, J COGNITIVE NEUROSCI, V9, P835, DOI 10.1162/jocn.1997.9.6.835; Colombo L., 2002, G ITAL PSICOL, V3, P613, DOI [10.1421/1256, DOI 10.1421/1256]; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; D'Agata F, 2011, NATURE PRECEDINGS; Dell'Osso L, 2000, COMPR PSYCHIAT, V41, P242, DOI 10.1053/comp.2000.7432; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Devue C, 2007, BRAIN RES, V1143, P169, DOI 10.1016/j.brainres.2007.01.055; Dias VV, 2008, ACTA PSYCHIAT SCAND, V117, P28, DOI 10.1111/j.1600-0447.2007.01110.x; Dias VV, 2008, J AFFECT DISORDERS, V110, P75, DOI 10.1016/j.jad.2008.01.010; Dimitrov M, 1999, BRAIN COGNITION, V41, P213, DOI 10.1006/brcg.1999.1121; Fernandez-Duque D, 2000, CONSCIOUS COGN, V9, P324, DOI 10.1006/ccog.2000.0449; First M.B., 1996, STRUCTURED CLIN INTE; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GAUTHIER L, 1989, INT J CLIN NEUROPSYC, V11, P49; Goldstein RZ, 2001, NEUROREPORT, V12, P2595, DOI 10.1097/00001756-200108080-00060; Guy, 1976, ECDEU ASSESSMENT MAN; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Jovanovski D, 2007, J NERV MENT DIS, V195, P165, DOI 10.1097/01.nmd.0000253765.05357.c7; KEEFE RSE, 1995, AM J PSYCHIAT, V152, P6; Koren D, 2004, SCHIZOPHR RES, V70, P195, DOI 10.1016/j.schres.2004.02.004; Koren D, 2006, SCHIZOPHRENIA BULL, V32, P310, DOI 10.1093/schbul/sbj035; LEYS D, 1989, REV NEUROL-FRANCE, V145, P443; Lezak M.D., 2004, NEUROPSYCHOLOGICAL A, Vfourth; MARIN RS, 1991, PSYCHIAT RES, V38, P143, DOI 10.1016/0165-1781(91)90040-V; MCGLYNN SM, 1989, J CLIN EXP NEUROPSYC, V11, P143, DOI 10.1080/01688638908400882; Medford N, 2010, BRAIN STRUCT FUNCT, V214, P535, DOI 10.1007/s00429-010-0265-x; Nelson HE, 1982, NATL ADULT READING T; O'Keeffe FM, 2007, BRAIN, V130, P753, DOI 10.1093/brain/awl367; O'Keeffe FM, 2004, COGNITIVE BRAIN RES, V22, P101, DOI 10.1016/j.cogbrainres.2004.07.012; Orsini A, 1997, WAIS R CONTRIBUTO TA; Ownsworth T, 2005, J HEAD TRAUMA REHAB, V20, P315, DOI 10.1097/00001199-200507000-00004; Ownsworth T, 2007, NEUROPSYCHOL REHABIL, V17, P129, DOI 10.1080/09602010600615506; Ownsworth TL, 2002, BRAIN INJURY, V16, P291, DOI 10.1080/02699050110103986; Palermo S, 2014, NEUROCASE, V20, P540, DOI 10.1080/13554794.2013.826686; Pavuluri MN, 2012, BEHAV BRAIN RES, V226, P493, DOI 10.1016/j.bbr.2011.10.003; Picard N, 1996, CEREB CORTEX, V6, P342, DOI 10.1093/cercor/6.3.342; Posner M.I., 1994, IMAGES MIND; RAICHLE ME, 1994, CEREB CORTEX, V4, P8, DOI 10.1093/cercor/4.1.8; REITAN RM, 1994, NEUROPSYCHOL REV, V4, P161, DOI 10.1007/BF01874891; Robinson LJ, 2006, J AFFECT DISORDERS, V93, P105, DOI 10.1016/j.jad.2006.02.016; Roncone R, 1999, ACTA PSYCHIAT SCAND, V100, P229, DOI 10.1111/j.1600-0447.1999.tb10850.x; Samame C, 2012, ACTA PSYCHIAT SCAND, V125, P266, DOI 10.1111/j.1600-0447.2011.01808.x; Sartori G., 1995, PROFESSIONE PSICOLOG, V4, P1; Shackman AJ, 2011, NAT REV NEUROSCI, V12, P154, DOI 10.1038/nrn2994; SPINNLER H, 1987, ITALIAN J NEUROLOGIC, V6; STARKSTEIN SE, 1995, J NEUROL NEUROSUR PS, V59, P55, DOI 10.1136/jnnp.59.1.55; Strakowski SM, 2005, AM J PSYCHIAT, V162, P1697, DOI 10.1176/appi.ajp.162.9.1697; Torres IJ, 2007, ACTA PSYCHIAT SCAND, V116, P17, DOI 10.1111/j.1600-0447.2007.01055.x; Trevisi M, 2012, PSYCHOPATHOLOGY, V45, P235, DOI 10.1159/000329998; Varga M, 2006, J AFFECT DISORDERS, V91, P1, DOI 10.1016/j.jad.2005.09.002; Ventura J, 1993, INT J METH PSYCH RES, V3, P227; Vogt BA, 2005, NAT REV NEUROSCI, V6, P533, DOI 10.1038/nrn1704; Vuilleumier P, 2004, CORTEX, V40, P9, DOI 10.1016/S0010-9452(08)70918-3; Wechsler D., 1981, WAIS R SCALA INTELLI; Wechsler D., 1945, WECHSLER MEMORY SCAL; Wilson BA, 1996, BEHAV ASSESSMENT DYS; Yen CF, 2002, J NERV MENT DIS, V190, P847, DOI 10.1097/00005053-200212000-00008; Yen CF, 2008, J AFFECT DISORDERS, V108, P121, DOI 10.1016/j.jad.2007.10.004; YOUNG RC, 1978, BRIT J PSYCHIAT, V133, P429, DOI 10.1192/bjp.133.5.429	74	11	11	0	14	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXFORDSHIRE, ENGLAND	1355-4794	1465-3656		NEUROCASE	Neurocase	JUL 4	2015	21	4					438	447		10.1080/13554794.2014.917682			10	Clinical Neurology; Psychiatry; Psychology	Neurosciences & Neurology; Psychiatry; Psychology	CG6IN	WOS:000353403300005	24837443				2021-06-18	
J	Barker-Collo, S; Jones, A; Jones, K; Theadom, A; Dowell, A; Starkey, N; Feigin, VL				Barker-Collo, S.; Jones, A.; Jones, K.; Theadom, A.; Dowell, A.; Starkey, N.; Feigin, V. L.		BIONIC Res Grp	Prevalence, natural course and predictors of depression 1 year following traumatic brain injury from a population-based study in New Zealand	BRAIN INJURY			English	Article						Depression; population-based; traumatic; brain injury	MAJOR DEPRESSION; HOSPITAL ANXIETY; RISK-FACTORS; HEAD-INJURY; SCALE; MANAGEMENT; DIAGNOSIS; MODERATE; OUTCOMES; ADULTS	Objective: Depression is common post-TBI, yet has not been studied longitudinally, nor at a population level. This study examined prevalence of depression in a population-based sample across the first year post-TBI. Design and methods: Prospective follow-up of 315 adults (>16 years) with assessments (Hospital Anxiety Depression Scale, DSM-IV criteria) at 1-, 6- and 12-months post-TBI. Demographic and injury-related predictors of depression at 1-year post-TBI were also explored. Results: The number of individuals identified as depressed reduced significantly between baseline and 12-months post-TBI from 21-12.4% using the HADS and 49-34% using DSM-IV criteria; with only 10 of the 28 individuals initially meeting criteria on the HADS continuing to do so at 12-month follow-up. Meeting HADS depression criteria was linked to pre-morbid depression and/or anxiety; while those meeting DSM-IV criteria were older, but not significantly so. Conclusions: The findings suggest depression is common post-TBI and that clinicians/researchers use caution in its diagnosis, as existing criteria have significant overlap with common TBI sequels.	[Barker-Collo, S.] Univ Auckland, Fac Sci, Sch Psychol, Auckland 1141, New Zealand; [Jones, A.; Jones, K.; Theadom, A.; Feigin, V. L.] Auckland Univ Technol, Sch Rehabil & Occupat Studies, Natl Inst Stroke & Appl Neurosci, Auckland, New Zealand; [Dowell, A.] Univ Otago, Dept Primary Hlth Care & Gen Practice, Wellington, New Zealand; [Starkey, N.] Univ Waikato, Fac Sci, Sch Psychol, Hamilton, New Zealand	Barker-Collo, S (corresponding author), Univ Auckland, Fac Sci, Sch Psychol, Private Bag 92019, Auckland 1141, New Zealand.	s.barker-collo@auckland.ac.nz	Feigin, Valery/AAF-2313-2019; Jones, Kelly/I-5199-2019; Starkey, Nicola/AAJ-3795-2020	Starkey, Nicola/0000-0002-4370-8186; Feigin, Valery L./0000-0002-6372-1740; Theadom, Alice/0000-0003-0351-6216	New Zealand Health Research CouncilHealth Research Council of New Zealand	The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper. This study was funded by the New Zealand Health Research Council.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Barker-Collo S, 2013, BRAIN INJURY, V27, P1124, DOI 10.3109/02699052.2013.801513; Bay E, 2008, BRAIN INJURY, V22, P233, DOI 10.1080/02699050801953073; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Feinstein A, 2001, MED SCI LAW, V41, P116, DOI 10.1177/002580240104100206; GOLDSTEIN M, 1990, ANN NEUROL, V27, P327, DOI 10.1002/ana.410270315; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Hibbird MR, 1998, AM J PSYCHIAT, V156, P374; Holsinger T, 2002, ARCH GEN PSYCHIAT, V59, P17, DOI 10.1001/archpsyc.59.1.17; Inzaghi M G, 2005, Eura Medicophys, V41, P265; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Levin HS, 2005, ARCH GEN PSYCHIAT, V62, P523, DOI 10.1001/archpsyc.62.5.523; Marsh NV, 2002, J CLIN EXP NEUROPSYC, V24, P434, DOI 10.1076/jcen.24.4.434.1030; Mooney G, 2001, BRAIN INJURY, V15, P865, DOI 10.1080/02699050110065286; National Institute of Health, 2002, TRAUM BRAIN INJ HOP; Ozanne-Smith J, 2004, AUST NZ J PUBL HEAL, V28, P109, DOI 10.1111/j.1467-842X.2004.tb00921.x; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Rao V, 2010, J NEUROPSYCH CLIN N, V22, P100, DOI 10.1176/appi.neuropsych.22.1.100; Rapoport MJ, 2012, CNS DRUGS, V26, P111, DOI 10.2165/11599560-000000000-00000; Rapoport MJ, 2003, PSYCHOSOMATICS, V44, P31, DOI 10.1176/appi.psy.44.1.31; Seel RT, 2010, J HEAD TRAUMA REHAB, V25, P99, DOI 10.1097/HTR.0b013e3181ce3966; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; Servadei F, 2001, J NEUROTRAUM, V18, P657, DOI 10.1089/089771501750357609; TEASDALE G, 1974, LANCET, V2, P81; Theadom A, 2012, NEUROEPIDEMIOLOGY, V38, P18, DOI 10.1159/000334746; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	33	11	13	0	8	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL	2015	29	7-8					859	865		10.3109/02699052.2015.1004759			7	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	CO0BJ	WOS:000358814800010	25914943				2021-06-18	
J	Chen, PY; Tsai, PS; Chen, NH; Chaung, LP; Lee, CC; Chen, CC; Chiu, HT; Lu, YJ; Wei, KC; Chiu, HY				Chen, Pin-Yuan; Tsai, Pei-Shan; Chen, Ning-Hung; Chaung, Li-Pang; Lee, Cheng-Chi; Chen, Ching-Chang; Chiu, Hsiao-Ting; Lu, Yu-Jen; Wei, Kuo-Chen; Chiu, Hsiao-Yean			Trajectories of Sleep and Its Predictors in the First Year Following Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article							CIRCADIAN-RHYTHMS; INVENTORY-II; DISTURBANCES; INSOMNIA; PREVALENCE; ACTIGRAPHY; PAIN; METAANALYSIS; COMPLAINTS; DISORDERS	Objectives: To examine how sleep patterns change over the first year following traumatic brain injury (TBI) and to determine whether specific demographic and disease characteristics predict the trajectories of sleep. Design: Prospective study. Participants: Fifty-three patients with first-ever mild to severe TBI. Main Measurements: Sleep measured by actigraphy for 7 consecutive days in the first, third, sixth, and twelfth months following TBI: Chinese versions of Beck Anxiety Inventory and Beck Depression Inventory-II (CBDI-II) measured at the same time points. Data were analyzed with a linear mixed model. Results: Sleep efficiency (the ratio of sleep time to the total time spent in bed) showed a significant upward trend during the study period. Scores on the Chinese version of the Beck Anxiety Inventory and the CBDI-II as well as the use of analgesics significantly predicted the slope of change in sleep efficiency over time. Conclusions: Poor sleep efficiency is a common symptom in the first year among patients with first-ever TBI. Healthcare providers should consider both mental health and pain issues when dealing with sleep complaints in patients with TBI.	[Tsai, Pei-Shan; Chiu, Hsiao-Ting; Chiu, Hsiao-Yean] Taipei Med Univ, Grad Inst Nursing, Coll Nursing, Taipei 110, Taiwan; [Chaung, Li-Pang] Chang Gung Mem Hosp, Dept Pulm & Crit Care Med, Sleep Ctr, Taoyuan, Taiwan; [Lee, Cheng-Chi; Lu, Yu-Jen; Wei, Kuo-Chen] Chang Gung Mem Hosp, Dept Neurosurg, Taoyuan, Taiwan; Taoyuan Gen Hosp, Minist Hlth & Welf, Sinwu Branch, Dept Phys Med & Rehabil, Taoyuan, Taiwan	Chiu, HY (corresponding author), Taipei Med Univ, Grad Inst Nursing, Coll Nursing, 250 Wu Hsing St, Taipei 110, Taiwan.	happyone680315@hotmail.com			Ministry of Science and Technology, TaiwanMinistry of Science and Technology, Taiwan [NSC 99-2314-B-182A-047-MY2]	This research was supported by a grant (NSC 99-2314-B-182A-047-MY2) from the Ministry of Science and Technology, Taiwan.	Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342; Arnau RC, 2001, HEALTH PSYCHOL, V20, P112, DOI 10.1037//0278-6133.20.2.112; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Beck A.T., 1993; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Beetar JT, 1996, ARCH PHYS MED REHAB, V77, P1298, DOI 10.1016/S0003-9993(96)90196-3; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Chan D. W., 1991, PSYCHOL ASSESSMENT J, V3, P616, DOI [10.1037/1040-3590.3.4.616, DOI 10.1037/1040-3590.3.4.616]; Chaput G, 2009, SLEEP MED, V10, P713, DOI 10.1016/j.sleep.2008.07.015; Che H-H., 2006, FORMOSA J MED, V10, P447; Chiu HY, 2013, J FORMOS MED ASSOC, V112, P545, DOI 10.1016/j.jfma.2013.06.007; Fichtenberg NL, 2000, BRAIN INJURY, V14, P659; Fichtenberg NL, 2002, BRAIN INJURY, V16, P197, DOI 10.1080/02699050110103940; Fogelberg DJ, 2012, ARCH PHYS MED REHAB, V93, P1313, DOI 10.1016/j.apmr.2012.04.031; Guilleminault C, 2000, NEUROLOGY, V54, P653, DOI 10.1212/WNL.54.3.653; Kempf J, 2010, J NEUROL NEUROSUR PS, V81, P1402, DOI 10.1136/jnnp.2009.201913; Khoury S, 2013, J NEUROTRAUM, V30, P633, DOI 10.1089/neu.2012.2519; Lavigne GJ, 2011, CURR RHEUMATOL REP, V13, P535, DOI 10.1007/s11926-011-0209-3; Makley MJ, 2008, NEUROREHAB NEURAL RE, V22, P341, DOI 10.1177/1545968308315598; Makley MJ, 2009, NEUROREHAB NEURAL RE, V23, P320, DOI 10.1177/1545968308325268; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Ohayon MM, 2004, SLEEP, V27, P1255, DOI 10.1093/sleep/27.7.1255; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Parcell DL, 2006, ARCH PHYS MED REHAB, V87, P278, DOI 10.1016/j.apmr.2005.10.024; Rao V, 2008, BRAIN INJURY, V22, P381, DOI 10.1080/02699050801935260; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; Saper CB, 2005, J COMP NEUROL, V493, P92, DOI 10.1002/cne.20770; Verma A, 2007, J CLIN SLEEP MED, V3, P357; Watson NF, 2007, J CLIN SLEEP MED, V3, P363; West B. T., 2007, LINEAR MIXED MODELS; Zeitzer JM, 2009, J REHABIL RES DEV, V46, P827, DOI 10.1682/JRRD.2008.08.0099; Zollman FS, 2010, BRAIN INJURY, V24, P748, DOI 10.3109/02699051003692167	32	11	11	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2015	30	4					E50	E55		10.1097/HTR.0000000000000086			6	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	CM8JB	WOS:000357944800006	25119653				2021-06-18	
J	Kankipati, P; Boninger, ML; Gagnon, D; Cooper, RA; Koontz, AM				Kankipati, Padmaja; Boninger, Michael L.; Gagnon, Dany; Cooper, Rory A.; Koontz, Alicia M.			Upper limb joint kinetics of three sitting pivot wheelchair transfer techniques in individuals with spinal cord injury	JOURNAL OF SPINAL CORD MEDICINE			English	Article						Activities of daily living; Secondary impairments; Biomechanics; Rehabilitation; Shoulder pain	CARPAL-TUNNEL SYNDROME; PARAPLEGIC PATIENTS; MEASUREMENT SYSTEM; KINEMATICS; SHOULDER; INDEPENDENCE; PATHOLOGY; MOTION; TRUNK; USERS	Study design: Repeated measures design. Objective: This study compared the upper extremity (UE) joint kinetics between three transfer techniques. Setting: Research laboratory. Methods: Twenty individuals with spinal cord injury performed three transfer techniques from their wheelchair to a level tub bench. Two of the techniques involved a head-hips method with leading hand position close (HH-I) and far (HH-A) from the body, and the third technique with the trunk upright (TU) and hand far from body. Motion analysis equipment recorded upper body movements and force sensors recorded their hand and feet reaction forces during the transfers. Results: Several significant differences were found between HH-A and HH-I and TU and HH-I transfers indicating that hand placement was a key factor influencing the UE joint kinetics. Peak resultant hand, elbow, and shoulder joint forces were significantly higher for the HH-A and TU techniques at the trailing arm (P < 0.036) and lower at the leading arm (P < 0.021), compared to the HH-I technique. Conclusion: Always trailing with the same arm if using HH-A or TU could predispose that arm to overuse related pain and injuries. Technique training should focus on initial hand placement close to the body followed by the amount of trunk flexion needed to facilitate movement.	[Kankipati, Padmaja; Boninger, Michael L.; Cooper, Rory A.; Koontz, Alicia M.] Dept Vet Affairs, Human Engn Res Labs, Pittsburgh, PA 15240 USA; [Kankipati, Padmaja; Cooper, Rory A.; Koontz, Alicia M.] Univ Pittsburgh, Dept Rehabil Sci & Technol, Pittsburgh, PA USA; [Boninger, Michael L.] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA USA; [Gagnon, Dany] Ctr Interdisciplinary Res Rehabil Greater Montrea, Pathokinesiol Lab, Inst Readaptat Gingras Lindsay de Montreal, Montreal, PQ, Canada; [Gagnon, Dany] Univ Montreal, Sch Rehabil, Montreal, PQ, Canada	Koontz, AM (corresponding author), Dept Vet Affairs, Human Engn Res Labs, 6425 Penn Ave, Pittsburgh, PA 15240 USA.	akoontz@pitt.edu		Boninger, Michael/0000-0001-6966-919X	VA Rehabilitation Research RD Services; National Institute on Disability and Rehabilitation Research; National Institute of Health (VA-RRD) [E3589V, B3079R]; National Institute of Health (NIDRR) [H133A011107]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG024827] Funding Source: NIH RePORTER	The funding for this study was provided by the VA Rehabilitation Research R&D Services and the National Institute on Disability and Rehabilitation Research and the National Institute of Health (VA-RR&D E3589V and B3079R NIDRR H133A011107).	ALJURE J, 1985, PARAPLEGIA, V23, P182, DOI 10.1038/sc.1985.31; Allison GT, 1996, DISABIL REHABIL, V18, P35, DOI 10.3109/09638289609167087; Allison GT, 1997, SPINAL CORD, V35, P217, DOI 10.1038/sj.sc.3100393; BURNHAM RS, 1994, ARCH PHYS MED REHAB, V75, P519; Cooper RA, 1999, AM J PHYS MED REHAB, V78, P435, DOI 10.1097/00002060-199909000-00006; Desroches G, 2013, CLIN BIOMECH, V28, P1, DOI 10.1016/j.clinbiomech.2012.11.001; FARLEY TE, 1994, SKELETAL RADIOL, V23, P641, DOI 10.1007/BF02580386; Gagnon D, 2003, CLIN BIOMECH, V18, P319, DOI 10.1016/S0268-0033(03)00016-0; Gagnon D., 2009, TOPICS SPINAL CORD I, V15, P33, DOI DOI 10.1310/SCI1502-33; Gagnon D, 2008, J REHABIL RES DEV, V45, P863, DOI 10.1682/JRRD.2007.11.0189; Gagnon D, 2008, J REHABIL MED, V40, P468, DOI 10.2340/16501977-0192; Gagnon D, 2008, CLIN BIOMECH, V23, P279, DOI 10.1016/j.clinbiomech.2007.09.017; Gagnon D, 2009, J REHABIL RES DEV, V46, P1099, DOI 10.1682/JRRD.2009.02.0012; GELLMAN H, 1988, J BONE JOINT SURG AM, V70A, P517, DOI 10.2106/00004623-198870040-00006; HANAVAN E P Jr, 1964, AMRL TR, P1; Kankipati P, 2011, 35 ANN M AM SOC BIOM; Koontz AM, 2011, J REHABIL RES DEV, V48, P1015, DOI 10.1682/JRRD.2010.09.0169; Koontz AM, 2011, CLIN BIOMECH, V26, P923, DOI 10.1016/j.clinbiomech.2011.05.005; Mercer JL, 2006, CLIN BIOMECH, V21, P781, DOI 10.1016/j.clinbiomech.2006.04.010; Minkel J. L., 2010, P 4 INT INT C POST W; Nyland J, 2000, SPINAL CORD, V38, P649, DOI 10.1038/sj.sc.3101070; Papuga M, 2004, THESIS CASE W RESERV; Paralyzed Veterans of America Consortium for Spinal Cord Medicine, 2005, J Spinal Cord Med, V28, P434; PENTLAND WE, 1994, PARAPLEGIA, V32, P211, DOI 10.1038/sc.1994.40; Requejo P., 2008, TOPICS SPINAL CORD I, V13, P86; SIE IH, 1992, ARCH PHYS MED REHAB, V73, P44; Somers M., 2001, SPINAL CORD INJURY F; Tanimoto Y, 2008, IEEE T INSTRUM MEAS, V57, P213, DOI 10.1109/TIM.2007.909501; TUN CG, 1988, J HAND SURG-AM, V13A, P716, DOI 10.1016/S0363-5023(88)80132-1; Winter D.A., 1990, BIOMECHANICS MOTOR C, V2nd; Wu G, 2005, J BIOMECH, V38, P981, DOI 10.1016/j.jbiomech.2004.05.042; Yarnall M, 2005, P 28 ANN RESNA C 200	32	11	12	0	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1079-0268	2045-7723		J SPINAL CORD MED	J. Spinal Cord. Med.	JUL	2015	38	4					485	497		10.1179/2045772314Y.0000000258			13	Clinical Neurology	Neurosciences & Neurology	CL4RS	WOS:000356941800011	25130053	Green Published			2021-06-18	
J	Shahim, P; Mattsson, N; Macy, EM; Crimmins, DL; Ladenson, JH; Zetterberg, H; Blennow, K; Tegner, Y				Shahim, Pashtun; Mattsson, Niklas; Macy, Elizabeth M.; Crimmins, Dan L.; Ladenson, Jack H.; Zetterberg, Henrik; Blennow, Kaj; Tegner, Yelverton			Serum visinin-like protein-1 in concussed professional ice hockey players	BRAIN INJURY			English	Article						Biomarker; brain injury; concussion; ice hockey; VILIP-1	BRAIN-INJURY; INTERNATIONAL-CONFERENCE; CEREBROSPINAL-FLUID; OVEREXPRESSION; BIOMARKERS; STATEMENT; SPORT	Primary objective: Visinin-like protein-1 (VILIP-1) has shown potential utility as a biomarker for neuronal injury in cerebrospinal fluid. This study investigated serum VILIP-1 as a diagnostic and prognostic marker in sports-related concussion. Methods: This multi-centre prospective cohort study involved the 12 teams of the professional ice hockey league in Sweden. A total of 288 players consented to participate in the study. Thirty-five players sustained concussions, of whom 28 underwent repeated blood samplings at 1, 12, 36 and 144 hours after the trauma or when the player returned to play (7-90+ days). Main outcomes and results: The highest levels of VILIP-1 were measured 1 hour after concussion and the levels decreased during rehabilitation, reaching a minimum level at the 36-hour sampling. However, the levels of serum VILIP-1 at 1 hour after concussion were not significantly higher than pre-season baseline values. Serum levels of VILIP-1 1 hour post-concussion did not correlate with-the number of days for the concussion symptoms to resolve. Further, serum levels of VILIP-1 increased after a friendly game in players who were not concussed. Conclusions: These results provide evidence that serum VILIP-1 may not be a useful biomarker for diagnosis and prognosis of sports-related concussion.	[Shahim, Pashtun; Mattsson, Niklas; Zetterberg, Henrik; Blennow, Kaj] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Clin Neurochem Lab,Sahlgrenska Univ Hosp, SE-43180 Molndal, Sweden; [Mattsson, Niklas] Univ Calif San Francisco, Ctr Imaging Neurodegenerat Dis, Dept Vet Affairs Med Ctr, San Francisco, CA 94143 USA; [Macy, Elizabeth M.; Crimmins, Dan L.; Ladenson, Jack H.] Washington Univ, Sch Med, Dept Pathol & Immunol, Div Lab & Genom Med, St Louis, MO USA; [Zetterberg, Henrik] UCL Inst Neurol, Dept Mol Neurosci, London, England; [Zetterberg, Henrik] UCL Inst Neurol, Reta Lila Weston Labs, London, England; [Tegner, Yelverton] Lulea Univ Technol, Dept Hlth Sci, Div Med Sci, S-95187 Lulea, Sweden	Shahim, P (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Clin Neurochem Lab,Sahlgrenska Univ Hosp, SE-43180 Molndal, Sweden.	pashtun.shahim@neuro.gu.se	Mattsson-Carlgren, Niklas/H-7597-2019	Mattsson-Carlgren, Niklas/0000-0002-8885-7724; Tegner, Yelverton/0000-0003-3628-0705	Swedish Research CouncilSwedish Research CouncilEuropean Commission; Knut and Alice Wallenberg FoundationKnut & Alice Wallenberg Foundation; Centrum for Idrottsforskning; Emil and Maria Palm Foundation	The authors report no conflicts of interest. The study was supported by grants from the Swedish Research Council, the Knut and Alice Wallenberg Foundation, Centrum for Idrottsforskning and the Emil and Maria Palm Foundation.	Akagi T, 2012, INT J CANCER, V131, P1307, DOI 10.1002/ijc.27341; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Braunewell KH, 2009, CELL TISSUE RES, V335, P301, DOI 10.1007/s00441-008-0716-3; Buttgereit J, 2010, REGUL PEPTIDES, V161, P51, DOI 10.1016/j.regpep.2009.12.019; Dai FHF, 2006, J BIOL CHEM, V281, P21942, DOI 10.1074/jbc.M512924200; Laterza OF, 2006, CLIN CHEM, V52, P1713, DOI 10.1373/clinchem.2006.070912; Lee JM, 2008, CLIN CHEM, V54, P1617, DOI 10.1373/clinchem.2008.104497; Mahloogi H, 2003, CANCER RES, V63, P4997; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Neselius S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081249; Neselius S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033606; Randall J, 2013, RESUSCITATION, V84, P351, DOI 10.1016/j.resuscitation.2012.07.027; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Stejskal D, 2011, BIOMED PAP, V155, P263, DOI 10.5507/bp.2011.049; Tarawneh R, 2012, NEUROLOGY, V78, P709, DOI 10.1212/WNL.0b013e318248e568; Tarawneh R, 2011, ANN NEUROL, V70, P274, DOI 10.1002/ana.22448; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9	18	11	11	0	11	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL	2015	29	7-8					872	876		10.3109/02699052.2015.1018324			5	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	CO0BJ	WOS:000358814800012	25955117				2021-06-18	
J	Winter, C; Bell, C; Whyte, T; Cardinal, J; Macfarlane, D; Rose, S				Winter, Craig; Bell, Christopher; Whyte, Timothy; Cardinal, John; Macfarlane, David; Rose, Stephen			Blood-brain barrier dysfunction following traumatic brain injury: correlation of K-trans (DCE-MRI) and SUVR (99mTc-DTPA SPECT) but not serum S100B	NEUROLOGICAL RESEARCH			English	Article						Blood-brain barrier; 99mTc-DTPA SPECT; S100B; Traumatic brain injury; DCE-MRI	PROTEIN; PERMEABILITY; S100-BETA; MARKER; DISRUPTION; BREAKDOWN; RELEASE; LEAKAGE; DAMAGE	Objective: Damage to the blood-brain barrier (BBB) is an important secondary mechanism that occurs following traumatic brain injury (TBI) and may provide a potential therapeutic target to improve patient outcome. For such a progress to be realised, an accurate assessment of BBB compromise needs to be established. Methods: Fourteen patients with TBI were prospectively recruited. Post-traumatic BBB dysfunction was assessed using dynamic contrast-enhanced MRI (DCE-MRI), single-photon emission computerised tomography (SPECT) and serum S100B levels. Results: A statistically significant correlation between standardised uptake value ratio (SUVR) calculated from 99mTc-DTPA SPECT and K-trans (a volume transfer constant) from DCE-MRI was found for those eight patients who had concurrent scans. The positive correlation persisted when the data were corrected for patient age, number of days following trauma and both parameters combined. We found no statistically significant correlation between either of the imaging modalities and concurrent serum S100B levels. Discussion: The correlation of SPECT with DCE-MRI suggests that either scan may be used to assess post-traumatic BBB damage. We could not support serum S100B to be an accurate measure of BBB damage when sampled a number of days following injury but the small number of patients, the heterogeneity in TBI patients and the delay following injury makes any firm conclusions regarding S100B and BBB difficult.	[Winter, Craig; Whyte, Timothy] Royal Brisbane & Womens Hosp, Kenneth Jamieson Dept Neurosurg, Herston, Qld 4029, Australia; [Winter, Craig; Bell, Christopher] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Bell, Christopher; Rose, Stephen] CSIRO, Computat Informat, Royal Brisbane & Womens Hosp, Herston, Qld, Australia; [Cardinal, John] Royal Brisbane & Womens Hosp, Dept Chem Pathol, Herston, Qld, Australia; [Macfarlane, David] Royal Brisbane & Womens Hosp, Dept Nucl Med, Herston, Qld, Australia	Winter, C (corresponding author), Royal Brisbane & Womens Hosp, Kenneth Jamieson Dept Neurosurg, Level 7,Ned Hanlon Bldg,Butterfield St, Herston, Qld 4029, Australia.	craigdw1@gmail.com	Rose, Stephen/C-8044-2009		Neurosurgical Trust Fund at the Royal Brisbane and Women's Hospital	Neurosurgical Trust Fund at the Royal Brisbane and Women's Hospital.	Armitage PA, 2011, MAGN RESON IMAGING, V29, P305, DOI 10.1016/j.mri.2010.09.002; BARGER SW, 1992, J BIOL CHEM, V267, P9689; Bazarian JJ, 2013, J NEUROTRAUM, V30, P1747, DOI 10.1089/neu.2013.2853; Bezerra FJ, 2014, NEUROL RES, V36, P847, DOI 10.1179/1743132814Y.0000000341; Bloomfield SM, 2007, NEUROCRIT CARE, V6, P121, DOI 10.1007/s12028-007-0008-x; Blyth BJ, 2009, J NEUROTRAUM, V26, P1497, DOI [10.1089/neu.2008.0738, 10.1089/neu.2008-0738]; BULLOCK R, 1990, ACT NEUR S, V51, P286; Cha S, 2006, AM J NEURORADIOL, V27, P409; Cohen DM, 2009, NMR BIOMED, V22, P332, DOI 10.1002/nbm.1343; Cotton BA, 2007, SHOCK, V27, P338, DOI 10.1097/01.shk.0000239756.59841.29; de Kruijk JR, 2001, ACTA NEUROL SCAND, V103, P175, DOI 10.1034/j.1600-0404.2001.103003175.x; Delgado P, 2006, STROKE, V37, P2837, DOI 10.1161/01.STR.0000245085.58807.ad; Duru S, 2012, NEUROL NEUROCHIR POL, V46, P450, DOI 10.5114/ninp.2012.31355; Ghanem G, 2001, INT J CANCER, V94, P586, DOI 10.1002/ijc.1504; Gilad R, 2012, J NEUROL, V259, P2041, DOI 10.1007/s00415-012-6445-2; Gowda NK, 2006, AM J NEURORADIOL, V27, P447; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jonsson H, 2000, J CARDIOTHOR VASC AN, V14, P698, DOI 10.1053/jcan.2000.18444; Kanner AA, 2003, CANCER, V97, P2806, DOI 10.1002/cncr.11409; Kapural M, 2002, BRAIN RES, V940, P102, DOI 10.1016/S0006-8993(02)02586-6; Kleindienst A, 2005, J NEUROTRAUM, V22, P645, DOI 10.1089/neu.2005.22.645; Kleindienst A, 2006, J NEUROTRAUM, V23, P1185, DOI 10.1089/neu.2006.23.1185; Korn A, 2005, J CLIN NEUROPHYSIOL, V22, P1, DOI 10.1097/01.WNP.0000150973.24324.A7; Lin AP, 2012, BRAIN IMAGING BEHAV, V6, P208, DOI 10.1007/s11682-012-9181-4; Liu HS, 2013, STROKE, V44, P1872, DOI 10.1161/STROKEAHA.113.001558; Lorberboym M, 2003, J NUCL MED, V44, P1898; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marchi N, 2003, RESTOR NEUROL NEUROS, V21, P109; Marchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056805; Marks W, 2006, Neuroradiol J, V19, P569; Masdeu JC, 2008, SEMIN NEUROL, V28, P423, DOI 10.1055/s-0028-1083683; McArthur C, 2011, CLIN RADIOL, V66, P651, DOI 10.1016/j.crad.2010.12.015; Mock C, 2004, LANCET, V363, P2172, DOI 10.1016/S0140-6736(04)16510-0; Murillo-Cabezas F, 2010, BRAIN INJURY, V24, P609, DOI 10.3109/02699051003652823; Nag S, 2011, NEUROPATH APPL NEURO, V37, P3, DOI 10.1111/j.1365-2990.2010.01138.x; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Petzold A, 2003, BRAIN RES BULL, V61, P281, DOI 10.1016/S0361-9230(03)00091-1; Raji CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091088; Reiber H, 2001, J NEUROL SCI, V184, P101, DOI 10.1016/S0022-510X(00)00501-3; Romner B, 2000, J NEUROTRAUM, V17, P641, DOI 10.1089/089771500415391; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Thelin EP, 2014, NEUROCRIT CARE, V20, P217, DOI 10.1007/s12028-013-9916-0; Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S; TOFTS PS, 1991, MAGNET RESON MED, V17, P357, DOI 10.1002/mrm.1910170208; Wei XE, 2014, NEUROL SCI, V35, P295, DOI 10.1007/s10072-013-1514-6; Winter C, 2013, WORLD J NEUROSCI, V3, P93; Zhang N, 2012, J MAGN RESON IMAGING, V36, P355, DOI 10.1002/jmri.23675; ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2	48	11	12	0	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	JUL	2015	37	7					599	606		10.1179/1743132815Y.0000000018			8	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CJ7FI	WOS:000355659500006	25749458				2021-06-18	
J	Yousuf, A; Khursheed, N; Rasool, I; Kundal, V; Jeelani, H; Afroze, D				Yousuf, Adfar; Khursheed, Nayil; Rasool, Ishrat; Kundal, Vijay; Jeelani, Humira; Afroze, Dil			Genetic Variation of ApoE Gene in Ethnic Kashmiri Population and Its Association with Outcome After Traumatic Brain Injury	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						Traumatic brain injury; Genotyping; Apolipoprotein E; PCR-RFLP	APOLIPOPROTEIN-E POLYMORPHISM; E GENOTYPE; MODERATE; E4; DISEASE; LIPIDS; E3	The outcome from traumatic brain injury (TBI) is variable and only partly explained by known prognostic factors. Genetic factors may influence the brain's susceptibility to injury or capacity for repair and regeneration. ApoE has been implicated in modifying neurological outcome after TBI, although the mechanisms by which this occurs remain poorly defined. Apolipoprotein E is an apparently multifunctional protein involved in the response of the brain to injury and in subsequent repair processes. Several studies have shown that patients with APOE e4 have a poorer outcome after TBI. This study was aimed to analyse the genotypes of ApoE in Kashmiri population and to examine the association of APOE genotype with outcome after TBI. A total of 450 subjects (300 healthy controls and 150 TBI patients) were recruited for the study. Genotyping was done by PCR-restriction fragment length polymorphism (RFLP).Our study indicated Apoe3/e3 to be the most common genotype in this study group. The allele frequency of the Apo E gene in these study subjects was observed to be 0.07 for the e2 allele, 0.82 for the e3 allele and 0.11 for the e4 allele. However, no association between the presence of APOe4 allele and outcome after head injury was observed in this study [p = 0.92]. Thus, genotype containing the e4 allele (e4/e3 and e4/e4) was not associated with unfavourable outcome after TBI in Kashmiri population.	[Yousuf, Adfar; Afroze, Dil] Sherikashmir Inst Med Sci, Dept Immunol & Mol Med, Srinagar, Jammu & Kashmir, India; [Khursheed, Nayil; Kundal, Vijay] Sherikashmir Inst Med Sci, Dept Neurosurg, Srinagar, Jammu & Kashmir, India; [Rasool, Ishrat] Amity Univ, Dept Virol & Immunol, Noida, UP, India; [Jeelani, Humira] Univ Kashmir, Dept Biochem, Srinagar 190006, Jammu & Kashmir, India	Afroze, D (corresponding author), Sherikashmir Inst Med Sci, Dept Immunol & Mol Med, Srinagar, Jammu & Kashmir, India.	afrozedil@gmail.com		KUNDAL, VIJAY KUMAR/0000-0003-0348-5173			Adamson MM, 2011, NEUROPSYCHOLOGIA, V49, P2448, DOI 10.1016/j.neuropsychologia.2011.04.022; Andersson EH, 2003, ACTA NEUROL SCAND, V107, P256, DOI 10.1034/j.1600-0404.2003.00112.x; Ariza M, 2006, J NEUROL NEUROSUR PS, V77, P1191, DOI 10.1136/jnnp.2005.085167; BELLOSTA S, 1995, J BIOL CHEM, V270, P27063, DOI 10.1074/jbc.270.45.27063; Brichtova E, 2008, CHILD NERV SYST, V24, P349, DOI 10.1007/s00381-007-0459-6; Chamelian L, 2004, BRAIN, V127, P2621, DOI 10.1093/brain/awh296; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; Crawford FC, 2002, NEUROLOGY, V58, P1115, DOI 10.1212/WNL.58.7.1115; DAS HK, 1985, J BIOL CHEM, V260, P6240; Djan I, 2011, ARCH BIOL SCI, V63, P89, DOI 10.2298/ABS1101089D; Eichner JE, 2002, AM J EPIDEMIOL, V155, P487, DOI 10.1093/aje/155.6.487; EVANS AE, 1993, HUM GENET, V92, P191; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; GAJRA B, 1994, GENET EPIDEMIOL, V11, P19, DOI 10.1002/gepi.1370110103; GAJRA B, 1994, HUM HERED, V44, P209, DOI 10.1159/000154219; Gennarelli T. A., 1998, SEM CLIN NEUR, V3, P160; GERDES LU, 1992, GENET EPIDEMIOL, V9, P155, DOI 10.1002/gepi.1370090302; Gururaj G, 2008, NATL MED J INDIA, V21, P14; HALLMAN DM, 1991, AM J HUM GENET, V49, P338; Hiekkanen H, 2009, BRAIN INJURY, V23, P396, DOI 10.1080/02699050902926259; Horsburgh K, 2000, NEUROBIOL AGING, V21, P245, DOI 10.1016/S0197-4580(00)00097-X; Ilveskoski E, 1999, CIRCULATION, V100, P608, DOI 10.1161/01.CIR.100.6.608; Jainh Y, 2006, NEUROSCI LETT, V408, P155; Kamboh MI, 1996, HUM BIOL, V68, P231; Liaquat I, 2002, J NEUROSURG, V96, P90, DOI 10.3171/jns.2002.96.1.0090; Mehta KM, 1999, NEUROLOGY, V53, P1959, DOI 10.1212/WNL.53.9.1959; Moran LM, 2009, J NEUROTRAUM, V26, P1489, DOI 10.1089/neu.2008.0767; NATHAN BP, 1994, SCIENCE, V264, P850, DOI 10.1126/science.8171342; Nathoo N, 2003, J NEUROSURG, V98, P302, DOI 10.3171/jns.2003.98.2.0302; PAIK YK, 1985, P NATL ACAD SCI USA, V82, P3445, DOI 10.1073/pnas.82.10.3445; Pathak A, 2008, J INDIAN ACAD FORENS, V30; Peden M., 2004, WORLD REPORT ROAD TR; Pruthi N, 2010, NEUROL INDIA, V58, P264, DOI 10.4103/0028-3886.63810; Romer CJ, 1995, PREVENTION CRITICAL; SMIT M, 1988, HUM GENET, V78, P90, DOI 10.1007/BF00291243; SORBI S, 1995, NAT MED, V1, P852, DOI 10.1038/nm0995-852; Teasdale GM, 2005, BRAIN, V128, P2556, DOI 10.1093/brain/awh595; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; UTERMANN G, 1980, AM J HUM GENET, V32, P339; World Health Organization, 2006, NEUR DIS PUBL HLTH C	41	11	11	0	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.	JUL	2015	56	3					597	601		10.1007/s12031-015-0554-1			5	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	CL0BN	WOS:000356603600011	25859935				2021-06-18	
J	Zhou, R; Liu, B; Lin, K; Wang, R; Qin, Z; Liao, R; Qiu, Y				Zhou, R.; Liu, B.; Lin, K.; Wang, R.; Qin, Z.; Liao, R.; Qiu, Y.			ECMO support for right main bronchial disruption in multiple trauma patient with brain injurya case report and literature review	PERFUSION-UK			English	Article						ECMO; bronchial disruption; respiratory failure; multiple trauma; brain injury	EXTRACORPOREAL MEMBRANE-OXYGENATION; RESPIRATORY-FAILURE; LIFE-SUPPORT; SHOCK; LUNG	Extracorporeal membrane oxygenation (ECMO) may offer life-saving treatment in severe pulmonary contusion or acute respiratory distress syndrome when conventional treatments have failed. However, because of the bleeding risk of systemic anticoagulation, ECMO should be performed only as a last resort in multiple trauma victims. Here, we report ECMO as a bridge for right main bronchus reconstruction and recovery of traumatic wet lung in a 31-year-old male multi-trauma patient with right main bronchial disruption, bilateral pulmonary contusion, cerebral contusion and long bone fracture. The patient was discharged without any obvious complication. ECMO support in a traumatic brain injured patient with severe hypoxemia caused by lung contusion and/or tracheal bronchus disruption is not an absolute contraindication.	[Zhou, R.; Liu, B.; Wang, R.; Qin, Z.; Liao, R.; Qiu, Y.] Sichuan Univ, West China Hosp, Dept Anesthesiol, Chengdu 610041, Sichuan, Peoples R China; [Lin, K.] Sichuan Univ, West China Hosp, Dept Cardiac Surg, Chengdu 610041, Sichuan, Peoples R China	Liu, B (corresponding author), Sichuan Univ, West China Hosp, Dept Anesthesiol, 37 Guoxue Xiang, Chengdu 610041, Sichuan, Peoples R China.	liubinhx@foxmail.com			Science&Technology Agency of Sichuan Province, China	This research received grant from Science&Technology Agency of Sichuan Province, China. The Approval Number is 2012FZ0123.	Arlt M, 2010, RESUSCITATION, V81, P804, DOI 10.1016/j.resuscitation.2010.02.020; Ballouhey Q, 2013, EUR J CARDIO-THORAC, V43, P864, DOI 10.1093/ejcts/ezs607; Bonacchi M, 2013, J THORAC CARDIOV SUR, V145, P1617, DOI 10.1016/j.jtcvs.2012.08.046; Campione A, 2007, J THORAC CARDIOV SUR, V133, P1673, DOI 10.1016/j.jtcvs.2007.02.011; Cordell-Smith JA, 2006, INJURY, V37, P29, DOI 10.1016/j.injury.2005.03.027; HILL JD, 1972, NEW ENGL J MED, V286, P629, DOI 10.1056/NEJM197203232861204; Korvenoja P, 2008, ANN THORAC SURG, V86, P1348, DOI 10.1016/j.athoracsur.2008.04.018; Madershahian N, 2007, J CARDIAC SURG, V22, P180, DOI 10.1111/j.1540-8191.2007.00381.x; Michaels AJ, 1999, J TRAUMA, V46, P638, DOI 10.1097/00005373-199904000-00013; Muellenbach RM, 2011, ANAESTHESIST, V60, P647, DOI 10.1007/s00101-011-1872-5; Muellenbach RM, 2012, J TRAUMA ACUTE CARE, V72, P1444, DOI 10.1097/TA.0b013e31824d68e3; Tiruvoipati R, 2012, J CRIT CARE, V27, P192, DOI 10.1016/j.jcrc.2011.04.003	12	11	12	1	6	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0267-6591	1477-111X		PERFUSION-UK	Perfusion-UK	JUL	2015	30	5					403	406		10.1177/0267659114554326			4	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	CK2AJ	WOS:000356011400008	25300436				2021-06-18	
J	Li, JX; Yang, F; Guo, J; Zhang, RR; Xing, XF; Qin, XY				Li, Jianxiong; Yang, Fei; Guo, Jia; Zhang, Rongrong; Xing, Xiangfeng; Qin, Xinyue			17-AAG post-treatment ameliorates memory impairment and hippocampal CA1 neuronal autophagic death induced by transient global cerebral ischemia	BRAIN RESEARCH			English	Article						GCI; Hsp70; 17-AAG; Inflammatory response; Autophagy; Functional recovery	INFLAMMATORY MECHANISMS; HSP70; OVEREXPRESSION; ACTIVATION; INJURY; DAMAGE; ROLES; MODEL	Neuro-inflammation plays an important role in global cerebral ischemia (GC). The 72-kDa heat shock protein (Hsp70) has been reported to be involved in the inflammatory response of many central nervous system diseases. Preclinical findings implicate that 17-allylamino-demethoxygeldanamycin (17-AAG), an anticancer drug in clinical, provide neuroprotection actions in a rat model of traumatic brain injury, and the beneficial effects of 17-AAG were specifically due to up-regulation of Hsp70. However, no experiments have tested whether 17-AAG has beneficial or harmful effects in the setting of GCI. The present study was designed to determine the hypothesis that administration of 17-AAG could attenuate cerebral infarction and improve neuronal survival, thereby ameliorating memory impairment in a rat model of GCI. Furthermore, to test whether any neuroprotective effect of 17-AAG was associated with inflammatory response and neuronal autophagy, we examined the expression of multiplex inflammatory cytokine levels as well as autophagy-associate protein in hippocampal CA1 of rat brain. Our results showed that post-GCI administration of 17-AAG significantly protected rats against GCI induced brain injury, and 17-AAG is also an effective antagonist of the inflammatory response and thereby ameliorates hippocampal CA1 neuronal autophagic death. We therefore believe that the present study provides novel clues in understanding the mechanisms by which 17-AAG exerts its neuroprotective activity in GCI. All data reveal that 17-AAG might be a potential neuroprotective agent for ischemic stroke. (C) 2015 Elsevier B.V. All rights reserved.	[Li, Jianxiong; Guo, Jia; Zhang, Rongrong; Xing, Xiangfeng; Qin, Xinyue] Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol, Chongqing 400016, Peoples R China; [Yang, Fei] Chinese Peoples Liberat Army Gen Hosp, Dept Neurol, Beijing 100853, Peoples R China	Qin, XY (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol, 1 Youyi Rd, Chongqin 400016, Peoples R China.	xinyueqin24k@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81271307]; National Key Clinical Specialties Construction Program of China	This study was supported by the General Program of National Natural Science Foundation of China (81271307), and National Key Clinical Specialties Construction Program of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amantea D, 2009, FEBS J, V276, P13, DOI 10.1111/j.1742-4658.2008.06766.x; Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; Bejarano Eloy, 2010, Proc Am Thorac Soc, V7, P29, DOI 10.1513/pats.200909-102JS; Danton GH, 2003, J NEUROPATH EXP NEUR, V62, P127, DOI 10.1093/jnen/62.2.127; Denes A, 2010, BRAIN BEHAV IMMUN, V24, P708, DOI 10.1016/j.bbi.2009.09.010; Dutta RK, 2012, INT J BIOCHEM CELL B, V44, P942, DOI 10.1016/j.biocel.2012.02.021; Giffard RG, 2004, J NEUROSURG ANESTH, V16, P53, DOI 10.1097/00008506-200401000-00010; Giffard RG, 2008, ANESTHESIOLOGY, V109, P339, DOI 10.1097/ALN.0b013e31817f4ce0; Jia GH, 2006, IMMUNOL CELL BIOL, V84, P448, DOI 10.1111/j.1440-1711.2006.01454.x; Jin R, 2010, J LEUKOCYTE BIOL, V87, P779, DOI 10.1189/jlb.1109766; Kim Nuri, 2012, Inflammopharmacology, V20, P177, DOI 10.1007/s10787-011-0115-3; KIRINO T, 1982, BRAIN RES, V239, P57, DOI 10.1016/0006-8993(82)90833-2; Lee SH, 2004, STROKE, V35, P2195, DOI 10.1161/01.STR.0000136150.73891.14; Lee SH, 2001, STROKE, V32, P2905, DOI 10.1161/hs1201.099604; Matsumori Y, 2005, J CEREBR BLOOD F MET, V25, P899, DOI 10.1038/sj.jcbfm.9600080; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; McLean PJ, 2004, BIOCHEM BIOPH RES CO, V321, P665, DOI 10.1016/j.bbrc.2004.07.021; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Neckers L, 2002, TRENDS MOL MED, V8, pS55, DOI 10.1016/S1471-4914(02)02316-X; Nesbit Gary M, 2004, J Vasc Interv Radiol, V15, pS103; Ortega L, 2014, NEUROPEPTIDES, V48, P221, DOI 10.1016/j.npep.2014.04.006; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Sahu R, 2011, DEV CELL, V20, P131, DOI 10.1016/j.devcel.2010.12.003; Sato S., 2006, Journal of Submicroscopic Cytology and Pathology, V38, P167; Shi CS, 2012, NAT IMMUNOL, V13, P255, DOI 10.1038/ni.2215; Stoll G, 2010, ANN NY ACAD SCI, V1207, P149, DOI 10.1111/j.1749-6632.2010.05730.x; Sugawara T, 2002, J NEUROTRAUM, V19, P85, DOI 10.1089/089771502753460268; Tsuchiya D, 2003, NEUROSURGERY, V53, P1179, DOI 10.1227/01.NEU.0000090341.38659.CF; Wang RM, 2013, HIPPOCAMPUS, V23, P634, DOI 10.1002/hipo.22126; Wen YD, 2008, AUTOPHAGY, V4, P762, DOI 10.4161/auto.6412; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Yenari MA, 2005, ANN NY ACAD SCI, V1053, P74, DOI 10.1196/annals.1344.007; Yenari MA, 1999, MOL MED TODAY, V5, P525, DOI 10.1016/S1357-4310(99)01599-3; Zhang HL, 2011, NEUROSCIENCE, V176, P381, DOI 10.1016/j.neuroscience.2010.12.029; Zheng Z, 2004, NEUROL RES, V26, P884, DOI 10.1179/016164104X2357; Zheng Z., 2005, FRONT BIOSCI J VIRTU, V11, P699	36	11	13	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JUN 12	2015	1610						80	88		10.1016/j.brainres.2015.03.051			9	Neurosciences	Neurosciences & Neurology	CJ7XT	WOS:000355714400009	25858486				2021-06-18	
J	Hsu, CY; Schneller, B; Ghaffari, M; Alaraj, A; Linninger, A				Hsu, Chih-Yang; Schneller, Ben; Ghaffari, Mahsa; Alaraj, Ali; Linninger, Andreas			Medical Image Processing for Fully Integrated Subject Specific Whole Brain Mesh Generation	TECHNOLOGIES			English	Article						image processing; computational meshes; simulation		Currently, anatomically consistent segmentation of vascular trees acquired with magnetic resonance imaging requires the use of multiple image processing steps, which, in turn, depend on manual intervention. In effect, segmentation of vascular trees from medical images is time consuming and error prone due to the tortuous geometry and weak signal in small blood vessels. To overcome errors and accelerate the image processing time, we introduce an automatic image processing pipeline for constructing subject specific computational meshes for entire cerebral vasculature, including segmentation of ancillary structures; the grey and white matter, cerebrospinal fluid space, skull, and scalp. To demonstrate the validity of the new pipeline, we segmented the entire intracranial compartment with special attention of the angioarchitecture from magnetic resonance imaging acquired for two healthy volunteers. The raw images were processed through our pipeline for automatic segmentation and mesh generation. Due to partial volume effect and finite resolution, the computational meshes intersect with each other at respective interfaces. To eliminate anatomically inconsistent overlap, we utilized morphological operations to separate the structures with a physiologically sound gap spaces. The resulting meshes exhibit anatomically correct spatial extent and relative positions without intersections. For validation, we computed critical biometrics of the angioarchitecture, the cortical surfaces, ventricular system, and cerebrospinal fluid (CSF) spaces and compared against literature values. Volumina and surface areas of the computational mesh were found to be in physiological ranges. In conclusion, we present an automatic image processing pipeline to automate the segmentation of the main intracranial compartments including a subject-specific vascular trees. These computational meshes can be used in 3D immersive visualization for diagnosis, surgery planning with haptics control in virtual reality. Subject-specific computational meshes are also a prerequisite for computer simulations of cerebral hemodynamics and the effects of traumatic brain injury.	[Hsu, Chih-Yang; Schneller, Ben; Ghaffari, Mahsa; Linninger, Andreas] Univ Illinois, Dept Bioengn, 851 S Morgan St, Chicago, IL 60607 USA; [Alaraj, Ali; Linninger, Andreas] Univ Illinois, Dept Neurosurg, Chicago, IL 60607 USA	Linninger, A (corresponding author), Univ Illinois, Dept Bioengn, 851 S Morgan St, Chicago, IL 60607 USA.	chsu33@uic.edu; bschne3@uic.edu; mghaff2@uic.edu; alaraj@uic.edu; linninge@uic.edu			NSFNational Science Foundation (NSF) [CBET-0756154, CBET-1301198]	The authors would like to gratefully partial support of this project by NSF grants CBET-0756154 and CBET-1301198.	Adams CM, 2011, ANAT SCI EDUC, V4, P340, DOI 10.1002/ase.256; Alaraj A, 2013, COMPREHENSIVE TXB HE, P415, DOI [10.1007/978-1-4614-5993-4_28, DOI 10.1007/978-1-4614-5993-4_28]; Alaraj A, 2015, OPER NEUROSURG, V11, P52, DOI 10.1227/NEU.0000000000000583; Alaraj A, 2013, NEUROSURGERY, V72, pA115, DOI 10.1227/NEU.0b013e3182753093; Alaraj Ali, 2011, Surg Neurol Int, V2, P52, DOI 10.4103/2152-7806.80117; Antiga L, 2008, MED BIOL ENG COMPUT, V46, P1097, DOI 10.1007/s11517-008-0420-1; Borouchaki H, 2000, INT J NUMER METH ENG, V49, P233; Cebral JR, 2005, IEEE T MED IMAGING, V24, P457, DOI 10.1109/TMI.2005.844159; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Dogdas B, 2005, HUM BRAIN MAPP, V26, P273, DOI 10.1002/hbm.20159; Doi K, 2007, COMPUT MED IMAG GRAP, V31, P198, DOI 10.1016/j.compmedimag.2007.02.002; Duncan JS, 2000, IEEE T PATTERN ANAL, V22, P85, DOI 10.1109/34.824822; Erdt M, 2008, LECT NOTES COMPUT SC, V5128, P403, DOI 10.1007/978-3-540-79982-5_44; Fischl B, 2004, NEUROIMAGE, V23, pS69, DOI 10.1016/j.neuroimage.2004.07.016; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Frangi AF, 1998, LECT NOTES COMPUT SC, V1496, P130, DOI 10.1007/bfb0056195; Ghaffari M., 2015, COMPUT AIDE IN PRESS; Ghaffari M., 2014, J MODERN ENG, V14, P54; GRANT R, 1987, MAGN RESON IMAGING, V5, P465, DOI 10.1016/0730-725X(87)90380-8; Ho J, 2009, J BIOMECH, V42, P2074, DOI 10.1016/j.jbiomech.2009.06.051; Ito H, 2001, ANN NUCL MED, V15, P111, DOI 10.1007/BF02988600; Lauwers F, 2008, NEUROIMAGE, V39, P936, DOI 10.1016/j.neuroimage.2007.09.024; Liao PS, 2001, J INF SCI ENG, V17, P713; Lim SP, 2014, ARTIF INTELL REV, V42, P59, DOI 10.1007/s10462-012-9329-z; Linninger AA, 2005, IEEE T BIO-MED ENG, V52, P557, DOI 10.1109/TBME.2005.844021; Linninger AA, 2007, IEEE T BIO-MED ENG, V54, P291, DOI 10.1109/TBME.2006.886853; Linninger AA, 2009, J MATH BIOL, V59, P729, DOI 10.1007/s00285-009-0250-2; Linninger AA, 2009, ANN BIOMED ENG, V37, P1434, DOI 10.1007/s10439-009-9691-4; Lorensen W. E., 1987, COMPUTER GRAPHICS, V21, P163; Luders E, 2002, NEUROREPORT, V13, P2371, DOI 10.1097/01.wnr.0000049603.85580.da; Meegama RGN, 2003, INT J PATTERN RECOGN, V17, P995, DOI 10.1142/S0218001403002745; Milner JS, 1998, J VASC SURG, V28, P143, DOI 10.1016/S0741-5214(98)70210-1; Nielson G. M., 1991, Proceedings Visualization '91 (Cat. No.91CH3046-0), P83, DOI 10.1109/VISUAL.1991.175782; Nowinski WL, 2015, J NEUROSCI METH, V246, P65, DOI 10.1016/j.jneumeth.2015.02.012; Nowinski WL, 2005, NEUROINFORMATICS, V3, P293, DOI 10.1385/NI:3:4:293; Nowinski WL, 2003, INT CONGR SER, V1256, P75, DOI 10.1016/S0531-5131(03)00269-3; Nowinski WL, 2003, NEUROIMAGE, V20, P50, DOI 10.1016/S1053-8119(03)00252-0; Oshima M, 2001, COMPUT METHOD APPL M, V191, P661, DOI 10.1016/S0045-7825(01)00307-3; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Penn RD, 2009, COLLECTIONS, V116, P1069; Pons JP, 2007, LECT NOTES COMPUT SC, V4584, P198; Reichold J, 2009, J CEREBR BLOOD F MET, V29, P1429, DOI 10.1038/jcbfm.2009.58; Risser L, 2009, INT J DEV NEUROSCI, V27, P185, DOI 10.1016/j.ijdevneu.2008.10.006; Sato Y, 1998, Med Image Anal, V2, P143, DOI 10.1016/S1361-8415(98)80009-1; Sethian JA, 1996, P NATL ACAD SCI USA, V93, P1591, DOI 10.1073/pnas.93.4.1591; Shikata H, 2004, PRO BIOMED OPT IMAG, V5, P107, DOI 10.1117/12.537032; Spiegel M, 2011, COMPUT METHOD BIOMEC, V14, P9, DOI 10.1080/10255842.2010.518565; Sundgren PC, 2004, NEURORADIOLOGY, V46, P339, DOI 10.1007/s00234-003-1114-x; Sweetman B, 2011, ANN BIOMED ENG, V39, P484, DOI 10.1007/s10439-010-0141-0; Takahashi T, 2007, P ANN INT IEEE EMBS, P3613, DOI 10.1109/IEMBS.2007.4353113; Wardlaw JM, 2005, RADIOLOGY, V235, P444, DOI 10.1148/radiol.2352040262; Yudkowsky R, 2013, SIMUL HEALTHC, V8, P25, DOI 10.1097/SIH.0b013e3182662c69; Zhang JY, 2013, INT J NUMER METH BIO, V29, P293, DOI 10.1002/cnm.2507; Zhu Dajiang, 2009, Conf Rec Asilomar Conf Signals Syst Comput, V2009, P1094, DOI 10.1109/ACSSC.2009.5470064; Zhu DC, 2006, J MAGN RESON IMAGING, V24, P756, DOI 10.1002/jmri.20679	56	11	11	0	0	MDPI AG	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	2227-7080			TECHNOLOGIES	Technologies	JUN	2015	3	2					126	141		10.3390/technologies3020126			16	Engineering, Multidisciplinary	Engineering	V3T7Z	WOS:000218580200006		DOAJ Gold			2021-06-18	
J	Ma, LS; Steinberg, JL; Keyser-Marcus, L; Ramesh, D; Narayana, PA; Merchant, RE; Moeller, FG; Cifu, DX				Ma, Liangsuo; Steinberg, Joel L.; Keyser-Marcus, Lori; Ramesh, Divya; Narayana, Ponnada A.; Merchant, Randall E.; Moeller, F. Gerard; Cifu, David X.			Altered white matter in cocaine-dependent subjects with traumatic brain injury: A diffusion tensor imaging study	DRUG AND ALCOHOL DEPENDENCE			English	Article						Diffusion tensor imaging; Cocaine dependence; Traumatic brain injury; TBSS	MEAN DIFFUSIVITY; FRACTIONAL ANISOTROPY; MULTIPLE-SCLEROSIS; CORPUS-CALLOSUM; SUBSTANCE-ABUSE; INTEGRITY; ABNORMALITIES; EIGENVALUES; INFERENCE; EXPOSURE	Background: Diffusion tensor imaging (DTI) is a useful technique for non-invasively investigating the microstructural organization of white matter (WM), and the most consistent DTI finding regarding cocaine-related WM alterations is in the corpus callosum (CC). WM injury has also been observed in subjects with traumatic brain injury (TB!), including in the CC. Methods: We used DTI to test if the WM microstructure is relatively more impaired in cocaine-dependent subjects who had suffered a mild TBI (mTBI). Fractional anisotropy (FA), which reflects the degree of alignment of cellular structures within fiber tracts and their structural integrity, was compared across cocaine-dependent subjects with mTBI (COCTBI group, n = 9), matched cocaine-dependent subjects without TBI (COC group, n=12), and matched healthy controls (CTL group, n=12). Results: The COCTBI group had significantly lower FA in the genu, body, and splenium of CC, than the CTL group whenever the education was controlled or not. The COC group had significantly lower FA in the left and right anterior corona radiata than the CTL group only when the education was controlled. There was no significant difference in FA between the COC and COCTBI groups. Conclusion: Cocaine dependence (or mTBI) related WM impairments in the CC were not detectable in this small subject sample. The significant finding in the CC suggests that the concurrence of cocaine dependence and mTBI might result in more severe damage to the CC, which could even be detected in small sample size. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Ma, Liangsuo; Steinberg, Joel L.; Keyser-Marcus, Lori; Ramesh, Divya; Moeller, F. Gerard] Virginia Commonwealth Univ, Inst Drug & Alcohol Studies, Richmond, VA 23219 USA; [Ma, Liangsuo] Virginia Commonwealth Univ, Dept Radiol, Richmond, VA 23219 USA; [Steinberg, Joel L.; Keyser-Marcus, Lori; Ramesh, Divya; Moeller, F. Gerard] Virginia Commonwealth Univ, Dept Psychiat, Richmond, VA 23219 USA; [Ramesh, Divya; Moeller, F. Gerard] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA 23219 USA; [Narayana, Ponnada A.] Univ Texas Hlth Sci Ctr Houston, Dept Diagnost & Intervent Imaging, Houston, TX 77030 USA; [Merchant, Randall E.] Virginia Commonwealth Univ, Dept Anat & Neurobiol, Richmond, VA 23219 USA; [Merchant, Randall E.] Virginia Commonwealth Univ, Dept Neurosurg, Richmond, VA 23219 USA; [Cifu, David X.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA 23219 USA	Ma, LS (corresponding author), Virginia Commonwealth Univ, Dept Radiol, Inst Drug & Alcohol Studies, 203 E Cary St Suite 202, Richmond, VA 23219 USA.	lma@vcu.edu		Keyser-Marcus, Lori/0000-0001-6014-2500; Cifu, David/0000-0003-1600-9387	National Institute on Drug Abuse (NIDA)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [R01 DA034131, U54 DA038999, P50 DA009262]; MCRR Shared Instrumentation Grant [1 S10 RR019186-01]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000371] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [S10RR019186] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [U54DA038999, P50DA009262, R01DA034131] Funding Source: NIH RePORTER	This work is financially supported by National Institute on Drug Abuse (NIDA) Grants no. R01 DA034131 (LM), U54 DA038999 (FGM/JLS), P50 DA009262 (FGM/JLS), and MCRR Shared Instrumentation Grant no. 1 S10 RR019186-01 (PAN). We thank Zahra N. Kamdar, Vipulkumar S. (Vips) Patel, and Edward A. Zuniga for their excellent technical support. We also thank the anonymous reviewers for their constructive comments which have resulted in significant improvement of this article.	Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Bell RP, 2011, DRUG ALCOHOL DEPEN, V114, P159, DOI 10.1016/j.drugalcdep.2010.10.001; Bjork JM, 2009, J NEUROTRAUM, V26, P1077, DOI 10.1089/neu.2008-0849; Cercignani M, 2001, AM J NEURORADIOL, V22, P952; Cherpitel CJ, 2007, DRUG ALCOHOL REV, V26, P201, DOI 10.1080/09595230601146686; First M.B., 1996, STRUCTURED CLIN INTE; First MB., 2002, STRUCTURED CLIN INTE; Hanlon CA, 2013, NEUROSCI BIOBEHAV R, V37, P2037, DOI 10.1016/j.neubiorev.2013.04.007; Hasan KM, 2006, MAGN RESON MED, V56, P130, DOI 10.1002/mrm.20935; Hasan KM, 2014, J NEUROTRAUM, V31, P466, DOI [10.1089/NEU.2013.3085, 10.1089/neu.2013.3085]; Hasan KM, 2003, MAGNET RESON MED, V50, P589, DOI 10.1002/mrm.10552; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Klawiter EC, 2011, NEUROIMAGE, V55, P1454, DOI 10.1016/j.neuroimage.2011.01.007; Lane SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011591; Lebel C, 2013, PSYCHIAT RES-NEUROIM, V213, P161, DOI 10.1016/j.pscychresns.2013.04.002; Li ZH, 2013, PSYCHIAT RES-NEUROIM, V213, P47, DOI 10.1016/j.pscychresns.2012.12.005; Lim KO, 2008, DRUG ALCOHOL DEPEN, V92, P164, DOI 10.1016/j.drugalcdep.2007.07.019; Ma LS, 2009, DRUG ALCOHOL DEPEN, V104, P262, DOI 10.1016/j.drugalcdep.2009.05.020; MCLELLAN AT, 1992, J SUBST ABUSE TREAT, V9, P199, DOI 10.1016/0740-5472(92)90062-S; Miller GA, 2001, J ABNORM PSYCHOL, V110, P40, DOI 10.1037//0021-843X.110.1.40; Moeller FG, 2007, PSYCHIAT RES-NEUROIM, V154, P253, DOI 10.1016/j.pscychresns.2006.11.004; Moeller FG, 2010, PSYCHIAT RES-NEUROIM, V181, P174, DOI 10.1016/j.pscychresns.2009.11.003; Moeller FG, 2005, NEUROPSYCHOPHARMACOL, V30, P610, DOI 10.1038/sj.npp.1300617; Mori S., 2005, MRI ATLAS HUMAN WHIT; Narayana PA, 2015, NEUROIMAGE-CLIN, V7, P87, DOI 10.1016/j.nicl.2014.07.010; Narayana PA, 2014, PSYCHIAT RES-NEUROIM, V221, P220, DOI 10.1016/j.pscychresns.2014.01.005; Narayana PA, 2009, PSYCHIAT RES-NEUROIM, V171, P242, DOI 10.1016/j.pscychresns.2008.04.004; Pfefferbaum A, 2009, BIOL PSYCHIAT, V65, P680, DOI 10.1016/j.biopsych.2008.10.039; Pocock SJ, 2002, STAT MED, V21, P2917, DOI 10.1002/sim.1296; Ramesh D, 2015, AM J ADDICTION, V24, P341, DOI 10.1111/ajad.12192; Salimi-Khorshidi G, 2011, NEUROIMAGE, V54, P2006, DOI 10.1016/j.neuroimage.2010.09.088; Schmitz Joy M, 2012, Front Psychiatry, V3, P77, DOI 10.3389/fpsyt.2012.00077; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Taber KH, 2002, J NEUROPSYCH CLIN N, V14, P1, DOI 10.1176/appi.neuropsych.14.1.1; Taylor LA, 2003, NEUROPSYCHOL REHABIL, V13, P165, DOI 10.1080/09602010244000336; Voelbel GT, 2012, NEUROREHABILITATION, V31, P281, DOI 10.3233/NRE-2012-0796; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; Xu JS, 2010, NEUROPSYCHOPHARMACOL, V35, P1541, DOI 10.1038/npp.2010.25	46	11	11	0	5	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0376-8716	1879-0046		DRUG ALCOHOL DEPEN	Drug Alcohol Depend.	JUN 1	2015	151						128	134		10.1016/j.drugalcdep.2015.03.015			7	Substance Abuse; Psychiatry	Substance Abuse; Psychiatry	CL1WX	WOS:000356736700015	25841982	Green Accepted			2021-06-18	
J	Miller, D; Barnes, P; Miller, M				Miller, David; Barnes, Patrick; Miller, Marvin			The Significance of Macrocephaly or Enlarging Head Circumference in Infants With the Triad Further Evidence of Mimics of Shaken Baby Syndrome	AMERICAN JOURNAL OF FORENSIC MEDICINE AND PATHOLOGY			English	Article						shaken baby syndrome; abusive head trauma; cortical/sinus thrombosis; child abuse; macrocephaly; increased extra-axial fluid spaces	BENIGN EXTERNAL HYDROCEPHALUS; CHRONIC SUBDURAL-HEMATOMA; PERIMACULAR RETINAL FOLDS; TRAUMATIC BRAIN-INJURY; NONACCIDENTAL INJURY; INTRACRANIAL HEMORRHAGE; SUBARACHNOID SPACES; NATURAL-HISTORY; TERM INFANTS; ENLARGEMENT	Infants with the triad (neurologic dysfunction, subdural hematoma [SDH], and retinal hemorrhage) are often diagnosed as victims of shaken baby syndrome. Medical conditions/predisposing factors to developing the triad are often dismissed: short falls, birth-related SDH that enlarges, macrocephaly, sinus/cortical vein thrombosis, and others. Six infants with the triad are described in which child abuse was diagnosed, but parents denied wrongdoing. All 6 had either macrocephaly or enlarging head circumference, which suggested medical explanations. Three infants incurred short falls, 1 had a difficult delivery in which there was likely a rebleed of a birth-related SDH, 1 had a spontaneous SDH associated with increased extra-axial fluid spaces, and 1 had a sinus thrombosis. Following legal proceedings, all 6 infants were returned to their parents, and there has been no child maltreatment in follow-up, suggesting child abuse never happened. The results indicate that alternative medical explanations for causing the triad should be considered and that macrocephaly or an enlarging head circumference raises the possibility of a medical explanation.	[Miller, David] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA; [Barnes, Patrick] Stanford Univ, Med Ctr, Lucile Packard Childrens Hosp, Dept Radiol, Palo Alto, CA 94304 USA; [Miller, Marvin] Wright State Univ, Boonshoft Sch Med, Dept Pediat Obstet Gynecol & Biomed Engn, Dayton, OH 45435 USA	Miller, M (corresponding author), Dayton Childrens Hosp, Dept Med Genet, 1 Childrens Plaza, Dayton, OH 45404 USA.	millerme@childrensdayton.org		Miller, David/0000-0002-6210-7941			ALVAREZ LA, 1986, PEDIATRICS, V77, P901; Amodio J, 2005, PEDIATR RADIOL, V35, P1113, DOI 10.1007/s00247-005-1503-x; AOKI N, 1984, J NEUROSURG, V61, P273, DOI 10.3171/jns.1984.61.2.0273; AZAIS M, 1992, ANN PEDIATR-PARIS, V39, P550; Bandak FA, 2005, FORENSIC SCI INT, V151, P71, DOI 10.1016/j.forsciint.2005.02.033; Bandak FA, 2006, FORENSIC SCI INT, V164, P282, DOI 10.1016/j.forsciint.2006.01.001; Barnes PD, 2011, RADIOL CLIN N AM, V49, P205, DOI 10.1016/j.rcl.2010.08.001; Center for Disease Control and Prevention, 2000, HEAD CIRC FOR AG CHA; Chamnanvanakij S, 2002, PEDIATR NEUROL, V26, P301, DOI 10.1016/S0887-8994(01)00420-9; DUHAIME AC, 1987, J NEUROSURG, V66, P409, DOI 10.3171/jns.1987.66.3.0409; Gabaeff SC, 2011, WEST J EMERG MED, V12, P144; Gardner HB, 2004, NEUROPATH APPL NEURO, V30, P192, DOI 10.1111/j.1365-2990.2003.00503.x; Gardner HB, 2007, PEDIATR NEUROSURG, V43, P433, DOI 10.1159/000106399; Geddes JF, 2003, NEUROPATH APPL NEURO, V29, P14, DOI 10.1046/j.1365-2990.2003.00434.x; Geddes JF, 2001, BRAIN, V124, P1299, DOI 10.1093/brain/124.7.1299; Geddes JF, 2001, BRAIN, V124, P1290, DOI 10.1093/brain/124.7.1290; Ghosh PS, 2011, CLIN PEDIATR, V50, P897, DOI 10.1177/0009922811406435; Girish M, 2013, J PEDIATR NEUROL, V11, P63, DOI 10.3233/JPN-120591; Greiner MV, 2013, AM J NEURORADIOL, V34, P2373, DOI 10.3174/ajnr.A3588; Gross Samuel R., 2012, EXONERATIONS US 1989; Hangique S, 2002, IND J RADIOL IMAG, V12, P197; Hellbusch LC, 2007, J NEUROSURG, V107, P119, DOI 10.3171/PED-07/08/119; ITO H, 1976, J NEUROSURG, V45, P26, DOI 10.3171/jns.1976.45.1.0026; ITO H, 1978, J NEUROSURG, V48, P197, DOI 10.3171/jns.1978.48.2.0197; Johnson K., 2015, US TODAY; Karimzadeh P, 2009, J PEDIATR NEUROL, V7, P157, DOI 10.3233/JPN-2009-0289; Krasnokutsky MV, 2011, AM J ROENTGENOL, V197, pW503, DOI 10.2214/AJR.10.5977; Lantz P, 2006, 58 ANN SCI M AM AC F; Lantz PE, 2004, BRIT MED J, V328, P754, DOI 10.1136/bmj.328.7442.754; Leestma J., 2014, FORENSIC NEUROPATHOL, P364, DOI 10.1201/b16882; Lloyd J., 2011, J FORENSIC BIOMECH, V2, P1, DOI DOI 10.4303/jfb/F110601; Looney CB, 2007, RADIOLOGY, V242, P535, DOI 10.1148/radiol.2422060133; Lueder GT, 2006, ARCH OPHTHALMOL-CHIC, V124, P1782, DOI 10.1001/archopht.124.12.1782; Marino MA, 2014, NEURORADIOL J, V27, P245, DOI 10.15274/NRJ-2014-10020; McKeag H, 2013, J NEUROSURG-PEDIATR, V11, P438, DOI 10.3171/2012.12.PEDS12289; McNeely PD, 2006, AM J NEURORADIOL, V27, P1725; Miller R, 2010, AM J FOREN MED PATH, V31, P165, DOI 10.1097/PAF.0b013e3181d96a8e; MORI K, 1993, CHILD NERV SYST, V9, P282, DOI 10.1007/BF00306274; MULLER PJ, 1974, NEUROSURGERY, V41, P160; Papasian NC, 2000, PEDIATR NEUROSURG, V33, P188, DOI 10.1159/000055951; Paterson CR, 2011, PEDIATR HEALTH MED T, V2, P55, DOI 10.2147/PHMT.S21449; Piatt JH, 1999, NEUROSURG FOCUS, V7, pE5; Plunkett J, 1999, AM J FOREN MED PATH, V20, P17, DOI 10.1097/00000433-199903000-00005; Plunkett J, 2001, AM J FOREN MED PATH, V22, P1, DOI 10.1097/00000433-200103000-00001; Ravid S, 2003, PEDIATR NEUROL, V28, P139, DOI 10.1016/S0887-8994(02)00500-3; Rooks VJ, 2008, AM J NEURORADIOL, V29, P1082, DOI 10.3174/ajnr.A1004; Shapiro K, 1983, PEDIAT HEAD TRAUMA, P45; Sherwood D, 1930, AM J DIS CHILD, V39, P980; Squier W, 2008, DEV MED CHILD NEUROL, V50, P10, DOI 10.1111/j.1469-8749.2007.02004.x; Uscinski R, 2002, BRIT J NEUROSURG, V16, P217, DOI 10.1080/02688690220148978; Vinchon M, 2010, CHILD NERV SYST, V26, P1195, DOI 10.1007/s00381-010-1105-2; Whitby EH, 2004, LANCET, V363, P846, DOI 10.1016/S0140-6736(04)15730-9	52	11	11	0	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-7910	1533-404X		AM J FOREN MED PATH	Am. J. Forensic Med. Pathol.	JUN	2015	36	2					111	120		10.1097/PAF.0000000000000152			10	Medicine, Legal; Pathology	Legal Medicine; Pathology	CH9WV	WOS:000354388100015	25893912	Green Published			2021-06-18	
J	Terry, DP; Adams, TE; Ferrara, MS; Miller, LS				Terry, Douglas P.; Adams, T. Eric; Ferrara, Michael S.; Miller, L. Stephen			FMRI Hypoactivation During Verbal Learning and Memory in Former High School Football Players with Multiple Concussions	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Childhood brain insult; Head injury; traumatic brain injury; Learning and memory; Neuroimaging (functional); Language and language disorders	TRAUMATIC BRAIN-INJURY; SPORTS-RELATED CONCUSSION; WORKING-MEMORY; NEUROCOGNITIVE PERFORMANCE; PREFRONTAL ACTIVATION; COLLEGIATE; LONG; DIAGNOSIS; RECOVERY; RISK	Multiple concussions before the age of 18 may be associated with late-life memory deficits. This study examined neural activation associated with verbal encoding and memory retrieval in former athletes ages 40-65 who received at least two concussions ( median = 3; range = 2-15) playing high school football and a group of former high school football players with no reported history of concussions matched on age, education, and pre-morbid IQ. Functional magnetic resonance imaging data collected during a modified verbal paired associates paradigm indicated that those with concussive histories had hypoactivation in left hemispheric language regions, including the inferior/middle frontal gyri and angular gyrus compared with controls. However, concussive history was not associated with worse memory functioning on neuropsychological tests or worse behavioral performance during the paradigm, suggesting that multiple early-life concussions may be associated with subtle changes in the verbal encoding system that limits one from accessing higher-order semantic networks, but this difference does not translate into measurable cognitive performance deficits.	[Terry, Douglas P.; Adams, T. Eric; Miller, L. Stephen] Univ Georgia, Dept Psychol, Athens, GA 30602 USA; [Ferrara, Michael S.] Univ New Hampshire, Coll Hlth & Human Serv, Durham, NH 03824 USA; [Miller, L. Stephen] Univ Georgia, Biomed & Hlth Sci Inst, BioImaging Res Ctr, Athens, GA 30602 USA	Terry, DP (corresponding author), Univ Georgia, 110 Hooper St,Psychol Bldg,Room 163, Athens, GA 30602 USA.	dpterry@uga.edu			John and Mary Franklin Foundation; BioImaging Research Center at the University of Georgia; Department of Kinesiology at the University of Georgia	This work was supported by the John and Mary Franklin Foundation, the BioImaging Research Center at the University of Georgia, and Department of Kinesiology at the University of Georgia.	Arciniegas D, 2000, J NEUROPSYCH CLIN N, V12, P77, DOI 10.1176/jnp.12.1.77; Bernstein DM, 2002, J INT NEUROPSYCH SOC, V8, P673, DOI 10.1017/S1355617702801400; Bonner-Jackson A, 2007, BIOL PSYCHIAT, V61, P1141, DOI 10.1016/j.biopsych.2006.07.006; Bookheimer SY, 2000, NEW ENGL J MED, V343, P450, DOI 10.1056/NEJM200008173430701; Braskie MN, 2009, HUM BRAIN MAPP, V30, P3981, DOI 10.1002/hbm.20823; Broglio SP, 2007, J ATHL TRAINING, V42, P504; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Cohen N.J., 1993, MEMORY AMNESIA HIPPO; Cohen NJ, 1999, HIPPOCAMPUS, V9, P83, DOI 10.1002/(SICI)1098-1063(1999)9:1<83::AID-HIPO9>3.0.CO;2-7; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Covassin T, 2013, AM J SPORT MED, V41, P2885, DOI 10.1177/0363546513499230; CRAIK FIM, 1972, J VERB LEARN VERB BE, V11, P671, DOI 10.1016/S0022-5371(72)80001-X; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Delis DC, 2000, CALIFORNIA VERBAL LE; Dettwiler A, 2014, J NEUROTRAUM, V31, P180, DOI 10.1089/neu.2013.2983; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Dikmen S S, 1995, J Int Neuropsychol Soc, V1, P67; Dobbins IG, 2005, CEREB CORTEX, V15, P1768, DOI 10.1093/cercor/bhi054; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Ettenhofer ML, 2009, J CLIN EXP NEUROPSYC, V31, P363, DOI 10.1080/13803390802175270; Ford JH, 2013, J NEUROTRAUM, V30, P1683, DOI 10.1089/neu.2012.2535; Fowler KS, 2002, J INT NEUROPSYCH SOC, V8, P58, DOI 10.1017/S1355617701020069; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Gaetz M, 2000, BRAIN INJURY, V14, P1077; Gardner A, 2010, ARCH CLIN NEUROPSYCH, V25, P174, DOI 10.1093/arclin/acq007; Ge YL, 2009, BRAIN INJURY, V23, P666, DOI 10.1080/02699050903014899; Gilchrist J., 2007, Morbidity and Mortality Weekly Report, V56, P733; Gioia G.A., 2006, ACUTE CONCUSSION EVA; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Giza CC, 2001, J ATHL TRAINING, V36, P228; Gosselin N, 2011, J NEUROTRAUM, V28, P329, DOI 10.1089/neu.2010.1493; Green, 2004, GREENS MED SYMPTOM V; Green REA, 2008, J CLIN EXP NEUROPSYC, V30, P163, DOI 10.1080/13803390701300524; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Hall RCW, 2005, PSYCHOSOMATICS, V46, P195, DOI 10.1176/appi.psy.46.3.195; Henke K, 1997, HIPPOCAMPUS, V7, P249, DOI 10.1002/(SICI)1098-1063(1997)7:3<249::AID-HIPO1>3.0.CO;2-G; Henson RNA, 2005, J COGNITIVE NEUROSCI, V17, P1058, DOI 10.1162/0898929054475208; Hollis SJ, 2009, AM J SPORT MED, V37, P2328, DOI 10.1177/0363546509341032; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; JACOBSON RR, 1995, J PSYCHOSOM RES, V39, P675, DOI 10.1016/0022-3999(95)00006-5; Jacques PLS, 2012, NEUROBIOL AGING, V33, P1298, DOI 10.1016/j.neurobiolaging.2010.11.007; Jantzen KJ, 2004, AM J NEURORADIOL, V25, P738; Kay T., 1993, J HEAD TRAUMA REHABI, V8, P86, DOI [10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Keightley ML, 2014, J NEUROTRAUM, V31, P437, DOI [10.1089/NEU.2013.3052, 10.1089/neu.2013.3052]; Kendler KS, 2008, PSYCHOL MED, V38, P1001, DOI 10.1017/S0033291707001821; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Kontos AP, 2014, BRAIN IMAGING BEHAV, V8, P621, DOI 10.1007/s11682-014-9289-9; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lieberman MD, 2009, SOC COGN AFFECT NEUR, V4, P423, DOI 10.1093/scan/nsp052; Lovell MR, 2007, NEUROSURGERY, V61, P352, DOI 10.1227/01.NEU.0000279985.94168.7F; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Macciocchi SN, 2001, J ATHL TRAINING, V36, P303; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Maldjian JA, 2004, NEUROIMAGE, V21, P450, DOI 10.1016/j.neuroimage.2003.09.032; Manoach DS, 2003, SCHIZOPHR RES, V60, P285, DOI 10.1016/S0920-9964(02)00294-3; Marvel CL, 2010, NEUROPSYCHOL REV, V20, P271, DOI 10.1007/s11065-010-9137-7; McAllister TW, 2001, J CLIN EXP NEUROPSYC, V23, P775, DOI 10.1076/jcen.23.6.775.1026; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2009, PM&R, V1, P406, DOI 10.1016/j.pmrj.2009.03.010; Mitchell KJ, 2000, COGNITIVE BRAIN RES, V10, P197, DOI 10.1016/S0926-6410(00)00029-X; Mitchell KJ, 2000, PSYCHOL AGING, V15, P527, DOI 10.1037//0882-7974.15.3.527; Moffitt TE, 2007, ARCH GEN PSYCHIAT, V64, P651, DOI 10.1001/archpsyc.64.6.651; Monti JM, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00041; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Moser RS, 2002, ARCH CLIN NEUROPSYCH, V17, P91, DOI 10.1016/S0887-6177(01)00108-1; Nelson DL, 2004, BEHAV RES METH INS C, V36, P402, DOI 10.3758/BF03195588; Park H, 2013, NEUROPSYCHOLOGIA, V51, P448, DOI 10.1016/j.neuropsychologia.2012.11.025; Pedersen HA, 2014, AM J ALZHEIMERS DIS, V29, P201, DOI 10.1177/1533317513517036; Ptito A, 2007, NEUROREHABILITATION, V22, P217; Ranganath C, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-22-j0005.2000; RAUSCH R, 1993, ARCH NEUROL-CHICAGO, V50, P812, DOI 10.1001/archneur.1993.00540080023008; Rorden C, 2007, J COGNITIVE NEUROSCI, V19, P1081, DOI 10.1162/jocn.2007.19.7.1081; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Segalowitz SJ, 2001, BRAIN COGNITION, V45, P342, DOI 10.1006/brcg.2000.1263; Slobounov SM, 2010, EXP BRAIN RES, V202, P341, DOI 10.1007/s00221-009-2141-6; Swainson R, 2001, DEMENT GERIATR COGN, V12, P265, DOI 10.1159/000051269; Terry DP, 2012, BRAIN INJURY, V26, P1684, DOI 10.3109/02699052.2012.722259; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Wagner AD, 1998, NEUROREPORT, V9, P3711, DOI 10.1097/00001756-199811160-00026; Wechsler D., 2009, WECHSLER MEMORY SCAL; Zhang K, 2010, EXP BRAIN RES, V204, P57, DOI 10.1007/s00221-010-2294-3	90	11	11	0	39	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	JUN	2015	30	4					341	355		10.1093/arclin/acv020			15	Psychology, Clinical; Psychology	Psychology	CJ6VF	WOS:000355632300006	25903375	Green Published			2021-06-18	
J	Yamazaki, J; Gilgien, M; Kleiven, S; Mcintosh, AS; Nachbauer, W; Muller, E; Bere, T; Bahr, R; Krosshaug, T				Yamazaki, Junya; Gilgien, Matthias; Kleiven, Svein; Mcintosh, Andrew S.; Nachbauer, Werner; Mueller, Erich; Bere, Tone; Bahr, Roald; Krosshaug, Tron			Analysis of a Severe Head Injury in World Cup Alpine Skiing	MEDICINE AND SCIENCE IN SPORTS AND EXERCISE			English	Article						TRAUMATIC BRAIN INJURY; SKIING INJURY; ALPINE SKIING; HELMET; BIOMECHANICS; MODEL-BASED IMAGE MATCHING TECHNIQUE	VIDEO SEQUENCES; HELMET USE; SKIERS; SNOWBOARDERS; RISK; RECONSTRUCTION; MECHANISMS; MOTION; COHORT	Traumatic brain injury (TBI) is the leading cause of death in alpine skiing. It has been found that helmet use can reduce the incidence of head injuries between 15% and 60%. However, knowledge on optimal helmet performance criteria in World Cup alpine skiing is currently limited owing to the lack of biomechanical data from real crash situations. Purpose: This study aimed to estimate impact velocities in a severe TBI case in World Cup alpine skiing. Methods: Video sequences from a TBI case in World Cup alpine skiing were analyzed using a model-based image matching technique. Video sequences from four camera views were obtained in full high-definition (1080p) format. A three-dimensional model of the course was built based on accurate measurements of piste landmarks and matched to the background video footage using the animation software Poser 4. A trunk-neck-head model was used for tracking the skier's trajectory. Results: Immediately before head impact, the downward velocity component was estimated to be 8 m.s(-1). After impact, the upward velocity was 3 m.s(-1), whereas the velocity parallel to the slope surface was reduced from 33 m.s(-1) to 22 m.s(-1). The frontal plane angular velocity of the head changed from 80 radIsj1 left tilt immediately before impact to 20 rad.s(-1) right tilt immediately after impact. Conclusions: A unique combination of high-definition video footage and accurate measurements of landmarks in the slope made possible a high-quality analysis of head impact velocity in a severe TBI case. The estimates can provide crucial information on how to prevent TBI through helmet performance criteria and design.	[Yamazaki, Junya; Bahr, Roald; Krosshaug, Tron] Oslo Sports Trauma Res Ctr, Oslo, Norway; [Yamazaki, Junya] Tokyo Med & Dent Univ Hosp, Sch Med, Sect Orthoped Surg, Tokyo, Japan; [Gilgien, Matthias] Norwegian Sch Sport Sci, Dept Phys Performance, Oslo, Norway; [Kleiven, Svein] Royal Inst Technol, Stockholm, Sweden; [Mcintosh, Andrew S.] Federat Univ Australia, ACRISP, Ballarat, Vic, Australia; [Nachbauer, Werner] Univ Innsbruck, Dept Sport Sci, A-6020 Innsbruck, Austria; [Mueller, Erich] Salzburg Univ, Dept Sport & Exercise Sci, A-5020 Salzburg, Austria; [Bere, Tone] Aspetar Orthopaed & Sports Med Hosp, Doha, Qatar	Yamazaki, J (corresponding author), 1-5-45 Yushima,Bunkyo Ku, Tokyo 1138519, Japan.	kuma-kuma@yd5.so-net.ne.jp			Royal Norwegian Ministry of Culture; South-Eastern Norway Regional Health Authority; International Olympic Committee; Norwegian Olympic Committee & Confederation of Sport; Norsk Tipping AS	The Oslo Sports Trauma Research Center has been established at the Norwegian School of Sport Sciences through generous grants from the Royal Norwegian Ministry of Culture, the South-Eastern Norway Regional Health Authority, the International Olympic Committee, the Norwegian Olympic Committee & Confederation of Sport, and Norsk Tipping AS.	Ackery A, 2007, INJURY PREV, V13, P368, DOI 10.1136/ip.2007.017285; Bere T, 2014, BRIT J SPORT MED, V48, P36, DOI 10.1136/bjsports-2013-092206; Chinn B, 2001, COST 327 MOTORCYCLE; Ekeland A, 2006, SKI TRAU SAF, V16, P1; Fauve M, 2002, PREPARATION MAINTENA, P134; Florenes TW, 2009, BRIT J SPORT MED, V43, P973, DOI 10.1136/bjsm.2009.068759; FURRER M, 1995, J TRAUMA, V39, P737, DOI 10.1097/00005373-199510000-00024; Gilgien M., 2014, THESIS NORWEGIAN SCH; Gilgien M, 2014, J SPORTS SC IN PRESS; Gilgien M, 2014, BRIT J SPORT MED, V48, P742, DOI 10.1136/bjsports-2013-092994; Gilgien M, 2013, SENSORS-BASEL, V13, P9821, DOI 10.3390/s130809821; Hagel B, 2005, ACCIDENT ANAL PREV, V37, P103, DOI 10.1016/j.aap.2004.04.003; International Ski Federation, 2013, SPEC COMP EQ COMM MA; Koehle MS, 2002, SPORTS MED, V32, P785, DOI 10.2165/00007256-200232120-00003; Koga H, 2010, AM J SPORT MED, V38, P2218, DOI 10.1177/0363546510373570; Krosshaug T, 2007, SCAND J MED SCI SPOR, V17, P508, DOI 10.1111/j.1600-0838.2006.00558.x; Krosshaug T, 2005, J BIOMECH, V38, P919, DOI 10.1016/j.jbiomech.2004.04.033; McIntosh AS, 2012, P I MECH ENG P-J SPO, V226, P193, DOI 10.1177/1754337111431024; McIntosh AS, 2011, BRIT J SPORT MED, V45, P1258, DOI 10.1136/bjsports-2011-090509; McIntosh AS, 2000, MED SCI SPORT EXER, V32, P1980, DOI 10.1097/00005768-200012000-00002; Ruedl G, 2011, WILD ENVIRON MED, V22, P326, DOI 10.1016/j.wem.2011.06.008; Russell K, 2010, CAN MED ASSOC J, V182, P333, DOI 10.1503/cmaj.091080; Steenstrup SE, 2014, BRIT J SPORT MED, V48, P41, DOI 10.1136/bjsports-2013-093145; Sulheim S, 2006, JAMA-J AM MED ASSOC, V295, P919, DOI 10.1001/jama.295.8.919; Westin M, 2012, KNEE SURG SPORT TR A, V20, P1175, DOI 10.1007/s00167-012-1921-x; Wolfsperger F, 2013, 6 INT C SCI SKIING	26	11	11	1	15	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-9131	1530-0315		MED SCI SPORT EXER	Med. Sci. Sports Exerc.	JUN	2015	47	6					1113	1118		10.1249/MSS.0000000000000511			6	Sport Sciences	Sport Sciences	CI4TC	WOS:000354745500002	25207934	Green Published, Green Accepted			2021-06-18	
J	Sherer, M; Davis, LC; Sander, AM; Nick, TG; Luo, CQ; Pastorek, N; Hanks, R				Sherer, Mark; Davis, Lynne C.; Sander, Angelle M.; Nick, Todd G.; Luo, Chunqiao; Pastorek, Nicholas; Hanks, Robin			Factors Associated with Word Memory Test Performance in Persons with Medically Documented Traumatic Brain Injury	CLINICAL NEUROPSYCHOLOGIST			English	Article						Performance validity; Traumatic brain injury; Neuropsychological assessment.; Word Memory Test; Effort	NEUROPSYCHOLOGICAL TEST-PERFORMANCE; POSTTRAUMATIC-STRESS-DISORDER; SYMPTOM VALIDITY TESTS; HEAD-INJURY; COGNITIVE SYMPTOMS; TEST FAILURE; POOR EFFORT; TEST-SCORES; VETERANS; CLAIMANTS	Objectives: (1) To examine the rate of poor performance validity in a large, multicenter, prospectively accrued cohort of community dwelling persons with medically documented traumatic brain injury (TBI), (2) to identify factors associated with Word Memory Test (WMT) performance in persons with TBI. Method: This was a prospective cohort, observational study of 491 persons with medically documented TBI. Participants were administered a battery of cognitive tests, questionnaires on emotional distress and post-concussive symptoms, and a performance validity test (WMT). Additional data were collected by interview and review of medical records. Results: One hundred and seventeen participants showed poor performance validity using the standard cutoff. Variable cluster analysis was conducted as a data reduction strategy. Findings revealed that the 10 cognitive tests and questionnaires could be summarized as 4 indices of emotional distress, speed of cognitive processing, verbal memory, and verbal fluency. Regression models revealed that verbal memory, emotional distress, age, and injury severity (time to follow commands) made unique contribution to prediction of poor performance validity. Conclusions: Poor performance validity was common in a research sample of persons with medically documented TBI who were not evaluated in conjunction with litigation, compensation claims, or current report of symptoms. Poor performance validity was associated with poor performance on cognitive tests, greater emotional distress, lower injury severity, and greater age. Many participants expected to have residual deficits based on initial injury severity showed poor performance validity.	[Sherer, Mark; Davis, Lynne C.] TIRR Mem Hermann, Brain Injury Res Ctr, Houston, TX 77030 USA; [Sander, Angelle M.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Sander, Angelle M.] TIRR Mem Hermann, Brain Injury Res Ctr, Harris Hlth Syst, Houston, TX 77030 USA; [Nick, Todd G.; Luo, Chunqiao] Univ Arkansas Med Sci, Coll Med, Dept Pediat, Biostat Program, Little Rock, AR 72205 USA; [Pastorek, Nicholas] Baylor Coll Med, Michael E DeBakey VA Med Ctr, Dept Phys Med & Rehabil, Rehabil & Extended Care Line, Houston, TX 77030 USA; [Hanks, Robin] Wayne State Univ, Sch Med, Dept Phys Med & Rehabil, Rehabil Inst Michigan, Detroit, MI USA	Sherer, M (corresponding author), TIRR Mem Hermann, Brain Injury Res Ctr, 1333 Moursund St, Houston, TX 77030 USA.	Mark.Sherer@memorialhermann.org					[Anonymous], 2009, SAS STAT VERS 9 2 CO; Armistead-Jehle P, 2015, APPL NEUROPSYCH-ADUL, V22, P147, DOI 10.1080/23279095.2014.880842; Armistead-Jehle P, 2013, ARCH CLIN NEUROPSYCH, V28, P297, DOI 10.1093/arclin/act017; Axelrod BN, 2010, CLIN NEUROPSYCHOL, V24, P873, DOI 10.1080/13854040903527295; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bowden SC, 2006, CLIN NEUROPSYCHOL, V20, P858, DOI 10.1080/13854040500246935; Brockhaus R, 2004, NERVENARZT, V75, P882, DOI 10.1007/s00115-003-1592-4; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Clark AL, 2014, CLIN NEUROPSYCHOL, V28, P802, DOI 10.1080/13854046.2014.904928; Cook KF, 2011, ARCH PHYS MED REHAB, V92, P818, DOI 10.1016/j.apmr.2010.12.008; Corrigan J, 2003, TECHNICAL REPORT PRO; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Donders J, 2007, BRAIN INJURY, V21, P319, DOI 10.1080/02699050701253129; Donders J, 2013, J CLIN EXP NEUROPSYC, V35, P827, DOI 10.1080/13803395.2013.824557; Drag LL, 2012, J INT NEUROPSYCH SOC, V18, P576, DOI 10.1017/S1355617712000203; Flaro L, 2007, BRAIN INJURY, V21, P373, DOI 10.1080/02699050701311133; Gervais RO, 2004, ARCH CLIN NEUROPSYCH, V19, P475, DOI 10.1016/j.acn.2003.05.001; Gladsjo JA, 1999, ASSESSMENT, V6, P147, DOI 10.1177/107319119900600204; Green P, 2009, BRAIN INJURY, V23, P741, DOI 10.1080/02699050903133962; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Green P, 1999, BRAIN INJURY, V13, P813, DOI 10.1080/026990599121205; Green P., 2003, GREENS WORD MEMORY T; Green P., 2003, J FORENSIC NEUROPSYC, V2, P97, DOI DOI 10.1300/J151V02N03_05; Green Paul, 2007, Phys Med Rehabil Clin N Am, V18, P43, DOI 10.1016/j.pmr.2006.11.002; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Harch PG, 2012, J NEUROTRAUM, V29, P168, DOI 10.1089/neu.2011.1895; Harrell F. E., 2009, RMS S FUNCTIONS BIOS; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Krishnan M, 2011, ARCH CLIN NEUROPSYCH, V26, P176, DOI 10.1093/arclin/acr010; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lange RT, 2012, J CLIN EXP NEUROPSYC, V34, P453, DOI 10.1080/13803395.2011.648175; Lange RT, 2010, J CLIN EXP NEUROPSYC, V32, P961, DOI 10.1080/13803391003645657; Larrabee GJ, 2000, J CLIN EXP NEUROPSYC, V22, P702, DOI 10.1076/1380-3395(200010)22:5;1-9;FT702; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; Lippa SM, 2014, ARCH CLIN NEUROPSYCH, V29, P236, DOI 10.1093/arclin/acu002; McCormick CL, 2013, ARCH CLIN NEUROPSYCH, V28, P808, DOI 10.1093/arclin/act050; Meyers JE, 2014, ARCH CLIN NEUROPSYCH, V29, P224, DOI 10.1093/arclin/acu001; Meyers JE, 2011, ARCH CLIN NEUROPSYCH, V26, P8, DOI 10.1093/arclin/acq083; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Reitan RM., 1985, HALSTEAD REITAN NEUR; Rey A., 1958, LEXAMEN CLINIQUE PSY; Rohling ML, 2010, CLIN NEUROPSYCHOL, V24, P119, DOI 10.1080/13854040903307243; Russo AC, 2012, ARCH CLIN NEUROPSYCH, V27, P840, DOI 10.1093/arclin/acs090; Sherer M., REHABILITAT IN PRESS; Spencer RJ, 2010, J REHABIL RES DEV, V47, P521, DOI 10.1682/JRRD.2009.11.0181; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Stevens A, 2008, PSYCHIAT RES, V157, P191, DOI 10.1016/j.psychres.2007.01.003; Tan JE, 2002, CLIN NEUROPSYCHOL, V16, P495, DOI 10.1076/clin.16.4.495.13909; Van Dyke SA, 2010, MIL MED, V175, P947, DOI 10.7205/MILMED-D-10-00337; Vanderploeg RD, 2013, J HEAD TRAUMA REHAB, V28, P211, DOI 10.1097/HTR.0b013e31828b50db; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th ed; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wisdom NM, 2014, CLIN NEUROPSYCHOL, V28, P128, DOI 10.1080/13854046.2013.863977	61	11	11	0	9	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	MAY 19	2015	29	4					522	541		10.1080/13854046.2015.1052763			20	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	CM8FZ	WOS:000357935100009	26063081				2021-06-18	
J	Clark, JF; Colosimo, A; Ellis, JK; Mangine, R; Bixenmann, B; Hasselfeld, K; Graman, P; Elgendy, H; Myer, G; Divine, J				Clark, Joseph F.; Colosimo, Angelo; Ellis, James K.; Mangine, Robert; Bixenmann, Benjamin; Hasselfeld, Kimberly; Graman, Patricia; Elgendy, Hagar; Myer, Gregory; Divine, Jon			Vision Training Methods for Sports Concussion Mitigation and Management	JOVE-JOURNAL OF VISUALIZED EXPERIMENTS			English	Article						Behavior; Issue 99; Vision training; peripheral vision; functional peripheral vision; concussion; concussion management; diagnosis; rehabilitation; eyes; sight; seeing; sight	TEST-RETEST RELIABILITY; POSITION STATEMENT; PERFORMANCE; PROGRAM; BATTERS	There is emerging evidence supporting the use vision training, including light board training tools, as a concussion baseline and neuro-diagnostic tool and potentially as a supportive component to concussion prevention strategies. This paper is focused on providing detailed methods for select vision training tools and reporting normative data for comparison when vision training is a part of a sports management program. The overall program includes standard vision training methods including tachistoscope, Brock's string, and strobe glasses, as well as specialized light board training algorithms. Stereopsis is measured as a means to monitor vision training affects. In addition, quantitative results for vision training methods as well as baseline and post-testing *A and Reaction Test measures with progressive scores are reported. Collegiate athletes consistently improve after six weeks of training in their stereopsis, *A and Reaction Test scores. When vision training is initiated as a team wide exercise, the incidence of concussion decreases in players who participate in training compared to players who do not receive the vision training. Vision training produces functional and performance changes that, when monitored, can be used to assess the success of the vision training and can be initiated as part of a sports medical intervention for concussion prevention.	[Clark, Joseph F.] Univ Cincinnati, Neurol & Rehabilitat Med, Cincinnati, OH 45221 USA; [Colosimo, Angelo; Hasselfeld, Kimberly; Elgendy, Hagar; Divine, Jon] Univ Cincinnati, Dept Orthopaed Surg, Div Sports Med, Cincinnati, OH 45221 USA; [Ellis, James K.; Mangine, Robert] Univ Cincinnati, Dept Athlet, Cincinnati, OH 45221 USA; [Bixenmann, Benjamin] Univ Cincinnati, Dept Neurosurg, Cincinnati, OH 45221 USA; [Graman, Patricia] Univ Cincinnati, Coll Educ Criminal Justice & Human Serv, Cincinnati, OH 45221 USA; [Myer, Gregory] Cincinnati Childrens Hosp Med Ctr, Div Sports Med, Cincinnati, OH 45229 USA	Hasselfeld, K (corresponding author), Univ Cincinnati, Dept Orthopaed Surg, Div Sports Med, Cincinnati, OH 45221 USA.	hasselky@ucmail.uc.edu	Myer, Gregory/H-6572-2016	Myer, Gregory/0000-0002-9983-8422	NIBIBUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [EB007954]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [U54EB007954] Funding Source: NIH RePORTER	This work was supported, in part by the NIBIB (EB007954) and a charitable donation from Geraldine Warner.	Bigsby K, 2014, INT J SPORTS PHYS TH, V9, P436; Clark J. F., 2015, OPTOMETRY VISUAL PER, V3; Clark JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029109; Fleisig GS, 2006, AM J SPORT MED, V34, P423, DOI 10.1177/0363546505280431; Ghasemi A, 2011, PERCEPT MOTOR SKILL, V112, P161, DOI 10.2466/05.22.24.27.PMS.112.1.161-171; Gray R, 2009, RES Q EXERCISE SPORT, V80, P491; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hayes A, 2012, NEUROREHABILITATION, V31, P19, DOI 10.3233/NRE-2012-0771; Howard I., 2012, PERCEIVING IN DEPTH, P978; Kato T, 2002, PERCEPT MOTOR SKILL, V94, P380, DOI 10.2466/pms.2002.94.2.380; KLAVORA P, 1994, PERCEPT MOTOR SKILL, V79, P448, DOI 10.2466/pms.1994.79.1.448; KLAVORA P, 1995, PERCEPT MOTOR SKILL, V80, P607, DOI 10.2466/pms.1995.80.2.607; Kuhn AW, 2014, J ATHL TRAINING, V49, P800, DOI 10.4085/1062-6050-49.3.66; Ramsey K, 2014, SEE HIT SAVE BRAIN G; Reed N, 2014, JOVE-J VIS EXP, DOI 10.3791/51892; Schwab S, 2012, J SPORT SCI MED, V11, P624; Solomon J, 2013, COLL FOOTBALL CONCUS; SOMERS WW, 1984, OPHTHAL PHYSL OPT, V4, P245, DOI 10.1111/j.1475-1313.1984.tb00362.x; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Vesia M, 2008, PERCEPT MOTOR SKILL, V107, P14, DOI 10.2466/PMS.107.1.14-20; Wells AJ, 2014, J SPORT SCI MED, V13, P145; Wilkerson GB, 2012, INT J ATHL THER TRAI, V17, P4, DOI 10.1123/ijatt.17.6.4; Wolverton B, 2013, COACH MAKES THE CALL; Zupan M., 2015, TRAINING CONDITIONIN, V21, P11	25	11	11	1	24	JOURNAL OF VISUALIZED EXPERIMENTS	CAMBRIDGE	1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA	1940-087X			JOVE-J VIS EXP	J. Vis. Exp.	MAY	2015		99							e52648	10.3791/52648			11	Multidisciplinary Sciences	Science & Technology - Other Topics	CR7MV	WOS:000361535300032	25992878	Green Published			2021-06-18	
J	Fowler, JN; Pallanta, AA; Swanik, CB; Wagner, NJ				Fowler, Jeremy N.; Pallanta, Anthony A.; Swanik, Charles B.; Wagner, Norman J.			The Use of Shear Thickening Nanocomposites in Impact Resistant Materials	JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME			English	Article							CHRONIC TRAUMATIC ENCEPHALOPATHY; COLLEGIATE FOOTBALL PLAYERS; RHEOLOGICAL PROPERTIES; BRAIN-INJURY; CONCUSSION; EPIDEMIOLOGY; BIOMECHANICS	The work presented here demonstrates using a novel, field-responsive nanocomposite based on shear thickening fluids (STFs) as responsive protective materials with superior damping and energy adsorption properties. Peak forces and accelerations measured using an instrumented Instron (TM) drop tower demonstrate that STF nanocomposite prototypes and impact foam taken from a commercial football helmet have similar performance for low kinetic energy impacts. However, tests with STF nanocomposite samples exhibit significantly reduced peak acceleration and peak force for impacts above 15 J. Thus, the STF containing nanocomposite material provides improved energy adsorption upon impact as compared to the commercial foam. These tests suggest that STF nanocomposite materials have promising potential as novel energy dissipating components in personal protective equipment.	[Fowler, Jeremy N.; Pallanta, Anthony A.; Wagner, Norman J.] Univ Delaware, Dept Chem & Biomol Engn, Newark, DE 19716 USA; [Swanik, Charles B.] Univ Delaware, Dept Kinesiol & Appl Physiol, Newark, DE 19716 USA	Fowler, JN (corresponding author), Syngenta Crop Protect LLC, POB 18300, Greensboro, NC 27419 USA.		Wagner, Norman J/B-6558-2012	Wagner, Norman J/0000-0001-9565-619X			Barth JT, 2001, J ATHL TRAINING, V36, P253; Bender J, 1996, J RHEOL, V40, P899, DOI 10.1122/1.550767; Binder S, 2005, J HEAD TRAUMA REHAB, V20, P189, DOI 10.1097/00001199-200505000-00002; Booher MA, 2003, CLIN J SPORT MED, V13, P93, DOI 10.1097/00042752-200303000-00005; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Decker MJ, 2007, COMPOS SCI TECHNOL, V67, P565, DOI 10.1016/j.compscitech.2006.08.007; Galindo-Rosales FJ, 2011, J NON-NEWTON FLUID, V166, P1421, DOI 10.1016/j.jnnfm.2011.08.008; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Kalman DP, 2009, ACS APPL MATER INTER, V1, P2602, DOI 10.1021/am900516w; Kalman DP, 2009, RHEOL ACTA, V48, P897, DOI 10.1007/s00397-009-0351-2; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LAUN HM, 1984, ANGEW MAKROMOL CHEM, V123, P335, DOI 10.1002/apmc.1984.051230115; Lee YS, 2006, IND ENG CHEM RES, V45, P7015, DOI 10.1021/ie0512690; Lee YS, 2003, J MATER SCI, V38, P2825, DOI 10.1023/A:1024424200221; Maranzano BJ, 2001, J CHEM PHYS, V114, P10514, DOI 10.1063/1.1373687; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Melrose JR, 2004, J RHEOL, V48, P937, DOI 10.1122/1.1784783; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Stojsih S, 2010, BRIT J SPORT MED, V44, P725, DOI 10.1136/bjsm.2008.052845; Thomas M, 2011, PEDIATRICS, V128, pE1, DOI 10.1542/peds.2010-2743; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; Viano DC, 2005, SOLID MECH APPL, V124, P121; Wagner NJ, 2009, PHYS TODAY, V62, P27, DOI 10.1063/1.3248476; YOGANANDAN N, 1995, J NEUROTRAUM, V12, P659, DOI 10.1089/neu.1995.12.659	31	11	13	1	51	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0148-0731	1528-8951		J BIOMECH ENG-T ASME	J. Biomech. Eng.-Trans. ASME	MAY	2015	137	5							054504	10.1115/1.4029982			6	Biophysics; Engineering, Biomedical	Biophysics; Engineering	CF0YQ	WOS:000352271000015	25751789				2021-06-18	
J	Ganti, L; Conroy, LM; Bodhit, A; Daneshvar, Y; Patel, PS; Ayala, S; Kuchibhotla, S; Hatchitt, K; Pulvinott, C; Peters, KR; Lottenberg, LL				Ganti, Latha; Conroy, Lauren M.; Bodhit, Aakash; Daneshvar, Yasamin; Patel, Pratik Shashikant; Ayala, Sarah; Kuchibhotla, Sudeep; Hatchitt, Kelsey; Pulvinott, Christa; Peters, Keith R.; Lottenberg, Lawrence L.			Understanding Why Patients Return to the Emergency Department after Mild Traumatic Brain Injury within 72 Hours	WESTERN JOURNAL OF EMERGENCY MEDICINE			English	Article							DETERIORATION; RECIDIVISM; UNIT; CARE	Introduction: Although there are approximately 1,1 million case presentations of mild traumatic brain injury (mTBI) in the emergency department (ED) each year, little data is available to clinicians to identify patients who are at risk for poor outcomes, including 72-hour ED return after discharge. An understanding of patients at risk for ED return visits during the hyperacute phase following head injury would allow ED providers to develop clinical interventions that reduce its occurrence and improve outcomes. Methods: This institutional review board-approved consecutive cohort study collected injury and outcome variables on adults with the purpose of identifying positive predictors for 72-hour ED return visits in mTBI patients. Results: Of 2,787 mTBI patients, 145 (5%) returned unexpectedly to the ED within 72 hours of hospital discharge. Positive predictors for ED return visits included being male (p=0,0298), being black (p=0.0456), having a lower prehospital Glasgow Coma Score (p=0.0335), suffering the injury due to a motor vehicle collision (p=0.0065), or having a bleed on head computed tomography (CT) (p=0.0334). ED return visits were not significantly associated with age, fracture on head CT, or synnptonnology following head trauma, Patients with retum visits most commonly reported post-concussion syndrome (43.1%), pain (18.7%), and recall for further clinical evaluation (14,6%) as the reason for retum. Of the 124 patients who returned to the ED within 72 hours, one out of five were admitted to the hospital for further care, with five requiring intensive care unit stays and four undergoing neurosurgery. Conclusion: Approximately 5% of adult patients who present to the ED for mTBI will return within 72 hours of discharge for further care. Clinicians should identify at-risk individuals during their initial visits and attempt to provide anticipatory guidance when possible.	[Ganti, Latha] North Florida South Georgia Vet Affairs Med Ctr, 619 S Marion Ave, Lake City, FL 32025 USA; [Conroy, Lauren M.] Univ Florida, Coll Med, Gainesville, FL USA; [Bodhit, Aakash] St Louis Univ, Dept Neurol, St Louis, MO 63103 USA; [Daneshvar, Yasamin] NYU, Coll Arts & Sci, New York, NY USA; [Patel, Pratik Shashikant] Univ Florida, Dept Emergency Med, Gainesville, FL USA; [Ayala, Sarah] Univ Calif San Diego, Coll Arts & Sci, San Diego, CA 92103 USA; [Kuchibhotla, Sudeep] Florida State Univ, Coll Med, Tallahassee, FL 32306 USA; [Hatchitt, Kelsey] George Washington Univ, Washington, DC USA; [Pulvinott, Christa] Tulane Univ, New Orleans, LA 70118 USA; [Peters, Keith R.] Univ Florida, Dept Radiol, Gainesville, FL 32610 USA; [Lottenberg, Lawrence L.] Univ Florida, Dept Surg, Gainesville, FL USA	Ganti, L (corresponding author), North Florida South Georgia Vet Affairs Med Ctr, 619 S Marion Ave, Lake City, FL 32025 USA.	lathagantimd@gmail.com	Ganti, Latha/AAF-6268-2020; Bodhit, Aakash/AAM-5786-2021	Ganti, Latha/0000-0001-7717-3864; Bodhit, Aakash/0000-0003-2722-025X			Carlson AP, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.8.FOCUS10182; Caufeild J, 2004, J TRAUMA, V57, P872, DOI 10.1097/01.TA.0000135350.06670.60; Centers for Disease Control and Prevention, 2010, TRAUMATIC BRAIN INJU; Choudhry OJ, 2013, NEUROSURGERY, V73, P753, DOI 10.1227/NEU.0000000000000105; Ganti L, 2014, INT J EMERG MED, V7, DOI 10.1186/s12245-014-0031-6; Goh S. H., 1996, Annals Academy of Medicine Singapore, V25, P541; Madden C, 1997, ACAD EMERG MED, V4, P772, DOI 10.1111/j.1553-2712.1997.tb03782.x; McCoy AM, 2013, J TRAUMA ACUTE CARE, V75, P116, DOI 10.1097/TA.0b013e31829231b7; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Miro O, 1999, MED CLIN-BARCELONA, V112, P610; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; REDELMEIER DA, 1995, LANCET, V345, P1131, DOI 10.1016/S0140-6736(95)90975-3; Reuben A, 2014, EMERG MED J, V31, P72, DOI 10.1136/emermed-2012-201667; Sayfan J, 1997, J TRAUMA, V43, P123, DOI 10.1097/00005373-199707000-00028; Schaller B, 2010, EMERG MED J, V27, P537, DOI 10.1136/emj.2009.073031; Stead LG, 2013, INT J EMERG MED, V6, DOI 10.1186/1865-1380-6-5; STERN RS, 1991, JAMA-J AM MED ASSOC, V266, P2238, DOI 10.1001/jama.266.16.2238; Williams JM, 1997, ANN EMERG MED, V30, P176, DOI 10.1016/S0196-0644(97)70139-2	18	11	11	0	3	WESTJEM	ORANGE	C/O SHAHRAM LOTFIPOUR, MD, MPH, 333 CITY BLVD W STE 640, RT 128-01, ORANGE, CA 92868 USA	1936-900X	1936-9018		WEST J EMERG MED	West. J. Emerg. Med.	MAY	2015	16	3					481	485		10.5811/westjem.2015.2.23546			5	Emergency Medicine	Emergency Medicine	DH9KV	WOS:000373115900027	25987933	DOAJ Gold, Green Published			2021-06-18	
J	Hall, EE; Ketcham, CJ; Crenshaw, CR; Baker, MH; McConnell, JM; Patel, K				Hall, Eric E.; Ketcham, Caroline J.; Crenshaw, Cayce R.; Baker, Martin H.; McConnell, Jodi M.; Patel, Kirtida			Concussion Management in Collegiate Student-Athletes: Return-To-Academics Recommendations	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						cognitive rest; brain injury; recovery	SPORT-RELATED CONCUSSION; INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; RECOVERY; SCHOOL; PATHOPHYSIOLOGY; ZURICH; REST	Concussions in collegiate athletics can affect student-athletes both on the field and in the classroom. As policies are made to outline return-to-play decisions and timelines, this article will make the case that return-to-academics should also be included and follow a step-wise protocol. Complete cognitive rest is a cornerstone of concussion recovery and slow reintroduction to academics should precede return-to-play. The college structure allows for student-athletes to begin small doses of cognitive activity after the recommended complete cognitive rest. It is recommended that return-to-academics involves a team approach to help the student-athlete navigate the responsibilities of course work while healing from a brain injury.	[Hall, Eric E.; Ketcham, Caroline J.] Elon Univ, Dept Exercise Sci, Elon, NC 27244 USA; [Crenshaw, Cayce R.; Baker, Martin H.; McConnell, Jodi M.; Patel, Kirtida] Elon Univ, Dept Athlet, Elon, NC 27244 USA	Hall, EE (corresponding author), Elon Univ, Dept Exercise Sci, 2525 Campus Box, Elon, NC 27244 USA.	ehall@elon.edu					Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Davis GA, 2014, BRIT J SPORT MED, V48, P98, DOI 10.1136/bjsports-2012-092132; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Grady MF, 2012, PEDIATR ANN, V41, P377, DOI 10.3928/00904481-20120827-12; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Iverson G, 2007, CLIN J SPORT MED, V17, P31; Johnson EW, 2011, CLIN SPORT MED, V30, P73, DOI 10.1016/j.csm.2010.08.007; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lau BC, 2012, NEUROSURGERY, V70, P371, DOI 10.1227/NEU.0b013e31823150f0; Lovell MR, 2006, SPORTS NEUROPSYCHOLO, P176; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Makdissi M, 2013, BRIT J SPORT MED, V47, P308, DOI 10.1136/bjsports-2013-092255; Master CL, 2012, PEDIATR ANN, V41, pE180, DOI 10.3928/00904481-20120827-09; McCrory Paul, 2005, Clin J Sport Med, V15, P48; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; McLeod TCV, 2010, ATHLET THER TODAY, V15, P1, DOI 10.1123/att.15.2.1; Moser RS, 2012, J PEDIATR-US, V161, P922, DOI 10.1016/j.jpeds.2012.04.012; National Collegiate Athletic Association, 2013, 2013 2014 NCAA SPORT; Nowinski C, 2013, CEREBRUM; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; Schatz P, 2006, SPORTS NEUROPSYCHOLO, P160; Schneider KJ, 2013, BRIT J SPORT MED, V47, P304, DOI 10.1136/bjsports-2013-092190; Scorza KA, 2012, AM FAM PHYSICIAN, V85, P123	26	11	11	0	24	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	MAY	2015	25	3					291	296		10.1097/JSM.0000000000000133			6	Orthopedics; Physiology; Sport Sciences	Orthopedics; Physiology; Sport Sciences	CH3EX	WOS:000353911700015	25010153				2021-06-18	
J	Kowalski, RG; Buitrago, MM; Duckworth, J; Chonka, ZD; Puttgen, HA; Stevens, RD; Geocadin, RG				Kowalski, Robert G.; Buitrago, Manuel M.; Duckworth, Josh; Chonka, Zachary D.; Puttgen, H. Adrian; Stevens, Robert D.; Geocadin, Romergryko G.			Neuroanatomical Predictors of Awakening in Acutely Comatose Patients	ANNALS OF NEUROLOGY			English	Article							TRAUMATIC BRAIN-INJURY; COMPUTERIZED-TOMOGRAPHY FINDINGS; SEVERE HEAD-INJURY; MIDLINE SHIFT; CT-SCAN; TRANSTENTORIAL HERNIATION; ADMISSION CHARACTERISTICS; INTRACEREBRAL HEMORRHAGE; SUBDURAL-HEMATOMA; CONSCIOUSNESS	ObjectiveLateral brain displacement has been associated with loss of consciousness and poor outcome in a range of acute neurologic disorders. We studied the association between lateral brain displacement and awakening from acute coma. MethodsThis prospective observational study included all new onset coma patients admitted to the Neurosciences Critical Care Unit (NCCU) over 12 consecutive months. Head computed tomography (CT) scans were analyzed independently at coma onset, after awakening, and at follow-up. Primary outcome measure was awakening, defined as the ability to follow commands before hospital discharge. Secondary outcome measures were discharge Glasgow Coma Scale (GCS), modified Rankin Scale, Glasgow Outcome Scale, and hospital and NCCU lengths of stay. ResultsOf the 85 patients studied, the mean age was 5816 years, 51% were female, and 78% had cerebrovascular etiology of coma. Fifty-one percent of patients had midline shift on head CT at coma onset and 43 (51%) patients awakened. In a multivariate analysis, independent predictors of awakening were younger age (odds ratio [OR]=1.039, 95% confidence interval [CI]=1.002-1.079, p=0.040), higher GCS score at coma onset (OR=1.455, 95% CI=1.157-1.831, p=0.001), nontraumatic coma etiology (OR=4.464, 95% CI=1.011-19.608, p=0.048), lesser pineal shift on follow-up CT (OR=1.316, 95% CI=1.073-1.615, p=0.009), and reduction or no increase in pineal shift on follow-up CT (OR=11.628, 95% CI=2.207-62.500, p=0.004). InterpretationReversal and/or limitation of lateral brain displacement are associated with acute awakening in comatose patients. These findings suggest objective parameters to guide prognosis and treatment in patients with acute onset of coma. Ann Neurol 2015;77:804-816	[Kowalski, Robert G.; Buitrago, Manuel M.; Duckworth, Josh; Puttgen, H. Adrian; Stevens, Robert D.; Geocadin, Romergryko G.] Johns Hopkins Univ Hosp, Neurosci Crit Care Div, Dept Neurol, Baltimore, MD 21287 USA; [Kowalski, Robert G.; Buitrago, Manuel M.; Duckworth, Josh; Puttgen, H. Adrian; Stevens, Robert D.; Geocadin, Romergryko G.] Johns Hopkins Univ Hosp, Neurosci Crit Care Div, Dept Neurosurg, Baltimore, MD 21287 USA; [Kowalski, Robert G.; Buitrago, Manuel M.; Duckworth, Josh; Puttgen, H. Adrian; Stevens, Robert D.; Geocadin, Romergryko G.] Johns Hopkins Univ Hosp, Neurosci Crit Care Div, Dept Anesthesiol Crit Care Med, Baltimore, MD 21287 USA; [Chonka, Zachary D.] Johns Hopkins Univ Hosp, Dept Radiol, Baltimore, MD 21287 USA; [Geocadin, Romergryko G.] Johns Hopkins Univ Hosp, Dept Med, Baltimore, MD 21287 USA	Kowalski, RG (corresponding author), Johns Hopkins Univ Hosp, Phipps 455,600 N Wolfe St, Baltimore, MD 21287 USA.	rkowalski@gmail.com		Puttgen, Hans/0000-0003-4016-6825	Johns Hopkins University School of MedicineJohns Hopkins University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL071568] Funding Source: NIH RePORTER	Johns Hopkins University School of Medicine.	Chiewvit Pipat, 2010, Journal of the Medical Association of Thailand, V93, P99; CLIFTON GL, 1980, J NEUROSURG, V52, P611, DOI 10.3171/jns.1980.52.5.0611; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Fogelholm R, 2005, J NEUROL NEUROSUR PS, V76, P1534, DOI 10.1136/jnnp.2004.055145; Hu K, 2009, J NEUROTRAUM, V26, P227, DOI 10.1089/neu.2008.0643; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Ibrahim GM, 2011, J NEUROSURG, V115, P1191, DOI 10.3171/2011.7.JNS11725; Jacobs B, 2010, J NEUROTRAUM, V27, P331, DOI 10.1089/neu.2009.1105; Koenig MA, 2008, NEUROLOGY, V70, P1023, DOI 10.1212/01.wnl.0000304042.05557.60; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; LOBATO RD, 1988, J NEUROSURG, V68, P417, DOI 10.3171/jns.1988.68.3.0417; LOBATO RD, 1991, J NEUROSURG, V75, P256, DOI 10.3171/jns.1991.75.2.0256; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Massaro F, 1996, ACTA NEUROCHIR, V138, P185, DOI 10.1007/BF01411359; Nelson DW, 2010, J NEUROTRAUM, V27, P51, DOI 10.1089/neu.2009.0986; QUATTROCCHI KB, 1991, SURG NEUROL, V35, P183, DOI 10.1016/0090-3019(91)90069-L; Qureshi AI, 2000, CRIT CARE MED, V28, P1556, DOI 10.1097/00003246-200005000-00049; ROPPER AH, 1986, NEW ENGL J MED, V314, P953, DOI 10.1056/NEJM198604103141504; ROSS DA, 1989, J NEUROSURG, V71, P498, DOI 10.3171/jns.1989.71.4.0498; SALVANT JB, 1993, NEUROSURGERY, V33, P387; Schmidt EA, 2003, J NEUROSURG, V99, P991, DOI 10.3171/jns.2003.99.6.0991; Song Z, 2012, CLIN NEUROL NEUROSUR, V114, P634, DOI 10.1016/j.clineuro.2011.12.029; Sternbach GL, 2000, J EMERG MED, V19, P67, DOI 10.1016/S0736-4679(00)00182-7; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; TOUTANT SM, 1984, J NEUROSURG, V61, P691, DOI 10.3171/jns.1984.61.4.0691; Voss HU, 2011, CLIN IMAG, V35, P253, DOI 10.1016/j.clinimag.2010.07.008; WONG CW, 1995, ACTA NEUROCHIR, V135, P131, DOI 10.1007/BF02187756; Young GB, 2011, NEUROL CLIN, V29, P765, DOI 10.1016/j.ncl.2011.07.008; Yuh EL, 2012, J NEUROTRAUM, V29, P735, DOI 10.1089/neu.2011.2008	30	11	11	0	6	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0364-5134	1531-8249		ANN NEUROL	Ann. Neurol.	MAY	2015	77	5					804	816		10.1002/ana.24381			13	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CG4EF	WOS:000353235400009	25628166	Green Accepted			2021-06-18	
J	Stelmashook, EV; Genrikhs, EE; Novikova, SV; Barskov, IV; Gudasheva, TA; Seredenin, SB; Khaspekov, LG; Isaev, NK				Stelmashook, Elena V.; Genrikhs, Elisaveta E.; Novikova, Svetlana V.; Barskov, Igor V.; Gudasheva, Tatyana A.; Seredenin, Sergey B.; Khaspekov, Leonid G.; Isaev, Nickolay K.			Behavioral effect of dipeptide NGF mimetic GK-2 in an in vivo model of rat traumatic brain injury and its neuroprotective and regenerative properties in vitro	INTERNATIONAL JOURNAL OF NEUROSCIENCE			English	Article						traumatic brain injury; neuroprotection; dipeptide mimetic of nerve growth factor; GK-2; cerebellar granule cultures	NERVE GROWTH-FACTOR; DEFICITS; MITOCHONDRIA; ISCHEMIA; DESIGN; LIGAND; EDEMA	A protective behavioral effect of a nerve growth factor dipeptide mimetic GK-2 in the model of open focal trauma of rat brain sensorimotor cortex and its antioxidative and regenerative properties in cultures of rat cerebellar granule cells and mouse embryonal spinal ganglion, respectively, were studied. Intraperitoneal injections of GK-2 (1 mg/kg) for 5 days daily after traumatic brain injury improved significantly motor function of limbs. Moreover, supplementation the incubation medium with GK-2 (0.5-1.5 mg/l) decreased neuronal death induced by H2O2] in cerebellar granule cell cultures and stimulated neurite outgrowth from cultured mouse embryonal spinal ganglia. Our results suggest that GK-2 exhibits pronounced positive behavioral effect in vivo as well as neuroprotective and regenerative effects in vitro, and that these neuroprotective properties probably associated with cell survival but not with cell differentiation pathway.	[Stelmashook, Elena V.; Genrikhs, Elisaveta E.; Novikova, Svetlana V.; Barskov, Igor V.; Khaspekov, Leonid G.; Isaev, Nickolay K.] Russian Acad Med Sci, Res Ctr Neurol, Moscow 125367, Russia; [Gudasheva, Tatyana A.; Seredenin, Sergey B.] Russian Acad Med Sci, VV Zakusov Inst Pharmacol, Moscow 125367, Russia; [Isaev, Nickolay K.] Lomonosov Moscow State Univ, Belozersky Inst Physicochem Biol, Moscow, Russia	Stelmashook, EV (corresponding author), Russian Acad Med Sci, Res Ctr Neurol, Volokolamskoe Shosse 80, Moscow 125367, Russia.	estelmash@mail.ru	Genrikhs, Elizaveta E/C-3854-2012; Stelmashook, Elena V/B-4442-2012; Isaev, Nikolay K/B-4194-2012; Gudasheva, Tatiana/A-5242-2017; Seredenin, Sergey B/S-6574-2016; Khaspekov, Leonid/B-9327-2012; Frumkina, Lidia E/B-9971-2012	Seredenin, Sergey B/0000-0003-4482-9331; Khaspekov, Leonid/0000-0002-6652-9412; 	Russian Foundation for Basic ResearchRussian Foundation for Basic Research (RFBR) [12-04-00025-a]	This work was supported by the Russian Foundation for Basic Research (project 12-04-00025-a).	Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Antipova TA, 2011, B EXP BIOL MED+, V150, P607, DOI 10.1007/s10517-011-1202-6; Beglova N, 2000, J MED CHEM, V43, P3530, DOI 10.1021/jm990441x; Bruno MA, 2004, J NEUROSCI, V24, P8009, DOI 10.1523/JNEUROSCI.1508-04.2004; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; Colangelo AM, 2008, J NEUROSCI, V28, P2698, DOI 10.1523/JNEUROSCI.5201-07.2008; DERYCK M, 1989, STROKE, V20, P1383, DOI 10.1161/01.STR.20.10.1383; EstenneBouhtou G, 1996, INT J PEPT PROT RES, V48, P337; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Gudasheva TA, 2010, DOKL BIOCHEM BIOPHYS, V434, P262, DOI 10.1134/S160767291005011X; Gudasheva TA, 2014, NEUROSCI MED, V5, P101, DOI DOI 10.4236/NM.2014.52013; HICKS SP, 1977, EXP NEUROL, V56, P410, DOI 10.1016/0014-4886(77)90357-0; Isaev NK, 2012, BIOCHEMISTRY-MOSCOW+, V77, P996, DOI 10.1134/S0006297912090052; Jolkkonen J, 2000, EUR J PHARMACOL, V400, P211, DOI 10.1016/S0014-2999(00)00409-X; LEVIMONTALCINI R, 1985, P NATL ACAD SCI USA, V82, P7111, DOI 10.1073/pnas.82.20.7111; Lv QS, 2013, BRAIN RES, V1493, P80, DOI 10.1016/j.brainres.2012.11.028; Maliartchouk S, 2000, MOL PHARMACOL, V57, P385; Markova E. G., 1992, Byulleten' Eksperimental'noi Biologii i Meditsiny, V113, P318; Massa SM, 2002, J MOL NEUROSCI, V19, P107, DOI 10.1007/s12031-002-0019-1; Neet KE, 2011, ALZHEIMER'S DISEASE PATHOGENESIS - CORE CONCEPTS, SHIFTING PARADIGMS AND THERAPEUTIC TARGETS, P243; Niizuma K, 2010, BBA-MOL BASIS DIS, V1802, P92, DOI 10.1016/j.bbadis.2009.09.002; Peleshok J, 2006, BIOCHEM SOC T, V34, P612, DOI 10.1042/BST0340612; Plotnikov EY, 2010, BIOCHEMISTRY-MOSCOW+, V75, P145, DOI 10.1134/S0006297910020045; Povarnina PY, 2013, ACTA NATURAE, V5, P84, DOI 10.32607/20758251-2013-5-3-84-91; Scarpi D, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.129; Seredenin SB, 2011, B EXP BIOL MED+, V151, P584; Seredenin SB, 2011, B EXP BIOL MED+, V150, P432, DOI 10.1007/s10517-011-1161-y; Seredenin S. B., 2011, [RU Pat, Byull. Izobret. , No. 3], Patent No. [2,410,392, 2410392]; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; Song SX, 2013, MOL MED REP, V7, P327, DOI 10.3892/mmr.2012.1147; Stelmashook EV, 2010, BIOCHEMISTRY-MOSCOW+, V75, P1039, DOI 10.1134/S0006297910080134; Tian LL, 2012, BRAIN RES, V1440, P47, DOI 10.1016/j.brainres.2011.12.059	32	11	13	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0020-7454	1563-5279		INT J NEUROSCI	Int. J. Neurosci.	MAY	2015	125	5					375	379		10.3109/00207454.2014.935376			5	Neurosciences	Neurosciences & Neurology	CL8SW	WOS:000357245400009	24950445				2021-06-18	
J	Zhang, XQ; Lu, JT; Jiang, WX; Lu, YB; Wu, M; Wei, EQ; Zhang, WP; Tang, C				Zhang, X. -Q.; Lu, J. -T.; Jiang, W. -X.; Lu, Y. -B.; Wu, M.; Wei, E. -Q.; Zhang, W. -P.; Tang, C.			NAMPT INHIBITOR AND METABOLITE PROTECT MOUSE BRAIN FROM CRYOINJURY THROUGH DISTINCT MECHANISMS	NEUROSCIENCE			English	Article						NAMPT; FK866; NMN; NAD; cryoinjury; brain injury	COLONY-ENHANCING FACTOR; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; CEREBRAL-ISCHEMIA; NAD BIOSYNTHESIS; ENZYMATIC-ACTIVITY; IN-VITRO; INJURY; NEUROPROTECTION; INFLAMMATION; PATHWAY	Nicotinamide phosphoribosyltransferase (NAMPT) is the key enzyme in the biosynthesis of nicotinamide adenine dinucleotide (NAD). In the brain, NAMPT is primarily expressed in neurons and can prevent neuronal degeneration. NAMPT is also highly expressed in inflammatory cells, and is responsible for their activation. Since inflammation following traumatic brain injury enhances neuronal damage, we assessed the effects of nicotinamide mononucleotide (NMN), the direct NAMPT metabolite, and FK866, a potent NAMPT inhibitor, on brain injury in a cryoinjury mouse model. Twenty-four hours after brain cryoinjury, the density of neuron and the level of NAD decreased. Both NMN and FK866 alleviated the neuronal loss and decreased the lesion volume. NMN prevented the cryoinjury-induced decrease of NAD level, and FK866 decreased it further. On day 14 after cryoinjury, further neuronal loss occurred, astrocytes and Iba1-positive macrophage/microglia activated, and the NAD level increased. At this time-point, NAMPT expression was strongly induced in Iba1-positive macrophages/microglia in the lesion core. NMN and FK866 also alleviated the neuronal loss and decreased the lesion volume. In addition, FK866 significantly attenuated the activation of astrocytes and Iba1-positive macrophages/microglia, and decreased the NAD, while NMN had no such effects. Taken together, both FK866 and NMN attenuate traumatic brain injury. However, FK866 acts via the inhibition of the NAMPT activity in inflammatory cells resulting in the inhibition of inflammation, whereas NMN is effective via replenishing NAD. (C) 2015 IBRO. Published by Elsevier Ltd. All rights reserved.	[Zhang, X. -Q.; Lu, J. -T.; Lu, Y. -B.; Wei, E. -Q.; Zhang, W. -P.] Zhejiang Univ, Sch Med, Dept Pharmacol, Hangzhou 310058, Zhejiang, Peoples R China; [Jiang, W. -X.; Tang, C.] Chinese Acad Sci, Natl Ctr Magnet Resonance Wuhan, Key Lab Magnet Resonance Biol Syst, State Key Lab Magnet Resonance & Atom Mol Phys, Wuhan 430071, Hubei Province, Peoples R China; [Jiang, W. -X.; Tang, C.] Chinese Acad Sci, Wuhan Inst Phys & Math, Wuhan 430071, Hubei Province, Peoples R China; [Wu, M.] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Cardiothorac Surg, Hangzhou 310058, Zhejiang, Peoples R China	Zhang, WP (corresponding author), Zhejiang Univ, Sch Med, Dept Pharmacol, 866 Yu Hang Tang Rd, Hangzhou 310058, Zhejiang, Peoples R China.	weiping601@zju.edu.cn	Tang, Chun/P-4060-2019	Tang, Chun/0000-0001-6477-6500	Ministry of Science and Technology of ChinaMinistry of Science and Technology, China [2013CB910200]; National Natural Sciences Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81373392, 81173041, 81273491, 81272594, 81072619]; Zhejiang Provincial Natural Science Foundation of ChinaNatural Science Foundation of Zhejiang Province [Z2110059]; Howard Hughes Medical InstituteHoward Hughes Medical Institute	This work was supported by funds from the Ministry of Science and Technology of China (2013CB910200), the National Natural Sciences Foundation of China (81373392, 81173041, 81273491, 81272594 and 81072619) and the Zhejiang Provincial Natural Science Foundation of China (Z2110059). We are grateful to the Core Facilities of Zhejiang University Institute of Neuroscience for technical assistance. We thank Dr. IC Bruce for critically reading and revising this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. C. T. is supported in part by the International Early Career Scientist grant from the Howard Hughes Medical Institute.	Algattas H, 2014, INT J MOL SCI, V15, P309, DOI 10.3390/ijms15010309; Bi J, 2012, J NEUROCHEM, V120, P334, DOI 10.1111/j.1471-4159.2011.07566.x; Billington RA, 2008, AUTOPHAGY, V4, P385, DOI 10.4161/auto.5635; Busso N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002267; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Covey MV, 2010, DEV NEUROSCI-BASEL, V32, P488, DOI 10.1159/000321607; Czlonkowska A, 2011, J NEUROIMMUNOL, V231, P78, DOI 10.1016/j.jneuroim.2010.09.020; Drevs J, 2003, ANTICANCER RES, V23, P4853; Fan YQ, 2011, INT J MOL MED, V27, P607, DOI 10.3892/ijmm.2011.621; Formentini L, 2009, BIOCHEM PHARMACOL, V77, P1612, DOI 10.1016/j.bcp.2009.02.017; Friebe D, 2011, DIABETOLOGIA, V54, P1200, DOI 10.1007/s00125-010-2042-z; Hasmann M, 2003, CANCER RES, V63, P7436; Hertz L, 2008, NEUROPHARMACOLOGY, V55, P289, DOI 10.1016/j.neuropharm.2008.05.023; Jennings JS, 2008, MINI-REV MED CHEM, V8, P689, DOI 10.2174/138955708784567377; Jin XM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041892; Kelso ML, 2014, CURR PHARM DESIGN, V20, P4284; Khan JA, 2007, EXPERT OPIN THER TAR, V11, P695, DOI 10.1517/14728222.11.5.695; Kim H, 2013, BRAIN RES, V1502, P11, DOI 10.1016/j.brainres.2013.01.043; Koczan D, 2005, EUR J DERMATOL, V15, P251; Liu LY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044933; Magni G, 2009, CURR MED CHEM, V16, P1372, DOI 10.2174/092986709787846505; Mayi TH, 2011, BIOCHEM BIOPH RES CO, V404, P458, DOI 10.1016/j.bbrc.2010.12.002; Montecucco F, 2013, CURR TOP MED CHEM, V13, P2930, DOI 10.2174/15680266113136660208; Montecucco F, 2013, CURR DRUG TARGETS, V14, P637; Montecucco F, 2013, ANTIOXID REDOX SIGN, V18, P630, DOI 10.1089/ars.2011.4487; Nencioni A, 2014, THROMB HAEMOSTASIS, V111, P308, DOI 10.1160/TH13-07-0531; Pogrebniak A, 2006, EUR J MED RES, V11, P313; Rajamohan SB, 2009, MOL CELL BIOL, V29, P4116, DOI 10.1128/MCB.00121-09; Rongvaux A, 2002, EUR J IMMUNOL, V32, P3225, DOI 10.1002/1521-4141(200211)32:11<3225::AID-IMMU3225>3.0.CO;2-L; Schilling E, 2012, INNATE IMMUN-LONDON, V18, P518, DOI 10.1177/1753425911423853; Soares HD, 1995, J NEUROSCI, V15, P8223; Streit WJ, 1999, PROG NEUROBIOL, V57, P563, DOI 10.1016/S0301-0082(98)00069-0; Sun ZJ, 2013, CYTOKINE GROWTH F R, V24, P433, DOI 10.1016/j.cytogfr.2013.05.006; Tobin MK, 2014, J CEREBR BLOOD F MET, V34, P1573, DOI 10.1038/jcbfm.2014.130; Turner RC, 2013, J NEUROSURG, V118, P1072, DOI 10.3171/2012.11.JNS12408; Venter G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097378; Wang P, 2012, AUTOPHAGY, V8, P77, DOI 10.4161/auto.8.1.18274; Wang P, 2011, ANN NEUROL, V69, P360, DOI 10.1002/ana.22236; WILSON DF, 1994, MED SCI SPORT EXER, V26, P37; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Yamamoto T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098972; Zhang T, 2010, BBA-PROTEINS PROTEOM, V1804, P1666, DOI 10.1016/j.bbapap.2009.10.022; Zhang WP, 2010, J CEREBR BLOOD F MET, V30, P1962, DOI 10.1038/jcbfm.2010.71	43	11	11	1	21	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	APR 16	2015	291						230	240		10.1016/j.neuroscience.2015.02.007			11	Neurosciences	Neurosciences & Neurology	CD7VN	WOS:000351303100020	25684751				2021-06-18	
J	Elbin, RJ; Beatty, A; Covassin, T; Schatz, P; Hydeman, A; Kontos, AP				Elbin, R. J.; Beatty, Amanda; Covassin, Tracey; Schatz, Philip; Hydeman, Ana; Kontos, Anthony P.			A Preliminary Examination of Neurocognitive Performance and Symptoms Following a Bout of Soccer Heading in Athletes Wearing Protective Soccer Headbands	RESEARCH IN SPORTS MEDICINE			English	Article						soccer heading; soccer headgear; neurocognitive performance	INJURY SURVEILLANCE SYSTEM; TEST-RETEST RELIABILITY; DESCRIPTIVE EPIDEMIOLOGY; ONLINE VERSION; HIGH-SCHOOL; IMPACT; SPECIFICITY; SENSITIVITY; CONCUSSIONS; HEADGEAR	This study compared changes in neurocognitive performance and symptom reports following an acute bout of soccer heading among athletes with and without protective soccer headgear. A total of 25 participants headed a soccer ball 15 times over a 15-minute period, using a proper linear heading technique. Participants in the experimental group completed the heading exercise while wearing a protective soccer headband and controls performed the heading exercise without wearing the soccer headband. Neurocognitive performance and symptom reports were assessed before and after the acute bout of heading. Participants wearing the headband showed significant decreases on verbal memory (p = 0.02) compared with the no headband group, while the no headband group demonstrated significantly faster reaction time (p = 0.03) than the headband group following the heading exercise. These findings suggest that protective soccer headgear likely does not mitigate the subtle neurocognitive effects of acute soccer heading.	[Elbin, R. J.; Hydeman, Ana] Univ Arkansas, Dept Hlth Human Performance & Recreat, Off Sport Concuss Res, Fayetteville, AR 72701 USA; [Beatty, Amanda] Carolina Sports Concuss Clin, Cary, NC USA; [Covassin, Tracey] Michigan State Univ, Dept Kinesiol, E Lansing, MI 48824 USA; [Schatz, Philip] St Josephs Univ, Philadelphia, PA 19131 USA; [Kontos, Anthony P.] Univ Pittsburgh, Sch Med, Dept Orthopaed Surg, UPMC Sports Med Concuss Program, Pittsburgh, PA 15261 USA	Elbin, RJ (corresponding author), Univ Arkansas, Dept Hlth Human Performance & Recreat, Off Sport Concuss Res, Fayetteville, AR 72701 USA.	rjelbin@uark.edu		Kontos, Anthony/0000-0002-3749-4310			Agel J, 2007, J ATHL TRAINING, V42, P270; Broglio SP, 2004, BRIT J SPORT MED, V38, P561, DOI 10.1136/bjsm.2003.004887; Broglio SP, 2003, J ATHL TRAINING, V38, P220; Delaney JS, 2008, BRIT J SPORT MED, V42, P110, DOI 10.1136/bjsm.2007.037689; Dick R, 2007, J ATHL TRAINING, V42, P278; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; Guskiewicz KM, 2002, AM J SPORT MED, V30, P157, DOI 10.1177/03635465020300020201; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Kirkendall DT, 2001, J ATHL TRAINING, V36, P328; Kirkendall DT, 2001, SPORTS MED, V31, P369, DOI 10.2165/00007256-200131050-00006; Koerte IK, 2012, JAMA-J AM MED ASSOC, V308, P1859, DOI 10.1001/jama.2012.13735; Kontos AP, 2011, BRAIN INJURY, V25, P1234, DOI 10.3109/02699052.2011.608209; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; Matser JT, 2001, J CLIN EXP NEUROPSYC, V23, P770, DOI 10.1076/jcen.23.6.770.1029; Muller NG, 2002, J COGNITIVE NEUROSCI, V14, P673, DOI 10.1162/08989290260138582; Putukian M, 2000, CLIN J SPORT MED, V10, P104, DOI 10.1097/00042752-200004000-00004; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P499, DOI 10.1093/arclin/act034; Schatz P, 2013, AM J SPORT MED, V41, P321, DOI 10.1177/0363546512466038; Tysvaer A, 1981, Br J Sports Med, V15, P163; Withnall C, 2005, BRIT J SPORT MED, V39, pI40, DOI 10.1136/bjsm.2005.019174	24	11	11	0	24	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1543-8627	1543-8635		RES SPORTS MED	Res. Sports Med.	APR 3	2015	23	2					203	214		10.1080/15438627.2015.1005293			12	Sport Sciences	Sport Sciences	CH0PH	WOS:000353723600008	25666112				2021-06-18	
J	Aadal, L; Mortensen, J; Nielsen, JF				Aadal, Lena; Mortensen, Jesper; Nielsen, Jorgen Feldbaek			Weight Reduction After Severe Brain Injury: A Challenge During the Rehabilitation Course	JOURNAL OF NEUROSCIENCE NURSING			English	Article						acquired brain injury; malnutrition; nursing care; nutritional risk factors; rehabilitation; weight loss	NUTRITIONAL ASSESSMENT; ENERGY-EXPENDITURE; STROKE; MALNUTRITION; PREVALENCE; MODERATE	Background: There is a paucity of studies, which have described malnutrition in patients with acquired brain injury (ABI) across etiology. This study describes weight change, malnutrition, and potential associations in patients with ABI at a subacute inpatient rehabilitation hospital. Method: This is a descriptive cohort study. Ninety-eight patients were admitted in a 3-month period, of whom n = 76 met inclusion criteria. The Malnutrition Universal Screening Tool was used for categorizing patients according to risk of malnutrition. Results: Patients had experienced weight loss of 5.59% +/- 5.89% (p < .001) at admission at the rehabilitation hospital, and patients with traumatic brain injury had experienced a greater weight loss than patients with stroke (p < .01). Thirty percent of patients were at high risk for malnutrition, and 52% of these patients received enteral or parenteral nutrition at admission at the rehabilitation hospital. No association was found between risk of malnutrition and severity of injury, complications, functional outcome, or length of stay. Conclusion: Results underline the importance that nurses, especially in acute care, adhere to clinical guidelines to minimize weight loss. Special attention should be on patients with traumatic brain injury. Weight gain in the following course of rehabilitation may facilitate positive rehabilitation outcomes.	[Aadal, Lena] Hammel Neurorehabil & Res Ctr, Clin Nursing Res, Hammel, Denmark; [Mortensen, Jesper; Nielsen, Jorgen Feldbaek] Hammel Neurorehabil & Res Ctr, Hammel, Denmark	Aadal, L (corresponding author), Hammel Neurorehabil & Res Ctr, Clin Nursing Res, Hammel, Denmark.	lena.aadal@hammel.rm.dk	Aadal, Lena/R-3444-2019; Fabricius, Jesper/AAO-1202-2021; Nielsen, Jorgen Feldbak/AAR-6384-2021	Aadal, Lena/0000-0001-7365-3916; Fabricius, Jesper/0000-0001-7285-3422; Nielsen, Jorgen Feldbak/0000-0001-5339-171X			Badjatia N, 2010, JPEN-PARENTER ENTER, V34, P64, DOI 10.1177/0148607109348797; Bouteloup C, 2009, J NEUROL, V256, P1236, DOI 10.1007/s00415-009-5100-z; Cook AM, 2008, NUTR CLIN PRACT, V23, P608, DOI 10.1177/0884533608326060; da Rocha EEM, 2005, CURR OPIN CLIN NUTR, V8, P319, DOI 10.1097/01.mco.0000165012.77567.1e; Denes Z, 2004, DISABIL REHABIL, V26, P1163, DOI 10.1080/09638280412331270380; Donaldson J, 2000, Crit Care Nurs Clin North Am, V12, P465; Erdman J., 2011, NUTR TRAUMATIC BRAIN; Esper DH, 2006, JPEN-PARENTER ENTER, V30, P71, DOI 10.1177/014860710603000271; Foley N, 2008, J NEUROTRAUM, V25, P1415, DOI 10.1089/neu.2008.0628; Foley NC, 2009, STROKE, V40, pE66, DOI 10.1161/STROKEAHA.108.518910; Frankenfield DC, 2012, NUTRITION, V28, P906, DOI 10.1016/j.nut.2011.12.008; Fuhrman MP, 2002, NUTRITION, V18, P199, DOI 10.1016/S0899-9007(01)00729-8; Hartl R, 2008, J NEUROSURG, V109, P50, DOI 10.3171/JNS/2008/109/7/0050; Jonsson AC, 2008, STROKE, V39, P918, DOI 10.1161/STROKEAHA.107.497602; Kirkwood B. R., 2006, MED STAT, V2; Kondrup J, 2003, CLIN NUTR, V22, P415, DOI 10.1016/S0261-5614(03)00098-0; Krakau K, 2007, NUTRITION, V23, P308, DOI 10.1016/j.nut.2007.01.010; Krakau K, 2006, BRAIN INJURY, V20, P345, DOI 10.1080/02699050500487571; Krakau K, 2010, SCAND J CARING SCI, V24, P3, DOI 10.1111/j.1471-6712.2008.00677.x; Kyle UG, 2006, CLIN NUTR, V25, P409, DOI 10.1016/j.clnu.2005.11.001; Mosselman MJ, 2013, J NEUROSCI NURS, V45, P194, DOI 10.1097/JNN.0b013e31829863cb; Pepe JL, 1999, J HEAD TRAUMA REHAB, V14, P462, DOI 10.1097/00001199-199910000-00007; Perel P., 2008, COMPETENCIA COMUNICA, P1; Perry L, 2013, WORLDV EVID-BASED NU, V10, P17, DOI 10.1111/j.1741-6787.2012.00255.x; Poels BJJ, 2006, DISABIL REHABIL, V28, P637, DOI 10.1080/09638280500276612; Raguso CA, 2003, CURR OPIN CLIN NUTR, V6, P211, DOI 10.1097/00075197-200303000-00010; Sundhedsstyrelsen, 2008, VEJL LOEG SYG SOC OG; Uniform Data System for Medical Rehabilitation, 1993, AD FIM COMP PROGR; Vizzini A, 2011, NUTRITION, V27, P129, DOI 10.1016/j.nut.2010.05.004; Wasik AM, 2013, SCI REP-UK, V3, DOI 10.1038/srep01400	30	11	13	0	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0888-0395	1945-2810		J NEUROSCI NURS	J. Neurosci. Nurs.	APR	2015	47	2					85	90		10.1097/JNN.0000000000000121			6	Clinical Neurology; Nursing	Neurosciences & Neurology; Nursing	CC7VU	WOS:000350577300005	25700193				2021-06-18	
J	Connesson, N; Clayton, EH; Bayly, PV; Pierron, F				Connesson, N.; Clayton, E. H.; Bayly, P. V.; Pierron, F.			Extension of the Optimised Virtual Fields Method to Estimate Viscoelastic Material Parameters from 3D Dynamic Displacement Fields	STRAIN			English	Article						elasticity; elasticity reconstruction; inverse problem; MR elastography; noise robustness; noise sensitivity; optimised virtual fields; virtual fields method; viscoelasticity	MAGNETIC-RESONANCE-ELASTOGRAPHY; ELASTIC PROPERTIES; VIBRATING PLATES; ANIMAL-MODEL; BRAIN-INJURY; IDENTIFICATION; STIFFNESS; TISSUE; STRAIN; DEFORMATION	In vivo measurement of the mechanical properties of soft tissues is essential to provide necessary data in biomechanics and medicine (early cancer diagnosis, study of traumatic brain injuries, etc.). Imaging techniques such as magnetic resonance elastography can provide 3D displacement maps in the bulk and in vivo, from which, using inverse methods, it is then possible to identify some mechanical parameters of the tissues (stiffness, damping, etc.). The main difficulties in these inverse identification procedures consist in dealing with the pressure waves contained in the data and with the experimental noise perturbing the spatial derivatives required during the processing. The optimised virtual fields method (OVFM) (Comput. Mech.34, 2004, 439), designed to be robust to noise, presents natural and rigorous solution to deal with these problems. The OVFM has been adapted to identify material parameter maps from magnetic resonance elastography data consisting of 3D displacement fields in harmonically loaded soft materials. In this work, the method has been developed to identify elastic and viscoelastic models. The OVFM sensitivity to spatial resolution and to noise has been studied by analysing 3D analytically simulated displacement data. This study evaluates and describes the OVFM identification performances: Different biases on the identified parameters are induced by the spatial resolution and experimental noise. The well-known identification problems in the case of quasi-incompressible materials also find a natural solution in the OVFM. Moreover, an a posteriori criterion to estimate the local identification quality is proposed. The identification results obtained on actual experiments are briefly presented.	[Connesson, N.] Univ Grenoble INPG UJF, Lab TIMC IMAG, BP 53, F-38041 Grenoble, France; [Clayton, E. H.; Bayly, P. V.] Washington Univ, Dept Mech Engn & Mat Sci, St Louis, MO 63130 USA; [Pierron, F.] Univ Southampton, Engn & Environm, Southampton SO17 1BJ, Hants, England	Connesson, N (corresponding author), Univ Grenoble INPG UJF, Lab TIMC IMAG, BP 53, F-38041 Grenoble, France.	nathanael.connesson@gmail.com	Pierron, Fabrice/D-2332-2011; Connesson, Nathanael/M-9709-2014	Pierron, Fabrice/0000-0003-2813-4994; Bayly, Philip/0000-0003-4303-0704; Connesson, Nathanael/0000-0002-2945-4263	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS 055951]; Arts et Metiers ParisTech, France; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS055951] Funding Source: NIH RePORTER	Funding was provided from NIH grant NS 055951 (Bayly) and from Arts et Metiers ParisTech, France.	Avril S, 2008, EXP MECH, V48, P479, DOI 10.1007/s11340-008-9128-2; Avril S, 2004, COMPUT MECH, V34, P439, DOI 10.1007/s00466-004-0589-6; Avril S, 2008, EXP MECH, V48, P381, DOI 10.1007/s11340-008-9148-y; Avril S, 2010, J BIOMECH, V43, P2978, DOI 10.1016/j.jbiomech.2010.07.004; Baghani A, 2009, J ACOUST SOC AM, V126, P1541, DOI 10.1121/1.3180495; Bayly PV, 2006, J BIOMECH, V39, P1086, DOI 10.1016/j.jbiomech.2005.02.014; Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845; Bayly PV, 2004, J BIOMECH ENG-T ASME, V126, P523, DOI 10.1115/1.1785811; Bensamoun SF, 2006, J MAGN RESON IMAGING, V23, P242, DOI 10.1002/jmri.20487; Gao L, 1996, ULTRASOUND MED BIOL, V22, P959, DOI 10.1016/S0301-5629(96)00120-2; Giraudeau A, 2005, J SOUND VIB, V284, P757, DOI 10.1016/j.jsv.2004.07.009; Giraudeau A, 2010, J SOUND VIB, V329, P1653, DOI 10.1016/j.jsv.2009.11.031; Green MA, 2008, NMR BIOMED, V21, P755, DOI 10.1002/nbm.1254; Grigoriu, 1993, RANDOM VIBRATION MEC; Hendriks FM, 2003, SKIN RES TECHNOL, V9, P274, DOI 10.1034/j.1600-0846.2003.00019.x; Kruse SA, 2008, NEUROIMAGE, V39, P231, DOI 10.1016/j.neuroimage.2007.08.030; Manduca A, 2001, MED IMAGE ANAL, V5, P237, DOI 10.1016/S1361-8415(00)00039-6; McGee KP, 2011, PHYS MED BIOL, V56, P4291, DOI 10.1088/0031-9155/56/14/006; MUTHUPILLAI R, 1995, SCIENCE, V269, P1854, DOI 10.1126/science.7569924; Oida T, 2004, INTERNATIONAL CONFERENCE ON INFORMATICS RESEARCH FOR DEVELOPMENT OF KNOWLEDGE SOCIETY INFRASTRUCTURE, PROCEEDINGS, P57, DOI 10.1109/ICKS.2004.1313409; Ophir J, 1999, P I MECH ENG H, V213, P203, DOI 10.1243/0954411991534933; Pierron F, 2007, STRAIN, V43, P250, DOI 10.1111/j.1475-1305.2007.00346.x; Pierron F, 2012, THE VIRTUAL FIELDS M; Pierron F., P 2010 SEM ANN C EXP, V1; Romano AJ, 2000, IEEE T ULTRASON FERR, V47, P1575, DOI 10.1109/58.883546; Sack I, 2008, NMR BIOMED, V21, P265, DOI 10.1002/nbm.1189; Schmitt JM, 1998, OPT EXPRESS, V3, P199, DOI 10.1364/OE.3.000199; Sinkus R, 2005, MAGNET RESON MED, V53, P372, DOI 10.1002/mrm.20355; Smith JA, 2000, MATER EVAL, V58, P1395; Toussaint E, 2006, INT J MECH SCI, V48, P256, DOI 10.1016/j.ijmecsci.2005.10.002; Venkatesh SK, 2008, AM J ROENTGENOL, V190, P1534, DOI 10.2214/AJR.07.3123; Yin M, 2007, MAGN RESON MED, V58, P346, DOI 10.1002/mrm.21286; Zhang J, 2011, J BIOMECH, V44, P1909, DOI 10.1016/j.jbiomech.2011.04.034	33	11	11	0	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1475-1305			STRAIN	Strain	APR	2015	51	2					110	134		10.1111/str.12126			25	Materials Science, Characterization & Testing	Materials Science	CE0BG	WOS:000351466500003	26146416	Green Accepted			2021-06-18	
J	Konda, S; Reichard, A; Tiesman, HM; Hendricks, S				Konda, Srinivas; Reichard, Audrey; Tiesman, Hope M.; Hendricks, Scott			Non-fatal work-related traumatic brain injuries treated in US hospital emergency departments, 1998-2007	INJURY PREVENTION			English	Article							UNITED-STATES; OLDER-ADULTS; COMMUNITY; NEISS; FALLS	Purpose Little is known about work-related traumatic brain injuries (WRTBI). This study describes non-fatal WRTBIs treated in US emergency departments (ED) from 1998 through 2007. Methods Non-fatal WRTBIs were identified from the National Electronic Injury Surveillance System occupational supplement (NEISS-Work) using the diagnoses of concussion, internal organ injury to the head and skull fracture. WRTBI rates and rate ratios were calculated, and the trend in rates was assessed. Results An estimated 586 600 (95% CI=+/- 150 000) WRTBIs were reported during the 10-year period at a rate of 4.3 (CI=+/- 1.1) per 10 000 full-time equivalent (FTE) workers (1 FTE=2000 h per year). From 1998 through 2007, the rate of WRTBIs increased at an average of 0.21 per 10 000 FTE per year (p<0.0001) and the rate of fall-related WRTBIs increased at an average of 0.10 per 10 000 FTE (p<0.0001). During the same period, the annual rate of WRTBIs resulting in hospitalisation increased 0.04 per 10 000 FTE (p<0.0001). Ten percent of WRTBIs were hospitalised, compared with hospitalisation of 2% all NEISS-Work injuries. Also, workers with highest fall-related TBI rates per 10 000 FTE were the youngest (2.4; CI=+/- 1.4) and oldest (55 and older) workers (1.9; CI=+/- 0.8). Conclusions Non-fatal WRTBIs are one of the most serious workplace injuries among ED-treated work-related injuries. Non-fatal WRTBIs are much more likely to result in hospitalisation compared with other types of injuries. The upward trend of WRTBI rates from 1998 through 2007 underscore the need for more directed effective prevention methods to reduce WRTBI injuries.	[Konda, Srinivas; Tiesman, Hope M.; Hendricks, Scott] NIOSH, Div Safety Res, Anal & Field Evaluat Branch, Morgantown, WV 26505 USA; [Reichard, Audrey] NIOSH, Div Safety Res, Surveillance & Field Invest Branch, Morgantown, WV 26505 USA	Konda, S (corresponding author), NIOSH, Div Safety Res, 1095 Willowdale Rd,M-S 1811, Morgantown, WV 26505 USA.	skonda@cdc.gov	Konda, Srinivas/G-2747-2015	Konda, Srinivas/0000-0002-8934-4111	Intramural CDC HHS [CC999999] Funding Source: Medline		Bell J, 2010, DHHS NIOSH PUBLICATI, V2011-123; Bobick TG, 2010, J SAFETY RES, V41, P203, DOI 10.1016/j.jsr.2010.02.008; Centers for Disease Control and Prevention, 2014, SEV TRAUM BRAIN INJ; Centers for Disease Control and Prevention, 2010, TRAUM BRAIN INJ; Chang VH, 2011, PHY MED REHAB, V3, P387; Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P883, DOI 10.1016/S0003-9993(96)90274-9; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Ferrell Richard B, 2002, Curr Psychiatry Rep, V4, P354; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Graves JM, 2013, J SAFETY RES, V45, P133, DOI 10.1016/j.jsr.2012.11.001; HEYER NJ, 1994, AM J PUBLIC HEALTH, V84, P1106, DOI 10.2105/AJPH.84.7.1106; Janicak CA, 1998, J OCCUP ENVIRON MED, V40, P347, DOI 10.1097/00043764-199804000-00009; Kim H, 2006, NEUROREHABILITATION, V21, P269; Moyer VA, 2012, ANN INTERN MED, V157, P197, DOI 10.7326/0003-4819-157-3-201208070-00462; National Institute for Occupational Safety and Health (NIOSH), 2010, TEACH YOUNG WORK JOB; National Institute of Neurological Disorders and Stroke, TRAUMATIC BRAIN INJU; Sears JM, 2013, J OCCUP ENVIRON MED, V55, P507, DOI 10.1097/JOM.0b013e31827ee018; Slavova S, 2012, J KY MED ASS, V110, P191; Thomas KE, 2008, J SAFETY RES, V39, P269, DOI 10.1016/j.jsr.2008.05.001; Thompson MC, 2014, BRAIN INJURY, V28, P431, DOI 10.3109/02699052.2014.887146; Tiesman HM, 2007, AM J PREV MED, V33, P464, DOI 10.1016/j.amepre.2007.07.034; Tiesman HM, 2011, AM J PREV MED, V41, P61, DOI 10.1016/j.amepre.2011.03.007; TINETTI ME, 1995, J AM GERIATR SOC, V43, P1214, DOI 10.1111/j.1532-5415.1995.tb07396.x; U.S Army, 2012, NFL ARM BOTH WORK CO; U.S. Census Bureau, 2002, ALPH IND IND OCC CEN; US Department of Labor Bureau of Labor Statistics, 2008, SPOTL STAT OLD WORK; US Department of Labor. Bureau of Labor Statistics, CURR POP SURV MICR F; Wei Chia, 2012, Minn Med, V95, P55; Wrona RM, 2006, J SAFETY RES, V37, P75, DOI 10.1016/j.jsr.2005.08.008; Xiang HY, 2007, BRAIN INJURY, V21, P293, DOI 10.1080/02699050701311034; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	31	11	11	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1353-8047	1475-5785		INJURY PREV	Inj. Prev.	APR	2015	21	2					115	120		10.1136/injuryprev-2014-041323			6	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CE2YU	WOS:000351689900008	25216672	Green Accepted			2021-06-18	
J	Tulsky, DS; Kisala, PA; Lai, JS; Carlozzi, N; Hammel, J; Heinemann, AW				Tulsky, David S.; Kisala, Pamela A.; Lai, Jin-Shei; Carlozzi, Noelle; Hammel, Joy; Heinemann, Allen W.			Developing an Item Bank to Measure Economic Quality of Life for Individuals With Disabilities	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Economics; Outcome assessment (health care); Psychometrics; Quality of life; Rehabilitation	TRAUMATIC BRAIN-INJURY; DATA-COLLECTION INSTRUMENT; RESPONSE THEORY; HEAD-INJURY; CANCER; CHILDREN; HEALTH; VALIDATION; ISSUES; BARRIERS	Objective: To develop and evaluate the psychometric properties of an item set measuring economic quality of life (QOL) for use by individuals with disabilities. Design: Survey. Setting: Community settings. Participants: Individuals with disabilities completed individual interviews (n=64), participated in focus groups (n=172), and completed cognitive interviews (n=15). Inclusion criteria included the following: traumatic brain injury, spinal cord injury, or stroke; age >= 18 years; and ability to read and speak English. We calibrated the items with 305 former rehabilitation inpatients. Interventions: None. Main Outcome Measure: Economic QOL. Results: Confirmatory factor analysis showed acceptable fit indices (comparative fit index=.939, root mean square error of approximation=.089) for the 37 items. However, 3 items demonstrated local item dependence. Dropping 9 items improved fit and obviated local dependence. Rasch analysis of the remaining 28 items yielded a person reliability of .92, suggesting that these items discriminate about 4 economic QOL levels. Conclusions: We developed a 28-item bank that measures economic aspects of QOL. Preliminary confirmatory factor analysis and Rasch analysis results support the psychometric properties of this new measure. It fills a gap in health-related QOL measurement by describing the economic barriers and facilitators of community participation. Future development will make the item bank available as a computer adaptive test. (C) 2015 by the American Congress of Rehabilitation Medicine	[Tulsky, David S.; Kisala, Pamela A.] NYU, Langone Med Ctr, New York, NY 10016 USA; [Tulsky, David S.] Kessler Fdn Res Ctr, W Orange, NJ USA; [Lai, Jin-Shei; Heinemann, Allen W.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Carlozzi, Noelle] Univ Michigan, Sch Med, Ann Arbor, MI USA; [Hammel, Joy] Univ Illinois, Chicago, IL USA; [Heinemann, Allen W.] Rehabil Inst Chicago, Chicago, IL 60611 USA	Tulsky, DS (corresponding author), NYU, Langone Med Ctr, Ctr Ambulatory Care, Dept Rehabil Me,Rusk Inst Rehabil, 240 E 38th St,17th Fl, New York, NY 10016 USA.	David.Tulsky@nyumc.org	Heinemann, Allen W./AAI-2790-2021	Heinemann, Allen W./0000-0003-2782-7326; Tulsky, David/0000-0002-4335-4509	National Institute on Disability and Rehabilitation Research [H133B090024, H133A030807, H133G070138]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5R01HD054659]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD054569] Funding Source: NIH RePORTER	Supported by the National Institute on Disability and Rehabilitation Research (grant nos. H133B090024, H133A030807, and H133G070138) and the National Institutes of Health (grant no. 5R01HD054659).	AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Alfano CM, 2006, ONCOLOGY-BASEL, V70, P190, DOI 10.1159/000094320; Bach C A, 1993, Rehabil Nurs, V18, P364; Bae DS, 2008, J PEDIATR ORTHOPED, V28, P584, DOI 10.1097/BPO.0b013e31817bb88b; Barry C., 1998, SOCIOLOGICAL RES ONL, P3; BECKER M, 1993, QUAL LIFE RES, V2, P239, DOI 10.1007/BF00434796; Becker MA, 1999, WISCONSIN QUALITY LI; Bergmark BA, 2008, SPINAL CORD, V46, P684, DOI 10.1038/sc.2008.15; Bradburn NM, 1969, STRUCTURE PSYCHOL WE; Brown I., 2006, FAMILY QUALITY LIFE; Browne M. W., 1992, SOCIOL METHOD RES, V21, P136; Campbell A., 1976, QUALITY AM LIFE PERC; Campbell A., 1981, SENSE WELL BEING AM; Carlozzi NE, 2011, ARCH PHYS MED REHAB, V92, pS52, DOI 10.1016/j.apmr.2010.12.046; Cella D F, 1990, Oncology (Williston Park), V4, P29; CELLA DF, 1993, CANCER INVEST, V11, P327, DOI 10.3109/07357909309024860; Costa P, 2001, EUR UROL, V39, P107, DOI 10.1159/000052421; Dedini RD, 2008, J PEDIATR ORTHOPED, V28, P259, DOI 10.1097/BPO.0b013e3181652135; Fajardo NR, 2003, AM J GASTROENTEROL, V98, P128; Hambleton RK, 1989, PRINCIPLES SELECTED, P147; Hammel J, 2015, ARCH PHYS MED REHAB, V96, P578, DOI 10.1016/j.apmr.2014.12.008; Heinemann AW, 2015, ARCH PHYS MED REHAB, V96, P589, DOI 10.1016/j.apmr.2013.11.024; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Huberman A.M., 1994, DATA MANAGEMENT ANAL; Huppert JD, 2001, SCHIZOPHR RES, V51, P171, DOI 10.1016/S0920-9964(99)00151-6; Isaacs B. J., 2007, J POLICY PRACT INTEL, V4, P177, DOI [DOI 10.1111/J.1741-1130.2007.00116.X, 10.1111/j.1741-1130.2007.00116.x]; Kahneman D, 2010, P NATL ACAD SCI USA, V107, P16489, DOI 10.1073/pnas.1011492107; Kisala Pamela A, 2010, J Appl Meas, V11, P315; Krueger R. A., 2000, Focus groups: A practical guide for applied research; Kuznets S., 1946, NATL PRODUCT 1869; Lai JS, 2007, J PEDIAT HEMATOL ONC, V29, P471, DOI 10.1097/MPH.0b013e318095057a; Lai JS, 2006, QUAL LIFE RES, V15, P1179, DOI 10.1007/s11136-006-0060-6; Lai JS, 2007, CHILD NERV SYST, V23, P47, DOI 10.1007/s00381-006-0176-6; Lai JS, 2011, ARCH PHYS MED REHAB, V92, pS20, DOI 10.1016/j.apmr.2010.08.033; Lai JS, 2011, J PEDIATR PSYCHOL, V36, P766, DOI 10.1093/jpepsy/jsr005; Leibson CL, 2012, J NEUROTRAUM, V29, P2038, DOI 10.1089/neu.2010.1713; Lew SQ, 2005, SEMIN DIALYSIS, V18, P119, DOI 10.1111/j.1525-139X.2005.18215.x; Linacre JM, 2014, WINSTEPS RASCH MEASU; Manns PJ, 2001, QUAL HEALTH RES, V11, P795, DOI 10.1177/104973201129119541; McCarthy ML, 2002, DEV MED CHILD NEUROL, V44, P468; MISHLER EG, 1990, HARVARD EDUC REV, V60, P415, DOI 10.17763/haer.60.4.n4405243p6635752; Muthen B. O., 2001, MPLUS USERS GUIDE; National Institute on Aging National Institutes of Health, 2007, 075757 US DEP HLTH H; National Spinal Cord Injury Statistical Center, 2011, SPIN CORD INJ FACTS; Nelson N D, 2003, J Palliat Med, V6, P417, DOI 10.1089/109662103322144736; PROMIS, 2012, INSTR DEV PSYCH EV S; Reed J, 1997, J ADV NURS, V26, P765, DOI 10.1046/j.1365-2648.1997.00395.x; ROTH E, 1989, PARAPLEGIA, V27, P480, DOI 10.1038/sc.1989.75; Sherer M, 2000, J HEAD TRAUMA REHAB, V15, P767, DOI 10.1097/00001199-200004000-00002; Smith R M, 2000, J Appl Meas, V1, P199; Smith T.W., 2011, General Social Surveys, 1972-2010; Steinberg L, 1996, PSYCHOL METHODS, V1, P81, DOI 10.1037/1082-989X.1.1.81; Todd A, 2012, REHABIL NURS, V37, P74, DOI 10.1002/RNJ.00013; Tulsky DS, 2011, ARCH PHYS MED REHAB, V92, pS44, DOI 10.1016/j.apmr.2011.04.024; Tulslcy D, 2005, PHYS MED REHABILITAT, P1193; U. S. Bureau of Labor Statistics, 2014, TABL A 6 EMPL STAT C; White GW, 2004, ARCH PHYS MED REHAB, V85, pS3, DOI 10.1016/j.apmr.2003.08.109; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Willis G. B., 1999, COGNITIVE INTERVIEWI; World Health Organization , 2008, INT CLASS FUNCT DIS; Wren TAL, 2007, J PEDIATR ORTHOPED, V27, P233, DOI 10.1097/01.bpb.0000242436.65940.1a; YOUNG NL, 1995, J PEDIATR ORTHOPED, V15, P244	62	11	12	0	6	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	APR	2015	96	4					604	613		10.1016/j.apmr.2014.02.030			10	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	CE9RC	WOS:000352180100005	24736400	Green Accepted			2021-06-18	
J	Bolzenius, JD; Roskos, PT; Salminen, LE; Paul, RH; Bucholz, RD				Bolzenius, Jacob D.; Roskos, P. Tyler; Salminen, Lauren E.; Paul, Robert H.; Bucholz, Richard D.			Cognitive and Self-Reported Psychological Outcomes of Blast-Induced Mild Traumatic Brain Injury in Veterans: A Preliminary Study	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						PTSD; blast injury; mild TBI; cognition; traumatic brain injury	POSTTRAUMATIC-STRESS-DISORDER; NEUROPSYCHOLOGICAL OUTCOMES; ENDURING FREEDOM; DEPRESSION; SYMPTOMS; COMPLAINTS; SEVERITY; VALIDITY; IRAQ; AFGHANISTAN	The increased use of explosives in combat has resulted in a large number of returning veterans suffering from blast-related mild traumatic brain injury (mTBI) and self-reported complications. It remains unclear whether this increase in self-reported difficulties is unique to the blast mechanism or stressful preinjury environment and whether cognitive-functioning deficits correspond with these difficulties in the postacute phase. This study examined the relationship between cognitive performance and self-reported psychological and somatic symptoms of blast-related mTBI compared with civilian mTBI, independent of comorbid posttraumatic stress disorder (PTSD) symptoms. Twelve veterans with blast-related mTBI were compared to 18 individuals with civilian mTBI on cognitive tests and self-report questionnaires. Univariate analyses failed to reveal differences on any individual cognitive test. Further, veterans reported more psychological and somatic complaints. These self-reported difficulties were not significantly correlated with neuropsychological performance. Overall, preliminary results suggest that in the postacute phase, subjective complaints related to blast-related mTBI do not covary with objective cognitive performance. Additionally, cognitive outcomes from blast-related mTBI were similar to those of civilian forms of mTBI. Future studies should identify the cognitive and self-reported sequelae of blast-related mTBI independent of comorbid PTSD in a larger sample of veterans.	[Bolzenius, Jacob D.; Salminen, Lauren E.; Paul, Robert H.] Univ Missouri, Dept Psychol, St Louis, MO 63121 USA; [Bolzenius, Jacob D.; Roskos, P. Tyler; Salminen, Lauren E.; Bucholz, Richard D.] St Louis Univ, Dept Neurosurg, St Louis, MO 63103 USA	Bolzenius, JD (corresponding author), Univ Missouri, Dept Psychol, 1 Univ Blvd,Stadler Hall 443, St Louis, MO 63121 USA.	jdbdgf@umsl.edu	Salminen, Lauren/T-1400-2019	Salminen, Lauren/0000-0002-0684-9991	Congressionally Directed Medical Research ProgramUnited States Department of Defense [W81XWH-08-2-0191]	This research was supported by grant W81XWH-08-2-0191 from the Congressionally Directed Medical Research Program (PI: Richard Bucholz).	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Army Individual Test Battery, 1944, MAN DIR SCOR; Barlow-Ogden K, 2012, J REHABIL RES DEV, V49, P1101, DOI 10.1682/JRRD.2010.09.0188; Bazarian JJ, 2013, J HEAD TRAUMA REHAB, V28, P1, DOI 10.1097/HTR.0b013e318256d3d3; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Beck AT., 1996, BECK DEPRESSION INVE, V2; Belanger HG, 2011, CLIN NEUROPSYCHOL, V25, P702, DOI 10.1080/13854046.2011.566892; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Brenner LA, 2010, NEUROPSYCHOLOGY, V24, P160, DOI 10.1037/a0017966; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chamelian L, 2006, J NEUROPSYCH CLIN N, V18, P33, DOI 10.1176/appi.neuropsych.18.1.33; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Delis D.C., 2001, DELIS KAPLAN EXECUTI; Delis DC, 2000, CALIFORNIA VERBAL LE; Dolan S, 2012, NEUROPSYCHOL REV, V22, P21, DOI 10.1007/s11065-012-9190-5; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Freeman T, 2008, PSYCHIAT RES, V158, P374, DOI 10.1016/j.psychres.2007.04.002; Golden C., 1978, STROOP COLOR WORD TE; Green P., 1996, WORD MEMORY TEST USE; Greiffenstein MF, 2008, ARCH CLIN NEUROPSYCH, V23, P801, DOI 10.1016/j.acn.2008.07.005; Heaton R., 1993, WISCONSIN CARD SORTI; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Homaifar BY, 2009, ARCH PHYS MED REHAB, V90, P652, DOI 10.1016/j.apmr.2008.10.028; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Kennedy JE, 2010, NEUROREHABILITATION, V26, P191, DOI 10.3233/NRE-2010-0555; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kroenke K, 2002, PSYCHOSOM MED, V64, P258, DOI 10.1097/00006842-200203000-00008; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Larrabee G.J., 2007, ASSESSMENT MALINGERE; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Matthews C, 1964, INSTRUCTIONAL MANUAL; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Spencer RJ, 2010, J REHABIL RES DEV, V47, P521, DOI 10.1682/JRRD.2009.11.0181; Stuhmiller JH, 2008, BLAST INJURY TRANSLA; Terhakopian A, 2008, J TRAUMA STRESS, V21, P290, DOI 10.1002/jts.20341; Trahan DE, 2001, ARCH CLIN NEUROPSYCH, V16, P435, DOI 10.1016/S0887-6177(00)00051-2; Vanderploeg RD, 2012, ARCH PHYS MED REHAB, V93, P1887, DOI 10.1016/j.apmr.2012.05.024; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Weathers F. W., 1993, ANN M INT SOC TRAUM; Wechsler D., 1997, WAIS 3 ADM SCORING M	48	11	11	0	7	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult	MAR 4	2015	22	2					79	87		10.1080/23279095.2013.845823			9	Clinical Neurology; Psychology	Neurosciences & Neurology; Psychology	CC5DR	WOS:000350379400001	24940794				2021-06-18	
J	Andelic, N; Perrin, PB; Forslund, MV; Soberg, HL; Sigurdardottir, S; Sveen, U; Jerstad, T; Roe, C				Andelic, Nada; Perrin, Paul B.; Forslund, Marit V.; Soberg, Helene L.; Sigurdardottir, Solrun; Sveen, Unni; Jerstad, Tone; Roe, Cecilie			Trajectories of physical health in the first 5 years after traumatic brain injury	JOURNAL OF NEUROLOGY			English	Article						TBI; Longitudinal study; SF-36; Physical functioning; General health	QUALITY-OF-LIFE; MULTIPLE INJURIES; HEAD-INJURY; POPULATION; MODERATE; SF-36; INDIVIDUALS; SATISFACTION; RELIABILITY; PREDICTORS	The aims of the study were to examine whether self-reported physical health changes over the first 5 years after traumatic brain injury (TBI), and whether the trajectories of physical health over that time period could be predicted by demographic and injury-related variables. A longitudinal cohort study was conducted with 97 individuals with moderate-to-severe TBI who had been admitted to a Trauma Referral Centre in 2005/2007. Patients were followed up at 1, 2 and 5 years post-injury. Physical health-related quality of life (HRQL) (i.e., physical health) was measured by four subscales of the Medical Outcomes 36-Item Short Form Health Survey (SF-36): Physical Functioning, Role-Physical, Bodily Pain and General Health. Only the Physical Functioning domain showed statistically significant improvements across time. Women had lower scores on Role-Physical, Bodily Pain (more pain) and General Health. Unemployment prior to injury and having been in a "blue collar" physical job was associated with lower Physical Functioning and General Health, while greater TBI severity was associated with lower Physical Functioning, but better Role-Physical. Bodily Pain, Role-Physical and General Health remained fairly stable over time, despite the improvement in Physical Functioning. There were a number of significant injury-related and demographic predictors across the four trajectories of physical health. A better understanding of factors influencing these domains over the first 5 years after TBI and effective pain reducing rehabilitation strategies are needed.	[Andelic, Nada; Forslund, Marit V.; Soberg, Helene L.; Sveen, Unni; Roe, Cecilie] Oslo Univ Hosp, Dept Phys Med & Rehabil, Oslo, Norway; [Andelic, Nada; Sigurdardottir, Solrun] Univ Oslo, CHARM Res Ctr Habilitat & Rehabil Models & Serv, Fac Med, Oslo, Norway; [Perrin, Paul B.] Virginia Commonwealth Univ, Dept Psychol, Richmond, VA 23284 USA; [Forslund, Marit V.; Roe, Cecilie] Univ Oslo, Fac Med, Oslo, Norway; [Sigurdardottir, Solrun] Sunnaas Rehabil Hosp Trust, Akershus, Norway; [Sveen, Unni] Oslo & Akershus Univ Coll, Fac Hlth Sci, Oslo, Norway; [Jerstad, Tone] Oslo Univ Hosp, Dept Neuroradiol, Oslo, Norway	Andelic, N (corresponding author), Oslo Univ Hosp, Dept Phys Med & Rehabil, Oslo, Norway.	nandelic@online.no	Perrin, Paul/L-5373-2015	Perrin, Paul/0000-0003-2070-215X; Andelic, Nada/0000-0002-3719-4406	Research Council of NorwayResearch Council of Norway; Institute of Health and Society, CHARM (Research Centre for Habilitation and Rehabilitation Models and Services), Faculty of Medicine, University of Oslo	The authors would like to thank all the patients for their participation. Special thanks to Nini Hammergren for assistance with patient registrations during the first 2 years post-injury. This study was funded by grants from The Research Council of Norway and Institute of Health and Society, CHARM (Research Centre for Habilitation and Rehabilitation Models and Services), Faculty of Medicine, University of Oslo.	Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Andelic N, 2013, J REHABIL MED, V45, P708, DOI [10.2340/16501977-1216, 10.2340/16501977-1224]; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Brown M, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199808000-00002; Colantonio A, 1998, ARCH PHYS MED REHAB, V79, P550, DOI 10.1016/S0003-9993(98)90072-7; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; Forslund MV, 2013, ACTA NEUROL SCAND, V128, P220, DOI 10.1111/ane.12130; Forslund MV, 2014, BRAIN INJURY, V28, P980, DOI 10.3109/02699052.2014.888770; Grauwmeijer E, 2014, ARCH PHYS MED REHAB, V95, P1268, DOI 10.1016/j.apmr.2014.02.002; Guilfoyle MR, 2010, J NEUROTRAUM, V27, P2173, DOI 10.1089/neu.2010.1353; Harris IA, 2008, J TRAUMA, V64, P969, DOI 10.1097/01.ta.0000245972.83948.1a; Hopman WM, 2006, QUAL LIFE RES, V15, P527, DOI 10.1007/s11136-005-2096-4; Hu XB, 2012, BRAIN INJURY, V26, P183, DOI 10.3109/02699052.2011.648707; Jacobsson LJ, 2010, BRAIN INJURY, V24, P1075, DOI 10.3109/02699052.2010.494590; Kjeldsberg M, 2013, SCAND J PRIM HEALTH, V31, P36, DOI 10.3109/02813432.2012.751697; Koskinen S, 1998, BRAIN INJURY, V12, P631, DOI 10.1080/026990598122205; Kwok OM, 2008, REHABIL PSYCHOL, V53, P370, DOI 10.1037/a0012765; Lin MR, 2010, ARCH PHYS MED REHAB, V91, P474, DOI 10.1016/j.apmr.2009.10.031; Lippert-Gruner M, 2007, BRAIN INJURY, V21, P451, DOI 10.1080/02699050701343961; Loge JH, 1998, SCAND J SOC MED, V26, P250; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Ponsford J, 2008, J TRAUMA, V64, P1001, DOI 10.1097/TA.0b013e31809fec16; Ponsford J, 2013, NEUROREHABILITATION, V32, P803, DOI 10.3233/NRE-130904; Resch JA, 2009, REHABIL PSYCHOL, V54, P51, DOI 10.1037/a0015051; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; Sigurdardottir S, 2013, J REHABIL MED, V45, P808, DOI 10.2340/16501977-1156; Sigurdardottir S, 2009, J INT NEUROPSYCH SOC, V15, P740, DOI 10.1017/S1355617709990452; Soberg HL, 2012, ARCH PHYS MED REHAB, V93, P765, DOI 10.1016/j.apmr.2011.08.050; Steel J, 2010, J TRAUMA, V69, P523, DOI 10.1097/TA.0b013e3181e90c24; TEASDALE G, 1974, LANCET, V2, P81; Tomberg T, 2007, BRAIN INJURY, V21, P479, DOI 10.1080/02699050701311737; Truelle JL, 2010, BRAIN INJURY, V24, P1272, DOI 10.3109/02699052.2010.506865; Vaananen A, 2004, WOMEN HEALTH, V40, P1, DOI [10.1300/J013v403_01, 10.1300/J013v40n03_01]; van Baalen B, 2006, CLIN REHABIL, V20, P686, DOI 10.1191/0269215506cre982oa; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002	37	11	11	0	6	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0340-5354	1432-1459		J NEUROL	J. Neurol.	MAR	2015	262	3					523	531		10.1007/s00415-014-7595-1			9	Clinical Neurology	Neurosciences & Neurology	CE0BX	WOS:000351469200003	25476694				2021-06-18	
J	Anthony, CA; Peterson, AR				Anthony, Christopher A.; Peterson, Andrew R.			Utilization of a Text-Messaging Robot to Assess Intraday Variation in Concussion Symptom Severity Scores	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						Concussion Symptom Severity Score; CSSS; SCAT2; SCAT3; concussion	INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; SPORT HELD; ZURICH; SCALE	Objective: To determine the amount of within-day variation of Concussion Symptom Severity Scores (CSSSs) in athletes with a clinically diagnosed concussion. Design: This prospective cohort study used a text-messaging robot to survey concussed athletes using the CSSS 5-times daily while they remained symptomatic. Setting: Academic sports concussion clinic at a large tertiary care medical center. Participants: Fourteen 14- to 22-year-old athletes with clinically diagnosed concussions were enrolled. All were injured in sport, still in season, English speaking, and used a cellular telephone to text message on a regular basis. Assessment of Risk Factors: This study did not collect any demographic or other information about the subjects. The only data collected were the individual responses to the questions in the Post Concussion Symptom Score (PCSS). The only aim of this study was to evaluate the variability in responses to the CSSS, which is calculated from the PCSS. Main Outcome Measurements: The primary outcome measure was a repeatability coefficient from a random-effects model. Concussion Symptom Severity Score, mean daily CSSS, and standard deviation of CSSS differences from the mean were also calculated. Results: Mean follow-up was 23.9 days. A total of 24 180 text messages were received from subjects. Eight hundred four complete surveys were analyzed. Repeatability coefficient was 623.1. Conclusions: When surveyed frequently by a text-messaging robot, concussed athletes report poorly repeatable Sport Concussion Assessment Tool 2 (SCAT2) Symptom Severity Scores.	[Anthony, Christopher A.] Univ Iowa, Carver Coll Med, Iowa City, IA USA; [Peterson, Andrew R.] Inst Orthopaed Sports Med & Rehabil, Iowa City, IA USA; [Peterson, Andrew R.] Univ Iowa, Dept Pediat, Carver Coll Med, Iowa City, IA 52242 USA	Peterson, AR (corresponding author), Univ Iowa Hosp & Clin, Dept Pediat, 200 Hawkins Dr,2607 JCP, Iowa City, IA 52242 USA.	andrew-r-peterson@uiowa.edu		Peterson, Andrew/0000-0003-4555-7366	University of Iowa Department of Pediatrics	Supported by the University of Iowa Department of Pediatrics.	Alla S, 2009, BRIT J SPORT MED, V43, pI3, DOI 10.1136/bjsm.2009.058339; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Fazio VC, 2007, NEUROREHABILITATION, V22, P207; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Mailer BJ, 2008, J SPORT REHABIL, V17, P11, DOI 10.1123/jsr.17.1.11; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; McLeod TCV, 2012, J ATHL TRAINING, V47, P221; Notebaert AJ, 2005, J ATHL TRAINING, V40, P320	10	11	11	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	MAR	2015	25	2					149	152		10.1097/JSM.0000000000000115			4	Orthopedics; Physiology; Sport Sciences	Orthopedics; Physiology; Sport Sciences	CD3RP	WOS:000350998200012	24905538				2021-06-18	
J	Johnston, JM; Ning, HB; Kim, JE; Kim, YH; Soni, B; Reynolds, R; Cooper, L; Andrews, JB; Vaidya, U				Johnston, James M.; Ning, Haibin; Kim, Jong-Eun; Kim, Young-Ho; Soni, Bharat; Reynolds, Richard; Cooper, Lloyd; Andrews, J. Barry; Vaidya, Uday			Simulation, fabrication and impact testing of a novel football helmet padding system that decreases rotational acceleration	SPORTS ENGINEERING			English	Article							CHRONIC TRAUMATIC ENCEPHALOPATHY; HEAD IMPACT; PROFESSIONAL FOOTBALL; BRAIN-INJURY; CONCUSSION; BIOMECHANICS; EXPOSURES; DISEASE; PLAYER; SPORT	Recent studies suggest that concussion may be associated with long-term neurological sequelae. Both linear impact and rotational acceleration have been identified as contributors to concussion and traumatic brain injury (TBI). Modern football helmets are designed according to the National Operating Committee on Standards for Athletic Equipment (NOCSAE) standard for protection from linear impact, without consideration of protection from rotational injury. A multidisciplinary team was assembled with expertise in brain injury, computational modeling, and materials engineering to design, fabricate and impact test a novel helmet padding system. A rotational fixture with magnesium headform and linear impactor was constructed using a rotary encoder to enable measurement of z axis rotational angle, velocity and acceleration. Helmet padding material designs were evaluated using finite element (FE) computational modeling, fabricated to specification and then impact tested. Models from two different manufacturers were retrofit with prototype pads and then compared with unmodified versions for attenuation of rotational acceleration. The helmets were then tested using a standard NOCSAE drop apparatus and headform for linear acceleration performance. Large-size Riddell Revolution and Schutt ION4D helmets retrofit with prototype padding demonstrated 21.6 and 33.6 % decreased peak z axis rotational acceleration following a 3.2 m/s side impact compared with their respective unmodified commercial models (717.7 vs. 914.0 rad/s(2) and 768.4 vs. 1,158.6 rad/s(2), p < 0.0001, respectively). The improved performance effect appeared consistent over at least 50 impacts without evidence of early material degradation or helmet damage. Compared with unmodified versions, drop test performance for hybridized helmets, measured by Peak G and severity index (SI), were comparable for most, but were worse for rear (Riddell Revolution) and side (Schutt ION4D) impact conditions. Rotational acceleration from side impacts may be attenuated by directed helmet design while maintaining acceptable linear impact performance. Future work will focus on optimization and durability testing of prototype padding for larger impacts.	[Johnston, James M.] Univ Alabama Birmingham, Dept Neurosurg, Birmingham, AL 35233 USA; [Ning, Haibin; Andrews, J. Barry; Vaidya, Uday] Univ Alabama Birmingham, Dept Mat Sci, Birmingham, AL 35233 USA; [Kim, Jong-Eun; Kim, Young-Ho; Soni, Bharat] Univ Alabama Birmingham, Dept Mech Engn, Birmingham, AL 35233 USA; [Reynolds, Richard] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Cooper, Lloyd] PUSH Prod Design, Birmingham, AL USA	Johnston, JM (corresponding author), Univ Alabama Birmingham, Dept Neurosurg, 1600 7th Ave South,Lowder 400, Birmingham, AL 35233 USA.	James.johnston@childrensal.org		Johnston, James/0000-0001-8564-1808			[Anonymous], 2011, CDC SPORTS REL CONC, P60; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Crisco JJ, 2012, J APPL BIOMECH, V28, P174, DOI 10.1123/jab.28.2.174; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Daniel RW, 2012, ANN BIOMED ENG, V40, P976, DOI 10.1007/s10439-012-0530-7; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Duma SM, 2009, IEEE ENG MED BIO, P1123, DOI 10.1109/IEMBS.2009.5333423; Fijalkowski RJ, 2007, J NEUROTRAUM, V24, P1387, DOI 10.1089/neu.2007.0268; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Gwin JT, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000249; HODGSON VR, 1975, MED SCI SPORT EXER, V7, P225; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; McCrory P, 2009, J CLIN NEUROSCI, V16, P755, DOI 10.1016/j.jocn.2009.02.002; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; OMMAYA AK, 1971, J BIOMECH, V4, P13, DOI 10.1016/0021-9290(71)90011-X; OMMAYA AK, 1973, J NEUROSURG, V39, P152, DOI 10.3171/jns.1973.39.2.0152; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Viano DC, 2012, ANN BIOMED ENG, V40, P160, DOI 10.1007/s10439-011-0384-4; Viano DC, 2005, NEUROSURGERY, V56, P266, DOI 10.1227/01.neu.0000150035.54230.3C; Weaver AA, 2012, ANN BIOMED ENG, V40, P2005, DOI 10.1007/s10439-012-0553-0	28	11	11	0	15	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	1369-7072	1460-2687		SPORTS ENG	Sports Eng.	MAR	2015	18	1					11	20		10.1007/s12283-014-0160-4			10	Sport Sciences	Sport Sciences	CY8RJ	WOS:000366675700002					2021-06-18	
J	Kavosi, Z; Jafari, A; Hatam, N; Enaami, M				Kavosi, Zahra; Jafari, Abdosaleh; Hatam, Nahid; Enaami, Meysam			The Economic Burden of Traumatic Brain Injury Due to Fatal Traffic Accidents in Shahid Rajaei Trauma Hospital, Shiraz, Iran	ARCHIVES OF TRAUMA RESEARCH			English	Article						Economic Burden; Potential Years of Life Lost (PYLL); Productivity Lost; Traffic Accidents; Traumatic Brain Injury	HEALTH; LIFE	Background: Traumatic Brain Injuries (TBIs) as a result of traffic accidents are one of the major causes of deaths, which lead to the loss of individuals' productive and working years of life. Objectives: This study aimed to calculate the economic burden of traumatic brain injuries in fatal crashes at Shahid Rajaei Trauma Hospital, Shiraz, Iran for a period of five years. Patients and Methods: In this descriptive, cross-sectional study the population included people who had died as a result of TBIs during 2009 to 2013 in Shiraz Shahid Rajaei Trauma Hospital. Cost and demographic data were obtained from the participants' medical records using data gathering forms, and some other information was also collected via telephone calls to the victims' families. Economic burden of TBIs due to traffic accidents, which led to death, was estimated using the human capital as direct costs of treatment, and the number of potential years of life lost and lost productivity as indirect costs. Results: Deaths resulting from TBIs due to traffic accidents in Shiraz imposed 6.2 billion Rials (511000 USD) of hospital costs, 6390 potential years of life lost, and 506 billion Rials (20 million USD) of productivity lost. In the present study, the mean age of the individuals who died was 38.4 +/- 19.41 and the productivity lost per capita was 1.8 billion Rials (73000 USD). Conclusions: The findings of this study indicated that the economic burden of TBIs was high in fatal accidents in Fars Province so that it was equivalent to 0.00011% of Iran's Gross Domestic Product (GDP) in 2013. Therefore, more attention has to be paid to the rules to prevent the fatal accidents.	[Kavosi, Zahra] Shiraz Univ Med Sci, Sch Management & Informat Sci, Social Determinants Hlth Res Ctr, Shiraz, Iran; [Jafari, Abdosaleh] Shiraz Univ Med Sci, Sch Management & Med Informat, Hlth Econ Dept, Shiraz, Iran; [Hatam, Nahid] Shiraz Univ Med Sci, Sch Management & Med Informat, Shiraz, Iran; [Enaami, Meysam] Shiraz Univ Med Sci, Sch Management & Med Informat, Student Res Comm, Shiraz, Iran	Enaami, M (corresponding author), Shiraz Univ Med Sci, Sch Management & Med Informat, Student Res Comm, Shiraz, Iran.	meysamenami@yahoo.com	Jafari, Abdosaleh/AAD-2632-2020; hatam, nahid/K-6957-2016	Jafari, Abdosaleh/0000-0003-3035-2798; hatam, nahid/0000-0001-7738-1970			af Geijerstam JL, 2004, EMERG MED J, V21, P54, DOI 10.1136/emj.2003.003178; Akbari M. E., 2006, Eastern Mediterranean Health Journal, V12, P382; Al-Masaeid HR, 1999, ACCIDENT ANAL PREV, V31, P347, DOI 10.1016/S0001-4575(98)00068-2; Ayatollahi ST, 2009, IRAN J EPIDEMIOL, V4, P51; Bazarian JJ, 2005, EMERG MED J, V22, P473, DOI 10.1136/emj.2004.019273; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Chen A, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-76; Dixey RA, 1999, HEALTH EDUC RES, V14, P197, DOI 10.1093/her/14.2.197; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; Hoang Hanh T M, 2008, Cost Eff Resour Alloc, V6, P17, DOI 10.1186/1478-7547-6-17; Karimi I, 2004, J HLTH ADM, V7, P22; Kayani NA, 2009, PUBLIC HLTH REP, V124, P551; Klemen P, 2006, ACTA ANAESTH SCAND, V50, P1250, DOI 10.1111/J.1399-6576.2006.01039.X; Krug EG, 2002, LANCET, V360, P1083, DOI 10.1016/S0140-6736(02)11133-0; Mathers C, 2008, GLOBAL BURDEN OF DISEASE: 2004 UPDATE, P1; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Passmore JW, 2010, B WORLD HEALTH ORGAN, V88, P783, DOI 10.2471/BLT.09.071662; Peden M., 2004, WORLD REPORT ROAD TR; Rezaei S, 2012, ARCH TRAUMA RES, V1, P93, DOI 10.5812/atr.6546; Rezaei Satar, 2014, J Inj Violence Res, V6, P57, DOI 10.5249/jivr.v6i2.191; Sanaei-Zadeh H, 2002, J CLIN FORENSIC MED, V9, P74, DOI DOI 10.1054/JCFM.2002.0547.[; Social Security Organization, 2014, TERMS BUR SUBS; Soori H, 1999, East Mediterr Health J, V5, P55; Soori H, 2009, HAKIM RES J, V12, P48; The World Bank, 2014, HEALTH; Wang CH, 2005, J ADV NURS, V52, P22, DOI 10.1111/j.1365-2648.2005.03560.x; World Health Organization, 1993, HANDL LIF CAR PREV V	27	11	11	0	3	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	2251-953X	2251-9599		ARCH TRAUMA RES	Arch. Trauma Res.	MAR	2015	4	1							e22594	10.5812/atr.22594			6	Orthopedics	Orthopedics	CP9GI	WOS:000360201400007	25834791	Green Published, Bronze			2021-06-18	
J	Makowiecki, K; Garrett, A; Clark, V; Graham, SL; Rodger, J				Makowiecki, Kalina; Garrett, Andrew; Clark, Vince; Graham, Stuart L.; Rodger, Jennifer			Reliability of VEP Recordings Using Chronically Implanted Screw Electrodes in Mice	TRANSLATIONAL VISION SCIENCE & TECHNOLOGY			English	Article						visual evoke potential; reliability; chronic electrode implant; approximate entropy; electroencephalogram	VISUAL-EVOKED POTENTIALS; TRAUMATIC BRAIN-INJURY; LONG-TERM POTENTIATION; MOUSE; CORTEX; RATS; ELECTROENCEPHALOGRAM; STIMULATION; COMPRESSION; INHIBITION	Purpose: Visual evoked potentials (VEPs) are widely used to objectively assess visual system function in animal models of ophthalmological diseases. Although use of chronically implanted electrodes is common in longitudinal VEP studies using rodent models, reliability of recordings over time has not been assessed. We compared VEPs 1 and 7 days after electrode implantation in the adult mouse. We also examined stimulus-independent changes over time, by assessing electroencephalogram (EEG) power and approximate entropy of the EEG signal. Methods: Stainless steel screws (600-mu m diameter) were implanted into the skull overlying the right visual cortex and the orbitofrontal cortex of adult mice (C57Bl/6J, n = 7). Animals were reanesthetized 1 and 7 days after implantation to record VEP responses (flashed gratings) and EEG activity. Brain sections were stained for glial activation (GFAP) and cell death (TUNEL). Results: Reliability analysis, using intraclass correlation coefficients, showed VEP recordings had high reliability within the same session, regardless of time after electrode implantation and peak latencies and approximate entropy of the EEG did not change significantly with time. However, there was poorer reliability between recordings obtained on different days, and a significant decrease in VEP amplitudes and EEG power. This amplitude decrease could be normalized by scaling to EEG power (within-subjects). Furthermore, glial activation was present at both time points but there was no evidence of cell death. Conclusions: These results indicate that VEP responses can be reliably recorded even after a relatively short recovery period but decrease response peak amplitude over time. Although scaling the VEP trace to EEG power normalized this decrease, our results highlight that time-dependent cortical excitability changes are an important consideration in longitudinal VEP studies. Translational Relevance: This study shows changes in VEP characteristics over time in chronically implanted mice. Thus, future preclinical longitudinal studies should consider time in addition to amplitude and latency when designing and interpreting research.	[Makowiecki, Kalina; Garrett, Andrew; Clark, Vince; Rodger, Jennifer] Univ Western Australia, Sch Anim Biol, Expt & Regenerat Neurosci, Crawley, WA, Australia; [Graham, Stuart L.] Macquarie Univ, Australian Sch Adv Med, N Ryde, NSW, Australia	Rodger, J (corresponding author), Univ Western Australia, Sch Anim Biol, Expt & Regenerat Neurosci M317, 35 Stirling Highway, Crawley, WA 6009, Australia.	jennifer.rodger@uwa.edu.au	Rodger, Jennifer/H-5735-2014	Rodger, Jennifer/0000-0003-3413-4229; Graham, Stuart/0000-0001-7519-969X; Makowiecki, Kalina/0000-0003-4550-3819	Neurotrauma Research Program (WA State Government); National Health and Medical Research Council Senior Research FellowshipNational Health and Medical Research Council of Australia; Australian Postgraduate AwardAustralian Government	Supported by grants from the Neurotrauma Research Program (WA State Government) and a The National Health and Medical Research Council Senior Research Fellowship (JR), as well as an Australian Postgraduate Award (KM).	Alwis DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052169; BIGNAMI A, 1976, NEUROPATH APPL NEURO, V2, P99, DOI 10.1111/j.1365-2990.1976.tb00488.x; Biran R, 2005, EXP NEUROL, V195, P115, DOI 10.1016/j.expneurol.2005.04.020; CALDERONE L, 1986, EXP EYE RES, V42, P331, DOI 10.1016/0014-4835(86)90026-6; Cambiaghi M, 2011, NEUROSCIENCE, V185, P161, DOI 10.1016/j.neuroscience.2011.04.022; Chang B, 2002, VISION RES, V42, P517, DOI 10.1016/S0042-6989(01)00146-8; Chen JR, 2003, J NEUROTRAUM, V20, P767, DOI 10.1089/089771503767869999; Cooke SF, 2010, J NEUROSCI, V30, P16304, DOI 10.1523/JNEUROSCI.4333-10.2010; CREEL D, 1974, VISION RES, V14, P725, DOI 10.1016/0042-6989(74)90070-4; Cruz JI, 1998, LAB ANIM-UK, V32, P18, DOI 10.1258/002367798780559383; Ding MC, 2008, NEUROSCIENCE, V154, P551, DOI 10.1016/j.neuroscience.2008.03.088; Ding MC, 2011, J NEUROSCI, V31, P14085, DOI 10.1523/JNEUROSCI.3572-11.2011; Franklin KB, 2008, MOUSE BRAIN STEREOTA; Frenkel MY, 2006, NEURON, V51, P339, DOI 10.1016/j.neuron.2006.06.026; He B, 2002, CLIN NEUROPHYSIOL, V113, P227, DOI 10.1016/S1388-2457(01)00740-4; Hirshler Y, 2010, EXP NEUROL, V222, P42, DOI 10.1016/j.expneurol.2009.12.006; Holland PR, 2010, CEPHALALGIA, V30, P519, DOI 10.1111/j.1468-2982.2009.02021.x; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Kim YT, 2004, BIOMATERIALS, V25, P2229, DOI 10.1016/j.biomaterials.2003.09.010; King CE, 1997, NEUROREPORT, V8, P1663; Klistorner AI, 2001, INVEST OPHTH VIS SCI, V42, P2145; Klistorner AI, 1998, AUST NZ J OPHTHALMOL, V26, pS91, DOI 10.1111/j.1442-9071.1998.tb01386.x; Kohtoh S, 2008, SLEEP BIOL RHYTHMS, V6, P163, DOI 10.1111/j.1479-8425.2008.00355.x; Lin JL, 2010, J CEREBR BLOOD F MET, V30, P1121, DOI 10.1038/jcbfm.2009.277; Makowiecki K, 2014, J NEUROSCI, V34, P10780, DOI 10.1523/JNEUROSCI.0723-14.2014; Manor T, 2008, NEUROL RES, V30, P1075, DOI 10.1179/174313208X346107; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.4.390; Meeren HKM, 1998, EVOKED POTENTIAL, V108, P306, DOI 10.1016/S0168-5597(97)00101-9; Mitzdorf U., 1985, AM PHYSL SOC, V65, P37; Peachey NS, 2003, DOC OPHTHALMOL, V107, P13, DOI 10.1023/A:1024448314608; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; Pinto LH, 2000, MAMM GENOME, V11, P531, DOI 10.1007/s003350010102; Porciatti V, 1999, VISUAL NEUROSCI, V16, P721, DOI 10.1017/S0952523899164113; Porciatti Vittorio, 2002, Documenta Ophthalmologica, V104, P69, DOI 10.1023/A:1014463212001; REEVES TM, 1995, EXP BRAIN RES, V106, P248; Ridder WH, 2006, VISION RES, V46, P902, DOI 10.1016/j.visres.2005.09.006; SCHUIRMANN DJ, 1987, J PHARMACOKINET BIOP, V15, P657, DOI 10.1007/BF01068419; Shrout P E, 1998, Stat Methods Med Res, V7, P301, DOI 10.1191/096228098672090967; You YY, 2012, INVEST OPHTH VIS SCI, V53, P1473, DOI 10.1167/iovs.11-8797; You YY, 2011, DOC OPHTHALMOL, V123, P109, DOI 10.1007/s10633-011-9288-8	40	11	11	0	3	ASSOC RESEARCH VISION OPHTHALMOLOGY INC	ROCKVILLE	12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA	2164-2591			TRANSL VIS SCI TECHN	Transl. Vis. Sci. Technol.	MAR	2015	4	2							15	10.1167/tvst.4.2.15			13	Ophthalmology	Ophthalmology	ED1DF	WOS:000388583500015	25938003	Green Published			2021-06-18	
J	Ross, PE; Ponsford, JL; Di Stefano, M; Spitz, G				Ross, Pamela E.; Ponsford, Jennie L.; Di Stefano, Marilyn; Spitz, Gershon			Predictors of On-Road Driver Performance Following Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article; Proceedings Paper	World Congress of NeuroRehabilitation	MAY 17, 2012	Melbourne, AUSTRALIA			Automobile driving; Brain injuries; Glasgow Coma Scale; Rehabilitation	HEAD-INJURY; COMMUNITY INTEGRATION; DRIVING ASSESSMENT; FITNESS; RETURN; RECOMMENDATIONS; POSTINJURY; IMPAIRMENT; CLINICIAN; EXPOSURE	Objective: To examine assessment outcomes and factors associated with passing an occupational therapy (OT) on-road driver assessment after traumatic brain injury (TBI). Design: Retrospective analysis of outcomes of on-road driver assessment completed by persons with TBI over an 8-year period. Setting: Inpatient and outpatient rehabilitation hospital. Participants: A consecutive sample of individuals (N=207) with mild to severe TBI who completed an on-road driver assessment and were assessed at least 3 months postinjury. Intervention: Not applicable. Main Outcome Measure: Outcome of on-road driver assessment. Results: Of the drivers with TBI, 66% (n=137) passed the initial on-road driver assessment (pass group), whereas 34% (n=70) required on-road driver rehabilitation and/or >= 1 on-road assessment (rehabilitation group). After driver rehabilitation, only 3 participants of the group did not resume driving. Participants who were men, had shorter posttraumatic amnesia (PTA) duration, had no physical and/or visual impairment, and had faster reaction times were significantly more likely to be in the pass group. In combination, these variables correctly classified 87.6% of the pass group and 71.2% of the rehabilitation group. Conclusions: PTA duration proved to be a better predictor of driver assessment outcome than Glasgow Coma Scale score. In combination with the presence of physical/visual impairment and slowed reaction times, PTA could assist clinicians to determine referral criteria for OT driver assessment. On-road driver rehabilitation followed by on-road reassessment were associated with a high probability of return to driving after TBI. (C) 2015 by the American Congress of Rehabilitation Medicine	[Ross, Pamela E.] Epworth HlthCare, Occupat Therapy Dept, Melbourne, Vic, Australia; [Ponsford, Jennie L.; Spitz, Gershon] Monash Univ, Sch Psychol & Psychiat, Melbourne, Vic 3004, Australia; [Ponsford, Jennie L.; Spitz, Gershon] Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [Di Stefano, Marilyn] La Trobe Univ, Sch Occupat Therapy, Melbourne, Vic, Australia	Ross, PE (corresponding author), Epworth HlthCare, Occupat Therapy Dept, 89 Bridge Rd, Richmond, Vic 3121, Australia.	pam.ross@epworth.org.au	Spitz, Gershon/H-7755-2014	Spitz, Gershon/0000-0002-7810-1480			[Anonymous], 1999, POLA CRIT; Austroads, 2012, ASS FITN DRIV COMM P; Bivona U, 2012, J HEAD TRAUMA REHAB, V27, P210, DOI 10.1097/HTR.0b013e31822178a9; Bliokas VV, 2011, BRAIN INJURY, V25, P471, DOI 10.3109/02699052.2011.559609; Brouwer WH, 1997, NEUROPSYCHOL REHABIL, V7, P177, DOI 10.1080/713755536; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; Bush BA, 2003, ARCH PHYS MED REHAB, V84, P1803, DOI 10.1016/S0003-9993(03)00367-8; Classen S, 2009, AM J OCCUP THER, V63, P580, DOI 10.5014/ajot.63.5.580; Coleman RD, 2002, ARCH PHYS MED REHAB, V83, P1415, DOI 10.1053/apmr.2002.35111; Cyr AA, 2009, J CLIN EXP NEUROPSYC, V31, P472, DOI 10.1080/13803390802255627; D'apolito A. -C., 2013, Annals of Physical and Rehabilitation Medicine, V56, P63, DOI 10.1016/j.rehab.2012.12.002; Di Stefano M, 2006, DRIVER REHABILITATIO, P255, DOI DOI 10.1016/B978-032302937-7.50018-6; Di Stefano M, 2010, AM J OCCUP THER, V64, P325, DOI 10.5014/ajot.64.2.325; Dimarco F, 2001, EURA MEDICOPHYS, V37, P215; DiStefano M, 2006, DRIVER REHABILITATIO, P297; Duquette J, 2010, AM J OCCUP THER, V64, P279, DOI 10.5014/ajot.64.2.279; Fisk GD, 1998, BRAIN INJURY, V12, P683; FORMISANO R, 2001, EUROPA MEDICOPHYSICA, V37, P257; Fox GK, 1998, ARCH PHYS MED REHAB, V79, P1288, DOI 10.1016/S0003-9993(98)90277-5; Galski T, 2000, J HEAD TRAUMA REHAB, V15, P895, DOI 10.1097/00001199-200006000-00004; Hawley CA, 2001, J NEUROL NEUROSUR PS, V70, P761, DOI 10.1136/jnnp.70.6.761; Hopewell CA, 2002, J HEAD TRAUMA REHAB, V17, P48, DOI 10.1097/00001199-200202000-00007; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; JONES R, 1983, AM J OCCUP THER, V37, P754, DOI 10.5014/ajot.37.11.754; Korner-Bitensky N, 2006, AM J OCCUP THER, V60, P428, DOI 10.5014/ajot.60.4.428; Korteling JE, 1996, ARCH PHYS MED REHAB, V77, P138, DOI 10.1016/S0003-9993(96)90158-6; Kosch Y, 2010, BRAIN INJURY, V24, P479, DOI 10.3109/02699051003610417; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; Labbe DR, 2014, J HEAD TRAUMA REHAB, V29, P185, DOI 10.1097/HTR.0b013e3182795211; Lew HL, 2005, BRAIN INJURY, V19, P177, DOI 10.1080/02699050400017171; Marosszeky NEV, 1997, PTA PROTOCOL GUIDELI; Marshall SC, 1999, CAN MED ASSOC J, V160, P1701; Novack TA, 2010, BRAIN INJURY, V24, P464, DOI 10.3109/02699051003601713; Ortoleva C, 2012, J HEAD TRAUMA REHAB, V27, P302, DOI 10.1097/HTR.0b013e3182236299; Pietrapiana P, 2005, BRAIN INJURY, V19, P197, DOI 10.1080/02699050400017197; Ponsford J, 2012, TRAUMATIC BRAIN INJU; PRIDDY D A, 1990, Brain Injury, V4, P267, DOI 10.3109/02699059009026176; Rapport L, 2006, J HEAD TRAUMA REHAB, V21, P34, DOI 10.1097/00001199-200601000-00004; Rapport LJ, 2008, ARCH PHYS MED REHAB, V89, P922, DOI 10.1016/j.apmr.2008.01.009; Roads Corporation (Vic), 1998, COMP STAND OCC THER; Schanke AK, 2008, J REHABIL MED, V40, P733, DOI 10.2340/16501977-0256; Schulte T, 1999, AM J PHYS MED REHAB, V78, P136, DOI 10.1097/00002060-199903000-00010; Schultheis MT, 2002, J HEAD TRAUMA REHAB, V17, P38, DOI 10.1097/00001199-200202000-00006; SHUTE RH, 1990, OPHTHAL PHYSL OPT, V10, P327, DOI 10.1111/j.1475-1313.1990.tb00878.x; Sommer M, 2010, ARCH CLIN NEUROPSYCH, V25, P99, DOI 10.1093/arclin/acp109; Tamietto M, 2006, NEUROREHABILITATION, V21, P81; Transport Accident Commission, 2010, TRANSP ACC COM SAF S; VANZOMEREN AH, 1988, ARCH PHYS MED REHAB, V69, P90	48	11	11	0	7	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAR	2015	96	3					440	446		10.1016/j.apmr.2014.09.027			7	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	CC3QZ	WOS:000350265400009	25316183				2021-06-18	
J	Berger, RP; Fromkin, J; Rubin, P; Snyder, J; Richichi, R; Kochanek, P				Berger, Rachel P.; Fromkin, Janet; Rubin, Pam; Snyder, John; Richichi, Rudolph; Kochanek, Patrick			Serum D-Dimer Concentrations Are Increased after Pediatric Traumatic Brain Injury	JOURNAL OF PEDIATRICS			English	Article							ABUSIVE HEAD TRAUMA; SICKLE-CELL-DISEASE; YOUNG-CHILDREN; COAGULATION; FRAGMENT; MARKERS; WELL; POPULATION; BIOMARKERS; CRISIS	Objective To determine whether D-dimer would be increased in children with traumatic brain injury (TBI), specifically mild abusive head trauma. Study design D-dimer was measured using multiplex bead technology in 195 children <4 years old (n = 93 controls without TBI, n = 102 cases with TBI) using previously collected serum. D-dimer was then measured prospectively in a clinical setting in 44 children (n = 24 controls, n = 20 cases). Receiver operator curves were generated for prospective data. Results In both the retrospective and prospective cohorts, median (25th-75th percentile) D-dimer was significantly higher in cases vs controls. A receiver operator curve demonstrated an area under the curve of 0.91 (95% CI 0.83-0.99) in the prospective cohort. At a cut-off of 0.59 mu g/L, the sensitivity and specificity for identification of a case was 90% and 75%, respectively. Conclusions Our data suggest that serum D-dimer may be able to be used to identify which young children at risk for abusive head trauma might benefit from a head computed tomography or other additional evaluation. Additional data are needed to better identify the clinical scenarios that may result in false positive or false negative D-dimer concentrations.	[Berger, Rachel P.; Kochanek, Patrick] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15224 USA; [Berger, Rachel P.; Fromkin, Janet; Rubin, Pam] Univ Pittsburgh, Med Ctr, Childrens Hosp Pittsburgh, Pittsburgh, PA 15224 USA; [Snyder, John] UPMC Hillman Canc Ctr, Pittsburgh, PA USA; [Richichi, Rudolph] Stat Anal & Measurement Consultants Inc, Lanexa, VA USA	Berger, RP (corresponding author), Univ Pittsburgh, Childrens Hosp Pittsburgh, Med Ctr, 4401 Penn Ave, Pittsburgh, PA 15224 USA.	rachel.berger@chp.edu	Kochanek, Patrick M/D-2371-2015	Kochanek, Patrick M/0000-0002-2627-913X	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01HD055986, 1K23HD43843]; General Clinical Resource Center of Children's Hospital of Pittsburgh of UPMC; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD055986] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD043843] Funding Source: NIH RePORTER	Funded by the National Institutes of Health (R01HD055986 AND 1K23HD43843 [to R.B.]) and the General Clinical Resource Center of Children's Hospital of Pittsburgh of UPMC. The authors declare no conflicts of interest.	Barnes DM, 2008, BIOMARK INSIGHTS, V3, P93; Berger RP, 2012, J NEUROTRAUM, V29, P162, DOI 10.1089/neu.2011.1989; Berger RP, 2011, PM&R, V3, pS31, DOI 10.1016/j.pmrj.2011.03.016; Berger RP, 2009, PEDIATR RES, V65, P97, DOI 10.1203/PDR.0b013e31818c7e27; Berger RP, 2006, DEV NEUROSCI-BASEL, V28, P327, DOI 10.1159/000094158; Berger RP, 2006, CLIN PEDIATR EMERG M, V7, P186, DOI 10.1016/j.cpem.2006.06.001; Berger RP, 2006, PEDIATRICS, V117, P325, DOI 10.1542/peds.2005-0711; Berger RP, 2005, J NEUROSURG, V103, P61, DOI 10.3171/ped.2005.103.1.0061; BOISCLAIR MD, 1990, BRIT J HAEMATOL, V74, P471, DOI 10.1111/j.1365-2141.1990.tb06337.x; Castellanos Mar, 2007, Cerebrovasc Dis, V24 Suppl 1, P7, DOI 10.1159/000107374; Chen JP, 1999, THROMB RES, V94, P175, DOI 10.1016/S0049-3848(98)00211-4; Chhabra Gaurav, 2013, J Emerg Trauma Shock, V6, P180, DOI 10.4103/0974-2700.115332; Corwin MT, 2009, AM J ROENTGENOL, V192, P1319, DOI 10.2214/AJR.08.1346; DeFazio MV, 2014, WORLD NEUROSURG, V81, P151, DOI 10.1016/j.wneu.2013.01.015; DEVINE DV, 1986, BLOOD, V68, P317; Ellingson KD, 2008, AM J PREV MED, V34, pS157, DOI 10.1016/j.amepre.2007.12.021; Ettaro L, 2004, CHILD ABUSE NEGLECT, V28, P1099, DOI 10.1016/j.chiabu.2004.06.006; FRANCIS RB, 1989, HAEMOSTASIS, V19, P105; Hymel KP, 1997, PEDIATRICS, V99, P371, DOI 10.1542/peds.99.3.371; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Letson M, 2013, PED AC SOC ANN M; Lo TYM, 2009, J NEUROTRAUM, V26, P1479, DOI [10.1089/neu.2008.0753, 10.1089/neu.2008-0753]; MINER ME, 1982, J PEDIATR-US, V100, P687, DOI 10.1016/S0022-3476(82)80565-9; Natorska J, 2011, THROMB HAEMOSTASIS, V105, P254, DOI 10.1160/TH10-09-0612; Niyonkuru C, 2013, J NEUROTRAUM, V30, P938, DOI 10.1089/neu.2012.2578; Shah N, 2012, THROMB RES, V130, pE241, DOI 10.1016/j.thromres.2012.08.307; Sheets LK, 2013, PEDIATRICS, V131, P701, DOI 10.1542/peds.2012-2780; Sieswerda-Hoogendoorn T, 2012, EUR J PEDIATR, V171, P415, DOI 10.1007/s00431-011-1598-z; Swanson CA, 2010, J TRAUMA, V68, P1072, DOI 10.1097/TA.0b013e3181d7a6f2	30	11	13	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-3476	1097-6833		J PEDIATR-US	J. Pediatr.	FEB	2015	166	2					383	388		10.1016/j.jpeds.2014.10.036			6	Pediatrics	Pediatrics	AZ8XY	WOS:000348496200038	25454315	Green Accepted			2021-06-18	
J	Eastman, CL; Fender, JS; Temkin, NR; D'Ambrosio, R				Eastman, Clifford L.; Fender, Jason S.; Temkin, Nancy R.; D'Ambrosio, Raimondo			Optimized methods for epilepsy therapy development using an etiologically realistic model of focal epilepsy in the rat	EXPERIMENTAL NEUROLOGY			English	Article						Drug development; Preclinical drug screening; Focal epilepsy; Non-convulsive seizure; Pharmacoresistance; Statistical power analysis	FLUID PERCUSSION INJURY; SPONTANEOUS RECURRENT SEIZURES; COMPLEX PARTIAL SEIZURES; KAINATE-INDUCED EPILEPSY; TEMPORAL-LOBE EPILEPSY; SPRAGUE-DAWLEY RATS; POSTTRAUMATIC EPILEPSY; BRAIN-INJURY; HEAD-INJURY; EPILEPTOGENESIS	Conventionally developed antiseizure drugs fail to control epileptic seizures in about 30% of patients, and no treatment prevents epilepsy. New etiologically realistic, syndrome-specific epilepsy models are expected to identify better treatments by capturing currently unknown ictogenic and epileptogenic mechanisms that operate in the corresponding patient populations. Additionally, the use of electrocorticography permits better monitoring of epileptogenesis and the full spectrum of acquired seizures, including focal nonconvulsive seizures that are typically difficult to treat in humans. Thus, the combined use of etiologically realistic models and electrocorticography may improve our understanding of the genesis and progression of epilepsy, and facilitate discovery and translation of novel treatments. However, this approach is labor intensive and must be optimized. To this end, we used an etiologically realistic rat model of posttraumatic epilepsy, in which the initiating fluid percussion injury closely replicates contusive closed-head injury in humans, and has been adapted to maximize epileptogenesis and focal non-convulsive seizures. We obtained week-long 5-electrode electrocorticography 1 month post-injury, and used a Monte-Carlo-based non-parametric bootstrap strategy to test the impact of. electrode montage design, duration-based seizure definitions, group size and duration of recordings on the assessment of posttraumatic epilepsy, and on statistical power to detect antiseizure and antiepileptogenic treatment effects. We found that use of seizure definition based on clinical criteria rather than event duration, and of recording montages closely sampling the activity of epileptic foci, maximize the power to detect treatment effects. Detection of treatment effects was marginally improved by prolonged recording, and 24 h recording epochs were sufficient to provide 80% power to detect clinically interesting seizure control or prevention of seizures with small groups of animals. We conclude that appropriate electrode montage and clinically relevant seizure definition permit convenient deployment of fluid percussion injury and electrocorticography for epilepsy therapy development. (C) 2014 Elsevier Inc. All rights reserved.	[Eastman, Clifford L.; Fender, Jason S.; Temkin, Nancy R.; D'Ambrosio, Raimondo] Univ Washington, Sch Med, Dept Neurol Surg, Seattle, WA 98104 USA; [Temkin, Nancy R.] Univ Washington, Sch Med, Dept Biostat, Seattle, WA 98104 USA; [D'Ambrosio, Raimondo] Univ Washington, Sch Med, Reg Epilepsy Ctr, Seattle, WA 98104 USA	D'Ambrosio, R (corresponding author), Univ Washington, Sch Med, Dept Neurol Surg, Seattle, WA 98104 USA.	raid@u.washington.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS076570]; Citizens United for Research in Epilepsy (Prevention of Acquired Epilepsies Award); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS076570] Funding Source: NIH RePORTER	National Institutes of Health (NS076570) and Citizens United for Research in Epilepsy (Prevention of Acquired Epilepsies Award) provided funding to R.D.	Bancaud J, 1992, Adv Neurol, V57, P3; Bialer M, 2010, EPILEPSY RES, V92, P89, DOI 10.1016/j.eplepsyres.2010.09.001; Buckingham SC, 2011, NAT MED, V17, P1269, DOI 10.1038/nm.2453; Butler T, 2013, J NEUROIMAGING, V23, P129, DOI 10.1111/j.1552-6569.2010.00572.x; Curia G., 2015, FRONTIERS N IN PRESS; Curia G, 2011, CEREB CORTEX, V21, P1574, DOI 10.1093/cercor/bhq218; D'Ambrosio R, 2005, BRAIN, V128, P174, DOI 10.1093/brain/awh337; D'Ambrosio R, 2004, BRAIN, V127, P304, DOI 10.1093/brain/awh038; D'Ambrosio R, 2013, ANN NEUROL, V73, P199, DOI 10.1002/ana.23764; D'Ambrosio R, 2010, EPILEPSY CURR, V10, P61, DOI 10.1111/j.1535-7511.2010.01358.x; D'Ambrosio R, 2009, BRAIN, V132, P2805, DOI 10.1093/brain/awp217; Diaz-Arrastia R, 2009, EPILEPSIA, V50, P14, DOI 10.1111/j.1528-1167.2008.02006.x; Dube CM, 2010, J NEUROSCI, V30, P7484, DOI 10.1523/JNEUROSCI.0551-10.2010; Eastman CL, 2011, J PHARMACOL EXP THER, V336, P779, DOI 10.1124/jpet.110.175133; Eastman CL, 2010, EXP NEUROL, V224, P369, DOI 10.1016/j.expneurol.2010.04.013; Efron B., 1998, INTRO BOOTSTRAP; Fisher RS, 2005, EPILEPSIA, V46, P470, DOI 10.1111/j.0013-9580.2005.66104.x; Gilliam F, 2004, NEUROLOGY, V63, pS9, DOI 10.1212/WNL.63.10_suppl_4.S9; Goffin K, 2007, EXP NEUROL, V205, P501, DOI 10.1016/j.expneurol.2007.03.008; Goodrich GS, 2013, J NEUROTRAUM, V30, P1434, DOI 10.1089/neu.2012.2712; Grabenstatter HL, 2008, EPILEPSIA, V49, P1787, DOI 10.1111/j.1528-1167.2008.01657.x; Grabenstatter HL, 2007, EPILEPSIA, V48, P2287; Gupta P., 2014, J NEUROTRAUMA; Ikeda A, 2009, EPILEPSIA, V50, P2072, DOI 10.1111/j.1528-1167.2009.02097.x; JUULJENSEN P, 1986, INTRACTABLE EPILEPSY, P5; Kelly KM, 2001, EPILEPSY RES, V47, P189, DOI 10.1016/S0920-1211(01)00294-7; Loscher W, 2013, NAT REV DRUG DISCOV, V12, P757, DOI 10.1038/nrd4126; Loscher W, 2012, EPILEPSIA, V53, P1841, DOI 10.1111/j.1528-1167.2012.03647.x; Loscher W, 2011, EPILEPSIA, V52, P657, DOI 10.1111/j.1528-1167.2011.03024.x; Mattson RH, 1996, NEUROLOGY, V47, P68, DOI 10.1212/WNL.47.1.68; Pearce PS, 2014, EPILEPSY BEHAV, V32, P121, DOI 10.1016/j.yebeh.2014.01.004; Rakhade SN, 2011, EPILEPSIA, V52, P753, DOI 10.1111/j.1528-1167.2011.02992.x; Semah F, 1998, NEUROLOGY, V51, P1256, DOI 10.1212/WNL.51.5.1256; Siegel S., 1956, NONPARAMETRIC STAT B; Smith M, 2007, NEUROTHERAPEUTICS, V4, P12, DOI 10.1016/j.nurt.2006.11.009; Stewart KAA, 2010, J NEUROPATH EXP NEUR, V69, P1210, DOI 10.1097/NEN.0b013e3181ffc420; Stewart TH, 2010, J NEUROPHYSIOL, V104, P3345, DOI 10.1152/jn.00398.2010; Temkin NR, 2009, EPILEPSIA, V50, P10, DOI 10.1111/j.1528-1167.2008.02005.x; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; White HS, 1998, NEUROPHARMACOLOGY ME, P27; Williams PA, 2007, NEUROSCIENCE, V149, P943, DOI 10.1016/j.neuroscience.2007.07.067; Williams PA, 2009, J NEUROSCI, V29, P2103, DOI 10.1523/JNEUROSCI.0980-08.2009; WILLIAMSON PD, 1986, EPILEPSIA, V27, pS46, DOI 10.1111/j.1528-1157.1986.tb05740.x; WILLIAMSON PD, 1985, ANN NEUROL, V18, P497, DOI 10.1002/ana.410180413; WILLOUGHBY JO, 1992, LAB ANIM SCI, V42, P551	45	11	11	0	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	FEB	2015	264						150	162		10.1016/j.expneurol.2014.12.010			13	Neurosciences	Neurosciences & Neurology	CB4IC	WOS:000349590400016	25523813	Green Accepted			2021-06-18	
J	Shulman, BS; Lee, JH; Liporace, FA; Ego, KA				Shulman, Brandon S.; Lee, James H.; Liporace, Frank A.; Ego, Kenneth A.			Minimally Displaced Radial Head/Neck Fractures (Mason Type-I, OTA Types 21A2.2 and 21B2.1): Are We "Over Treating" Our Patients?	JOURNAL OF ORTHOPAEDIC TRAUMA			English	Article						radial head; Mason type-I; cost; radiograph; orthopaedic trauma; elbow	HEAD FRACTURES; NECK FRACTURES; CLASSIFICATION; EPIDEMIOLOGY; TRIAL; ELBOW	Objective: The purpose of this study was to investigate the nonoperative treatment strategies for Mason-Johnson type-I radial head fractures. Design and Setting: Retrospective review of every patient with a closed radial head/neck fracture who presented to our tertiary care specialty institution in the past 2 years. Patients/Participants: A search of ICD-9 code 813.05, closed fracture of the radial head/neck, in our electronic record system yielded 82 consecutive patients. Main Outcome Measurements: Complications and treatment interventions were recorded. Demographic, radiographic, and physical examination data were collected for all patients treated non-operatively and analyzed for association with recommendation for continued follow-up and radiographic assessment. Results: Fifty-four patients (68%) had 56 nondisplaced or minimally displaced (<2 mm) radial head or neck fractures without an additional injury to the affected limb. All patients were treated nonoperatively, and no patient in this cohort developed a complication or had any medical or surgical intervention other than physical therapy. No radiographic or physical examination measure was significantly associated with recommendation for the second outpatient follow-up, third outpatient follow-up, or with the number of additional radiographs ordered beyond the initial examination. An average of 4.4 (SD, 3.3) additional x-rays were taken of each affected elbow after initial outpatient presentation. Conclusions: Orthopaedic surgeons are likely over treating patients with Mason-Johnson type-I radial head fractures by recommending frequent radiographic follow-up without modifying treatment, leading to unnecessary patient visits, radiation exposure, and increased costs.	[Shulman, Brandon S.; Lee, James H.; Liporace, Frank A.; Ego, Kenneth A.] NYU, Hosp Joint Dis, Dept Orthopaed Surg, New York, NY 10003 USA	Ego, KA (corresponding author), NYU, Hosp Joint Dis, 301 East 17th St,Suite 1402, New York, NY 10003 USA.	Kennth.Egol@nyumc.org			Biomet; Synthes; De Puy; MedtronicMedtronic; Stryker; Omega; OREF	F. A. Lipoarce is a consultant, paid lecturer, and educational presenter for Biomet, Synthes, De Puy, Medtronic, and Stryker. He has patents with and receives royalties from De Puy and Biomet. K. Egol receives research support from Synthes, Omega, and OREF. He is a consultant for and receives royalties from Exactech and owns stock in Johnson and Johnson. B. S. Shulman and J. H. Lee report no conflict of interest.	BROBERG MA, 1987, CLIN ORTHOP RELAT R, P109; Cutler E C, 1926, Ann Surg, V84, P256, DOI 10.1097/00000658-192608000-00013; Duckworth AD, 2012, J HAND SURG-AM, V37A, P112, DOI 10.1016/j.jhsa.2011.09.034; Duckworth AD, 2011, J TRAUMA, V71, P643, DOI 10.1097/TA.0b013e3181f8fa5f; Egol KA, 2010, HDB FRACTURES; Furey MJ, 2013, J SHOULDER ELB SURG, V22, P636, DOI 10.1016/j.jse.2013.01.019; Harding P, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008130.pub2; Hausmann JT, 2009, J TRAUMA, V66, P457, DOI 10.1097/TA.0b013e31817fdedd; Herbertsson P, 2005, J SHOULDER ELB SURG, V14, P73, DOI 10.1016/j.jse.2004.07.001; HOLDSWORTH BJ, 1987, INJURY, V18, P44, DOI 10.1016/0020-1383(87)90385-8; Hotchkiss, 1997, J Am Acad Orthop Surg, V5, P1; Iannuzzi NP, 2012, CLIN ORTHOP RELAT R, V470, P1799, DOI 10.1007/s11999-012-2319-2; Kaas L, 2010, J SHOULDER ELB SURG, V19, P520, DOI 10.1016/j.jse.2009.10.015; Kovar FM, 2013, WORLD J ORTHOP, V4, P80, DOI 10.5312/wjo.v4.i2.80; Marsh JL, 2007, J ORTHOP TRAUMA, V21, pS1, DOI 10.1097/00005131-200711101-00001; MASON ML, 1954, BRIT J SURG, V42, P123, DOI 10.1002/bjs.18004217203; Pappas N, 2010, CLIN ORTHOP RELAT R, V468, P914, DOI 10.1007/s11999-009-1183-1; Paschos NK, 2013, J ORTHOP TRAUMA, V27, P134, DOI 10.1097/BOT.0b013e31825cf765; Rineer CA, 2010, J SHOULDER ELB SURG, V19, P21, DOI 10.1016/j.jse.2009.05.015; Ruchelsman DE, 2013, J BONE JOINT SURG AM, V95A, P469, DOI 10.2106/JBJS.J.01989; Sheehan SE, 2013, RADIOGRAPHICS, V33, P869, DOI 10.1148/rg.333125176; UNSWORTHWHITE J, 1994, INJURY, V25, P165, DOI 10.1016/0020-1383(94)90154-6; Yoon A, 2012, J HAND SURG-AM, V37A, P2626, DOI 10.1016/j.jhsa.2012.10.001	23	11	11	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0890-5339	1531-2291		J ORTHOP TRAUMA	J. Orthop. Trauma	FEB	2015	29	2					E31	E35					5	Orthopedics; Sport Sciences	Orthopedics; Sport Sciences	CA3TH	WOS:000348828500002	24978945				2021-06-18	
J	Sharma, A; Sane, H; Kulkarni, P; Yadav, J; Gokulchandran, N; Biju, H; Badhe, P				Sharma, Alok; Sane, Hemangi; Kulkarni, Pooja; Yadav, Jayanti; Gokulchandran, Nandini; Biju, Hema; Badhe, Prerna			Cell therapy attempted as a novel approach for chronic traumatic brain injury - a pilot study	SPRINGERPLUS			English	Article						Traumatic brain injury; Cellular therapy; Autologous; Bone marrow; Mononuclear cells; Intrathecal; PET CT scan	SPINAL-CORD-INJURY; MARROW STROMAL CELLS; STEM-CELLS; NEURAL CELLS; TRANSPLANTATION; DIFFERENTIATE; DEFICITS; CULTURE	Traumatic brain injury is an injury to the brain parenchyma resulting from external factors such as vehicular accidents, falls, or sports injuries. Its outcome involves primary insult followed by a cascade of secondary insult, resulting in diffuse axonal injury further causing white matter damage. Surgical intervention targets the primary damage, whereas only few treatment alternatives are available to treat the secondary damage. Cellular therapy could be one of the prospective therapeutic options, as it has the potential to arrest the degeneration and promote regeneration of new cells in the brain. We conducted a pilot study on 14 cases who were administered with autologous bone marrow mononuclear cells, intrathecally. The follow up was done at 1 week, 3 months and 6 months after the intervention. The Functional Independence Measure scale, the SF-8 Health Survey Scoring and the disability rating scale were used as outcome measures. These scales showed a positive shift in scores at the end of 6 months. Improvements were observed in various symptoms, along with activities of daily living. Improvement in PET CT scan performed before and 6 months after the intervention in 3 patients corresponded to the clinical and functional improvements observed in these patients. The results of this study suggest that cell therapy may promote functional recovery leading to an improved quality of life in chronic TBI. Although the results are positive, the improvements after cell therapy are not optimal. Hence, additional multicenter, controlled studies are required to establish cell therapy as a standard therapeutic approach.	[Sharma, Alok; Gokulchandran, Nandini; Badhe, Prerna] Stem Asia Hosp & Res Ctr, NeuroGen Brain & Spine Inst, Dept Med Serv & Clin Res, Seawood W 400706, New Mumbai, India; [Sane, Hemangi; Kulkarni, Pooja] Stem Asia Hosp & Res Ctr, NeuroGen Brain & Spine Inst, Dept Res & Dev, Seawood W 400706, New Mumbai, India; [Yadav, Jayanti; Biju, Hema] Stem Asia Hosp & Res Ctr, NeuroGen Brain & Spine Inst, Dept NeuroRehabil, Seawood W 400706, New Mumbai, India	Kulkarni, P (corresponding author), Stem Asia Hosp & Res Ctr, NeuroGen Brain & Spine Inst, Dept Res & Dev, Sect 40,Plot 19,Palm Beach Rd, Seawood W 400706, New Mumbai, India.	poojakul28@gmail.com					Ahmed A, 2014, LANCET, V383, P18; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; Bunch J, 2000, TBI CHALLENGE, V4; Fischer UM, 2009, STEM CELLS DEV, V18, P683, DOI 10.1089/scd.2008.0253; Horner PJ, 2000, NATURE, V407, P963, DOI 10.1038/35039559; Hsu Yi-Chao, 2013, Biomed J, V36, P98, DOI 10.4103/2319-4170.113226; Jorge RE, 2005, J HEAD TRAUMA REHAB, V20, P475, DOI 10.1097/00001199-200511000-00001; Kato T, 2007, J NEUROTRAUM, V24, P919, DOI 10.1089/neu.2006.0203; Kim HJ, 2010, J NEUROTRAUM, V27, P131, DOI [10.1089/neu.2008.0818, 10.1089/neu.2008-0818]; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Lawall H, 2010, THROMB HAEMOSTASIS, V103, P696, DOI 10.1160/TH09-10-0688; Lee JS, 2010, STEM CELLS, V28, P1099, DOI 10.1002/stem.430; Liu S, 2000, P NATL ACAD SCI USA, V97, P6126, DOI 10.1073/pnas.97.11.6126; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Morizane A, 2013, STEM CELL REP, V1, P283, DOI 10.1016/j.stemcr.2013.08.007; Muotri Alysson Renato, 2010, Estud. av., V24, P71, DOI 10.1590/S0103-40142010000300005; Nakashima T, 2007, AM J NEURORADIOL, V28, P236; Park KI, 2006, EXP NEUROL, V199, P156, DOI 10.1016/j.expneurol.2006.04.002; Parr AM, 2007, BONE MARROW TRANSPL, V40, P609, DOI 10.1038/sj.bmt.1705757; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Riess P, 2002, NEUROSURGERY, V51, P1043, DOI 10.1097/00006123-200210000-00035; Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389; Schwarzbold Marcelo, 2008, Neuropsychiatr Dis Treat, V4, P797; Sharma A, 2012, J CLIN CASE REP, V2, P195; Sharma A, 2012, J STEM CELL RES THER, V2, P129; Sharma A, 2012, INDIAN J CLIN PRACTI, V23, P100; Sharma A, 2013, CASE REP NEUROL MED, V2013, DOI 10.1155/2013/141983; Sharma A, 2013, J NEURORESTORATOLOGY, V1, P13, DOI 10.2147/JN.S43712; Sharma A, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/623875; Sharma A, 2012, CELL TRANSPLANT, V21, pS79, DOI 10.3727/096368912X633798; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Ul Hassan Ashfaq, 2009, Int J Health Sci (Qassim), V3, P227; General Assembly of the World Medical Association, 2014, J Am Coll Dent, V81, P14, DOI 10.1001/jama.2013.281053; Yoon SH, 2007, STEM CELLS, V25, P2066, DOI 10.1634/stemcells.2006-0807; Zhang R, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-106; Zhao LR, 2002, EXP NEUROL, V174, P11, DOI 10.1006/exnr.2001.7853; Zhong C, 2003, NEUROSCI LETT, V342, P93, DOI 10.1016/S0304-3940(03)00255-6	37	11	11	0	1	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND	2193-1801			SPRINGERPLUS	SpringerPlus	JAN 17	2015	4								26	10.1186/s40064-015-0794-0			8	Multidisciplinary Sciences	Science & Technology - Other Topics	CO4PC	WOS:000359142000003	25628985	Other Gold, Green Published			2021-06-18	
J	Berlin, T; Murray-Krezan, C; Yonas, H				Berlin, Tracey; Murray-Krezan, Cristina; Yonas, Howard			Comparison of parenchymal and ventricular intracranial pressure readings utilizing a novel multi-parameter intracranial access system	SPRINGERPLUS			English	Article						Parenchymal ICP; Ventricular ICP; Intracranial pressure; External ventricular drain; Cerebrospinal fluid; Neurocritical care; Traumatic brain injury; Subarachnoid hemorrhage; InnerSpace Neuro Solutions, Inc; Hummingbird Synergy Ventricular System	AGREEMENT	Introduction: Both ventricular and parenchymal devices are available for measurement of intracranial pressure (ICP). The Hummingbird (R) Synergy Ventricular System is a novel device allowing multi-parametric neurological monitoring, including both ventricular and parenchymal ICP. The purpose of this study is to compare the congruence of the device's ventricular and parenchymal ICP readings. Methods: This single-center, quantitative, interventional study compared parenchymal and ventricular ICP readings from 35 patients with the Hummingbird (R) System. If a difference of > +/- 3 mmHg existed between an individual patient's parenchymal and ventricular values, progressive intervention strategies were applied to correct identified issues. Results: From a total of 2,259 observations, statistical analysis revealed congruence (within +/- 0-3 mmHg) of 93% of readings comparing parenchymal and ventricular ICP. Of the observations requiring intervention, 58% involved the parenchymal component, 30% involved the ventricular component, and 12% involved both components. Following prescribed interventions, 98% of readings became congruent (within +/- 0-3 mmHg). The adjusted mean difference between the two methods was -0.95 (95% CI: -0.97, -0.93) mmHg and all mean ICP readings fell between -2 and 2 mmHg. Conclusion: The Hummingbird (R) Synergy Ventricular System demonstrates congruence between ventricular and parenchymal ICP measurements within accepted parameters. Interventions required to realign parenchymal and ventricular readings serve as reminders to clinicians to be vigilant with catheter/cable connections and to maintain appropriate positioning of the ventricular drainage system. The results of this study support the recommendation to use the parenchymal ICP component for routine ICP monitoring, allowing dedication of the ventricular catheter to drainage of cerebrospinal fluid (CSF).	[Berlin, Tracey] Univ New Mexico Hosp, Dept Neurosurg, Albuquerque, NM 87131 USA; [Murray-Krezan, Cristina] Univ New Mexico, Sch Med, Dept Internal Med, Div Epidemiol Biostat & Prevent Med, Albuquerque, NM 87131 USA; [Yonas, Howard] Univ New Mexico, Sch Med, Dept Neurosurg, Albuquerque, NM 87131 USA	Berlin, T (corresponding author), Univ New Mexico Hosp, Dept Neurosurg, MSC10 5615,1 Univ New Mexico, Albuquerque, NM 87131 USA.	tmberlin@verizon.net	Murray-Krezan, Cristina/O-3834-2016	Murray-Krezan, Cristina/0000-0002-5488-1080	Department of Neurosurgery at the University of New Mexico Hospital; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001449] Funding Source: NIH RePORTER	This project was supported by the Department of Neurosurgery at the University of New Mexico Hospital. The authors wish to thank the dedicated nursing staff in the Neuroscience ICU for their involvement in this study. We wish to acknowledge Arthur Stidfole BSN, RN, MM, CNRN and Kim Olin MSN, RN, CCRN for their assistance with data validation. We also extend our gratitude to Kristina Anderson for her assistance with manuscript editing.	Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Brean A, 2006, J Clin Monit Comput, V20, P411, DOI 10.1007/s10877-006-9047-7; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Chambers IR, 2001, J NEUROL NEUROSUR PS, V71, P383, DOI 10.1136/jnnp.71.3.383; Chohan MO, 2014, OPER NEUROSURG, V10, P400, DOI 10.1227/NEU.0000000000000451; Eide PK, 2008, J NEUROSURG, V109, P912, DOI 10.3171/JNS/2008/109/11/0912; Frattalone AR, 2011, INTENS CARE MED, V37, P1051, DOI 10.1007/s00134-011-2226-0; Hintze J., 2011, PASS 11; InnerSpace Neuro Solutions Inc, 2010, HUMM SYN VENTR SYST; Lescot T, 2011, INTENS CARE MED, V37, P875, DOI 10.1007/s00134-011-2182-8; Littlejohns LR, 2008, AACN AACN PROTOCOLS; Myles PS, 2007, BRIT J ANAESTH, V99, P309, DOI 10.1093/bja/aem214; SAS Institute Inc, 2012, SAS 9 4; Schimpf Melissa M, 2012, J Trauma Nurs, V19, P160, DOI 10.1097/JTN.0b013e318261cfb4; Smith M, 2008, ANESTH ANALG, V106, P240, DOI 10.1213/01.ane.0000297296.52006.8e; Stata Corp LP, 2014, STATA SE 13 1; Vender J, 2011, J CLIN MONIT COMPUT, V25, P231, DOI 10.1007/s10877-011-9300-6; Zhong J, 2003, NEUROL RES, V25, P339, DOI 10.1179/016164103101201661	18	11	11	0	2	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND	2193-1801			SPRINGERPLUS	SpringerPlus	JAN 6	2015	4								10	10.1186/2193-1801-4-10			8	Multidisciplinary Sciences	Science & Technology - Other Topics	CO4NP	WOS:000359137900001	25674495	Green Published, Other Gold			2021-06-18	
J	Bates, KA; Rodger, J				Bates, Kristyn Alissa; Rodger, Jennifer			Repetitive transcranial magnetic stimulation for stroke rehabilitation-potential therapy or misplaced hope?	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						Repetitive transcranial magnetic stimulation; brain plasticity; stroke; neuroprotection	THETA-BURST-STIMULATION; MOTOR FUNCTION RECOVERY; LOW-FREQUENCY RTMS; PULSED ELECTROMAGNETIC-FIELDS; LONG-TERM POTENTIATION; CORTEX EXCITABILITY; PREFRONTAL CORTEX; CONTROLLED TRIAL; POSTSTROKE REORGANIZATION; CORTICOMOTOR EXCITABILITY	Repeated sessions of transcranial magnetic stimulation (rTMS) are capable of changing and modulating neural activity beyond the period of stimulation. Because many neurological disorders are thought to involve abnormal or dysfunctional neuronal activity, it is hypothesised that the therapeutic action of rTMS may occur through modulating and reversing abnormal activity and facilitating neuroplasticity. Numerous clinical studies have investigated the safety and efficacy of rTMS treatment for a wide variety of conditions including depression, anxiety disorders including obsessive compulsive disorder, Parkinson's disease, stroke, tinnitus, affective disorders, schizophrenia and chronic pain. Despite some promising results, rTMS is not currently widely used to assist in recovery from neurotrama. In this review, we argue that the therapeutic promise of rTMS is limited because the mechanisms of action of rTMS are not completely understood and therefore it is difficult to determine which treatment protocols are appropriate for specific neurological conditions. We use the application of rTMS in motor functional recovery from cerebral ischemic stroke to illustrate the difficulties in interpreting and assessing the therapeutic potential of rTMS for neurotrauma in terms of the presumed mechanisms of action of rTMS. Future directions for research will also be discussed.	[Bates, Kristyn Alissa; Rodger, Jennifer] Univ Western Australia, Sch Anim Biol, Expt & Regenerat Neurosci, Crawley, WA 6009, Australia	Bates, KA (corresponding author), Univ Western Australia, M317,35 Stirling Highway, Crawley, WA 6009, Australia.	kristyn.bates@uwa.edu.au	Rodger, Jennifer/H-5735-2014	Rodger, Jennifer/0000-0003-3413-4229	National Health and Medical Research Council (NHMRC)National Health and Medical Research Council of Australia; Raine Medical Research Foundation; Neurotrauma Research Program of Western Australia (NRP)	The authors acknowledge funding from the National Health and Medical Research Council (NHMRC, JR), the Raine Medical Research Foundation (KAB) and the Neurotrauma Research Program of Western Australia (NRP, KAB and JR).	Ackerley SJ, 2014, CLIN NEUROPHYSIOL, V125, P1451, DOI 10.1016/j.clinph.2013.11.020; Ahmed Z, 2006, BIOELECTROMAGNETICS, V27, P288, DOI 10.1002/bem.20211; Aldinucci C, 2000, BBA-MOL CELL RES, V1499, P101, DOI 10.1016/S0167-4889(00)00111-7; Arias-Carrion Oscar, 2008, Int Arch Med, V1, P2, DOI 10.1186/1755-7682-1-2; Avenanti A, 2012, NEUROLOGY, V78, P256, DOI 10.1212/WNL.0b013e3182436558; Aydin-Abidin S, 2008, EXP BRAIN RES, V188, P249, DOI 10.1007/s00221-008-1356-2; Barwood CHS, 2011, EUR J NEUROL, V18, P935, DOI 10.1111/j.1468-1331.2010.03284.x; Bates KA, 2012, BRAIN RES, V1458, P76, DOI 10.1016/j.brainres.2012.04.006; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Bocchio-Chiavetto L, 2008, NEUROSCI LETT, V437, P130, DOI 10.1016/j.neulet.2008.04.005; Bohning DE, 1999, BIOL PSYCHIAT, V45, P385, DOI 10.1016/S0006-3223(98)00368-0; Buffo A, 2010, BIOCHEM PHARMACOL, V79, P77, DOI 10.1016/j.bcp.2009.09.014; Carson RG, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00823; Chen R, 1997, NEUROLOGY, V48, P1398, DOI 10.1212/WNL.48.5.1398; Cicinelli P, 2003, STROKE, V34, P2653, DOI 10.1161/01.STR.0000092122.96722.72; Cicinelli P, 1997, ELECTROMYOGR MOTOR C, V105, P438, DOI 10.1016/S0924-980X(97)00052-0; Delvaux V, 2003, CLIN NEUROPHYSIOL, V114, P1217, DOI 10.1016/S1388-2457(03)00070-1; Di Lazzaro V, 2009, EXP BRAIN RES, V194, P661, DOI 10.1007/s00221-009-1774-9; Dimyan MA, 2011, NAT REV NEUROL, V7, P76, DOI 10.1038/nrneurol.2010.200; Durukan A, 2007, PHARMACOL BIOCHEM BE, V87, P179, DOI 10.1016/j.pbb.2007.04.015; Escudero JV, 1998, STROKE, V29, P1854, DOI 10.1161/01.STR.29.9.1854; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; Fitzgerald PB, 2006, CLIN NEUROPHYSIOL, V117, P2584, DOI 10.1016/j.clinph.2006.06.712; Fox P, 1997, NEUROREPORT, V8, P2787, DOI 10.1097/00001756-199708180-00027; Fregni F, 2007, NAT CLIN PRACT NEURO, V3, P383, DOI 10.1038/ncpneuro0530; Fregni F, 2006, STROKE, V37, P2115, DOI 10.1161/01.STR.0000231390.58967.6b; Fujiki M, 2003, J NEUROSURG, V99, P1063, DOI 10.3171/jns.2003.99.6.1063; Fujiwara T, 2004, CLIN NEUROPHYSIOL, V115, P1514, DOI 10.1016/j.clinph.2004.01.021; Gersner R, 2011, J NEUROSCI, V31, P7521, DOI 10.1523/JNEUROSCI.6751-10.2011; Goldstein LB, 1998, ARCH NEUROL-CHICAGO, V55, P454, DOI 10.1001/archneur.55.4.454; Grefkes C, 2010, NEUROIMAGE, V50, P233, DOI 10.1016/j.neuroimage.2009.12.029; Hao ZL, 2013, SAO PAULO MED J, V131, P440, DOI [10.1590/1516-3180.20131316T2, 10.1002/14651858.CD008862.pub2]; Hausmann A, 2000, MOL BRAIN RES, V76, P355, DOI 10.1016/S0169-328X(00)00024-3; Hoogendam JM, 2010, BRAIN STIMUL, V3, P95, DOI 10.1016/j.brs.2009.10.005; Hsu WY, 2012, STROKE, V43, P1849, DOI 10.1161/STROKEAHA.111.649756; Hsu YF, 2013, BRAIN STIMUL, V6, P166, DOI 10.1016/j.brs.2012.04.007; Huang YZ, 2007, CLIN NEUROPHYSIOL, V118, P1028, DOI 10.1016/j.clinph.2007.01.021; Ikeda T, 2005, BIOCHEM BIOPH RES CO, V327, P218, DOI 10.1016/j.bbrc.2004.12.009; Ji RR, 1998, P NATL ACAD SCI USA, V95, P15635, DOI 10.1073/pnas.95.26.15635; Jorge RE, 2004, BIOL PSYCHIAT, V55, P398, DOI 10.1016/j.biopsych.2003.08.017; Kanno M, 2004, J NEUROL SCI, V217, P73, DOI 10.1016/j.jns.2003.08.013; Khaleel SH, 2010, EUR NEUROL, V63, P337, DOI 10.1159/000302708; Khedr EM, 2010, ACTA NEUROL SCAND, V121, P30, DOI 10.1111/j.1600-0404.2009.01195.x; Khedr EM, 2009, EUR J NEUROL, V16, P1323, DOI 10.1111/j.1468-1331.2009.02746.x; Khedr EM, 2005, NEUROLOGY, V65, P466, DOI 10.1212/01.wnl.0000173067.84247.36; Khedr EM, 2010, RESTOR NEUROL NEUROS, V28, P545, DOI 10.3233/RNN-2010-0558; Kim YH, 2006, STROKE, V37, P1471, DOI 10.1161/01.STR.0000221233.55497.51; Kimbrell TA, 2002, PSYCHIAT RES-NEUROIM, V115, P101, DOI 10.1016/S0925-4927(02)00041-0; Kirton A, 2008, LANCET NEUROL, V7, P507, DOI 10.1016/S1474-4422(08)70096-6; Koch G, 2012, NEUROLOGY, V78, P24, DOI 10.1212/WNL.0b013e31823ed08f; Kolominsky-Rabas PL, 2001, STROKE, V32, P2735, DOI 10.1161/hs1201.100209; Lefaucheur JP, 2006, NEUROPHYSIOL CLIN, V36, P105, DOI 10.1016/j.neucli.2006.08.011; Levkovitz Y, 1999, J NEUROSCI, V19, P3198; Li LZ, 2008, J CEREBR BLOOD F MET, V28, P468, DOI 10.1038/sj.jcbfm.9600546; Liepert J, 2007, RESTOR NEUROL NEUROS, V25, P461; Lisanby SH, 2000, INT J NEUROPSYCHOPH, V3, P259, DOI 10.1017/S1461145700002005; Luborzewski A, 2007, J PSYCHIATR RES, V41, P606, DOI 10.1016/j.jpsychires.2006.02.003; Malcolm MP, 2007, AM J PHYS MED REHAB, V86, P707, DOI 10.1097/PHM.0b013e31813e0de0; Manganotti P, 2002, CLIN NEUROPHYSIOL, V113, P936, DOI 10.1016/S1388-2457(02)00062-7; Mansur CG, 2005, NEUROLOGY, V64, P1802, DOI 10.1212/01.WNL.0000161839.38079.92; Massie CL, 2013, CLIN NEUROPHYSIOL, V124, P371, DOI 10.1016/j.clinph.2012.07.026; May A, 2007, CEREB CORTEX, V17, P205, DOI 10.1093/cercor/bhj138; Michael N, 2003, EUR J NEUROSCI, V17, P2462, DOI 10.1046/j.1460-9568.2003.02683.x; Muller MB, 2000, NEUROPSYCHOPHARMACOL, V23, P205, DOI 10.1016/S0893-133X(00)00099-3; Murase N, 2004, ANN NEUROL, V55, P400, DOI 10.1002/ana.10848; Ogiue-Ikeda M, 2003, BRAIN RES, V993, P222, DOI 10.1016/j.brainres.2003.09.009; PASCUALLEONE A, 1994, BRAIN, V117, P847, DOI 10.1093/brain/117.4.847; Pell GS, 2011, PROG NEUROBIOL, V93, P59, DOI 10.1016/j.pneurobio.2010.10.003; Pessina GP, 2001, BIOELECTROMAGNETICS, V22, P503, DOI 10.1002/bem.79.abs; Plow EB, 2009, STROKE, V40, P1926, DOI 10.1161/STROKEAHA.108.540823; Pomeroy VM, 2007, NEUROREHAB NEURAL RE, V21, P509, DOI 10.1177/1545968307300418; Rodger J, 2012, FASEB J, V26, P1593, DOI 10.1096/fj.11-194878; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Ruohonen J, 2012, CLIN NEUROPHYSIOL, V123, P2006, DOI 10.1016/j.clinph.2012.02.082; Seniow J, 2012, NEUROREHAB NEURAL RE, V26, P1072, DOI 10.1177/1545968312445635; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Speer AM, 2000, BIOL PSYCHIAT, V48, P1133, DOI 10.1016/S0006-3223(00)01065-9; Stinear C, 2010, LANCET NEUROL, V9, P1228, DOI 10.1016/S1474-4422(10)70247-7; Stinear CM, 2012, BRAIN, V135, P2527, DOI 10.1093/brain/aws146; Strafella AP, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-15-j0003.2001; Szaflarski JP, 2011, MED SCI MONITOR, V17, pCR132, DOI 10.12659/MSM.881446; Takeuchi N, 2005, STROKE, V36, P2681, DOI 10.1161/01.STR.0000189658.51972.34; Takeuchi N, 2008, J REHABIL MED, V40, P298, DOI 10.2340/16501977-0181; Takeuchi N, 2012, STROKE RES TREAT, V2012, DOI 10.1155/2012/584727; Talelli P, 2007, CLIN NEUROPHYSIOL, V118, P333, DOI 10.1016/j.clinph.2006.10.014; Talelli P, 2012, NEUROREHAB NEURAL RE, V26, P976, DOI 10.1177/1545968312437940; Tan T, 2013, BRAIN RES, V1520, P23, DOI 10.1016/j.brainres.2013.04.053; Tokay T, 2009, NEUROSCI LETT, V461, P150, DOI 10.1016/j.neulet.2009.06.032; Trippe J, 2009, EXP BRAIN RES, V199, P411, DOI 10.1007/s00221-009-1961-8; Vlachos A, 2012, J NEUROSCI, V32, P17514, DOI 10.1523/JNEUROSCI.0409-12.2012; Wang HY, 2011, J NEUROSCI, V31, P11044, DOI 10.1523/JNEUROSCI.2125-11.2011; Wang RY, 2012, NEUROREHAB NEURAL RE, V26, P222, DOI 10.1177/1545968311423265; Ward NS, 2004, ARCH NEUROL-CHICAGO, V61, P1844, DOI 10.1001/archneur.61.12.1844; Weiduschat N, 2011, STROKE, V42, P409, DOI 10.1161/STROKEAHA.110.597864; Yue L, 2009, BRAIN RES, V1260, P94, DOI 10.1016/j.brainres.2009.01.009; Zanardini R, 2006, J AFFECT DISORDERS, V91, P83, DOI 10.1016/j.jad.2005.12.029; Zangen A, 2002, NEUROREPORT, V13, P2401, DOI 10.1097/00001756-200212200-00005	98	11	12	0	16	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028	1878-3627		RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2015	33	4					557	569		10.3233/RNN-130359			13	Neurosciences	Neurosciences & Neurology	CQ1IP	WOS:000360350900013	24595227				2021-06-18	
J	Bell, KR; Brockway, JA; Fann, JR; Cole, WR; De Lore, JS; Bush, N; Lang, AJ; Hart, T; Warren, M; Dikmen, S; Temkin, N; Jain, S; Raman, R; Stein, MB				Bell, Kathleen R.; Brockway, Jo Ann; Fann, Jesse R.; Cole, Wesley R.; De Lore, Jef St.; Bush, Nigel; Lang, Ariel J.; Hart, Tessa; Warren, Michael; Dikmen, Sureyya; Temkin, Nancy; Jain, Sonia; Raman, Rema; Stein, Murray B.			Concussion treatment after combat trauma: Development of a telephone based, problem solving intervention for service members	CONTEMPORARY CLINICAL TRIALS			English	Article						Concussion; Brain Injury; Military; Problem solving training; Telephone intervention; Telehealth	POSTTRAUMATIC-STRESS-DISORDER; COGNITIVE-BEHAVIORAL THERAPY; IDENTIFICATION TEST AUDIT; BRAIN-INJURY; MENTAL-HEALTH; PRIMARY-CARE; PSYCHOLOGICAL TREATMENT; 1ST YEAR; DEPRESSION; VETERANS	Military service members (SMs) and veterans who sustain mild traumatic brain injuries (mTBI) during combat deployments often have co-morbid conditions but are reluctant to seek out therapy in medical or mental health settings. Efficacious methods of intervention that are patient-centered and adaptable to a mobile and often difficult-to-reach population would be useful in improving quality of life. This article describes a new protocol developed as part of a randomized clinical trial of a telephone-mediated program for SMs with mTBI. The 12-session program combines problem solving training (PST) with embedded modules targeting depression, anxiety, insomnia, and headache. The rationale and development of this behavioral intervention for implementation with persons with multiple co-morbidities is described along with the proposed analysis of results. In particular, we provide details regarding the creation of a treatment that is manualized yet flexible enough to address a wide variety of problems and symptoms within a standard framework. The methods involved in enrolling and retaining an often hard-to-study population are also highlighted. (C) 2014 Elsevier Inc. All rights reserved.	[Bell, Kathleen R.; Brockway, Jo Ann; Dikmen, Sureyya; Temkin, Nancy] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Fann, Jesse R.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Cole, Wesley R.] WAMC, Dept Brain Injury Med, Def & Vet Brain Injury Ctr, Ft Bragg, NC 28310 USA; [De Lore, Jef St.; Dikmen, Sureyya; Temkin, Nancy] Univ Washington, Dept Neurol Surg, Seattle, WA 98104 USA; [Bush, Nigel] Natl Ctr Telehlth & Technol, Tacoma, WA 98431 USA; [Lang, Ariel J.; Stein, Murray B.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Hart, Tessa] Moss Rehabil Res Inst, Elkins Pk, PA 19027 USA; [Warren, Michael] Fielding Behav Hlth, Clin Psychol Doctoral Intern, Kirkland, WA 98034 USA; [Temkin, Nancy] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Jain, Sonia; Raman, Rema; Stein, Murray B.] Univ Calif San Diego, Dept Family & Prevent Med, La Jolla, CA 92093 USA	Bell, KR (corresponding author), Univ Washington, Dept Rehabil Med, Box 356490,1959 NE Pacific St, Seattle, WA 98195 USA.	Icrbell@uw.edu; brockja@uw.edu; fann@uw.edu; wesley.r.cole.ctr@mail.mil; saint@uw.edu; nigel.e.bush.civ@mail.mil; ajlang@ucsd.edu; thart@einstein.edu; mwarren@email.fielding.edu; dilcmen@uw.edu; temIdn@uw.edu; sojain@ucsd.edu; reraman@ucsd.edu; mstein@ucsd.edu		Bell, Kathleen/0000-0002-0928-2046; Bush, Nigel/0000-0002-8137-7998	U.S. Army Medical Research and Materiel Command (USAMRMC)U.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-08-2-0159]; National Institute on Disability and Rehabilitation Research [H133G070143]	The research reported in this article was supported by the U.S. Army Medical Research and Materiel Command (USAMRMC), USAMRMC Funding Mechanism: Contract# W81XWH-08-2-0159. Supplemental funding for development of the treatment manual and fidelity assessment system was provided by the National Institute on Disability and Rehabilitation Research, grant # H133G070143.	[Anonymous], 2009, VA DOD CLIN PRACTICE; Attkisson CC, 1999, UCSF CLIENT SATISFAC; Bell AC, 2009, CLIN PSYCHOL REV, V29, P348, DOI 10.1016/j.cpr.2009.02.003; Bell KR, 2008, J NEUROL NEUROSUR PS, V79, P1275, DOI 10.1136/jnnp.2007.141762; Bell KR, 2011, ARCH PHYS MED REHAB, V92, P1552, DOI 10.1016/j.apmr.2011.05.018; Bell KR, 2005, ARCH PHYS MED REHAB, V86, P851, DOI 10.1016/j.apmr.2004.09.015; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1002/jts.2490080106; Bombardier CH, 2009, J HEAD TRAUMA REHAB, V24, P230, DOI 10.1097/HTR.0b013e3181ad65f0; Bradley KA, 2003, ARCH INTERN MED, V163, P821, DOI 10.1001/archinte.163.7.821; Britt TW, 2008, J SOC CLIN PSYCHOL, V27, P317, DOI 10.1521/jscp.2008.27.4.317; Britt TW, 2000, J APPL SOC PSYCHOL, V30, P1599, DOI 10.1111/j.1559-1816.2000.tb02457.x; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; CATALAN J, 1991, PSYCHOL MED, V21, P1013, DOI 10.1017/S0033291700030002; CDC, 2003, REP C MILD TRAUM BRA; Choi NG, 2014, DEPRESS ANXIETY, V31, P653, DOI 10.1002/da.22242; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Donker T, 2011, PSYCHIAT RES, V188, P58, DOI 10.1016/j.psychres.2011.01.016; Duggan M., 2014, SOCIAL MEDIA UPDATE; Fann JR, 2014, J NEUROTRAUMA; French L., 2008, J SPEC OPER MED, V8, P68; GRANGER CV, 1995, AM J PHYS MED REHAB, V74, P107; Gray MJ, 2004, ASSESSMENT, V11, P330, DOI 10.1177/1073191104269954; Group E, 2009, HLTH POLICY, V37, P53; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hughes KL, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-46; Johnson DR, 1997, J TRAUMA STRESS, V10, P391, DOI 10.1023/A:1024885103409; Kasckow J, 2014, INT J GERIATR PSYCHI; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kosinski M, 2003, QUAL LIFE RES, V12, P963, DOI 10.1023/A:1026119331193; Kroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3C; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kroenke K, 2007, ANN INTERN MED, V146, P317, DOI 10.7326/0003-4819-146-5-200703060-00004; Kroenke K, 2009, PSYCHOSOMATICS, V50, P613, DOI 10.1176/appi.psy.50.6.613; Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; Lorig K R, 2001, Eff Clin Pract, V4, P256; Lorig KR, 1999, MED CARE, V37, P5, DOI 10.1097/00005650-199901000-00003; Lynch DJ, 1997, J FAM PRACTICE, V44, P293; Mai N, 1991, NEUROPSYCHOL REHABIL, V1, P45, DOI DOI 10.1080/09602019108401379; Makdissi M, 2013, BRIT J SPORT MED, V47, P308, DOI 10.1136/bjsports-2013-092255; Marx B. P., 2009, 25 ANN M INT SOC TRA; Meachen SJ, 2008, ARCH PHYS MED REHAB, V89, P958, DOI 10.1016/j.apmr.2007.12.028; Meyer KS, 2010, PSYCHIAT CLIN N AM, V33, P783, DOI 10.1016/j.psc.2010.08.007; Mikami K, 2014, J NEUROPSYCHIATRY CL; Mohr DC, 2012, JAMA-J AM MED ASSOC, V307, P2278, DOI 10.1001/jama.2012.5588; Mott TF, 2012, AM FAM PHYSICIAN, V86, P1045; Pfeiffer PN, 2012, MIL MED, V177, P1471, DOI 10.7205/MILMED-D-12-00115; Posner K, 2007, AM J PSYCHIAT, V164, P1035, DOI 10.1176/appi.ajp.164.7.1035; Rath JF, 2003, NEUROPSYCHOL REHABIL, V13, P461, DOI 10.1080/09602010343000039; Rosen CS, 2006, COMMUNITY MENT HLT J, V42, P501, DOI 10.1007/s10597-006-9047-6; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Sayer NA, 2009, J REHABIL RES DEV, V46, P703, DOI 10.1682/JRRD.2009.01.0008; Schnurr PP, 2007, JAMA-J AM MED ASSOC, V297, P820, DOI 10.1001/jama.297.8.820; Schnurr PP, 2003, ARCH GEN PSYCHIAT, V60, P481, DOI 10.1001/archpsyc.60.5.481; Seal KH, 2010, J TRAUMA STRESS, V23, P5, DOI 10.1002/jts.20493; Sheehan DV, 1996, INT CLIN PSYCHOPHARM, V11, P89, DOI 10.1097/00004850-199606003-00015; Sirey JA, 2005, PSYCHIAT SERV, V56, P1564, DOI 10.1176/appi.ps.56.12.1564; Slaughter J, 1999, BRAIN INJURY, V13, P125, DOI 10.1080/026990599121782; Stewart CD, 2009, SUICIDE LIFE-THREAT, V39, P538, DOI 10.1521/suli.2009.39.5.538; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Unutzer J, 2002, JAMA-J AM MED ASSOC, V288, P2836, DOI 10.1001/jama.288.22.2836; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Weathers F., 1991, PTSD CHECKLIST MILIT; Wilson JAB, 2008, CYBERPSYCHOL BEHAV, V11, P767, DOI 10.1089/cpb.2008.0071; Wright KM, 2009, PSYCHOL SERV, V6, P108, DOI 10.1037/a0012620; Zinzow HM, 2012, CLIN PSYCHOL REV, V32, P741, DOI 10.1016/j.cpr.2012.09.002	67	11	11	0	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1551-7144	1559-2030		CONTEMP CLIN TRIALS	Contemp. Clin. Trials	JAN	2015	40						54	62		10.1016/j.cct.2014.11.001			9	Medicine, Research & Experimental; Pharmacology & Pharmacy	Research & Experimental Medicine; Pharmacology & Pharmacy	CB6IZ	WOS:000349732000007	25460344				2021-06-18	
J	Bernard, SA; Smith, K; Porter, R; Jones, C; Gailey, A; Cresswell, B; Cudini, D; Hill, S; Moore, B; St Clair, T				Bernard, S. A.; Smith, K.; Porter, R.; Jones, C.; Gailey, A.; Cresswell, B.; Cudini, D.; Hill, S.; Moore, B.; St Clair, T.			Paramedic rapid sequence intubation in patients with non-traumatic coma	EMERGENCY MEDICINE JOURNAL			English	Article							TRAUMATIC BRAIN-INJURY; ENDOTRACHEAL INTUBATION; STATUS EPILEPTICUS; SUCCESS RATES; METAANALYSIS; KETAMINE	Introduction Pre-hospital intubation by paramedics is widely used in comatose patients prior to transportation to hospital, but the optimal technique for intubation is uncertain. One approach is paramedic rapid sequence intubation (RSI), which may improve outcomes in adult patients with traumatic brain injury. However, many patients present to emergency medical services with coma of non-traumatic cause and the role of paramedic RSI in these patients remains uncertain. Methods The electronic Victorian Ambulance Clinical Information System was searched for the term 'suxamethonium' between 2008 and 2011. We reviewed the patient care records and included patients with suspected non-traumatic coma who were treated and transported by road-based paramedics. Demographics, intubation conditions, vital signs (before and after drug administration) and complications were recorded. Younger patients (<60 years) were compared with older patients. Results There were 1152 paramedic RSI attempts of which 551 were for non-traumatic coma. The success rate for intubation was 97.5%. There was a significant drop in blood pressure in younger patients (<60 years) with the mean systolic blood pressure decreasing by 16 mm Hg (95% CI 11 to 21). In older patients, the systolic blood pressure also decreased significantly by 20 mm Hg (95% CI 17 to 24). Four patients suffered brief cardiac arrest during pre-hospital care, all of whom were successfully resuscitated and transported to hospital. Conclusions Paramedic RSI in patients with non-traumatic coma has a high procedural success rate. Further studies are required to determine whether this procedure improves outcomes.	[Bernard, S. A.; Smith, K.; Jones, C.; Gailey, A.; Cresswell, B.; Cudini, D.; Hill, S.; Moore, B.; St Clair, T.] Ambulance Victoria, Doncaster, Vic, Australia; [Bernard, S. A.; Smith, K.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Bernard, S. A.; Porter, R.] Alfred Hosp, Intens Care Unit, Melbourne, Vic 3004, Australia	Bernard, SA (corresponding author), Alfred Hosp, Intens Care Unit, Commercial Rd, Melbourne, Vic 3004, Australia.	s.bernard@alfred.org.au		Smith, Karen/0000-0002-9057-0685			Anderson CS, 2013, NEW ENGL J MED, V368, P2355, DOI 10.1056/NEJMoa1214609; Bernard Stephen, 2002, Emerg Med (Fremantle), V14, P406, DOI 10.1046/j.1442-2026.2002.00382.x; Bernard SA, 2010, ANN SURG, V252, P959, DOI 10.1097/SLA.0b013e3181efc15f; Bernard Stephen A, 2006, Emerg Med Australas, V18, P221, DOI 10.1111/j.1742-6723.2006.00850.x; Bochicchio GV, 2003, J TRAUMA, V54, P307, DOI 10.1097/01.TA.0000046252.97590.BE; Davis DP, 2005, J TRAUMA, V58, P933, DOI 10.1097/01.TA.0000162731.53812.58; Harris T, 2011, EMERG MED J, V28, P225, DOI 10.1136/emj.2009.088302; Hiestand B, 2011, PREHOSP EMERG CARE, V15, P457, DOI 10.3109/10903127.2011.569853; Hubble MW, 2010, PREHOSP EMERG CARE, V14, P377, DOI 10.3109/10903121003790173; Kramer AH, 2012, NEUROCRIT CARE, V16, P299, DOI 10.1007/s12028-011-9668-7; Lecky F, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001429.pub2; Lossius HM, 2012, CRIT CARE, V16, DOI 10.1186/cc11189; Nielsen K, 2012, EMERG MED J, V29, P887, DOI 10.1136/emermed-2011-200119; Sibley A, 2011, EMERG MED J, V28, P521, DOI 10.1136/emj.2009.088237; Silbergleit R, 2012, NEW ENGL J MED, V366, P591, DOI 10.1056/NEJMoa1107494	15	11	11	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1472-0205	1472-0213		EMERG MED J	Emerg. Med. J.	JAN	2015	32	1					60	64		10.1136/emermed-2013-202930			5	Emergency Medicine	Emergency Medicine	AW5UU	WOS:000346340000015	24473409				2021-06-18	
S	Chesnut, RM		Fink, ME; Barchas, JD; Sheikh, JI		Chesnut, Randall M.			A conceptual approach to managing severe traumatic brain injury in a time of uncertainty	AFFECTIVE DISORDERS AND TRAUMATIC BRAIN INJURY	Annals of the New York Academy of Sciences		English	Article; Proceedings Paper	Qatar Clinical Neuroscience Conference	MAR 15-17, 2014	Doha, QATAR	Qatar Fdn Educ Sci & Community Dev			CEREBRAL PERFUSION-PRESSURE; SEVERE HEAD-INJURIES; INTRACRANIAL-PRESSURE; BLOOD-FLOW; AUTOREGULATION; HYPERTENSION; THRESHOLDS; REACTIVITY; MANAGEMENT; RESISTANCE	Current controversies in the literature suggest that a reassessment of the current management of severe traumatic brain injury (sTBI) is necessary. This article presents a conceptual framework toward individualizing sTBI treatment with respect to targeting thresholds and strategies on the basis of known physiologic processes and available monitors. Intracranial pressure (ICP) is modeled as an epiphenomenon of cerebral compliance and herniation tendency, as well as cerebral ischemia. By combining serial neurological examinations, imaging studies, and ICP measurements (values, trends, and area-under-the-curve calculations) over time, evidence can be accrued on the necessity of maintaining ICP at a given threshold in the realm of physical changes in the brain. Similarly, by collecting and trending clinical, imaging, and monitoring data on the status of cerebral blood flow, the balance of oxygen consumption and delivery, and the status of cerebral static pressure autoregulation, and analyzing them with respect to measured parameters, such as blood pressure, ICP, and cerebral perfusion pressure, one can attempt to fine-tune these variables as well. Such individualization of management optimizes the possibility of successfully treating demonstrated pathophysiological processes while avoiding unnecessary interventions and treatment toxicity. Monitor values must not be seen as targets but rather as indicators of targetable pathology.	[Chesnut, Randall M.] Univ Washington, Harborview Med Ctr, Dept Neurol Surg, Seattle, WA 98104 USA; [Chesnut, Randall M.] Univ Washington, Harborview Med Ctr, Dept Orthopaed & Sports Med, Seattle, WA 98104 USA; [Chesnut, Randall M.] Univ Washington, Sch Global Hlth, Seattle, WA 98104 USA	Chesnut, RM (corresponding author), Univ Washington, Harborview Med Ctr, Dept Neurol Surg, 325 9Th Ave, Seattle, WA 98104 USA.	chesnutr@uw.edu		Chesnut, Randall/0000-0001-6377-3666			Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Balestreri M, 2004, ACTA NEUROCHIR, V146, P131, DOI 10.1007/s00701-003-0187-y; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; Brady KM, 2009, PEDIATRICS, V124, pE1205, DOI 10.1542/peds.2009-0550; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Bullock R., 2000, J NEUROTRAUM, V17, P538; Chen Jeff W, 2011, Surg Neurol Int, V2, P82, DOI 10.4103/2152-7806.82248; Chesnut RM, 2015, ANN NY ACAD SCI, V1345, P74, DOI 10.1111/nyas.12482; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CHESNUT RM, 1994, NEUROSURGERY, V34, P840, DOI 10.1227/00006123-199405000-00008; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka M, 2008, ANESTH ANALG, V106, P234, DOI 10.1213/01.ane.0000295802.89962.13; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; HSIANG JK, 1994, CRIT CARE MED, V22, P1471, DOI 10.1097/00003246-199409000-00019; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; Kirkness C J, 2000, J Neurosci Nurs, V32, P271; Kuhn T., 1962, STRUCTURE SCI REVOLU; LASSEN NA, 1959, PHYSIOL REV, V39, P183; Lazaridis C, 2014, J NEUROSURG, V120, P893, DOI 10.3171/2014.1.JNS131292; Lazaridis C, 2013, NEUROL RES, V35, P138, DOI 10.1179/1743132812Y.0000000150; MARION DW, 1993, J NEUROSURG, V79, P354, DOI 10.3171/jns.1993.79.3.0354; MARMAROU A, 1975, J NEUROSURG, V43, P523, DOI 10.3171/jns.1975.43.5.0523; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MARSHALL LF, 1983, J NEUROSURG, V58, P566, DOI 10.3171/jns.1983.58.4.0566; MASET AL, 1987, J NEUROSURG, V67, P832, DOI 10.3171/jns.1987.67.6.0832; MILLER JD, 1987, ACTA NEUROCHIR, V85, P80, DOI 10.1007/BF01456102; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; PIPER IR, 1993, NEUROSURGERY, V32, P805, DOI 10.1227/00006123-199305000-00014; Resnick DK, 1997, J TRAUMA, V42, P1108, DOI 10.1097/00005373-199706000-00021; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Shafi S, 2008, J TRAUMA, V64, P335, DOI 10.1097/TA.0b013e31815dd017; Skoglund K, 2009, NEUROCRIT CARE, V11, P135, DOI 10.1007/s12028-009-9255-3; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Steiner LA, 2003, STROKE, V34, P2404, DOI 10.1161/01.STR.0000089014.59668.04; Taylor WR, 2003, J NEUROSURG, V98, P205, DOI 10.3171/jns.2003.98.1.0205; Vik A, 2008, J NEUROSURG, V109, P678, DOI 10.3171/JNS/2008/109/10/0678; Weiner GM, 2010, NEUROSURGERY, V66, P1111, DOI 10.1227/01.NEU.0000369607.71913.3E	41	11	11	0	1	BLACKWELL SCIENCE PUBL	OXFORD	OSNEY MEAD, OXFORD OX2 0EL, ENGLAND	0077-8923			ANN NY ACAD SCI	Ann.NY Acad.Sci.		2015	1345						99	107		10.1111/nyas.12483			9	Clinical Neurology; Psychiatry	Neurosciences & Neurology; Psychiatry	BC7XP	WOS:000355312300012	25040396				2021-06-18	
J	Cohen, A; Lerner-Yardeni, J; Meridor, D; Kasher, R; Nathan, I; Parola, AH				Cohen, Aviv; Lerner-Yardeni, Jenny; Meridor, David; Kasher, Roni; Nathan, Ilana; Parola, Abraham H.			Humanin Derivatives Inhibit Necrotic Cell Death in Neurons	MOLECULAR MEDICINE			English	Article							RESCUE FACTOR HUMANIN; ALZHEIMERS-DISEASE; INTRACELLULAR ATP; IN-VITRO; MECHANISMS; APOPTOSIS; NEUROPROTECTION; COLIVELIN; BAX; RECEPTOR-LIKE-1	Humanin and its derivatives are peptides known for their protective antiapoptotic effects against Alzheimer's disease. Herein, we identify a novel function of the humanin-derivative AGA(C8R)-HNG17 (namely, protection against cellular necrosis). Necrosis is one of the main modes of cell death, which was until recently considered an unmoderated process. However, recent findings suggest the opposite. We have found that AGA(C8R)-HNG17 confers protection against necrosis in the neuronal cell lines PC-12 and NSC-34, where necrosis is induced in a glucose-free medium by either chemohypoxia or by a shift from apoptosis to necrosis. Our studies in traumatic brain injury models in mice, where necrosis is the main mode of neuronal cell death, have shown that AGA(C8R)-HNG17 has a protective effect. This result is demonstrated by a decrease in a neuronal severity score and by a reduction in brain edema, as measured by magnetic resonance imaging (MRI). An insight into the peptide's antinecrotic mechanism was attained through measurements of cellular ATP levels in PC-12 cells under necrotic conditions, showing that the peptide mitigates a necrosis-associated decrease in ATP levels. Further, we demonstrate the peptide's direct enhancement of the activity of ATP synthase activity, isolated from rat-liver mitochondria, suggesting that AGA(C8R)-HNG17 targets the mitochondria and regulates cellular ATP levels. Thus, AGA(C8R)-HNG17 has potential use for the development of drug therapies for necrosis-related diseases, for example, traumatic brain injury, stroke, myocardial infarction, and other conditions for which no efficient drug-based treatment is currently available. Finally, this study provides new insight into the mechanisms underlying the antinecrotic mode of action of AGA(C8R)-HNG17.	[Cohen, Aviv; Lerner-Yardeni, Jenny; Meridor, David; Parola, Abraham H.] Ben Gurion Univ Negev, Dept Chem, Fac Nat Sci, Beer Sheva, Israel; [Kasher, Roni] Ben Gurion Univ Negev, Dept Desalinat & Water Treatment, Zuckerberg Inst Water Res, Blaustein Inst Desert Res, Midreshet Sede Boqer, Israel; [Nathan, Ilana] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Clin Biochem & Pharmacol, Beer Sheva, Israel; [Nathan, Ilana] Soroka Univ, Med Ctr, Inst Hematol, Beer Sheva, Israel	Kasher, R (corresponding author), Ben Gurion Univ Negev, Dept Desalinat & Water Treatment, Zuckerberg Inst Water Res, Blaustein Inst Desert Res, IL-8499000 Ben Gurion, Israel.	kahser@bgu.ac.il; nathan@bgu.ac.il; aparola@bgu.ac.il		Parola, Abraham H./0000-0002-3953-5454	Kamin Program from the Chief Scientist of the Ministry of Economy of Israel; James-Frank Center for Laser-Matter Interaction; Edmund Safra Foundation for Functional Bio-polymer; New-York University Shanghai (NYUSH) research grant; Lyonel Israels' Chair Fund	The authors thank Mark M Karpasas and Lina Saveliev from the Analytical Research Services Unit, Ben-Gurion University of the Negev, for mass spectrometric analysis of the peptides, and Svetlana Lublinsky from the Brain Imaging Center, Ben-Gurion University of the Negev, for magnetic resonance imaging of the mice. The financial support of the Kamin Program from the Chief Scientist of the Ministry of Economy of Israel (to AH Parola, I Nathan, and R Kasher), the James-Frank Center for Laser-Matter Interaction (to A H Parola), the Edmund Safra Foundation for Functional Bio-polymer, the New-York University Shanghai (NYUSH) research grant (to AH Parola) and the Lyonel Israels' Chair Fund (I Nathan) are gratefully acknowledged.	Alavian KN, 2011, NAT CELL BIOL, V13, P1224, DOI 10.1038/ncb2330; ALISON MR, 1994, GUT, V35, P577, DOI 10.1136/gut.35.5.577; Arakawa T, 2008, CURR MED CHEM, V15, P2086, DOI 10.2174/092986708785747616; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; Chiba T, 2006, BIOCHEM BIOPH RES CO, V343, P793, DOI 10.1016/j.bbrc.2006.02.184; Chiba T, 2005, J NEUROSCI, V25, P10252, DOI 10.1523/JNEUROSCI.3348-05.2005; Cohen-Yeshurun A, 2011, J CEREBR BLOOD F MET, V31, P1768, DOI 10.1038/jcbfm.2011.53; Dewson G, 2009, J CELL SCI, V122, P2801, DOI 10.1242/jcs.038166; Eguchi Y, 1997, CANCER RES, V57, P1835; Feldman Z, 1996, J NEUROSURG, V85, P131, DOI 10.3171/jns.1996.85.1.0131; Guo B, 2003, NATURE, V423, P456, DOI 10.1038/nature01627; Hallak M, 2008, APOPTOSIS, V13, P147, DOI 10.1007/s10495-007-0156-7; Hallak M, 2009, BRIT J HAEMATOL, V147, P459, DOI 10.1111/j.1365-2141.2009.07867.x; Harada M, 2004, BIOCHEM BIOPH RES CO, V324, P255, DOI 10.1016/j.bbrc.2004.09.046; Hashimoto Y, 2005, LIFE SCI, V77, P3092, DOI 10.1016/j.lfs.2005.03.031; Hashimoto Y, 2001, J NEUROSCI, V21, P9235, DOI 10.1523/JNEUROSCI.21-23-09235.2001; Hashimoto Y, 2001, P NATL ACAD SCI USA, V98, P6336, DOI 10.1073/pnas.101133498; Hashimoto Y, 2001, BIOCHEM BIOPH RES CO, V283, P460, DOI 10.1006/bbrc.2001.4765; Hashimoto Y, 2009, MOL BIOL CELL, V20, P2864, DOI 10.1091/mbc.E09-02-0168; Hoang PT, 2010, METABOLISM, V59, P343, DOI 10.1016/j.metabol.2009.08.001; Jin H, 2010, NEUROCHEM INT, V56, P417, DOI 10.1016/j.neuint.2009.11.015; Kariya S, 2005, ACTA NEUROPATHOL, V109, P367, DOI 10.1007/s00401-004-0965-5; Kariya S, 2005, NEUROPEPTIDES, V39, P97, DOI 10.1016/j.npep.2004.11.004; Kariya S, 2002, NEUROREPORT, V13, P903, DOI 10.1097/00001756-200205070-00034; Leist M, 1997, J EXP MED, V185, P1481, DOI 10.1084/jem.185.8.1481; Li L, 2005, TOXICOL SCI, V86, P116, DOI 10.1093/toxsci/kfi164; Luciano F, 2005, J BIOL CHEM, V280, P15825, DOI 10.1074/jbc.M413062200; Matsuoka M, 2006, CNS DRUG REV, V12, P113, DOI 10.1111/j.1527-3458.2006.00113.x; Matsuoka M, 2010, MOL NEUROBIOL, V41, P22, DOI 10.1007/s12035-009-8090-z; Moquin D, 2010, TRENDS BIOCHEM SCI, V35, P434, DOI 10.1016/j.tibs.2010.03.001; Muzumdar RH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006334; Nicotera P, 1998, TOXICOL LETT, V103, P139; Niikura T, 2004, MOL NEUROBIOL, V30, P327, DOI 10.1385/MN:30:3:327; Prabhakaran K, 2004, J SURG RES, V116, P288, DOI 10.1016/j.jss.2003.08.008; Prabhakaran K, 2002, J PHARMACOL EXP THER, V303, P510, DOI 10.1124/jpet.102.039453; Puyal J, 2013, PROG NEUROBIOL, V105, P24, DOI 10.1016/j.pneurobio.2013.03.002; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Saikumar P, 1998, ONCOGENE, V17, P3341, DOI 10.1038/sj.onc.1202579; Shapira MG, 2014, MOL MED, V20, P417, DOI 10.2119/molmed.2014.00054; Shchepina LA, 2002, ONCOGENE, V21, P8149, DOI 10.1038/sj.onc.1206053; Shi YG, 2001, NAT STRUCT BIOL, V8, P394, DOI 10.1038/87548; Sponne I, 2004, MOL CELL NEUROSCI, V25, P95, DOI 10.1016/j.mcn.2003.09.017; Strober Warren, 2015, Curr Protoc Immunol, V111, DOI 10.1002/0471142735.ima03bs111; Terashita K, 2003, J NEUROCHEM, V85, P1521, DOI 10.1046/j.1471-4159.2003.01797.x; Tsesin N, 2014, CHEM PHYS LIPIDS, V183, P159, DOI 10.1016/j.chemphyslip.2014.06.007; Xu XS, 2006, STROKE, V37, P2613, DOI 10.1161/01.STR.0000242772.94277.1f; Ying GG, 2004, J IMMUNOL, V172, P7078, DOI 10.4049/jimmunol.172.11.7078; Zalk R, 2005, BIOCHEM J, V386, P73, DOI 10.1042/BJ20041356; Zelig U, 2009, BIOPHYS J, V97, P2107, DOI 10.1016/j.bpj.2009.07.026; Zhai DY, 2005, J BIOL CHEM, V280, P15815, DOI 10.1074/jbc.M411902200; Zhivotovsky B, 2010, EXP CELL RES, V316, P1374, DOI 10.1016/j.yexcr.2010.02.037	51	11	11	0	4	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1076-1551	1528-3658		MOL MED	Mol. Med.		2015	21						505	514		10.2119/molmed.2015.00073			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CX5WC	WOS:000365772200004	26062019	DOAJ Gold, Green Published			2021-06-18	
J	de Guise, E; LeBlanc, J; Dagher, J; Tinawi, S; Lamoureux, J; Marcoux, J; Maleki, M; Feyz, M				de Guise, Elaine; LeBlanc, Joanne; Dagher, Jehane; Tinawi, Simon; Lamoureux, Julie; Marcoux, Judith; Maleki, Mohammed; Feyz, Mitra			Traumatic brain injury in the elderly: A level 1 trauma centre study	BRAIN INJURY			English	Article						Ageing; level 1 trauma centre; older age; outcome; traumatic brain injury	OLDER-ADULTS; GENDER-DIFFERENCES; HEAD-INJURIES; AGE; MORTALITY; HEALTH; CONSEQUENCES; SPEED	Objective: To explore the characteristics and outcome of patients with TBI over 65 years old admitted to an acute care Level 1 Trauma centre in Montreal, Canada. Methods: Data were retrospectively collected on patients (n = 1812) who were admitted post-TBI to the McGill University Health Centre-Montreal General Hospital from 2000-2011. The cohort was composed of four groups over 65 years old (65-75; 76-85; 86-95; and 96 and more). Outcome measures used were the extended Glasgow Outcome Scale (GOSE) as well as discharge destination. Results: As the patients got older, the odds of having a poor outcome increased (OR = 2.344 for those 75-85 years old, 4.313 for those 86-95 years of age and 3.465 for those aged 96 years of age or older). Also, the proportion of patients going home or going home with out-patient rehabilitation decreased as age increased (p = 0.001 and p<0.001, respectively). In contrast, the proportion of patients being discharged to long-term care facilities increased significantly as age increased (p<0.001). Conclusion: This descriptive study provides a better understanding of characteristics and outcome of different age groups of patients with TBI all over 65 years old in Montreal, Canada.	[de Guise, Elaine; Marcoux, Judith; Maleki, Mohammed] McGill Univ, Ctr Hlth, Neurol & Neurosurg Dept, Montreal, PQ H3G 1A4, Canada; [de Guise, Elaine] Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada; [de Guise, Elaine; LeBlanc, Joanne; Dagher, Jehane; Tinawi, Simon; Feyz, Mitra] McGill Univ, Ctr Hlth, Traumat Brain Injury Program, Montreal, PQ H3G 1A4, Canada; [Dagher, Jehane; Tinawi, Simon] McGill Univ, Ctr Hlth, Phys Med & Rehabil Serv, Montreal, PQ H3G 1A4, Canada; [Lamoureux, Julie] Univ Montreal, Social & Prevent Med Dept, Montreal, PQ, Canada	de Guise, E (corresponding author), McGill Univ, Ctr Hlth, Traumat Brain Injury Program, Montreal Gen Hosp Site,Room D13-124, Montreal, PQ H3G 1A4, Canada.	elaine.de.guise@umontreal.ca			Research Institute of the McGill University Health Center	We thank the Research Institute of the McGill University Health Center for their support.	Arber S, 1999, SOC SCI MED, V48, P61, DOI 10.1016/S0277-9536(98)00289-5; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Case A, 2005, DEMOGRAPHY, V42, P189, DOI 10.1353/dem.2005.0011; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Denton M, 2004, SOC SCI MED, V58, P2585, DOI 10.1016/j.socscimed.2003.09.008; Edwards JD, 2002, GERONTOLOGY, V48, P329, DOI 10.1159/000065259; Ferrell Richard B, 2002, Curr Psychiatry Rep, V4, P354; Frankel JE, 2006, ARCH PHYS MED REHAB, V87, P57, DOI 10.1016/j.apmr.2005.07.309; Gaetani P, 2012, J NEUROSURG SCI, V56, P231; Harvey LA, 2012, INJURY, V43, P1821, DOI 10.1016/j.injury.2012.07.188; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kannus P, 2007, INJURY, V38, P81, DOI 10.1016/j.injury.2006.08.027; Kraus J, 2005, J HEAD TRAUMA REHAB, V20, P239, DOI 10.1097/00001199-200505000-00007; Leblanc J, 2006, BRAIN INJURY, V20, P779, DOI 10.1080/02699050600831835; McDonough P, 2001, SOC SCI MED, V52, P547, DOI 10.1016/S0277-9536(00)00159-3; McIntyre A, 2013, NEUROREHABILITATION, V32, P409, DOI 10.3233/NRE-130862; MILLER J D, 1989, Neurosurgical Review, V12, P441; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Rapoport MJ, 2001, BRAIN INJURY, V15, P857, DOI 10.1080/02699050110065303; Ritchie PD, 2011, J CLIN NEUROSCI, V7, P301; Roenker DL, 2003, HUM FACTORS, V45, P218, DOI 10.1518/hfes.45.2.218.27241; Rothweiler B, 1998, ARCH PHYS MED REHAB, V79, P881, DOI 10.1016/S0003-9993(98)90082-X; Salthouse T, 2012, ANNU REV PSYCHOL, V63, P201, DOI 10.1146/annurev-psych-120710-100328; Seidler RD, 2010, NEUROSCI BIOBEHAV R, V34, P721, DOI 10.1016/j.neubiorev.2009.10.005; Statistique Canada, 2011, RAPP LEST POP SEL GR; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Utomo WK, 2009, INJURY, V40, P973, DOI 10.1016/j.injury.2009.05.034; Vollmer DG, 1991, J NEUROSURG S, V75, P37; Watson WL, 2011, OSTEOPOROSIS INT, V22, P2623, DOI 10.1007/s00198-010-1511-z	30	11	11	0	6	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2015	29	5					558	564		10.3109/02699052.2014.976593			7	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	CH3GL	WOS:000353917000003	25625679				2021-06-18	
J	Fortier, CB; Amick, MM; Kenna, A; Milberg, WP; McGlinchey, RE				Fortier, Catherine Brawn; Amick, Melissa M.; Kenna, Alexandra; Milberg, William P.; McGlinchey, Regina E.			Correspondence of the Boston Assessment of Traumatic Brain Injury-Lifetime (BAT-L) Clinical Interview and the VA TBI Screen	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						TBI; screen; Veteran; OEF/OIF	ADMINISTERED PTSD SCALE; VETERANS	Objective: Mild traumatic brain injury is the signature injury of Operation Enduring Freedom (OEF), Operation Iraqi Freedom (OIF), and Operation New Dawn (OND), yet its identification and diagnosis is controversial and fraught with challenges. Setting: In 2007, the Department of Veterans Affairs (VA) implemented a policy requiring traumatic brain injury (TBI) screening on all individuals returning from deployment in the OEF/OIF/OND theaters of operation that lead to the rapid and widespread use of the VA TBI screen. The Boston Assessment of TBI-Lifetime (BAT-L) is the first validated, postcombat semistructured clinical interview to characterize head injuries and diagnose TBIs throughout the life span, including prior to, during, and post-military service. Participants: Community-dwelling convenience sample of 179 OEF/OIF/OND veterans. Main measures: BAT-L, VA TBI screen. Results: Based on BAT-L diagnosis of military TBI, the VA TBI screen demonstrated similar sensitivity (0.85) and specificity (0.82) when administered by research staff. When BAT-L diagnosis was compared with historical clinician-administered VA TBI screen in a subset of participants, sensitivity was reduced. Conclusions: The specificity of the research-administered VA TBI screen was more than adequate. The sensitivity of the VA TBI screen, although relatively high, suggests that it does not oversample or "catch all" possible military TBIs. Traumatic brain injuries identified by the BAT-L, but not identified by the VA TBI screen, were predominantly noncombat military injuries. There is potential concern regarding the validity and reliability of the clinician administered VA TBI screen, as we found poor correspondence between it and the BAT-L, as well as low interrater reliability between the clinician-administered and research-administered screen.	[Fortier, Catherine Brawn; Amick, Melissa M.; Kenna, Alexandra; Milberg, William P.; McGlinchey, Regina E.] VA Boston Healthcare Syst, Translat Res Ctr TBI & Stress Disorders TRACTS, Boston, MA 02130 USA; [Fortier, Catherine Brawn; Milberg, William P.; McGlinchey, Regina E.] VA Boston Healthcare Syst, GRECC, Boston, MA 02130 USA; [Fortier, Catherine Brawn; Milberg, William P.; McGlinchey, Regina E.] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [Amick, Melissa M.] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA	Fortier, CB (corresponding author), VA Boston Healthcare Syst, Translat Res Ctr TBI & Stress Disorders, Geriatr Res Educ & Clin Ctr JP 182, 150 South Huntington Ave, Boston, MA 02130 USA.	Catherine_Fortier@hms.harvard.edu	McGlinchey, Regina E/R-1971-2016		Translational Research Center for TBI and Stress Disorders (TRACTS); VA Rehabilitation Research and Development Traumatic Brain Injury Center of Excellence [B6796-C]; NIH NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K23AG034258]; VA Merit Review AwardUS Department of Veterans Affairs; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K23AG034258] Funding Source: NIH RePORTER	This research was supported by the Translational Research Center for TBI and Stress Disorders (TRACTS), a VA Rehabilitation Research and Development Traumatic Brain Injury Center of Excellence (B6796-C), NIH NIA K23AG034258, and VA Merit Review Award to Regina McGlinchey.	Bailes JE, 2001, NEUROSURGERY, V48, P26, DOI 10.1097/00006123-200101000-00005; Belanger HG, 2012, ARCH PHYS MED REHAB, V93, P1234, DOI 10.1016/j.apmr.2012.03.003; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1002/jts.2490080106; Department of Veterans Affairs Department of Defense, VA DOD CLIN PRACT GU; Donnelly KT, 2011, J HEAD TRAUMA REHAB, V26, P439, DOI 10.1097/HTR.0b013e3182005de3; Fortier CB, 2014, J HEAD TRAUMA REHAB, V29, P89, DOI 10.1097/HTR.0b013e3182865859; Sayer NA, 2012, ANNU REV MED, V63, P405, DOI 10.1146/annurev-med-061610-154046; Terrio HP, 2011, REHABIL PSYCHOL, V56, P26, DOI 10.1037/a0022685; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029	9	11	11	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2015	30	1					E1	E7		10.1097/HTR.0000000000000008			7	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	AY8BW	WOS:000347780400001	24336147	Green Accepted			2021-06-18	
J	Gerace, E; Pellegrini-Giampietro, DE; Moroni, F; Mannaioni, G				Gerace, Elisabetta; Pellegrini-Giampietro, Domenico E.; Moroni, Flavio; Mannaioni, Guido			Poly(ADP-Ribose) Polymerase 1 (PARP-1) Activation and Ca2+ Permeable alpha-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid (AMPA) Channels in Post-Ischemic Brain Damage: New Therapeutic Opportunities?	CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS			English	Article						alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors; cell death; Dementia; Neuroprotection; Poly(ADP-ribose) polymerases; stroke	APOPTOSIS-INDUCING FACTOR; FOCAL CEREBRAL-ISCHEMIA; NEURONAL DEATH; CELL-DEATH; RECEPTOR ANTAGONISTS; RAT HIPPOCAMPUS; 1-AMINOINDAN-1,5-DICARBOXYLIC ACID; MICROGLIAL ACTIVATION; SYNAPTIC PLASTICITY; GLOBAL-ISCHEMIA	A significant number of laboratories observed that poly (ADP-ribose) polymerase (PARP) inhibitors, administered a few hours after ischemic or traumatic brain injury, may drastically reduce the subsequent neurological damage. It has also been shown that PARP inhibitors, administered for 24 hours to rats with permanent middle cerebral artery occlusion (MCAO), may reduce the number of dying neurons for a long period after surgery, thus suggesting that these agents could reduce the delayed brain damage and the neurological and cognitive impairment (dementia) frequently observed a few months after a stroke. In organotypic hippocampal slices exposed to N-methyl-N'-nitro-N'-nitrosoguanidine (MNNG), an alkylating agent able to activate PARP, a selective and delayed degeneration of the CA1 pyramidal cells which was anatomically similar to that observed after a short period of oxygen and glucose deprivation (OGD) has been described. Biochemical and electrophysiological approaches showed that MNNG exposure caused an increased expression and function of the calcium permeable alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) channels in the CA1 but not in the CA3 hippocampal region. PARP inhibitors prevented this increase and reduced CA1 cell death. The AMPA receptor antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo[f] quinoxaline-2,3-dione or the selective Ca2+ permeable AMPA channel blocker 1-Naphthyl acetyl spermine (NASPM), also reduced the MNNG-induced CA1 pyramidal cell death. Since activation of PARP-1 facilitate the expression of Ca2+ permeable channels and the subsequent delayed cell death, PARP inhibitors administered a few hours after a stroke may not only reduce the early post-ischemic brain damage but also the late neuronal death frequently occurring after severe stroke.	[Gerace, Elisabetta; Pellegrini-Giampietro, Domenico E.] Univ Florence, Sect Clin Pharmacol & Oncol, Dept Hlth Sci, I-50121 Florence, Italy; [Moroni, Flavio; Mannaioni, Guido] Univ Florence, Dept Neurosci, Pharmacol Sect, I-50139 Florence, Italy	Moroni, F (corresponding author), Pharmacol Sect, Dept Neurosci, Viale Pieraccini 6, I-50139 Florence, Italy.	flavio.moroni@unifi.it		Pellegrini-Giampietro, Domenico E./0000-0002-3920-2297	University of Florence; Ente Cassa di Risparmio di Firenze GrantsFondazione Cassa Risparmio Firenze	This work was supported by University of Florence; and Ente Cassa di Risparmio di Firenze Grants to F.M. and G.M.	Alano CC, 2006, P NATL ACAD SCI USA, V103, P9685, DOI 10.1073/pnas.0600554103; Ame JC, 2004, BIOESSAYS, V26, P882, DOI 10.1002/bies.20085; Bellone C, 2006, NAT NEUROSCI, V9, P636, DOI 10.1038/nn1682; BENVENISTE H, 1984, J NEUROCHEM, V43, P1369, DOI 10.1111/j.1471-4159.1984.tb05396.x; BERGER NA, 1985, RADIAT RES, V101, P4, DOI 10.2307/3576299; Bhakar AL, 2002, J NEUROSCI, V22, P8466; BOCHET P, 1994, NEURON, V12, P383, DOI 10.1016/0896-6273(94)90279-8; BRUSA R, 1995, SCIENCE, V270, P1677, DOI 10.1126/science.270.5242.1677; BURNASHEV N, 1992, NEURON, V8, P189, DOI 10.1016/0896-6273(92)90120-3; Chiarugi A, 2003, J NEUROCHEM, V85, P306, DOI 10.1046/j.1471-4159.2003.01684.x; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; Cipriani G, 2005, J BIOL CHEM, V280, P17227, DOI 10.1074/jbc.M414526200; COSI C, 1994, J NEUROSCI RES, V39, P38, DOI 10.1002/jnr.490390106; Cozzi A, 2006, J CEREBR BLOOD F MET, V26, P684, DOI 10.1038/sj.jcbfm.9600222; Culmsee C, 2005, J NEUROSCI, V25, P10262, DOI 10.1523/JNEUROSCI.2818-05.2005; del Zoppo GJ, 2003, J CEREBR BLOOD F MET, V23, P879, DOI 10.1097/01.WCB.0000078322.96027.78; del Zoppo GJ, 2006, NEW ENGL J MED, V354, P553, DOI 10.1056/NEJMp058312; DEMURCIA G, 1994, TRENDS BIOCHEM SCI, V19, P172, DOI 10.1016/0968-0004(94)90280-1; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; EASTWOOD SL, 1995, MOL BRAIN RES, V29, P211, DOI 10.1016/0169-328X(94)00247-C; Endres M, 1997, J CEREBR BLOOD F MET, V17, P1143, DOI 10.1097/00004647-199711000-00002; Fatokun AA, 2013, BRIT J PHARMACOL, V169, P1263, DOI 10.1111/bph.12201; Fatokun AA, 2014, BRIT J PHARMACOL, V171, P2000, DOI 10.1111/bph.12416; Fisher M, 2009, STROKE, V40, P2244, DOI 10.1161/STROKEAHA.108.541128; Fonfria E, 2004, BRIT J PHARMACOL, V143, P186, DOI 10.1038/sj.bjp.0705914; FRIEDMAN LK, 1994, J NEUROSCI, V14, P2697; Fumagalli S, 2013, GLIA, V61, P827, DOI 10.1002/glia.22474; Gerace E, 2014, NEUROBIOL DIS, V70, P43, DOI 10.1016/j.nbd.2014.05.023; Gerace E, 2012, EUR J NEUROSCI, V36, P1993, DOI 10.1111/j.1460-9568.2012.08116.x; Giovannelli L, 2002, J CEREBR BLOOD F MET, V22, P697, DOI 10.1097/00004647-200206000-00008; Goto S, 2002, STROKE, V33, P1101, DOI 10.1161/01.STR.0000014203.65693.1E; Grooms SY, 2000, P NATL ACAD SCI USA, V97, P3631, DOI 10.1073/pnas.050586497; Gu JG, 1996, NATURE, V381, P793, DOI 10.1038/381793a0; Ha HC, 2000, NEUROBIOL DIS, V7, P225, DOI 10.1006/nbdi.2000.0324; Haddad M, 2006, BRIT J PHARMACOL, V149, P23, DOI 10.1038/sj.bjp.0706837; Hamby AM, 2007, STROKE, V38, P632, DOI 10.1161/01.STR.0000250742.61241.79; HEURTEAUX C, 1994, BRAIN RES, V659, P67, DOI 10.1016/0006-8993(94)90864-8; HOLLMANN M, 1991, SCIENCE, V252, P851, DOI 10.1126/science.1709304; Iadecola C, 2001, CURR OPIN NEUROL, V14, P89, DOI 10.1097/00019052-200102000-00014; Ikonomovic MD, 1997, J NEUROPATH EXP NEUR, V56, P1018, DOI 10.1097/00005072-199709000-00007; Jagtap P, 2005, NAT REV DRUG DISCOV, V4, P421, DOI 10.1038/nrd1718; JORGENSEN MB, 1993, EXP NEUROL, V120, P70, DOI 10.1006/exnr.1993.1041; Koh SH, 2005, TOXICOLOGY, V214, P131, DOI 10.1016/j.tox.2005.06.023; Koh SH, 2004, EUR J NEUROSCI, V20, P1461, DOI 10.1111/j.1460-9568.2004.03632.x; Kraus WL, 2013, MOL ASPECTS MED, V34, P1109, DOI 10.1016/j.mam.2013.01.005; Kraus WL, 2003, CELL, V113, P677, DOI 10.1016/S0092-8674(03)00433-1; Krishnakumar R, 2008, SCIENCE, V319, P819, DOI 10.1126/science.1149250; Lampl Y, 2007, NEUROLOGY, V69, P1404, DOI 10.1212/01.wnl.0000277487.04281.db; Langelier MF, 2010, J BIOL CHEM, V285, P18877, DOI 10.1074/jbc.M110.105668; Lee Y, 2013, NAT NEUROSCI, V16, P1392, DOI 10.1038/nn.3500; Lenzser G, 2007, J CEREBR BLOOD F MET, V27, P1318, DOI 10.1038/sj.jcbfm.9600437; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; Liu SH, 2004, NEURON, V43, P43, DOI 10.1016/j.neuron.2004.06.017; Liu SJ, 2007, TRENDS NEUROSCI, V30, P126, DOI 10.1016/j.tins.2007.01.006; LOMBARDI G, 1994, EUR J PHARMACOL, V271, P489, DOI 10.1016/0014-2999(94)90810-9; LOMBARDI G, 1992, NEUROSCI LETT, V134, P171, DOI 10.1016/0304-3940(92)90509-6; Lu P, 2014, J NEUROSCI, V34, P15975, DOI 10.1523/JNEUROSCI.2499-14.2014; Mameli M, 2009, NAT NEUROSCI, V12, P1036, DOI 10.1038/nn.2367; MELDRUM B, 1985, CLIN SCI, V68, P113, DOI 10.1042/cs0680113; Meli E, 2004, MOL CELL NEUROSCI, V25, P172, DOI 10.1016/j.mcn.2003.09.016; Moroni F, 2012, BRIT J PHARMACOL, V165, P1487, DOI 10.1111/j.1476-5381.2011.01666.x; Moroni F, 2009, BRIT J PHARMACOL, V157, P854, DOI 10.1111/j.1476-5381.2009.00232.x; Moroni F, 1997, J PHARMACOL EXP THER, V281, P721; Moroni F, 2008, CURR OPIN PHARMACOL, V8, P96, DOI 10.1016/j.coph.2007.10.005; Moroni F, 2009, FEBS J, V276, P36, DOI 10.1111/j.1742-4658.2008.06768.x; Moskowitz MA, 2010, STROKE, V41, pS85, DOI 10.1161/STROKEAHA.110.598458; Noh KM, 2005, P NATL ACAD SCI USA, V102, P12230, DOI 10.1073/pnas.0505408102; Oguro K, 1999, J NEUROSCI, V19, P9218; Orsini F, 2012, CIRCULATION, V126, P1484, DOI 10.1161/CIRCULATIONAHA.112.103051; OTSUKA A, 1991, IMMUNOPHARM IMMUNOT, V13, P263, DOI 10.3109/08923979109019705; Pellegrini-Giampietro DE, 1999, EUR J NEUROSCI, V11, P3637, DOI 10.1046/j.1460-9568.1999.00786.x; Pellegrini-Giampietro DE, 1999, NEUROPHARMACOLOGY, V38, P1607, DOI 10.1016/S0028-3908(99)00097-0; PELLEGRINIGIAMPIETRO DE, 1994, NEUROSCIENCE, V63, P701, DOI 10.1016/0306-4522(94)90516-9; PellegriniGiampietro DE, 1997, TRENDS NEUROSCI, V20, P464, DOI 10.1016/S0166-2236(97)01100-4; PELLEGRINIGIAMPIETRO DE, 1992, P NATL ACAD SCI USA, V89, P10499, DOI 10.1073/pnas.89.21.10499; Pieper AA, 1999, TRENDS PHARMACOL SCI, V20, P171, DOI 10.1016/S0165-6147(99)01292-4; POLLARD H, 1993, NEUROSCIENCE, V57, P545, DOI 10.1016/0306-4522(93)90004-Y; Scartabelli T, 2008, NEUROPHARMACOLOGY, V55, P509, DOI 10.1016/j.neuropharm.2008.06.019; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; SCHWARCZ R, 1985, LANCET, V2, P140; Scobie KN, 2014, P NATL ACAD SCI USA, V111, P2005, DOI 10.1073/pnas.1319703111; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; Sun JH, 2014, ANN TRANSL MED, V2, DOI 10.3978/j.issn.2305-5839.2014.08.05; Szabo C, 1998, TRENDS PHARMACOL SCI, V19, P287, DOI 10.1016/S0165-6147(98)01193-6; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; TSUBOKAWA H, 1994, J NEUROPHYSIOL, V71, P1190; Tymianski M, 2014, NAT REV NEUROL, V10, P66, DOI 10.1038/nrneurol.2013.271; Tymianski M, 2013, STROKE, V44, P2942, DOI 10.1161/STROKEAHA.113.000731; VERDOORN TA, 1991, SCIENCE, V252, P1715, DOI 10.1126/science.1710829; Virgo L, 1996, NEUROREPORT, V7, P2507, DOI 10.1097/00001756-199611040-00021; Wang YF, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2000902; Weiss JH, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00042; Ying WH, 2005, J NEUROSCI RES, V79, P216, DOI 10.1002/jnr.20289; Ying WH, 2002, J CEREBR BLOOD F MET, V22, P774, DOI 10.1097/00004647-200207000-00002; Yrjanheikki J, 1998, P NATL ACAD SCI USA, V95, P15769, DOI 10.1073/pnas.95.26.15769; Yu SW, 2006, P NATL ACAD SCI USA, V103, P18314, DOI 10.1073/pnas.0606528103; ZHANG J, 1994, SCIENCE, V263, P687, DOI 10.1126/science.8080500; Zhang YH, 2005, J CEREBR BLOOD F MET, V25, P868, DOI 10.1038/sj.jcbfm.9600081; Zingarelli B, 1998, CIRC RES, V83, P85, DOI 10.1161/01.RES.83.1.85	99	11	12	0	4	BENTHAM SCIENCE PUBL	BUSUM	PO BOX 294, BUSUM, 1400 AG, NETHERLANDS	1871-5273	1996-3181		CNS NEUROL DISORD-DR	CNS Neurol. Disord.-Drug Targets		2015	14	5					636	646		10.2174/1871527314666150430162841			11	Neurosciences; Pharmacology & Pharmacy	Neurosciences & Neurology; Pharmacology & Pharmacy	CI8DM	WOS:000354999100009	25924998				2021-06-18	
J	Goldberg, A; Curtis, CL; Kleim, JA				Goldberg, Allon; Curtis, Catherine L.; Kleim, Jeffrey A.			Linking Genes to Neurological Clinical Practice: The Genomic Basis for Neurorehabilitation	JOURNAL OF NEUROLOGIC PHYSICAL THERAPY			English	Article						epigenetics; genetics; neural plasticity; personalized medicine; polymorphisms	TRAUMATIC BRAIN-INJURY; BDNF VAL66MET POLYMORPHISM; CENTRAL-NERVOUS-SYSTEM; RARE CODING VARIATION; THAN-T POLYMORPHISMS; CAG REPEAT LENGTH; ISCHEMIC-STROKE; PARKINSONS-DISEASE; HUNTINGTONS-DISEASE; NEUROTROPHIC FACTOR	Large-scale genomics projects such as the Human Genome Project and the International HapMap Project promise significant advances in the ability to diagnose and treat many conditions, including those with a neurological basis. A major focus of research has emerged in the neurological sciences to elucidate the molecular and genetic basis of various neurological diseases. Indeed, genetic factors are implicated in susceptibility for many neurological disorders, with family history studies providing strong evidence of familial risk for conditions such as stroke, Parkinson's, Alzheimer's, and Huntington's diseases. Heritability studies also suggest a strong genetic contribution to the risk for neurological diseases. Genome-wide association studies are also uncovering novel genetic variants associated with neurological disorders. Whole-genome and exome sequencing are likely to provide novel insights into the genetic basis of neurological disorders. Genetic factors are similarly associated with clinical phenotypes such as symptom severity and progression as well as response to treatment. Specifically, disease progression and functional restoration depend, in part, on the capacity for neural plasticity within residual neural tissues. Furthermore, such plasticity may be influenced in part by the presence of polymorphisms in several genes known to orchestrate neural plasticity including brain-derived neurotrophic factor (BDNF) and Apolipoprotein E. (APOE). It is important for neurorehabilitation therapist practicing in the "genomic era" to be aware of the potential influence of genetic factors during clinical encounters, as advances in molecular sciences are revealing information of critical relevance to the clinical rehabilitation management of individuals with neurological conditions. Video Abstract available (See Video, Supplemental Digital Content 1, http://links.lww.com/JNPT/A88) for more insights from the authors.	[Goldberg, Allon] Univ Michigan, Sch Hlth Profess & Studies, Phys Therapy Dept, Flint, MI 48502 USA; [Curtis, Catherine L.] New York Med Coll, Inst Publ Hlth, Sch Hlth Sci & Practice, Dept Phys Therapy, Valhalla, NY 10595 USA; [Kleim, Jeffrey A.] Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ USA	Goldberg, A (corresponding author), Univ Michigan, Sch Hlth Profess & Studies, Phys Therapy Dept, 303 East Kearsley St, Flint, MI 48502 USA.	allong@umich.edu					Abul-Husn NS, 2014, PHARMACOGEN PERS MED, V7, P227, DOI 10.2147/PGPM.S48887; Adams Stacie D, 2013, N C Med J, V74, P494; Adamson Joy, 2004, J Stroke Cerebrovasc Dis, V13, P171, DOI 10.1016/j.jstrokecerebrovasdis.2004.06.003; Agundez JAG, 2013, EXPERT OPIN DRUG MET, V9, P859, DOI 10.1517/17425255.2013.789018; Vilatela MEA, 2012, ARCH MED RES, V43, P622, DOI 10.1016/j.arcmed.2012.10.017; Ashley EA, 2010, LANCET, V375, P1525, DOI 10.1016/S0140-6736(10)60452-7; Bagnato S, 2012, J NEUROTRAUM, V29, P2050, DOI 10.1089/neu.2011.2184; Bainbridge MN, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002243; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Barbey AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088733; Bath KG, 2006, COGN AFFECT BEHAV NE, V6, P79, DOI 10.3758/CABN.6.1.79; Battie MC, 2008, J APPL PHYSIOL, V104, P379, DOI 10.1152/japplphysiol.01009.2007; Beaudet A, 1995, METABOLIC MOL BASES, P53; Bevan S, 2012, STROKE, V43, P3161, DOI 10.1161/STROKEAHA.112.665760; Binia A, 2014, GENES NUTR, V9, DOI 10.1007/s12263-014-0421-7; Birkenmeier RL, 2010, NEUROREHAB NEURAL RE, V24, P620, DOI 10.1177/1545968310361957; Blix A, 2014, CLIN J ONCOL NURS, V18, P437, DOI 10.1188/14.CJON.437-441; Bloss CS, 2012, GENET EPIDEMIOL, V36, P66, DOI 10.1002/gepi.20664; Booth FW, 2007, PHYSIOL GENOMICS, V28, P146, DOI 10.1152/physiolgenomics.00174.2006; Bouchard C, 2011, EXERC SPORT SCI REV, V39, P212, DOI 10.1097/JES.0b013e31822643f6; Chang WH, 2014, BRAIN STIMUL, V7, P553, DOI 10.1016/j.brs.2014.03.008; Chen H, 2005, NEUROLOGY, V64, P664, DOI 10.1212/01.WNL.0000151960.28687.93; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Collins FS, 2001, JAMA-J AM MED ASSOC, V285, P540, DOI 10.1001/jama.285.5.540; Collins FS, 2003, NATURE, V422, P835, DOI 10.1038/nature01626; Collins FS, 1999, NEW ENGL J MED, V341, P28, DOI 10.1056/NEJM199907013410106; Cramer SC, 2012, EUR J NEUROL, V19, P718, DOI 10.1111/j.1468-1331.2011.03615.x; CRAUFURD D, 1993, J MED GENET, V30, P1008, DOI 10.1136/jmg.30.12.1008; de Lau LML, 2014, PARKINSONISM RELAT D, V20, P613, DOI 10.1016/j.parkreldis.2014.02.030; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; Devan WJ, 2013, STROKE, V44, P1578, DOI 10.1161/STROKEAHA.111.000089; Falcone GJ, 2014, LANCET NEUROL, V13, P405, DOI 10.1016/S1474-4422(14)70029-8; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Freburger JK, 2011, ARCH PHYS MED REHAB, V92, P1220, DOI 10.1016/j.apmr.2011.03.019; Gandhi S, 2010, NAT NEUROSCI, V13, P789, DOI 10.1038/nn.2584; George AL, 2008, J AM SOC NEPHROL, V19, P1840, DOI 10.1681/ASN.2008050524; Goldberg A, 2005, J PHYS THER ED, V19, P8; Goldberg A, 2010, J NEUROL SCI, V298, P91, DOI 10.1016/j.jns.2010.08.002; Greenberg ME, 2009, J NEUROSCI, V29, P12764, DOI 10.1523/JNEUROSCI.3566-09.2009; Gromadzka G, 2007, ACTA NEUROL SCAND, V116, P392, DOI 10.1111/j.1600-0404.2007.00880.x; Guo SW, 2001, HUM HERED, V51, P121, DOI 10.1159/000053333; Guttmacher AE, 2002, NEW ENGL J MED, V347, P1512, DOI 10.1056/NEJMra012240; Guttmacher AE, 2004, NEW ENGL J MED, V351, P2333, DOI 10.1056/NEJMsb042979; Hakim AJ, 2002, ARTHRIT RHEUM-ARTHR, V47, P275, DOI 10.1002/art.10395; Hallowell N, 2015, J MED ETHICS, V41, P317, DOI 10.1136/medethics-2013-101996; Han Guangchun, 2014, Genomics Proteomics & Bioinformatics, V12, P156, DOI 10.1016/j.gpb.2014.07.002; Houlden H, 2012, ACTA NEUROPATHOL, V124, P325, DOI 10.1007/s00401-012-1013-5; Houston JP, 2012, J CLIN PSYCHIAT, V73, P878, DOI 10.4088/JCP.10m06744; Hu XD, 2011, J COMB OPTIM, V21, P1, DOI 10.1007/s10878-010-9361-3; Hudson KL, 2011, NEW ENGL J MED, V365, P1033, DOI 10.1056/NEJMra1010517; Hunter DJ, 2007, NEW ENGL J MED, V357, P436, DOI 10.1056/NEJMp078120; Jarvis JN, 2014, ARTHRITIS RHEUMATOL, V66, pS227, DOI 10.1002/art.38600; Jordan BD, 2007, NEUROCHEM RES, V32, P905, DOI 10.1007/s11064-006-9251-3; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Kilarski LL, 2014, NEUROLOGY, V83, P678, DOI 10.1212/WNL.0000000000000707; Kim DS, 2014, J LIPID RES, V55, P1173, DOI 10.1194/jlr.P049247; Kim JM, 2008, NEUROBIOL AGING, V29, P789, DOI 10.1016/j.neurobiolaging.2006.11.021; Kim JS, 2003, J NEUROL SCI, V206, P31, DOI 10.1016/S0022-510X(02)00361-1; Kim WS, 2013, ANN REHABIL MED-ARM, V37, P311, DOI 10.5535/arm.2013.37.3.311; Kleim JA, 2006, NAT NEUROSCI, V9, P735, DOI 10.1038/nn1699; Knowles JW, 2012, CIRC-CARDIOVASC GENE, V5, P368, DOI 10.1161/CIRCGENETICS.112.962746; Kohen R, 2008, ARCH GEN PSYCHIAT, V65, P1296, DOI 10.1001/archpsyc.65.11.1296; Krueger F, 2011, J NEUROSCI, V31, P598, DOI 10.1523/JNEUROSCI.1399-10.2011; Kummer MP, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt258; Labbadia J, 2013, TRENDS BIOCHEM SCI, V38, P378, DOI 10.1016/j.tibs.2013.05.003; Lander ES, 2011, NATURE, V470, P187, DOI 10.1038/nature09792; Lang CE, 2009, ARCH PHYS MED REHAB, V90, P1692, DOI 10.1016/j.apmr.2009.04.005; Lazaros L, 2010, EUR J NEUROL, V17, P757, DOI 10.1111/j.1468-1331.2009.02860.x; Le Q, 2014, AM J PHYS MED REHAB, V93, P422, DOI 10.1097/PHM.0000000000000027; Lesage Suzanne, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS66, DOI 10.1016/S1353-8020(11)70022-0; Lesage S, 2009, HUM MOL GENET, V18, pR48, DOI 10.1093/hmg/ddp012; Lichtman SW, 2000, NEUROLOGY, V55, P1536, DOI 10.1212/WNL.55.10.1536; Lisabeth LD, 2005, BMC NEUROL, V5, DOI 10.1186/1471-2377-5-20; Loprinzi PD, 2013, BRAIN RES, V1539, P95, DOI 10.1016/j.brainres.2013.10.004; Lovati C, 2010, INT J MOL EPIDEMIOL, V1, P193; Lundy MG, 2014, J GENET COUNS, V23, P618, DOI 10.1007/s10897-014-9692-9; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mang CS, 2013, PHYS THER, V93, P1707, DOI 10.2522/ptj.20130053; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marder K, 2002, NEUROLOGY, V59, P1622, DOI 10.1212/01.WNL.0000035627.16789.23; Markus HS, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-113; Markus HS, 2011, HUM MOL GENET, V20, pR124, DOI 10.1093/hmg/ddr345; Markus HS, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000225; Martinez-Levy Gabriela A., 2014, Yale Journal of Biology and Medicine, V87, P173; McHughen SA, 2011, EXP BRAIN RES, V213, P415, DOI 10.1007/s00221-011-2791-z; Mirowsha-Guzel D, 2014, TOP STROKE REHABIL, V21, pS33, DOI 10.1310/tsr21S1-S33; Mirowska-Guzel D, 2013, NEUROREHABILITATION, V32, P573, DOI 10.3233/NRE-130879; Morgan JC, 2014, PARKINSONS DIS-US, V2014, DOI 10.1155/2014/426976; Nalls MA, 2011, LANCET, V377, P641, DOI 10.1016/S0140-6736(10)62345-8; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Ormond KE, 2010, LANCET, V375, P1749, DOI 10.1016/S0140-6736(10)60599-5; Ortega-Alonso A, 2006, J GERONTOL A-BIOL, V61, P1082, DOI 10.1093/gerona/61.10.1082; Ost M, 2008, ACTA ANAESTH SCAND, V52, P1364, DOI 10.1111/j.1399-6576.2008.01675.x; Pal R, 2014, MOL NEUROBIOL, V49, P1181, DOI 10.1007/s12035-013-8590-8; Pam A., 1996, Acta Geneticae Medicae et Gemellologiae, V45, P349; Payami H, 2014, NEUROTHERAPEUTICS, V11, P111, DOI 10.1007/s13311-013-0237-y; Pearson-Fuhrhop KM, 2009, TOP STROKE REHABIL, V16, P282, DOI 10.1310/tsr1604-282; Pedersen NL, 2004, ANN NEUROL, V55, P180, DOI 10.1002/ana.10999; Petzinger GM, 2013, LANCET NEUROL, V12, P716, DOI 10.1016/S1474-4422(13)70123-6; Raber J, 2004, NEUROBIOL AGING, V25, P641, DOI 10.1016/j.neurobiolaging.2003.12.023; Rahimzadeh V, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0238-6; Ravina B, 2008, MOVEMENT DISORD, V23, P1223, DOI 10.1002/mds.21988; Reistetter TA, 2014, ARCH PHYS MED REHAB, V95, P29, DOI 10.1016/j.apmr.2013.07.018; Rich EC, 2004, J GEN INTERN MED, V19, P273, DOI 10.1111/j.1525-1497.2004.30401.x; Richardson K, 2005, BRIT J EDUC PSYCHOL, V75, P339, DOI 10.1348/000709904X24690; Rinaldi C, 2012, CAN J NEUROL SCI, V39, P48, DOI 10.1017/S0317167100012671; Ritz B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036199; Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918; Rosen AR, 2007, NEUROGENETICS, V8, P263, DOI 10.1007/s10048-007-0100-6; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Schmid AW, 2013, MOL CELL PROTEOMICS, V12, P3543, DOI 10.1074/mcp.R113.032730; Schweizer S, 2013, J CEREBR BLOOD F MET, V33, P1335, DOI 10.1038/jcbfm.2013.93; Seshadri S, 2010, CIRCULATION, V121, P1304, DOI 10.1161/CIRCULATIONAHA.109.854240; Sharma P, 2013, J NEUROL NEUROSUR PS, V84, P1302, DOI 10.1136/jnnp-2012-304834; Siironen J, 2007, STROKE, V38, P2858, DOI 10.1161/STROKEAHA.107.485441; Stankovic S, 2010, CRIT REV CL LAB SCI, V47, P72, DOI 10.3109/10408361003791520; Stoykov ME, 2015, J NEUROL PHYS THER, V39, P33, DOI 10.1097/NPT.0000000000000065; Taylor JG, 2001, TRENDS MOL MED, V7, P507, DOI 10.1016/S1471-4914(01)02183-9; Teasdale GM, 2005, BRAIN, V128, P2556, DOI 10.1093/brain/awh595; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Traylor M, 2012, LANCET NEUROL, V11, P951, DOI 10.1016/S1474-4422(12)70234-X; Treger I, 2003, ARCH PHYS MED REHAB, V84, P973, DOI 10.1016/S0003-9993(03)00043-1; Vallon M, 2014, CELL MOL LIFE SCI, V71, P3489, DOI 10.1007/s00018-014-1625-0; van Dellen A, 2000, NATURE, V404, P721, DOI 10.1038/35008142; Vassy JL, 2013, J COMMUN GENET, V4, P263, DOI 10.1007/s12687-013-0140-6; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Wang LL, 2011, GENOMICS, V98, P1, DOI 10.1016/j.ygeno.2011.04.006; Weydt P, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-1; Wirdefeldt K, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2011.02.017; Xu Q, 2010, NEUROLOGY, V75, P341, DOI 10.1212/WNL.0b013e3181ea1597; Yin KJ, 2015, METAB BRAIN DIS, V30, P401, DOI 10.1007/s11011-013-9468-1; Zeng S, 2014, GENET TEST MOL BIOMA, V18, P202, DOI 10.1089/gtmb.2013.0421; Zhang JL, 2013, NEUROREHABILITATION, V32, P391, DOI 10.3233/NRE-130860; Zhao J, 2013, BRAIN RES, V1537, P312, DOI 10.1016/j.brainres.2013.08.061; Zhou BS, 2014, INT J MOL SCI, V15, P8931, DOI 10.3390/ijms15058931; Zhou WD, 2008, J NEUROTRAUM, V25, P279, DOI 10.1089/neu.2007.0489; Zhou ZM, 2011, CLIN CHEM LAB MED, V49, P185, DOI 10.1515/CCLM.2011.039	138	11	11	0	22	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1557-0576	1557-0584		J NEUROL PHYS THER	J. Neurol. Phys. Ther.	JAN	2015	39	1					52	61		10.1097/NPT.0000000000000066			10	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	AX2GX	WOS:000346762600008	25415554				2021-06-18	
J	Hawkins, BL; McGuire, FA; Britt, TW; Linder, SM				Hawkins, Brent L.; McGuire, Francis A.; Britt, Thomas W.; Linder, Sandra M.			Identifying contextual influences of community reintegration among injured servicemembers	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						assistance barriers; community dwelling; community reintegration; contextual factors; CR; environmental factors; general self-efficacy; injured military servicemembers; personal factors; rehabilitation	SOCIAL COGNITIVE THEORY; TRAUMATIC BRAIN-INJURY; ENVIRONMENTAL-FACTORS; INTERNATIONAL CLASSIFICATION; MEASURING PARTICIPATION; DISABILITY; EMPLOYMENT; CHALLENGES; TYPOLOGY; OUTCOMES	Research suggests that community reintegration (CR) after injury and rehabilitation is difficult for many servicemembers. However, little is known about the influence of the contextual factors, both personal and environmental, on CR. Framed within the International Classification of Functioning, Disability and Health and social cognitive theory, the quantitative portion of a larger mixed-methods study of 51 injured, community-dwelling servicemembers compared the relative contribution of contextual factors between groups of servicemembers with different levels of CR. Cluster analysis indicated three groups of servicemembers showing low, moderate, and high levels of CR. Statistical analyses identified contextual factors that significantly discriminated between CR clusters. Multivariate analysis of variance and discriminant analysis indicated significant contributions of general self-efficacy, services and assistance barriers, physical and structural barriers, attitudes and support barriers, perceived level of disability and/or handicap, work and school barriers, and policy barriers to CR scores. Overall, analyses indicated that injured servicemembers with lower CR scores had lower general self-efficacy scores, reported more difficulty with environmental barriers, and reported their injuries as more disabling.	[Hawkins, Brent L.; McGuire, Francis A.] Clemson Univ, Dept Pk Recreat & Tourism Management, 128 McGinty Ct,263 Lehotsky Hall, Clemson, SC 29634 USA; [Britt, Thomas W.] Clemson Univ, Dept Psychol, Clemson, SC 29634 USA; [Linder, Sandra M.] Clemson Univ, Eugene T Moore Sch Educ, Clemson, SC 29634 USA	Hawkins, BL (corresponding author), Clemson Univ, Dept Pk Recreat & Tourism Management, 128 McGinty Ct,263 Lehotsky Hall, Clemson, SC 29634 USA.	blhawki@clemson.edu					Bandura A, 2001, ANNU REV PSYCHOL, V52, P1, DOI 10.1146/annurev.psych.52.1.1; Bandura A., 1986, SOCIAL FDN THOUGHT A; Benight CC, 2004, BEHAV RES THER, V42, P1129, DOI 10.1016/j.brat.2003.08.008; Bryan CJ, 2010, MIL MED, V175, P713, DOI 10.7205/MILMED-D-09-00248; Chen G, 2001, ORGAN RES METHODS, V4, P62, DOI 10.1177/109442810141004; Corrigan JD, 2007, ARCH PHYS MED REHAB, V88, P1400, DOI 10.1016/j.apmr.2007.08.006; Gary KW, 2009, ARCH PHYS MED REHAB, V90, P1699, DOI 10.1016/j.apmr.2009.04.014; Hawkins BL, 2011, THER RECREAT J, V45, P309; Heinemann AW, 2011, ARCH PHYS MED REHAB, V92, P564, DOI 10.1016/j.apmr.2010.07.220; Khaylis A, 2011, MIL MED, V176, P126, DOI 10.7205/MILMED-D-10-00094; Law M, 2007, ARCH PHYS MED REHAB, V88, P1636, DOI 10.1016/j.apmr.2007.07.035; Lysack Cathy, 2007, Can J Occup Ther, V74 Spec No., P243; Minnes P, 2003, BRAIN INJURY, V17, P149, DOI 10.1080/02699050301828; Mowatt RA, 2011, THER RECREAT J, V45, P286; Onwuegbuzie AJ, 2007, QUAL REP, V12, P281; Resnik L, 2012, J REHABIL RES DEV, V49, P557, DOI 10.1682/JRRD.2011.04.0081; Resnik L, 2012, J REHABIL RES DEV, V49, P87, DOI 10.1682/JRRD.2010.06.0107; Resnik L, 2011, J REHABIL RES DEV, V48, P89, DOI 10.1682/JRRD.2010.04.0070; Resnik L, 2009, J REHABIL RES DEV, V46, P469, DOI 10.1682/JRRD.2008.07.0082; Resnik L, 2009, ARCH PHYS MED REHAB, V90, P856, DOI 10.1016/j.apmr.2008.11.010; Resnik LJ, 2007, J REHABIL RES DEV, V44, P991, DOI 10.1682/JRRD.2007.05.0071; Sarajuuri JM, 2005, ARCH PHYS MED REHAB, V86, P2296, DOI 10.1016/j.apmr.2005.06.018; Sayer NA, 2010, PSYCHIAT SERV, V61, P589, DOI 10.1176/ps.2010.61.6.589; Tabachnick B. G., 2006, USING MULTIVARIATE S; Teddlie C, 2007, J MIX METHOD RES, V1, P77, DOI 10.1177/2345678906292430; Wang PP, 2006, DISABIL REHABIL, V28, P135, DOI 10.1080/09638280500167761; Whiteneck G, 2004, ARCH PHYS MED REHAB, V85, P1793, DOI 10.1016/j.apmr.2004.04.024; Whiteneck GG, 2004, ARCH PHYS MED REHAB, V85, P1324, DOI 10.1016/j.apmr.2003.09.027; Whiteneck GG, 2004, J HEAD TRAUMA REHAB, V19, P191, DOI 10.1097/00001199-200405000-00001; World Health Organization, 2001, INT CLASS FUNCT DIS; Yazicioglu K, 2006, MIL MED, V171, P1083, DOI 10.7205/MILMED.171.11.1083	31	11	11	0	3	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2015	52	2					235	246		10.1682/JRRD.2014.08.0195			12	Rehabilitation	Rehabilitation	CK6DB	WOS:000356317600011	26237496	Bronze			2021-06-18	
J	Jin, XQ; Ye, F; Zhang, JJ; Zhao, Y; Zhou, XL				Jin, Xiao-Qing; Ye, Fei; Zhang, Jun-Jian; Zhao, Yan; Zhou, Xian-Long			Triptolide attenuates cerebral ischemia and reperfusion injury in rats through the inhibition the nuclear factor kappa B signaling pathway	NEUROPSYCHIATRIC DISEASE AND TREATMENT			English	Article						ischemic stroke; inflammation; rat model; NF-kappa B pathway	TRAUMATIC BRAIN-INJURY; CELL-DEATH; STROKE; INFLAMMATION; ACTIVATION; EXPRESSION; CONTRIBUTES; INFARCTION; OCCLUSION; HEART	Inflammation plays critical roles in the acute progression of the pathology of ischemic injury. Previous studies have shown that triptolide interferes with a number of pro-inflammatory mechanisms. In this study, we investigated whether triptolide has protective effects during acute cerebral ischemia/reperfusion (I/R) injury. Male Sprague Dawley rats received triptolide or vehicle at the onset of reperfusion following middle cerebral artery occlusion. Twenty-four hours after reperfusion, we evaluated neurological injuries, the expression of pro-inflammatory markers, and NF-kappa B activation. I/R rats treated with triptolide showed significantly better neurological deficit scores, decreased neural apoptosis, and reduced cerebral infarct volume and brain edema, and triptolide treatment suppressed the activation of NF-kappa B following I/R injury. Furthermore, the expression levels of pro-inflammatory cytokines at both the mRNA and protein levels were significantly decreased in rats receiving triptolide. These results indicate that the neuroprotective effects of triptolide during acute cerebral I/R injury are possibly related to the inhibition of both the NF-kappa B signaling pathway and inflammation.	[Jin, Xiao-Qing; Ye, Fei; Zhang, Jun-Jian] Wuhan Univ, Zhongnan Hosp, Dept Neurol, Wuhan 430071, Hunan, Peoples R China; [Jin, Xiao-Qing; Zhao, Yan; Zhou, Xian-Long] Wuhan Univ, Zhongnan Hosp, Emergency Ctr, Wuhan 430071, Hunan, Peoples R China	Zhang, JJ (corresponding author), Wuhan Univ, Zhongnan Hosp, Dept Neurol, 169 Donghu Rd, Wuhan 430071, Hunan, Peoples R China.	xsssm@sina.cn			Emergency Diagnostic and Therapeutic Center of Central China	The authors would like to thank the Center for Animal Experiments, Wuhan University (Wuhan, Hubei, People's Republic of China) for assistance. This study was financially supported by the Emergency Diagnostic and Therapeutic Center of Central China.	Arrick DM, 1985, J APPL PHYSIOL, V2012, P1121; Berti R, 2002, J CEREBR BLOOD F MET, V22, P1068, DOI 10.1097/00004647-200209000-00004; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Chao XD, 2010, BRAIN RES, V1363, P206, DOI 10.1016/j.brainres.2010.09.052; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Durukan A, 2007, PHARMACOL BIOCHEM BE, V87, P179, DOI 10.1016/j.pbb.2007.04.015; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Faul JL, 2000, AM J RESP CRIT CARE, V162, P2252, DOI 10.1164/ajrccm.162.6.2002018; Hill WD, 2001, BRAIN RES BULL, V55, P375, DOI 10.1016/S0361-9230(01)00503-2; Huang J, 2006, SURG NEUROL, V66, P232, DOI 10.1016/j.surneu.2005.12.028; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Kwon SW, 2011, BIOCHEM BIOPH RES CO, V411, P354, DOI 10.1016/j.bbrc.2011.06.147; Lakhan SE, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-97; Lee HF, 2012, RESP PHYSIOL NEUROBI, V182, P1, DOI 10.1016/j.resp.2012.01.016; Lin N, 2007, BIOCHEM PHARMACOL, V73, P136, DOI 10.1016/j.bcp.2006.08.027; Lu Y, 2006, INVEST OPHTH VIS SCI, V47, P3796, DOI 10.1167/iovs.06-0319; Mao YP, 1999, J LIQ CHROMATOGR R T, V22, P1355, DOI 10.1081/JLC-100101737; Matta R, 2009, AM J TRANSL RES, V1, P267; Meldrum DR, 1997, J MOL CELL CARDIOL, V29, P2849, DOI 10.1006/jmcc.1997.0506; Molina CA, 2009, CEREBROVASC DIS, V27, P162, DOI 10.1159/000200455; Murakami K, 1998, J NEUROSCI, V18, P205; Nonaka M, 1999, J NEUROTRAUM, V16, P1023, DOI 10.1089/neu.1999.16.1023; Nurmi A, 2004, STROKE, V35, P987, DOI 10.1161/01.STR.0000120732.45951.26; Patzer A, 2008, EUR J NEUROSCI, V28, P1786, DOI 10.1111/j.1460-9568.2008.06478.x; Schneider A, 1999, NAT MED, V5, P554; Shah IM, 2009, CURR MOL MED, V9, P336, DOI 10.2174/156652409787847236; Shao F, 2007, BIOL PHARM BULL, V30, P702, DOI 10.1248/bpb.30.702; Stephenson D, 2000, J CEREBR BLOOD F MET, V20, P592, DOI 10.1097/00004647-200003000-00017; Tuttolomondo A, 2009, CURR TOP MED CHEM, V9, P1240, DOI 10.2174/156802609789869619; Zhang W, 2005, J CEREBR BLOOD F MET, V25, P30, DOI 10.1038/sj.jcbfm.9600004	30	11	12	0	9	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1178-2021			NEUROPSYCH DIS TREAT	Neuropsychiatr. Dis. Treat.		2015	11						1395	1403		10.2147/NDT.S82052			9	Clinical Neurology; Psychiatry	Neurosciences & Neurology; Psychiatry	CJ9UI	WOS:000355848300001	26082636	DOAJ Gold, Green Published			2021-06-18	
J	Johansson, B; Ronnback, L				Johansson, Birgitta; Ronnback, Lars			Novel computer tests for identification of mental fatigue after traumatic brain injury	NEUROREHABILITATION			English	Article						Mental fatigue; novel computer test; traumatic brain injury; cognitive function	DIVIDED ATTENTION; HEAD-INJURY; MILD; SYMPTOMS; DEFICITS; STROKE	BACKGROUND: Mental fatigue is one of the most significant post-traumatic brain injury symptoms. It is currently not possible to objectively identify. OBJECTIVE: This study investigated whether a complex computer cognitive test with load on endurance, processing speed and attention were more demanding for participants suffering from mental fatigue after brain injury compared with a control group. METHOD: Seventy-six subjects of mild traumatic brain injury (mTBI) and 45 healthy controls were included in the study. All subjects with mTBI had been suffering from mental fatigue for six months or more. Mental fatigue was screened using the Mental Fatigue Scale (MFS). Cognitive function was measured for information processing speed and working memory, and with a novel computer test. RESULTS: The mTBI group rated MFS significantly higher than the control group. The results revealed a significantly slower information processing speed for the mTBI subjects and a poorer performance on the working memory test. The computer test revealed a less efficient performance over time for the TBI subjects compared to the control group. CONCLUSIONS: The results indicate a less efficient performance over time in complex and demanding cognitive tasks for individuals experiencing from mental fatigue after brain injury.	[Johansson, Birgitta; Ronnback, Lars] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Clin Neurosci & Rehabil, S-41345 Gothenburg, Sweden	Johansson, B (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Clin Neurosci & Rehabil, Dubbsgatan 14,1tr, S-41345 Gothenburg, Sweden.	birgitta.johansson@neuro.gu.se		, Birgitta/0000-0003-0240-1142	AFA Insurance; The Local Research and Development Board for Gothenburg and Sodra Bohuslan; Health & Medical Care Committee of the Vastra Gotaland Region; Swedish Stroke Association; Swedish Association for Survivors of Accident and Injury (RTP)	This work was supported by grants from AFA Insurance, The Local Research and Development Board for Gothenburg and Sodra Bohuslan, The Health & Medical Care Committee of the Vastra Gotaland Region, The Swedish Stroke Association and the Swedish Association for Survivors of Accident and Injury (RTP).	Ashman TA, 2008, J HEAD TRAUMA REHAB, V23, P33, DOI 10.1097/01.HTR.0000308719.70288.22; Azouvi P, 2004, NEUROPSYCHOLOGIA, V42, P1260, DOI 10.1016/j.neuropsychologia.2004.01.001; Belmont A., 2006, Annales de Readaptation et de Medecine Physique, V49, P370, DOI 10.1016/j.annrmp.2006.04.018; Belmont A, 2009, NEUROREHAB NEURAL RE, V23, P939, DOI 10.1177/1545968309340327; Blanchet S, 2009, BRAIN INJURY, V23, P111, DOI 10.1080/02699050802649688; DeLuca J, 2005, ISS CLIN COGN NEUROP, P1; Donkelaar P. V., 2005, BRAIN INJURY, V19, P1031; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Jacobs L, 2011, MILD BRAIN INJURY IM; Johansson B, 2014, BRAIN INJURY, V28, P304, DOI 10.3109/02699052.2013.865267; Johansson B, 2012, BRAIN INJURY, V26, P1621, DOI 10.3109/02699052.2012.700082; Johansson B., 2012, BRAIN INJURY FUNCTIO, V1, P3, DOI [10.5772/27042, DOI 10.5772/27042]; Johansson B., 2014, INT J PHYS MED REHAB, V2, P1, DOI [10.4172/2329-9096.1000182, DOI 10.4172/2329-9096.1000182]; Johansson B, 2012, ACTA NEUROPSYCHIATR, V24, P266, DOI 10.1111/j.1601-5215.2012.00678.x; Johansson B, 2010, BRAIN INJURY, V24, P2, DOI 10.3109/02699050903452961; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Kohl AD, 2009, BRAIN INJURY, V23, P420, DOI 10.1080/02699050902788519; Mathias JL, 2004, J INT NEUROPSYCH SOC, V10, P286, DOI 10.1017/S1355617704102117; O'Connor C, 2005, PSYCHOL REP, V97, P169, DOI 10.2466/PR0.97.5.169-179; Ozen LJ, 2012, ARCH CLIN NEUROPSYCH, V27, P85, DOI 10.1093/arclin/acr087; Park NW, 1999, NEUROPSYCHOLOGIA, V37, P1119, DOI 10.1016/S0028-3932(99)00034-2; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Pontifex MB, 2009, NEUROPSYCHOLOGIA, V47, P3210, DOI 10.1016/j.neuropsychologia.2009.07.021; Reitan RM, 1999, ARCH CLIN NEUROPSYCH, V14, P191, DOI 10.1016/S0887-6177(98)00012-2; Ronnback L., 2012, LONG LASTING MENTAL; Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; Stulemeijer M, 2006, J NEUROL, V253, P1041, DOI 10.1007/s00415-006-0156-5; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Wechsler D., 2004, WECHSLER ADULT INTEL, V3rd ed; Ziino C, 2006, J INT NEUROPSYCH SOC, V12, P100, DOI 10.1017/S1355617706060139; Ziino C, 2006, NEUROPSYCHOLOGY, V20, P383, DOI 10.1037/0894-4105.20.3.383; Zomeren V. A. H., 1999, J NEUROL NEUROSUR PS, V66, P207	32	11	11	0	11	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2015	36	2					195	202		10.3233/NRE-151207			8	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	CK9CW	WOS:000356539100005	25882202				2021-06-18	
J	Maegele, M; Stuermer, EK; Hoeffgen, A; Uhlenkueken, U; Mautes, A; Schaefer, N; Lippert-Gruener, M; Schaefer, U; Hoehn, M				Maegele, Marc; Stuermer, Ewa K.; Hoeffgen, Alexander; Uhlenkueken, Ulla; Mautes, Angelika; Schaefer, Nadine; Lippert-Gruener, Marcela; Schaefer, Ute; Hoehn, Mathias			Multimodal MR imaging of acute and subacute experimental traumatic brain injury: Time course and correlation with cerebral energy metabolites	ACTA RADIOLOGICA OPEN			English	Article						Traumatic brain injury; vasogenic edema; cytotoxic edema; ATP imaging; magnetic resonance imaging (MRI); transient reduction of energy metabolism	LASER-DOPPLER FLOWMETRY; EARLY-ONSET STIMULATION; CORTICAL IMPACT INJURY; ENRICHED ENVIRONMENT; RATS; DIFFUSION; EDEMA; SPECTROSCOPY; DYSFUNCTION; NEUROMOTOR	Background: Traumatic brain injury (TBI) is one of the leading causes of death and permanent disability world-wide. The predominant cause of death after TBI is brain edema which can be quantified by non-invasive diffusion-weighted magnetic resonance imaging (DWI). Purpose: To provide a better understanding of the early onset, time course, spatial development, and type of brain edema after TBI and to correlate MRI data and the cerebral energy state reflected by the metabolite adenosine triphosphate (ATP). Material and Methods: The spontaneous development of lateral fluid percussion-induced TBI was investigated in the acute (6 h), subacute (48 h), and chronic (7 days) phase in rats by MRI of quantitative T2 and apparent diffusion coefficient (ADC) mapping as well as perfusion was combined with ATP-specific bioluminescence imaging and histology. Results: An induced TBI led to moderate to mild brain damages, reflected by transient, pronounced development of vasogenic edema and perfusion reduction. Heterogeneous ADC patterns indicated a parallel, but mixed expression of vasogenic and cytotoxic edema. Cortical ATP levels were reduced in the acute and subacute phase by 13% and 27%, respectively, but were completely normalized at 7 days after injury. Conclusion: The partial ATP reduction was interpreted to be partially caused by a loss of neurons in parallel with transient dilution of the regional ATP concentration by pronounced vasogenic edema. The normalization of energy metabolism after 7 days was likely due to infiltrating glia and not to recovery. The MRI combined with metabolite measurement further improves the understanding and evaluation of brain damages after TBI.	[Maegele, Marc] Univ Witten Herdecke, Dept Traumatol Orthoped Surg & Sporttraumatol, CMMC, D-51109 Cologne, Germany; [Maegele, Marc; Stuermer, Ewa K.; Schaefer, Nadine] Univ Witten Herdecke, Inst Res Operat Med, D-51109 Cologne, Germany; [Hoeffgen, Alexander] Hosp Gummerbach, Dept Anaesthesiol & Intens Care Med, Gummersbach, Germany; [Uhlenkueken, Ulla; Hoehn, Mathias] Max Planck Inst Neurol Res, In Vivo NMR Lab, D-50931 Cologne, Germany; [Mautes, Angelika] Univ Saarland, Inst Neurosurg Res, Dept Neurosurg, Homburg, Germany; [Lippert-Gruener, Marcela] Univ Cologne, Ctr Neurosurg, D-50931 Cologne, Germany; [Schaefer, Ute] Med Univ Graz, Dept Neurosurg, FE Expt Neurotraumatol, Graz, Austria; [Hoehn, Mathias] Leiden Univ, Med Ctr, Dept Radiol, Leiden, Netherlands	Stuermer, EK (corresponding author), Univ Witten Herdecke, Inst Res Operat Med, Fac Hlth, Sch Med, D-51109 Cologne, Germany.	ewa.stuermer@uni.wh.de					Albensi BC, 2000, EXP NEUROL, V162, P61, DOI 10.1006/exnr.2000.7256; Alsop DC, 1996, J NEUROTRAUM, V13, P515, DOI 10.1089/neu.1996.13.515; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Hoehn-Berlage M, 1995, J CEREB BLOOD FLOW M, V15, pS62; Huisman TAGM, 2003, EUR RADIOL, V13, P2283, DOI 10.1007/s00330-003-1843-6; Immonen RJ, 2009, NEUROIMAGE, V45, P1, DOI 10.1016/j.neuroimage.2008.11.022; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; Kerskens CM, 1996, NMR BIOMED, V9, P20, DOI 10.1002/(SICI)1099-1492(199602)9:1<20::AID-NBM381>3.0.CO;2-R; Kharatishvili I, 2009, EXP NEUROL, V217, P154, DOI 10.1016/j.expneurol.2009.01.026; KIMURA M, 1994, STROKE, V25, P2227, DOI 10.1161/01.STR.25.11.2227; LEBIHAN D, 1986, RADIOLOGY, V161, P401, DOI 10.1148/radiology.161.2.3763909; Lescot T, 2010, J NEUROTRAUM, V27, P85, DOI 10.1089/neu.2009.0982; Li YH, 2012, NEUROL SCI, V33, P731, DOI 10.1007/s10072-011-0768-0; Long JB, 1996, J NEUROTRAUM, V13, P149, DOI 10.1089/neu.1996.13.149; Maegele M, 2005, J NEUROTRAUM, V22, P772, DOI 10.1089/neu.2005.22.772; Maegele M, 2005, EUR J NEUROSCI, V21, P2406, DOI 10.1111/j.1460-9568.2005.04070.x; Marmarou A, 2000, J NEUROSURG, V93, P183, DOI 10.3171/jns.2000.93.2.0183; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MUIR JK, 1992, J NEUROTRAUM, V9, P355, DOI 10.1089/neu.1992.9.355; OKADA Y, 1992, J NEUROSURG, V77, P917, DOI 10.3171/jns.1992.77.6.0917; PASCHEN W, 1990, PROG HISTOCHEM CYTOC, V20, P1; Pascual JM, 2007, J NEUROTRAUM, V24, P944, DOI 10.1089/neu.2006.0190; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; PONTEN U, 1973, J NEUROCHEM, V21, P1127, DOI 10.1111/j.1471-4159.1973.tb07567.x; Schaefer PW, 2000, RADIOLOGY, V217, P331, DOI 10.1148/radiology.217.2.r00nv24331; Schneider G, 2002, MAGN RESON MATER PHY, V14, P233, DOI 10.1016/S1352-8661(02)00068-6; Thomale UW, 2002, ACTA NEUROCHIR SUPPL, V81, P229; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Wegener S, 2006, J CEREBR BLOOD F MET, V26, P38, DOI 10.1038/sj.jcbfm.9600166; Xu S, 2011, J NEUROTRAUM, V28, P2091, DOI 10.1089/neu.2010.1739; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	32	11	11	0	4	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	2058-4601			ACTA RADIOL OPEN	Acta Radiol. Open	JAN	2015	4	1								10.1177/2047981614555142			10	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CX9BL	WOS:000365999600003	25610615	DOAJ Gold, Green Published			2021-06-18	
J	Martinez-Valverde, T; Vidal-Jorge, M; Montoya, N; Sanchez-Guerrero, A; Manrique, S; Munar, F; Pellegri, MD; Poca, MA; Sahuquillo, J				Martinez-Valverde, Tamara; Vidal-Jorge, Marian; Montoya, Noelia; Sanchez-Guerrero, Angela; Manrique, Susana; Munar, Francisca; Pellegri, Maria-Dolors; Poca, Maria-Antonia; Sahuquillo, Juan			Brain Microdialysis as a Tool To Explore the Ionic Profile of the Brain Extracellular Space in Neurocritical Patients: A Methodological Approach and Feasibility Study	JOURNAL OF NEUROTRAUMA			English	Article						ionic profile; relative recovery; brain microdialysis; brain edema; potassium	CEREBRAL MICRODIALYSIS; IN-VITRO; HEAD-INJURY; POTASSIUM; TISSUE; ISCHEMIA; VIVO; CONSENSUS; PRESSURE; ROBUST	Our aim is to determine whether the ionic concentration in brain microdialysate enables calculations of the actual Na+, K+, and Cl- concentrations in vitro and whether this method can be applied to determine the ionic concentrations in the brain extracellular fluid. We designed an experiment using CMA-71 probes (M Dialysis, Stockholm, Sweden) and the standard conditions used in a clinical setting. Nine CMA-71 probes were inserted in different matrices and perfused with mock cerebrospinal fluid containing 3% albumin at the standard infusion rate used in the clinical setting (0.3 mu L/min). Microvials were replaced every 12 h, and the ionic concentrations, both in the dialysate and the matrix, were analyzed. For each ion, scatter plots were built, with [Na+], [K+], and [Cl-] in the dialysate as the predictor variables and the matrix concentrations as the outcome variables. A linear regression model allowed us to calculate the true ionic concentrations in the matrix. To demonstrate the feasibility of the method, we present the calculated ionic profile of one patient with a malignant infarction and a second with a severe traumatic brain injury. Our results confirm that the ionic concentration in microdialysate can be used to calculate the true concentrations of ions in a matrix and the actual concentrations in the extracellular fluid. Microdialysis offers the unique possibility of monitoring the dynamic changes of ions in the brain over time and opens a new avenue to explore the brain's ionic profile, its changes in brain edema, and how this profile can be modified with different therapies.	[Martinez-Valverde, Tamara; Vidal-Jorge, Marian; Montoya, Noelia; Sanchez-Guerrero, Angela; Poca, Maria-Antonia; Sahuquillo, Juan] Univ Autonoma Barcelona, Vall dHebron Univ Hosp, Neurotraumatol & Neurosurg Res Unit UNINN, Barcelona 08035, Spain; [Manrique, Susana; Munar, Francisca] Univ Autonoma Barcelona, Vall dHebron Univ Hosp, Dept Anesthesiol, Barcelona 08035, Spain; [Pellegri, Maria-Dolors] Univ Autonoma Barcelona, Vall dHebron Univ Hosp, Dept Biochem, Barcelona 08035, Spain; [Poca, Maria-Antonia; Sahuquillo, Juan] Univ Autonoma Barcelona, Vall dHebron Univ Hosp, Dept Neurosurg, Barcelona 08035, Spain	Sahuquillo, J (corresponding author), Univ Autonoma Barcelona, Vall dHebron Univ Hosp, Dept Neurosurg & Neurotraumatol, Paseo Vall dHebron 119-129, Barcelona 08035, Spain.	sahuquillo@neurotrauma.net	Bauza, Francisca Munar/AAB-6682-2019; Vidal-Jorge, Marian/D-4402-2017; Sahuquillo, Juan/B-3577-2008; Montoya, Noelia/AAB-7839-2019; Poca, Maria A./B-8475-2008	Bauza, Francisca Munar/0000-0003-4579-3027; Vidal-Jorge, Marian/0000-0002-3459-9336; Sahuquillo, Juan/0000-0003-0713-5875; Montoya, Noelia/0000-0002-8634-5303; Poca, Maria A./0000-0002-3831-0536	Fondo de Investigacion Sanitaria (Instituto de Salud Carlos III)Instituto de Salud Carlos III [PI10/00302, FIS PI11/00700]; European Regional DevelopmentEuropean Commission; Instituto de Salud Carlos IIIInstituto de Salud Carlos IIIEuropean Commission [FI11/00195, FI12/00074]	This work has been supported, in part, by the Fondo de Investigacion Sanitaria (Instituto de Salud Carlos III) with grants PI10/00302 and FIS PI11/00700, which were cofinanced by the European Regional Development and awarded to M.A. Poca and J. Sahuquillo, respectively. T. Martinez-Valverde and A. Sanchez-Guerrero are the recipients of personal predoctoral grants from the Instituto de Salud Carlos III (grant nos. FI11/00195 and FI12/00074, respectively).	Bellander BM, 2004, INTENS CARE MED, V30, P2166, DOI 10.1007/s00134-004-2461-8; BENVENISTE H, 1989, J NEUROCHEM, V52, P1667, DOI 10.1111/j.1471-4159.1989.tb07243.x; Bungay PM, 2011, J PHARMACEUT BIOMED, V55, P54, DOI 10.1016/j.jpba.2011.01.005; BUNGAY PM, 1990, LIFE SCI, V46, P105, DOI 10.1016/0024-3205(90)90043-Q; De Los Rios JA, 2009, NEUROCIRUGIA, V20, P433; Dipylon Medical, 2011, CMA 71 HIGH CUT OFF; Doppenberg EMR, 1999, ACT NEUR S, V75, P31; Elmquist WF, 1997, PHARMACEUT RES, V14, P267, DOI 10.1023/A:1012081501464; Fox J., 2011, R COMPANION APPL REG, V2; Galea JP, 2014, PHYSIOL MEAS, V35, pN21, DOI 10.1088/0967-3334/35/3/N21; Goodman JC, 1999, ACT NEUR S, V75, P35; Grubb BR, 2002, AM J PHYSIOL-CELL PH, V282, pC1423, DOI 10.1152/ajpcell.00612.2001; Helmy A, 2007, CURR MED CHEM, V14, P1525, DOI 10.2174/092986707780831113; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Helmy A, 2009, J NEUROTRAUM, V26, P549, DOI 10.1089/neu.2008.0719; Horn PS, 2003, CLIN CHIM ACTA, V334, P5, DOI 10.1016/S0009-8981(03)00133-5; Horn PS, 1999, CLIN CHEM, V45, P2284; Horn PS, 1998, CLIN CHEM, V44, P622; HSIAO JK, 1990, J NEUROCHEM, V54, P1449, DOI 10.1111/j.1471-4159.1990.tb01982.x; Hutchinson PJ, 2000, J NEUROSURG, V93, P37, DOI 10.3171/jns.2000.93.1.0037; Katayama Y, 2003, ACTA NEUROCHIR SUPPL, V86, P323; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Katayama Y., 1994, INTRACRANIAL PRESSUR, P324; Kitagawa R, 2013, NEUROSURG CLIN N AM, V24, P417, DOI 10.1016/j.nec.2013.02.002; Landolt H, 1996, EUR J ANAESTH, V13, P269, DOI 10.1046/j.1365-2346.1996.00975.x; Li ZH, 2008, PROG NAT SCI-MATER, V18, P503, DOI 10.1016/j.pnsc.2008.02.001; Lieutaud T., 2007, HDB MICRODIALYSIS ME, pxiv; Mori K, 2002, J NEUROTRAUM, V19, P1261, DOI 10.1089/08977150260338047; NORDENVALL M, 1989, GYNECOL OBSTET INVES, V28, P73, DOI 10.1159/000293518; Perez-Barcena J, 2011, CRIT CARE MED, V39, P533, DOI 10.1097/CCM.0b013e318205c7a4; Poca MA, 2006, J NEUROTRAUM, V23, P1510, DOI 10.1089/neu.2006.23.1510; R Core Team, 2013, R LANG ENV STAT COMP; Reiber H, 2003, CLIN CHEM LAB MED, V41, P331, DOI 10.1515/CCLM.2003.053; Reinert M, 2000, J NEUROSURG, V93, P800, DOI 10.3171/jns.2000.93.5.0800; RStudio, 2013, RSTUD INT DEV ENV R; Seehusen DA, 2003, AM FAM PHYSICIAN, V68, P1103; Simard JM, 2007, LANCET NEUROL, V6, P258, DOI 10.1016/S1474-4422(07)70055-8; Simard JM, 2010, STROKE, V41, P531, DOI 10.1161/STROKEAHA.109.572644; Somjen GG., 2004, IONS BRAIN NORMAL FU; STAHLE L, 1991, J PHARMACOL METHOD, V25, P41, DOI 10.1016/0160-5402(91)90021-V; Thomas R, 2008, PRACT SPECTROSC, P1; Torto N, 2009, CHROMATOGRAPHIA, V70, P1305, DOI 10.1365/s10337-009-1335-1; Valadka AB, 1998, J NEUROTRAUM, V15, P509, DOI 10.1089/neu.1998.15.509; Waelchli R O, 2000, J Reprod Fertil Suppl, P327	44	11	12	0	10	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2015	32	1					7	16		10.1089/neu.2014.3473			10	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	AX4JX	WOS:000346900100002	25019674	Green Published			2021-06-18	
J	Nardone, A; Sampson, E; Stauffer, C; Leopold, A; Jacobs, K; Hendricks, DJ; Elias, E; Chen, H; Rumrill, P				Nardone, Amanda; Sampson, Elaine; Stauffer, Callista; Leopold, Anne; Jacobs, Karen; Hendricks, Deborah J.; Elias, Eileen; Chen, Hui; Rumrill, Phillip			Project Career: A qualitative examination of five college students with traumatic brain injuries	NEUROREHABILITATION			English	Article						Traumatic brain injury; secondary education; employment; cognitive support technology		BACKGROUND: Project Career is an interprofessional five-year development project designed to improve the employment success of undergraduate college and university students with traumatic brain injury (TBI). The case study information was collected and synthesized by the project's Technology and Employment Coordinators (TECs) at each of the project's three university sites. The project's evaluation is occurring independently through JBS International, Inc. OBJECTIVE: Five case studies are presented to provide an understanding of student participants' experiences within Project Career. Each case study includes background on the student, engagement with technology, vocational supports, and interactions with his/her respective TEC. METHODS: A qualitative analysis from the student's case notes is provided within each case study, along with a discussion of the overall qualitative analysis. RESULTS: Across all five students, the theme Positive Outcomes was mentioned most often in the case notes. Of all the different type of challenges, Cognitive Challenges were most often mentioned during meetings with the TECs, followed by Psychological Challenges, Physical Challenges, Other Challenges, and Academic Challenges, respectively. CONCLUSION: Project Career is providing academic enrichment and career enhancement that may substantially improve the unsatisfactory employment outcomes that presently await students with TBI following graduation.	[Nardone, Amanda; Jacobs, Karen] Boston Univ, Boston, MA 02215 USA; [Sampson, Elaine; Hendricks, Deborah J.] W Virginia Univ, Morgantown, WV 26506 USA; [Stauffer, Callista; Rumrill, Phillip] Kent State Univ, Kent, OH 44242 USA; [Leopold, Anne; Elias, Eileen; Chen, Hui] JBS Int Inc, North Bethesda, MD USA	Jacobs, K (corresponding author), Boston Univ, 635 Commonwealth Ave, Boston, MA 02215 USA.	kjacobs@bu.edu		Jacobs, Karen/0000-0002-4718-990X	United States Department of Education, NIDRRUS Department of Education [H133A130066]	The contents of this article were developed under a grant from the United States Department of Education, NIDRR grant #H133A130066. However, those contents do not necessarily represent the policy of the Department of Education, and readers should not assume endorsement by the Federal Government.	Basso A., 2006, WHO NEUROLOGICAL DIS, P164; Bryan-Hancock C, 2010, INJURY PREV, V16, pA17, DOI 10.1136/ip.2010.029215.61; Centers for Disease Control and Prevention, 2015, TRAUM BRAIN INJ US F; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Kennedy MRT, 2008, NEUROREHABILITATION, V23, P511; Leopold A, 2015, NEUROREHABILITATION, V37, P359, DOI 10.3233/NRE-151267; Scherer M. J., 1998, MATCHING PERSON TECH; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Todis B, 2008, J HEAD TRAUMA REHAB, V23, P252, DOI 10.1097/01.HTR.0000327257.84622.bc	9	11	11	0	1	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2015	37	3					459	469		10.3233/NRE-151274			11	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	CY3QH	WOS:000366324100011	26518535				2021-06-18	
J	Nguyen, HS; Doan, N; Gelsomino, M; Shabani, S; Mueller, W; Zaidat, OO				Nguyen, Ha Son; Doan, Ninh; Gelsomino, Michael; Shabani, Saman; Mueller, Wade; Zaidat, Osama O.			Coincidence of an anterior cerebral artery aneurysm and a glioblastoma: case report and review of literature	INTERNATIONAL MEDICAL CASE REPORTS JOURNAL			English	Article						intracranial aneurysm; glioblastoma; traumatic brain injury		Background: The association between glioblastoma and intracranial aneurysm is rare. Treatment guidelines do not exist, and operative mortality and morbidity are significantly high. To our knowledge, no prior cases have employed endovascular therapy for the treatment of these intratumor intracranial aneurysms followed by tumor resection. Case presentation: A 74-year-old male, history of a left A2 aneurysm, presented after a motor vehicle accident at low speeds. Imaging was concerning for a possible traumatic brain contusion, an aneurysmal hemorrhage given history of left A2 aneurysm, or a hemorrhage from an underlying tumor given profound edema. The patient was discussed at the brain tumor board, where the plan was to address the aneurysm followed by resection of the mass versus close monitoring with subsequent imaging. The high risk of rehemorrhage, given the real possibility of an aneurysmal hemorrhage, motivated prompt treatment of the aneurysm. The patient was taken to the angiography suite; an anterosuperiorly projecting azygous A2 aneurysm, measuring 4.5 mm x 5.5 mm with a neck width at 3.5 mm and a small daughter sac, was completely obliterated with primary coiling. The following day, he underwent a left craniotomy along a forehead skin crease for mass excision. Final pathology revealed glioblastoma. The patient recovered well from both procedures, with a baseline neurological exam. The patient subsequently underwent hypofractionated radiation and temodar. Conclusion: To our knowledge, no prior cases have employed endovascular therapy for the treatment of these intracranial aneurysms. We emphasize that efforts to introduce less invasive elements may improve the overall outcomes in this rare patient population.	[Nguyen, Ha Son; Doan, Ninh; Gelsomino, Michael; Shabani, Saman; Mueller, Wade] Med Coll Wisconsin, Dept Neurosurg, 9200 West Wisconsin Ave, Milwaukee, WI 53226 USA; [Zaidat, Osama O.] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA	Nguyen, HS (corresponding author), Med Coll Wisconsin, Dept Neurosurg, 9200 West Wisconsin Ave, Milwaukee, WI 53226 USA.	hsnguyen@mcw.edu		Nguyen, Ha/0000-0002-3515-278X			Ali Rushna, 2015, Surg Neurol Int, V6, P66, DOI 10.4103/2152-7806.155759; ANDREWS BT, 1985, NEUROSURGERY, V17, P645, DOI 10.1227/00006123-198510000-00019; Aoki N, 1999, ACTA NEUROCHIR, V141, P1005, DOI 10.1007/s007010050408; Cheng WY, 2004, MINIM INVAS NEUROSUR, V47, P181, DOI 10.1055/s-2004-818378; COWEN RL, 1970, RADIOLOGY, V97, P577, DOI 10.1148/97.3.577; DECHIARA A, 1986, NEUROCHIRURGIA, V29, P58; GLASS B, 1955, ARCH NEURO PSYCHIATR, V73, P369, DOI 10.1001/archneurpsyc.1955.02330100001001; GOKALP HZ, 1980, ACTA NEUROCHIR, V53, P267, DOI 10.1007/BF02074799; Hashiguchi A, 2007, CLIN NEUROL NEUROSUR, V109, P302, DOI 10.1016/j.clineuro.2006.12.002; HONDA M, 1980, Neurological Surgery, V8, P1065; Inamasu J, 2009, NEUROL MED-CHIR, V49, P427, DOI 10.2176/nmc.49.427; Kim YJ, 2008, J KOREAN NEUROSURG S, V44, P405, DOI 10.3340/jkns.2008.44.6.405; KONDZIOLKA D, 1987, J NEUROSURG, V67, P852, DOI 10.3171/jns.1987.67.6.0852; Lakicevic G, 2014, J NEUROL SURG REP, V75, pE117, DOI 10.1055/s-0034-1376198; LICATA C, 1986, ACTA NEUROCHIR, V82, P28, DOI 10.1007/BF01456316; LOCKSLEY HB, 1966, J NEUROSURG, V24, P1034, DOI 10.3171/jns.1966.24.6.1034; Matsukawa H, 2013, J NEUROSURG, V118, P978, DOI 10.3171/2012.11.JNS121210; Morita A, 2012, NEW ENGL J MED, V366, P2474, DOI 10.1056/NEJMoa1113260; Nanney AD, 2014, WORLD NEUROSURG, V81, P511, DOI 10.1016/j.wneu.2013.10.044; OKAMURA T, 1981, Neurologia Medico-Chirurgica, V21, P601; Paoletti P, 1983, J Neurosurg Sci, V27, P211; PIA HW, 1973, ACTA NEUROCHIR, V27, P189; TAYLOR PE, 1961, NEUROLOGY, V11, P225, DOI 10.1212/WNL.11.3.225; WAKAI S, 1982, NEUROSURGERY, V10, P437, DOI 10.1227/00006123-198204000-00004; Wiebers D, 2003, LANCET, V362, P103, DOI 10.1016/S0140-6736(03)13860-3; Yamada H, 1989, Neurol Med Chir (Tokyo), V29, P846, DOI 10.2176/nmc.29.846; Yoon WS, 2011, J KOREAN NEUROSURG S, V50, P457, DOI 10.3340/jkns.2011.50.5.457	27	11	11	0	0	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1179-142X			INT MED CASE REP J	INT. MED. CASE REP. J.		2015	8						295	299		10.2147/IMCRJ.S93271			5	Medicine, General & Internal	General & Internal Medicine	V26QT	WOS:000215307400062	26648761	DOAJ Gold, Green Published			2021-06-18	
J	Silver, JM				Silver, Jonathan M.			Invalid symptom reporting and performance: What are we missing?	NEUROREHABILITATION			English	Article						Concussion; validity; effort; stereotype threat; injustice; malingering	TRAUMATIC BRAIN-INJURY; DEPRESSIVE SYMPTOMS; ILLNESS PERCEPTIONS; PERCEIVED INJUSTICE; TEST FAILURE; HEAD-INJURY; FOLLOW-UP; VALIDITY; RECOVERY; PAIN	BACKGROUND: In the evaluation of neurorehabilitation patients involved in compensation or litigation, it is often assumed that poor performance or exaggerated symptoms reflects an intentional attempt to game the system. PURPOSE: The purpose of this article is to review multiple issues that can contribute to invalid symptom reporting and performance. CONCLUSIONS: Multiple factors relevant to normal behavior, including observations from social psychology and behavioral economics, are important in the context of invalid symptom reporting and performance. These factors, which include pre-injury traits and beliefs (e.g., beliefs about prognosis and symptoms after TBI), factors at the time of initial treatment (e.g., expectations of recovery, nocebo effects, stereotype threat), and thoughts and feelings during evaluations (e.g., anger, resentment, injustice), may be important explanations. To best serve our patients, further research is needed to illuminate these relative effects on performance compared to "not trying."	[Silver, Jonathan M.] NYU, Sch Med, New York, NY 10028 USA	Silver, JM (corresponding author), NYU, Sch Med, Psychiat, 40 East 83rd St,Suite 1E, New York, NY 10028 USA.	jonsilver@gmail.com					American Association of Justice, 2015, PROM ACC SAF; Ariely D., 2010, UPSIDE IRRATIONALITY; Ariely D., 2009, PREDICTABLY IRRATION; Bell KR, 2008, J NEUROL NEUROSUR PS, V79, P1275, DOI 10.1136/jnnp.2007.141762; Bertisch HC, 2013, REHABIL PSYCHOL, V58, P429, DOI 10.1037/a0034554; Bigler E. D., 2014, BRAIN INJURY, DOI 10.3109/02699052.2014.947627; Bigler ED, 2012, J INT NEUROPSYCH SOC, V18, P632, DOI 10.1017/S1355617712000252; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Bombardier CH, 2009, J HEAD TRAUMA REHAB, V24, P230, DOI 10.1097/HTR.0b013e3181ad65f0; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Carone DA, 2008, BRAIN INJURY, V22, P960, DOI 10.1080/02699050802491297; Carter EC, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00823; Cragar DE, 2006, CLIN NEUROPSYCHOL, V20, P552, DOI 10.1080/13854040590947380; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; Feinstein A, 2001, MED SCI LAW, V41, P116, DOI 10.1177/002580240104100206; Fresson M, 2014, ARCH CLIN NEUROPSYCH, V29; Gino F, 2013, J ECON BEHAV ORGAN, V93, P285, DOI 10.1016/j.jebo.2013.04.005; Grant GM, 2014, JAMA PSYCHIAT, V71, P446, DOI 10.1001/jamapsychiatry.2013.4023; Hanna-Pladdy B, 2001, CLIN NEUROPSYCHOL, V15, P289, DOI 10.1076/clin.15.3.289.10272; HarrisPoll, 2000, PUBL PERC BRAIN HEAD; Ho B., 2011, DOES SORRY WORK IMPA; Hou R., 2011, J NEUROL NEUROSUR PS, V83, P217; Job V, 2013, P NATL ACAD SCI USA, V110, P14837, DOI 10.1073/pnas.1313475110; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kirkwood MW, 2014, PEDIATRICS, V133, P643, DOI 10.1542/peds.2013-3195; Koren D, 1999, AM J PSYCHIAT, V156, P367; Lahmann C, 2015, J NEUROL NEUROSUR PS, V86, P302, DOI 10.1136/jnnp-2014-307601; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; Larson EB, 2013, J INT NEUROPSYCH SOC, V19, P88, DOI 10.1017/S1355617712000999; Lazare A, 2006, JAMA-J AM MED ASSOC, V296, P1401, DOI 10.1001/jama.296.11.1401; Lineweaver TT, 2014, AM J PSYCHIAT, V171, P201, DOI 10.1176/appi.ajp.2013.12121590; Loring DW, 2005, J CLIN EXP NEUROPSYC, V27, P610, DOI 10.1080/13803390490918471; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; MacDonald N, 2009, CAN MED ASSOC J, V180, P11, DOI 10.1503/cmaj.081997; Marcopulos BA, 2014, CLIN NEUROPSYCHOL, V28, P633, DOI 10.1080/13854046.2014.896416; McCauley SR, 2013, J NEUROTRAUM, V30, P642, DOI 10.1089/neu.2012.2393; McCormick CL, 2013, ARCH CLIN NEUROPSYCH, V28, P808, DOI 10.1093/arclin/act050; McCullough ME, 2014, P NATL ACAD SCI USA, V111, P11211, DOI 10.1073/pnas.1405072111; Mihalik JP, 2013, AM J SPORT MED, V41, P1490, DOI 10.1177/0363546513487982; Murgatroyd DF, 2011, INJURY PREV, V17, P222, DOI 10.1136/ip.2010.029546; Murrie DC, 2013, PSYCHOL SCI, V24, P1889, DOI 10.1177/0956797613481812; Ozen LJ, 2011, J INT NEUROPSYCH SOC, V17, P219, DOI 10.1017/S135561771000144X; Provance AJ, 2014, SPORTS HEALTH, V6, P410, DOI 10.1177/1941738114544444; Rapoport MJ, 2003, PSYCHOSOMATICS, V44, P31, DOI 10.1176/appi.psy.44.1.31; Rief W, 2005, PSYCHONEUROENDOCRINO, V30, P996, DOI 10.1016/j.psyneuen.2005.03.018; Ross JS, 2012, AM J PUBLIC HEALTH, V102, P72, DOI 10.2105/AJPH.2011.300187; Scott W, 2013, PAIN, V154, P1691, DOI 10.1016/j.pain.2013.05.015; Silver JM, 2012, J NEUROL NEUROSUR PS, V83, P836, DOI 10.1136/jnnp-2011-302078; Snell DL, 2011, BRAIN INJURY, V25, P1126, DOI 10.3109/02699052.2011.607786; STAAL MA, 2004, NASATM2004212824; Steele ClaudeM., 2010, WHISTLING VIVALDI OT; Steinbrook R, 2009, NEW ENGL J MED, V360, P2160, DOI 10.1056/NEJMp0810200; Suhr JA, 2005, J INT NEUROPSYCH SOC, V11, P23, DOI 10.1017/S1355617705050010; Sullivan MJL, 2012, CLIN J PAIN, V28, P484, DOI 10.1097/AJP.0b013e3182527d13; Sullivan MJL, 2009, PAIN, V145, P325, DOI 10.1016/j.pain.2009.06.031; Sullivan-Singh SJ, 2014, ARCH PHYS MED REHAB, V95, P1100, DOI 10.1016/j.apmr.2014.02.001; TENNEN H, 1990, PSYCHOL BULL, V108, P209, DOI 10.1037/0033-2909.108.2.209; Thompson J, 2014, REHABIL PSYCHOL, V59, P376, DOI 10.1037/rep0000012; Vanderploeg RD, 2014, PSYCHOL INJ LAW, V7, P245, DOI 10.1007/s12207-014-9201-3; Wade DT, 1998, J NEUROL NEUROSUR PS, V65, P177, DOI 10.1136/jnnp.65.2.177; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; Zasler ND, 2011, TXB TRAUMATIC BRAIN, P375	62	11	11	0	9	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2015	36	4					463	469		10.3233/NRE-151234			7	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	CN8YP	WOS:000358732300008	26409494				2021-06-18	
J	Steel, J; Ferguson, A; Spencer, E; Togher, L				Steel, Joanne; Ferguson, Alison; Spencer, Elizabeth; Togher, Leanne			Language and cognitive communication during post-traumatic amnesia: A critical synthesis	NEUROREHABILITATION			English	Article						Post-traumatic amnesia; traumatic brain injury; cognitive-communication; speech pathology; aphasia; assessment; acute; recovery	TRAUMATIC BRAIN-INJURY; CLOSED-HEAD-INJURY; MINIMALLY CONSCIOUS STATE; OF-THE-LITERATURE; INCOG RECOMMENDATIONS; VERBAL IMPAIRMENT; ACUTE CONFUSION; REALITY ORIENTATION; ACUTE-CARE; RECOVERY	BACKGROUND: There is minimal speech pathology literature on communication presentation during post-traumatic amnesia (PTA) and the early recovery period after traumatic brain injury. While a body of research reports on other cognitive and behavioural functions during PTA, language and/or cognitive communication are not routinely the primary focus of current research literature. OBJECTIVE: This critical synthesis provides an overview of research to date on communication during PTA to inform speech pathology assessment practice and to assist with information provision to the multidisciplinary team and family members. METHODS: A search was conducted of studies reporting on language, cognition, and cognitive communication during the acute, inpatient and early recovery period after TBI. These were examined for relevance to speech pathology practice during PTA and acute confusional state. RESULTS: Historic and recent literature has described types of language and communication impairment during PTA and early recovery after TBI. Recently, aspects of communication impairment during PTA have been found relevant for outcome prediction. Few studies were found originating from speech pathology on communication during PTA. CONCLUSIONS: Communication disruption forms a key feature of PTA. Existing literature indicates that speech pathology monitoring of communication during PTA may be of benefit as part of multidisciplinary team management during early recovery.	[Steel, Joanne; Ferguson, Alison; Spencer, Elizabeth] Univ Newcastle, Speech Pathol, Newcastle, NSW 2300, Australia; [Togher, Leanne] Univ Sydney, Speech Pathol, Sydney, NSW 2006, Australia; [Steel, Joanne; Ferguson, Alison; Togher, Leanne] NHMRC Clin Ctr Res Excellence Aphasia Rehabil, Brisbane, Qld, Australia	Steel, J (corresponding author), Univ Newcastle, Sch Humanities & Social Sci, Sch Off, 1st Floor,McMullin Bldg, Callaghan Campus, NSW 2308, Australia.	Joanne.Steel@uon.edu.au	Togher, Leanne/AAC-7083-2019; Steel, Joanne/M-2585-2018	Steel, Joanne/0000-0002-5478-5865; Togher, Leanne/0000-0002-4518-6748			Ahmed S, 2000, BRAIN INJURY, V14, P765; American Speech-Language-Hearing Association, 2005, ROL SPEECH LANG PATH; Blyth T, 2012, BRAIN INJURY, V26, P234, DOI 10.3109/02699052.2012.654587; Chabok SY, 2012, NEUROPSYCHOLOGIA, V50, P1444, DOI 10.1016/j.neuropsychologia.2012.02.029; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Coelho Carl, 2005, Seminars in Speech and Language, V26, P223, DOI 10.1055/s-2005-922102; De Guise E, 2005, BRAIN INJURY, V19, P263, DOI 10.1080/02699050400004971; De Monte VE, 2006, BRAIN INJURY, V20, P1345, DOI 10.1080/02699050601082073; Ellis C, 2009, NEUROREHABILITATION, V24, P255, DOI 10.3233/NRE-2009-0476; Goodglass H., 1983, BOSTON DIAGNOSTIC AP; GROHER M, 1977, J SPEECH HEAR RES, V20, P212, DOI 10.1044/jshr.2002.212; GRUEN AK, 1990, J COMMUN DISORD, V23, P163, DOI 10.1016/0021-9924(90)90020-Y; Hagen C, 1980, RANCHO LEVELS COGNIT; Hagen C, 1984, LANGUAGE DISORDERS A, P245; HALPERN H, 1973, J SPEECH HEAR DISORD, V38, P162, DOI 10.1044/jshd.3802.162; Hanks RA, 2008, ARCH PHYS MED REHAB, V89, P950, DOI 10.1016/j.apmr.2008.01.011; Hart RP, 1996, PSYCHOSOMATICS, V37, P533, DOI 10.1016/S0033-3182(96)71517-7; HEILMAN KM, 1971, J NEUROL NEUROSUR PS, V34, P265, DOI 10.1136/jnnp.34.3.265; Jakabek D. D., 2012, THESIS; Joanette Y., 2004, PROTOCOLE MONTREAL E; Kalmar K, 2008, ARCH PHYS MED REHAB, V89, P942, DOI 10.1016/j.apmr.2008.01.008; Katz R, 2002, J MED SPEECH-LANG PA, V10, pix; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; LeBlanc J, 2006, BRAIN INJURY, V20, P1391, DOI 10.1080/02699050601081927; LeBlanc J, 2014, INT J SPEECH-LANG PA, V16, P582, DOI 10.3109/17549507.2013.871335; LeBlanc J, 2014, BRAIN INJURY, V28, P951, DOI 10.3109/02699052.2014.888760; LEVIN HS, 1981, BRAIN LANG, V12, P360, DOI 10.1016/0093-934X(81)90025-0; LEVIN HS, 1976, J NEUROL NEUROSUR PS, V39, P1062, DOI 10.1136/jnnp.39.11.1062; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; MANDLEBERG IA, 1976, J NEUROL NEUROSUR PS, V39, P1001, DOI 10.1136/jnnp.39.10.1001; MANDLEBERG IA, 1975, J NEUROL NEUROSUR PS, V38, P1127, DOI 10.1136/jnnp.38.11.1127; Marosszeky NEV, 1998, PTA PROTOCOL GUIDELI; Marshman LAG, 2013, J CLIN NEUROSCI, V20, P1475, DOI 10.1016/j.jocn.2012.11.022; McGhee H, 2006, BRAIN INJURY, V20, P1307, DOI 10.1080/02699050601081851; Nakase-Richardson R, 2008, J NEUROL NEUROSUR PS, V79, DOI 10.1136/jnnp.2007.127795; Nakase-Richardson R, 2009, NEUROLOGY, V73, P1120, DOI 10.1212/WNL.0b013e3181bacf34; Nakase-Richardson R, 2007, J NEUROL NEUROSUR PS, V78, P872, DOI 10.1136/jnnp.2006.104190; Nakase-Thompson R, 2004, BRAIN INJURY, V18, P131, DOI 10.1080/0269905031000149542; Nilipour R, 1993, PERSIAN APHASIA TEST; Nott MT, 2010, BRAIN INJURY, V24, P1214, DOI 10.3109/02699052.2010.506858; O'Halloran R, 2007, J MED SPEECH-LANG PA, V15, P39; Pastorek NJ, 2004, J INT NEUROPSYCH SOC, V10, P807, DOI 10.1017/S1355617704106012; Paterson A., 1942, LANCET, V240, P717; Pfaff A., 1996, THESIS; Ponsford J, 2014, J HEAD TRAUMA REHAB, V29, P307, DOI 10.1097/HTR.0000000000000074; Ponsford J, 2014, J HEAD TRAUMA REHAB, V29, P321, DOI 10.1097/HTR.0000000000000072; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Porch B.E., 1967, PORCH INDEX COMMUNIC; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; Russell WR, 1932, BRAIN, V55, P549, DOI 10.1093/brain/55.4.549; SARNO MT, 1986, ARCH PHYS MED REHAB, V67, P400; SARNO MT, 1980, J NERV MENT DIS, V168, P685, DOI 10.1097/00005053-198011000-00008; SARNO MT, 1984, J NERV MENT DIS, V172, P475, DOI 10.1097/00005053-198408000-00006; Sherer M, 2005, ARCH PHYS MED REHAB, V86, P896, DOI 10.1016/j.apmr.2004.09.029; Sherer M, 2008, ARCH PHYS MED REHAB, V89, P42, DOI 10.1016/j.apmr.2007.08.128; Sherer M, 2009, ARCH PHYS MED REHAB, V90, P1749, DOI 10.1016/j.apmr.2009.05.011; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Snow P., 2013, TRAUMATIC BRAIN INJU; Steel J, 2013, BRAIN INJURY, V27, P819, DOI 10.3109/02699052.2013.775492; Stuss DT, 1999, J NEUROSURG, V90, P635, DOI 10.3171/jns.1999.90.4.0635; Symonds C., 1943, LANCET, V241, P7, DOI DOI 10.1016/S0140-6736(00)70687-8; Symonds C P, 1937, Proc R Soc Med, V30, P1081; Tate RL, 2001, J HEAD TRAUMA REHAB, V16, P525, DOI 10.1097/00001199-200112000-00002; Tate RL, 2000, J NEUROL NEUROSUR PS, V68, P178, DOI 10.1136/jnnp.68.2.178; Tate R, 2014, J HEAD TRAUMA REHAB, V29, P338, DOI 10.1097/HTR.0000000000000068; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Thomas H, 2003, J HEAD TRAUMA REHAB, V18, P292, DOI 10.1097/00001199-200305000-00007; THOMSEN IV, 1975, J NEUROL NEUROSUR PS, V38, P713, DOI 10.1136/jnnp.38.7.713; Togher L, 2014, J HEAD TRAUMA REHAB, V29, P353, DOI 10.1097/HTR.0000000000000071; Turkstra L, 2005, J MED SPEECH-LANG PA, V13, pIX; Turkstra L., 2003, TECHNICAL REPORT; Valitchka L, 2013, SEMIN SPEECH LANG, V34, P142, DOI 10.1055/s-0033-1358371; van Velzen JM, 2009, BRAIN INJURY, V23, P385, DOI 10.1080/02699050902838165; Velikonja D, 2014, J HEAD TRAUMA REHAB, V29, P369, DOI 10.1097/HTR.0000000000000069; Vukovic M, 2008, J COMMUN DISORD, V41, P531, DOI 10.1016/j.jcomdis.2008.04.001; WEINSTEIN EA, 1963, NEUROPSYCHOLOGIA, V1, P79, DOI 10.1016/0028-3932(63)90001-0; WEINSTEIN EA, 1968, ARCH GEN PSYCHIAT, V18, P348; WEINSTEIN EA, 1971, J PSYCHIATR RES, V8, P439, DOI 10.1016/0022-3956(71)90036-7; WEINSTEIN EA, 1952, AMA ARCH NEUROL PSY, V67, P72, DOI 10.1001/archneurpsyc.1952.02320130078008; Weir N, 2006, BRAIN INJURY, V20, P927, DOI 10.1080/02699050600832684; Wiig E. H., 1988, NEUROPSYCHOLOGICAL S, P186; Wilson BA, 1999, BRAIN INJURY, V13, P505, DOI 10.1080/026990599121412; WILSON BA, 1994, NEUROPSYCHOL REHABIL, V4, P307, DOI 10.1080/09602019408401463; Zangwill O., 1945, BRIT J PSYCHIAT, V91, P322, DOI DOI 10.1192/BJP.91.384.322; Zasler ND, 1997, ARCH PHYS MED REHAB, V78, pS12, DOI 10.1016/S0003-9993(97)90150-7	85	11	11	1	14	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2015	37	2					221	234		10.3233/NRE-151255			14	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	CV9HB	WOS:000364597200007	26484514				2021-06-18	
J	Tzimenatos, L; Kim, E; Kuppermann, N				Tzimenatos, Leah; Kim, Emily; Kuppermann, Nathan			The Pediatric Emergency Care Applied Research Network A History of Multicenter Collaboration in the United States	PEDIATRIC EMERGENCY CARE			English	Article						PECARN; research infrastructure; multicenter collaboration	TRAUMATIC BRAIN-INJURIES; BLUNT HEAD TRAUMA; CHILDREN; SERVICES; DESIGN; SYSTEM; SAFETY; RISK	In this article, we review the history and progress of a large multicenter research network pertaining to emergency medical services for children. We describe the history, organization, infrastructure, and research agenda of the Pediatric Emergency Care Applied Research Network and highlight some of the important accomplishments since its inception. We also describe the network's strategy to grow its research portfolio, train new investigators, and study how to translate new evidence into practice. This strategy ensures not only the sustainability of the network in the future but the growth of research in emergency medical services for children in general.	[Tzimenatos, Leah; Kim, Emily; Kuppermann, Nathan] Univ Calif Davis, Med Ctr, Dept Emergency Med, Sacramento, CA 95817 USA; [Kuppermann, Nathan] Univ Calif Davis, Med Ctr, Dept Pediat, Sacramento, CA 95817 USA	Tzimenatos, L (corresponding author), Univ Calif Davis, Med Ctr, Dept Emergency Med, 2315 Stockton Blvd,PSSB Suite 2100, Sacramento, CA 95817 USA.	leah.tzimenatos@ucdmc.ucdavis.edu					Alessandrini E, 2011, ACAD EMERG MED, V18, P518, DOI 10.1111/j.1553-2712.2011.01057.x; Alessandrini EA, 2012, ACAD EMERG MED, V19, P70, DOI 10.1111/j.1553-2712.2011.01250.x; Alessandrini EA, 2010, ACAD EMERG MED, V17, P204, DOI 10.1111/j.1553-2712.2009.00635.x; Alpern ER, 2006, PEDIATR EMERG CARE, V22, P689, DOI 10.1097/01.pec.0000236830.39194.c0; Badaki-Makun O, 2014, PEDIATR BLOOD CANCER, V61, P1049, DOI 10.1002/pbc.24925; Chamberlain JM, 2014, JAMA-J AM MED ASSOC, V311, P1652, DOI 10.1001/jama.2014.2625; Chamberlain JM, 2013, PEDIATR EMERG CARE, V29, P125, DOI 10.1097/PEC.0b013e31828043a5; Corneli HM, 2007, NEW ENGL J MED, V357, P331, DOI 10.1056/NEJMoa071255; Dalziel SR, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4836; Dayan P, 2006, CLIN PEDIATR EMERG M, V7, P128, DOI 10.1016/j.cpem.2006.03.006; Dayan PS, 2014, ANN EMERG MED, V64, P153, DOI 10.1016/j.annemergmed.2014.02.003; Dayan PS, 2014, ANN EMERG MED, V63, P657, DOI 10.1016/j.annemergmed.2014.01.009; Deakyne SJ, 2013, HARMONIZING EHR DATA; Glaser NS, 2013, PEDIATR DIABETES, V14, P435, DOI 10.1111/pedi.12027; Goldkind Sara F, 2014, IRB, V36, P1; Gorelick MH, 2007, ACAD EMERG MED, V14, P646, DOI 10.1197/j.aem.2007.03.1357; Gorelick MH, 2005, ACAD EMERG MED, V12, P1195, DOI 10.1197/j.aem.2005.06.028; Holmes JF, 2013, ANN EMERG MED, V62, P107, DOI 10.1016/j.annemergmed.2012.11.009; Klassen TP, 2010, PEDIATR EMERG CARE, V26, P541, DOI 10.1097/PEC.0b013e3181e5bec1; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lee LK, 2014, JAMA PEDIATR, V168, P837, DOI 10.1001/jamapediatrics.2014.361; Leonard JC, 2011, ANN EMERG MED, V58, P145, DOI 10.1016/j.annemergmed.2010.08.038; Mahajan P, PEDIAT EMER IN PRESS; Mahajan P, 2012, RNA TRANSCRIPTIONAL; Miller SZ, 2008, ACAD EMERG MED, V15, P377, DOI 10.1111/j.1553-2712.2008.00072.x; Mintegi S, 2014, INT EPIDEMIOLOGICAL; Moler FW, 2013, PEDIATR CRIT CARE ME, V14, pE304, DOI 10.1097/PCC.0b013e31828a863a; Nigrovic LE, 2012, ARCH PEDIAT ADOL MED, V166, P356, DOI 10.1001/archpediatrics.2011.1156; Pediat Emergency Care Applied Res, 2003, ACAD EMERG MED, V10, P661; Shaw KN, 2013, EMERG MED J, V30, P815, DOI 10.1136/emermed-2012-201642; Shaw KN, 2009, PEDIATRICS, V124, P485, DOI 10.1542/peds.2008-2858; Sheehan B, 2013, J BIOMED INFORM, V46, P905, DOI 10.1016/j.jbi.2013.07.005; Stanley RM, 2007, ACAD EMERG MED, V14, P532, DOI 10.1197/j.aem.2007.01.016	33	11	11	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	JAN	2015	31	1					70	76		10.1097/PEC.0000000000000303			7	Emergency Medicine; Pediatrics	Emergency Medicine; Pediatrics	AY2NK	WOS:000347426700017	25560626				2021-06-18	
J	Velazquez, A; Ortega, M; Rojas, S; Gonzalez-Olivan, FJ; Rodriguez-Baeza, A				Velazquez, Antonio; Ortega, Marisa; Rojas, Santiago; Javier Gonzalez-Olivan, Francisco; Rodriguez-Baeza, Alfonso			Widespread microglial activation in patients deceased from traumatic brain injury	BRAIN INJURY			English	Article						Human; microglial activation; traumatic brain injury; Ricinus communis lectin	PARENCHYMAL MICROGLIA/MACROPHAGES; REGIONAL VULNERABILITY; PARKINSONS-DISEASE; EXPRESSION; INFLAMMATION; MONOCYTES; CELLS; MICE; CNS; STIMULATION	Primary objective: The role of microglial activation in traumatic brain injury (TBI) has been extensively described in established animal models. In contrast, very few studies have analysed this process in human patients, the majority being focused on the local reaction in the contused parenchyma. In this work, the main objective was the analysis of microglial activation in brain regions distant from the primary lesion. Research design: Morphological changes of microglia were evaluated in the cerebral cortex of patients deceased from TBI in comparison with control subjects. Methods and procedures: Cortical samples from five cases with TBI and 10 controls were evaluated using Ricinus communis lectin histochemistry and conventional Hematoxylin- eosin staining. Main outcomes and results: It was observed that microglial cells from patients with TBI presented shorter and thicker cellular projections compared with controls. Moreover, the percentage of histological area reactive to lectin was statistically higher in samples from subjects with TBI. These signs of microglial activation were observed in all of the analysed cortical areas, thus indicating a generalized effect on the whole cerebral cortex. The results are consistent with previous imaging PET studies performed in living patients with the C-11-PK11195 radiotracer. Conclusions: The findings indicate that TBI induces a widespread activation of brain microglia which affects all cortical areas, including those distant from the contusion site.	[Velazquez, Antonio; Ortega, Marisa; Rojas, Santiago; Rodriguez-Baeza, Alfonso] Univ Autonoma Barcelona, Fac Med, Dept Ciencias Morfol, E-08193 Barcelona, Spain; [Ortega, Marisa; Javier Gonzalez-Olivan, Francisco] Inst Med Legal Cataluna, Barcelona, Spain	Rodriguez-Baeza, A (corresponding author), Univ Autonoma Barcelona, Fac Med, Unit Human Anat, E-08193 Barcelona, Spain.	alfonso.rodriguez@uab.es	sanchez, marisa ortega/AAB-2253-2019; Rodriguez Baeza, Alfonso/L-8284-2014	sanchez, marisa ortega/0000-0003-0764-1452; Rodriguez Baeza, Alfonso/0000-0002-9181-5613	Fondo de Investigaciones Sanitarias Instituto Carlos IIIInstituto de Salud Carlos III [01/0008-01]	The study is financially supported by Fondo de Investigaciones Sanitarias Instituto Carlos III (01/0008-01).	Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Beschorner R, 2002, J NEUROIMMUNOL, V126, P107, DOI 10.1016/S0165-5728(02)00046-2; Beschorner R, 2002, ACTA NEUROPATHOL, V103, P541, DOI 10.1007/s00401-001-0503-7; Boche D, 2013, NEUROPATH APPL NEURO, V39, P3, DOI 10.1111/nan.12011; Castejon OJ, 1997, BRAIN INJURY, V11, P363, DOI 10.1080/026990597123520; Elliott MB, 2011, J NEUROTRAUM, V28, P973, DOI 10.1089/neu.2010.1672; Engel S, 2000, ACTA NEUROPATHOL, V100, P313, DOI 10.1007/s004019900172; Fenn AM, 2012, BRAIN BEHAV IMMUN, V26, P766, DOI 10.1016/j.bbi.2011.10.003; Folkersma H, 2011, J NUCL MED, V52, P1235, DOI 10.2967/jnumed.110.084061; Graeber MB, 2011, FEBS LETT, V585, P3798, DOI 10.1016/j.febslet.2011.08.033; Haselkorn ML, 2010, J NEUROTRAUM, V27, P901, DOI 10.1089/neu.2009.1075; Homsi S, 2010, J NEUROTRAUM, V27, P911, DOI 10.1089/neu.2009.1223; Igarashi T, 2001, EXP NEUROL, V172, P332, DOI 10.1006/exnr.2001.7820; Ito S, 2007, EXP GERONTOL, V42, P532, DOI 10.1016/j.exger.2006.11.012; James ML, 2012, ANESTHESIOLOGY, V116, P1299, DOI 10.1097/ALN.0b013e318253a02a; Kim YS, 2006, EXP MOL MED, V38, P333, DOI 10.1038/emm.2006.40; Luheshi NM, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-186; Nakajima K, 2007, NEUROCHEM INT, V50, P807, DOI 10.1016/j.neuint.2007.02.006; Oehmichen M., 2009, Legal Medicine, V11, P118, DOI 10.1016/j.legalmed.2008.11.003; Polazzi E, 2010, PROG NEUROBIOL, V92, P293, DOI 10.1016/j.pneurobio.2010.06.009; Prinz M, 2011, GLIA, V59, P177, DOI 10.1002/glia.21104; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Reijerkerk A, 2012, J NEUROCHEM, V121, P730, DOI 10.1111/j.1471-4159.2011.07393.x; Saijo K, 2011, NAT REV IMMUNOL, V11, P775, DOI 10.1038/nri3086; Schnell L, 1999, EUR J NEUROSCI, V11, P3648, DOI 10.1046/j.1460-9568.1999.00792.x; Shavali S, 2006, NEUROCHEM RES, V31, P85, DOI 10.1007/s11064-005-9233-x; Taylor DL, 2005, J NEUROSCI, V25, P2952, DOI 10.1523/JNEUROSCI.4456-04.2005; Tong W, 2002, EXP NEUROL, V176, P105, DOI 10.1006/exnr.2002.7941; Van Den Heuvel C, 2007, PROG BRAIN RES, V161, P303, DOI 10.1016/S0079-6123(06)61021-2; Voss EV, 2012, NEUROBIOL DIS, V45, P519, DOI 10.1016/j.nbd.2011.09.008	30	11	12	0	7	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2015	29	9					1126	1133		10.3109/02699052.2015.1018325			8	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	CR1UG	WOS:000361110000013	26067626				2021-06-18	
J	Jacqmain, J; Nudi, ET; Fluharty, S; Smith, JS				Jacqmain, Justin; Nudi, Evan T.; Fluharty, Sarah; Smith, Jeffrey S.			Pre and post-injury environmental enrichment effects functional recovery following medial frontal cortical contusion injury in rats	BEHAVIOURAL BRAIN RESEARCH			English	Article						TBI; Behavior; Neuroplasticity; Rat	TRAUMATIC BRAIN-INJURY; MORRIS WATER MAZE; PREFRONTAL CORTEX; COGNITIVE DEFICITS; CELL-PROLIFERATION; NERVOUS-SYSTEM; ANIMAL-MODELS; ADULT-RATS; OPEN-FIELD; INCREASES	The rodent has been the preferred research model for evaluating the mechanisms related to, and potential treatments for, traumatic brain injury (TB!). Many therapies previously determined to be effective in preclinical investigations have failed to show the same effectiveness in clinical trials. The environment a rodent is housed in plays an important role in brain and behavioral development. Housing rodents in non-enriched environments significantly alters the development of the rodent brain and its behavioral profile, negatively impacting the ecological validity of the rodent model. This investigation employed 113 male Long-Evans rats assigned to either an enriched environment (EE) or standard environment (SE) from post-natal day 25. At four months of age, rats received either a controlled cortical impact (CCI) to the medial frontal cortex (mFC) or sham injury. Rats assigned to EE or SE pre-injury were re-assigned to remain in, or switch to, EE or SE post-injury. The open-field test (OFT), vermicelli handling test (VHT) Morris water maze (MWM), and rotor-rod (RR), were used to evaluate the animals response to TBI. The data from the current investigation indicates that the performance of TBI rats assigned to pre-injury EE was improved on the MWM compared to the TBI rats assigned to pre-injury SE. However, those that were reared in the EE performed better on the MWM if placed into a SE post-injury as compared to those placed into the EE after insult. The TBI and sham groups that were raised, and remained, in the SE performed worse than any of the EE groups on the RR. TBI rats that were placed in the EE had larger cortices and more cells in the hippocampus than the TBI rats housed in the SE. These data strongly suggest that the pre-injury housing environment should be considered as investigators refine pre-clinical models of TBI. (C) 2014 Elsevier B.V. All rights reserved.	[Jacqmain, Justin; Nudi, Evan T.; Fluharty, Sarah; Smith, Jeffrey S.] Saginaw Valley State Univ, Brain Res Lab, University Ctr, MI 48710 USA	Smith, JS (corresponding author), Saginaw Valley State Univ, Malcolm & Lois Field Endowed Chair Hlth Sci, Dept Hlth Sci, Crystal M Lange Coll Hlth & Human Serv, 7400 Bay Rd, University Ctr, MI 48710 USA.	jmjacqma@svsu.edu; etnudi@svsu.edu; snfluhar@svsu.edu; jsmith12@svsu.edu		Smith, Jeffrey/0000-0001-5499-4475	Saginaw Valley State University Student Research and Creativity Institute	Both JJ and EN contributed equally to the development of this manuscript. This work was supported by funding from the Saginaw Valley State University Student Research and Creativity Institute. The authors would like to thank Jacob Dunkerson, Kasey Moritz, David Mudd, Garrick Salois, Madeleine Searles, Robert Underly, and Jennica Young for their help with animal care and assistance throughout the course of the study.	Adekoya Nelson, 2002, MMWR Surveill Summ, V51, P1; Allred RP, 2008, J NEUROSCI METH, V170, P229, DOI 10.1016/j.jneumeth.2008.01.015; Champion HR, 2009, J TRAUMA, V66, P1468, DOI 10.1097/TA.0b013e3181a27e7f; COGGESHALL RE, 1992, TRENDS NEUROSCI, V15, P9, DOI 10.1016/0166-2236(92)90339-A; COOPER RM, 1958, CAN J PSYCHOLOGY, V12, P159, DOI 10.1037/h0083747; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Crane AT, 2012, RESTOR NEUROL NEUROS, V30, P325, DOI 10.3233/RNN-2012-120232; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; DENENBERG VH, 1969, ANN NY ACAD SCI, V159, P852, DOI 10.1111/j.1749-6632.1969.tb12983.x; DIAMOND MC, 1966, J COMP NEUROL, V128, P117, DOI 10.1002/cne.901280110; DIAMOND MC, 1964, J COMP NEUROL, V123, P111, DOI 10.1002/cne.901230110; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Finnie JW, 2002, VET PATHOL, V39, P679, DOI 10.1354/vp.39-6-679; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Garner JP, 2002, BEHAV BRAIN RES, V136, P83, DOI 10.1016/S0166-4328(02)00111-0; Gold EM, 2013, REGEN MED, V8, P483, DOI 10.2217/rme.13.41; GRABOWSKI M, 1995, EXP NEUROL, V133, P96, DOI 10.1006/exnr.1995.1011; GREENOUGH WT, 1973, EXP NEUROL, V40, P491, DOI 10.1016/0014-4886(73)90090-3; Griesbach GS, 2007, J NEUROTRAUM, V24, P1161, DOI 10.1089/neu.2006.0255; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; HELD JM, 1985, BEHAV NEUROSCI, V99, P678, DOI 10.1037/0735-7044.99.4.678; Johansson BB, 1996, STROKE, V27, P324, DOI 10.1161/01.STR.27.2.324; Kabadi SV, 2014, INT J MOL SCI, V15, P1216, DOI 10.3390/ijms15011216; KATZ HB, 1984, EXP NEUROL, V83, P274, DOI 10.1016/0014-4886(84)90098-0; Kleim JA, 1996, J NEUROSCI, V16, P4529; Kline AE, 2007, BEHAV BRAIN RES, V177, P186, DOI 10.1016/j.bbr.2006.11.036; KOLB B, 1982, BEHAV BRAIN RES, V6, P365, DOI 10.1016/0166-4328(82)90018-3; KOLB B, 1983, CAN J PSYCHOL, V37, P211, DOI 10.1037/h0080724; Kolb B., 2013, CORTEX; Komitova M, 2005, STROKE, V36, P1278, DOI 10.1161/01.STR.0000166197.94147.59; Kozlowski DA, 2004, J NEUROTRAUM, V21, P513, DOI 10.1089/089771504774129856; KRECH D, 1966, PHYSIOL BEHAV, V1, P99, DOI 10.1016/0031-9384(66)90051-5; Landers MS, 2011, NEUROSCIENCE, V199, P143, DOI 10.1016/j.neuroscience.2011.10.040; Larsson F, 2002, PHARMACOL BIOCHEM BE, V73, P193, DOI 10.1016/S0091-3057(02)00782-7; Laviola G, 2008, NEUROBIOL DIS, V31, P159, DOI 10.1016/j.nbd.2008.05.001; Matter AM, 2011, NEUROREHAB NEURAL RE, V25, P558, DOI 10.1177/1545968310397206; MISSLIN R, 1986, BEHAV PROCESS, V12, P45, DOI 10.1016/0376-6357(86)90069-0; MOHAMMED AK, 1986, BRAIN RES, V398, P6, DOI 10.1016/0006-8993(86)91243-6; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; OWENS DGC, 1982, ARCH GEN PSYCHIAT, V39, P452; Passineau MJ, 2001, EXP NEUROL, V168, P373, DOI 10.1006/exnr.2000.7623; PAYLOR R, 1992, BEHAV BRAIN RES, V52, P49, DOI 10.1016/S0166-4328(05)80324-9; Peruzzaro ST, 2013, RESTOR NEUROL NEUROS, V31, P431, DOI 10.3233/RNN-120299; Peterson TC, 2012, J NEUROTRAUM, V29, P2823, DOI 10.1089/neu.2012.2471; Piao CS, 2013, NEUROBIOL DIS, V54, P252, DOI 10.1016/j.nbd.2012.12.017; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Pinaud R, 2004, INT J NEUROSCI, V114, P321, DOI 10.1080/00207450490264142; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Ragozzino ME, 1999, J NEUROSCI, V19, P4585; Renner M.J., 1987, ENRICHED IMPOVERISHE; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; Shaw CL, 2013, BEHAV BRAIN RES, V236, P94, DOI 10.1016/j.bbr.2012.08.024; Smith JS, 2000, NEURAL PLAST, V7, P73, DOI 10.1155/NP.2000.73; Sozda CN, 2010, J NEUROTRAUM, V27, P1047, DOI 10.1089/neu.2010.1313; Spolidoro M, 2009, EXP BRAIN RES, V192, P335, DOI 10.1007/s00221-008-1509-3; SUTTON RL, 1993, J NEUROTRAUM, V10, P135, DOI 10.1089/neu.1993.10.135; Tennant KA, 2010, J VIS EXP, P41; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; van Praag H, 1999, NAT NEUROSCI, V2, P266; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Vink R, 2003, NEUROSCI LETT, V336, P41, DOI 10.1016/S0304-3940(02)01244-2; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; WALSH RN, 1969, J COMP NEUROL, V137, P361, DOI 10.1002/cne.901370309; Wang RY, 2001, BRAIN RES, V922, P140, DOI 10.1016/S0006-8993(01)03154-7; Wiedenmayer C, 1997, ANIM BEHAV, V53, P461, DOI 10.1006/anbe.1996.0296; Wright RL, 2008, BEHAV BRAIN RES, V187, P41, DOI 10.1016/j.bbr.2007.08.025; Wurbel H, 2001, TRENDS NEUROSCI, V24, P207, DOI 10.1016/S0166-2236(00)01718-5; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407	73	11	12	0	19	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	DEC 15	2014	275						201	211		10.1016/j.bbr.2014.08.056			11	Behavioral Sciences; Neurosciences	Behavioral Sciences; Neurosciences & Neurology	AS7IX	WOS:000344431100027	25196632				2021-06-18	
J	Edut, S; Rubovitch, V; Rehavi, M; Schreiber, S; Pick, CG				Edut, S.; Rubovitch, V.; Rehavi, M.; Schreiber, S.; Pick, C. G.			A Study on the Mechanism by Which MDMA Protects Against Dopaminergic Dysfunction After Minimal Traumatic Brain Injury (mTBI) in Mice	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						Traumatic brain injury; MDMA; Mice; Tyrosine hydroxylase; BDNF	SPATIAL WORKING-MEMORY; NECROSIS-FACTOR-ALPHA; TYROSINE-HYDROXYLASE; PREFRONTAL CORTEX; BEHAVIORAL RECOVERY; COGNITIVE DEFICITS; ATTENTION DEFICITS; FRONTAL-CORTEX; D2 RECEPTORS; BDNF	Driving under methylenedioxymethamphetamine (MDMA) influence increases the risk of being involved in a car accident, which in turn can lead to traumatic brain injury. The behavioral deficits after traumatic brain injury (TBI) are closely connected to dopamine pathway dysregulation. We have previously demonstrated in mice that low MDMA doses prior to mTBI can lead to better performances in cognitive tests. The purpose of this study was to assess in mice the changes in the dopamine system that occurs after both MDMA and minimal traumatic brain injury (mTBI). Experimental mTBI was induced using a concussive head trauma device. One hour before injury, animals were subjected to MDMA. Administration of MDMA before injury normalized the alterations in tyrosine hydroxylase (TH) levels that were observed in mTBI mice. This normalization was also able to lower the elevated dopamine receptor type 2 (D-2) levels observed after mTBI. Brain-derived neurotrophic factor (BDNF) levels did not change following injury alone, but in mice subjected to MDMA and mTBI, significant elevations were observed. In the behavioral tests, haloperidol reversed the neuroprotection seen when MDMA was administered prior to injury. Altered catecholamine synthesis and high D-2 receptor levels contribute to cognitive dysfunction, and strategies to normalize TH signaling and D-2 levels may provide relief for the deficits observed after injury. Pretreatment with MDMA kept TH and D-2 receptor at normal levels, allowing regular dopamine system activity. While the beneficial effect we observe was due to a dangerous recreational drug, understanding the alterations in dopamine and the mechanism of dysfunction at a cellular level can lead to legal therapies and potential candidates for clinical use.	[Edut, S.; Rubovitch, V.; Pick, C. G.] Tel Aviv Univ, Dept Anat & Anthropol, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Rehavi, M.] Tel Aviv Univ, Dept Physiol & Pharmacol, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Schreiber, S.] Tel Aviv Univ, Dept Psychiat, Tel Aviv Sourasky Med Ctr, Sackler Fac Med, IL-69978 Tel Aviv, Israel	Edut, S (corresponding author), Tel Aviv Univ, Dept Anat & Anthropol, Sackler Fac Med, IL-69978 Tel Aviv, Israel.	eshaha12@campus.haifa.ac.il; rubovitc@post.tau.ac.il; mrehavi@post.tau.ac.il; shaulsch@tlvmc.gov.il; pickc@post.tau.ac.il	Pick, Chaim/D-4789-2009; Schreiber, Shaul/E-5821-2010	Schreiber, Shaul/0000-0002-2189-0693	Dr. Herman Schauder Endowment Fund for Research; Dr. Miriam and Sheldon G. Adelson Center for the Biology of Addictive Diseases, Tel Aviv University, Tel Aviv, Israel	This study was supported (in part) by a grant from the Dr. Herman Schauder Endowment Fund for Research and by a grant from The Dr. Miriam and Sheldon G. Adelson Center for the Biology of Addictive Diseases, Tel Aviv University, Tel Aviv, Israel. We would like to thank Netta Roz for her expert technical assistance in the dopamine type 2 receptor binding assay and analyses.	Ahmed R. H., 2010, Society for Neuroscience Abstract Viewer and Itinerary Planner, V40; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Assaf F, 2011, BEHAV BRAIN RES, V220, P194, DOI 10.1016/j.bbr.2011.02.005; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Baratz R, 2010, J NEUROTRAUM, V27, P555, DOI 10.1089/neu.2009.0891; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Beaulieu JM, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00038; Bullinger M, 2002, RESTOR NEUROL NEUROS, V20, P111; Camarero J, 2002, J NEUROCHEM, V81, P961, DOI 10.1046/j.1471-4159.2002.00879.x; Cassol OJ, 2011, J NEUROIMMUNOL, V230, P48, DOI 10.1016/j.jneuroim.2010.08.026; Connor B, 1998, BRAIN RES REV, V27, P1, DOI 10.1016/S0165-0173(98)00004-6; Connor TJ, 2000, LIFE SCI, V67, P1601, DOI 10.1016/S0024-3205(00)00743-8; Connor TJ, 2005, J PHARMACOL EXP THER, V312, P134, DOI 10.1124/jpet.104.073023; Cools R, 2011, BIOL PSYCHIAT, V69, pE113, DOI 10.1016/j.biopsych.2011.03.028; DAVIS KL, 1991, AM J PSYCHIAT, V148, P1474; DELLU F, 1992, BRAIN RES, V588, P132, DOI 10.1016/0006-8993(92)91352-F; Di Cara B, 2011, J NEUROSCI, V31, P16928, DOI 10.1523/JNEUROSCI.2502-11.2011; Dix SL, 1999, BEHAV BRAIN RES, V99, P191, DOI 10.1016/S0166-4328(98)00079-5; Dixon CE, 1999, RESTOR NEUROL NEUROS, V14, P285; Edut S, 2011, PSYCHOPHARMACOLOGY, V214, P877, DOI 10.1007/s00213-010-2098-y; Gerstenbrand F, 2001, BRAIN INJURY, V15, P95; Granado N, 2008, J NEUROCHEM, V107, P1102, DOI 10.1111/j.1471-4159.2008.05705.x; Granado N, 2011, NEUROBIOL DIS, V42, P391, DOI 10.1016/j.nbd.2011.01.033; Green AR, 2003, PHARMACOL REV, V55, P463, DOI 10.1124/pr.55.3.3; Griesbach GS, 2009, BRAIN RES, V1288, P105, DOI 10.1016/j.brainres.2009.06.045; Griesbach GS, 2009, J NEUROSCI RES, V87, P795, DOI 10.1002/jnr.21893; Haavik J, 1998, MOL NEUROBIOL, V16, P285, DOI 10.1007/BF02741387; HAMM RJ, 1993, BEHAV BRAIN RES, V59, P169, DOI 10.1016/0166-4328(93)90164-L; Han XG, 2011, NEUROSCI LETT, V487, P255, DOI 10.1016/j.neulet.2010.09.007; HEWITT KE, 1994, NEUROPHARMACOLOGY, V33, P1589, DOI 10.1016/0028-3908(94)90134-1; Hoffman AN, 2008, LIFE SCI, V83, P602, DOI 10.1016/j.lfs.2008.08.007; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Hutson CB, 2011, J NEUROTRAUM, V28, P1783, DOI 10.1089/neu.2010.1723; Kaplan GB, 2010, BEHAV PHARMACOL, V21, P427, DOI 10.1097/FBP.0b013e32833d8bc9; Kehagia AA, 2010, CURR OPIN NEUROBIOL, V20, P199, DOI 10.1016/j.conb.2010.01.007; Kellendonk C, 2006, NEURON, V49, P603, DOI 10.1016/j.neuron.2006.01.023; Kline AE, 2002, J NEUROTRAUM, V19, P415, DOI 10.1089/08977150252932370; Kline AE, 2004, J NEUROTRAUM, V21, P1712, DOI 10.1089/0897715042664849; Kline AE, 2008, NEUROSCI LETT, V448, P263, DOI 10.1016/j.neulet.2008.10.076; Kobori N, 2006, J NEUROTRAUM, V23, P1094, DOI 10.1089/neu.2006.23.1094; Li BJ, 2010, EUR J PHARMACOL, V628, P104, DOI 10.1016/j.ejphar.2009.11.036; Li YC, 2011, P NATL ACAD SCI USA, V108, P12107, DOI 10.1073/pnas.1109718108; Li YC, 2011, NEUROSCI BIOBEHAV R, V35, P645, DOI 10.1016/j.neubiorev.2010.08.001; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Ma X., 2000, Journal of Neurotrauma, V17, P951; MCINTOSH TK, 1994, J NEUROCHEM, V63, P1426; Mehta MA, 2005, PSYCHOPHARMACOLOGY, V180, P654, DOI 10.1007/s00213-004-2128-8; Meisner F, 2008, NEUROPSYCHOPHARMACOL, V33, P2228, DOI 10.1038/sj.npp.1301615; Messier C, 1997, NEUROBIOL LEARN MEM, V67, P172, DOI 10.1006/nlme.1996.3755; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Pan WH, 2003, EXP BRAIN RES, V149, P195, DOI 10.1007/s00221-002-1355-7; Prigatano GP, 2011, CURR OPIN PSYCHIATR, V24, P243, DOI 10.1097/YCO.0b013e328344698b; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Savitz J, 2006, GENES BRAIN BEHAV, V5, P311, DOI 10.1111/j.1601-183X.2005.00163.x; SCHMIDT CJ, 1990, EUR J PHARMACOL, V181, P59, DOI 10.1016/0014-2999(90)90245-2; Seeman P, 2006, SYNAPSE, V60, P319, DOI 10.1002/syn.20303; Shin S. S., 2010, Society for Neuroscience Abstract Viewer and Itinerary Planner, V40; Shin SS, 2011, BRAIN RES, V1369, P208, DOI 10.1016/j.brainres.2010.10.096; Sil'kis I G, 2002, Neurosci Behav Physiol, V32, P205, DOI 10.1023/A:1015093619476; Simpson EH, 2010, NEURON, V65, P585, DOI 10.1016/j.neuron.2010.02.014; Sumi-Ichinose C, 2010, J PHARMACOL SCI, V114, P17, DOI 10.1254/jphs.09R28FM; Takahashi H, 2006, BIOL PSYCHIAT, V59, P919, DOI 10.1016/j.biopsych.2006.01.022; Tang YP, 1997, EUR J NEUROSCI, V9, P1720, DOI 10.1111/j.1460-9568.1997.tb01529.x; Taniguchi N, 2006, NEUROSCI LETT, V406, P38, DOI 10.1016/j.neulet.2006.06.071; Tio DL, 2011, J NEUROTRAUM, V28, pA80; Valjent E, 2011, NEUROPSYCHOPHARMACOL, V36, P2561, DOI 10.1038/npp.2011.144; Wagner AK, 2005, J NEUROCHEM, V95, P457, DOI 10.1111/j.1471-4159.2005.03382.x; Wagner AK, 2005, EXP NEUROL, V195, P475, DOI 10.1016/j.expneurol.2005.06.009; Wagner AK, 2007, BEHAV BRAIN RES, V181, P200, DOI 10.1016/j.bbr.2007.04.006; Wagner AK, 2007, J NEUROSURG, V106, P538, DOI 10.3171/jns.2007.106.4.538; Wagner AK, 2009, J NEUROCHEM, V108, P986, DOI 10.1111/j.1471-4159.2008.05840.x; WEINBERGER DR, 1988, ARCH GEN PSYCHIAT, V45, P609; Whyte J, 2006, BRAIN COGNITION, V60, P191; Whyte J, 2004, AM J PHYS MED REHAB, V83, P401, DOI 10.1097/01.PHM.0000128789.75375.D3; Williams WH, 2010, J NEUROL NEUROSUR PS, V81, P1116, DOI 10.1136/jnnp.2008.171298; WOTHERSPOON G, 1994, MOL BRAIN RES, V25, P34, DOI 10.1016/0169-328X(94)90275-5; Wu HT, 2008, J NEUROTRAUM, V25, P130, DOI 10.1089/neu.2007.0369; Yamada K, 2003, J PHARMACOL SCI, V91, P267; Yan HO, 2004, J NEUROTRAUM, V21, P1338; Yan HQ, 2007, BRAIN RES, V1134, P171, DOI 10.1016/j.brainres.2006.11.087; Yan HQ, 2002, NEUROREPORT, V13, P1899, DOI 10.1097/00001756-200210280-00013; Yan HQ, 2001, NEUROREPORT, V12, P2323, DOI 10.1097/00001756-200108080-00009; Yan HQ, 2007, J NEUROTRAUMA, V24, pP182; Zhan LX, 2010, J NEUROCHEM, V114, P897, DOI 10.1111/j.1471-4159.2010.06816.x; Zhang HX, 2003, NEUROL RES, V25, P471; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4	88	11	12	0	7	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.	DEC	2014	54	4					684	697		10.1007/s12031-014-0399-z			14	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	AW0PP	WOS:000345995700010	25124230				2021-06-18	
J	Karnatovskaia, LV; Lee, AS; Festic, E; Kramer, CL; Freeman, WD				Karnatovskaia, Lioudmila V.; Lee, Augustine S.; Festic, Emir; Kramer, Christopher L.; Freeman, William D.			Effect of Prolonged Therapeutic Hypothermia on Intracranial Pressure, Organ Function, and Hospital Outcomes Among Patients with Aneurysmal Subarachnoid Hemorrhage	NEUROCRITICAL CARE			English	Article						Subarachnoid hemorrhage; Targeted temperature management; Therapeutic hypothermia; Global cerebral edema; Intracranial pressure; Decompressive hemicraniectomy	RESPIRATORY-DISTRESS-SYNDROME; TRAUMATIC BRAIN-INJURY; GLOBAL CEREBRAL EDEMA; SEVERE HEAD-INJURY; ACUTE LUNG INJURY; DECOMPRESSIVE HEMICRANIECTOMY; INTRACEREBRAL HEMORRHAGE; MILD HYPOTHERMIA; COMPLICATIONS; HYPERTENSION	Global cerebral edema (GCE) with subsequent refractory intracranial hypertension complicates some cases of aneurysmal subarachnoid hemorrhage (aSAH), and typically is associated with poorer outcome. Treatment options for refractory intracranial pressure (ICP) cases are limited to decompressive hemicraniectomy (DHC) and targeted temperature management (TTM) with induced hypothermia (32-34 A degrees C). No outcomes comparison between patients treated with either or both forms of refractory ICP therapy exists, and data on the effect of prolonged hypothermia on ICP and organ function among patients with aSAH are limited. This is a retrospective study of aSAH patients who underwent DHC and/or prolonged hypothermia (greater than 48 h) for refractory ICP (i.e., ICP > 20 mmHg after osmotherapy) in the intensive care unit of a single, tertiary-care academic center. Nineteen individuals with aSAH underwent TTM with or without DHC; sixteen patients underwent DHC alone. The patients in TTM group were younger (median age 44 years) than the DHC without TTM population (median age 60 years). TTM was started on median day 2 with a median duration of 7 days. There were no significant group differences in survival to discharge (59 % vs. 69 %) or in the mean modified Rankin score on follow-up (3.6 vs. 3.7), despite the TTM group having longer hospital length of stay (24 vs. 19 days, p = 0.03), longer duration of mechanical ventilation (20 vs. 9 days, p = 0.04), a higher cumulative fluid balance (12.8 vs. 5.1 L, p = 0.01), and higher APACHEII scores. The median maximal ICP decreased from 23.5 to 21 mmHg within 24 h of hypothermia initiation. There were no significant differences in other markers of end-organ function (respiratory, hematologic, renal, liver, and cardiac), infection rate, or adverse events between groups. Use of prolonged TTM among aSAH patients with GCE and refractory ICP elevations is associated with a longer duration of mechanical ventilation but is not different in terms of neurological outcomes measured by modified Rankin score or organ function outcomes compared to patients who received DHC alone.	[Karnatovskaia, Lioudmila V.; Lee, Augustine S.; Festic, Emir] Mayo Clin, Dept Pulm & Crit Care Med, Jacksonville, FL 32224 USA; [Kramer, Christopher L.] Mayo Clin, Dept Neurol, Rochester, MA USA; [Freeman, William D.] Mayo Clin, Dept Neurol, Jacksonville, FL 32224 USA	Karnatovskaia, LV (corresponding author), Mayo Clin, Dept Pulm & Crit Care Med, 4500 San Pablo Rd,Davis Bldg E-7A, Jacksonville, FL 32224 USA.	karnatovskaia.lioudmila@mayo.edu		Freeman, M.D., William D./0000-0003-2326-0633			Andrews PJD, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-8; Anei R, 2010, NEUROL MED-CHIR, V50, P879, DOI 10.2176/nmc.50.879; Bratton SL, 1997, NEUROSURGERY, V40, P707, DOI 10.1097/00006123-199704000-00009; Burger CD, 2006, MAYO CLIN PROC, V81, P849, DOI 10.4065/81.6.849; Claassen J, 2002, STROKE, V33, P1225, DOI 10.1161/01.STR.0000015624.29071.1F; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; D'Ambrosio AL, 2005, NEUROSURGERY, V56, P12, DOI 10.1227/01.NEU.0000144820.38439.63; Dorfer C, 2010, WORLD NEUROSURG, V74, P465, DOI 10.1016/j.wneu.2010.08.001; Duan M, 2011, RESP CARE, V56, P1956, DOI 10.4187/respcare.01211; Gasser S, 2003, J NEUROSURG ANESTH, V15, P240, DOI 10.1097/00008506-200307000-00012; Heuer GG, 2004, J NEUROSURG, V101, P408, DOI 10.3171/jns.2004.101.3.0408; Hoesch RE, 2012, CRIT CARE MED, V40, P587, DOI 10.1097/CCM.0b013e3182329617; Kamps M, 2011, CRIT CARE, V15, DOI 10.1186/cc10012; Kollmar R, 2010, STROKE, V41, P1684, DOI 10.1161/STROKEAHA.110.587758; Kreiter KT, 2002, STROKE, V33, P200, DOI 10.1161/hs0102.101080; le Roux AA, 2010, NEUROSURG CLIN N AM, V21, P235, DOI 10.1016/j.nec.2009.10.014; Mourand I, 2012, J NEUROL SCI, V316, P104, DOI 10.1016/j.jns.2012.01.014; Murakami M, 2007, NEUROL MED-CHIR, V47, P116, DOI 10.2176/nmc.47.116; Nagao S, 2000, ACT NEUR S, V76, P547; Ng H Kee, 2009, J Vasc Interv Neurol, V2, P142; Nunnally ME, 2011, CRIT CARE MED, V39, P1113, DOI 10.1097/CCM.0b013e318206bab2; Petridis AK, 2010, ACTA NEUROCHIR, V152, P2143, DOI 10.1007/s00701-010-0761-z; Pillai S, 2004, NEUROL INDIA, V52, P67; Polderman KH, 2009, CRIT CARE MED, V37, pS186, DOI 10.1097/CCM.0b013e3181aa5241; Polderman KH, 2009, CRIT CARE MED, V37, P1101, DOI 10.1097/CCM.0b013e3181962ad5; Polderman KH, 2002, INTENS CARE MED, V28, P1563, DOI 10.1007/s00134-002-1511-3; Ramsey D, 2011, 9 ANN NEUR CAR SOC M; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Rodling-Wahlstrom M, 2012, SCAND J CLIN LAB INV, V72, P484, DOI 10.3109/00365513.2012.699098; Salim A, 2008, INJURY, V39, P30, DOI 10.1016/j.injury.2007.06.015; Scaravilli V, 2011, NEUROCRIT CARE, V15, P287, DOI 10.1007/s12028-011-9588-6; Schirmer CM, 2007, STROKE, V38, P987, DOI 10.1161/01.STR.0000257962.58269.e2; Seule MA, 2009, NEUROSURGERY, V64, P86, DOI 10.1227/01.NEU.0000336312.32773.A0; Smith ER, 2002, NEUROSURGERY, V51, P117, DOI 10.1097/00006123-200207000-00018; Staykov D, 2013, NEUROCRIT CARE, V18, P178, DOI 10.1007/s12028-012-9762-5; VILLAR J, 1993, RESUSCITATION, V26, P183, DOI 10.1016/0300-9572(93)90178-S; YOUNG AB, 1988, J NEUROSURG, V69, P375, DOI 10.3171/jns.1988.69.3.0375; Zetterling M, 2010, ACTA NEUROCHIR, V152, P1527, DOI 10.1007/s00701-010-0684-8; Zetterling M, 2010, NEUROSURGERY, V66, P1102, DOI 10.1227/01.NEU.0000370893.04586.73; Ziai WC, 2003, J NEUROSURG ANESTH, V15, P25, DOI 10.1097/00008506-200301000-00005	41	11	13	1	6	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	DEC	2014	21	3					451	461		10.1007/s12028-014-9989-4			11	Critical Care Medicine; Clinical Neurology	General & Internal Medicine; Neurosciences & Neurology	AT2TY	WOS:000344790100011	24865270				2021-06-18	
J	LeBlanc, J; de Guise, E; Champoux, MC; Couturier, C; Lamoureux, J; Marcoux, J; Maleki, M; Feyz, M				LeBlanc, Joanne; de Guise, Elaine; Champoux, Marie-Claude; Couturier, Celine; Lamoureux, Julie; Marcoux, Judith; Maleki, Mohammed; Feyz, Mitra			Acute evaluation of conversational discourse skills in traumatic brain injury	INTERNATIONAL JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article						Traumatic brain injury; conversational discourse; acute care; Protocole Montreal d'evaluation de la communication; Montreal Communication Evaluation Battery	CLOSED-HEAD-INJURY; NARRATIVE DISCOURSE; SOCIAL INTEGRATION; COMMUNICATION; MILD; ABILITIES; ADULTS; DISABILITY; MODERATE; OUTCOMES	This study looked at performance on the conversational discourse checklist of the Protocole Montreal d'evaluation de la communication (D-MEC) in 195 adults with TBI of all severity hospitalized in a Level 1 Trauma Centre. To explore validity, results were compared to findings on tests of memory, mental flexibility, confrontation naming, semantic and letter category naming, verbal reasoning, and to scores on the Montreal Cognitive Assessment. The relationship to outcome as measured with the Disability Rating Scale (DRS), the Extended Glasgow Outcome Scale (GOS-E), length of stay, and discharge destinations was also determined. Patients with severe TBI performed significantly worse than mild and moderate groups (chi(2)(KW2df) = 24.435, p = .0001). The total D-MEC score correlated significantly with all cognitive and language measures (p < .05). It also had a significant moderate correlation with the DRS total score (r - -.6090, p < .0001) and the GOS-E score (r = .539, p < .0001), indicating that better performance on conversational discourse was associated with a lower disability rating and better global outcome. Finally, the total D-MEC score was significantly different between the discharge destination groups (F-(3,F-90) = 20.19, p < .0001). Thus, early identification of conversational discourse impairment in acute care post-TBI was possible with the D-MEC and could allow for early intervention in speech-language pathology.	[LeBlanc, Joanne; de Guise, Elaine; Champoux, Marie-Claude; Couturier, Celine; Marcoux, Judith; Maleki, Mohammed; Feyz, Mitra] McGill Univ, Ctr Hlth, Montreal Gen Hosp, Montreal, PQ H3G 1A4, Canada; [Lamoureux, Julie] Univ Montreal, Montreal, PQ, Canada	LeBlanc, J (corresponding author), McGill Univ, Ctr Hlth, Traumat Brain Injury Program, Montreal Gen Hosp Site,Room D13-124, Montreal, PQ H3G 1A4, Canada.	joanne.leblanc@mcgill.ca					Baker H. J., 1965, DETROIT TEST LEARNIN; Bashore TR, 2002, PSYCHOL BULL, V128, P151, DOI 10.1037/0033-2909.128.1.151; Benton A., 1976, MULTILINGUAL APHASIA; Bittner RM, 2006, BRAIN INJURY, V20, P971, DOI 10.1080/02699050600909763; Body R, 2004, BRAIN INJURY, V18, P707, DOI 10.1080/02699050310001596914; Bracy C. A., 2005, BRAIN IMPAIR, V6, P1, DOI [10.1375/brim.6.1.1.65476., DOI 10.1375/BRIM.6.1.1.65476, DOI 10.1375/brim.6.1.1.65476]; Brandt J., 1991, CLIN NEUROPSYCHOL, V5, P125, DOI 10.1080/13854049108403297.; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; Coelho C. A., 2002, APHASIOLOGY, V16, P659, DOI [10.1080/02687030244000275, DOI 10.1080/02687030244000275]; COELHO CA, 1991, ARCH PHYS MED REHAB, V72, P465; Coelho CA, 2003, APHASIOLOGY, V17, P499, DOI 10.1080/02687030344000111; Coelho CA, 2002, J SPEECH LANG HEAR R, V45, P1232, DOI 10.1044/1092-4388(2002/099); Coelho Carl, 2005, Seminars in Speech and Language, V26, P223, DOI 10.1055/s-2005-922102; Coelho Carl A., 2007, Seminars in Speech and Language, V28, P122, DOI 10.1055/s-2007-970570; Cote H., 2004, REEDUCATION ORTHOPHO, V219, P107; Dahlberg C, 2006, BRAIN INJURY, V20, P425, DOI 10.1080/02699050600664574; Damico JS, 1985, COMMUNICATION SKILLS, P165; Douglas JM, 2010, J SPEECH LANG HEAR R, V53, P365, DOI 10.1044/1092-4388(2009/08-0205); Douglas JM, 2000, APHASIOLOGY, V14, P251, DOI 10.1080/026870300401469; Ferraro FR, 1996, BRAIN COGNITION, V32, P429, DOI 10.1006/brcg.1996.0075; Fonseca RP, 2008, SPAN J PSYCHOL, V11, P678, DOI 10.1017/S1138741600004686; Galski T, 1998, BRAIN INJURY, V12, P769, DOI 10.1080/026990598122160; Goldstein FC, 2001, J CLIN EXP NEUROPSYC, V23, P739, DOI 10.1076/jcen.23.6.739.1028; Goodglass H., 1983, BOSTON DIAGNOSTIC AP; GRANT DA, 1948, J EXP PSYCHOL, V38, P404, DOI 10.1037/h0059831; HARTLEY L L, 1991, Brain Injury, V5, P267, DOI 10.3109/02699059109008097; Hoofien D, 2001, BRAIN INJURY, V15, P189; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Joanette Y., 2004, PROTOCOLE MONTREAL E; Kaplan E., 1983, BOSTON NAMING TEST; KERR C, 1995, BRAIN INJURY, V9, P777, DOI 10.3109/02699059509008234; Le K., 2011, DISCOURSE ANAL CHARA; LIVINGSTON M, 1988, J HEAD TRAUMA REHAB, V3, P6, DOI DOI 10.1097/00001199-198812000-00004; McDonald S, 1998, BRAIN LANG, V61, P88, DOI 10.1006/brln.1997.1846; MCDONALD S, 1992, APPL PSYCHOLINGUIST, V13, P295, DOI 10.1017/S0142716400005658; McDonald S, 1999, COMMUNICATION DISORD; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; OFlaherty CA, 1997, APHASIOLOGY, V11, P889, DOI 10.1080/02687039708250463; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rey A, 1964, EXAMEN CLIN PSYCHOL; Snow P, 1998, BRAIN INJURY, V12, P911, DOI 10.1080/026990598121981; Stout CE, 2000, J MED SPEECH-LANG PA, V8, P15; Struchen MA, 2008, NEUROREHABILITATION, V23, P185; Struchen MA, 2011, J HEAD TRAUMA REHAB, V26, P4, DOI 10.1097/HTR.0b013e3182048e98; TEASDALE G, 1974, LANCET, V2, P81; Togher L, 1997, BRAIN INJURY, V11, P169, DOI 10.1080/026990597123629; Tompkins CA, 2012, ARCH PHYS MED REHAB, V93, pS61, DOI 10.1016/j.apmr.2011.10.015; Tucker FM, 1998, BRAIN INJURY, V12, P783, DOI 10.1080/026990598122179; Wechsler D., 1997, WMS 3 MANUAL; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Ylvisaker M., 2008, LANGUAGE INTERVENTIO, P879; Ylvisaker Mark, 1992, Seminars in Speech and Language, V13, P239, DOI 10.1055/s-2008-1064200; Youse KM, 2005, BRAIN INJURY, V19, P1001, DOI 10.1080/02699050500109951	57	11	12	0	18	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1754-9507	1754-9515		INT J SPEECH-LANG PA	Int. J. Speech-Lang. Pathol.	DEC	2014	16	6					582	593		10.3109/17549507.2013.871335			12	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	AT4QK	WOS:000344925300005	24447162				2021-06-18	
J	McKinlay, A				McKinlay, Audrey			Long-Term Outcomes of Traumatic Brain Injury in Early Childhood	AUSTRALIAN PSYCHOLOGIST			English	Article						brain injury; concussion; early childhood; mTBI	MILD HEAD-INJURY; NEUROPSYCHOLOGICAL FUNCTION; ADOLESCENTS 6; BIRTH COHORT; YOUNG-ADULTS; CHILDREN; PLASTICITY; CONCUSSION; PREDICTORS; VULNERABILITY	Mild traumatic brain injury (mTBI) is a leading cause of injury among children, with approximately 15% of children experiencing a TBI prior to 15 years of age. Acutely, mTBI has been associated with a range of cognitive, physical, emotional and behavioural impairments. However, few studies have examined outcomes beyond five years post injury, long before the developmental process is complete and the full extent of any deficits may manifest. Our group had the unique opportunity to use data from a longitudinal birth cohort of 1265 children (Christchurch Health and Development Study) to examine the long term outcomes of early injury (0-5 years). Information about these children, including mTBI events, had been collected at birth, 4 months and at yearly intervals until age 16, and again at ages 18, 21 and 25 years. We found that even after statistical control for a wide range of child and family confounds, children who had been hospitalized for an mTBI had increased inattention/hyperactivity and conduct as rated by mothers and teachers over ages 7-13 years. Increased rates of psychiatric disorders were over 14-16 years for those injured in the preschool, including symptoms consistent with Attention Deficit/Hyperactivity Disorder (ADHD), Odds Ratio=4.6, Conduct Disorder (CD), Odds Ratio=5.6 and Substance Abuse (Odds Ratio=9.1). Over ages 21-25 ongoing behaviour problems were assessed using self-reported arrests, violent offenses and property offenses. Compared to non-injured individuals, mTBI groups were more likely to be arrested, involved in property, and violent offences. We controlled for a wide range of factors and there was still clear evidence of ongoing problems for individuals who had experienced a mTBI compared to their non injured counterparts. These findings provide compelling evidence of long term psychosocial and psychiatric outcomes following mTBI.	[McKinlay, Audrey] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic 3010, Australia; [McKinlay, Audrey] Univ Canterbury, Christchurch 1, New Zealand	McKinlay, A (corresponding author), Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic 3010, Australia.	audrey.mckinlay@unimelb.edu.au		McKinlay, Audrey/0000-0001-9846-8514			Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V., 2001, RECOVERY EARLY BRAIN; Anderson V, 2011, BRAIN, V134, P2197, DOI 10.1093/brain/awr103; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Catroppa C, 2007, J PEDIATR PSYCHOL, V32, P354, DOI 10.1093/jpepsy/jsl019; Colantonio A, 1998, ARCH PHYS MED REHAB, V79, P550, DOI 10.1016/S0003-9993(98)90072-7; COSTEFF H, 1988, BRAIN DEV-JPN, V10, P371, DOI 10.1016/S0387-7604(88)80095-0; DeMatteo CA, 2010, PEDIATRICS, V125, P327, DOI 10.1542/peds.2008-2720; Ewing-Cobbs L, 2003, DEV NEUROPSYCHOL, V24, P669, DOI 10.1207/S15326942DN242&3_08; Giza CC, 2006, DEV NEUROSCI-BASEL, V28, P364, DOI 10.1159/000094163; Hessen E, 2007, BRAIN INJURY, V21, P963, DOI 10.1080/02699050701528454; Hessen E, 2006, SCAND J PSYCHOL, V47, P245, DOI 10.1111/j.1467-9450.2006.00514.x; Horowitz I, 1983, Int Rehabil Med, V5, P32; JORDAN F M, 1992, Brain Injury, V6, P39, DOI 10.3109/02699059209008120; Kibby MY, 1996, BRAIN INJURY, V10, P159, DOI 10.1080/026990596124494; KLONOFF H, 1993, J NEUROL NEUROSUR PS, V56, P410, DOI 10.1136/jnnp.56.4.410; Kraus J. F., 1995, EPIDEMIOLOGICAL FEAT; Max JE, 1998, J AM ACAD CHILD PSY, V37, P841, DOI 10.1097/00004583-199808000-00014; Max JE, 2006, J NEUROPSYCH CLIN N, V18, P21, DOI 10.1176/appi.neuropsych.18.1.21; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1041, DOI 10.1097/01.chi.0000173292.05817.f8; Max JE, 1998, J AM ACAD CHILD PSY, V37, P83, DOI 10.1097/00004583-199801000-00021; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; Mckinlay A, 2011, BRAIN INJURY, V25, P761, DOI 10.3109/02699052.2011.579935; McKinlay A, 2010, INJURY PREV, V16, P31, DOI 10.1136/ip.2009.022483; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P3, DOI 10.1111/j.1365-2214.2009.01006.x; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P22, DOI 10.1111/j.1365-2214.2009.00947.x; McKinlay A, 2012, MILD TRAUMATIC BRAIN, V18, P361; McKinlay A., 2013, NEUROTRAUMA LETT; McKinlay A, 2003, BRAIN INJ S1, V17, P39; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P498, DOI 10.1097/HTR.0000000000000001; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P233, DOI 10.1097/HTR.0b013e3182a2dd7f; McKinlay A, 2012, NEUROREHABILITATION, V30, P183, DOI 10.3233/NRE-2012-0743; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; McLellan T, 2010, J INT NEUROPSYCH SOC, V16, P705, DOI 10.1017/S1355617710000524; McLellan TL, 2011, BRIT J SPORT MED, V45, P993, DOI 10.1136/bjsm.2011.083618; Meekes J, 2006, PEDIATRICS, V117, P2330, DOI 10.1542/peds.2006-0083; Satz P, 1997, PSYCHOL BULL, V122, P107, DOI 10.1037/0033-2909.122.2.107; Satz P, 2001, CURR DIR PSYCHOL SCI, V10, P106, DOI 10.1111/1467-8721.00127	40	11	11	0	48	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0005-0067	1742-9544		AUST PSYCHOL	Aust. Psychol.	DEC	2014	49	6					323	327		10.1111/ap.12084			5	Psychology, Multidisciplinary	Psychology	AU1DO	WOS:000345361500001					2021-06-18	
J	Quarrie, KL; Murphy, IR				Quarrie, Kenneth Lincoln; Murphy, Ian Robert			Towards an operational definition of sports concussion: identifying a limitation in the 2012 Zurich consensus statement and suggesting solutions	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							INJURY DEFINITIONS; DATA-COLLECTION; RUGBY UNION; TIME		[Quarrie, Kenneth Lincoln; Murphy, Ian Robert] New Zealand Rugby, High Performance Unit, Wellington 6140, New Zealand	Quarrie, KL (corresponding author), New Zealand Rugby, High Performance Unit, 100 Molesworth St, Wellington 6140, New Zealand.	ken.quarrie@nzrugby.co.nz					Coggon D, 2005, INT J EPIDEMIOL, V34, P949, DOI 10.1093/ije/dyi012; Craton N, 2014, CLIN J SPORT MED, V24, P93, DOI 10.1097/JSM.0000000000000023; Fuller CW, 2007, CLIN J SPORT MED, V17, P182, DOI 10.1097/JSM.0b013e31805930b0; Fuller CW, 2007, BRIT J SPORT MED, V41, P328, DOI 10.1136/bjsm.2006.033282; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Junge A, 2000, AM J SPORT MED, V28, pS40; King D, 2013, J NEUROL SCI, V326, P59, DOI 10.1016/j.jns.2013.01.012; Langley J, 2004, INJURY PREV, V10, P69, DOI 10.1136/ip.2003.003715; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mueller-Wohlfahrt HW, 2013, BRIT J SPORT MED, V47, P342, DOI 10.1136/bjsports-2012-091448; Orchard J, 2007, CLIN J SPORT MED, V17, P192, DOI 10.1097/JSM.0b013e3180547527; ROSENBERG ML, 1991, VIOLENCE AM PUBLIC H; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002	13	11	11	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	DEC	2014	48	22					1589	1591		10.1136/bjsports-2014-094112			3	Sport Sciences	Sport Sciences	AT7PU	WOS:000345130900005	25257231				2021-06-18	
J	Radhakrishna, M; Makriyianni, I; Marcoux, J; Zhang, X				Radhakrishna, Mohan; Makriyianni, Ioli; Marcoux, Judith; Zhang, Xun			Effects of injury level and severity on direct costs of care for acute spinal cord injury	INTERNATIONAL JOURNAL OF REHABILITATION RESEARCH			English	Article						cost; epidemiology; traumatic spinal cord injury		New treatments are being investigated for spinal cord injury (SCI), and any improvement may result in incremental cost savings. The objective of this study was to determine the direct costs of care 2 years after an SCI, stratifying for completeness and level of injury. A retrospective database analysis was carried out using data from the Quebec Trauma Registry, the Quebec Medical Insurance Board, and the Quebec Automobile Insurance Corporation between 1997 and 2007. Excluding individuals sustaining moderate or severe traumatic brain injuries, 481 individuals who sustained an SCI from motor vehicle accidents were identified. Individuals were classified as complete and incomplete in the following categories: C1-C7, C8-T6, T7-L1, L2-S5. Using data from governmental public healthcare organizations makes this study comprehensive. For C1-C7 complete and incomplete spinal cord injuries, the first-year cost was $157 718 and $56 505, respectively (2009 Canadian dollars calculated per patient). Similar differences between complete and incomplete spinal cord injuries were seen for the other groups. Furthermore, for complete injuries, costs were higher for higher levels of injury during both the first and the second year after injury. For incomplete lesions, costs did not differ significantly between groups during the first or the second year. Incomplete spinal cord injuries result in lower healthcare costs compared with complete injuries across all groups during the first 2 years after injury. As less severe levels of injury result in measurably lower costs, the funds spent to reduce the severity or level of SCI could at least partially be recouped through healthcare savings. (C) 2014 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.	[Radhakrishna, Mohan; Makriyianni, Ioli; Marcoux, Judith; Zhang, Xun] McGill Univ, Ctr Hlth, Montreal, PQ H3G 1A4, Canada	Radhakrishna, M (corresponding author), McGill Univ, Ctr Hlth, Montreal Gen Hosp Campus,1650 Cedar Ave, Montreal, PQ H3G 1A4, Canada.	mohan.radhakrishna@muhc.mcgill.ca					Anderson KD, 2004, J NEUROTRAUM, V21, P1371, DOI 10.1089/neu.2004.21.1371; Berkowitz M, 1992, EC CONSEQUENCES TRAU; Canadian Institute for Health Information, 2008, INP REH CAN 2006 200, P59; Canadian Institute for Health Information, 2009, HIGHL 2008 2009 INP, P6; Cifu DX, 1999, J NEUROTRAUM, V16, P805, DOI 10.1089/neu.1999.16.805; DeVivo M, 2011, TOP SPINAL CORD INJ, V16, P1, DOI DOI 10.1310/SCI1604-1; DeVivo MJ, 1997, SPINAL CORD, V35, P809, DOI 10.1038/sj.sc.3100501; Dryden DM, 2005, J TRAUMA, V59, P441, DOI 10.1097/01.ta.0000174732.90517.df; Fiedler IG, 1999, ARCH PHYS MED REHAB, V80, P1441, DOI 10.1016/S0003-9993(99)90256-3; French DD, 2007, J SPINAL CORD MED, V30, P477, DOI 10.1080/10790268.2007.11754581; Hamilton BB, 1999, ARCH PHYS MED REHAB, V80, P385, DOI 10.1016/S0003-9993(99)90274-5; HARVEY C, 1992, PARAPLEGIA, V30, P834, DOI 10.1038/sc.1992.160; Johnson RL, 1996, SPINAL CORD, V34, P470, DOI 10.1038/sc.1996.81; Krueger H, 2013, CHRON DIS INJ CAN, V33, P113; Munce SEP, 2013, SPINAL CORD, V51, P64, DOI 10.1038/sc.2012.81; New PW, 2010, SPINE, V35, P796, DOI 10.1097/BRS.0b013e3181be76f5; PRICE C, 1994, AM J EPIDEMIOL, V139, P37, DOI 10.1093/oxfordjournals.aje.a116933; Priebe MM, 2007, ARCH PHYS MED REHAB, V88, pS84, DOI 10.1016/j.apmr.2006.12.005; TATOR CH, 1993, PARAPLEGIA, V31, P700, DOI 10.1038/sc.1993.112; WALSH J, 1988, PARAPLEGIA, V26, P380, DOI 10.1038/sc.1988.58; Wehman P, 1994, Int J Rehabil Res, V17, P268, DOI 10.1097/00004356-199409000-00008	21	11	11	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0342-5282	1473-5660		INT J REHABIL RES	Int. J. Rehabil. Res.	DEC	2014	37	4					349	353		10.1097/MRR.0000000000000081			5	Rehabilitation	Rehabilitation	AT4NM	WOS:000344916100010	25192008				2021-06-18	
J	Sethuraman, KN; Marcolini, EG; McCunn, M; Hansoti, B; Vaca, FE; Napolitano, LM				Sethuraman, Kinjal N.; Marcolini, Evie G.; McCunn, Maureen; Hansoti, Bhakti; Vaca, Federico E.; Napolitano, Lena M.			Gender-specific Issues in Traumatic Injury and Resuscitation: Consensus-based Recommendations for Future Research	ACADEMIC EMERGENCY MEDICINE			English	Article							CRITICALLY-ILL TRAUMA; MAJOR TRAUMA; INTENSIVE-CARE; BRAIN-INJURY; SEXUAL-DIMORPHISM; ADVERSE OUTCOMES; MORTALITY; WOMEN; MEDICINE; SURVIVAL	Traumatic injury remains an unacceptably high contributor to morbidity and mortality rates across the United States. Gender-specific research in trauma and emergency resuscitation has become a rising priority. In concert with the 2014 Academic Emergency Medicine consensus conference Gender-specific Research in Emergency Care: Investigate, Understand, and Translate How Gender Affects Patient Outcomes, a consensus-building group consisting of experts in emergency medicine, critical care, traumatology, anesthesiology, and public health convened to generate research recommendations and priority questions to be answered and thus move the field forward. Nominal group technique was used for the consensus-building process and a combination of face-to-face meetings, monthly conference calls, e-mail discussions, and preconference surveys were used to refine the research questions. The resulting research agenda focuses on opportunities to improve patient outcomes by expanding research in sex-and gender-specific emergency care in the field of traumatic injury and resuscitation.	[Sethuraman, Kinjal N.] Univ Maryland, Sch Med, Dept Emergency Med, Baltimore, MD 21201 USA; [Sethuraman, Kinjal N.] Univ Maryland, Div Hyperbar Med, R Adams Cowley Shock Trauma Ctr, Baltimore, MD 21201 USA; [Marcolini, Evie G.; Vaca, Federico E.] Yale Univ, Dept Emergency Med, New Haven, CT USA; [McCunn, Maureen] Dept Anesthesiol, Div Trauma Anesthesiol, Baltimore, MD USA; [McCunn, Maureen] Dept Anesthesiol, Div Surg Crit Care, Baltimore, MD USA; [Hansoti, Bhakti] Johns Hopkins Univ, Dept Emergency Med, Baltimore, MD USA; [Napolitano, Lena M.] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA	Sethuraman, KN (corresponding author), Univ Maryland, Sch Med, Dept Emergency Med, Baltimore, MD 21201 USA.	ksethuraman@umm.edu		Hansoti, Bhakti/0000-0003-0188-9764	National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R13NS087861-01]; Office of Research on Women's Health at the National Institutes of Health; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R13NS087861] Funding Source: NIH RePORTER	The consensus conference was supported by grant 1R13NS087861-01 from the National Institute of Neurological Disorders and Stroke and the Office of Research on Women's Health at the National Institutes of Health. Additional funding was provided by several organizational, institutional, and individual donors. Non-CME events were supported by Janssen Pharmaceuticals and Besins Critical Care/BH Pharma. See the executive summary elsewhere in this issue for full funding information.	ALSPACH JG, 2012, CRIT CARE NURSE, V32, P8; ANGELE MK, 2000, EUR J TRAUMA Q, V26, P267; Arcaroli J, 2006, AM J RESP CRIT CARE, V173, P1335, DOI 10.1164/rccm.200603-341OC; Axinn WG, 2013, J HEALTH SOC BEHAV, V54, P444, DOI 10.1177/0022146513501518; Bartels C, 2008, J WOMENS HEALTH, V17, P1615, DOI 10.1089/jwh.2008.0798; Blasius AL, 2010, IMMUNITY, V32, P305, DOI 10.1016/j.immuni.2010.03.012; Bowles BJ, 2003, INJURY, V34, P27; Centers for Disease Control and Prevention, WEB BAS INJ STAT QUE; Coimbra R, 2003, J TRAUMA, V54, P689, DOI 10.1097/01.TA.0000058314.31655.5F; Colantonio A, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-102; Croce MA, 2013, J TRAUMA ACUTE CARE, V74, P354, DOI 10.1097/TA.0b013e31827a0c65; Deitch EA, 2007, ANN SURG, V246, P447, DOI 10.1097/SLA.0b013e318148566; Dossett LA, 2008, J TRAUMA, V64, P580, DOI 10.1097/TA.0b013e31816543dd; Eagly AH, 2002, PSYCHOL REV, V109, P573, DOI 10.1037//0033-295X.109.3.573; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Fowler RA, 2007, CAN MED ASSOC J, V177, P1513, DOI 10.1503/cmaj.071112; Fowler RA, 2009, CURR OPIN CRIT CARE, V15, P442, DOI 10.1097/MCC.0b013e3283307a12; Frink M, 2007, SHOCK, V27, P151, DOI 10.1097/01.shk.0000239767.64786.de; Gale SC, 2007, AM SURGEON, V73, P454; Gannon CJ, 2004, SHOCK, V21, P410, DOI 10.1097/00024382-200405000-00003; Gannon CJ, 2002, J AM COLL SURGEONS, V195, P11, DOI 10.1016/S1072-7515(02)01187-0; Garwe T, 2010, ACAD EMERG MED, V17, P1223, DOI 10.1111/j.1553-2712.2010.00918.x; Gee AC, 2008, SHOCK, V29, P334, DOI 10.1097/shk.0b013e3181506ee5; George RL, 2005, J BURN CARE REHABIL, V26, P416, DOI 10.1097/01.bcr.0000176888.44949.87; George RL, 2003, J TRAUMA, V54, P464, DOI 10.1097/01.TA.0000051939.95039.E6; Gilliver SC, 2010, J STEROID BIOCHEM, V120, P105, DOI 10.1016/j.jsbmb.2009.12.015; Gomez D, 2012, SURGERY, V152, P179, DOI 10.1016/j.surg.2012.04.006; Guidry CA, 2014, CRIT CARE MED, V42, P1110, DOI 10.1097/CCM.0000000000000139; Haas B, 2012, J TRAUMA ACUTE CARE, V72, P1510, DOI 10.1097/TA.0b013e318252510a; Hagemo JS, 2014, CRIT CARE, V18, DOI 10.1186/cc13798; Haider AH, 2010, J TRAUMA, V69, P537, DOI 10.1097/TA.0b013e3181efc67b; Haider AH, 2009, SURGERY, V146, P308, DOI 10.1016/j.surg.2009.05.006; Heffernan DS, 2011, J TRAUMA, V71, P878, DOI 10.1097/TA.0b013e31822c0d31; Holbrook TL, 2002, J TRAUMA, V53, P882, DOI 10.1097/00005373-200211000-00012; Holbrook TL, 2004, J TRAUMA, V56, P284, DOI 10.1097/01.TA.0000109758.75406.F8; Holbrook TL, 2001, J TRAUMA, V50, P270, DOI 10.1097/00005373-200102000-00012; HoustonBolze MS, 1996, CRIT CARE MED, V24, P1988; HoustonBolze MS, 1996, CRIT CARE MED, V24, P1982, DOI 10.1097/00003246-199612000-00009; Kerby JD, 2006, J BURN CARE RES, V27, P452, DOI 10.1097/01.BCR.0000225957.01854.EE; KNAUS WA, 1986, ANN INTERN MED, V104, P410, DOI 10.7326/0003-4819-104-3-410; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Magnotti LJ, 2008, J AM COLL SURGEONS, V206, P984, DOI 10.1016/j.jamcollsurg.2007.12.038; May AK, 2008, CRIT CARE MED, V36, P62, DOI 10.1097/01.CCM.0000292015.16171.6D; McCunn M, 2014, MID REG M SOC AC EM; McCunn M, 2014, ANN SCI M E ASS SURG; McGregor AJ, 2013, ACAD EMERG MED, V20, P313, DOI 10.1111/acem.12085; Mohr AM, 2010, AM SURGEON, V76, P896; Napolitano LM, 2012, CRIT CARE MED, V40, P990, DOI 10.1097/CCM.0b013e3182411154; Napolitano LM, 2001, J TRAUMA, V50, P274, DOI 10.1097/00005373-200102000-00013; Niemeier JP, 2007, NEUROPSYCHOL REHABIL, V17, P293, DOI 10.1080/09602010600814729; Osborn TM, 2004, CRIT CARE MED, V32, P2234, DOI 10.1097/01.CCM.0000145586.23276.0F; Rappold JF, 2002, J TRAUMA, V53, P436, DOI 10.1097/00005373-200209000-00007; Ratcliff JJ, 2007, BRAIN INJURY, V21, P1023, DOI 10.1080/02699050701633072; Rice TW, 2012, CRIT CARE MED, V40, P778, DOI 10.1097/CCM.0b013e318236f168; Rowell SE, 2011, J TRAUMA, V71, pS375, DOI 10.1097/TA.0b013e318227f1aa; Schoeneberg C, 2013, CRIT CARE, V17, DOI 10.1186/cc13132; Sexton JB, 2000, BMJ-BRIT MED J, V320, P745, DOI 10.1136/bmj.320.7237.745; SHORTELL SM, 1994, MED CARE, V32, P508, DOI 10.1097/00005650-199405000-00009; Sperry J, 2014, 134 ANN M AM SURG AS; Sperry JL, 2008, CRIT CARE MED, V36, P1838, DOI 10.1097/CCM.0b013e3181760c14; Sperry JL, 2012, J AM COLL SURGEONS, V214, P973, DOI 10.1016/j.jamcollsurg.2012.02.020; Spoerke N, 2010, J TRAUMA, V68, P1106, DOI 10.1097/TA.0b013e3181d86860; Summers JI, 2014, J BURN CARE RES; Toubiana J, 2010, CRIT CARE MED, V38, P2287, DOI 10.1097/CCM.0b013e3181f9f9c7; Wohltmann CD, 2001, AM J SURG, V181, P297, DOI 10.1016/S0002-9610(01)00582-7; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Yang KC, 2014, SHOCK, V42, P11, DOI 10.1097/SHK.0000000000000168	67	11	11	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1069-6563	1553-2712		ACAD EMERG MED	Acad. Emerg. Med.	DEC	2014	21	12					1386	1394		10.1111/acem.12536			9	Emergency Medicine	Emergency Medicine	AW9KS	WOS:000346576700013	25420732	Green Published, Green Accepted			2021-06-18	
J	Suderman, BL; Hoover, RW; Ching, RP; Scher, IS				Suderman, Bethany L.; Hoover, Ryan W.; Ching, Randal P.; Scher, Irving S.			The effect of hardhats on head and neck response to vertical impacts from large construction objects	ACCIDENT ANALYSIS AND PREVENTION			English	Article						Hardhat; Vertical impact; Dropped object; Head acceleration; Neck compression	TRAUMATIC BRAIN-INJURY; CERVICAL-SPINE; CONCUSSION	We evaluated the effectiveness of hardhats in attenuating head acceleration and neck force in vertical impacts from large construction objects. Two weight-matched objects (lead shot bag and concrete block) weighing 9.1 kg were dropped from three heights (0.91 m, 1.83 in and 2.74m) onto the head of a 50th percentile male Hybrid III anthropomorphic test device (ATD). Two headgear conditions were tested: no head protection and an ANSI Type-I, Class-E hardhat. A third headgear condition (snow sport helmet) was tested at 1.83 m for comparison with the hardhat. Hardhats significantly reduced the resultant linear acceleration for the concrete block impacts by 70-95% when compared to the unprotected head condition. Upper neck compression was also significantly reduced by 26-60% with the use of a hardhat when compared to the unprotected head condition for the 0.91 and 1.83 m drop heights for both lead shot and concrete block drop objects. In this study we found that hardhats can be effective in reducing both head accelerations and compressive neck forces for large construction objects in vertical impacts. (C) 2014 Elsevier Ltd. All rights reserved.	[Suderman, Bethany L.; Scher, Irving S.] Guidance Engn & Appl Res, Seattle, WA 98116 USA; [Hoover, Ryan W.] CAPE, Westfield, IN 46074 USA; [Ching, Randal P.; Scher, Irving S.] Univ Washington, Dept Mech Engn, Appl Biomech Lab, Seattle, WA 98109 USA	Suderman, BL (corresponding author), Guidance Engn & Appl Res, 3909 Calif Ave,SW Suite 202, Seattle, WA 98116 USA.	suderman@guidanceengineering.com; rhoover@imminet.com; rc@u.washington.edu					ANSI, 2009, Z8912009 ANSI, P1; Bacon K., 2001, OCCUP HLTH SAFETY; Bureau of Labor Statistics (BLS), 2013, INJ ILLN FAT DAT; CPSC, 2011, NEISS INJ DAT 2002 2; Funk J R, 2007, Annu Proc Assoc Adv Automot Med, V51, P343; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Hutchinson J, 1998, APPL MATH COMPUT, V96, P1, DOI 10.1016/S0096-3003(97)10106-0; Mertz Harold J, 2003, Stapp Car Crash J, V47, P155; Nightingale RW, 2002, J BIOMECH, V35, P725, DOI 10.1016/S0021-9290(02)00037-4; Nightingale RW, 1996, J BIOMECH, V29, P307, DOI 10.1016/0021-9290(95)00056-9; Nightingale RW, 1996, J BONE JOINT SURG AM, V78A, P412, DOI 10.2106/00004623-199603000-00013; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Scher I., 2006, J ASTM INT, V3, P9; Scher I., 2009, SAE INT, P1; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	16	11	11	0	6	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0001-4575	1879-2057		ACCIDENT ANAL PREV	Accid. Anal. Prev.	DEC	2014	73						116	124		10.1016/j.aap.2014.08.011			9	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	AW7OO	WOS:000346453600015	25215927				2021-06-18	
J	Jeong, S; Lei, BL; Wang, HC; Dawson, HN; James, ML				Jeong, Seongtae; Lei, Beilei; Wang, Haichen; Dawson, Hana N.; James, Michael L.			Intravenous immunoglobulin G improves neurobehavioral and histological outcomes after traumatic brain injury in mice	JOURNAL OF NEUROIMMUNOLOGY			English	Article						Traumatic brain injury (TBI); Intravenous immunoglobulin (IVIG); Neuroinflammation; Blood-brain barrier (BBB); Murine model; Long-term outcome	CLOSED-HEAD INJURY; MICROGLIAL ACTIVATION; FUNCTIONAL RECOVERY; MURINE MODEL; INFLAMMATION; BARRIER; RATS; NEUROPROTECTION; PERMEABILITY; HEMORRHAGE	Intravenous immunoglobulin (WIG) may improve neuroinflammation after traumatic brain injury (TBI). MG administration after TBI improved rotarod latencies over the first 7 days (p = 0.039) and water maze latencies over 29-32 days (p = 0.027), decreased F4/80-positive cells at 2 (p = 0.001) and 7 days (p < 0.001), decreased Fluoro-jade B-positive cells (p = 0.020), increased NeuN-positive cells (p = 0.014), decreased IL-6 production at 4 (p = 0.032) and 24 h (p = 0.023), and decreased blood-brain barrier breakdown by IgG extravasation (p = 0.001) and brain edema (p = 0.006); however, TNF-alpha concentration was unchanged. MG administration was associated with long-term neurobehavioral and histological improvement through modulation of neuroinflammation and blood-brain barrier permeability in a murine TBI model. (C) 2014 Elsevier B.V. All rights reserved.	[Jeong, Seongtae; Lei, Beilei; Wang, Haichen; Dawson, Hana N.; James, Michael L.] Duke Univ, Multidisciplinary Neuroprotect Labs, Durham, NC USA; [Jeong, Seongtae] Chonnam Natl Univ, Sch Med, Dept Anesthesiol & Pain Med, Gwangiu, South Korea; [Lei, Beilei; James, Michael L.] Duke Univ, Dept Anesthesiol, Durham, NC USA; [Wang, Haichen; Dawson, Hana N.; James, Michael L.] Duke Univ, Dept Neurol, Durham, NC USA	James, ML (corresponding author), DUMC 3094, Durham, NC 27710 USA.	michael.james@duke.edu	Jeong, Seongtae/AAZ-2067-2020; James, Michael L./AAJ-5592-2020	James, Michael L./0000-0002-8715-5210			Ahishali B, 2005, INT J NEUROSCI, V115, P151, DOI 10.1080/00207450590519030; Arumugam TV, 2007, P NATL ACAD SCI USA, V104, P14104, DOI 10.1073/pnas.0700506104; Aschermann S, 2010, CLIN EXP IMMUNOL, V160, P161, DOI 10.1111/j.1365-2249.2009.04081.x; Banks WA, 2010, NEUROBIOL DIS, V37, P26, DOI 10.1016/j.nbd.2009.07.031; Bye N, 2007, EXP NEUROL, V204, P220, DOI 10.1016/j.expneurol.2006.10.013; Dawson HN, 2007, J NEUROSCI, V27, P9155, DOI 10.1523/JNEUROSCI.5492-06.2007; Dudesek A, 2006, J NEUROL, V253, P50, DOI 10.1007/s00415-006-5007-x; Engel S, 2000, ACTA NEUROPATHOL, V100, P313, DOI 10.1007/s004019900172; Esen F, 2012, CRIT CARE MED, V40, P1214, DOI 10.1097/CCM.0b013e31823779ca; Felker GM, 2010, CIRC-HEART FAIL, V3, P314, DOI 10.1161/CIRCHEARTFAILURE.109.893222; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Gatson JW, 2013, J TRAUMA ACUTE CARE, V74, P470, DOI 10.1097/TA.0b013e31827e1f51; HAHN RG, 1989, J UROLOGY, V142, P1102, DOI 10.1016/S0022-5347(17)39005-5; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hardman JM, 2002, NEUROIMAG CLIN N AM, V12, P175, DOI 10.1016/S1052-5149(02)00009-6; Hughes RAC, 2009, CLIN EXP IMMUNOL, V158, P34, DOI [10.1111/j.1365-2249.2009.04025.X, 10.1111/j.1365-2249.2009.04025.x]; Indraswari F, 2012, J NEUROTRAUM, V29, P1388, DOI 10.1089/neu.2011.2117; James ML, 2012, ANESTHESIOLOGY, V116, P1299, DOI 10.1097/ALN.0b013e318253a02a; James ML, 2010, J NEUROTRAUM, V27, P217, DOI 10.1089/neu.2009.1022; Lapointe BM, 2004, BRAIN, V127, P2649, DOI 10.1093/brain/awh297; Laskowitz DT, 2007, J NEUROTRAUM, V24, P1093, DOI 10.1089/neu.2006.0192; Lei BL, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-103; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Lu J, 2001, J NEUROTRAUM, V18, P399, DOI 10.1089/089771501750170976; Lynch JR, 2005, EXP NEUROL, V192, P109, DOI 10.1016/j.expneurol.2004.11.014; Mannix Rebekah C, 2012, Int J Alzheimers Dis, V2012, P608732, DOI 10.1155/2012/608732; McIntosh TK, 1996, LAB INVEST, V74, P315; Misra N, 2005, J NEUROL, V252, P1, DOI 10.1007/s00415-005-1102-7; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Nimmerjahn F, 2007, J EXP MED, V204, P11, DOI 10.1084/jem.20061788; Petty MA, 2002, PROG NEUROBIOL, V68, P311, DOI 10.1016/S0301-0082(02)00128-4; RAMILO O, 1990, J EXP MED, V172, P497, DOI 10.1084/jem.172.2.497; Relkin NR, 2009, NEUROBIOL AGING, V30, P1728, DOI 10.1016/j.neurobiolaging.2007.12.021; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; STALBERG HP, 1993, ACTA ANAESTH SCAND, V37, P281, DOI 10.1111/j.1399-6576.1993.tb03716.x; VANDERMECHE FGA, 1992, NEW ENGL J MED, V326, P1123, DOI 10.1056/NEJM199204233261705; Wang B, 2013, NEUROCRIT CARE, V19, P125, DOI 10.1007/s12028-012-9808-8; Wang HC, 2007, EXP NEUROL, V206, P59, DOI 10.1016/j.expneurol.2007.03.031; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411	40	11	11	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-5728	1872-8421		J NEUROIMMUNOL	J. Neuroimmunol.	NOV 15	2014	276	1-2					112	118		10.1016/j.jneuroim.2014.08.626			7	Immunology; Neurosciences	Immunology; Neurosciences & Neurology	AU3CI	WOS:000345490000014	25241288				2021-06-18	
J	Chen, HI; Attiah, M; Baltuch, G; Smith, DH; Hamilton, RH; Lucas, TH				Chen, H. Isaac; Attiah, Mark; Baltuch, Gordon; Smith, Douglas H.; Hamilton, Roy H.; Lucas, Timothy H.			Harnessing Plasticity for the Treatment of Neurosurgical Disorders: An Overview	WORLD NEUROSURGERY			English	Article						Functional recovery; Network remodeling; Plasticity; Restorative neurosurgery; Stem cells; Stimulation; Tissue engineering	NEURAL STEM-CELLS; MOTOR CORTEX STIMULATION; GRADE-II GLIOMAS; CORTICAL ELECTRICAL-STIMULATION; EXPERIENCE-DEPENDENT PLASTICITY; DEEP-BRAIN-STIMULATION; DORSAL PREMOTOR CORTEX; RAT BARREL CORTEX; FUNCTIONAL RECOVERY; CORTICOSPINAL PROJECTIONS	Plasticity is fundamental to normal central nervous system function and its response to injury. Understanding this adaptive capacity is central to the development of novel surgical approaches to neurologic disease. These innovative interventions offer the promise of maximizing functional recovery for patients by harnessing targeted plasticity. Developing novel therapies will require the unprecedented integration of neuroscience, bioengineering, molecular biology, and physiology. Such synergistic approaches will create therapeutic options for patients previously outside of the scope of neurosurgery, such as those with permanent disability after traumatic brain injury or stroke. In this review, we synthesize the rapidly evolving field of plasticity and explore ways that neurosurgeons may enhance functional recovery in the future. We conclude that understanding plasticity is fundamental to modern neurosurgical education and practice.	[Chen, H. Isaac; Baltuch, Gordon; Smith, Douglas H.; Lucas, Timothy H.] Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA; [Hamilton, Roy H.] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA; [Attiah, Mark] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Lucas, Timothy H.] Univ Penn, Ctr Neuroengn & Therapeut, Philadelphia, PA 19104 USA	Chen, HI (corresponding author), Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA.	Isaac.Chen@uphs.upenn.edu					Adkins DL, 2008, EXP NEUROL, V212, P14, DOI 10.1016/j.expneurol.2008.01.031; Adkins-Muir DL, 2003, NEUROL RES, V25, P780, DOI 10.1179/016164103771953853; Alvarez-Dolado M, 2006, J NEUROSCI, V26, P7380, DOI 10.1523/JNEUROSCI.1540-06.2006; Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; BARKER AT, 1985, LANCET, V1, P1106; BARTH TM, 1994, CEREB CORTEX, V4, P271, DOI 10.1093/cercor/4.3.271; Bavelier D, 2010, J NEUROSCI, V30, P14964, DOI 10.1523/JNEUROSCI.4812-10.2010; Benzagmout M, 2007, NEUROSURGERY, V61, P741, DOI 10.1227/01.NEU.0000298902.69473.77; Berger TW, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046017; Berman JI, 2013, AM J NEURORADIOL, V34, P1573, DOI 10.3174/ajnr.A3471; Bestmann S, 2010, J NEUROSCI, V30, P11926, DOI 10.1523/JNEUROSCI.5642-09.2010; Beuter A, 2009, CHAOS, V19, DOI 10.1063/1.3127585; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Boakye M, 2009, SURG NEUROL, V71, P5, DOI 10.1016/j.surneu.2008.09.007; Borchers S, 2012, NAT REV NEUROSCI, V13, P63, DOI 10.1038/nrn3140; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; BRASILNETO JP, 1993, BRAIN, V116, P511, DOI 10.1093/brain/116.3.511; BRASILNETO JP, 1992, NEUROLOGY, V42, P1302, DOI 10.1212/WNL.42.7.1302; Brown JA, 2008, NEUROSURGERY, V62, P853, DOI [10.1227/01.NEU.0000197100.63931.04, 10.1227/01.neu.0000316287.37618.78]; Brus-Ramer M, 2007, J NEUROSCI, V27, P13793, DOI 10.1523/JNEUROSCI.3489-07.2007; Brus-Ramer M, 2009, J NEUROSCI, V29, P6196, DOI 10.1523/JNEUROSCI.5852-08.2009; BuchkremerRatzmann I, 1996, STROKE, V27, P1105, DOI 10.1161/01.STR.27.6.1105; Buckner RL, 1996, P NATL ACAD SCI USA, V93, P1249, DOI 10.1073/pnas.93.3.1249; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Carey LM, 2006, NEUROREHAB NEURAL RE, V20, P24, DOI 10.1177/1545968305283053; Carmichael ST, 2001, NEUROBIOL DIS, V8, P910, DOI 10.1006/nbdi.2001.0425; Carmichael ST, 2005, EXP NEUROL, V193, P291, DOI 10.1016/j.expneurol.2005.01.004; Chen H Isaac, 2007, Curr Stem Cell Res Ther, V2, P13; Chen R, 2002, NEUROSCIENCE, V111, P761, DOI 10.1016/S0306-4522(02)00025-8; Chrysikou EG, 2011, RESTOR NEUROL NEUROS, V29, P375, DOI 10.3233/RNN-2011-0610; Cisek P, 2003, J NEUROPHYSIOL, V89, P922, DOI 10.1152/jn.00607.2002; Cornelissen K, 2003, J COGNITIVE NEUROSCI, V15, P444, DOI 10.1162/089892903321593153; Cramer SC, 2006, EXP BRAIN RES, V168, P25, DOI 10.1007/s00221-005-0082-2; Cramer SC, 1997, STROKE, V28, P2518, DOI 10.1161/01.STR.28.12.2518; Cramer SC, 2011, BRAIN, V134, P1591, DOI 10.1093/brain/awr039; Dancause N, 2005, J NEUROSCI, V25, P10167, DOI 10.1523/JNEUROSCI.3256-05.2005; Dancause N, 2011, PROG BRAIN RES, V192, P273, DOI 10.1016/B978-0-444-53355-5.00015-4; De Benedictis A, 2011, NEUROSURGERY, V68, P1709, DOI 10.1227/NEU.0b013e3182124690; de Ribaupierre S, 2012, EPILEPSY RES TREAT, V2012; Desmurget M, 2007, BRAIN, V130, P898, DOI 10.1093/brain/awl300; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; DONOGHUE JP, 1988, J NEUROSCI, V8, P3221; DONOGHUE JP, 1987, P NATL ACAD SCI USA, V84, P1123, DOI 10.1073/pnas.84.4.1123; Duffau H, 2005, LANCET NEUROL, V4, P476, DOI 10.1016/S1474-4422(05)70140-X; Duffau H, 2001, J NEUROL NEUROSUR PS, V70, P506, DOI 10.1136/jnnp.70.4.506; Duffau H, 2000, ANN NEUROL, V47, P132, DOI 10.1002/1531-8249(200001)47:1<132::AID-ANA23>3.3.CO;2-S; Duffau H, 2003, J NEUROL NEUROSUR PS, V74, P901, DOI 10.1136/jnnp.74.7.901; Duffau H, 2006, J CLIN NEUROSCI, V13, P885, DOI 10.1016/j.jocn.2005.11.045; DUM RP, 1991, J NEUROSCI, V11, P667; DUNCAN PW, 1992, STROKE, V23, P1084, DOI 10.1161/01.STR.23.8.1084; EbrahimiGaillard A, 1996, J COMP NEUROL, V365, P129, DOI 10.1002/(SICI)1096-9861(19960129)365:1<129::AID-CNE10>3.0.CO;2-L; Edwardson MA, 2013, EXP BRAIN RES, V224, P335, DOI 10.1007/s00221-012-3315-1; ELBERT T, 1994, NEUROREPORT, V5, P2593, DOI 10.1097/00001756-199412000-00047; Englund U, 2002, P NATL ACAD SCI USA, V99, P17089, DOI 10.1073/pnas.252589099; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Eysel UT, 1997, ADV NEUROL, V73, P195; Feldman DE, 2009, ANNU REV NEUROSCI, V32, P33, DOI 10.1146/annurev.neuro.051508.135516; Frappe I, 1999, NEUROSCIENCE, V89, P409, DOI 10.1016/S0306-4522(98)00379-0; FRIES W, 1993, BRAIN, V116, P369, DOI 10.1093/brain/116.2.369; Gaillard A, 2007, NAT NEUROSCI, V10, P1294, DOI 10.1038/nn1970; Gaillard F, 2008, RESTOR NEUROL NEUROS, V26, P267; Garcia JO, 2011, J NEUROPHYSIOL, V106, P1734, DOI 10.1152/jn.00739.2010; Garraghty PE, 1996, J COMP NEUROL, V367, P319, DOI 10.1002/(SICI)1096-9861(19960401)367:2<319::AID-CNE12>3.0.CO;2-L; Garraghty PE, 2006, J COMP NEUROL, V497, P636, DOI 10.1002/cne.21018; Ge SY, 2008, J PHYSIOL-LONDON, V586, P3759, DOI 10.1113/jphysiol.2008.155655; Ghanbari Y, 2012, LECT NOTES COMPUT SC, V7512, P231, DOI 10.1007/978-3-642-33454-2_29; GIRMAN SV, 1990, BRAIN RES, V523, P78, DOI 10.1016/0006-8993(90)91637-V; Giussani C, 2010, NEUROSURGERY, V66, P113, DOI 10.1227/01.NEU.0000360392.15450.C9; Grafton ST, 2006, NEUROLOGY, V66, P1192, DOI 10.1212/01.wnl.0000214237.58321.c3; Gulati S, 2011, WORLD NEUROSURG, V76, P572, DOI 10.1016/j.wneu.2011.06.014; Hanajima R, 2001, J PHYSIOL-LONDON, V531, P849, DOI 10.1111/j.1469-7793.2001.0849h.x; Hansen DV, 2011, NEURON, V70, P645, DOI 10.1016/j.neuron.2011.05.006; Harvey RL, 2009, NEUROREHAB NEURAL RE, V23, P32, DOI 10.1177/1545968308317532; HE SQ, 1995, J NEUROSCI, V15, P3284; HE SQ, 1993, J NEUROSCI, V13, P952; Hebb M, 2007, MOVEMENT DISORD, V22, P1958, DOI 10.1002/mds.21616; Heiss WD, 2006, BRAIN LANG, V98, P118, DOI 10.1016/j.bandl.2006.02.002; Hickmott PW, 2002, J NEUROPHYSIOL, V88, P1288, DOI 10.1152/jn.00994.2001; Hodge CJ, 2001, NEUROSURGERY, V48, P2, DOI 10.1097/00006123-200101000-00002; Huang M, 2008, TOP STROKE REHABIL, V15, P160, DOI 10.1310/tsr1502-160; Ius T, 2011, NEUROIMAGE, V56, P992, DOI 10.1016/j.neuroimage.2011.03.022; Jackson A, 2006, NATURE, V444, P56, DOI 10.1038/nature05226; JACOBS KM, 1991, SCIENCE, V251, P944, DOI 10.1126/science.2000496; Jensen MB, 2013, J STROKE CEREBROVASC, V22, P304, DOI 10.1016/j.jstrokecerebrovasdis.2011.09.008; Johansson Barbro B., 2004, Keio Journal of Medicine, V53, P231, DOI 10.2302/kjm.53.231; Johansson BB, 2004, RESTOR NEUROL NEUROS, V22, P163; JONES TA, 1994, J NEUROSCI, V14, P2140; Kaas JH, 2004, RESTOR NEUROL NEUROS, V22, P145; Karbe H, 1998, BRAIN LANG, V64, P215, DOI 10.1006/brln.1998.1961; Karl A, 2001, J NEUROSCI, V21, P3609, DOI 10.1523/JNEUROSCI.21-10-03609.2001; Kelly S, 2004, P NATL ACAD SCI USA, V101, P11839, DOI 10.1073/pnas.0404474101; Kelly-Hayes M, 1989, J NEUROL REHABIL, V3, P65; Kim JH, 2002, NATURE, V418, P50, DOI 10.1038/nature00900; Kleim JA, 2003, NEUROL RES, V25, P789, DOI 10.1179/016164103771953862; Kondziolka D, 2005, J NEUROSURG, V103, P38, DOI 10.3171/jns.2005.103.1.0038; KOTILA M, 1984, STROKE, V15, P1039, DOI 10.1161/01.STR.15.6.1039; Krainik A, 2004, NEUROLOGY, V62, P1323, DOI 10.1212/01.WNL.0000120547.83482.B1; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Kury P, 2004, EUR J NEUROSCI, V19, P1708, DOI 10.1111/j.1460-9568.2004.03226.x; Laska AC, 2001, J INTERN MED, V249, P413, DOI 10.1046/j.1365-2796.2001.00812.x; Lebedev MA, 2000, CEREB CORTEX, V10, P23, DOI 10.1093/cercor/10.1.23; LENDREM W, 1985, J NEUROL NEUROSUR PS, V48, P743, DOI 10.1136/jnnp.48.8.743; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Levy R, 2008, J NEUROSURG, V108, P707, DOI 10.3171/JNS/2008/108/4/0707; Li L, 2011, JOVE-J VIS EXP, DOI 10.3791/2937; Li Y, 2009, CURR TOP DEV BIOL, V87, P149, DOI 10.1016/S0070-2153(09)01205-8; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; Lucas TH, 2013, J NEUROSCI, V33, P5261, DOI 10.1523/JNEUROSCI.4683-12.2013; Marshall RS, 2000, STROKE, V31, P656, DOI 10.1161/01.STR.31.3.656; Martino J, 2009, ACTA NEUROCHIR, V151, P427, DOI 10.1007/s00701-009-0232-6; McGirt MJ, 2008, NEUROSURGERY, V63, P700, DOI 10.1227/01.NEU.0000325729.41085.73; McGirt MJ, 2009, NEUROSURGERY, V65, P463, DOI 10.1227/01.NEU.0000349763.42238.E9; Merrill EG, 1978, NEURONAL PLASTICITY, P94; MERZENICH MM, 1983, NEUROSCIENCE, V10, P639, DOI 10.1016/0306-4522(83)90208-7; MERZENICH MM, 1983, NEUROSCIENCE, V8, P33, DOI 10.1016/0306-4522(83)90024-6; Miura K, 1999, J NEUROL, V246, P939, DOI 10.1007/s004150050486; Moritz CT, 2008, NATURE, V456, P639, DOI 10.1038/nature07418; Murase N, 2004, ANN NEUROL, V55, P400, DOI 10.1002/ana.10848; Musso M, 1999, BRAIN, V122, P1781, DOI 10.1093/brain/122.9.1781; Naeser MA, 2005, BRAIN LANG, V93, P95, DOI 10.1016/j.bandl.2004.08.004; Napieralski JA, 1996, J COMP NEUROL, V373, P484; NICHOLAS ML, 1993, ARCH PHYS MED REHAB, V74, P830, DOI 10.1016/0003-9993(93)90009-Y; Nouri S, 2011, NEUROLOGY, V77, P1076, DOI 10.1212/WNL.0b013e31822e1482; Nudo RJ, 1996, J NEUROPHYSIOL, V75, P2144; Nudo RJ, 1996, J NEUROSCI, V16, P785; Nudo RJ, 1996, SCIENCE, V272, P1791, DOI 10.1126/science.272.5269.1791; Ohyama M, 1996, STROKE, V27, P897, DOI 10.1161/01.STR.27.5.897; OJEMANN JG, 1995, J NEUROSURG, V82, P641, DOI 10.3171/jns.1995.82.4.0641; Pais-Vieira M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01319; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Pascual-Leone A, 2005, ANNU REV NEUROSCI, V28, P377, DOI 10.1146/annurev.neuro.27.070203.144216; PASCUALLEONE A, 1991, NEUROLOGY, V41, P697, DOI 10.1212/WNL.41.5.697; Pfister BJ, 2004, J NEUROSCI, V24, P7978, DOI 10.1523/JNEUROSCI.1974-04.2004; Pillai JJ, 2010, AM J NEURORADIOL, V31, P990, DOI 10.3174/ajnr.A1896; Plautz EJ, 2003, NEUROL RES, V25, P801, DOI 10.1179/016164103771953880; Plow EB, 2009, STROKE, V40, P1926, DOI 10.1161/STROKEAHA.108.540823; PONS TP, 1991, SCIENCE, V252, P1857, DOI 10.1126/science.1843843; Postman-Caucheteux WA, 2010, J COGNITIVE NEUROSCI, V22, P1299, DOI 10.1162/jocn.2009.21261; Qi HX, 2000, J NEUROPHYSIOL, V84, P2133; Redecker C, 2000, J NEUROSCI, V20, P5045; Reekmans K, 2012, STEM CELL REV REP, V8, P262, DOI 10.1007/s12015-011-9266-2; Rickhag M, 2006, J NEUROCHEM, V96, P14, DOI 10.1111/j.1471-4159.2005.03508.x; Riecker A, 2010, HUM BRAIN MAPP, V31, P1017, DOI 10.1002/hbm.20914; Riess P, 2002, NEUROSURGERY, V51, P1043, DOI 10.1097/00006123-200210000-00035; Riley JD, 2011, STROKE, V42, P421, DOI 10.1161/STROKEAHA.110.599340; Robles SG, 2008, J NEUROSURG, V109, P615, DOI 10.3171/JNS/2008/109/10/0615; Rosen HJ, 2000, NEUROLOGY, V55, P1883, DOI 10.1212/WNL.55.12.1883; ROSSINI PM, 1994, BRAIN RES, V642, P169, DOI 10.1016/0006-8993(94)90919-9; Ruge D, 2011, BRAIN, V134, P2106, DOI 10.1093/brain/awr122; Sanai N, 2008, NEW ENGL J MED, V358, P18, DOI 10.1056/NEJMoa067819; Sanai N, 2012, ADV EXP MED BIOL, V746, P12, DOI 10.1007/978-1-4614-3146-6_2; Sanai N, 2011, J NEUROSURG, V115, P3, DOI 10.3171/2011.2.JNS10998; Santos-Torres J, 2009, J NEUROTRAUM, V26, P1593, DOI 10.1089/neu.2008.0702; Saur D, 2006, BRAIN, V129, P1371, DOI 10.1093/brain/awl090; Schiene K, 1996, J CEREBR BLOOD F MET, V16, P906, DOI 10.1097/00004647-199609000-00014; Shear DA, 2004, BRAIN RES, V1026, P11, DOI 10.1016/j.brainres.2004.07.087; Smith DH, 2001, TISSUE ENG, V7, P131, DOI 10.1089/107632701300062714; STROEMER RP, 1995, STROKE, V26, P2135, DOI 10.1161/01.STR.26.11.2135; Suthana N, 2012, NEW ENGL J MED, V366, P502, DOI 10.1056/NEJMoa1107212; Takeuchi N, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/823285; TAUB E, 1993, ARCH PHYS MED REHAB, V74, P347; Taylor MD, 1999, J NEUROSURG, V90, P35, DOI 10.3171/jns.1999.90.1.0035; Teskey GC, 2003, NEUROL RES, V25, P794, DOI 10.1179/016164103771953871; Thiel A, 2006, BRAIN LANG, V98, P57, DOI 10.1016/j.bandl.2006.01.007; Thiel A, 2001, ANN NEUROL, V50, P620, DOI 10.1002/ana.1253; Thompson CK, 2000, J COMMUN DISORD, V33, P357, DOI 10.1016/S0021-9924(00)00031-9; Thompson CK, 2010, NEUROPSYCHOLOGIA, V48, P3211, DOI 10.1016/j.neuropsychologia.2010.06.036; Ulmer JL, 2003, AM J NEURORADIOL, V24, P213; Van Essen DC, 2012, NEUROIMAGE, V62, P2222, DOI 10.1016/j.neuroimage.2012.02.018; Warburton E, 1999, J NEUROL NEUROSUR PS, V66, P155, DOI 10.1136/jnnp.66.2.155; Weick JP, 2011, P NATL ACAD SCI USA, V108, P20189, DOI 10.1073/pnas.1108487108; Weidner N, 2001, P NATL ACAD SCI USA, V98, P3513, DOI 10.1073/pnas.051626798; WEILLER C, 1993, ANN NEUROL, V33, P181; Wieloch T, 2006, CURR OPIN NEUROBIOL, V16, P258, DOI 10.1016/j.conb.2006.05.011; Winhuisen L, 2005, STROKE, V36, P1759, DOI 10.1161/01.STR.0000174487.81126.ef; Witte OW, 1997, ADV NEUROL, V73, P207; Zhou Q, 2010, BRAIN RES, V1311, P148, DOI 10.1016/j.brainres.2009.11.022	178	11	11	1	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	NOV	2014	82	5					648	659		10.1016/j.wneu.2014.02.003			12	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	AX9XK	WOS:000347252300063	24518888				2021-06-18	
J	Davis, A				Davis, Alice			Violence-Related Mild Traumatic Brain Injury in Women: Identifying a Triad of Postinjury Disorders	JOURNAL OF TRAUMA NURSING			English	Article						Depression; Interpersonal violence; Mild traumatic brain injury and violence in women; Postconcussion syndrome and posttraumatic stress disorder; Violence and women	INTIMATE PARTNER VIOLENCE; PHYSICAL HEALTH; DEPRESSION; ETIOLOGY; PHYSIOGENESIS; PSYCHOGENESIS; CONSEQUENCE; VICTIMS; HISTORY; STRESS	Violence against women whether from domestic partner abuse, sex trafficking injuries, or sexual assault is a pervasive health problem without racial or social boundaries. Regardless of cause, violence results in a complex triad of physical, emotional, and psychological injuries. There is clear evidence that female victims of violence or "battered women" experience brain injury. What is less certain is whether the constellations of events surrounding brain injury including postconcussion syndrome, depression, and posttraumatic stress disorder are acute symptoms after the brain injury, premorbid as a result of persistent abuse, or a synergistic triad of combined disorders as a result of the injuries. The purpose of this article is to examine the relationship between physical violence-associated mild traumatic brain injury (MTBI) and postinjury cognitive, emotional, and psychological disorders. The review of the literature addresses epidemiological factors associated with domestic partners and sexual violence, abuse and health outcomes in women, physical injury, and its consequences. Along with MTBI, a triad of disorders is hypothesized that includes postconcussion syndrome, depression, and posttraumatic stress disorder. Screening for MTBI and the triad of disorders is advocated, and assessment methods are offered.	[Davis, Alice] Univ Hawaii, Sch Nursing, Hilo, HI 96720 USA	Davis, A (corresponding author), 7923A Ululi Rd 673, Kekaha, HI 96720 USA.	aedavis@hawaii.edu					American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5, DOI [10.1176/appi.books.9780890425596., DOI 10.1176/APPI.BOOKS.9780890425596, 10.1176/appi.books.9780890425596]; [Anonymous], 1989, US PREV SERV TASK FO; Banks ME, 2007, TRAUMA VIOLENCE ABUS, V8, P290, DOI 10.1177/1524838007303503; Bernstein DP, 2003, CHILD ABUSE NEGLECT, V27, P169, DOI 10.1016/S0145-2134(02)00541-0; Black M, 2005, AM J LIFESTYLE MED, V5, P428; Black M.C., 2011, NATL INTIMATE PARTNE; Bogat GA, 2003, J INTERPERS VIOLENCE, V18, P1271, DOI 10.1177/0886260503256657; Buck PW, 2011, HEALTH SOC WORK, V36, P299, DOI 10.1093/hsw/36.4.299; Campbell J, 2002, ARCH INTERN MED, V162, P1157, DOI 10.1001/archinte.162.10.1157; Centers for Disease Control and Prevention, HEADS FACTS PHYS MIL; Centers for Disease Control and Prevention, 2010, INT PARTN VIOL RISK; Ciechanowski P, 2012, UPTODATE; Corrigan John D., 2003, American Journal of Obstetrics and Gynecology, V188, pS71, DOI 10.1067/mob.2003.404; Hux K, 2009, BRAIN INJURY, V23, P8, DOI 10.1080/02699050802590353; Jackson H, 2002, PROF PSYCHOL-RES PR, V33, P39, DOI 10.1037//0735-7028.33.1.39; Kendler KS, 2000, AM J PSYCHIAT, V157, P1243, DOI 10.1176/appi.ajp.157.8.1243; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; Loxton D, 2006, VIOLENCE AGAINST WOM, V12, P715, DOI 10.1177/1077801206291483; MacMillan HL, 2009, JAMA-J AM MED ASSOC, V302, P493, DOI 10.1001/jama.2009.1089; Magnussen Lois, 2004, J Am Acad Nurse Pract, V16, P502, DOI 10.1111/j.1745-7599.2004.tb00430.x; Maletic V, 2007, INT J CLIN PRACT, V61, P2030, DOI 10.1111/j.1742-1241.2007.01602.x; Marshall S, 2012, CAN FAM PHYSICIAN, V58, P257; Monroe SM, 2005, PSYCHOL REV, V112, P417, DOI 10.1037/0033-295X.112.2.417; Nelson HD, 2012, ANN INTERN MED, V156, P796, DOI 10.7326/0003-4819-156-11-201206050-00447; Oram S, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001224; Paranjape A, 2006, J NATL MED ASSOC, V98, P1663; Picard M, 1991, HELPS TBI SCREENING; Remick RA, 2002, CAN MED ASSOC J, V167, P1253; Roberts A, 2007, J SOC SER RES, V32, P33; Saddki N, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-268; SHEPHERD JP, 1990, J ROY SOC MED, V83, P75, DOI 10.1177/014107689008300206; Sherin K M, 1998, Fam Med, V30, P508; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Sohal H, 2007, BMC FAM PRACT, V8, DOI 10.1186/1471-2296-8-49; Sutherland CA, 2002, AM J COMMUN PSYCHOL, V30, P609, DOI 10.1023/A:1016317130710; Tam S, 2010, J OTOLARYNGOL-HEAD N, V39, P737, DOI 10.2310/7070.2010.090292; U.S. Preventive Services Task Force, 2013, SCREEN INT PARTN VIO; Valera EM, 2003, J CONSULT CLIN PSYCH, V71, P797, DOI 10.1037/0022-006X.71.4.797; Weiss Steve J, 2003, Violence Vict, V18, P131, DOI 10.1891/vivi.2003.18.2.131	40	11	11	0	29	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1078-7496	1932-3883		J TRAUMA NURS	J. Trauma Nurs.	NOV-DEC	2014	21	6					300	308		10.1097/JTN.0000000000000086			9	Critical Care Medicine; Nursing	General & Internal Medicine; Nursing	CB5DA	WOS:000349646500010	25397339				2021-06-18	
J	Parchani, A; El-Menyar, A; Al-Thani, H; El-Faramawy, A; Zarour, A; Asim, M; Latifi, R				Parchani, Ashok; El-Menyar, Ayman; Al-Thani, Hassan; El-Faramawy, Ahmed; Zarour, Ahmad; Asim, Mohammad; Latifi, Rifat			Traumatic Subarachnoid Hemorrhage Due To Motor Vehicle Crash Versus Fall From Height: A 4-Year Epidemiologic Study	WORLD NEUROSURGERY			English	Article						Fall from height; Motor vehicle crash; Subarachnoid hemorrhage; Traumatic brain injury	NONPENETRATING HEAD-INJURY; BRAIN-INJURY; TOMOGRAPHY; VASOSPASM; MODERATE; IMPACT	BACKGROUND: Traumatic brain injury (TBI) is a common cause of morbidity and mortality worldwide. It is difficult to estimate the real incidence of traumatic subarachnoid hemorrhage (TSAH). Although TSAH after trauma is associated with poor prognoses, the impact of mechanism of injury (MOI) and the pathophysiology remains unknown. We hypothesized that outcome of TSAH caused by motor vehicle crash (MVC) or fall from height (FFH) varies based on the MOI. METHODS: Data were collected retrospectively from a prospectively created database registry in the section of Trauma Surgery at Hamad General Hospital between January 2008 and July 2012. All patients presented with head trauma and TSAH were included. Patient data included age, gender, nationality, mechanism of injury, injury severity score (ISS), types of head injuries, and associated injuries. Ventilator days, intensive care unit length of stay, pneumonia, and mortality were also studied. RESULTS: A total of 1665 patients with TBI were identified, of them 403 had TSAH with a mean age of 35 +/- 15 years. Of them 93% were male patients and 86% were expatriates. MVC (53%) and FFH (35%) were the major mechanisms of injury. The overall mean ISS and head abbreviated injury score were 19 +/- 10.6 and 3.4 +/- 0.96, respectively. Patients in MVC group sustained severe TSAH, had significantly greater head abbreviated injury score (3.5 +/- 0.9 vs. 3.2 +/- 0.9; P = 0.009) and ISS (21.6 +/- 10.6 vs. 15.9 +/- 9.5; P = 0.001), and lower scene Glasgow coma scale (10.8 +/- 4.8 vs. 13.2 +/- 3.4; P = 0.001) compared with the FFH group. In addition, the MVC group sustained more intraventricular hemorrhage (4.7 vs. 0.7; P = 0.001) and diffuse axonal injury (4.2 vs. 2.9; P = 0.001). In contrast, extradural hemorrhage (14.3% vs. 11.6%; P = 0.008) was higher in the FFH group. Lower extremities (14% vs. 4.3%; P = 0.004) injury was mainly associated with the MVC group. The overall mortality was 19 % among patients with TSAH. The mortality rate was higher in the MVC group when compared with the FFH group (24% vs. 10%; P = 0.001). In both groups, ISS and Glasgow coma scale at the scene were independent predictors of mortality. CONCLUSIONS: Patients with TSAH have a higher mortality rate. In this population, MVCs are associated with a 3-fold increased risk of mortality. Therefore, prevention of MVC and fall can reduce the incidence and severity of TBI in Qatar.	[Parchani, Ashok; Al-Thani, Hassan; El-Faramawy, Ahmed; Zarour, Ahmad; Latifi, Rifat] Hamad Gen Hosp, Dept Surg, Doha, Qatar; [El-Menyar, Ayman; Asim, Mohammad] Hamad Gen Hosp, Dept Clin Surg, Doha, Qatar; [Parchani, Ashok; El-Menyar, Ayman; Latifi, Rifat] Weill Cornell Med Coll, Doha, Qatar; [Latifi, Rifat] Univ Arizona, Dept Surg, Tucson, AZ USA	El-Menyar, A (corresponding author), Weill Cornell Med Coll, Doha, Qatar.	aymanco65@yahoo.com	El-Menyar, Ayman/F-6734-2015	El-Menyar, Ayman/0000-0003-2584-953X			Armin SS, 2008, ACTA NEUROCHIR SUPPL, V104, P421; Bener Abdulbari, 2009, Int Emerg Nurs, V17, P52, DOI 10.1016/j.ienj.2008.07.007; Borczuk P, 2013, J TRAUMA ACUTE CARE, V74, P1504, DOI 10.1097/TA.0b013e31829215cf; BRAAKMAN R, 1994, J NEUROSURG, V80, P797; Centers for Disease Control and Prevention, TRAUMATIC BRAIN INJU; Chieregato A, 2005, NEUROSURGERY, V56, P671, DOI 10.1227/01.NEU.0000156200.76331.7A; Choi JH, 2008, J TRAUMA, V65, P1028, DOI 10.1097/TA.0b013e31815eba9b; Compagnone C, 2009, NEUROSURGERY, V64, P690, DOI 10.1227/01.NEU.0000340796.18738.F7; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; El-Matbouly M, 2013, SCI WORLD J, DOI 10.1155/2013/354920; GREENE KA, 1995, J NEUROSURG, V83, P445, DOI 10.3171/jns.1995.83.3.0445; Greene KA, 1996, J TRAUMA, V41, P964, DOI 10.1097/00005373-199612000-00004; Hanlon RE, 2005, BRAIN INJURY, V19, P257, DOI 10.1080/02699050400004955; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; KAKARIEKA A, 1997, TRAUMATIC SUBARACHNO; Lee KH, 2006, NEUROCRIT CARE, V4, P68, DOI 10.1385/NCC:4:1:068; Leon-Carrion Jose, 2005, Pituitary, V8, P197, DOI 10.1007/s11102-006-6041-5; Miki T, 1998, J CLIN NEUROSCI, V5, P49, DOI 10.1016/S0967-5868(98)90202-8; Morris GF, 1997, CLIN NEUROL NEURO S1, V99, pS16; National Institutes of Health (NIH), SUB HEM MEDLINEPLUS; Pobereskin LH, 2001, J NEUROL NEUROSUR PS, V70, P340, DOI 10.1136/jnnp.70.3.340; Servadei F, 2002, NEUROSURGERY, V50, P261, DOI 10.1097/00006123-200202000-00006; Steyeberg EW, 2008, PLOS MED, V5, P2151; Tuma Mazin A, 2013, Int J Crit Illn Inj Sci, V3, P3, DOI 10.4103/2229-5151.109408; Wong GKC, 2011, J NEUROSURG, V114, P1510, DOI 10.3171/2011.1.JNS101102; Wu Z, 2010, AM J NEURORADIOL, V31, P1302, DOI 10.3174/ajnr.A2022; Zacharia TT, 2010, EMERG RADIOL, V17, P97, DOI 10.1007/s10140-009-0842-6	27	11	11	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	NOV	2014	82	5					E639	E644		10.1016/j.wneu.2014.06.022			6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	AX9XK	WOS:000347252300013	24947116				2021-06-18	
J	Studer, M; Simonetti, BG; Joeris, A; Margelisch, K; Steinlin, M; Roebers, CM; Heinks, T				Studer, Martina; Simonetti, Barbara Goeggel; Joeris, Alexander; Margelisch, Katja; Steinlin, Maja; Roebers, Claudia Maria; Heinks, Theda			Post-concussive Symptoms and Neuropsychological Performance in the Post-acute Period following Pediatric Mild Traumatic Brain Injury	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Concussion; Children; Recovery; Pre-injury attention problems; Everyday attention problems; Verbal learning and memory performance	DEFICIT HYPERACTIVITY DISORDER; POSTCONCUSSIVE SYMPTOMS; HEAD-INJURY; NEUROCOGNITIVE OUTCOMES; EXECUTIVE FUNCTIONS; COGNITIVE RESERVE; AGED CHILDREN; ADOLESCENTS; PREDICTORS; MANAGEMENT	Objective: There is evidence that children after mild traumatic brain injuries (mTBI) suffer ongoing post-concussive symptoms (PCS). However, results concerning neuropsychological outcome after mTBI are controversial. Thus, our aim was to examine group differences regarding neuropsychological outcome and PCS. Additionally, we explored the influence of current and pre-injury everyday attention problems on neuropsychological outcome in children after mTBI. Method: In a prospective short-term longitudinal study, 40 children (aged 6-16 years) after mTBI and 38 children after orthopedic injury (OI) underwent neuropsychological, socio-behavioral and PCS assessments in the acute stage and at 1 week, at 4 weeks, and 4 months after the injury. Results: Parents of children after mTBI observed significantly more PCS compared to parents of children after OI, especially in the acute stage. Our results revealed no neuropsychological or socio-behavioral differences over time between both groups. However, in children after mTBI, we found negative correlations between elevated levels of everyday attention problems and reduced neuropsychological performance. Furthermore, there was a negative influence of pre-injury everyday attention problems on neuropsychological performance in children after mTBI. Conclusion: In accordance with earlier studies, parents of children after mTBI initially observed significantly more PCS compared to parents of children after OI. There were no neuropsychological or socio-behavioral group differences between children after mTBI and OI in the post-acute period. However, our exploratory findings concerning the influence of everyday attention problems on neuropsychological outcome indicate that current and pre-injury everyday attention problems were negatively associated with neuropsychological performance in children after mTBI.	[Studer, Martina; Simonetti, Barbara Goeggel; Margelisch, Katja; Steinlin, Maja; Heinks, Theda] Univ Childrens Hosp Bern, Dept Pediat Neurol Dev & Rehabil, Bern, Switzerland; [Studer, Martina; Simonetti, Barbara Goeggel; Margelisch, Katja; Steinlin, Maja; Roebers, Claudia Maria; Heinks, Theda] Univ Bern, Ctr Cognit & Learning, Bern, Switzerland; [Simonetti, Barbara Goeggel] Univ Hosp Bern, Dept Neurol, CH-3010 Bern, Switzerland; [Joeris, Alexander] Univ Childrens Hosp Bern, Dept Pediat Surg, Bern, Switzerland; [Margelisch, Katja; Roebers, Claudia Maria] Univ Bern, Dept Dev Psychol, Bern, Switzerland	Studer, M (corresponding author), Univ Childrens Hosp, Inselspital, Dept Pediat Neurol Dev & Rehabil, CH-3010 Bern, Switzerland.	martina.studer@insel.ch	Joeris, Alexander/J-4688-2019	Joeris, Alexander/0000-0002-7748-7115; Margelisch, Katja/0000-0001-9594-4247	Johanna Durmuller-Bol Foundation; Batzebar Foundation of the University Children's Hospital of Bern; Anna Muller-Grocholski Foundation	This work was financially supported by following foundations: the Johanna Durmuller-Bol Foundation, the Batzebar Foundation of the University Children's Hospital of Bern, and the Anna Muller-Grocholski Foundation. There are no conflicts of interest. Portions of this research were presented at the Mid-Year Meeting of the International Neuropsychological Society (INS) in Amsterdam, 2013 as well as at the Annual Meeting of the INS in Seattle, 2014. We thank all parents and children for participating in this research project. In addition, we thank the Psychology graduate students Venera Gashaj, Sandra Hartmann, and Elisabeth Ruprecht for helping with data collection. Besides, the authors express gratitude to the anonymous Reviewers for their helpful suggestions and thank Thomas Mettler for support with data plotting.	Anderson V, 2001, J CLIN EXP NEUROPSYC, V23, P705, DOI 10.1076/jcen.23.6.705.1015; Asarnow R, 1995, TRAUMATIC BRAIN INJU, P117; Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Babikian T, 2013, J INT NEUROPSYCH SOC, V19, P145, DOI 10.1017/S135561771200104X; Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bonfield CM, 2013, J NEUROSURG-PEDIATR, V12, P97, DOI 10.3171/2013.5.PEDS12424; Brown L., 1997, TEST NONVERBAL INTEL; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Catale C, 2009, J CLIN EXP NEUROPSYC, V31, P331, DOI 10.1080/13803390802134616; Conners C, 2004, CONNERS CONTINUOUS P; Dean PJA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00030; Delis D.C., 2001, DELIS KAPLAN EXECUTI; DiScala C, 1998, PEDIATRICS, V102, P1415, DOI 10.1542/peds.102.6.1415; Donders J, 2003, J HEAD TRAUMA REHAB, V18, P106, DOI 10.1097/00001199-200303000-00002; Donlon K, 2015, CHILD NEUROPSYCHOL, V21, P803, DOI 10.1080/09297049.2014.944491; Duff K, 2005, ARCH CLIN NEUROPSYCH, V20, P111, DOI 10.1016/j.acn.2004.03.003; DURKIN MS, 1994, AM J PUBLIC HEALTH, V84, P587, DOI 10.2105/AJPH.84.4.587; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Epstein JN, 2003, J ABNORM CHILD PSYCH, V31, P543, DOI 10.1023/A:1025405216339; Farmer JE, 2002, DEV NEUROPSYCHOL, V22, P455, DOI 10.1207/S15326942DN2202_2; Fay TB, 2010, J INT NEUROPSYCH SOC, V16, P94, DOI 10.1017/S1355617709991007; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Gioia GA, 2011, MANUAL PEDIAT IMMEDI; Giza CC, 2001, J ATHL TRAINING, V36, P228; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Heim S, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00277; Helmstaedter C., 2001, VERBALER LERN MERKFA; Kay T., 1993, J HEAD TRAUMA REHABI, V8, P86, DOI [10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; Kraus JF, 1995, TRAUMATIC HEAD INJUR, P22; Loher S, 2014, APPL NEUROPSYCH-CHIL, V3, P103, DOI 10.1080/21622965.2012.716752; Maillard-Wermelinger A, 2009, DEV NEUROREHABIL, V12, P330, DOI 10.3109/17518420903087251; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; McCullagh S, 2003, J NEUROL NEUROSUR PS, V74, P39, DOI 10.1136/jnnp.74.1.39; McNally KA, 2013, NEUROPSYCHOLOGY, V27, P1, DOI 10.1037/a0031370; Menascu S., 2007, HEAD INJURY CHILDREN, P41; Mittenberg W, 1997, NEUROPSYCHOLOGY, V11, P447, DOI 10.1037/0894-4105.11.3.447; Petermann F, 2008, KINDH ENTWICKL, V17, P71, DOI 10.1026/0942-5403.17.2.71; Pickering S.J., 2001, WORKING MEMORY TEST; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Ramsay LJ, 2003, PUBLIC HEALTH, V117, P404, DOI 10.1016/S0033-3506(03)00072-6; Rieger BP, 2013, BRAIN INJURY, V27, P169, DOI 10.3109/02699052.2012.729290; Roebers CM, 2011, EUR J DEV PSYCHOL, V8, P526, DOI 10.1080/17405629.2011.571841; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; Satz P, 1997, PSYCHOL BULL, V122, P107, DOI 10.1037/0033-2909.122.2.107; Satz P., 1993, NEUROPSYCHOLOGY, V7, P273, DOI DOI 10.1037/0894-4105.7.3.273; Scherwath A, 2011, BRAIN INJURY, V25, P401, DOI 10.3109/02699052.2011.557351; Simma B, 2013, AM J EMERG MED, V31, P1133, DOI 10.1016/j.ajem.2013.04.007; Smallwood J, 2007, PSYCHON B REV, V14, P230, DOI 10.3758/BF03194057; Sroufe NS, 2010, PEDIATRICS, V125, pE1331, DOI 10.1542/peds.2008-2364; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Yeates K. O., 2010, PEDIAT NEUROPSYCHOLO, P112; Yeates KO, 2010, J INT NEUROPSYCH SOC, V16, P953, DOI 10.1017/S1355617710000986; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64	63	11	11	0	19	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	NOV	2014	20	10					982	993		10.1017/S1355617714000927			12	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Neurosciences & Neurology; Psychiatry; Psychology	AW3FN	WOS:000346171700004	25382292	Green Published			2021-06-18	
J	Higashi, Y; Hoshijima, M; Yawata, T; Nobumoto, A; Tsuda, M; Shimizu, T; Saito, M; Ueba, T				Higashi, Youichirou; Hoshijima, Michihiro; Yawata, Toshio; Nobumoto, Atsuya; Tsuda, Masayuki; Shimizu, Takahiro; Saito, Motoaki; Ueba, Tetuya			Suppression of Oxidative Stress and 5-Lipoxygenase Activation by Edaravone Improves Depressive-Like Behavior after Concussion	JOURNAL OF NEUROTRAUMA			English	Article						concussion; depression; edaravone; 5-lipoxygenase	TRAUMATIC BRAIN-INJURY; NITRIC-OXIDE SYNTHASE; FREE-RADICAL SCAVENGER; CHRONIC MILD STRESS; COGNITIVE DEFICITS; HEAD-INJURY; EXPRESSION; ACID; DAMAGE; IMMUNOREACTIVITY	Brain concussions are a serious public concern and are associated with neuropsychiatric disorders, such as depression. Patients with concussion who suffer from depression often experience distress. Nevertheless, few pre-clinical studies have examined concussion-induced depression, and there is little information regarding its pharmacological management. Edaravone, a free radical scavenger, can exert neuroprotective effects in several animal models of neurological disorders. However, the effectiveness of edaravone in animal models of concussion-induced depression remains unclear. In this study, we examined whether edaravone could prevent concussion-induced depression. Mice were subjected to a weight-drop injury and intravenously administered edaravone (3.0 mg/kg) or vehicle immediately after impact. Serial magnetic resonance imaging showed no abnormalities of the cerebrum on diffusion T1- and T2-weighted images. We found that edaravone suppressed concussion-induced depressive-like behavior in the forced swim test, which was accompanied by inhibition of increased hippocampal and cortical oxidative stress (OS) and suppression of 5-lipoxygenase (5-LOX) translocation to the nuclear envelope in hippocampal astrocytes. Hippocampal OS in concussed mice was also prevented by the nicotinamide adenine dinucleotide phosphate oxidase inhibitor, apocynin, and administration of BWB70C, a 5-LOX inhibitor, immediately and 24 h after injury prevented depressive-like behaviors in concussed mice. Further, antidepressant effects of edaravone were observed in mice receiving 1.0 or 3.0 mg/kg of edaravone immediately after impact, but not at a lower dose of 0.1 mg/kg. This antidepressant effect persisted up to 1 h after impact, whereas edaravone treatment at 3 h after impact had no effect on concussion-induced depressive-like behavior. These results suggest that edaravone protects against concussion-induced depression, and this protection is mediated by suppression of OS and 5-LOX translocation.	[Higashi, Youichirou; Hoshijima, Michihiro; Yawata, Toshio; Ueba, Tetuya] Kochi Univ, Kochi Med Sch, Dept Neurosurg, Nankoku, Kochi 7838505, Japan; [Nobumoto, Atsuya; Tsuda, Masayuki] Kochi Univ, Kochi Med Sch, Inst Lab Anim Res, Nankoku, Kochi 7838505, Japan; [Shimizu, Takahiro; Saito, Motoaki] Kochi Univ, Kochi Med Sch, Dept Pharmacol, Nankoku, Kochi 7838505, Japan	Higashi, Y (corresponding author), Kochi Univ, Kochi Med Sch, Dept Neurosurg, Okoh Cho, Nankoku, Kochi 7838505, Japan.	higasi@kochi-u.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and TechnologyMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [24592133]; General Insurance Association of Japan; Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [26462184, 24592133] Funding Source: KAKEN	This work was supported, in part, by Grants-in-Aid for Scientific Research ([C], No. 24592133) from the Japanese Ministry of Education, Culture, Sports, Science and Technology, and The General Insurance Association of Japan. The authors thank Mitsubishi Tanabe Pharma for providing the edaravone used in this study.	Ahn MJ, 2004, J NEUROTRAUM, V21, P1431, DOI 10.1089/neu.2004.21.1431; Allam F, 2013, J NUTR, V143, P835, DOI 10.3945/jn.113.174649; Avila MA, 2008, J CEREBR BLOOD F MET, V28, P1733, DOI 10.1038/jcbfm.2008.66; Banno M, 2005, NEUROPHARMACOLOGY, V48, P283, DOI 10.1016/j.neuropharm.2004.10.002; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Besson VC, 2003, BRAIN RES, V989, P58, DOI 10.1016/S0006-8993(03)03362-6; Castren E, 2007, CURR OPIN PHARMACOL, V7, P18, DOI 10.1016/j.coph.2006.08.009; Cherian L, 2000, J NEUROPHYSIOL, V83, P2171; Choi BY, 2012, BRAIN RES, V1481, P49, DOI 10.1016/j.brainres.2012.08.032; Cooney SJ, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-155; Dzitoyeva S, 2008, J NEURAL TRANSM, V115, P823, DOI 10.1007/s00702-008-0034-7; Elizalde N, 2008, PSYCHOPHARMACOLOGY, V199, P1, DOI 10.1007/s00213-007-1035-1; Erlemann KR, 2006, BIOCHEM BIOPH RES CO, V350, P151, DOI 10.1016/j.bbrc.2006.09.011; Erlemann KR, 2004, J BIOL CHEM, V279, P40376, DOI 10.1074/jbc.M401294200; Forster C, 1999, ACTA NEUROPATHOL, V97, P215, DOI 10.1007/s004010050977; Hartig W, 2013, BRAIN RES, V1498, P69, DOI 10.1016/j.brainres.2012.12.022; Hammarberg T, 2000, J BIOL CHEM, V275, P38787, DOI 10.1074/jbc.M006136200; Hsieh HL, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/484613; Ikonomovic MD, 2008, J HISTOCHEM CYTOCHEM, V56, P1065, DOI 10.1369/jhc.2008.951855; Itoh T, 2010, NEUROCHEM RES, V35, P348, DOI 10.1007/s11064-009-0061-2; Kamida T, 2009, NEUROSCI LETT, V461, P298, DOI 10.1016/j.neulet.2009.06.039; Kawai H, 1997, J PHARMACOL EXP THER, V281, P921; Kibby MY, 1996, BRAIN INJURY, V10, P159, DOI 10.1080/026990596124494; Kulkarni S, 2002, J BIOL CHEM, V277, P13167, DOI 10.1074/jbc.M112393200; Lammers CH, 1996, J NEUROCHEM, V66, P147; Lee SY, 2013, PROG NEURO-PSYCHOPH, V46, P224, DOI 10.1016/j.pnpbp.2012.09.008; Li CT, 2010, ACTA PHARMACOL SIN, V31, P137, DOI 10.1038/aps.2009.196; Li CT, 2009, J NEUROSCI RES, V87, P991, DOI 10.1002/jnr.21913; Li LF, 2013, EUR J PHARMACOL, V711, P42, DOI 10.1016/j.ejphar.2013.04.008; Maller JJ, 2010, BRAIN RES REV, V64, P213, DOI 10.1016/j.brainresrev.2010.04.003; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Naritomi Hiroaki, 2010, Drugs R D, V10, P155, DOI 10.2165/11586550-000000000-00000; Ohta M, 2013, BRAIN RES, V1490, P184, DOI 10.1016/j.brainres.2012.09.011; Pandey DK, 2009, BEHAV BRAIN RES, V205, P436, DOI 10.1016/j.bbr.2009.07.027; Peng YL, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-75; Perez-Nievas BG, 2007, PSYCHONEUROENDOCRINO, V32, P703, DOI 10.1016/j.psyneuen.2007.04.011; Radmark O, 2007, TRENDS BIOCHEM SCI, V32, P332, DOI 10.1016/j.tibs.2007.06.002; Reddy CC, 2011, PM&R, V3, pS396, DOI 10.1016/j.pmrj.2011.07.012; Royle SJ, 1999, BRAIN RES, V816, P337, DOI 10.1016/S0006-8993(98)01122-6; Schwarzbold ML, 2010, J NEUROTRAUM, V27, P1883, DOI 10.1089/neu.2010.1318; Seo JS, 2012, J NEUROSCI, V32, P9690, DOI 10.1523/JNEUROSCI.0794-12.2012; SHAPIRA Y, 1989, Neurological Research, V11, P169; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Uz T, 1998, FASEB J, V12, P439; Uz T, 2008, NEUROSCI LETT, V436, P269, DOI 10.1016/j.neulet.2008.03.041; Wada K, 1998, NEUROSURGERY, V43, P1427, DOI 10.1097/00006123-199812000-00096; WATANABE T, 1994, J PHARMACOL EXP THER, V268, P1597; Watanabe T, 2008, CARDIOVASC THER, V26, P101, DOI 10.1111/j.1527-3466.2008.00041.x; Whalen MJ, 1999, J CEREBR BLOOD F MET, V19, P835, DOI 10.1097/00004647-199908000-00002; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; YEADON M, 1993, AGENTS ACTIONS, V38, P8, DOI 10.1007/BF02027207; Zhang L, 2006, NEUROPATHOLOGY, V26, P99, DOI 10.1111/j.1440-1789.2006.00658.x; Zhang QG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034504; Zhou QG, 2011, J NEUROSCI, V31, P7579, DOI 10.1523/JNEUROSCI.0004-11.2011; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4; Zohar O, 2011, ACTA NEUROBIOL EXP, V71, P36	58	11	11	0	18	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 15	2014	31	20					1689	1699		10.1089/neu.2014.3331			11	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	AP8BF	WOS:000342302200002	24849726	Green Published			2021-06-18	
J	Skardelly, M; Gaber, K; Burdack, S; Scheidt, F; Schuhmann, MU; Hilbig, H; Meixensberger, J; Boltze, J				Skardelly, Marco; Gaber, Khaled; Burdack, Swen; Scheidt, Franziska; Schuhmann, Martin U.; Hilbig, Heidegard; Meixensberger, Juergen; Boltze, Johannes			Transient but not permanent benefit of neuronal progenitor cell therapy after traumatic brain injury: potential causes and translational consequences	FRONTIERS IN CELLULAR NEUROSCIENCE			English	Article						neural progenitor cells; cell therapy; TBI; long-term functional outcome; translational research	NEURAL STEM-CELLS; IMMUNE-RESPONSES; NITRIC-OXIDE; TRANSPLANTATION; NEUROGENESIS; STROKE; RECOVERY; CNS; ANGIOGENESIS; REGENERATION	Background: Numerous studies have reported a beneficial impact of neural progenitor cell transplantation on functional outcome after traumatic brain injury (TBI) during short and medium follow-up periods. However, our knowledge regarding long-term functional effects is fragmentary while a direct comparison between local and systemic transplantation is missing so far. Objectives: This study investigated the long-term (12 week) impact of human fetal neuronal progenitor cell (hNPC) transplantation 24 h after severe TB I in rats. Methods: Cells were either transplanted stereotactically (1 x 105) into the putamen or systemically (5 x 105) via the tail vein. Control animals received intravenous transplantation of vehicle solution. Results: An overall functional benefit was observed after systemic, but not local hNPC transplantation by area under the curve analysis (p < 0.01). Surprisingly, this effect vanished during later stages after TBI with all groups exhibiting comparable functional outcomes 84 days after TBI. Investigation of cell-mediated inflammatory processes revealed increasing microglial activation and macrophage presence during these stages, which was statistically significant after systemic cell administration (p < 0.05). Intracerebral hNPC transplantation slightly diminished astrogliosis in perilesional areas (p < 0.01), but did not translate into a permanent functional benefit. No significant effects on angiogenesis were observed among the groups. Conclusion: Our results suggest the careful long-term assessment of cell therapies for TBI, as well as to identify potential long-term detrimental effects of such therapies before moving on to clinical trials. Moreover, immunosuppressive protocols, though widely used, should be rigorously assessed for their applicability in the respective setup.	[Skardelly, Marco; Gaber, Khaled; Burdack, Swen; Scheidt, Franziska; Schuhmann, Martin U.; Meixensberger, Juergen] Univ Leipzig, Dept Neurosurg, D-04109 Leipzig, Germany; [Hilbig, Heidegard] Univ Leipzig, Inst Anat, D-04109 Leipzig, Germany; [Boltze, Johannes] Univ Leipzig, Fraunhofer Inst Cell Therapy & Immunol, D-04109 Leipzig, Germany; [Boltze, Johannes] Univ Leipzig, Translat Ctr Regenerat Med, D-04109 Leipzig, Germany; [Boltze, Johannes] Massachusetts Gen Hosp, Stroke & Neurovasc Regulat Lab, Charlestown, MA USA; [Boltze, Johannes] Harvard Univ, Sch Med, Charlestown, MA USA	Skardelly, M (corresponding author), Univ Tubingen, Dept Neurosurg, Hoppe Seyler Str 3, D-72076 Tubingen, Germany.	marco.skardelly@med.uni-tuebingen.de	Skardelly, Marco/AAF-8680-2021	Boltze, Johannes/0000-0003-3956-4164	funds of the Free State of Saxony distributed by the University of Leipzig [1-56]; Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG); Open Access Publishing Fund of Tuebingen University	The authors would like to thank Ingo Roeder for statistical support and Jochen Neuhaus for technical support. This work was supported by funds of the Free State of Saxony distributed by the University of Leipzig (Formel-1-program, 1-56). The authors acknowledge support from Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Tuebingen University.	Balseanu AT, 2014, FRONT AGING NEUROSCI, V6, DOI [10.3389/fnagi.2014.00130, 10.3389/fnagi.2014.00044]; Beck H, 2009, ACTA NEUROPATHOL, V117, P481, DOI 10.1007/s00401-009-0483-6; Boltze J, 2012, CELL TRANSPLANT, V21, P1199, DOI 10.3727/096368911X589609; Carson MJ, 2006, IMMUNOL REV, V213, P48, DOI 10.1111/j.1600-065X.2006.00441.x; Chen JL, 2005, J NEUROSCI, V25, P2366, DOI 10.1523/JNEUROSCI.5071-04.2005; Fischer UM, 2009, STEM CELLS DEV, V18, P683, DOI 10.1089/scd.2008.0253; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Galea I, 2007, TRENDS IMMUNOL, V28, P12, DOI 10.1016/j.it.2006.11.004; Gao JL, 2006, EXP NEUROL, V201, P281, DOI 10.1016/j.expneurol.2006.04.039; Gao X, 2013, EXP NEUROL, V239, P38, DOI 10.1016/j.expneurol.2012.09.012; Halloran PF, 1999, TRANSPLANTATION, V68, P1356, DOI 10.1097/00007890-199911150-00023; Harting MT, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/3-4/E17; Holmin S, 1999, NEUROREPORT, V10, P1889, DOI 10.1097/00001756-199906230-00017; Ji S, 2009, EXP NEUROL, V216, P321, DOI 10.1016/j.expneurol.2008.12.007; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Kiani A, 2000, IMMUNITY, V12, P359, DOI 10.1016/S1074-7613(00)80188-0; Kokaia Z, 2012, NAT NEUROSCI, V15, P1078, DOI 10.1038/nn.3163; Lu DY, 2002, CELL TRANSPLANT, V11, P275; Lu P, 2003, EXP NEUROL, V181, P115, DOI 10.1016/S0014-4886(03)00037-2; Maegele M, 2008, MINIM INVASIV THER, V17, P119, DOI 10.1080/13645700801970087; Mahmood A, 2006, J NEUROSURG, V104, P272, DOI 10.3171/jns.2006.104.2.272; Mahmood A, 2005, NEUROSURGERY, V57, P1026, DOI 10.1227/01.NEU.0000181369.76323.50; McIntosh TK, 1996, LAB INVEST, V74, P315; Mosher KI, 2012, NAT NEUROSCI, V15, P1485, DOI 10.1038/nn.3233; Mrass P, 2006, IMMUNOL REV, V213, P195, DOI 10.1111/j.1600-065X.2006.00433.x; Napoli I, 2009, NEUROSCIENCE, V158, P1030, DOI 10.1016/j.neuroscience.2008.06.046; Neumann H, 2001, GLIA, V36, P191, DOI 10.1002/glia.1108; Oki K, 2012, STEM CELLS, V30, P1120, DOI 10.1002/stem.1104; Richardson RM, 2010, J NEUROSURG, V112, P1125, DOI 10.3171/2009.4.JNS081087; Riess P, 2002, NEUROSURGERY, V51, P1043, DOI 10.1097/00006123-200210000-00035; Schouten JW, 2004, J NEUROTRAUM, V21, P1501, DOI 10.1089/neu.2004.21.1501; Schrepfer S, 2007, TRANSPL P, V39, P573, DOI 10.1016/j.transproceed.2006.12.019; Schwab JM, 2002, J NEUROSURG, V96, P892, DOI 10.3171/jns.2002.96.5.0892; Schwarz SC, 2006, PARKINSONISM RELAT D, V12, P302, DOI 10.1016/j.parkreldis.2006.01.003; Shindo T, 2006, J MED INVESTIG, V53, P42, DOI 10.2152/jmi.53.42; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Skardelly M, 2011, J NEUROTRAUM, V28, P401, DOI 10.1089/neu.2010.1526; Smith Quentin R, 2003, Methods Mol Med, V89, P193; Stichel CC, 1998, CELL TISSUE RES, V294, P1, DOI 10.1007/s004410051151; Teasdale GM, 1998, NEUROSURGERY, V43, P723, DOI 10.1097/00006123-199810000-00001; Walter L, 2009, SEMIN IMMUNOPATHOL, V31, P513, DOI 10.1007/s00281-009-0180-5; Wang L, 2009, EXP NEUROL, V216, P177, DOI 10.1016/j.expneurol.2008.11.017; Xiong Y, 2010, CURR OPIN INVEST DR, V11, P298; Yang Y, 2009, J GENE MED, V11, P899, DOI 10.1002/jgm.1377	44	11	12	0	5	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-5102		FRONT CELL NEUROSCI	Front. Cell. Neurosci.	OCT 14	2014	8								318	10.3389/fncel.2014.00318			13	Neurosciences	Neurosciences & Neurology	AS8WF	WOS:000344525200003	25352780	DOAJ Gold, Green Published			2021-06-18	
J	Fletcher, TL; Kolias, AG; Hutchinson, PJ; Sutcliffe, MPF				Fletcher, Tim L.; Kolias, Angelos G.; Hutchinson, Peter J.; Sutcliffe, Michael P. F.			A New Improved Method for Assessing Brain Deformation after Decompressive Craniectomy	PLOS ONE			English	Article							INJURY; PLATFORM	Background: Decompressive craniectomy (DC) is a surgical intervention used following traumatic brain injury to prevent or alleviate raised intracranial pressure. However the clinical effectiveness of the intervention remains in doubt. The location of the craniectomy (unilateral or bifrontal) might be expected to change the brain deformation associated with the operation and hence the clinical outcome. As existing methods for assessing brain deformation have several limitations, we sought to develop and validate a new improved method. Methods: Computed tomography (CT) scans were taken from 27 patients who underwent DC (17 bifrontal patients and 10 unilateral patients). Pre-operative and post-operative images were processed and registered to determine the change in brain position associated with the operation. The maximum deformation in the herniated brain, the change in volume and estimates of the craniectomy area were determined from the images. Statistical comparison was made using the Pearson's correlation coefficient r and a Welch's two-tailed T-test, with statistical significance reported at the 5% level. Results: There was a reasonable correlation between the volume increase and the maximum brain displacement (r = 0.64), a low correlation between the volume increase and the craniectomy area (r = 0.30) and no correlation between the maximum displacement and the craniectomy area (r = -0.01). The maximum deformation was significantly lower (P = 0.023) in the bifrontal patients (mean = 22.5 mm) compared with the unilateral patients (mean = 29.8 mm). Herniation volume was significantly lower (P = 0.023) in bifrontal (mean = 50.0 ml) than unilateral patients (mean = 107.3 ml). Craniectomy area was not significantly different for the two craniectomy locations (P = 0.29). Conclusions: A method has been developed to quantify changes in brain deformation due to decompressive craniectomy from CT images and allow comparison between different craniectomy locations. Measured displacement is a reasonable way to characterise volume changes.	[Fletcher, Tim L.; Sutcliffe, Michael P. F.] Univ Cambridge, Dept Engn, Cambridge CB2 1PZ, England; [Kolias, Angelos G.; Hutchinson, Peter J.] Addenbrookes Hosp, Div Neurosurg, Dept Clin Neurosci, Cambridge, England; [Kolias, Angelos G.; Hutchinson, Peter J.] Univ Cambridge, Cambridge, England	Sutcliffe, MPF (corresponding author), Univ Cambridge, Dept Engn, Cambridge CB2 1PZ, England.	mpfs@eng.cam.ac.uk		Kolias, Angelos/0000-0003-3992-0587; Hutchinson, Peter/0000-0002-2796-1835	Engineering and Physical Sciences Research Council (EPSRC)UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC); Royal College of Surgeons of England Research Fellowship - Freemasons and the Rosetrees Trust; National Institute of Health Research (NIHR) Academic Clinical FellowshipNational Institute for Health Research (NIHR); Raymond and Beverly Sackler Studentship; NIHR Research Professorship; NIHR Cambridge Biomedical Research CentreNational Institute for Health Research (NIHR); Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0601025] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NIHR-RP-R3-12-013, 12/35/57] Funding Source: researchfish	TLF acknowledges funding from the Engineering and Physical Sciences Research Council (EPSRC). AGK is supported by a Royal College of Surgeons of England Research Fellowship (funded by the Freemasons and the Rosetrees Trust), a National Institute of Health Research (NIHR) Academic Clinical Fellowship and a Raymond and Beverly Sackler Studentship. PJH is supported by a NIHR Research Professorship and the NIHR Cambridge Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Flint AC, 2008, J NEUROTRAUM, V25, P503, DOI 10.1089/neu.2007.0442; Frise E, 2008, LEVEL SETS FAST MARC; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Hutchinson Peter, 2007, Neurosurg Focus, V22, pE14; Hutchinson PJ, 2011, BRIT J NEUROSURG, V25, P441, DOI 10.3109/02688697.2011.583366; Johnson H, 2007, INSIGHT J; Kenning TJ, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0960; Kolias AG, 2013, NAT REV NEUROL, V9, P405, DOI 10.1038/nrneurol.2013.106; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Nock R, 2004, IEEE T PATTERN ANAL, V26, P1452, DOI 10.1109/TPAMI.2004.110; Pieper S, 2004, 2004 2ND IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING: MACRO TO NANO, VOLS 1 and 2, P632; Pieper S, 2006, I S BIOMED IMAGING, P698; Quinn TM, 2011, ACTA NEUROL SCAND, V123, P239, DOI 10.1111/j.1600-0404.2010.01397.x; Quintus K, 2010, MODULES LABELSTATIST; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Scahill RI, 2003, ARCH NEUROL-CHICAGO, V60, P989, DOI 10.1001/archneur.60.7.989; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Timofeev I, 2012, Adv Tech Stand Neurosurg, V38, P115, DOI 10.1007/978-3-7091-0676-1_6; Unser M, 1999, IEEE SIGNAL PROC MAG, V16, P22, DOI 10.1109/79.799930; Vashu R, 2011, ACTA NEUROCHIR, V153, P2065, DOI 10.1007/s00701-011-1101-7; von Holst H, 2012, ACTA NEUROCHIR, V154, P1583, DOI 10.1007/s00701-012-1393-2; Wirtz CR, 1997, NEUROSURG FOCUS, V2	22	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e110408	10.1371/journal.pone.0110408			7	Multidisciplinary Sciences	Science & Technology - Other Topics	AR6ZS	WOS:000343730400129	25303305	DOAJ Gold, Green Published			2021-06-18	
J	Chang, VC; Ruseckaite, R; Collie, A; Colantonio, A				Chang, Vicky C.; Ruseckaite, Rasa; Collie, Alex; Colantonio, Angela			Examining the epidemiology of work-related traumatic brain injury through a sex/gender lens: analysis of workers' compensation claims in Victoria, Australia	OCCUPATIONAL AND ENVIRONMENTAL MEDICINE			English	Article							GENDER-DIFFERENCES; WASHINGTON-STATE; SEX-DIFFERENCES; DISABILITY; PATTERNS; ONTARIO; HEALTH; IMPACT; COSTS; RATES	Objectives To provide an overview of the epidemiology of work-related traumatic brain injury (wrTBI) in the state of Victoria, Australia. Specifically, we investigated sex differences in incidence, demographics, injury characteristics, in addition to outcomes associated with wrTBI. Methods This study involved secondary analysis of administrative workers' compensation claims data obtained from the Victorian WorkCover Authority for the period 2004-2011. Sex-specific and industry-specific rates of wrTBI were calculated using denominators derived from the Australian Bureau of Statistics. A descriptive analysis of all variables was conducted for the total wrTBI population and stratified by sex. Results Among 4186 wrTBI cases identified, 36.4% were females. The annual incidence of wrTBI was estimated at 19.8/100 000 workers. The rate for males was 1.43 (95% CI 1.35 to 1.53) times that for females, but the gap between the two sexes appeared to have narrowed over time. Compared to males, females were older at time of injury and had lower preinjury income. Males had higher rates than females across most industry sectors, with the exception of education/training (RR 0.77, 95% CI 0.64 to 0.93) and professional/scientific/technical services (RR 0.64, 95% CI 0.44 to 0.93). For both sexes, the most common injury mechanism was struck by/against, followed by falls. WrTBI among males was associated with longer duration of work disability and higher claim costs compared to females. Conclusions This study found significant sex differences in various risk factors and outcomes of wrTBI. Sex/gender should be taken into consideration in future research and prevention strategies.	[Chang, Vicky C.; Colantonio, Angela] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5G 1V7, Canada; [Ruseckaite, Rasa; Collie, Alex] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Ruseckaite, Rasa; Collie, Alex] Monash Univ, Inst Safety Compensat & Recovery Res, Melbourne, Vic 3004, Australia; [Colantonio, Angela] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON M5G 1V7, Canada; [Colantonio, Angela] Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON, Canada	Colantonio, A (corresponding author), Univ Toronto, Dept Occupat Sci & Occupat Therapy, 160-500 Univ Ave, Toronto, ON M5G 1V7, Canada.	angela.colantonio@utoronto.ca	Ruseckaite, Rasa/H-4060-2014	Collie, Alex/0000-0003-2617-9339; Ruseckaite, Rasa/0000-0002-9078-2696; Colantonio, Angela/0000-0003-2094-4765; Chang, Vicky/0000-0002-2528-9387	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [494372]	This study, including support for Dr. Colantonio and Ms. Chang, was funded by the Canadian Institutes of Health Research (grant #494372). Data for the analysis conducted was provided by the Victorian WorkCover Authority via a grant to the Institute for Safety, Compensation and Recovery Research.	[Anonymous], 2013, 4125 0 GEND IND AUST; Australian Bureau of Statistics, 2006, ANZSCO AUSTR NZ STAN; Australian Bureau of Statistics, 2006, AUSTR NZ STAND IND C; Australian Bureau of Statistics, 2014, 6291 0 55 003 LAB FO; Australian Safety and Compensation Council, 2008, TYP OCC CLASS SYST; Baldo V, 2003, EUR J EPIDEMIOL, V18, P1059, DOI 10.1023/A:1026192020963; Berecki-Gisolf J, 2012, J OCCUP ENVIRON MED, V54, P318, DOI 10.1097/JOM.0b013e31823fdf9d; Chang VH, 2011, PM&R, V3, pS387, DOI 10.1016/j.pmrj.2011.08.007; Colantonio A, 2010, CAN J PUBLIC HEALTH, V101, pS58, DOI 10.1007/BF03403848; Cowley S, 2007, BRIT J SPORT MED, V41, P639, DOI 10.1136/bjsm.2006.032888; Driscoll T, 2003, OCCUP ENVIRON MED, V60, P195, DOI 10.1136/oem.60.3.195; Eng A, 2011, OCCUP ENVIRON MED, V68, P888, DOI 10.1136/oem.2010.064097; European Agency for Safety and Health at Work, 2003, GEND ISS SAF HLTH WO; Fan J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038750; Graves JM, 2013, J SAFETY RES, V45, P133, DOI 10.1016/j.jsr.2012.11.001; Harrold LR, 2008, DISABIL REHABIL, V30, P36, DOI 10.1080/09638280701192949; Helps Y., 2008, INJURY RES STAT SERI, V45; HEYER NJ, 1994, AM J PUBLIC HEALTH, V84, P1106, DOI 10.2105/AJPH.84.7.1106; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Institute for Safety Compensation and Recovery Research, 2014, WORKSAFE VICT DAT DI; Islam SS, 2001, AM J IND MED, V39, P84, DOI 10.1002/1097-0274(200101)39:1<84::AID-AJIM8>3.0.CO;2-T; Kim H, 2006, NEUROREHABILITATION, V21, P269; Kristman VL, 2008, BRAIN INJURY, V22, P51, DOI 10.1080/02699050701849991; Kristman VL, 2010, OPEN OCCUP HLTH SAF, V2, P1, DOI DOI 10.2174/1876216601002010001; Moore IC, 2011, OCCUP ENVIRON MED, V68, P837, DOI 10.1136/oem.2010.055913; Prang KH, 2012, BRAIN INJURY, V26, P1611, DOI 10.3109/02699052.2012.698790; Ruseckaite R, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002396; Ruseckaite R, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-492; Safe Work Australia, 2013, COMP WORK COMP STAT; Safe Work Australia, 2013, WORK REL INJ RES HOS; Sears JM, 2013, J OCCUP ENVIRON MED, V55, P507, DOI 10.1097/JOM.0b013e31827ee018; Sears JM, 2011, J OCCUP ENVIRON MED, V53, P1243, DOI 10.1097/JOM.0b013e31822cff63; Smith PM, 2004, OCCUP ENVIRON MED, V61, P750, DOI 10.1136/oem.2003.009860; Taiwo OA, 2009, AM J EPIDEMIOL, V169, P161, DOI 10.1093/aje/kwn304; Thompson A, 2007, CAN MED ASSOC J, V176, P343, DOI 10.1503/cmaj.060953; Tiesman HM, 2011, AM J PREV MED, V41, P61, DOI 10.1016/j.amepre.2011.03.007; Tricco AC, 2006, BRAIN INJURY, V20, P719, DOI 10.1080/02699050600664640; Wei Chia, 2012, Minn Med, V95, P55; Wrona RM, 2006, J SAFETY RES, V37, P75, DOI 10.1016/j.jsr.2005.08.008	39	11	11	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1351-0711	1470-7926		OCCUP ENVIRON MED	Occup. Environ. Med.	OCT	2014	71	10					695	703		10.1136/oemed-2014-102097			9	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	AP1SC	WOS:000341850500007	25052083				2021-06-18	
J	Foster, KA; Recker, MJ; Lee, PS; Bell, MJ; Tyler-Kabara, EC				Foster, Kimberly A.; Recker, Matthew J.; Lee, Philip S.; Bell, Michael J.; Tyler-Kabara, Elizabeth C.			Factors Associated with Hemispheric Hypodensity after Subdural Hematoma following Abusive Head Trauma in Children	JOURNAL OF NEUROTRAUMA			English	Article						abusive head trauma; hemispheric hypodensity; intracranial hypertension; severe traumatic brain injury; subdural hematoma	SHAKEN BABY SYNDROME; NONTRAUMATIC INFANT DEATHS; HYPOXIC-ISCHEMIC INJURY; PERMANENT BRAIN-DAMAGE; GLASGOW COMA SCALE; YOUNG-CHILDREN; PREDICTIVE FACTORS; INTRACRANIAL-PRESSURE; CEREBROSPINAL-FLUID; MENTAL-RETARDATION	Abusive head trauma (AHT) is a unique form of pediatric TBI with increased mortality and neurologic sequelae. Hemispheric hypodensity (HH) in association with subdural blood after AHT has been described. Though risk factors for HH are not understood, we hypothesized that risk factors could be identified. We retrospectively enrolled children under 5 years with TBI secondary to AHT (child advocacy diagnosis) who had undergone initial and interval brain imaging. Records were interrogated for prearrival and in-hospital physiologic and radiographic findings. HH was determined by a blinded observer. Twenty-four children were enrolled and 13 developed HH. HH was not significantly associated with age, initial Glascow Coma Scale, or mortality. Pediatric Intensity Level of Therapy (PILOT) scores (p = 0.01) and daily maximal intracranial pressure (ICPmax; p = 0.037) were higher in HH. Hypoxia, hypotension, cardiopulmonary arrest, need for blood transfusion, and daily blood glucoses tended to be greater in HH. Whereas all children with HH had acute subdural hematoma (SBH), many children without HH also had subdural blood; the presence of skull fracture was more likely in the children who did not develop HH (p = 0.04), but no other intracranial radiographic pattern of injury was associated with HH. Surgical intervention did not appear to protect against development of HH. A variety of insults associated with ischemia, including intracranial hypertension, ICP-directed therapies, hypoxia, hypotension, and cardiac arrest, occurred in the children who developed HH. Given the morbidity and mortality of this condition, larger studies to identify mechanisms leading to the development of HH and mitigating clinical approaches are warranted.	[Foster, Kimberly A.; Recker, Matthew J.; Lee, Philip S.; Bell, Michael J.; Tyler-Kabara, Elizabeth C.] Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15224 USA; [Bell, Michael J.] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA 15224 USA; [Bell, Michael J.] Univ Pittsburgh, Dept Pediat, Pittsburgh, PA 15224 USA; [Bell, Michael J.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15224 USA	Foster, KA (corresponding author), Univ Pittsburgh, Dept Neurosurg, 4th Floor Fac Pavil 4401 Penn Ave, Pittsburgh, PA 15224 USA.	fosterka@upmc.edu	Tyler-Kabara, Elizabeth/H-4930-2013	Tyler-Kabara, Elizabeth/0000-0003-3286-1094	ADAPT [U01 NS08 1041]	This work received grant support from ADAPT (U01 NS08 1041; to M.J.B.).	Adamo MA, 2009, J NEUROSURG-PEDIATR, V4, P414, DOI 10.3171/2009.6.PEDS0939; Barlow KM, 2005, PEDIATRICS, V116, pE174, DOI 10.1542/peds.2004-2739; Bayir H, 2002, PEDIATR RES, V51, P571, DOI 10.1203/00006450-200205000-00005; CAFFEY J, 1974, PEDIATRICS, V54, P396; CAFFEY J, 1972, AM J DIS CHILD, V124, P161, DOI 10.1001/archpedi.1972.02110140011001; Campbell CGN, 2004, CAN J NEUROL SCI, V31, P213, DOI 10.1017/S0317167100053853; Case ME, 2001, AM J FOREN MED PATH, V22, P112, DOI 10.1097/00000433-200106000-00002; Chiaretti A, 2002, CHILD NERV SYST, V18, P129, DOI 10.1007/s00381-002-0558-3; COHEN RA, 1986, AM J ROENTGENOL, V146, P97, DOI 10.2214/ajr.146.1.97; Dias MS, 1998, PEDIATR NEUROSURG, V29, P77, DOI 10.1159/000028694; Ducrocq SC, 2006, PEDIATR CRIT CARE ME, V7, P461, DOI 10.1097/01.PCC.0000235245.49129.27; Duhaime A.C., 1993, J NEUROTRAUMA S1, V10, pS59; Duhaime AC, 1996, PEDIATR NEUROSURG, V24, P292, DOI 10.1159/000121058; DUHAIME AC, 1987, J NEUROSURG, V66, P409, DOI 10.3171/jns.1987.66.3.0409; Duhaime AC, 2007, PROG BRAIN RES, V161, P293, DOI 10.1016/S0079-6123(06)61020-0; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Feickert HJ, 1999, J TRAUMA, V47, P33, DOI 10.1097/00005373-199907000-00008; Geddes JF, 2004, BMJ-BRIT MED J, V328, P719, DOI 10.1136/bmj.328.7442.719; Geddes JF, 2003, NEUROPATH APPL NEURO, V29, P14, DOI 10.1046/j.1365-2990.2003.00434.x; Geddes JF, 2001, BRAIN, V124, P1299, DOI 10.1093/brain/124.7.1299; Geddes JF, 2001, BRAIN, V124, P1290, DOI 10.1093/brain/124.7.1290; Gilles EE, 1998, PEDIATR NEUROL, V19, P119, DOI 10.1016/S0887-8994(98)00038-1; GOLDSTEIN B, 1993, CRIT CARE MED, V21, P1328, DOI 10.1097/00003246-199309000-00016; Graupman P, 2006, J NEUROSURG, V104, P245, DOI 10.3171/ped.2006.104.4.245; GUTHKELCH AN, 1971, BMJ-BRIT MED J, V2, P430, DOI 10.1136/bmj.2.5759.430; Hackbarth RM, 2002, CRIT CARE MED, V30, P1630, DOI 10.1097/00003246-200207000-00038; Hamilton BE, 2013, PEDIATRICS, V131, P548, DOI 10.1542/peds.2012-3769; Han Yong Y, 2002, Pediatr Crit Care Med, V3, P39, DOI 10.1097/00130478-200201000-00010; Harding B, 2004, BMJ-BRIT MED J, V328, P720, DOI 10.1136/bmj.328.7442.720; Hattori N, 2004, J NUCL MED, V45, P775; Haviland J, 1997, ARCH DIS CHILD, V77, P504, DOI 10.1136/adc.77.6.504; Hymel KP, 2007, PEDIATRICS, V119, P922, DOI 10.1542/peds.2006-3111; Ichord RN, 2007, J NEUROTRAUM, V24, P106, DOI 10.1089/neu.2006.0087; Jagannathan J, 2008, J NEUROSURG-PEDIATR, V2, P240, DOI 10.3171/PED.2008.2.10.240; Jayawant S, 1998, BMJ-BRIT MED J, V317, P1558, DOI 10.1136/bmj.317.7172.1558; Johnston MV, 2001, PEDIATR RES, V49, P735, DOI 10.1203/00006450-200106000-00003; Keenan HT, 2006, PEDIATRICS, V117, P1291, DOI 10.1542/peds.2005-1883; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Kemp AM, 2003, ARCH DIS CHILD, V88, P472, DOI 10.1136/adc.88.6.472; King WJ, 2003, CAN MED ASSOC J, V168, P155; Kokoska ER, 1998, J PEDIATR SURG, V33, P333, DOI 10.1016/S0022-3468(98)90457-2; KURODA Y, 1992, NEUROSURGERY, V30, P687; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LEVI L, 1991, BRIT J NEUROSURG, V5, P617, DOI 10.3109/02688699109002885; LEVIN HS, 1992, NEUROSURGERY, V31, P435, DOI 10.1227/00006123-199209000-00008; LIEHLAI MW, 1992, J PEDIATR-US, V120, P195, DOI 10.1016/S0022-3476(05)80426-3; Matschke J, 2009, PEDIATRICS, V124, P1587, DOI 10.1542/peds.2008-3734; MICHAUD LJ, 1992, NEUROSURGERY, V31, P254, DOI 10.1227/00006123-199208000-00010; MICHAUD LJ, 1993, PEDIATR CLIN N AM, V40, P553; MILLER JD, 1990, NEUROSURGERY, V27, P433, DOI 10.1227/00006123-199009000-00016; Miller M, 2004, PEDIATRICS, V114, P326, DOI 10.1542/peds.114.1.326; Muir ER, 2014, METHODS MOL BIOL, V1135, P205, DOI 10.1007/978-1-4939-0320-7_17; Ong LC, 1996, PEDIATR NEUROSURG, V24, P285, DOI 10.1159/000121057; Punt J, 2006, ARCH DIS CHILD, V91, P714; Punt J, 2004, Pediatr Rehabil, V7, P173, DOI 10.1080/13638490410001711515; Ragan DK, 2013, J CEREBR BLOOD F MET, V33, P48, DOI 10.1038/jcbfm.2012.130; Raghupathi R, 2004, J NEUROTRAUM, V21, P307, DOI 10.1089/089771504322972095; Rose ME, 2002, BRAIN RES, V943, P15, DOI 10.1016/S0006-8993(02)02471-X; Ruppel RA, 2002, NEUROSURG CLIN N AM, V13, P169, DOI 10.1016/S1042-3680(01)00005-5; Scavarda D, 2010, CHILD NERV SYST, V26, P1555, DOI 10.1007/s00381-010-1150-x; Shaver EG, 1996, PEDIATR NEUROSURG, V25, P123, DOI 10.1159/000121109; Shein SL, 2012, CRIT CARE MED, V40, P3115, DOI 10.1097/CCM.0b013e31826563c8; Shein SL, 2012, J PEDIATR-US, V161, P716, DOI 10.1016/j.jpeds.2012.03.046; Shore PM, 2006, CRIT CARE MED, V34, P1981, DOI 10.1097/01.CCM.0000220765.22184.ED; Smith C, 2003, NEUROPATH APPL NEURO, V29, P411, DOI 10.1046/j.1365-2990.2003.00500.x; Smith SL, 1998, J NEUROTRAUM, V15, P693, DOI 10.1089/neu.1998.15.693; Thakker JC, 1997, CRIT CARE MED, V25, P1396, DOI 10.1097/00003246-199708000-00030; Varma S, 2003, J NEUROTRAUM, V20, P781, DOI 10.1089/089771503767870005; White JRM, 2001, CRIT CARE MED, V29, P534, DOI 10.1097/00003246-200103000-00011	69	11	11	0	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 1	2014	31	19					1625	1631		10.1089/neu.2014.3372			7	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	AP5VI	WOS:000342146400004	24693985	Green Published			2021-06-18	
J	Lange, RP; Everett, A; Dulloor, P; Korley, FK; Bettegowda, C; Blair, C; Grossman, SA; Holdhoff, M				Lange, Ryan P.; Everett, Allen; Dulloor, Pratima; Korley, Frederick K.; Bettegowda, Chetan; Blair, Cherie; Grossman, Stuart A.; Holdhoff, Matthias			Evaluation of Eight Plasma Proteins as Candidate Blood-Based Biomarkers for Malignant Gliomas	CANCER INVESTIGATION			English	Article						Brain Tumors; Cancer Biomarkers; Circulating Biomarkers; Proteins; Glioma	FIBRILLARY ACIDIC PROTEIN; NEUROTROPHIC FACTOR BDNF; TRAUMATIC BRAIN-INJURY; SOLUBLE TELENCEPHALIN; METALLOTHIONEIN-III; ADHESION MOLECULE; GAMMA-SYNUCLEIN; BETA-SYNUCLEIN; SERUM; EXPRESSION	Eight brain-derived proteins were evaluated regarding their potential for further development as a blood-based biomarker for malignant gliomas. Plasma levels for glial fibrillary acidic protein, neurogranin, brain-derived neurotrophic factor, intracellular adhesion molecule 5, metallothionein-3, beta-synuclein, S100 and neuron specific enolase were tested in plasma of 23 patients with high-grade gliomas (WHO grade IV), 11 low-grade gliomas (WHO grade II), and 15 healthy subjects. Compared to the healthy controls, none of the proteins appeared to be specific for glioblastomas. However, the data are suggestive of higher protein levels in gliosarcomas (n = 2), which may deserve further exploration.	[Everett, Allen; Dulloor, Pratima] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Korley, Frederick K.] Johns Hopkins Univ, Sch Med, Dept Emergency Med, Baltimore, MD USA; [Bettegowda, Chetan] Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA; [Grossman, Stuart A.; Holdhoff, Matthias] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Bettegowda, Chetan; Blair, Cherie; Grossman, Stuart A.; Holdhoff, Matthias] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD 21287 USA	Holdhoff, M (corresponding author), Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Brain Canc Program, 1550 Orleans St,1M16, Baltimore, MD 21287 USA.	mholdho1@jhmi.edu			Robert H. Gross Memorial Fund; Retired Professional Fire Fighters Cancer Fund, Inc. (RPFFCF); Sidney Kimmel Comprehensive Cancer Center core grant [P30CA006973]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA006973] Funding Source: NIH RePORTER	This study was supported by the Robert H. Gross Memorial Fund, and Retired Professional Fire Fighters Cancer Fund, Inc. (RPFFCF). Support also came from P30CA006973 (Sidney Kimmel Comprehensive Cancer Center core grant).	Ahmad M, 2007, FASEB J, V21, P3419, DOI 10.1096/fj.07-8379rev; Bloomfield SM, 2007, NEUROCRIT CARE, V6, P121, DOI 10.1007/s12028-007-0008-x; Bohmer AE, 2011, NEUROSURGERY, V68, P1624, DOI 10.1227/NEU.0b013e318214a81f; Borusiak P, 2005, J NEUROL, V252, P493, DOI 10.1007/s00415-005-0668-4; Brandsma D, 2008, LANCET ONCOL, V9, P453, DOI 10.1016/S1470-2045(08)70125-6; Brommeland T, 2007, ACTA NEUROL SCAND, V116, P380, DOI 10.1111/j.1600-0404.2007.00889.x; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Frota ERC, 2009, NEUROSCI LETT, V460, P130, DOI 10.1016/j.neulet.2009.05.057; Dabrowski W, 2012, J CARDIOTHOR VASC AN, V26, P395, DOI 10.1053/j.jvca.2011.10.014; Di Lazzaro V, 2007, NEUROSCI LETT, V422, P128, DOI 10.1016/j.neulet.2007.06.001; Donato R, 2013, CURR MOL MED, V13, P24, DOI 10.2174/156652413804486214; Duffy MJ, 2007, EUR J CANCER, V43, P1348, DOI 10.1016/j.ejca.2007.03.021; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; FAGNART OC, 1988, CLIN CHEM, V34, P1387; Fujita M, 2009, J NEUROL, V256, pS286, DOI 10.1007/s00415-009-5246-8; Fung KM, 2003, ACTA NEUROPATHOL, V106, P167, DOI 10.1007/s00401-003-0718-x; Gahmberg CG, 2008, IMMUNOL LETT, V117, P131, DOI 10.1016/j.imlet.2008.02.004; Gartner W, 2010, NEURO-ONCOLOGY, V12, P1004, DOI 10.1093/neuonc/noq034; George JM, 2002, GENOME BIOL, V3; Holdhoff M, 2013, J NEURO-ONCOL, V113, P345, DOI 10.1007/s11060-013-1144-0; Howells C, 2010, FEBS J, V277, P2931, DOI 10.1111/j.1742-4658.2010.07718.x; Husain H, 2012, J NEURO-ONCOL, V109, P123, DOI 10.1007/s11060-012-0874-8; Ilhan-Mutlu A, 2013, J NEURO-ONCOL, V113, P359, DOI 10.1007/s11060-013-1134-2; Ilhan-Mutlu A, 2013, NEUROSURG REV, V36, P45, DOI 10.1007/s10143-012-0401-6; Jansen JFA, 2008, ACTA NEUROL SCAND, V118, P232, DOI 10.1111/j.1600-0404.2008.01005.x; Diez-Guerra FJ, 2010, IUBMB LIFE, V62, P597, DOI 10.1002/iub.357; Jung CS, 2007, BRAIN, V130, P3336, DOI 10.1093/brain/awm263; Kanner AA, 2003, CANCER, V97, P2806, DOI 10.1002/cncr.11409; Kleindienst A, 2006, J NEUROTRAUM, V23, P1185, DOI 10.1089/neu.2006.23.1185; Li Wen-bin, 2012, Cancer Biology Medicine, V9, P120, DOI 10.3969/j.issn.2095-3941.2012.02.007; Lin BY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010210; Lindsberg PJ, 2002, NEUROLOGY, V58, P446, DOI 10.1212/WNL.58.3.446; Luo Y, 2013, J BIOL INORG CHEM, V18, P39, DOI 10.1007/s00775-012-0947-3; Lyubimova NV, 2011, B EXP BIOL MED+, V150, P732, DOI 10.1007/s10517-011-1236-9; MACDONALD DR, 1990, J CLIN ONCOL, V8, P1277, DOI 10.1200/JCO.1990.8.7.1277; Mercier E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1757; Morita K, 2009, J MOL NEUROSCI, V38, P31, DOI 10.1007/s12031-008-9156-5; NAKAGAWARA A, 1994, MOL CELL BIOL, V14, P759, DOI 10.1128/MCB.14.1.759; Nordberg M, 1998, TALANTA, V46, P243, DOI 10.1016/S0039-9140(97)00345-7; PARTIN AW, 1993, J UROLOGY, V150, P110, DOI 10.1016/S0022-5347(17)35410-1; Rose EJ, 2012, TWIN RES HUM GENET, V15, P296, DOI 10.1017/thg.2012.7; Saruta J, 2012, ACTA HISTOCHEM CYTOC, V45, P211, DOI 10.1267/ahc.12005; Schiff L, 2012, MOL DIAGN THER, V16, P79, DOI 10.2165/11631580-000000000-00000; Stein DM, 2012, J NEUROTRAUM, V29, P1140, DOI 10.1089/neu.2011.2149; Surguchov A, 2013, J NEUROSCI RES, V91, P161, DOI 10.1002/jnr.23149; Thorsell A, 2010, BRAIN RES, V1362, P13, DOI 10.1016/j.brainres.2010.09.073; Tian L, 2008, BLOOD, V111, P3615, DOI 10.1182/blood-2007-09-111179; Vasak M, 2011, J BIOL INORG CHEM, V16, P1067, DOI 10.1007/s00775-011-0799-2; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Vutskits L, 2008, NEUROCHEM RES, V33, P1325, DOI 10.1007/s11064-007-9586-4; Wei H, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-7; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541; Werynska B, 2013, ANTICANCER RES, V33, P965; Wijeyaratne SM, 2009, EUR J VASC ENDOVASC, V38, P262, DOI 10.1016/j.ejvs.2009.05.011; Xie Q, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-77; Xiong J, 2013, NEURO-ONCOLOGY, V15, P990, DOI 10.1093/neuonc/not039; Yan T, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-524; Yanagitani S, 1999, LIFE SCI, V64, P707, DOI 10.1016/S0024-3205(98)00612-2; Yousuf S, 2013, NEUROSCIENCE, V239, P92, DOI 10.1016/j.neuroscience.2012.10.017	59	11	11	0	9	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0735-7907	1532-4192		CANCER INVEST	Cancer Invest.	OCT	2014	32	8					423	429		10.3109/07357907.2014.933237			7	Oncology	Oncology	AP3RA	WOS:000341993400007	25019213	Green Accepted			2021-06-18	
J	Mollica, RF; Chernoff, MC; Berthold, SM; Lavelle, J; Lyoo, IK; Renshaw, P				Mollica, Richard F.; Chernoff, Miriam C.; Berthold, S. Megan; Lavelle, James; Lyoo, In Kyoon; Renshaw, Perry			The mental health sequelae of traumatic head injury in South Vietnamese ex-political detainees who survived torture	COMPREHENSIVE PSYCHIATRY			English	Article							POSTTRAUMATIC-STRESS-DISORDER; HOPKINS SYMPTOM CHECKLIST-25; CONCENTRATION-CAMP SURVIVORS; DOSE-EFFECT RELATIONSHIPS; BRAIN-INJURY; PSYCHOLOGICAL SEQUELAE; PSYCHIATRIC-DISORDERS; CAMBODIAN SURVIVORS; POW SURVIVORS; FOLLOW-UP	Little is known about the relationship between traumatic head injury (THI) and psychiatric morbidity in torture survivors. We examine the relationship between THI and depression, PTSD, post-concussive syndrome (PCS), disability and poor health status in Vietnamese ex-political detainees who survived incarceration in Vietnamese re-education camps. A community sample of ex-political detainees (n = 337) and a non-THI, non-ex-detainee comparison group (n = 82) were surveyed. Seventy-eight percent of the ex-political detainees had experienced THI; 90.6% of the ex-political detainees and 3.6% of the comparison group had experienced 7 or more trauma events. Depression and PTSD were greater in ex-detainees than in the comparison group (40.9% vs 23.2% and 13.4% vs 0%). Dose-effect relationships for THI and trauma/torture in the ex-political detainee group were significant. Logistic regression in the pooled sample of ex-detainees and the comparison group confirmed the independent impact of THI from trauma/torture on psychiatric morbidity (OR for PTSD = 22.4; 95% CI: 3.0-165.8). These results demonstrate important effects of THI on depression and PTSD in Vietnamese ex-detainees who have survived torture. (C) 2014 Elsevier Inc. All rights reserved.	[Mollica, Richard F.; Lavelle, James] Massachusetts Gen Hosp, Dept Psychiat, Harvard Program Refugee Trauma, Boston, MA 02114 USA; [Chernoff, Miriam C.] Harvard Univ, Sch Publ Hlth, Ctr Biostat AIDS Res, Boston, MA 02115 USA; [Berthold, S. Megan] Univ Connecticut, Sch Social Work, West Harford, CT USA; [Lyoo, In Kyoon] Ewha Womans Univ, Grad Sch Pharmaceut Sci, Seoul, South Korea; [Lyoo, In Kyoon] Ewha Womans Univ, Ewha Brain Inst, Seoul, South Korea; [Renshaw, Perry] Univ Utah, Interdept Program Neurosci, Salt Lake City, UT USA	Mollica, RF (corresponding author), Harvard Program Refugee Trauma, 22 Putnam Ave, Cambridge, MA 02139 USA.	rmollica@partners.org; miriam.chernoff@juno.com; megan.berthold@uconn.edu; jlavelle@partners.org; inkylyoo@ewha.ac.kr; Perry.Renshaw@hsc.utah.edu			National Institute of Health, Bethesda, MarylandUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [MH R01-059559-04]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH059559] Funding Source: NIH RePORTER	Research for this manuscript was made possible by Grant No. MH R01-059559-04 from the National Institute of Health, Bethesda, Maryland. There are no conflicts of interest. The authors would like to acknowledge the following for their contributions to this study: (1) Vietnamese American Civic Association (VACA) and (2) Daniel H. Hovelson, BA, Harvard Program in Refugee Trauma.	ACS Strom, 1968, NORW CONC CAMP SURV; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069; ARMSTRONG C, 1991, J REHABIL, V57, P15; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; Bryant RA, 2001, CLIN PSYCHOL REV, V21, P931; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; Bryant RA, 2013, JAMA PSYCHIAT, V70, P839, DOI 10.1001/jamapsychiatry.2013.1137; Burnett A, 2001, BRIT MED J, V322, P606, DOI 10.1136/bmj.322.7286.606; Cassano P, 2002, J PSYCHOSOM RES, V53, P849, DOI 10.1016/S0022-3999(02)00304-5; Centers for Disease Control Prevention, 2004, HEADS FACTS PHYS MIL; Chemtob CM, 1998, J NERV MENT DIS, V186, P701, DOI 10.1097/00005053-199811000-00007; Cicerone KD, 2004, ARCH PHYS MED REHAB, V85, P943, DOI 10.1016/j.apmr.2003.07.019; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Doyle ST, 2013, BRAIN INJURY, V27, P1441, DOI 10.3109/02699052.2013.826505; Eaton WW, 1996, DIABETES CARE, V19, P1097, DOI 10.2337/diacare.19.10.1097; EITINGER L, 1965, ISRAEL J MED SCI, V1, P883; Eitinger L., 1973, MORTALITY MOBIDITY E; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; Fawzi MCS, 1997, J TRAUMA STRESS, V10, P101, DOI 10.1023/A:1024812514796; FLAHERTY JA, 1988, J NERV MENT DIS, V176, P257; Flannelly KJ, 2007, J NERV MENT DIS, V195, P996, DOI 10.1097/NMD.0b013e31815c19b1; Freedland KE, 2004, DIABETES SPECTR, V17, P150; Gil S, 2005, AM J PSYCHIAT, V162, P963, DOI 10.1176/appi.ajp.162.5.963; GOLDFELD AE, 1988, JAMA-J AM MED ASSOC, V259, P2725, DOI 10.1001/jama.259.18.2725; Gorst-Unsworth C, 1998, BRIT J PSYCHIAT, V172, P90, DOI 10.1192/bjp.172.1.90; GUALTIERI CT, 1995, NEUROPSY NEUROPSY BE, V8, P127; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; Hatch SL, 2007, AM J COMMUN PSYCHOL, V40, P313, DOI 10.1007/s10464-007-9134-z; Hendrickson Paul, 1996, LIVING DEAD R MCNAMA; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hollander AC, 2007, J NERV MENT DIS, V195, P955, DOI 10.1097/NMD.0b013e318159604b; Hunter JV, 2012, J NEUROTRAUM, V29, P654, DOI 10.1089/neu.2011.1906; IDLER EL, 1991, J GERONTOL, V46, pS55, DOI 10.1093/geronj/46.2.S55; International Amnesty, 1990, VIETN REN DOI MOI LA; Jacobs U, 2001, PROF PSYCHOL-RES PR, V32, P458, DOI 10.1037/0735-7028.32.5.458; JENSEN TS, 1982, NEW ENGL J MED, V307, P1341; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Joseph S, 1999, J TRAUMA STRESS, V12, P437, DOI 10.1023/A:1024762919372; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kay T., 1992, NEUROPSYCHOLOGY, V6, P371, DOI DOI 10.1037/0894-4105.6.4.371; Keatley E, 2013, J HEAD TRAUMA REHAB, V28, pE8, DOI 10.1097/HTR.0b013e3182776a70; King BS, 2000, SURG CLIN N AM, V80, P855, DOI 10.1016/S0039-6109(05)70100-6; King H, 2005, LANCET, V366, P1633, DOI 10.1016/S0140-6736(05)67662-3; Kleijn WC, 2001, PSYCHOL REP, V88, P527, DOI 10.2466/PR0.88.2.527-532; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; LEMESHOW S, 1982, AM J EPIDEMIOL, V115, P92, DOI 10.1093/oxfordjournals.aje.a113284; Manley GT, 2013, JAMA-J AM MED ASSOC, V310, P473, DOI 10.1001/jama.2013.169158; McAllister TW, 1997, COMMUNITY MENT HLT J, V33, P341, DOI 10.1023/A:1025055426260; Michael M, 1984, BIOMEDICAL BESTIARY; Mollica R, 1988, CLIN GUIDELINES CROS, P262; Mollica R. F., 2004, MEASURING TRAUMA MEA; MOLLICA RF, 1992, J NERV MENT DIS, V180, P111, DOI 10.1097/00005053-199202000-00008; MOLLICA RF, 1987, AM J PSYCHIAT, V144, P497; Mollica RF, 1998, J NERV MENT DIS, V186, P543, DOI 10.1097/00005053-199809000-00005; Mollica RF, 2002, BRIT J PSYCHIAT, V181, P339, DOI 10.1192/bjp.181.4.339; Mollica RF, 1998, BRIT J PSYCHIAT, V173, P482, DOI 10.1192/bjp.173.6.482; MOLLICA RF, 1993, JAMA-J AM MED ASSOC, V270, P581, DOI 10.1001/jama.270.5.581; Mollica RF, 2007, J NERV MENT DIS, V195, P572, DOI 10.1097/NMD.0b013e318093ed2c; Mollica RF, 2009, ARCH GEN PSYCHIAT, V66, P1221, DOI 10.1001/archgenpsychiatry.2009.127; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Moreno A, 2002, SPINAL CORD, V40, P213, DOI 10.1038/sj.sc.3101284; Murphy MP, 2012, NEUROREHABILITATION, V31, P85, DOI 10.3233/NRE-2012-0777; PETERSEN HD, 1985, FORENSIC SCI INT, V29, P179, DOI 10.1016/0379-0738(85)90111-2; QUIROGA J, 2006, TORTURE, V15, P1; Rasekh Z, 1998, JAMA-J AM MED ASSOC, V280, P449, DOI 10.1001/jama.280.5.449; RASMUSSEN OV, 1990, DAN MED BULL, V37, P1; Roemer L, 1998, J TRAUMA STRESS, V11, P597, DOI 10.1023/A:1024469116047; Ropper AH, 2007, NEW ENGL J MED, V356, P166, DOI 10.1056/NEJMcp064645; Ruff RM, 1999, BRAIN INJURY, V13, P943; *SAS I, 2001, SAS STAT SOFTW CHANG; Shrestha NM, 1998, JAMA-J AM MED ASSOC, V280, P443, DOI 10.1001/jama.280.5.443; Sinnerbrink I, 1997, J PSYCHOL, V131, P463, DOI 10.1080/00223989709603533; Southwick SM, 1997, AM J PSYCHIAT, V154, P173; Steel Z, 2002, LANCET, V360, P1056, DOI 10.1016/S0140-6736(02)11142-1; STEWART AL, 1988, MED CARE, V26, P724, DOI 10.1097/00005650-198807000-00007; STROM A, 1962, J NEUROPSYCHIATRY, V4, P43; Strom A, 1984, NORWEGIAN CONCENTRAT; Stulemeijer M, 2006, J NEUROL, V253, P1041, DOI 10.1007/s00415-006-0156-5; SUTKER PB, 1995, NEUROPSYCHOLOGY, V9, P118, DOI 10.1037/0894-4105.9.1.118; SUTKER PB, 1990, J PERS ASSESS, V54, P170, DOI 10.1207/s15327752jpa5401&2_17; The SAS Institute, 1999, SAS STAT US GUID VER; THYGESEN P, 1970, DAN MED BULL, V17, P65; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Vasterling JJ, 2000, J TRAUMA STRESS, V13, P441, DOI 10.1023/A:1007781107513; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; VonKorff M, 1996, J CLIN EPIDEMIOL, V49, P297, DOI 10.1016/0895-4356(95)00512-9; Ware J. E., 2001, SCORE INTERPRET SING; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Weinstein CS, 2001, NEUROPSYCHOL REV, V11, P131, DOI 10.1023/A:1016650623996; Weiss L, 1994, ATL MON, V273, P32; WESTERMEYER J, 1985, AM J PSYCHIAT, V142, P798; World Health Organization, 1980, INT CLASS IMP DIS HA	95	11	11	0	8	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0010-440X	1532-8384		COMPR PSYCHIAT	Compr. Psychiat.	OCT	2014	55	7					1626	1638		10.1016/j.comppsych.2014.04.014			13	Psychiatry	Psychiatry	AP5LX	WOS:000342121800023	24962448	Green Accepted			2021-06-18	
J	Varsos, GV; Budohoski, KP; Kolias, AG; Liu, XY; Smielewski, P; Varsos, VG; Hutchinson, PJ; Pickard, JD; Czosnyka, M				Varsos, Georgios V.; Budohoski, Karol P.; Kolias, Angelos G.; Liu, Xiuyun; Smielewski, Peter; Varsos, Vassilis G.; Hutchinson, Peter J.; Pickard, John D.; Czosnyka, Marek			Relationship of Vascular Wall Tension and Autoregulation Following Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						Traumatic brain injury; Wall tension; Critical closing pressure; Autoregulation; Outcome	CRITICAL CLOSING PRESSURE; CEREBRAL-BLOOD-FLOW; INTRACRANIAL-PRESSURE; PERFUSION-PRESSURE; HEAD-INJURY; REACTIVITY; HYPOTENSION; FREQUENCY; IMPEDANCE	The vascular wall tension (WT) of small cerebral vessels can be quantitatively estimated through the concept of critical closing pressure (CrCP), which denotes the lower limit of arterial blood pressure (ABP), below which small cerebral arterial vessels collapse and blood flow ceases. WT can be expressed as the difference between CrCP and intracranial pressure (ICP) and represent active vasomotor tone. In this study, we investigated the association of WT and CrCP with autoregulation and outcome of a large group of patients after traumatic brain injury (TBI). We retrospectively analysed recordings of ABP, ICP and transcranial Doppler (TCD) blood flow velocity from 280 TBI patients (median age: 29 years; interquartile range: 20-43). CrCP and WT were calculated using the cerebrovascular impedance methodology. Autoregulation was assessed based on TCD-based indices, Mx and ARI. Low values of WT were found to be associated with an impaired autoregulatory capacity, signified by its correlation to FV-based indices Mx (R = -0.138; p = 0.021) and ARI (R = 0.118; p = 0.048). No relationship could be established between CrCP and any of the autoregulatory indices. Neither CrCP nor WT was found to correlate with outcome. Impaired autoregulation was found to be associated with a lower WT supporting the role of vasoparalysis in the loss of autoregulatory capacity. In contrast, no links between CrCP and autoregulation could be identified.	[Varsos, Georgios V.; Budohoski, Karol P.; Kolias, Angelos G.; Liu, Xiuyun; Smielewski, Peter; Hutchinson, Peter J.; Pickard, John D.; Czosnyka, Marek] Univ Cambridge, Div Neurosurg, Dept Clin Neurosci, Addenbrookes Hosp, Cambridge CB2 0QQ, England; [Varsos, Vassilis G.] Red Cross Hosp, Dept Neurosurg, Athens, Greece; [Czosnyka, Marek] Warsaw Univ Technol, Inst Elect Syst, Warsaw, Poland	Varsos, GV (corresponding author), Univ Cambridge, Div Neurosurg, Dept Clin Neurosci, Addenbrookes Hosp, Hills Rd, Cambridge CB2 0QQ, England.	gv249@cam.ac.uk	Liu, Xiuyun/V-4427-2017	Liu, Xiuyun/0000-0001-9540-4865; Hutchinson, Peter/0000-0002-2796-1835; Kolias, Angelos/0000-0003-3992-0587; Smielewski, Peter/0000-0001-5096-3938	A. G. Leventis Foundation; St Edmund's College, Cambridge; Royal College of Surgeons of England Research Fellowship; National Institute for Health Research (NIHR)National Institute for Health Research (NIHR); Raymond and Beverly Sackler Studentship; NIHR Research Professorship; NIHR Cambridge Biomedical Research CentreNational Institute for Health Research (NIHR); NIHR Senior Investigator Award; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0001354, G1000183B, G0001237, G0600986, G9439390, G0001354B] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0508-10327, NIHR-RP-R3-12-013] Funding Source: researchfish	We would like to thank Gordon Stevenson, PhD, from Evelyn Perinatal Imaging Center, Rosie Hospital, Cambridge, for proof reading of this article. GVV is supported by an A. G. Leventis Foundation Scholarship, and a Charter Studentship from St Edmund's College, Cambridge. AGK is supported by a Royal College of Surgeons of England Research Fellowship, a National Institute for Health Research (NIHR) Academic Clinical Fellowship, and a Raymond and Beverly Sackler Studentship. PJH is supported by an NIHR Research Professorship, the NIHR Cambridge Biomedical Research Centre and has been appointed as the Surgical Specialty Lead for Neurosurgery, Royal College of Surgeons of England Clinical Research Initiative. JDP is supported by the NIHR Cambridge Biomedical Research Centre and an NIHR Senior Investigator Award. MC is NIHR Cambridge Biomedical Research Centre principal investigator on cerebrospinal dynamics.	Aaslid R, 1992, TRANSCRANIAL DOPPLER, P49; BOUMA GJ, 1992, J NEUROTRAUM, V9, pS333; Budohoski KP, 2012, NEUROSURGERY, V71, P652, DOI 10.1227/NEU.0b013e318260feb1; Carrera E, 2011, EUR J NEUROL, V18, P711, DOI 10.1111/j.1468-1331.2010.03247.x; COLD GE, 1978, ACTA ANAESTH SCAND, V22, P270, DOI 10.1111/j.1399-6576.1978.tb01301.x; Czosnyka M, 2006, ACTA NEUROCHIR SUPPL, V96, P114; CZOSNYKA M, 1994, ACTA NEUROCHIR, V126, P113, DOI 10.1007/BF01476419; Czosnyka M, 2005, J NEUROSURG, V102, P450, DOI 10.3171/jns.2005.102.3.0450; Czosnyka M, 1996, STROKE, V27, P1829, DOI 10.1161/01.STR.27.10.1829; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka M, 1998, J NEUROSURG, V88, P802, DOI 10.3171/jns.1998.88.5.0802; Czosnyka M, 1996, NEUROSURGERY, V38, P219, DOI 10.1097/00006123-199601000-00053; Czosnyka M, 2001, J NEUROSURG, V95, P756, DOI 10.3171/jns.2001.95.5.0756; Czosnyka M, 1999, J NEUROL NEUROSUR PS, V66, P606, DOI 10.1136/jnnp.66.5.606; de Riva N, 2012, NEUROCRIT CARE, V17, P58, DOI 10.1007/s12028-012-9672-6; DEWEY RC, 1974, J NEUROSURG, V41, P597, DOI 10.3171/jns.1974.41.5.0597; Kasprowicz M, 2012, NEUROCRIT CARE, V16, P213, DOI 10.1007/s12028-011-9653-1; Kim DJ, 2009, PHYSIOL MEAS, V30, P647, DOI 10.1088/0967-3334/30/7/009; Kolias Angelos G, 2013, Pract Neurol, V13, P228, DOI 10.1136/practneurol-2012-000268; KONTOS HA, 1978, AM J PHYSIOL, V234, pH371; Kumar A, 2005, J NEUROL NEUROSUR PS, V76, P1570, DOI 10.1136/jnnp.2004.059493; LASSEN NA, 1964, CIRC RES, V15, P201; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; Menon DK, 2005, ANAEST INTENS CARE M, V6, P184, DOI 10.1383/anes.6.6.184.65786; Michel E, 1997, J CEREBR BLOOD F MET, V17, P1127, DOI 10.1097/00004647-199710000-00015; NICHOL J, 1951, AM J PHYSIOL, V164, P330; OROURKE MF, 1967, CIRC RES, V20, P365, DOI 10.1161/01.RES.20.4.365; OVERGAARD J, 1974, J NEUROSURG, V41, P531, DOI 10.3171/jns.1974.41.5.0531; Panerai RB, 2003, MED ENG PHYS, V25, P621, DOI 10.1016/S1350-4533(03)00027-4; Panerai RB, 2004, BRIT J NEUROSURG, V18, P471, DOI 10.1080/02688690400012343; Panerai RB, 1999, AM J PHYSIOL-HEART C, V277, pH1089; PAULSON OB, 1990, CEREBROVAS BRAIN MET, V2, P161; Puppo Corina, 2012, Acta Neurochir Suppl, V114, P283, DOI 10.1007/978-3-7091-0956-4_55; TIECKS FP, 1995, STROKE, V26, P1014, DOI 10.1161/01.STR.26.6.1014; Varsos GV, 2014, NEUROCRIT CARE, V20, P40, DOI 10.1007/s12028-013-9913-3; Varsos GV, 2013, NEUROCRIT CARE, V18, P341, DOI 10.1007/s12028-013-9830-5; Varsos GV, 2013, J CEREBR BLOOD F MET, V33, P235, DOI 10.1038/jcbfm.2012.161	37	11	11	0	4	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	OCT	2014	21	2					266	274		10.1007/s12028-014-9971-1			9	Critical Care Medicine; Clinical Neurology	General & Internal Medicine; Neurosciences & Neurology	AQ9AR	WOS:000343132900014	24682849				2021-06-18	
J	Zheng, HB; Zhang, ZH; Luo, N; Liu, YY; Chen, QZ; Yan, H				Zheng, Huabin; Zhang, Zhuhong; Luo, Na; Liu, Yuanyuan; Chen, Qingzhong; Yan, Hua			Increased Th17 cells and IL-17 in rats with traumatic optic neuropathy	MOLECULAR MEDICINE REPORTS			English	Article						traumatic optic neuropathy; T helper 17 cells; interleukin-17; retina; optic nerve	REGULATORY T-CELLS; DISEASE; INJURY; AUTOIMMUNITY	T helper 17 (Th17) cells are strong inducers of numerous autoimmune diseases and inflammation. However, the role of Th17 cells and interleukin (IL)-17 in traumatic optic neuropathy (TON) are yet to be elucidated. In the present study, a rat model of TON was established using a fluid percussion brain injury device. Th17 cells were found to be upregulated in the spleens of rats in the TON group. In addition, the level of IL-17 in the retina of rats in the TON group was observed to increase with the upregulation of the Th17 cells. Furthermore, the expression of IL-17 in the optic nerve was found to be upregulated between one and seven days following injury in the rats in the TON group. These findings strongly suggest that the ratio of Th17 cells and the expression of IL-17 are upregulated in rats with TON. These findings also provide a rationale for developing therapeutic agents to treat TON.	[Zheng, Huabin; Zhang, Zhuhong; Liu, Yuanyuan; Chen, Qingzhong; Yan, Hua] Tianjin Med Univ, Gen Hosp, Dept Ophthalmol, Tianjin 300052, Peoples R China; [Luo, Na] Nankai Univ, Sch Med, Dept Immunol, Tianjin 300071, Peoples R China	Yan, H (corresponding author), Tianjin Med Univ, Gen Hosp, Dept Ophthalmol, 154 Anshan Rd, Tianjin 300052, Peoples R China.	phuayan2000@163.com			Tianjin application infrastructure and cutting-edge technology research program of China [10JCZDJC20300]	This study was supported by the Tianjin application infrastructure and cutting-edge technology research program of China (grant no. 10JCZDJC20300)	Afzali B, 2007, CLIN EXP IMMUNOL, V148, P32, DOI 10.1111/j.1365-2249.2007.03356.x; Basu R, 2013, IMMUNOL REV, V252, P89, DOI 10.1111/imr.12035; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bodanapally UK, 2013, J NEURO-OPHTHALMOL, V33, P128, DOI 10.1097/WNO.0b013e3182842553; Dardalhon V, 2008, J AUTOIMMUN, V31, P252, DOI 10.1016/j.jaut.2008.04.017; Dragon S, 2008, MOL IMMUNOL, V45, P160, DOI 10.1016/j.molimm.2007.04.027; Fisher J, 2001, J NEUROIMMUNOL, V119, P1, DOI 10.1016/S0165-5728(01)00342-3; Kipnis J, 2002, J NEUROIMMUNOL, V130, P78, DOI 10.1016/S0165-5728(02)00219-9; Li Y, 2011, J NEUROIMMUNOL, V234, P155, DOI 10.1016/j.jneuroim.2011.03.009; Miliaras G, 2013, J NEUROL SURG PART A, V74, P168, DOI 10.1055/s-0032-1330115; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; Mosmann TR, 2005, J IMMUNOL, V175, P5; Negi Akira, 2013, Nippon Ganka Gakkai Zasshi, V117, P187; Ortega C, 2013, INT REV IMMUNOL, V32, P534, DOI 10.3109/08830185.2013.834898; Peng Y, 2007, INVEST OPHTH VIS SCI, V48, P4153, DOI 10.1167/iovs.07-0251; Ropposch T, 2013, LARYNGOSCOPE, V123, P1082, DOI 10.1002/lary.23845; Schwartz M, 2004, BRAIN RES BULL, V62, P467, DOI 10.1016/S0361-9230(03)00076-5; Shi W, 2013, CHINESE MED J-PEKING, V126, P1292, DOI 10.3760/cma.j.issn.0366-6999.20122854; Steinsapir KD, 2011, AM J OPHTHALMOL, V151, P928, DOI 10.1016/j.ajo.2011.02.007; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Yan H, 2012, CURR EYE RES, V37, P941, DOI 10.3109/02713683.2012.691599; Yu Wai Man P, 2013, COCHRANE DB SYST REV, V6; Yu Wai Man P, 2013, COCHRANE DB SYST REV, V6	23	11	11	0	3	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	OCT	2014	10	4					1954	1958		10.3892/mmr.2014.2448			5	Oncology; Medicine, Research & Experimental	Oncology; Research & Experimental Medicine	AQ4AQ	WOS:000342735000044	25110203	Bronze			2021-06-18	
J	Hillary, FG; Medaglia, JD; Gates, KM; Molenaar, PC; Good, DC				Hillary, F. G.; Medaglia, J. D.; Gates, K. M.; Molenaar, P. C.; Good, D. C.			Examining network dynamics after traumatic brain injury using the extended unified SEM approach	BRAIN IMAGING AND BEHAVIOR			English	Article						fMRI; TBI; Brain injury; Rehabilitation; Working memory; Cognitive control	WORKING-MEMORY; EFFECTIVE CONNECTIVITY; PREFRONTAL CORTEX; FMRI; PERFORMANCE; ACTIVATION; SPEED; TASK; 2-DEOXYGLUCOSE; ATTENTION	The current study uses effective connectivity modeling to examine how individuals with traumatic brain injury (TBI) learn a new task. We make use of recent advancements in connectivity modeling (extended unified structural equation modeling, euSEM) and a novel iterative grouping procedure (Group Iterative Multiple Model Estimation, GIMME) in order to examine network flexibility after injury. The study enrolled 12 individuals sustaining moderate and severe TBI to examine the influence of task practice on connections between 8 network nodes (bilateral prefrontal cortex, anterior cingulate, inferior parietal lobule, and Crus I in the cerebellum). The data demonstrate alterations in networks from pre to post practice and differences in the models based upon distinct learning trajectories observed within the TBI sample. For example, better learning in the TBI sample was associated with diminished connectivity within frontal systems and increased frontal to parietal connectivity. These findings reveal the potential for using connectivity modeling and the euSEM to examine dynamic networks during task engagement and may ultimately be informative regarding when networks are moving in and out of periods of neural efficiency.	[Hillary, F. G.; Medaglia, J. D.] Penn State Univ, Dept Psychol, University Pk, PA 16802 USA; [Hillary, F. G.; Good, D. C.] Hershey Med Ctr, Dept Neurol, Hershey, PA USA	Hillary, FG (corresponding author), Penn State Univ, Dept Psychol, 347 Moore Bldg, University Pk, PA 16802 USA.	fhillary@psu.edu	Hillary, Frank/AAN-8622-2021		New Jersey Comission for Brain Injury Research [09.001.BIR1]	We wish to thank Julia Slocomb and Jeffrey Vesek for their efforts in subject recruitment and MRI data acquisition. This work was funded in part by the New Jersey Comission for Brain Injury Research (09.001.BIR1).	Albantakis L, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002086; Baddeley A, 1996, PHILOS T ROY SOC B, V351, P1397, DOI 10.1098/rstb.1996.0123; BADDELEY A, 1996, PHILOS T R SOC LON B, V351, P1403, DOI DOI 10.1098/RSTB.1996.0123; Bergerbest D, 2004, J COGNITIVE NEUROSCI, V16, P966, DOI 10.1162/0898929041502760; Braver TS, 1997, NEUROIMAGE, V5, P49, DOI 10.1006/nimg.1996.0247; Cohen JD, 2000, NAT NEUROSCI, V3, P421, DOI 10.1038/74783; Collette F, 1999, NEUROPSYCHOLOGIA, V37, P905, DOI 10.1016/S0028-3932(98)00148-1; DeLuca J, 2000, ARCH PHYS MED REHAB, V81, P1327, DOI 10.1053/apmr.2000.9390; Demaree HA, 1999, J NEUROL NEUROSUR PS, V67, P661, DOI 10.1136/jnnp.67.5.661; Friston KJ, 2009, PLOS BIOL, V7, P220, DOI 10.1371/journal.pbio.1000033; Friston KJ, 1996, NEUROIMAGE, V4, P97, DOI 10.1006/nimg.1996.0033; Gates KM, 2012, NEUROIMAGE, V63, P310, DOI 10.1016/j.neuroimage.2012.06.026; Gates KM, 2011, NEUROIMAGE, V54, P1151, DOI 10.1016/j.neuroimage.2010.08.051; Gates KM, 2010, NEUROIMAGE, V50, P1118, DOI 10.1016/j.neuroimage.2009.12.117; Gazzaniga MS, 2000, BRAIN, V123, P1293, DOI 10.1093/brain/123.7.1293; Hillary F., 2011, BRAIN 5, V134; Hillary FG, 2008, J INT NEUROPSYCH SOC, V14, P526, DOI 10.1017/S1355617708080788; Hillary FG, 2006, HUM BRAIN MAPP, V27, P837, DOI 10.1002/hbm.20226; Hillary FG, 2010, BRAIN IMAGING BEHAV, V4, P141, DOI 10.1007/s11682-010-9094-z; Honma M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012923; J oreskog KG, 1992, LISREL; JENSEN AR, 1966, ACTA PSYCHOL, V25, P36, DOI 10.1016/0001-6918(66)90004-7; Katori Y, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002266; Kim J, 2007, HUM BRAIN MAPP, V28, P85, DOI 10.1002/hbm.20259; KIRCHNER WK, 1958, J EXP PSYCHOL, V55, P352, DOI 10.1037/h0043688; Leavitt VM, 2012, MULT SCLER J, V18, P409, DOI 10.1177/1352458511423651; Maruishi M, 2007, J NEUROL NEUROSUR PS, V78, P168, DOI 10.1136/jnnp.2006.097345; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; MCINTOSH AR, 1991, BRAIN RES, V547, P295, DOI 10.1016/0006-8993(91)90974-Z; MCINTOSH AR, 1992, BRAIN RES, V578, P75, DOI 10.1016/0006-8993(92)90232-X; Medaglia JD, 2012, HUM BRAIN MAPP, V33, P979, DOI 10.1002/hbm.21264; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; MORRIS RG, 1988, J CLIN EXP NEUROPSYC, V10, P279, DOI 10.1080/01688638808408242; PARDO JV, 1991, NATURE, V349, P61, DOI 10.1038/349061a0; Price CJ, 2006, J MAGN RESON IMAGING, V23, P816, DOI 10.1002/jmri.20580; Price CJ, 1999, HUM BRAIN MAPP, V8, P102, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<102::AID-HBM6>3.0.CO;2-J; Price CJ, 2002, NEUROCASE, V8, P345, DOI 10.1076/neur.8.4.345.16186; Rosanova M, 2012, BRAIN, V135, P1308, DOI 10.1093/brain/awr340; Rypma B, 2006, NEUROIMAGE, V33, P969, DOI 10.1016/j.neuroimage.2006.05.065; Sanchez-Carrion R, 2008, J NEUROTRAUM, V25, P479, DOI 10.1089/neu.2007.0417; Sanchez-Carrion R, 2008, NEUROIMAGE, V43, P421, DOI 10.1016/j.neuroimage.2008.08.003; Scheibel RS, 2007, NEUROREHAB NEURAL RE, V21, P36, DOI 10.1177/1545968306294730; Smith SM, 2011, NEUROIMAGE, V54, P875, DOI 10.1016/j.neuroimage.2010.08.063; Speck O, 2000, NEUROREPORT, V11, P2581, DOI 10.1097/00001756-200008030-00046; Sporns O., 2011, NETWORKS BRAIN, P207; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; TEASDALE G, 1974, LANCET, V2, P81; Turner GR, 2008, NEUROLOGY, V71, P812, DOI 10.1212/01.wnl.0000325640.18235.1c; Turner GR, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00009; War Department Adjutant General's Office, 1944, ARM IND TEST BATT MA; Wechsler D., 1997, WAIS 3 ADM SCORING M	51	11	11	0	21	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	SEP	2014	8	3			SI		435	445		10.1007/s11682-012-9205-0			11	Neuroimaging	Neurosciences & Neurology	AP9ZR	WOS:000342441400012	23138853				2021-06-18	
J	Lacny, S; Marshall, DA; Currie, G; Kulin, NA; Meeuwisse, WH; Kang, J; Emery, CA				Lacny, Sarah; Marshall, Deborah A.; Currie, Gillian; Kulin, Nathalie A.; Meeuwisse, Willem H.; Kang, Jian; Emery, Carolyn A.			Reality check: the cost-effectiveness of removing body checking from youth ice hockey	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							RISK-FACTORS; SPORT PARTICIPATION; ECONOMIC-EVALUATION; INJURY RATES; SURVEILLANCE; CONCUSSION; PLAYERS; PROGRAM; CALGARY	Background/aim The risk of injury among Pee Wee (ages 11-12 years) ice hockey players in leagues that allow body checking is threefold greater than in leagues that do not allow body checking. We estimated the cost-effectiveness of a no body checking policy versus a policy that allows body checking in Pee Wee ice hockey. Methods Cost-effectiveness analysis alongside a prospective cohort study during the 2007-2008 season, including players in Quebec (n=1046), where policy did not allow body checking, and in Alberta (n=1108), where body checking was allowed. Injury incidence rates (injuries/1000 player-hours) and incidence proportions (injuries/100 players), adjusted for cluster using Poisson regression, allowed for standardised comparisons and meaningful translation to community stakeholders. Based on Alberta fee schedules, direct healthcare costs (physician visits, imaging, procedures) were adjusted for cluster using bootstrapping. We examined uncertainty in our estimates using cost-effectiveness planes. Results Associated with significantly higher injury rates, healthcare costs where policy allowed body checking were over 2.5 times higher than where policy disallowed body checking ($C473/1000 player-hours (95% CI $C358 to $C603) vs $C184/1000 player-hours (95% CI $C120 to $C257)). The difference in costs between provinces was $C289/1000 player-hours (95% CI $C153 to $C432). Projecting results onto Alberta Pee Wee players registered in the 2011-2012 season, an estimated 1273 injuries and $C213 280 in healthcare costs would be avoided during just one season with the policy change. Conclusion Our study suggests that a policy disallowing body checking in Pee Wee ice hockey is cost-saving (associated with fewer injuries and lower costs) compared to a policy allowing body checking. As we did not account for long-term outcomes, our results underestimate the economic impact of these injuries.	[Lacny, Sarah; Marshall, Deborah A.; Currie, Gillian; Kulin, Nathalie A.; Meeuwisse, Willem H.; Emery, Carolyn A.] Univ Calgary, Fac Med, Dept Community Hlth Sci, Calgary, AB T2N 1N4, Canada; [Marshall, Deborah A.] Alberta Bone & Joint Hlth Inst, Calgary, AB, Canada; [Marshall, Deborah A.] McCaig Inst Bone & Joint Hlth, Calgary, AB, Canada; [Currie, Gillian; Emery, Carolyn A.] Univ Calgary, Fac Med, Dept Pediat, Calgary, AB T2N 1N4, Canada; [Currie, Gillian; Emery, Carolyn A.] Alberta Childrens Prov Gen Hosp, Res Inst, Calgary, AB, Canada; [Meeuwisse, Willem H.; Kang, Jian; Emery, Carolyn A.] Univ Calgary, Fac Kinesiol, Sport Injury Prevent Res Ctr, Calgary, AB T2N 1N4, Canada	Emery, CA (corresponding author), Univ Calgary, Fac Kinesiol, Sport Injury Prevent Res Ctr, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	caemery@ucalgary.ca	Marshall, Deborah/J-7248-2015; Emery, Carolyn/AAI-2761-2020	Marshall, Deborah/0000-0002-8467-8008; 	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Max Bell Foundation; Alberta Innovates [201201160] Funding Source: researchfish	This study was funded by the Canadian Institutes of Health Research and Max Bell Foundation.	Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Billette JM., 2011, INJURIES CANADA INSI; Canadian Heritage, 2012, SPORT PART 2010; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Currie G, 2000, Inj Prev, V6, P175, DOI 10.1136/ip.6.3.175; Cusimano Michael D, 2011, Open Med, V5, pe57; DANIEL DM, 1994, AM J SPORT MED, V22, P632, DOI 10.1177/036354659402200511; Darling SR, 2011, BRIT J SPORT MED, V45, P492, DOI 10.1136/bjsm.2009.063693; Drawer S, 2001, BRIT J SPORT MED, V35, P402, DOI 10.1136/bjsm.35.6.402; Drummond MF, 2005, METHODS EVALUATION H; Emery CA, 2009, PAED CHILD HEALT-CAN, V14, P439, DOI 10.1093/pch/14.7.439; Emery CA, 2006, CLIN J SPORT MED, V16, P20, DOI 10.1097/01.jsm.0000184638.72075.b7; Emery CA, 2006, AM J SPORT MED, V34, P1960, DOI 10.1177/0363546506290061; Emery CA, 2010, JAMA-J AM MED ASSOC, V303, P2265, DOI 10.1001/jama.2010.755; Emery CA, 2010, INJURY PREV, V16, P113, DOI 10.1136/ip.2009.022764; Gillquist J, 1999, SPORTS MED, V27, P143, DOI 10.2165/00007256-199927030-00001; Goldberg AS, 2007, SPORTS MED, V37, P265, DOI 10.2165/00007256-200737030-00005; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hagel BE, 2006, CAN MED ASSOC J, V175, P155, DOI 10.1503/cmaj.051531; Harris AW, 2012, CLIN J SPORT MED, V22, P455, DOI 10.1097/JSM.0b013e318259ed09; Hockey Alberta, HOCK ALB 2012 ANN RE; Hupperets MDW, 2010, AM J SPORT MED, V38, P2194, DOI 10.1177/0363546510373470; Krist MR, 2013, J PHYSIOTHER, V59, P15, DOI 10.1016/S1836-9553(13)70142-5; Kukaswadia A, 2010, PEDIATRICS, V125, P735, DOI 10.1542/peds.2009-2083; SMARTRISK, 2009, EC BURD INJ CAN, P12; StataCorp, 2011, STAT STAT SOFTW REL; Statistics Canada, 2012, CANSIM TABL 326 0021; STUART MJ, 1995, MAYO CLIN PROC, V70, P350, DOI 10.4065/70.4.350; Verhagen EALM, 2005, BRIT J SPORT MED, V39, P111, DOI 10.1136/bjsm.2003.011031; Warsh JM, 2009, CLIN J SPORT MED, V19, P134, DOI 10.1097/JSM.0b013e3181987783	30	11	11	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	SEP	2014	48	17					1299	1305		10.1136/bjsports-2014-093493			7	Sport Sciences	Sport Sciences	AM9ZQ	WOS:000340241000008	24907373				2021-06-18	
J	Latini, L; Bisicchia, E; Sasso, V; Chiurchiu, V; Cavallucci, V; Molinari, M; Maccarrone, M; Viscomi, MT				Latini, L.; Bisicchia, E.; Sasso, V.; Chiurchiu, V.; Cavallucci, V.; Molinari, M.; Maccarrone, M.; Viscomi, M. T.			Cannabinoid CB2 receptor (CB2R) stimulation delays rubrospinal mitochondrial-dependent degeneration and improves functional recovery after spinal cord hemisection by ERK1/2 inactivation	CELL DEATH & DISEASE			English	Article							MESSENGER-RNA EXPRESSION; TRAUMATIC BRAIN-INJURY; RED NUCLEUS; ENDOCANNABINOID SYSTEM; MOTOR RECOVERY; BROWN-SEQUARD; CELL-DEATH; NEURONS; AXOTOMY; RAT	Spinal cord injury (SCI) is a devastating condition of CNS that often results in severe functional impairments for which there are no restorative therapies. As in other CNS injuries, in addition to the effects that are related to the primary site of damage, these impairments are caused by degeneration of distal regions that are connected functionally to the primary lesion site. Modulation of the endocannabinoid system (ECS) counteracts this neurodegeneration, and pharmacological modulation of type-2 cannabinoid receptor (CB2R) is a promising therapeutic target for several CNS pathologies, including SCI. This study examined the effects of CB2R modulation on the fate of axotomized rubrospinal neurons (RSNs) and functional recovery in a model of spinal cord dorsal hemisection (SCH) at the cervical level in rats. SCH induced CB2R expression, severe atrophy, and cell death in contralateral RSNs. Furthermore, SCH affected molecular changes in the apoptotic cascade in RSNs - increased cytochrome c release, apoptosome formation, and caspase-3 activity. CB2R stimulation by its selective agonist JWH-015 significantly increased the bcl-2/bax ratio, reduced cytochrome c release, delayed atrophy and degeneration, and improved spontaneous functional recovery through ERK1/2 inactivation. These findings implicate the ECS, particularly CB2R, as part of the endogenous neuroprotective response that is triggered after SCI. Thus, CB2R modulation might represent a promising therapeutic target that lacks psychotropic effects and can be used to exploit ECS-based approaches to counteract neuronal degeneration.	[Latini, L.; Bisicchia, E.; Sasso, V.; Chiurchiu, V.; Cavallucci, V.; Molinari, M.; Maccarrone, M.; Viscomi, M. T.] Santa Lucia Fdn, IRCCS 65, I-00179 Rome, Italy; [Chiurchiu, V.] Univ Teramo, Fac Vet Med, Teramo, Italy; [Maccarrone, M.] Campus Biomed Univ Rome, Ctr Integrated Res, Sch Med, Rome, Italy	Molinari, M (corresponding author), Santa Lucia Fdn, IRCCS 65, Via Ardeatina 354, I-00179 Rome, Italy.	m.molinari@hsantalucia.it; mt.viscomi@hsantalucia.it	Molinari, Marco/A-9624-2010; Viscomi, Maria Teresa/AAL-6625-2021; Latini, Laura/AAA-7654-2019; Viscomi, Maria Teresa/G-4173-2011; Maccarrone, Mauro/K-5398-2012; Chiurchiu, Valerio/G-6227-2011	Molinari, Marco/0000-0001-9808-9688; Viscomi, Maria Teresa/0000-0002-9096-4967; Maccarrone, Mauro/0000-0002-3990-2963; Chiurchiu, Valerio/0000-0002-0316-7311; Cavallucci, Virve/0000-0003-3082-6359; Latini, Laura/0000-0001-6480-0355	Italian Ministry of Health (Ricerca Corrente)Ministry of Health, Italy; Wings for Life Spinal Cord Research Foundation; International Foundation for Research in Paraplegia (IFP); program Young Researchers of Italian Ministry of Health [GR10.184]; PRINMinistry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)	This work was supported by Italian Ministry of Health (Ricerca Corrente; to M Molinari); by Wings for Life Spinal Cord Research Foundation (to MTV); partially by International Foundation for Research in Paraplegia (IFP) (to MTV); by program Young Researchers of Italian Ministry of Health (GR10.184; to MTV); and by PRIN 2010-2011 (to M Maccarrone). We thank Professor G Bernardi for his continuous support and encouragement. The professional editorial work of Blue Pencil Science is also acknowledged.	Adhikary S, 2011, J NEUROTRAUM, V28, P2417, DOI 10.1089/neu.2011.1853; Alger BE, 2011, TRENDS NEUROSCI, V34, P304, DOI 10.1016/j.tins.2011.03.003; Amantea D, 2007, FEBS J, V274, P4464, DOI 10.1111/j.1742-4658.2007.05975.x; Arevalo-Martin A, 2003, J NEUROSCI, V23, P2511; Arevalo-Martin A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049057; Arevalo-Martin A, 2010, NEUROBIOL DIS, V38, P304, DOI 10.1016/j.nbd.2010.02.002; Ashton JC, 2007, NEUROSCI LETT, V412, P114, DOI 10.1016/j.neulet.2006.10.053; Atwood BK, 2010, BRIT J PHARMACOL, V160, P467, DOI 10.1111/j.1476-5381.2010.00729.x; BARRON KD, 1989, J NEUROSCI RES, V22, P331, DOI 10.1002/jnr.490220313; Binkofski F, 1996, ANN NEUROL, V39, P460, DOI 10.1002/ana.410390408; Block F, 2005, PROG NEUROBIOL, V75, P342, DOI 10.1016/j.pneurobio.2005.03.004; Carter LM, 2011, EXP NEUROL, V228, P149, DOI 10.1016/j.expneurol.2010.12.023; Chiurchiu V, 2013, ANN NEUROL, V73, P626, DOI 10.1002/ana.23875; Cohen-Yeshurun A, 2011, J CEREBR BLOOD F MET, V31, P1768, DOI 10.1038/jcbfm.2011.53; Di Marzo V, 2008, REV PHYSIOL BIOCH P, V160, P1, DOI 10.1007/112_0505; EGAN DA, 1977, ACTA NEUROPATHOL, V37, P13, DOI 10.1007/BF00684534; Elliott MB, 2011, J NEUROTRAUM, V28, P973, DOI 10.1089/neu.2010.1672; FERINGA ER, 1988, EXP NEUROL, V100, P112, DOI 10.1016/0014-4886(88)90205-1; Fukuoka T, 1997, BRAIN RES, V767, P250, DOI 10.1016/S0006-8993(97)00715-4; Galluzzi L, 2012, NAT REV MOL CELL BIO, V13, P780, DOI 10.1038/nrm3479; Garcia-Ovejero D, 2009, NEUROBIOL DIS, V33, P57, DOI 10.1016/j.nbd.2008.09.015; Garrido C, 2006, CELL DEATH DIFFER, V13, P1423, DOI 10.1038/sj.cdd.4401950; Hamers FPT, 2006, J NEUROTRAUM, V23, P537, DOI 10.1089/neu.2006.23.537; Howlett AC, 2005, HANDB EXP PHARMACOL, V168, P53; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; JENKINS R, 1993, EUR J NEUROSCI, V5, P203, DOI 10.1111/j.1460-9568.1993.tb00486.x; Juan WS, 2012, CYTOM PART A, V81A, P400, DOI 10.1002/cyto.a.22021; Kobayashi NR, 1997, J NEUROSCI, V17, P9583; Kwon BK, 2002, P NATL ACAD SCI USA, V99, P3246, DOI 10.1073/pnas.052308899; Kwon BK, 2007, SPINE, V32, P1164, DOI 10.1097/BRS.0b013e318053ec35; LITTLE JW, 1985, PARAPLEGIA, V23, P39, DOI 10.1038/sc.1985.7; Liu PH, 2003, EXP NEUROL, V179, P111, DOI 10.1006/exnr.2002.8057; Liu Y, 2002, EXP NEUROL, V178, P150, DOI 10.1006/exnr.2002.7977; Maccarrone M, 2003, CELL DEATH DIFFER, V10, P946, DOI 10.1038/sj.cdd.4401284; MCBRIDE RL, 1989, J NEUROPATH EXP NEUR, V48, P568, DOI 10.1097/00005072-198909000-00007; Molina-Holgado F, 2005, MOL CELL NEUROSCI, V28, P189, DOI 10.1016/j.mcn.2004.09.004; Mori F, 1997, EXP NEUROL, V143, P45, DOI 10.1006/exnr.1996.6318; Oddi S, 2012, J MOL MED, V90, P371, DOI 10.1007/s00109-011-0846-z; Onaivi ES, 2011, CURR NEUROPHARMACOL, V9, P205, DOI 10.2174/157015911795017416; Onaivi ES, 2012, J PSYCHOPHARMACOL, V26, P92, DOI 10.1177/0269881111400652; Panikashvili D, 2001, NATURE, V413, P527, DOI 10.1038/35097089; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Raghupathi R, 2003, J NEUROTRAUM, V20, P421, DOI 10.1089/089771503765355504; Rossignol S, 2009, PHYSIOLOGY, V24, P127, DOI 10.1152/physiol.00042.2008; Rossignol S, 2011, ANNU REV NEUROSCI, V34, P413, DOI 10.1146/annurev-neuro-061010-113746; ROTH EJ, 1991, PARAPLEGIA, V29, P582, DOI 10.1038/sc.1991.86; Shohami E, 2011, BRIT J PHARMACOL, V163, P1402, DOI 10.1111/j.1476-5381.2011.01343.x; TETZLAFF W, 1991, J NEUROSCI, V11, P2528; Thuret S, 2006, NAT REV NEUROSCI, V7, P628, DOI 10.1038/nrn1955; Velayudhan L, 2014, CURR PHARM DESIGN, V20, P2218, DOI 10.2174/13816128113199990434; Viscomi MT, 2012, AUTOPHAGY, V8, P222, DOI 10.4161/auto.8.2.18599; Viscomi MT, 2009, J NEUROSCI, V29, P4564, DOI 10.1523/JNEUROSCI.0786-09.2009; Viscomi MT, 2014, MOL NEUROBIOL, V163, P1402; Xu M, 2000, EXP NEUROL, V161, P472, DOI 10.1006/exnr.1999.7278; Zhang M, 2007, J CEREBR BLOOD F MET, V27, P1387, DOI 10.1038/sj.jcbfm.9600447; Zhou LQ, 1999, NEUROREPORT, V10, P3417, DOI 10.1097/00001756-199911080-00029	56	11	12	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-4889			CELL DEATH DIS	Cell Death Dis.	SEP	2014	5								e1404	10.1038/cddis.2014.364			14	Cell Biology	Cell Biology	AQ9HS	WOS:000343162000005	25188514	DOAJ Gold, Green Published			2021-06-18	
J	Lovstad, M; Andelic, N; Knoph, R; Jerstad, T; Anke, A; Skandsen, T; Hauger, SL; Giacino, JT; Roe, C; Schanke, AK				Lovstad, Marianne; Andelic, Nada; Knoph, Rein; Jerstad, Tone; Anke, Audny; Skandsen, Toril; Hauger, Solveig L.; Giacino, Joseph T.; Roe, Cecilie; Schanke, Anne-Kristine			Rate of Disorders of Consciousness in a Prospective Population-Based Study of Adults With Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						incidence; minimally conscious state; outcome assessment; traumatic brain injury; vegetative state	HEAD-INJURY; VEGETATIVE STATE; RECOVERY; COMA; EPIDEMIOLOGY; SCALE; REHABILITATION; NEUROPATHOLOGY; MANAGEMENT; DIAGNOSIS	Objective: Establish rate of disorders of consciousness (DOC) and course of recovery in adults who have sustained severe traumatic brain injury (sTBI). Setting: Four Norwegian neurosurgical departments. Participants: Vegetative or minimally conscious patients. Design: Prospective, longitudinal population-based study of adults with sTBI with follow-ups at 3, 12, and 24-36 months postinjury. Main Measures: Coma Recovery Scale-Revised, Glasgow Coma Scale, Extended Glasgow Outcome Scale, and Disability Rating Scale. Results: Three months postinjury, 2% of the sTBI population remained in a vegetative or minimally conscious state, reduced by the half after 1 year, corresponding to average annual age-adjusted incidence rates of DOC of 0.09 per 100 000 3 months post-sTBI. At 3 and 12 months, the incidence was 0.06 and 0.01 per 100 000 for the vegetative state and 0.03 and 0.04 per 100 000 for the minimally conscious state. Diagnostic categorization was stable between 12 and 24-36 months, although clinically relevant improvements were observed in minimally conscious patients. Conclusion: The data suggest that prolonged DOC is rare following sTBI in Norway, contrary to the commonly held belief that improvements in intensive care treatment have resulted in an increased incidence of DOC. Prolonged DOC was associated with severity of injury, subcortical lesions, and diffuse axonal injury.	[Lovstad, Marianne; Hauger, Solveig L.; Schanke, Anne-Kristine] Sunnaas Rehabil Hosp, Res Dept, Nesodden, Norway; [Lovstad, Marianne; Schanke, Anne-Kristine] Univ Oslo, Dept Psychol, Oslo, Norway; [Andelic, Nada; Roe, Cecilie] Oslo Univ Hosp, Dept Phys Med & Rehabil, Oslo, Norway; [Jerstad, Tone] Oslo Univ Hosp, Dept Radiol, Oslo, Norway; [Knoph, Rein] Sorlandet Hosp, Dept Phys Med & Rehabil, Kristiansand, Norway; [Anke, Audny] Univ Hosp North Norway, Dept Rehabil, Tromso, Norway; [Anke, Audny] Univ Tromso, Dept Clin Med, Fac Hlth Sci, Tromso, Norway; [Skandsen, Toril] Univ Trondheim Hosp, Dept Phys Med & Rehabil, Trondheim, Norway; [Skandsen, Toril] Norwegian Univ Sci & Technol, Dept Neurosci, N-7034 Trondheim, Norway; [Giacino, Joseph T.] Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA USA; [Giacino, Joseph T.] Harvard Univ, Sch Med, Dept Phys Med & Rehabil, Boston, MA USA; [Roe, Cecilie] Univ Oslo, Fac Med, Oslo, Norway	Lovstad, M (corresponding author), Sunnaas Rehabil Hosp, Res Dept, N-1450 Nesoddtangen, Nesoddtangen, Norway.	mar.lovstad@gmail.com	Giacino, Joseph/AAF-1952-2021; Skandsen, Toril/P-6767-2014	Giacino, Joseph/0000-0002-7916-9698; Skandsen, Toril/0000-0001-5495-9338; Andelic, Nada/0000-0002-3719-4406; Anke, Audny/0000-0002-2491-2560	Norwegian Research CouncilResearch Council of NorwayEuropean Commission [185267]	This study was conducted with grants from the Norwegian Research Council (grant no. 185267).	ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Adams JH, 2000, BRAIN, V123, P1327, DOI 10.1093/brain/123.7.1327; Andelic N, 2012, NEUROEPIDEMIOLOGY, V38, P259, DOI 10.1159/000338032; Andelic N, 2008, NEUROEPIDEMIOLOGY, V30, P120, DOI 10.1159/000120025; Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; Annoni J M, 1992, Disabil Rehabil, V14, P23; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Beaumont JG, 2005, NEUROPSYCHOL REHABIL, V15, P184, DOI 10.1080/09602010443000489; Boly M, 2004, ARCH NEUROL-CHICAGO, V61, P233, DOI 10.1001/archneur.61.2.233; Borg J, 2011, AM J PHYS MED REHAB, V90, P65, DOI 10.1097/PHM.0b013e3181fc80e7; Bruno MA, 2012, J NEUROL, V259, P1087, DOI 10.1007/s00415-011-6303-7; CHILDS NL, 1993, NEUROLOGY, V43, P1465, DOI 10.1212/WNL.43.8.1465; Colantonio A, 2009, J TRAUMA, V66, P179, DOI 10.1097/TA.0b013e3181715d66; Coleman MR, 2009, BRAIN, V132, P2541, DOI 10.1093/brain/awp183; Estraneo A, 2010, NEUROLOGY, V75, P239, DOI 10.1212/WNL.0b013e3181e8e8cc; Gennarelli T.A., 2008, ABBREVIATED INJURY S; Giacino J, 2005, J HEAD TRAUMA REHAB, V20, P30, DOI 10.1097/00001199-200501000-00005; Giacino JT, 2006, ARCH PHYS MED REHAB, V87, pS67, DOI 10.1016/j.apmr.2006.07.272; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Godbolt AK, 2013, J REHABIL MED, V45, P741, DOI 10.2340/16501977-1167; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; Jennett B, 2002, J NEUROL NEUROSUR PS, V73, P355, DOI 10.1136/jnnp.73.4.355; Jennett B, 2001, NEUROLOGY, V56, P486, DOI 10.1212/WNL.56.4.486; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; Kelly DF, 2001, WORLD J SURG, V25, P1179; Kotchoubey B, 2005, PROG BRAIN RES, V150, P427, DOI 10.1016/S0079-6123(05)50030-X; Lammi MH, 2005, ARCH PHYS MED REHAB, V86, P746, DOI 10.1016/j.apmr.2004.11.004; Laureys S, 2002, NEUROIMAGE, V17, P732, DOI 10.1006/nimg.2002.1236; Laureys S, 2000, LANCET, V355, P1790, DOI 10.1016/S0140-6736(00)02271-6; Laureys S, 2000, BRAIN, V123, P1589, DOI 10.1093/brain/123.8.1589; Laureys S, 2007, CURR OPIN NEUROL, V20, P609, DOI 10.1097/WCO.0b013e3282f1d6dd; Lieberman JD, 2003, J TRAUMA, V55, P437, DOI 10.1097/01.TA.0000081882.79587.17; Lovstad M, 2010, J HEAD TRAUMA REHAB, V25, P349, DOI 10.1097/HTR.0b013e3181cec841; Luaute J, 2010, NEUROLOGY, V75, P246, DOI 10.1212/WNL.0b013e3181e8e8df; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maegele M, 2007, EUR SURG RES, V39, P372, DOI 10.1159/000107097; Masson F, 2003, BRAIN INJURY, V17, P279, DOI 10.1080/0269905021000030805; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; Nakase-Richardson R, 2012, J NEUROTRAUM, V29, P59, DOI 10.1089/neu.2011.1829; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Pisa FE, 2014, J HEAD TRAUMA REHAB, V29, pE23, DOI 10.1097/HTR.0b013e3182a4469f; Pryor JP, 2003, J TRAUMA, V55, P442; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Roe C, 2012, J NEUROL RES, V2, P134, DOI DOI 10.4021/JNR133W; Sazbon L, 2002, POST-TRAUMATIC VEGETATIVE STATE, P3; SAZBON L, 1992, Brain Injury, V6, P359, DOI 10.3109/02699059209034950; Schirmer-Mikalsen K, 2013, ACTA ANAESTH SCAND, V57, P46, DOI 10.1111/j.1399-6576.2012.02785.x; Schnakers C, 2008, NEUROLOGY, V71, P1614, DOI 10.1212/01.wnl.0000334754.15330.69; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Skandsen T, 2008, CLIN REHABIL, V22, P653, DOI 10.1177/0269215508089067; Sollid S, 2009, EMERG MED J, V26, P769, DOI 10.1136/emj.2008.061630; Strauss DJ, 2000, PEDIATR NEUROL, V23, P312, DOI 10.1016/S0887-8994(00)00194-6; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Taylor CM, 2007, ARCH PHYS MED REHAB, V88, P521, DOI 10.1016/j.apmr.2007.01.013; TEASDALE G, 1974, LANCET, V2, P81; Walder B, 2013, J NEUROTRAUMA; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	62	11	11	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2014	29	5					E31	E43		10.1097/HTR.0000000000000017			13	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	AP2GW	WOS:000341891700003	24413075				2021-06-18	
J	Mast, JE; Antonini, TN; Raj, SP; Oberjohn, KS; Cassedy, A; Makoroff, KL; Wade, SL				Mast, Jennifer E.; Antonini, Tanya N.; Raj, Stacey P.; Oberjohn, Karen S.; Cassedy, Amy; Makoroff, Kathi L.; Wade, Shari L.			Web-based parenting skills to reduce behavior problems following abusive head trauma: A pilot study	CHILD ABUSE & NEGLECT			English	Article						Traumatic brain injury; Rehabilitation; Abusive head trauma; Pediatrics; Online intervention	BRAIN-INJURY; YOUNG-CHILDREN; INFANTS	Pediatric abusive head trauma causes significant cognitive and behavioral morbidity, yet very few post-acute interventions exist to facilitate long-term recovery. To meet the needs of this vulnerable population, we piloted a web-based intervention with live coaching designed to improve positive parenting and child behavior. The efficacy of this parenting skills intervention was compared with access to Internet resources on brain injury. Participants included seven families (four randomized to the parenting intervention and three randomized to receive Internet resources). Parenting skills were observed and child behavior was rated at baseline and intervention completion. At completion, parents who received the parenting skills intervention showed significantly more positive parenting behaviors and fewer undesirable behaviors during play than parents who received access to Internet resources. Additionally, during play, children in the parenting skills intervention group were more compliant following parent commands than children in the Internet resources group. Lastly, parents who received the parenting intervention reported less intense oppositional and conduct behavior problems in their children post-intervention than did parents in the Internet resources group. These findings provide preliminary evidence for the use of this web-based positive parenting skills intervention to improve parenting skills and child behavior following abusive head trauma. (C) 2014 Elsevier Ltd. All rights reserved.	[Mast, Jennifer E.; Antonini, Tanya N.; Raj, Stacey P.; Oberjohn, Karen S.; Cassedy, Amy; Makoroff, Kathi L.; Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA; [Mast, Jennifer E.; Wade, Shari L.] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Antonini, Tanya N.] Univ Cincinnati, Cincinnati, OH USA; [Raj, Stacey P.] Miami Univ, Oxford, OH 45056 USA	Wade, SL (corresponding author), Cincinnati Childrens Hosp Med Ctr, 3333 Burnet Ave,ML 4009, Cincinnati, OH 45229 USA.						Achenbach T. M., 2000, MANUAL ASEBA PRESCHO; Achenbach TM, 2001, MANUAL ASEBA SCH AGE; Antonini TN, 2012, J TELEMED TELECARE, V18, P333, DOI 10.1258/jtt.2012.120404; Barlow J, 2006, COCHRANE DATABASE SY, V3; Berger RP, 2011, PEDIATRICS, V128, P637, DOI 10.1542/peds.2010-2185; BILLMIRE ME, 1985, PEDIATRICS, V75, P340; Carbaugh Suzanne Franklin, 2004, Adv Neonatal Care, V4, P105, DOI 10.1016/S1536-0903(04)00031-1; Duhaime AC, 1996, PEDIATR NEUROSURG, V24, P292, DOI 10.1159/000121058; Ekeland AG, 2010, INT J MED INFORM, V79, P736, DOI 10.1016/j.ijmedinf.2010.08.006; Ewing-Cobbs L., 2013, J INT NEUROPSYCH SOC, V19, P1; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Eyberg S., 1988, CHILD FAM BEHAV THER, V10, P33, DOI [DOI 10.1300/J019V10N01_04, 10.1300/J019v10n01_04]; Eyberg S., 1999, EYBERG CHILD BEHAV I; Eyberg S.M., 2005, MANUAL DYADIC PARENT, V3rd ed; EYBERG SM, 1995, PSYCHOPHARMACOL BULL, V31, P83; FEENEY TJ, 1995, J HEAD TRAUMA REHAB, V10, P67; Glueckauf RL, 2011, CAREGIVING-RES PRACT, P85, DOI 10.1007/978-1-4419-8031-1_7; Huang MI, 2011, J NEUROSURG-PEDIATR, V8, P171, DOI 10.3171/2011.5.PEDS1139; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Rosner B., 2006, FUNDAMENTALS BIOSTAT; Starling SP, 2000, SOUTHERN MED J, V93, P463; Woodcock R. W., 2001, EXAMINERS MANUAL WOO	22	11	11	0	16	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0145-2134	1873-7757		CHILD ABUSE NEGLECT	Child Abuse Negl.	SEP	2014	38	9					1487	1495		10.1016/j.chiabu.2014.04.012			9	Family Studies; Psychology, Social; Social Work	Family Studies; Psychology; Social Work	AP2IX	WOS:000341897000007	24844734				2021-06-18	
J	McCrea, M; Guskiewicz, K; Doncevic, S; Helmick, K; Kennedy, J; Boyd, C; Asmussen, S; Ahn, KW; Wang, Y; Hoelzle, J; Jaffee, M				McCrea, Michael; Guskiewicz, Kevin; Doncevic, Selina; Helmick, Katherine; Kennedy, Jan; Boyd, Cynthia; Asmussen, Sarah; Ahn, Kwang W.; Wang, Yanzhi; Hoelzle, James; Jaffee, Michael			Day of Injury Cognitive Performance on the Military Acute Concussion Evaluation (MACE) by US Military Service Members in OEF/OIF	MILITARY MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY	Objectives: The study investigated the clinical validity of the cognitive screening component of the Military Acute Concussion Evaluation (MACE) for the evaluation of acute mild traumatic brain injury (mTBI) in a military operational setting. Methods: This was a retrospective data study involving analysis of MACE data on Operation Enduring Freedom/Operation Iraqi Freedom deployed service members with mTBI. In total, 179 cases were included in analyses based on ICD-9 diagnostic codes and characteristics of mTBI, and availability of MACE data on day of injury. MACE data from the mTBI group was compared to a military sample without mTBI administered the MACE as part of a normative data project. Results: On day of injury, the mTBI group performed worse than controls on the MACE cognitive test (d = 0.90), with significant impairments in all cognitive domains assessed. MACE cognitive score was strongly associated with established indicators of acute injury severity. Lower MACE cognitive performance on day of injury was predictive of lengthier postinjury recovery time and time until return to duty after mTBI. Conclusions: Findings from the current study support the use of the MACE as a valid screening tool to assess for cognitive dysfunction in military service members during the acute phase after mTBI.	[McCrea, Michael] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [McCrea, Michael] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA; [Guskiewicz, Kevin] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC 27599 USA; [Guskiewicz, Kevin] Univ N Carolina, Dept Orthoped, Chapel Hill, NC 27599 USA; [Guskiewicz, Kevin] Univ N Carolina, Injury Prevent Res Ctr, Chapel Hill, NC 27599 USA; [Doncevic, Selina] Dept Vet Affairs, Bethesda, MD 20889 USA; [Kennedy, Jan; Boyd, Cynthia; Asmussen, Sarah] Def & Vet Brain Injury Ctr, Silver Spring, MD 20910 USA; [Ahn, Kwang W.; Wang, Yanzhi] Med Coll Wisconsin, Dept Biostat, Milwaukee, WI 53226 USA; [Hoelzle, James] Marquette Univ, Dept Psychol, Milwaukee, WI 53233 USA; [Jaffee, Michael] Univ Virginia, Dept Neurol, Charlottesville, VA 22908 USA	McCrea, M (corresponding author), Med Coll Wisconsin, Dept Neurosurg, 8701 West Watertown Plank Rd, Milwaukee, WI 53226 USA.			Guskiewicz, Kevin/0000-0002-8682-2130	United States Medical Research and Military Command (USAMRMC) through USAMRMC [PT 073286W81XWH-07-TBI-CA]	This study was funded by a cooperative agreement with the United States Medical Research and Military Command (USAMRMC) (PT 073286) through USAMRMC Funding Opportunity Number W81XWH-07-TBI-CA (M. McCrea, Principal Investigator).	Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Coldren RL, 2010, MIL MED, V175, P477, DOI 10.7205/MILMED-D-09-00258; *DVBIC, 2006, DEF VET BRAIN INJ CT; French L., 2008, J SPEC OPER MED, V8, P68; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Kelly MP, 2012, ARCH CLIN NEUROPSYCH, V27, P375, DOI 10.1093/arclin/acs036; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004	12	11	11	0	6	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	SEP	2014	179	9					990	997		10.7205/MILMED-D-13-00349			8	Medicine, General & Internal	General & Internal Medicine	CA7LF	WOS:000349098100015	25181717	Bronze			2021-06-18	
J	Messing, JA; Agnihothri, RV; Van Dusen, R; Najam, F; Dunne, JR; Honig, JR; Sarani, B				Messing, Jonathan A.; Agnihothri, Ritesh V.; Van Dusen, Rachel; Najam, Farzad; Dunne, James R.; Honig, Jacqueline R.; Sarani, Babak			Prolonged Use of Extracorporeal Membrane Oxygenation as a Rescue Modality Following Traumatic Brain Injury	ASAIO JOURNAL			English	Article						extracorporeal membrane oxygenation; traumatic brain injury; adult respiratory distress syndrome; anticoagulation	RESPIRATORY-FAILURE; LIFE-SUPPORT; ECMO; PROPHYLAXIS; CRANIOTOMY; BENEFITS; PATIENT; ADULT	A 21-year-old male trauma patient presented after a motor vehicle crash, witnessed massive aspiration and sustained traumatic brain injury. On postinjury day 3, the patient progressed to adult respiratory distress syndrome (ARDS) refractory to all conventional therapies, prompting the use of extracorporeal membrane oxygenation (ECMO). After 5 days of ECMO support and 3 thrombosed oxygenators, systemic anticoagulation was initiated. After 20 days of ECMO, 15 of which required systemic anticoagulation, the patient was decannulated and transferred to a rehabilitation facility. The patient is currently home without any neurological deficits. Although controversial, ECMO may serve a role as a rescue therapy in ARDS when conventional therapies fail in the brain-injured patient.	[Messing, Jonathan A.; Dunne, James R.; Sarani, Babak] George Washington Univ Hosp, Dept Trauma & Acute Care Surg, Washington, DC 20037 USA; [Agnihothri, Ritesh V.] George Washington Univ, Sch Med, Washington, DC USA; [Van Dusen, Rachel] George Washington Univ, Dept Surg Resident, Washington, DC USA; [Najam, Farzad] George Washington Univ Hosp, Dept Cardiothorac Surg, Washington, DC USA; [Honig, Jacqueline R.] George Washington Univ Hosp, Cardiothorac Intens Care Unit, Washington, DC USA	Messing, JA (corresponding author), George Washington Univ Hosp, Dept Trauma & Acute Care Surg, 900 23rd St, Washington, DC 20037 USA.	jmessing@mfa.gwu.edu		Sarani, Babak/0000-0001-6247-3004			Dudley RR, 2010, J NEUROTRAUM, V27, P2165, DOI 10.1089/neu.2010.1366; Friesenecker BE, 2005, ACTA NEUROCHIR, V147, P993, DOI 10.1007/s00701-005-0568-5; Kasirajan V, 1999, EUR J CARDIO-THORAC, V15, P508, DOI 10.1016/S1010-7940(99)00061-5; Kwiatt ME, 2012, J TRAUMA ACUTE CARE, V73, P625, DOI 10.1097/TA.0b013e318265cab9; Lidegran MK, 2007, ACAD RADIOL, V14, P62, DOI 10.1016/j.acra.2006.10.004; Madershahian N, 2007, J CARDIAC SURG, V22, P180, DOI 10.1111/j.1540-8191.2007.00381.x; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; Michaels AJ, 1999, J TRAUMA, V46, P638, DOI 10.1097/00005373-199904000-00013; Muellenbach RM, 2012, J TRAUMA ACUTE CARE, V72, P1444, DOI 10.1097/TA.0b013e31824d68e3; Peek GJ, 2009, LANCET, V374, P1351, DOI 10.1016/S0140-6736(09)61069-2; Peek GJ, 1997, CHEST, V112, P759, DOI 10.1378/chest.112.3.759; Pranikoff T, 1997, CRIT CARE MED, V25, P28, DOI 10.1097/00003246-199701000-00008; Reynolds HN, 1999, PERFUSION-UK, V14, P489, DOI 10.1177/026765919901400612; Scudday T, 2011, J AM COLL SURGEONS, V213, P148, DOI 10.1016/j.jamcollsurg.2011.02.027; Yen TS, 2008, CLIN NEUROL NEUROSUR, V110, P295, DOI 10.1016/j.clineuro.2007.10.017	15	11	11	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1058-2916	1538-943X		ASAIO J	Asaio J.	SEP-OCT	2014	60	5					597	599		10.1097/MAT.0000000000000103			3	Engineering, Biomedical; Transplantation	Engineering; Transplantation	AO9UR	WOS:000341704100018	24830802				2021-06-18	
J	Mojtahedzadeh, M; Ahmadi, A; Mahmoodpoor, A; Beigmohammadi, MT; Abdollahi, M; Khazaeipour, Z; Shaki, F; Kuochaki, B; Hendouei, N				Mojtahedzadeh, Mojtaba; Ahmadi, Arezoo; Mahmoodpoor, Ata; Beigmohammadi, Mohammad Taghi; Abdollahi, Mohammad; Khazaeipour, Zahra; Shaki, Fatemeh; Kuochaki, Bizhan; Hendouei, Narjes			Hypertonic saline solution reduces the oxidative stress responses in traumatic brain injury patients	JOURNAL OF RESEARCH IN MEDICAL SCIENCES			English	Article						Hypertonic saline; mannitol; oxidative stress response; traumatic brain injury patients	INFLAMMATORY RESPONSE; HEAD-INJURY; RATS; PATHOPHYSIOLOGY; MANAGEMENT; THERAPY; SYSTEM; RESUSCITATION; MECHANISMS; PRESSURE	Background: Oxidative stress processes play an important role in the pathogenesis of secondary brain injury after traumatic brain injury (TBI). Hypertonic saline (HTS) has advantages as being preferred osmotic agent, but few studies investigated oxidant and antioxidant effects of HTS in TBI. This study was designed to compare two different regimens of HTS 5% with mannitol on TBI-induced oxidative stress. Materials and Methods: Thirty-three adult patients with TBI were recruited and have randomly received one of the three protocols: 125 cc of HTS 5% every 6 h as bolus, 500 cc of HTS 5% as infusion for 24 h or 1 g/kg mannitol of 20% as a bolus, repeated with a dose of 0.25-0.5 g/kg every 6 h based on patient's response for 3 days. Serum total antioxidant power (TAP), reactive oxygen species (ROS) and nitric oxide (NO) were measured at baseline and daily for 3 days. Results: Initial serum ROS and NO levels in patients were higher than control (6.86 +/- [3.2] vs. 1.57 +/- [0.5] picoM, P = 0.001, 14.6 +/- [1.6] vs. 7.8 +/- [3.9] mM, P = 0.001, respectively). Levels of ROS have decreased for all patients, but reduction was significantly after HTS infusion and mannitol (3.08 [+/- 3.1] to 1.07 [+/- 1.6], P = 0.001, 5.6 [+/- 3.4] to 2.5 [+/- 1.8], P = 0.003 respectively). During study, NO levels significantly decreased in HTS infusion but significantly increased in mannitol. TAP Levels had decreased in all patients during study especially in mannitol (P = 0.004). Conclusion: Hypertonic saline 5% has significant effects on the oxidant responses compared to mannitol following TBI that makes HTS as a perfect therapeutic intervention for reducing unfavorable outcomes in TBI patients.	[Mojtahedzadeh, Mojtaba; Hendouei, Narjes] Univ Tehran Med Sci, Fac Pharm, Dept Pharmacotherapy, Tehran, Iran; [Abdollahi, Mohammad] Univ Tehran Med Sci, Dept Pharmacol & Toxicol, Fac Pharm, Toxicol Lab, Tehran, Iran; [Abdollahi, Mohammad] Univ Tehran Med Sci, Pharmaceut Sci Res Ctr, Tehran, Iran; [Khazaeipour, Zahra] Univ Tehran Med Sci, Inst Neurosci, Brain & Spinal Injury Res Ctr, Tehran, Iran; [Ahmadi, Arezoo; Beigmohammadi, Mohammad Taghi] Univ Tehran Med Sci, Sch Med, Dept Anesthesia & Crit Care, Tehran, Iran; [Ahmadi, Arezoo; Beigmohammadi, Mohammad Taghi] Univ Tehran Med Sci, Hlth Serv, Tehran, Iran; [Mahmoodpoor, Ata] Tabriz Univ Med Sci, Sch Med, Dept Anesthesia & Crit Care, Tabriz, Iran; [Mahmoodpoor, Ata] Tabriz Univ Med Sci, Hlth Serv, Tabriz, Iran; [Shaki, Fatemeh] Mazandaran Univ Med Sci, Dept Pharmacol & Toxicol, Sari, Iran; [Kuochaki, Bizhan; Hendouei, Narjes] Mazandaran Univ Med Sci, Fac Pharm, Dept Pharmacotherapy, Sari, Iran; [Kuochaki, Bizhan; Hendouei, Narjes] Mazandaran Univ Med Sci, Hlth Serv, Sari, Iran	Hendouei, N (corresponding author), Mazandaran Univ Med Sci, Addict Inst, Fac Pharm & Psychiat, Dept Pharmacotherapy, 20th Km Farahabad Rd, Sari, Iran.	hendoieen@yahoo.com	mahmoodpoor, Ata/AAD-6597-2021; Abdollahi, Mohammad/B-9232-2008	mahmoodpoor, Ata/0000-0002-4361-6230; Abdollahi, Mohammad/0000-0003-0123-1209; Shaki, Fatemeh/0000-0001-5861-656X	Tehran University of Medical SciencesTehran University of Medical Sciences [45861]	This research was financially supported by Tehran University of Medical Sciences (grant number: 45861).	Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Bratton SL., 2007, J NEUROTRAUM, V24, pS91, DOI [10.1089/neu.2007.9981, DOI 10.1089/NEU.2007.9981]; Bulger EM, 2007, ANN SURG, V245, P635, DOI 10.1097/01.sla.0000251367.44890.ae; Haddad SH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-12; HALL ED, 1993, ANN EMERG MED, V22, P1022, DOI 10.1016/S0196-0644(05)82745-3; Hendoui N, 2013, EUR REV MED PHARMACO, V17, P477; Hicdonmez T, 2006, NEUROCHEM RES, V31, P473, DOI 10.1007/s11064-006-9040-z; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kamel H, 2011, CRIT CARE MED, V39, P554, DOI 10.1097/CCM.0b013e318206b9be; Khanna S, 2000, CRIT CARE MED, V28, P1144, DOI 10.1097/00003246-200004000-00038; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Madikians A, 2006, INDIAN J NEUROTRAUM, V3, P9; Mazzeo AT, 2009, EXP NEUROL, V218, P363, DOI 10.1016/j.expneurol.2009.05.026; Mohammadi H, 2011, TOXICOL IND HEALTH, V27, P417, DOI 10.1177/0748233710387634; Mostafalou S, 2012, ADV PHARM BULL, V2, P79, DOI 10.5681/apb.2012.011; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; Oh RC, 2011, AM FAM PHYSICIAN, V84, P1003; Palevsky PM, 2013, UP TO DATE      0911; Ray SK, 2002, HISTOL HISTOPATHOL, V17, P1137, DOI 10.14670/HH-17.1137; Ropper AH, 2012, NEW ENGL J MED, V367, P746, DOI 10.1056/NEJMct1206321; Shohami E, 1997, J CEREBR BLOOD F MET, V17, P1007, DOI 10.1097/00004647-199710000-00002; Simma B, 1998, CRIT CARE MED, V26, P1265, DOI 10.1097/00003246-199807000-00032; Sivonova M, 2008, CELL MOL NEUROBIOL, V28, P431, DOI 10.1007/s10571-007-9246-x; Sun YX, 2013, J SURG RES, V185, P477, DOI 10.1016/j.jss.2013.06.039; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; Veenith Tonny, 2009, World J Emerg Surg, V4, P7, DOI 10.1186/1749-7922-4-7; Vosylius S, 2004, CROAT MED J, V45, P715; Wagner AK, 2005, CRIT CARE MED, V33, P407, DOI 10.1097/01.CCM.0000153931.23488.DD; Wagner AK, 2004, J NEUROTRAUM, V21, P125, DOI 10.1089/089771504322778596; Weant KA, 2008, ADV EMERG NURS J, V30, P17, DOI 10.1097/01.TME.0000311542.95656.92; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Yancy CW, 2013, CIRCULATION, V128, P1810, DOI 10.1161/CIR.0b013e31829e8807; Yilmaz N, 2007, BRAIN RES, V1164, P132, DOI 10.1016/j.brainres.2007.06.017; Zeng HK, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-153; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	36	11	13	0	5	ISFAHAN UNIV MED SCIENCES	ISFAHAN	HEZARJERIB AVE, PO BOX 81745-319, ISFAHAN, 00000, IRAN	1735-1995	1735-7136		J RES MED SCI	J. Res. Med. Sci.	SEP	2014	19	9					867	874					8	Medicine, General & Internal	General & Internal Medicine	AY4LG	WOS:000347549000013	25535502				2021-06-18	
J	Orman, G; Tekes, A; Poretti, A; Robertson, C; Huisman, TAGM				Orman, Gunes; Tekes, Aylin; Poretti, Andrea; Robertson, Courtney; Huisman, Thierry A. G. M.			Posttraumatic Carotid Artery Dissection in Children: Not to be missed!	JOURNAL OF NEUROIMAGING			English	Article						Children; head trauma; neck trauma; carotid artery; dissection; neuroimaging	TRAUMATIC BRAIN-INJURY; UNIQUE FEATURES; PEDIATRIC SKULL; ISCHEMIC-STROKE; COMPLICATIONS; ANGIOGRAPHY; MECHANISMS; CHILDHOOD; DIAGNOSIS; PATTERNS	BACKGROUND Post-traumatic carotid artery dissection (PTCAD) may result in acute arterial ischemic stroke (AIS). Pediatric PTCAD is rarely diagnosed prior to onset of neurological symptoms. We report on neuroimaging findings in a series of children with PTCAD. METHODS Five children with head or neck trauma were included in this study. Clinical histories were reviewed for mechanism of trauma, symptoms, complications, therapy, and outcome. Computed tomography (CT), magnetic resonance imaging (MRI), and CT/MR angiography (CTA, MRA) studies were retrospectively evaluated for signs and complications of PTCAD and presence and extent of skull base fractures. RESULTS PTCAD was located at the level of the skull base in all children and was associated with a skull base fracture in two. The diagnosis was made in five children by combined MRI/MRA and in two by CTA. Air in the carotid canal suggested skull base injury with PTCAD in two children. PTCAD was complicated by AIS in three children. CONCLUSION PTCAD may result from neck and head trauma. To avoid secondary AIS, radiologists should be familiar with neuroimaging findings in children, especially as acute PTCAD may initially be clinically silent. Consequently, pediatric neuroradiologists should actively exclude PTCAD in children with head and neck trauma.	[Orman, Gunes; Tekes, Aylin; Poretti, Andrea; Huisman, Thierry A. G. M.] Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol, Sect Pediat Neuroradiol,Div Pediat Radiol, Baltimore, MD USA; [Robertson, Courtney] Johns Hopkins Univ, Sch Med, Dept Pediat, Pediat Intens Care Unit, Baltimore, MD 21205 USA	Huisman, TAGM (corresponding author), Charlotte R Bloomberg Childrens Ctr, Russell H Morgan Dept Radiol & Radiol Sci, Sheikh Zayed Tower,Room 4174,1800 Orleans St, Baltimore, MD 21287 USA.	thuisma1@jhmi.edu	Poretti, Andrea/H-6269-2019	Poretti, Andrea/0000-0002-9594-3858			Agner C, 2005, CHILD NERV SYST, V21, P416, DOI 10.1007/s00381-004-1056-6; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Camacho A, 2001, PEDIATR NEUROL, V25, P250, DOI 10.1016/S0887-8994(01)00294-6; Chabrier S, 2003, EUR J PAEDIATR NEURO, V7, P39, DOI 10.1016/S1090-3798(02)00138-1; Chamoun RB, 2008, J NEUROS-PEDIATR, V2, P101, DOI 10.3171/PED/2008/2/8/101; de Borst GJ, 2006, PEDIATR NEUROL, V34, P408, DOI 10.1016/j.pediatrneurol.2005.09.005; Fullerton HJ, 2001, NEUROLOGY, V57, P1155, DOI 10.1212/WNL.57.7.1155; Ganesan V, 2011, NEUROLOGY, V76, P166, DOI 10.1212/WNL.0b013e318205d4d5; Giroud M, 1997, ACTA NEUROL SCAND, V96, P401, DOI 10.1111/j.1600-0404.1997.tb00306.x; Jones TS, 2012, AM J SURG, V204, P7, DOI 10.1016/j.amjsurg.2011.07.015; Kopelman TR, 2011, J TRAUMA, V71, P559, DOI 10.1097/TA.0b013e318226eadd; Lequin MH, 2004, EUR J PAEDIATR NEURO, V8, P155, DOI 10.1016/j.ejpn.2004.02.001; Levack MM, 2009, J PEDIATR SURG, V44, pE29, DOI 10.1016/j.jpedsurg.2009.05.026; LEVY C, 1994, RADIOLOGY, V190, P97, DOI 10.1148/radiology.190.1.8259436; Lew SM, 1999, PEDIATR NEUROSURG, V30, P239, DOI 10.1159/000028804; Moriarty JM, 2009, IRISH J MED SCI, V178, P535, DOI 10.1007/s11845-009-0374-9; Mortazavi MM, 2011, CHILD NERV SYST, V27, P2045, DOI 10.1007/s00381-011-1409-x; Oelerich M, 1999, EUR RADIOL, V9, P1385, DOI 10.1007/s003300050853; PATEL H, 1995, PEDIATR NEUROL, V13, P55, DOI 10.1016/0887-8994(95)00056-L; Pierrot S, 2006, ANN OTO RHINOL LARYN, V115, P323, DOI 10.1177/000348940611500501; Pinto PS, 2012, J NEUROIMAGING, V22, pe18, DOI 10.1111/j.1552-6569.2011.00690.x; Pinto PS, 2012, J NEUROIMAGING, V22, pe1, DOI 10.1111/j.1552-6569.2011.00688.x; Rafay MF, 2006, J CHILD NEUROL, V21, P8, DOI 10.1177/08830738060210010101; Robertson WC, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-16; Rommel O, 1999, CEREBROVASC DIS, V9, P202, DOI 10.1159/000015956; Silverboard G, 2000, Semin Pediatr Neurol, V7, P289, DOI 10.1053/spen.2000.2077; Tabarki B, 1997, ARCH PEDIATRIE, V4, P763, DOI 10.1016/S0929-693X(97)83418-5; York G, 2005, AM J ROENTGENOL, V184, P1672, DOI 10.2214/ajr.184.5.01841672	28	11	13	0	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1051-2284	1552-6569		J NEUROIMAGING	J. Neuroimaging	SEP-OCT	2014	24	5					467	472		10.1111/jon.12071			6	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	AP3PW	WOS:000341990200005	24251954				2021-06-18	
J	Zhou, L; Lin, JH; Lin, JM; Kui, GJ; Zhang, JH; Yu, YG				Zhou, Long; Lin, Jinhuang; Lin, Junming; Kui, Guoju; Zhang, Jianhua; Yu, Yigang			Neuroprotective effects of vagus nerve stimulation on traumatic brain injury	NEURAL REGENERATION RESEARCH			English	Article						nerve regeneration; brain injury; vagus nerve stimulation; tumor necrosis factor-alpha; interleukin-1 beta; interleukin-10; brain tissue pathology; protection; explosive injury; mechanisms; hydrocephalus; neural regeneration	SYSTEMIC INFLAMMATORY RESPONSE; CLOSED-HEAD INJURY; ALZHEIMERS-DISEASE; CLINICAL-TRIAL; RATS; SECONDARY; EPILEPSY; BARRIER; NEURONS	Previous studies have shown that vagus nerve stimulation can improve the prognosis of traumatic brain injury. The aim of this study was to elucidate the mechanism of the neuroprotective effects of vagus nerve stimulation in rabbits with brain explosive injury. Rabbits with brain explosive injury received continuous stimulation (10 V, 5 Hz, 5 ms, 20 minutes) of the right cervical vagus nerve. Tumor necrosis factor-alpha, interleukin-1 beta and interleulcin-10 concentrations were detected in serum and brain tissues, and water content in brain tissues was measured. Results showed that vagus nerve stimulation could reduce the degree of brain edema, decrease tumor necrosis factor-alpha and interleuldn-1 beta concentrations, and increase interleukin-10 concentration after brain explosive injury in rabbits. These data suggest that vagus nerve stimulation may exert neuroprotective effects against explosive injury via regulating the expression of tumor necrosis factor-alpha, interleukin-1 beta and interleukin-10 in the serum and brain tissue.	[Zhou, Long; Lin, Jinhuang; Lin, Junming; Kui, Guoju; Yu, Yigang] Xiamen Univ, Affiliated Dongnan Hosp, Hosp Chinese PLA 175, Trauma Neurosurg Ctr Nanjing Mil Reg, Xiamen 363000, Fujian, Peoples R China; [Zhang, Jianhua] 73131 Corps Chinese PLA, Xiamen, Fujian, Peoples R China	Yu, YG (corresponding author), Xiamen Univ, Affiliated Dongnan Hosp, Hosp Chinese PLA 175, Trauma Neurosurg Ctr Nanjing Mil Reg, Xiamen 363000, Fujian, Peoples R China.	yu-yg@tom.com					Arundine M, 2004, J NEUROSCI, V24, P8106, DOI 10.1523/JNEUROSCI.1362-04.2004; Ben-Menachem E, 2002, LANCET NEUROL, V1, P477, DOI 10.1016/S1474-4422(02)00220-X; Borovikova LV, 2000, NATURE, V405, P458; Clough RW, 2007, NEUROSCIENCE, V147, P286, DOI 10.1016/j.neuroscience.2007.04.043; Englot DJ, 2012, J NEUROSURG, V117, P970, DOI 10.3171/2012.8.JNS122; Hayward P, 2008, LANCET NEUROL, V7, P200, DOI 10.1016/S1474-4422(08)70032-2; Kilbourne M, 2009, J NEUROTRAUM, V26, P2233, DOI 10.1089/neu.2009.0968; Kumaria A, 2008, BRIT J NEUROSURG, V22, P200, DOI 10.1080/02688690701772413; Kumaria A, 2012, BRIT J NEUROSURG, V26, P316, DOI 10.3109/02688697.2012.663517; Lopez NE, 2012, J TRAUMA ACUTE CARE, V72, P1562, DOI 10.1097/TA.0b013e3182569875; Lu J, 2000, NEUROSCI LETT, V290, P89, DOI 10.1016/S0304-3940(00)01307-0; Lu J, 2001, J NEUROTRAUM, V18, P399, DOI 10.1089/089771501750170976; Lu J, 2009, FRONT BIOSCI-LANDMRK, V14, P3795, DOI 10.2735/3489; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Jimenez CM, 2013, WORLD NEUROSURG, V79, P749, DOI 10.1016/j.wneu.2012.06.025; Merrill CA, 2006, J CLIN PSYCHIAT, V67, P1171, DOI 10.4088/JCP.v67n0801; Neese SL, 2007, BRAIN RES, V1128, P157, DOI 10.1016/j.brainres.2006.09.073; Shi C, 2013, NEUROL RES, V35, P263, DOI 10.1179/1743132813Y.0000000167; Sjogren MJC, 2002, J CLIN PSYCHIAT, V63, P972, DOI 10.4088/JCP.v63n1103; Stella N, 2012, SCIENCE, V338, P1303, DOI 10.1126/science.1232331; Wang GH, 2011, J NEUROTRAUM, V28, P2123, DOI 10.1089/neu.2011.1939; Wang XL, 2013, ZHONGHUA SHIYAN WAIK, V30, P1484; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	23	11	14	0	6	SHENYANG EDITORIAL DEPT NEURAL REGENERATION RES	SHENYANG	PO BOX 1234, SHENYANG, LIAONING 110004, PEOPLES R CHINA	1673-5374			NEURAL REGEN RES	Neural Regen. Res.	SEP	2014	9	17					1585	1591		10.4103/1673-5374.141783			7	Cell Biology; Neurosciences	Cell Biology; Neurosciences & Neurology	AQ7AK	WOS:000342964800004	25368644	DOAJ Gold, Green Published			2021-06-18	
J	Augustine, C; Cepinskas, G; Fraser, DD				Augustine, C.; Cepinskas, G.; Fraser, D. D.		Canadian Critical Care Translation	TRAUMATIC INJURY ELICITS JNK-MEDIATED HUMAN ASTROCYTE RETRACTION IN VITRO	NEUROSCIENCE			English	Article						trauma; human; astrocytes; brain microvascular endothelial cells; blood-brain barrier	BLOOD-BRAIN-BARRIER; STRETCH-INDUCED INJURY; ACTIVATED PROTEIN-KINASE; N-TERMINAL KINASE; SIGNAL-TRANSDUCTION; ENDOTHELIAL-CELLS; INHIBITION; CHILDREN; VIVO; SP600125	Brain injury causes dysfunction of the blood-brain barrier (BBB). The BBB is comprised of perivascular astrocytes whose end-feet ensheath brain microvascular endothelial cells. We investigated trauma-induced morphological changes of human astrocytes (HA) and human cerebral microvascular endothelial cells (hCMEC/D3) in vitro, including the potential role of mitogen-activated protein kinase (MAPK) signal-transduction pathways. HA or hCMEC/D3 were grown on flexible culture membranes and subjected to single traumatic injury normalized to 20%, 30% or 55% membrane deformation. Cells were assayed for morphological changes (i.e. retraction) and MAPK phosphorylation and/or expression (c-Jun NH2-terminal kinase (JNK) 1/2, extracellular signal-regulated kinase (ERK) 1/2, and p38). HA retraction was rapidly elicited with a single traumatic injury (55% membrane deformation; p < 0.01). Morphological recovery of HA was observed within 2 h (p < 0.05). Traumatic injuries increased phospho-JNK1/2 (p < 0.05) in HA, indicating MAPK activation. Pre-treatment of HA with structurally distinct JNK inhibitors (25 mu M), either SP600125 or SU3327, reduced JNK phosphorylation (p < 0.05) and trauma-induced HA retraction (P < 0.05). In contrast to HA, traumatic injury failed to induce either morphological changes or MAPK activation in hCMEC/D3. In summary, traumatic injury induces JNK-mediated HA retraction in vitro, while sparing morphological changes in cerebral microvascular endothelial cells. Astrocyte retraction from microvascular endothelial cells in vivo may occur after brain trauma, resulting in cellular uncoupling and BBB dysfunction. JNK may represent a potential therapeutic target for traumatic brain injuries. (C) 2014 IBRO. Published by Elsevier Ltd. All rights reserved.	[Augustine, C.; Fraser, D. D.] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada; [Augustine, C.; Fraser, D. D.] Childrens Hlth Res Inst, London, ON, Canada; [Augustine, C.; Cepinskas, G.; Fraser, D. D.] Ctr Crit Illness Res, London, ON, Canada; [Cepinskas, G.] Univ Western Ontario, Dept Med Biophys, London, ON, Canada; [Cepinskas, G.] Univ Western Ontario, Dept Med, London, ON, Canada; [Fraser, D. D.] Univ Western Ontario, Dept Paediat, London, ON, Canada; [Fraser, D. D.] Univ Western Ontario, Dept Clin Neurol Sci, London, ON, Canada	Fraser, DD (corresponding author), Childrens Hosp, LHSC, Room C2-C82,800,Commissioners Rd E, London, ON N6A 5W9, Canada.	douglas.fraser@lhsc.on.ca	Cepinskas, Gediminas/V-3810-2019	Cepinskas, Gediminas/0000-0002-0267-6659	Department of Pediatrics, Western University; Children's Health Foundation; PSI Foundation; Heart and Stroke FoundationHeart & Stroke Foundation of Canada [NA-6914]	We thank Drs. Jamie Hutchison and Greg Hare of the Canadian Critical Care Translational Biology Group for independent manuscript review, and Dr. Jamie Seabrook of the Children's Health Research Institute for an independent statistical review. CA received graduate student funding from the Department of Pediatrics, Western University, and the Children's Health Foundation. DDF is supported by the PSI Foundation and the Children's Health Foundation. GC is supported by the Heart and Stroke Foundation (NA-6914).	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; BRADBURY MWB, 1985, CIRC RES, V57, P213, DOI 10.1161/01.RES.57.2.213; Castejon OJ, 1998, BRAIN INJURY, V12, P409, DOI 10.1080/026990598122539; Chang LF, 2003, DEV CELL, V4, P521, DOI 10.1016/S1534-5807(03)00094-7; Daoud H, 2013, NEUROCRIT CARE; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; De SK, 2009, J MED CHEM, V52, P1943, DOI 10.1021/jm801503n; DeVries HE, 1997, PHARMACOL REV, V49, P143; Dhandapani KM, 2003, J BIOL CHEM, V278, P43329, DOI 10.1074/jbc.M305835200; Ducrocq SC, 2006, PEDIATR CRIT CARE ME, V7, P461, DOI 10.1097/01.PCC.0000235245.49129.27; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Fraser DD, 2011, PEDIATR CRIT CARE ME, V12, P319, DOI 10.1097/PCC.0b013e3181e8b32d; Gadea A, 2008, J NEUROSCI, V28, P2394, DOI 10.1523/JNEUROSCI.5652-07.2008; Heo JS, 2004, EMBO J, V23, P2185, DOI 10.1038/sj.emboj.7600212; Hu YC, 2014, INFLAMM RES, V63, P109, DOI 10.1007/s00011-013-0677-1; Inglese M, 2005, AM J NEURORADIOL, V26, P719; Jacobson J, 2002, J CELL SCI, V115, P1175; Jayakumar AR, 2008, J NEUROPATH EXP NEUR, V67, P417, DOI 10.1097/NEN.0b013e31816fc9d4; Kramerov AA, 2012, J CELL BIOCHEM, V113, P2948, DOI 10.1002/jcb.24171; Kyriakis JM, 2012, PHYSIOL REV, V92, P689, DOI 10.1152/physrev.00028.2011; Lam WH, 1999, PAEDIATR ANAESTH, V9, P377; Lamb RG, 1997, J NEUROCHEM, V68, P1904; Lok J, 2007, NEUROCHEM RES, V32, P2032, DOI 10.1007/s11064-007-9342-9; Marmarou Anthony, 2004, Cleve Clin J Med, V71 Suppl 1, pS6; Mathiisen TM, 2010, GLIA, V58, P1094, DOI 10.1002/glia.20990; McKinney JS, 1996, STROKE, V27, P934, DOI 10.1161/01.STR.27.5.934; Mori T, 2002, J NEUROTRAUM, V19, P1411, DOI 10.1089/089771502320914642; Mori T, 2002, J CEREBR BLOOD F MET, V22, P444, DOI 10.1097/00004647-200204000-00008; Morrison Gavin, 2013, Pathophysiology, V20, P49, DOI 10.1016/j.pathophys.2012.02.006; Neary JT, 2003, J NEUROSCI, V23, P2348, DOI 10.1523/jneurosci.23-06-02348.2003; PASCUCCI RC, 1988, INTENS CARE MED, V14, P185, DOI 10.1007/BF00717985; Rzigalinski BA, 1997, J NEUROCHEM, V68, P289; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Shore PM, 2007, J NEUROTRAUM, V24, P75, DOI 10.1089/neu.2006.0062; Slemmer JE, 2002, BRAIN, V125, P2699, DOI 10.1093/brain/awf271; Spinella PC, 2003, CRIT CARE MED, V31, P939, DOI 10.1097/01.CCM.0000053644.16336.52; Takano T, 2006, NAT NEUROSCI, V9, P260, DOI 10.1038/nn1623; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Wang DD, 2008, PROG NEUROBIOL, V86, P342, DOI 10.1016/j.pneurobio.2008.09.015; Weber JT, 1999, CELL CALCIUM, V26, P289, DOI 10.1054/ceca.1999.0082; Weksler BB, 2005, FASEB J, V19, P1872; Zhu DH, 2009, BIOCHEM J, V421, P201, DOI 10.1042/BJ20090356; Zurek J, 2011, J TRAUMA, V71, P854, DOI 10.1097/TA.0b013e3182140c8c	46	11	12	0	10	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	AUG 22	2014	274						1	10		10.1016/j.neuroscience.2014.05.009			10	Neurosciences	Neurosciences & Neurology	AK8XO	WOS:000338712300001	24838066				2021-06-18	
J	Ghadiri, T; Sharifzadeh, M; Khodagholi, F; Mousavi, SMM; Hassanzadeh, G; Zarrindast, MR; Gorji, A				Ghadiri, Tahereh; Sharifzadeh, Mohammad; Khodagholi, Fariba; Mousavi, Sayed Mostafa Modarres; Hassanzadeh, Gholamreza; Zarrindast, Mohammad-Reza; Gorji, Ali			A novel traumatic brain injury model for induction of mild brain injury in rats	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Brain injury; Weight drop; Dark neurons; Head trauma; CNS	HEAD-INJURY; SPREADING DEPRESSION; CEREBROSPINAL-FLUID; NEURONAL DAMAGE; PATHOPHYSIOLOGY; EPIDEMIOLOGY; IMPAIRMENT; DEATH; BLOOD; MICE	Background: Due to the marked heterogeneity of human traumatic brain injury (TBI), none of the available animal model can reproduce the entire spectrum of TBI, especially mild focal TBI. This study was designed to develop a modified TBI weight drop model for induction of focal mild cerebral injury. New method: A stereotaxic coupled weight drop device was designed. Principle arm of device carries up to 500 g weights which their force was conveyed to animal skull through a thin nail like metal tip. To determine the optimal configuration of the device to induce mild TBI, six different trials were designed. The optimal configuration of the instrument was used for evaluation of behavioral, histopathological and molecular changes of mild TBI. Results: Neurologic and motor coordination deficits observed sharply within 24h post injury period. Histological studies revealed a remarkable increase in the number of dark neurons in trauma site. TBI increased the expression of apoptotic proteins, Bax, BCl2 and cleaved caspase-3 in the hippocampus. Comparison with existing methods: Our designed TBI device is capable to produce variable severity of TBI from mild to severe. The main advantage of the new TBI model is induction of mild local unilateral brain injury instead of traumatization of the whole brain. This model does not require craniotomy for induction of brain injury. Conclusion: This novel animal TBI model mimics human mild focal brain injury. This model is suitable for evaluation of pathophysiology. as well as screening of new therapies for mild TBI. (C) 2014 Elsevier B.V. All rights reserved.	[Ghadiri, Tahereh; Sharifzadeh, Mohammad; Hassanzadeh, Gholamreza; Zarrindast, Mohammad-Reza] Univ Tehran Med Sci, Sch Adv Technol Med, Tehran, Iran; [Ghadiri, Tahereh; Mousavi, Sayed Mostafa Modarres; Gorji, Ali] Shefa Neurosci Res Ctr, Tehran, Iran; [Sharifzadeh, Mohammad] Univ Tehran Med Sci, Fac Pharm, Dept Toxicol, Tehran, Iran; [Khodagholi, Fariba] Shahid Beheshti Univ Med Sci, Neurosci Res Ctr, Tehran, Iran; [Gorji, Ali] Univ Munster, Epilepsy Res Ctr, Dept Neurosurg, Inst Physiol 1, D-48149 Munster, Germany; [Gorji, Ali] Univ Munster, Epilepsy Res Ctr, Dept Neurol, Inst Physiol 1, D-48149 Munster, Germany	Gorji, A (corresponding author), Univ Munster, Epilepsy Res Ctr, Robert Koch Str 27a, D-48149 Munster, Germany.	gorjial@uni-muenster.de	Mousapour Gorji, Ahmad/D-3670-2017; Khodagholi, Fariba/AAZ-4436-2020; Ghadiri, Tahereh/AAU-7811-2020	Khodagholi, Fariba/0000-0002-4911-4530; Gorji, Ali/0000-0002-4557-3270; sharifzadeh, mohammad/0000-0003-2991-7384; Ghadiri, Tahereh/0000-0002-3568-8699	Shefa Neuroscience Center, Iran [25604]	Authors would like to thanks Thomas Westhoff, Ludger Sasse and Manfred Daweke for their technical assistance. This work was funded by the Shefa Neuroscience Center, Iran (grant related to Dr. Thesis 25604).	Aligholi H, 2014, J NEUROSCI METH, V225, P81, DOI 10.1016/j.jneumeth.2013.12.008; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Arciniegas DB, 2001, BRAIN INJURY, V15, P649, DOI 10.1080/02699050010019800; Ates O, 2007, MOL CELL BIOCHEM, V294, P137, DOI 10.1007/s11010-006-9253-0; Bigler ED, 2003, ARCH CLIN NEUROPSYCH, V18, P595; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Buccafusco JJ, 2009, FRONT NEUROSCI, P1; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Clark RSB, 1999, FASEB J, V13, P813; Dikmen S, 2001, J CLIN EXP NEUROPSYC, V23, P729, DOI 10.1076/jcen.23.6.729.1019; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Finnie JW, 2002, VET PATHOL, V39, P679, DOI 10.1354/vp.39-6-679; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; HARAD FT, 1992, J TRAUMA, V32, P359, DOI 10.1097/00005373-199203000-00014; Ishida K, 2004, NEUROSCIENCE, V125, P633, DOI 10.1016/j.neuroscience.2004.02.002; Jafarian M, 2010, NEUROSCIENCE, V169, P388, DOI 10.1016/j.neuroscience.2010.04.062; Jennett B, 1998, ARCH DIS CHILD, V78, P403, DOI 10.1136/adc.78.5.403; Kemp AM, 2003, ARCH DIS CHILD, V88, P472, DOI 10.1136/adc.88.6.472; Kramer M, 2010, J NEUROSCI METH, V187, P84, DOI 10.1016/j.jneumeth.2009.12.020; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Macmillan PJ, 2002, BRAIN INJURY, V16, P41, DOI 10.1080/0269905011008812; Marklund N, 2006, CURR PHARM DESIGN, V12, P1645, DOI 10.2174/138161206776843340; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Marmarou CR, 2006, EXP NEUROL, V197, P353, DOI 10.1016/j.expneurol.2005.10.003; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; O'Connor C, 2003, J NEUROTRAUM, V20, P985, DOI 10.1089/089771503770195830; Petzold A, 2011, BRAIN, V134, P464, DOI 10.1093/brain/awq360; POVLISHOCK JT, 1995, BRAIN PATHOL, V5, P415, DOI 10.1111/j.1750-3639.1995.tb00620.x; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Sadeghian H, 2012, EXP NEUROL, V233, P438, DOI 10.1016/j.expneurol.2011.11.017; Sashindranath M, 2012, BRAIN, V135, P3251, DOI 10.1093/brain/aws178; STEIN SC, 1992, J TRAUMA, V33, P11, DOI 10.1097/00005373-199207000-00003; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Uzan M, 2006, ACTA NEUROCHIR, V148, P1157, DOI 10.1007/s00701-006-0887-1; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xiong Y, 2010, J NEUROSURG, V113, P598, DOI 10.3171/2009.9.JNS09844; Yamaki T, 1997, BRAIN RES, V752, P151, DOI 10.1016/S0006-8993(96)01469-2; Yuan XQ, 1988, J NEUROTRAUM, V5, P289, DOI 10.1089/neu.1988.5.289; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zhao S, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-67	45	11	11	0	10	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	AUG 15	2014	233						18	27		10.1016/j.jneumeth.2014.05.035			10	Biochemical Research Methods; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	AM9TT	WOS:000340224600003	24906055				2021-06-18	
J	Desgranges, FP; Javouhey, E; Mottolese, C; Migeon, A; Szathmari, A; Baudin, F; de Queiroz, M; Cogniat, B; Chassard, D				Desgranges, Francois-Pierrick; Javouhey, Etienne; Mottolese, Carmine; Migeon, Anne; Szathmari, Alexandru; Baudin, Florent; de Queiroz, Mathilde; Cogniat, Berengere; Chassard, Dominique			Intraoperative blood loss during decompressive craniectomy for intractable intracranial hypertension after severe traumatic brain injury in children	CHILDS NERVOUS SYSTEM			English	Article						Decompressive craniectomy; Traumatic brain injury; Child; Blood loss; Coagulopathy; Hemodynamics	SINGLE-CENTER EXPERIENCE; SEVERE HEAD-INJURY; SURGERY; COAGULOPATHY; COAGULATION; MANAGEMENT	There are no data available on the risk of intraoperative bleeding during decompressive craniectomy (DC) after traumatic brain injury (TBI) in children. The objectives of this study were to assess the risk of intraoperative bleeding during DC for intractable intracranial hypertension after TBI, to identify potential factors associated with the risk of bleeding during DC, and to assess the impact of DC on systemic and cerebral hemodynamics and on coagulation. Twelve children were identified as having undergone DC after TBI from April 2009 to June 2013 in our center. Subjects were allocated into two groups according to the percentage of blood loss (IBL) during the intraoperative period (< or a parts per thousand yen50 % of the estimated blood volume (EBV)). The median IBL during DC was 49 [17-349] % of the EBV. Children with an IBL a parts per thousand yenaEuro parts per thousand 50 % of EBV had higher preoperative intracranial pressure (ICP) (p = 0.03) and international normalized ratio (INR) (p = 0.02) than those with an IBL < 50 % of EBV. DC induced significant decreases in ICP (p = 0.0005), mean arterial pressure (p = 0.01), and a significant increase in norepinephrine flow rate (p = 0.04) between the immediate pre- and postoperative periods. DC allows a significant decrease in ICP after severe pediatric TBI but is a surgical procedure at a high risk of bleeding. High ICP and INR during the immediate preoperative period are the main factors associated with increased IBL during DC. Further studies are needed to confirm our results and to assess the impact of the amount of IBL on the postoperative survival and functional outcome.	[Desgranges, Francois-Pierrick; Migeon, Anne; de Queiroz, Mathilde; Cogniat, Berengere; Chassard, Dominique] Univ Lyon 1, Hosp Civils Lyon, Dept Pediat Anesthesia, Hop Femme Mere Enfant, F-69365 Lyon, France; [Javouhey, Etienne; Baudin, Florent] Univ Lyon 1, Hosp Civils Lyon, Dept Pediat Intens Care Unit, Hop Femme Mere Enfant, F-69365 Lyon, France; [Mottolese, Carmine; Szathmari, Alexandru] Univ Lyon 1, Hop Neurol Pierre Weirtheimer, Dept Pediat Neurosurg, F-69365 Lyon, France; [Mottolese, Carmine; Szathmari, Alexandru] Univ Lyon 1, Hosp Civils Lyon, Hop Femme Mere Enfant, F-69365 Lyon, France; [Desgranges, Francois-Pierrick] Hosp Civils Lyon, Dept Anesthesie Reanimat, Hop Femme Mere Enfant, F-69677 Bron, France	Desgranges, FP (corresponding author), Hosp Civils Lyon, Dept Anesthesie Reanimat, Hop Femme Mere Enfant, 59 Blvd Pinel, F-69677 Bron, France.	fp_desgranges@yahoo.fr	Javouhey, Etienne/G-3651-2013				Appelboom G, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.8.FOCUS11177; Carrick MM, 2005, J TRAUMA, V58, P725, DOI 10.1097/01.TA.0000159249.68363.78; Chaiwat O, 2009, J NEUROTRAUM, V26, P657, DOI 10.1089/neu.2008.0770; Chiaretti A, 2002, CHILD NERV SYST, V18, P129, DOI 10.1007/s00381-002-0558-3; Gerlach R, 2009, ACTA NEUROCHIR, V151, P873, DOI 10.1007/s00701-009-0409-z; Glick RP, 2011, PEDIATR NEUROSURG, V47, P152, DOI 10.1159/000330709; Goobie SM, 2011, ANESTHESIOLOGY, V114, P862, DOI 10.1097/ALN.0b013e318210fd8f; Guresir E, 2012, NEUROSURGERY, V70, P881, DOI 10.1227/NEU.0b013e318237a6a6; Haas T, 2012, BRIT J ANAESTH, V108, P36, DOI 10.1093/bja/aer342; Jacob AT, 2011, PEDIATR NEUROSURG, V47, P81, DOI 10.1159/000329624; Jagannathan J, 2007, J NEUROSURG, V106, P268, DOI 10.3171/ped.2007.106.4.268; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Manohar C, 2011, J CLIN NEUROSCI, V18, P1180, DOI 10.1016/j.jocn.2011.02.018; Miller P, 2006, ANESTH ANALG, V103, P869, DOI 10.1213/01.ane.0000237327.12205.dc; Orliaguet GA, 2008, PEDIATR ANESTH, V18, P455, DOI 10.1111/j.1460-9592.2008.02507.x; Philip S, 2009, J TRAUMA, V67, pS128, DOI 10.1097/TA.0b013e3181ad32c7; Piastra M, 2008, J NEURO-ONCOL, V90, P191, DOI 10.1007/s11060-008-9643-0; Talving P, 2011, J TRAUMA, V71, P1205, DOI 10.1097/TA.0b013e31820d151d; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Thomale UW, 2010, CHILD NERV SYST, V26, P1563, DOI 10.1007/s00381-010-1103-4; Vavilala MS, 2003, J TRAUMA, V55, P1039, DOI 10.1097/01.TA.0000101759.23607.57	21	11	11	1	6	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	AUG	2014	30	8					1393	1398		10.1007/s00381-014-2417-4			6	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	AM3CY	WOS:000339730800008	24748064				2021-06-18	
J	Palmer, GA; Happe, MC; Paxson, JM; Jurek, BK; Graca, JJ; Olson, SA				Palmer, Glen A.; Happe, Maggie C.; Paxson, Janine M.; Jurek, Benjamin K.; Graca, Joseph J.; Olson, Stephen A.			Psychometric Properties of the Beck Depression Inventory-II for OEF/OIF Veterans in a Polytrauma Sample	MILITARY MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; CONFIRMATORY FACTOR-ANALYSIS; POSTTRAUMATIC GROWTH INVENTORY; BDI-II; MANAGEMENT	Objective: The Beck Depression Inventory-II (BDI-II) is widely used as a screening instrument for depressive symptomatology in clinical settings. The factor structure has been researched in a variety of settings with results ranging from a single factor to a five-factor structure. The purpose of this study was to examine several identified factor structures when applied to a mixed polytrauma sample. Method: A sample of 310 veterans was used for this study. All subjects were administered the BDI-II screening measure as part of an evaluation in an outpatient polytrauma clinic. Confirmatory factor analysis was used to determine the best model. Results: Confirmatory factor analysis revealed that a three-factor model provided a best fit. A model previously identified for individuals in residential treatment for substance abuse provided a best fit for this sample. Conclusions: The BDI-II may provide additional information for clinicians when examining the three-factor model with veterans in polytrauma settings.	[Palmer, Glen A.; Happe, Maggie C.; Paxson, Janine M.; Jurek, Benjamin K.; Graca, Joseph J.; Olson, Stephen A.] St Cloud VA Hlth Care Syst, Dept Psychol, St Cloud, MN 56303 USA	Palmer, GA (corresponding author), St Cloud VA Hlth Care Syst, Dept Psychol, 4801 Vet Dr,EC-117, St Cloud, MN 56303 USA.			Palmer, Glen/0000-0001-8043-3487			Beck A. T., 1996, BECK DEPRESSION INVE, VII; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Brown T.A, 2006, CONFIRMATORY FACTOR, V3rd; Buckley TC, 2001, J SUBST ABUSE TREAT, V20, P197, DOI 10.1016/S0740-5472(00)00169-0; Byrne B.M., 2010, MULTIVARIATE APPL SE, DOI 10.4324/9781410600219; CHRISTENSEN BK, 1995, J INT NEUROPSYCH SOC, V1, P122; Cronbach L., 1984, ESSENTIALS PSYCHOL T; Glenn MB, 2001, BRAIN INJURY, V15, P811, DOI 10.1080/02699050010025777; Green A, 2001, BRAIN INJURY, V15, P1021, DOI 10.1080/02699050110074187; Halbauer JD, 2009, J REHABIL RES DEV, V46, P757, DOI 10.1682/JRRD.2008.08.0119; Hoyle R. H., 1995, STRUCTURAL EQUATION; Jorge RE, 2005, J HEAD TRAUMA REHAB, V20, P475, DOI 10.1097/00001199-200511000-00001; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Lew HL, 2008, J REHABIL RES DEV, V45, pXI, DOI 10.1682/JRRD.2008.05.0064; Lew HL, 2007, J REHABIL RES DEV, V44, P1027, DOI 10.1682/JRRD.2007.05.0073; Linley PA, 2007, J LOSS TRAUMA, V12, P321, DOI 10.1080/15325020601162823; Meterko M, 2012, J HEAD TRAUMA REHAB, V27, P55, DOI 10.1097/HTR.0b013e318230fb17; Palmer GA, 2012, J LOSS TRAUMA, V17, P545, DOI 10.1080/15325024.2012.678779; Rapoport MJ, 2012, CNS DRUGS, V26, P111, DOI 10.2165/11599560-000000000-00000; Rowland SM, 2005, BRAIN INJURY, V19, P77, DOI 10.1080/02699050410001719988; Schinka JA, 2007, J TRAUMA STRESS, V20, P281, DOI 10.1002/jts.20202; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P1621, DOI 10.1053/S0003-9993(03)00270-3; Siegert RJ, 2009, J INT NEUROPSYCH SOC, V15, P142, DOI 10.1017/S1355617708090048; United States Department of Veterans Affairs, 2011, UND TRAUM BRAIN INJ; United States Department of Veterans Affairs, 2008, PUTT POL CAR MAP	26	11	11	0	6	ASSOC MILITARY SURG US	BETHESDA	9320 OLD GEORGETOWN RD, BETHESDA, MD 20814 USA	0026-4075	1930-613X		MIL MED	Milit. Med.	AUG	2014	179	8					879	884		10.7205/MILMED-D-14-00048			6	Medicine, General & Internal	General & Internal Medicine	AN7UO	WOS:000340806700009	25102530	Bronze			2021-06-18	
J	Peters, DM; Jain, S; Liuzzo, DM; Middleton, A; Greene, J; Blanck, E; Sun, S; Raman, R; Fritz, SL				Peters, Denise M.; Jain, Sonia; Liuzzo, Derek M.; Middleton, Addie; Greene, Jennifaye; Blanck, Erika; Sun, Shelly; Raman, Rema; Fritz, Stacy L.			Individuals With Chronic Traumatic Brain Injury Improve Walking Speed and Mobility With Intensive Mobility Training	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Gait; Rehabilitation	QUALITY-OF-LIFE; BALANCE; GAIT; STROKE; REHABILITATION; PROBABILITY; RELIABILITY; VALIDITY; FALLS	Objective: To determine the feasibility and impact of different dosages of Intensive Mobility Training (IMT) on mobility, balance, and gait speed in individuals with chronic traumatic brain injury (TBI). Design: Prospective, single group design with 3-month follow-up. Setting: University research laboratory. Participants: Volunteer sample of participants with chronic TBI (N=10; >= 3mo post-TBI; able to ambulate 3.05m with or without assistance; median age, 35.4y; interquartile range, 23.5-46y; median time post-TBI, 9.91y; interquartile range, 6.3-14.2y). Follow-up data were collected for all participants. Interventions: Twenty days (5d/wk for 4wk), with 150min/d of repetitive, task-specific training equally divided among balance; gait training; and strength, coordination, and range. Main Outcome Measures: Pain and fatigue were recorded before and after each session to assess feasibility. Treatment outcomes were assessed before training (pre), after 10 sessions (interim), after 20 sessions (post), and at 3-months follow-up and included the Berg Balance Scale and gait speed. Results: Participants averaged 150.1 +/- 2.7 minutes per session. Median presession and postsession pain scores were 0 (out of 10) for 20 sessions; median presession fatigue scores ranged from 0 to 2.5 (out of 10); and postsession scores ranged from 3 to 5.5 (out of 10). Four outcome measures demonstrated significant improvement from the pretest to interim, with 7 out of 10 participants exceeding the minimal detectable change (MDC) for fast walking speed. At the posttest, 2 additional measures were significant, with more participants exceeding the MDCs. Changes in fast walking speed and Timed Up and Go test were significant at follow-up. Conclusions: Limited fluctuations in pain and fatigue scores indicate feasibility of IMT in this population. Participants demonstrated improvements in walking speed, mobility, and balance postintervention and maintained gains in fast walking speed and mobility at 3 months. (C) 2014 by the American Congress of Rehabilitation Medicine	[Peters, Denise M.; Liuzzo, Derek M.; Middleton, Addie; Greene, Jennifaye; Fritz, Stacy L.] Univ S Carolina, Phys Therapy Program, Dept Exercise Sci, Columbia, SC 29208 USA; [Jain, Sonia] Univ Calif San Diego, Dept Family & Prevent Med, Div Biostat & Bioinformat, San Diego, CA 92103 USA; [Blanck, Erika] Univ S Carolina, Sch Med, Dept Cell Biol & Anat, Columbia, SC 29208 USA; [Sun, Shelly] Univ Calif San Diego, Biostat Res Ctr, San Diego, CA 92103 USA; [Raman, Rema] Univ Calif San Diego, Dept Family & Prevent Med, San Diego, CA 92103 USA; [Raman, Rema] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA	Peters, DM (corresponding author), Univ S Carolina, Publ Hlth Res Ctr, 921 Assembly St,3rd Fl, Columbia, SC 29208 USA.	petersd20@gmail.com		Middleton, Addie/0000-0001-8970-3703	Posttraumatic Stress Coordinating Center and Clinical Site [W81XWH-08-2-0159]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM081740] Funding Source: NIH RePORTER	Supported by the Posttraumatic Stress Coordinating Center and Clinical Site (award no. W81XWH-08-2-0159).	Behmran AL, 2000, PHYS THER, V80, P688, DOI 10.1093/ptj/80.7.688; Benedetti MG, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-64; Bowden MG, 2011, STROKE RES TREAT, V2011, DOI 10.4061/2011/601416; Centers for Disease Control and Prevention, 30 SEC CHAIR STAND T; Coronado Victor G, 2010, TRAUMATIC BRAIN INJU; Flansbjer UB, 2005, J REHABIL MED, V37, P75, DOI 10.1080/16501970410017215; Fritz NE, 2013, J NEUROL PHYS THER, V37, P37, DOI 10.1097/NPT.0b013e318282a20d; Fritz SL, 2011, EUR J PHYS REHAB MED, V47, P569; Fritz S, 2011, J NEUROL PHYS THER, V35, P141, DOI 10.1097/NPT.0b013e31822a2a09; Fritz Stacy L, 2007, J Neurol Phys Ther, V31, P71; Fritz SL, 2011, ARCH PHYS MED REHAB, V92, P1776, DOI 10.1016/j.apmr.2011.05.006; Graham JE, 2008, J EVAL CLIN PRACT, V14, P552, DOI 10.1111/j.1365-2753.2007.00917.x; JAESCHKE R, 1989, CONTROL CLIN TRIALS, V10, P407, DOI 10.1016/0197-2456(89)90005-6; Kimberley TJ, 2010, J REHABIL RES DEV, V47, P851, DOI 10.1682/JRRD.2010.02.0019; Lang CE, 2009, ARCH PHYS MED REHAB, V90, P1692, DOI 10.1016/j.apmr.2009.04.005; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lei-Rivera L, 2013, NEUROREHABILITATION, V32, P463, DOI 10.3233/NRE-130869; Medley A, 2006, BRAIN INJURY, V20, P1403, DOI 10.1080/02699050601082057; Mossberg KA, 2003, AM J PHYS MED REHAB, V82, P385, DOI 10.1097/01.PHM.0000052589.96202.BE; Mossberg KA, 2012, PHYS THER, V92, P726, DOI 10.2522/ptj.20110157; Newstead Ann H, 2005, J Neurol Phys Ther, V29, P18; Schneiders AG, 2010, J SCI MED SPORT, V13, P196, DOI 10.1016/j.jsams.2009.05.004; Shumway-Cook A, 2000, PHYS THER, V80, P896, DOI 10.1093/ptj/80.9.896; Vearrier LA, 2005, GAIT POSTURE, V22, P154, DOI 10.1016/j.gaitpost.2004.09.001; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; Watson M.J., 2002, PHYSIOTHERAPY, P386, DOI DOI 10.1016/S0031-9406(05)61264-3; Wevers LEG, 2011, J REHABIL MED, V43, P1027, DOI 10.2340/16501977-0881; Williams G, 2009, ARCH PHYS MED REHAB, V90, P587, DOI 10.1016/j.apmr.2008.10.013	29	11	11	0	17	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	AUG	2014	95	8					1454	1460		10.1016/j.apmr.2014.04.006			7	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	AM2ND	WOS:000339687200006	24769069	Green Accepted			2021-06-18	
J	Wong, D; Mckay, A; Stolwyk, R				Wong, Dana; Mckay, Adam; Stolwyk, Rene			Delivery of Psychological Interventions by Clinical Neuropsychologists: Current Practice in Australia and Implications for Training	AUSTRALIAN PSYCHOLOGIST			English	Article						interventions; neuropsychologist; placements; postgraduate; supervision; survey	TRAUMATIC BRAIN-INJURY; REHABILITATION; TRIAL	Clinical neuropsychologists are increasingly involved in delivering psychological interventions to people with neurological conditions. This is a key competency for accredited Australian postgraduate neuropsychology courses; however it is not clear how effective courses are in preparing neuropsychologists to deliver interventions. The study aims were to (a) determine the frequency and confidence with which particular types of interventions are delivered by Australian neuropsychologists, (b) examine the availability of opportunities to deliver interventions on clinical placements, (c) identify barriers to delivering interventions in current workplaces; and (d) determine which factors influence the frequency and confidence with which neuropsychologists deliver interventions. An online survey was completed by 114 participants who had graduated from a postgraduate neuropsychology program. Results indicated that respondents delivered different intervention types with varying frequency. They reported limited opportunities to practice these interventions on placements. The majority wanted to be doing more interventions, with lack of time, resources, and adequate training being the major barriers. There were several significant relationships between the frequency and confidence with which respondents delivered interventions and the perceived quality of their postgraduate training. These results highlight the need to consider appropriate postgraduate training options in delivery of interventions, including increasing opportunities to practice interventions on placements.	[Wong, Dana; Mckay, Adam; Stolwyk, Rene] Monash Univ, Sch Psychol Sci, Clayton, Vic 3800, Australia	Wong, D (corresponding author), Monash Univ, Sch Psychol Sci, Wellington Rd, Clayton, Vic 3800, Australia.	dana.wong@monash.edu	Wong, Dana/AAD-3410-2020; McKay, Adam JD/M-6003-2017	McKay, Adam JD/0000-0002-0479-7681; Wong, Dana/0000-0001-9619-1929			Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Field A.P., 2005, DISCOVERING STAT USI; Gould KR, 2011, PSYCHOL MED, V41, P2099, DOI 10.1017/S003329171100033X; Hsieh MY, 2012, NEUROPSYCHOL REHABIL, V22, P585, DOI 10.1080/09602011.2012.678860; Miller WR, 2004, J CONSULT CLIN PSYCH, V72, P1050, DOI 10.1037/0022-006X.72.6.1050; National Stroke Foundation, 2010, CLIN GUID STROK MAN; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; Worthington AD, 2006, BRAIN INJURY, V20, P947, DOI 10.1080/02699050600888314; Ylvisaker Mark, 2005, Seminars in Speech and Language, V26, P256, DOI 10.1055/s-2005-922104	9	11	11	0	5	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0005-0067	1742-9544		AUST PSYCHOL	Aust. Psychol.	AUG	2014	49	4					209	222		10.1111/ap.12061			14	Psychology, Multidisciplinary	Psychology	AM7TA	WOS:000340070400003					2021-06-18	
J	Fletcher, TL; Kolias, AG; Hutchinson, PJA; Sutcliffe, MPF				Fletcher, Tim L.; Kolias, Angelos G.; Hutchinson, Peter J. A.; Sutcliffe, Michael P. F.			Development of a Finite Element Model of Decompressive Craniectomy	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; INTRACRANIAL-PRESSURE; MICROSCOPY	Decompressive craniectomy (DC), an operation whereby part of the skull is removed, is used in the management of patients with brain swelling. While the aim of DC is to reduce intracranial pressure, there is the risk that brain deformation and mechanical strain associated with the operation could damage the brain tissue. The nature and extent of the resulting strain regime is poorly understood at present. Finite element (FE) models of DC can provide insight into this applied strain and hence assist in deciding on the best surgical procedures. However there is uncertainty about how well these models match experimental data, which are difficult to obtain clinically. Hence there is a need to validate any modelling approach outside the clinical setting. This paper develops an axisymmetric FE model of an idealised DC to assess the key features of such an FE model which are needed for an accurate simulation of DC. The FE models are compared with an experimental model using gelatin hydrogel, which has similar poro-viscoelastic material property characteristics to brain tissue. Strain on a central plane of the FE model and the front face of the experimental model, deformation and load relaxation curves are compared between experiment and FE. Results show good agreement between the FE and experimental models, providing confidence in applying the proposed FE modelling approach to DC. Such a model should use material properties appropriate for brain tissue and include a more realistic whole head geometry.	[Fletcher, Tim L.; Sutcliffe, Michael P. F.] Univ Cambridge, Dept Engn, Cambridge CB2 1PZ, England; [Kolias, Angelos G.; Hutchinson, Peter J. A.] Addenbrookes Hosp, Div Neurosurg, Dept Clin Neurosci, Cambridge, England; [Kolias, Angelos G.; Hutchinson, Peter J. A.] Univ Cambridge, Cambridge, England	Sutcliffe, MPF (corresponding author), Univ Cambridge, Dept Engn, Cambridge CB2 1PZ, England.	mpfs@eng.cam.ac.uk		Kolias, Angelos/0000-0003-3992-0587; Hutchinson, Peter/0000-0002-2796-1835	Engineering and Physical Sciences Research Council (EPSRC)UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC); Royal College of Surgeons of England Research Fellowship; Freemasons; Rosetrees TrustRosetrees Trust; NIHR Academic Clinical Fellowship; Raymond and Beverly Sackler Studentship; NIHR Research Professorship; NIHR Cambridge Biomedical Research CentreNational Institute for Health Research (NIHR); Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0601025] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [12/35/57, NIHR-RP-R3-12-013] Funding Source: researchfish	TLF acknowledges funding from the Engineering and Physical Sciences Research Council (EPSRC). AGK is supported by a Royal College of Surgeons of England Research Fellowship (funded by the Freemasons and the Rosetrees Trust), an NIHR Academic Clinical Fellowship and a Raymond and Beverly Sackler Studentship. PJH is supported by a NIHR Research Professorship and the NIHR Cambridge Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bor-Seng-Shu E, 2012, J NEUROSURG, V117, P589, DOI 10.3171/2012.6.JNS101400; Cheng S, 2007, J BIOMECH, V40, P117, DOI 10.1016/j.jbiomech.2005.11.004; Cloots RJH, 2011, BIOMECH MODEL MECHAN, V10, P413, DOI 10.1007/s10237-010-0243-5; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217; Cruz-Flores S, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003435.pub2; Dassault Systemes Simulia, 2011, AB US MAN 6 11 1 SEC; Detournay E., 1993, ANAL DESIGN METHOD, P113, DOI DOI 10.1016/B978-0-08-040615-2.50011-3; Elkin BS, 2007, STAPP CAR CRASH JO, V51, P127; Franceschini G., 2006, THESIS U TRENTO; Galli M, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2957993; Gao CP, 2008, ACTA NEUROCHIR SUPPL, V102, P279, DOI 10.1007/978-3-211-85578-2_52; Hert S, 2010, CGAL USER REFERENCE; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Hutchinson PJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1000; Ivarsson J, 2000, J BIOMECH, V33, P181, DOI 10.1016/S0021-9290(99)00144-X; Kalyanam S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3127250; Kolias AG, 2013, NAT REV NEUROL, V9, P405, DOI 10.1038/nrneurol.2013.106; Kyriacou SK, 2002, BIOMECH MODEL MECHAN, V1, P151, DOI 10.1007/s10237-002-0013-0; Lakes R., 2009, VISCOELASTIC MAT, DOI [10.1017/CBO9780511626722, DOI 10.1017/CB09780511626722, 10.1017/CB09780511626722]; Miller K, 1997, J BIOMECH, V30, P1115, DOI 10.1016/S0021-9290(97)00092-4; Miller K, 2010, INT J NUMER METH BIO, V26, P117, DOI 10.1002/cnm.1260; Nalbach SV, 2012, J CLIN NEUROSCI, V19, P1222, DOI 10.1016/j.jocn.2012.01.016; Screen HRC, 2009, J STRAIN ANAL ENG, V44, P327, DOI 10.1243/03093247JSA491; Strange DGT, 2012, J MECH BEHAV BIOMED, V11, P16, DOI 10.1016/j.jmbbm.2011.10.003; Suh JK, 1999, J APPL MECH-T ASME, V66, P528, DOI 10.1115/1.2791079; Timofeev I, 2012, Adv Tech Stand Neurosurg, V38, P115, DOI 10.1007/978-3-7091-0676-1_6; Timofeev I, 2008, J NEUROSURG, V108, P66, DOI 10.3171/JNS/2008/108/01/0066; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; von Holst H, 2012, ACTA NEUROCHIR, P1; Wright RM, 2011, BIOMECH MODEL MECHAN, V11, P245; Zhang JY, 2007, J BIOMECH, V40, P2341, DOI 10.1016/j.jbiomech.2006.10.021	32	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102131	10.1371/journal.pone.0102131			9	Multidisciplinary Sciences	Science & Technology - Other Topics	AM6RN	WOS:000339992400044	25025666	DOAJ Gold, Green Published			2021-06-18	
J	Missios, S; Bekelis, K				Missios, Symeon; Bekelis, Kimon			Transport Mode to Level I and II Trauma Centers and Survival of Pediatric Patients with Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						ground emergency medical services; helicopter; mortality; NTDB; pediatric; traumatic brain injury	EMERGENCY MEDICAL-SERVICES; HELICOPTER TRANSPORT; HOSPITAL MORTALITY; GROUND TRANSPORT; DATA-BANK; PATTERNS; SYSTEM; ASSOCIATION; OUTCOMES; ADULTS	The use of helicopter emergency medical services (EMS) for pediatric trauma patients is an issue of debate. We investigated the association of helicopter transport with survival of pediatric patients with traumatic brain injury (TBI). We conducted a retrospective cohort study of pediatric patients with TBI who were transported to level I and II trauma centers and were registered in the National Trauma Data Bank (NTDB) between 2009 and 2011. We used regression techniques, integrating the results of propensity score matching, to investigate the association of helicopter transport with survival, in comparison with ground EMS. There were 15,704 pediatric patients with TBI who met the inclusion criteria. Of these, 3142 were transported via helicopters, and 12,562 via ground EMS. The mortality for children transported to level I trauma centers was 7.5% (183 deaths) for helicopter transport and 3.8% (337 deaths) for ground. Multivariable logistic regression analysis demonstrated an association of helicopter transport with increased survival (odds ratio [OR], 1.76; 95% confidence interval [CI], 1.27-2.46; absolute risk reduction [ARR], 2.70%). This persisted after propensity score matching (OR, 1.77; 95% CI, 1.25-2.52; ARR 2.73%). The mortality for children transported to level II trauma centers was 8.0% (52 deaths) for helicopter transport, and 4.4% (163 deaths) for ground. Multivariable logistic regression analysis demonstrated an association of helicopter transport with increased survival (OR, 2.35; 95% CI, 1.30-4.25; ARR 5.36%). This again persisted after propensity score matching (OR 2.56; 95% CI 1.28-5.11; ARR 6.14). Pediatric patients with TBI transported to level I and II trauma centers had improved survival in comparison with similar patients transported via ground EMS.	[Missios, Symeon] Cleveland Clin, Dept Neurosurg, Cleveland, OH 44106 USA; [Bekelis, Kimon] Dartmouth Hitchcock Med Ctr, Sect Neurosurg, Lebanon, NH 03756 USA	Bekelis, K (corresponding author), Dartmouth Hitchcock Med Ctr, One Med Ctr Dr, Lebanon, NH 03756 USA.	kbekelis@gmail.com	Bekelis, Kimon/Y-3402-2019				American College of Surgeons, 2011, ANN REPORT; Bankole S, 2011, PEDIATR CRIT CARE ME, V12, pE166, DOI 10.1097/PCC.0b013e3181f36f6e; BAXT WG, 1987, J TRAUMA, V27, P365, DOI 10.1097/00005373-198704000-00004; Berlot G, 2009, EUR J EMERG MED, V16, P312, DOI 10.1097/MEJ.0b013e32832d3aa1; Bhullar IS, 2010, AM SURGEON, V76, P966; Bledsoe BE, 2006, J TRAUMA, V60, P1257, DOI 10.1097/01.ta.0000196489.19928.c0; Bledsoe Bryan E, 2003, Emerg Med Serv, V32, P88; Brown JB, 2010, J TRAUMA, V69, P1030, DOI 10.1097/TA.0b013e3181f6f450; Davis DP, 2005, ANN EMERG MED, V46, P115, DOI 10.1016/j.annemergmed.2005.01.024; Di Bartolomeo S, 2001, ARCH SURG-CHICAGO, V136, P1293, DOI 10.1001/archsurg.136.11.1293; Eckstein M, 2002, J TRAUMA, V53, P340, DOI 10.1097/00005373-200208000-00025; Fukuda AM, 2012, NEUROSCIENCE, V222, P366, DOI 10.1016/j.neuroscience.2012.06.033; Galvagno SM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009228.pub2; Galvagno SM, 2012, JAMA-J AM MED ASSOC, V307, P1602, DOI 10.1001/jama.2012.467; Haider AH, 2012, J AM COLL SURGEONS, V214, P756, DOI 10.1016/j.jamcollsurg.2011.12.013; Hirano K., 2001, HLTH SERVICE OUTCOME, V2, P259, DOI [10.1023/A:1020371312283, DOI 10.1023/A:1020371312283]; Ho D, 2007, J STAT SOFTWARE; Honaker J., 2009, J STAT SOFTWARE; Imai K., 2009, ZELIG EVERYONES STAT; Imai K, 2008, J COMPUT GRAPH STAT, V17, P892, DOI 10.1198/106186008X384898; Larson JT, 2004, J TRAUMA, V56, P89, DOI 10.1097/01.TA.0000061163.35582.A5; Lindenauer PK, 2004, JAMA-J AM MED ASSOC, V291, P2092, DOI 10.1001/jama.291.17.2092; Mitchell AD, 2007, CAN J SURG, V50, P129; Moront ML, 1996, J PEDIATR SURG, V31, P1183, DOI 10.1016/S0022-3468(96)90114-1; Oyetunji TA, 2011, J SURG RES, V165, pE37, DOI 10.1016/j.jss.2010.09.025; Ringburg Akkie N, 2009, Air Med J, V28, P298, DOI 10.1016/j.amj.2009.03.007; Roudsari B, 2008, INJURY PREV, V14, P96, DOI 10.1136/ip.2007.017129; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; Rubin DB, 2007, STAT MED, V26, P20, DOI 10.1002/sim.2739; SCHILLER WR, 1988, J TRAUMA, V28, P1127, DOI 10.1097/00005373-198808000-00004; Stewart KE, 2011, ACAD EMERG MED, V18, P1208, DOI 10.1111/j.1553-2712.2011.01207.x; Sullivent EE, 2011, PREHOSP EMERG CARE, V15, P295, DOI 10.3109/10903127.2011.569849; Thomas SH, 2002, J TRAUMA, V52, P136, DOI 10.1097/00005373-200201000-00023; Thomas Stephen H, 2003, Curr Opin Anaesthesiol, V16, P153, DOI 10.1097/00001503-200304000-00008; Thomas Stephen H, 2002, Prehosp Emerg Care, V6, P359, DOI 10.1080/10903120290938508; Tortella B J, 1996, Air Med J, V15, P24, DOI 10.1016/S1067-991X(96)90015-2; Tracy ET, 2013, J PEDIATR SURG, V48, P1384, DOI 10.1016/j.jpedsurg.2013.03.041; Traumatic Brain Injury in the United States, EM DEP VIS HOSP DEAT	38	11	11	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 15	2014	31	14					1321	1328		10.1089/neu.2014.3325			8	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	AN4CA	WOS:000340534000009	24605922				2021-06-18	
J	Austin, BS; Lee, CL				Austin, Bryan S.; Lee, Chun-Lung			A Structural Equation Model of Vocational Rehabilitation Services: Predictors of Employment Outcomes for Clients with Intellectual and Co-occurring Psychiatric Disabilities	JOURNAL OF REHABILITATION			English	Article							TRAUMATIC BRAIN-INJURY; MENTAL-RETARDATION; DEVELOPMENTAL-DISABILITIES; COMPETITIVE EMPLOYMENT; SUPPORTED EMPLOYMENT; INDIVIDUALS; PEOPLE; ADULTS; OPPORTUNITIES; ILLNESS	Despite low employment rates and significant barriers to competitive employment, individuals with intellectual disabilities (ID) and co-occurring psychiatric disabilities want to work and are capable of working. From the context of the state-federal vocational rehabilitation (VR) program, this study analyzed variables from the Rehabilitation Services Administration 911 national data set through structural equation modeling. New knowledge about the state-federal VR program was generated. In particular, job-related VR services (Job Placement, Job Search Assistance, Job Readiness Training, and On-the-Job Support) were found to significantly predict employment outcomes for VR clients with ID and co-occurring psychiatric disabilities. Implications for VR practice and future research are discussed.	[Austin, Bryan S.] Univ Idaho, Boise, ID 83702 USA; [Lee, Chun-Lung] Michigan State Univ, E Lansing, MI 48824 USA	Austin, BS (corresponding author), Univ Idaho, Dept Leadership & Counseling, Rehabil Counseling & Human Serv Program, 322 E Front St,Suite 440, Boise, ID 83702 USA.	baustin@uidaho.edu					Baron R. C., 2002, BEHAV SCI LAW, V20, P585; Bolton BF, 2000, REHABIL COUNS BULL, V44, P10, DOI 10.1177/003435520004400103; Bond GR, 2008, J REHABIL, V74, P33; Butterworth J, 2012, J REHABIL, V78, P20; Catalano D, 2006, NEUROREHABILITATION, V21, P279; Centers for Disease Control and Prevention (CDC), 1996, MMWR Morb Mortal Wkly Rep, V45, P61; Chan F, 2007, REHABIL COUNS BULL, V51, P44; Chan Fong, 2008, J Cancer Surviv, V2, P169, DOI 10.1007/s11764-008-0057-y; Chiu CY, 2013, MULT SCLER J, V19, P1655, DOI 10.1177/1352458513482372; Cimera R. E., 2001, J DISABIL POLICY STU, V11, P194, DOI DOI 10.1177/104420730101100401; Degeneffe C. E., 2000, J APPL REHABILITATIO, V31, P41; Dutta A, 2008, J OCCUP REHABIL, V18, P326, DOI 10.1007/s10926-008-9154-z; Equal Employment Opportunity Commission [EEOC], 2011, QUEST ANSW IND INT D; Erickson W, 2010, DISABILITY STAT 2008; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Huang I. C., 2013, DEV MED CHILD NEUROL, DOI [10.1111/dmcn.1224, DOI 10.1111/DMCN.1224]; Huang WH, 1997, J REHABIL, V63, P27; Institute for Community Inclusion, 2011, REAL PEOPL REAL JOBS; Jacobson JW, 1996, J REHABIL, V62, P11; Jahoda A, 2008, J APPL RES INTELLECT, V21, P1, DOI 10.1111/j.1468-3148.2007.00365.x; Johnstone B, 2003, ARCH PHYS MED REHAB, V84, P161, DOI 10.1053/apmr.2003.50098; Joreskog K. G., 2001, LISREL 8 USERS REFER; Kaplan D., 2009, STRUCTURAL EQUATION, V2nd ed.; Kiernan W., 2000, FOCUS AUTISM OTHER D, V15, P90, DOI DOI 10.1177/108835760001500204; Kline R.B., 2011, PRINCIPLES PRACTICE; Kosciulek JF, 2001, REHABIL COUNS BULL, V44, P209, DOI 10.1177/003435520104400403; Luecking D. M., 2006, J APPL REHABILITATIO, V37, P22; Mank D, 1998, MENT RETARD, V36, P205, DOI 10.1352/0047-6765(1998)036<0205:EOFPWS>2.0.CO;2; Mank D, 1997, MENT RETARD, V35, P185, DOI 10.1352/0047-6765(1997)035<0185:AOTTOS>2.0.CO;2; Marcoulides George A., 2001, NEW DEV TECHNIQUES S; Martin Luecking D., 2006, J APPL REHABILITATIO, V37, P14; Migliore A, 2008, REHABIL COUNS BULL, V52, P35, DOI 10.1177/0034355208320075; Moore C. L., 2000, J APPL REHABILITATIO, V31, P36; Moore C. L., 2001, J APPL REHABILITATIO, V32, P31; Moore CL, 2004, MENT RETARD, V42, P253, DOI 10.1352/0047-6765(2004)42<253:EAOCEO>2.0.CO;2; Moore CL, 2002, J REHABIL, V68, P14; Moore CL, 2002, REHABIL COUNS BULL, V45, P162, DOI 10.1177/003435520204500305; National Association of State Mental Health Program Directors [NASMHPD], 2004, SERV IND COOCC DEV D; National Association of the Dually Diagnosed [NADD], 2011, INF DUAL DIAGN; Olney MF, 2001, MENT RETARD, V39, P32, DOI 10.1352/0047-6765(2001)039<0032:NEOVSU>2.0.CO;2; Raykov T., 2006, 1 COURSE STRUCTURAL; Rehabilitation Services Administration, 2008, 911 RSA; Rosenthal DA, 2007, INT J SOC PSYCHIATR, V53, P357, DOI 10.1177/0020764006074555; Rubin S. E., 1995, FDN VOCATIONAL REHAB, P175; Saunders J. L., 2006, J APPL REHABILITATIO, V37, P3; Schreiber JB, 2006, J EDUC RES, V99, P323, DOI 10.3200/JOER.99.6.323-338; Strauser D, 2010, J CANCER SURVIV, V4, P179, DOI 10.1007/s11764-010-0119-9; Strauser DR, 2004, REHABIL COUNS BULL, V47, P215, DOI 10.1177/00343552040470040301; Timmons JC, 2002, J VOCATIONAL REHABIL, V17, P183; Valentine J., 2003, EFFECT SIZE SUBSTANT; VanderSchie-Bezyak JL, 2003, J REHABIL, V69, P53; Yamaki K, 2002, MENT RETARD, V40, P132, DOI 10.1352/0047-6765(2002)040<0132:EAISOA>2.0.CO;2	52	11	12	0	17	NATL REHABILITATION ASSOC-NRA	ALEXANDRIA	633 S WASHINGTON ST, ALEXANDRIA, VA 22314-4109 USA	0022-4154			J REHABIL	J. Rehabil.	JUL-SEP	2014	80	3					11	20					10	Rehabilitation	Rehabilitation	AU8ZK	WOS:000345881600003					2021-06-18	
J	Meekes, J; Braams, OB; Braun, KPJ; Jennekens-Schinkel, A; van Rijen, PC; Alpherts, WCJ; Hendriks, MPH; van Nieuwenhuizen, O				Meekes, Joost; Braams, Olga B.; Braun, Kees P. J.; Jennekens-Schinkel, Aag; van Rijen, Peter C.; Alpherts, Willem C. J.; Hendriks, Marc P. H.; van Nieuwenhuizen, Onno			Visual memory after epilepsy surgery in children: A standardized regression-based analysis of group and individual outcomes	EPILEPSY & BEHAVIOR			English	Article						Child; Epilepsy surgery; Temporal/extratemporal resection; Visual memory; SRB analysis	TEMPORAL-LOBE EPILEPSY; FACE-RECOGNITION ALGORITHMS; TRAUMATIC BRAIN-INJURY; VERBAL MEMORY; FOLLOW-UP; HEMISPHERIC-SPECIALIZATION; PEDIATRIC-PATIENTS; CHILDHOOD; LOBECTOMY; IMPAIRMENTS	Visual memory is vulnerable to epilepsy surgery in adults, but studies in children suggest no change or small improvements. We investigated visual memory after epilepsy surgery, both group-wise and in individual children, using two techniques to assess change: 1) repeated measures analysis of variance (ANOVA) and 2) an empirically based technique for detecting cognitive change [standardized regression-based (SRB) analysis]. A prospective cohort consisting of 21 children completed comprehensive assessments of memory both before surgery (TO) and 6 (T1), 12 (72), and 24 months (73) after surgery. For each patient, two age- and gender-matched controls were assessed with the same tests at the same intervals. Repeated measures ANOVA replicated the results of previous studies reporting no change or minor improvements after surgery. However, group analysis of SRB results eliminated virtually all improvements, indicating that the ANOVA results were confounded by practice effects. Standardized regression-based group results showed that in fact patients scored lower after surgery than would be predicted based on their presurgical performance. Analysis of individual SRB results showed that per visual memory measure, an average of 18% of patients obtained a significantly negative SRB score, whereas, on average, only 2% obtained a significantly positive SRB score. At T3, the number of significantly negative SRB scores outweighed the number of significantly positive SRB scores in 62% of patients. There were no clear associations of clinical variables (including side and site of surgery and postsurgical seizure freedom) with memory outcome. The present analysis revealed that given their individual presurgical functioning, many children obtained disappointing results on some visual memory tests after epilepsy surgery. Comparison of the SRB analysis with ANOVA results emphasizes the importance of empirically based techniques for detecting cognitive effects of epilepsy surgery in childhood. (C) 2014 Elsevier Inc. All rights reserved.	[Meekes, Joost; Braams, Olga B.; Jennekens-Schinkel, Aag] Univ Med Ctr Utrecht, Sect Neuropsychol Children & Adolescents, Brain Ctr Rudolf Magnus, NL-3508 AB Utrecht, Netherlands; [Meekes, Joost; Braams, Olga B.; Jennekens-Schinkel, Aag; van Nieuwenhuizen, Onno] Bio Res Ctr Children, NL-6816 VS Arnhem, Netherlands; [Braun, Kees P. J.; van Nieuwenhuizen, Onno] Univ Med Ctr Utrecht, Dept Child Neurol, Brain Ctr Rudolf Magnus, NL-3508 AB Utrecht, Netherlands; [van Rijen, Peter C.] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Neurosurg, NL-3508 GA Utrecht, Netherlands; [Alpherts, Willem C. J.] Epilepsy Inst Netherlands Fdn, SEIN, NL-2103 SW Heemstede, Netherlands; [Hendriks, Marc P. H.] Kempenhaeghe Expertise Ctr Epileptol Sleep Med &, Dept Behav Sci, NL-5590 AB Heeze, Netherlands; [Hendriks, Marc P. H.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6500 HE Nijmegen, Netherlands	Meekes, J (corresponding author), Univ Med Ctr Utrecht, Sect Neuropsychol Children & Adolescents, Hp KG 01-327-1,POB 85090, NL-3508 AB Utrecht, Netherlands.	meekes.joost@gmail.com; o.b.braams@umcutrecht.nl; k.braun@umcutrecht.nl; a.jennekens@umcutrecht.nl; p.v.rijen@umcutrecht.nl; walpherts@sein.nl; HendriksM@kempenhaeghe.nl; OnnovanNieuwenhuizen@umcutrecht.nl	Hendriks, Marc P.H./D-9688-2012	Hendriks, Marc P.H./0000-0002-5321-7970; Meekes, Joost/0000-0001-6902-8958	Bio Foundation; Epilepsies of Childhood (EpoCH) Foundation; Netherlands Epilepsy Fund [NEF 08-09, NEF 08-10]	This study was financially supported by the Bio Foundation, the Epilepsies of Childhood (EpoCH) Foundation, and the Netherlands Epilepsy Fund grants NEF 08-09 to OBB and NEF 08-10 to KPJB.	Alexander AI, 2005, ARCH CLIN NEUROPSYCH, V20, P587, DOI 10.1016/j.acn.2004.12.005; Alpherts WCJ, 2006, NEUROLOGY, V67, P626, DOI 10.1212/01.wnl.0000230139.45304.eb; Baxendale S, 2008, NEUROLOGY, V71, P1319, DOI 10.1212/01.wnl.0000319699.04265.fd; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; COHEN M, 1992, BRAIN COGNITION, V20, P315, DOI 10.1016/0278-2626(92)90024-G; Cormack F, 2012, EPILEPSY RES, V98, P255, DOI 10.1016/j.eplepsyres.2011.09.004; D'Argenzio L, 2011, EPILEPSIA, V52, P1966, DOI 10.1111/j.1528-1167.2011.03272.x; Delis DC, 2000, CALIFORNIA VERBAL LE; Dlugos DJ, 1999, PEDIATR NEUROL, V21, P444, DOI 10.1016/S0887-8994(99)00032-6; Duff K, 2005, ARCH CLIN NEUROPSYCH, V20, P111, DOI 10.1016/j.acn.2004.03.003; Duff K, 2012, ARCH CLIN NEUROPSYCH, V27, P248, DOI 10.1093/arclin/acr120; Engle JA, 2010, NEUROPSYCHOLOGIA, V48, P38, DOI 10.1016/j.neuropsychologia.2009.08.005; Ganzeboom H., INT SOCIOECONOMIC IN; Gleissner U, 2004, EPILEPSIA, V45, P960, DOI 10.1111/j.0013-9580.2004.42203.x; Gleissner U, 2005, BRAIN, V128, P2822, DOI 10.1093/brain/awh597; Gleissner U, 2002, EPILEPSY RES, V51, P287, DOI 10.1016/S0920-1211(02)00158-4; Gleissner U, 2008, EPILEPSIA, V49, P700, DOI 10.1111/j.1528-1167.2007.01497.x; Gonzalez LM, 2007, EPILEPSIA, V48, P124, DOI 10.1111/j.1528-1167.2006.00907.x; Guimaraes CA, 2007, J CHILD NEUROL, V22, P836, DOI 10.1177/0883073807304701; Guimond A, 2013, EPILEPSY BEHAV, V29, P53, DOI 10.1016/j.yebeh.2013.05.034; Gulgonen S, 2000, EPILEPSIA, V41, P405, DOI 10.1111/j.1528-1157.2000.tb00181.x; Hernandez MT, 2003, EPILEPSY BEHAV, V4, P522, DOI 10.1016/j.yebeh.2003.07.014; International Labour Office, INT STAND CLASS OCC; Jackson DC, 2013, J PEDIATR-US, V162, P1047, DOI 10.1016/j.jpeds.2012.10.046; Jager G, 2003, NEUROPSYCHOLOGIA, V41, P504, DOI 10.1016/S0028-3932(02)00086-6; JAMBAQUE I, 1993, NEUROPSYCHOLOGIA, V31, P1321, DOI 10.1016/0028-3932(93)90101-5; Jambaque I, 2007, NEUROPSYCHOLOGIA, V45, P2850, DOI 10.1016/j.neuropsychologia.2007.05.008; KAUFMAN AS, 1993, MANUAL KAUFMAN ADOLE; Kernan CL, 2012, EPILEPSIA, V53, P2156, DOI 10.1111/j.1528-1167.2012.03706.x; Kort W., 2005, WISC 3 NL HANDLEIDIN; Lah S, 2004, EPILEPSY BEHAV, V5, P804, DOI 10.1016/j.yebeh.2004.08.005; Laurent A, 2006, EPILEPSIA, V47, P99, DOI 10.1111/j.1528-1167.2006.00703.x; Lawrence MA, 2012, EZ EASY ANAL VISUALI; Lee GP, 2005, EPILEPSIA, V46, P97, DOI 10.1111/j.0013-9580.2005.41704.x; Lendt M, 1999, EPILEPSIA, V40, P1543, DOI 10.1111/j.1528-1157.1999.tb02038.x; Lendt M, 2002, EPILEPSY BEHAV, V3, P51, DOI 10.1006/ebeh.2001.0296; Leunen D, 2009, EPILEPSY BEHAV, V16, P534, DOI 10.1016/j.yebeh.2009.09.004; Liang SL, 2012, PEDIATR NEUROL, V47, P284, DOI 10.1016/j.pediatrneurol.2012.06.014; Lillywhite LM, 2007, EPILEPSY BEHAV, V10, P553, DOI 10.1016/j.yebeh.2007.03.002; Mabbott DJ, 2003, NEUROPSYCHOLOGIA, V41, P995, DOI 10.1016/S0028-3932(02)00318-4; Martin RC, 2002, ARCH NEUROL-CHICAGO, V59, P1895, DOI 10.1001/archneur.59.12.1895; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; McSweeny A., 1993, CLIN NEUROPSYCHOL, V7, P300, DOI DOI 10.1080/13854049308401901; Meekes J, 2013, EPILEPSY RES, V107, P146, DOI 10.1016/j.eplepsyres.2013.08.017; Moye J, 1997, NEUROPSYCHOL REV, V7, P157, DOI 10.1023/B:NERV.0000005907.34499.43; Mulder J.L., 2004, KAUFMAN INTELLIGENTI; Nolan MA, 2004, J PAEDIATR CHILD H, V40, P20, DOI 10.1111/j.1440-1754.2004.00284.x; Oitment C, 2013, EPILEPSY BEHAV, V28, P141, DOI 10.1016/j.yebeh.2013.04.013; Phillips PJ, 2000, IEEE T PATTERN ANAL, V22, P1090, DOI 10.1109/34.879790; Phillips PJ, 1998, IMAGE VISION COMPUT, V16, P295, DOI 10.1016/S0262-8856(97)00070-X; Postma A, 2008, NEUROSCI BIOBEHAV R, V32, P1339, DOI 10.1016/j.neubiorev.2008.05.001; R Core Team, 2013, R LANG ENV STAT COMP; Reynolds C. R., 2007, TEST MEMORY LEARNING; Rzezak P, 2014, EPILEPSY BEHAV, V31, P117, DOI 10.1016/j.yebeh.2013.12.005; Rzezak P, 2012, EPILEPSY BEHAV, V25, P577, DOI 10.1016/j.yebeh.2012.09.043; Saling MM, 2009, BRAIN, V132, P570, DOI 10.1093/brain/awp012; Schouten A, 2002, DEV MED CHILD NEUROL, V44, P803; Sherman EMS, 2011, EPILEPSIA, V52, P857, DOI 10.1111/j.1528-1167.2011.03022.x; Skirrow C, 2011, NEUROLOGY, V76, P1330, DOI 10.1212/WNL.0b013e31821527f0; Smith ML, 2014, EPILEPSY BEHAV, V32, P79, DOI 10.1016/j.yebeh.2014.01.006; Smith ML, 2011, NEUROPSYCHOLOGY, V25, P634, DOI 10.1037/a0023770; Smith ML, 2004, EPILEPSIA, V45, P650, DOI 10.1111/j.0013-9580.2004.21903.x; Smith ML, 2012, EPILEPSY MEMORY, P309; Spencer S, 2008, LANCET NEUROL, V7, P525, DOI 10.1016/S1474-4422(08)70109-1; Statistics Netherlands, STAND OND; Thaler NS, 2011, APPL NEUROPSYCHOL, V18, P168, DOI 10.1080/09084282.2011.595443; UNESCO Institute for Statistics, 2011, INT STAND CLASS ED; van Geldorp B, 2014, BRAIN COGNITION, V85, P231, DOI 10.1016/j.bandc.2013.12.009; Van Schooneveld MMJ, 2013, BRAIN DEV-JPN, V35, P721, DOI 10.1016/j.braindev.2013.01.011; Venables W.N., 2002, MODERN APPL STAT S; Wechsler D., 2002, WECHSLER INTELLIGENC; West S, 2012, ARCH ASSESS PSYCHOL, V2, P32	72	11	11	0	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1525-5050	1525-5069		EPILEPSY BEHAV	Epilepsy Behav.	JUL	2014	36						57	67		10.1016/j.yebeh.2014.04.016			11	Behavioral Sciences; Clinical Neurology; Psychiatry	Behavioral Sciences; Neurosciences & Neurology; Psychiatry	AL4WW	WOS:000339136500013	24857810				2021-06-18	
J	Nordeman, P; Estrada, S; Odell, LR; Larhed, M; Antoni, G				Nordeman, Patrik; Estrada, Sergio; Odell, Luke R.; Larhed, Mats; Antoni, Gunnar			C-11-Labeling of a potent hydroxyethylamine BACE-1 inhibitor and evaluation in vitro and in vivo	NUCLEAR MEDICINE AND BIOLOGY			English	Article						beta-secretase; BACE-1; Position emission tomography; PET; Alzheimer's disease	CATALYZED CARBONYLATION REACTIONS; TRAUMATIC BRAIN-INJURY; STRUCTURE-BASED DESIGN; BETA-SECRETASE; ALZHEIMERS-DISEASE; AMYLOID-BETA; ARYL BROMIDES; AXONS; C-11; PET	Introduction: The enzyme beta-secretase 1 (BACE-1) is associated with the catalytic cleavage of amyloid precursor protein (APP) which leads to the production of amyloid-p, an amyloidogenic peptide that forms insoluble fibrils and is linked to neurodegeneration and Alzheimer's disease (AD). A PET-radioligand for the quantification of BACE-1 would be useful for the understanding of AD. In this report, we describe the synthesis and carbon-11 radiolabeling of a potent hydroxyethylamine BACE-1 enzyme inhibitor (BSI-IV) and its evaluation in vitro and in vivo. Methods: (11)[C]-N-1-((2S,3R)-4-(cyclopropylamino)-3-hydroxy-1-phenylbutan-2-y1)-5-(N-methylmethylsulfonamido)-N-3-((R)-1-phenylethyl)isophthalamide, a p-secretase inhibitor, denoted here as [C-11]BSIIV was synthesized through a palladium-mediated aminocarbonylation with an aryl halide precursor (I or Br) and [C-11]CO. The effect of different palladium/ligand-complexes on radiochemical yield in the carbonylative reaction was investigated. The binding of the labeled compound to BACE-1 enzyme was studied in vitro by frozen section autoradiography from brains of healthy rats. Dynamic small animal PET-CT studies and ex vivo biodistribution were performed in male rats. Results: The halide precursors were synthesized in six steps starting from methyl-3-nitrobenzoate with an overall yield of 21-26%. [C-11]BSI-IV was obtained in 29 +/- 12% decay corrected radiochemical yield (n = 12) with a specific activity of 790 +/- 155 GBq/umol at the end of synthesis with a radiochemical purity of >99%. The predinical studies showed that [C-11]BSI-IV has a rapid metabolism in rat with excretion to the small intestines. Conclusion: [C-11]BSI-IV was obtained in sufficient amount and purity to enable predinical investigation. The predinical studies showed low specific binding in vitro and fast clearance in vivo and a low uptake in the brain. These findings suggests that [C-11]BSI-IV has limited use as a PET-ligand for the study of BACE-1 or AD. (c) 2014 Elsevier Inc. All rights reserved.	[Nordeman, Patrik; Estrada, Sergio; Antoni, Gunnar] Uppsala Univ, Dept Med Chem, Preclin PET Platform, SE-75123 Uppsala, Sweden; [Odell, Luke R.; Larhed, Mats] Uppsala Univ, Dept Med Chem, SE-75123 Uppsala, Sweden	Antoni, G (corresponding author), Uppsala Univ, Dept Med Chem, Preclin PET Platform, SE-75123 Uppsala, Sweden.	gunnar.antoni@pet.medchem.uu.se		Nordeman, Patrik/0000-0002-4334-7368	Knut and Alice Wallenberg FoundationKnut & Alice Wallenberg Foundation	We thank Knut and Alice Wallenberg Foundation for financial support, Veronica Asplund for technical support and Ashkan Fardost for help with LC-MS-MS.	Alzheimers Assoc, 2012, ALZHEIMERS DEMENT, V8, P131, DOI 10.1016/j.jalz.2012.02.001; Blasko I, 2004, J NEURAL TRANSM, V111, P523, DOI 10.1007/s00702-003-0095-6; Brennfuhrer A, 2009, ANGEW CHEM INT EDIT, V48, P4114, DOI 10.1002/anie.200900013; Chen XH, 2004, AM J PATHOL, V165, P357, DOI 10.1016/S0002-9440(10)63303-2; Clark CM, 2011, JAMA-J AM MED ASSOC, V305, P275, DOI 10.1001/jama.2010.2008; CLINTON J, 1991, NEUROPATH APPL NEURO, V17, P69, DOI 10.1111/j.1365-2990.1991.tb00695.x; Cole SL, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-22; Dahl K, 2013, EUR J ORG CHEM, V2013, P1228, DOI 10.1002/ejoc.201201708; Decourt B, 2011, J ALZHEIMERS DIS, V24, P53, DOI 10.3233/JAD-2011-110017; DISCHINO DD, 1983, J NUCL MED, V24, P1030; FARDE L, 1995, SYNAPSE, V20, P200, DOI 10.1002/syn.890200303; Ghosh AK, 2000, J AM CHEM SOC, V122, P3522, DOI 10.1021/ja000300g; Ghosh AK, 2001, J MED CHEM, V44, P2865, DOI 10.1021/jm0101803; Grigg R, 2010, TETRAHEDRON, V66, P5515, DOI 10.1016/j.tet.2010.03.090; Guo T, 2006, CURR MED CHEM, V13, P1811, DOI 10.2174/092986706777452489; Honer M, 2013, 11 INT C QUANT BRAIN; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Karimi F, 2003, ORG BIOMOL CHEM, V1, P541, DOI 10.1039/b209553j; Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505; Kawai T, 2013, NUCL MED BIOL, V40, P705, DOI 10.1016/j.nucmedbio.2013.03.008; Kihlberg T, 2002, PCT INT APPL, Patent No. WO:2002102711 A1; Ling Y, 2003, INT J BIOCHEM CELL B, V35, P1505, DOI 10.1016/S1357-2725(03)00133-X; Ludwig JA, 2005, NAT REV CANCER, V5, P845, DOI 10.1038/nrc1739; Mane RS, 2013, TETRAHEDRON LETT, V54, P6912, DOI 10.1016/j.tetlet.2013.10.040; Martinelli JR, 2008, J ORG CHEM, V73, P7102, DOI 10.1021/jo801279r; Martinelli JR, 2006, ORG LETT, V8, P4843, DOI 10.1021/ol061902t; Meredith JE, 2008, J PHARMACOL EXP THER, V326, P502, DOI 10.1124/jpet.108.138974; Miller PW, 2008, ANGEW CHEM INT EDIT, V47, P8998, DOI 10.1002/anie.200800222; Minati L, 2009, AM J ALZHEIMERS DIS, V24, P95, DOI 10.1177/1533317508328602; Mulder SD, 2010, J ALZHEIMERS DIS, V20, P253, DOI 10.3233/JAD-2010-1367; Nordeman P, 2012, J ORG CHEM, V77, P11393, DOI 10.1021/jo302322w; Odell LR, 2012, SYNLETT, P685, DOI 10.1055/s-0031-1290350; Patel S, 2008, NUCL MED BIOL, V35, P805, DOI 10.1016/j.nucmedbio.2008.10.002; Pennington LD, 2013, BIOORG MED CHEM LETT, V23, P4459, DOI 10.1016/j.bmcl.2013.05.028; PIKE CJ, 1993, J NEUROSCI, V13, P1676; Schmidt B, 2006, CURR TOP MED CHEM, V6, P377, DOI 10.2174/156802606776287027; Selkoe DJ, 2012, SCIENCE, V337, P1488, DOI 10.1126/science.1228541; Stachel SJ, 2006, J MED CHEM, V49, P6147, DOI 10.1021/jm060884i; Stachel SJ, 2006, BIOORG MED CHEM LETT, V16, P641, DOI 10.1016/j.bmcl.2005.10.032; Stachel SJ, 2004, J MED CHEM, V47, P6447, DOI 10.1021/jm049379g; Thompson LA, 2005, CURR PHARM DESIGN, V11, P3383, DOI 10.2174/138161205774370825; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018	42	11	11	0	22	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0969-8051	1872-9614		NUCL MED BIOL	Nucl. Med. Biol.	JUL	2014	41	6					536	543		10.1016/j.nucmedbio.2014.03.024			8	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AI5YH	WOS:000336946400014	24857866				2021-06-18	
J	Ping, XJ; Jiang, KW; Lee, SY; Cheng, JX; Jin, XM				Ping, Xingjie; Jiang, Kewen; Lee, Seung-Young; Cheng, Ji-Xing; Jin, Xiaoming			PEG-PDLLA Micelle Treatment Improves Axonal Function of the Corpus Callosum following Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						axon; CAP; cerebral cortex; micelles; TBI	CONTROLLED CORTICAL IMPACT; UNMYELINATED AXONS; FLUID PERCUSSION; SPINAL-CORD; INTRACRANIAL-PRESSURE; MEMBRANE PORATION; UNITED-STATES; PERMEABILITY; REPAIR; RAT	The initial pathological changes of diffuse axonal injury following traumatic brain injury (TBI) include membrane disruption and loss of ionic homeostasis, which further lead to dysfunction of axonal conduction and axon disconnection. Resealing the axolemma is therefore a potential therapeutic strategy for the early treatment of TBI. Monomethoxy poly (ethylene glycol)-poly (D, L-lactic acid) di-block copolymer micelles (mPEG-PDLLA) have been shown to restore depressed compound action potentials (CAPs) of spinal axons and promote functional recovery after spinal cord injury. Here, we evaluate the effect of the micelles on repairing the injured cortical axons following TBI. Adult mice subjected to controlled cortical impact (CCI) were treated with intravenous injection of the micelles at 0 h or 4 h after injury. Evoked CAPs were recorded from the corpus callosum of coronal cortical slices at 2 days after injury. The CCI caused significant decreases in the amplitudes of two CAP peaks that were respectively generated by the faster myelinated axons and slower unmyelinated axons. Micelle treatment at both 0 h and 4 h after CCI resulted in significant increases in both CAP peak amplitudes. Injection of fluorescent dye-labeled micelles revealed high fluorescent staining in cortical gray and white matters underneath the impact site. Labeling membrane-perforated neurons by injecting a membrane impermeable dye Texas Red-labeled dextran into lateral ventricles at 2 h post-CCI revealed that immediate micelle injection after CCI did not reduce the number of dye-stained cortical neurons and dentate granule cells of the hippocampus, indicating its ineffectiveness in repairing plasma membrane of neuronal somata. We conclude that intravenous administration of mPEG-PDLLA micelles immediately or at 4 h after TBI allows brain penetration via the compromised blood brain-barrier, and thereby improves the function of both myelinated and unmyelinated axons of the corpus callosum.	[Ping, Xingjie; Jiang, Kewen; Jin, Xiaoming] Indiana Univ Sch Med, Stark Neurosci Res Inst, Dept Anat & Cell Biol, Indiana Spinal Cord & Brain Injury Res Grp, Indianapolis, IN 46202 USA; [Jiang, Kewen] Zhejiang Univ, Sch Med, Childrens Hosp, Dept Neurol, Hangzhou 310003, Zhejiang, Peoples R China; [Lee, Seung-Young; Cheng, Ji-Xing] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA; [Lee, Seung-Young; Cheng, Ji-Xing] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA	Jin, XM (corresponding author), Indiana Univ Sch Med, Stark Neurosci Res Inst, 980 W Walnut St R3,Room C426B, Indianapolis, IN 46202 USA.	xijin@iupui.edu	Jin, Xiaoming/AAH-3555-2020; Jin, Xiaoming/N-8545-2016; ping, xingjie/AAW-4597-2020	Jin, Xiaoming/0000-0002-8671-8640; Lee, Seung-Young/0000-0003-1349-3759	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS057940]; Indiana Spinal Cord and Brain Injury Research Fund from the Indiana State Department of Health [A70-0-079212]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R00NS057940, K99NS057940] Funding Source: NIH RePORTER	This research was supported by National Institutes of Health Grant NS057940 and by the Indiana Spinal Cord and Brain Injury Research Fund from the Indiana State Department of Health (A70-0-079212 to X.J.).	Ai JL, 2007, J NEUROTRAUM, V24, P960, DOI 10.1089/neu.2006.0224; Ajao DO, 2012, J NEUROTRAUM, V29, P2060, DOI 10.1089/neu.2011.1883; Baker AJ, 2002, J NEUROTRAUM, V19, P587, DOI 10.1089/089771502753754064; Borgens RB, 2000, FASEB J, V14, P27; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Chen HT, 2008, P NATL ACAD SCI USA, V105, P6596, DOI 10.1073/pnas.0707046105; Cho Y, 2012, EXP NEUROL, V233, P126, DOI 10.1016/j.expneurol.2011.09.028; CHRISTMAN CW, 1994, J NEUROTRAUM, V11, P173, DOI 10.1089/neu.1994.11.173; Clausen F, 2005, ACTA NEUROCHIR, V147, P775, DOI 10.1007/s00701-005-0550-2; Colley BS, 2010, EXP NEUROL, V224, P241, DOI 10.1016/j.expneurol.2010.03.026; CORDOBES F, 1986, ACTA NEUROCHIR, V81, P27, DOI 10.1007/BF01456261; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Crawford DK, 2009, J NEUROSCI METH, V182, P25, DOI 10.1016/j.jneumeth.2009.05.013; Farkas O, 2006, J NEUROSCI, V26, P3130, DOI 10.1523/JNEUROSCI.5119-05.2006; Gao XA, 2011, J NEUROPATH EXP NEUR, V70, P183, DOI 10.1097/NEN.0b013e31820c6878; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; GRAVEL C, 1990, J COMP NEUROL, V291, P147, DOI 10.1002/cne.902910110; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kilinc D, 2008, EXP NEUROL, V212, P422, DOI 10.1016/j.expneurol.2008.04.025; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; KRAUSE TL, 1990, P NATL ACAD SCI USA, V87, P1471, DOI 10.1073/pnas.87.4.1471; Lafrenaye AD, 2012, J CEREBR BLOOD F MET, V32, P1919, DOI 10.1038/jcbfm.2012.95; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; Mbye LH, 2012, J CEREBR BLOOD F MET, V32, P515, DOI 10.1038/jcbfm.2011.158; Newcombe V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019214; PETTUS EH, 1994, J NEUROTRAUM, V11, P507, DOI 10.1089/neu.1994.11.507; Povlishock JT, 1996, ACT NEUR S, V66, P81; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; PRESTON RJ, 1983, EXP NEUROL, V79, P808, DOI 10.1016/0014-4886(83)90044-4; Reeves TM, 2007, BRAIN RES, V1154, P225, DOI 10.1016/j.brainres.2007.04.002; Reeves TM, 2012, J NEUROPATH EXP NEUR, V71, P198, DOI 10.1097/NEN.0b013e3182482590; Reeves TM, 2005, EXP NEUROL, V196, P126, DOI 10.1016/j.expneurol.2005.07.014; Salmond CH, 2005, CURR OPIN CRIT CARE, V11, P111, DOI 10.1097/01.ccx.0000155358.31983.37; Shi R, 1999, J NEUROPHYSIOL, V81, P2406; Shi RY, 1999, J NEUROTRAUM, V16, P727, DOI 10.1089/neu.1999.16.727; Shi YZ, 2010, NAT NANOTECHNOL, V5, P80, DOI [10.1038/NNANO.2009.303, 10.1038/nnano.2009.303]; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Son AHPWV, 2007, CLIN REHABIL, V21, P1024, DOI 10.1177/0269215507077603; Swanson TH, 1998, BRAIN RES, V784, P188, DOI 10.1016/S0006-8993(97)01323-1; Whalen MJ, 2008, J CEREBR BLOOD F MET, V28, P490, DOI 10.1038/sj.jcbfm.9600544; Xu J, 2007, J NEUROTRAUM, V24, P753, DOI 10.1089/neu.2006.0208	42	11	11	0	19	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 1	2014	31	13					1172	1179		10.1089/neu.2013.3147			8	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	AL2VK	WOS:000338983500006	24579802	Green Published			2021-06-18	
J	Radomski, MV; Finkelstein, M; Llanos, I; Scheiman, M; Wagener, SG				Radomski, Mary Vining; Finkelstein, Marsha; Llanos, Imelda; Scheiman, Mitchell; Wagener, Sharon Gowdy			Composition of a Vision Screen for Servicemembers With Traumatic Brain Injury: Consensus Using a Modified Nominal Group Technique	AMERICAN JOURNAL OF OCCUPATIONAL THERAPY			English	Article						brain injuries; military personnel; vision disorders; vision screening	INSUFFICIENCY SYMPTOM SURVEY; OCCUPATIONAL-THERAPY; VISUAL IMPAIRMENTS; CONVERGENCE; VALIDITY; MILITARY; VETERANS	Vision impairment is common in the first year after traumatic brain injury (TBI), including among service members whose brain injuries occurred during deployment in Iraq and Afghanistan. Occupational therapy practitioners provide routine vision screening to inform treatment planning and referral to vision specialists, but existing methods are lacking because many tests were developed for children and do not screen for vision dysfunction typical of TBI. An expert panel was charged with specifying the composition of a vision screening protocol for servicemembers with TBI. A modified nominal group technique fostered discussion and objective determinations of consensus. After considering 29 vision tests, the panel recommended a nine-test vision screening that examines functional performance, self-reported problems, far near acuity, reading, accommodation, convergence, eye alignment and binocular vision, saccades, pursuits, and visual fields. Research is needed to develop reliable, valid, and clinically feasible vision screening protocols to identify TBI-related vision disorders in adults.	[Radomski, Mary Vining; Finkelstein, Marsha] Courage Kenny Res Ctr, Minneapolis, MN 55407 USA; [Llanos, Imelda] James A Haley Vet Hosp, Tampa, FL USA; [Scheiman, Mitchell] Penn Coll Optometry, Philadelphia, PA 19141 USA; [Wagener, Sharon Gowdy] Courage Kenny Rehabil Inst, Minneapolis, MN USA	Radomski, MV (corresponding author), Courage Kenny Res Ctr, 800 East 28th St & Chicago 12212, Minneapolis, MN 55407 USA.	mary.radomski@allina.com		Scheiman, Mitchell/0000-0002-9274-5696			Anderson AJ, 2009, CLIN EXP OPTOM, V92, P45, DOI 10.1111/j.1444-0938.2008.00280.x; Berger S, 2013, AM J OCCUP THER, V67, P263, DOI 10.5014/ajot.2013.007203; Bulson R, 2012, J REHABIL RES DEV, V49, P1075, DOI 10.1682/JRRD.2011.02.0017; Capo-Aponte JE, 2012, J REHABIL RES DEV, V49, P1377, DOI 10.1682/JRRD.2011.07.0128; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; Cate Y, 2000, AM J OCCUP THER, V54, P326, DOI 10.5014/ajot.54.3.326; Ciuffreda K. J., 2001, DOWNEY DARLINGS PHYS, P241; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Daugherty K. M., 2007, OPTOMETRY VISION DEV, V38, P75; Davies S, 2011, HEALTH SERV RES, V46, P2005, DOI 10.1111/j.1475-6773.2011.01297.x; Defense and Veterans Brain Injury Center, 2013, DOD NUMB TRAUM BRAIN; DELBECQ AL, 1971, J APPL BEHAV SCI, V7, P466, DOI 10.1177/002188637100700404; Fricke T. R., 1997, CLIN EXPT OPTOMETRY, V80, P165, DOI DOI 10.1111/J.1444-0938.1997.TB04876.X; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Gallaway M, 2010, OPTOMETRY, V81, P571, DOI 10.1016/j.optm.2010.07.024; Garzia R P, 1990, J Am Optom Assoc, V61, P124; Gene-Sampedro A., 2003, J BEHAV OPTOM, V14, P101; Gillen G, 2009, COGNITIVE PERCEPTUAL; Goodrich GL, 2013, OPTOMETRY VISION SCI, V90, P105, DOI 10.1097/OPX.0b013e31827f15a1; Greenwald BD, 2012, BRAIN INJURY, V26, P1338, DOI 10.3109/02699052.2012.706356; Janet M. P., 2005, J BEHAV OPTOMETRY, V16, P38; Kaiser Peter K, 2009, Trans Am Ophthalmol Soc, V107, P311; Kent C., 2013, USING LOW TECH ASSES; Lew HL, 2011, J HEAD TRAUMA REHAB, V26, P489, DOI 10.1097/HTR.0b013e318204e54b; Lew HL, 2009, J REHABIL RES DEV, V46, P819, DOI 10.1682/JRRD.2008.09.0129; Maples W C, 1988, J Am Optom Assoc, V59, P549; Maples WC, 1992, J BEHAV OPTOM, V3, P143; Powell J. M., 2006, J BEHAV OPTOMETRY, V17, P59; Radomski MV, 2009, AM J OCCUP THER, V63, P646, DOI 10.5014/ajot.63.5.646; Raphael BA, 2006, AM J OPHTHALMOL, V142, P1026, DOI 10.1016/j.ajo.2006.06.060; Rouse M, 2009, OPTOMETRY VISION SCI, V86, P357, DOI 10.1097/OPX.0b013e3181989252; Rouse MW, 2004, OPHTHAL PHYSL OPT, V24, P384, DOI 10.1111/j.1475-1313.2004.00202.x; Sample J. A., 1984, J EXTENSION, V22; Scheiman M, 2011, UNDERSTANDING AND MANAGING VISION DEFICITS: A GUIDE FOR OCCUPATIONAL THERAPISTS, THIRD EDITION, P1; Scheiman M, 2003, OPTOMETRY VISION SCI, V80, P214, DOI 10.1097/00006324-200303000-00011; Stelmack JA, 2009, OPTOMETRY, V80, P419, DOI 10.1016/j.optm.2009.02.011; Suchoff I., 2001, Visual Vestibular Conseq Acq Brain Inj, P1; Suchoff I B, 1999, J Am Optom Assoc, V70, P301; Sue Stevens, 2007, Community Eye Health, V20, P52; WAINAPEL SF, 1995, AM J PHYS MED REHAB, V74, P313, DOI 10.1097/00002060-199507000-00010; Weisser-Pike O., 2014, OCCUPATIONAL THERAPY, P105; Yothers Tracey, 2002, Optometry, V73, P91	42	11	11	0	11	AMER OCCUPATIONAL THERAPY ASSOC, INC	BETHESDA	4720 MONTGOMERY LANE, BETHESDA, MD 20814-3425 USA	0272-9490	1943-7676		AM J OCCUP THER	Am. J. Occup. Ther.	JUL-AUG	2014	68	4					422	429		10.5014/ajot.2014.011445			8	Rehabilitation	Rehabilitation	AL4FR	WOS:000339088800007	25005505	Green Published, Bronze			2021-06-18	
J	Schwarzbold, ML; Diaz, AP; Nunes, JC; Sousa, DS; Hohl, A; Guarnieri, R; Linhares, MN; Walz, R				Schwarzbold, Marcelo L.; Diaz, Alexandre P.; Nunes, Jean C.; Sousa, Daniel S.; Hohl, Alexandre; Guarnieri, Ricardo; Linhares, Marcelo N.; Walz, Roger			Validity and screening properties of three depression rating scales in a prospective sample of patients with severe traumatic brain injury	REVISTA BRASILEIRA DE PSIQUIATRIA			English	Article						Traumatic brain injury; depression; ROC curve; screening	HOSPITAL ANXIETY; PSYCHIATRIC-DISORDERS; INVENTORY; MORTALITY; DIAGNOSIS; INTERVIEW; STROKE	Objective: To evaluate the validity and utility of the Hamilton Rating Scale for Depression (HAM-D), Beck Depression Inventory (BDI), and Hospital Anxiety and Depression Scale (HADS) as screening tools for depression after severe traumatic brain injury (TBI). Methods: Forty-six consecutive survivors of severe TBI were evaluated at a median of 15 months after injury. Receiver operating characteristic (ROC) analysis was performed using HAM-D, BDI, and HADS as predictors, and the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I) as gold standard. Results: The area under the curve (AUC) for HAM-D was 0.89, and the optimal cutoff point was 7 (sensitivity 92.9%, specificity 78.1%); for the BDI, the AUC was 0.946 and the optimal cutoff point was 14 (sensitivity 92.3%, specificity 96.7%); for the HADS, the AUC was 0.947 and the optimal cutoff point was 9 (sensitivity 100%, specificity 80.7%); and for the HADS depression subscale, the AUC was 0.937 and the optimal cutoff point was 6 (sensitivity 92.9%, specificity 83.9%). There were no statistically significant differences among the AUCs. Conclusion: Our findings support a high validity and utility for the HAM-D, BDI, and HADS as screening tools for depression in patients with severe TBI, without major changes in standard cutoff points.	[Schwarzbold, Marcelo L.; Diaz, Alexandre P.; Nunes, Jean C.; Sousa, Daniel S.; Hohl, Alexandre; Guarnieri, Ricardo; Linhares, Marcelo N.; Walz, Roger] Univ Fed Santa Catarina, HU, Ctr Appl Neurosci CeNAp, Florianopolis, SC, Brazil; [Schwarzbold, Marcelo L.; Diaz, Alexandre P.; Sousa, Daniel S.; Guarnieri, Ricardo; Linhares, Marcelo N.] Hosp Governador Celso Ramos, Neurosurg Serv, Florianopolis, SC, Brazil; [Schwarzbold, Marcelo L.; Walz, Roger] Univ Fed Santa Catarina, Dept Clin Med, Univ Hosp, BR-88040970 Florianopolis, SC, Brazil	Schwarzbold, ML (corresponding author), Univ Fed Santa Catarina, Dept Clin Med, Univ Hosp, 3 Andar,Campus Univ, BR-88040970 Florianopolis, SC, Brazil.	schwlib@gmail.com	Hohl, Alexandre/R-9269-2019; Schwarzbold, Marcelo Liborio/J-8960-2014; Diaz, Alexandre Paim/AAD-8323-2019; Diaz, Alexandre Paim/J-9042-2014; Walz, Roger/K-9096-2013	Hohl, Alexandre/0000-0002-8073-5837; Diaz, Alexandre Paim/0000-0002-6591-6648; Walz, Roger/0000-0002-9875-6687	PRONEX Program (NENASC Project); PPSUS Program of Fundacao de Amparo a Pesquisa e Inovacao do Estado de Santa Catarina (FAPESC); National Science and Technology Institute for Translational Medicine (INCT-TM)	The authors thank Prof. Emil Kupek for statistical assistance. This work was supported by PRONEX Program (NENASC Project) and PPSUS Program of Fundacao de Amparo a Pesquisa e Inovacao do Estado de Santa Catarina (FAPESC) and the National Science and Technology Institute for Translational Medicine (INCT-TM).	Aben I, 2002, PSYCHOSOMATICS, V43, P386, DOI 10.1176/appi.psy.43.5.386; Akobeng AK, 2007, ACTA PAEDIATR, V96, P644, DOI 10.1111/j.1651-2227.2006.00178.x; Al-Adawi S, 2007, BRAIN INJURY, V21, P385, DOI 10.1080/02699050701311059; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Berg A, 2009, STROKE, V40, P523, DOI 10.1161/STROKEAHA.108.527705; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Botega NJ, 1998, J BRAS PSIQUIAT, V47, P285; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; Dahm J, 2013, J AFFECT DISORDERS, V151, P392, DOI 10.1016/j.jad.2013.06.011; Davydow DS, 2010, CRIT CARE, V14, DOI 10.1186/cc8867; Thais MERD, 2012, CNS NEUROSCI THER, V18, P606, DOI 10.1111/j.1755-5949.2012.00346.x; Diaz AP, 2012, J NEUROTRAUM, V29, P1029, DOI 10.1089/neu.2011.2089; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; First M.B., 1996, STRUCTURED CLIN INTE; FRANK E, 1991, ARCH GEN PSYCHIAT, V48, P851, DOI 10.1001/archpsyc.1991.01810330075011; Gorenstein C, 1996, BRAZ J MED BIOL RES, V29, P453; Gullo JD, 2011, NEUROCRIT CARE, V14, P194, DOI 10.1007/s12028-010-9462-y; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Hohl A, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.06.007; Homaifar BY, 2009, ARCH PHYS MED REHAB, V90, P652, DOI 10.1016/j.apmr.2008.10.028; Hudak AM, 2012, J HEAD TRAUMA REHAB, V27, P87, DOI 10.1097/HTR.0b013e3182114efd; Langley J, 2010, BRAIN INJURY, V24, P939, DOI 10.3109/02699052.2010.491494; Lecrubier Y, 2007, J CLIN PSYCHIAT, V68, P36; Martins ET, 2009, J TRAUMA, V67, P85, DOI 10.1097/TA.0b013e318187acee; Mojtabai R, 2013, PSYCHOTHER PSYCHOSOM, V82, P161, DOI 10.1159/000345968; Moreno RA, 1998, REV PSIQUIATR CLIN, V25, P262; Naarding P, 2002, J NEUROPSYCH CLIN N, V14, P329, DOI 10.1176/appi.neuropsych.14.3.329; Schwarzbold Marcelo, 2008, Neuropsychiatr Dis Treat, V4, P797; SPITZER RL, 1983, COMPR PSYCHIAT, V24, P399, DOI 10.1016/0010-440X(83)90032-9; Tavares M, 1996, ENTREVISTA CLIN ESTR; US Preventive Serv Task Force, 2009, ANN INTERN MED, V151, P784, DOI 10.7326/0003-4819-151-11-200912010-00006; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Whelan-Goodinson R, 2009, J AFFECT DISORDERS, V114, P94, DOI 10.1016/j.jad.2008.06.007; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	37	11	12	0	9	ASSOC BRASILEIRA PSIQUIATRIA	SAO PAULO	SUBSCRIPTION DEPARTMENT, RUA PEDRO DE TOLEDO, 967 - CASA 01, SAO PAULO, SP 04039-032  A, BRAZIL	1516-4446	1809-452X		REV BRAS PSIQUIATR	Rev. Bras. Psiquiatr.	JUL-SEP	2014	36	3					206	212		10.1590/1516-4446-2013-1308			7	Psychiatry	Psychiatry	AN2PD	WOS:000340426900005	24770656	DOAJ Gold			2021-06-18	
J	Solbakk, AK; Funderud, I; Lovstad, M; Endestad, T; Meling, T; Lindgren, M; Knight, RT; Kramer, UM				Solbakk, Anne-Kristin; Funderud, Ingrid; Lovstad, Marianne; Endestad, Tor; Meling, Torstein; Lindgren, Magnus; Knight, Robert T.; Kraemer, Ulrike M.			Impact of Orbitofrontal Lesions on Electrophysiological Signals in a Stop Signal Task	JOURNAL OF COGNITIVE NEUROSCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; ERROR-RELATED NEGATIVITY; INFERIOR FRONTAL GYRUS; EVENT-RELATED POTENTIALS; GLASGOW OUTCOME SCALE; RESPONSE-INHIBITION; PREFRONTAL CORTEX; DECISION-MAKING; BRAIN POTENTIALS; EMOTIONAL STIMULI	Behavioral inhibition and performance monitoring are critical cognitive functions supported by distributed neural networks including the pFC. We examined neurophysiological correlates of motor response inhibition and action monitoring in patients with focal orbitofrontal (OFC) lesions (n = 12) after resection of a primary intracranial tumor or contusion because of traumatic brain injury. Healthy participants served as controls (n = 14). Participants performed a visual stop signal task. We analyzed behavioral performance as well as event-related brain potentials and oscillations. Inhibition difficulty was adjusted individually to yield an equal amount of successful inhibitions across participants. RTs of patients and controls did not differ significantly in go trials or in failed stop trials, and no differences were observed in estimated stop signal RT. However, electrophysiological response patterns during task performance distinguished the groups. Patients with OFC lesions had enhanced P3 amplitudes to congruent condition go signals and to stop signals. In stop trials, patients had attenuated N2 and error-related negativity, but enhanced error positivity. Patients also showed enhanced and prolonged post-error beta band increases for stop errors. This effect was particularly evident in patients whose lesion extended to the subgenual cingulate cortex. In summary, although response inhibition was not impaired, the diminished stop N2 and ERN support a critical role of the OFC in action monitoring. Moreover, the increased stop P3, error positivity, and post-error beta response indicate that OFC injury affected action outcome evaluation and support the notion that the OFC is relevant for the processing of abstract reinforcers such as performing correctly in the task.	[Solbakk, Anne-Kristin; Funderud, Ingrid; Meling, Torstein] Rigshosp, Oslo Univ Hosp, N-0424 Oslo, Norway; [Lovstad, Marianne] Sunnaas Rehabil Hosp, Nesodden, Norway; [Endestad, Tor] Univ Oslo, N-0316 Oslo, Norway; [Lindgren, Magnus] Lund Univ, S-22100 Lund, Sweden; [Knight, Robert T.] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Kraemer, Ulrike M.] Univ Lubeck, Lubeck, Germany	Solbakk, AK (corresponding author), Rigshosp, Oslo Univ Hosp, Div Surg & Clin Neurosci, Dept Neurosurg, POB 4956 Nydalen, N-0424 Oslo, Norway.	annesolbakk@gmail.com	Kramer, Ulrike M./A-8871-2019; Kramer, Ulrike/AAF-2966-2020; Meling, Torstein/Q-2568-2019	Kramer, Ulrike M./0000-0002-3841-1812; Meling, Torstein/0000-0001-6595-0873; Funderud, Ingrid/0000-0002-4481-7237; Endestad, Tor/0000-0002-4403-6887	Research Council of NorwayResearch Council of Norway [186504/V50]; South-Eastern Norway Regional Health Authority [2008047]; German Research FoundationGerman Research Foundation (DFG) [KR 3691/1-1]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R37NS021135] Funding Source: NIH RePORTER	The study was supported by the Research Council of Norway (186504/V50 to A. K. S.), the South-Eastern Norway Regional Health Authority (2008047 to A. K. S.), and the German Research Foundation (KR 3691/1-1 to U. M. K.). We would like to thank Clay Campbell Clayworth and Hakon Engen for support in establishing routines for lesion reconstructions and Dr. Paulina Due-Tonnessen for evaluating the structural MRI scans.	Aron AR, 2007, J NEUROSCI, V27, P3743, DOI 10.1523/JNEUROSCI.0519-07.2007; Aron AR, 2011, BIOL PSYCHIAT, V69, pE55, DOI 10.1016/j.biopsych.2010.07.024; Aron AR, 2003, NAT NEUROSCI, V6, P115, DOI 10.1038/nn1003; Band GPH, 2003, ACTA PSYCHOL, V112, P105, DOI 10.1016/S0001-6918(02)00079-3; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Berlin HA, 2004, BRAIN, V127, P1108, DOI 10.1093/brain/awh135; Beyer F, 2012, NEUROPSYCHOLOGIA, V50, P3304, DOI 10.1016/j.neuropsychologia.2012.10.007; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Brazdil M, 2002, EXP BRAIN RES, V146, P460, DOI 10.1007/s00221-002-1201-y; Bruin KJ, 2001, CLIN NEUROPHYSIOL, V112, P1660, DOI 10.1016/S1388-2457(01)00601-0; Burle B, 2008, J COGNITIVE NEUROSCI, V20, P1637, DOI 10.1162/jocn.2008.20110; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Cavanagh JF, 2009, J NEUROSCI, V29, P98, DOI 10.1523/JNEUROSCI.4137-08.2009; Chikazoe J, 2010, CURR OPIN PSYCHIATR, V23, P267, DOI 10.1097/YCO.0b013e3283387a9f; Cohen MX, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.054.2009; Crawford JR, 2012, CORTEX, V48, P1009, DOI 10.1016/j.cortex.2011.06.021; Crawford JR, 1998, CLIN NEUROPSYCHOL, V12, P482, DOI 10.1076/clin.12.4.482.7241; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dimoska A, 2006, BRAIN COGNITION, V62, P98, DOI 10.1016/j.bandc.2006.03.011; Elliott R, 2005, INT REV NEUROBIOL, V65, P89, DOI 10.1016/S0074-7742(04)65004-5; Falkenstein M., 1990, PSYCHOPHYSIOLOGICAL, P192; Ferree TC, 2001, CLIN NEUROPHYSIOL, V112, P536, DOI 10.1016/S1388-2457(00)00533-2; Gauggel S, 2004, J NEUROL NEUROSUR PS, V75, P539; Gehring WJ, 2001, J NEUROSCI, V21, P9430, DOI 10.1523/JNEUROSCI.21-23-09430.2001; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Gehring WJ, 2002, SCIENCE, V295, P2279, DOI 10.1126/science.1066893; Hajcak G, 2008, PSYCHOL SCI, V19, P103, DOI 10.1111/j.1467-9280.2008.02053.x; Hartikainen KA, 2001, BRAIN COGNITION, V47, P339; Hayden BY, 2008, NEURON, V60, P19, DOI 10.1016/j.neuron.2008.09.012; Hayden BY, 2010, J NEUROSCI, V30, P3339, DOI 10.1523/JNEUROSCI.4874-09.2010; Huettel SA, 2004, NEUROPSYCHOLOGIA, V42, P379, DOI 10.1016/j.neuropsychologia.2003.07.009; Huster RJ, 2013, INT J PSYCHOPHYSIOL, V87, P217, DOI 10.1016/j.ijpsycho.2012.08.001; Huynh H, 1976, J EDUC STATIST, V1, P69, DOI DOI 10.3102/10769986001001069; Ito S, 2003, SCIENCE, V302, P120, DOI 10.1126/science.1087847; Jung JL, 2011, INT J PSYCHOPHYSIOL, V79, P64, DOI 10.1016/j.ijpsycho.2010.09.014; Karnath HO, 2004, CEREB CORTEX, V14, P1164, DOI 10.1093/cercor/bhh076; KOK A, 1986, BIOL PSYCHOL, V23, P21, DOI 10.1016/0301-0511(86)90087-6; Kok A, 2004, PSYCHOPHYSIOLOGY, V41, P9, DOI 10.1046/j.1469-8986.2003.00127.x; Kramer UM, 2007, J NEUROSCI, V27, P14190, DOI 10.1523/JNEUROSCI.4229-07.2007; Kramer UM, 2013, CORTEX, V49, P837, DOI 10.1016/j.cortex.2012.05.003; Kramer UM, 2011, J COGNITIVE NEUROSCI, V23, P2481, DOI 10.1162/jocn.2010.21573; Krikorian R, 2004, BRAIN COGNITION, V54, P257, DOI 10.1016/j.bandc.2004.02.038; LOGAN GD, 1984, J EXP PSYCHOL HUMAN, V10, P276, DOI 10.1037/0096-1523.10.2.276; Luck S.J., 2005, **DROPPED REF**; Luu P, 2001, CLIN NEUROPHYSIOL, V112, P1295, DOI 10.1016/S1388-2457(01)00559-4; Marco-Pallares J, 2008, J COGNITIVE NEUROSCI, V20, P1595, DOI 10.1162/jocn.2008.20117; Munakata Y, 2011, TRENDS COGN SCI, V15, P453, DOI 10.1016/j.tics.2011.07.011; Murray EA, 2007, J NEUROSCI, V27, P8166, DOI 10.1523/JNEUROSCI.1556-07.2007; Navarro-Cebrian A, 2013, J NEUROSCI, V33, P12375, DOI 10.1523/JNEUROSCI.0447-13.2013; Neuper C, 2001, CLIN NEUROPHYSIOL, V112, P2084, DOI 10.1016/S1388-2457(01)00661-7; Nieuwenhuis S, 2001, PSYCHOPHYSIOLOGY, V38, P752, DOI 10.1017/S0048577201001111; Noonan MP, 2012, EUR J NEUROSCI, V35, P997, DOI 10.1111/j.1460-9568.2012.08023.x; O'Connell RG, 2007, EUR J NEUROSCI, V25, P2571, DOI 10.1111/j.1460-9568.2007.05477.x; Overbeek TJM, 2005, J PSYCHOPHYSIOL, V19, P319, DOI 10.1027/0269-8803.19.4.319; Pearson JM, 2013, J EXP ANAL BEHAV, V99, P74, DOI 10.1002/jeab.5; Picton TW, 2007, CEREB CORTEX, V17, P826, DOI 10.1093/cercor/bhk031; Pliszka SR, 2000, BIOL PSYCHIAT, V48, P238, DOI 10.1016/S0006-3223(00)00890-8; Ramautar JR, 2006, BIOL PSYCHOL, V72, P96, DOI 10.1016/j.biopsycho.2005.08.001; Rosenbloom MH, 2012, J NEUROPSYCH CLIN N, V24, P266, DOI 10.1176/appi.neuropsych.11060139; Rubia K, 1998, BEHAV BRAIN RES, V94, P25, DOI 10.1016/S0166-4328(97)00166-6; Rubia K, 2003, NEUROIMAGE, V20, P351, DOI 10.1016/S1053-8119(03)00275-1; Rubia K, 2001, NEUROIMAGE, V13, P250, DOI 10.1006/nimg.2000.0685; Rudebeck PH, 2013, NAT NEUROSCI, V16, P1140, DOI 10.1038/nn.3440; Rule RR, 2002, COGN AFFECT BEHAV NE, V2, P264, DOI 10.3758/CABN.2.3.264; Rushworth MFS, 2011, NEURON, V70, P1054, DOI 10.1016/j.neuron.2011.05.014; Rushworth MFS, 2005, CURR BIOL, V15, pR54, DOI 10.1016/j.cub.2004.12.054; Schachar R, 2007, J ABNORM CHILD PSYCH, V35, P229, DOI 10.1007/s10802-006-9075-2; Schmahmann JD, 2007, BRAIN, V130, P630, DOI 10.1093/brain/awl359; Schmajuk M, 2006, NEUROPSYCHOLOGIA, V44, P384, DOI 10.1016/j.neuropsychologia.2005.06.005; Schoenbaum G, 2009, NAT REV NEUROSCI, V10, P885, DOI 10.1038/nrn2753; Senderecka M, 2012, INT J PSYCHOPHYSIOL, V85, P93, DOI 10.1016/j.ijpsycho.2011.05.007; Shalgi S, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00124; Sharp DJ, 2010, P NATL ACAD SCI USA, V107, P6106, DOI 10.1073/pnas.1000175107; SIMON JR, 1967, J APPL PSYCHOL, V51, P300, DOI 10.1037/h0020586; Solbakk AK, 2005, J CLIN EXP NEUROPSYC, V27, P205, DOI 10.1080/13803390490515739; Stemmer B, 2004, NEUROPSYCHOLOGIA, V42, P118, DOI 10.1016/S0028-3932(03)00121-0; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; Swann NC, 2012, NEUROIMAGE, V59, P2860, DOI 10.1016/j.neuroimage.2011.09.049; Swick D, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-102; TallonBaudry C, 1997, J NEUROSCI, V17, P722; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Tekin S, 2002, J PSYCHOSOM RES, V53, P647, DOI 10.1016/S0022-3999(02)00428-2; Turken U, 2008, NEUROSCI LETT, V441, P7, DOI 10.1016/j.neulet.2008.05.115; Ullsperger M, 2001, NEUROIMAGE, V14, P1387, DOI 10.1006/nimg.2001.0935; Ullsperger M, 2002, NEUROPSYCHOLOGY, V16, P548, DOI 10.1037//0894-4105.16.4.548; Ursu S, 2005, COGNITIVE BRAIN RES, V23, P51, DOI 10.1016/j.cogbrainres.2005.01.004; Verbruggen F, 2008, J EXP PSYCHOL HUMAN, V34, P413, DOI 10.1037/0096-1523.34.2.413; Verbruggen F, 2009, NEUROSCI BIOBEHAV R, V33, P647, DOI 10.1016/j.neubiorev.2008.08.014; Verbruggen F, 2009, J EXP PSYCHOL HUMAN, V35, P835, DOI 10.1037/a0012726; Vocat R, 2008, NEUROPSYCHOLOGIA, V46, P2545, DOI 10.1016/j.neuropsychologia.2008.04.006; Voytek B, 2010, NEURON, V68, P401, DOI 10.1016/j.neuron.2010.09.018; Wechsler D., 2011, WECHLSER ABBREVIATED; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yeung N, 2004, PSYCHOL REV, V111, P931, DOI [10.1037/0033-295X.111.4.931, 10.1037/0033-295x.111.4.931]; Yeung N, 2007, PSYCHOPHYSIOLOGY, V44, P39, DOI 10.1111/j.1469-8986.2006.00482.x	95	11	11	0	12	MIT PRESS	CAMBRIDGE	ONE ROGERS ST, CAMBRIDGE, MA 02142-1209 USA	0898-929X	1530-8898		J COGNITIVE NEUROSCI	J. Cogn. Neurosci.	JUL	2014	26	7					1528	1545		10.1162/jocn_a_00561			18	Neurosciences; Psychology, Experimental	Neurosciences & Neurology; Psychology	AI9CW	WOS:000337226700016	24392904	Green Accepted			2021-06-18	
J	Yang, KC; Zhou, MJ; Sperry, JL; Rong, L; Zhu, XG; Geng, L; Wu, W; Zhao, G; Billiar, TR; Feng, QM				Yang, Kai-Chao; Zhou, Min-Jie; Sperry, Jason L.; Rong, Liu; Zhu, Xiao-Guang; Geng, Lei; Wu, Wei; Zhao, Gang; Billiar, Timothy R.; Feng, Qi-Ming			SIGNIFICANT SEX-BASED OUTCOME DIFFERENCES IN SEVERELY INJURED CHINESE TRAUMA PATIENTS	SHOCK			English	Article						Blunt trauma; sex; injury severity; sex hormone; nosocomial infection; mortality	IMMUNE-RESPONSES; GENDER-DIFFERENCES; INFLAMMATORY RESPONSE; TESTOSTERONE LEVELS; REPRODUCTIVE-CYCLE; HEMORRHAGIC-SHOCK; IMPROVED SURVIVAL; BRAIN-INJURY; FEMALE; DIMORPHISM	A body of experimental evidence suggests that the female sex is associated with a lower risk of mortality after trauma-hemorrhage. However, controversy remains regarding the mechanism responsible for these differences and if basic science findings correspond to clinical differences. Racial disparities in trauma outcomes have also been increasingly described. Until now, research on the association between sex and trauma patient outcomes mainly focused on patients in Europe and the United States. Our research attempted to determine whether the female sex is associated with a survival advantage among severely injured Chinese trauma patients. A retrospective analysis of data derived from the Emergency Intensive Care Unit of the Shanghai Sixth People';s Hospital Acute Trauma Center during 2010 to 2013 was performed to characterize differences in sex-based outcomes after severe blunt trauma. The patient study cohort (858 Asian subjects) was then stratified by age and injury severity (using the Injury Severity Score [ISS]). Crude and adjusted odds ratios (ORs) were calculated to evaluate the association between sex and nosocomial infection rate and hospitalized mortality, both overall and by age and ISS category subgroups. Among all trauma patients, females had a significantly lower risk of in-hospital mortality compared with males (OR, 0.41; 95% confidence interval [95% CI], 0.20 - 0.85). This difference was most apparent for patients younger than 50 years (OR, 0.31; 95% CI, 0.12 - 0.82) and the group with ISS scores of 25 or higher (OR, 0.39; 95% CI, 0.17 - 0.91). No differences in the development of nosocomial infections between sexes were seen among the overall patient group and subgroups. This study revealed a statistically significant association between sex and mortality among severe blunt trauma patients, particularly those patients younger than 50 years and with ISSs of 25 or higher. Women had significantly lower mortality than men after severe blunt trauma. These results highlight the important role of sex hormones and sex-based outcome differences after severe traumatic injury in the Chinese population.	[Yang, Kai-Chao; Zhou, Min-Jie; Rong, Liu; Zhu, Xiao-Guang; Geng, Lei; Wu, Wei; Zhao, Gang; Feng, Qi-Ming] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Emergency Med, Shanghai 200233, Peoples R China; [Sperry, Jason L.] Univ Pittsburgh, Dept Surg, Med Ctr, Pittsburgh, PA USA	Feng, QM (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Emergency Med, 600 Yishan Rd, Shanghai 200233, Peoples R China.	fengqiming04@126.com			Shanghai Committee of Science and Technology, ChinaShanghai Science & Technology Committee [12410710700]	This study was supported by the Shanghai Committee of Science and Technology, China (grant no. 12410710700).	Angele MK, 2000, SHOCK, V14, P81, DOI 10.1097/00024382-200014020-00001; Angele MK, 2001, CYTOKINE, V16, P22, DOI 10.1006/cyto.2001.0945; Ba ZF, 2008, SHOCK, V30, P585, DOI 10.1097/SHK.0b013e31816f1a45; Bertoni AG, 2005, J NATL MED ASSOC, V97, P317; Bowles BJ, 2003, INJURY, V34, P27; Chaudry IH, 2003, J TRAUMA, V54, pS118, DOI 10.1097/01.TA.0000064511.14322.F1; Choudhry MA, 2005, SHOCK, V24, P101, DOI 10.1097/01.shk.0000191341.31530.5e; Coimbra R, 2003, J TRAUMA, V54, P689, DOI 10.1097/01.TA.0000058314.31655.5F; Combes A, 2009, CRIT CARE MED, V37, P2506, DOI 10.1097/CCM.0b013e3181a569df; Deitch EA, 2008, SHOCK, V29, P78, DOI 10.1097/shk.0b013e318063e98a; Diodato MD, 2001, CYTOKINE, V14, P162, DOI 10.1006/cyto.2001.0861; Dossett LA, 2008, J TRAUMA, V64, P580, DOI 10.1097/TA.0b013e31816543dd; Frink M, 2007, SHOCK, V27, P151, DOI 10.1097/01.shk.0000239767.64786.de; Gannon CJ, 2004, SHOCK, V21, P410, DOI 10.1097/00024382-200405000-00003; Ghafoori B, 2012, J TRAUMA STRESS, V25, P106, DOI 10.1002/jts.21663; Haider AH, 2008, ARCH SURG-CHICAGO, V143, P945, DOI 10.1001/archsurg.143.10.945; Haider AH, 2007, J TRAUMA, V62, P1259, DOI 10.1097/TA.0b013e31803c760e; Haider AH, 2010, J TRAUMA, V69, P537, DOI 10.1097/TA.0b013e3181efc67b; Haider AH, 2009, SURGERY, V146, P308, DOI 10.1016/j.surg.2009.05.006; Harman SM, 2001, J CLIN ENDOCR METAB, V86, P724, DOI 10.1210/jc.86.2.724; Jarrar D, 2000, SURGERY, V128, P246, DOI 10.1067/msy.2000.107376; Jarrar D, 2000, AM J PHYSIOL-HEART C, V279, pH1015; JUDD H L, 1976, Clinical Obstetrics and Gynecology, V19, P775, DOI 10.1097/00003081-197612000-00005; Kher A, 2005, SHOCK, V23, P1, DOI 10.1097/01.shk.0000148055.12387.15; Knoferl MW, 2000, ARCH SURG-CHICAGO, V135, P425, DOI 10.1001/archsurg.135.4.425; Knoferl MW, 2002, ANN SURG, V235, P105, DOI 10.1097/00000658-200201000-00014; Knoferl MW, 2001, AM J PHYSIOL-CELL PH, V281, pC1131, DOI 10.1152/ajpcell.2001.281.4.C1131; Krausz MM, 2003, SHOCK, V20, P444, DOI 10.1097/01.shk.0000094560.76615.91; Leifke E, 2000, CLIN ENDOCRINOL, V53, P689, DOI 10.1046/j.1365-2265.2000.01159.x; Lucas FL, 2006, ANN SURG, V243, P281, DOI 10.1097/01.sla.0000197560.92456.32; Magnotti LJ, 2008, J AM COLL SURGEONS, V206, P984, DOI 10.1016/j.jamcollsurg.2007.12.038; Matsumoto AM, 2002, J GERONTOL A-BIOL, V57, pM76, DOI 10.1093/gerona/57.2.M76; May AK, 2008, CRIT CARE MED, V36, P62, DOI 10.1097/01.CCM.0000292015.16171.6D; Mizushima Y, 2000, ANN SURG, V232, P673, DOI 10.1097/00000658-200011000-00009; Napolitano LM, 2001, J TRAUMA, V50, P274, DOI 10.1097/00005373-200102000-00013; Pathak EB, 2009, NEUROEPIDEMIOLOGY, V32, P302, DOI 10.1159/000208795; Rappold JF, 2002, J TRAUMA, V53, P436, DOI 10.1097/00005373-200209000-00007; Samy TSA, 2000, SHOCK, V14, P465; Schneider CP, 2000, SHOCK, V14, P347, DOI 10.1097/00024382-200014030-00019; Sperry JL, 2008, CRIT CARE MED, V36, P1838, DOI 10.1097/CCM.0b013e3181760c14; Sperry JL, 2012, J AM COLL SURGEONS, V214, P973, DOI 10.1016/j.jamcollsurg.2012.02.020; Wohltmann CD, 2001, AM J SURG, V181, P297, DOI 10.1016/S0002-9610(01)00582-7; Young MF, 2013, J EMERG MED, V45, P46, DOI 10.1016/j.jemermed.2012.07.088	43	11	13	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	JUL	2014	42	1					11	15		10.1097/SHK.0000000000000168			5	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	AJ5CZ	WOS:000337700600003	24667619				2021-06-18	
J	Wang, HC; Lin, YJ; Tsai, NW; Su, BYJ; Kung, CT; Chen, WF; Kwan, AL; Lu, CH				Wang, Hung-Chen; Lin, Yu-Jun; Tsai, Nai-Wen; Su, Ben Yu-Jih; Kung, Chia-Te; Chen, Wu-Fu; Kwan, Aij-Lie; Lu, Cheng-Hsien			Serial Plasma Deoxyribonucleic Acid Levels as Predictors of Outcome in Acute Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						mitochondrial DNA; nuclear DNA; outcome; traumatic brain injury	MITOCHONDRIAL-DNA LEVELS; CELL-FREE DNA; QUANTITATIVE-ANALYSIS; PROGNOSTIC MARKER; ACUTE STROKE; NUCLEAR; HEMORRHAGE; SEPSIS	Increased plasma deoxyribonucleic acid (DNA) levels may be associated with disease severity after acute traumatic brain injury (TBI). This study posits that increased plasma DNA levels in acute TBI are predictive of outcome. Both serial plasma nuclear DNA (nDNA) and mitochondrial DNA (mtDNA) levels were examined in 88 consecutive patients with acute TBI and 66 control subjects. Additional samples were obtained on day 4 and day 7. Results showed that plasma nDNA and mtDNA on admission were significantly increased in patients with TBI compared with controls. Plasma nDNA, but not plasma mtDNA, levels in patients with acute TBI significantly correlated with Glasgow Coma Scale (GCS) score and Injury Severity Score (ISS) on presentation. Plasma nDNA increased significantly from day 1 to day 7 in patients with poor outcome. Its levels on presentation were independently associated with outcome and higher levels (cutoff value >72.95 ng/mL) were associated with poorer outcomes. These findings suggest plasma nDNA levels reflect the severity of cerebral damage and can be considered a neuropathologic marker of patients with acute TBI. Further studies with bigger patient populations are warranted for better unbiased comparison.	[Wang, Hung-Chen; Lin, Yu-Jun; Chen, Wu-Fu] Kaohsiung Chang Gung Mem Hosp, Dept Neurosurg, Kaohsiung, Taiwan; [Tsai, Nai-Wen; Lu, Cheng-Hsien] Kaohsiung Chang Gung Mem Hosp, Dept Neurol, Kaohsiung, Taiwan; [Su, Ben Yu-Jih] Kaohsiung Chang Gung Mem Hosp, Dept Med, Kaohsiung, Taiwan; [Kung, Chia-Te] Kaohsiung Chang Gung Mem Hosp, Dept Emergency Med, Kaohsiung, Taiwan; Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Wang, Hung-Chen; Kwan, Aij-Lie] Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung, Taiwan; [Kwan, Aij-Lie] Kaohsiung Med Univ, Coll Med, Dept Neurosurg, Kaohsiung, Taiwan; [Lin, Yu-Jun; Lu, Cheng-Hsien] Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung 80424, Taiwan	Lu, CH (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Neurol, 123 Ta Pei Rd, Kaohsiung, Taiwan.	chlu99@ms44.url.com.tw		WANG, HUNG-CHEN/0000-0003-3962-1958; Su, Yu-Jih/0000-0002-7274-3458			Arnalich F, 2013, CRIT CARE, V17, DOI 10.1186/cc12735; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Chiu RWK, 2003, CLIN CHEM, V49, P719, DOI 10.1373/49.5.719; FOURNIE GJ, 1993, GERONTOLOGY, V39, P215; Kung CT, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-130; Lam NYL, 2006, RESUSCITATION, V68, P71, DOI 10.1016/j.resuscitation.2005.05.021; Lam NYL, 2003, CLIN CHEM, V49, P1286, DOI 10.1373/49.8.1286; Lo YMD, 2000, CLIN CHEM, V46, P319; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; Lu CH, 2010, QJM-INT J MED, V103, P169, DOI 10.1093/qjmed/hcp201; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Macher H, 2012, CLIN CHIM ACTA, V414, P12, DOI 10.1016/j.cca.2012.08.001; Ohayon S, 2012, J NEUROTRAUM, V29, P261, DOI 10.1089/neu.2011.1938; Perez-Polo JR, 2013, J NEUROTRAUM, V30, P727, DOI 10.1089/neu.2012.2650; Rainer TH, 2003, CLIN CHEM, V49, P562, DOI 10.1373/49.4.562; Rainer TH, 2007, CLIN CHIM ACTA, V376, P190, DOI 10.1016/j.cca.2006.08.025; Rhodes A, 2006, CRIT CARE, V10, DOI 10.1186/cc4894; Schmidt OI, 2007, ORTHOPADE, V36, P248, DOI 10.1007/s00132-007-1061-z; Tsai NW, 2011, CLIN CHIM ACTA, V412, P476, DOI 10.1016/j.cca.2010.11.036; TSUMITA T, 1963, NATURE, V198, P1088, DOI 10.1038/1981088a0; Wang HC, 2012, EUR J NEUROL, V19, P1532, DOI 10.1111/j.1468-1331.2012.03761.x; Wang HC, 2013, J NEUROSURG, V118, P13, DOI 10.3171/2012.8.JNS112093; Wu TL, 2002, CLIN CHIM ACTA, V321, P77, DOI 10.1016/S0009-8981(02)00091-8; Yurgel VC, 2007, J NEUROTRAUM, V24, P1172, DOI 10.1089/neu.2006.0160	24	11	12	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 1	2014	31	11					1039	1045		10.1089/neu.2013.3070			7	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	AJ7RS	WOS:000337895300006	24467366				2021-06-18	
J	Zhang, L; Zhao, MG; Fu, WH; Gao, XQ; Shen, J; Zhang, ZY; Xian, M; Jiao, YZ; Jiang, J; Wang, JQ; Gao, GM; Tang, B; Chen, L; Li, WM; Zhou, CH; Deng, SP; Gu, JW; Zhang, D; Zheng, Y; Chen, XM				Zhang, Li; Zhao, Minggang; Fu, Wenhao; Gao, Xinqiang; Shen, Ji; Zhang, Zuyun; Xian, Ming; Jiao, Yunzhi; Jiang, Jian; Wang, Jinqian; Gao, Guomin; Tang, Bin; Chen, Liang; Li, Weimin; Zhou, Changhua; Deng, Shaoping; Gu, Jianwen; Zhang, Dong; Zheng, Ying; Chen, Xiangmei			Epidemiological Analysis of Trauma Patients following the Lushan Earthquake	PLOS ONE			English	Article							2008 WENCHUAN EARTHQUAKE; 2010 YUSHU EARTHQUAKE; WOUND INFECTIONS; MANAGEMENT; DISASTER; VICTIMS; RESCUE; EVACUATION; CHINA; NEEDS	Background: A 7.0-magnitude earthquake hit Lushan County in China's Sichuan province on April 20, 2013, resulting in 196 deaths and 11,470 injured. This study was designed to analyze the characteristics of the injuries and the treatment of the seismic victims. Methods: After the earthquake, an epidemiological survey of injured patients was conducted by the Health Department of Sichuan Province. Epidemiological survey tools included paper-and-pencil questionnaires and a data management system based on the Access Database. Questionnaires were completed based on the medical records of inpatients with earthquake-related injuries. Outpatients or non-seismic injured inpatients were excluded. A total of 2010 patients from 140 hospitals were included. Results: The most common type of injuries involved bone fractures (58.3%). Children younger than 10 years of age suffered fewer fractures and chest injuries, but more skin and soft -tissue injuries. Patients older than 80 years were more likely to suffer hip and thigh fractures, pelvis fractures, and chest injuries, whereas adult patients suffered more ankle and foot fractures. A total of 207 cases of calcaneal fracture were due to high falling injuries related to extreme panic. The most common type of infection in hospitalized patients was pulmonary infections. A total of 70.5% patients had limb dysfunction, and 60.1% of this group received rehabilitation. Most patients received rehabilitation within 1 week, and the median duration of rehabilitation was 3 weeks. The cause of death of all seven hospitalized patients who died was severe traumatic brain injuries; five of this group died within 24 h after the earthquake. Conclusions: Injuries varied as a function of the age of the victim. As more injuries were indirectly caused by the Lushan earthquake, disaster education is urgently needed to avoid secondary injuries.	[Zhang, Li; Zhang, Dong; Zheng, Ying; Chen, Xiangmei] Chinese Peoples Liberat Army Gen Hosp, Dept Nephrol, State Key Lab Kidney Dis, Beijing, Peoples R China; [Zhang, Li; Zhang, Dong; Zheng, Ying; Chen, Xiangmei] Mil Med Coll, Beijing, Peoples R China; [Zhao, Minggang; Fu, Wenhao; Gao, Xinqiang] Natl Hlth & Family Planning Commiss Peoples Repub, Beijing, Peoples R China; [Shen, Ji; Zhang, Zuyun; Xian, Ming; Jiao, Yunzhi; Jiang, Jian; Wang, Jinqian] Hlth & Family Planning Commiss Sichuan Prov, Chengdu, Peoples R China; [Gao, Guomin; Tang, Bin; Chen, Liang] United Logist Minist, Dept Hlth, Chengdu, Chengdu Militar, Peoples R China; [Li, Weimin] Sichuan Univ, West China Hosp, Chengdu 610064, Peoples R China; [Zhou, Changhua] Publ Hlth Bur Yaan City, Yaan, Peoples R China; [Deng, Shaoping] Sichuan Prov Peoples Hosp, Chengdu, Peoples R China; [Gu, Jianwen] Chengdu Mil Command, Gen Hosp, Chengdu, Peoples R China	Chen, XM (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Nephrol, State Key Lab Kidney Dis, Beijing, Peoples R China.	xmchen301@126.com		Zhang, Dong/0000-0002-6521-9586	Chinese PLA 12th FiveYear Plan for Medical Sciences [BWS11J027]; National Science & Technology Pillar Program [2011BAI10B00, 2013BAI09B05]	The study was funded by grants from Chinese PLA 12th FiveYear Plan for Medical Sciences (BWS11J027) and National Science & Technology Pillar Program (No. 2011BAI10B00, 2013BAI09B05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardagh MW, 2012, LANCET, V379, P2109, DOI 10.1016/S0140-6736(12)60313-4; Bartels SA, 2012, LANCET, V379, P748, DOI 10.1016/S0140-6736(11)60887-8; Chen EQ, 2011, J HUAZHONG U SCI-MED, V31, P83, DOI 10.1007/s11596-011-0155-3; [陈锦 CHEN Jin], 2009, [中国循证医学杂志, Chinese Journal of Evidence-Based Medicine], V9, P1267; DEBRUYCKER M, 1983, B WORLD HEALTH ORGAN, V61, P1021; Emily YY., 2008, LANCET, V372, P359; Jiang Jie, 2012, J Evid Based Med, V5, P114, DOI 10.1111/j.1756-5391.2012.01186.x; Kang P, 2012, J TRAUMA ACUTE CARE, V72, P1626, DOI 10.1097/TA.0b013e3182479e07; Landry MD, 2010, PHYSIOTHER RES INT, V15, P123, DOI 10.1002/pri.488; Li SS, 2013, J REHABIL MED, V45, P603, DOI 10.2340/16501977-1176; Li Yuanfeng, 2009, J Evid Based Med, V2, P258, DOI 10.1111/j.1756-5391.2009.01045.x; Liu X, 2013, J EMERG MED, V45, P865, DOI 10.1016/j.jemermed.2013.05.054; Lushan earthquake medical expert team, 2013, CHINESE MED J, V93, P1527; Mace SE, 2007, AM J EMERG MED, V25, P762, DOI 10.1016/j.ajem.2006.12.011; Miskin IN, 2010, NEW ENGL J MED, V363, P2571, DOI 10.1056/NEJMc1005578; Oda J, 1997, J TRAUMA, V42, P470, DOI 10.1097/00005373-199703000-00015; Ouyang Y, 2013, LANCET, V381, P1801, DOI 10.1016/S0140-6736(13)61105-8; Raissi GR, 2007, J SPINAL CORD MED, V30, P369, DOI 10.1080/10790268.2007.11753954; Ran YC, 2010, SCAND J INFECT DIS, V42, P347, DOI 10.3109/00365540903510682; Sever MS, 2001, KIDNEY INT, V60, P1114, DOI 10.1046/j.1523-1755.2001.0600031114.x; Shen Ji, 2012, J Evid Based Med, V5, P75, DOI 10.1111/j.1756-5391.2012.01176.x; Sugihara G, 2011, LANCET, V378, P485, DOI 10.1016/S0140-6736(11)61250-6; Tang BH, 2013, LANCET, V381, P1984, DOI 10.1016/S0140-6736(13)61201-5; Tao C, 2009, DIAGN MICR INFEC DIS, V63, P268, DOI 10.1016/j.diagmicrobio.2008.11.009; van der Tol A, 2009, NEPHROL DIAL TRANSPL, V24, P907, DOI 10.1093/ndt/gfn557; Wang Y, 2010, EMERG INFECT DIS, V16, P974, DOI 10.3201/eid1606.091523; Zhang H, 2013, CHIN J TRAUMATOL, V16, P10, DOI 10.3760/cma.j.issn.1008-1275.2013.01.002; Zhang L, 2014, CHINESE MED J-PEKING, V127, P995, DOI 10.3760/cma.j.issn.0366-6999.20131708; Zhang L, 2012, INJURY, V43, P1470, DOI 10.1016/j.injury.2010.11.036; Zhang LL, 2012, LANCET, V379, P853, DOI 10.1016/S0140-6736(11)61876-X	30	11	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97416	10.1371/journal.pone.0097416			8	Multidisciplinary Sciences	Science & Technology - Other Topics	AM0UW	WOS:000339563400027	24846207	DOAJ Gold, Green Published			2021-06-18	
J	Xu, BX; Chen, X; Lu, WY; Zhao, C; Qiao, Y				Xu, Baoxing; Chen, Xi; Lu, Weiyi; Zhao, Cang; Qiao, Yu			Non-dissipative energy capture of confined liquid in nanopores	APPLIED PHYSICS LETTERS			English	Article							TRAUMATIC BRAIN-INJURY; NANOSCALE; ABSORPTION; TRANSPORT; PRESSURE	In the past, energy absorption of protection/damping materials is mainly based on energy dissipation, which causes a fundamental conflict between the requirements of safety/comfort and efficiency. In the current study, a nanofluidic "energy capture" system is reported, which is based on nanoporous materials and nonwetting liquid. Both molecular dynamics simulations and experiments show that as the liquid overcomes the capillary effect and infiltrates into the nanopores, the mechanical energy of a stress wave could be temporarily stored by the confined liquid phase and isolated from the wave energy transmission path. Such a system can work under a relatively low pressure for mitigating high-pressure stress waves, not necessarily involved in any energy dissipation processes. (C) 2014 AIP Publishing LLC.	[Xu, Baoxing; Chen, Xi] Columbia Univ, Dept Earth & Environm Engn, Columbia Nanomech Res Ctr, New York, NY 10027 USA; [Lu, Weiyi; Zhao, Cang; Qiao, Yu] Univ Calif San Diego, Dept Struct Engn, La Jolla, CA 92093 USA; [Qiao, Yu] Univ Calif San Diego, Program Mat Sci & Engn, La Jolla, CA 92093 USA	Qiao, Y (corresponding author), Univ Calif San Diego, Dept Struct Engn, La Jolla, CA 92093 USA.	yqiao@ucsd.edu	Zhao, Cang/A-4633-2017; Lu, Weiyi/D-5001-2012; Chen, Xi/B-1539-2008; Xu, Baoxing/A-4777-2009	Zhao, Cang/0000-0002-2464-2409; Chen, Xi/0000-0002-1263-1024; 	National Science FoundationNational Science Foundation (NSF) [ECCS-1028010, CMMI-0643726]; Army Research Office [W91CRB-11-C-0112]; DARPAUnited States Department of DefenseDefense Advanced Research Projects Agency (DARPA) [W91CRB-11-C-0112]; Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [11172231]	The concept generation, the theoretical analysis, and the system design were supported by the National Science Foundation under Grant No. ECCS-1028010. The experimental investigation was supported by the Army Research Office under Grant No. W91CRB-11-C-0112, and the materials preparation was supported by DARPA under Grant No. W91CRB-11-C-0112 (subaward to UCSD). The program development for the computer simulation was supported by the National Science Foundation under Grant No. CMMI-0643726. The computational case study was supported by DARPA under Grant No. W91CRB-11-C-0112 (subaward to Columbia University). The data analysis of computer simulation was supported by the Natural Science Foundation of China under Grant No. 11172231.	Aizenberg J, 2005, SCIENCE, V309, P275, DOI 10.1126/science.1112255; Ando K, 2011, J FLUID MECH, V671, P339, DOI 10.1017/S0022112010005707; Brothers AH, 2006, SCRIPTA MATER, V54, P513, DOI 10.1016/j.scriptamat.2005.10.048; Cao AY, 2005, SCIENCE, V310, P1307, DOI 10.1126/science.1118957; Carretero-Gonzalez R, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.024102; Chen X, 2008, NANO LETT, V8, P2988, DOI 10.1021/nl802046b; Courtney AC, 2009, MED HYPOTHESES, V72, P76, DOI 10.1016/j.mehy.2008.08.015; Cox BN, 2000, ACTA MATER, V48, P755, DOI 10.1016/S1359-6454(99)00344-4; Cranford SW, 2012, NATURE, V482, P72, DOI 10.1038/nature10739; Decker MJ, 2007, COMPOS SCI TECHNOL, V67, P565, DOI 10.1016/j.compscitech.2006.08.007; Dubey DD, 1998, J COMPOS MATER, V32, P158, DOI 10.1177/002199839803200204; Evans AG, 2001, PROG MATER SCI, V46, P309, DOI 10.1016/S0079-6425(00)00016-5; Falk K, 2010, NANO LETT, V10, P4067, DOI 10.1021/nl1021046; Gao HJ, 2003, P NATL ACAD SCI USA, V100, P5597, DOI 10.1073/pnas.0631609100; Gibson LJ., 1997, CELLULAR SOLIDS STRU, V2nd; Han A, 2008, CHEM ENG J, V139, P426, DOI 10.1016/j.cej.2007.12.002; Hong J, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.108001; Lu G., 2003, ENERGY ABSORPTION ST; Lu WY, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3534198; McKittrick J, 2010, MAT SCI ENG C-MATER, V30, P331, DOI 10.1016/j.msec.2010.01.011; Needham CE, 2010, SHOCK WAVE HIGH PRES, P1, DOI 10.1007/978-3-642-05288-0; Nesterenko V. F., 2003, MATER RES SOC S P, V729; Nyein MK, 2010, P NATL ACAD SCI USA, V107, P20703, DOI 10.1073/pnas.1014786107; Schaedler TA, 2011, SCIENCE, V334, P962, DOI 10.1126/science.1211649; Tai K, 2007, NAT MATER, V6, P454, DOI 10.1038/nmat1911; Wang LF, 2011, ADV MATER, V23, P1524, DOI 10.1002/adma.201003956	26	11	12	3	34	AMER INST PHYSICS	MELVILLE	1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA	0003-6951	1077-3118		APPL PHYS LETT	Appl. Phys. Lett.	MAY 19	2014	104	20							203107	10.1063/1.4878097			4	Physics, Applied	Physics	AI8EQ	WOS:000337140800060					2021-06-18	
J	Egea-Guerrero, JJ; Murillo-Cabezas, F; Rodriguez-Rodriguez, A; Gordillo-Escobar, E; Revuelto-Rey, J; Munoz-Sanchez, MA; Leon-Justel, A; Vilches-Arenas, A				Egea-Guerrero, J. J.; Murillo-Cabezas, F.; Rodriguez-Rodriguez, A.; Gordillo-Escobar, E.; Revuelto-Rey, J.; Munoz-Sanchez, M. A.; Leon-Justel, A.; Vilches-Arenas, A.			An experimental model of mass-type brain damage in the rat: Expression of brain damage based on neurospecific enolase and protein S100B	MEDICINA INTENSIVA			Spanish	Article						S100B protein; Neurospecifie enolase; Traumatic brain injury; Experimental model; Rat	NEURON-SPECIFIC ENOLASE; FLUID-PERCUSSION INJURY; SUBARACHNOID HEMORRHAGE; MODERATE HYPOTHERMIA; COGNITIVE RECOVERY; S100-BETA PROTEIN; CEREBRAL-ISCHEMIA; MARKER; RODENTS; LESION	Objective: To determine whether a model of transient mass-type brain damage (MTBD) in the rat produces early release of neurospecific enolase (NSE) and protein S100B in peripheral blood, as an expression of the induced brain injury. Design: An experimental study with a control group. Setting: Experimental operating room of the Institute of Biomedicine (IBiS) of Virgen del Rocio University Hospital (Seville, Spain). Participants: Fourteen adult Wistar rats. Interventions: Blood was sampled at baseline, followed by: MTBD group, a trephine perforation was used to insert and inflate the balloon of a catheter at a rate of 500 mu l/20 sec, followed by 4 blood extractions every 20 min. Control group, the same procedure as before was carried out, though without trephine perforation. Primary study variables: Weight, early mortality, serum NSE and S100B concentration. Results: Differences in NSE and S100B concentration were observed over time within the MTBD group (P < .001), though not so in the control group. With the exception of the baseline determination, differences were observed between the two groups in terms of the mean NSE and S100B values. Following MTBD, NSE and S100B progressively increased at all measurement time-points, with r = 0.765; P= .001 and r = 0.628; P= .001, respectively. In contrast, the control group showed no such correlation for either biomarker. Conclusions: Serum NSE and S100B concentrations offer an early indication of brain injury affecting the gray and white matter in an experimental model of mass-type MTBD in the rat. (C) 2013 Elsevier Espana, S.L. and SEMICYUC. All rights reserved.	[Egea-Guerrero, J. J.; Murillo-Cabezas, F.; Gordillo-Escobar, E.; Revuelto-Rey, J.; Munoz-Sanchez, M. A.] Univ Seville, IBiS CSIC, HU Virgen Rocio, Unidad Neurocrit, Seville, Spain; [Rodriguez-Rodriguez, A.; Leon-Justel, A.] Univ Seville, IBiS CSIC, HU Virgen Rocio, Dept Bioquim Clin, Seville, Spain; [Vilches-Arenas, A.] Univ Seville, IBiS CSIC Univ Sevilla, Dept Med Prevent & Salud Publ, Seville, Spain	Egea-Guerrero, JJ (corresponding author), Univ Seville, IBiS CSIC, HU Virgen Rocio, Unidad Neurocrit, Seville, Spain.	juanjoegea@hotmail.com	Murillo-Cabezas, Francisco/AAO-3348-2021; IBIS, NEUROCRITICOS/C-1805-2016; Vilches-Arenas, Angel/C-1167-2015; IBIS, NEUROINMUNO/O-9306-2015; Rodriguez-Rodriguez, Ana/F-4718-2016; Egea-Guerrero, Juan Jose/P-5080-2014	Vilches-Arenas, Angel/0000-0003-2197-3760; Rodriguez-Rodriguez, Ana/0000-0002-6854-9695; Revuelto-Rey, Jaume/0000-0001-8350-9555; Egea-Guerrero, Juan Jose/0000-0002-4166-313X			Ahlemeyer B, 2000, BRAIN RES, V858, P121, DOI 10.1016/S0006-8993(99)02438-5; Ahmed SM, 2000, J NEUROCHEM, V74, P1951, DOI 10.1046/j.1471-4159.2000.741951000000000.x; Bloomfield SM, 2007, NEUROCRIT CARE, V6, P121, DOI 10.1007/s12028-007-0008-x; Burger R, 2004, NEUROSURGERY, V54, P701, DOI 10.1227/01.NEU.0000108784.80585.EE; Burger R, 2003, J NEUROTRAUM, V20, P543, DOI 10.1089/089771503767168474; Burger R, 2002, J NEUROSURG, V97, P1410, DOI 10.3171/jns.2002.97.6.1410; Cheng JM, 2010, J NEUROL SCI, V294, P23, DOI 10.1016/j.jns.2010.04.010; DAY INM, 1984, CLIN CHIM ACTA, V136, P219, DOI 10.1016/0009-8981(84)90295-X; Donato Rosario, 2010, Cardiovasc Psychiatry Neurol, V2010, P929712, DOI 10.1155/2010/929712; Egea-Guerrero JJ, 2012, TRANSPL P, V44, P2050, DOI 10.1016/j.transproceed.2012.07.070; Egea-Guerrero JJ, 2012, BRAIN INJURY, V26, P76, DOI 10.3109/02699052.2011.635360; Ellis EF, 2007, J NEUROCHEM, V101, P1463, DOI 10.1111/j.1471-4159.2007.04515.x; Bernal EF, 2013, MED INTENSIVA, V37, P327, DOI 10.1016/j.medin.2012.05.015; GINSBERG MD, 1989, STROKE, V20, P1627, DOI 10.1161/01.STR.20.12.1627; HARDEMARK HG, 1988, STROKE, V19, P1140, DOI 10.1161/01.STR.19.9.1140; HATFIELD RH, 1992, BRAIN RES, V577, P249, DOI 10.1016/0006-8993(92)90280-M; He XS, 2000, J NEUROSURG, V93, P626, DOI 10.3171/jns.2000.93.4.0626; Ingebrigtsen T, 2003, RESTOR NEUROL NEUROS, V21, P171; KAISER E, 1989, CLIN CHIM ACTA, V183, P13, DOI 10.1016/0009-8981(89)90268-4; Kleindienst A, 2005, J NEUROSURG, V102, P1115, DOI 10.3171/jns.2005.102.6.1115; Kleindienst A, 2005, J NEUROTRAUM, V22, P645, DOI 10.1089/neu.2005.22.645; Kleindienst A, 2004, J NEUROTRAUM, V21, P541, DOI 10.1089/089771504774129874; Kleindienst A, 2006, J NEUROTRAUM, V23, P1185, DOI 10.1089/neu.2006.23.1185; Kobeissy FH, 2008, PROTEOM CLIN APPL, V2, P1467, DOI 10.1002/prca.200800011; Macher H, 2012, CLIN CHIM ACTA, V414, P12, DOI 10.1016/j.cca.2012.08.001; MARANGOS PJ, 1980, J NEUROCHEM, V34, P1254, DOI 10.1111/j.1471-4159.1980.tb09967.x; MILLER JD, 1990, NEUROSURGERY, V27, P433, DOI 10.1227/00006123-199009000-00016; Munoz-Sanchez MA, 2012, J NEUROSCI METH, V211, P88, DOI 10.1016/j.jneumeth.2012.08.010; Murillo-Cabezas F, 2010, BRAIN INJURY, V24, P609, DOI 10.3109/02699051003652823; Oertel M, 2006, J CLIN NEUROSCI, V13, P834, DOI 10.1016/j.jocn.2005.11.030; Revuelto-Rey J, 2012, MED INTENSIVA, V36, P213, DOI 10.1016/j.medin.2011.08.002; Rodriguez-Rodriguez A, 2012, CLIN CHIM ACTA, V414, P228, DOI 10.1016/j.cca.2012.09.025; SCHMECHEL D, 1978, NATURE, V276, P834, DOI 10.1038/276834a0; Shimamura M, 2005, NEUROSCIENCE, V131, P87, DOI 10.1016/j.neuroscience.2004.10.041; Streitburger DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043284; Svetlov SI, 2010, J TRAUMA, V69, P795, DOI 10.1097/TA.0b013e3181bbd885; Van Eldik LJ, 2003, RESTOR NEUROL NEUROS, V21, P97; Warnat Jan, 2012, Acta Neurochir Suppl, V114, P393, DOI 10.1007/978-3-7091-0956-4_76; Whiteley W, 2009, STROKE, V40, pE380, DOI 10.1161/STROKEAHA.108.528752	39	11	12	0	11	ELSEVIER DOYMA SL	BARCELONA	TRAVESERA DE GARCIA, 17-21, BARCELONA, 08021, SPAIN	0210-5691	1578-6749		MED INTENSIVA	Med. Intensiv.	MAY	2014	38	4					218	225		10.1016/j.medin.2013.03.015			8	Critical Care Medicine	General & Internal Medicine	AG9CH	WOS:000335715800004	23786666				2021-06-18	
J	Lipszyc, J; Levin, H; Hanten, G; Hunter, J; Dennis, M; Schachar, R				Lipszyc, Jonathan; Levin, Harvey; Hanten, Gerri; Hunter, Jill; Dennis, Maureen; Schachar, Russell			Frontal White Matter Damage Impairs Response Inhibition in Children Following Traumatic Brain Injury	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Traumatic brain injury; Response inhibition; Impulsiveness; Brain lesions; White matter; Frontal lobe	ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; STOP-SIGNAL TASK; DEFICIT HYPERACTIVITY DISORDER; BEHAVIOR RATING INVENTORY; EVENT-RELATED FMRI; EXECUTIVE FUNCTION; PREFRONTAL CORTEX; HEAD-INJURY; ONGOING RESPONSES; PERFORMANCE	Inhibition, the ability to suppress inappropriate cognitions or behaviors, can be measured using computer tasks and questionnaires. Inhibition depends on the frontal cortex, but the role of the underlying white matter (WM) is unclear. We assessed the specific impact of frontal WM damage on inhibition in 29 children with moderate-to-severe traumatic brain injury (15 with and 14 without frontal WM damage), 21 children with orthopedic injury, and 29 population controls. We used the Stop Signal Task to measure response inhibition, the Behavior Rating Inventory of Executive Function to assess everyday inhibition, and T2 fluid-attenuated inversion recovery magnetic resonance imaging to identify lesions. Children with frontal WM damage had impaired response inhibition compared with all other groups and poorer everyday inhibition than the orthopedic injury group. Frontal WM lesions most often affected the superior frontal gyrus. These results provide evidence for the critical role of frontal WM in inhibition.	[Lipszyc, Jonathan; Schachar, Russell] Hosp Sick Children, Dept Psychiat Neurosci & Mental Hlth, Toronto, ON M5G 1X8, Canada; [Lipszyc, Jonathan; Schachar, Russell] Univ Toronto, Fac Med, Inst Med Sci, Toronto, ON, Canada; [Levin, Harvey; Hanten, Gerri] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Hunter, Jill] Texas Childrens Hosp, Dept Pediat Neuroradiol, Houston, TX 77030 USA; [Dennis, Maureen] Hosp Sick Children, Dept Psychol Neurosci & Mental Hlth, Toronto, ON M5G 1X8, Canada	Schachar, R (corresponding author), Hosp Sick Children, Dept Psychiat Neurosci & Mental Hlth, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	russell.schachar@sickkids.ca		Schachar, Russell/0000-0002-2015-4395	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [MOP-64277, MOP-44070, MOP-74699]; Hospital for Sick ChildrenUniversity of Toronto; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS-21889]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021889] Funding Source: NIH RePORTER	This work was supported by the Canadian Institutes of Health Research (Frederick Banting and Charles Best Canada Graduate Scholarship to J.L. and MOP-64277, MOP-44070, and MOP-74699 to R. S.); the Hospital for Sick Children (Restracomp Studentship to J.L.); and the National Institutes of Health (NS-21889 to H.L.).	Anderson VA, 2002, CHILD NEUROPSYCHOL, V8, P231, DOI 10.1076/chin.8.4.231.13509; ARNETT PA, 1994, NEUROLOGY, V44, P420, DOI 10.1212/WNL.44.3_Part_1.420; Aron AR, 2007, J NEUROSCI, V27, P3743, DOI 10.1523/JNEUROSCI.0519-07.2007; Aron AR, 2005, BIOL PSYCHIAT, V57, P1285, DOI 10.1016/j.biopsych.2004.10.026; Aron AR, 2003, NAT NEUROSCI, V6, P115, DOI 10.1038/nn1003; Bari A, 2011, J NEUROSCI, V31, P9254, DOI 10.1523/JNEUROSCI.1543-11.2011; Bunce D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013567; Chambers CD, 2006, J COGNITIVE NEUROSCI, V18, P444, DOI 10.1162/jocn.2006.18.3.444; Chen CY, 2009, NEUROIMAGE, V44, P537, DOI 10.1016/j.neuroimage.2008.09.005; Chevrier AD, 2007, HUM BRAIN MAPP, V28, P1347, DOI 10.1002/hbm.20355; Clark L, 2007, BIOL PSYCHIAT, V61, P1395, DOI 10.1016/j.biopsych.2006.07.020; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Damasio H., 1995, HUMAN BRAIN ANATOMY; Damasio H., 1989, LESION ANAL NEUROPSY; Eagle DM, 2008, PSYCHOPHARMACOLOGY, V199, P439, DOI 10.1007/s00213-008-1127-6; Eagle DM, 2008, CEREB CORTEX, V18, P178, DOI 10.1093/cercor/bhm044; Easdon C, 2004, BRAIN COGNITION, V54, P136; Floden D, 2006, J COGNITIVE NEUROSCI, V18, P1843, DOI 10.1162/jocn.2006.18.11.1843; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Ghajar J, 2008, NEUROREHAB NEURAL RE, V22, P217, DOI 10.1177/1545968308315600; Gioia G.A., 2000, BEHAV RATING INVENTO; Gioia GA, 2002, CHILD NEUROPSYCHOL, V8, P121, DOI 10.1076/chin.8.2.121.8727; Hogan AM, 2006, BRAIN, V129, P2177, DOI 10.1093/brain/awl160; Johnstone SJ, 2007, INT J PSYCHOPHYSIOL, V63, P25, DOI 10.1016/j.ijpsycho.2006.07.001; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Konrad KN, 2000, BRAIN INJURY, V14, P859; Leblanc N, 2005, DEV NEUROPSYCHOL, V28, P829, DOI 10.1207/s15326942dn2803_5; Levin H S, 1997, J Int Neuropsychol Soc, V3, P598; Levin HS, 2008, J HEAD TRAUMA REHAB, V23, P197, DOI 10.1097/01.HTR.0000327252.54128.7c; Levin HS, 2005, PEDIATR NEUROL, V33, P79, DOI 10.1016/j.pediatrneurol.2005.02.002; Levine B., 2002, PRINCIPLES FRONTAL L, P448; Lipszyc J, 2010, J INT NEUROPSYCH SOC, V16, P1064, DOI 10.1017/S1355617710000895; Logan GD, 1994, INHIBITORY PROCESSES, P189; Madsen KS, 2010, NEUROPSYCHOLOGIA, V48, P854, DOI 10.1016/j.neuropsychologia.2009.11.001; Mangeot S, 2002, CHILD NEUROPSYCHOL, V8, P271, DOI 10.1076/chin.8.4.271.13503; McAuley T, 2010, J INT NEUROPSYCH SOC, V16, P495, DOI 10.1017/S1355617710000093; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Muggleton NG, 2010, J COGNITIVE NEUROSCI, V22, P2804, DOI 10.1162/jocn.2010.21416; Noppeney U, 2004, J ANAT, V205, P433, DOI 10.1111/j.0021-8782.2004.00343.x; Ornstein TJ, 2009, J CHILD PSYCHOL PSYC, V50, P506, DOI 10.1111/j.1469-7610.2008.01997.x; Rieger M, 2003, NEUROPSYCHOLOGY, V17, P272, DOI 10.1037/0894-4105.17.2.272; Rieger M, 2002, NEUROPSYCHOLOGIA, V40, P76, DOI 10.1016/S0028-3932(01)00068-9; Schachar R, 2000, J ABNORM CHILD PSYCH, V28, P227, DOI 10.1023/A:1005140103162; Schachar R, 2004, DEV NEUROPSYCHOL, V25, P179, DOI 10.1207/s15326942dn2501&2_10; Schachar R, 2007, J ABNORM CHILD PSYCH, V35, P229, DOI 10.1007/s10802-006-9075-2; Schutter DJ, 2009, METHODS SOCIAL NEURO, P233; Seamans JK, 2008, NEUROTOX RES, V14, P249, DOI 10.1007/BF03033814; Shallice T, 1996, PHILOS T R SOC B, V351, P1405, DOI 10.1098/rstb.1996.0124; Slomine BS, 2002, BRAIN INJURY, V16, P759, DOI 10.1080/02699050210127286; Stancin T, 1998, J TRAUMA, V45, P1031, DOI 10.1097/00005373-199812000-00010; Stewart JAL, 1999, BRAIN COGNITION, V41, P411, DOI 10.1006/brcg.1999.1141; Swick D, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-102; TEASDALE G, 1974, LANCET, V2, P81; Williams BR, 1999, DEV PSYCHOL, V35, P205, DOI 10.1037/0012-1649.35.1.205; WILSON JTL, 1988, J NEUROL NEUROSUR PS, V51, P391, DOI 10.1136/jnnp.51.3.391; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Wu TC, 2010, DEV NEUROSCI-BASEL, V32, P361, DOI 10.1159/000317058; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Young SE, 2009, J ABNORM PSYCHOL, V118, P117, DOI 10.1037/a0014657	59	11	12	0	18	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAY	2014	29	3					289	299		10.1093/arclin/acu004			11	Psychology, Clinical; Psychology	Psychology	AG9WC	WOS:000335769700008	24618405	Green Published			2021-06-18	
J	Liu, CL; Chen, CC; Lee, HC; Cho, DY				Liu, Chun-Lin; Chen, Chun-Chang; Lee, Han-Chung; Cho, Der-Yang			Matrix Metalloproteinase-9 in the Ventricular Cerebrospinal Fluid Correlated with the Prognosis of Traumatic Brain Injury	TURKISH NEUROSURGERY			English	Article						Cerebrospinal fluid; Biomarker; Matrix metalloproteinase-9; Traumatic brain injury; Glasgow Coma Scale	MATRIX-METALLOPROTEINASE EXPRESSION; SPECTRIN BREAKDOWN PRODUCTS; SEVERE HEAD-INJURY; CEREBRAL-ISCHEMIA; HUMAN STROKE; BLOOD; BARRIER; SERUM; INHIBITION; DISRUPTION	AIM: Matrix metalloproteinase 9 (MMP-9) has been shown to be a potential biomarker for outcome prediction after neuron damage. This study investigated whether MMP-9 could be used for outcome prediction after traumatic brain injury (TBI). MATERIAL and METHODS: For the TBI group, cerebrospinal fluid (CSF) was collected at different days after surgery from 6 head injury patients who had received surgical intervention with external ventricular drainage insertion. CSF collected from non-TBI patients (N=85) diagnosed with isolated hydrocephalus by a ventricular puncture during a ventriculo-peritoneal shunt surgery was used as control. RESULTS: The mean concentration of MMP-9 in the CSF of 85 non-TBI patients was determined to be 1.172 +/- 0.859 ng/mL. We found that the CSF MMP-9 concentration from TBI patients was elevated immediately after head injury with a median of 1.926 ng/mL (range, 0.673 to 24.990). Despite an early increase in the concentration of MMP-9, levels decreased within 72 hrs and nearly reached the normal range. Nevertheless, the concentration of MMP-9 was negatively correlated with the Glasgow Coma Scale (gamma = - 0.337, p = 0.013). CONCLUSION: MMP-9 concentration in the CSF of TBI patients correlated with neurological outcome and may represent an early indicator for the prognosis of this condition.	[Liu, Chun-Lin; Chen, Chun-Chang; Lee, Han-Chung; Cho, Der-Yang] China Med Univ, Grad Inst Clin Med Sci, Taichung 40402, Taiwan; [Chen, Chun-Chang; Lee, Han-Chung; Cho, Der-Yang] China Med Univ Hosp, Dept Neurosurg, Taichung 40402, Taiwan	Liu, CL (corresponding author), China Med Univ, Grad Inst Clin Med Sci, Taichung 40402, Taiwan.	chunlin_lliu@yeah.net					Armstead WM, 2011, NEUROL RES, V33, P726, DOI 10.1179/016164110X12807570509853; Barr TL, 2010, STROKE, V41, pE123, DOI 10.1161/STROKEAHA.109.570515; Batra A, 2010, J CEREBR BLOOD F MET, V30, P1188, DOI 10.1038/jcbfm.2010.1; Candelario-Jalil E, 2009, NEUROSCIENCE, V158, P983, DOI 10.1016/j.neuroscience.2008.06.025; Dash PK, 2010, NEUROTHERAPEUTICS, V7, P100, DOI 10.1016/j.nurt.2009.10.019; De Georgia MA, 2005, NEUROLOGIST, V11, P45, DOI 10.1097/01.nrl.0000149993.99956.09; Ghajar J, 2009, MT SINAI J MED, V76, P190, DOI 10.1002/msj.20095; Gottschall PE, 1996, NEUROIMMUNOMODULAT, V3, P69, DOI 10.1159/000097229; Grossetete M, 2009, NEUROSURGERY, V65, P702, DOI 10.1227/01.NEU.0000351768.11363.48; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Kleindienst A, 2010, ACTA NEUROCHIR SUPPL, V106, P247, DOI 10.1007/978-3-211-98811-4_46; Kovesdi E, 2010, ACTA NEUROCHIR, V152, P1, DOI 10.1007/s00701-009-0463-6; Kolar M, 2008, ACTA NEUROCHIR SUPPL, V102, P373, DOI 10.1007/978-3-211-85578-2_71; Mondello S, 2010, J NEUROTRAUM, V27, P1203, DOI 10.1089/neu.2010.1278; Montaner J, 2003, CIRCULATION, V107, P598, DOI 10.1161/01.CIR.0000046451.38849.90; Pfefferkorn T, 2003, STROKE, V34, P2025, DOI 10.1161/01.STR.0000083051.93319.28; Pineda JA, 2007, J NEUROTRAUM, V24, P354, DOI 10.1089/neu.2006.003789; Raabe A, 1998, ACTA NEUROCHIR, V140, P787, DOI 10.1007/s007010050180; Ramos-Fernandez M, 2011, J STROKE CEREBROVASC, V20, P47, DOI 10.1016/j.jstrokecerebrovasdis.2009.10.008; Romanic AM, 1998, STROKE, V29, P1020, DOI 10.1161/01.STR.29.5.1020; Rosell A, 2006, STROKE, V37, P1399, DOI 10.1161/01.STR.0000223001.06264.af; Rosenberg GA, 2009, LANCET NEUROL, V8, P205, DOI 10.1016/S1474-4422(09)70016-X; Rothoerl RD, 1998, J TRAUMA, V45, P765, DOI 10.1097/00005373-199810000-00025; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Stangl AP, 1998, SURG NEUROL, V50, P77, DOI 10.1016/S0090-3019(97)00301-7; Stein DM, 2011, NEUROCRIT CARE, V14, P200, DOI 10.1007/s12028-010-9496-1; Steiner LA, 2003, J NEUROL NEUROSUR PS, V74, P765, DOI 10.1136/jnnp.74.6.765; Svedin P, 2007, J NEUROSCI, V27, P1511, DOI 10.1523/JNEUROSCI.4391-06.2007; Tejima E, 2007, J CEREBR BLOOD F MET, V27, P460, DOI 10.1038/sj.jcbfm.9600354; Vilalta A, 2008, INTENS CARE MED, V34, P1384, DOI 10.1007/s00134-008-1056-1; Wagner AK, 2011, J CEREBR BLOOD F MET, V31, P1886, DOI 10.1038/jcbfm.2011.31	32	11	13	0	4	TURKISH NEUROSURGICAL SOC	BAHCELIEVLER	TASKENT CADDESI 13-4, BAHCELIEVLER, ANKARA 06500, TURKEY	1019-5149			TURK NEUROSURG	Turk. Neurosurg.	MAY	2014	24	3					363	368		10.5137/1019-5149.JTN.8551-13.0			6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	AI5ZO	WOS:000336949700015	24848175	Bronze			2021-06-18	
J	Murayama, H; Hitosugi, M; Motozawa, Y; Ogino, M; Koyama, K				Murayama, Haruo; Hitosugi, Masahito; Motozawa, Yasuki; Ogino, Masahiro; Koyama, Katsuhiro			Rotational Acceleration during Head Impact Resulting from Different Judo Throwing Techniques	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						head injury; judo; prevention; head acceleration; biomechanics	TRAUMATIC BRAIN-INJURIES; UNITED-STATES; BIOMECHANICS; EPIDEMIOLOGY; SPORTS	Most severe head injuries in judo are reported as acute subdural hematoma. It is thus necessary to examine the rotational acceleration of the head to clarify the mechanism of head injuries. We determined the rotational acceleration of the head when the subject is thrown by judo techniques. One Japanese male judo expert threw an anthropomorphic test device using two throwing techniques, Osoto-gari and Ouchigari. Rotational and translational head accelerations were measured with and without an under-mat. For Osoto-gari, peak resultant rotational acceleration ranged from 4,284.2 rad/s(2) to 5,525.9 rad/s(2) and peak resultant translational acceleration ranged from 64.3 g to 87.2 g; for Ouchi-gari, the accelerations respectively ranged from 1,708.0 rad/s(2) to 2,104.1 rad/s(2) and from 120.2 g to 149.4 g. The resultant rotational acceleration did not decrease with installation of an under-mat for both Ouchi-gari and Osoto-gari. We found that head contact with the tatami could result in the peak values of translational and rotational accelerations, respectively. In general, because kinematics of the body strongly affects translational and rotational accelerations of the head, both accelerations should be measured to analyze the underlying mechanism of head injury. As a primary preventative measure, throwing techniques should be restricted to participants demonstrating ability in ukemi techniques to avoid head contact with the tatami.	[Murayama, Haruo] Dokkyo Med Univ, Dept Sports Sci, Sch Med, Shimotsuga, Tochigi 3210293, Japan; [Hitosugi, Masahito; Motozawa, Yasuki] Dokkyo Med Univ, Dept Legal Med, Sch Med, Shimotsuga, Tochigi 3210293, Japan; [Ogino, Masahiro] Dokkyo Med Univ, Dept Neurosurg, Sch Med, Shimotsuga, Tochigi 3210293, Japan; [Murayama, Haruo; Koyama, Katsuhiro] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Hlth Sci, Kofu, Yamanashi, Japan	Murayama, H (corresponding author), Dokkyo Med Univ, Dept Sports Sci, Sch Med, 880 Kita Kobayashi, Shimotsuga, Tochigi 3210293, Japan.	hmurayam@dokkyomed.ac.jp		Hitosugi, Masahito/0000-0001-5243-8766	Honda RD (Tochigi)	The authors gratefully acknowledge Honda R&D (Tochigi) for support of the experiment.	Akiyama A., 2001, ESV PAP, V463, P1; Gilchrist J., 2007, Morbidity and Mortality Weekly Report, V56, P733; GURDJIAN ES, 1966, J TRAUM, V6, P600, DOI 10.1097/00005373-196609000-00005; HARDY WN, 1994, INT J IMPACT ENG, V15, P561, DOI 10.1016/0734-743X(94)80034-7; Kerrigan JK, 2005, P 19 C ENH SAF VEH E; Kumar Sri, 2012, Biomed Sci Instrum, V48, P239; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Murayama H, 2013, NEUROL MED-CHIR, V53, P580; Nagahiro Shinji, 2011, No Shinkei Geka, V39, P1139; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; Pieter W, 2005, MED SPORT SCI, V48, P59, DOI 10.1159/000084283; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Schmitt KU, 2010, TRAUMA BIOMECHANICS: ACCIDENTAL INJURY IN TRAFFIC AND SPORTS, THIRD EDITION, P1, DOI 10.1007/978-3-642-03713-9; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003	14	11	11	0	24	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.	MAY	2014	54	5					374	378		10.2176/nmc.oa.2013-0227			5	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	AI5DA	WOS:000336884400004	24477065	Green Published, Bronze			2021-06-18	
J	Ferreira, APO; Rodrigues, FS; Della-Pace, ID; Mota, BC; Oliveira, SM; Gewehr, CDV; Bobinski, F; de Oliveira, CV; Brum, JS; Oliveira, MS; Furian, AF; de Barros, CSL; dos Santos, ARS; Ferreira, J; Fighera, MR; Royes, LFF				Oliveira Ferreira, Ana Paula; Rodrigues, Fernanda Silva; Della-Pace, Iuri Domingues; Mota, Bibiana Castagna; Oliveira, Sara Marchesan; Velho Gewehr, Camila de Campos; Bobinski, Franciane; de Oliveira, Clarissa Vasconcelos; Brum, Juliana Sperotto; Oliveira, Mauro Schneider; Furian, Ana Flavia; Lombardo de Barros, Claudio Severo; Soares dos Santos, Adair Roberto; Ferreira, Juliano; Fighera, Michele Rechia; Freire Royes, Luiz Fernando			HOE-140, an antagonist of B2 receptor, protects against memory deficits and brain damage induced by moderate lateral fluid percussion injury in mice	PSYCHOPHARMACOLOGY			English	Article						Traumatic brain injury; Bradykinin; Inflammation; Object recognition task; Oxidative stress	BRADYKININ B-2 RECEPTOR; CONTROLLED CORTICAL IMPACT; CLOSED-HEAD TRAUMA; PENTYLENETETRAZOL-INDUCED SEIZURES; KALLIKREIN-KININ SYSTEM; FOCAL CEREBRAL-ISCHEMIA; NITRIC-OXIDE SYNTHASE; K+-ATPASE ACTIVITY; OXIDATIVE STRESS; CELL-DEATH	There are evidences indicating the role of kinins in pathophysiology of traumatic brain injury, but little is known about their action on memory deficits. Our aim was to establish the role of bradykinin receptors B-1 (B1R) and B-2 (B2R) on the behavioral, biochemical, and histologic features elicited by moderate lateral fluid percussion injury (mLFPI) in mice. The role of kinin B-1 and B-2 receptors in brain damage, neuromotor, and cognitive deficits induced by mLFPI, was evaluated by means of subcutaneous injection of B2R antagonist (HOE-140; 1 or 10 nmol/kg) or B1R antagonist (des-Arg9-[Leu8]-bradykinin (DAL-Bk; 1 or 10 nmol/kg) 30 min and 24 h after brain injury. Brain damage was evaluated in the cortex, being considered as lesion volume, inflammatory, and oxidative damage. The open field and elevated plus maze tests were performed to exclude the nonspecific effects on object recognition memory test. Our data revealed that HOE-140 (10 nmol/kg) protected against memory impairment. This treatment attenuated the brain edema, interleukin-1 beta, tumor necrosis factor-alpha, and nitric oxide metabolites content elicited by mLFPI. Accordingly, HOE-140 administration protected against the increase of nicotinamide adenine dinucleotide phosphate oxidase activity, thiobarbituric-acid-reactive species, protein carbonylation generation, and Na+ K+ ATPase inhibition induced by trauma. Histologic analysis showed that HOE-140 reduced lesion volume when analyzed 7 days after brain injury. This study suggests the involvement of the B-2 receptor in memory deficits and brain damage caused by mLFPI in mice.	[Oliveira Ferreira, Ana Paula; Rodrigues, Fernanda Silva; Della-Pace, Iuri Domingues; Mota, Bibiana Castagna; Fighera, Michele Rechia; Freire Royes, Luiz Fernando] Univ Fed Santa Maria, Ctr Educ Fis & Desportos, Dept Metodos & Tecn Desport, Lab Bioquim Exercicio, BR-97105900 Santa Maria, RS, Brazil; [Oliveira Ferreira, Ana Paula; Rodrigues, Fernanda Silva; Della-Pace, Iuri Domingues; Mota, Bibiana Castagna; Oliveira, Sara Marchesan; Velho Gewehr, Camila de Campos; Ferreira, Juliano; Fighera, Michele Rechia; Freire Royes, Luiz Fernando] Univ Fed Santa Maria, Programa Posgrad Ciencias Biol Bioquim Toxicol, BR-97105900 Santa Maria, RS, Brazil; [Bobinski, Franciane; Soares dos Santos, Adair Roberto] Univ Fed Santa Catarina, Ctr Ciencias Biol, Dept Ciencias Fisiol, Florianolpolis, SC, Brazil; [de Oliveira, Clarissa Vasconcelos; Oliveira, Mauro Schneider] Univ Fed Santa Maria, Ctr Ciencias Saude, Dept Fisiol & Farmacol, BR-97105900 Santa Maria, RS, Brazil; [Brum, Juliana Sperotto; Lombardo de Barros, Claudio Severo] Univ Fed Santa Maria, Ctr Ciencias Rurais, Dept Patol, BR-97105900 Santa Maria, RS, Brazil; [Furian, Ana Flavia] Univ Fed Santa Maria, Ctr Ciencias Saude, Dept Ciencia & Tecnol Alimentos, BR-97105900 Santa Maria, RS, Brazil; [Fighera, Michele Rechia] Univ Fed Santa Maria, Ctr Ciencias Saude, Dept Neuropsiquiatria, BR-97105900 Santa Maria, RS, Brazil	Royes, LFF (corresponding author), Univ Fed Santa Maria, Ctr Educ Fis & Desportos, Dept Metodos & Tecn Desport, Lab Bioquim Exercicio, BR-97105900 Santa Maria, RS, Brazil.	nandoroyes@yahoo.com.br	Ferreira, Juliano/A-9803-2013; Fighera, Michele R/J-9576-2014; Bobinski, Franciane/AAV-8234-2020; Oliveira, Mauro Schneider/G-3437-2012; royes, luiz/T-3581-2019; Santos, Adair/C-5565-2013	Ferreira, Juliano/0000-0002-9562-0602; Bobinski, Franciane/0000-0002-3537-1712; Oliveira, Mauro Schneider/0000-0002-5381-1208; Santos, Adair/0000-0002-6435-4698; royes, luiz/0000-0003-4045-4827; oliveira, sara/0000-0003-2960-5284	Conselho Nacional de Desenvolvimento Cientifico (CNPq)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (CAPES; Brazil)Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); CNPqConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) [301552/2007-0]; CNPq/FAPERGSConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS) [11/2082-4]	The presente study was supported by Conselho Nacional de Desenvolvimento Cientifico (CNPq) and by Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (CAPES; Brazil). Ferreira J is the recipient of CNPq fellowships, grant numbers 301552/2007-0. Royes L. F. F is recipient of CNPq/FAPERGS fellowships, grant numbers 11/2082-4. The funding sources had no involvement in study design, in the collection, analysis, interpretation of data, and in the writing of the report. We also attest that all the experimentswere performed in compliance with Brazilian (law no. 6638 of 1979-Standards for the Practice Teaching-scientific Animal use) law currently in force, and that experiments were previously approved by the Committee on the Use and Care of Laboratory Animals of the Federal University of the Santa Maria (process number: 113/2010).	Albert-Weissenberger C, 2012, J CEREBR BLOOD F MET, V32, P1747, DOI 10.1038/jcbfm.2012.62; Silva LFA, 2013, J NEUROTRAUM, V30, P1278, DOI 10.1089/neu.2012.2577; Silva LFA, 2011, J NEUROL SCI, V308, P35, DOI 10.1016/j.jns.2011.06.030; Ates O, 2007, MOL CELL BIOCHEM, V294, P137, DOI 10.1007/s11010-006-9253-0; Austinat M, 2009, STROKE, V40, P285, DOI 10.1161/STROKEAHA.108.526673; Ayer R, 2011, ACTA NEUROCHIR SUPPL, V111, P145, DOI 10.1007/978-3-7091-0693-8_24; Baratz R, 2011, J NEUROCHEM, V118, P1032, DOI 10.1111/j.1471-4159.2011.07377.x; Bay E, 2012, ARCH PSYCHIAT NURS, V26, P477, DOI 10.1016/j.apnu.2012.06.002; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carbonell WS, 1998, J NEUROTRAUM, V15, P217, DOI 10.1089/neu.1998.15.217; CHAO J, 1983, J BIOL CHEM, V258, P5173; Clausen F, 2004, J NEUROTRAUM, V21, P1168, DOI 10.1089/neu.2004.21.1168; Clausen F, 2009, EUR J NEUROSCI, V30, P385, DOI 10.1111/j.1460-9568.2009.06820.x; CORREA FMA, 1979, P NATL ACAD SCI USA, V76, P1489, DOI 10.1073/pnas.76.3.1489; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Gahm C, 2006, J NEUROTRAUM, V23, P1343, DOI 10.1089/neu.2006.23.1343; Gilgun-Sherki Y, 2002, PHARMACOL REV, V54, P271, DOI 10.1124/pr.54.2.271; Gorlach C, 2001, J NEUROTRAUM, V18, P833, DOI 10.1089/089771501316919193; Groger M, 2005, J CEREBR BLOOD F MET, V25, P978, DOI 10.1038/sj.jcbfm.9600096; HALL JM, 1992, PHARMACOL THERAPEUT, V56, P131, DOI 10.1016/0163-7258(92)90016-S; Hellal F, 2003, J NEUROTRAUM, V20, P841, DOI 10.1089/089771503322385773; Hsieh HL, 2010, ANTIOXID REDOX SIGN, V13, P1829, DOI 10.1089/ars.2009.2957; Ivashkova Y, 2006, J TRAUMA, V61, P879, DOI 10.1097/01.ta.0000234722.98537.01; Jamme I, 1995, NEUROREPORT, V7, P333; Kaplanski J, 2003, RESUSCITATION, V56, P207, DOI 10.1016/S0300-9572(02)00371-4; Kaplanski J, 2002, J NEUROTRAUM, V19, P953, DOI 10.1089/089771502320317104; Klasner B, 2006, NEUROCHEM INT, V49, P442, DOI 10.1016/j.neuint.2006.02.010; Komada Munekazu, 2008, J Vis Exp, DOI 10.3791/1088; Lee YJ, 2002, MOL CELL NEUROSCI, V19, P186, DOI 10.1006/mcne.2001.1073; LEVINE RL, 1990, METHOD ENZYMOL, V186, P464; Lima FD, 2008, BEHAV BRAIN RES, V193, P306, DOI 10.1016/j.bbr.2008.05.013; Lima FD, 2009, BRAIN RES, V1279, P147, DOI 10.1016/j.brainres.2009.04.052; Lin CC, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-35; Liu HT, 2009, J PHYSIOL-LONDON, V587, P2197, DOI 10.1113/jphysiol.2008.165084; Lu J, 2003, NEUROPHARMACOLOGY, V44, P253, DOI 10.1016/S0028-3908(02)00380-5; Marceau F, 2004, NAT REV DRUG DISCOV, V3, P845, DOI 10.1038/nrd1522; Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319; Moreau ME, 2005, J PHARMACOL SCI, V99, P6, DOI 10.1254/jphs.SRJ05001X; Noda M, 2003, LIFE SCI, V72, P1573, DOI 10.1016/S0024-3205(02)02449-9; Noda M, 2007, J NEUROCHEM, V101, P397, DOI 10.1111/j.1471-4159.2006.04339.x; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Oliveira MS, 2004, NEUROSCIENCE, V128, P721, DOI 10.1016/j.neuroscience.2004.07.012; Plesnila N, 2001, J NEUROTRAUM, V18, P1049, DOI 10.1089/08977150152693746; Potts Mathew B, 2006, NeuroRx, V3, P143; Pun PBL, 2009, FREE RADICAL RES, V43, P348, DOI 10.1080/10715760902751902; Raghupathi R, 1998, J CEREBR BLOOD F MET, V18, P1259, DOI 10.1097/00004647-199811000-00013; Raidoo DM, 1998, PHARMACOL THERAPEUT, V79, P105, DOI 10.1016/S0163-7258(98)00011-4; Raslan F, 2010, J CEREBR BLOOD F MET, V30, P1477, DOI 10.1038/jcbfm.2010.28; Singleton RH, 2010, J NEUROTRAUM, V27, P1091, DOI 10.1089/neu.2010.1291; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; Souza MA, 2009, EPILEPSIA, V50, P811, DOI 10.1111/j.1528-1167.2008.01908.x; Stokely ME, 2008, J NEUROTRAUM, V25, P52, DOI 10.1089/neu.2007.0397; Stover JF, 2000, J NEUROSURG, V92, P853, DOI 10.3171/jns.2000.92.5.0853; Su JJ, 2009, BIOCHEM BIOPH RES CO, V388, P205, DOI 10.1016/j.bbrc.2009.07.135; Thannickal VJ, 1995, J BIOL CHEM, V270, P30334, DOI 10.1074/jbc.270.51.30334; Theodoros D G, 1998, Pediatr Rehabil, V2, P107; Trabold R, 2010, J CEREBR BLOOD F MET, V30, P130, DOI 10.1038/jcbfm.2009.196; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Wada K, 1999, J NEUROTRAUM, V16, P203, DOI 10.1089/neu.1999.16.203; Wada K, 1998, NEUROSURGERY, V43, P1427, DOI 10.1097/00006123-199812000-00096; Wada K, 1998, J NEUROSURG, V89, P807, DOI 10.3171/jns.1998.89.5.0807; WALKER K, 1995, NEUROCHEM INT, V26, P1, DOI 10.1016/0197-0186(94)00114-A; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Writer BW, 2009, J NEUROPSYCH CLIN N, V21, P362, DOI 10.1176/appi.neuropsych.21.4.362; Wu AG, 2010, NEUROREHAB NEURAL RE, V24, P290, DOI 10.1177/1545968309348318; YAN LJ, 1995, ANAL BIOCHEM, V228, P349, DOI 10.1006/abio.1995.1362; Yang CM, 2013, MOL NEUROBIOL, V47, P1020, DOI 10.1007/s12035-013-8402-1; Zhan H, 2004, NEUROL RES, V26, P35, DOI 10.1179/016164104773026507; Ziebell JM, 2011, BRAIN RES, V1414, P94, DOI 10.1016/j.brainres.2011.07.056; Zink BJ, 2001, ANN EMERG MED, V37, P318, DOI 10.1067/mem.2001.113505; Zweckberger K, 2006, J NEUROTRAUM, V23, P1083, DOI 10.1089/neu.2006.23.1083	71	11	11	0	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0033-3158	1432-2072		PSYCHOPHARMACOLOGY	Psychopharmacology	MAY	2014	231	9					1935	1948		10.1007/s00213-013-3336-x			14	Neurosciences; Pharmacology & Pharmacy; Psychiatry	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	AF2AE	WOS:000334514200006	24202114				2021-06-18	
J	Si, DW; Yang, P; Jiang, RC; Zhou, HX; Wang, HT; Zhang, YX				Si, Daowen; Yang, Peng; Jiang, Rongcai; Zhou, Hongxia; Wang, Haitao; Zhang, Yuxin			Improved cognitive outcome after progesterone administration is associated with protecting hippocampal neurons from secondary damage studied in vitro and in vivo	BEHAVIOURAL BRAIN RESEARCH			English	Article						Progesterone; Traumatic brain injury; Cognitive function; Hippocampal neuron		Previous studies reported that progesterone could improve cognitive outcome following TBI. Moreover, some evidence implied that the hippocampus is associated with cognitive function. The aim of this study was to investigate the neuroprotective effects of progesterone on hippocampal neurons in vitro and in vivo, and its influence on the cognitive outcome. In vitro, the model of primary cultured hippocampal neurons against glutamate-induced excitotoxic damage was used. After 10-day culture, neurons were pretreated with progesterone in a concentration 10 ng/ml, 48 h before a 5-min exposure to 200 mu mol/l glutamate. Then 24 h after glutamate exposure, the nerve cells were observed and LDH was detected. The results showed progesterone protected the cultured hippocampal neurons morphology and significantly reduced the amount of LDH. In vivo, the model of TBI was established by modified Feeney's weight-dropping method. The progesterone was given in a dose of 16 mg/kg by intraperitoneal injection 1 h post injury and subsequent injections subcutaneously at 6 h and 12 h after TBI. Brain samples were extracted at 24 h after injury. Histology and the iNOS expression were examined by Nissl stain, immunohistochemistry and Western blot. The cognitive outcome was assessed by Morris water maze test (MWM). The results revealed that the neuronal cell damage and the expression of iNOS in the hippocampus CA1 were significantly decreased after progesterone administration. Progesterone significantly improved cognitive outcome after TBI. The results suggest that the positive effects of progesterone on cognitive outcome may be linked to protecting hippocampal neurons from secondary damage. (C) 2014 Elsevier B.V. All rights reserved.	[Si, Daowen; Zhou, Hongxia; Wang, Haitao; Zhang, Yuxin] Hebei United Univ, Sch Basic Med Sci, Tangshan 063000, Hebei, Peoples R China; [Yang, Peng] Hebei United Univ, Affiliated Hosp, Dept Neurosurg, Tangshan 063000, Hebei, Peoples R China; [Jiang, Rongcai] Tianjin Med Univ, Gen Hosp, Dept Neurosurg, Tianjin 300000, Peoples R China	Wang, HT (corresponding author), Hebei United Univ, Sch Basic Med Sci, Tangshan 063000, Hebei, Peoples R China.	sidaowen@126.com; wht92725@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81201048]; Natural Science Foundation of Hebei ProvinceNatural Science Foundation of Hebei Province [H2012401009]; Tangshan Science and Technology Research and Development Program [12140209a-55]	This work was supported by National Natural Science Foundation of China (81201048); Natural Science Foundation of Hebei Province (H2012401009); Tangshan Science and Technology Research and Development Program (12140209a-55).	Aktan F, 2004, LIFE SCI, V75, P639, DOI 10.1016/j.lfs.2003.10.042; Ariza M, 2006, NEUROPSYCHOLOGIA, V44, P1956, DOI 10.1016/j.neuropsychologia.2005.11.007; Barha CK, 2011, EXP NEUROL, V231, P72, DOI 10.1016/j.expneurol.2011.05.016; Bottino MC, 2011, BREAST CANCER RES TR, V126, P621, DOI 10.1007/s10549-010-0971-3; Cherian L, 2004, BRAIN PATHOL, V14, P195, DOI 10.1111/j.1750-3639.2004.tb00053.x; Ciriza I, 2004, J NEUROENDOCRINOL, V16, P58, DOI 10.1111/j.1365-2826.2004.01121.x; Cooke PS, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00108; Coughlan T, 2005, J NEUROCHEM, V93, P932, DOI 10.1111/j.1471-4159.2005.03068.x; Dawson VL, 1996, J CHEM NEUROANAT, V10, P179, DOI 10.1016/0891-0618(96)00148-2; Djebaili M, 2004, NEUROSCIENCE, V123, P349, DOI 10.1016/j.neuroscience.2003.09.023; EVANS RM, 1988, CELL, V52, P1, DOI 10.1016/0092-8674(88)90522-3; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Gibbs RB, 2000, NEUROBIOL AGING, V21, P107, DOI 10.1016/S0197-4580(00)00103-2; Goss CW, 2003, PHARMACOL BIOCHEM BE, V76, P231, DOI 10.1016/j.pbb.2003.07.003; Grossman KJ, 2004, BRAIN RES, V1008, P29, DOI 10.1016/j.brainres.2004.02.022; He J, 2004, RESTOR NEUROL NEUROS, V22, P19; Jones NC, 2004, J NEUROPATH EXP NEUR, V63, P708, DOI 10.1093/jnen/63.7.708; KOH JY, 1987, J NEUROSCI METH, V20, P83, DOI 10.1016/0165-0270(87)90041-0; Li ZY, 2012, J NEUROTRAUM, V29, P343, DOI 10.1089/neu.2011.1807; Lockhart EM, 2002, NEUROSCI LETT, V328, P33, DOI 10.1016/S0304-3940(02)00448-2; Mani SK, 2006, NEUROSCIENCE, V138, P773, DOI 10.1016/j.neuroscience.2005.07.034; Mohler H, 2008, PHARMACOL BIOCHEM BE, V90, P58, DOI 10.1016/j.pbb.2008.03.003; Morali G, 2005, NEUROSCI LETT, V382, P286, DOI 10.1016/j.neulet.2005.03.066; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Nilsen J, 2003, P NATL ACAD SCI USA, V100, P10506, DOI 10.1073/pnas.1334098100; Nilsen J, 2002, ENDOCRINOLOGY, V143, P205, DOI 10.1210/en.143.1.205; O'Connor CA, 2007, EXP NEUROL, V205, P145, DOI 10.1016/j.expneurol.2007.01.034; OGATA T, 1993, NEUROSCIENCE, V55, P445, DOI 10.1016/0306-4522(93)90513-F; Pierson RC, 2005, MOL BRAIN RES, V138, P105, DOI 10.1016/j.molbrainres.2004.10.047; Reddy DS, 2005, NEUROPHARMACOLOGY, V48, P14, DOI 10.1016/j.neuropharm.2004.09.002; ROOF RL, 1993, BEHAV BRAIN RES, V57, P47, DOI 10.1016/0166-4328(93)90060-4; Roof RL, 1997, MOL CHEM NEUROPATHOL, V31, P1, DOI 10.1007/BF02815156; ROOF RL, 1994, EXP NEUROL, V129, P64, DOI 10.1006/exnr.1994.1147; Schmidt BMW, 2000, FRONT NEUROENDOCRIN, V21, P57, DOI 10.1006/frne.1999.0189; Schumacher M, 2007, PHARMACOL THERAPEUT, V116, P77, DOI 10.1016/j.pharmthera.2007.06.001; Shahrokhi N, 2010, CAN J PHYSIOL PHARM, V88, P414, DOI [10.1139/Y09-126, 10.1139/y09-126]; Shear DA, 2002, EXP NEUROL, V178, P59, DOI 10.1006/exnr.2002.8020; Silva MAD, 2008, NEUROSCIENCE, V157, P196, DOI 10.1016/j.neuroscience.2008.09.003; SIMON RP, 1984, SCIENCE, V226, P850, DOI 10.1126/science.6093256; Sinson G, 1997, J NEUROSURG, V86, P511, DOI 10.3171/jns.1997.86.3.0511; Stein DG, 2008, BRAIN RES REV, V57, P386, DOI 10.1016/j.brainresrev.2007.06.012; SyNAPSe, 2011, RAND DOUBL BLIND PLA; Wali B, 2011, RESTOR NEUROL NEUROS, V29, P61, DOI 10.3233/RNN-2011-0579; Wang JP, 2009, BRAIN RES BULL, V79, P426, DOI 10.1016/j.brainresbull.2009.05.018; Wang YS, 2009, J NEUROL SCI, V285, P172, DOI 10.1016/j.jns.2009.06.034; WOOLLEY CS, 1993, J COMP NEUROL, V336, P293, DOI 10.1002/cne.903360210; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; YAMADA KA, 1992, J PHYSIOL-LONDON, V458, P409, DOI 10.1113/jphysiol.1992.sp019424	49	11	11	1	15	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	MAY 1	2014	264						135	142		10.1016/j.bbr.2014.01.049			8	Behavioral Sciences; Neurosciences	Behavioral Sciences; Neurosciences & Neurology	AE3CA	WOS:000333853300015	24518203				2021-06-18	
J	Yildirim, AO; Eryilmaz, M; Kaldirim, U; Eyi, YE; Tuncer, SK; Eroglu, M; Durusu, M; Topal, T; Kurt, B; Dilmen, S; Bilgic, S; Serdar, M				Yildirim, Ali Osman; Eryilmaz, Mehmet; Kaldirim, Umit; Eyi, Yusuf Emrah; Tuncer, Salim Kemal; Eroglu, Murat; Durusu, Murat; Topal, Turgut; Kurt, Bulent; Dilmen, Serkan; Bilgic, Serkan; Serdar, Muhittin			Effectiveness of hyperbaric oxygen and ozone applications in tissue healing in generated soft tissue trauma model in rats: an experimental study	ULUSAL TRAVMA VE ACIL CERRAHI DERGISI-TURKISH JOURNAL OF TRAUMA & EMERGENCY SURGERY			English	Article						Experimental; hyperbaric oxygen; ozone; soft tissue trauma	BRAIN-INJURY; INTERMITTENT; EXPOSURE; THERAPY; HEME; PAIN	BACKGROUND: Soft tissue trauma is a type of acute traumatic ischemia. We investigated in this study whether the edema, inflammation and ischemia caused by the trauma could be affected positively by hyperbaric oxygen (HBO) and ozone therapy. METHODS: Soft tissue trauma was generated in a total of 63 adult male Sprague-Dawley rats. Subsequently, rats were divided into three groups. The first group was treated with ozone, the second group with HBO, and the third group served as controls. Tissue and blood samples were taken at the end of the procedures. Tissue lipid peroxidation (LPO), superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), inducible nitric oxide synthase (iNOS), heme oxygenase (HO)-I, and hypoxia-inducible factor (HIF)-I levels were detected. Hematoxylin-eosin staining was used to determine the inflammation and edema histopathologically. RESULTS: We also detected HIF-I activity, which decreases when the oxygen concentration increases, HO-I activity, which has anti-inflammatory effects, and iNOS activity, which releases in any type of acute case. We determined a statistically significant reduction in iNOS and LPO levels in both the HBO and Ozone groups. A significant decrease in inflammation was detected in both the Ozone and HBO groups compared with the Control group, and a significant decrease in edema was detected in all three groups. CONCLUSION: We think that HBO and Ozone therapy have beneficial effects on biochemical and histopathological findings. Related clinical trials will be helpful in clarifying the effects.	[Yildirim, Ali Osman; Eroglu, Murat] Haydarpasa Mil Hosital, GATA, Dept Emergency Med, Istanbul, Turkey; [Eryilmaz, Mehmet; Kaldirim, Umit; Tuncer, Salim Kemal; Durusu, Murat] GATA Sch Med, Dept Emergency Med, Ankara, Turkey; [Eyi, Yusuf Emrah] Hakkari Mil Hosp, Dept Emergency Med, Hakkari, Turkey; [Topal, Turgut] GATA Sch Med, Dept Physiol, Ankara, Turkey; [Kurt, Bulent] GATA Sch Med, Dept Pathol, Ankara, Turkey; [Dilmen, Serkan] Elazig Mil Hosp, Dept Emergency Med, Elazig, Turkey; [Bilgic, Serkan] Haydarpasa Mil Hosital, GATA, Dept Orthopaed & Traumatol, Istanbul, Turkey; [Serdar, Muhittin] GATA Sch Med, Dept Biochem, Ankara, Turkey	Yildirim, AO (corresponding author), GATA Haydarpasa Hastanesi, Acil Tip Anabilim Dali, Istanbul, Turkey.	draliosmanyildirim@gmail.com	SERDAR, Muhittin A./D-2493-2015	SERDAR, Muhittin A./0000-0002-3014-748X; ERYILMAZ, MEHMET/0000-0003-0551-1136			ALBERTS B, 2002, MOL BIOL CELL, P1259; Babul S, 2003, CLIN J SPORT MED, V13, P138, DOI 10.1097/00042752-200305000-00003; Bach FH, 2005, FASEB J, V19, P1216, DOI 10.1096/fj.04-3485cmt; Bennett MH, 2009, COCHRANE DB SYST REV; Bocci V, 2007, BRIT J BIOMED SCI, V64, P44, DOI 10.1080/09674845.2007.11732755; Bocci V, 2007, MEDIAT INFLAMM, V2007, DOI 10.1155/2007/26785; Bocci Velio, 2005, P1; Bywaters EGL, 1998, J AM SOC NEPHROL, V9, P322; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Communal C, 2002, P NATL ACAD SCI USA, V99, P6252, DOI 10.1073/pnas.092022999; Davies SL, 2005, J NEUROSCI METH, V148, P161, DOI 10.1016/j.jneumeth.2005.04.020; DIXON CE, 1991, J NEUROSCI METH, V39, P253; FELDMEIER JJ, 2003, INDICATIONS RESULTS; Germain G, 2003, UNDERSEA HYPERBAR M, V30, P135; HARABIN AL, 1990, J APPL PHYSIOL, V69, P328; Harrison BC, 2001, MED SCI SPORT EXER, V33, P36; Horvath I, 1998, THORAX, V53, P867, DOI 10.1136/thx.53.10.867; Kim HS, 2009, J KOREAN MED SCI, V24, P368, DOI 10.3346/jkms.2009.24.3.368; Koca K, 2010, J SURG RES, V164, pE83, DOI 10.1016/j.jss.2010.06.030; Kranke P, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004123.pub3; Kubes P, 2000, AM J MED, V109, P150, DOI 10.1016/S0002-9343(00)00480-0; Mabvuure Nigel Tapiwa, 2012, Open Orthop J, V6, P535, DOI 10.2174/1874325001206010535; Martinez-Sanchez G, 2005, EUR J PHARMACOL, V523, P151, DOI 10.1016/j.ejphar.2005.08.020; Mekjavic IB, 2000, MED SCI SPORT EXER, V32, P558, DOI 10.1097/00005768-200003000-00002; Muto M, 2008, RADIOL MED, V113, P695, DOI 10.1007/s11547-008-0302-5; Nogales Carlos Goes, 2008, J Contemp Dent Pract, V9, P75; Oter S, 2005, CLIN BIOCHEM, V38, P706, DOI 10.1016/j.clinbiochem.2005.04.005; Otterbein LE, 2003, TRENDS IMMUNOL, V24, P449, DOI 10.1016/S1471-4906(03)00181-9; SOOLSMA S, 1996, THESIS U BRIT COLUMB; Staples JR, 1999, AM J SPORT MED, V27, P600, DOI 10.1177/03635465990270050901; Stubinger S, 2006, QUINTESSENCE INT, V37, P353; Tavazzi B, 2005, NEUROSURGERY, V56, P582, DOI 10.1227/01.NEU.0000156715.04900.E6; Yucesir I, 2010, TURKIYE KLIN J ORTHO, V3, P24	33	11	11	0	9	TURKISH ASSOC TRAUMA EMERGENCY SURGERY	ISTANBUL	KOPRULU MEHMET PASA SOC, DENIZ ABDAL MAH, DADASOGLU AP, 25-1 SEHREMINI, ISTANBUL, 00000, TURKEY	1306-696X			ULUS TRAVMA ACIL CER	Ulus. Travma Acil Cerrahi Derg.	MAY	2014	20	3					167	175		10.5505/tjtes.2014.09465			9	Emergency Medicine	Emergency Medicine	AI8KU	WOS:000337163600003	24936837	Bronze			2021-06-18	
J	Tajiri, N; Hernandez, D; Acosta, S; Shinozuka, K; Ishikawa, H; Ehrhart, J; Diamandis, T; Gonzales-Portillo, C; Borlongan, MC; Tan, J; Kaneko, Y; Borlongan, CV				Tajiri, Naoki; Hernandez, Diana; Acosta, Sandra; Shinozuka, Kazutaka; Ishikawa, Hiroto; Ehrhart, Jared; Diamandis, Theo; Gonzales-Portillo, Chiara; Borlongan, Mia C.; Tan, Jun; Kaneko, Yuji; Borlongan, Cesar V.			Suppressed cytokine expression immediatey following traumatic brain injury in neonatal rats indicates an expeditious endogenous anti-inflammatory response	BRAIN RESEARCH			English	Article						Traumatic brain injury; Neonatal traumatic brain injury; Cytokine expression; Neuroinflammation	SHAKEN-BABY-SYNDROME; INFLAMMATION; OUTCOMES; INFANTS	The timing of therapeutic intervention in traumatic brain injury (TBI) is critical. Although immediate cell death cascades have become established in adult TBI, the pathophysiology underlying neonatal TBI is poorly understood. The objective of the present study was to determine the role of cytokine regulation following TBI in neonatal rats. Seven-day-old Sprague-Dawley rats were subjected to TBI using the controlled cortical impact (CCI) injury model. Age-matched littermates that did not receive TBI served as the controls. Immediately following TBI, rats were euthanized, and the brains were divided into the ipsilateral and contralateral hemispheres then flash frozen. A BioRad 23-Flex panel was used to measure cytokine levels. Surprisingly, the data revealed that 18 of the 23 cytokines analyzed were significantly downregulated in the hemisphere contralateral to the TBI impacted hemisphere. IL-5, IL-6 and MIP-3a were significantly suppressed in both ipsilateral and contralateral hemispheres of neonatal TBI rats compared to the control rats. A parallel study processing the plasma of the same cohort of neonatal rats revealed no difference in the same cytokines analyzed in the brain tissue, suggesting highly localized cytokine suppression in the brain during early injury. In stark contrast to the reported early pro-inflammatory response exhibited in adult TBI, the present neonatal TBI study demonstrated a reversed cytokine profile of downregulation. These results suggest a robust, immediate anti-inflammatory response mounted by the contralateral hemisphere of the young brain. (C) 2014 Elsevier B.V. All rights reserved.	[Tajiri, Naoki; Hernandez, Diana; Acosta, Sandra; Shinozuka, Kazutaka; Ishikawa, Hiroto; Ehrhart, Jared; Diamandis, Theo; Gonzales-Portillo, Chiara; Borlongan, Mia C.; Tan, Jun; Kaneko, Yuji; Borlongan, Cesar V.] Univ S Florida, Coll Med, Ctr Excellence Aging & Brain Repair, Dept Neurosurg & Brain Repair, Tampa, FL 33612 USA; [Ehrhart, Jared; Tan, Jun] Univ S Florida, Coll Med, Dept Psychiat & Behav Med, Rashid Lab Dev Neurobiol,Silver Child Dev Ctr, Tampa, FL 33612 USA	Borlongan, CV (corresponding author), Univ S Florida, Coll Med, Ctr Excellence Aging & Brain Repair, Dept Neurosurg & Brain Repair, 12901 Bruce B Downs Blvd, Tampa, FL 33612 USA.	cborlong@health.usf.edu	Borlongan, Cesar/I-5696-2012	Borlongan, Cesar/0000-0002-2966-9782; Borlongan, Mia/0000-0003-3223-8374; Ishikawa, Hiroto/0000-0003-0760-7203; Shinozuka, Kazutaka/0000-0002-6435-4460	Department of Neurosurgery and Brain Repair funds; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS071956] Funding Source: NIH RePORTER	This research was supported by the Department of Neurosurgery and Brain Repair funds.	Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053376; Altimier L, 2008, J PERINAT NEONAT NUR, V22, P68, DOI 10.1097/01.JPN.0000311877.32614.69; Andelic N, 2008, NEUROEPIDEMIOLOGY, V30, P120, DOI 10.1159/000120025; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 2009, BRAIN, V132, P45, DOI 10.1093/brain/awn293; Ashton R, 2010, J CHILD PSYCHOL PSYC, V51, P967, DOI 10.1111/j.1469-7610.2010.02272.x; Barr RG, 2006, CHILD ABUSE NEGLECT, V30, P7, DOI 10.1016/j.chiabu.2005.06.009; Case Mary E., 2007, Legal Medicine, V9, P83, DOI 10.1016/j.legalmed.2006.11.017; Chung C.S., 2013, COCHRANE DB SYST REV, P30; Crowe LM, 2012, J PEDIATR PSYCHOL, V37, P745, DOI 10.1093/jpepsy/jss070; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Gatson JW, 2013, J TRAUMA ACUTE CARE, V74, P470, DOI 10.1097/TA.0b013e31827e1f51; Giunta B, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-185; Glover LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033646; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Kaneko Y, 2012, CELL MED, V4, P55, DOI 10.3727/215517912X639306; Karasu A, 2009, ULUS TRAVMA ACIL CER, V15, P159; Levchakov A, 2006, J NEUROTRAUM, V23, P1570, DOI 10.1089/neu.2006.23.1570; Lloyd E, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-28; Maxwell WL, 2012, INT J DEV NEUROSCI, V30, P167, DOI 10.1016/j.ijdevneu.2011.12.008; Niedzwecki CM, 2008, J HEAD TRAUMA REHAB, V23, P209, DOI 10.1097/01.HTR.0000327253.61751.29; Pabon MM, 2013, FUTUR NEUROL, V8, P193, DOI 10.2217/FNL.12.85; Paiva WS, 2011, ACTA MEDICA PORT, V 24, P805; Rovegno M, 2012, MED INTENSIVA, V36, P37, DOI 10.1016/j.medin.2011.06.008; Shojo H, 2010, NEUROSCIENCE, V171, P1273, DOI 10.1016/j.neuroscience.2010.10.018; Shrivastava K, 2013, DEV NEUROSCI-BASEL, V35, P212, DOI 10.1159/000348432; Sun D, 2009, EXP NEUROL, V216, P56, DOI 10.1016/j.expneurol.2008.11.011; Tajiri N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043779; Timaru-Kast R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043829; Utagawa A, 2008, EXP NEUROL, V211, P283, DOI 10.1016/j.expneurol.2008.02.001; Waters R.J., 2013, J NEUROTRAUMA; Wheaton P, 2011, J CLIN PSYCHOPHARM, V31, P745, DOI 10.1097/JCP.0b013e318235f4ac; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018	34	11	12	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	APR 22	2014	1559						65	71		10.1016/j.brainres.2014.02.041			7	Neurosciences	Neurosciences & Neurology	AG0NU	WOS:000335113000007	24602693	Green Accepted			2021-06-18	
J	Pugh, MJ; Leykum, LK; Lanham, HJ; Finley, EP; Noel, PH; McMillan, KK; Pugh, JA				Pugh, Mary Jo; Leykum, Luci K.; Lanham, Holly J.; Finley, Erin P.; Noel, Polly H.; McMillan, Katharine K.; Pugh, Jacqueline A.			Implementation of the epilepsy center of excellence to improve access to and quality of care - protocol for a mixed methods study	IMPLEMENTATION SCIENCE			English	Article						Epilepsy; Relational Coordination; Veterans Health Administration (VA)	RELATIONAL COORDINATION; ANTIEPILEPTIC DRUG; HEALTH-STATUS; IMPACT; OUTCOMES; MECHANISMS; VETERANS; SERVICES; DISEASE; PATIENT	Background: To address the growing problem of epilepsy among aging Veterans and younger Veterans who have experienced a traumatic brain injury (TBI), the Veterans Health Administration (VA) has implemented 16 Epilepsy Centers of Excellence (ECOE) to assure increased access to high quality of care for Veterans with epilepsy. Each ECOE consists of a network of regional hubs to which spoke facilities refer Veterans for subspecialty treatment. The ECOEs are expected to improve access to and quality of epilepsy care through patient care, consultation and education. This study aims to: evaluate the effectiveness of the ECOE structure by describing changes in the quality of and access to care for epilepsy before and after the ECOE initiative using QUality Indicators in Epilepsy Treatment (QUIET Indicators); describe associations between changes in the structure and processes of care and Relational Coordination (RC), a model of task-oriented communication that has been shown to play a role in implementation science; and determine if variations in care are related to levels of RC. Methods: This four-year comparative case study uses a mixed-methods approach. We will use VA inpatient, outpatient, pharmacy, and chart abstraction data to identify changes in the quality of and access to epilepsy care in the VA between Fiscal Year 2008 and Fiscal Year 2014. Qualitative and survey methods will be used to identify changes in the structure and processes of epilepsy care and RC over the course of the study. We will then link data from the first two objectives to determine the extent to which quality of and access to epilepsy care is associated with RC using multivariable models. Discussion: This innovative study has the potential to improve understanding of hub-and-spoke model effectiveness, VA epilepsy care, and models of epilepsy specialty care more globally. Moreover, it contributes to implementation science by advancing understanding of the role of RC in the context of a major transformation in the structure of care delivery in a national integrated healthcare system.	[Pugh, Mary Jo; Leykum, Luci K.; Lanham, Holly J.; Finley, Erin P.; Noel, Polly H.; McMillan, Katharine K.; Pugh, Jacqueline A.] Univ Texas Hlth Sci Ctr San Antonio, South Texas Vet Hlth Care Syst, San Antonio, TX 78229 USA; [Pugh, Mary Jo] VA Epilepsy Ctr Excellence, San Antonio, TX 78229 USA	Pugh, MJ (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, South Texas Vet Hlth Care Syst, 7400 Merton Minter BLVD, San Antonio, TX 78229 USA.	Maryjo.Pugh2@va.gov	Pugh, Mary Jo/K-5336-2019; Pugh, Jacqueline/I-6199-2013	Pugh, Mary Jo/0000-0003-4196-7763; Finley, Erin/0000-0003-4497-7721; Noel, Polly/0000-0002-1519-7489; Pugh, Jacqueline/0000-0003-4933-141X	Department of Veterans Affairs, VA Health Services Research and Development ServiceUS Department of Veterans Affairs [IIR-062]; National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R25 MH080916-01A2]; Department of Veterans Affairs, Health Services Research & Development Service, Quality Enhancement Research Initiative (QUERI); NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R25MH080916] Funding Source: NIH RePORTER	This project was funded by the Department of Veterans Affairs, VA Health Services Research and Development Service (IIR-062; MJ Pugh PI). Dr. Finley is an investigator with the Implementation Research Institute (IRI), at the George Warren Brown School of Social Work, Washington University in St. Louis; through an award from the National Institute of Mental Health (R25 MH080916-01A2) and the Department of Veterans Affairs, Health Services Research & Development Service, Quality Enhancement Research Initiative (QUERI).	Aldenkamp AP, 2006, SEIZURE-EUR J EPILEP, V15, P219, DOI 10.1016/j.seizure.2006.02.010; [Anonymous], 2012, EP SPECTR; Baker GA, 1997, EPILEPSIA, V38, P353, DOI 10.1111/j.1528-1157.1997.tb01128.x; Bar-Yam Y, 2004, COMPLEXITY, V9, P15, DOI 10.1002/cplx.20029; Barbour R S, 1999, J Health Serv Res Policy, V4, P39; Begley CE, 2000, EPILEPSIA, V41, P342, DOI 10.1111/j.1528-1157.2000.tb00166.x; Buck D, 1997, EPILEPSIA, V38, P439, DOI 10.1111/j.1528-1157.1997.tb01733.x; Farmer T, 2006, QUAL HEALTH RES, V16, P377, DOI 10.1177/1049732305285708; Ficker DM, 2000, EPILEPSIA, V41, pS7, DOI 10.1111/j.1528-1157.2000.tb01519.x; Finley EP, 2013, ANN FAM MED, V11, P543, DOI 10.1370/afm.1554; Fisher RS, 2000, EPILEPSY RES, V41, P39, DOI 10.1016/S0920-1211(00)00126-1; Fountain NB, 2011, NEUROLOGY, V76, P94, DOI 10.1212/WNL.0b013e318203e9d1; Gittell JH, 2000, MED CARE, V38, P807, DOI 10.1097/00005650-200008000-00005; Gittell JH, 2004, J MANAGE STUD, V41, P127, DOI 10.1111/j.1467-6486.2004.00424.x; Gittell JH, 2002, MANAGE SCI, V48, P1408; Haneef Z, 2010, NEUROLOGY, V75, P699, DOI 10.1212/WNL.0b013e3181eee457; Holland JohnHenry., 2000, EMERGENCE CHAOS ORDE; Jones JE, 2003, EPILEPSY BEHAV, V4, pS31, DOI 10.1016/j.yebeh.2003.08.019; Jordan ME, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-15; Kanner AM, 2003, BIOL PSYCHIAT, V54, P388, DOI 10.1016/S0006-3223(03)00469-4; Labiner DM, 2010, EPILEPSIA, V51, P2322, DOI 10.1111/j.1528-1167.2010.02648.x; Lanham HJ, 2009, JT COMM J QUAL PATIE, V35, P457, DOI 10.1016/S1553-7250(09)35064-3; Leykum Luci K, 2010, J Hosp Med, V5, pE2, DOI 10.1002/jhm.642; Leykum LK, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-66; Leykum LK, 2007, IMPLEMENT SCI, V2, DOI 10.1186/1748-5908-2-28; McDaniel RR, 2009, HEALTH CARE MANAGE R, V34, P191, DOI 10.1097/HMR.0b013e31819c8b38; Pugh MJV, 2008, NEUROLOGY, V70, P2171, DOI 10.1212/01.wnl.0000313157.15089.e6; Pugh MJ, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-1; Pugh MJV, 2008, PSYCHIAT SERV, V59, P925, DOI 10.1176/ps.2008.59.8.925; Pugh MJV, 2010, J AM GERIATR SOC, V58, P465, DOI 10.1111/j.1532-5415.2010.02732.x; Pugh MJV, 2004, J AM GERIATR SOC, V52, P417, DOI 10.1111/j.1532-5415.2004.52115.x; Pugh MJV, 2005, EPILEPSIA, V46, P1820, DOI 10.1111/j.1528-1167.2005.00291.x; Sperling MR, 2004, CNS SPECTRUMS, V9, P98, DOI 10.1017/S1092852900008464; TAGUE N, 2005, QUALITY TOOLBOX, P35; Taylor J, 2010, EPILEPSY BEHAV, V18, P397, DOI 10.1016/j.yebeh.2010.05.007; Vogus TJ, 2010, ACAD MANAGE PERSPECT, V24, P60; Weinberg DB, 2007, HEALTH SERV RES, V42, P7, DOI 10.1111/j.1475-6773.2006.00653.x; Zeber JE, 2007, EPILEPSY BEHAV, V10, P539, DOI 10.1016/j.yebeh.2007.02.008	38	11	11	0	9	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1748-5908			IMPLEMENT SCI	Implement. Sci.	APR 9	2014	9								44	10.1186/1748-5908-9-44			10	Health Care Sciences & Services; Health Policy & Services	Health Care Sciences & Services	AF7KI	WOS:000334893300001	24712733	DOAJ Gold, Green Published			2021-06-18	
J	Karam, O; Tucci, M; Lacroix, J; Rimensberger, PC				Karam, Oliver; Tucci, Marisa; Lacroix, Jacques; Rimensberger, Peter C.		Canadian Critical Care Trials Grp; Pediatric Acute Lung Injury Sepsis	International survey on plasma transfusion practices in critically ill children	TRANSFUSION			English	Article							FRESH-FROZEN PLASMA; ORGAN FAILURE; POSTINJURY COMPLICATIONS; GUIDELINES; ASSOCIATION; CLINICIAN; REDUCTION; PROTOCOLS; RISK	BackgroundStudies have shown heterogeneity in red blood cell transfusion practices. Although plasma transfusion is common in intensive care, there are no data on plasma transfusion practices in pediatric critical care units. Study Design and MethodsA scenario-based survey was sent to 718 pediatric critical care physicians working in Europe, North America, Australia, and New Zealand. Respondents were asked to report their decisions regarding plasma transfusion practice with respect to four scenarios: pneumonia, septic shock, traumatic brain injury (TBI), and postoperative care after a Tetralogy of Fallot correction. ResultsThe response rate was 187 of 718 (26%); half of the responders worked in North America. The proportion of physicians who transfused plasma to nonbleeding patients, solely based on abnormal international normalized ratio (INR), varied from 66% for pneumonia to 84% for TBI (p<0.001). In such nonbleeding patients, the median INR threshold that would trigger plasma transfusion was 2.5 for pneumonia and septic shock patients and 2.0 for TBI and the cardiac postoperative patients (p<0.001). Minor bleeding, minor surgery, insertion of a femoral line, hypotension, abnormal activated partial thromboplastin time, thrombocytopenia, and anemia levels were important determinants of plasma transfusion, whereas none of the respondents' demographic characteristics were important. ConclusionMore than two-thirds of responding pediatric critical care physicians prescribe plasma transfusions for nonbleeding critically ill children. Additionally, there is a significant variation in transfusion practice patterns with respect to plasma transfusion thresholds.	[Karam, Oliver; Rimensberger, Peter C.] Univ Hosp Geneva, Pediat Crit Care Unit, CH-1211 Geneva, Switzerland; [Tucci, Marisa; Lacroix, Jacques] Univ Montreal, Hop St Justine, Pediat Crit Care Unit, Montreal, PQ H3T 1C5, Canada	Karam, O (corresponding author), Univ Hosp Geneva, Pediat Crit Care Unit, 6 Rue Willy Donze, CH-1211 Geneva, Switzerland.	oliver.karam@hcuge.ch	Karam, Oliver/N-6216-2014	Karam, Oliver/0000-0001-6606-1736	Fonds de la Recherche en Sante du QuebecFonds de la Recherche en Sante du Quebec [24460]	Supported by the Fonds de la Recherche en Sante du Quebec (Grant 24460).	Abdel-Wahab OI, 2006, TRANSFUSION, V46, P1279, DOI 10.1111/j.1537-2995.2006.00891.x; [Anonymous], 2010, RAPP ANN HEM 2010, V2011, P68; [Anonymous], 2011, REP US DEP HLTH HUM; Arnold DM, 2011, J CRIT CARE, V26, DOI 10.1016/j.jcrc.2011.02.005; BOLTONMAGGS PHB, 2012, ANN SHOT REPORT 2011; Burns KEA, 2008, CAN MED ASSOC J, V179, P245, DOI 10.1503/cmaj.080372; Church GD, 2009, PEDIATR CRIT CARE ME, V10, P297, DOI 10.1097/PCC.0b013e3181988952; Cotton BA, 2009, J TRAUMA, V66, P41, DOI 10.1097/TA.0b013e31819313bb; Dara SI, 2005, CRIT CARE MED, V33, P2667, DOI [10.1097/01.CCM.0000186745.53059.F0, 10.1097/01.CCM.0000151062.00501.60]; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Dillman D.A., 1978, MAIL TELEPHONE SURVE; Holland LL, 2006, AM J CLIN PATHOL, V126, P133, DOI 10.1309/NQXHUG7HND78LFFK; Karam O, 2013, VOX SANG, V104, P342, DOI 10.1111/vox.12009; Kian H, 2007, CHEST, V131, P1308, DOI 10.1378/chest.06-3048; Lauzier F, 2007, CRIT CARE MED, V35, P1655, DOI 10.1097/01.CCM.0000269370.59214.97; Laverdiere Caroline, 2002, Pediatr Crit Care Med, V3, P335, DOI 10.1097/00130478-200210000-00001; Liumbruno G, 2009, BLOOD TRANSFUS-ITALY, V7, P132, DOI 10.2450/2009.0005-09; Luk C, 2002, CAN MED ASSOC J, V166, P1539; National Research Council, 2010, APP SECR COMM COAST, P1; O'Shaughnessy DF, 2004, BRIT J HAEMATOL, V126, P11, DOI 10.1111/j.1365-2141.2004.04972.x; Puetz J, 2012, J PEDIATR-US, V160, P210, DOI 10.1016/j.jpeds.2011.08.013; Roback JD, 2010, TRANSFUSION, V50, P1227, DOI 10.1111/j.1537-2995.2010.02632.x; Sarani B, 2008, CRIT CARE MED, V36, P1114, DOI 10.1097/CCM.0b013e318168f89d; Stanworth SJ, 2007, TRANSFUS CLIN BIOL, V14, P551, DOI 10.1016/j.tracli.2008.03.008; Watson DM, 2011, TRANSFUSION MED, V21, P124, DOI 10.1111/j.1365-3148.2010.01049.x; Watson GA, 2009, J TRAUMA, V67, P221, DOI 10.1097/TA.0b013e3181ad5957	26	11	12	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0041-1132	1537-2995		TRANSFUSION	Transfusion	APR	2014	54	4					1125	1132		10.1111/trf.12393			8	Hematology	Hematology	AE7DF	WOS:000334156200024	24032693				2021-06-18	
J	Melcer, T; Walker, J; Sechriest, VF; Lebedda, M; Quinn, K; Galarneau, M				Melcer, Ted; Walker, Jay; Sechriest, V. Franklin, II; Lebedda, Martin; Quinn, Kimberly; Galarneau, Michael			Glasgow Coma Scores, Early Opioids, and Posttraumatic Stress Disorder Among Combat Amputees	JOURNAL OF TRAUMATIC STRESS			English	Article							TRAUMATIC BRAIN-INJURY; SYMPTOMS; MORPHINE; IRAQ; PTSD	A recent study found that combat amputees had a reduced prevalence of posttraumatic stress disorder (PTSD) compared with nonamputees with serious extremity injuries. We hypothesized that an extended period of impaired consciousness or early treatment with morphine could prevent consolidation of traumatic memory and the development of PTSD. To examine this hypothesis, we retrospectively reviewed 258 combat casualty records from the Iraq or Afghanistan conflicts from 2001-2008 in the Expeditionary Medical Encounter Database, including medications and Glasgow Coma Scale (GCS) scores recorded at in-theater facilities within hours of the index injury. All patients sustained amputations from injuries. Psychological diagnoses were extracted from medical records for 24 months postinjury. None of 20 patients (0%) with GCS scores of 12 or lower had PTSD compared to 20% of patients with GCS scores of 12 or greater who did have PTSD. For patients with traumatic brain injury, those treated with intravenous morphine within hours of injury had a significantly lower prevalence of PTSD (6.3%) and mood disorders (15.6%) compared to patients treated with fentanyl only (prevalence of PTSD = 41.2%, prevalence of mood disorder = 47.1%). GCS scores and morphine and fentanyl treatments were not significantly associated with adjustment, anxiety, or substance abuse disorders.	[Melcer, Ted; Walker, Jay; Quinn, Kimberly; Galarneau, Michael] Naval Hlth Res Ctr, Dept Med Modeling & Simulat & Mission Support, San Diego, CA 92106 USA; [Sechriest, V. Franklin, II] Orthoped Med Grp, San Diego, CA USA; [Lebedda, Martin] Naval Med Ctr, San Diego, CA USA	Melcer, T (corresponding author), Naval Hlth Res Ctr, Med Modeling & Simulat Dept, 140 Sylvester Rd, San Diego, CA 92106 USA.	ted.melcer@med.navy.mil					AC Hart, 2008, ICD 9 CM PROFESSIONA; Andero R, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005656; Armed Forces Health Surveillance Center, 2011, MED SURVEILLANCE MON, V18, P17; Benedek DM, 2007, MIL MED, V172, P681; Black IH, 2009, PREHOSP EMERG CARE, V13, P223, DOI 10.1080/10903120802290778; Brown TA, 2001, J ABNORM PSYCHOL, V110, P585, DOI 10.1037//0021-843X.110.4.585; Bryant RA, 2009, BIOL PSYCHIAT, V65, P438, DOI 10.1016/j.biopsych.2008.10.032; Centers for Disease Control and Prevention, 2012, BLAST INJ TRAUM BRAI; Centers for Disease Control and Prevention, 2012, TRAUM BRAIN INJ US R; Chiu KB, 2011, ACAD EMERG MED, V18, P1156, DOI 10.1111/j.1553-2712.2011.01206.x; Claxton AR, 1997, ANESTH ANALG, V84, P509, DOI 10.1097/00000539-199703000-00008; COPES WS, 1988, J TRAUMA, V28, P69, DOI 10.1097/00005373-198801000-00010; Fox DJ, 1995, ANESTHESIA PERIOPERA, P211; Galarneau MR, 2006, MIL MED, V171, P691, DOI 10.7205/MILMED.171.8.691; Gravely AA, 2011, J REHABIL RES DEV, V48, P21, DOI 10.1682/JRRD.2009.08.0116; Hart AC, 2008, ICD 9 CM PROFESSIONA; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Holbrook TL, 2010, NEW ENGL J MED, V362, P110, DOI 10.1056/NEJMoa0903326; Kacprowicz R. F., 2008, J SPEC OPER MED, V8, P48, DOI [10.1097/TA. 0b013e3182754674, DOI 10.1097/TA.0B013E3182754674]; Lew HL, 2008, J REHABIL RES DEV, V45, pXI, DOI 10.1682/JRRD.2008.05.0064; MacGregor AJ, 2010, J HEAD TRAUMA REHAB, V25, P1, DOI 10.1097/HTR.0b013e3181c2993d; MacGregor AJ, 2009, MIL MED, V174, P224, DOI 10.7205/MILMED-D-03-9107; McGhee LL, 2011, J BURN CARE RES, V32, P46, DOI 10.1097/BCR.0b013e318204b359; Melcer T, 2013, J ORTHOP TRAUMA, V27, pE31, DOI 10.1097/BOT.0b013e3182517e1c; Pasternak GW, 2012, PAIN MED, V13, pS4, DOI 10.1111/j.1526-4637.2012.01335.x; Pittman JOE, 2012, QUAL LIFE RES, V21, P99, DOI 10.1007/s11136-011-9918-3; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Steckler T, 2012, NEUROPHARMACOLOGY, V62, P617, DOI 10.1016/j.neuropharm.2011.06.012; Stoddard FJ, 2009, J BURN CARE RES, V30, P836, DOI 10.1097/BCR.0b013e3181b48102; Sumpter RE, 2006, BRAIN INJURY, V20, P93, DOI 10.1080/02699050500394090; TEASDALE G, 1974, LANCET, V2, P81; Wain HJ, 2009, CARE COMBAT AMPUTEE, P265	33	11	12	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-9867	1573-6598		J TRAUMA STRESS	J. Trauma Stress	APR	2014	27	2					152	159		10.1002/jts.21909			8	Psychology, Clinical; Psychiatry	Psychology; Psychiatry	AF2II	WOS:000334535400005	24668780				2021-06-18	
J	Melo, JRT; Di Rocco, F; Bourgeois, M; Puget, S; Blauwblomme, T; Sainte-Rose, C; Meyer, PG; Zerah, M				Tude Melo, Jose Roberto; Di Rocco, Federico; Bourgeois, Marie; Puget, Stephanie; Blauwblomme, Thomas; Sainte-Rose, Christian; Meyer, Philippe G.; Zerah, Michel			Surgical options for treatment of traumatic subdural hematomas in children younger than 2 years of age	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						brain injury; craniocerebral trauma; surgical procedures; shaken baby syndrome; subdural hematoma; abusive head trauma	SHAKEN BABY SYNDROME; ABUSIVE HEAD TRAUMA; EARLY DECOMPRESSIVE CRANIECTOMY; BRAIN-INJURY; PREDICTIVE FACTORS; INFANTS; MANAGEMENT; HEMORRHAGE; MORTALITY; DIAGNOSIS	Object. Subdural hematoma (SDH) is the most common finding on cranial CT in pediatric victims of abusive head trauma (AHT). The hematomas are commonly bilateral and sometimes associated with interhemispheric hyperdensity and/or convexity hemorrhages. There is no consensus regarding the best surgical treatment in such cases nor are there standardized surgical protocols. The authors report their experience and discuss the routine surgical options in the management of traumatic SDH at a Level 1 Pediatric Trauma Center. Methods. In this paper, the authors describe a cross-sectional study with consecutive revision of data described in the medical records of Hopital Universitaire Necker Enfants Malades between January 2008 and January 2013. During this period, all children younger than 2 years of age who were admitted with a traumatic SDH identified on CT scans were included in this study. Results. One hundred eighty-four children who had SDH and were younger than 2 years of age were included. Their median age was 5.8 months (range 5 days-23 months), and 70% of the children were male. On admission CT scans, the SDH was bilateral in 52% of cases and homogeneously hypodense in 77%. Neurosurgical treatment was undertaken in 111 children (60%) with an admission Glasgow Coma Scale score of 12 or less, bulging fontanels, or other signs suggestive of intracranial hypertension. The first surgical option was craniotomy in 1.8% (2) of these 111 cases, decompressive craniectomy in 1.8% (2), transcutaneous subdural puncture in 15% (17), external subdural drainage in 16% (18), subdural-subgaleal shunt placement in 17% (19), and subdural-peritoneal shunt placement in 48% (53). In 82% of the children initially treated with transcutaneous subdural puncture and in 50% of those treated with external subdural drainage, increase or persistence of the SDH, CSF or skin infection, or shunt system malfunction was observed and further surgical intervention was required. There was a 26% rate of complications in patients initially treated with a subdural-peritoneal shunt. Although 52% of the patients had bilateral SDH, bilateral drainage was only required in 9.4%. Conclusions. The choice of treatment should be determined by the clinical and radiological characteristics of the individual case. Although effective on an emergency basis, subdural puncture and external subdural drainage are frequently insufficient to obtain complete resolution of SDH, and temporary placement of a subdural-peritoneal shunt is needed in most cases.	[Tude Melo, Jose Roberto; Di Rocco, Federico; Bourgeois, Marie; Puget, Stephanie; Blauwblomme, Thomas; Sainte-Rose, Christian; Zerah, Michel] Hop Univ Necker Enfants Malad, AP HP, Dept Pediat Neurosurg, Paris, France; [Meyer, Philippe G.] Hop Univ Necker Enfants Malades, AP HP, Pediat Neurosurg Intens Care Unit, Paris, France; [Meyer, Philippe G.] Univ Paris 05, Paris, France; [Tude Melo, Jose Roberto] Hosp Pediat Martagao Gesteira Liga Alvaro Bahia C, Pediat Neurosurg Unit, Salvador, BA, Brazil	Melo, JRT (corresponding author), Rua Jose Duarte 114 CEP 40-000, Salvador, BA, Brazil.	robertotude@gmail.com	ZERAH, Michel/E-6473-2012; Meyer, Philippe/ABE-4242-2020; DI ROCCO, Federico/C-6343-2015	Meyer, Philippe/0000-0002-3829-6631; Di Rocco, Federico/0000-0003-2145-5533			Adamsbaum C, 2010, PEDIATRICS, V126, P546, DOI 10.1542/peds.2009-3647; Bourgeois M, 2008, CHILD NERV SYST, V24, P169, DOI 10.1007/s00381-007-0493-4; Bradford R, 2013, J NEUROSURG-PEDIATR, V12, P110, DOI 10.3171/2013.4.PEDS12596; Case Mary E., 2007, Legal Medicine, V9, P83, DOI 10.1016/j.legalmed.2006.11.017; Case ME, 2001, AM J FOREN MED PATH, V22, P112, DOI 10.1097/00000433-200106000-00002; Csokay A, 2012, CHILD NERV SYST, V28, P441, DOI 10.1007/s00381-011-1661-0; Ewing-Cobbs L, 2000, CHILD NERV SYST, V16, P25, DOI 10.1007/s003810050006; Fanconi M, 2010, EUR J PEDIATR, V169, P1023, DOI 10.1007/s00431-010-1175-x; Feldman KW, 2001, PEDIATRICS, V108, P636, DOI 10.1542/peds.108.3.636; Gabaeff SC, 2011, WEST J EMERG MED, V12, P144; Galarza M, 2013, CHILD NERV SYST, V29, P973, DOI 10.1007/s00381-013-2051-6; Gerber P, 2007, CHILD NERV SYST, V23, P499, DOI 10.1007/s00381-006-0267-4; Ghahreman A, 2005, J NEUROSURG, V103, P213, DOI 10.3171/ped.2005.103.3.0213; Jacobi G, 2010, DTSCH ARZTEBL INT, V107, P231, DOI 10.3238/arztebl.2010.0231; Josan VA, 2006, CHILD NERV SYST, V22, P1268, DOI 10.1007/s00381-006-0064-0; Kesler H, 2008, J NEUROSURG-PEDIATR, V1, P351, DOI 10.3171/PED/2008/1/5/351; Kurschel S, 2007, J NEUROSURG, V106, P172, DOI 10.3171/ped.2007.106.3.172; Larionov SN, 2008, CHILD NERV SYST, V24, P437, DOI 10.1007/s00381-007-0496-1; Matschke J, 2009, DTSCH ARZTEBL INT, V106, P211, DOI 10.3238/arztebl.2009.0211; Meyer PG, 2005, CHILD NERV SYST, V21, P133, DOI 10.1007/s00381-004-1016-1; Paiva WS, 2011, ACTA MEDICA PORT, V 24, P805; Reece RM, 2000, ARCH PEDIAT ADOL MED, V154, P11; Scavarda D, 2010, CHILD NERV SYST, V26, P1555, DOI 10.1007/s00381-010-1150-x; Sieswerda-Hoogendoorn T, 2012, EUR J PEDIATR, V171, P415, DOI 10.1007/s00431-011-1598-z; Sun DTF, 2006, CHILD NERV SYST, V22, P593, DOI 10.1007/s00381-006-0094-7; Trenchs V, 2008, CHILD NERV SYST, V24, P815, DOI 10.1007/s00381-008-0583-y; Melo JRT, 2010, NEUROSURGERY, V67, P1542, DOI 10.1227/NEU.0b013e3181fa7049; Melo JRT, 2009, CHILD NERV SYST, V25, P1077, DOI 10.1007/s00381-009-0924-5; Vinchon M, 2001, J NEUROSURG, V95, P249, DOI 10.3171/jns.2001.95.2.0249; Vinchon M, 2010, CHILD NERV SYST, V26, P755, DOI 10.1007/s00381-009-1047-8; Vinchon M, 2010, CHILD NERV SYST, V26, P637, DOI 10.1007/s00381-009-1048-7	31	11	11	0	11	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	APR	2014	13	4					456	461		10.3171/2014.1.PEDS13393			6	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	AD7IY	WOS:000333438700016	24559279				2021-06-18	
J	Dai, YX; Sun, Q; Zhang, X; Hu, YC; Zhou, ML; Shi, JX				Dai, Yuxiang; Sun, Qing; Zhang, Xing; Hu, Yangchun; Zhou, Mengliang; Shi, Jixin			Cyclosporin A ameliorates early brain injury after subarachnoid hemorrhage through inhibition of a Nur77 dependent apoptosis pathway	BRAIN RESEARCH			English	Article						Cyclosporin A; Nur77; Apoptosis; Arly brain injury; Subarachnoid hemorrhage	ORPHAN STEROID-RECEPTOR; CEREBRAL-BLOOD-FLOW; MITOCHONDRIAL TRANSLOCATION; TRANSCRIPTION FACTORS; AKT PHOSPHORYLATES; CYTOCHROME-C; ACTIVATION; MODEL; MECHANISMS; VASOSPASM	Nur77 is a potent pro-apoptotic member of the orphan nuclear receptor superfamily. It has been demonstrated that can mediate apoptosis in many system cells in response to extracellular stimuli. Our previous study revealed Nur77-mediated apoptotic also involved in early brain injury (EBI) after experimental subarachnoid hemorrhage (SAH). CsA, a Nur77 inhibitor, can abolish DNA binding activity of Nur77, further inhibit the Nur77 dependent apoptosis pathway. CsA has the neuroprotective effects and has been demonstrated in ischemic stroke and traumatic brain injury. Hence, in this study was designed to explore the neuroprotective effects of CsA in EBI after SAH. Adult male SD rats were randomly assigned to four groups: (1) control group (n=24); (2) SAN (n=24); (3) SAH+DMSO group (n=24); and (4) SAH+CsA (n=24), 10 mg/kg of CsA or same volume of DMSO was administered by femoral vein injection at 15 min before SAN. CsA markedly decreased expressions of Nur77, p-Nur77, Bcl-2 and cyto C, and inhibited apoptosis. Improvement of neurological deficit, alleviation of brain edema and amelioration of EBI were obtained after prophylactic use of CsA. TUNEL-positive cells were reduced markedly in brain cortex by CsA. These findings suggest that neuroprotective effects of CsA during early peroid after SAH may be related to its inhibition of Nur77 dependent apoptosis pathway. (C) 2014 Elsevier B.V. All rights reserved.	[Dai, Yuxiang; Sun, Qing; Zhang, Xing; Hu, Yangchun; Zhou, Mengliang; Shi, Jixin] Nanjing Univ, Sch Med, Jinling Hosp, Dept Neurosurg, Nanjing 210008, Jiangsu, Peoples R China	Shi, JX (corresponding author), Nanjing Univ, Sch Med, Jinling Hosp, Dept Neurosurg, Nanjing 210008, Jiangsu, Peoples R China.	shijixinnj@hotmail.com		Zhou, Meng-liang/0000-0002-1165-5489			Ansar S, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-107; Balasubramanian S, 2012, J AM SOC NEPHROL, V23, P674, DOI 10.1681/ASN.2011070646; BRODERICK JP, 1994, STROKE, V25, P1342, DOI 10.1161/01.STR.25.7.1342; Cahill WJ, 2006, J CEREBR BLOOD F MET, V26, P1341, DOI 10.1038/sj.jcbfm.9600283; Caner B, 2012, J NEUROCHEM, V123, P12, DOI 10.1111/j.1471-4159.2012.07939.x; Chang LF, 2011, J SURG ONCOL, V103, P442, DOI 10.1002/jso.21809; Chen HZ, 2008, CARCINOGENESIS, V29, P2078, DOI 10.1093/carcin/bgn197; Cheng ZK, 2011, EUR HEART J, V32, P2179, DOI 10.1093/eurheartj/ehq496; Domanska-Janik K, 2004, MOL BRAIN RES, V121, P50, DOI 10.1016/j.molbrainres.2003.11.006; Endo H, 2006, STROKE, V37, P2140, DOI 10.1161/01.STR.0000229888.55078.72; Gao C, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-7; GARCIA JH, 1995, STROKE, V26, P627, DOI 10.1161/01.STR.26.4.627; Gules I, 2002, AM J PHYSIOL-HEART C, V283, pH2551, DOI 10.1152/ajpheart.00616.2002; Guo ZD, 2010, NEUROL SCI, V31, P143, DOI 10.1007/s10072-009-0192-x; Han YH, 2006, ONCOGENE, V25, P2974, DOI 10.1038/sj.onc.1209358; Hasegawa Y, 2011, ACTA NEUROCHIR SUPPL, V110, P43, DOI 10.1007/978-3-7091-0353-1_8; He ZH, 2012, STROKE, V43, P484, DOI 10.1161/STROKEAHA.111.626432; Huo JX, 2010, J BIOL CHEM, V285, P11827, DOI 10.1074/jbc.M109.072744; Kelekar A, 1998, TRENDS CELL BIOL, V8, P324, DOI 10.1016/S0962-8924(98)01321-X; Kusaka G, 2004, J CEREBR BLOOD F MET, V24, P916, DOI 10.1097/01.WCB.0000125886.48838.7E; Li H, 2000, SCIENCE, V289, P1159, DOI 10.1126/science.289.5482.1159; Lin BZ, 2004, CELL, V116, P527, DOI 10.1016/S0092-8674(04)00162-X; Liu SJ, 2011, CANCER BIOL THER, V12, P1005, DOI 10.4161/cbt.12.11.18380; Lulic D, 2011, NEUROSURGERY, V68, P1172, DOI 10.1227/NEU.0b013e31820c6cdc; Manno EM, 1997, NEUROSURGERY, V40, P289, DOI 10.1097/00006123-199702000-00010; Martinez-Gonzalez J, 2005, CARDIOVASC RES, V65, P609, DOI 10.1016/j.cardiores.2004.10.002; MILBRANDT J, 1988, NEURON, V1, P183, DOI 10.1016/0896-6273(88)90138-9; Moll UM, 2006, ONCOGENE, V25, P4725, DOI 10.1038/sj.onc.1209601; Osman MM, 2011, NEUROPEPTIDES, V45, P359, DOI 10.1016/j.npep.2011.04.002; Ostrowski RP, 2006, NEUROL RES, V28, P399, DOI 10.1179/016164106X115008; Pekarsky Y, 2001, P NATL ACAD SCI USA, V98, P3690, DOI 10.1073/pnas.051003198; Prunell GF, 2005, J NEUROSURG, V102, P1046, DOI 10.3171/jns.2005.102.6.1046; Prunell GF, 2002, NEUROREPORT, V13, P2553, DOI 10.1097/00001756-200212200-00034; Sabri M, 2013, STROKE RES TREAT, V2013, DOI 10.1155/2013/394036; Schievink WI, 2004, NEUROEPIDEMIOLOGY, V23, P299, DOI 10.1159/000080096; Tseng MY, 2005, STROKE, V36, P1627, DOI 10.1161/01.STR.0000176743.67564.5d; Wang AB, 2009, J IMMUNOL, V183, P3268, DOI 10.4049/jimmunol.0900894; Wang XX, 2012, STRESS, V15, P545, DOI 10.3109/10253890.2011.644603; WORONICZ JD, 1995, MOL CELL BIOL, V15, P6364; WORONICZ JD, 1994, NATURE, V367, P277, DOI 10.1038/367277a0; Xie ZY, 2012, BRAIN RES, V1472, P113, DOI 10.1016/j.brainres.2012.06.053; Yang H, 2011, HEPATOLOGY, V53, P865, DOI 10.1002/hep.24101; YAZDANBAKHSH K, 1995, P NATL ACAD SCI USA, V92, P437, DOI 10.1073/pnas.92.2.437; Yoon K, 2011, CARCINOGENESIS, V32, P836, DOI 10.1093/carcin/bgr040; Yoshimoto T, 1999, BRAIN RES, V839, P283, DOI 10.1016/S0006-8993(99)01733-3; Zhou L, 2013, LEUKEMIA, V27, P1358, DOI 10.1038/leu.2012.366; Zhuang Z, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-47	47	11	13	0	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	MAR 27	2014	1556						67	76		10.1016/j.brainres.2014.01.052			10	Neurosciences	Neurosciences & Neurology	AE5BK	WOS:000334002600008	24508908				2021-06-18	
J	Minter, MR; Zhang, M; Ates, RC; Taylor, JM; Crack, PJ				Minter, Myles Robert; Zhang, Moses; Ates, Robert Charles; Taylor, Juliet Marie; Crack, Peter John			Type-1 interferons contribute to oxygen glucose deprivation induced neuro-inflammation in BE(2) M17 human neuroblastoma cells	JOURNAL OF NEUROINFLAMMATION			English	Article						Type-1 interferon; Neuro-inflammation; Hypoxia-ischaemia; Cytokines; JAK-Stat	TOLL-LIKE RECEPTORS; AICARDI-GOUTIERES-SYNDROME; FOCAL CEREBRAL-ISCHEMIA; CYTOKINE EXPRESSION; ENDOGENOUS LIGAND; I INTERFERONS; BRAIN-INJURY; T-CELLS; ALPHA; LOCALIZATION	Background: Hypoxic-ischaemic injuries such as stroke and traumatic brain injury exhibit features of a distinct neuro-inflammatory response in the hours and days post-injury. Microglial activation, elevated pro-inflammatory cytokines and macrophage infiltration contribute to core tissue damage and contribute to secondary injury within a region termed the penumbra. Type-1 interferons (IFNs) are a super-family of pleiotropic cytokines that regulate pro-inflammatory gene transcription via the classical Jak/Stat pathway; however their role in hypoxia-ischaemia and central nervous system neuro-inflammation remains unknown. Using an in vitro approach, this study investigated the role of type-1 IFN signalling in an inflammatory setting induced by oxygen glucose deprivation (OGD). Methods: Human BE(2) M17 neuroblastoma cells or cells expressing a type-1 interferon-a receptor 1 (IFNAR1) shRNA or negative control shRNA knockdown construct were subjected to 4.5 h OGD and a time-course reperfusion period (0 to 24 h). Q-PCR was used to evaluate IFN alpha, IFN beta, IL-1 beta, IL-6 and TNF-alpha cytokine expression levels. Phosphorylation of signal transducers and activators of transcription (STAT)-1, STAT-3 and cleavage of caspase-3 was detected by western blot analysis. Post-OGD cellular viability was measured using a MTT assay. Results: Elevated IFNa and IFN beta expression was detected during reperfusion post-OGD in parental M17 cells. This correlated with enhanced phosphorylation of STAT-1, a downstream type-1 IFN signalling mediator. Significantly, ablation of type-1 IFN signalling, through IFNAR1 knockdown, reduced IFN alpha, IFN beta, IL-6 and TNF-alpha expression in response to OGD. In addition, MTT assay confirmed the IFNAR1 knockdown cells were protected against OGD compared to negative control cells with reduced pro-apoptotic cleaved caspase-3 levels. Conclusions: This study confirms a role for type-1 IFN signalling in the neuro-inflammatory response following OGD in vitro and suggests its modulation through therapeutic blockade of IFNAR1 may be beneficial in reducing hypoxia-induced neuro-inflammation.	[Minter, Myles Robert; Zhang, Moses; Ates, Robert Charles; Taylor, Juliet Marie; Crack, Peter John] Univ Melbourne, Dept Pharmacol, Parkville, Vic 3010, Australia	Crack, PJ (corresponding author), Univ Melbourne, Dept Pharmacol, 8th Floor,Med Bldg,Grattan St, Parkville, Vic 3010, Australia.	pcrack@unimelb.edu.au	Crack, Peter/ABE-2065-2020	Crack, Peter/0000-0002-5030-0330	National Health and Medical Research Council (NHMRC) of AustraliaNational Health and Medical Research Council of Australia	This study was supported by grants from the National Health and Medical Research Council (NHMRC) of Australia. PJC is an Australian Research Council (ARC) Future Fellow. The authors thank Ms. Ila P. Karve for her critical analysis of this manuscript.	Acarin L, 2000, EUR J NEUROSCI, V12, P3505, DOI 10.1046/j.1460-9568.2000.00226.x; Akabayov SR, 2010, BIOCHEMISTRY-US, V49, P687, DOI 10.1021/bi901313x; BERRIDGE MV, 1993, ARCH BIOCHEM BIOPHYS, V303, P474, DOI 10.1006/abbi.1993.1311; Block F, 2000, NEUROREPORT, V11, P963, DOI 10.1097/00001756-200004070-00013; Campbell IL, 1999, BRAIN RES, V835, P46, DOI 10.1016/S0006-8993(99)01328-1; Choi S, 2009, ASN NEURO, V1, DOI 10.1042/AN20090009; CICCARONE V, 1989, CANCER RES, V49, P219; Cowell RM, 2002, STROKE, V33, P795, DOI 10.1161/hs0302.103740; Crow YJ, 2006, NAT GENET, V38, P910, DOI 10.1038/ng1842; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; Cunningham C, 2007, BRAIN BEHAV IMMUN, V21, P490, DOI 10.1016/j.bbi.2006.12.007; Dai JH, 2004, J IMMUNOL, V173, P1535, DOI 10.4049/jimmunol.173.3.1535; de Weerd NA, 2007, J BIOL CHEM, V282, P20053, DOI 10.1074/jbc.R700006200; de Weerd NA, 2013, NAT IMMUNOL, V14, P901, DOI 10.1038/ni.2667; de Weerd NA, 2012, IMMUNOL CELL BIOL, V90, P483, DOI 10.1038/icb.2012.9; Downes CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057948; Downes CE, 2010, BRIT J PHARMACOL, V160, P1872, DOI 10.1111/j.1476-5381.2010.00864.x; Dunn GP, 2005, NAT IMMUNOL, V6, P722, DOI 10.1038/ni1213; Gelderblom M, 2009, STROKE, V40, P1849, DOI 10.1161/STROKEAHA.108.534503; GIULIAN D, 1993, STROKE, V24, pI84; Guan QH, 2006, BRAIN RES, V1092, P36, DOI 10.1016/j.brainres.2006.03.086; Hilkens CMU, 2001, FEBS LETT, V505, P87, DOI 10.1016/S0014-5793(01)02783-1; Jaks E, 2007, J MOL BIOL, V366, P525, DOI 10.1016/j.jmb.2006.11.053; Kariko K, 2004, J BIOL CHEM, V279, P12542, DOI 10.1074/jbc.M310175200; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kwon SJ, 2008, BRAIN RES, V1205, P116, DOI 10.1016/j.brainres.2008.02.030; Lambertsen KL, 2005, J CEREBR BLOOD F MET, V25, P119, DOI 10.1038/sj.jcbfm.9600014; Lamken P, 2005, J MOL BIOL, V350, P476, DOI 10.1016/j.jmb.2005.05.008; Meyer O, 2009, JOINT BONE SPINE, V76, P464, DOI 10.1016/j.jbspin.2009.03.012; Mishra BB, 2006, J NEUROIMMUNOL, V181, P46, DOI 10.1016/j.jneuroim.2006.07.019; Mishra BB, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-53; MIURA M, 1993, CELL, V75, P653, DOI 10.1016/0092-8674(93)90486-A; Nichane M, 2010, EMBO J, V29, P55, DOI 10.1038/emboj.2009.313; Ohashi K, 2000, J IMMUNOL, V164, P558, DOI 10.4049/jimmunol.164.2.558; OHNO M, 1995, DEV BRAIN RES, V84, P294, DOI 10.1016/0165-3806(94)00194-5; Paris D, 2013, EUR J PHARMACOL, V698, P145, DOI 10.1016/j.ejphar.2012.11.017; Paul S, 2007, BIOCHIMIE, V89, P770, DOI 10.1016/j.biochi.2007.02.009; Petry KG, 2007, NEUROTHERAPEUTICS, V4, P434, DOI 10.1016/j.nurt.2007.05.005; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Platanias LC, 1996, J BIOL CHEM, V271, P23630, DOI 10.1074/jbc.271.39.23630; Pregi N, 2009, EXP CELL RES, V315, P419, DOI 10.1016/j.yexcr.2008.11.005; Prehaud C, 2005, J VIROL, V79, P12893, DOI 10.1128/JVI.79.20.12893-12904.2005; Raza SS, 2013, NEUROSCIENCE, V230, P157, DOI 10.1016/j.neuroscience.2012.10.041; Rho MB, 1995, BRAIN BEHAV IMMUN, V9, P366, DOI 10.1006/brbi.1995.1034; Rosenberg GA, 1998, STROKE, V29, P2189, DOI 10.1161/01.STR.29.10.2189; Shichita T, 2009, NAT MED, V15, P946, DOI 10.1038/nm.1999; SMITH ML, 1984, ACTA NEUROPATHOL, V64, P319, DOI 10.1007/BF00690397; Sugawara Taku, 2004, NeuroRx, V1, P17, DOI 10.1602/neurorx.1.1.17; Tang SC, 2013, EXP NEUROL, V250, P341, DOI 10.1016/j.expneurol.2013.10.012; Taylor JM, 2014, NEUROBIOL AGING, V35, P1012, DOI 10.1016/j.neurobiolaging.2013.10.089; Termeer C, 2002, J EXP MED, V195, P99, DOI 10.1084/jem.20001858; Tough DF, 1999, IMMUNOL REV, V170, P39, DOI 10.1111/j.1600-065X.1999.tb01327.x; Vila N, 2001, STROKE, V32, P1234, DOI 10.1161/01.STR.32.5.1234-a; Wang JP, 2005, J VIROL, V79, P8295, DOI 10.1128/JVI.79.13.8295-8302.2005; YAMADA T, 1995, NEUROSCI LETT, V189, P73, DOI 10.1016/0304-3940(95)11452-3; Yasuda Y, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-70; Yilmaz G, 2006, CIRCULATION, V113, P2105, DOI 10.1161/CIRCULATIONAHA.105.593046; Zhou W, 2013, BRAIN PATHOL, V23, P34, DOI 10.1111/j.1750-3639.2012.00614.x	58	11	12	0	9	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1742-2094			J NEUROINFLAMM	J. Neuroinflamm.	MAR 6	2014	11								43	10.1186/1742-2094-11-43			13	Immunology; Neurosciences	Immunology; Neurosciences & Neurology	AF8DA	WOS:000334944400001	24602263	DOAJ Gold, Green Published			2021-06-18	
J	Cohn, B; Keim, SM; Sanders, AB				Cohn, Brian; Keim, Samuel M.; Sanders, Arthur B.			CAN ANTICOAGULATED PATIENTS BE DISCHARGED HOME SAFELY FROM THE EMERGENCY DEPARTMENT AFTER MINOR HEAD INJURY?	JOURNAL OF EMERGENCY MEDICINE			English	Article						head injury; anticoagulation; medical imaging; prognosis	TRAUMATIC BRAIN-INJURY; INTRACRANIAL HEMORRHAGE; PREINJURY WARFARIN; ATRIAL-FIBRILLATION; ELDERLY-PATIENTS; OLDER-ADULTS; MILD; RISK; MANAGEMENT; MORTALITY	Background: Anticoagulated patients have increased risk for bleeding, and serious outcomes could occur after head injury. Controversy exists regarding the utility of head computed tomography (CT) in allowing safe discharge dispositions for anticoagulated patients suffering minor head injury. Clinical Question: What is the risk of delayed intracranial hemorrhage in anticoagulated patients with minor head injury and a normal initial head CT scan? Evidence Review: Four observational studies were reviewed that investigated the outcomes of anticoagulated patients who presented after minor head injury. Results: Overall incidence of death or neurosurgical intervention ranged from 0 to 1.1% among the patients investigated. The studies did not clarify which patients were at highest risk. Conclusion: The literature does not support mandatory admission for all anticoagulated patients after minor head injury, but further studies are needed to identify the higher-risk patients for delayed bleeding to determine appropriate management. (C) 2014 Elsevier Inc.	[Cohn, Brian] Washington Univ, Sch Med, Div Emergency Med, St Louis, MO USA; [Keim, Samuel M.; Sanders, Arthur B.] Univ Arizona, Coll Med, Dept Emergency Med, Tucson, AZ 85724 USA	Keim, SM (corresponding author), Univ Arizona, Coll Med, Dept Emergency Med, POB 245057, Tucson, AZ 85724 USA.						Batchelor JS, 2012, BRIT J NEUROSURG, V26, P525, DOI 10.3109/02688697.2011.650736; Brewer ES, 2011, J TRAUMA, V70, pE1, DOI 10.1097/TA.0b013e3181e5e286; Carpenter CR, 2011, WEST J EMERG MED, V12, P489, DOI 10.5811/westjem.2011.1.1962; Carpenter CR, 2011, ANN EMERG MED, V57, P653, DOI 10.1016/j.annemergmed.2010.06.560; Carpenter Christopher R, 2009, Ann Emerg Med, V53, P398, DOI 10.1016/j.annemergmed.2008.04.020; Caterino JM, 2012, J AM GERIATR SOC, V60, P304, DOI 10.1111/j.1532-5415.2011.03823.x; Cohen DB, 2006, J TRAUMA, V60, P553, DOI 10.1097/01.ta.0000196542.54344.05; Dossett LA, 2011, ARCH SURG-CHICAGO, V146, P565, DOI 10.1001/archsurg.2010.313; ELIASTAM M, 1989, ANN EMERG MED, V18, P1222, DOI 10.1016/S0196-0644(89)80064-2; Fabbri A, 2004, J NEUROL NEUROSUR PS, V75, P1787, DOI 10.1136/jnnp.2004.041384; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Fleming TR, 1996, ANN INTERN MED, V125, P605, DOI 10.7326/0003-4819-125-7-199610010-00011; Franko J, 2006, J TRAUMA, V61, P107, DOI 10.1097/01.ta.0000224220.89528.fc; Gittleman AM, 2005, AM J NEURORADIOL, V26, P603; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P395, DOI 10.1016/j.jclinepi.2010.09.012; Han JH, 2010, EMERG MED CLIN N AM, V28, P611, DOI 10.1016/j.emc.2010.03.005; Hansen ML, 2010, ARCH INTERN MED, V170, P1433, DOI 10.1001/archinternmed.2010.271; Hastings SN, 2008, AM J EMERG MED, V26, P454, DOI 10.1016/j.ajem.2007.07.005; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; Johnson SG, 2007, CHEST, V131, P1500, DOI 10.1378/chest.06-2374; Kaen A, 2010, J TRAUMA, V68, P895, DOI 10.1097/TA.0b013e3181b28a76; Li J, 2001, LANCET, V357, P771, DOI 10.1016/S0140-6736(00)04163-5; Li J, 2012, ANN EMERG MED, V59, P457, DOI 10.1016/j.annemergmed.2012.01.010; Menditto VG, 2012, ANN EMERG MED, V59, P451, DOI 10.1016/j.annemergmed.2011.12.003; Mower WR, 2005, J TRAUMA, V59, P954, DOI 10.1097/01.ta.0000187813.79047.42; Nishijima DK, 2012, ANN EMERG MED, V59, P460, DOI 10.1016/j.annemergmed.2012.04.007; Peck KA, 2011, J TRAUMA, V71, P1600, DOI 10.1097/TA.0b013e31823b9ce1; Pieracci FM, 2007, J TRAUMA, V63, P519, DOI 10.1097/TA.0b013e31812e519b; Pieracci FM, 2007, J TRAUMA, V63, P525, DOI 10.1097/TA.0b013e31812e5216; Shireman TI, 2004, STROKE, V35, P2362, DOI 10.1161/01.STR.0000141933.75462.c2; Sternberg SA, 2011, J AM GERIATR SOC, V59, P2129, DOI 10.1111/j.1532-5415.2011.03597.x; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Temple RJ, 1995, CLIN MEASUREMENT DRU, P3; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x	35	11	11	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0736-4679	1090-1280		J EMERG MED	J. Emerg. Med.	MAR	2014	46	3					410	416		10.1016/j.jemermed.2013.08.107			7	Emergency Medicine	Emergency Medicine	AC3BZ	WOS:000332391300036	24360352				2021-06-18	
J	Hoppe, IC; Kordahi, AM; Paik, AM; Lee, ES; Granick, MS				Hoppe, Ian C.; Kordahi, Anthony M.; Paik, Angie M.; Lee, Edward S.; Granick, Mark S.			Pediatric Facial Fractures as a Result of Gunshot Injuries: An Examination of Associated Injuries and Trends in Management	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						orbital fractures; mandibular fractures; maxillary fractures; skull fractures; zygomatic fractures; pediatrics; wounds; gunshot	SHOTGUN WOUNDS; RIGID FIXATION; FACE; RECONSTRUCTION; BONE; GROWTH; TRAUMA; HEAD	Introduction Facial fractures are relatively uncommon in the pediatric population, especially those inflicted as a result of interpersonal violence in the form of gunshot injuries. Few studies have examined the unique management of such high-energy injuries in the pediatric population. Oftentimes the resultant damage to soft tissue and bony structures is so great that it challenges the previously accepted standards in the management of pediatric facial fractures. This study will examine a level 1 trauma center's experience with these unique injuries. Methods A retrospective review of all facial fractures occurring in a pediatric population (those 18 years of age or younger) as a result of gunshot wounds in a level 1 trauma center in an urban environment was performed for the years 2000 to 2012. Descriptive information was collected regarding each case as well as information regarding concomitant injuries, treatment modalities, and selected outcomes. Results During this time period, there were 3147 facial fractures treated at our institution, 353 of which were in pediatric patients. Of these, 17 were the results of gunshot wounds. Three patients were excluded due to insufficient data, leaving a total of 14 patients. The average age of patients was 16.5 (range 14-18); all patients were African-American males. The most common fracture was that of the mandible (n = 10), with 2 of those patients exhibiting panfacial fractures. The average Glasgow Coma Scale on admission was 13.5 (range 3-15). Six of the patients were intubated in the emergency department. The most common concomitant injury was a skull fracture (n = 3), followed by cervical spine fractures (n = 2) and intracranial hemorrhages (n = 2). All patients were admitted to the hospital for reasons other than fracture management. Seven patients ultimately went to the operating room for fracture management. The treatment modalities employed were conservative management with closed techniques (n = 11), rigid internal fixation (n = 2), and the use of an external fixator device (n = 1). Minimal to no soft-tissue debridement was performed in 10 of the 14 patients, 2 of which presented between 6 months and 10 years post-injury with soft-tissue complications related to retained material. The mean hospital length of stay was 8.2 days (range 1-18 days). One patient expired. Discussion Pediatric facial fractures as a result of gunshot wounds represent a unique and fortunately rare entity that presents a challenge to all disciplines involved in treatment. In our patients, there was a tendency towards conservative management, with only 3 patients undergoing some form of fixation and only 7 undergoing some form of operative debridement. Concomitant injuries and the high-energy nature of gunshot wounds often preclude traditional management with rigid fixation to ensure adequate bony healing. However, it is important to adequately debride devitalized soft tissue and remove all foreign material to avoid future soft tissue-related complications.	[Hoppe, Ian C.; Kordahi, Anthony M.; Paik, Angie M.; Lee, Edward S.; Granick, Mark S.] Rutgers State Univ, New Jersey Med Sch, Div Plast Surg, Dept Surg, Newark, NJ 07103 USA	Hoppe, IC (corresponding author), Rutgers State Univ, New Jersey Med Sch, Div Plast Surg, Dept Surg, 140 Bergen St,E1620, Newark, NJ 07103 USA.	ianhoppe@gmail.com	Kordahi, Anthony/AAB-7641-2020	Granick, Mark/0000-0001-6507-1633			BROADBENT TR, 1972, J TRAUM, V12, P229, DOI 10.1097/00005373-197203000-00006; Clark N, 1996, PLAST RECONSTR SURG, V98, P583, DOI 10.1097/00006534-199609001-00001; COHEN RA, 1986, AM J ROENTGENOL, V146, P97, DOI 10.2214/ajr.146.1.97; EPPLEY BL, 1993, CLEFT PALATE-CRAN J, V30, P164, DOI 10.1597/1545-1569(1993)030<0164:EEOBPI>2.3.CO;2; FINCH DR, 1979, J TRAUMA, V19, P965, DOI 10.1097/00005373-197912000-00006; Glapa M, 2007, WORLD J SURG, V31, P2104, DOI 10.1007/s00268-007-9220-2; GOODSTEIN WA, 1979, J TRAUMA, V19, P961, DOI 10.1097/00005373-197912000-00005; GRUSS JS, 1985, PLAST RECONSTR SURG, V75, P17; GRUSS JS, 1991, PLAST RECONSTR SURG, V87, P436, DOI 10.1097/00006534-199103000-00008; GUSSACK GS, 1987, LARYNGOSCOPE, V97, P925; Hollier L, 2001, J ORAL MAXIL SURG, V59, P277, DOI 10.1053/joms.2001.20989; KABAN LB, 1977, PLAST RECONSTR SURG, V59, P15, DOI 10.1097/00006534-197701000-00002; LIN KY, 1991, PLAST RECONSTR SURG, V87, P229, DOI 10.1097/00006534-199102000-00003; Marschall M A, 1991, J Craniofac Surg, V2, P63, DOI 10.1097/00001665-199102020-00005; MAY M, 1973, ARCH OTOLARYNGOL, V98, P373; Robertson BC, 1999, SURG CLIN N AM, V79, P1489, DOI 10.1016/S0039-6109(05)70089-X; THORNE CH, 1992, CLIN PLAST SURG, V19, P233; WONG L, 1991, PLAST RECONSTR SURG, V88, P395, DOI 10.1097/00006534-199109000-00003; Wong L, 1993, J Craniofac Surg, V4, P234; ZIDE MF, 1979, J ORAL SURG, V37, P319; Zun LS, 2005, PEDIATR EMERG CARE, V21, P568, DOI 10.1097/01.pec.0000177195.45537.95	21	11	11	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	MAR	2014	25	2					400	405		10.1097/SCS.0000000000000657			6	Surgery	Surgery	AG4IB	WOS:000335381800063	24561367				2021-06-18	
J	Ott, S; Schatz, P; Solomon, G; Ryan, JJ				Ott, Summer; Schatz, Philip; Solomon, Gary; Ryan, Joseph J.			Neurocognitive Performance and Symptom Profiles of Spanish-Speaking Hispanic Athletes on the ImPACT Test	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						ImPACT; Baseline testing; Neurocognitive performance; Concussion; Spanish-speaking; Language	NEUROPSYCHOLOGICAL TEST-PERFORMANCE; TEST-RETEST RELIABILITY; AFRICAN-AMERICAN ACCULTURATION; SPORT-RELATED CONCUSSION; INTERNATIONAL-CONFERENCE; COGNITIVE-ABILITIES; CONSENSUS STATEMENT; CONSTRUCT-VALIDITY; CLINICAL UTILITY; SEX-DIFFERENCES	This study documented baseline neurocognitive performance of 23,815 athletes on the Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) test. Specifically, 9,733 Hispanic, Spanish-speaking athletes who completed the ImPACT test in English and 2,087 Hispanic, Spanish-speaking athletes who completed the test in Spanish were compared with 11,955 English-speaking athletes who completed the test in English. Athletes were assigned to age groups (13-15, 16-18). Results revealed a significant effect of language group (p < .001; partial eta(2) = 0.06) and age (p < .001; partialh eta(2) = 0.01) on test performance. Youngerathletes performed more poorly than older athletes, and Spanish-speaking athletes completing the test in Spanish scored more poorly than Spanish-speaking and English-speaking athletes completing the test in English, on all Composite scores and Total Symptom scores. Spanish-speaking athletes completing the test in English also performed more poorly than English-speaking athletes completing the test in English on three Composite scores. These differences in performance and reported symptoms highlight the need for caution in interpreting ImPACT test data for Hispanic Americans.	[Ott, Summer] Univ Texas Houston, Sch Med, Houston, TX 77030 USA; [Schatz, Philip] St Josephs Univ, Philadelphia, PA 19131 USA; [Solomon, Gary] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Ryan, Joseph J.] Univ Cent Missouri, Warrensburg, MO USA	Ott, S (corresponding author), Univ Texas Houston, Sch Med, 6400 Fannin St,Suite 1620, Houston, TX 77030 USA.	summer.d.ott@uth.tmc.edu	Solomon, Gary/K-9011-2019				Alegret M, 2012, J CLIN EXP NEUROPSYC, V34, P209, DOI 10.1080/13803395.2011.630652; Allen BJ, 2011, BRAIN INJURY, V25, P179, DOI 10.3109/02699052.2010.541897; Arnold B. R., 1993, ASSESSMENT, V1, P239; Aubry M., 2002, BRIT J SPORT MED, V36, P3; Barr WB, 2003, ARCH CLIN NEUROPSYCH, V18, P91, DOI 10.1016/S0887-6177(01)00185-8; Barth JT., 1989, MILD HEAD INJURY, P257; Broglio SP, 2007, J ATHL TRAINING, V42, P504; Brown CN, 2007, J ATHL TRAINING, V42, P515; Bure-Reyes A, 2013, J CLIN EXP NEUROPSYC, V35, P404, DOI 10.1080/13803395.2013.778232; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Cosentino S, 2007, J INT NEUROPSYCH SOC, V13, P228, DOI 10.1017/S1355617707070257; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Covassin T., 2010, J NEUROL NEUROSUR PS, V8, P734; Echemendia RJ, 2003, APPL NEUROPSYCHOL, V10, P48, DOI 10.1207/S15324826AN1001_7; Echemendia RJ, 2012, CLIN NEUROPSYCHOL, V26, P1077, DOI 10.1080/13854046.2012.721006; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; Fazio VC, 2007, NEUROREHABILITATION, V22, P207; Gasquoine PG, 2007, ARCH CLIN NEUROPSYCH, V22, P991, DOI 10.1016/j.acn.2007.08.003; Gasquoine PG, 2012, ARCH CLIN NEUROPSYCH, V27, P268, DOI 10.1093/arclin/acs004; Grindel SH, 2001, CLIN J SPORT MED, V11, P134, DOI 10.1097/00042752-200107000-00003; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Harris J. G., 2003, CLIN INTERPRETATION; Heaton RK, 2004, REVISED COMPREHENSIV; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Johnson EW, 2011, CLIN SPORT MED, V30, P73, DOI 10.1016/j.csm.2010.08.007; Kaminski TW, 2007, J CLIN EXP NEUROPSYC, V29, P742, DOI 10.1080/13825580600976911; Keith TZ, 2008, INTELLIGENCE, V36, P502, DOI 10.1016/j.intell.2007.11.001; Kennepohl S, 2004, J INT NEUROPSYCH SOC, V10, P566, DOI 10.1017/S1355617704104128; Kontos AP, 2011, BRAIN INJURY, V25, P1234, DOI 10.3109/02699052.2011.608209; Kontos AP, 2010, ARCH CLIN NEUROPSYCH, V25, P734, DOI 10.1093/arclin/acq068; Lau BC, 2011, AM J SPORT MED, V39, P1209, DOI 10.1177/0363546510392016; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Lovell M.R., 2006, SPORTS NEUROPSYCHOLO, P193; Lovell M. R., 2012, CLIN INTERPRETATION; Lynn R., 2006, RACE DIFFERENCES INT; Maerlender A, 2013, CLIN NEUROPSYCHOL, V27, P290, DOI 10.1080/13854046.2012.744098; Maerlender A, 2010, CLIN NEUROPSYCHOL, V24, P1309, DOI 10.1080/13854046.2010.516072; Maitland SB, 2000, AGING NEUROPSYCHOL C, V7, P32, DOI 10.1076/anec.7.1.32.807; Manly JJ, 2007, ARCH CLIN NEUROPSYCH, V22, P319, DOI 10.1016/j.acn.2007.01.006; Manly JJ, 1998, J INT NEUROPSYCH SOC, V4, P291, DOI 10.1017/S1355617798002914; Manly JJ, 2004, APPL NEUROPSYCHOL, V11, P37, DOI 10.1207/s15324826an1101_5; Mayers LB, 2012, J CLIN EXP NEUROPSYC, V34, P235, DOI 10.1080/13803395.2011.630655; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, J CLIN NEUROSCI, V16, P755, DOI 10.1016/j.jocn.2009.02.002; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Moser RS, 2007, ARCH CLIN NEUROPSYCH, V22, P909, DOI 10.1016/j.acn.2007.09.004; NCAA, 2010, RAC GEND MEMB I PERS; Norman MA, 2011, J CLIN EXP NEUROPSYC, V33, P793, DOI 10.1080/13803395.2011.559157; Pena-Casanova J, 2009, ARCH CLIN NEUROPSYCH, V24, P307, DOI 10.1093/arclin/acp027; Prifitera A, 2008, WISC 4 CLIN ASSESSME; Putukian M, 2011, PM&R, V3, pS425, DOI 10.1016/j.pmrj.2011.08.003; Quintana M, 2011, ARCH CLIN NEUROPSYCH, V26, P144, DOI 10.1093/arclin/acq098; Randolph C, 2005, J ATHL TRAINING, V40, P139; Randolph C, 2011, PM&R, V3, pS433, DOI 10.1016/j.pmrj.2011.08.002; Randolph C, 2009, J INT NEUROPSYCH SOC, V15, P512, DOI 10.1017/S135561770909064X; Razani J, 2007, CLIN NEUROPSYCHOL, V21, P776, DOI 10.1080/13854040701437481; Resch J, 2013, J ATHL TRAINING, V48, P506, DOI 10.4085/1062-6050-48.3.09; Rieder C, 2011, ARCH CLIN NEUROPSYCH, V26, P583, DOI 10.1093/arclin/acr055; Roivainen E, 2010, INTELLIGENCE, V38, P187, DOI 10.1016/j.intell.2009.10.001; Rosselli N, 2003, BRAIN COGNITION, V52, P326, DOI 10.1016/S0278-2626(03)00170-2; Rutherford A, 2009, J CLIN EXP NEUROPSYC, V31, P664, DOI 10.1080/13803390802484755; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2003, APPL NEUROPSYCHOL, V10, P42, DOI 10.1207/S15324826AN1001_6; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P499, DOI 10.1093/arclin/act034; Schatz P, 2013, AM J SPORT MED, V41, P321, DOI 10.1177/0363546512466038; Schatz P, 2012, J CLIN EXP NEUROPSYC, V34, P428, DOI 10.1080/13803395.2012.667789; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Shuttleworth-Edwards AB, 2004, J CLIN EXP NEUROPSYC, V26, P903, DOI 10.1080/13803390490510824; Shuttleworth-Edwards Ann B, 2009, Phys Sportsmed, V37, P45, DOI 10.3810/psm.2009.12.1741; Stephens R, 2005, CHILD NEUROPSYCHOL, V11, P513, DOI 10.1080/092970490959629; US Census, 2010, CENS SUMM; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677; Wechsler D., 2013, WAIS 4; Weiss L. G., 2010, WAIS 4 CLIN INTERPRE; Witol AD, 2003, ARCH CLIN NEUROPSYCH, V18, P397, DOI 10.1016/S0887-6177(02)00151-8; Zuckerman S., 2012, PEDIATRICS, V10, P1	78	11	11	0	16	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAR	2014	29	2					152	163		10.1093/arclin/act091			12	Psychology, Clinical; Psychology	Psychology	AB8FY	WOS:000332026800004	24389704	Bronze			2021-06-18	
J	Sandhi, J; Singh, JP; Kaur, T; Ghuman, SS; Singh, AP				Sandhi, Jasmine; Singh, Jaswinder Pal; Kaur, Tajpreet; Ghuman, Sarvpreet Singh; Singh, Amrit Pal			Involvement of progesterone receptors in ascorbic acid-mediated protection against ischemia-reperfusion-induced acute kidney injury	JOURNAL OF SURGICAL RESEARCH			English	Article						Ascorbic acid; Progesterone; Ischemia-reperfusion; Acute kidney injury; Oxidative stress	ACUTE-RENAL-FAILURE; TRAUMATIC BRAIN-INJURY; VITAMIN-C; MALE RATS; FUNCTIONAL DEFICITS; GONADAL-STEROIDS; PLASMA-LEVEL; MODULATION; ALLOPREGNANOLONE; EXPRESSION	Background: Ascorbic acid (AA) is an established antioxidant and has been used for treatment of various disorders. Recent reports suggest that administration of AA increases the level of steroids such as progesterone in the body. The present study investigated the protective role of progesterone against ischemia-reperfusion-induced acute kidney injury (AKI) and possible involvement of progesterone receptors in AA-mediated renoprotection in rats. Materials and methods: The male rats were subjected to bilateral renal ischemia for 40 min followed by reperfusion for 24 h to induce AKI. The rats were treated with progesterone (5 and 10 mg/kg, intraperitoneally) and AA (500 mg/kg, intraperitoneally for 1, 2, and 5 d) before AKI. In separate groups, mifepristone, the progesterone receptor antagonist was administered to rats before progesterone (10 mg/kg) and AA treatment (5 d). Various parameters including creatinine clearance, serum urea, uric acid, potassium level, fractional excretion of sodium, lactate dehydrogenase, and microproteinuria were used to assess kidney injury. Moreover, renal tissues were subjected to quantification of oxidative stress and evaluation of histopathologic changes. Results: The exogenous administration of progesterone afforded protection against AKI in a dose-dependent manner that was abolished by mifepristone. The administration of AA for 1, 2, and 5 d induced significant increase in serum progesterone levels and afforded protection against AKI. The antioxidant and renoprotective effect of AA was abolished by prior treatment with mifepristone. Conclusions: It is concluded that exogenous administration of progesterone exerts significant antioxidant and renoprotective effect. Moreover, the progesterone receptors find their explicit involvement in AA-mediated renoprotection against ischemia-reperfusion einduced AKI in rats. (C) 2014 Elsevier Inc. All rights reserved.	[Sandhi, Jasmine; Singh, Jaswinder Pal; Singh, Amrit Pal] Guru Nanak Dev Univ, Dept Pharmaceut Sci, Amritsar 143005, Punjab, India; [Kaur, Tajpreet] Khalsa Coll Pharm, Dept Pharmacol, Amritsar, Punjab, India; [Ghuman, Sarvpreet Singh] Guru Angad Dev Vet & Anim Sci Univ, Coll Vet Sci, Dept Vet Gynaecol & Obstet, Ludhiana, Punjab, India	Singh, AP (corresponding author), Guru Nanak Dev Univ, Dept Pharmaceut Sci, Amritsar 143005, Punjab, India.	apsingh82@gmail.com	Kaur, Tajpreet/AAA-2282-2021; Singh, Amrit Pal/ABI-8109-2020	Kaur, Tajpreet/0000-0002-3987-4069; Singh, Amrit Pal/0000-0002-7658-241X			AEBI H, 1974, EUR J BIOCHEM, V48, P137, DOI 10.1111/j.1432-1033.1974.tb03751.x; Alkayed NJ, 2000, STROKE, V31, P161, DOI 10.1161/01.STR.31.1.161; Andersen ML, 2005, HORM BEHAV, V47, P477, DOI 10.1016/j.yhbeh.2004.12.005; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; Brann DW, 2005, NEUROENDOCRINOLOGY, V81, P120, DOI 10.1159/000086405; Brown AA, 2001, AM J CLIN NUTR, V73, P673; Buttros JB, 2009, PHARMACOLOGY, V84, P29, DOI 10.1159/000222245; CHAO TC, 1994, AM J REPROD IMMUNOL, V32, P43, DOI 10.1111/j.1600-0897.1994.tb00877.x; Clayden EC, 1971, PRACTICAL SECTION CU; Conlon PJ, 1999, NEPHROL DIAL TRANSPL, V14, P1158, DOI 10.1093/ndt/14.5.1158; Deicher R, 2005, J AM SOC NEPHROL, V16, P1811, DOI 10.1681/ASN.2004100850; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Duffy SJ, 2001, AM J PHYSIOL-HEART C, V280, pH528; Gemzell-Danielsson K, 2004, HUM REPROD UPDATE, V10, P341, DOI 10.1093/humupd/dmh027; Gonzalez-Ramirez M, 2010, PHARMACOL BIOCHEM BE, V97, P267, DOI 10.1016/j.pbb.2010.08.009; Haliloglu S, 2008, REPROD DOMEST ANIM, V43, P573, DOI 10.1111/j.1439-0531.2007.00954.x; He J, 2004, EXP NEUROL, V189, P404, DOI 10.1016/j.expneurol.2004.06.008; He J, 2004, RESTOR NEUROL NEUROS, V22, P19; Higa OH, 2007, CLINICS, V62, P315, DOI 10.1590/S1807-59322007000300017; Honparkhe M, 2008, INDIAN VET J, V85, P906; Hosseinzadeh H, 2005, J PHARM PHARM SCI, V8, P387; Ishrat T, 2009, BRAIN RES, V1257, P94, DOI 10.1016/j.brainres.2008.12.048; Jaroenporn S, 2008, BIOL PHARM BULL, V31, P1205, DOI 10.1248/bpb.31.1205; Joosten SA, 2005, KIDNEY INT, V68, P1, DOI 10.1111/j.1523-1755.2005.00376.x; Kapper S, 2002, TRANSPLANTATION, V74, P253, DOI 10.1097/00007890-200207270-00017; Kelly RW, 1997, BIOCHEM BIOPH RES CO, V239, P557, DOI 10.1006/bbrc.1997.7502; Korkmaz A, 2009, RENAL FAILURE, V31, P36, DOI 10.1080/08860220802546271; KRAWISZ JE, 1984, GASTROENTEROLOGY, V87, P1344; Lemale J, 2008, BBA-MOL CELL RES, V1783, P2234, DOI 10.1016/j.bbamcr.2008.07.023; Lu Na, 2008, Nan Fang Yi Ke Da Xue Xue Bao, V28, P2026; Mandl J, 2009, BRIT J PHARMACOL, V157, P1097, DOI 10.1111/j.1476-5381.2009.00282.x; Mani SK, 2006, NEUROSCIENCE, V138, P773, DOI 10.1016/j.neuroscience.2005.07.034; Molitoris BA, 2004, KIDNEY INT, V66, P496, DOI 10.1111/j.1523-1755.2004.761_5.x; Nakamura M, 1997, TRANSPL INT, V10, P89, DOI 10.1111/j.1432-2277.1997.tb00547.x; NIEHAUS WG, 1968, EUR J BIOCHEM, V6, P126, DOI 10.1111/j.1432-1033.1968.tb00428.x; Nissenson AR, 1998, KIDNEY INT, V53, pS7; Parikh CR, 2004, AM J KIDNEY DIS, V43, P405, DOI 10.1053/j.ajkd.2003.10.040; Pierson RC, 2005, MOL BRAIN RES, V138, P105, DOI 10.1016/j.molbrainres.2004.10.047; Quinkler M, 2004, HORM METAB RES, V36, P381, DOI 10.1055/s-2004-814572; Rana T, 2010, HUM EXP TOXICOL, V29, P965, DOI 10.1177/0960327110364641; Rhyu DY, 2005, J AM SOC NEPHROL, V16, P667, DOI 10.1681/ASN.2004050425; Robert R, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-14; Roscetti G, 1998, J NEUROCHEM, V71, P1108; Sanchez-Criado JE, 1999, J ENDOCRINOL, V160, P197, DOI 10.1677/joe.0.1600197; Schumacher M, 2004, GROWTH HORM IGF RES, V14, pS18, DOI 10.1016/j.ghir.2004.03.007; Sebrel WH, 1967, VITAMINS CHEM PHYSL; Sekhon CS, 2003, J NEPHROL, V16, P63; Singh R, 2011, FREE RADICAL BIO MED, V50, P363, DOI 10.1016/j.freeradbiomed.2010.11.020; Stein DG, 2005, ANN NY ACAD SCI, V1052, P152, DOI 10.1196/annals.1347.011; SUBRAMANIAN M, 1993, NEUROSCI LETT, V155, P151, DOI 10.1016/0304-3940(93)90695-H; Takahashi N, 2011, NEPHROL DIAL TRANSPL, V26, P1252, DOI 10.1093/ndt/gfq547; Thadhani R, 1996, NEW ENGL J MED, V334, P1448, DOI 10.1056/NEJM199605303342207; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Weinberg JM, 2000, AM J PHYSIOL-RENAL, V279, pF927; Wilson JX, 2002, FEBS LETT, V527, P5, DOI 10.1016/S0014-5793(02)03167-8	56	11	11	0	5	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	MAR	2014	187	1					278	288		10.1016/j.jss.2013.10.025			11	Surgery	Surgery	AB2FB	WOS:000331607500040	24246438				2021-06-18	
J	Velmurugan, J; Sinha, S; Satishchandra, P				Velmurugan, Jayabal; Sinha, Sanjib; Satishchandra, Parthasarathy			Magnetoencephalography recording and analysis	ANNALS OF INDIAN ACADEMY OF NEUROLOGY			English	Article						Epilepsy analysis; head and source model; Magnetoencephalography (MEG); MEG acquisition	HUMAN BRAIN; MEG; LOCALIZATION; EEG; IDENTIFICATION; SCHIZOPHRENIA; EPILEPSY; NETWORK; MODELS; SPIKE	Magnetoencephalography (MEG) non-invasively measures the magnetic field generated due to the excitatory postsynaptic electrical activity of the apical dendritic pyramidal cells. Such a tiny magnetic field is measured with the help of the biomagnetometer sensors coupled with the Super Conducting Quantum Interference Device (SQUID) inside the magnetically shielded room (MSR). The subjects are usually screened for the presence of ferromagnetic materials, and then the head position indicator coils, electroencephalography (EEG) electrodes (if measured simultaneously), and fiducials are digitized using a 3D digitizer, which aids in movement correction and also in transferring the MEG data from the head coordinates to the device and voxel coordinates, thereby enabling more accurate co-registration and localization. MEG data pre-processing involves filtering the data for environmental and subject interferences, artefact identification, and rejection. Magnetic resonance Imaging (MRI) is processed for correction and identifying fiducials. After choosing and computing for the appropriate head models (spherical or realistic; boundary/finite element model), the interictal/ictal epileptiform discharges are selected and modeled by an appropriate source modeling technique (clinically and commonly used - single equivalent current dipole - ECD model). The equivalent current dipole (ECD) source localization of the modeled interictal epileptiform discharge (IED) is considered physiologically valid or acceptable based on waveform morphology, isofield pattern, and dipole parameters (localization, dipole moment, confidence volume, goodness of fit). Thus, MEG source localization can aid clinicians in sublobar localization, lateralization, and grid placement, by evoking the irritative/seizure onset zone. It also accurately localizes the eloquent cortex-like visual, language areas. MEG also aids in diagnosing and delineating multiple novel findings in other neuropsychiatric disorders, including Alzheimers disease, Parkinsonism, Traumatic brain injury, autistic disorders, and so oon.	[Velmurugan, Jayabal; Sinha, Sanjib; Satishchandra, Parthasarathy] Natl Inst Mental Hlth & Neurosci, Dept Neurol, Bangalore 560029, Karnataka, India	Sinha, S (corresponding author), Natl Inst Mental Hlth & Neurosci NIMHANS, Hosur Rd, Bangalore 560029, Karnataka, India.	sanjib_sinha2004@yahoo.co.in		Jayabal, Velmurugan/0000-0002-5479-7786			AHONEN AI, 1993, PHYS SCRIPTA, VT49A, P198, DOI 10.1088/0031-8949/1993/T49A/033; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Anninos R, 2007, ACTA NEUROL BELG, V107, P5; Bagic A, 2009, J CLIN NEUROPHYSIOL, V26, P290, DOI 10.1097/WNP.0b013e3181b49d50; Bagic AI, 2011, J CLIN NEUROPHYSIOL, V28, P362, DOI 10.1097/WNO.0b013e3181cde4ad; DALE AM, 1993, J COGNITIVE NEUROSCI, V5, P162, DOI 10.1162/jocn.1993.5.2.162; Ebersole JS, 2007, J CLIN NEUROPHYSIOL, V24, P120, DOI 10.1097/WNP.0b013e31803ece13; Fehr T, 2003, SCHIZOPHR RES, V63, P63, DOI 10.1016/S0920-9964(02)00213-X; Fernandes JM, 2005, J CLIN NEUROPHYSIOL, V22, P68, DOI 10.1097/01.WNP.0000150999.67749.6D; Fuchs M, 2007, J CLIN NEUROPHYSIOL, V24, P101, DOI 10.1097/WNP.0b013e318038fb3e; Guide MU, 2005, EL NEUR OY; Hansen P. C., 2010, MEG INTRO METHODS; Hoechstetter K, 2010, BESA RES TUTORIAL, P1; Leahy RM, 1998, ELECTROEN CLIN NEURO, V107, P159, DOI 10.1016/S0013-4694(98)00057-1; LEWINE JD, 1995, FUNCTIONAL BRAIN IMA, P369; Martino J, 2011, ANN NEUROL, V69, P521, DOI 10.1002/ana.22167; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; Mosher JC, 1999, J CLIN NEUROPHYSIOL, V16, P225, DOI 10.1097/00004691-199905000-00004; Ochi A, 2008, INT J PSYCHOPHYSIOL, V68, P104, DOI 10.1016/j.ijpsycho.2007.12.008; Pascual-Marqui RD, 1999, PSYCHIAT RES-NEUROIM, V90, P169, DOI 10.1016/S0925-4927(99)00013-X; Rockstroh BS, 2007, BMC PSYCHIATRY, V7, DOI 10.1186/1471-244X-7-44; SATO S, 1991, J CLIN NEUROPHYSIOL, V8, P144, DOI 10.1097/00004691-199104000-00003; SCHERG M, 1986, ELECTROEN CLIN NEURO, V65, P344, DOI 10.1016/0168-5597(86)90014-6; Schwartz D, 1996, BRAIN TOPOGR, V9, P101, DOI 10.1007/BF01200710; Timmermann L, 2003, BRAIN, V126, P199, DOI 10.1093/brain/awg022; Toga AW, 2006, NAT REV NEUROSCI, V7, P952, DOI 10.1038/nrn2012; Uusitalo MA, 1997, MED BIOL ENG COMPUT, V35, P135, DOI 10.1007/BF02534144; Zijlmans M, 2002, J CLIN NEUROPHYSIOL, V19, P183, DOI 10.1097/00004691-200206000-00001	28	11	11	0	12	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	0972-2327	1998-3549		ANN INDIAN ACAD NEUR	Ann. Indian Acad. Neurol.	MAR	2014	17			1			S113	S119		10.4103/0972-2327.128678			7	Clinical Neurology	Neurosciences & Neurology	AF6PE	WOS:000334836200019	24791077	DOAJ Gold, Green Published			2021-06-18	
J	Xu, W; Cao, MH; Zheng, HY; Tan, X; Li, L; Cui, G; Xu, J; Cao, JH; Ke, KF; Wu, QY				Xu, Wei; Cao, Maohong; Zheng, Heyi; Tan, Xiang; Li, Lei; Cui, Gang; Xu, Jian; Cao, Jianhua; Ke, Kaifu; Wu, Qiyun			Upregulation of SYF2 Is Associated With Neuronal Apoptosis Caused by Reactive Astrogliosis to Neuroinflammation	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						SYF2; cyclin D1; astrocyte proliferation; neuronal apoptosis; neuroinflammation; rat	CELL-CYCLE PROGRESSION; TRAUMATIC BRAIN-INJURY; DNA-DAMAGE RESPONSES; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; CEREBRAL-ISCHEMIA; GENE-EXPRESSION; PROTEIN; LIPOPOLYSACCHARIDE; INFLAMMATION	SYF2, known as CCNDBP1-interactor or p29, is likely involved in pre-mRNA splicing and cell cycle progression. The present study was designed to elucidate dynamic changes in SYF2 expression and distribution in the cerebral cortex in a lipopolysaccharide (LPS)-induced neuroinflammation rat model. It was found that SYF2 expression was induced strongly in active astrocytes after LPS injection. In vitro studies showed that the upregulation of SYF2 might be involved in the activation of C6 cells after LPS challenge and the neuronal apoptosis after conditioned media challenge. In addition, with silencing of SYF2 in C6 and PC12 cells by siRNA, the results indicated that SYF2 was required for astrocyte activation and neuronal apoptosis induced by LPS. Our findings on the cellular signaling pathway may provide a new therapeutic strategy against neuroinflammation in the CNS. (c) 2013 Wiley Periodicals, Inc.	[Xu, Wei; Cao, Maohong; Zheng, Heyi; Tan, Xiang; Li, Lei; Xu, Jian; Cao, Jianhua; Ke, Kaifu; Wu, Qiyun] Nantong Univ, Affiliated Hosp, Dept Neurol, Nantong 226001, JS, Peoples R China; [Cui, Gang] Soochow Univ, Dept Neurol, Affiliated Hosp, Suzhou, Peoples R China	Ke, KF (corresponding author), Nantong Univ, Affiliated Hosp, Dept Neurol, Nantong 226001, JS, Peoples R China.	kekaifu1234@hotmail.com; wuqiyun-nt@hotmail.com					Allaman I, 2011, TRENDS NEUROSCI, V34, P76, DOI 10.1016/j.tins.2010.12.001; BALDIN V, 1993, GENE DEV, V7, P812, DOI 10.1101/gad.7.5.812; Bamberger ME, 2002, NEUROSCIENTIST, V8, P276, DOI 10.1177/1073858402008003013; Becker EBE, 2004, PROG NEUROBIOL, V72, P1, DOI 10.1016/j.pneurobio.2003.12.005; Bonda DJ, 2009, AGING-US, V1, P382, DOI 10.18632/aging.100044; Bonow RH, 2009, PHARMACOGENOMICS J, V9, P116, DOI 10.1038/tpj.2008.15; Chang MS, 2002, BIOCHEM BIOPH RES CO, V299, P241, DOI 10.1016/S0006-291X(02)02605-0; Chang MS, 2000, BIOCHEM BIOPH RES CO, V279, P732, DOI 10.1006/bbrc.2000.3992; Chen C.C., 2012, PLOS ONE, V7; Chu PC, 2006, CANCER RES, V66, P8484, DOI 10.1158/0008-5472.CAN-05-3229; Chu PC, 2009, CARCINOGENESIS, V30, P1710, DOI 10.1093/carcin/bgp204; Dahan O, 2002, NUCLEIC ACIDS RES, V30, P4361, DOI 10.1093/nar/gkf563; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Felts PA, 2005, BRAIN, V128, P1649, DOI 10.1093/brain/awh516; Hirsch EC, 2003, ANN NY ACAD SCI, V991, P214; Hirsch EC, 2009, LANCET NEUROL, V8, P382, DOI 10.1016/S1474-4422(09)70062-6; Hoozemans JJM, 2006, INT J DEV NEUROSCI, V24, P157, DOI 10.1016/j.ijdevneu.2005.11.001; Kabadi SV, 2012, J NEUROTRAUM, V29, P813, DOI 10.1089/neu.2011.1980; Kato H, 2003, BRAIN RES BULL, V60, P215, DOI 10.1016/S0361-9230(03)00036-4; Koguchi K, 2002, GLIA, V37, P93, DOI 10.1002/glia.10017; Ledeboer A, 2002, AM J PHYSIOL-REG I, V282, pR1762, DOI 10.1152/ajpregu.00766.2001; Ma WB, 2007, J CELL BIOCHEM, V100, P1376, DOI 10.1002/jcb.21140; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Minghetti L, 2005, CURR OPIN NEUROL, V18, P315, DOI 10.1097/01.wco.0000169752.54191.97; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Renton KW, 1999, BRAIN RES, V842, P139, DOI 10.1016/S0006-8993(99)01773-4; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Vincent K, 2003, GENETICS, V164, P895; Witzel II, 2010, BIOCHEM SOC T, V38, P217, DOI 10.1042/BST0380217; Zawadzka M, 2003, MOL CELL NEUROSCI, V22, P202, DOI 10.1016/S1044-7431(03)00036-8; Zhang ZH, 2010, J HYPERTENS, V28, P806, DOI 10.1097/HJH.0b013e3283358b6e; Zhu Z, 2007, GLIA, V55, P546, DOI 10.1002/glia.20476	33	11	12	0	15	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	MAR	2014	92	3					318	328		10.1002/jnr.23312			11	Neurosciences	Neurosciences & Neurology	289JA	WOS:000329677000005	24301298				2021-06-18	
J	Wahlstrom, MR; Olivecrona, M; Ahlm, C; Bengtsson, A; Koskinen, LOD; Naredi, S; Hultin, M				Wahlstrom, Marie Rodling; Olivecrona, Magnus; Ahlm, Clas; Bengtsson, Anders; Koskinen, Lars-Owe D.; Naredi, Silvana; Hultin, Magnus			Effects of prostacyclin on the early inflammatory response in patients with traumatic brain injury -a randomised clinical study	SPRINGERPLUS			English	Article						Traumatic brain injury; Epoprostenol; Systemic inflammatory response; Cytokines; Asymmetric dimethylarginine	ASYMMETRIC DIMETHYLARGININE; MICRODIALYSIS; SUBSTANCE; SEVERITY; DISEASE; SEPSIS; PLASMA; PGI(2); ROLES; SCORE	Objective and design: A prospective, randomised, double-blinded, clinical trial was performed at a level 1 trauma centre to determine if a prostacyclin analogue, epoprostenol (Flolan(R)), could attenuate systemic inflammatory response in patients with severe traumatic brain injury (TBI). Subjects: 46 patients with severe TBI, randomised to epoprostenol (n = 23) or placebo (n = 23). Treatment: Epoprostenol, 0.5 ng.kg(-1).min(-1), or placebo (saline) was given intravenously for 72 hours and then tapered off over the next 24 hours. Methods: Interleukin-6 (IL-6), interleukin-8 (IL-8), soluble intracellular adhesion molecule-1 (sICAM-1), C-reactive protein (CRP), and asymmetric dimethylarginine (ADMA) levels were measured over five days. Measurements were made at 24 h intervals <= 24 h after TBI to 97-120 h after TBI. Results: A significantly lower CRP level was detected in the epoprostenol group compared to the placebo group within 73-96 h (p = 0.04) and within 97-120 h (p = 0.008) after trauma. IL-6 within 73-96 h after TBI was significantly lower in the epoprostenol group compared to the placebo group (p = 0.04). ADMA was significantly increased within 49-72 h and remained elevated, but there was no effect of epoprostenol on ADMA levels. No significant differences between the epoprostenol and placebo groups were detected for IL-8 or sICAM-1. Conclusions: Administration of the prostacyclin analogue epoprostenol significantly decreased CRP and, to some extent, IL-6 levels in patients with severe TBI compared to placebo. These findings indicate an interesting option for treatment of TBI and warrants future larger studies.	[Wahlstrom, Marie Rodling; Naredi, Silvana; Hultin, Magnus] Umea Univ, Dept Surg & Perioperat Sci Anaesthesiol & Intens, S-90187 Umea, Sweden; [Olivecrona, Magnus; Koskinen, Lars-Owe D.] Umea Univ, Dept Pharmacol & Clin Neurosci, Neurosurg, S-90187 Umea, Sweden; [Ahlm, Clas] Umea Univ, Dept Clin Microbiol Infect Dis, S-90187 Umea, Sweden; [Bengtsson, Anders] Univ Gothenburg, Inst Clin Sci, Dept Anesthesiol & Intens Care, Sahlgrenska Acad, S-40530 Gothenburg, Sweden	Hultin, M (corresponding author), Umea Univ, Dept Surg & Perioperat Sci Anaesthesiol & Intens, S-90187 Umea, Sweden.	magnus.hultin@umu.se	Hultin, Magnus/A-1321-2010; Koskinen, Lars-Owe/AAQ-8957-2020	Hultin, Magnus/0000-0003-2935-7161; Naredi, Silvana/0000-0002-4409-6089; Koskinen, Lars-Owe/0000-0003-3528-8502	Department of Clinical Neurosciences at Umea University Hospital Research Foundation; Tore Nilsson Foundation; Kempe Foundation; Capio Research Foundation; Swedish Society of Medicine; Faculty of Medicine at Umea University; Department of Research and Development, Vasternorrland County Council, Sweden	This study was financially supported by grants from the Department of Clinical Neurosciences at Umea University Hospital Research Foundation, the Tore Nilsson Foundation, the Kempe Foundation, the Capio Research Foundation, the Swedish Society of Medicine, the Faculty of Medicine at Umea University, and the Department of Research and Development, Vasternorrland County Council, Sweden.	Andersson J, 2010, MENOPAUSE, V17, P365, DOI 10.1097/gme.0b013e3181c12b26; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Boger RH, 2003, CLIN CHEM LAB MED, V41, P1467, DOI 10.1515/CCLM.2003.225; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Chin KM, 2009, CHEST, V135, P130, DOI 10.1378/chest.08-1323; Du Clos TW, 2000, ANN MED, V32, P274, DOI 10.3109/07853890009011772; Grande PO, 2006, INTENS CARE MED, V32, P1475, DOI 10.1007/s00134-006-0294-3; Grande PO, 2000, ACTA ANAESTH SCAND, V44, P886, DOI 10.1034/j.1399-6576.2000.440718.x; Holmin S, 1998, NEUROSURGERY, V42, P291, DOI 10.1097/00006123-199802000-00047; Jawa Randeep S, 2011, J Intensive Care Med, V26, P73, DOI 10.1177/0885066610395679; JONES G, 1984, J PATHOL, V142, P51, DOI 10.1002/path.1711420110; Jungner M, 2009, J TRAUMA, V67, P1345, DOI 10.1097/TA.0b013e3181a5f211; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Lawson C, 2009, PHARMACOL REP, V61, P22, DOI 10.1016/S1734-1140(09)70004-0; Lenz A, 2007, INJURY, V38, P1336, DOI 10.1016/j.injury.2007.10.003; Lu J, 2009, FRONT BIOSCI-LANDMRK, V14, P3795, DOI 10.2735/3489; MONCADA S, 1976, NATURE, V263, P663, DOI 10.1038/263663a0; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/s0140-6736(04)17188-2; Naredi S, 2001, ACTA ANAESTH SCAND, V45, P402, DOI 10.1034/j.1399-6576.2001.045004402.x; Neunaber C, 2011, RECENT PATENTS INFLA, V5, P17, DOI 10.2174/187221311794474892; Ohta S, 2005, LIVER INT, V25, P1061, DOI 10.1111/j.1478-3231.2005.01143.x; Olivecrona M, 2009, J NEUROTRAUM, V26, P1251, DOI [10.1089/neu.2008.0605, 10.1089/neu.2008-0605]; ORFEO T, 1994, J TRAUMA, V37, P347, DOI 10.1097/00005373-199409000-00003; Scheeren T, 1997, INTENS CARE MED, V23, P146, DOI 10.1007/s001340050309; Siekmeier R, 2008, J CARDIOVASC PHARM T, V13, P279, DOI 10.1177/1074248408326488; Stahel PF, 2007, INJURY, V38, P1409, DOI 10.1016/j.injury.2007.09.023; Stanisic M, 2012, INFLAMM RES, V61, P845, DOI 10.1007/s00011-012-0476-0; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; TEASDALE G, 1974, LANCET, V2, P81; Teerlink T, 2002, ANAL BIOCHEM, V303, P131, DOI 10.1006/abio.2001.5575; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751	31	11	12	0	2	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND	2193-1801			SPRINGERPLUS	SpringerPlus	FEB 18	2014	3								98	10.1186/2193-1801-3-98			8	Multidisciplinary Sciences	Science & Technology - Other Topics	CO1XW	WOS:000358950600004	24600548	Green Published, Other Gold			2021-06-18	
J	Aarnink, SH; Vos, SB; Leemans, A; Jernigan, TL; Madsen, KS; Baare, WFC				Aarnink, Saskia H.; Vos, Sjoerd B.; Leemans, Alexander; Jernigan, Terry L.; Madsen, Kathrine Skak; Baare, William F. C.			Automated longitudinal intra-subject analysis (ALISA) for diffusion MRI tractography	NEUROIMAGE			English	Article						Tractography; Diffusion; DTI; DTI Longitudinal data analyses	WHITE-MATTER TRACTS; TENSOR IMAGING TRACTOGRAPHY; TRAUMATIC BRAIN-INJURY; FRACTIONAL ANISOTROPY; AXONAL PROJECTIONS; MEAN DIFFUSIVITY; CORPUS-CALLOSUM; FIBER PATHWAYS; ATLAS; TRACKING	Fiber tractography (FT), which aims to reconstruct the three-dimensional trajectories of white matter (WM). fibers non-invasively, is one of the most popular approaches for analyzing diffusion tensor imaging (DTI) data given its high inter- and intra-rater reliability and scan-rescan reproducibility. The major disadvantage of manual FT segmentations, unfortunately, is that placing regions-of-interest for tract selection can be very labor-intensive and time-consuming. Although there are several methods that can identify specific WM fiber bundles in an automated way, manual FT segmentations across multiple subjects performed by a trained rater with neuroanatomical expertise are generally assumed to be more accurate. However, for longitudinal DTI analyses it may still be beneficial to automate the segmentation across multiple time points, but then for each individual subject separately. Both the inter-subject and intra-subject automation in this situation are intended for subjects without gross pathology. In this work, we propose such an automated longitudinal intra-subject analysis (dubbed ALISA) approach, and assessed whether ALISA could preserve the same level of reliability as obtained with manual FT segmentations. In addition, we compared ALISA with an automated inter-subject analysis. Based on DTI data sets from (i) ten healthy subjects that were scanned five times (six-month intervals, aged 7.6-8.6 years at the first scan) and (ii) one control subject that was scanned ten times (weekly intervals, 12.2 years at the first scan), we demonstrate that the increased efficiency provided by ALISA does not compromise the high degrees of precision and accuracy that can be achieved with manual FT segmentations. Further automation for inter-subject analyses, however, did not provide similarly accurate FT segmentations. (C) 2013 Elsevier Inc. All rights reserved.	[Aarnink, Saskia H.; Vos, Sjoerd B.; Leemans, Alexander] Univ Med Ctr Utrecht, Image Sci Inst, Heidelberglaan 100,Room QS4-300, NL-3584 CX Utrecht, Netherlands; [Aarnink, Saskia H.] Elkerliek Hosp, Helmond, Netherlands; [Jernigan, Terry L.; Madsen, Kathrine Skak; Baare, William F. C.] Copenhagen Univ Hosp, Danish Res Ctr Magnet Resonance, Ctr Funct & Diagnost Imaging & Res, Hvidovre, Denmark; [Jernigan, Terry L.; Madsen, Kathrine Skak] Ctr Integrated Mol Brain Imaging, Copenhagen, Denmark; [Jernigan, Terry L.] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark; [Jernigan, Terry L.] Univ Calif San Diego, Ctr Human Dev, La Jolla, CA 92093 USA	Vos, SB (corresponding author), Univ Med Ctr Utrecht, Image Sci Inst, Heidelberglaan 100,Room QS4-300, NL-3584 CX Utrecht, Netherlands.	Sjoerd@isi.uu.nl	Leemans, Alexander/A-1784-2011	Leemans, Alexander/0000-0002-9306-6126; Madsen, Kathrine Skak/0000-0001-8884-5902	Danish Medical Research CouncilDanish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC); Lundbeck FoundationLundbeckfonden	The HUBU project is supported by the Danish Medical Research Council, and the Lundbeck Foundation.	[Anonymous], 2011, FRONT NEUROINFORM, P5; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Caeyenberghs K, 2010, NEUROPSYCHOLOGIA, V48, P1472, DOI 10.1016/j.neuropsychologia.2010.01.017; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Cercignani M, 2001, AM J NEURORADIOL, V22, P952; Cercignani M, 2010, DIFFUSION MRI THEORY, P485; Chang LC, 2005, MAGN RESON MED, V53, P1088, DOI 10.1002/mrm.20426; Ciccarelli O, 2006, BRAIN, V129, P1859, DOI 10.1093/brain/awl100; Ciccarelli O, 2003, NEUROIMAGE, V18, P348, DOI 10.1016/S1053-8119(02)00042-3; Clark KA, 2011, J PSYCHIATR RES, V45, P980, DOI 10.1016/j.jpsychires.2011.01.006; Clayden JD, 2007, IEEE T MED IMAGING, V26, P1555, DOI 10.1109/TMI.2007.905826; Colby JB, 2012, NEUROIMAGE, V59, P3227, DOI 10.1016/j.neuroimage.2011.11.004; Concha L, 2005, AM J NEURORADIOL, V26, P2267; Concha L, 2005, ANN NEUROL, V57, P188, DOI 10.1002/ana.20334; Concha L, 2009, J NEUROL NEUROSUR PS, V80, P312, DOI 10.1136/jnnp.2007.139287; Concha L, 2007, EPILEPSIA, V48, P931, DOI 10.1111/j.1528-1167.2007.01006.x; Conturo TE, 1999, P NATL ACAD SCI USA, V96, P10422, DOI 10.1073/pnas.96.18.10422; Cook PA, 2006, P INT SOC MAGNETIC R, V14, P2759; Danielian LE, 2010, NEUROIMAGE, V49, P1572, DOI 10.1016/j.neuroimage.2009.08.062; DEKABAN AS, 1978, ANN NEUROL, V4, P345, DOI 10.1002/ana.410040410; Deprez S, 2012, J CLIN ONCOL, V30, P274, DOI 10.1200/JCO.2011.36.8571; Deprez S, 2011, HUM BRAIN MAPP, V32, P480, DOI 10.1002/hbm.21033; Descoteaux M, 2009, IEEE T MED IMAGING, V28, P269, DOI 10.1109/TMI.2008.2004424; Eluvathingal TJ, 2007, CEREB CORTEX, V17, P2760, DOI 10.1093/cercor/bhm003; Emsell L, 2009, P 17 ANN M INT SOC M, P1224; Faria AV, 2011, NEUROIMAGE, V54, P1854, DOI 10.1016/j.neuroimage.2010.09.061; Giorgio A, 2010, NEUROIMAGE, V49, P94, DOI 10.1016/j.neuroimage.2009.08.003; Gong G, 2008, EPILEPSIA, V49, P1941, DOI 10.1111/j.1528-1167.2008.01666.x; Hagler DJ, 2009, HUM BRAIN MAPP, V30, P1535, DOI 10.1002/hbm.20619; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hasan KM, 2011, COMPUT BIOL MED, V41, P1062, DOI 10.1016/j.compbiomed.2010.10.008; Hasan KM, 2009, BRAIN RES, V1276, P67, DOI 10.1016/j.brainres.2009.04.025; Heiervang E, 2006, NEUROIMAGE, V33, P867, DOI 10.1016/j.neuroimage.2006.07.037; Hsu JL, 2008, NEUROIMAGE, V39, P566, DOI 10.1016/j.neuroimage.2007.09.017; Hsu JL, 2010, NEUROIMAGE, V49, P32, DOI 10.1016/j.neuroimage.2009.08.031; Jansons KM, 2003, INVERSE PROBL, V19, P1031, DOI 10.1088/0266-5611/19/5/303; Jernigan TL, 2011, PROG BRAIN RES, V189, P77, DOI 10.1016/B978-0-444-53884-0.00019-1; Jeurissen B, 2013, HUM BRAIN MAPP, V34, P2747, DOI 10.1002/hbm.22099; Jeurissen B, 2011, HUM BRAIN MAPP, V32, P461, DOI 10.1002/hbm.21032; Johansen-Berg H, 2010, CURR OPIN NEUROL, V23, P351, DOI 10.1097/WCO.0b013e32833b7631; Jones DK, 2008, CORTEX, V44, P936, DOI 10.1016/j.cortex.2008.05.002; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Jones DK, 2011, METHODS MOL BIOL, V711, P127, DOI 10.1007/978-1-61737-992-5_6; Jones DK, 1999, MAGN RESON MED, V42, P37, DOI 10.1002/(SICI)1522-2594(199907)42:1<37::AID-MRM7>3.0.CO;2-O; Jones DK, 2005, MAGNET RESON MED, V53, P1462, DOI 10.1002/mrm.20484; Jones DK, 2002, NEUROIMAGE, V17, P592, DOI 10.1006/nimg.2002.1148; Jones DK, 2006, HUM BRAIN MAPP, V27, P230, DOI 10.1002/hbm.20179; Jones DK, 2005, NEUROIMAGE, V26, P546, DOI 10.1016/j.neuroimage.2005.02.013; Jones DK, 1999, MAGNET RESON MED, V42, P515, DOI 10.1002/(SICI)1522-2594(199909)42:3<515::AID-MRM14>3.3.CO;2-H; Karaus AHS, 2009, OPEN MED IMAGING J, V3, P21; Keller TA, 2009, NEURON, V64, P624, DOI 10.1016/j.neuron.2009.10.018; Kitchen CMR, 2009, AM J OPHTHALMOL, V147, P571, DOI 10.1016/j.ajo.2008.06.031; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Koch M, 2001, NEUROIMAGE, V13, pS176; Kristo G, 2013, MAGN RESON MED, V70, P1544, DOI 10.1002/mrm.24602; Kristo G, 2013, EUR RADIOL, V23, P28, DOI 10.1007/s00330-012-2589-9; Kumar R, 2009, J NEUROTRAUM, V26, P481, DOI 10.1089/neu.2008.0461; Lebel C, 2008, NEUROIMAGE, V40, P1044, DOI 10.1016/j.neuroimage.2007.12.053; Lebel C, 2011, J NEUROSCI, V31, P10937, DOI 10.1523/JNEUROSCI.5302-10.2011; Lebel C, 2010, NEUROIMAGE, V52, P20, DOI 10.1016/j.neuroimage.2010.03.072; Leemans A, 2006, MAGN RESON MED, V55, P1414, DOI 10.1002/mrm.20898; Leemans A., 2009, P INT SOC MAG RESON, V17, P3537, DOI DOI 10.1093/occmed/kqr069; Leemans A, 2009, MAGN RESON MED, V61, P1336, DOI 10.1002/mrm.21890; Ljungqvist J, 2011, BRAIN INJURY, V25, P370, DOI 10.3109/02699052.2011.558038; Madsen KS, 2011, NEUROIMAGE, V58, P1090, DOI 10.1016/j.neuroimage.2011.07.032; Madsen KS, 2010, NEUROPSYCHOLOGIA, V48, P854, DOI 10.1016/j.neuropsychologia.2009.11.001; Malykhin N, 2008, PSYCHIAT RES-NEUROIM, V164, P132, DOI 10.1016/j.pscychresns.2007.11.007; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Nimsky C, 2005, RADIOLOGY, V234, P218, DOI 10.1148/radiol.2341031984; Nimsky C, 2006, NEUROIMAGE, V30, P1219, DOI 10.1016/j.neuroimage.2005.11.001; O'Donnell LJ, 2009, NEUROIMAGE, V45, P832, DOI 10.1016/j.neuroimage.2008.12.023; Parker GJM, 2002, NEUROIMAGE, V15, P797, DOI 10.1006/nimg.2001.0994; Parker GJM, 2003, J MAGN RESON IMAGING, V18, P242, DOI 10.1002/jmri.10350; Pfefferbaum A, 2003, J MAGN RESON IMAGING, V18, P427, DOI 10.1002/jmri.10377; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Poupon C, 2000, NEUROIMAGE, V12, P184, DOI 10.1006/nimg.2000.0607; Price G, 2008, NEUROIMAGE, V39, P949, DOI 10.1016/j.neuroimage.2007.09.012; Reese TG, 2003, MAGN RESON MED, V49, P177, DOI 10.1002/mrm.10308; Reich DS, 2010, NEUROIMAGE, V49, P3047, DOI 10.1016/j.neuroimage.2009.11.043; Reijmer YD, 2013, NEUROLOGY, V80, P1370, DOI 10.1212/WNL.0b013e31828c2ee5; Rohde GK, 2004, MAGN RESON MED, V51, P103, DOI 10.1002/mrm.10677; Sage CA, 2009, HUM BRAIN MAPP, V30, P3657, DOI 10.1002/hbm.20794; Schlaug G, 2009, ANN NY ACAD SCI, V1169, P385, DOI 10.1111/j.1749-6632.2009.04587.x; Scholz J, 2009, NAT NEUROSCI, V12, P1370, DOI 10.1038/nn.2412; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Snook L, 2005, NEUROIMAGE, V26, P1164, DOI 10.1016/j.neuroimage.2005.03.016; Suarez RO, 2012, NEUROIMAGE, V59, P3690, DOI 10.1016/j.neuroimage.2011.11.043; Sullivan EV, 2007, BRIT J RADIOL, V80, pS99, DOI 10.1259/bjr/22893432; Sullivan EV, 2010, DEV NEUROPSYCHOL, V35, P233, DOI 10.1080/87565641003689556; Tournier JD, 2011, MAGN RESON MED, V65, P1532, DOI 10.1002/mrm.22924; van der Aa NE, 2011, STROKE, V42, P3410, DOI 10.1161/STROKEAHA.111.624858; Van Hecke W, 2008, NEUROIMAGE, V43, P69, DOI 10.1016/j.neuroimage.2008.07.006; Van Hecke W, 2007, IEEE T MED IMAGING, V26, P1598, DOI 10.1109/TMI.2007.906786; Van Hecke W, 2011, NEUROIMAGE, V55, P566, DOI 10.1016/j.neuroimage.2010.12.005; Van Hecke W, 2010, J MAGN RESON IMAGING, V31, P1492, DOI 10.1002/jmri.22198; Van Hecke W, 2010, HUM BRAIN MAPP, V31, P98, DOI 10.1002/hbm.20848; Van Hecke W, 2008, J MAGN RESON IMAGING, V27, P978, DOI 10.1002/jmri.21338; Van Hecke W, 2009, NEUROIMAGE, V46, P692, DOI 10.1016/j.neuroimage.2009.02.032; Verhoeven JS, 2010, HUM BRAIN MAPP, V31, P470, DOI 10.1002/hbm.20880; Vos SB, 2011, NEUROIMAGE, V55, P1566, DOI 10.1016/j.neuroimage.2011.01.048; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Wedeen VJ, 2008, NEUROIMAGE, V41, P1267, DOI 10.1016/j.neuroimage.2008.03.036; Yogarajah M, 2008, NEUROIMAGE, V40, P1755, DOI 10.1016/j.neuroimage.2007.12.046; Yogarajah M, 2010, BRAIN, V133, P2348, DOI 10.1093/brain/awq175; Zhang JY, 2007, NEUROIMAGE, V38, P239, DOI 10.1016/j.neuroimage.2007.07.033; Zhang YJ, 2010, NEUROIMAGE, V52, P1289, DOI 10.1016/j.neuroimage.2010.05.049	110	11	11	0	9	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	FEB 1	2014	86						404	416		10.1016/j.neuroimage.2013.10.026			13	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	298OZ	WOS:000330335300042	24157921	Green Published			2021-06-18	
J	Chabok, SY; Yazdanshenas, H; Naeeni, AF; Ziabakhsh, A; Bidar, SS; Reihanian, A; Bazargan-Hejazi, S				Chabok, S. Y.; Yazdanshenas, H.; Naeeni, A. F.; Ziabakhsh, A.; Bidar, S. S.; Reihanian, A.; Bazargan-Hejazi, S.			The impact of body mass index on treatment outcomes among traumatic brain injury patients in intensive care units	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article						Obesity; Body mass index; ICU; Traumatic brain injury; Mortality; Hospital length of stay; ICU length of stay	GLASGOW COMA SCALE; BLUNT TRAUMA; RESPIRATORY-FUNCTION; MORBIDLY OBESE; MORTALITY; RISK; ICU; LUNG	Obesity is a risk factor in treatment outcomes of critically ill patients. This study was conducted to determine the impact of obesity on the likelihood of recovery from traumatic brain injury (TBI) in intensive care unit (ICU) patients. We carried out a prospective study on 115 head injury patients who were admitted to the ICU of Poursina Hospital, Rasht, in the one-year period between July 2006 and June 2007. Obese patients (body mass index [BMI] a parts per thousand yen 30 kg/m(2)) were compared with non-obese patients (BMI < 30 kg/m(2)). Demographic information, acute physiology and chronic health evaluation scores, Injury Severity Scores (ISS), Glasgow Coma Scale scores, and ICU mortality incidences were recorded. Obese patients had significantly higher ICU mortality rates compared to non-obese patients (p = 0.02). Furthermore, we observed a trend towards a higher ICU mortality rate in obese patients with ISS > 25 (p = 0.04). Moreover, obesity was associated with prolonged mechanical ventilation, ICU length of stay (ILOS), and hospital length of stay (HLOS) (p < 0.001). Obesity was associated with increased ICU mortality and prolonged dependency on mechanical ventilation, ILOS, and HLOS in patients with TBI. However, further prospective studies with larger sample sizes are needed to substantiate these findings.	[Chabok, S. Y.; Naeeni, A. F.] Guilan Univ Med Sci, Rasht, Iran; [Yazdanshenas, H.] Charles R Drew Univ Med & Sci, Coll Med, Los Angeles, CA 90059 USA; [Ziabakhsh, A.; Reihanian, A.] Guilan Univ Med Sci, Rd Trauma Res Ctr, Rasht, Iran; [Bidar, S. S.] Univ Tehran Med Sci, Tehran, Iran; [Bazargan-Hejazi, S.] Charles R Drew Univ, Coll Med, Los Angeles, CA 90059 USA; [Bazargan-Hejazi, S.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	Bazargan-Hejazi, S (corresponding author), Charles R Drew Univ, Coll Med, 1731 East 120th St, Los Angeles, CA 90059 USA.	sh.yousefzadeh@gmail.com; Hamedyazdanshenas@cdrewu.edu; fadaenaeeni@yahoo.com; aziabakhsh@yahoo.com; s.shabbidar@yahoo.com; atossa73@yahoo.com; shahrzadbazargan@cdrewu.edu	Shab-Bidar, Sakineh/H-9525-2017	Shab-Bidar, Sakineh/0000-0002-0167-7174; Yousefzadeh-Chabok, Shahrokh/0000-0002-8825-3015	Guilan Road Trauma Research Center (GTRC); Clinical Research Development Unit of Poursina Hospital; National Institutes of Health, National Institute on Minority Health and Health Disparities (NIH-NIMHD) [U54RR026138]	Research supported in part by: Guilan Road Trauma Research Center (GTRC); Clinical Research Development Unit of Poursina Hospital, and the National Institutes of Health, National Institute on Minority Health and Health Disparities (NIH-NIMHD Grant U54MD007598-formerly U54RR026138).	Akinnusi ME, 2008, CRIT CARE MED, V36, P151, DOI 10.1097/01.CCM.0000297885.60037.6E; Alban RF, 2006, AM SURGEON, V72, P966; ALPERT MA, 1993, AM J MED SCI, V306, P117, DOI 10.1097/00000441-199308000-00011; Anzueto A, 2011, THORAX, V66, P66, DOI 10.1136/thx.2010.145086; Bercault N, 2004, CRIT CARE MED, V32, P998, DOI 10.1097/01.CCM.0000119422.93413.08; Bochicchio GV, 2006, J AM COLL SURGEONS, V203, P533, DOI 10.1016/j.jamcollsurg.2006.07.001; Brown CVR, 2006, J TRAUMA, V61, P572, DOI 10.1097/01.ta.0000200842.19740.38; Byrnes MC, 2005, J TRAUMA, V58, P232, DOI 10.1097/01.TA.0000152081.67588.10; CHOBAN PS, 1991, J TRAUMA, V31, P1253, DOI 10.1097/00005373-199109000-00009; Ciesla DJ, 2006, J AM COLL SURGEONS, V203, P539, DOI 10.1016/j.jamcollsurg.2006.06.029; Duane TM, 2006, J TRAUMA, V61, P1218, DOI 10.1097/01.ta.0000241022.43088.e1; El-Solh A, 2001, CHEST, V120, P1989, DOI 10.1378/chest.120.6.1989; Evans DC, 2011, AM SURGEON, V77, P1003; Farshchian N, 2012, J INJ VIOLENCE RES, V4, P44; Frat JP, 2008, INTENS CARE MED, V34, P1991, DOI 10.1007/s00134-008-1245-y; Frezza E E, 2005, Minerva Chir, V60, P391; Garrouste-Orgeas M, 2004, INTENS CARE MED, V30, P437, DOI 10.1007/s00134-003-2095-2; Goulenok C, 2004, CHEST, V125, P1441, DOI 10.1378/chest.125.4.1441; Kopelman PG, 2000, NATURE, V404, P635; Landi F, 2000, ARCH INTERN MED, V160, P2641, DOI 10.1001/archinte.160.17.2641; Liu T, 2012, INJURY; Livingston DH, 2013, AM SURGEON, V79, P247; Lown DJ, 2013, CRIT CARE RESUSC, V15, P49; Margot S, 2011, NCHS DATA BRIEF 2011; Marik PE, 2006, CRIT CARE MED, V34, P1251, DOI 10.1097/01.CCM.0000209142.99742.0B; Neville AL, 2004, ARCH SURG-CHICAGO, V139, P983, DOI 10.1001/archsurg.139.9.983; Newell MA, 2007, J AM COLL SURGEONS, V204, P1056, DOI 10.1016/j.jamcollsurg.2006.12.042; O'Brien JM, 2006, CRIT CARE MED, V34, P738, DOI 10.1097/01.CCM.0000202207.87891.FC; Pelosi P, 1996, CHEST, V109, P144, DOI 10.1378/chest.109.1.144; RAY CS, 1983, AM REV RESPIR DIS, V128, P501, DOI 10.1164/arrd.1983.128.3.501; Sampalis JS, 2009, ANN SURG, V249, P488, DOI 10.1097/SLA.0b013e31819a8b4f; Shakeri M, 2012, J INJ VIOLENCE RES, V4, P11; SHARP JT, 1964, J CLIN INVEST, V43, P728, DOI 10.1172/JCI104957; Sifri ZC, 2008, J TRAUMA, V65, P396, DOI 10.1097/TA.0b013e31817f97fd; Stocchetti N, 2012, J NEUROTRAUM, V29, P1119, DOI 10.1089/neu.2011.1995; Teoh LSG, 2000, INTENS CARE MED, V26, P157, DOI 10.1007/s001340050039; THOMAS PS, 1989, THORAX, V44, P382, DOI 10.1136/thx.44.5.382; Tremblay A, 2003, CHEST, V123, P1202, DOI 10.1378/chest.123.4.1202; Udekwu P, 2004, J TRAUMA, V56, P1084, DOI 10.1097/01.TA.0000124283.02605.A5; Varon J, 2001, CRIT CARE CLIN, V17, P187, DOI 10.1016/S0749-0704(05)70159-7; World Health Organisation, 2012, OB OV; Zali Ali Reza, 2012, Glob J Health Sci, V4, P179, DOI 10.5539/gjhs.v4n3p179; Zimmerman DW, 2004, BRIT J MATH STAT PSY, V57, P173, DOI 10.1348/000711004849222	43	11	11	0	6	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.	FEB	2014	40	1					51	55		10.1007/s00068-013-0314-2			5	Emergency Medicine	Emergency Medicine	AA2VV	WOS:000330953200007	26815777				2021-06-18	
J	Khan, SA; Shallwani, H; Shamim, MS; Murtaza, G; Enam, SA; Qureshi, RO; Tahir, MZ				Khan, Saad Akhtar; Shallwani, Hussain; Shamim, Muhammad Shahzad; Murtaza, Ghulam; Enam, Syed Ather; Qureshi, Reema Obaid; Tahir, Muhammad Zubair			Predictors of poor outcome of decompressive craniectomy in pediatric patients with severe traumatic brain injury: a retrospective single center study from Pakistan	CHILDS NERVOUS SYSTEM			English	Article						Traumatic brain injury; Decompressive craniectomy; Pediatric population	INTRACRANIAL HYPERTENSION; HEAD-INJURY; CHILDREN; MULTICENTER; IMPACT; TRIAL	This study aimed to determine the risk factors associated with poor outcome of decompressive craniectomy (DC) for severe traumatic brain injury (TBI) in pediatric patients. This retrospective study is conducted on pediatric population (age 1-15 years) presenting with TBI who underwent DC at our institute between January 2000 and 2010. Based on Glasgow outcome score (GOS) at a minimum follow-up of 5 months, patients were divided into two groups, namely poor outcome (GOS 1, 2, and 3) and good outcome (GOS 4 and 5). Records were reviewed and analyzed for preoperative and intraoperative predictors. We found 25 patients who were eligible as per selection criteria. Mean age at presentation was 6 +/- 4 years and there was male preponderance (84 %). Fall (60 %) was the most common mechanism of injury followed by gunshots and road traffic accident. On univariate analysis, presenting GCS a parts per thousand currency sign5 (p value = 0.009), delay in presentation of more than 150 min (p value = 0.010), DC performed after more than 4 h of arrival in hospital (p value = 0.042), and intraoperative blood loss exceeding 300 ml (p value = 0.001) were significant predictors of poor outcome. Our study suggests that DC in children is not only a life-saving procedure, but also leads to a good functional outcome after severe injury. However, patient selection still remains an important aspect, and the above-mentioned factors should be considered while deciding for DC to improve survival. Further prospective studies on larger sample size are warranted to validate our results.	[Khan, Saad Akhtar; Shallwani, Hussain; Shamim, Muhammad Shahzad; Murtaza, Ghulam; Enam, Syed Ather; Qureshi, Reema Obaid; Tahir, Muhammad Zubair] Aga Khan Univ Hosp, Dept Surg, Neurosurg Sect, Karachi, Pakistan	Shamim, MS (corresponding author), Aga Khan Univ Hosp, Dept Surg, Neurosurg Sect, Karachi, Pakistan.	shahzad.shamim@aku.edu					ALDRICH EF, 1992, J NEUROSURG, V76, P450, DOI 10.3171/jns.1992.76.3.0450; ANDREWS BT, 1991, NEUROSURGERY, V29, P227, DOI 10.1227/00006123-199108000-00010; Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Bruce D A, 1990, Curr Probl Pediatr, V20, P61; BRUCE DA, 1978, J NEUROSURG, V48, P679, DOI 10.3171/jns.1978.48.5.0679; Guresir E, 2012, NEUROSURGERY, V70, P881, DOI 10.1227/NEU.0b013e318237a6a6; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Hieu PD, 1996, CHILD NERV SYST, V12, P270; Howard JL, 2008, J TRAUMA, V65, P380, DOI 10.1097/TA.0b013e31817c50d4; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Irfan FB, 2010, CHILD NERV SYST, V26, P61, DOI 10.1007/s00381-009-0971-y; Jagannathan J, 2007, J NEUROSURG, V106, P268, DOI 10.3171/ped.2007.106.4.268; Johnson DL, 1998, PEDIATR NEUROSURG, V28, P167, DOI 10.1159/000028643; Josan VA, 2006, CHILD NERV SYST, V22, P1268, DOI 10.1007/s00381-006-0064-0; Kim KT, 2009, ACTA NEUROCHIR, V151, P21, DOI 10.1007/s00701-008-0164-6; Marion DW, 2006, NEUROSURGERY, V58, P655; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Prasad MR, 2002, PEDIATR NEUROSURG, V36, P64, DOI 10.1159/000048355; Shamim MS, 2011, INT J INJ CONTROL SA, V18, P213, DOI 10.1080/17457300.2011.555559; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Vahedi K, 2007, STROKE, V38, P2506, DOI 10.1161/STROKEAHA.107.485235; Veen E, 2006, CRITICAL CARE, V10, P1; von Elm E, 2009, BRIT J ANAESTH, V103, P371, DOI 10.1093/bja/aep202; Williams RF, 2009, J TRAUMA, V66, P1570, DOI 10.1097/TA.0b013e3181a594c4; ZIMMERMAN RA, 1981, J NEURORADIOLOGY, V8, P257	25	11	12	0	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	FEB	2014	30	2					277	281		10.1007/s00381-013-2225-2			5	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	AA4NQ	WOS:000331073200010	23873518				2021-06-18	
J	Wei, XE; Li, YH; Zhao, H; Li, MH; Fu, M; Li, WB				Wei, Xiao-Er; Li, Yue-Hua; Zhao, Hui; Li, Ming-Hua; Fu, Min; Li, Wen-Bin			Quantitative evaluation of hyperbaric oxygen efficacy in experimental traumatic brain injury: an MRI study	NEUROLOGICAL SCIENCES			English	Article						Hyperbaric oxygen; Dynamic contrast-enhanced MRI; Diffusion-weighted imaging; Traumatic brain injury; Neuroprotection	FOCAL CEREBRAL-ISCHEMIA; INTRACRANIAL-PRESSURE; RAT MODEL; THERAPY; BARRIER; MECHANISMS; CONTUSION; EDEMA; AREA	To use DCE-magnetic resonance imaging (MRI) and diffusion-weighted imaging to evaluate the hyperbaric oxygen efficacy (HBO) in experimental traumatic brain injury (TBI). Forty-two rabbits were randomly divided into four groups: TBI, TBI + HBO, sham group, sham + HBO. The TBI + HBO and sham + HBO received a total of 10 HBO treatments within 7 days following TBI, and MRI was performed within a month after TBI. Functional assessments were performed pre-TBI, and at 1 and 30 days. In focal lesion area, K-trans in TBI + HBO group was lower than TBI group at both acute and subacute phase (p < 0.05). ADC was higher in TBI + HBO group than TBI group at acute phase (p < 0.01), but lower at subacute phase (p < 0.05). In perifocal area, K-trans were lower in TBI + HBO group than TBI group at acute phase (p < 0.01) after TBI. ADC was lower in the TBI + HBO group than in the TBI group at both acute and subacute phase (p < 0.01).The VCS was higher in TBI + HBO group than TBI group at 30 days (p < 0.05). HBO could improve the impaired BBB and cytotoxic edema after TBI and promote the recovery of neurofunction.	[Wei, Xiao-Er; Li, Yue-Hua; Li, Ming-Hua; Li, Wen-Bin] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Radiol, Shanghai 200233, Peoples R China; [Zhao, Hui; Fu, Min] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Hyperbar Oxygen, Shanghai 200233, Peoples R China	Li, WB (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Radiol, 600 Yi Shan Rd, Shanghai 200233, Peoples R China.	liwenbin_2003@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81271540, 81000609]	This study is supported by the National Natural Science Foundation of China (Grant No. 81271540, No. 81000609).	Adamides AA, 2006, ANZ J SURG, V76, P163, DOI 10.1111/j.1445-2197.2006.03674.x; Baldwin SA, 1996, J NEUROSURG, V85, P476, DOI 10.3171/jns.1996.85.3.0476; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Bennett M.H., 2004, COCHRANE DB SYST REV, V4; Biegon A, 2004, P NATL ACAD SCI USA, V101, P5117, DOI 10.1073/pnas.0305741101; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Gill AL, 2004, QJM-INT J MED, V97, P385, DOI 10.1093/qjmed/hch074; Gunther A, 2005, EUR J NEUROSCI, V21, P3189, DOI 10.1111/j.1460-9568.2005.04151.x; Huang L, 2011, MED GAS RES, V1, DOI 10.1186/2045-9912-1-21; Immonen RJ, 2009, EXP NEUROL, V215, P29, DOI 10.1016/j.expneurol.2008.09.009; King DR, 2004, SURGERY, V136, P355, DOI 10.1016/j.surg.2004.05.011; Li YH, 2012, NEUROL SCI, V33, P731, DOI 10.1007/s10072-011-0768-0; Lin JW, 2008, ACTA NEUROCHIR SUPPL, V101, P145; Masel BE, 2011, ARCH PHYS MED REHAB, V92, P1519, DOI 10.1016/j.apmr.2011.06.011; Matchett GA, 2009, NEUROL RES, V31, P114, DOI 10.1179/174313209X389857; McDonagh M, 2004, ARCH PHYS MED REHAB, V85, P1198, DOI 10.1016/j.apmr.2003.12.026; Palzur E, 2008, BRAIN RES, V1221, P126, DOI 10.1016/j.brainres.2008.04.078; Rockswold SB, 2007, NEUROL RES, V29, P162, DOI 10.1179/016164107X181798; Rockswold SB, 2010, J NEUROSURG, V112, P1080, DOI 10.3171/2009.7.JNS09363; Rockswold SB, 2001, J NEUROSURG, V94, P403, DOI 10.3171/jns.2001.94.3.0403; Sahni T, 2012, BRIT J NEUROSURG, V26, P202, DOI 10.3109/02688697.2011.626879; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S; TOFTS PS, 1991, MAGNET RESON MED, V17, P357, DOI 10.1002/mrm.1910170208; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Veltkamp R, 2006, BRAIN RES, V1076, P231, DOI 10.1016/j.brainres.2006.01.013; Vlodavsky E, 2006, NEUROPATH APPL NEURO, V32, P40, DOI 10.1111/j.1365-2990.2005.00698.x; Vlodavsky E, 2005, ACTA NEUROPATHOL, V110, P120, DOI 10.1007/s00401-004-0946-8; Wang GH, 2010, J NEUROTRAUM, V27, P1733, DOI 10.1089/neu.2009.1175; Wei XE, 2012, J NEUROTRAUM, V29, P2413, DOI 10.1089/neu.2010.1510; Zhou ZW, 2007, J NEUROSURG, V106, P687, DOI 10.3171/jns.2007.106.4.687	31	11	14	1	8	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1590-1874	1590-3478		NEUROL SCI	Neurol. Sci.	FEB	2014	35	2					295	302		10.1007/s10072-013-1514-6			8	Clinical Neurology; Neurosciences	Neurosciences & Neurology	AA3GE	WOS:000330980100022	23955096				2021-06-18	
J	Zhang, H; Tang, B; Yin, CG; Chen, Y; Meng, QL; Jiang, L; Wang, WP; Niu, GZ				Zhang, Hao; Tang, Bo; Yin, Cong-Guo; Chen, Yan; Meng, Qing-Lian; Jiang, Lin; Wang, Wei-Ping; Niu, Guo-Zhong			Plasma adrenomedullin levels are associated with long-term outcomes of acute ischemic stroke	PEPTIDES			English	Article						Ischemic stroke; Outcome; Adrenomedullin	TRAUMATIC BRAIN-INJURY; CEREBROSPINAL-FLUID; SUBARACHNOID HEMORRHAGE; CAROTID ATHEROSCLEROSIS; NEUROLOGICAL DEFICITS; PEPTIDE; PHEOCHROMOCYTOMA; CHILDREN	Plasma adrenomedullin concentration has been found to be enhanced in ischemic stroke. Up to now, little is known about the association of plasma adrenomedullin concentration with clinical outcomes of ischemic stroke. This study recruited 138 patients with ischemic stroke and 138 healthy volunteers. Unfavorable outcome was defined as modified Rankin Scale score >2 at 3 months. Plasma adrenomedullin concentrations were determined by enzyme-linked immunosorbent assay. Plasma adrenomedullin concentrations were statistically significantly higher in patients than in healthy individuals (79.9 +/- 27.3 pg/mL vs. 36.8 +/- 10.4 pg/mL; 13< 0.001). 3-Month mortality was 20.3% (281138) and sixty-six patients (47.8%) had unfavorable outcome in 3 months. A logistic regression analysis identified plasma adrenomedullin concentration as an independent predictor of 3-month mortality (odds ratio, 1.211; 95% confidence interval, 1.101-1.582; P=0.004) and unfavorable outcome (odds ratio, 1.193; 95% confidence interval, 1.082-1.447; 13= 0.006). Receiver operating characteristic curve analysis showed that plasma adrenomedullin concentration predicted 3-month mortality (area under curve, 0.806; 95% confidence interval, 0.730-0.868) and unfavorable outcome (area under curve, 0.816; 95% confidence interval, 0.742-0.877) with the high predictive value. Its predictive performance was similar to that of National Institutes of Health Stroke Scale score (P=0.694 or 0.206). Its combined use with National Institutes of Health Stroke Scale score did not improve the predictive value (13= 0.236 or 0.590). Thus, adrenomedullin may aid to predict long-term clinical outcomes of patients with ischemic stroke. (C) 2013 Elsevier Inc. All rights reserved.	[Zhang, Hao; Tang, Bo; Yin, Cong-Guo; Chen, Yan; Meng, Qing-Lian; Jiang, Lin; Wang, Wei-Ping; Niu, Guo-Zhong] Nanjing Med Univ, Peoples Hosp Hangzhou 1, Dept Neurol, Hangzhou 310006, Zhejiang, Peoples R China	Niu, GZ (corresponding author), Nanjing Med Univ, Peoples Hosp Hangzhou 1, Dept Neurol, 261 Huansha Rd, Hangzhou 310006, Zhejiang, Peoples R China.	guozhongniu@126.com					BASKAYA MK, 1995, J CEREBR BLOOD F MET, V15, P827, DOI 10.1038/jcbfm.1995.103; Charung WW, 2011, MOL MED, V17, P1075; Demir H, 2013, PEPTIDES, V43, P27, DOI 10.1016/j.peptides.2013.02.018; Dogan A, 1997, J CEREBR BLOOD F MET, V17, P19, DOI 10.1097/00004647-199701000-00004; Hamada H, 2010, MOD RHEUMATOL, V20, P389, DOI 10.1007/s10165-010-0295-5; Hosomi N, 2004, J HYPERTENS, V22, P1945, DOI 10.1097/00004872-200410000-00017; ICHIKI Y, 1994, FEBS LETT, V338, P6, DOI 10.1016/0014-5793(94)80106-1; Kikumoto K, 1998, ANESTH ANALG, V87, P859, DOI 10.1097/00000539-199810000-00021; KITAMURA K, 1993, BIOCHEM BIOPH RES CO, V192, P553, DOI 10.1006/bbrc.1993.1451; KITAMURA K, 1993, BIOCHEM BIOPH RES CO, V194, P720, DOI 10.1006/bbrc.1993.1881; Kondoh T, 2011, BRAIN RES BULL, V84, P69, DOI 10.1016/j.brainresbull.2010.11.005; Kubo Y, 2008, CEREBROVASC DIS, V25, P164, DOI 10.1159/000113734; Kubo Y, 2013, NEUROL RES, V35, P713, DOI 10.1179/1743132813Y.0000000222; Lang MG, 1997, STROKE, V28, P181, DOI 10.1161/01.STR.28.1.181; Liu J, 2014, INT J NEUROSCI, V124, P271, DOI 10.3109/00207454.2013.837462; Nicholls MG, 2004, BRAZ J MED BIOL RES, V37, P1247, DOI 10.1590/S0100-879X2004000800016; Peckova M, 2012, J INT MED RES, V40, P1552, DOI 10.1177/147323001204000435; Robertson CL, 2000, ACT NEUR S, V76, P419; Robertson CL, 2001, J NEUROTRAUM, V18, P861, DOI 10.1089/089771501750451785; SATOH F, 1995, J CLIN ENDOCR METAB, V80, P1750, DOI 10.1210/jc.80.5.1750; Shinomiya K, 2001, PEPTIDES, V22, P1873, DOI 10.1016/S0196-9781(01)00507-1; WANG XK, 1995, P NATL ACAD SCI USA, V92, P11480, DOI 10.1073/pnas.92.25.11480; Wong H. K., 2012, JRSM CARDIOVASC DIS, V1, P14	23	11	11	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0196-9781	1873-5169		PEPTIDES	Peptides	FEB	2014	52						44	48		10.1016/j.peptides.2013.11.025			5	Biochemistry & Molecular Biology; Endocrinology & Metabolism; Pharmacology & Pharmacy	Biochemistry & Molecular Biology; Endocrinology & Metabolism; Pharmacology & Pharmacy	AD5EU	WOS:000333275400007	24333654				2021-06-18	
J	Koutseff, A; Mittelhaeuser, C; Essabri, K; Auwerx, J; Meziane, H				Koutseff, Alexis; Mittelhaeuser, Christophe; Essabri, Karim; Auwerx, Johan; Meziane, Hamid			Impact of the apolipoprotein E polymorphism, age and sex on neurogenesis in mice: Pathophysiological relevance for Alzheimer's disease?	BRAIN RESEARCH			English	Article						Neurogenesis; Apolipoprotein E2; Apolipoprotein E3; Apolipoprotein E4; Knock-in mice; Age factor; Sex factor; Alzheimer's disease	TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; HIPPOCAMPAL NEUROGENESIS; ADULT NEUROGENESIS; DENTATE GYRUS; ENVIRONMENTAL ENRICHMENT; TRANSGENIC MICE; OLD-AGE; NEURONS; PROLIFERATION	Apolipoprotein E (ApoE) is found in three different forms in humans (ApoE2, ApoE3 and ApoE4), and ApoE polymorphism is recognized as a major risk factor for Alzheimer's disease (AD). ApoE is involved in lipid and cholesterol transport, cell repair, and amyloid-13 deposition and certain studies suggest potential implications in neurogenesis. In this regard, we investigated the possible impact of the three different human ApoE isoforms on neurogenesis. We used ApoE knock-in mice of different ages and sex, and quantified newborn cells in the hippocampus by flow cytometry. Young adult ApoE4 mice (10-12 week-old) from both sexes displayed reduced neurogenesis compared with wild-types and the other genotypes. In addition, young adult ApoE2 female mice showed improved hippocampal progenitor cell proliferation. In older mice (1 year), hippocampal neurogenesis was globally decreased, particularly in females, and the difference between ApoE4 and the other genotypes observed in young animals disappeared for the two sexes, except for aged ApoE3 females. Indeed, a surprising protective effect of the ApoE3 genotype was observed in aged females. Our study highlights the role of ApoE in neurogenesis, and shows for the first time an early inequality between the ApoE genotypes. The reduced neurogenesis observed for the ApoE4 genotype and the improved results obtained in young ApoE2 females support the idea of a difference in the balance between neuronal birth and death modulated by the ApoE polymorphism in young animals. The maintenance of this balance and its modulation can influence pathophysiological mechanisms predisposing to neurodegenerative diseases like AD. (C) 2013 Elsevier B.V. All rights reserved.	[Koutseff, Alexis; Mittelhaeuser, Christophe; Essabri, Karim; Meziane, Hamid] ICS, Illkirch Graffenstaden, France; [Auwerx, Johan] Ecole Polytech Fed Lausanne, Lab Integrat & Syst Physiol LISP NCEM, CH-1015 Lausanne, Switzerland	Meziane, H (corresponding author), ICS, Illkirch Graffenstaden, France.	meziane@igbmc.fr			Institut Clinique de la Souris (ICS); ICS	This work was supported by the Institut Clinique de la Souris (ICS). A. Koutseff was supported by a grant from the ICS.	Ashford JW, 2004, J MOL NEUROSCI, V23, P157, DOI 10.1385/JMN:23:3:157; Balu Darrick T., 2009, Journal of Pharmacological and Toxicological Methods, V59, P100, DOI 10.1016/j.vascn.2008.12.002; Bilsland JG, 2006, J NEUROSCI METH, V157, P54, DOI 10.1016/j.jneumeth.2006.03.026; Buttini M, 2002, J NEUROSCI, V22, P10539; Buttini M, 1999, J NEUROSCI, V19, P4867; Cameron HA, 1999, NAT NEUROSCI, V2, P894, DOI 10.1038/13197; Champy MF, 2004, MAMM GENOME, V15, P768, DOI 10.1007/s00335-004-2393-1; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; COROTTO FS, 1993, NEUROSCI LETT, V149, P111, DOI 10.1016/0304-3940(93)90748-A; Crawford F, 2009, NEUROSCIENCE, V159, P1349, DOI 10.1016/j.neuroscience.2009.01.033; Crews L, 2010, BRAIN STRUCT FUNCT, V214, P111, DOI 10.1007/s00429-009-0232-6; DAS GD, 1970, BRAIN RES, V21, P122, DOI 10.1016/0006-8993(70)90026-0; Ehninger D, 2003, CEREB CORTEX, V13, P845, DOI 10.1093/cercor/13.8.845; Gould E, 1997, J NEUROSCI, V17, P2492; HANDELMANN GE, 1992, J LIPID RES, V33, P1677; Hauser P.S., 2010, PROG LIPID RES; Heine VM, 2004, NEUROBIOL AGING, V25, P361, DOI 10.1016/S0197-4580(03)00090-3; Hsieh J, 2012, GENE DEV, V26, P1010, DOI 10.1101/gad.187336.112; Huang Y, 2006, CURR OPIN DRUG DISC, V9, P627; Huang YD, 2004, J MOL NEUROSCI, V23, P189, DOI 10.1385/JMN:23:3:189; Huang YD, 2006, NEUROLOGY, V66, pS79, DOI 10.1212/01.wnl.0000192102.41141.9e; Jordan BD, 2007, NEUROCHEM RES, V32, P905, DOI 10.1007/s11064-006-9251-3; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kempermann G, 2002, J NEUROSCI, V22, P635, DOI 10.1523/JNEUROSCI.22-03-00635.2002; Kempermann G, 2012, NAT REV NEUROSCI, V13, P727, DOI 10.1038/nrn3319; Knouff C, 1999, J CLIN INVEST, V103, P1579, DOI 10.1172/JCI6172; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Leuner B, 2007, P NATL ACAD SCI USA, V104, P17169, DOI 10.1073/pnas.0708228104; Levi O, 2007, J NEUROCHEM, V100, P202, DOI 10.1111/j.1471-4159.2006.04189.x; Li G, 2009, CELL STEM CELL, V5, P634, DOI 10.1016/j.stem.2009.10.015; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Mahley RW, 2006, P NATL ACAD SCI USA, V103, P5644, DOI 10.1073/pnas.0600549103; Mahley RW, 1996, ANN NY ACAD SCI, V777, P139, DOI 10.1111/j.1749-6632.1996.tb34412.x; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Mattson MP, 2006, NAT REV NEUROSCI, V7, P278, DOI 10.1038/nrn1886; NATHAN BP, 1994, SCIENCE, V264, P850, DOI 10.1126/science.8171342; Phillips W, 2006, STEM CELLS DEV, V15, P359, DOI 10.1089/scd.2006.15.359; Prickaerts J, 2004, NEUROCHEM INT, V45, P915, DOI 10.1016/j.neuint.2004.03.022; REED T, 1994, ARCH NEUROL-CHICAGO, V51, P1189, DOI 10.1001/archneur.1994.00540240033012; Riddle D.R., 2007, BRAIN AGING MODELS M; Roses AD, 1998, ANN NY ACAD SCI, V855, P738, DOI 10.1111/j.1749-6632.1998.tb10653.x; Roses AD, 1996, ANNU REV MED, V47, P387, DOI 10.1146/annurev.med.47.1.387; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; SCHIPPER HM, 2009, NEUROBIOL AGING; Simpson J.M., 2010, NEUROBIOL DIS; Siwak-Tapp CT, 2007, NEUROBIOL LEARN MEM, V88, P249, DOI 10.1016/j.nlm.2007.05.001; STRITTMATTER WJ, 1995, P NATL ACAD SCI USA, V92, P4725, DOI 10.1073/pnas.92.11.4725; Struble RG, 2007, EXP GERONTOL, V42, P54, DOI 10.1016/j.exger.2006.05.013; Sullivan PM, 1997, J BIOL CHEM, V272, P17972, DOI 10.1074/jbc.272.29.17972; Sullivan PM, 1998, J CLIN INVEST, V102, P130, DOI 10.1172/JCI2673; Tanzi R.E., 2012, COLD SPRING HARB PER, V2, DOI DOI 10.1101/CSHPEREPET.A006296; Taupin P, 2002, J NEUROSCI RES, V69, P745, DOI 10.1002/jnr.10378; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Thompson A, 2008, GENES BRAIN BEHAV, V7, P28, DOI 10.1111/j.1601-183X.2007.00379.x; Weisgraber Karl H., 1994, Current Opinion in Lipidology, V5, P110, DOI 10.1097/00041433-199404000-00007; WEISGRABER KH, 1994, CURR OPIN STRUC BIOL, V4, P507, DOI 10.1016/S0959-440X(94)90212-7; Zou LQ, 2010, INT J NEUROSCI, V120, P192, DOI 10.3109/00207450903464579	58	11	11	1	12	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JAN 13	2014	1542						32	40		10.1016/j.brainres.2013.10.003			9	Neurosciences	Neurosciences & Neurology	299UF	WOS:000330420500004	24140109				2021-06-18	
J	Beskind, DL; Stolz, U; Gross, A; Earp, R; Mitchelson, J; Judkins, D; Bowlby, P; Guillen-Rodriguez, JM				Beskind, Daniel L.; Stolz, Uwe; Gross, Austin; Earp, Ryan; Mitchelson, Justin; Judkins, Dan; Bowlby, Paul; Guillen-Rodriguez, Jose M.			A COMPARISON OF THE PREHOSPITAL MOTOR COMPONENT OF THE GLASGOW COMA SCALE (MGCS) TO THE PREHOSPITAL TOTAL GCS (TGCS) AS A PREHOSPITAL RISK ADJUSTMENT MEASURE FOR TRAUMA PATIENTS	PREHOSPITAL EMERGENCY CARE			English	Article						Glasgow coma scale; motor score of the GCS; out-of-hospital care; prehospital emergency care; risk adjustment measure	BRAIN-INJURY OUTCOMES; MULTIPLE IMPUTATION; MISSING DATA; EMERGENCY-DEPARTMENT; ADVANCED STATISTICS; CLINICAL-RESEARCH; FIELD TRIAGE; PREDICTION; SCORE; RECOMMENDATIONS	Objective. This study compared the prehospital motor component subscale of the Glasgow Coma Scale (mGCS) to the prehospital total GCS (tGCS) score for its ability to predict the need for intubation, survival to hospital discharge, and neurosurgical intervention in trauma patients. Methods. This is a retrospective analysis of an urban level 1 trauma registry. All trauma patients presenting to the trauma center emergency department via emergency medical services from July 2008 through June 2010 were included. The area under the receiver operating characteristics curve (AUC) analysis was used to compare the predictive ability of the prehospital mGCS to tGCS for three outcomes: intubation, survival to hospital discharge, and neurosurgical intervention. Two subgroups (patients with injury severity score [ISS] >= 16 and traumatic brain injury [TBI] [head abbreviated injury score (AIS) >= 3]) were analyzed. An a priori statistically significant absolute difference of 0.050 in AUC between mGCS and tGCS for these clinical outcomes was used as a clinically significant difference. Multiple imputation was used for missing prehospital GCS data. Results. There were 9,816 patients, of which 4% were intubated, 3.8% had neurosurgical intervention, and 97.1% survived to hospital discharge. The absolute difference in AUC (prehospital tGCS minus mGCS) for all cases was statistically significant for all three outcomes but did not reach the clinical significance threshold: survival = 0.010 (95% CI: 0.002-0.018), intubation = 0.018 (95% CI: 0.011-0.024), and neurosurgical intervention = 0.019 (95% CI: 0.007-0.029). The difference in AUC between tGCS and mGCS for the subgroups ISS >= 16 (n = 1,151) and TBI (n = 1,165) did not reach clinical significance for the three outcomes. The discriminatory ability of the prehospital mGCS was good for survival (AUC: all patients = 0.89, ISS >= 16 = 0.84, traumatic brain injury = 0.86) excellent for intubation (AUC: all patients = 0.95, ISS >= 16 = 0.91, traumatic brain injury = 0.91), and poor for neurosurgical intervention (AUC: all patients = 0.67, ISS >= 16 = 0.57, traumatic brain injury = 0.60). Conclusion. The prehospital mGCS appears have good discriminatory power and is equivalent to the prehospital tGCS for predicting intubation and survival to hospital discharge in this trauma population as a whole, those with ISS >= 16, or TBI.	[Beskind, Daniel L.; Stolz, Uwe; Gross, Austin; Earp, Ryan; Mitchelson, Justin] Univ Arizona, Dept Emergency Med, Arizona Emergency Med Res Ctr, Tucson, AZ 85724 USA; [Judkins, Dan; Bowlby, Paul] Univ Arizona, Dept Surg, Tucson, AZ 85724 USA; [Earp, Ryan] Kaiser Permanente, Kaiser Permanente Med Ctr, Sacramento, CA USA; [Mitchelson, Justin] Kaiser Permanente, San Diego Med Ctr, Kaiser Fdn Hosp, San Diego, CA USA; [Guillen-Rodriguez, Jose M.] Univ Arizona, Arizona Canc Ctr, Tucson, AZ 85724 USA	Beskind, DL (corresponding author), Univ Arizona, Dept Emergency Med, Arizona Emergency Med Res Ctr, 1501 N Campbell Ave, Tucson, AZ 85724 USA.	dbeskind@aemrc.arizona.edu					Al-Salamah MA, 2004, ACAD EMERG MED, V11, P834, DOI 10.1197/j.aem.2004.03.008; Beskind DL, 2011, ACAD EMERG MED, V18, P988, DOI 10.1111/j.1553-2712.2011.01148.x; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Garrison HG, 2002, ANN EMERG MED, V40, P81, DOI 10.1067/mem.2002.124758; Gill M, 2005, ANN EMERG MED, V45, P37, DOI 10.1016/j.annemergmed.2004.07.429; Gill M, 2006, ACAD EMERG MED, V13, P968, DOI 10.1197/j.aem.2006.05.019; Gill MR, 2004, ANN EMERG MED, V43, P215, DOI 10.1016/S0196-0644(03)00814-X; Haukoos JS, 2007, ACAD EMERG MED, V14, P662, DOI 10.1197/j.aem.2006.11.037; Haukoos JS, 2007, ANN EMERG MED, V50, P18, DOI 10.1016/j.annemergmed.2006.10.004; Healey C, 2003, J TRAUMA, V54, P671, DOI 10.1097/01.TA.0000058130.30490.5D; Heron R, 2001, Aust Crit Care, V14, P100, DOI 10.1016/S1036-7314(01)80026-6; Martinez R., 2009, BUREAU EMERGENCY MED; McNett Molly, 2007, J Neurosci Nurs, V39, P68; Meredith W, 1998, J TRAUMA, V44, P839, DOI 10.1097/00005373-199805000-00016; MEREDITH W, 1995, J TRAUMA, V38, P129, DOI 10.1097/00005373-199501000-00030; Newgard CD, 2006, ACAD EMERG MED, V13, P314, DOI 10.1197/j.aem.2005.09.011; Newgard CD, 2007, ACAD EMERG MED, V14, P669, DOI 10.1197/j.aem.2006.11.038; Ross SE, 1998, J TRAUMA, V45, P42, DOI 10.1097/00005373-199807000-00008; Royston P, 2011, J STAT SOFTW, V45, P1, DOI 10.18637/jss.v045.i04; Rubin C., 1988, MULTIPLE IMPUTATION; Rubin D.B., 1988, P SURVEY RES METHODS, P79; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.2307/2335739; RUBIN DB, 1991, STAT MED, V10, P585, DOI 10.1002/sim.4780100410; Sasser Scott M., 2009, Morbidity and Mortality Weekly Report, V58, P1; Thompson DO, 2011, ANN EMERG MED, V58, P417, DOI 10.1016/j.annemergmed.2011.05.033; Vivien B, 2012, AM J EMERG MED, V30, P1032, DOI 10.1016/j.ajem.2011.06.022; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067	27	11	11	0	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1090-3127	1545-0066		PREHOSP EMERG CARE	Prehosp. Emerg. Care	JAN-MAR	2014	18	1					68	75		10.3109/10903127.2013.844870			8	Emergency Medicine; Public, Environmental & Occupational Health	Emergency Medicine; Public, Environmental & Occupational Health	270OO	WOS:000328328200010	24329032				2021-06-18	
J	Carlsson, A; Chang, F; Lemmen, P; Kullgren, A; Schmitt, KU; Linder, A; Svensson, MY				Carlsson, Anna; Chang, Fred; Lemmen, Paul; Kullgren, Anders; Schmitt, Kai-Uwe; Linder, Astrid; Svensson, Mats Y.			Anthropometric Specifications, Development, and Evaluation of EvaRID-A 50th Percentile Female Rear Impact Finite Element Dummy Model	TRAFFIC INJURY PREVENTION			English	Article						rear impact; whiplash; crash dummies; finite elements; females; neck injury; impact responses	TOTAL HEAD EXCURSION; GENDER-DIFFERENCES; CERVICAL STRENGTH; MALE-VOLUNTEERS; NECK INJURY; WHIPLASH; DRIVERS; MOTION; FREQUENCY; RESPONSES	Objectives: Whiplash-associated disorders (WADs), or whiplash injuries, due to low-severity vehicle crashes are of great concern in motorized countries and it is well established that the risk of such injuries is higher for females than for males, even in similar crash conditions. Recent protective systems have been shown to be more beneficial for males than for females. Hence, there is a need for improved tools to address female WAD prevention when developing and evaluating the performance of whiplash protection systems. The objective of this study is to develop and evaluate a finite element model of a 50th percentile female rear impact crash test dummy. Methods: The anthropometry of the 50th percentile female was specified based on literature data. The model, called EvaRID (female rear impact dummy), was based on the same design concept as the existing 50th percentile male rear impact dummy, the BioRID II. A scaling approach was developed and the first version, EvaRID V1.0, was implemented. Its dynamic response was compared to female volunteer data from rear impact sled tests. Results: The EvaRID V1.0 model and the volunteer tests compared well until similar to 250 ms of the head and T1 forward accelerations and rearward linear displacements and of the head rearward angular displacement. Markedly less T1 rearward angular displacement was found for the EvaRID model compared to the female volunteers. Similar results were received for the BioRID II model when comparing simulated responses with experimental data under volunteer loading conditions. The results indicate that the biofidelity of the EvaRID V1.0 and BioRID II FE models have limitations, predominantly in the T1 rearward angular displacement, at low velocity changes (7 km/h). The BioRID II model was validated against dummy test results in a loading range close to consumer test conditions (EuroNCAP) and lower severity levels of volunteer testing were not considered. Conclusions: The EvaRID dummy model demonstrated the potential of becoming a valuable tool when evaluating and developing seats and whiplash protection systems. However, updates of the joint stiffness will be required to provide better correlation at lower load levels. Moreover, the seated posture, curvature of the spine, and head position of 50th percentile female occupants needs to be established and implemented in future models.	[Carlsson, Anna; Kullgren, Anders; Svensson, Mats Y.] Chalmers Univ Technol, SE-40278 Gothenburg, Sweden; [Chang, Fred; Lemmen, Paul] Humanet Innovat Solut, Plymouth, MI USA; [Kullgren, Anders] Folksam, Stockholm, Sweden; [Schmitt, Kai-Uwe] AGU Zurich, Zurich, Switzerland; [Linder, Astrid] Swedish Natl Rd & Transport Res Inst VTI, Gothenburg, Sweden	Carlsson, A (corresponding author), Chalmers Univ Technol, Dept Appl Mech, Div Vehicle Safety, SE-40278 Gothenburg, Sweden.	anna.carlsson@chalmers.se	Svensson, Mats Yngve/A-6014-2013	Svensson, Mats Yngve/0000-0002-8304-1398; Schmitt, Kai-Uwe/0000-0003-3439-9323; Carlsson, Anna/0000-0002-3216-8145	European CommissionEuropean CommissionEuropean Commission Joint Research Centre; Swedish Transport Agency	This study is part of the ADSEAT (Adaptive Seat to Reduce Neck Injuries for Female and Male Occupants) project funded by the European Commission within the 7th Framework Programme. Additional funding has been received from the Swedish Transport Agency.	Abraham S, 1979, VITAL HLTH STAT SERI, V11; [Anonymous], 2012, 725022012 SIS CEN IS; BUCK C A, 1959, Arch Phys Med Rehabil, V40, P390; Carlsson A, 2012, TRAFFIC INJ PREV, V13, P378, DOI 10.1080/15389588.2012.659362; Carlsson A, 2011, TRAFFIC INJ PREV, V12, P347, DOI 10.1080/15389588.2011.585408; Carstensen TBW, 2012, EUR J PAIN, V16, P49, DOI 10.1016/j.ejpain.2011.06.002; Chapline JF, 2000, ACCIDENT ANAL PREV, V32, P287, DOI 10.1016/S0001-4575(99)00126-8; Cheng H, 1994, ALCFTR19940051 HUM E; Chiu TTW, 2002, CLIN REHABIL, V16, P772, DOI 10.1191/0269215502cr552oa; Croft AC, 2002, IRCOBI C SEPT 18 20; Desantis Klinich Kathleen, 2004, Stapp Car Crash J, V48, P301; Diffrient N., 1974, HUMANSCALE 1 2 3 POR; Dolinis J, 1997, INJURY, V28, P173, DOI 10.1016/S0020-1383(96)00186-6; Eichberger A, 1996, IRCOBI C SEPT 11 13; Farmer CM, 1999, ACCIDENT ANAL PREV, V31, P719, DOI 10.1016/S0001-4575(99)00035-4; FOUST DR, 1973, 17 STAPP CAR CRASH C; Galasko CSB, 1996, 15 ESV C MAY 13 17 1; Garces GL, 2002, MED SCI SPORT EXER, V34, P464, DOI 10.1097/00005768-200203000-00013; Hanson L, 2009, APPL ERGON, V40, P797, DOI 10.1016/j.apergo.2008.08.007; HANTEN WP, 1991, ARCH PHYS MED REHAB, V72, P877, DOI 10.1016/0003-9993(91)90003-2; Hanten WP, 2000, ARCH PHYS MED REHAB, V81, P62, DOI 10.1053/apmr.2000.0810062; Hell W, 1999, IRCOBI C SEPT 23 24; Jakobsson L, 2000, ACCIDENT ANAL PREV, V32, P307, DOI 10.1016/S0001-4575(99)00107-4; Jakobsson Lotta, 2004, Traffic Inj Prev, V5, P156, DOI 10.1080/15389580490435989; Jonsson Bertil, 2007, Traffic Inj Prev, V8, P87, DOI 10.1080/15389580600911010; Jonsson B, 2008, ERGONOMICS, V51, P232, DOI 10.1080/00140130701561793; Kihlberg JK, 1969, 13 AAAM C OCT 16 17; Krafft Maria, 2003, Traffic Inj Prev, V4, P136, DOI 10.1080/15389580309862; Kullgren A, 2010, IRCOBI C SEPT 15 16; Kullgren A., 2003, 18 ESV C MAY 19 22 2; Kullgren A, 2007, 20 ESV C JUN 18 21 2; Kumar S, 2001, CLIN BIOMECH, V16, P380, DOI 10.1016/S0268-0033(01)00023-7; Lemmen P, 2013, 23 ESV C MAY 27 30 2; Linder A, 2008, TRAFFIC INJ PREV, V9, P592, DOI 10.1080/15389580802384669; Maag U, 1990, IRCOBIO C SEPT 12 14; McConville J. T., 1980, AMRLTR80119; Mordaka J, 2003, ACTA POLITECHNICA, V43, P47; MORRIS A, 1996, 40 STAPP CAR CRASH C; Moss S, 2000, 220012202 SAE; Narragon EA, 1965, VJ1823R15 CAL CORN U; National Highway Traffic Safety Administration, 2004, FED REGISTER, V69, P74848; Nygren A, 1984, AKTA OTO LARYNG S395; ONEILL B, 1972, AM J PUBLIC HEALTH N, V62, P399, DOI 10.2105/AJPH.62.3.399; Ono K, 2006, IRCOBI C SEPT 20 22; Osakabe T, 2001, ANN CLIN BIOCHEM, V38, P527, DOI 10.1258/0004563011901118; OTREMSKI I, 1989, INJURY, V20, P349, DOI 10.1016/0020-1383(89)90011-9; Peolsson A, 2001, Physiother Res Int, V6, P15, DOI 10.1002/pri.210; Richter M, 2000, EUR SPINE J, V9, P109, DOI 10.1007/s005860050220; Robbins D. H., 1983, UMTRI83532; ROBBINS DH, 1983, UMTRI83533; Schick S, 2008, 2 TUV SUD C WHIPL NE; Schneider L. W., 1983, UMTRI83531; Seacrist T, 2009, 21 ESV C JUN 15 18 2; SEIDL A, 1997, 970088 SAE; Siegmund G. P., 1997, 41 STAPP CAR CRASH C; Siegmund GP, 2003, SPINE, V28, P671, DOI 10.1097/00007632-200304010-00010; Stahlschmidt S, 2006, 5 GERM LS DYNA FOR O; States JD, 1972, 16 STAPP CAR CRASH C; Stemper BD, 2007, IRCOBI C SEPT 19 21; Stemper BD, 2008, SPINE, V33, pE44, DOI 10.1097/BRS.0b013e318160462a; Storvik Steven G, 2009, Biomed Sci Instrum, V45, P244; Svensson MY, 1993, SAESP93963; Szabo TJ, 1994, 38 STAPP CAR CRASH C; Temming J, 1998, IRCOBI C SEPT 16 18; The Whiplash Commission, 2005, WHIPL COMM FIN REP; Thomas C, 1982, IRCOBI C SEPT 8 10 1; Vasavada AN, 2001, SPINE, V26, P1904, DOI 10.1097/00007632-200109010-00018; Vasavada AN, 2008, J BIOMECH, V41, P114, DOI 10.1016/j.jbiomech.2007.07.007; Viano David C, 2003, Traffic Inj Prev, V4, P228, DOI 10.1080/15389580309880; Watanabe Y, 2000, ACCIDENT ANAL PREV, V32, P243, DOI 10.1016/S0001-4575(99)00082-2; Welcher JB, 2001, ACCIDENT ANAL PREV, V33, P289, DOI 10.1016/S0001-4575(00)00043-9; Welsh R, 2001, 45 AAAM C SEPT 24 26; YOUDAS JW, 1992, PHYS THER, V72, P770, DOI 10.1093/ptj/72.11.770; Young JW, 1983, ANTHROPOMETRIC MASS	74	11	12	1	20	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1538-9588	1538-957X		TRAFFIC INJ PREV	Traffic Inj. Prev.		2014	15	8					855	865		10.1080/15389588.2014.885647			11	Public, Environmental & Occupational Health; Transportation	Public, Environmental & Occupational Health; Transportation	AM8PD	WOS:000340138300011	24484526				2021-06-18	
J	Ciaramella, A; Della Vedova, C; Salani, F; Viganotti, M; D'Ippolito, M; Caltagirone, C; Formisano, R; Sabatini, U; Bossu, P				Ciaramella, Antonio; Della Vedova, Cecilia; Salani, Francesca; Viganotti, Mara; D'Ippolito, Mariagrazia; Caltagirone, Carlo; Formisano, Rita; Sabatini, Umberto; Bossu, Paola			Increased Levels of Serum IL-18 Are Associated with the Long-Term Outcome of Severe Traumatic Brain Injury	NEUROIMMUNOMODULATION			English	Article						Interleukin-18; Chronic traumatic brain injury; Long-term outcome; Cognitive impairment; Disability severity	ACUTE ISCHEMIC-STROKE; ALZHEIMERS-DISEASE; HEAD-INJURY; PRACTICAL SCALE; INTERLEUKIN-18; CYTOKINES; INFLAMMATION; NEUROINFLAMMATION; CHEMOKINES; DISABILITY	Objective: A long-lasting neuroinflammatory cascade may lead to the progression of brain damage, favoring neurodegeneration and cognitive impairment in patients with traumatic brain injury (TBI), but the potential mechanisms underlying this sequence of events remain elusive. Here we aimed to evaluate the impact of interleukin (IL)-18, a proinflannmatory cytokine elevated in post-acute head injury and associated with neurodegeneration, on the long-term outcome of patients with chronic TBI. Methods: The serum content of IL-18 was evaluated in 16 patients with severe TBI, during their rehabilitation phase, and in a matched group of 16 healthy controls. The disability of the enrolled patients was evaluated by means of the Glasgow Outcome Scale, Levels of Cognitive Functioning, and the Disability Rating Scale. Results: The circulating levels of IL-18 were significantly increased in chronic TBI patients, as compared to healthy subjects, and correlated with the patients' cognitive impairment and disability severity. Conclusions: IL-18 may contribute to the long-term outcome and neurodegeneration in TBI patients. Even though further studies are needed to understand the molecular mechanisms underlying the effects of IL-18 on TBI progression and its associated drop in cognitive function, a possible role of this cytokine as a therapeutic target in TBI can be envisaged. (C) 2013 S. Karger AG, Basel	[Ciaramella, Antonio; Salani, Francesca; Viganotti, Mara; Caltagirone, Carlo; Bossu, Paola] IRCCS Santa Lucia Fdn, Rome, Italy; [Della Vedova, Cecilia; D'Ippolito, Mariagrazia; Formisano, Rita] IRCCS Santa Lucia Fdn, Postcoma Unit, Rome, Italy; [Sabatini, Umberto] IRCCS Santa Lucia Fdn, Dept Radiol, Rome, Italy	Bossu, P (corresponding author), IRCCS Fdn Santa Lucia, Dept Clin & Behav Neurol, Expt Neuropsychobiol Lab, Via Ardeatina 306, IT-00179 Rome, Italy.	p.bossu@hsantalucia.it	Ciaramella, Antonio/AAM-4320-2020; D'Ippolito, Mariagrazia/K-4010-2016; ciaramella, antonio/F-1170-2011; ciaramella, antonio/P-9009-2019; Sabatini, Umberto/K-4659-2016; Bosso, Paola/E-4832-2014; SALANI, FRANCESCA/I-1314-2012; NACMIAS, Benedetta/J-5084-2018	Ciaramella, Antonio/0000-0001-9888-8156; D'Ippolito, Mariagrazia/0000-0001-7818-7352; ciaramella, antonio/0000-0001-9888-8156; Sabatini, Umberto/0000-0001-5321-8626; Bosso, Paola/0000-0002-1432-0078; SALANI, FRANCESCA/0000-0002-6901-6057; NACMIAS, Benedetta/0000-0001-9338-9040	Italian Ministry of HealthMinistry of Health, Italy [RC-11-12-13]	This work was supported by grants from the Italian Ministry of Health (RC-11-12-13) (P.B., R.F.).	Anthony DC, 2012, BRAIN BEHAV IMMUN, V26, P534, DOI 10.1016/j.bbi.2011.10.011; Bossu P, 2008, BRAIN BEHAV IMMUN, V22, P487, DOI 10.1016/j.bbi.2007.10.001; Bossu P, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-101; Bossu P, 2010, CURR PHARM DESIGN, V16, P4213, DOI 10.2174/138161210794519147; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Fassbender K, 1999, NEUROLOGY, V53, P1104, DOI 10.1212/WNL.53.5.1104; Felderhoff-Mueser U, 2005, TRENDS NEUROSCI, V28, P487, DOI 10.1016/j.tins.2005.06.008; Ghirnikar RS, 1998, NEUROCHEM RES, V23, P329, DOI 10.1023/A:1022453332560; Giunta B, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-185; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Hagen C, 1979, REHABILITATION HEAD; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Jander S, 2002, J CEREBR BLOOD F MET, V22, P62, DOI 10.1097/00004647-200201000-00008; JENNETT B, 1975, LANCET, V1, P480; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Menge T, 2001, J NEUROSCI RES, V65, P332, DOI 10.1002/jnr.1158; Merrill JE, 1996, TRENDS NEUROSCI, V19, P331, DOI 10.1016/0166-2236(96)10047-3; Ojala J, 2009, NEUROBIOL AGING, V30, P198, DOI 10.1016/j.neurobiolaging.2007.06.006; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Shechter R, 2013, TRENDS MOL MED, V19, P135, DOI 10.1016/j.molmed.2012.11.007; Swardfager W, 2010, BIOL PSYCHIAT, V68, P930, DOI 10.1016/j.biopsych.2010.06.012; TEASDALE G, 1974, LANCET, V2, P81; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Yatsiv I, 2002, J CEREBR BLOOD F MET, V22, P971, DOI 10.1097/00004647-200208000-00008; Yuen CM, 2007, CIRC J, V71, P1691, DOI 10.1253/circj.71.1691; Zaremba J, 2003, NEUROL SCI, V24, P117, DOI 10.1007/s10072-003-0096-0; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	31	11	11	0	11	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1021-7401	1423-0216		NEUROIMMUNOMODULAT	Neuroimmunomodulation		2014	21	1					8	12		10.1159/000354764			5	Endocrinology & Metabolism; Immunology; Neurosciences	Endocrinology & Metabolism; Immunology; Neurosciences & Neurology	265AQ	WOS:000327922500002	24080899				2021-06-18	
J	Fan, Y; Li, J; Zhang, YQ; Jiang, LH; Zhang, YN; Yan, CQ				Fan, Ying; Li, Jing; Zhang, Yan-Qiao; Jiang, Li-Hong; Zhang, Yi-Na; Yan, Chao-Qi			Protein kinase C delta mediated cytotoxicity of 6-Hydroxydopamine via sustained extracellular signal-regulated kinase 1/2 activation in PC12 cells	NEUROLOGICAL RESEARCH			English	Article						6-Hydroxydopamine; Protein kinase C; Subtype delta; Extracellular signal-regulated kinases (ERK); Parkinson's disease; Apoptosis; Rottlerin	DOPAMINERGIC NEURONAL CELLS; TRAUMATIC BRAIN INJURY; NF-KAPPA-B; PARKINSONS-DISEASE; PROTEOLYTIC ACTIVATION; PKC-DELTA; INDUCED APOPTOSIS; OXIDATIVE STRESS; MITOCHONDRIAL DYSFUNCTION; MOLECULAR PATHWAYS	Objectives: The incidence of Parkinson's disease (PD) is increasing as the global population ages. 6-hydroxydopamine (6-OHDA) can induce PD-like neuropathology and biochemical changes in both in vitro and in vivo models. Therefore, clarification of the molecular mechanism of 6-OHDA-induced cell death might contribute to the understanding of the pathogenesis of PD. Methods: With this goal in mind, we investigated the role of protein kinase C delta (PKC delta) in 6-OHDA-dependent death using the pheochromocytoma cell line, PC12. Cells were treated with 6-OHDA to induce toxicity with or without pretreatment using rottlerin (a PKC delta inhibitor), bisindolylmaleimide I (a general PKC inhibitor), Go "6976 (a PKC inhibitor selective for calcium-dependent PKC isoforms), or phorbol-12-myristate- 13-acetate (PMA, a PKC activator). Results: Phorbol-12-myristate-13-acetate decreased cell survival and increased the rate of apoptosis while rottlerin increased cell survival and decreased the rate of apoptosis. In contrast, neither bisindolylmaleimide I nor Go "6976 affected 6-OHDA-induced cell death. Western analysis demonstrated that phosphorylation of PKC delta on Thr 505 as well as extracellular signal-regulated kinase (ERK) phosphorylation increased after exposure to 6-OHDA. This increase in PKC delta phosphorylation was potentiated by PMA. However, rottlerin attenuated the 6-OHDA-stimulated increase in PKC delta and ERK phosphorylation. Conclusion: These data suggest that PKC delta, rather than classic-type PKC (alpha, beta1, beta2, gamma), participates in 6-OHDA-induced neurotoxicity in PC12 cells, and PKC delta activity is required for subsequent ERK activation during cell death.	[Fan, Ying; Li, Jing; Jiang, Li-Hong; Zhang, Yi-Na] Harbin Med Univ, Affiliated Hosp 2, Dept Geriatr, Harbin, Peoples R China; [Zhang, Yan-Qiao] Harbin Med Univ, Affiliated Hosp 3, Dept Internal Med 8, Harbin, Peoples R China; [Yan, Chao-Qi] Harbin Med Univ, Affiliated Hosp 2, Dept Surg, Harbin, Peoples R China	Yan, CQ (corresponding author), 194 Xuefu Rd, Harbin 150081, Peoples R China.	yanchaoqi2002@163.com			International Cooperation Project of Science and Technology Department of Heilongjiang Province, China [WB08B05]; Science and Technology Foundation of Education Department of Heilongjiang Province, China [11521076]	This work was supported by the International Cooperation Project of Science and Technology Department of Heilongjiang Province, China (No. WB08B05), and the Science and Technology Foundation of Education Department of Heilongjiang Province, China (No. 11521076). We are grateful to Prof. Hulun Li and Dr Bo Sun (Neurobiology Department of Harbin Medical University), Prof. Baoliang Guo (Surgery Department of the Second Affiliated Hospital of Harbin Medical University), Dr Ryun Huang and Dr Xiangning Meng (Genetic and Molecular Biology Department of the Harbin Medical University) for their kind assistance. We thank Medjaden Bioscience Limited for assisting in the preparation of this manuscript.	Alessandrini A, 1999, P NATL ACAD SCI USA, V96, P12866, DOI 10.1073/pnas.96.22.12866; Battaini F, 2001, PHARMACOL RES, V44, P353, DOI 10.1006/phrs.2001.0893; Benito-Leon J, 2004, NEUROLOGY, V62, P734, DOI 10.1212/01.WNL.0000113727.73153.68; Bernstein AI, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-2; Blum D, 2001, PROG NEUROBIOL, V65, P135, DOI 10.1016/S0301-0082(01)00003-X; Brodie C, 2003, APOPTOSIS, V8, P19, DOI 10.1023/A:1021640817208; ChoiLundberg DL, 1997, SCIENCE, V275, P838, DOI 10.1126/science.275.5301.838; COHEN G, 1974, J BIOL CHEM, V249, P2447; Collier TJ, 2003, ANN NY ACAD SCI, V991, P140; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; Efimova T, 2004, MOL CELL BIOL, V24, P8167, DOI 10.1128/MCB.24.18.8167-8183.2004; Fan Y, 2009, NEUROSCI BULL, V25, P187, DOI 10.1007/s12264-009-0416-3; Fujii T, 2000, J BIOL CHEM, V275, P7574, DOI 10.1074/jbc.275.11.7574; Glading A, 2001, J BIOL CHEM, V276, P23341, DOI 10.1074/jbc.M008847200; Goldberg M, 1996, BIOCHEM PHARMACOL, V51, P1089, DOI 10.1016/0006-2952(96)00046-9; GSCHWENDT M, 1994, BIOCHEM BIOPH RES CO, V199, P93, DOI 10.1006/bbrc.1994.1199; GSCHWENDT M, 1994, FEBS LETT, V338, P85, DOI 10.1016/0014-5793(94)80121-5; Hanrott K, 2006, J BIOL CHEM, V281, P5373, DOI 10.1074/jbc.M511560200; Hou ST, 2001, NEUROSCI LETT, V306, P153, DOI 10.1016/S0304-3940(01)01909-7; Ishikawa Y, 1999, BIOCHEM BIOPH RES CO, V264, P696, DOI 10.1006/bbrc.1999.1542; Kanthasamy AG, 2003, ANTIOXID REDOX SIGN, V5, P609, DOI 10.1089/152308603770310275; Kaul S, 2005, J BIOL CHEM, V280, P28721, DOI 10.1074/jbc.M501092200; Kaul S, 2003, EUR J NEUROSCI, V18, P1387, DOI 10.1046/j.1460-9568.2003.02864.x; Kikkawa U, 2002, J BIOCHEM, V132, P831, DOI 10.1093/oxfordjournals.jbchem.a003294; Kitazawa M, 2003, NEUROSCIENCE, V119, P945, DOI 10.1016/S0306-4522(03)00226-4; Kolch W, 2000, BIOCHEM J, V351, P289, DOI 10.1042/0264-6021:3510289; Konishi H, 2001, P NATL ACAD SCI USA, V98, P6587, DOI 10.1073/pnas.111158798; Kulich SM, 2007, FREE RADICAL BIO MED, V43, P372, DOI 10.1016/j.freeradbiomed.2007.04.028; Kulich SM, 2001, J NEUROCHEM, V77, P1058, DOI 10.1046/j.1471-4159.2001.00304.x; Kulich SM, 2003, J BIOSCIENCE, V28, P3; Kumar S, 2001, J BIOL CHEM, V276, P17281, DOI 10.1074/jbc.M101414200; Kuperstein F, 2002, EUR J NEUROSCI, V16, P44, DOI 10.1046/j.1460-9568.2002.02056.x; Lane EL, 2005, J PHARMACOL EXP THER, V312, P1124, DOI 10.1124/jpet.104.076554; Lang AE, 1998, NEW ENGL J MED, V339, P1044, DOI 10.1056/NEJM199810083391506; Latchoumycandane C, 2005, J PHARMACOL EXP THER, V313, P46, DOI 10.1124/jpet.104.078469; Lev N, 2003, PROG NEURO-PSYCHOPH, V27, P245, DOI 10.1016/S0278-5846(03)00019-8; Leverrier S, 2002, BIOCHEM J, V368, P905, DOI 10.1042/BJ20021253; Liu J, 2006, MOL CELL, V21, P467, DOI 10.1016/j.molcel.2005.12.020; Malecki EA, 2001, BRAIN RES BULL, V55, P225, DOI 10.1016/S0361-9230(01)00456-7; Mori T, 2002, J NEUROTRAUM, V19, P1411, DOI 10.1089/089771502320914642; MouattPrigent A, 1996, NEUROSCIENCE, V73, P979, DOI 10.1016/0306-4522(96)00100-5; Otani N, 2002, J CEREBR BLOOD F MET, V22, P327, DOI 10.1097/00004647-200203000-00010; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Seth K, 2002, NEUROSCI LETT, V330, P89, DOI 10.1016/S0304-3940(02)00714-0; Singh S, 2007, BRAIN RES REV, V54, P233, DOI 10.1016/j.brainresrev.2007.02.001; Soltoff SP, 2007, TRENDS PHARMACOL SCI, V28, P453, DOI 10.1016/j.tips.2007.07.003; Stanciu M, 2000, J BIOL CHEM, V275, P12200, DOI 10.1074/jbc.275.16.12200; Subramaniam S, 2003, J BIOL CHEM, V278, P8904, DOI 10.1074/jbc.M210037200; Tobon-Velasco JC, 2013, TOXICOLOGY, V304, P109, DOI 10.1016/j.tox.2012.12.011; UNGERSTEDT U, 1968, EUR J PHARMACOL, V5, P107, DOI 10.1016/0014-2999(68)90164-7; WALKINSHAW G, 1994, NEUROSCIENCE, V63, P975, DOI 10.1016/0306-4522(94)90566-5; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yang YJ, 2004, MOL CELL NEUROSCI, V25, P406, DOI 10.1016/j.mcn.2003.11.011; Zhu JH, 2002, AM J PATHOL, V161, P2087, DOI 10.1016/S0002-9440(10)64487-2; Zuch CL, 2000, J COMP NEUROL, V427, P440, DOI 10.1002/1096-9861(20001120)427:3<440::AID-CNE10>3.0.CO;2-7	55	11	11	0	5	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	JAN	2014	36	1					53	64		10.1179/1743132813Y.0000000267			12	Clinical Neurology; Neurosciences	Neurosciences & Neurology	AI7VH	WOS:000337108300007	24107416				2021-06-18	
J	Katsifaraki, M; Wood, RL				Katsifaraki, Maria; Wood, Rodger Ll			The impact of alexithymia on burnout amongst relatives of people who suffer from traumatic brain injury	BRAIN INJURY			English	Article						Alexithymia; caregiver burden; emotional burnout	DEPRESSION INVENTORY-II; BLUNT HEAD-INJURY; SOCIAL SUPPORT; VALIDITY; RELIABILITY; SCALE	Background: Although previous research has provided some indication of the association of alexithymia and burnout, this is the first study exploring the association of these two variables in a sample of relatives of individuals who have sustained traumatic brain injury (TBI). Objective: To explore the degree to which relatives experience burnout and the extent to which alexithymia acts as a pre-disposing factor, controlling for depression and coping strategies. Method: Toronto Alexithymia Scale-20, Maslach Burnout Inventory-Human Services, Estonian COPE Dispositional Inventory and Beck Depression Inventory-II were completed by 60 relatives of patients with TBI drawn from a tertiary head injury clinic population. Results: Levels of emotional exhaustion, reduced personal accomplishment and depression were significantly higher in the sub-group of relatives with alexithymia than in the sub-group of relatives without alexithymia. Difficulty describing feelings and externally oriented thinking style were significant predictors of emotional exhaustion, while difficulty identifying feelings and difficulty describing feelings were important predictors of depersonalization. Conclusions: Relatives who present with alexithymia need to be identified at an early stage to minimize risks of burnout leading to adverse effects on patient-caregiver relationships.	[Katsifaraki, Maria; Wood, Rodger Ll] Swansea Univ, Dept Psychol, Swansea SA2 8PP, W Glam, Wales	Katsifaraki, M (corresponding author), Swansea Univ, Dept Psychol, Swansea SA2 8PP, W Glam, Wales.	mariakatsifaraki@yahoo.gr					ALLEN K, 1994, REHABIL PSYCHOL, V39, P29, DOI 10.1037/h0080313; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P23, DOI 10.1016/0022-3999(94)90005-1; Beck AT., 1996, BECK DEPRESSION INVE, V2; Bouteyre E, 2007, STRESS HEALTH, V9, P3, DOI 10.3109/02699052.2014.919538; Bratis D, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-72; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; BROWN BW, 1988, FAM RELAT, V37, P12, DOI 10.2307/584423; BRYANT RA, 1995, BEHAV RES THER, V33, P631, DOI 10.1016/0005-7967(94)00093-Y; CARVER CS, 1989, J PERS SOC PSYCHOL, V56, P267, DOI 10.1037/0022-3514.56.2.267; Cohen J, 1988, STAT POWER ANAL BEHA, DOI DOI 10.3109/02699052.2014.919538; COMPAS BE, 1988, J CONSULT CLIN PSYCH, V56, P405, DOI 10.1037/0022-006X.56.3.405; de Vente W, 2006, PSYCHOTHER PSYCHOSOM, V75, P304, DOI 10.1159/000093953; Demerouti E, 2001, J APPL PSYCHOL, V86, P499, DOI 10.1037//0021-9010.86.3.499; GREEN DE, 1991, J SOC BEHAV PERS, V6, P453; Greenglass ER, 2001, J COMMUNITY APPL SOC, V11, P211, DOI 10.1002/casp.614; Honkalampi K, 2000, J PSYCHOSOM RES, V48, P99, DOI 10.1016/S0022-3999(99)00083-5; Katsifaraki M, 2013, J NURS EDUC, V52, P627, DOI 10.3928/01484834-20131014-04; Koponen S, 2005, PSYCHOSOM MED, V67, P807, DOI 10.1097/01.psy.0000181278.92249.e5; Lane RD, 1996, PSYCHOSOM MED, V58, P203, DOI 10.1097/00006842-199605000-00002; Lefebvre H, 2005, BRAIN INJURY, V19, P585, DOI 10.1080/02699050400025026; Leiter MP, 2003, EMERALD GROUP PUBLIS, V3, P91, DOI DOI 10.1016/S1479-3555(03)03003-8; Lumley MA, 1996, J PSYCHOSOM RES, V41, P519, DOI 10.1016/S0022-3999(96)00227-9; Man DWK, 2002, BRAIN INJURY, V16, P1025, DOI 10.1080/0269905021000010087; Maslach C, 2001, ANNU REV PSYCHOL, V52, P397, DOI 10.1146/annurev.psych.52.1.397; Maslach C., 1986, MASLACH BURNOUT INVE; Mattila AK, 2007, J PSYCHOSOM RES, V62, P657, DOI 10.1016/j.jpsychores.2007.01.002; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; Parker JDA, 1998, COMPR PSYCHIAT, V39, P91, DOI 10.1016/S0010-440X(98)90084-0; Parker JDA, 2001, PERS INDIV DIFFER, V30, P107, DOI 10.1016/S0191-8869(00)00014-3; Saarijorvi S, 2001, J PSYCHOSOM RES, V51, P729, DOI 10.1016/S0022-3999(01)00257-4; Schaufeli W. B., 2003, SA J IND PSYCHOL, V29, P1, DOI DOI 10.4102/SAJIP.V29I4.127; Spitzer C, 2005, PSYCHOTHER PSYCHOSOM, V74, P240, DOI 10.1159/000085148; Sprinkle SD, 2002, J COUNS PSYCHOL, V49, P381, DOI 10.1037//0022-0167.49.3.381; Steer RA, 1997, PSYCHOL REP, V80, P443, DOI 10.2466/pr0.1997.80.2.443; Steer RA, 1997, MEAS EVAL COUNS DEV, V30, P128, DOI 10.1080/07481756.1997.12068933; Sundin L, 2007, INT J NURS STUD, V44, P758, DOI 10.1016/j.ijnurstu.2006.01.004; Taylor G. J., 1997, DISORDERS AFFECT REG; TAYLOR GJ, 1992, PSYCHOTHER PSYCHOSOM, V57, P34, DOI 10.1159/000288571; Vaezi S, 2011, J LANGUAGE TEACHING, V2, P1122, DOI DOI 10.4304/JLTR.2.5.1122-1129; Williams C, 2013, J HEAD TRAUMA REHAB, V28, pE21, DOI 10.1097/HTR.0b013e318267b0ab; Williams C, 2010, J CLIN EXP NEUROPSYC, V32, P259, DOI 10.1080/13803390902976940; Wood RL, 2005, BRAIN INJURY, V19, P845, DOI 10.1080/02699050500058778; Wood RL, 1997, BRAIN INJURY, V11, P491, DOI 10.1080/713802183; Wood RL, 2006, J NEUROPSYCH CLIN N, V18, P333, DOI 10.1176/appi.neuropsych.18.3.333; Wood RL, 2008, J INT NEUROPSYCH SOC, V14, P289, DOI 10.1017/S1355617708080326; Wood RL, 2013, J HEAD TRAUMA REHAB, V28, P98, DOI 10.1097/HTR.0b013e3182426029	47	11	12	0	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2014	28	11					1389	1395		10.3109/02699052.2014.919538			7	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	AP3IQ	WOS:000341969200005	24945712				2021-06-18	
J	Krause, M; Richards, S				Krause, Miriam; Richards, Stephanie			Prevalence of traumatic brain injury and access to services in an undergraduate population: A pilot study	BRAIN INJURY			English	Article						College; concussion; survey	POSTCONCUSSION-LIKE SYMPTOMS; DEPRESSION; STUDENTS; DEFICITS	Objectives: The aim of this pilot study was to identify the prevalence of traumatic brain injury (TBI) among undergraduate college students, compare common TBI symptoms reported by students with and without a history of TBI and explore how often students with and without TBI access campus services. Methods: A campus-wide email recruited participants to an online survey containing questions about their history of TBI, experience of TBI symptoms and use of services. Results: Of 201 undergraduates, 55.7% reported no history of TBI or hospitalization, 27.9% reported a history of hospitalization but not TBI and 16.4% reported a history of TBI. Significant differences were seen among groups in their experience of some physical and psychosocial symptoms such as dizziness and difficulty with relationships. Healthy and TBI groups reported significantly more symptoms than the hospitalized group, but did not differ from each other. Most participants reported using no services and there were no significant differences in the average number of symptoms experienced by those seeking vs not seeking services. Conclusions: A substantial proportion of undergraduates reported a history of TBI and the experience of symptoms that could negatively impact academic performance. Further study is needed to examine factors influencing their use of available services.	[Krause, Miriam] Bowling Green State Univ, Dept Commun Sci & Disorders, Bowling Green, OH 43403 USA; [Richards, Stephanie] Cent Michigan Univ, Dept Commun Disorders, Mt Pleasant, MI 48859 USA	Krause, M (corresponding author), Bowling Green State Univ, Bowling Green, OH 43403 USA.	miriamk@bgsu.edu		Krause, Miriam/0000-0002-6798-3991			Alvarez L, 2008, NY TIMES; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Chan RCK, 2002, J CLIN EXP NEUROPSYC, V24, P1081, DOI 10.1076/jcen.24.8.1081.8371; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Dawson DR, 2007, DISABIL REHABIL, V29, P301, DOI 10.1080/09638280600756687; FOX DD, 1995, NEUROPSYCHOLOGY, V9, P606, DOI 10.1037/0894-4105.9.4.606; Gordon WA, 2000, BRAIN INJURY, V14, P21, DOI 10.1080/026990500120907; Gosling SD, 2004, AM PSYCHOL, V59, P93, DOI 10.1037/0003-066X.59.2.93; Gunstad J, 2004, ARCH CLIN NEUROPSYCH, V19, P391, DOI 10.1016/S0887-6177(03)00073-8; Gunstad J, 2002, J INT NEUROPSYCH SOC, V8, P37, DOI 10.1017/S1355617701020045; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; JOHNSTONE B, 1994, J CLIN PSYCHOL MED S, V1, P375, DOI 10.1007/BF01991080; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kennedy MRT, 2008, NEUROREHABILITATION, V23, P511; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Lehmkuhl D, 1988, TIRR SYMPTOM CHECKLI; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; O'Connor C, 2005, PSYCHOL REP, V97, P169, DOI 10.2466/PR0.97.5.169-179; ORGEL SA, 1967, J CONSULT PSYCHOL, V31, P77, DOI 10.1037/h0024216; POWELL BD, 1995, PERCEPT MOTOR SKILL, V81, P227, DOI 10.2466/pms.1995.81.1.227; Santa Maria MP, 2001, ARCH CLIN NEUROPSYCH, V16, P133; Schwartz Alan, 2011, NY TIMES; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Trahan DE, 2001, ARCH CLIN NEUROPSYCH, V16, P435, DOI 10.1016/S0887-6177(00)00051-2; Wagner M., 2005, HIGH SCH 1 LOOK POST; Wang Y, 2006, ARCH CLIN NEUROPSYCH, V21, P339, DOI 10.1016/j.acn.2006.03.006; Woods AJ, 2011, PM&R, V3, P426, DOI 10.1016/j.pmrj.2011.02.018; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	28	11	11	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2014	28	10					1301	1310		10.3109/02699052.2014.916416			10	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	AN2ZZ	WOS:000340455900011	24865186				2021-06-18	
S	Lee, RR; Huang, MX		Niranjan, A; Lunsford, LD		Lee, Roland R.; Huang, Mingxiong			Magnetoencephalography in the Diagnosis of Concussion	CONCUSSION	Progress in Neurological Surgery		English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; DIFFUSE AXONAL INJURY; DELTA WAVES; IMAGING APPROACH; HEAD TRAUMA; MEG; MILD; DOMINANCE; BLAST; EEG	Magnetoencephalography (MEG) is a biomedical technique which measures the magnetic fields emitted by the brain, generated by neuronal activity. Commercial whole-head MEG units have been available for about 15 years, but currently there are only about 20 such units operating in the USA. Here, we review the basic concepts of MEG and list some of the usual clinical indications: noninvasive localization of epileptic spikes and presurgical mapping of eloquent cortex. We then discuss using MEG to diagnose mild traumatic brain injury (mTBI; concussions). Injured brain tissues in TBI patients generate abnormal low-frequency magnetic activity (delta-waves: 1-4 Hz) that can be measured and localized by MEG. These abnormal delta-waves originate from neurons that experience deafferentation from axonal injury to the associated white matter fiber tracts, also manifested on diffusion tensor imaging as reduced fractional anisotropy. Magnetoencephalographic evaluation of abnormal delta-waves (1-4 Hz) is probably the most sensitive objective test to diagnose concussions. An automated MEG low-frequency (slow wave) source imaging method, frequency-domain vector-based spatiotemporal analysis using a L1-minimum norm (VESTAL), achieved a positive finding rate of 87% for diagnosing concussions (blast-induced plus nonblast), 100% for moderate TBI, and no false-positive diagnoses in normal controls. There were also significant correlations between the number of cortical regions generating abnormal slow waves and the total postconcussive symptom scores in TBI patients. (C) 2014 S. Karger AG, Basel	VA San Diego Healthcare Syst, Dept Radiol, San Diego, CA USA; Univ Calif San Diego, San Diego, CA 92161 USA	Lee, RR (corresponding author), Univ Calif San Diego, VA San Diego Healthcare Syst, Dept Radiol, 3350 La Jolla Village Dr,MC 114, San Diego, CA 92161 USA.	rrlee@ucsd.edu					ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Alberstone CD, 2000, J NEUROSURG, V92, P79, DOI 10.3171/jns.2000.92.1.0079; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; American Medical Association, 2003, CURR PROC TECHN CPT; BALL GJ, 1977, ELECTROEN CLIN NEURO, V43, P346, DOI 10.1016/0013-4694(77)90258-9; Basser PJ, 1995, NMR BIOMED, V8, P333, DOI 10.1002/nbm.1940080707; Bigler ED, 2004, STUD NEUROPSYCHOL DE, P71; Canive JM, 1996, PSYCHOPHARMACOL BULL, V32, P741; Castillo EM, 2004, NEUROIMAGE, V21, P973, DOI 10.1016/j.neuroimage.2003.10.020; COHEN D, 1972, SCIENCE, V175, P664, DOI 10.1126/science.175.4022.664; CUFFIN BN, 1977, IEEE T BIO-MED ENG, V24, P372, DOI 10.1109/TBME.1977.326145; Culotta VP, 1996, NEUROSURGERY, V38, P245, DOI 10.1097/00006123-199602000-00002; Davenport ND, 2012, NEUROIMAGE, V59, P2017, DOI 10.1016/j.neuroimage.2011.10.050; FERGUSON AS, 1994, IEEE T BIO-MED ENG, V41, P455, DOI 10.1109/10.293220; Fernandez A, 2002, BIOL PSYCHIAT, V52, P764, DOI 10.1016/S0006-3223(02)01366-5; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; GLOOR P, 1977, NEUROLOGY, V27, P326, DOI 10.1212/WNL.27.4.326; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; HAMALAINEN MS, 1989, IEEE T BIO-MED ENG, V36, P165, DOI 10.1109/10.16463; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Hirata M, 2004, NEUROIMAGE, V23, P46, DOI 10.1016/j.neuroimage.2004.05.009; Huang M, 1998, EVOKED POTENTIAL, V108, P32, DOI 10.1016/S0168-5597(97)00091-9; Huang MX, 2012, NEUROIMAGE, V61, P1067, DOI 10.1016/j.neuroimage.2012.04.029; Huang MX, 2009, J NEUROTRAUM, V26, P1213, DOI 10.1089/neu.2008.0672; Huang MX, 2006, NEUROIMAGE, V31, P1025, DOI 10.1016/j.neuroimage.2006.01.029; Knowlton RC, 2008, ANN NEUROL, V64, P25, DOI 10.1002/ana.21389; Knowlton RC, 2008, ANN NEUROL, V64, P35, DOI 10.1002/ana.21419; Leahy RM, 1998, ELECTROEN CLIN NEURO, V107, P159, DOI 10.1016/S0013-4694(98)00057-1; Lewine JD, 1999, AM J NEURORADIOL, V20, P857; LEWINE JD, 1995, FUNCTIONAL BRAIN IMA, P369; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; MacGregor AJ, 2010, J HEAD TRAUMA REHAB, V25, P1, DOI 10.1097/HTR.0b013e3181c2993d; MEIJS JWH, 1987, ELECTROEN CLIN NEURO, V66, P286, DOI 10.1016/0013-4694(87)90078-2; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; Papanicolaou AC, 2004, J NEUROSURG, V100, P867, DOI 10.3171/jns.2004.100.5.0867; Roberts T P, 2000, Brain Tumor Pathol, V17, P57, DOI 10.1007/BF02482736; Rockstroh BS, 2007, BMC PSYCHIATRY, V7, DOI 10.1186/1471-244X-7-44; SARVAS J, 1987, PHYS MED BIOL, V32, P11, DOI 10.1088/0031-9155/32/1/004; SCHAUL N, 1978, BRAIN RES, V143, P475, DOI 10.1016/0006-8993(78)90358-X; SCHLITT HA, 1995, IEEE T BIO-MED ENG, V42, P52, DOI 10.1109/10.362919; Simos PG, 2000, J CLIN NEUROPHYSIOL, V17, P143, DOI 10.1097/00004691-200003000-00004; Sutherling WW, 2008, NEUROLOGY, V71, P990, DOI 10.1212/01.wnl.0000326591.29858.1a; Ulmer JL, 2004, NEUROSURGERY, V55, P569, DOI 10.1227/01.NEU.0000134384.94749.B2; Vieth JB, 1996, BRAIN TOPOGR, V8, P215, DOI 10.1007/BF01184772; WADA J, 1960, J NEUROSURG, V17, P266, DOI 10.3171/jns.1960.17.2.0266; Wienbruch C, 2003, CLIN NEUROPHYSIOL, V114, P2052, DOI 10.1016/S1388-2457(03)00210-4; Xu J, 2007, J NEUROTRAUM, V24, P753, DOI 10.1089/neu.2006.0208	47	11	11	0	4	KARGER	BASEL	POSTFACH, CH-4009 BASEL, SWITZERLAND	0079-6492		978-3-318-02649-8; 978-3-318-02648-1	PROG NEUROL SURG			2014	28						94	111		10.1159/000358768	10.1159/isbn.978-3-318-02649-8		18	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	BC8EJ	WOS:000355566000010	24923396				2021-06-18	
J	Mutschler, M; Nienaber, U; Munzberg, M; Fabian, T; Paffrath, T; Wolfl, C; Bouillon, B; Maegele, M				Mutschler, Manuel; Nienaber, Ulrike; Muenzberg, Matthias; Fabian, Tobias; Paffrath, Thomas; Woelfl, Christoph; Bouillon, Bertil; Maegele, Marc			Assessment of hypovolaemic shock at scene: is the PHTLS classification of hypovolaemic shock really valid?	EMERGENCY MEDICINE JOURNAL			English	Article						Trauma; triage; prehospital care; major trauma management	SYSTOLIC BLOOD-PRESSURE; INCREASED MORTALITY; TRAUMA PATIENTS; 110 MMHG; HYPOTENSION; RISK	Objective Validation of the classification of hypovolaemic shock suggested by the prehospital trauma life support (PHTLS) in its sixth student course manual. Methods Adults, entered into the TraumaRegister DGU((R)) database between 2002 and 2011, were classified into reference ranges for heart rate (HR), systolic blood pressure (SBP) and Glasgow coma scale (GCS) according to the PHTLS classification of hypovolaemic shock. First, patients were grouped by a combination of all three parameters (HR, SBP and GCS) as suggested by PHTLS. Second, patients were classified by only one parameter (HR, SBP or GCS) according to PHTLS and alterations in the remaining two parameters were assessed. Furthermore, subgroup analysis for trauma mechanism and traumatic brain injury (TBI) were performed. Results Out of 46689 patients, only 12432 (26.5%) could be adequately classified according to PHTLS if a combination of all three criteria was assessed. In TBI patients, only 12.2% could be classified adequately, whereas trauma mechanism had no significant influence. When patients were grouped by HR, there was only a slight reduction in SBP. When grouped by SBP, GCS dropped from 14 to 8, while no significant tachycardia was observed in any group. In patients with a GCS less than 12, HR was unaltered whereas SBP was slightly reduced to 114 (42)mmHg. On average, GCS in TBI patients was lower within all shock groups. In penetrating trauma patients, changes in HR and SBP were more distinct, but still less than predicted by PHTLS. Conclusions The PHTLS classification of hypovolaemic shock displays substantial deficits in adequately risk-stratifying trauma patients.	[Mutschler, Manuel; Fabian, Tobias; Paffrath, Thomas; Bouillon, Bertil; Maegele, Marc] Univ Witten Herdecke, CMMC, Dept Trauma & Orthoped Surg, D-51109 Cologne, Germany; [Nienaber, Ulrike] Acad Trauma Surg, Berlin, Germany; [Muenzberg, Matthias; Woelfl, Christoph] BG Hosp Ludwigshafen, Dept Trauma & Orthoped Surg, Ludwigshafen, Germany	Mutschler, M (corresponding author), Univ Witten Herdecke, CMMC, Dept Trauma & Orthoped Surg, Ostmerheimerstr 200, D-51109 Cologne, Germany.	manuelmutschler@web.de					Baker SP, 1974, J TRAUMA, V14, P87; BARDENHEUE M, 1994, UNFALLCHIRURG, V97, P230; Brasel KJ, 2007, J TRAUMA, V62, P812, DOI 10.1097/TA.0b013e31803245a1; Bruns B, 2008, J TRAUMA, V65, P1217, DOI 10.1097/TA.0b013e318184ee63; Committee on Trauma American College of Surgeons, 2008, ADV TRAUM LIF SUPP D; Eastridge BJ, 2007, J TRAUMA, V63, P291, DOI 10.1097/TA.0b013e31809ed924; GREENSPAN L, 1985, J TRAUMA, V25, P60, DOI 10.1097/00005373-198501000-00010; Grote S, 2011, J NEUROTRAUM, V28, P527, DOI 10.1089/neu.2010.1433; Guly HR, 2011, RESUSCITATION, V82, P556, DOI 10.1016/j.resuscitation.2011.01.013; Guly HR, 2010, RESUSCITATION, V81, P1142, DOI 10.1016/j.resuscitation.2010.04.007; Hasler RM, 2012, RESUSCITATION, V83, P476, DOI 10.1016/j.resuscitation.2011.10.018; Hasler RM, 2011, RESUSCITATION, V82, P1202, DOI 10.1016/j.resuscitation.2011.04.021; Jansen TC, 2008, CRIT CARE, V12, DOI 10.1186/cc7159; Ley EJ, 2009, J TRAUMA, V67, P1051, DOI 10.1097/TA.0b013e3181bba222; Meregalli A, 2004, CRIT CARE, V8, pR60, DOI 10.1186/cc2423; Mutschler M, 2012, RESUSCITATION; National Association of Emergency Medical Technicians (U.S.) Prehospital Trauma Life Support Committee A.C.o.S.-C. o.T., 2007, PREH TRAUM LIF SUPP; Parks JK, 2006, AM J SURG, V192, P727, DOI 10.1016/j.amjsurg.2006.08.034; TEASDALE G, 1974, LANCET, V2, P81; Vandromme MJ, 2011, J TRAUMA, V70, P384, DOI 10.1097/TA.0b013e3182095a0a; Victorino GP, 2003, J AM COLL SURGEONS, V196, P679, DOI 10.1016/S1072-7515(03)00128-5	21	11	11	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1472-0205	1472-0213		EMERG MED J	Emerg. Med. J.	JAN	2014	31	1					35	39		10.1136/emermed-2012-202130			5	Emergency Medicine	Emergency Medicine	276JB	WOS:000328745500011	23302502				2021-06-18	
J	Pang, L; Wu, Y; Dong, N; Xu, DH; Wang, DW; Wang, ZH; Li, XL; Bian, M; Zhao, HJ; Liu, XL; Zhang, N				Pang, Li; Wu, Yang; Dong, Ning; Xu, Da-hai; Wang, Da-wei; Wang, Zhi-hao; Li, Xing-Liang; Bian, Miao; Zhao, Hui-jie; Liu, Xiao-liang; Zhang, Nan			Elevated serum ubiquitin C-terminal hydrolase-L1 levels in patients with carbon monoxide poisoning	CLINICAL BIOCHEMISTRY			English	Article						Biomarkers; Brain damage; CO poisoning; Ubiquitin C-terminal hydrolase L1	TRAUMATIC BRAIN-INJURY; HYPERBARIC-OXYGEN; RISK-FACTORS; BIOMARKER; L1	Objective: Ubiquitin C-terminal hydrolase-L1 (UCH-L1) has been established as a reliable and potential biomarker of neuronal damage after acute neurologic insults, such as ischemic stroke, subarachnoid hemorrhage, and traumatic brain injury. However, the effect of serum UCH-L1 levels has not been investigated in carbon monoxide (CO)-poisoned patients. The aim of the present study was to evaluate whether serum UCH-L1 levels are a reliable marker of brain damage and the association of UCH-L1 with outcome. Design and methods: This case-control study enrolled 46 CO-poisoned subjects and 30 controls. Using an enzyme-linked immunosorbent assay (ELISA) kit, we studied the temporal profile of serum UCH-L1 levels at 6, 12, 24 and 48 h after acute CO poisoning. Poisoning severity was assessed using the Glasgow Coma Scale (GCS) score. Long-term outcome was assessed using the Glasgow Outcome Scale (GOS) at 6 months after poisoning. Results: Compared with controls, CO-poisoned patients had significantly elevated serum levels of UCH-L1 at each time point after poisoning. There were significantly higher levels of UCH-L1 in CO-poisoned patients with a lower GCS score as well as in those with a poor 6-month outcome dichotomized GOS. Conclusions: Serum levels of UCH-L1 appear to have potential clinical utility in providing valuable information about poisoning severity and outcome after CO poisoning. (C) 2013 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.	[Pang, Li; Wu, Yang; Dong, Ning; Xu, Da-hai; Wang, Da-wei; Wang, Zhi-hao; Li, Xing-Liang; Liu, Xiao-liang; Zhang, Nan] Jilin Univ, Affiliated Hosp 1, Dept Emergency, Changchun 130021, Jilin, Peoples R China; [Bian, Miao; Zhao, Hui-jie] Qianwei Hosp Jilin Prov, Dept Resp, Changchun, Jilin, Peoples R China	Liu, XL (corresponding author), Jilin Univ, Affiliated Hosp 1, Dept Emergency, 71 Xinmin Ave, Changchun 130021, Jilin, Peoples R China.	466634002@qq.com					Blyth BJ, 2011, J NEUROTRAUM, V28, P2453, DOI 10.1089/neu.2010.1653; Buckley Nicholas A, 2005, Toxicol Rev, V24, P75, DOI 10.2165/00139709-200524020-00002; Douglas-Escobar M, 2010, PEDIATR RES, V68, P531, DOI 10.1203/PDR.0b013e3181f85a03; Gong B, 2007, DRUG NEWS PERSPECT, V20, P365, DOI 10.1358/dnp.2007.20.6.1138160; Hampson NB, 2008, CRIT CARE MED, V36, P2523, DOI 10.1097/CCM.0b013e31818419d8; JACKSON P, 1981, J NEUROL SCI, V49, P429, DOI 10.1016/0022-510X(81)90032-0; Lewis SB, 2010, J NEUROSCI RES, V88, P1475, DOI 10.1002/jnr.22323; Liu MC, 2010, EUR J NEUROSCI, V31, P722, DOI 10.1111/j.1460-9568.2010.07097.x; Meric E, 2010, J EMERG MED, V38, P297, DOI 10.1016/j.jemermed.2007.11.032; Setsuie R, 2007, NEUROCHEM INT, V51, P105, DOI 10.1016/j.neuint.2007.05.007; Silver Shawna, 2006, CJEM, V8, P43; Stoller KP, 2007, NEUROL RES, V29, P146, DOI 10.1179/016164107X181770; Weaver LK, 2007, AM J RESP CRIT CARE, V176, P491, DOI 10.1164/rccm.200701-026OC; Weaver LK, 2009, NEW ENGL J MED, V360, P1217, DOI 10.1056/NEJMcp0808891; Wolf SJ, 2008, ANN EMERG MED, V51, P138, DOI 10.1016/j.annemergmed.2007.10.012	15	11	11	0	5	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0009-9120	1873-2933		CLIN BIOCHEM	Clin. Biochem.	JAN	2014	47	1-2					72	76		10.1016/j.clinbiochem.2013.09.015			5	Medical Laboratory Technology	Medical Laboratory Technology	285UX	WOS:000329421600014	24080464				2021-06-18	
J	Pogoda, TK; Iverson, KM; Meterko, M; Baker, E; Hendricks, AM; Stolzmann, KL; Krengel, M; Charns, MP; Amara, J; Kimerling, R; Lew, HL				Pogoda, Terri K.; Iverson, Katherine M.; Meterko, Mark; Baker, Errol; Hendricks, Ann M.; Stolzmann, Kelly L.; Krengel, Maxine; Charns, Martin P.; Amara, Jomana; Kimerling, Rachel; Lew, Henry L.			Concordance of clinician judgment of mild traumatic brain injury history with a diagnostic standard	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						American Congress of Rehabilitation Medicine guidelines; blast injuries; comprehensive traumatic brain injury evaluation; diagnosis; mild traumatic brain injury; neurobehavioral manifestations; non-blast injuries; posttraumatic stress disorder; psychological factors; Veterans	POSTTRAUMATIC-STRESS-DISORDER; PERSISTENT POSTCONCUSSIVE SYMPTOMS; IRAQ; AFGHANISTAN; DEPLOYMENT; MILITARY; VETERANS; ASSOCIATION; PREVALENCE; CHALLENGES	The concordance of Department of Veterans Affairs (VA) clinician judgment of mild traumatic brain injury (mTBI) history with American Congress of Rehabilitation Medicine (ACRM)-based criteria was examined for Operation Iraqi Freedom (OIF) and Operation Enduring Freedom (OEF) Veterans. In order to understand inconsistencies in agreement, we also examined the associations between evaluation outcomes and conceptually relevant patient characteristics, deployment-related events, current self-reported health symptoms, and suspected psychiatric conditions. The Veteran sample comprised 14,026 OIF/OEF VA patients with deployment-related mTBI history (n = 9,858) or no history of mTBI (n = 4,168) as defined by ACRM-based criteria. In the majority of cases (76.0%), clinician judgment was in agreement with the ACRM-based criteria. The most common inconsistency was between clinician judgment (no) and ACRM-based criteria (yes) for 21.3% of the patients. Injury etiology, current self-reported health symptoms, and suspected psychiatric conditions were additional factors associated with clinician diagnosis and ACRM-based criteria disagreement. Adherence to established diagnostic guidelines is essential for accurate determination of mTBI history and for understanding the extent to which mTBI symptoms resolve or persist over time in OIF/OEF Veterans.	[Pogoda, Terri K.; Meterko, Mark; Baker, Errol; Stolzmann, Kelly L.; Charns, Martin P.] Dept Vet Affairs VA Boston Hlthcare Syst, Ctr Healthcare Org & Implementat Res, Boston, MA USA; [Pogoda, Terri K.; Meterko, Mark; Hendricks, Ann M.; Charns, Martin P.] Boston Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA USA; [Iverson, Katherine M.] VA Boston Healthcare Syst, Natl Ctr Posttraumat Stress Disorder, Boston, MA 02130 USA; [Iverson, Katherine M.] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA; [Pogoda, Terri K.; Hendricks, Ann M.] VA Boston Healthcare Syst, Boston, MA 02130 USA; [Krengel, Maxine] VA Boston Healthcare Syst, Res & Dev Serv, Boston, MA 02130 USA; [Krengel, Maxine] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Amara, Jomana] Naval Postgrad Sch, Def Resource Management Inst, Monterey, CA USA; [Kimerling, Rachel] VA Palo Alto Healthcare Syst, Natl Ctr Posttraumat Stress Disorder, Palo Alto, CA USA; [Kimerling, Rachel] VA Palo Alto Healthcare Syst, Ctr Hlth Care Evaluat, Palo Alto, CA USA; [Lew, Henry L.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Def & Vet Brain Injury Ctr, Richmond, VA USA; [Lew, Henry L.] Univ Hawaii Manoa, John A Burns Sch Med, Dept Commun Sci & Disorders, Honolulu, HI 96822 USA	Pogoda, TK (corresponding author), VA Boston Healthcare Syst, 150 S Huntington Ave 152M, Boston, MA 02130 USA.	terri.pogoda@va.gov	Pogoda, Terri/F-6243-2012	Pogoda, Terri/0000-0003-1397-8780; Kimerling, Rachel/0000-0003-0996-4212; Charns, Martin/0000-0002-7102-5331	VA Office of Research and Development, Health Services Research and Development ServiceUS Department of Veterans Affairs [SDR 08-405]; Health Services Research and Development Service Career Development Award [CDA-2, 10-029]	This material was based on work supported by the VA Office of Research and Development, Health Services Research and Development Service (grant SDR 08-405). Dr. Iverson's contribution was supported by a Health Services Research and Development Service Career Development Award (CDA-2; 10-029).	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Bass CR, 2012, ANN BIOMED ENG, V40, P185, DOI 10.1007/s10439-011-0424-0; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Bryant RA, 2011, DEPRESS ANXIETY, V28, P802, DOI 10.1002/da.20737; Bryant RA, 2011, J CLIN PSYCHIAT, V72, P233, DOI 10.4088/JCP.09r05072blu; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Centers for Disease Control and Prevention, 2010, INJ PREV CONTR TRAUM; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Corrin A, 2013, C GAO TAKE AIM DOD V; Donnelly KT, 2011, J HEAD TRAUMA REHAB, V26, P439, DOI 10.1097/HTR.0b013e3182005de3; Gondusky JS, 2005, MIL MED, V170, P546, DOI 10.7205/MILMED.170.6.546; Hendricks AM, 2013, BRAIN INJURY, V27, P125, DOI 10.3109/02699052.2012.729284; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Iverson GL, 2009, CLIN NEUROPSYCHOL, V23, P1299, DOI 10.1080/13854040903153902; Iverson KM, 2011, WOMEN HEALTH ISS, V21, pS210, DOI 10.1016/j.whi.2011.04.019; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Lew HL, 2008, J REHABIL RES DEV, V45, pXI, DOI 10.1682/JRRD.2008.05.0064; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; McAllister TW, 2010, ANN NY ACAD SCI, V1208, P46, DOI 10.1111/j.1749-6632.2010.05720.x; Meterko M, 2012, J HEAD TRAUMA REHAB, V27, P55, DOI 10.1097/HTR.0b013e318230fb17; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Sayer NA, 2011, J HEAD TRAUMA REHAB, V26, P454, DOI 10.1097/HTR.0b013e3181ff393c; Sayer NA, 2009, J REHABIL RES DEV, V46, P703, DOI 10.1682/JRRD.2009.01.0008; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Scott SG, 2006, J AM OSTEOPATH ASSOC, V106, P265; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Tanielian T, 2008, INVISIBLE WOUNDS WAR, P492; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; U. S. Department of the Army Office of the Surgeon General Traumatic Brain Injury Task Force, 2008, REP SURG GEN; U. S. Government Accountability Office, 2008, VA HLTH CAR MILD TRA, P1; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604	43	11	11	0	3	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2014	51	3					363	375		10.1682/JRRD.2013.05.0115			13	Rehabilitation	Rehabilitation	AL5KL	WOS:000339172400005	25019660	Bronze			2021-06-18	
J	Rike, PO; Ulleberg, P; Schultheis, MT; Lundqvist, A; Schanke, AK				Rike, Per-Ola; Ulleberg, Pal; Schultheis, Maria T.; Lundqvist, Anna; Schanke, Anne-Kristine			Behavioural ratings of self-regulatory mechanisms and driving behaviour after an acquired brain injury	BRAIN INJURY			English	Article						Automobile driving; executive function; neuropsychology; personality; self-regulation; stroke; traumatic brain injuries	EXECUTIVE FUNCTION; ACCIDENT RATE; FOLLOW-UP; PERSONALITY; DRIVERS; STROKE; PREDICTORS; AWARENESS; FITNESS; ABILITY	Objective: To explore whether measurements of self-regulatory mechanisms and cognition predict driving behaviour after an acquired brain injury (ABI). Design: Consecutive follow-up study. Participants: At baseline participants included 77 persons with stroke and 32 persons with a traumatic brain injury (TBI), all of whom completed a multidisciplinary driving assessment (MDA). A follow-up cohort of 34 persons that succeeded the MDA was included. Baseline measurements: Neuropsychological tests and measurements of self-regulatory mechanisms (BRIEF-A and UPPS Impulsive Behaviour Scale), driving behaviour (DBQ) and pre-injury driving characteristics (mileage, compensatory driving strategies and accident rates). Follow-up measurements: Post-injury driving characteristics were collected by mailed questionnaires from the participants who succeeded the MDA. Methods: A MDA, which included a medical examination, neuropsychological testing and an on-road driving test, was considered in the decision for or against granting a driver's license. Self-regulatory mechanisms and driving behaviour were examined for research purposes only. Results: At baseline, self-regulatory mechanisms were significantly associated to aberrant driving behaviour, but not with neuropsychological data or with the outcome of the on-road driving test. Aspects of self-regulation were associated to driving behaviour at follow-up. Conclusion: It is recommended that self-regulatory measurements should regularly be considered in the driving assessments after ABI.	[Rike, Per-Ola; Schanke, Anne-Kristine] Sunnaas Rehabil Hosp, Nesodden, Norway; [Ulleberg, Pal; Schanke, Anne-Kristine] Univ Oslo, Dept Psychol, N-0316 Oslo, Norway; [Schultheis, Maria T.] Drexel Univ, Dept Psychol, Philadelphia, PA 19104 USA; [Lundqvist, Anna] Linkoping Univ Hosp, Dept Rehabil Med, S-58185 Linkoping, Sweden	Rike, PO (corresponding author), Sunnaas Rehabil Hosp, N-1450 Nesoddtangen, Norway.	perola.rike@gmail.com		Schultheis, Maria/0000-0002-6558-548X	Extrastiftelsen [2008/2/0113]	The authors thank all persons for their participation and Frank Becker, MD, for the medical data quality assurance. The study was supported by grants from Extrastiftelsen (grant number 2008/2/0113).	Aberg L, 1998, ERGONOMICS, V41, P39, DOI 10.1080/001401398187314; Adrian J, 2011, ACCIDENT ANAL PREV, V43, P1652, DOI 10.1016/j.aap.2011.03.023; Af Wahlberg A, 2011, THEOR ISS ERGON SCI, V12, P66, DOI 10.1080/14639220903023376; Andelic N, 2008, NEUROEPIDEMIOLOGY, V30, P120, DOI 10.1159/000120025; Baumeister R. F., 2011, HDB SELF REGULATION; Bieliauskas LA, 1998, CLIN NEUROPSYCHOL, V12, P206, DOI 10.1076/clin.12.2.206.1994; Bivona U, 2012, J HEAD TRAUMA REHAB, V27, P210, DOI 10.1097/HTR.0b013e31822178a9; Burgess P. W., 1996, BEHAV ASSESSMENT DYS; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; Classen S, 2009, AM J OCCUP THER, V63, P580, DOI 10.5014/ajot.63.5.580; Coleman BR., 2005, DRIVER REHABILITATIO, P165; Coleman RD, 2002, ARCH PHYS MED REHAB, V83, P1415, DOI 10.1053/apmr.2002.35111; Constantinou E, 2011, ACCIDENT ANAL PREV, V43, P1323, DOI 10.1016/j.aap.2011.02.002; Costa P., 1992, REVISED NEO PERSONAL; D'Argembeau A, 2005, NEUROIMAGE, V25, P616, DOI 10.1016/j.neuroimage.2004.11.048; de Winter JCF, 2010, J SAFETY RES, V41, P463, DOI 10.1016/j.jsr.2010.10.007; de Winter JCF, 2011, THEORETICAL ISSUES E, V13, P528; Delis DC, 2001, EXAMINERS MANUAL DEL; Dolan SL, 2008, BEHAV SCI LAW, V26, P799, DOI 10.1002/bsl.845; Ellekjaer Hanne, 2007, Tidsskr Nor Laegeforen, V127, P740; Formisano R, 2005, BRAIN INJURY, V19, P159, DOI 10.1080/02699050400017163; Fox GK, 1997, J AM GERIATR SOC, V45, P949, DOI 10.1111/j.1532-5415.1997.tb02965.x; Galovski Tara E, 2006, ROAD RAGE ASSESSMENT, Vxi, P83, DOI [10.1037/11297-005, DOI 10.1037/11297-005]; Galovski TE, 2006, ROAD RAGE ASSESSMENT, P27; Gianutsos R, 1981, COMPUTER PROGRAMS CO; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Gioia GA, 2010, J HEAD TRAUMA REHAB, V25, P433, DOI 10.1097/HTR.0b013e3181fbc272; Griffen JA, 2011, CLIN NEUROPSYCHOL, V25, P1158, DOI 10.1080/13854046.2011.609841; GRIFFITHS KM, 1988, J CLIN EXP NEUROPSYC, V10, P800, DOI 10.1080/01688638808402815; Hargrave DD, 2012, NEUROPSYCHOL REHABIL, V22, P489, DOI 10.1080/09602011.2012.662333; Haselkorn JK, 1998, ARCH PHYS MED REHAB, V79, P738, DOI 10.1016/S0003-9993(98)90349-5; Hatakka M., 2002, TRANSPORTATION RES F, V5, P201, DOI [10.1016/S1369-8478(02)00018-9., 10.1016/S1369-8478]; Heaton R.K., 1991, COMPREHENSIVE NORMS; Heikkila VM, 1999, ACTA NEUROL SCAND, V99, P349, DOI 10.1111/j.1600-0404.1999.tb07363.x; Hofmann W, 2012, TRENDS COGN SCI, V16, P174, DOI 10.1016/j.tics.2012.01.006; Hunt AW, 2013, NEUROPSYCHOL REHABIL, V23, P914, DOI 10.1080/09602011.2013.835739; KATZ RT, 1990, ARCH PHYS MED REHAB, V71, P133; Korteling JE, 1996, ARCH PHYS MED REHAB, V77, P138, DOI 10.1016/S0003-9993(96)90158-6; Lundberg C, 2003, SCAND J PSYCHOL, V44, P23, DOI 10.1111/1467-9450.00317; Lundqvist A, 2008, BRAIN INJURY, V22, P295, DOI 10.1080/02699050801966133; Lundqvist A, 2007, BRAIN INJURY, V21, P1109, DOI 10.1080/02699050701651660; Lundqvist A, 1997, APPL NEUROPSYCHOL, V4, P220, DOI 10.1207/s15324826an0404_3; Marshall SC, 2007, TOP STROKE REHABIL, V14, P98, DOI 10.1310/tsr1401-98; Michon J.A., 1985, HUMAN BEHAV TRAFFIC, P485, DOI [10.1007/978-1-4613-2173-6 19, DOI 10.1007/978-1-4613-2173-619]; Morris LJ, 2008, RELATIONSHIPS AGE EX; Neyens DM, 2012, ACCIDENT ANAL PREV, V49, P266, DOI 10.1016/j.aap.2012.01.008; Nichols AL, 2012, TRAFFIC INJ PREV, V13, P133, DOI 10.1080/15389588.2011.644254; Ortoleva C, 2012, J HEAD TRAUMA REHAB, V27, P302, DOI 10.1097/HTR.0b013e3182236299; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Peden M., 2004, WORLD REPORT ROAD TR; Pietrapiana P, 2005, BRAIN INJURY, V19, P197, DOI 10.1080/02699050400017197; Pietrzak RH, 2008, J RES PERS, V42, P1347, DOI 10.1016/j.jrp.2008.03.004; Rabin LA, 2006, ARCH CLIN NEUROPSYCH, V21, P721, DOI 10.1016/j.acn.2006.08.004; Radford KA, 2004, ARCH PHYS MED REHAB, V85, P324, DOI 10.1016/S0003-9993(03)00765-2; Rapport LJ, 2008, ARCH PHYS MED REHAB, V89, P922, DOI 10.1016/j.apmr.2008.01.009; REASON J, 1990, ERGONOMICS, V33, P1315, DOI 10.1080/00140139008925335; Roca J, 2013, TRANSPORT RES F-TRAF, V17, P98, DOI 10.1016/j.trf.2012.10.005; Rochat L, 2010, NEUROPSYCHOL REHABIL, V20, P778, DOI 10.1080/09602011.2010.495245; Rodriguez-Bailon M, 2012, SPAN J PSYCHOL, V15, P967, DOI 10.5209/rev_SJOP.2012.v15.n3.39388; Roth R.M., 2005, BEHAV RATING INVENTO; Schanke AK, 2000, SCAND J PSYCHOL, V41, P113, DOI 10.1111/1467-9450.00179; Schanke AK, 2008, J REHABIL MED, V40, P733, DOI 10.2340/16501977-0256; Schultheis MT, 2009, HANDBOOK FOR THE ASSESSMENT OF DRIVING CAPACITY, P1; Schultheis MT, 2002, J HEAD TRAUMA REHAB, V17, P38, DOI 10.1097/00001199-200202000-00006; Schwebel DC, 2007, J SAFETY RES, V38, P501, DOI 10.1016/j.jsr.2007.04.005; Scott CA, 2009, J CLIN EXP NEUROPSYC, V31, P353, DOI 10.1080/13803390802169067; Sherer M, 1998, BRAIN INJURY, V12, P63, DOI 10.1080/026990598122863; Smith A, 1982, SYMBOL DIGITS MODALI; Sommer M, 2010, ARCH CLIN NEUROPSYCH, V25, P99, DOI 10.1093/arclin/acp109; Stuss D. T., 2007, HUMAN FRONTAL LOBES, P292; Stuss D. T., 2009, REHABILITATION EXECU, P3; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Sumer N, 2003, ACCIDENT ANAL PREV, V35, P949, DOI 10.1016/S0001-4575(02)00103-3; SUNDET K, 1995, SCAND J PSYCHOL, V36, P47, DOI 10.1111/j.1467-9450.1995.tb00967.x; Tamietto M, 2006, NEUROREHABILITATION, V21, P81; Temple CM, 1997, DEV COGNITIVE NEUROP; Toglia J, 2010, BRAIN INJURY, V24, P664, DOI 10.3109/02699051003610474; Ulleberg P, 2002, SCAND J PSYCHOL, V43, P227, DOI 10.1111/1467-9450.00291; VANZOMEREN AH, 1987, ARCH PHYS MED REHAB, V68, P697; Verdejo-Garcia A, 2010, PSYCHOPHARMACOLOGY, V210, P377, DOI 10.1007/s00213-010-1833-8; Wechsler D, 1997, WAIS 3 ADM SCORING M; Whiteside SP, 2001, PERS INDIV DIFFER, V30, P669, DOI 10.1016/S0191-8869(00)00064-7; Withaar FK, 2000, J INT NEUROPSYCH SOC, V6, P480, DOI 10.1017/S1355617700644065; Wood RL, 2006, ARCH CLIN NEUROPSYCH, V21, P429, DOI 10.1016/j.acn.2005.06.014; Ylvisaker M, 1998, TRAUMATIC BRAIN INJU, Vxiv, P479; Zinn S, 2007, ARCH PHYS MED REHAB, V88, P173, DOI 10.1016/j.apmr.2006.11.015; ZUCKERMAN M, 1978, J CONSULT CLIN PSYCH, V46, P139, DOI 10.1037/0022-006X.46.1.139	87	11	11	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2014	28	13-14					1687	1699		10.3109/02699052.2014.947632			13	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	AT1LY	WOS:000344696600008	25158241				2021-06-18	
J	Sullivan, KA; Edmed, SL; Kempe, C				Sullivan, Karen A.; Edmed, Shannon L.; Kempe, Chloe			The Effect of Injury Diagnosis on Illness Perceptions and Expected Postconcussion Syndrome and Posttraumatic Stress Disorder Symptoms	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						mild traumatic brain injury; acquired brain injury; head injury; neurocognitive disorder; postconcussion syndrome; neuropsychology; posttraumatic stress disorder	TRAUMATIC BRAIN-INJURY; MILD HEAD-INJURY; COGNITIVE PERFORMANCE; SERVICE MEMBERS; CONCUSSION; NEUROPSYCHOLOGY; RECOMMENDATIONS; INDIVIDUALS; TERMINOLOGY; EXPECTATION	Objective: To determine if systematic variation of diagnostic terminology (ie, concussion, minor head injury [MHI], mild traumatic brain injury [mTBI]) following a standardized injury description produced different expected symptoms and illness perceptions. We hypothesized that worse outcomes would be expected of mTBI, compared with other diagnoses, and that MHI would be perceived as worse than concussion. Method: 108 volunteers were randomly allocated to conditions in which they read a vignette describing a motor vehicle accident-related mTBI followed by a diagnosis of mTBI (n = 27), MHI (n = 24), concussion (n = 31), or, no diagnosis (n = 26). All groups rated (a) event "undesirability," (b) illness perception, and (c) expected postconcussion syndrome (PCS) and posttraumatic stress disorder (PTSD) symptoms 6 months after injury. Results: There was a statistically significant group effect on undesirability (mTBI > concussion and MHI), PTSD symptomatology (mTBI and no diagnosis > concussion), and negative illness perception (mTBI and no diagnosis > concussion). Conclusion: In general, diagnostic terminology did not affect anticipated PCS symptoms 6 months after injury, but other outcomes were affected. Given that these diagnostic terms are used interchangeably, this study suggests that changing terminology can influence known contributors to poor mTBI outcome.	[Sullivan, Karen A.; Edmed, Shannon L.; Kempe, Chloe] Queensland Univ Technol, Clin Neuropsychol Res Grp, Sch Psychol & Counselling, Brisbane, Qld 4001, Australia; [Sullivan, Karen A.; Edmed, Shannon L.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia	Sullivan, KA (corresponding author), Queensland Univ Technol, O Block,B Wing,Kelvin Grove Campus,Victoria Pk Rd, Kelvin Grove, Qld 4059, Australia.	karen.sullivan@qut.edu.au			School of Psychology and Counselling, Queensland University of Technology	The Human Research Ethics Committee of Queensland University of Technology (QUT-HREC 1000000311) approved this research. This project was granted an occupational workplace health and safety clearance. Funding for this project was provided by the School of Psychology and Counselling, Queensland University of Technology. Parts of this project were presented at the Australian Psychological Society, College of Clinical Neuropsychology Conference, Launceston Tasmania, November 22-25, 2012.	Al Sayegh A, 2010, J NEUROL NEUROSUR PS, V81, P1128, DOI 10.1136/jnnp.2008.170092; American Psychological Association, 2000, DIAGN STAT MAN MENT, V4; Anderson T, 2006, PRACT NEUROL, V6, P342, DOI DOI 10.1136/JNNP.2006.106583; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cooper DB, 2011, ARCH CLIN NEUROPSYCH, V26, P718, DOI 10.1093/arclin/acr070; DeMatteo CA, 2010, PEDIATRICS, V125, P327, DOI 10.1542/peds.2008-2720; Ettenhofer ML, 2012, J INT NEUROPSYCH SOC, V18, P451, DOI 10.1017/S1355617711001895; Ferrari R, 2011, J NEUROL NEUROSUR PS, V82, P826, DOI 10.1136/jnnp.2010.213520; Gunstad J, 2002, J INT NEUROPSYCH SOC, V8, P37, DOI 10.1017/S1355617701020045; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Iverson G.L., 2012, PTSD MILD TRAUMATIC; Iverson G.L., 2012, PTSD MILD TRAUMATIC, P37; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 2011, LITTLE BLACK BOOK NE, P688; JACOBSON RR, 1995, J PSYCHOSOM RES, V39, P675, DOI 10.1016/0022-3999(95)00006-5; Kennedy JE, 2010, NEUROREHABILITATION, V26, P191, DOI 10.3233/NRE-2010-0555; King P A, 2011, PSYCHOMETRIC STUDY N; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; McCrae M. A., 2008, MILD TRAUMATIC BRAIN; Mckinlay A, 2011, BRAIN INJURY, V25, P761, DOI 10.3109/02699052.2011.579935; McLellan T, 2010, J INT NEUROPSYCH SOC, V16, P705, DOI 10.1017/S1355617710000524; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Moss-Morris R, 2002, PSYCHOL HEALTH, V17, P1, DOI 10.1080/08870440290001494; NIES KJ, 1994, ARCH CLIN NEUROPSYCH, V9, P501, DOI 10.1016/0887-6177(94)90041-8; Oppenheimer DM, 2009, J EXP SOC PSYCHOL, V45, P867, DOI 10.1016/j.jesp.2009.03.009; Ozen LJ, 2011, J INT NEUROPSYCH SOC, V17, P219, DOI 10.1017/S135561771000144X; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Sbordone RJ, 2010, PSYCHOL INJ LAW, V3, P63, DOI 10.1007/s12207-010-9066-z; Suhr JA, 2005, J INT NEUROPSYCH SOC, V11, P23, DOI 10.1017/S1355617705050010; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P448, DOI 10.1076/jcen.24.4.448.1039; Sullivan KA, 2013, BRAIN INJURY, V27, P19, DOI 10.3109/02699052.2012.698360; Sullivan KA, 2012, CLIN NEUROPSYCHOL, V26, P1255, DOI 10.1080/13854046.2012.735254; Sullivan KA, 2012, J HEAD TRAUMA REHAB, V27, P293, DOI 10.1097/HTR.0b013e31822123ce; Summers CR, 2009, MT SINAI J MED, V76, P105, DOI 10.1002/msj.20100; Tabachnick BG, 2007, USING MULTIVARIATE S; Weathers F. W., 1993, ANN M INT SOC TRAUM; Weber M, 2010, BRAIN INJURY, V24, P1364, DOI 10.3109/02699052.2010.507110; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Williams WH, 2010, J NEUROL NEUROSUR PS, V81, P1116, DOI 10.1136/jnnp.2008.171298; Wills SM, 2001, BRAIN INJURY, V15, P645, DOI 10.1080/02699050010010502; World Health Organization, 1992, ICD 10 INT STAT CLAS	44	11	12	0	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2014	29	1					54	64		10.1097/HTR.0b013e31828c708a			11	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	AH1OC	WOS:000335889400011	23640540				2021-06-18	
J	Wehman, P; Chen, CC; West, M; Cifu, G				Wehman, Paul; Chen, Chin-Chih; West, Michael; Cifu, Gabriella			Transition planning for youth with traumatic brain injury: Findings from the National Longitudinal Transition Survey-2	NEUROREHABILITATION			English	Article						Traumatic brain injury; school-to-work transition; postschool outcomes	SHORT-TERM; OUTCOMES; PREDICTORS; BEHAVIOR; WORK	BACKGROUND: Despite of a growing body of research on vocational and educational difficulties for students with traumatic brain injury (TBI), only limited empirical studies specifically examined how school transition services facilitate later employment outcomes. OBJECTIVE: This exploratory, prospective longitudinal study examined the prevalence of employment and characteristics of transition planning practices that promoted positive school-to-work transition for students with TBI. METHOD: The participants (n = 200) was drawn from the National Longitudinal Transition Study-2 (NLTS-2), a ten-year study which followed a large nationally representative sample of youth with disabilities through secondary education in into young adulthood. Logistic regression was used to investigate the associations between student, school, and collaborative engagement in the planning process and employment outcomes up to 8 years after high school. RESULTS: Among youth with TBI, 51% held current employment at the time of interview and 73% had been employed at any time after high school. Findings showed that students with TBI who had transition goals for postsecondary education were more likely to be employed at some point since leaving high school. The findings also support active student engagement and leadership in the transition planning process, and the inclusion of outside organizations and individuals. CONCLUSIONS: Findings indicate the impact of student, school and adult service agency engagement in transition planning processes. Implications for educational practices and future research are discussed.	[West, Michael; Cifu, Gabriella] Virginia Commonwealth Univ, Rehabil Res & Training Ctr, Richmond, VA 23284 USA; [Wehman, Paul] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA; [Chen, Chin-Chih] Virginia Commonwealth Univ, Sch Educ, Richmond, VA USA	West, M (corresponding author), Virginia Commonwealth Univ, Rehabil Res & Training Ctr, Richmond, VA 23284 USA.	mdwest@vcu.edu	Chen, Chin-Chih/AAI-3139-2021	Chen, Chin-Chih/0000-0002-9503-8145	National Institute on Disability and Rehabilitation Research, U.S. Department of EducationUS Department of Education [H133A100007]	Preparation of this manuscript was supported in part by Cooperative Agreement H133A100007 from the National Institute on Disability and Rehabilitation Research, U.S. Department of Education.	Anderson V, 2011, NEUROPSYCHOLOGY, V25, P176, DOI 10.1037/a0021217; Cameto R., 2005, NLTS2 DATA BRIEF TRA; Carter EW, 2012, J DISABIL POLICY STU, V23, P50, DOI 10.1177/1044207311414680; Carter EW, 2011, INTELLECT DEV DISAB, V49, P233, DOI 10.1352/1934-9556-49.4.233; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Centers for Disease Control and Prevention, 2010, INJ PREV CONTR TRAUM; Cimera R. E., 2007, J VOCATIONAL REHABIL, V28, P15; Hoofien D, 2001, BRAIN INJURY, V15, P189; Kaye HS, 2010, MON LABOR REV, V133, P19; Landmark LJ, 2010, CAREER DEV TRANSIT E, V33, P165, DOI 10.1177/0885728810376410; Martin JE, 2006, EXCEPT CHILDREN, V72, P299, DOI 10.1177/001440290607200303; Migliore A, 2007, J VOCAT REHABIL, V26, P5; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Test DW, 2009, CAREER DEV TRANSIT E, V32, P115, DOI 10.1177/0885728809336859; Thurman D. J., 2013, BRAIN INJURY MED PRI, P45; Todis B, 2008, J HEAD TRAUMA REHAB, V23, P252, DOI 10.1097/01.HTR.0000327257.84622.bc; Todis B, 2011, J HEAD TRAUMA REHAB, V26, P138, DOI 10.1097/HTR.0b013e3181e5a87a; Wagner M., 2012, J EMOT BEHAV DISORD, V14, P86; Wehman P., 2013, LIFE CLASSROOM TRANS; Yasuda S, 2001, AM J PHYS MED REHAB, V80, P852, DOI 10.1097/00002060-200111000-00011; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Yeates KO, 2000, SCI PRACT NEUROPSYCH, P92	23	11	11	0	8	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2014	34	2					365	372		10.3233/NRE-131029			8	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	AG3NM	WOS:000335326300018	24419015				2021-06-18	
J	White, PE; Shee, AW; Finch, CF				White, Peta E.; Shee, Anna Wong; Finch, Caroline F.			Independent appraiser assessment of the quality, methodological rigour and transparency of the development of the 2008 international consensus statement on concussion in sport	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article						Implementation; Injury Prevention; Concussion	CLINICAL GUIDELINE DEVELOPMENT; AGREE II; IMPLEMENTATION; ZURICH; RETURN	Aim In recent years, considerable effort has been devoted to the development and revisions to an international consensus statement on concussion in sport (ICSCS). The aim of this study was to obtain expert views on the methodological rigour and transparency with which the 2008 ICSCS was developed, as a precursor to the development of the 2012 update. Methods Delegates registered for the 2012 fourth International Conference on Concussion in Sport, selected local concussion researchers not involved in any prior international consensus meetings, and all authors of the 2008 ICSCS published paper were invited to assess the methodological rigour and transparency with which the 2008 ICSCS was developed. The online Appraisal of Guidelines for Research and Evaluation (AGREE) II assessment tool, with six quality domains, was used and domain scores were expressed as a percentage of the maximum possible score for that domain. Results 18 appraisers completed the online AGREE II assessment. Ten appraisers said they would recommend the 2008 ICSCS for use (without modification) and seven said they would recommend its use with some modification. The scope and purpose' and clarity of presentation' were rated highest, both scoring 78%. The lowest scoring domain was applicability' with a score of 55%. Conclusions The quality of the ICSCS is important because it is used to guide return-to-play decisions and the management of sport-related concussions. This appraisal of the 2008 ICSCS suggests that a greater focus is needed on the actual implementation of future ICSCS and the relationship between implementation and desired health outcomes.	[White, Peta E.; Shee, Anna Wong; Finch, Caroline F.] Univ Ballarat, Ctr Hlth & Safe Sport, Ballarat, Vic 3353, Australia	Finch, CF (corresponding author), Univ Ballarat, Ctr Hlth & Safe Sport, Ballarat, Vic 3353, Australia.	c.finch@ballarat.edu.au		Wong Shee, Anna/0000-0001-5095-218X	Victorian Sports Injury Prevention Research Grant from the Department of Planning and Community Development, Victoria, Australia; National Health and Medical Research CouncilNational Health and Medical Research Council of Australia [565900]	This work was supported by a Victorian Sports Injury Prevention Research Grant from the Department of Planning and Community Development, Victoria, Australia. CFF was supported by a National Health and Medical Research Council Principal Research Fellowship (ID: 565900).	AGREE Next Steps Consortium, 2009, AGR 2 INSTR; Alla S, 2011, BRIT J SPORT MED, V45, P132, DOI 10.1136/bjsm.2010.074088; Alonso-Coello P, 2010, QUAL SAF HEALTH CARE, V19, DOI 10.1136/qshc.2010.042077; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Brouwers MC, 2010, CAN MED ASSOC J, V182, pE472, DOI 10.1503/cmaj.091716; Brouwers MC, 2010, CAN MED ASSOC J, V182, P1045, DOI 10.1503/cmaj.091714; Burgers JS, 2003, INT J TECHNOL ASSESS, V19, P148, DOI 10.1017/S026646230300014X; Burgers JS, 2003, INT J QUAL HEALTH C, V15, P31, DOI 10.1093/intqhc/15.1.31; Donaldson A, 2012, BRIT J SPORT MED, V46, P306, DOI 10.1136/bjsports-2011-090461; Finch CF, 2013, BRIT J SPORT MED, V47, P12, DOI 10.1136/bjsports-2012-091796; Finch CF, 2010, BRIT J SPORT MED, V44, P913; Fretheim Atle, 2006, Health Res Policy Syst, V4, P15, DOI 10.1186/1478-4505-4-15; Hollis SJ, 2012, BRIT J SPORT MED, V46, P735, DOI 10.1136/bjsm.2011.085332; Knai C, 2012, HEALTH POLICY, V107, P157, DOI 10.1016/j.healthpol.2012.06.004; Legido-Quigley H, 2012, HEALTH POLICY, V107, P146, DOI 10.1016/j.healthpol.2012.08.004; Lohr K N, 1990, J Dent Educ, V54, P699; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; *NAT HLTH MED RES, 2000, PUT EV PRACT IMPL DI; Polus S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038891; Price J, 2012, BRIT J SPORT MED, V46, P1000, DOI 10.1136/bjsports-2011-090687; Van der Wees PJ, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-191	23	11	11	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	JAN	2014	48	2					130	U139		10.1136/bjsports-2013-092720			6	Sport Sciences	Sport Sciences	276KK	WOS:000328749000015	24128756	Green Published, Other Gold			2021-06-18	
J	Wilson, V; Mallipedhi, A; Stephens, JW; Redfern, RM; Price, DE				Wilson, V.; Mallipedhi, A.; Stephens, J. W.; Redfern, R. M.; Price, D. E.			The causes of hypopituitarism in the absence of abnormal pituitary imaging	QJM-AN INTERNATIONAL JOURNAL OF MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; IDIOPATHIC HYPOPITUITARISM; DIABETES-INSIPIDUS; HEMOCHROMATOSIS; INSUFFICIENCY; NEUROSARCOIDOSIS	Background: Hypopituitarism in the absence of a history of pituitary pathology or abnormal pituitary imaging is rare. Aim: To identify the cause of hypopituitarism in individuals in whom pituitary imaging was normal. Design: Retrospective analysis of electronic patient record. Method: A review of the pituitary function in the 506 patients on the Morriston Hospital pituitary database revealed 230 had some degree of hypopituitarism and of these, 21 (9%) had normal pituitary imaging. Results: Of this group, six patients had a past medical history of subarachnoid haemorrhage, head injury or meningitis, and mainly suffered from a deficiency of antidiuretic hormone. One patient had a stroke resulting in multiple anterior hormone deficiencies and six individuals had idiopathic cranial diabetes insipidus (DI). Subsequent investigations of the remaining eight patients with normal pituitary imaging revealed that two had neurosarcoidosis both of whom had panhypopituitarism. Four patients had haemochromatosis which resulted in gonadotropin deficiency in two, DI in one and panhypopituitarism in the other. There were two individuals with confirmed hypopituitarism and multiple hormone deficiencies in which no cause could be identified. Conclusion: These results show that hypopituitarism in the absence of pituitary pathology or an identifiable cause is rare. In patients with multiple anterior pituitary hormone deficiencies haemochromatosis and sarcoidosis should be considered.	[Wilson, V.; Mallipedhi, A.; Stephens, J. W.; Price, D. E.] Morriston Hosp, Dept Endocrinol & Diabet, Swansea SA6 6NL, W Glam, Wales; [Redfern, R. M.] Morriston Hosp, Dept Neurosurg, Swansea SA6 6NL, W Glam, Wales	Wilson, V (corresponding author), Morriston Hosp, Dept Endocrinol & Diabet, Swansea SA6 6NL, W Glam, Wales.	victoriawilson@doctors.org.uk					Agha A, 2004, J CLIN ENDOCR METAB, V89, P5987, DOI 10.1210/jc.2004-1058; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Al-Haddad S, 2011, ENDOCR PATHOL, V22, P6, DOI 10.1007/s12022-011-9148-9; Bates AS, 1996, J CLIN ENDOCR METAB, V81, P1169, DOI 10.1210/jc.81.3.1169; CARDOSO ER, 1984, NEUROSURGERY, V14, P363, DOI 10.1227/00006123-198403000-00021; CHARBONNEL B, 1981, ACTA ENDOCRINOL-COP, V98, P178, DOI 10.1530/acta.0.0980178; de Graaff LCG, 2009, HORM RES, V71, P22, DOI 10.1159/000173738; GAMA R, 1995, POSTGRAD MED J, V71, P297, DOI 10.1136/pgmj.71.835.297; Hadjizacharia P, 2008, J AM COLL SURGEONS, V207, P477, DOI 10.1016/j.jamcollsurg.2008.04.017; Klose M, 2007, CLIN ENDOCRINOL, V67, P598, DOI 10.1111/j.1365-2265.2007.02931.x; Lamberts SWJ, 1998, LANCET, V352, P127; Lewis AS, 2009, PITUITARY, V12, P273, DOI 10.1007/s11102-008-0090-x; Marko NF, 2012, J CLIN NEUROSCI, V19, P1282, DOI 10.1016/j.jocn.2011.05.031; Murialdo G, 2002, J ENDOCRINOL INVEST, V25, P650, DOI 10.1007/BF03345093; STUART CA, 1978, ANN INTERN MED, V88, P589, DOI 10.7326/0003-4819-88-5-589; Tanaka K, 2012, INTERNAL MED, V51, P2175, DOI 10.2169/internalmedicine.51.6957; Tsiakalos A, 2010, J CLIN ENDOCR METAB, V95, P3277, DOI 10.1210/jc.2010-0144; Wagner J, 2010, J NEUROTRAUM, V27, P1007, DOI 10.1089/neu.2009.1092; Young J, 2007, PRESSE MED, V36, P1319, DOI 10.1016/j.lpm.2007.01.041	19	11	12	0	5	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1460-2725	1460-2393		QJM-INT J MED	QJM-An Int. J. Med.	JAN	2014	107	1					21	24		10.1093/qjmed/hct193			4	Medicine, General & Internal	General & Internal Medicine	280SM	WOS:000329051100005	24106315	Bronze			2021-06-18	
J	Wu, X; Du, ZY; Yu, J; Sun, YR; Pei, BB; Lu, X; Tang, ZY; Yin, M; Zhou, LF; Hu, J				Wu, Xing; Du, Zhuoying; Yu, Jian; Sun, Yirui; Pei, Bingbing; Lu, Xin; Tang, Zhengyu; Yin, Mao; Zhou, Liangfu; Hu, Jin			Activity of factor VII in patients with isolated blunt traumatic brain injury: Association with coagulopathy and progressive hemorrhagic injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Factor VII; isolated traumatic brain injury; coagulopathy; progressive hemorrhagic injury	RECOMBINANT FACTOR VIIA; HEAD TRAUMA; INTRACEREBRAL HEMORRHAGE; COAGULATION DISORDERS; HYPOPERFUSION; RISK	BACKGROUND: Given the importance of factor VII (FVII) in extrinsic pathway of coagulation cascade, we sought to elucidate the relationship between FVII and traumatic brain injury-induced coagulopathy and progressive hemorrhagic injury (PHI). METHODS: Eighty-one patients with isolated traumatic brain injury, 16 years or older, were recruited between 2010 and 2012. Blood was collected on arrival in the emergency department and analyzed with activated partial thromboplastic time, international normalized ratio, platelet count, and activity of FVII. Coagulopathy was defined as thrombocytopenia (platelet count < 120,000/KL) or elevated international normalized ratio of greater than 1.2 or prolonged activated partial thromboplastin time greater than 40 seconds at admission. PHI was present when the follow-up computed tomographic scan reported any increase in size or number of the hemorrhagic lesions. Logistic regression examined the risks for coagulopathy and PHI. RESULTS: Mean (SD) FVII activity in patients with coagulopathy was 85.69% (34.88%), which was significantly lower than patients without coagulopathy (99.57% [29.37%], p = 0.04). Isolated traumatic brain injury patients with FVII activity less than 77.5% have an odds ratio for coagulopathy of 5.52 (95% confidence interval, 1.82-16.68; p = 0.03) relative to patients with FVII activity of 77.5% or greater. Mean (SD) FVII activity in patients with PHI was 70.76% (18.21%), which was significantly lower than patients without PHI (105.76% [32.27%], p < 0.001). A stepwise logistic regression analysis identified FVII less than 77.5% (odds ratio, 4.53; 95% confidence interval, 1.62-12.67; p = 0.004) as a predisposing risk factors independently associated with the presence of PHI. The overall mortality rate in the study population was 7.4% (n = 6). The plasma FVII in death patients (91.44% [47.19%]) was slightly lower than that in survival patients (92.01% [32.04%]). However, there was no statistical difference between the two groups (p = 0.95). CONCLUSION: A decrease of FVII activity significantly contributes to the coagulopathy and PHI in patients with isolated traumatic brain injury. (Copyright (C) 2014 by Lippincott Williams & Wilkins)	[Wu, Xing; Du, Zhuoying; Yu, Jian; Sun, Yirui; Yin, Mao; Zhou, Liangfu; Hu, Jin] Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai 200433, Peoples R China; [Tang, Zhengyu] Chinese Acad Sci, Shanghai Adv Res Inst, SARI Ctr Stem Cell & NanoMed, Shanghai, Peoples R China; [Pei, Bingbing] Xinxiang Med Univ, Henan Prov Peoples Hosp, Dept Neurosurg, Xinxiang City, Henan Province, Peoples R China; [Lu, Xin] Soochow Univ, Affiliated Hosp 1, Dept Neurosurg, Suzhou, Jiangsu, Peoples R China	Hu, J (corresponding author), Fudan Univ, Huashan Hosp, Dept Neurosurg, Wulumuqizhong Rd 12, Shanghai 200433, Peoples R China.	xggbtt@gmail.com			National Natural Science Foundation of China (NSFC)National Natural Science Foundation of China (NSFC) [30870805, 81271003, 90919002, 30770824, 81000518, 81171133, 81271375, 08dj1400503]; National Basic Research ProgramNational Basic Research Program of China [2009CB941100, 2010CB945500, 2012CB966300]; Science and Technology Commission of Shanghai MunicipalityScience & Technology Commission of Shanghai Municipality (STCSM) [10JC1402300]; Shanghai Nature Science Foundation [08411952000]	This work is supported, in part, by funds from the National Natural Science Foundation of China (NSFC Grants 30870805, 81271003, 90919002, 30770824, 81000518, 81171133, 81271375, and 08dj1400503), the National Basic Research Program (2009CB941100, 2010CB945500, 2012CB966300), The Science and Technology Commission of Shanghai Municipality Project (10JC1402300), and the Shanghai Nature Science Foundation (08411952000).	Allard CB, 2009, J TRAUMA, V67, P959, DOI 10.1097/TA.0b013e3181ad5d37; Boto GR, 2006, J NEUROL NEUROSUR PS, V77, P1054, DOI 10.1136/jnnp.2005.087056; BRODERICK JP, 1993, STROKE, V24, P987, DOI 10.1161/01.STR.24.7.987; Brohi K, 2003, J TRAUMA, V54, P1127, DOI 10.1097/01.TA.0000069184.82147.06; Brown CVR, 2010, J TRAUMA, V68, P348, DOI 10.1097/TA.0b013e3181bbfb6b; Corral J, 2001, BLOOD, V97, P2979, DOI 10.1182/blood.V97.10.2979; Dutton RP, 2004, J TRAUMA, V57, P709, DOI 10.1097/01.TA.0000140646.66852.AB; Engstrom M, 2005, J NEUROTRAUM, V22, P291, DOI 10.1089/neu.2005.22.291; FRANKE CL, 1992, J NEUROL NEUROSUR PS, V55, P653, DOI 10.1136/jnnp.55.8.653; Franschman G, 2012, J NEUROTRAUM, V29, P128, DOI 10.1089/neu.2011.2044; Greuters S, 2011, CRIT CARE, V15, DOI 10.1186/cc9399; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Indrayan A., 2012, MED BIOSTATISTICS; Jansen JO, 2011, J TRAUMA, V71, pS435, DOI 10.1097/TA.0b013e318232e5cb; KUMURA E, 1987, ACTA NEUROCHIR, V85, P23, DOI 10.1007/BF01402365; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; Letarte PB, 2008, J TRAUMA, V64, P627; Lustenberger T, 2010, J TRAUMA, V69, P1410, DOI 10.1097/TA.0b013e3181cdae81; Mayer SA, 2005, NEW ENGL J MED, V352, P777, DOI 10.1056/NEJMoa042991; Narayan RK, 2008, NEUROSURGERY, V62, P776, DOI 10.1227/01.NEU.0000297095.04013.C4; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; OLSON JD, 1989, NEUROSURGERY, V24, P825, DOI 10.1227/00006123-198906000-00007; Schurr MJ, 2004, J TRAUMA, V57, P718; Shaz BH, 2011, J TRAUMA, V70, P1401, DOI 10.1097/TA.0b013e31821266e0; Stein DM, 2008, J TRAUMA, V64, P620, DOI 10.1097/TA.0b013e3181650fc7; Stein DM, 2009, J TRAUMA, V66, P63, DOI 10.1097/TA.0b013e318191bc8a; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; Talving P, 2011, J TRAUMA, V71, P1205, DOI 10.1097/TA.0b013e31820d151d; Vaslef SN, 2002, J TRAUMA, V53, P291, DOI 10.1097/00005373-200208000-00017; Wada R, 2007, STROKE, V38, P1257, DOI 10.1161/01.STR.0000259633.59404.f3; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1	32	11	21	1	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JAN	2014	76	1					114	120		10.1097/TA.0b013e3182a8fe48			7	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	AH8JN	WOS:000336384200023	24368365				2021-06-18	
J	Zimmermann, N; Netto, TM; Amodeo, MT; Ska, B; Fonseca, RP				Zimmermann, Nicolle; Netto, Tania Maria; Amodeo, Maria Teresa; Ska, Bernadette; Fonseca, Rochele Paz			Working memory training and poetry-based stimulation programs: Are there differences in cognitive outcome in healthy older adults?	NEUROREHABILITATION			English	Article						Cognitive training; older adults; transfer; working memory	TRAUMATIC BRAIN-INJURY; EXECUTIVE COMPONENT; AGE-DIFFERENCES; WHITE-MATTER; REHABILITATION; PERFORMANCE; RETRIEVAL; CAPACITY	BACKGROUND: Neuropsychological interventions have been mainly applied with clinical populations, in spite of the need of preventing negative changes across life span. Among the few studies of cognitive stimulation in elderly, surprisingly there is no enough research comparing direct and indirect active stimulation programs. OBJECTIVE: This study aims to verify wheter there are differences between two cognitive interventions approaches in older adults: a structured Working Memory (WM) Training Program versus a Poetry-based Stimulation Program. METHODS: Fourteen older adults were randomly assigned to participate into one of the two intervention groups. The assessed neurocognitive components were attention, episodic and working memory, communicative and executive functions. WM Training activities were based on Baddeley's model; Poetry-based Stimulation Program was composed by general language activities. Data were analyzed with one-way ANCOVA with Delta scores and pre and post-training tests raw scores. RESULTS: WM group improved performance on WM, inhibition, and cognitive flexibility measures, while Poetry group improved on verbal fluency and narrative discourse tasks. DISCUSSION: Both approaches presented benefits; however WM Training improved its target function with transfer effects to executive functions, being useful for future studies with a variety of dementias. Poetry-based Stimulation also improved complex linguistic abilities. Both approaches may be helpful as strategies to prevent dysfunctional aging changes.	[Zimmermann, Nicolle; Amodeo, Maria Teresa; Fonseca, Rochele Paz] Pontificia Univ Catolica Rio Grande do Sul, Postgrad Program Psychol, BR-90619900 Porto Alegre, RS, Brazil; [Zimmermann, Nicolle; Netto, Tania Maria] Univ Fed Rio de Janeiro, Dept Radiol, Rio De Janeiro, Brazil; [Ska, Bernadette] Univ Montreal, Geriatr Inst, Montreal, PQ, Canada; [Amodeo, Maria Teresa] Pontificia Univ Catolica Rio Grande do Sul, Postgrad Program Language, BR-90619900 Porto Alegre, RS, Brazil	Fonseca, RP (corresponding author), Pontificia Univ Catolica Rio Grande do Sul, Postgrad Program Psychol, Av Ipiranga 6681,Predio 11-9 Andar,Sala 932, BR-90619900 Porto Alegre, RS, Brazil.	rochele.fonseca@gmail.com		ZIMMERMANN, NICOLLE/0000-0003-4771-4070	Conselho Nacional de Desenvolvimento Cientifico e TecnologicoConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); Coordenacao de Aperfeicoamento de Pessoal de Nivel SuperiorCoordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Pontifical Catholic University of Rio Grande do Sul	We thank Conselho Nacional de Desenvolvimento Cientifico e Tecnologico and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior for students scholarships; and Pontifical Catholic University of Rio Grande do Sul for grant and scholarships for this project. We express our special thanks to Michelle Bordin Bez for her distinct work during the groups interventions and data organization.	Anderson M. C., 2009, MEMORY; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Bisiacchi PS, 2008, J CLIN EXP NEUROPSYC, V30, P723, DOI 10.1080/13803390701689587; Borella E, 2010, PSYCHOL AGING, V25, P767, DOI 10.1037/a0020683; Borella E, 2010, J LEARN DISABIL-US, V43, P541, DOI 10.1177/0022219410371676; Brehmer Y, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00063; Buschkuehl M, 2008, PSYCHOL AGING, V23, P743, DOI 10.1037/a0014342; Carretti B, 2007, EXP PSYCHOL, V54, P311, DOI 10.1027/1618-3169.54.4.311; Charlton RA, 2008, NEUROBIOL AGING, V29, P1547, DOI 10.1016/j.neurobiolaging.2007.03.017; Clare L, 2004, NEUROPSYCHOL REHABIL, V14, P385, DOI 10.1080/09602010443000074; Dahlin E, 2009, RESTOR NEUROL NEUROS, V27, P405, DOI 10.3233/RNN-2009-0492; DANEMAN M, 1983, J EXP PSYCHOL LEARN, V9, P561, DOI 10.1037/0278-7393.9.4.561; DOBBS AR, 1989, PSYCHOL AGING, V4, P500, DOI 10.1037/0882-7974.4.4.500; Duval J, 2008, NEUROPSYCHOL REHABIL, V18, P430, DOI 10.1080/09602010701573950; Engle RW, 2002, CURR DIR PSYCHOL SCI, V11, P19, DOI 10.1111/1467-8721.00160; FINKE RA, 1988, MEM COGNITION, V16, P252, DOI 10.3758/BF03197758; Fonseca R. P., 2008, BATERIA MONTREAL AVA; Fonseca RP., 2009, INSTRUMENTO AVALIACA; Izquierdo, 1992, ACTA NEUROL SCAND, V11, P412; Joanette Y., 2004, PROTOCOLE MONTREAL E; Karbach J, 2009, DEVELOPMENTAL SCI, V12, P978, DOI 10.1111/j.1467-7687.2009.00846.x; Kennedy KM, 2009, NEUROPSYCHOLOGIA, V47, P916, DOI 10.1016/j.neuropsychologia.2009.01.001; Klusmann V, 2010, J GERONTOL A-BIOL, V65, P680, DOI 10.1093/gerona/glq053; Matlin M. W., 2008, COGNITION; Moreland RL, 2000, ORGAN BEHAV HUM DEC, V82, P117, DOI 10.1006/obhd.2000.2891; Morrison AB, 2011, PSYCHON B REV, V18, P46, DOI 10.3758/s13423-010-0034-0; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; Nessler D, 2006, NEUROIMAGE, V30, P299, DOI 10.1016/j.neuroimage.2005.09.005; Osaka M, 2012, BEHAV BRAIN RES, V233, P90, DOI 10.1016/j.bbr.2012.04.044; Rosen VM, 1997, J EXP PSYCHOL GEN, V126, P211, DOI 10.1037/0096-3445.126.3.211; Serino A, 2007, BRAIN INJURY, V21, P11, DOI 10.1080/02699050601151811; Shallice, 1997, HAYLING BRIXTON TEST; Shipstead Z, 2012, PSYCHOL BULL, V138, P628, DOI 10.1037/a0027473; Vallat-Azouvi C, 2009, BRAIN INJURY, V23, P585, DOI 10.1080/02699050902970711; Van Dijk J. G., 2010, DISCOURSE CONTEXT SO; Wechsler D., 1945, WECHSLER MEMORY SCAL; Wegner D., 1985, COMPATIBLE INCOMPATI, DOI [10.1007/978-1-4612-5044-9, DOI 10.1007/978-1-4612-5044-9]; Wolfson D., 1993, HALSTEAD REITAN NEUR; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	39	11	13	1	29	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2014	35	1					159	170		10.3233/NRE-141104			12	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	AP0PN	WOS:000341764700019	24990015				2021-06-18	
J	Zonfrillo, MR; Durbin, DR; Winston, FK; Zhang, XM; Stineman, MG				Zonfrillo, Mark R.; Durbin, Dennis R.; Winston, Flaura K.; Zhang, Xuemei; Stineman, Margaret G.			Residual Cognitive Disability after Completion of Inpatient Rehabilitation among Injured Children	JOURNAL OF PEDIATRICS			English	Article							TRAUMATIC BRAIN-INJURY; UNIFORM DATA SYSTEM; PHYSICAL-DISABILITY; PROGRAMS; RECOVERY; VALIDITY; OUTCOMES; TBI	Objective To determine the prevalence and nature of residual cognitive disability after inpatient rehabilitation for children aged 7-18 years with traumatic injuries. Study design This retrospective cohort study included children aged 7-18 years in the Uniform Data System for Medical Rehabilitation who underwent inpatient rehabilitation for traumatic injuries in 523 facilities from 2002-2011. Traumatic injuries were identified by standardized Medicare Inpatient Rehabilitation Facility-Patient Assessment Instrument codes. Cognitive outcomes were measured by the Functional Independence Measure instrument. A validated, categorical staging system derived from responses to the items in the cognitive domain of the functional independence measure was used and consisted of clinically relevant levels of cognitive achievement from stage 1 (total cognitive disability) to stage 7 (completely independent cognitive function). Results There were 13 798 injured children who completed inpatient rehabilitation during the 10-year period. On admission to inpatient rehabilitation, patients with traumatic brain injury (TBI) had more cognitive disability (median stage 2) than those with spinal cord injury or other injuries (median stage 5). Cognitive functioning improved for all patients, but children with TBI still tended to have significant residual cognitive disability (median stage on discharge, 4). Conclusions Injured children gained cognitive functionality throughout inpatient rehabilitation. Those with TBI had more severe cognitive disability on admission and more residual disability on discharge. This is important not only for patient and family expectation setting but also for resource and service planning, as discharge from inpatient rehabilitation is a critical milestone for reintegration into society for children with serious injury.	[Zonfrillo, Mark R.; Durbin, Dennis R.; Winston, Flaura K.] Childrens Hosp Philadelphia, Ctr Injury Res & Prevent, Philadelphia, PA 19104 USA; [Zonfrillo, Mark R.; Durbin, Dennis R.; Winston, Flaura K.] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Zonfrillo, Mark R.; Durbin, Dennis R.; Stineman, Margaret G.] Univ Penn, Perelman Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Winston, Flaura K.; Stineman, Margaret G.] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; [Zhang, Xuemei] Childrens Hosp Philadelphia, Biostat & Data Management Core, Philadelphia, PA 19104 USA; [Stineman, Margaret G.] Univ Penn, Perelman Sch Med, Dept Phys Med & Rehabil, Philadelphia, PA 19104 USA	Zonfrillo, MR (corresponding author), Childrens Hosp Philadelphia, Div Emergency Med, 34th & Civ Ctr Blvd, Philadelphia, PA 19104 USA.	Zonfrillo@email.chop.edu	Zonfrillo, Mark R./H-9403-2017	Zonfrillo, Mark R./0000-0002-0610-9563	Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [1K08HD073241-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K08HD073241] Funding Source: NIH RePORTER	Supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (1K08HD073241-01 to M.Z.). The views presented are those of the authors and not necessarily the views of the National Institutes of Health. The authors declare no conflicts of interest.	Aitken ME, 1999, ARCH PHYS MED REHAB, V80, P889, DOI 10.1016/S0003-9993(99)90079-5; Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; Anderson V, 2009, PEDIATRICS, V124, pE1064, DOI 10.1542/peds.2009-0365; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Bkin SH, 2008, DEV MED CHILD NEUROL, V50, P89, DOI [10.1111/j.1469-8749-2007.02021.x, 10.1111/j.1469-8749.2007.02021.x]; Burd RS, 2009, ACAD EMERG MED, V16, P639, DOI 10.1111/j.1553-2712.2009.00446.x; Centers for Disease Control and Prevention, 10 LEAD CAUS DEATH I; Centers for Medicare & Medicaid Services (CMS), INP REH FAC IRF PAT; Fuhrer MJ, 1987, REHABILITATION OUTCO, P137; Glang A, 2008, NEUROREHABILITATION, V23, P477; Granger CV, 2012, AM J PHYS MED REHAB, V91, P289, DOI 10.1097/PHM.0b013e31824ad2fd; Granger CV, 2010, AM J PHYS MED REHAB, V89, P265, DOI 10.1097/PHM.0b013e3181d3eb20; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; Horneman G, 2009, BRAIN INJURY, V23, P907, DOI 10.1080/02699050903283239; Jaffe KM, 2008, J TRAUMA, V64, P819, DOI 10.1097/TA.0b013e318165f177; Katz-Leurer M, 2011, BRAIN INJURY, V25, P581, DOI 10.3109/02699052.2011.572943; Keith R A, 1987, Adv Clin Rehabil, V1, P6; McCarthy ML, 2006, ARCH PEDIAT ADOL MED, V160, P252, DOI 10.1001/archpedi.160.3.252; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Rivara FP, 2012, ARCH PHYS MED REHAB, V93, P381, DOI 10.1016/j.apmr.2011.08.015; Rivara FP, 2011, PEDIATRICS, V128, pE1129, DOI 10.1542/peds.2011-0840; Stineman MG, 2003, ARCH PHYS MED REHAB, V84, P38, DOI 10.1053/apmr.2003.50060; Stineman MG, 2003, ARCH PHYS MED REHAB, V84, P29, DOI 10.1053/apmr.2003.50061; Wechsler B, 2005, J TRAUMA, V58, P940, DOI 10.1097/01.TA.0000162630.78386.98; Willis CD, 2006, INJURY, V37, P1185, DOI 10.1016/j.injury.2006.07.011; Zonfrillo MR, 2013, PEDIATRICS, V131, pE206, DOI 10.1542/peds.2012-1418	26	11	11	0	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-3476	1097-6833		J PEDIATR-US	J. Pediatr.	JAN	2014	164	1					130	135		10.1016/j.jpeds.2013.09.022			6	Pediatrics	Pediatrics	276FU	WOS:000328734700030	24268846	Green Accepted			2021-06-18	
J	Hanley, DF; Chabot, R; Mould, WA; Morgan, T; Naunheim, R; Sheth, KN; Chiang, W; Prichep, LS				Hanley, Daniel F.; Chabot, Robert; Mould, W. Andrew; Morgan, Timothy; Naunheim, Rosanne; Sheth, Kevin N.; Chiang, William; Prichep, Leslie S.			Use of Brain Electrical Activity for the Identification of Hematomas in Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						hematoma; mild traumatic brain injury; neuroimaging; quantitative EEG	NEAR-INFRARED SPECTROSCOPY; DEVICE	This study investigates the potential clinical utility in the emergency department (ED) of an index of brain electrical activity to identify intracranial hematomas. The relationship between this index and depth, size, and type of hematoma was explored. Ten minutes of brain electrical activity was recorded from a limited montage in 38 adult patients with traumatic hematomas (CT scan positive) and 38 mild head injured controls (CT scan negative) in the ED. The volume of blood and distance from recording electrodes were measured by blinded independent experts. Brain electrical activity data were submitted to a classification algorithm independently developed traumatic brain injury (TBI) index to identify the probability of a CT+traumatic event. There was no significant relationship between the TBI-Index and type of hematoma, or distance of the bleed from recording sites. A significant correlation was found between TBI-Index and blood volume. The sensitivity to hematomas was 100%, positive predictive value was 74.5%, and positive likelihood ratio was 2.92. The TBI-Index, derived from brain electrical activity, demonstrates high accuracy for identification of traumatic hematomas. Further, this was not influenced by distance of the bleed from the recording electrodes, blood volume, or type of hematoma. Distance and volume limitations noted with other methods, (such as that based on near-infrared spectroscopy) were not found, thus suggesting the TBI-Index to be a potentially important adjunct to acute assessment of head injury. Because of the life-threatening risk of undetected hematomas (false negatives), specificity was permitted to be lower, 66%, in exchange for extremely high sensitivity.	[Hanley, Daniel F.; Mould, W. Andrew] Johns Hopkins Univ, Sch Med, Div Brain Injury Outcomes, Baltimore, MD USA; [Chabot, Robert; Prichep, Leslie S.] NYU, Sch Med, Brain Res Labs, Dept Psychiat, New York, NY 10016 USA; [Morgan, Timothy] Johns Hopkins Univ, Dept Clin Res, Baltimore, MD USA; [Naunheim, Rosanne] Washington Univ, Sch Med, Dept Emergency Med, St Louis, MO USA; [Sheth, Kevin N.] Univ Maryland, Sch Med, Div Neurocrit Care & Stroke, Baltimore, MD 21201 USA; [Sheth, Kevin N.] R Adams Cowley Shock Trauma Ctr, Baltimore, MD USA; [Chiang, William] NYU, Sch Med, Dept Emergency Med, New York, NY 10016 USA; [Chiang, William] Bellevue Hosp Ctr, New York, NY 10016 USA	Prichep, LS (corresponding author), NYU, Sch Med, Brain Res Labs, 462 1st Ave,OBV Room 885, New York, NY 10016 USA.	Leslie.prichep@nyumc.org		Chiang, William/0000-0003-3562-8896	BrainScope Co., Inc., Bethesda, MD	The authors acknowledge the contributions of those who made this research possible, including the primary investigators and research technicians at all the clinical sites and the patients who volunteered. This research was supported by BrainScope Co., Inc., Bethesda, MD, who granted expenses related to data acquisition.	DeRenzo E G, 1998, J Health Care Law Policy, V1, P66; JOHN ER, 1988, SCIENCE, V239, P162, DOI 10.1126/science.3336779; Kahraman S, 2006, J TRAUMA, V61, P1480, DOI 10.1097/01.ta.0000197616.10279.48; Kessel B, 2007, INJURY, V38, P1065, DOI 10.1016/j.injury.2007.05.009; Kohavi R., 1995, 14 INT JOINT C ART I; Leon-Carrion J, 2010, BRAIN INJURY, V24, P1193, DOI 10.3109/02699052.2010.506636; Naunheim RS, 2010, BRAIN INJURY, V24, P1324, DOI 10.3109/02699052.2010.506862; O'Neil B, 2012, WEST J EMERG MED, V13, P394, DOI 10.5811/westjem.2011.12.6815; Prichep LS, 2012, IEEE T NEUR SYS REH, V20, P806, DOI 10.1109/TNSRE.2012.2206609; Robertson CS, 2010, J NEUROTRAUM, V27, P1597, DOI 10.1089/neu.2010.1340; Rosset A, 2004, J DIGIT IMAGING, V17, P205, DOI 10.1007/s10278-004-1014-6; U. S. Food and Drug Administration Center for Devices and Radiological Health, 2011, FDA PERM MARK 1 HAND; United States Food and Drug Administration Center for Devices and Radiological Health, 2011, INFR MOD 1000 EV AUT	13	11	11	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 15	2013	30	24					2051	2056		10.1089/neu.2013.3062			6	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	271QK	WOS:000328406500006	24040943				2021-06-18	
J	Heather, NL; Derraik, JGB; Beca, J; Hofman, PL; Dansey, R; Hamill, J; Cutfield, WS				Heather, Natasha L.; Derraik, Jose G. B.; Beca, John; Hofman, Paul L.; Dansey, Rangi; Hamill, James; Cutfield, Wayne S.			Glasgow Coma Scale and Outcomes after Structural Traumatic Head Injury in Early Childhood	PLOS ONE			English	Article							BRAIN-INJURY; CHILDREN; MORTALITY; SCORE; RELIABILITY; SEVERITY	Objective: To assess the association of the Glasgow Coma Scale (GCS) with radiological evidence of head injury (the Abbreviated Injury Scale for the head region, AIS-HR) in young children hospitalized with traumatic head injury (THI), and the predictive value of GCS and AIS-HR scores for long-term impairment. Methods: Our study involved a 10-year retrospective review of a database encompassing all patients admitted to Starship Children's Hospital (Auckland, New Zealand, 2000-2010) with THI. Results: We studied 619 children aged <5 years at the time of THI, with long-term outcome data available for 161 subjects. Both GCS and AIS-HR scores were predictive of length of intensive care unit and hospital stay (all p<0.001). GCS was correlated with AIS-HR (rho=-0.46; p<0.001), although mild GCS scores (13-15) commonly undere-stimated the severity of radiological injury: 42% of children with mild GCS scores had serious-critical THI (AIS-HR 3-5). Increasingly severe GCS or AIS-HR scores were both associated with a greater likelihood of long-term impairment (neurological disability, residual problems, and educational support). However, long-term impairment was also relatively common in children with mild GCS scores paired with structural THI more severe than a simple linear skull fracture. Conclusion: Severe GCS scores will identify most cases of severe radiological injury in early childhood, and are good predictors of poor long-term outcome. However, young children admitted to hospital with structural THI and mild GCS scores have an appreciable risk of long-term disability, and also warrant long-term follow-up.	[Heather, Natasha L.; Derraik, Jose G. B.; Hofman, Paul L.; Cutfield, Wayne S.] Univ Auckland, Liggins Inst, Auckland 1, New Zealand; [Hofman, Paul L.; Cutfield, Wayne S.] Univ Auckland, Natl Res Ctr Growth & Dev, Auckland 1, New Zealand; [Beca, John] Starship Childrens Hosp, Auckland Dist Hlth Board, Paediat Intens Care Unit, Auckland, New Zealand; [Dansey, Rangi; Hamill, James] Starship Childrens Hosp, Auckland Dist Hlth Board, Trauma Serv, Auckland, New Zealand	Cutfield, WS (corresponding author), Univ Auckland, Liggins Inst, Auckland 1, New Zealand.	w.cutfield@auckland.ac.nz	Heather, Natasha/AAV-8425-2020; Derraik, Jose Guilherme Behrensdorf/A-1925-2008	Derraik, Jose Guilherme Behrensdorf/0000-0003-1226-1956	Health Research Council of New ZealandHealth Research Council of New Zealand; Australasian Paediatric Endocrine Group; Starship Foundation Fellowship	This study was supported by grants from the Health Research Council of New Zealand and the Australasian Paediatric Endocrine Group. NLH was supported by a Starship Foundation Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; *ASS ADV AUT MED, 2001, ABBR INJ SCAL; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Chung CY, 2006, PEDIATR NEUROL, V34, P379, DOI 10.1016/j.pediatrneurol.2005.10.012; Crouchman M, 2001, ARCH DIS CHILD, V84, P120, DOI 10.1136/adc.84.2.120; Crowe LM, 2012, PEDIATRICS, V129, pE262, DOI 10.1542/peds.2011-0438; Demetriades D, 2004, J AM COLL SURGEONS, V199, P216, DOI 10.1016/j.jamcollsurg.2004.02.030; Douglas NM, 2007, J PAEDIATR CHILD H, V43, P173, DOI 10.1111/j.1440-1754.2007.01038.x; Ducrocq SC, 2006, PEDIATR CRIT CARE ME, V7, P461, DOI 10.1097/01.PCC.0000235245.49129.27; Dunning J, 2004, ARCH DIS CHILD, V89, P653, DOI 10.1136/adc.2003.027722; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; Fortune PM, 2010, PEDIATR CRIT CARE ME, V11, P339, DOI 10.1097/PCC.0b013e3181c014ab; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; Gill MR, 2004, ANN EMERG MED, V43, P215, DOI 10.1016/S0196-0644(03)00814-X; Heather NL, 2012, J CLIN ENDOCR METAB, V97, P599, DOI 10.1210/jc.2011-2284; Holdgate Anna, 2006, Emerg Med Australas, V18, P379, DOI 10.1111/j.1742-6723.2006.00867.x; Holmes JF, 2005, ACAD EMERG MED, V12, P814, DOI 10.1197/j.aem.2005.04.019; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lam WH, 1999, PAEDIATR ANAESTH, V9, P377; MARION DW, 1994, J TRAUMA, V36, P89, DOI 10.1097/00005373-199401000-00014; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; ROWLEY G, 1991, LANCET, V337, P535, DOI 10.1016/0140-6736(91)91309-I; Salmond C, 2007, NZDEP2006 INDEX DEPR; SIMPSON DA, 1991, CHILD NERV SYST, V7, P183; TEASDALE G, 1974, LANCET, V2, P81; Timmons SD, 2011, J TRAUMA, V71, P1172, DOI 10.1097/TA.0b013e31822b0f4b; Udekwu P, 2004, J TRAUMA, V56, P1084, DOI 10.1097/01.TA.0000124283.02605.A5	28	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e82245	10.1371/journal.pone.0082245			8	Multidisciplinary Sciences	Science & Technology - Other Topics	265IN	WOS:000327944500131	24312648	DOAJ Gold, Green Published			2021-06-18	
J	Kieffer-Kristensen, R; Johansen, KLG				Kieffer-Kristensen, Rikke; Johansen, Karen Lise Gaardsvig			Hidden loss: A qualitative explorative study of children living with a parent with acquired brain injury	BRAIN INJURY			English	Article						Children; coping; distress; family; post-traumatic stress disorder; stress	POSTTRAUMATIC-STRESS; MARITAL RELATIONSHIPS; FAMILY; SYMPTOMS; CANCER; IMPACT	Primary objective: The purpose of this study was to listen to and learn from children showing high levels of post-traumatic stress symptoms after parental acquired brain injury (ABI), in order to achieve an in-depth understanding of the difficulties the children face in their everyday lives and identify possible trauma-related feelings and relational losses. Design: The study was qualitative, using a phenomenological approach. Methods and procedure: Fourteen children between 7-14 years of age were interviewed at home using a semi-structured interview guide. Siblings were also invited to participate. Results: All children were affected by their parents' ABI and the altered family situation. The children's expressions led the authors to identify six themes, including fear of losing the parent, distress and estrangement, chores and responsibilities, hidden loss, coping and support. The main finding indicates that the children experienced numerous losses, many of which were often suppressed or neglected by the children to protect the ill parents. Conclusions: The findings indicated that the children seemed to make a special effort to hide their feelings of loss and grief in order to protect the ill parent. These findings contribute to a deeper understanding of the traumatic process of parental ABI that some children experience and emphasize the importance of family-centred interventions that include the children.	[Kieffer-Kristensen, Rikke; Johansen, Karen Lise Gaardsvig] Univ Copenhagen, Dept Psychol, Copenhagen, Denmark	Kieffer-Kristensen, R (corresponding author), Dept Psychol, Oster Farimagsgade 2A, DK-1353 Copenhagen K, Denmark.	rikke.kieffer@psy.ku.dk					Binderkrantz AS, 2009, GUIDE NVIVO 9; Boss P, 2002, J CLIN PSYCHOL, V58, P1351, DOI 10.1002/jclp.10083; Boszormenyi-Nagy I, 1973, INVISIBLE LOYALTIES; Bruce M, 2006, CLIN PSYCHOL REV, V26, P233, DOI 10.1016/j.cpr.2005.10.002; Butera-Prinzi F, 2004, BRAIN INJURY, V18, P83, DOI 10.1080/0269905031000118500; Byng-Hall J, 2008, J FAM THER, V30, P147, DOI 10.1111/j.1467-6427.2008.00423.x; Camic P. M., 2004, QUALITATIVE RES PSYC; Cohen JA, 2004, J AM ACAD CHILD PSY, V43, P1225, DOI 10.1097/01.chi.0000135620.15522.38; Cohen JA, 2008, ARCH PEDIAT ADOL MED, V162, P447, DOI 10.1001/archpedi.162.5.447; Cohen Judith A, 2009, Dialogues Clin Neurosci, V11, P91; Copeland WE, 2010, AM J PSYCHIAT, V167, P1059, DOI 10.1176/appi.ajp.2010.09020178; Gosling J, 1999, BRAIN INJURY, V13, P785; Huizinga GA, 2005, EUR J CANCER, V41, P288, DOI 10.1016/j.ejca.2004.10.005; Kieffer-Kristensen R, 2011, NEUROREHABILITATION, V28, P321, DOI 10.3233/NRE-2011-0660; Kieffer-Kristensen R, 2011, BRAIN INJURY, V25, P752, DOI 10.3109/02699052.2011.579933; Kreutzer JS, 2007, NEUROREHABILITATION, V22, P53; Kvale S, 2009, INTERVIEWS LEARNING; Lazarus RS, 1992, STRESS APPRAISAL COP; LECLERE FB, 1994, J MARRIAGE FAM, V56, P457, DOI 10.2307/353112; McDermott BM, 2000, AUST NZ J PSYCHIAT, V34, P446, DOI 10.1046/j.1440-1614.2000.00753.x; Osborn T, 2007, PSYCHO-ONCOLOGY, V16, P101, DOI 10.1002/pon.1113; QSR International Pty Ltd, 2010, NVIVO QUAL DAT AN SO; Smith P, 2003, PERS INDIV DIFFER, V34, P315, DOI 10.1016/S0191-8869(02)00047-8; Thastum Mikael, 2008, Clin Child Psychol Psychiatry, V13, P123, DOI 10.1177/1359104507086345; Webster G, 2007, CLIN REHABIL, V21, P1097, DOI 10.1177/0269215507079833	25	11	11	0	13	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC	2013	27	13-14					1562	1569		10.3109/02699052.2013.841995			8	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	259BW	WOS:000327503400010	24111586				2021-06-18	
J	Mountney, A; Shear, DA; Potter, B; Marcsisin, SR; Sousa, J; Melendez, V; Tortella, FC; Lu, XCM				Mountney, Andrea; Shear, Deborah A.; Potter, Brittney; Marcsisin, Sean R.; Sousa, Jason; Melendez, Victor; Tortella, Frank C.; Lu, Xi-Chun M.			Ethosuximide and Phenytoin Dose-Dependently Attenuate Acute Nonconvulsive Seizures after Traumatic Brain Injury in Rats	JOURNAL OF NEUROTRAUMA			English	Article						EEG; ETX; NCS; PBBI; PHT; Rats; TBI	SPONTANEOUSLY EPILEPTIC RAT; ANTIEPILEPTIC DRUGS; MODEL; ANTICONVULSANTS; LEVETIRACETAM; HEMORRHAGE; ISCHEMIA	Acute seizures frequently occur following severe traumatic brain injury (TBI) and have been associated with poor patient prognosis. Silent or nonconvulsive seizures (NCS) manifest in the absence of motor convulsion, can only be detected via continuous electroencephalographic (EEG) recordings, and are often unidentified and untreated. Identification of effective anti-epileptic drugs (AED) against post-traumatic NCS remains crucial to improve neurological outcome. Here, we assessed the anti-seizure profile of ethosuximide (ETX, 12.5-187.5 mg/kg) and phenytoin (PHT, 5-30 mg/kg) in a spontaneously occurring NCS model associated with penetrating ballistic-like brain injury (PBBI). Rats were divided between two drug cohorts, PHT or ETX, and randomly assigned to one of four doses or vehicle within each cohort. Following PBBI, NCS were detected by continuous EEG monitoring for 72 h post-injury. Drug efficacy was evaluated on NCS parameters of incidence, frequency, episode duration, total duration, and onset latency. Both PHT and ETX attenuated NCS in a dose-dependent manner. In vehicle-treated animals, 69-73% experienced NCS (averaging 9-10 episodes/rat) with average onset of NCS occurring at 30 h post-injury. Compared with control treatment, the two highest PHT and ETX doses significantly reduced NCS incidence to 13-40%, reduced NCS frequency (1.8-6.2 episodes/rat), and delayed seizure onset: <20% of treated animals exhibited NCS within the first 48 h. NCS durations were also dose-dependently mitigated. For the first time, we demonstrate that ETX and PHT are effective against spontaneously occurring NCS following PBBI, and suggest that these AEDs may be effective at treating post-traumatic NCS.	[Mountney, Andrea; Shear, Deborah A.; Tortella, Frank C.; Lu, Xi-Chun M.] Walter Reed Army Inst Res, Branch Brain Trauma Neuroprotect & Neurorestorat, Ctr Mil Psychiat & Neurosci, Silver Spring, MD USA; [Potter, Brittney; Marcsisin, Sean R.; Sousa, Jason; Melendez, Victor] Walter Reed Army Inst Res, Div Expt Therapeut, Silver Spring, MD USA	Mountney, A (corresponding author), US Army, Branch Brain Trauma Neuroprotect & Neurorestorat, Ctr Mil Psychiat & Neurosci, Walter Reed Army Inst Res, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	andrea.mountney.mil@mail.mil	Sousa, Jason/A-9177-2011		U.S. Army Medical Research and Material CommandU.S. Army Medical Research & Materiel Command (USAMRMC); Combat Casualty Care Research ProgramUnited States Department of Defense; Defence Medical Research and Development Program [DIO_1_AR_J6_414]; Walter Reed Army Institute of Research	This work was supported by core funding provided by the U.S. Army Medical Research and Material Command, Combat Casualty Care Research Program and Defence Medical Research and Development Program, Grant DIO_1_AR_J6_414. The work was performed while the first author held a National Research Council Research Associateship Award at Walter Reed Army Institute of Research.	Abend NS, 2010, NEUROCRIT CARE, V12, P382, DOI 10.1007/s12028-010-9337-2; ALBERTSON TE, 1980, NEUROPHARMACOLOGY, V19, P1141, DOI 10.1016/0028-3908(80)90115-X; Bailer M, 2004, EPILEPSY BEHAV, V5, P866, DOI 10.1016/j.yebeh.2004.08.021; Chang BS, 2003, NEUROLOGY, V60, P10, DOI 10.1212/01.WNL.0000031432.05543.14; Claassen J, 2004, CLIN NEUROPHYSIOL, V115, P2699, DOI 10.1016/j.clinph.2004.06.017; CONSROE P, 1977, J PHARMACOL EXP THER, V201, P26; Dietrich WD, 2010, NEUROTHERAPEUTICS, V7, P43, DOI 10.1016/j.nurt.2009.10.015; Edmonds HL, 1996, LIFE SCI, V59, pPL127, DOI 10.1016/0024-3205(96)00379-7; Goren MZ, 2007, CNS DRUG REV, V13, P224, DOI 10.1111/j.1527-3458.2007.00009.x; Ji-qun C, 2005, EPILEPSIA, V46, P1362, DOI 10.1111/j.1528-1167.2005.29604.x; Khan AA, 2010, INT J EMERG MED, V3, P187, DOI 10.1007/s12245-010-0180-1; KILPATRICK CJ, 1992, ARCH NEUROL-CHICAGO, V49, P509, DOI 10.1001/archneur.1992.00530290097017; Knollmann B.C., 2011, GOODMAN GILMANS PHAR; LEITE JP, 1995, EPILEPSY RES, V20, P93, DOI 10.1016/0920-1211(94)00070-D; Loscher W, 2007, EPILEPSIA, V48, P1245, DOI 10.1111/j.1528-1167.2007.01093.x; Loscher W, 1998, EPILEPSY RES, V30, P69, DOI 10.1016/S0920-1211(97)00098-3; Lu XCM, 2013, J NEUROTRAUM, V30, P580, DOI 10.1089/neu.2012.2641; Lu XCM, 2011, J NEUROTRAUM, V28, P71, DOI 10.1089/neu.2010.1471; Manning JPA, 2003, TRENDS PHARMACOL SCI, V24, P542, DOI 10.1016/j.tips.2003.08.006; SASA M, 1988, EPILEPSIA, V29, P505, DOI 10.1111/j.1528-1157.1988.tb03754.x; Schierhout G, 1998, J NEUROL NEUROSUR PS, V64, P108, DOI 10.1136/jnnp.64.1.108; SCHMUTZ M, 1988, J NEURAL TRANSM, V72, P245, DOI 10.1007/BF01243423; SILVER JM, 1991, ANN NEUROL, V29, P356, DOI 10.1002/ana.410290404; So EL, 1996, NEUROLOGY, V46, P350, DOI 10.1212/WNL.46.2.350; SWINYARD EA, 1952, J PHARMACOL EXP THER, V106, P319; Szaflarski JP, 2010, NEUROCRIT CARE, V12, P165, DOI 10.1007/s12028-009-9304-y; Teasell R, 2007, BRAIN INJURY, V21, P201, DOI 10.1080/02699050701201854; van Rijn CM, 2004, EPILEPSY RES, V59, P181, DOI 10.1016/j.eplepsyres.2004.04.003; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; Vespa PM, 2007, CRIT CARE MED, V35, P1153, DOI 10.1097/01.CCM.0000259466.66310.4F; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Vespa PM, 2003, NEUROLOGY, V60, P1441, DOI 10.1212/01.WNL.0000063316.47591.B4; Walker MC, 1996, EPILEPSIA, V37, P421, DOI 10.1111/j.1528-1157.1996.tb00586.x; Williams AJ, 2005, J NEUROTRAUM, V22, P313, DOI 10.1089/neu.2005.22.313; Williams AJ, 2004, J PHARMACOL EXP THER, V311, P220, DOI 10.1124/jpet.104.069146; Williams AJ, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-17; Williams AJ, 2006, J PHARMACOL EXP THER, V318, P947, DOI 10.1124/jpet.106.105999; Williams AJ, 2006, J NEUROTRAUM, V23, P1828, DOI 10.1089/neu.2006.23.1828	39	11	11	0	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC	2013	30	23					1973	1982		10.1089/neu.2013.3001			10	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	AI0FA	WOS:000336520400006	23822888	Green Published			2021-06-18	
J	Palacios, EM; Sala-Llonch, R; Junque, C; Roig, T; Tormos, JM; Bargallo, N; Vendrell, P				Palacios, Eva M.; Sala-Llonch, Roser; Junque, Carme; Roig, Teresa; Tormos, Jose M.; Bargallo, Nuria; Vendrell, Pere			White Matter/Gray Matter Contrast Changes in Chronic and Diffuse Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						cognitive deficits; diffusion tensor imaging (DTI); traumatic brain injury; white matter/gray matter signal-intensity contrast	HUMAN CEREBRAL-CORTEX; INTEGRITY; THICKNESS; NETWORKS	Signal-intensity contrast of T1-weighted magnetic resonance imaging scans has been associated with tissue integrity and reported as a sign of neurodegenerative changes in diseases such as Alzheimer's disease. After severe traumatic brain injury (TBI), progressive structural changes occur in white (WM) and gray matter (GM). In the current study, we assessed the signal-intensity contrast of GM and WM in patients with diffuse TBI in the chronic stage to (1) characterize the regional pattern of WM/GM changes in intensity contrast associated with traumatic axonal injury, (2) evaluate possible associations between this measure and diffusion tensor image (DTI)/fractional anisotropy (FA) for detecting WM damage, and (3) investigate the correlates of both measures with cognitive outcomes. Structural T1 scans were processed with FreeSurfer software to identify the boundary and calculate the WM/GM contrast maps. DTIs were processed with the FMRIB software library to obtain FA maps. The WM/GM contrast in TBI patients showed a pattern of reduction in almost all of the brain, except the visual and motor primary regions. Global FA values obtained from DTI correlated with the intensity contrast of all associative cerebral regions. WM/GM contrast correlated with memory functions, whereas FA global values correlated with tests measuring memory and mental processing speed. In conclusion, tissue-contrast intensity is a very sensitive measure for detecting structural brain damage in chronic, severe and diffuse TBI, but is less sensitive than FA for reflecting neuropsychological sequelae, such as impaired mental processing speed.	[Palacios, Eva M.; Sala-Llonch, Roser; Junque, Carme; Vendrell, Pere] Univ Barcelona, Dept Psychiat & Clin Psychobiol, E-08036 Barcelona, Spain; [Roig, Teresa; Tormos, Jose M.] Neurorehabil Hosp, Inst Guttmann, Barcelona, Spain; [Bargallo, Nuria] Hosp Clin Barcelona, Ctr Diagnost Imatge Hosp Clin Barcelona CDIC, Barcelona, Spain	Junque, C (corresponding author), Univ Barcelona, Dept Psychiat & Clin Psychobiol, C Casanova 143, E-08036 Barcelona, Spain.	cjunque@ub.edu	Bargallo, Nuria/G-6854-2016; Sala-Llonch, Roser/L-4135-2015; Sala-Llonch, Roser/E-7882-2012; Vendrell, Pere/B-4392-2011; Junque, Carme/B-4400-2011	Bargallo, Nuria/0000-0001-6284-5402; Sala-Llonch, Roser/0000-0003-3576-0475; Sala-Llonch, Roser/0000-0003-3576-0475; Vendrell, Pere/0000-0001-8918-5440; Junque, Carme/0000-0002-6381-3063; Tormos Munoz, Jose Maria/0000-0002-8764-2289			Alstott J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000408; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; Grydeland H, 2013, HUM BRAIN MAPP, V34, P2775, DOI 10.1002/hbm.22103; Honey CJ, 2008, HUM BRAIN MAPP, V29, P802, DOI 10.1002/hbm.20579; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Maxwell WL, 2010, BRAIN, V133, P139, DOI 10.1093/brain/awp264; Palacios EM, 2012, NEUROLOGY, V78, P852, DOI 10.1212/WNL.0b013e31824c465a; Palacios EM, 2013, CORTEX, V49, P646, DOI 10.1016/j.cortex.2012.02.011; Salat DH, 2009, NEUROIMAGE, V48, P21, DOI 10.1016/j.neuroimage.2009.06.074; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024	14	11	11	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC	2013	30	23					1991	1994		10.1089/neu.2012.2836			4	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	AI0FA	WOS:000336520400008	23822854	Green Published			2021-06-18	
J	Bryan, CJ				Bryan, Craig J.			Multiple traumatic brain injury and concussive symptoms among deployed military personnel	BRAIN INJURY			English	Article						Concussion; depression; PTSD; TBI	IRAQ; TBI	Objective: To identify if concussive symptoms occur with greater frequency among military personnel with multiple lifetime TBIs and if a history of TBI increases risk for subsequent TBI. Patients: One hundred and sixty-one military personnel referred to a TBI clinic for evaluation and treatment of suspected head injury at a military clinic in Iraq. Methods: Military patients completed standardized self-report measures of concussion, depression and post-traumatic stress symptoms; clinical interview; and physical examination. Group comparisons were made according to number of lifetime TBIs and logistic regression was utilized to determine the association of past TBIs on current TBI. Results: Patients with one or more previous TBIs were more likely to report concussion symptoms immediately following a recent injury and during the evaluation. Although differences between single and multiple TBI groups were observed, these did not reach the level of statistical significance. A history of any TBI increased the likelihood of current TBI diagnosis, but this relationship was no longer significant when adjusting for injury mechanism, depression and post-traumatic stress symptoms. Conclusion: Among deployed military personnel, the relationship of previous TBI with recent TBI and concussive symptoms may be largely explained by the presence of psychological symptoms.	Natl Ctr Vet Studies, Salt Lake City, UT 84112 USA	Bryan, CJ (corresponding author), Natl Ctr Vet Studies, 260 S Cent Campus Dr,Room 205, Salt Lake City, UT 84112 USA.	craig.bryan@utah.edu		Bryan, Craig/0000-0002-9714-0733			Anstey KJ, 2004, J CLIN EPIDEMIOL, V57, P1202, DOI 10.1016/j.jclinepi.2003.11.011; Blount TH, 2010, ANN M ASS BEH COGN T; Bryan CJ, 2013, JAMA PSYCHIAT, V70, P686, DOI 10.1001/jamapsychiatry.2013.1093; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Defense and Veterans Brain Injury Center, 2007, MIL AC CONC EV; Defense and Veterans Brain Injury Center [Internet], 2012, TBI FACTS; Department of Defense/Department of Veterans Affairs Traumatic Brain Injury Task Force, 2008, REP SURG GEN TRAUM B; Drake AI, 2000, J HEAD TRAUMA REHAB, V15, P1103, DOI 10.1097/00001199-200010000-00004; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kopta SM, 2002, PSYCHOTHER RES, V12, P413, DOI 10.1093/ptr/12.4.413; MacGregor AJ, 2010, J HEAD TRAUMA REHAB, V25, P1, DOI 10.1097/HTR.0b013e3181c2993d; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Tanielian T, 2008, INVISIBLE WOUNDS WAR; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Vanderploeg RD, 2012, J REHABIL RES DEV, V49, P545, DOI 10.1682/JRRD.2011.04.0069; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Weathers F. W., 1993, ANN M INT SOC TRAUM	17	11	11	0	19	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	NOV	2013	27	12					1333	1337		10.3109/02699052.2013.823651			5	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	235UF	WOS:000325745500001	24070144				2021-06-18	
J	Choudhry, OJ; Prestigiacomo, CJ; Gala, N; Slasky, S; Sifri, ZC				Choudhry, Osamah J.; Prestigiacomo, Charles J.; Gala, Nihar; Slasky, Shira; Sifri, Ziad C.			Delayed Neurological Deterioration After Mild Head Injury: Cause, Temporal Course, and Outcomes	NEUROSURGERY			English	Article						Acute neurologic deterioration; Delayed neurologic deterioration; Elderly; GOS; Mild head injury; Mild traumatic brain injury; Talk and deteriorate	TRAUMATIC BRAIN-INJURY; CRANIAL COMPUTED-TOMOGRAPHY; INTRACRANIAL HEMORRHAGE; INTRACEREBRAL HEMORRHAGE; INDEPENDENT PREDICTOR; ANTIPLATELET THERAPY; ELDERLY-PATIENTS; TALK; MORTALITY; AGE	BACKGROUND: Mild head injury (MHI) complicated by an intracranial hemorrhage (ICH) is a common cause of hospital admission after head trauma. Most patients are treated nonoperatively, remain neurologically stable, and are discharged uneventfully. However, a small percentage of patients suffer delayed neurological deterioration (DND). Little is known about the characteristics of DND after an MHI complicated by ICH. OBJECTIVE: To identify the cause, temporal course, and outcomes of patients who deteriorated neurologically after presenting with MHI and ICH. METHODS: A retrospective review was performed of all adult patients presenting over 54 consecutive months with MHI and ICH. Patients who were treated nonoperatively after initial head computed tomography and had a subsequent DND (Glasgow Coma Scale score decrease >= 2) were identified. Demographics, neurological status, clinical course, radiographic findings, and outcome data were collected. RESULTS: Over 54 months, 757 patients with MHI plus ICH were admitted for observation; of these, 31 (4.1%) experienced DND. Eighty-seven percent of patients deteriorated within 24 hours after admission. Twenty-one patients (68%) deteriorated as a result of progressive intracranial hemorrhage, and 10 patients (32%) deteriorated as a result of medical causes. Seven patients (23%) died. Variables significantly associated with mortality included age. 60 years, coagulopathy, and change in Marshall computed tomography classification. CONCLUSION: The incidence of delayed neurological deterioration after MHI with ICH is low and usually occurs within 24 hours after admission. It results in significant morbidity and mortality if it is the result of progressive intracranial hemorrhage. Further research is needed to identify risk factors that can allow early detection and improve outcomes in these patients.	[Choudhry, Osamah J.; Prestigiacomo, Charles J.; Gala, Nihar] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Neurol Surg, Newark, NJ 07101 USA; [Prestigiacomo, Charles J.; Slasky, Shira] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Radiol, Newark, NJ 07101 USA; [Sifri, Ziad C.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Surg, Div Trauma Surg, Newark, NJ 07101 USA	Sifri, ZC (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Surg, Div Trauma Surg, 90 Bergen St, Newark, NJ 07101 USA.	sifrizi@umdnj.edu	Prestigiacomo, Charles J/B-3911-2018	Prestigiacomo, Charles J/0000-0002-5979-2378			AFGEIJERSTAM JL, 2003, ACTA NEUROCHIR WIEN, V145, P850; Bouzat P, 2009, ANN FR ANESTH, V28, P135, DOI 10.1016/j.annfar.2008.12.019; Bouzat P, 2011, NEUROSURGERY, V68, P1603, DOI 10.1227/NEU.0b013e31820cd43e; Brown CVR, 2012, AM SURGEON, V78, P57; Carlson AP, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.8.FOCUS10182; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Davis DP, 2007, J TRAUMA, V62, P277, DOI 10.1097/TA.0b013e31802ef4a3; Fischer J, 2001, Crit Care Nurs Q, V23, P52; Geijerstam JLA, 2003, ACTA NEUROCHIR, V145, P843, DOI 10.1007/s00701-003-0115-1; Glass TF, 1999, J NEUROTRAUM, V16, P771, DOI 10.1089/neu.1999.16.771; Homnick A, 2012, INJURY, V43, P2122, DOI 10.1016/j.injury.2012.04.013; Inamasu J, 2010, NEUROL MED-CHIR, V50, P1051, DOI 10.2176/nmc.50.1051; Ivascu FA, 2008, J TRAUMA, V65, P785, DOI 10.1097/TA.0b013e3181848caa; KOTWICA Z, 1992, ACTA NEUROCHIR, V118, P98, DOI 10.1007/BF01401293; LEE ST, 1995, ACTA NEUROCHIR, V135, P136, DOI 10.1007/BF02187757; Livingston DH, 2000, ANN SURG, V232, P126, DOI 10.1097/00000658-200007000-00018; LOBATO RD, 1991, J NEUROSURG, V75, P256, DOI 10.3171/jns.1991.75.2.0256; MARSHALL LF, 1983, J NEUROSURG, V59, P285, DOI 10.3171/jns.1983.59.2.0285; Mina AA, 2002, J TRAUMA, V53, P668, DOI 10.1097/00005373-200210000-00008; MORAN SG, 1994, AM SURGEON, V60, P533; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Nagy KK, 1999, J TRAUMA, V46, P268, DOI 10.1097/00005373-199902000-00012; Ohm C, 2005, J TRAUMA, V58, P518, DOI 10.1097/01.TA.0000151671.35280.8B; Ratanalert S, 2002, J CLIN NEUROSCI, V9, P640, DOI 10.1054/jocn.2002.1085; Reilly PL, 2001, J CLIN NEUROSCI, V8, P398, DOI 10.1054/jocn.2001.0916; ROCKSWOLD GL, 1993, ANN EMERG MED, V22, P1004, DOI 10.1016/S0196-0644(05)82742-8; ROCKSWOLD GL, 1987, NEUROSURGERY, V21, P51, DOI 10.1227/00006123-198707000-00010; Roquer J, 2005, J NEUROL, V252, P412, DOI 10.1007/s00415-005-0659-5; Sifri ZC, 2006, J TRAUMA, V61, P862, DOI 10.1097/01.ta.0000224225.54982.90; Sing RF, 2006, J TRAUMA, V60, P499; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P13; Thiruppathy SP, 2004, ACTA NEUROCHIR, V146, P1075, DOI 10.1007/s00701-004-0335-z; Toyoda K, 2005, NEUROLOGY, V65, P1000, DOI 10.1212/01.wnl.0000179178.37713.69; Velmahos GC, 2006, J TRAUMA, V60, P494, DOI 10.1097/01.ta.0000203546.14824.0d; Zumstein MA, 2011, J TRAUMA, V71, P120, DOI 10.1097/TA.0b013e3181f2d670	37	11	11	0	2	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	NOV	2013	73	5					753	760		10.1227/NEU.0000000000000105			8	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	300MH	WOS:000330467500013	23867298				2021-06-18	
J	Collie, A; Prang, KH				Collie, A.; Prang, K-H.			Patterns of healthcare service utilisation following severe traumatic brain injury: An idiographic analysis of injury compensation claims data	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Brain injury; Transport; Idiographic; Health service use; Trajectory	DEVELOPMENTAL TRAJECTORIES; SAS PROCEDURE; OUTCOMES; REHABILITATION; RECOVERY; PROFILE	Background: The rate and extent of recovery after severe traumatic brain injury (TBI) is heterogeneous making prediction of likely healthcare service utilisation (HSU) difficult. Patterns of HSU derived from nomothetic samples do not represent the diverse range of outcomes possible within this patient group. Group-based trajectory model is a semi-parametric statistical technique that seeks to identify clusters of individuals whose outcome (however measured) follows a similar pattern of change over time. Aim: To identify and characterise patterns of HSU in the 5-year period following severe TBI. Methods: Detailed healthcare treatment payments data in 316 adults with severe TBI (Glasgow Coma Scale score 3-8) from the transport accident compensation system in the state of Victoria, Australia was accessed for this analysis. A semi-parametric group-based trajectory analytical technique for longitudinal data was applied to monthly observation counts of HSU data to identify distinct clusters of participants' trajectories. Comparison between trajectory groups on demographic, injury, disability and compensation relevant outcomes was undertaken. Results: Four distinct patterns (trajectories) of HSU were identified in the sample. The first trajectory group comprised 27% of participants and displayed a rapid decrease in HSU in the first year post-injury. The second group comprised 24% of participants and showed a sharp peak in HSU during the first 12 months post-injury followed by a decline over time. The third group comprised 32% of participants and showed a slight peak in HSU in the first few months post-injury and then a slow decline over time. The fourth group comprised 17% of participants and displayed a steady rise in HSU up to 30 months post-injury, followed by a gradual decline to a level consistent with that received in the first months post-injury. Significant differences were observed between groups on factors such as age, injury severity, and use of disability services. Conclusions: There is substantial variation in patterns of HSU following severe TBI. Idiographic analysis can provide rich information for describing and understanding the resources required to help people with TBI. (C) 2013 Elsevier Ltd. All rights reserved.	[Collie, A.; Prang, K-H.] Monash Univ, Inst Safety Compensat & Recovery Res, Clayton, Vic 3800, Australia; [Collie, A.] Monash Univ, Dept Epidemiol & Prevent Med, Clayton, Vic 3800, Australia	Collie, A (corresponding author), Level 11,499 St Kilda Rd, Melbourne, Vic 3004, Australia.	alex.collie@monash.edu		Collie, Alex/0000-0003-2617-9339	Transport Accident Commission (TAC); WorkSafe Victoria via the Institute for Safety Compensation and Recovery Research	The authors thank Professor Bobby Jones for his assistance in using SAS Proc Traj for the data analysis. Funding for this project was provided by a research grant from the Transport Accident Commission (TAC) and WorkSafe Victoria via the Institute for Safety Compensation and Recovery Research. Views expressed are those of the authors and not the funding agencies.	American Medical Association, 1993, GUIDES EVALUATION PE; Andruff H, 2009, TUTOR QUANT METHODS, V5, P11, DOI 10.20982/tqmp.05.1.p011; BROOKS CA, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199508000-00002; Cameron CM, 2008, BRAIN INJURY, V22, P437, DOI 10.1080/02699050802060621; Dombovy ML, 1997, BRAIN INJURY, V11, P305, DOI 10.1080/026990597123467; Foster M, 2000, BRAIN INJURY, V14, P1035; Gabbe BJ, 2007, MED J AUSTRALIA, V187, P14, DOI 10.5694/j.1326-5377.2007.tb01108.x; Hoeppner BB, 2008, ADDICT BEHAV, V33, P623, DOI 10.1016/j.addbeh.2007.11.005; Jones BL, 2001, SOCIOL METHOD RES, V29, P374, DOI 10.1177/0049124101029003005; Jones BL, 2007, SOCIOL METHOD RES, V35, P542, DOI 10.1177/0049124106292364; Lippel K, 2007, INT J LAW PSYCHIAT, V30, P427, DOI 10.1016/j.ijlp.2007.06.013; Mellick D, 2003, BRAIN INJURY, V17, P55, DOI 10.1080/0269905021000010159; Molenaar P.C.M., 2004, MEAS INTERDISCIP RES, V2, P201, DOI [10.1207/s15366359mea0204_1., DOI 10.1207/S15366359MEA0204_1]; Nagin DS, 1999, PSYCHOL METHODS, V4, P139, DOI 10.1037/1082-989X.4.2.139; Nandi A, 2009, ANN EPIDEMIOL, V19, P761, DOI 10.1016/j.annepidem.2009.06.005; O'Callaghan AM, 2010, INT J SPEECH-LANG PA, V12, P107, DOI 10.3109/17549500903431774; OTTENBACHER KJ, 1990, AM J PHYS MED REHAB, V69, P286, DOI 10.1097/00002060-199012000-00002; Ponsford J., 2012, INPSYCH; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; Prang KH, 2012, BRAIN INJURY, V26, P1611, DOI 10.3109/02699052.2012.698790; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Ruseckaite R, 2011, INJURY; Schmidt M, 2010, Z PSYCHOL, V218, P166, DOI 10.1027/0044-3409/a000026; Sterling M, 2010, PAIN, V150, P22, DOI 10.1016/j.pain.2010.02.013; Swaine BR, 1996, BRAIN INJURY, V10, P347, DOI 10.1080/026990596124368; Transport Accident Commission (TAC), 2011, ANN REPORT, P1; Transport Accident Commission (TAC), 2012, MAK CLAIM; Transport Accident Commission (TAC), 2012, COMMUN LAW; Velicer WF, 2005, ED PSYCHOL MEASUREME, V65; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; Windle M, 2004, DEV PSYCHOPATHOL, V16, P1007, DOI 10.1017/S0954579404040118; Xie HY, 2006, ADM POLICY MENT HLTH, V33, P423, DOI 10.1007/s10488-006-0048-0	32	11	11	0	14	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383			INJURY	Injury-Int. J. Care Inj.	NOV	2013	44	11					1514	1520		10.1016/j.injury.2013.03.006			7	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	227ZT	WOS:000325155000024	23566704				2021-06-18	
J	Donders, J; Elzinga, B; Kuipers, D; Helder, E; Crawford, JR				Donders, Jacobus; Elzinga, Brianne; Kuipers, David; Helder, Emily; Crawford, John R.			Development of an eight-subtest short form of the WISC-IV and evaluation of its clinical utility in children with traumatic brain injury	CHILD NEUROPSYCHOLOGY			English	Article						Assessment; Intelligence; Psychometrics; Short form	WECHSLER-INTELLIGENCE-SCALE; HIGHER-ORDER; VALIDITY; EDITION; SAMPLE; SCORES	This study evaluated the degree to which an 8-subtest short form of the Wechsler Intelligence Scale for ChildrenFourth Edition would yield acceptable estimates of the long-form Full-Scale IQ index while clarifying the underlying factor structure in a sample of 100 children and adolescents with traumatic brain injury. The short-form Full-Scale IQ had sufficient (i.e., at least two thirds) nonerror covariance with its full-length counterpart. In addition, a sufficient proportion (i.e., > 80%) of these short-form estimates fell within the 90% confidence interval of the respective full-length scores. Importantly, the elimination of 2 subtests, and in particular the Picture Concepts subtest, resulted in a factor structure where each remaining subtest was fairly specifically associated with its intended scale. It is concluded that this short form can be used clinically in children with traumatic brain injury without sacrificing reliability and with more straightforward interpretability at the level of the factor index scores.	[Donders, Jacobus] Mary Free Bed Rehabil Hosp, Psychol Serv, Grand Rapids, MI 49503 USA; [Elzinga, Brianne; Kuipers, David; Helder, Emily] Calvin Coll, Dept Psychol, Grand Rapids, MI 49506 USA; [Crawford, John R.] Univ Aberdeen, Sch Psychol, Aberdeen, Scotland	Donders, J (corresponding author), Mary Free Bed Rehabil Hosp, Psychol Serv, 235 Wealthy SE, Grand Rapids, MI 49503 USA.	jacobus.donders@maryfreebed.com	Crawford, John R/A-4165-2008	Crawford, John R/0000-0003-3403-3428	Campbell Foundation [1.1099.0014]	This research was supported by a grant from the Campbell Foundation (#1.1099.0014).	Allen DN, 2010, PSYCHOL ASSESSMENT, V22, P57, DOI 10.1037/a0016056; American Educational Research Association, 1999, STAND ED PSYCH TEST; Bodin D, 2009, CHILD NEUROPSYCHOL, V15, P417, DOI 10.1080/09297040802603661; Crawford JR, 2007, NEUROPSYCHOLOGY, V21, P419, DOI 10.1037/0894-4105.21.4.419; Crawford JR, 2010, BRIT J CLIN PSYCHOL, V49, P235, DOI 10.1348/014466509X455470; Delis DC, 2003, J INT NEUROPSYCH SOC, V9, P936, DOI 10.1017/S1355617703960139; Donders J, 2002, PSYCHOL ASSESSMENT, V14, P360, DOI 10.1037//1040-3590.14.3.360; Donders J, 1996, CHILD NEUROPSYCHOL, V2, P227, DOI 10.1080/09297049608402255; Donders J, 2008, J INT NEUROPSYCH SOC, V14, P651, DOI 10.1017/S1355617708080752; Kaufman A.S., 1994, INTELLIGENT TESTING; Keith TZ, 2006, SCHOOL PSYCHOL REV, V35, P108; LEVY P, 1967, J CLIN PSYCHOL, V23, P84, DOI 10.1002/1097-4679(196701)23:1<84::AID-JCLP2270230123>3.0.CO;2-2; Millis SR, 2003, CHILD NEUROPSYCHOL, V9, P221, DOI 10.1076/chin.9.3.221.16455; Nunnally J.C., 1978, PSYCHOMETRIC THEORY; Ryan JJ, 2007, J CLIN PSYCHOL, V63, P309, DOI 10.1002/jclp.20343; Stevens J.P., 2002, APPL MULTIVARIATE ST, V4th ed; Tombaugh TN, 1996, TEST MEMORY MALINGER; Watkins MW, 2010, PSYCHOL ASSESSMENT, V22, P782, DOI 10.1037/a0020043; Wechsler D., 2003, WECHSLER INTELLIGENC; Wechsler D., 2011, WECHSLER ABBREVIATED	20	11	11	0	11	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0929-7049	1744-4136		CHILD NEUROPSYCHOL	Child Neuropsychol.	NOV 1	2013	19	6					662	670		10.1080/09297049.2012.723681			9	Clinical Neurology	Neurosciences & Neurology	240BY	WOS:000326070900009	22950806				2021-06-18	
J	Fares, Y; Ayoub, F; Fares, J; Khazim, R; Khazim, M; Gebeily, S				Fares, Youssef; Ayoub, Fouad; Fares, Jawad; Khazim, Rabi; Khazim, Mahmoud; Gebeily, Souheil			Pain and neurological sequelae of cluster munitions on children and adolescents in South Lebanon	NEUROLOGICAL SCIENCES			English	Article						Cluster bombs; Cluster munitions; Neurological effects; Psychological effects; Pain	UNEXPLODED ORDNANCE; LAND MINES	This paper aims at evaluating the neurological repercussions arising from injuries sustained due to cluster munitions in children up to 18 years in South Lebanon following the 2006 conflict. Data on neurological and pain symptoms suffered during and after treatment because of sub-munitions in South Lebanon from August 2006 till late 2011 were prospectively recorded. Patients were divided into subcategories; children aged 12 and under and adolescents aged between 13 and 18. During the study period, there were 407 casualties, 122 (30 %) of which were aged 18 years or younger. There were 116 (95 %) males and six (5 %) females. Average age was 14 years. 10 (8.2 %), all males, died as a result of their injuries. 42 (34.4 %) were children and 80 (65.6 %) were adolescents. 112 had surgical treatments for their injuries. 83 out of 112 patients (74 %) with non-lethal injuries had amputations, 67 % children and 78 % adolescents. Among those who had amputations, 31 (37.4 %) suffered from phantom limb pain and 71 % suffered from stump/residual limb pain. 88 % of patients were diagnosed with post-traumatic stress disorder (44 % children and 77 % adolescents) and 41 % were diagnosed with post-concussion syndrome. Four patients (3.6 %) suffered from traumatic brain injuries, both penetrating and closed. Pain syndromes were found in all patients who had amputation. The injury related comorbidities together with many post-concussion syndrome cases, and fewer traumatic brain injuries lead into a high level of physical, psychosocial and economic burdens on the community.	[Fares, Youssef] Lebanese Univ, Fac Med Sci, Div Neurosurg, Beirut, Lebanon; [Ayoub, Fouad] Lebanese Univ, Fac Med Dent, Dept Basic Sci, Beirut, Lebanon; [Fares, Jawad] Amer Univ Beirut, Fac Med, Beirut, Lebanon; [Khazim, Rabi] Southend Univ Hosp, Westcliff On Sea, Essex, England; [Khazim, Mahmoud] Newcastle Univ, Inst Human Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Gebeily, Souheil] Lebanese Univ, Fac Med Sci, Div Neurol, Beirut, Lebanon	Fares, Y (corresponding author), Lebanese Univ, Fac Med Sci, Div Neurosurg, Beirut, Lebanon.	yfares@ul.edu.lb; jyf04@mail.aub.edu	Fares, Jawad/X-4341-2018	Fares, Jawad/0000-0002-5368-8764; GEBEILY, SOUHEIL/0000-0001-8476-2149			American Psychiatric Association, 1994, DIAGN STAT MAN MENT; [Anonymous], 2010, INT CAMP BAN LANDM; [Anonymous], 2011, CHILDR LANDM DEADL L; Bandak FA, 1996, TRAUMATIC BRAIN INJU, P167; Beehner L, 2006, CAMPAIGN BAN CLUSTER; Bendinelli C, 2009, WORLD J SURG, V33, P1070, DOI 10.1007/s00268-009-9978-5; Borrie J, 2006, CLUST MUNITIONS, V4, P5; Bouhassira D, 2005, PAIN, V114, P29, DOI 10.1016/j.pain.2004.12.010; Fares Y, 2013, NEUROL SCI, V34, P2095, DOI 10.1007/s10072-013-1343-7; Flor H, 1998, EXP BRAIN RES, V119, P205, DOI 10.1007/s002210050334; Jaber H, 2009, CLUSTER BOMBS LEAVE; Kalauokalani DAK, 1999, EPIDEMIOLOGY PAIN, P143; Kooijman CM, 2000, PAIN, V87, P33, DOI 10.1016/S0304-3959(00)00264-5; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Nixon R, 2007, CULT CRIT, P160; Roth W, 2011, GLOBALIZATIONS; Sherman RA, 1984, PAIN, V8, P85; Walsh NE, 2003, B WORLD HEALTH ORGAN, V81, P665; Watts HG, 2009, J PEDIATR REHAB MED, V2, P217, DOI 10.3233/PRM-2009-0083; Williamson B, 2011, J ERW MINE ACTION, V15, P29	20	11	11	1	2	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1590-1874	1590-3478		NEUROL SCI	Neurol. Sci.	NOV	2013	34	11					1971	1976		10.1007/s10072-013-1427-4			6	Clinical Neurology; Neurosciences	Neurosciences & Neurology	250OJ	WOS:000326861800013	23563862				2021-06-18	
J	Johnston, BD; Ebel, BE				Johnston, Brian D.; Ebel, Beth E.			Child Injury Control: Trends, Themes, and Controversies	ACADEMIC PEDIATRICS			English	Article						concussion; drowning; injury prevention; road traffic injury; surveillance	UNEXPECTED INFANT DEATHS; HIGH-SCHOOL; RECREATIONAL BOATERS; COST-EFFECTIVENESS; YOUTH SUICIDE; UNITED-STATES; HEALTH; CONCUSSION; PREVENTION; SAFETY	Injury is a major cause of morbidity and mortality among US children, and an important driver of health status globally. Despite its enormous burden, injury is preventable. Over the last 10 years, significant progress has been made in the reduction of unintentional injury among US children. However, aggregate trends mask important disparities by age group, region, and injury mechanism. Basic and translation research is needed to develop and test prevention strategies to address these new or recalcitrant problems. Motor vehicle occupant injury has fallen to historic lows, but challenges remain in protecting novice drivers and managing the distraction of new technologies. Injury to pedestrians has also declined, but likely as a result of decreased exposure as fewer children walk. This calls for a broader public health perspective to promote activity while enhancing safety. Deaths due to drowning are common and illustrate the difficulty in measuring and promoting appropriate supervision. Environmental modification and use of protective products may be a more appropriate response. Concussion in sport is another challenging issue: public health laws promote identification and appropriate management of concussed athletes, but less progress has been made on primary prevention of these injuries. Unintentional poisoning is on the rise, attributable to misuse of, and overdose with, prescription opioids. Injury deaths to infants are also increasing. This trend is driven in part by better death investigation that classifies more sleep-related deaths as suffocation events. Finally, we examine a sample of cross-cutting themes and controversies in injury control that might be amenable to empiric evaluation.	[Johnston, Brian D.; Ebel, Beth E.] Univ Washington, Dept Pediat, Harborview Injury Prevent & Res Ctr, 325 9th Ave,Box 359774, Seattle, WA 98104 USA	Johnston, BD (corresponding author), Univ Washington, Dept Pediat, Harborview Injury Prevent & Res Ctr, 325 9th Ave,Box 359774, Seattle, WA 98104 USA.	bdj@uw.edu					Ackaah W, INJ PREV IN PRESS; Agran PF, 2003, PEDIATRICS, V111, pE683, DOI 10.1542/peds.111.6.e683; [Anonymous], 2012, CONCUSSION LEGISLATI; [Anonymous], 2010, GLOB PLAN DEC ACT RO; Barber C, 2011, ACCIDENT ANAL PREV, V43, P724, DOI 10.1016/j.aap.2010.10.018; Benden ME, 2012, J HLTH BEHAV PUB HLT, V2, P20; Benson BW, 2009, BRIT J SPORT MED, V43, pI56, DOI 10.1136/bjsm.2009.058271; Bonnie RJ, 2004, US NATL RES COUNCIL; Brach RM, 2011, COLLISION, P6; Brenner RA, 2009, ARCH PEDIAT ADOL MED, V163, P203, DOI 10.1001/archpediatrics.2008.563; Carrera C, 2012, LANCET, V380, P1341, DOI 10.1016/S0140-6736(12)61378-6; Carver A, 2008, HEALTH PLACE, V14, P217, DOI 10.1016/j.healthplace.2007.06.004; Cash SJ, 2009, CURR OPIN PEDIATR, V21, P613, DOI 10.1097/MOP.0b013e32833063e1; Centers for Disease Contro and Prevention, 2012, MMWR-MORBID MORTAL W, V61, P270; Centers for Disease Control and Prevention, 2012, WEB BAS INJ STAT QUE; Chalkidou K, 2012, CLIN TRIALS, V9, P436, DOI 10.1177/1740774512450097; Cooper Gregory D, 2011, Issues Ment Health Nurs, V32, P696, DOI 10.3109/01612840.2011.597911; Covington TM, 2011, INJURY PREV, V17, P34, DOI 10.1136/ip.2010.031203; Cummings P, 1997, JAMA-J AM MED ASSOC, V278, P1084, DOI 10.1001/jama.278.13.1084; Cummings P, 2011, INJURY PREV, V17, P156, DOI 10.1136/ip.2010.028688; Dalziel K, 2012, ARCH DIS CHILD, V97, P787, DOI 10.1136/archdischild-2011-300795; de Hartog JJ, 2010, ENVIRON HEALTH PERSP, V118, P1109, DOI 10.1289/ehp.0901747; DiGuiseppi C, 1997, BRIT MED J, V314, P710, DOI 10.1136/bmj.314.7082.710; Durbin DR, 2011, PEDIATRICS, V127, pE1050, DOI 10.1542/peds.2011-0215; Eaton Danice K., 2012, Morbidity and Mortality Weekly Report, V61, P1; Ebel BE, 2009, INJURY PREV, V15, P212, DOI 10.1136/ip.2009.022475; Eng HL, 2008, IEEE T CIRC SYST VID, V18, P196, DOI 10.1109/TCSVT.2007.913960; Fagan AA, RES SOCIAL IN PRESS; Farmer CM, 2010, J SAFETY RES, V41, P39, DOI 10.1016/j.jsr.2009.12.002; Farrington DP, 2009, CRIME JUSTICE, V38, P281, DOI 10.1086/599198; Feng ZY, 2010, INJURY PREV, V16, DOI 10.1136/ip.2009.024646; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Fischer B, 2010, ADDICTION, V105, P2062, DOI 10.1111/j.1360-0443.2010.03092.x; Foss RD, 2009, ACCIDENT ANAL PREV, V41, P419, DOI 10.1016/j.aap.2009.01.004; Garcia-Espana JF, 2012, AM J PUBLIC HEALTH, V102, P1128, DOI 10.2105/AJPH.2011.300493; Grossman DC, 2005, JAMA-J AM MED ASSOC, V293, P707, DOI 10.1001/jama.293.6.707; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Hosking SG, 2009, HUM FACTORS, V51, P582, DOI 10.1177/0018720809341575; Jacobsen PL, 2003, INJURY PREV, V9, P205, DOI 10.1136/ip.9.3.205; Jimenez-Mejias E, INJURY PREV, DOI DOI 10.1136/INJURYPREV-2012-040467.ACCESSED; Johnston BD, 2008, INJURY PREV, V14, P145, DOI 10.1136/ip.2008.019265; Johnston BD, 2011, INJURY PREV, V17, P1, DOI 10.1136/ip.2010.031161; Johnston BD, 2010, INJURY PREV, V16, P1, DOI 10.1136/ip.2009.026096; Johnston BD, 2008, J URBAN DES, V13, P141, DOI 10.1080/13574800701803407; Johnston BD, 2009, INJURY PREV, V15, P73, DOI 10.1136/ip.2009.021790; Kassam-Adams N, 2004, J AM ACAD CHILD PSY, V43, P403, DOI 10.1097/00004583-200404000-00006; Koepsell TD, 2011, AM J PREV MED, V40, P191, DOI 10.1016/j.amepre.2010.10.022; Laosee Orapin C., 2012, Morbidity and Mortality Weekly Report, V61, P344; Lee SE, 2011, ACCIDENT ANAL PREV, V43, P1472, DOI 10.1016/j.aap.2011.02.026; Linnan HA, 2011, INJURY PREV, V17, P74, DOI 10.1136/ip.2010.026443; Linnan M, 2007, SPECIAL SERIES CHILD, V3; Liu X, 2009, INJURY PREV, V15, P105, DOI 10.1136/ip.2008.019877; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Lyon JD, 2012, J SAFETY RES, V43, P29, DOI 10.1016/j.jsr.2011.10.007; Mangione TW, 2012, J PUBLIC HEALTH POL, V33, P59, DOI 10.1057/jphp.2011.55; Martinotti G, 2011, J PUBLIC HEALTH-HEID, V19, P545, DOI 10.1007/s10389-011-0422-6; Matjasko JL, 2012, AGGRESS VIOLENT BEH, V17, P540, DOI 10.1016/j.avb.2012.06.006; McAndrews C, 2011, INJURY PREV, V17, P204, DOI 10.1136/ip.2010.029306; McCartt AT, 2010, TRAFFIC INJ PREV, V11, P361, DOI 10.1080/15389588.2010.486428; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; McDonald NC, 2007, AM J PREV MED, V32, P509, DOI 10.1016/j.amepre.2007.02.022; McDonald NC, 2011, AM J PREV MED, V41, P146, DOI 10.1016/j.amepre.2011.04.006; McGehee DV, 2007, J SAFETY RES, V38, P215, DOI 10.1016/j.jsr.2007.02.009; Merolli ML, 2011, COLLISION, P6; Mock C, 2004, LANCET, V363, P2172, DOI 10.1016/S0140-6736(04)16510-0; Molcho M, 2011, INJURY PREV, V17, P147, DOI 10.1136/ip.2010.030023; Morrongiello BA, 2006, INJURY PREV, V12, P19, DOI 10.1136/ip.2005.008862; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Mytton JA, 2012, INJURY PREV, V18, P334, DOI 10.1136/injuryprev-2012-040343; Naci H, 2009, INJURY PREV, V15, P55, DOI 10.1136/ip.2008.018721; O'Brien NP, ACCIDENT AN IN PRESS; Office of Statistics and Programming, 2012, COST INJ REP; Ogden Cynthia L, 2012, NCHS Data Brief, P1; Paulozzi Leonard J., 2011, Morbidity and Mortality Weekly Report, V60, P1487; Paulozzi LJ, 2011, PAIN MED, V12, P747, DOI 10.1111/j.1526-4637.2011.01062.x; Peden M., 2008, WORLD REPORT CHILD I; Petrass LA, 2011, INJURY PREV, V17, P244, DOI 10.1136/ip.2010.031062; Pless IB, 2012, INJURY PREV, V18, P285, DOI 10.1136/injuryprev-2012-040449; Polinder S, 2012, EPIDEMIOL REV, V34, P17, DOI 10.1093/epirev/mxr022; Pucher J, 2003, AM J PUBLIC HEALTH, V93, P1509, DOI 10.2105/AJPH.93.9.1509; Quan LA, 2011, INJURY PREV, V17, P28, DOI 10.1136/ip.2010.026849; Rahman A, 2010, INJURY PREV, V16, P21, DOI 10.1136/ip.2008.021311; Rahman F, PEDIATRICS IN PRESS; Richardson EG, 2011, J TRAUMA, V70, P238, DOI 10.1097/TA.0b013e3181dbaddf; Rivara FP, 2012, J NEUROTRAUM, V29, P2499, DOI 10.1089/neu.2012.2434; Sanders MR, 2003, CHILD ABUSE REV, V12, P155, DOI [DOI 10.1002/CAR.798, 10.1002/car.798.]; Schnitzer PG, 2012, AM J PUBLIC HEALTH, V102, P1204, DOI 10.2105/AJPH.2011.300613; Shain BN, 2007, PEDIATRICS, V120, P669, DOI 10.1542/peds.2007-1908; Shalini RT, 2011, POLICY POLIT, V39, P221, DOI 10.1332/030557310X501767; Shapiro-Mendoza CK, 2009, PEDIATRICS, V123, P533, DOI 10.1542/peds.2007-3746; Shapiro-Mendoza CK, 2006, AM J EPIDEMIOL, V163, P762, DOI 10.1093/aje/kwj117; Shiffman J, 2007, LANCET, V370, P1370, DOI 10.1016/S0140-6736(07)61579-7; Shope JT, 2008, AM J PREV MED, V35, pS261, DOI 10.1016/j.amepre.2008.06.022; Sidman EA, 2005, PEDIATRICS, V115, pE654, DOI 10.1542/peds.2004-1625; Sivak M, 2009, INJURY PREV, V15, P205, DOI 10.1136/ip.2009.021964; Starfield B, 2012, ANNU REV PUBL HEALTH, V33, P89, DOI 10.1146/annurev-publhealth-031811-124528; Sullivan MD, 2010, CLIN J PAIN, V26, P512, DOI 10.1097/AJP.0b013e3181dc7adc; Thomas DR, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002968.pub2; U.S. Department of Health and Human Services Administration for Children and Families Children'sBureau, 2011, CHILD MALTREATMENT; *UNICEF, 2001, LEAG TABL CHILD DEAT; US Department of Transportation. National Highway Traffic Safety Administration, 2012, 811680 DOT HS NAT HI; Virginia Tech Transportation Institute, 2009, NEW DAT VTT PROV INS; Wald NJ, 1999, BMJ-BRIT MED J, V319, P1562, DOI 10.1136/bmj.319.7224.1562; Warner M, 2011, NCHS DATA BRIEF, V81, P1; Washington State Department of Health, CONC MAN SCH; Weiss J, 2010, PEDIATRICS, V126, P178, DOI 10.1542/peds.2010-1264; Williams A, 2012, TENNAGE DRIVER FATAL; Yip PSF, 2012, LANCET, V379, P2393, DOI 10.1016/S0140-6736(12)60521-2	109	11	11	0	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1876-2859	1876-2867		ACAD PEDIATR	Acad. Pediatr.	NOV-DEC	2013	13	6					499	507		10.1016/j.acap.2013.04.016			9	Pediatrics	Pediatrics	261TX	WOS:000327688600005	24021529				2021-06-18	
J	Leonard, AV; Thornton, E; Vink, R				Leonard, Anna V.; Thornton, Emma; Vink, Robert			Substance P as a Mediator of Neurogenic Inflammation after Balloon Compression Induced Spinal Cord Injury	JOURNAL OF NEUROTRAUMA			English	Article						blood spinal cord barrier; edema; neurogenic inflammation; spinal cord injury; substance P	BLOOD-BRAIN-BARRIER; EDEMA FORMATION; FUNCTIONAL DEFICITS; TRAUMATIC INJURY; MODEL; RAT; PATHOPHYSIOLOGY; NEUROTOXICITY; PERMEABILITY; TRANSECTION	Although clinical spinal cord injury (SCI) occurs within a closed environment, most experimental models of SCI create an open injury. Such an open environment precludes the measurement of intrathecal pressure (ITP), whose increase after SCI has been linked to the development of greater tissue damage and functional deficits. Raised ITP may be potentiated by edema, which we have recently shown to be associated with substance P (SP) induced neurogenic inflammation in both traumatic brain injury and stroke. The present study investigates whether SP plays a similar role as a mediator of neurogenic inflammation after SCI. A closed balloon compression injury was induced at T10 in New Zealand white rabbits. Animals were thereafter assessed for blood spinal cord barrier (BSCB) permeability, edema, ITP, histological outcome, and functional outcome from 5h to 2 weeks post-SCI. The balloon compression model produced significant increases in BSCB permeability, edema, and ITP along with significant functional deficits that persisted for 2 weeks. Histological assessment demonstrated decreased SP immunoreactivity in the injured spinal cord while NK1 receptor immunoreactivity initially increased before returning to sham levels. In addition, aquaporin 4 immunoreactivity increased early post-SCI, implicating this water channel in the development of edema after SCI. The changes described in the present study support a role for SP as a mediator of neurogenic inflammation after SCI.	[Leonard, Anna V.; Thornton, Emma; Vink, Robert] Univ Adelaide, Sch Med Sci, Med Sch South, Adelaide, SA 5005, Australia	Leonard, AV (corresponding author), Univ Adelaide, Sch Med Sci, Level Med Sch South 4, Frome Rd, Adelaide, SA 5005, Australia.	anna.leonard@adelaide.edu.au	Vink, Robert/J-7351-2012; AM, Robert Vink/S-5616-2019	Vink, Robert/0000-0002-4885-0667; AM, Robert Vink/0000-0002-4885-0667	Neil Sacshe Foundation, Australia	Supported in part by the Neil Sacshe Foundation, Australia.	Aslan A, 2009, EUR SPINE J, V18, P1442, DOI 10.1007/s00586-009-1033-6; Ates O, 2007, J CLIN NEUROSCI, V14, P658, DOI 10.1016/j.jocn.2006.03.023; Austin JW, 2012, J NEUROTRAUM, V29, P1838, DOI 10.1089/neu.2012.2354; Batchelor PE, 2011, J NEUROTRAUM, V28, P809, DOI 10.1089/neu.2010.1622; Bresnahan JC, 1991, J NEUROTRAUM, V8, P91, DOI 10.1089/neu.1991.8.91; CHAO CC, 1992, J IMMUNOL, V149, P2736; Corrigan F, 2012, CNS NEUROSCI THER, V18, P513, DOI 10.1111/j.1755-5949.2012.00332.x; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; Demediuk P, 1990, Adv Neurol, V52, P225; Detloff MR, 2012, JOVE-J VIS EXP, DOI 10.3791/3247; Donkin JJ, 2009, J CEREBR BLOOD F MET, V29, P1388, DOI 10.1038/jcbfm.2009.63; FADEN AI, 1985, NEUROPEPTIDES, V6, P215, DOI 10.1016/0143-4179(85)90092-7; Fukuda S, 2005, BRAIN RES PROTOC, V14, P171, DOI 10.1016/j.brainresprot.2005.01.001; GOODMAN JH, 1976, J NEUROSURG, V44, P418, DOI 10.3171/jns.1976.44.4.0418; GRIFFITHS IR, 1975, J NEUROSURG, V42, P155, DOI 10.3171/jns.1975.42.2.0155; Harford-Wright E, 2010, NEUROSCI LETT, V481, P26, DOI 10.1016/j.neulet.2010.06.044; Helps SC, 2012, APPL IMMUNOHISTO M M, V20, P82, DOI 10.1097/PAI.0b013e31821fc8cd; Horn EM, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E12; HUGHES JT, 1984, PARAPLEGIA, V22, P131, DOI 10.1038/sc.1984.25; Jaeger CB, 1997, EXP NEUROL, V144, P381, DOI 10.1006/exnr.1996.6405; Kimura A, 2010, ANN NEUROL, V67, P794, DOI 10.1002/ana.22023; Mao L, 2011, BRAIN INJURY, V25, P300, DOI 10.3109/02699052.2010.542432; MARTIN D, 1992, J NEUROSCI RES, V32, P539, DOI 10.1002/jnr.490320409; MARTIN SH, 1973, J NEUROSURG, V39, P75, DOI 10.3171/jns.1973.39.1.0075; NAKAYA Y, 1994, J COMP NEUROL, V347, P249, DOI 10.1002/cne.903470208; NEMECEK S, 1977, ACTA NEUROCHIR, V37, P7, DOI 10.1007/BF01401922; Nesathurai S, 2006, J MED PRIMATOL, V35, P401, DOI 10.1111/j.1600-0684.2006.00162.x; Nesic O, 2006, NEUROSCIENCE, V143, P779, DOI 10.1016/j.neuroscience.2006.08.079; Nimmo AJ, 2004, NEUROPEPTIDES, V38, P40, DOI 10.1016/j.npep.2003.12.003; NOBLE LJ, 1989, BRAIN RES, V482, P57, DOI 10.1016/0006-8993(89)90542-8; NOBLE LJ, 1987, BRAIN RES, V424, P177, DOI 10.1016/0006-8993(87)91208-X; O'Connor TM, 2004, J CELL PHYSIOL, V201, P167, DOI 10.1002/jcp.20061; Pan WH, 1999, J NEUROSCI, V19, P3649; Papadopoulos MC, 2004, FASEB J, V18, P1291, DOI 10.1096/fj.04-1723fje; PIANI D, 1991, NEUROSCI LETT, V133, P159, DOI 10.1016/0304-3940(91)90559-C; Poon PC, 2007, SPINE, V32, P2853, DOI 10.1097/BRS.0b013e31815b7e6b; Popovich PG, 1996, EXP NEUROL, V142, P258, DOI 10.1006/exnr.1996.0196; Rybarova S, 1999, Gen Physiol Biophys, V18 Suppl 1, P75; Saadoun S, 2008, BRAIN, V131, P1087, DOI 10.1093/brain/awn014; Schwab JM, 2001, J NEUROIMMUNOL, V119, P214, DOI 10.1016/S0165-5728(01)00375-7; Schwartz ED, 2005, AM J NEURORADIOL, V26, P1609; SHARMA HS, 1993, NEUROSCIENCE, V57, P443, DOI 10.1016/0306-4522(93)90076-R; SHARMA HS, 1990, NEUROSCIENCE, V38, P205, DOI 10.1016/0306-4522(90)90386-I; Sharma HS, 2005, CURR PHARM DESIGN, V11, P1353, DOI 10.2174/1381612053507837; SHARMA HS, 1991, J NEUROL SCI, V102, P150, DOI 10.1016/0022-510X(91)90063-D; SYPERT GW, 1990, CLIN NEUR, V36, P186; TARLOV IM, 1953, AMA ARCH NEUROL PSY, V70, P813, DOI 10.1001/archneurpsyc.1953.02320360128010; TARLOV IM, 1954, AMA ARCH NEUROL PSY, V71, P271, DOI 10.1001/archneurpsyc.1954.02320390001001; Thornton E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034138; Tian DS, 2009, J NEUROCHEM, V109, P1658, DOI 10.1111/j.1471-4159.2009.06077.x; Tikka TM, 2001, J IMMUNOL, V166, P7527, DOI 10.4049/jimmunol.166.12.7527; Turner RJ, 2006, ACTA NEUROCHIR SUPPL, V96, P263; Turner RJ, 2011, BRAIN RES, V1393, P84, DOI 10.1016/j.brainres.2011.03.066; Vanicky I, 2001, J NEUROTRAUM, V18, P1399, DOI 10.1089/08977150152725687; Vink R, 2003, ACT NEUR S, V86, P257; VITA G, 1990, NEUROPEPTIDES, V17, P147, DOI 10.1016/0143-4179(90)90078-D; WANG R, 1993, SURG NEUROL, V39, P348, DOI 10.1016/0090-3019(93)90198-A; WINKLER T, 1994, NEUROSCI RES, V21, P91, DOI 10.1016/0168-0102(94)90072-8; WOIE K, 1993, CIRC RES, V73, P839, DOI 10.1161/01.RES.73.5.839	59	11	12	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV 1	2013	30	21					1812	1823		10.1089/neu.2013.2993			12	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	236UN	WOS:000325825000004	23924052	Green Published			2021-06-18	
J	Li, N; Zhao, WG; Xu, FL; Zhang, WF; Gu, WT				Li, Ning; Zhao, Wei-Guo; Xu, Fu-Lin; Zhang, Wei-Feng; Gu, Wei-Ting			Neutrophil gelatinase-associated lipocalin as an early marker of acute kidney injury in patients with traumatic brain injury	JOURNAL OF NEPHROLOGY			English	Article						Acute kidney injury; Neutrophil gelatinase-associated lipocalin; Traumatic brain injury	ACUTE-RENAL-FAILURE; ANEURYSMAL SUBARACHNOID HEMORRHAGE; ORGAN DYSFUNCTION; CARDIAC-SURGERY; NGAL; BIOMARKER; THERAPY	Background: Recent studies have shown that urinary neutrophil gelatinase-associated lipocalin (NGAL) is rapidly up-regulated early after murine renal injury, and in patients after cardiac Surgery or patients critically ill with multiple trauma. In this study, we evaluated urinary NGAL levels as a potential biomarker of early acute kidney injury (AKI) in patients with severe traumatic brain injury (TBI). Methods: All patients with severe TBI admitted to our neurosurgical intensive care unit from March to September 2011 were enrolled prospectively: Urinary NGAL was measured using a chemiluminescent microparticle immunoassay upon admission and at 24 and, 48 hours after TBI. The presence of AKI was defined by 1 the Acute Kidney Injury Network (AKIN) criteria. Results: Using AKIN criteria, a total of 13 patients were identified with AKI, an incidence of 24%. Those who subsequently developed AKI had a striking rise in urinary NGAL early after TBI and a sustained increase over the entire duration of the study. The urinary NGAL level of the AKI group was significantly higher than the group without AKI at all time points. Using a cutoff value of 53.9 ng/mL, the area under the receiver-operating characteristic curve for urinary NGAL at 48 hours was 0.876 with a sensitivity of 0.69 and specificity of 0.95. Conclusions: Increased urinary NGAL is associated with an increased occurrence of AKI in patients with severe TBI. It is possible that urinary NGAL could provide a screening tool for AKI immediately after severe TBI, and this may in turn allow early intervention to ameliorate the adverse effects of AKI.	[Li, Ning; Zhao, Wei-Guo; Zhang, Wei-Feng; Gu, Wei-Ting] Rui Jin Hosp, Shanghai 200025, Peoples R China; [Xu, Fu-Lin] Ming Hang Dist Cent Hosp, Shanghai, Peoples R China	Gu, WT (corresponding author), Rui Jin Hosp, 197 Rui Jin Er Rd, Shanghai 200025, Peoples R China.	rjneurosurgeon@yahoo.com.cn					Bachorzewska-Gajewska H, 2006, AM J NEPHROL, V26, P287, DOI 10.1159/000093961; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Bolignano D, 2008, AM J KIDNEY DIS, V52, P595, DOI 10.1053/j.ajkd.2008.01.020; Brunner HI, 2006, ARTHRITIS RHEUM, V54, P2577, DOI 10.1002/art.22008; Coca SG, 2007, AM J KIDNEY DIS, V50, P712, DOI 10.1053/j.ajkd.2007.07.018; Devarajan P, 2006, J AM SOC NEPHROL, V17, P1503, DOI 10.1681/ASN.2006010017; Ding HL, 2007, CLIN IMMUNOL, V123, P227, DOI 10.1016/j.clim.2007.01.010; Endre ZH, 2008, NEPHROLOGY, V13, P91, DOI 10.1111/j.1440-1797.2007.00905.x; Gruber A, 1999, CRIT CARE MED, V27, P505, DOI 10.1097/00003246-199903000-00026; Levy MM, 2005, CRIT CARE MED, V33, P2194, DOI 10.1097/01.CCM.0000182798.39709.84; Li N, 2011, NEUROCRIT CARE, V14, P377, DOI 10.1007/s12028-011-9511-1; Makris K, 2009, CLIN CHEM LAB MED, V47, P79, DOI 10.1515/CCLM.2009.004; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Mishra J, 2003, J AM SOC NEPHROL, V14, P2534, DOI 10.1097/01.ASN.0000088027.54400.C6; Mishra J, 2006, PEDIATR NEPHROL, V21, P856, DOI 10.1007/s00467-006-0055-0; Mishra Jaya, 2005, Lancet, V365, P1231, DOI 10.1016/S0140-6736(05)74811-X; Molitoris BA, 2003, J AM SOC NEPHROL, V14, P265, DOI 10.1097/01.ASN.0000048852.53881.D9; Moore EM, 2010, RENAL FAILURE, V32, P1060, DOI 10.3109/0886022X.2010.510234; Mori K, 2005, J CLIN INVEST, V115, P610, DOI 10.1172/JCI200523056; Nickolas TL, 2008, ANN INTERN MED, V148, P810, DOI 10.7326/0003-4819-148-11-200806030-00003; Schrier RW, 2004, J CLIN INVEST, V114, P5, DOI 10.1172/JC1200422353; Star RA, 1998, KIDNEY INT, V54, P1817, DOI 10.1046/j.1523-1755.1998.00210.x; Supavekin S, 2003, KIDNEY INT, V63, P1714, DOI 10.1046/j.1523-1755.2003.00928.x; Tuladhar SM, 2009, J CARDIOVASC PHARM, V53, P261, DOI 10.1097/FJC.0b013e31819d6139; Wagener G, 2006, ANESTHESIOLOGY, V105, P485, DOI 10.1097/00000542-200609000-00011; Zacharia BE, 2009, STROKE, V40, P2375, DOI 10.1161/STROKEAHA.108.545210; Zygun DA, 2003, J CRIT CARE, V18, P238, DOI 10.1016/j.jcrc.2003.10.007	27	11	11	0	4	WICHTIG EDITORE	MILAN	72/74 VIA FRIULI, 20135 MILAN, ITALY	1121-8428	1724-6059		J NEPHROL	J. Nephrol.	NOV-DEC	2013	26	6					1083	1088		10.5301/jn.5000282			6	Urology & Nephrology	Urology & Nephrology	AB5UI	WOS:000331853800015	24249209				2021-06-18	
J	Nelson, LA; MacDonald, M; Stall, C; Pazdan, R				Nelson, Lonnie A.; MacDonald, Margaret; Stall, Christina; Pazdan, Renee			Effects of Interactive Metronome Therapy on Cognitive Functioning After Blast-Related Brain Injury: A Randomized Controlled Pilot Trial	NEUROPSYCHOLOGY			English	Article						blast-related brain injury; cognitive rehabilitation; attention; memory; mTBI; recovery of function	OF-THE-LITERATURE; TEST-PERFORMANCE; REHABILITATION; SYMPTOMS; DISORDER; VALIDITY	Objective: We report preliminary findings on the efficacy of interactive metronome (IM) therapy for the remediation of cognitive difficulties in soldiers with persisting cognitive complaints following blast-related mild-to-moderate traumatic brain injury (TBI). Method: Forty-six of a planned sample of 50 active duty soldiers with persistent cognitive complaints following a documented history of blast-related TBI of mild-to-moderate severity were randomly assigned to receive either standard rehabilitation care (SRC) or SRC plus a 15-session standardized course of IM therapy. Primary outcome measures were Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) Index Scores. Secondary outcome measures included selected subtests from the Delis Kaplan Executive Functioning System (Trail Making Test and Color Word Interference) and the Wechsler Adult Intelligence Scale Fourth Edition (Symbol Search, Digit Symbol Coding, Digit Span, and Letter Number Sequencing) as well as the Integrated Visual and Auditory Continuous Performance Test. Results: Significant group differences (SRC vs. IM) were observed for RBANS Attention (p = .044), Immediate Memory (p = .019), and Delayed Memory (p = .031) indices in unadjusted analyses, with the IM group showing significantly greater improvement at Time 2 than the SRC group, with effect sizes in the medium-to-large range in the adjusted analyses for each outcome (Cohen's d = 0.511, 0.768, and 0.527, respectively). Though not all were statistically significant, effects in 21 of 26 cognitive outcome measures were consistently in favor of the IM treatment group (binomial probability = .00098). Conclusion: The addition of IM therapy to SRC appears to have a positive effect on neuropsychological outcomes for soldiers who have sustained mild-to-moderate TBI and have persistent cognitive complaints after the period for expected recovery has passed.	[Nelson, Lonnie A.; MacDonald, Margaret; Stall, Christina; Pazdan, Renee] Def & Vet Brain Injury Ctr, Ft Carson, CO USA	MacDonald, M (corresponding author), 7489 Sutherland Circle, Ft Carson, CO 80913 USA.	margaret.e.macdonald3.ctr@mail.mil			Defense and Veterans Brain Injury CenterUS Department of Veterans Affairs; Henry M. Jackson Foundation [W91 YTZ-11-C-0033]	Supported by the Defense and Veterans Brain Injury Center and, in part, through contract support provided by the Henry M. Jackson Foundation for the Advancement of Military Medicine (contract # W91 YTZ-11-C-0033). Clinical Trial Registration clinicaltrials.gov; identifier: NCT01248390.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Arciniegas DB, 2011, INT J PSYCHOPHYSIOL, V82, P41, DOI 10.1016/j.ijpsycho.2011.03.004; Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; Bagiella E, 2010, J HEAD TRAUMA REHAB, V25, P375, DOI 10.1097/HTR.0b013e3181d27fe3; Bogdanova Y, 2012, NEUROPSYCHOL REV, V22, P4, DOI 10.1007/s11065-012-9192-3; Bradley KA, 2007, ALCOHOL CLIN EXP RES, V31, P1208, DOI 10.1111/j.1530-0277.2007.00403.x; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Cooper DB, 2011, ARCH CLIN NEUROPSYCH, V26, P718, DOI 10.1093/arclin/acr070; Cooper DB, 2010, NEUROREHABILITATION, V26, P233, DOI 10.3233/NRE-2010-0559; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; Department of the Army, 1999, PERS SEL CLASS MIL O; Fan J, 2005, NEUROIMAGE, V26, P471, DOI 10.1016/j.neuroimage.2005.02.004; Ferguson CJ, 2009, PROF PSYCHOL-RES PR, V40, P532, DOI 10.1037/a0015808; Gordon WA, 2006, AM J PHYS MED REHAB, V85, P343, DOI 10.1097/01.phm.0000202106.01654.61; Halbauer JD, 2009, J REHABIL RES DEV, V46, P757, DOI 10.1682/JRRD.2008.08.0119; Hartikainen KM, 2010, J CLIN EXP NEUROPSYC, V32, P767, DOI 10.1080/13803390903521000; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Institute of Medicine, 2011, COGN REH THER TRAUM; JORGE RE, 1993, J NERV MENT DIS, V181, P91, DOI 10.1097/00005053-199302000-00004; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Koomar J, 2001, AM J OCCUP THER, V55, P163, DOI 10.5014/ajot.55.2.163; Lange RT, 2012, J CLIN EXP NEUROPSYC, V34, P453, DOI 10.1080/13803395.2011.648175; Larson MJ, 2011, INT J PSYCHOPHYSIOL, V82, P69, DOI 10.1016/j.ijpsycho.2011.02.018; Levy M, 2005, NEUROREHABILITATION, V20, P279; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; Malec J. F., 2003, MANUAL MAYO PORTLAND; Malec JF, 2003, J HEAD TRAUMA REHAB, V18, P479, DOI 10.1097/00001199-200311000-00002; Mathias JL, 2007, BRIT J CLIN PSYCHOL, V46, P457, DOI 10.1348/014466507X190197; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McCauley SR, 2005, J NERV MENT DIS, V193, P540, DOI 10.1097/01.nmd.0000172592.05801.71; McKay C, 2007, ARCH CLIN NEUROPSYCH, V22, P91, DOI 10.1016/j.acn.2006.11.003; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Moucha R, 2006, PROG BRAIN RES, V157, P111, DOI 10.1016/S0079-6123(06)57007-4; Nelson LA, 2007, TOP STROKE REHABIL, V14, P59, DOI 10.1310/tsr1404-59; Nelson LA, 2009, J HEAD TRAUMA REHAB, V24, P32, DOI 10.1097/HTR.0b013e3181957016; Ozen LJ, 2012, ARCH CLIN NEUROPSYCH, V27, P85, DOI 10.1093/arclin/acr087; Roebuck-Spencer TM, 2012, CLIN NEUROPSYCHOL, V26, P473, DOI 10.1080/13854046.2011.650214; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; Shaffer RJ, 2001, AM J OCCUP THER, V55, P155, DOI 10.5014/ajot.55.2.155; Sponheim SR, 2011, NEUROIMAGE, V54, pS21, DOI 10.1016/j.neuroimage.2010.09.007; Terrio HP, 2011, REHABIL PSYCHOL, V56, P26, DOI 10.1037/a0022685; Tinius TP, 2003, ARCH CLIN NEUROPSYCH, V18, P439, DOI 10.1016/S0887-6177(02)00144-0; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Warriner Erin M, 2006, Curr Psychiatry Rep, V8, P73, DOI 10.1007/s11920-006-0083-2; Zakzanis KK, 2011, J CLIN EXP NEUROPSYC, V33, P785, DOI 10.1080/13803395.2011.558496	48	11	11	0	24	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	NOV	2013	27	6					666	679		10.1037/a0034117			14	Psychology, Clinical; Neurosciences; Psychology	Psychology; Neurosciences & Neurology	252YX	WOS:000327049900005	24059443				2021-06-18	
J	Williams, G; Weragoda, N; Paterson, K; Clark, R				Williams, Gavin; Weragoda, Natasha; Paterson, Kade; Clark, Ross			Cardiovascular Fitness Is Unrelated to Mobility Limitations in Ambulant People With Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						activity levels; brain trauma; cardiovascular fitness; mobility limitations	ASSESSMENT-TOOL HIMAT; CARDIORESPIRATORY FITNESS; SUBMAXIMAL EXERCISE; RETEST RELIABILITY; WALKING SPEED; VALIDITY; INDIVIDUALS; IMPAIRMENT; CAPACITY; OUTCOMES	Objective: The aim of this study was to evaluate the relationship between mobility, activity levels, and cardiovascular fitness in patients with traumatic brain injury (TBI) currently undergoing rehabilitation, and to determine whether mobility and cardiovascular fitness differs between people with TBI and matched healthy controls (HCs). Design: Cross-sectional cohort study. Participants: Twenty-eight people with TBI and 28 matched HCs. Outcome Measures: The primary outcome measure for mobility was the high-level mobility assessment tool. Steps per day was the outcome measure for activity level, and the physical work capacity at 130 (PWC130) submaximal VO2 Monark bike test was the primary outcome measure for cardiovascular fitness. Results: Results revealed no relationship (P > .05) between mobility, activity levels, and cardiovascular fitness in the TBI cohort. Participants with TBI had significantly reduced capacity for mobility (P <.001) and performed less physical activity (P =.002) than matched HCs; however, there was no significant difference in cardiovascular fitness (P =.094) between groups. Conclusions: Despite reduced physical activity and a wide range in capacity to mobilize, no relationship was identified between mobility and cardiovascular fitness following TBI.	[Williams, Gavin; Weragoda, Natasha] Epworth Healthcare, Melbourne, Vic, Australia; [Williams, Gavin; Clark, Ross] Univ Melbourne, Melbourne, Vic, Australia; [Paterson, Kade] Australian Catholic Univ, Ctr Phys Act Across Lifespan COPAAL, Sch Exercise Sci, Melbourne, Vic, Australia	Williams, G (corresponding author), Epworth Med Fdn, Physiotherapy Dept, 89 Bridge Rd, Richmond, Vic 3121, Australia.	gavin.williams@epworth.org.au	Clark, Ross/K-7613-2019; Paterson, Kade L/G-4715-2012; Clark, Ross A/R-5664-2018	Clark, Ross/0000-0002-7291-8553; Paterson, Kade L/0000-0002-0323-6129; Clark, Ross A/0000-0002-7291-8553; Williams, Gavin/0000-0003-2758-7473			Bateman A, 2001, ARCH PHYS MED REHAB, V82, P174, DOI 10.1053/apmr.2001.19744; Bland DC, 2011, BRAIN INJURY, V25, P664, DOI 10.3109/02699052.2011.576306; Cink R E, 1981, Br J Sports Med, V15, P182; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; DAUGHTON DM, 1982, ARCH PHYS MED REHAB, V63, P620; Davidson M, 2007, CLIN REHABIL, V21, P151, DOI 10.1177/0269215506069475; Eng JJ, 2004, ARCH PHYS MED REHAB, V85, P113, DOI 10.1016/S0003-9993(03)00436-2; Eng JJ, 2002, STROKE, V33, P756, DOI 10.1161/hs0302.104195; Fix AJ., 1988, HUMAN ACTIVITY PROFI; Harrison G, 1988, ANTHROPOMETRIC STAND, P55; Harrison-Felix C, 2006, J HEAD TRAUMA REHAB, V21, P22, DOI 10.1097/00001199-200601000-00003; Hassett LM, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006123.pub2; Hassett LM, 2007, BRAIN INJURY, V21, P1069, DOI 10.1080/02699050701630375; Hassett LM, 2009, J REHABIL MED, V41, P247, DOI 10.2340/16501977-0316; Hillier SL, 1997, BRAIN INJURY, V11, P661; Jackson D, 2001, CLIN REHABIL, V15, P535, DOI 10.1191/026921501680425252; KEYS A, 1972, J CHRON DIS, V25, P329, DOI 10.1016/0021-9681(72)90027-6; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; King NS, 1997, J NEUROL NEUROSUR PS, V62, P38, DOI 10.1136/jnnp.62.1.38; LaMonte MJ, 2000, CIRCULATION, V102, P1623, DOI 10.1161/01.CIR.102.14.1623; Macsween A, 2001, J SPORT MED PHYS FIT, V41, P312; Marshall S, 2007, BRAIN INJURY, V21, P133, DOI 10.1080/02699050701201383; McLennan W., 1997, AUSTR STANDARD CLASS; McTigue DM, 2007, EXP NEUROL, V205, P396, DOI 10.1016/j.expneurol.2007.02.009; Moseley AM, 2004, J HEAD TRAUMA REHAB, V19, P341, DOI 10.1097/00001199-200407000-00008; Mossberg KA, 2008, PHYS THER, V88, P77, DOI 10.2522/ptj.20070022; Mossberg KA, 2007, ARCH PHYS MED REHAB, V88, P315, DOI 10.1016/j.apmr.2006.12.006; Noonan V, 2000, PHYS THER REHABIL J, V80, P782, DOI 10.1093/ptj/80.8.782; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; Shavelle RM, 2001, AM J PHYS MED REHAB, V80, P510, DOI 10.1097/00002060-200107000-00009; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; State Government of Victoria, BOD MASS IND BMI; Thomas MD, 2009, BRAIN INJURY, V23, P516, DOI 10.1080/02699050902926333; Van Loo MA, 2004, BRAIN INJURY, V18, P1041, DOI 10.1080/02699050410001672314; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Williams G, 2012, BRAIN INJURY, V26, P1065, DOI 10.3109/02699052.2012.667586; Williams G, 2009, INT J THER REHABIL, V16, P2; Williams GP, 2006, PHYS THER, V86, P395, DOI 10.1093/ptj/86.3.395; Williams GP, 2005, BRAIN INJURY, V19, P833, DOI 10.1080/02699050500058711; Zitnay GA, 2008, J NEUROTRAUM, V25, P1135, DOI 10.1089/neu.2008.0599	41	11	11	0	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2013	28	6					E1	E7		10.1097/HTR.0b013e318279536d			7	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	299AA	WOS:000330365200001	23348405				2021-06-18	
J	Zheng, KB; Li, CH; Shan, XS; Liu, HP; Fan, WF; Wang, ZS; Zheng, P				Zheng, Kebin; Li, Chunhui; Shan, Xiaosong; Liu, Haipeng; Fan, Wufang; Wang, Zhenshan; Zheng, Ping			Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of patients with moderate and severe traumatic brain injury	NEUROLOGY INDIA			English	Article						Cerebrospinal fluid; matrix metalloproteinase; tissue inhibitor of metalloproteinase; traumatic brain injury	FOCAL CEREBRAL-ISCHEMIA; NEURODEGENERATIVE DISEASES; BLOOD; MATRIX-METALLOPROTEINASE-9; INCREASE; RAT; MENINGITIS; DIAGNOSIS; DAMAGE	Objective: In this study, we investigated matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinase (TIMPs) in cerebrospinal fluid (CSF) and plasma of traumatic brain injury (TBI) patients. Patients and Methods: A total of 30 patients with moderate and severe TBI and 15 age-matched controls were enrolled in this study. Plasma and CSF samples were collected within 24 h (as the initial value), at 72 and 120 h post injury. CSF and plasma MMP-9, MMP-2, TIMP-1 and TIMP-2 were estimated using ELISA. Different levels of these indexes were compared in the two groups and further investigated the correlation between each other. Results: There was a significant elevation in the levels of the initial MMP-9 in the CSF (P < 0.05), which lasted for 72 h post injury. TIMP-1 kept increasing within 120 h post injury and it was different compared with TIMP-1 at 24 and 72 h post injury. Plasma levels of MMP-9, MMP-2, TIMP-1 and TIMP-2 in TBI patients were also significantly different from those in controls. Furthermore the CSF MMP-9 in patients with severe TBI was higher than that in patients with moderate TBI. In addition, there was a positive relationship between the initial MMP-9 and TIMP-1 at 120 h post injury (r = 0.614, P < 0.01). Conclusion: MMPs and TIMPs are increased in both CSF and plasma of TBI patients. TIMP-1 has a positive correlation with MMP-9 and the initial MMP-9 is associated with the neurological outcomes.	[Zheng, Kebin; Fan, Wufang; Wang, Zhenshan] Hebei Univ, Coll Life Sci, Dept Neurosci, Baoding 071000, Hebei Province, Peoples R China; [Li, Chunhui; Shan, Xiaosong; Liu, Haipeng] Hebei Univ, Affiliated Hosp, Dept Neurosurg, Baoding 071000, Hebei Province, Peoples R China; [Zheng, Ping] Shanghai Pudong New Area Peoples Hosp, Shanghai 201299, Peoples R China	Wang, ZS (corresponding author), Hebei Univ, Coll Life Sci, Baoding 071000, Hebei Province, Peoples R China.	jiwen0008@126.com		Li, Chunhui/0000-0003-4055-1248	Natural Science Foundation of Hebei ProvinceNatural Science Foundation of Hebei Province [2012201136]; Medical Science Special Foundation of Hebei University [2012B2004]; Hebei postdoctoral fund	Supported by the Natural Science Foundation of Hebei Province (No. 2012201136) and Medical Science Special Foundation of Hebei University (No. 2012B2004), Conflict of Interest: Hebei postdoctoral fund (No. 111867).	Ahmed SH, 2006, CIRCULATION, V113, P2089, DOI 10.1161/CIRCULATIONAHA.105.573865; Azeh I, 1998, NEUROSCI LETT, V256, P127, DOI 10.1016/S0304-3940(98)00776-9; Begaz T, 2006, J NEUROTRAUM, V23, P1201, DOI 10.1089/neu.2006.23.1201; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Gasche Y, 1999, J CEREBR BLOOD F MET, V19, P1020, DOI 10.1097/00004647-199909000-00010; Grossetete M, 2009, NEUROSURGERY, V65, P702, DOI 10.1227/01.NEU.0000351768.11363.48; Heo JH, 1999, J CEREBR BLOOD F MET, V19, P624, DOI 10.1097/00004647-199906000-00005; Jiang JY, 2012, INJURY IN PRESS; Johanson M, 2013, J PERIODONTOL, V84, P634, DOI 10.1902/jop.2012.120224; Kanoh Y, 2008, INFLAMMATION, V31, P99, DOI 10.1007/s10753-007-9054-y; Kavalci C, 2011, BRATISL MED J, V112, P398; Khrestchatisky Michel, 2003, Journal de la Societe de Biologie, V197, P133; Kochanek PM, 2008, CURR OPIN CRIT CARE, V14, P135, DOI 10.1097/MCC.0b013e3282f57564; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lin Y, 2012, LAB INVEST, V92, P1623, DOI 10.1038/labinvest.2012.118; Lorenzl S, 2003, J NEUROL SCI, V207, P71, DOI 10.1016/S0022-510X(02)00398-2; Niebroj-Dobosz I, 2010, EUR J NEUROL, V17, P226, DOI 10.1111/j.1468-1331.2009.02775.x; Renaud S, 2007, MUSCLE NERVE, V36, P1, DOI 10.1002/mus.20772; Rosenberg GA, 1996, J CEREBR BLOOD F MET, V16, P360, DOI 10.1097/00004647-199605000-00002; Rosenberg GA, 2009, LANCET NEUROL, V8, P205, DOI 10.1016/S1474-4422(09)70016-X; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Wang JJ, 2013, ARCH MED SCI, V9, P332, DOI 10.5114/aoms.2012.30949; Wang XY, 2002, J NEUROTRAUM, V19, P615, DOI 10.1089/089771502753754082; Wang XY, 2000, J NEUROSCI, V20, P7037, DOI 10.1523/JNEUROSCI.20-18-07037.2000	24	11	12	1	11	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	0028-3886	1998-4022		NEUROL INDIA	Neurol. India	NOV-DEC	2013	61	6					606	609		10.4103/0028-3886.125258			4	Neurosciences	Neurosciences & Neurology	AB3OS	WOS:000331700700008	24441327				2021-06-18	
J	Blakeman, TC				Blakeman, Thomas C.			Evidence for Oxygen Use in the Hospitalized Patient: Is More Really the Enemy of Good?	RESPIRATORY CARE			English	Article						oxygen therapy; normoxia; hypoxemia; hyperoxemia; oxygen efficacy; oxygen safety	OBSTRUCTIVE PULMONARY-DISEASE; RESPIRATORY-DISTRESS-SYNDROME; TRAUMATIC BRAIN-INJURY; ACUTE MYOCARDIAL-INFARCTION; SURGICAL-WOUND-INFECTION; ACUTE ISCHEMIC-STROKE; ACUTE LUNG INJURY; HIGH-FLOW OXYGEN; SUPPLEMENTAL OXYGEN; POSTOPERATIVE NAUSEA	Oxygen in arguably one of the most frequently utilized drugs in modern healthcare, but is often administered to patients at caregivers' discretion with scant evidence as to its efficacy or safety. Although oxygen is administered for varied medical conditions in the hospital setting, published literature supports the use of oxygen to reverse hypoxemia, for trauma victims with traumatic brain injury and hemorrhagic shock, for resuscitation during cardiac arrest, and for carbon monoxide poisoning. Oxygen should be titrated to target an S-pO2 of 94-98%, except with carbon monoxide poisoning (100% oxygen), ARDS (88-95%), those at risk for hypercapnia (S-pO2 88-92%), and premature infants (S-pO2 88-94%). Evidence for use with other conditions for which oxygen is administered relies on anecdotal experiences, case reports, or small, underpowered studies. Definitive conclusions for oxygen use in these conditions where efficacy and/or safety are uncertain will require large randomized controlled clinical trials.	[Blakeman, Thomas C.] Univ Cincinnati, Dept Surg, Coll Med, Div Trauma & Crit Care, Cincinnati, OH 45267 USA	Blakeman, TC (corresponding author), Univ Cincinnati, Dept Surg, ML 0558,231 Albert Sabin Way, Cincinnati, OH 45267 USA.	Thomas.Blakeman@uc.edu					Abernethy AP, 2010, LANCET, V376, P784, DOI 10.1016/S0140-6736(10)61115-4; Abernethy AP, 2005, PALLIATIVE MED, V19, P168, DOI 10.1177/026921630501900219; Adams HP, 2003, STROKE, V34, P1056, DOI 10.1161/01.STR.0000064841.47697.22; Akca O, 2002, Minerva Anestesiol, V68, P166; Allen DB, 1997, ARCH SURG-CHICAGO, V132, P991; American Association for Respiratory Care, 2002, RESP CARE, V47, P707; American College of Surgeons, 1997, ADV TRAUM LIF SUPP; American Heart Association, 2002, HDB EM CARD CAR HEAL; American Lung Association, STAT LUNG DIS DIV CO; ANDERSON DC, 1991, STROKE, V22, P1137, DOI 10.1161/01.STR.22.9.1137; [Anonymous], 1920, BMJ-BRIT MED J, V1, P150; Askie LM, 2003, NEW ENGL J MED, V349, P959, DOI 10.1056/NEJMoa023080; Austin MA, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5462; Barnes SL, 2008, J TRAUMA, V64, pS129, DOI 10.1097/TA.0b013e318160a5b4; Bateman NT, 1998, BRIT MED J, V317, P798, DOI 10.1136/bmj.317.7161.798; Bausewein C, 2010, PALLIATIVE MED, V24, P777, DOI 10.1177/0269216310378785; BENSON JM, 1992, CLIN PHARMACY, V11, P965; Blodgett AN, 1890, BOSTON MED SURG J, V123, P481, DOI DOI 10.1056/NEJM189011201232101; BREMMELGAARD A, 1989, J HOSP INFECT, V13, P1, DOI 10.1016/0195-6701(89)90090-X; *BRIT THOR SOC, 1997, THORAX S5, V52, pS16; Brower RG, 2001, CHEST, V120, P347; Burls A, 2011, EMERG MED J, V28, P917, DOI 10.1136/emj.2010.103564; CAMPBELL K, 1951, Med J Aust, V2, P48; Centers for Disease Control and Prevention, HEART DIS FACTS; Chi JH, 2006, J TRAUMA, V61, P1134, DOI 10.1097/01.ta.0000196644.64653.d8; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Cohen AS, 2009, JAMA-J AM MED ASSOC, V302, P2451, DOI 10.1001/jama.2009.1855; Currow DC, 2010, J PAIN SYMPTOM MANAG, V39, P680, DOI 10.1016/j.jpainsymman.2009.09.017; DALY WJ, 1962, J CLIN INVEST, V41, P126, DOI 10.1172/JCI104454; Davis DP, 2009, J NEUROTRAUM, V26, P2217, DOI 10.1089/neu.2009.0940; Denniston AKO, 2002, CLIN MED, V2, P449, DOI 10.7861/clinmedicine.2-5-449; DOUGLAS ME, 1977, CHEST, V71, P18, DOI 10.1378/chest.71.1.18; Downs JB., 1984, MAJOR ISSUES CRITICA, P149; Downs John B, 2003, Respir Care, V48, P611; DOYLE RL, 1995, AM J RESP CRIT CARE, V152, P1818, DOI 10.1164/ajrccm.152.6.8520742; Edmark L, 2003, ANESTHESIOLOGY, V98, P28, DOI 10.1097/00000542-200301000-00008; EGGERS GWN, 1962, J APPL PHYSIOL, V17, P75; FOGAN L, 1985, ARCH NEUROL-CHICAGO, V42, P362, DOI 10.1001/archneur.1985.04060040072015; FOSTER GL, 1969, CARDIOVASC RES, V3, P179, DOI 10.1093/cvr/3.2.179; Franschman G, 2011, J TRAUMA, V71, P826, DOI 10.1097/TA.0b013e31820cebf0; Fu ES, 1999, ANESTH ANALG, V88, pU40; GANZ W, 1972, CIRCULATION, V45, P763, DOI 10.1161/01.CIR.45.4.763; GARNER WL, 1989, SURGERY, V105, P747; Garza I, 2011, CURR NEUROL NEUROSCI, V11, P121, DOI 10.1007/s11910-010-0171-x; Geerlings RPJ, 2011, CEPHALALGIA, V31, P1145, DOI 10.1177/0333102411412087; Ghods Ali Asghar, 2005, J Perianesth Nurs, V20, P200; Grainge C, 2004, J ROY SOC MED, V97, P489, DOI 10.1258/jrsm.97.10.489; Greif R, 1999, ANESTHESIOLOGY, V91, P1246, DOI 10.1097/00000542-199911000-00014; Greif R, 2000, NEW ENGL J MED, V342, P161, DOI 10.1056/NEJM200001203420303; Haldane JBS, 1927, BIOCHEM J, V21, P1068, DOI 10.1042/bj0211068; Haldane JS, 1917, BRIT MED J, V1917, P181, DOI 10.1136/bmj.1.2928.181; Haldane JS, 1922, RESPIRATION; HALEY RW, 1985, AM J EPIDEMIOL, V121, P206, DOI 10.1093/oxfordjournals.aje.a113991; Haque WA, 1996, J AM COLL CARDIOL, V27, P353, DOI 10.1016/0735-1097(95)00474-2; Harris W., 1926, NEURITIS NEURALGIA; Heffner JE, 2013, RESP CARE, V58, P18, DOI 10.4187/respcare.01831; Holtzapple GE, 1887, NEW YORK MED J, V46, P264; HORTON B T, 1952, J Lancet, V72, P92; Hua Shao-dong, 2009, Zhonghua Er Ke Za Zhi, V47, P757; Johnson MJ, 2013, J PAIN SYMPTOM MANAG, V45, P763, DOI 10.1016/j.jpainsymman.2012.03.017; Joris JL, 2003, BRIT J ANAESTH, V91, P857, DOI 10.1093/bja/aeg267; Kallet RH, 2007, RESP CARE, V52, P461; Kallstrom Thomas J, 2002, Respir Care, V47, P717; KEELING NJ, 1995, ANN ROY COLL SURG, V77, P245; KENMURE ACF, 1968, BMJ-BRIT MED J, V4, P360, DOI 10.1136/bmj.4.5627.360; KETY SS, 1948, J CLIN INVEST, V27, P484, DOI 10.1172/JCI101995; Kilgannon JH, 2011, CIRCULATION, V123, P2717, DOI 10.1161/CIRCULATIONAHA.110.001016; Kilgannon JH, 2010, JAMA-J AM MED ASSOC, V303, P2165, DOI 10.1001/jama.2010.707; KINSEY VE, 1977, PEDIATRICS, V60, P655; Knight AR, 2011, NURS CRIT CARE, V16, P28, DOI 10.1111/j.1478-5153.2010.00403.x; Koivuranta M, 1997, ANAESTHESIA, V52, P443, DOI 10.1111/j.1365-2044.1997.117-az0113.x; Kones R, 2011, AM J MED, V124, P1000, DOI 10.1016/j.amjmed.2011.04.034; KUDROW L, 1981, HEADACHE, V21, P1, DOI 10.1111/j.1526-4610.1981.hed2101001.x; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Kurz A, 1996, NEW ENGL J MED, V334, P1209, DOI 10.1056/NEJM199605093341901; Martini RP, 2013, RESP CARE, V58, P162, DOI 10.4187/respcare.01942; Mayzler O, 2005, Minerva Anestesiol, V71, P21; McNulty PH, 2005, AM J PHYSIOL-HEART C, V288, pH1057, DOI 10.1152/ajpheart.00625.2004; MCSWAIN NE, 2003, PREHOSPITAL TRAUMA L; MICKEL HS, 1987, STROKE, V18, P426, DOI 10.1161/01.STR.18.2.426; MILES AA, 1957, BRIT J EXP PATHOL, V38, P79; MINK RB, 1995, CRIT CARE MED, V23, P1398, DOI 10.1097/00003246-199508000-00014; MURDOCH C, 1995, ANESTHESIOLOGY, V83, pA258; Negovsky V A, 1972, Resuscitation, V1, P1, DOI 10.1016/0300-9572(72)90058-5; NIGHOGHOSSIAN N, 1995, STROKE, V26, P1369, DOI 10.1161/01.STR.26.8.1369; O'Driscoll BR, 2011, CLIN MED, V11, P372, DOI 10.7861/clinmedicine.11-4-372; Pancioli AM, 2002, ARCH INTERN MED, V162, P49, DOI 10.1001/archinte.162.1.49; PATZ A, 1952, AM J OPHTHALMOL, V35, P1248, DOI 10.1016/0002-9394(52)91140-9; Peberdy MA, 2003, RESUSCITATION, V58, P297, DOI 10.1016/S0300-9572(03)00215-6; Plant PK, 2000, THORAX, V55, P550, DOI 10.1136/thorax.55.7.550; Prockop LD, 2007, J NEUROL SCI, V262, P122, DOI 10.1016/j.jns.2007.06.037; QUINN AC, 1994, ANAESTHESIA, V49, P62, DOI 10.1111/j.1365-2044.1994.tb03316.x; Raju TNK, 1999, LANCET, V353, P1281, DOI 10.1016/S0140-6736(05)75208-9; REGISTER SD, 1987, CRIT CARE MED, V15, P598, DOI 10.1097/00003246-198706000-00012; Richmond S, 2008, SEMIN FETAL NEONAT M, V13, P368, DOI 10.1016/j.siny.2008.04.002; Robertson AF, 2005, SEMIN FETAL NEONAT M, V10, P23, DOI 10.1016/j.siny.2004.09.006; Ronning OM, 1999, STROKE, V30, P2033, DOI 10.1161/01.STR.30.10.2033; Rusyniak DE, 2003, STROKE, V34, P571, DOI 10.1161/01.STR.0000050644.48393.D0; Severinghaus J W, 1986, J Clin Monit, V2, P174, DOI 10.1007/BF01620550; Singhal AB, 2006, INT J STROKE, V1, P191, DOI 10.1111/j.1747-4949.2006.00058.x; SLOANE PJ, 1992, AM REV RESPIR DIS, V146, P419, DOI 10.1164/ajrccm/146.2.419; SMALL D, 1992, AM J MED, V92, P591, DOI 10.1016/0002-9343(92)90775-7; Steele C., 1900, BMJ-BRIT MED J, V2, P1568; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Stenson BJ, 2013, NEW ENGL J MED, V368, P2094, DOI 10.1056/NEJMoa1302298; Stockinger ZT, 2004, MIL MED, V169, P609, DOI 10.7205/MILMED.169.8.609; Stofft H, 1997, Hist Sci Med, V31, P341; SUCHYTA MR, 1992, CHEST, V101, P1074, DOI 10.1378/chest.101.4.1074; Tang RP, 2001, ANN SURG, V234, P181, DOI 10.1097/00000658-200108000-00007; Terry T L, 1944, Trans Am Ophthalmol Soc, V42, P383; The Acute Respiratory Distress Syndrome Network, 2001, NEW ENGL J MED, V342, P1301; THOMAS M, 1965, BRIT HEART J, V27, P401; Thomson AJ, 2006, J APPL PHYSIOL, V101, P809, DOI 10.1152/japplphysiol.01185.2005; TIBBLES PM, 1994, ANN EMERG MED, V24, P269, DOI 10.1016/S0196-0644(94)70141-5; Treschan TA, 2005, ANESTHESIOLOGY, V103, P6, DOI 10.1097/00000542-200507000-00005; USHER RH, 1961, NEW YORK STATE J MED, V61, P1677; Waring WS, 2003, J CARDIOVASC PHARM, V42, P245, DOI 10.1097/00005344-200308000-00014; Weaver LK, 2000, CHEST, V117, P801, DOI 10.1378/chest.117.3.801; Weaver LK, 1995, UNDERSEA HYPERB ME S, V22, P14; Western Australia Department of Health, US AC OX THER W AUST; WESTLAKE EK, 1955, Q J MED, V24, P155; WETCHLER BV, 1992, BRIT J ANAESTH, V69, pS33, DOI 10.1093/bja/69.supplement_1.33S; Wijesinghe M, 2009, HEART, V95, P198, DOI 10.1136/hrt.2008.148742; World Health Organization, 2010, CHRON RESP DIS CHRON; Zilberberg MD, 1998, AM J RESP CRIT CARE, V157, P1159, DOI 10.1164/ajrccm.157.4.9704088	125	11	12	0	4	DAEDALUS ENTERPRISES INC	IRVING	9425 N MAC ARTHUR BLVD, STE 100, IRVING, TX 75063-4706 USA	0020-1324	1943-3654		RESP CARE	Respir. Care	OCT	2013	58	10					1679	1693		10.4187/respcare.02677			15	Critical Care Medicine; Respiratory System	General & Internal Medicine; Respiratory System	245RH	WOS:000326481000015	24064627	Bronze			2021-06-18	
J	Kontos, AP; Elbin, RJ; Appaneal, RN; Covassin, T; Collins, MW				Kontos, Anthony P.; Elbin, R. J.; Appaneal, Renee Newcomer; Covassin, Tracey; Collins, Michael W.			A Comparison of Coping Responses Among High School and College Athletes With Concussion, Orthopedic Injuries, and Healthy Controls	RESEARCH IN SPORTS MEDICINE			English	Article						coping; mild traumatic brain injury; sport-related concussion; orthopedic injury; psychology of sport injury	SPORT-RELATED CONCUSSION; EMOTIONAL RESPONSE; SOCIAL SUPPORT; BRIEF-COPE; GENDER; METAANALYSIS; ASSOCIATION; STRATEGIES; STRESS; MODEL	This study compared the coping responses of concussed athletes with those with an orthopedic injury and healthy controls and explored sex differences in coping behaviors following sport injury. Sixty-eight athletes with a concussion (CONCUSS), 42 with an orthopedic injury (ORTHO), and 33 healthy controls (CONTROL) completed the Brief COPE approximately 1 week following sport injury. The CONCUSS group reported lower active, planning, acceptance, religion, self-distraction, venting, and self-blame coping than the ORTHO group. The ORTHO group reported lower acceptance, venting, and substance use coping than CONTROLS. Females reported higher levels of planning, humor, instrumental support, and venting than males. Females reported more venting than males in the ORTHO and CONTROL groups, but not in the CONCUSS group. In conclusion, concussed athletes may not engage in coping to the same extent as athletes with other injuries.	[Kontos, Anthony P.; Elbin, R. J.; Collins, Michael W.] Univ Pittsburgh, Sch Med, Dept Orthopaed Surg, UPMC Sports Med Concuss Program, Pittsburgh, PA 15261 USA; [Appaneal, Renee Newcomer] Univ N Carolina, Greensboro, NC 27412 USA; [Covassin, Tracey] Michigan State Univ, E Lansing, MI 48824 USA	Kontos, AP (corresponding author), UPMC Ctr Sports Med, UPMC Sports Med Concuss Program, 3200 South Water St, Pittsburgh, PA 15203 USA.	akontos@pitt.edu		Kontos, Anthony/0000-0002-3749-4310; Appaneal, Renee/0000-0003-3971-8303			Aldridge AA, 2007, J BEHAV MED, V30, P115, DOI 10.1007/s10865-006-9087-y; American Academy of Orthopaedic Surgeons (AAOS), 1991, ATHL TRAIN SPORTS ME; Anshel MH, 2010, SCAND J PSYCHOL, V51, P341, DOI 10.1111/j.1467-9450.2009.00796.x; Bianco T, 1999, RES Q EXERCISE SPORT, V70, P157, DOI 10.1080/02701367.1999.10608033; Bloom GA, 2004, BRIT J SPORT MED, V38, P519, DOI 10.1136/bjsm.2004.011999; Carver CS, 1997, INT J BEHAV MED, V4, P92, DOI 10.1207/s15327558ijbm0401_6; Connor-Smith JK, 2007, J PERS SOC PSYCHOL, V93, P1080, DOI 10.1037/0022-3514.93.6.1080; Deroche T, 2011, ANXIETY STRESS COPIN, V24, P579, DOI 10.1080/10615806.2011.552717; Duangdao KM, 2008, J BEHAV MED, V31, P291, DOI 10.1007/s10865-008-9155-6; Giza CC, 2001, J ATHL TRAINING, V36, P228; Goyen MJ, 1998, J APPL DEV PSYCHOL, V19, P469, DOI 10.1016/S0193-3973(99)80051-3; Granito J, 2001, J SPORT BEHAV, V24, P63; HAMMERMEISTER J, 2004, J SPORT BEHAV, V27, P148, DOI DOI 10.1080/02640410600630654; [黄峥 HUANG Zheng], 2010, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V18, P5; Hutchison M, 2009, CLIN J SPORT MED, V19, P13, DOI 10.1097/JSM.0b013e318190ba06; Johnson U, 1997, SCAND J MED SCI SPOR, V7, P367; Johnston LH, 2000, J SPORT REHABIL, V9, P290, DOI 10.1123/jsr.9.4.290; Kapsou M, 2010, J HEALTH PSYCHOL, V15, P215, DOI 10.1177/1359105309346516; Lazarus R.S., 1984, STRESS APPRAISAL COP; Mainwaring LM, 2004, J SPORT EXERCISE PSY, V26, P119, DOI 10.1123/jsep.26.1.119; Mainwaring LM, 2010, BRAIN INJURY, V24, P589, DOI 10.3109/02699051003610508; McCrory Paul, 2009, J Athl Train, V44, P434, DOI 10.4085/1062-6050-44.4.434; McGrath N, 2010, J ATHL TRAINING, V45, P492, DOI 10.4085/1062-6050-45.5.492; National Collegiate Athletic Association (NCAA), 1996, ALL SPORT INJ SUMM; Nicholls AR, 2007, J SPORT SCI, V25, P1521, DOI 10.1080/02640410701230479; Noyes F R, 1988, Am J Sports Med, V16 Suppl 1, pS65; Penley JA, 2002, J BEHAV MED, V25, P551, DOI 10.1023/A:1020641400589; Quinn AM, 1999, J APPL SPORT PSYCHOL, V11, P210, DOI 10.1080/10413209908404201; Shultz S. J., 2000, ASSESSMENT ATHLETIC; Snell DL, 2011, J HEAD TRAUMA REHAB, V26, P468, DOI 10.1097/HTR.0b013e3181fc5e1e; Stone AA, 1998, J PERS SOC PSYCHOL, V74, P1670, DOI 10.1037/0022-3514.74.6.1670; STONE AA, 1995, HEALTH PSYCHOL, V14, P341, DOI 10.1037/0278-6133.14.4.341; Tamres LK, 2002, PERS SOC PSYCHOL REV, V6, P2, DOI 10.1207/S15327957PSPR0601_1; Tracey J, 2003, J APPL SPORT PSYCHOL, V15, P279, DOI 10.1080/714044197; Udry E, 1997, J SPORT EXERCISE PSY, V19, P229, DOI 10.1123/jsep.19.3.229; Udry E, 1997, J SPORT EXERCISE PSY, V19, P71, DOI 10.1123/jsep.19.1.71; Wiese-Bjornstal DM, 1998, J APPL SPORT PSYCHOL, V10, P46, DOI 10.1080/10413209808406377; Williams JM, 1998, J APPL SPORT PSYCHOL, V10, P5, DOI 10.1080/10413209808406375	38	11	11	0	34	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1543-8627			RES SPORTS MED	Res. Sports Med.	OCT 1	2013	21	4					367	379		10.1080/15438627.2013.825801			13	Sport Sciences	Sport Sciences	223GN	WOS:000324792800007	24067122				2021-06-18	
J	Rossi, JL; Todd, T; Bazan, NG; Belayev, L				Rossi, Janet L.; Todd, Tracey; Bazan, Nicolas G.; Belayev, Ludmila			Inhibition of Myosin Light-Chain Kinase Attenuates Cerebral Edema after Traumatic Brain Injury in Postnatal Mice	JOURNAL OF NEUROTRAUMA			English	Article						BBB; brain injury; closed head injury model; edema; mice	BARRIER DYSFUNCTION; LUNG INJURY; RHO-KINASE; CHILDREN; DIFFUSE; STRESS; VULNERABILITY; ACTIVATION; PLASTICITY; AQUAPORIN	Traumatic brain injury (TBI) in children less than 8 years of age leads to decline in intelligence and executive functioning. Neurological outcomes after TBI correlate to development of cerebral edema, which affect survival rates after TBI. It has been shown that myosin light-chain kinase (MLCK) increases cerebral edema and that pretreatment with an MLCK inhibitor (ML-7) reduces cerebral edema. The aim of this study was to determine whether inhibition of MLCK after TBI in postnatal day 24 (PND-24) mice would prevent breakdown of the blood-brain barrier (BBB) and development of cerebral edema and improve neurological outcome. We used a closed head injury model of TBI. ML-7 or saline treatment was administered at 4h and every 24h until sacrifice or 5 days after TBI. Mice were sacrificed at 24h, 48h, and 72h and 7 days after impact. Mice treated with ML-7 after TBI had decreased levels of MLCK-expressing cells (20.7 +/- 4.8 vs. 149.3 +/- 40.6), less albumin extravasation (28.3 +/- 11.2 vs. 116.2 +/- 60.7mm(2)) into surrounding parenchymal tissue, less Evans Blue extravasation (339 +/- 314 vs. 4017 +/- 560ng/g), and showed a significant difference in wet/dry weight ratio (1.9 +/- 0.07 vs. 2.2 +/- 0.05g), compared to saline-treated groups. Treatment with ML-7 also resulted in preserved neurological function measured by the wire hang test (57 vs. 21sec) and two-object novel recognition test (old vs. new, 10.5 touches). We concluded that inhibition of MLCK reduces cerebral edema and preserves neurological function in PND-24 mice.	[Rossi, Janet L.; Bazan, Nicolas G.; Belayev, Ludmila] Louisiana State Univ, Hlth Sci Ctr, Neurosci Ctr Excellence, New Orleans, LA 70112 USA; [Belayev, Ludmila] Louisiana State Univ, Hlth Sci Ctr, Dept Neurosurg, New Orleans, LA 70112 USA; [Rossi, Janet L.; Todd, Tracey] Louisiana State Univ, Hlth Sci Ctr, Dept Pediat, Div Crit Care,Sch Med, New Orleans, LA 70112 USA; [Rossi, Janet L.] Childrens Hosp New Orleans, New Orleans, LA USA	Rossi, JL (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Lions Eye Ctr, Neurosci Ctr Excellence, 2020 Gravier 8th Floor, New Orleans, LA 70112 USA.	jross5@lsuhsc.edu	Bazan, Nicolas/AAN-4121-2020	Bazan, Nicolas/0000-0002-9243-5444	Department of Pediatrics; Neuroscience Center of Excellence; Louisiana State University Health Sciences Center (New Orleans, LA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P30GM103340] Funding Source: NIH RePORTER	Funding for this work was provided by the Department of Pediatrics (to R.S.) and the Neuroscience Center of Excellence (to N.G.B.), Louisiana State University Health Sciences Center (New Orleans, LA).	Abbott NJ, 2002, J ANAT, V200, P629, DOI 10.1046/j.1469-7580.2002.00064.x; Abbott NJ, 2000, CELL MOL NEUROBIOL, V20, P131, DOI 10.1023/A:1007074420772; Adelson PD, 1996, J NEUROSURG, V85, P877, DOI 10.3171/jns.1996.85.5.0877; ALDRICH EF, 1992, J NEUROSURG, V76, P450, DOI 10.3171/jns.1992.76.3.0450; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; BAORTO DM, 1992, J CELL BIOL, V117, P357, DOI 10.1083/jcb.117.2.357; Belayev L, 1996, BRAIN RES, V739, P88, DOI 10.1016/S0006-8993(96)00815-3; Centers for Disease Control and Prevention, 2010, TRAUMATIC BRAIN INJU; Chen S-F, 2012, PLOS ONE, V7; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; EDELMAN AM, 1992, MOL BRAIN RES, V14, P27, DOI 10.1016/0169-328X(92)90006-W; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V26, P487, DOI 10.1207/s15326942dn2601_7; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V25, P107, DOI 10.1207/s15326942dn2501&2_7; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Falo MC, 2006, J NEUROSCI RES, V84, P768, DOI 10.1002/jnr.20986; GARCIA JGN, 1995, J CELL PHYSIOL, V163, P510, DOI 10.1002/jcp.1041630311; Ghirnikar RS, 1998, NEUROCHEM RES, V23, P329, DOI 10.1023/A:1022453332560; Gourgiotis I, 2012, PHARMACOL BIOCHEM BE, V102, P507, DOI 10.1016/j.pbb.2012.06.013; Haorah J, 2005, ALCOHOL CLIN EXP RES, V29, P999, DOI 10.1097/01.ALC.0000166944.79914.0A; Haorah J, 2005, J LEUKOCYTE BIOL, V78, P1223, DOI 10.1189/jlb.0605340; Haorah J, 2007, J NEUROCHEM, V100, P324, DOI 10.1111/j.1471-4159.2006.04245.x; Hayashi T, 2009, BRAIN RES, V1280, P172, DOI 10.1016/j.brainres.2009.05.040; Higgins JNP, 2008, J NEUROSURG, V108, P372, DOI 10.3171/JNS/2008/108/2/0372; Isotani E, 2004, P NATL ACAD SCI USA, V101, P6279, DOI 10.1073/pnas.0308742101; Katoh K, 2001, AM J PHYSIOL-CELL PH, V280, pC1669; KLATZO I, 1987, ACTA NEUROPATHOL, V72, P236, DOI 10.1007/BF00691095; Kudryashov DS, 2004, EXP CELL RES, V298, P407, DOI 10.1016/j.yexcr.2004.04.025; Kuhlmann CRW, 2007, J NEUROCHEM, V102, P501, DOI 10.1111/j.1471-4159.2007.04506.x; Liu H, 2012, ARQ NEURO-PSIQUIAT, V70, P214, DOI 10.1590/S0004-282X2012000300012; Luh C, 2010, J NEUROCHEM, V112, P1015, DOI 10.1111/j.1471-4159.2009.06514.x; Marmarou A, 2006, ACTA NEUROCHIR SUPPL, V96, P24; Marmarou A, 2000, ACT NEUR S, V76, P349; Max JE, 2000, J INT NEUROPSYCH SOC, V6, P279, DOI 10.1017/S1355617700633039; Mirzapoiazova T, 2011, AM J RESP CELL MOL, V44, P40, DOI 10.1165/rcmb.2009-0197OC; Miyakawa T, 2001, J NEUROSCI, V21, P5239, DOI 10.1523/JNEUROSCI.21-14-05239.2001; Nadal A, 1996, J PHYSIOL-LONDON, V492, P737, DOI 10.1113/jphysiol.1996.sp021342; Nag S, 2009, ACTA NEUROPATHOL, V118, P197, DOI 10.1007/s00401-009-0541-0; Papadopoulos MC, 2004, FASEB J, V18, P1291, DOI 10.1096/fj.04-1723fje; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Reynoso R, 2007, SHOCK, V28, P589, DOI 10.1097/SHK.0b013c31804d415f; Rice D, 2000, ENVIRON HEALTH PERSP, V108, P511, DOI 10.2307/3454543; Rossi JL, 2007, AM J PHYSIOL-LUNG C, V292, pL1327, DOI 10.1152/ajplung.00380.2006; Rossi JL, 2011, J NEUROSCI RES, V89, P852, DOI 10.1002/jnr.22600; Shenaq M, 2012, J NEUROL SCI, V323, P134, DOI 10.1016/j.jns.2012.08.036; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Totsukawa G, 2000, J CELL BIOL, V150, P797, DOI 10.1083/jcb.150.4.797; Tran ND, 2010, J NEUROSURG, V112, P1095, DOI 10.3171/2009.8.JNS081704; Tsuru-Aoyagi K, 2009, ANN NEUROL, V65, P540, DOI 10.1002/ana.21600; Vilalta A, 2008, INTENS CARE MED, V34, P1384, DOI 10.1007/s00134-008-1056-1; Wainwright MS, 2003, P NATL ACAD SCI USA, V100, P6233, DOI 10.1073/pnas.1031595100	51	11	14	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 1	2013	30	19					1672	1679		10.1089/neu.2013.2898			8	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	227WQ	WOS:000325146800008	23984869	Green Published			2021-06-18	
J	Teixeira, PG; Karamanos, E; Okoye, OT; Talving, P; Inaba, K; Lam, L; Demetriades, D				Teixeira, Pedro G.; Karamanos, Efstathios; Okoye, Obi T.; Talving, Peep; Inaba, Kenji; Lam, Lydia; Demetriades, Demetrios			Splenectomy in patients with traumatic brain injury: Protective or harmful? A National Trauma Data Bank analysis	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Traumatic brain injury; splenectomy; complications; outcomes; mortality	PROXIMAL SPLENIC ANGIOEMBOLIZATION; NONOPERATIVE MANAGEMENT; ARTERY EMBOLIZATION; IMPROVE OUTCOMES; COHORT ANALYSIS; INFLAMMATION; PATHOPHYSIOLOGY; MULTICENTER; ACTIVATION; INCREASES	BACKGROUND: Experimental data have demonstrated a potential survival benefit for animals undergoing splenectomy immediately after traumatic brain injury. The aim of this study was to investigate the effect of splenectomy on survival in patients with moderate or severe traumatic brain injury (TBI). METHODS: This is a National Trauma Data Bank (2002-2009) analysis and included patients sustaining moderate or severe blunt head trauma (head Abbreviated Injury Scale [AIS] score, 3-5), with an associated splenic injury and an exploratory laparotomy. The population was divided into two arms: those that had a splenectomy and those who did not. The primary outcome was in-hospital mortality. Logistic regression was performed to adjust for factors that were significantly different between the study groups. RESULTS: During the 9-year study period, 2,625 patients met the criteria for inclusion in the analysis. Of these, 1,450 (55%) had a splenectomy, and 1,175 (45%) did not. Mortality was 13% for the splenectomized compared with 9% for the nonsplenectomized population (p = 0.001). After logistic regression, mortality remained significantly higher in the splenectomized population (adjusted odds ratio [AOR], 1.62; 95% confidence interval [CI], 1.16-2.26; p = 0.005). After stratification according to the severity of brain injury, the association between splenectomy and increased mortality persisted for both patients with moderate head injury (8% vs. 6%; AOR, 2.43; 95% CI, 1.26-4.71; p = 0.008) and for patients with severe head injury (17% vs. 10%; AOR, 1.49; 95% CI, 1.03-2.19; p = 0.036). CONCLUSION: Splenectomy was independently associated with increased mortality in patients with moderate or severe TBI. This finding warrants further investigation regarding splenic preservation in patients with TBI. Copyright (C) 2013 by Lippincott Williams & Wilkins	[Teixeira, Pedro G.; Karamanos, Efstathios; Okoye, Obi T.; Talving, Peep; Inaba, Kenji; Lam, Lydia; Demetriades, Demetrios] Los Angeles Cty Univ So Calif, Med Ctr, Los Angeles, CA USA	Demetriades, D (corresponding author), Univ So Calif, LAC USC Med Ctr, Div Trauma & Crit Care, IPT, 2051 Marengo St,C5L100, Los Angeles, CA 90033 USA.	demetria@usc.edu	Karamanos, Efstathios/AAU-8082-2020; Talving, Peep/E-6015-2013; Teixeira, Pedro/H-2239-2011; Talving, Peep/G-8621-2015; INABA, KENJI/AAC-8532-2020	Karamanos, Efstathios/0000-0002-5118-4642; Teixeira, Pedro/0000-0002-7258-7977; Talving, Peep/0000-0002-9741-2073; Okoye, Obi/0000-0003-4794-4335			Ajmo CT, 2008, J NEUROSCI RES, V86, P2227, DOI 10.1002/jnr.21661; Bessoud B, 2006, AM J ROENTGENOL, V186, P779, DOI 10.2214/AJR.04.1800; Demetriades D, 2012, J TRAUMA ACUTE CARE, V72, P229, DOI 10.1097/TA.0b013e31823fe0b6; Di Sabatino A, 2011, LANCET, V378, P86, DOI 10.1016/S0140-6736(10)61493-6; Duchesne JC, 2008, J TRAUMA, V65, P1346, DOI 10.1097/TA.0b013e31818c29ea; Haan J, 2008, J TRAUMA, V65, P1351; Harbrecht BG, 2007, J TRAUMA, V63, P44, DOI 10.1097/TA.0b013e3180686531; Keel M, 2005, INJURY, V36, P691, DOI 10.1016/j.injury.2004.12.037; Li M, 2011, J TRAUMA, V71, P141, DOI [10.1097/TA.0b013e3181f30fc9, 10.1088/1742-5468/2011/12/P12001]; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Marshall L F, 2000, Clin Neurosurg, V46, P105; Marshall LF, 2000, NEUROSURGERY, V47, P546, DOI 10.1097/00006123-200009000-00002; Nakae H, 2009, J TRAUMA, V67, P557, DOI 10.1097/TA.0b013e3181af6ca9; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; Offner H, 2006, J CEREBR BLOOD F MET, V26, P654, DOI 10.1038/sj.jcbfm.9600217; Perl M, 2012, SHOCK, V37, P210, DOI 10.1097/SHK.0b013e31823f1776; Sabe AA, 2009, J TRAUMA, V67, P565, DOI 10.1097/TA.0b013e3181b17010; Velmahos GC, 2010, ARCH SURG-CHICAGO, V145, P456, DOI 10.1001/archsurg.2010.58; Walusimbi MS, 2012, INJURY, V43, P180, DOI 10.1016/j.injury.2011.05.028; Wiseman J, 2006, AM SURGEON, V72, P947; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	21	11	11	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	OCT	2013	75	4					596	601		10.1097/TA.0b013e31829bb976			6	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	300IK	WOS:000330457400008	24064871				2021-06-18	
J	Silk, T; Beare, R; Crossley, L; Rogers, K; Emsell, L; Catroppa, C; Beauchamp, M; Anderson, V				Silk, Timothy; Beare, Richard; Crossley, Louise; Rogers, Kirrily; Emsell, Louise; Catroppa, Cathy; Beauchamp, Miriam; Anderson, Vicki			Cavum septum pellucidum in pediatric traumatic brain injury	PSYCHIATRY RESEARCH-NEUROIMAGING			English	Article						Traumatic brain injury; Pediatric; Magnetic resonance imaging (MRI); Cavum septum pellucidum	ULTRA-HIGH-RISK; BIPOLAR DISORDER; SCHIZOPHRENIA; MRI; PREVALENCE; MODERATE; ATROPHY; SEGMENTATION; HIPPOCAMPUS; CHILDREN	The cavum septum pellucidum (CSP) is a fluid-filled cavity in the thin midline structure of the septum pellucidum. The CSP has been linked to several neurodevelopmental disorders, but it also occurs as a result of head injury. The aims were to assess the presence and characterization of the CSP in youth with traumatic brain injury (TBI), to assess whether injury severity or IQ measures were related to CSP size, and to examine brain morphometry changes associated with the CSP size. Ninety-eight survivors of TBI and 34 control children underwent magnetic resonance imaging (MRI). Numerous methods were used to define the presence and characterization of the CSP including length, classification of abnormally large CSP, rating of the CSP, and volume. There was no difference in presence of CSP between TBI patients and controls; however, there was larger and more severely graded CSP in the patient group. Size of the CSP correlated positively with injury severity, and regions that correlated most significantly with CSP size were the right entorhinal cortex and bilateral hippocampus. Characterizing the CSP and related brain changes may provide important information concerning disturbances seen after a TBI. (C) 2013 Elsevier Ireland Ltd. All rights reserved.	[Silk, Timothy; Beare, Richard; Crossley, Louise; Rogers, Kirrily; Catroppa, Cathy; Anderson, Vicki] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic 3052, Australia; [Beauchamp, Miriam] Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada; [Emsell, Louise] Katholieke Univ Leuven, Dept Imaging & Pathol, Translat MRI, Louvain, Belgium; [Emsell, Louise] Katholieke Univ Leuven Hosp, Louvain, Belgium	Silk, T (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic 3052, Australia.	tim.silk@mcri.edu.au	Emsell, Louise/ABA-8107-2020; Silk, Tim/K-4295-2019	Emsell, Louise/0000-0003-0011-4158; Beare, Richard/0000-0002-7530-5664; Silk, Tim/0000-0002-7290-512X; Rogers, Kirrily/0000-0001-8282-537X	Victorian Neurotrauma Initiative; Victorian Government's Operational Infrastructure Support Program; NHMRC Career Development AwardNational Health and Medical Research Council of Australia	This work was supported by the Victorian Neurotrauma Initiative, by the Victorian Government's Operational Infrastructure Support Program and by the Royal Children's Hospital staff and patients. TS was supported by an NHMRC Career Development Award.	Anderson V, 2005, BRAIN INJURY, V19, P699, DOI 10.1080/02699050400025281; Beauchamp MH, 2011, INT J DEV NEUROSCI, V29, P137, DOI 10.1016/j.ijdevneu.2010.12.003; Bigler ED, 1999, J HEAD TRAUMA REHAB, V14, P406, DOI 10.1097/00001199-199908000-00009; BODENSTEINER JB, 1990, PEDIATR NEUROL, V6, P391, DOI 10.1016/0887-8994(90)90007-N; Bodensteiner JB, 1998, J CHILD NEUROL, V13, P120, DOI 10.1177/088307389801300305; BOGDANOFF B, 1989, NEUROLOGY, V39, P991, DOI 10.1212/WNL.39.7.991; Cabanis E A, 1986, Acta Radiol Suppl, V369, P365; Choi JS, 2008, PROG NEURO-PSYCHOPH, V32, P1326, DOI 10.1016/j.pnpbp.2008.04.011; Chon MW, 2010, EUR ARCH PSY CLIN N, V260, P337, DOI 10.1007/s00406-009-0081-6; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; DEGREEF G, 1992, PSYCHIAT RES-NEUROIM, V45, P1, DOI 10.1016/0925-4927(92)90009-S; DEGREEF G, 1992, AM J NEURORADIOL, V13, P835; DeLisi L., 1993, NEUROIMAGING, V45, P1; Dickey CC, 2007, SCHIZOPHR RES, V89, P49, DOI 10.1016/j.schres.2006.08.004; Fischl B, 2004, NEUROIMAGE, V23, pS69, DOI 10.1016/j.neuroimage.2004.07.016; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Flashman LA, 2007, PSYCHIAT RES-NEUROIM, V154, P147, DOI 10.1016/j.pscychresns.2006.09.001; Fukuzako T, 1996, PSYCHIAT CLIN NEUROS, V50, P125, DOI 10.1111/j.1440-1819.1996.tb01675.x; Gale SD, 2005, J NEUROL NEUROSUR PS, V76, P984, DOI 10.1136/jnnp.2004.036210; Handratta V, 2010, NEUROCASE, V16, P125, DOI 10.1080/13554790903329166; Jordan BD, 2000, SEMIN NEUROL, V20, P179, DOI 10.1055/s-2000-9826; Jovicich J, 2009, NEUROIMAGE, V46, P177, DOI 10.1016/j.neuroimage.2009.02.010; Kasai K, 2004, SCHIZOPHR RES, V71, P65, DOI 10.1016/j.schres.2003.12.010; Kim KJ, 2003, BIOL PSYCHIAT, V54, P76, DOI 10.1016/S0006-3223(02)01830-9; Kim MJ, 2007, BIPOLAR DISORD, V9, P274, DOI 10.1111/j.1399-5618.2007.00442.x; Kwon JS, 1998, AM J PSYCHIAT, V155, P509, DOI 10.1176/ajp.155.4.509; Li XD, 2012, PSYCHIAT CLIN NEUROS, V66, P587, DOI 10.1111/pcn.12002; McCrory P, 2002, BRIT J SPORT MED, V36, P157, DOI 10.1136/bjsm.36.3.157; Merkley TL, 2008, J NEUROTRAUM, V25, P1343, DOI 10.1089/neu.2008.0615; Nopoulos P, 1996, J NEUROPSYCH CLIN N, V8, P147; Nopoulos P, 2000, J NEUROPSYCH CLIN N, V12, P344, DOI 10.1176/appi.neuropsych.12.3.344; Nopoulos P, 1997, BIOL PSYCHIAT, V41, P1102, DOI 10.1016/S0006-3223(96)00209-0; Nopoulos PC, 1998, AM J PSYCHIAT, V155, P1074, DOI 10.1176/ajp.155.8.1074; Orrison WW, 2009, J NEUROTRAUM, V26, P689, DOI 10.1089/neu.2008.0636; Pittella JEH, 2005, SURG NEUROL, V63, P30, DOI 10.1016/j.surneu.2004.09.012; Raine A, 2010, BRIT J PSYCHIAT, V197, P186, DOI 10.1192/bjp.bp.110.078485; RAKIC P, 1968, J COMP NEUROL, V132, P45, DOI 10.1002/cne.901320103; ROSSI A, 1994, PSYCHIAT RES, V52, P43, DOI 10.1016/0165-1781(94)90119-8; SCHAEFER GB, 1994, DEV MED CHILD NEUROL, V36, P554; Shioiri T, 1996, PSYCHOL MED, V26, P431, DOI 10.1017/S0033291700034838; Spanos GK, 2007, AM J NEURORADIOL, V28, P537; Takahashi T, 2008, SCHIZOPHR RES, V105, P236, DOI 10.1016/j.schres.2008.06.021; Takahashi T, 2007, PROG NEURO-PSYCHOPH, V31, P1235, DOI 10.1016/j.pnpbp.2007.04.019; Tasker RC, 2005, PEDIATR RES, V58, P302, DOI 10.1203/01.PDR.0000169965.08854.25; TEASDALE G, 1974, LANCET, V2, P81; Verger K, 2001, BRAIN INJURY, V15, P211; Warner MA, 2010, ARCH NEUROL-CHICAGO, V67, P1336, DOI 10.1001/archneurol.2010.149; Wechsler D., 2011, WECHLSER ABBREVIATED; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Wilde EA, 2007, DEV MED CHILD NEUROL, V49, P294, DOI 10.1111/j.1469-8749.2007.00294.x	52	11	12	0	12	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0925-4927	1872-7506		PSYCHIAT RES-NEUROIM	Psychiatry Res. Neuroimaging	SEP 30	2013	213	3					186	192		10.1016/j.pscychresns.2013.03.001			7	Clinical Neurology; Neuroimaging; Psychiatry	Neurosciences & Neurology; Psychiatry	211TV	WOS:000323934800002	23816190				2021-06-18	
J	Mondragon-Lozano, R; Diaz-Ruiz, A; Rios, C; Gonzalez, RO; Favila, R; Salgado-Ceballos, H; Roldan-Valadez, E				Mondragon-Lozano, Rodrigo; Diaz-Ruiz, Araceli; Rios, Camilo; Olayo Gonzalez, Roberto; Favila, Rafael; Salgado-Ceballos, Hermelinda; Roldan-Valadez, Ernesto			Feasibility of In Vivo Quantitative Magnetic Resonance Imaging With Diffusion Weighted Imaging, T2-Weighted Relaxometry, and Diffusion Tensor Imaging in a Clinical 3 Tesla Magnetic Resonance Scanner for the Acute Traumatic Spinal Cord Injury of Rats Technical Note	SPINE			English	Article						magnetic resonance imaging; diffusion-weighted imaging; diffusion tensor imaging; fractional anisotropy; apparent diffusion coefficient; T-2 relaxometry mapping; biomarker; spinal cord injury; weight-drop device	LOCOMOTOR OUTCOMES; MRI; BRAIN; ANISOTROPY; CORRELATE; DEVICE; TIME	Study Design. Prospective longitudinal study. Objective. To verify the feasibility of performing in vivo quantitative magnetic resonance imaging evaluation of moderate traumatic spinal cord injury (SCI) in rats using a clinical 3T scanner. Summary of Background Data. Animal models of human diseases are essential for translational medicine. Potential treatments of SCI are evaluated in 2 ways: anatomical and functional. Advanced magnetic resonance sequences allow a noninvasive assessment of the spinal cord depicting both. This study describes and validates a very reproducible, feasible, affordable, and reliable method, designed to be applied in commercial 3T equipment, using a novel stereotactic device for spinal cord, leading to a readily available assessment of the progression of damage generated after traumatic SCI in rats. Methods. Four Long-Evans female rats were injured with a New York University weight-drop device to produce the SCI by contusion at thoracic level 10. All animals were placed in a fixation system, using a commercial wrist antenna to obtain magnetic resonance imaging data of the relaxometry time, apparent diffusion coefficient, and fractional anisotropy. Three sets of data obtained before SCI and 1 and 4 weeks after injury were compared. Results. The data showed a progressive decline in fractional anisotropy measurements after SCI comparing baseline versus the 1-week period (P < 0.001) and baseline versus the 4-week period (P < 0.019), with a significant progressive increase in apparent diffusion coefficient values and T 2 after SCI only in the baseline versus the 4-week period (P < 0.045 and P < 0.024, respectively). Conclusion. Our results helped us to validate a novel method to acquire highly reproducible and reliable quantitative biomarkers of traumatic SCI in vivo by using a 3T clinical MR scanner coupled with a novel stereotactic device for rats.	[Mondragon-Lozano, Rodrigo] Univ Autonoma Metropolitana, Dept Ingn Elect, Mexico City, DF, Mexico; [Diaz-Ruiz, Araceli; Rios, Camilo] Inst Nacl Neurol & Neurocirug, Dept Neuroquim, Mexico City, DF, Mexico; [Rios, Camilo] Univ Autonoma Metropolitana, Dept Sistemas Biol, Mexico City, DF, Mexico; [Olayo Gonzalez, Roberto] Univ Autonoma Metropolitana, Dept Fis, Mexico City, DF, Mexico; [Favila, Rafael] GE Healthcare, Mexico City, DF, Mexico; [Salgado-Ceballos, Hermelinda] Inst Mexicano Seguro Social, Ctr Med Nacl Siglo 21, Hosp Especialidades, Unidad Invest Med Enfermedades Neurol, Mexico City, DF, Mexico; [Roldan-Valadez, Ernesto] Med Sur Clin & Fdn, Magnet Resonance Unit, Mexico City 14050, DF, Mexico	Roldan-Valadez, E (corresponding author), Med Sur Clin & Fdn, Magnet Resonance Unit, Puente Piedra 150, Mexico City 14050, DF, Mexico.	ernest.roldan@usa.net	Roldan-Valadez, Ernesto/D-1661-2011; Mondragon-Lozano, Rodrigo/Y-9663-2019; Olayo, Roberto/B-4635-2008	Roldan-Valadez, Ernesto/0000-0002-7116-5289; Mondragon-Lozano, Rodrigo/0000-0002-7060-6185; Olayo, Roberto/0000-0002-1728-958X; Diaz-Ruiz, Araceli/0000-0002-1481-0966			[Anonymous], 2010, J PHARMACOL PHARMACO, V1, P42; [Anonymous], GUIDE CARE USE LAB A; Bartlett PA, 2007, AM J NEURORADIOL, V28, P1095, DOI 10.3174/ajnr.A0505; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Bhagat YA, 2006, J CEREBR BLOOD F MET, V26, P1442, DOI 10.1038/sj.jcbfm.9600294; Bonny JM, 2004, NEUROBIOL DIS, V15, P474, DOI 10.1016/j.nbd.2003.11.026; Bozzo A, 2011, J NEUROTRAUM, V28, P1401, DOI 10.1089/neu.2009.1236; Budde MD, 2009, J NEUROSCI, V29, P2805, DOI 10.1523/JNEUROSCI.4605-08.2009; Callot V, 2008, NMR BIOMED, V21, P868, DOI 10.1002/nbm.1274; Callot V, 2011, METHODS MOL BIOL, V771, P355, DOI 10.1007/978-1-61779-219-9_19; CAPIZZI RL, 1971, ANN INTERN MED, V74, P74, DOI 10.7326/0003-4819-74-1-74; Carneiro AAO, 2006, BRAZ J PHYS, V36, P9; Cortez-Conradis D, 2013, EUR RADIOL, V23, P1112, DOI 10.1007/s00330-012-2688-7; Ellingson BM, 2010, J NEUROSURG-SPINE, V13, P181, DOI 10.3171/2010.3.SPINE09523; Freund P, 2010, MULT SCLER J, V16, P1193, DOI 10.1177/1352458510376180; Galvan EE, 2010, STEREOT FUNCT NEUROS, V88, P115, DOI 10.1159/000289355; Griffin JF, 2013, J MAGN RESON IMAGING, V37, P632, DOI 10.1002/jmri.23862; Gupta RK, 2005, AM J NEURORADIOL, V26, P1107; Kim JH, 2006, NEUROBIOL DIS, V21, P626, DOI 10.1016/j.nbd.2005.09.009; Kim JH, 2012, EXP NEUROL, V235, P188, DOI 10.1016/j.expneurol.2011.11.015; Kulkarni M V, 1988, Radiographics, V8, P1059; Liang ZJ, 2007, J NEUROL NEUROSUR PS, V78, P581, DOI 10.1136/jnnp.2006.099077; Mukherjee P, 2005, NEUROIMAG CLIN N AM, V15, P655, DOI 10.1016/j.nic.2005.08.010; Neil J, 2002, NMR BIOMED, V15, P543, DOI 10.1002/nbm.784; Pallant J., 2011, SPSS SURVIVAL MANUAL, P249; Parizel PM, 2010, EUR SPINE J, V19, P8, DOI 10.1007/s00586-009-1123-5; Pease A, 2011, VET RADIOL ULTRASOUN, V52, P492, DOI 10.1111/j.1740-8261.2011.01837.x; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Pillai DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016091; Rugg-Gunn FJ, 2005, NEUROLOGY, V64, P318, DOI 10.1212/01.WNL.0000149642.93493.F4; Sandner B, 2009, J MAGN RESON IMAGING, V29, P725, DOI 10.1002/jmri.21477; Schaefers G, 2008, IEEE ENG MED BIOL, V27, P23, DOI 10.1109/EMB.2007.910267; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Sundberg LM, 2010, J NEUROTRAUM, V27, P1753, DOI 10.1089/neu.2010.1369; Van Goethem JWM, 2005, EUR RADIOL, V15, P582, DOI 10.1007/s00330-004-2625-5	36	11	13	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0362-2436	1528-1159		SPINE	SPINE	SEP 15	2013	38	20					E1242	E1249		10.1097/BRS.0b013e31829ef69c			8	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	299BM	WOS:000330369600002	23759823				2021-06-18	
J	Amonette, WE; Mossberg, KA				Amonette, William E.; Mossberg, Kurt A.			Ventilatory Anaerobic Thresholds of Individuals Recovering From Traumatic Brain Injury Compared With Noninjured Controls	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						exercise prescription; exercise tolerance; fatigue; head injury rehabilitation	CHRONIC HEART-FAILURE; GAS-EXCHANGE; EXERCISE; FATIGUE; RELIABILITY; EFFICIENCY; RESPONSES; CAPACITY; VALIDITY; DEATH	Objective: The purpose of this study was to compare the peak aerobic capacities and ventilatory anaerobic thresholds (V-AT) of individuals with a traumatic brain injury (TBI) to age- and gender-matched controls. Methods: Nineteen participants that previously suffered a mild to moderate TBI and 19 apparently healthy controls volunteered as subjects. Traumatic brain injury and healthy controls were matched for age and gender and were similar in weight and body mass index. Volunteers performed a maximal graded treadmill test to volitional failure where oxygen consumption ((V) over dotO(2)), carbon dioxide production ((V) over dotCO(2)), ventilation ((V) over dot(E)), and heart rate were measured continuously. From metabolic and ventilatory data, V-AT was measured using a previously described method. V-AT and peak exercise responses of participants with a TBI were compared with healthy controls. Results: The (V) over dotO(2), and (V) over dotCO(2) at V-AT and peak exercise were lower for TBI compared with healthy controls. (V) over dot(E) was also lower for TBI at V-AT and peak exercise. Heart rate was lower for TBI at V-AT; however, TBI had similar heart rate to healthy controls at peak exercise. Conclusions: The V-AT and peak exercise capacities of participants with a TBI were below the metabolic demands of many routine daily activities. The data suggest that therapeutic interventions for individuals with a TBI should include targeted exercise prescriptions to improve cardiorespiratory fitness.	[Amonette, William E.; Mossberg, Kurt A.] Univ Texas Med Branch, Dept Phys Therapy, Rehabil Sci Div, Galveston, TX 77555 USA	Mossberg, KA (corresponding author), Univ Texas Med Branch, Dept Phys Therapy, 301 Univ Blvd, Galveston, TX 77555 USA.	kmossber@utmb.edu			Moody Foundation; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01-HD046570]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD046570] Funding Source: NIH RePORTER	This work was supported, in part, by the Moody Foundation and NIH grant R01-HD046570 to Dr Mossberg. The authors thank P. Skinkis for technical assistance and Dr James Graham for his assistance with statistical analysis.	Amann M, 2004, MED SCI SPORT EXER, V36, P1716, DOI 10.1249/01.MSS.0000142305.18543.34; [Anonymous], 2001, NAT CTR INJ PREV CON; BEAVER WL, 1986, J APPL PHYSIOL, V60, P2020; Bhambhani Y, 2005, ARCH PHYS MED REHAB, V86, P268, DOI 10.1016/j.apmr.2004.04.022; Bushnik T, 2008, J HEAD TRAUMA REHAB, V23, P25, DOI 10.1097/01.HTR.0000308718.88214.bb; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Caviedes IR, 2012, RESP CARE, V57, P583, DOI 10.4187/respcare.01342; CHWALBINSKAMONETA J, 1989, J APPL PHYSIOL, V66, P2710; Coucke W, 2012, CLIN CHIM ACTA, V413, P582, DOI 10.1016/j.cca.2011.11.030; Crouter SE, 2006, J APPL PHYSIOL, V100, P1324, DOI 10.1152/japplphysiol.00818.2005; Gaskill SE, 2001, MED SCI SPORT EXER, V33, P1841, DOI 10.1097/00005768-200111000-00007; Gitt AK, 2000, EUR HEART J, V21, P586; Gitt AK, 2002, CIRCULATION, V106, P3079, DOI 10.1161/01.CIR.0000041428.99427.06; Greenspan AI, 1996, BRAIN INJURY, V10, P207, DOI 10.1080/026990596124520; HAGBERG JM, 1981, MED SCI SPORT EXER, V13, P115, DOI 10.1249/00005768-198101320-00228; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI 10.1249/mss.0b013e3180616b27; Hoofien D, 2001, BRAIN INJURY, V15, P189; HOPKINS SR, 1994, J APPL PHYSIOL, V77, P912; JANKOWSKI LW, 1990, ARCH PHYS MED REHAB, V71, P500; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Malek MH, 2007, J STRENGTH COND RES, V21, P29, DOI 10.1519/00124278-200702000-00006; Midgley AW, 2007, CLIN PHYSIOL FUNCT I, V27, P122, DOI 10.1111/j.1475-097X.2007.00725.x; Mossberg K, 2010, REHABILITATION MOBIL, P276; Mossberg KA, 2005, AM J PHYS MED REHAB, V84, P492, DOI 10.1097/01.phm.0000166883.97562.cd; Mossberg KA, 2007, ARCH PHYS MED REHAB, V88, P315, DOI 10.1016/j.apmr.2006.12.006; Nanas SN, 2006, EUR J HEART FAIL, V8, P420, DOI 10.1016/j.ejheart.2005.10.003; Papazachou O, 2007, INT J CARDIOL, V118, P28, DOI 10.1016/j.ijcard.2006.04.091; Pollock ML, 1990, EXERCISE HLTH DIS; Riffenburgh RH, 2006, STATISTICS IN MEDICINE, 2ND EDITION, P1; Robergs RA, 2004, AM J PHYSIOL-REG I, V287, pR502, DOI 10.1152/ajpregu.00114.2004; Shavelle RM, 2001, AM J PHYS MED REHAB, V80, P510, DOI 10.1097/00002060-200107000-00009; Thompson WR., 2010, ACSMS GUIDELINES EXE; Thurman DA, 1999, TRAUMATIC BRAIN INJU, P1; Valim V, 2002, J RHEUMATOL, V29, P353; Williams PT, 2001, MED SCI SPORT EXER, V33, P754, DOI 10.1097/00005768-200105000-00012; WOLTHUIS RA, 1977, AM J CARDIOL, V39, P697, DOI 10.1016/S0002-9149(77)80131-8; Ziino C, 2006, J INT NEUROPSYCH SOC, V12, P100, DOI 10.1017/S1355617706060139	37	11	11	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2013	28	5					E13	E20		10.1097/HTR.0b013e31826463a1			8	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	298ZU	WOS:000330364600002	22935575	Green Accepted			2021-06-18	
J	Blakely, ML; Kao, LS; Tsao, K; Huang, EY; Tsai, A; Tanaka, S; Younas, S; Lu, ZQ; Lally, KP				Blakely, Martin L.; Kao, Lillian S.; Tsao, Kuojen; Huang, Eunice Y.; Tsai, Anthony; Tanaka, Stacy; Younas, Shiraz; Lu, Zengqi; Lally, Kevin P.		Pediat Surg Res Collaborative	Adherence of Randomized Trials Within Children's Surgical Specialties Published During 2000 to 2009 to Standard Reporting Guidelines	JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS			English	Article; Proceedings Paper	98th Annual Clinical Congress of the American-College-of-Surgeons (ACS) / 67th Annual Sessions of the Owen H Wangensteen Forum on Fundamental Surgical Problems	SEP 30-OCT 04, 2012	Chicago, IL	Amer Coll Surg			SUPRACONDYLAR HUMERAL FRACTURES; ASSISTED THORACOSCOPIC SURGERY; HYPERTROPHIC PYLORIC-STENOSIS; PEDIATRIC CARDIAC-SURGERY; PLACEBO-CONTROLLED TRIAL; CENTRAL VENOUS CATHETERS; TRAUMATIC BRAIN-INJURY; BLALOCK-TAUSSIG SHUNT; QUALITY-OF-LIFE; DOUBLE-BLIND	BACKGROUND: Randomized clinical trials (RCTs) are uncommon in pediatric surgical specialties and the quality of reporting is unknown. Our primary purpose was to analyze published surgical RCTs involving children to measure adherence to the Consolidated Standards of Reporting Trials (CONSORT) guidelines. STUDY DESIGN: Published RCTs from January 1, 2000 through December 31, 2009 were reviewed. The trials were evaluated for the presence of 7 CONSORT guidelines and also graded according to the Jadad scale. RESULTS: Two hundred and twenty-eight trials were included. Five trials met all 7 CONSORT criteria (2%) and 53 had a Jadad score of >= 3 (23%). Slightly more than 50% of all trials specified primary outcomes and <25% described power calculations according to CONSORT. Adherence to CONSORT guidelines for allocation concealment, randomization description, and attrition details was even lower. There were significant differences between surgical specialties with regard to CONSORT adherence to the majority of the guidelines. Pediatric general surgery had the largest number of published RCTs. Pediatric orthopaedic surgery had the highest proportion of trials with a Jadad score >= 3 (40%). CONCLUSIONS: Adherence to CONSORT guidelines is low across the spectrum of children's surgical specialties, although significant differences do exist. Future RCTs in children's surgical specialties should specifically focus on areas of low adherence to reporting guidelines. ((c) 2013 by the American College of Surgeons)	[Blakely, Martin L.] Vanderbilt Univ, Monroe Carell Jr Childrens Hosp, Sch Med, Dept Pediat Surg, Nashville, TN 37232 USA; [Tanaka, Stacy] Vanderbilt Univ, Monroe Carell Jr Childrens Hosp, Sch Med, Div Pediat Urol, Nashville, TN 37232 USA; [Lu, Zengqi] Vanderbilt Univ, Dept Biostat, Sch Med, Nashville, TN 37232 USA; [Huang, Eunice Y.; Tsai, Anthony] Univ Tennessee, Ctr Hlth Sci, Div Pediat Surg, LeBonheur Childrens Hosp, Memphis, TN 38163 USA; [Kao, Lillian S.; Tsao, Kuojen; Younas, Shiraz; Lally, Kevin P.] Univ Texas Hlth Sci Ctr Houston, Dept Pediat Surg, Childrens Mem Hermann Hosp, Houston, TX 77030 USA	Blakely, ML (corresponding author), Vanderbilt Univ, Dept Pediat Surg, Sch Med, 2200 Childrens Way,DOT 7104, Nashville, TN 37232 USA.	martin.blakely@vanderbilt.edu		Huang, Eunice/0000-0003-1413-7860			Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; Adibe OO, 2012, ARCH SURG-CHICAGO, V147, P899, DOI 10.1001/archsurg.2012.1796; Agati S, 2006, J THORAC CARDIOV SUR, V131, P1306, DOI 10.1016/j.jtcvs.2006.02.013; Al-Mazrou KA, 2009, INT J PEDIATR OTORHI, V73, P1650, DOI 10.1016/j.ijporl.2009.08.019; Albers MJIJ, 2005, ANN SURG, V241, P599, DOI 10.1097/01.sla.0000157270.24991.71; Altman DG, 1996, BRIT MED J, V313, P570; Aminsharifi A, 2008, UROLOGY, V72, P305, DOI 10.1016/j.urology.2008.02.034; Arda IS, 2001, SCAND J UROL NEPHROL, V35, P505; Arda RS, 2002, PEDIATR INT, V44, P78, DOI 10.1046/j.1442-200X.2002.01502.x; Austin PF, 2008, PEDIATRICS, V122, P1027, DOI 10.1542/peds.2007-3691; Ayan S, 2007, J UROLOGY, V177, P2325, DOI 10.1016/j.juro.2007.02.001; Aydogdu O, 2009, J UROLOGY, V182, P2880, DOI 10.1016/j.juro.2009.08.061; Barret JP, 2000, PLAST RECONSTR SURG, V105, P62, DOI 10.1097/00006534-200001000-00010; Bellinger DC, 2003, J THORAC CARDIOV SUR, V126, P1385, DOI 10.1016/S0022-5223(03)00711-6; Ben Meir D, 2004, J UROLOGY, V171, P2621, DOI 10.1097/01.ju.0000124007.55430.d3; Blank J, 2003, J SPINAL DISORD TECH, V16, P508, DOI 10.1097/00024720-200312000-00004; Bohm ER, 2006, J BONE JOINT SURG AM, V88A, P1, DOI 10.2106/JBJS.E.00320; Bolla G, 2008, MED SURG PEDIAT, V30, P89; Branski LK, 2008, BURNS, V34, P393, DOI 10.1016/j.burns.2007.06.007; Branski LK, 2007, CRIT CARE MED, V35, P2615, DOI 10.1097/01.CCM.0000285991.36698.E2; Brooke BS, 2009, ANN SURG, V249, P162, DOI 10.1097/SLA.0b013e31819291f9; Brown JK, 2009, J PEDIATR SURG, V44, P1418, DOI 10.1016/j.jpedsurg.2009.02.051; Bu LN, 2003, J PEDIATR SURG, V38, P590, DOI 10.1053/jpsu.2003.50128; Burgu B, 2010, UROLOGY, V76, P169, DOI 10.1016/j.urology.2009.09.080; Capozza N, 2002, J PEDIATR-US, V140, P230, DOI 10.1067/mpd.2002.121380; Caputo M, 2002, ANN THORAC SURG, V74, P530, DOI 10.1016/S0003-4975(02)03695-0; Cartwright PC, 2009, J UROLOGY, V182, P1548, DOI 10.1016/j.juro.2009.06.058; Casselbrant ML, 2009, INT J PEDIATR OTORHI, V73, P1718, DOI 10.1016/j.ijporl.2009.09.007; Cassidy C, 2005, BURNS, V31, P890, DOI 10.1016/j.burns.2005.04.029; Cavusoglu YH, 2009, EUR J PEDIATR SURG, V19, P171, DOI 10.1055/s-0029-1202776; CHALMERS I, 1994, BMJ-BRIT MED J, V309, P862, DOI 10.1136/bmj.309.6958.862; Chan AW, 2005, LANCET, V365, P1159, DOI 10.1016/S0140-6736(05)71879-1; Chan KH, 2004, ARCH OTOLARYNGOL, V130, P1303, DOI 10.1001/archotol.130.11.1303; Chan KL, 2005, SURG ENDOSC, V19, P927, DOI 10.1007/s00464-004-8224-3; Chang KW, 2008, OTOLARYNG HEAD NECK, V138, P153, DOI 10.1016/j.otohns.2007.11.006; Chattopadhyay A, 2004, PEDIATR SURG INT, V20, P127, DOI 10.1007/s00383-003-1104-4; Chauhan S, 2004, J CARDIOTHOR VASC AN, V18, P141, DOI 10.1053/j.jvca.2004.01.016; Chen YL, 2007, INT J PEDIATR OTORHI, V71, P921, DOI 10.1016/j.ijporl.2007.03.002; Chertin B, 2007, J UROLOGY, V178, P1744, DOI 10.1016/j.juro.2007.03.171; Cheung MMH, 2006, J AM COLL CARDIOL, V47, P2277, DOI 10.1016/j.jacc.2006.01.066; Chin-Peuckert L, 2004, J UROLOGY, V172, P1657, DOI 10.1097/01.ju.0000138520.95101.02; Clarke MCC, 2009, J PEDIATR SURG, V44, P1268, DOI 10.1016/j.jpedsurg.2009.02.031; Clarke MCC, 2009, J PEDIATR SURG, V44, P408, DOI 10.1016/j.jpedsurg.2008.10.100; Clarke SA, 2005, J PEDIATR SURG, V40, P568, DOI 10.1016/j.jpedsurg.2004.11.027; Codispoti M, 2002, EUR J CARDIO-THORAC, V22, P200, DOI 10.1016/S1010-7940(02)00271-3; Collins KK, 2004, J THORAC CARDIOV SUR, V127, P721, DOI 10.1016/S0022-5223(03)01055-9; Cowley CG, 2005, CIRCULATION, V111, P3453, DOI 10.1161/CIRCULATIONAHA.104.510198; Curry JI, 2004, J PEDIATR SURG, V39, P565, DOI 10.1016/j.jpedsurg.2003.12.020; D'Agostino R, 2008, INT J PEDIATR OTORHI, V72, P1077, DOI 10.1016/j.ijporl.2008.03.018; D'Eredita R, 2006, INT J PEDIATR OTORHI, V70, P1077, DOI 10.1016/j.ijporl.2005.11.003; D'Eredita R, 2004, OTOLARYNG HEAD NECK, V131, P732, DOI 10.1016/j.otohns.2004.04.031; D'Eredita R, 2009, LARYNGOSCOPE, V119, P1897, DOI 10.1002/lary.20210; Davenport M, 2007, HEPATOLOGY, V46, P1821, DOI 10.1002/hep.21873; De Moura CP, 2008, J LARYNGOL OTOL, V122, P1318, DOI 10.1017/S002221510800279X; Dechartres A, 2011, J CLIN EPIDEMIOL, V64, P136, DOI 10.1016/j.jclinepi.2010.04.015; Derkay CS, 2006, OTOLARYNG HEAD NECK, V134, P114, DOI 10.1016/j.otohns.2005.10.039; Dillon PW, 2004, J CLIN ONCOL, V22, P2718, DOI 10.1200/JCO.2004.07.019; Dimick JB, 2001, ARCH SURG-CHICAGO, V136, P796, DOI 10.1001/archsurg.136.7.796; Doniger SJ, 2009, PEDIATR EMERG CARE, V25, P154, DOI 10.1097/PEC.0b013e31819a8946; Ekemen S, 2008, PEDIATR SURG INT, V24, P695, DOI 10.1007/s00383-008-2147-3; Ekingen G, 2005, NUTRITION, V21, P142, DOI 10.1016/j.nut.2004.10.003; El-Ghoneimi A, 2002, J UROLOGY, V168, P694, DOI 10.1016/S0022-5347(05)64726-X; Erfanian K, 2003, J PEDIATR SURG, V38, P1059, DOI 10.1016/S0022-3468(03)00192-1; Ericsson E, 2007, LARYNGOSCOPE, V117, P654, DOI 10.1097/mlg.0b013e318030ca69; Fanta K, 2006, J PEDIATR SURG, V41, P277, DOI 10.1016/j.jpedsurg.2005.10.049; Farrokhyar F, 2010, ANN SURG, V251, P409, DOI 10.1097/SLA.0b013e3181cf863d; Foead A, 2004, J Orthop Surg (Hong Kong), V12, P76; Ford Henri R, 2005, Surg Infect (Larchmt), V6, P313, DOI 10.1089/sur.2005.6.313; Frommelt PC, 2007, J AM SOC ECHOCARDIOG, V20, P1364, DOI 10.1016/j.echo.2007.04.009; Ghanayem NS, 2006, ANN THORAC SURG, V82, P1603, DOI 10.1016/j.athoracsur.2006.05.103; Giguere CM, 2002, ARCH OTOLARYNGOL, V128, P1137, DOI 10.1001/archotol.128.10.1137; Glat PM, 2009, J BURN CARE RES, V30, P262, DOI 10.1097/BCR.0b013e318198a2e8; Goldberg CS, 2007, J THORAC CARDIOV SUR, V133, P880, DOI 10.1016/j.jtcvs.2006.11.029; Gopal SC, 2008, J PEDIATR SURG, V43, P1869, DOI 10.1016/j.jpedsurg.2008.04.022; Gorecki WJ, 2001, MED SCI MONITOR, V7, P289; Graubert C, 2000, J PEDIATR ORTHOPED, V20, P496, DOI 10.1097/00004694-200007000-00014; Green R, 2005, PEDIATRICS, V116, P978, DOI 10.1542/peds.2005-0273; Gross CW, 2001, LARYNGOSCOPE, V111, P259, DOI 10.1097/00005537-200102000-00014; Guarino N, 2009, J UROLOGY, V181, P1318, DOI 10.1016/j.juro.2008.10.056; Gudas R, 2009, J PEDIATR ORTHOPED, V29, P741, DOI 10.1097/BPO.0b013e3181b8f6c7; GUYATT GH, 1995, JAMA-J AM MED ASSOC, V274, P1800, DOI 10.1001/jama.274.22.1800; Hall NJ, 2009, LANCET, V373, P390, DOI 10.1016/S0140-6736(09)60006-4; Hall NJ, 2005, PEDIATR SURG INT, V21, P507, DOI 10.1007/s00383-005-1478-6; Hanasono MM, 2004, ARCH OTOLARYNGOL, V130, P917, DOI 10.1001/archotol.130.8.917; Hardin WD, 1999, J PEDIATR SURG, V34, P908, DOI 10.1016/S0022-3468(99)90396-2; Hartnick CJ, 2001, ARCH OTOLARYNGOL, V127, P1260, DOI 10.1001/archotol.127.10.1260; Hegazy HM, 2008, J LARYNGOL OTOL, V122, P369, DOI 10.1017/S0022215107008328; Henkel KO, 2004, CLEFT PALATE-CRAN J, V41, P1, DOI 10.1597/02-011; Hernandez-Gonzalez M, 2003, ARCH MED RES, V34, P305, DOI 10.1016/S0188-4409(03)00055-9; Hirschl RB, 2003, J PEDIATR SURG, V38, P283, DOI 10.1053/jpsu.2003.50095; Hollis S, 1999, BRIT MED J, V319, P670, DOI 10.1136/bmj.319.7211.670; Hotz Gillian A, 2004, Traffic Inj Prev, V5, P132, DOI 10.1080/15389580490435097; Hung T, 2002, J LARYNGOL OTOL, V116, P33; Inoue M, 2005, J PEDIATR SURG, V40, P1301, DOI 10.1016/j.jpedsurg.2005.05.015; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jagannathan N, 2009, PEDIATR ANESTH, V19, P892, DOI 10.1111/j.1460-9592.2009.03092.x; Jallouli M, 2009, UROLOGY, V73, P1251, DOI 10.1016/j.urology.2008.10.078; Jonas NE, 2007, INT J PEDIATR OTORHI, V71, P1687, DOI 10.1016/j.ijporl.2007.07.001; Jonas NE, 2007, INT J PEDIATR OTORHI, V71, P1555, DOI 10.1016/j.ijporl.2007.06.008; Kaewpornsawan K, 2001, J PEDIATR ORTHOP B, V10, P131, DOI 10.1097/00009957-200104000-00010; Kaewpornsawan Kamolporn, 2007, Journal of the Medical Association of Thailand, V90, P936; Kaiser S, 2004, ACAD RADIOL, V11, P971, DOI 10.1016/j.acra.2004.05.023; Kaiser S, 2002, RADIOLOGY, V223, P633, DOI 10.1148/radiol.2233011076; Kajbafzadeh AM, 2009, UROLOGY, V74, P324, DOI 10.1016/j.urology.2008.12.085; Kamikawa S, 2001, MINIM INVAS NEUROSUR, V44, P25, DOI 10.1055/s-2001-13587; Karaman I, 2004, EUR J PEDIATR SURG, V14, P250, DOI 10.1055/s-2004-817840; Kargi E, 2010, UROLOGY, V75, P672, DOI 10.1016/j.urology.2009.06.108; Kaya C, 2008, J UROLOGY, V179, P684, DOI 10.1016/j.juro.2007.09.098; Kazem MM, 2010, J PEDIATR UROL, V6, P258, DOI 10.1016/j.jpurol.2009.08.007; Keshtgar AS, 2007, J PEDIATR SURG, V42, P672, DOI 10.1016/j.jpedsurg.2006.12.045; Kestle JRW, 2003, J NEUROSURG, V98, P284, DOI 10.3171/jns.2003.98.2.0284; Kibar Y, 2010, UROLOGY, V75, P1472, DOI 10.1016/j.urology.2009.09.008; Kim EK, 2009, J CRANIOFAC SURG, V20, P1886, DOI 10.1097/SCS.0b013e3181b2d1d1; Kinnari TJ, 2007, LARYNGOSCOPE, V117, P2213, DOI 10.1097/MLG.0b013e3181468631; Kinnari TJ, 2004, LARYNGOSCOPE, V114, P2038, DOI 10.1097/01.mlg.0000147944.20676.17; Kiris T, 2000, NEUROSURG FOCUS, V8, P1; Kiss A, 2001, J UROLOGY, V165, P219, DOI 10.1097/00005392-200101000-00062; Klijn AJ, 2006, J UROLOGY, V175, P2263, DOI 10.1016/S0022-5347(06)00331-4; Kocaturk S, 2005, AM J OTOLARYNG, V26, P123, DOI 10.1016/j.amjoto.2004.11.004; Kocher MS, 2007, J BONE JOINT SURG AM, V89A, P706, DOI 10.2106/JBJS.F.00379; Koivusalo AI, 2009, PEDIATRICS, V123, P332, DOI 10.1542/peds.2007-3752; Kono T, 2006, LASER SURG MED, V38, P112, DOI 10.1002/lsm.20257; Korkmaz O, 2008, INT J PEDIATR OTORHI, V72, P1007, DOI 10.1016/j.ijporl.2008.03.003; Kovacs AF, 2008, J PEDIATR SURG, V43, P2075, DOI 10.1016/j.jpedsurg.2008.03.057; Kramer SA, 2005, J UROLOGY, V173, P2121, DOI 10.1097/01.ju.0000157689.98314.69; Kumar RJ, 2004, ANZ J SURG, V74, P622, DOI 10.1111/j.1445-1433.2004.03106.x; Kurt BA, 2006, PEDIATRICS, V118, pE547, DOI 10.1542/peds.2005-2719; Lal S, 2000, SHOCK, V14, P314, DOI 10.1097/00024382-200014030-00013; Lally KP, 2006, J PEDIATR SURG, V41, P668, DOI 10.1016/j.jpedsurg.2005.12.007; Lassen K, 2012, REV RECENT CLIN TRIA, V7, P244, DOI 10.2174/157488712802281402; Leaper M, 2006, INT J PEDIATR OTORHI, V70, P1389, DOI 10.1016/j.ijporl.2006.02.004; Leclair MD, 2007, J PEDIATR SURG, V42, P692, DOI 10.1016/j.jpedsurg.2006.12.016; Lee T, 2005, J UROLOGY, V174, P1084, DOI 10.1097/01.ju.0000169160.84418.15; Lemler MS, 2002, CIRCULATION, V105, P207, DOI 10.1161/hc0202.102237; Letendre J, 2009, J UROLOGY, V182, P1759, DOI 10.1016/j.juro.2009.03.016; Levy I, 2005, PEDIATR INFECT DIS J, V24, P676, DOI 10.1097/01.inf.0000172934.98865.14; Li HCW, 2008, J SPEC PEDIATR NURS, V13, P63, DOI 10.1111/j.1744-6155.2008.00138.x; Licameli G, 2008, INT J PEDIATR OTORHI, V72, P1323, DOI 10.1016/j.ijporl.2008.05.018; Lintula H, 2002, J PEDIATR SURG, V37, P1317, DOI 10.1053/jpsu.2002.34998; Lintula H, 2009, LANGENBECK ARCH SURG, V394, P999, DOI 10.1007/s00423-008-0425-0; Lister MT, 2006, ARCH OTOLARYNGOL, V132, P599, DOI 10.1001/archotol.132.6.599; Lodge AJ, 2008, ANN THORAC SURG, V86, P614, DOI 10.1016/j.athoracsur.2008.04.103; Logghe HL, 2005, J PEDIATR SURG, V40, P1726, DOI 10.1016/j.jpedsurg.2005.07.047; Lund L, 2000, SCAND J UROL NEPHROL, V34, P267, DOI 10.1080/003655900750042013; Lund L, 2005, SCAND J UROL NEPHROL, V39, P78, DOI 10.1080/00365590410002519; Luo WJ, 2001, ANN THORAC SURG, V71, P473, DOI 10.1016/S0003-4975(00)02443-7; McHoney M, 2005, J PEDIATR SURG, V40, P908, DOI 10.1016/j.jpedsurg.2005.03.003; McLauchlan GJ, 2002, J BONE JOINT SURG BR, V84B, P413, DOI 10.1302/0301-620X.84B3.11432; McLorie G, 2001, J UROLOGY, V165, P1669, DOI 10.1016/S0022-5347(05)66388-4; Mendez-Gallart R, 2009, J PEDIATR SURG, V44, P2048, DOI 10.1016/j.jpedsurg.2009.06.008; Merei JM, 2006, PEDIATR SURG INT, V22, P446, DOI 10.1007/s00383-006-1677-9; Merei JM, 2004, J PEDIATR SURG, V39, P1871, DOI 10.1016/j.jpedsurg.2004.08.017; Merguerian PA, 2004, J UROLOGY, V172, P1621, DOI 10.1097/01.ju.0000139953.04938.07; Mitchell C, 2006, EUR J CANCER, V42, P2554, DOI 10.1016/j.ejca.2006.05.026; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; Moher D, 2010, BMJ-BRIT MED J, V340, DOI [10.1016/j.jclinepi.2010.03.004, 10.1136/bmj.c869]; Morpeth JF, 2001, INT J PEDIATR OTORHI, V61, P99, DOI 10.1016/S0165-5876(01)00552-3; Moss RL, 2006, NEW ENGL J MED, V354, P2225, DOI 10.1056/NEJMoa054605; Moss RL, 2001, J PEDIATR SURG, V36, P1182, DOI 10.1053/jpsu.2001.25749; Moss RL, 2001, J PEDIATR SURG, V36, P1739, DOI 10.1053/jpsu.2001.28809; Navali AM, 2008, J HAND SURG-EUR VOL, V33E, P424, DOI 10.1177/1753193408090761; Neel KF, 2007, J UROLOGY, V178, P2593, DOI 10.1016/j.juro.2007.08.032; Newburger JW, 2008, J THORAC CARDIOV SUR, V135, P347, DOI 10.1016/j.jtcvs.2007.01.051; Newcomb AE, 2005, EUR J CARDIO-THORAC, V27, P395, DOI 10.1016/j.ejcts.2004.11.023; Nguyen LHP, 2004, LARYNGOSCOPE, V114, P863, DOI 10.1097/00005537-200405000-00014; Nijman RJM, 2005, J UROLOGY, V173, P1334, DOI 10.1097/01.ju.0000152322.17542.63; Nunez DA, 2000, ARCH OTOLARYNGOL, V126, P837, DOI 10.1001/archotol.126.7.837; Oka T, 2004, SURG ENDOSC, V18, P242, DOI 10.1007/s00464-003-8140-y; Oko MO, 2005, OTOLARYNG HEAD NECK, V133, P579, DOI 10.1016/j.otohns.2005.08.002; Ong CCP, 2002, PEDIATR SURG INT, V18, P553, DOI 10.1007/s00383-002-0728-0; Ordorica-Flores R, 2001, J PEDIATR SURG, V36, P1000, DOI 10.1053/jpsu.2001.24724; Ostlie DJ, 2010, J PEDIATR SURG, V45, P1940, DOI 10.1016/j.jpedsurg.2010.05.008; Oswald J, 2002, UROLOGY, V60, P894, DOI 10.1016/S0090-4295(02)01903-9; Palmu S, 2008, J BONE JOINT SURG AM, V90A, P463, DOI 10.2106/JBJS.G.00072; Park A, 2007, INT J PEDIATR OTORHI, V71, P1205, DOI 10.1016/j.ijporl.2007.04.010; Pasquale K, 2003, LARYNGOSCOPE, V113, P139, DOI 10.1097/00005537-200301000-00026; Pastor AC, 2008, J PEDIATR SURG, V43, P1807, DOI 10.1016/j.jpedsurg.2008.04.003; Patikas D, 2006, ARCH PHYS MED REHAB, V87, P619, DOI 10.1016/j.apmr.2006.01.023; Pereira PL, 2003, J UROLOGY, V170, P1978, DOI 10.1097/01.ju.0000085667.05190.ad; Peter SDS, 2008, J PEDIATR SURG, V43, P981, DOI 10.1016/j.jpedsurg.2008.02.018; Petratos PB, 2002, J UROLOGY, V167, P677, DOI 10.1016/S0022-5347(01)69123-7; Pileggi FD, 2007, J PEDIATR SURG, V42, P1749, DOI 10.1016/j.jpedsurg.2007.05.035; Pittner DE, 2008, J PEDIATR ORTHOPED, V28, P250, DOI 10.1097/BPO.0b013e318164f8e7; Pizzuto MP, 2000, INT J PEDIATR OTORHI, V52, P239, DOI 10.1016/S0165-5876(00)00293-7; Plint AC, 2006, MED J AUSTRALIA, V185, P263, DOI 10.5694/j.1326-5377.2006.tb00557.x; Podkamenev VV, 2002, J PEDIATR SURG, V37, P727, DOI 10.1053/jpsu.2002.32264; Poetker DM, 2006, ARCH OTOLARYNGOL, V132, P1294, DOI 10.1001/archotol.132.12.1294; Polkki Tarja, 2008, J Pediatr Nurs, V23, P217, DOI 10.1016/j.pedn.2006.11.001; Ragab SM, 2005, OTOLARYNG HEAD NECK, V133, P961, DOI 10.1016/j.otohns.2005.07.037; Ramadan HH, 2001, ARCH OTOLARYNGOL, V127, P188, DOI 10.1001/archotol.127.2.188; Ramkumar S, 2006, J PLAST RECONSTR AES, V59, P969, DOI 10.1016/j.bjps.2006.01.011; Rebello G, 2009, J PEDIATR ORTHOPED, V29, P626, DOI 10.1097/BPO.0b013e3181b2ba1b; Rees CM, 2008, ANN SURG, V248, P44, DOI 10.1097/SLA.0b013e318176bf81; Reilly CW, 2009, J PEDIATR ORTHOPED, V29, P275, DOI 10.1097/BPO.0b013e31819bcd14; Rice HE, 2001, ARCH SURG-CHICAGO, V136, P1391, DOI 10.1001/archsurg.136.12.1391; Rodriguez RA, 2001, J THORAC CARDIOV SUR, V121, P3, DOI 10.1067/mtc.2001.111177; Rozzelle CJ, 2008, J NEUROSURG-PEDIATR, V2, P111, DOI 10.3171/PED/2008/2/8/111; Sakellaris G, 2004, J PEDIATR SURG, V39, P1400, DOI 10.1016/j.jpedsurg.2004.05.002; Sampaio ALL, 2007, INT J PEDIATR OTORHI, V71, P645, DOI 10.1016/j.ijporl.2006.12.016; Sarhan O, 2009, J UROLOGY, V182, P682, DOI 10.1016/j.juro.2009.04.034; Schulz KF, 2010, J CLIN EPIDEMIOL, V63, P834, DOI [10.1016/j.jclinepi.2010.02.005, 10.1016/j.ijsu.2011.09.004, 10.1186/1741-7015-8-18]; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Schwentner C, 2006, EUR UROL, V49, P388, DOI 10.1016/j.eururo.2005.11.015; Schwentner C, 2005, J UROLOGY, V173, P974, DOI 10.1097/01.ju.0000153562.07287.77; Shah UK, 2002, ARCH OTOLARYNGOL, V128, P672, DOI 10.1001/archotol.128.6.672; Sharma S, 2007, PEDIATR SURG INT, V23, P1215, DOI 10.1007/s00383-007-2008-5; Shehata EM, 2005, LARYNGOSCOPE, V115, P162, DOI 10.1097/01.mlg.0000150704.13204.20; Sidman JD, 2008, LARYNGOSCOPE, V118, P1765, DOI 10.1097/MLG.0b013e31817f18e7; Sinha M, 2006, PEDIATRICS, V117, P1162, DOI 10.1542/peds.2005-1100; Smith DP, 2004, J UROLOGY, V172, P1760, DOI 10.1097/01.ju.0000139830.42599.a6; Smith HAB, 2006, J THORAC CARDIOV SUR, V132, P58, DOI 10.1016/j.jtcvs.2006.02.012; Sobol SE, 2006, ARCH OTOLARYNGOL, V132, P270, DOI 10.1001/archotol.132.3.270; Sonmez K, 2002, J PEDIATR SURG, V37, P1313, DOI 10.1053/jpsu.2002.34997; Sonnappa S, 2006, AM J RESP CRIT CARE, V174, P221, DOI 10.1164/rccm.200601-027OC; St Peter SD, 2006, ANN SURG, V244, P363, DOI 10.1097/01.sla.0000234647.03466.27; St Peter SD, 2009, J PEDIATR SURG, V44, P106, DOI 10.1016/j.jpedsurg.2008.10.018; Stanislaw P, 2000, ARCH OTOLARYNGOL, V126, P845, DOI 10.1001/archotol.126.7.845; Stringer MD, 2007, J PEDIATR SURG, V42, P1324, DOI 10.1016/j.jpedsurg.2007.03.026; Sud A, 2008, INT ORTHOP, V32, P409, DOI 10.1007/s00264-007-0332-y; Tander B, 2003, PEDIATR SURG INT, V19, P548, DOI 10.1007/s00383-003-1029-y; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Temple RH, 2001, INT J PEDIATR OTORHI, V61, P195, DOI 10.1016/S0165-5876(01)00553-5; Testa B, 2001, LARYNGOSCOPE, V111, P1486, DOI 10.1097/00005537-200108000-00028; Thakur A, 2001, J PEDIATR SURG, V36, P1160, DOI 10.1053/jpsu.2001.25737; Tripuraneni KR, 2009, J PEDIATR ORTHOP B, V18, P93, DOI 10.1097/BPB.0b013e32832989ff; Tsai S, 2005, J PEDIATR SURG, V40, P263, DOI 10.1016/j.jpedsurg.2004.09.036; Upadhyaya VD, 2007, WORLD J SURG, V31, P2412, DOI 10.1007/s00268-007-9244-7; van den Ende ED, 2004, J PEDIATR SURG, V39, P1249, DOI 10.1016/j.jpedsurg.2004.04.013; Van Savage JG, 2000, J UROLOGY, V164, P981, DOI 10.1016/S0022-5347(05)67231-X; Venter M, 2007, BURNS, V33, P464, DOI 10.1016/j.burns.2006.08.008; Verhagen AP, 1998, J CLIN EPIDEMIOL, V51, P1235, DOI 10.1016/S0895-4356(98)00131-0; Vogt M, 2010, BJU INT, V105, P1456, DOI 10.1111/j.1464-410X.2009.08872.x; Waldhausen JH, 2002, J AM COLL SURGEONS, V194, P411, DOI 10.1016/S1072-7515(02)01113-4; Washington A Eugene, 2011, N Engl J Med, V365, pe31, DOI 10.1056/NEJMp1109407; Webb GR, 2006, J BONE JOINT SURG AM, V88A, P9, DOI 10.2106/JBJS.E.00131; Wei B, 2004, ANN THORAC SURG, V77, P918, DOI 10.1016/j.athoracsur.2003.09.072; Whitelaw A, 2007, PEDIATRICS, V119, pE1071, DOI 10.1542/peds.2006-2841; Wilson YL, 2009, LARYNGOSCOPE, V119, P162, DOI 10.1002/lary.20024; Wright JG, 2005, LANCET, V365, P1153, DOI 10.1016/S0140-6736(05)71878-X; Yang SSD, 2005, J UROLOGY, V173, P1361, DOI 10.1097/01.ju.0000156556.11235.3f; Yellin AE, 2007, AM J SURG, V194, P367, DOI 10.1016/j.amjsurg.2007.01.023; Yurtcu M, 2009, WORLD J GASTROENTERO, V15, P4919, DOI 10.3748/wjg.15.4919; Zeifang F, 2005, J BONE JOINT SURG BR, V87B, P1663, DOI 10.1302/0301-620X.87B12.16551; Zhu XL, 2001, CLIN THER, V23, P1281, DOI 10.1016/S0149-2918(01)80107-7; Zwick EB, 2009, CLIN ORTHOP RELAT R, V467, P2668, DOI 10.1007/s11999-009-0819-5	245	11	11	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1072-7515	1879-1190		J AM COLL SURGEONS	J. Am. Coll. Surg.	SEP	2013	217	3					394	+		10.1016/j.jamcollsurg.2013.03.032			13	Surgery	Surgery	213GK	WOS:000324043300003	23969114				2021-06-18	
J	Mounce, LTA; Williams, H; Jones, JM; Harris, A; Haslam, SA; Jetten, J				Mounce, Luke T. A.; Williams, Huw; Jones, Janelle M.; Harris, Adrian; Haslam, S. Alexander; Jetten, Jolanda			Neurogenic and Psychogenic Acute Postconcussion Symptoms Can Be Identified After Mild Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						concussion; emergency medicine; mild traumatic brain injury	POSTTRAUMATIC-STRESS-DISORDER; POST-CONCUSSION SYMPTOMS; ROAD TRAFFIC ACCIDENT; HEAD-INJURY; EMERGENCY; QUESTIONNAIRE; RELIABILITY; POPULATION; PREDICTION; COMPLAINTS	Objectives: As provenance of postconcussion symptoms after mild traumatic brain injury (mTBI) is controversial, with similar rates found in other populations, we aimed to identify postconcussion symptoms specific to mTBI compared with controls. We also compared differences between complicated and uncomplicated mTBIs. Setting: Hospital emergency department. Participants: Adult individuals (34 individuals with complicated mTBI, 76 individuals with uncomplicated mTBI, and 47 orthopedic controls) who sought care in the emergency department and were consecutively recruited by post at 2 weeks postinjury. Main Measures: Rivermead Postconcussion Symptom Questionnaire. Preinjury factors were used as covariates. Results: Compared with orthopedic controls, complicated mTBI group reported greater severity of headaches, dizziness, and nausea, as well as concentration difficulties, suggesting that these are neurogenic. Severity of other symptoms measured on the Rivermead Postconcussion Symptom Questionnaire was not significantly different between these groups, suggesting that these are psychogenic. Differences were evident between the 2 mTBI samples on the items of dizziness, nausea, fatigue, sleep disturbance, and concentration difficulties. Conclusions: Neurogenic and psychogenic postconcussion symptoms were identified at the acute-phase postinjury. Findings suggest that treating persons with mTBI as a homogenous sample is not prudent. This should inform prognostic models and follow-up support offered after leaving the emergency department.	[Mounce, Luke T. A.; Williams, Huw; Haslam, S. Alexander] Univ Exeter, Ctr Clin Neuropsychol Res, Exeter EX4 4QG, Devon, England; [Harris, Adrian] Royal Devon & Exeter Fdn Trust, Emergency Dept, Exeter, Devon, England; [Jones, Janelle M.; Jetten, Jolanda] Univ Queensland, Sch Psychol, Brisbane, Qld, Australia	Mounce, LTA (corresponding author), Univ Exeter, Dept Psychol, Coll Life & Environm Sci, Singer Labs, Perry Rd, Exeter EX4 4QG, Devon, England.	L.Mounce@exeter.ac.uk	Mounce, Luke/AAX-1911-2020; Jetten, Jolanda/H-3285-2014; Haslam, Alex/AAA-2512-2019	Mounce, Luke/0000-0002-6089-0661; Jetten, Jolanda/0000-0002-7588-5355; Haslam, Alex/0000-0001-9523-7921; williams, huw/0000-0003-0670-2620; Jones, Janelle/0000-0002-0910-2404	Economic and Social Research CouncilUK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)	This study was funded by The Economic and Social Research Council.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Bryant RA, 1999, J HEAD TRAUMA REHAB, V14, P588, DOI 10.1097/00001199-199912000-00007; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P727, DOI 10.1136/jnnp.73.6.727; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Ehlers A, 2000, BEHAV RES THER, V38, P319, DOI 10.1016/S0005-7967(99)00123-0; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Garden N, 2010, APPL NEUROPSYCHOL, V17, P1, DOI 10.1080/09084280903297495; Hessen E, 2008, BRAIN INJURY, V22, P39, DOI 10.1080/02699050701846179; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Iverson GL, 2006, BRAIN INJURY, V20, P1335, DOI 10.1080/02699050601082156; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; KRAUS JF, 1996, NEUROTRAUMA, P13; Lippa SM, 2010, J INT NEUROPSYCH SOC, V16, P856, DOI 10.1017/S1355617710000743; Mayou R, 2001, BRIT J PSYCHIAT, V179, P528, DOI 10.1192/bjp.179.6.528; Mayou RA, 2000, BRIT J PSYCHIAT, V177, P540, DOI 10.1192/bjp.177.6.540; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McLean SA, 2009, AM J EMERG MED, V27, P182, DOI 10.1016/j.ajem.2008.01.054; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Mickeviciene D, 2004, EUR J NEUROL, V11, P411, DOI 10.1111/j.1468-1331.2004.00816.x; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Stulemeijer M, 2006, J NEUROL, V253, P1041, DOI 10.1007/s00415-006-0156-5; Tellier A, 1999, BRAIN INJURY, V13, P463; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; Williams WH, 2010, J NEUROL NEUROSUR PS, V81, P1116, DOI 10.1136/jnnp.2008.171298; Yates PJ, 2006, J NEUROL NEUROSUR PS, V77, P699, DOI 10.1136/jnnp.2005.081901	30	11	11	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2013	28	5					397	405		10.1097/HTR.0b013e318252dd75			9	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	298ZU	WOS:000330364600087	22691962				2021-06-18	
J	Leung, YY; Lee, TCP; Ho, SMY; Cheung, LK				Leung, Yiu Yan; Lee, Terence Chak Pui; Ho, Samuel Mun Yin; Cheung, Lim Kwong			Trigeminal Neurosensory Deficit and Patient Reported Outcome Measures: The Effect on Life Satisfaction and Depression Symptoms	PLOS ONE			English	Article							SPINAL-CORD-INJURY; TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; SCALE; SURGERY	Objectives: To investigate the effect of persistent neurosensory disturbance of the lingual nerve (LN) or inferior alveolar nerve (IAN) on life satisfaction and depression symptoms. Methods: This study recruited patients with persistent LN or IAN deficit as a consequence of lower third molar surgery for 12 months or more to form the study group. A control group was formed by matching age and gender of recruited subjects in the study group with patients without the neurosensory complications. Life satisfaction was assessed with Satisfaction With Life Scale (SWLS) and depression symptoms were assessed with 20-item Center for Epidemiological Studies Depression scale (CESD-20). Results: Fourty-eight participants (24 cases and 24 controls) were recruited. Patients with LN or IAN deficits after lower third molar surgery were less satisfied with their lives when compared to the control group (p<0.001). They were presenting with more depression symptoms (p = 0.001). 45.8% of the study group subjects had a CESD-20 score of 16 or above. Older patients presented with more depression symptoms among the subjects with neurosensory disturbance after lower third molar surgery (p = 0.02). Conclusions: Individuals with permanent trigeminal neurosensory deficit after lower third molar surgery have worse life satisfaction and more depressive symptoms when compared to those who did not suffer from the surgical complication.	[Leung, Yiu Yan; Cheung, Lim Kwong] Univ Hong Kong, Fac Dent, Hong Kong, Hong Kong, Peoples R China; [Lee, Terence Chak Pui] Hong Kong Baptist Univ, Fac Social Sci, Psychol Unit, Hong Kong, Hong Kong, Peoples R China; [Ho, Samuel Mun Yin] City Univ Hong Kong, Dept Appl Social Studies, Hong Kong, Hong Kong, Peoples R China	Leung, YY (corresponding author), Univ Hong Kong, Fac Dent, Hong Kong, Hong Kong, Peoples R China.	mikeyyleung@hku.hk	Ho, Samuel M.Y. M.Y./D-2454-2014	Ho, Samuel M.Y. M.Y./0000-0001-7803-1657; /0000-0001-7038-3279; Cheung, Lim Kwong/0000-0002-2248-286X			American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Arrindell WA, 1999, PERS INDIV DIFFER, V26, P815, DOI 10.1016/S0191-8869(98)00180-9; BLAIS MR, 1989, CAN J BEHAV SCI, V21, P210, DOI 10.1037/h0079854; Bombardier CH, 2012, ARCH PHYS MED REHAB, V93, P775, DOI 10.1016/j.apmr.2011.12.020; Cheng ST, 2005, INT J GERIATR PSYCH, V20, P465, DOI 10.1002/gps.1314; Cheung LK, 2010, INT J ORAL MAX SURG, V39, P320, DOI 10.1016/j.ijom.2009.11.010; Davis LC, 2012, ARCH PHYS MED REHAB, V93, P1324, DOI 10.1016/j.apmr.2012.02.036; DIENER E, 1984, PSYCHOL BULL, V95, P542, DOI 10.1037/0033-2909.95.3.542; Ferrus-Torres E, 2011, J ORAL MAXIL SURG, V69, P54, DOI 10.1016/j.joms.2010.05.036; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; Jacobsson LJ, 2010, BRAIN INJURY, V24, P1075, DOI 10.3109/02699052.2010.494590; Khanna D, 2011, ARTHRIT CARE RES, V63, pS486, DOI 10.1002/acr.20581; Latoo J, 2012, BRIT J HOSP MED, V73, P331, DOI 10.12968/hmed.2012.73.6.331; Leung YY, PLOS ONE UNPUB; PAVOT W, 1991, J PERS ASSESS, V57, P149, DOI 10.1207/s15327752jpa5701_17; Pavot W., 1993, PSYCHOL ASSESSMENT, V5, P164, DOI DOI 10.1037/1040-3590.5.2.164; Post MW, 2012, ARCH PHYS MED REHAB, V93, P1832, DOI 10.1016/j.apmr.2012.03.025; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Saveanu RV, 2012, PSYCHIAT CLIN N AM, V35, P51, DOI 10.1016/j.psc.2011.12.001; SHIN DC, 1978, SOC INDIC RES, V5, P475, DOI 10.1007/BF00352944; Tonack M, 2008, SPINAL CORD, V46, P380, DOI 10.1038/sj.sc.3102088	21	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72891	10.1371/journal.pone.0072891			6	Multidisciplinary Sciences	Science & Technology - Other Topics	209DO	WOS:000323734600041	24009712	DOAJ Gold, Green Published			2021-06-18	
J	Dean, PJA; Otaduy, MCG; Harris, LM; McNamara, A; Seiss, E; Sterr, A				Dean, Philip J. A.; Otaduy, Maria C. G.; Harris, Lisa M.; McNamara, Adam; Seiss, Ellen; Sterr, Annette			Monitoring long-term effects of mild traumatic brain injury with magnetic resonance spectroscopy: a pilot study	NEUROREPORT			English	Article						cognitive tasks; creatine; magnetic resonance spectroscopy; mild traumatic brain injury; persistent postconcussion syndrome	PROTON MR SPECTROSCOPY; CREATINE	This pilot study explores the metabolic changes associated with persistent postconcussion syndrome (PCS) after mild traumatic brain injury (mTBI; >12 months after injury) using magnetic resonance spectroscopy. We hypothesized that those mTBI participants with PCS will have larger metabolic differences than those without. Data were collected from mTBI participants with PCS, mTBI participants without PCS and non-head-injured participants (all groups: n=8). Magnetic resonance spectroscopy metabolite profiles within the dorsolateral prefrontal cortex showed a reduced creatine/choline ratio in mTBI patients compared with control participants. This data provides initial evidence for residual metabolic changes in chronic mTBI patients, but there was no conclusive relationship between these metabolic changes and PCS symptom report. Creatine is involved in maintaining energy levels in cells with high or fluctuating energy demand, suggesting that there may be some residual energy impairment in chronic mTBI.	[Dean, Philip J. A.; Harris, Lisa M.; McNamara, Adam; Seiss, Ellen; Sterr, Annette] Univ Surrey, Dept Psychol, Guildford GU2 7XH, Surrey, England; [Otaduy, Maria C. G.] Univ Sao Paulo FM USP, Sch Med, Dept Radiol, Lab Med Invest LIM 44, Sao Paulo, Brazil	Dean, PJA (corresponding author), Univ Surrey, Dept Psychol, Guildford GU2 7XH, Surrey, England.	p.dean@surrey.ac.uk	Otaduy, Maria/AAV-6070-2020; Seiss, Ellen/Y-6216-2019	Otaduy, Maria/0000-0003-2515-1131; Dean, Philip/0000-0002-2362-513X	Wingate Foundation Scholarship, UK	This work was supported by a Wingate Foundation Scholarship, UK.	Andres RH, 2008, BRAIN RES BULL, V76, P329, DOI 10.1016/j.brainresbull.2008.02.035; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Cohen BA, 2007, AM J NEURORADIOL, V28, P907; Dean PJA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00030; Dean PJA, 2012, BRAIN INJURY, V26, P14, DOI 10.3109/02699052.2011.635354; Friedman SD, 1998, AM J NEURORADIOL, V19, P1879; Garnett MR, 2000, BRAIN, V123, P2046, DOI 10.1093/brain/123.10.2046; Garnett MR, 2001, J NEUROTRAUM, V18, P231, DOI 10.1089/08977150151070838; Gasparovic C, 2009, J NEUROTRAUM, V26, P1635, DOI [10.1089/neu.2009.0896, 10.1089/neu.2009-0896]; Giza CC, 2001, J ATHL TRAINING, V36, P228; Govindaraju V, 2004, AM J NEURORADIOL, V25, P730; Haga KK, 2009, NEUROBIOL AGING, V30, P353, DOI 10.1016/j.neurobiolaging.2007.07.005; Hattingen E, 2008, NEURORADIOLOGY, V50, P759, DOI 10.1007/s00234-008-0409-3; Kirov I, 2007, BRAIN INJURY, V21, P1147, DOI 10.1080/02699050701630383; Lin AP, 2012, BRAIN IMAGING BEHAV, V6, P208, DOI 10.1007/s11682-012-9181-4; Maniega SM, 2008, STROKE, V39, P2467, DOI 10.1161/STROKEAHA.107.507020; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; Mittenberg W, 2000, J HEAD TRAUMA REHAB, V15, P783, DOI 10.1097/00001199-200004000-00003; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Sakellaris G, 2008, ACTA PAEDIATR, V97, P31, DOI 10.1111/j.1651-2227.2007.00529.x; Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; Sullivan PG, 2000, ANN NEUROL, V48, P723, DOI 10.1002/1531-8249(200011)48:5&lt;723::AID-ANA5&gt;3.0.CO;2-W; World Health Organization, 1992, ICD 10 INT STAT CLAS; Wyss M, 2000, PHYSIOL REV, V80, P1107	25	11	11	0	19	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0959-4965	1473-558X		NEUROREPORT	Neuroreport	AUG 21	2013	24	12					677	681		10.1097/WNR.0b013e3283637aa4			5	Neurosciences	Neurosciences & Neurology	202OE	WOS:000323226300007	23820737	Green Accepted			2021-06-18	
J	Moon, Y; Kim, JY; Kim, WR; Kim, HJ; Jang, MJ; Nam, Y; Kim, K; Kim, H; Sun, W				Moon, Younghye; Kim, Joo Yeon; Kim, Woon Ryoung; Kim, Hyun Jung; Jang, Min Jee; Nam, Yoonkey; Kim, Kyungjin; Kim, Hyun; Sun, Woong			Function of Ezrin-Radixin-Moesin Proteins in Migration of Subventricular Zone-Derived Neuroblasts Following Traumatic Brain Injury	STEM CELLS			English	Article						ERM proteins; Phosphorylation; SDF1-CXCR4; Migration; Brain injury	NEURAL PROGENITOR CELLS; ERM PROTEINS; OLFACTORY-BULB; NEURONAL PRECURSORS; DIRECTED MIGRATION; CEREBRAL-CORTEX; ADULT BRAIN; STEM-CELLS; ACTIVATION; GROWTH	Throughout life, newly generated neuroblasts from the subventricular zone migrate toward the olfactory bulb through the rostral migratory stream. Upon brain injury, these migrating neuroblasts change their route and begin to migrate toward injured regions, which is one of the regenerative responses after brain damage. This injury-induced migration is triggered by stromal cell-derived factor 1 (SDF1) released from microglia near the damaged site; however, it is still unclear how these cells transduce SDF1 signals and change their direction. In this study, we found that SDF1 promotes the phosphorylation of ezrin-radixin-moesin (ERM) proteins, which are key molecules in organizing cell membrane and linking signals from the extracellular environment to the intracellular actin cytoskeleton. Blockade of ERM activation by overexpressing dominant-negative ERM (DN-ERM) efficiently perturbed the migration of neuroblasts. Considering that DN-ERM-expressing neuroblasts failed to maintain proper migratory cell morphology, it appears that ERM-dependent regulation of cell shape is required for the efficient migration of neuroblasts. These results suggest that ERM activation is an important step in the directional migration of neuroblasts in response to SDF1-CXCR4 signaling following brain injury. STEM CELLS 2013;31:1696-1705	[Moon, Younghye; Kim, Joo Yeon; Kim, Woon Ryoung; Kim, Hyun Jung; Kim, Hyun; Sun, Woong] Korea Univ, Coll Med, Dept Anat, Seoul 136705, South Korea; [Moon, Younghye; Kim, Joo Yeon; Kim, Woon Ryoung; Kim, Hyun Jung; Kim, Hyun; Sun, Woong] Korea Univ, Coll Med, Div Brain Korea Biomed Sci 21, Seoul 136705, South Korea; [Moon, Younghye; Kim, Kyungjin] Seoul Natl Univ, Coll Nat Sci, Sch Biol Sci, Brain & Neuroendocrine Lab, Seoul 151742, South Korea; [Jang, Min Jee; Nam, Yoonkey] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Taejon 305701, South Korea	Sun, W (corresponding author), Korea Univ, Coll Med, Dept Anat, Seoul 136705, South Korea.	woongsun@korea.ac.kr	Jang, Min Jee/F-1083-2014; Nam, Yoonkey/C-1662-2011; Jang, Min Jee/AAO-2892-2020	Nam, Yoonkey/0000-0003-4801-9547; Moon, Younghye/0000-0002-3737-0043	Korean Ministry of Education, Science and Technology, via the Brain Research Center of the 21st Century Frontier Program in Neuroscience [2012K001108]; National Research Foundation of KoreaNational Research Foundation of Korea [20120006433, 20120005815, 2012049933, 2012014385]	This work was supported by grants from the Korean Ministry of Education, Science and Technology, via the Brain Research Center of the 21st Century Frontier Program in Neuroscience (2012K001108) and the National Research Foundation of Korea (20120006433, 20120005815, 2012049933, and 2012014385).	Alonso G, 2001, GLIA, V34, P253, DOI 10.1002/glia.1059; Antoine-Bertrand J, 2011, MOL BIOL CELL, V22, P3734, DOI 10.1091/mbc.E10-11-0917; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Barkho BZ, 2008, STEM CELLS, V26, P3139, DOI 10.1634/stemcells.2008-0519; Belvindrah R, 2011, J NEUROSCI, V31, P7551, DOI 10.1523/JNEUROSCI.6716-10.2011; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Chiaramello S, 2007, EUR J NEUROSCI, V26, P1780, DOI 10.1111/j.1460-9568.2007.05818.x; CLARK P, 1993, J CELL SCI, V105, P203; Cleary MA, 2006, NEUROSCIENCE, V143, P851, DOI 10.1016/j.neuroscience.2006.08.028; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; de Rouvroit CL, 2001, MECH DEVELOP, V105, P47, DOI 10.1016/S0925-4773(01)00396-3; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Fievet BT, 2004, J CELL BIOL, V164, P653, DOI 10.1083/jcb.200307032; Gatto CL, 2007, J CELL PHYSIOL, V210, P122, DOI 10.1002/jcp.20844; Gatto CL, 2003, J CELL BIOL, V162, P489, DOI 10.1083/jcb.200303039; Goings GE, 2004, BRAIN RES, V996, P213, DOI 10.1016/j.brainres.2003.10.034; Haas MA, 2007, J NEUROSCI RES, V85, P34, DOI 10.1002/jnr.21102; Hao JJ, 2009, J CELL BIOL, V184, P451, DOI 10.1083/jcb.200807047; Hill WD, 2004, J NEUROPATH EXP NEUR, V63, P84, DOI 10.1093/jnen/63.1.84; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; Jang MJ, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/4/046019; Jin K, 2003, MOL CELL NEUROSCI, V24, P171, DOI 10.1016/S1044-7431(03)00159-3; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kim WR, 2011, EUR J NEUROSCI, V33, P599, DOI 10.1111/j.1460-9568.2010.07557.x; Koizumi H, 2006, NAT NEUROSCI, V9, P779, DOI 10.1038/nn1704; Kojima T, 2010, STEM CELLS, V28, P545, DOI 10.1002/stem.306; Kokovay E, 2010, CELL STEM CELL, V7, P163, DOI 10.1016/j.stem.2010.05.019; Lee JH, 2004, J CELL BIOL, V167, P327, DOI 10.1083/jcb.200403091; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; Mackay DJG, 1997, J CELL BIOL, V138, P927, DOI 10.1083/jcb.138.4.927; MARTIN M, 1995, J CELL BIOL, V128, P1081, DOI 10.1083/jcb.128.6.1081; Mintz CD, 2008, J COMP NEUROL, V510, P351, DOI 10.1002/cne.21799; Moon Y, 2013, HISTOCHEM CELL BIOL, V139, P403, DOI 10.1007/s00418-012-1048-7; Moon Y, 2011, NEUROREPORT, V22, P304, DOI 10.1097/WNR.0b013e3283460265; Nam SC, 2007, J COMP NEUROL, V505, P190, DOI 10.1002/cne.21473; Neisch AL, 2011, CURR OPIN CELL BIOL, V23, P377, DOI 10.1016/j.ceb.2011.04.011; Nguyen-Ba-Charvet KT, 2004, J NEUROSCI, V24, P1497, DOI 10.1523/JNEUROSCI.4729-03.2004; Niggli V, 2008, INT J BIOCHEM CELL B, V40, P344, DOI 10.1016/j.biocel.2007.02.012; Ohab JJ, 2006, J NEUROSCI, V26, P13007, DOI 10.1523/JNEUROSCI.4323-06.2006; Osman AM, 2011, STROKE, V42, P3559, DOI 10.1161/STROKEAHA.111.627802; Oudin MJ, 2011, J NEUROSCI, V31, P4000, DOI 10.1523/JNEUROSCI.5483-10.2011; Parent JM, 2002, J NEUROSCI, V22, P3174, DOI 10.1523/JNEUROSCI.22-08-03174.2002; Peng H, 2004, J NEUROSCI RES, V76, P35, DOI 10.1002/jnr.20045; Persson A, 2010, NEUROSCIENCE, V167, P312, DOI 10.1016/j.neuroscience.2010.01.035; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Prag S, 2007, MOL BIOL CELL, V18, P2935, DOI 10.1091/mbc.E06-11-1031; Ramaswamy S, 2005, BRAIN RES, V1053, P38, DOI 10.1016/j.brainres.2005.06.042; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Robin AM, 2006, J CEREBR BLOOD F MET, V26, P125, DOI 10.1038/sj.jcbfm.9600172; Schlatter MC, 2008, J NEUROCHEM, V104, P731, DOI 10.1111/j.1471-4159.2007.05013.x; Shiue H, 2005, J BIOL CHEM, V280, P1688, DOI 10.1074/jbc.M409471200; Speck O, 2003, NATURE, V421, P83, DOI 10.1038/nature01295; Sun W, 2004, J NEUROSCI, V24, P11205, DOI 10.1523/JNEUROSCI.1436-04.2004; Thored P, 2006, STEM CELLS, V24, P739, DOI 10.1634/stemcells.2005-0281; Tran PB, 2004, J NEUROSCI RES, V76, P20, DOI 10.1002/jnr.20001; Wang K, 2004, BRAIN RES, V1024, P193, DOI 10.1016/j.brainres.2004.07.086; Yamashita T, 2006, J NEUROSCI, V26, P6627, DOI 10.1523/JNEUROSCI.0149-06.2006; Zhang RL, 2009, J CEREBR BLOOD F MET, V29, P1240, DOI 10.1038/jcbfm.2009.55; Zhou BB, 2010, LEUKEMIA RES, V34, P769, DOI 10.1016/j.leukres.2009.11.025	60	11	11	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1066-5099	1549-4918		STEM CELLS	Stem Cells	AUG	2013	31	8					1696	1705		10.1002/stem.1420			10	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Oncology; Cell Biology; Hematology	Cell Biology; Biotechnology & Applied Microbiology; Oncology; Hematology	205CM	WOS:000323418700022	23649635	Bronze			2021-06-18	
J	Roscigno, CI; Savage, TA; Grant, G; Philipsen, G				Roscigno, Cecelia I.; Savage, Teresa A.; Grant, Gerald; Philipsen, Gerry			How healthcare provider talk with parents of children following severe traumatic brain injury is perceived in early acute care	SOCIAL SCIENCE & MEDICINE			English	Article						United States; Place; Provider-parent interaction; Communication; Culture; Severe traumatic brain injury; Ethnography of speaking	DECISION-MAKING; COMMUNICATION; UNIT; PREDICTORS; DOCTORS; PLACE; VIEWS; TRUST	Healthcare provider talk with parents in early acute care following children's severe traumatic brain injury (TBI) affects parents' orientations to these locales, but this connection has been minimally studied. This lack of attention to this topic in previous research may reflect providers' and researchers' views that these locales are generally neutral or supportive to parents' subsequent needs. This secondary analysis used data from a larger descriptive phenomenological study (2005-2007) with parents of children following moderate to severe TBI recruited from across the United States. Parents of children with severe TBI consistently had strong negative responses to the early acute care talk processes they experienced with providers, while parents of children with moderate TBI did not. Transcript data were independently coded using discourse analysis in the framework of ethnography of speaking. The purpose was to understand the linguistic and paralinguistic talk factors parents used in their meta-communications that could give a preliminary understanding of their cultural expectations for early acute care talk in these settings. Final participants included 27 parents of children with severe TBI from 23 families. We found the human constructed talk factors that parents reacted to were: a) access to the child, which is where information was; b) regular discussions with key personnel; c) updated information that is explained; d) differing expectations for talk in this context; and, e) perceived parental involvement in decisions. We found that the organization and nature of providers' talk with parents was perceived by parents to positively or negatively shape their early acute care identities in these locales, which influenced how they viewed these locales as places that either supported them and decreased their workload or discounted them and increased their workload for getting what they needed. (c) 2013 Elsevier Ltd. All rights reserved.	[Roscigno, Cecelia I.; Savage, Teresa A.] Univ Illinois, Coll Nursing, Chicago, IL USA; [Grant, Gerald] Duke Univ, Med Ctr, Dept Neurosurg, Durham, NC USA; [Philipsen, Gerry] Univ Washington, Dept Commun, Seattle, WA 98195 USA	Roscigno, CI (corresponding author), Univ N Carolina, Sch Nursing, Carrington Hall,CB 7460, Chapel Hill, NC 27599 USA.	croscign@email.unc.edu			Irving B. Harris Foundation Faculty Scholars Initiative at the College of Nursing, University of Illinois at Chicago; National Institutes of Nursing Research postdoctoral fellowship Interventions for Preventing and Managing Chronic Illness [5T32NR007091-17]; NINR Ruth L. Kirschstein Predoctoral Research Fellowship [1 F31 NR009599-02]; Psi Chapter of Sigma Theta Tau Grant; American Nurses Foundation Martha E. Brill Scholars Award; University of Washington School of Nursing Hester McLaws Scholarship Fund; University of Washington LEND Training Grant [6 T73 MC 00041-11-03]; University of Washington Gatzert Child Welfare Fellowship; Integra Lifesciences Grant; Society of Pediatric Nurses; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [F31NR009599, T32NR007091] Funding Source: NIH RePORTER	The authors disclosed receipt of the following financial support for the research, training, or authorship of this article: This secondary analysis was funded by the Society of Pediatric Nurses. The first author's training during the analysis was funded by the Irving B. Harris Foundation Faculty Scholars Initiative at the College of Nursing, University of Illinois at Chicago (PI: R. White-Traut, PhD), and the authorship of the manuscript was funded by a National Institutes of Nursing Research postdoctoral fellowship Interventions for Preventing and Managing Chronic Illness (5T32NR007091-17; PI: M. Mishel, PhD).; The original research study and training was funded by an NINR Ruth L. Kirschstein Predoctoral Research Fellowship (1 F31 NR009599-02); a Psi Chapter of Sigma Theta Tau Grant; a 2006 American Nurses Foundation Martha E. Brill Scholars Award; a University of Washington School of Nursing Hester McLaws Scholarship Fund; a University of Washington LEND Training Grant (TG # 6 T73 MC 00041-11-03); a University of Washington Gatzert Child Welfare Fellowship; and an Integra Lifesciences Grant. The contents of this manuscript are solely the responsibility of the authors and do not necessarily represent the official views of any of the funders.	Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; Basso K. H., 1996, WISDOM SITS PLACES L; Berger CR, 2005, J COMMUN, V55, P415, DOI 10.1111/j.1460-2466.2005.tb02680.x; Boos Virginia D, 2010, Adv Neonatal Care, V10, P301, DOI 10.1097/ANC.0b013e3181f36e4c; BOURHIS RY, 1989, SOC SCI MED, V28, P339, DOI 10.1016/0277-9536(89)90035-X; Bronner MB, 2010, J PEDIATR PSYCHOL, V35, P966, DOI 10.1093/jpepsy/jsq004; Collins S, 2005, SOC SCI MED, V61, P2611, DOI 10.1016/j.socscimed.2005.04.047; Conway J., 2006, PARTNERING PATIENTS; Coulter A, 2002, BRIT MED J, V325, P668, DOI 10.1136/bmj.325.7366.668; Cummins S, 2007, SOC SCI MED, V65, P1825, DOI 10.1016/j.socscimed.2007.05.036; DeLemos D, 2010, PEDIATR CRIT CARE ME, V11, P378, DOI 10.1097/PCC.0b013e3181b8088b; Edwards D, 2000, RES LANG SOC INTERAC, V33, P347, DOI 10.1207/S15327973RLSI3304_01; Gillotti C, 2002, SOC SCI MED, V54, P1011, DOI 10.1016/S0277-9536(01)00073-9; Gordon Cynthia, 2009, Commun Med, V6, P177; Gustafson P, 2001, J ENVIRON PSYCHOL, V21, P5, DOI 10.1006/jevp.2000.0185; Hoonakker P., 2008, HUMAN FACTORS ORG DE, P715; Hymes D. H., 1972, DIRECTIONS SOCIOLING, P35; *I MED, 2001, CROSS QUAL CHASM NEW; Jee RA, 2012, PEDIATR CRIT CARE ME, V13, pE166, DOI 10.1097/PCC.0b013e31823893ad; Karnieli-Miller O, 2009, SOC SCI MED, V69, P1, DOI 10.1016/j.socscimed.2009.04.030; Kearns R. A., 1998, PUTTING HLTH PLACE L; Madrigal VN, 2012, CRIT CARE MED, V40, P2876, DOI 10.1097/CCM.0b013e31825b9151; Meadors P, 2008, J PEDIATR HEALTH CAR, V22, P24, DOI 10.1016/j.pedhc.2007.01.006; ONG LML, 1995, SOC SCI MED, V40, P903, DOI 10.1016/0277-9536(94)00155-M; Patton M.Q., 2002, QUALITATIVE RES EVAL; Philipsen G, 2005, LEA COMMUN SER, P355; Philipsen G., 2005, THEORIZING INTERCULT, P55; Potter J., 2004, HDB DATA ANAL, DOI [10.4135/9781848608184.n27, DOI 10.4135/9781848608184.N27]; Revenson T. A., 2012, HDB HLTH PSYCHOL, P193; Roscigno CI, 2012, QUAL HEALTH RES, V22, P1232, DOI 10.1177/1049732312449210; Roscigno CI, 2011, QUAL HEALTH RES, V21, P1413, DOI 10.1177/1049732311410988; Thorne S, 1993, NEGOTIATING HLTH CAR; Ularntinon S, 2010, CURR PSYCHIATRY REV, V6, P261, DOI 10.2174/157340010793499422	33	11	12	0	12	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0277-9536			SOC SCI MED	Soc. Sci. Med.	AUG	2013	90						32	39		10.1016/j.socscimed.2013.04.017			8	Public, Environmental & Occupational Health; Social Sciences, Biomedical	Public, Environmental & Occupational Health; Biomedical Social Sciences	174RX	WOS:000321174200004	23746606	Green Accepted			2021-06-18	
J	Smith, HL; Chrischilles, E; Janus, TJ; Sidwell, RA; Ramirez, M; Peek-Asa, C; Sahr, SM				Smith, Hayden L.; Chrischilles, Elizabeth; Janus, Todd J.; Sidwell, Richard A.; Ramirez, Marizen; Peek-Asa, Corinne; Sahr, Sheryl M.			Clinical indicators of midface fracture in patients with trauma	DENTAL TRAUMATOLOGY			English	Article						diagnosis; etiology; examination; soft tissue; trauma; midface	FACIAL FRACTURES; CONCOMITANT INJURIES; COMPUTED-TOMOGRAPHY; RISK-FACTORS; HEAD; SCALE; SCANS; CARE	Background/Aim: Midface fractures are commonly present and difficult to diagnose in trauma patients. The objective of this study was to determine clinically accessible indicators of midface fracture. Material and Methods: A case-control study design was used to determine clinical indicators of midface fracture. Population source was a level I trauma center registry for years 2007-2009. Cases had a documented midface fracture. Patient and trauma characteristics were compared between cases and controls. Multivariate logistic regression analysis determined significant indicators of midface fracture. Results: Study sample included 83 cases and 83 frequency-matched controls. Cases had a total of 211 fractures with a median of two midface fractures per person. Common fractures were orbital (41%), malar and maxillary (28%), and nasal bones (19%). Patients with midface fracture were significantly different than patients without midface fracture in severity of injury and were more likely to have a traumatic brain injury. Significant clinical indicators of fracture were maxillary sinus opacification, ethmoid sinus opacification, forehead laceration, periorbital contusion, epistaxis, and injury mechanism (P < 0.05). Patients with midface fracture had a 63 times greater odds for maxillary sinus opacification. The multivariable model correctly classified the presence and absence of midface fracture in 95% of study sample. Conclusions: Determined indicators of midface fracture provided a high level of discrimination in fracture status. Indicators can be used by clinicians to help detect possible midface fractures. Future prospective research on midface fracture indicators can assist in establishing their generalizability and impact on fracture detection, care, and outcomes.	[Smith, Hayden L.; Janus, Todd J.; Sidwell, Richard A.; Sahr, Sheryl M.] Iowa Methodist Med Ctr, Des Moines, IA 50309 USA; [Chrischilles, Elizabeth; Ramirez, Marizen; Peek-Asa, Corinne] Univ Iowa, Iowa City, IA USA	Smith, HL (corresponding author), Iowa Methodist Med Ctr, Med Educ Serv, 1415 Woodland Ave,Suite 140, Des Moines, IA 50309 USA.	smithhl@ihs.org		Chrischilles, Elizabeth/0000-0002-1843-1955			Adkinson JM, 2011, ANN PLAS SURG, V66, P472, DOI 10.1097/SAP.0b013e318214532c; Alvi A, 2003, LARYNGOSCOPE, V113, P102, DOI 10.1097/00005537-200301000-00019; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; Brant WE, 2007, FUNDAMENTALS DIAGNOS, P1559; BUCHANAN RT, 1983, PLAST RECONSTR SURG, V71, P768, DOI 10.1097/00006534-198306000-00003; Burkitt HG., 2007, ESSENTIAL SURG PROBL; Daffner R H, 1997, Curr Probl Diagn Radiol, V26, P153; DOLAN KD, 1978, SEMIN ROENTGENOL, V13, P37, DOI 10.1016/S0037-198X(78)80017-0; ELLIS E, 1985, J ORAL MAXIL SURG, V43, P417, DOI 10.1016/S0278-2391(85)80049-5; Gassner R, 2003, J CRANIO MAXILL SURG, V31, P51, DOI 10.1016/S1010-5182(02)00168-3; Gennarelli TA, 2006, INJURY, V37, P1083, DOI 10.1016/j.injury.2006.07.009; Gonen M., 2007, ANAL RECEIVER OPERAT; Harrel F.E., 2001, REGRESSION MODELING; HAUG RH, 1990, J ORAL MAXIL SURG, V48, P926, DOI 10.1016/0278-2391(90)90004-L; Hohlrieder M, 2003, INTENS CARE MED, V29, P1095, DOI 10.1007/s00134-003-1804-1; Holmgren EP, 2004, J ORAL MAXIL SURG, V62, P913, DOI 10.1016/j.joms.2003.12.026; Laine F J, 1993, Curr Probl Diagn Radiol, V22, P145; Marinaro J, 2007, AM J EMERG MED, V25, P616, DOI 10.1016/j.ajem.2006.11.029; McAuley Clyde E., 1992, Journal of Trauma, V33, P948; McMullin BT, 2009, ARCH FACIAL PLAST S, V11, P165, DOI 10.1001/archfacial.2009.11; MOILANEN A, 1987, INT J ORAL MAX SURG, V16, P572, DOI 10.1016/S0901-5027(87)80108-X; Raby N, 1998, CLIN RADIOL, V53, P218, DOI 10.1016/S0009-9260(98)80105-0; REHM CG, 1995, J ORAL MAXIL SURG, V53, P522, DOI 10.1016/0278-2391(95)90063-2; Leles JLR, 2010, J APPL ORAL SCI, V18, P23, DOI 10.1590/S1678-77572010000100006; SCHERER M, 1989, J TRAUMA, V29, P388, DOI 10.1097/00005373-198903000-00020; Shapiro AJ, 2001, INJURY, V32, P353, DOI 10.1016/S0020-1383(00)00245-X; SHOCKLEY WW, 1988, LARYNGOSCOPE, V98, P18; Smith Hayden, 2012, J Trauma Nurs, V19, P57, DOI 10.1097/JTN.0b013e31823a4c0e; TEASDALE G, 1974, LANCET, V2, P81; University Of Washington. Department of Radiology, 2007, MUSC RAD FAC MAND FR	31	11	12	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1600-4469	1600-9657		DENT TRAUMATOL	Dent. Traumatol.	AUG	2013	29	4					313	318		10.1111/edt.12006			6	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	178GO	WOS:000321433900010	23067335				2021-06-18	
J	Soehle, M; Gies, B; Smielewski, P; Czosnyka, M				Soehle, Martin; Gies, Bernadette; Smielewski, Peter; Czosnyka, Marek			Reduced complexity of intracranial pressure observed in short time series of intracranial hypertension following traumatic brain injury in adults	JOURNAL OF CLINICAL MONITORING AND COMPUTING			English	Article; Proceedings Paper	SCAI 10th International Conference on Complexity in Acute Illness (ICCAI)	SEP, 2011	Bonn, GERMANY	Soc Complex Acute Illness (SCAI)		Intracranial pressure; Traumatic brain injury; Detrended fluctuation analysis; Scaling exponent; Sample entropy; Multiscale entropy	HEART-RATE-VARIABILITY; ARTERIAL-BLOOD PRESSURE; APPROXIMATE ENTROPY; PHYSIOLOGICAL SIGNALS; SAMPLE ENTROPY; MORTALITY; DYNAMICS; FAILURE; DISEASE; SYSTEM	Physiological parameters, such as intracranial pressure (ICP), are regulated by interconnected feedback loops, resulting in a complex time course. According to the decomplexification theory, disease is characterised by a loss of feedback loops resulting in a reduced complexity of the time course of physiological parameters. We hypothesized that complexity of the ICP time series is decreased during periods of intracranial hypertension (IHT) following adult traumatic brain injury. In an observational retrospective cohort study, ICP was continuously monitored using intraparenchymally implanted probes and stored using ICM + -software. Periods of IHT (ICP > 25 mmHg for at least 1,024 s), were compared with preceding periods of intracranial normotension (ICP < 20 mmHg) and analysed at 1 s-intervals. ICP data (length = 1,024 s) were normalised (mean = 0, SD = 1) and complexity was estimated using the scaling exponent alpha (as derived from detrended fluctuation analysis), sample entropy (SampEn, m = 1, r = 0.2 x SD) and multiscale entropy. 344 episodes were analysed in 22 patients. During IHT (ICP = 31.7 +/- A 7.8 mmHg, mean +/- A SD), alpha was significantly elevated (alpha A = 1.02 +/- A 0.22, p < 0.001) and SampEn significantly reduced (SampEn = 1.45 +/- A 0.46, p = 0.004) as compared to before IHT (ICP = 15.7 +/- A 3.2 mmHg, alpha = 0.81 +/- A 0.14, SampEn = 1.81 +/- A 0.24). In addition, MSE revealed a significantly (p < 0.05) decreased entropy at scaling factors ranging from 1 to 10. Both the increase in alpha as well as the decrease in SampEn and MSE indicate a loss of ICP complexity. Therefore following traumatic brain injury, periods of IHT seem to be characterised by a decreased complexity of the ICP waveform.	[Soehle, Martin; Gies, Bernadette] Univ Bonn, Dept Anaesthesiol & Intens Care Med, D-53105 Bonn, Germany; [Smielewski, Peter; Czosnyka, Marek] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Div Neurosurg, Cambridge CB2 2QQ, England	Soehle, M (corresponding author), Univ Bonn, Dept Anaesthesiol & Intens Care Med, Sigmund Freud Str 25, D-53105 Bonn, Germany.	martin.soehle@ukb.uni-bonn.de		Smielewski, Peter/0000-0001-5096-3938	Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0600986, G0001237, G9439390] Funding Source: Medline; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0508-10327] Funding Source: researchfish		Angelini L, 2007, ARTIF INTELL MED, V41, P237, DOI 10.1016/j.artmed.2007.07.012; BEAUMONT A, 2000, NEUROSURGERY SCI BAS, V0001, P00460; Burr RL, 2008, IEEE T BIO-MED ENG, V55, P2509, DOI 10.1109/TBME.2008.2001286; Chandra FA, 2011, SCIENCE, V333, P187, DOI 10.1126/science.1200705; Costa M, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.021906; Costa M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.068102; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; Czosnyka M, 1997, J NEUROL NEUROSUR PS, V63, P721, DOI 10.1136/jnnp.63.6.721; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka Marek, 2007, Neurosurg Focus, V22, pE10; Eke A, 2000, PFLUG ARCH EUR J PHY, V439, P403, DOI 10.1007/s004249900135; Eke A, 2002, PHYSIOL MEAS, V23, pR1, DOI 10.1088/0967-3334/23/1/201; Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Goldberger AL, 1997, PERSPECT BIOL MED, V40, P543; GRASSBERGER P, 1983, PHYS REV A, V28, P2591, DOI 10.1103/PhysRevA.28.2591; Hornero R, 2006, CRIT CARE MED, V34, P87, DOI 10.1097/01.CCM.0000190426.44782.F0; Lake DE, 2002, AM J PHYSIOL-REG I, V283, pR789, DOI 10.1152/ajpregu.00069.2002; Lake DE, 2011, AM J PHYSIOL-HEART C, V300, pH319, DOI 10.1152/ajpheart.00561.2010; Lu CW, 2012, BRAIN, V135, P2399, DOI 10.1093/brain/aws155; MARMAROU A, 1978, J NEUROSURG, V48, P332, DOI 10.3171/jns.1978.48.3.0332; Menon DK, 1999, BRIT MED BULL, V55, P226, DOI 10.1258/0007142991902231; Moorman JR, 2011, J PEDIATR-US, V159, P900, DOI 10.1016/j.jpeds.2011.06.044; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; PENG CK, 1994, PHYS REV E, V49, P1685, DOI 10.1103/PhysRevE.49.1685; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; Ponikowski P, 1997, AM J CARDIOL, V79, P1645, DOI 10.1016/S0002-9149(97)00215-4; RICH MW, 1988, AM J CARDIOL, V62, P714, DOI 10.1016/0002-9149(88)91208-8; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Seely AJE, 2004, CRIT CARE, V8, pR367, DOI 10.1186/cc2948; Soehle M, 2008, J CEREBR BLOOD F MET, V28, P64, DOI 10.1038/sj.jcbfm.9600506; Stadnitski T, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00127; Taqqu MS, 1995, SCI REP, V3, P785; TUININGA YS, 1994, BRIT HEART J, V72, P509; Ursino M, 1997, J APPL PHYSIOL, V82, P1256	36	11	11	1	17	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1387-1307	1573-2614		J CLIN MONIT COMPUT	J. Clin. Monitor. Comp.	AUG	2013	27	4			SI		395	403		10.1007/s10877-012-9427-0			9	Anesthesiology	Anesthesiology	175VJ	WOS:000321261400004	23306818				2021-06-18	
J	Yang, CC; Huang, SJ; Lin, WC; Tsai, YH; Hua, MS				Yang, Chi-Cheng; Huang, Sheng-Jean; Lin, Wei-Chi; Tsai, Yi-Hsin; Hua, Mau-Sun			Divergent manifestations of irritability in patients with mild and moderate-to-severe traumatic brain injury: Perspectives of awareness and neurocognitive correlates	BRAIN INJURY			English	Article						Awareness; information processing; irritability; traumatic brain injury	HEAD-INJURY; AGGRESSION; SEQUELAE; CAREGIVERS; SYMPTOMS; MEMORY	Primary objectives: To evaluate irritability in patients with mild traumatic brain injury (mTBI) and moderate-to-severe traumatic brain injury (msTBI), respectively. Research design: A prospective study was conducted at a level I trauma centre. Methods and procedures: A total of 160 participants, which included 80 healthy subjects and 80 patients with TBI, were recruited. Irritability was assessed by the National Taiwan University Irritability Scale and other cognitive functions, which included memory, executive function and information processing, were also evaluated. Main outcomes and results: The results showed post-injury self-reported irritability in patients with mTBI and family-reported irritability in patients with msTBI were significantly higher than irritability reported by healthy participants. Irritability was significantly associated with information processing ability in patients with mTBI, but it was not associated with any cognitive functions in patients with msTBI. Conclusions: Irritability was found to be prominent after TBI. Divergent causes of irritability seemed apparent in patients with mTBI and msTBI. Irritability after mTBI appeared might be related to the cognitive functions disrupted after the injury, whereas irritability after msTBI appeared to result directly from the brain lesions involved.	[Yang, Chi-Cheng; Lin, Wei-Chi] Chang Gung Univ, Div Clin Psychol, Dept Occupat Therapy, Coll Med, Tao Yuan, Taiwan; [Huang, Sheng-Jean] Natl Taiwan Univ Hosp, Jin Shan Branch, New Taipei City, Taiwan; [Huang, Sheng-Jean] Natl Taiwan Univ, Dept Surg, Coll Med, Taipei 10764, Taiwan; [Tsai, Yi-Hsin] Far Eastern Mem Hosp, Div Neurosurg, New Taipei City, Taiwan; [Hua, Mau-Sun] Natl Taiwan Univ, Dept Psychol, Taipei 10764, Taiwan	Yang, CC (corresponding author), Chang Gung Univ, Div Clin Psychol, Dept Occupat Therapy, Coll Med, Tao Yuan, Taiwan.	ccyang@mail.cgu.edu.tw; huams@ntu.edu.tw			National Science Council of TaiwanMinistry of Science and Technology, Taiwan [NSC 99-2410-H-182-012-MY2]	This study was supported by the National Science Council of Taiwan (NSC 99-2410-H-182-012-MY2).	Alderman N, 2003, NEUROPSYCHOL REHABIL, V13, P211, DOI 10.1080/09602010244000327; Beck A. T., 1996, BECK DEPRESSION INVE, VII; Berg EA, 1948, J GEN PSYCHOL, V39, P15, DOI 10.1080/00221309.1948.9918159; Busch CR, 1998, NEUROPSYCHOL REV, V8, P95, DOI 10.1023/A:1025661200911; BUSS AH, 1992, J PERS SOC PSYCHOL, V63, P452, DOI 10.1037/0022-3514.63.3.452; Deb S, 1998, J NEUROL NEUROSUR PS, V65, P899, DOI 10.1136/jnnp.65.6.899; Deb S, 1999, BRIT J PSYCHIAT, V174, P360, DOI 10.1192/bjp.174.4.360; Department of Health, 2005, HLTH NAT HLTH INS AN; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Eslinger PJ, 2000, BEHAVIOR AND MOOD DISORDERS IN FOCAL BRAIN LESIONS, P217; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; Pagulayan KF, 2007, J INT NEUROPSYCH SOC, V13, P561, DOI 10.1017/S1355617707070713; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; Granacher Jr RP, 2003, TRAUMATIC BRAIN INJU, P25; GRONWALL D, 1981, J NEUROL NEUROSUR PS, V44, P889, DOI 10.1136/jnnp.44.10.889; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Haboubi NHJ, 2001, DISABIL REHABIL, V23, P635; Hanks RA, 2007, NEUROREHABILITATION, V22, P43; Heaton R. K, 1981, WISCONSIN CARD SORTI; Hua M.-S., 1986, WORD SEQUENCE UNPUB; Hua MS, 1997, NEUROPSYCHOLOGY, V11, P156, DOI 10.1037/0894-4105.11.1.156; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; JENNETT B, 1975, LANCET, V1, P480; Kalechstein AD, 2003, J CLIN EXP NEUROPSYC, V25, P1186, DOI 10.1076/jcen.25.8.1186.16723; Kay T., 1993, J HEAD TRAUMA REHABI, V8, P86, DOI [10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; KREUTZER JS, 1994, BRAIN INJURY, V8, P211, DOI 10.3109/02699059409150974; LARRABEE GJ, 1995, J CLIN EXP NEUROPSYC, V17, P536, DOI 10.1080/01688639508405144; Levin H. S., 1983, PACED AUDITORY UNPUB; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; ODER W, 1992, J NEUROL NEUROSUR PS, V55, P475, DOI 10.1136/jnnp.55.6.475; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Roberts RJ, 1983, WORD SEQUENCE LEARNI; Salmon DP, 2001, FRONTAL-SUBCORTICAL CIRCUITS IN PSYCHIATRIC AND NEUROLOGICAL DISORDERS, P114; Starkstein S. E., 1991, FRONTAL LOBE FUNCTIO; Stuss DT, 1987, NEUROBEHAVIORAL RECO; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; van der Naalt J, 2000, BRAIN INJURY, V14, P781; Wallace CA, 1998, BRAIN INJURY, V12, P483, DOI 10.1080/02699052.1998.11910751; Watt S, 1999, NEUROPSYCHOLOGY, V13, P338, DOI 10.1037/0894-4105.13.3.338; Yang CC, 2005, ARCH CLIN PSYCHOL, V2, P49; Yang CC, 2007, J TRAUMA, V62, P657, DOI 10.1097/01.ta.0000203577.68764.b8; Yang CC, 2012, BRAIN INJURY, V26, P1185, DOI 10.3109/02699052.2012.666374; Yang CC, 2011, BRAIN IMPAIR, V12, P200; Zasler N. D., 2007, BRAIN INJURY MED PRI, P779	49	11	11	0	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	AUG	2013	27	9					1008	1015		10.3109/02699052.2013.794975			8	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	180HZ	WOS:000321586100004	23662733				2021-06-18	
J	Zhou, HH; Ongodia, D; Liu, Q; Yang, RT; Li, ZB				Zhou, Hai-Hua; Ongodia, David; Liu, Qi; Yang, Rong-Tao; Li, Zu-Bing			Dental trauma in patients with maxillofacial fractures	DENTAL TRAUMATOLOGY			English	Article						dental trauma; maxillofacial fractures; prevalence	CONDYLE FRACTURES; MOUTHGUARD USE; INJURIES; ASSOCIATION; TURKEY	Purpose: The purpose of this study was to analyze and evaluate the correlation between dental injuries and the pattern of maxillofacial fractures. The correlation with age, gender, trauma mechanism and type of maxillofacial fracture was also investigated. Materials and methods: From January 2000 to December 2009, 1131 patients with facial fractures were registered. Of these, 473 presented with associated dental trauma. The information and data collected and analyzed included: age, gender, mechanism of injury, type of facial fracture, type of dental injury, and the relationship between dental injury and facial fracture. Results: Dental injury was sustained by 473 patients (41.8%), with a total of 2215 injured teeth. Of the 2215 injured teeth, 1191 (53.8%) were in the maxilla and 1024 (46.2%) in the mandible. Fall from a height had the highest risk of dental injuries (OR = 4.145, P = 0.002). The central incisor was the most injured tooth for both the maxilla (388, 36.2%) and mandible (284, 27.7%). The most common type of dental injury was avulsion (1070, 47.4%). More anterior teeth in the maxilla were of crown fracture, avulsion, and intrusion than that in the mandible, whereas more anterior teeth in the mandible were of subluxation and concussion than that in the maxilla. Dental injuries were more prone to occur in patients who sustained only symphysis fractures (OR = 2.817, P < 0.001), only 0.236-fold risk in patients who sustained only mandible angle fracture (P < 0.001). Conclusions: The occurrence of dental trauma is significantly related to the pattern and position of the maxillofacial fractures.	[Zhou, Hai-Hua; Ongodia, David; Liu, Qi; Yang, Rong-Tao; Li, Zu-Bing] Wuhan Univ, Sch & Hosp Stomatol, State Key Lab Breeding Base Basic Sci Stomatol Hu, Wuhan 430079, Hubei, Peoples R China; [Zhou, Hai-Hua; Ongodia, David; Liu, Qi; Yang, Rong-Tao; Li, Zu-Bing] Wuhan Univ, Sch & Hosp Stomatol, Key Lab Oral Biomed, Minist Educ, Wuhan 430079, Hubei, Peoples R China; [Zhou, Hai-Hua; Liu, Qi; Yang, Rong-Tao; Li, Zu-Bing] Wuhan Univ, Coll & Hosp Stomatol, Dept Oral & Maxillofacial Surg, Wuhan 430079, Hubei, Peoples R China	Li, ZB (corresponding author), Wuhan Univ, Coll & Hosp Stomatol, Dept Oral & Maxillofacial Surg, 237 Luoyu Rd, Wuhan 430079, Hubei, Peoples R China.	lizubing0827@163.com	zhou, haihua/F-5179-2012	zhou, haihua/0000-0002-6838-0113			Andreasen J O, 1970, Scand J Dent Res, V78, P329; Bastone EB, 2000, AUST DENT J, V45, P2, DOI 10.1111/j.1834-7819.2000.tb00234.x; Burden DJ, 1995, EUR J ORTHODONT, V17, P513, DOI 10.1093/ejo/17.6.513; da Silva AC, 2004, DENT TRAUMATOL, V20, P6, DOI 10.1111/j.1600-4469.2004.00212.x; Eyuboglu O, 2009, DENT TRAUMATOL, V25, P110, DOI 10.1111/j.1600-9657.2008.00668.x; Gassner R, 2004, J ORAL MAXIL SURG, V62, P399, DOI 10.1016/j.joms.2003.05.013; Gassner R, 1999, ORAL SURG ORAL MED O, V87, P27, DOI 10.1016/S1079-2104(99)70290-8; Gassner R, 2003, J CRANIO MAXILL SURG, V31, P51, DOI 10.1016/S1010-5182(02)00168-3; Gutmann J L, 1995, Dent Clin North Am, V39, P1; IGNATIUS ET, 1992, ENDOD DENT TRAUMATOL, V8, P235; Kececi AD, 2005, DENT TRAUMATOL, V21, P76, DOI 10.1111/j.1600-9657.2004.00302.x; Lam R, 2008, DENT TRAUMATOL, V24, P663, DOI 10.1111/j.1600-9657.2008.00689.x; Levin L, 2003, DENT TRAUMATOL, V19, P237, DOI 10.1034/j.1600-9657.2003.00196.x; Lieger O, 2009, J ORAL MAXIL SURG, V67, P1680, DOI 10.1016/j.joms.2009.03.052; Ma WL, 2008, DENT TRAUMATOL, V24, P430, DOI 10.1111/j.1600-9657.2008.00586.x; OIKARINEN K, 1987, ENDOD DENT TRAUMATOL, V3, P220; SILVENNOINEN U, 1993, ENDOD DENT TRAUMATOL, V9, P254; Thoren H, 2010, INT J ORAL MAX SURG, V39, P774, DOI 10.1016/j.ijom.2010.03.024; Yamada T, 1998, ENDOD DENT TRAUMATOL, V14, P84	19	11	11	0	11	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1600-4469			DENT TRAUMATOL	Dent. Traumatol.	AUG	2013	29	4					285	290		10.1111/j.1600-9657.2012.01169.x			6	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	178GO	WOS:000321433900005	22783913				2021-06-18	
J	Baumann, G; Travieso, L; Liebl, DJ; Theus, MH				Baumann, Gisela; Travieso, Lissette; Liebl, Daniel J.; Theus, Michelle H.			Pronounced hypoxia in the subventricular zone following traumatic brain injury and the neural stem/progenitor cell response	EXPERIMENTAL BIOLOGY AND MEDICINE			English	Article						Hypoxia; Eph; ephrin; subventricular zone; AKT; Hif1-alpha; neural stem/progenitor cell; traumatic brain injury	ADULT MAMMALIAN BRAIN; CENTRAL-NERVOUS-SYSTEM; STEM-CELLS; COMMISSURAL AXONS; PROGENITOR CELLS; OLFACTORY-BULB; PROLIFERATION; NEUROGENESIS; DIFFERENTIATION; SURVIVAL	Traumatic brain injury (TBI) elicits identifiable changes within the adult subventricular zone (SVZ). Previously, we demonstrated that EphB3/ephrinB3 interaction inhibits neural stem/progenitor cell (NSPC) proliferation and downregulating this pathway following TBI plays a pivotal role in the expansion of the SVZ neurogenic compartment. It remains unclear, however, what early initiating factors may precede these changes. Using hypoxyprobe-1 (HPb) to identify regions of low oxygen tension or hypoxia (<1%), we found HPb uptake throughout the cortex (CTX), corpus callosum (CC) and SVZ within the first 24 h following controlled cortical impact (CCI) injury. At this early time point, HPb co-localized with EphB3 in the SVZ. NSPC specific markers also co-localized with HPb staining throughout the lateral wall of the ventricle. To determine the cell autonomous effects of hypoxia on EphB3/ephrinB3 signaling in NSPCs, we used an in vitro model of hypoxia to mimic 1% oxygen in the presence and absence of soluble aggregated ephrinB3 (eB3). As expected, hypoxia stimulated the uptake of 5-bromo-2'-deoxyuridine (BrdU) and reduced cell death. Coincident with these proliferative changes, both Hif1-alpha and phospho (p)-AKT were increased while EphB3 expression was decreased. Stimulation of EphB3 attenuated hypoxia-induced proliferation and prevented phosphorylation of AKT. Hif1-alpha accumulation, on the other hand, was not affected by EphB3/ephrinB3 signaling. These findings indicate that this pathway limits the NSPC response to hypoxic stimuli. These studies also suggest that early transient changes in oxygen tension following localized cortical injury may initiate a growth-promoting response in the SVZ.	[Baumann, Gisela; Travieso, Lissette; Liebl, Daniel J.] Univ Miami, Miami Project Cure Paralysis, Miami, FL 33136 USA; [Baumann, Gisela; Travieso, Lissette; Liebl, Daniel J.] Univ Miami, Dept Neurol Surg, Miami, FL 33136 USA; [Theus, Michelle H.] Virginia Polytech Inst & State Univ, Virginia Maryland Reg Coll Vet Med, Dept Biomed Sci & Pathobiol, Blacksburg, VA 24061 USA	Theus, MH (corresponding author), Virginia Polytech Inst & State Univ, Virginia Maryland Reg Coll Vet Med, Dept Biomed Sci & Pathobiol, Blacksburg, VA 24061 USA.	mtheus@vt.edu			NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS049545, NS30291, NS007459, NS064699]; Virginia Tech's Open Access Subvention Fund; Miami Project to Cure Paralysis; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F32NS064699, P50NS030291, R01NS049545] Funding Source: NIH RePORTER	This work was supported by NIH/NINDS NS049545 (DJL), NS30291 (DJL), NS007459 (MHT), NS064699 (MHT), Virginia Tech's Open Access Subvention Fund and the Miami Project to Cure Paralysis.	ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Alvarez-Buylla A, 2002, BRAIN RES BULL, V57, P751, DOI 10.1016/S0361-9230(01)00770-5; Bessis A, 2007, GLIA, V55, P233, DOI 10.1002/glia.20459; Blits-Huizinga CT, 2004, IUBMB LIFE, V56, P257, DOI 10.1080/15216540412331270076; Chakraborty D, 2012, CELL CYCLE, V11, P2427, DOI 10.4161/cc.20542; Chen BS, 2012, ENDOCRINOLOGY, V153, P4946, DOI 10.1210/en.2012-1472; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Conover JC, 2000, NAT NEUROSCI, V3, P1091, DOI 10.1038/80606; Cowan CA, 2000, NEURON, V26, P417, DOI 10.1016/S0896-6273(00)81174-5; Culver JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053546; Doetsch F, 1999, P NATL ACAD SCI USA, V96, P11619, DOI 10.1073/pnas.96.20.11619; Doetsch F, 2002, J NEUROSCI, V22, P2255, DOI 10.1523/JNEUROSCI.22-06-02255.2002; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 1997, J NEUROSCI, V17, P5046; Doetsch F, 1996, P NATL ACAD SCI USA, V93, P14895, DOI 10.1073/pnas.93.25.14895; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Gritti A, 2002, J NEUROSCI, V22, P437, DOI 10.1523/JNEUROSCI.22-02-00437.2002; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; Jin KL, 2003, AGING CELL, V2, P175, DOI 10.1046/j.1474-9728.2003.00046.x; Katakowski M, 2005, NEUROSCI LETT, V385, P204, DOI 10.1016/j.neulet.2005.05.060; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Leone DP, 2005, J CELL SCI, V118, P2589, DOI 10.1242/jcs.02396; Lu DY, 2003, J NEUROSURG, V99, P351, DOI 10.3171/jns.2003.99.2.0351; Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964; Milosevic J, 2005, J NEUROCHEM, V92, P718, DOI 10.1111/j.1471-4159.2004.02893.x; Morrison SJ, 2000, J NEUROSCI, V20, P7370; Mottet D, 2003, J BIOL CHEM, V278, P31277, DOI 10.1074/jbc.M300763200; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Nelersa CM, 2012, J BIOMOL SCREEN, V17, P785, DOI 10.1177/1087057112440880; Ogasawara MA, 2009, ANTIOXID REDOX SIGN, V11, P1107, DOI [10.1089/ars.2008.2308, 10.1089/ARS.2008.2308]; Ohnuma S, 2003, NEURON, V40, P199, DOI 10.1016/S0896-6273(03)00632-9; Orioli D, 1996, EMBO J, V15, P6035, DOI 10.1002/j.1460-2075.1996.tb00992.x; Ostrakhovitch EA, 2013, ARCH BIOCHEM BIOPHYS, V534, P44, DOI 10.1016/j.abb.2012.08.002; Panchision DM, 2009, J CELL PHYSIOL, V220, P562, DOI 10.1002/jcp.21812; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Pore N, 2006, MOL CANCER RES, V4, P471, DOI 10.1158/1541-7786.MCR-05-0234; Ramaswamy S, 2005, BRAIN RES, V1053, P38, DOI 10.1016/j.brainres.2005.06.042; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Ricard J, 2006, MOL CELL NEUROSCI, V31, P713, DOI 10.1016/j.mcn.2006.01.002; Rice AC, 2003, EXP NEUROL, V183, P406, DOI 10.1016/S0014-4886(03)00241-3; Roy S, 2012, EUR J HAEMATOL, V88, P396, DOI 10.1111/j.1600-0609.2012.01759.x; Scheffler B, 2005, P NATL ACAD SCI USA, V102, P9353, DOI 10.1073/pnas.0503965102; Skold MK, 2005, J NEUROTRAUM, V22, P353, DOI 10.1089/neu.2005.22.353; Studer L, 2000, J NEUROSCI, V20, P7377; Theus MH, 2010, STEM CELLS, V28, P1231, DOI 10.1002/stem.449; Theus MH, 2008, EXP NEUROL, V210, P656, DOI 10.1016/j.expneurol.2007.12.020; Urrea C, 2007, RESTOR NEUROL NEUROS, V25, P65; Vieira HLA, 2011, PROG NEUROBIOL, V93, P444, DOI 10.1016/j.pneurobio.2011.01.007; Wang TW, 2005, DEVELOPMENT, V132, P2721, DOI 10.1242/dev.01867; Xing SH, 2008, BRAIN RES, V1230, P237, DOI 10.1016/j.brainres.2008.06.097; Yokoyama N, 2001, NEURON, V29, P85, DOI 10.1016/S0896-6273(01)00182-9	51	11	11	0	5	ROYAL SOC MEDICINE PRESS LTD	LONDON	1 WIMPOLE STREET, LONDON W1G 0AE, ENGLAND	1535-3702			EXP BIOL MED	Exp. Biol. Med.	JUL	2013	238	7					830	841		10.1177/1535370213494558			12	Medicine, Research & Experimental	Research & Experimental Medicine	203ZY	WOS:000323335200013	23828590	Green Published			2021-06-18	
J	El Ahmadieh, TY; Adel, JG; El Tecle, NE; Daou, MR; Aoun, SG; Nanney, AD; Bendok, BR				El Ahmadieh, Tarek Y.; Adel, Joseph G.; El Tecle, Najib E.; Daou, Marc R.; Aoun, Salah G.; Nanney, Allan D., III; Bendok, Bernard R.			Surgical Treatment of Elevated Intracranial Pressure: Decompressive Craniectomy and Intracranial Pressure Monitoring	NEUROSURGERY CLINICS OF NORTH AMERICA			English	Article						Elevated intracranial pressure; Decompressive craniectomy; Intraventricular catheter; Intracranial pressure monitoring; Intracranial mass; Intracranial hypertension hemicraniectomy	MIDDLE CEREBRAL-ARTERY; TRAUMATIC BRAIN-INJURY; SUBARACHNOID HEMORRHAGE PATIENTS; SEVERE HEAD-INJURY; INTRACEREBRAL HEMORRHAGE; MALIGNANT INFARCTION; PERFUSION-PRESSURE; BACTERIAL-MENINGITIS; TERRITORY INFARCTION; CONTROLLED-TRIAL	Surgical techniques that address elevated intracranial pressure include (1) intraventricular catheter insertion and cerebrospinal fluid drainage, (2) removal of an intracranial space-occupying lesion, and (3) decompressive craniectomy. This review discusses the role of surgery in the management of elevated intracranial pressure, with special focus on intraventricular catheter placement and decompressive craniectomy. The techniques and potential complications of each procedure are described, and the existing evidence regarding the impact of these procedures on patient outcome is reviewed. Surgical management of mass lesions and ischemic or hemorrhagic stroke occurring in the posterior fossa is not discussed herein.	[El Ahmadieh, Tarek Y.; Adel, Joseph G.; El Tecle, Najib E.; Daou, Marc R.; Nanney, Allan D., III; Bendok, Bernard R.] Northwestern Univ, Dept Neurol Surg, Mcgaw Med Ctr, Feinberg Sch Med, Chicago, IL 60611 USA; [Aoun, Salah G.] Univ Texas SW Med Ctr Dallas, Dept Neurol Surg, Dallas, TX 75390 USA	Bendok, BR (corresponding author), Northwestern Univ, Dept Neurol Surg, Mcgaw Med Ctr, Feinberg Sch Med, 676 North St Clair St,Suite 2210, Chicago, IL 60611 USA.	bbendok@nmff.org	Aoun, Salah G./J-2406-2019; AHMADIEH, TAREK Y. EL/K-5921-2019	Aoun, Salah G./0000-0003-3499-7569; el Tecle, Najib/0000-0002-5242-1646			Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Agrawal D, 2005, EUR J CLIN MICROBIOL, V24, P772, DOI 10.1007/s10096-005-0017-7; Albanese J, 2003, CRIT CARE MED, V31, P2535, DOI 10.1097/01.CCM.0000089927.67396.F3; Amantini A, 2008, EUR J ANAESTH, V25, P196, DOI 10.1017/S0265021507003183; Amantini A, 2009, NEUROPHYSIOL CLIN, V39, P85, DOI 10.1016/j.neucli.2009.01.006; Anton G, 1908, MUNCHEN MED WCHNSCHR, V55, P1673; Apuzzo MLJ, 2007, NEUROSURGERY, V61, P5, DOI 10.1227/01.NEU.0000255493.34063.7B; Arac A, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0958; Arnaout OM, 2011, NEUROSURG FOCUS, V30, DOI 10.3171/2011.3.FOCUS1160; Ausman J I, 1976, Surg Neurol, V6, P97; Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Baussart B, 2006, ACTA ANAESTH SCAND, V50, P762, DOI 10.1111/j.1399-6576.2006.01038.x; Bell RS, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1022; Binz DD, 2009, NEUROCRIT CARE, V10, P253, DOI 10.1007/s12028-009-9193-0; Broca P., 1867, B ACAD MED PARIS, V32, P866; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Bullock M Ross, 2006, Neurosurgery, V58, pS7; Buschmann U, 2007, ACTA NEUROCHIR, V149, P59, DOI 10.1007/s00701-006-1069-x; Carmel P W, 1999, Neurosurg Focus, V7, pe7; Carter BS, 1997, NEUROSURGERY, V40, P1168, DOI 10.1097/00006123-199706000-00010; Chen Jeff W, 2012, Surg Neurol Int, V3, P57, DOI 10.4103/2152-7806.96868; Chesler DA, 2011, MINIM INVAS NEUROSUR, V54, P243, DOI 10.1055/s-0031-1297249; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; CHOKSEY M, 1993, BRIT J NEUROSURG, V7, P611, DOI 10.3109/02688699308995090; Clower WT, 2001, NEUROSURGERY, V49, P1417, DOI 10.1097/00006123-200112000-00021; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Coplin WM, 1998, STROKE, V29, P1573, DOI 10.1161/01.STR.29.8.1573; D'Ambrosio AL, 2005, NEUROSURGERY, V56, P12, DOI 10.1227/01.NEU.0000144820.38439.63; Dandy WE, 1918, ANN SURG, V68, P5, DOI 10.1097/00000658-191807000-00002; Dasic D, 2006, BRIT J NEUROSURG, V20, P296, DOI 10.1080/02688690600999901; Dey M, 2012, CURR NEUROL NEUROSCI, V12, P24, DOI 10.1007/s11910-011-0231-x; DOCZI T, 1993, ACTA NEUROCHIR, V121, P1, DOI 10.1007/BF01405174; Dunn LT, 2002, J NEUROL NEUROSUR PS, V73, pI23; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Fortune JB, 1995, J TRAUMA, V39, P1091, DOI 10.1097/00005373-199512000-00014; Frank JI CD, 2003, 55 ANN M AM AC NEUR; Ghajar J, 1995, New Horiz, V3, P395; Gigante P, 2010, BRIT J NEUROSURG, V24, P625, DOI 10.3109/02688697.2010.505989; Gregson BA, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-193; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; GUILLAUME J, 1951, PRESSE MED, V59, P953; GUILLAUME J, 1951, REV NEUROL, V84, P131; Gutierrez-Gonzalez R, 2010, J INFECTION, V61, P9, DOI 10.1016/j.jinf.2010.03.030; Hacke W, 1996, ARCH NEUROL-CHICAGO, V53, P309, DOI 10.1001/archneur.1996.00550040037012; Heuer GG, 2004, J NEUROSURG, V101, P408, DOI 10.3171/jns.2004.101.3.0408; Hillered L, 2006, CURR OPIN CRIT CARE, V12, P112, DOI 10.1097/01.ccx.0000216576.11439.df; Hofmeijer J, 2004, STROKE, V35, P1476, DOI 10.1161/01.STR.0000128415.31274.3a; Hofmeijer J, 2006, TRIALS, V7, DOI 10.1186/1745-6215-7-29; Howard JL, 2008, J TRAUMA, V65, P380, DOI 10.1097/TA.0b013e31817c50d4; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Hutchinson Peter, 2007, Neurosurg Focus, V22, pE14; Jaffe J, 2012, NEUROSURGERY, V70, P1258, DOI 10.1227/NEU.0b013e31823f6571; Jamora R, 2004, 29 INT STROK C FEBR; Jantzen JPAH, 2007, BEST PRACT RES-CLIN, V21, P517, DOI 10.1016/j.bpa.2007.09.001; Jennett B, 1998, ARCH DIS CHILD, V78, P403, DOI 10.1136/adc.78.5.403; JENNETT B, 1976, LANCET, V1, P1031; Johnson RD, 2011, J CLIN NEUROSCI, V18, P1023, DOI 10.1016/j.jocn.2010.12.025; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Kakar V, 2009, BRIT J NEUROSURG, V23, P147, DOI 10.1080/02688690902756702; Kakarla UK, 2008, NEUROSURGERY, V63, P162, DOI 10.1227/01.NEU.0000312390.83127.7F; Keen WW., 1890, LANCET, V136, P553, DOI DOI 10.1016/S0140-6736(00)48676-9; Keller E, 2005, ACTA NEUROCHIR SUPPL, V94, P177; Keong NCH, 2012, NEUROSURGERY, V71, P394, DOI 10.1227/NEU.0b013e318257bebb; Kerr M E, 2001, Neurosurg Focus, V11, pE1; Kilincer C, 2005, CLIN NEUROL NEUROSUR, V107, P412, DOI 10.1016/j.clineuro.2004.09.018; Kilincer C, 2005, ACTA NEUROCHIR, V147, P587, DOI 10.1007/s00701-005-0493-7; Kirkman Matthew A, 2012, Anesthesiol Clin, V30, P269, DOI 10.1016/j.anclin.2012.05.007; KISHORE PRS, 1981, AM J ROENTGENOL, V137, P829, DOI 10.2214/ajr.137.4.829; Lang Shih-Shan, 2012, Anesthesiol Clin, V30, P289, DOI 10.1016/j.anclin.2012.05.008; Lee SC, 2013, J CLIN NEUROSCI, V20, P49, DOI 10.1016/j.jocn.2012.05.027; Li LM, 2010, ANESTH ANALG, V111, P736, DOI 10.1213/ANE.0b013e3181e75cd1; Maira G, 2002, NEUROL RES, V24, P54, DOI 10.1179/016164102101199549; Mangat Halinder S, 2012, Continuum (Minneap Minn), V18, P532, DOI 10.1212/01.CON.0000415426.76524.e1; Maniker AH, 2006, NEUROSURGERY, V59, P419, DOI 10.1227/01.NEU.0000222817.99752.E6; Marion DW, 2006, NEUROSURGERY, V58, P655; Mendelow AD, 2005, LANCET, V365, P387; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; Miller MT, 2004, J TRAUMA, V56, P967, DOI 10.1097/01.TA.0000123699.16465.8B; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Murthy JMK, 2005, NEUROCRIT CARE, V2, P258, DOI 10.1385/NCC:2:3:258; Naff NJ, 2000, STROKE, V31, P841, DOI 10.1161/01.STR.31.4.841; Narotam PK, 2009, J NEUROSURG, V111, P672, DOI 10.3171/2009.4.JNS081150; Oddo M, 2012, CURR OPIN CRIT CARE, V18, P111, DOI 10.1097/MCC.0b013e32835132a5; Park P, 2004, NEUROSURGERY, V55, P594, DOI 10.1227/01.NEU.0000134289.04500.EE; Patton N, 2000, J ROY SOC MED, V93, P80, DOI 10.1177/014107680009300210; Pillai A, 2007, J NEUROSURG, V106, P59, DOI 10.3171/jns.2007.106.1.59; Pople I, 2012, NEUROSURGERY, V71, P6, DOI 10.1227/NEU.0b013e3182544e31; Quinn TM, 2011, ACTA NEUROL SCAND, V123, P239, DOI 10.1111/j.1600-0404.2010.01397.x; Rahme R, 2012, J NEUROSURG, V117, P749, DOI 10.3171/2012.6.JNS111140; Rangel-Castillo L, 2008, NEUROL CLIN, V26, P521, DOI 10.1016/j.ncl.2008.02.003; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Ronning P, 2008, ACTA NEUROL SCAND, V118, P347, DOI 10.1111/j.1600-0404.2008.01023.x; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Sahjpaul R, 2000, CAN J NEUROL SCI, V27, P143; Sankhyan N, 2010, INDIAN J PEDIATR, V77, P1409, DOI 10.1007/s12098-010-0190-2; Schade RP, 2005, J NEUROSURG, V102, P229, DOI 10.3171/jns.2005.102.2.0229; Schirmer CM, 2008, NEUROCRIT CARE, V8, P456, DOI 10.1007/s12028-008-9082-y; Schirmer CM, 2007, STROKE, V38, P987, DOI 10.1161/01.STR.0000257962.58269.e2; Schwab S, 1996, NEUROLOGY, V47, P393, DOI 10.1212/WNL.47.2.393; Schwab S, 1997, NEUROLOGY, V48, P412, DOI 10.1212/WNL.48.2.412; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; SELHORST JB, 1985, NEUROSURGERY, V16, P357, DOI 10.1227/00006123-198503000-00013; Smith ER, 2002, NEUROSURGERY, V51, P117, DOI 10.1097/00006123-200207000-00018; Smith M, 2008, ANESTH ANALG, V106, P240, DOI 10.1213/01.ane.0000297296.52006.8e; SPERRY B, 1979, J AM OSTEOPATH ASSOC, V78, P816; Spiotta AM, 2011, NEUROSURGERY, V69, P755, DOI 10.1227/NEU.0b013e31821d2b61; Spiotta AM, 2010, J NEUROSURG, V113, P571, DOI 10.3171/2010.1.JNS09506; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; Suzuki M, 2000, NEUROSURGERY, V47, P1098, DOI 10.1097/00006123-200011000-00014; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Timofeev I, 2012, Adv Tech Stand Neurosurg, V38, P115, DOI 10.1007/978-3-7091-0676-1_6; Timofeev I, 2008, ACTA NEUROCHIR SUPPL, V102, P99, DOI 10.1007/978-3-211-85578-2_20; Tisdall MM, 2006, BRIT J ANAESTH, V97, P18, DOI 10.1093/bja/ael109; Treggiari MM, 2007, NEUROCRIT CARE, V6, P104, DOI 10.1007/s12028-007-0012-1; Tyrrell P, 2008, STROKE NATL CLIN GUI; Vahedi K, 2007, STROKE, V38, P2506, DOI 10.1161/STROKEAHA.107.485235; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; Vespa Paul, 2003, Neurosurg Focus, V15, pE4; Wada Y, 2002, NEUROL MED-CHIR, V42, P414, DOI 10.2176/nmc.42.414; Wagner S, 2001, J NEUROSURG, V94, P693, DOI 10.3171/jns.2001.94.5.0693; Wan WH, 2008, J CLIN NEUROSCI, V15, P223, DOI 10.1016/j.jocn.2007.05.025; Webb AJS, 2012, STROKE, V43, P1666, DOI 10.1161/STROKEAHA.112.650523; Whitfield PC, 2001, BRIT J NEUROSURG, V15, P500, DOI 10.1080/02688690120105110; Williams RF, 2009, J TRAUMA, V66, P1570, DOI 10.1097/TA.0b013e3181a594c4; Winter CD, 2005, J CLIN NEUROSCI, V12, P619, DOI 10.1016/j.jocn.2005.02.002; Wirtz C R, 1997, Neurosurg Focus, V2, pE3; Wolfe TJ, 2009, CURR NEUROL NEUROSCI, V9, P477, DOI 10.1007/s11910-009-0070-1; Zabramski JM, 2003, J NEUROSURG, V98, P725, DOI 10.3171/jns.2003.98.4.0725; Ziai WC, 2003, J NEUROSURG ANESTH, V15, P25, DOI 10.1097/00008506-200301000-00005; ZUMKELLER M, 1992, NEUROSURG REV, V15, P33, DOI 10.1007/BF02352065	132	11	12	0	8	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1042-3680	1558-1349		NEUROSURG CLIN N AM	Neurosurg. Clin. N. Am.	JUL	2013	24	3					375	+		10.1016/j.nec.2013.03.003			18	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	191NY	WOS:000322421100007	23809032				2021-06-18	
J	Harris, NG; Chen, SF; Pickard, JD				Harris, Neil G.; Chen, Szu-Fu; Pickard, John D.			Cortical Reorganization after Experimental Traumatic Brain Injury: A Functional Autoradiography Study	JOURNAL OF NEUROTRAUMA			English	Article						autoradiography; blood flow; cortical contusion injury; plasticity	CEREBRAL-BLOOD-FLOW; FORELIMB SENSORIMOTOR CORTEX; PRIMARY SOMATOSENSORY CORTEX; MOTOR CORTEX; BEHAVIORAL RECOVERY; NEOCORTICAL DAMAGE; EVOKED-POTENTIALS; AXONAL INJURY; ADULT-RATS; STROKE	Cortical sensorimotor (SM) maps are a useful readout for providing a global view of the underlying status of evoked brain function, as well as a gross overview of ongoing mechanisms of plasticity. Recent evidence in the rat controlled cortical impact (CCI) injury model shows that the ipsilesional (injured) hemisphere is temporarily permissive for axon sprouting. This would predict that size and spatial alterations in cortical maps may occur much earlier than previously tested and that they might be useful as potential markers of the postinjury plasticity period as well as indicators of outcome. We investigated the evolution of changes in brain activation evoked by affected hindlimb electrical stimulation at 4, 7, and 30 days following CCI or sham injury over the hindlimb cortical region of adult rats. [C-14]-iodoantipyrine autoradiography was used to quantitatively examine the local cerebral blood flow changes in response to hindlimb stimulation as a marker for neuronal activity. The results show that although ipsilesional hindlimb SM activity was persistently depressed from 4 days, additional novel regions of ipsilesional activity appeared concurrently within SM barrel and S2 regions as well as posterior auditory cortex. Simultaneously with this was the appearance of evoked activity within the intact, contralesional cortex that was maximal at 4 and 7 days, compared to stimulated sham-injured rats, where activation was solely unilateral. By 30 days, however, contralesional activation had greatly subsided and existing ipsilesional activity was enhanced within the same novel cortical regions that were identified acutely. These data indicate that significant reorganization of the cortical SM maps occurs after injury that evolves with a particular postinjury time course. We discuss these data in terms of the known mechanisms of plasticity that are likely to underlie these map changes, with particular reference to the differences and similarities that exist between rodent models of stroke and traumatic brain injury.	[Harris, Neil G.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, UCLA Brain Injury Res Ctr, Los Angeles, CA 90095 USA; [Harris, Neil G.] Univ Calif Los Angeles, David Geffen Sch Med, Brain Res Inst, Los Angeles, CA 90095 USA; [Chen, Szu-Fu] Cheng Hsin Gen Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Chen, Szu-Fu] Natl Def Med Ctr, Dept Physiol, Taipei, Taiwan; [Pickard, John D.] Univ Cambridge, Cambridge Ctr Brain Repair, Neurosurg Unit, Cambridge, England; [Pickard, John D.] Univ Cambridge, Wolfson Brain Imaging Ctr, Cambridge, England	Harris, NG (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Box 957039, Los Angeles, CA 90095 USA.	ngharris@mednet.ucla.edu		Harris, Neil/0000-0002-1965-6750	National Institutes of Health/National Institute of Neurological Disorders and Stroke award [NS055910]; UCLA Brain Injury Research Center; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0600986, G0001237, G0001354B, G1000183B, G0001354, G9439390] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0508-10327] Funding Source: researchfish; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS055910] Funding Source: NIH RePORTER	This work was supported by a National Institutes of Health/National Institute of Neurological Disorders and Stroke award (#NS055910) and the UCLA Brain Injury Research Center.	Adkins DL, 2004, NEUROSCIENCE, V128, P473, DOI 10.1016/j.neuroscience.2004.07.019; Allred RP, 2010, BEHAV NEUROSCI, V124, P124, DOI 10.1037/a0018457; Biernaskie J, 2005, EUR J NEUROSCI, V21, P989, DOI 10.1111/j.1460-9568.2005.03899.x; Carmichael ST, 2005, EXP NEUROL, V193, P291, DOI 10.1016/j.expneurol.2005.01.004; CASTROALAMANCOS MA, 1995, NEUROSCIENCE, V68, P793, DOI 10.1016/0306-4522(95)00178-L; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Chen SF, 2004, J CEREBR BLOOD F MET, V24, P1025, DOI 10.1097/01.WCB.0000129415.34520.47; Cho YR, 2007, MAGN RESON MED, V58, P901, DOI 10.1002/mrm.21408; CHOLLET F, 1991, ANN NEUROL, V29, P63, DOI 10.1002/ana.410290112; Clarey JC, 1996, CEREB CORTEX, V6, P196, DOI 10.1093/cercor/6.2.196; Cramer SC, 1997, STROKE, V28, P2518, DOI 10.1161/01.STR.28.12.2518; Dijkhuizen RM, 2001, P NATL ACAD SCI USA, V98, P12766, DOI 10.1073/pnas.231235598; DUNNMEYNELL AA, 1995, BRAIN RES, V675, P143, DOI 10.1016/0006-8993(95)00050-Z; Emery DL, 2000, J COMP NEUROL, V424, P521; Gagnon I, 1998, BRAIN INJURY, V12, P843, DOI 10.1080/026990598122070; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Hall KD, 2010, BRAIN RES, V1323, P161, DOI 10.1016/j.brainres.2010.01.067; Harris N., 2010, J NEUROTRAUM, V27, P1; Harris NG, 2009, J NEUROSCI RES, V87, P2937, DOI 10.1002/jnr.22115; Harris N.G., 2011, 25 INT S CER BLOOD F; Harris N, 2009, J NEUROTRAUM, V26, pA37; Harris NG, 2012, J NEUROTRAUM, V29, P1469, DOI 10.1089/neu.2011.2161; Harris NG, 2010, J NEUROPATH EXP NEUR, V69, P139, DOI 10.1097/NEN.0b013e3181cb5bee; Hillier SL, 1997, BRAIN INJURY, V11, P661; Ip EY, 2003, J CEREBR BLOOD F MET, V23, P900, DOI 10.1097/01.WCB.0000076702.71231.F2; JACOBS KM, 1991, SCIENCE, V251, P944, DOI 10.1126/science.2000496; JONES TA, 1994, J NEUROSCI, V14, P2140; JONES TA, 1992, BRAIN RES, V581, P156, DOI 10.1016/0006-8993(92)90356-E; Jones TA, 2012, J NEUROTRAUM, V29, P1455, DOI 10.1089/neu.2011.2207; Kasahara M, 2010, NEUROLOGY, V75, P168, DOI 10.1212/WNL.0b013e3181e7ca58; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Katz DI, 1998, ARCH PHYS MED REHAB, V79, P488, DOI 10.1016/S0003-9993(98)90060-0; Keyvani K, 2002, J NEUROPATH EXP NEUR, V61, P831, DOI 10.1093/jnen/61.10.831; Kozlowski DA, 1998, BEHAV BRAIN RES, V97, P89, DOI 10.1016/S0166-4328(98)00030-8; Lee S, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.16; Li Y, 1998, STROKE, V29, P1972, DOI 10.1161/01.STR.29.9.1972; Luke LM, 2004, SYNAPSE, V54, P187, DOI 10.1002/syn.20080; Maggiolini E, 2008, EUR J NEUROSCI, V27, P2733, DOI 10.1111/j.1460-9568.2008.06248.x; Marshall RS, 2000, STROKE, V31, P656, DOI 10.1161/01.STR.31.3.656; Mathiesen C, 1998, J PHYSIOL-LONDON, V512, P555, DOI 10.1111/j.1469-7793.1998.555be.x; Matthews MA, 1998, BRAIN RES, V794, P1, DOI 10.1016/S0006-8993(98)00107-3; Matyas F, 2010, SCIENCE, V330, P1240, DOI 10.1126/science.1195797; Mohajerani MH, 2011, P NATL ACAD SCI USA, V108, pE183, DOI 10.1073/pnas.1101914108; Moro N, 2011, NEUROSCI LETT, V491, P158, DOI 10.1016/j.neulet.2011.01.029; Ngai AC, 1999, BRAIN RES, V837, P221, DOI 10.1016/S0006-8993(99)01649-2; NILSSON P, 1993, J CEREBR BLOOD F MET, V13, P183, DOI 10.1038/jcbfm.1993.22; Nishibe M, 2010, J NEUROTRAUM, V27, P2221, DOI 10.1089/neu.2010.1456; Nordin M, 1995, J PHYSIOL-LONDON, V489, P885, DOI 10.1113/jphysiol.1995.sp021101; OHTA M, 1989, COMP BIOCHEM PHYS A, V94, P99, DOI 10.1016/0300-9629(89)90791-3; Passineau MJ, 2000, AM J PHYSIOL-HEART C, V279, pH924; Rasband W.S., 2008, IMAGEJ; Rema V, 2003, J NEUROSCI, V23, P10378; Richards HK, 2001, J CEREBR BLOOD F MET, V21, P779, DOI 10.1097/00004647-200107000-00002; Roy C S, 1890, J Physiol, V11, P85; Seitz RJ, 1998, ARCH NEUROL-CHICAGO, V55, P1081, DOI 10.1001/archneur.55.8.1081; Shanina EV, 2006, NEUROSCIENCE, V139, P1495, DOI 10.1016/j.neuroscience.2006.01.016; SHAW NA, 1986, J NEUROL SCI, V74, P257, DOI 10.1016/0022-510X(86)90111-5; Shuler MG, 2001, J NEUROSCI, V21, P5251, DOI 10.1523/JNEUROSCI.21-14-05251.2001; STROEMER RP, 1995, STROKE, V26, P2135, DOI 10.1161/01.STR.26.11.2135; Teasdale GM, 1998, NEUROSURGERY, V43, P723, DOI 10.1097/00006123-199810000-00001; Tremblay S, 2011, J NEUROTRAUM, V28, P493, DOI 10.1089/neu.2010.1615; Verley D., 2011, J NEUROTRAUM, V28, p[A, P220]; Ward NS, 2004, CURR OPIN NEUROL, V17, P725, DOI 10.1097/00019052-200412000-00013; WEILLER C, 1992, ANN NEUROL, V31, P463, DOI 10.1002/ana.410310502	64	11	11	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	JUL	2013	30	13					1137	1146		10.1089/neu.2012.2785			10	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	174WB	WOS:000321186400005	23305562	Green Published			2021-06-18	
J	Jungner, M; Lundblad, C; Bentzer, P				Jungner, M.; Lundblad, C.; Bentzer, P.			Rosuvastatin. in experimental brain trauma: Improved capillary patency but no effect on edema or cerebral blood flow	MICROVASCULAR RESEARCH			English	Article							CORTICAL IMPACT INJURY; NITRIC-OXIDE SYNTHASE; L-ARGININE; MICROVASCULAR PERMEABILITY; ENDOTHELIAL DYSFUNCTION; HEMODYNAMIC DEPRESSION; REDUCTASE INHIBITOR; IN-VIVO; ATORVASTATIN; RAT	Background: Microvascular dysfunction, characterized by edema formation secondary to increased blood-brain barrier (BBB) permeability and decreased blood flow, contributes to poor outcome following brain trauma. Recent studies have indicated that statins may counteract edema formation following brain trauma but little is known about other circulatory effects of statins in this setting. The objective of this study was to investigate whether statin treatment improves brain microcirculation early after traumatic brain injury, and whether microvascular effects are associated with altered production of nitric oxide and prostacyclin. Methods: After fluid percussion injury, rats were randomized to intravenous treatment with 20 mg/kg of rosuvastatin or vehicle. Brain edema (wet/dry weight), BBB integrity (Cr-51-EDTA blood to brain transfer), cerebral blood flow (C-14-iodoantipyrine autoradiography), and number of perfused cortical capillaries (FITC-albumin fluorescence microscopy), were measured at 4 and 24 h. NO and prostacyclin production was estimated from plasma concentration of the degradation products NO2- and NO3- (NOx) and 6-keto-PGF(1-alpha), respectively. Sham injured animals were treated with vehicle and analyzed at 4 h. Results: Trauma resulted in brain edema, BBB dysfunction, and reduced cortical blood flow, with no effect of statin treatment. Trauma also induced a reduction in the number of perfused capillaries, which was improved by statin treatment Stalin treatment led to increased NO levels and reduced mean arterial blood pressure. 6-Keto-PGF(1-alpha) levels tended to increase after trauma, and were significantly reduced by rosuvastatin. Conclusions: Rosuvastatin treatment may improve microcirculation after traumatic brain injury by preserved patency of cerebral capillaries. This effect is associated with increased NO and reduced prostacyclin production. No effect on brain edema or BBB integrity was found. (C) 2013 Elsevier Inc. All rights reserved.	[Jungner, M.; Lundblad, C.; Bentzer, P.] Lund Univ, Dept Anesthesiol & Intens Care, SE-22185 Lund, Sweden	Bentzer, P (corresponding author), Lund Univ, Dept Anesthesiol & Intens Care, SE-22185 Lund, Sweden.	marten.jungner@med.lu.se; cornelia.lundblad@med.lu.se; peter.bentzer@hotmail.com		Lundblad, Cornelia/0000-0001-9686-2112	Swedish Research CouncilSwedish Research CouncilEuropean Commission [11581]; Medical Faculty of Lund University, Region Skane (ALF); Anna and Edwin Berger Foundation	The study was supported by grants from the Swedish Research Council (11581), the Medical Faculty of Lund University, Region Skane (ALF), and the Anna and Edwin Berger Foundation.	Ahn MJ, 2004, J NEUROTRAUM, V21, P1431, DOI 10.1089/neu.2004.21.1431; Bellia A, 2010, ATHEROSCLEROSIS, V210, P199, DOI 10.1016/j.atherosclerosis.2009.11.021; Bentzer P, 2003, J NEUROTRAUM, V20, P447, DOI 10.1089/089771503765355522; Bentzer P, 2001, J NEUROTRAUM, V18, P275, DOI 10.1089/08977150151070919; Beretta S, 2011, NEUROPHARMACOLOGY, V60, P878, DOI 10.1016/j.neuropharm.2011.01.003; Beziaud T, 2011, CRIT CARE MED, V39, P2300, DOI 10.1097/CCM.0b013e3182227e4a; Birnbaum Y, 2005, CARDIOVASC RES, V65, P345, DOI 10.1016/j.cardiores.2004.10.018; BLASBERG RG, 1983, J CEREBR BLOOD F MET, V3, P215, DOI 10.1038/jcbfm.1983.29; Bulhak A, 2007, AM J PHYSIOL-HEART C, V292, pH3158, DOI 10.1152/ajpheart.01354.2006; Chen SF, 2007, LIFE SCI, V81, P288, DOI 10.1016/j.lfs.2007.05.023; Chen XR, 2008, J PHARMACOL EXP THER, V326, P966, DOI 10.1124/jpet.108.140368; Cherian L, 2003, J NEUROTRAUM, V20, P77, DOI 10.1089/08977150360517209; Cherian L, 2003, J PHARMACOL EXP THER, V304, P617, DOI 10.1124/JPET.102.043430; Czosnyka M, 2001, J NEUROSURG, V95, P756, DOI 10.3171/jns.2001.95.5.0756; de Sotomayor MA, 2005, BRIT J PHARMACOL, V146, P1130, DOI 10.1038/sj.bjp.0706420; Degraeve F, 2001, J BIOL CHEM, V276, P46849, DOI 10.1074/jbc.M104197200; Engelhorn T, 2006, NEUROSCI LETT, V406, P92, DOI 10.1016/j.neulet.2006.07.022; Fenstermacher J.D., 1984, EDEMA, P384; FITZGERALD GA, 1983, CIRCULATION, V67, P1174, DOI 10.1161/01.CIR.67.6.1174; Fujita M, 2012, J NEUROTRAUM, V29, P1491, DOI 10.1089/neu.2011.2278; GOBEL U, 1989, J CEREBR BLOOD F MET, V9, P491; Golding EA, 2003, J CEREBR BLOOD F MET, V23, P210, DOI 10.1097/01.WCB.0000044739.64940.B5; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; Grande PO, 2006, INTENS CARE MED, V32, P1475, DOI 10.1007/s00134-006-0294-3; HEKMATPANAH J, 1985, J NEUROSURG, V62, P888, DOI 10.3171/jns.1985.62.6.0888; Hernandez-Presa MA, 2002, ATHEROSCLEROSIS, V160, P49, DOI 10.1016/S0021-9150(01)00547-0; Jungner M, 2010, ANESTHESIOLOGY, V112, P1194, DOI 10.1097/ALN.0b013e3181d94d6e; Laufs U, 2000, STROKE, V31, P2442, DOI 10.1161/01.STR.31.10.2442; Liuni A, 2010, J AM COLL CARDIOL, V55, P1002, DOI 10.1016/j.jacc.2009.11.046; Lu DY, 2007, J NEUROTRAUM, V24, P1132, DOI 10.1089/neu.2007.0288; Lu DY, 2004, J NEUROSURG, V101, P813, DOI 10.3171/jns.2004.101.5.0813; Lundblad C, 2007, MICROVASC RES, V74, P1, DOI 10.1016/j.mvr.2007.03.001; Lundblad C, 2004, J NEUROTRAUM, V21, P741, DOI 10.1089/0897715041269614; Lundblad C, 2008, J CEREBR BLOOD F MET, V28, P367, DOI 10.1038/sj.jcbfm.9600533; Maeda T, 1997, ACT NEUR S, V70, P102; McAdam BF, 1999, P NATL ACAD SCI USA, V96, P272, DOI 10.1073/pnas.96.1.272; McTaggart F, 2001, AM J CARDIOL, V87, p28B; Miller J.D., 1978, JAMA-J AM MED ASSOC, V105, P770; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Naito Y, 2006, WORLD J GASTROENTERO, V12, P2024, DOI 10.3748/wjg.v12.i13.2024; Prinz V, 2008, STROKE, V39, P433, DOI 10.1161/STROKEAHA.107.492470; Prinz V, 2009, ANESTH ANALG, V109, P572, DOI 10.1213/ane.0b013e3181a85d0e; Rikitake Y, 2005, CIRC RES, V97, P1232, DOI 10.1161/01.RES.0000196564.18314.23; RIPPE B, 1994, PHYSIOL REV, V74, P163; Robertson CS, 2011, J NEUROTRAUM, V28, P727, DOI 10.1089/neu.2010.1476; SAKURADA O, 1978, AM J PHYSIOL, V234, pH59; SHOHAMI E, 1987, J CEREBR BLOOD F MET, V7, P58, DOI 10.1038/jcbfm.1987.8; Tsikas D, 2007, J CHROMATOGR B, V851, P51, DOI 10.1016/j.jchromb.2006.07.054; Turkoglu OF, 2009, SURG NEUROL, V72, P146, DOI 10.1016/j.surneu.2008.07.004; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; VILLRINGER A, 1994, CIRC RES, V75, P55, DOI 10.1161/01.RES.75.1.55; von Oettingen G, 2002, NEUROSURGERY, V50, P781, DOI 10.1097/00006123-200204000-00019; Wada K, 1998, J NEUROSURG, V89, P807, DOI 10.3171/jns.1998.89.5.0807; Wang HC, 2007, EXP NEUROL, V206, P59, DOI 10.1016/j.expneurol.2007.03.031; WEST GB, 1977, INT ARCH ALLER A IMM, V55, P542, DOI 10.1159/000231969; WESTCOTT JY, 1987, PROSTAGLANDINS, V34, P877, DOI 10.1016/0090-6980(87)90068-2; Wood WG, 2010, ANN NY ACAD SCI, V1199, P69, DOI 10.1111/j.1749-6632.2009.05359.x	57	11	11	0	5	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0026-2862	1095-9319		MICROVASC RES	Microvasc. Res.	JUL	2013	88						48	55		10.1016/j.mvr.2013.03.004			8	Peripheral Vascular Disease	Cardiovascular System & Cardiology	239FI	WOS:000326007600007	23538316				2021-06-18	
J	King, T; Rosenberg, M; Braham, R; Ferguson, R; Dawson, B				King, Tyler; Rosenberg, Michael; Braham, Rebecca; Ferguson, Renee; Dawson, Brian			Life after the game - Injury profile of past elite Australian Football players	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						Australian football; Health and well-being; Injuries; Concussion; Retirement	SPORTS; CONSEQUENCES; CONCUSSION; RETIREMENT; LEAGUE	Objectives: To investigate the long-term health and well-being of past elite Australian Football League (AFL) players, with particular emphasis on the effect of playing injuries on current lifestyle. Design: Cross sectional survey. Methods: A health and well-being survey, completed by past AFL players (n=592) with mean (+/- SD) age of 55.1 y (+/- 15.8) and playing career of 7.7 y (+/- 4.1) sought information on demographics, education and employment, subjective well-being, lifestyle behaviours, physical health, disease prevalence, community and social structures, and playing history. Results: A majority of past players experienced serious injuries (76%) and concussion (73%) throughout their career, both increasing significantly with the number of games played. Of those who received injuries, 60% require on-going treatment, yet only 6% receive treatment costs covered by their club or the AFL Players' Association. A large proportion (64%) of respondents are affected in daily life from previous AFL injuries. Conclusions: AFL careers are compounded by high injury rates, including loss of consciousness with a high incidence of multiple concussions amongst those players reporting a serious injury. Greater number of injuries received will further the likelihood of requiring on-going treatment and being affected later in life. Additional research and planning may be important in assisting other improvements in the quality of life of past AFL players. (C) 2012 Sports Medicine Australia. Published by Elsevier Ltd. All rights reserved.	[King, Tyler; Rosenberg, Michael; Braham, Rebecca; Ferguson, Renee; Dawson, Brian] Univ Western Australia, Sch Sport Sci Exercise & Hlth, Nedlands, WA 6009, Australia	Braham, R (corresponding author), Univ Western Australia, Sch Sport Sci Exercise & Hlth, Nedlands, WA 6009, Australia.	Rebecca.Braham@uwa.edu.au	Rosenberg, Michael/H-5748-2014		Australian Football Leagues Past Players Association	Funding for this research was received from The Australian Football Leagues Past Players Association. Past players are thanked for their involvement in this work.	AFL Medical Officers Association, 2011, MAN CONC AUSTR FOOTB; Australain Football League Players, 2012, LIV PLAYERS DAT; BAILLIE PHF, 1993, COUNS PSYCHOL, V21, P399, DOI 10.1177/0011000093213004; Braham R, 2004, J SCI MED SPORT, V7, P451, DOI 10.1016/S1440-2440(04)80263-9; Braham R, 2004, J SCI MED SPORT, V7, P96, DOI 10.1016/S1440-2440(04)80048-3; Deacon A, 1997, MED J AUSTRALIA, V166, P187, DOI 10.5694/j.1326-5377.1997.tb140072.x; Finch C, 1998, BRIT J SPORT MED, V32, P220, DOI 10.1136/bjsm.32.3.220; Fortunato V, 1999, J PERS INTERPERS LOS, V4, P269, DOI 10.1080/10811449908409735; Gabbe B, 2001, J SCI MED SPORT, V4, P386, DOI 10.1016/S1440-2440(01)80048-7; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Hickey C, 2007, ED REGULATION MANAGI; McIntosh AS, 2005, BRIT J SPORT MED, V39, P314, DOI 10.1136/bjsm.2005.018200; Meir RA, 1997, BRIT J SPORT MED, V31, P132, DOI 10.1136/bjsm.31.2.132; Meir RA, 2007, J SCI MED SPORT, V10, P187, DOI 10.1016/j.jsams.2006.06.002; Nicholas SJ, 2007, AM J SPORT MED, V35, P1674, DOI 10.1177/0363546507302219; Orchard J, 2002, BRIT J SPORT MED, V36, P39, DOI 10.1136/bjsm.36.1.39; Orchard J, 2012, 20 ANN AFL INJURY RE; Rabadi MH, 2001, CLIN J SPORT MED, V11, P194, DOI 10.1097/00042752-200107000-00011; The Australian Football League, 2010, 2010 RET DEL TRAD	19	11	11	0	25	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440			J SCI MED SPORT	J. Sci. Med. Sport	JUL	2013	16	4					302	306		10.1016/j.jsams.2012.09.003			5	Sport Sciences	Sport Sciences	174RP	WOS:000321173400004	23058879				2021-06-18	
J	Kitagawa, R; Yokobori, S; Mazzeo, AT; Bullock, R				Kitagawa, Ryan; Yokobori, Shoji; Mazzeo, Anna T.; Bullock, Ross			Microdialysis in the Neurocritical Care Unit	NEUROSURGERY CLINICS OF NORTH AMERICA			English	Article						Microdialysis; Neuromonitoring; Traumatic brain injury; Subarachnoid hemorrhage	TRAUMATIC BRAIN-INJURY; ANEURYSMAL SUBARACHNOID HEMORRHAGE; INTRACEREBRAL MICRODIALYSIS; CEREBRAL MICRODIALYSIS; NEUROLOGICAL DEFICITS; METABOLIC CRISIS; HEAD-INJURY; VASOSPASM; LACTATE; ISCHEMIA	Effective monitoring is critical for neurologically compromised patients, and several techniques are available. One of these tools, cerebral microdialysis (MD), was designed to detect derangements in cerebral metabolism. Although this monitoring device began as a research instrument, favorable results and utility have broadened its clinical applications. Combined with other brain monitoring techniques, MD can be used to estimate cerebral vulnerability, to assess tissue outcome, and possibly to prevent secondary ischemic injury by guiding therapy. This article reviews the literature regarding the past, present, and future uses of MD along with its advantages and disadvantages in the intensive care unit setting.	[Kitagawa, Ryan; Yokobori, Shoji; Bullock, Ross] Univ Miami, Miller Sch Med, Dept Neurosurg, Lois Pope LIFE Ctr, Miami, FL 33136 USA; [Yokobori, Shoji] Nippon Med Sch, Dept Emergency & Crit Care Med, Bunkyo Ku, Tokyo 1130083, Japan; [Mazzeo, Anna T.] Univ Turin, Dept Anesthesia & Crit Care, Azienda Osped Citta Salute & Sci Torino Presidio, I-10126 Turin, Italy	Bullock, R (corresponding author), Univ Miami, Miller Sch Med, Dept Neurosurg, Lois Pope LIFE Ctr, 1095 Northwest 14th Terrace, Miami, FL 33136 USA.	rbullock@med.miami.edu		Mazzeo, Anna Teresa/0000-0002-8454-7243			Alves OL, 2003, ANN NY ACAD SCI, V993, P25, DOI 10.1111/j.1749-6632.2003.tb07508.x; AMBERG G, 1989, J PHARMACOL METHOD, V22, P157, DOI 10.1016/0160-5402(89)90012-0; Bellander BM, 2004, INTENS CARE MED, V30, P2166, DOI 10.1007/s00134-004-2461-8; Belli A, 2008, ACTA NEUROCHIR, V150, P461, DOI 10.1007/s00701-008-1580-3; Bjerring PN, 2008, NEUROCRIT CARE, V9, P3, DOI 10.1007/s12028-008-9060-4; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; Chamoun R, 2010, J NEUROSURG, V113, P564, DOI 10.3171/2009.12.JNS09689; Chen Jeff W, 2012, Surg Neurol Int, V3, P57, DOI 10.4103/2152-7806.96868; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; Dhawan V, 2012, J NEUROINTERV SURG, V4, P407, DOI 10.1136/neurintsurg-2011-010158; Engstrom M, 2005, J NEUROSURG, V102, P460, DOI 10.3171/jns.2005.102.3.0460; Fried I, 2001, NAT NEUROSCI, V4, P201, DOI 10.1038/84041; Goodman JC, 2009, CURR OPIN CRIT CARE, V15, P110, DOI 10.1097/MCC.0b013e328325d142; Goodman JC, 1999, CRIT CARE MED, V27, P1965, DOI 10.1097/00003246-199909000-00041; Goodman JC, 1996, J NEUROTRAUM, V13, P549, DOI 10.1089/neu.1996.13.549; Helmy A, 2009, J NEUROTRAUM, V26, P549, DOI 10.1089/neu.2008.0719; Hillered L, 2006, CURR OPIN CRIT CARE, V12, P112, DOI 10.1097/01.ccx.0000216576.11439.df; HILLERED L, 1990, ACTA NEUROCHIR, V102, P91, DOI 10.1007/BF01405420; Hlatky R, 2004, J NEUROTRAUM, V21, P894, DOI 10.1089/0897715041526195; Hutchinson PJ, 2005, PHYSIOL MEAS, V26, P423, DOI 10.1088/0967-3334/26/4/008; Jones DA, 2000, J NEUROCHEM, V75, P1703, DOI 10.1046/j.1471-4159.2000.0751703.x; Khaldi A, 2001, NEUROSURGERY, V49, P33; Kim DH, 2006, NEUROCRIT CARE, V4, P83, DOI 10.1385/NCC:4:1:083; Kolias AG, 2009, J NEUROSCI RES, V87, P1, DOI 10.1002/jnr.21823; Lee GJ, 2008, NEUROL RES, V30, P661, DOI 10.1179/174313208X289570; Low D, 2009, J NEUROTRAUM, V26, P1177, DOI [10.1089/neu.2008.0841, 10.1089/neu.2008-0841]; Magnoni S, 2012, BRAIN, V135, P1268, DOI 10.1093/brain/awr286; Maurer MH, 2007, J CEREBR BLOOD F MET, V27, P1675, DOI 10.1038/sj.jcbfm.9600466; Mazzeo AT, 2008, ACTA NEUROCHIR, V150, P1019, DOI 10.1007/s00701-008-0021-7; Mazzeo AT, 2006, J NEUROSURG ANESTH, V18, P170, DOI 10.1097/01.ana.0000210999.18033.f6; Mellergard P, 2010, BRIT J NEUROSURG, V24, P261, DOI 10.3109/02688690903521605; Merenda A, 2008, J NEUROTRAUM, V25, P527, DOI 10.1089/neu.2007.0359; Miller CM, 2012, CURR NEUROL NEUROSCI, V12, P474, DOI 10.1007/s11910-012-0274-7; Nagel A, 2009, NEUROCRIT CARE, V11, P384, DOI 10.1007/s12028-009-9269-x; Noske DP, 2005, SURG NEUROL, V64, P109, DOI 10.1016/j.surneu.2004.09.036; Oddo M, 2012, CURR OPIN CRIT CARE, V18, P111, DOI 10.1097/MCC.0b013e32835132a5; Pan JW, 2008, EPILEPSIA, V49, P31, DOI 10.1111/j.1528-1167.2008.01508.x; Paraforou Theoniki, 2011, BMC Res Notes, V4, P540, DOI 10.1186/1756-0500-4-540; Pellerin L, 2004, NEUROSCIENTIST, V10, P53, DOI 10.1177/1073858403260159; Petzold A, 2011, BRAIN, V134, P464, DOI 10.1093/brain/awq360; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; Sakowitz OW, 2001, J CEREBR BLOOD F MET, V21, P1067, DOI 10.1097/00004647-200109000-00004; Sarrafzadeh A, 2003, STROKE, V34, P1382, DOI 10.1161/01.STR.0000074036.97859.02; Schulz MK, 2000, J NEUROSURG, V93, P808, DOI 10.3171/jns.2000.93.5.0808; Skjoth-Rasmussen J, 2004, J NEUROSURG, V100, P8, DOI 10.3171/jns.2004.100.1.0008; Staub F, 2000, NEUROSURGERY, V47, P1106, DOI 10.1097/00006123-200011000-00016; Stein NR, 2012, NEUROCRIT CARE, V17, P49, DOI 10.1007/s12028-012-9708-y; Stuart RM, 2010, NEUROCRIT CARE, V12, P188, DOI 10.1007/s12028-010-9330-9; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; Tisdall MM, 2006, BRIT J ANAESTH, V97, P18, DOI 10.1093/bja/ael109; Unterberg AW, 2001, J NEUROSURG, V94, P740, DOI 10.3171/jns.2001.94.5.0740; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Wright WL, 2007, J NEUROL SCI, V261, P10, DOI 10.1016/j.jns.2007.04.027; Wu CT, 2011, ANESTH ANALG, V112, P666, DOI 10.1213/ANE.0b013e318207c51f; Yokobori S, 2001, NEUROL MED CHIR TOKY, V51, P265; Yokobori S, 2011, J TRAUMA, V71, P1235, DOI 10.1097/TA.0b013e3182140dd7; Zetterling M, 2009, ACTA NEUROCHIR, V151, P771, DOI 10.1007/s00701-009-0384-4	57	11	11	0	7	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1042-3680	1558-1349		NEUROSURG CLIN N AM	Neurosurg. Clin. N. Am.	JUL	2013	24	3					417	+		10.1016/j.nec.2013.02.002			11	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	191NY	WOS:000322421100010	23809035				2021-06-18	
J	Kurki, TJI; Laalo, JP; Oksaranta, OM				Kurki, Timo J. I.; Laalo, Jussi P.; Oksaranta, Olli M.			Diffusion tensor tractography of the uncinate fasciculus: Pitfalls in quantitative analysis due to traumatic volume changes	JOURNAL OF MAGNETIC RESONANCE IMAGING			English	Article						diffusion tensor imaging; tractography; traumatic brain injury	WHITE-MATTER INJURY; BRAIN-INJURY; AXONAL INJURY; DISTORTION CORRECTION; HEAD TRAUMA; MR; INTEGRITY; TRACTS; REPRODUCIBILITY; ASSOCIATION	Purpose: To demonstrate the sensitivity of quantitative diffusion tensor tractography to traumatic injury of the uncinate fasciculus (UF), and to evaluate the effect of volume changes on the accuracy of quantitative analysis. Materials and Methods: Diffusion tensor imaging (DTI) was performed at 3 T for 110 patients with traumatic brain injury (TBI) and 60 control subjects. Volume, mean diffusivity (MD), and mean fractional anisotropy (FA) of the UF were measured by means of tractography. The influence of FA threshold on mean FA values was determined and the values were further related to the tract volume. Results: In patients with TBI, 16% of the volumes and 29% of the FA values were decreased and 25% of the MD values were increased (> 2 SD from the mean of controls). Small tracts (6% of trajectories) often had normal mean FA, but low volume-related FA values. Large UFs often had decreased mean FA values, but normal volumerelated central values (3% of trajectories). Conclusion: Posttraumatic FA and MD changes and volume reductions are common in the tractography of UF. Trauma-induced volume changes can cause misleading whole-tract mean FA values. Therefore, additional volume- based analysis of the central part is beneficial for clinical assessment.	[Kurki, Timo J. I.; Oksaranta, Olli M.] Pulssi Med Ctr, FI-20100 Turku, Finland; [Kurki, Timo J. I.; Laalo, Jussi P.] Univ Turku, Dept Radiol, Turku, Finland	Kurki, TJI (corresponding author), Pulssi Med Ctr, MRI Unit, FI-20100 Turku, Finland.	timo.kurki@pulssi.fi		Kurki, Timo/0000-0001-5532-3534			Anderson CV, 1996, J NEUROTRAUM, V13, P59, DOI 10.1089/neu.1996.13.59; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Bammer R, 2002, MAGNET RESON MED, V48, P128, DOI 10.1002/mrm.10184; Catani M, 2002, NEUROIMAGE, V17, P77, DOI 10.1006/nimg.2002.1136; Ciccarelli O, 2003, NEUROIMAGE, V18, P348, DOI 10.1016/S1053-8119(02)00042-3; EBELING U, 1992, ACTA NEUROCHIR, V115, P143, DOI 10.1007/BF01406373; Eluvathingal TJ, 2007, CEREB CORTEX, V17, P2760, DOI 10.1093/cercor/bhm003; Fork M, 2005, BRAIN INJURY, V19, P101, DOI 10.1080/02699050410001726086; Gale SD, 1995, J NEUROTRAUM, V12, P51; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; Hasan KM, 2010, BRAIN STRUCT FUNCT, V214, P361, DOI 10.1007/s00429-009-0238-0; Hasan KM, 2009, BRAIN RES, V1276, P67, DOI 10.1016/j.brainres.2009.04.025; Hsu JL, 2010, NEUROIMAGE, V49, P32, DOI 10.1016/j.neuroimage.2009.08.031; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jaermann T, 2004, MAGN RESON MED, V51, P230, DOI 10.1002/mrm.10707; Jahanshad N, 2010, NEUROIMAGE, V52, P455, DOI 10.1016/j.neuroimage.2010.04.236; Kanaan RA, 2006, PSYCHIAT RES-NEUROIM, V146, P73, DOI 10.1016/j.pscychresns.2005.11.002; KELLY AB, 1988, AM J NEURORADIOL, V9, P699; Kier EL, 2002, AM J NEURORADIOL, V23, P677; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kubicki M, 2002, AM J PSYCHIAT, V159, P813, DOI 10.1176/appi.ajp.159.5.813; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Mamere AE, 2009, AM J NEURORADIOL, V30, P947, DOI 10.3174/ajnr.A1477; Mori S, 2002, MAGN RESON MED, V47, P215, DOI 10.1002/mrm.10074; Mukherjee P, 2008, AM J NEURORADIOL, V29, P843, DOI 10.3174/ajnr.A1052; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; Netsch T, 2004, IEEE T MED IMAGING, V23, P789, DOI 10.1109/TMI.2004.827479; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Partridge SC, 2005, J MAGN RESON IMAGING, V22, P467, DOI 10.1002/jmri.20410; Rohde GK, 2004, MAGN RESON MED, V51, P103, DOI 10.1002/mrm.10677; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; Stadlbauer A, 2008, RADIOLOGY, V247, P179, DOI 10.1148/radiol.2471070707; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Wang JY, 2011, NEUROLOGY, V77, P818, DOI 10.1212/WNL.0b013e31822c61d7; Wang JY, 2008, ARCH NEUROL-CHICAGO, V65, P619, DOI 10.1001/archneur.65.5.619; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; Yoshikawa T, 2008, RADIAT MED, V26, P481, DOI 10.1007/s11604-008-0262-7; Yu CS, 2008, NEUROIMAGE, V40, P1533, DOI 10.1016/j.neuroimage.2008.01.063	42	11	11	0	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1053-1807			J MAGN RESON IMAGING	J. Magn. Reson. Imaging	JUL	2013	38	1					46	53		10.1002/jmri.23901			8	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	180SA	WOS:000321614600006	23733545	Bronze			2021-06-18	
J	Moon, JH; Seo, BR; Jang, JW; Lee, JK; Moon, HS				Moon, Jung-Ho; Seo, Bo-Ra; Jang, Jae-Won; Lee, Jung-Kil; Moon, Hyung-Sik			Evaluation of Probability of Survival Using Trauma and Injury Severity Score Method in Severe Neurotrauma Patients	JOURNAL OF KOREAN NEUROSURGICAL SOCIETY			English	Article						Traumatic brain injury; TRISS; Survival	STATISTICAL VALIDATION; TRISS METHOD; MORTALITY; ASCOT; CARE	Objective : Despite several limitations, the Trauma Injury Severity Score (TRISS) is normally used to evaluate trauma systems. The aim of this study was to evaluate the preventable trauma death rate using the TRISS method in severe trauma patients with traumatic brain injury using our emergency department data. Methods : The use of the TRISS formula has been suggested to consider definitively preventable death (DP); the deaths occurred with a probability of survival (Ps) higher than 0.50 and possible preventable death (PP); the deaths occurred with a Ps between 0.50 and 0.25. Deaths in patients with a calculated Ps of less than 0.25 is considered as non-preventable death (NP). A retrospective case review of deaths attributed to mechanical trauma occurring between January 1, 2011 and December 31, 2011 was conducted. Results : A total of 565 consecutive severe trauma patients with ISS>15 or Revised Trauma Score<7 were admitted in our institute. We excluded a total of 24 patients from our analysis : 22 patients younger than 15 years, and 2 patients with burned injury. Of these, 221 patients with head injury were analyzed in the final study. One hundred eighty-two patients were in DP, 13 in PP and 24 in NP. The calculated predicted mortality rates were 11.13%, 59.04%, and 90.09%. The actual mortality rates were 12.64%, 61.547%, and 91.67%, respectively. Conclusion : Although it needs to make some improvements, the present study showed that TRISS performed well in predicting survival of traumatic brain injured patients. Also, TRISS is relatively exact and acceptable compared with actual data, as a simple and time-saving method.	[Moon, Jung-Ho; Jang, Jae-Won; Lee, Jung-Kil] Chonnam Natl Univ Hosp & Med Sch, Dept Neurosurg, Kwangju, South Korea; [Seo, Bo-Ra; Moon, Hyung-Sik] Mokpo Hankook Hosp, Dept Neurosurg, Mokpo 530822, South Korea	Seo, BR (corresponding author), Mokpo Hankook Hosp, Dept Neurosurg, 483 Yeongsan Ro, Mokpo 530822, South Korea.	cd1379@naver.com					Al West T, 2000, J TRAUMA, V49, P530, DOI 10.1097/00005373-200009000-00022; Barmparas G, 2012, AM SURGEON, V78, P1166; CAYTEN CG, 1991, J TRAUMA, V31, P471, DOI 10.1097/00005373-199104000-00005; Champion HR, 1996, J TRAUMA, V40, P42, DOI 10.1097/00005373-199601000-00009; CHAMPION HR, 1990, J TRAUMA, V30, P1356, DOI 10.1097/00005373-199011000-00008; Chiara Osvaldo, 2006, World J Emerg Surg, V1, P12, DOI 10.1186/1749-7922-1-12; COPES WS, 1988, J TRAUMA, V28, P69, DOI 10.1097/00005373-198801000-00010; Gabbe BJ, 2004, ACAD EMERG MED, V11, P181, DOI 10.1197/j.aem.2003.08.019; HANNAN EL, 1995, J TRAUMA, V38, P83, DOI 10.1097/00005373-199501000-00022; Kilgo PD, 2006, J TRAUMA, V60, P1002, DOI 10.1097/01.ta.0000215827.54546.01; Kilgo PD, 2004, J TRAUMA, V57, P479, DOI 10.1097/01.TA.0000141024.96440.7C; Kim JJ, 2011, NEUROTHERAPEUTICS, V8, P39, DOI 10.1007/s13311-010-0003-3; Kirkham JJ, 2008, STAT MED, V27, P5725, DOI 10.1002/sim.3379; Millham FH, 2004, J TRAUMA, V56, P1090, DOI 10.1097/01.TA.0000119689.81910.06; Moore L, 2006, J TRAUMA, V60, P305, DOI 10.1097/01.ta.0000200840.89685.b0; Moore L, 2006, J TRAUMA, V60, P1238, DOI 10.1097/01.ta.0000195593.60245.80; Moore L, 2010, J TRAUMA, V68, P698, DOI 10.1097/TA.0b013e3181aa093d; Schluter PJ, 2010, J TRAUMA, V68, P761, DOI 10.1097/TA.0b013e3181d3223b; TRUNKEY DD, 1983, SCI AM, V249, P28, DOI 10.1038/scientificamerican0883-28	19	11	11	0	3	KOREAN NEUROSURGICAL SOC	SEOUL	#402 POSCO # OFFICE BUILDING 151 SUNHWA-DONG, JUNG-GU, SEOUL, 100-130, SOUTH KOREA	2005-3711	1598-7876		J KOREAN NEUROSURG S	J. Korean. Neurosurg. Soc.	JUL	2013	54	1					42	46		10.3340/jkns.2013.54.1.42			5	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	211OB	WOS:000323916600009	24044080	DOAJ Gold, Green Published			2021-06-18	
J	Hogan, NS; Coolican, M; Schmidt, LA				Hogan, Nancy S.; Coolican, Maggie; Schmidt, Lee A.			Making meaning in the legacy of tissue donation for donor families	PROGRESS IN TRANSPLANTATION			English	Article							PEDIATRIC ORGAN DONATION; BRAIN-DEATH; CONSENT; GRIEF; BEREAVEMENT; KNOWLEDGE; ATTITUDES; REFUSAL	Context-Individuals needing lifesaving (heart valves, skin grafts for repair of critical burn injuries) and life-enhancing (corneas, bone and tendon grafts, skin, and veins) tissue donations outnumber the tissues available for transplant. Objective-To describe the grief family members experienced 6 months after donation and to learn how family decision makers gained meaning from the decision to donate a loved one's tissues. This is phase 1 of a longitudinal study in which family decision makers will be surveyed again at 13 and 25 months after donation. Design-Qualitative descriptive. Participants-One hundred seven family decision makers whose family member died a traumatic sudden death and who authorized donating tissues for transplant. Data Collection and Analysis-Data were written responses to the questions, "If you could ask or tell your dead family member something, what would it be?" and "What meaning does donating tissue to others have for you?" Data were analyzed by using content analysis procedures. Results-Concepts derived from the first question represent the context of family members grieving the sudden death of a loved one. Concepts were (1) feeling empty, (2) missing and loving, (3) being grateful, and (4) having regrets. The concepts derived from the second question were (1) fulfilling their family member's wish, (2) doing the right thing, (3) believing something good came from the death, (4) helping others, and (5) living on. Reasons for donating were based, in part, on honoring the legacy of their loved ones who had given of themselves to others in life and now continued to give to others after death. Conclusion-The results of this study provide a basis for health professionals and donation staffs to better understand the context within which families grieve and give meaning to tissue donation. (C) 2013 NATCO, The Organization for Transplant Professionals	[Hogan, Nancy S.; Schmidt, Lee A.] Loyola Univ Chicago, Chicago, IL USA; [Coolican, Maggie] Musculoskeletal Transplant Fdn, East Hampton, CT USA	Hogan, NS (corresponding author), Loyola Univ Chicago, Marcella Niehoff Sch Nursing, 2160 South First Ave 105-2846, Maywood, IL 60153 USA.	nhogdn@luc.edu			Musculoskeletal Transplant Foundation	This study was partially supported by the Musculoskeletal Transplant Foundation.	Bellali T, 2007, Intensive Crit Care Nurs, V23, P216, DOI 10.1016/j.iccn.2007.01.002; Bellali T, 2006, DEATH STUD, V30, P883, DOI 10.1080/07481180600923257; Bredehorn T, 2002, TRANSPLANT P, V34, P2353, DOI 10.1016/S0041-1345(02)03284-0; Burnett P, 1997, PSYCHOL MED, V27, P49, DOI 10.1017/S0033291796004151; Burroughs TE, 1998, PSYCHOSOM MED, V60, P156, DOI 10.1097/00006842-199803000-00007; Cleiren MPHD, 2002, DEATH STUD, V26, P837, DOI 10.1080/07481180290106607; Core C, 2008, BEREAVEMENT CENTERED; Corr CA, 2011, PROG TRANSPLANT, V21, P220, DOI 10.7182/prtr.21.3.d33p21p72089213m; Corr CA, 2010, PROG TRANSPLANT, V20, P169, DOI 10.7182/prtr.20.2.w7727276m86241w4; DOUGLASS GE, 1995, ANAESTH INTENS CARE, V23, P96, DOI 10.1177/0310057X9502300126; Gallup Organization, 1993, AM PUBLICS ATTITUDES; GORDON AK, 1995, CLIN TRANSPLANT, V9, P141; Gumbley E, 2006, Nurs Stand, V21, P51; Haire MC, 1996, MED J AUSTRALIA, V164, P28, DOI 10.5694/j.1326-5377.1996.tb94106.x; Hogan NS, 2002, DEATH STUD, V26, P615, DOI 10.1080/07481180290088338; Hogan NS, 2001, DEATH STUD, V25, P1, DOI 10.1080/074811801750058609; Hogan NS., 1992, QUAL HEALTH RES, V2, P159, DOI [10.1177/104973239200200204, DOI 10.1177/104973239200200204]; Jacobs J. E., 2005, DEV JUDGMENT DECISIO; Krippendorff K., 2013, CONTENT ANAL INTRO I, V3rd; Lichtenthal WG, 2010, J CLIN PSYCHOL, V66, P791, DOI 10.1002/jclp.20700; Long T, 2008, SOC SCI MED, V67, P253, DOI 10.1016/j.socscimed.2008.03.039; Merchant SJ, 2008, CLIN TRANSPLANT, V22, P341, DOI 10.1111/j.1399-0012.2008.00790.x; Morse J M, 1995, Holist Nurs Pract, V9, P38; Nasrollahzadeh D, 2003, TRANSPL P, V35, P2545, DOI 10.1016/j.transproceed.2003.08.052; Neimeyer RA, 2001, HDB BEREAVEMENT RES, P89, DOI DOI 10.1037/10436-004; Niday Patricia, 2007, Prog Transplant, V17, P289; Razek T, 2000, SURG CLIN N AM, V80, P1021, DOI 10.1016/S0039-6109(05)70111-0; Rodrigue JR, 2008, PEDIATR CRIT CARE ME, V9, P180, DOI 10.1097/PCC.0b013e3181668605; Saviozzi A, 2010, TRANSPL P, V42, P2195, DOI 10.1016/j.transproceed.2010.05.024; Sebach AM, 2012, J EMERG NURS, V38, P63, DOI 10.1016/j.jen.2011.01.013; Shabanzadeh AP, 2009, TRANSPL P, V41, P1480, DOI 10.1016/j.transproceed.2009.01.113; Shih FJ, 2001, PSYCHOSOM MED, V63, P69, DOI 10.1097/00006842-200101000-00009; Siminoff LA, 2010, J TRAUMA, V69, P956, DOI 10.1097/TA.0b013e3181d8924b; Siminoff LA, 2009, PROG TRANSPLANT, V19, P35, DOI 10.7182/prtr.19.1.9q02364408755h18; Sque M, 2005, TRANSPLANT P, V37, P543, DOI 10.1016/j.transproceed.2004.11.038; Sque M, 1996, SOC SCI MED, V43, P1359, DOI 10.1016/0277-9536(96)00002-0; Stouder DB, 2009, PROG TRANSPLANT, V19, P358; Tebourski Fethi, 2003, Tunis Med, V81, P482; WALKER JA, 1990, CAN MED ASSOC J, V142, P1383; Waters G, 2002, BEHAV BRAIN SCI, V25, P644, DOI 10.1017/S0140525X02480119; Wilson Penelope, 2006, Prog Transplant, V16, P52	41	11	11	0	11	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1526-9248	2164-6708		PROG TRANSPLANT	Prog. Transplant.	JUN	2013	23	2					180	187		10.7182/pit2013862			8	Surgery; Transplantation	Surgery; Transplantation	AT5KZ	WOS:000344983300012	23782667	Green Published			2021-06-18	
J	Moore, NA; Brennan, PM; Baillie, JK				Moore, N. A.; Brennan, P. M.; Baillie, J. K.			Wide variation and systematic bias in expert clinicians' perceptions of prognosis following brain injury	BRITISH JOURNAL OF NEUROSURGERY			English	Article						head injury; intensive care; neurosurgery; prognosis; traumatic brain injury	INTENSIVE-CARE; DECISIONS; DOCTORS; TRIAGE; ILL	Background. The heterogeneous nature of traumatic brain injury (TBI) makes outcome prediction difficult. Although a considerable evidence base exists in the form of well-validated predictive models, these models are not widely used. We hypothesised that this prognostic gap, between the availability and use of prognostic data, leads to inaccurate perceptions of patient outcome. We investigated whether outcome predictions in TBI made by expert clinicians were consistent and accurate when compared to a well-validated prognostic model (IMPACT). Methods. Neurosurgeons and neurointensivists were asked to predict probability of death at 6 months for 12 case vignettes describing patients with isolated TBI. Predictions were compared to IMPACT prognosis for each vignette. To interrogate potential sources of bias in clinical predictions, respondents were given one of two sets of vignettes (A or B) identical apart from one critical factor known to make a large difference to outcome. Results. 27 of 33 questionnaires were returned. Clinicians were consistently more pessimistic about outcomes than the IMPACT model, predicting a significantly greater probability of death (mean difference + 16.3%, 95% CI 13.3-19.4, p < 0.001). There was wide variation between clinicians predicting outcomes for any given vignette (mean range 68.3%), and within the predictions made by each individual: 30% of clinicians were both the most pessimistic respondent, and the most optimistic, for at least one vignette. Clinicians modified their predictions appropriately for most of the factors altered between corresponding vignettes. However when the reported blood glucose was changed, clinicians 'predictions deviated widely from IMPACT predictions, indicating that clinicians systematically overlooked the prognostic relevance of this information. Conclusion. Clinical experts 'predictions of outcome in TBI are widely variable and systematically pessimistic compared to IMPACT. Clinicians overlook important factors in formulating these predictions. Use of well-validated outcome models may add value and consistency to prognostication.	[Moore, N. A.] Univ Edinburgh, Sch Med, Edinburgh EH16 4TJ, Midlothian, Scotland; [Brennan, P. M.] Western Gen Hosp, Dept Clin Neurosci, Honorary SPR Neurosurg, Edinburgh EH4 2XU, Midlothian, Scotland; [Baillie, J. K.] Univ Edinburgh, Dept Crit Care Med, Edinburgh EH16 4TJ, Midlothian, Scotland	Baillie, JK (corresponding author), Univ Edinburgh, Dept Crit Care Med, 47 Little France Crescent, Edinburgh EH16 4TJ, Midlothian, Scotland.	j.k.baillie@ed.ac.uk	Baillie, John Kenneth/F-3124-2011	Baillie, John Kenneth/0000-0001-5258-793X			ALEXANDER E, 1992, SURG NEUROL, V38, P478, DOI 10.1016/0090-3019(92)90124-6; Azoulay E, 2001, CRIT CARE MED, V29, P2132, DOI 10.1097/00003246-200111000-00014; Cook D, 2003, NEW ENGL J MED, V349, P1123, DOI 10.1056/NEJMoa030083; EISENBERG JM, 1979, ANN INTERN MED, V90, P957, DOI 10.7326/0003-4819-90-6-957; Escher M, 2004, BRIT MED J, V329, P425, DOI 10.1136/bmj.329.7463.425; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perel P, 2007, J EVAL CLIN PRACT, V13, P464, DOI 10.1111/j.1365-2753.2006.00713.x; Rocker G, 2004, CRIT CARE MED, V32, P1149, DOI 10.1097/01.CCM.0000126402.51524.52; Skrobik Y, 2006, CAN J ANAESTH, V53, P432, DOI 10.1007/BF03022613; Sprung CL, 1997, INTENS CARE MED, V23, P1011, DOI 10.1007/s001340050449; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; WACHTER RM, 1989, ANN INTERN MED, V111, P525, DOI 10.7326/0003-4819-111-6-525	12	11	11	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.	JUN	2013	27	3					340	343		10.3109/02688697.2012.754402			4	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	136HR	WOS:000318353500010	23461749				2021-06-18	
J	Pastore, V; Colombo, K; Villa, F; Galbiati, S; Adduci, A; Poggi, G; Massimino, M; Recla, M; Liscio, M; Strazzer, S				Pastore, Valentina; Colombo, Katia; Villa, Federica; Galbiati, Susanna; Adduci, Annarita; Poggi, Geraldina; Massimino, Maura; Recla, Monica; Liscio, Mariarosaria; Strazzer, Sandra			Psychological and adjustment problems due to acquired brain lesions in pre-school-aged patients	BRAIN INJURY			English	Article						Acquired brain injury; children; psychological problems	TERM-FOLLOW-UP; HEAD-INJURY; PSYCHIATRIC-DISORDERS; SOCIAL COMPETENCE; TUMOR SURVIVORS; CHILDREN; CHILDHOOD; ADOLESCENTS; RECOVERY; OUTCOMES	Objective: To describe and compare psychological, behavioural and adjustment problems in pre-school patients with acquired brain lesions of different aetiology. Methods: Three groups of patients with acquired brain lesions (14 patients post-TBI, 18 brain tumour survivors and 23 patients with vascular or infectious brain lesions), ranging in age between 24-47 months, received a psychological evaluation, including the Child Behavior Checklist for Ages 2-3 (CBCL) and the Vineland Adaptive Behavior Scales (VABS). Results: About half of the total sample (47.2%) showed psychological and behavioural problems. Difficulties vary according to the aetiology of the brain lesions. Brain tumour survivors showed more marked internalizing problems, whereas children with vascular or infectious brain lesions scored higher on the CBCL externalizing scales. Children with traumatic brain injury reported intermediate scores on most of the CBCL scales. Conclusions: Psychological and behavioural difficulties are very common, not only among school-aged children and adolescents, but also among pre-schoolers with acquired brain lesions. The relevance and the impact of these difficulties must necessarily be considered when developing psychological treatment and rehabilitation plans and planning for social re-entry.	[Pastore, Valentina; Colombo, Katia; Villa, Federica; Galbiati, Susanna; Adduci, Annarita; Poggi, Geraldina; Recla, Monica; Liscio, Mariarosaria; Strazzer, Sandra] IRCCS Eugenio Medea, I-23842 Bosisio Parini, LC, Italy; [Massimino, Maura] Natl Tumor Inst, Milan, Italy	Pastore, V (corresponding author), IRCCS Eugenio Medea, Via Don Luigi Monza 20, I-23842 Bosisio Parini, LC, Italy.	valentina.pastore@bp.lnf.it	Recla, Monica/ABG-1905-2020; Galbiati, Susanna/AAH-6883-2019; Strazzer, Sandra/AAH-5712-2019; Colombo, Katia/ABE-5754-2020; massimino, maura/K-7310-2016; Pastore, Valentina/AAH-6831-2019; Poggi, Geraldina/K-4490-2016	Recla, Monica/0000-0002-3001-8872; Galbiati, Susanna/0000-0001-7209-4251; Strazzer, Sandra/0000-0001-8414-6565; Colombo, Katia/0000-0002-5390-106X; massimino, maura/0000-0002-5506-2001; Pastore, Valentina/0000-0002-3170-3070; Poggi, Geraldina/0000-0003-0589-6347			Achenbach TM., 1992, MANUAL CHILD BEHAV C; Adduci A, 2012, PEDIATR BLOOD CANCER, V59, P290, DOI 10.1002/pbc.24165; Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Anderson V, 2000, PEDIATR NEUROSURG, V32, P282, DOI 10.1159/000028956; Andrews TK, 1998, BRAIN INJURY, V12, P133, DOI 10.1080/026990598122755; Barbero P, 2003, REV NEUROLOGIA, V36, P143; Berg S, 2002, EUR J PEDIATR, V161, P330, DOI 10.1007/s00431-002-0957-1; BOONYAPRAKOB V, 1981, J MED ASSOC THAILAND, V64, P249; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; CAPLAN R, 1987, J AM ACAD CHILD PSY, V26, P440, DOI 10.1097/00004583-198705000-00029; Catroppa C, 2012, J NEUROTRAUM, V29, P2539, DOI 10.1089/neu.2012.2403; Cattelani R, 1998, BRAIN INJURY, V12, P283, DOI 10.1080/026990598122584; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; DANOFF BF, 1982, CANCER, V48, P1580, DOI 10.1002/1097-0142(19820415)49:8<1580::AID-CNCR2820490810>3.0.CO;2-7; Daseking M, 2008, FORTSCHR NEUROL PSYC, V76, P662, DOI 10.1055/s-2008-1038262; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Fossen A, 1998, PEDIATR HEMAT ONCOL, V15, P479, DOI 10.3109/08880019809018309; Fuemmeler BF, 2002, CLIN PSYCHOL REV, V22, P547, DOI 10.1016/S0272-7358(01)00120-9; Ganesalingam K, 2007, J NEUROPSYCHOL, V1, P149, DOI 10.1348/174866407X185300; Griffiths R., 1996, GRIFFITHS MENTAL DEV; Gualtieri CT, 1999, NEUROREHABILITATION, V13, P103; Halket S, 2003, ARCH DIS CHILD, V88, P395, DOI 10.1136/adc.88.5.395; Hooper L, 2007, NEUROPSYCHOL REHABIL, V17, P621, DOI 10.1080/09602010601137054; JENNETT B, 1975, LANCET, V1, P480; Lannoo E, 2001, BRAIN INJURY, V15, P1, DOI 10.1080/02699050150209084; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1278, DOI 10.1097/00004583-199709000-00021; Max JE, 1998, J NEUROPSYCH CLIN N, V10, P290, DOI 10.1176/jnp.10.3.290; MICHAUD LJ, 1993, PEDIATR CLIN N AM, V40, P553; Micklewright JL, 2012, J INT NEUROPSYCH SOC, V18, P343, DOI 10.1017/S1355617711001792; MULHERN RK, 1993, J PEDIATR PSYCHOL, V18, P339, DOI 10.1093/jpepsy/18.3.339; MULHERN RK, 1989, PEDIATRICS, V83, P18; Nassau JH, 1997, J PEDIATR PSYCHOL, V22, P771, DOI 10.1093/jpepsy/22.6.771; Nybo T, 1999, BRAIN INJURY, V13, P759; Pastore V, 2011, DISABIL REHABIL, V33, P675, DOI 10.3109/09638288.2010.506239; Petersen C, 2008, BRAIN INJURY, V22, P215, DOI 10.1080/02699050801935245; Poggi G, 2005, BRAIN INJURY, V19, P777, DOI 10.1080/0269905500110132; Poggi G, 2005, PSYCHO-ONCOLOGY, V14, P386, DOI 10.1002/pon.855; Poggi G, 2009, DISABIL REHABIL, V31, P1066, DOI 10.1080/09638280802509546; Sparrow S., 1984, VINELAND ADAPTIVE BE; Thompson JR, 1999, ADAPTIVE BEHAVIOR AND ITS MEASUREMENT, P15; Wells R, 2009, DEV NEUROREHABIL, V12, P12, DOI 10.1080/17518420902773109; WIDAMAN KF, 1996, MANUAL DIAGNOSIS PRO; Ylvisaker Mark, 2007, Phys Med Rehabil Clin N Am, V18, P133, DOI 10.1016/j.pmr.2006.11.007	44	11	11	0	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN	2013	27	6					677	684		10.3109/02699052.2013.775482			8	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	143QO	WOS:000318882500006	23560501				2021-06-18	
J	Saxena, MK; Taylor, CB; Hammond, NE; Young, PJ; Seppelt, IM; Glass, P; Myburgh, JA				Saxena, Manoj K.; Taylor, Colman B.; Hammond, Naomi E.; Young, Paul J.; Seppelt, Ian M.; Glass, Parisa; Myburgh, John A.		George Inst Global Hlth; ANZICS Clinical Trials Grp	Temperature management in patients with acute neurological lesions: an Australian and New Zealand point prevalence study	CRITICAL CARE AND RESUSCITATION			English	Article							PERCUSSION BRAIN-INJURY; LENGTH-OF-STAY; BODY-TEMPERATURE; PARACETAMOL ACETAMINOPHEN; SUBARACHNOID HEMORRHAGE; CRITICALLY-ILL; PROTEIN-LEVELS; HYPERTHERMIA; STROKE; HYPOTHERMIA	Background: Given the scientific uncertainty of the efficacy and safety of normothermia (36.0 degrees C to 37.5 degrees C) on disability and death after acute neurological lesions, we sought to understand how temperature is managed in usual clinical care for this patient population in Australia and New Zealand. Objective: To describe temperature management in patients with acute neurological lesions. Design: Prospective, observational, multicentre, single-day point-prevalence study. Participants, setting and methods: Observational data of usual practice were recorded for all patients with an intensive care admission diagnosis of acute neurological lesions and who were present in 33 intensive care units at 10:00 on the study day. Data were collected prospectively for the ensuing 24-hour period. Main outcome measures: Achieved temperature, interventions used to modify temperature and target temperature. Results: There were 106 patients with acute neurological lesions (61% with either stroke or traumatic brain injury) with a mean APACHE (Acute Physiology and Chronic Health Evaluation) II score of 19.3 +/- 7.4, age of 53.5 +/- 19.0 years and median time from intensive care admission to data capture of 3 days (interquartile range, 1-9). A target temperature was specified in 24% of patients. Although paracetamol was commonly used (56%), it was infrequently used at the maximum licensed dose and there was no use recorded of non-steroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors. Physical cooling was used in 25% of patients and core temperature was measured in 32%. Measured temperature often exceeded 37.0 degrees C (62% of readings), 37.5 degrees C (43%) and 38.0 degrees C (22%). Conclusions: Temperature readings above 37.5 degrees C are common. Further cohort studies are required to validate these preliminary, exploratory findings.	[Saxena, Manoj K.; Myburgh, John A.] St George Hosp, Dept Intens Care Med, Sydney, NSW, Australia; [Saxena, Manoj K.; Taylor, Colman B.; Hammond, Naomi E.; Seppelt, Ian M.; Glass, Parisa; Myburgh, John A.] George Inst Global Hlth, Sydney, NSW, Australia; [Saxena, Manoj K.; Myburgh, John A.] Univ New S Wales, St George Clin Sch, Sydney, NSW, Australia; [Young, Paul J.] Med Res Inst New Zealand, Wellington, New Zealand; [Young, Paul J.] Wellington Reg Hosp, Intens Care Unit, Wellington, New Zealand; [Seppelt, Ian M.] Australian & New Zealand Intens Care Soc Clin Tri, Melbourne, Vic, Australia; [Seppelt, Ian M.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia	Saxena, MK (corresponding author), St George Hosp, Dept Intens Care Med, Sydney, NSW, Australia.	m.saxena@unsw.edu.au		Glass, Parisa/0000-0002-1334-7156; Saxena, Manoj/0000-0002-0385-6731; Hammond, Naomi/0000-0002-6559-7747; Young, Paul/0000-0002-3428-3083	Intensive Care Foundation; St George Honda Critical Care; Trauma Fellowship	The Point Prevalence Program is funded by the Intensive Care Foundation. Manoj Saxena and John Myburgh are recipients of an unrestricted grant from the St George Honda Critical Care and Trauma Fellowship.	Adelson P David, 2003, Pediatr Crit Care Med, V4, pS53; AZZIMONDI G, 1995, STROKE, V26, P2040, DOI 10.1161/01.STR.26.11.2040; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Chatzipanteli K, 2000, J CEREBR BLOOD F MET, V20, P531, DOI 10.1097/00004647-200003000-00012; Childs Charmaine, 2010, Front Neurol, V1, P146, DOI 10.3389/fneur.2010.00146; *CURR CONTR TRIALS, EUR SOC INT CAR MED; den Hertog HM, 2009, LANCET NEUROL, V8, P434, DOI 10.1016/S1474-4422(09)70051-1; Den Hertog HM, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001247.pub2; Dippel DWJ, 2001, STROKE, V32, P1607, DOI 10.1161/01.STR.32.7.1607; Diringer MN, 2004, CRIT CARE MED, V32, P1489, DOI 10.1097/01.CCM.0000129484.61912.84; Drennan K, 2010, INTENSIVE CARE RESOU; Geffroy A, 2004, INTENS CARE MED, V30, P785, DOI 10.1007/s00134-004-2280-y; Greer DM, 2008, STROKE, V39, P3029, DOI 10.1161/STROKEAHA.108.521583; Harris B, 2011, J ADV NURS, V67, P1173, DOI 10.1111/j.1365-2648.2011.05703.x; Huschak G, 2008, J NEUROSURG ANESTH, V20, P105, DOI 10.1097/ANA.0b013e31815f528c; Jefferies S, 2011, CRIT CARE RESUSC, V13, P194; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; Jorgensen HS, 2001, CEREBROVASC DIS, V11, P207, DOI 10.1159/000047640; KATO H, 1991, NEUROSCI LETT, V126, P21, DOI 10.1016/0304-3940(91)90361-V; Kilpatrick MM, 2000, NEUROSURGERY, V47, P850, DOI 10.1097/00006123-200010000-00011; Kim Y, 1996, STROKE, V27, P2274, DOI 10.1161/01.STR.27.12.2274; Kinoshita K, 2002, NEUROSURGERY, V51, P195, DOI 10.1097/00006123-200207000-00027; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Manno EM, 2004, CRIT CARE MED, V32, P1611, DOI 10.1097/01.CCM.0000131864.83506.86; Marion DW, 2004, CRIT CARE MED, V32, pS43, DOI 10.1097/01.CCM.0000110731.69637.16; Matsui T, 2008, J NEUROTRAUM, V25, P709, DOI 10.1089/neu.2007.0482; Mcilvoy Laura, 2007, J Neurosci Nurs, V39, P324; Moran JL, 2007, CRIT CARE MED, V35, P155, DOI 10.1097/01.CCM.0000250318.31453.CB; Natale JE, 2000, CRIT CARE MED, V28, P2608, DOI 10.1097/00003246-200007000-00071; Oddo M, 2009, STROKE, V40, P1913, DOI 10.1161/STROKEAHA.108.534115; Oliveira J, 2001, NEUROLOGY, V56, P1299, DOI 10.1212/WNL.56.10.1299; Reith J, 1996, LANCET, V347, P422, DOI 10.1016/S0140-6736(96)90008-2; Saxena M, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006811.pub2; Soukup J, 2002, J NEUROTRAUM, V19, P559, DOI 10.1089/089771502753754046; Stocchetti N, 2005, J NEUROL NEUROSUR PS, V76, P1135, DOI 10.1136/jnnp.2004.041269; Stocchetti N, 2002, INTENS CARE MED, V28, P1555, DOI 10.1007/s00134-002-1513-1; Suehiro E, 1999, J NEUROTRAUM, V16, P285, DOI 10.1089/neu.1999.16.285; TAKAGI K, 1994, AM J PHYSIOL-HEART C, V267, pH1770; Todd MM, 2005, NEW ENGL J MED, V352, P135, DOI 10.1056/NEJMoa040975; Vitarbo EA, 2004, NEUROSURGERY, V55, P416, DOI 10.1227/01.NEU.0000130036.52521.2C	41	11	11	0	4	AUSTRALASIAN MED PUBL CO LTD	PYRMONT	LEVEL 2, 26-32 PYRMONT BRIDGE RD, PYRMONT, NSW 2009, AUSTRALIA	1441-2772			CRIT CARE RESUSC	Crit Care Resusc.	JUN	2013	15	2					110	118					9	Critical Care Medicine	General & Internal Medicine	151UJ	WOS:000319485400007	23931042				2021-06-18	
J	Selvan, V; Ganpule, S; Kleinschmit, N; Chandra, N				Selvan, Veera; Ganpule, Shailesh; Kleinschmit, Nick; Chandra, Namas			Blast Wave Loading Pathways in Heterogeneous Material Systems-Experimental and Numerical Approaches	JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME			English	Article						blast wave; pressure; transmission; deflection; impedance; shell thickness	TRAUMATIC BRAIN-INJURY; SHOCK-WAVES; RAT; PROPAGATION; MECHANISM; IMPACT; MODEL	Blast waves generated in the field explosions impinge on the head-brain complex and induce mechanical pressure pulses in the brain resulting in traumatic brain injury. Severity of the brain injury (mild to moderate to severe) is dependent upon the magnitude and duration of the pressure pulse, which in turn depends on the intensity and duration of the oncoming blast wave. A fluid-filled cylinder is idealized to represent the head-brain complex in its simplest form; the cylinder is experimentally subjected to an air blast of Friedlander type, and the temporal variations of cylinder surface pressures and strains and fluid pressures are measured. Based on these measured data and results from computational simulations, the mechanical loading pathways from the external blast to the pressure field in the fluid are identified; it is hypothesized that the net loading at a given material point in the fluid comprises direct transmissive loads and deflection-induced indirect loads. Parametric studies show that the acoustic impedance mismatches between the cylinder and the contained fluid as well as the flexural rigidity of the cylinder determine the shape/intensity of pressure pulses in the fluid.	[Selvan, Veera; Ganpule, Shailesh; Kleinschmit, Nick; Chandra, Namas] Univ Nebraska, Dept Mech & Mat Engn, Lincoln, NE 68588 USA		veera_1431@yahoo.co.in; shailesh@huskers.unl.edu; n_kleinschmit@yahoo.com; nchandra2@unl.edu			US Army Research Office for the project on 'Army-UNL Center for Trauma Mechanics' [W911NF-08-1-0483]	The authors acknowledge the financial support provided by the US Army Research Office for the project on 'Army-UNL Center for Trauma Mechanics', Contract No. W911NF-08-1-0483 (Project manager: Larry Russell, PI: Namas Chandra). The authors thank Ruqiang Feng for his valuable suggestions during discussions.	Alley MD, 2011, NEUROIMAGE, V54, pS45, DOI 10.1016/j.neuroimage.2010.05.030; Anderson J. D., 2001, J NEUROL NEUROSUR PS; Arun P, 2011, NEUROREPORT, V22, P379, DOI 10.1097/WNR.0b013e328346b138; Bir C., 2011, MEASURING BLAST RELA; Bolander R, 2011, ANN BIOMED ENG, V39, P2550, DOI 10.1007/s10439-011-0343-0; Carlucci P., 2010, SIMULIA CUST C; Cernak I, 1997, WORLD J SURG, V21, P240, DOI 10.1007/s002689900223; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Chafi MS, 2009, INT J IMPACT ENG, V36, P1269, DOI 10.1016/j.ijimpeng.2009.03.007; Chandra N, 2012, SHOCK WAVES, V22, P403, DOI 10.1007/s00193-012-0399-2; Chandra N., 2011, U.S. provisional patent application, Patent No. 61542354; Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; Chavko M, 2011, J NEUROSCI METH, V195, P61, DOI 10.1016/j.jneumeth.2010.11.019; Chen X, 2004, INT J SOLIDS STRUCT, V41, P4635, DOI 10.1016/j.ijsolstr.2004.02.064; Chen X, 2004, COMPOS SCI TECHNOL, V64, P1477, DOI 10.1016/j.compscitech.2003.10.024; Cheng JM, 2010, J NEUROL SCI, V294, P23, DOI 10.1016/j.jns.2010.04.010; CLEMEDSON CJ, 1953, AM J PHYSIOL, V174, P316; CLEMEDSON CJ, 1956, AM J PHYSIOL, V184, P119, DOI 10.1152/ajplegacy.1955.184.1.119; Courtney AC, 2009, MED HYPOTHESES, V72, P76, DOI 10.1016/j.mehy.2008.08.015; CRAMER F, 1949, ARCH NEURO PSYCHIATR, V61, P1; Cullis I G, 2001, J R Army Med Corps, V147, P16; El Sayed T, 2008, COMPUT METHOD APPL M, V197, P4692, DOI 10.1016/j.cma.2008.06.006; FRY FJ, 1978, J ACOUST SOC AM, V63, P1576, DOI 10.1121/1.381852; Ganpule S, 2012, COMPUT METHOD BIOMEC, V15, P1233, DOI 10.1080/10255842.2011.597353; Ganpule S., 2012, BIOMECH MODEL MECHAN; Ganpule S., 2013, INTRACRANIA IN PRESS; Goeller J, 2012, J NEUROTRAUM, V29, P1970, DOI 10.1089/neu.2011.2224; Honma H, 2003, SHOCK WAVES, V13, P179, DOI 10.1007/s00193-003-0206-1; King AI, 2001, ANNU REV BIOMED ENG, V3, P27, DOI 10.1146/annurev.bioeng.3.1.27; Kodama T, 2000, BIOPHYS J, V79, P1821, DOI 10.1016/S0006-3495(00)76432-0; Krohn P., 1941, REPORT HO, V195, P249; Leonardi AD, 2011, J NEUROTRAUM, V28, P85, DOI 10.1089/neu.2010.1324; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; LUDWIG GD, 1950, J ACOUST SOC AM, V22, P862, DOI 10.1121/1.1906706; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Mowatt S, 2011, SHOCK WAVES, V21, P467, DOI 10.1007/s00193-011-0322-2; Narayan Yoganandan P. D., 1998, FRONTIERS HEAD NECK; Ofengeim DK, 1997, SHOCK WAVES, V7, P305, DOI 10.1007/s001930050085; Rafaels K, 2011, J NEUROTRAUM, V28, P2319, DOI 10.1089/neu.2009.1207; Rahman M.A., 2005, P INT C MECH ENG 200; Romba J. J., 1961, TM1761 HUM ENG LAB A; Skotak M., 2013, J NEUROTRAU IN PRESS; Skotak M, 2012, J NEUROSCI METH, V205, P159, DOI 10.1016/j.jneumeth.2012.01.001; Stewart OW, 1941, LANCET, V1, P172; Sundaramurthy A, 2012, J NEUROTRAUM, V29, P2352, DOI 10.1089/neu.2012.2413; SUNESON A, 1990, J TRAUMA, V30, P295, DOI 10.1097/00005373-199003000-00007; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765; TEASDALE G, 1974, LANCET, V2, P81; Varas J. M., 2011, FRONTIERS NEUROLOGY, V2; YOUNG MW, 1945, WAR MED, V8, P73; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhu F, 2012, BIOMECH MODEL MECHAN, V11, P341, DOI 10.1007/s10237-011-0314-2	52	11	12	0	14	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0148-0731	1528-8951		J BIOMECH ENG-T ASME	J. Biomech. Eng.-Trans. ASME	JUN	2013	135	6							061002	10.1115/1.4024132			14	Biophysics; Engineering, Biomedical	Biophysics; Engineering	240GO	WOS:000326083300002	23699714				2021-06-18	
J	Yan, H; Zhang, HW; Fu, P; Liu, BL; Jin, WZ; Duan, SB; Xue, J; Liu, K; Sun, ZM; Zeng, XW				Yan, Hua; Zhang, Hong-Wei; Fu, Paul; Liu, Bao-Long; Jin, Wen-Zhe; Duan, Shi-Bo; Xue, Jing; Liu, Kui; Sun, Zhi-Ming; Zeng, Xian-Wei			Leptin's effect on accelerated fracture healing after traumatic brain injury	NEUROLOGICAL RESEARCH			English	Article						TBI; Fracture; leptin; GH; IGF-1	DEFICIENT OB/OB MICE; GROWTH-HORMONE; CALLUS FORMATION; HUMORAL-FACTORS; GENE-THERAPY; DOUBLE-BLIND; BONE; EXPRESSION; RATS; MASS	Objective: To investigate mechanisms behind the faster rehabilitation of limb fractures when associated with traumatic brain injury (TBI). Methods: New Zealand rabbits were divided into TBI group and sham-operation group for four studies as follows: (1) blood and cerebrospinal fluid (CSF) were drawn on days 1, 3, and 7 to demonstrate changes in serum leptin, growth hormone (GH), insulin-like growth factor 1 (IGF-1), and CSF leptin; (2) bone defection was created by drilling in the tibial bone and either leptin or normal saline was injected into rabbit's cerebellomedullary cistern. X-ray was taken at 1 days, 2 weeks, and 5 weeks and evaluated by criteria to determine rate of bone healing; (3) FITC-labeled rabbit leptin was injected into TBI and sham-operation groups, and frozen sections of rabbit brain were observed to identify differences in central nervous system (CNS) leptin by fluorescence; (4) polymerase chain reaction (PCR) was used to evaluate the expression of leptin production by brain tissue. Results: Serum and CSF leptin, GH, and IGF-1 concentrations were found to be higher in the TBI group than the sham-operation group at days 1, 3, and 7 (P<0.05). CSF leptin of the TBI group was positively correlated with serum leptin on day 1 (P<0.05), and positively correlated with GH and IGF-1 on days 3 and 7 (P<0.05). X-ray criteria demonstrated that leptin administration caused significantly faster healing calluses at 3 and 5 weeks as compared to control animals (P<0.05). FITC-labeled leptin study demonstrated that TBI animals had stronger expression of leptin in the brain than sham-operated animals. However, PCR of brain tissue leptin showed no significant differences between TBI and sham-operated animals in the expression of leptin. Conclusions: Our study suggests that increased CSF leptin, likely from blood-brain barrier breakdown, combined with elevated serum GH and IGF-1 after TBI, leads to accelerated fracture healing.	[Yan, Hua; Liu, Bao-Long; Xue, Jing; Sun, Zhi-Ming] Tianjin Huanhu Hosp, Dept Neurosurg, Tianjin, Peoples R China; [Zhang, Hong-Wei] Tianjin Med Univ, Hosp 2, Dept Neurosurg, Tianjin, Peoples R China; [Fu, Paul] Wayne State Univ, Sch Med, Dept Neurosurg, Detroit, MI USA; [Jin, Wen-Zhe] Hebei Univ, Affiliated Hosp, Dept Neurosurg, Baoding, Peoples R China; [Duan, Shi-Bo] Cangzhou Cent Hosp, Dept Neurosurg, Cangzhou, Peoples R China; [Liu, Kui] Tianjin Peoples Hosp, Dept Neurosurg, Tianjin, Peoples R China; [Zeng, Xian-Wei] Weifang Med Coll, Affiliated Hosp, Dept Neurosurg, Weifang 261053, Peoples R China	Zeng, XW (corresponding author), Weifang Med Coll, Affiliated Hosp, Dept Neurosurg, Weifang 261053, Peoples R China.	szm618@yahoo.com.cn; zengxwei@163.com			Tianjin Public Health Bureau [2011KZ41, 10KG208]; Tianjin Municipal Science and Technology Commission [008ZCGYSF01600]	Hua Yan and Hong-Wei Zhang contributed equally to this study. This study was supported by grants from Tianjin Public Health Bureau (Nos. 2011KZ41 and 10KG208) and from Tianjin Municipal Science and Technology Commission (No. 008ZCGYSF01600).	Andreassen TT, 2003, CALCIFIED TISSUE INT, V73, P258, DOI 10.1007/S00223-002-2074-6; ANDREW JG, 1993, CALCIFIED TISSUE INT, V53, P97, DOI 10.1007/BF01321886; Bartell SM, 2011, J BONE MINER RES, V26, P1710, DOI 10.1002/jbmr.406; Burguera B, 2001, ENDOCRINOLOGY, V142, P3546, DOI 10.1210/en.142.8.3546; Cadosch D, 2009, J BONE JOINT SURG AM, V91A, P282, DOI 10.2106/JBJS.G.01613; Carro E, 1997, ENDOCRINOLOGY, V138, P2203, DOI 10.1210/en.138.5.2203; Cernak I, 1999, BRAIN INJURY, V13, P1005; Chiu WT, 1997, NEUROL RES, V19, P261, DOI 10.1080/01616412.1997.11740811; Dieguez C, 2011, NEUROENDOCRINOLOGY, V94, P1, DOI 10.1159/000328122; Dieter C, 2009, J BONE JOINT SURG AM, V91, P282; Federico G, 2003, HORM RES, V60, P46, DOI 10.1159/000071225; Frank SJ, 2007, ENDOCRINOLOGY, V148, P1486, DOI 10.1210/en.2007-0064; Hamrick MW, 2004, BONE, V34, P376, DOI 10.1016/j.bone.2003.11.020; Hedstrom M, 2004, ACTA ORTHOP SCAND, V75, P394, DOI 10.1080/00016470410001141-1; Iwaniec UT, 2007, PEPTIDES, V28, P1012, DOI 10.1016/j.peptides.2007.02.001; Kakuma T, 2000, ENDOCRINOLOGY, V141, P4576, DOI 10.1210/en.141.12.4576; Murad A, 2003, FASEB J, V17, P1895, DOI 10.1096/fj.03-0068fje; PERKINS R, 1987, J BONE JOINT SURG BR, V69, P521; Raschke M, 2007, EUR J ENDOCRINOL, V156, P341, DOI 10.1530/EJE-06-0598; Reseland JE, 2001, J BONE MINER RES, V16, P1426, DOI 10.1359/jbmr.2001.16.8.1426; Rosenbaum M, 1998, TRENDS ENDOCRIN MET, V9, P117, DOI 10.1016/S1043-2760(98)00028-9; Shenaq SM, 1996, CLIN PLAST SURG, V23, P157; Steppan CM, 2000, REGUL PEPTIDES, V92, P73, DOI 10.1016/S0167-0115(00)00152-X; Takahashi MO, 1999, BIOCHEM BIOPH RES CO, V263, P100; Takeda Shu, 2011, Clin Calcium, V21, P691, DOI CliCa1105691696; Tena-Sempere M, 2001, J ENDOCRINOL, V170, P413, DOI 10.1677/joe.0.1700413; Toffoli AM, 2008, BRAIN INJURY, V22, P511, DOI 10.1080/02699050802158235; Wlodarski Krzysztof, 2009, Ortop Traumatol Rehabil, V11, P1; Yi YS, 2000, DIAGNOSIS TREATMENT, P1; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	30	11	16	0	11	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	0161-6412			NEUROL RES	Neurol. Res.	JUN	2013	35	5					537	544		10.1179/1743132813Y.0000000201			8	Clinical Neurology; Neurosciences	Neurosciences & Neurology	156IY	WOS:000319816500015	23594570				2021-06-18	
J	Yuan, Q; Liu, H; Wu, X; Sun, YR; Zhou, LF; Hu, J				Yuan, Qiang; Liu, Hua; Wu, Xing; Sun, Yirui; Zhou, Liangfu; Hu, Jin			Predictive value of initial intracranial pressure for refractory intracranial hypertension in persons with traumatic brain injury: A prospective observational study	BRAIN INJURY			English	Article						Brain injuries; intracranial pressure; prognosis; intracranial hypertension	CEREBRAL PERFUSION-PRESSURE; DECOMPRESSIVE CRANIECTOMY; BARBITURATE-COMA; GUIDELINES; MANAGEMENT; IMPACT	Objective: To prospectively investigate the predictive value of initial intracranial pressure (ICP) for refractory intracranial hypertension and outcomes in persons with diffuse traumatic brain injury (TBI). Methods: A prospective observational study was conducted in 107 adult persons with diffuse TBI (Marshall CT Class II-IV). Initial ICP was defined as the first ICP recorded in the operating room. Refractory intracranial hypertension was defined as ICP increases to more than 30mmHg and/or reduces in cerebral perfusion pressure to less than 60mmHg for a period longer than 15 minutes and failure to respond to the maximum medical treatment. Baseline demographics and injury-specific data were recorded. Multiple logistic regression models were used to determine independent risk factors for refractory intracranial hypertension and unfavourable outcomes. A receiver-operating characteristic (ROC) curve was then drawn. Results: The initial ICP allowed for a better refractory intracranial hypertension prediction (ROC area 0.868; 95% CI 0.799-0.937) than the Marshall Classification (ROC area 0.670; 95% CI 0.569-0.772) or Rotterdam Classification scores (ROC area 0.679; 95% CI 0.5770.780). An initial ICP value higher than 20mmHg had 83% sensitivity and 83% specificity, whereas an initial ICP value higher than 25mmHg had 64% sensitivity and 92% specificity for refractory intracranial hypertension. A multivariable logistic regression model showed that any 5mmHg pressure increase in a patient with initial ICP led to 2.884-times higher odds of refractory intracranial hypertension (95% CI 1.893-4.395; p<0.001). Head Abbreviated Injury Scale score, initial Glasgow Coma Scale (GCS) and initial GCS motor scores were not predictive of refractory intracranial hypertension (p>0.05). Conclusion: For persons with diffuse TBI, the initial ICP provides great prognostic discrimination and is an independent predictor of refractory intracranial hypertension.	[Yuan, Qiang; Wu, Xing; Sun, Yirui; Zhou, Liangfu; Hu, Jin] Fudan Univ, Dept Neurosurg, Huashan Hosp, Shanghai 200433, Peoples R China; [Liu, Hua] Jiangsu Univ, Peoples Hosp Kunshan 1, Dept Neurosurg, Suzhou, Peoples R China	Hu, J (corresponding author), Fudan Univ, Dept Neurosurg, Huashan Hosp, Wulumuqizhong Rd 12, Shanghai 200433, Peoples R China.	277089712@qq.com			National Natural Science Foundation of China (NSFC)National Natural Science Foundation of China (NSFC) [30371454, 81271375, 81171133]; Science and Technology Commission of Shanghai Municipality ProjectScience & Technology Commission of Shanghai Municipality (STCSM) [10JC1402300]; Shanghai Nature Science Foundation [08411952000]	This study was funded by the National Natural Science Foundation of China (NSFC Grants 30371454, 81271375 and 81171133), The Science and Technology Commission of Shanghai Municipality Project (10JC1402300), Shanghai Nature Science Foundation (08411952000). The authors report no conflicts of interest.	Bader MK, 2005, AACN ADV CRIT CARE, V16, P526, DOI 10.1097/00044067-200510000-00009; Bor-Seng-Shu E, 2012, J NEUROSURG, V117, P589, DOI 10.3171/2012.6.JNS101400; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; BULLOCK R, 2000, MANAGEMENT PROGNOSIS; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; Farahvar A, 2011, CURR OPIN ANESTHESIO, V24, P209, DOI 10.1097/ACO.0b013e328344016d; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Kahraman S, 2010, J TRAUMA, V69, P110, DOI 10.1097/TA.0b013e3181c99853; Katsnelson M, 2012, NEUROSURGERY, V70, P1095, DOI 10.1227/NEU.0b013e318240c1ed; LEE MW, 1994, J NEUROTRAUM, V11, P325, DOI 10.1089/neu.1994.11.325; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Miller MT, 2004, J TRAUMA, V56, P967, DOI 10.1097/01.TA.0000123699.16465.8B; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Padayachy LC, 2010, CHILD NERV SYST, V26, P441, DOI 10.1007/s00381-009-1034-0; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Stein DM, 2011, J TRAUMA, V71, P364, DOI 10.1097/TA.0b013e31822820da; TEASDALE G, 1974, LANCET, V2, P81; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	23	11	12	0	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN	2013	27	6					664	670		10.3109/02699052.2013.775497			7	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	143QO	WOS:000318882500004	23611440				2021-06-18	
J	Wang, SY; Chopp, M; Nazem-Zadeh, MR; Ding, GL; Nejad-Davarani, SP; Qu, CS; Lu, M; Li, L; Davoodi-Bojd, E; Hu, JN; Li, QJ; Mahmood, A; Jiang, Q				Wang, Shiyang; Chopp, Michael; Nazem-Zadeh, Mohammad-Reza; Ding, Guangliang; Nejad-Davarani, Siamak P.; Qu, Changsheng; Lu, Mei; Li, Lian; Davoodi-Bojd, Esmaeil; Hu, Jiani; Li, Qingjiang; Mahmood, Asim; Jiang, Quan			Comparison of Neurite Density Measured by MRI and Histology after TBI	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; MARROW STROMAL CELLS; NONRIGID REGISTRATION; WATER DIFFUSION; AXON DIAMETER; TRANSPLANTATION; STROKE; MODEL; RATS; QUANTIFICATION	Background: Functional recovery after brain injury in animals is improved by marrow stromal cells (MSC) which stimulate neurite reorganization. However, MRI measurement of neurite density changes after injury has not been performed. In this study, we investigate the feasibility of MRI measurement of neurite density in an animal model of traumatic brain injury (TBI) with and without MSC treatment. Methods: Fifteen male Wistar rats, were treated with saline (n = 6) or MSCs (n = 9) and were sacrificed at 6 weeks after controlled cortical impact (CCI). Healthy non-CCI rats (n = 5), were also employed. Ex-vivo MRI scans were performed two days after the rats were sacrificed. Multiple-shell hybrid diffusion imaging encoding scheme and spherical harmonic expansion of a two-compartment water diffusion displacement model were used to extract neurite related parameters. Bielshowski and Luxol Fast blue was used for staining axons and myelin, respectively. Modified Morris water maze and neurological severity score (mNSS) test were performed for functional evaluation. The treatment effects, the correlations between neurite densities measured by MRI and histology, and the correlations between MRI and functional variables were calculated by repeated measures analysis of variance, the regression correlation analysis tests, and spearman correlation coefficients. Results: Neurite densities exhibited a significant correlation (R-2>0.80, p<1E-20) between MRI and immuno-histochemistry measurements with 95% lower bound of the intra-correlation coefficient (ICC) as 0.86. The conventional fractional anisotropy (FA) correlated moderately with histological neurite density (R-2 = 0.59, P<1E-5) with 95% lower bound of ICC as 0.76. MRI data revealed increased neurite reorganization with MSC treatment compared with saline treatment, confirmed by histological data from the same animals. mNSS were significantly correlated with MRI neurite density in the hippocampus region. Conclusions: The present studies demonstrated that neurite density can be estimated by MRI after TBI and MRI measurement of neurite density is a sensitive marker to MSC treatment response.	[Wang, Shiyang; Chopp, Michael; Nazem-Zadeh, Mohammad-Reza; Ding, Guangliang; Nejad-Davarani, Siamak P.; Li, Lian; Davoodi-Bojd, Esmaeil; Li, Qingjiang; Jiang, Quan] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [Qu, Changsheng; Mahmood, Asim] Henry Ford Hosp, Dept Neurosurg, Detroit, MI 48202 USA; [Lu, Mei] Henry Ford Hosp, Dept Biostat & Res Epidemiol, Detroit, MI 48202 USA; [Wang, Shiyang; Chopp, Michael; Jiang, Quan] Oakland Univ, Dept Phys, Rochester, MI USA; [Nazem-Zadeh, Mohammad-Reza] Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA; [Hu, Jiani] Wayne State Univ, Harper Hosp, MR Ctr, Detroit, MI USA	Jiang, Q (corresponding author), Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA.	qjiang1@hfhs.org	Nejad-Davarani, Siamak/AAH-8399-2021	Ding, Guangliang/0000-0003-1286-5901; Nejad-Davarani, Siamak/0000-0002-2415-6689	National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01 NS23393, RO1 NS064134, RO1 NS48349, RO1 AG037506, HL64766]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL064766] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS064134, P01NS023393, R01NS048349] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG037506] Funding Source: NIH RePORTER	The research presented herein was supported by National Institute of Neurological Disorders and Stroke, grants P01 NS23393, RO1 NS064134, RO1 NS48349, RO1 AG037506 and HL64766. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DC, 2010, NEUROIMAGE, V52, P1374, DOI 10.1016/j.neuroimage.2010.05.043; Alexander DC, 2005, NEUROIMAGE, V27, P357, DOI 10.1016/j.neuroimage.2005.04.008; Alexander DC, 2002, MAGN RESON MED, V48, P331, DOI 10.1002/mrm.10209; Assaf Y, 2004, MAGN RESON MED, V52, P965, DOI 10.1002/mrm.20274; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; Chopp M, 2006, ADV EXP MED BIOL, V585, P49; Cox CS, 2011, NEUROSURGERY, V68, P588, DOI 10.1227/NEU.0b013e318207734c; Denton ERE, 1999, J COMPUT ASSIST TOMO, V23, P800, DOI 10.1097/00004728-199909000-00031; DIXON CE, 1991, J NEUROSCI METH, V39, P253; DZIABIS MD, 1958, STAIN TECHNOL, V33, P96; Grider MH, 2006, J NEUROSCI METH, V155, P172, DOI 10.1016/j.jneumeth.2005.12.021; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; HUMPHREY PA, 2008, WASHINGTON MANUAL SU; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Janowitz T, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000330; Jensen JH, 2005, MAGNET RESON MED, V53, P1432, DOI 10.1002/mrm.20508; Jespersen SN, 2007, NEUROIMAGE, V34, P1473, DOI 10.1016/j.neuroimage.2006.10.037; Jespersen SN, 2010, NEUROIMAGE, V49, P205, DOI 10.1016/j.neuroimage.2009.08.053; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; Jiang Q, 2006, NEUROIMAGE, V32, P1080, DOI 10.1016/j.neuroimage.2006.05.025; Jiang Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042845; Jiang Q, 2011, NMR BIOMED, V24, P1119, DOI 10.1002/nbm.1667; Kybic J, 2008, METH APPL MAGEJ US D; Li Y, 2002, J NEUROL SCI, V193, P137, DOI 10.1016/S0022-510X(01)00657-8; Li Y, 2009, NEUROSCI LETT, V456, P120, DOI 10.1016/j.neulet.2008.03.096; Liu HS, 2011, NEUROIMAGE, V56, P280, DOI 10.1016/j.neuroimage.2011.02.049; Liu ZW, 2008, STROKE, V39, P2571, DOI 10.1161/STROKEAHA.107.511659; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Lu D, 2001, NEUROREPORT, V12, P559, DOI 10.1097/00001756-200103050-00025; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Mahmood A, 2006, J NEUROSURG, V104, P272, DOI 10.3171/jns.2006.104.2.272; Mahmood A, 2007, J NEUROSURG, V107, P392, DOI 10.3171/JNS-07/08/0392; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Ong HH, 2008, NEUROIMAGE, V40, P1619, DOI 10.1016/j.neuroimage.2008.01.017; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Shen LH, 2006, NEUROSCIENCE, V137, P393, DOI 10.1016/j.neuroscience.2005.08.092; Stanisz GJ, 1997, MAGNET RESON MED, V37, P103, DOI 10.1002/mrm.1910370115; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; Ueno Y, 2009, NEUROSCIENCE, V162, P317, DOI 10.1016/j.neuroscience.2009.04.065; Wedeen VJ, 2005, MAGN RESON MED, V54, P1377, DOI 10.1002/mrm.20642; Wu YC, 2008, IEEE T MED IMAGING, V27, P858, DOI 10.1109/TMI.2008.922696; Xiong Y, 2009, BRAIN RES, V1263, P183, DOI 10.1016/j.brainres.2009.01.032; Yi L, 2005, GLIA, V49, P407, DOI 10.1002/glia.20126	44	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63511	10.1371/journal.pone.0063511			8	Multidisciplinary Sciences	Science & Technology - Other Topics	163UP	WOS:000320362700029	23717439	DOAJ Gold, Green Published			2021-06-18	
J	Ma, QY; Chen, S; Klebe, D; Zhang, JH; Tang, JP				Ma, Qingyi; Chen, Sheng; Klebe, Damon; Zhang, John H.; Tang, Jiping			Adhesion Molecules in CNS Disorders: Biomarker and Therapeutic Targets	CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS			English	Article						Adhesion molecule; CNS disorders; leukocyte adhesion cascade; vascular adhesion protein-1	CEREBRAL-ARTERY OCCLUSION; TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; ENDOTHELIAL CELL-INTERACTIONS; VASCULAR ADHESION; E-SELECTIN; MONOCLONAL-ANTIBODY; LEUKOCYTE ADHESION; P-SELECTIN; SUBARACHNOID HEMORRHAGE	Mounting evidence has been provided regarding the crucial role of leukocyte extravasation and subsequent inflammatory response in several central nervous system (CNS) disorders. The infiltrated leukocytes release pro-inflammatory mediators and activate resident cells, leading to tissue injury. Leukocyte-endothelia interaction is critical for leukocyte extravasation and migration from the intravascular space into the tissue during inflammation. The basic physiology of leukocyte-endothelia interaction has been investigated extensively. Traditionally, three kinds of adhesion molecules, selectin, integrin, and immunoglobulin families, are responsible for this multiple-step interaction. Furthermore, blocking adhesion molecule function by genetic knockout, antagonizing antibodies, or inhibitory pharmacological drugs provides neuroprotection, which is associated with a reduction in leukocyte accumulation within the tissue. Detection of the soluble form of adhesion molecules has also been proven to predict outcomes in CNS disorders. Lately, vascular adhesion protein-1, a novel adhesion molecule and endothelial cell surface enzyme, has been implicated as a brake in the rolling step of the adhesion cascade, and also a regulator of leukocyte transmigration step. In this review, we summarize the functions of traditional adhesion molecules as well as vascular adhesion protein-1 in the leukocyte adhesion cascade. We also discuss the diagnostic and therapeutic potential of adhesion molecules in CNS disorders.	[Ma, Qingyi; Chen, Sheng; Klebe, Damon; Zhang, John H.; Tang, Jiping] Loma Linda Univ, Dept Physiol & Pharmacol, Loma Linda, CA 92354 USA; [Chen, Sheng] Zhejiang Univ, Sch Med, Dept Neurosurg, Affiliated Hosp 2, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, John H.] Loma Linda Med Ctr, Dept Anesthesiol, Loma Linda, CA USA; [Zhang, John H.] Loma Linda Med Ctr, Dept Neurosurg, Loma Linda, CA USA	Tang, JP (corresponding author), Loma Linda Univ, Sch Med, Dept Physiol & Pharmacol, Loma Linda, CA 92354 USA.	jtang@llu.edu	Ma, Qingyi/E-6353-2014	Ma, Qingyi/0000-0002-3499-0992; chen, sheng/0000-0002-8374-136X	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS060936, R01 NS053407]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS060936, R01NS053407] Funding Source: NIH RePORTER	This study was supported by NIH R01 NS060936 to Jiping Tang and NIH R01 NS053407 to John H. Zhang	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Aihara Y, 2001, STROKE, V32, P212, DOI 10.1161/01.STR.32.1.212; Airas L, 2008, NEUROPATH APPL NEURO, V34, P394, DOI 10.1111/j.1365-2990.2007.00911.x; Airas L, 2006, J NEUROIMMUNOL, V177, P132, DOI 10.1016/j.jneuroim.2006.05.014; ANDERSON DC, 1987, ANNU REV MED, V38, P175, DOI 10.1146/annurev.me.38.020187.001135; Arumugam TV, 2004, AM J PHYSIOL-HEART C, V287, pH2555, DOI 10.1152/ajpheart.00588.2004; Atkins CM, 2011, TRANSL STROKE RES, V2, P546, DOI 10.1007/s12975-011-0123-z; Balabanov R, 2001, NEUROL RES, V23, P175, DOI 10.1179/016164101101198514; BARGATZE RF, 1994, J EXP MED, V180, P1785, DOI 10.1084/jem.180.5.1785; Bavbek M, 1998, STROKE, V29, P1930, DOI 10.1161/01.STR.29.9.1930; Becker K, 2001, STROKE, V32, P206, DOI 10.1161/01.STR.32.1.206; Becker Kyra J, 2002, Curr Med Res Opin, V18 Suppl 2, ps18, DOI 10.1185/030079902125000688; Bednar MM, 1996, NEUROL RES, V18, P171; Bill R, 2011, J NEUROIMMUNOL, V232, P207, DOI 10.1016/j.jneuroim.2010.10.008; Blann A, 1999, BLOOD COAGUL FIBRIN, V10, P277, DOI 10.1097/00001721-199907000-00009; Blum A, 2006, EUR CYTOKINE NETW, V17, P295; Bogdan C, 2000, CURR OPIN IMMUNOL, V12, P64, DOI 10.1016/S0952-7915(99)00052-7; BOWES MP, 1995, NEUROLOGY, V45, P815, DOI 10.1212/WNL.45.4.815; BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8; Campanella M, 2002, STROKE, V33, P586, DOI 10.1161/hs0202.103399; Carlos TM, 1997, J LEUKOCYTE BIOL, V61, P279; CARLOS TM, 1990, BLOOD, V76, P965; Carvalho-Tavares J, 2000, CIRC RES, V87, P1141, DOI 10.1161/01.RES.87.12.1141; Casoli T, 2010, BIOGERONTOLOGY, V11, P627, DOI 10.1007/s10522-010-9281-8; Ceulemans AG, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-74; Chaichana KL, 2010, WORLD NEUROSURG, V73, P22, DOI 10.1016/j.surneu.2009.05.027; Chang CZ, 2010, ACTA NEUROCHIR, V152, P861, DOI 10.1007/s00701-010-0602-0; CHEN H, 1994, ANN NEUROL, V35, P458, DOI 10.1002/ana.410350414; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; CHOPP M, 1994, STROKE, V25, P869, DOI 10.1161/01.STR.25.4.869; Chopp M, 1996, J CEREBR BLOOD F MET, V16, P578, DOI 10.1097/00004647-199607000-00007; Chou SHY, 2011, TRANSL STROKE RES, V2, P600, DOI 10.1007/s12975-011-0117-x; Clatterbuck RE, 2002, J NEUROSURG, V97, P676, DOI 10.3171/jns.2002.97.3.0676; Connolly ES, 1996, J CLIN INVEST, V97, P209, DOI 10.1172/JCI118392; Crunkhorn S, 2012, NAT REV DRUG DISCOV, V11, P178, DOI 10.1038/nrd3676; DeGraba TJ, 1998, NEUROLOGY, V51, pS62, DOI 10.1212/WNL.51.3_Suppl_3.S62; DIAMOND MS, 1991, CELL, V65, P961, DOI 10.1016/0092-8674(91)90548-D; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Doerck S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015478; Doring A, 2007, J IMMUNOL, V179, P8470, DOI 10.4049/jimmunol.179.12.8470; Dunne JL, 2002, BLOOD, V99, P336, DOI 10.1182/blood.V99.1.336; EIKELENBOOM P, 1994, VIRCHOWS ARCH, V424, P421, DOI 10.1007/BF00190565; ELICES MJ, 1990, CELL, V60, P577, DOI 10.1016/0092-8674(90)90661-W; Engelhardt B, 1997, BLOOD, V90, P4459, DOI 10.1182/blood.V90.11.4459.4459_4459_4472; Engelhardt B, 2005, TRENDS IMMUNOL, V26, P485, DOI 10.1016/j.it.2005.07.004; Engelhardt B, 2008, J NEUROL SCI, V274, P23, DOI 10.1016/j.jns.2008.05.019; Engelhardt B, 2008, NEURODEGENER DIS, V5, P16, DOI 10.1159/000109933; Ewers M, 2010, EXP GERONTOL, V45, P75, DOI 10.1016/j.exger.2009.09.005; FUJIMOTO T, 1993, BLOOD, V82, P1758; GAMBLE JR, 1990, SCIENCE, V249, P414; Gan Y, 2012, J NEUROIMMUNOL, V247, P9, DOI 10.1016/j.jneuroim.2012.03.011; GENG JG, 1990, NATURE, V343, P757, DOI 10.1038/343757a0; Gong C, 2000, BRAIN RES, V871, P57, DOI 10.1016/S0006-8993(00)02427-6; HALLENBECK JM, 1986, STROKE, V17, P246, DOI 10.1161/01.STR.17.2.246; Hammond MD, 2012, TRANSL STROKE RES, V3, pS125, DOI 10.1007/s12975-012-0174-9; HANDA Y, 1995, ACTA NEUROCHIR, V132, P92, DOI 10.1007/BF01404854; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Hernandez-Guillamon M, 2012, CEREBROVASC DIS, V33, P55, DOI 10.1159/000333370; Hernandez-Guillamon M, 2010, STROKE, V41, P1528, DOI 10.1161/STROKEAHA.110.584623; Hidalgo A, 2007, IMMUNITY, V26, P477, DOI 10.1016/j.immuni.2007.03.011; Huang J, 2000, STROKE, V31, P3047, DOI 10.1161/01.STR.31.12.3047; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Irjala H, 2001, J IMMUNOL, V166, P6937, DOI 10.4049/jimmunol.166.11.6937; Ishikawa M, 2004, J CEREBR BLOOD F MET, V24, P907, DOI 10.1097/01.WCB.0000132690.96836.7F; Jaakkola K, 2000, AM J PATHOL, V157, P463, DOI 10.1016/S0002-9440(10)64558-0; Jalkanen S, 2008, ARTERIOSCL THROM VAS, V28, P18, DOI 10.1161/ATVBAHA.107.153130; Jalkanen S, 2007, BLOOD, V110, P1864, DOI 10.1182/blood-2007-01-069674; Janner G, 1978, Occup Health (Lond), V30, P110; Jean WC, 1998, NEUROSURGERY, V43, P1382, DOI 10.1097/00006123-199812000-00076; Jha Mithilesh Kumar, 2012, Immune Netw, V12, P41, DOI 10.4110/in.2012.12.2.41; Jiang N, 1995, ANN NEUROL, V38, P935, DOI 10.1002/ana.410380615; Johnston B, 1996, AM J PHYSIOL-HEART C, V271, pH614; Jung U, 1998, J CLIN INVEST, V102, P1526, DOI 10.1172/JCI119893; Kallen J, 1999, J MOL BIOL, V292, P1, DOI 10.1006/jmbi.1999.3047; Kanemoto Y, 2002, NEUROSURGERY, V51, P1034, DOI 10.1097/00006123-200210000-00033; Kerfoot SM, 2006, J IMMUNOL, V176, P6225, DOI 10.4049/jimmunol.176.10.6225; KISHIMOTO TK, 1989, SCIENCE, V245, P1238, DOI 10.1126/science.2551036; Kitagawa K, 1998, J CEREBR BLOOD F MET, V18, P1336, DOI 10.1097/00004647-199812000-00008; Knoblach SM, 2002, J NEUROTRAUM, V19, P1039, DOI 10.1089/089771502760341956; Knorr R, 1997, J EXP MED, V186, P719, DOI 10.1084/jem.186.5.719; Koskinen K, 2004, BLOOD, V103, P3388, DOI 10.1182/blood-2003-09-3275; Kozubski W, 2002, ALZ DIS ASSOC DIS, V16, P52, DOI 10.1097/00002093-200201000-00009; Kramer AH, 2008, NEUROSURGERY, V62, P422, DOI 10.1227/01.neu.0000316009.19012.e3; Krams M, 2003, STROKE, V34, P2543, DOI 10.1161/01.STR.0000092527.33910.89; Lalor PF, 2007, HEPATOLOGY, V45, P465, DOI 10.1002/hep.21497; Lalor PF, 2002, J IMMUNOL, V169, P983, DOI 10.4049/jimmunol.169.2.983; LASKY LA, 1992, SCIENCE, V258, P964, DOI 10.1126/science.1439808; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Li X, 1998, J EXP MED, V188, P1385, DOI 10.1084/jem.188.7.1385; Licastro F, 2011, J ALZHEIMERS DIS, V23, P421, DOI 10.3233/JAD-2010-090871; Lin CL, 2005, SURG NEUROL, V64, P201, DOI 10.1016/j.surneu.2005.04.038; Lin ZX, 2011, CLIN CHIM ACTA, V412, P1678, DOI 10.1016/j.cca.2011.05.031; Lively S, 2012, TRANSL STROKE RES, V3, pS132, DOI 10.1007/s12975-012-0151-3; Ma QY, 2011, J CEREBR BLOOD F MET, V31, P881, DOI 10.1038/jcbfm.2010.167; MA XL, 1993, CIRCULATION, V88, P649, DOI 10.1161/01.CIR.88.2.649; Maiuri F, 1987, J Neurosurg Sci, V31, P45; Man SM, 2007, BRAIN PATHOL, V17, P243, DOI 10.1111/j.1750-3639.2007.00067.x; Marklund N, 2006, CURR PHARM DESIGN, V12, P1645, DOI 10.2174/138161206776843340; MARLIN SD, 1987, CELL, V51, P813, DOI 10.1016/0092-8674(87)90104-8; Martelius T, 2004, AM J PATHOL, V165, P1993, DOI 10.1016/S0002-9440(10)63250-6; McEver RP, 1997, J CLIN INVEST, V100, P485, DOI 10.1172/JCI119556; McGirt MJ, 2003, J NEUROSURG, V98, P1222, DOI 10.3171/jns.2003.98.6.1222; Merinen M, 2005, AM J PATHOL, V166, P793, DOI 10.1016/S0002-9440(10)62300-0; Murakami K, 2011, TRANSL STROKE RES, V2, P72, DOI 10.1007/s12975-010-0052-2; NEILDWYER G, 1974, BRAIN, V97, P79, DOI 10.1093/brain/97.1.79; Nielsen HM, 2007, NEUROBIOL DIS, V26, P27, DOI 10.1016/j.nbd.2006.11.011; Nissen JJ, 2000, ACT NEUR S, V76, P55; Nissen JJ, 2001, J NEUROL NEUROSUR PS, V71, P329, DOI 10.1136/jnnp.71.3.329; Noda K, 2008, FASEB J, V22, P2928, DOI 10.1096/fj.07-105346; Nourshargh S, 2010, NAT REV MOL CELL BIO, V11, P366, DOI 10.1038/nrm2889; Offner H, 2012, TRANSL STROKE RES, V3, P324, DOI 10.1007/s12975-012-0187-4; Ohmori K, 2000, BIOCHEM BIOPH RES CO, V278, P90, DOI 10.1006/bbrc.2000.3768; Oshiro EM, 1997, STROKE, V28, P2031, DOI 10.1161/01.STR.28.10.2031; Osmers I, 2005, J NEUROIMMUNOL, V166, P193, DOI 10.1016/j.jneuroim.2005.06.001; Penberthy TW, 1997, CRIT REV ORAL BIOL M, V8, P380, DOI 10.1177/10454411970080040201; Piraino PS, 2002, J NEUROIMMUNOL, V131, P147, DOI 10.1016/S0165-5728(02)00273-4; Pleines UE, 1998, J NEUROTRAUM, V15, P399, DOI 10.1089/neu.1998.15.399; Pleines UE, 2001, J NEUROTRAUM, V18, P491, DOI 10.1089/089771501300227297; Polin RS, 1998, J NEUROSURG, V89, P559, DOI 10.3171/jns.1998.89.4.0559; Rentzos A, 2004, J GERIATR PSYCH NEUR, V17, P225, DOI 10.1177/0891988704269822; Rentzos M, 2005, J NEUROL SCI, V228, P129, DOI 10.1016/j.jns.2004.11.001; Rivera-Nieves J, 2008, INFLAMM BOWEL DIS, V14, P1715, DOI 10.1002/ibd.20501; Ruehl ML, 2002, NEUROL RES, V24, P226, DOI 10.1179/016164102101199738; RUOSLAHTI E, 1991, J CLIN INVEST, V87, P1, DOI 10.1172/JCI114957; Salmi M, 2005, NAT REV IMMUNOL, V5, P760, DOI 10.1038/nri1705; Salmi M, 2001, TRENDS IMMUNOL, V22, P211, DOI 10.1016/S1471-4906(01)01870-1; SALMI M, 1992, SCIENCE, V257, P1407, DOI 10.1126/science.1529341; SALMI M, 1993, J EXP MED, V178, P2255, DOI 10.1084/jem.178.6.2255; Salmi M, 2012, EUR J IMMUNOL, V42, P284, DOI 10.1002/eji.201142223; Sanchez-Moreno C, 2004, STROKE, V35, P163, DOI 10.1161/01.STR.0000105391.62306.2E; SCHLEIFFENBAUM B, 1992, J CELL BIOL, V119, P229, DOI 10.1083/jcb.119.1.229; SCHMIDSCHONBEIN GW, 1994, STROKE, V25, P875; Schouten JW, 2007, CURR OPIN CRIT CARE, V13, P134, DOI 10.1097/MCC.0b013e3280895d5c; Selakovic V, 2009, DIS MARKERS, V26, P65, DOI [10.3233/DMA-2009-0608, 10.1155/2009/490867]; Setiadi H, 1998, J CELL BIOL, V142, P859, DOI 10.1083/jcb.142.3.859; Sherman DG, 2001, NEUROLOGY, V57, P1428, DOI 10.1212/wnl.57.8.1428; Shyu KG, 1997, J NEUROL, V244, P90, DOI 10.1007/s004150050055; Sills AK, 1997, NEUROSURGERY, V41, P453, DOI 10.1097/00006123-199708000-00025; Simard J.M., 2012, TRANSL STROKE RES S1, V3, P155; SIMON RH, 1986, J CLIN INVEST, V78, P1375, DOI 10.1172/JCI112724; Simundic AM, 2004, CLIN INVEST MED, V27, P86; Smith DJ, 1998, J EXP MED, V188, P17, DOI 10.1084/jem.188.1.17; SOBEL RA, 1990, AM J PATHOL, V136, P1309; STAUNTON DE, 1989, NATURE, V339, P61, DOI 10.1038/339061a0; Sughrue ME, 2004, INFLAMM RES, V53, P497, DOI 10.1007/s00011-004-1282-0; TEDDER TF, 1995, FASEB J, V9, P866; Titova E, 2008, J NEUROSCI RES, V86, P3240, DOI 10.1002/jnr.21762; Tohka S, 2001, FASEB J, V15, P373, DOI 10.1096/fj.00-0240com; Tseng MY, 2007, STROKE, V38, P1545, DOI 10.1161/STROKEAHA.106.475905; Tseng MY, 2005, STROKE, V36, P1627, DOI 10.1161/01.STR.0000176743.67564.5d; Vemuganti R, 2004, STROKE, V35, P179, DOI 10.1161/01.STR.0000106479.53235.3E; Vestweber D, 1999, PHYSIOL REV, V79, P181; Vestweber D, 2007, IMMUNOL REV, V218, P178, DOI 10.1111/j.1600-065X.2007.00533.x; Vexler ZS, 2006, CLIN NEUROSCI RES, V6, P293, DOI 10.1016/j.cnr.2006.09.008; Vuorte J, 1999, J IMMUNOL, V162, P2353; WALCHECK B, 1992, EUR J IMMUNOL, V22, P469, DOI 10.1002/eji.1830220227; Wang J, 2005, BRAIN, V128, P1622, DOI 10.1093/brain/awh489; Wang J, 2007, J CEREBR BLOOD F MET, V27, P894, DOI 10.1038/sj.jcbfm.9600403; Wang Q, 2007, J NEUROIMMUNOL, V184, P53, DOI 10.1016/j.jneuroim.2006.11.014; WANG XK, 1995, J NEUROTRAUM, V12, P825, DOI 10.1089/neu.1995.12.825; WASHINGTON R, 1994, ANN NEUROL, V35, P89, DOI 10.1002/ana.410350114; Weber C, 1997, J AM COLL CARDIOL, V30, P1212, DOI 10.1016/S0735-1097(97)00324-0; Whalen MJ, 1998, J NEUROTRAUM, V15, P777, DOI 10.1089/neu.1998.15.777; Whalen MJ, 1999, J NEUROTRAUM, V16, P299, DOI 10.1089/neu.1999.16.299; Wittchen ES, 2009, FRONT BIOSCI-LANDMRK, V14, P2522, DOI 10.2741/3395; Wraith DC, 2012, J CLIN INVEST, V122, P1172, DOI 10.1172/JCI58648; Xu HL, 2006, J PHARMACOL EXP THER, V317, P19, DOI 10.1124/jpet.105.096958; Xue MZ, 2000, STROKE, V31, P1721, DOI 10.1161/01.STR.31.7.1721; Xue MZ, 2000, NEUROSCI LETT, V283, P230, DOI 10.1016/S0304-3940(00)00971-X; Yenari MA, 1998, EXP NEUROL, V153, P223, DOI 10.1006/exnr.1998.6876; Yilmaz G, 2008, NEUROL RES, V30, P783, DOI 10.1179/174313208X341085; Yoong KF, 1998, J IMMUNOL, V160, P3978; Yu PH, 1997, DIABETOLOGIA, V40, P1243, DOI 10.1007/s001250050816; Zhang RL, 1996, J CEREBR BLOOD F MET, V16, P1126, DOI 10.1097/00004647-199611000-00006; Zhang RL, 1998, BRAIN RES, V785, P207, DOI 10.1016/S0006-8993(97)01343-7; ZHANG RL, 1994, J NEUROL SCI, V125, P3, DOI 10.1016/0022-510X(94)90234-8; Zuliani G, 2008, J NEUROL SCI, V272, P164, DOI 10.1016/j.jns.2008.05.020	177	11	11	0	9	BENTHAM SCIENCE PUBL	BUSUM	PO BOX 294, BUSUM, 1400 AG, NETHERLANDS	1871-5273	1996-3181		CNS NEUROL DISORD-DR	CNS Neurol. Disord.-Drug Targets	MAY	2013	12	3					392	404		10.2174/1871527311312030012			13	Neurosciences; Pharmacology & Pharmacy	Neurosciences & Neurology; Pharmacology & Pharmacy	145CE	WOS:000318990800012	23469854	Green Accepted			2021-06-18	
J	Stout, EE; Beloozerova, IN				Stout, Erik E.; Beloozerova, Irina N.			Differential responses of fast- and slow-conducting pyramidal tract neurons to changes in accuracy demands during locomotion	JOURNAL OF PHYSIOLOGY-LONDON			English	Article							CAT MOTOR CORTEX; PRIMATE CORTICOMOTONEURONAL CELLS; VOLUNTARY GAIT MODIFICATIONS; MULTIJOINT ARM MOVEMENTS; DORSAL PREMOTOR CORTEX; CEREBRAL-CORTEX; CORTICOSPINAL PROJECTIONS; DISCHARGE PATTERNS; REACHING MOVEMENTS; CORTICAL ACTIVITY	Key points center dot The motor cortex is highly involved in performing complex movements including skilled locomotion. center dot Slow-conducting pyramidal tract neurons (PTNs) in the motor cortex are much more numerous than fast-conducting PTNs, but little is known about their function during movements. center dot We find here that slow-conducting PTNs show vigorous and concerted changes to their activities during accurate targeted stepping versus simple locomotion over a flat surface, while changes to the activities of fast-conducting PTNs vary. center dot This suggests that slow-conducting PTNs are involved to a greater extent in control of accuracy during locomotion. center dot The results may be relevant to developing therapies for stroke and traumatic brain injury. Abstract Most movements need to be accurate. The neuronal mechanisms controlling accuracy during movements are poorly understood. In this study we compare the activity of fast- and slow-conducting pyramidal tract neurons (PTNs) of the motor cortex in cats as they walk over both a flat surface, a task that does not require accurate stepping and can be accomplished without the motor cortex, as well as along a horizontal ladder, a task that requires accuracy and the activity of the motor cortex to be successful. Fast- and slow-conducting PTNs are known to have distinct biophysical properties as well as different afferent and efferent connections. We found that while the activity of all PTNs changes substantially upon transition from simple locomotion to accurate stepping on the ladder, slow-conducting PTNs respond in a much more concerted manner than fast-conducting ones. As a group, slow-conducting PTNs increase discharge rate, especially during the late stance and early swing phases, decrease discharge variability, have a tendency to shift their preferred phase of the discharge into the swing phase, and almost always produce a single peak of activity per stride during ladder locomotion. In contrast, the fast-conducting PTNs do not display such concerted changes to their activity. In addition, upon transfer from simple locomotion to accurate stepping on the ladder slow-conducting PTNs more profoundly increase the magnitude of their stride-related frequency modulation compared with fast-conducting PTNs. We suggest that slow-conducting PTNs are involved in control of accuracy of locomotor movements to a greater degree than fast-conducting PTNs.	[Stout, Erik E.; Beloozerova, Irina N.] St Josephs Hosp, Barrow Neurol Inst, Phoenix, AZ 85013 USA	Beloozerova, IN (corresponding author), St Josephs Hosp, Barrow Neurol Inst, 350 W Thomas Rd, Phoenix, AZ 85013 USA.	ibelooz@chw.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS-39340, R01 NS-058659]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS058659, R01NS039340] Funding Source: NIH RePORTER	The authors are thankful to Dr Zinaida Tamarova for help with data acquisition, to Mr Peter Wettenstein for excellent engineering assistance, and to Drs Mikhail Sirota and Vladimir Marlinski for valuable suggestions and discussions. The research reported in this paper was supported by NIH grants R01 NS-39340 and R01 NS-058659 to I.N.B.	AMOS A, 1990, NEUROSCI LETT, V109, P107, DOI 10.1016/0304-3940(90)90546-L; ANTAL M, 1984, J HIRNFORSCH, V25, P647; ARMSTRONG DM, 1984, J PHYSIOL-LONDON, V346, P471, DOI 10.1113/jphysiol.1984.sp015036; ARMSTRONG DM, 1985, J PHYSIOL-LONDON, V367, P309, DOI 10.1113/jphysiol.1985.sp015826; ARMSTRONG DM, 1984, J PHYSIOL-LONDON, V346, P497, DOI 10.1113/jphysiol.1984.sp015037; BARANYI A, 1993, J NEUROPHYSIOL, V69, P1865; Bastian AJ, 2000, J NEUROPHYSIOL, V83, P3019; BATSHELET E, 1981, CIRCULAR STAT BIOL; Beer RF, 2000, EXP BRAIN RES, V131, P305, DOI 10.1007/s002219900275; BELOOZEROVA I N, 1985, Neirofiziologiya, V17, P406; BELOOZEROVA IN, 1993, J PHYSIOL-LONDON, V461, P27, DOI 10.1113/jphysiol.1993.sp019499; Beloozerova IN, 2005, J NEUROPHYSIOL, V93, P1831, DOI 10.1152/jn.00577.2004; BELOOZEROVA IN, 1993, J PHYSIOL-LONDON, V461, P1; Beloozerova IN, 2003, J NEUROSCI, V23, P1087; Beloozerova IN, 1988, STANCE MOTION FACTS, P163; Beloozerova IN, 2007, 2007 NEUR M PLANN; Beloozerova IN, 2010, J NEUROPHYSIOL, V103, P2285, DOI 10.1152/jn.00360.2009; BISHOP PO, 1962, J PHYSIOL-LONDON, V162, P409, DOI 10.1113/jphysiol.1962.sp006942; Bishop PO, 1953, J PHYSL, V5, P537; BROOKHART J M, 1952, Res Publ Assoc Res Nerv Ment Dis, V30, P157; BROOKHART JM, 1948, J NEUROPHYSIOL, V11, P387; CALVIN WH, 1976, J NEUROPHYSIOL, V39, P420; Canedo A, 1997, PROG NEUROBIOL, V51, P287, DOI 10.1016/S0301-0082(96)00058-5; CHAMBERS WW, 1957, J COMP NEUROL, V108, P23, DOI 10.1002/cne.901080103; CHENEY PD, 1980, J NEUROPHYSIOL, V44, P773; CRAMMOND DJ, 1994, J NEUROPHYSIOL, V71, P1281; Criado JM, 1997, PFLUG ARCH EUR J PHY, V434, P91, DOI 10.1007/s004240050367; DESCHENES M, 1979, BRAIN RES, V178, P251, DOI 10.1016/0006-8993(79)90693-0; DESCHENES M, 1982, NEUROSCIENCE, V7, P2149, DOI 10.1016/0306-4522(82)90126-9; Dounskaia N, 2005, EXP BRAIN RES, V166, P1, DOI 10.1007/s00221-005-2339-1; Dounskaia N, 2005, EXP BRAIN RES, V164, P505, DOI 10.1007/s00221-005-2271-4; Drew T, 1996, CAN J PHYSIOL PHARM, V74, P426, DOI 10.1139/cjpp-74-4-426; DREW T, 1991, J NEUROSCI METH, V38, P171, DOI 10.1016/0165-0270(91)90167-X; DREW T, 1993, J NEUROPHYSIOL, V70, P179; Drew T, 2008, BRAIN RES REV, V57, P199, DOI 10.1016/j.brainresrev.2007.07.017; DYACHKOVA LN, 1971, EXP BRAIN RES, V12, P105; EVARTS EV, 1965, J NEUROPHYSIOL, V28, P216; FETZ EE, 1980, J NEUROPHYSIOL, V44, P751; Fisher N.I., 1993, STAT ANAL CIRCULAR D; Friel KM, 2007, J NEUROPHYSIOL, V97, P3396, DOI 10.1152/jn.00750.2006; FROMM C, 1984, EXP BRAIN RES, V54, P177; FROMM C, 1977, NEUROSCI LETT, V5, P259, DOI 10.1016/0304-3940(77)90076-3; FROMM C, 1981, J NEUROSCI, V1, P453; FULLER JH, 1976, BRAIN RES, V112, P283, DOI 10.1016/0006-8993(76)90284-5; Galloway JC, 2002, EXP BRAIN RES, V142, P163, DOI 10.1007/s002210100882; GHOSH S, 1988, J PHYSIOL-LONDON, V400, P593, DOI 10.1113/jphysiol.1988.sp017138; Ghosh S, 1997, J COMP NEUROL, V388, P371, DOI 10.1002/(SICI)1096-9861(19971124)388:3<371::AID-CNE3>3.0.CO;2-Y; Ghosh S, 1997, J COMP NEUROL, V380, P191, DOI 10.1002/(SICI)1096-9861(19970407)380:2<191::AID-CNE4>3.0.CO;2-Z; Gomez JE, 2000, EUR J NEUROSCI, V12, P3748, DOI 10.1046/j.1460-9568.2000.00232.x; GOODALE MA, 1986, NATURE, V320, P748, DOI 10.1038/320748a0; GORDON J, 1994, EXP BRAIN RES, V99, P97, DOI 10.1007/BF00241415; GRILLNER S, 1978, BRAIN RES, V146, P269, DOI 10.1016/0006-8993(78)90973-3; HASSLER R, 1964, J Hirnforsch, V7, P377; Hoff EC, 1934, BRAIN, V57, P454, DOI 10.1093/brain/57.4.454; HUMPHREY DR, 1978, J NEUROPHYSIOL, V41, P216; JONES EG, 1978, J COMP NEUROL, V181, P291, DOI 10.1002/cne.901810206; Kakei S, 1999, SCIENCE, V285, P2136, DOI 10.1126/science.285.5436.2136; LABELLE A, 1979, BRAIN RES, V164, P309, DOI 10.1016/0006-8993(79)90027-1; Lacroix S, 2004, J COMP NEUROL, V473, P147, DOI 10.1002/cne.20051; Lassek AM, 1940, J COMP NEUROL, V72, P417, DOI 10.1002/cne.900720209; LEMON RNP, 1993, CORTICOSPINAL FUNCTI; Liddell EGT, 1944, BRAIN, V67, P1, DOI 10.1093/brain/67.1.1; Lloyd DPC, 1941, J NEUROPHYSIOL, V4, P525; Marconi B, 2001, CEREB CORTEX, V11, P513, DOI 10.1093/cercor/11.6.513; Marlinski V, 2012, J NEUROPHYSIOL, V107, P455, DOI 10.1152/jn.01113.2010; MARPLEHORVAT DE, 1993, J PHYSIOL-LONDON, V462, P87, DOI 10.1113/jphysiol.1993.sp019545; MARTIN JH, 1993, EXP BRAIN RES, V94, P429; MATSUNAMI K, 1980, NEUROSCI LETT, V16, P245, DOI 10.1016/0304-3940(80)90005-1; Messier J, 1999, EXP BRAIN RES, V125, P139, DOI 10.1007/s002210050669; Metz GA, 2002, J NEUROSCI METH, V115, P169, DOI 10.1016/S0165-0270(02)00012-2; Mihaltchev P, 2005, EXP BRAIN RES, V163, P468, DOI 10.1007/s00221-004-2202-9; Myasnikov AA, 1997, BRAIN RES, V750, P95, DOI 10.1016/S0006-8993(96)01337-6; NIEOULLON A, 1976, BRAIN RES, V105, P405, DOI 10.1016/0006-8993(76)90590-4; Novak KE, 2002, EXP BRAIN RES, V144, P351, DOI 10.1007/s00221-002-1060-6; PRABLANC C, 1992, J NEUROPHYSIOL, V67, P455; Prilutsky BI, 2005, J NEUROPHYSIOL, V94, P2959, DOI 10.1152/jn.00704.2004; Pryor K., 1975, LADS WIND; REITBOECK HJ, 1983, J NEUROSCI METH, V8, P249, DOI 10.1016/0165-0270(83)90038-9; Rosenzweig ES, 2009, J COMP NEUROL, V513, P151, DOI 10.1002/cne.21940; Sakai H, 1982, Nihon Seirigaku Zasshi, V44, P199; Sirota MG, 2005, J NEUROSCI, V25, P5915, DOI 10.1523/JNEUROSCI.0489-05.2005; Skinner BF, 1938, BEHAV ORGANISMS; SOECHTING JF, 1989, J NEUROPHYSIOL, V62, P595; Stout EE, 2010, 2010 NEUR M PLANN; Stout EE, 2012, J NEUROPHYSIOL, V107, P1890, DOI 10.1152/jn.00650.2011; TAKAHASHI K, 1965, J NEUROPHYSIOL, V28, P908; TANJI J, 1978, J PHYSIOL-PARIS, V74, P293; Tibshirani, 1994, INTRO BOOTSTRAP, DOI 10.1201/9780429246593; TOWE AL, 1963, EXP NEUROL, V8, P220, DOI 10.1016/0014-4886(63)90033-5; TOWE AL, 1968, EXP NEUROL, V20, P497, DOI 10.1016/0014-4886(68)90105-2; TOYOSHIMA K, 1982, J HIRNFORSCH, V23, P257; Trendelenburg W, 1911, PFLUG ARCH GES PHYS, V137, P515, DOI 10.1007/BF01680423; TSUKAHARA N, 1968, J NEUROPHYSIOL, V31, P467; UDO M, 1982, EXP BRAIN RES, V46, P438; VICARIO DS, 1983, EXP BRAIN RES, V51, P351; Vigneswaran G, 2011, J NEUROSCI, V31, P14235, DOI 10.1523/JNEUROSCI.3142-11.2011; WIDAJEWICZ W, 1994, J NEUROPHYSIOL, V72, P2070; Wiesendanger M, 1981, HDB BEHAVIORAL NEURO, V5, P401; WISE SP, 1992, J NEUROPHYSIOL, V68, P969; Woodworth R. S., 1899, ACCURACY VOLUNTARY M	100	11	11	0	7	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3751			J PHYSIOL-LONDON	J. Physiol.-London	MAY	2013	591	10					2647	2666		10.1113/jphysiol.2012.232538			20	Neurosciences; Physiology	Neurosciences & Neurology; Physiology	145LB	WOS:000319016200022	23381901	Green Published			2021-06-18	
J	Liu, YQ; Zhang, ZY; Luo, BW; Schluesener, HJ; Zhang, ZR				Liu, Yuqi; Zhang, Zhiyuan; Luo, Bangwei; Schluesener, Hermann J.; Zhang, Zhiren			Lesional accumulation of heme oxygenase-1 (+) microglia/macrophages in rat traumatic brain injury	NEUROREPORT			English	Article						heme oxygenase-1; macrophages; microglia; traumatic brain injury	EXPRESSION; MACROPHAGES/MICROGLIA; INFLAMMATION; INDUCTION; SYSTEM; HO-1	Heme oxygenase-1 (HO-1) is an inducible rate-limiting enzyme for heme degradation. Here, we studied the HO-1 expression in an open-skull weight-drop-induced traumatic brain injury, with a focus on the early phase, most amenable to therapy. In normal rat brains of our study, HO-1 (+) cells were rarely observed. Significant parenchymal accumulation of HO-1 (+) non-neuron cells was observed 18 h post-traumatic brain injury and increased continuously during the investigating time. We also observed that the accumulated HO-1 (+) non-neuron cells were mainly distributed in the perilesional areas and showed activated microglia/macrophage phenotypes with ramified or amoeboid morphologic characteristics. Further double-labeling experiments showed that most HO-1 (+) non-neuron cells coexpressed CD68 and CD163, but not glial fibrillary acid protein. Our data suggest that HO-1 expression defines a subtype of activated microglia/macrophages involved in the early processes following traumatic brain injury. NeuroReport 24:281-286 (C) 2013 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.	[Liu, Yuqi; Luo, Bangwei; Zhang, Zhiren] Third Mil Med Univ PLA, Inst Immunol, Chongqing 400038, Peoples R China; [Zhang, Zhiyuan; Schluesener, Hermann J.] Univ Tubingen, Inst Brain Res, Tubingen, Germany	Zhang, ZR (corresponding author), Third Mil Med Univ PLA, Inst Immunol, 30 Gaotanyan Main St, Chongqing 400038, Peoples R China.	zhangzhiren@yahoo.com	Zhang, Zhiren/O-1012-2019; zhang, zhiren/I-1046-2014	Zhang, Zhiren/0000-0002-5238-2835; zhang, zhiren/0000-0002-5238-2835	Natural Science Foundation Project of CQ CSTCNatural Science Foundation Project of CQ CSTC [2010BB5025]; National Nature Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81070954]	This research was partly supported by the Natural Science Foundation Project of CQ CSTC (contract no. 2010BB5025) and the National Nature Science Foundation of China (no. 81070954).	Bergeron M, 1998, DEV BRAIN RES, V105, P181, DOI 10.1016/S0165-3806(97)00169-7; Beschorner R, 2000, ACTA NEUROPATHOL, V100, P377, DOI 10.1007/s004010000202; Bortscher S, 2012, J SURG RES, V178, P866, DOI 10.1016/j.jss.2012.07.064; Chora AA, 2007, J CLIN INVEST, V117, P438, DOI 10.1172/JCI28844; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; Jofro-Monseny L, 2007, BIOCHEM BIOPH RES CO, V357, P319, DOI 10.1016/j.bbrc.2007.03.150; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Ladeby R, 2005, BRAIN RES REV, V48, P196, DOI 10.1016/j.brainresrev.2004.12.009; Lehrmann E, 1997, J COMP NEUROL, V386, P461; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; MAINES MD, 1988, FASEB J, V2, P2557; Orihara Yoshiyuki, 2003, Leg Med (Tokyo), V5 Suppl 1, pS278; Orozco LD, 2007, CIRC RES, V100, P1703, DOI 10.1161/CIRCRESAHA.107.151720; Petersen B, 2011, XENOTRANSPLANTATION, V18, P355, DOI 10.1111/j.1399-3089.2011.00674.x; SCHIPPER HM, 1995, ANN NEUROL, V37, P758, DOI 10.1002/ana.410370609; Schluesener HJ, 2000, J NEUROIMMUNOL, V110, P114, DOI 10.1016/S0165-5728(00)00352-0; Shen XD, 2011, LIVER TRANSPLANT, V17, P201, DOI 10.1002/lt.22214; Snyder SH, 2001, NEUROPSYCHOPHARMACOL, V25, P294, DOI 10.1016/S0893-133X(01)00275-5; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Wagener FADTG, 2010, CURR DRUG TARGETS, V11, P1571; Whitney NP, 2009, J NEUROCHEM, V108, P1343, DOI 10.1111/j.1471-4159.2009.05886.x; Wu JM, 2003, STROKE, V34, P2964, DOI 10.1161/01.STR.0000103140.52838.45; Yi JH, 2005, BRAIN RES, V1033, P13, DOI 10.1016/j.brainres.2004.10.055; Zhang Z, 2006, NEUROSCIENCE, V141, P637, DOI 10.1016/j.neuroscience.2006.04.027; Zhang ZR, 2012, BRAIN RES, V1461, P102, DOI 10.1016/j.brainres.2012.04.038	25	11	11	0	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0959-4965	1473-558X		NEUROREPORT	Neuroreport	APR 17	2013	24	6					281	286		10.1097/WNR.0b013e32835f2810			6	Neurosciences	Neurosciences & Neurology	114KE	WOS:000316739000003	23470432				2021-06-18	
J	Baranyi, A; Rothenhausler, HB				Baranyi, Andreas; Rothenhaeusler, Hans-Bernd			The impact of S100b and persistent high levels of neuron-specific enolase on cognitive performance in elderly patients after cardio-pulmonary bypass	BRAIN INJURY			English	Article						Neuron-specific enolase; S100 calcium-binding protein B; cognitive performance; cardiopulmonary bypass; intensive care unit	CORONARY-ARTERY-BYPASS; TRAUMATIC BRAIN-INJURY; CARDIAC-SURGERY; FOLLOW-UP; NEUROCOGNITIVE FUNCTION; BIOCHEMICAL MARKERS; VALVE-REPLACEMENT; S-100 PROTEIN; DAMAGE; ASSOCIATION	Primary objectives: The primary aim was to investigate the impact of neuron-specific enolase (NSE) and S100 calcium-binding protein B (S100b) on cognitive functioning after cardiopulmonary bypass (CPB). Research design: Prospective exploratory study. Setting: Psychiatric Consultation-Liaison Service, Ludwig-Maximilians-University Medical School, Munich, Germany. Participants: Thirty-four patients who underwent elective CPB. Measurements: Before the CPB and on the day before discharge neurocognitive tests based on the Syndrom Kurztest (SKT) were carried out. During the ICU stay and shortly after discharge from the ICU, the delirious state was evaluated daily using the Delirium-Rating-Scale. NSE and S100b levels were assayed before CPB, 24 hours and 48 hours post-operatively and on the day before discharge. Results: After the CPB, 1 day before discharge, six (17.6%) participants had sub-threshold cognitive deficits and seven (20.6%) had clinically significant cognitive deficits. A trend toward persistently high NSE levels at discharge indicates greater cognitive impairment at the time of discharge. After surgical intervention S100b is elevated in all patients, independent of cognitive status. Conclusions: Persistently high levels of NSE might be a useful biomarker to identify patients with cognitive performance impairments, while no significant correlation between levels of S100b and impaired cognitive function were found.	[Baranyi, Andreas; Rothenhaeusler, Hans-Bernd] Univ Med Graz, Dept Psychiat, A-8036 Graz, Austria; [Rothenhaeusler, Hans-Bernd] Univ Munich, Dept Psychiat, D-80539 Munich, Germany	Baranyi, A (corresponding author), Univ Med Graz, Dept Psychiat, Auenbruggerpl 31, A-8036 Graz, Austria.	andreas.baranyi@klinikum-graz.at		Baranyi, Andreas/0000-0003-2389-1945			Anastasiadis K, 2011, HEART, V97, P1082, DOI 10.1136/hrt.2010.218610; Bankier B, 2002, PSYCHOTHER PSYCHOSOM, V71, P133, DOI 10.1159/000056280; Basile AM, 2001, EUR NEUROL, V45, P151, DOI 10.1159/000052114; Chiappini B, 2003, CARDIOVASC SURG, V11, P359, DOI 10.1016/S0967-2109(03)00104-2; de boussard CN, 2004, BRAIN INJURY, V18, P671, DOI 10.1080/02699050310001646215; Feil D, 2003, AM J GERIAT PSYCHIAT, V11, P551, DOI 10.1176/appi.ajgp.11.5.551; Ferguson TB, 2002, ANN THORAC SURG, V73, P480, DOI 10.1016/S0003-4975(01)03339-2; Gerriets T, 2010, AM J CARDIOL, V105, P1095, DOI 10.1016/j.amjcard.2009.12.009; Herrmann M, 1999, EUR J CARDIO-THORAC, V16, P513, DOI 10.1016/S1010-7940(99)00245-6; Kendel F, 2011, PSYCHOSOM MED, V73, P280, DOI 10.1097/PSY.0b013e3182114d35; KIMBALL CP, 1973, PSYCHOTHER PSYCHOSOM, V22, P310, DOI 10.1159/000286536; Kneebone AC, 2005, J NEUROL NEUROSUR PS, V76, P1121, DOI 10.1136/jnnp.2004.047456; Lehfeld H, 1997, Int Psychogeriatr, V9 Suppl 1, P115; MATTLAR CE, 1991, PSYCHOTHER PSYCHOSOM, V55, P145, DOI 10.1159/000288422; McDonagh DL, 2010, ANESTHESIOLOGY, V112, P852, DOI 10.1097/ALN.0b013e3181d31fd7; McKhann GM, 1997, LANCET, V349, P1282, DOI 10.1016/S0140-6736(96)09466-4; McKhann GM, 1997, ANN THORAC SURG, V63, P510; MURKIN JM, 1995, J THORAC CARDIOV SUR, V110, P349, DOI 10.1016/S0022-5223(95)70230-X; Naeimi ZS, 2006, BRAIN INJURY, V20, P463, DOI 10.1080/02699050600664418; Newman MF, 2001, NEW ENGL J MED, V344, P395, DOI 10.1056/NEJM200102083440601; Peterson JC, 2002, AM J GERIAT PSYCHIAT, V10, P192, DOI 10.1176/appi.ajgp.10.2.192; Phillips-Bute B, 2006, PSYCHOSOM MED, V68, P369, DOI 10.1097/01.psy.0000221272.77984.e2; Prohl J, 2009, J INT NEUROPSYCH SOC, V15, P344, DOI 10.1017/S1355617709090493; Ramlawi B, 2006, ANN SURG, V244, P593, DOI 10.1097/01.sla.0000239087.00826.b4; Rasmussen LS, 1999, ACTA ANAESTH SCAND, V43, P495, DOI 10.1034/j.1399-6576.1999.430502.x; Rohan D, 2005, CAN J ANAESTH, V52, P137, DOI 10.1007/BF03027718; Rothenhausler HB, 2005, GEN HOSP PSYCHIAT, V27, P18, DOI 10.1016/j.genhosppsych.2004.09.001; SHAW PJ, 1985, BRIT MED J, V291, P1384, DOI 10.1136/bmj.291.6506.1384; Sojka P, 2006, BRAIN INJURY, V20, P613, DOI 10.1080/02699050600676982; Stalnacke BM, 2004, BRAIN INJURY, V18, P899, DOI 10.1080/02699050410001671865; Stroobant N, 2009, HEART, V95, P1820, DOI 10.1136/hrt.2009.168237; TRZEPACZ PT, 1988, PSYCHIAT RES, V23, P89, DOI 10.1016/0165-1781(88)90037-6; van Dijk D, 2004, HEART, V90, P431, DOI 10.1136/hrt.2003.010173; Zetterberg H, 2009, BRAIN INJURY, V23, P723, DOI 10.1080/02699050903120399	34	11	18	0	7	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	APR	2013	27	4					417	424		10.3109/02699052.2012.750751			8	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	117LG	WOS:000316954300006	23473361				2021-06-18	
J	Liang, XY; Li, HN; Yang, XY; Zhou, WY; Niu, JG; Chen, BD				Liang, Xue-Yun; Li, Hai-Ning; Yang, Xiao-Yan; Zhou, Wen-Yan; Niu, Jian-Guo; Chen, Ben-Dong			Effect of Danshen aqueous extract on serum hs-CRP, IL-8, IL-10, TNF-alpha levels, and IL-10 mRNA, TNF-alpha mRNA expression levels, cerebral TGF-beta 1 positive expression level and its neuroprotective mechanisms in CIR rats	MOLECULAR BIOLOGY REPORTS			English	Article						Cerebral; Ischemia reperfusion; Danshen aqueous extract; Neuroprotection; IL-10 mRNA; TNF-alpha mRNA; RT-PCR	C-REACTIVE PROTEIN; ISCHEMIC-STROKE PATIENTS; NEURON-SPECIFIC ENOLASE; TRAUMATIC BRAIN-INJURY; CORONARY-HEART-DISEASE; TUMOR-NECROSIS-FACTOR; CHINESE HERBAL DRUG; SALVIA-MILTIORRHIZA; PROSTATE-CANCER; OXIDATIVE STRESS	To observe the effects of Danshen aqueous extract (DSAE) on the cerebral tissue and nerve stem cells in cerebral ischemia reperfusion (CIR) rats. The model rats were prepared by occlusion of the middle cerebral artery for 2 h and then by reperfusion. They were randomly divided into five groups: a control group, an CIR group and three DSAE-treated groups. As compared with the sham control group, there was significant increase (P < 0.05, P < 0.01) in the serum high-sensitivity C-reactive protein (hs-CRP) and interleukin-8 (IL-8) levels, interleukin-10 (IL-10), tumor necrosis factor-alpha (TNF-alpha) levels, and IL-10 mRNA, TNF-alpha mRNA expression levels, function score, Infarct size, TUNEL + cell counts, cerebral transforming growth factor beta 1 (TGF-beta 1) positive expression and cerebral neuron specific enolase (NSE) levels, and decrease in fas-associated protein with death domain (FADD) and death-associated protein (Daxx) positive expression levels in the CIR group. Compared with CIR group, DSAE treatment dose-dependently significantly decreased serum hs-CRP, IL-8, IL-10, TNF-alpha levels, and IL-10 mRNA, TNF-alpha mRNA expression levels, function score, Infarct size, TUNEL + cell counts, cerebral TGF-beta 1 positive expression and cerebral NSE levels, and increase FADD and Daxx positive expression levels in the CIR + DSAE groups. Taken together, these results suggest that DSAE has a neuroprotective role in the CIR rats, which may be related to improvement of immunity function, proteins and genes expression.	[Liang, Xue-Yun; Yang, Xiao-Yan] Gen Hosp Ningxia Med Univ, Dept Lab Med, Yinchuan 750004, Peoples R China; [Li, Hai-Ning] Gen Hosp Ningxia Med Univ, Dept Neurol, Yinchuan 750004, Peoples R China; [Zhou, Wen-Yan] Gen Hosp Ningxia Med Univ, Dept ICU, Yinchuan 750004, Peoples R China; [Niu, Jian-Guo] Ningxia Med Univ, Sch Basic Med Sci, Dept Anat Histol & Embryol, Yinchuan 750004, Peoples R China; [Chen, Ben-Dong] Gen Hosp Ningxia Med Univ, Dept Hepatobiliary Surg, Yinchuan 750004, Peoples R China	Niu, JG (corresponding author), Ningxia Med Univ, Sch Basic Med Sci, Dept Anat Histol & Embryol, Yinchuan 750004, Peoples R China.	jguoniu@163.com; prbdchen@163.com					Albers GW, 2008, CHEST, V133, p630S, DOI 10.1378/chest.08-0720; Ata AK, 1997, ACTA NEUROPATHOL, V93, P326, DOI 10.1007/s004010050623; BARONE FC, 1992, STROKE, V23, P1337, DOI 10.1161/01.STR.23.9.1337; Bemeur C, 2005, NEUROCHEM INT, V46, P399, DOI 10.1016/j.neuint.2004.11.007; Berger RP, 2007, J NEUROTRAUM, V24, P1793, DOI 10.1089/neu.2007.0316; Bertolino P, 2005, CHEST, V128, p585S, DOI 10.1378/chest.128.6_suppl.585S; Chambers JC, 2001, CIRCULATION, V104, P145, DOI 10.1161/01.CIR.104.2.145; Chan K, 2004, LIFE SCI, V75, P3157, DOI 10.1016/j.lfs.2004.06.010; Cheng TO, 2006, INT J CARDIOL, V110, P411, DOI 10.1016/j.ijcard.2005.08.069; Cheng TO, 2006, INT J CARDIOL, V113, P437, DOI 10.1016/j.ijcard.2005.10.026; Date I, 2006, NEUROSCI LETT, V407, P141, DOI 10.1016/j.neulet.2006.08.050; del Zoppo G, 2000, BRAIN PATHOL, V10, P95; Dietl M, 2009, FORTSCHR NEUROL PSYC, V77, P714, DOI 10.1055/s-0028-1109912; Dietrich WD, 1999, EXP NEUROL, V158, P444, DOI 10.1006/exnr.1999.7115; Dirnagl U, 2009, BRIT J PHARMACOL, V157, P1154, DOI 10.1111/j.1476-5381.2009.00211.x; Ellnain-Wojtaszek M, 2003, FITOTERAPIA, V74, P1, DOI 10.1016/S0367-326X(02)00306-4; Emsley HCA, 2002, J CEREBR BLOOD F MET, V22, P1399, DOI 10.1097/01.WCB.0000037880.62590.28; Frohlich M, 2000, DIABETES CARE, V23, P1835, DOI 10.2337/diacare.23.12.1835; Guo BQ, 2004, ANTICANCER RES, V24, P1337; Hak AE, 1999, ARTERIOSCL THROM VAS, V19, P1986, DOI 10.1161/01.ATV.19.8.1986; Hallenbeck JM, 2002, NAT MED, V8, P1363, DOI 10.1038/nm1202-1363; Huang JT, 2005, AM J PATHOL, V166, P1807, DOI 10.1016/S0002-9440(10)62490-X; Inoue K, 2000, CANCER RES, V60, P2290; Inoue K, 2000, CLIN CANCER RES, V6, P2104; Ji XY, 2000, ACTA PHARMACOL SIN, V21, P1089; Kang DG, 2002, AM J CHINESE MED, V30, P87, DOI 10.1142/S0192415X02000107; KEJI C, 1981, AM J CHINESE MED, V9, P193, DOI 10.1142/S0192415X81000251; KOCHANEK PM, 1992, STROKE, V23, P1367, DOI 10.1161/01.STR.23.9.1367; Krupinski J, 1996, STROKE, V27, P852, DOI 10.1161/01.STR.27.5.852; Krupinski J, 1998, NITRIC OXIDE-BIOL CH, V2, P442, DOI 10.1006/niox.1998.0204; Lee EJ, 2002, J NEUROSCI RES, V68, P636, DOI 10.1002/jnr.10251; Lee JC, 2005, GLIA, V50, P168, DOI 10.1002/glia.20164; Lee LF, 2004, ONCOGENE, V23, P2197, DOI 10.1038/sj.onc.1207344; Lehrer S, 2004, TECHNOL CANCER RES T, V3, P411, DOI 10.1177/153303460400300501; Li MH, 2008, J ETHNOPHARMACOL, V120, P419, DOI 10.1016/j.jep.2008.09.013; Lipton P, 1999, PHYSIOL REV, V79, P1431; Liu CS, 2006, ACTA PHARMACOL SIN, V27, P1137, DOI 10.1111/j.1745-7254.2006.00378.x; Liu LS, 2006, INT J STROKE, V1, P150, DOI 10.1111/j.1747-4949.2006.00041.x; Liu Nan, 2007, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V23, P498; Mendall MA, 1996, BRIT MED J, V312, P1061; Meric E, 2010, J EMERG MED, V38, P297, DOI 10.1016/j.jemermed.2007.11.032; Mostaza JM, 2009, CEREBROVASC DIS, V27, P77, DOI 10.1159/000200443; Ormstad H, 2011, J NEUROL, V258, P677, DOI 10.1007/s00415-011-6006-0; Palmio J, 2010, PSYCHIAT RES, V177, P97, DOI 10.1016/j.psychres.2009.01.027; Patel BJ, 2000, J UROLOGY, V164, P1420, DOI 10.1016/S0022-5347(05)67210-2; Perini F, 2001, NEUROL SCI, V22, P289, DOI 10.1007/s10072-001-8170-y; PULSINELLI WA, 1979, STROKE, V10, P267, DOI 10.1161/01.STR.10.3.267; PULSINELLI WA, 1982, ANN NEUROL, V11, P491, DOI 10.1002/ana.410110509; Qian SH, 2011, J ETHNOPHARMACOL, V137, P985, DOI 10.1016/j.jep.2011.07.018; Ramsden N, 2011, ACS CHEM BIOL, V6, P1021, DOI 10.1021/cb2002413; Razonable RR, 2005, ANTIMICROB AGENTS CH, V49, P3546, DOI 10.1128/AAC.49.8.3546-3549.2005; Reiland J, 1999, PROSTATE, V41, P78; Rosen H, 2001, RESUSCITATION, V49, P183, DOI 10.1016/S0300-9572(00)00348-8; Shore PM, 2007, J NEUROTRAUM, V24, P75, DOI 10.1089/neu.2006.0062; SMITH ML, 1984, ACTA NEUROL SCAND, V69, P385, DOI 10.1111/j.1600-0404.1984.tb07822.x; Song IU, 2010, EUR NEUROL, V64, P304, DOI 10.1159/000321415; Tam WY, 2009, J ALTERN COMPLEM MED, V15, P415, DOI 10.1089/acm.2008.0400; Tarkowski E, 1997, CLIN EXP IMMUNOL, V110, P492, DOI 10.1046/j.1365-2249.1997.4621483.x; Tian Xiao-hui, 2005, Zhongguo Zhong Xi Yi Jie He Za Zhi, V25, P404; Veltri RW, 1999, UROLOGY, V53, P139, DOI 10.1016/S0090-4295(98)00455-5; Vila N, 2003, STROKE, V34, P671, DOI 10.1161/01.STR.0000057976.53301.69; Vila N, 2000, STROKE, V31, P2325, DOI 10.1161/01.STR.31.10.2325; Wang Xue-feng, 2003, Di Yi Jun Yi Da Xue Xue Bao, V23, P969; Wei Z M, 1996, Zhongguo Zhong Xi Yi Jie He Za Zhi, V16, P402; Woiciechowsky C, 2004, MED SCI MONITOR, V10, pBR325; Wu WWP, 2010, PHYTOMEDICINE, V17, P219, DOI 10.1016/j.phymed.2009.05.005; Youn CS, 2012, AM J EMERG MED, V30, P124, DOI 10.1016/j.ajem.2010.11.006; Yue KKM, 2006, J ETHNOPHARMACOL, V106, P136, DOI 10.1016/j.jep.2005.12.026; Zhai QH, 1997, J NEUROL SCI, V152, P119, DOI 10.1016/S0022-510X(97)00154-8; Zhang Mei, 2003, Zhong Yao Cai, V26, P738; Zhang ZG, 2002, CIRC RES, V90, P284, DOI 10.1161/hh0302.104460; Zheng Z, 2004, NEUROL RES, V26, P884, DOI 10.1179/016164104X2357; Zhou LM, 2005, J CLIN PHARMACOL, V45, P1345, DOI 10.1177/0091270005282630	73	11	13	0	18	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0301-4851	1573-4978		MOL BIOL REP	Mol. Biol. Rep.	APR	2013	40	4					3419	3427		10.1007/s11033-012-2419-9			9	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	107MH	WOS:000316221100071	23378241				2021-06-18	
J	Shen, J; Fan, ZX; Ji, T; Pan, JW; Zhou, YQ; Zhan, RY				Shen, Jian; Fan, Zuoxu; Ji, Tao; Pan, Jianwei; Zhou, Yongqing; Zhan, Renya			Contralateral Acute Subdural Hematoma Following Traumatic Acute Subdural Hematoma Evacuation-Case Report	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						acute subdural hematoma; decompressive craniectomy; postoperative hemorrhage	DECOMPRESSIVE SURGERY; CRANIECTOMY; MORTALITY; INJURY	Contralateral acute subdural hematoma (ASDH) occurring after removal of traumatic ASDH is a rare, but nearly devastating postoperative complication. We treated a 26-year-old male who developed a contralateral ASDH shortly after craniectomy for evacuation of a traumatic ASDH. Burr-hole craniotomy was performed before decompressive craniectomy, and the bleeding source was a cortex artery within the frontal lobe contusion. Despite supportive therapy with barbiturate and mild hypothermia he expired 3 days later of brain death. Literature review suggests that the old are more susceptible to contralateral ASDH following evacuation of traumatic ASDH. Contralateral ASDH following evacuation of traumatic ASDH is a rare but potentially lethal complication, so neurosurgeons should try to detect such contralateral hematoma formation and prevent clinical deterioration.	[Shen, Jian; Fan, Zuoxu; Ji, Tao; Pan, Jianwei; Zhou, Yongqing; Zhan, Renya] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Neurosurg, Hangzhou 310003, Zhejiang, Peoples R China	Zhan, RY (corresponding author), Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Neurosurg, 79 Qingchun Rd, Hangzhou 310003, Zhejiang, Peoples R China.			Pan, Jianwei/0000-0001-6353-1843			BAN M, 1991, Neurologia Medico-Chirurgica, V31, P927, DOI 10.2176/nmc.31.927; Brisman MH, 1996, NEUROSURGERY, V39, P1114, DOI 10.1097/00006123-199612000-00009; Danish SF, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS945; Fridley J, 2011, J CLIN NEUROSCI, V18, P422, DOI 10.1016/j.jocn.2010.05.004; Guilburd JN, 2001, J NEUROSURG, V95, P263, DOI 10.3171/jns.2001.95.2.0263; Harada Katsuhiko, 1992, Neurologia Medico-Chirurgica, V32, P969, DOI 10.2176/nmc.32.969; Huang APH, 2011, J TRAUMA, V70, P1578, DOI 10.1097/TA.0b013e3182178c71; Kontopoulos V, 2002, ACTA NEUROCHIR, V144, P791, DOI 10.1007/s00701-002-0948-z; Matsuno A, 2003, SURG NEUROL, V60, P23, DOI 10.1016/S0090-3019(03)00023-5; MODESTI LM, 1982, NEUROSURGERY, V10, P689, DOI 10.1227/00006123-198206010-00002; Mohindra S, 2005, BRIT J NEUROSURG, V19, P490, DOI 10.1080/02688690500495216; Moon KS, 2007, J CLIN NEUROSCI, V14, P283, DOI 10.1016/j.jocn.2005.11.016; Murzin V E, 1979, Zh Vopr Neirokhir Im N N Burdenko, P43; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; STONE JL, 1986, J TRAUMA, V26, P445, DOI 10.1097/00005373-198605000-00006; Su TM, 2008, J TRAUMA, V65, P1298, DOI 10.1097/TA.0b013e31815885d9; Su TM, 2001, J TRAUMA, V50, P557, DOI 10.1097/00005373-200103000-00025; Tomycz Nestor D, 2010, J Trauma, V68, pE11, DOI 10.1097/TA.0b013e31811eaaf5; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9	20	11	11	0	4	JAPAN NEUROSURGICAL SOC	TOKYO	7-3-1 HONGO BUNKYO-KU, TOKYO, 113-8655, JAPAN	0470-8105			NEUROL MED-CHIR	Neurol. Med.-Chir.	APR	2013	53	4					221	224		10.2176/nmc.53.221			4	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	128WT	WOS:000317801100005	23615411	Bronze			2021-06-18	
J	Uruma, G; Hashimoto, K; Abo, M				Uruma, Go; Hashimoto, Keiji; Abo, Masahiro			A new method for evaluation of mild traumatic brain injury with neuropsychological impairment using statistical imaging analysis for Tc-ECD SPECT	ANNALS OF NUCLEAR MEDICINE			English	Article						Mild traumatic brain injury; Neuropsychological impairments; Single photon emission computed tomography; Statistical imaging analysis	DIFFUSE AXONAL INJURY; CEREBRAL-BLOOD-FLOW; EMISSION-TOMOGRAPHY; GLUCOSE-METABOLISM; HEAD-INJURY; ACUTE STAGE; CORTEX; SUPPORTS; BEHAVIOR; DEFICITS	The objective of this study was to identify specific brain lesions with regional perfusion abnormalities possibly associated with neuropsychological impairments (NPI), as sequela after mild traumatic brain injury (MTBI), using 99mTc-ethylcysteinate dimer single photon emission computed tomography (Tc-99m ECD SPECT) and its novel analytic software. We studied 23 patients with diffuse axonal injury with NPI group (Impaired-DAI), 26 with MTBI with NPI group (Impaired-MTBI) and 24 with MTBI without NPI group (Healthy-MTBI). In each subject, Tc-99m ECD SPECT images were analyzed by easy Z score imaging system (eZIS) and voxel-based stereotactic extraction estimation (vbSEE). Segmented into lobule levels, ROIs were set in 140 areas in whole brain, and relative regional low Tc-99m ECD uptake was computed as "extent" (rate of coordinates with Z score > 2.0 in the ROI). Receiver operating characteristic analysis was performed using "extent" to discriminate the three groups. The highest area under the curve (AUC) value for data of Impaired-DAI and Healthy-MTBI groups was obtained in ROI on the left anterior cingulate gyrus (LtACG), with AUC of 0.93, optimal "extent" cutoff value of 10.9 %, sensitivity 87.0 %, specificity 83.3 %. The highest AUC value for data of Impaired-MTBI and Healthy-MTBI groups was also in the LtACG, with AUC of 0.87, optimal "extent" cutoff value of 9.2 %, sensitivity 73.1 %, specificity 83.3 %. Using two analytic software packages, eZIS and vbSEE, we identified specific lesions with low regional Tc-99m ECD uptake possibly associated with NPIs after MTBI. Especially, this trend was most marked in the left anterior cingulate gyrus in MTBI patients with NPIs and those with DAI. The optimal "extent" cutoff value, as a criterion for SPECT abnormality, might help the diagnosis of NPIs after MTBI.	[Uruma, Go; Hashimoto, Keiji; Abo, Masahiro] Jikei Univ, Sch Med, Dept Rehabil Med, Minato Ku, Tokyo, Japan; [Uruma, Go] Kanagawa Rehabil Hosp, Dept Rehabil Med, Atsugi, Kanagawa, Japan; [Hashimoto, Keiji] Natl Ctr Child Hlth & Dev, Div Rehabil Med, Tokyo, Japan	Uruma, G (corresponding author), Jikei Univ, Sch Med, Dept Rehabil Med, Minato Ku, 3-25-8 Nishi Shinbashi, Tokyo, Japan.	uruma-jk@jikei.ac.jp		Hashimoto, Keiji/0000-0003-2412-860X; Abo, Masahiro/0000-0001-6701-4974	General Insurance Association of Japan	The authors appreciate the excellent technical support provided by Dr. M. Uchiyama and the radiological technologists at the Department of Radiology, Jikei University School of Medicine. This study was supported by a grant from The General Insurance Association of Japan. The authors declare that we have no conflict of interest.	ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Bonne O, 2003, PSYCHIAT RES-NEUROIM, V124, P141, DOI 10.1016/S0925-4927(03)00109-4; Davalos Deana B, 2002, Appl Neuropsychol, V9, P92, DOI 10.1207/S15324826AN0902_4; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Friston KJ, 1996, CEREB CORTEX, V6, P156, DOI 10.1093/cercor/6.2.156; Gardner RM, 2003, J HEAD TRAUMA REHAB, V18, P52, DOI 10.1097/00001199-200301000-00007; Gennarelli T A, 1984, Emerg Med Clin North Am, V2, P749; Gowda NK, 2006, AM J NEURORADIOL, V27, P447; GRAHAM DI, 2000, HEAD INJURY, P176; Gross H, 1996, J NEUROPSYCH CLIN N, V8, P324; Hashimoto K, 2009, J REHABIL MED, V41, P661, DOI 10.2340/16501977-0388; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Kasahara K, 2012, MAGN RESON IMAGING, V30, P496, DOI 10.1016/j.mri.2011.12.018; Katagi H, 2008, JIKEIKAI MED J, V123, P237; Kato T, 2007, J NEUROTRAUM, V24, P919, DOI 10.1089/neu.2006.0203; Kawai N, 2010, J NEUROTRAUM, V27, P2131, DOI 10.1089/neu.2010.1464; Matsuda H, 2007, AM J NEURORADIOL, V28, P731; Matsuda H, 2004, NUCL MED COMMUN, V25, P67, DOI 10.1097/00006231-200401000-00010; Matsushita M, 2011, J NEUROSURG, V115, P130, DOI 10.3171/2011.2.JNS101547; Meares S, 2006, J INT NEUROPSYCH SOC, V12, P792, DOI 10.1017/S1355617706060978; Mizumura S, 2003, ANN NUCL MED, V17, P289, DOI 10.1007/BF02988523; Momosaki R, 2012, EUR NEUROL, V67, P74, DOI 10.1159/000333778; Nakashima T, 2007, AM J NEURORADIOL, V28, P236; Okamoto T, 2007, EUR J NEUROL, V14, P540, DOI 10.1111/j.1468-1331.2007.01742.x; Ponsford J, 2005, CURR OPIN NEUROL, V18, P692, DOI 10.1097/01.wco.0000186840.61431.44; Talairach J., 1988, COPLANAR STEREOTAXIC; Uruma G, 2010, EUR J NEUROL, V17, P461, DOI 10.1111/j.1468-1331.2009.02849.x; Uruma Go, 2006, Jikeikai Medical Journal, V53, P141; Van Laere KJ, 2002, J NUCL MED, V43, P458; Ylvisaker M, 2003, J HEAD TRAUMA REHAB, V18, P7, DOI 10.1097/00001199-200301000-00005	31	11	11	0	6	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0914-7187	1864-6433		ANN NUCL MED	Ann. Nucl. Med.	APR	2013	27	3					187	202		10.1007/s12149-012-0674-4			16	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	122FD	WOS:000317302500001	23255125				2021-06-18	
J	Valdez, M; Balachandran, B				Valdez, M.; Balachandran, B.			Longitudinal nonlinear wave propagation through soft tissue	JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS			English	Article						Brain fibers; Nonlinear viscoelasticity; Nonlinear wave propagation; Attenuation; Wave speed; Wave front steepening	TRAUMATIC BRAIN-INJURY; HUMAN HEAD; DEFORMATION; IMPACT; ATTENUATION; STRUTS; MODEL	In this paper, wave propagation through soft tissue is investigated. A primary aim of this investigation is to gain a fundamental understanding of the influence of soft tissue nonlinear material properties on the propagation characteristics of stress waves generated by transient loadings. Here, for computational modeling purposes, the soft tissue is modeled as a nonlinear visco-hyperelastic material, the geometry is assumed to be one-dimensional rod geometry, and uniaxial propagation of longitudinal waves is considered. By using the linearized model, a basic understanding of the characteristics of wave propagation is developed through the dispersion relation and in terms of the propagation speed and attenuation. In addition, it is illustrated as to how the linear system can be used to predict brain tissue material parameters through the use of available experimental ultrasonic attenuation curves. Furthermore, frequency thresholds for wave propagation along internal structures, such as axons in the white matter of the brain, are obtained through the linear analysis. With the nonlinear material model, the authors analyze cases in which one of the ends of the rods is fixed and the other end is subjected to a loading. Two variants of the nonlinear model are analyzed and the associated predictions are compared with the predictions of the corresponding linear model. The numerical results illustrate that one of the imprints of the nonlinearity on the wave propagation phenomenon is the steepening of the wave front, leading to jump-like variations in the stress wave profiles. This phenomenon is a consequence of the dependence of the local wave speed on the local deformation of the material. As per the predictions of the nonlinear material model, compressive waves in the structure travel faster than tensile waves. Furthermore, it is found that wave pulses with large amplitudes and small elapsed times are attenuated over shorter spans. This feature is due to the elevated strain-rates introduced at the end of the structure where the load is applied. In addition, it is shown that when steep wave fronts are generated in the nonlinear viscoelastic material, energy dissipation is focused in those wave fronts implying deposition of energy in a highly localized region of the material. Novel mechanisms for brain tissue damage are proposed based on the results obtained. The first mechanism is related to the dissipation of energy at steep wave fronts, while the second one is related to the interaction of steep wave fronts with axons encountered on its way through the structure. (C) 2013 Elsevier Ltd. All rights reserved.	[Valdez, M.; Balachandran, B.] Univ Maryland, Dept Mech Engn, College Pk, MD 20742 USA	Balachandran, B (corresponding author), Univ Maryland, Dept Mech Engn, College Pk, MD 20742 USA.	mvaldez@umd.edu; balab@umd.edu		Valdez, Marcelo/0000-0001-5574-1461	Center for Energetic Concepts Development at University of Maryland	Partial support received for this work through the Center for Energetic Concepts Development at University of Maryland is gratefully acknowledged.	Balachandran B., 2009, VIBRATIONS; Bayly PV, 2006, J BIOMECH, V39, P1086, DOI 10.1016/j.jbiomech.2005.02.014; CHIVERS RC, 1978, J ACOUST SOC AM, V63, P940, DOI 10.1121/1.381774; Clayton E., 2011, MECH BIOL SYSTEMS MA, V2, P57; Darvish KK, 2001, MED ENG PHYS, V23, P633, DOI 10.1016/S1350-4533(01)00101-1; ETOH A, 1994, JPN J APPL PHYS 1, V33, P2874, DOI 10.1143/JJAP.33.2874; Franceschini G, 2006, J MECH PHYS SOLIDS, V54, P2592, DOI 10.1016/j.jmps.2006.05.004; Gao L, 1996, ULTRASOUND MED BIOL, V22, P959, DOI 10.1016/S0301-5629(96)00120-2; GROSS AG, 1958, J NEUROSURG, V15, P548, DOI 10.3171/jns.1958.15.5.0548; Halabieh O, 2008, LECT NOTES COMPUT SC, V5104, P107, DOI 10.1007/978-3-540-70521-5_12; Haslach HW, 2011, MAXIMUM DISSIPATION NON-EQUILIBRIUM THERMODYNAMICS AND ITS GEOMETRIC STRUCTURE, P1; HOLBOURN AHS, 1945, BRIT MED BULL, V3, P147, DOI 10.1093/oxfordjournals.bmb.a071895; Holzapfel G., 2000, NONLINEAR SOLID MECH; Huang HM, 2000, MED BIOL ENG COMPUT, V38, P253, DOI 10.1007/BF02347044; Humphrey JD, 2003, P ROY SOC A-MATH PHY, V459, P3, DOI 10.1098/rspa.2002.1060; Imielinska C, 2006, LECT NOTES COMPUT SC, V3994, P822; Kolsky H., 2003, STRESS WAVES SOLIDS; KREMKAU FW, 1981, J ACOUST SOC AM, V70, P29, DOI 10.1121/1.386578; Kumaresan S, 1996, MED BIOL ENG COMPUT, V34, P27, DOI 10.1007/BF02637019; Mahapatra DR, 2001, SMART MATER STRUCT, V10, P1046, DOI 10.1088/0964-1726/10/5/321; MENDIS KK, 1995, J BIOMECH ENG-T ASME, V117, P279, DOI 10.1115/1.2794182; Miller K, 1997, J BIOMECH, V30, P1115, DOI 10.1016/S0021-9290(97)00092-4; Miller K, 2002, J BIOMECH, V35, P483, DOI 10.1016/S0021-9290(01)00234-2; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; NEWLAND DE, 1993, P ROY SOC LOND A MAT, V443, P203, DOI 10.1098/rspa.1993.0140; NOLTE J, 2002, HUMAN BRAIN INTRO IT; Nyein M., 2008, TECHNICAL REPORT; Nyein MK, 2010, P NATL ACAD SCI USA, V107, P20703, DOI 10.1073/pnas.1014786107; Pelinescu I, 2001, SMART MATER STRUCT, V10, P121, DOI 10.1088/0964-1726/10/1/312; Pervin F, 2009, J BIOMECH, V42, P731, DOI 10.1016/j.jbiomech.2009.01.023; Pinnoji PK, 2007, SADHANA-ACAD P ENG S, V32, P445, DOI 10.1007/s12046-007-0034-6; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Valdez M., 2011, SIMULATION BASED INN; Valdez MF, 2010, IFMBE PROC, V32, P13, DOI 10.1007/978-3-642-14998-6_4; Voo L, 1996, MED BIOL ENG COMPUT, V34, P375, DOI 10.1007/BF02520009; Zong Z, 2006, J BIOMECH, V39, P284, DOI 10.1016/j.jbiomech.2004.11.015; Zou H, 2007, J BIOMECH, V40, P1183, DOI 10.1016/j.jbiomech.2006.06.018	37	11	11	1	34	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1751-6161			J MECH BEHAV BIOMED	J. Mech. Behav. Biomed. Mater.	APR	2013	20						192	208		10.1016/j.jmbbm.2013.01.002			17	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	137RP	WOS:000318455400020	23510921				2021-06-18	
J	Akelma, AZ; Celik, A; Ozdemir, O; Akelma, FK; Abaci, A; Razi, CH; Kislal, FM; Akin, O				Akelma, Ahmet Zulfikar; Celik, Aydin; Ozdemir, Osman; Akelma, Fatma Kavak; Abaci, Ayhan; Razi, Cem Hasan; Kislal, Fatih Mehmet; Akin, Okhan			Neuron-specific enolase and S100B protein in children with carbon monoxide poisoning: children are not just small adults	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; CEREBROSPINAL-FLUID; MARKERS; DAMAGE; S-100; RATS; NSE	Introduction: The aim of this study was to evaluate the role of S100B protein and neuron-specific enolase (NSE) in children with carbon monoxide (CO) poisoning. Methods: In this prospective, case-controlled study, children with CO poisoning were recruited. Patient demographics features and Glasgow Coma Scale (GCS) were recorded. Blood samples were collected from all children with CO poisoning at their admission to the hospital and at 3 and 6 hours after admission. Levels of NSE and S100B were measured. The control group consisted of age-matched healthy children. Results: A total of 30 children with CO poisoning (mean age, 7.88 +/- 3.75 years; 17 boys) and 30 healthy children (mean age, 8.16 +/- 3.05 years; 7 boys) were enrolled in the study. Mean carboxyhemoglobin level (%) measured at admission was 30.05 +/- 8.00. Serum NSE levels of the children with CO poisoning were significantly higher than those of children from the control group at 0 hour and also at 3 and 6 hours (P < .001, P = .001, and P = .005, respectively). Serum S100B protein levels were similar between the 2 groups at 0 and 3 and 6 hours (P > .05). Serum NSE levels of patients with CO poisoning demonstrated a negative correlation with the admission GCS scores. No correlation was found between GCS scores and S100B protein levels. Conclusion: We have shown that NSE levels increase in CO-associated hypoxic brain damage in accordance with clinical findings. We have also found that, contrary to the studies conducted on adults, S100B protein levels do not increase in response to hypoxic brain damage. (C) 2013 Elsevier Inc. All rights reserved.	[Akelma, Ahmet Zulfikar] Fatih Univ, Sch Med, Dept Pediat, Ankara, Turkey; [Celik, Aydin; Ozdemir, Osman; Razi, Cem Hasan; Kislal, Fatih Mehmet] Kecioren Teaching & Res Hosp, Dept Pediat, Ankara, Turkey; [Akelma, Fatma Kavak] Ankara Zubeyde Hanim Etlik Matern & Gynecol Teach, Dept Anesthesiol, Ankara, Turkey; [Abaci, Ayhan] Dokuz Eylul Univ, Sch Med, Dept Pediat, Izmir, Turkey; [Akin, Okhan] Kecioren Teaching & Res Hosp, Dept Biochem, Ankara, Turkey	Akelma, AZ (corresponding author), Alparslan Turkes Cad 57, TR-06510 Ankara, Turkey.	akelma@gmail.com	RAZI, CEM/AAY-1772-2020; Abaci, Ayhan/A-4356-2016	Abaci, Ayhan/0000-0002-1812-0321; RAZI, CEM/0000-0003-0005-1409			Andiran N, 2004, TURKISH J PEDIATR, V46, P147; [Anonymous], 2008, MMWR MORB MORTAL WKL, V57, P896; Berger RP, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e31; Brvar M, 2004, CRIT CARE MED, V32, P2128, DOI 10.1097/01.CCM.0000142702.39718.A0; Brvar M, 2004, RESUSCITATION, V61, P357, DOI 10.1016/j.resuscitation.2004.01.009; Brvar M, 2006, CRIT CARE MED, V34, P2228, DOI 10.1097/01.CCM.0000228913.61710.9D; Cakir Z, 2010, AM J EMERG MED, V28, P61, DOI 10.1016/j.ajem.2008.10.032; DEGIORGIO CM, 1995, NEUROLOGY, V45, P1134, DOI 10.1212/WNL.45.6.1134; HARDEMARK HG, 1989, J NEUROSURG, V71, P727, DOI 10.3171/jns.1989.71.5.0727; Ide T, 2008, AM J EMERG MED, V26, P908, DOI 10.1016/j.ajem.2007.11.021; Ide T, 2012, AM J EMERG MED, V30, P222, DOI 10.1016/j.ajem.2010.11.025; Kao LW, 2005, MED CLIN N AM, V89, P1161, DOI 10.1016/j.mcna.2005.06.007; Kirkham FJ, 2008, DEV MED CHILD NEUROL, V50, P267, DOI 10.1111/j.1469-8749.2008.02042.x; Oertel M, 2006, J CLIN NEUROSCI, V13, P834, DOI 10.1016/j.jocn.2005.11.030; Prockop LD, 2005, J NEUROIMAGING, V15, P144, DOI 10.1177/1051228404273819; Prockop LD, 2007, J NEUROL SCI, V262, P122, DOI 10.1016/j.jns.2007.06.037; Rasmussen LS, 2004, ACTA ANAESTH SCAND, V48, P469, DOI 10.1111/j.1399-6576.2004.00362.x; Rosen H, 2001, RESUSCITATION, V49, P183, DOI 10.1016/S0300-9572(00)00348-8; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Wunderlich MT, 2004, J NEUROL SCI, V227, P49, DOI 10.1016/j.jns.2004.08.005; Yardan T, 2009, AM J EMERG MED, V27, P838, DOI 10.1016/j.ajem.2008.04.016	21	11	12	0	8	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757			AM J EMERG MED	Am. J. Emerg. Med.	MAR	2013	31	3					524	528		10.1016/j.ajem.2012.10.009			5	Emergency Medicine	Emergency Medicine	110SU	WOS:000316466800012	23380091				2021-06-18	
J	Anakwenze, OA; Namdari, S; Hsu, JE; Benham, J; Keenan, MA				Anakwenze, Oke A.; Namdari, Surena; Hsu, Jason E.; Benham, Joshua; Keenan, Mary Ann			Myotendinous lengthening of the elbow flexor muscles to improve active motion in patients with elbow spasticity following brain injury	JOURNAL OF SHOULDER AND ELBOW SURGERY			English	Article						Elbow spasticity; fractional lengthening; outcomes; upper motor neuron syndrome; flexor release; arc of motion	UPPER EXTREMITY; DYNAMIC ELECTROMYOGRAPHY; ORTHOPEDIC MANAGEMENT; FLEXION; DYSFUNCTION; DEFORMITY; STROKE	Background: The objective of this study was to evaluate the outcomes of a novel technique of fractional myotendinous lengthening of the elbow flexors in patients with volitional motor control and spastic elbow flexion deformities after brain injury. Methods: A retrospective review of 42 consecutive patients with spastic elbow flexion deformities and upper motor neuron (UMN) syndrome was performed. Each patient had volitional motor control but limited elbow extension and underwent myotendinous lengthening of the elbow flexor muscles. Outcome measures included pre and post-operative active and passive arc of motion, Modified Ashworth Scale (MAS) of spasticity, and complications. Results: There were 26 men and 16 women. The etiologies of UMN syndrome were stroke (30 patients), traumatic brain injury (11 patients), and cerebral palsy (1 patient). Average duration between injury and surgery was 6.6 years. At an average follow-up of 14 months, improvements were noted in active extension (42 degrees to 20 degrees; P < .001). In addition, active arc of motion increased from 77 degrees (range of motion [ROM]: 42 degrees to 119 degrees) to 113 degrees (ROM: 20 degrees to 133 degrees) (P < .001) and passive arc of motion increased from 103 degrees (ROM: 24 degrees-127 degrees ) to 131 degrees (ROM: 8 degrees-139 degrees) (P < .001). Significant improvement in MAS was also noted after surgery (2.7 to 1.9; P < .001). Superficial wound dehiscence occurred in 2 patients and was successfully treated nonoperatively. Conclusion: In patients with spastic elbow flexion deformities and active motor control, fractional myotendinous lengthening of the elbow flexors safely improves active extension and the overall arc of motion while affording immediate postoperative elbow motion. Level of evidence: Level IV, Case Series, Treatment Study. (C) 2013 Journal of Shoulder and Elbow Surgery Board of Trustees.	[Anakwenze, Oke A.; Namdari, Surena; Hsu, Jason E.; Keenan, Mary Ann] Univ Penn, Dept Orthopaed Surg, Philadelphia, PA 19102 USA; [Benham, Joshua] Univ Penn, Sch Med, Philadelphia, PA 19102 USA	Anakwenze, OA (corresponding author), Univ Penn, 3400 Spruce St, Philadelphia, PA 19102 USA.	oanakwenze@gmail.com	Keenan, Mary Ann/ABB-1551-2020				Barus D, 2006, J HAND THER, V19, P192, DOI 10.1197/j.jht.2006.02.012; Flowers K R, 1994, J Hand Ther, V7, P150; Francis HP, 2004, J NEUROL NEUROSUR PS, V75, P1547, DOI 10.1136/jnnp.2003.025551; GARLAND DE, 1980, J BONE JOINT SURG AM, V62, P108, DOI 10.2106/00004623-198062010-00016; KAPLAN PE, 1977, ARCH PHYS MED REHAB, V58, P415; Keenan MA, 1996, J HEAD TRAUMA REHAB, V11, P57, DOI 10.1097/00001199-199608000-00008; Keenan MA, 2003, ARCH PHYS MED REHAB, V84, P291, DOI 10.1053/apmr.2003.50099; Keenan MA, 2010, GREENS OPERATIVE HAN, P1173; Keenan MAE, 2004, J HEAD TRAUMA REHAB, V19, P143, DOI 10.1097/00001199-200403000-00006; KEENAN MAE, 1990, J HAND SURG-AM, V15A, P607, DOI 10.1016/S0363-5023(09)90023-5; KEENAN MAE, 1990, J HAND SURG-AM, V15A, P340, DOI 10.1016/0363-5023(90)90120-G; KEENAN MAE, 1990, J HEAD TRAUMA REHAB, V5, P13; KOZIN SH, 1993, CLIN ORTHOP RELAT R, P109; MCCLURE PW, 1994, PHYS THER, V74, P1101, DOI 10.1093/ptj/74.12.1101; MITAL MA, 1979, J BONE JOINT SURG AM, V61, P515, DOI 10.2106/00004623-197961040-00005; Namdari S, 2012, J SHOULDER ELB SURG, V21, P1357, DOI 10.1016/j.jse.2011.09.029; Namdari S, 2012, J SHOULDER ELB SURG, V21, P691, DOI 10.1016/j.jse.2011.03.026; Simpson DM, 1996, NEUROLOGY, V46, P1306, DOI 10.1212/WNL.46.5.1306; Tafti MA, 2008, J AM ACAD ORTHOP SUR, V16, P462, DOI 10.5435/00124635-200808000-00005	19	11	11	1	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	1058-2746			J SHOULDER ELB SURG	J. Shoulder Elbow Surg.	MAR	2013	22	3					318	322		10.1016/j.jse.2012.10.043			5	Orthopedics; Sport Sciences; Surgery	Orthopedics; Sport Sciences; Surgery	123UT	WOS:000317417400008	23352184				2021-06-18	
J	Audi, L; Fernandez-Cancio, M; Camats, N; Carrascosa, A				Audi, L.; Fernandez-Cancio, M.; Camats, N.; Carrascosa, A.			Growth hormone deficiency: an update	MINERVA ENDOCRINOLOGICA			English	Article						Growth hormone; Pituitary hormones; Phenotype	TRAUMATIC BRAIN-INJURY; ISOLATED GH DEFICIENCY; INSULIN TOLERANCE-TEST; BODY-MASS INDEX; IGF-I; ANTERIOR-PITUITARY; RECEPTOR GENE; DIFFERENT IMMUNOASSAYS; FUNCTIONAL-ANALYSIS; MOLECULAR ANALYSIS	Growth hormone (GH) deficiency (GHD) in humans manifests differently according to the individual developmental stage (early after birth, during childhood, at puberty or in adulthood), the cause or mechanism (genetic, acquired or idiopathic), deficiency intensity and whether it is the only pituitary-affected hormone or is combined with that of other pituitary hormones or forms part of a complex syndrome. Growing knowledge of the genetic basis of GH deficiency continues to provide us with useful information to further characterise mutation types and mechanisms for previously described and new candidate genes. Despite these advances, a high proportion of Gil deficiencies with no recognisable acquired basis continue to be labelled as idiopathic, although less frequently when they are congenital and/or familial. The clinical and biochemical diagnoses continue to be a conundrum despite efforts to harmonise biochemical assays for GH and IGF-1 analysis, probably because the diagnosis based on the so-called GH secretion stimulation tests will prove to be of limited usefulness for predicting therapy indications.	[Audi, L.; Camats, N.; Carrascosa, A.] Autonomous Univ Barcelona, CIBERER Ctr Biomed Res Rare Dis, Inst Salud Carlos III,Pediat Serv, Vall dHebron Hosp,Pediat Endocrinol Res Unit,VHIR, Barcelona, Spain	Audi, L (corresponding author), Autonomous Univ Barcelona, CIBERER Ctr Biomed Res Rare Dis, Inst Salud Carlos III,Pediat Serv, Vall dHebron Hosp,Pediat Endocrinol Res Unit,VHIR, Barcelona, Spain.	laura.audi@vhir.org		Camats Tarruella, Nuria/0000-0002-4863-8201; Fernandez Cancio, Monica/0000-0003-1872-3488			Acharya SV, 2011, INDIAN J PEDIATR, V78, P49, DOI 10.1007/s12098-010-0211-1; Ahmad T, 2011, GROWTH HORM IGF RES, V21, P37, DOI 10.1016/j.ghir.2010.12.003; Alatzoglou KS, 2012, INDIAN J PEDIATR, V79, P99, DOI 10.1007/s12098-011-0614-7; Alatzoglou KS, 2011, J CLIN ENDOCR METAB, V96, pE685, DOI 10.1210/jc.2010-1239; Alatzoglou KS, 2010, NAT REV ENDOCRINOL, V6, P562, DOI 10.1038/nrendo.2010.147; Alatzoglou KS, 2009, J CLIN ENDOCR METAB, V94, P3191, DOI 10.1210/jc.2008-2783; Appelman-Dijkstra NM, 2011, J CLIN ENDOCR METAB, V96, P2330, DOI 10.1210/jc.2011-0306; Audi L, 2001, MED CLIN-BARCELONA, V116, P6; Bechtold-Dalla Pozza S, 2012, HORM RES PAEDIAT, V77, P41, DOI 10.1159/000335929; Berberoglu Merih, 2008, J Clin Res Pediatr Endocrinol, V1, P30, DOI 10.4008/jcrpe.v1i1.7; Berg C, 2010, EXP CLIN ENDOCR DIAB, V118, P139, DOI 10.1055/s-0029-1225611; Berg C, 2010, EUR J ENDOCRINOL, V162, P477, DOI 10.1530/EJE-09-0824; Berton A, 2012, EUR J ENDOCRINOL; Bidlingmaier M, 2010, GROWTH HORM IGF RES, V20, P19, DOI 10.1016/j.ghir.2009.09.005; Bidlingmaier M, 2009, HORM RES, V71, P30, DOI 10.1159/000178034; Binder G, 2011, GROWTH HORM IGF RES, V21, P314, DOI 10.1016/j.ghir.2011.07.009; Binder G, 2011, GROWTH HORM IGF RES, V21, P212, DOI 10.1016/j.ghir.2011.05.007; Binder Gerhard, 2011, Pediatr Endocrinol Rev, V9 Suppl 1, P535; Bogazzi F, 2011, EUR J ENDOCRINOL, V164, P685, DOI 10.1530/EJE-10-1068; Brabant G, 2009, EUR J ENDOCRINOL, V161, pS25, DOI 10.1530/EJE-09-0273; Buscher AK, 2012, EUR J ENDOCRINOL, V166, P923, DOI 10.1530/EJE-11-0923; Camats N, 2012, CLIN ENDOCRINOL, V77, P564, DOI 10.1111/j.1365-2265.2012.04410.x; Carlomagno Y, 2009, J ENDOCRINOL INVEST, V32, P653, DOI 10.1007/BF03345736; Carrascosa A, 2011, HORM RES PAEDIAT, V75, P106, DOI 10.1159/000318782; Casanueva FF, 2009, HORM RES, V71, P112, DOI 10.1159/000178051; Clemmons DR, 2007, ENDOCRIN METAB CLIN, V36, P109, DOI 10.1016/j.ecl.2006.11.008; Clemmons DR, 2011, CLIN CHEM, V57, P555, DOI 10.1373/clinchem.2010.150631; Cody JD, 2010, J PEDIATR ENDOCR MET, V23, P1159, DOI 10.1515/jpem.2010.181; Colao A, 2009, J CLIN ENDOCR METAB, V94, P4414, DOI 10.1210/jc.2009-1134; Corneli G, 2008, J ENDOCRINOL INVEST, V31, P689, DOI 10.1007/BF03346416; Cruz JB, 2010, ARQ BRAS ENDOCRINOL, V54, P482, DOI 10.1590/S0004-27302010000500009; Cuatrecasas G, 2010, J CLIN ENDOCR METAB, V95, P4331, DOI 10.1210/jc.2010-0061; Dateki S, 2008, J CLIN ENDOCR METAB, V93, P3697, DOI 10.1210/jc.2008-0720; Dateki S, 2010, J CLIN ENDOCR METAB, V95, P756, DOI 10.1210/jc.2009-1334; De Bellis A, 2012, J CLIN ENDOCR METAB, V97, P3684, DOI 10.1210/jc.2012-2269; De Bellis A, 2011, CLIN ENDOCRINOL, V75, P361, DOI 10.1111/j.1365-2265.2011.04056.x; de Graaff LCG, 2009, CLIN ENDOCRINOL, V70, P742, DOI 10.1111/j.1365-2265.2008.03414.x; Del Blanco DG, 2012, EUR J ENDOCRINOL, V167, P441, DOI 10.1530/EJE-12-0333; Del Blanco DG, 2011, EUR J ENDOCRINOL, V165, P537, DOI 10.1530/EJE-11-0478; Delvecchio M, 2009, J ENDOCRINOL INVEST, V32, P637, DOI [10.1007/BF03345733, 10.3275/6332]; Desai MP, 2012, INDIAN J PEDIATR, V79, P875, DOI 10.1007/s12098-011-0588-5; Di Somma C, 2011, MINERVA ENDOCRINOL, V36, P243; Di Somma C, 2008, J Endocrinol Invest, V31, P21; Diaczok D, 2008, J CLIN ENDOCR METAB, V93, P4351, DOI 10.1210/jc.2008-1189; Domene HM, 2011, BEST PRACT RES CL EN, V25, P101, DOI 10.1016/j.beem.2010.08.010; Domene Horacio M, 2010, Pediatr Endocrinol Rev, V7, P339; Duche L, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-29; Eskes SA, 2009, NETH J MED, V67, P127; Esteban C, 2007, CLIN ENDOCRINOL, V66, P258, DOI 10.1111/j.1365-2265.2006.02718.x; Federico G, 2010, HORM RES PAEDIAT, V74, P145, DOI 10.1159/000314895; Fernandez-Rodriguez E, 2011, NEUROENDOCRINOLOGY, V93, P181, DOI 10.1159/000324087; Franca MM, 2011, J CLIN ENDOCR METAB, V96, pE1457, DOI 10.1210/jc.2011-0170; Franca MM, 2010, J CLIN ENDOCR METAB, V95, pE384, DOI 10.1210/jc.2010-1050; Franca MM, 2012, CLIN ENDOCRINOL OXF; Galluzzi F, 2010, J PEDIATR ENDOCR MET, V23, P1273, DOI 10.1515/jpem.2010.201; Gasco V, 2008, EUR J ENDOCRINOL, V159, pS45, DOI 10.1530/EJE-08-0293; Gat-Yablonski G, 2011, AM J MED GENET A, V155A, P2242, DOI 10.1002/ajmg.a.34136; Giacomozzi C, 2012, J ENDOCRINOL INVEST, V35, P742, DOI 10.3275/8008; Glynn N, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/972617; Godi M, 2009, J CLIN ENDOCR METAB, V94, P3939, DOI 10.1210/jc.2009-0833; Goldenberg N, 2007, ENDOCRIN METAB CLIN, V36, P37, DOI 10.1016/j.ecl.2006.11.003; Granada ML, 2008, CLIN ENDOCRINOL, V68, P942, DOI 10.1111/j.1365-2265.2007.03120.x; GRANADA ML, 1990, ACTA PAEDIATR SCAND, P63; Granada ML, 1990, ACTA PAEDIAT SC S370, V370, P71; Gucev Z, 2012, HORM RES PAEDIAT, V77, P1, DOI 10.1159/000334643; Gucev ZS, 2009, J GENET, V88, P239, DOI 10.1007/s12041-009-0033-y; Hamid R, 2009, J CLIN ENDOCR METAB, V94, P4728, DOI 10.1210/jc.2009-0746; Hazem A, 2011, EUR J ENDOCRINOL, V165, P841, DOI 10.1530/EJE-11-0476; Heather NL, 2012, J CLIN ENDOCR METAB, V97, P599, DOI 10.1210/jc.2011-2284; Hess O, 2012, J PEDIATR ENDOCR MET, V25, P537, DOI 10.1515/jpem-2012-0044; Idrees F, 2006, AM J MED GENET B, V141B, P184, DOI 10.1002/ajmg.b.30237; Inoue H, 2011, CLIN ENDOCRINOL, V74, P223, DOI 10.1111/j.1365-2265.2010.03911.x; Inoue H, 2011, J CLIN ENDOCR METAB, V96, pE373, DOI 10.1210/jc.2010-1570; Jagtap VS, 2012, PITUITARY, V15, P243, DOI 10.1007/s11102-011-0321-4; Janssen JAMJL, 2011, HORM RES PAEDIAT, V76, P106, DOI 10.1159/000329191; Kargi AY, 2012, CURR OPIN ENDOCRINOL, V19, P300, DOI 10.1097/MED.0b013e32835430da; Kayemba-Kay's S, 2011, ANN ENDOCRINOL-PARIS, V72, P218, DOI 10.1016/j.ando.2011.01.002; Kelberman D, 2009, CLIN ENDOCRINOL, V70, P96, DOI 10.1111/j.1365-2265.2008.03326.x; Kelberman D, 2006, J CLIN INVEST, V116, P2442, DOI 10.1172/JCI28658; Kelberman D, 2009, ENDOCR REV, V30, P790, DOI 10.1210/er.2009-0008; Kelberman D, 2009, ENDOCR DEV, V14, P67, DOI 10.1159/000207478; Khadr SN, 2010, CLIN ENDOCRINOL, V73, P637, DOI 10.1111/j.1365-2265.2010.03857.x; Kinoshita Y, 2012, ENDOCR J; Klose M, 2009, EUR J ENDOCRINOL, V161, pS75, DOI 10.1530/EJE-09-0328; Kokshoorn NE, 2011, EUR J ENDOCRINOL, V165, P225, DOI 10.1530/EJE-11-0365; Kokshoorn NE, 2010, EUR J ENDOCRINOL, V162, P11, DOI 10.1530/EJE-09-0601; Lee HS, 2011, NEUROENDOCRINOLOGY, V93, P259, DOI 10.1159/000326838; Lee PA, 2003, PEDIATRICS, V111, P1253, DOI 10.1542/peds.111.6.1253; Martari M, 2009, PROG MOL BIOL TRANSL, V88, P57, DOI 10.1016/S1877-1173(09)88003-4; Marui S, 2012, HORM RES PAEDIAT, V78, P165, DOI 10.1159/000342760; McMahon SK, 2010, J CLIN ENDOCR METAB, V95, P297, DOI 10.1210/jc.2009-1003; Meazza C, 2012, HORM METAB RES; Mehta A, 2009, CLIN ENDOCRINOL, V71, P376, DOI 10.1111/j.1365-2265.2009.03572.x; Mohamadi A, 2009, J CLIN ENDOCR METAB, V94, P2565, DOI 10.1210/jc.2009-0512; Molitch ME, 2011, J CLIN ENDOCR METAB, V96, P1587, DOI 10.1210/jc.2011-0179; Muller A, 2011, CLIN CHEM LAB MED, V49, P1135, DOI 10.1515/CCLM.2011.201; Mukherjee A, 2009, EUR J ENDOCRINOL, V161, pS33, DOI 10.1530/EJE-09-0247; Mulder RL, 2009, CANCER TREAT REV, V35, P616, DOI 10.1016/j.ctrv.2009.06.004; Mullis Primus E, 2010, J Clin Res Pediatr Endocrinol, V2, P52, DOI 10.4274/jcrpe.v2i2.52; Murray PG, 2009, CLIN ENDOCRINOL, V71, P215, DOI 10.1111/j.1365-2265.2009.03554.x; Nakagama Y, 2012, ACTA PAEDIATR, V101, pe259, DOI 10.1111/j.1651-2227.2012.02606.x; Nystrom HF, 2011, PITUITARY, V14, P208, DOI 10.1007/s11102-010-0278-8; Oliveira CRP, 2012, J CLIN ENDOCR METAB, V97, P1013, DOI 10.1210/jc.2011-2590; Padidela R, 2009, J CLIN ENDOCR METAB, V94, P2686, DOI 10.1210/jc.2008-2788; Pantel J, 2009, J CLIN ENDOCR METAB, V94, P4334, DOI 10.1210/jc.2009-1327; Pedicelli Stefania, 2009, J Clin Res Pediatr Endocrinol, V1, P105, DOI 10.4008/jcrpe.v1i3.53; Pellecchia MT, 2010, EUR J NEUROL, V17, P666, DOI 10.1111/j.1468-1331.2009.02896.x; Petkovic V, 2011, GROWTH HORM IGF RES, V21, P160, DOI 10.1016/j.ghir.2011.04.002; Petkovic V, 2010, J CLIN ENDOCR METAB, V95, P731, DOI 10.1210/jc.2009-1247; Pfaeffle RW, 2008, J CLIN ENDOCR METAB, V93, P1062, DOI 10.1210/jc.2007-1525; Pfaffle Roland, 2011, Pediatr Endocrinol Rev, V9 Suppl 1, P529; Rohrer TR, 2009, J ENDOCRINOL INVEST, V32, P294, DOI 10.1007/BF03345714; Ronchi CL, 2009, EUR J ENDOCRINOL, V161, P37, DOI 10.1530/EJE-09-0222; Sara M, 2011, RADIOTHER ONCOL, V99, P23, DOI 10.1016/j.radonc.2011.02.015; Saveanu A, 2012, PITUITARY; Secco A, 2009, J CLIN ENDOCR METAB, V94, P4195, DOI 10.1210/jc.2009-0602; Shohreh R, 2011, J CLIN ENDOCR METAB, V96, P2982, DOI 10.1210/jc.2011-1031; Siklar Zeynep, 2010, J Clin Res Pediatr Endocrinol, V2, P164, DOI 10.4274/jcrpe.v2i4.164; Spiliotis BE, 2009, HORM-INT J ENDOCRINO, V8, P117, DOI 10.14310/horm.2002.1228; Stanley TL, 2009, J CLIN ENDOCR METAB, V94, P4875, DOI 10.1210/jc.2009-1369; Tajima T, 2009, J CLIN ENDOCR METAB, V94, P314, DOI 10.1210/jc.2008-1219; Tanimoto K, 2011, ENDOCR J, V58, P193, DOI 10.1507/endocrj.K10E-405; Tanriverdi F, 2012, CLIN ENDOCRINOL OXF; Tenenbaum-Rakover Y, 2011, CLIN ENDOCRINOL, V75, P214, DOI 10.1111/j.1365-2265.2011.04028.x; Toogood A, 2012, ENDOCR PRACT, V18, P325, DOI 10.4158/EP11146.OR; Turton JP, 2012, CLIN ENDOCRINOL, V76, P387, DOI 10.1111/j.1365-2265.2011.04236.x; Tzanela M, 2010, EUR J ENDOCRINOL, V162, P29, DOI 10.1530/EJE-09-0390; van Vught AJAH, 2009, J PEDIATR ENDOCR MET, V22, P679; Varewijck AJ, 2011, J CLIN ENDOCR METAB, V96, P2248, DOI 10.1210/jc.2011-0051; Veldhuis JD, 2012, METHOD ENZYMOL, V514, P231, DOI 10.1016/B978-0-12-381272-8.00014-3; Verhelst J, 2011, EUR J ENDOCRINOL, V165, P881, DOI 10.1530/EJE-11-0599; Vivenza D, 2011, EUR J ENDOCRINOL, V164, P705, DOI 10.1530/EJE-11-0047; Wang Q, 2009, MOL CELL ENDOCRINOL, V313, P50, DOI 10.1016/j.mce.2009.08.021; Wit JM, 2011, BEST PRACT RES CL EN, V25, P1, DOI 10.1016/j.beem.2010.06.007; Wit Jan M, 2008, Pediatr Endocrinol Rev, V5 Suppl 3, P862; Yamada S, 2011, EUR J ENDOCRINOL, V165, P873, DOI 10.1530/EJE-11-0657; Yamamoto M, 2012, EXP CLIN ENDOCR DIAB, V120, P308, DOI 10.1055/s-0032-1309011; Yamamoto M, 2011, J CLIN INVEST, V121, P113, DOI 10.1172/JCI44073; Yuen Kevin C J, 2011, ISRN Endocrinol, V2011, P608056, DOI 10.5402/2011/608056; Yuen KCJ, 2009, J CLIN ENDOCR METAB, V94, P2702, DOI 10.1210/jc.2009-0299; Zueger T, 2011, EUR J ENDOCRINOL, V165, P723, DOI 10.1530/EJE-11-0539	141	11	13	0	10	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0391-1977	1827-1634		MINERVA ENDOCRINOL	Minerva Endocrinol.	MAR	2013	38	1					1	16					16	Endocrinology & Metabolism	Endocrinology & Metabolism	127NF	WOS:000317705000001	23435439				2021-06-18	
J	Cho, HK; Jang, SH; Lee, E; Kim, SY; Kim, S; Kwon, YH; Son, SM				Cho, H. K.; Jang, S. H.; Lee, E.; Kim, S. Y.; Kim, S.; Kwon, Y. H.; Son, S. M.			Diffusion Tensor Imaging-Demonstrated Differences between Hemiplegic and Diplegic Cerebral Palsy with Symmetric Periventricular Leukomalacia	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article							GROSS MOTOR FUNCTION; TRAUMATIC BRAIN-INJURY; PRETERM INFANTS; FIBER TRACTOGRAPHY; CHILDREN; LESIONS; MRI; ABNORMALITIES; RELIABILITY; ULTRASOUND	BACKGROUND AND PURPOSE: Patients with cerebral palsy have variable clinical presentations such as hemiplegic, diplegic, or quadriplegic patterns though they have PVL on conventional MR images. The authors investigated whether DTT can differentiate between hemiplegic and diplegic CP in patients presenting with symmetric PVL on conventional MR images. MATERIALS AND METHODS: One hundred thirteen consecutive pediatric patients with definite hemiplegic (59 patients; 30 boys, 29 girls; mean age, 34.19 months; range, 24-52 months) or diplegic (54 patients; 27 boys, 27 girls; mean age, 31.07 months; range, 24-48 months) symptoms and bilateral symmetric PVL on conventional brain MR imaging were recruited. The states of CSTs were examined by using DTT, and the asymmetries of right and left CSTs in the hemiplegic and diplegic groups were compared by using asymmetric anisotropy indexes and asymmetric mean diffusivity indexes. RESULTS: All patients in the hemiplegic group with asymmetric results exhibited disrupted integrities of more affected CSTs and sparing of less affected CSTs. However, diplegic patients revealed symmetric disrupted findings of the right and left CSTs at the upper periventricular level. Asymmetric anisotropy index and asymmetric mean diffusivity index values were significantly higher in the hemiplegic group than in the diplegic group (P < .05), and these results of DTT significantly corresponded with their typical clinical manifestation. CONCLUSIONS: DTT may be very useful for the detailed estimation of the CST state in patients with bilateral symmetric PVL.	[Cho, H. K.; Jang, S. H.; Son, S. M.] Yeungnam Univ, Coll Med, Coll Sci & Technol, Dept Phys Med & Rehabil, Taegu 705717, South Korea; [Lee, E.; Kim, S.] Yeungnam Univ, Coll Med, Coll Sci & Technol, Dept Pediat, Taegu 705717, South Korea; [Kwon, Y. H.] Yeungnam Univ, Coll Med, Coll Sci & Technol, Dept Phys Therapy, Taegu 705717, South Korea; [Kim, S. Y.] Eulji Univ, Coll Med, Dept Pediat, Taejon, South Korea	Son, SM (corresponding author), Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyungdong, Taegu 705717, South Korea.	sumin430@hanmail.net		Kim, Seung Yeon/0000-0002-7004-4821	Basic Science Research Program through the National Research Foundation of Korea; Ministry of Education, Science and TechnologyMinistry of Education, Science and Technology, Republic of Korea [2011-0003426]	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (2011-0003426).	Argyropoulou MI, 2010, PEDIATR RADIOL, V40, P811, DOI 10.1007/s00247-010-1585-y; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; Benedict RE, 2011, PAEDIATR PERINAT EP, V25, P88, DOI 10.1111/j.1365-3016.2010.01164.x; Chang MC, 2012, NEUROSCI LETT, V512, P53, DOI 10.1016/j.neulet.2012.01.065; Fan GG, 2006, CLIN RADIOL, V61, P358, DOI 10.1016/j.crad.2006.01.001; Faria AV, 2010, DEV MED CHILD NEUROL, V52, P887, DOI 10.1111/j.1469-8749.2010.03693.x; Folkerth RD, 2006, PEDIATR DEVEL PATHOL, V9, P3, DOI 10.2350/06-01-0024.1; Glenn OA, 2003, J MAGN RESON IMAGING, V18, P641, DOI 10.1002/jmri.10420; Hoon AH, 2009, DEV MED CHILD NEUROL, V51, P697, DOI 10.1111/j.1469-8749.2009.03306.x; Jang SH, 2008, ANN NEUROL, V64, P460, DOI 10.1002/ana.21444; Jinnou H, 2009, PEDIATR INT, V51, P780, DOI 10.1111/j.1442-200X.2009.02857.x; Kakita H, 2009, BRAIN DEV-JPN, V31, P641, DOI 10.1016/j.braindev.2008.10.008; KUBAN KCK, 1994, NEW ENGL J MED, V330, P188, DOI 10.1056/NEJM199401203300308; Kunimatsu Akira, 2004, Magn Reson Med Sci, V3, P11, DOI 10.2463/mrms.3.11; Le TH, 2005, NEUROSURGERY, V56, P189, DOI 10.1227/01.NEU.0000144846.00569.3A; Lee JD, 2011, BRAIN, V134, P1199, DOI 10.1093/brain/awr021; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Nagae LM, 2007, AM J NEURORADIOL, V28, P1213, DOI 10.3174/ajnr.A0534; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; Nanba Y, 2007, PEDIATRICS, V120, pE10, DOI 10.1542/peds.2006-1844; Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x; Palisano RJ, 2000, PHYS THER, V80, P974, DOI 10.1093/ptj/80.10.974; Rha DW, 2012, NEURORADIOLOGY, V54, P615, DOI 10.1007/s00234-011-0996-2; Roelants-van Rijn AM, 2001, NEUROPEDIATRICS, V32, P80, DOI 10.1055/s-2001-13875; Son SM, 2007, NEUROSCI LETT, V420, P34, DOI 10.1016/j.neulet.2007.04.054; Son SM, 2009, NEUROSCI LETT, V451, P94, DOI 10.1016/j.neulet.2008.12.033; STEWART AL, 1987, DEV MED CHILD NEUROL, V29, P3; Thomas B, 2005, BRAIN, V128, P2562, DOI 10.1093/brain/awh600; Tzarouchi LC, 2009, PEDIATR RADIOL, V39, P1327, DOI 10.1007/s00247-009-1389-0; van Haastert IC, 2008, DEV MED CHILD NEUROL, V50, P684, DOI 10.1111/j.1469-8749.2008.03061.x; Wahl M, 2010, PEDIATR RADIOL, V40, P59, DOI 10.1007/s00247-009-1448-6; Wilson-Costello D, 1998, PEDIATRICS, V102, P315, DOI 10.1542/peds.102.2.315	33	11	14	0	3	AMER SOC NEURORADIOLOGY	DENVILLE	PO BOX 3000, DENVILLE, NJ 07834-9349 USA	0195-6108	1936-959X		AM J NEURORADIOL	Am. J. Neuroradiol.	MAR	2013	34	3					650	654		10.3174/ajnr.A3272			5	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	291RN	WOS:000329846900033	22976239	Green Published, Other Gold			2021-06-18	
J	Dambinova, SA; Shikuev, AV; Weissman, JD; Mullins, JD				Dambinova, Svetlana A.; Shikuev, Alexey V.; Weissman, Joseph D.; Mullins, John D.			AMPAR Peptide Values in Blood of Nonathletes and Club Sport Athletes With Concussions	MILITARY MEDICINE			English	Article								Objectives: alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) peptide, a product of the proteolytic degradation of AMPA receptors in healthy nonathletes and athletes with concussions, is assessed. The detection of AMPAR peptide in conjunction with neuropsychological testing and neuroimaging is undertaken. Subjects: Persons (n = 124, 19-23 years) are enrolled in the pilot-blinded study according to approved Institutional Review Board protocols at Kennesaw State University and DeKalb Medical. Methods: AMPAR peptide plasma assay was performed using magnetic particles-enzyme-linked immunosorbent assay. All participants had neurocognitive tests (ImPACT); selected subjects with concussions were followed-up with magnetic resonance imaging and neurologic consultations. Results: Athletes (n = 33) with clinically defined single or multiple concussions were compared to 91 age and gender matched controls without a history of concussion. AMPAR peptide values of 0.05-0.40 ng/mL for controls and 1.0-8.5 ng/mL for concussions are found. The biomarker sensitivity of 91% and a specificity of 92% (0.4 ng/mL cut off) to assess concussions are calculated. Poorer ImPACT scores correlated with abnormal levels of the biomarker. In athletes with multiple concussions, increased AMPAR peptide values (2.0-12.0 ng/mL) were associated with minor findings on magnetic resonance imaging. Conclusion: AMPAR peptide assay combined with ImPACT and neuroimaging is a promising tool for assessment of concussions. Additional clinical validation studies are required.	[Dambinova, Svetlana A.; Shikuev, Alexey V.] Kennesaw State Univ, WellStar Coll Hlth & Human Serv, Kennesaw, GA 30144 USA; [Weissman, Joseph D.] DeKalb Med, Decatur, GA 30033 USA; [Mullins, John D.] Headquarters Georgia Natl Guards SAS, Atlanta, GA 30309 USA	Dambinova, SA (corresponding author), Kennesaw State Univ, WellStar Coll Hlth & Human Serv, 1000 Chastain Rd,MD 4101,HS,Bldg 41,4211, Kennesaw, GA 30144 USA.		Dambinova, Svetlana A/G-1724-2017	Dambinova, Svetlana A/0000-0003-4411-5726	KSU Foundation; U.S. Army Medical Research and Materiel Command grantU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-11-2-0081]	The study was partly supported by KSU Foundation and U.S. Army Medical Research and Materiel Command grant no. W81XWH-11-2-0081.	Beneyto M, 2004, J COMP NEUROL, V468, P530, DOI 10.1002/cne.10981; Bergles DE, 2010, BRAIN RES REV, V63, P130, DOI 10.1016/j.brainresrev.2009.12.003; Dambinova SA, 2007, IVD TECHNOLOGY, V3, P3; Dambinova SA, 2012, RSC DRUG DISCOV, V24, P66, DOI 10.1039/9781849734745-00066; Enders J, 2011, BMC MED IMAGING, V11, DOI 10.1186/1471-2342-11-4; Eng J, 2012, ROC ANAL JROCFIT COM; Faul M, 2006, TRAUMATIC BRAIN INJU; Gill S, 2010, EXCITATORY TRANSMISS, P3; Hammond JC, 2010, NEUROPSYCHOPHARMACOL, V35, P2110, DOI 10.1038/npp.2010.87; Inglese M, 2006, BRAIN INJURY, V20, P15, DOI 10.1080/02699050500309593; Klinke T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031766; Lai MZ, 2009, ANN NEUROL, V65, P424, DOI 10.1002/ana.21589; Lau BC, 2012, NEUROSURGERY, V70, P371, DOI 10.1227/NEU.0b013e31823150f0; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Shrey DW, 2011, PHYS MED REH CLIN N, V22, P577, DOI 10.1016/j.pmr.2011.08.002; Siuda Edward R., 2007, V403, P37, DOI 10.1007/978-1-59745-529-9_3; Smith GB, 2009, PHILOS T R SOC B, V364, P357, DOI 10.1098/rstb.2008.0198; Zhou WG, 2008, J NEUROSCI, V28, P10220, DOI 10.1523/JNEUROSCI.3434-08.2008	19	11	11	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	MAR	2013	178	3					285	290		10.7205/MILMED-D-12-00368			6	Medicine, General & Internal	General & Internal Medicine	AN7TX	WOS:000340805000009	23707115	Bronze			2021-06-18	
J	Frisina, PG; Kutlik, AM; Barrett, AM				Frisina, Pasquale G.; Kutlik, Ann M.; Barrett, Anna M.			Left-Sided Brain Injury Associated With More Hospital-Acquired Infections During Inpatient Rehabilitation	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain; Infection; Injuries; Rehabilitation	TOLL-LIKE RECEPTORS; IMMUNE-RESPONSE; STIMULATION; PROBIOTICS; RISK; LATERALIZATION; MODULATION; NEOCORTEX	Objective: To test the hypothesis that a left-dominant brain immune network (LD-BIN) might affect the occurrence of infection during inpatient rehabilitation of stroke and traumatic brain injury (TBI). Design: A retrospective analysis was performed on electronic medical records between January 2009 and December 2010. All patients with left-or right-sided stroke or TBI were included into the study. The LD-BIN hypothesis was tested by comparing HAI rates depending on whether patients had left- or right-sided brain lesions. Setting: A large inpatient rehabilitation hospital. Participants: Among the patients (N=2236) with stroke or TBI who had either a left- or right-sided brain lesion, 163 patients were identified with HAIs. Intervention: Not applicable. Main Outcome Measure: Frequency of HAIs. Results: In the 163 patients identified with HAIs with a diagnosis of stroke or TBI, chi-square analysis revealed a significantly higher proportion of HAls among patients with left-sided (n=98; 60.1%) relative to right-sided (n=65; 39.9%) brain injuries (chi(2)=6.68, P<.01). These effects could not be attributed to either clinical or demographic factors. Conclusions: Our findings are consistent with the hypothesis that an LD-BIN may mediate vulnerability to infection during rehabilitation of patients with stroke or TBI. Further translational research investigating novel means of managing patients based on brain lesion location, and modulating the LD-BIN via behavioral and physiologic interventions, may result in neuroscience-based methods to improve infection resistance in brain-injured patients. Archives of Physical Medicine and Rehabilitation 2013;94:516-21 (C) 2013 by the American Congress of Rehabilitation Medicine	[Frisina, Pasquale G.; Kutlik, Ann M.; Barrett, Anna M.] Kessler Inst Rehabil, W Orange, NJ 07052 USA; [Barrett, Anna M.] Kessler Fdn Res Ctr, W Orange, NJ USA; [Barrett, Anna M.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Phys Med & Rehabil, Newark, NJ 07103 USA	Frisina, PG (corresponding author), Kessler Inst Rehabil, 1199 Pleasant Valley Way, W Orange, NJ 07052 USA.	pfrisina@kessler-rehab.com		Barrett, A.M./0000-0002-0789-2887	Kessler Foundation; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS055808, K24HD062647]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K24HD062647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS055808] Funding Source: NIH RePORTER	Supported by the Kessler Foundation and the National Institutes of Health (grant nos. R01NS055808, K24HD062647).	American Medical Association, 2008, INT CLASS DIS 9 REV; BARDOS P, 1981, SCAND J IMMUNOL, V13, P609, DOI 10.1111/j.1365-3083.1981.tb00176.x; BARNEOUD P, 1987, PHYSIOL BEHAV, V41, P525, DOI 10.1016/0031-9384(87)90306-4; Brandl K, 2008, NATURE, V455, P804, DOI 10.1038/nature07250; Czlonkowska A, 1988, Ann N Y Acad Sci, V540, P608, DOI 10.1111/j.1749-6632.1988.tb27188.x; Dial S, 2004, CAN MED ASSOC J, V171, P33, DOI 10.1503/cmaj.1040876; Dial S, 2005, JAMA-J AM MED ASSOC, V294, P2984; Diamond MC, 2001, COGNITIVE BRAIN RES, V12, P329, DOI 10.1016/S0926-6410(01)00059-3; Dziedzic T, 2004, CRIT CARE, V8, P266, DOI 10.1186/cc2828; Fassbender K, 1997, J LAB CLIN MED, V130, P535, DOI 10.1016/S0022-2143(97)90131-1; Galletta EE, 2011, TOP STROKE REHABIL, V18, P87, DOI 10.1310/tsr1802-87; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Goldin BR, 2008, CLIN INFECT DIS, V46, pS96, DOI 10.1086/523333; Griffin GD, 2011, MIL MED, V176, P364, DOI 10.7205/MILMED-D-10-00021; Gruzelier J, 1996, INT J PSYCHOPHYSIOL, V23, P215, DOI 10.1016/S0167-8760(96)00064-5; Hamilton B., 1987, REHABILITATION OUTCO; Harris AD, 2007, EMERG INFECT DIS, V13, P1144, DOI 10.3201/eid1308.070071; HELLING TS, 1988, J TRAUMA, V28, P1575, DOI 10.1097/00005373-198811000-00009; Hilker R, 2003, STROKE, V34, P975, DOI 10.1161/01.STR.0000063373.70993.CD; Hopkins PA, 2005, CLIN EXP IMMUNOL, V140, P395, DOI 10.1111/j.1365-2249.2005.02801.x; Iyer MB, 2005, NEUROLOGY, V64, P872, DOI 10.1212/01.WNL.0000152986.07469.E9; Jarchum I, 2011, INFECT IMMUN, V79, P1498, DOI 10.1128/IAI.01196-10; Kim AS, 2011, J CLIN GASTROENTEROL, V45, P844, DOI 10.1097/MCG.0b013e31823336cd; Kinnebrew MA, 2010, J INFECT DIS, V201, P534, DOI 10.1086/650203; Koch G, 2012, NEUROLOGY, V78, P24, DOI 10.1212/WNL.0b013e31823ed08f; Koch HJ, 2006, NEUROIMMUNOMODULAT, V13, P8, DOI 10.1159/000092108; Lan JG, 2005, WORLD J GASTROENTERO, V11, P3375, DOI 10.3748/wjg.v11.i22.3375; Meador KJ, 2004, ANN NEUROL, V55, P840, DOI 10.1002/ana.20105; Minnerup J, 2010, J NEUROL NEUROSUR PS, V81, P198, DOI 10.1136/jnnp.2009.182394; Mylotte JM, 2000, CLIN INFECT DIS, V30, P425, DOI 10.1086/313708; NEVEU PJ, 1989, J NEUROSCI RES, V22, P188, DOI 10.1002/jnr.490220212; Pochapin M, 2000, AM J GASTROENTEROL, V95, pS11, DOI 10.1016/S0002-9270(99)00809-6; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; RENOUX G, 1983, J NEUROIMMUNOL, V5, P227, DOI 10.1016/0165-5728(83)90043-7; Rosenkranz MA, 2003, P NATL ACAD SCI USA, V100, P11148, DOI 10.1073/pnas.1534743100; Sumner RC, 2011, J NEUROIMMUNOL, V240, P1, DOI 10.1016/j.jneuroim.2011.08.017; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Vlajkovic S, 1994, Int J Neurosci, V78, P123	38	11	12	0	8	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAR	2013	94	3					516	521		10.1016/j.apmr.2012.10.012			6	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	106PZ	WOS:000316158500016	23123439	Green Accepted			2021-06-18	
J	Fritz, NE; Basso, DM				Fritz, Nora E.; Basso, D. Michele			Dual-Task Training for Balance and Mobility in a Person With Severe Traumatic Brain Injury: A Case Study	JOURNAL OF NEUROLOGIC PHYSICAL THERAPY			English	Article						balance; divided attention; dual-task; dual-task training; gait speed; severe traumatic brain injury; Walking While Talking Test (WWTT)	DIVIDED ATTENTION; WALKING SPEED; REHABILITATION; GAIT; RELIABILITY; PERFORMANCE; PREDICTION; STABILITY; VALIDITY; PROGRAM	Background and Purpose: Attentional impairments following severe traumatic brain injury (TBI) are common and can lead to decreased functional mobility and balance, as well as deficits in previously automatic movements such as walking and stair climbing. The purpose of this case study was to determine the feasibility and potential value of incorporating a cognitive-motor dual-task training program into physical therapy for a patient with a severe TBI. Case Description: The patient was a 26-year-old woman who sustained a severe TBI during a motor vehicle accident 46 days prior to physical therapy evaluation. On the 8-level Rancho Los Amigos Cognitive Function Scale, her functioning was classified as level IV. She had impairments in attention, functional mobility, and balance, all of which limited her ability to participate in activities of daily living. Intervention: Physical therapy was provided over 26 days within the inpatient rehabilitation setting. Interventions included mobility tasks such as walking, balancing, and stair climbing. Mobility training was paired with specific secondary cognitive and motor tasks. Outcomes: Dual-task trainingmay have contributed to improvements on outcome measures designed to test divided attention including the Walking While Talking Test and Trail Making Test and a greater rate of improvement in walking speed and time to descend stairs when compared to the baseline phase. Discussion: Addition of cognitive-motor dual-task training to standard physical therapy in the inpatient rehabilitation setting appears to be feasible and may have value for improving function in individuals with severe TBI.	[Fritz, Nora E.; Basso, D. Michele] Ohio State Univ, Sch Hlth & Rehabil Sci, Columbus, OH 43210 USA	Fritz, NE (corresponding author), Ohio State Univ, Sch Hlth & Rehabil Sci, 453 W 10th Ave, Columbus, OH 43210 USA.	nora.fritz@osumc.edu	Fritz, Nora/ABG-6696-2020; Basso, Michele/B-3817-2011		Florence P. Kendall Doctoral Scholarship from the Foundation for Physical Therapy; Dodd Hall Inpatient Rehabilitation Hospital	This research was supported in part by a Florence P. Kendall Doctoral Scholarship from the Foundation for Physical Therapy.; We thank Sara Rismiller, MPT, NCS, for her mentorship and assistance in data collection, Dr Meredith Wilhelm for her thoughtful manuscript edits, and all of the providers on the traumatic brain injury service at Dodd Hall Inpatient Rehabilitation Hospital for their support.	Azouvi P, 2004, NEUROPSYCHOLOGIA, V42, P1260, DOI 10.1016/j.neuropsychologia.2004.01.001; Bogner JA, 2001, AM J PHYS MED REHAB, V80, P636, DOI 10.1097/00002060-200109000-00002; Chua KSG, 2007, ANN ACAD MED SINGAP, V36, P31; Couillet J, 2010, NEUROPSYCHOL REHABIL, V20, P321, DOI 10.1080/09602010903467746; Crowe SF, 1998, J CLIN PSYCHOL, V54, P585, DOI 10.1002/(SICI)1097-4679(199808)54:5<585::AID-JCLP4>3.0.CO;2-K; Cusick CP, 2000, J HEAD TRAUMA REHAB, V15, P739, DOI 10.1097/00001199-200002000-00012; de Guise E, 2006, J HEAD TRAUMA REHAB, V21, P527, DOI 10.1097/00001199-200611000-00007; Fritz S, 2009, J GERIATR PHYS THER, V32, P2, DOI 10.1519/00139143-200932020-00002; Gentile A. M., 1987, MOVEMENT SCI FDN PHY; Hamilton F, 2009, MULT SCLER J, V15, P1215, DOI 10.1177/1352458509106712; Hart T, 2006, ARCH PHYS MED REHAB, V87, P647, DOI 10.1016/j.apmr.2006.01.016; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; Katz DI, 2004, ARCH PHYS MED REHAB, V85, P865, DOI 10.1016/j.apmr.2003.11.020; Kim E, 2006, J NEUROPSYCH CLIN N, V18, P547, DOI 10.1176/appi.neuropsych.18.4.547; Kraus MF, 2007, TRAUMATIC BRAIN INJU; Lange RT, 2005, J CLIN EXP NEUROPSYC, V27, P897, DOI 10.1080/1380339049091290; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Mateer CA, 1996, J LEARN DISABIL, V29, P618, DOI 10.1177/002221949602900606; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; McCulloch Karen, 2007, J Neurol Phys Ther, V31, P104; McDowd Joan M, 2007, J Neurol Phys Ther, V31, P98; Medley A, 2006, BRAIN INJURY, V20, P1403, DOI 10.1080/02699050601082057; Meythaler JM, 2001, BRAIN INJURY, V15, P321, DOI 10.1080/026990501750111274; Moseley AM, 2004, J HEAD TRAUMA REHAB, V19, P341, DOI 10.1097/00001199-200407000-00008; Mossberg KA, 2008, PHYS THER, V88, P77, DOI 10.2522/ptj.20070022; Mysiw WJ, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199612000-00003; Newstead Ann H, 2005, J Neurol Phys Ther, V29, P18; Parker TM, 2005, CLIN BIOMECH, V20, P389, DOI 10.1016/j.clinbiomech.2004.12.004; Pellecchia GL, 2005, J MOTOR BEHAV, V37, P239, DOI 10.3200/JMBR.37.3.239-246; Rabago CA, 2011, J NEUROL PHYS THER, V35, P185, DOI 10.1097/NPT.0b013e318235d7e6; Rancho Los Amigos National Rehabilitation Center, FAM GUID RANCH LEV C; Roskell C, 1998, PHYSIOTHERAPY, V84, P118, DOI DOI 10.1016/S0031-9406(05)66508-X; SANEDA D L, 1992, Brain Injury, V6, P167, DOI 10.3109/02699059209029655; Silsupadol P, 2009, ARCH PHYS MED REHAB, V90, P381, DOI 10.1016/j.apmr.2008.09.559; Soukup V M, 1998, Appl Neuropsychol, V5, P65, DOI 10.1207/s15324826an0502_2; Tilson JK, 2010, PHYS THER, V90, P196, DOI 10.2522/ptj.20090079; Vallat-Azouvi C, 2009, BRAIN INJURY, V23, P585, DOI 10.1080/02699050902970711; Vallee M, 2006, ARCH PHYS MED REHAB, V87, P806, DOI 10.1016/j.apmr.2006.02.031; Van Loo MA, 2004, BRAIN INJURY, V18, P1041, DOI 10.1080/02699050410001672314; Verghese J, 2002, J AM GERIATR SOC, V50, P1572, DOI 10.1046/j.1532-5415.2002.50415.x; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4; Yang YR, 2007, ARCH PHYS MED REHAB, V88, P1236, DOI 10.1016/j.apmr.2007.06.762; Yogev-Seligmann G, 2008, MOVEMENT DISORD, V23, P329, DOI 10.1002/mds.21720; Yogev-Seligmann G, 2012, ARCH PHYS MED REHAB, V93, P176, DOI 10.1016/j.apmr.2011.06.005	45	11	11	0	28	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1557-0576	1557-0584		J NEUROL PHYS THER	J. Neurol. Phys. Ther.	MAR	2013	37	1					37	43		10.1097/NPT.0b013e318282a20d			7	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	107LA	WOS:000316217200007	23364169				2021-06-18	
